FN Thomson Reuters Web of Science™
VR 1.0
PT J
AU Montoliu-Gaya, L
   Villegas, S
AF Montoliu-Gaya, Laia
   Villegas, Sandra
TI Protein structures in Alzheimer's disease: The basis for rationale
   therapeutic design
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Alzheimer's disease; Protein structures; Therapies' rational design
ID AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE ACTIVITY; BETA-PEPTIDE
   PRODUCTION; APOLIPOPROTEIN-E; A-BETA; LIPOPROTEIN RECEPTORS;
   ALPHA-SECRETASE; INTRACELLULAR DOMAIN; CASCADE HYPOTHESIS; TERMINAL
   FRAGMENT
AB Alzheimer's disease (AD) is a neurodegenerative disorder that affects memory, behavior, thinking and emotion. Current therapies to treat AD patients are only capable for temporarily slowing-down the cognitive decline, as they are focused on ameliorating symptoms instead of targeting its underlying causes. The aim of this review is to describe what is known about the protein structures implicated in AD pathogenesis, amyloid cascade members, as well as those structures involved in A beta clearance. Thus, structural information available for APP, alpha-beta- and gamma-secretases, CTF beta and derived All peptides, AICDs, apoE and apoJ, LRP-1 and RAGE, and neprilysin and insulin-degrading enzyme is provided. The recently solved structure for the gamma-secretase complex opens the rational design of a new generation of inhibitors, whereas that for All oligomers offers a putative mechanism explaining why monoclonal antibodies targeted to the N-terminus are effective. Then, an overview on therapies targeting some of these molecules presents their benefits and drawbacks. As a general conclusion our knowledge on the protein structures involved in AD has recently substantially advanced, allowing for the rational design of different therapeutic approaches. Hopefully, we are getting closer to finding a strong disease-modifying drug to cure this devastating disease. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Montoliu-Gaya, Laia; Villegas, Sandra] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Prot Folding & Stabil Grp, E-08193 Barcelona, Spain.
RP Villegas, S (reprint author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Prot Folding & Stabil Grp, E-08193 Barcelona, Spain.
EM sandra.villegas@uab.cat
FU Instituto de Salud Carlos III [FIS-PI113-01330]; Generalitat de
   Catalunya [SGR-GRC-2014-00885]; Generalitat de Catalunya/FEDER
   [2014-PROD00032]; PIF-UAB [406-01-3/2012-2]
FX Instituto de Salud Carlos III [FIS-PI113-01330], Generalitat de
   Catalunya [SGR-GRC-2014-00885] & Generalitat de Catalunya/FEDER
   [2014-PROD00032]. PIF-UAB student grant 406-01-3/2012-2 (LMG).
CR Agostinho P, 2015, J ALZHEIMERS DIS, V45, P329, DOI 10.3233/JAD-142730
   Alzheimer's Disease International, 2014, WORLD ALZH REP 2014
   De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8
   Cappai R, 2014, J NEUROCHEM, V130, P325, DOI 10.1111/jnc.12707
   Nicolas M, 2014, DEVELOPMENT, V141, P2543, DOI 10.1242/dev.108712
   Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019
   Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200
   Villegas S, 2015, MED CLIN-BARCELONA, V145, P76, DOI 10.1016/j.medcli.2014.05.023
   Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571
   Wang H, 2014, TRENDS ENDOCRIN MET, V25, P8, DOI 10.1016/j.tem.2013.10.003
   McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M
   Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590
   Leeb C, 2014, J BIOL CHEM, V289, P4161, DOI 10.1074/jbc.M113.529271
   Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007
   Bai XC, 2015, NATURE, V525, P212, DOI 10.1038/nature14892
   Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810
   Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191
   Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889
   Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035
   DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299
   Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390
   Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610
   Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623
   Morley JE, 2014, BIOCHEM PHARMACOL, V88, P479, DOI 10.1016/j.bcp.2013.12.018
   Muresan V, 2015, EXP CELL RES, V334, P45, DOI 10.1016/j.yexcr.2014.12.014
   Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200
   Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143
   Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200
   Capell A, 2002, J BIOL CHEM, V277, P5637, DOI 10.1074/jbc.M109119200
   Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567
   KOO EH, 1993, P NATL ACAD SCI USA, V90, P4748, DOI 10.1073/pnas.90.10.4748
   Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635
   Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341
   Radzimanowski J, 2008, EMBO REP, V9, P1134, DOI 10.1038/embor.2008.188
   Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085
   Reitz C, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0307-3
   Cong L, 2011, NEUROBIOL AGING, V32, P54, DOI 10.1016/j.neurobiolaging.2009.01.001
   Poirier J, 2014, NEUROBIOL AGING, V35, pS3, DOI 10.1016/j.neurobiolaging.2014.03.037
   Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263
   Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866
   Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200
   Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620
   Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811
   Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951
   Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663
   Tian YA, 2010, J BIOL CHEM, V285, P32549, DOI 10.1074/jbc.M110.128439
   Bodendorf U, 2001, J BIOL CHEM, V276, P12019, DOI 10.1074/jbc.M008861200
   Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167
   Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x
   Ong WY, 2013, J ALZHEIMERS DIS, V35, P643, DOI 10.3233/JAD-121990
   Ricciarelli R, 2012, IUBMB LIFE, V64, P931, DOI 10.1002/iub.1091
   Bencina M, 2013, SENSORS-BASEL, V13, P16736, DOI 10.3390/s131216736
   Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040
   Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015
   Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028
   Golabek AA, 1996, J BIOL CHEM, V271, P10602
   LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168
   Tang Z, 2013, J BIOL CHEM, V288, P15556, DOI 10.1074/jbc.M112.435123
   Winkler K, 1999, J LIPID RES, V40, P447
   CASTANO EM, 1995, BIOCHEM J, V306, P599
   Giuffrida ML, 2010, REV NEUROSCIENCE, V21, P83
   O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613
   Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705
   Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433
   Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7
   Endres K, 2010, FEBS J, V277, P1585, DOI 10.1111/j.1742-4658.2010.07566.x
   Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626
   Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045
   Maruyama M, 2005, ANN NEUROL, V57, P832, DOI 10.1002/ana.20494
   ZANNIS VI, 1984, J BIOL CHEM, V259, P5495
   Marr RA, 2003, J NEUROSCI, V23, P1992
   Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K
   Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012
   Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200
   Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j
   Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024
   HAASS C, 1993, J BIOL CHEM, V268, P3021
   Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008
   Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505
   Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x
   Popugaeva E, 2014, NEURODEGENER DIS, V13, P139, DOI 10.1159/000354778
   Wood SJ, 1996, CHEM BIOL, V3, P949, DOI 10.1016/S1074-5521(96)90183-0
   Weksler ME, 2002, EXP GERONTOL, V37, P943
   Cascella R, 2013, BBA-MOL BASIS DIS, V1832, P1217, DOI 10.1016/j.bbadis.2013.04.012
   Hoefgen S, 2015, J MOL BIOL, V427, P433, DOI 10.1016/j.jmb.2014.12.005
   Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001
   Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005
   Dash C, 2003, CRIT REV BIOCHEM MOL, V38, P89, DOI 10.1080/713609213
   Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064
   Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008
   Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200
   Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108
   Pettersson M, 2013, EXPERT OPIN THER PAT, V23, P1349, DOI 10.1517/13543776.2013.821465
   Leduc V, 2010, TRENDS MOL MED, V16, P469, DOI 10.1016/j.molmed.2010.07.008
   Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x
   Zhao Z, 2007, NEUROBIOL AGING, V28, P824, DOI 10.1016/j.neurobiolaging.2006.05.001
   Kojro E, 2005, SUB CELL BIOCHEM, V38, P105
   Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32
   Bohm C, 2015, MOL CELL NEUROSCI, V66, P3, DOI 10.1016/j.mcn.2015.02.016
   Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22
   Cole S, 2007, MOL NEURODEGENER, V2, P1, DOI DOI 10.1186/1750-1326-2-22
   De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304
   Gertsik Natalya, 2014, Front Aging Neurosci, V6, P342, DOI 10.3389/fnagi.2014.00342
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001
   Kanekiyo T, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00093
   Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57
   Marr RA, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00187
   Menting KW, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00165
   Miners JS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00238
   Morishima-Kawashima M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00463
   Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288
   Nhan HS, 2015, ACTA NEUROPATHOL, V129, P1, DOI 10.1007/s00401-014-1347-2
   Rail Jr S.C., 1982, J BIOL CHEM, V257, P4171
   Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839
   Solomon Beka, 2009, ScientificWorldJournal, V9, P909, DOI 10.1100/tsw.2009.99
   Tamagno E., 2011, NEUROTOX RES, V22, P208
   Webster CI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104001
   WHO, 2012, DEM PUBL HLTH PRIOR
   Zhang X, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00427
   Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27
NR 121
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2015
VL 588
BP 1
EP 14
DI 10.1016/j.abb.2015.10.005
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CY5HM
UT WOS:000366438700001
PM 26475676
ER

PT J
AU Saund, SS
   Sosa, V
   Henriquez, S
   Nguyen, QNN
   Bianco, CL
   Soeda, S
   Millikin, R
   White, C
   Le, H
   Ono, K
   Tantillo, DJ
   Kumagai, Y
   Akaike, T
   Lin, J
   Fukuto, JM
AF Saund, Simran S.
   Sosa, Victor
   Henriquez, Stephanie
   Nguyen, Q. Nhu N.
   Bianco, Christopher L.
   Soeda, Shuhei
   Millikin, Robert
   White, Corey
   Le, Henry
   Ono, Katsuhiko
   Tantillo, Dean J.
   Kumagai, Yoshito
   Akaike, Takaaki
   Lin, Joseph
   Fukuto, Jon M.
TI The chemical biology of hydropersulfides (RSSH): Chemical stability,
   reactivity and redox roles
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Hydropersulfide; Thiols; Redox regulation; Nucleophilicity;
   Electrophilicity
ID TYROSINE-PHOSPHATASE 1B; SULFUR-SULFUR BOND; HYDROGEN-SULFIDE; ARALKYL
   HYDRODISULFIDES; CYSTINE/GLUTAMATE ANTIPORTER; DENSITY FUNCTIONALS;
   AQUEOUS-SOLUTIONS; XANTHINE-OXIDASE; OXIDATIVE STRESS; THIOL COMPOUNDS
AB Recent reports indicate the ubiquitous prevalence of hydropersulfides (RSSH) in mammalian systems. The biological utility of these and related species is currently a matter of significant speculation. The function, lifetime and fate of hydropersulfides will be assuredly based on their chemical properties and reactivity. Thus, to serve as the basis for further mechanistic studies regarding hydropersulfide biology, some of the basic chemical properties/reactivity of hydropersulfides was studied. The nucleophilicity, electrophilicity and redox properties of hydropersulfides were examined under biological conditions. These studies indicate that hydropersulfides can be nucleophilic or electrophilic, depending on the pH (i.e. the protonation state) and can act as good one- and two-electron reductants. These diverse chemical properties in a single species make hydropersulfides chemically distinct from other, well-known sulfur containing biological species, giving them unique and potentially important biological function. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Saund, Simran S.; Sosa, Victor; Bianco, Christopher L.; Soeda, Shuhei; Millikin, Robert; White, Corey; Le, Henry; Ono, Katsuhiko; Fukuto, Jon M.] Sonoma State Univ, Dept Chem, Rohnert Pk, CA 94928 USA.
   [Henriquez, Stephanie; Lin, Joseph] Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA.
   [Nguyen, Q. Nhu N.; Tantillo, Dean J.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.
   [Kumagai, Yoshito] Univ Tsukuba, Fac Med, Environm Biol Sect, Tsukuba, Ibaraki 3058575, Japan.
   [Akaike, Takaaki] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci & Mol Toxicol, Sendai, Miyagi, Japan.
RP Fukuto, JM (reprint author), Sonoma State Univ, Dept Chem, Rohnert Pk, CA 94928 USA.
EM linj@sonoma.edu; fukuto@sonoma.edu
FU National Institutes of Health [HL106598]; National Science Foundation
   [CHE-1148641, CHE-1126482]; ACS-PRF grant [52801-ND4]
FX This work was supported by grants from the National Institutes of Health
   (HL106598) and the National Science Foundation (CHE-1148641) to JMF, an
   MRI grant from the National Science Foundation (CHE-1126482) to the
   Sonoma State University Chemistry Department and an ACS-PRF grant
   (52801-ND4) to DJT. Computational support from the NSF's XSEDE program
   is also gratefully acknowledged.
CR AGRO A F, 1976, Biochemical and Biophysical Research Communications, V68, P553
   Souness RJ, 2013, BIOCHEMISTRY-US, V52, P7606, DOI 10.1021/bi400661a
   Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t
   Bento AP, 2008, J ORG CHEM, V73, P7290, DOI 10.1021/jo801215z
   HARGROVE JL, 1988, J BIOL CHEM, V263, P17262
   EVERETT SA, 1995, METHOD ENZYMOL, V251, P55
   Sivaramakrishnan S, 2010, BIOORG MED CHEM LETT, V20, P444, DOI 10.1016/j.bmcl.2009.12.001
   Greiner R, 2013, ANTIOXID REDOX SIGN, V19, P1749, DOI 10.1089/ars.2012.5041
   RAO GS, 1959, J ORG CHEM, V24, P749, DOI 10.1021/jo01088a005
   BUNNETT JF, 1963, ANNU REV PHYS CHEM, V14, P271, DOI 10.1146/annurev.pc.14.100163.001415
   Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x
   KHARASCH MS, 1951, J ORG CHEM, V16, P524, DOI 10.1021/jo01144a005
   Jaramillo P, 2008, J MOL STRUC-THEOCHEM, V865, P68, DOI 10.1016/j.theochem.2008.06.022
   Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657
   Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5
   BONOMI F, 1977, EUR J BIOCHEM, V72, P17, DOI 10.1111/j.1432-1033.1977.tb11219.x
   GAWRON O, 1961, J AM CHEM SOC, V83, P2906, DOI 10.1021/ja01474a027
   van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681
   MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3
   PARKER AJ, 1960, J AM CHEM SOC, V82, P3071, DOI 10.1021/ja01497a024
   Pan J, 2013, ACS CHEM BIOL, V8, P1110, DOI 10.1021/cb4001052
   Fox B, 2012, J CELL MOL MED, V16, P896, DOI 10.1111/j.1582-4934.2011.01357.x
   HEMMERICH P, 1963, EXPERIENTIA, V19, P488, DOI 10.1007/BF02150666
   HISKEY RG, 1961, J AM CHEM SOC, V83, P4644, DOI 10.1021/ja01483a033
   MASSEY V, 1970, J BIOL CHEM, V245, P6595
   [Anonymous], 2004, GAUSSIAN 09 REVISION
   Ono K, 2014, FREE RADICAL BIO MED, V77, P82, DOI 10.1016/j.freeradbiomed.2014.09.007
   Shen XG, 2012, FREE RADICAL BIO MED, V52, P2276, DOI 10.1016/j.freeradbiomed.2012.04.007
   BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098
   KAWAMURA S, 1968, J ORG CHEM, V33, P1179, DOI 10.1021/jo01267a053
   BRANZOLI U, 1974, J BIOL CHEM, V249, P4346
   TSURUGI J, 1965, J ORG CHEM, V30, P2707, DOI 10.1021/jo01019a047
   Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x
   Jaramillo P, 2006, J PHYS CHEM A, V110, P8181, DOI 10.1021/jp057351q
   Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391
   MISRA HP, 1974, J BIOL CHEM, V249, P2151
   Bagiyan GA, 2003, RUSS CHEM B+, V52, P1135, DOI 10.1023/A:1024761324710
   FLAVIN M, 1962, J BIOL CHEM, V237, P768
   BENSON SW, 1978, CHEM REV, V78, P23, DOI 10.1021/cr60311a003
   Wright CM, 2006, CHEM COMMUN, P3104, DOI 10.1039/b604040c
   GAWRON O, 1964, J AM CHEM SOC, V86, P2283, DOI 10.1021/ja01065a036
   Kimura Y, 2013, FASEB J, V27, P2451, DOI 10.1096/fj.12-226415
   FUKUI K, 1981, ACCOUNTS CHEM RES, V14, P363, DOI 10.1021/ar00072a001
   STIPANUK MH, 1986, ANNU REV NUTR, V6, P179, DOI 10.1146/annurev.nu.06.070186.001143
   Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021
   Golchoubian H, 2007, CATAL COMMUN, V8, P697, DOI 10.1016/j.catcom.2006.08.036
   Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111
   Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680
   KAWAMURA S, 1965, J ORG CHEM, V30, P2711, DOI 10.1021/jo01019a048
   Bagiyan GA, 2004, KINET CATAL+, V45, P372, DOI 10.1023/B:KICA.0000032171.81652.91
   Fukuto JM, 2012, CHEM RES TOXICOL, V25, P769, DOI 10.1021/tx2005234
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Francoleon NE, 2011, ARCH BIOCHEM BIOPHYS, V516, P146, DOI 10.1016/j.abb.2011.09.015
   Bailey T.S., 2015, J AM CHEM SOC, V136, P10573
   CAVALLIN.D, 1970, EUR J BIOCHEM, V14, P169, DOI 10.1111/j.1432-1033.1970.tb00275.x
   CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002
   EDMONDSO.D, 1972, J BIOL CHEM, V247, P1597
   Hratchian HP, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P195, DOI 10.1016/B978-044451719-7/50053-6
   Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n
   Mustafa A. K., 2009, SCI SIGNAL, V2, P1
   PARKER AJ, 1959, CHEM REV, V59, P583, DOI 10.1021/cr50028a003
   Rüegg U T, 1977, Methods Enzymol, V47, P111
   SCHNEIDE.JF, 1969, J BIOL CHEM, V244, P5735
   Vasas A., 2014, NITRIC OXIDE
   Wang MX, 2012, GENE EXPRESSION, V15, P235, DOI 10.3727/105221613X13571653093286
   Wang R., 2011, PHYSIOL REV, V92, P791
NR 66
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2015
VL 588
BP 15
EP 24
DI 10.1016/j.abb.2015.10.016
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CY5HM
UT WOS:000366438700002
PM 26519887
ER

PT J
AU Martin, GG
   Landrock, D
   Landrock, KK
   Howles, PN
   Atshaves, BP
   Kier, AB
   Schroeder, F
AF Martin, Gregory G.
   Landrock, Danilo
   Landrock, Kerstin K.
   Howles, Philip N.
   Atshaves, Barbara P.
   Kier, Ann B.
   Schroeder, Friedhelm
TI Relative contributions of L-FABP, SCP-2/SCP-x, or both to hepatic
   biliary phenotype of female mice
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE L-FABP; SCP-2; SCP-x; Gene ablation; Bile acid; Sexual dimorphism
ID ACID-BINDING-PROTEIN; STEROL CARRIER PROTEIN-2; CHAIN FATTY-ACID; LIPID
   TRANSFER PROTEIN; CONJUGATED BILE-SALTS; RAT-LIVER PEROXISOMES; L-CELL
   FIBROBLASTS; CHOLESTEROL ACCUMULATION; PHYTOESTROGEN CONTENT;
   LIGAND-BINDING
AB Both sterol carrier protein-2/sterol carrier protein-x (SCP-2/SCP-x) and liver fatty acid binding protein (L-FABP) have been proposed to function in hepatobiliary bile acid metabolism/accumulation. To begin to address this issue, the impact of ablating L-FABP (LKO) or SCP-2/SCP-x (DKO) individually or both together (TKO) was examined in female mice. Biliary bile acid levels were decreased in LKO, DKO, and TKO mice; however, hepatic bile acid concentration was decreased in LKO mice only. In contrast, biliary phospholipid level was decreased only in TKO mice, while biliary cholesterol levels were unaltered regardless of phenotype. The loss of either or both genes increased hepatic expression of the major bile acid synthetic enzymes (CYP7A1 and/or CYP27A1). Loss of L-FABP and/or SCP-2/SCP-x genes significantly altered the molecular composition of biliary bile acids, but not the proportion of conjugated/unconjugated bile acids or overall bile acid hydrophobicity index. These data suggested that L-FABP was more important in hepatic retention of bile acids, while SCP-2/SCP-x more broadly affected biliary bile acid and phospholipid levels. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Martin, Gregory G.; Landrock, Kerstin K.; Schroeder, Friedhelm] Texas A&M Univ, Dept Physiol & Pharmacol, College Stn, TX 77843 USA.
   [Landrock, Danilo; Kier, Ann B.] Texas A&M Univ, Dept Pathobiol, College Stn, TX 77843 USA.
   [Howles, Philip N.] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45219 USA.
   [Atshaves, Barbara P.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
RP Schroeder, F (reprint author), Texas A&M Univ, Dept Physiol & Pharmacol, TAMU 4466, College Stn, TX 77843 USA.
EM fschroeder@cvm.tamu.edu
FU United States Public Health Service, National Institutes of Health
   [DK41402, DK70965, HL078900]
FX This work was supported in part by the United States Public Health
   Service, National Institutes of Health Grants DK41402 (F.S. and A.B.K.),
   DK70965 (B.P.A), and HL078900 (P.N.H.). HPLC services were provided by
   the University of Cincinnati Mouse Metabolic Phenotyping Center (U24
   DK059630).
CR Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002
   CAREY MC, 1978, J LIPID RES, V19, P945
   Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712
   Chao H, 2003, J LIPID RES, V44, P72, DOI 10.1194/jlr.M200191-JLR200
   KAIKAUS RM, 1990, EXPERIENTIA, V46, P617, DOI 10.1007/BF01939701
   Fuchs M, 2001, J BIOL CHEM, V276, P48058, DOI 10.1074/jbc.M106732200
   Ren SL, 2004, J LIPID RES, V45, P2123, DOI 10.1194/jlr.M400233-JLR200
   Wouters FS, 1998, EMBO J, V17, P7179, DOI 10.1093/emboj/17.24.7179
   Antoine B, 1997, J BIOL CHEM, V272, P17937, DOI 10.1074/jbc.272.29.17937
   Adida A, 2002, PROSTAG LEUKOTR ESS, V67, P91, DOI 10.1054/plef.404
   Atshaves BP, 2004, J LIPID RES, V45, P812, DOI 10.1194/jlr.M300408-JLR200
   Ellinghaus P, 1999, J BIOL CHEM, V274, P2766, DOI 10.1074/jbc.274.5.2766
   Atshaves BP, 2004, J BIOL CHEM, V279, P30954, DOI 10.1074/jbc.M313571200
   Martin GG, 2015, ARCH BIOCHEM BIOPHYS, V580, P41, DOI 10.1016/j.abb.2015.06.009
   Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7
   SINGER SS, 1992, BIOCHEM INT, V27, P373
   Monaco HL, 2009, BIOPOLYMERS, V91, P1196, DOI 10.1002/bip.21257
   Catalano G, 2008, J LIPID RES, V49, P635, DOI 10.1194/jlr.M700510-JLR200
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   STOLZ A, 1989, ANNU REV PHYSIOL, V51, P161, DOI 10.1146/annurev.physiol.51.1.161
   Martin GG, 2005, BIOCHEM J, V391, P549, DOI 10.1042/BJ20050296
   Murphy EJ, 1997, BBA-LIPID LIPID MET, V1345, P283, DOI 10.1016/S0005-2760(97)00003-9
   Thigpen JE, 1999, LAB ANIM SCI, V49, P530
   DIETRICH A, 1995, J LIPID RES, V36, P1729
   Hagan RM, 2005, J BIOL CHEM, V280, P1782, DOI 10.1074/jbc.M407131200
   Atshaves BP, 2009, J LIPID RES, V50, P1429, DOI 10.1194/jlr.M900020-JLR200
   Favretto F, 2013, CHEMBIOCHEM, V14, P1807, DOI 10.1002/cbic.201300156
   Guariento M, 2008, PROTEINS, V70, P462, DOI 10.1002/prot.21518
   Di Pietro SM, 2000, BBA-PROTEIN STRUCT M, V1478, P186, DOI 10.1016/S0167-4838(00)00042-X
   Thumser AEA, 1996, BIOCHEM J, V320, P729
   Stolowich NJ, 1997, BIOCHEMISTRY-US, V36, P1719, DOI 10.1021/bi962317a
   McArthur MJ, 1999, J LIPID RES, V40, P1371
   Frolov A, 1996, J LIPID RES, V37, P1862
   Stolowich NJ, 2002, CELL MOL LIFE SCI, V59, P193, DOI 10.1007/s00018-002-8416-8
   Wolfrum C, 1999, J LIPID RES, V40, P708
   HEUMAN DM, 1989, J LIPID RES, V30, P719
   Antonenkov VD, 2006, BIOCHEM J, V394, P475, DOI 10.1042/BJ20051058
   Wanders RJA, 1997, BIOCHEM BIOPH RES CO, V236, P565, DOI 10.1006/bbrc.1997.7007
   Lonardo A, 2000, J GASTROEN HEPATOL, V15, P775, DOI 10.1046/j.1440-1746.2000.02226.x
   Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023
   GAVEY KL, 1981, J BIOL CHEM, V256, P2993
   Hanhoff T, 2005, EUR J LIPID SCI TECH, V107, P716, DOI 10.1002/ejit.200401076
   Atshaves BP, 2007, J LIPID RES, V48, P2193, DOI 10.1194/jlr.M700102-JLR200
   Huang H, 2015, BBA-MOL CELL BIOL L, V1851, P946, DOI 10.1016/j.bbalip.2015.02.015
   CHANDERBHAN RF, 1986, ENDOCR RES, V12, P351
   Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008
   Agellon LB, 2000, BBA-MOL CELL BIOL L, V1486, P198, DOI 10.1016/S1388-1981(00)00057-3
   TAKIKAWA H, 1986, ARCH BIOCHEM BIOPHYS, V251, P385, DOI 10.1016/0003-9861(86)90086-X
   Martin GG, 2008, BIOCHEMISTRY-US, V47, P5915, DOI 10.1021/bi800251e
   Denzer C, 2009, J CLIN ENDOCR METAB, V94, P3872, DOI 10.1210/jc.2009-1125
   NEMECZ G, 1991, J BIOL CHEM, V266, P17180
   DIETRICH A, 1995, J LIPID RES, V36, P1745
   Sodre FL, 2006, J CLIN LAB ANAL, V20, P113, DOI 10.1002/jcla.20111
   Martin GG, 2009, AM J PHYSIOL-GASTR L, V297, pG1053, DOI 10.1152/ajpgi.00116.2009
   Atshaves BP, 2005, AM J PHYSIOL-CELL PH, V288, pC543, DOI 10.1152/ajpcell.00359.2004
   KAWATA S, 1991, CLIN CHIM ACTA, V197, P201, DOI 10.1016/0009-8981(91)90140-8
   McIntosh AL, 2009, ARCH BIOCHEM BIOPHYS, V485, P160, DOI 10.1016/j.abb.2009.03.004
   Martin GG, 2006, AM J PHYSIOL-GASTR L, V290, pG36, DOI 10.1152/ajpgi.00510.2004
   Stolowich N, 1999, J BIOL CHEM, V274, P35425, DOI 10.1074/jbc.274.50.35425
   Antonenkov VD, 2000, PROTEIN EXPRES PURIF, V18, P249, DOI 10.1006/prep.2000.1192
   Chao H, 1999, BBA-MOL CELL BIOL L, V1439, P371, DOI 10.1016/S1388-1981(99)00109-2
   SEEDORF U, 1994, J BIOL CHEM, V269, P21277
   Amigo L, 2003, J LIPID RES, V44, P399, DOI 10.1194/jlr.M200306-JLR200
   MENDISHANDAGAMA SMLC, 1995, TISSUE CELL, V27, P483, DOI 10.1016/S0040-8166(05)80056-4
   Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200
   Seedorf U, 1998, GENE DEV, V12, P1189, DOI 10.1101/gad.12.8.1189
   Kannenberg F, 1999, J BIOL CHEM, V274, P35455, DOI 10.1074/jbc.274.50.35455
   JEFFERSON JR, 1991, J BIOL CHEM, V266, P5486
   Atshaves B.P., 2007, AM J PHYSIOL, V292, P939
   Chanderbhan RF, 1998, INTRACELLULAR CHOLESTEROL TRAFFICKING, P197
   Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x
   Farrell G.C., 2013, NONALCOHOLIC FATTY L, P1
   Favretto F, 2015, FEBS J, V282, P1271, DOI 10.1111/febs.13218
   Li T., 2009, PPAR RES, V2009
   Martin GG, 2014, AM J PHYSIOL-GASTR L, V307, pG1130, DOI 10.1152/ajpgi.00209.2014
   Storey S.M., 2010, AM J PHYSIOL, V299, P244
   Thigpen JE, 1999, ENVIRON HEALTH PERSP, V107, pA182, DOI 10.2307/3434577
NR 77
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2015
VL 588
BP 25
EP 32
DI 10.1016/j.abb.2015.10.018
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CY5HM
UT WOS:000366438700003
PM 26541319
ER

PT J
AU Alves, AC
   Vasconcelos, MA
   Santiago, MQ
   Pinto, VR
   Osterne, VJS
   Lossio, CF
   Bringel, PHSF
   Castro, RR
   Nagano, CS
   Delatorre, P
   Souza, LAG
   Nascimento, KS
   Assreuy, AMS
   Cavada, BS
AF Alves, Ana Cecilia
   Vasconcelos, Mayron Alves
   Santiago, Mayara Queiroz
   Pinto-Junior, Vanir Reis
   Silva Osterne, Vinicius Jose
   Lossio, Claudia Figueiredo
   Souza Ferreira Bringel, Pedro Henrique
   Castro, Rondinelle Ribeiro
   Nagano, Celso Shiniti
   Delatorre, Plinio
   Gomes Souza, Luiz Augusto
   Nascimento, Kyria Santiago
   Sampaio Assreuy, Ana Maria
   Cavada, Benildo Sousa
TI A novel vasorelaxant lectin purified from seeds of Clathrotropis nitida:
   partial characterization and immobilization in chitosan beads
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Lectin Purification; Clathrotropis nitida; Immobilization; Toxicity;
   Vasorelaxation
ID PRO-INFLAMMATORY LECTIN; BINDING LECTIN; VATAIREA-MACROCARPA;
   NITRIC-OXIDE; QUINOLIZIDINE ALKALOIDS; CRYSTAL-STRUCTURE; LEGUME
   LECTINS; PURIFICATION; CELLS; PROTEINS
AB A novel lectin from seeds of Clathrotropis nitida (CNA) was purified and characterized. CNA is a glycoprotein containing approximately 3.3% carbohydrates in its structure. CNA promoted intense agglutination of rabbit erythrocytes, which was inhibited by galactosides and porcine stomach mucin (PSM). The lectin maintained its hemagglutinating activity after incubation in a wide range of temperatures (30 -60 degrees C) and pH (6.0-7.0), and its binding activity was dependent on divalent cations (Ca+2 and Mg+2). SDS-PAGE showed an electrophoretic profile consisting of a single band of 28 kDa, as confirmed by electrospray ionization mass spectrometry, which indicated an average molecular mass of 27,406 +/- 2 Da and the possible presence of isoforms and glycoforms. In addition, CNA exhibited no toxicity to Artemia sp. nauplii and elicited reversible and dose-dependent vasorelaxation in precontracted aortic rings. CNA was successfully immobilized on chitosan beads and was able to capture PSM in solution. This study demonstrated that CNA is a lectin that has potential as a biotechnological tool in glycomics and glycoproteomics applications. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Alves, Ana Cecilia; Santiago, Mayara Queiroz; Pinto-Junior, Vanir Reis; Silva Osterne, Vinicius Jose; Lossio, Claudia Figueiredo; Cavada, Benildo Sousa] Univ Fed Ceara, Dept Bioquim & Biol Mol, BioMol Lab, Lab Mol Biol At, Fortaleza, Ceara, Brazil.
   [Vasconcelos, Mayron Alves] Univ Fed Ceara, Dept Patol & Med Legal, Lab Integrado Biomol LIBS, Fortaleza, Ceara, Brazil.
   [Souza Ferreira Bringel, Pedro Henrique; Castro, Rondinelle Ribeiro] Univ Estadual Ceara, ISCB, Fortaleza, Ceara, Brazil.
   [Souza Ferreira Bringel, Pedro Henrique; Castro, Rondinelle Ribeiro] Univ Estadual Ceara, Fac Filosofia Dom Aureliano Matos FAFIDAM, Fortaleza, Ceara, Brazil.
   [Nagano, Celso Shiniti] Univ Fed Ceara, Dept Engn Pesca, LEMAP, Fortaleza, Ceara, Brazil.
   [Delatorre, Plinio] Univ Fed Paraiba, Ctr Ciencias Exatas & Nat, Dept Biol Mol, BR-58059900 Joao Pessoa, Paraiba, Brazil.
   [Gomes Souza, Luiz Augusto] INPA, Manaus, Amazonas, Brazil.
RP Cavada, BS (reprint author), Univ Fed Ceara, Dept Bioquim & Biol Mol, BioMol Lab, Lab Mol Biol At, Fortaleza, Ceara, Brazil.
EM bscavada@ufc.br
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   [307291/2013-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) [815/2015]; Fundacao Cearense de Apoio ao
   Desenvolvimento Cientifico e Tecnologico (FUNCAP) [2015]
FX This study was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (Grant Number:
   307291/2013-8), the Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) (Grant number: 815/2015), and the Fundacao Cearense de
   Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) (Project
   Fellowships, 2015). B.S.C. and AMSA are senior investigators of CNPq.
CR Ali M. A., 2003, Journal of Medical Sciences (Pakistan), V3, P240
   Almeida A.C., 2014, INT J INDIG MED PLAN, V47, P1567
   Fernandes AV, 2012, PROTEIN PEPTIDE LETT, V19, P1082
   FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0
   Alencar NMN, 2003, INT J BIOCHEM CELL B, V35, P1674, DOI 10.1016/S1357-2725(03)00138-9
   Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Cavada BS, 1998, PHYTOCHEMISTRY, V49, P675, DOI 10.1016/S0031-9422(98)00144-7
   RICKER M, 1994, BRITTONIA, V46, P355, DOI 10.2307/2806921
   Rangel TBA, 2012, BIOCHIMIE, V94, P525, DOI 10.1016/j.biochi.2011.09.001
   Bari AU, 2013, J MOL RECOGNIT, V26, P351, DOI 10.1002/jmr.2279
   Pereira FN, 2012, J MOL RECOGNIT, V25, P443, DOI 10.1002/jmr.2207
   Silva HC, 2011, PROTEIN PEPTIDE LETT, V18, P396
   Ohba H, 2002, CANCER LETT, V184, P207, DOI 10.1016/S0304-3835(02)00207-0
   Silva HC, 2012, PROCESS BIOCHEM, V47, P2347, DOI 10.1016/j.procbio.2012.09.014
   Mislovicova D, 2009, J MOL CATAL B-ENZYM, V60, P45, DOI 10.1016/j.molcatb.2009.03.009
   Alencar NMN, 2010, INFLAMM RES, V59, P245, DOI 10.1007/s00011-009-0092-9
   Assreuy AMS, 2009, N-S ARCH PHARMACOL, V380, P509, DOI 10.1007/s00210-009-0465-1
   Sagen AL, 2002, PHYTOCHEMISTRY, V61, P975, DOI 10.1016/S0031-9422(02)00394-1
   Osterne VJS, 2014, APPL BIOCHEM BIOTECH, V172, P3342, DOI 10.1007/s12010-014-0751-3
   Li TT, 2012, ACTA BIOCH BIOPH SIN, V44, P606, DOI 10.1093/abbs/gms037
   Oliveira JTA, 2002, PHYTOCHEMISTRY, V61, P301, DOI 10.1016/S0031-9422(02)00239-X
   Zwierzina H, 2011, EUR J CANCER, V47, P1450, DOI 10.1016/j.ejca.2011.02.022
   Biswas S, 2009, PROTEIN J, V28, P391, DOI 10.1007/s10930-009-9206-z
   Singh AN, 2011, J AGR FOOD CHEM, V59, P6256, DOI 10.1021/jf200472x
   FERRIGE AG, 1992, RAPID COMMUN MASS SP, V6, P707, DOI 10.1002/rcm.1290061115
   KLEHA JF, 1991, BRIT J PHARMACOL, V104, P287
   Liu JP, 2010, MOL BIOSYST, V6, P954, DOI 10.1039/b927040j
   Santiago MQ, 2014, J MOL RECOGNIT, V27, P117, DOI 10.1002/jmr.2340
   Gemeiner P, 2009, BIOTECHNOL ADV, V27, P1, DOI 10.1016/j.biotechadv.2008.07.003
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   ANIMASHAUN T, 1989, J BIOL CHEM, V264, P4657
   Regnier Fred E., 2007, P193
   Agrawal P, 2010, J PROTEOMICS, V73, P1573, DOI 10.1016/j.jprot.2010.03.006
   Silva HC, 2013, J MOL RECOGNIT, V26, P470, DOI 10.1002/jmr.2289
   Bezerra MJB, 2013, INT J BIOCHEM CELL B, V45, P807, DOI 10.1016/j.biocel.2013.01.012
   Brinda KV, 2004, PROTEIN SCI, V13, P1735, DOI 10.1110/ps.04651004
   HANKINS CN, 1988, PLANT PHYSIOL, V86, P67, DOI 10.1104/pp.86.1.67
   Pan YT, 2013, TALANTA, V115, P842, DOI 10.1016/j.talanta.2013.06.031
   Sousa BL, 2015, INT J BIOCHEM CELL B, V59, P103, DOI [10.1016/j.biocel.2014.12.002, 10.1016/j.bioce1.2014.12.002]
   Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200
   Van Damme EJM, 1998, CRIT REV PLANT SCI, V17, P575
   HATFIELD GM, 1980, J NAT PROD, V43, P164, DOI 10.1021/np50007a018
   Bauer V, 2010, GEN PHYSIOL BIOPHYS, V29, P319, DOI 10.4149/gpb_2010_04_319
   GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001
   Liu Z, 2008, PHYTOMEDICINE, V15, P867, DOI 10.1016/j.phymed.2008.02.025
   Barroso-Neto IL, 2014, ARCH BIOCHEM BIOPHYS, V543, P31, DOI 10.1016/j.abb.2013.12.006
   Carballo JL, 2002, BMC BIOTECHNOL, V2, P1
   Gavrovic-Jankulovic M., 2011, J BIOMAT NANOBIOTECH, V2, P614, DOI DOI 10.4236/JBNB.2011
   Lam Sze Kwan, 2011, Appl Microbiol Biotechnol, V89, P45, DOI 10.1007/s00253-010-2892-9
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   Pervin F., 2006, Journal of Medical Sciences (Pakistan), V6, P999
   Pinto-Junior V.R., 2015, J MOL RECOGNIT
   Pinto VR, 2013, MOLECULES, V18, P10857, DOI 10.3390/molecules180910857
   Poretz R.D., 1974, BIOCHEMISTRY, V13
   Ramos Marcio Viana, 1996, Revista Brasileira de Fisiologia Vegetal, V8, P193
   Santos AF, 2010, BIORESOURCE TECHNOLO, V101, P794, DOI DOI 10.1016/J.BIORTECH.2009.07.062
   Strathmann M, 2002, J MICROBIOL METH, V50, P237, DOI 10.1016/S0167-7012(02)00032-5
   Vaz F.M.A., 2010, FOOD CHEM, V119, P1507
   ZACHARIU.RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2
NR 62
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2015
VL 588
BP 33
EP 40
DI 10.1016/j.abb.2015.10.020
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CY5HM
UT WOS:000366438700004
PM 26545483
ER

PT J
AU Shah, S
   Hayden, CA
   Fischer, ME
   Rao, AG
   Howard, JA
AF Shah, Shweta
   Hayden, Celine A.
   Fischer, Maria E.
   Rao, A. Gururaj
   Howard, John A.
TI Biochemical and biophysical characterization of maize-derived HBsAg for
   the development of an oral vaccine
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Hepatitis B surface antigen; Zea mays; Mucosal vaccine; Supercritical
   fluid extraction; TEM; Virus-like particle
ID B SURFACE-ANTIGEN; HEPATITIS-B; TRANSGENIC PLANTS; PICHIA-PASTORIS;
   EDIBLE VACCINE; PROTEIN; VIRUS; IMMUNOGENICITY; PARTICLES; EXPRESSION
AB Although a vaccine against hepatitis B virus (HBV) has been available since 1982, it is estimated that 600,000 people die every year due to HBV. An affordable oral vaccine could help alleviate the disease burden and to this end the hepatitis B surface antigen (HBsAg) was expressed in maize. Orally delivered maize material induced the strongest immune response in mice when lipid was extracted by CO2 supercritical fluid extraction (SFE), compared to full fat and hexane-extracted material. The present study provides a biochemical and biophysical basis for these immunological differences by comparing the active ingredient in the differently treated maize material. Purified maize-derived HBsAg underwent biophysical characterization by gel filtration, transmission electron microscopy (TEM), dynamic light scattering (DLS). UV-CD, and fluorescence. Gel filtration showed that HBsAg forms higher-order oligomers and TEM demonstrated virus-like particle (VLP) formation. The VLPs obtained from SFE were more regular in shape and size compared to hexane or full fat material. In addition, SFE-derived HBsAg showed the greatest extent of cc-helical structure by far UV-CD spectrum. Fluorescence experiments also revealed differences in protein conformation. This work establishes SFE-treated maize material as a viable oral vaccine candidate and advances the development of the first oral subunit vaccine. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Shah, Shweta; Rao, A. Gururaj] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.
   [Hayden, Celine A.; Fischer, Maria E.; Howard, John A.] Appl Biotechnol Inst, San Luis Obispo, CA 93407 USA.
RP Rao, AG (reprint author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.
EM gururao@iastate.edu; jhoward@appliedbiotech.org
FU NIH [2R44A1068239-03A1]
FX We thank Tracey Stewart for providing help with TEM analysis. This
   project was supported by NIH grant 2R44A1068239-03A1.
CR Chen YC, 2015, ANAL BIOCHEM, V478, P49, DOI 10.1016/j.ab.2015.03.020
   Greiner VJ, 2010, BIOCHIMIE, V92, P994, DOI 10.1016/j.biochi.2010.04.014
   VYAS GN, 1972, SCIENCE, V178, P1300, DOI 10.1126/science.178.4067.1300
   MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745
   Gurramkonda C, 2013, J CHROMATOGR B, V940, P104, DOI 10.1016/j.jchromb.2013.09.030
   Lorber B, 2012, BIOCHEM MOL BIOL EDU, V40, P372, DOI 10.1002/bmb.20644
   Beckman EJ, 2004, J SUPERCRIT FLUID, V28, P121, DOI 10.1016/S0896-8446(03)00029-9
   Smith ML, 2003, VACCINE, V21, P4011, DOI 10.1016/S0264-410X(03)00268-8
   Kong QX, 2001, P NATL ACAD SCI USA, V98, P11539, DOI 10.1073/pnas.191617598
   Gilbert RJC, 2005, P NATL ACAD SCI USA, V102, P14783, DOI 10.1073/pnas.0505062102
   Patil A, 2012, J CHROMATOGR B, V898, P7, DOI 10.1016/j.jchromb.2012.03.041
   Brunner G, 2005, J FOOD ENG, V67, P21, DOI 10.1016/j.jfoodeng.2004.05.060
   Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001
   Desombere I, 2006, J VIROL, V80, P3506, DOI 10.1128/JVI.80.7.3506-3514.2006
   Clapp T, 2014, VACCINE, V32, P3765, DOI 10.1016/j.vaccine.2014.05.037
   Kapusta J, 1999, FASEB J, V13, P1796
   MANGOLD CMT, 1995, VIROLOGY, V211, P535, DOI 10.1006/viro.1995.1435
   Thanavala Y, 2005, P NATL ACAD SCI USA, V102, P3378, DOI 10.1073/pnas.0409899102
   GAVILANES F, 1990, BIOCHEM J, V265, P857
   EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283
   Hayden CA, 2012, VACCINE, V30, P2937, DOI 10.1016/j.vaccine.2012.02.072
   MANGOLD CMT, 1993, J VIROL, V67, P4588
   Sojikul P, 2003, P NATL ACAD SCI USA, V100, P2209, DOI 10.1073/pnas.0438037100
   Pniewski T, 2011, J APPL GENET, V52, P125, DOI 10.1007/s13353-010-0001-5
   Huang Z, 2008, PLANT BIOTECHNOL J, V6, P202, DOI 10.1111/j.1467-7652.2007.00316.x
   Diminsky D, 1997, VACCINE, V15, P637, DOI 10.1016/S0264-410X(96)00239-3
   Hayden CA, 2012, PLANT BIOTECHNOL J, V10, P979, DOI 10.1111/j.1467-7652.2012.00727.x
   Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206
   Zhao QJ, 2013, TRENDS BIOTECHNOL, V31, P654, DOI 10.1016/j.tibtech.2013.09.002
   VANDAMME P, 1992, VACCINE, V10, P366, DOI 10.1016/0264-410X(92)90064-Q
   Greiner VJ, 2014, VACCINE, V32, P1049, DOI 10.1016/j.vaccine.2014.01.012
   Hayden C.A., COMMERCIAL IN PRESS
   Hayden CA, 2014, VACCINE, V32, P1240, DOI 10.1016/j.vaccine.2014.01.037
   Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007
   Kumru OS, 2014, BIOLOGICALS, V42, P237, DOI 10.1016/j.biologicals.2014.05.007
   Lakowicz J.R., 1999, PRINCIPLES FLUORESCE
NR 36
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2015
VL 588
BP 41
EP 49
DI 10.1016/j.abb.2015.10.015
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CY5HM
UT WOS:000366438700005
PM 26519888
ER

PT J
AU Yamaoka, K
   Shindo, M
   Iwasaki, K
   Yamaoka, I
   Yamamoto, Y
   Kitagawa, H
   Kato, S
AF Yamaoka, Kazuyoshi
   Shindo, Masayo
   Iwasaki, Kei
   Yamaoka, Ikuko
   Yamamoto, Yoko
   Kitagawa, Hirochika
   Kato, Shigeaki
TI Multiple co-activator complexes support ligand-induced transactivation
   function of VDR (vol 460, pg 166, 2007)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Correction
C1 [Shindo, Masayo; Yamamoto, Yoko; Kitagawa, Hirochika; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.
   [Yamaoka, Kazuyoshi; Iwasaki, Kei; Yamaoka, Ikuko; Kato, Shigeaki] Japan Sci & Technol Agcy, ERATO, Kawaguchi, Saitama 3320012, Japan.
RP Kato, S (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.
EM uskato@mail.ecc.u-tokyo.ac.jp
CR Yamaoka K, 2007, ARCH BIOCHEM BIOPHYS, V460, P166, DOI 10.1016/j.abb.2006.07.015
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2015
VL 588
BP 50
EP 50
DI 10.1016/j.abb.2015.10.017
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CY5HM
UT WOS:000366438700006
ER

PT J
AU Iverson, D
   Serrano, C
   Brahan, AM
   Shams, A
   Totsingan, F
   Bell, AJ
AF Iverson, Douglas
   Serrano, Crystal
   Brahan, Ann Marie
   Shams, Arik
   Totsingan, Filbert
   Bell, Anthony J., Jr.
TI Characterization of the structural and protein recognition properties of
   hybrid PNA-DNA four-way junctions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Four-way junctions; Peptide nucleic acids (PNAs); High mobility group
   proteins (HMG); A-DNA helices; B-DNA helices
ID PEPTIDE NUCLEIC-ACIDS; SITE-SPECIFIC RECOMBINATION; HOLLIDAY JUNCTIONS;
   TRANSCRIPTION FACTOR; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE; DECOY
   MOLECULES; BINDING-SITES; IMMOBILE; OLIGONUCLEOTIDES
AB The objective of this study is to evaluate the structure and protein recognition properties of hybrid four-way junctions (4WJs) composed of DNA and peptide nucleic acid (PNA) strands. We compare a classic immobile DNA junction, J1, vs. six PNA-DNA junctions, including a number with blunt DNA ends and multiple PNA strands. Circular dichroism (CD) analysis reveals that hybrid 4WJs are composed of helices that possess structures intermediate between A- and B-form DNA, the apparent level of A-form structure correlates with the PNA content. The structure of hybrids that contain one PNA strand is sensitive to Mg+2. For these constructs, the apparent B-form structure and conformational stability (T-m) increase in high Mg+2. The blunt-ended junction, b4WJ-PNA(3), possesses the highest B-form CD signals and T-m (40.1 degrees C) values vs. all hybrids and J1. Protein recognition studies are carried out using the recombinant DNA-binding protein, HMGB1b. HMGB1b binds the blunt ended single-PNA hybrids, b4WJ-PNA(1) and b4WJ-PNA(3), with high affinity. HMGB1b binds the multi-PNA hybrids, 4WJ-PNA(1,3) and b4WJ-PNA(1,3), but does not form stable protein-nucleic acid complexes. Protein interactions with hybrid 4WJs are influenced by the ratio of A- to B-form helices: hybrids with helices composed of higher levels of B-form structure preferentially associate with HMGB1b. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Iverson, Douglas; Serrano, Crystal; Brahan, Ann Marie; Shams, Arik; Bell, Anthony J., Jr.] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.
   [Totsingan, Filbert] NYU, Dept Chem, New York, NY 10003 USA.
RP Bell, AJ (reprint author), 118 Coll Dr 5043, Hattiesburg, MS 39406 USA.
EM Anthony.Bell@usm.edu
FU Mississippi INBRE - Institutional Development Award (IDeA) from the
   National Institute of General Medical Sciences of the National
   Institutes of Health [P20GM103476]; University of Southern Mississippi
FX This work was supported by the Mississippi INBRE, funded by an
   Institutional Development Award (IDeA) from the National Institute of
   General Medical Sciences of the National Institutes of Health under
   grant number P20GM103476 and startup funds from The University of
   Southern Mississippi.
CR Li JH, 2003, MOL MED, V9, P37
   Eriksson M, 1996, NAT STRUCT BIOL, V3, P410, DOI 10.1038/nsb0596-410
   FRANKLIN RE, 1953, ACTA CRYSTALLOGR, V6, P673, DOI 10.1107/S0365110X53001939
   Zhang WS, 2003, BIOCHEMISTRY-US, V42, P6596, DOI 10.1021/bi034280h
   Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997
   Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398
   EGHOLM M, 1992, J AM CHEM SOC, V114, P1895, DOI 10.1021/ja00031a062
   CHOW CS, 1995, BIOCHEMISTRY-US, V34, P2956, DOI 10.1021/bi00009a027
   CLEGG RM, 1992, BIOCHEMISTRY-US, V31, P4846, DOI 10.1021/bi00135a016
   PEFFER NJ, 1993, P NATL ACAD SCI USA, V90, P10648, DOI 10.1073/pnas.90.22.10648
   WITTUNG P, 1995, J AM CHEM SOC, V117, P10167, DOI 10.1021/ja00146a001
   Miick SM, 1997, P NATL ACAD SCI USA, V94, P9080, DOI 10.1073/pnas.94.17.9080
   COOPER JP, 1987, J MOL BIOL, V198, P711, DOI 10.1016/0022-2836(87)90212-9
   DUCKETT DR, 1995, PHILOS T ROY SOC B, V347, P27, DOI 10.1098/rstb.1995.0005
   Gambari R, 2004, CURR DRUG TARGETS, V5, P419, DOI 10.2174/1389450043345416
   KALLENBACH NR, 1983, J BIOMOL STRUCT DYN, V1, P159
   McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883
   KALLENBACH NR, 1983, NATURE, V305, P829, DOI 10.1038/305829a0
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   HOESS R, 1987, P NATL ACAD SCI USA, V84, P6840, DOI 10.1073/pnas.84.19.6840
   Borgatti M, 2003, J BIOL CHEM, V278, P7500, DOI 10.1074/jbc.M206780200
   Piva R, 2006, ANN NY ACAD SCI, V1091, P509, DOI 10.1196/annals.1378.092
   Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x
   Hyrup B, 1996, BIOORGAN MED CHEM, V4, P5, DOI 10.1016/0968-0896(95)00171-9
   Nielsen PE, 2010, CHEM BIODIVERS, V7, P786, DOI 10.1002/cbdv.201000005
   Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026
   Totsingan F, 2013, PROTEIN SCI, V22, P1552, DOI 10.1002/pro.2342
   Nielsen PE, 2008, SCI AM, V299, P64
   DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6
   Grainger RJ, 1998, BIOCHEMISTRY-US, V37, P23, DOI 10.1021/bi9721492
   Wu Q, 2003, ARCH BIOCHEM BIOPHYS, V411, P105, DOI 10.1016/S0003-9861(02)00721-X
   Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590
   NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210
   Gambari R, 2010, BIOCHEM PHARMACOL, V80, P1887, DOI 10.1016/j.bcp.2010.06.047
   LEIJON M, 1994, BIOCHEMISTRY-US, V33, P9820, DOI 10.1021/bi00199a002
   DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6
   Cabrini G, 2010, CURR MED CHEM, V17, P4392, DOI 10.2174/092986710793361243
   Mischiati C, 1999, J BIOL CHEM, V274, P33114, DOI 10.1074/jbc.274.46.33114
   Hays FA, 2003, J BIOL CHEM, V278, P49663, DOI 10.1074/jbc.R3000332300
   Xin H, 2000, NUCLEIC ACIDS RES, V28, P4044, DOI 10.1093/nar/28.20.4044
   CHURCHILL MEA, 1988, P NATL ACAD SCI USA, V85, P4653, DOI 10.1073/pnas.85.13.4653
   Khuu P, 2009, BIOCHEMISTRY-US, V48, P7824, DOI 10.1021/bi900829b
   Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175
   Kypr J, 1999, NUCLEIC ACIDS RES, V27, P3466, DOI 10.1093/nar/27.17.3466
   SEEMAN NC, 1983, BIOPHYS J, V44, P201
   PIKKEMAAT JA, 1994, BIOCHEMISTRY-US, V33, P14896, DOI 10.1021/bi00253a029
   HANVEY JC, 1992, SCIENCE, V258, P1481, DOI 10.1126/science.1279811
   Howell LA, 2011, CHEM COMMUN, V47, P8262, DOI 10.1039/c1cc12922h
   SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4
   DUCKETT DR, 1990, EMBO J, V9, P583
   Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548
   Ortiz-Lombardia M, 1999, NAT STRUCT BIOL, V6, P913
   Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135
   KITTS PA, 1987, NATURE, V329, P346, DOI 10.1038/329346a0
   Jayaram B, 1998, J AM CHEM SOC, V120, P10629, DOI 10.1021/ja981307p
   Joo C, 2004, J MOL BIOL, V341, P739, DOI 10.1016/j.jmb.2004.06.024
   MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0
   Gasser G, 2011, DALTON T, V40, P7061, DOI 10.1039/c0dt01706j
   Larsen HJ, 1996, NUCLEIC ACIDS RES, V24, P458, DOI 10.1093/nar/24.3.458
   Bell T., 2015, BELL DATAINBRI UNPUB
   EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0
   Finotti Alessia, 2012, Artif DNA PNA XNA, V3, P97, DOI 10.4161/adna.21061
   McConnell KJ, 2000, J MOL BIOL, V304, P803, DOI 10.1006/jmbi.2000.4167
   PACE CN, 1995, PROTEIN SCI, V4, P2411
   Seeman N C, 1985, Prog Clin Biol Res, V172A, P99
   Shida T, 1996, J BIOCHEM-TOKYO, V119, P653
   Wang J.C., 1979, NUCLEIC ACIDS RES, V27, P3466
   Weir H.M., 1993, NATURE, V12, P1311
NR 68
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2015
VL 587
BP 1
EP 11
DI 10.1016/j.abb.2015.08.017
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW7BL
UT WOS:000365152800001
PM 26348651
ER

PT J
AU Li, ML
   Jiang, S
   Mo, CC
   Zeng, ZC
   Li, XW
   Chen, CK
   Yang, YJ
   Wang, JL
   Huang, JL
   Chen, DX
   Peng, T
   Cai, MS
AF Li, Meili
   Jiang, Si
   Mo, Chuncong
   Zeng, Zhancheng
   Li, Xiaowei
   Chen, Chunke
   Yang, Yanjia
   Wang, Jinlin
   Huang, Jinlu
   Chen, Daixiong
   Peng, Tao
   Cai, Mingsheng
TI Identification of molecular determinants for the nuclear import of
   pseudorabies virus UL31
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE PRV UL31; Nuclear import; Importin; Ran-GTP
ID SUBCELLULAR TRANSPORT MECHANISM; INTRACELLULAR-LOCALIZATION; EXPORT
   SIGNALS; GENE-PRODUCTS; EGRESS COMPLEX; PROTEIN IMPORT; U(L)34 PROTEIN;
   MATURE VIRIONS; CELL-NUCLEUS; US3 PROTEIN
AB Herpes simplex virus 1 (HSV-1) UL31 is a multifunctional protein and important for HSV-1 infection. Pseudorabies virus (PRV) UL31 is a late protein homologous to HSV-1 UL31. Previous studies showed that PRV 0131 is predominantly localized to nucleus, however, the molecular determinants for its nuclear import were unclear to date. Here, by utilizing live cells fluorescent microscopy, UL31 fused with enhanced yellow fluorescent protein was transiently expressed in live cells and confirmed to exclusively target to the nucleus in the absence of other viral proteins. Furthermore, the nuclear import of UL31 was found to be dependent on the Ran-, importin alpha 1-, alpha 3-, alpha 5-, beta 1-and transportin-l-mediated pathway. Therefore, these results would open up new avenues for depicting the biological functions of UL31 during PRV infection. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Li, Meili; Jiang, Si; Mo, Chuncong; Zeng, Zhancheng; Li, Xiaowei; Chen, Chunke; Yang, Yanjia; Wang, Jinlin; Chen, Daixiong; Cai, Mingsheng] Guangzhou Med Univ, Dept Pathogen Biol & Immunol, Sch Basic Sci, Guangzhou 511436, Guangdong, Peoples R China.
   [Li, Meili; Jiang, Si; Chen, Daixiong; Peng, Tao; Cai, Mingsheng] Guangzhou Med Univ, Sch Basic Sci, Guangzhou Hoffmann Inst Immunol, Guangzhou 511436, Guangdong, Peoples R China.
   [Huang, Jinlu] Guangdong Haid Grp Co Ltd, Guangzhou 511400, Guangdong, Peoples R China.
RP Cai, MS (reprint author), Guangzhou Med Univ, Dept Pathogen Biol & Immunol, Guangzhou 511436, Guangdong, Peoples R China.
EM mingshengcai@hotmail.com
FU National Natural Science Foundation of China [31200120, 31400150];
   Natural Science Foundation of Guangdong Province [S2013040016596,
   2015A030313473]; Foundation for Distinguished Young Talents in Higher
   Education of Guangdong, China [2013LYM_0096]; Pearl River S&T Nova
   Program of Guangzhou [2013J2200018]; Science and Technology Program of
   Guangzhou, China [201504291022514]; Scientific Research Projects in
   Colleges and universities of Guangzhou [1201430024]; Scientific Research
   Foundation [2014C02]; Medical Scientific Research Foundation of
   Guangdong Province, China [B2012165]; First Batch of Young Core
   Instructor of Guangzhou Medical University; Thousand Hundred Ten
   Projects of Guangzhou Medical University, Guangdong; Science and
   Technology Plan Projects of Guangdong Province, China [2013B031800022];
   National Undergraduate Training Programs for Innovation and
   Entrepreneurship [201510570006]; Guangzhou Medical University [2014005]
FX This work was supported by grants from the National Natural Science
   Foundation of China (31200120 and 31400150); the Natural Science
   Foundation of Guangdong Province (S2013040016596 and 2015A030313473);
   the Foundation for Distinguished Young Talents in Higher Education of
   Guangdong, China (2013LYM_0096); the Pearl River S&T Nova Program of
   Guangzhou (2013J2200018); the Science and Technology Program of
   Guangzhou, China (201504291022514); the Scientific Research Projects in
   Colleges and universities of Guangzhou (1201430024); the Scientific
   Research Foundation for the Ph.D., Guangzhou Medical University
   (2014C02); the Medical Scientific Research Foundation of Guangdong
   Province, China (B2012165); the First Batch of Young Core Instructor of
   Guangzhou Medical University; the Thousand Hundred Ten Projects of
   Guangzhou Medical University, Guangdong; the Science and Technology Plan
   Projects of Guangdong Province, China (2013B031800022); the National
   Undergraduate Training Programs for Innovation and Entrepreneurship
   (201510570006); and the Students' extracurricular scientific and
   technological activities in Guangzhou Medical University (2014005). We
   thank Drs. Lynn W. Enquist, Yoshinari Yasuda, Haitao Guo, Nobuyuki
   Nukina, Yoshihiro Yoneda, Ben Margolis, Christopher F. Basler, Donna D.
   Zhang, Christoph Kaether and Reinhard Depping for the generous gifts of
   pBecker2, pGEX-Ran-Q69L, DN k alpha l, DN k beta 1, RFP-M9M/RFP-Bimax2,
   pcDNA-Flag-k alpha l (importin alpha 5), pCMV9-3 x FLAG-importin beta 1,
   Flag-k alpha 6 (importin alpha 7), Flag-k alpha 2 (importin alpha 1) and
   Flag-k alpha 4 (importin alpha 3), respectively.
CR Liang L, 2005, J VIROL, V79, P3797, DOI 10.1128/JVI.79.6.3797-3806.2005
   Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229
   Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005
   Chi NC, 1997, J BIOL CHEM, V272, P6818
   Reid SP, 2007, J VIROL, V81, P13469, DOI 10.1128/JVI.01097-07
   CHANG YE, 1993, J VIROL, V67, P6348
   Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625
   Simpson-Holley M, 2004, J VIROL, V78, P5591, DOI 10.1128/JVI.78.11.5591-5600.2004
   Kino Y, 2011, NUCLEIC ACIDS RES, V39, P2781, DOI 10.1093/nar/gkq1162
   Guo HT, 2010, J VIROL, V84, P387, DOI 10.1128/JVI.01921-09
   Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032
   Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153
   Kato A, 2006, J VIROL, V80, P1476, DOI 10.1128/JVI.80.3.1476-1486.2006
   Granzow H, 2004, J VIROL, V78, P1314, DOI 10.1128/JVI.78.3.1314-1323.2004
   Passvogel L, 2015, J VIROL, V89, P2002, DOI 10.1128/JVI.03143-14
   Ye GJ, 2000, P NATL ACAD SCI USA, V97, P11002, DOI 10.1073/pnas.97.20.11002
   Desai PJ, 2012, J VIROL, V86, P594, DOI 10.1128/JVI.05988-11
   Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006
   Lake CM, 2004, VIROLOGY, V320, P99, DOI 10.1016/j.virol.2003.11.018
   Grimm KS, 2012, J VIROL, V86, P6512, DOI 10.1128/JVI.00068-12
   Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/j.molcel.2004.10.026
   Roberts KL, 2011, J VIROL, V85, P4947, DOI 10.1128/JVI.00068-11
   Zhu HY, 1999, ARCH VIROL, V144, P1923, DOI 10.1007/s007050050715
   Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016
   Cai MS, 2011, J GEN VIROL, V92, P621, DOI 10.1099/vir.0.027029-0
   Isegawa Y, 2008, J VIROL, V82, P710, DOI 10.1128/JVI.00736-07
   Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506
   Mizuguchi C, 2011, HYBRIDOMA, V30, P307, DOI 10.1089/hyb.2011.0006
   Smith GA, 2000, P NATL ACAD SCI USA, V97, P4873, DOI 10.1073/pnas.080502497
   Mou F, 2009, J VIROL, V83, P5181, DOI 10.1128/JVI.00090-09
   Bubeck A, 2004, J VIROL, V78, P8026, DOI 10.1128/JVI.78.15.8026-8035
   Reynolds AE, 2001, J VIROL, V75, P8803, DOI 10.1128/JVI.75.18.8803-8817.2001
   Li ML, 2011, J VIROL, V85, P10239, DOI 10.1128/JVI.05223-11
   Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607
   Ushijima R, 2005, BIOCHEM BIOPH RES CO, V330, P880, DOI 10.1016/j.bbrc.2005.03.063
   Li ML, 2015, ARCH VIROL, V160, P2591, DOI 10.1007/s00705-015-2527-7
   Palacios I, 1996, J CELL BIOL, V133, P485, DOI 10.1083/jcb.133.3.485
   Li ML, 2011, VIROLOGY, V417, P385, DOI 10.1016/j.virol.2011.06.004
   Klupp BG, 2007, P NATL ACAD SCI USA, V104, P7241, DOI 10.1073/pnas.0701757104
   Cai MS, 2012, MED MICROBIOL IMMUN, V201, P103, DOI 10.1007/s00430-011-0211-4
   Lotzerich M, 2006, J VIROL, V80, P73, DOI 10.1128/JVI.80.1.73-84.2006
   Yamauchi Y, 2001, J GEN VIROL, V82, P1423
   Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375
   Yang K, 2011, P NATL ACAD SCI USA, V108, P14276, DOI 10.1073/pnas.1108564108
   Fuchs W, 2002, J VIROL, V76, P364, DOI 10.1128/JVI.76.1.364-378.2002
   Granato M, 2008, J VIROL, V82, P4042, DOI 10.1128/JVI.02436-07
   Gonnella R, 2005, J VIROL, V79, P3713, DOI 10.1128/JVI.79.6.3713-3727.2005
   Cai MS, 2015, ACTA VIROL, V59, P295, DOI 10.4149/av_2015_03_295
   Dal Monte P, 2002, J GEN VIROL, V83, P1005
   MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0
   Li ML, 2014, MOL BIOL REP, V41, P5997, DOI 10.1007/s11033-014-3477-y
   Wu FQ, 2011, MED MICROBIOL IMMUN, V200, P203, DOI 10.1007/s00430-011-0196-z
   Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019
   Camozzi D, 2008, J GEN VIROL, V89, P731, DOI 10.1099/vir.0.83377-0
   Bigalke JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5131
NR 55
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2015
VL 587
BP 12
EP 17
DI 10.1016/j.abb.2015.09.024
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW7BL
UT WOS:000365152800002
PM 26450651
ER

PT J
AU Jamdar, SN
   Are, VN
   Navamani, M
   Kumar, S
   Nagar, V
   Makde, RD
AF Jamdar, Sahayog N.
   Are, Venkata N.
   Navamani, Mallikarjunan
   Kumar, Saurabh
   Nagar, Vandan
   Makde, Ravindra D.
TI The members of M20D peptidase subfamily from Burkholderia cepacia,
   Deinococcus radiodurans and Staphylococcus aureus (HmrA) are
   carboxydipeptidases, primarily specific for Met-X dipeptides
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Burkholderia cepacia; Peptidase family M20D; HmrA; Deinococcus
   radiodurans; Staphylococcus aureus; Aminoacylase/carboxypeptidase
ID INDOLE-3-ACETYL-L-ASPARTIC ACID HYDROLASE; ESCHERICHIA-COLI;
   THERMOSTABLE AMINOACYLASE; ENTEROBACTER-AGGLOMERANS;
   PYROCOCCUS-HORIKOSHII; PURIFICATION; BACTERIA; GENE; AMIDOHYDROLASE;
   ARABIDOPSIS
AB Three members of peptidase family M20D from Burkholderia cepacia (BcepM20D; Uniprot accession no. A0A0F7GQ23), Deinococcus radiodurans R1 (DradM20D; Uniprot accession no. Q9RTP6) and Staphylococcus aureus (HmrA; Uniprot accession no. Q99Q45) were characterized in terms of their preference for various substrates. The results thus reveal that all the enzymes including HmrA lack endopeptidase as well as aminopeptidase activities and possess strong carboxypeptidase activity. Further, the amidohydrolase activity exerted on other substrates like N-Acetyl-Amino acids, N-Carbobenzoxyl-Amino acids and Indole acetic acid (IAA)-Amino acids is due to the ability of these enzymes to accommodate different types of chemical groups other than the amino acid at the S1 pocket. Further, data on peptide hydrolysis strongly suggests that all the three enzymes are primarily carboxydipeptidases exhibiting highest catalytic efficiency (k(cat)-K-m 5-36 x 10(5) M-1 s(-1)) for Met-X substrates, where -X could be Ala/Gly/Ser/Tyr/Phe/Leu depending on the source organism. The supportive evidence for the substrate specificities was also provided with the molecular docking studies carried out using structure of SACOL0085 and homology modelled structure of BcepM20D. The preference for different substrates, their binding at active site of the enzyme and possible role of these enzymes in recycling of methionine are discussed in this study. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Jamdar, Sahayog N.; Navamani, Mallikarjunan; Kumar, Saurabh; Nagar, Vandan] Bhabha Atom Res Ctr, Food Technol Div, Bombay 400085, Maharashtra, India.
   [Are, Venkata N.; Makde, Ravindra D.] Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Bombay 400085, Maharashtra, India.
RP Jamdar, SN (reprint author), Bhabha Atom Res Ctr, Food Technol Div, FIPLY, Bombay 400085, Maharashtra, India.
EM snjam2@gmail.com
CR Chou JC, 1998, MOL GEN GENET, V259, P172
   Rodionov DA, 2004, NUCLEIC ACIDS RES, V32, P3340, DOI 10.1093/nar/gkh659
   Tanimoto K, 2008, FEBS J, V275, P1140, DOI 10.1111/j.1742-4658.2008.06274.x
   Jamdar SN, 2009, FEMS MICROBIOL LETT, V295, P230, DOI 10.1111/j.1574-6968.2009.01601.x
   MEINNEL T, 1992, J BACTERIOL, V174, P2323
   Bitto E, 2009, PROTEINS, V74, P61, DOI 10.1002/prot.22124
   BROWN JL, 1973, J BIOL CHEM, V248, P409
   Chou JC, 1996, PLANT PHYSIOL, V112, P1281
   Bauer K, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1601, DOI 10.1016/B978-0-12-382219-2.00362-8
   DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5
   Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x
   Torres M, 2013, MICROBIOL RES, V168, P547, DOI 10.1016/j.micres.2013.04.011
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Story SV, 2001, J BACTERIOL, V183, P4259, DOI 10.1128/JB.183.14.4259-4268.2001
   Green JM, 2010, J BACTERIOL, V192, P2407, DOI 10.1128/JB.01362-09
   Girish TS, 2013, ACTA CRYSTALLOGR F, V69, P103, DOI 10.1107/S1744309112049822
   Berger BJ, 2003, J BACTERIOL, V185, P2418, DOI 10.1128/JB.185.8.2418-2431.2003
   LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200
   COLOMBO S, 1992, EUR J BIOCHEM, V206, P349, DOI 10.1111/j.1432-1033.1992.tb16934.x
   Chou JC, 2005, J PLANT GROWTH REGUL, V24, P11, DOI 10.1007/s00344-005-0013-2
   Curley P, 2003, ARCH MICROBIOL, V179, P402, DOI 10.1007/s00203-003-0544-5
   WANG ZX, 1992, BIOCHEM J, V281, P285
   Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002
   Ishikawa K, 2001, APPL ENVIRON MICROB, V67, P673, DOI 10.1128/AEM.67.2.673-679.2001
   SAKANYAN V, 1993, APPL ENVIRON MICROB, V59, P3878
   Botelho TO, 2011, J BIOL CHEM, V286, P25697, DOI 10.1074/jbc.M111.247437
   Velasco AM, 2002, J MOL EVOL, V55, P445, DOI 10.1007/s00239-002-2340-2
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Veiga-da-Cunha M, 2014, J BIOL CHEM, V289, P19726, DOI 10.1074/jbc.M114.576579
   Lin LL, 2007, J BIOTECHNOL, V128, P322, DOI 10.1016/j.jbiotec.2006.10.011
   Daniela J., 2002, STRUCTURE, V10, P1097
   DeLano W, PYMOL MOL GRAPHICS S
   Laemmli U.K., 1970, NATURE, V390, P364
   Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x
   Minasov G., 2005, STRUCTURE BACILLUS S
   Morris G.M., 2009, J COMPUT CHEM, V30, P2785
   Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P325, DOI 10.1016/B978-0-12-382219-2.00077-6
   Shukla JK, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1586, DOI 10.1016/B978-0-12-382219-2.00358-6
NR 38
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2015
VL 587
BP 18
EP 30
DI 10.1016/j.abb.2015.10.003
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW7BL
UT WOS:000365152800003
PM 26456402
ER

PT J
AU Sohda, M
   Misumi, Y
   Oda, K
AF Sohda, Miwa
   Misumi, Yoshio
   Oda, Kimimitsu
TI TNF alpha triggers release of extracellular vesicles containing TNFR1
   and TRADD, which can modulate TNF alpha responses of the parental cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE TNF alpha; TNFR1; TRADD; Extracellular vesicles
ID EXOSOME-LIKE VESICLES; NECROSIS-FACTOR RECEPTORS; TUMOR; ACTIVATION;
   GENERATION; SECRETION; CERAMIDE; PROTEIN; DEATH; BIG2
AB Tumor necrosis factor-alpha (TNF alpha)-induced reactions are effective to maintain homeostasis; however, excessive responses play progressive roles in the pathogenesis of various chronic inflammatory diseases. We demonstrate that TNF alpha triggered the release of its receptor TNFR1 as a content of extracellular vesicles (EVs) from the human bronchial epithelial cell, BEAS-2b. The TNFR1 cytoplasmic domain binding partner, TNFR-associated death domain (TRADD), was released by TNFa treatment along with TNFR1. TNF alpha-triggered release of EVs was decreased in the presence of amitriptyline, an inhibitor of acid sphingomyelinase (A-SMase), or of GW4869, an inhibitor of neutral sphingomyelinase (N-SMase), indicating that EVs containing TNFR1 and TRADD are released through A-SMase and N-SMase dependent manners. From sucrose density gradient analysis, each sphingomyelinase is involved in the generation of distinct populations of EVs. Inhibition of A-SMase or N-SMase resulted in significantly increased responses to TNFa in parental cells. Given that TRADD serves as a platform for the assembly of subsequent signaling molecules, the TNFa triggered release of TNFR1 and TRADD might be an effective strategy for down regulation of the TNFa responses of parental cells. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Sohda, Miwa; Oda, Kimimitsu] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Biochem, Chuo Ku, Niigata 9518514, Japan.
   [Misumi, Yoshio] Fukuoka Univ, Sch Med, Dept Cell Biol, Jonan Ku, Fukuoka 8140180, Japan.
RP Sohda, M (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Biochem, Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.
EM sohda@dent.niigata-u.ac.jp
CR TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292
   Islam A, 2008, J BIOL CHEM, V283, P25364, DOI 10.1074/jbc.M804966200
   BROIDE DH, 1992, J ALLERGY CLIN IMMUN, V89, P958, DOI 10.1016/0091-6749(92)90218-Q
   Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100
   Walczak H, 2011, IMMUNOL REV, V244, P9, DOI 10.1111/j.1600-065X.2011.01066.x
   Islam A, 2006, J BIOL CHEM, V281, P6860, DOI 10.1074/jbc.M509397200
   Zhang J, 2008, BIOCHEM BIOPH RES CO, V366, P579, DOI 10.1016/j.bbrc.2007.12.011
   Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569
   Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725
   Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x
   Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425
   Ogawa Y, 2011, BIOL PHARM BULL, V34, P13, DOI 10.1248/bpb.34.13
   BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127
   PORTEU F, 1990, J EXP MED, V172, P599, DOI 10.1084/jem.172.2.599
   Puimege L, 2014, CYTOKINE GROWTH F R, V25, P285, DOI 10.1016/j.cytogfr.2014.03.004
   Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200
   Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189
   Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45
   Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009
   WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5
   Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616
   Geminard C, 2004, TRAFFIC, V5, P181, DOI 10.1111/j.1600-0854.2004.00167.x
   MacKichan ML, 1999, J BIOL CHEM, V274, P1767, DOI 10.1074/jbc.274.3.1767
   Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124
   Wang J, 2003, J BIOL CHEM, V278, P21751, DOI 10.1074/jbc.M212662200
   Bobrie A, 2012, J EXTRACELL VESICLES, V1, P18397, DOI DOI 10.3402/JEV.V1I0.18397
   Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004
   Schneider-Brachert W, 2013, INT J MOL SCI, V14, P14475, DOI 10.3390/ijms140714475
   Sonoda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122212
   Witwer K. W., 2013, J EXTRACELL VESICLES, V2, P20360, DOI DOI 10.3402/JEV.V2I0.20360
   Yanez-Mo M., 2015, VESICLES, V14, P27066
NR 31
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2015
VL 587
BP 31
EP 37
DI 10.1016/j.abb.2015.10.009
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW7BL
UT WOS:000365152800004
PM 26475675
ER

PT J
AU Wu, F
   Kumar, P
   Lu, C
   El Marjou, A
   Qiu, W
   Lim, CT
   Thiery, JP
   Liu, RC
AF Wu, Fei
   Kumar, Prashant
   Lu, Chen
   El Marjou, Ahmed
   Qiu, Wu
   Lim, Chwee Teck
   Thiery, Jean Paul
   Liu, Ruchuan
TI Homophilic interaction and deformation of E-cadherin and cadherin 7
   probed by single molecule force spectroscopy
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Force spectroscopy; Cell adhesion; Atomic force microscopy; Magnetic
   tweezers
ID CELL-CELL ADHESION; EXTRACELLULAR DOMAINS; ADHERENS JUNCTIONS; MEDIATED
   ADHESIONS; VINCULIN BINDING; C-CADHERIN; DYNAMICS; SWITCH;
   MECHANOTRANSDUCTION; SPECIFICITY
AB Cadherin-mediated adhesion plays a crucial role in multicellular organisms. Dysfunction within this adhesion system has major consequences in many pathologies, including cancer invasion and metastasis. However, mechanisms controlling cadherin recognition and adhesive strengthening are only partially understood. Here, we investigated the homophilic interactions and mechanical stability of the extracellular (EC) domains of E-cadherin and cadherin 7 using atomic force microscopy and magnetic tweezers. Besides exhibiting stronger interactions. E-cadherin also showed more efficient force-induced self-strengthening of interactions than cadherin 7. In addition, the distributions of the unbinding forces for both cadherins partially overlap with those of the unfolding forces, indicating that partial unfolding/deformation of the cadherin EC domains may take place during their homophilic interactions. These conformational changes may be involved in cadherins physiology function and contribute to the significant differences in adhesive strength mediated by type I and type II cadherins. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Wu, Fei; Qiu, Wu; Liu, Ruchuan] Chongqing Univ, Coll Phys, Chongqing 401331, Peoples R China.
   [Wu, Fei; Qiu, Wu; Liu, Ruchuan] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore.
   [Wu, Fei; Lu, Chen; Lim, Chwee Teck; Liu, Ruchuan] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore.
   [Kumar, Prashant; Thiery, Jean Paul] Inst Mol & Cell Biol, Singapore 138673, Singapore.
   [El Marjou, Ahmed] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore.
   [El Marjou, Ahmed] Inst Curie, CNRS144, F-75005 Paris, France.
   [Lim, Chwee Teck] Natl Univ Singapore, Dept Bioengn, Singapore 117576, Singapore.
RP Liu, RC (reprint author), Chongqing Univ, Coll Phys, 55 Daxuecheng South Rd, Chongqing 401331, Peoples R China.
EM phyliurc@cqu.edu.cn
RI ASTAR, IMCB/E-2320-2012
FU Research Start Fund for Talent Recruitment, Chongqing University, China;
   Mechanobiology Institute, Singapore. [WBS R-714-002-007-271]
FX We gratefully acknowledge support from the Research Start Fund for
   Talent Recruitment, Chongqing University, China, and the seed grant (WBS
   R-714-002-007-271) from the Mechanobiology Institute, Singapore.
CR Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202
   UMBAS R, 1992, CANCER RES, V52, P5104
   Huang J, 2011, J CELL SCI, V124, P4001, DOI 10.1242/jcs.086694
   Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583
   Chen H, 2011, BIOPHYS J, V100, P517, DOI 10.1016/j.bpj.2010.12.3700
   Verbelen C, 2007, J MOL RECOGNIT, V20, P490, DOI 10.1002/jmr.833
   Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109
   Fisher TE, 1999, TRENDS BIOCHEM SCI, V24, P379, DOI 10.1016/S0968-0004(99)01453-X
   Liu RC, 2009, BIOPHYS J, V96, P3810, DOI 10.1016/j.bpj.2009.01.043
   Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020
   Chu YS, 2006, J BIOL CHEM, V281, P2901, DOI 10.1074/jbc.M506185200
   van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006
   Dufour S, 1999, J CELL BIOL, V146, P501, DOI 10.1083/jcb.146.2.501
   Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Leckband DE, 2011, CURR OPIN CELL BIOL, V23, P523, DOI 10.1016/j.ceb.2011.08.003
   Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719
   Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044
   Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043
   Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928
   Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107
   Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699
   Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046
   Shrestha Binesh, 2008, V439, P269, DOI 10.1007/978-1-59745-188-8_19
   Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559
   Wong J, 1999, BIOMOL ENG, V16, P45, DOI 10.1016/S1050-3862(99)00035-2
   Cavallaro U, 2002, CANCER LETT, V176, P123, DOI 10.1016/S0304-3835(01)00759-5
   OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937
   Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108
   Jiang YX, 2003, ANAL CHEM, V75, P2112, DOI 10.1021/ac026182s
   TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237
   Canel M, 2010, CELL ADHES MIGR, V4, P491, DOI 10.4161/cam.4.4.12661
   Posy S, 2008, J MOL BIOL, V378, P954, DOI 10.1016/j.jmb.2008.02.063
   Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016
   Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101
   Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106
   Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007
   Liu RC, 2013, J BIOMOL STRUCT DYN, V31, P1137, DOI 10.1080/07391102.2012.726530
   Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004
   Oroz J, 2011, J BIOL CHEM, V286, P9405, DOI 10.1074/jbc.M110.170399
   Shi QM, 2010, BIOPHYS J, V99, P95, DOI 10.1016/j.bpj.2010.03.062
   Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159
   Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106
   Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183
   Tabdili H, 2012, J CELL SCI, V125, P4362, DOI 10.1242/jcs.105775
   Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002
   de Beco S, 2009, P NATL ACAD SCI USA, V106, P7010, DOI 10.1073/pnas.0811253106
   le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149
   Roy R, 2008, NAT METHODS, V5, P507, DOI [10.1038/nmeth.1208, 10.1038/NMETH.1208]
   del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912
   Rakshit S, 2012, P NATL ACAD SCI USA, V109, P18815, DOI 10.1073/pnas.1208349109
   Harrison O.J., 2010, NAT STRUCT MOL BIOL, V17
   Horvath L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07974
   Manibog K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4941
   Petrova Y.I., 2012, MOL BIOL CELL, V23, P2092
   Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591
   Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525
NR 57
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2015
VL 587
BP 38
EP 47
DI 10.1016/j.abb.2015.10.008
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW7BL
UT WOS:000365152800005
PM 26476343
ER

PT J
AU Chia, YCJ
   Catimel, B
   Lio, DSS
   Ang, CS
   Peng, BM
   Wu, H
   Zhu, HJ
   Cheng, HC
AF Chia, Yeong-Chit Joel
   Catimel, Bruno
   Lio, Daisy Sio Seng
   Ang, Ching-Seng
   Peng, Benjamin
   Wu, Hong
   Zhu, Hong-Jian
   Cheng, Heung-Chin
TI The C-terminal tail inhibitory phosphorylation sites of PTEN regulate
   its intrinsic catalytic activity and the kinetics of its binding to
   phosphatidylinositol-4,5-bisphosphate
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE PTEN; C-terminal tail; Phosphorylation; Phosphatase;
   Phosphatidylinositol-4,5-bisphosphate; Kinetics
ID TUMOR-SUPPRESSOR PTEN; TENSIN-HOMOLOG PTEN;
   PROTEIN-PHOSPHATASE-ACTIVITIES; MEMBRANE ASSOCIATION; STABILITY; CELL;
   ACTIVATION; KINASES; DOMAIN; INTERACTOME
AB Dephosphorylation of four major C-terminal tail sites and occupancy of the phosphatidylinositol-4,5-bisphosphate [PI(4,5)P-2]-binding site of PTEN cooperate to activate its phospholipid phosphatase activity and facilitate its recruitment to plasma membrane. Our investigation of the mechanism by which phosphorylation of these C-terminal sites controls the PI(4,5)P-2-binding affinity and catalytic activity of PTEN resulted in the following findings. First, dephosphorylation of all four sites leads to full activation; and phosphorylation of any one site significantly reduces the intrinsic catalytic activity of PTEN. These findings suggest that coordinated inhibition of the upstream protein kinases and activation of the protein phosphatases targeting the four sites are needed to fully activate PTEN phosphatase activity. Second, PI(4,5)P-2 cannot activate the phosphopeptide phosphatase activity of PTEN, suggesting that PI(4,5)P-2 can only activate the phospholipid phosphatase activity but not the phosphoprotein phosphatase activity of PTEN. Third, dephosphorylation of all four sites significantly decreases the affinity of PTEN for PI(4,5)P-2. Since PI(4,5)P-2 is a major phospholipid co-localizing with the phospholipid- and phosphoprotein-substrates in plasma membrane, we hypothesise that the reduced affinity facilitates PTEN to "hop" on the plasma membrane to dephosphorylate these substrates. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Chia, Yeong-Chit Joel; Lio, Daisy Sio Seng; Peng, Benjamin; Wu, Hong; Cheng, Heung-Chin] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.
   [Chia, Yeong-Chit Joel; Lio, Daisy Sio Seng; Ang, Ching-Seng; Wu, Hong; Cheng, Heung-Chin] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Parkville, Vic 3010, Australia.
   [Catimel, Bruno] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.
   [Zhu, Hong-Jian] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3052, Australia.
RP Cheng, HC (reprint author), Univ Melbourne, Dept Biochem & Mol Biol, 30 Flemington Rd, Parkville, Vic 3010, Australia.
EM heung@unimelb.edu.au
FU National Health and Medical Research Council of Australia [APP1050486];
   Australian Research Council
FX The work described in this manuscript was supported by project grants
   from the National Health and Medical Research Council of Australia
   (APP1050486) and Australian Research Council (to H.-C.C., H.-J. Z. and
   B.C.).
CR Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375
   Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000
   Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236
   Hodakoski C, 2014, P NATL ACAD SCI USA, V111, P155, DOI 10.1073/pnas.1213773111
   Choi BH, 2014, J BIOL CHEM, V289, P14066, DOI 10.1074/jbc.M114.558155
   Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3
   Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907
   Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n
   Catimel B, 2013, J PROTEOMICS, V82, P35, DOI 10.1016/j.jprot.2013.01.031
   Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185
   Shenoy SS, 2012, J STRUCT BIOL, V180, P394, DOI 10.1016/j.jsb.2012.10.003
   Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384
   Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103
   Fenton TR, 2012, P NATL ACAD SCI USA, V109, P14164, DOI 10.1073/pnas.1211962109
   Xiao Y, 2007, CELL SIGNAL, V19, P1434, DOI 10.1016/j.cellsig.2007.01.021
   Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1067/jbc.C100556200
   Li ZG, 2014, MOL CELL BIOL, V34, P3642, DOI 10.1128/MCB.00814-14
   Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200
   Cordier F, 2012, J AM CHEM SOC, V134, P20533, DOI 10.1021/ja310214g
   Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200
   Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839
   Poon JS, 2010, CELL CYCLE, V9, P4450, DOI 10.4161/cc.9.22.13936
   Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111
   Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200
   FOULKES JG, 1981, FEBS LETT, V130, P197, DOI 10.1016/0014-5793(81)81118-0
   Gajewski JE, 2007, PROTEIN EXPRES PURIF, V55, P334, DOI 10.1016/j.pep.2007.04.024
   Dey N, 2008, CANCER RES, V68, P1862, DOI 10.1158/0008-5472.CAN-07-1182
   Zhang XC, 2012, BIOCHEM J, V444, P457, DOI 10.1042/BJ20120098
   Shi YJ, 2014, NAT STRUCT MOL BIOL, V21, P522, DOI 10.1038/nsmb.2828
   Catimel B, 1997, J CHROMATOGR A, V776, P15, DOI 10.1016/S0021-9673(97)00087-3
   Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100
   Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200
   Nice EC, 1999, BIOESSAYS, V21, P339, DOI 10.1002/(SICI)1521-1878(199904)21:4<339::AID-BIES11>3.0.CO;2-C
   Chia JYC, 2010, BBA-PROTEINS PROTEOM, V1804, P1785, DOI 10.1016/j.bbapap.2010.05.009
   Cheung NS, 2004, CELL MOL LIFE SCI, V61, P1926, DOI 10.1007/s00018-004-4127-7
   Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012
   Lumb CN, 2013, BIOPHYS J, V104, P613, DOI 10.1016/j.bpj.2012.12.002
   Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389
   Mehenni H, 2005, HUM MOL GENET, V14, P2209, DOI 10.1093/hmg/ddi225
   Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200
   Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200
   Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182
   McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848
   Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w
   Cordier F, 2015, METHODS, V77-78, P82, DOI 10.1016/j.ymeth.2014.10.007
   Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026
   Johnson TM, 1997, J PEPT RES, V50, P365
   Blume-Jensen P, 2001, Methods Mol Biol, V124, P49
   Bolduc D, 2013, ELIFE, V2, DOI 10.7554/eLife.00691
   Cadmel B, 2008, J PROTEOME RES, V7, P5295, DOI 10.1021/pr800540h
   Gil A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119287
   Malaney P, 2013, SCI REP-UK, V3, DOI 10.1038/srep02035
   Nakahata S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4393
   Randar M., 2009, P NATL ACAD SCI USA, V106, P480
   Wei Y, 2015, J BIOL CHEM, V290, P1592, DOI 10.1074/jbc.M114.588590
   Yasui M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003817
NR 56
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2015
VL 587
BP 48
EP 60
DI 10.1016/j.abb.2015.10.004
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW7BL
UT WOS:000365152800006
PM 26471078
ER

PT J
AU Ababou, A
   Zaleska, M
AF Ababou, Abdessamad
   Zaleska, Mariola
TI Electrostatics effects on Ca2+ binding and conformational changes in
   EF-hand domains: Functional implications for EF-hand proteins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE EF-hand proteins; Ca2+ binding affinity; Electrostatic effect; Protein
   stability; MD simulation; CD and fluorescence spectroscopy
ID NUCLEAR-MAGNETIC-RESONANCE; NMR SPIN-RELAXATION; C-TERMINAL DOMAIN;
   MOLECULAR-DYNAMICS; CALCIUM-BINDING; CRYSTAL-STRUCTURE;
   CALMODULIN-BINDING; SIGNAL-TRANSDUCTION; REGULATORY DOMAINS; STRUCTURAL
   BASIS
AB Mutations of GIn41 and Lys75 with nonpolar residues in the N-terminal domain of calmodulin (N-Cam) revealed the importance of solvation energetics in conformational change of Ca2+ sensor EF-hand domains. While in general these domains have polar residues at these corresponding positions yet the extent of their conformational response to Ca2+ binding and their Ca2+ binding affinity can be different from N-Cam. Consequently, here we address the charge state of the polar residues at these positions. The results show that the charge state of these polar residues can affect substantially the conformational change and the Ca2+ binding affinity of our N-Cam variants. Since all the variants kept their conformational activity in the presence of Ca2+ suggests that the differences observed among them mainly originate from the difference in their molecular dynamics. Hence we propose that the molecular dynamics of Ca2+ sensor EF-hand domains is a key factor in the multifunctional aspect of EF-hand proteins. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ababou, Abdessamad] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England.
   [Zaleska, Mariola] Kings Coll London, Cardiovasc & Randall Div, London SE1 1UL, England.
RP Ababou, A (reprint author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.
EM a.ababou10@yahoo.co.uk
FU Department of Biochemistry at University College London (London, UK);
   Department of Chemistry & Biological Sciences at University of
   Huddersfield (Huddersfield, UK); Department of Pathology at University
   of Cambridge (Cambridge, UK)
FX We thank the Department of Biochemistry at University College London
   (London, UK), the Department of Chemistry & Biological Sciences at
   University of Huddersfield (Huddersfield, UK), and the Department of
   Pathology at University of Cambridge (Cambridge, UK) for their support.
   We would like to thank Dr Mark Pfuhl (King's College London, UK) for his
   support and critical reading of the manuscript.
CR LIM WA, 1994, P NATL ACAD SCI USA, V91, P423, DOI 10.1073/pnas.91.1.423
   Swint-Kruse L, 1998, BIOPHYS J, V74, P413
   Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X
   Lian LY, 2007, BIOCHEM BIOPH RES CO, V353, P565, DOI 10.1016/j.bbrc.2006.12.070
   Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017
   Villarroel A, 2014, J MOL BIOL, V426, P2717, DOI 10.1016/j.jmb.2014.05.016
   Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186
   Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106
   Li MX, 1997, BIOCHEMISTRY-US, V36, P12519, DOI 10.1021/bi971222l
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Sheehan JH, 2006, J BIOL CHEM, V281, P2876, DOI 10.1074/jbc.M509886200
   Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004
   Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103
   Jin LH, 1999, J MOL BIOL, V285, P361, DOI 10.1006/jmbi.1998.2311
   Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103
   CHANDRASEKHAR I, 1992, J MOL BIOL, V226, P239, DOI 10.1016/0022-2836(92)90136-8
   Capozzi F, 2006, J BIOL INORG CHEM, V11, P949, DOI 10.1007/s00775-006-0163-0
   Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010
   Malmendal A, 1998, BIOCHEMISTRY-US, V37, P2586, DOI 10.1021/bi971798a
   Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876
   Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228
   O'Connell DJ, 2010, MOL CELL PROTEOMICS, V9, P1118, DOI 10.1074/mcp.M900324-MCP200
   Hu HT, 2003, J MOL BIOL, V330, P473, DOI 10.1016/S0022-2836(03)00619-3
   Lau SY, 2012, J GEN PHYSIOL, V140, P541, DOI 10.1085/jgp.201210810
   Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029
   Krebs S, 1999, PROTEIN SCI, V8, P1393
   Fiorin G, 2005, PROTEINS, V61, P829, DOI 10.1002/prot.20597
   Ababou A, 2001, BIOCHEMISTRY-US, V40, P12719, DOI 10.1021/bi010405b
   Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y
   Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255
   Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296
   Heidary DK, 2005, J MOL BIOL, V353, P1187, DOI 10.1016/j.jmb.2005.08.072
   Trbovic N, 2008, PROTEINS, V71, P684, DOI 10.1002/prot.21750
   CHAZIN WJ, 1995, NAT STRUCT BIOL, V2, P707, DOI 10.1038/nsb0995-707
   LINSE S, 1991, J BIOL CHEM, V266, P8050
   Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188
   BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0
   Fisette O, 2010, BIOPHYS J, V98, P637, DOI 10.1016/j.bpj.2009.08.061
   KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0
   Kragelund BB, 1998, BIOCHEMISTRY-US, V37, P8926, DOI 10.1021/bi9726436
   Evenas J, 1998, BIOCHEMISTRY-US, V37, P13744, DOI 10.1021/bi9806448
   Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x
   Ababou A, 2001, PROTEIN SCI, V10, P301, DOI 10.1110/ps.33601
   Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019
   Yoshida T, 2003, BIOCHEMISTRY-US, V42, P4101, DOI 10.1021/bi027191y
   Vigil D, 2001, BIOPHYS J, V80, P2082
   TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x
   Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33
   Case DA, 2002, ACCOUNTS CHEM RES, V35, P325, DOI 10.1021/ar010020l
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   KRETSING.RH, 1973, J BIOL CHEM, V248, P3313
   Kumar V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01392
   Lu Q, 2015, NAT STRUCT MOL BIOL, V22, P81, DOI 10.1038/nsmb.2923
   Tidow H., 2013, NATURE, V491, P468
NR 54
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2015
VL 587
BP 61
EP 69
DI 10.1016/j.abb.2015.10.011
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW7BL
UT WOS:000365152800007
PM 26494044
ER

PT J
AU Azarashvili, T
   Krestinina, O
   Baburina, Y
   Odinokova, I
   Grachev, D
   Papadopoulos, V
   Akatov, V
   Lemasters, JJ
   Reiser, G
AF Azarashvili, T.
   Krestinina, O.
   Baburina, Yu
   Odinokova, I.
   Grachev, D.
   Papadopoulos, V.
   Akatov, V.
   Lemasters, J. J.
   Reiser, G.
TI Combined effect of G3139 and TSPO ligands on Ca2+-induced permeability
   transition in rat brain mitochondria
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE VDAC; TSPO; Mitochondria; Permeability transition pore; PK11195; G3139
ID PERIPHERAL BENZODIAZEPINE-RECEPTOR; PROTEIN 18 KDA; DEPENDENT ANION
   CHANNEL; TRANSLOCATOR-PROTEIN; CHOLESTEROL-BINDING; OUTER-MEMBRANE;
   IN-VIVO; CANCER-CELLS; VDAC; APOPTOSIS
AB Permeability of the mitochondrial outer membrane is determined by the activity of voltage-dependent anion channels (VDAC) which are regulated by many factors and proteins. One of the main partner-regulator of VDAC is the 18 kDa translocator protein (TSPO), whose role in the regulation of membrane permeability is not completely understood. We show that TSPO ligands, 1 mu M PPIX and PK11195 at concentrations of 50 mu M, accelerate opening of permeability transition pores (mPTP) in Ca2+-overloaded rat brain mitochondria (RBM). By contrast, PK11195 at 100 nM and anti-TSPO antibodies suppressed pore opening. Participation of VDAC in these processes was demonstrated by blocking VDAC with G3139, an 18-mer phosphorothioate oligonucleotides, which sensitized mitochondria to Ca2+-induced mPTP opening. Despite the inhibitory effect of 100 nM PK11195 and anti-TSPO antibodies alone, their combination with G3139 considerably stimulated the mPTP opening. Thus, 100 nM PK11195 and anti-TSPO antibody can modify permeability of the VDAC channel and mPTP. When VDAC channels are closed and TSPO is blocked, permeability of the VDAC for calcium seems to be the highest, which leads to accelerated pore opening. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Azarashvili, T.; Krestinina, O.; Baburina, Yu; Odinokova, I.; Grachev, D.; Akatov, V.; Lemasters, J. J.] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142290, Moscow Region, Russia.
   [Papadopoulos, V.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3H 2R9, Canada.
   [Papadopoulos, V.] McGill Univ, Dept Med, Montreal, PQ H3H 2R9, Canada.
   [Papadopoulos, V.] McGill Univ, Dept Biochem, Montreal, PQ H3H 2R9, Canada.
   [Papadopoulos, V.] McGill Univ, Dept Pharmacol, Montreal, PQ H3H 2R9, Canada.
   [Papadopoulos, V.] McGill Univ, Dept Therapeut, Montreal, PQ H3H 2R9, Canada.
   [Lemasters, J. J.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.
   [Lemasters, J. J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.
   [Reiser, G.] Univ Magdeburg, Fac Med, Inst Neurobiochem, D-39120 Magdeburg, Germany.
RP Azarashvili, T (reprint author), Russian Acad Sci, Inst Theoret & Expt Biophys, Inst Skaya Str 3, Pushchino 142290, Moscow Region, Russia.
EM tamara.azarashvili@gmail.com; krestinina@rambler.ru; byul@rambler.ru;
   odinokova@rambler.ru; grachew@rambler.ru;
   vassilios.papadopoulos@mcgill.ca; akatov.vladimir@gmail.com;
   JJLemasters@musc.edu; georg.reiser@med.ovgu.de
FU Russian Foundation for Basic Research [13-04-00935]; Russian Federation
   Government [N14.Z50.0028]; Deutsche Forschungsgemeinschaft (DFG grant)
   [Re563/22-1]; Canadian Institutes of Health Research [MOP 125983];
   Canada Research Chair in Biochemical Pharmacology
FX This study was supported by grants from the Russian Foundation for Basic
   Research (13-04-00935 to T.A.), the Russian Federation Government
   (N14.Z50.0028 to J.L.), Deutsche Forschungsgemeinschaft (DFG grant
   Re563/22-1 to G.R.) the Canadian Institutes of Health Research (MOP
   125983 to V.P.), and a Canada Research Chair in Biochemical Pharmacology
   (V.P.).
CR Jorda EG, 2005, APOPTOSIS, V10, P91, DOI 10.1007/s10495-005-6064-9
   Palmieri F, 1996, BBA-BIOENERGETICS, V1275, P127, DOI 10.1016/0005-2728(96)00062-X
   ROSSI CS, 1967, PROTOPLASMA, V63, P90, DOI 10.1007/BF01248008
   Tan WZ, 2007, BIOPHYS J, V93, P1184, DOI 10.1529/biophysj.107.105379
   SNYDER SH, 1987, FASEB J, V1, P282
   Rao VLR, 2001, J NEUROSCI RES, V64, P493, DOI 10.1002/jnr.1101
   Rostovtseva T, 1997, BIOPHYS J, V72, P1954
   Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429
   Rechichi M, 2008, BBA-MOL BASIS DIS, V1782, P118, DOI 10.1016/j.bbadis.2007.12.001
   Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005
   THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446
   Weiser BP, 2014, J PHYS CHEM B, V118, P9852, DOI 10.1021/jp504516a
   Xu X, 2001, J MEMBRANE BIOL, V180, P73, DOI 10.1007/s002320010060
   Ricchelli F, 2011, BBA-BIOENERGETICS, V1807, P482, DOI 10.1016/j.bbabio.2011.02.012
   Fan J, 2012, CURR MOL MED, V12, P369
   Hatty CR, 2014, BBA-BIOMEMBRANES, V1838, P1019, DOI 10.1016/j.bbamem.2013.12.013
   Lee AC, 1998, J MEMBRANE BIOL, V161, P173, DOI 10.1007/s002329900324
   Song JM, 1998, J BIOL CHEM, V273, P24406, DOI 10.1074/jbc.273.38.24406
   Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d
   Krestinina OV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P421, DOI 10.1134/S0006297909040105
   Guo Q, 2012, NEUROIMAGE, V60, P902, DOI 10.1016/j.neuroimage.2011.12.078
   Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003
   MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170
   Wendler G, 2003, BIOCHEM BIOPH RES CO, V311, P847, DOI 10.1016/j.bbrc.2003.10.070
   Hirsch T, 1998, EXP CELL RES, V241, P426, DOI 10.1006/excr.1998.4084
   ITZHAK Y, 1994, BRAIN RES, V660, P346, DOI 10.1016/0006-8993(94)91311-0
   Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295
   Tan WZ, 2007, BBA-BIOMEMBRANES, V1768, P2510, DOI 10.1016/j.bbamem.2007.06.002
   Azarashvili T, 2010, BIOL CHEM, V391, P619, DOI 10.1515/BC.2010.070
   Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988
   Decaudin D, 2002, CANCER RES, V62, P1388
   Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y
   Rostovtseva T, 1996, J BIOL CHEM, V271, P28006
   Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105
   Gavish M, 1999, PHARMACOL REV, V51, P629
   BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454
   Walsh C, 2009, BBA-BIOENERGETICS, V1787, P1374, DOI 10.1016/j.bbabio.2009.01.007
   Casellas P, 2002, NEUROCHEM INT, V40, P475, DOI 10.1016/S0197-0186(01)00118-8
   Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540
   Li F, 2013, BIOCHEMISTRY-US, V52, P5884, DOI 10.1021/bi400431t
   Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111
   Jaremko L, 2014, SCIENCE, V343, P1363, DOI 10.1126/science.1248725
   Azarashvili T, 2005, J NEUROCHEM, V94, P1054, DOI 10.1111/j.1741-4159.2005.03260.x
   TAKETANI S, 1995, J BIOCHEM-TOKYO, V117, P875
   Golani I, 2001, BIOCHEMISTRY-US, V40, P10213, DOI 10.1021/bi010431+
   Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004
   Song JM, 1998, BIOPHYS J, V74, P2926
   Tikunov A, 2010, ARCH BIOCHEM BIOPHYS, V495, P174, DOI 10.1016/j.abb.2010.01.008
   Veenman L, 2008, J BIOENERG BIOMEMBR, V40, P199, DOI 10.1007/s10863-008-9142-1
   Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006
   Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487
   Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6
   Owen DRJ, 2011, INT REV NEUROBIOL, V101, P19, DOI 10.1016/B978-0-12-387718-5.00002-X
   Azuma M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003070
   BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3
   Colombini M, 1996, Ion Channels, V4, P169
   Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534
   Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008
   Li F, 2015, SCIENCE, V347, P555, DOI 10.1126/science.1260590
   Tamse C.T., 2008, J CLIN BASIC CARDIOL, V11, P24
   Vander Heiden Matthew G., 2001, Journal of Biological Chemistry, V276, P19414, DOI 10.1074/jbc.M101590200
NR 61
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2015
VL 587
BP 70
EP 77
DI 10.1016/j.abb.2015.10.012
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW7BL
UT WOS:000365152800008
PM 26498031
ER

PT J
AU Luo, T
   Yue, RC
   Hu, HX
   Zhou, Z
   Yiu, KH
   Zhang, S
   Xu, L
   Li, K
   Yu, ZP
AF Luo, Tao
   Yue, Rongchuan
   Hu, Houxiang
   Zhou, Zhou
   Yiu, Kai Hang
   Zhang, Shuang
   Xu, Lei
   Li, Ke
   Yu, Zhengping
TI PD150606 protects against ischemia/reperfusion injury by preventing
   mu-calpain-induced mitochondrial apoptosis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE PD150606; Ischemia/reperfusion; Mitochondrial dysfunction; Apoptosis;
   mu-Calpain
ID ACUTE MYOCARDIAL-INFARCTION; ISCHAEMIA/REPERFUSION INJURY; PERMEABILITY
   TRANSITION; DEPENDENT APOPTOSIS; ANEMIC RATS; CELL-DEATH; ACTIVATION;
   INHIBITION; ISCHEMIA; MODEL
AB Calpain plays an important role in myocardial ischemia/reperfusion (I/R) injury. PD150606, a nonpeptide, cell-permeable and noncompetitive calpain inhibitor, has be2n shown to have protective properties in ischemic disease. The aims of the present study were to investigate whether PD150606 could alleviate myocardial I/R injury and to examine the possible mechanisms involved. The I/R model was established in vivo in C57BL/6 mice and in vitro using neonatal mouse cardiomyocytes, respectively. To evaluate the protective effects of PD150606 on I/R injury, we measured the myocardial infarct area, apoptosis, and expression of cleaved caspase-3. We also investigated the underlying mechanisms by examining mitochondrial function as reflected by the ATP concentration, translocation of cytochrome c, dynamics of mPTP opening, and membrane potential (Delta Psi m), coupled with calpain activity. Pretreatment with PD150606 significantly reduced the infarct area and apoptosis caused by I/R. PD150606 pretreatment also reduced mitochondrial dysfunction by inhibiting calpain activation. Moreover, we found that mu-calpain is the main contributor to I/R-induced calpain activation. Knockdown of mu-calpain with siRNA significantly reversed calpain activation, mitochondrial dysfunction, and cardiomyocyte apoptosis caused by I/R in vitro. Our results suggest that PD 150606 may protect against I/R injury via preventing mu-calpain-induced mitochondrial apoptosis. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Luo, Tao; Yue, Rongchuan; Hu, Houxiang; Zhang, Shuang; Xu, Lei; Li, Ke] Affiliated Hosp 1, North Sichuan Med Coll, Dept Cardiol, Nanchong 637000, Sichuan, Peoples R China.
   [Hu, Houxiang] Affiliated Hosp 1, North Sichuan Med Coll, Med Res Ctr, Nanchong 637000, Sichuan, Peoples R China.
   [Zhou, Zhou; Yu, Zhengping] Third Military Med Univ, Dept Occupat Hlth, Chongqing 400038, Peoples R China.
   [Luo, Tao] Hubei Univ Med, Taihe Hosp, Dept Cardiol, Shiyan 442000, Hubei, Peoples R China.
   [Yiu, Kai Hang] Univ Hong Kong, Dept Med, Hong Kong 999077, Hong Kong, Peoples R China.
RP Hu, HX (reprint author), Affiliated Hosp 1, North Sichuan Med Coll, Dept Cardiol, Nanchong 637000, Sichuan, Peoples R China.
EM houxianghu@yahoo.com
FU National Natural Science Foundation of China [81070101]
FX Grant support was obtained from the National Natural Science Foundation
   of China (No. 81070101). We thank Medjaden Bioscience Limited for their
   assistance in the preparation of this manuscript.
CR Khalil PN, 2005, EUR J PHARMACOL, V528, P124, DOI 10.1016/j.ejphar.2005.10.032
   Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200
   Makary S, 2011, CIRC RES, V109, P1031, DOI 10.1161/CIRCRESAHA.111.253120
   Choi D, 2009, J CONTROL RELEASE, V140, P194, DOI 10.1016/j.jconrel.2009.06.016
   Ha TZ, 2010, CARDIOVASC RES, V87, P694, DOI 10.1093/cvr/cvq116
   Garcia-Dorado D, 2012, CARDIOVASC RES, V94, P168, DOI 10.1093/cvr/cvs116
   Inserte J, 2012, CARDIOVASC RES, V96, P23, DOI 10.1093/cvr/cvs232
   Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638
   Brundel BJJM, 2004, CARDIOVASC RES, V62, P521, DOI 10.1016/j.cardiores.2004.02.007
   Yellon DM, 2000, HEART, V83, P381, DOI 10.1136/heart.83.4.381
   Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163
   Farkas B, 2004, BRAIN RES, V1024, P150, DOI 10.1016/j.brainres.2004.07.059
   Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687
   Wu J, 2006, CELL MOL LIFE SCI, V63, P949, DOI 10.1007/s00018-005-5565-6
   Maekawa A, 2003, J MOL CELL CARDIOL, V35, P1277, DOI 10.1016/S0022-2828(03)00238-4
   Zhang CM, 2012, CIRC J, V76, P1993, DOI 10.1253/circj.CJ-11-1431
   Hernando V, 2010, J MOL CELL CARDIOL, V49, P271, DOI 10.1016/j.yjmcc.2010.02.024
   Hu HX, 2012, CRIT CARE MED, V40, P740, DOI 10.1097/CCM.0b013e3182376e84
   Hillis LD, 2006, NEW ENGL J MED, V355, P2475, DOI 10.1056/NEJMe068251
   Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314
   Chang H, 2011, J CELL BIOCHEM, V112, P571, DOI 10.1002/jcb.22947
   Lee MJ, 2009, TOXICOLOGY, V264, P205, DOI 10.1016/j.tox.2009.08.012
   Martin LJ, 2011, J NEUROSCI, V31, P359, DOI 10.1523/JNEUROSCI.2225-10.2011
   Han F, 2006, J PHARMACOL EXP THER, V317, P529, DOI 10.1124/jpet.105.095018
   Xenocostas A, 2010, CRIT CARE MED, V38, P2215, DOI 10.1097/CCM.0b013e3181f17d6e
   Hu HX, 2009, MICROVASC RES, V78, P33, DOI 10.1016/j.mvr.2009.04.005
   Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200
   Shulga N, 2006, J BIOL CHEM, V281, P30824, DOI 10.1074/jbc.M602503200
   Sarkey JP, 2011, J MOL CELL CARDIOL, V50, P1044, DOI 10.1016/j.yjmcc.2011.03.004
   Scalia R, 2011, CIRC RES, V108, P1102, DOI 10.1161/CIRCRESAHA.110.229393
   Trumbeckaite S, 2003, BIOCHEM PHARMACOL, V65, P911, DOI 10.1016/S0006-2952(02)01610-6
   Ertracht O, 2014, PHARMACOL THERAPEUT, V142, P33, DOI 10.1016/j.pharmthera.2013.11.003
   Li XP, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-8
   Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147
   Perrelli Maria-Giulia, 2011, World J Cardiol, V3, P186, DOI 10.4330/wjc.v3.i6.186
   Yue R., 2015, J CELL PHYSL
   Yue RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050778
NR 37
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2015
VL 586
BP 1
EP 9
DI 10.1016/j.abb.2015.06.005
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW6XO
UT WOS:000365141900001
PM 26091952
ER

PT J
AU Okamoto, T
   Ishida, R
   Yamamoto, H
   Tanabe-Ishida, M
   Haga, A
   Takahashi, H
   Takahashi, K
   Goto, D
   Grave, E
   Itoh, H
AF Okamoto, Tomoya
   Ishida, Ryuichi
   Yamamoto, Hiroshi
   Tanabe-Ishida, Masako
   Haga, Asami
   Takahashi, Hiroki
   Takahashi, Kyosuke
   Goto, Daisuke
   Grave, Ewa
   Itoh, Hideaki
TI Functional structure and physiological functions of mammalian wild-type
   HSP60
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Molecular chaperone; Wild-type HSP60; Chaperonin; Chaperonin homolog;
   Structure: TEM
ID BACTERIAL CHAPERONIN GROEL; MITOCHONDRIAL CHAPERONIN-60; YEAST
   MITOCHONDRIA; SUBSTRATE PROTEIN; COMPLEX; MATRIX; RING; FORM
AB The Chaperonins comprise a family of molecular chaperones having a double-ring structure and similar sequence homology. These proteins play an essential role in biological reactions that mediate the folding of newly synthesized polypeptides and partially denatured proteins. In the prokaryotic group I chaperonins, structural and reaction cycle analyses of GroEL and its co-chaperone GroES have been performed in detail. While in eukaryotes, there have been limited reports analyzing the group I chaperonin HSP60 and its co-chaperone HSP10. In the present study, we purified the wild type HSP60 from porcine liver and investigated the interaction between HSP60 and HSP10, including conformation and physiological relationships. Based on the results of transmission electron microscopy, native PAGE, and gel filtration column chromatography, the wild type HSP60 displayed a heptameric single-ring structure in the absence of ATP. In contrast, HSP60 formed mainly a "football-type" complex with HSP10 in the presence of ATP and mediated the refolding of denatured substrate protein. The functional conformation cycle of the purified mammalian HSP60 is distinct from the cycle of the prokaryotic GroEL/GroES chaperonin. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Okamoto, Tomoya; Ishida, Ryuichi; Yamamoto, Hiroshi; Tanabe-Ishida, Masako; Haga, Asami; Takahashi, Hiroki; Takahashi, Kyosuke; Goto, Daisuke; Grave, Ewa; Itoh, Hideaki] Akita Univ, Grad Sch, Dept Life Sci, Akita 0108502, Japan.
   [Okamoto, Tomoya; Ishida, Ryuichi; Yamamoto, Hiroshi; Tanabe-Ishida, Masako; Haga, Asami; Takahashi, Hiroki; Takahashi, Kyosuke; Goto, Daisuke; Grave, Ewa; Itoh, Hideaki] Akita Univ, Fac Engn Sci, Akita 0108502, Japan.
   [Ishida, Ryuichi] Osaka Univ, Inst Sci & Ind Res, Dept Biomol Sci & Engn, Osaka 5650871, Japan.
RP Itoh, H (reprint author), Akita Univ, Grad Sch, Dept Life Sci, 1-1 Tegata Gakuen Town, Akita 0108502, Japan.
EM itohh@ipc.akita-u.ac.jp
FU Japanese Ministry of Education, Science, Sports and Culture
FX We are very grateful to Dr. David Morris, University of Washington, for
   helpful comments on the manuscripts. H.I. was supported by a
   Grant-in-Aid for Scientific Research from the Japanese Ministry of
   Education, Science, Sports and Culture.
CR Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110
   Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v
   Clare DK, 2013, BIOPOLYMERS, V99, P846, DOI 10.1002/bip.22361
   Parnas A, 2009, J BIOL CHEM, V284, P28198, DOI 10.1074/jbc.M109.031997
   Motojima F, 2012, P NATL ACAD SCI USA, V109, P15740, DOI 10.1073/pnas.1204547109
   Rospert S, 1996, EMBO J, V15, P764
   Ye X, 2013, P NATL ACAD SCI USA, V110, pE4289, DOI 10.1073/pnas.1317702110
   Fei X, 2014, P NATL ACAD SCI USA, V111, P12775, DOI 10.1073/pnas.1412922111
   Leung WH, 2015, J IMMUNOL, V194, P2930, DOI 10.4049/jimmunol.1400817
   Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028
   Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047
   OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0
   Weaver J, 2014, J BIOL CHEM, V289, P23219, DOI 10.1074/jbc.M114.577205
   Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027
   Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9
   Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317
   Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096
   Sameshima T, 2010, BIOCHEM J, V427, P247, DOI 10.1042/BJ20091845
   Large AT, 2009, BIOCHEM SOC T, V37, P46, DOI 10.1042/BST0370046
   Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x
   BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0
   VIITANEN PV, 1992, J BIOL CHEM, V267, P695
   ITOH H, 1995, J BIOL CHEM, V270, P13429
   Itoh H, 2002, EUR J BIOCHEM, V269, P5931, DOI 10.1046/j.1432-1033.2002.03317.x
   Viitanen PV, 1998, METHOD ENZYMOL, V290, P203, DOI 10.1016/S0076-6879(98)90020-9
   Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3
   Ishii N, 2013, BBA-GEN SUBJECTS, V1830, P2907, DOI 10.1016/j.bbagen.2013.01.003
   BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285
   CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0
   KOLL H, 1992, CELL, V68, P1163, DOI 10.1016/0092-8674(92)90086-R
   Nisemblat S, 2014, ACTA CRYSTALLOGR F, V70, P116, DOI 10.1107/S2053230X1303389X
   Parnas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050318
   Sameshima T, 2010, J BIOL CHEM, V285, P23157, DOI 10.1074/jbc.M110.122101
   Vilasi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097657
NR 34
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2015
VL 586
BP 10
EP 19
DI 10.1016/j.abb.2015.09.022
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW6XO
UT WOS:000365141900002
PM 26427351
ER

PT J
AU Gasparski, AN
   Beningo, KA
AF Gasparski, Alexander N.
   Beningo, Karen A.
TI Mechanoreception at the cell membrane: More than the integrins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Mechanoreceptors; Mechanotransduction; Cell migration; Cell mechanics
ID FLUID SHEAR-STRESS; VASCULAR ENDOTHELIAL-CELLS; RECEPTOR TYROSINE
   KINASES; TRP CHANNELS; EXTRACELLULAR-MATRIX; ACTIN CYTOSKELETON;
   ADHESION MOLECULE-1; LIPID RAFTS; ION-CHANNEL; MECHANOTRANSDUCTION
AB A cell receives mechanical cues from its surrounding microenvironment and transduces this mechanical information into a biochemical signal within the cell, ultimately resulting in physiological change. Several molecules within the plasma membrane have been identified that are capable of receiving and translating a mechanical signal. Although integrins are most often discussed as the cell's primary method of mechanoreception at the cell membrane, several non-integrin mechanoreceptors have emerged over the last decade. Specifically, multiple G-protein coupled receptors, the glycocalyx, ion channels, lipid rafts and receptor tyrosine kinases have been found to translate mechanical stimuli from the environment into cellular change. This review will discuss these non-integrin mechanoreceptors associated with the plasma membrane, and their impact on cell physiology. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Gasparski, Alexander N.; Beningo, Karen A.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.
RP Beningo, KA (reprint author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.
EM dw5087@wayne.edu; beningo@wayne.edu
CR Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5
   Schilling T, 2007, BRAIN RES, V1186, P21, DOI 10.1016/j.brainres.2007.10.027
   Leonova EI, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1071, DOI 10.1134/S0006297913100015
   Zeng Y, 2011, CYTOKINE, V53, P42, DOI 10.1016/j.cyto.2010.09.007
   Weinbaum S, 2003, P NATL ACAD SCI USA, V100, P7988, DOI 10.1073/pnas.1332808100
   DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177
   Firth AL, 2007, BBA-MOL BASIS DIS, V1772, P895, DOI 10.1016/j.bbadis.2007.02.009
   Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007
   Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577
   Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006
   Soya M, 2014, CELL CALCIUM, V55, P208, DOI 10.1016/j.ceca.2014.02.015
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8
   Roca-Cusachs P, 2012, J CELL SCI, V125, P3025, DOI 10.1242/jcs.095794
   Stuart LM, 2007, J BIOL CHEM, V282, P27392, DOI 10.1074/jbc.M702887200
   Kang HY, 2011, AM J PHYSIOL-HEART C, V300, pH76, DOI 10.1152/ajpheart.00905.2010
   Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e
   Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5
   Muessel MJ, 2013, GLIA, V61, P1620, DOI 10.1002/glia.22543
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101
   Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100
   Salcedo R, 2000, FASEB J, V14, P2055, DOI 10.1096/fj.99-0963com
   Pla AF, 2012, ONCOGENE, V31, P200, DOI 10.1038/onc.2011.231
   Newell EW, 2005, J PHYSIOL-LONDON, V567, P869, DOI 10.1113/jphysiol.2005.092056
   Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137
   MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X
   Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6
   Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1
   Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614
   Sanchez-Esteban J, 2004, AM J RESP CELL MOL, V30, P76
   Yoshikawa N, 1999, LIFE SCI, V65, P2643, DOI 10.1016/S0024-3205(99)00533-0
   Chiu YJ, 2008, J CELL BIOL, V182, P753, DOI 10.1083/jcb.200801062
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Qazi H, 2013, INTEGR BIOL-UK, V5, P1334, DOI 10.1039/c3ib40057c
   SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535
   Kamat A, 2002, TRENDS ENDOCRIN MET, V13, P122, DOI 10.1016/S1043-2760(02)00567-2
   Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333
   Curat CA, 2002, J AM SOC NEPHROL, V13, P2648, DOI 10.1097/01.ASN.0000032419.13208.0C
   Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200
   Dietrich A, 2010, J AM SOC NEPHROL, V21, P736, DOI 10.1681/ASN.2009090948
   Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049
   Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720
   Clark K, 2008, EUR J CELL BIOL, V87, P631, DOI 10.1016/j.ejcb.2008.01.009
   Isshiki M, 2002, J CELL SCI, V115, P475
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004
   JOHNSON JD, 1993, P NATL ACAD SCI USA, V90, P10891, DOI 10.1073/pnas.90.22.10891
   Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856
   Thompson IR, 2014, MOL CELL ENDOCRINOL, V385, P28, DOI 10.1016/j.mce.2013.09.012
   Pla AF, 2008, MOL CANCER RES, V6, P535, DOI 10.1158/1541-7786.MCR-07-0271
   Lecuit T, 2015, NAT CELL BIOL, V17, P533, DOI 10.1038/ncb3136
   Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018
   Bargal R, 2009, AM J HUM GENET, V84, P80, DOI 10.1016/j.ajhg.2008.12.004
   Lehen'kyi V, 2011, ADV EXP MED BIOL, V704, P929, DOI 10.1007/978-94-007-0265-3_48
   LAVAL S, 1994, CELL GROWTH DIFFER, V5, P1173
   Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200
   Huveneers S, 2013, J CELL SCI, V126, P403, DOI 10.1242/jcs.109447
   Bukoreshtliev NV, 2013, CELL TISSUE RES, V352, P77, DOI 10.1007/s00441-012-1531-4
   Radel C, 2007, BIOCHEM BIOPH RES CO, V358, P626, DOI 10.1016/j.bbrc.2007.04.179
   Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002
   Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040
   Xing YH, 2011, J CELL PHYSIOL, V226, P2350, DOI 10.1002/jcp.22579
   Fuentes DE, 2012, CELL MOL BIOENG, V5, P143, DOI 10.1007/s12195-012-0225-z
   Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z
   Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014
   Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307
   Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999
   Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x
   Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094
   OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0
   Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930
   Nakagawa T, 1996, J NEURO-ONCOL, V28, P13, DOI 10.1007/BF00300442
   Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716
   Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7
   Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Wang YL, 2010, AM J PHYSIOL-LUNG C, V298, pL775, DOI 10.1152/ajplung.00327.2009
   Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596
   Singh S, 2009, BRIT J CANCER, V100, P1638, DOI 10.1038/sj.bjc.6605055
   THALMANN I, 1993, CONNECT TISSUE RES, V29, P191, DOI 10.3109/03008209309016826
   Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843
   Hu SH, 2003, AM J PHYSIOL-CELL PH, V285, pC1082, DOI 10.1152/ajpcell.00159.2003
   Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094
   Fu HL, 2013, J BIOL CHEM, V288, P12114, DOI 10.1074/jbc.M112.409599
   Kuipers AJ, 2012, EUR J CELL BIOL, V91, P834, DOI 10.1016/j.ejcb.2012.05.006
   Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079
   Fujiwara K, 2006, J INTERN MED, V259, P373, DOI 10.1111/j.1365-2796.2006.01623.x
   Asamura K, 2005, NEUROSCIENCE, V132, P493, DOI 10.1016/j.neuroscience.2005.01.013
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   REMUZZI A, 1984, BIORHEOLOGY, V21, P617
   Walker D, 2010, NAT REV MOL CELL BIO, V11, P311, DOI 10.1038/nrm2884
   Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931
   ALVES F, 1995, ONCOGENE, V10, P609
   Nakamoto M, 2002, MICROSC RES TECHNIQ, V59, P58, DOI 10.1002/jemt.10177
   Dejmek J, 2003, INT J CANCER, V103, P344, DOI 10.1002/ijc.10752
   Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952
   Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229
   Mochizuki S, 2003, AM J PHYSIOL-HEART C, V285, pH722, DOI 10.1152/ajpheart.00691.2002
   Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056
   Wei CL, 2012, CURR OPIN CELL BIOL, V24, P254, DOI 10.1016/j.ceb.2011.12.002
   Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729
   Brown AEX, 2009, CURR BIOL, V19, pR781, DOI 10.1016/j.cub.2009.06.054
   Conway Daniel, 2012, F1000 Biol Rep, V4, P1, DOI 10.3410/B4-1
   Davies P., 1994, ENDOTHEL CELL SURF I
   Leckband DE, 2014, ANNU REV CELL DEV BI, V30, P291, DOI 10.1146/annurev-cellbio-100913-013212
   DeMali KA, 2014, BIOCHEMISTRY-US, V53, P7706, DOI 10.1021/bi501181p
   Ghosh S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2794
   Gulino-Debrac D, 2013, TISSUE BARRIERS, V1, DOI [10.4161/tisb.24180, DOI 10.4161/TISB.24180]
   Hooper S.B., 2004, THE LUNG, P131
   Liu-Bryan Ru, 2005, Biochemical and Biophysical Research Communications, V332, P117, DOI 10.1016/j.bbrc.2005.04.139
   Meyer zum Gottesberge A.M., 2008, LAB INVEST, V88, P27
   Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006
   STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545
   Tejada MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110833
   Vennekens R, 2011, J PHYSIOL-LONDON, V589, P1527, DOI 10.1113/jphysiol.2010.202077
   Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209
NR 117
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2015
VL 586
BP 20
EP 26
DI 10.1016/j.abb.2015.07.017
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW6XO
UT WOS:000365141900003
PM 26241498
ER

PT J
AU Furukawa, K
   Yamane, M
   Tatsukawa, H
   Hitomi, K
AF Furukawa, Kentaro
   Yamane, Mild
   Tatsukawa, Hideki
   Hitomi, Kiyotaka
TI Early response as shown by enhancement of transglutaminase 1 expression
   after cisplatin-induced acute kidney injury
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Transglutaminase; Kidney; Cisplatin; Renal failure
ID CELL-DEATH; IDENTIFICATION; PROTECTS; PEPTIDE; ENZYME; SKIN
AB Acute kidney injury (AKI) is caused by drugs and other stimuli, which limits the use of several therapeutic approaches. The AKI mouse model generated by intraperitoneal administration with cisplatin, one of the most widely used anti-cancer drugs, is generally applied to study on this disease. Transglutaminases are posttranslational modifying enzymes that catalyze irreversible cross-linking reactions between proteins in several biological events such as skin formation and blood coagulation. In this study, we found an increase in the expression level of transglutaminase (TG1) in the kidney of mice which had been injected with cisplatin and underwent progressive nephrotoxicity. Before the appearance of the tentative symptoms of renal failure, which is apparent by morphological damage in the kidney and increases in blood creatinine levels, both the expression level and activity of TG1 rapidly increased mainly at the proximal tubule. On the other hand, the protein expression level of another major isozyme (TG2) remained mostly unaltered. This investigation will provide a possible basal-level biomarker and also information on progression of renal failure from the aspect of the protein-modifying enzyme, transglutaminase. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Furukawa, Kentaro; Yamane, Mild; Tatsukawa, Hideki; Hitomi, Kiyotaka] Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4648601, Japan.
RP Hitomi, K (reprint author), Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4648601, Japan.
EM hitomi@ps.nagoya-u.ac.jp
FU JSPS, KAKENHI, Japan [26860500, 26292192]
FX This work was supported by a Grant-in-Aid for Scientific Research (B)
   (No. 26292192 to K. H.) and also Grant-in-Aid for Young Scientists
   Research (No. 26860500 to H. T.) (JSPS, KAKENHI, Japan).
CR dos Santos NAG, 2012, ARCH TOXICOL, V86, P1233, DOI 10.1007/s00204-012-0821-7
   Zhang Z, 2009, J BIOL CHEM, V284, P3345, DOI 10.1074/jbc.M808396200
   Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200
   Itoh M, 2011, J HISTOCHEM CYTOCHEM, V59, P180, DOI 10.1369/jhc.2010.957225
   Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619
   Kumar S, 2013, AMINO ACIDS, V44, P81, DOI 10.1007/s00726-011-1139-0
   Faubel S, 2004, KIDNEY INT, V66, P2202, DOI 10.1111/j.1523-1755.2004.66010.x
   Berthelot L, 2012, J EXP MED, V209, P793, DOI 10.1084/jem.20112005
   Li JZ, 2014, KIDNEY INT, V86, P86, DOI 10.1038/ki.2013.559
   Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014
   Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025
   Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013
   Telci D, 2006, FRONT BIOSCI, V11, P867, DOI 10.2741/1843
   Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010
   Sugimura Y, 2008, FEBS J, V275, P5667, DOI 10.1111/j.1742-4658.2008.06692.x
   Scarpellini A, 2014, J AM SOC NEPHROL, V25, P1013, DOI [10.1681/ASN.2013050563, 10.1681/ASN.2013070791]
   Ponnusamy M., 2009, AM J PHYSIOL-RENAL, V297, P1361
NR 17
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2015
VL 586
BP 27
EP 32
DI 10.1016/j.abb.2015.09.021
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW6XO
UT WOS:000365141900004
PM 26427353
ER

PT J
AU Peres, PS
   Valerio, A
   Cadena, SMSC
   Winnischofer, SMB
   Scalfo, AC
   Di Mascio, P
   Martinez, GR
AF Peres, Patricia S.
   Valerio, Andressa
   Cadena, Silvia M. S. C.
   Winnischofer, Sheila M. B.
   Scalfo, Alexsandra C.
   Di Mascio, Paolo
   Martinez, Glaucia R.
TI Glutathione modifies the oxidation products of 2 '-deoxyguanosine by
   singlet molecular oxygen
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE DNA damage; Glutathione; Singlet molecular oxygen; ROS; 2
   '-Deoxyguanosine; 8-Oxo-7,8-dihydro-2 '-deoxyguanosine;
   Spiroiminodihydantoin-2 '-deoxyribonucleosides
ID CELLULAR-DNA; HYDROGEN-PEROXIDE; AQUEOUS-SOLUTION; IN-VIVO;
   SPIROIMINODIHYDANTOIN; DAMAGE; ACID; PEROXYNITRITE; MECHANISM; EFFICIENT
AB The oxidation of the free nucleoside 2'-deoxyguanosine (dGuo) by singlet molecular oxygen (O-1(2)) has been studied over the three last decades due to the major role of DNA oxidation products in process such as ageing, mutation and carcinogenesis. In the present work we investigated the dGuo oxidation by O-1(2) in the presence of the important low molecular antioxidant, glutathione, in its reduced (GSH) and oxidized (GSSG) forms. There were applied different conditions of concentration, pH, time of incubation, and the use of a [O-18]-labeled thermolabile endoperoxide naphthalene derivative as a source of [O-18]labeled O-1(2). Data was obtained through high performance liquid chromatography (HPLC) and HPLC coupled to micrOTOF Q-II analysis of the main oxidation products: the diastereomers of spiroiminodihydantoin-2'-deoxyribonucleosides (dSp) and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo). An intriguing result was that 8-oxodGuo levels increased by 100 fold when dGuo was oxidized by O-1(2) in the presence of GSH and by 2 fold in the presence of GSSG, while dSp levels dropped to zero for both conditions. All data from dGuo, 8-oxodGuo and dSp quantification together with the analysis of residual GSH/GSSG content in each sample strongly suggest that glutathione modifies the mechanism of dGuo oxidation by O-1(2) by disfavoring the pathway of dSp formation. (C) 2015 Published by Elsevier Inc.
C1 [Peres, Patricia S.; Valerio, Andressa; Cadena, Silvia M. S. C.; Winnischofer, Sheila M. B.; Martinez, Glaucia R.] Univ Fed Parana, Setor Ciencias Biol, Dept Bioquim & Biol Mol, Lab Oxidacoes Biol, BR-80060000 Curitiba, PR, Brazil.
   [Scalfo, Alexsandra C.; Di Mascio, Paolo] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, PR, Brazil.
RP Martinez, GR (reprint author), Univ Fed Parana, Setor Ciencias Biol, Dept Bioquim & Biol Mol, Lab Oxidacoes Biol, BR-80060000 Curitiba, PR, Brazil.
EM grmartinez@pq.cnpq.br
FU CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)
   [482550/2012-0, 311629/2013-0]; CAPES (Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior); INCT de Processos Redox em Biomedicina -
   Redoxoma [573530/2008-4]; PRPUSP (Pro-Reitoria de Pesquisa da
   Universidade de Sao Paulo); NAP Redoxoma (PRPUSP) [2011.1.9352.1.8];
   CEPID Redoxoma (FAPESP) [2013/07937-8]; FAPESP (Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo) [2012/12663-1]; John Simon Guggenheim
   Memorial Foundation
FX The authors acknowledge the Research Funding institutions, CNPq
   (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)
   Processos 482550/2012-0 and 311629/2013-0, CAPES (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior), INCT de Processos Redox
   em Biomedicina - Redoxoma Processo 573530/2008-4, PRPUSP (Pro-Reitoria
   de Pesquisa da Universidade de Sao Paulo), NAP Redoxoma (PRPUSP; No.
   2011.1.9352.1.8), CEPID Redoxoma (FAPESP; No. 2013/07937-8), FAPESP
   (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; No. 2012/12663-1)
   and John Simon Guggenheim Memorial Foundation (P.D.M. Fellowship).
   Authors gratefully thank PhD. Maria Eliane Merlin Rocha for her
   suggestions to this work and Lauro Mera de Souza (UFPR) and Fernanda
   Manso Prado (USP) for the technical assistance in MS/MS analysis.
CR HELD AM, 1978, J AM CHEM SOC, V100, P5732, DOI 10.1021/ja00486a025
   Ye Y, 2003, J AM CHEM SOC, V125, P13926, DOI 10.1021/ja0378660
   Raoul S, 1996, J AM CHEM SOC, V118, P1892, DOI 10.1021/ja952347l
   Martinez GR, 2007, J MASS SPECTROM, V42, P1326, DOI 10.1002/jms.1213
   DEVASAGAYAM TPA, 1991, J PHOTOCH PHOTOBIO B, V9, P105, DOI 10.1016/1011-1344(91)80008-6
   WEFERS H, 1983, EUR J BIOCHEM, V137, P29, DOI 10.1111/j.1432-1033.1983.tb07791.x
   Martinez GR, 2004, J AM CHEM SOC, V126, P3056, DOI 10.1021/ja039111z
   Xu XY, 2008, J AM CHEM SOC, V130, P703, DOI 10.1021/ja077102a
   Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4
   SHIGENAGA MK, 1990, METHOD ENZYMOL, V186, P521
   DI MASCIO P, 1994, FEBS LETT, V355, P287, DOI 10.1016/0014-5793(94)01224-5
   Huber PC, 2008, QUIM NOVA, V31, P1170, DOI 10.1590/S0100-40422008000500046
   Richie JP, 1996, CLIN CHEM, V42, P64
   RAVANAT JL, 1995, CHEM RES TOXICOL, V8, P379, DOI 10.1021/tx00045a009
   Cnubben NHP, 2001, ENVIRON TOXICOL PHAR, V10, P141, DOI 10.1016/S1382-6689(01)00077-1
   DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0
   FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x
   DEVASAGAYAM TPA, 1991, BIOCHEMISTRY-US, V30, P6283, DOI 10.1021/bi00239a029
   Shimizu M, 2007, BIOCHEMISTRY-US, V46, P5515, DOI 10.1021/bi062238r
   BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016
   Cadet J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1219, DOI 10.1562/2006-06-09-IR-914
   Ravanat JL, 2000, J BIOL CHEM, V275, P40601, DOI 10.1074/jbc.M006681200
   Niles JC, 2001, ORG LETT, V3, P963, DOI 10.1021/ol006993n
   Men L, 2005, RAPID COMMUN MASS SP, V19, P23, DOI 10.1002/rcm.1748
   SHEU C, 1993, J AM CHEM SOC, V115, P10446, DOI 10.1021/ja00075a105
   KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137
   Carneiro CD, 2010, FOOD CHEM TOXICOL, V48, P2380, DOI 10.1016/j.fct.2010.05.075
   Henderson PT, 2003, BIOCHEMISTRY-US, V42, P9257, DOI 10.1021/bi0347252
   Martinez GR, 2002, BIOL CHEM, V383, P607, DOI 10.1515/BC.2002.063
   Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491
   DiMascio P, 1991, AM J CLIN NUTR S, V53, p194S
   Pierlot Christel, 2000, V319, P3
   Ravanat JL, 2004, BIOL CHEM, V385, P17, DOI 10.1515/BC.2004.003
   Cadet J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012559
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2015
VL 586
BP 33
EP 44
DI 10.1016/j.abb.2015.09.020
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW6XO
UT WOS:000365141900005
PM 26427352
ER

PT J
AU Asahi, T
   Nakamura, Y
   Kato, Y
   Osawa, T
AF Asahi, Takashi
   Nakamura, Yoshimasa
   Kato, Yoji
   Osawa, Toshihiko
TI Specific role of taurine in the 8-brominated-2 '-deoxyguanosine
   formation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Taurine; Hypobromous acid; 8-bromo-2 '-deoxyguanosine; Bromamine;
   Nicotine
ID EOSINOPHIL PEROXIDASE; HYPOCHLOROUS ACID; HYDROGEN-PEROXIDE;
   MYELOPEROXIDASE; INFLAMMATION; BROMINATION; MUTAGENESIS; OXIDATION;
   CHLORIDE; DNA
AB At the sites of inflammation, hypohalous acids, such as hypochlorous acid and hypobromous acid (HOBr), are produced by myeloperoxidase. These hypohalous acids rapidly react with the primary amino groups to produce haloamines, which are relatively stable and can diffuse long distances and cross the plasma membrane. In this study, we examined the effects of taurine, the most abundant free amino acid in the leukocyte cytosol, on the hypohalous acid-dependent formation of 8-chloro-2'-deoxyguanosine (8-CldG) and 8-bromo-2'-deoxyguanosine (8-BrdG). The reaction of taurine with HOBr yielded taurine bromamine, which is the most stable among other bromamines of amino acids. Taurine also enhanced the bromination of only dG among the four 2'-deoxynucleosides, whereas it inhibited the 8-CldG formation. The specificity of taurine for the enhanced formation of halogenated dG is completely different from that of nicotine, an enhancer of chlorination. The amount of dibrominated taurine (taurine dibromamine) closely correlated with the formation of 8-BrdG, suggesting that taurine dibromamine might be a plausible mediator for the dG bromination in vivo. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Asahi, Takashi; Nakamura, Yoshimasa] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan.
   [Asahi, Takashi; Osawa, Toshihiko] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.
   [Kato, Yoji] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6700092, Japan.
RP Nakamura, Y (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan.
EM yossan@cc.okayama-u.ac.jp; yojikato@shse.u-hyogo.ac.jp
FU MEXT KAKENHI Grant [25292073]
FX This study was partly supported by MEXT KAKENHI Grant Number 25292073
   (YN).
CR Senthilmohan R, 2006, ARCH BIOCHEM BIOPHYS, V445, P235, DOI 10.1016/j.abb.2005.07.005
   Henderson JP, 2001, J BIOL CHEM, V276, P7867, DOI 10.1074/jbc.M005379200
   Sassa A, 2011, J MOL BIOL, V406, P679, DOI 10.1016/j.jmb.2011.01.005
   Ximenes VF, 2015, J INORG BIOCHEM, V146, P61, DOI 10.1016/j.jinorgbio.2015.02.014
   Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379
   Salama SA, 2014, INFLAMMATION, V37, P785, DOI 10.1007/s10753-013-9797-6
   Asahi T, 2010, J BIOL CHEM, V285, P9282, DOI 10.1074/jbc.M109.054213
   Masuda M, 2001, J BIOL CHEM, V276, P40486, DOI 10.1074/jbc.M102700200
   THOMAS EL, 1995, J BIOL CHEM, V270, P2906
   Gottardi W, 2002, ARCH PHARM, V335, P411, DOI 10.1002/1521-4184(200212)335:9<411::AID-ARDP411>3.0.CO;2-D
   Marcinkiewicz J, 2005, INFLAMM RES, V54, P42, DOI 10.1007/s00011-004-1322-9
   THOMAS EL, 1986, J BIOL CHEM, V261, P9694
   Kawai Y, 2004, J BIOL CHEM, V279, P51241, DOI 10.1074/jbc.M408210200
   Hazen SL, 1996, J BIOL CHEM, V271, P23080
   Shen ZZ, 2001, BIOCHEMISTRY-US, V40, P2041, DOI 10.1021/bi001961t
   KAUFMAN ER, 1988, MUTAT RES, V199, P65
   Henderson JP, 2001, P NATL ACAD SCI USA, V98, P1631, DOI 10.1073/pnas.041146998
   Christensen J.J., 1976, HDB PROTON IONIZATIO
   Crooks P.A., 1999, ANAL DETERMINATION N, P69, DOI 10.1016/B978-044450095-3/50005-X
   Kim C, 2014, AMINO ACIDS, V46, P89, DOI 10.1007/s00726-013-1545-6
   Marcinkiewicz J, 2014, AMINO ACIDS, V46, P7, DOI 10.1007/s00726-012-1361-4
   Priitz W.A., 1998, BIOCH BIOPHYS, V357, P265
   Takeshita J, 2006, J BIOL CHEM, V281, P3096, DOI 10.1074/jbc.M509236200
NR 23
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2015
VL 586
BP 45
EP 50
DI 10.1016/j.abb.2015.10.002
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW6XO
UT WOS:000365141900006
PM 26456401
ER

PT J
AU Wada, R
   Sato, D
   Nakamura, T
   Hatori, K
AF Wada, Reito
   Sato, Daisuke
   Nakamura, Takao
   Hatori, Kuniyuki
TI Temperature control of the motility of actin filaments interacting with
   myosin molecules using an electrically conductive glass in the presence
   of direct current
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Motor protein; Motility assay; Indium tin oxide; Temperature dependence;
   Velocity distribution
ID IN-VITRO; HEAVY-MEROMYOSIN; SKELETAL-MUSCLE; MOVEMENT; FLUCTUATIONS;
   DEPENDENCE; ACTIVATION; MOTORS; ATP
AB The motility of actin filaments interacting with heavy meromyosin molecules was directly observed on indium tin oxide-coated glass (ITO-glass), over which a surface current flowed. Because the increase in surface current applied to ITO-glass increases the temperature, we focused on the temperature-dependence of the sliding velocity and the effect of the current flow on the orientation of filament motion. Using high precision fluorescence measurements, the displacement vectors of filaments were collected at intervals of 1/30 s. The direction of filament motion was independent to that of current flow up to 0.17 A (7.7 A/m of surface current density); however, the velocity increased by approximately 2-fold when the surface temperature increased from 25 degrees C to 37 degrees C. The moving actin filaments exhibited a broader velocity distribution at high temperature than at low temperature. Collectively, these data suggest that using ITO-glass with a surface current to generate a well-controlled temperature change may serve to evaluate temperature-dependent transient responses in protein activity under a microscope, without interference from electrical effects. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Wada, Reito; Sato, Daisuke; Nakamura, Takao] Yamagata Univ, Grad Sch Med Sci, Dept Biomed Informat Engn, Yamagata 9909585, Japan.
   [Hatori, Kuniyuki] Yamagata Univ, Grad Sch Sci & Engn, Dept Biosyst Engn, Yonezawa, Yamagata 9928510, Japan.
RP Hatori, K (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Biosyst Engn, Yonezawa, Yamagata 9928510, Japan.
EM khatori@yz.yamagata-u.ac.jp
FU JSPS KAKENHI Grant [25390041]
FX This work was supported by JSPS KAKENHI Grant Number 25390041.
CR HOMSHER E, 1992, AM J PHYSIOL, V262, pC714
   KRON SJ, 1991, METHOD ENZYMOL, V196, P399, DOI 10.1016/0076-6879(91)96035-P
   Hatori K, 2004, BIOPHYS CHEM, V107, P283, DOI 10.1016/j.bpc.2003.09.011
   Kawai M, 2006, J PHYSIOL-LONDON, V574, P877, DOI 10.1113/jphysiol.2006.111708
   Hatori K, 2009, BIOSYSTEMS, V96, P14, DOI 10.1016/j.biosystems.2008.11.003
   Hatori K, 1996, BIOPHYS CHEM, V58, P267, DOI 10.1016/0301-4622(95)00100-X
   Hatori K, 1998, BIOPHYS CHEM, V70, P241, DOI 10.1016/S0301-4622(97)00129-4
   Lee YK, 2013, J COLLOID INTERF SCI, V394, P312, DOI 10.1016/j.jcis.2012.11.072
   Kato H, 1999, P NATL ACAD SCI USA, V96, P9602, DOI 10.1073/pnas.96.17.9602
   ELZINGA M, 1973, P NATL ACAD SCI USA, V70, P2687, DOI 10.1073/pnas.70.9.2687
   Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128
   KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272
   Okubo H, 2010, BIOCHEM BIOPH RES CO, V396, P539, DOI 10.1016/j.bbrc.2010.04.139
   Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089
   Hatori K, 2004, BIOPHYS CHEM, V109, P345, DOI 10.1016/j.bpc.2003.12.007
   Kumemoto R, 2012, BBA-GEN SUBJECTS, V1820, P1597, DOI 10.1016/j.bbagen.2012.06.006
   ANSON M, 1992, J MOL BIOL, V224, P1029, DOI 10.1016/0022-2836(92)90467-X
   Yengo CM, 2012, J MUSCLE RES CELL M, V33, P385, DOI 10.1007/s10974-012-9316-7
   Rossi R, 2005, J APPL PHYSIOL, V99, P2239, DOI 10.1152/japplphysiol.00543.2005
   Riveline D, 1998, EUR BIOPHYS J BIOPHY, V27, P403, DOI 10.1007/s002490050147
   Mihajlovic G, 2004, APPL PHYS LETT, V85, P1060, DOI 10.1063/1.1777815
   Huang L, 2006, LANGMUIR, V22, P8635, DOI 10.1021/la061008a
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2015
VL 586
BP 51
EP 56
DI 10.1016/j.abb.2015.10.001
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CW6XO
UT WOS:000365141900007
PM 26456400
ER

PT J
AU Polticelli, F
   Zobnina, V
   Ciaccio, C
   de Sanctis, G
   Ascenzi, P
   Coletta, M
AF Polticelli, Fabio
   Zobnina, Veranika
   Ciaccio, Chiara
   de Sanctis, Giampiero
   Ascenzi, Paolo
   Coletta, Massimo
TI Enhanced heme accessibility in horse heart mini-myoglobin: Insights from
   molecular modelling and reactivity studies
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Mini-myoglobin; Structure; Molecular modelling; Reactivity properties;
   Protein matrix tunnels
ID APLYSIA-LIMACINA MYOGLOBIN; RAY CRYSTAL-STRUCTURE; ANIONIC LIGANDS;
   CARBON-MONOXIDE; BINDING; AFFINITY; LEGHEMOGLOBIN; COORDINATION;
   HEMOGLOBIN; RESOLUTION
AB Mini-myoglobin (mini-HHMb) is a fragment of horse-heart myoglobin (HHMb) considered to be the prototype of the product encoded by the central exon of the HHMb gene. For this reason, mini-HHMb has been studied extensively showing that carbonylation and oxygenation properties of the ferrous form are similar to those of the full-length protein, while kinetics and thermodynamics of azide binding to the ferric form are significantly different from those of HHMb. To analyze the structure function relationships in mini-HHMb and the role of conformational fluctuations in ligand accessibility, the molecular model of mini-HHMb has been built and refined by molecular dynamics simulations, and analyzed in parallel with that of full length HHMb. Moreover, imidazole binding parameters of ferric mini-HHMb and HHMb have been determined. Furthermore, structural data of ferric mini-HHMb and HHMb have been correlated with the imidazole and previously determined azide binding properties. Present results indicate that, despite the extensive trimming, the heme-alpha-helices E-F substructure is essentially unaltered in mini-HHMb with respect to HHMb. However, the heme-Fe atom displays an enhanced accessibility in mini-HHMb, which may affect both ligand association and dissociation kinetics. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Polticelli, Fabio] Univ Rome Tre, Dept Sci, I-00146 Rome, Italy.
   [Polticelli, Fabio] Roma Tre Univ Sect, Natl Inst Nucl Phys, I-00146 Rome, Italy.
   [Zobnina, Veranika] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Sch Med & Med Sci, Dublin 4, Ireland.
   [Ciaccio, Chiara; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, I-00133 Rome, Italy.
   [Ciaccio, Chiara; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, I-70125 Bari, Italy.
   [de Sanctis, Giampiero] Univ Camerino, Biosci & Biotechnol Sch, I-62032 Camerino, MC, Italy.
   [Ascenzi, Paolo] Roma Tre Univ, Interdept Lab Electron Microscopy, I-00146 Rome, Italy.
   [Ascenzi, Paolo] CNR, Inst Prot Biochem, I-80181 Naples, Italy.
RP Polticelli, F (reprint author), Univ Rome Tre, Dept Sci, Viale Guglielmo Marconi 446, I-00146 Rome, Italy.
EM polticel@uniroma3.it
OI Polticelli, Fabio/0000-0002-7657-2019
FU Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy
   (Universita Roma Tre, Roma, Italy) [CAL 2014]
FX This work was partially supported by a grant from Ministero
   dell'Istruzione, dell'Universita e della Ricerca of Italy (Universita
   Roma Tre, Roma, Italy; CAL 2014 to F.P.).
CR DESANCTIS G, 1986, J MOL BIOL, V188, P73, DOI 10.1016/0022-2836(86)90481-X
   Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7
   Vallone B, 2004, P NATL ACAD SCI USA, V101, P17351, DOI 10.1073/pnas.0407633101
   GIACOMETTI GM, 1981, J MOL BIOL, V151, P315, DOI 10.1016/0022-2836(81)90518-0
   CRAIK CS, 1981, NATURE, V291, P87, DOI 10.1038/291087a0
   Maurus R, 1997, BBA-PROTEIN STRUCT M, V1341, P1, DOI 10.1016/S0167-4838(97)00064-2
   Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11310, DOI 10.1021/bi9603736
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063
   DESANCTIS G, 1988, J MOL BIOL, V200, P725, DOI 10.1016/0022-2836(88)90483-4
   DESANCTIS G, 1994, P NATL ACAD SCI USA, V91, P11507
   Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316
   De Sanctis G, 2007, BIOPHYS J, V93, P2135, DOI 10.1529/biophysj.106.098764
   GO M, 1981, NATURE, V291, P90, DOI 10.1038/291090a0
   HARUTYUNYAN EH, 1995, J MOL BIOL, V251, P104, DOI 10.1006/jmbi.1995.0419
   BOLOGNESI M, 1989, J MOL BIOL, V205, P529, DOI 10.1016/0022-2836(89)90224-6
   Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942
   Elber R, 2010, CURR OPIN STRUC BIOL, V20, P162, DOI 10.1016/j.sbi.2010.01.002
   CUTRUZZOLA F, 1991, FEBS LETT, V282, P281, DOI 10.1016/0014-5793(91)80495-O
   EATON WA, 1980, NATURE, V284, P183, DOI 10.1038/284183a0
   CONTI E, 1993, J MOL BIOL, V233, P498, DOI 10.1006/jmbi.1993.1527
   Milani M, 2004, BIOCHEMISTRY-US, V43, P5213, DOI 10.1021/bi049870+
   BOLOGNESI M, 1990, J MOL BIOL, V213, P621, DOI 10.1016/S0022-2836(05)80249-9
   Pesce A, 2002, STRUCTURE, V10, P725, DOI 10.1016/S0969-2126(02)00763-3
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Coletta M, 1996, EUR J BIOCHEM, V235, P49, DOI 10.1111/j.1432-1033.1996.00049.x
   Antonini E., 1971, HEMOGLOBIN MYOGLOBIN
   BRISSON N, 1982, P NATL ACAD SCI-BIOL, V79, P4055, DOI 10.1073/pnas.79.13.4055
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708
   Craig G.A., 2010, J CHEM SOC DA, P4874
   Mattevi A, 1991, J Mol Recognit, V4, P1, DOI 10.1002/jmr.300040102
   PENNESI G, 1985, J CHEM SOC DALTON, P1113, DOI 10.1039/dt9850001113
NR 33
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 1
EP 9
DI 10.1016/j.abb.2015.09.005
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700001
PM 26363214
ER

PT J
AU Zhang, XL
   Wang, HS
   Liu, N
   Ge, LC
AF Zhang, Xiao-Lin
   Wang, Hong-Sheng
   Liu, Na
   Ge, Li-Chen
TI Bisphenol A stimulates the epithelial mesenchymal transition of estrogen
   negative breast cancer cells via FOXA1 signals
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE BPA; Breast cancer cells; EMT; FOXA1
ID OVARIAN-CANCER; MIGRATION; PATHWAYS; EXPOSURE; METASTASIS; INVASION;
   GROWTH; BPA; CARCINOGENESIS; PROLIFERATION
AB Estrogen receptor negative (ER-) breast cancer are associated with increased risks for metastasis and high rates of recurrence. Our present study revealed that nanomolar bisphenol A (BPA), a typical endocrine disrupting chemical, promoted the in vitro migration and induced mesenchymal transition (EMT) of ER-breast cancer cells. PCR array revealed that BPA can down regulate 12 and up regulate 2 genes involved in regulation of signal transduction and biological pathways of breast cancer. The down regulated genes included FOXA1, which is a key determinant of endocrine response and down regulated by BPA via a time dependent manner. Silencing of FOXA1 by siRNA triggered the EMT of SkBr3 cells. While over expression of FOXA1 abolished BPA induced EMT. Further, 10(-8) M BPA significantly increased the phosphorylation of ERK1/2, p38-MAPK, and Akt in SkBr3 cells, while only PI3K/Akt inhibitor LY294002 attenuated the BPA induced down regulation of FOXA1 and E-Cadherin (E-Cad). Over expression of Akt also suppressed FOXA1 expression in SkBr3 cells. It suggested that PI3K/Akt mediated, at least partially, BPA induced EMT of ER-breast cancer cells. In summary, our data provided the first evidence that BPA can promote the EMT of ER-breast cancer cells through down regulation of FOXA1. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Zhang, Xiao-Lin; Liu, Na] Foshan Univ, Sch Med, Foshan 528000, Peoples R China.
   [Wang, Hong-Sheng; Ge, Li-Chen] Sun Yat Sen Univ, Dept Microbial & Biochem Pharm, Sch Pharmaceut Sci, Guangzhou 510005, Guangdong, Peoples R China.
RP Zhang, XL (reprint author), Foshan Univ, Sch Med, Foshan 528000, Peoples R China.
EM zhangxlfsu@126.com
FU National Natural Science Foundation of China [81472470, 81302317]
FX This research was supported by the National Natural Science Foundation
   of China (Grant No. 81472470 and No. 81302317).
CR Liu R, 2013, FOOD CHEM TOXICOL, V52, P76, DOI 10.1016/j.fct.2012.10.033
   Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468
   Fernandez SV, 2010, TOXICOL PATHOL, V38, P110, DOI [10.1177/0192623309354108, 10.1177/019263309354108]
   Ge LC, 2014, BBA-GEN SUBJECTS, V1840, P2663, DOI 10.1016/j.bbagen.2014.05.018
   Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059
   Yang M, 2009, ARCH TOXICOL, V83, P281, DOI 10.1007/s00204-008-0364-0
   Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839
   Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396
   Jenkins S, 2009, ENVIRON HEALTH PERSP, V117, P910, DOI 10.1289/ehp.11751
   Kirkpatrick P, 2009, NAT REV DRUG DISCOV, V8, P21, DOI 10.1038/nrd2789
   Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367
   Huang YQ, 2012, ENVIRON INT, V42, P91, DOI 10.1016/j.envint.2011.04.010
   Agurs-Collins T, 2010, SEMIN ONCOL, V37, P384, DOI 10.1053/j.seminoncol.2010.05.002
   Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6
   Jenkins S, 2011, ENVIRON HEALTH PERSP, V119, P1604, DOI 10.1289/ehp.1103850
   Kim YS, 2015, CHEM RES TOXICOL, V28, P662, DOI 10.1021/tx500443p
   Potter AS, 2012, J CELL BIOCHEM, V113, P110, DOI 10.1002/jcb.23333
   Gilbert JA, 2012, LANCET ONCOL, V13, pE330
   Chang MC, 2012, BIOCHEM J, V442, P293, DOI 10.1042/BJ20110282
   Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299
   Smith-Bindman R, 2012, ARCH INTERN MED, V172, P1023, DOI 10.1001/archinternmed.2012.2329
   Ptak A, 2012, TOXICOL LETT, V210, P332, DOI 10.1016/j.toxlet.2012.02.003
   Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0
   Le HH, 2008, TOXICOL LETT, V176, P149, DOI 10.1016/j.toxiet.2007.11.001
   Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730
   Zhu HT, 2010, ONCOL REP, V23, P129, DOI 10.3892/or_00000614
   Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979
   Wolf I, 2007, INT J CANCER, V120, P1013, DOI 10.1002/ijc.22389
   Ptak A, 2014, TOXICOL LETT, V229, P357, DOI 10.1016/j.toxlet.2014.07.001
   Durando M, 2007, ENVIRON HEALTH PERSP, V115, P80, DOI 10.1289/ehp.9282
   Ge LC, 2014, TOXICOL LETT, V226, P81, DOI 10.1016/j.toxlet.2014.01.035
   Putti TC, 2005, MODERN PATHOL, V18, P26, DOI 10.1038/modpathol.3800255
   Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100
   Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010
   Betancourt AM, 2012, J NUTR, V142, p1382S, DOI 10.3945/jn.111.152058
   Chen Z.J., 2014, ARCH TOXICOL
   Derouiche S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-54
   DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203
   Ken RA, 2007, REPROD TOXICOL, V24, P240
   Robinson Jessica L L, 2012, Front Endocrinol (Lausanne), V3, P68, DOI 10.3389/fendo.2012.00068
   Shi T., 2014, ENV TOXICOL
   Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87
   Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716
   Weber Lozada Kristen, 2011, Biol Reprod, V85, P490, DOI 10.1095/biolreprod.110.090431
   Zhang KS, 2014, BIOMED PHARMACOTHER, V68, P1037, DOI 10.1016/j.biopha.2014.09.003
NR 45
TC 1
Z9 1
U1 16
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 10
EP 16
DI 10.1016/j.abb.2015.09.006
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700002
PM 26363213
ER

PT J
AU Ohnuma, T
   Anzai, E
   Suzuki, Y
   Shimoda, M
   Saito, S
   Nishiyama, T
   Ogura, K
   Hiratsuka, A
AF Ohnuma, Tomokazu
   Anzai, Eri
   Suzuki, Yohei
   Shimoda, Mai
   Saito, Shin
   Nishiyama, Takahito
   Ogura, Kenichiro
   Hiratsuka, Akira
TI Selective antagonization of activated Nrf2 and inhibition of cancer cell
   proliferation by procyanidins from Cinnamomi Cortex extract
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Nrf2; Cinnamomi Cortex; Cancer cells; Antiproliferation; Procyanidin;
   Suppression
ID HUMAN BREAST-CANCER; HUMAN LUNG-CANCER; TUMOR-GROWTH; ANTICANCER DRUGS;
   KEAP1; EXPRESSION; PATHWAY; ANTIOXIDANT; MUTATIONS; INDUCTION
AB Nuclear factor-E2-related factor 2 (Nrf2) is an important transcription factor and plays a central role in inducible expression of many cytoprotective genes. Recent studies have reported that various cancer cells having unrestrained Nrf2 due to its overexpression exhibit increased proliferation and resistance to chemotherapy. Suppression of abnormal Nrf2 activation is needed for a new therapeutic approach against these cancers. Our previous study found that procyanidins prepared from Cinnamomi Cortex extract (CCE) have an ability to suppress Nrf2-regulated enzyme activity and Nrf2 expression in human lung cancer A549 cells. In the present study, we investigated the effect of CCE procyanidins on Nrf2 activity and cell proliferation in several cancer cells, which have normal or constitutively active Nrf2. Interestingly, CCE procyanidin treatment selectively reduced Nrf2 expression and inhibited cell proliferation in cancer cells that overexpress Nrf2, but these phenomena were not seen in cells with low Nrf2 expression. Moreover, transfection assay demonstrated that CCE procyanidins had selective inhibition of activated Nrf2. These results suggest that CCE procyanidins might be an effective cancer therapeutic agent to selectively suppress abnormal Nrf2 activation responsible for enhanced proliferation. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ohnuma, Tomokazu; Anzai, Eri; Suzuki, Yohei; Shimoda, Mai; Saito, Shin; Nishiyama, Takahito; Ogura, Kenichiro; Hiratsuka, Akira] Tokyo Univ Pharm & Life Sci, Dept Drug Metab & Mol Toxicol, Sch Pharm, Hachioji, Tokyo 1920392, Japan.
RP Hiratsuka, A (reprint author), Tokyo Univ Pharm & Life Sci, Dept Drug Metab & Mol Toxicol, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.
EM hiratuka@toyaku.ac.jp
CR Takahashi T, 2010, J SURG ONCOL, V101, P500, DOI 10.1002/jso.21520
   Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105
   HAGERMAN AE, 1981, J BIOL CHEM, V256, P4494
   Yanagida A, 2007, J CHROMATOGR A, V1143, P153, DOI 10.1016/j.chroma.2007.01.004
   Chian S, 2014, BIOCHEM BIOPH RES CO, V447, P602, DOI 10.1016/j.bbrc.2014.04.039
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   CANCE WG, 1995, BREAST CANCER RES TR, V35, P105, DOI 10.1007/BF00694751
   Ramljak D, 2005, MOL CANCER THER, V4, P537, DOI 10.1158/1535-7163.MCT-04-0286
   Yang EB, 1997, CANCER J, V10, P319
   McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200
   Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822
   Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589
   Cao HP, 2007, ARCH BIOCHEM BIOPHYS, V459, P214, DOI 10.1016/j.abb.2006.12.034
   Thimmulappa RK, 2002, CANCER RES, V62, P5196
   Ohnuma T, 2009, ARCH BIOCHEM BIOPHYS, V488, P34, DOI 10.1016/j.abb.2009.06.006
   Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046
   Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003
   Ohnuma T, 2011, BIOCHEM BIOPH RES CO, V413, P623, DOI 10.1016/j.bbrc.2011.09.014
   Wang R, 2008, BIOCHEM BIOPH RES CO, V373, P151, DOI 10.1016/j.bbrc.2008.06.004
   Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401
   Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016
   Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006
   Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420
NR 23
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 17
EP 24
DI 10.1016/j.abb.2015.09.007
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700003
PM 26365032
ER

PT J
AU Robinson, R
   Qureshi, IA
   Klancher, CA
   Rodriguez, PJ
   Tanner, JJ
   Sobrado, P
AF Robinson, Reeder
   Qureshi, Insaf A.
   Klancher, Catherine A.
   Rodriguez, Pedro J.
   Tanner, John J.
   Sobrado, Pablo
TI Contribution to catalysis of ornithine binding residues in ornithine
   N5-monooxygenase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Flavin-dependent monooxygneases; Siderophore; Ornithine hydroxylase;
   Hydroperoxyflavin
ID FLAVIN-DEPENDENT MONOOXYGENASES; CYCLOHEXANONE MONOOXYGENASE;
   FLAVOPROTEIN MONOOXYGENASES; N-5-MONOOXYGENASE SIDA; OXYGEN ACTIVATION;
   SIDEROPHORES; MECHANISM; HYDROXYLASE; NADP(H); SELECTIVITY
AB The SidA ornithine N5-monooxygenase from Aspergillus fumigatus is a flavin monooxygenase that catalyzes the NADPH-dependent hydroxylation of ornithine. Herein we report a mutagenesis study targeting four residues that contact ornithine in crystal structures of SidA: Lys107, Asn293, Asn323, and Ser469. Mutation of Lys107 to Ala abolishes activity as measured in steady-state oxygen consumption and ornithine hydroxylation assays, indicating that the ionic interaction of Lys107 with the carboxylate of ornithine is essential for catalysis. Mutation of Asn293, Asn323, or Ser469 individually to Ala results in >14-fold increases in K-m values for ornithine. Asn323 to Ala also increases the rate constant for flavin reduction by NADPH by 18-fold. Asn323 is unique among the four ornithine binding residues in that it also interacts with NADPH by forming a hydrogen bond with the nicotinamide ribose. The crystal structure of N323A complexed with NADP(+) and ornithine shows that the nicontinamide riboside group of NADP is disordered. This result suggests that the increase in flavin reduction rate results from an increase in conformational space available to the enzyme-bound NADP(H). Asn323 thus facilitates ornithine binding at the expense of hindering flavin reduction, which demonstrates the delicate balance that exists within protein-ligand interaction networks in enzyme active sites. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Robinson, Reeder; Klancher, Catherine A.; Rodriguez, Pedro J.; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.
   [Qureshi, Insaf A.] Univ Hyderabad, Dept Biotechnol & Bioinformat, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India.
   [Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.
   [Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA.
RP Sobrado, P (reprint author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.
EM tannerjj@missouri.edu; psobrado@vt.edu
FU National Science Foundation [MCB-1021384]; National Institute of General
   Medical Sciences from the National Institutes of Health [P41 GM103403];
   DOE Office of Science [DE-AC02-06CH11357]
FX This work was supported in part by a grant from the National Science
   Foundation MCB-1021384. We thank Dr. Jonathan Schuermann of the
   Northeastern Collaborative Access Team for help with X-ray diffraction
   data collection and processing. Part of this work is based upon research
   conducted at the Northeastern Collaborative Access Team beamlines, which
   are funded by the National Institute of General Medical Sciences from
   the National Institutes of Health (P41 GM103403). This research used
   resources of the Advanced Photon Source, a U.S. Department of Energy
   (DOE) Office of Science User Facility operated for the DOE Office of
   Science by Argonne National Laboratory under Contract No.
   DE-AC02-06CH11357.
CR Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Binda C, 2015, J BIOL CHEM, V290, P12676, DOI 10.1074/jbc.M114.629485
   Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x
   Setser JW, 2014, BIOCHEMISTRY-US, V53, P6063, DOI 10.1021/bi500655q
   Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101
   Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372
   Robinson R, 2011, BIOCHEMISTRY-US, V50, P8489, DOI 10.1021/bi200933h
   Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d
   Dhatwalia R, 2012, J AM CHEM SOC, V134, P18132, DOI 10.1021/ja308188z
   van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044
   Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811
   Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236
   Shirey C, 2013, J BIOL CHEM, V288, P32440, DOI 10.1074/jbc.M113.487181
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Olucha J, 2011, J BIOL CHEM, V286, P31789, DOI 10.1074/jbc.M111.265876
   Olucha J, 2011, BIOORG CHEM, V39, P171, DOI 10.1016/j.bioorg.2011.07.006
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h
   Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004
   Dimkpa C, 2008, CAN J MICROBIOL, V54, P163, DOI 10.1139/w07-130
   Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100
   Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n
   Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075
   JEONG SS, 1994, ANAL BIOCHEM, V221, P273, DOI 10.1006/abio.1994.1411
   Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338
   Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w
   Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105
   Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005
   Robinson R, 2013, BIOCHEMISTRY-US, V52, P9089, DOI 10.1021/bi4014903
   Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005
   Robinson RM, 2014, ARCH BIOCHEM BIOPHYS, V550, P58, DOI 10.1016/j.abb.2014.04.006
   CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450
   Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970
   Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404
   Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578
   BEATY NB, 1981, J BIOL CHEM, V256, P4619
   Badieyan S, 2015, J ORG CHEM, V80, P2139, DOI 10.1021/jo502651v
   Kapral G.J., 2010, ACTA CRYSTALLOGR D, V66, P12
   Robinson R, 2014, BBA-PROTEINS PROTEOM, V1844, P778, DOI 10.1016/j.bbapap.2014.02.005
   Romero E., 2012, JOVE, V61, P3803
   Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128
NR 45
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 25
EP 31
DI 10.1016/j.abb.2015.09.008
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700004
PM 26375201
ER

PT J
AU Dhatwalia, R
   Singh, H
   Reilly, TJ
   Tanner, JJ
AF Dhatwalia, Richa
   Singh, Harkewal
   Reilly, Thomas J.
   Tanner, John J.
TI Crystal structure and tartrate inhibition of Legionella pneumophila
   histidine acid phosphatase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE X-ray crystallography; Histidine acid phosphatase; Histidine phosphatase
   superfamily; Substrate recognition
ID FRANCISELLA-TULARENSIS; 3-DIMENSIONAL STRUCTURE; MOLECULAR-GRAPHICS;
   CHRONIC PAIN; ACTIVE-SITE; CELLS; ECTONUCLEOTIDASE; CRYSTALLIZATION;
   L(+)-TARTRATE; EXPRESSION
AB Histidine acid phosphatases (HAPs) utilize a nucleophilic histidine residue to catalyze the transfer of a phosphoryl group from phosphomonoesters to water. HAPs function as protein phosphatases and pain suppressors in mammals, are essential for Giardia lamblia excystation, and contribute to virulence of the category A pathogen Francisella tularensis. Herein we report the first crystal structure and steady-state kinetics measurements of the HAP from Legionella pneumophila (LpHAP), also known as Legionella major acid phosphatase. The structure of LpHAP complexed with the inhibitor L(+)-tartrate was determined at 2.0 angstrom resolution. Kinetics assays show that L(+)-tartrate is a 50-fold more potent inhibitor of LpHAP than of other HAPs. Electrostatic potential calculations provide insight into the basis for the enhanced tartrate potency: the tartrate pocket of LpHAP is more positive than other HAPs because of the absence of an ion pair partner for the second Arg of the conserved RHGXRXP HAP signature sequence. The structure also reveals that LpHAP has an atypically expansive active site entrance and lacks the nucleotide substrate base clamp found in other HAPs. These features imply that nucleoside monophosphates may not be preferred substrates. Kinetics measurements confirm that AMP is a relatively inefficient in vitro substrate of LpHAP. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Dhatwalia, Richa; Singh, Harkewal; Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.
   [Reilly, Thomas J.] Univ Missouri, Vet Med Diagnost Lab, Columbia, MO 65211 USA.
   [Reilly, Thomas J.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
   [Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.
RP Tanner, JJ (reprint author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.
EM tannerjj@missouri.edu
FU National Institute of General Medical Sciences from the National
   Institutes of Health [P41 GM103403]; DOE Office of Science
   [DE-AC02-06CH11357]
FX We thank Dr. Jonathan Schuermann of Advanced Photon Source NECAT
   beamlines for help with X-ray data collection and processing. This work
   is based upon research conducted at the Northeastern Collaborative
   Access Team beamlines, which are funded by the National Institute of
   General Medical Sciences from the National Institutes of Health (P41
   GM103403). This research used resources of the Advanced Photon Source, a
   U.S. Department of Energy (DOE) Office of Science User Facility operated
   for the DOE Office of Science by Argonne National Laboratory under
   Contract No. DE-AC02-06CH11357.
CR LINDQVIST Y, 1994, EUR J BIOCHEM, V221, P139, DOI 10.1111/j.1432-1033.1994.tb18722.x
   Georgieva D, 2009, BIOCHEM BIOPH RES CO, V378, P711, DOI 10.1016/j.bbrc.2008.11.101
   Aragon V, 2001, INFECT IMMUN, V69, P177, DOI 10.1128/IAI.69.1.177-185.2001
   VANETTEN RL, 1991, J BIOL CHEM, V266, P2313
   Grunwald T, 2006, J ALLERGY CLIN IMMUN, V117, P848, DOI 10.1016/j.jaci.2005.12.1331
   Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   Zylka MJ, 2011, TRENDS MOL MED, V17, P188, DOI 10.1016/j.molmed.2010.12.006
   Slavin I, 2002, MOL BIOCHEM PARASIT, V122, P95, DOI 10.1016/S0166-6851(02)00065-8
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096
   Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024
   OSTANIN K, 1994, J BIOL CHEM, V269, P8971
   Mohapatra NP, 2008, INFECT IMMUN, V76, P3690, DOI 10.1128/IAI.00262-08
   Felts RL, 2006, ACTA CRYSTALLOGR F, V62, P32, DOI 10.1107/S1744309105039813
   Singh H, 2009, J MOL BIOL, V394, P893, DOI 10.1016/j.jmb.2009.10.009
   SCHNEIDER G, 1993, EMBO J, V12, P2609
   LIN MF, 1988, MOL CELL BIOL, V8, P5477
   OSTANIN K, 1993, J BIOL CHEM, V268, P20778
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28
   LINDQVIST Y, 1993, J BIOL CHEM, V268, P20744
   Zhou D, 2015, ACTA CRYSTALLOGR F, V71, P779, DOI 10.1107/S2053230X15008213
   Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Reilly TJ, 2006, PROTEIN EXPRES PURIF, V45, P132, DOI 10.1016/j.pep.2005.05.001
   LAM KW, 1973, CLIN CHEM, V19, P483
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Sowa NA, 2010, J NEUROSCI, V30, P10282, DOI 10.1523/JNEUROSCI.2162-10.2010
   LaCount MW, 1998, J BIOL CHEM, V273, P30406, DOI 10.1074/jbc.273.46.30406
   Jakob CG, 2000, PROSTATE, V42, P211, DOI 10.1002/(SICI)1097-0045(20000215)42:3<211::AID-PROS7>3.0.CO;2-U
   GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X
   BUCHWALD SL, 1984, J BIOL CHEM, V259, P2208
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281
   Ortlund E, 2003, BIOCHEMISTRY-US, V42, P383, DOI 10.1021/bi0265067
   Hurt JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048562
   Hurt JK, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-28
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   SAINI MS, 1981, J BIOL CHEM, V256, P453
   Sowa NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004248
   Taylor-Blake B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008674
   Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780
   Wilson K.S., 1978, ACTA CRYSTALLOGR A, VA34, P517, DOI DOI 10.1107/S0567739478001114
NR 44
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 32
EP 38
DI 10.1016/j.abb.2015.09.010
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700005
PM 26380880
ER

PT J
AU Shin, SM
   Choi, JM
   di Luccio, E
   Lee, YJ
   Lee, SJ
   Lee, SJ
   Lee, SH
   Lee, DW
AF Shin, Sun-Mi
   Choi, Jin Myung
   di Luccio, Eric
   Lee, Yong-Jik
   Lee, Sang-Jae
   Lee, Sang Jun
   Lee, Sung Haeng
   Lee, Dong-Woo
TI The structural basis of substrate promiscuity in UDP-hexose 4-epimerase
   from the hyperthermophilic Eubacterium Thermotoga maritima
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Crystal structure; UDP-galactose 4-epimerase; Substrate specificity;
   Hyperthermophiles; Evolution
ID DIPHOSPHATE GALACTOSE 4-EPIMERASE; ESCHERICHIA-COLI;
   N-ACETYLGLUCOSAMINE; CRYSTAL-STRUCTURE; LELOIR PATHWAY; ACTIVE-SITE;
   MOLECULAR-STRUCTURE; METAL-IONS; METABOLISM; GLUCOSE
AB UDP-galactose 4-epimerase (GalE) catalyzes the interconversion of UDP-glucose (UDP-Glc) and UDPgalactose (UDP-Gal), which is a pivotal step in the Leloir pathway for D-galactose metabolism. Although GalE is widely distributed in prokaryotes and eukaryotes, little information is available regarding hyperthermophilic GalE. We overexpressed the TM0509 gene, encoding a putative GalE from Thermotoga maritima (TMGalE), in Escherichia coli and characterized the encoded protein. To further investigate the molecular basis of this enzyme's catalytic function, we determined the crystal structures of TMGalE and TMGalE bound to UDP-Glc at resolutions of 1.9 angstrom and 2.0 angstrom, respectively. The enzyme was determined to be a homodimer with a molecular mass of 70 kDa. The enzyme could reversibly catalyze the epimerization of UDP-GalNAc/UDP-GlcNAc as well as UDP-Gal/UDP-Glc at elevated temperatures, with an apparent optimal temperature and pH of 80 degrees C and 7.0, respectively. Our data showed that TM0509 is a UDP-galactosugar 4-epimerase involved in D-galactose metabolism; consequently, this study provides the first detailed characterization of a hyperthermophilic GalE. Moreover, the promiscuous substrate specificity of TMGalE, which is more similar to human GalE than E. coli GalE, supports the notion that TMGalE might exhibit the earliest form of sugar-epimerizing enzymes in the evolution of galactose metabolism. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Shin, Sun-Mi; Lee, Yong-Jik; Lee, Dong-Woo] Kyungpook Natl Univ, Sch Appl Biosci, Daegu 702701, South Korea.
   [Choi, Jin Myung; Lee, Sung Haeng] Chosun Univ, Dept Cellular & Mol Med, Sch Med, Gwangju 501759, South Korea.
   [di Luccio, Eric] Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu 702701, South Korea.
   [Lee, Sang-Jae] Silla Univ, Major Food Biotechnol, Busan 617736, South Korea.
   [Lee, Sang Jun] Korea Res Inst Biosci & Biotechnol, Infect & Immun Res Ctr, Daejeon 305806, South Korea.
RP Lee, DW (reprint author), Kyungpook Natl Univ, Sch Appl Biosci, Daegu 702701, South Korea.
EM leehicam@knu.ac.kr
FU National Research Foundation of Korea (NRF) - Korean government (MSIP)
   [2014R1A2A2A01006765, 2013R1A1A2057465]; Korea Institute of Planning &
   Evaluation for Technology (iPET) - Ministry for Food, Agriculture,
   Forestry and Fisheries [311042-05-1-HD120]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grants (2014R1A2A2A01006765 & 2013R1A1A2057465) to Dr. Dong-Woo
   Lee and to Dr. Sung Haeng Lee, respectively, funded by the Korean
   government (MSIP), and by a Grant 311042-05-1-HD120 from the Korea
   Institute of Planning & Evaluation for Technology (iPET) funded by the
   Ministry for Food, Agriculture, Forestry and Fisheries to Dr. Dong-Woo
   Lee.
CR Frey PA, 1996, FASEB J, V10, P461
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sakuraba H, 2011, ARCH BIOCHEM BIOPHYS, V512, P126, DOI 10.1016/j.abb.2011.05.013
   Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200
   Thoden JB, 2000, BIOCHEMISTRY-US, V39, P5691, DOI 10.1021/bi000215l
   Ross KL, 2004, MOL GENET METAB, V83, P103, DOI 10.1016/j.ymgme.2004.07.005
   Petry KG, 1998, TRENDS GENET, V14, P98, DOI 10.1016/S0168-9525(97)01379-6
   BAUER AJ, 1992, PROTEINS, V12, P372, DOI 10.1002/prot.340120409
   Allard STM, 2001, CELL MOL LIFE SCI, V58, P1650, DOI 10.1007/PL00000803
   Schulz JM, 2004, J BIOL CHEM, V279, P32796, DOI 10.1074/jbc.M405005200
   Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106
   Shaw MP, 2003, MOL BIOCHEM PARASIT, V126, P173, DOI 10.1016/S0166-6851(02)00243-8
   WEE TG, 1972, J BIOL CHEM, V247, P1339
   Chhabra SR, 2003, J BIOL CHEM, V278, P7540, DOI 10.1074/jbc.M211748200
   Thoden JB, 1996, BIOCHEMISTRY-US, V35, P5137, DOI 10.1021/bi9601114
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Frock AD, 2012, APPL ENVIRON MICROB, V78, P1978, DOI 10.1128/AEM.07069-11
   Demendi M, 2005, BIOCHEM J, V389, P173, DOI 10.1042/BJ20050263
   Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001
   Thoden JB, 1996, PROTEIN SCI, V5, P2149
   ARABSHAHI A, 1988, J BIOL CHEM, V263, P2638
   WONG SS, 1977, BIOCHEMISTRY-US, V16, P298, DOI 10.1021/bi00621a022
   Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002
   HUCHO F, 1971, EUR J BIOCHEM, V23, P489, DOI 10.1111/j.1432-1033.1971.tb01645.x
   BOUFFARD GG, 1994, J MOL BIOL, V244, P269, DOI 10.1006/jmbi.1994.1728
   Rodionova IA, 2012, J BACTERIOL, V194, P5552, DOI 10.1128/JB.01136-12
   Lee LV, 2000, BIOCHEMISTRY-US, V39, P4821, DOI 10.1021/bi9928952
   Nelson KE, 1999, NATURE, V399, P323
   Dormann P, 1998, PLANT J, V13, P641, DOI 10.1046/j.1365-313X.1998.00067.x
   Chung SK, 2012, BIORESOURCE TECHNOL, V110, P423, DOI 10.1016/j.biortech.2012.01.046
   Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200
   Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866
   Shockley KR, 2005, APPL ENVIRON MICROB, V71, P5572, DOI 10.1128/AEM.71.9.5572-5576.2005
   Kluskens LD, 2003, BIOCHEM J, V370, P651, DOI 10.1042/BJ20021595
   Kopp J, 1999, J MOL BIOL, V287, P761, DOI 10.1006/jmbi.1999.2643
   Bernatchez S, 2005, J BIOL CHEM, V280, P4792
   METZGER M, 1994, J BACTERIOL, V176, P450
   KONOPKA JM, 1989, BIOCHEMISTRY-US, V28, P2645, DOI 10.1021/bi00432a043
   Thoden JB, 2002, J BIOL CHEM, V277, P27528, DOI 10.1074/jbc.M204413200
   Thoden JB, 1998, BIOCHEMISTRY-US, V37, P11469, DOI 10.1021/bi9808969
   Morgan PM, 1997, J AM CHEM SOC, V119, P10269, DOI 10.1021/ja971718q
   KANG UG, 1975, J BIOL CHEM, V250, P7099
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Johnson MR, 2005, MOL MICROBIOL, V55, P664, DOI 10.1111/j.1365-2958.2004.04419.x
   Soldo B, 2003, GENE, V319, P65, DOI 10.1016/S0378-1119(03)00793-5
   Novelli G, 2000, MOL GENET METAB, V71, P62, DOI 10.1006/mgme.2000.3073
   Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200
   WILSON DB, 1964, J BIOL CHEM, V239, P2469
   Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   SHIRLEY BA, 1992, BIOCHEMISTRY-US, V31, P725, DOI 10.1021/bi00118a013
   Baba Tomoya, 2006, Mol Syst Biol, V2
   Barupal DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078360
   Chai Y., 2012, MBIO, V3, DOI DOI 10.1128/MBIO.00184-12
   DEUPREEE JD, 1972, J BIOL CHEM, V247, P3093
   HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880
   Kowal P, 2002, BIOCHEMISTRY-US, V41, P15410, DOI 10.1021/bi026384i
   Latif H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003485
   Lee SJ, 2014, MBIO, V5, DOI 10.1128/mBio.00972-13
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Taylor TJ, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S5
   Wang ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046463
NR 63
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 39
EP 51
DI 10.1016/j.abb.2015.08.025
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700006
PM 26344854
ER

PT J
AU Jain, R
   Kumar, R
   Kumar, S
   Chhabra, R
   Agarwal, MC
   Kumar, R
AF Jain, Rishu
   Kumar, Rajesh
   Kumar, Sandeep
   Chhabra, Ritika
   Agarwal, Mukesh Chand
   Kumar, Rajesh
TI Analysis of the pH-dependent stability and millisecond folding kinetics
   of horse cytochrome c
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Protein folding; Thermodynamic stability; Electrostatic interactions;
   Wyman-Tanford linkage relation
ID MOLTEN GLOBULE STATE; EQUILIBRIUM UNFOLDING INTERMEDIATE; VIBRATIONAL
   CIRCULAR-DICHROISM; CONTINUUM ELECTROSTATIC MODEL; A BETA-LACTAMASES;
   FERRICYTOCHROME-C; PROTEIN STABILITY; PK(A) VALUES; FERROCYTOCHROME-C;
   TRANSITION-STATE
AB This paper analyzes the effect of pH on thermodynamic stability and folding kinetics of horse cytochrome c (cyt c). Analysis of equilibrium unfolding transitions of Ferricyt c and Ferrocyt c measured between pH 3.0 and pH 13.0 reveal that these proteins have maximum thermodynamic stability between pH 8.0 and pH 9.5. Theoretically predicted pH-dependent electrostatic unfolding energy of Ferricyt c also supports this result. Unfolded Ferrocyt c in refolding buffer at pH 7.0 and pH 12.7 refolds rapidly to native state. Between pH 7.0 and pH 12.7, the activation free energy barrier for folding of Ferrocyt c varies by <1.0 kcal mol(-1) while the folding free energy, which is measured by two-state analysis of equilibrium unfolding transitions of Ferrocyt c varies by 8.0 kcal mol(-1). This finding reveals that the large disparity in thermodynamic stability between pH 7.0 and pH 12.7 is not strongly reflected in the refolding rates. The Wyman Tanford linkage relation was used to calculate the beta(PH)-value for folding of Ferrocyt c, which is <0.1 between pH 7.0 and pH 12.7, indicating that the electrostatic interactions are weakly formed in transition state and exhibit a very small effect on the folding kinetics. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Jain, Rishu; Kumar, Rajesh; Kumar, Sandeep; Chhabra, Ritika; Agarwal, Mukesh Chand; Kumar, Rajesh] Thapar Univ, Sch Chem & Biochem, Patiala 147004, Punjab, India.
RP Kumar, R (reprint author), Thapar Univ, Sch Chem & Biochem, Patiala 147004, Punjab, India.
EM rajesh.kumar@thapar.edu
FU University Grant Commission (UGC) [41-258/2012 (SR)]; CSIR, Government
   of India [37(148s)/1r/EMR-II]
FX Funds for this research were provided by the University Grant Commission
   (UGC) major research project [to R.K., F. no. 41-258/2012 (SR)], and
   CSIR Grant [to R.K. No. 37(148s)/1r/EMR-II], Government of India. We
   gratefully acknowledge many helpful suggestions and support of Prof.
   Abani K Bhuyan and Prof. Purnananda Guptasarma.
CR Alexov EG, 1997, BIOPHYS J, V72, P2075
   Rao DK, 2006, BIOCHEMISTRY-US, V45, P3412, DOI 10.1021/bi051882n
   Kumar R, 2006, J MOL BIOL, V364, P483, DOI 10.1016/j.jmb.2006.09.025
   Castaneda CA, 2009, PROTEINS, V77, P570, DOI 10.1002/prot.22470
   Horng JC, 2003, PROTEINS, V52, P193, DOI 10.1002/prot.10406
   Lamotte-Brasseur J, 2000, PROTEINS, V40, P23, DOI 10.1002/(SICI)1097-0134(20000701)40:1<23::AID-PROT40>3.0.CO;2-7
   Whitten ST, 2001, J MOL BIOL, V309, P1165, DOI 10.1006/jmbi.2001.4726
   Antosiewicz J, 1996, BIOCHEMISTRY-US, V35, P7819, DOI 10.1021/bi9601565
   Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218
   TAN YJ, 1995, J MOL BIOL, V254, P980, DOI 10.1006/jmbi.1995.0670
   PACE CN, 1990, BIOCHEMISTRY-US, V29, P2564, DOI 10.1021/bi00462a019
   Schaefer M, 1997, J PHYS CHEM B, V101, P1663, DOI 10.1021/jp962972s
   WU ML, 1994, PROTEINS, V20, P185, DOI 10.1002/prot.340200208
   Vila-Vicosa D, 2012, J PHYS CHEM B, V116, P8812, DOI 10.1021/jp3034837
   Lee AC, 2009, J CHEM INF MODEL, V49, P2013, DOI 10.1021/ci900209w
   Bhuyan AK, 2001, J MOL BIOL, V312, P1135, DOI 10.1006/jmbi.2001.4993
   Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   Kumar S, 2014, BBA-PROTEINS PROTEOM, V1844, P641, DOI 10.1016/j.bbapap.2014.01.012
   ODA Y, 1994, BIOCHEMISTRY-US, V33, P5275, DOI 10.1021/bi00183a034
   Horng JC, 2005, J MOL BIOL, V345, P163, DOI 10.1016/j.jmb.2004.10.023
   Blasie CA, 1997, BIOCHEMISTRY-US, V36, P6218, DOI 10.1021/bi962805i
   Mukaiyama A, 2013, J MOL BIOL, V425, P257, DOI 10.1016/j.jmb.2012.11.004
   Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657
   COHEN DS, 1994, PROTEIN SCI, V3, P1253
   YASUI SC, 1986, J AM CHEM SOC, V108, P5576, DOI 10.1021/ja00278a035
   KURODA Y, 1992, J MOL BIOL, V223, P1139, DOI 10.1016/0022-2836(92)90265-L
   Qi PXR, 1996, BIOCHEMISTRY-US, V35, P12275, DOI 10.1021/bi961042w
   DICK YP, 1966, ARCH BIOCHEM BIOPHYS, V117, P466, DOI 10.1016/0003-9861(66)90436-X
   TAKANO T, 1981, J MOL BIOL, V153, P95, DOI 10.1016/0022-2836(81)90529-5
   Sanchez KM, 2008, J CHEM EDUC, V85, P1253
   YANG AS, 1993, PROTEINS, V15, P252, DOI 10.1002/prot.340150304
   YANG AS, 1994, J MOL BIOL, V237, P602, DOI 10.1006/jmbi.1994.1258
   Kumar R, 2005, BIOCHEMISTRY-US, V44, P9359, DOI 10.1021/bi050384b
   Bhuyan AK, 2005, BIOCHEMISTRY-US, V44, P3034, DOI 10.1021/bi047897n
   Raquet X, 1997, BIOPHYS J, V73, P2416
   MANLY SP, 1985, BIOCHEMISTRY-US, V24, P3842, DOI 10.1021/bi00336a004
   Luisi DL, 2000, J MOL BIOL, V299, P1091, DOI 10.1006/jmbi.2000.3752
   Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102
   Allen DL, 1998, PROTEIN SCI, V7, P1262
   ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025
   Latypov RF, 2008, J MOL BIOL, V383, P437, DOI 10.1016/j.jmb.2008.08.025
   VANDERKOOI JM, 1975, EUR J BIOCHEM, V60, P199, DOI 10.1111/j.1432-1033.1975.tb20992.x
   BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5
   HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7
   Varhac R, 2004, J BIOL INORG CHEM, V9, P12, DOI 10.1007/s00775-003-0492-1
   LUMB KJ, 1995, SCIENCE, V268, P436, DOI 10.1126/science.7716550
   Latypov RF, 2006, J MOL BIOL, V357, P1009, DOI 10.1016/j.jmb.2006.01.055
   Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P12821, DOI 10.1021/bi0204443
   Cho JH, 2008, ARCH BIOCHEM BIOPHYS, V469, P20, DOI 10.1016/j.abb.2007.08.004
   You TJ, 1995, BIOPHYS J, V69, P1721
   Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660
   Carvalho ASL, 2003, ARCH BIOCHEM BIOPHYS, V415, P257, DOI 10.1016/S0003-9861(03)00275-3
   Arthur EJ, 2011, PROTEINS, V79, P3276, DOI 10.1002/prot.23195
   Lamotte-Brasseur J, 1999, PROTEIN SCI, V8, P404
   SALI D, 1991, J MOL BIOL, V220, P779, DOI 10.1016/0022-2836(91)90117-O
   NICHOLLS P, 1974, BIOCHIM BIOPHYS ACTA, V346, P261, DOI 10.1016/0304-4173(74)90003-2
   WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.biophys.20.1.267
   Kumar R, 2005, BIOCHEMISTRY-US, V44, P3024, DOI 10.1021/bi0478998
   OSTERHOUT JJ, 1985, BIOCHEMISTRY-US, V24, P6680, DOI 10.1021/bi00344a057
   PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0
   MYERS JK, 1995, PROTEIN SCI, V4, P2138
   Fano M, 2011, ARCH BIOCHEM BIOPHYS, V506, P92, DOI 10.1016/j.abb.2010.11.012
   Shosheva A, 2003, EUR BIOPHYS J BIOPHY, V31, P617, DOI 10.1007/s00249-002-0259-6
   TSONG TY, 1974, J BIOL CHEM, V249, P1988
   Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y
   Stanton CL, 2008, J CHEM THEORY COMPUT, V4, P951, DOI 10.1021/ct8000014
   ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301
   YASUI SC, 1990, J BIOL CHEM, V265, P3780
   ANTALIK M, 1995, GEN PHYSIOL BIOPHYS, V14, P19
   Fetrow JS, 1998, BIOCHEMISTRY-US, V37, P2477, DOI 10.1021/bi972279a
   HENDSCH ZS, 1994, PROTEIN SCI, V3, P211
   Enoki S, 2006, J MOL BIOL, V361, P969, DOI 10.1016/j.jmb.2006.07.009
   WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4
   Russell BS, 2000, P NATL ACAD SCI USA, V97, P8312, DOI 10.1073/pnas.150239397
   Tan YJ, 1996, J MOL BIOL, V264, P377, DOI 10.1006/jmbi.1996.0647
   MATTHEW JB, 1986, METHOD ENZYMOL, V130, P413
   OLIVEBERG M, 1995, BIOCHEMISTRY-US, V34, P9424, DOI 10.1021/bi00029a018
   Cavagnero S, 1998, BIOCHEMISTRY-US, V37, P3369, DOI 10.1021/bi9721795
   Qin J, 1996, BIOCHEMISTRY-US, V35, P7, DOI 10.1021/bi952299h
   Rabenstein B, 2001, BIOPHYS J, V80, P1141
   PERUTZ MF, 1978, SCIENCE, V201, P1187, DOI 10.1126/science.694508
   Kawai C, 2005, J BIOL CHEM, V280, P34709, DOI 10.1074/jbc.M412532200
   Spector S, 2000, BIOCHEMISTRY-US, V39, P872, DOI 10.1021/bi992091m
   BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6
   Uchiyama S, 2004, J AM CHEM SOC, V126, P14684, DOI 10.1021/ja046667t
   Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903
   TREWHELLA J, 1988, BIOCHEMISTRY-US, V27, P1121, DOI 10.1021/bi00404a007
   WOOD LC, 1988, BIOCHEMISTRY-US, V27, P8562, DOI 10.1021/bi00423a009
   BAGELOVA J, 1994, BIOCHEM J, V297, P99
   BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010
   Campos S.R., 2010, J PHYS CHEM B, V7, P12692
   Davies Matthew N, 2006, BMC Biochem, V7, P18, DOI 10.1186/1471-2091-7-18
   EDGE V, 1985, BIOCHEMISTRY-US, V24, P5899, DOI 10.1021/bi00342a032
   FISHER MT, 1991, BIOCHEMISTRY-US, V30, P10012, DOI 10.1021/bi00105a028
   Gilson M.K., 1995, J MOL BIOL, V183, P503
   HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829
   HU CQ, 1987, BIOCHEMISTRY-US, V26, P178, DOI 10.1021/bi00375a025
   JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10436, DOI 10.1021/bi00107a011
   Linderstrom-Lang K.U., 1924, C R TRAV LAB CARLSB, V5, P70
   LoA pez-Arenas L., 1999, BIOCHEMISTRY-US, V38, P15936
   PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573
   Prisco G.D., 1975, ARCH BIOCHEM BIOPHYS, V171, P604
   Richman DE, 2014, PROTEINS, V82, P3132, DOI 10.1002/prot.24673
   Rosell FI, 2005, BIOCHEMISTRY-US, V44, P1872, DOI 10.1021/bi0480077
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   Sato S, 2002, J MOL BIOL, V318, P571, DOI 10.1016/S0022-2836(02)00015-3
   SoloAs-Mendiola S., 1998, BIOCHIM BIOPHYS ACTA, V1388, P363
   Tanford C., 1970, CHEM ADV PROT, V24, P1
   Tissot C., 1996, BIOCHEMISTRY-US, V35, P6786
   Ullmann GM, 1999, EUR BIOPHYS J BIOPHY, V28, P533, DOI 10.1007/s002490050236
   WARSHEL A, 1981, ACCOUNTS CHEM RES, V14, P284, DOI 10.1021/ar00069a004
   WARSHEL A, 1981, BIOCHEMISTRY-US, V20, P3167, DOI 10.1021/bi00514a028
   WARSHEL A, 1978, P NATL ACAD SCI USA, V75, P5250, DOI 10.1073/pnas.75.11.5250
   Yang A.S., 1993, J MOL BIOL, V231, P474
NR 115
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 52
EP 63
DI 10.1016/j.abb.2015.09.011
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700007
PM 26386309
ER

PT J
AU Rimal, H
   Lee, SW
   Lee, JH
   Oh, TJ
AF Rimal, Hemraj
   Lee, Seung-Won
   Lee, Joo-Ho
   Oh, Tae-Jin
TI Understanding of real alternative redox partner of Streptomyces
   peucetius DoxA: Prediction and validation using in silico and in vitro
   analyses
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cytochrome P450; Electron-transport system; Homology modeling; In silica
   analysis; Streptomyces peucetius ATCC27952
ID CYTOCHROME P450CAM; ELECTRON-TRANSFER; ESCHERICHIA-COLI; HYDROXYLATION;
   BIOSYNTHESIS; PROTEIN; DOCKING; SYSTEM; PUTIDAREDOXIN; CATALYSTS
AB Streptomyces peucetius ATCC27952 contains the cytochrome P450 monoxygenase DoxA that is responsible for the hydroxylation of daunorubicin into doxorubicin. Although S. peucetius ATCC27952 contains several potential redox partners, the most suitable endogenous electron-transport system is still unclear; therefore, we conducted a study of potential redox partners using Accelrys Discovery Studio 3.5. Recombinant DoxA along with its redox partners from S. peucetius FDX1, FDR2, and FDX3, and the putidaredoxin and putidaredoxin reductase from Pseudomonas putida that are essential equivalents of the class I type of bacterial electron-transport system were over-expressed and purified. The successful development of an efficient redox system was achieved by an in vitro enzymatic catalysis reaction with DoxA. The optimal pH for the activation of the heme was 7.6 and the optimal temperature was 30 degrees C. Our findings suggest a two-fold increase of DoxA activity via the NADH -> FDR2 -> FDX1 -> DoxA pathway for the hydroxylation of the daunorubicin, and indicate that the usage of a native redox partner may increase daunorubicin-derived doxorubicin production due to the inclusion of DoxA. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Rimal, Hemraj; Lee, Seung-Won; Lee, Joo-Ho; Oh, Tae-Jin] SunMoon Univ, Dept Pharmaceut Engn, Asan 336708, Chungnam, South Korea.
RP Oh, TJ (reprint author), SunMoon Univ, Dept Pharmaceut Engn, 100 Kalsan Ri, Asan 336708, Chungnam, South Korea.
EM tjoh3782@sunmoon.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education, Science and Technology
   [2013R1A1A2062228, 2012-0007803]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education, Science and Technology (2013R1A1A2062228 &
   2012-0007803).
CR Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   Purdy MM, 2004, BIOCHEMISTRY-US, V43, P271, DOI 10.1021/bi0356045
   Bhattarai S, 2012, J MICROBIOL BIOTECHN, V22, P917, DOI 10.4014/jmb.1112.12053
   FUJII K, 1974, J BIOL CHEM, V249, P6745
   SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306
   Sevrioukova IF, 2010, J BIOL CHEM, V285, P13616, DOI 10.1074/jbc.M110.104968
   Gillam EMJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P176, DOI 10.1016/j.abb.2007.04.033
   McLean KJ, 2005, BIOCHEM SOC T, V33, P796
   TYSON CA, 1972, J BIOL CHEM, V247, P5777
   McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x
   Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026
   Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460
   Hussain HA, 2003, APPL ENVIRON MICROB, V69, P373, DOI 10.1128/AEM.69.1.373-382.2003
   Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389
   Mouri T, 2006, APPL MICROBIOL BIOT, V72, P514, DOI 10.1007/s00253-005-0289-y
   Walczak RJ, 1999, J BACTERIOL, V181, P298
   Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022
   Volokhan O, 2006, APPL ENVIRON MICROB, V72, P2514, DOI 10.1128/AEM.72.4.2514-2519.2006
   Bhattarai S, 2013, ARCH BIOCHEM BIOPHYS, V539, P63, DOI 10.1016/j.abb.2013.09.008
   Connors N.C., 1991, THESIS OHIO STATE U
   Girhard M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-36
   Goni G, 2009, BBA-PROTEINS PROTEOM, V1794, P1635, DOI 10.1016/j.bbapap.2009.07.012
   Kieser T., 2000, PRACTICAL STREPTOMYC
   Natalie L., 1999, J BACTERIOL, V181, P305
   Sambrook J., 2001, MOL CLONING LAB MANU
   Shrestha P., 2009, ENZYME MICROB TECHNO, V46, P372
   Werck R.D., 2000, GENOME BIOL, V6
   Yeom J., 2008, J BIOCH, V145, P481
NR 29
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 64
EP 74
DI 10.1016/j.abb.2015.08.019
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700008
PM 26334717
ER

PT J
AU Lopez, E
   Bermejo, N
   Berna-Erro, A
   Alonso, N
   Salido, GM
   Redondo, PC
   Rosado, JA
AF Lopez, E.
   Bermejo, N.
   Berna-Erro, A.
   Alonso, N.
   Salido, G. M.
   Redondo, P. C.
   Rosado, J. A.
TI Relationship between calcium mobilization and platelet alpha- and
   delta-granule secretion. A role for TRPC6 in thrombin-evoked
   delta-granule exocytosis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Calcium; alpha-granules; delta-granules; Platelets; Thrombin; TRPC6
ID OPERATED CA2+ ENTRY; DIFFERENTIAL SENSITIVITY; SEVERING PROTEIN;
   ACTIVATION; STIM1; AGGREGATION; RELEASE; KINASE; ORAI1; MEMBRANE
AB Changes in cytosolic Ca2+ concentration ([Ca2+](c)) regulate granule secretion in different cell types. Thrombin activates PAR1 and PAR4 receptors and promotes release of Ca2+ from distinct intracellular stores, which, in turn, activates store-operated Ca2+ entry (SOCE). A crucial step during platelet function is the release of physiological agonists stored in secretory granules to the extracellular compartment during activation. We aim to study the role of Ca2+ mobilization from the extracellular compartment or from different intracellular stores in platelet granule secretion. By using flow cytometry, we have found that alpha- and delta-granules are secreted in thrombin-stimulated platelets in the absence of extracellular Ca2+, and in a concentration-dependent manner. Our findings show that thrombin-stimulated granule secretion depends on Ca2+ mobilization from intracellular stores. Analysis of the kinetics of granule secretion reveals that platelet stimulation with thrombin results in rapid release of alpha-granules which precedes the secretion of delta-granules. Incubation of platelets with a specific antibody, which recognizes the extracellular amino acid sequence 573-586 of TRPC6, inhibited thrombin-evoked delta-granule exocytosis. Our results indicate that the mechanisms underlying thrombin-induced alpha- and delta-granule secretion show differences in dependency on Ca2+ mobilization. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Lopez, E.; Berna-Erro, A.; Salido, G. M.; Redondo, P. C.; Rosado, J. A.] Univ Extremadura, Dept Physiol, Phycell 10003, Spain.
   [Bermejo, N.] Hosp San Pedro de Alcantara, Dept Hematol, Caceres 10003, Spain.
   [Alonso, N.] Hosp Infanta Cristina, Dept Hematol, Badajoz 06006, Spain.
RP Rosado, JA (reprint author), Univ Extremadura, Dept Physiol, Phycell 10003, Spain.
EM jarosado@unex.es
FU MINECO [BFU2013-45564-C2-1-P]; Junta de Extremadura-FEDER; University of
   Extremadura Posdoc-Research Contracts
FX Supported by MINECO (Grant BFU2013-45564-C2-1-P) and Junta de
   Extremadura-FEDER. AB-E and EL were supported by University of
   Extremadura Posdoc-Research Contracts.
CR Albarran L, 2014, BIOCHEM J, V463, P373, DOI 10.1042/BJ20140523
   Hampson A, 2013, J THROMB HAEMOST, V11, P161, DOI 10.1111/jth.12068
   Vretenbrant K, 2007, THROMB HAEMOSTASIS, V97, P417, DOI 10.1160/TH06-07-0397
   Pihusch R, 2002, BONE MARROW TRANSPL, V30, P381, DOI 10.1038/sj.bmt.1703663
   Dionisio N, 2011, BBA-MOL CELL RES, V1813, P1483, DOI 10.1016/j.bbamcr.2011.05.005
   Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200
   Ye SJ, 2012, BLOOD, V120, P2484, DOI 10.1182/blood-2012-05-430603
   DELCASTILLO AR, 1992, THROMB HAEMOSTASIS, V67, P248
   Ramanathan G, 2012, J THROMB HAEMOST, V10, P419, DOI 10.1111/j.1538-7836.2011.04596.x
   Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200
   Jardin I, 2007, ARCH BIOCHEM BIOPHYS, V465, P16, DOI 10.1016/j.abb.2007.04.038
   Lopez JJ, 2005, BIOCHEM J, V390, P243, DOI 10.1042/BJ20050168
   Lopez JJ, 2006, CELL SIGNAL, V18, P373, DOI 10.1016/j.cellsig.2005.05.006
   Jardin I, 2012, BIOCHEM J, V445, P29, DOI 10.1042/BJ20120471
   Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768
   Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934
   Lopez E, 2012, J PHYSIOL BIOCHEM, V68, P619, DOI 10.1007/s13105-012-0163-1
   Ohlmann P, 1998, BIOCHEM J, V331, P431
   Redondo PC, 2006, BLOOD, V107, P973, DOI 10.1182/blood-2005-05-2015
   Bergmeier W, 2009, J THROMB HAEMOST, V7, P187, DOI 10.1111/j.1538-7836.2009.03379.x
   Deb S, 2011, NANOMED-NANOTECHNOL, V7, P376, DOI 10.1016/j.nano.2011.01.007
   PHILLIPS DR, 1988, BLOOD, V71, P831
   Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/1098
   Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302
   Rosado JA, 2005, J CELL PHYSIOL, V205, P262, DOI 10.1002/jcp.20399
   Berna-Erro A, 2012, BBA-MOL CELL RES, V1823, P1242, DOI 10.1016/j.bbamcr.2012.05.023
   Cohen S, 2011, FEBS LETT, V585, P3208, DOI 10.1016/j.febslet.2011.09.014
   Harper MT, 2010, J THROMB HAEMOST, V8, P454, DOI 10.1111/j.1538-7836.2009.03722.x
   Galan C, 2011, BIOCHEM PHARMACOL, V82, P400, DOI 10.1016/j.bcp.2011.05.017
   Grosse J, 2007, J CLIN INVEST, V117, P3540, DOI 10.1172/JC132312
   Jardin I, 2008, TRENDS CARDIOVAS MED, V18, P57, DOI 10.1016/j.tcm.2007.12.004
   Rolf MG, 2002, THROMB HAEMOSTASIS, V88, P495
   BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972
   Salido GM, 2009, CELL SIGNAL, V21, P457, DOI 10.1016/j.cellsig.2008.11.005
   CAVALLINI L, 1995, BIOCHEM J, V310, P449
   Marcu MG, 1996, BLOOD, V87, P20
   Mushtaq M, 2011, J BIOL CHEM, V286, P12952, DOI 10.1074/jbc.M110.207100
   Bowman CL, 2007, TOXICON, V49, P249, DOI 10.1016/j.toxicon.2006.09.030
   Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611
   RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431
   Redondo PC, 2007, CELL SIGNAL, V19, P2147, DOI 10.1016/j.cellsig.2007.06.011
   Lopez JJ, 2012, BBA-MOL CELL RES, V1823, P1976, DOI 10.1016/j.bbamcr.2012.08.002
   Peters CG, 2012, BLOOD, V120, P199, DOI 10.1182/blood-2011-10-389247
   Neumuller O, 2009, BLOOD, V114, P1396, DOI 10.1182/blood-2008-05-155234
   Harper MT, 2011, CELL CALCIUM, V50, P351, DOI 10.1016/j.ceca.2011.06.005
   Redondo PC, 2005, CELL SIGNAL, V17, P1011, DOI 10.1016/j.cellsig.2004.11.019
   Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001
   Kondkar AA, 2010, J THROMB HAEMOST, V8, P369, DOI 10.1111/j.1538-7836.2009.03700.x
   Gilio K, 2010, J BIOL CHEM, V285, P23629, DOI 10.1074/jbc.M110.108696
   FEINSTEIN MB, 1975, J GEN PHYSIOL, V66, P561, DOI 10.1085/jgp.66.5.561
   Desai PN, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa8323
   Robinson M, 2000, BRIT J HAEMATOL, V108, P859, DOI 10.1046/j.1365-2141.2000.01939.x
   STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880
   Vemana HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125764
   Yoshioka A, 2001, J BIOL CHEM, V276, P39379, DOI 10.1074/jbc.M102933200
NR 55
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 75
EP 81
DI 10.1016/j.abb.2015.09.012
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700009
PM 26386308
ER

PT J
AU Pichert, A
   Arnhold, J
AF Pichert, Annelie
   Arnhold, Juergen
TI Interaction of the chlorite-based drug WF10 and chlorite with
   hemoglobin, methemoglobin and ferryl hemoglobin
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE WF10; Chlorite; Oxyhemoglobin; Methemoglobin; Ferryl hemoglobin;
   Hemolysis
ID HEMORRHAGIC RADIATION CYSTITIS; PLACEBO-CONTROLLED TRIAL;
   SICKLE-CELL-DISEASE; SODIUM-CHLORITE; DOUBLE-BLIND; HEME; BLOOD;
   MECHANISM; TOXICITY; CARBOXYHEMOGLOBIN
AB The interaction of the chlorite-based drug solution WF10 with human oxyhemoglobin and oxidized hemoglobin forms was investigated monitoring the corresponding spectral changes in heme states. The chlorite component of WF10 converts oxyhemoglobin into methemoglobin with a rate of 35.4 M(-1)s(-1). Methemoglobin is also formed upon the interaction of ferryl hemoglobin and WF10/chlorite. The rate of this interconversion depends on the oxidation state of ferryl hemoglobin. This rate is 114 M(-1)s(-1), when ferryl hemoglobin was generated upon reaction of oxyhemoglobin and hydrogen peroxide. A considerable higher rate (6600 M(-1)s(-1)) is measured between the chlorite components of WF10 and ferryl hemoglobin after formation of the latter species from methemoglobin. WF10/chlorite inactivates also methemoglobin as evidenced by the continuous decrease of the Soret band and all other absorbances with a rate of 8.3 M(-1)s(-1). In all interconversions, the chlorite component of WF10 was the active principle as shown in experiments applying pure chlorite at the same concentration as in WF10. Thus, WF10 is able to diminish efficiently the yield of cytotoxic hemoglobin species that might appear after excessive hemolysis of red blood cells under pathologic situations. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Pichert, Annelie; Arnhold, Juergen] Univ Leipzig, Inst Med Phys & Biophys, Fac Med, D-04107 Leipzig, Germany.
RP Arnhold, J (reprint author), Univ Leipzig, Inst Med Phys & Biophys, Fac Med, Hartelstr 16-18, D-04107 Leipzig, Germany.
EM juergen.arnhold@medizin.uni-leipzig.de
FU Sachsische Aufbaubank of the European Regional Development Fund (ERDF)
   (SAB) [100116526]; German Federal Ministry of Education and Research
   [BMBF 1315883]
FX The authors gratefully acknowledge the financial support provided by the
   Sachsische Aufbaubank from a funding of the European Regional
   Development Fund (ERDF) (SAB Project Nr: 100116526) and the German
   Federal Ministry of Education and Research (BMBF 1315883).
CR MANSOURI A, 1993, AM J HEMATOL, V42, P7, DOI 10.1002/ajh.2830420104
   Jakopitsch C, 2014, J INORG BIOCHEM, V135, P10, DOI 10.1016/j.jinorgbio.2014.02.010
   Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787
   Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879
   VANSLYKE DD, 1946, J BIOL CHEM, V166, P121
   Veerasarn V, 2004, RADIOTHER ONCOL, V73, P179, DOI 10.1016/j.rradonc.2004.05.007
   Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738
   Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200
   Nagababu E, 2002, BIOCHEMISTRY-US, V41, P7407, DOI 10.1021/bi0121048
   Everse J, 1997, FREE RADICAL BIO MED, V22, P1075, DOI 10.1016/S0891-5849(96)00499-6
   LIN JL, 1993, RENAL FAILURE, V15, P645, DOI 10.3109/08860229309069417
   FRENCH CL, 1995, J APPL TOXICOL, V15, P167, DOI 10.1002/jat.2550150306
   Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030
   GIULIVI C, 1990, J BIOL CHEM, V265, P19453
   Raffanti SP, 1998, INFECTION, V26, P202, DOI 10.1007/BF02962364
   Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974
   Gebicka L, 2009, ACTA BIOCHIM POL, V56, P509
   MOORE GS, 1980, J ENVIRON PATHOL TOX, V4, P271
   Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799
   BERCZ JP, 1982, ENVIRON HEALTH PERSP, V46, P47, DOI 10.2307/3429421
   Cooper CE, 2008, BBA-PROTEINS PROTEOM, V1784, P1415, DOI 10.1016/j.bbapap.2008.03.019
   Jakopitsch C, 2008, J INORG BIOCHEM, V102, P293, DOI 10.1016/j.jinorgbio.2007.09.002
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Patel RP, 1996, FREE RADICAL RES, V25, P117, DOI 10.3109/10715769609149916
   LANGLOIS CJ, 1992, HUM EXP TOXICOL, V11, P223
   Veerasarn V, 2006, GYNECOL ONCOL, V100, P179, DOI 10.1016/j.ygyno.2005.08.014
   Balla J, 2005, MOL NUTR FOOD RES, V49, P1030, DOI 10.1002/mnfr.200500076
   SATO K, 1981, FORENSIC SCI INT, V17, P177, DOI 10.1016/0379-0738(81)90010-4
   Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004
   Jia YP, 2008, FREE RADICAL BIO MED, V45, P659, DOI 10.1016/j.freeradbiomed.2008.05.010
   HEFFERNAN WP, 1979, J ENVIRON PATHOL TOX, V2, P1501
   Sztiller M, 2006, REDOX REP, V11, P263, DOI 10.1179/135100006X155012
   Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008
   BUNN HF, 1968, J BIOL CHEM, V243, P465
   HABERMANN E, 1989, KLIN WOCHENSCHR, V67, P20, DOI 10.1007/BF01736530
   Yingsakmongkol N, 2011, J FOOT ANKLE SURG, V50, P635, DOI 10.1053/j.jfas.2011.05.006
   Hofbauer S, 2014, BIOCHEMISTRY-US, V53, P3145, DOI 10.1021/bi500401k
   Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887
   Chiabrando D., 2011, ACUTE PHASE PROTEINS, P261
   Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g
   Hunter J.D., 2006, CONTIN ED ANAESTHESI, P141
   McGrath Michael S, 2002, Curr Opin Investig Drugs, V3, P365
   RODKEY FL, 1974, BIOCHEM MED METAB B, V9, P261, DOI 10.1016/0006-2944(74)90061-1
   Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653
   Schempp H., 2001, DRUG RES, V51, P3
   Sharma Sujata, 2013, Int J Biochem Mol Biol, V4, P108
   Siggaard-Andersen O., 1972, J REM CLIN CHIM ACTA, V42, P85
   Yingsakmongkol N., 2013, J WOUND CARE, V22, P1
NR 48
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 82
EP 89
DI 10.1016/j.abb.2015.09.009
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700010
PM 26391926
ER

PT J
AU Luevano-Martinez, LA
   Kowaltowski, AJ
AF Luevano-Martinez, Luis Alberto
   Kowaltowski, Alicia J.
TI Phosphatidylglycerol-derived phospholipids have a universal,
   domain-crossing role in stress responses
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Cardiolipin; Membrane; Archaea; Eukarya; Bacteria; Stress
ID YEAST SACCHAROMYCES-CEREVISIAE; EXTREMELY HALOPHILIC ARCHAEON;
   POLYMORPHIC PHASE-BEHAVIOR; HEART CYTOCHROME-C; ESCHERICHIA-COLI;
   BARTH-SYNDROME; OSMOTIC-STRESS; CARDIOLIPIN BIOSYNTHESIS; PURPLE
   MEMBRANE; LIPID-MEMBRANES
AB Phosphatidylglycerol and phospholipids derived from it are widely distributed throughout the three domains of life. Cardiolipin is the best characterized of these phospholipids, and plays a key role in the response to environmental variations. Phosphatidylglycerol-derived phospholipids confer cell membranes with a wide range of responses, including changes in surface charge, fluidity, flexibility, morphology, biosynthesis and remodeling, that adapt the cell to these situations. Furthermore, the synthesis and remodeling of these phospholipids is finely regulated, highlighting the importance of these lipids in cell homeostasis and responses during stressful situations. In this article, we review the most important roles of these anionic phospholipids across domains, focusing on the biophysical basis by which these phospholipids are used in stress responses. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Luevano-Martinez, Luis Alberto; Kowaltowski, Alicia J.] Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508 Sao Paulo, SP, Brazil.
RP Kowaltowski, AJ (reprint author), Ave Prof Lineu Prestes 748,Cidade Univ, BR-05508000 Sao Paulo, SP, Brazil.
EM alicia@iq.usp.br
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Instituto
   Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT
   Redoxoma) [10/51906]; Nucleo de Apoio a Pesquisa Redoxoma (NAP
   Redoxoma), Centro de Pesquisa, Inovacao e Difusao de Processos Redox em
   Biomedicina (CEPID Redoxoma) [13/07937-8]; John Simon Guggenheim
   Memorial Foundation; postdoctoral FAPESP fellowship [13/04919-9]
FX This work was supported by the Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP); grant 10/51906, Instituto Nacional de Ciencia e
   Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); grant
   13/07937-8, Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma), Centro
   de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (CEPID
   Redoxoma) grant 13/07937-8 and the John Simon Guggenheim Memorial
   Foundation. LALM (grant 13/04919-9) is supported by a postdoctoral
   FAPESP fellowship.
CR Lobasso S, 2015, CHEM PHYS LIPIDS, V186, P1, DOI 10.1016/j.chemphyslip.2014.11.002
   Mejia EM, 2014, CHEM PHYS LIPIDS, V179, P11, DOI 10.1016/j.chemphyslip.2013.10.001
   Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920
   Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286
   PINHEIRO TJT, 1994, BIOCHIMIE, V76, P489, DOI 10.1016/0300-9084(94)90173-2
   Ascenzi P, 2015, IUBMB LIFE, V67, P98, DOI 10.1002/iub.1350
   Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7
   KENNEDY EP, 1956, J BIOL CHEM, V222, P193
   Lopalco P, 2004, J LIPID RES, V45, P194, DOI 10.1194/jlr.M300329-JLR200
   Lobasso Simona, 2008, Archaea, V2, P177, DOI 10.1155/2008/870191
   Romantsov T, 2008, J BIOL CHEM, V283, P12314, DOI 10.1074/jbc.M709871200
   Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480
   Yokoyama Y, 2014, J PHYS CHEM B, V118, P9322, DOI 10.1021/jp5036234
   Dahlberg M, 2007, J PHYS CHEM B, V111, P7194, DOI 10.1021/jp071954f
   Liu JH, 2003, MOL CANCER RES, V1, P892
   Corcelli A, 2007, BIOCHEM BIOPH RES CO, V354, P795, DOI 10.1016/j.bbrc.2007.01.060
   Patil VA, 2013, ADV EXP MED BIOL, V991, P195, DOI 10.1007/978-94-007-6331-9_11
   Lombard J, 2012, NAT REV MICROBIOL, V10, P507, DOI 10.1038/nrmicro2815
   De Leo V, 2009, J LIPID RES, V50, P256, DOI 10.1194/jlr.M800312-JLR200
   Lobasso S, 2003, J LIPID RES, V44, P2120, DOI 10.1194/jlr.M300212-JLR200
   Hsu P, 2015, AUTOPHAGY, V11, P643, DOI 10.1080/15548627.2015.1023984
   Kitchen JL, 1999, BIOCHEMISTRY-US, V38, P6213, DOI 10.1021/bi982733q
   Koshkin V, 2002, BIOCHEM J, V364, P317
   RUSSELL NJ, 1989, J BIOENERG BIOMEMBR, V21, P93, DOI 10.1007/BF00762214
   Dalebroux ZD, 2014, P NATL ACAD SCI USA, V111, P1963, DOI 10.1073/pnas.1316901111
   Guillot A, 2000, INT J FOOD MICROBIOL, V55, P47, DOI 10.1016/S0168-1605(00)00193-8
   Lopez CA, 2002, ARCH BIOCHEM BIOPHYS, V408, P220, DOI 10.1016/S0003-9861(02)00566-0
   He Q, 2004, MOL MICROBIOL, V53, P1243, DOI 10.1111/j.1365-2958.2004.04202.x
   Lattanzio VMT, 2002, EXTREMOPHILES, V6, P437, DOI 10.1007/s00792-002-0279-2
   Tenchov B, 2006, J BIOL CHEM, V281, P10016, DOI 10.1074/jbc.M600369200
   Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486
   Sinibaldi F, 2010, J BIOL INORG CHEM, V15, P689, DOI 10.1007/s00775-010-0636-z
   Raja V, 2014, CHEM PHYS LIPIDS, V179, P49, DOI 10.1016/j.chemphyslip.2013.12.009
   Cosentino K, 2014, CHEM PHYS LIPIDS, V181, P62, DOI 10.1016/j.chemphyslip.2014.04.001
   Heit B, 2011, AM J PHYSIOL-CELL PH, V300, pC33, DOI 10.1152/ajpcell.00139.2010
   Saha SK, 1996, BIOSCI BIOTECH BIOCH, V60, P111
   Ridone P, 2015, EUR BIOPHYS J BIOPHY, V44, P567, DOI 10.1007/s00249-015-1020-2
   Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829
   Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330
   XIA WM, 1995, P NATL ACAD SCI USA, V92, P783, DOI 10.1073/pnas.92.3.783
   Muller AO, 2012, CHEM PHYS LIPIDS, V165, P787, DOI 10.1016/j.chemphyslip.2012.09.005
   FERREIRA GC, 1987, J BIOL CHEM, V262, P4407
   Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054
   Sorice M, 2009, FEBS LETT, V583, P2447, DOI 10.1016/j.febslet.2009.07.018
   Gbelska Y, 1999, FOLIA MICROBIOL, V44, P697, DOI 10.1007/BF02825665
   Li XX, 2015, J HISTOCHEM CYTOCHEM, V63, P301, DOI 10.1369/0022155415574818
   Khalifat N, 2008, BIOPHYS J, V95, P4924, DOI 10.1529/biophysj.108.136077
   Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839
   Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938
   RAETZ CRH, 1972, J BIOL CHEM, V247, P2008
   Lopez CS, 2006, MICROBIOL-SGM, V152, P605, DOI 10.1099/mic.0.28345-0
   Kagan VE, 2014, CHEM PHYS LIPIDS, V179, P64, DOI 10.1016/j.chemphyslip.2013.11.010
   Maltseva E, 2006, J PHYS CHEM B, V110, P919, DOI 10.1021/jp0555697
   Luevano-Martinez LA, 2015, BBA-BIOENERGETICS, V1847, P587, DOI 10.1016/j.bbabio.2015.03.007
   MALAMED S, 1959, J BIOL CHEM, V234, P3027
   Thomas E, 2013, ANTIMICROB AGENTS CH, V57, P5580, DOI 10.1128/AAC.00889-13
   Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121
   HANCOCK AJ, 1973, J LIPID RES, V14, P430
   Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200
   Koprivnjak T, 2011, J BACTERIOL, V193, P4134, DOI 10.1128/JB.00288-11
   Arechaga I, 2013, J MOL MICROB BIOTECH, V23, P13, DOI 10.1159/000346515
   van Werkhoven MA, 2006, J LIPID RES, V47, P2346, DOI 10.1194/jlr.D600024-JLR200
   Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005
   Khalifat N, 2011, BBA-BIOMEMBRANES, V1808, P2724, DOI 10.1016/j.bbamem.2011.07.013
   Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014
   HIRAOKA S, 1993, FEBS LETT, V336, P221, DOI 10.1016/0014-5793(93)80807-7
   Le Dain AC, 1998, J BIOL CHEM, V273, P12116, DOI 10.1074/jbc.273.20.12116
   Luevano-Martinez LA, 2013, FUNGAL GENET BIOL, V60, P150, DOI 10.1016/j.fgb.2013.03.005
   Kloda A, 2001, CELL BIOCHEM BIOPHYS, V34, P349, DOI 10.1385/CBB:34:3:349
   Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733
   Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837
   Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007
   Corcelli A, 2000, BIOCHEMISTRY-US, V39, P3318, DOI 10.1021/bi992462z
   Copp J, 2005, AM J PHYSIOL-CELL PH, V288, pC403, DOI 10.1152/ajpcell.00095.2004
   Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x
   Lobasso S, 2012, ARCHAEA, DOI 10.1155/2012/957852
   Yoshinaga MY, 2012, ARCHAEA, DOI 10.1155/2012/832097
   Morii H, 2003, J BACTERIOL, V185, P1181, DOI 10.1128/JB.185.4.1181-1189.2003
   Lobasso S, 2009, CHEM PHYS LIPIDS, V157, P12, DOI 10.1016/j.chemphyslip.2008.09.002
   Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/nchem.1924, 10.1038/NCHEM.1924]
   Muenzner J, 2013, J PHYS CHEM B, V117, P12878, DOI 10.1021/jp402104r
   Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009
   KATES M, 1993, EXPERIENTIA, V49, P1027, DOI 10.1007/BF01929909
   HIRAMATSU T, 1980, FEMS MICROBIOL LETT, V7, P289, DOI 10.1111/j.1574-6941.1980.tb01606.x
   Baile MG, 2014, CHEM PHYS LIPIDS, V179, P25, DOI 10.1016/j.chemphyslip.2013.10.008
   Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487
   MORRIS GJ, 1985, J CELL SCI, V76, P145
   Nichols-Smith S, 2004, BBA-BIOMEMBRANES, V1663, P82, DOI 10.1016/j.bbamem.2004.02.002
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   Angelini R, 2012, BBA-BIOMEMBRANES, V1818, P1365, DOI 10.1016/j.bbamem.2012.02.014
   SHIBUYA I, 1985, J BACTERIOL, V161, P473
   Cerbon J., 1994, EUR J BIOCHEM, V15, P195
   Corcelli A, 2009, BBA-BIOMEMBRANES, V1788, P2101, DOI 10.1016/j.bbamem.2009.05.010
   Corcelli Angela, 2007, Biochim Biophys Acta, V1768, P2157, DOI 10.1016/j.bbamem.2007.06.029
   Daiyasu Hiromi, 2005, Archaea, V1, P399, DOI 10.1155/2005/452563
   Dalebroux ZD, 2015, CELL HOST MICROBE, V17, P441, DOI 10.1016/j.chom.2015.03.003
   Erkut Cihan, 2012, Worm, V1, P61, DOI 10.4161/worm.19040
   Friedman JR, 2015, ELIFE, V4
   Gaspard GJ, 2015, J BIOL CHEM, V290, P9284, DOI 10.1074/jbc.M115.641878
   HACKENBR.CR, 1969, J CELL BIOL, V42, P221, DOI 10.1083/jcb.42.1.221
   HACKENBR.CR, 1968, J CELL BIOL, V37, P345, DOI 10.1083/jcb.37.2.345
   HIRSCHBE.CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648
   Jouhet J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00494
   Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13
   KARLSSON OP, 1994, J BIOL CHEM, V269, P23484
   Koynova R., 2013, OA BIOCH, V1, P9
   Luevano-Martinez LA, 2015, BBA-BIOENERGETICS, V1847, P599, DOI [10.1016/j.bbabio.2015.03.005, 10.1016/j.bbabio2015.03.005]
   Olofsson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073040
   Parsons J.B., 2013, BMC MICROBIOL, V16, P260
   POWELL GL, 1985, BIOCHEMISTRY-US, V24, P2902, DOI 10.1021/bi00333a013
   ROBINSON NC, 1982, BIOCHEMISTRY-US, V21, P184, DOI 10.1021/bi00530a031
   Saxena R., 2003, INT J MOL SCI, V14, P8517
   Sohlenkamp C., 2015, FEMS MICROB IN PRESS
   Sprott G.D., 2003, BIOCHIM BIOPHYS ACTA, V22, P179
   Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, P161, DOI 10.1093/nar/gkt1015
   Tian HF, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-32
   Tropp BE, 1997, BBA-LIPID LIPID MET, V1348, P192, DOI 10.1016/S0005-2760(97)00100-8
   Zulys M., 2008, THESIS U TORONTO
NR 118
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 90
EP 97
DI 10.1016/j.abb.2015.09.015
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700011
PM 26391924
ER

PT J
AU Swetha, M
   Ramaiah, KVA
AF Swetha, Medchalmi
   Ramaiah, Kolluru V. A.
TI Insulin treatment promotes tyrosine phosphorylation of PKR and inhibits
   polyIC induced PKR threonine phosphorylation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Eukaryotic initiation factor 2; Insulin receptor; Insulin sensitivity
   and resistance; RNA-dependent protein kinase; Tyrosine and threonine
   phosphorylation; HepG2 cells
ID DEPENDENT PROTEIN-KINASE; NUCLEOTIDE EXCHANGE ACTIVITY;
   INITIATION-FACTOR 2-ALPHA; GLYCOGEN-SYNTHASE KINASE; ACTIVATION; CELLS;
   DEPHOSPHORYLATION; RECEPTOR; SERINE; STRESS
AB Tyrosine phosphorylation of insulin receptor beta (IR beta) in insulin treated HepG2 cells is inversely correlated to ser(51) phosphorylation in the alpha-subunit of eukaryotic initiation factor 2 (eIF2 alpha) that regulates protein synthesis. Insulin stimulates interaction between IR beta and PKR, double stranded RNA-dependent protein kinase, also known as EIF2AK2, and phosphorylation of tyrosine residues in PKR, as analyzed by immunoprecipitation and pull down assays using anti-IR beta and anti-phosphotyrosine antibodies, recombinant IR beta and immunopurified PKR. Further polyIC or synthetic double stranded RNA-induced threonine phosphorylation or activation of immunopurified and cellular PKR is suppressed in the presence of insulin treated purified IR beta and cell extracts. Acute, but not chronic, insulin treatment enhances tyrosine phosphorylation of IR beta, its interaction with PKR and tyrosine phosphorylation of PKR. In contrast, lipopolysaccharide that stimulates threonine phosphorylation of PKR and eIF2 alpha phosphorylation and AG 1024, an inhibitor of the tyrosine kinase activity of IR beta, reduces PKR association with the receptor, IR beta in HepG2 cells. These findings therefore may suggest that tyrosine phosphorylated PKR plays a role in the regulation of insulin induced protein synthesis and in maintaining insulin sensitivity, whereas, suppression of polyIC-mediated threonine phosphorylation of PKR by insulin compromises its ability to fight against virus infection in host cells. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Swetha, Medchalmi; Ramaiah, Kolluru V. A.] Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500046, Telangana, India.
RP Ramaiah, KVA (reprint author), Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500046, Telangana, India.
EM kvarsl@uohyd.ernet.in
FU Council of Scientific and Industrial Research (CSIR), New-Delhi, India;
   Department of Science and Technology, New-Delhi, India
   [SR/SO/BB-83/2010]
FX M.S thanks Council of Scientific and Industrial Research (CSIR),
   New-Delhi, India for a research fellowship and Dr K V A R thanks
   Department of Science and Technology, New-Delhi, India for a research
   grant SR/SO/BB-83/2010 and also to DST-PURSE grant of the University of
   Hyderabad, and DST-FIST grant of the Department of Biochemistry,
   University of Hyderabad.
CR RAMAIAH KVA, 1994, MOL CELL BIOL, V14, P4546
   Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2
   Su QZ, 2006, P NATL ACAD SCI USA, V103, P63, DOI 10.1073/pnas.0508207103
   Machida K, 2009, METHODS MOL BIOL, V536, P313, DOI 10.1007/978-1-59745-542-8_34
   Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003
   Babu SVN, 1996, ARCH BIOCHEM BIOPHYS, V327, P201, DOI 10.1006/abbi.1996.0110
   Dabo S, 2012, VIRUSES-BASEL, V4, P2598, DOI 10.3390/v4112598
   White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619
   Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001
   Lodhi IJ, 2007, CELL METAB, V5, P59, DOI 10.1016/j.cmet.2006.12.006
   Eley HL, 2008, MOL CELL BIOCHEM, V313, P63, DOI 10.1007/s11010-008-9742-4
   Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459
   Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911
   Youngren JF, 2007, CELL MOL LIFE SCI, V64, P873, DOI 10.1007/s00018-007-6359-9
   Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290
   SRINIVASAN M, 1994, J BIOL CHEM, V269, P16662
   Ge XM, 2008, FREE RADICAL RES, V42, P582, DOI 10.1080/10715760802158448
   Brady MJ, 2001, RECENT PROG HORM RES, V56, P157, DOI 10.1210/rp.56.1.157
   Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292
   Su QZ, 2007, EMBO REP, V8, P265, DOI 10.1038/sj.embor.7400891
   Singh LP, 1996, BIOCHEMISTRY-US, V35, P3206, DOI 10.1021/bi9522099
   Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x
   Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008
   Yuan L, 2003, ACTA PHARMACOL SIN, V24, P55
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Woods YL, 2001, BIOCHEM J, V355, P609
   Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198
   Pryor PR, 2000, BIOCHEM J, V348, P83, DOI 10.1042/0264-6021:3480083
   Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113
   Proud CG, 2006, BIOCHEM SOC T, V34, P213
   Yang XR, 2010, MOL BIOL CELL, V21, P3449, DOI 10.1091/mbc.E10-06-0481
   Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06
   Hinnebusch AG, 2005, NAT STRUCT MOL BIOL, V12, P835, DOI 10.1038/nsmb1005-835
   Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200
   Nguyen TN, 2006, NAT METHODS, V3, P135, DOI 10.1038/nmeth0206-135
   Sullivan JM, 1999, J CEREBR BLOOD F MET, V19, P1010
   Carvalho MA, 2012, ENDOCRINOLOGY, V153, P5261, DOI 10.1210/en.2012-1400
   Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682
   Wu M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008040
NR 39
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 98
EP 108
DI 10.1016/j.abb.2015.07.012
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700012
PM 26321373
ER

PT J
AU Onouchi, T
   Kishino-Kaneko, Y
   Kameshita, I
   Ishida, A
   Sueyoshi, N
AF Onouchi, Takashi
   Kishino-Kaneko, Yoshimi
   Kameshita, Isamu
   Ishida, Atsuhiko
   Sueyoshi, Noriyuki
TI Regulation of Ca2+/calmodulin-dependent protein kinase phosphatase
   (CaMKP/PPM1F) by protocadherin-gamma C5 (Pcdh-gamma C5)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE PPM1F; Protocadherin; CaM kinase; N-cadherin; PPM1A/PP2C alpha;
   gamma-secretase
ID N-CADHERIN; ACTIVATION; CAMKP; PHOSPHORYLATION; P120-CATENIN;
   EXPRESSION; ZEBRAFISH; PROMOTER; ADHESION; CATENIN
AB Ca2+/calmodulin-dependent protein kinase phosphatase (CaMKP/PPM1F) is a Ser/Thr protein phosphatase that belongs to the PPM family. It is important to identify an endogenous regulator of CaMKP. Using an Escherichia coli two-hybrid screening method, we identified the C-terminal cytoplasmic fragment of protocadherin gamma subfamily C5 (Pcdh-gamma C5), which was generated by intracellular processing, as a CaMKP-binding protein. Dephosphorylation of phosphorylated Ca2+/calmodulin-dependent protein kinase I (CaMKI) by CaMKP was significantly activated by the C-terminal cytoplasmic fragment, Pcdh-gamma C5(715-944), both in vitro and in cells, suggesting that the C-terminal fragment functions as an endogenous activator of CaMKP. The nuclear translocation of the fragment was blocked by its binding to cytoplasmic CaMKP to form a ternary complex with CaMKI. Taken together, these results strongly suggest that the C-terminal cytoplasmic fragment of Pcdh-gamma C5 acts as a scaffold for CaMKP and CaMKI to regulate CaMKP,activity. These findings may provide new insights into the reversible regulation of CaMKP in cells. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Onouchi, Takashi; Kishino-Kaneko, Yoshimi; Kameshita, Isamu; Sueyoshi, Noriyuki] Kagawa Univ, Dept Life Sci, Fac Agr, Takamatsu, Kagawa 7610795, Japan.
   [Ishida, Atsuhiko] Hiroshima Univ, Lab Mol Brain Sci, Grad Sch Integrated Arts & Sci, Higashihiroshima 7398521, Japan.
RP Ishida, A (reprint author), Hiroshima Univ, Lab Mol Brain Sci, Grad Sch Integrated Arts & Sci, Higashihiroshima 7398521, Japan.
EM aishida@hiroshima-u.ac.jp; sueyoshi@ag.kagawa-u.ac.jp
FU JSPS [25850244, 25350978, 15K01824]; Kagawa University;  [15J07644]
FX This work was supported in part by JSPS Grant-in-Aid for Scientific
   Research (Grant Numbers 25850244, 25350978, 15K01824), Grant-in-Aid for
   JSPS Fellows (Grant Number 15J07644), and Kagawa University Specially
   Promoted Research Fund 2013.
CR BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4
   Li YF, 2012, J NEUROSCI, V32, P11780, DOI 10.1523/JNEUROSCI.0969-12.2012
   Baba H, 2012, ARCH BIOCHEM BIOPHYS, V526, P9, DOI 10.1016/j.abb.2012.06.005
   Kameshita I, 1999, FEBS LETT, V456, P249, DOI 10.1016/S0014-5793(99)00958-8
   IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785
   Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471
   Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/S0092-8674(03)00651-2
   McLachlan RW, 2011, CYTOSKELETON, V68, P32, DOI 10.1002/cm.20492
   Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Harvey BP, 2004, J BIOL CHEM, V279, P24889, DOI 10.1074/jbc.M400656200
   Onouchi T, 2012, BIOCHEM BIOPH RES CO, V422, P703, DOI 10.1016/j.bbrc.2012.05.062
   Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200
   Yoshida K, 1999, FEBS LETT, V460, P93, DOI 10.1016/S0014-5793(99)01309-5
   Sueyoshi N, 2009, ARCH BIOCHEM BIOPHYS, V488, P48, DOI 10.1016/j.abb.2009.06.003
   Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410
   Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P
   Fujisawa H, 2001, J BIOCHEM-TOKYO, V129, P193
   Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111
   Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807
   Kinoshita S, 2004, J BIOCHEM, V135, P619, DOI 10.1093/jb.mvh075
   Kitani T, 1999, J BIOCHEM-TOKYO, V125, P1022
   Buchanan SM, 2010, P NATL ACAD SCI USA, V107, P17774, DOI 10.1073/pnas.1013105107
   Shimomura S, 2007, ARCH BIOCHEM BIOPHYS, V463, P218, DOI 10.1016/j.abb.2007.03.036
   Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8
   Marion S, 2014, J BIOL CHEM, V289, P11715, DOI 10.1074/jbc.M113.544312
   Tada Y, 2006, ARCH BIOCHEM BIOPHYS, V452, P174, DOI 10.1016/j.abb.2006.06.005
   Ishida A, 2002, ARCH BIOCHEM BIOPHYS, V408, P229, DOI 10.1016/S0003-9861(02)00592-1
   Ishida A, 1998, J BIOL CHEM, V273, P1904, DOI 10.1074/jbc.273.4.1904
   Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R
   Gee KR, 1999, ANAL BIOCHEM, V273, P41, DOI 10.1006/abio.1999.4202
   Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6
   Voss M, 2011, CELL SIGNAL, V23, P114, DOI 10.1016/j.cellsig.2010.08.010
   Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090
   Li YF, 2010, J COMP NEUROL, V518, P3439, DOI 10.1002/cne.22390
   Kameshita I, 2003, ANAL BIOCHEM, V322, P215, DOI 10.1016/j.ab.2003.08.014
   Koh CG, 2002, CURR BIOL, V12, P317, DOI 10.1016/S0960-9822(02)00652-8
   Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801
   Phang HQ, 2014, J CELL SCI, V127, P727, DOI 10.1242/jcs.126482
   Sueyoshi N., 2007, BIOCHEM BIOPH RES CO, V363, P205
NR 40
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2015
VL 585
BP 109
EP 120
DI 10.1016/j.abb.2015.09.014
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CU2NR
UT WOS:000363360700013
PM 26386307
ER

PT J
AU Lu, NH
   Li, JY
   Gao, ZH
AF Lu, Naihao
   Li, Jiayu
   Gao, Zhonghong
TI Key roles of Tyr 10 in Cu bound A beta complexes and its relevance to
   Alzheimer's disease
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE A beta-Cu(II) complex; Tyrosine; Oxidation; A beta aggregation;
   Neurochemistry
ID AMYLOID PRECURSOR PROTEIN; ACTIVE METAL-IONS; OXIDATIVE STRESS; TYROSINE
   NITRATION; CU(II) BINDING; PEPTIDE; COPPER; AGGREGATION; COORDINATION;
   DITYROSINE
AB Recent studies show that the accumulation of redox-active Cu mediates the aggregation of amyloid beta-peptide (A beta) and conspicuous oxidative damage to the brain in Alzheimer's disease (AD). However, the key roles for Tyr 10 in A beta-Cu(II) complex and its potential biological relevance to AD etiology under oxidative stress, were not stressed enough. Interestingly, our results indicated that A beta(40) (not A beta(16))-Cu(II) complex showed obviously enhanced peroxidase activity than free Cu(II). Although Tyr 10 was not the residue binding Cu(II), the mutation of Tyr 10 residue in A beta(40) decreased the peroxidase activity of A beta(40)-Cu(II) complex, and the mutation of Tyr 10 could inhibit A beta(40) aggregation. Under oxidative and nitrative stress conditions, the A beta-Cu(II) complex caused oxidation and nitration of the All Tyr 10 residue through peroxidase-like reactions, where the formation of Cu(I) and hydroxyl radical (center dot OH) was proposed as a chemical mechanism. We also showed that, when A beta(40) aggregates were bound to Cu(II), they retained peroxidase-like activity. Therefore, Tyr 10 residue is pivotal in A beta-Cu(II) complex and shows important relevance to oxidative stress, implicating the novel significance of Tyr 10 residue as well as A beta-Cu(II) complex in the pathology of AD. (C) 2015 Published by Elsevier Inc.
C1 [Lu, Naihao; Li, Jiayu] Jiangxi Normal Univ, Key Lab Funct Small Organ Mol, Minist Educ, Key Lab Green Chem, Nanchang, Jiangxi Provinc, Peoples R China.
   [Lu, Naihao; Li, Jiayu] Jiangxi Normal Univ, Coll Chem & Chem Engn, Nanchang, Jiangxi Provinc, Peoples R China.
   [Gao, Zhonghong] Huazhong Univ Sci & Technol, Sch Chem & Chem Engn, Wuhan 430074, Peoples R China.
RP Lu, NH (reprint author), Jiangxi Normal Univ, Key Lab Funct Small Organ Mol, Minist Educ, Key Lab Green Chem, Nanchang, Jiangxi Provinc, Peoples R China.
EM naihaolu@jxnu.edu.cn; zhgao144@mail.hust.edu.cn
FU National Natural Science Foundation of China [31100608, 31170808,
   31260216, 31560255]; Natural Science Foundation of Jiangxi Province
   [20114BAB204013]; Education Department of Jiangxi Province [GJJ12183];
   Sponsored Program for Cultivating Youths of Outstanding Ability in
   Jiangxi Normal University; Open Project Program of Key Laboratory of
   Functional Small Organic Molecule, Ministry of Education, Jiangxi Normal
   University [KLFS-KF-201207]
FX Financial support from the National Natural Science Foundation of China
   (Nos. 31100608, 31170808, 31260216, 31560255), the Natural Science
   Foundation of Jiangxi Province (No. 20114BAB204013), Education
   Department of Jiangxi Province (No. GJJ12183), the Sponsored Program for
   Cultivating Youths of Outstanding Ability in Jiangxi Normal University,
   the Open Project Program of Key Laboratory of Functional Small Organic
   Molecule, Ministry of Education, Jiangxi Normal University (No.
   KLFS-KF-201207).
CR Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101
   Hensley K, 1998, J NEUROSCI, V18, P8126
   Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994
   Du XB, 2014, INORG CHEM, V53, P1672, DOI 10.1021/ic4028282
   Zhu X, 2007, CELL MOL LIFE SCI, V64, P2202, DOI 10.1007/s00018-007-7218-4
   Rauk A, 2009, CHEM SOC REV, V38, P2698, DOI 10.1039/b807980n
   La Penna G, 2013, J PHYS CHEM B, V117, P16455, DOI 10.1021/jp410046w
   Thiabaud G, 2013, ANGEW CHEM INT EDIT, V52, P8041, DOI 10.1002/anie.201302989
   Brzyska M, 2009, CHEMBIOCHEM, V10, P1045, DOI 10.1002/cbic.200800732
   Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje
   Butterfield DA, 2009, J NEUROCHEM, V111, P915, DOI 10.1111/j.1471-4159.2009.06397.x
   JOSEPHY PD, 1982, J BIOL CHEM, V257, P3669
   Sohn OS, 2000, ANAL BIOCHEM, V279, P202, DOI 10.1006/abio.1999.4471
   Nakamura M, 2007, BIOCHEMISTRY-US, V46, P12737, DOI 10.1021/bi701079z
   Furlan S, 2010, J PHYS CHEM B, V114, P15119, DOI 10.1021/jp102928h
   Feaga HA, 2011, INORG CHEM, V50, P1614, DOI 10.1021/ic100967s
   Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355
   Lu NH, 2015, CHEM RES TOXICOL, V28, P365, DOI 10.1021/tx5003035
   Hureau C, 2012, COORDIN CHEM REV, V256, P2164, DOI 10.1016/j.ccr.2012.03.037
   Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824
   Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001
   Zhao J, 2015, CHEM RES TOXICOL, V28, P401, DOI 10.1021/tx500353s
   Qiao L, 2011, J AM CHEM SOC, V133, P19823, DOI 10.1021/ja206980q
   Manevich Y, 1997, RADIAT RES, V148, P580, DOI 10.2307/3579734
   Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246
   Hureau C, 2012, COORDIN CHEM REV, V256, P2175, DOI 10.1016/j.ccr.2012.03.034
   Zhou YL, 2013, ACS CHEM NEUROSCI, V4, P535, DOI 10.1021/cn300231q
   Bao QG, 2011, J BIOL INORG CHEM, V16, P809, DOI 10.1007/s00775-011-0783-x
   Pramanik D, 2011, J AM CHEM SOC, V133, P15545, DOI 10.1021/ja204628b
   Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106
   Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690
   Yuan C, 2012, J BIOL INORG CHEM, V17, P197, DOI 10.1007/s00775-011-0842-3
   Pithadia AS, 2012, CURR OPIN CHEM BIOL, V16, P67, DOI 10.1016/j.cbpa.2012.01.016
   Karr JW, 2008, BIOCHEMISTRY-US, V47, P5006, DOI 10.1021/bi702423h
   Lu NH, 2014, BIOCHEM BIOPH RES CO, V452, P676, DOI 10.1016/j.bbrc.2014.08.130
   Mayes J, 2014, J BIOL CHEM, V289, P12052, DOI 10.1074/jbc.M113.525212
NR 36
TC 0
Z9 0
U1 15
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 1
EP 9
DI 10.1016/j.abb.2015.07.009
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100001
PM 26247837
ER

PT J
AU Alam, MM
   Iqbal, S
   Naseem, I
AF Alam, Md. Maroof
   Iqbal, Sarah
   Naseem, Imrana
TI Ameliorative effect of riboflavin on hyperglycemia, oxidative stress and
   DNA damage in type-2 diabetic mice: Mechanistic and therapeutic
   strategies
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Riboflavin; Oxidative stress; Glutathione reductase; GLUT-4; DNA damage
ID GLUTATHIONE; ANTIOXIDANTS; ABNORMALITIES; COMPLICATIONS; DEPLETION;
   REDUCTASE; MELLITUS; DISEASE; INJURY; GLUT4
AB Increasing evidence in both experimental and clinical studies suggests that oxidative stress play a major role in the pathogenesis of type-2 diabetes mellitus (T2DM). Abnormally high levels of free radicals and the simultaneous decline of antioxidant defence mechanisms can lead to damage of cellular organelles and enzymes. Riboflavin constitutes an essential nutrient for humans and is also an important food additive for animals. It is a precursor of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) which serves as a coenzyme for several enzymes. The aim of this study was to observe the effects of illuminated and non-illuminated riboflavin in a diabetic mice model. The protocol included treatment of diabetic mice with illuminated RF and a control set without light. To our surprise, group receiving RF without light gave better results in a dose dependent manner. Significant amelioration of oxidative stress was observed with an increased glucose uptake in skeletal muscles and white adipose tissue. Histological studies showed recovery in the liver and kidney tissue injury. Cellular DNA damage was also recovered. Therefore, it is suggested that supplementation with dietary riboflavin might help in the reduction of diabetic complications. A possible mechanism of action is also proposed. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Alam, Md. Maroof; Iqbal, Sarah; Naseem, Imrana] Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh 202002, Uttar Pradesh, India.
RP Naseem, I (reprint author), Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh 202002, Uttar Pradesh, India.
EM imrananaseem2009@gmail.com
FU University Grant Commission (UGC), New Delhi under SAP programme
FX The authors acknowledge the financial assistance provided by the
   University Grant Commission (UGC), New Delhi under SAP programme and the
   facilities provided by the Department of Biochemistry, Aligarh Muslim
   University. We are grateful to Professor S.M.A. Abidi and Ahammed
   Shareef (Department of Zoology, AMU, Aligarh) for histopathology. We are
   also thankful to Dr. Sandesh Chibbar, all the friends, lab colleagues
   and fellows who directly or indirectly helped us during different phases
   of treatment and experimentation in this work.
CR Aebi H, 1984, METHOD ENZYMOL, V6, P105, DOI DOI 10.1016/S0076-6879(84)05016-3
   Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x
   YOUNES M, 1981, CHEM-BIOL INTERACT, V34, P257, DOI 10.1016/0009-2797(81)90098-3
   Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062
   Sheikh-Ali M, 2011, AM J THER, V18, P266, DOI 10.1097/MJT.0b013e3181b7badf
   Rahimi R, 2005, BIOMED PHARMACOTHER, V59, P365, DOI 10.1016/j.biopha.2005.07.002
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Bjorklund A, 2000, DIABETES, V49, P1840, DOI 10.2337/diabetes.49.11.1840
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   Cuerda C, 2011, NUTR HOSP, V26, P68, DOI 10.3305/nh.2011.26.1.5115
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56
   Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006
   BEACH RS, 1992, AIDS, V6, P701, DOI 10.1097/00002030-199207000-00013
   Iwanaga K, 2007, TRANSPLANTATION, V83, P747, DOI 10.1097/01.tp.0000256283.06469.d4
   LEE SS, 1983, BIOCHEM BIOPH RES CO, V117, P788, DOI 10.1016/0006-291X(83)91666-2
   MACK CP, 1995, BIOCHEM BIOPH RES CO, V212, P35, DOI 10.1006/bbrc.1995.1932
   Hasani-Ranjbar Shirin, 2009, Inflammation & Allergy Drug Targets, V8, P2
   Hasani-Ranjbar S, 2008, ARCH MED SCI, V4, P285
   Worrall DS, 2002, MOL ENDOCRINOL, V16, P378, DOI 10.1210/me.16.2.378
   HIRANO H, 1983, INT J VITAM NUTR RES, V53, P377
   [Anonymous], 1974, EUR J BIOCHEM, DOI DOI 10.1111/J.1432-1033.1974.TB03714.X
   BETZ AL, 1994, ACT NEUR S, V60, P314
   Huang JW, 2010, FISH PHYSIOL BIOCHEM, V36, P55, DOI 10.1007/s10695-008-9279-1
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485
   Abdollahi M, 2004, MED SCI MONITOR, V10, pRA141
   Buege J A, 1978, Methods Enzymol, V52, P302
   Cooperman J.M., 1991, HDB VITAMINS, P283
   FERNANDEZBANARES F, 1989, AM J GASTROENTEROL, V84, P744
   Hassan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036273
   Kind R.N., 1954, J CLIN PATHOL, V7, P322
   Liang H, 1999, Wei Sheng Yan Jiu, V28, P370
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058
   Rahman I., 2000, EUR RESPIR J, V16, P524
   Sedalk J., 1968, ANAL BIOCHEM, V25, P192
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Spare D.P., 1964, CLIN CHEM, V10, P726
   Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793
   Tatyana AK, 1999, J BIOL CHEM, V274, P1458
   Trinder P, 1969, ANNALS CLINICAL BIOC, V6, P24
   Tumkiratiwong Panas, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P480
NR 44
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 10
EP 19
DI 10.1016/j.abb.2015.08.013
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100002
PM 26319175
ER

PT J
AU Hsu, CN
   West, AH
   Cook, PF
AF Hsu, Chaonan
   West, Ann H.
   Cook, Paul F.
TI Evidence for an induced conformational change in the catalytic mechanism
   of homoisocitrate dehydrogenase for Saccharomyces cerevisiae:
   Characterization of the D271N mutant enzyme
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Homoisocitrate dehydrogenase; Site-directed mutagenesis; Initial rate
   studies; pH-Rate profiles; Isotope effects; Viscosity
ID ALPHA-AMINOADIPATE PATHWAY; HYDROXYACID OXIDATIVE DECARBOXYLASES;
   DEPENDENT ISOCITRATE DEHYDROGENASE; ACID-BASE CHEMISTRY; INHIBITOR;
   COMPLEX; FUNGI
AB Homoisocitrate dehydrogenase (HIcDH) catalyzes the NAD(+)-dependent oxidative decarboxylation of HIc to alpha-ketoadipate, the fourth step in the alpha-aminoadipate pathway responsible for the de novo synthesis of L-lysine in fungi. A mechanism has been proposed for the enzyme that makes use of a Lys-Tyr pair as acid-base catalysts, with Lys acting as a base to accept a proton from the alpha-hydroxyl of homoisocitrate, and Tyr acting as an acid to protonate the C3 of the enol of alpha-ketoadipate in the enolization reaction. Three conserved aspartate residues, D243, D267 and D271, coordinate Mg2+, which is also coordinated to the alpha-carboxylate and alpha-hydroxyl of homoisocitrate. On the basis of kinetic isotope effects, it was proposed that a conformational change to close the active site and organize the active site for catalysis contributed to rate limitation of the overall reaction of the Saccharomyces cerevisiae HIcDH (Lin, Y., Volkman, J., Nicholas, K. M., Yamamoto, T., Eguchi, T., Nimmo, S. L., West, A. H., and Cook, P. F. (2008) Biochemistry 47,4169-4180.). In order to test this hypothesis, site-directed mutagenesis was used to change D271, a metal ion ligand and binding determinant for MgHIc, to N. The mutant enzyme was characterized using initial rate studies. A decrease of 520-fold was observed in V and V/K-MgHIc suggesting the same step(s) limit the reaction at limiting and saturating MgHIc concentrations. Solvent kinetic deuterium isotope effects (SKIE) and viscosity effects are consistent with a rate-limiting pre-catalytic conformational change at saturating reactant concentrations. In addition, at limiting MgHIc, an inverse (SKIE) of 0.7 coupled to a significant normal effect of viscosogen (2.1) indicates equilibrium binding of MgHIc prior to the rate-limiting conformational change. The maximum rate exhibits a small partial change at high pH suggesting a pH-dependent conformational change, while V/K-MgHIc exhibits the same partial change observed in V, and a decrease at low pH with a pK(a) of 6 reflecting the requirement for the unprotonated form of MgHIc to bind to enzyme. However, neither parameter reflects the pH dependence of the chemical reaction. This pH independence of the chemical reaction over the range 5.5-9.5 is consistent with the much slower conformational change that would effectively perturb the observed pK values for catalytic groups to lower and higher pH. In other words, the pH dependence of the chemical reaction will only be observed when chemistry becomes slower than the rate of the conformational change. Data support the hypothesis of the existence of a pre-catalytic conformational change coupled to the binding of MgHIc. (C) 2015 Elsevier Inc. All rights reserved.
C1 [West, Ann H.; Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.
RP West, AH (reprint author), Univ Oklahoma, Dept Chem & Biochem, 101 Stephenson Pkwy, Norman, OK 73019 USA.
EM awest@ou.edu; pcook@ou.edu
FU National Institutes of Health [GM 071417]
FX This work was supported by a grant (GM 071417) from the National
   Institutes of Health (to P.F.C. and Oklahoma to support the research of
   P.F.C.
CR Lin Y, 2008, BIOCHEMISTRY-US, V47, P10809, DOI 10.1021/bi801370h
   Lin Y, 2008, BIOCHEMISTRY-US, V47, P4169, DOI 10.1021/bi702361j
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Karsten WE, 2005, BIOCHEMISTRY-US, V44, P3626, DOI 10.1021/bi047826o
   Lin Y, 2007, BIOCHEMISTRY-US, V46, P890, DOI 10.1021/bi062067q
   Ma GX, 2000, TETRAHEDRON LETT, V41, P9209, DOI 10.1016/S0040-4039(00)01707-X
   Lin Y, 2009, BIOCHEMISTRY-US, V48, P7305, DOI 10.1021/bi900175z
   Malik R, 2010, ACTA CRYSTALLOGR D, V66, P673, DOI 10.1107/S0907444910008851
   HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026
   Karsten WE, 2000, PROTEIN PEPTIDE LETT, V7, P281
   Yamamoto T, 2008, BIOORGAN MED CHEM, V16, P3372, DOI 10.1016/j.bmc.2007.12.002
   Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43
   Nango E, 2011, J BIOCHEM, V150, P607, DOI 10.1093/jb/mvr097
   SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551
   Aktas DF, 2009, BIOCHEMISTRY-US, V48, P3565, DOI 10.1021/bi8022976
   Imada K, 1998, STRUCT FOLD DES, V6, P971, DOI 10.1016/S0969-2126(98)00099-9
   DYSON JED, 1973, ARCH BIOCHEM BIOPHYS, V154, P623, DOI 10.1016/0003-9861(73)90017-9
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   BAZELYANSKY M, 1986, BIOCHEMISTRY-US, V25, P125, DOI 10.1021/bi00349a019
   Bulfer S.L., 2011, PROTEINS STRUCT NOTE, P661
   Cook P., 2007, ENZYME KINETICS MECH
   Grodsky NB, 2000, BIOCHEMISTRY-US, V39, P2193, DOI 10.1021/bi9919753
   Quinn D.M., 1991, ENZYME MECH ISOTOPE, P73
NR 23
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 20
EP 27
DI 10.1016/j.abb.2015.08.016
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100003
PM 26325079
ER

PT J
AU Fu, HH
   Yuan, J
   Gao, HC
AF Fu, Huihui
   Yuan, Jie
   Gao, Haichun
TI Microbial oxidative stress response: Novel insights from environmental
   facultative anaerobic bacteria
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Bacteria; Oxidative stress response; Regulation; Viability; OxyR;
   Hydrogen peroxide
ID NONTYPABLE HAEMOPHILUS-INFLUENZAE; ENTERICA SEROVAR TYPHIMURIUM; ORGANIC
   HYDROPEROXIDE STRESS; HYDROGEN-PEROXIDE PRODUCTION; GROWING
   ESCHERICHIA-COLI; FAMILY NADPH OXIDASES; TO-HEAD HYDROCARBON; SUBUNIT C
   AHPC; SHEWANELLA-ONEIDENSIS; EICOSAPENTAENOIC ACID
AB Facultative bacteria can grow under either oxic or anoxic conditions. While oxygen provides substantial advantages in energy yield by respiration, it can become life-threatening because of reactive oxygen species that derive from the molecule naturally. Thus, to survive and thrive in a given niche, these bacteria have to constantly regulate physiological processes to make maximum benefits from oxygen respiration while restraining oxidative stress. Molecular mechanisms and physiological consequences of oxidative stress have been under extensive investigation for decades, mostly on research model Escherichia coli, from which our understanding of bacterial oxidative stress response is largely derived. Nevertheless, given that bacteria live in enormously diverse environments, to cope with oxidative stress different strategies are conceivably developed. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Gao, Haichun] Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China.
   [Gao, Haichun] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.
RP Gao, HC (reprint author), Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China.
EM jieyuan@zju.edu.cn; haichung@zju.edu.cn
RI Gao, Haichun/A-2160-2014
FU National Natural Science Foundation of China [31270097, 41476105,
   31100600]; Fundamental Research Funds for the Central Universities
   [2014FZA6002]; Ministry of Education Science and Technology Development
   Center [20120541]
FX This research was supported by National Natural Science Foundation of
   China (31270097, 41476105) to HG; and by National Natural Science
   Foundation of China (31100600), Fundamental Research Funds for the
   Central Universities (2014FZA6002), and Ministry of Education Science
   and Technology Development Center (20120541) to JY.
CR Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112
   STORZ G, 1990, ANTON LEEUW INT J G, V58, P157, DOI 10.1007/BF00548927
   Becerra MC, 2006, MOL CELL BIOCHEM, V285, P29, DOI 10.1007/s11010-005-9051-0
   Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749
   TSANEVA IR, 1990, J BACTERIOL, V172, P4197
   Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x
   Italiani VCS, 2011, J BACTERIOL, V193, P1734, DOI 10.1128/JB.01339-10
   Jiang YM, 2014, J BACTERIOL, V196, P445, DOI 10.1128/JB.01077-13
   Nishida T, 2006, FEBS LETT, V580, P6690, DOI 10.1016/j.febslet.2006.11.030
   Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938
   Wang HW, 2013, APPL ENVIRON MICROB, V79, P3734, DOI 10.1128/AEM.00560-13
   Mahavihakanont A, 2012, J BACTERIOL, V194, P209, DOI 10.1128/JB.05603-11
   Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06
   MASSEY V, 1969, BIOCHEM BIOPH RES CO, V36, P891, DOI 10.1016/0006-291X(69)90287-3
   Harrison A, 2007, J BACTERIOL, V189, P1004, DOI 10.1128/JB.01040-063
   Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947
   Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007
   Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006
   Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001
   KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533
   Shi MM, 2015, J BACTERIOL, V197, P2179, DOI 10.1128/JB.00154-15
   Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108
   Nishida T, 2006, FEBS LETT, V580, P2731, DOI 10.1016/j.febslet.2006.04.032
   Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962
   Kumar SR, 2013, J BACTERIOL, V195, P4569, DOI 10.1128/JB.00737-13
   Teramoto H, 2013, FEBS J, V280, P3298, DOI 10.1111/febs.12312
   WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003
   Wong SMS, 2007, MOL MICROBIOL, V64, P1375, DOI 10.1111/j.1365-2958.2007.05747.x
   Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004
   Pomposiello PJ, 2000, J BACTERIOL, V182, P23
   Korshunov S, 2010, MOL MICROBIOL, V75, P1389, DOI 10.1111/j.1365-2958.2010.07059.x
   Maciver I, 1996, INFECT IMMUN, V64, P4618
   Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022
   Hillion M, 2015, BIOL CHEM, V396, P415, DOI 10.1515/hsz-2015-0102
   Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x
   Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313
   Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102
   Hahn JS, 2002, J BACTERIOL, V184, P5214, DOI 10.1128/JB.184.19.5214-5222.2002
   KUO CF, 1987, J BIOL CHEM, V262, P4724
   Partridge JD, 2007, MICROBIOL-SGM, V153, P1499, DOI 10.1099/mic.0.2006/004838-0
   Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257
   Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7
   Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x
   Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000
   Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032
   Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2
   Heo YJ, 2010, J BACTERIOL, V192, P381, DOI 10.1128/JB.00980-09
   Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251
   Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200
   Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10
   Korshunov S, 2006, J BACTERIOL, V188, P6326, DOI 10.1128/JB.00554-06
   Caswell CC, 2012, J BACTERIOL, V194, P5065, DOI 10.1128/JB.00873-12
   WU J, 1992, J BACTERIOL, V174, P3915
   Maier TM, 2001, J BACTERIOL, V183, P4918, DOI 10.1128/JB.183.16.4918-4926.2001
   DEMPLE B, 1991, ANNU REV GENET, V25, P315
   Saffarini DA, 2003, J BACTERIOL, V185, P3668, DOI 10.1128/JB.185.12.3668-3671.2003
   Shroff NP, 2010, J BACTERIOL, V192, P3227, DOI 10.1128/JB.01695-09
   Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361
   FARR SB, 1986, P NATL ACAD SCI USA, V83, P8268, DOI 10.1073/pnas.83.21.8268
   Georgellis D, 1997, J BACTERIOL, V179, P5429
   Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002
   Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537
   Kawamoto J, 2009, J BACTERIOL, V191, P632, DOI 10.1128/JB.00881-08
   Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625
   Ieva R, 2008, MOL MICROBIOL, V70, P1152, DOI 10.1111/j.1365-2958.2008.06468.x
   IVANOVA A, 1994, MOL MICROBIOL, V12, P571, DOI 10.1111/j.1365-2958.1994.tb01043.x
   Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x
   Rabaey K, 2010, NAT REV MICROBIOL, V8, P706, DOI 10.1038/nrmicro2422
   Liochev SI, 1999, J BIOL CHEM, V274, P9479, DOI 10.1074/jbc.274.14.9479
   Zhang AX, 1998, EMBO J, V17, P6061, DOI 10.1093/emboj/17.20.6061
   Zhou GQ, 2013, ISME J, V7, P1752, DOI 10.1038/ismej.2013.62
   Li N, 2014, ENVIRON MICROBIOL, V16, P1821, DOI 10.1111/1462-2920.12418
   Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3850, DOI 10.1128/AEM.00436-10
   Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000
   Wang G, 2004, J BIOL CHEM, V279, P51908, DOI 10.1074/jbc.M408450200
   Fujikawa M, 2012, J BIOL CHEM, V287, P35702, DOI 10.1074/jbc.M112.395079
   GONZALEZFLECHA B, 1995, BBA-GEN SUBJECTS, V1243, P361, DOI 10.1016/0304-4165(94)00160-Y
   BIELSKI BHJ, 1983, J BIOL CHEM, V258, P4759
   FARR SB, 1991, MICROBIOL REV, V55, P561
   Deffert C, 2014, CELL MICROBIOL, V16, P1168, DOI 10.1111/cmi.12322
   Crack J, 2004, J BIOL CHEM, V279, P9278, DOI 10.1074/jbc.M309878200
   Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005
   Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856
   Donovan GT, 2013, INFECT IMMUN, V81, P249, DOI 10.1128/IAI.00796-12
   Daugherty A, 2012, MICROBIOL RES, V167, P238, DOI 10.1016/j.micres.2011.09.004
   DEMPLE B, 1991, CELL, V67, P837, DOI 10.1016/0092-8674(91)90355-3
   Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200
   Nishida T, 2007, FEBS LETT, V581, P4212, DOI 10.1016/j.febslet.2007.07.065
   Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014
   Sheplock R, 2013, MOL MICROBIOL, V87, P368, DOI 10.1111/mmi.12101
   Fu HH, 2013, ENVIRON MICROBIOL, V15, P2198, DOI 10.1111/1462-2920.12091
   Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549
   Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85
   Barth E, 2009, MICROBIOL-SGM, V155, P1680, DOI 10.1099/mic.0.026021-0
   Robbe-Saule V, 2001, MOL MICROBIOL, V39, P1533, DOI 10.1046/j.1365-2958.2001.02340.x
   Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3842, DOI 10.1128/AEM.00433-10
   Vinckx T, 2008, FEMS MICROBIOL LETT, V288, P258, DOI 10.1111/j.1574-6968.2008.01360.x
   Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055
   ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x
   Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09
   Jangiam W, 2010, MICROBIOL IMMUNOL, V54, P389, DOI 10.1111/j.1348-0421.2010.00230.x
   Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619
   Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004
   Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119
   Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4
   Hong R, 2012, APPL ENVIRON MICROB, V78, P1776, DOI 10.1128/AEM.07068-11
   GonzalezFlecha B, 1997, J BACTERIOL, V179, P382
   Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357
   Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12
   Palma M, 2005, INFECT IMMUN, V73, P2958, DOI 10.1128/IAI.73.5.2958-2966.2005
   Zhao Y, 2014, ENVIRON SCI TECHNOL, V48, P10614, DOI 10.1021/es5023416
   Arenas FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015979
   Neto JFD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047090
   Derecho I, 2014, ASTROBIOLOGY, V14, P837, DOI 10.1089/ast.2014.1193
   Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3
   Dong Y., 2012, PLOS ONE, V7
   Dong Y. M., 2014, ACTA CHROMATOGR, V1, P1
   Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42
   Gao HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015295
   Gao H, 2011, INT J MICROBIOL, V2011
   García Ana V, 2014, Front Microbiol, V5, P141, DOI 10.3389/fmicb.2014.00141
   GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181
   Halliwell B., 2006, FREE RADICALS BIOL M
   Harrison A, 2015, J BACTERIOL, V197, P277, DOI 10.1128/JB.01973-14
   Harrison C J, 2009, Minerva Pediatr, V61, P503
   Hasset DJ, 2000, J BACTERIOL, V182, P4557, DOI 10.1128/JB.182.16.4557-4563.2000
   Helmann J. D., 2010, ANTIOXID REDOX SIGN, V14, P1049
   IMLAY JA, 1991, FREE RADICAL RES COM, V12-3, P59, DOI 10.3109/10715769109145768
   Janda JM, 2014, CRIT REV MICROBIOL, V40, P293, DOI 10.3109/1040841X.2012.726209
   Kim JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031709
   Loi VV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00187
   Loui C, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-183
   Madigan M. T., 2012, BROCK BIOL MICROORGA
   Morales EH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-63
   Rosner JL, 1997, CURR TOP CELL REGUL, V35, P163, DOI 10.1016/S0070-2137(97)80007-6
   Saikolappan S, 2015, J BACTERIOL, V197, P51, DOI 10.1128/JB.02252-14
   Stael S, 2015, TRENDS PLANT SCI, V20, P3, DOI 10.1016/j.tplants.2014.10.002
   Wan F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10228
   Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053383
   Wu GF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00374
   Yoon SJ, 2002, J BIOCHEM MOL BIOL, V35, P297
   Zhang HM, 2015, MICROBIOLOGYOPEN, V4, P282, DOI 10.1002/mbo3.237
   Zuo FL, 2014, RES MICROBIOL, V165, P581, DOI 10.1016/j.resmic.2014.05.040
NR 143
TC 0
Z9 0
U1 14
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 28
EP 35
DI 10.1016/j.abb.2015.08.012
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100004
PM 26319291
ER

PT J
AU Shenkman, BS
   Belova, SP
   Lomonosova, YN
   Kostrominova, TY
   Nemirovskaya, TL
AF Shenkman, Boris S.
   Belova, Svetlana P.
   Lomonosova, Yulia N.
   Kostrominova, Tatiana Y.
   Nemirovskaya, Tatyana L.
TI Calpain-dependent regulation of the skeletal muscle atrophy following
   unloading
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Skeletal muscle unloading; MAFbx; pFOXO3; Calpain; Ubiquitin proteasome
   pathway
ID KAPPA-B-ALPHA; NUCLEAR TRANSLOCATION; SOLEUS ATROPHY; ACTIVATION;
   PROTEIN; EXPRESSION; PATHWAY; DISUSE; APOPTOSIS; SEPSIS
AB Unloading causes rapid skeletal muscle atrophy due to increased protein degradation via activation of calpains and decreased protein synthesis. Our study elucidated role of calpain-1 in the regulation of ubiquitin proteasome pathway (UPP) and anabolic processes mediated by Akt-mTOR-p70S6K and MAPK-Erk (p90RSK) signaling. We hypothesized that blocking calpain will inhibit activation of UPP and decrease protein degradation resulting in reduction of unloading-induced skeletal muscle atrophy. Rats were divided into three groups: non-treated control (C), three day hindlimb suspension with (HSPD) or without (HS) treatment with calpain inhibitor PD150606. When compared with control PD150606 treatment during unloading: 1) attenuated loss of muscle mass, 2) prevented accumulation of calpain-1 (1.8-fold in HS vs 1.3-fold in HSPD) and ubiquitin (2.3-fold in HS vs 0.7-fold in HSPD) mRNA and ubiquitinated proteins (1.6-fold in HS vs 0.8-fold in HSPD), 3) prevented decrease in the pAkt (0.4-fold in HS vs 1-fold in HSPD) and pFOXO3 (0.2-fold in HS vs 1.2-fold in HSPD) levels, 4) prevented increase in MAFbx (3.8-fold in HS vs 1.3-fold in HSPD) and eEF2k (1.8-fold in HS vs 0.6-fold in HSPD) mRNA. Our study indicates that blocking of calpain during unloading decreases skeletal muscle atrophy by inhibiting UPP activation and preserving anabolic signaling. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Shenkman, Boris S.; Belova, Svetlana P.; Lomonosova, Yulia N.; Nemirovskaya, Tatyana L.] RAS, Inst Biomed Problems, Moscow 117901, Russia.
   [Kostrominova, Tatiana Y.] Indiana Univ Sch Med Northwest, Dept Anat & Cell Biol, Gary, IN USA.
   [Kostrominova, Tatiana Y.] Moscow MV Lomonosov State Univ, Fac Basic Med, Moscow 117191, Russia.
RP Nemirovskaya, TL (reprint author), Moscow MV Lomonosov State Univ, Fac Basic Med, Lomonosovsky Pr 31-5, Moscow 117191, Russia.
EM nemirovskaya@bk.ru
FU Russian Foundation for Basic Research [14-04-01632]; IUSM-NW
FX This work was supported by the Russian Foundation for Basic Research
   (project no. 14-04-01632) and by funds from the IUSM-NW. The funding
   sources had no involvement in study design; in the collection, analysis
   and interpretation of data; in the writing of the report; and in the
   decision to submit the article for publication.
CR Dupont E, 2011, AM J PHYSIOL-REG I, V300, pR408, DOI 10.1152/ajpregu.00793.2009
   Sharma N, 2011, AM J PHYSIOL-ENDOC M, V300, pE966, DOI 10.1152/ajpendo.00659.2010
   Chatterjee PK, 2005, BIOCHEM PHARMACOL, V69, P1121, DOI 10.1016/j.bcp.2005.01.003
   Salazar JJ, 2010, J APPL PHYSIOL, V108, P120, DOI 10.1152/japplphysiol.01080.2009
   Kachaeva EV, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/493618
   Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009
   Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011
   Nozaki K, 2010, EXP NEUROL, V225, P430, DOI 10.1016/j.expneurol.2010.07.021
   Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009
   Fareed MU, 2006, AM J PHYSIOL-REG I, V290, pR1589, DOI 10.1152/ajpregu.00668.2005
   Otani K, 2004, J BIOL CHEM, V279, P20915, DOI 10.1074/jbc.M400213200
   Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003
   Attaix D, 2010, CURR OPIN CLIN NUTR, V13, P223, DOI 10.1097/MCO.0b013e328338b9a6
   Solomon V, 1996, J BIOL CHEM, V271, P26690
   BALDWIN KM, 1990, FASEB J, V4, P79
   Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687
   Ma XW, 2011, MOL CELL BIOCHEM, V354, P171, DOI 10.1007/s11010-011-0816-3
   Beehler BC, 2006, EXP BIOL MED, V231, P335
   Supinski GS, 2009, J APPL PHYSIOL, V107, P1389, DOI 10.1152/japplphysiol.00341.2009
   Wang XW, 2012, J CELL PHYSIOL, V227, P1168, DOI 10.1002/jcp.22839
   Lomonosova YN, 2012, FASEB J, V26, P4295, DOI 10.1096/fj.12-204412
   Kim H, 2014, EXP CELL RES, V320, P62, DOI 10.1016/j.yexcr.2013.10.012
   Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289
   Chang H, 2011, J CELL BIOCHEM, V112, P571, DOI 10.1002/jcb.22947
   Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067
   Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052
   Smith IJ, 2007, EXP PHYSIOL, V92, P561, DOI 10.1113/expphysiol.2006.035790
   Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11
   Rose AJ, 2009, J PHYSIOL-LONDON, V587, P1547, DOI 10.1113/jphysiol.2008.167528
   Tidball JG, 2002, J PHYSIOL-LONDON, V545, P819, DOI 10.1113/jphysiol.2002.024935
   Dupont-Versteegden EE, 2006, AM J PHYSIOL-REG I, V291, pR1730, DOI 10.1152/ajpregu.00176.2006
   Goll D E, 2008, J Anim Sci, V86, pE19
   Istomina V E, 2007, J Gravit Physiol, V14, pP97
   Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006
   Li XP, 2014, AM J PHYSIOL-HEART C, V306, pH833, DOI 10.1152/ajpheart.00893.2012
   Li XP, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-8
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Wu CL, 2014, AM J PHYSIOL-CELL PH, V306, pC762, DOI 10.1152/ajpcell.00361.2013
NR 38
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 36
EP 41
DI 10.1016/j.abb.2015.07.011
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100005
PM 26297661
ER

PT J
AU Shahid, S
   Ahmad, F
   Hassan, MI
   Islam, A
AF Shahid, Sumra
   Ahmad, Faizan
   Hassan, Md. Imtaiyaz
   Islam, Asimul
TI Relationship between protein stability and functional activity in the
   presence of macromolecular crowding agents alone and in mixture: An
   insight into stability-activity trade-off
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Macromolecular crowding; Thermal stability; Enzyme activity; Excluded
   volume effect; Stability-activity trade-off; Crowding agent
ID GLOBULAR-PROTEINS; CREATINE-KINASE; IN-VITRO; BIOCHEMICAL REACTIONS;
   CATALYZED HYDROLYSIS; ESCHERICHIA-COLI; ENZYME-KINETICS; UNFOLDED STATE;
   DIFFUSION; LYSOZYME
AB The cellular environment is crowded with different kinds of molecules with varying sizes, shapes and compositions. Most of the experiments studying the nature and behaviour of a protein have been done on the isolated protein in dilute buffer solutions which actually do not imitate the in vivo situation. To understand the consequences of such crowded environment, we investigated the effect of macromolecular crowding on the stability and activity of hen egg white lysozyme. Two crowding agents, dextran 70 and ficoll 70 which have different shapes and composition, have been employed in this study. To mimic the cellular condition from physiological point of view, the effect of mixtures of both the crowding agents has been also studied. The results indicate that owing to volume exclusion, lysozyme is stabilized while its activity decays with the increasing concentration of both the crowders elucidating the hypothesis of stability-activity trade-off. Mixed macromolecular crowding exerts greater effect than the sum of constituent crowding agents (dextran 70 and ficoll 70). (C) 2015 Elsevier Inc. All rights reserved.
C1 [Shahid, Sumra; Ahmad, Faizan; Hassan, Md. Imtaiyaz; Islam, Asimul] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
RP Islam, A (reprint author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
EM aislam@jmi.ac.in
FU Science & Engineering Research Board (SERB), India [SR/FT/LS-48/2010];
   FIST Program [SR/FST/LSI-541/2012]; Council of Scientific and Industrial
   Research (CSIR), India [37(1604)/13/EMR-II]; Maulana Azad National
   Fellowship, University Grants Commission (Government of India)
FX This work was supported by grant from the Science & Engineering Research
   Board (SERB), India (SR/FT/LS-48/2010), FIST Program
   (SR/FST/LSI-541/2012) and Council of Scientific and Industrial Research
   (CSIR), India (37(1604)/13/EMR-II). Sumra Shahid is thankful to Maulana
   Azad National Fellowship, University Grants Commission (Government of
   India) for providing fellowship.
CR Zhang DL, 2012, ACTA BIOCH BIOPH SIN, V44, P703, DOI 10.1093/abbs/gms052
   Stagg L, 2007, P NATL ACAD SCI USA, V104, P18976, DOI 10.1073/pnas.0705127104
   Wenner JR, 1999, BIOPHYS J, V77, P3234
   Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200
   Olsen SN, 2007, COMP BIOCHEM PHYS A, V148, P339, DOI 10.1016/j.cbpa.2007.05.009
   Balcells C, 2014, J PHYS CHEM B, V118, P4062, DOI 10.1021/jp4118858
   Yadav S, 2000, ANAL BIOCHEM, V283, P207, DOI 10.1006/abio.2000.4641
   Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X
   Kuhnert DC, 2008, S AFR J SCI, V104, P76
   Sasaki Yoshiharu, 2006, Biotechnology Journal, V1, P440, DOI 10.1002/biot.200500032
   Zhou HX, 2008, PROTEINS, V72, P1109, DOI 10.1002/prot.22111
   Poggi CG, 2015, BIOCHEMISTRY-US, V54, P260, DOI 10.1021/bi5011255
   Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200
   Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013
   Perham M, 2007, FEBS LETT, V581, P5065, DOI 10.1016/j.febslet.2007.09.049
   Asaad N, 2003, J AM CHEM SOC, V125, P6874, DOI 10.1021/ja034298f
   Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X
   Wang YQ, 2012, J AM CHEM SOC, V134, P16614, DOI 10.1021/ja305300m
   Hong JA, 2010, J AM CHEM SOC, V132, P10445, DOI 10.1021/ja103166y
   Wang Q, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3656692
   Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808
   Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107
   Spencer DS, 2005, J MOL BIOL, V351, P219, DOI 10.1016/j.jmb.2005.05.029
   Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102
   Norris MGS, 2011, BIOCHEM BIOPH RES CO, V405, P388, DOI 10.1016/j.bbrc.2011.01.037
   SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452
   Jiang M, 2007, J AM CHEM SOC, V129, P730, DOI 10.1021/ja065064+
   Christiansen A, 2013, BIOPHYS J, V105, P1689, DOI 10.1016/j.bpj.2013.08.038
   Li CG, 2009, J PHYS CHEM B, V113, P13390, DOI 10.1021/jp907744m
   Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711
   Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018
   Mikaelsson T, 2013, BIOPHYS J, V104, P694, DOI 10.1016/j.bpj.2012.12.020
   Mukherjee S, 2009, J MOL BIOL, V393, P227, DOI 10.1016/j.jmb.2009.08.016
   Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824
   Sharma GS, 2015, INT J BIOL MACROMOL, V79, P86, DOI 10.1016/j.ijbiomac.2015.04.051
   ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V
   Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063
   Senske M, 2014, J AM CHEM SOC, V136, P9036, DOI 10.1021/ja503205y
   van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927
   Christiansen A, 2010, BIOCHEMISTRY-US, V49, P6519, DOI 10.1021/bi100578x
   BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104
   Aden J, 2014, BIOCHEMISTRY-US, V53, P2271, DOI 10.1021/bi500222g
   Homouz D, 2008, P NATL ACAD SCI USA, V105, P11754, DOI 10.1073/pnas.0803672105
   Gellerich FN, 1998, EUR J BIOCHEM, V254, P172, DOI 10.1046/j.1432-1327.1998.2540172.x
   RALSTON GB, 1990, J CHEM EDUC, V67, P857
   Homouz D, 2009, BIOPHYS J, V96, P671, DOI 10.1016/j.bpj.2008.10.014
   Pozdnyakova I, 2010, BBA-PROTEINS PROTEOM, V1804, P740, DOI 10.1016/j.bbapap.2009.11.013
   MINTON AP, 1981, BIOCHEMISTRY-US, V20, P4821, DOI 10.1021/bi00520a003
   Ai XJ, 2006, J AM CHEM SOC, V128, P3916, DOI 10.1021/ja057832n
   Pastor I, 2014, BIOPHYS CHEM, V185, P8, DOI 10.1016/j.bpc.2013.10.006
   Garcia-Perez AI, 1999, ARCH BIOCHEM BIOPHYS, V362, P329, DOI 10.1006/abbi.1998.1051
   MAUREL P, 1976, J MOL BIOL, V102, P253, DOI 10.1016/S0022-2836(76)80052-6
   Moran-Zorzano MT, 2007, FEBS LETT, V581, P1035, DOI 10.1016/j.febslet.2007.02.004
   Kulothungan SR, 2009, LANGMUIR, V25, P6637, DOI 10.1021/la900198h
   Batra J, 2009, PROTEINS, V77, P133, DOI 10.1002/prot.22425
   MURPHY KP, 1992, J MOL BIOL, V227, P293, DOI 10.1016/0022-2836(92)90699-K
   Olsen SN, 2006, THERMOCHIM ACTA, V448, P12, DOI 10.1016/j.tca.2006.06.019
   Zhou BR, 2008, BBA-PROTEINS PROTEOM, V1784, P472, DOI 10.1016/j.bbapap.2008.01.004
   Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200
   Derham BK, 2006, BBA-PROTEINS PROTEOM, V1764, P1000, DOI 10.1016/j.bbapap.2006.01.005
   Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X
   Wang YJ, 2010, BIOCHEMISTRY-MOSCOW+, V75, P648, DOI 10.1134/S0006297910050160
   LAURENT TC, 1971, EUR J BIOCHEM, V21, P498, DOI 10.1111/j.1432-1033.1971.tb01495.x
   HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111
   Aguilar X, 2011, BIOCHEMISTRY-US, V50, P3034, DOI 10.1021/bi2002086
   LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910
   Sasaki Y, 2007, NUCLEIC ACIDS RES, V35, P4086, DOI 10.1093/nar/gkm445
   Homchaudhuri L, 2006, BIOPOLYMERS, V83, P477, DOI 10.1002/bip.20578
   Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2
   Dumitriu S., 2004, POLYSACCHARIDES STRU
   Fulton A., 1982, CELL, V30
   Masuelli MA, 2013, J POLYM BIOPOLYM PHY, V1, P13
   Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7
   Mittal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078936
   Nozaki Y, 1972, Methods Enzymol, V26, P43
   Pitulice L., 2013, J BIOCATAL BIOTRANSF, V2
   DELPINO IMP, 1995, BIOCHEMISTRY-US, V34, P8621
   Rivas German, 2004, EMBO Reports, V5, P23, DOI 10.1038/sj.embor.7400056
   TELLAM RL, 1983, BIOCHEM J, V213, P651
   Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002
   Venturoli D., 2005, FICOLL DEXTRAN VS GL
   Vopel T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039418
NR 82
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 42
EP 50
DI 10.1016/j.abb.2015.08.015
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100006
PM 26325080
ER

PT J
AU Hara, H
   Taniguchi, M
   Kobayashi, M
   Kamiya, T
   Adachi, T
AF Hara, Hirokazu
   Taniguchi, Miko
   Kobayashi, Mari
   Kamiya, Tetsuro
   Adachi, Tetsuo
TI Plasma-activated medium-induced intracellular zinc liberation causes
   death of SH-SY5Y cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Zinc; Non-thermal atmospheric pressure plasma; PARP-1; Cell death;
   Reactive oxygen species; Zinc-binding protein
ID INDUCED NEURONAL APOPTOSIS; HYDROGEN-PEROXIDE; POLY(ADP-RIBOSE)
   POLYMERASE; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; RELEASE;
   METALLOTHIONEIN; NEUROTOXICITY; HOMEOSTASIS; INHIBITION
AB Plasma is an ionized gas consisting of ions, electrons, free radicals, neutral particles, and photons. Plasma-activated medium (PAM), which is prepared by the irradiation of cell-free medium with non-thermal atmospheric pressure plasma, induces cell death in various types of cancer cell. Since PAM contains reactive oxygen species (ROS), its anti-cancer effects are thought to be attributable to oxidative stress. Meanwhile, oxidative stress has been shown to induce the liberation of zinc (Zn2+) from intracellular Zn2+ stores and to provoke Zn2+-dependent cell death. In this study, we thus examined whether Zn2+ is involved in PAM-induced cell death using human neuroblastoma SH-SY5Y cells. Exposure to PAM triggered cell death in SH-SY5Y cells. The cell-permeable Zn2+ chelator N,N,N',N'-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN) protected against PAM-induced cell death. Zn2+ imaging using the fluorescent Zn2+ probe FluoZin-3 revealed that PAM elicited a rise of intracellular free Zn2+. In addition, PAM stimulated PARP-1 activation, mitochondrial ROS generation, and the depletion of intracellular NAD(+) and ATP. These findings suggest that PAM-induced PARP-1 activation causes energy supply exhaustion. Moreover, TPEN suppressed all of these events elicited by PAM. Taken together, we demonstrated here that Zn2+ released from intracellular Zn2+ stores serves as a key mediator of PAM-induced cell death in SH-SY5Y cells. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Hara, Hirokazu; Taniguchi, Miko; Kobayashi, Mari; Kamiya, Tetsuro; Adachi, Tetsuo] Gifu Pharmaceut Univ, Lab Clin Pharmaceut, Gifu 5011196, Japan.
RP Hara, H (reprint author), Gifu Pharmaceut Univ, Lab Clin Pharmaceut, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.
EM harah@gifu-pu.ac.jp
FU Japan Society for the Promotion of Science [26460630]; Ministry of
   Education, Culture, Sports, Science and Technology [25108511]
FX This work was supported by a Grant-in-Aid for Scientific Research (C)
   from the Japan Society for the Promotion of Science (to H.H.; No.
   26460630) and in part by a Grant-in-Aid for Scientific Research on
   Innovative Areas from the Ministry of Education, Culture, Sports,
   Science and Technology (to T.A.; No. 25108511).
CR Adachi T, 2015, FREE RADICAL BIO MED, V79, P28, DOI 10.1016/j.freeradbiomed.2014.11.014
   Zhang YM, 2004, J NEUROSCI, V24, P10616, DOI 10.1523/JNEUROSCI.2469-04.2004
   Sheline CT, 2000, J NEUROSCI, V20, P3139
   Obrosova IG, 2005, DIABETES, V54, P3435, DOI 10.2337/diabetes.54.12.3435
   Desagher S, 1997, J NEUROSCI, V17, P9060
   St Croix CM, 2002, AM J PHYSIOL-LUNG C, V282, pL185
   Hara H, 2009, NEUROCHEM RES, V34, P1498, DOI 10.1007/s11064-009-9937-4
   Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x
   Mizutani H, 2002, J BIOL CHEM, V277, P30684, DOI 10.1074/jbc.M204353200
   Klein C, 2006, APOPTOSIS, V11, P1933, DOI 10.1007/s10495-006-0089-6
   Cai AL, 2006, EUR J NEUROSCI, V24, P2169, DOI 10.1111/j.1460-9568.2006.05110.x
   Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081
   Berendji D, 1997, FEBS LETT, V405, P37, DOI 10.1016/S0014-5793(97)00150-6
   Virag L, 1998, J IMMUNOL, V161, P3753
   Zhang B, 2003, MOL CELL BIOL, V23, P8471, DOI 10.1128/MCB.23.23.8471-8485.2003
   Wiseman DA, 2007, AM J PHYSIOL-LUNG C, V292, pL165, DOI 10.1152/ajplung.00459.2005
   Dineley KE, 2005, MITOCHONDRION, V5, P55, DOI 10.1016/j.mito.2004.11.001
   Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331
   KRONCKE KD, 1994, BIOCHEM BIOPH RES CO, V200, P1105, DOI 10.1006/bbrc.1994.1564
   McLaughlin B, 2001, J NEUROSCI, V21, P3303
   Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010
   Isbary G, 2012, BRIT J DERMATOL, V167, P404, DOI 10.1111/j.1365-2133.2012.10923.x
   Canzoniero LMT, 1997, NEUROBIOL DIS, V4, P275, DOI 10.1006/nbdi.1997.0160
   Knoch ME, 2008, GLIA, V56, P89, DOI 10.1002/glia.20592
   Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x
   MARET W, 1994, P NATL ACAD SCI USA, V91, P237, DOI 10.1073/pnas.91.1.237
   Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414
   Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x
   Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x
   Jain SS, 2014, DIABETES, V63, P1907, DOI 10.2337/db13-0816
   Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718
   Choi K, 2009, CURR NEUROVASC RES, V6, P213
   Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088
   He K, 2010, J NEUROCHEM, V114, P452, DOI 10.1111/j.1471-4159.2010.06762.x
   Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270
   Okazaki Y, 2014, J CLIN BIOCHEM NUTR, V55, P207, DOI 10.3164/jcbn.14-40
   Tanaka H, 2011, PLASMA MED, V1, P265
   Utsumi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081576
   Wang H, 2000, FREE RADICAL BIO MED, V28, P1222, DOI 10.1016/S0891-5849(00)00241-0
NR 39
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 51
EP 60
DI 10.1016/j.abb.2015.08.014
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100007
PM 26319292
ER

PT J
AU Jang, HH
   Liu, JB
   Lee, GY
   Halpert, JR
   Wilderman, PR
AF Jang, Hyun-Hee
   Liu, Jingbao
   Lee, Ga-Young
   Halpert, James R.
   Wilderman, P. Ross
TI Functional importance of a peripheral pocket in mammalian cytochrome
   P450 2B enzymes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cytochrome P450; Structure-function relationship; Site-directed
   mutagenesis; Monooxygenase coupling
ID MONOXIDE-BINDING PIGMENT; SITE-DIRECTED MUTANTS; ACTIVE-SITE;
   SUBSTRATE-SPECIFICITY; HEME MONOOXYGENASES; CONFORMATIONAL STATES;
   CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; LIVER MICROSOMES; LIGAND-BINDING
AB The functional importance of a peripheral pocket found in previously published X-ray crystal structures of CYP2B4 and CYP2B6 was probed using a biophysical approach. Introduction of tryptophan within the pocket of CYP2B4 at F202 or 1241 leads to marked impairment of 7-ethoxy-4-(trifluoromethyl)coumarin (7-EFC) or 7-benzyloxyresorufin O-dealkylation efficiency; a similar substitution at F195, near the surface access to the pocket, does not affect these activities. The analogous CYP2B6 F202W mutant is inactive in the 7-EFC O-dealkylation assay. The stoichiometry of 7-EFC deethylation suggested that the decreased activity of F202W and I241W in CYP2B4 and lack of activity of F202W in CYP2B6 coincided with a sharp increase in the flux of reducing equivalents through the oxidase shunt to produce excess water. The results indicate that the chemical identity of residues within this peripheral pocket, but not at the mouth of the pocket, is important in substrate turnover and redox coupling, likely through effects on active site topology. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Jang, Hyun-Hee; Lee, Ga-Young] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
   [Liu, Jingbao; Halpert, James R.; Wilderman, P. Ross] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA.
RP Wilderman, PR (reprint author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 North Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.
EM ross.wilderman@uconn.edu
RI Wilderman, Ross/J-8315-2012
OI Wilderman, Ross/0000-0002-0264-1704
FU NIH [ES003619]
FX This research was supported by NIH grant ES003619 to J.R.H.
CR Al Omari A, 2007, J PHARM PRACT, V20, P206
   Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483
   Mo SL, 2009, CURR DRUG METAB, V10, P730
   Fang XJ, 1997, FEBS LETT, V416, P77, DOI 10.1016/S0014-5793(97)01173-3
   Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736
   Harlow GR, 1997, J BIOL CHEM, V272, P5396
   GRUENKE LD, 1995, J BIOL CHEM, V270, P24707
   Wilderman PR, 2010, J BIOL CHEM, V285, P38602, DOI 10.1074/jbc.M110.180646
   Gay SC, 2011, BIOCHEMISTRY-US, V50, P4903, DOI 10.1021/bi200482g
   Talakad JC, 2009, DRUG METAB DISPOS, V37, P644, DOI 10.1124/dmd.108.023655
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   Shah MB, 2013, ARCH BIOCHEM BIOPHYS, V530, P64, DOI 10.1016/j.abb.2012.12.016
   Anzenbacher P, 2008, ACTA CHIM SLOV, V55, P63
   Domanski TL, 2001, CURR DRUG METAB, V2, P117, DOI 10.2174/1389200013338612
   Pochapsky TC, 2010, ANTIOXID REDOX SIGN, V13, P1273, DOI 10.1089/ars.2010.3109
   Davydov DR, 2013, BIOCHEM J, V453, P219, DOI 10.1042/BJ20130398
   Kumar S, 2005, J BIOL CHEM, V280, P19569, DOI 10.1074/jbc.M500158200
   Lewis DFV, 2010, J ENZYM INHIB MED CH, V25, P679, DOI 10.3109/14756360903514149
   HE YQ, 1995, CHEM RES TOXICOL, V8, P574, DOI 10.1021/tx00046a011
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   Zhao YH, 2007, BBA-GEN SUBJECTS, V1770, P402, DOI 10.1016/j.bbagen.2006.07.006
   Sun L, 2007, ARCH BIOCHEM BIOPHYS, V458, P167, DOI 10.1016/j.abb.2006.12.021
   Kumar S, 2007, MOL PHARMACOL, V72, P1191, DOI 10.1124/mol.107.039693
   Davydov DR, 2012, J BIOL CHEM, V287, P6797, DOI 10.1074/jbc.M111.325654
   Talakad JC, 2010, ARCH BIOCHEM BIOPHYS, V494, P151, DOI 10.1016/j.abb.2009.11.026
   Poulos TL, 2005, DRUG METAB DISPOS, V33, P10, DOI 10.1124/dmd.104.002071
   Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200
   Wilderman PR, 2012, FEBS J, V279, P1607, DOI 10.1111/j.1742-4658.2011.08411.x
   Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583
   Renaud JP, 1996, BIOCHEM J, V319, P675
   Kobayashi Y, 1998, BIOCHEMISTRY-US, V37, P6679, DOI 10.1021/bi9731450
   Hays AMA, 2004, J MOL BIOL, V344, P455, DOI 10.1016/j.jmb.2004.09.046
   Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407
   Gay SC, 2009, BIOCHEMISTRY-US, V48, P4762, DOI 10.1021/bi9003765
   Wilderman PR, 2013, J AM CHEM SOC, V135, P10433, DOI 10.1021/ja403042k
   Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805
   Poulos TL, 2005, BIOCHEM BIOPH RES CO, V338, P337, DOI 10.1016/j.bbrc.2005.07.204
   Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590
   Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200
   DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9
   Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478
   Scott EE, 2002, CHEM RES TOXICOL, V15, P1407, DOI 10.1021/tx020057u
   Scott EE, 2001, ARCH BIOCHEM BIOPHYS, V395, P57, DOI 10.1006/abbi.2001.2574
   Sim SC, 2013, PHARMACOGENOMICS J, V13, P1, DOI 10.1038/tpj.2012.45
   Grinkova YV, 2013, BIOCHEM BIOPH RES CO, V430, P1223, DOI 10.1016/j.bbrc.2012.12.072
   LOIDA PJ, 1993, BIOCHEMISTRY-US, V32, P11530, DOI 10.1021/bi00094a009
   Shah MB, 2013, J PHARMACOL EXP THER, V346, P113, DOI 10.1124/jpet.113.204776
   Wilderman PR, 2012, CURR DRUG METAB, V13, P167
   HOLMANS PL, 1994, ARCH BIOCHEM BIOPHYS, V312, P554, DOI 10.1006/abbi.1994.1345
   Gay SC, 2010, MOL PHARMACOL, V77, P529, DOI 10.1124/mol.109.062570
   Shah MB, 2012, BIOCHEMISTRY-US, V51, P7225, DOI 10.1021/bi300894z
   Gotoh J, 1992, BIOL CHEM, V267, P83
   Ingelman-Sundberg M., 2004, PHARMACOLOGY, V369, P89
   JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N
   Schrodinger L. L. C., 2010, PYMOL MOL GRAPHICS S
   Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39
   Zanger UM, 2014, CLIN PHARMACOL THER, V95, P258, DOI 10.1038/clpt.2013.220
   Zanger Ulrich M., 2013, Frontiers in Genetics, V4, P24, DOI 10.3389/fgene.2013.00024
NR 58
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 61
EP 69
DI 10.1016/j.abb.2015.08.007
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100008
PM 26319176
ER

PT J
AU Hsu, CH
   Chang, CF
   Liao, YD
   Wu, SH
   Chen, CP
AF Hsu, Chun-Hua
   Chang, Chi-Fon
   Liao, You-Di
   Wu, Shih-Hsiung
   Chen, Chinpan
TI Solution structure and base specificity of cytotoxic RC-RNase 2 from
   Rana catesbeiana
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Ribonuclease; Solution structure; RC-RNase 2; Base specificity; NMR
ID MULTIDIMENSIONAL NMR METHODS; RIBONUCLEASE-A; RESONANCE ASSIGNMENTS;
   SECONDARY STRUCTURE; PROTEIN-STRUCTURE; AMPHIBIAN RIBONUCLEASE;
   ATOMIC-RESOLUTION; CHEMICAL-SHIFT; ONCONASE; OOCYTES
AB Cytotoxic ribonucleases found in the oocytes and early embryos of frogs with antitumor activity are well-documented. RC-RNase 2, a cytotoxic ribonuclease isolated from oocytes of bullfrog Rana catesbeiana, consists of 105 residues linked with 4 disulfide bridges and belongs to the bovine pancreatic ribonuclease (RNase A) superfamily. Among the RC-RNases, the base preference for RNase 2 is UpG but CpG for RC-RNase 4; while RC-RNase possesses the base specificity of both UpG and CpG. Interestingly, RC-RNase 2 or 4 has much lower catalytic activity but only three-fold less cytotoxicity than RC-RNase. Here, we report the NMR solution structure of rRC-RNase 2, comprising three alpha-helices and two sets of antiparallel beta-sheets. The differences of side-chain conformations of subsite residues among RNase A, RC-RNase, RC-RNase 4 and rRNase 2 are related to their distinct catalytic activities and base preferences. Furthermore, the substrate-related residues in the base specificity among native RC-RNases are derived using the chemical shift perturbation on ligand binding. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Hsu, Chun-Hua] Natl Taiwan Univ, Dept Agr Chem, Taipei 10617, Taiwan.
   [Hsu, Chun-Hua] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Ctr Syst Biol, Taipei 10617, Taiwan.
   [Chang, Chi-Fon] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan.
   [Liao, You-Di; Chen, Chinpan] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.
   [Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.
RP Hsu, CH (reprint author), Natl Taiwan Univ, Dept Agr Chem, Taipei 10617, Taiwan.
EM andyhsu@ntu.edu.tw; bmchinp@ibms.sinica.edu.tw
FU Academia Sinica; National Science Council; National Taiwan University
   [NTU-ERP-101R8600-1, NTU-ICRP-102R7560-5]
FX Financial support was from Academia Sinica, the National Science
   Council, and National Taiwan University (NTU-ERP-101R8600-1 and
   NTU-ICRP-102R7560-5 to CHH).
CR Hsu CH, 2001, J BIOMOL NMR, V19, P87, DOI 10.1023/A:1008348302036
   Mikulski SM, 1998, INT J ONCOL, V13, P633
   Smolewski P, 2014, INT J ONCOL, V45, P419, DOI 10.3892/ijo.2014.2405
   WISHART DS, 1994, METHOD ENZYMOL, V239, P363
   NITTA K, 1994, CANCER RES, V54, P920
   Lee JE, 2003, BIOCHEMISTRY-US, V42, P11443, DOI 10.1021/bi035147s
   Chang CF, 1998, J MOL BIOL, V283, P231, DOI 10.1006/jmbi.1998.2082
   Boix E, 1996, J MOL BIOL, V257, P992, DOI 10.1006/jmbi.1996.0218
   Liao YD, 2000, NUCLEIC ACIDS RES, V28, P4097, DOI 10.1093/nar/28.21.4097
   Lee I, 2003, ADV EXP MED BIOL, V530, P187
   Chen CP, 1996, J BIOMOL NMR, V8, P331, DOI 10.1007/BF00410331
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Saxena SK, 1996, J BIOL CHEM, V271, P20783
   WISHART DS, 1995, J BIOMOL NMR, V6, P135
   Berisio R, 1999, J MOL BIOL, V292, P845, DOI 10.1006/jmbi.1999.3093
   HYBERTS SG, 1987, EUR J BIOCHEM, V164, P625, DOI 10.1111/j.1432-1033.1987.tb11173.x
   Gorbatyuk VY, 2004, J BIOL CHEM, V279, P5772, DOI 10.1074/jbc.M311233200
   Rutkoski TJ, 2008, CURR PHARM BIOTECHNO, V9, P185, DOI 10.2174/138920108784567344
   Fisher BM, 1998, BIOCHEMISTRY-US, V37, P12121, DOI 10.1021/bi980743l
   Fisher BM, 1998, J BIOL CHEM, V273, P34134, DOI 10.1074/jbc.273.51.34134
   LYONS BA, 1993, BIOCHEMISTRY-US, V32, P7839, DOI 10.1021/bi00082a001
   Leu YJ, 2003, J BIOL CHEM, V278, P7300, DOI 10.1074/jbc.M206701200
   Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0
   Hsu CH, 2010, J BIOCHEM, V148, P209, DOI 10.1093/jb/mvq058
   RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Berisio R, 2002, ACTA CRYSTALLOGR D, V58, P441, DOI 10.1107/S0907444901021758
   Merlino A, 2005, J BIOL CHEM, V280, P17953, DOI 10.1074/jbc.M501339200
   Hsu CH, 2001, J BIOMOL NMR, V20, P93, DOI 10.1023/A:1011255913840
   ARDELT W, 1991, J BIOL CHEM, V266, P245
   D'Alessio Giuseppe, 1993, Trends in Cell Biology, V3, P106, DOI 10.1016/0962-8924(93)90166-X
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   MOSIMANN SC, 1994, J MOL BIOL, V236, P1141, DOI 10.1016/0022-2836(94)90017-5
   Kurpiewska K, 2014, BIOPOLYMERS, V101, P454, DOI 10.1002/bip.22403
   Leland PA, 1998, P NATL ACAD SCI USA, V95, P10407, DOI 10.1073/pnas.95.18.10407
   Holloway DE, 2011, FEBS J, V278, P4136, DOI 10.1111/j.1742-4658.2011.08320.x
   Liao YD, 2003, NUCLEIC ACIDS RES, V31, P5247, DOI 10.1093/nar/gkg746
   Leland PA, 2001, CHEM BIOL, V8, P405, DOI 10.1016/S1074-5521(01)00030-8
   Lee JE, 2008, J MOL BIOL, V375, P165, DOI 10.1016/j.jmb.2007.09.089
   Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147
   Hsu CH, 2003, J MOL BIOL, V326, P1189, DOI 10.1016/S0022-2836(02)01472-9
   Kay LE, 1997, BIOCHEM CELL BIOL, V75, P1
   Koradi R., 1996, J MOL GRAPHICS, V14, P29
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Sundlass NK, 2013, BIOCHEMISTRY-US, V52, P6304, DOI 10.1021/bi400619m
NR 48
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 70
EP 78
DI 10.1016/j.abb.2015.08.010
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100009
PM 26302448
ER

PT J
AU Bolean, M
   Simao, AMS
   Kiffer-Moreira, T
   Hoylaerts, MF
   Millan, JL
   Itri, R
   Ciancaglini, P
AF Bolean, Mayte
   Simao, Ana Maria S.
   Kiffer-Moreira, Tina
   Hoylaerts, Marc F.
   Millan, Jose Luis
   Itri, Rosangela
   Ciancaglini, Pietro
TI Proteoliposomes with the ability to transport Ca2+ into the vesicles and
   hydrolyze phosphosubstrates on their surface
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Annexin V; Alkaline phosphatase; Matrix vesicles; DPPC; DPPS; Liposome;
   Calorimetry; Proteoliposome
ID PLATE ALKALINE-PHOSPHATASE; AIR-WATER-INTERFACE; DIFFERENTIAL SCANNING
   CALORIMETRY; MATRIX VESICLES; ANNEXIN-V; CARTILAGE MINERALIZATION;
   SKELETAL MINERALIZATION; LIPID-COMPOSITION; ANCHORED PROTEIN; MEMBRANE
AB We describe the production of stable DPPC and DPPC:DPPS-proteoliposomes harboring annexin V (AnxA5) and tissue-nonspecific alkaline phosphatase (TNAP) and their use to investigate whether the presence of AnxA5 impacts the kinetic parameters for hydrolysis of TNAP substrates at physiological pH. The best catalytic efficiency was achieved in DPPS 10%-proteoliposomes (molar ratio), conditions that also increased the specificity of TNAP hydrolysis of PPi. Melting behavior of liposomes and proteoliposomes was analyzed via differential scanning calorimetry. The presence of 10% DPPS in DPPC-liposomes causes a broadening of the transition peaks, with AnxA5 and TNAP promoting a decrease in Delta H values. AnxA5 was able to mediate Ca2+-influx into the DPPC and DPPC:DPPS 10%-vesicles at physiological Ca2+ concentrations (similar to 2 mM). This process was not affected by the presence of TNAP in the proteoliposomes. However, AnxA5 significantly affects the hydrolysis of TNAP substrates. Studies with GUVs confirmed the functional reconstitution of AnxA5 in the mimetic systems.
   These proteoliposomes are useful as mimetics of mineralizing cell-derived matrix vesicles, known to be responsible for the initiation of endochondral ossification, as they successfully transport Ca2+ and possess the ability to hydrolyze phosphosubstrates in the lipid water interface. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Bolean, Mayte; Simao, Ana Maria S.; Ciancaglini, Pietro] Univ Sao Paulo, FFCLRP USP, Dept Quim, BR-14049 Ribeirao Preto, SP, Brazil.
   [Kiffer-Moreira, Tina; Millan, Jose Luis] Sanford Childrens Hlth Res Ctr, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA.
   [Hoylaerts, Marc F.] Univ Leuven, Dept Cardiovasc Sci, Ctr Mol & Vasc Biol, Leuven, Belgium.
   [Itri, Rosangela] IF USP, Inst Fis, Dept Fis Aplicada, Sao Paulo, SP, Brazil.
RP Ciancaglini, P (reprint author), FFCLRP USP, Dept Quim, Av Bandeirantes 3900, BR-14040901 Ribeirao Preto, SP, Brazil.
EM pietro@ffclrp.usp.br
FU National Institutes of Health, USA [DE12889, AR53102]; FAPESP
   [2014/11941-3]; CAPES (NanoBiotech); CNPq [400146/2014-2,
   443758/2014-0]; CAPES; FAPESP scholarship; CNPq
FX The authors thank Dr. Omar Mertins for helpful assistance in GUVs
   experiments, Prof. Dr. Bruno Maggio for assistance in DSC analysis and
   Priscila Cerviglieri for linguistic advice. This work was supported in
   part by grants DE12889 and AR53102 from the National Institutes of
   Health, USA. We also thank FAPESP (2014/11941-3), CAPES (NanoBiotech)
   and CNPq (400146/2014-2 and 443758/2014-0). for the financial support
   given to our laboratory. MB and AMSS received a CAPES and FAPESP
   scholarship, respectively. PC and RI also acknowledge CNPq for research
   fellowships.
CR Anderson H.C., 1984, SCANNING ELECTRON MI, V2, P953
   Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z
   Liemann S, 1997, CELL MOL LIFE SCI, V53, P516, DOI 10.1007/s000180050065
   Caseli L, 2008, J COLLOID INTERF SCI, V320, P476, DOI 10.1016/j.jcis.2008.01.043
   Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019
   HAUPTMANN R, 1989, EUR J BIOCHEM, V185, P63, DOI 10.1111/j.1432-1033.1989.tb15082.x
   Pedersen TB, 2001, CHEM PHYS LIPIDS, V113, P83, DOI 10.1016/S0009-3084(01)00177-3
   Camolezi FL, 2002, INT J BIOCHEM CELL B, V34, P1091, DOI 10.1016/S1357-2725(02)00029-8
   Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195
   Ierardi DF, 2002, BBA-BIOMEMBRANES, V1567, P183, DOI 10.1016/S0005-2736(02)00615-6
   Riske KA, 2005, BIOPHYS J, V88, P1143, DOI 10.1529/biophysj.104.050310
   Tas AC, 2014, ACTA BIOMATER, V10, P1771, DOI 10.1016/j.actbio.2013.12.047
   Simao AMS, 2007, COMP BIOCHEM PHYS A, V146, P679, DOI 10.1016/j.cbpa.2006.05.008
   Damek-Poprawa M, 2006, BIOCHEMISTRY-US, V45, P3325, DOI 10.1021/bi0515927
   dos Santos GA, 2010, BBA-BIOMEMBRANES, V1798, P1714, DOI 10.1016/j.bbamem.2010.05.013
   Wu LNY, 1997, J BIOL CHEM, V272, P4404
   Ciancaglini P, 2010, J BONE MINER RES, V25, P716, DOI 10.1359/jbmr.091023
   Thouverey C, 2009, J CELL BIOCHEM, V106, P127, DOI 10.1002/jcb.21992
   Demetzos C, 2008, J LIPOSOME RES, V18, P159, DOI 10.1080/08982100802310261 
   Caseli L, 2005, LANGMUIR, V21, P4090, DOI 10.1021/la047292s
   Simao AMS, 2010, BRAZ J MED BIOL RES, V43, P234, DOI 10.1590/S0100-879X2010007500008
   SCHLAEPFER DD, 1992, BIOCHEMISTRY-US, V31, P1886, DOI 10.1021/bi00121a043
   Aranda S, 2008, BIOPHYS J, V95, pL19, DOI 10.1529/biophysj.108.132548
   BOYAN BD, 1989, ANAT REC, V224, P211, DOI 10.1002/ar.1092240210
   Ciancaglini P, 2006, BRAZ J MED BIOL RES, V39, P603, DOI 10.1590/S0100-879X2006000500006
   Kirsch T, 1997, BIOCHEMISTRY-US, V36, P3359, DOI 10.1021/bi9626867
   Giocondi MC, 2007, LANGMUIR, V23, P9358, DOI 10.1021/la700892z
   DAVIDSON FF, 1990, J BIOL CHEM, V265, P5602
   ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303
   Zhang L, 2005, J BIOL CHEM, V280, P37289, DOI 10.1074/jbc.M504260200
   Simao AMS, 2013, CALCIFIED TISSUE INT, V93, P222, DOI 10.1007/s00223-013-9745-3
   MCELHANEY RN, 1982, CHEM PHYS LIPIDS, V30, P229, DOI 10.1016/0009-3084(82)90053-6
   Bolean M, 2011, BIOPHYS CHEM, V158, P111, DOI 10.1016/j.bpc.2011.05.019
   PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V401, P317, DOI 10.1016/0005-2736(75)90233-3
   Bolean M, 2010, BIOPHYS CHEM, V152, P74, DOI 10.1016/j.bpc.2010.08.002
   Kirsch T, 2005, FRONT BIOSCI, V10, P576, DOI 10.2741/1553
   Yen TC, 2010, ANAL BIOCHEM, V406, P70, DOI 10.1016/j.ab.2010.06.048
   Bellet-Amalric E, 2000, BBA-BIOMEMBRANES, V1467, P131, DOI 10.1016/S0005-2736(00)00218-2
   Simao AMS, 2007, CELL BIOL INT, V31, P1405, DOI 10.1016/j.cellbi.2007.06.002
   Leone FA, 2005, BIOCHEM MOL BIOL EDU, V33, P399, DOI 10.1002/bmb.2005.49403306399
   Ronzon F, 2002, BBA-BIOMEMBRANES, V1560, P1, DOI 10.1016/S0005-2736(01)00405-9
   PIZAURO JM, 1993, BIOCHIM BIOPHYS ACTA, V1202, P22, DOI 10.1016/0167-4838(93)90058-Y
   Abdallah D, 2014, BIOCHEM BIOPH RES CO, V446, P1161, DOI 10.1016/j.bbrc.2014.03.069
   Buchet R, 2013, METHODS MOL BIOL, V1053, P115, DOI 10.1007/978-1-62703-562-0_7
   Mertins O, 2014, BIOPHYS J, V106, P162, DOI 10.1016/j.bpj.2013.11.4457
   Sesana S, 2008, BIOCHEMISTRY-US, V47, P5433, DOI 10.1021/bi800005s
   ANDREE HAM, 1992, J BIOL CHEM, V267, P17907
   Liu C, 1999, BLOOD, V93, P2297
   Simao AMS, 2010, J BIOL CHEM, V285, P7598, DOI 10.1074/jbc.M109.079830
   MCELHANEY RN, 1986, BIOCHIM BIOPHYS ACTA, V864, P361, DOI 10.1016/0304-4157(86)90004-3
   HUBER R, 1990, EMBO J, V9, P3867
   WUTHIER RE, 1976, FED PROC, V35, P117
   Chen ZX, 2014, PROTEINS, V82, P312, DOI 10.1002/prot.24389
   Pizauro JM, 1995, MOL CELL BIOCHEM, V152, P121, DOI 10.1007/BF01076074
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   Wu LNY, 2002, J BIOL CHEM, V277, P5126, DOI 10.1074/jbc.M107899200
   Logue SE, 2009, NAT PROTOC, V4, P1383, DOI 10.1038/nprot.2009.143
   Wu FJ, 1998, BIOPHYS J, V74, P3273
   PIZAURO JM, 1987, COMP BIOCHEM PHYS B, V87, P921, DOI 10.1016/0305-0491(87)90413-5
   Hsu HHT, 1999, ATHEROSCLEROSIS, V143, P353, DOI 10.1016/S0021-9150(98)00322-0
   Ciancaglini P., 2012, Biophysical Reviews, V4, DOI 10.1007/s12551-011-0065-4
   Santos HD, 2005, COLLOID SURFACE B, V41, P239, DOI 10.1016/j.colsurfb.2004.12.013
   EANES ED, 1985, CALCIFIED TISSUE INT, V37, P390, DOI 10.1007/BF02553708
   Golub E.E., 2011, SEMIN IMMUNOPATHOL, V5, P409
   Kirsch T., 2012, CONNECT TISSUE RES, V6, P438
   Kleinschmidt J.H., 2013, LIPID PROTEIN INTERA
   Leone F.A., 1997, TRENDS COMP BIOCH PH, V3, P57
   Milian JL, 2006, PURINERG SIGNAL, V2, P335
   Rezende A.A., 1998, CELL MOL BIOL, V44, P293
   Wu LNY, 1997, CLIN ORTHOP RELAT R, P310
   Wuthier R.E., 2011, FRONT BIOSCI, V17, P2812
NR 71
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 79
EP 89
DI 10.1016/j.abb.2015.08.018
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100010
PM 26325078
ER

PT J
AU Kim, DI
   Park, MJ
   Heo, YR
   Park, SH
AF Kim, Dong-il
   Park, Min-jung
   Heo, Young-ran
   Park, Soo-hyun
TI Metformin ameliorates lipotoxicity-induced mesangial cell apoptosis
   partly via upregulation of glucagon like peptide-1 receptor (GLP-1R)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE GLP-1R; Glucagon like peptide-1 receptor; Mesangial cell; Apoptosis;
   Palmitate; Metformin
ID ACTIVATED PROTEIN-KINASE; TYPE-2 DIABETIC-PATIENTS; PROXIMAL TUBULAR
   CELLS; OXIDATIVE STRESS; HIGH GLUCOSE; DB/DB MICE; IN-VITRO;
   NEPHROPATHY; EXPRESSION; INHIBITION
AB Glucagon like peptide-1 receptor (GLP-1R), known to be expressed in pancreatic beta cells, is also expressed in glomerular mesangial cells and its agonist has protective effects in diabetic nephropathy. However, its regulatory mechanisms by lipotoxicity in glomerular mesangial cells are not understood. We found that palmitate-mediated lipotoxicity increased apoptosis and decreased GLP-1R expression in a rat mesangial cell line. Silencing GLP-1R expression also increased mesangial cell apoptosis. Interestingly, metformin, one of the biguanide drugs that has anti-diabetic effects, attenuated lipotoxicity-induced mesangial cell apoptosis and restored GLP-1R expression. Moreover, this treatment alleviated GLP-1R knockdown-induced mesangial cell apoptosis. To further evaluate in vivo, diabetic obese db/db mice were administered metformin. Glomerular GLP-1R expression was diminished in db/db mice, as compared with db/m control mice. However, this decrease significantly recovered on metformin administration. Together, these data provide novel evidence that lipotoxicity decreases the mesangial GLP-1R expression in intact cells and in vivo. The decrease induced mesangial cell apoptosis. Furthermore, we provided the evidence that metformin treatment has a renal protective effect partly via increased mesangial GLP-1R expression. Our data suggested that regulation of GLP-1R expression could be a promising approach to treat diabetic nephropathy and the novel mechanism of metformin mediated GLP-1R regulation. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Kim, Dong-il; Park, Min-jung; Park, Soo-hyun] Chonnam Natl Univ, Coll Vet Med, Kwangju 500757, South Korea.
   [Kim, Dong-il] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.
   [Park, Min-jung] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.
   [Park, Min-jung] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA.
   [Heo, Young-ran] Chonnam Natl Univ, Dept Food & Nutr, Kwangju 500757, South Korea.
RP Park, SH (reprint author), Chonnam Natl Univ, Dept Vet Physiol, Coll Vet Med, Biotherapy Human Resources Ctr, Kwangju 500757, South Korea.
EM dongil@umich.edu; parksh@chonnam.ac.kr
FU National Research Foundation of Korea [NRF-2010-0023627]; Animal Medical
   Institute of Chonnam National University
FX This work was supported financially by a basic science research grant
   from the National Research Foundation of Korea (NRF-2010-0023627). The
   animal experiment in this study was supported by the Animal Medical
   Institute of Chonnam National University.
CR Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505
   White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083
   Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025
   Murea M, 2010, CLIN J AM SOC NEPHRO, V5, P2373, DOI 10.2215/CJN.08160910
   Gu JF, 2014, CHINESE MED J-PEKING, V127, P1755, DOI 10.3760/cma.j.issn.0366-6999.20132781
   Theriault JR, 2011, BIOCHEM BIOPH RES CO, V409, P500, DOI 10.1016/j.bbrc.2011.05.034
   Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894
   Mima A, 2012, DIABETES, V61, P2967, DOI 10.2337/db11-1824
   Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118
   Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569
   Lim JC, 2010, J CELL PHYSIOL, V225, P654, DOI 10.1002/jcp.22255
   Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2
   Fujita H, 2014, KIDNEY INT, V85, P579, DOI 10.1038/ki.2013.427
   Park CW, 2007, J AM SOC NEPHROL, V18, P1227, DOI 10.1681/ASN.2006070778
   Imamura S, 2013, TOHOKU J EXP MED, V231, P57, DOI 10.1620/tjem.231.57
   Schlatter P, 2007, REGUL PEPTIDES, V141, P120, DOI 10.1016/j.regpep.2006.12.016
   Kappe C, 2013, J GASTROENTEROL, V48, P322, DOI 10.1007/s00535-012-0637-5
   Tanaka Y, 2011, KIDNEY INT, V79, P871, DOI 10.1038/ki.2010.530
   Mori J, 2014, AM J PHYSIOL-RENAL, V306, pF812, DOI 10.1152/ajprenal.00655.2013
   Li WB, 2012, CELL PHYSIOL BIOCHEM, V30, P749, DOI 10.1159/000341454
   Xu WW, 2014, CELL PHYSIOL BIOCHEM, V33, P423, DOI 10.1159/000358623
   Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014
   Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x
   Pan QR, 2009, HORM METAB RES, V41, P799, DOI 10.1055/s-0029-1234043
   Lee SK, 2011, J CELL BIOCHEM, V112, P1259, DOI 10.1002/jcb.23000
   Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002
   Khera T, 2006, LAB INVEST, V86, P566, DOI 10.1038/labinvest.3700418
   Ishibashi Y, 2012, HORM METAB RES, V44, P891, DOI 10.1055/s-0032-1321878
   Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054
   Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970
   BAKER AJ, 1994, J CLIN INVEST, V94, P2105, DOI 10.1172/JCI117565
   Hong YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096147
   Jiang Y., 2013, YI KE DA XUE XUE BAO, V33, P930
   Kim DI, 2015, DIABETES, V64, P60, DOI 10.2337/db13-1394
   Mather KJ, 2001, J AM COLL CARDIOL, V37, P1344, DOI 10.1016/S0735-1097(01)01129-9
   Mishra R, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-2
   Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934
   Qiu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.153
   Shughrue PJ, 1996, ENDOCRINOLOGY, V137, P5159, DOI 10.1210/en.137.11.5159
   Simon-Szabo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097868
   Tanaka T, 2014, KIDNEY INT, V86, P701, DOI 10.1038/ki.2014.236
   Wang Wei, 2006, Beijing Da Xue Xue Bao, V38, P170
NR 43
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 90
EP 97
DI 10.1016/j.abb.2015.08.009
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100011
PM 26302449
ER

PT J
AU Vashishtha, AK
   West, AH
   Cook, PF
AF Vashishtha, Ashwani K.
   West, Ann H.
   Cook, Paul F.
TI Probing the chemical mechanism of saccharopine reductase from
   Saccharomyces cerevisiae using site-directed mutagenesis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Saccharopine reductase; Site-directed mutagenesis; Initial rate studies;
   pH-rate profiles; Isotope effects; Viscosity
ID ALPHA-AMINOADIPATE PATHWAY; LYSINE BIOSYNTHESIS; ENZYME
AB Saccharopine reductase catalyzes the reductive amination of L-alpha-aminoadipate-delta-semialdehyde with glutamate to give saccharopine. Two mechanisms have been proposed for the reductase, one that makes use of enzyme side chains as acid base catalytic groups, and a second, in which the reaction is catalyzed by enzyme-bound reactants. Site-directed mutagenesis was used to change acid base candidates in the active site of the reductase to eliminate their ionizable side chain. Thus, the D126A, C154S and Y99F and several double mutant enzymes were prepared. Kinetic parameters in the direction of glutamate formation exhibited modest decreases, inconsistent with the loss of an acid base catalyst. The pH-rate profiles obtained with all mutant enzymes decrease at low and high pH, suggesting acid and base catalytic groups are still present in all enzymes. Solvent kinetic deuterium isotope effects are all larger than those observed for wild type enzyme, and approximately equal to one another, suggesting the slow step is the same as that of wild type enzyme, a conformational change to open the site and release products (in the direction of saccharopine formation). Overall, the acid base chemistry is likely catalyzed by bound reactants, with the exception of deprotonation of the alpha-amine of glutamate, which likely requires an enzyme residue. (C) 2015 Elsevier Inc. All rights reserved.
C1 [West, Ann H.; Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.
   [Vashishtha, Ashwani K.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA.
RP West, AH (reprint author), Univ Oklahoma, Dept Chem & Biochem, 101 Stephenson Blvd, Norman, OK 73019 USA.
EM awest@ou.edu; pcook@ou.edu
FU National Institutes of Health [GM 071417]; Grayce B. Kerr Endowment;
   George Lynn Cross research fund
FX This work was supported by a grant (GM 071417) from the National
   Institutes of Health (to P.F.C. and A.H.W), and the Grayce B. Kerr
   Endowment to the University of Oklahoma and the George Lynn Cross
   research fund to support the research of P.F.C.
CR Andi B., 2006, ARCH BIOCHEM BIOPHYS, V46, P243
   Ho MC, 2009, NATURE, V459, P393, DOI 10.1038/nature07938
   Johansson E, 2000, STRUCTURE, V8, P1037, DOI 10.1016/S0969-2126(00)00512-8
   Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43
   Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175
   SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551
   Almasi JN, 2011, MOLECULES, V16, P8569, DOI 10.3390/molecules16108569
   Broquist H.P., 1971, METHODS ENZYMOL B, V17, P112, DOI 10.1016/0076-6879(71)17021-8
   Cook P., 2007, ENZYME KINETICS MECH
   KIICK DM, 1983, BIOCHEMISTRY-US, V22, P375, DOI 10.1021/bi00271a022
   Quinn D.M., 1991, ENZYME MECH ISOTOPE, P73
   Vashishtha AK, 2009, BIOCHEMISTRY-US, V48, P5899, DOI 10.1021/bi900599s
   Vashishtha AK, 2008, BIOCHEMISTRY-US, V47, P5417, DOI 10.1021/bi800086g
NR 13
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 98
EP 106
DI 10.1016/j.abb.2015.08.023
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100012
PM 26342457
ER

PT J
AU Whitelaw, DA
   Tonkin, R
   Meints, CE
   Wolthers, KR
AF Whitelaw, Douglas A.
   Tonkin, Rochelle
   Meints, Carla E.
   Wolthers, Kirsten R.
TI Kinetic analysis of electron flux in cytochrome P450 reductases reveals
   differences in rate-determining steps in plant and mammalian enzymes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cytochrome P450 reductase; Stopped-flow spectroscopy; Flavin;
   Charge-transfer complex
ID P450 OXIDOREDUCTASE; FERREDOXIN-NADP(+) REDUCTASE; TAXOL BIOSYNTHESIS;
   ESCHERICHIA-COLI; FLAVIN REDUCTION; P-450 REDUCTASE; C REDUCTASE; NADPH;
   FMN; FAD
AB Herein, we compare the kinetic properties of CPR from Arabidopsis thaliana (ATR2), with CPR from Artemisia annua (aaCPR) and human CPR (hCPR). While all three CPR forms elicit comparable rates for cytochrome c(3+) turnover, NADPH reduction of the FAD cofactor is similar to 50-fold faster in aaCPR and ATR2 compared to hCPR, with k(obs) of similar to 500 s(-1) (6 degrees C). Stopped-flow analysis of the isolated FAD-domains reveals that NADP(+)-FADH(2) charge-transfer complex formation is also significantly faster in the plant enzymes, but the rate of its decay is comparable for all three proteins. In hCPR, transfer of a hydride ion from NADPH to FAD is tightly coupled to subsequent FAD to FMN electron transfer, indicating that the former catalytic event is slow relative to the latter. In contrast, interflavin electron transfer is slower than NADPH hydride transfer in aaCPR and ATR2, occurring with an observed rate constant of similar to 50 s(-1). Finally, the transfer of electrons from FMN to cytochrome c(3+) is rapid (>10(3) s(-1)) in all three enzymes and does not limit catalytic turnover. In combination, the data reveal differences in rate-determining steps between plant CPR and their mammalian equivalent in mediating the flux of reducing equivalents from NADPH to external electron acceptors. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Whitelaw, Douglas A.; Tonkin, Rochelle; Meints, Carla E.; Wolthers, Kirsten R.] Univ British Columbia, Dept Chemishy, Kelowna, BC V1V 1V7, Canada.
RP Wolthers, KR (reprint author), Univ British Columbia, Dept Chemishy, Okanagan Campus,3247 Univ Way, Kelowna, BC V1V 1V7, Canada.
EM kirsten.wolthers@ubc.ca
FU Natural Sciences and Engineering Research Council of Canada
   [RGPIN-2015-06130]
FX We would like to thank Dr. James Bailey for assistance in HPLC analysis
   of the flavin content in ATR1 and ATR2. This work is supported by a
   grant from the Natural Sciences and Engineering Research Council of
   Canada (RGPIN-2015-06130).
CR Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411
   Deng Z, 1999, NAT STRUCT BIOL, V6, P847
   Brenner S, 2008, FEBS J, V275, P4540, DOI 10.1111/j.1742-4658.2008.06597.x
   Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017
   Park HG, 2010, BIOCHEM BIOPH RES CO, V396, P534, DOI 10.1016/j.bbrc.2010.04.138
   OPRIAN DD, 1982, J BIOL CHEM, V257, P8935
   VERMILION JL, 1978, J BIOL CHEM, V253, P8812
   Schuckel J, 2012, CHEMBIOCHEM, V13, P2758, DOI 10.1002/cbic.201200572
   Croteau Rodney, 2006, Phytochemistry Reviews, V5, P75, DOI 10.1007/s11101-005-3748-2
   VERMILION JL, 1981, J BIOL CHEM, V256, P266
   MASTERS BSS, 1965, J BIOL CHEM, V240, P4081
   Iyanagi T, 2012, ARCH BIOCHEM BIOPHYS, V528, P72, DOI 10.1016/j.abb.2012.09.002
   Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200
   Simtchouk S, 2013, FEBS J, V280, P6627, DOI 10.1111/febs.12567
   Mizutani M, 2011, ARCH BIOCHEM BIOPHYS, V507, P194, DOI 10.1016/j.abb.2010.09.026
   GUENGERICH FP, 1994, TOXICOL LETT, V70, P133
   Winzer T, 2015, SCIENCE, V349, P309, DOI 10.1126/science.aab1852
   Shen AL, 1999, J BIOL CHEM, V274, P5391, DOI 10.1074/jbc.274.9.5391
   Jennewein S, 2005, BIOTECHNOL BIOENG, V89, P588, DOI 10.1002/bit.20390
   Tejero J, 2007, ARCH BIOCHEM BIOPHYS, V459, P79, DOI 10.1016/j.abb.2006.10.023
   IYANAGI T, 1973, BIOCHEMISTRY-US, V12, P2297, DOI 10.1021/bi00736a018
   Leonard E, 2007, APPL ENVIRON MICROB, V73, P7246, DOI 10.1128/AEM.01411-07
   Pudney CR, 2012, FEBS J, V279, P1534, DOI 10.1111/j.1742-4658.2011.08442.x
   Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304
   Meints CE, 2011, BIOCHEMISTRY-US, V50, P11131, DOI 10.1021/bi2012228
   Aigrain L, 2009, EMBO REP, V10, P742, DOI 10.1038/embor.2009.82
   Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200
   Gutierrez A, 2003, BIOCHEM SOC T, V31, P497, DOI 10.1042/BST0310497
   Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875
   Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m
   SHEN AL, 1989, J BIOL CHEM, V264, P7584
   Vincent B, 2012, J MOL BIOL, V420, P296, DOI 10.1016/j.jmb.2012.03.022
   Meints CE, 2014, ARCH BIOCHEM BIOPHYS, V547, P18, DOI [10.1016/j.abb.2014.02.009, 10.1016/j.abb.2014.02.0090003-9861]
   Grunau A, 2006, BIOCHEMISTRY-US, V45, P1421, DOI 10.1021/bi052115r
   Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022
   Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640
NR 36
TC 0
Z9 0
U1 19
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 107
EP 115
DI 10.1016/j.abb.2015.09.002
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100013
PM 26361974
ER

PT J
AU Banthiya, S
   Pekarova, M
   Kuhn, H
   Heydeck, D
AF Banthiya, Swathi
   Pekarova, Maria
   Kuhn, Hartmut
   Heydeck, Dagmar
TI Secreted lipoxygenase from Pseudomonas aeruginosa exhibits biomembrane
   oxygenase activity and induces hemolysis in human red blood cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Eicosanoids; Bacterial infections; Biomembranes; Oxidative stress
ID ALLENE OXIDE SYNTHASE; RETICULOCYTE LIPOXYGENASE; ORGANELLE DEGRADATION;
   15-LIPOXYGENASE; PHOSPHOLIPIDS; PURIFICATION; MEMBRANES;
   12/15-LIPOXYGENASE; CYANOBACTERIUM; ENZYMOLOGY
AB Pseudomonas aeruginosa (PA) expresses a secreted lipoxygenase (LOX), which oxygenates free arachidonic acid predominantly to 15S-H(p)ETE. The enzyme is capable of binding phospholipids at its active site and physically interacts with model membranes. However, its membrane oxygenase activity has not been quantified. To address this question, we overexpressed PA-LOX as intracellular his-tag fusion protein in Escherichia coli, purified it to electrophoretic homogeneity and compared its biomembrane oxygenase activity with that of rabbit ALOX15. We found that both enzymes were capable of oxygenating mitochondrial membranes to specific oxygenation products and 13S-H(p)ODE and 15S-H(p)ETE esterified to phosphatidylcholine and phosphatidylethanolamine were identified as major oxygenation products. When normalized to similar linoleic acid oxygenase activity, the rabbit enzyme exhibited a much more effective mitochondrial membrane oxygenase activity. In contrast, during long-term incubations (24 h) with red blood cells PA-LOX induced significant (50%) hemolysis whereas rabbit ALOX15 was more or less ineffective. These data indicate the principle capability of PA-LOX of oxygenating membrane bound phospholipids which is likely to alter the barrier function of the biomembranes. Although the membrane oxygenase activity was lower than the fatty acid oxygenase activity of PA-LOX red blood cell membrane oxygenation might be of biological relevance for P. aeruginosa septicemia. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Banthiya, Swathi; Pekarova, Maria; Kuhn, Hartmut; Heydeck, Dagmar] Charite, Inst Biochem, D-10117 Berlin, Germany.
   [Pekarova, Maria] Comenius Univ, Fac Pharm, Dept Cell & Mol Biol Drugs, Bratislava 83232, Slovakia.
RP Kuhn, H (reprint author), Charite, Inst Biochem, Charitepl 1, D-10117 Berlin, Germany.
EM hartmut.kuehn@charite.de
FU VEGA [1/0392/14]; DFG [GRK1673]
FX This work was supported in part by a research grant from VEGA 1/0392/14
   (MP) and by DFG (GRK1673, SB, HK). The prokaryotic expression plasmid
   pET28a(+) containing the coding sequence of PA-LOX was kindly provided
   by Prof. Xavi Carpena (Institut de Biologia Molecular, Parc Cientific de
   Barcelona, Barcelona, Spain).
CR Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016
   KUHN H, 1990, EUR J BIOCHEM, V191, P221, DOI 10.1111/j.1432-1033.1990.tb19113.x
   PATTON GM, 1982, J LIPID RES, V23, P190
   Grullich C, 2001, FEBS LETT, V489, P51, DOI 10.1016/S0014-5793(01)02080-4
   Wang XM, 2014, J AGR FOOD CHEM, V62, P1713, DOI 10.1021/jf405425c
   Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003
   Vidal-Mas J, 2005, ANTON LEEUW INT J G, V87, P245, DOI 10.1007/s10482-004-4021-1
   Hansen J, 2013, APPL MICROBIOL BIOT, V97, P4737, DOI 10.1007/s00253-013-4887-9
   Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d
   Andreou AZ, 2008, PHYTOCHEMISTRY, V69, P1832, DOI 10.1016/j.phytochem.2008.03.002
   Gao BL, 2010, BBA-MOL CELL BIOL L, V1801, P58, DOI 10.1016/j.bbalip.2009.09.004
   Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787
   SCHEWE T, 1986, ADV ENZYMOL RAMB, V58, P191
   Koeduka T, 2007, CURR MICROBIOL, V54, P315, DOI 10.1007/s00284-006-0512-9
   Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151
   Morgan AH, 2015, REDOX BIOL, V4, P40, DOI 10.1016/j.redox.2014.11.005
   Garreta A, 2013, FASEB J, V27, P4811, DOI 10.1096/fj.13-235952
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   RAPOPORT SM, 1986, BIOCHIM BIOPHYS ACTA, V864, P471, DOI 10.1016/0304-4157(86)90006-7
   Krieg P, 2014, BBA-MOL CELL BIOL L, V1841, P390, DOI 10.1016/j.bbalip.2013.08.005
   KUHN H, 1990, J BIOL CHEM, V265, P1454
   Hallenborg P, 2010, MOL CELL BIOL, V30, P4077, DOI 10.1128/MCB.01806-08
   Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9
   Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764
   HAWKINS DJ, 1987, J BIOL CHEM, V262, P7629
   KUHN H, 1990, J BIOL CHEM, V265, P18351
   TAKAHASHI Y, 1993, EUR J BIOCHEM, V218, P165, DOI 10.1111/j.1432-1033.1993.tb18362.x
   CRANE FL, 1956, BIOCHIM BIOPHYS ACTA, V22, P475, DOI 10.1016/0006-3002(56)90058-0
   KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N
   Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101
   Lu XY, 2013, APPL MICROBIOL BIOT, V97, P5793, DOI 10.1007/s00253-012-4457-6
   van Leyen K, 1998, NATURE, V395, P392
   Adolph S, 2012, CURR MICROBIOL, V65, P649, DOI 10.1007/s00284-012-0207-3
   Rai G, 2014, J MED CHEM, V57, P4035, DOI 10.1021/jm401915r
   Xu Z, 2014, J SCI FOOD AGR, V94, P1753, DOI 10.1002/jsfa.6487
   Hersberger M, 2010, CLIN CHEM LAB MED, V48, P1063, DOI 10.1515/CCLM.2010.212
   Busquets M., 2011, RECENT ADV PHARM SCI, P247
   Horn T., 2014, PROG LIPID RES C, V57C, P13
   Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002
   Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012
   Rao C.V., 2012, CURR COLORECTAL CANC, V8, P316, DOI 10.1007/s11888-012-0146-1
NR 41
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 116
EP 124
DI 10.1016/j.abb.2015.09.003
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100014
PM 26361973
ER

PT J
AU Reszczynska, E
   Welc, R
   Grudzinski, W
   Trebacz, K
   Gruszecki, WI
AF Reszczynska, Emilia
   Welc, Renata
   Grudzinski, Wojciech
   Trebacz, Kazimierz
   Gruszecki, Wieslaw I.
TI Carotenoid binding to proteins: Modeling pigment transport to lipid
   membranes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Retina; Macula; Carotenoids; Xanthophylls; Lutein; Zeaxanthin;
   Carotenoid-protein complexes
ID HUMAN EYE; ZEAXANTHIN; SPECTROSCOPY; LUTEIN; IDENTIFICATION; ASSOCIATION
AB Carotenoid pigments play numerous important physiological functions in human organism. Very special is a role of lutein and zeaxanthin in the retina of an eye and in particular in its central part, the macula lutea. In the retina, carotenoids can be directly present in the lipid phase of the membranes or remain bound to the protein-pigment complexes. In this work we address a problem of binding of carotenoids to proteins and possible role of such structures in pigment transport to lipid membranes. Interaction of three carotenoids, beta-carotene, lutein and zeaxanthin with two proteins: bovine serum albumin and glutathione S-transferase (GST) was investigated with application of molecular spectroscopy techniques: UV-Vis absorption, circular dichroism and Fourier transform infrared spectroscopy (FTIR). Interaction of pigment protein complexes with model lipid bilayers formed with egg yolk phosphatidylcholine was investigated with application of FTIR, Raman imaging of liposomes and electrophysiological technique, in the planar lipid bilayer models. The results show that in all the cases of protein and pigment studied, carotenoids bind to protein and that the complexes formed can interact with membranes. This means that protein carotenoid complexes are capable of playing physiological role in pigment transport to biomembranes. (C) 2015 Published by Elsevier Inc.
C1 [Reszczynska, Emilia; Welc, Renata; Grudzinski, Wojciech; Gruszecki, Wieslaw I.] Maria Curie Skiodowska Univ, Inst Phys, Dept Biophys, PL-20031 Lublin, Poland.
   [Reszczynska, Emilia; Trebacz, Kazimierz] Maria Curie Sktodowska Univ, Inst Biol & Biochem, Dept Biophys, PL-20031 Lublin, Poland.
RP Gruszecki, WI (reprint author), Maria Curie Skiodowska Univ, Inst Phys, Dept Biophys, PL-20031 Lublin, Poland.
EM wieslaw.gruszecki@umcs.pl
FU Foundation for Polish Science within the TEAM program [TEAM/2011-7/2];
   European Regional Development Fund in the framework of the Development
   of Eastern Poland Operational Programme
FX This research has been performed within the framework of the project,
   Molecular Spectroscopy for BioMedical Studies" financed by the
   Foundation for Polish Science within the TEAM program (TEAM/2011-7/2).
   The research was carried out with the equipment purchased thanks to the
   financial support of the European Regional Development Fund in the
   framework of the Development of Eastern Poland Operational Programme.
CR Bhosale P, 2004, J BIOL CHEM, V279, P49447, DOI 10.1074/jbc.M405334200
   Adamkiewicz P, 2013, J MOL STRUCT, V1046, P44, DOI 10.1016/j.molstruc.2013.04.053
   Herec M, 2008, BBA-BIOMEMBRANES, V1778, P872, DOI 10.1016/j.bbamem.2007.12.004
   Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375
   Li XR, 2015, FOOD CHEM, V179, P213, DOI 10.1016/j.foodchem.2015.01.133
   Bhosale P, 2007, ARCH BIOCHEM BIOPHYS, V458, P121, DOI 10.1016/j.abb.2006.10.005
   Bernstein PS, 2001, EXP EYE RES, V72, P215, DOI 10.1006/exer.2000.0954
   Kupisz K, 2008, BBA-BIOMEMBRANES, V1778, P2334, DOI 10.1016/j.bbamem.2008.06.005
   Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015
   Wardak A, 2000, J PHOTOCH PHOTOBIO B, V56, P12, DOI 10.1016/S1011-1344(00)00050-6
   Sujak A, 1999, ARCH BIOCHEM BIOPHYS, V371, P301, DOI 10.1006/abbi.1999.1437
   Milanowska J, 2005, J PHOTOCH PHOTOBIO B, V80, P178, DOI 10.1016/j.jphotobiol.2005.05.004
   Vachali PP, 2015, ARCH BIOCHEM BIOPHYS, V572, P66, DOI 10.1016/j.abb.2014.12.005
   Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171
   Khachik F, 2006, PURE APPL CHEM, V78, P1551, DOI 10.1351/pac200678081551
   MENDELSOHN R, 1979, BIOPHYS J, V27, P221
   Zsila F, 2006, BIOORG MED CHEM LETT, V16, P3797, DOI 10.1016/j.bmcl.2006.04.028
   Britton G., 2008, CAROTENOIDS NATURAL, V4
   Britton G., 1995, CAROTENOIDS, V1B, P13
   Landrum JT, 2010, CAROTENOIDS: PHYSICAL, CHEMICAL, AND BIOLOGICAL FUNCTIONS AND PROPERTIES, P1
   Starzyk J, 2014, J PHYS CHEM B, V118, P13821, DOI 10.1021/jp510245n
   Tien H.T., 1974, BILAYER LIPID MEMBRA
   Wisniewska-Becker A, 2013, WOODH PUB SER BIOMED, P47, DOI 10.1533/9781908818348.47
NR 23
TC 0
Z9 0
U1 17
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 125
EP 133
DI 10.1016/j.abb.2015.09.004
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100015
PM 26361975
ER

PT J
AU Perez-Henarejos, SA
   Alcaraz, LA
   Donaire, A
AF Alejo Perez-Henarejos, Sergio
   Alcaraz, Luis A.
   Donaire, Antonio
TI Blue Copper Proteins: A rigid machine for efficient electron transfer, a
   flexible device for metal uptake
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Blue Copper Proteins; Azurin; Rusticyanin; Rack/entatic; Cancer therapy
ID SITE-DIRECTED MUTAGENESIS; CYTOCHROME-C-OXIDASE; PSEUDOMONAS-AERUGINOSA
   AZURIN; CRYSTAL-STRUCTURE ANALYSIS; BOND MEDIATED RECOGNITION; TRANSFER
   COMPLEX; ACTIVE-SITES; THIOBACILLUS-FERROOXIDANS;
   PARACOCCUS-DENITRIFICANS; NATRONOBACTERIUM-PHARAONIS
AB Blue Copper Proteins (BCPs) are small and generally soluble copper-containing proteins which participate in monoelectron transfer processes in biological systems. An overview of their electronic and tertiary structure is detailed here. The well-established entatic/rack-induced mechanism is explained by comparing thermodynamic parameters between the folded (tense) and the unfolded (relaxed) forms of the BCP rusticyanin.
   Recently, NMR solution data have shown that the active sites of BCPs in absence of the metal ion, i.e. in the apoforms, are flexible in the micro-to-second timescale. The rigidity proposed by the entatic/rack-induced mechanism is an imperative for the holoprotein to perform electron transfer; while the flexibility of the apocupredoxin is necessary to uptake the metal ion from the metallochaperones. These apparently contradictory requirements are discussed in the present work. Finally, the role of azurin and some peptides derived from it in anticancer therapy are also described. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Alejo Perez-Henarejos, Sergio; Donaire, Antonio] Univ Murcia, Fac Chem, Dept Inorgan Chem, Murcia 30100, Spain.
   [Alcaraz, Luis A.] Bioarray SL, Alicante 03202, Spain.
RP Donaire, A (reprint author), Univ Murcia, Fac Chem, Dept Inorgan Chem, Campus Univ Espinardo, Murcia 30100, Spain.
EM adonaire@um.es
FU Spanish Ministerio de Economia y Competitividad; FEDER [SAF2011-26611];
   Fundacion Seneca de la Region de Murcia [15354/PI/10]; Spanish
   Ministerio de Economia y Competitividad, Programme Torres Quevedo
   [PTQ-11-04960]
FX d This work has been financially supported by the Spanish Ministerio de
   Economia y Competitividad and FEDER (Project SAF2011-26611) and the
   Fundacion Seneca de la Region de Murcia (Project 15354/PI/10). L.A.A.
   also acknowledges the Spanish Ministerio de Economia y Competitividad,
   Programme Torres Quevedo, for a grant (PTQ-11-04960).
CR Alcaraz LA, 2007, BIOINORG CHEM APPL, DOI 10.1155/2007/54232
   de Romana DL, 2011, J TRACE ELEM MED BIO, V25, P3, DOI 10.1016/j.jtemb.2010.11.004
   Yamanaka T, 1995, FEMS MICROBIOL REV, V17, P401
   Spreckelmeyer S, 2014, MOLECULES, V19, P15584, DOI 10.3390/molecules191015584
   MARGALIT R, 1984, P NATL ACAD SCI USA, V81, P6554, DOI 10.1073/pnas.81.20.6554
   Hall JF, 1999, BIOCHEMISTRY-US, V38, P12675, DOI 10.1021/bi990983g
   Scharf B, 1997, BIOCHEMISTRY-US, V36, P4471, DOI 10.1021/bi962312d
   Kachalova GS, 2012, J INORG BIOCHEM, V115, P174, DOI 10.1016/j.jinorgbio.2012.07.015
   Ubbink M, 1998, STRUCTURE, V6, P323, DOI 10.1016/S0969-2126(98)00035-5
   VILA AJ, 1994, FEBS LETT, V355, P15, DOI 10.1016/0014-5793(94)01141-9
   Winkler JR, 1997, P NATL ACAD SCI USA, V94, P4246, DOI 10.1073/pnas.94.9.4246
   Lange C, 2005, BBA-BIOENERGETICS, V1707, P179, DOI 10.1016/j.bbabio.2004.12.002
   Yamada T, 2005, CELL MICROBIOL, V7, P1418, DOI 10.1111/j.1462-5822.2005.00567.x
   Yamada T, 2004, P NATL ACAD SCI USA, V101, P4770, DOI 10.1073/pnas.0400899101
   Jimenez B, 2003, BIOCHEMISTRY-US, V42, P10396, DOI 10.1021/bi034692q
   Clark KM, 2010, J AM CHEM SOC, V132, P10093, DOI 10.1021/ja102632p
   Crichton RR, 2001, BIOMETALS, V14, P99, DOI 10.1023/A:1016710810701
   Abriata LA, 2014, J BIOL INORG CHEM, V19, P565, DOI 10.1007/s00775-014-1108-7
   Yamada T, 2013, BRIT J CANCER, V108, P2495, DOI 10.1038/bjc.2013.266
   Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677
   CHO KC, 1984, BIOCHEMISTRY-US, V23, P1858, DOI 10.1021/bi00303a042
   NAR H, 1992, FEBS LETT, V306, P119, DOI 10.1016/0014-5793(92)80981-L
   VALLEE BL, 1968, P NATL ACAD SCI USA, V59, P498, DOI 10.1073/pnas.59.2.498
   Papa S, 1998, BIOCHIMIE, V80, P821, DOI 10.1016/S0300-9084(00)88877-X
   Buning C, 2000, J AM CHEM SOC, V122, P204, DOI 10.1021/ja992796b
   REGAN JJ, 1995, CHEM BIOL, V2, P489, DOI 10.1016/1074-5521(95)90266-X
   Marks J, 2004, J BIOL INORG CHEM, V9, P281, DOI 10.1007/s00775-004-0523-6
   Choi M, 2011, METALLOMICS, V3, P140, DOI 10.1039/c0mt00061b
   Pearson IV, 2003, J BACTERIOL, V185, P6308, DOI 10.1128/JB.185.21.6308-6315.2003
   Jeuken LJC, 2000, J MOL BIOL, V299, P737, DOI 10.1006/jmbi.2000.3754
   Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110
   Randall DW, 2000, J BIOL INORG CHEM, V5, P16
   Brown K, 2000, J BIOL CHEM, V275, P41133, DOI 10.1074/jbc.M008617200
   CHEN LY, 1994, SCIENCE, V264, P86, DOI 10.1126/science.8140419
   Diaz-Moreno I, 2005, J BIOL CHEM, V280, P18908, DOI 10.1074/jbc.M413298200
   Alcaraz LA, 2005, FEBS LETT, V579, P5223, DOI 10.1016/j.febslet.2005.08.048
   Molina-Heredia FP, 2003, NATURE, V424, P33, DOI 10.1038/424033b
   Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100
   Einsle O, 2000, J BIOL INORG CHEM, V5, P666, DOI 10.1007/s007750000154
   Yanagisawa S, 2003, J AM CHEM SOC, V125, P4974, DOI 10.1021/ja0345827
   SHEPARD WEB, 1993, ACTA CRYSTALLOGR D, V49, P331, DOI 10.1107/S0907444992013544
   Gast P, 2014, J INORG BIOCHEM, V137, P57, DOI 10.1016/j.jinorgbio.2014.03.016
   Mukhopadhyay BP, 2008, J BIOMOL STRUCT DYN, V25, P543
   Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532
   Chan S, 1998, CLIN LAB MED, V18, P673
   Bernardes N, 2013, APPL MICROBIOL BIOT, V97, P5189, DOI 10.1007/s00253-013-4926-6
   Hart PJ, 1996, PROTEIN SCI, V5, P2175
   GARRETT TPJ, 1984, J BIOL CHEM, V259, P2822
   Hay M, 1996, P NATL ACAD SCI USA, V93, P461, DOI 10.1073/pnas.93.1.461
   Warren JJ, 2012, J INORG BIOCHEM, V115, P119, DOI 10.1016/j.jinorgbio.2012.05.002
   Hope AB, 2000, BBA-BIOENERGETICS, V1456, P5, DOI 10.1016/S0005-2728(99)00101-2
   Battistuzzi G, 2005, BIOCHEMISTRY-US, V44, P9944, DOI 10.1021/bi050261r
   Kanbi LD, 2002, J MOL BIOL, V320, P263, DOI 10.1016/S0022-2836(02)00443-6
   Dell'Acqua S, 2011, J BIOL INORG CHEM, V16, P1241, DOI 10.1007/s00775-011-0812-9
   Jones SM, 2015, CELL MOL LIFE SCI, V72, P869, DOI 10.1007/s00018-014-1826-6
   NAR H, 1991, J MOL BIOL, V221, P765, DOI 10.1016/0022-2836(91)80173-R
   Sukumar N, 2006, BIOCHEMISTRY-US, V45, P13500, DOI 10.1021/bi0612972
   Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011
   MALMSTROM BG, 1994, EUR J BIOCHEM, V223, P711, DOI 10.1111/j.1432-1033.1994.tb19044.x
   PETRATOS K, 1995, FEBS LETT, V368, P432, DOI 10.1016/0014-5793(95)00705-E
   Farver O, 2013, P NATL ACAD SCI USA, V110, P10536, DOI 10.1073/pnas.1215081110
   Milardi D, 2003, ARCH BIOCHEM BIOPHYS, V414, P121, DOI 10.1016/S0003-9861(03)00167-X
   FARAGGI M, 1971, BIOCHEM BIOPH RES CO, V45, P842, DOI 10.1016/0006-291X(71)90415-3
   Donaire A, 2001, BIOCHEMISTRY-US, V40, P837, DOI 10.1021/bi001971u
   Cutruzzola F, 2002, J INORG BIOCHEM, V88, P353, DOI 10.1016/S0162-0134(01)00390-7
   Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a
   Yellol GS, 2013, CHEM COMMUN, V49, P11533, DOI 10.1039/c3cc46239k
   Gorelsky SI, 2006, J AM CHEM SOC, V128, P16452, DOI 10.1021/ja067583i
   Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797
   Neese F, 1996, J AM CHEM SOC, V118, P8692, DOI 10.1021/ja960125x
   Pearson AR, 2007, J SYNCHROTRON RADIAT, V14, P92, DOI 10.1107/S0909049506051259
   Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539
   Ryde U, 2000, J BIOL INORG CHEM, V5, P565, DOI 10.1007/s007750000147
   Palm-Espling ME, 2012, BBA-MOL CELL RES, V1823, P1594, DOI 10.1016/j.bbamcr.2012.01.013
   Hall JF, 1998, BIOCHEMISTRY-US, V37, P11451, DOI 10.1021/bi980960m
   Solomon EI, 2008, CHEM SOC REV, V37, P623, DOI 10.1039/b714577m
   King JD, 2014, ARCH BIOCHEM BIOPHYS, V564, P237, DOI 10.1016/j.abb.2014.10.003
   Nersissian AM, 1998, PROTEIN SCI, V7, P1915
   Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200
   Chaudhari A, 2007, BIOCHEMISTRY-US, V46, P1799, DOI 10.1021/bi061661x
   DURLEY R, 1993, PROTEIN SCI, V2, P739
   Diederix REM, 2000, BIOCHEMISTRY-US, V39, P9551, DOI 10.1021/bi000648o
   Donaire A, 2002, J AM CHEM SOC, V124, P13698, DOI 10.1021/ja0267019
   MARCUS RA, 1965, J CHEM PHYS, V43, P2654, DOI 10.1063/1.1697190
   Lancaster KM, 2009, NAT CHEM, V1, P711, DOI [10.1038/nchem.412, 10.1038/NCHEM.412]
   Gray HB, 2000, J BIOL INORG CHEM, V5, P551, DOI 10.1007/s007750000146
   Bernardes N, 2014, INT J BIOCHEM CELL B, V50, P1, DOI 10.1016/j.biocel.2014.01.023
   BLAKE RC, 1994, BIOCHEMISTRY-US, V33, P9220, DOI 10.1021/bi00197a025
   WHERLAND S, 1975, J AM CHEM SOC, V97, P5260, DOI 10.1021/ja00851a040
   Chaudhari A, 2006, CELL CYCLE, V5, P1642, DOI 10.4161/cc.5.15.2992
   Basumallick L, 2005, J AM CHEM SOC, V127, P3531, DOI 10.1021/ja044412+
   Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388
   LANGEN R, 1995, SCIENCE, V268, P1733, DOI 10.1126/science.7792598
   Amouric A, 2011, MICROBIOL-SGM, V157, P111, DOI 10.1099/mic.0.044537-0
   Zaballa ME, 2012, P NATL ACAD SCI USA, V109, P9254, DOI 10.1073/pnas.1119460109
   Remenyi R, 2001, J BIOL INORG CHEM, V6, P23, DOI 10.1007/s007750000178
   DENBLAAUWEN T, 1993, BIOCHEMISTRY-US, V32, P12455, DOI 10.1021/bi00097a025
   Alcaraz LA, 2005, PROTEIN SCI, V14, P1710, DOI 10.1110/ps.051337505
   DiBilio AJ, 1997, J AM CHEM SOC, V119, P9921, DOI 10.1021/ja971518e
   Solomon EI, 1996, INORG CHIM ACTA, V243, P67, DOI 10.1016/0020-1693(95)04893-6
   Ryde U, 1996, J MOL BIOL, V261, P586, DOI 10.1006/jmbi.1996.0484
   Grossmann JG, 2002, BIOCHEMISTRY-US, V41, P3613, DOI 10.1021/bi015955o
   Bertini I, 2000, J AM CHEM SOC, V122, P3701, DOI 10.1021/ja992674j
   Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t
   Sun DP, 2005, BIOCHEMISTRY-US, V44, P7200, DOI 10.1021/bi050288a
   GROSS EL, 1993, PHOTOSYNTH RES, V37, P103, DOI 10.1007/BF02187469
   Szilagyi RK, 2002, CURR OPIN CHEM BIOL, V6, P250, DOI 10.1016/S1367-5931(02)00304-6
   ROMERO A, 1993, J MOL BIOL, V229, P1007, DOI 10.1006/jmbi.1993.1101
   Warren JJ, 2012, COORDIN CHEM REV, V256, P2478, DOI 10.1016/j.ccr.2012.03.032
   Romero C, 1998, FEBS LETT, V440, P93, DOI 10.1016/S0014-5793(98)01438-0
   GOLDBERG M, 1975, ISRAEL J MED SCI, V11, P1182
   Libeu CAP, 1997, BIOCHEMISTRY-US, V36, P13160, DOI 10.1021/bi9704111
   Cruz-Gallardo I, 2013, J BIOL CHEM, V288, P20896, DOI 10.1074/jbc.M113.460162
   SCHARF B, 1993, BIOCHEMISTRY-US, V32, P12894, DOI 10.1021/bi00210a043
   Pozdnyakova I, 2001, J AM CHEM SOC, V123, P10135, DOI 10.1021/ja016252x
   Giudici-Orticoni MT, 1999, J BIOL CHEM, V274, P30365, DOI 10.1074/jbc.274.43.30365
   Marshall NM, 2009, NATURE, V462, P113, DOI 10.1038/nature08551
   Miotto MC, 2014, INORG CHEM, V53, P4350, DOI 10.1021/ic4031377
   Machczynski MC, 2002, J INORG BIOCHEM, V88, P375, DOI 10.1016/S0162-0134(02)00364-1
   Brown DR, 1997, NATURE, V390, P684
   Taylor BN, 2009, CANCER RES, V69, P537, DOI 10.1158/0008-5472.CAN-08-2932
   Yamada T, 2009, MOL CANCER THER, V8, P2947, DOI 10.1158/1535-7163.MCT-09-0444
   Lieberman RL, 2001, BIOCHEMISTRY-US, V40, P5674, DOI 10.1021/bi0102611
   Alama A, 2009, DRUG DISCOV TODAY, V14, P500, DOI 10.1016/j.drudis.2009.02.002
   Dennison C, 2008, NAT PROD REP, V25, P15, DOI 10.1039/b707987g
   Fedorova M, 2002, PLANT PHYSIOL, V130, P519, DOI 10.1104/pp.006833
   MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X
   Yang HX, 2015, BBA-BIOENERGETICS, V1847, P838, DOI 10.1016/j.bbabio.2014.12.011
   Feio MJ, 2006, BIOCHEMISTRY-US, V45, P4900, DOI 10.1021/bi052312q
   Li C, 2011, INORG CHEM, V50, P482, DOI 10.1021/ic101413e
   Ramirez BE, 1995, P NATL ACAD SCI USA, V92, P11949, DOI 10.1073/pnas.92.26.11949
   Yamada T, 2004, CELL CYCLE, V3, P1182
   Xia ZX, 2003, J BIOL INORG CHEM, V8, P843, DOI 10.1007/s00775-003-0485-0
   Dell'Acqua S, 2011, J BIOL INORG CHEM, V16, P183, DOI 10.1007/s00775-011-0753-3
   Fialho AM, 2007, RECENT PAT ANTI-CANC, V2, P224, DOI 10.2174/157489207782497163
   Blaby-Haas CE, 2014, P NATL ACAD SCI USA, V111, pE5480, DOI 10.1073/pnas.1421545111
   Olsson MHM, 2003, J AM CHEM SOC, V125, P5025, DOI 10.1021/ja0212157
   Mehta RR, 2011, ANGIOGENESIS, V14, P355, DOI 10.1007/s10456-011-9220-6
   Mukhopadhyay BP, 2007, J BIOMOL STRUCT DYN, V25, P157
   Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073
   Barrett ML, 2006, BIOCHEMISTRY-US, V45, P2927, DOI 10.1021/bi052372w
   Chakrabarty AM, 2014, ADV EXP MED BIOL, V808, P41, DOI 10.1007/978-81-322-1774-9_4
   Dde O. Silva, 2010, ANTI-CANCER AGENT ME, V10, P312
   Einarsdottir O, 2015, BBA-BIOENERGETICS, V1847, P109, DOI [10.1016/j.bbabio.2014.06.008, 10.1016/j.ibbabio.2014.06.008]
   Gaetke LM, 2014, ARCH TOXICOL, V88, P1929, DOI 10.1007/s00204-014-1355-y
   Gray H. B., 1981, COPPER PROTEINS, P1
   Guckert G. A., 1995, J AM CHEM SOC, V117, P2817
   Hadt RG, 2014, J AM CHEM SOC, V136, P15034, DOI 10.1021/ja508361h
   Kaintz Cornelia, 2014, Adv Protein Chem Struct Biol, V97, P1, DOI 10.1016/bs.apcsb.2014.07.001
   Leone A., 1999, MOL CELLULAR ASPECTS, V448
   Machonkin TE, 1998, BIOCHEMISTRY-US, V37, P9570, DOI 10.1021/bi980434v
   MacPherson IS, 2007, CELL MOL LIFE SCI, V64, P2887, DOI 10.1007/s00018-007-7310-9
   MALMSTRO.BG, 1965, Z NAT WISS-MED GRUND, V2, P259
   Montes S, 2014, OXID MED CELL LONGEV, DOI 10.1155/2014/147251
   Nersissian AM, 2002, ADV PROTEIN CHEM, V60, P271
   Patil Mallikarjun, 2013, J Clin Exp Hepatol, V3, P321, DOI 10.1016/j.jceh.2013.06.002
   Riordan J F, 1974, Adv Exp Med Biol, V48, P33
   Tang KH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-334
   Tiefenbrunn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022348
   Wittung-Stafshede P, 1998, BBA-PROTEIN STRUCT M, V1388, P437, DOI 10.1016/S0167-4838(98)00205-2
   Yamada T., 2011, J CLIN ONCOL, V29
NR 161
TC 0
Z9 0
U1 19
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2015
VL 584
BP 134
EP 148
DI 10.1016/j.abb.2015.08.020
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CS8BQ
UT WOS:000362311100016
PM 26334718
ER

PT J
AU Li, MS
   Deguchi, T
   Nareoja, T
   Jena, BP
   Hanninen, P
   Larsson, L
AF Li, Meishan
   Deguchi, Takahiro
   Nareoja, Tuomas
   Jena, Bhanu P.
   Hanninen, Pekka
   Larsson, Lars
TI Nanometric features of myosin filaments extracted from a single muscle
   fiber to uncover the mechanisms underlying organized motility
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Myosin filament; Single fiber; In vitro motility assay; Transmission
   electron microscopy; Atomic force microscopy
ID ATOMIC-FORCE MICROSCOPY; MOLECULE
AB The single muscle fiber in vitro motility assay (SF-IVMA) is characterized by organized linear motility of actin filaments, i.e., actin filaments motility showing a parallel or anti-parallel direction with similar speed independent of direction in the central part of the flow-cell where density of myosin is high. In contrast, the low myosin density region in the flow-cell exhibits random filament movements, but the mechanisms underlying the organized motility remain unknown. Transmission electron microscopy (TEM) and atomic force microscopy (AFM) imaging techniques have been combined to investigate the morphological features of myosin extracted from single muscle fiber segments in the flow cell. Nanometric scale imaging of myosin filaments in the SF-IVMA showed intact spatial distances between myosin heads being essential for myosin filament function. However, angular spectrum analyses of myosin filaments in the high myosin density region showed organized myosin filament orientation only in small areas, while unorganized filament orientation were dominantly presented when larger areas were analyzed. Thus, parallel myosin filament organization is a less likely mechanism underlying the organized motility of actin filaments and the high myosin density per se is therefore forwarded as the primary "driver" that promotes organized linear motility. (C) 2015 Published by Elsevier Inc.
C1 [Li, Meishan; Larsson, Lars] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden.
   [Li, Meishan; Larsson, Lars] Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden.
   [Deguchi, Takahiro; Nareoja, Tuomas; Hanninen, Pekka] Univ Turku, Biophys Lab, FI-20520 Turku, Finland.
   [Deguchi, Takahiro; Nareoja, Tuomas; Hanninen, Pekka] Univ Turku, Med Res Lab, FI-20520 Turku, Finland.
   [Jena, Bhanu P.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA.
RP Larsson, L (reprint author), Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden.
EM lars.larssoon@ki.se
RI Nareoja, Tuomas/K-3800-2014
OI Nareoja, Tuomas/0000-0002-2174-4434
FU Academy of Finland [126998]; Swedish Research Council [8651]; Swedish
   Foundation for International Cooperation in Research and Higher
   Education (STINT); King Gustaf V and Queen Victoria's Foundation
FX We are grateful to Prof. Alf Mansson for comments on the manuscript, to
   Jan Saras and Marianne Ljungkvist for the technical support in the TEM
   imaging, and to Turku BioImaging for AFM imaging. This study was
   supported by Grants from Academy of Finland (project #126998) to T.N.
   and P.H., the Swedish Research Council (8651), the Swedish Foundation
   for International Cooperation in Research and Higher Education (STINT)
   and King Gustaf V and Queen Victoria's Foundation to L.L.
CR Hook P, 1999, J PHYSIOL-LONDON, V520, P463, DOI 10.1111/j.1469-7793.1999.00463.x
   ELLIOTT A, 1978, J MOL BIOL, V123, P505, DOI 10.1016/0022-2836(78)90204-8
   HANSMA HG, 1994, ANNU REV BIOPH BIOM, V23, P115, DOI 10.1146/annurev.bb.23.060194.000555
   Iwasaki T, 2005, J AGR FOOD CHEM, V53, P4589, DOI 10.1021/jf0500381
   Asakawa H, 2011, BIOPHYS J, V101, P1270, DOI 10.1016/j.bpj.2011.07.020
   Schneider SW, 1997, P NATL ACAD SCI USA, V94, P316, DOI 10.1073/pnas.94.1.316
   Butt T, 2010, J BIOL CHEM, V285, P4964, DOI 10.1074/jbc.M109.044792
   Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006
   Jin SE, 2010, MICROSC RES TECHNIQ, V73, P813, DOI 10.1002/jemt.20847
   CHOWRASHI PK, 1986, J MUSCLE RES CELL M, V7, P413, DOI 10.1007/BF01753584
   Hook P, 2000, J MUSCLE RES CELL M, V21, P357, DOI 10.1023/A:1005614212575
   Schaller V, 2010, NATURE, V467, P73, DOI 10.1038/nature09312
   Frontera WR, 1997, MUSCLE NERVE, V20, P948, DOI 10.1002/(SICI)1097-4598(199708)20:8<948::AID-MUS3>3.0.CO;2-6
   HALLETT P, 1995, BIOPHYS J, V68, P1604
   Ramamurthy B, 2001, FASEB J, V15, P2415, DOI 10.1096/fj.01-0183com
   Yamada T, 2003, ADV EXP MED BIOL, V538, P285
   Li MS, 2010, J PHYSIOL-LONDON, V588, P5105, DOI 10.1113/jphysiol.2010.199067
   Mammadov R, 2012, MICRON, V43, P69, DOI 10.1016/j.micron.2011.07.006
   Cho SJ, 2002, BIOPHYS J, V83, P2522
   Li MS, 2015, AGING CELL, V14, P228, DOI 10.1111/acel.12307
NR 20
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 1
EP 8
DI 10.1016/j.abb.2015.06.010
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400001
PM 26116379
ER

PT J
AU Rai, AK
   Kundu, N
   Chattopadhyay, K
AF Rai, Anand Kumar
   Kundu, Nidhi
   Chattopadhyay, Kausik
TI Physicochemical constraints of elevated pH affect efficient membrane
   interaction and arrest an abortive membrane-bound oligomeric
   intermediate of the beta-barrel pore-forming toxin Vibrio cholerae
   cytolysin
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Bacterial toxin; Protein assembly; Protein structure; Vibrio cholerae
   cytolysin; Pore-forming toxin; Oligomerization
ID FORMATION-MECHANISM; CRYSTAL-STRUCTURE; TOR HEMOLYSIN; PROTEINS;
   ERYTHROCYTE; RECOGNIZES; BINDING; DOMAIN; MODE
AB Vibrio cholerae cytolysin (vcc) is a potent membrane-damaging cytotoxic protein. VCC causes permeabilization of the target cell membranes by forming transmembrane oligomeric beta-barrel pores. Membrane pore formation by VCC involves following key steps: (i) membrane binding, (ii) formation of a pre-pore oligomeric intermediate, (iii) membrane insertion of the pore-forming motifs, and (iv) formation of the functional transmembrane pore. Membrane binding, oligomerization, and subsequent pore-formation process of VCC appear to be facilitated by multiple regulatory mechanisms that are only partly understood. Here, we have explored the role(s) of the physicochemical constraints, specifically imposed by the elevated pH conditions, on the membrane pore-formation mechanism of VCC. Elevated pH abrogates efficient interaction of VCC with the target membranes, and blocks its pore-forming activity. Under the elevated pH conditions, membrane-bound fractions of VCC remain trapped in the form of abortive oligomeric species that fail to generate the functional transmembrane pores. Such an abortive oligomeric assembly appears to represent a distinct, more advanced intermediate state than the pre-pore state. The present study offers critical insights regarding the implications of the physicochemical constraints for regulating the efficient membrane interaction and pore formation by VCC. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Rai, Anand Kumar; Kundu, Nidhi; Chattopadhyay, Kausik] Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Ctr Prot Sci Design & Engn, Mohali 140306, Punjab, India.
RP Chattopadhyay, K (reprint author), Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Ctr Prot Sci Design & Engn, Sect 81, Mohali 140306, Punjab, India.
EM kausik@iisermohali.ac.in
RI Chattopadhyay, Kausik/H-5044-2015
OI Chattopadhyay, Kausik/0000-0001-8529-9475
FU Department of Biotechnology (DBT), India (DBT)
   [BT/PR13350/BRB/10/751/2009]; Centre of Excellence (COE) in Frontier
   Areas of Science and Technology (FAST) program of the Ministry of Human
   Resource Development, Govt. of India; Department of Science and
   Technology (DST), India; IISER Mohali
FX This work was supported by a grant from the Department of Biotechnology
   (DBT), India (DBT Grant No. BT/PR13350/BRB/10/751/2009) (to K. C.), and
   also through funding under the Centre of Excellence (COE) in Frontier
   Areas of Science and Technology (FAST) program of the Ministry of Human
   Resource Development, Govt. of India, in the area of protein science,
   design and engineering (to K. C.). We acknowledge Department of Science
   and Technology (DST), India for the INSPIRE Junior Research Fellowship
   (to N. K.). We also thank IISER Mohali for financial support.
CR Alouf J. E., 2006, COMPREHENSIVE SOURCE
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48
   Zitzer A, 2001, J BIOL CHEM, V276, P14628, DOI 10.1074/jbc.M100241200
   Zhang DY, 1999, INFECT IMMUN, V67, P5332
   Paul K, 2012, FEBS J, V279, P4039, DOI 10.1111/j.1742-4658.2012.08809.x
   Levan S, 2013, J MOL BIOL, V425, P944, DOI 10.1016/j.jmb.2012.12.016
   Chattopadhyay K, 2003, J BIOL CHEM, V278, P38470, DOI 10.1074/jbc.M305965200
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x
   Rai AK, 2013, J BIOL CHEM, V288, P1665, DOI 10.1074/jbc.M112.430181
   Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394
   Mazumdar B, 2011, INDIAN J MED RES, V133, P131
   [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760
   Ikigai H, 1997, FEMS MICROBIOL LETT, V150, P249, DOI 10.1016/S0378-1097(97)00122-5
   De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108
   ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090
   Lohner S, 2009, FASEB J, V23, P2521, DOI 10.1096/fj.08-127688
   Schuck P, 2002, BIOPHYS J, V82, P1096
   ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788
   Rai AK, 2014, J BIOL CHEM, V289, P16978, DOI 10.1074/jbc.M114.567099
   Chattopadhyay K, 2002, EUR J BIOCHEM, V269, P4351, DOI 10.1046/j.1432-1033.2002.03137.x
   Saha N, 1997, J BIOL CHEM, V272, P162, DOI 10.1074/jbc.272.1.162
   Paul K, 2011, BIOCHEMISTRY-US, V50, P3936, DOI 10.1021/bi200332g
   Paul K, 2014, BIOCHEM BIOPH RES CO, V443, P189, DOI 10.1016/j.bbrc.2013.11.078
   Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045
   Zitzer A, 1997, INFECT IMMUN, V65, P1293
   BORDIER C, 1981, J BIOL CHEM, V256, P1604
   Khilwani B, 2015, BIOCHEM J, V466, P147, DOI 10.1042/BJ20140718
   Rai AK, 2015, ADV EXP MED BIOL, V842, P109, DOI 10.1007/978-3-319-11280-0_7
NR 30
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 9
EP 17
DI 10.1016/j.abb.2015.07.019
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400002
PM 26235489
ER

PT J
AU Mahdi, SHA
   Cheng, HY
   Li, JF
   Feng, RQ
AF Mahdi, Shah H. A.
   Cheng, Huanyi
   Li, Jinfeng
   Feng, Renqing
TI The effect of TGF-beta-induced epithelial mesenchymal transition on the
   expression of intracellular calcium-handling proteins in T47D and MCF-7
   human breast cancer cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Breast cancer; TGF-beta; EMT; Calcium channel; Calcium pump; NCX
ID GENE-EXPRESSION; DOWN-REGULATION; E-CADHERIN; CA2+; CHANNELS; PUMPS;
   CARCINOMA; UNIPORTER; INVASION; STORE
AB The contribution of Ca2+ in TGE-beta-induced EMT is poorly understood. We aimed to confirm the effect of TGF-beta on the gene expression of intracellular calcium-handling proteins and to investigate the potential underlying mechanisms in TGF-beta-induced EMT. T47D and MCF-7 cells were cultured in vitro and treated with TGF-beta. The mRNA expression of EMT marker genes and intracellular calcium-handling proteins were quantified by qRT-PCR. qRT-PCR and Western blot analysis results verified the changes of EMT marker gene expression. Furthermore, we found that TGF-beta induced cell morphological changes significantly with an increase of cell surface area and cell length. These results indicated that TGF-beta induced EMT. The mRNA expression levels of SPCA1, SPCA2 and MCU were not influenced by TGF-beta treatment, while NCX1 expression was decreased in T47D cells. In addition, the mRNA levels of SERCAs and IP(3)Rs were significantly changed due to TGE-beta-induced EMT. The TGF-beta-treated T47D cells exhibited markedly greater response to ATP than the control cells, and the descent velocity of cytosolic calcium concentration was faster in TGF-beta-treated cells than in control cells. This is the first report to demonstrate that TGF-beta-induced EMT in human breast cancer cells is associated with alterations in endoplasmic reticulum calcium homeostasis. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Mahdi, Shah H. A.; Cheng, Huanyi; Feng, Renqing] Peking Univ, Coll Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.
   [Mahdi, Shah H. A.] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.
   [Li, Jinfeng] Peking Univ, Canc Hosp & Inst, Minist Educ, Breast Canc Ctr,Key Lab Carcinogenesis & Translat, Beijing 100142, Peoples R China.
RP Feng, RQ (reprint author), Peking Univ, Coll Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.
EM rqfeng@pku.edu.cn
FU National Natural Science Foundation of China [81272379]; Seeding Grant
   for Medicine and Life Sciences of Peking University [2014-MB-26]
FX We thank Professor Shiqiang Wang (College of Life Sciences, Peking
   University) for guidance in accomplishing this work and Dr. John M.
   Olson (College of Life Sciences, Peking University) for revision of our
   manuscript. SHAM is grateful to the University of Rajshahi, Bangladesh
   for providing his leave to carry out the research. This work is
   supported by the grant from the National Natural Science Foundation of
   China (No. 81272379), and is partially supported by the Seeding Grant
   for Medicine and Life Sciences of Peking University (No. 2014-MB-26).
CR Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055
   Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234
   Vassort G, 2001, PHYSIOL REV, V81, P767
   Robson EJD, 2006, DIFFERENTIATION, V74, P254, DOI 10.1111/j.1432-0436.2006.00075.x
   Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061
   Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107
   Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434
   Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136
   Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620
   Pacifico F, 2003, J MOL ENDOCRINOL, V30, P399, DOI 10.1677/jme.0.0300399
   Grice DM, 2010, J BIOL CHEM, V285, P37458, DOI 10.1074/jbc.M110.163329
   Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455
   Wuytack F, 2003, PFLUG ARCH EUR J PHY, V446, P148, DOI 10.1007/s00424-003-1011-5
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835
   Marchi S, 2013, CURR BIOL, V23, P58, DOI 10.1016/j.cub.2012.11.026
   Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105
   Arbabian A, 2013, FEBS J, V280, P5408, DOI 10.1111/febs.12064
   Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X
   Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118
   Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639
   Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006
   Liu XA, 2010, ACTA BIOCH BIOPH SIN, V42, P496, DOI 10.1093/abbs/gmq043
   Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374
   Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147
   Castaldo P, 2009, PROG NEUROBIOL, V87, P58, DOI 10.1016/j.pneurobio.2008.09.017
   Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122
   Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025
   Dai M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3441
   Davis FM, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-76
   Davis FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036923
   Krizanova O., 2014, GEN PHYSL BIOPHYS, V33, P137
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
NR 33
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 18
EP 26
DI 10.1016/j.abb.2015.07.008
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400003
PM 26247838
ER

PT J
AU Trevino, S
   Waalkes, MP
   Hernandez, JAF
   Leon-Chavez, BA
   Aguilar-Alonso, P
   Brambila, E
AF Trevino, Samuel
   Waalkes, Michael P.
   Flores Hernandez, Jose Angel
   Alicia Leon-Chavez, Bertha
   Aguilar-Alonso, Patricia
   Brambila, Eduardo
TI Chronic cadmium exposure in rats produces pancreatic impairment and
   insulin resistance in multiple peripheral tissues
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cadmium; Hyperglycemia; Hyperinsulinemia; Insulin resistance; Insulin
   sensitivity; Insulin indexes
ID BETA-CELL FUNCTION; MAGNETIC-RESONANCE-SPECTROSCOPY; HEPATIC
   GLUCOSE-PRODUCTION; TYPE-2 DIABETES-MELLITUS; LOW-DENSITY-LIPOPROTEIN;
   FATTY LIVER-DISEASE; FASTING GLUCOSE; CARDIOVASCULAR-DISEASE;
   GLUCONEOGENIC ENZYMES; ATHEROGENIC INDEX
AB Previous studies have linked cadmium exposure to disturbances in carbohydrate and lipid metabolism. In this study we investigate the effects in Wistar rats of an oral cadmium exposure in drinking water on carbohydrates, lipids and insulin release. Also, using mathematical models we studied the effect of cadmium on insulin resistance and sensitivity in liver, muscle, adipose and cardiovascular tissue. Cadmium exposure induced hyperglycemia, increased insulin release after a glucose load, and caused increases in serum triglycerides, cholesterol, LDL-C and VLDL-C, and a decrease of HDL-C. In addition, there was an accumulation of cadmium in pancreas and an increase of insulin. After exposure, HOMA-IR was increased, while the HOMA-5%, QUICKI and Matsuda-DeFronzo indexes showed decreases. A decrease of insulin sensitivity was shown in muscle and liver. Additionally, cadmium increases insulin resistance in the liver, adipose tissue and cardiovascular system. Finally, beta-cell functioning was evaluated by HOMA-B% index and insulin disposition index, which were decreased, while insulin generation index increased. In conclusion, cadmium increases insulin release, induces hyperglycemia and alters lipid metabolism. These changes likely occur as a consequence of reduced sensitivity and increased insulin resistance in multiple insulin-dependent and non-dependent tissues, producing a biochemical phenotype similar to metabolic syndrome and diabetes. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Trevino, Samuel; Alicia Leon-Chavez, Bertha; Aguilar-Alonso, Patricia; Brambila, Eduardo] Benemerita Univ Autonoma Puebla, Fac Ciencias Quim, Lab Invest Quim Clin, Puebla, Mexico.
   [Waalkes, Michael P.] NIEHS, Stem Cell Toxicol Grp, Natl Toxicol Program Lab, Div Natl Toxicol Program,NIH, Res Triangle Pk, NC 27709 USA.
   [Flores Hernandez, Jose Angel] Benemerita Univ Autonoma Puebla, Fac Ciencias Quim, Dept Anal Clin, Puebla, Mexico.
RP Brambila, E (reprint author), 14 Sur Esq Av San Claudio,Edif CQ1,Ciudad Univ, Puebla 72570, Pue, Mexico.
EM eduardobrambilal@yahoo.com.mx
FU VIEP, BUAP [BRME-NAT143-G]; CONACYT [297337]
FX This work was supported by the grant BRME-NAT143-G from VIEP, BUAP and
   Samuel Tevino Mora was recipient of a scholarship (297337) from CONACYT.
   We thanks Dr. Carlos Escamilla W. (Bioterio Calude Bernard, BUAP) for
   his assistance and the donation of the animals used in this work.
CR GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84
   Schwartz GG, 2003, DIABETES CARE, V26, P468, DOI 10.2337/diacare.26.2.468
   BRATUSCHMARRAIN PR, 1986, DIABETES, V35, P922, DOI 10.2337/diabetes.35.8.922
   WARNICK GR, 1990, CLIN CHEM, V36, P15
   Edwards JR, 2009, TOXICOL APPL PHARM, V238, P289, DOI 10.1016/j.taap.2009.03.007
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020
   DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013
   Schafer A, 2004, CIRCULATION, V109, P1819, DOI 10.1161/01.CIR.0000126837.88743.DD
   RIZZA RA, 1985, DIABETOLOGIA, V28, P70
   CHAPATWALA KD, 1982, TOXICOL LETT, V12, P27, DOI 10.1016/0378-4274(82)90194-1
   Bernard A, 2004, BIOMETALS, V17, P519, DOI 10.1023/B:BIOM.0000045731.75602.b9
   Tan MH, 2004, CLIN CHEM, V50, P1184, DOI 10.1373/clinchem.2004.031757
   Prabu SM, 2013, EUR REV MED PHARMACO, V17, P582
   Staessen JA, 1999, LANCET, V353, P1140, DOI 10.1016/S0140-6736(98)09356-8
   ROGERS P, 1980, BRIT J NUTR, V43, P83, DOI 10.1079/BJN19800066
   Olisekodiaka MJ, 2012, MED PRIN PRACT, V21, P156, DOI 10.1159/000333385
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Messner B, 2009, ARTERIOSCL THROM VAS, V29, P1392, DOI 10.1161/ATVBAHA.109.190082
   WAALKES MP, 1992, FUND APPL TOXICOL, V19, P512, DOI 10.1016/0272-0590(92)90089-Z
   Lei LJ, 2007, BIOMED ENVIRON SCI, V20, P295
   Kazantzis G, 2004, BIOMETALS, V17, P493, DOI 10.1023/B:BIOM.0000045727.76054.f3
   Harisa GI, 2014, BIOL TRACE ELEM RES, V158, P289, DOI 10.1007/s12011-014-9939-1
   Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264
   DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028
   MERALI Z, 1980, BRIT J PHARMACOL, V69, P151
   ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610
   SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534
   Koopmans SJ, 1996, DIABETOLOGIA, V39, P391, DOI 10.1007/BF00400670
   Han JC, 2003, ARCH BIOCHEM BIOPHYS, V413, P213, DOI 10.1016/S0003-9861(03)00120-6
   Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123
   VAGUE P, 1982, METABOLISM, V31, P139, DOI 10.1016/0026-0495(82)90125-1
   Maoujoud O., 2011, Eastern Mediterranean Health Journal, V17, P56
   REVIS NW, 1981, P NATL ACAD SCI-BIOL, V78, P6494, DOI 10.1073/pnas.78.10.6494
   Krssak M, 2000, J CLIN ENDOCR METAB, V85, P748, DOI 10.1210/jc.85.2.748
   HOSKER JP, 1985, DIABETOLOGIA, V28, P401, DOI 10.1007/BF00280882
   Vangipurapu J, 2011, DIABETOLOGIA, V54, P540, DOI 10.1007/s00125-010-1966-7
   Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008
   Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106
   Muniyappa R, 2009, AM J PHYSIOL-ENDOC M, V297, pE1023, DOI 10.1152/ajpendo.00397.2009
   Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519
   TURNER RC, 1979, METABOLISM, V28, P1086, DOI 10.1016/0026-0495(79)90146-X
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5
   DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
   Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200
   Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295
   Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6
   Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179
   Vangipurapu J, 2012, J INTERN MED, V272, P402, DOI 10.1111/j.1365-2796.2012.02540.x
   Bugiardini R, 2004, CIRCULATION, V109, P2518, DOI 10.1161/01.CIR.0000128208.22378.E3
   Bonner-Weir S, 2001, DIABETES, V50, pS20, DOI 10.2337/diabetes.50.2007.S20
   BRUNK SD, 1981, CLIN CHEM, V27, P924
   NILSSON T, 1986, BIOCHIM BIOPHYS ACTA, V888, P270, DOI 10.1016/0167-4889(86)90225-9
   SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X
   CHAPATWALA KD, 1980, DRUG CHEM TOXICOL, V3, P407, DOI 10.3109/01480548009030129
   Sesti G, 2013, NUTR METAB CARDIOVAS, V23, P1182, DOI 10.1016/j.numecd.2013.01.006
   Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7
   Hecht EM, 2013, J CARDIOVASC PHARM T, V18, P550, DOI 10.1177/1074248413494815
   Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032
   Martelli A, 2006, BIOCHIMIE, V88, P1807, DOI 10.1016/j.biochi.2006.05.013
   Larregle EV, 2008, FOOD CHEM TOXICOL, V46, P1786, DOI 10.1016/j.fct.2008.01.018
   SHANBAKY IO, 1978, TOXICOL APPL PHARM, V44, P99, DOI 10.1016/0041-008X(78)90288-0
   Chung JO, 2012, KOREAN J INTERN MED, V27, P66, DOI 10.3904/kjim.2012.27.1.66
   Bertoluci MC, 2010, DIABETOL METAB SYNDR, V3, P2
   Chang KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054374
   DEFRONZO RA, 1988, DIABETES, V37, P667
   Godt Johannes, 2006, J Occup Med Toxicol, V1, P22, DOI 10.1186/1745-6673-1-22
   Habeebu S.S., 2000, TOXICOL SCI, V56, P212
   Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1
   Kearney M.T., 2007, EXP PHYSIOL, V93, P158, DOI 10.1113/expphysiol.2007.039172
   Klaassen D.C., 2009, TOXICOL APPL PHARM, V238, P215
   LUZI L, 1989, AM J PHYSIOL, V257, pE241
   Packard CJ, 2003, BIOCHEM SOC T, V31, P1066
   Sarafidis P.A., 2007, J HUM HYPERTENS, V21, P702
   Sciacqua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053968
   Sesti G., 2014, BMJ OPEN DIABETES RE, V2
   SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403
   Tellez-Plaza M, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0356-2
   Tellez-Plaza M., 2010, NAT REV CARDIOL CNIC, V7, P41
NR 80
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 27
EP 35
DI 10.1016/j.abb.2015.07.010
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400004
PM 26253262
ER

PT J
AU Hua, YL
   Ekkhara, W
   Sansenya, S
   Srisomsap, C
   Roytrakul, S
   Saburi, W
   Takeda, R
   Matsuura, H
   Mori, H
   Cairns, JRK
AF Hua, Yanling
   Ekkhara, Watsamon
   Sansenya, Sompong
   Srisomsap, Chantragan
   Roytrakul, Sittiruk
   Saburi, Wataru
   Takeda, Ryosuke
   Matsuura, Hideyuki
   Mori, Haruhide
   Cairns, James R. Ketudat
TI Identification of rice Os4BGlu13 as a beta-glucosidase which hydrolyzes
   gibberellin A4 1-O-beta-D-glucosyl ester, in addition to tuberonic acid
   glucoside and salicylic acid derivative glucosides
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE beta-glucosidase; Rice; Gibberellin glucosyl ester; Recombinant
   expression; Phytohormone conjugates
ID ORYZA-SATIVA L.; D-GLUCOPYRANOSIDE; EXPRESSION; METABOLISM
AB Gibberellin 1-O-beta-D-glucose ester hydrolysis activity has been detected in rice seedling extracts, but no enzyme responsible for this activity has ever been purified and identified. Therefore, gibberellin A4 glucosyl ester (GA(4)-GE) beta-D-glucosidase activity was purified from ten-day rice seedling stems and leaves. The family 1 glycoside hydrolase Os4BGlu13 was identified in the final purification fraction. The Os4BGlu13 cDNA was amplified from rice seedlings and expressed as an N-terminal thioredoxin-tagged fusion protein in Escherichia coll. The purified recombinant Os4BGlu13 protein (rOs4BGlu13) had an optimum pH of 4.5, for hydrolysis of p-nitrophenyl beta-D-glucopyranoside (pNPGlc), which was the best substrate identified, with a k(cat)/K-m of 637 mM(-1) s(-1). rOs4BGlu13 hydrolyzed helicin best among natural glycosides tested (K-cat/K-m, of 74.4 mM(-1) s(-1)). Os4BGlu13 was previously designated tuberonic acid glucoside (TAG) beta-glucosidase (TAGG), and here the k(cat)/K-m of rOsBGlu13 for TAG was 6.68 mM(-1) s(-1), while that for GA4-GE was 3.63 mM(-1) s(-1) and for salicylic acid glucoside (SAG) is 0.88 mM(-1) s(-1). rOs4BGlu13 also hydrolyzed oligosaccharides, with preference for short beta-(1 -> 3)-linked over beta-(1 -> 4)linked glucooligosaccharides. The enzymatic data suggests that Os4BGlu13 may contribute to TAG, SAG, oligosaccharide and GA4-GE hydrolysis in the rice plant, although helicin or a similar compound may be its primary target. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Hua, Yanling] Suranaree Univ Technol, Ctr Sci & Technol Equipment, Nakhon Ratchasima 30000, Thailand.
   [Hua, Yanling; Ekkhara, Watsamon; Cairns, James R. Ketudat] Suranaree Univ Technol, Ctr Biomol Struct Funct & Applicat, Nakhon Ratchasima 30000, Thailand.
   [Ekkhara, Watsamon; Cairns, James R. Ketudat] Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima 30000, Thailand.
   [Sansenya, Sompong] Rajamangala Univ Technol, Dept Chem, Fac Sci, Thanyaburi 12110, Pathun Thani, Thailand.
   [Srisomsap, Chantragan; Cairns, James R. Ketudat] Chulabhorn Res Inst, Bangkok 10210, Thailand.
   [Roytrakul, Sittiruk] Natl Ctr Genet Engn & Biotechnol, Pathum Thani 12120, Thailand.
   [Saburi, Wataru; Takeda, Ryosuke; Matsuura, Hideyuki; Mori, Haruhide] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan.
RP Cairns, JRK (reprint author), Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima 30000, Thailand.
EM cairns@sut.ac.th
OI Ketudat Cairns, James/0000-0003-3042-1626
FU Suranaree University of Technology [SUT1-102-55-36-01]; National
   Research University Project of the Commission on Higher Education of
   Thailand; Thailand Research Fund [BRG5680012]
FX We thank Ms. Chiraporn Saetang for assistance with protein purification
   and Ms. Daranee Chokchaichamnankit from the Chulabhorn Research
   Institute (CRI) and Ms. Atchara Paemanee from the National Center for
   Genetic Engineering and Biotechnology (BIOTEC) for their help on peptide
   analysis by LC-MS. This work was supported by Suranaree University of
   Technology (SUT1-102-55-36-01), the National Research University Project
   of the Commission on Higher Education of Thailand and the Thailand
   Research Fund (Grant BRG5680012).
CR Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224
   Reuveni M, 1999, PLANT SCI, V147, P19, DOI 10.1016/S0168-9452(99)00097-7
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   GRYNKIEWICZ G, 1993, POL J CHEM, V67, P1251
   Kuntothom T, 2009, ARCH BIOCHEM BIOPHYS, V491, P85, DOI 10.1016/j.abb.2009.09.004
   BRZOBOHATY B, 1993, SCIENCE, V262, P1051, DOI 10.1126/science.8235622
   SCHNEIDER G, 1992, P NATL ACAD SCI USA, V89, P8045, DOI 10.1073/pnas.89.17.8045
   Matsuura H, 2000, BIOSCI BIOTECH BIOCH, V64, P2380, DOI 10.1271/bbb.64.2380
   HIRAGA K, 1974, PHYTOCHEMISTRY, V13, P2371
   Caboni P, 2013, J AGR FOOD CHEM, V61, P1794, DOI 10.1021/jf305164m
   Hua YL, 2013, ARCH BIOCHEM BIOPHYS, V537, P39, DOI 10.1016/j.abb.2013.06.005
   SCHLIEMANN W, 1984, J PLANT PHYSIOL, V116, P123, DOI 10.1016/S0176-1617(84)80069-3
   Wakuta S, 2010, PHYTOCHEMISTRY, V71, P1280, DOI 10.1016/j.phytochem.2010.04.025
   Sansenya S, 2011, ARCH BIOCHEM BIOPHYS, V510, P62, DOI 10.1016/j.abb.2011.04.005
   POULTON JE, 1990, PLANT PHYSIOL, V94, P401, DOI 10.1104/pp.94.2.401
   DHARMAWARDHANA DP, 1995, PLANT PHYSIOL, V107, P331, DOI 10.1104/pp.107.2.331
   Kai K, 2007, PHYTOCHEMISTRY, V68, P2512, DOI 10.1016/j.phytochem.2007.05.040
   Barleben L, 2005, BBA-PROTEINS PROTEOM, V1747, P89, DOI 10.1016/j.bbapap.2004.09.026
   Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125
   Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034
   McIlvaine TC, 1921, J BIOL CHEM, V49, P183
   Duroux L, 1998, BIOCHEM J, V333, P275
   FALK A, 1995, PLANT PHYSIOL, V108, P1369, DOI 10.1104/pp.108.4.1369
   Opassiri R, 2003, PLANT SCI, V165, P627, DOI 10.1016/S0168-9452(03)00235-8
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Seshadri S, 2009, PLANT PHYSIOL, V151, P47, DOI 10.1104/pp.109.139436
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Davies P. J., 1995, PLANT HORMONES PHYSL
   FOWLER T, 1993, ACS SYM SER, V533, P56
   Gupta R., 2005, NETNGLYC PREDICTION
   Koshioka M., 13 INT C PLANT GROWT, P217
   Mauseth J. D., 1991, BOT INTRO PLANT BIOL, P348
   Opassiri R, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-33
   Raven P. H., 1992, BIOL PLANTS, P545
   Roepke J, 2015, PHYTOCHEMISTRY, V109, P14, DOI 10.1016/j.phytochem.2014.10.028
   Rouyi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096712
   Salisbury F. B., 1992, PLANT PHYSIOL, p[357, 531]
   Schneider G., 1983, BIOCH PHYSL GIBBEREL, V1, P389
   Sponsel V. M., 2004, PLANT HORMONES BIOSY, P62
   Wakuta S., 2011, J APPL GLYCOSCI, V58, P67
NR 40
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 36
EP 46
DI 10.1016/j.abb.2015.07.021
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400005
PM 26241499
ER

PT J
AU Luo, Q
   Li, W
   Zhao, T
   Tian, X
   Liu, YM
   Zhang, XB
AF Luo, Quan
   Li, Wei
   Zhao, Tian
   Tian, Xin
   Liu, Yumei
   Zhang, Xibao
TI Role of miR-148a in cutaneous squamous cell carcinoma by repression of
   MAPK pathway
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE miR-148a; MAP3K4; MAP3K9; CSCC
ID CANCER; PROLIFERATION; MICRORNA-148A; MIGRATION; INVASION
AB Dysregulation of miRNAs is a common feature in human cancers, but there are lack of studies on roles of miRNAs in cutaneous squamous cell carcinoma (CSCC). miR-148a, a member of the miR-148/152 family, has been found to be downregulated in different types of cancer and its role in CSCC remains unknown. The study was aimed to investigate the expression and cellular function of miR-148a in CSCC. We found that miR-148a was underexpressed in CSCC tissues and cell lines. MAP3K2, MAP3K4 and MAP3K9 were predicted as the target genes of miR-148a and the latter two genes were verified as the target genes of miR-148a in CSCC cells. Importantly, we demonstrated that the overexpression of miR-148a significantly inhibited CSCC cell proliferation and metastasis via down-regulation of MAP3K9 and MAP3K4 expression. MAP3K4 and MAP3K9 were negatively associated with the expression of miR-148a in CSCC tissues. Our results suggested indicated that miR-148a acts as a tumor suppressor of CSCC via inhibiting MAPK pathway. These results may provide a promising alterative strategy for CSCC therapy. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Luo, Quan; Li, Wei; Zhao, Tian; Tian, Xin; Liu, Yumei; Zhang, Xibao] Guangzhou Inst Dermatol, Dept Dermatol, Guangzhou, Guangdong, Peoples R China.
RP Zhang, XB (reprint author), Guangzhou Inst Dermatol, Dept Dermatol, 56 Hengfu Rd, Guangzhou, Guangdong, Peoples R China.
EM xibao_zhang@126.com
CR Yamane K, 2013, J MOL MED, V91, P69, DOI 10.1007/s00109-012-0935-7
   Aprelikova O, 2013, ONCOGENE, V32, P3246, DOI 10.1038/onc.2012.351
   Sand M, 2012, J DERMATOL SCI, V68, P119, DOI 10.1016/j.jdermsci.2012.09.004
   Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28
   Gastaldi C, 2014, CARCINOGENESIS, V35, P1110, DOI 10.1093/carcin/bgt490
   Fawdar S, 2013, P NATL ACAD SCI USA, V110, P12426, DOI 10.1073/pnas.1305207110
   Heo MJ, 2014, ONCOTARGET, V5, P2792
   Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714
   Zuo JB, 2013, MOL CELLS, V35, P313, DOI 10.1007/s10059-013-2314-9
   Sapkota GP, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130067
   Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243
   Liffers ST, 2011, LAB INVEST, V91, P1472, DOI 10.1038/labinvest.2011.99
   Chen Y, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-43
   Greenberg ES, 2014, CANCER LETT, V342, P170, DOI 10.1016/j.canlet.2012.01.020
   Hameetman L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-58
   Kanitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049568
   Wang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103206
   Wang SH, 2014, INT J CLIN EXP PATHO, V7, P7131
   Yu Jing, 2011, J Biomed Res, V25, P170, DOI 10.1016/S1674-8301(11)60022-5
   Zhou MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100620
NR 20
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 47
EP 54
DI 10.1016/j.abb.2015.07.022
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400006
PM 26253263
ER

PT J
AU Boteanu, RM
   Uyy, E
   Suica, VI
   Antohe, F
AF Boteanu, Raluca Maria
   Uyy, Elena
   Suica, Viorel Iulian
   Antohe, Felicia
TI High-mobility group box 1 enhances the inflammatory process in diabetic
   lung
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Diabetes mellitus; Lung; HMGB1; RAGE; AKT1; beta-Catenin
ID BETA-CATENIN; C-JUN; EXPRESSION; MELLITUS; HMGB1; CYCLOOXYGENASE-2;
   PHOSPHORYLATION; RECEPTOR; DISEASE; CANCER
AB Diabetes mellitus generates metabolic changes associated with inflammatory events that may eventually affect all body tissues. Both high-mobility group box 1 (HMGB1) and beta-catenin are active players in inflammation. The study aimed to determine whether HMGB1 modulates the beta-catenin activity in supporting inflammation, using an experimental type 1 diabetes mouse model. The protein and gene expression of HMGB1 were significantly increased (2-fold) in the diabetic lung compared to control and were positively correlated with the HMGB1 levels detected in serum. Co-immunoprecipitation of HMGB1 with RAGE co-exists with activation of PI3K/AKT1 and NF-kB signaling pathways. At the same time beta-catenin was increased in nuclear fraction (3.5 fold) while it was down-regulated in diabetic plasma membrane (2-fold). There was no difference of beta-catenin gene expression between the control and diabetic mice. beta-Catenin phosphorylation at Ser552 was higher in diabetic nuclear fraction, suggesting that AKT1 activation promotes beta-catenin nuclear translocation. In addition, c-Jun directly binds beta-catenin indicating the transcriptional activity of beta-catenin in diabetes, sustained by significantly COX2 increase by 6-fold in the cytosolic extract of diabetic lung compared to control. Taken together, the data support the new concept that HMGB1 maintains the inflammation through RAGE/AKT1/beta-catenin pathway in the diabetic lung. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Boteanu, Raluca Maria; Uyy, Elena; Suica, Viorel Iulian; Antohe, Felicia] Inst Cellular Biol & Pathol Nicolae Simionescu, Bucharest 050568, Romania.
RP Antohe, F (reprint author), Inst Cellular Biol & Pathol Nicolae Simionescu, 8 BP Hasdeu St,POB 35-14, Bucharest 050568, Romania.
EM felicia.antohe@icbp.ro
FU Romanian Academy; Ministry of Education and Research [135, 153/2012];
   European Social Fund within the Sectorial Operational Program Human
   Resources Development [POSDRU/159/1.5/S/133391]
FX The authors are grateful to Dr. D.L. Radu for the transgenic mice, Mrs.
   M. Pascu for excellent technical support and Dr. E. Dragan for expert
   assistance with animal tissues sampling. We thank Dr. Madalina Oppermann
   from Thermo Scientific, for valuable collaboration. This work was
   supported by the Romanian Academy and Ministry of Education and Research
   grant CNDI-UEFISCDI PN-II-PCCA-2011-3 no. 135 and 153/2012. The authors
   RMB and EU acknowledge the support of the strategic grant
   POSDRU/159/1.5/S/133391-financed by the European Social Fund within the
   Sectorial Operational Program Human Resources Development 2007-2013.
CR Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133
   van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5
   Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune
   Devaraj S, 2009, DIABETOLOGIA, V52, P1665, DOI 10.1007/s00125-009-1394-8
   Rodriguez DA, 2009, MOL BIOL CELL, V20, P2297, DOI 10.1091/mbc.E08-09-0939
   Li M, 2012, EXP MOL MED, V44, P260, DOI 10.3858/emm.2012.44.4.021
   Zhurinsky J, 2000, J CELL SCI, V113, P3127
   Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014
   Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200
   Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914
   Fuso L, 2012, DIABETES-METAB RES, V28, P370, DOI 10.1002/dmrr.2284
   Yun K, 2009, J IMMUNOL, V183, P5129, DOI 10.4049/jimmunol.0802744
   Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5
   Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388
   Araki Y, 2003, CANCER RES, V63, P728
   Uyy E, 2010, MICROVASC RES, V79, P154, DOI 10.1016/j.mvr.2009.11.008
   Manigrasso MB, 2014, TRENDS ENDOCRIN MET, V25, P15, DOI 10.1016/j.tem.2013.08.002
   Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200
   OFULUE AF, 1994, EXP LUNG RES, V20, P27, DOI 10.3109/01902149409064371
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050
   MYINT T, 1995, BBA-MOL BASIS DIS, V1272, P73, DOI 10.1016/0925-4439(95)00067-E
   Han JY, 2008, DIABETES, V57, P2118, DOI 10.2337/db07-1499
   Nin JWM, 2012, DIABETOLOGIA, V55, P2489, DOI 10.1007/s00125-012-2622-1
   KIDA K, 1983, AM REV RESPIR DIS, V128, P125
   VRACKO R, 1979, AM REV RESPIR DIS, V120, P973
   Radu DL, 2004, J CELL MOL MED, V8, P349, DOI 10.1111/j.1582-4934.2004.tb00324.x
   Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06
   Kronstein R, 2012, CARDIOVASC RES, V93, P130, DOI 10.1093/cvr/cvr256
   Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s
   IRIZAR A, 1995, XENOBIOTICA, V25, P941
   Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698
   Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614
   MINDEN A, 1994, MOL CELL BIOL, V14, P6683
   Popov D, 1997, EUR RESPIR J, V10, P1850, DOI 10.1183/09031936.97.10081850
   Chuah YK, 2013, INT J INFLAM, V2013, DOI DOI 10.1155/2013/403460
   Elghazi L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00693
   ERMAN A, 1993, EUR J CLIN INVEST, V23, P615, DOI 10.1111/j.1365-2362.1993.tb00722.x
   Huang K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-252
   Jacobs K. M., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/930710
   Nunez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018562
   Pisetsky DS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2440
   Pitocco Dario, 2012, Rev Diabet Stud, V9, P23, DOI 10.1900/RDS.2012.9.23
   Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17
NR 44
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 55
EP 64
DI 10.1016/j.abb.2015.07.020
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400007
PM 26254814
ER

PT J
AU Homma, T
   Kurahashi, T
   Lee, J
   Kang, ES
   Fujii, J
AF Homma, Takujiro
   Kurahashi, Toshihiro
   Lee, Jaeyong
   Kang, Eun Sil
   Fujii, Junichi
TI SOD1 deficiency decreases proteasomal function, leading to the
   accumulation of ubiquitinated proteins in erythrocytes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE SOD1; Oxidative stress; Proteasome; Anemia; Protein degradation
ID 20 S PROTEASOME; OXIDATIVE-STRESS; 26S PROTEASOME; ALZHEIMERS-DISEASE;
   OXIDIZED PROTEINS; HEMOLYTIC-ANEMIA; MICE; LIVER; AGE; PHENYLHYDRAZINE
AB We previously demonstrated that elevated levels of ROS in red blood cells (RBCs) are responsible for anemia in SOD1-deficient mice, suggesting that the oxidative stress-induced massive destruction of RBCs is an underlying mechanism for autoimmune hemolytic anemia. In the current study, we examined the issue of how elevated ROS are involved in the destruction of RBCs and the onset of anemia from the view point of the proteolytic removal of oxidatively-damaged proteins. We found that poly-ubiquitinated proteins had accumulated and had undergone aggregation in RBCs from SOD1-deficient mice and from phenylhydrazine-induced anemic mice. Although the protein levels of the three catalytic components of the proteasome, beta(1), beta(2), and beta(5), were not significantly altered, their proteolytic activities were decreased in the SOD1-deficient RBCs. These data suggest that oxidative-stress triggers the dysfunction of the proteasomal system, which results in the accumulation of the aggregation of poly-ubiquitinated proteins. We conclude that an oxidative stress-induced malfunction in the scavenging activity of proteasomes accelerates the accumulation of damaged proteins, leading to a shortened lifespan of RBCs and, hence, anemia. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Homma, Takujiro; Kurahashi, Toshihiro; Lee, Jaeyong; Kang, Eun Sil; Fujii, Junichi] Yamagata Univ, Grad Sch Med Sci, Dept Biochem & Mol Biol, Yamagata 9909585, Japan.
RP Fujii, J (reprint author), Yamagata Univ, Grad Sch Med Sci, Dept Biochem & Mol Biol, 2-2-2 Iidanishi, Yamagata 9909585, Japan.
EM jfujii@med.id.yamagata-u.ac.jp
FU Otsuka Toshimi Scholarship Foundation; Tokyo Biochemical Research
   Foundation; Japan Society for the Promotion of Science [S2402]
FX J.L. is a scholarship recipient from the Otsuka Toshimi Scholarship
   Foundation. E.S.K. is supported by the Tokyo Biochemical Research
   Foundation Postdoctoral Fellowship for Asian Researchers in Japan. This
   work was supported by the Strategic Young Researcher Overseas Visits
   Program for Accelerating Brain Circulation from the Japan Society for
   the Promotion of Science (S2402).
CR Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x
   DICOLA D, 1989, FREE RADICAL RES COM, V6, P379
   Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548
   Orlowski M, 2000, ARCH BIOCHEM BIOPHYS, V383, P1, DOI 10.1006/abbi.2000.2036
   Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x
   Deriziotis P, 2011, EMBO J, V30, P3065, DOI 10.1038/emboj.2011.224
   Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316
   Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029
   Anselmi B, 1998, J GERONTOL A-BIOL, V53, pB173
   FRIGUET B, 1994, J BIOL CHEM, V269, P21639
   SHETLAR MD, 1985, ENVIRON HEALTH PERSP, V64, P265, DOI 10.2307/3430016
   Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001
   Reinheckel T, 1998, BIOCHEM J, V335, P637
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   Neslund-Dudas C, 2012, BIOL TRACE ELEM RES, V149, P5, DOI 10.1007/s12011-012-9391-z
   Majetschak M, 2008, J IMMUNOL METHODS, V334, P91, DOI 10.1016/j.jim.2008.02.004
   Konno T, 2013, FREE RADICAL BIO MED, V65, P1378, DOI 10.1016/j.freeradbiomed.2013.09.021
   Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008
   Kapeta S, 2010, J BIOL CHEM, V285, P8171, DOI 10.1074/jbc.M109.031575
   Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285
   McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8
   Takabe W, 2006, FREE RADICAL RES, V40, P21, DOI 10.1080/10715760500354430
   Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386
   Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490
   Shringarpure R, 2000, CELL MOL LIFE SCI, V57, P1802, DOI 10.1007/PL00000660
   Caballero M, 2003, BIOCHEM BIOPH RES CO, V308, P346, DOI 10.1016/S0006-291X(03)01385-8
   GOLDBERG B, 1976, J BIOL CHEM, V251, P3045
   Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003
   Ding QX, 2003, FEBS LETT, V546, P228, DOI 10.1016/S0014-5793(03)00582-9
   Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0
   Cecarini V, 2007, FREE RADICAL RES, V41, P673, DOI 10.1080/10715760701286159
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Hohn A, 2013, J PROTEOMICS, V92, P132, DOI 10.1016/j.jprot.2013.01.004
   Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717
   Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630
   Iuchi Y, 2009, BIOCHEM J, V422, P313, DOI 10.1042/BJ20090176
   Goldberg B., 1975, J BIOL CHEM, P2401
   Luchi Y, 2010, FREE RADIC BIOL MED, V48, P935
   Starzynski RR, 2009, BIOCHEM J, V420, P383, DOI 10.1042/BJ20082137
   Vilchez D., 2014, NAT COMMUN, V5, P1
NR 46
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 65
EP 72
DI 10.1016/j.abb.2015.07.023
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400008
PM 26264915
ER

PT J
AU Jordan, DB
   Braker, JD
AF Jordan, Douglas B.
   Braker, Jay D.
TI Rate-limiting steps of a stereochemistry retaining beta-D-xylosidase
   from Geobacillus stearothermophilus acting on four substrates
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Glycoside hydrolase; beta-xylosidase; Burst-steady state;
   Dexylosylation; Rate limitation; Kinetic data reinterpretation
ID FAMILY-52 GLYCOSIDE HYDROLASE; ENZYME; T-6
AB Kinetic experiments of GSXynB2, a GH52 retaining beta-xylosidase, acting on 2-nitrophenyl-beta-D-xylopyranoside (2NPX), 4-nitrophenyl-beta-D-xylopyranoside (4NPX), 4-methylumbelliferyl-beta-D-xylopyranoside (MuX) and xylobiose (X2) were conducted at pH 7.0 and 25 degrees C. Catalysis proceeds in two steps (xylodidation followed by dexylosidation): E + substrate TO E-xylose + leaving group TO E + xylose. kcat falls into two groups: 4NPX (1.95 s(-1)) and 2NPX, MuX and X2 (15.8 s(-1), 12.6 s(-1), 12.8 s(-1), respectively). Dexylosylation (E-xylose to E + xylose), the common step for the enzymatic hydrolysis of the four substrates, must exceed 15.8 s(-1). kcat of 4NPX would seem mainly limited by xylosylation (step 1) and the other three substrates would seem mainly limited by dexylosylation (step 2) - a conclusion that critically lacks chemical justification (compare 4NPX and 2NPX). Presteady-state rates indicate rapid xylosidation rates for all substrates so a later step (not dexylosidation) is rate-limiting for 4NPX. That 2NPX is an onlier and 4NPX is an outlier (both leaving group pK(a) of 7.2) of the Bronsted plot pattern (logk(cat) vs pK(a) of phenol leaving group) is thus possibly explained by 4NP release. The pH dependency of k(cat) 2NPX encompasses 2 bell-shaped curves with peaks of pH 3 and pH 7. Published by Elsevier Inc.
C1 [Jordan, Douglas B.; Braker, Jay D.] USDA ARS, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA.
RP Jordan, DB (reprint author), USDA ARS, Natl Ctr Agr Utilizat Res, 1815 N Univ St, Peoria, IL 61604 USA.
EM douglas.jordan@ars.usda.gov
CR Jordan DB, 2012, BIOCHEM J, V442, P241, DOI 10.1042/BJ20111922
   Bravman T, 2003, BIOCHEMISTRY-US, V42, P10528, DOI 10.1021/bi034505o
   Jordan DB, 2007, APPL BIOCHEM BIOTECH, V141, P51, DOI 10.1007/s12010-007-9210-8
   Bravman T, 2001, FEBS LETT, V495, P39, DOI 10.1016/S0014-5793(01)02360-2
   Jordan DB, 2010, APPL MICROBIOL BIOT, V86, P1647, DOI 10.1007/s00253-010-2538-y
   Bravman T, 2003, J BIOL CHEM, V278, P26742, DOI 10.1074/jbc.M304144200
   Ludwiczek ML, 2007, J MOL BIOL, V373, P337, DOI 10.1016/j.jmb.2007.07.057
   Cook P., 2007, ENZYME KINETICS MECH
   Jordan DB, 2013, ARCH BIOCHEM BIOPHYS, V537, P176, DOI 10.1016/j.abb.2013.07.020
   Leatnerbarrow R.J., 2001, GRAFIT VERSION 5
NR 10
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 73
EP 78
DI 10.1016/j.abb.2015.08.004
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400009
PM 26271441
ER

PT J
AU Kim, M
   Cho, HJ
   Jeong, YJ
   Chung, IK
   Magae, J
   Chang, YC
AF Kim, Mihyun
   Cho, Hyun-Ji
   Jeong, Yun-Jeong
   Chung, Il-Kyung
   Magae, Junji
   Chang, Young-Chae
TI 4-O-methylascochlorin suppresses differentiation of 3T3-L1 preadipocytes
   by inhibiting PPAR gamma expression through regulation of AMPK/mTOR
   signaling pathways
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Adipocyte; Differentiation; PPAR gamma; AMPK; mTOR
ID ACTIVATED-RECEPTOR-GAMMA; MESENCHYMAL STEM-CELLS; WHITE ADIPOSE-TISSUE;
   ADIPOCYTE DIFFERENTIATION; PROTEIN-KINASE; CARCINOMA CELLS; ADIPOGENIC
   DIFFERENTIATION; CLONAL EXPANSION; MAMMALIAN TARGET; AMPK ACTIVATION
AB Obesity increases the risk of developing many chronic diseases, including type 2 diabetes and certain cancers, and is thereby associated with premature death. The present study was conducted to identify the inhibitory effect of the ascochlorin derivative 4-O-methylascochlorin (MAC) on the differentiation of 3T3-L1 preadipocytes. MAC suppressed the differentiation of 3T3-L1 preadipocytes and inhibited the expression of adipocyte differentiation marker genes, FABP4, PPAR gamma and C/EBP alpha. In addition, we found that the inhibitory effects of MAC on differentiation of 3T3-L1 preadipocytes were caused by suppression of mTORC1 via inhibition of mTOR/p7056K/4E-BP1 phosphorylation and activation of Raptor phosphorylation. MAC also regulated the PPAR gamma expression and the mTORC1 activation by increasing AMPK phosphorylation and inhibiting PI3K/Akt, which suggest that MAC suppresses the differentiation of 3T3-L1 adipocytes by regulating the AMPK- and PI3K-mTOR-PPAR gamma signaling pathways. Furthermore, animal model results showed that the phosphorylation of AMPK was enhanced in the liver of C57BL/6 mice intraperitoneally injected with MAC. These results indicate that MAC could be a therapeutic agent for obesity involving PPAR gamma and AMPK. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Kim, Mihyun] Inje Univ, Dept Phys Therapy, Gimhae 621749, South Korea.
   [Cho, Hyun-Ji; Jeong, Yun-Jeong; Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Res Inst Biomed Engn, Daegu 705718, South Korea.
   [Cho, Hyun-Ji; Jeong, Yun-Jeong; Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Dept Med, Daegu 705718, South Korea.
   [Chung, Il-Kyung] Catholic Univ Daegu, Dept Biotechnol, Gyongsan 712702, South Korea.
   [Magae, Junji] Magae Biosci Inst, Tsukuba, Ibaraki 3001263, Japan.
RP Chang, YC (reprint author), Catholic Univ Daegu, Dept Cell Biol, Sch Med, 3056-6,Daemyung 4 Dong, Daegu 705718, South Korea.
EM ycchang@cu.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT and Future Planning
   [2014R1A2A1A11050776]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Science, ICT and Future Planning (2014R1A2A1A11050776).
CR Lee YK, 2010, CARCINOGENESIS, V31, P1092, DOI 10.1093/carcin/bgq040
   Kola B, 2008, FRONT HORM RES, V36, P198, DOI 10.1159/0000115366
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200
   Yu WH, 2008, MOL CELL BIOCHEM, V310, P11, DOI 10.1007/s11010-007-9661-9
   Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565
   Ceddia RB, 2013, MOL CELL ENDOCRINOL, V366, P194, DOI 10.1016/j.mce.2012.06.014
   Tsuruga M, 2007, J ANTIBIOT, V60, P20
   Pereira MJ, 2012, MOL CELL ENDOCRINOL, V355, P96, DOI 10.1016/j.mce.2012.01.024
   Cho HJ, 2007, CARCINOGENESIS, V28, P1104, DOI 10.1093/carcin/bgl217
   Jeong JH, 2012, J CELL BIOCHEM, V113, P1302, DOI 10.1002/jcb.24001
   Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966
   Kang JH, 2007, J CELL BIOCHEM, V102, P506, DOI 10.1002/jcb.21312
   Mulligan JD, 2007, J PHYSIOL-LONDON, V580, P677, DOI 10.1113/jphysiol.2007.128652
   Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003
   Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055
   Shaw RJ, 2008, TRENDS BIOCHEM SCI, V33, P565, DOI 10.1016/j.tibs.2008.09.005
   Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839
   Kang JH, 2012, J BIOL CHEM, V287, P15661, DOI 10.1074/jbc.M112.358473
   Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748
   Tsuruga M, 2004, APOPTOSIS, V9, P429, DOI 10.1023/B:APPT.0000031456.09297.8f
   Lee YH, 2013, CELL MOL LIFE SCI, V70, P3959, DOI 10.1007/s00018-013-1363-8
   Togashi M, 2003, J MED CHEM, V46, P4113, DOI 10.1021/jm0205649
   Blanchard PG, 2012, J LIPID RES, V53, P1117, DOI 10.1194/jlr.M021485
   Arai K, 2004, METABOLISM, V53, P28, DOI 10.1016/j.metabol.2003.08.007
   Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200
   Pung YF, 2013, ARTERIOSCL THROM VAS, V33, P1911, DOI 10.1161/ATVBAHA.113.301591
   Togashi M, 2002, J ANTIBIOT, V55, P417
   Dagon Y, 2006, BIOCHEM BIOPH RES CO, V340, P43, DOI 10.1016/j.bbrc.2005.11.159
   Hutley LJ, 2003, EUR J CLIN INVEST, V33, P574, DOI 10.1046/j.1365-2362.2003.01178.x
   Gao Y, 2008, BIOL PHARM BULL, V31, P1716, DOI 10.1248/bpb.31.1716
   Jeong JH, 2011, BIOCHEM BIOPH RES CO, V406, P353, DOI 10.1016/j.bbrc.2011.02.043
   Gregoire FM, 1998, PHYSIOL REV, V78, P783
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195
   Dudley GB, 2000, ORG LETT, V2, P3407, DOI 10.1021/ol006561c
   Jeong JH, 2010, BIOCHEM BIOPH RES CO, V398, P68, DOI 10.1016/j.bbrc.2010.06.037
   Wang P, 2007, DIABETOLOGIA, V50, P654, DOI 10.1007/s00125-006-0565-0
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Walczak R, 2002, J LIPID RES, V43, P177
   Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049
   HOSOKAWA T, 1981, EUR J PHARMACOL, V69, P429, DOI 10.1016/0014-2999(81)90446-5
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Chuang CC, 2007, ENDOCRINOLOGY, V148, P4267, DOI 10.1210/en.2007-0179
   Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324
   Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47
   Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802
   Tao Rong, 2010, J Mol Signal, V5, P1, DOI 10.1186/1750-2187-5-1
   YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086
   Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001
NR 53
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 79
EP 86
DI 10.1016/j.abb.2015.07.007
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400010
PM 26271443
ER

PT J
AU Wennman, A
   Jerneren, F
   Magnuson, A
   Oliw, EH
AF Wennman, Anneli
   Jerneren, Fredrik
   Magnuson, Ann
   Oliw, Ernst H.
TI Expression and characterization of manganese lipoxygenase of the rice
   blast fungus reveals prominent sequential lipoxygenation of
   alpha-linolenic acid
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Gene expression; Magnaporthe oryzae; Oxygenation mechanism; Oxylipins;
   Pichia pastoris; Yeast expression
ID EPOXY ALCOHOL SYNTHASE; MAGNAPORTHE-ORYZAE; PICHIA-PASTORIS; ENZYMES;
   SECRETION; SUBFAMILY; PATHWAYS; DISEASE; BIOLOGY
AB Magnaporthe oryzae causes rice blast disease and has become a model organism of fungal infections. M. oryzae can oxygenate fatty acids by 7,8-linoleate diol synthase, 10R-dioxygenase-epoxy alcohol synthase, and by a putative manganese lipoxygenase (Mo-MnLOX). The latter two are transcribed during infection. The open reading frame of Mo-MnLOX was deduced from genome and cDNA analysis. Recombinant Mo-MnLOX was expressed in Pichia pastoris and purified to homogeneity. The enzyme contained protein-bound Mn and oxidized 18:2n-6 and 18:3n-3 to 9S-, 11-, and 13R-hydroperoxy metabolites by suprafacial hydrogen abstraction and oxygenation. The 11-hydroperoxides were subject to beta-fragmentation with formation of 9S- and 13R-hydroperoxy fatty acids. Oxygen consumption indicated apparent k(cat) values of 2.8 s(-1) (18:2n-6) and 3.9 s(-1) (18(:)3n-3), and UV analysis yielded apparent K-m values of 8 and 12 mu M, respectively, for biosynthesis of cis-trans conjugated metabolites. 9S-Hydroperoxy-10E,12Z,15Z-octadecatrienoic acid was rapidly further oxidized to a triene, 9S,16S-dihydroperoxy10E,12Z,14E-octadecatrienoic acid. In conclusion, we have expressed, purified and characterized a new MnLOX from M. oryzae. The pathogen likely secretes Mo-MnLOX and phospholipases to generate oxylipins and to oxidize lipid membranes of rice cells and the cuticle. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Wennman, Anneli; Jerneren, Fredrik; Oliw, Ernst H.] Uppsala Univ, Biomed Ctr, Dept Pharmaceut Biosci, Div Biochem Pharmacol, SE-75124 Uppsala, Sweden.
   [Magnuson, Ann] Uppsala Univ, Dept Chem, Angstrom Lab, SE-75120 Uppsala, Sweden.
RP Wennman, A (reprint author), Uppsala Univ, Div Biochem Pharmacol, Dept Pharmaceut Biosci, POB 591, SE-75124 Uppsala, Sweden.
EM anneli.wennman@farmbio.uu.se
FU Vetenskapsradet [03X-06523]; Knut and Alice Wallenberg Foundation [KAW
   2004.0123]; Uppsala University; Swedish Energy Agency
FX This research was supported by Vetenskapsradet (03X-06523), the Knut and
   Alice Wallenberg Foundation (KAW 2004.0123), and Uppsala University. AM
   acknowledges the Swedish Energy Agency for financial support. We thank
   Dr. M. Hamberg, Karolinska Institutet, for generous gift of deuterated
   linoleic acid and Dr. J. Pettersson (Department of Analytical Chemistry,
   Uppsala University) for atomic emission spectroscopy measurements.
CR Hamberg M, 2011, LIPIDS, V46, P201, DOI 10.1007/s11745-010-3510-4
   Zheng YX, 2011, J BIOL CHEM, V286, P24046, DOI 10.1074/jbc.M111.251496
   Newcomer ME, 2015, PROTEIN SCI, V24, P298, DOI 10.1002/pro.2626
   Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u
   Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719
   Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072
   Hansen J, 2013, APPL MICROBIOL BIOT, V97, P4737, DOI 10.1007/s00253-013-4887-9
   Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d
   Jerneren F, 2010, J BIOL CHEM, V285, P5308, DOI 10.1074/jbc.M109.062810
   Su C, 2000, J BIOL CHEM, V275, P18830, DOI 10.1074/jbc.M001408200
   Serhan CN, 2006, J IMMUNOL, V176, P1848
   Hoffmann I, 2014, J LIPID RES, V55, P2113, DOI 10.1194/jlr.M051755
   Garscha U, 2008, J CHROMATOGR B, V872, P90, DOI 10.1016/j.jchromb.2008.07.013
   Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x
   GRECHKIN AN, 1991, BIOCHIM BIOPHYS ACTA, V1081, P79, DOI 10.1016/0005-2760(91)90253-E
   Damasceno LM, 2012, APPL MICROBIOL BIOT, V93, P31, DOI 10.1007/s00253-011-3654-z
   Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002
   Tasaki Y, 2013, BIOSCI BIOTECH BIOCH, V77, P38, DOI 10.1271/bbb.120484
   Liu M, 2013, J LIPID RES, V54, P2083, DOI 10.1194/jlr.M035139
   Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122
   Vicente J, 2012, MOL PLANT, V5, P914, DOI 10.1093/mp/ssr105
   Cristea M, 2005, ARCH BIOCHEM BIOPHYS, V434, P201, DOI 10.1016/j.abb.2004.10.026
   Wennman A, 2013, J LIPID RES, V54, P762, DOI 10.1194/jlr.M033787
   Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228
   Heshof R, 2014, APPL MICROBIOL BIOT, V98, P1261, DOI 10.1007/s00253-013-5392-x
   SOK DE, 1990, ARCH BIOCHEM BIOPHYS, V277, P86, DOI 10.1016/0003-9861(90)90554-C
   Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032
   Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x
   Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080
   Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919
   Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145
   Gaffney BJ, 2014, ACCOUNTS CHEM RES, V47, P3588, DOI 10.1021/ar500290r
   Kuhn H., 2014, BIOCHIM BIOPHYS ACTA, V185, P308
   MacPherson IS, 2007, CELL MOL LIFE SCI, V64, P2887, DOI 10.1007/s00018-007-7310-9
   Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514
   Xue MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002869
NR 36
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 87
EP 95
DI 10.1016/j.abb.2015.07.014
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400011
PM 26264916
ER

PT J
AU Scian, M
   Atkins, WM
AF Scian, Michele
   Atkins, William M.
TI The busulfan metabolite EdAG irreversibly glutathionylates glutaredoxins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Busulfan; Glutathionylation; Drug metabolism; Redox regulation; Mass
   spectrometry
ID HEPATIC VENOOCCLUSIVE-DISEASE; BONE-MARROW-TRANSPLANTATION; STEM-CELL
   TRANSPLANTATION; S-TRANSFERASE A1-1; RISK-FACTORS; PROTEIN
   GLUTATHIONYLATION; MASS-SPECTROMETRY; MECHANISMS; CHILDREN; EFFICACY
AB The DNA alkylating agent busulfan is used to `precondition' patients with leukemia, lymphomas and other hematological disorders prior to hematopoietic stem cell transplants. Busulfan is metabolized via conjugation with glutathione (GSH) followed by intramolecular rearrangement to the GSH analog gamma-glutamyl-dehydroalanyl -glycine (EdAG). EdAG contains the electrophilic dehydroalanine, which is expected to react with protein nucleophiles, particularly proteins with GSH binding sites such as glutaredoxins (Grx's). Incubation of EdAG with human Grx-1 or Grx-2 results in facile adduction of cys-23 and cys-77, respectively, as determined by ESI-MS/MS. The resulting modified proteins are catalytically inactive. In contrast, the glutathione transferase A1-1 includes a GSH binding site with a potentially reactive tyrosinate (Tyr-9) but it does not react with EdAG. Similarly, Cys-112 of GSTA1-1, which lies outside the active site and is known to form disulfides with GSH, does not react with EdAG. The results provide the first demonstration of the reactivity of any busulfan metabolites with intact proteins, and they suggest that GSH-binding sites containing thiolates are most susceptible. The adduction of Grx's by EdAG suggests the possible alteration of proteins that are normally regulated via Grx-dependent reversible glutathionylation or deglutathionylation. Dysregulation of Grx-dependent processes could contribute to cellular toxicity of busulfan. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Scian, Michele; Atkins, William M.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA.
RP Atkins, WM (reprint author), Univ Washington, Dept Med Chem, Box 357610, Seattle, WA 98195 USA.
EM winky@u.washington.edu
FU Department of Medicinal Chemistry, University of Washington; 
   [R01CA182963]
FX This work was supported by The Department of Medicinal Chemistry,
   University of Washington and grant R01CA182963. The authors acknowledge
   Professor Caryn Outten Department of Chemistry and Biochemistry,
   University of South Carolina for supplying constructs for the expression
   of GRx-1 and Grx-2.
CR Knerr PJ, 2012, ANNU REV BIOCHEM, V81, P479, DOI 10.1146/annurev-biochem-060110-113521
   Townsend Danyelle M., 2014, V122, P177, DOI 10.1016/B978-0-12-420117-0.00005-0
   Menon D, 2013, J BIOL CHEM, V288, P25769, DOI 10.1074/jbc.M113.487785
   Diestelhorst C, 2013, CANCER CHEMOTH PHARM, V72, P991, DOI 10.1007/s00280-013-2275-x
   Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018
   Bruno B, 2004, BONE MARROW TRANSPL, V34, P143, DOI 10.1038/sj.bmt.1704549
   McCune JS, 2009, EXPERT OPIN DRUG MET, V5, P957, DOI 10.1517/17425250903107764
   Jian WY, 2012, J AM SOC MASS SPECTR, V23, P964, DOI 10.1007/s13361-012-0354-6
   Findlay VJ, 2005, BIOMED PHARMACOTHER, V59, P374, DOI 10.1016/j.biopha.2005.07.003
   Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w
   Lyon RP, 2002, BIOCHEMISTRY-US, V41, P10920, DOI 10.1021/bi0262810
   Reiss U, 2002, J PEDIAT HEMATOL ONC, V24, P746, DOI 10.1097/00043426-200212000-00013
   Sun CH, 1998, J MOL BIOL, V280, P687, DOI 10.1006/jmbi.1998.1913
   Barker CC, 2003, BONE MARROW TRANSPL, V32, P79, DOI 10.1038/sj.bmt.1704069
   ATKINS WM, 1993, J BIOL CHEM, V268, P19188
   ASQUITH RS, 1972, BIOCHIM BIOPHYS ACTA, V285, P346, DOI 10.1016/0005-2795(72)90319-4
   Bouldin SD, 2012, BIOCHEM J, V446, P59, DOI 10.1042/BJ20120075
   El-Serafi I, 2013, J CHROMATOGR B, V913, P98, DOI 10.1016/j.jchromb.2012.12.001
   Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599
   Carreras E, 1998, BLOOD, V92, P3599
   Cooper AJL, 2011, EXPERT OPIN DRUG MET, V7, P891, DOI 10.1517/17425255.2011.577738
   Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200
   Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354
   JONES RJ, 1987, TRANSPLANTATION, V44, P778, DOI 10.1097/00007890-198712000-00011
   Stroher E, 2012, BIOCHEM J, V446, P333, DOI 10.1042/BJ20112131
   Srivastava A, 2004, BLOOD, V104, P1574, DOI 10.1182/blood-2003-11-3778
   Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003
   Ferry C, 2003, EXP HEMATOL, V31, P1182, DOI 10.1016/j.exphem.2003.09.008
   Xie C, 2013, ANAL CHIM ACTA, V788, P89, DOI 10.1016/j.aca.2013.06.022
   Uppugunduri CRS, 2014, PHARMACOGENOMICS J, V14, P263, DOI 10.1038/tpj.2013.38
   Cesaro S, 2005, HAEMATOL-HEMATOL J, V90, P1396
   Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003
   Reece D, 2013, ONCOLOGIST, V18, P611, DOI 10.1634/theoncologist.2012-0384
   Eberly AL, 2008, PHARMACOTHERAPY, V28, P1502, DOI 10.1592/phco.28.12.1502
   Younis IR, 2008, J PHARMACOL EXP THER, V327, P770, DOI 10.1124/jpet.108.142208
   Li JP, 2008, DRUG SAFETY, V31, P127
   Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200
   Czerwinski Maciej, 1996, Drug Metabolism and Disposition, V24, P1015
   Krivoy Norberto, 2008, Curr Drug Saf, V3, P60, DOI 10.2174/157488608783333899
   Mailloux Ryan J, 2014, Front Cell Dev Biol, V2, P68, DOI 10.3389/fcell.2014.00068
   Scian M., SUPPORTING DAT UNPUB
   Younis I. R., 2008, THESIS W VIRGINIA U
NR 42
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 96
EP 104
DI 10.1016/j.abb.2015.08.005
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400012
PM 26278353
ER

PT J
AU Spyrakis, F
   Cavasotto, CN
AF Spyrakis, Francesca
   Cavasotto, Claudio N.
TI Open challenges in structure-based virtual screening: Receptor modeling,
   target flexibility consideration and active site water molecules
   description
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Structure-based drug discovery; Homology modeling; Ligand docking;
   Virtual screening; Protein flexibility; Active site water molecules
ID PROTEIN-LIGAND DOCKING; SIDE-CHAIN FLEXIBILITY; STRUCTURE-BASED DESIGN;
   MULTIPLE SEQUENCE ALIGNMENT; COMPUTATIONAL DRUG DESIGN; SOLVATION
   FREE-ENERGIES; HIGH-THROUGHPUT DOCKING; REPLICA-EXCHANGE METHOD;
   HOMOLOGY MODELS; COUPLED RECEPTORS
AB Structure-based virtual screening is currently an established tool in drug lead discovery projects. Although in the last years the field saw an impressive progress in terms of algorithm development, computational performance, and retrospective and prospective applications in ligand identification, there are still long-standing challenges where further improvement is needed. In this review, we consider the conceptual frame, state-of-the-art and recent developments of three critical "structural" issues in structure-based drug lead discovery: the use of homology modeling to accurately model the binding site when no experimental structures are available, the necessity of accounting for the dynamics of intrinsically flexible systems as proteins, and the importance of considering active site water molecules in lead identification and optimization campaigns. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Spyrakis, Francesca] Univ Modena & Reggio Emilia, Dept Life Sci, I-41125 Modena, Italy.
   [Cavasotto, Claudio N.] Inst Invest Biomed Buenos Aires IBioBA, CONICET, Max Planck Soc IBioBA MPSP, Partner Inst, RA-C1425FQD Buenos Aires, DF, Argentina.
RP Cavasotto, CN (reprint author), Inst Invest Biomed Buenos Aires IBioBA, CONICET, Max Planck Soc IBioBA MPSP, Partner Inst, Godoy Cruz 2390,C1425FQD, RA-C1425FQD Buenos Aires, DF, Argentina.
EM cnc@cavasotto-lab.net
FU Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina
   [PICT-2011-2778]; FOCEM-Mercosur [COF 03/11]
FX This work has been supported by the Agencia Nacional de Promocion
   Cientifica y Tecnologica, Argentina (PICT-2011-2778 to CNC) and
   FOCEM-Mercosur (COF 03/11).
CR Ahmed MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024712
   GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002
   Li Z, 2006, J PHYS CHEM B, V110, P1464, DOI 10.1021/jp056020a
   de Beer SBA, 2010, CURR TOP MED CHEM, V10, P55
   Huang N, 2008, J MED CHEM, V51, P4862, DOI 10.1021/jm8006239
   Cheng XL, 2005, J PHYS CHEM B, V109, P8220, DOI 10.1021/jp045437y
   Vass M, 2014, EUR J MED CHEM, V77, P38, DOI 10.1016/j.ejmech.2014.02.034
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197
   Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250
   Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897
   Huang N, 2006, J CHEM INF MODEL, V46, P243, DOI 10.1021/ci0502855
   Evers A, 2004, J MED CHEM, V47, P5381, DOI 10.1021/jm0311487
   Sinko W, 2013, CHEM BIOL DRUG DES, V81, P41, DOI 10.1111/cbdd.12051
   Roy S, 2012, J PHYS CHEM B, V116, P2958, DOI 10.1021/jp209437j
   Barillari C, 2007, J AM CHEM SOC, V129, P2577, DOI 10.1021/ja066980q
   Bortolato A, 2013, J CHEM INF MODEL, V53, P1700, DOI 10.1021/ci4001458
   Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162
   Singh R, 2013, J BIOMOL STRUCT DYN, V31, P694, DOI 10.1080/07391102.2012.707460
   Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232
   Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010
   Sirci F, 2012, J CHEM INF MODEL, V52, P3308, DOI 10.1021/ci3004094
   TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0
   Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356
   Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p
   Rueda M, 2010, J CHEM INF MODEL, V50, P186, DOI 10.1021/ci9003943
   [Anonymous], 2012, MACROMODEL
   Petrov RR, 2013, EUR J MED CHEM, V69, P881, DOI 10.1016/j.ejmech.2013.09.038
   Bren U, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4732514
   Hritz J, 2008, J MED CHEM, V51, P7469, DOI 10.1021/jm801005m
   BORGIS D, 1995, CHEM PHYS LETT, V238, P187, DOI 10.1016/0009-2614(95)00380-0
   Horn HW, 2004, J CHEM PHYS, V120, P9665, DOI 10.1063/1.1683075
   Barducci A, 2011, WIRES COMPUT MOL SCI, V1, P826, DOI 10.1002/wcms.31
   Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005
   Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505
   Koppen H, 2009, CURR OPIN DRUG DISC, V12, P397
   Stegmann CM, 2009, ANGEW CHEM INT EDIT, V48, P5207, DOI 10.1002/anie.200900481
   Hu LH, 2009, J PHYS CHEM A, V113, P11793, DOI 10.1021/jp9029024
   Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e
   Korb O, 2012, J CHEM INF MODEL, V52, P1262, DOI 10.1021/ci2005934
   Obiol-Pardo C, 2011, PROTEINS, V79, P1695, DOI 10.1002/prot.23021
   Alcaro S, 2009, J CHEM INF MODEL, V49, P1751, DOI 10.1021/ci900012k
   Therrien E, 2014, J CHEM INF MODEL, V54, P3198, DOI 10.1021/ci500299h
   Okamoto M, 2009, J MED CHEM, V52, P7323, DOI 10.1021/jm901191q
   Sisay MT, 2010, J MED CHEM, V53, P5523, DOI 10.1021/jm100183e
   Monti MC, 2007, CHEMBIOCHEM, V8, P1585, DOI 10.1002/cbic.200700217
   Cavasotto CN, 2012, METHODS MOL BIOL, V819, P157, DOI 10.1007/978-1-61779-465-0_11
   Monecke P, 2006, BIOPHYS J, V90, P841, DOI 10.1529/biophysj.105.065524
   Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074
   Snyder PW, 2011, P NATL ACAD SCI USA, V108, P17889, DOI 10.1073/pnas.1114107108
   Jain AN, 2009, J COMPUT AID MOL DES, V23, P355, DOI 10.1007/s10822-009-9266-3
   Zheng MY, 2013, J COMPUT CHEM, V34, P583, DOI 10.1002/jcc.23170
   Chin SP, 2014, J MOL GRAPH MODEL, V49, P91, DOI 10.1016/j.jmgm.2014.02.002
   Beier C, 2010, EXPERT OPIN DRUG DIS, V5, P347, DOI 10.1517/17460441003713462
   Baroni M, 2007, J CHEM INF MODEL, V47, P279, DOI 10.1021/ci600253e
   Verdonk ML, 1999, J MOL BIOL, V289, P1093, DOI 10.1006/jmbi.1999.2809
   LAM PYS, 1994, SCIENCE, V263, P380, DOI 10.1126/science.8278812
   Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067
   Abel R, 2011, CHEMMEDCHEM, V6, P1049, DOI 10.1002/cmdc.201000533
   Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877
   Yuriev E, 2015, J MOL RECOGNIT, V28, P581, DOI 10.1002/jmr.2471
   Evers A, 2004, ANGEW CHEM INT EDIT, V43, P248, DOI 10.1002/anie.200352776
   Cheng JL, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-18
   Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4
   Mortier J, 2010, BIOORG MED CHEM LETT, V20, P4515, DOI 10.1016/j.bmcl.2010.06.027
   Corbeil CR, 2009, J CHEM INF MODEL, V49, P997, DOI 10.1021/ci8004176
   Lobaugh J, 1997, J CHEM PHYS, V106, P2400, DOI 10.1063/1.473151
   Lundstrom K, 2007, J CELL MOL MED, V11, P224, DOI 10.1111/j.1582-4934.2007.00028.x
   Mortier J, 2010, BIOCHEM PHARMACOL, V79, P1462, DOI 10.1016/j.bcp.2010.01.007
   Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656
   Kairys V, 2002, J COMPUT CHEM, V23, P1656, DOI 10.1002/jcc.10168
   Ghosh A, 1998, J PHYS CHEM B, V102, P10983, DOI 10.1021/jp982533o
   Zavodszky MI, 2005, PROTEIN SCI, V14, P1104, DOI 10.1110/ps.041153605
   Hayik SA, 2010, J CHEM THEORY COMPUT, V6, P3079, DOI 10.1021/ct100315g
   Liu P, 2005, P NATL ACAD SCI USA, V102, P13749, DOI 10.1073/pnas.0506346102
   Huang N, 2006, PHYS CHEM CHEM PHYS, V8, P5166, DOI 10.1039/b608269f
   Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515
   Anisimov VM, 2009, CHEMPHYSCHEM, V10, P3194, DOI 10.1002/cphc.200900535
   Kokubo H, 2013, J COMPUT CHEM, V34, P2601, DOI 10.1002/jcc.23427
   Cavasotto CN, 2015, CHEM COMMUN, V51, P13576, DOI 10.1039/c5cc05050b
   Genheden S, 2011, J AM CHEM SOC, V133, P13081, DOI 10.1021/ja202972m
   Verdonk ML, 2008, J CHEM INF MODEL, V48, P2214, DOI 10.1021/ci8002254
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003
   Osterberg F, 2002, PROTEINS, V46, P34, DOI 10.1002/prot.10028
   Park H, 2011, J CHEM INF MODEL, V51, P2986, DOI 10.1021/ci200378s
   Costanzi S, 2014, ADV EXP MED BIOL, V796, P3, DOI 10.1007/978-94-007-7423-0_1
   Bordogna A, 2011, J COMPUT CHEM, V32, P81, DOI 10.1002/jcc.21601
   Garcia-Sosa AT, 2006, J MOL MODEL, V12, P422, DOI 10.1007/s00894-005-0063-1
   Salmon L, 2009, ANGEW CHEM INT EDIT, V48, P4154, DOI 10.1002/anie.200900476
   Ahmed MH, 2013, COMPUT BIOL CHEM, V47, P126, DOI 10.1016/j.compbiolchem.2013.08.009
   Diaz P, 2009, J MED CHEM, V52, P433, DOI 10.1021/jm801353p
   Lopes PEM, 2009, THEOR CHEM ACC, V124, P11, DOI 10.1007/s00214-009-0617-x
   Bolstad ESD, 2008, PROTEINS, V73, P566, DOI 10.1002/prot.22081
   Swaminathan CP, 1999, J BIOL CHEM, V274, P31272, DOI 10.1074/jbc.274.44.31272
   Diaz C, 2013, MOL INFORM, V32, P213, DOI 10.1002/minf.201200047
   Levitt M, 2007, P NATL ACAD SCI USA, V104, P3183, DOI 10.1073/pnas.0611678104
   Pierce LCT, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3581093
   Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406
   Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793
   Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w
   Diaz C, 2011, MOL INFORM, V30, P345, DOI 10.1002/minf.201000180
   Cavasotto CN, 2005, J AM CHEM SOC, V127, P9632, DOI 10.1021/ja042260c
   Okamoto Y, 2013, ADV PROTEIN CHEM STR, V92, P63, DOI 10.1016/B978-0-12-411636-8.00002-X
   Cozzini P, 2006, INT J QUANTUM CHEM, V106, P647, DOI 10.1002/qua.20812
   KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104
   Leone V, 2010, CURR OPIN STRUC BIOL, V20, P148, DOI 10.1016/j.sbi.2010.01.011
   Amadasi A, 2008, J MED CHEM, V51, P1063, DOI 10.1021/jm701023h
   Vilar S, 2011, J MOL GRAPH MODEL, V29, P614, DOI 10.1016/j.jmgm.2010.11.005
   Soderhjelm P, 2009, J PHYS CHEM B, V113, P11085, DOI 10.1021/jp810551h
   Dong BL, 2011, J MOL MODEL, V17, P1727, DOI 10.1007/s00894-010-0881-7
   Andaloussi M, 2011, J MED CHEM, V54, P4964, DOI 10.1021/jm2000085
   [Anonymous], 2009, GLID
   Kellogg GE, 2004, J MOL GRAPH MODEL, V22, P479, DOI 10.1016/j.jmgm.2004.03.008
   Guimaraes CRW, 2010, J CHEM INF MODEL, V50, P547, DOI 10.1021/ci900497d
   Li Z, 2005, J PHYS CHEM B, V109, P662, DOI 10.1021/jp0477912
   Koska J, 2008, J CHEM INF MODEL, V48, P1965, DOI 10.1021/ci800081s
   [Anonymous], 2014, NUCL ACIDS RES, V42, pD191
   Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129
   Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w
   Fan H, 2009, J CHEM INF MODEL, V49, P2512, DOI 10.1021/ci9003706
   Setny P, 2010, J CHEM THEORY COMPUT, V6, P2866, DOI 10.1021/ct1003077
   Nabuurs SB, 2007, J MED CHEM, V50, P6507, DOI 10.1021/jm070593p
   Li SL, 2011, J CHEM INF MODEL, V51, P2939, DOI 10.1021/ci2002445
   Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155
   Liu CJ, 2005, J MED CHEM, V48, P6261, DOI 10.1021/jm0503594
   MIKOL V, 1995, J MED CHEM, V38, P3361, DOI 10.1021/jm00017a020
   Michel J, 2009, J PHYS CHEM B, V113, P13337, DOI 10.1021/jp9047456
   Clark DE, 2008, EXPERT OPIN DRUG DIS, V3, P841, DOI [10.1517/17460441.3.8.841, 10.1517/17460440802281978]
   Gonzalez-Cestari TF, 2009, J PHARMACOL EXP THER, V328, P504, DOI 10.1124/jpet.108.144576
   Seo J, 2007, J MED CHEM, V50, P2089, DOI 10.1021/jm061305c
   Nikolic D, 2012, J CHEM THEORY COMPUT, V8, P3356, DOI 10.1021/ct300257v
   Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129
   Dobes P, 2011, J COMPUT AID MOL DES, V25, P223, DOI 10.1007/s10822-011-9413-5
   Huggins DJ, 2011, PROTEIN ENG DES SEL, V24, P777, DOI 10.1093/protein/gzr036
   Lu YP, 2007, J CHEM INF MODEL, V47, P668, DOI 10.1021/ci6003527
   Congreve M, 2005, DRUG DISCOV TODAY, V10, P895, DOI 10.1016/S1359-6446(05)03484-7
   Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445
   Zoete V, 2009, J CELL MOL MED, V13, P238, DOI [10.1111/j.1582-4934.2008.00665.x, 10.1111/j.1582-4934.2009.00665.x]
   Trujillo JI, 2012, BIOORG MED CHEM LETT, V22, P3795, DOI 10.1016/j.bmcl.2012.04.004
   Tang H, 2012, PROTEINS, V80, P1503, DOI 10.1002/prot.24035
   deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O
   Young T, 2007, P NATL ACAD SCI USA, V104, P808, DOI 10.1073/pnas.0610202104
   Garcia-Sosa AT, 2011, J CHEM INF MODEL, V51, P2595, DOI 10.1021/ci200203h
   Mobarec JC, 2009, J MED CHEM, V52, P5207, DOI 10.1021/jm9005252
   Spyrakis F, 2014, CHEMMEDCHEM, V9, P1501, DOI 10.1002/cmdc.201300527
   Sugita Y, 2000, J CHEM PHYS, V113, P6042, DOI 10.1063/1.1308516
   Tsai CJ, 1999, PROTEIN SCI, V8, P1181
   Edinger SR, 1997, J PHYS CHEM B, V101, P1190, DOI 10.1021/jp962156k
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   Barril X, 2005, J MED CHEM, V48, P4432, DOI 10.1021/jm048972v
   Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477
   Anisimov VM, 2011, J COMPUT AID MOL DES, V25, P1071, DOI 10.1007/s10822-011-9484-3
   Phatak SS, 2010, J CHEM INF MODEL, V50, P2119, DOI 10.1021/ci100285f
   Garcia-Sosa AT, 2003, J MOL MODEL, V9, P172, DOI 10.1007/s00894-003-0129-x
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Thomas T, 2014, J CHEM INF MODEL, V54, P243, DOI 10.1021/ci400502u
   Craig IR, 2010, J CHEM INF MODEL, V50, P511, DOI 10.1021/ci900407c
   Teodoro ML, 2003, CURR PHARM DESIGN, V9, P1635, DOI 10.2174/1381612033454595
   Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302
   Diaz P, 2009, CHEMMEDCHEM, V4, P1615, DOI 10.1002/cmdc.200900226
   Amadasi A, 2006, J MOL BIOL, V358, P289, DOI 10.1016/j.jmb.2006.01.053
   Ferrari AM, 2004, J MED CHEM, V47, P5076, DOI 10.1021/jm049756p
   Wong SE, 2011, EXPERT OPIN DRUG DIS, V6, P65, DOI 10.1517/17460441.2011.534452
   Brylinski M, 2013, J CHEM INF MODEL, V53, P3097, DOI 10.1021/ci400510e
   Kovacs JA, 2005, J COMPUT THEOR NANOS, V2, P354, DOI 10.1166/jctn.2005.204
   Villacanas O, 2009, CURR COMPUT-AID DRUG, V5, P145
   Chen JM, 1998, BIOCHEMISTRY-US, V37, P17735, DOI 10.1021/bi981848r
   Garcia-Sosa AT, 2005, J CHEM INF MODEL, V45, P624, DOI 10.1021/ci049694b
   Hann MM, 2012, NAT REV DRUG DISCOV, V11, P355, DOI 10.1038/nrd3701
   Beuming T, 2012, J CHEM INF MODEL, V52, P3263, DOI [10.1021/ci300411b, 10.1021/ci3004111]
   Forti F, 2012, J CHEM THEORY COMPUT, V8, P1808, DOI 10.1021/ct300097s
   Cavasotto CN, 2008, J MED CHEM, V51, P581, DOI 10.1021/jm070759m
   Sousa SF, 2013, CURR MED CHEM, V20, P2296
   Moro S, 2006, CURR PHARM DESIGN, V12, P2175, DOI 10.2174/138161206777585265
   Sedlak R, 2013, J CHEM THEORY COMPUT, V9, P3364, DOI 10.1021/ct400036b
   Gatica EA, 2012, J CHEM INF MODEL, V52, P1, DOI 10.1021/ci200412p
   Henzler AM, 2010, MOL INFORM, V29, P164, DOI 10.1002/minf.200900078
   Shin WH, 2013, J COMPUT CHEM, V34, P2647, DOI 10.1002/jcc.23438
   Hamelberg D, 2004, J AM CHEM SOC, V126, P7683, DOI 10.1021/ja0377908
   Costanzi S, 2008, J MED CHEM, V51, P2907, DOI [10.1021/jm800044k, 10.1021/jim800044k]
   Cavasotto CN, 2004, J MOL BIOL, V337, P209, DOI 10.1016/j.jmb.2004.01.003
   Seeliger D, 2007, STRUCTURE, V15, P1482, DOI 10.1016/j.str.2007.09.017
   Damm KL, 2007, J AM CHEM SOC, V129, P8225, DOI 10.1021/ja0709728
   Ekstrom JL, 2002, CHEM BIOL, V9, P915, DOI 10.1016/S1074-5521(02)00186-2
   Cavasotto CN, 2009, DRUG DISCOV TODAY, V14, P676, DOI 10.1016/j.drudis.2009.04.006
   Rossato G, 2011, J CHEM INF MODEL, V51, P1867, DOI 10.1021/ci200150p
   Garcia-Sosa AT, 2013, J CHEM INF MODEL, V53, P1388, DOI 10.1021/ci3005786
   Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791
   Engels K, 2010, CHEMMEDCHEM, V5, P1259, DOI 10.1002/cmdc.201000157
   Novoa EM, 2010, J CHEM THEORY COMPUT, V6, P2547, DOI 10.1021/ct100246y
   Katz BA, 2004, J MOL BIOL, V344, P527, DOI 10.1016/j.jmb.2004.09.032
   Corbeil CR, 2008, J CHEM INF MODEL, V48, P902, DOI 10.1021/ci700398h
   Phatak SS, 2009, EXPERT OPIN DRUG DIS, V4, P947, DOI 10.1517/17460440903190961
   Cozzini P, 2008, J MED CHEM, V51, P6237, DOI 10.1021/jm800562d
   Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171
   Dalton JAR, 2010, J MOL BIOL, V399, P645, DOI 10.1016/j.jmb.2010.04.047
   Mahasenan KV, 2011, ACS MED CHEM LETT, V2, P855, DOI 10.1021/ml2001714
   Anisimov VM, 2011, J COMPUT CHEM, V32, P2254, DOI 10.1002/jcc.21808
   JIANG F, 1991, J MOL BIOL, V219, P79, DOI 10.1016/0022-2836(91)90859-5
   Ivetac A, 2010, CHEM BIOL DRUG DES, V76, P201, DOI 10.1111/j.1747-0285.2010.01012.x
   Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+
   Schnecke V, 2000, PERSPECT DRUG DISCOV, V20, P171, DOI 10.1023/A:1008737207775
   Raha K, 2007, DRUG DISCOV TODAY, V12, P725, DOI 10.1016/j.drudis.2007.07.006
   Rarey M, 1999, PROTEINS, V34, P17, DOI 10.1002/(SICI)1097-0134(19990101)34:1<17::AID-PROT3>3.0.CO;2-1
   Illingworth CJR, 2008, J PHYS CHEM A, V112, P12157, DOI 10.1021/jp710169m
   May A, 2008, J MED CHEM, V51, P3499, DOI 10.1021/jm800071v
   Brooijmans N, 2003, ANNU REV BIOPH BIOM, V32, P335, DOI 10.1146/annurev.biophys.32.110601.142532
   Michel J, 2009, J AM CHEM SOC, V131, P15403, DOI 10.1021/ja906058w
   Wang L, 2011, P NATL ACAD SCI USA, V108, P1326, DOI 10.1073/pnas.1016793108
   Wissner A, 2000, J MED CHEM, V43, P3244, DOI 10.1021/jm000206a
   Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399
   Kufareva I, 2014, STRUCTURE, V22, P1120, DOI 10.1016/j.str.2014.06.012
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Cavasotto CN, 2003, PROTEINS, V51, P423, DOI 10.1002/prot.10362
   Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907
   Birch L, 2002, J COMPUT AID MOL DES, V16, P855, DOI 10.1023/A:1023844626572
   Horvath D, 2011, METHODS MOL BIOL, V672, P261, DOI 10.1007/978-1-60761-839-3_11
   Santos R, 2010, J CHEM INF MODEL, V50, P146, DOI 10.1021/ci900293e
   Cavasotto CN, 2011, CURR TOP MED CHEM, V11, P1528
   Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n
   Sperandio O, 2010, EUR BIOPHYS J BIOPHY, V39, P1365, DOI 10.1007/s00249-010-0592-0
   Yoshikawa Y, 2013, J MED CHEM, V56, P4236, DOI 10.1021/jm400307y
   Raymer ML, 1997, J MOL BIOL, V265, P445, DOI 10.1006/jmbi.1996.0746
   Lloyd DG, 2004, J COMPUT AID MOL DES, V18, P89, DOI 10.1023/B:jcam.0000030032.81753.b4
   Amira S, 2004, CHEM PHYS, V303, P327, DOI 10.1016/j.chemphys.2004.04.024
   Monti MC, 2009, CHEM-EUR J, V15, P1155, DOI 10.1002/chem.200801512
   Pala D, 2013, J CHEM INF MODEL, V53, P821, DOI [10.1021/ci4000147, 10.1021/ci40001471]
   Muddana HS, 2012, J CHEM THEORY COMPUT, V8, P2023, DOI 10.1021/ct3002738
   Lin XY, 2012, J MED CHEM, V55, P5749, DOI 10.1021/jm300338m
   Moult J, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22589
   MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412
   Biela A, 2013, ANGEW CHEM INT EDIT, V52, P1822, DOI 10.1002/anie.201208561
   LEACH AR, 1994, J MOL BIOL, V235, P345, DOI 10.1016/S0022-2836(05)80038-5
   Park IH, 2010, J PHYS CHEM B, V114, P5144, DOI 10.1021/jp911085d
   Corbeil CR, 2007, J CHEM INF MODEL, V47, P435, DOI 10.1021/ci6002637
   McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012
   Moitessier N, 2004, J MED CHEM, V47, P4178, DOI 10.1021/jm0311386
   de Courcy B, 2010, J AM CHEM SOC, V132, P3312, DOI 10.1021/ja9059156
   Kolaczkowski M, 2013, J CHEM INF MODEL, V53, P638, DOI 10.1021/ci300413h
   Zhang QY, 2010, J CHEM INF MODEL, V50, P317, DOI 10.1021/ci900425t
   Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012
   Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c
   Cavasotto CN, 2008, CURR COMPUT-AID DRUG, V4, P221, DOI 10.2174/157340908785747474
   Forli S, 2012, J MED CHEM, V55, P623, DOI 10.1021/jm2005145
   McRobb FM, 2010, J CHEM INF MODEL, V50, P626, DOI 10.1021/ci900444q
   Tame JRH, 1996, NAT STRUCT BIOL, V3, P998, DOI 10.1038/nsb1296-998
   [Anonymous], 2013, SCHROD SUIT PROT PRE
   Bottegoni G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018845
   B-Rao C, 2009, DRUG DISCOV TODAY, V14, P394
   Cavasotto CN, 2012, RSC DRUG DISCOV, P195, DOI 10.1039/9781849735377-00195
   CHOTHIA C, 1986, EMBO J, V5, P823
   Cohen EML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S4-S7
   Costanzi Stefano, 2012, Methods Mol Biol, V857, P259, DOI 10.1007/978-1-61779-588-6_11
   DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670
   Fernandez-Fuentes N, 2007, BIOINFORMATICS, V23, P2558, DOI 10.1093/bioinformatics/btm377
   Fiser A, 2004, EXPERT REV PROTEOMIC, V1, P97, DOI 10.1586/14789450.1.1.97
   Fisher E., 1894, BER DTSCH CHEM GES, V27, P2985
   Fukunishi F, 2002, J CHEM PHYS, V116, P9058
   Fukunishi Yoshifumi, 2013, Pharmaceuticals (Basel), V6, P604, DOI 10.3390/ph6050604
   Garcia-Sosa AT, 2013, SAR QSAR ENVIRON RES, V24, P585, DOI 10.1080/1062936X.2013.773373
   Gordon T. Head, 1995, P NATL ACAD SCI USA, V92, P8308
   Grant BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025711
   Kastner KW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-434
   Kaufmann KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050769
   Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601
   Lemieux RU, 1996, ACCOUNTS CHEM RES, V29, P373, DOI 10.1021/ar9600087
   Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10
   Lounnas V., 2013, COMPUT STRUCT BIOTEC, V5
   Lushington GH, 2015, METHODS MOL BIOL, V1215, P309, DOI 10.1007/978-1-4939-1465-4_14
   Nguyen CN, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4733951
   Nguyen ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067302
   Orry A. J. W., 2006, 231 M AM CHEM SOC AT
   Palomba D., 2015, SILICO DRUG DISCOVER, P215
   Park H, 2014, J BIOMOL SCREEN, V19, P1383, DOI 10.1177/1087057114550784
   Patey G., 1975, J CHEM PHYS, V64, P2334
   Ramirez-Duran LA, 2013, CURR PHARM DESIGN, V19, P2204
   Rossi M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.113
   Söderhjelm Pär, 2010, Interdiscip Sci, V2, P21, DOI 10.1007/s12539-010-0083-0
   Spoel DVD, 2005, J COMPUT CHEM, V26, P1701, DOI DOI 10.1002/JCC.20291
   Spyrakis F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077558
   Spyrakis F., 2010, BURGERS MED CHEM DRU, P601
   Spyrakis F., 2015, UNPUB
   Spyrakis F., 2007, FRONT DRUG DES DISCO, V3, P317
   Spyrakis F, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-4
   Tsui Vickie, 2000, Biopolymers, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E
   Vass M, 2014, ACS MED CHEM LETT, V5, P1010, DOI [10.1021/ml500201u, 10.1021/m1500201u]
   Waszkowycz B., 2011, WILEY INTERDISCIP RE, P229
NR 292
TC 1
Z9 1
U1 18
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 105
EP 119
DI 10.1016/j.abb.2015.08.002
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400013
PM 26271444
ER

PT J
AU Sosa, MH
   Giordana, L
   Nowicki, C
AF Hernan Sosa, Maximo
   Giordana, Lucila
   Nowicki, Cristina
TI Exploring biochemical and functional features of Leishmania major
   phosphoenolpyruvate carboxykinase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Leishmania parasites; Phosphoenolyruvate carboxykinase;
   3-Mercaptopicolinic acid; Mutagenesis studies
ID TRYPANOSOMA-CRUZI; SACCHAROMYCES-CEREVISIAE; PHOSPHORYL-TRANSFER;
   CRYSTAL-STRUCTURE; MEXICANA; PROTEINS; ACID; EPIMASTIGOTES;
   PROMASTIGOTES; PURIFICATION
AB This work reports the first functional characterization of leishmanial PEPCK. The recombinant Leishmania major enzyme (Lmj_PEPCK) exhibits equivalent k(cat) values for the phosphoenolpyruvate (PEP) and oxaloacetate (OAA) forming reactions. The apparent K-m towards OAA is 10-fold lower than that for PEP, while the K-m values for ADP and ATP are equivalent. Mutagenesis studies showed that D241, D242 and H205 of Lmj_PEPCK like the homologous residues of all known PEPCKs are implicated in metal ions binding. In contrast, the replacement of R43 for Q nearly abolishes Lmj_PEPCK activity. Moreover, the Y180F variant exhibits unchanged K-m values for PEP, Mn2+, and HCO3-, being the k(cat) for PEP- but not that for OAA-forming reaction more notably decreased. Instead, the Y180A mutant displays an increase in the K-m value towards Mn2+. Therefore in Lmj_PEPCK, Y180 seems to exert different functions to those of the analogous residue in ATP- and GTP-dependant enzymes. Besides, the guanidinium group of R43 appears to play an essential but yet unknown role. These findings promote the need for further structural studies to disclose whether Y180 and R43 participate in the catalytic mechanism or/and in the transitions between the open and the catalytically competent (closed) forms of Lmj_PEPCK (C) 2015 Elsevier Inc. All rights reserved.
C1 [Hernan Sosa, Maximo; Giordana, Lucila; Nowicki, Cristina] Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Quim & Fisicoquim Biol IQUIFIB, RA-1113 Buenos Aires, DF, Argentina.
RP Nowicki, C (reprint author), Univ Buenos Aires, Fac Farm & Bioquim, CONICET, Inst Quim & Fisicoquim Biol IQUIFIB, Junin 956,C1113AAD, RA-1113 Buenos Aires, DF, Argentina.
EM cnowicki@qb.ffyb.uba.ar
FU Universidad de Buenos Aires [UBACYT 20100100618]; Agenda Nacional de
   Promocion Cientifica y Tecnologica (ANPCYT, Argentina) [PICT 2008-0219];
   UBA; CONICET
FX This work was performed with grants to CN from Universidad de Buenos
   Aires (UBACYT 20100100618) and Agenda Nacional de Promocion Cientifica y
   Tecnologica (ANPCYT, Argentina, PICT 2008-0219). We are indebted to Dr.
   Gabriela Gomez for her invaluable help with the circular dichroism
   spectroscopy analysis. CN is a member of the Research Career from
   CONICET; MHS and LG are PhD students supported by UBA and CONICET
   respectively.
CR Sullivan SM, 2007, BIOCHEMISTRY-US, V46, P10078, DOI 10.1021/bi701038x
   Delbaere LTJ, 2004, BBA-PROTEINS PROTEOM, V1697, P271, DOI 10.1016/j.bbapap.2003.11.030
   Dunten P, 2002, J MOL BIOL, V316, P257, DOI 10.1006/jmbi.2001.5364
   CYMERYNG C, 1995, MOL BIOCHEM PARASIT, V73, P91, DOI 10.1016/0166-6851(95)00099-M
   Matte A, 1997, J BIOL CHEM, V272, P8105
   Nugent PG, 2004, MOL BIOCHEM PARASIT, V136, P51, DOI 10.1016/j.molbiopara.2004.02.009
   Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553
   Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543
   MOTTRAM JC, 1985, EXP PARASITOL, V59, P151, DOI 10.1016/0014-4894(85)90067-0
   Dharmarajan L, 2008, FEBS J, V275, P5810, DOI 10.1111/j.1742-4658.2008.06702.x
   Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x
   HUNT M, 1995, BBA-PROTEIN STRUCT M, V1249, P15, DOI 10.1016/0167-4838(95)00061-X
   Andrade C, 2010, BIOL RES, V43, P191, DOI [/S0716-97602010000200007, 10.4067/S0716-97602010000200007]
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Jurado LA, 1996, BBA-PROTEIN STRUCT M, V1292, P188, DOI 10.1016/0167-4838(95)00201-4
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Brotherton MC, 2010, J PROTEOME RES, V9, P3842, DOI 10.1021/pr100048m
   Paape D, 2010, MOL BIOCHEM PARASIT, V169, P108, DOI 10.1016/j.molbiopara.2009.10.009
   Cotelesage JJH, 2007, INT J BIOCHEM CELL B, V39, P1204, DOI 10.1016/j.biocel.2007.03.015
   Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com
   URBINA JA, 1990, ARCH BIOCHEM BIOPHYS, V282, P91, DOI 10.1016/0003-9861(90)90091-C
   McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913
   Trapani S, 2001, J MOL BIOL, V313, P1059, DOI 10.1006/jmbi.2001.5093
   Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Yevenes A, 2000, BIOCHIMIE, V82, P123, DOI 10.1016/S0300-9084(00)00189-9
   URBINA JA, 1987, ARCH BIOCHEM BIOPHYS, V258, P186, DOI 10.1016/0003-9861(87)90335-3
   Carlson GM, 2009, J BIOL CHEM, V284, P27037, DOI 10.1074/jbc.R109.040568
   Copeland R.A., 2000, ENZYMES PRACTICAL IN
   Creek D.J., 2015, PLOS PATHOG, V16
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   MAKINEN AL, 1983, J BIOL CHEM, V258, P1654
   MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L
   Motulsky H.J., 2003, FITTING MODELS BIOL
   Ravanal C.M., 2004, BIOCHIMIE, V86, P357
   Rodriguez-Contreras D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.569434
   Saunders E.C., 2014, PLOS PATHOG, DOI 10.1371
   Szoor B, 2014, CURR OPIN MICROBIOL, V22, P79, DOI 10.1016/j.mib.2014.09.006
   Tari LW, 1997, NAT STRUCT BIOL, V4, P990, DOI 10.1038/nsb1297-990
NR 40
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 120
EP 129
DI 10.1016/j.abb.2015.07.015
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400014
PM 26271440
ER

PT J
AU Jiang, N
   Hu, LJ
   Liu, CN
   Gao, XL
   Zheng, SM
AF Jiang, Nan
   Hu, Lijun
   Liu, Chaonan
   Gao, Xueli
   Zheng, Shimin
TI 60S ribosomal protein L35 regulates beta-casein translational elongation
   and secretion in bovine mammary epithelial cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE 60S ribosomal protein L35; Translational elongation; Secretion;
   beta-Casein; Bovine mammary epithelial cells
ID TRANSFER-RNA SYNTHETASE; LACTATING DAIRY-COWS; AMINO-ACID; SIGNALING
   PATHWAY; INITIATION-FACTOR; MESSENGER-RNA; MOLECULAR-MECHANISMS;
   MAMMALIAN TARGET; PROLIFERATION; MTOR
AB 60S ribosomal protein L35 (RPL35) is an important component of the 60S ribosomal subunit and has a role in protein translation and endoplasmic reticulum (ER) docking. However, few studies have investigated RPL35 in eukaryotes and much remains to be learned. Here, we analyzed the function of RPL35 in beta-casein (CSN2) synthesis and secretion in bovine mammary epithelial cells (BMECs). We found that methionine (Met) could promote the expressions of CSN2 and RPL35. Analysis of overexpression and inhibition of RPL35 confirmed that it could mediate the Met signal and regulate CSN2 expression. The mechanism of CSN2 regulation by RPL35 was analyzed by coimmunoprecipitation (Co-IP), colocalization, fluorescence resonance energy transfer (FRET) and gene mutation. We found that RPL35 could control ribosome translational elongation during synthesis of CSN2 by interacting with eukaryotic translational elongation factor 2 (eEF2), and that eEF2 was the signaling molecule downstream of RPL35 controlling this process. RPL35 could also control the secretion of CSN2 by locating it to the ER. Taken together, these results revealed that, RPL35 was an important positive regulatory factor involving in the Met-mediated regulation of CSN2 translational elongation and secretion. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Jiang, Nan] Dalian Univ, Coll Life Sci & Technol, Dalian Econ Technol Dev Zone, Liaoning 116622, Peoples R China.
   [Jiang, Nan; Hu, Lijun; Liu, Chaonan; Gao, Xueli; Zheng, Shimin] Northeast Agr Univ, Coll Vet Med, Lab Pathophysiol, Harbin 150030, Peoples R China.
RP Zheng, SM (reprint author), Northeast Agr Univ, Coll Vet Med, Lab Pathophysiol, Harbin 150030, Peoples R China.
EM jiangnan678@sohu.com; ljhu1011@163.com; Yangliweiwela@tom.com;
   wangjingjing0719@163.com; zhengshiminbl@sohu.com
FU National Key Basic Research Program of China [31472169]
FX This work was supported by the National Key Basic Research Program of
   China (Project No. 31472169).
CR Kitten T, 1996, J BACTERIOL, V178, P1548
   Brake DW, 2013, J DAIRY SCI, V96, P3064, DOI 10.3168/jds.2012-6005
   CLARK RM, 1978, J DAIRY SCI, V61, P408
   Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308
   Chen IJ, 2008, BIOCHEM CELL BIOL, V86, P271, DOI 10.1139/o08-032
   Guillier M, 2002, RNA, V8, P878, DOI 10.1017/S1355838202029084
   Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5
   Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219
   Haentjens-Sitri J, 2008, J MOL BIOL, V375, P612, DOI 10.1016/j.jmb.2007.10.058
   Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672
   Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724
   Appuhamy JADRN, 2014, J DAIRY SCI, V97, P419, DOI 10.3168/jds.2013-7189
   Hanigan MD, 2002, J THEOR BIOL, V217, P311, DOI 10.1006/yjtbi.3037
   Rius AG, 2010, J DAIRY SCI, V93, P3114, DOI 10.3168/jds.2009-2743
   Rodnina MV, 2011, BIOCHEM SOC T, V39, P658, DOI 10.1042/BST0390658
   Lu LM, 2012, CAN J ANIM SCI, V92, P433, DOI 10.4141/CJAS2012-063
   Li X, 2005, ACTA BIOCH BIOPH SIN, V37, P573, DOI 10.1111/j.1745-7270.2005.00072.x
   Lu LM, 2013, MOLECULES, V18, P263, DOI 10.3390/molecules18010263
   Bequette BJ, 1998, J DAIRY SCI, V81, P2540
   Achenbach J, 2015, BIOCHIMIE, V114, P80, DOI 10.1016/j.biochi.2014.12.003
   Burgos SA, 2010, DOMEST ANIM ENDOCRIN, V38, P211, DOI 10.1016/j.domaniend.2009.10.005
   Yu CP, 2014, ARCH BIOCHEM BIOPHYS, V564, P142, DOI 10.1016/j.abb.2014.09.014
   Luo CC, 2013, ANIM BIOTECHNOL, V24, P66, DOI 10.1080/10495398.2012.745417
   Wang LN, 2014, INT J MOL SCI, V15, P5952, DOI 10.3390/ijms15045952
   Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740
   Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044
   Rhoads RE, 2007, J MAMMARY GLAND BIOL, V12, P283, DOI 10.1007/s10911-007-9058-0
   Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113
   Bruscella P, 2011, MOL MICROBIOL, V81, P1526, DOI 10.1111/j.1365-2958.2011.07793.x
   Babiano R, 2010, NUCLEIC ACIDS RES, V38, P5177, DOI 10.1093/nar/gkq260
   Zhang X, 2014, MOLECULES, V19, P9435, DOI 10.3390/molecules19079435
   Gamalinda M, 2013, NUCLEIC ACIDS RES, V41, P1965, DOI 10.1093/nar/gks1272
   Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042
   Burgos SA, 2010, J DAIRY SCI, V93, P153, DOI 10.3168/jds.2009-2444
   Huang YL, 2013, MOLECULES, V18, P12987, DOI 10.3390/molecules181012987
   Menzies KK, 2010, FUNCT INTEGR GENOMIC, V10, P87, DOI 10.1007/s10142-009-0140-0
   Margerison JK, 2013, J DAIRY SCI, V96, P6539, DOI 10.3168/jds.2012-6489
   Menzies KK, 2009, FUNCT INTEGR GENOMIC, V9, P197, DOI 10.1007/s10142-008-0103-x
   Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Huang JG, 2012, IN VITRO CELL DEV-AN, V48, P449, DOI 10.1007/s11626-012-9531-y
   Korobeinikova AV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P562, DOI 10.1134/S0006297912060028
   Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798
   Arriola Apelo S I, 2014, J Dairy Sci, V97, P2998, DOI 10.3168/jds.2013-7422
   Bionaz Massimo, 2011, Bioinform Biol Insights, V5, P83, DOI 10.4137/BBI.S7003
   Cascio S., 2014, CANCERS, V2015, P342
   Doepel L, 2014, J DAIRY SCI, V93, P3264
   Ghosh AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039586
   Hague MN, 2013, J DAIRY SCI, V96, P420
   Koromilas A.-E., 2014, BIOCH BIOPHYS ACTA B, V1849, P871
   Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064
   Piccioli-Cappelli F, 2014, J DAIRY SCI, V97, P7788, DOI 10.3168/jds.2014-8336
   Rajesh K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.554
NR 53
TC 0
Z9 0
U1 19
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 130
EP 139
DI 10.1016/j.abb.2015.08.006
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400015
PM 26297660
ER

PT J
AU Chatterjee, T
   Mukherjee, D
   Banerjee, M
   Chatterjee, BK
   Chakrabarti, P
AF Chatterjee, Tanaya
   Mukherjee, Debadrita
   Banerjee, Mousumi
   Chatterjee, Barun K.
   Chakrabarti, Pinak
TI Crystal structure and activity of protein
   L-isoaspartyl-O-methyltransferase from Vibrio cholerae, and the effect
   of AdoHcy binding
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE AdoHcy binding; Crystal structure; Enzyme activity; Methyltransferase;
   Protein repair
ID ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASES; S-ADENOSYLMETHIONINE;
   REPAIR METHYLTRANSFERASE; PYROCOCCUS-FURIOSUS; PEPTIDE SUBSTRATE; ACID
   TOLERANCE; D-ASPARTYL; RECOGNITION; ENZYME; ACCUMULATION
AB The repair enzyme Protein L-isoaspartyl-O-methyltransferase (PIMT) is widely distributed in various organisms. PIMT catalyzes S-adenosylmethionine (AdoMet) dependent methylation of abnormal L-isoaspartyl residues, formed by the deamidation of asparagines and isomerization of aspartates. We report the crystal structure of PIMT of Vibrio cholerae (VcPIMT), the aetiological agent for cholera, complexed with the demethylated cofactor S-adenosyl-L-homocysteine (AdoHcy) to 2.05 A resolution. A stretch of residues (39-58), lining the substrate-binding site, is disordered. Urea-induced unfolding free energy for apo and VcPIMT-AdoHcy complex reveals greater stability for the cofactor-bound protein. The kinetic parameters for the methyltransferase activity of the recombinant VcPIMT was determined using a continuous spectrophotometric color-based assay using the peptide substrate [VYP(L-isoD)HA]. The enzyme exhibited activity higher than the Escherichia coli enzyme and closer to those from thermophilic bacteria and the mammalian source. The association constant for substrate binding is 2.29 x 10(6) M-1, quite similar to that for AdoHcy. The crystal structure and the model of the peptide-bound structure indicate that the majority of the interactions used for cofactor/substrate binding are provided by the main-chain atoms. Evolutionary relationships derived based on a phylogenetic tree constructed using the PIMT sequences are in conformity with the crystal structures of nine AdoHcy-bound PIMTs. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Chatterjee, Tanaya; Chakrabarti, Pinak] Bose Inst, Dept Biochem, Kolkata 700054, India.
   [Mukherjee, Debadrita; Chakrabarti, Pinak] Bose Inst, Bioinformat Ctr, Kolkata 700054, India.
   [Chatterjee, Barun K.] Bose Inst, Dept Phys, Kolkata 700009, India.
   [Banerjee, Mousumi] West Bengal Univ Technol, Dept Biotechnol, Kolkata 700064, India.
RP Chakrabarti, P (reprint author), Bose Inst, Dept Biochem, P1-12 CIT Scheme VIIM, Kolkata 700054, India.
EM pinak@jcbose.ac.in
FU Department of Science and Technology [SR/WOS-A/LS-390/2011]; Dr. D.S.
   Kothari postdoctoral fellowship
FX We thank Dr. A.B. Datta for discussion and P. Chakraborty for his
   assistance during data collection. TC has been supported by the grants
   from the Department of Science and Technology (SR/WOS-A/LS-390/2011). MB
   is supported by Dr. D.S. Kothari postdoctoral fellowship. PC is a JC
   Bose National Fellow.
CR Kagan RM, 1997, COMP BIOCHEM PHYS B, V117, P379, DOI 10.1016/S0305-0491(96)00333-1
   Thapar N, 2002, J BIOL CHEM, V277, P1058, DOI 10.1074/jbc.M108261200
   Kumar A, 2011, J BIOL CHEM, V286, P19652, DOI 10.1074/jbc.M110.200428
   Merrell DS, 2000, J BACTERIOL, V182, P5342, DOI 10.1128/JB.182.19.5342-5350.2000
   Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19
   Lim WK, 2009, P NATL ACAD SCI USA, V106, P2595, DOI 10.1073/pnas.0812588106
   Smith CD, 2002, PROTEIN SCI, V11, P625, DOI 10.1110/ps.37802
   LOWENSON JD, 1991, J BIOL CHEM, V266, P19396
   Bennett EJ, 2003, BIOCHEMISTRY-US, V42, P12844, DOI 10.1021/bi034891+
   Hendricks CL, 2004, ANAL BIOCHEM, V326, P100, DOI 10.1016/j.ab.2003.11.014
   Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217
   Fang PF, 2010, CELL BIOCHEM BIOPHYS, V58, P163, DOI 10.1007/s12013-010-9103-2
   Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4
   [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760
   JOHNSON BA, 1987, J BIOL CHEM, V262, P5622
   Najbauer J, 1996, BIOCHEMISTRY-US, V35, P5183, DOI 10.1021/bi953063g
   DAVID CL, 1995, PROTEIN EXPRES PURIF, V6, P312, DOI 10.1006/prep.1995.1041
   Mudgett MB, 1997, PLANT PHYSIOL, V115, P1481, DOI 10.1104/pp.115.4.1481
   Ryttersgaard C, 2002, J BIOL CHEM, V277, P10642, DOI 10.1074/jbc.M200229200
   Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Sack DA, 2006, NEW ENGL J MED, V355, P649, DOI 10.1056/NEJMp068144
   Dorgan KM, 2006, ANAL BIOCHEM, V350, P249, DOI 10.1016/j.ab.2006.01.004
   Chatterjee T, 2013, BIOCHIMIE, V95, P912, DOI 10.1016/j.biochi.2012.12.013
   JOHNSON BA, 1993, NEUROCHEM RES, V18, P87, DOI 10.1007/BF00966926
   Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556
   Merrell DS, 2001, J BACTERIOL, V183, P2746, DOI 10.1128/JB.183.9.2746-2754.2001
   Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200
   Skinner MM, 2000, STRUCTURE, V8, P1189, DOI 10.1016/S0969-2126(00)00522-0
   Griffith SC, 2001, J MOL BIOL, V313, P1103, DOI 10.1006/jmbi.2001.5095
   Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7
   Thapar N, 2000, PROTEIN EXPRES PURIF, V20, P237, DOI 10.1006/prep.2000.1311
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   DOOLITTLE RF, 1986, COLD SPRING HARB SYM, V51, P447
   HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151
   Ichikawa JK, 1998, ARCH BIOCHEM BIOPHYS, V358, P222, DOI 10.1006/abbi.1998.0830
   Ioerger T.R., 2002, ACTA CRYSTALLOGR D, V58, P1948
   Lowenson J. D., 1995, DEAMIDATION ISOASPAR, P47
NR 38
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 140
EP 149
DI 10.1016/j.abb.2015.08.001
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400016
PM 26255776
ER

PT J
AU Gardi, C
   Bauerova, K
   Stringa, B
   Kuncirova, V
   Slovak, L
   Ponist, S
   Drafi, F
   Bezakova, L
   Tedesco, I
   Acquaviva, A
   Bilotto, S
   Russo, GL
AF Gardi, C.
   Bauerova, K.
   Stringa, B.
   Kuncirova, V.
   Slovak, L.
   Ponist, S.
   Drafi, F.
   Bezakova, L.
   Tedesco, I.
   Acquaviva, A.
   Bilotto, S.
   Russo, G. L.
TI Quercetin reduced inflammation and increased antioxidant defense in rat
   adjuvant arthritis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Quercetin; Adjuvant arthritis; NF-kappa B; ERK pathway; Inflammation;
   Oxidative stress
ID NF-KAPPA-B; NITRIC-OXIDE PRODUCTION; NECROSIS-FACTOR-ALPHA;
   RHEUMATOID-ARTHRITIS; OXIDATIVE STRESS; FLAVONOID QUERCETIN; HEME
   OXYGENASE-1; THERAPEUTIC TARGETS; SIGNALING PATHWAY; PROTEIN-KINASES
AB Novel therapies for rheumatoid arthritis also include the use of naturally occurring compounds possessing antioxidant properties. In the present work, the effects of oral administration of quercetin were investigated in a rat model of adjuvant arthritis. Arthritis was induced by a single intradermal injection of heat-inactivated Mycobacterium butyricum in incomplete Freund's adjuvant. The experimental groups were treated with an oral daily dose of 150 mg/kg b.w. of quercetin for 28 days. Results indicated that quercetin was able to ameliorate all markers of inflammation and oxidative stress measured. Quercetin lowered levels of interleukin-1 beta, C-reactive protein, and monocyte chemotactic protein-1 and restored plasma antioxidant capacity. In addition, quercetin inhibited the enzymatic activity of pro-inflammatory 12/15-lipoxygenase in lung and liver and increased the expression of heme oxygenase-1 in joint and lung of arthritic rats. Finally, quercetin inhibited the 2-fold increase of NF-kappa B activity observed in lung, liver and joint after induction of arthritis. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Gardi, C.; Tedesco, I.; Bilotto, S.; Russo, G. L.] CNR, Inst Food Sci, I-83100 Avellino, Italy.
   [Gardi, C.; Stringa, B.; Acquaviva, A.] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy.
   [Bauerova, K.; Kuncirova, V.; Slovak, L.; Ponist, S.; Drafi, F.] Slovak Acad Sci, Inst Expt Pharmacol & Toxicol, SK-84104 Bratislava, Slovakia.
   [Bauerova, K.; Bezakova, L.] Comenius Univ, Fac Pharm, Bratislava, Slovakia.
RP Gardi, C (reprint author), Univ Siena, Dept Mol & Dev Med, Via A Moro 2, I-53100 Siena, Italy.
EM concetta.gardi@unisi.it; glrusso@isa.cnr.it
FU Italian Ministry of Economy and Finance;  [VEGA 2/0045/11];  [VEGA
   2/0044/15]
FX The study was supported by grants: VEGA 2/0045/11, VEGA 2/0044/15 and
   performed in the frame of two SAV-CNR bilateral projects coordinated by
   Dr. Katarina Bauerova (Slovakia) and Dr. Gian Luigi Russo (Italy)
   entitled: "In vitro and in vivo models of arthritic processes to study
   the mechanisms of inflammation and oxidative stress link-up: New
   perspectives for arthritis therapy" and "Phytochemicals in ameliorating
   rheumatoid arthritis therapy: from preclinical studies to clinical
   applications." This work was also partially supported by a grant from
   the Italian Ministry of Economy and Finance to the National Research
   Council for the project "Innovazione e Sviluppo del Mezzogiorno -
   Conoscenze Integrate per Sostenibilita ed Innovazione del Made in Italy
   Agroalimentare -Legge 191/2009".
CR Alghasham A, 2014, AUTOIMMUNITY, V47, P77, DOI 10.3109/08916934.2013.873413
   Okazaki Y, 2005, J RHEUMATOL, V32, P1440
   Guardia T, 2001, FARMACO, V56, P683, DOI 10.1016/S0014-827X(01)01111-9
   Martinez-Florez S, 2005, J NUTR, V135, P1359
   Makarov SS, 2001, ARTHRITIS RES, V3, P200, DOI 10.1186/ar300
   Tsao PW, 1997, CLIN IMMUNOL IMMUNOP, V83, P173, DOI 10.1006/clin.1997.4333
   Morley JE, 2006, AM J CLIN NUTR, V83, P735
   Thiel MJ, 2007, ARTHRITIS RHEUM, V56, P3347, DOI 10.1002/art.22869
   Hou DX, 2010, ANTIOXID REDOX SIGN, V13, P691, DOI 10.1089/ars.2009.2816
   Santos EOL, 2014, INT IMMUNOPHARMACOL, V21, P102, DOI 10.1016/j.intimp.2014.04.014
   Lee CS, 2013, INT IMMUNOPHARMACOL, V16, P481, DOI 10.1016/j.intimp.2013.05.001
   Benallaoua M, 2007, ARTHRITIS RHEUM, V56, P2585, DOI 10.1002/art.22749
   Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045
   de Launay D, 2012, ANN RHEUM DIS, V71, P415, DOI 10.1136/ard.2010.143529
   Park HK, 2010, LIFE SCI, V87, P181, DOI 10.1016/j.lfs.2010.06.011
   Kang CH, 2013, INT IMMUNOPHARMACOL, V17, P808, DOI 10.1016/j.intimp.2013.09.009
   Lopez-Lopez G, 2004, MOL PHARMACOL, V65, P851, DOI 10.1124/mol.65.4.851
   Russo GL, 2014, CANCER TREAT RES, V159, P185, DOI 10.1007/978-3-642-38007-5_11
   Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193
   Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778
   Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740
   Blaho VA, 2011, J IMMUNOL, V186, P3076, DOI 10.4049/jimmunol.1003473
   Bauerova K, 2010, ACTA BIOCHIM POL, V57, P347
   Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014
   Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200
   Gerhauser C, 2013, CURR OPIN CLIN NUTR, V16, P405, DOI 10.1097/MCO.0b013e328362014e
   Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556
   Boots AW, 2007, TOXICOL APPL PHARM, V222, P89, DOI 10.1016/j.taap.2007.04.004
   Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010
   Bauerova K, 1999, GEN PHYSIOL BIOPHYS, V18, P15
   Sung MS, 2012, INFLAMMATION, V35, P1585, DOI 10.1007/s10753-012-9473-2
   Matsuno H, 2009, BIOSCI BIOTECH BIOCH, V73, P288, DOI 10.1271/bbb.80418
   Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P2157, DOI 10.1089/ars.2007.1811
   Rotelli AE, 2003, PHARMACOL RES, V48, P601, DOI 10.1016/S1043-6618(03)00225-1
   Rothwell JA, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas031
   Campbell J, 2004, J IMMUNOL, V173, P6928
   Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153
   Kitamura A, 2011, MOD RHEUMATOL, V21, P150, DOI 10.1007/s10165-010-0372-9
   Min YD, 2007, INFLAMM RES, V56, P210, DOI 10.1007/s00011-007-6172-9
   Kobayashi H, 2006, ARTHRITIS RHEUM, V54, P1132, DOI 10.1002/art.21754
   Takahama U, 2006, ARCH ORAL BIOL, V51, P629, DOI 10.1016/j.archoralbio.2006.02.011
   Jackson JK, 2006, INFLAMM RES, V55, P168, DOI 10.1007/s00011-006-0067-z
   Na HK, 2014, FREE RADICAL BIO MED, V67, P353, DOI 10.1016/j.freeradbiomed.2013.10.819
   Wu MY, 2012, J CELL BIOCHEM, V113, P2279, DOI 10.1002/jcb.24098
   Bae SC, 2009, J AM COLL NUTR, V28, P56
   Ji JJ, 2013, AFR J TRADIT COMPLEM, V10, P418, DOI 10.4314/ajtcam.v10i3.5
   Walsmith J, 2002, INT J CARDIOL, V85, P89, DOI 10.1016/S0167-5273(02)00237-1
   Huang JQ, 2012, J PHARM PHARMACOL, V64, P1119, DOI 10.1111/j.2042-7158.2012.01504.x
   Khanna D, 2007, CURR OPIN PHARMACOL, V7, P344, DOI 10.1016/j.coph.2007.03.002
   Ribeiro D, 2014, EUR J MED CHEM, V72, P137, DOI 10.1016/j.ejmech.2013.11.030
   Nair MP, 2006, CLIN VACCINE IMMUNOL, V13, P319, DOI 10.1128/CVI.13.3.319-328.2006
   Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.1015
   Roubenoff R, 1997, ARTHRITIS RHEUM, V40, P534, DOI 10.1002/art.1780400320
   Kundu S, 2012, FREE RADICAL RES, V46, P1482, DOI 10.3109/10715762.2012.727991
   Gay RE, 2001, J RHEUMATOL, V28, P2060
   Sato M, 1997, J RHEUMATOL, V24, P1680
   Peet GW, 1999, J BIOL CHEM, V274, P32655, DOI 10.1074/jbc.274.46.32655
   Mamani-Matsuda M, 2006, BIOCHEM PHARMACOL, V72, P1304, DOI 10.1016/j.bcp.2006.08.001
   Justino GC, 2004, ARCH BIOCHEM BIOPHYS, V432, P109, DOI 10.1016/j.abb.2004.09.007
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Ohori M, 2008, DRUG NEWS PERSPECT, V21, P245, DOI 10.1358/DNP.2008.21.5.1219006
   Rahman I, 2006, BIOCHEM PHARMACOL, V72, P1439, DOI 10.1016/j.bcp.2006.07.004
   Turpaev KT, 2013, BIOCHEMISTRY-MOSCOW+, V78, P111, DOI 10.1134/S0006297913020016
   Bauerova K, 2015, AUTOIMMUNITY, V48, P46, DOI 10.3109/08916934.2014.939268
   Biniecka M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3424
   Chang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080744
   Drafi Frantisek, 2012, Interdiscip Toxicol, V5, P84, DOI 10.2478/v10102-012-0015-4
   Gheorghe KR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2717
   Indra Mochamad Rasjad, 2013, BMC Res Notes, V6, P275, DOI 10.1186/1756-0500-6-275
   Javadi Fatemeh, 2014, Int J Prev Med, V5, P293
   Kelly Gregory S, 2011, Altern Med Rev, V16, P172
   Kuncirova V, 2014, FUND CLIN PHARMACOL, V28, P616, DOI 10.1111/fcp.12085
   Kunsch Charles, 2005, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V5, P249, DOI 10.2174/1568013054022490
   Lamson D W, 2000, Altern Med Rev, V5, P196
   Lee JH, 2010, J FOOD SCI, V75, pH212, DOI 10.1111/j.1750-3841.2010.01755.x
   Manach Claudine, 2005, Am J Clin Nutr, V81, p230S
   Ramos-Romero S, 2012, PHARMACOL RES, V66, P207, DOI 10.1016/j.phrs.2012.05.009
   Russo GL, 2014, FOOD FUNCT, V5, P2393, DOI [10.1039/c4fo00413b, 10.1039/C4FO00413B]
   Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017
NR 79
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2015
VL 583
BP 150
EP 157
DI 10.1016/j.abb.2015.08.008
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CR9AA
UT WOS:000361644400017
PM 26297952
ER

PT J
AU Moliner, V
AF Moliner, V.
TI Special issue in computational modeling on biological systems
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
C1 Univ Jaume 1, Dept Quim Fis & Analit, Castellon de La Plana 12071, Spain.
RP Moliner, V (reprint author), Univ Jaume 1, Dept Quim Fis & Analit, Castellon de La Plana 12071, Spain.
EM moliner@uji.es
RI Moliner, Vicent/D-5499-2015
OI Moliner, Vicent/0000-0002-3665-3391
CR Carvalho Alexandra, ABBI1526
   Cerqueira Nuno, ABBI15101
   de La Lande Aurelien, ABBI1571
   Martin Field, ABBI1556
   Melia Conchin, ABBI14569
   Piazzetta Paolo, ABBI14662
   Pinto Jose, ABBI14650
   Rossetti Giulia, ABBI14661
   Swiderek Katarzyna, ABBI14619
   Truhlar Donald, ABBI15106
   Tunon Inaki, ABBI15134
   Vardi-Kilshtain Alexandra, ABBI1548
NR 12
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 1
EP 2
DI 10.1016/j.abb.2015.07.013
PG 2
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200001
PM 26215562
ER

PT J
AU Field, MJ
AF Field, Martin J.
TI Technical advances in molecular simulation since the 1980s
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Algorithms; Hardware; Molecular simulation; Software; The last 30 years
ID DENSITY-FUNCTIONAL THEORY; FREE-ENERGY CALCULATIONS; PARTICLE MESH
   EWALD; SELF-CONSISTENT-FIELD; DYNAMICS SIMULATIONS; ELECTRON-DENSITY;
   COMBINED QUANTUM; CONDENSED-PHASE; SYSTEMS; APPROXIMATION
AB This review describes how the theory and practice of molecular simulation have evolved since the beginning of the 1980s when the author started his career in this field. The account is of necessity brief and subjective and highlights the changes that the author considers have had significant impact on his research and mode of working. (C) 2015 Elsevier Inc. All rights reserved.
C1 Univ Grenoble 1, CNRS, Inst Biol Struct, Dynamo Team,DYNAMOP Grp,UMR 5075,CEA, F-38044 Grenoble 9, France.
RP Field, MJ (reprint author), Univ Grenoble 1, CNRS, Inst Biol Struct, Dynamo Team,DYNAMOP Grp,UMR 5075,CEA, 71 Ave Martyrs,CS 10090, F-38044 Grenoble 9, France.
EM martin.field@ibs.fr
FU Commissariat a l'Energie Atomique et aux Energies Alternatives
FX The author would like to thank Alexander MacKerell, Andrew Miranker and
   Jeremy Smith for helping to jog his memory, and the Commissariat a
   l'Energie Atomique et aux Energies Alternatives for financial support.
CR Grimme S, 2011, WIRES COMPUT MOL SCI, V1, P211, DOI 10.1002/wcms.30
   FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605
   Hagen JB, 2000, NAT REV GENET, V1, P231, DOI 10.1038/35042090
   Schollwock U, 2005, REV MOD PHYS, V77, P259, DOI 10.1103/RevModPhys.77.259
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   SINGH UC, 1986, J COMPUT CHEM, V7, P718, DOI 10.1002/jcc.540070604
   DUNLAP BI, 1979, J CHEM PHYS, V71, P3396, DOI 10.1063/1.438728
   RUNGE E, 1984, PHYS REV LETT, V52, P997, DOI 10.1103/PhysRevLett.52.997
   Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098
   STRAATSMA TP, 1992, ANNU REV PHYS CHEM, V43, P407
   WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9
   Suarez E, 2014, J CHEM THEORY COMPUT, V10, P2658, DOI 10.1021/ct401065r
   [Anonymous], 2014, J CHEM PHYS
   ELBER R, 1987, CHEM PHYS LETT, V139, P375, DOI 10.1016/0009-2614(87)80576-6
   Piana S, 2014, CURR OPIN STRUC BIOL, V24, P98, DOI 10.1016/j.sbi.2013.12.006
   CAR R, 1985, PHYS REV LETT, V55, P2471, DOI 10.1103/PhysRevLett.55.2471
   Szalay PG, 2012, CHEM REV, V112, P108, DOI 10.1021/cr200137a
   PETERSEN HG, 1995, J CHEM PHYS, V103, P3668, DOI 10.1063/1.470043
   Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009
   DEWAR MJS, 1977, J AM CHEM SOC, V99, P4899, DOI 10.1021/ja00457a004
   CHANDLER D, 1978, J CHEM PHYS, V68, P2959, DOI 10.1063/1.436049
   BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   Goedecker S, 1999, REV MOD PHYS, V71, P1085, DOI 10.1103/RevModPhys.71.1085
   POPLE JA, 1992, CHEM PHYS LETT, V199, P557, DOI 10.1016/0009-2614(92)85009-Y
   SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505
   Liu MY, 2014, ISR J CHEM, V54, P1250, DOI 10.1002/ijch.201400036
   DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024
   KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004
   Dongarra J, 2000, COMPUT SCI ENG, V2, P22, DOI 10.1109/MCISE.2000.814652
   VandeVondele J, 2012, J CHEM THEORY COMPUT, V8, P3565, DOI 10.1021/ct200897x
   STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038
   Majek P, 2010, J CHEM THEORY COMPUT, V6, P1805, DOI 10.1021/ct100114j
   BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098
   TOMASI J, 1994, CHEM REV, V94, P2027, DOI 10.1021/cr00031a013
   Willett P, 2011, WIRES COMPUT MOL SCI, V1, P46, DOI 10.1002/wcms.1
   BECKE AD, 1988, J CHEM PHYS, V88, P2547, DOI 10.1063/1.454033
   Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399
   WEINER PK, 1981, J COMPUT CHEM, V2, P287, DOI 10.1002/jcc.540020311
   PULAY P, 1980, CHEM PHYS LETT, V73, P393, DOI 10.1016/0009-2614(80)80396-4
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864
   BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.biophys.18.1.431
   SIEGBAHN PEM, 1981, J CHEM PHYS, V74, P2384, DOI 10.1063/1.441359
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Antosiewicz JM, 2011, MOL BIOSYST, V7, P2923, DOI 10.1039/c1mb05170a
   Baker NA, 2005, REV COMP CH, V21, P349, DOI 10.1002/0471720895.ch5
   BASH PA, 1987, J AM CHEM SOC, V109, P8092, DOI 10.1021/ja00260a028
   Borrell B, 2008, NATURE, V451, P240, DOI 10.1038/451240a
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Chipot C., 2007, FREE ENERGY CALCULAT, VSpringer
   Corminboeuf C, 2006, J MOL STRUC-THEOCHEM, V762, P1, DOI 10.1016/j.theochem.2005.07.036
   Cramer C.J., 1995, REV COMPUTATIONAL CH, P1
   Czerminiski R., 1990, CHEM PHYS LETT, V24, P167
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Dellago C, 1998, J CHEM PHYS, V108, P9236, DOI 10.1063/1.476378
   Dellago C., 2002, ADV CHEM PHYS, V123, P291
   Field M.J., 1997, NEW HORIZONS COMPUTA, P133
   Field M.J., 2003, HDB NUMERICAL ANAL, p[10, 667], DOI 10.1016/S1570-8659(03)10012-9
   FINE R, 1991, PROTEINS, V11, P242, DOI 10.1002/prot.340110403
   GREENGARD L, 1987, J COMPUT PHYS, V73, P325, DOI 10.1016/0021-9991(87)90140-9
   Jonsson H., 1998, CLASSICAL QUANTUM DY, P385, DOI DOI 10.1142/9789812839664_0016
   JORGENSEN WL, 1989, ACCOUNTS CHEM RES, V22, P184, DOI 10.1021/ar00161a004
   Khronos Group, 2015, OP STAND PAR PROGR H
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   Koch W., 2000, CHEM GUIDE DENSITY F
   KOHN W, 1965, PHYS REV, V140, P1133
   Lindahl G., 2015, REAL PROGRAMMERS DON
   Maragliano L, 2014, J CHEM THEORY COMPUT, V10, P524, DOI 10.1021/ct400606c
   Netlib LAPACK - Linear Algebra PACKage, 2015, LAPACK LIN ALG PACKA
   Nobel Foundation, 2015, NOB PRIZ CHEM 1998
   Ochsenfeld C., 2007, REV COMPUTATIONAL CH, V23, P1, DOI 10.1002/9780470116449.ch1
   Ohmura I, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0387
   OpenMP Architecture Review Board, 2015, OPENMP API SPEC PAR
   PRATT LR, 1986, J CHEM PHYS, V85, P5045, DOI 10.1063/1.451695
   Ren W., 2002, PHYS REV B, V66
   Schaefer III H.F., 1976, COMPUT CHEM, V1, P85
   Shaw D. E., 2014, P INT C HIGH PERF CO, P41
   Szabo A., 1989, INTRO ADV ELECT STRU, Vfirst
   Tildesley D. J., 1987, COMPUTER SIMULATION
   Towler M., 2015, QUANTUM MONTE CARLO
   Viswanath S, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4827495
   YANG WT, 1991, PHYS REV LETT, V66, P1438, DOI 10.1103/PhysRevLett.66.1438
   Zalesny R, 2011, CHALL ADV COMPUT CHE, V13, P1, DOI 10.1007/978-90-481-2853-2
NR 86
TC 0
Z9 0
U1 14
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 3
EP 9
DI 10.1016/j.abb.2015.03.005
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200002
PM 25772387
ER

PT J
AU Truhlar, DG
AF Truhlar, Donald G.
TI Transition state theory for enzyme kinetics
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Transition state theory; Enzyme kinetics; Quantum effects; Tunneling;
   Free energy
ID CHEMICAL-REACTION RATES; CATECHOL O-METHYLTRANSFERASE; COLI
   DIHYDROFOLATE-REDUCTASE; CANONICAL VARIATIONAL THEORY; FREE-ENERGY
   CALCULATIONS; GROTE-HYNES THEORY; HYDRIDE TRANSFER; TRANSMISSION
   COEFFICIENT; TEMPERATURE-DEPENDENCE; BIMOLECULAR REACTIONS
AB This article is an essay that discusses the concepts underlying the application of modern transition state theory to reactions in enzymes. Issues covered include the potential of mean force, the quantization of vibrations, the free energy of activation, and transmission coefficients to account for nonequilibrium effect, recrossing, and tunneling. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Truhlar, Donald G.] Univ Minnesota, Chem Theory Ctr, Dept Chem, Minneapolis, MN 55455 USA.
   [Truhlar, Donald G.] Univ Minnesota, Supercomp Inst, Minneapolis, MN 55455 USA.
RP Truhlar, DG (reprint author), Univ Minnesota, Chem Theory Ctr, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.
EM truhlar@umn.edu
FU National Institutes of Health [NIGMS/1RC1GM091445]
FX This work was supported in part by the National Institutes of Health
   through Grant No. NIGMS/1RC1GM091445.
CR Swiderek K, 2015, ACS CATAL, V5, P1172, DOI 10.1021/cs501704f
   Garrett BC, 2000, THEOR CHEM ACC, V103, P200, DOI 10.1007/s002149900046
   Gao JL, 2006, CHEM REV, V106, P3188, DOI 10.1021/cr050293k
   Truhlar DG, 2004, INT J QUANTUM CHEM, V100, P1136, DOI 10.1002/qua.20205
   LIU YP, 1993, J AM CHEM SOC, V115, P2408, DOI 10.1021/ja00059a041
   Masgrau L, 2015, ACCOUNTS CHEM RES, V48, P431, DOI 10.1021/ar500319e
   Klippenstein SJ, 2014, J AM CHEM SOC, V136, P528, DOI 10.1021/ja408723a
   MARCUS RA, 1977, J CHEM PHYS, V67, P2609, DOI 10.1063/1.435172
   TRUHLAR DG, 1984, ANNU REV PHYS CHEM, V35, P159, DOI 10.1146/annurev.pc.35.100184.001111
   Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f
   Kanaan N, 2011, J AM CHEM SOC, V133, P6692, DOI 10.1021/ja1114369
   Ruiz-Pernia JJ, 2013, J AM CHEM SOC, V135, P18689, DOI 10.1021/ja410519h
   Garcia-Viloca M, 2001, J CHEM PHYS, V114, P9953, DOI 10.1063/1.1371497
   Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172
   Hansen N, 2014, J CHEM THEORY COMPUT, V10, P2632, DOI 10.1021/ct500161f
   Poulsen TD, 2003, J PHYS CHEM B, V107, P9567, DOI 10.1021/jp030107j
   Agarwal PK, 2002, J PHYS CHEM B, V106, P3283, DOI 10.1021/jp020190v
   Alhambra C, 2000, J AM CHEM SOC, V122, P8197, DOI 10.1021/ja001476l
   Luk LYP, 2014, J AM CHEM SOC, V136, P17317, DOI 10.1021/ja5102536
   ISAACSON AD, 1982, J CHEM PHYS, V76, P1380, DOI 10.1063/1.443130
   Pu JZ, 2005, J PHYS CHEM B, V109, P8551, DOI 10.1021/jp051184c
   Evans MG, 1935, T FARADAY SOC, V31, P0875, DOI 10.1039/tf9353100875
   Pu JZ, 2006, CHEM REV, V106, P3140, DOI 10.1021/cr050308e
   Gao JL, 2002, ANNU REV PHYS CHEM, V53, P467, DOI 10.1146/annurev.physchem.53.091301.150114
   GARRETT BC, 1979, J CHEM PHYS, V70, P1593, DOI 10.1063/1.437698
   TRUHLAR DG, 1972, J CHEM PHYS, V56, P2232, DOI 10.1063/1.1677525
   Eyring H, 1935, CHEM REV, V17, P65, DOI 10.1021/cr60056a006
   GARRETT BC, 1983, J CHEM PHYS, V78, P4400, DOI 10.1063/1.445323
   Kanaan N, 2010, J PHYS CHEM B, V114, P13593, DOI 10.1021/jp1072457
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   VANDERZWAN G, 1983, J CHEM PHYS, V78, P4174, DOI 10.1063/1.445094
   Alhambra C, 2001, J PHYS CHEM B, V105, P11326, DOI 10.1021/jp0120312
   Ruiz-Pernia JJ, 2008, J AM CHEM SOC, V130, P7477, DOI 10.1021/ja801156y
   Bohm A., 1993, QUANTUM MECH FDN APP
   Castillo R., 2008, J PHYS CHEM B, P529
   CHATFIELD DC, 1991, J AM CHEM SOC, V113, P486, DOI 10.1021/ja00002a016
   CHATFIELD DC, 1992, J PHYS CHEM-US, V96, P2414, DOI 10.1021/j100185a007
   Chatfield D.C., 1996, DYNAMICS MOL CHEM RE, P323
   Chipot C., 2007, FREE ENERGY CALCULAT, VSpringer
   Dybala-Defratyka A, 2007, P NATL ACAD SCI USA, V104, P10774, DOI 10.1073/pnas.0702188104
   Dybala-Defratyka Agnjeszka, 2009, P36, DOI 10.1039/9781847559975-00036
   Fernandez-Ramos A, 2001, J CHEM PHYS, V114, P1491, DOI 10.1063/1.1329893
   Fernandez-Ramos A., 2007, REV COMPUTATIONAL CH, V23, p125 232, DOI 10.1002/9780470116449.ch3
   Garcia-Meseguer R, 2015, J PHYS CHEM B, V119, P873, DOI 10.1021/jp505746x
   Garcia-Meseguer R., 2013, NAT CHEM, P566
   GARRETT BC, 1983, J CHEM PHYS, V79, P4931, DOI 10.1063/1.445586
   Kim Y., 2010, J AM CHEM SOC, V131, P11071
   Kreevoy M.M., 1986, INVESTIGATION RATE 1, Vfourth, P13
   LIM C, 1983, J PHYS CHEM-US, V87, P2683, DOI 10.1021/j100238a004
   MAHAN BH, 1974, J CHEM EDUC, V51, P709
   Meana-Paneda R, 2010, J CHEM THEORY COMPUT, V6, P6, DOI 10.1021/ct900420e
   Mullen RG, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4862504
   Roca M., 2010, CHEM-EUR J, V165, P11399
   Roca M, 2006, J AM CHEM SOC, V128, P6186, DOI 10.1021/ja058826u
   Ruiz-Pernia JJ, 2009, J AM CHEM SOC, V131, P2687, DOI 10.1021/ja8087423
   Stillinger F.H., 1999, PHYS REV E, V59, P49
   Thomas A, 2002, J AM CHEM SOC, V124, P12432, DOI 10.1021/ja0206846
   TROE J, 1979, J PHYS CHEM-US, V83, P114, DOI 10.1021/j100464a019
   TRUHLAR DG, 1994, J PHYS CHEM-US, V98, P8396, DOI 10.1021/j100085a021
   TRUHLAR DG, 1992, ACS SYM SER, V502, P16
   Truhlar D.G., 2006, ISOTOPE EFFECTS CHEM, P579
   Truhlar D.G., 2008, CONTINUUM SOLVATION, P338
   Truhlar DG, 2002, ACCOUNTS CHEM RES, V35, P341, DOI 10.1021/ar0100226
   Truhlar DG, 2010, J PHYS ORG CHEM, V23, P660, DOI 10.1002/poc.1676
   Truhlar D.G., 2007, HYDROGEN TRANSFER RE, V2, P833
   Truhlar D.G., 1984, AM CHEM SOC S SERIES, V263
   Tucker S.C., 1995, UNDERS CH R, P5
   WIDOM B, 1965, SCIENCE, V148, P1555, DOI 10.1126/science.148.3677.1555
   Wigner E, 1932, Z PHYS CHEM B-CHEM E, V19, P203
   Yu T, 2011, CHEM SCI, V2, P2199, DOI 10.1039/c1sc00225b
   Zheng JJ, 2012, FARADAY DISCUSS, V157, P59, DOI 10.1039/c2fd20012k
NR 71
TC 0
Z9 0
U1 31
U2 31
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 10
EP 17
DI 10.1016/j.abb.2015.05.004
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200003
PM 26008760
ER

PT J
AU Vardi-Kilshtain, A
   Nitoker, N
   Major, DT
AF Vardi-Kilshtain, Alexandra
   Nitoker, Neta
   Major, Dan Thomas
TI Nuclear quantum effects and kinetic isotope effects in enzyme reactions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE QM/MM; Kinetic isotope effects; Nuclear quantum effects; Enzyme
   catalysis
ID OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE; HYDRIDE TRANSFER-REACTION;
   TRANSITION-STATE STRUCTURE; PATH-INTEGRAL SIMULATIONS; LIVER
   ALCOHOL-DEHYDROGENASE; POTENTIAL-ENERGY SURFACE; MOLECULAR-DYNAMICS
   SIMULATIONS; COUPLED ELECTRON-TRANSFER; CONDENSED-PHASE REACTIONS;
   PROTON-TRANSFER REACTION
AB Enzymes are extraordinarily effective catalysts evolved to perform well-defined and highly specific chemical transformations. Studying the nature of rate enhancements and the mechanistic strategies in enzymes is very important, both from a basic scientific point of view, as well as in order to improve rational design of biomimetics. Kinetic isotope effect (KIE) is a very important tool in the study of chemical reactions and has been used extensively in the field of enzymology. Theoretically, the prediction of KIEs in condensed phase environments such as enzymes is challenging due to the need to include nuclear quantum effects (NQEs). Herein we describe recent progress in our group in the development of multiscale simulation methods for the calculation of NQEs and accurate computation of KIEs. We also describe their application to several enzyme systems. In particular we describe the use of combined quantum mechanics/molecular mechanics (QM/MM) methods in classical and quantum simulations. The development of various novel path-integral methods is reviewed. These methods are tailor suited to enzyme systems, where only a few degrees of freedom involved in the chemistry need to be quantized. The application of the hybrid QM/MM quantum-classical simulation approach to three case studies is presented. The first case involves the proton transfer in alanine racemase. The second case presented involves orotidine 5'-monophosphate decarboxylase where multidimensional free energy simulations together with kinetic isotope effects are combined in the study of the reaction mechanism. Finally, we discuss the proton transfer in nitroalkane oxidase, where the enzyme employs tunneling as a catalytic fine-tuning tool. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Major, Dan Thomas] Bar Ilan Univ, Dept Chem, IL-52900 Ramat Gan, Israel.
   Bar Ilan Univ, Lise Meitner Minerva Ctr Computat Quantum Chem, IL-52900 Ramat Gan, Israel.
RP Major, DT (reprint author), Bar Ilan Univ, Dept Chem, IL-52900 Ramat Gan, Israel.
EM majort@biu.ac.il
FU Israel Science Foundation; Binational Science Foundation
FX This research has been supported by the Israel Science Foundation and
   the Binational Science Foundation.
CR ACHESON SA, 1990, BIOCHEMISTRY-US, V29, P3198, DOI 10.1021/bi00465a007
   ALBERTY RA, 1958, J PHYS CHEM-US, V62, P154, DOI 10.1021/j150560a005
   Alhambra C, 2001, CHEM PHYS LETT, V347, P512, DOI 10.1016/S0009-2614(01)00921-6
   Amyes TL, 2008, J AM CHEM SOC, V130, P1574, DOI 10.1021/ja710384t
   HWANG JK, 1993, J PHYS CHEM-US, V97, P10053, DOI 10.1021/j100141a026
   Gao JL, 2006, CHEM REV, V106, P3188, DOI 10.1021/cr050293k
   SWAIN CG, 1958, J AM CHEM SOC, V80, P5885, DOI 10.1021/ja01554a077
   Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654
   Singleton DA, 2000, J AM CHEM SOC, V122, P3296, DOI 10.1021/ja993392m
   Pang JY, 2006, J AM CHEM SOC, V128, P8015, DOI 10.1021/ja061585l
   Sun SX, 1999, BIOCHEMISTRY-US, V38, P4058, DOI 10.1021/bi982924t
   Luk LYP, 2013, P NATL ACAD SCI USA, V110, P16344, DOI 10.1073/pnas.1312437110
   Chin SA, 1997, PHYS LETT A, V226, P344, DOI 10.1016/S0375-9601(97)00003-0
   Klinman JP, 2013, ANNU REV BIOCHEM, V82, P471, DOI 10.1146/annurev-biochem-051710-133623
   Hatcher E, 2007, J AM CHEM SOC, V129, P187, DOI 10.1021/ja0667211
   Friesner RA, 2005, ANNU REV PHYS CHEM, V56, P389, DOI 10.1146/annurev.physchem.55.091602.094410
   Watanabe A, 2002, J BIOL CHEM, V277, P19166, DOI 10.1074/jbc.M201615200
   Kamerlin SCL, 2011, WIRES COMPUT MOL SCI, V1, P30, DOI 10.1002/wcms.10
   WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9
   Fan Y, 2013, BIOCHEMISTRY-US, V52, P2036, DOI 10.1021/bi301559q
   Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690
   Swiderek K, 2013, CHEM REV, V113, P7851, DOI 10.1021/cr300515x
   Wolfenden R, 2011, ANNU REV BIOCHEM, V80, P645, DOI 10.1146/annurev-biochem-060409-093051
   Silva RG, 2011, P NATL ACAD SCI USA, V108, P18661, DOI 10.1073/pnas.1114900108
   Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f
   Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899
   Kanaan N, 2011, J AM CHEM SOC, V133, P6692, DOI 10.1021/ja1114369
   Zhang XY, 2005, ACCOUNTS CHEM RES, V38, P379, DOI 10.1021/ar040257s
   CLELAND WW, 1987, BIOORG CHEM, V15, P283, DOI 10.1016/0045-2068(87)90026-5
   Chin SA, 2002, J CHEM PHYS, V117, P1409, DOI 10.1063/1.1485725
   Schramm VL, 2007, CURR OPIN CHEM BIOL, V11, P529, DOI 10.1016/j.cbpa.2007.07.013
   LEVITT M, 1975, NATURE, V253, P694, DOI 10.1038/253694a0
   Major DT, 2007, J CHEM THEORY COMPUT, V3, P949, DOI 10.1021/ct600371k
   Francis K, 2014, CURR OPIN CHEM BIOL, V21, P19, DOI 10.1016/j.cbpa.2014.03.009
   Cui Q, 2001, J PHYS CHEM B, V105, P569, DOI 10.1021/jp0029109
   Mavri J, 2008, J PHYS CHEM B, V112, P5950, DOI 10.1021/jp0758420
   Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604
   Poulsen TD, 2003, J PHYS CHEM B, V107, P9567, DOI 10.1021/jp030107j
   Van Vleet JL, 2008, BIOCHEMISTRY-US, V47, P798, DOI 10.1021/bi701664n
   Major DT, 2006, J AM CHEM SOC, V128, P16345, DOI 10.1021/ja066334r
   Pang JY, 2008, J AM CHEM SOC, V130, P7092, DOI 10.1021/ja800471f
   Luk LYP, 2014, J AM CHEM SOC, V136, P17317, DOI 10.1021/ja5102536
   Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i
   ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420
   Ruggiero GD, 2004, J PHYS ORG CHEM, V17, P592, DOI 10.1002/poc.781
   Kanaan N, 2007, BIOCHEMISTRY-US, V46, P3704, DOI 10.1021/bi061953y
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   Boekelheide N, 2011, P NATL ACAD SCI USA, V108, P16159, DOI 10.1073/pnas.1106397108
   BERNE BJ, 1986, ANNU REV PHYS CHEM, V37, P401
   Cui Q, 2002, J PHYS CHEM B, V106, P2721, DOI 10.1021/jp013012v
   DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024
   Senn HM, 2009, ANGEW CHEM INT EDIT, V48, P1198, DOI 10.1002/anie.200802019
   LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8
   CEPERLEY DM, 1995, REV MOD PHYS, V67, P279, DOI 10.1103/RevModPhys.67.279
   Hay S, 2012, NAT CHEM, V4, P161, DOI [10.1038/nchem.1223, 10.1038/NCHEM.1223]
   WARSHEL A, 1980, J AM CHEM SOC, V102, P6218, DOI 10.1021/ja00540a008
   Pu JZ, 2005, J PHYS CHEM B, V109, P8551, DOI 10.1021/jp051184c
   Watababe A, 1999, J BIOL CHEM, V274, P4189, DOI 10.1074/jbc.274.7.4189
   Garcia-Viloca M, 2003, J COMPUT CHEM, V24, P177, DOI 10.1002/jcc.10154
   Riccardi D, 2006, J PHYS CHEM B, V110, P6458, DOI 10.1021/jp056361o
   SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551
   Major DT, 2005, J MOL GRAPH MODEL, V24, P121, DOI 10.1016/j.jmgm.2005.04.002
   Feierberg I, 2000, J BIOL CHEM, V275, P22657, DOI 10.1074/jbc.M000726200
   van der Kamp MW, 2013, BIOCHEMISTRY-US, V52, P2708, DOI 10.1021/bi400215w
   Rommel JB, 2012, J PHYS CHEM B, V116, P13682, DOI 10.1021/jp308526t
   Pu JZ, 2006, CHEM REV, V106, P3140, DOI 10.1021/cr050308e
   Major DT, 2009, P NATL ACAD SCI USA, V106, P20734, DOI 10.1073/pnas.0911416106
   HWANG JK, 1988, J AM CHEM SOC, V110, P5297, DOI 10.1021/ja00224a011
   Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646
   Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h
   Gao JL, 2008, J COMPUT CHEM, V29, P514, DOI 10.1002/jcc.20810
   Kamerlin SCL, 2013, Q REV BIOPHYS, V46, P1, DOI 10.1017/S0033583512000157
   Olsson MHM, 2006, PHILOS T R SOC B, V361, P1417, DOI 10.1098/rstb.2006.1880
   FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195
   Nagel ZD, 2009, NAT CHEM BIOL, V5, P543, DOI 10.1038/nchembio.204
   Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399
   Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146
   Azuri A, 2011, J CHEM THEORY COMPUT, V7, P1273, DOI 10.1021/ct100716c
   Hirschi J, 2005, J AM CHEM SOC, V127, P3294, DOI 10.1021/ja0430752
   Liu HB, 2007, J PHYS CHEM B, V111, P7852, DOI 10.1021/jp070938f
   Glowacki DR, 2012, NAT CHEM, V4, P169, DOI [10.1038/nchem.1244, 10.1038/NCHEM.1244]
   CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219
   CARTER EA, 1989, CHEM PHYS LETT, V156, P472, DOI 10.1016/S0009-2614(89)87314-2
   Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797
   PATEY GN, 1975, J CHEM PHYS, V63, P2334, DOI 10.1063/1.431685
   Alhambra C, 2001, J PHYS CHEM B, V105, P11326, DOI 10.1021/jp0120312
   Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515
   Antoniou D, 2004, J CHEM PHYS, V121, P6442, DOI 10.1063/1.1782813
   Barnes JA, 1996, CHEM COMMUN, P193, DOI 10.1039/cc9960000193
   Barnes JA, 1996, BIOCHEM SOC T, V24, P263
   BASH PA, 1987, SCIENCE, V235, P574, DOI 10.1126/science.3810157
   Bash PA, 1996, P NATL ACAD SCI USA, V93, P3698, DOI 10.1073/pnas.93.8.3698
   BEAK P, 1976, J AM CHEM SOC, V98, P3601, DOI 10.1021/ja00428a035
   Bell J.B., 1991, J BIOL CHEM, V366, P12662
   Carvalho A. T. P., 2015, J MOL GRAPH MODEL, V54, P62
   Castillo R, 2008, J PHYS CHEM B, V112, P10012, DOI 10.1021/jp8025896
   Castillo R, 1999, J AM CHEM SOC, V121, P12140, DOI 10.1021/ja9843019
   Ceriotti M, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4772676
   Chan KK, 2009, BIOCHEMISTRY-US, V48, P5518, DOI 10.1021/bi900623r
   Chen DZ, 2009, J MOL STRUC-THEOCHEM, V897, P139, DOI 10.1016/j.theochem.2008.12.004
   Chin SA, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046118
   Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509
   Cleland W. W., 1995, ENZYME KINETICS MECH, V249, P341, DOI 10.1016/0076-6879(95)49041-8
   CLELAND WW, 1982, CRC CR REV BIOCH MOL, V13, P385
   Cook P., 2007, ENZYME KINETICS MECH
   Cramer CJ, 2004, ESSENTIALS COMPUTATI
   Doron D, 2011, J CHEM THEORY COMPUT, V7, P3420, DOI 10.1021/ct2004808
   Doron D, 2014, ISR J CHEM, V54, P1108, DOI 10.1002/ijch.201400026
   Dybala-Defratyka A, 2007, P NATL ACAD SCI USA, V104, P10774, DOI 10.1073/pnas.0702188104
   Dybala-Defratyka A, 2008, ARCH BIOCHEM BIOPHYS, V474, P274, DOI 10.1016/j.abb.2008.01.012
   Ehrlich JI, 1999, J AM CHEM SOC, V121, P6966, DOI 10.1021/ja990737s
   Engel H, 2015, CHEM PHYS, V450, P95, DOI 10.1016/j.chemphys.2015.01.001
   Engel H, 2012, J CHEM THEORY COMPUT, V8, P1223, DOI 10.1021/ct200874q
   Fang YR, 2003, CHEM-EUR J, V9, P2696, DOI 10.1002/chem.200204119
   FARACI WS, 1988, BIOCHEMISTRY-US, V27, P3267, DOI 10.1021/bi00409a022
   FARACI WS, 1989, BIOCHEMISTRY-US, V28, P431, DOI 10.1021/bi00428a004
   Feng WY, 2000, BIOCHEMISTRY-US, V39, P1778, DOI 10.1021/bi992553w
   Feynman R. P., 1965, QUANTUM MECH PATH IN
   Frey P. A., 2007, ENZYMATIC REACTION M
   Gao J., 1995, REV COMPUTATIONAL CH, P119
   Gao JL, 2011, SCI CHINA CHEM, V54, P1841, DOI 10.1007/s11426-011-4433-5
   Goryanova B, 2013, BIOCHEMISTRY-US, V52, P537, DOI 10.1021/bi301650d
   GRUBMULLER H, 1995, PHYS REV E, V52, P2893, DOI 10.1103/PhysRevE.52.2893
   Hammes-Schiffer S, 2008, COORDIN CHEM REV, V252, P384, DOI 10.1016/j.ccr.2007.07.019
   Hammes-Schiffer S, 2001, INT REV PHYS CHEM, V20, P591, DOI 10.1080/01442350110067402
   Hinsen K, 1997, J CHEM PHYS, V106, P3567, DOI 10.1063/1.473439
   Hu H, 2008, J AM CHEM SOC, V130, P14493, DOI 10.1021/ja801202j
   Hwang JK, 1996, J AM CHEM SOC, V118, P11745, DOI 10.1021/ja962007f
   HWANG JK, 1991, J PHYS CHEM-US, V95, P8445, DOI 10.1021/j100175a009
   Iiams Vanessa, 2011, Biochemistry, V50, P8497, DOI 10.1021/bi2012355
   Johansson AL, 2011, BBA-BIOENERGETICS, V1807, P1083, DOI 10.1016/j.bbabio.2011.03.012
   Kamerlin SCL, 2010, FARADAY DISCUSS, V145, P71, DOI 10.1039/b907354j
   Klinman J P, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P415
   Kohen A., 2014, ACCOUNTS CHEM RES, V48, P466
   Kohen A., 2006, ISOTOPE EFFECTS CHEM
   Lee JK, 1997, SCIENCE, V276, P942
   Lin YL, 2011, J AM CHEM SOC, V133, P4398, DOI 10.1021/ja108209w
   Lin YL, 2011, BBA-PROTEINS PROTEOM, V1814, P1438, DOI 10.1016/j.bbapap.2011.05.002
   Liu Hanbin, 2009, P242, DOI 10.1039/9781847559975-00242
   Ludlow MK, 2009, J AM CHEM SOC, V131, P7094, DOI 10.1021/ja9001184
   Major DT, 2006, J AM CHEM SOC, V128, P8114, DOI 10.1021/ja062272t
   Major DT, 2005, J AM CHEM SOC, V127, P16374, DOI 10.1021/ja055881u
   Major DT, 2006, J CHEM THEORY COMPUT, V2, P236, DOI 10.1021/ct050257t
   Marti S, 2003, ORG BIOMOL CHEM, V1, P483, DOI 10.1039/b210508j
   Marti S, 2005, J PHYS CHEM B, V109, P3707, DOI 10.1021/jp044387u
   MCCAMMON JA, 1979, P NATL ACAD SCI USA, V76, P3585, DOI 10.1073/pnas.76.8.3585
   Nitoker N, 2015, BIOCHEMISTRY-US, V54, P516, DOI 10.1021/bi500984m
   NORTHRUP SH, 1982, P NATL ACAD SCI-BIOL, V79, P4035, DOI 10.1073/pnas.79.13.4035
   Nunez S, 2006, PHILOS T R SOC B, V361, P1387, DOI 10.1098/rstb.2006.1867
   Olsson MHM, 2004, J AM CHEM SOC, V126, P2820, DOI 10.1021/ja037233l
   Olsson MHM, 2004, J BIOL INORG CHEM, V9, P96, DOI 10.1007/s00775-003-0503-2
   Phillips LM, 2001, J AM CHEM SOC, V123, P12067, DOI 10.1021/ja0117332
   POLLOCK EL, 1984, PHYS REV B, V30, P2555, DOI 10.1103/PhysRevB.30.2555
   RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611
   Ranaghan KE, 2007, CHEMPHYSCHEM, V8, P1816, DOI 10.1002/cphc.200700143
   Raugei S, 2004, J AM CHEM SOC, V126, P15730, DOI 10.1021/ja0455143
   Rishavy MA, 2000, BIOCHEMISTRY-US, V39, P4569, DOI 10.1021/bi000376p
   ROSSI I, 1995, CHEM PHYS LETT, V233, P231, DOI 10.1016/0009-2614(94)01450-A
   SATO S, 1955, J CHEM PHYS, V23, P592
   Schwartz SD, 2009, NAT CHEM BIOL, V5, P552, DOI 10.1038/nchembio.202
   Shaw JP, 1997, BIOCHEMISTRY-US, V36, P1329, DOI 10.1021/bi961856c
   Sicinska D, 2005, J AM CHEM SOC, V127, P5414, DOI 10.1021/ja042298p
   SMILEY JA, 1992, BIOCHEMISTRY-US, V31, P12162, DOI 10.1021/bi00163a027
   SMILEY JA, 1991, BIOCHEMISTRY-US, V30, P6216, DOI 10.1021/bi00239a020
   Spies MA, 2004, J AM CHEM SOC, V126, P7464, DOI 10.1021/ja049579h
   Spies MA, 2003, BIOCHEMISTRY-US, V42, P5099, DOI 10.1021/bi027064
   Spies MA, 2007, J AM CHEM SOC, V129, P10678, DOI 10.1021/ja067643k
   SPRIK M, 1985, PHYS REV B, V31, P4234, DOI 10.1103/PhysRevB.31.4234
   Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s
   Stanton CL, 2007, J PHYS CHEM B, V111, P12573, DOI 10.1021/jp074858n
   Toth K, 2010, J AM CHEM SOC, V132, P7018, DOI 10.1021/ja102408k
   Toth K, 2007, J AM CHEM SOC, V129, P12946, DOI 10.1021/ja076222f
   Tresadern G, 2003, THEOR CHEM ACC, V109, P108, DOI 10.1007/s00214-002-0416-0
   Tresadern G, 2003, FARADAY DISCUSS, V122, P223, DOI 10.1039/b201183m
   Tresadern G, 2003, MOL PHYS, V101, P2775, DOI 10.1080/0026897031000121271
   Tsang WY, 2012, J AM CHEM SOC, V134, P14580, DOI 10.1021/ja3058474
   Valley MP, 2004, J AM CHEM SOC, V126, P6244, DOI 10.1021/ja0484506
   Vanicek J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768930
   Vardi-Kilshtain A, 2012, J CHEM THEORY COMPUT, V8, P4786, DOI 10.1021/ct300628e
   Vardi-Kilshtain A, 2012, J COMPUT CHEM, V33, P435, DOI 10.1002/jcc.21986
   Vardi-Kilshtain A, 2013, BIOCHEMISTRY-US, V52, P4382, DOI 10.1021/bi400190v
   Voth G.A., 1993, J PHYS CHEM-US, V97, P8365
   Wang ML, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2181145
   Wang Q., 2006, J CHEM PHYS, V125
   WARSHEL A, 1970, J CHEM PHYS, V52, P1262, DOI 10.1063/1.1673124
   Warshel A., 1991, COMPUTER MODELING CH
   Warshel A, 2000, BIOCHEMISTRY-US, V39, P14728, DOI 10.1021/bi000987h
   Watanabe A, 1999, J BIOCHEM-TOKYO, V126, P781
   Wepukhulu WO, 2008, ORG BIOMOL CHEM, V6, P4533, DOI 10.1039/b812979g
   Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797
   Wu WM, 1997, BIOORG MED CHEM LETT, V7, P2623, DOI 10.1016/S0960-894X(97)10028-2
   YADAV A, 1991, J AM CHEM SOC, V113, P4800, DOI 10.1021/ja00013a013
NR 192
TC 0
Z9 0
U1 41
U2 41
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 18
EP 27
DI 10.1016/j.abb.2015.03.001
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200004
PM 25769515
ER

PT J
AU de la Lande, A
   Gillet, N
   Chen, SF
   Salahub, DR
AF de la Lande, Aurelien
   Gillet, Natacha
   Chen, Shufeng
   Salahub, Dennis R.
TI Progress and challenges in simulating and understanding electron
   transfer in proteins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Electron transfers; Proteins; Numerical simulations; Tunelling; Marcus
   theory
ID PHOTOSYNTHETIC REACTION-CENTER; CYTOCHROME-C-OXIDASE; REORGANIZATION
   FREE-ENERGIES; DENSITY-FUNCTIONAL THEORY; COLI DNA PHOTOLYASE;
   POLARIZABLE MOLECULAR-DYNAMICS; BACTERIAL REACTION CENTERS; PRIMARY
   CHARGE SEPARATION; PROTON-TRANSFER REACTIONS; ACYL-COA DEHYDROGENASE
AB This Review presents an overview of the most common numerical simulation approaches for the investigation of electron transfer (ET) in proteins. We try to highlight the merits of the different approaches but also the current limitations and challenges. The article is organized into three sections. Section 2 deals with direct simulation algorithms of charge migration in proteins. Section 3 summarizes the methods for testing the applicability of the Marcus theory for ET in proteins and for evaluating key thermodynamic quantities entering the reaction rates (reorganization energies and driving force). Recent studies interrogating the validity of the theory due to the presence of non-ergodic effects or of non-linear responses are also described. Section 4 focuses on the tunneling aspects of electron transfer. How can the electronic coupling between charge transfer states be evaluated by quantum chemistry approaches and rationalized? What interesting physics regarding the impact of protein dynamics on tunneling can be addressed? We will illustrate the different sections with examples taken from the literature to show what types of system are currently manageable with current methodologies. We also take care to recall what has been learned on the biophysics of ET within proteins thanks to the advent of atomistic simulations. (C) 2015 Elsevier Inc. All rights reserved.
C1 [de la Lande, Aurelien; Gillet, Natacha; Chen, Shufeng] Univ Paris 11, CNRS, UMR 8000, Lab Chim Phys, F-91405 Orsay, France.
   [Salahub, Dennis R.] Univ Calgary, Dept Chem, CMS, Calgary, AB T2N 1N4, Canada.
   [Salahub, Dennis R.] Univ Calgary, IQST, Calgary, AB T2N 1N4, Canada.
RP de la Lande, A (reprint author), Univ Paris 11, CNRS, UMR 8000, Lab Chim Phys, 15 Ave Jean Perrin, F-91405 Orsay, France.
EM aurelien.de-la-lande@u-psud.fr; dsalahub@ucalgary.ca
FU NSERC-Canada
FX We thank Laura Baciou (LCP) for insightful discussions on experimental
   approaches for ET in proteins. DRS thanks NSERC-Canada for ongoing
   Discovery Grant support.
CR Tipmanee V, 2010, J AM CHEM SOC, V132, P17032, DOI 10.1021/ja107876p
   de la Lande A, 2010, P NATL ACAD SCI USA, V107, P11799, DOI 10.1073/pnas.0914457107
   WESOLOWSKI TA, 1993, J PHYS CHEM-US, V97, P8050, DOI 10.1021/j100132a040
   Prytkova TR, 2007, P NATL ACAD SCI USA, V104, P802, DOI 10.1073/pnas.0605319104
   MARONCELLI M, 1989, SCIENCE, V243, P1674, DOI 10.1126/science.243.4899.1674
   Rabenstein B, 2000, BIOCHEMISTRY-US, V39, P10487, DOI 10.1021/bi000413c
   Patel S, 2004, J COMPUT CHEM, V25, P1, DOI 10.1002/jcc.10355
   KUHARSKI RA, 1988, J CHEM PHYS, V89, P3248, DOI 10.1063/1.454929
   Blumberger J, 2006, J AM CHEM SOC, V128, P13854, DOI 10.1021/ja063852t
   Cascella M, 2006, P NATL ACAD SCI USA, V103, P19641, DOI 10.1073/pnas.0607890103
   Fricke K, 2008, ENERG ENVIRON SCI, V1, P144, DOI 10.1039/b802363h
   Rezac J, 2012, J CHEM THEORY COMPUT, V8, P418, DOI 10.1021/ct200570u
   Woiczikowski PB, 2011, J PHYS CHEM B, V115, P9846, DOI 10.1021/jp204696t
   WARSHEL A, 1984, Q REV BIOPHYS, V17, P283
   Brenner S, 2008, FEBS J, V275, P4540, DOI 10.1111/j.1742-4658.2008.06597.x
   BERATAN DN, 1987, J CHEM PHYS, V86, P4488, DOI 10.1063/1.452723
   Curutchet C, 2009, J CHEM THEORY COMPUT, V5, P1838, DOI 10.1021/ct9001366
   Clarke TA, 2011, P NATL ACAD SCI USA, V108, P9384, DOI 10.1073/pnas.1017200108
   Page CC, 1999, NATURE, V402, P47
   Stuchebrukhov AA, 2003, THEOR CHEM ACC, V110, P291, DOI 10.1007/s00214-003-0462-2
   Matyushov DV, 2000, J CHEM PHYS, V113, P5413, DOI 10.1063/1.1289886
   Simonneaux G, 2005, CHEM REV, V105, P2627, DOI 10.1021/cr030731s
   Beratan DN, 2009, ACCOUNTS CHEM RES, V42, P1669, DOI 10.1021/ar900123t
   CREIGHTON S, 1988, BIOCHEMISTRY-US, V27, P774, DOI 10.1021/bi00402a043
   Bentzien J, 1998, J PHYS CHEM B, V102, P2293, DOI 10.1021/jp973480y
   Migliore A, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3232007
   Heyes DJ, 2009, CHEM COMMUN, P1124, DOI 10.1039/b820386e
   BADER JS, 1989, CHEM PHYS LETT, V157, P501, DOI 10.1016/S0009-2614(89)87399-3
   Haffa ALM, 2002, J PHYS CHEM B, V106, P7376, DOI 10.1021/jp0257552
   Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868
   WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9
   El Hammi E, 2012, PHYS CHEM CHEM PHYS, V14, P13872, DOI 10.1039/c2cp41261f
   Daizadeh I, 1997, P NATL ACAD SCI USA, V94, P3703, DOI 10.1073/pnas.94.8.3703
   Hayashi T, 2010, P NATL ACAD SCI USA, V107, P19157, DOI 10.1073/pnas.1009181107
   Gresh N, 2007, J CHEM THEORY COMPUT, V3, P1960, DOI 10.1021/ct700134r
   Troisi A, 2003, J CHEM PHYS, V119, P5782, DOI 10.1063/1.1601600
   Olsen JM, 2010, J CHEM THEORY COMPUT, V6, P3721, DOI 10.1021/ct1003803
   Ludemann G, 2015, J AM CHEM SOC, V137, P1147, DOI 10.1021/ja510550g
   MARCUS RA, 1965, J CHEM PHYS, V43, P679, DOI 10.1063/1.1696792
   DEDERICHS PH, 1984, PHYS REV LETT, V53, P2512, DOI 10.1103/PhysRevLett.53.2512
   Wu Q, 2006, J CHEM THEORY COMPUT, V2, P765, DOI 10.1021/ct0503163
   Balabin IA, 2000, SCIENCE, V290, P114, DOI 10.1126/science.290.5489.114
   Hu LH, 2011, J PHYS CHEM B, V115, P13111, DOI 10.1021/jp205897z
   Crane BR, 2001, J AM CHEM SOC, V123, P11623, DOI 10.1021/ja0115870
   KING G, 1990, J CHEM PHYS, V93, P8682, DOI 10.1063/1.459255
   Stuchebrukhov AA, 1996, J CHEM PHYS, V104, P8424, DOI 10.1063/1.471592
   VOS MH, 1991, P NATL ACAD SCI USA, V88, P8885, DOI 10.1073/pnas.88.20.8885
   Bhattacharyya S, 2007, J PHYS CHEM A, V111, P5729, DOI 10.1021/jp07l526+
   Small DW, 2003, J AM CHEM SOC, V125, P7470, DOI 10.1021/ja029595j
   Breuer M, 2012, J AM CHEM SOC, V134, P9868, DOI 10.1021/ja3027696
   BHATTACHARYYA AK, 1991, BIOCHEMISTRY-US, V30, P759, DOI 10.1021/bi00217a027
   Bortolotti CA, 2012, J AM CHEM SOC, V134, P13670, DOI 10.1021/ja3030356
   Ludemann G, 2013, J PHYS CHEM B, V117, P10769, DOI 10.1021/jp406319b
   Stuchebrukhov AA, 1996, J CHEM PHYS, V105, P10819, DOI 10.1063/1.472890
   Noy D, 2006, BBA-BIOENERGETICS, V1757, P90, DOI 10.1016/j.bbabio.2005.11.010
   NEWTON MD, 1991, CHEM REV, V91, P767, DOI 10.1021/cr00005a007
   Schwabe T, 2015, PHYS CHEM CHEM PHYS, V17, P2582, DOI 10.1039/c4cp04524f
   Matyushov DV, 2007, ACCOUNTS CHEM RES, V40, P294, DOI 10.1021/ar7000167
   Coulter ED, 2001, ARCH BIOCHEM BIOPHYS, V394, P76, DOI 10.1006/abbi.2001.2531
   Steinmann C, 2014, J CHEM THEORY COMPUT, V10, P981, DOI 10.1021/ct400880n
   Breuer M, 2012, BIOCHEM SOC T, V40, P1198, DOI 10.1042/BST20120139
   Victoria D, 2013, BBA-BIOENERGETICS, V1827, P365, DOI 10.1016/j.bbabio.2012.10.012
   Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102
   de la Lande A, 2010, J MOL STRUC-THEOCHEM, V943, P115, DOI 10.1016/j.theochem.2009.11.012
   Breuer M, 2014, P NATL ACAD SCI USA, V111, P611, DOI 10.1073/pnas.1316156111
   Gray HB, 2000, J BIOL INORG CHEM, V5, P551, DOI 10.1007/s007750000146
   Prytkova TR, 2005, J PHYS CHEM B, V109, P1618, DOI 10.1021/jp0457491
   LARSSON S, 1981, J AM CHEM SOC, V103, P4034, DOI 10.1021/ja00404a010
   HWANG JK, 1987, J AM CHEM SOC, V109, P715, DOI 10.1021/ja00237a013
   Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316
   Wu Q, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.024502
   Migliore A, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166233
   Schroder U, 2007, PHYS CHEM CHEM PHYS, V9, P2619, DOI [10.1039/b703627m, 10.1039/003627m]
   Voityuk AA, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2841421
   ZICHI DA, 1989, J PHYS CHEM-US, V93, P6261, DOI 10.1021/j100354a001
   Millett F, 2013, BBA-BIOENERGETICS, V1827, P1309, DOI 10.1016/j.bbabio.2012.09.002
   Blumberger J, 2008, MOL PHYS, V106, P1597, DOI 10.1080/00268970802220112
   Kimura S, 2003, J BIOL CHEM, V278, P3580, DOI 10.1074/jbc.M209838200
   Lamoureux G, 2003, J CHEM PHYS, V119, P3025, DOI 10.1063/1.1589749
   Cave RJ, 1997, J CHEM PHYS, V106, P9213, DOI 10.1063/1.474023
   Van Voorhis T, 2010, ANNU REV PHYS CHEM, V61, P149, DOI 10.1146/annurev.physchem.012809.103324
   Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a
   Torres RA, 2003, J AM CHEM SOC, V125, P1923, DOI 10.1021/ja0211104
   RICK SW, 1994, J CHEM PHYS, V101, P6141, DOI 10.1063/1.468398
   Blumberger J, 2008, PHYS CHEM CHEM PHYS, V10, P5651, DOI 10.1039/b807444e
   LeBard DN, 2010, PHYS CHEM CHEM PHYS, V12, P15335, DOI 10.1039/c0cp01004a
   Kuznetsov AM, 2010, BBA-BIOENERGETICS, V1797, P347, DOI 10.1016/j.bbabio.2009.12.004
   Ponder JW, 2010, J PHYS CHEM B, V114, P2549, DOI 10.1021/jp910674d
   Hu H, 2007, J CHEM THEORY COMPUT, V3, P390, DOI 10.1021/ct600240y
   Takada S, 2012, CURR OPIN STRUC BIOL, V22, P130, DOI 10.1016/j.sbi.2012.01.010
   Zeng XC, 2012, J CHEM THEORY COMPUT, V8, P4960, DOI 10.1021/ct300758v
   Hu H, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2816557
   Kitoh-Nishioka H, 2012, J PHYS CHEM B, V116, P12933, DOI 10.1021/jp3062948
   Mueller RM, 2011, J PHYS CHEM B, V115, P3632, DOI 10.1021/jp1107922
   Wu Q, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2360263
   Migliore A, 2007, J PHYS CHEM B, V111, P3774, DOI 10.1021/jp068773i
   Kaila VRI, 2010, P NATL ACAD SCI USA, V107, P21470, DOI 10.1073/pnas.1005889107
   LeBard DN, 2008, J PHYS CHEM B, V112, P10322, DOI 10.1021/jp8016503
   Matyushov DV, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4812788
   Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m
   Tipmanee V, 2012, J PHYS CHEM B, V116, P1876, DOI 10.1021/jp209175j
   MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X
   Wesolowski T, 1996, J PHYS CHEM-US, V100, P15444, DOI 10.1021/jp961068x
   Kubas A, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4867077
   Oberhofer H, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3507878
   Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105
   MARCHI M, 1993, J AM CHEM SOC, V115, P4178, DOI 10.1021/ja00063a041
   Vuilleumier R, 2012, J AM CHEM SOC, V134, P2067, DOI 10.1021/ja2069104
   Kubar T, 2010, J PHYS CHEM B, V114, P11221, DOI 10.1021/jp102814p
   Olsson MHM, 2003, J AM CHEM SOC, V125, P5025, DOI 10.1021/ja0212157
   Nishioka H, 2005, J PHYS CHEM B, V109, P1978, DOI 10.1021/jp046282x
   Blumberger J, 2008, J AM CHEM SOC, V130, P16065, DOI 10.1021/ja805471a
   Saen-Oon S, 2013, PHYS CHEM CHEM PHYS, V15, P15271, DOI 10.1039/c3cp50484k
   Oberhofer H, 2010, ANGEW CHEM INT EDIT, V49, P3631, DOI 10.1002/anie.200906455
   Parson WW, 1998, BIOPHYS J, V74, P182
   Aschi M, 2001, CHEM PHYS LETT, V344, P374, DOI 10.1016/S0009-2614(01)00638-8
   Balabin IA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.158102
   Balabin IA, 2012, J COMPUT CHEM, V33, P906, DOI 10.1002/jcc.22927
   Beratan D. N., 2014, ACCOUNTS CHEM RES, V48, P474
   BIALEK W, 1989, PHOTOSYNTH RES, V22, P15, DOI 10.1007/BF00114763
   Cailliez F, 2014, J AM CHEM SOC, V136, P12974, DOI 10.1021/ja506084f
   Cheung MS, 1999, BIOPHYS J, V76, P1241
   CHURG AK, 1983, J PHYS CHEM-US, V87, P1683, DOI 10.1021/j100233a010
   Cieplak P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/33/333102
   Daizadeh I, 1999, J CHEM PHYS, V110, P8865, DOI 10.1063/1.478807
   Daizadeh I, 2002, MOL BIOL EVOL, V19, P406
   Ding FZ, 2010, J PHYS CHEM A, V114, P6039, DOI 10.1021/jp912049p
   GEHLEN JN, 1994, SCIENCE, V263, P499, DOI 10.1126/science.263.5146.499
   Gianazza E, 2006, ELECTROPHORESIS, V27, P1182, DOI 10.1002/elps.200500687
   Gillet N, 2014, J CHEM THEORY COMPUT, V10, P5036, DOI 10.1021/ct500173y
   Gray HB, 2009, CHEM PHYS LETT, V483, P1, DOI 10.1016/j.cplett.2009.10.051
   Gu J, 2014, CHEM COMMUN, V50, P5355, DOI 10.1039/c3cc47943a
   Guallar V, 2010, BIOPHYS CHEM, V149, P1, DOI 10.1016/j.bpc.2010.03.010
   Guengerich FP, 2002, BIOCHEMISTRY-US, V41, P11025, DOI 10.1021/bi020341k
   Heck A, 2012, J PHYS CHEM B, V116, P2284, DOI 10.1021/jp2086297
   Hsu CP, 2009, ACCOUNTS CHEM RES, V42, P509, DOI 10.1021/ar800153f
   Kaduk B., 2011, CHEM REV, V112, P321
   Kawatsu T., 2013, PEPT SCI, V100, P100
   Kilic M, 2013, J CHEM THEORY COMPUT, V9, P3889, DOI 10.1021/ct400088g
   Kovacic P, 2000, CURR PHARM DESIGN, V6, P143
   Kubar T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0415
   Kurnikov IV, HARLEM MOL MODELLING
   Lagardere L, 2015, J CHEM THEORY COMPUT, V11, P2589, DOI 10.1021/acs.jctc.5b00171
   LeBard DN, 2008, J PHYS CHEM B, V112, P5218, DOI 10.1021/jp709586e
   Liang ZX, 2004, J AM CHEM SOC, V126, P2785, DOI 10.1021/ja038163l
   Lipparini F, 2015, J CHEM THEORY COMPUT, V11, P623, DOI 10.1021/ct500998q
   Livshits GI, 2014, NAT NANOTECHNOL, V9, P1040, DOI [10.1038/nnano.2014.246, 10.1038/NNANO.2014.246]
   Martin DR, 2013, J PHYS CHEM LETT, V4, P3602, DOI 10.1021/jz401910e
   Miyashita O, 2005, P NATL ACAD SCI USA, V102, P3558, DOI 10.1073/pnas.0409600102
   Monari A, 2012, ACCOUNTS CHEM RES, V46, P596
   Nazmutdinov RR, 2012, PHYS CHEM CHEM PHYS, V14, P5953, DOI 10.1039/c2cp24084j
   Nishioka H, 2008, J PHYS CHEM B, V112, P9948, DOI 10.1021/jp710689s
   Nishioka H, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3594100
   Nishioka H, 2005, J PHYS CHEM B, V109, P15621, DOI 10.1021/jp051606i
   Oberhofer H, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3190169
   Parks JH, 2013, J PHYS CHEM B, V117, P1756, DOI 10.1021/jp3078437
   Pilme J, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2368-4
   Prytkova TR, 2015, J PHYS CHEM B, V119, P1288, DOI 10.1021/jp5086894
   Rezae C.J., SOFTWARE FRAMEWORK C
   SAVEANT JM, 1993, ACCOUNTS CHEM RES, V26, P455, DOI 10.1021/ar00033a001
   Semrouni D, 2013, J PHYS CHEM B, V117, P1746, DOI 10.1021/jp3078375
   Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409
   SIDDARTH P, 1993, J PHYS CHEM-US, V97, P2400, DOI 10.1021/j100112a047
   SIDDARTH P, 1990, J PHYS CHEM-US, V94, P2985, DOI 10.1021/j100370a046
   Srivatsan N, 2001, J PHYS CHEM B, V105, P12391, DOI 10.1021/jp011676z
   Steinbrecher T, 2008, J PHYS CHEM B, V112, P16935, DOI 10.1021/jp8076134
   Stephens PJ, 1996, CHEM REV, V96, P2491, DOI 10.1021/cr950045w
   Stuchebrukhov A. A., 2000, J QUANTUM CHEM, V77, P16
   SUTIN N, 1982, ACCOUNTS CHEM RES, V15, P275, DOI 10.1021/ar00081a002
   TACHIYA M, 1989, J PHYS CHEM-US, V93, P7050, DOI 10.1021/j100357a005
   van Amsterdam IMC, 2002, NAT STRUCT BIOL, V9, P48, DOI 10.1038/nsb736
   Vladimirov E, 2009, J PHYS CHEM B, V113, P4425, DOI 10.1021/jp809774q
   WARSHEL A, 1982, J PHYS CHEM-US, V86, P2218, DOI 10.1021/j100209a016
   Wikstrom M, 2000, BIOCHEMISTRY-US, V39, P3515, DOI 10.1021/bi9925322
   Wolfgang J, 1997, J PHYS CHEM B, V101, P2986, DOI 10.1021/jp963771r
   Yue HJ, 2006, J PHYS CHEM B, V110, P5062, DOI 10.1021/jp055768q
   Zeng X., 2010, MULTISCALE SIMULATIO
   Zeng XC, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3120605
   Zeng XC, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2832946
NR 179
TC 1
Z9 1
U1 33
U2 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 28
EP 41
DI 10.1016/j.abb.2015.06.016
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200005
PM 26116376
ER

PT J
AU Tunon, I
   Laage, D
   Hynes, JT
AF Tunon, Inaki
   Laage, Damien
   Hynes, James T.
TI Are there dynamical effects in enzyme catalysis? Some thoughts
   concerning the enzymatic chemical step
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Enzyme catalysis; Dynamical effects; Transition State Theory
AB We offer some thoughts on the much debated issue of dynamical effects in enzyme catalysis, and more specifically on their potential role in the acceleration of the chemical step. Since the term 'dynamics' has been used with different meanings, we find it useful to first return to the Transition State Theory rate constant, its assumptions and the choices it involves, and detail the various sources of deviations from it due to dynamics (or not). We suggest that much can be learned about the key current questions for enzyme catalysis from prior extensive studies of dynamical and other effects in the case of reactions in solution. We analyze dynamical effects both in the neighborhood of the transition state and far from it, together with the situation when quantum nuclear motion is central to the reaction, and we illustrate our discussion with various examples of enzymatic reactions. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.
C1 [Tunon, Inaki] Univ Valencia, Dept Quim Fis, E-46003 Valencia, Spain.
   [Laage, Damien; Hynes, James T.] Univ Paris 06, Univ Paris 04, Dept Chem, Ecole Normale Super,PSL Res Univ,CNRS,UMR Pasteur, F-75005 Paris, France.
   [Hynes, James T.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA.
RP Tunon, I (reprint author), Univ Paris 06, Univ Paris 04, Dept Chem, Ecole Normale Super,PSL Res Univ,CNRS,UMR Pasteur, 24 Rue Lhomond, F-75005 Paris, France.
EM ignacio.tunon@uv.es; damien.laage@ens.fr; james.hynes@colorado.edu
RI Laage, Damien/C-6859-2008
OI Laage, Damien/0000-0001-5706-9939
FU FEDER funds; Ministerio de Economia y Competitividad
   [CTQ2012-36253-C03-03]; European Research Council under the European
   Union's Seventh Framework Program/ERC [279977]; USA NSF [CHE-1112564];
   CNRS Program for Scientific Cooperation
FX IT gratefully acknowledges financial support from FEDER funds and the
   Ministerio de Economia y Competitividad (Project CTQ2012-36253-C03-03).
   The research leading to these results has received funding from the
   European Research Council under the European Union's Seventh Framework
   Program (FP7/2007-2013)/ERC Grant Agreement No. 279977 (DL). This
   research was supported in part by the USA NSF Grant CHE-1112564 (JTH).
   This work was also supported in part by the CNRS Program for Scientific
   Cooperation. The authors gratefully acknowledge correspondence with
   Profs. A Kohen, S. Hammes-Schiffer, J. Klinman, S.D. Schwartz, and D.G.
   Truhlar. Of course, the opinions expressed in the present article are
   those of its authors, unless otherwise noted.
NR 0
TC 1
Z9 1
U1 8
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 42
EP 55
DI 10.1016/j.abb.2015.06.004
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200006
PM 26087289
ER

PT J
AU Cerqueira, NMFSA
   Gesto, D
   Oliveira, EF
   Santos-Martins, D
   Bras, NF
   Sousa, SF
   Fernandes, PA
   Ramos, MJ
AF Cerqueira, Nuno M. F. S. A.
   Gesto, Diana
   Oliveira, Eduardo F.
   Santos-Martins, Diogo
   Bras, Natercia F.
   Sousa, Sergio F.
   Fernandes, Pedro A.
   Ramos, Maria J.
TI Receptor-based virtual screening protocol for drug discovery
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Virtual screening; Molecular docking; Scoring functions; Search
   algorithms; Drug discovery
ID PROTEIN-LIGAND INTERACTIONS; EMPIRICAL SCORING FUNCTIONS; INCREMENTAL
   CONSTRUCTION ALGORITHM; MOLECULAR DOCKING; BINDING-SITES; AUTOMATED
   DOCKING; FLEXIBLE DOCKING; GENETIC ALGORITHM; 3-DIMENSIONAL STRUCTURE;
   SHAPE COMPLEMENTARITY
AB Computational aided drug design (CADD) is presently a key component in the process of drug discovery and development as it offers great promise to drastically reduce cost and time requirements.
   In the pharmaceutical arena, virtual screening is normally regarded as the top CADD tool to screen large libraries of chemical structures and reduce them to a key set of likely drug candidates regarding a specific protein target. This chapter provides a comprehensive overview of the receptor-based virtual screening process and of its importance in the present drug discovery and development paradigm. Following a focused contextualization on the subject, the main stages of a virtual screening campaign, including its strengths and limitations, are the subject of particular attention in this review. In all of these stages special consideration will be given to practical issues that are normally the Achilles heel of the virtual screening process. (C) 2015 Published by Elsevier Inc.
C1 [Cerqueira, Nuno M. F. S. A.; Gesto, Diana; Oliveira, Eduardo F.; Santos-Martins, Diogo; Bras, Natercia F.; Sousa, Sergio F.; Fernandes, Pedro A.; Ramos, Maria J.] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, UCIBIO,REQUIMTE, P-4169007 Oporto, Portugal.
RP Ramos, MJ (reprint author), Univ Porto, Fac Ciencias, Dept Quim & Bioquim, UCIBIO,REQUIMTE, Rua Campo Alegre, P-4169007 Oporto, Portugal.
EM mjramos@fc.up.pt
RI Ramos, Maria/D-6183-2013; Santos Martins, Diogo/L-5050-2014; Oliveira,
   Eduardo/L-5665-2014; Cerqueira, Nuno M. F. Sousa A./A-5182-2008; Gesto,
   Diana/L-6184-2014
OI Ramos, Maria/0000-0002-7554-8324; Santos Martins,
   Diogo/0000-0003-4622-3747; Oliveira, Eduardo/0000-0003-4637-2099;
   Cerqueira, Nuno M. F. Sousa A./0000-0003-0342-7424; Fernandes,
   Pedro/0000-0003-2748-4722; Gesto, Diana/0000-0002-3583-8407
FU FEDER/COMPETE; Fundacao para a Ciencia e a Tecnologia (FCT)
   [EXCL/QEQ-COM/0394/2012, PTDC/QUI-QUI/121744/2010, IF/01310/2013,
   PEST-C/EQB/LA0006/2011]
FX This work has been funded by FEDER/COMPETE and the Fundacao para a
   Ciencia e a Tecnologia (FCT) through projects EXCL/QEQ-COM/0394/2012,
   PTDC/QUI-QUI/121744/2010, IF/01310/2013 and PEST-C/EQB/LA0006/2011.
CR Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203
   Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897
   Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m
   Apostolakis J, 1998, J COMPUT CHEM, V19, P21, DOI 10.1002/(SICI)1096-987X(19980115)19:1<21::AID-JCC2>3.0.CO;2-0
   Nisius B, 2012, J BIOTECHNOL, V159, P123, DOI 10.1016/j.jbiotec.2011.12.005
   Carlson HA, 2002, CURR PHARM DESIGN, V8, P1571, DOI 10.2174/1381612023394232
   Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356
   Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
   Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X
   Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545
   Muegge I, 2001, J COMPUT CHEM, V22, P418, DOI 10.1002/1096-987X(200103)22:4<418::AID-JCC1012>3.0.CO;2-3
   Kalyaanamoorthy S, 2011, DRUG DISCOV TODAY, V16, P831, DOI 10.1016/j.drudis.2011.07.006
   Ghosh S, 2006, CURR OPIN CHEM BIOL, V10, P194, DOI 10.1016/j.cbpa.2006.04.002
   Roberts BC, 2008, J CHEM INF MODEL, V48, P397, DOI 10.1021/ci700285e
   Knegtel RMA, 1997, J MOL BIOL, V266, P424, DOI 10.1006/jmbi.1996.0776
   Murray CW, 1999, J COMPUT AID MOL DES, V13, P547, DOI 10.1023/A:1008015827877
   Chen J, 2005, BIOINFORMATICS, V21, P4133, DOI 10.1093/bioinformatics/bti683
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Amaro RE, 2008, J COMPUT AID MOL DES, V22, P693, DOI 10.1007/s10822-007-9159-2
   Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365
   Schneider G, 2010, NAT REV DRUG DISCOV, V9, P273, DOI 10.1038/nrd3139
   Welch W, 1996, CHEM BIOL, V3, P449, DOI 10.1016/S1074-5521(96)90093-9
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Osterberg F, 2002, PROTEINS, V46, P34, DOI 10.1002/prot.10028
   Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315
   Ghose RP, 1999, ANN INTERN MED, V131, P105
   Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
   Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2
   Williams AJ, 2008, CURR OPIN DRUG DISC, V11, P393
   Henrich S, 2010, J MOL RECOGNIT, V23, P209, DOI 10.1002/jmr.984
   Zsoldos Z, 2007, J MOL GRAPH MODEL, V26, P198, DOI 10.1016/j.jmgm.2006.06.002
   ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503
   Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8
   MILLER MD, 1994, J COMPUT AID MOL DES, V8, P153, DOI 10.1007/BF00119865
   Good AC, 2008, J COMPUT AID MOL DES, V22, P169, DOI 10.1007/s10822-007-9167-2
   Baxter CA, 1998, PROTEINS, V33, P367, DOI 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.0.CO;2-W
   Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h
   WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216
   Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741
   Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm.020406h
   Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450
   Makino S, 1997, J COMPUT CHEM, V18, P1812, DOI 10.1002/(SICI)1096-987X(19971115)18:14<1812::AID-JCC10>3.3.CO;2-X
   GEHLHAAR DK, 1995, CHEM BIOL, V2, P317, DOI 10.1016/1074-5521(95)90050-0
   Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882
   McMartin C, 1997, J COMPUT AID MOL DES, V11, P333, DOI 10.1023/A:1007907728892
   Beuming T, 2012, PROTEINS, V80, P871, DOI 10.1002/prot.23244
   Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549
   Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361
   Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477
   JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9
   Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460
   DESJARLAIS RL, 1988, J MED CHEM, V31, P722, DOI 10.1021/jm00399a006
   Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P233, DOI 10.1038/nsb0396-233
   Bolstad ESD, 2009, PROTEINS, V75, P62, DOI 10.1002/prot.22214
   Charifson PS, 1999, J MED CHEM, V42, P5100, DOI 10.1021/jm990352k
   Muegge I, 2006, J MED CHEM, V49, P5895, DOI 10.1021/jm050038s
   Van Drie JH, 2007, J COMPUT AID MOL DES, V21, P591, DOI 10.1007/s10822-007-9142-y
   PANG YP, 1994, J COMPUT AID MOL DES, V8, P683, DOI 10.1007/BF00124015
   KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X
   Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389
   Kapetanovic IM, 2008, CHEM-BIOL INTERACT, V171, P165, DOI 10.1016/j.cbi.2006.12.006
   Kortvelyesi T, 2003, PROTEINS, V51, P340, DOI 10.1002/prot.10287
   Kirchmair J, 2008, J COMPUT AID MOL DES, V22, P213, DOI 10.1007/s10822-007-9163-6
   Paul N, 2002, PROTEINS, V47, P521, DOI 10.1002/prot.10119
   Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j
   Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371
   Schnecke V, 1998, PROTEINS, V33, P74, DOI 10.1002/(SICI)1097-0134(19981001)33:1<74::AID-PROT7>3.0.CO;2-L
   Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n
   LEVITT DG, 1992, J MOL GRAPHICS, V10, P229, DOI 10.1016/0263-7855(92)80074-N
   Yuriev E, 2013, J MOL RECOGNIT, V26, P215, DOI 10.1002/jmr.2266
   Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277
   Claussen H, 2001, J MOL BIOL, V308, P377, DOI 10.1006/jmbi.2001.4551
   Park H, 2009, BIOORG MED CHEM LETT, V19, P4330, DOI 10.1016/j.bmcl.2009.05.084
   Cavasotto CN, 2008, CURR COMPUT-AID DRUG, V4, P221, DOI 10.2174/157340908785747474
   Perola E, 2000, J MED CHEM, V43, P401, DOI 10.1021/jm990408a
   BOHM HJ, 1992, J COMPUT AID MOL DES, V6, P61, DOI 10.1007/BF00124387
   Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1
   Bras NF, 2008, INT J QUANTUM CHEM, V108, P2030, DOI 10.1002/qua.21755
   Budzik B, 2010, ACS MED CHEM LETT, V1, P244, DOI 10.1021/ml100105x
   Cerqueira NMFSA, 2009, PROTEINS, V74, P192, DOI 10.1002/prot.22146
   CLARK KP, 1995, J COMPUT CHEM, V16, P1210, DOI 10.1002/jcc.540161004
   HART TN, 1992, PROTEINS, V13, P206, DOI 10.1002/prot.340130304
   Hashmi I, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-S1-S6
   Hendlich M, 1997, J MOL GRAPH MODEL, V15, P389
   Irwin J.J., 2007, ABSTR PAP AM CHEM SO, V234
   Ishchenko AV, 2002, J MED CHEM, V45, P2770, DOI 10.1021/jm0105833
   Ke YY, 2014, EUR J MED CHEM, V83, P226, DOI 10.1016/j.ejmech.2014.06.029
   Khandelwal A, 2005, J MED CHEM, V48, P5437, DOI 10.1021/jm049050v
   Kortagere S, 2010, J PHARMACOL TOX MET, V61, P67, DOI 10.1016/j.vascn.2010.02.005
   Laskowski R. A., 1995, J MOL GRAPHICS, V13, P307
   Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168
   Liu M, 1999, J COMPUT AID MOL DES, V13, P435, DOI 10.1023/A:1008005918983
   MIZUTANI MY, 1994, J MOL BIOL, V243, P310, DOI 10.1006/jmbi.1994.1656
   Morris G.M., 2008, CURR PROTOC BIOINFOR, V8, P8
   Murray CW, 1998, J COMPUT AID MOL DES, V12, P503, DOI 10.1023/A:1008040323669
   Pak YS, 2000, J PHYS CHEM B, V104, P354, DOI 10.1021/jp993073h
   REYNOLDS CA, 1989, J MOL GRAPHICS, V7, P103, DOI 10.1016/S0263-7855(89)80013-X
   Rognan D, 1999, J MED CHEM, V42, P4650, DOI 10.1021/jm9910775
   Sauton N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-184
   Tanrikulu Y, 2009, CHEMMEDCHEM, V4, P820, DOI 10.1002/cmdc.200800443
   Taylor JS, 2000, PROTEINS, V41, P173, DOI 10.1002/1097-0134(20001101)41:2<173::AID-PROT30>3.0.CO;2-3
   Trosset JY, 1999, J COMPUT CHEM, V20, P412, DOI 10.1002/(SICI)1096-987X(199903)20:4<412::AID-JCC3>3.3.CO;2-E
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Velec HFG, 2005, J MED CHEM, V48, P6296, DOI 10.1021/jm050436v
   Viegas A, 2008, FEBS J, V275, P2524, DOI 10.1111/j.1742-4658.2008.06401.x
   WADE RC, 1993, J MED CHEM, V36, P148, DOI 10.1021/jm00053a019
   Wang RX, 1998, J MOL MODEL, V4, P379, DOI 10.1007/s008940050096
   Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7
NR 110
TC 1
Z9 1
U1 38
U2 38
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 56
EP 67
DI 10.1016/j.abb.2015.05.011
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200007
PM 26045247
ER

PT J
AU Swiderek, K
   Tunon, I
   Moliner, V
   Bertran, J
AF Swiderek, K.
   Tunon, I.
   Moliner, V.
   Bertran, J.
TI Computational strategies for the design of new enzymatic functions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Protein design; De novo design; QM/MM; Molecular dynamics; Kemp
   elimination; Diels-Alder; Retro-Aldolase
ID DIELS-ALDER REACTION; MONONUCLEAR ZINC METALLOENZYME; BASE-CATALYZED
   DECOMPOSITION; PHYSICAL ORGANIC-CHEMISTRY; PROTON-TRANSFER CATALYSIS;
   NITRIC-OXIDE REDUCTASE; ANTIBODY ACTIVE-SITE; ARTIFICIAL METALLOENZYMES;
   KEMP ELIMINATION; PROTEIN DESIGN
AB In this contribution, recent developments in the design of biocatalysts are reviewed with particular emphasis in the de novo strategy. Studies based on three different reactions, Kemp elimination, Diels- Alder and Retro-Aldolase, are used to illustrate different success achieved during the last years. Finally, a section is devoted to the particular case of designed metalloenzymes. As a general conclusion, the interplay between new and more sophisticated engineering protocols and computational methods, based on molecular dynamics simulations with Quantum Mechanics/Molecular Mechanics potentials and fully flexible models, seems to constitute the bed rock for present and future successful design strategies. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Swiderek, K.; Tunon, I.] Univ Valencia, Dept Quim Fis, Burjassot 46100, Spain.
   [Swiderek, K.] Lodz Univ Technol, Inst Appl Radiat Chem, PL-90924 Lodz, Poland.
   [Moliner, V.] Univ Jaume 1, Dept Quim Fis & Analit, Castellon de La Plana 12071, Spain.
   [Bertran, J.] Univ Autonoma Barcelona, Dept Quim, Bellaterra 08193, Spain.
RP Bertran, J (reprint author), Univ Autonoma Barcelona, Dept Quim, Bellaterra 08193, Spain.
EM bertran@klingon.uab.es
RI Swiderek, Katarzyna/B-2851-2012; Moliner, Vicent/D-5499-2015; Tunon,
   Inaki/F-7973-2012
OI Swiderek, Katarzyna/0000-0002-7528-1551; Moliner,
   Vicent/0000-0002-3665-3391; Tunon, Inaki/0000-0002-6995-1838
FU Spanish Ministerio de Economia y Competitividad [CTQ2012-36253-C03];
   Universitat Jaume I - Spain [P1.1B2014-26]; Generalitat Valenciana -
   Spain [PROMETEOII/2014/022, ACOMP/2014/277]; Polish National Center for
   Science (NCN) [2011/02/A/ST4/00246]; Polish Ministry of Science and
   Higher Education ("Iuventus Plus" program) [0478/IP3/2015/73]; USA
   National Institute of Health [NIH R01 GM065368]
FX This work was supported by the Spanish Ministerio de Economia y
   Competitividad for project CTQ2012-36253-C03, Universitat Jaume I -
   Spain (project P1.1B2014-26), Generalitat Valenciana - Spain
   (PROMETEOII/2014/022 and ACOMP/2014/277 projects), Polish National
   Center for Science (NCN) (grant 2011/02/A/ST4/00246, 2012-2017), the
   Polish Ministry of Science and Higher Education ("Iuventus Plus" program
   project no. 0478/IP3/2015/73, 2015-2016) and the USA National Institute
   of Health (ref. NIH R01 GM065368). Authors acknowledge computational
   resources from the Servei d'Informatica of Universitat de Valencia on
   the 'Tirant' supercomputer and the Servei d'Informatica of Universitat
   Jaume I.
CR Acevedo O, 2009, J PHYS CHEM B, V113, P15372, DOI 10.1021/jp9069114
   Alexandrova AN, 2009, J PHYS CHEM B, V113, P497, DOI 10.1021/jp8076084
   Korendovych IV, 2011, P NATL ACAD SCI USA, V108, P6823, DOI 10.1073/pnas.1018191108
   Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692
   Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443
   Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108
   Lassila JK, 2006, P NATL ACAD SCI USA, V103, P16710, DOI 10.1073/pnas.0607591103
   PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678
   Hilvert D, 2013, ANNU REV BIOCHEM, V82, P447, DOI 10.1146/annurev-biochem-072611-101825
   Steinreiber J, 2008, COORDIN CHEM REV, V252, P751, DOI 10.1016/j.ccr.2007.09.016
   Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304
   Petrik ID, 2014, CURR OPIN CHEM BIOL, V19, P67, DOI [10.1016/j.cbpa.2014.01.006, 10.1016/j.cpba.2014.01.006]
   Rosati F, 2010, CHEMCATCHEM, V2, P916, DOI 10.1002/cctc.201000011
   Romesberg FE, 1998, SCIENCE, V279, P1929, DOI 10.1126/science.279.5358.1929
   Khersonsky O, 2011, J MOL BIOL, V407, P391, DOI 10.1016/j.jmb.2011.01.041
   HILVERT D, 1989, J AM CHEM SOC, V111, P9261, DOI 10.1021/ja00208a037
   CASEY ML, 1973, J ORG CHEM, V38, P2294, DOI 10.1021/jo00953a006
   Wijma HJ, 2013, FEBS J, V280, P2948, DOI 10.1111/febs.12324
   Drienovska I, 2015, CHEM SCI, V6, P770, DOI 10.1039/c4sc01525h
   Zastrow ML, 2012, NAT CHEM, V4, P118, DOI [10.1038/nchem.1201, 10.1038/NCHEM.1201]
   Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106
   Kelly WL, 2008, ORG BIOMOL CHEM, V6, P4483, DOI 10.1039/b814552k
   Frushicheva MP, 2011, BIOCHEMISTRY-US, V50, P3849, DOI 10.1021/bi200063a
   Tantillo DJ, 1998, CURR OPIN CHEM BIOL, V2, P743, DOI 10.1016/S1367-5931(98)80112-9
   Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591
   Mandell DJ, 2009, CURR OPIN BIOTECH, V20, P420, DOI 10.1016/j.copbio.2009.07.006
   Lin YW, 2010, P NATL ACAD SCI USA, V107, P8581, DOI 10.1073/pnas.1000526107
   Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077
   Hoffmann T, 1998, J AM CHEM SOC, V120, P2768, DOI 10.1021/ja973676b
   Khersonsky O, 2010, J MOL BIOL, V396, P1025, DOI 10.1016/j.jmb.2009.12.031
   Marti S, 2004, CHEM SOC REV, V33, P98, DOI 10.1039/b301875j
   Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tiblech.2005.03.005
   Frushicheva MP, 2010, P NATL ACAD SCI USA, V107, P16869, DOI 10.1073/pnas.1010381107
   Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086
   WAGNER J, 1995, SCIENCE, V270, P1797, DOI 10.1126/science.270.5243.1797
   Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481
   Boersma AJ, 2007, ORG LETT, V9, P3647, DOI 10.1021/ol7015274
   Zhu XY, 2009, J AM CHEM SOC, V131, P18206, DOI 10.1021/ja907271a
   Hollfelder F, 1997, J AM CHEM SOC, V119, P9578, DOI 10.1021/ja971970y
   Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172
   Heinisch T, 2010, CURR OPIN CHEM BIOL, V14, P184, DOI 10.1016/j.cbpa.2009.11.026
   Humble MS, 2011, EUR J ORG CHEM, P3391, DOI 10.1002/ejoc.201001664
   Barrozo A, 2012, INT J MOL SCI, V13, P12428, DOI 10.3390/ijms131012428
   Moroz OV, 2013, ANGEW CHEM INT EDIT, V52, P6246, DOI 10.1002/anie.201302339
   Miner KD, 2012, ANGEW CHEM INT EDIT, V51, P5589, DOI 10.1002/anie.201201981
   Marti S, 2008, CHEM SOC REV, V37, P2634, DOI 10.1039/b710705f
   Na J, 1996, J AM CHEM SOC, V118, P6462, DOI 10.1021/ja953550j
   Kries H, 2013, CURR OPIN CHEM BIOL, V17, P221, DOI 10.1016/j.cbpa.2013.02.012
   Obexer R, 2014, CHEMCATCHEM, V6, P1043, DOI 10.1002/cctc.201300933
   Liu XH, 2012, ANGEW CHEM INT EDIT, V51, P4312, DOI 10.1002/anie.201108756
   Yu FT, 2014, CHEM REV, V114, P3495, DOI 10.1021/cr400458x
   Patel SC, 2009, PROTEIN SCI, V18, P1388, DOI 10.1002/pro.147
   Althoff EA, 2012, PROTEIN SCI, V21, P717, DOI 10.1002/pro.2059
   Alexandrova AN, 2008, J AM CHEM SOC, V130, P15907, DOI 10.1021/ja804040s
   Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109
   Blomberg R, 2013, NATURE, V503, P418, DOI 10.1038/nature12623
   Zimbron JM, 2013, J AM CHEM SOC, V135, P5384, DOI 10.1021/ja309974s
   WILSON ME, 1978, J AM CHEM SOC, V100, P306, DOI 10.1021/ja00469a064
   Yeung N, 2009, NATURE, V462, P1079, DOI 10.1038/nature08620
   Hollfelder F, 1996, NATURE, V383, P60, DOI 10.1038/383060a0
   THORN SN, 1995, NATURE, V373, P228, DOI 10.1038/373228a0
   Toscano MD, 2007, ANGEW CHEM INT EDIT, V46, P3212, DOI 10.1002/anie.200604205
   Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82
   Durrenberger M, 2014, CURR OPIN CHEM BIOL, V19, P99, DOI 10.1016/j.cbpa.2014.01.018
   Linder M, 2011, J CHEM INF MODEL, V51, P1906, DOI 10.1021/ci200177d
   Linder M, 2012, J COMPUT AID MOL DES, V26, P1079, DOI 10.1007/s10822-012-9601-y
   Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106
   Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879
   Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132
   Khare SD, 2013, FEBS LETT, V587, P1147, DOI 10.1016/j.febslet.2012.12.009
   Der BS, 2012, J AM CHEM SOC, V134, P375, DOI 10.1021/ja208015j
   Damborsky J, 2014, CURR OPIN CHEM BIOL, V19, P8, DOI [10.1016/j.cbpa.2013.12.003, 10.1016/j.cbpa.2013.12.0,03]
   Bos J, 2012, ANGEW CHEM INT EDIT, V51, P7472, DOI 10.1002/anie.201202070
   Debler EW, 2009, P NATL ACAD SCI USA, V106, P18539, DOI 10.1073/pnas.0902700106
   Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108
   Podtetenieff J, 2010, ANGEW CHEM INT EDIT, V49, P5151, DOI 10.1002/anie.201002106
   Reetz MT, 2012, CHEM REC, V12, P391, DOI 10.1002/tcr.201100043
   Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085
   Khersonsky O, 2012, P NATL ACAD SCI USA, V109, P10358, DOI 10.1073/pnas.1121063109
   Pordea A, 2008, J AM CHEM SOC, V130, P8085, DOI 10.1021/ja8017219
   Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106
   Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p
   Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981
   Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398
   Deuss PJ, 2013, CHEMCATCHEM, V5, P1184, DOI 10.1002/cctc.201200671
   Chakraborty S, 2011, ANGEW CHEM INT EDIT, V50, P2049, DOI 10.1002/anie.201006413
   Khare SD, 2012, NAT CHEM BIOL, V8, P294, DOI [10.1038/nchembio.777, 10.1038/NCHEMBIO.777]
   Xu JA, 1999, SCIENCE, V286, P2345, DOI 10.1126/science.286.5448.2345
   Preiswerk N, 2014, P NATL ACAD SCI USA, V111, P8013, DOI 10.1073/pnas.1401073111
   Giger L, 2013, NAT CHEM BIOL, V9, P494, DOI 10.1038/nchembio.1276
   Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117
   Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509
   Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304
   Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515
   Arno M, 2003, ORG BIOMOL CHEM, V1, P637, DOI 10.1039/b209636f
   Bos J, 2014, CURR OPIN CHEM BIOL, V19, P135, DOI 10.1016/j.cbpa.2014.02.002
   BRAISTED AC, 1990, J AM CHEM SOC, V112, P7430, DOI 10.1021/ja00176a073
   Cannizzaro CE, 2003, J AM CHEM SOC, V125, P2489, DOI 10.1021/ja020879d
   Carbone MN, 2007, CURR OPIN STRUC BIOL, V17, P454, DOI 10.1016/j.sbi.2007.08.005
   Debler EW, 2005, P NATL ACAD SCI USA, V102, P4984, DOI 10.1073/pnas.0409207102
   Debler EW, 2008, J BIOL CHEM, V283, P16554, DOI 10.1074/jbc.M710256200
   Der BS, 2012, BIOCHEMISTRY-US, V51, P3933, DOI 10.1021/bi201881p
   Farinas E, 1998, PROTEIN SCI, V7, P1939
   Fazelinia H., 2008, PROTEIN SCI, V18, P180
   Frushicheva MP, 2014, CURR OPIN CHEM BIOL, V21, P56, DOI 10.1016/j.cbpa.2014.03.022
   GenreGrandpierre A, 1997, BIOORG MED CHEM LETT, V7, P2497, DOI 10.1016/S0960-894X(97)10003-8
   Golinelli-Pimpaneau B, 2000, CURR OPIN STRUC BIOL, V10, P697, DOI 10.1016/S0959-440X(00)00157-3
   GOUVERNEUR VE, 1993, SCIENCE, V262, P204, DOI 10.1126/science.8211138
   Heine A, 1998, SCIENCE, V279, P1934, DOI 10.1126/science.279.5358.1934
   Hohne M, 2014, ANGEW CHEM INT EDIT, V53, P1200, DOI 10.1002/anie.201309591
   Hollfelder F, 2000, J AM CHEM SOC, V122, P1022, DOI 10.1021/ja993471y
   Hu YF, 2004, J AM CHEM SOC, V126, P8197, DOI 10.1021/ja0490727
   Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109
   Huang XQ, 2013, PROTEIN SCI, V22, P929, DOI 10.1002/pro.2275
   James LC, 2001, PROTEIN SCI, V10, P2600, DOI 10.1110/ps.ps.14601
   Keinan E., 2005, CATALYTIC ANTIBODIES
   KEMP DS, 1995, NATURE, V373, P196, DOI 10.1038/373196a0
   KEMP DS, 1973, J AM CHEM SOC, V95, P6670, DOI 10.1021/ja00801a024
   Kikuchi K, 1996, J AM CHEM SOC, V118, P8184, DOI 10.1021/ja9617395
   Kirby AJ, 1997, ACCOUNTS CHEM RES, V30, P290, DOI 10.1021/ar960056r
   Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462
   Labas A, 2013, BBA-PROTEINS PROTEOM, V1834, P908, DOI 10.1016/j.bbapap.2013.01.005
   Laschat S, 1996, ANGEW CHEM INT EDIT, V35, P289, DOI 10.1002/anie.199602891
   Lassila JK, 2010, P NATL ACAD SCI USA, V107, P4937, DOI 10.1073/pnas.0913638107
   Leaver-Fay Andrew, 2011, Methods Enzymol, V487, P545, DOI 10.1016/B978-0-12-381270-4.00019-6
   Lei YL, 2011, PROTEIN SCI, V20, P1566, DOI 10.1002/pro.685
   Leitgeb S, 2010, CHEMBIOCHEM, V11, P502, DOI 10.1002/cbic.200900688
   Lightstone FC, 1996, J AM CHEM SOC, V118, P2595, DOI 10.1021/ja952589l
   Lin YW, 2010, J AM CHEM SOC, V132, P9970, DOI 10.1021/ja103516n
   Lin YW, 2012, J MOL MODEL, V18, P4409, DOI 10.1007/s00894-012-1451-y
   Linder M, 2012, CHEM COMMUN, V48, P5665, DOI 10.1039/c2cc31502e
   List B, 1998, P NATL ACAD SCI USA, V95, P15351, DOI 10.1073/pnas.95.26.15351
   Malisi C, 2009, PROTEINS, V77, P74, DOI 10.1002/prot.22418
   Marti S, 2008, CHEM-EUR J, V14, P596, DOI 10.1002/chem.200700290
   Merski M, 2012, P NATL ACAD SCI USA, V109, P16179, DOI 10.1073/pnas.1208076109
   Mills JH, 2013, J AM CHEM SOC, V135, P13393, DOI 10.1021/ja403503m
   Muller R, 2007, J AM CHEM SOC, V129, P460, DOI 10.1021/ja066578b
   Munoz-Robles V., 2014, ACS CATAL, V4, P833
   Nanda V, 2008, NAT CHEM BIOL, V4, P273, DOI 10.1038/nchembio0508-273
   Nosrati GR, 2012, PROTEIN SCI, V21, P697, DOI 10.1002/pro.2055
   Panek JJ, 2010, J COMPUT AID MOL DES, V24, P719, DOI 10.1007/s10822-010-9369-x
   Pordea A, 2009, J ORGANOMET CHEM, V694, P930, DOI 10.1016/j.jorganchem.2008.11.023
   Renfrew PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032637
   Richter F., 2011, PLOS ONE, V6, p[el, 9230]
   Ringenberg MR, 2011, CHEM COMMUN, V47, P8470, DOI 10.1039/c1cc11592h
   Roelfes G, 2006, CHEM COMMUN, P635, DOI 10.1039/b516552k
   Romesberg FE, 1999, BIOORG MED CHEM LETT, V9, P1741, DOI 10.1016/S0960-894X(99)00281-4
   Rosati F, 2009, CHEM-EUR J, V15, P9596, DOI 10.1002/chem.200900456
   Saven JG, 2011, CURR OPIN CHEM BIOL, V15, P452, DOI [10.1016/j.cbpa.2011.03.014, 10.1016/j.cpa.2011.03.014]
   Seebeck FP, 2005, J AM CHEM SOC, V127, P1307, DOI 10.1021/ja0446471
   Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239
   Singh MK, 2014, J PHYS CHEM B, V118, P12146, DOI 10.1021/jp507592g
   Sparta M, 2011, MOL SIMULAT, V37, P557, DOI 10.1080/08927022.2011.565760
   Steiner K., 2012, COMPUT STRUCT BIOTEC, V2
   Swiderek K, 2015, ACS CATAL, V5, P2587, DOI 10.1021/cs501904w
   Valdez CE, 2012, J PHYS CHEM B, V116, P10649, DOI 10.1021/jp302771n
   Valdez CE, 2014, ACCOUNTS CHEM RES, V47, P3110, DOI 10.1021/ar500227u
   Wang L, 2012, J MOL BIOL, V415, P615, DOI 10.1016/j.jmb.2011.10.043
   Ward TR, 2011, ACCOUNTS CHEM RES, V44, P47, DOI 10.1021/ar100099u
   Zastrow M.L., 2013, BIOCHEMISTRY-US, V53, P957
   Zastrow ML, 2013, J AM CHEM SOC, V135, P5895, DOI 10.1021/ja401537t
   Zhong GF, 1999, ANGEW CHEM INT EDIT, V38, P3738, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3738::AID-ANIE3738>3.0.CO;2-2
NR 162
TC 0
Z9 0
U1 36
U2 36
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 68
EP 79
DI 10.1016/j.abb.2015.03.013
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200008
PM 25797438
ER

PT J
AU Carvalho, ATP
   Szeler, K
   Vavitsas, K
   Aqvist, J
   Kamerlin, SCL
AF Carvalho, Alexandra T. P.
   Szeler, Klaudia
   Vavitsas, Konstantinos
   Aqvist, Johan
   Kamerlin, Shina C. L.
TI Modeling the mechanisms of biological GTP hydrolysis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE GTP hydrolysis; Ras GTPase; EF-Tu; EF-G; Computational biology
ID ELONGATION-FACTOR TU; AMINOACYL-TRANSFER-RNA;
   PHOSPHORYL-TRANSFER-REACTIONS; TIME-RESOLVED FTIR; GUANOSINE
   TRIPHOSPHATE HYDROLYSIS; SUBSTRATE-ASSISTED CATALYSIS; P-NITROPHENYL
   PHOSPHATE; H-RAS P21; EF-G; CRYSTAL-STRUCTURE
AB Enzymes that hydrolyze GTP are currently in the spotlight, due to their molecular switch mechanism that controls many cellular processes. One of the best-known classes of these enzymes are small GTPases such as members of the Ras superfamily, which catalyze the hydrolysis of the gamma-phosphate bond in GTP. In addition, the availability of an increasing number of crystal structures of translational GTPases such as EF-Tu and EF-G have made it possible to probe the molecular details of GTP hydrolysis on the ribosome. However, despite a wealth of biochemical, structural and computational data, the way in which GTP hydrolysis is activated and regulated is still a controversial topic and well-designed simulations can play an important role in resolving and rationalizing the experimental data. In this review, we discuss the contributions of computational biology to our understanding of GTP hydrolysis on the ribosome and in small GTPases. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.
C1 [Carvalho, Alexandra T. P.; Szeler, Klaudia; Aqvist, Johan; Kamerlin, Shina C. L.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, SE-75124 Uppsala, Sweden.
   [Vavitsas, Konstantinos] Univ Copenhagen, Dept Plant & Environm Sci, CPSC, DK-1871 Frederiksberg C, Denmark.
RP Kamerlin, SCL (reprint author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, BMC Box 596, SE-75124 Uppsala, Sweden.
EM kamerlin@icm.uu.se
RI Kamerlin, Shina/G-9554-2011; Vavitsas, Konstantinos/A-5871-2015; 
OI Kamerlin, Shina/0000-0002-3190-1173; Vavitsas,
   Konstantinos/0000-0002-6828-1000; Pires Carvalho, Alexandra
   Teresa/0000-0003-2827-5527
FU Swedish Research Council (VR); Knut and Alice Wallenberg Foundation
   through a Wallenberg Academy Fellowship; ERC [306474]; Knut and Alice
   Wallenberg Foundation through a RiboCORE consortium
FX The authors would like to thank the Swedish Research Council (VR) and
   the Knut and Alice Wallenberg Foundation (through a Wallenberg Academy
   Fellowship and the RiboCORE consortium) for funding and support.
   S.C.L.K. is an ERC Starting Grantee (306474).
CR Aleksandrov A, 2013, RNA, V19, P1218, DOI 10.1261/rna.040097.113
   Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5
   Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798
   Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024
   KIRBY AJ, 1965, J AM CHEM SOC, V87, P3209, DOI 10.1021/ja01092a036
   Martin-Garcia F, 2012, BIOPHYS J, V102, P152, DOI 10.1016/j.bpj.2011.11.4005
   Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721
   Grigorenko BL, 2005, PROTEINS, V60, P495, DOI 10.1002/prot.20472
   Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800
   NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464
   Glennon TM, 2000, BIOCHEMISTRY-US, V39, P9641, DOI 10.1021/bi000640e
   TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0
   THOMPSON RC, 1986, J BIOL CHEM, V261, P4868
   BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0
   Diaz JF, 1997, PROTEINS, V28, P434
   Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333
   Scheidig AJ, 1999, STRUCT FOLD DES, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0
   Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X
   Cepus V, 1998, BIOCHEMISTRY-US, V37, P10263, DOI 10.1021/bi973183j
   BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0
   de Graauw M, 2006, ELECTROPHORESIS, V27, P2676, DOI 10.1002/elps.200600018
   Topol IA, 2004, BBA-PROTEINS PROTEOM, V1700, P125, DOI 10.1016/j.bbapap.2004.04.007
   KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305
   Pasqualato S, 2005, STRUCTURE, V13, P533, DOI 10.1016/j.str.2005.01.014
   SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F
   Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378
   PAI EF, 1990, EMBO J, V9, P2351
   Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z
   MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0
   Takai Y, 2001, PHYSIOL REV, V81, P153
   Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639
   Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476
   NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7
   GIDEON P, 1992, MOL CELL BIOL, V12, P2050
   Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018
   Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3
   Shurki A, 2004, PROTEINS, V55, P1, DOI 10.1002/prot.20004
   HENGGE AC, 1994, J AM CHEM SOC, V116, P5045, DOI 10.1021/ja00091a003
   Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023
   Maertens Ophelia, 2014, Advances in Biological Regulation, V55, P1, DOI 10.1016/j.jbior.2014.04.002
   Wohlgemuth I, 2010, EMBO J, V29, P3701, DOI 10.1038/emboj.2010.229
   Maracci C, 2014, P NATL ACAD SCI USA, V111, P14418, DOI 10.1073/pnas.1412676111
   Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103
   Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490
   Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P9827, DOI 10.1073/pnas.1105714108
   Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700
   Kamerlin SCL, 2013, Q REV BIOPHYS, V46, P1, DOI 10.1017/S0033583512000157
   Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490
   Kotting C, 2004, CHEM PHYS, V307, P227, DOI 10.1016/j.chemphys.2004.06.051
   Zhou J, 2014, SCIENCE, V345, P1188, DOI 10.1126/science.1255030
   Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460
   Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741
   Grigorenko BL, 2007, PROTEINS, V66, P456, DOI 10.1002/prot.21228
   Khrenova MG, 2014, BIOCHEMISTRY-US, V53, P7093, DOI 10.1021/bi5011333
   Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660
   Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1
   Aqvist J, 1999, CHEM BIOL, V6, pR71, DOI 10.1016/S1074-5521(99)89003-6
   Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106
   Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018
   Parmeggiani A, 2006, BIOCHEMISTRY-US, V45, P6846, DOI 10.1021/bi0525122
   ALEXANDER C, 1995, J BIOL CHEM, V270, P14541
   ADMIRAAL SJ, 1995, CHEM BIOL, V2, P729, DOI 10.1016/1074-5521(95)90101-9
   Aqvist J., 2014, BIOCHEMISTRY-US, V54, P546
   Avarsson A, 1995, J Mol Evol, V41, P1096
   Bora R.P., 2013, P NATL ACAD SCI USA, V110, P20509
   Bora R.P., 2013, J PHYS CHEM B, V117, P153
   BOURNE HR, 1990, NATURE, V348, P678, DOI 10.1038/348678a0
   BRUNGER AT, 1990, P NATL ACAD SCI USA, V87, P4849, DOI 10.1073/pnas.87.12.4849
   Burnett BJ, 2013, J BIOL CHEM, V288, P13917, DOI 10.1074/jbc.M113.460014
   Cai YC, 2000, J BIOL CHEM, V275, P20308, DOI 10.1074/jbc.M001899200
   Chen Y, 2013, NAT STRUCT MOL BIOL, V20, P1077, DOI 10.1038/nsmb.2645
   Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13
   Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027
   Cunha C.E., 2013, TRANSLATION, V1
   CZWORKOWSKI J, 1994, EMBO J, V13, P3661
   Dawson R. M. C., 1959, DATA BIOCH RES
   Du XL, 2000, J BIOL CHEM, V275, P8492, DOI 10.1074/jbc.275.12.8492
   Duarte F., 2014, J AM CHEM SOC, V137, P1081
   Ehrenberg M, 2010, NATURE, V466, P325, DOI 10.1038/466325a
   FRECH M, 1994, BIOCHEMISTRY-US, V33, P3237, DOI 10.1021/bi00177a014
   Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126
   Green R, 2000, CURR BIOL, V10, pR369, DOI 10.1016/S0960-9822(00)00481-4
   Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798
   Hamrita B, 2011, CLIN BIOCHEM, V44, P1097, DOI 10.1016/j.clinbiochem.2011.06.005
   HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2
   te Heesen Henrik, 2007, FEBS Lett, V581, P5677, DOI 10.1016/j.febslet.2007.11.026
   HERSCHLAG D, 1989, J AM CHEM SOC, V111, P7579, DOI 10.1021/ja00201a047
   Hilgenfeld R., 2000, INSIGHTS GTPASE MECH
   Holtkamp W, 2014, EMBO J, V33, P1073, DOI 10.1002/embj.201387465
   Kamerlin SCL, 2007, ORG BIOMOL CHEM, V5, P2098, DOI 10.1039/b701274h
   Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6
   KIRBY AJ, 1967, J AM CHEM SOC, V89, P415, DOI 10.1021/ja00978a044
   Klahn M, 2006, J AM CHEM SOC, V128, P15310, DOI 10.1021/ja065470t
   Knudsen C, 2001, J BIOL CHEM, V276, P22183, DOI 10.1074/jbc.M102186200
   Kuhle B, 2014, EMBO J, V33, P2547, DOI 10.15252/embj.201488517
   LANGEN R, 1992, BIOCHEMISTRY-US, V31, P8691, DOI 10.1021/bi00152a002
   Liljas A, 2011, SCIENCE, V333, P37, DOI 10.1126/science.1202472
   Liljas A, 1995, BIOCHEM CELL BIOL, V73, P1209
   Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160
   Olson MF, 2000, SEMIN IMMUNOL, V12, P63, DOI 10.1006/smim.2000.0208
   Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970
   Rodnina MV, 1996, J BIOL CHEM, V271, P646
   Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0
   SATOH T, 1992, J BIOL CHEM, V267, P24149
   Satpati P, 2014, BIOCHEMISTRY-US, V53, P1714, DOI 10.1021/bi5000355
   Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884
   SCARANO G, 1995, FEBS LETT, V365, P214, DOI 10.1016/0014-5793(95)00469-P
   Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x
   SCHWEINS T, 1994, NAT STRUCT BIOL, V1, P476, DOI 10.1038/nsb0794-476
   SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36
   Sharma D, 2004, RNA, V10, P102, DOI 10.1261/rna.5148704
   Shi HJ, 2012, PATHOLOGY, V44, P506, DOI 10.1097/PAT.0b013e3283559cbe
   van Dam TJ, 2011, SMALL GTPASES, V2, P4, DOI DOI 10.4161/SGTP.2.1.15113
   Vega FM, 2007, CELL, V129, P1430, DOI 10.1016/j.cell.2007.06.021
   Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106
   Voorhees RM, 2011, SCIENCE, V333, P37
   Vorstenbosch ELH, 2000, J BIOCHEM BIOPH METH, V42, P1, DOI 10.1016/S0165-022X(99)00032-9
   Wallin G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2741
   Wang JH, 1998, BIOCHEMISTRY-US, V37, P11106, DOI 10.1021/bi980471m
   Xu CY, 2011, INT J MOL SCI, V12, P6645, DOI 10.3390/ijms12106645
   Yamamoto H, 2014, NAT REV MICROBIOL, V12, P89, DOI 10.1038/nrmicro3176
   Yi H, 2010, J PROTEOME RES, V9, P1416, DOI 10.1021/pr9009386
   ZEIDLER W, 1995, EUR J BIOCHEM, V229, P596, DOI 10.1111/j.1432-1033.1995.tb20503.x
   Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086
   Zhu GY, 2003, J BIOL CHEM, V278, P2452, DOI 10.1074/jbc.M211042200
   Zor T, 1997, EUR J BIOCHEM, V249, P330, DOI 10.1111/j.1432-1033.1997.00330.x
NR 126
TC 2
Z9 2
U1 24
U2 24
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 80
EP 90
DI 10.1016/j.abb.2015.02.027
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200009
PM 25731854
ER

PT J
AU Rossetti, G
   Dibenedetto, D
   Calandrini, V
   Giorgetti, A
   Carloni, P
AF Rossetti, Giulia
   Dibenedetto, Domenica
   Calandrini, Vania
   Giorgetti, Alejandro
   Carloni, Paolo
TI Structural predictions of neurobiologically relevant G-protein coupled
   receptors and intrinsically disordered proteins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE G-protein coupled receptors; Intrinsic disordered proteins;
   Computational biophysics; Bioinformatics
ID MOLECULAR-DYNAMICS SIMULATIONS; NATIVELY UNFOLDED PROTEINS; IMPLICIT
   SOLVENT MODELS; MULTIPLE-MINIMA PROBLEM; SPIN-GLASS SIMULATIONS;
   MECHANICS FORCE-FIELDS; FREE-ENERGY LANDSCAPE; REPLICA-EXCHANGE;
   UNSTRUCTURED PROTEINS; MONTE-CARLO
AB G protein coupled receptors (GPCRs) and intrinsic disordered proteins (IDPs) are key players for neuronal function and dysfunction. Unfortunately, their structural characterization is lacking in most cases. From one hand, no experimental structure has been determined for the two largest GPCRs subfamilies, both key proteins in neuronal pathways. These are the odorant (450 members out of 900 human GPCRs) and the bitter taste receptors (25 members) subfamilies. On the other hand, also IDPs structural characterization is highly non-trivial. They exist as dynamic, highly flexible structural ensembles that undergo conformational conversions on a wide range of timescales, spanning from picoseconds to milliseconds. Computational methods may be of great help to characterize these neuronal proteins. Here we review recent progress from our lab and other groups to develop and apply in silico methods for structural predictions of these highly relevant, fascinating and challenging systems. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Rossetti, Giulia; Dibenedetto, Domenica; Calandrini, Vania; Giorgetti, Alejandro; Carloni, Paolo] Forschungszentrum Julich, German Res Sch Simulat Sci & Computat Biomed, Computat Biophys, Inst Adv Simulat IAS 5, D-52425 Julich, Germany.
   [Rossetti, Giulia; Dibenedetto, Domenica; Calandrini, Vania; Giorgetti, Alejandro; Carloni, Paolo] Forschungszentrum Julich, Inst Neurosci & Med INM 9, D-52425 Julich, Germany.
   [Rossetti, Giulia] Forschungszentrum Julich, Julich Supercomp Ctr, D-52425 Julich, Germany.
   [Giorgetti, Alejandro] Univ Verona, Dept Biotechnol, I-37134 Verona, Italy.
RP Giorgetti, A (reprint author), Univ Verona, Dept Biotechnol, Ca Vignal 1,Str Grazie 15, I-37134 Verona, Italy.
EM alejandro.giorgetti@univr.it
CR Aliev AE, 2010, J PHYS CHEM B, V114, P12358, DOI 10.1021/jp101581h
   Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480
   Nymeyer H, 2008, J CHEM THEORY COMPUT, V4, P626, DOI 10.1021/ct7003337
   Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008
   Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747
   Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483
   Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004
   Chen JH, 2009, J AM CHEM SOC, V131, P2088, DOI 10.1021/ja809547p
   Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256
   Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504
   Kang M, 2006, J COMPUT CHEM, V27, P1477, DOI 10.1002/jcc.20441
   Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3
   Rzepiela AJ, 2011, PHYS CHEM CHEM PHYS, V13, P10437, DOI 10.1039/c0cp02981e
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045
   Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x
   Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401
   Terakawa T, 2011, J COMPUT CHEM, V32, P1228, DOI 10.1002/jcc.21703
   Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0
   LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611
   Nakajima N, 1997, J PHYS CHEM B, V101, P817, DOI 10.1021/jp962142e
   Cavasotto CN, 2012, METHODS MOL BIOL, V819, P157, DOI 10.1007/978-1-61779-465-0_11
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858
   Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060101o
   Feig M, 2004, CURR OPIN STRUC BIOL, V14, P217, DOI 10.1016/j.sbi.2004.03.009
   Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877
   Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p
   Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8
   Staus DP, 2014, MOL PHARMACOL, V85, P472, DOI 10.1124/mol.113.089516
   Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.0.CO;2-7
   Bowman GR, 2010, J CHEM THEORY COMPUT, V6, P787, DOI 10.1021/ct900620b
   Bruno A, 2012, MOL INFORM, V31, P222, DOI 10.1002/minf.201100138
   Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377
   Shi Q, 2006, J PHYS CHEM B, V110, P15045, DOI 10.1021/jp062700h
   Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321
   Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375
   James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X
   Matsunami H, 2000, NATURE, V404, P601
   Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   Jacobson KA, 2007, TRENDS PHARMACOL SCI, V28, P111, DOI 10.1016/j.tips.2007.01.006
   Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Salmon L, 2010, J AM CHEM SOC, V132, P8407, DOI 10.1021/ja101645g
   Rodriguez D, 2013, CURR PHARM DESIGN, V19, P2216
   Voelz VA, 2010, J AM CHEM SOC, V132, P1526, DOI 10.1021/ja9090353
   HANSMANN UHE, 1993, J COMPUT CHEM, V14, P1333, DOI 10.1002/jcc.540141110
   Tosh DK, 2012, J MED CHEM, V55, P4297, DOI 10.1021/jm300095s
   Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6
   Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102
   MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Costanzi S, 2013, CURR OPIN STRUC BIOL, V23, P185, DOI 10.1016/j.sbi.2013.01.008
   Qiao Q, 2013, J AM CHEM SOC, V135, P16092, DOI 10.1021/ja403147m
   Zheng WH, 2007, P NATL ACAD SCI USA, V104, P15340, DOI 10.1073/pnas.0704418104
   Wassenaar TA, 2013, J PHYS CHEM B, V117, P3516, DOI 10.1021/jp311533p
   Rauscher S, 2009, J CHEM THEORY COMPUT, V5, P2640, DOI 10.1021/ct900302n
   Bevc S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/10/105007
   Jacobson KA, 2012, MOL PHARMACOL, V82, P361, DOI 10.1124/mol.112.079335
   Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924
   Lange OF, 2010, BIOPHYS J, V99, P647, DOI 10.1016/j.bpj.2010.04.062
   Shelokar PS, 2008, EUR J OPER RES, V185, P1213, DOI 10.1016/j.ejor.2006.06.049
   SALI A, 1994, PROTEIN SCI, V3, P1582
   Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325
   Chen JH, 2008, CURR OPIN STRUC BIOL, V18, P140, DOI 10.1016/j.sbi.2008.01.003
   Nerenberg PS, 2011, J CHEM THEORY COMPUT, V7, P1220, DOI 10.1021/ct2000183
   Scheraga HA, 2007, ANNU REV PHYS CHEM, V58, P57, DOI 10.1146/annurev.physchem.58.032806.104614
   Praprotnik M, 2008, ANNU REV PHYS CHEM, V59, P545, DOI 10.1146/annurev.physchem.59.032607.093707
   Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102
   Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d
   Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4
   Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008
   Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011
   SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294
   Okamoto Y, 2004, J MOL GRAPH MODEL, V22, P425, DOI 10.1016/j.jmgm.2003.12.009
   Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o
   Costanzi S, 2008, J MED CHEM, V51, P2907, DOI [10.1021/jm800044k, 10.1021/jim800044k]
   Fritsch S, 2012, J CHEM THEORY COMPUT, V8, P398, DOI 10.1021/ct200706f
   Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087
   Rezaei-Ghaleh N, 2012, CHEMBIOCHEM, V13, P930, DOI 10.1002/cbic.201200093
   Perez RG, 2002, J NEUROSCI, V22, P3090
   Neri M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.218102
   Rauscher S, 2010, BIOCHEM CELL BIOL, V88, P269, DOI [10.1139/o09-169, 10.1139/O09-169]
   Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577
   Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f
   Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072
   Han W, 2012, J CHEM THEORY COMPUT, V8, P4413, DOI 10.1021/ct300696c
   Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592
   Vitalis A, 2009, ANN REP COMP CHEM, V5, P49, DOI 10.1016/S1574-1400(09)00503-9
   Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002
   Wang LL, 2011, J PHYS CHEM B, V115, P9431, DOI 10.1021/jp204407d
   Voelz VA, 2010, J AM CHEM SOC, V132, P4702, DOI 10.1021/ja908369h
   Bourhis JM, 2007, CURR PROTEIN PEPT SC, V8, P135, DOI 10.2174/138920307780363451
   Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003
   Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604
   Roux B, 1999, BIOPHYS CHEM, V78, P1, DOI 10.1016/S0301-4622(98)00226-9
   Jiang JK, 2014, BIOORG MED CHEM LETT, V24, P1148, DOI 10.1016/j.bmcl.2013.12.122
   Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9
   Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896
   Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039
   Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004
   Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e
   MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002
   Bowman GR, 2010, P NATL ACAD SCI USA, V107, P10890, DOI 10.1073/pnas.1003962107
   Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123
   Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j
   Zhou RH, 2003, PROTEINS, V53, P148, DOI 10.1002/prot.10483
   Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012
   Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c
   Baker C. M., 2013, INSIGHTS BINDING INT
   BERG BA, 1992, PHYS REV LETT, V69, P2292, DOI 10.1103/PhysRevLett.69.2292
   BERG BA, 1994, PHYS REV B, V50, P16444, DOI 10.1103/PhysRevB.50.16444
   Bertini G., 2012, NMR BIOMOLECULES MEC
   Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696
   Bhattacharya Supriyo, 2012, Methods Mol Biol, V914, P167, DOI 10.1007/978-1-62703-023-6_10
   Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394
   Bowman GR, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216567
   Cascella M, 2008, J CHEM THEORY COMPUT, V4, P1378, DOI 10.1021/ct800122x
   Chen J., 2008, IMPLICIT MODELING NO
   Chen JH, 2007, J AM CHEM SOC, V129, P2444, DOI 10.1021/ja068383+
   Choo Y., NAT STRUCT BIOL, P253
   Click TH, 2010, INT J MOL SCI, V11, P5293, DOI 10.3390/ijms11125292
   Cong X, 2013, J CHEM THEORY COMPUT, V9, P5158, DOI 10.1021/ct400534k
   Das R.K., 2013, P NATL ACAD SCI
   Demchenko AP, 2001, J MOL RECOGNIT, V14, P42, DOI 10.1002/1099-1352(200101/02)14:1<42::AID-JMR518>3.0.CO;2-8
   Dong D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031540
   Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108
   Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161
   Dunker A K, 1998, Pac Symp Biocomput, P473
   Frenkel D, 1997, PHYS TODAY, V50, P66, DOI 10.1063/1.881812
   Ganguly D, 2009, J AM CHEM SOC, V131, P5214, DOI 10.1021/ja808999m
   Giorgetti A, 2005, BIOINFORMATICS, V21, P72, DOI 10.1093/bioinformatics/bti1112
   Grossfield A, 2011, BBA-BIOMEMBRANES, V1808, P1868, DOI 10.1016/j.bbamem.2011.03.010
   Haynes C., 2006, INTRINSIC DISORDER I, P1553
   Higo Junichi, 2012, Biophysical Reviews, V4, DOI 10.1007/s12551-011-0063-6
   Higo J, 2009, CHEM PHYS LETT, V473, P326, DOI 10.1016/j.cplett.2009.03.077
   Higo J, 2011, J AM CHEM SOC, V133, P10448, DOI 10.1021/ja110338e
   Huang XH, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2908251
   Ikebe J, 2011, J COMPUT CHEM, V32, P1286, DOI 10.1002/jcc.21710
   Irback A, 2005, BIOPHYS J, V88, P1560, DOI 10.1529/biophysj.104.050427
   Jang S, 2007, PROTEINS, V66, P53, DOI 10.1002/prot.21173
   Johnston JM, 2014, ADV EXP MED BIOL, V796, P95, DOI 10.1007/978-94-007-7423-0_6
   Johnston JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090694
   Johnston JM, 2011, CURR OPIN STRUC BIOL, V21, P552, DOI 10.1016/j.sbi.2011.06.008
   Junghans C, 2010, COMPUT PHYS COMMUN, V181, P1447, DOI 10.1016/j.cpc.2010.04.013
   Kjaergaard Magnus, 2012, Methods Mol Biol, V896, P233, DOI 10.1007/978-1-4614-3704-8_15
   Kruse A. C., 2014, NAT REV DRUG DISCOVE
   Kruse AC, 2014, CURR OPIN PHARMACOL, V16, P24, DOI 10.1016/j.coph.2014.02.006
   lakoucheva L. M., 2002, J MOL BIOL, P573
   Leguebe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047332
   Lehmensiek V., 2002, NEUROREPORT, V13
   Lei H., 2007, IMPROVED SAMPLING ME
   Levit Anat, 2012, Methods Mol Biol, V914, P179, DOI 10.1007/978-1-62703-023-6_11
   Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131
   Mackerell A. D., 2004, EMPIRICAL FORCE FIEL
   Marchiori A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064675
   Mitsutake Ayori, 2013, Methods Mol Biol, V924, P153, DOI 10.1007/978-1-62703-017-5_7
   Mittal J, 2010, BIOPHYS J, V99, pL26, DOI 10.1016/j.bpj.2010.05.005
   Musiani F, 2014, ADV EXP MED BIOL, V805, P441, DOI 10.1007/978-3-319-02970-2_18
   NADLER W, 1987, P NATL ACAD SCI USA, V84, P7933, DOI 10.1073/pnas.84.22.7933
   Nair AV, 2006, BIOPHYS J, V90, P3599, DOI 10.1529/biophysj.105.073346
   Neri M, 2008, BIOPHYS J, V94, P71, DOI 10.1529/biophysj.107.116301
   Okur A, 2003, J COMPUT CHEM, V24, P21, DOI 10.1002/jcc.10184
   Orry Andrew J W, 2012, Methods Mol Biol, V857, P351, DOI 10.1007/978-1-61779-588-6_16
   Periole X., 2007, CONVERGENCE SAMPLING
   Petrenko R., 2001, MOL DYNAMICS ELS
   Piggot T. J., 2013, PROTEINS SOLUT INTER, P193
   Plans S., 2011, BIOPHYS J, V100, pL47
   Plaxco K. W., NATURE, P657
   Ponder J. W., 2003, FORCE FIELDS PROTEIN
   Pontius B. W., 1993, CLOSE ENCOUNTERS WHY
   Rao F, 2003, J CHEM PHYS, V119, P4035, DOI 10.1063/1.1591721
   Romero P, 1998, Pac Symp Biocomput, P437
   Rosenfeld R., 1995, FLEXIBLE DOCKING DES
   Scarabelli G, 2014, BIOPOLYMERS, V101, P21, DOI 10.1002/bip.22251
   Schulz G. E., 1979, MOL MECH BIOL RECOGN
   Sindhikara D., 2008, EXCHANGE FREQUENCY R
   Staneva I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002682
   Uversky V. N., 2014, FRONT MOL BIOSCI, V1
   Vanni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001053
   Vanommeslaeghe K., 2009, ABSTR PAP AM CHEM SO, V238
   Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n
   Williams R M, 2001, Pac Symp Biocomput, P89
   Wu K.-P., 2011, J AM CHEM SOC
   Yoda T, 2004, CHEM PHYS, V307, P269, DOI 10.1016/j.chemphys.2004.08.002
   Zhang W, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2056540
   Zhang WH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002353
   Zuckerman D.M., 2006, J CHEM THEORY COMPUT, V2
NR 189
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 91
EP 100
DI 10.1016/j.abb.2015.03.011
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200010
PM 25797436
ER

PT J
AU Piazzetta, P
   Marino, T
   Russo, N
AF Piazzetta, Paolo
   Marino, Tiziana
   Russo, Nino
TI Theoretical investigation on the restoring step of the carbonic
   anhydrase catalytic cycle for natural and promiscuous substrates
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE hCAll; Ureate; Bicarbonate; SMD; Binding energy; Enzymatic catalytic
   turnover
ID COMPUTATIONAL ENZYMATIC CATALYSIS; FREE-ENERGY DIFFERENCES;
   MOLECULAR-DYNAMICS; CYANAMIDE HYDRATION; PHOSPHOLIPASE-C;
   PROTON-TRANSFER; MECHANISM; MODEL; METALLOENZYMES; SIMULATIONS
AB In the present study steered molecular dynamics simulations were applied to investigate the unbinding process of the complex of human carbonic anhydrase with the natural HCO3- and promiscuous H2NCOHN- products. This process is crucial for restoring the catalytic cycle of the enzyme. This investigation set out to give further insights on the release mechanism involved in the case of the promiscuous product believed suicide inhibitor for the hCAII against the natural final product. In particular, on the basis of the NPT molecular dynamics simulations performed on the bicarbonate, the penta-coordinated complex with the water is observed, while in the case of the ureate the same event does not take place. At this purpose the calculated potential of mean force based on the steered molecular dynamics (SMD) simulations shed light on an optimal pathway for the releasing of the products. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Piazzetta, Paolo; Marino, Tiziana; Russo, Nino] Univ Calabria, Dipartimento Chim & Tecnol Chim, I-87036 Arcavacata Di Rende, Italy.
RP Russo, N (reprint author), Univ Calabria, Dipartimento Chim & Tecnol Chim, Via P Bucci,Cubo 14c, I-87036 Arcavacata Di Rende, Italy.
FU Department of Chemistry and Chemical Technologies of the Universita
   della Calabria (Italy); Commissione Europea, Fondo Sociale Europeo;
   Regione Calabria
FX This work was financially supported through Department of Chemistry and
   Chemical Technologies of the Universita della Calabria (Italy). P.
   Piazzetta gratefully acknowledges Commissione Europea, Fondo Sociale
   Europeo, and Regione Calabria for the financial support.
CR Sjoblom B, 2009, P NATL ACAD SCI USA, V106, P10609, DOI 10.1073/pnas.0904184106
   FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648
   Kumar S, 2010, PHYS REP, V486, P1, DOI 10.1016/j.physrep.2009.11.001
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690
   Blomberg MRA, 2014, CHEM REV, V114, P3601, DOI 10.1021/cr400388t
   Ugwumba IN, 2011, J AM CHEM SOC, V133, P326, DOI 10.1021/ja106416g
   Cui Q, 2003, J PHYS CHEM B, V107, P1071, DOI 10.1021/jp021931v
   Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316
   Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367
   Mauksch M, 2001, CHEMBIOCHEM, V2, P190, DOI 10.1002/1439-7633(20010302)2:3<190::AID-CBIC190>3.3.CO;2-Z
   Merkel R, 1999, NATURE, V397, P50
   Kouza M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2822272
   Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i
   Bottoni A, 2004, J AM CHEM SOC, V126, P1542, DOI 10.1021/ja030336j
   Yu FT, 2014, CHEM REV, V114, P3495, DOI 10.1021/cr400458x
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965
   Zhang JL, 2010, CHEM PHYS LETT, V484, P338, DOI 10.1016/j.cplett.2009.12.022
   Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104
   Sousa SF, 2012, PHYS CHEM CHEM PHYS, V14, P12431, DOI 10.1039/c2cp41180f
   Schramm VL, 2006, CHEM REV, V106, P3029, DOI 10.1021/cr050246s
   Jackson CJ, 2009, P NATL ACAD SCI USA, V106, P21631, DOI 10.1073/pnas.0907548106
   Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311
   Briganti F, 1999, J BIOL INORG CHEM, V4, P528, DOI 10.1007/s007750050375
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   ELSAYED MY, 1985, BIOCHIM BIOPHYS ACTA, V837, P325, DOI 10.1016/0005-2760(85)90056-6
   Guerri A, 2000, BIOCHEMISTRY-US, V39, P12391, DOI 10.1021/bi000937c
   Heymann B, 1999, CHEM PHYS LETT, V303, P1, DOI 10.1016/S0009-2614(99)00183-9
   Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018
   Klinman JP, 2015, ACCOUNTS CHEM RES, V48, P449, DOI 10.1021/ar5003347
   Martin SF, 1996, BIOCHEMISTRY-US, V35, P12970, DOI 10.1021/bi961316f
   Mellot-Draznieks C, 2012, ACS CATAL, V2, P2673, DOI 10.1021/cs300538z
   Park C, 2003, BIOCHEMISTRY-US, V42, P3509, DOI 10.1021/bi026076k
   Piazzetta P, 2014, INORG CHEM, V53, P3488, DOI 10.1021/ic402932y
   Piazzetta P, 2014, PHYS CHEM CHEM PHYS, V16, P16671, DOI 10.1039/c4cp02363c
   Ramos MJ, 2008, ACCOUNTS CHEM RES, V41, P689, DOI 10.1021/ar7001045
   Schmid M, 2012, CHEM SCI, V3, P690, DOI 10.1039/c1sc00628b
   Scolnick LR, 1996, BIOCHEMISTRY-US, V35, P16429, DOI 10.1021/bi9617872
   SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005
NR 40
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 101
EP 106
DI 10.1016/j.abb.2015.03.022
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200011
PM 25849760
ER

PT J
AU Pinto, GP
   Ribeiro, AJM
   Ramos, MJ
   Fernandes, PA
   Toscano, M
   Russo, N
AF Pinto, Gaspar P.
   Ribeiro, Antonio J. M.
   Ramos, Maria J.
   Fernandes, Pedro A.
   Toscano, Marirosa
   Russo, Nino
TI New insights in the catalytic mechanism of tyrosine ammonia-lyase given
   by QM/MM and QM cluster models
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Tyrosine ammonia lyase; QM; QM/MM; Catalytic mechanism; DFT; Enzymatic
   catalysis
ID PHOTOACTIVE YELLOW PROTEIN; MOLECULAR-ORBITAL METHODS; P-HYDROXYCINNAMIC
   ACID; GAUSSIAN-BASIS SETS; ORGANIC-MOLECULES; ESCHERICHIA-COLI;
   FORCE-FIELD; PHENYLALANINE; BIOSYNTHESIS; ENZYME
AB Tyrosine ammonia lyase (TAL) catalyzes the deamination of tyrosine to p-coumaric acid in purple phototropic bacteria and Actinomycetales. The enzyme is used in bioengineering and has the potential to be used industrially. It belongs to a family of enzymes that uses a 4-methylidene-imidazole-5-one (MIO) cofactor to catalyze the deamination amino acids. In the present work, we used a QM/MM and a QM cluster models of TAL to explore two putative reaction paths for its catalytic mechanism. Part of the N-MIO mechanism was previously studied by computational methods. We improved on previous studies by using a larger, more complete model of the enzyme, and by describing the complete reaction path. The activation energy for this mechanism, in agreement with the previous study, is 28.5 kcal/mol. We also found another reaction path that has overall better kinetics and reaches the products in a single reaction step. The barrier for this Single-Step mechanism is 16.6 kcal/mol, which agrees very well with the experimental kat of 16.0 kcal/mol. The geometrical parameters obtained for the cluster and QM/ MM models are very similar, despite differences in the relative energies. This means that both approaches are capable of describing the correct catalytic path of TAL. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Pinto, Gaspar P.; Ribeiro, Antonio J. M.; Ramos, Maria J.; Fernandes, Pedro A.] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, REQUIMTE,UCIBIO, P-4169007 Oporto, Portugal.
   [Pinto, Gaspar P.; Ribeiro, Antonio J. M.; Toscano, Marirosa; Russo, Nino] Univ Calabria, Dipartimento Chim, I-87036 Arcavacata Di Rende, Italy.
RP Russo, N (reprint author), Univ Calabria, Dipartimento Chim, I-87036 Arcavacata Di Rende, Italy.
EM nrusso@unical.it
RI Ramos, Maria/D-6183-2013; 
OI Ramos, Maria/0000-0002-7554-8324; Fernandes, Pedro/0000-0003-2748-4722
FU Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/61549/2009];
   Dipartimento di Fisica of Unical
FX We would like to thank Professor Laszlo Poppe for providing us the
   structures of their model. A.J.M.R. thanks Fundacao para a Ciencia e
   Tecnologia (FCT) for a doctoral scholarship (SFRH/BD/61549/2009). J.S.P.
   thanks to Dipartimento di Fisica of Unical for a doctoral scholarship.
CR Watts KT, 2006, CHEM BIOL, V13, P1317, DOI 10.1016/j.chembiol.2006.10.008
   Poppe L, 2005, ANGEW CHEM INT EDIT, V44, P3668, DOI 10.1002/anie.200461377
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Schwede TF, 1999, BIOCHEMISTRY-US, V38, P5355, DOI 10.1021/bi982929q
   Kyndt JA, 2003, BIOCHEMISTRY-US, V42, P965, DOI 10.1021/bi027037b
   Zhang YS, 2006, J AM CHEM SOC, V128, P13030, DOI 10.1021/ja0622094
   Pilbak S, 2012, CHEM-EUR J, V18, P7793, DOI 10.1002/chem.201103662
   Berner M, 2006, J BACTERIOL, V188, P2666, DOI 10.1128/JB.188.7.2666-2673.2006
   MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   ROOTHAAN CCJ, 1951, REV MOD PHYS, V23, P69, DOI 10.1103/RevModPhys.23.69
   Xue Z, 2007, ENZYME MICROB TECH, V42, P58, DOI 10.1016/j.enzmictec.2007.07.025
   Kyndt JA, 2002, FEBS LETT, V512, P240, DOI 10.1016/S0014-5793(02)02272-X
   Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005
   LANGER M, 1995, ANGEW CHEM INT EDIT, V34, P1464, DOI 10.1002/anie.199514641
   Schroeder AC, 2008, PHYTOCHEMISTRY, V69, P1496, DOI 10.1016/j.phytochem.2008.02.007
   HERMES JD, 1985, BIOCHEMISTRY-US, V24, P2959, DOI 10.1021/bi00333a023
   Ritter H, 2004, PLANT CELL, V16, P3426, DOI 10.1105/tpc.104.025288
   Louie GV, 2006, CHEM BIOL, V13, P1327, DOI 10.1016/j.chembiol.2006.11.011
   CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Baedeker M, 2002, STRUCTURE, V10, P61, DOI 10.1016/S0969-2126(01)00692-X
   BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004
   Case DA, 2008, AMBER 10
   DITCHFIE.R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902
   FRISCH MJ, 1984, J CHEM PHYS, V80, P3265, DOI 10.1063/1.447079
   Schrodinger L.L.C., 2010, PYMOL MOL GRAPHICS S
   Vannelli T, 2007, ENZYME MICROB TECH, V41, P413, DOI 10.1016/j.enzmictec.2007.03.013
   Watts KT, 2004, CHEMBIOCHEM, V5, P500, DOI 10.1002/cbic.200300783
NR 30
TC 1
Z9 1
U1 18
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 107
EP 115
DI 10.1016/j.abb.2015.03.002
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200012
PM 25772386
ER

PT J
AU Melia, C
   Ferrer, S
   Moliner, V
   Bertran, J
AF Melia, C.
   Ferrer, S.
   Moliner, V.
   Bertran, J.
TI Theoretical studies of the hydrolysis of antibiotics catalyzed by a
   metallo-beta-lactamase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Mono zinc M beta Ls; CphA; IMI; CEF; QM/MM; Enzyme promiscuity
ID DENSITY-FUNCTIONAL THEORY; X-RAY CRYSTALLOGRAPHY; REACTION-MECHANISM;
   ALKALINE-PHOSPHATASE; BACILLUS-CEREUS; MOLECULAR SIMULATIONS;
   SEMIEMPIRICAL METHODS; BACTEROIDES-FRAGILIS; PROTONATION STATE;
   SUBSTRATE-BINDING
AB In this paper, hybrid QM/MM molecular dynamics (MD) simulations have been performed to explore the mechanisms of hydrolysis of two antibiotics, Imipenen (IMI), an antibiotic belonging to the subgroup of carbapenems, and the Cefotaxime (CEF), a third-generation cephalosporin antibiotic, in the active site of a mono-nuclear p-lactamase, CpbA from Aeromonas hydrophila. Significant different transition state structures are obtained for the hydrolysis of both antibiotics: while the TS of the CEF is an ionic species with negative charge on nitrogen, the NI TS presents a tetrahedral-like character with negative charge on oxygen atom of the carbonyl group of the lactam ring. Thus, dramatic conformational changes can take place in the cavity of CphA to accommodate different substrates, which would be the origin of its substrate promiscuity. Since CphA shows only activity against carbapenem antibiotic, this study sheds some light into the origin of the selectivity of the different MbL and, as a consequence, into the discovery of specific and potent MpL inhibitors against a broad spectrum of bacterial pathogens. We have finally probed that a re-parametrization of semiempirical methods should be done to properly describe the behavior the metal cation in active site, Zn2+, when used in QM/MM calculations. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Melia, C.; Ferrer, S.; Moliner, V.] Univ Jaume 1, Dept Quim Fis & Analit, Castellon de La Plana 12071, Spain.
   [Bertran, J.] Univ Autonoma Barcelona, Dept Quim, Bellaterra 08193, Spain.
RP Ferrer, S (reprint author), Univ Jaume 1, Dept Quim Fis & Analit, Castellon de La Plana 12071, Spain.
EM sferrer@uji.es; moliner@uji.es
RI Moliner, Vicent/D-5499-2015
OI Moliner, Vicent/0000-0002-3665-3391
FU FEDER; Spanish Ministerio de Economia y Competitividad
   [CTQ2012-36253-C03]; Universitat Jaume I [P1 1B2011-23]; Generalitat
   Valenciana [PROMETEOII/2014/022, ACOMP/2014/277]
FX We thank FEDER and the Spanish Ministerio de Economia y Competitividad
   (project CTQ2012-36253-C03), Universitat Jaume I (project P1 1B2011-23)
   and Generalitat Valenciana (PROMETEOII/2014/022 and ACOMP/2014/277
   projects). The authors also acknowledge the Servei d'Informatica of the
   Universitat Jaume I for generous allotment of computer time.
CR Ackerman SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055136
   AMBLER RP, 1980, PHILOS T ROY SOC B, V289, P321, DOI 10.1098/rstb.1980.0049
   Field MJ, 2000, J COMPUT CHEM, V21, P1088, DOI 10.1002/1096-987X(200009)21:12<1088::AID-JCC5>3.0.CO;2-8
   Yamaguchi Y, 2005, J BIOL CHEM, V280, P20824, DOI 10.1074/jbc.M414314200
   Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i
   Breece RM, 2009, J AM CHEM SOC, V131, P11642, DOI 10.1021/ja902534b
   Ruiz-Pernia JJ, 2006, J PHYS CHEM B, V110, P17663, DOI 10.1021/jp063520a
   Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x
   SINGH UC, 1986, J COMPUT CHEM, V7, P718, DOI 10.1002/jcc.540070604
   Spencer J, 2005, J AM CHEM SOC, V127, P14439, DOI 10.1021/ja0536062
   STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   Wong KY, 2007, BIOCHEMISTRY-US, V46, P13352, DOI 10.1021/bi700460c
   Xu D, 2007, J AM CHEM SOC, V129, P10814, DOI 10.1021/ja072532m
   Duarte F, 2013, PHYS CHEM CHEM PHYS, V15, P11160, DOI 10.1039/c3cp51179k
   Schenter GK, 2003, J CHEM PHYS, V119, P5828, DOI 10.1063/1.1597477
   VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98
   Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102
   Chuang YY, 1999, J PHYS CHEM A, V103, P1140, DOI 10.1021/jp9842493
   Lopez-Canut V, 2011, J AM CHEM SOC, V133, P12050, DOI 10.1021/ja2017575
   Humble MS, 2011, EUR J ORG CHEM, P3391, DOI 10.1002/ejoc.201001664
   Fonseca F, 2011, J MOL BIOL, V411, P951, DOI 10.1016/j.jmb.2011.06.043
   Llarrull LI, 2008, J AM CHEM SOC, V130, P15842, DOI 10.1021/ja801168r
   Neuwald AF, 1997, NUCLEIC ACIDS RES, V25, P1665, DOI 10.1093/nar/25.9.1665
   Tioni MF, 2008, J AM CHEM SOC, V130, P15852, DOI 10.1021/ja801169j
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070
   Toney JH, 1998, CHEM BIOL, V5, P185, DOI 10.1016/S1074-5521(98)90632-9
   Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241
   Ferrer S, 2012, PHYS CHEM CHEM PHYS, V14, P3482, DOI 10.1039/c2cp23149b
   Wu SS, 2010, J AM CHEM SOC, V132, P17986, DOI 10.1021/ja104241g
   Lopez-Canut V, 2009, J PHYS CHEM B, V113, P7816, DOI 10.1021/jp901444g
   Sharma NP, 2006, BIOCHEMISTRY-US, V45, P10729, DOI 10.1021/bi060893t
   ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301
   Dal Peraro M, 2004, J AM CHEM SOC, V126, P12661, DOI 10.1021/ja048071b
   Ben-David M, 2013, J MOL BIOL, V425, P1028, DOI 10.1016/j.jmb.2013.01.009
   Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r
   Dal Peraro M, 2007, J AM CHEM SOC, V129, P2808, DOI 10.1021/ja0657556
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005
   STEWART JJP, 1989, J COMPUT CHEM, V10, P221, DOI 10.1002/jcc.540100209
   Simona F, 2009, J BIOL CHEM, V284, P28164, DOI 10.1074/jbc.M109.049502
   Lopez-Canut V, 2010, J AM CHEM SOC, V132, P6955, DOI 10.1021/ja908391v
   Brothers EN, 2004, J COMPUT CHEM, V25, P1677, DOI 10.1002/jcc.20086
   Dal Peraro M, 2004, PROTEINS, V54, P412, DOI 10.1002/prot.10554
   Ferrer S, 2005, CHEM COMMUN, P5873, DOI 10.1039/b510735k
   Frisch M.J., 2009, GAUSSIAN 09 REVISION
   Gatti DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030079
   Gonzalez JM, 2007, J MOL BIOL, V373, P1141, DOI 10.1016/j.jmb.2007.08.031
   Hou GH, 2012, J AM CHEM SOC, V134, P229, DOI 10.1021/ja205226d
   Kohn W, 1996, J PHYS CHEM-US, V100, P12974, DOI 10.1021/jp960669l
   Leonard DA, 2013, ACCOUNTS CHEM RES, V46, P2407, DOI 10.1021/ar300327a
   Melia C, 2012, J COMPUT CHEM, V33, P1948, DOI 10.1002/jcc.23030
   Oelschlaeger P, 2010, J MED CHEM, V53, P3013, DOI 10.1021/jm9012938
   Simona F, 2007, PROTEINS, V69, P595, DOI 10.1002/prot.21476
   Tomatis PE, 2005, P NATL ACAD SCI USA, V102, P13761, DOI 10.1073/pnas.0503495102
   Xu DG, 2005, J MED CHEM, V48, P6679, DOI 10.1021/jm0505112
   Xu DG, 2006, J BIOL CHEM, V281, P8740, DOI 10.1074/jbc.M512517200
NR 59
TC 0
Z9 0
U1 19
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2015
VL 582
SI SI
BP 116
EP 126
DI 10.1016/j.abb.2015.01.013
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CQ7JY
UT WOS:000360781200013
PM 25622886
ER

PT J
AU Valpuesta, JM
   Carrascosa, JL
AF Valpuesta, Jose M.
   Carrascosa, Jose L.
TI Electron microscopy: the coming of age of a structural biology technique
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
C1 [Valpuesta, Jose M.; Carrascosa, Jose L.] Ctr Nacl Biotecnol CNB CSIC, Madrid 28049, Spain.
RP Valpuesta, JM (reprint author), Ctr Nacl Biotecnol CNB CSIC, Darwin 3, Madrid 28049, Spain.
EM jlcarrascosa@cnb.csic.es
CR Do M, 2015, ARCH BIOCHEM BIOPHYS, V581, P111, DOI 10.1016/j.abb.2015.01.011
   Henderson R, 2015, ARCH BIOCHEM BIOPHYS, V581, P19, DOI 10.1016/j.abb.2015.02.036
   Fonta CL, 2015, ARCH BIOCHEM BIOPHYS, V581, P98, DOI 10.1016/j.abb.2015.05.017
   Carazo JM, 2015, ARCH BIOCHEM BIOPHYS, V581, P39, DOI 10.1016/j.abb.2015.05.003
   Dubrovsky A, 2015, ARCH BIOCHEM BIOPHYS, V581, P78, DOI 10.1016/j.abb.2015.04.006
   Egelman EH, 2015, ARCH BIOCHEM BIOPHYS, V581, P54, DOI 10.1016/j.abb.2015.04.004
   Fontana J, 2015, ARCH BIOCHEM BIOPHYS, V581, P86, DOI 10.1016/j.abb.2015.04.011
   Harris R.J., 2015, ARCH BIOCHEM BIOPHYS, V581, P3
   Rigort A, 2015, ARCH BIOCHEM BIOPHYS, V581, P122, DOI 10.1016/j.abb.2015.02.009
   San Martin C., 2015, ARCH BIOCHEM BIOPHYS, V581, P59
   Schroder RR, 2015, ARCH BIOCHEM BIOPHYS, V581, P25, DOI 10.1016/j.abb.2015.05.010
   Stahlberg H, 2015, ARCH BIOCHEM BIOPHYS, V581, P68, DOI 10.1016/j.abb.2015.06.006
   Xu XP, 2015, ARCH BIOCHEM BIOPHYS, V581, P49, DOI 10.1016/j.abb.2015.06.017
NR 13
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 1
EP 2
DI 10.1016/j.abb.2015.06.018
PG 2
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700001
PM 26142372
ER

PT J
AU Harris, JR
AF Harris, J. Robin
TI Transmission electron microscopy in molecular structural biology: A
   historical survey
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE TEM; Thin sectioning; Metal shadowing; Negative staining; Vitrification;
   Cryo-electron microscopy; Electron diffraction; Digital image analysis;
   2D crystal; Single particle averaging
ID LIMPET HEMOCYANIN KLH; PAPILLOMA-POLYOMA TYPE; TOBACCO-MOSAIC-VIRUS;
   3-DIMENSIONAL RECONSTRUCTION; CRYOELECTRON MICROSCOPY; PROTEIN
   MOLECULES; ESCHERICHIA-COLI; LIVER CATALASE; GLUTAMINE-SYNTHETASE; 3-D
   RECONSTRUCTION
AB In this personal, historic account of macromolecular transmission electron microscopy (TEM), published data from the 1940s through to recent times is surveyed, within the context of the remarkable progress that has been achieved during this time period. The evolution of present day molecular structural biology is described in relation to the associated biological disciplines. The contribution of numerous electron microscope pioneers to the development of the subject is discussed. The principal techniques for TEM specimen preparation, thin sectioning, metal shadowing, negative staining and plunge-freezing (vitrification) of thin aqueous samples are described, with a selection of published images to emphasise the virtues of each method. The development of digital image analysis and 3D reconstruction is described in detail as applied to electron crystallography and reconstructions from helical structures, 2D membrane crystals as well as single particle 3D reconstruction of icosahedral viruses and macromolecules. The on-going development of new software, algorithms and approaches is highlighted before specific examples of the historical progress of the structural biology of proteins and viruses are presented. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Harris, J. Robin] Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany.
   [Harris, J. Robin] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
RP Harris, JR (reprint author), Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany.
EM rharris@uni-mainz.de
CR AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   ALGERA L, 1947, BIOCHIM BIOPHYS ACTA, V1, P517, DOI 10.1016/0006-3002(47)90168-6
   Anderson T.F., 1962, INTERPRETATION ULTRA, P251
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0
   TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036
   vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004
   Kausche GA, 1939, NATURWISSENSCHAFTEN, V27, P292
   Harris JR, 2002, MICRON, V33, P461, DOI 10.1016/S0968-4328(01)00039-7
   HANSON J, 1953, NATURE, V172, P530, DOI 10.1038/172530b0
   Mitchell JC, 2004, J AM CHEM SOC, V126, P16342, DOI 10.1021/ja043890h
   Taylor KA, 2008, J STRUCT BIOL, V163, P214, DOI 10.1016/j.jsb.2008.06.004
   MUHLETHALER K, 1949, BIOCHIM BIOPHYS ACTA, V3, P15, DOI 10.1016/0006-3002(49)90075-X
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   Plevka P, 2013, P NATL ACAD SCI USA, V110, P5463, DOI 10.1073/pnas.1222379110
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080
   Harris JR, 2013, MICRON, V49, P60, DOI 10.1016/j.micron.2013.03.004
   Crowther RA, 2010, ADV PROTEIN CHEM STR, V81, P1, DOI [10.1016/B978-0-12-381357-2.00001-3, 10.1016/S1876-1623(10)81001-6]
   DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0
   TAYLOR KA, 1976, J ULTRA MOL STRUCT R, V55, P448, DOI 10.1016/S0022-5320(76)80099-8
   KLUG A, 1968, J MOL BIOL, V31, P1, DOI 10.1016/0022-2836(68)90050-8
   Rossmann MG, 2013, Q REV BIOPHYS, V46, P133, DOI 10.1017/S0033583513000012
   Taylor DW, 2007, J STRUCT BIOL, V160, P305, DOI 10.1016/j.jsb.2007.04.011
   Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493
   BRENNER S, 1959, BIOCHIM BIOPHYS ACTA, V34, P103, DOI 10.1016/0006-3002(59)90237-9
   Hainfeld JF, 1999, J STRUCT BIOL, V127, P185, DOI 10.1006/jsbi.1999.4149
   Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0
   Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088
   VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0
   HOVMOLLER S, 1992, ULTRAMICROSCOPY, V41, P121, DOI 10.1016/0304-3991(92)90102-P
   HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0
   KLUG A, 1965, J MOL BIOL, V11, P403
   Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465
   Zhang QF, 2013, STRUCTURE, V21, P604, DOI 10.1016/j.str.2013.02.018
   Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1
   HEUSER JE, 1983, J MOL BIOL, V169, P155, DOI 10.1016/S0022-2836(83)80179-X
   van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644
   Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652
   CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0
   Dubochet J, 2012, J MICROSC-OXFORD, V245, P221, DOI 10.1111/j.1365-2818.2011.03569.x
   HUXLEY HE, 1960, J MOL BIOL, V2, P10
   LEPAULT J, 1983, J MICROSC-OXFORD, V129, P89
   ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   Harris JR, 2001, BBA-PROTEIN STRUCT M, V1547, P221, DOI 10.1016/S0167-4838(01)00184-4
   Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   ASTBURY WT, 1947, BIOCHIM BIOPHYS ACTA, V1, P379, DOI 10.1016/0006-3002(47)90149-2
   Baumeister W., 1980, ELECT MICROSCOPY MOL
   BEER M, 1974, Q REV BIOPHYS, V7, P211
   BENEDETT.EL, 1965, J CELL BIOL, V26, P299, DOI 10.1083/jcb.26.1.299
   BLAUROCK AE, 1976, J CELL BIOL, V71, P1, DOI 10.1083/jcb.71.1.1
   BRADLEY DE, 1962, J GEN MICROBIOL, V29, P503
   BRADLEY DE, 1967, BACTERIOL REV, V31, P230
   Braun N, 2002, J MOL BIOL, V321, P341, DOI 10.1016/S0022-2836(02)00622-8
   BRISSON A, 1984, J CELL BIOL, V99, P1202, DOI 10.1083/jcb.99.4.1202
   Cardone G, 2013, J STRUCT BIOL, V183, P329, DOI 10.1016/j.jsb.2013.07.007
   Chanzy N., 1976, BIOCHEM J, V153, P139
   Chen CC, 2003, MOL MICROBIOL, V49, P1657, DOI 10.1046/j.1365-2958.2003.03663.x
   Chiu PL, 2011, MICRON, V42, P762, DOI 10.1016/j.micron.2011.06.005
   Chiu W., 1981, ELECT MICROSCOPY PRO, V2, P233
   CHIU W, 1986, ANNU REV BIOPHYS BIO, V15, P237
   Chiu W, 1997, STRUCTURAL BIOL VIRU
   Chiu W., 2003, ADV PROTEIN CHEM, V64
   Crowther R.A., 1996, J STRUCT BIOL, V116, P123
   CROWTHER RA, 1971, PHILOS T ROY SOC B, V261, P221, DOI 10.1098/rstb.1971.0054
   Dalton A.J., 1973, ULTRASTRUCTURE ANIMA
   De Carlo S., 2010, METHOD ENZYMOL, V418, P127
   Dobro MJ, 2010, METHOD ENZYMOL, V481, P63, DOI 10.1016/S0076-6879(10)81003-1
   DORSET DL, 1975, ACTA CRYSTALLOGR A, VA 31, P210, DOI 10.1107/S0567739475000423
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   FERNANDE.H, 1966, J MOL BIOL, V16, P191
   FERNANDEZMORAN H, 1960, ANN NY ACAD SCI, V85, P689, DOI 10.1111/j.1749-6632.1960.tb49990.x
   FINCH JT, 1974, J MOL BIOL, V87, P633, DOI 10.1016/0022-2836(74)90074-6
   JACKSON SF, 1956, PROC R SOC SER B-BIO, V144, P556, DOI 10.1098/rspb.1956.0011
   FRANK J, 1989, ELECTRON MICROSC REV, V2, P53, DOI 10.1016/0892-0354(89)90010-5
   FRANK J, 1990, Q REV BIOPHYS, V23, P281
   FRANK J, 1978, ULTRAMICROSCOPY, V3, P283, DOI 10.1016/S0304-3991(78)80038-2
   GROSS H, 1985, ULTRAMICROSCOPY, V16, P287, DOI 10.1016/0304-3991(85)90098-1
   GROSS J, 1948, J EXP MED, V88, P555, DOI 10.1084/jem.88.5.555
   GROSS J, 1954, P NATL ACAD SCI USA, V40, P679, DOI 10.1073/pnas.40.8.679
   HALL CE, 1958, J AM CHEM SOC, V80, P1269, DOI 10.1021/ja01539a001
   HALL CE, 1955, J BIOPHYS BIOCHEM CY, V1, P1, DOI 10.1083/jcb.1.1.1
   HALL CE, 1956, P NATL ACAD SCI USA, V42, P801, DOI 10.1073/pnas.42.11.801
   Harris Jr, 1999, METH MOL B, V117, P31
   Harris J. Robin, 1996, Methods (Orlando), V10, P234, DOI 10.1006/meth.1996.0098
   Harris JR, 1998, MICRON, V29, P329, DOI 10.1016/S0968-4328(98)00019-5
   Harris JR, 2008, MICRON, V39, P168, DOI 10.1016/j.micron.2007.07.003
   Harris JR, 2014, METHODS MOL BIOL, V1117, P215, DOI 10.1007/978-1-62703-776-1_11
   HARRIS JR, 1969, J MOL BIOL, V46, P329, DOI 10.1016/0022-2836(69)90425-2
   Harris J.R., 1997, RMS HDB, V53
   Harris J.R., 1986, VIRUS STRUCTURE, V5
   Harris JR, 1997, MICRON, V28, P43
   Harris J.R., 1968, THESIS U EDINBURGH
   HASCHEME.RH, 1974, ANNU REV BIOCHEM, V43, P279, DOI 10.1146/annurev.bi.43.070174.001431
   Henderson R., 2015, ARCH BIOCH BIOPHYS, VXX
   Hendricks GM, 2014, METHODS MOL BIOL, V1117, P73, DOI 10.1007/978-1-62703-776-1_5
   HEYN ANJ, 1966, J CELL BIOL, V29, P181, DOI 10.1083/jcb.29.2.181
   HIGHBERGER JH, 1951, P NATL ACAD SCI USA, V37, P286, DOI 10.1073/pnas.37.5.286
   Home R.W., 1974, VIRUS STRUCTURE
   Home R.W., 1973, PRACTICAL METHODS EL, V1, P327
   Home R.W., 1964, ADV VIRUS RES, V10, P102
   HORNE RW, 1974, J ULTRA MOL STRUCT R, V47, P361, DOI 10.1016/S0022-5320(74)90015-X
   Home R.W., 1977, ANALYTICAL QUANTITAT, P29
   Hoppe W., 1970, ACTA CRYSTALLOGR A, VA26
   HOPPE W, 1986, J MOL BIOL, V192, P291, DOI 10.1016/0022-2836(86)90366-9
   HOPPE W, 1977, ULTRAMICROSCOPY, V2, P153
   HOPPE W, 1968, NATURWISSENSCHAFTEN, V55, P333
   HOPPE W, 1986, ULTRAMICROSCOPY, V20, P217, DOI 10.1016/0304-3991(86)90188-9
   HOPPE W, 1974, NATURWISSENSCHAFTEN, V61, P239
   Husemann E., 1940, NATURWISSENSCHAFTEN, V28, P534
   Huxley H.E., 1953, BIOCHIM BIOPHYS ACTA, V12, P375
   Huxley H.E., 1956, 1 EUR C EL MICR STOC, P260
   HUXLEY HE, 1960, J MOL BIOL, V2, P189
   Kahn L., 1981, J MOL BIOL, V145, P193
   KISELEV NA, 1990, ELECTRON MICROSC REV, V3, P43, DOI 10.1016/0892-0354(90)90013-I
   KISELEV NA, 1978, J MOL BIOL, V126, P109, DOI 10.1016/0022-2836(78)90283-8
   KLEINSCHMIDT A., 1959, ZEIT NATURFORSCH, V14b, P770
   KLUG A, 1964, J MOL BIOL, V10, P565
   Kuo J., 2014, ELECT MICROSCOPY MET, Vthird
   LABAW LW, 1957, BIOCHIM BIOPHYS ACTA, V25, P263, DOI 10.1016/0006-3002(57)90467-5
   Lake J A, 1979, Methods Enzymol, V61, P250
   LAMBERT O, 1994, J MOL BIOL, V244, P640, DOI 10.1006/jmbi.1994.1757
   LANGE RH, 1985, INT REV CYTOL, V97, P133
   LONGLEY W, 1967, J MOL BIOL, V30, P323
   Luria SE, 1943, J BACTERIOL, V46, P57
   MacFarlane A.S., 1949, BMJ-BRIT MED J, V3, P1247
   Markham R., 1947, NATURE, V159, P547
   Marles-Wright J., 2008, SCIENCE, V322, P92
   Marton L., 1934, B ACAD ROY BELG, V20, P439
   MATRICAR.VR, 1972, SCIENCE, V177, P268, DOI 10.1126/science.177.4045.268
   Meissner U, 2007, MICRON, V38, P29, DOI 10.1016/j.micron.2006.04.010
   MELLEMA JE, 1972, NATURE, V239, P146, DOI 10.1038/239146a0
   Neil KJ, 1996, NUCLEIC ACIDS RES, V24, P1472, DOI 10.1093/nar/24.8.1472
   Nermut M.V., 1987, ANIMAL VIRUS STRUCTU
   PALADE GE, 1971, J CELL BIOL, V50, pD5, DOI 10.1083/jcb.50.1.5d
   RADERMACHER M, 1994, ULTRAMICROSCOPY, V53, P121, DOI 10.1016/0304-3991(94)90003-5
   RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405
   Roche B., 1960, BIOCHIM BIOPHYS ACTA, V41, P182
   Ruben GC, 1998, MICRON, V29, P359, DOI 10.1016/S0968-4328(98)00003-1
   RUSKA HELMUT, 1939, ARCH GES VIRUSFORSCH, V1, P155, DOI 10.1007/BF01243399
   Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035
   Schmidt-Krey I., 2013, ELECT CRYSTALLOGRAPH
   Schroeter JP, 1996, J STRUCT BIOL, V116, P131, DOI 10.1006/jsbi.1996.0021
   Serafini-Fracassini A., 1982, ELECTRON MICROS, V2, P195
   Shi D, 2013, ELIFE, V2, DOI 10.7554/eLife.01345
   SHIRAHAM.T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679
   SKOGLUND U, 1986, NATURE, V319, P560, DOI 10.1038/319560a0
   Slayter H.S., 1981, ELECT MICROSCOPY PRO, V1, P198
   Stanley WM, 1942, J BIOL CHEM, V146, P25
   Stewart M., 1991, ELECTRON MICROS, P229
   Tsuprun M.B., 1981, ULTRAMICROSCOPY, V7, P131
   UNWIN PNT, 1975, J MOL BIOL, V98, P235, DOI 10.1016/S0022-2836(75)80111-2
   VALENTIN.RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017
   VALENTINE RC, 1959, NATURE, V184, P1838, DOI 10.1038/1841838a0
   Valentine R.C., 1962, INTERPRETATION ULTRA, P263
   VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7
   VANHOLDE KE, 1991, J MOL BIOL, V217, P307, DOI 10.1016/0022-2836(91)90545-H
   VANITERSON W, 1947, BIOCHIM BIOPHYS ACTA, V1, P527, DOI 10.1016/0006-3002(47)90169-8
   von Ardenne M., 1940, NATURWISSENSCHAFTEN, V8, P112
   WELLS B, 1981, MICRON, V12, P37, DOI 10.1016/0047-7206(81)90018-2
   WILLIAMS RC, 1954, ADV VIRUS RES, V2, P183, DOI 10.1016/S0065-3527(08)60533-3
   WILLIAMS RC, 1945, NATURE, V156, P68, DOI 10.1038/156068a0
   WYCKOFF RWG, 1948, ACTA CRYSTALLOGR, V1, P292, DOI 10.1107/S0365110X48000818
   WYCKOFF RWG, 1947, BIOCHIM BIOPHYS ACTA, V1, P143, DOI 10.1016/0006-3002(47)90129-7
   WYCKOFF RWG, 1951, ADV PROTEIN CHEM, V6, P1, DOI 10.1016/S0065-3233(08)60501-X
NR 167
TC 0
Z9 0
U1 26
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 3
EP 18
DI 10.1016/j.abb.2014.11.011
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700002
PM 25475529
ER

PT J
AU Henderson, R
AF Henderson, Richard
TI Overview and future of single particle electron cryomicroscopy
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Electron cryomicroscopy; CryoEM; Single particle; Amorphous ice;
   Radiation damage; Beam-induced movement
ID MAXIMUM-LIKELIHOOD APPROACH; BEAM-INDUCED MOTION; CRYO-EM; PROTEIN
   CRYSTALS; HUMAN ADENOVIRUS; HIGH-RESOLUTION; IMAGE-CONTRAST; MICROSCOPY;
   ICE; RECONSTRUCTION
AB Electron cryomicroscopy (cryoEM) has experienced a quantum leap in its capability in recent years, due to improved microscopes, better detectors and better software. It is now possible to obtain near-atomic resolution 3D density maps of macromolecular assemblies using single particle cryoEM without the need for crystals. Although this recent progress has produced some outstanding achievements, we have still only partly realised the full potential of single particle cryoEM. If one or two remaining problems can be solved, it will become an even more powerful method in structural biology that should closely approach the limit of what is theoretically possible. (C) 2015 Elsevier Inc. All rights reserved.
C1 MRC Lab Mol Biol, Cambridge CB2 0QH, England.
RP Henderson, R (reprint author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.
EM rh15@mrc-Imb.cam.ac.uk
FU Medical Research Council, United Kingdom [U105184322]
FX I would like to thank Prof. Hong Zhou for providing Fig. 2, and Drs.
   Vinothkumar and Scheres for the plots used in Fig. 6. This article was
   prepared with support from the Medical Research Council, United Kingdom
   Grant No. U105184322.
CR ALLEGRETTI M, 2014, ELIFE, V0003
   HENDERSON R, 1995, Q REV BIOPHYS, V28, P171
   TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   McMullan G, 2014, ULTRAMICROSCOPY, V147, P156, DOI 10.1016/j.ultramic.2014.08.002
   Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530
   Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003
   Wright ER, 2006, J STRUCT BIOL, V153, P241, DOI 10.1016/j.jsb.2005.12.003
   Russo CJ, 2014, NAT METHODS, V11, P649, DOI [10.1038/nmeth.2931, 10.1038/NMETH.2931]
   Stark H, 1996, ULTRAMICROSCOPY, V63, P75, DOI 10.1016/0304-3991(96)00045-9
   Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433
   HENDERSON R, 1985, ULTRAMICROSCOPY, V16, P139, DOI 10.1016/0304-3991(85)90069-5
   Stagg SM, 2006, J STRUCT BIOL, V155, P470, DOI 10.1016/j.jsb.2006.04.005
   Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823
   Vinothkumar KR, 2014, STRUCTURE, V22, P621, DOI 10.1016/j.str.2014.01.011
   Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013
   Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410
   Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830
   Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652
   Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822
   des Georges A, 2014, NUCLEIC ACIDS RES, V42, P3409, DOI 10.1093/nar/gkt1279
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026
   Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008
   Cong Y, 2010, METHOD ENZYMOL, V482, P211, DOI 10.1016/S0076-6879(10)82009-9
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005
   Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461
   Crowther R.A., 1970, P R SOC A, V317
   CROWTHER RA, 1971, PHILOS T ROY SOC B, V261, P221, DOI 10.1098/rstb.1971.0054
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129
   Glaeser RM, 1999, J STRUCT BIOL, V128, P3, DOI 10.1006/jsbi.1999.4172
   HENDERSON R, 1992, ULTRAMICROSCOPY, V46, P1, DOI 10.1016/0304-3991(92)90003-3
   Liu HR, 2011, J MOL BIOL, V406, P764, DOI 10.1016/j.jmb.2010.11.043
   McMullan G., 2015, ULTRAMICROS IN PRESS
   Meyerson JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07084
   Rubinstein J.R., 2014, ARXIV14096789
   Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665
   Sigworth FJ, 1998, J STRUCT BIOL, V122, P328, DOI 10.1006/jsbi.1998.4014
   STEWART PL, 1991, CELL, V67, P145, DOI 10.1016/0092-8674(91)90578-M
   Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031
   Zeng X, 2007, J STRUCT BIOL, V160, P362, DOI 10.1016/j.jsb.2007.09.013
NR 44
TC 2
Z9 2
U1 18
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 19
EP 24
DI 10.1016/j.abb.2015.02.036
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700003
PM 25796174
ER

PT J
AU Schroder, RR
AF Schroeder, Rasmus R.
TI Advances in electron microscopy: A qualitative view of instrumentation
   development for macromolecular imaging and tomography
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Cryo electron microscopy; Cryo electron tomography; Direct electron
   detection; Energy filtered imaging; Aberration correction; Physical
   phase plates
ID BEAM-INDUCED MOTION; PHASE-PLATE; ZERO-LOSS; CONTRAST ENHANCEMENT;
   CRYOELECTRON TOMOGRAPHY; CRYO-EM; CRYOMICROSCOPY; PROTEIN; CELLS; MODEL
AB Macromolecular imaging and tomography of ice embedded samples has developed into a mature imaging technology, in structural biology today widely referred to simply as cryo electron microscopy.(1) While the pioneers of the technique struggled with ill-suited instruments, state-of-the-art cryo microscopes are now readily available and an increasing number of groups are producing excellent high-resolution structural data of macromolecular complexes, of cellular organelles, or the morphology of whole cells. Instrumentation developers, however, are offering yet more novel electron optical devices, such as energy filters and monochromators, aberration correctors or physical phase plates. Here we discuss how current instrumentation has already changed cryo EM, and how newly available instrumentation - often developed in other fields of electron microscopy - may further develop the use and applicability of cryo EM to the imaging of single isolated macromolecules of smaller size or molecules embedded in a crowded cellular environment. (C) 2015 Elsevier Inc. All rights reserved.
C1 Heidelberg Univ, Univ Klinikum Heidelberg, Cryo Electron Microscopy, CellNetwork,BioQuant, D-69115 Heidelberg, Germany.
RP Schroder, RR (reprint author), Heidelberg Univ, Univ Klinikum Heidelberg, Cryo Electron Microscopy, CellNetwork,BioQuant, Bergheimer Str 58, D-69115 Heidelberg, Germany.
EM rasmus.schroeder@bioquant.uni-heidelberg.de
CR ALLEGRETTI M, 2014, ELIFE, V0003
   Alloyeau D, 2010, ULTRAMICROSCOPY, V110, P563, DOI 10.1016/j.ultramic.2009.11.016
   Majorovits E, 2007, ULTRAMICROSCOPY, V107, P213, DOI 10.1016/j.ultramic.2006.07.006
   Cambie R, 2007, ULTRAMICROSCOPY, V107, P329, DOI 10.1016/j.ultramic.2006.09.001
   Angert I, 2000, ULTRAMICROSCOPY, V81, P203, DOI 10.1016/S0304-3991(99)00190-4
   Yonekura K, 2006, J STRUCT BIOL, V156, P524, DOI 10.1016/j.jsb.2006.07.016
   McMullan G, 2014, ULTRAMICROSCOPY, V147, P156, DOI 10.1016/j.ultramic.2014.08.002
   Danev R, 2014, P NATL ACAD SCI USA, V111, P15635, DOI 10.1073/pnas.1418377111
   Kaiser U, 2011, ULTRAMICROSCOPY, V111, P1239, DOI 10.1016/j.ultramic.2011.03.012
   Russo CJ, 2014, SCIENCE, V346, P1377, DOI 10.1126/science.1259530
   LANGMORE JP, 1992, ULTRAMICROSCOPY, V46, P349, DOI 10.1016/0304-3991(92)90024-E
   Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003
   Flannigan DJ, 2010, P NATL ACAD SCI USA, V107, P9933, DOI 10.1073/pnas.1005653107
   Fukuda Y, 2015, J STRUCT BIOL, V190, P143, DOI 10.1016/j.jsb.2015.03.004
   HUXLEY HE, 1963, J MOL BIOL, V7, P281, DOI 10.1016/S0022-2836(63)80008-X
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Blackburn AM, 2014, ULTRAMICROSCOPY, V136, P127, DOI 10.1016/j.ultramic.2013.08.009
   Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010
   Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930
   Barends TRM, 2014, NATURE, V505, P244, DOI 10.1038/nature12773
   Barty A, 2013, ANNU REV PHYS CHEM, V64, P415, DOI 10.1146/annurev-physchem-032511-143708
   Ruskin RS, 2013, J STRUCT BIOL, V184, P385, DOI 10.1016/j.jsb.2013.10.016
   Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010
   Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206
   Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830
   Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823
   Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184
   von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033
   SCHERZER O, 1949, J APPL PHYS, V20, P20, DOI 10.1063/1.1698233
   Kisielowski C, 2008, MICROSC MICROANAL, V14, P469, DOI 10.1017/S1431927608080902
   Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006
   Danev R, 2001, ULTRAMICROSCOPY, V88, P243, DOI 10.1016/S0304-3991(01)00088-2
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Zernike F, 1942, PHYSICA, V9, P686, DOI 10.1016/S0031-8914(42)80035-X
   Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197
   BADDE HG, 1970, Z NATURFORSCH PT A, VA 25, P760
   Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461
   Baudoin JP, 2013, MICROSC MICROANAL, V19, P814, DOI 10.1017/S1431927613001475
   BOERSCH H, 1947, Z NATURFORSCH A, V2, P615
   Brink J, 1998, ULTRAMICROSCOPY, V72, P41, DOI 10.1016/S0304-3991(97)00126-5
   Dai W., 2014, MICROB CELL, V1, P45
   Danev R, 2008, J STRUCT BIOL, V161, P211, DOI 10.1016/j.jsb.2007.10.015
   Dyck D. van, 2013, MICROSC MICROANAL, V19, P540
   Edgcombe CJ, 2014, ULTRAMICROSCOPY, V136, P154, DOI 10.1016/j.ultramic.2013.09.004
   Edgcombe CJ, 2012, ULTRAMICROSCOPY, V120, P78, DOI 10.1016/j.ultramic.2012.06.011
   Fischer N., NATURE ONLINE ADV PU
   Freitag B, 2005, ULTRAMICROSCOPY, V102, P209, DOI 10.1016/j.ultramic.2004.09.013
   Frindt N, 2014, MICROSC MICROANAL, V20, P175, DOI 10.1017/S1431927613013901
   Gamm B, 2008, ULTRAMICROSCOPY, V108, P878, DOI 10.1016/j.ultramic.2008.02.009
   Gamm B, 2010, ULTRAMICROSCOPY, V110, P807, DOI 10.1016/j.ultramic.2010.02.006
   Glaeser RM, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4830355
   Glaeser RM, 2004, MICROSC MICROANAL, V10, P790, DOI 10.1017/S1431927604040668
   Guerrero-Ferreira RC, 2014, J STRUCT BIOL, V185, P129, DOI 10.1016/j.jsb.2013.09.011
   Hawkes P.W., 1994, PRINCIPLES ELECT OPT, V3
   Hettler S., 2014, MICROSC MICROANAL S3, V20, P216
   Huang SH, 2006, J ELECTRON MICROSC, V55, P273, DOI 10.1093/jmicro/dfl037
   Kuhlbrandt W., 2014, SCIENCE, V343, P143
   Majorovits E., 2013, MICROSC MICROANAL S2, V19, P1234
   Malac M, 2012, ULTRAMICROSCOPY, V118, P77, DOI 10.1016/j.ultramic.2012.02.004
   McMullan G, 2009, ULTRAMICROSCOPY, V109, P1144, DOI 10.1016/j.ultramic.2009.05.005
   Muller H, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073011
   Murata K, 2010, STRUCTURE, V18, P903, DOI 10.1016/j.str.2010.06.006
   Nagayama K., 2008, BIOPHYS J, V37, P345
   Nakamura E, 2013, ANGEW CHEM INT EDIT, V52, P236, DOI 10.1002/anie.201205693
   Rose H., 2012, GEOMETRICAL CHARGED, V2nd
   Rose HH, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/0031-8949/9/1/014107
   SCHRODER RR, 1992, J MICROSC-OXFORD, V166, P389
   SCHRODER RR, 1990, J STRUCT BIOL, V105, P28, DOI 10.1016/1047-8477(90)90095-T
   Schroder RR, 2007, MICROSC MICROANAL, V13, P136, DOI 10.1017/S1431927607074867
   Schultheiss K, 2010, MICROSC MICROANAL, V16, P785, DOI 10.1017/S1431927610093803
   UNWIN PNT, 1972, PROC R SOC LON SER-A, V329, P327, DOI 10.1098/rspa.1972.0116
   Unwin P.N.T., 2005, J MOL BIOL, V246, P967
   UNWIN PNT, 1979, J MOL BIOL, V132, P69, DOI 10.1016/0022-2836(79)90496-0
   Van Dyck D, 2010, ULTRAMICROSCOPY, V110, P571, DOI 10.1016/j.ultramic.2009.12.016
   Wacker I.U., 2010, MICROSC MICROANAL, V16, P972
   Yonekura K, 2002, BIOPHYS J, V82, P2784
NR 76
TC 1
Z9 1
U1 23
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 25
EP 38
DI 10.1016/j.abb.2015.05.010
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700004
PM 26032338
ER

PT J
AU Carazo, JM
   Sorzano, COS
   Oton, J
   Marabini, R
   Vargas, J
AF Carazo, J. M.
   Sorzano, C. O. S.
   Oton, J.
   Marabini, R.
   Vargas, J.
TI Three-dimensional reconstruction methods in Single Particle Analysis
   from transmission electron microscopy data
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Cryo electron microscopy; Image processing
ID COMMON-LINES; CRYO-EM; PROJECTIONS; ASSIGNMENT
AB The Transmission Electron Microscope provides two-dimensional (2D) images of the specimens under study. However, the architecture of these specimens is defined in a three-dimensional (3D) coordinate space, in volumetric terms, making the direct microscope output somehow "short" in terms of dimensionality. This situation has prompted the development of methods to quantitatively estimate 3D volumes from sets of 2D images, which are usually referred to as "three-dimensional reconstruction methods". These 3D reconstruction methods build on four considerations: (1) The relationship between the 2D images and the 3D volume must be of a particularly simple type, (2) many 2D images are needed to gain 3D volumetric information, (3) the 2D images and the 3D volume have to be in the same coordinate reference frame and (4), in practical terms, the reconstructed 3D volume will only be an approximation to the original 3D volume which gave raise to the 2D projections. In this work we will adopt a quite general view, trying to address a large community of interested readers, although some sections will be particularly devoted to the 3D analysis of isolated macromolecular complexes in the application area normally referred to as Single Particle Analysis (SPA). (C) 2015 Elsevier Inc. All rights reserved.
C1 [Carazo, J. M.; Sorzano, C. O. S.; Oton, J.; Vargas, J.] Natl Ctr Biotechnol CSIC, Biocomp Unit, Madrid 28049, Spain.
   [Marabini, R.] Univ Autonoma Madrid, Escuela Politecn Super, E-28049 Madrid, Spain.
   [Sorzano, C. O. S.] Univ CEU San Pablo, Bioengn Lab, Madrid 28668, Spain.
RP Carazo, JM (reprint author), Natl Ctr Biotechnol CSIC, Biocomp Unit, C Darwin 3,Campus Univ Autonoma, Madrid 28049, Spain.
RI Vargas, Javier/L-5546-2015; Marabini, Roberto/B-6141-2014
OI Marabini, Roberto/0000-0001-7876-1684
FU Comunidad de Madrid [S2010/BMD-2305]; Spanish Ministry of Economy and
   Competitiveness [AIC-A-2011-0638, BIO2013-44647-R]; Ramon y Cajal
   fellowship
FX Authors would like to acknowledge economical support from: Comunidad de
   Madrid through grant CAM (S2010/BMD-2305) and the Spanish Ministry of
   Economy and Competitiveness through Grants AIC-A-2011-0638 and
   BIO2013-44647-R. C.O.S. Sorzano is recipient of a Ramon y Cajal
   fellowship.
CR Abrishami V., 2015, ULTRAMICROS IN PRESS
   Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003
   LANCZOS C, 1952, J RES NAT BUR STAND, V49, P33, DOI 10.6028/jres.049.006
   Singer A, 2011, SIAM J IMAGING SCI, V4, P543, DOI 10.1137/090767777
   Leschziner AE, 2007, ANNU REV BIOPH BIOM, V36, P43, DOI 10.1146/annurev.biophys.36.040306.132742
   Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010
   CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0
   Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992
   Carazo J.-M., 1992, ELECT TOMOGRAPHY, P117
   Dashti A, 2014, P NATL ACAD SCI USA, V111, P17492, DOI 10.1073/pnas.1419276111
   Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002
   Frank J, 2006, 3 DIMENSIONAL ELECT
   Hawkes P., 1992, ELECT TOMOGRAPHY 3 D, P17
   Hawkes P., 1996, PRINCIPLES ELECT OPT, V3
   Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7
   Jin QY, 2014, STRUCTURE, V22, P496, DOI 10.1016/j.str.2014.01.004
   Kak A. C., 1988, PRINCIPLES COMPUTERI
   Kirkland E., 2010, ADV COMPUTING ELECT, V40
   Nunez-Ramirez R, 2011, NUCLEIC ACIDS RES, V39, P8187, DOI 10.1093/nar/gkr534
   Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016
   Penczek PA, 1996, ULTRAMICROSCOPY, V63, P205, DOI 10.1016/0304-3991(96)00037-X
   RADON J, 1986, IEEE T MED IMAGING, V5, P170, DOI 10.1109/TMI.1986.4307775
   Sanz-Garcia E, 2010, J STRUCT BIOL, V171, P216, DOI 10.1016/j.jsb.2010.03.017
   Singer A, 2010, J STRUCT BIOL, V169, P312, DOI 10.1016/j.jsb.2009.11.003
   Sorzano C.O.S., 2014, INTERCHANGING GEOMET, P7
   Spahn CMT, 2009, CURR OPIN STRUC BIOL, V19, P623, DOI 10.1016/j.sbi.2009.08.001
   VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7
   Vargas J, 2014, BIOINFORMATICS, V30, P2891, DOI 10.1093/bioinformatics/btu404
   Zhou ZH, 2014, STRUCTURE, V22, P1385, DOI 10.1016/j.str.2014.05.019
NR 29
TC 1
Z9 1
U1 14
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 39
EP 48
DI 10.1016/j.abb.2015.05.003
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700005
PM 26008761
ER

PT J
AU Xu, XP
   Volkmann, N
AF Xu, Xiao-Ping
   Volkmann, Niels
TI Validation methods for low-resolution fitting of atomic structures to
   electron microscopy data
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Fitting; Electron microscopy; Validation
ID CRYO-EM DATA; CRYOELECTRON MICROSCOPY; ANGSTROM RESOLUTION;
   CROSS-VALIDATION; RECONSTRUCTIONS; CRYOMICROSCOPY; REFINEMENT; MODELS;
   CONSENSUS; CHANNEL
AB Fitting of atomic-resolution structures into reconstructions from electron cryo-microscopy is routinely used to understand the structure and function of macromolecular machines. Despite the fact that a plethora of fitting methods has been developed over recent years, standard protocols for quality assessment and validation of these fits have not been established. Here, we present the general concepts underlying current validation ideas as they relate to fitting of atomic-resolution models into electron cryo-microscopy reconstructions, with an emphasis on reconstructions with resolutions below the sub-nanometer range. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Xu, Xiao-Ping; Volkmann, Niels] Sanford Burnham Med Res Inst, Bioinformat & Struct Biol Program, La Jolla, CA 92037 USA.
RP Volkmann, N (reprint author), Sanford Burnham Med Res Inst, Bioinformat & Struct Biol Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM niels@sbmri.org
FU National Institutes of Health [R01 CA179087]
FX This work was supported by National Institutes of Health Grant R01
   CA179087.
CR Ahmed A, 2013, J STRUCT BIOL, V182, P67, DOI 10.1016/j.jsb.2013.02.002
   Ahmed A, 2012, J STRUCT BIOL, V177, P561, DOI 10.1016/j.jsb.2011.10.002
   ALLEGRETTI M, 2014, ELIFE, V0003
   Villa E, 2014, CURR OPIN STRUC BIOL, V25, P118, DOI 10.1016/j.sbi.2014.04.001
   Falkner B, 2013, P NATL ACAD SCI USA, V110, P8930, DOI 10.1073/pnas.1119041110
   Stewart A, 2004, ULTRAMICROSCOPY, V102, P67, DOI 10.1016/j.ultramic.2004.08.008
   Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105
   Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111
   Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471
   Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080
   DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008
   Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683
   Vasishtan D, 2011, J STRUCT BIOL, V174, P333, DOI 10.1016/j.jsb.2011.01.012
   Lawson CL, 2011, NUCLEIC ACIDS RES, V39, pD456, DOI 10.1093/nar/gkq880
   Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024
   DiMaio F, 2013, PROTEIN SCI, V22, P865, DOI 10.1002/pro.2267
   Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109
   Schur FKM, 2013, J STRUCT BIOL, V184, P394, DOI 10.1016/j.jsb.2013.10.015
   Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410
   EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844
   Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822
   Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014
   Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404
   Volkmann N, 2009, ACTA CRYSTALLOGR D, V65, P679, DOI 10.1107/S0907444909012876
   Brunger A.T., 1992, NATURE, V355, P472
   Campos M, 2011, J STRUCT BIOL, V173, P436, DOI 10.1016/j.jsb.2010.11.015
   Grigorieff N, 2013, ELIFE, V2, DOI 10.7554/eLife.00573
   Kuhlbrandt W., 2014, ELIFE, V3
   Lopez-Blanco J.R., 2014, WIRES COMPUT MOL SCI, V5, P62
   Volkmann N, 2003, METHOD ENZYMOL, V374, P204, DOI 10.1016/S0076-6879(03)74010-5
   Volkmann N, 2014, ADV EXP MED BIOL, V805, P137, DOI 10.1007/978-3-319-02970-2_6
   Xu X.-P., 2011, EMBO J, V31, P236, DOI DOI 10.1038/EMBOJ.2011.343
   Xu X.P., 2013, J STRUCT BIOL, V184, P78
   Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063
   Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950
NR 35
TC 1
Z9 1
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 49
EP 53
DI 10.1016/j.abb.2015.06.017
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700006
PM 26116787
ER

PT J
AU Egelman, EH
AF Egelman, Edward H.
TI Three-dimensional reconstruction of helical polymers
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Helical polymers; Direct electron detectors; Variable twist
ID TOBACCO-MOSAIC-VIRUS; RAY FIBER DIFFRACTION; SINGLE-PARTICLE
   RECONSTRUCTION; NUCLEAR MAGNETIC-RESONANCE; CRYO-ELECTRON-MICROSCOPY;
   NEAR-ATOMIC-RESOLUTION; FD-COAT PROTEIN; FILAMENTOUS-BACTERIOPHAGE;
   CRYOELECTRON MICROSCOPY; ANGSTROM RESOLUTION
AB The field of three-dimensional electron microscopy began more than 45 years ago with a reconstruction of a helical phage tail, and helical polymers continue to be important objects for three-dimensional reconstruction due to the centrality of helical protein and nucleoprotein polymers in all aspects of biology. We are now witnessing a fundamental revolution in this area, made possible by direct electron detectors, which has led to near-atomic resolution for a number of important helical structures. Most importantly, the possibility of achieving such resolution routinely for a vast number of helical samples is within our reach. One of the main problems in helical reconstruction, ambiguities in assigning the helical symmetry, is overcome when one reaches a resolution where secondary structure is clearly visible. However, obstacles still exist due to the intrinsic variability within many helical filaments. (C) 2015 Elsevier Inc. All rights reserved.
C1 Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.
RP Egelman, EH (reprint author), Univ Virginia, Dept Biochem & Mol Genet, Box 800733, Charlottesville, VA 22908 USA.
EM egelman@virginia.edu
FU NIH [EB001567]
FX This work has been supported by NIH EB001567.
CR WANG H, 1994, J MOL BIOL, V239, P371, DOI 10.1006/jmbi.1994.1379
   Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073
   Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015
   Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010
   Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169
   Bharat TAM, 2014, P NATL ACAD SCI USA, V111, P8233, DOI 10.1073/pnas.1401455111
   Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567
   DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0
   Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053
   Bhella D, 2004, J MOL BIOL, V340, P319, DOI 10.1016/j.jmb.2004.05.015
   NAMBA K, 1989, J MOL BIOL, V208, P307, DOI 10.1016/0022-2836(89)90391-4
   Bartesaghi A, 2014, P NATL ACAD SCI USA, V111, P11709, DOI 10.1073/pnas.1402809111
   Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088
   Kendall A, 2008, J VIROL, V82, P9546, DOI 10.1128/JVI.00895-08
   Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313
   Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048
   Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003
   KLUG A, 1958, ACTA CRYSTALLOGR, V11, P199, DOI 10.1107/S0365110X58000517
   Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930
   Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024
   NAMBA K, 1986, SCIENCE, V231, P1401, DOI 10.1126/science.3952490
   JENG TW, 1989, J MOL BIOL, V205, P251, DOI 10.1016/0022-2836(89)90379-3
   Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830
   OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314
   Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106
   Wang YA, 2006, J MOL BIOL, V361, P209, DOI 10.1016/j.jmb.2006.06.027
   Bakker SE, 2013, J GEN VIROL, V94, P1734, DOI 10.1099/vir.0.053025-0
   von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033
   Bammes BE, 2012, J STRUCT BIOL, V177, P589, DOI 10.1016/j.jsb.2012.01.008
   Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008
   Heymann JB, 2013, J BIOL CHEM, V288, P25276, DOI 10.1074/jbc.M113.456145
   Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971
   Ge P, 2011, P NATL ACAD SCI USA, V108, P9637, DOI 10.1073/pnas.1018104108
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121
   Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461
   Barrett A N, 1972, Cold Spring Harb Symp Quant Biol, V36, P433
   Behrmann E, 2012, J STRUCT BIOL, V177, P302, DOI 10.1016/j.jsb.2011.12.020
   Bernal JD, 1941, J GEN PHYSIOL, V25, P147, DOI 10.1085/jgp.25.1.147
   Beroukhim R, 1997, ULTRAMICROSCOPY, V70, P57, DOI 10.1016/S0304-3991(97)00070-3
   Clemens DL, 2015, CELL, V160, DOI 10.1016/j.cell.2015.02.005
   Cochran W.C., 1951, ACTA CRYSTALLOGR A, V5
   COLNAGO LA, 1987, BIOCHEMISTRY-US, V26, P847, DOI 10.1021/bi00377a028
   Communie G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003631
   CROSS TA, 1985, J MOL BIOL, V182, P367, DOI 10.1016/0022-2836(85)90197-4
   Desfosses A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2435
   Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003
   Duggin I.G., 2014, NATURE
   Egelman EH, 2010, METHOD ENZYMOL, V482, P167, DOI 10.1016/S0076-6879(10)82006-3
   Egelman EH, 2007, CURR OPIN STRUC BIOL, V17, P556, DOI 10.1016/j.sbi.2007.07.006
   EGELMAN EH, 1986, ULTRAMICROSCOPY, V19, P367, DOI 10.1016/0304-3991(86)90096-3
   Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0
   EGELMAN EH, 1982, ACTA CRYSTALLOGR A, V38, P796, DOI 10.1107/S0567739482001624
   EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0
   Egelman EH, 2015, STRUCTURE, V23, P280, DOI 10.1016/j.str.2014.12.008
   Egelman EH, 2014, ELIFE, V3, DOI 10.7554/eLife.04969
   Ferrao R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003124
   Fischer N, 2015, NATURE
   FRANKLIN RE, 1956, BIOCHIM BIOPHYS ACTA, V21, P405, DOI 10.1016/0006-3002(56)90043-9
   Galkin VE, 2012, CURR BIOL, V22, pR96, DOI 10.1016/j.cub.2011.12.010
   Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006
   HOLMES KC, 1975, NATURE, V254, P192, DOI 10.1038/254192a0
   HOLMES KC, 1972, NATURWISSENSCHAFTEN, V59, P247
   HOLMES KC, 1958, VIROLOGY, V6, P328, DOI 10.1016/0042-6822(58)90086-2
   Kudryashev M, 2015, CELL, V160, DOI 10.1016/j.cell.2015.01.037
   Landau L.D., 1980, STAT PHYS, V3
   MANDELKO.E, 1974, J MOL BIOL, V87, P265, DOI 10.1016/0022-2836(74)90148-X
   Marvin DA, 2006, J MOL BIOL, V355, P294, DOI 10.1016/j.jmb.2005.10.048
   OPELLA SJ, 1980, BIOPHYS J, V32, P531
   Owen CH, 1996, J STRUCT BIOL, V116, P167, DOI 10.1006/jsbi.1996.0027
   Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032
   STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0
   Straus SK, 2011, EUR BIOPHYS J BIOPHY, V40, P221, DOI 10.1007/s00249-010-0640-9
   Straus SK, 2008, EUR BIOPHYS J BIOPHY, V37, P521, DOI 10.1007/s00249-007-0222-7
   Stubbs G, 2012, ADV EXP MED BIOL, V726, P631, DOI 10.1007/978-1-4614-0980-9_28
   Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031
   WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355
   Wang H, 1997, J MOL BIOL, V269, P769, DOI 10.1006/jmbi.1997.1048
   Ward A, 2003, J STRUCT BIOL, V144, P172, DOI 10.1016/j.jsb.2003.10.008
   Xu H, 2014, ELIFE, V3, DOI 10.7554/eLife.01489
   Yang SX, 2003, J STRUCT BIOL, V144, P162, DOI 10.1016/j.jsb.2003.09.016
   Zen A.C., 2003, P NATL ACAD SCI USA, V100, P6458
   Zhu YX, 2001, J STRUCT BIOL, V135, P302, DOI 10.1006/jsbi.2001.4415
NR 85
TC 1
Z9 1
U1 12
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 54
EP 58
DI 10.1016/j.abb.2015.04.004
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700007
PM 25912526
ER

PT J
AU San Martin, C
AF San Martin, Carmen
TI Transmission electron microscopy and the molecular structure of
   icosahedral viruses
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Virus structure; Virus assembly; Three-dimensional reconstruction;
   Cryo-electron microscopy; Cryo-electron tomography; Icosahedral
   symmetry; Symmetry mismatch
ID NEAR-ATOMIC-RESOLUTION; X-RAY CRYSTALLOGRAPHY; CRYO-EM STRUCTURE;
   CYTOPLASMIC POLYHEDROSIS-VIRUS; HERPES-SIMPLEX-VIRUS; BUSHY STUNT VIRUS;
   CRYOELECTRON MICROSCOPY; 3-DIMENSIONAL STRUCTURE;
   CONFORMATIONAL-CHANGES; ANGSTROM RESOLUTION
AB The field of structural virology developed in parallel with methodological advances in X-ray crystallography and cryo-electron microscopy. At the end of the 1970s, crystallography yielded the first high resolution structure of an icosahedral virus, the T = 3 tomato bushy stunt virus at 2.9 angstrom. It took longer to reach near-atomic resolution in three-dimensional virus maps derived from electron microscopy data, but this was finally achieved, with the solution of complex icosahedral capsids such as the T = 25 human adenovirus at similar to 3.5 angstrom. Both techniques now work hand-in-hand to determine those aspects of virus assembly and biology that remain unclear. This review examines the trajectory followed by EM imaging techniques in showing the molecular structure of icosahedral viruses, from the first two-dimensional negative staining images of capsids to the latest sophisticated techniques that provide high resolution three-dimensional data, or snapshots of the conformational changes necessary to complete the infectious cycle. (C) 2015 Elsevier Inc. All rights reserved.
C1 [San Martin, Carmen] Ctr Nacl Biotecnol CNB CSIC, Dept Macromol Struct, Madrid 28049, Spain.
   [San Martin, Carmen] Ctr Nacl Biotecnol CNB CSIC, NanoBioMed Initiat, Madrid 28049, Spain.
RP San Martin, C (reprint author), Ctr Nacl Biotecnol CNB CSIC, Dept Macromol Struct, Darwin 3, Madrid 28049, Spain.
EM carmen@cnb.csic.es
RI San Martin, Carmen/A-4074-2010
OI San Martin, Carmen/0000-0001-9799-175X
FU Spanish Interdisciplinary Network on the Biophysics of Viruses
   (Biofivinet) from the Ministerio de Economia y Competitividad of Spain
   [FIS2011-16090-E];  [BFU2013-41249-P]
FX Cryo-EM analysis of icosahedral virus structure and assembly is a
   rapidly growing field, and it therefore is impossible to properly
   reflect all contributions involved in its development and all its
   achievements in limited space and time. I apologize to those colleagues
   whose work has not been mentioned and acknowledge them all for their
   outstanding work. I also thank those authors who gave permission and
   provided high resolution copies to reproduce figures from their
   published work, and Catherine Mark for editorial assistance. Research in
   the CSM laboratory is funded by grant BFU2013-41249-P and the Spanish
   Interdisciplinary Network on the Biophysics of Viruses (Biofivinet,
   FIS2011-16090-E), from the Ministerio de Economia y Competitividad of
   Spain.
CR Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893
   Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Chen DH, 2011, P NATL ACAD SCI USA, V108, P1355, DOI 10.1073/pnas.1015739108
   Zhang Y, 2007, J STRUCT BIOL, V157, P356, DOI 10.1016/j.jsb.2006.09.002
   DOKLAND T, 1993, J MOL BIOL, V233, P682, DOI 10.1006/jmbi.1993.1545
   Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041
   Zhang XZ, 2012, P NATL ACAD SCI USA, V109, P18431, DOI 10.1073/pnas.1211702109
   Baker ML, 2011, J STRUCT BIOL, V174, P360, DOI 10.1016/j.jsb.2011.01.015
   Lerch TF, 2012, STRUCTURE, V20, P1310, DOI 10.1016/j.str.2012.05.004
   Stewart A, 2004, ULTRAMICROSCOPY, V102, P67, DOI 10.1016/j.ultramic.2004.08.008
   Zlotnick A, 1997, P NATL ACAD SCI USA, V94, P9556, DOI 10.1073/pnas.94.18.9556
   Cheng LP, 2011, P NATL ACAD SCI USA, V108, P1373, DOI 10.1073/pnas.1014995108
   Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Perez-Berna AJ, 2015, NUCLEIC ACIDS RES, V43, P4274, DOI 10.1093/nar/gkv187
   Rossmann MG, 2013, Q REV BIOPHYS, V46, P133, DOI 10.1017/S0033583513000012
   Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003
   Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487
   Bernal JD, 1941, J GEN PHYSIOL, V25, P111, DOI 10.1085/jgp.25.1.111
   Grigorieff N, 2011, CURR OPIN STRUC BIOL, V21, P265, DOI 10.1016/j.sbi.2011.01.008
   Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0
   Zhu B, 2014, J MOL BIOL, V426, P2167, DOI 10.1016/j.jmb.2014.03.013
   Nemecek D, 2013, STRUCTURE, V21, P1374, DOI 10.1016/j.str.2013.06.007
   Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107
   Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665
   PRASAD BVV, 1993, J MOL BIOL, V231, P65, DOI 10.1006/jmbi.1993.1257
   Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683
   Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhou ZH, 2003, STRUCTURE, V11, P651, DOI 10.1016/S0969-2126(03)00091-1
   Luque D, 2014, P NATL ACAD SCI USA, V111, P7641, DOI 10.1073/pnas.1404330111
   Yang CW, 2012, P NATL ACAD SCI USA, V109, P6118, DOI 10.1073/pnas.1200206109
   Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284
   CRICK FHC, 1956, NATURE, V177, P473, DOI 10.1038/177473a0
   Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840
   Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694
   Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823
   Veesler D, 2013, P NATL ACAD SCI USA, V110, P5504, DOI 10.1073/pnas.1300601110
   Zhou ZH, 2008, CURR OPIN STRUC BIOL, V18, P218, DOI 10.1016/j.sbi.2008.03.004
   Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105
   Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0
   Schur FKM, 2013, J STRUCT BIOL, V184, P394, DOI 10.1016/j.jsb.2013.10.015
   Veesler D, 2013, J STRUCT BIOL, V184, P193, DOI 10.1016/j.jsb.2013.09.003
   HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0
   CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1
   Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069
   Zhou ZH, 2000, SCIENCE, V288, P877, DOI 10.1126/science.288.5467.877
   Baker TS, 1996, CURR OPIN STRUC BIOL, V6, P585, DOI 10.1016/S0959-440X(96)80023-6
   Canady MA, 2000, J MOL BIOL, V299, P573, DOI 10.1006/jmbi.2000.3723
   Chang J, 2012, ADV EXP MED BIOL, V726, P49, DOI 10.1007/978-1-4614-0980-9_4
   Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005
   Dai W, 2013, NATURE, V502, P707, DOI 10.1038/nature12604
   Yu XK, 2011, STRUCTURE, V19, P652, DOI 10.1016/j.str.2011.03.003
   CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0
   Cao CC, 2012, J VIROL, V86, P12322, DOI 10.1128/JVI.01608-12
   Reddy VS, 2010, SCIENCE, V329, P1071, DOI 10.1126/science.1187292
   Baker ML, 2012, BIOPOLYMERS, V97, P655, DOI 10.1002/bip.22065
   Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0
   Zeev-Ben-Mordehai T, 2014, CURR OPIN VIROL, V5, P42, DOI 10.1016/j.coviro.2014.01.008
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Baker ML, 2013, P NATL ACAD SCI USA, V110, P12301, DOI 10.1073/pnas.1309947110
   Grimes JM, 1997, STRUCTURE, V5, P885, DOI 10.1016/S0969-2126(97)00243-8
   Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115
   ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   Subramaniam S, 2007, CURR OPIN STRUC BIOL, V17, P596, DOI 10.1016/j.sbi.2007.09.009
   Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026
   Strauss M, 2015, J VIROL, V89, P4143, DOI 10.1128/JVI.03101-14
   Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322
   Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887
   Badia-Martinez Daniel, 2013, Subcell Biochem, V68, P203, DOI 10.1007/978-94-007-6552-8_7
   Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461
   Baker ML, 2010, NAT PROTOC, V5, P1697, DOI 10.1038/nprot.2010.126
   Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862
   Bernal JD, 1941, J GEN PHYSIOL, V25, P147, DOI 10.1085/jgp.25.1.147
   Campbell M.G., 2014, J STRUCT BIOL, V188, P183
   Campos SK, 2014, P NATL ACAD SCI USA, V111, pE4542, DOI 10.1073/pnas.1415364111
   CASPAR D L, 1956, Nature, V177, P475, DOI 10.1038/177475a0
   Castón José R, 2013, Subcell Biochem, V68, P79, DOI 10.1007/978-94-007-6552-8_3
   Chang L., 2010, J MOL BIOL, V397, P852
   Cheng LP, 2014, VIROLOGY, V450, P174, DOI 10.1016/j.virol.2013.12.012
   Conway JF, 1998, P NATL ACAD SCI USA, V95, P14622, DOI 10.1073/pnas.95.25.14622
   DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]
   Fu CY, 2011, CURR OPIN VIROL, V1, P125, DOI 10.1016/j.coviro.2011.06.008
   Fu CY, 2010, STRUCTURE, V18, P1579, DOI 10.1016/j.str.2010.10.005
   FULLER SD, 1987, CELL, V48, P923, DOI 10.1016/0092-8674(87)90701-X
   Gan L, 2006, STRUCTURE, V14, P1655, DOI 10.1016/j.str.2006.09.006
   Gilbert RJC, 2003, ADV PROTEIN CHEM, V64, P37
   Grunewald K, 2006, CURR OPIN MICROBIOL, V9, P437, DOI 10.1016/j.mib.2006.06.016
   Guo F, 2014, P NATL ACAD SCI USA, V111, pE4606, DOI 10.1073/pnas.1407020111
   He YN, 2001, NAT STRUCT BIOL, V8, P874, DOI 10.1038/nsb1001-874
   Hewat EA, 1996, EMBO J, V15, P1515
   Hewat EA, 1997, EMBO J, V16, P1492, DOI 10.1093/emboj/16.7.1492
   Home R.W., 1959, J MOL BIOL, V1, P84
   Hong C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002024
   Hryc CF, 2011, CURR OPIN VIROL, V1, P110, DOI 10.1016/j.coviro.2011.05.019
   Lee KK, 2008, STRUCTURE, V16, P1491, DOI 10.1016/j.str.2008.06.014
   Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9
   Perez-Berna AJ, 2012, J BIOL CHEM, V287, P31582, DOI 10.1074/jbc.M112.389957
   PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0
   Reddy VS, 2014, P NATL ACAD SCI USA, V111, P11715, DOI 10.1073/pnas.1408462111
   Reddy VS, 2001, J VIROL, V75, P11943, DOI 10.1128/JVI.75.24.11943-11947.2001
   Rodriguez JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004157
   Rosier D.J. Be, 1968, NATURE, V217, P130
   Rossmann MG, 2005, STRUCTURE, V13, P355, DOI 10.1016/j.str.2005.01.005
   Saibil HR, 2015, ACTA CRYSTALLOGR D, V71, P127, DOI 10.1107/S1399004714025280
   San Martin C, 2001, STRUCTURE, V9, P917, DOI 10.1016/S0969-2126(01)00642-6
   SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6
   STEWART PL, 1991, CELL, V67, P145, DOI 10.1016/0092-8674(91)90578-M
   Tang JH, 2009, J MOL BIOL, V392, P803, DOI 10.1016/j.jmb.2009.07.038
   Wang RYR, 2015, NAT METHODS, V12, P335, DOI [10.1038/nmeth.3287, 10.1038/NMETH.3287]
   Wang Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5808
   WINKLER FK, 1977, NATURE, V265, P509, DOI 10.1038/265509a0
   Wolf M, 2006, ULTRAMICROSCOPY, V106, P376, DOI 10.1016/j.ultramic.2005.11.001
   Yu XK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069729
   Zhang X, 2013, ELIFE, V2, DOI 10.7554/eLife.01299
   Zhou ZH, 2011, ADV PROTEIN CHEM STR, V82, P1, DOI 10.1016/B978-0-12-386507-6.00001-4
NR 121
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 59
EP 67
DI 10.1016/j.abb.2015.06.001
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700008
PM 26072114
ER

PT J
AU Stahlberg, H
   Biyani, N
   Engel, A
AF Stahlberg, Henning
   Biyani, Nikhil
   Engel, Andreas
TI 3D reconstruction of two-dimensional crystals
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE 2D crystallization; 3D reconstruction; Electron crystallography; Lipid;
   Membrane protein; Missing cone
ID RESOLUTION ELECTRON CRYSTALLOGRAPHY; MEMBRANE-PROTEINS; 2D
   CRYSTALLIZATION; ACETYLCHOLINE-RECEPTOR; SPECIMEN PREPARATION; ANGSTROM
   RESOLUTION; LATERAL PRESSURE; PURPLE MEMBRANE; CRYO-EM; MICROSCOPY
AB Electron crystallography of two-dimensional (2D) crystals determines the structure of membrane proteins in the lipid bilayer by imaging with cryo-electron microscopy and image processing. Membrane proteins can be packed in regular 2D arrays by their reconstitution in the presence of lipids at low lipid to protein weight-to-weight ratio. The crystal quality depends on the protein purity and homogeneity, its stability, and on the crystallization conditions. A 2D crystal presents the membrane protein in a functional and fully lipidated state. Electron crystallography determines the 3D structure even of small membrane proteins up to atomic resolution, but 3D density maps have a better resolution in the membrane plane than in the vertical direction. This problem can be partly eliminated by applying an iterative algorithm that exploits additional known constraints about the 2D crystal. 2D electron crystallography is particularly attractive for the structural analysis of membrane proteins that are too small for single particle analyses and too unstable to form 3D crystals. With the recent introduction of direct electron detector cameras, the routine determination of the atomic 3D structure of membrane-embedded membrane proteins is in reach. (C) 2015 Published by Elsevier Inc.
C1 [Stahlberg, Henning; Biyani, Nikhil] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland.
   [Engel, Andreas] Delft Univ Technol, Dept BioNanosci, NL-2628 CH Delft, Netherlands.
   [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
RP Engel, A (reprint author), Delft Univ Technol, Dept BioNanosci, Van der Waalsweg 8, NL-2628 CH Delft, Netherlands.
EM a.h.engel@tudelft.nl
FU Swiss National Science Foundation [315230_146929, 205320_144427]; Swiss
   National Science Foundation (NCCR TransCure); Transcontinental EM
   Initiative for Membrane Protein Structure - NIH Protein Structure
   Initiative [U54GM094598]
FX The authors thank Dimitrios Fotiadis for insightful discussions on
   protein purification and 2D crystallization. This work has been
   supported by the Swiss National Science Foundation (Grants
   315230_146929, 205320_144427, and the NCCR TransCure), and by the
   Transcontinental EM Initiative for Membrane Protein Structure, funded by
   the NIH Protein Structure Initiative under Grant U54GM094598.
CR AGARD DA, 1982, BIOPHYS J, V37, P589
   Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010
   Schmidt-Krey I, 2007, METHODS, V41, P417, DOI 10.1016/j.ymeth.2006.07.011
   Schmidt-Krey I, 2011, MICRON, V42, P107, DOI 10.1016/j.micron.2010.07.004
   HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2
   Philippsen A, 2007, ULTRAMICROSCOPY, V107, P202, DOI 10.1016/j.ultramic.2006.07.010
   Faruqi AR, 2000, Q REV BIOPHYS, V33, P1, DOI 10.1017/S0033583500003577
   Faruqi AR, 2011, Q REV BIOPHYS, V44, P357, DOI 10.1017/S0033583511000035
   Levy D, 2001, FEBS LETT, V504, P187, DOI 10.1016/S0014-5793(01)02748-X
   Schenk AD, 2013, J STRUCT BIOL, V182, P173, DOI 10.1016/j.jsb.2013.02.017
   Gipson BR, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011916
   Signorell GA, 2007, J STRUCT BIOL, V157, P321, DOI 10.1016/j.jsb.2006.07.011
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)90004-1
   Mariani V, 2011, J STRUCT BIOL, V174, P259, DOI 10.1016/j.jsb.2011.02.008
   Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614
   Hite RK, 2010, METHOD ENZYMOL, V481, P251, DOI 10.1016/S0076-6879(10)81011-0
   Hirai T, 1999, J ELECTRON MICROSC, V48, P653
   Abeyrathne PD, 2010, METHOD ENZYMOL, V481, P25, DOI 10.1016/S0076-6879(10)81001-8
   Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004
   Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652
   Lucic V, 2013, J CELL BIOL, V202, P407, DOI 10.1083/jcb.201304193
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   THON F, 1966, Z NATURFORSCH PT A, VA 21, P476
   Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748
   Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529
   Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848
   Murata K, 2000, NATURE, V407, P599
   Dietrich U, 2009, BBA-BIOMEMBRANES, V1788, P1474, DOI 10.1016/j.bbamem.2009.04.001
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9
   Fujiyoshi Y, 2011, J ELECTRON MICROSC, V60, pS149, DOI 10.1093/jmicro/dfr033
   Grigorieff N, 2013, ELIFE, V2, DOI 10.7554/eLife.00573
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   Jeckelmann JM, 2011, J STRUCT BIOL, V176, P395, DOI 10.1016/j.jsb.2011.09.012
   Kuhlbrandt W., 2003, MEMBRANE PROTEIN PUR, VSecond, P253, DOI 10.1016/B978-012361776-7/50016-4
   KUHLBRANDT W, 1992, Q REV BIOPHYS, V25, P1
   Lebeau L, 2001, J MOL BIOL, V308, P639, DOI 10.1006/jmbi.2001.4629
   Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3
   Remigy HW, 2003, FEBS LETT, V555, P160, DOI 10.1016/S0014-5793(03)01105-0
   Ringler P., 2000, MEMBRANE TRANSPORT, P229
   Rosenbusch JP, 2001, J STRUCT BIOL, V136, P144, DOI 10.1006/jsbi.2001.4431
   Scherer S, 2014, J STRUCT BIOL, V185, P267, DOI 10.1016/j.jsb.2013.12.011
   Scherer S, 2014, J STRUCT BIOL, V186, P302, DOI 10.1016/j.jsb.2014.03.016
   Schultz P, 2009, METHODS MOL BIOL, V543, P353, DOI 10.1007/978-1-60327-015-1_22
   Stokes DL, 2010, METHODS MOL BIOL, V654, P187, DOI 10.1007/978-1-60761-762-4_10
   Tani K, 2009, J MOL BIOL, V389, P694, DOI 10.1016/j.jmb.2009.04.049
   Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031
   Vink M, 2007, J STRUCT BIOL, V160, P295, DOI 10.1016/j.jsb.2007.09.003
   Zeng X, 2007, J STRUCT BIOL, V160, P353, DOI 10.1016/j.jsb.2007.08.008
NR 58
TC 1
Z9 1
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 68
EP 77
DI 10.1016/j.abb.2015.06.006
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700009
PM 26093179
ER

PT J
AU Dubrovsky, A
   Sorrentino, S
   Harapin, J
   Sapra, KT
   Medalia, O
AF Dubrovsky, Anna
   Sorrentino, Simona
   Harapin, Jan
   Sapra, K. Tanuj
   Medalia, Ohad
TI Developments in cryo-electron tomography for in situ structural analysis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Cryo-electron tomography; Cryo-focused-ion beam; Direct electron
   detector; Phase plate
ID NUCLEAR-PORE COMPLEX; TRANSMISSION ELECTRON-MICROSCOPY; DIRECT-DETECTION
   DEVICE; BEAM-INDUCED MOTION; PHASE-CONTRAST; MOLECULAR ARCHITECTURE;
   PROTEIN COMPLEXES; FOCAL ADHESIONS; NUCLEOCYTOPLASMIC TRANSPORT;
   BIOLOGICAL SPECIMENS
AB Structural analysis of macromolecular assemblies and their remodeling during physiological processes is instrumental to defining the fundament of cellular and molecular biology. Recent advances in computational and analytical tools for cryo-electron tomography have enabled the study of macromolecular structures in their native environment, providing unprecedented insights into cell function. Moreover, the recent implementation of direct electron detectors has progressed cryo-electron tomography to a stage where it can now be applied to the reconstruction of macromolecular structures at high resolutions. Here, we discuss some of the recent technical developments in cryo-electron tomography to reveal structures of macromolecular complexes in their physiological medium, focusing mainly on eukaryotic cells. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Dubrovsky, Anna; Sorrentino, Simona; Harapin, Jan; Sapra, K. Tanuj; Medalia, Ohad] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland.
   [Medalia, Ohad] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.
   [Medalia, Ohad] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.
RP Medalia, O (reprint author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM omedalia@bioc.uzh.ch
FU European Research Council (ERC) [243047 INCEL]; Swiss National Science
   Foundation [SNSF 31003A_159706/1]; Forschungskredit of the University of
   Zurich [FK-13-049]
FX This work was supported by a European Research Council (ERC) Starting
   Grant (243047 INCEL) and the Swiss National Science Foundation Grant
   (SNSF 31003A_159706/1).; KTS was supported by the Forschungskredit of
   the University of Zurich, [FK-13-049].
CR Danev R, 2009, ULTRAMICROSCOPY, V109, P312, DOI 10.1016/j.ultramic.2008.12.006
   Tocheva EI, 2013, MOL MICROBIOL, V88, P673, DOI 10.1111/mmi.12201
   Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170
   AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   McMullan G, 2014, ULTRAMICROSCOPY, V147, P156, DOI 10.1016/j.ultramic.2014.08.002
   Nagayama K, 2008, PHILOS T R SOC B, V363, P2153, DOI 10.1098/rstb.2008.2268
   Winkler H, 2003, J STRUCT BIOL, V143, P24, DOI 10.1016/S1047-8477(03)00120-5
   Wang K, 2012, J STRUCT BIOL, V180, P318, DOI 10.1016/j.jsb.2012.07.003
   Grossman E, 2012, J STRUCT BIOL, V177, P113, DOI 10.1016/j.jsb.2011.11.002
   Danev R, 2010, J STRUCT BIOL, V171, P174, DOI 10.1016/j.jsb.2010.03.013
   Danev R, 2014, P NATL ACAD SCI USA, V111, P15635, DOI 10.1073/pnas.1418377111
   Zwerger M, 2013, HISTOCHEM CELL BIOL, V140, P3, DOI 10.1007/s00418-013-1104-y
   Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919
   Philippsen A, 2007, ULTRAMICROSCOPY, V107, P202, DOI 10.1016/j.ultramic.2006.07.010
   TOYOSHIMA C, 1988, ULTRAMICROSCOPY, V25, P279, DOI 10.1016/0304-3991(88)90003-4
   Guesdon A, 2013, J STRUCT BIOL, V181, P169, DOI 10.1016/j.jsb.2012.11.004
   Kurner J, 2005, SCIENCE, V307, P436, DOI 10.1126/science.1104031
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003
   Ben-Harush K, 2009, J MOL BIOL, V386, P1392, DOI 10.1016/j.jmb.2008.12.024
   Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003
   Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112
   CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119
   Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055
   Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034
   Faruqi AR, 2007, CURR OPIN STRUC BIOL, V17, P549, DOI 10.1016/j.sbi.2007.08.014
   Medalia O, 2007, CURR BIOL, V17, P79, DOI 10.1016/j.cub.2006.11.022
   Ho CY, 2012, J CELL SCI, V125, P2087, DOI 10.1242/jcs.087288
   Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102
   Zanetti G, 2009, J STRUCT BIOL, V168, P305, DOI 10.1016/j.jsb.2009.08.002
   Li XM, 2013, J STRUCT BIOL, V184, P251, DOI 10.1016/j.jsb.2013.08.005
   Hsieh C, 2014, J STRUCT BIOL, V185, P32, DOI 10.1016/j.jsb.2013.10.019
   Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1
   HARTWIG JH, 1991, J CELL BIOL, V112, P407, DOI 10.1083/jcb.112.3.407
   Horowitz RA, 1997, J STRUCT BIOL, V120, P353, DOI 10.1006/jsbi.1997.3921
   Mercogliano CP, 2006, J MOL BIOL, V355, P211, DOI 10.1016/j.jmb.2005.10.026
   GOLDMAN AE, 1986, P NATL ACAD SCI USA, V83, P3839, DOI 10.1073/pnas.83.11.3839
   Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284
   Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109
   Forster F, 2007, METHOD CELL BIOL, V79, P741, DOI 10.1016/S0091-679X(06)79029-X
   Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014
   Grimm R, 1998, BIOPHYS J, V74, P1031
   Yahav T, 2011, CURR OPIN STRUC BIOL, V21, P670, DOI 10.1016/j.sbi.2011.07.004
   Eibauer M, 2012, J STRUCT BIOL, V180, P488, DOI 10.1016/j.jsb.2012.09.008
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Nicastro D, 2000, J STRUCT BIOL, V129, P48, DOI 10.1006/jsbi.1999.4204
   Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933
   Ruskin RS, 2013, J STRUCT BIOL, V184, P385, DOI 10.1016/j.jsb.2013.10.016
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299
   Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095
   Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184
   Dai W, 2013, NATURE, V502, P707, DOI 10.1038/nature12604
   Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004
   Lucic V, 2013, J CELL BIOL, V202, P407, DOI 10.1083/jcb.201304193
   Bammes BE, 2012, J STRUCT BIOL, V177, P589, DOI 10.1016/j.jsb.2012.01.008
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Stick R, 2010, METHODS, V51, P170, DOI 10.1016/j.ymeth.2010.01.015
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Nieswandt B, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2009.03370.x
   Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025
   Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x
   Danev R, 2011, ULTRAMICROSCOPY, V111, P1305, DOI 10.1016/j.ultramic.2011.04.004
   Jin L, 2008, J STRUCT BIOL, V161, P352, DOI 10.1016/j.jsb.2007.10.007
   Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   FAWCETT DW, 1966, AM J ANAT, V119, P129, DOI 10.1002/aja.1001190108
   Zernike F, 1942, PHYSICA, V9, P686, DOI 10.1016/S0031-8914(42)80035-X
   Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010
   Bartesaghi A, 2009, CURR OPIN STRUC BIOL, V19, P402, DOI 10.1016/j.sbi.2009.06.005
   Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179
   Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197
   Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461
   Ben-Harush K, 2010, J CELL SCI, V123, P7, DOI 10.1242/jcs.060111
   Best C, 2007, METHOD CELL BIOL, V79, P615, DOI 10.1016/S0091-679X(06)79025-2
   Bokstad M, 2012, J STRUCT BIOL, V178, P76, DOI 10.1016/j.jsb.2011.10.013
   Carlson D. B., 2012, TRANSMISSION ELECT M, P85
   ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403
   Clough R.N., 2014, J PHYS C SER, V522, P1
   Coquelle F.M., 2011, METHOD MOL BIOL, V777, P193
   Dai W., 2014, MICROB CELL, V1, P45
   Dai W, 2014, NAT PROTOC, V9, P2630, DOI 10.1038/nprot.2014.176
   Danev R., 2010, METHOD ENZYMOL, P343
   DIERKSEN K, 1993, ULTRAMICROSCOPY, V49, P109, DOI 10.1016/0304-3991(93)90217-L
   Dubochet J., 1988, Q REV BIOPHYS, V21, P129
   Dubochet J., 1983, J BACTERIOL, V155, P381
   Elad N, 2011, J CELL SCI, V124, P207, DOI 10.1242/jcs.073486
   Elad N, 2013, J CELL SCI, V126, P4099, DOI 10.1242/jcs.120295
   Elad N, 2009, CURR OPIN STRUC BIOL, V19, P226, DOI 10.1016/j.sbi.2009.02.009
   Engel B. D., 2015, ELIFE, V4
   Faini M, 2012, SCIENCE, V336, P1451, DOI 10.1126/science.1221443
   Frank J, 2002, J STRUCT BIOL, V138, P85, DOI 10.1016/S1047-8477(02)00019-9
   Frank J., 2006, ELECT TOMOGRAPHY MET
   Fukuda Y, 2012, J STRUCT BIOL, V177, P484, DOI 10.1016/j.jsb.2011.11.018
   Fukuda Y, 2009, J STRUCT BIOL, V168, P476, DOI 10.1016/j.jsb.2009.08.011
   Gall JG, 2004, EXP CELL RES, V296, P28, DOI 10.1016/j.yexcr.2004.03.017
   Giannuzzi L. A., 2005, INTRO FOCUSED ION BE
   Gold VAM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5129
   Grimm R, 1996, J MICROSC-OXFORD, V183, P60, DOI 10.1046/j.1365-2818.1996.77441.x
   Grimm R, 1997, BIOPHYS J, V72, P482
   Gruenbaum Y, 2015, CURR OPIN CELL BIOL, V32, P7, DOI 10.1016/j.ceb.2014.09.009
   Harapin J, 2013, STRUCTURE, V21, P1522, DOI 10.1016/j.str.2013.08.003
   McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009
   Medalia O, 2010, CURR OPIN CELL BIOL, V22, P659, DOI 10.1016/j.ceb.2010.08.006
   Michelson A.D., 2012, PLATELETS, Vthird, P1398
   Murata K, 2010, STRUCTURE, V18, P903, DOI 10.1016/j.str.2010.06.006
   Nagayama K., 2013, ENCY BIOPHYSICS, P1837
   Nagayama K., 2011, J ELECT MICROSC T S1, V60, pS43
   Nagayama Kuniaki, 2009, Biophysical Reviews, V1, DOI 10.1007/s12551-008-0006-z
   Penczek P.A., 1997, SCANNING MICROSCOPY, V11, P147
   Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7019
   RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405
   Ramachandra R, 2014, MICROSC MICROANAL, V20, P706, DOI 10.1017/S1431927614000452
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Sarkar P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106928
   Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665
   Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838
   Sorrentino S, 2015, EUR J CELL BIOL, V94, P129, DOI 10.1016/j.ejcb.2015.01.001
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Subramaniam S, 2003, ASM NEWS, V69, P240
   Talmon Y., 1987, CRYOTECHNIQUES BIOL, P64
   Tocheva EI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003442
   Walter A, 2015, ULTRAMICROSCOPY, V153, P22, DOI 10.1016/j.ultramic.2015.01.005
   Wiesner S, 2006, TRENDS CELL BIOL, V16, P327, DOI 10.1016/j.tcb.2006.05.002
   Woodward CL, 2015, J VIROL, V89, P1267, DOI [10.1128/JVI.02997-14, 10.1128/JVI02997-14]
   Xu M., 2011, BIOINFORMATICS, V27, P69
NR 126
TC 1
Z9 1
U1 16
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 78
EP 85
DI 10.1016/j.abb.2015.04.006
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700010
PM 25921875
ER

PT J
AU Fontana, J
   Steven, AC
AF Fontana, Juan
   Steven, Alasdair C.
TI Influenza virus-mediated membrane fusion: Structural insights from
   electron microscopy
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Influenza virus; Viral fusion; Hemagglutinin; Cryo-electron microscopy;
   Cryo-electron tomography; Subtomogram averaging
ID MATRIX PROTEIN M1; LOW-PH; CRYOELECTRON TOMOGRAPHY; A VIRUS;
   CONFORMATIONAL-CHANGE; FUSOGENIC ACTIVITY; HEMAGGLUTININ; PARTICLES;
   RIBONUCLEOPROTEINS; ENTRY
AB Influenza virus, the causative agent of flu, enters the host cell by endocytosis. The low pH encountered inside endosomes triggers conformational changes in the viral glycoprotein hemagglutinin (HA), that mediate fusion of the viral and cellular membranes. This releases the viral genome into the cytoplasm of the infected cell, establishing the onset of the replication cycle. To investigate the structural basis of HA-mediated membrane fusion, a number of techniques have been employed. These include X-ray crystallography, which has provided atomic models of the HA ectodomain in its initial (pre-fusion) state and of part of HA in its final (post-fusion) state. However, this left an information deficit concerning many other aspects of the fusion process. Electron microscopy (EM) approaches are helping to fill this void. For example, influenza virions at neutral pH have been imaged by cryo-EM and cryo-electron tomography (cryo-ET); thin section EM has shown that influenza viruses enter the cell by endocytosis; the large-scale structural changes in HA when virions are exposed to low pH (pre-fusion to post-fusion states) have been visualized by negative staining and cryo-EM; acidification also induces structural changes in the M1 matrix layer and its separation from the viral envelope; intermediate HA conformations between its pre- and post-fusion states have been detected by cryo-ET supplemented with subtomogram averaging; and fusion of influenza virions with liposomes has been visualized by cryo-ET. In this review, we survey EM-based contributions towards the characterization of influenza virus-mediated membrane fusion and anticipate the potential for future developments. Published by Elsevier Inc.
C1 [Fontana, Juan; Steven, Alasdair C.] NIAMSD, Struct Biol Res Lab, NIH, Bethesda, MD 20892 USA.
RP Fontana, J (reprint author), NIAMS, Struct Biol Res Lab, NIH, 50 South Dr,Bldg 50,Room 1517, Bethesda, MD 20892 USA.
EM fontana@mail.nih.gov; stevena@mail.nih.gov
OI Fontana, Juan/0000-0002-9084-2927
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health
FX This research was supported by the Intramural Research Program of the
   National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health.
CR Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378
   PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I
   Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270
   FUJIYOSHI Y, 1994, EMBO J, V13, P318
   Chou YY, 2012, P NATL ACAD SCI USA, V109, P9101, DOI 10.1073/pnas.1206069109
   Wasilewski S, 2012, VACCINE, V30, P7368, DOI 10.1016/j.vaccine.2012.09.082
   Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07
   BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0
   RUIGROK RWH, 1986, EMBO J, V5, P41
   DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0
   Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003
   RUIGROK RWH, 1984, ARCH VIROL, V82, P181, DOI 10.1007/BF01311162
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119
   WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0
   Rigort A, 2012, METHOD CELL BIOL, V111, P259, DOI 10.1016/B978-0-12-416026-2.00014-5
   Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531
   GODLEY L, 1992, CELL, V68, P635, DOI 10.1016/0092-8674(92)90140-8
   White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI 10.1080/10409230802058320 
   Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284
   Baquero E, 2013, CURR OPIN VIROL, V3, P143, DOI 10.1016/j.coviro.2013.03.006
   Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172
   MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K
   HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404
   Ruskin RS, 2013, J STRUCT BIOL, V184, P385, DOI 10.1016/j.jsb.2013.10.016
   MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601
   Li S, 2014, BIOPHYS J, V106, P1447, DOI 10.1016/j.bpj.2014.02.018
   Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016
   WHITE J, 1982, EMBO J, V1, P217
   Hamilton BS, 2012, VIRUSES-BASEL, V4, P1144, DOI 10.3390/v4071144
   Fontana J, 2012, J VIROL, V86, P2919, DOI 10.1128/JVI.06698-11
   Rossman JS, 2012, J VIROL, V86, P10950, DOI 10.1128/JVI.05992-11
   PURI A, 1990, J VIROL, V64, P3824
   LEPAULT J, 1983, J MICROSC-OXFORD, V129, P89
   ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002
   Harris AK, 2013, P NATL ACAD SCI USA, V110, P4592, DOI 10.1073/pnas.1214913110
   RUIGROK RWH, 1989, VIROLOGY, V173, P311, DOI 10.1016/0042-6822(89)90248-1
   Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103
   BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0
   Bonnafous P, 2014, BBA-BIOMEMBRANES, V1838, P355, DOI 10.1016/j.bbamem.2013.09.021
   BOOY FP, 1985, J MOL BIOL, V184, P667, DOI 10.1016/0022-2836(85)90312-2
   Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107
   Cardone G, 2012, J VIROL, V86, P12129, DOI 10.1128/JVI.01880-12
   Chen J, 1995, P NATL ACAD SCI USA, V92, P12205, DOI 10.1073/pnas.92.26.12205
   COMPANS RW, 1972, J VIROL, V10, P795
   DOMS RW, 1985, J BIOL CHEM, V260, P2973
   Fontana J, 2013, J VIROL, V87, P5621, DOI 10.1128/JVI.00276-13
   Frank J., 1996, 3 DIMENSIONAL ELECT, P12
   HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3
   Kanaseki T, 1997, J CELL BIOL, V137, P1041, DOI 10.1083/jcb.137.5.1041
   Kozlov MM, 2002, TRAFFIC, V3, P256, DOI 10.1034/j.1600-0854.2002.030403.x
   Lee DW, 2014, BIOPHYS J, V106, P843, DOI 10.1016/j.bpj.2013.12.048
   Lee KK, 2010, EMBO J, V29, P1299, DOI 10.1038/emboj.2010.13
   Leikina E, 2004, J BIOL CHEM, V279, P26526, DOI 10.1074/jbc.M401883200
   Leikina E, 2002, EMBO J, V21, P5701, DOI 10.1093/emboj/cdf559
   MURTI KG, 1986, VIROLOGY, V149, P36, DOI 10.1016/0042-6822(86)90084-X
   MURTI KG, 1992, VIROLOGY, V186, P294, DOI 10.1016/0042-6822(92)90084-3
   MURTI KG, 1980, VIROLOGY, V104, P224, DOI 10.1016/0042-6822(80)90380-3
   Nagayama K, 2014, METHODS MOL BIOL, V1117, P385, DOI 10.1007/978-1-62703-776-1_18
   Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838
   Shangguan T, 1998, BIOPHYS J, V74, P54
   Shaw M. L., 2013, FIELDS VIROLOGY
   STEGMANN T, 1987, J BIOL CHEM, V262, P17744
   Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657
   Vijayakrishnan S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003413
   Yamaguchi M, 2008, J STRUCT BIOL, V162, P271, DOI 10.1016/j.jsb.2008.01.009
NR 67
TC 1
Z9 1
U1 28
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 86
EP 97
DI 10.1016/j.abb.2015.04.011
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700011
PM 25958107
ER

PT J
AU Fonta, CL
   Humbel, BM
AF Fonta, Celine Loussert
   Humbel, Bruno M.
TI Correlative microscopy
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Correlative microscopy; Light and Electron microscopy; STEM scanning
   transmission electron microscopy; Mouse brain; GFP green fluorescent
   protein; Epoxy; Methacrylate; Cryo-fixation and Freeze-substitution;
   Tokuyasu cryo-sectioning; Immuno-(gold) labelling
ID SCANNING-ELECTRON-MICROSCOPY; ULTRATHIN FROZEN-SECTIONS; GFP-EXPRESSING
   CELLS; X-RAY TOMOGRAPHY; FLUORESCENCE MICROSCOPY; FREEZE-SUBSTITUTION;
   EPOXY-RESIN; CRYOELECTRON MICROSCOPY; VITREOUS SECTIONS; EMBEDDING
   MEDIUM
AB In recent years correlative microscopy, combining the power and advantages of different imaging system, e.g., light, electrons, X-ray, NMR, etc., has become an important tool for biomedical research. Among all the possible combinations of techniques, light and electron microscopy, have made an especially big step forward and are being implemented in more and more research labs.
   Electron microscopy profits from the high spatial resolution, the direct recognition of the cellular ultrastructure and identification of the organelles. It, however, has two severe limitations: the restricted field of view and the fact that no live imaging can be done. On the other hand light microscopy has the advantage of live imaging, following a fluorescently tagged molecule in real time and at lower magnifications the large field of view facilitates the identification and location of sparse individual cells in a large context, e.g., tissue. The combination of these two imaging techniques appears to be a valuable approach to dissect biological events at a submicrometer level.
   Light microscopy can be used to follow a labelled protein of interest, or a visible organelle such as mitochondria, in time, then the sample is fixed and the exactly same region is investigated by electron microscopy. The time resolution is dependent on the speed of penetration and fixation when chemical fixatives are used and on the reaction time of the operator for cryo-fixation. Light microscopy can also be used to identify cells of interest, e.g., a special cell type in tissue or cells that have been modified by either transfections or RNAi, in a large population of non-modified cells. A further application is to find fluorescence labels in cells on a large section to reduce searching time in the electron microscope. Multiple fluorescence labelling of a series of sections can be correlated with the ultrastructure of the individual sections to get 3D information of the distribution of the marked proteins: array tomography. More and more efforts are put in either converting a fluorescence label into an electron dense product or preserving the fluorescence throughout preparation for the electron microscopy.
   Here, we will review successful protocols and where possible try to extract common features to better understand the importance of the individual steps in the preparation. Further the new instruments and software, intended to ease correlative light and electron microscopy, are discussed. Last but not least we will detail the approach we have chosen for correlative microscopy. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Fonta, Celine Loussert; Humbel, Bruno M.] Univ Lausanne, Electron Microscopy Facil, Biophore, CH-1015 Lausanne, Switzerland.
RP Humbel, BM (reprint author), Univ Lausanne, Electron Microscopy Facil, Biophore, CH-1015 Lausanne, Switzerland.
EM Celine.Loussert@rdls.nestle.com; Bruno.Humbel@unil.ch
FU Faculty of Biology and Medicine of the University of Lausanne,
   Switzerland; Swiss National Science Foundation [316030_128692]
FX The authors would like to thank Dr. J.M. Mateos and Dr. J. Ster for
   brain tissue with Lucifer yellow labelled neurons and Dr. A. Volterra
   for brain tissue with GPF labelled astrocytes. W. Blanchard provided the
   images in Figs. 1 and 4. We are especially indebted to B. Lich, C.
   Mathisen, Dr. M. Langhorst, Dr. A. de Marco and Dr. L Hekking, I.
   Gestmann, FEI Company, for the fruitful collaboration with the Maps
   software. Dr. H. Schwarz and Dr. C. Wurm are acknowledged for their
   collaboration on on-section labelling (Fig. 2) and M. van der Werff and
   S. Gerrits for their support during the writing of the article. We also
   thank P. Brey for critical reading the manuscript. The STEM work was
   made possible by the financial support of the Faculty of Biology and
   Medicine of the University of Lausanne, Switzerland, and the Swiss
   National Science Foundation, R'Equip grant 316030_128692.
CR van Driel LF, 2009, EUR J CELL BIOL, V88, P669, DOI 10.1016/j.ejcb.2009.07.002
   PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067
   Biel SS, 2003, J MICROSC-OXFORD, V212, P91, DOI 10.1046/j.1365-2818.2003.01227.x
   Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201
   Fukuda Y, 2014, ULTRAMICROSCOPY, V143, P15, DOI 10.1016/j.ultramic.2013.11.008
   Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344
   Schwartz CL, 2007, J MICROSC-OXFORD, V227, P98, DOI 10.1111/j.1365-2818.2007.01794.x
   Luby-Phelps K, 2003, J HISTOCHEM CYTOCHEM, V51, P271
   Modla S, 2011, MICRON, V42, P773, DOI 10.1016/j.micron.2011.07.001
   Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014
   Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806
   Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x
   Watanabe S, 2011, NAT METHODS, V8, P80, DOI [10.1038/nmeth.1537, 10.1038/NMETH.1537]
   Sartori A, 2007, J STRUCT BIOL, V160, P135, DOI 10.1016/j.jsb.2007.07.011
   Rigort A, 2010, J STRUCT BIOL, V172, P169, DOI 10.1016/j.jsb.2010.02.011
   GRIFFITHS G, 1983, METHOD ENZYMOL, V96, P466
   Gruska M, 2008, J STRUCT BIOL, V161, P384, DOI 10.1016/j.jsb.2007.10.008
   Fonta CL, 2015, J STRUCT BIOL, V189, P53, DOI 10.1016/j.jsb.2014.10.011
   Brown E, 2010, PROTOPLASMA, V244, P91, DOI 10.1007/s00709-010-0165-1
   Nolte C, 2001, GLIA, V33, P72
   Henriques R, 2011, BIOPOLYMERS, V95, P322, DOI 10.1002/bip.21586
   Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365
   Matsko N, 2005, J STRUCT BIOL, V152, P92, DOI 10.1016/j.jsb.2005.07.005
   Studer D, 2001, J MICROSC-OXFORD, V203, P285, DOI 10.1046/j.1365-2818.2001.00919.x
   Liv N, 2014, ULTRAMICROSCOPY, V143, P93, DOI 10.1016/j.ultramic.2013.09.002
   Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793
   Verkade P, 2008, J MICROSC-OXFORD, V230, P317, DOI 10.1111/j.1365-2818.2008.01989.x
   Mironov AA, 2009, J MICROSC-OXFORD, V235, P308, DOI 10.1111/j.1365-2818.2009.03222.x
   Forestier CL, 2011, CELL HOST MICROBE, V9, P319, DOI 10.1016/j.chom.2011.03.011
   TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956
   Loussert C, 2012, METHOD CELL BIOL, V111, P59, DOI 10.1016/B978-0-12-416026-2.00004-2
   McDonald KL, 2011, J MICROSC-OXFORD, V243, P227, DOI 10.1111/j.1365-2818.2011.03526.x
   TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551
   Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929
   Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   Lucas MS, 2012, METHOD CELL BIOL, V111, P325, DOI 10.1016/B978-0-12-416026-2.00017-0
   Hell SW, 2004, CURR OPIN NEUROBIOL, V14, P599, DOI 10.1016/j.conb.2004.08.015
   Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010
   Bishop D, 2011, NAT METHODS, V8, P568, DOI [10.1038/nmeth.1622, 10.1038/NMETH.1622]
   Wang LC, 2005, BRAIN RES PROTOC, V15, P155, DOI 10.1016/j.brainresprot.2005.07.001
   Nishiyama H, 2014, ULTRAMICROSCOPY, V147, P86, DOI 10.1016/j.ultramic.2014.06.001
   DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901
   ACETARIN JD, 1986, J MICROSC-OXFORD, V143, P81
   Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x
   SCALA C, 1992, J HISTOCHEM CYTOCHEM, V40, P1799
   Vicidomini G, 2008, TRAFFIC, V9, P1828, DOI 10.1111/j.1600-0854.2008.00815.x
   Grabenbauer M, 2012, METHOD CELL BIOL, V111, P117, DOI 10.1016/B978-0-12-416026-2.00007-8
   Agronskaia AV, 2008, J STRUCT BIOL, V164, P183, DOI 10.1016/j.jsb.2008.07.003
   Robinson JM, 2001, J HISTOCHEM CYTOCHEM, V49, P803
   CARLEMALM E, 1982, J MICROSC-OXFORD, V126, P123
   Tsien RY, 2010, INTEGR BIOL-UK, V2, P77, DOI 10.1039/b926500g
   Armbruster B.L., 1983, SCI BIOL SPECIMEN PR, P77
   Behrman E.J., 1984, SCI BIOL SPECIMEN PR, P1
   Bell K, 2013, PLANT PHYSIOL, V161, P1595, DOI 10.1104/pp.112.212365
   BERNHARD W, 1969, J ULTRA MOL STRUCT R, V27, P250, DOI 10.1016/S0022-5320(69)80016-X
   Bogers JJ, 1996, J HISTOCHEM CYTOCHEM, V44, P43
   Buser C, 2008, J MICROSC-OXFORD, V230, P268, DOI 10.1111/j.1365-2818.2008.01984.x
   Carlson DB, 2013, MICROSC MICROANAL, V19, P22, DOI 10.1017/S1431927612013827
   Carzaniga R, 2014, METHOD CELL BIOL, V124, P151, DOI 10.1016/B978-0-12-801075-4.00008-2
   Causton B.E., 1984, IMMUNOLABELLING ELEC, P29
   Causton B.E., 1985, P209
   Causton B.E., 1981, P ROY MICROSC SOC, V16, P265
   Dubochet J., 2008, HDB CRYOPREPARATION, P255
   DUBOCHET J, 1983, J BACTERIOL, V155, P381
   Faas FGA, 2013, J STRUCT BIOL, V181, P283, DOI 10.1016/j.jsb.2012.12.004
   FERNANDEZMORAN H, 1959, SCIENCE, V129, P1284
   FERNANDEZMORAN H, 1960, ANN NY ACAD SCI, V85, P689, DOI 10.1111/j.1749-6632.1960.tb49990.x
   FREDERIK PM, 1982, J MICROSC-OXFORD, V126, pRP1
   GIBBONS IR, 1959, NATURE, V184, P375, DOI 10.1038/184375b0
   GLAUERT AM, 1958, J BIOPHYS BIOCHEM CY, V4, P191, DOI 10.1083/jcb.4.2.191
   Goping G, 1996, J HISTOCHEM CYTOCHEM, V44, P289
   Hagen C, 2014, ULTRAMICROSCOPY, V146, P46, DOI 10.1016/j.ultramic.2014.05.009
   Hobot J A, 1991, Scanning Microsc Suppl, V5, pS27
   Humbel B., 1986, SCI BIOL SPECIMEN PR, P175
   Humbel BM, 1983, BEDO, V16, P585
   Humbel BM, 1998, MICROSC RES TECHNIQ, V42, P43, DOI 10.1002/(SICI)1097-0029(19980701)42:1<43::AID-JEMT6>3.0.CO;2-S
   Humbel B.M., 1989, IMMUNOGOLD LABELING, P115
   Humbel B.M., 2008, HDB CRYOPREPARATION, P320
   Husain M., 2011, MICROSC MICROANAL, V17, P242
   Iijima H., 2010, GORD RES C 3DEM IL C
   Iijima H, 2014, J STRUCT BIOL, V185, P107, DOI 10.1016/j.jsb.2013.10.018
   JONES S, 1982, J CLIN PATHOL, V35, P425, DOI 10.1136/jcp.35.4.425
   Karreman MA, 2012, J STRUCT BIOL, V180, P382, DOI 10.1016/j.jsb.2012.09.002
   Karreman MA, 2009, BIOL CELL, V101, P287, DOI 10.1042/BC20080076
   Kinoshita T, 2014, MICROSC MICROANAL, V20, P470, DOI 10.1017/S1431927614000178
   Kukulski W, 2012, METHOD CELL BIOL, V111, P235, DOI 10.1016/B978-0-12-416026-2.00013-3
   Kurth T, 1996, CELL TISSUE RES, V286, P1, DOI 10.1007/s004410050669
   Kushida H., 1963, J ELECTRON MICROSC, V12, P71
   LENNETTE DA, 1978, AM J CLIN PATHOL, V69, P647
   Liv N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055707
   LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409
   Manninen A, 2005, MOL CELL BIOL, V25, P10087, DOI 10.1128/MCB.25.22.10087-10096.2005
   MAUPINSZAMIER P, 1978, J CELL BIOL, V77, P837, DOI 10.1083/jcb.77.3.837
   Meisslitzer-Ruppitsch C, 2009, J MICROSC-OXFORD, V235, P322, DOI 10.1111/j.1365-2818.2009.03220.x
   Meisslitzer-Ruppitsch C, 2008, HISTOCHEM CELL BIOL, V130, P407, DOI 10.1007/s00418-008-0429-4
   Mironov AA, 2008, METHOD CELL BIOL, V88, P83, DOI 10.1016/S0091-679X(08)00405-6
   Moemer W. E., 1999, SCIENCE, V283, P1670
   Moor H., 1987, CRYOTECHNIQUES BIOL, P175
   Muller M., 1984, SCI BIOL SPECIMEN PR, P131
   Muller M., 1980, P 7 EUR C EL MICR HA, P720
   NEWMAN GR, 1987, J HISTOCHEM CYTOCHEM, V35, P971
   Newman G.R., 2001, RESIN MICROSCOPY ON
   Oberti D, 2011, FRONT NEUROSCI, V5, P1
   OSBORN M, 1978, J CELL BIOL, V77, pR27, DOI 10.1083/jcb.77.3.R27
   OTTEN MT, 1992, SCANNING, V14, P282
   Paez-Segala M.G., 2014, NAT METHODS
   Peddie CJ, 2014, METHOD CELL BIOL, V124, P363, DOI 10.1016/B978-0-12-801075-4.00017-3
   Peddie C.J., 2014, ULTRAMICROSCOPY
   Perkovic M, 2014, J STRUCT BIOL, V186, P205, DOI 10.1016/j.jsb.2014.03.018
   Pluk H, 2009, J MICROSC-OXFORD, V233, P353, DOI 10.1111/j.1365-2818.2009.03140.x
   Pohl K, 1998, MICROSC RES TECHNIQ, V42, P59
   Riehle U., 1968, VITRIFIZIERUNG VERDU
   RODRIGUEZ J, 1960, VIROLOGY, V12, P316, DOI 10.1016/0042-6822(60)90205-1
   ROSENBERG M, 1960, J ULTRA MOL STRUCT R, V4, P298, DOI 10.1016/S0022-5320(60)80024-X
   ROTH J, 1981, J HISTOCHEM CYTOCHEM, V29, P663
   Roudeau S, 2014, ANAL BIOANAL CHEM, V406, P6979, DOI 10.1007/s00216-014-8004-4
   Sartori A, 2005, MICROSC MICROANAL, V11, P16
   Schwarz H, 2014, METHODS MOL BIOL, V1117, P559, DOI 10.1007/978-1-62703-776-1_25
   SCHWARZ H, 1989, SCANNING MICROSCOPY, P57
   Schwarz H, 1998, ELECTRON MICROSCOPY 1998, VOL 4, P865
   Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041
   Smith EA, 2014, ULTRAMICROSCOPY, V143, P33, DOI 10.1016/j.ultramic.2013.10.013
   Solomonov I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05987
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   STAUBLI W, 1963, J CELL BIOL, V16, P197, DOI 10.1083/jcb.16.1.197
   Stierhof Y.-D., 2008, HDB CRYOPREPARATION, P588
   Stierhof Y.-D., 2008, HDB CRYOPREPARATION, P343
   STINCHCOMBE JC, 1995, J CELL BIOL, V131, P1387, DOI 10.1083/jcb.131.6.1387
   STUDER D, 1995, J MICROSC-OXFORD, V179, P321
   Studer D, 1996, J STRUCT BIOL, V117, P81, DOI 10.1006/jsbi.1996.0073
   Takado Y, 2015, NANOMED-NANOTECHNOL, V11, P239, DOI 10.1016/j.nano.2014.09.007
   Takizawa T, 2003, PLACENTA, V24, P557, DOI 10.1053/plac.2002.0942
   Takizawa Toshihiro, 2004, Journal of Nippon Medical School, V71, P306, DOI 10.1272/jnms.71.306
   TIMMS BG, 1986, AM J ANAT, V175, P267, DOI 10.1002/aja.1001750211
   TOKUYASU KT, 1976, J CELL BIOL, V71, P894, DOI 10.1083/jcb.71.3.894
   TOKUYASU KT, 1981, P NATL ACAD SCI-BIOL, V78, P7619, DOI 10.1073/pnas.78.12.7619
   VANHARRE.A, 1965, J CELL BIOL, V25, P117, DOI 10.1083/jcb.25.1.117
   Wang WJ, 2013, NAT CELL BIOL, V15, P591, DOI 10.1038/ncb2739
   Watanabe S, 2012, METHOD CELL BIOL, V111, P283, DOI 10.1016/B978-0-12-416026-2.00015-7
   WEBSTER RE, 1978, EXP CELL RES, V117, P47, DOI 10.1016/0014-4827(78)90426-3
   WENDT-GALLITELLI M F, 1980, Scanning Electron Microscopy, P499
   WHITE DL, 1976, BIOCHIM BIOPHYS ACTA, V436, P577, DOI 10.1016/0005-2736(76)90442-9
   Wilke K, 2008, EXP DERMATOL, V17, P73, DOI 10.1111/j.1600-0625.2007.00635.x
   Yakushevska AE, 2007, J STRUCT BIOL, V159, P381, DOI 10.1016/j.jsb.2007.04.006
   ZIEROLD K, 1982, SCAN ELECTRON MICROS, P1205
   Zonnevylle A.C., 2013, J MICROSC-OXFORD, V252, P48
   Zuber B, 2006, J BACTERIOL, V188, P6652, DOI 10.1128/JB.00391-06
NR 148
TC 2
Z9 2
U1 22
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 98
EP 110
DI 10.1016/j.abb.2015.05.017
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700012
ER

PT J
AU Do, M
   Isaacson, SA
   McDermott, G
   Le Gros, MA
   Larabell, CA
AF Do, Myan
   Isaacson, Samuel A.
   McDermott, Gerry
   Le Gros, Mark A.
   Larabell, Carolyn A.
TI Imaging and characterizing cells using tomography
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Correlated; Cryogenic; Fluorescence; Microscopy; Modeling; Nucleus; Soft
   X-ray tomography
ID X-RAY TOMOGRAPHY; DNA-BINDING SITES; ELECTRON TOMOGRAPHY; BIOLOGICAL
   SPECIMENS; SPATIAL-RESOLUTION; LIGHT-MICROSCOPY; CORRELATED LIGHT;
   RECONSTRUCTION; MOLECULES; FLUORESCENCE
AB We can learn much about cell function by imaging and quantifying sub-cellular structures, especially if this is done non-destructively without altering said structures. Soft X-ray tomography (SXT) is a high-resolution imaging technique for visualizing cells and their interior structure in 3D. A tomogram of the cell, reconstructed from a series of 2D projection images, can be easily segmented and analyzed. SXT has a very high specimen throughput compared to other high-resolution structure imaging modalities; for example, tomographic data for reconstructing an entire eukaryotic cell is acquired in a matter of minutes. SXT visualizes cells without the need for chemical fixation, dehydration, or staining of the specimen. As a result, the SXT reconstructions are close representations of cells in their native state. SXT is applicable to most cell types. The deep penetration of soft X-rays allows cells, even mammalian cells, to be imaged without being sectioned. Image contrast in SXT is generated by the differential attenuation soft X-ray illumination as it passes through the specimen. Accordingly, each voxel in the tomographic reconstruction has a measured linear absorption coefficient (LAC) value. LAC values are quantitative and give rise to each sub-cellular component having a characteristic LAC profile, allowing organelles to be identified and segmented from the milieu of other cell contents. In this chapter, we describe the fundamentals of SXT imaging and how this technique can answer real world questions in the study of the nucleus. We also describe the development of correlative methods for the localization of specific molecules in a SXT reconstruction. The combination of fluorescence and SXT data acquired from the same specimen produces composite 3D images, rich with detailed information on the inner workings of cells. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Do, Myan; McDermott, Gerry; Le Gros, Mark A.; Larabell, Carolyn A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.
   [Do, Myan; McDermott, Gerry; Le Gros, Mark A.; Larabell, Carolyn A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Natl Ctr Xray Tomog, Berkeley, CA 94720 USA.
   [Do, Myan; McDermott, Gerry; Le Gros, Mark A.; Larabell, Carolyn A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.
   [Isaacson, Samuel A.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA.
RP Larabell, CA (reprint author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.
EM Carolyn.Larabell@ucsf.edu
OI Isaacson, Samuel/0000-0002-7543-8619
FU US Department of Energy, Office of Biological and Environmental Research
   [DE-AC02-05CH11231]; National Center for Research Resources of the
   National Institutes of Health [P41RR019664]; National Institutes of
   General Medicine of the National Institutes of Health [GM63948]; Gordon
   and Betty Moore Foundation [3497]; NSF [DMS-0920886, DMS-1255408]
FX This work was supported by the US Department of Energy, Office of
   Biological and Environmental Research (DE-AC02-05CH11231), the National
   Center for Research Resources of the National Institutes of Health
   (P41RR019664), the National Institutes of General Medicine of the
   National Institutes of Health (GM63948), and the Gordon and Betty Moore
   Foundation (3497). S.A.I. was supported by NSF DMS-0920886 and NSF
   DMS-1255408. S.A.I. also thanks Dr. Larabell and The National Center for
   X-ray Tomography for hosting him during his fall 2014 sabbatical.
CR Wolf D, 2014, ULTRAMICROSCOPY, V136, P15, DOI 10.1016/j.ultramic.2013.07.016
   Le Gros MA, 2005, CURR OPIN STRUC BIOL, V15, P593, DOI 10.1016/j.sbi.2006.08.008
   Smith EA, 2014, BIOPHYS J, V107, P1988, DOI 10.1016/j.bpj.2014.09.011
   Weiss D, 2000, ULTRAMICROSCOPY, V84, P185, DOI 10.1016/S0304-3991(00)00034-6
   [Anonymous], 2014, COMPUTATIONAL METHOD
   Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382
   Smith EA, 2013, J STRUCT BIOL, V184, P12, DOI 10.1016/j.jsb.2013.03.006
   Parkinson DY, 2008, J STRUCT BIOL, V162, P380, DOI 10.1016/j.jsb.2008.02.003
   Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043
   Mazzarello P, 1999, NAT CELL BIOL, V1, pE13, DOI 10.1038/8964
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Subramaniam S, 2005, CURR OPIN MICROBIOL, V8, P316, DOI 10.1016/j.mib.2005.04.012
   Duke EMH, 2014, ULTRAMICROSCOPY, V143, P77, DOI 10.1016/j.ultramic.2013.10.006
   DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0
   KIRZ J, 1995, Q REV BIOPHYS, V28, P33
   Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112
   CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119
   Larabell CA, 2010, CURR OPIN STRUC BIOL, V20, P623, DOI 10.1016/j.sbi.2010.08.008
   Parkinson DY, 2012, J STRUCT BIOL, V177, P259, DOI 10.1016/j.jsb.2011.11.027
   Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819
   Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891
   Baumeister W, 1999, TRENDS CELL BIOL, V9, P81, DOI 10.1016/S0962-8924(98)01423-8
   Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106
   Ellisman MH, 2012, METHOD CELL BIOL, V111, P139, DOI 10.1016/B978-0-12-416026-2.00008-X
   Hertz HM, 2012, J STRUCT BIOL, V177, P267, DOI 10.1016/j.jsb.2011.11.015
   Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895
   Le Gros MA, 2009, J MICROSC-OXFORD, V235, P1, DOI 10.1111/j.1365-2818.2009.03184.x
   Hagen C, 2012, J STRUCT BIOL, V177, P193, DOI 10.1016/j.jsb.2011.12.012
   Chao WL, 2005, NATURE, V435, P1210, DOI 10.1038/nature03719
   Tsien RY, 2005, FEBS LETT, V579, P927, DOI 10.1016/j.febslet.2004.11.025
   Legall H, 2012, OPT EXPRESS, V20, P18362, DOI 10.1364/OE.20.018362
   Falcone R, 2011, CONTEMP PHYS, V52, P293, DOI 10.1080/00107514.2011.589662
   Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343
   McDermott G, 2012, ANNU REV PHYS CHEM, V63, P225, DOI 10.1146/annurev-physchem-032511-143818
   Attwood D., 1999, SOFT XRAYS EXTREME U
   Attwood D, 2006, J BIOMED NANOTECHNOL, V2, P75, DOI 10.1166/jbn.2006.011
   BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028
   Berglund M., 1998, REV SCI INSTRUM, V69, P2362
   Bertilson MC, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2842422
   Briggs JAG, 2012, MOL BIOL CELL, V23, P979, DOI 10.1091/mbc.E11-12-0971
   Carzaniga R, 2014, PROTOPLASMA, V251, P449, DOI 10.1007/s00709-013-0583-y
   Cinquin BP, 2014, J CELL BIOCHEM, V115, P209, DOI 10.1002/jcb.24658
   Denbeaux G, 2001, NUCL INSTRUM METH A, V467, P841, DOI 10.1016/S0168-9002(01)00480-6
   Isaacson SA, 2013, B MATH BIOL, V75, P2093, DOI 10.1007/s11538-013-9883-9
   Isaacson SA, 2011, P NATL ACAD SCI USA, V108, P3815, DOI 10.1073/pnas.1018821108
   Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42
   Larabell C, 2004, BIOPHYS J, V86, p185A
   Le Gros MA, 2014, J SYNCHROTRON RADIAT, V21, P1370, DOI 10.1107/S1600577514015033
   Le Gros M. A., 2012, COMPREHENSIVE BIOPHY, P90
   Leis A., 2005, MICROSC MICROANAL, V11
   McDermott G, 2012, BIOESSAYS, V34, P320, DOI 10.1002/bies.201100125
   Natterer F., 2001, MATH METHODS IMAGE R
   Natterer F., 1986, MATH COMPUTERIZED TO
   Parkinson Dilworth Y, 2013, Methods Mol Biol, V950, P457, DOI 10.1007/978-1-62703-137-0_25
   Patwardhan A, 2014, NAT STRUCT MOL BIOL, V21, P841, DOI 10.1038/nsmb.2897
   Radon J., 1917, MATH PHYS KLASSE, V69, P262
   Roukos V, 2014, HISTOCHEM CELL BIOL, V142, P125, DOI 10.1007/s00418-014-1239-5
   Sakdinawat A, 2007, OPT LETT, V32, P2635, DOI 10.1364/OL.32.002635
   Smith E. A., 2014, IMAGING LIFE BIOL SY
   Smith EA, 2014, ULTRAMICROSCOPY, V143, P33, DOI 10.1016/j.ultramic.2013.10.013
   Tsien RY, 2003, NAT CELL BIOL, pSS16, DOI 10.1038/nrm1196
   Uchida M, 2011, YEAST, V28, P227, DOI 10.1002/yea.1834
   Weiss D, 2001, NUCL INSTRUM METH A, V467, P1308, DOI 10.1016/S0168-9002(01)00648-9
NR 63
TC 3
Z9 3
U1 22
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 111
EP 121
DI 10.1016/j.abb.2015.01.011
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700013
PM 25602704
ER

PT J
AU Rigort, A
   Plitzko, JM
AF Rigort, Alexander
   Plitzko, Juergen M.
TI Cryo-focused-ion-beam applications in structural biology
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE In situ thinning; Cryo-lamella preparation; Frozen-hydrated cells;
   Electron cryo-tomography; Cryo-FIB; Volume imaging; FIB/SEM tomography
ID TRANSMISSION ELECTRON-MICROSCOPY; CRYOELECTRON TOMOGRAPHY; IN-SITU;
   FLUORESCENCE MICROSCOPY; CELLS; SPECIMENS; SECTIONS; RECONSTRUCTION;
   ORGANIZATION; PROSPECTS
AB The ability to precisely control the preparation of biological samples for investigations by electron cryo-microscopy is becoming increasingly important for ultrastructural imaging in biology. Precision machining instruments such as the focused ion beam microscope (FIB) were originally developed for applications in materials science. However, today we witness a growing use of these tools in the life sciences mainly due to their versatility, since they can be used both as manipulation and as imaging devices, when complemented with a scanning electron microscope (SEM). The advent of cryo-preparation equipment and accessories made it possible to pursue work on frozen-hydrated biological specimens with these two beam (FIB/SEM) instruments. In structural biology, the cryo-FIB can be used to site-specifically thin vitrified specimens for transmission electron microscopy (TEM) and tomography. Having control over the specimen thickness is a decisive factor for TEM imaging, as the thickness of the object under scrutiny determines the attainable resolution. Besides its use for TEM preparation, the FIB/SEM microscope can be additionally used to obtain three-dimensional volumetric data from biological specimens. The unique combination of an imaging and precision manipulation tool allows sequentially removing material with the ion beam and imaging the milled block faces by scanning with the electron beam, an approach known as FIB/SEM tomography. This review covers both fields of cryo-FIB applications: specimen preparation for TEM cryo-tomography and volume imaging by cryo-FIB/SEM tomography. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Rigort, Alexander; Plitzko, Juergen M.] Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany.
   [Rigort, Alexander] Zeiss Microscopy, Adv Dev, D-07745 Jena, Germany.
   [Plitzko, Juergen M.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands.
RP Rigort, A (reprint author), Zeiss Microscopy, Adv Dev, Carl Zeiss Promenade 10, D-07745 Jena, Germany.
EM rigort@biochem.mpg.de
CR van Driel LF, 2009, EUR J CELL BIOL, V88, P669, DOI 10.1016/j.ejcb.2009.07.002
   Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008
   OVERWIJK MHF, 1993, J VAC SCI TECHNOL B, V11, P2021, DOI 10.1116/1.586537
   Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109
   Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344
   Schwartz CL, 2007, J MICROSC-OXFORD, V227, P98, DOI 10.1111/j.1365-2818.2007.01794.x
   Wang K, 2012, J STRUCT BIOL, V180, P318, DOI 10.1016/j.jsb.2012.07.003
   Kaufmann R, 2014, NANO LETT, V14, P4171, DOI 10.1021/nl501870p
   Brandt F, 2010, MOL CELL, V39, P560, DOI 10.1016/j.molcel.2010.08.003
   Pierson J, 2010, J STRUCT BIOL, V169, P219, DOI 10.1016/j.jsb.2009.10.001
   Pierson J, 2011, J STRUCT BIOL, V173, P345, DOI 10.1016/j.jsb.2010.09.017
   Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345
   Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105
   Ziegler JF, 2010, NUCL INSTRUM METH B, V268, P1818, DOI 10.1016/j.nimb.2010.02.091
   de Winter DAM, 2013, J STRUCT BIOL, V183, P11, DOI 10.1016/j.jsb.2013.05.016
   Sartori A, 2007, J STRUCT BIOL, V160, P135, DOI 10.1016/j.jsb.2007.07.011
   Hayles MF, 2010, J STRUCT BIOL, V172, P180, DOI 10.1016/j.jsb.2010.07.004
   Briggs JAG, 2013, CURR OPIN STRUC BIOL, V23, P261, DOI 10.1016/j.sbi.2013.02.003
   Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006
   MCDOWALL AW, 1983, J MICROSC-OXFORD, V131, P1
   Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016
   Rigort A, 2010, J STRUCT BIOL, V172, P169, DOI 10.1016/j.jsb.2010.02.011
   Kizilyaprak C, 2014, J MICROSC-OXFORD, V254, P109, DOI 10.1111/jmi.12127
   Al-Amoudi A, 2005, J STRUCT BIOL, V150, P109, DOI 10.1016/j.jsb.2005.01.003
   Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102
   Reyntjens S, 2001, J MICROMECH MICROENG, V11, P287, DOI 10.1088/0960-1317/11/4/301
   Hsieh C, 2014, J STRUCT BIOL, V185, P32, DOI 10.1016/j.jsb.2013.10.019
   Al-Amoudi A, 2007, NATURE, V450, P832, DOI 10.1038/nature05994
   Giannuzzi LA, 1999, MICRON, V30, P197, DOI 10.1016/S0968-4328(99)00005-0
   Rigort A, 2012, METHOD CELL BIOL, V111, P259, DOI 10.1016/B978-0-12-416026-2.00014-5
   Schertel A, 2013, J STRUCT BIOL, V184, P355, DOI 10.1016/j.jsb.2013.09.024
   Rigort A, 2012, P NATL ACAD SCI USA, V109, P4449, DOI 10.1073/pnas.1201333109
   Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014
   Yahav T, 2011, CURR OPIN STRUC BIOL, V21, P670, DOI 10.1016/j.sbi.2011.07.004
   Rubino S, 2012, J STRUCT BIOL, V180, P572, DOI 10.1016/j.jsb.2012.08.012
   Schur FKM, 2013, J STRUCT BIOL, V184, P394, DOI 10.1016/j.jsb.2013.10.015
   Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929
   Hsieh CE, 2006, J STRUCT BIOL, V153, P1, DOI 10.1016/j.jsb.2005.10.004
   Marko M, 2006, J MICROSC-OXFORD, V222, P42, DOI 10.1111/j.1365-2818.2006.01567.x
   Lucic V, 2013, J CELL BIOL, V202, P407, DOI 10.1083/jcb.201304193
   Hayles MF, 2007, J MICROSC-OXFORD, V226, P263, DOI 10.1111/j.1365-2818.2007.01775.x
   Villa E, 2013, CURR OPIN STRUC BIOL, V23, P771, DOI 10.1016/j.sbi.2013.08.006
   Chang YW, 2014, NAT METHODS, V11, P737, DOI [10.1038/nmeth.2961, 10.1038/NMETH.2961]
   Ballerini M., 2001, FOCUSED ION BEAM TEC
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129
   Forster F., 2012, COMPREHENSIVE BIOPHY, P245
   Giannuzzi L. A., 2005, INTRO FOCUSED ION BE
   Harapin J, 2013, STRUCTURE, V21, P1522, DOI 10.1016/j.str.2013.08.003
   Holzer L., 2012, NANOFABRICATION USIN, P410
   Kaufmann R, 2014, CURR OPIN CHEM BIOL, V20, P86, DOI [10.1016/j.cbpa.2014.05.007, 10.1016/j:cbpa.2014.05.007]
   Kirk E.C.G., 1989, I PHYS C SER, V100, P501
   Lau Wilson C Y, 2013, Methods Mol Biol, V955, P401, DOI 10.1007/978-1-62703-176-9_22
   Merchan-Perez A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.018.2009
   Mulders H., 2003, GIT IMAGING MICROSC, V2, P8
   Steven AC, 2008, J STRUCT BIOL, V163, P186, DOI 10.1016/j.jsb.2008.06.002
   Volkert CA, 2007, MRS BULL, V32, P389, DOI 10.1557/mrs2007.62
   Yao N, 2007, FOCUSED ION BEAM SYS
NR 57
TC 1
Z9 1
U1 28
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2015
VL 581
SI SI
BP 122
EP 130
DI 10.1016/j.abb.2015.02.009
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CP9BC
UT WOS:000360187700014
PM 25703192
ER

PT J
AU Chinnadurai, RK
   Saravanaraman, P
   Boopathy, R
AF Chinnadurai, Raj Kumar
   Saravanaraman, Ponne
   Boopathy, Rathanam
TI Understanding the molecular mechanism of aryl acylamidase activity of
   acetylcholinesterase - An in silico study
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Acetylcholinesterase; Aryl acylamidase; o-Nitroacetanilide;
   o-Nitrotrifluoroacetanilide; Side door; Steered molecular dynamics
ID TORPEDO-CALIFORNICA; LIGAND INTERACTIONS; DYNAMICS; SITE;
   CHOLINESTERASES; SIMULATION; DISEASE
AB Acetylcholinesterase (AChE) exhibits two different activities, namely esterase and aryl acylamidase (AAA). Unlike esterase, AAA activity of AChE is inhibited by the active site inhibitors while remaining unaffected by the peripheral anionic site inhibitors. This differential inhibitory pattern of active and peripheral anionic site inhibitors on the AAA activity remains unanswered. To answer this, we investigated the mechanism of binding and trafficking of AAA substrates using in silico tools. Molecular docking of serotonin and AAA substrates (o-nitroacetanilide, and o-nitrotrifluoroacetanilide,) onto AChE shows that these compounds bind at the side door of AChE. Thus, we conceived that the AAA substrates prefer the side door to reach the active site for their catalysis. Further, steered molecular dynamics simulations show that the force required for binding and trafficking of the AAA substrate through the side door is comparatively lesser than their dissociation (900 kJ/mol/nm). Among the two substrates, o-nitrotrifluoroacetanilide required lesser force (380 kJ/mol/nm) than o-nitroacetanilide the (550 kJ/mol/nm) for its binding, thus validating o-nitrotrifluoroacetanilide as a better substrate. With these observations, we resolve that the AAA activity of AChE is mediated through its side door. Therefore, binding of PAS inhibitors at the main door of AChE remain ineffective against AAA activity. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Chinnadurai, Raj Kumar; Saravanaraman, Ponne; Boopathy, Rathanam] Bharathiar Univ, Dept Biotechnol, Coimbatore 641046, Tamil Nadu, India.
RP Boopathy, R (reprint author), Bharathiar Univ, Dept Biotechnol, Coimbatore 641046, Tamil Nadu, India.
EM boopathybiotech@gmail.com
FU DST-PURSE; Department of Science and Technology, Government of India
FX RKC acknowledges the research fellowship provided by DST-PURSE. PS is
   thankful to DST-INSPIRE for her research fellowship provided by the
   Department of Science and Technology, Government of India.
CR Allebrandt K.V., 2005, CHEM-BIOL INTERACT, V157-158, P353
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Kryger G, 2000, ACTA CRYSTALLOGR D, V56, P1385, DOI 10.1107/S0907444900010659
   GILSON MK, 1994, SCIENCE, V263, P1276, DOI 10.1126/science.8122110
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005
   Darvesh S, 2006, BIOORGAN MED CHEM, V14, P4586, DOI 10.1016/j.bmc.2006.02.021
   Koellner G, 2000, J MOL BIOL, V296, P713, DOI 10.1006/jmbi.1999.3468
   Lindahl E, 2001, J MOL MODEL, V7, P306
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m
   BALASUBRAMANIAN AS, 1993, FASEB J, V7, P1354
   Berendsen H., 1981, INTERMOLECULAR FORCE, V331, P331
   Boopathy R, 2004, PROTEIN J, V23, P325, DOI 10.1023/B:JOPC.0000032652.99257.19
   Costagli C, 1998, BIOCHEM PHARMACOL, V55, P1733, DOI 10.1016/S0006-2952(97)00676-X
   Enyedy IJ, 1998, J AM CHEM SOC, V120, P8043, DOI 10.1021/ja973131h
   Eswar N., 2001, CURRENT PROTOCOLS PR
   Felder CE, 2002, ACTA CRYSTALLOGR D, V58, P1765, DOI 10.1107/S0907444902011642
   FUJIMOTO D, 1976, FEBS LETT, V71, P121, DOI 10.1016/0014-5793(76)80912-X
   GEORGE ST, 1980, EUR J BIOCHEM, V111, P511, DOI 10.1111/j.1432-1033.1980.tb04967.x
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679
   Wiesner J, 2010, J BIOMOL STRUCT DYN, V28, P393
   Wlodek ST, 1997, J AM CHEM SOC, V119, P9513, DOI 10.1021/ja971226d
   WRIGHT CI, 1993, P NATL ACAD SCI USA, V90, P683, DOI 10.1073/pnas.90.2.683
NR 27
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 1
EP 13
DI 10.1016/j.abb.2015.06.002
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700001
PM 26072115
ER

PT J
AU Karabina, A
   Kazmierczak, K
   Szczesna-Cordary, D
   Moore, JR
AF Karabina, Anastasia
   Kazmierczak, Katarzyna
   Szczesna-Cordary, Danuta
   Moore, Jeffrey R.
TI Myosin regulatory light chain phosphorylation enhances cardiac
   beta-myosin in vitro motility under load
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Hypertrophic cardiomyopathy; Regulatory light chain phosphorylation;
   Cardiac ventricular myosin; Load dependence
ID FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HEAVY-CHAIN; MUSCLE CONTRACTION;
   RLC PHOSPHORYLATION; SARCOMERIC PROTEINS; CA2+ BINDING; HUMAN HEART;
   MUTATIONS; FIBERS; EXPRESSION
AB Familial hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy and myofibrillar disarray, and often results in sudden cardiac death. Two HCM mutations, N47K and R58Q are located in the myosin regulatory light chain (RLC). The RLC mechanically stabilizes the myosin lever arm, which is crucial to myosin's ability to transmit contractile force. The N47K and R58Q mutations have previously been shown to reduce actin filament velocity under load, stemming from a more compliant lever arm (Greenberg, 2010). In contrast, RLC phosphorylation was shown to impart stiffness to the myosin lever arm (Greenberg, 2009). We hypothesized that phosphorylation of the mutant HCM-RLC may mitigate distinct mutation-induced structural and functional abnormalities. In vitro motility assays were utilized to investigate the effects of RLC phosphorylation on the HCM-RLC mutant phenotype in the presence of an alpha-actinin frictional load. Porcine cardiac beta-myosin was depleted of its native RLC and reconstituted with mutant or wild-type human RLC in phosphorylated or non-phosphorylated form. Consistent with previous findings, in the presence of load, myosin bearing the HCM mutations reduced actin sliding velocity compared to WT resulting in 31-41% reductions in force production. Myosin containing phosphorylated RLC (WT or mutant) increased sliding velocity and also restored mutant myosin force production to near WT unphosphorylated values. These results point to RLC phosphorylation as a general mechanism to increase force production of the individual myosin motor and as a potential target to ameliorate the HCM-induced phenotype at the molecular level. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Karabina, Anastasia; Moore, Jeffrey R.] Boston Univ, Dept Physiol & Biophys, Sch Med, Boston, MA 02215 USA.
   [Kazmierczak, Katarzyna; Szczesna-Cordary, Danuta] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.
RP Moore, JR (reprint author), Univ Massachusetts, Dept Biol Sci, 198 Riverside St, Lowell, MA 01854 USA.
EM Jeffrey_Moore@uml.edu
FU American Heart Association [12PRE11910009]; National Institutes of
   Health [NIH- HL071778, HL108343, HL077280]
FX The authors thank Dr. Priya Muthu for her expert help with experiments
   and insightful discussions. This work was supported by American Heart
   Association Grant 12PRE11910009 (AK), and National Institutes of Health
   Grants NIH- HL071778 & HL108343 (DSC) and HL077280 (JM).
CR Alpert NR, 2002, AM J PHYSIOL-HEART C, V283, pH1446, DOI 10.1152/ajpheart.00274.2002
   Alpert NR, 2005, AM J PHYSIOL-HEART C, V288, pH1097, DOI 10.1152/ajpheart.00650.2004
   Andersen P S, 2001, J Med Genet, V38, pE43, DOI 10.1136/jmg.38.12.e43
   Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202
   Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5
   Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54
   Scruggs SB, 2010, MOL CELL PROTEOMICS, V9, P1804, DOI 10.1074/mcp.M110.000075
   Abraham TP, 2009, CARDIOVASC RES, V82, P84, DOI 10.1093/cvr/cvp016
   Greenberg MJ, 2010, CYTOSKELETON, V67, P273, DOI 10.1002/cm.20441
   Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050
   Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499
   Frey N, 2012, NAT REV CARDIOL, V9, P91, DOI 10.1038/nrcardio.2011.159
   Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687
   Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897
   SPUDICH JA, 1971, J BIOL CHEM, V246, P4866
   Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011
   Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085
   Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200
   Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001
   Chang AN, 2010, J BIOL CHEM, V285, P5122, DOI 10.1074/jbc.C109.076489
   Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200
   Miyata S, 2000, CIRC RES, V86, P386
   CHANG KC, 1993, J CELL SCI, V106, P331
   FITZSIMONS DP, 1990, J APPL PHYSIOL, V69, P305
   Greenberg MJ, 2010, P NATL ACAD SCI USA, V107, P17403, DOI 10.1073/pnas.1009619107
   Greenberg MJ, 2009, J MOL CELL CARDIOL, V46, P108, DOI 10.1016/j.yjmcc.2008.09.126
   Greenberg MJ, 2009, AM J PHYSIOL-REG I, V297, pR265, DOI 10.1152/ajpregu.00171.2009
   Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200
   Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020
   JAENICKE T, 1990, GENOMICS, V8, P194, DOI 10.1016/0888-7543(90)90272-V
   Kabaeva ZT, 2002, EUR J HUM GENET, V10, P741, DOI 10.1038/sj.ejhg.5200872
   Kerrick WGL, 2009, FASEB J, V23, P855, DOI 10.1096/fj.08-118182
   Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842
   Moore JR, 2004, J MUSCLE RES CELL M, V25, P29, DOI 10.1023/B:JURE.0000021394.48560.71
   MORANO I, 1995, ACTA PHYSIOL SCAND, V154, P343, DOI 10.1111/j.1748-1716.1995.tb09918.x
   MORANO I, 1992, BASIC RES CARDIOL, V87, P129
   Muthu P, 2012, J CELL MOL MED, V16, P911, DOI 10.1111/j.1582-4934.2011.01371.x
   Muthu P, 2014, ARCH BIOCHEM BIOPHYS, V552, P29, DOI 10.1016/j.abb.2013.12.011
   NGAI PK, 1984, BIOCHEM J, V218, P863
   Pant K., 2009, FASEB J
   RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857
   Richard P, 2004, CIRCULATION, V109, P3258
   Stelzer JE, 2006, J GEN PHYSIOL, V128, P261, DOI 10.1085/jgp.200609547
   SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657
   Szczesna-Cordary D, 2004, J BIOL CHEM, V279, P3535, DOI 10.1074/jbc.M307092200
   Toepfer C, 2013, J BIOL CHEM, V288, P13446, DOI 10.1074/jbc.M113.455444
   Wang Y, 2006, J MOL BIOL, V361, P286, DOI 10.1016/j.jmb.2006.06.018
   Wang YH, 2014, J MOL CELL CARDIOL, V72, P231, DOI 10.1016/j.yjmcc.2014.03.022
NR 48
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 14
EP 21
DI 10.1016/j.abb.2015.06.014
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700002
PM 26116789
ER

PT J
AU Raczynski, P
   Raczynska, V
   Gorny, K
   Gburski, Z
AF Raczynski, Przemyslaw
   Raczynska, Violetta
   Gorny, Krzysztof
   Gburski, Zygmunt
TI Properties of ultrathin cholesterol and phospholipid layers surrounding
   silicon-carbide nanotube: MD simulations
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Molecular dynamics; Silicon-carbide nanotube; Carbon nanotube;
   Cholesterol; Phospholipid; Thin film
ID CARBON NANOTUBES; MOLECULAR-DYNAMICS; DRUG-DELIVERY; MICE; MEMBRANES;
   AGENTS; CELLS; WATER
AB Computer simulation technique was used to study the dynamics of cholesterol and POPC phospholipid molecules forming a thin layer on the surface of the carbon and silicon-carbide nanotubes. Each nanotube was surrounded by an ultra-thin film formed by n lipid molecules, where n varies from 15 to 50. All studies were done for five temperatures, including physiological one (T = 260, 285, 310, 335 and 360 K). The influence of a nanotube on the dynamics of cholesterol or phospholipid molecules in a layer is presented and discussed. The water is ubiquitous in all biological milieus, where the cholesterol or lipids occur. Thus, simulations were performed in a water environment. Moreover, to show different behavior of lipids in systems with water the results were compared with the samples without it. The dynamical and structural observables, such as the mean square displacement, diffusion coefficient, radial distribution function, and activation energy were calculated to qualitatively investigate the behavior of cholesterol and phospholipid molecules in the layers. We observed remarkable differences between the cholesterol dynamics depending whether the ultrathin film surrounds carbon or silicon-carbide nanotube and whether the water environment appeared. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Raczynski, Przemyslaw; Raczynska, Violetta; Gorny, Krzysztof; Gburski, Zygmunt] Univ Silesia, Inst Phys, PL-40007 Katowice, Poland.
RP Raczynski, P (reprint author), Univ Silesia, Inst Phys, Uniwersytecka 4, PL-40007 Katowice, Poland.
EM przemyslaw.raczynski@us.edu.pl
FU computational center at ICM University of Warsaw-Poland [G53-6]
FX We appreciate the computational center at ICM University of
   Warsaw-Poland, Grant No. G53-6, for CPU time allocation.
CR Alberts B, 2008, MOL BIOL CELL
   Allen M. P., 1989, COMPUTER SIMULATION
   Henin J, 2006, CHEM PHYS LETT, V425, P329, DOI 10.1016/j.cplett.2006.04.115
   Alexiadis A, 2008, CHEM REV, V108, P5014, DOI 10.1021/cr078140f
   Feller SE, 2000, CURR OPIN COLLOID IN, V5, P217, DOI 10.1016/S1359-0294(00)00058-3
   Bhirde AA, 2009, ACS NANO, V3, P307, DOI 10.1021/nn800551s
   Mavrandonakis A, 2003, NANO LETT, V3, P1481, DOI 10.1021/nl0343250
   Ziemys A, 2009, J NANOSCI NANOTECHNO, V9, P6349, DOI 10.1166/jnn.2009.1822
   Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843
   Saito N, 2009, CHEM SOC REV, V38, P1897, DOI 10.1039/b804822n
   Keren S, 2008, P NATL ACAD SCI USA, V105, P5844, DOI 10.1073/pnas.0710575105
   Pogodin S, 2010, ACS NANO, V4, P5293, DOI 10.1021/nn1016549
   Zhang Y, 2010, DRUG DISCOV TODAY, V15, P428, DOI 10.1016/j.drudis.2010.04.005
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Battigelli A, 2013, ADV DRUG DELIVER REV, V65, P1899, DOI 10.1016/j.addr.2013.07.006
   Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203
   Delogu LG, 2012, P NATL ACAD SCI USA, V109, P16612, DOI 10.1073/pnas.1208312109
   Lu FS, 2009, ADV MATER, V21, P139, DOI 10.1002/adma.200801491
   Lopez CF, 2004, P NATL ACAD SCI USA, V101, P4431, DOI 10.1073/pnas.0400352101
   Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241
   De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231
   Welsher K, 2011, P NATL ACAD SCI USA, V108, P8943, DOI 10.1073/pnas.1014501108
   Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.006
   Tong L, 2012, NAT NANOTECHNOL, V7, P56, DOI [10.1038/nnano.2011.210, 10.1038/NNANO.2011.210]
   Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201
   Brfinger A., 1984, CHEM PHYS LETT, V105, P495, DOI [http://dx.doLorg/10.1016/0009-2614(84)80098-6, DOI 10.1016/0009-2614(84)80098-6]
   Cal D., 2005, NAT METHODS, V2, P449, DOI [http://dx.doi.org/10.1038/nmeth761, DOI 10.1038/NMETH761]
   Capaldi F. M., 2011, J NANOMATER, V2011, DOI http://dx.doi.org/10.1155/2011/830436
   Cox M.M., 2013, LEHNINGER PRINCIPLES
   Dai Y, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/38/385402
   Gburski Z, 2010, SOLID STATE COMMUN, V150, P415, DOI 10.1016/j.ssc.2009.12.005
   Lopez CF, 2005, BIOPHYS J, V88, P3083, DOI 10.1529/biophysj.104.053769
   MacKerell D. Bashford, 1998, J PHYS CHEM B, V102, P3586
   Moradi Garakani F., 2012, INT J NANO DIM, V2, P151
   Raczynski P, 2014, J PHYS CHEM C, V118, P30115, DOI 10.1021/jp505532f
   Raczynski P, 2013, COMP MATER SCI, V70, P13, DOI 10.1016/j.commatsci.2012.12.031
   Raczynski P., PERSP NAN NAN ACT MA, P141
   Raczynski P, 2007, BIOMOL ENG, V24, P572, DOI 10.1016/j.bioeng.2007.08.010
   Rapaport D. C., 2004, ART MOL DYNAMICS SIM
   Scott HL, 2002, CURR OPIN STRUC BIOL, V12, P495, DOI 10.1016/S0959-440X(02)00353-6
   Wallace EJ, 2008, NANO LETT, V8, P2751, DOI 10.1021/nl801217f
   Zhang LY, 2015, RSC ADV, V5, P11776, DOI 10.1039/c4ra16944a
NR 44
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 22
EP 30
DI 10.1016/j.abb.2015.06.008
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700003
PM 26113257
ER

PT J
AU Farhan, M
   Zafar, A
   Chibber, S
   Khan, HY
   Arif, H
   Hadi, SM
AF Farhan, Mohd
   Zafar, Atif
   Chibber, Sandesh
   Khan, Husain Yar
   Arif, Hussain
   Hadi, S. M.
TI Mobilization of copper ions in human peripheral lymphocytes by catechins
   leading to oxidative DNA breakage: A structure activity study
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Catechin; Epicatechin; Epigallocatechin; Epigallocatechin-3-gallate;
   Comet assay; Structure activity relationship; Molecular docking; ITC;
   Galloyl moieties
ID CELLULAR-DNA; PLANT POLYPHENOLS; ENDOGENOUS COPPER; ANTICANCER
   MECHANISM; PUTATIVE MECHANISM; TANNIC-ACID; APOPTOSIS; CU(II); CANCER;
   CELLS
AB Epidemiological studies suggest that dietary consumption of plant polyphenols is related to a lower incidence of various cancers. Among these compounds catechins (present in green tea and other beverages) are considered to be potent inducers of apoptosis and cytotoxicity to cancer cells. Thus these compounds can be used as leads to synthesize novel anticancer drugs with greater bioavailability. In view of this in this paper we have examined the chemical basis of cytotoxicity of catechins by studying the structure-activity relationship between catechin (C), epicatechin (EC), epigallocatechin (EGC) and epigallocatechin-3-gallate (EGCG). Using single cell alkaline gel electrophoresis (comet assay) we have established the relative efficiency of cellular DNA breakage as EGCG > EGC > EC > C. We also show that cellular DNA breakage is the result of mobilization of copper ions bound to chromatin and the generation of reactive oxygen species. Further the relative DNA binding affinity order was confirmed using molecular docking and thermodynamic studies by studying the interaction of catechins with calf thymus DNA. The results suggest that the synthesis of any novel anti cancer molecule based on the structure of catechins should have as many galloyl moieties as possible resulting in an increased number of hydroxyl groups that may facilitate the binding of the molecule to cellular DNA. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Farhan, Mohd; Zafar, Atif; Chibber, Sandesh; Khan, Husain Yar; Arif, Hussain; Hadi, S. M.] Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh 202002, Uttar Pradesh, India.
RP Hadi, SM (reprint author), Aligarh Muslim Univ, Dept Biochem, Fac Life Sci, Aligarh 202002, Uttar Pradesh, India.
EM smhadi@vsnl.com
CR Ahsan H, 1998, CANCER LETT, V124, P23, DOI 10.1016/S0304-3835(97)00442-4
   Hanif S, 2008, TOXICOLOGY, V249, P19, DOI 10.1016/j.tox.2008.03.024
   Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008
   Clement MV, 1998, BLOOD, V92, P996
   Thomasset SC, 2007, INT J CANCER, V120, P451, DOI 10.1002/ijc.22419
   Jaruga E, 1998, FEBS LETT, V433, P287, DOI 10.1016/S0014-5793(98)00919-3
   Hou DX, 2003, INT J ONCOL, V23, P705
   Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0
   Khan HY, 2014, MOL NUTR FOOD RES, V58, P437, DOI 10.1002/mnfr.201300417
   Asad SF, 2001, CHEM-BIOL INTERACT, V137, P59, DOI 10.1016/S0009-2797(01)00209-5
   BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403
   AHMAD MS, 1992, CARCINOGENESIS, V13, P605, DOI 10.1093/carcin/13.4.605
   Burkitt MJ, 1996, BIOCHEM J, V313, P163
   Khan HY, 2011, BIOMETALS, V24, P1169, DOI 10.1007/s10534-011-9475-9
   Yang GY, 1998, CARCINOGENESIS, V19, P611, DOI 10.1093/carcin/19.4.611
   Cemeli E, 2004, ENVIRON MOL MUTAGEN, V44, P420, DOI 10.1002/em.20071
   Hadi SM, 2010, PHARM RES-DORDR, V27, P979, DOI 10.1007/s11095-010-0055-4
   Ullah MF, 2013, CELL BIOCHEM BIOPHYS, V67, P431, DOI 10.1007/s12013-011-9303-4
   Czene S, 1997, BIOCHEM J, V323, P337
   BHAT R, 1994, MUTAT RES-ENVIR MUTA, V313, P39, DOI 10.1016/0165-1161(94)90031-0
   POOLZOBEL BL, 1993, FOOD CHEM TOXICOL, V31, P271, DOI 10.1016/0278-6915(93)90077-C
   Ahmad A, 2000, CANCER LETT, V154, P29, DOI 10.1016/S0304-3835(00)00351-7
   KAGAWA TF, 1991, J BIOL CHEM, V266, P20175
   Ullah MF, 2009, MOL NUTR FOOD RES, V53, P1376, DOI 10.1002/mnfr.200800547
   Shamim U, 2008, FREE RADICAL RES, V42, P764, DOI 10.1080/10715760802302251
   ROGULJIC A, 1980, CANCER, V46, P565, DOI 10.1002/1097-0142(19800801)46:3<565::AID-CNCR2820460324>3.0.CO;2-N
   Kuo HW, 2002, BIOL TRACE ELEM RES, V89, P1, DOI 10.1385/BTER:89:1:1
   Khan HY, 2012, CURR DRUG TARGETS, V13, P1738
   Hadi SM, 2007, SEMIN CANCER BIOL, V17, P370, DOI 10.1016/j.semcancer.2007.04.002
   Ahmad N, 1997, J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   RAHMAN A, 1990, CARCINOGENESIS, V11, P2001, DOI 10.1093/carcin/11.11.2001
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   PRYOR WA, 1988, FREE RADICAL BIO MED, V4, P219, DOI 10.1016/0891-5849(88)90043-3
   Hadi SM, 2000, IUBMB LIFE, V50, P167, DOI 10.1080/152165400300001471
   Long LH, 2000, BIOCHEM BIOPH RES CO, V273, P50, DOI 10.1006/bbrc.2000.2895
   Ullah MF, 2011, MOL NUTR FOOD RES, V55, P553, DOI 10.1002/mnfr.201000329
   Zuo XL, 2006, BIOL TRACE ELEM RES, V114, P41, DOI 10.1385/BTER:114:1:41
   Nakayama T, 2012, J FOOD DRUG ANAL, V20, P305
   Azmi S., 2006, FEBS LETT, V580, P533
   Bryan SE, 1979, METAL IONS BIOL SYST
   Gupte R.J., 2009, CANC TREAT REV, V35, P32
   INOUE M, 1994, BIOCHEM BIOPH RES CO, V204, P898, DOI 10.1006/bbrc.1994.2544
   Khan NS, 1998, MUTAGENESIS, V13, P271, DOI 10.1093/mutage/13.3.271
   Peng C., 1995, J COMPUT CHEM, V16, P49
   Rogers E., 1993, CARCINOGENESIS, V14, P2205
   Uekusa Y., 2011, BIOCHIM BIOPHYS ACTA, V1808, P1654
   Zubair H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.172
NR 48
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 31
EP 40
DI 10.1016/j.abb.2015.06.019
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700004
PM 26142371
ER

PT J
AU Martin, GG
   Atshaves, BP
   Landrock, KK
   Landrock, D
   Schroeder, F
   Kier, AB
AF Martin, Gregory G.
   Atshaves, Barbara P.
   Landrock, Kerstin K.
   Landrock, Danilo
   Schroeder, Friedhelm
   Kier, Ann B.
TI Loss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation
   in female mice
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE L-FABP; SCP-2; SCP-x; Gene ablation
ID ACID-BINDING-PROTEIN; STEROL CARRIER PROTEIN-2; FATTY LIVER-DISEASE;
   L-CELL FIBROBLASTS; ACYL-COA TRANSACYLATION; RAT-LIVER; T94A VARIANT;
   NONALCOHOLIC STEATOHEPATITIS; COENZYME-A; PPAR-ALPHA
AB Although roles for both sterol carrier protein-2/sterol carrier protein-x (SCP-2/SCP-x) and liver fatty acid binding protein (L-FABP) have been proposed in hepatic lipid accumulation, individually ablating these genes has been complicated by concomitant alterations in the other gene product(s). For example, ablating SCP2/SCP-x induces upregulation of L-FABP in female mice. Therefore, the impact of ablating SCP-2/SCP-x (DKO) or L-FABP (LKO) individually or both together (TKO) was examined in female mice. Loss of SCP-2/SCP-x (DKO, TKO) more so than loss of L-FABP alone (LKO) increased hepatic total lipid and total cholesterol content, especially cholesteryl ester. Hepatic accumulation of nonesterified long chain fatty acids (LCFA) and phospholipids occurred only in DKO and TKO mice. Loss of SCP-2/SCP-x (DKO, TKO) increased serum total lipid primarily by increasing triglycerides. Altered hepatic level of proteins involved in cholesterol uptake, efflux, and/or secretion was observed, but did not compensate for the loss of L-FABP, SCP-2/SCP-x or both. However, synergistic responses were not seen with the combinatorial knock out animals suggesting that inhibiting SCP-2/SCP-x is more correlative with hepatic dysfunction than L-FABP. The DKO- and TKO-induced hepatic accumulation of cholesterol and long chain fatty acids shared significant phenotypic similarities with non-alcoholic fatty liver disease (NAFLD). (C) 2015 Elsevier Inc. All rights reserved.
C1 [Martin, Gregory G.; Schroeder, Friedhelm] Texas A&M Univ, Dept Physiol & Pharmacol, College Stn, TX 77843 USA.
   [Atshaves, Barbara P.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
   [Landrock, Kerstin K.; Landrock, Danilo; Kier, Ann B.] Texas A&M Univ, Dept Pathobiol, College Stn, TX 77843 USA.
RP Kier, AB (reprint author), Texas A&M Univ, Dept Pathobiol, TAMU 4467, College Stn, TX 77843 USA.
EM akier@cvm.tamu.edu
FU United States Public Health Service, National Institutes of Health
   [DK41402, DK70965]
FX This work was supported in part by the United States Public Health
   Service, National Institutes of Health Grants DK41402 (F.S. and A.B.K.)
   and DK70965 (B.P.A).
CR McIntosh AL, 2014, AM J PHYSIOL-GASTR L, V307, pG164, DOI 10.1152/ajpgi.00369.2013
   Chao H, 2003, J LIPID RES, V44, P72, DOI 10.1194/jlr.M200191-JLR200
   Fuchs M, 2001, J BIOL CHEM, V276, P48058, DOI 10.1074/jbc.M106732200
   Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714
   Yan J, 2009, J LIPID RES, V50, P2445, DOI 10.1194/jlr.M900177-JLR200
   Murphy EJ, 1998, AM J PHYSIOL-GASTR L, V275, pG244
   Adida A, 2002, PROSTAG LEUKOTR ESS, V67, P91, DOI 10.1054/plef.404
   Atshaves BP, 2004, J LIPID RES, V45, P812, DOI 10.1194/jlr.M300408-JLR200
   Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005
   Ellinghaus P, 1999, J BIOL CHEM, V274, P2766, DOI 10.1074/jbc.274.5.2766
   Atshaves BP, 2004, J BIOL CHEM, V279, P30954, DOI 10.1074/jbc.M313571200
   Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7
   Quiroga AD, 2012, BBA-MOL CELL BIOL L, V1821, P762, DOI 10.1016/j.bbalip.2011.09.007
   Atshaves BP, 2001, J BIOL CHEM, V276, P25324, DOI 10.1074/jbc.M100560200
   Murphy EJ, 1997, BBA-LIPID LIPID MET, V1345, P283, DOI 10.1016/S0005-2760(97)00003-9
   Frolov A, 1997, BIOCHEMISTRY-US, V36, P6545, DOI 10.1021/bi970205t
   Thigpen JE, 1999, LAB ANIM SCI, V49, P530
   Newberry EP, 2008, AM J PHYSIOL-GASTR L, V294, pG307, DOI 10.1152/ajpgi.00377.2007
   Huang H, 2014, FEBS J, V281, P2266, DOI 10.1111/febs.12780
   Brouillette C, 2004, J HUM GENET, V49, P424, DOI 10.1007/s10038-004-0171-2
   Atshaves BP, 2009, J LIPID RES, V50, P1429, DOI 10.1194/jlr.M900020-JLR200
   Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763
   Stolowich NJ, 1997, BIOCHEMISTRY-US, V36, P1719, DOI 10.1021/bi962317a
   Wiegman CH, 2003, DIABETES, V52, P1081, DOI 10.2337/diabetes.52.5.1081
   Wang GQ, 2007, EUR J PHARMACOL, V560, P61, DOI 10.1016/j.ejphar.2007.01.015
   Wang GQ, 2005, HEPATOLOGY, V42, P871, DOI 10.1002/hep.20857
   Stolowich NJ, 2002, CELL MOL LIFE SCI, V59, P193, DOI 10.1007/s00018-002-8416-8
   Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200
   Wolfrum C, 1999, J LIPID RES, V40, P708
   Wanders RJA, 1997, BIOCHEM BIOPH RES CO, V236, P565, DOI 10.1006/bbrc.1997.7007
   GAVEY KL, 1981, J BIOL CHEM, V256, P2993
   Hanhoff T, 2005, EUR J LIPID SCI TECH, V107, P716, DOI 10.1002/ejit.200401076
   Ferdinandusse S, 2006, AM J HUM GENET, V78, P1046, DOI 10.1086/503921
   Atshaves BP, 2007, J LIPID RES, V48, P2193, DOI 10.1194/jlr.M700102-JLR200
   Huang H, 2015, BBA-MOL CELL BIOL L, V1851, P946, DOI 10.1016/j.bbalip.2015.02.015
   Chen AP, 2013, HEPATOLOGY, V57, P2202, DOI 10.1002/hep.26318
   BORDEWICK U, 1989, BIOL CHEM H-S, V370, P229, DOI 10.1515/bchm3.1989.370.1.229
   Vluggens A, 2012, CURR DRUG METAB, V13, P1422
   PROWS DR, 1995, LIPIDS, V30, P907, DOI 10.1007/BF02537481
   Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016
   Martin GG, 2008, BIOCHEMISTRY-US, V47, P5915, DOI 10.1021/bi800251e
   Xie Y, 2009, J LIPID RES, V50, P977, DOI 10.1194/jlr.M800645-JLR200
   NEMECZ G, 1991, J BIOL CHEM, V266, P17180
   Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283
   Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229
   Gariani K, 2013, DIABETES METAB, V39, P16, DOI 10.1016/j.diabet.2012.11.002
   Martin GG, 2009, AM J PHYSIOL-GASTR L, V297, pG1053, DOI 10.1152/ajpgi.00116.2009
   Baumgardner JN, 2008, AM J PHYSIOL-GASTR L, V294, pG27, DOI 10.1152/ajpgi.00296.2007
   COLLES SM, 1995, LIPIDS, V30, P795, DOI 10.1007/BF02533954
   KAWATA S, 1991, CLIN CHIM ACTA, V197, P201, DOI 10.1016/0009-8981(91)90140-8
   McIntosh AL, 2009, ARCH BIOCHEM BIOPHYS, V485, P160, DOI 10.1016/j.abb.2009.03.004
   Jensen-Urstad APL, 2012, BBA-MOL CELL BIOL L, V1821, P747, DOI 10.1016/j.bbalip.2011.09.017
   Charlton M, 2009, HEPATOLOGY, V49, P1375, DOI 10.1002/hep.22927
   Murphy EJ, 1996, BBA-LIPID LIPID MET, V1301, P191, DOI 10.1016/0005-2760(96)00024-0
   Stolowich N, 1999, J BIOL CHEM, V274, P35425, DOI 10.1074/jbc.274.50.35425
   Chao H, 1999, BBA-MOL CELL BIOL L, V1439, P371, DOI 10.1016/S1388-1981(99)00109-2
   SEEDORF U, 1994, J BIOL CHEM, V269, P21277
   Fisher E, 2007, MOL GENET METAB, V91, P278, DOI 10.1016/j.ymgme.2007.03.002
   Higuchi N, 2011, EXP THER MED, V2, P1077, DOI 10.3892/etm.2011.328
   Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5
   Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200
   Martin GG, 2013, BIOCHEMISTRY-US, V52, P9347, DOI 10.1021/bi401014k
   Seedorf U, 1998, GENE DEV, V12, P1189, DOI 10.1101/gad.12.8.1189
   Peng XE, 2012, GENE, V500, P54, DOI 10.1016/j.gene.2012.03.050
   JEFFERSON JR, 1991, J BIOL CHEM, V266, P5486
   Anstee QM, 2011, BBA-MOL BASIS DIS, V1812, P1557, DOI 10.1016/j.bbadis.2011.07.017
   Atshaves BP, 1999, J LIPID RES, V40, P610
   Atshaves B.P., 2007, AM J PHYSIOL, V292, P939
   Bu LM, 2011, DIABETES RES CLIN PR, V92, P82, DOI 10.1016/j.diabres.2011.01.005
   BURNETT DA, 1979, GASTROENTEROLOGY, V77, P241
   Chao H., 2002, WILEY ENCY MOL MED, P44
   Chao H, 2002, BIOCHEMISTRY-US, V41, P10540, DOI 10.1021/bi0259498
   Fan WJ, 2013, J INORG BIOCHEM, V124, P46, DOI 10.1016/j.jinorgbio.2013.03.015
   Frolov A, 1998, J BIOL CHEM, V273, P11049, DOI 10.1074/jbc.273.18.11049
   Frolov A, 1996, J BIOL CHEM, V271, P31878
   Gossett RE, 1998, ARCH BIOCHEM BIOPHYS, V350, P201, DOI 10.1006/abbi.1997.0521
   Guzman C, 2013, BBA-MOL CELL BIOL L, V1831, P803, DOI 10.1016/j.bbalip.2012.12.014
   Hinsdale ME, 2002, J LIPID RES, V43, P1520, DOI 10.1194/jlr.M200103-JLR200
   Hostetler HA, 2011, MOL CELL BIOCHEM, V355, P135, DOI 10.1007/s11010-011-0847-9
   HUBBELL T, 1994, BIOCHEMISTRY-US, V33, P3327, DOI 10.1021/bi00177a025
   JAMDAR SC, 1979, ARCH BIOCHEM BIOPHYS, V195, P81, DOI 10.1016/0003-9861(79)90329-1
   Jolly CA, 1997, ARCH BIOCHEM BIOPHYS, V341, P112, DOI 10.1006/abbi.1997.9957
   Jolly CA, 2000, BBA-MOL CELL BIOL L, V1483, P185, DOI 10.1016/S1388-1981(99)00170-5
   Jolly CA, 1998, BBA-LIPID LIPID MET, V1390, P258, DOI 10.1016/S0005-2760(97)00186-0
   Kannan L, 2003, BBA-MOL CELL BIOL L, V1631, P12, DOI 10.1016/S1388-1981(02)00367-0
   Mansego ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031853
   Martin GG, 2014, AM J PHYSIOL-GASTR L, V307, pG1130, DOI 10.1152/ajpgi.00209.2014
   MARZO A, 1971, CLIN CHEM, V17, P145
   MISHKIN S, 1974, BIOCHEM BIOPH RES CO, V60, P376
   Moncecchi DM, 1991, PHYSL BIOCH STEROLS, P1
   Murphy EJ, 2000, J LIPID RES, V41, P788
   Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193
   Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473
   Paz-Filho Gilberto, 2013, J Mol Endocrinol, V51, P167, DOI 10.1530/JME-13-0072
   Rajaraman G, 2007, MOL CELL BIOCHEM, V295, P27, DOI 10.1007/s11010-006-9268-6
   RICHIERI GV, 1994, J BIOL CHEM, V269, P23918
   Robitaille J, 2004, MOL GENET METAB, V82, P296, DOI 10.1016/j.ymgme.2004.06.002
   Rolf B, 1995, BBA-LIPID LIPID MET, V1259, P245, DOI 10.1016/0005-2760(95)00170-0
   SCHROEDER F, 1998, INTR CHOL TRAFF, P213
   Schroeder F, 1998, CHEM PHYS LIPIDS, V92, P1, DOI 10.1016/S0009-3084(98)00003-6
   Smathers RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038459
   Starodub O, 2000, AM J PHYSIOL-CELL PH, V279, pC1259
   Storey S.M., 2010, AM J PHYSIOL, V299, P244
   Thigpen JE, 1999, ENVIRON HEALTH PERSP, V107, pA182, DOI 10.2307/3434577
   Tian YY, 2015, LIPIDS, V50, P275, DOI 10.1007/s11745-015-3990-3
   Weikert M. O., 2007, AM J PHYSIOL-ENDOC M, V293, pE1078
   Yamada Y, 2008, INT J MOL MED, V21, P801
   Yan J, 2010, J LIPID RES, V50, P2445
   YANG SY, 1987, J BIOL CHEM, V262, P13027
NR 109
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 41
EP 49
DI 10.1016/j.abb.2015.06.009
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700005
PM 26116377
ER

PT J
AU Weiss, PHE
   Alvares, ACM
   Gomes, AA
   Miletti, LC
   Skoronski, E
   da Silva, GF
   de Freitas, SM
   Magalhaes, MLB
AF Weiss, Paulo H. E.
   Alvares, Alice C. M.
   Gomes, Anderson A.
   Miletti, Luiz C.
   Skoronski, Everton
   da Silva, Gustavo F.
   de Freitas, Sonia M.
   Magalhaes, Maria L. B.
TI Beta glucosidase from Bacillus polymyxa is activated by
   glucose-6-phosphate
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE BGLA; Bioethanol; Enzyme activation; Enzyme kinetics; Fluorescence
   spectroscopy
ID PRODUCT INHIBITION; HYDROLYSIS; PURIFICATION; CELLULASES; TOLERANCE;
   CELLULOSE; INSIGHTS; BIOMASS
AB Optimization of cellulose enzymatic hydrolysis is crucial for cost effective bioethanol production from lignocellulosic biomass. Enzymes involved in cellulose hydrolysis are often inhibited by their end-products, cellobiose and glucose. Efforts have been made to produce more efficient enzyme variants that are highly tolerant to product accumulation; however, further improvements are still necessary. Based on an alternative approach we initially investigated whether recently formed glucose could be phosphorylated into glucose-6-phosphate to circumvent glucose accumulation and avoid inhibition of beta-glucosidase from Bacillus polymyxa (BGLA). The kinetic properties and structural analysis of BGLA in the presence of glucose-6-phosphate (G6P) were investigated. Kinetic studies demonstrated that enzyme was not inhibited by G6P. In contrast, the presence of G6P activated the enzyme, prevented beta glucosidase feedback inhibition by glucose accumulation and improved protein stability. G6P binding was investigated by fluorescence quenching experiments and the respective association constant indicated high affinity binding of G6P to BGLA. Data reported here are of great impact for future design strategies for second-generation bioethanol production. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Weiss, Paulo H. E.; Miletti, Luiz C.; da Silva, Gustavo F.; Magalhaes, Maria L. B.] Univ Estado Santa Catarina, Ctr Agrovet Sci, Dept Food & Anim Prod, Biochem Lab, BR-88520000 Lages, Santa Catarina, Brazil.
   [Alvares, Alice C. M.; de Freitas, Sonia M.] Univ Brasilia, Dept Cellular Biol, Biophys Lab, BR-70910900 Brasilia, DF, Brazil.
   [Gomes, Anderson A.; Skoronski, Everton] Univ Estado Santa Catarina, Ctr Agrovet Sci, Dept Environm Engn, Water Treatment Lab, BR-88520000 Lages, Santa Catarina, Brazil.
RP Magalhaes, MLB (reprint author), Univ Estado Santa Catarina, Dept Food & Anim Prod, 2090 Luiz de Camoes, BR-88520000 Lages, SC, Brazil.
EM maria.magalhaes@udesc.br
RI Miletti, Luiz/C-6949-2008
OI Miletti, Luiz/0000-0001-5926-0286
FU State University of Santa Catarina (UDESC); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a
   Pesquisa do Distrito Federal (FAP-DF); Financiadora de Estudos e
   Projetos (FINEP)
FX The authors received financial support from the State University of
   Santa Catarina (UDESC), Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Distrito Federal
   (FAP-DF) and Financiadora de Estudos e Projetos (FINEP).
CR Rajasree KP, 2013, J IND MICROBIOL BIOT, V40, P967, DOI 10.1007/s10295-013-1291-5
   Thongpoo P, 2014, BIOSCI BIOTECH BIOCH, V78, P1167, DOI 10.1080/09168451.2014.915727
   Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012
   Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8
   Hu YJ, 2004, ACTA CHIM SINICA, V62, P1519
   de Giuseppe PO, 2014, ACTA CRYSTALLOGR D, V70, P1631, DOI 10.1107/S1399004714006920
   Hardiman E, 2010, APPL BIOCHEM BIOTECH, V161, P301, DOI 10.1007/s12010-009-8794-6
   Xiao ZZ, 2004, APPL BIOCHEM BIOTECH, V113, P1115
   Liu WJ, 2009, BIOTECHNOL BIOENG, V103, P1087, DOI 10.1002/bit.22340
   Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007
   Haggag WM, 2008, J APPL MICROBIOL, V104, P961, DOI 10.1111/j.1365-2672.2007.03611.x
   Bezerra RMF, 2011, APPL BIOCHEM BIOTECH, V165, P178, DOI 10.1007/s12010-011-9242-y
   Borak B, 2013, CURR OPIN BIOTECH, V24, P369, DOI 10.1016/j.copbio.2013.02.018
   Du FY, 2010, APPL BIOCHEM BIOTECH, V161, P313, DOI 10.1007/s12010-009-8796-4
   Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, Vthird
   Leskovac V., 2003, COMPREHENSIVE ENZYME
   Murphy L, 2013, ENZYME MICROB TECH, V52, P163, DOI 10.1016/j.enzmictec.2013.01.002
   Olofsson K, 2008, BIOTECHNOL BIOFUELS, V1, P1, DOI DOI 10.1186/1754-6834-1-7.PMCID:PMC2397418
   Olsen S. N., 2014, APPL BIOCH BIOTECHNO
   PAINBENI E, 1992, J BACTERIOL, V174, P3087
   Prawitwong P, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-184
   Preedy VR, 2014, HANDBOOK OF NUTRITION, DIET, AND THE EYE, pXIX
   Sanz-Aparicio J, 1998, J MOL BIOL, V275, P491, DOI 10.1006/jmbi.1997.1467
   Segel I. H., 1975, ENZYME KINETICS, P227
   Sørensen Annette, 2013, Biomolecules, V3, P612, DOI 10.3390/biom3030612
   Tabacchioni S., 2009, INDIAN J MICROBIOL, V49, P2
   Yu WL, 2013, J BIOL CHEM, V288, P14949, DOI 10.1074/jbc.M113.454751
   Yue Zhao, 2004, Sci China C Life Sci, V47, P18
NR 28
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 50
EP 56
DI 10.1016/j.abb.2015.06.012
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700006
PM 26116788
ER

PT J
AU Ishida, T
   Yamaguchi, T
   Takechi, S
AF Ishida, Takumi
   Yamaguchi, Tadatoshi
   Takechi, Shinji
TI 3-Hydro-2,2,5,6-tetramethylpyrazine: A novel inducer of zinc
   transporter-1 in HepG2 human hepatocellular carcinoma cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Zinc transporter-1; Induction; Metal-responsive transcription factor 1;
   Oxidative stress; Glycation product; 3-Hydro-2,2,5,6-tetramethylpyrazine
ID TRANSCRIPTION FACTOR-I; GLYCATION END-PRODUCTS; OXIDATIVE STRESS; FACTOR
   MTF-1; POSSIBLE INVOLVEMENT; METALLOTHIONEIN; BINDING; DIHYDROPYRAZINES;
   GENE; SPECIFICITY
AB Dihydropyrazine compounds, including 3-hydro-2,2,5,6-tetramethylpyrazine (DHP-3), are low-molecular-weight glycation products spontaneously generated in vivo and also ingested via food. Our preliminary study using microarray analysis demonstrated that DHP-3 induced zinc transporter-1 (ZnT-1) in HepG2 cells. It is well known that the increase of intracellular zinc is a sensitive stimulating factor for ZnT-1 protein induction; however, there is little information about the induction of ZnT-1 by low-molecular-weight chemical compounds. Here, we attempted to clarify the mechanism of ZnT-1 induction by DHP-3. A significant increase of ZnT-1 mRNA was observed 6 h after DHP-3 treatment at concentrations over 0.5 mM, and disappeared 24 h after exposure. This induction pattern followed that of metal-responsive transcription factor 1 (MTF-1) mRNA, a metalloregulatory protein that serves as a major transcription factor of ZnT-1. Moreover, DHP-3 yielded transcriptional activation of MTF-1 in a luciferase reporter assay. The intracellular zinc content was unaffected by the compound; however, oxidative stress was observed in cells under the same conditions that activated the MTF-1 signaling pathway. These results suggest that DHP-3 is a novel ZnT-1 inducer and acts via activation of the MTF-1 signaling pathway. Additionally, the activation of MTF-1 by this compound likely occurs through oxidative stress. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ishida, Takumi; Yamaguchi, Tadatoshi; Takechi, Shinji] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Kumamoto 8600082, Japan.
RP Ishida, T (reprint author), Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan.
EM ishida@ph.sojo-u.ac.jp; ta-yamaguchi@jcom.home.ne.jp;
   stakechi@ph.sojo-u.ac.jp
FU Japan Society for the Promotion of Science [23590160]
FX The study was a part supported by a Grant-in-Aid for Scientific Research
   (C) (No. 23590160) from Japan Society for the Promotion of Science.
CR Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200
   Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081
   Zhang B, 2003, MOL CELL BIOL, V23, P8471, DOI 10.1128/MCB.23.23.8471-8485.2003
   Niwa T, 1997, J CLIN INVEST, V99, P1272, DOI 10.1172/JCI119285
   PALMITER RD, 1995, EMBO J, V14, P639
   Li JL, 2012, J NEUROL SCI, V317, P1, DOI 10.1016/j.jns.2012.02.018
   Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854
   Dalton TP, 1996, J BIOL CHEM, V271, P26233
   WESTIN G, 1988, EMBO J, V7, P3763
   RADTKE F, 1993, EMBO J, V12, P1355
   POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505
   Chen XH, 1999, BIOCHEMISTRY-US, V38, P12915, DOI 10.1021/bi9913000
   Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052
   Wang ZQ, 2012, ATHEROSCLEROSIS, V221, P387, DOI 10.1016/j.atherosclerosis.2012.01.019
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9
   Bittel DC, 2000, J BIOL CHEM, V275, P37194, DOI 10.1074/jbc.M003863200
   Daniels PJ, 2002, NUCLEIC ACIDS RES, V30, P3130, DOI 10.1093/nar/gkf432
   He JL, 2014, EUR FOOD RES TECHNOL, V238, P367, DOI 10.1007/s00217-013-2085-8
   Ishida T, 2014, J TOXICOL SCI, V39, P601
   Ishida T, 2012, J TOXICOL SCI, V37, P1065
   KASHIGE N, 1995, BIOL PHARM BULL, V18, P653
   Kashige N, 2000, BIOL PHARM BULL, V23, P1281
   KENNEDY AL, 1978, BRIT MED J, V2, P1191
   Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146
   GLOMB MA, 1995, J BIOL CHEM, V270, P10017
   Motomiya Y, 1998, KIDNEY INT, V54, P1357, DOI 10.1046/j.1523-1755.1998.00091.x
   Song JM, 2004, CURR EYE RES, V28, P195, DOI 10.1076/ceyr.28.3.195.26251
   Takechia S, 2004, MUTAT RES-GEN TOX EN, V560, P49, DOI 10.1016/j.mrgentox.2004.02.007
   TATSUMI T, 1994, J MOL CELL CARDIOL, V26, P471, DOI 10.1006/jmcc.1994.1058
   Teixeira PC, 2001, BIOL CHEM, V382, P913, DOI 10.1515/BC.2001.113
   Xiao WS, 2015, TOXICOL LETT, V233, P258, DOI 10.1016/j.toxlet.2015.02.005
   Yamaguchi T, 1998, TETRAHEDRON LETT, V39, P8311, DOI 10.1016/S0040-4039(98)01859-0
   Yamaguchi T, 1996, BIOL PHARM BULL, V19, P1261
NR 34
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 57
EP 63
DI 10.1016/j.abb.2015.07.002
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700007
PM 26145010
ER

PT J
AU Wang, G
   Wang, JJ
   Tang, HM
   To, SST
AF Wang, Gang
   Wang, Jun Jie
   Tang, Hong Ming
   To, Shing Shun Tony
TI Targeting strategies on miRNA-21 and PDCD4 for glioblastoma
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Glioblastoma; miRNA; Oncogenes; Apoptosis; Resistance; Signaling
   pathways
ID TUMOR-SUPPRESSOR PDCD4; NUCLEAR RIBONUCLEOPROTEIN C1/C2; GLIOMA-CELL
   GROWTH; NF-KAPPA-B; DOWN-REGULATION; TRANSFORMATION SUPPRESSOR;
   OVARIAN-CANCER; IN-VITRO; SYNERGISTIC INHIBITION; COLORECTAL-CANCER
AB MicroRNAs (miRNAs) are often deregulated in glioblastoma multiforme (GBM). Downregulation of microRNA-21 (miR-21), especially in GBM, is responsible for increased apoptosis, decreased cell proliferation and invasion, increased GO/G1 cell cycle arrest, and reduced chemotherapeutic resistance to doxorubicin. Furthermore, it is a critical regulator of multiple downstream genes and signaling pathways involved in gliomagenesis. Programmed cell death 4 (PDCD4) is critical in mediating apoptosis in GBM, and is downregulated by miR-21, which may mediate the resistance of glioblastoma cells against chemotherapy or radiation via its target genes PDCD4. Evidence is mounting that how alterations of these miRNAs transcription factors provide initiation, maintenance, or progression of tumors. This review will focus on the roles of miRNAs family members (particularly miR-21 and its target gene PDCD4) in tumors like glioblastoma and new targeting strategies, as examples some new targeting therapeutic methods and molecular mechanisms of signal pathways in glioblastoma therapeutics, to give the reader the current trends of approach to target regulation of these miRNA and genes for future glioma therapies. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Wang, Gang; Wang, Jun Jie] Shanghai Eighth Peoples Hosp, Dept Pharmaceut, Shanghai 200235, Peoples R China.
   [Wang, Gang; Tang, Hong Ming] Tongji Univ, Sch Med, Shanghai East Hosp, Shanghai 200000, Peoples R China.
   [To, Shing Shun Tony] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China.
RP Wang, G (reprint author), Shanghai Eighth Peoples Hosp, Dept Pharmaceut, Shanghai 200235, Peoples R China.
EM wangan139@163.com
CR Allgayer H., 2009, CRIT REV ONCOL HEMAT, V73, P185
   Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72
   Zhang J, 2012, BRIT J CANCER, V107, P352, DOI 10.1038/bjc.2012.251
   Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001
   Chan JK, 2014, GYNECOL ONCOL, V132, P739, DOI 10.1016/j.ygyno.2014.01.034
   Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126
   Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469
   Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24
   Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9
   Shi L, 2010, BRAIN RES, V1352, P255, DOI 10.1016/j.brainres.2010.07.009
   Fu JS, 2013, NEURO-ONCOLOGY, V15, P691, DOI 10.1093/neuonc/not011
   Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041
   Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579
   Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086
   Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117
   Goke R, 2004, ANN NY ACAD SCI, V1014, P220, DOI 10.1196/annals.1294.024
   Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620
   Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918
   Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200
   Ren WH, 2014, MOL CELL BIOCHEM, V390, P253, DOI 10.1007/s11010-014-1976-8
   Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856
   Wang J, 2012, BASIC CLIN PHARMACOL, V111, P106, DOI 10.1111/j.1742-7843.2012.00870.x
   Kohanbash G, 2012, SEMIN CANCER BIOL, V22, P70, DOI 10.1016/j.semcancer.2011.12.010
   Dong CG, 2012, INT J ONCOL, V41, P1005, DOI 10.3892/ijo.2012.1542
   Qian XM, 2014, BIOMATERIALS, V35, P2322, DOI 10.1016/j.biomaterials.2013.11.039
   Li YN, 2013, BIOCHEM BIOPH RES CO, V441, P661, DOI 10.1016/j.bbrc.2013.10.077
   Wong STS, 2012, ANTICANCER RES, V32, P2835
   Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137
   Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020
   Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028
   Costa PM, 2013, HUM MOL GENET, V22, P904, DOI 10.1093/hmg/dds496
   Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003
   Sintupisut N, 2013, NUCLEIC ACIDS RES, V41, P8803, DOI 10.1093/nar/gkt656
   Costa PM, 2012, HUM MOL GENET, V21, P5118, DOI 10.1093/hmg/dds358
   Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921
   Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037
   Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535
   Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022
   Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033
   Frost EE, 2009, NEUROCHEM RES, V34, P169, DOI 10.1007/s11064-008-9748-z
   Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888
   Mycko MP, 2012, P NATL ACAD SCI USA, V109, pE1248, DOI 10.1073/pnas.1114325109
   Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006
   Tao T, 2013, EUR J CANCER, V49, P3055, DOI 10.1016/j.ejca.2013.05.010
   Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08
   Liu C, 2011, CANCER RES, V71, P5950, DOI 10.1158/0008-5472.CAN-11-1035
   Park YM, 2012, MOL CELL BIOL, V32, P4237, DOI 10.1128/MCB.00443-12
   Griveau A, 2013, INT J PHARMACEUT, V454, P765, DOI 10.1016/j.ijpharm.2013.05.049
   Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004
   Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064
   Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136
   Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045
   Qian XM, 2012, MOL PHARMACEUT, V9, P2636, DOI 10.1021/mp3002039
   Liwak U, 2013, ONCOTARGET, V4, P1365
   Ferraro A, 2014, EPIGENETICS-US, V9, P129, DOI 10.4161/epi.26842
   Christian KJ, 2008, MOL PHARMACOL, V73, P1558, DOI 10.1124/mol.107.042507
   Darido C, 2011, CANCER CELL, V20, P635, DOI 10.1016/j.ccr.2011.10.014
   Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133
   Chen Y, 2008, CANCER LETT, V272, P197, DOI 10.1016/j.canlet.2008.06.034
   Zhang KL, 2014, CANCER LETT, V342, P139, DOI 10.1016/j.canlet.2013.08.043
   Grunder E, 2011, EUR J CANCER, V47, P2479, DOI 10.1016/j.ejca.2011.06.041
   Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102
   Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276
   Koshkin PA, 2014, CLIN CHIM ACTA, V430, P55, DOI 10.1016/j.cca.2014.01.001
   Tomimaru Y, 2010, BRIT J CANCER, V103, P1617, DOI 10.1038/sj.bjc.6605958
   White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173
   ARMSTRONG RC, 1990, J NEUROSCI RES, V27, P400, DOI 10.1002/jnr.490270319
   Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050165
   Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115
   Bradtmoller M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047595
   Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752
   Cartron PF, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.150
   Chao TF, 2013, J HUAZHONG U SCI-MED, V33, P525, DOI 10.1007/s11596-013-1153-4
   Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378
   Echevarria-Vargas IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097094
   Gao F, 2007, ONCOL REP, V17, P123
   Gopinath S, 2009, CELL MOL LIFE SCI, V66, P3967, DOI 10.1007/s00018-009-0157-5
   Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x
   Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191
   Lankat-Buttgereit B, 2004, MOL CELL ENDOCRINOL, V214, P149, DOI 10.1016/j.mce.2003.10.058
   Li HX, 2013, MOL CELL BIOCHEM, V382, P137, DOI 10.1007/s11010-013-1728-1
   Li Y, 2009, BRAIN RES, V1286, P13, DOI 10.1016/j.brainres.2009.06.053
   Liu SG, 2013, ACTA BIOCH BIOPH SIN, V45, P756, DOI 10.1093/abbs/gmt075
   Liwak U, 2012, MOL CELL BIOL, V32, P1818, DOI 10.1128/MCB.06317-11
   Masui K, 2010, GLIA, V58, P1050, DOI 10.1002/glia.20986
   Neyns B., 2011, J NEUROONCOL, V103, P491
   Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI DOI 10.1158/0008-5472.CAN-08-1305
   Ren Y, 2010, J BIOMAT SCI-POLYM E, V21, P303, DOI 10.1163/156856209X415828
   Ren Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-27
   Rozovski U, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-50
   She XL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0892-9
   Shetty S, 2005, MOL CELL BIOCHEM, V272, P107, DOI 10.1007/s11010-005-7644-2
   Shi ZD, 2013, CANCER RES, V73, P5519, DOI 10.1158/0008-5472.CAN-13-0280
   Subedi A, 2013, FEBS LETT, V587, P1556, DOI 10.1016/j.febslet.2013.03.040
   Tergaonkar V, 2007, MOL CELL, V26, P158, DOI 10.1016/j.molcel.2007.04.006
   Thales P., 2008, CANCER RES, V68, P8164
   Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103
   Wang YY, 2012, CNS NEUROSCI THER, V18, P722, DOI 10.1111/j.1755-5949.2012.00349.x
   Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70
   Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137
   Zhou X, 2014, ONCOL REP, V31, P2173, DOI 10.3892/or.2014.3114
   Zhou XA, 2010, ONCOL REP, V24, P195, DOI 10.3892/or_00000846
NR 104
TC 1
Z9 1
U1 15
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 64
EP 74
DI 10.1016/j.abb.2015.07.001
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700008
PM 26142886
ER

PT J
AU Bonke, E
   Zwicker, K
   Drose, S
AF Bonke, Erik
   Zwicker, Klaus
   Droese, Stefan
TI Manganese ions induce H2O2 generation at the ubiquinone binding site of
   mitochondrial complex II
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Mitochondria; Manganese; Reactive oxygen species (ROS); Complex II
   (succinate:ubiquinone oxidoreductase); Superoxide dismutation
ID OXYGEN SPECIES GENERATION; CYTOCHROME BC(1) COMPLEX; REACTIVE OXYGEN;
   SUPEROXIDE-PRODUCTION; SUCCINATE-DEHYDROGENASE; HYDROGEN-PEROXIDE;
   MOLECULAR-MECHANISMS; RESPIRATORY-CHAIN; OXIDATIVE STRESS; ROS
   PRODUCTION
AB Manganese-induced toxicity has been recently associated with an increased ROS generation from mitochondrial complex II (succinate:ubiquinone oxidoreductase). To achieve a deeper mechanistic understanding how divalent manganese ions (Mn2+) could stimulate mitochondrial ROS production we performed investigations with bovine heart submitochondrial particles (SMP). In succinate fueled SMP, the Mn2+ induced hydrogen peroxide (H2O2) production was blocked by the specific complex II ubiquinone binding site (IIQ) inhibitor atpenin A5 while a further downstream block at complex III increased the rate markedly. This suggests that site IIQ was the source of the reactive oxygen species. Moreover, Mn2+ ions also accelerated the rate of superoxide dismutation, explaining the general increase in the measured rates of H2O2 production and an attenuation of direct superoxide detection. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Bonke, Erik; Droese, Stefan] Univ Hosp, Clin Anesthesiol Intens Care Med & Pain Therapy, D-60590 Frankfurt, Germany.
   [Zwicker, Klaus] Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, D-60590 Frankfurt, Germany.
RP Drose, S (reprint author), Univ Hosp, Clin Anesthesiol Intens Care Med & Pain Therapy, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
EM stefan.droese@kgu.de
RI Drose, Stefan/E-4903-2010
OI Drose, Stefan/0000-0002-9361-9034
FU Deutsche Forschungsgemeinschaft [SFB 815]
FX This work was supported by the Deutsche Forschungsgemeinschaft (SFB 815
   project A02). We would like to thank Ilka Siebels and Lars Heerdegen for
   excellent technical assistance and Ulrich Brandt (Radboud University,
   Nijmegen) for critical reading of a primary version of the manuscript
   and helpful discussion.
CR Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181
   Alaimo A, 2013, NEUROSCI LETT, V554, P76, DOI 10.1016/j.neulet.2013.08.061
   Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365
   Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957
   Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013
   Vinogradov AD, 2005, BIOCHEMISTRY-MOSCOW+, V70, P120, DOI 10.1007/s10541-005-0090-7
   FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007
   Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200
   Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160
   Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004
   Owens KM, 2012, FREE RADICAL BIO MED, V52, P160, DOI 10.1016/j.freeradbiomed.2011.10.435
   Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828
   Ishii T, 2011, MITOCHONDRION, V11, P155, DOI 10.1016/j.mito.2010.09.006
   Drose S, 2009, BBA-GEN SUBJECTS, V1790, P558, DOI 10.1016/j.bbagen.2009.01.011
   Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004
   ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2
   Zhang SR, 2003, ENVIRON RES, V93, P149, DOI 10.1016/S0013-9351(03)00109-9
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Culotta VC, 2013, ANTIOXID REDOX SIGN, V19, P933, DOI 10.1089/ars.2012.5093
   Barnese K, 2012, P NATL ACAD SCI USA, V109, P6892, DOI 10.1073/pnas.1203051109
   Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e
   Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025
   MCCORD JM, 1968, J BIOL CHEM, V243, P5753
   Siebels I, 2013, BBA-BIOENERGETICS, V1827, P1156, DOI 10.1016/j.bbabio.2013.06.005
   MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281
   Kamibayashi M, 2006, FREE RADICAL RES, V40, P1166, DOI 10.1080/10715760600883254
   Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301
   GAVIN CE, 1992, TOXICOL APPL PHARM, V115, P1, DOI 10.1016/0041-008X(92)90360-5
   Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n
   Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200
   Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729
   Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002
   Mailloux RJ, 2015, REDOX BIOL, V4, P381, DOI 10.1016/j.redox.2015.02.001
   Roth J, 2013, METAL IONS LIFE SCI, V12, P169, DOI 10.1007/978-94-007-5561-1_6
   Lanciano P, 2013, BBA-BIOENERGETICS, V1827, P1332, DOI 10.1016/j.bbabio.2013.03.009
   Maklashina E, 2010, BBA-BIOENERGETICS, V1797, P1877, DOI 10.1016/j.bbabio.2010.02.015
   Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006
   Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605
   Martinez-Finley EJ, 2013, FREE RADICAL BIO MED, V62, P65, DOI 10.1016/j.freeradbiomed.2013.01.032
   Drose S, 2011, MOL PHARMACOL, V79, P814, DOI 10.1124/mol.110.070342
   ALI SF, 1995, NEURODEGENERATION, V4, P329, DOI 10.1016/1055-8330(95)90023-3
   Sarewicz M, 2013, BIOCHEMISTRY-US, V52, P6388, DOI 10.1021/bi400624m
   Rao KVR, 2004, J BIOL CHEM, V279, P32333, DOI 10.1074/jbc.M402096200
   Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629
   Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200
   Andreyev AY, 2015, BIOCHEMISTRY-MOSCOW+, V80, P517, DOI 10.1134/S0006297915050028
   Drose S, 2006, J BIOL CHEM, V281, P23733, DOI 10.1074/jbc.M602570200
   Drose S, 2009, METHOD ENZYMOL, V456, P475, DOI 10.1016/S0076-6879(08)04426-1
   Guillaud F, 2014, BBA-BIOENERGETICS, V1837, P1643, DOI 10.1016/j.bbabio.2014.05.358
   Gunter TE, 2010, TOXICOL APPL PHARM, V249, P65, DOI 10.1016/j.taap.2010.08.018
   Huang JZ, 2009, J MOL BIOL, V387, P559, DOI 10.1016/j.jmb.2009.02.028
   IMLAY JA, 1995, J BIOL CHEM, V270, P19767
   Iverson TM, 2013, BBA-BIOENERGETICS, V1827, P648, DOI 10.1016/j.bbabio.2012.09.008
   Keen CL, 2000, MET IONS BIOL SYST, V37, P89
   Kluckova K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.110
   Liu Y, 2013, TOXICOL SCI, V132, P298, DOI 10.1093/toxsci/kfs344
   Mracek T, 2014, BBA-BIOENERGETICS, V1837, P98, DOI 10.1016/j.bbabio.2013.08.007
   Paranagama MP, 2010, MITOCHONDRION, V10, P158, DOI 10.1016/j.mito.2009.12.145
   Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005
   Rodrigues JV, 2012, FREE RADICAL BIO MED, V53, P12, DOI 10.1016/j.freeradbiomed.2012.04.016
   Senoo-Matsuda N, 2001, J BIOL CHEM, V276, P41553, DOI 10.1074/jbc.M104718200
   Szeto SSW, 2007, J BIOL CHEM, V282, P27518, DOI 10.1074/jbc.M700601200
NR 64
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 75
EP 83
DI 10.1016/j.abb.2015.06.011
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700009
PM 26116786
ER

PT J
AU Wang, G
   Wang, JJ
   Zhao, HF
   Wang, J
   To, SST
AF Wang, Gang
   Wang, JunJie
   Zhao, HuaFu
   Wang, Jing
   To, Shing Shun Tony
TI The role of Myc and let-7a in glioblastoma, glucose metabolism and
   response to therapy
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Myc; Let-7a miRNA; Tumor growth; Glucose metabolism; Pathways;
   Glioblastoma
ID GROWTH-FACTOR EXPRESSION; CELL-CYCLE ARREST; STEM-LIKE CELLS; C-MYC;
   CANCER-CELLS; GLIOMA-CELLS; GLUTAMINE-METABOLISM; AEROBIC GLYCOLYSIS;
   TRANSFORMED-CELLS; MULTIFORME CELLS
AB Glioblastoma multiforme (GBM) is thought to result from an imbalance between glucose metabolism and tumor growth. The Myc oncogene and lethal-7a microRNA (let-7a miRNA) have been suggested to cooperatively regulate multiple downstream targets leading to changes in chromosome stability, gene mutations, and/or modulation of tumor growth. Here, we review the roles of Myc and let-7a in glucose metabolism and tumor growth and addresses their future potential as prognostic markers and therapeutic tools in GBM. We focus on the functions of Myc and let-7a in glucose uptake, tumor survival, proliferation, and mobility of glioma cells. In addition, we discuss how regulation of different pathways by Myc or let-7a may be useful for future GBM therapies. A large body of evidence suggests that targeting Myc and let-7a may provide a selective mechanism for the deregulation of glucose metabolic pathways in glioma cells. Indeed, Myc and let-7a are aberrantly expressed in GBM and have been linked to the regulation of cell growth and glucose metabolism in GBM. This article is part of a Special Issue entitled "Targeting alternative glucose metabolism and regulate pathways in GBM cells for future glioblastoma therapies". (C) 2015 Elsevier Inc. All rights reserved.
C1 [Wang, Gang; Wang, JunJie] Shanghai Eighth Peoples Hosp, Dept Pharmaceut, Shanghai 200235, Peoples R China.
   [Wang, Gang; Wang, JunJie] Hubei Univ Med, Shiyan City 442000, Hubei Province, Peoples R China.
   [Zhao, HuaFu; To, Shing Shun Tony] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China.
   [Wang, Jing] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Neurosurg Neurooncol, Guangzhou 510275, Guangdong, Peoples R China.
RP Wang, G (reprint author), Shanghai Eighth Peoples Hosp, Dept Pharmaceut, Shanghai 200235, Peoples R China.
EM wangan139@163.com
CR Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960
   Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281
   Guo P, 2013, BIOCHEM BIOPH RES CO, V441, P186, DOI 10.1016/j.bbrc.2013.10.034
   Heine VM, 2010, CANCER RES, V70, P5220, DOI 10.1158/0008-5472.CAN-10-0554
   Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033
   Song Y, 2014, J NEURO-ONCOL, V119, P285, DOI 10.1007/s11060-014-1512-4
   Guo QM, 2000, CANCER RES, V60, P5922
   Bangert A, 2012, ONCOGENE, V31, P4677, DOI 10.1038/onc.2011.614
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005
   Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374
   Buechner J, 2011, BRIT J CANCER, V105, P296, DOI 10.1038/bjc.2011.220
   Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443
   Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x
   Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   De Salvo M, 2011, INT J RADIAT BIOL, V87, P518, DOI 10.3109/09553002.2011.556173
   Wang XR, 2013, NEURO-ONCOLOGY, V15, P1491, DOI 10.1093/neuonc/not107
   Huang XP, 2013, NEOPLASIA, V15, P952, DOI 10.1593/neo.13376
   Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014
   Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113
   Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903
   Hui ABY, 2001, LAB INVEST, V81, P717
   Lee ST, 2011, J NEURO-ONCOL, V102, P19, DOI 10.1007/s11060-010-0286-6
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Serguienko A, 2015, ONCOTARGET, V6, P2451
   Ashizawa T, 2013, INT J ONCOL, V43, P219, DOI 10.3892/ijo.2013.1916
   Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331
   Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231
   Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313
   Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918
   Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007
   Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013
   Wong TS, 2011, J CANCER RES CLIN, V137, P415, DOI 10.1007/s00432-010-0898-4
   Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154
   Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462
   Sachdeva M, 2010, AM J TRANSL RES, V2, P170
   Marie SKN, 2011, CLINICS, V66, P33, DOI 10.1590/S1807-59322011001300005
   Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109
   Venneti S, 2013, BRAIN PATHOL, V23, P217, DOI 10.1111/bpa.12022
   Perry A, 2009, BRAIN PATHOL, V19, P81, DOI 10.1111/j.1750-3639.2008.00167.x
   Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705
   Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003
   Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5
   Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101
   Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155
   Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106
   Suh SS, 2012, P NATL ACAD SCI USA, V109, P5316, DOI 10.1073/pnas.1202465109
   Babic I, 2013, CELL METAB, V17, P1000, DOI 10.1016/j.cmet.2013.04.013
   Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861
   Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x
   Leppert U, 2011, J MOL BIOL, V409, P710, DOI 10.1016/j.jmb.2011.04.041
   Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099
   Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408
   Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007
   Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345
   Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105
   Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904
   Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184
   Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667
   Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823
   Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106
   Wolf A, 2011, NEUROBIOL DIS, V44, P84, DOI 10.1016/j.nbd.2011.06.007
   O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677
   Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850
   Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622
   Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509
   Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294
   Barr LF, 2000, CANCER RES, V60, P143
   Ben-Porath I, 1999, MOL CELL BIOL, V19, P3529
   Bidwell GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055104
   Broaddus WC, 1997, NEUROSURGERY, V41, P908, DOI 10.1097/00006123-199710000-00027
   Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65
   Browd SR, 2006, CANCER RES, V66, P2666, DOI 10.1158/0008-5472.CAN-05-2198
   Choi JW, 2014, CANCER RES, V74, P484, DOI 10.1158/0008-5472.CAN-13-0771
   Colen RR, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-30
   Corbin R, 2009, BMB REP, V42, P131
   DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104
   Faria MH, 2008, ACTA NEUROPATHOL, V116, P87, DOI 10.1007/s00401-008-0368-0
   Frattini V, 2012, ONCOTARGET, V3, P1146
   Fults D, 2002, NEOPLASIA, V4, P32, DOI 10.1038/sj.neo.7900200
   Gessi M, 2012, J NEURO-ONCOL, V106, P135, DOI 10.1007/s11060-011-0648-8
   Herms JW, 1999, SURG NEUROL, V51, P536, DOI 10.1016/S0090-3019(98)00028-7
   Hooker CW, 2006, J CELL SCI, V119, P208, DOI 10.1242/jcs.02815
   Hu YH, 2012, CHINESE MED J-PEKING, V125, P2025, DOI 10.3760/cma.j.issn.0366-6999.2012.11.033
   Kaadige Mohan R, 2010, Transcription, V1, P36, DOI 10.4161/trns.1.1.12142
   Karsy Michael, 2012, Genes Cancer, V3, P3, DOI 10.1177/1947601912448068
   Lai JH, 2013, NEURO-ONCOLOGY, V15, P1330, DOI 10.1093/neuonc/not086
   Lassman AB, 2004, NEURON GLIA BIOL, V1, P157, DOI 10.1017/S1740925X04000249
   Le Mercier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045475
   Lee JS, 2012, STEM CELL REV REP, V8, P532, DOI 10.1007/s12015-011-9280-4
   Li FY, 2000, BIOCHEM BIOPH RES CO, V278, P821, DOI 10.1006/bbrc.2000.3849
   Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385
   Momota H, 2008, ONCOGENE, V27, P4392, DOI 10.1038/onc.2008.81
   Ott German, 2014, Hematology Am Soc Hematol Educ Program, V2014, P100, DOI 10.1182/asheducation-2014.1.100
   Pyko IV, 2013, CARCINOGENESIS, V34, P2206, DOI 10.1093/carcin/bgt182
   Raeder MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054873
   Ramakrishna R., 2010, SURG NEUROL INT, V10, P1
   Rice JE, 1996, BIOCHEM SOC T, V24, P540
   Roderick JE, 2014, BLOOD, V123, P1040, DOI 10.1182/blood-2013-08-522698
   Sai K, 2012, J NEURO-ONCOL, V107, P487, DOI 10.1007/s11060-011-0786-z
   Sareddy GR, 2013, NEUROCHEM RES, V38, P2313, DOI 10.1007/s11064-013-1142-9
   Scrideli CA, 2007, J NEURO-ONCOL, V83, P233, DOI 10.1007/s11060-007-9328-0
   Stallings RL, 2010, EXPERT OPIN THER TAR, V14, P951, DOI 10.1517/14728222.2010.510136
   Stanton B. R., 1992, GENES DEV, V6
   Vander Heiden Matthew G, 2009, Science, V324, P1029, DOI 10.1126/science.1160809
   Vander Heiden Matthew G, 2010, Science, V329, P1492, DOI 10.1126/science.1188015
   Venter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096786
   Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769
   Yamaki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01160
   Zamorano A, 2003, J NEUROSCI RES, V71, P256, DOI 10.1002/jnr.10461
NR 111
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 84
EP 92
DI 10.1016/j.abb.2015.07.005
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700010
PM 26151775
ER

PT J
AU Zamora-Carreras, H
   Torres, M
   Bustamante, N
   Macedo, AL
   Rodriguez, R
   Villalba, M
   Bruix, M
AF Zamora-Carreras, Hector
   Torres, Maria
   Bustamante, Noemi
   Macedo, Anjos L.
   Rodriguez, Rosalia
   Villalba, Mayte
   Bruix, Marta
TI The C-terminal domains of two homologous Oleaceae beta-1,3-glucanases
   recognise carbohydrates differently: Laminarin binding by NMR
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Fra e 9; Ole e 9; Allergy; Ash pollen; beta-1,3-Glucanase;
   Carbohydrate-binding protein; NMR
ID OLIVE TREE POLLEN; BACKBONE DYNAMICS; MAJOR ALLERGEN; PROTEIN; TOBACCO;
   MODULES; EXPRESSION; RELAXATION; MECHANISM; OLE-E-9
AB Ole e 9 and Fra e 9 are two allergenic beta-1,3-glucanases from olive and ash tree pollens, respectively. Both proteins present a modular structure with a catalytic N-terminal domain and a carbohydrate-binding module (CBM) at the C-terminus. Despite their significant sequence resemblance, they differ in some functional properties, such as their catalytic activity and the carbohydrate-binding ability. Here, we have studied the different capability of the recombinant C-terminal domain of both allergens to bind laminarin by NMR titrations, binding assays and ultracentrifugation. We show that rCtD-Ole e 9 has a higher affinity for laminarin than rCtD-Fra e 9. The complexes have different exchange regimes on the NMR time scale in agreement with the different affinity for laminarin observed in the biochemical experiments. Utilising NMR chemical shift perturbation data, we show that only one side of the protein surface is affected by the interaction and that the binding site is located in the inter-helical region between alpha(1) and alpha(2), which is buttressed by aromatic side chains. The binding surface is larger in rCtD-Ole e 9 which may account for its higher affinity for laminarin relative to rCtD-Fra e 9. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Zamora-Carreras, Hector; Bustamante, Noemi; Bruix, Marta] CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, E-28006 Madrid, Spain.
   [Torres, Maria; Rodriguez, Rosalia; Villalba, Mayte] Univ Complutense, Fac Quim, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain.
   [Macedo, Anjos L.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, UCIBIO,REQUIMTE, P-2829516 Caparica, Portugal.
RP Bruix, M (reprint author), CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, Serrano 119, E-28006 Madrid, Spain.
EM mbruix@igfr.csic.es
RI Macedo, Anjos/D-7216-2013
OI Macedo, Anjos/0000-0002-2613-4838
FU Ministerio de Economia y Competitividad [CTQ2011-22514, SAF2011-26716];
   FCT-MEC from the Fundacao para a Ciencia e a Tecnologia
   [SFRH/BSAB/452/2004];  [BES-2012-057717]
FX This work was financially supported with projects CTQ2011-22514 to M.B.
   and SAF2011-26716 to R.R. and M.V. from the Ministerio de Economia y
   Competitividad and FCT-MEC, SFRH/BSAB/452/2004 to A.L.M., from the
   Fundacao para a Ciencia e a Tecnologia; and also by grant
   BES-2012-057717 to H.Z.
CR GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007
   Fuchs KP, 2003, MICROBIOL-SGM, V149, P1021, DOI 10.1099/mic.0.26153-0
   HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D
   Leubner-Metzger G, 2005, PLANT J, V41, P133, DOI 10.1111/j.1365-313X.2004.02284.x
   Huecas S, 2001, J BIOL CHEM, V276, P27959, DOI 10.1074/jbc.M103041200
   Fernandez-Alonso MD, 2012, CURR PROTEIN PEPT SC, V13, P816
   Boraston AB, 2004, BIOCHEM J, V382, P769
   Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
   Garcia-Mayoral MF, 2013, ACS CHEM BIOL, V8, P144, DOI 10.1021/cb300386v
   WORRALL D, 1992, PLANT CELL, V4, P759, DOI 10.1105/tpc.4.7.759
   Chen CH, 2000, PLANT MOL BIOL, V42, P387, DOI 10.1023/A:1006399311615
   de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170
   Batista PR, 2011, PHYS CHEM CHEM PHYS, V13, P13709, DOI 10.1039/c0cp02697b
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   Schuck P, 2000, BIOPHYS J, V78, P1606
   Palomares O, 2003, BIOCHEM J, V369, P593, DOI 10.1042/BJ20020423
   Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
   ASENSIO JL, 1995, EUR J BIOCHEM, V230, P621
   Barral P, 2005, BIOCHEM J, V390, P77, DOI 10.1042/BJ20050456
   Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200
   CASACUBERTA JM, 1992, MOL GEN GENET, V234, P97
   Castrillo I, 2006, J BIOMOL NMR, V36, P67, DOI 10.1007/s10858-006-9053-6
   Durchschlag H, 1986, THERMODYNAMIC DATA B, P45
   Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kneller D. G., 2005, SPARKY 3, V3
   Laue T. M., 1992, BIOCH POLYM SCI, P90
   Lewis MS, 2000, METHOD ENZYMOL, V321, P136
   LINTHORST HJM, 1990, P NATL ACAD SCI USA, V87, P8756, DOI 10.1073/pnas.87.22.8756
   MEMELINK J, 1990, PLANT MOL BIOL, V14, P119, DOI 10.1007/BF00018553
   NELSON TE, 1963, CAN J CHEM, V41, P1671, DOI 10.1139/v63-241
   Perez-Canadillas JM, 2002, J BIOMOL NMR, V24, P301, DOI 10.1023/A:1021698308683
   PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x
   Takeda T, 2015, PHYTOCHEMISTRY, V116, P21, DOI 10.1016/j.phytochem.2015.05.010
   Torres M., 2014, TAUMATINAS  B 1 3 GL
   Trevino MA, 2008, PROTEIN SCI, V17, P371, DOI 10.1110/ps.073230008
   Trevino MA, 2004, J BIOL CHEM, V279, P39035, DOI 10.1074/jbc.M406045200
   Varea J, 2000, J BIOL CHEM, V275, P26842
   Verma DPS, 2005, TRENDS PLANT SCI, V10, P159, DOI 10.1016/j.tplants.2005.02.004
   VOGELILANGE R, 1994, PLANT MOL BIOL, V25, P299, DOI 10.1007/BF00023245
   WISHART DS, 1995, J BIOMOL NMR, V5, P332, DOI 10.1007/BF00211764
NR 42
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 93
EP 101
DI 10.1016/j.abb.2015.07.004
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700011
PM 26151774
ER

PT J
AU Guzzi, R
   Bartucci, R
AF Guzzi, Rita
   Bartucci, Rosa
TI Electron spin resonance of spin-labeled lipid assemblies and proteins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Spin-label; ESR; Membrane; Protein; Rotational dynamics; Polarity
ID BOUND ALPHA-SYNUCLEIN; HIGH-FIELD EPR; INELASTIC NEUTRON-SCATTERING;
   LIBRATIONAL MOTION; WATER PENETRATION; T4 LYSOZYME; PULSED EPR;
   STRUCTURAL HETEROGENEITY; PARAMAGNETIC-RESONANCE; CONFORMATIONAL-CHANGES
AB Spin-label electron spin resonance (ESR) spectroscopy is a valuable means to study molecular mobility and interactions in biological systems. This paper deals with conventional, continuous wave ESR of nitroxide spin-labels at 9-GHz providing an introduction to the basic principles of the technique and applications to self-assembled lipid aggregates and proteins. Emphasis is given to segmental lipid chain order and rotational dynamics of lipid structures, environmental polarity of membranes and proteins, structure and conformational dynamics of proteins. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Guzzi, Rita; Bartucci, Rosa] Univ Calabria, Dept Phys, I-87036 Arcavacata Di Rende, CS, Italy.
RP Bartucci, R (reprint author), Univ Calabria, Dept Phys, I-87036 Arcavacata Di Rende, CS, Italy.
EM rosa.bartucci@fis.unical.it
RI Guzzi, Rita/M-7654-2015
OI Guzzi, Rita/0000-0001-6769-3399
CR Zhang ZW, 2010, J PHYS CHEM B, V114, P5503, DOI 10.1021/jp910606h
   Liang ZC, 1999, J PHYS CHEM B, V103, P6384, DOI 10.1021/jp9907746
   Lopez CJ, 2012, BIOCHEMISTRY-US, V51, P6568, DOI 10.1021/bi3005686
   Klare JP, 2009, PHOTOSYNTH RES, V102, P377, DOI 10.1007/s11120-009-9490-7
   Borbat PP, 2001, SCIENCE, V291, P266, DOI 10.1126/science.291.5502.266
   GRIFFITH OH, 1974, J MEMBRANE BIOL, V15, P159, DOI 10.1007/BF01870086
   Bordignon E, 2010, APPL MAGN RESON, V37, P391, DOI 10.1007/s00723-009-0072-9
   Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105
   Volkov A, 2009, BIOPHYS J, V96, P1124, DOI 10.1016/j.bpj.2008.09.047
   Kurad D, 2003, BIOPHYS J, V85, P1025, DOI 10.1016/S0006-3495(03)74541-X
   Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k
   Ivanisenko NV, 2013, APPL MAGN RESON, V44, P883, DOI 10.1007/s00723-012-0436-4
   Carmieli R, 2006, BIOPHYS J, V90, P492, DOI 10.1529/biophysj.105.062992
   Plato M, 2002, MOL PHYS, V100, P3711, DOI 10.1080/00268970210166246
   HUBBELL WL, 1971, J AM CHEM SOC, V93, P314
   Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214
   Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9
   Erilov DA, 2005, J PHYS CHEM B, V109, P12003, DOI 10.1021/jp050886z
   ALTENBACH C, 1989, BIOCHEMISTRY-US, V28, P7806, DOI 10.1021/bi00445a042
   Shabestari MH, 2014, BIOPHYS J, V106, P1349, DOI 10.1016/j.bpj.2013.11.4506
   Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101
   Steinhoff HJ, 2000, BBA-BIOENERGETICS, V1457, P253, DOI 10.1016/S0005-2728(00)00106-7
   Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m
   Bartucci R, 2005, BIOCHEMISTRY-US, V44, P15017, DOI 10.1021/bi051101i
   Fanucci GE, 2006, CURR OPIN STRUC BIOL, V16, P644, DOI 10.1016/j.sbi.2006.08.008
   DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0
   Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k
   Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956
   Aziz A, 2010, J BIOL CHEM, V285, P15278, DOI 10.1074/jbc.M109.075598
   Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101
   Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8
   Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716
   SLATER JL, 1988, PROG LIPID RES, V27, P325, DOI 10.1016/0163-7827(88)90010-0
   Belle V, 2007, BIOCHEMISTRY-US, V46, P2205, DOI 10.1021/bi0616089
   FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451
   Poluektov OG, 2003, J PHYS CHEM B, V107, P6239, DOI 10.1021/jp0342374
   Ringe D, 2003, BIOPHYS CHEM, V105, P667, DOI 10.1016/S0301-4622(03)00096-6
   Bartucci R, 2003, CHEM PHYS LIPIDS, V124, P111, DOI 10.1016/S0009-3084(03)00047-1
   Bartucci R, 2014, BIOPHYS J, V107, P1375, DOI 10.1016/j.bpj.2014.07.057
   Bartucci R, 2006, CHEM PHYS LIPIDS, V141, P142, DOI 10.1016/j.chemphyslip.2006.02.009
   Bartucci R, 1997, APPL MAGN RESON, V12, P41
   Bartucci R, 2003, J MAGN RESON, V162, P371, DOI 10.1016/S1090-7807(03)00049-1
   BARTUCCI R, 1993, BIOCHEMISTRY-US, V32, P274, DOI 10.1021/bi00052a035
   Bartucci R, 2009, BIOPHYS J, V96, P997, DOI 10.1016/j.bpj.2008.10.024
   Berliner L. J., 1989, SPIN LABELING THEORY
   Berliner L.J., 2007, ESR SPECTROSCOPY MEM
   Berliner L.J., 2000, DISTANCE MEASUREMENT
   Berliner L.J., 1976, THEORY APPL
   BOGGS JM, 1989, BIOCHIM BIOPHYS ACTA, V981, P243, DOI 10.1016/0005-2736(89)90034-5
   Bridges MD, 2010, APPL MAGN RESON, V37, P363, DOI 10.1007/s00723-009-0079-2
   Brutlach H, 2006, APPL MAGN RESON, V30, P359, DOI 10.1007/BF03166206
   Cafiso DS, 2014, ACCOUNTS CHEM RES, V47, P3102, DOI 10.1021/ar500228s
   Cevc G., 1987, PHOSPHOLIPID BILAYER
   Chen G, 2008, PHILOS MAG, V88, P3877, DOI 10.1080/14786430802585117
   De Simone F, 2007, BBA-BIOMEMBRANES, V1768, P1541, DOI 10.1016/j.bbamem.2007.02.019
   DZUBA SA, 1992, CHEM PHYS LETT, V188, P217, DOI 10.1016/0009-2614(92)90012-C
   Dzuba SA, 1996, PHYS LETT A, V213, P77, DOI 10.1016/0375-9601(96)00081-3
   Erilov DA, 2004, BIOPHYS J, V87, P3873, DOI 10.1529/biophysj.104.046631
   Giamello E, 2009, ELECT PARAMAGNETIC R
   Glasgow BJ, 1999, BIOCHEMISTRY-US, V38, P13707, DOI 10.1021/bi9913449
   Grell E., 1981, MEMBRANE SPECTROSCOP, P51
   Griffith O.H., 1982, LIPID PROTEIN INTERA, P53
   Guzzi R, 2009, BIOCHEMISTRY-US, V48, P8343, DOI 10.1021/bi900849z
   Guzzi R, 2012, J PHYS CHEM B, V116, P11608, DOI 10.1021/jp3074392
   Guzzi R, 2001, EUR BIOPHYS J BIOPHY, V30, P171, DOI 10.1007/s002490000146
   Guzzi R, 2011, BBA-BIOMEMBRANES, V1808, P1618, DOI 10.1016/j.bbamem.2010.11.008
   Guzzi R, 1997, BIOPHYS CHEM, V63, P211, DOI 10.1016/S0301-4622(96)02252-1
   Guzzi R, 2014, BIOPHYS J, V106, P716, DOI 10.1016/j.bpj.2013.12.039
   Hagen W., 2009, BIOMOLECULAR EPR SPE
   JOHNSON ME, 1981, BIOCHEMISTRY-US, V20, P3319, DOI 10.1021/bi00515a001
   JOHNSON ME, 1978, BIOCHEMISTRY-US, V17, P1223, DOI 10.1021/bi00600a014
   Kokorin A.I., 2012, NITROXIDES THEORY EX, P3
   Lasic D. D., 1995, STEALTH LIPOSOMES
   Lopez CJ, 2013, P NATL ACAD SCI USA, V110, pE4306, DOI 10.1073/pnas.1318754110
   Marsh D, 2010, APPL MAGN RESON, V37, P435, DOI 10.1007/s00723-009-0078-3
   Marsh D, 1989, ADV EPR APPL BIOL BI, P707
   Marsh D, 2002, CHEM PHYS LIPIDS, V116, P93, DOI 10.1016/S0009-3084(02)00022-1
   Marsh D, 2001, P NATL ACAD SCI USA, V98, P7777, DOI 10.1073/pnas.131023798
   Marsh D, 2013, BBA-PROTEINS PROTEOM, V1834, P1591, DOI 10.1016/j.bbapap.2013.05.001
   Marsh D, 2008, METHODS, V46, P83, DOI 10.1016/j.ymeth.2008.07.001
   Meyers R.A., 2000, ENCY ANAL CHEM, P5725
   MILLHAUSER GL, 1984, J CHEM PHYS, V81, P37, DOI 10.1063/1.447316
   Mokdad A, 2012, J MOL BIOL, V423, P818, DOI 10.1016/j.jmb.2012.09.003
   Narayan M, 1997, BIOCHEMISTRY-US, V36, P1906, DOI 10.1021/bi9621526
   Pantusa M, 2010, EUR BIOPHYS J BIOPHY, V39, P921, DOI 10.1007/s00249-009-0442-0
   PARAK F, 1988, HYPERFINE INTERACT, V40, P147, DOI 10.1007/BF02049086
   PARAK F, 1987, EUR BIOPHYS J BIOPHY, V15, P237, DOI 10.1007/BF00577072
   Pilbrow J. R., 1990, TRANSITION ION ELECT
   RUGGIERO J, 1986, CAN J CHEM, V64, P366, DOI 10.1139/v86-060
   Sahu ID, 2013, BIOCHEMISTRY-US, V52, P5967, DOI 10.1021/bi400834a
   Savitsky A, 2009, PHOTOSYNTH RES, V102, P311, DOI 10.1007/s11120-009-9432-4
   Scarpelli F, 2011, EUR BIOPHYS J BIOPHY, V40, P273, DOI 10.1007/s00249-010-0644-5
   Schiro G., 2012, PHYS REV LETT, V109
   Schweiger A., 2001, PRINCIPLES PULSE ELE
   Singh C.P., 1981, PHYS REV LETT, V47, P685
   STEINHOFF HJ, 1989, Z NATURFORSCH C, V44, P280
   Steinhoff H.J., 2004, SUPRAMOLECULAR STRUC, V8, P157
   Stirpe A, 2014, CHEM PHYS LIPIDS, V183, P176, DOI 10.1016/j.chemphyslip.2014.07.004
   Stoll S, 2007, BIO MAGN RE, V27, P299
   SUBCZYNSKI WK, 1994, BIOCHEMISTRY-US, V33, P7670, DOI 10.1021/bi00190a022
   VAN SP, 1974, J MAGN RESON, V15, P444, DOI 10.1016/0022-2364(74)90147-4
   Weil J. A., 2007, ELECT PARAMAGNETIC R
   Wu F, 2006, BIOCHEMISTRY-US, V45, P12510, DOI 10.1021/bi0614151
NR 103
TC 0
Z9 0
U1 21
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 102
EP 111
DI 10.1016/j.abb.2015.06.015
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700012
PM 26116378
ER

PT J
AU Cao, WW
   Chen, JW
   Chen, YF
   Chen, SR
   Chen, X
   Huang, HQ
   Liu, PQ
AF Cao, Weiwei
   Chen, Jianwen
   Chen, Yanfang
   Chen, Shaorui
   Chen, Xi
   Huang, Heqing
   Liu, Peiqing
TI Advanced glycation end products induced immune maturation of dendritic
   cells controls heart failure through NF-kappa B signaling pathway
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Heart failure; Advanced glycation end product; Dendritic cells; NF-kappa
   B signaling
ID MYOCARDIAL-INFARCTION; GLUCOSE; PYRIDOXAMINE; COMPLICATIONS;
   NEPHROPATHY; INHIBITION; MECHANISM; PROTEINS; DEATH
AB Background and aims: It is commonly believed that diabetes is an important contributor to heart failure (HF) development. However, the detail effect of diabetogenesis on HF is controversy: both beneficial and harmful roles were reported. In the present study, we aim to explore the unambiguous action of diabetes on chronic HF progression and the underlying mechanism.
   Methods: Diabetes and myocardial infarction (MI) were induced by streptozotocin (STZ) injection and left-sided thoracotomy and left anterior descending coronary artery (LAD) ligation, respectively. Pyridoxamine was used as the antagonist of advanced glycation end products (AGEs). Adult male SD rats were assigned to 5 groups: Sham; MI; Diabetes (D); Diabetes + MI (DMI) and DMI + pyridoxamine (DMI + P). Animals were sacrificed at the end of 12 weeks. The comparison of LV myocardium was made between border zone from MI or DMI animals and control LV tissues from sham-operated animals. Cardiomyocytes and dendritic cells were prepared from the Sprague-Dawley rats and cocultured in the presence or absence of AGEs.
   Results: DMI group showed highest level of AGEs and inflammatory markers, which were significantly reduced in the presence of pyridoxamine. In vitro experiment disclosed AGEs could stimulate DCs differentiation and promote cytokines production, finally upregulated hypertrophy-related genes expression in cardiocytes. Intervention DCs differentiation was sufficient to improve cardiocytes morphology.
   Conclusion: Our results clearly demonstrate that diabetes would promote chronic HF progression at least in part through stimulating DCs differentiation and series downstream inflammatory responses induced by AGEs. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Cao, Weiwei; Chen, Jianwen; Chen, Shaorui; Chen, Xi; Huang, Heqing; Liu, Peiqing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Guangzhou 510006, Guangdong, Peoples R China.
   [Chen, Yanfang] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou 510260, Guangdong, Peoples R China.
   [Huang, Heqing; Liu, Peiqing] Engn Lab Guangdong Prov Druggabil & New Drug Eval, Guangzhou, Guangdong, Peoples R China.
RP Liu, PQ (reprint author), Sun Yat Sen Univ, Guangzhou Higher Educ Mega Ctr, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, East Ring Rd 132, Guangzhou 510006, Guangdong, Peoples R China.
EM weiweiivy82@126.com; liupq@mail.sysu.edu.cn
FU National Natural Science Foundation of China [81072641, 81026548,
   81273499]; National Science and Technology Major Project of China "Key
   New Drug Creation and Manufacturing Program" [2011ZX09401-307]; Team
   item of Natural Science Foundation of Guangdong Province
   [S2011030003190]; Major Project of Guangdong Province [2013B090700010,
   2012A080201007]
FX This work was supported by grants from the National Natural Science
   Foundation of China (Nos. 81072641, 81026548, 81273499); the National
   Science and Technology Major Project of China "Key New Drug Creation and
   Manufacturing Program" (No. 2011ZX09401-307), Team item of Natural
   Science Foundation of Guangdong Province (No. S2011030003190), Major
   Project of Guangdong Province (Nos. 2013B090700010, 2012A080201007).
CR Alderson NL, 2004, DIABETOLOGIA, V47, P1385, DOI 10.1007/s00125-004-1474-8
   Ding L, 2009, CIRCULATION, V120, P764, DOI 10.1161/CIRCULATIONAHA.109.870725
   Fiordaliso F, 2000, LAB INVEST, V80, P513
   Kakuta T, 2011, AM J KIDNEY DIS, V57, P422, DOI 10.1053/j.ajkd.2010.10.055
   Miele C, 2003, J BIOL CHEM, V278, P47376, DOI 10.1074/jbc.M301088200
   Nagai R, 2012, DIABETES, V61, P549, DOI 10.2337/db11-1120
   Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239
   Kallwellis-Opara A, 2007, CLIN RES CARDIOL, V96, P469, DOI 10.1007/s00392-007-0524-x
   Malmberg K, 1999, CIRCULATION, V99, P2626
   Hartog JWL, 2007, EUR J HEART FAIL, V9, P1146, DOI 10.1016/j.ejheart.2007.09.009
   Williams ME, 2007, AM J NEPHROL, V27, P605, DOI 10.1159/000108104
   Kannan K, 2004, FREE RADICAL BIO MED, V36, P423, DOI 10.1016/j.freeradbiomed.2003.09.012
   Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363
   Thrainsdottir IS, 2005, DIABETES CARE, V28, P612, DOI 10.2337/diacare.28.3.612
   Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162
   Hofmann SM, 2002, DIABETES, V51, P2082, DOI 10.2337/diabetes.51.7.2082
   Cao WW, 2014, APPL BIOCHEM BIOTECH, V172, P4062, DOI 10.1007/s12010-014-0804-7
   Chang KC, 2009, BRIT J PHARMACOL, V157, P1419, DOI 10.1111/j.1476-5381.2009.00309.x
   Gkogkolou Paraskevi, 2012, Dermatoendocrinol, V4, P259, DOI 10.4161/derm.22028
   Hegab Zeinab, 2012, World J Cardiol, V4, P90, DOI 10.4330/wjc.v4.i4.90
   Kamalesh M, 2006, EUR J HEART FAIL, V8, P404, DOI 10.1016/j.ejheart.2005.10.005
   Kannan K, 2000, PATHOPHYSIOLOGY, V7, P153, DOI DOI 10.1016/S0928-4680(00)00053-5
   Martin Doug, 2008, Cardiovasc Hematol Disord Drug Targets, V8, P297
   Voziyan PA, 2003, J BIOL CHEM, V278, P46616, DOI 10.1074/jbc.M307155200
NR 26
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 112
EP 120
DI 10.1016/j.abb.2015.07.003
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700013
PM 26163748
ER

PT J
AU Aguado, A
   Fernandez-Higuero, JA
   Moro, F
   Muga, A
AF Aguado, Alejandra
   Angel Fernandez-Higuero, Jose
   Moro, Fernando
   Muga, Arturo
TI Chaperone-assisted protein aggregate reactivation: Different solutions
   for the same problem
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
ID NUCLEOTIDE EXCHANGE FACTORS; N-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE
   HSP104; AAA PLUS DISAGGREGASE; AMINO-ACID-RESIDUES; ATP-BINDING-SITES;
   MOLECULAR CHAPERONE; ESCHERICHIA-COLI; THERMUS-THERMOPHILUS;
   SUBSTRATE-BINDING
AB The oligomeric AAA+ chaperones Hsp104 in yeast and ClpB in bacteria are responsible for the reactivation of aggregated proteins, an activity essential for cell survival during severe stress. The protein disaggregase activity of these members of the Hsp100 family is linked to the activity of chaperones from the Hsp70 and Hsp40 families. The precise mechanism by which these proteins untangle protein aggregates remains unclear. Strikingly, Hsp100 proteins are not present in metazoans. This does not mean that animal cells do not have a disaggregase activity, but that this activity is performed by the Hsp70 system and a representative of the Hsp110 family instead of a Hsp100 protein. This review describes the actual view of Hsp100-mediated aggregate reactivation, including the ATP-induced conformational changes associated with their disaggregase activity, the dynamics of the oligomeric assembly that is regulated by its ATPase cycle and the DnaK system, and the tight allosteric coupling between the ATPase domains within the hexameric ring complexes. The lack of homologs of these disaggregases in metazoans has suggested that they might be used as potential targets to develop antimicrobials. The current knowledge of the human disaggregase machinery and the role of Hsp110 are also discussed. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Muga, Arturo] Univ Basque Country, EHU, CSIC, Fac Ciencias & Tecnol,Unidad Biofis, E-48080 Bilbao, Spain.
   Univ Basque Country, EHU, Fac Ciencias & Tecnol, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain.
RP Muga, A (reprint author), Univ Basque Country, EHU, CSIC, Fac Ciencias & Tecnol,Unidad Biofis, E-48080 Bilbao, Spain.
EM arturo.muga@ehu.es
FU Spanish Ministry of Economy and Innovation [BFU2013-47059]; Basque
   Government [IT709-13]
FX This work has been supported by the Spanish Ministry of Economy and
   Innovation (Grant BFU2013-47059), and the Basque Government (Grant
   IT709-13). We are grateful to past and present collaborators in protein
   aggregation reactivation studies.
CR Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020
   Acebron SP, 2008, J BIOL CHEM, V283, P1381, DOI 10.1074/jbc.M706189200
   Aguado A, 2015, BIOCHEM J, V466, P561, DOI 10.1042/BJ20141390
   Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200
   Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108
   Kannan TR, 2008, INFECT IMMUN, V76, P5082, DOI 10.1128/IAI.00698-08
   Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074
   Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546
   Song YY, 2013, P NATL ACAD SCI USA, V110, P5428, DOI 10.1073/pnas.1303279110
   Beinker P, 2002, J BIOL CHEM, V277, P47160, DOI 10.1074/jbc.M207853200
   Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442
   Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9
   Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057
   Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200
   Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200
   Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106
   Jackrel ME, 2014, CELL, V156, P170, DOI 10.1016/j.cell.2013.11.047
   Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268
   Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200
   Kim KI, 2000, J MOL BIOL, V303, P655, DOI 10.1006/jmbi.2000.4165
   Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253
   Sabate R, 2010, CELL MOL LIFE SCI, V67, P2695, DOI 10.1007/s00018-010-0344-4
   FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397
   Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022
   Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636
   Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008
   Goeckeler JL, 2008, FEBS LETT, V582, P2393, DOI 10.1016/j.febslet.2008.05.047
   Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066
   Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030
   Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]
   Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455
   Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441
   Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026
   Barends TRM, 2010, CURR OPIN STRUC BIOL, V20, P46, DOI 10.1016/j.sbi.2009.12.014
   Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646
   Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574
   Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014
   Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623
   Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023
   del Castillo U, 2011, BIOCHEMISTRY-US, V50, P1991, DOI 10.1021/bi101670s
   Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07
   Doyle SM, 2013, NAT REV MOL CELL BIO, V14, P617, DOI 10.1038/nrm3660
   Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501
   Zolkiewski M, 1999, PROTEIN SCI, V8, P1899
   Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200
   Yamagishi N, 2011, BIOCHEM BIOPH RES CO, V409, P90, DOI 10.1016/j.bbrc.2011.04.114
   Jackrel ME, 2015, PRION, V9, P90, DOI 10.1080/19336896.2015.1020277
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868
   Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425
   Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012
   Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264
   SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365
   Poole K, 2012, J ANTIMICROB CHEMOTH, V67, P2069, DOI 10.1093/jac/dks196
   Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x
   Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11
   Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200
   Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787
   Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108
   Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502
   Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200
   Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712
   DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038
   Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9
   Bieschke J, 2009, PROTEIN SCI, V18, P2231, DOI 10.1002/pro.234
   Murray AN, 2010, PROTEIN SCI, V19, P836, DOI 10.1002/pro.363
   Vacher C, 2005, HUM MOL GENET, V14, P3425, DOI 10.1093/hmg/ddi372
   Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138
   Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110
   Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120
   Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297
   Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200
   Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09
   Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431
   Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/S0968-0004(96)10038-4
   Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027
   Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008
   Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589
   Chastanet A, 2004, J BACTERIOL, V186, P1165, DOI 10.1128/JB.186.4.1165-1174.2004
   Saxena A, 2012, J BIOL CHEM, V287, P19158, DOI 10.1074/jbc.M111.297580
   Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838
   Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010
   Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012
   Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012
   Minton AP, 2006, CURR BIOL, V16, pR269, DOI 10.1016/j.cub.2006.03.047
   Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317
   DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014
   Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997
   Doyle SM, 2015, J MOL BIOL, V427, P312, DOI 10.1016/j.jmb.2014.10.013
   Grant SS, 2013, VIRULENCE, V4, P273, DOI 10.4161/viru.23987
   Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555
   Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s
   Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941
   Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875
   Martin I, 2013, J MED CHEM, V56, P7177, DOI 10.1021/jm400499k
   Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x
   Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817
   Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001
   Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982
   Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9
   Hodson S, 2012, J STRUCT BIOL, V179, P161, DOI 10.1016/j.jsb.2012.05.015
   DeSantis ME, 2014, J BIOL CHEM, V289, P848, DOI 10.1074/jbc.M113.520759
   Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592
   Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448
   Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4
   Winkler J, 2012, J STRUCT BIOL, V179, P152, DOI 10.1016/j.jsb.2012.05.002
   Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970
   Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020
   Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604
   Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128
   Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139
   Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12
   Mohamed BA, 2014, AM J RESP CELL MOL, V50, P817, DOI 10.1165/rcmb.2013-0132OC
   Widakowich C, 2007, ONCOLOGIST, V12, P1443, DOI 10.1634/theoncologist.12-12-1443
   Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039
   Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200
   Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247
   Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002
   Barnett ME, 2002, BIOCHEMISTRY-US, V41, P11277, DOI 10.1021/bi02161s
   Beinker P, 2005, J BIOL CHEM, V280, P37965, DOI 10.1074/jbc.M506672200
   Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200
   Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109
   Carroni M., 2014, ELIFE, V3
   Chow IT, 2005, FEBS LETT, V579, P4235, DOI 10.1016/j.febslet.2005.06.054
   Chow IT, 2005, FEBS LETT, V579, P4242, DOI 10.1016/j.febslet.2005.06.035
   Clarke AK, 2000, J BACTERIOL, V182, P7092, DOI 10.1128/JB.182.24.7092-7096.2000
   Clos J, 2001, MED MICROBIOL IMMUN, V190, P47
   Cowen LE, 2012, MBIO, V3
   Cushman-Nick M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003781
   del Castillo U, 2010, FEBS LETT, V584, P929, DOI 10.1016/j.febslet.2010.01.029
   Duennwald ML, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001346
   Dulle JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087521
   Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2
   Farbman ME, 2008, BIOCHEMISTRY-US, V47, P13497, DOI 10.1021/bi801140y
   Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365
   Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176
   Galam L, 2007, BIOORGAN MED CHEM, V15, P1939, DOI 10.1016/j.bmc.2007.01.004
   Gassler CS, 2001, J BIOL CHEM, V276, P32538, DOI 10.1074/jbc.M105328200
   Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051
   Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199
   Held T, 2011, REPRODUCTION, V142, P133, DOI 10.1530/REP-11-0023
   Hines JK, 2011, PRION, V5, P238, DOI [10.4161/pri.17818, 10.4161/pri.5.4.17818]
   Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106
   Hubei A., 1997, J CLOS MOL CELL BIOL, V17, P5987
   Jackrel ME, 2014, DIS MODEL MECH, V7, P1175, DOI 10.1242/dmm.016113
   Kedzierska S, 2003, BIOCHEMISTRY-US, V42, P14242, DOI 10.1021/bi035573d
   Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107
   Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3
   Liu ZH, 2002, J MOL BIOL, V321, P111, DOI 10.1016/S0022-2836(02)00591-0
   Lo C., 2008, J CLIN INVEST, V118, P3087
   Lum R., 2008, BIOL CHEM, V283, P30139
   Makhnevych T, 2012, J CELL BIOL, V198, P623, DOI 10.1083/jcb.201111105
   Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779
   Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002
   Martin I, 2014, BIOPHYS J, V106, P2017, DOI 10.1016/j.bpj.2014.03.042
   Mizuno S, 2012, FEBS J, V279, P1474, DOI 10.1111/j.1742-4658.2012.08540.x
   Mogk A., 2015, FRONT MOL BIOSCI, V2, DOI DOI 10.3389/FM0LB.2015.00022
   Nagy M, 2010, J MOL BIOL, V396, P697, DOI 10.1016/j.jmb.2009.11.059
   Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l
   Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200
   PARSELL DA, 1994, J BIOL CHEM, V269, P4480
   Quan S, 2014, ELIFE, V3, DOI 10.7554/eLife.01584
   Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febstet.2005.11.069
   Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307
   Reidy M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004720
   Rivas German, 2004, EMBO Reports, V5, P23, DOI 10.1038/sj.embor.7400056
   Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011
   Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763
   Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070
   Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006
   Schweizer RS, 2011, CHEMBIOCHEM, V12, P1559, DOI 10.1002/cbic.201000786
   Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319
   Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f
   Sweeny EA, 2015, MOL CELL, V57, P836, DOI 10.1016/j.molcel.2014.12.021
   Torrente M. P., 2014, PLOS ONE, V9
   Uchiyama Y, 2006, J BIOCHEM, V140, P805, DOI 10.1093/jb/mvj212
   Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z
   Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4
   Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200
   Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200
   Watanabe YH, 2009, BIOCHEM J, V421, P71, DOI 10.1042/BJ20082238
   Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026
   Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047
   Werbeck ND, 2011, BIOCHEMISTRY-US, V50, P899, DOI 10.1021/bi1018286
   Werbeck ND, 2009, BIOCHEMISTRY-US, V48, P7240, DOI 10.1021/bi900880c
   Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200
   Yamagishi N, 2004, J BIOL CHEM, V279, P41727, DOI 10.1074/jbc.M407947200
   Yamasaki T, 2015, J BIOL CHEM, V290, P9789, DOI 10.1074/jbc.M114.617696
   Yamasaki T, 2011, FEBS J, V278, P2395, DOI 10.1111/j.1742-4658.2011.08167.x
   Yamashita H, 2007, J NEUROCHEM, V102, P1497, DOI 10.1111/j.1471-4159.2007.04534.x
   Zeymer C, 2013, J BIOL CHEM, V288, P7065, DOI 10.1074/jbc.M112.432583
   Zeymer C, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.608828
   Zhang T, 2012, PROTEINS, V80, P2758, DOI 10.1002/prot.24159
   Zietkiewicz S, 2010, BIOPOLYMERS, V93, P47, DOI 10.1002/bip.21294
NR 194
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 15
PY 2015
VL 580
BP 121
EP 134
DI 10.1016/j.abb.2015.07.006
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CO0EU
UT WOS:000358823700014
PM 26159839
ER

PT J
AU Hudson, DA
   Thorpe, C
AF Hudson, Devin A.
   Thorpe, Colin
TI Mia40 is a facile oxidant of unfolded reduced proteins but shows minimal
   isomerase activity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Augmenter of liver regeneration; Mia40; Mitochondrial intermembrane
   space targeting sequence; Protein disulfide isomerase; Oxidative protein
   folding; Disulfide exchange
ID MITOCHONDRIAL INTERMEMBRANE SPACE; DISULFIDE BOND FORMATION;
   QUIESCIN-SULFHYDRYL OXIDASE; ELECTRON-TRANSFER; RELAY SYSTEM; EGG-WHITE;
   LIVER-REGENERATION; SUBSTRATE; THIOREDOXIN; INHIBITORS
AB Mia40 participates in oxidative protein folding within the mitochondrial intermembrane space (IMS) by mediating the transfer of reducing equivalents from client proteins to FAD-linked oxidoreductases of the Erv1 family (lfALR in mammals). Here we investigate the specificity of the human Mia40/lfALR system towards non-cognate unfolded protein substrates to assess whether the efficient introduction of disulfides requires a particular amino acid sequence context or the presence of an IMS targeting signal. Reduced pancreatic ribonuclease A (rRNase), avian lysozyme, and riboflavin binding protein are all competent substrates of the Mia40/lfALR system, although they lack those sequence features previously thought to direct disulfide bond formation in cognate IMS substrates. The oxidation of rRNase by Mia40 does not limit overall turnover of unfolded substrate by the Mia40/lfALR system. Mia40 is an ineffective protein disulfide isomerase when its ability to restore enzymatic activity from scrambled RNase is compared to that of protein disulfide isomerase. Mia40's ability to bind amphipathic peptides is evident by avid binding to the isolated B-chain during the insulin reductase assay. In aggregate these data suggest that the Mia40/lfALR system has a broad sequence specificity and that potential substrates may be protected from adventitious oxidation by kinetic sequestration within the mitochondrial IMS. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Hudson, Devin A.; Thorpe, Colin] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.
RP Thorpe, C (reprint author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.
EM cthorpe@udel.edu
FU NIH Grant [GM26643]; USPHS Training Grant [1-T32-GM008550]
FX This work was supported by NIH Grant GM26643 (CT) and USPHS Training
   Grant 1-T32-GM008550 (DH). We thank Dr. Vidyadhar Daithankar and Mr.
   Jason Cargill for helpful discussions.
CR Ang SK, 2009, J BIOL CHEM, V284, P28754, DOI 10.1074/jbc.M109.021113
   Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7
   Hoober KL, 1999, J BIOL CHEM, V274, P22147, DOI 10.1074/jbc.274.32.22147
   Fass D, 2008, BBA-MOL CELL RES, V1783, P557, DOI 10.1016/j.bbamcr.2007.11.009
   Sideris DP, 2010, ANTIOXID REDOX SIGN, V13, P1189, DOI 10.1089/ars.2010.3157
   Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107
   Rancy PC, 2008, BIOCHEMISTRY-US, V47, P12047, DOI 10.1021/bi801604x
   Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108
   Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v
   LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114
   Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017
   Kodali VK, 2010, ANTIOXID REDOX SIGN, V13, P1217, DOI 10.1089/ars.2010.3098
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653
   Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028
   Sapra A, 2015, BIOCHEMISTRY-US, V54, P612, DOI 10.1021/bi501360e
   Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108
   Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024
   HOLMGREN A, 1979, J BIOL CHEM, V254, P9627
   Longen S, 2014, DEV CELL, V28, P30, DOI 10.1016/j.devcel.2013.11.007
   Banci L, 2011, CHEM BIOL, V18, P794, DOI 10.1016/j.chembiol.2011.03.015
   Kojer K, 2014, BBA-PROTEINS PROTEOM, V1844, P1383, DOI 10.1016/j.bbapap.2014.02.004
   Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553
   Israel BA, 2014, J BIOL CHEM, V289, P5274, DOI 10.1074/jbc.M113.536219
   Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1
   Weckbecker D, 2012, EMBO J, V31, P4348, DOI 10.1038/emboj.2012.263
   Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q
   Jasuja R, 2012, J CLIN INVEST, V122, P2104, DOI 10.1172/JCI61228
   Guo PC, 2012, J BIOL CHEM, V287, P34961, DOI 10.1074/jbc.M112.394759
   Xu SL, 2012, P NATL ACAD SCI USA, V109, P16348, DOI 10.1073/pnas.1205226109
   Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389
   Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011
   Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555
   Vogtle FN, 2012, MOL CELL PROTEOMICS, V11, P1840, DOI 10.1074/mcp.M112.021105
   Hoober KL, 1996, J BIOL CHEM, V271, P30510
   Banci L, 2012, J AM CHEM SOC, V134, P1442, DOI 10.1021/ja209881f
   Chatzi A, 2013, ANTIOXID REDOX SIGN, V19, P54, DOI 10.1089/ars.2012.4855
   Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605
   Deponte M, 2009, J BIOCHEM, V146, P599, DOI 10.1093/jb/mvp133
   Endo T, 2010, ANTIOXID REDOX SIGN, V13, P1359, DOI 10.1089/ars.2010.3099
   Fischer M., 2013, INT J CELL BIOL, V2013
   Ge JY, 2013, ACS CHEM BIOL, V8, P2577, DOI 10.1021/cb4002602
   HABER E, 1962, J BIOL CHEM, V237, P1839
   Heckler EJ, 2008, BBA-MOL CELL RES, V1783, P567, DOI 10.1016/j.bbamcr.2007.10.002
   Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060
   Hoober KL, 1999, BIOCHEMISTRY-US, V38, P3211, DOI 10.1021/bi9820816
   Hoober KL, 1999, J BIOL CHEM, V274, P31759, DOI 10.1074/jbc.274.45.31759
   Horibe T, 2014, CHEMBIOCHEM, V15, P1598, DOI 10.1002/cbic.201400050
   Koch JR, 2014, J MOL BIOL, V426, P4087, DOI 10.1016/j.jmb.2014.10.022
   Koch JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4041
   Kojer K, 2015, MOL BIOL CELL, V26, P195, DOI 10.1091/mbc.E14-10-1422
   Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1
   LUTHMAN M, 1982, J BIOL CHEM, V257, P6686
   LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004
   MILLER MS, 1986, METHOD ENZYMOL, V122, P227
   SANGER F, 1949, BIOCHEM J, V44, P126
   Schaefer-Ramadan S, 2013, BIOCHEMISTRY-US, V52, P8323, DOI 10.1021/bi401305w
   Smith AM, 2004, J BIOMOL SCREEN, V9, P614, DOI 10.1177/1087057104265292
   Stojanovski D., 2012, CSH PERSPECT BIOL, V4
   Thorpe C, 2007, J BIOL CHEM, V282, P13929, DOI 10.1074/jbc.R600037200
   Wenz LS, 2015, BBA-MOL CELL RES, V1853, P1119, DOI 10.1016/j.bbamcr.2015.01.012
NR 63
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 1
EP 7
DI 10.1016/j.abb.2015.05.005
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000001
PM 26014136
ER

PT J
AU de Araujo, SS
   Neves, CML
   Guimaraes, SL
   Whitman, CP
   Johnson, WH
   Aparicio, R
   Nagem, RAP
AF de Araujo, Simara Semiramis
   Leal Neves, Cintia Mara
   Guimaraes, Samuel Leite
   Whitman, Christian P.
   Johnson, William H., Jr.
   Aparicio, Ricardo
   Pinto Nagem, Ronaldo Alves
TI Structural and kinetic characterization of recombinant 2-hydroxymuconate
   semialdehyde dehydrogenase from Pseudomonas putida G7
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Pseudomonas putida G7; Naphthalene degradation; 2-Hydroxymuconate
   semialdehyde dehydrogenase; Structure; Kinetics
ID X-RAY-SCATTERING; TOL PLASMID PWWO; NAPHTHALENE-DEGRADATION;
   META-CLEAVAGE; BIOLOGICAL MACROMOLECULES; CATECHOL 2,3-DIOXYGENASE;
   PATHWAY; IDENTIFICATION; BIODEGRADATION; BIOREMEDIATION
AB The first enzyme in the oxalocrotonate branch of the naphthalene-degradation lower pathway in Pseudomonas putida G7 is NahI, a 2-hydroxymuconate semialdehyde dehydrogenase which converts 2-hydroxymuconate semialdehyde to 2-hydroxymuconate in the presence of NAD(+). NahI is in family 8 (ALDH8) of the NAD(P)(+)-dependent aldehyde dehydrogenase superfamily. In this work, we report the cloning, expression, purification and preliminary structural and kinetic characterization of the recombinant NahI. The nahI gene was subcloned into a T7 expression vector and the enzyme was overexpressed in Escherichia coli ArcticExpress as a hexa-histidine-tagged fusion protein. After purification by affinity and size-exclusion chromatography, dynamic light scattering and small-angle X-ray scattering experiments were conducted to analyze the oligomeric state and the overall shape of the enzyme in solution. The protein is a tetramer in solution and has nearly perfect 222 point group symmetry. Protein stability and secondary structure content were evaluated by a circular dichroism spectroscopy assay under different thermal conditions. Furthermore, kinetic assays were conducted and, for the first time, KM (1.3 +/- 0.3 mu M) and kcat (0.9 s(-1)) values were determined at presumed NAD+ saturation. NahI is highly specific for its biological substrate and has no activity with salicylaldehyde, another intermediate in the naphthalene-degradation pathway. (C) 2015 Elsevier Inc. All rights reserved.
C1 [de Araujo, Simara Semiramis; Leal Neves, Cintia Mara; Guimaraes, Samuel Leite; Pinto Nagem, Ronaldo Alves] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Whitman, Christian P.; Johnson, William H., Jr.] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.
   [Aparicio, Ricardo] Univ Estadual Campinas, Inst Quim, Lab Biol Estrutural & Cristalog, BR-13083970 Campinas, SP, Brazil.
RP Nagem, RAP (reprint author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM nagem@icb.ufmg.br
RI Nagem, Ronaldo/K-3995-2012
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   [482173/2010-6]; Fundacao de Desenvolvimento a Pesquisa do Estado de
   Minas Gerais (FAPEMIG) [EDT-0185-0.00-07, Rede-170/08, RDP-00174-10];
   VALE S.A. [RDP-00174-10]; National Institutes of Health Grant
   [GM-41239]; Robert A. Welch Foundation [F-1334]; CNPq
FX We gratefully thank Dr Masataka Tsuda and Dr Masahiro Sota for kindly
   providing us with the P. putida G7 strain and the Laboratorio Nacional
   de Luz Sincrotron (CNPEM, Campinas, Brazil) for provision of
   synchrotron-radiation facilities (SAXS-1 beam line). This work was
   supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq; Project 482173/2010-6), Fundacao de Desenvolvimento a
   Pesquisa do Estado de Minas Gerais (FAPEMIG; Projects EDT-0185-0.00-07,
   Rede-170/08 and RDP-00174-10), VALE S.A. (RDP-00174-10), the National
   Institutes of Health Grant (GM-41239, CPW), and the Robert A. Welch
   Foundation (F-1334, CPW). SSA, CMLN and RA are recipients of
   scholarships and research fellowship from CNPq.
CR Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408
   Singh S, 2008, CURR OPIN BIOTECH, V19, P437, DOI 10.1016/j.copbio.2008.07.012
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137
   Cao B, 2009, APPL MICROBIOL BIOT, V85, P207, DOI 10.1007/s00253-009-2192-4
   ROSSELLOMORA RA, 1994, APPL ENVIRON MICROB, V60, P966
   Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638
   BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Bosch R, 2000, GENE, V245, P65, DOI 10.1016/S0378-1119(00)00038-X
   Sutherland TD, 2004, CLIN EXP PHARMACOL P, V31, P817, DOI 10.1111/j.1440-1681.2004.04088.x
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338
   Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X
   CERDAN P, 1994, J BACTERIOL, V176, P6074
   Alcalde M, 2006, TRENDS BIOTECHNOL, V24, P281, DOI 10.1016/j.tibtech.2005.04.002
   Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216
   Carneiro FRG, 2006, BIOCHEM BIOPH RES CO, V343, P260, DOI 10.1016/j.bbrc.2006.02.140
   Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k
   Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662
   Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243
   Coitinho JB, 2012, ACTA CRYSTALLOGR F, V68, P93, DOI 10.1107/S174430911105038X
   DAVIES JI, 1964, BIOCHEM J, V91, P251
   EPA, 2004, TOX REV NAPHTH
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   HARAYAMA S, 1993, MOL GEN GENET, V239, P81
   He ZQ, 1998, J BACTERIOL, V180, P4591
   I. Agilent Technologies, 2010, ARCTICEXPRESS COMP C
   INOUE J, 1995, J BACTERIOL, V177, P1196
   KOBAYASHI T, 1995, J BIOCHEM, V117, P614
   Lin M, 2000, J BIOL CHEM, V275, P40106, DOI 10.1074/jbc.M008027200
   Luo M, 2013, J MOL BIOL, V425, P3106, DOI 10.1016/j.jmb.2013.05.027
   Pemberton TA, 2014, BIOCHEMISTRY-US, V53, P1350, DOI 10.1021/bi500048b
   Porod G., 1982, SMALL ANGLE XRAY SCA, P17
   Saeed M, 2009, FREE RADICAL BIO MED, V47, P1075, DOI 10.1016/j.freeradbiomed.2009.07.020
   SALATREP.JM, 1971, EUR J BIOCHEM, V20, P400, DOI 10.1111/j.1432-1033.1971.tb01406.x
   SALATREP.JM, 1972, EUR J BIOCHEM, V28, P347, DOI 10.1111/j.1432-1033.1972.tb01920.x
   SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5
   Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020
   Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461
   Semisotnov G.V., 1996, J MOL BIOL, V262, P559
   Wang MF, 2009, CHEM-BIOL INTERACT, V178, P36, DOI 10.1016/j.cbi.2008.10.002
   YEN KM, 1982, P NATL ACAD SCI-BIOL, V79, P874, DOI 10.1073/pnas.79.3.874
   YEN KM, 1985, J BACTERIOL, V162, P1008
NR 52
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 8
EP 17
DI 10.1016/j.abb.2015.05.006
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000002
ER

PT J
AU Rizzuti, B
   Bartucci, R
   Sportelli, L
   Guzzi, R
AF Rizzuti, Bruno
   Bartucci, Rosa
   Sportelli, Luigi
   Guzzi, Rita
TI Fatty acid binding into the highest affinity site of human serum albumin
   observed in molecular dynamics simulation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Human serum albumin; Stearic acid; Molecular dynamics; Kinetics;
   Association; Binding site
ID PARTICLE MESH EWALD; CRYSTAL-STRUCTURE; PROTEIN; LACTOGLOBULIN;
   SPECTROSCOPY; REVEALS; ENTRY
AB Multiple molecular dynamics simulations were performed to investigate the association of stearic acid into the highest affinity binding site of human serum albumin.
   All binding events ended with a rapid (<10 ps) lock-in of the fatty acid due to formation of a hydrogen bond with Tyr401. The kinetics and energetics of the penetration process both depended linearly on the positional shift of the fatty acid, with an average insertion time and free energy reduction of, respectively, 32 +/- 20 ps and 0.70 +/- 0.15 kcal/mol per methylene group absorbed. Binding, events of longer duration (t(bind) > 1 ns) were characterized by a slow exploration of the pocket entry and, frequently, of a nearby protein crevice corresponding to a metastable state along the route to the binding site.
   Taken all together, these findings reconstruct the following pathway for the binding process of stearic acid: (i) contact with the protein surface, possibly facilitated by the presence of an intermediate location, (ii) probing of the site entry, (iii) insertion into the protein, and (iv) lock-in at the final position. This general description may also apply to other long-chain fatty acids binding into any of the high-affinity sites of albumin, or to specific sites of other lipid-binding proteins. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Rizzuti, Bruno] Univ Calabria, CNR NANOTEC, Licryl Lab, I-87036 Arcavacata Di Rende, Italy.
   [Rizzuti, Bruno] Univ Calabria, CEMIF Cal, I-87036 Arcavacata Di Rende, Italy.
   [Bartucci, Rosa; Sportelli, Luigi; Guzzi, Rita] Univ Calabria, Dept Phys, Mol Biophys Lab, I-87036 Arcavacata Di Rende, Italy.
   [Bartucci, Rosa; Sportelli, Luigi; Guzzi, Rita] Univ Calabria, Dept Phys, CNISM Unit, I-87036 Arcavacata Di Rende, Italy.
RP Rizzuti, B (reprint author), Univ Calabria, CNR NANOTEC, Licryl Lab, I-87036 Arcavacata Di Rende, Italy.
EM bruno.rizzuti@cnr.it
RI Rizzuti, Bruno/B-5781-2013; Guzzi, Rita/M-7654-2015
OI Rizzuti, Bruno/0000-0003-1110-764X; Guzzi, Rita/0000-0001-6769-3399
CR BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439
   Nerukh D, 2012, J PHYS CHEM LETT, V3, P3476, DOI 10.1021/jz301635h
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b
   Simard JR, 2006, J MOL BIOL, V361, P336, DOI 10.1016/j.jmb.2006.06.028
   Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002
   Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Fujiwara SI, 2008, BIOPHYS J, V94, P95, DOI 10.1529/biophysj.107.111377
   Sampath H, 2005, LIPIDS, V40, P1187, DOI 10.1007/s11745-005-1484-z
   Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093
   Tsfadia Y, 2007, FEBS LETT, V581, P1243, DOI 10.1016/j.febslet.2007.02.033
   Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869
   BERG HC, 1977, BIOPHYS J, V20, P193
   Smathers Rebecca L., 2011, Human Genomics, V5, P170
   Fujiwara S, 2013, BBA-GEN SUBJECTS, V1830, P5427, DOI 10.1016/j.bbagen.2013.03.032
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Pace CN, 1996, FASEB J, V10, P75
   Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108
   Rizzuti B, 2013, ARCH BIOCHEM BIOPHYS, V531, P128, DOI 10.1016/j.abb.2012.12.015
   Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090
   Simard JR, 2005, P NATL ACAD SCI USA, V102, P17958, DOI 10.1073/pnas.0506440102
   ASHBROOK JD, 1975, J BIOL CHEM, V250, P2333
   BATES RG, 1978, ANAL CHEM, V50, P1295, DOI 10.1021/ac50031a026
   Bello M, 2014, BIOPOLYMERS, V101, P744, DOI 10.1002/bip.22454
   Berendsen H. J. C., 1981, INTERMOLECULAR FORCE
   Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Dockal M, 1999, J BIOL CHEM, V274, P29303, DOI 10.1074/jbc.274.41.29303
   Evoli S, 2014, PROTEINS, V82, P2609, DOI 10.1002/prot.24625
   Friedman R, 2006, BIOPHYS J, V90, P1535, DOI 10.1529/biophysj.105.071571
   Guzzi R, 2012, J PHYS CHEM B, V116, P11608, DOI 10.1021/jp3074392
   Levin LB, 2010, J MOL MODEL, V16, P929, DOI 10.1007/s00894-009-0599-6
   Long D., 2009, PLOS ONE, V4
   Mihajlovic M, 2007, PROTEIN SCI, V16, P2042, DOI 10.1110/ps.072875307
   PEDERSEN AO, 1988, J BIOL CHEM, V263, P10236
   Peters Jr T., 1995, ALL ALBUMIN BIOCH GE
   RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032
   Rizzuti B, 2010, SPECTROSC-INT J, V24, P159, DOI 10.3233/SPE-2010-0424
   SAIFER A, 1961, J LIPID RES, V2, P268
   Taylor J. R., 1997, METHOD ENZYMOL
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   ZANOTTI G, 1994, BIOCHEM J, V301, P459
NR 45
TC 0
Z9 0
U1 16
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 18
EP 25
DI 10.1016/j.abb.2015.05.018
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000003
PM 26048999
ER

PT J
AU Sehanobish, E
   Chacon-Verdu, MD
   Sanchez-Amat, A
   Davidson, VL
AF Sehanobish, Esha
   Chacon-Verdu, Maria Dolores
   Sanchez-Amat, Antonio
   Davidson, Victor L.
TI Roles of active site residues in LodA, a cysteine tryptophylquinone
   dependent epsilon-lysine oxidase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Enzyme mechanism; Posttranslational modification; Quinoprotein; Amine
   oxidase; Cofactor; Redox enzyme
ID MARINOMONAS-MEDITERRANEA; METHYLAMINE DEHYDROGENASE; STEADY-STATE;
   MARINOCINE; MECHANISM; COFACTOR
AB Site-directed mutagenesis identified residues in the substrate channel of LodA that play multiple roles in regulating K-m values of substrates, kcat and the extent of biosynthesis of the protein-derived cysteine tryptophylquinone (CTQ) cofactor. Mutations of Cys448 increase K-m values for lysine and O-2, with the larger effect on K-lysine. Tyr211 resides within a mobile loop and is seen in the crystal structure of LodA to form a hydrogen bond with Lys530 that appears to stabilize its position in the channel. Y211F LodA had reduced levels of CTQ but near normal levels of k(cat). K530A and K530R variants exhibited diminished levels of CTQ but significantly increased kcat. The Y211F, K530A and K530R mutations each caused large increases in the K-m values for lysine and O-2. These effects of the mutations of Tyr211 and Lys530 suggest that when these residues are hydrogen-bonded they may form a gate that controls entry and exit of substrates and products from the active site. Y211A and Y211E variants had the highest level of CTQ but exhibited no activity. These results highlight the different evolutionary factors that must be considered for enzymes which possess protein-derived cofactors, in which the catalytic cofactor must be generated by posttranslational modifications. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Sehanobish, Esha; Davidson, Victor L.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA.
   [Chacon-Verdu, Maria Dolores; Sanchez-Amat, Antonio] Univ Murcia, Dept Genet & Microbiol, E-30100 Murcia, Spain.
RP Davidson, VL (reprint author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.
EM victor.davidson@ucf.edu
FU Burnett School of Biomedical Sciences; National Institute of General
   Medical Sciences of the National Institutes of Health [R37GM41574]
FX We acknowledge the collaboration of Patricia Lucas-Elio in the
   construction of some of the mutants used in this study, Yu Tang for
   technical assistance and Heather Williamson for helpful discussions.
   This research was supported by internal funds from the Burnett School of
   Biomedical Sciences and in part by the National Institute of General
   Medical Sciences of the National Institutes of Health under award number
   R37GM41574 (V.L.D.).
CR Mai-Prochnow A, 2008, J BACTERIOL, V190, P5493, DOI 10.1128/JB.00549-08
   Chen LY, 1998, J MOL BIOL, V276, P131, DOI 10.1006/jmbi.1997.1511
   Campillo-Brocal J.C., 2015, BMC GENOMICS, V16, P231
   Chacon-Verdu M.D., 2014, BIOCH BIOPHYS ACTA
   Chacon-Verdu MD, 2014, APPL MICROBIOL BIOT, V98, P2981, DOI 10.1007/s00253-013-5168-3
   Datta S, 2001, P NATL ACAD SCI USA, V98, P14268, DOI 10.1073/pnas.241429098
   Davidson VL, 2007, BIOCHEMISTRY-US, V46, P5283, DOI 10.1021/bi700468t
   Davidson VL, 2005, BIOORG CHEM, V33, P159, DOI 10.1016/j.bioorg.2004.10.001
   GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7
   Gomez D, 2006, BBA-PROTEINS PROTEOM, V1764, P1577, DOI 10.1016/j.bbapap.2006.08.014
   Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n
   Jones LH, 2005, J BIOL CHEM, V280, P17392, DOI 10.1074/jbc.M500943200
   Lucas-Elio P, 2006, J BACTERIOL, V188, P2493, DOI 10.1128/JB.188.7.2493-2501.2006
   Lucas-Elio P, 2005, BBA-GEN SUBJECTS, V1721, P193, DOI 10.1016/j.bbagen.2004.11.002
   Okazaki S, 2013, J BIOCHEM, V154, P233, DOI 10.1093/jb/mvt070
   Sehanobish E, 2014, FEBS LETT, V588, P752, DOI 10.1016/j.febslet.2014.01.021
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
NR 17
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 26
EP 32
DI 10.1016/j.abb.2015.05.013
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000004
PM 26048732
ER

PT J
AU Oka, M
   Takegawa, K
   Kimura, Y
AF Oka, Manami
   Takegawa, Kaoru
   Kimura, Yoshio
TI Enzymatic characterization of a class II lysyl-tRNA synthetase, LysS,
   from Myxococcus xanthus
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Lysyl-tRNA synthetase; Diadenosine tetraphosphate; Diadenosine
   triphosphate; Myxococcus xanthus
ID ESCHERICHIA-COLI; ADENYLYLATED NUCLEOTIDES; APPPPA; TETRAPHOSPHATE;
   TYPHIMURIUM; OXIDATION; STRESS; SITE
AB Lysyl-tRNA synthetases efficiently produce diadenosine tetraphosphate (ANA) from lysyl-AMP with ATP in the absence of tRNA. We characterized recombinant class II lysyl-tRNA synthetase (LysS) from Myxococcus xanthus and found that it is monomeric and requires Mn2+ for the synthesis of ANA. Surprisingly, Ze(2+) inhibited enzyme activity in the presence of Mn2+. When incubated with ATP, Mn2+, lysine, and inorganic pyrophosphatase, LysS first produced ANA and ADP, then converted ANA to diadenosine triphosphate (Ap(3)A), and finally converted Ap(3)A to ADP, the end product of the reaction. Recombinant LysS retained ANA synthase activity without lysine addition. Additionally, when incubated with ANA (minus pyrophosphatase), LysS converted AP(4)A mainly ATP and AMP, or ADP in the presence or absence of lysine, respectively. These results demonstrate that M. xanthus LysS has different enzymatic properties from class II lysyl-tRNA synthetases previously reported. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Oka, Manami; Kimura, Yoshio] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 76107, Japan.
   [Takegawa, Kaoru] Kyushu Univ, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka, Japan.
RP Kimura, Y (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 76107, Japan.
EM kimura@ag.kagawa-u.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [25440087]
FX This study was supported by Grants-in-Aid for Scientific Research from
   the Ministry of Education, Culture, Sports, Science and Technology of
   Japan (25440087).
CR Wright M, 2006, FEBS J, V273, P3534, DOI 10.1111/j.1742-4658.2006.05361.x
   Kisselev LL, 1998, FEBS LETT, V427, P157, DOI 10.1016/S0014-5793(98)00420-7
   GOERLICH O, 1982, EUR J BIOCHEM, V126, P135, DOI 10.1111/j.1432-1033.1982.tb06757.x
   ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08
   ZAMECNIK PC, 1966, BIOCHEM BIOPH RES CO, V24, P91, DOI 10.1016/0006-291X(66)90415-3
   LEE PC, 1983, P NATL ACAD SCI-BIOL, V80, P7496, DOI 10.1073/pnas.80.24.7496
   BLANQUET S, 1983, MOL CELL BIOCHEM, V52, P3
   Blanquet S., 2005, AMINOACYL TRNA SYNTH, P227
   BOCHNER BR, 1984, CELL, V37, P225, DOI 10.1016/0092-8674(84)90318-0
   BREVET A, 1995, J BIOL CHEM, V270, P14439
   [陈晓龙 Chen Xiaolong], 2013, [生物物理学报, Acta Biophysica Sinica], V29, P35
   Chen XL, 2013, FEBS J, V280, P102, DOI 10.1111/febs.12053
   Desogus G, 2000, BIOCHEMISTRY-US, V39, P8418, DOI 10.1021/bi0006722
   DIBBELT L, 1980, NUCLEIC ACIDS RES, V8, P4021, DOI 10.1093/nar/8.17.4021
   Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105
   Guo RT, 2009, J BIOL CHEM, V284, P28968, DOI 10.1074/jbc.M109.030692
   Ismail TM, 2003, J BIOL CHEM, V278, P32602, DOI 10.1074/jbc.M305994200
   LEE PC, 1983, J BIOL CHEM, V258, P6827
   LEVEQUE F, 1991, J BACTERIOL, V173, P7903
   LEVEQUE F, 1990, NUCLEIC ACIDS RES, V18, P305, DOI 10.1093/nar/18.2.305
NR 22
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 33
EP 39
DI 10.1016/j.abb.2015.05.014
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000005
PM 26048731
ER

PT J
AU Gainutdinov, T
   Molkentin, JD
   Siemen, D
   Ziemer, M
   Debska-Vielhaber, G
   Vielhaber, S
   Gizatullina, Z
   Orynbayeva, Z
   Gellerich, FN
AF Gainutdinov, T.
   Molkentin, J. D.
   Siemen, D.
   Ziemer, M.
   Debska-Vielhaber, G.
   Vielhaber, S.
   Gizatullina, Z.
   Orynbayeva, Z.
   Gellerich, F. N.
TI Knockout of cyclophilin D in Ppif(-/-) mice increases stability of brain
   mitochondria against Ca2+ stress
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cyclophilin D; Cyclosporin A; Brain mitochondria; Glutamate; Complex I
   respiration; Mitochondrial permeability transition; Ca2+ stress
ID PERMEABILITY TRANSITION PORE; CYCLOSPORINE-A CAUSES; CELL-DEATH; INNER
   MEMBRANE; RESPIRATORY-CHAIN; OXIDATIVE STRESS; CALCIUM; INHIBITION;
   COMPLEX; BINDING
AB The mitochondrial peptidyl prolyl isomerase cyclophilin D (CypD) activates permeability transition (PT). To study the role of CypD in this process we compared the functions of brain mitochondria isolated from wild type (BMWT) and CypD knockout (Ppif(-/-)) mice (BMKO) with and without CypD inhibitor Cyclosporin A (CsA) under normal and Ca2+ stress conditions. Our data demonstrate that BMKO are characterized by higher rates of glutamate/malate-dependent oxidative phosphorylation, higher membrane potential and higher resistance to detrimental Ca2+ effects than BMWT. Under the elevated Ca2+ and correspondingly decreased membrane potential the dose response in BMKO shifts to higher Ca2+ concentrations as compared to BMWT. However, significantly high Ca2+ levels result in complete loss of membrane potential in BMKO, too. CsA diminishes the loss of membrane potential in BMWT but has no protecting effect in BMKO. The results are in line with the assumption that PT is regulated by CypD under the control of matrix Ca2+. Due to missing of CypD the BMKO can favor PT only at high Ca2+ concentrations. It is concluded that CypD sensitizes the brain mitochondria to PT, and its inhibition by CsA or CypD absence improves the complex I-related mitochondrial function and increases mitochondria stability against Ca2+ stress. (C) 2015 Published by Elsevier Inc.
C1 [Gainutdinov, T.; Siemen, D.; Ziemer, M.; Debska-Vielhaber, G.; Vielhaber, S.; Gellerich, F. N.] Univ Magdeburg, Dept Neurol, D-39120 Magdeburg, Germany.
   [Gainutdinov, T.] Acad Sci Tatarstan, Inst Ecol & Use Mineral Resources, Kazan 420087, Russia.
   [Molkentin, J. D.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Dept Pediat, Cincinnati, OH 45229 USA.
   [Gizatullina, Z.; Gellerich, F. N.] Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany.
   [Orynbayeva, Z.] Drexel Univ, Coll Med, Dept Surg, Philadelphia, PA 19102 USA.
RP Orynbayeva, Z (reprint author), Leibniz Inst Neurobiol, Dept Behav Neurol, Brennecke Str 6, D-39118 Magdeburg, Germany.
EM zorynbay@drexelmed.edu; frank.gellerich@med.ovgu.de
FU Deutsches Zentrum fur Neurodegenerative Erkrankungen (DZNE); Drexel
   University Professional Enrichment and Growth Grant
FX The support of Deutsches Zentrum fur Neurodegenerative Erkrankungen
   (DZNE) and Drexel University Professional Enrichment and Growth Grant
   (to Z.O.) are appreciated. We thank Richard Sensenig for help with
   manuscript preparation.
CR Di Lisa F, 2011, BBA-MOL CELL RES, V1813, P1316, DOI 10.1016/j.bbamcr.2011.01.031
   Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104
   HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408
   CONNERN CP, 1994, BIOCHEM J, V302, P321
   Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171
   Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176
   Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009
   Bernardi P, 1999, PHYSIOL REV, V79, P1127
   Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469
   Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434
   Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006
   Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321
   Zhong Z, 2001, J PHARMACOL EXP THER, V299, P858
   Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005
   Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662
   Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200
   Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22
   Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3
   Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102
   Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115
   Siemen D, 2013, IUBMB LIFE, V65, P255, DOI 10.1002/iub.1130
   Gellerich FN, 2012, BIOCHEM J, V443, P747, DOI 10.1042/BJ20110765
   BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826
   Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200
   Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095
   Brust D, 2010, AGING CELL, V9, P761, DOI 10.1111/j.1474-9726.2010.00609.x
   Brustovetsky N, 2000, J NEUROSCI, V20, P8229
   CROMPTON M, 1994, BIOCHEM J, V302, P181
   De Hornedo JP, 2007, NEFROLOGIA, V27, P565
   Doczi J, 2011, J BIOL CHEM, V286, P6345, DOI 10.1074/jbc.M110.196600
   Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003
   Eliseev RA, 2007, NEUROBIOL AGING, V28, P1532, DOI 10.1016/j.neurobiolaging.2006.06.022
   FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0
   Gizatullina ZZ, 2011, MITOCHONDRION, V11, P421, DOI 10.1016/j.mito.2010.12.012
   Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914
   HOKANSON JF, 1995, AM J RESP CRIT CARE, V151, P1848
   JUNG K, 1985, FEBS LETT, V183, P167, DOI 10.1016/0014-5793(85)80977-7
   LANOUE KF, 1974, J BIOL CHEM, V249, P7522
   Li B, 2012, BBA-BIOENERGETICS, V1817, P1628, DOI 10.1016/j.bbabio.2012.05.011
   Lin DT, 2002, J BIOL CHEM, V277, P31134, DOI 10.1074/jbc.M112035200
   Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200
   Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654
   Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010
   Panov AV, 2004, ARCH BIOCHEM BIOPHYS, V424, P44, DOI 10.1016/j.abb.2004.01.013
   Pottecher J, 2013, J VASC SURG, V57, P1100, DOI 10.1016/j.jvs.2012.09.020
   Rodriguez LCD, 2007, J APPL TOXICOL, V27, P310, DOI 10.1002/jat.1192
   Thomas B, 2012, ANTIOXID REDOX SIGN, V16, P855, DOI 10.1089/ars.2010.3849
   WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1
   Zhang YX, 2005, J BIOL CHEM, V280, P4842, DOI 10.1074/jbc.M409178200
NR 51
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 40
EP 46
DI 10.1016/j.abb.2015.05.009
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000006
PM 26032335
ER

PT J
AU Purkrtoya, Z
   Chardot, T
   Froissard, M
AF Purkrtoya, Zita
   Chardot, Thierry
   Froissard, Marine
TI N-terminus of seed caleosins is essential for lipid droplet sorting but
   not for lipid accumulation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Lipid droplets; Seed; Caleosin; Structure-function study; Saccharomyces
   cerevisiae; Lipid accumulation
ID ARTIFICIAL OIL BODIES; CENTRAL HYDROPHOBIC DOMAIN; CALCIUM-BINDING
   PROTEINS; ARABIDOPSIS-THALIANA; IN-VITRO; ABSCISIC-ACID; HETEROLOGOUS
   EXPRESSION; STRUCTURAL-PROPERTIES; CA2+-BINDING PROTEIN; SUNFLOWER
   OLEOSIN
AB Caleosin, a calcium-binding protein associated with plant lipid droplets, stimulates lipid accumulation when heterologously expressed in Saccharomyces cerevisiae. Accumulated lipids are stored in cytoplasmic lipid droplets that are stabilised by incorporated caleosin. We designed a set of mutants affecting putative crucial sites for caleosin function and association with lipid droplets, i.e. the N-terminus, the EF-hand motif and the proline-knot motif. We investigated the effect of introduced mutations on caleosin capacity to initiate lipid accumulation and on caleosin sorting within cell as well as on its association with lipid droplets. Our results strongly suggest that the N-terminal domain is essential for proper protein sorting and targeting to lipid droplets but not for enhancing lipid accumulation. (C) 2015 Elsevier Inc. All rights reserved.
C1 INRA, CNRS, Inst Jean Pierre Bourgin, Saclay Plant Sci,UMR 1318,ERL 3559, F-78026 Versailles, France.
   AgroParisTech, CNRS, Inst Jean Pierre Bourgin, Saclay Plant Sci,UMR 1318,ERL 3559, F-78026 Versailles, France.
RP Purkrtoya, Z (reprint author), Inst Chem Technol, Dept Biochem & Microbiol, Tech 5, CR-16628 Prague 6, Czech Republic.
EM purkrtova@gmail.com; thierry.chardot@versailles.inra.fr;
   marine.froissard@versailles.inra.fr
FU DGA (Direction Generale de l'Armement)/DGAC (Direction Generale de
   l'Aviation Civile) [2012 93 0805]
FX This study was part of the CAER programme funded by the DGA (Direction
   Generale de l'Armement)/DGAC (Direction Generale de l'Aviation Civile)
   under the agreement no. 2012 93 0805. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abell BM, 2002, J BIOL CHEM, V277, P8602, DOI 10.1074/jbc.M103712200
   Poxleitner M, 2006, PLANT J, V47, P917, DOI 10.1111/j.1365-313X.2006.02845.x
   Khalil HB, 2011, PLANT MOL BIOL, V77, P145, DOI 10.1007/s11103-011-9801-1
   Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1
   Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648
   Parthibane V, 2012, J BIOL CHEM, V287, P1946, DOI 10.1074/jbc.M111.309955
   Partridge M, 2009, PLANT PHYSIOL BIOCH, V47, P796, DOI 10.1016/j.plaphy.2009.04.005
   Abell BM, 1997, PLANT CELL, V9, P1481
   KOLLING R, 1994, EMBO J, V13, P3261
   Hanano A, 2006, J BIOL CHEM, V281, P33140, DOI 10.1074/jbc.M605395200
   BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6
   Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004
   Takahashi S, 2000, PLANT CELL PHYSIOL, V41, P898, DOI 10.1093/pcp/pcd010
   Lin IP, 2012, PLANT PHYSIOL BIOCH, V61, P80, DOI 10.1016/j.plaphy.2012.09.008
   Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x
   Froissard M, 2009, FEMS YEAST RES, V9, P428, DOI 10.1111/j.1567-1364.2009.00483.x
   Blee E, 2014, PLANT PHYSIOL, V166, P109, DOI 10.1104/pp.114.245316
   Blee E, 2012, FEBS J, V279, P3981, DOI 10.1111/j.1742-4658.2012.08757.x
   Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x
   Aubert Y, 2010, PLANT CELL PHYSIOL, V51, P1975, DOI 10.1093/pcp/pcq155
   Zhou Y, 2006, PROTEINS, V65, P643, DOI 10.1002/prot.21139
   Beaudoin F, 2000, PLANT J, V23, P159, DOI 10.1046/j.1365-313x.2000.00769.x
   Beaudoin F, 2002, PLANTA, V215, P293, DOI 10.1007/s00425-002-0737-1
   Beaudoin F, 2000, PLANTA, V210, P439, DOI 10.1007/PL00008152
   Chen JCF, 2001, PLANT CELL PHYSIOL, V42, P1245, DOI 10.1093/pcp/pce160
   Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713
   Frandsen G, 1996, J BIOL CHEM, V271, P343
   Froissard Marine, 2006, Biotechnology Journal, V1, P308, DOI 10.1002/biot.200500034
   Hernandez-Pinzon I, 2001, PLANT PHYSIOL BIOCH, V39, P615, DOI 10.1016/S0981-9428(01)01274-8
   Hsiao ESL, 2011, PLANT PHYSIOL BIOCH, V49, P77, DOI 10.1016/j.plaphy.2010.10.001
   Jiang PL, 2009, PLANT PHYSIOL BIOCH, V47, P1009, DOI 10.1016/j.plaphy.2009.07.004
   Jiang Pei-Luen, 2010, Plant Signal Behav, V5, P447, DOI 10.4161/psb.5.4.10874
   Jimenez JA, 2008, J PLANT PHYSIOL, V165, P1798, DOI 10.1016/j.jplph.2007.11.013
   Jolivet P, 2013, PROTEOMICS, V13, P1836, DOI 10.1002/pmic.201200431
   Lin LJ, 2005, PLANT PHYSIOL BIOCH, V43, P770, DOI 10.1016/j.plaphy.2005.07.008
   Liu TH, 2009, J AGR FOOD CHEM, V57, P2308, DOI 10.1021/jf803566w
   Liu TH, 2011, BIOTECHNOL PROGR, V27, P1760, DOI 10.1002/btpr.684
   Maniatis T., 1982, MOL CLONING LAB MANU
   Ohsaki Y, 2014, CHEM BIOL, V21, P86, DOI 10.1016/j.chembiol.2013.08.009
   Peng CC, 2007, J AGR FOOD CHEM, V55, P5604, DOI 10.1021/jf070977o
   Purkrtova Z, 2008, J AGR FOOD CHEM, V56, P11217, DOI 10.1021/jf802305b
   Purkrtova Z, 2007, ARCH BIOCHEM BIOPHYS, V464, P335, DOI 10.1016/j.abb.2007.04.041
   Rigden DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021507
   Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716
   Shen Y, 2014, BIOCHEM BIOPH RES CO, V448, P365, DOI 10.1016/j.bbrc.2014.04.115
   Song WL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-124
   THOYTS PJE, 1995, PLANT MOL BIOL, V29, P403, DOI 10.1007/BF00043664
   Ting JTL, 1997, J BIOL CHEM, V272, P3699, DOI 10.1074/jbc.272.6.3699
   Toorop PE, 2005, PLANTA, V221, P637, DOI 10.1007/s00425-004-1477-1
   Tzen JT, 2012, ISRN BOT 2012, V2012
   VANROOIJEN GJH, 1995, PLANT PHYSIOL, V109, P1353, DOI 10.1104/pp.109.4.1353
   VOLLAND C, 1994, J BIOL CHEM, V269, P9833
   Zienkiewicz K, 2010, J EXP BOT, V61, P1537, DOI 10.1093/jxb/erq022
NR 53
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 47
EP 54
DI 10.1016/j.abb.2015.05.008
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000007
PM 26032334
ER

PT J
AU Hu, MY
   Tian, GW
   Gibbons, DE
   Jiao, J
   Qin, YX
AF Hu, Minyi
   Tian, Guo-Wei
   Gibbons, Daniel E.
   Jiao, Jian
   Qin, Yi-Xian
TI Dynamic fluid flow induced mechanobiological modulation of in situ
   osteocyte calcium oscillations
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Osteocyte; Mechanotransduction; Calcium signaling; Wnt signaling; Bone
   fluid flow; Calcium homeostasis
ID SKELETAL-MUSCLE STIMULATION; FUNCTIONAL DISUSE MODEL; TRABECULAR BONE
   LOSS; INTRAMEDULLARY PRESSURE; CORTICAL BONE; TRANSCRIPTION FACTORS;
   LOW-AMPLITUDE; SHEAR-STRESS; LONG BONES; FREQUENCY
AB Distribution of intramedullary pressure (Imp) induced bone fluid flow has been suggested to influence the magnitude of mechanotransductory signals within bone. As osteocytes have been suggested as major mechanosensors in bone network, it is still unclear how osteocytes embedded within a mineralized bone matrix respond to the external mechanical stimuli derived from direct coupling of dynamic fluid flow stimulation (DFFS). While in vitro osteocytes show unique Ca2+ oscillations to fluid shear, the objective of this study was to use a confocal imaging technique to visualize and quantify Ca2+ responses in osteocytes in situ under DFFS into the marrow cavity of an intact ex vivo mouse femur. This study provided significant technical development for evaluating mechanotransduction mechanism in bone cell response by separation of mechanical strain and fluid flow factors using ImP stimulation, giving the ability for true real-time imaging and monitoring of bone cell activities during the stimulation. Loading frequency dependent Ca2+ oscillations in osteocytes indicated the optimized loading at 10 Hz, where such induced response was significantly diminished via blockage of the Wnt/beta-catenin signaling pathway. The results provided a pilot finding of the potential crosstalk or interaction between Wnt/beta-catenin signaling and Ca2+ influx signaling of in situ osteocytes in response to mechanical signals. Findings from the present study make a valuable tool to investigate how in situ osteocytes respond and transduce mechanical signals, e.g. DFFS, as a central mechanosensor. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Hu, Minyi; Gibbons, Daniel E.; Jiao, Jian; Qin, Yi-Xian] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
   [Tian, Guo-Wei] SUNY Stony Brook, CMIC Two Photon Imaging Ctr, Stony Brook, NY 11794 USA.
RP Qin, YX (reprint author), SUNY Stony Brook, Dept Biomed Engn, Bioengn Bldg,Rm 215, Stony Brook, NY 11794 USA.
EM Yi-Xian.Qin@stonybrook.edu
FU National Institute of Health [R01 AR52379, AR61821]; US Army Medical
   Research and Materiel Command; National Space Biomedical Research
   Institute through NASA Cooperative Agreement [NCC 9-58]
FX This research is kindly supported by the National Institute of Health
   (R01 AR52379 and AR61821, YXQ), the US Army Medical Research and
   Materiel Command, and the National Space Biomedical Research Institute
   through NASA Cooperative Agreement NCC 9-58 (YXQ). The authors are
   grateful to CMIC-Two Photon Imaging Center at Stony Brook University for
   technical supports.
CR Qin YX, 1998, J ORTHOPAED RES, V16, P482, DOI 10.1002/jor.1100160414
   Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122
   Warden SJ, 2004, BONE, V34, P261, DOI 10.1016/j.bone.2003.11.011
   Jing D, 2014, FASEB J, V28, P1582, DOI 10.1096/fj.13-237578
   Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012
   Qin YX, 2003, J BIOMECH, V36, P1427, DOI [10.1016/S0021-9290(03)00127-1, 10.1016/S0021-92900(03)00127-1]
   Hung CT, 1996, J BIOMECH, V29, P1411, DOI 10.1016/0021-9290(96)84536-2
   Qin YX, 2009, J BIOMECH, V42, P140, DOI 10.1016/j.jbiomech.2008.10.018
   Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044
   Burger EH, 1999, FASEB J, V13, pS101
   Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224
   TURNER CH, 1995, AM J PHYSIOL-ENDOC M, V269, pE438
   Hu MY, 2014, ARCH BIOCHEM BIOPHYS, V545, P154, DOI 10.1016/j.abb.2014.01.021
   Civitelli R, 2008, ARCH BIOCHEM BIOPHYS, V473, P188, DOI 10.1016/j.abb.2008.04.005
   Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6
   Rubin CT, 2001, DRUG DISCOV TODAY, V6, P848, DOI 10.1016/S1359-6446(01)01872-4
   Kwon RY, 2010, J BONE MINER RES, V25, P1798, DOI 10.1002/jbmr.74
   Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011
   Rubin J, 1997, J CELL PHYSIOL, V170, P81, DOI 10.1002/(SICI)1097-4652(199701)170:1<81::AID-JCP9>3.0.CO;2-H
   Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200
   Hu MY, 2013, BONE, V57, P137, DOI 10.1016/j.bone.2013.07.030
   Lu XL, 2012, J BONE MINER RES, V27, P563, DOI 10.1002/jbmr.1474
   Hsieh YF, 2001, J BONE MINER RES, V16, P918, DOI 10.1359/jbmr.2001.16.5.918
   Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001
   Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087
   Zhang P, 2007, J BONE MINER METAB, V25, P383, DOI 10.1007/s00774-007-0774-8
   Qin YX, 2014, BIOMED RES INT, DOI 10.1155/2014/863421
   Lam HY, 2008, BONE, V43, P1093, DOI 10.1016/j.bone.2008.07.253
   REICH KM, 1990, J CELL PHYSIOL, V143, P100, DOI 10.1002/jcp.1041430113
   Hu MY, 2012, BONE, V51, P819, DOI 10.1016/j.bone.2012.06.030
   Ishihara Y, 2013, BONE, V53, P204, DOI 10.1016/j.bone.2012.12.002
   Capulli M, 2014, ARCH BIOCHEM BIOPHYS, V561, P3, DOI 10.1016/j.abb.2014.05.003
   Hu M., 2013, BONE RES, V1
   Hu MY, 2014, BONE, V66, P178, DOI 10.1016/j.bone.2014.05.018
   Huang RP, 1999, J GERONTOL A-BIOL, V54, pB352, DOI 10.1093/gerona/54.8.B352
   Lam H, 2011, BONE, V48, P399, DOI 10.1016/j.bone.2010.09.018
   Lam H, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-18
   LeBlanc A., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P157
   Midura RJ, 2005, MED ENG PHYS, V27, P285, DOI 10.1016/j.medengphy.2004.12.014
   MONTGOMERY RJ, 1988, MICROVASC RES, V35, P295, DOI 10.1016/0026-2862(88)90084-2
   Otter MW, 1999, MED HYPOTHESES, V53, P363, DOI 10.1054/mehy.1998.0782
   Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223
   Pollack S.R., 1977, J BIOMED MATER RES, V11, P670
   Qin YX, 2010, J MUSCULOSKEL NEURON, V10, P12
   Rubin C.T., 1994, CLIN ORTHOP RELAT R, P165
   Winet H., 2003, EUR CELLS MATER, V6, P10
   Winet H., 2003, European Cells & Materials, V6, P1
NR 47
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 55
EP 61
DI 10.1016/j.abb.2015.05.012
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000008
PM 26045248
ER

PT J
AU Beaupre, BA
   Hoag, MR
   Moran, GR
AF Beaupre, Brett A.
   Hoag, Matthew R.
   Moran, Graham R.
TI Rena lase does not catalyze the oxidation of catecholamines
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Renalase; FAD; Oxidase; Catecholamines; NAD; Dioxygen
ID HEART-TRANSPLANT RECIPIENTS; BLOOD-PRESSURE REGULATION; KIDNEY-FUNCTION;
   ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR FUNCTION; MONOAMINE-OXIDASE;
   HYPERTENSION; DISEASE; ENZYME; DOPAMINE
AB It is widely accepted that the function of human renalase is to oxidize catecholamines in blood. However, this belief is based on experiments that did not account for slow, facile catecholamine autoxidation reactions. Recent evidence has shown that renalase has substrates with which it reacts rapidly. The reaction catalyzed defines renalase as an oxidase, one that harvests two electrons from either 2-dihydroNAD(P) or 6-dihydroNAD(P) to form beta-NAD(P)(+) and hydrogen peroxide. The apparent metabolic purpose of such a reaction is to avoid inhibition of primary dehydrogenase enzymes by these beta-NAD(P)H isomers. This article demonstrates that renalase does not catalyze the oxidation of neurotransmitter catecholamines. Using high-performance liquid chromatography we show that there is no evidence of consumption of epinephrine by renalase. Using time-dependent spectrophotometry we show that the renalase FAD cofactor spectrum is unresponsive to added catecholamines, that adrenochromes are not observed to accumulate in the presence of renalase and that the kinetics of single turnover reactions with 6-dihydroNAD are unaltered by the addition of catecholamines. Lastly we show using an oxygen electrode assay that plasma renalase activity is below the level of detection and only when exogenous renalase and 6-dihydroNAD are added can dioxygen be observed to be consumed. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Beaupre, Brett A.; Hoag, Matthew R.; Moran, Graham R.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53211 USA.
RP Moran, GR (reprint author), Univ Wisconsin, Dept Chem & Biochem, 3210 N Cramer St, Milwaukee, WI 53211 USA.
EM moran@uwm.edu
FU National Science Foundation Grant [CHE-1402475]; University of
   Wisconsin-Milwaukee Research Growth Initiative Grant
FX This research was supported by a National Science Foundation Grant to
   G.R.M. (CHE-1402475) and by a University of Wisconsin-Milwaukee Research
   Growth Initiative Grant to G.R.M.
CR Desir GV, 2009, KIDNEY INT, V76, P366, DOI 10.1038/ki.2009.169
   Baroni S, 2013, CURR PHARM DESIGN, V19, P2540
   Desir GV, 2008, CURR OPIN NEPHROL HY, V17, P181, DOI 10.1097/MNH.0b013e3282f521ba
   Desir GV, 2012, J AM SOC HYPERTENS, V6, P417, DOI 10.1016/j.jash.2012.09.002
   Lee HT, 2013, J AM SOC NEPHROL, V24, P445, DOI 10.1681/ASN.2012090943
   Wu YL, 2011, KIDNEY INT, V79, P853, DOI 10.1038/ki.2010.488
   Wybraniec MT, 2014, J AM SOC HYPERTENS, V8, P464, DOI 10.1016/j.jash.2014.04.009
   Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066
   Zbroch E, 2013, RENAL FAILURE, V35, P673, DOI 10.3109/0886022X.2013.778754
   Xu JC, 2007, CURR OPIN NEPHROL HY, V16, P373, DOI 10.1097/MNH.0b013e3281bd8877
   Wang J, 2008, MOL BIOL REP, V35, P613, DOI 10.1007/s11033-007-9131-1
   Zbroch E, 2012, POL ARCH MED WEWN, V122, P40
   Zbroch E, 2012, KIDNEY BLOOD PRESS R, V35, P395, DOI 10.1159/000338178
   Przybylowski P, 2011, TRANSPL P, V43, P3888, DOI 10.1016/j.transproceed.2011.08.075
   Buraczynska M, 2011, NEUROMOL MED, V13, P321, DOI 10.1007/s12017-011-8158-6
   Przybylowski P, 2013, TRANSPL P, V45, P394, DOI 10.1016/j.transproceed.2012.02.042
   Napolitano A, 2011, CURR MED CHEM, V18, P1832
   Desir GV, 2014, NEPHROL DIAL TRANSPL, V29, P22, DOI 10.1093/ndt/gft083
   Eikelis N, 2011, KIDNEY INT, V79, P1380, DOI 10.1038/ki.2011.90
   Pandini V, 2010, PROTEIN EXPRES PURIF, V72, P244, DOI 10.1016/j.pep.2010.03.008
   Zhao Q, 2007, J MOL MED-JMM, V85, P877, DOI 10.1007/s00109-006-0151-4
   Hennebry SC, 2010, MOL PSYCHIATR, V15, P234, DOI 10.1038/mp.2009.74
   Baraka A, 2012, J CARDIOVASC PHARM T, V17, P412, DOI 10.1177/1074248412446977
   Beaupre BA, 2015, BIOCHEMISTRY-US, V54, P795, DOI 10.1021/bi5013436
   Beaupre BA, 2013, BIOCHEMISTRY-US, V52, P8929, DOI 10.1021/bi401185m
   Beaupre BA, 2013, J AM CHEM SOC, V135, P13980, DOI 10.1021/ja407384h
   Boomsma F, 2007, J NEURAL TRANSM, V114, P775, DOI 10.1007/s00702-007-0672-1
   Czarkowska-Paczek B, 2013, TOHOKU J EXP MED, V231, P321, DOI 10.1620/tjem.231.321
   Desir G, 2012, PEDIATR NEPHROL, V27, P719, DOI 10.1007/s00467-011-1828-7
   Desir GV, 2007, J AM SOC HYPERTENS, V1, P99, DOI 10.1016/j.jash.2006.12.001
   Desir GV, 2011, CURR OPIN NEPHROL HY, V20, P31, DOI 10.1097/MNH.0b013e3283412721
   Desir GV, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002634
   Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013496
   GODTFREDSEN SE, 1978, CARLSBERG RES COMMUN, V43, P171, DOI 10.1007/BF02914239
   Gu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014633
   Guo Yunzhong, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P537, DOI 10.3969/j.issn.1672-7347.2012.05.021
   Li G, 2008, CIRCULATION, V117, P1277, DOI 10.1161/CIRCULATIONAHA.107.732032
   Li Xiaogang, 2014, Med Sci Monit, V20, P688, DOI 10.12659/MSM.890261
   MALYSZKO J, 2014, ADV MED SCI, V60, P41
   Medvedev AE, 2010, BIOCHEMISTRY-MOSCOW+, V75, P951, DOI 10.1134/S0006297910080018
   Milani M, 2011, J MOL BIOL, V411, P463, DOI 10.1016/j.jmb.2011.06.010
   Quelhas-Santos J., 2015, CURR HYPERTENS REV
   Sizova D, 2013, AM J PHYSIOL-RENAL, V305, pF839, DOI 10.1152/ajprenal.00616.2012
   Sonawane PJ, 2014, BIOCHEMISTRY-US, V53, P6878, DOI 10.1021/bi500798n
   Wang F, 2014, KIDNEY BLOOD PRESS R, V39, P252, DOI 10.1159/000355802
   Wang F., 2014, CLIN EXP NEPHROL
   Wang F, 2014, RENAL FAILURE, V36, P552, DOI 10.3109/0886022X.2013.876352
   Wang Y, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000044
   Zbroch E, 2012, POL ARCH MED WEWN, V122, P174
NR 49
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 62
EP 66
DI 10.1016/j.abb.2015.05.016
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000009
PM 26049000
ER

PT J
AU Blbulyan, S
   Trchounian, A
AF Blbulyan, Syuzanna
   Trchounian, Armen
TI Impact of membrane-associated hydrogenases on the FOF1-ATPase in
   Escherichia coli during glycerol and mixed carbon fermentation: ATPase
   activity and its inhibition by N,N '-dicyclohexylcarbodiimide in the
   mutants lacking hydrogenases
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Membrane proteins; Hydrogenases; FOF1-ATPase; Fermentation; Mutants;
   Escherichia coli
ID H-2 PRODUCTION; ANAEROBIC FERMENTATION; DIFFERENT PHS; F0F1-ATPASE;
   VESICLES; GLUCOSE; STOICHIOMETRY; METABOLISM; MATURATION; TRANSPORT
AB Escherichia coli is able to ferment glycerol and to produce molecular hydrogen (H-2) by four membrane-associated hydrogenases (Hyd) changing activity in response to different conditions. In this study, overall ATPase activity of glycerol alone and mixed carbon sources (glucose and glycerol) fermented E. coli wild type and different Hyd mutants and its inhibition by N,N'-dicyclohexylcarbodiimide (DCCD) were first investigated. ATPase activity was higher in glycerol fermented wild type cells at pH 7.5 compared to pH 6.5 and pH 5.5; DCCD inhibited markedly ATPase activity at pH 7.5. The ATPase activity at pH 7.5, compared with wild type, was lower in selC and less in hypF single mutants, suppressed in hyaB hybC selC triple mutant. Moreover, total ATPase activity of mixed carbon fermented wild type cells was maximal at pH 7.5 and lowered at pH 5.5. The ATPase activities of hypF and hyaB hybC selC mutants were higher at pH 5.5, compared with wild type; DCCD inhibited markedly ATPase activity of hypF mutant. These results demonstrate that in E. coli during glycerol fermentation the membrane proton-translocating FOF1-ATPase has major input in overall ATPase activity and alkaline pH is more optimal for the FOF1-ATPase operation. Hyd-1 and Hyd-2 are required for the FOF1-ATPase activity upon anaerobic fermentation of glycerol. The impact of Hyd-1 and Hyd-2 on the FOF1-ATPase is more obvious during mixed carbon fermentation at slightly acidic pH. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Blbulyan, Syuzanna; Trchounian, Armen] Yerevan State Univ, Fac Biol, Dept Microbiol & Plants & Microbes Biotechnol, Yerevan 0025, Armenia.
RP Trchounian, A (reprint author), Yerevan State Univ, Fac Biol, Dept Microbiol & Plants & Microbes Biotechnol, 1 A Manoukian Str, Yerevan 0025, Armenia.
EM Trchounian@ysu.am
FU State Committee of Science, Ministry of Science and Education of Armenia
   [14A-1f81, 13-1F002]
FX We would like to thank to Prof. L. Navasardyan (Department of
   Biochemistry, Yerevan State University, Armenia) for help in using of
   French press. This work was supported by the Research Grants from State
   Committee of Science, Ministry of Science and Education of Armenia, to
   SB (14A-1f81) and to AT (13-1F002).
CR ADLER LW, 1977, J BACTERIOL, V129, P959
   Trchounian K, 2013, INT J HYDROGEN ENERG, V38, P3921, DOI 10.1016/j.ijhydene.2013.01.138
   Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025
   Bagramyan K, 2002, FEBS LETT, V516, P172, DOI 10.1016/S0014-5793(02)02555-3
   Sanchez-Torres V, 2013, INT J HYDROGEN ENERG, V38, P3905, DOI 10.1016/j.ijhydene.2013.01.031
   FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0
   Durnin G, 2009, BIOTECHNOL BIOENG, V103, P148, DOI 10.1002/bit.22246
   Gonzalez R, 2008, METAB ENG, V10, P234, DOI 10.1016/j.ymben.2008.05.001
   Trchounian K, 2013, CELL BIOCHEM BIOPHYS, V66, P103, DOI 10.1007/s12013-012-9458-7
   CHEN GFT, 1993, J BIOL CHEM, V268, P23128
   Andrews SC, 1997, MICROBIOL-SGM, V143, P3633
   Trchounian K, 2009, INT J HYDROGEN ENERG, V34, P8839, DOI 10.1016/j.ijhydene.2009.08.056
   Lee HS, 2009, BIOTECHNOL BIOENG, V102, P749, DOI 10.1002/bit.22107
   Trchounian A, 2004, BIOCHEM BIOPH RES CO, V315, P1051, DOI 10.1016/j.bbrc.2004.02.005
   Murarka A, 2008, APPL ENVIRON MICROB, V74, P1124, DOI 10.1128/AEM.02192-07
   Liu Y, 2011, CURR MICROBIOL, V62, P152, DOI 10.1007/s00284-010-9683-5
   AZZI A, 1984, BIOCHIM BIOPHYS ACTA, V768, P209, DOI 10.1016/0304-4173(84)90017-X
   Bagramyan K, 2003, BIOCHEM BIOPH RES CO, V306, P361, DOI 10.1016/S0006-291X(03)00967-7
   Blbulyan S, 2011, BIOSCIENCE REP, V31, P179, DOI 10.1042/BSR20100053
   FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725
   KONINGS WN, 1973, P NATL ACAD SCI USA, V70, P3376, DOI 10.1073/pnas.70.12.3376
   Mnatsakanyan N., 2002, BIOSCIENCE REP, V22, P423
   Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200
   Pinske C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-134
   Poladyan A, 2013, CURR MICROBIOL, V66, P49, DOI 10.1007/s00284-012-0240-2
   Poladyan A, 2013, FEMS MICROBIOL LETT, V348, P143, DOI 10.1111/1574-6968.12281
   Rangarajan ES, 2008, J BACTERIOL, V190, P1447, DOI 10.1128/JB.01610-07
   REENSTRA WW, 1980, BIOCHEMISTRY-US, V19, P1, DOI 10.1021/bi00542a001
   Sawers G., 2004, ECOSAL ESCHERICHIA C
   Schemidt RA, 1998, J BACTERIOL, V180, P3205
   Thapa LP, 2014, BIOPROC BIOSYST ENG, V37, P1073, DOI 10.1007/s00449-013-1079-z
   Trchounian A, 2014, IUBMB LIFE, V66, P1, DOI 10.1002/iub.1236
   TRCHOUNIAN AA, 1994, J BIOENERG BIOMEMBR, V26, P563, DOI 10.1007/BF00762741
   Trchounian K, 2012, CELL BIOCHEM BIOPHYS, V62, P433, DOI 10.1007/s12013-011-9325-y
   Trchounian K, 2013, J BIOENERG BIOMEMBR, V45, P253, DOI 10.1007/s10863-012-9498-0
   Trchounian K, 2012, CRIT REV BIOCHEM MOL, V47, P236, DOI 10.3109/10409238.2012.655375
   Trchounian K, 2014, P 13 INT C CLEAN EN, P1322
   Trchounian K, 2014, INT J HYDROGEN ENERG, V39, P6419, DOI 10.1016/j.ijhydene.2014.02.050
   Trchounian K, 2011, INT J HYDROGEN ENERG, V36, P4323, DOI 10.1016/j.ijhydene.2010.12.128
   Trchounian K, 2011, J BIOENERG BIOMEMBR, V43, P645, DOI 10.1007/s10863-011-9397-9
NR 40
TC 2
Z9 2
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 67
EP 72
DI 10.1016/j.abb.2015.05.015
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000010
PM 26049001
ER

PT J
AU Nardella, J
   Terrado, M
   Honson, NS
   Plettner, E
AF Nardella, Jason
   Terrado, Mailyn
   Honson, Nicolette S.
   Plettner, Erika
TI Endogenous fatty acids in olfactory hairs influence pheromone binding
   protein structure and function in Lymantria dispar
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Pheromone-binding protein; Fatty acid; Endogenous ligand; Insect;
   Emulsion; Partition
ID CIRCULAR-DICHROISM SPECTRA; INSECT PLASMA-MEMBRANE; GYPSY-MOTH;
   ANTHERAEA-POLYPHEMUS; ODORANT-BINDING; SECONDARY STRUCTURE; SENSITIVE
   NEURONS; SILKWORM MOTH; PH; DROSOPHILA
AB The gypsy moth utilizes a pheromone, (7R,8S)-2-methyl-7,8-epoxyoctadecane, for mate location. The pheromone is detected by sensory hairs (sensilla) on the antennae of adult males. Sensilla contain the dendrites of olfactory neurons bathed in lymph, which contains pheromone binding proteins (PBPs). We have extracted and identified free fatty acids from lymph of sensory hairs, and we demonstrate that these function as endogenous ligands for gypsy moth PBP1 and PBP2. Homology modeling of both PBPs, and docking of fatty acids reveal multiple binding sites: one internal, the others external. Pheromone binding assays suggest that these fatty acids increase PBP-pheromone binding affinity. We show that fatty acid binding causes an increase in a-helix content in the N-terminal domain, but not in the C-terminal peptide of both proteins. The C-terminal peptide was shown to form a a-helix in a hydrophobic, homogeneous environment, but not in the presence of fatty acid micelles. Through partition assays we show that the fatty acids prevent adsorption of the pheromone on hydrophobic surfaces and facilitate pheromone partition into an aqueous phase. We propose that lymph is an emulsion of fatty acids and PBP that influence each other and thereby control the partition equilibria of hydrophobic odorants. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Nardella, Jason; Terrado, Mailyn; Plettner, Erika] Simon Fraser Univ, Dept Chem, Burnaby, BC V5S 1S6, Canada.
   [Honson, Nicolette S.] Ctr Drug Res & Dev, Vancouver, BC V6T 1Z3, Canada.
RP Plettner, E (reprint author), Simon Fraser Univ, Dept Chem, 8888 Univ Dr, Burnaby, BC V5S 1S6, Canada.
EM plettner@sfu.ca
FU NSERC Discovery Grant [222923-2010]
FX This work was funded by NSERC Discovery Grant 222923-2010 to EP. We
   thank Ms. C. Iggulden, Mr. K. Rauwerda, Mr. M. Sangha and Ms. J. Parker
   for technical assistance.
CR Kanicky JR, 2000, LANGMUIR, V16, P172, DOI 10.1021/la990719o
   Golebiowski M, 2012, LIPIDS, V47, P1001, DOI 10.1007/s11745-012-3702-1
   Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105
   Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879
   VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827
   Wang YM, 2006, J LIPID RES, V47, P530, DOI 10.1194/jlr.M500346-JLR200
   CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170
   Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046
   Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031
   Golebiowski M, 2013, J INSECT PHYSIOL, V59, P416, DOI 10.1016/j.jinsphys.2013.02.001
   Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8
   Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267
   Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861
   Leary GP, 2012, P NATL ACAD SCI USA, V109, P14081, DOI 10.1073/pnas.1204661109
   Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356
   Kim MS, 1998, GENETICS, V150, P711
   Kanicky JR, 2002, J COLLOID INTERF SCI, V256, P201, DOI 10.1006/jcis.2001.8009
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   HARGREAVES WR, 1978, BIOCHEMISTRY-US, V17, P3759, DOI 10.1021/bi00611a014
   Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x
   CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013
   Damberger FF, 2013, P NATL ACAD SCI USA, V110, P18680, DOI 10.1073/pnas.1317706110
   DU GH, 1994, BIOCHEMISTRY-US, V33, P4812, DOI 10.1021/bi00182a009
   Figueiras ANL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-8
   Gomez-Diaz C., 2013, PLOS BIOL, V11
   Gong Y, 2009, CHEM BIOL, V16, P162, DOI 10.1016/j.chembiol.2009.01.005
   Gong YM, 2011, CHEM SENSES, V36, P291, DOI 10.1093/chemse/bjq130
   Gong YM, 2010, BIOCHEMISTRY-US, V49, P793, DOI 10.1021/bi901145a
   Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479
   Honson N.S., 2006, THESIS S FRASER U
   Kaissling K. E., 1980, RECEPTORS NEUROTRANS
   KANAUJIA S, 1985, J INSECT PHYSIOL, V31, P71, DOI 10.1016/0022-1910(85)90044-7
   Katre UV, 2013, BIOCHEMISTRY-US, V52, P1037, DOI 10.1021/bi301393v
   Klei C., 2011, CAN J CHEM, V89, P568
   KLEIN U, 1991, CELL TISSUE RES, V266, P265, DOI 10.1007/BF00318182
   Kowcun A, 2001, J BIOL CHEM, V276, P44770, DOI 10.1074/jbc.M104688200
   Lee D, 2002, FEBS LETT, V531, P314, DOI 10.1016/S0014-5793(02)03548-2
   Lee MCG, 2014, ANAL BIOCHEM, V465, P102, DOI 10.1016/j.ab.2014.07.031
   LOCKE M, 1961, J BIOPHYS BIOCHEM CY, V10, P589, DOI 10.1083/jcb.10.4.589
   Miller KE, 2003, J CHROMATOGR A, V1007, P117, DOI 10.1016/S0021-9673(03)00958-0
   MORITZ RFA, 1991, NATURWISSENSCHAFTEN, V78, P179, DOI 10.1007/BF01136209
   Oguri E, 2003, GEN COMP ENDOCR, V132, P46, DOI 10.1016/S0016-6480(03)00029-7
   Oldham NJ, 2000, ANGEW CHEM INT EDIT, V39, P4341, DOI 10.1002/1521-3773(20001201)39:23<4341::AID-ANIE4341>3.0.CO;2-1
   Paduraru PA, 2008, J COMB CHEM, V10, P123, DOI 10.1021/cc700139y
   Pesenti ME, 2008, J MOL BIOL, V380, P158, DOI 10.1016/j.jmb.2008.04.048
   Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x
   SCHEFFLER HJ, 1975, Z MORPHOL TIERE, V80, P203
   Skoog D. A., 1988, FUNDAMENTALS ANAL CH
   Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040
   VANDENBERG MJ, 1991, J INSECT PHYSIOL, V37, P79, DOI 10.1016/0022-1910(91)90022-R
   Wieczorek H, 2003, J BIOENERG BIOMEMBR, V35, P359, DOI 10.1023/A:1025733016473
   Yu Y, 2013, BIOORGAN MED CHEM, V21, P1811, DOI 10.1016/j.bmc.2013.01.043
   Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015
NR 55
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 73
EP 84
DI 10.1016/j.abb.2015.05.007
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000011
PM 26032337
ER

PT J
AU Roy, J
   Sen Santara, S
   Adhikari, A
   Mukherjee, A
   Adak, S
AF Roy, Jayasree
   Sen Santara, Sumit
   Adhikari, Ayan
   Mukherjee, Aditi
   Adak, Subrata
TI Control of catalysis in globin coupled adenylate cyclase by a globin-B
   domain
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Leishmania; Heme protein; Mutation; Spectroscopic studies; Adenylate
   cyclase; Gas sensor proteins
ID HEME-REGULATED PHOSPHODIESTERASE; SENSOR DIGUANYLATE CYCLASE; OXYGEN
   SENSOR; FE(II)-O-2 COMPLEX; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DISTAL
   SIDE; BINDING; NEUROGLOBIN; BICARBONATE
AB The globin coupled heme containing adenylate cyclase from Leishmania major (HemAC-Lm) has two globin domains (globin-A and globin-B). Globin-B domain (210-360 amino acids) may guide the interaction between globin-A and adenylate cyclase domains for the regulation of catalysis. We investigated the role of globin-B domain in HemAC-Lm by constructing a series of mutants namely Delta 209 (209 amino acids deleted), Delta 360 (360 amino acids deleted), H161A, H311A and H311A-Delta 209. Spectroscopic data suggest that the Delta 209 and H311A-Delta 209 proteins to be Fe2+-O-2 form and apo form, respectively, indicating that His311 residue in the globin-B domain is crucial for heme binding in Delta 209 protein. However, the H311A mutant is still of the Fe2+-O-2 form whereas H161A mutant shows the apo form, indicating that only His161 residue in the globin-A domain is responsible for heme binding in full length enzyme. cAMP measurements suggest that the activities of Delta 360 and Delta 209 proteins were similar to 10 and similar to 1000 times lesser than full length enzyme, respectively, leading to the fact that globin-B domain inhibited catalysis rather than activation in absence of globin-A domain. These data suggest that the O-2 bound globin-A domain in HemAC-Lm allows the best cooperation of the catalytic domain interactions to generate optimum cAMP. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Roy, Jayasree; Sen Santara, Sumit; Adhikari, Ayan; Mukherjee, Aditi; Adak, Subrata] CSIR, Indian Inst Chem Biol, Div Struct Biol & Bioinformat, Kolkata 700032, India.
RP Adak, S (reprint author), CSIR, Indian Inst Chem Biol, Div Struct Biol & Bioinformat, 4 Raja SC Mullick Rd, Kolkata 700032, India.
EM adaks@iicb.res.in
FU Council of Scientific and Industrial Research (CSIR) [BSC 0114];
   CSIR-Shyama Prasad Mukherjee fellowships; CSIR fellowships; University
   Grants Commission fellowships
FX We thank Dr. Antoine Danchin (AMAbiotic SAS) for providing the strain
   TP610. This work was supported by Council of Scientific and Industrial
   Research (CSIR) Project BSC 0114, CSIR-Shyama Prasad Mukherjee
   fellowships (to S.S.S.), CSIR fellowships (to J.R. and A.M), University
   Grants Commission fellowships (to A.A.).
CR Nurizzo D, 1997, STRUCTURE, V5, P1157, DOI 10.1016/S0969-2126(97)00267-0
   Czjzek M, 2007, J MOL BIOL, V365, P1176, DOI 10.1016/j.jmb.2006.10.063
   Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570
   Thijs L, 2007, J BIOL CHEM, V282, P37325, DOI 10.1074/jbc.M705541200
   Nagao S, 2012, DALTON T, V41, P11378, DOI 10.1039/c2dt30893b
   Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950
   BENNETT MJ, 1995, PROTEIN SCI, V4, P2455
   Nakajima K, 2012, J INORG BIOCHEM, V108, P163, DOI 10.1016/j.jinorgbio.2011.09.019
   Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625
   Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2
   Hirota S, 2010, P NATL ACAD SCI USA, V107, P12854, DOI 10.1073/pnas.1001839107
   Lin YW, 2015, ANGEW CHEM INT EDIT, V54, P511, DOI 10.1002/anie.201409267
   Kitanishi K, 2010, BIOCHEMISTRY-US, V49, P10381, DOI 10.1021/bi100733q
   Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g
   Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200
   Sen Santara S, 2013, P NATL ACAD SCI USA, V110, P16790, DOI 10.1073/pnas.1304145110
   Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236
   Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Martinkova M, 2013, J BIOL CHEM, V288, P27702, DOI 10.1074/jbc.R113.473249
   Hayashi Y, 2012, BIOCHEMISTRY-US, V51, P8608, DOI 10.1021/bi3011303
   McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688
   Wan XH, 2009, J MOL BIOL, V388, P262, DOI 10.1016/j.jmb.2009.03.015
   Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200
   Horecker BL, 1943, J BIOL CHEM, V148, P173
   Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876
   Avella G, 2014, ACTA CRYSTALLOGR D, V70, P1640, DOI 10.1107/S1399004714007032
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9
   Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456
   Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145
   HEDEGAARD L, 1985, MOL GEN GENET, V201, P38, DOI 10.1007/BF00397984
   GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0
   Junedi S, 2014, CHEMBIOCHEM, V15, P517, DOI 10.1002/cbic.201300728
   Roy J., 1844, BIOCHIM BIOPHYS ACTA, V2014, P615
   Saha R., 1834, BIOCHIM BIOPHYS ACTA, V2013, P2057
   Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525
   Sawai H., 1804, BIOCHIM BIOPHYS ACTA, V2010, P166
   Silva MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046328
   Wang ZH, 2011, ORG BIOMOL CHEM, V9, P4766, DOI 10.1039/c1ob05552f
   Yadav RK, 2008, BBA-PROTEINS PROTEOM, V1784, P863, DOI 10.1016/j.bbapap.2008.02.006
   Yoshimura T, 2003, J BIOL CHEM, V278, P53105, DOI 10.1074/jbc.M304408200
NR 41
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 2015
VL 579
BP 85
EP 90
DI 10.1016/j.abb.2015.06.007
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CN6NR
UT WOS:000358552000012
PM 26095616
ER

PT J
AU Romero-Rodriguez, A
   Ruiz-Villafan, B
   Rocha-Mendoza, D
   Manzo-Ruiz, M
   Sanchez, S
AF Romero-Rodriguez, Alba
   Ruiz-Villafan, Beatriz
   Rocha-Mendoza, Diana
   Manzo-Ruiz, Monserrat
   Sanchez, Sergio
TI Biochemistry and regulatory functions of bacterial glucose kinases
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Glucokinases; Diversity; Cloning; Tertiary structure; Mechanism of
   action; Regulatory functions
ID CARBON CATABOLITE REPRESSION; ADP-DEPENDENT GLUCOKINASE;
   STREPTOMYCES-COELICOLOR A3(2); ARCHAEON PYROCOCCUS-FURIOSUS; INORGANIC
   POLYPHOSPHATE/ATP-GLUCOMANNOKINASE; THERMOPHILIC ROK GLUCOKINASE; BROAD
   SUBSTRATE-SPECIFICITY; PREVOTELLA-BRYANTII B(1)4; PEUCETIUS VAR.
   CAESIUS; HYPERTHERMOPHILIC ARCHAEON
AB Glucokinases (Glks) are enzymes widely distributed in all three domains of life. They are located at the beginning of the glycolytic pathway and are responsible for the glucose phosphorylation from various phosphate group donors such as ATP, ADP and polyphosphate. So far, there are eight crystallized Glks, and at least one belongs to each of the three reported Glk families. Structural studies have elucidated the mechanism for Glk action and multimerization. Cloning, overexpression and biochemical characterization have demonstrated the wide diversity of these enzymes. As reported for various microorganisms, in addition to their catalytic activity, some Glks, possessing ROK (Repressor Orf Kinases) motifs, also display a regulatory role. This function has been associated to the mechanisms of carbon catabolite regulation, morphological differentiation and antibiotic production. The present review covers the classification, detailed tertiary structure, mechanism of action, biochemical characterization and some regulatory aspects of bacterial Glks. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Romero-Rodriguez, Alba; Ruiz-Villafan, Beatriz; Rocha-Mendoza, Diana; Manzo-Ruiz, Monserrat; Sanchez, Sergio] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Mol Biol & Biotechnol, Mexico City 04510, DF, Mexico.
RP Sanchez, S (reprint author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Mol Biol & Biotechnol, Mexico City 04510, DF, Mexico.
EM albaromero@comunidad.unam.mx; brvillafan@unam.mx; divonne29@hotmail.com;
   monseb.27@gmail.com; sersan@biomedicas.unam.mx
FU CONACYT, Mexico [CB-219686]; DGAPA; PAPIIT; UNAM [IN201413]
FX We are indebted to M.A. Ortiz-Jimenez for his support during manuscript
   preparation. We thank Elizabeth Langley for critical reading of this
   review. This work was supported by grants from DGAPA, PAPIIT, UNAM
   IN201413 and CB-219686 from CONACYT, Mexico.
CR ANGELL S, 1992, MOL MICROBIOL, V6, P2833, DOI 10.1111/j.1365-2958.1992.tb01463.x
   ANGELL S, 1994, MOL GEN GENET, V244, P135
   [Anonymous], 2012, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKR1065
   Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7
   GOWARD CR, 1986, BIOCHEM J, V237, P415
   Lindner SN, 2010, APPL MICROBIOL BIOT, V87, P703, DOI 10.1007/s00253-010-2568-5
   WAGNER E, 1995, J BACTERIOL, V177, P6144
   Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141
   Jankovic I, 2002, J MOL MICROB BIOTECH, V4, P309
   van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a
   Conejo MS, 2010, J MOL EVOL, V70, P545, DOI 10.1007/s00239-010-9351-1
   Ronimus RS, 2004, BIOCHEM BIOPH RES CO, V315, P652, DOI 10.1016/j.bbrc.2004.01.103
   Kengen SWM, 1995, J BIOL CHEM, V270, P30453
   Labes A, 2003, ARCH MICROBIOL, V180, P69, DOI 10.1007/s00203-003-0563-2
   Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007
   Dahl MK, 2002, J MOL MICROB BIOTECH, V4, P315
   Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200
   KWAKMAN JHJM, 1994, J BACTERIOL, V176, P2694
   Swiatek MA, 2013, J BACTERIOL, V195, P1236, DOI 10.1128/JB.02191-12
   Koga S, 2000, J BIOCHEM-TOKYO, V128, P1079
   Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014
   Gubbens J, 2012, MOL MICROBIOL, V86, P1490, DOI 10.1111/mmi.12072
   Zheng L, 2012, J IND MICROBIOL BIOT, V39, P1685, DOI 10.1007/s10295-012-1176-z
   Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602
   Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479
   Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039
   Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9
   Kawai S, 2005, J BIOSCI BIOENG, V99, P320, DOI 10.1263/jbb.99.320
   Bae J, 2005, BIOCHEM BIOPH RES CO, V334, P754, DOI 10.1016/j.bbrc.2005.06.160
   Concha MI, 2000, FEMS MICROBIOL LETT, V186, P97, DOI 10.1016/S0378-1097(00)00124-5
   Fields MW, 2002, ANAEROBE, V8, P69, DOI 10.1006/anae.2002.0420
   Fields MW, 2001, MICROBIOL-UK, V147, P1035
   Finn Robert D., 2013, NUCLEIC ACIDS RES, V42, pD222, DOI DOI 10.1093/NAR/GKT1223
   GLASS TL, 1994, ARCH MICROBIOL, V162, P180, DOI 10.1007/BF00314472
   Görke Boris, 2008, Nat Rev Microbiol, V6, P613, DOI 10.1038/nrmicro1932
   Han B, 2007, APPL ENVIRON MICROB, V73, P3581, DOI 10.1128/AEM.02863-06
   Hansen T, 2003, FEMS MICROBIOL LETT, V226, P405, DOI 10.1016/S0378-1097(03)00642-6
   Hansen T, 2002, J BACTERIOL, V184, P5955, DOI 10.1128/JB.184.21.5955-5965.2002
   Hsieh PC, 1996, J BIOL CHEM, V271, P4909
   Hsieh PC, 1996, BIOCHEMISTRY-US, V35, P9772, DOI 10.1021/bi9528659
   HSIEH PC, 1993, PROTEIN EXPRES PURIF, V4, P76, DOI 10.1006/prep.1993.1012
   Imriskova I, 2005, RES MICROBIOL, V156, P361, DOI 10.1016/j.resmic.2004.11.001
   ISHIKAWA H, 1987, BIOCHEM J, V248, P13
   Koide M, 2013, BIOSCI BIOTECH BIOCH, V77, P2322, DOI 10.1271/bbb.130498
   Lakshmi Hanumanthu Prasanna, 2013, Bioinformation, V9, P169, DOI 10.6026/97320630009169
   Lengsfeld C, 2009, J BACTERIOL, V191, P701, DOI 10.1128/JB.00767-08
   Liao HH, 2012, APPL MICROBIOL BIOT, V93, P1109, DOI 10.1007/s00253-011-3458-1
   Lu GT, 2007, MICROBIOL-SGM, V153, P4284, DOI 10.1099/mic.0.2007/010538-0
   Lunin VV, 2004, J BACTERIOL, V186, P6915, DOI 10.1128/JB.186.20.6915-6927.2004
   Mahr K, 2000, ANTON LEEUW INT J G, V78, P253, DOI 10.1023/A:1010234916745
   MARTIN SA, 1986, APPL ENVIRON MICROB, V52, P1348
   Mesak LR, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-6
   Meyer D, 1997, J BACTERIOL, V179, P1298
   Miyazono K.I., 2012, J BACTERIOL, V194, P607
   Mukai T, 2003, APPL ENVIRON MICROB, V69, P3849, DOI 10.1128/AEM.69.7.3849-3857.2003
   Mukai T, 2004, J BIOL CHEM, V279, P50591, DOI 10.1074/jbc.M408126200
   Nakamura T, 2011, ACTA CRYSTALLOGR F, V67, P1559, DOI 10.1107/S1744309111041145
   Nakamura T, 2012, J BIOSCI BIOENG, V114, P150, DOI 10.1016/j.jbiosc.2012.03.018
   Nishimasu H, 2006, J BACTERIOL, V188, P2014, DOI 10.1128/JB.188.5.2014-2019.2006
   Pimentel-Schmitt EF, 2007, J MOL MICROB BIOTECH, V12, P75, DOI 10.1159/000096462
   PORTER EV, 1982, BIOCHIM BIOPHYS ACTA, V709, P178
   Rosana-Ani L, 1999, FEMS MICROBIOL LETT, V171, P89, DOI 10.1111/j.1574-6968.1999.tb13416.x
   Ruiz-Villafan B, 2014, APPL MICROBIOL BIOT, V98, P6061, DOI 10.1007/s00253-014-5662-2
   Sakuraba H, 2002, J BIOL CHEM, V277, P12495, DOI 10.1074/jbc.C200059200
   Sakuraba H, 2003, J BIOCHEM, V133, P219, DOI 10.1093/jb/mvg027
   Sakuraba H, 2004, CHEM REC, V3, P281, DOI 10.1002/tcr.10066
   SCOPES RK, 1985, BIOCHEM J, V228, P627
   Skarlatos P, 1998, J BACTERIOL, V180, P3222
   Spath C, 1997, J BACTERIOL, V179, P7603
   SZYMONA M, 1964, BIOCHIM BIOPHYS ACTA, V85, P283, DOI 10.1016/0926-6569(64)90249-4
   Tanaka S, 2003, J BACTERIOL, V185, P5654, DOI 10.1128/JB.185.18.5654-5656.2003
   Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023
   van Wezel GP, 2007, J MOL MICROB BIOTECH, V12, P67, DOI 10.1159/000096461
   Vastermark A, 2014, CURR OPIN MICROBIOL, V18, P8, DOI 10.1016/j.mib.2014.01.002
   Verhees CH, 2002, BIOCHEM J, V366, P121
   Verhees CH, 2001, J BACTERIOL, V183, P7145, DOI 10.1128/JB.183.24.7145-7153.2001
   Whitehead Michael P, 2013, BMC Res Notes, V6, P221, DOI 10.1186/1756-0500-6-221
   Zhang Q, 2011, ACTA BIOCH BIOPH SIN, V43, P618, DOI 10.1093/abbs/gmr049
NR 78
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL
PY 2015
VL 577
BP 1
EP 10
DI 10.1016/j.abb.2015.05.001
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3MJ
UT WOS:000356119900001
PM 25978980
ER

PT J
AU Borovikov, YS
   Avrova, SV
   Rysev, NA
   Sirenko, VV
   Simonyan, AO
   Chernev, AA
   Karpicheva, OE
   Piers, A
   Redwood, CS
AF Borovikov, Yurii S.
   Avrova, Stanislava V.
   Rysev, Nikita A.
   Sirenko, Vladimir V.
   Simonyan, Armen O.
   Chernev, Aleksey A.
   Karpicheva, Olga E.
   Piers, Adam
   Redwood, Charles S.
TI Aberrant movement of beta-tropomyosin associated with congenital
   myopathy causes defective response of myosin heads and actin during the
   ATPase cycle
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Tropomyosin; F-actin; Myosin; Troponin; Ghost muscle fibers; Congenital
   myopathies; Fluorescence polarization
ID THIN FILAMENT ACTIVATION; DILATED CARDIOMYOPATHY MUTATIONS; CAUSE DISTAL
   ARTHROGRYPOSIS; SKELETAL-MUSCLE FIBERS; F-ACTIN; CONFORMATIONAL-CHANGES;
   POLARIZED FLUORESCENCE; ALPHA-TROPOMYOSIN; TROPONIN-I; CONTRACTILE
   FUNCTION
AB We have investigated the effect of the E41K, R91G, and E139del beta-tropomyosin (TM) mutations that cause congenital myopathy on the position of TM and orientation of actin monomers and myosin heads at different mimicked stages of the ATPase cycle in troponin-free ghost muscle fibers by polarized fluorimetry. A multi-step shifting of wild-type TM to the filament center accompanied by an increase in the amount of switched on actin monomers and the strongly bound myosin heads was observed during the ATPase cycle. The R91G mutation shifts TM further towards the inner and outer domains of actin at the strong- and weak-binding stages, respectively. The E139del mutation retains TM near the inner domains, while the E41K mutation captures it near the outer domains. The E41K and R91G mutations can induce the strong binding of myosin heads to actin, when TM is located near the outer domains. The E139del mutation inhibits the amount of strongly bound myosin heads throughout the ATPase cycle. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Borovikov, Yurii S.; Avrova, Stanislava V.; Rysev, Nikita A.; Sirenko, Vladimir V.; Simonyan, Armen O.; Chernev, Aleksey A.; Karpicheva, Olga E.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.
   [Simonyan, Armen O.; Chernev, Aleksey A.] St Petersburg State Univ, St Petersburg 199034, Russia.
   [Piers, Adam; Redwood, Charles S.] Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England.
RP Borovikov, YS (reprint author), Russian Acad Sci, Inst Cytol, 4 Tikhoretsky Ave, St Petersburg 194064, Russia.
EM borovikov@incras.ru
RI Karpicheva, Olga/D-8520-2014; Simonyan, Armen/G-6775-2013; Borovikov,
   Yurii/O-7433-2015
OI Karpicheva, Olga/0000-0003-0601-5978; Simonyan,
   Armen/0000-0002-8045-7419; 
FU Russian Foundation for Basic Research [14-04-00454, 14-04-31527];
   Muscular Dystrophy Campaign
FX This work was supported by the Russian Foundation for Basic Research
   (Nos. 14-04-00454 and 14-04-31527) and the Muscular Dystrophy Campaign.
CR De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lehtokari VL, 2007, NEUROMUSCULAR DISORD, V17, P433, DOI 10.1016/j.nmd.2007.02.015
   MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461
   Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0
   Avrova SV, 2012, ARCH BIOCHEM BIOPHYS, V521, P1, DOI 10.1016/j.abb.2012.03.004
   Tajsharghi H, 2007, ARCH NEUROL-CHICAGO, V64, P1334, DOI 10.1001/archneur.64.9.1334
   Sung SS, 2003, AM J HUM GENET, V72, P681, DOI 10.1086/368294
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   Marston S, 2013, HUM MOL GENET, V22, P4978, DOI 10.1093/hmg/ddt345
   MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7
   Deriu MA, 2011, J BIOMECH, V44, P630, DOI 10.1016/j.jbiomech.2010.11.014
   Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0
   Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200
   Marttila M, 2014, HUM MUTAT, V35, P779, DOI 10.1002/humu.22554
   SPUDICH JA, 1971, J BIOL CHEM, V246, P4866
   WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422
   Craig R, 2001, J MOL BIOL, V311, P1027, DOI 10.1006/jmbi.2001.4897
   Xu C, 1999, BIOPHYS J, V77, P985
   Robinson P, 2007, FASEB J, V21, P896, DOI 10.1096/fj.06-6899com
   Clarke NF, 2009, NEUROMUSCULAR DISORD, V19, P348, DOI 10.1016/j.nmd.2009.03.003
   ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9
   Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8
   Berger CL, 1996, BIOPHYS J, V71, P3330
   Bobkov AA, 1997, BIOCHEMISTRY-US, V36, P7733, DOI 10.1021/bi963185o
   BOREJDO J, 1977, BIOCHIM BIOPHYS ACTA, V459, P578, DOI 10.1016/0005-2728(77)90056-1
   BOREJDO J, 1982, J MOL BIOL, V158, P391, DOI 10.1016/0022-2836(82)90205-4
   Borejdo J, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2697286
   Borejdo J, 2006, EXP BIOL MED, V231, P28
   Borejdo J, 2004, BIOPHYS J, V86, P2308
   BOREJDO J, 1979, P NATL ACAD SCI USA, V76, P6346, DOI 10.1073/pnas.76.12.6346
   Borovikov Y.S., 1999, REV CYTOL, V189, P267
   Borovikov YS, 2009, ARCH BIOCHEM BIOPHYS, V489, P20, DOI 10.1016/j.abb.2009.07.018
   BOROVIKOV YS, 1993, BIOCHIM BIOPHYS ACTA, V1163, P280, DOI 10.1016/0167-4838(93)90163-L
   Borovikov YS, 2009, BIOCHEM BIOPH RES CO, V381, P403, DOI 10.1016/j.bbrc.2009.02.054
   Borovikov YS, 2004, BIOPHYS J, V86, P3020, DOI 10.1016/S0006-3495(04)74351-9
   BOROVIKOV YS, 1983, EUR J BIOCHEM, V136, P363, DOI 10.1111/j.1432-1033.1983.tb07750.x
   Borovikov YS, 2009, BBA-PROTEINS PROTEOM, V1794, P985, DOI 10.1016/j.bbapap.2008.11.014
   Borovikov YS, 2011, BIOCHEM BIOPH RES CO, V411, P496, DOI 10.1016/j.bbrc.2011.06.138
   Borovikov Yu.S., 1974, TSITOLOGIYA, V16, P1045
   Brenner B, 1999, BIOPHYS J, V77, P2692, DOI 10.1016/S0006-3495(99)77103-1
   BUKATINA AE, 1994, J MUSCLE RES CELL M, V15, P29, DOI 10.1007/BF00123830
   Burghardt TP, 2001, BIOCHEMISTRY-US, V40, P4821, DOI 10.1021/bi002387o
   Clarke NF, 2012, NEUROMUSCULAR DISORD, V22, P955, DOI 10.1016/j.nmd.2012.06.002
   Corrie JET, 1999, NATURE, V400, P425
   DANCKER P, 1975, BIOCHIM BIOPHYS ACTA, V400, P407, DOI 10.1016/0005-2795(75)90196-8
   Ebashi S., 1969, REV BIOPHYS, V2, P351
   EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0
   GOODY R S, 1980, Journal of Muscle Research and Cell Motility, V1, P101, DOI 10.1007/BF00711928
   Greenberg MJ, 2008, CELL MOTIL CYTOSKEL, V65, P156, DOI 10.1002/cm.20251
   Hitchcock-DeGregori SE, 2010, J STRUCT BIOL, V170, P319, DOI 10.1016/j.jsb.2009.12.013
   IRVING M, 1995, NATURE, V375, P688, DOI 10.1038/375688a0
   KAKOL I, 1987, BIOCHIM BIOPHYS ACTA, V913, P1, DOI 10.1016/0167-4838(87)90225-1
   Karpicheva OE, 2014, ARCH BIOCHEM BIOPHYS, V549, P12, DOI 10.1016/j.abb.2014.03.007
   Karpicheva OE, 2013, ARCH BIOCHEM BIOPHYS, V536, P25, DOI 10.1016/j.abb.2013.05.001
   Laing NG, 2005, BIOESSAYS, V27, P809, DOI 10.1002/bies.20269
   LAMKIN M, 1983, BIOCHEMISTRY-US, V22, P3053, DOI 10.1021/bi00282a005
   Lehman W, 2013, J MUSCLE RES CELL M, V34, P155, DOI 10.1007/s10974-013-9342-0
   LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628
   MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55
   Marttila M, 2012, BIOCHEM J, V442, P231, DOI 10.1042/BJ20111030
   MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2
   Miki M, 2012, J MOL BIOL, V420, P40, DOI 10.1016/j.jmb.2012.03.029
   Nevzorov I, 2008, J MUSCLE RES CELL M, V29, P173, DOI 10.1007/s10974-009-9171-3
   NOWAK E, 1991, FEBS LETT, V281, P51, DOI 10.1016/0014-5793(91)80356-8
   Ochala J, 2008, J PHYSIOL-LONDON, V586, P2993, DOI 10.1113/jphysiol.2008.153650
   Ohlsson M, 2008, NEUROLOGY, V71, P1896, DOI 10.1212/01.wnl.0000336654.44814.b8
   OKAMOTO Y, 1985, J BIOCHEM-TOKYO, V98, P1143
   Onishi H, 2008, BIOCHEM BIOPH RES CO, V369, P115, DOI 10.1016/j.bbrc.2007.11.148
   Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441
   Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013
   Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020
   PROCHNIEWICZNAKAYAMA E, 1983, J CELL BIOL, V97, P1663, DOI 10.1083/jcb.97.6.1663
   Resetar AM, 2002, BIOPHYS J, V83, P1039
   Roopnarine O, 1996, BIOPHYS J, V70, P2795
   Rysev NA, 2014, ARCH BIOCHEM BIOPHYS, V543, P57, DOI 10.1016/j.abb.2013.12.016
   Rysev NA, 2012, BBA-PROTEINS PROTEOM, V1824, P366, DOI 10.1016/j.bbapap.2011.11.004
   Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006336
   Sung SS, 2003, AM J HUM GENET, V73, P212, DOI 10.1086/376418
   Tajsharghi H, 2012, NEUROMUSCULAR DISORD, V22, P923, DOI 10.1016/j.nmd.2012.05.018
   TITUS MA, 1989, J MUSCLE RES CELL M, V10, P25, DOI 10.1007/BF01739854
   Tregear G.W., 1975, BIOPHYS J, V15, P455
   WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0
   Wieczorek DF, 2008, ADV EXP MED BIOL, V644, P132
   YANAGIDA T, 1974, J MOL BIOL, V90, P509, DOI 10.1016/0022-2836(74)90231-9
   YANAGIDA T, 1978, J MOL BIOL, V126, P507, DOI 10.1016/0022-2836(78)90056-6
NR 90
TC 0
Z9 0
U1 6
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL
PY 2015
VL 577
BP 11
EP 23
DI 10.1016/j.abb.2015.05.002
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3MJ
UT WOS:000356119900002
PM 25978979
ER

PT J
AU Washington, C
   Maxwell, J
   Stevenson, J
   Malone, G
   Lowe, EW
   Zhang, Q
   Wang, GD
   McIntyre, NR
AF Washington, Courtney
   Maxwell, Jamere
   Stevenson, Joenathan
   Malone, Gregory
   Lowe, Edward W., Jr.
   Zhang, Qiang
   Wang, Guangdi
   McIntyre, Neil R.
TI Mechanistic studies of the tyrosinase-catalyzed oxidative
   cyclocondensation of 2-aminophenol to 2-aminophenoxazin-3-one
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Isotope effect; Tyrosinase; 2-Aminophenol; Mechanism; Cyclocondensation;
   Kinetics
ID RAY CRYSTALLOGRAPHIC ANALYSIS; GLOBAL KINETIC EXPLORER; PHENOXAZINONE
   SYNTHASE; MUSHROOM TYROSINASE; O-DIPHENOLS; CRYSTAL-STRUCTURE;
   AGARICUS-BISPORUS; CATECHOL OXIDASE; COPPER CENTER; ACTIVE-SITE
AB Tyrosinase (EC 1.14.18.1) catalyzes the monophenolase and diphenolase reaction associated with vertebrate pigmentation and fruit/vegetable browning. Tyrosinase is an oxygen-dependent, dicopper enzyme that has three states: E-met, E-oxy, and E-deoxy. The diphenolase activity can be carried out by both the met and the oxy states of the enzyme while neither mono- nor diphenolase activity results from the deoxy state. In this study, the oxidative cyclocondensation of 2-aminophenol (OAP) to the corresponding 2-aminophenoxazin-3-one (APX) by mushroom tyrosinase was investigated. Using a combination of various steady- and pre-steady state methodologies, we have investigated the kinetic and chemical mechanism of this reaction. The k(cat) for OAP is 75 +/- 2 s(-1), K-M(OAP) = 1.8 +/- 0.2 mM, K-M(O2) = 25 +/- 4 mu M with substrates binding in a steady-state preferred fashion. Stopped flow and global analysis support a model where OAP preferentially binds to the oxy form over the met (k(7) >> k(1)). For the met form, His269 and His61 are the proposed bases, while the oxy form uses the copper-peroxide and His61 for the sequential deprotonation of anilinic and phenolic hydrogens. Solvent KIEs show proton transfer to be increasingly rate limiting for k(cat)/K-M(OAP) as [O-2] --> 0 mu M (1.38 +/- 0.06) decreasing to 0.83 +/- 0.03 as [O-2] --> infinity reflecting a partially rate limiting mu-OH bond cleavage (E-met) and formation (E-oxy) following protonation in the transition state. The coupling and cyclization reactions of o-quinone imine and OAP pass through a phenyliminocyclohexadione intermediate to APX, forming at a rate of 6.91 +/- 0.03 mu M-1 s(-1) and 2.59E-2 +/- 5.31E-4 s(-1). Differences in reactivity attributed to the anilinic moiety of OAP with o-diphenols are discussed. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Washington, Courtney; Maxwell, Jamere; Stevenson, Joenathan; Malone, Gregory; Zhang, Qiang; Wang, Guangdi; McIntyre, Neil R.] Xavier Univ Louisiana, Dept Chem, Div Math & Phys Sci, New Orleans, LA 70125 USA.
   [Lowe, Edward W., Jr.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA.
RP McIntyre, NR (reprint author), Xavier Univ Louisiana, Dept Chem, Div Math & Phys Sci, New Orleans, LA 70125 USA.
EM nmcintyr@xula.edu
FU Louisiana Cancer Research Consortium (LCRC); NSF-Louis Stokes Alliance
   for Minority Participation; Center for Undergraduate Research (CUR);
   Louisiana Board of Regents Research Commercialization and Education
   Enhancement Program (RCEEP), Department of Chemistry Work/Study; NSF
   [OCI-1122919]; Department of Defense grant [W81XWH-04-1-0557]; Office of
   Naval Research Grant [N00014-99-1-0763]; LCRC; NIH-RCMI Grant
   [2G12MD007595-06];  [NIH-1SC3GM112558-01]
FX Neil R. McIntyre would like to acknowledge support from
   NIH-1SC3GM112558-01, NIH-RCMI Grant 2G12MD007595-06, Louisiana Cancer
   Research Consortium (LCRC), NSF-Louis Stokes Alliance for Minority
   Participation (JM), Center for Undergraduate Research (CUR)(JS),
   Louisiana Board of Regents Research Commercialization and Education
   Enhancement Program (RCEEP)(GM), Department of Chemistry Work/Study.
   Edward W. Lowe, Jr. acknowledges NSF support through the CI-TraCS
   fellowship (OCI-1122919). Guangdi Wang would like to acknowledge support
   from Department of Defense grant W81XWH-04-1-0557, Office of Naval
   Research Grant N00014-99-1-0763, and LCRC. We would also like to
   acknowledge the insightful recommendations of Dr. Larry Byers (Tulane)
   during the preparation of this manuscript.
CR Alvarez F.J., 1987, ISOTOPES ORGANIC CHE, P1
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193
   RODRIGUEZLOPEZ JN, 1993, BIOCHEM J, V293, P859
   Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x
   Ramsden CA, 2014, BIOORGAN MED CHEM, V22, P2388, DOI 10.1016/j.bmc.2014.02.048
   Kieber-Emmons MT, 2014, ANGEW CHEM INT EDIT, V53, P4935, DOI 10.1002/anie.201402166
   Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t
   Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025
   Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024
   Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647
   Suzuki H, 2006, J BIOL CHEM, V281, P824, DOI 10.1074/jbc.M505806200
   Sendovski M, 2011, J MOL BIOL, V405, P227, DOI 10.1016/j.jmb.2010.10.048
   MASON HS, 1948, J BIOL CHEM, V172, P83
   SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551
   Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t
   Rodriguez-Lopez JN, 2000, BIOCHEMISTRY-US, V39, P10497, DOI 10.1021/bi000539+
   Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200
   Fenoll LG, 2001, BBA-PROTEIN STRUCT M, V1548, P1, DOI 10.1016/S0167-4838(01)00207-2
   Cong Y, 2009, STRUCTURE, V17, P749, DOI 10.1016/j.str.2009.03.005
   Sendovski M, 2010, ACTA CRYSTALLOGR F, V66, P1101, DOI 10.1107/S1744309110031520
   Chen P, 2004, P NATL ACAD SCI USA, V101, P13105, DOI 10.1073/pnas.0402114101
   Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390
   Kaizer J, 2008, J INORG BIOCHEM, V102, P773, DOI 10.1016/j.jinorgbio.2007.11.014
   Osako T, 2003, J AM CHEM SOC, V125, P11027, DOI 10.1021/ja029380
   Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3
   Baird S, 2007, BBA-PROTEINS PROTEOM, V1774, P1380, DOI 10.1016/j.bbapap.2007.08.019
   BARRY CE, 1989, BIOCHEMISTRY-US, V28, P6323, DOI 10.1021/bi00441a026
   Borovansky J, 2006, PIGM CELL RES, V19, P170, DOI 10.1111/j.1600-0749.2006.00295.x
   Bruyneel F, 2009, CHEM-EUR J, V15, P8283, DOI 10.1002/chem.200900681
   Cleland W W, 1979, Methods Enzymol, V63, P103
   DUCKWORT.HW, 1970, J BIOL CHEM, V245, P1613
   Fenoll LG, 2004, BIOCHEM J, V380, P643, DOI 10.1042/BJ20040136
   FREEMAN JC, 1993, BIOCHEMISTRY-US, V32, P4826, DOI 10.1021/bi00069a018
   GOODWIN DC, 1995, ANAL BIOCHEM, V231, P333, DOI 10.1006/abio.1995.0059
   Ismaya WT, 2011, ACTA CRYSTALLOGR F, V67, P575, DOI 10.1107/S174430911100738X
   JACKMAN MP, 1992, BIOCHEM J, V282, P915
   JOLLEY RL, 1974, J BIOL CHEM, V249, P335
   Kresge A. J., 1987, ISOTOPES ORGANIC CHE, V7, P177
   Land EJ, 2006, TETRAHEDRON, V62, P4884, DOI 10.1016/j.tet.2006.03.016
   MAKINO N, 1973, J BIOL CHEM, V248, P5731
   MASON HS, 1949, J BIOL CHEM, V181, P803
   Matsumoto T, 2006, J AM CHEM SOC, V128, P3874, DOI 10.1021/ja058117g
   McIntyre NR, 2006, FEBS LETT, V580, P521, DOI 10.1016/j.febslet.2005.12.058
   Molina FG, 2007, INT J BIOCHEM CELL B, V39, P238, DOI 10.1016/j.biocel.2006.08.007
   Munoz-Munoz J. L., 1814, BIOCHIM BIOPHYS ACTA, V2011, P1974
   Munoz-Munoz JL, 2013, IUBMB LIFE, V65, P793, DOI 10.1002/iub.1191
   Munoz-Munoz JL, 2011, ACTA BIOCHIM POL, V58, P303
   Naish-Byfield S, 1998, PIGM CELL RES, V11, P127, DOI 10.1111/j.1600-0749.1998.tb00722.x
   Penalver MJ, 2002, BBA-PROTEIN STRUCT M, V1597, P140, DOI 10.1016/S0167-4838(02)00264-9
   Penalver MJ, 2003, BBA-PROTEINS PROTEOM, V1650, P128, DOI 10.1016/S1570-9639(03)00208-5
   Powell A., 2007, J CHEM, V1, P1
   Quinn D.M., 1991, ENZYME MECH ISOTOPE, P73
   SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1
   Schowen K.B.J., 1978, TRANSITION STATES BI, P225
   Schowen R., 1977, ISOTOPE EFFECTS ENZY, P64
   Shearer J, 2005, J AM CHEM SOC, V127, P5469, DOI 10.1021/ja045191a
   Smith AW, 2006, BIOCHEMISTRY-US, V45, P4378, DOI 10.1021/bi0525526
   Solomon EI, 2011, FARADAY DISCUSS, V148, P11, DOI 10.1039/c005500j
   Solomon E.I., 2011, FARADAY DISCUSS, V148, P97
   TOUSSAINT O, 1987, BIOCHEMISTRY-US, V26, P8567, DOI 10.1021/bi00400a011
   VENKATASUBBAN KS, 1984, CRC CR REV BIOCH MOL, V17, P1, DOI 10.3109/10409238409110268
   WRIGHT CI, 1946, J BIOL CHEM, V165, P45
NR 63
TC 1
Z9 1
U1 13
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL
PY 2015
VL 577
BP 24
EP 34
DI 10.1016/j.abb.2015.04.007
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3MJ
UT WOS:000356119900003
PM 25982123
ER

PT J
AU Gacche, RN
   Meshram, RJ
   Shegokar, HD
   Gond, DS
   Kamble, SS
   Dhabadge, VN
   Utage, BG
   Patil, KK
   More, RA
AF Gacche, R. N.
   Meshram, R. J.
   Shegokar, H. D.
   Gond, D. S.
   Kamble, S. S.
   Dhabadge, V. N.
   Utage, B. G.
   Patil, K. K.
   More, R. A.
TI Flavonoids as a scaffold for development of novel anti-angiogenic
   agents: An experimental and computational enquiry
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Flavonoids; Anti-angiogenesis; Antioxidant; Cytotoxicity; Cyclooxygenase
   inhibition; Molecular docking; VEGFR and EGFR
ID MOLECULAR-DYNAMICS SIMULATIONS; TYROSINE KINASE INHIBITORS; VASCULAR
   ENDOTHELIAL-CELLS; UNIVERSAL FORCE-FIELD; COLON-CANCER CELLS; IN-SILICO
   ANALYSIS; TUMOR ANGIOGENESIS; INDUCED CYTOTOXICITY; ANTIOXIDANT
   ACTIVITY; OXIDATIVE STRESS
AB Relationship between structural diversity and biological activities of flavonoids has remained an important discourse in the mainstream of flavonoid research. In the current study anti-angiogenic, cytotoxic, antioxidant and cyclooxygenase (COX) inhibitory activities of diverse class of flavonoids including hydroxyl and methoxy substituted flavones, flavonones and flavonols have been evaluated in the light of developing flavonoids as a potential scaffold for designing novel anti-antiangiogenic agents. We demonstrate anti-angiogenic potential of flavonoids using in vivo chorioallantoic membrane model (CAM) and further elaborate the possible structural reasoning behind observed anti-angiogenic effect using in silica methods. Additionally, we report antioxidant potential and kinetics of free radical scavenging activity using DPPH and SOR scavenging assays. Current study indicates that selected flavonoids possess considerable. COX inhibition potential. Furthermore, we describe cytotoxicity of flavonoids against selected cancer cell lines using MTT cell viability assay. Structural analysis of in silica docking poses and predicted binding free energy values are not only in accordance with the experimental anti-angiogenic CAM values from this study but also are in agreement with the previously reported literature on crystallographic data concerning EGFR and VEGFR inhibition. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Gacche, R. N.; Meshram, R. J.; Shegokar, H. D.; Kamble, S. S.; Dhabadge, V. N.; Patil, K. K.; More, R. A.] Swami Ramanand Teerth Marathwada Univ, Sch Life Sci, Nanded 431606, MS, India.
   [Gond, D. S.] Savitribai Phule Pune Univ, Dept Microbiol, Pune 411007, MS, India.
   [Utage, B. G.] Natl Ctr Cell Sci, Pune 411007, MS, India.
RP Gacche, RN (reprint author), Swami Ramanand Teerth Marathwada Univ, Sch Life Sci, Nanded 431606, MS, India.
EM rngacche@rediffmail.com
FU UGC, New Delhi [42-196/2013(SR)]
FX The authors are thankful to UGC, New Delhi for financial assistance (F.
   No. 42-196/2013(SR) and Prof. Pandit Vidyasagar, Vice Chancellor, SRTM
   University for providing facilities and encouragement.
CR Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200
   Singh RP, 2004, CURR CANCER DRUG TAR, V4, P1, DOI 10.2174/1568009043481605
   Plochmann K, 2007, ARCH BIOCHEM BIOPHYS, V460, P1, DOI 10.1016/j.abb.2007.02.003
   Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u
   Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1016/j.semincol.2004.03.040
   Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408
   Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867
   Gietema JA, 2006, ANN ONCOL, V17, P1320, DOI 10.1093/annonc/mdl102
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Zima T, 2001, J BIOMED SCI, V8, P59, DOI 10.1007/BF02255972
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x
   Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768
   Auyeung KKW, 2012, ONCOL REP, V28, P2188, DOI 10.3892/or.2012.2056
   Gacche RN, 2014, BBA-REV CANCER, V1846, P161, DOI 10.1016/j.bbcan.2014.05.002
   Soucy NV, 2003, TOXICOL SCI, V76, P271, DOI 10.1093/toxsci/kfg231
   Trouillas P, 2004, FOOD CHEM, V88, P571, DOI 10.1016/j.foodchem.2004.02.009
   Hasegawa M, 2007, J MED CHEM, V50, P4453, DOI 10.1021/jm0611051
   Brunetti C, 2013, INT J MOL SCI, V14, P3540, DOI 10.3390/ijms14023540
   Azizian H, 2010, J MOL GRAPH MODEL, V28, P626, DOI 10.1016/j.jmgm.2009.12.007
   Potashman MH, 2007, J MED CHEM, V50, P4351, DOI 10.1021/jm070034i
   Kadam A, 2014, BIOORG CHEM, V53, P67, DOI 10.1016/j.bioorg.2014.02.002
   Fong TAT, 1999, CANCER RES, V59, P99
   Salvado MD, 2012, TRENDS MOL MED, V18, P233, DOI 10.1016/j.molmed.2012.02.002
   YANAGIHARA K, 1993, CANCER RES, V53, P5815
   Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32
   Rathore K, 2012, CARCINOGENESIS, V33, P174, DOI 10.1093/carcin/bgr244
   Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238
   Saleh M, 1996, CANCER RES, V56, P393
   Liu F, 1997, LIFE SCI, V60, P763, DOI 10.1016/S0024-3205(97)00004-0
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bandgar BP, 2010, BIOORG MED CHEM LETT, V20, P730, DOI 10.1016/j.bmcl.2009.11.068
   Fotsis T, 1997, CANCER RES, V57, P2916
   RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040
   Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017
   LIOTTA LA, 1974, CANCER RES, V34, P997
   Harlozinska A, 2005, ANTICANCER RES, V25, P3327
   Tanaka T, 1997, CARCINOGENESIS, V18, P957, DOI 10.1093/carcin/18.5.957
   HAVSTEEN B, 1983, BIOCHEM PHARMACOL, V32, P1141, DOI 10.1016/0006-2952(83)90262-9
   Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014
   Lee JY, 2004, J ETHNOPHARMACOL, V93, P409, DOI 10.1016/j.jep.2004.04.017
   Bandgar BP, 2012, BIOORG MED CHEM LETT, V22, P5839, DOI 10.1016/j.bmcl.2012.07.080
   Rusk A, 2006, CLIN CANCER RES, V12, P7444, DOI 10.1158/1078-0432.CCR-06-0109
   Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200
   Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6
   CASEWIT CJ, 1992, J AM CHEM SOC, V114, P10035, DOI 10.1021/ja00051a041
   Tao BB, 2013, ANTIOXID REDOX SIGN, V19, P448, DOI 10.1089/ars.2012.4565
   SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0
   RAPPE AK, 1993, INORG CHEM, V32, P3438, DOI 10.1021/ic00068a012
   Augustin HG, 1998, TRENDS PHARMACOL SCI, V19, P216, DOI 10.1016/S0165-6147(98)01211-5
   Blencke S, 2003, J BIOL CHEM, V278, P15435, DOI 10.1074/jbc.M211158200
   Cao YH, 2004, SEMIN CANCER BIOL, V14, P139, DOI 10.1016/j.semcancer.2003.09.018
   Chen ZY, 1996, CHEM PHYS LIPIDS, V79, P157, DOI 10.1016/0009-3084(96)02523-6
   Czaplińska Małgorzata, 2012, Postepy Biochem, V58, P235
   Das L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099583
   Yao LP, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-13
   Folkman J, 1976, Adv Pathobiol, V4, P12
   Folkman J, 1992, Semin Cancer Biol, V3, P65
   Gacche RN, 2011, CELL BIOCHEM BIOPHYS, V61, P651, DOI 10.1007/s12013-011-9251-z
   Gacche RN, 2013, PROG BIOPHYS MOL BIO, V113, P333, DOI 10.1016/j.pbiomolbio.2013.10.001
   GAWRON A, 1992, Polish Journal of Pharmacology and Pharmacy, V44, P51
   Gond D.S., 2013, DRUG INVENT TODAY, V5, P182
   Gotoh T, 1998, JPN J CANCER RES, V89, P137
   Gourley M, 2000, CURR PHARM DESIGN, V6, P417, DOI 10.2174/1381612003400867
   Huey B., 2007, J COMPUT CHEM, V28, P1145
   Kim SF, 2014, VITAM HORM, V96, P211, DOI 10.1016/B978-0-12-800254-4.00009-X
   Kumar B, 2012, VASC PHARMACOL, V57, P201, DOI 10.1016/j.vph.2012.02.007
   Li CY, 2000, CANCER METAST REV, V19, P7, DOI 10.1023/A:1026538601947
   Lin CH, 2013, BRIT J PHARMACOL, V168, P920, DOI 10.1111/j.1476-5381.2012.02227.x
   Martinez AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106372
   McTigue MA, 1999, STRUCT FOLD DES, V7, P319, DOI 10.1016/S0969-2126(99)80042-2
   Meyer AG, 2014, PEERJ, V2, DOI 10.7717/peerj.266
   Miteva MA, 2010, NUCLEIC ACIDS RES, V38, pW622, DOI 10.1093/nar/gkq325
   Morales J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040548
   Nourazarian AR, 2014, ASIAN PAC J CANCER P, V15, P4745, DOI 10.7314/APJCP.2014.15.12.4745
   Park K, 2004, B KOR CHEM SOC, V25, P1331
   Qi L, 2003, CANCER BIOL THER, V2, P526
   Quintero A, 1999, J PHARM PHARM SCI, V2, P108
   Rajesh G, 2010, EUR J PHARM SCI, V39, P37, DOI 10.1016/j.ejps.2009.10.008
   Rashid K, 2014, NUTR NEUROSCI, V17, P178, DOI 10.1179/1476830513Y.0000000081
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Rice L, 2002, PROSTATE, V52, P201, DOI 10.1002/pros.10100
   Rocchetti R, 2005, CHEMOTHERAPY, V51, P291, DOI 10.1159/000088950
   Sasamura H, 2002, BRIT J CANCER, V86, P768, DOI 10.1038/sj/bjc/6600152
   Tanaka T, 1997, CARCINOGENESIS, V18, P761, DOI 10.1093/carcin/18.4.761
   Tanaka T, 1997, CANCER RES, V57, P246
   Toomey DP, 2009, SURG-J R COLL SURG E, V7, P174
   Weng C., 2014, INT J BIOL MACROMO C, V72C, P430
   Yao JHS, 2004, CIRC RES, V95, P364, DOI 10.1161/01.RES.0000138581.04174.2f
NR 89
TC 0
Z9 0
U1 14
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL
PY 2015
VL 577
BP 35
EP 48
DI 10.1016/j.abb.2015.04.009
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3MJ
UT WOS:000356119900004
PM 25937258
ER

PT J
AU Johns, M
   Fyalka, R
   Shea, JA
   Neumann, WL
   Rausaria, S
   Msengi, EN
   Imani-Nejad, M
   Zollars, H
   McPherson, T
   Schober, J
   Wooten, J
   Kwon, G
AF Johns, Michael
   Fyalka, Robert
   Shea, Jennifer A.
   Neumann, William L.
   Rausaria, Smita
   Msengi, Eliwaza Naomi
   Imani-Nejad, Maryam
   Zollars, Harry
   McPherson, Timothy
   Schober, Joseph
   Wooten, Joshua
   Kwon, Guim
TI SR-135, a peroxynitrite decomposing catalyst, enhances beta-cell
   function and survival in B6D2F1 mice fed a high fat diet
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Diabetes; Peroxynitrite; Pancreatic beta-cell; Insulin; Nitrotyrosine;
   Apoptosis
ID NITRIC-OXIDE SYNTHASE; INSULIN-RESISTANCE; TYROSINE NITRATION; OXIDATIVE
   STRESS; LIPID-PEROXIDATION; METABOLIC SYNDROME; DIABETES-MELLITUS; NOD
   MICE; OBESITY; INFLAMMATION
AB Peroxynitrite has been implicated in beta-cell dysfunction and insulin resistance in obesity. Chemical catalysts that destroy peroxynitrite, therefore, may have therapeutic value for treating type 2 diabetes. To this end, we have recently demonstrated that Mn(III) bis(hydroxyphenyl)-dipyrromethene complexes, SR-135 and its analogs, can effectively catalyze the decomposition of peroxynitrite in vitro and in vivo through a 2-electron mechanism (Rausaria et al., 2011). To study the effects of SR-135 on glucose homeostasis in obesity, B6D2F1 mice were fed with a high fat-diet (HFD) for 12 weeks and treated with vehicle, SR-135 (5 mg/kg), or a control drug SRB for 2 weeks. SR-135 significantly reduced fasting blood glucose and insulin levels, and enhanced glucose tolerance as compared to HFD control, vehicle or SRB. SR-135 also enhanced glucose-stimulated insulin secretion based on ex vivo studies. Moreover, SR-135 increased insulin content, restored islet architecture, decreased islet size, and reduced tyrosine nitration and apoptosis. These results suggest that a peroxynitrite decomposing catalyst enhances beta-cell function and survival under nutrient overload. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Neumann, William L.; Rausaria, Smita; Msengi, Eliwaza Naomi; Imani-Nejad, Maryam; Zollars, Harry; McPherson, Timothy; Schober, Joseph; Kwon, Guim] So Illinois Univ, Sch Pharm, Edwardsville, IL 62026 USA.
   [Johns, Michael; Fyalka, Robert; Shea, Jennifer A.] So Illinois Univ, Dept Biol Sci, Edwardsville, IL 62026 USA.
   [Wooten, Joshua] So Illinois Univ, Dept Kinesiol & Hlth Educ, Edwardsville, IL 62026 USA.
RP Kwon, G (reprint author), So Illinois Univ, Sch Pharm, Dept Pharmaceut Sci, 220 Univ Pk, Edwardsville, IL 62026 USA.
EM gkwon@siue.edu
FU NIH [1R15DK094142-01A1]; SIUE internal grants; NIH NIAMS [RC1AR058231]
FX This work was supported by NIH Grants 1R15DK094142-01A1 (GK) and NIH
   NIAMS RC1AR058231 (WLN) and SIUE internal grants (GK and WLN).
CR Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669
   Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222
   Zeyda M, 2009, GERONTOLOGY, V55, P379, DOI 10.1159/000212758
   El-Remessy AB, 2010, EXP DIABETES RES, DOI 10.1155/2010/247861
   Vernier S, 2012, ISLETS, V4, P379, DOI 10.4161/isl.22720
   Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI200421625]
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Styskal J, 2012, FREE RADICAL BIO MED, V52, P46, DOI 10.1016/j.freeradbiomed.2011.10.441
   Torres SH, 2004, J ENDOCRINOL, V181, P419, DOI 10.1677/joe.0.1810419
   Pacher P, 2006, CURR OPIN PHARMACOL, V6, P136, DOI 10.1016/j.coph.2006.01.001
   Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pauli JR, 2008, J PHYSIOL-LONDON, V586, P659, DOI 10.1113/jphysiol.2007.142414
   Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q
   Zhou J, 2009, TOXICOL APPL PHARM, V241, P101, DOI 10.1016/j.taap.2009.08.005
   Sawa T, 2000, J BIOL CHEM, V275, P32467, DOI 10.1074/jbc.M910169199
   Ceriello A, 2001, DIABETOLOGIA, V44, P834
   Szabo C, 1997, NITRIC OXIDE-BIOL CH, V1, P373, DOI 10.1006/niox.1997.0143
   Kesavulu MM, 2000, DIABETES METAB, V26, P387
   Rausaria S, 2011, J AM CHEM SOC, V133, P4200, DOI 10.1021/ja110427e
   Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8
   Charbonneau A, 2010, DIABETES, V59, P861, DOI 10.2337/db09-1238
   Beckman JS, 2009, ARCH BIOCHEM BIOPHYS, V484, P114, DOI 10.1016/j.abb.2009.03.013
   Broniowska KA, 2013, J BIOL CHEM, V288, P36567, DOI 10.1074/jbc.M113.522243
   Cahuana GM, 2003, BIOCHEM PHARMACOL, V66, P1963, DOI 10.1016/j.bcp.2003.07.004
   Chen YJ, 2011, AM J PHYSIOL-HEART C, V300, pH1125, DOI 10.1152/ajpheart.00768.2010
   DiMatteo MA, 1997, APOPTOSIS, V2, P164, DOI 10.1023/A:1026412414666
   Duplain H, 2008, J PHYSIOL-LONDON, V586, P4011, DOI 10.1113/jphysiol.2008.154302
   Hou RR, 2010, APOPTOSIS, V15, P877, DOI 10.1007/s10495-010-0510-z
   Jain SK, 1998, FREE RADICAL BIO MED, V24, P197, DOI 10.1016/S0891-5849(97)00223-2
   Kaiser N, 2005, DIABETES, V54, P138, DOI 10.2337/diabetes.54.1.138
   Karasawa H, 2009, METABOLISM, V58, P296, DOI 10.1016/j.metabol.2008.09.028
   Koeck T, 2009, ARCH BIOCHEM BIOPHYS, V484, P221, DOI 10.1016/j.abb.2009.01.021
   Lakey JRT, 2001, LAB INVEST, V81, P1683
   Misko TP, 1998, J BIOL CHEM, V273, P15646, DOI 10.1074/jbc.273.25.15646
   Palomares SM, 2012, J CEREBR BLOOD F MET, V32, P1035, DOI 10.1038/jcbfm.2012.14
   Pilon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015912
   Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9
   RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7
   Rausaria S, 2011, J MED CHEM, V54, P8658, DOI 10.1021/jm201233r
   SuarezPinzon WL, 1997, DIABETES, V46, P907, DOI 10.2337/diabetes.46.5.907
   Suarez-Pinzon WL, 2001, J AUTOIMMUN, V16, P449, DOI 10.1006/jaut.2001.0507
   Yamaguchi Y, 2006, NITRIC OXIDE-BIOL CH, V15, P380, DOI 10.1016/j.niox.2006.04.264
   Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200
   Zhao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078620
NR 48
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL
PY 2015
VL 577
BP 49
EP 59
DI 10.1016/j.abb.2015.04.005
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3MJ
UT WOS:000356119900005
PM 25935364
ER

PT J
AU Ikeno, Y
AF Ikeno, Yuji
TI New insights and current concepts of the oxidative stress theory of
   aging
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
C1 Audie L Murphy Mem VA Hosp, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
RP Ikeno, Y (reprint author), Audie L Murphy Mem VA Hosp, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
NR 0
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2015
VL 576
BP 1
EP 1
DI 10.1016/j.abb.2015.03.019
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3LQ
UT WOS:000356118000001
PM 25823831
ER

PT J
AU Huang, TT
   Leu, D
   Zou, YN
AF Huang, Ting-Ting
   Leu, David
   Zou, Yani
TI Oxidative stress and redox regulation on hippocampal-dependent cognitive
   functions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE SOD deficiency; Irradiation; Hippocampal neurogenesis; Cognitive
   function
ID MANGANESE SUPEROXIDE-DISMUTASE; BREAST-CANCER CELLS; DENTATE GYRUS;
   ADULT NEUROGENESIS; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; MUTANT
   MICE; THERAPEUTIC IRRADIATION; DILATED CARDIOMYOPATHY; HISTONE
   MODIFICATIONS
AB Hippocampal-dependent cognitive functions rely on production of new neurons and maintenance of dendritic structures to provide the synaptic plasticity needed for learning and formation of new memories. Hippocampal formation is exquisitely sensitive to patho-physiological changes, and reduced antioxidant capacity and exposure to low dose irradiation can significantly impede hippocampal-dependent functions of learning and memory by reducing the production of new neurons and alter dendritic structures in the hippocampus. Although the mechanism leading to impaired cognitive functions is complex, persistent oxidative stress likely plays an important role in the SOD-deficient and radiation-exposed hippocampal environment. Aging is associated with increased production of pro-oxidants and accumulation of oxidative end products. Similar to the hippocampal defects observed in SOD-deficient mice and mice exposed to low dose irradiation, reduced capacity in learning and memory, diminishing hippocampal neurogenesis, and altered dendritic network are universal in the aging brains. Given the similarities in cellular and structural changes in the aged, SOD-deficient, and radiation-exposed hippocampal environment and the corresponding changes in cognitive decline, understanding the shared underlying mechanism will provide more flexible and efficient use of SOD deficiency or irradiation to model age-related changes in cognitive functions and identify potential therapeutic or intervention methods. Published by Elsevier Inc.
C1 VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA USA.
   Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.
RP Huang, TT (reprint author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, GRECC,VA Palo Alto Hlth Care Syst, 3801 Miranda Ave,Bldg 100,D3-101, Palo Alto, CA 94304 USA.
EM tthuang@stanford.edu
FU VA Merit Review, Geriatric Research, Education, and clinical Center
   (GRECC)
FX This work was supported by VA Merit Review, Geriatric Research,
   Education, and clinical Center (GRECC), and the use of facility and
   resources at the VA Palo Alto Health Care System.
CR Ali SS, 2006, AGING CELL, V5, P565, DOI 10.1111/j.1474-9726.2006.00252.x
   AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7
   Manns JR, 2009, LEARN MEMORY, V16, P616, DOI 10.1101/lm.1484509
   Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0
   Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011
   Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847
   Bowler RP, 2002, J BIOL CHEM, V277, P16505, DOI 10.1074/jbc.M105409200
   Sarsour EH, 2005, J BIOL CHEM, V280, P18033, DOI 10.1074/jbc.M501939200
   Zeng Y, 2012, J ALZHEIMERS DIS, V31, P765, DOI 10.3233/JAD-2012-120886
   Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006
   Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8
   Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042
   Hu DY, 2006, J NEUROSCI, V26, P3933, DOI 10.1523/JNEUROSCI.5566-05.2006
   Huang TT, 2012, SEMIN CELL DEV BIOL, V23, P738, DOI 10.1016/j.semcdb.2012.04.003
   Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3
   Flood JF, 1998, NEUROSCI BIOBEHAV R, V22, P1
   van Praag H, 1999, NAT NEUROSCI, V2, P266
   Kempermann G, 1998, J NEUROSCI, V18, P3206
   Prickaerts J, 2004, NEUROBIOL LEARN MEM, V81, P1, DOI 10.1016/j.nlm.2003.09.001
   Meyers CA, 2000, INT J RADIAT ONCOL, V46, P51, DOI 10.1016/S0360-3016(99)00376-4
   Braun SMG, 2014, DEVELOPMENT, V141, P1983, DOI 10.1242/dev.104596
   Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432
   Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006
   Cyr AR, 2013, ANTIOXID REDOX SIGN, V18, P1946, DOI 10.1089/ars.2012.4850
   Jinno S, 2011, J COMP NEUROL, V519, P451, DOI 10.1002/cne.22527
   Santos RX, 2013, ANTIOXID REDOX SIGN, V18, P2444, DOI 10.1089/ars.2012.5039
   Sentman ML, 2006, J BIOL CHEM, V281, P6904, DOI 10.1074/jbc.M510764200
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   SHELINE GE, 1980, INT J RADIAT ONCOL, V6, P1215
   ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555
   van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a
   Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   CARLSSON LM, 1995, P NATL ACAD SCI USA, V92, P6264, DOI 10.1073/pnas.92.14.6264
   Menon SG, 2003, CANCER RES, V63, P2109
   Jaholkowski P, 2009, LEARN MEMORY, V16, P439, DOI 10.1101/lm.1459709
   Eichenbaum H, 2001, BEHAV BRAIN RES, V127, P199, DOI 10.1016/S0166-4328(01)00365-5
   Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6
   Huang TT, 2012, FREE RADICAL RES, V46, P951, DOI 10.3109/10715762.2012.664770
   Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011
   Raber J, 2011, HIPPOCAMPUS, V21, P72, DOI 10.1002/hipo.20724
   KARLSSON K, 1987, BIOCHEM J, V242, P55
   GALLAGHER M, 1988, NEUROBIOL AGING, V9, P549, DOI 10.1016/S0197-4580(88)80112-X
   Grill J, 1999, INT J RADIAT ONCOL, V45, P137, DOI 10.1016/S0360-3016(99)00177-7
   Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308
   Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459
   Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700
   Kamsler A, 2007, ANTIOXID REDOX SIGN, V9, P181, DOI 10.1089/ars.2007.9.181
   de Vanssay-Maigne A, 2011, NEUROIMAGE, V58, P1131, DOI 10.1016/j.neuroimage.2011.06.086
   Huang FL, 2006, J NEUROSCI, V26, P6230, DOI 10.1523/JNEUROSCI.1182-06.2006
   Limoli CL, 2007, RADIAT ENVIRON BIOPH, V46, P167, DOI 10.1007/s00411-006-0077-9
   Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812
   Fishman K, 2009, FREE RADICAL BIO MED, V47, P1459, DOI 10.1016/j.freeradbiomed.2009.08.016
   Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4
   RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041
   Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003
   Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI 10.1089/ARS.2009.2513
   Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515
   Surma-aho O, 2001, NEUROLOGY, V56, P1285
   Kempermann G, 2002, J NEUROSCI, V22, P635
   Bizon JL, 2003, EUR J NEUROSCI, V18, P215, DOI 10.1046/j.1460-9568.2003.02733.x
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569
   Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034
   Ranganathan AC, 2001, J BIOL CHEM, V276, P14264
   van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05-2005
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895
   Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204
   Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5
   Hempel N, 2011, ANTI-CANCER AGENT ME, V11, P191
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002
   van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427
   Dhar SK, 2012, FREE RADICAL BIO MED, V52, P2209, DOI 10.1016/j.freeradbiomed.2012.03.009
   Opitz B, 2014, FRONT NEUROL NEUROSC, V34, P51, DOI 10.1159/000356422
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Bachevalier J, 2008, HIPPOCAMPUS, V18, P64, DOI 10.1002/hipo.20369
   Budson AE, 2009, NEUROLOGIST, V15, P71, DOI 10.1097/NRL.0b013e318188040d
   Chakraborti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040844
   Corniola R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049367
   Gu Yan, 2013, Curr Top Behav Neurosci, V15, P31, DOI 10.1007/7854_2012_217
   Hitchiler MJ, 2008, FREE RADICAL BIO MED, V45, P1573, DOI 10.1016/j.freeradbiomed.2008.09.005
   Hitchler MJ, 2006, EPIGENETICS-US, V1, P163
   Huang TT, 1997, ARCH BIOCHEM BIOPHYS, V344, P424, DOI 10.1006/abbi.1997.0237
   Huang YH, 1999, DNA CELL BIOL, V18, P643, DOI 10.1089/104454999315051
   Kim A, 2010, FREE RADICAL BIO MED, V48, P1501, DOI 10.1016/j.freeradbiomed.2010.02.028
   Kim SU, 2014, STEM CELLS, V32, P998, DOI 10.1002/stem.1593
   Kim SU, 2011, NEUROBIOL AGING, V32, P1054, DOI 10.1016/j.neurobiolaging.2009.05.017
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   MacKay DG, 2013, NEUROPSYCHOLOGIA, V51, P2633, DOI 10.1016/j.neuropsychologia.2013.08.009
   MARGOLIS FL, 1991, PROG BRAIN RES, V89, P97, DOI 10.1016/S0079-6123(08)61718-5
   Markakis EA, 1999, J COMP NEUROL, V406, P449
   Martinez-Canabal A., 2012, HIPPOCAMPUS
   Meyer RC, 1998, ANN NY ACAD SCI, V854, P307, DOI 10.1111/j.1749-6632.1998.tb09911.x
   Middei S, 2010, LEARN MEMORY, V17, P236, DOI 10.1101/lm.1748310
   Motomura K, 2010, NEUROSCI LETT, V485, P65, DOI 10.1016/j.neulet.2010.08.065
   Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970
   Papp G, 2007, LEARN MEMORY, V14, P732, DOI 10.1101/lm.687407
   Parihar V.K., 2013, P NATL ACAD SCI USA, V110, P12822
   Petralia RS, 2014, AGEING RES REV, V14, P31, DOI 10.1016/j.arr.2014.01.003
   Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77
   Rola R., 2007, FREE RADICAL BIO MED, V42, P1133
   Rola R., 2007, FREE RADICAL BIO MED, V42, P1131
   Rosi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031094
   Stuchlik A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00106
   Sturtz LA, 2001, J BIOL CHEM, V276, P38084
   Zou Y., 2012, P NATL ACAD SCI USA, V109, P21522
NR 108
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2015
VL 576
BP 2
EP 7
DI 10.1016/j.abb.2015.03.014
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3LQ
UT WOS:000356118000002
PM 25797440
ER

PT J
AU Garbarino, VR
   Orr, ME
   Rodriguez, KA
   Buffenstein, R
AF Garbarino, Valentina R.
   Orr, Miranda E.
   Rodriguez, Karl A.
   Buffenstein, Rochelle
TI Mechanisms of oxidative stress resistance in the brain: Lessons learned
   from hypoxia tolerant extremophilic vertebrates
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Oxidative damage; Turtle; Hibernation; Hypoxia; Naked mole-rat; Brain;
   Antioxidant; Anoxia
ID NAKED MOLE-RAT; SENESCENCE-ACCELERATED MOUSE; LONG-TERM POTENTIATION;
   FREE-RADICAL THEORY; HIBERNATING GROUND-SQUIRRELS; BASE EXCISION-REPAIR;
   HEAT-SHOCK PROTEINS; DNA DELETION LEVELS; NEURAL STEM-CELLS;
   ALZHEIMERS-DISEASE
AB The Oxidative Stress Theory of Aging has had tremendous impact in research involving aging and age-associated diseases including those that affect the nervous system. With over half a century of accrued data showing both strong support for and against this theory, there is a need to critically evaluate the data acquired from common biomedical research models, and to also diversify the species used in studies involving this proximate theory. One approach is to follow Orgel's second axiom that "evolution is smarter than we are" and judiciously choose species that may have evolved to live with chronic or seasonal oxidative stressors. Vertebrates that have naturally evolved to live under extreme conditions (e.g., anoxia or hypoxia), as well as those that undergo daily or seasonal torpor encounter both decreased oxygen availability and subsequent reoxygenation, with concomitant increased oxidative stress. Due to its high metabolic activity, the brain may be particularly vulnerable to oxidative stress. Here, we focus on oxidative stress responses in the brains of certain mouse models as well as extremophilic vertebrates. Exploring the naturally evolved biological tools utilized to cope with seasonal or environmentally variable oxygen availability may yield key information pertinent for how to deal with oxidative stress and thereby mitigate its propagation of age-associated diseases. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Garbarino, Valentina R.; Orr, Miranda E.; Rodriguez, Karl A.; Buffenstein, Rochelle] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Aging & Longev Studies, Dept Physiol, San Antonio, TX 78245 USA.
RP Buffenstein, R (reprint author), Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Aging & Longev Studies, 15355 Lambda Dr,STCBM 2-325, San Antonio, TX 78245 USA.
EM garbarino@livemail.uthscsa.edu; orr-m3@uthscsa.edu;
   rodriguezk@uthscsa.edu; buffenstei-n@uthscsa.edu
FU NIH/NIA [1R21AG043912]; Glenn Foundation; Owen Foundation; AFAR,
   Breakthroughs in Gerontology
FX This work was funded by awards to R.B. from the NIH/NIA (1R21AG043912),
   The Glenn Foundation, The Owen Foundation and AFAR, Breakthroughs in
   Gerontology.
CR Abboud J, 2013, PEERJ, V1, DOI 10.7717/peerj.12
   ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153
   ADNJ D. G., 2000, ANTIOXID REDOX SIGN, V2, P937
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529
   KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Prentice HM, 2004, J CEREBR BLOOD F MET, V24, P826, DOI 10.1097/01.WCB.0000126565.27130.79
   Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371
   GOLDBERG MP, 1993, J NEUROSCI, V13, P3510
   Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x
   ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285
   Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x
   Lutz PL, 2004, RESP PHYSIOL NEUROBI, V141, P285, DOI 10.1016/j.resp.2004.03.013
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928
   Shringarpure R, 2001, CELL MOL LIFE SCI, V58, P1442, DOI 10.1007/PL00000787
   Bryantsev AL, 2007, BIOCHEM J, V407, P407, DOI 10.1042/BJ20070195
   Barja G, 2000, FASEB J, V14, P312
   Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477
   Edrey YH, 2011, ILAR J, V52, P41
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   GROSS NJ, 1969, J BIOL CHEM, V244, P1552
   Salway KD, 2011, MECH AGEING DEV, V132, P287, DOI 10.1016/j.mad.2011.06.002
   Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485
   Edrey YH, 2013, NEUROBIOL AGING, V34, P2352, DOI 10.1016/j.neurobiolaging.2013.03.032
   Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7
   Bartsch H, 2006, LANGENBECK ARCH SURG, V391, P499, DOI 10.1007/s00423-006-0073-1
   BENZI G, 1995, FREE RADICAL BIO MED, V19, P77, DOI 10.1016/0891-5849(94)00244-E
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911
   Kokolus KM, 2013, P NATL ACAD SCI USA, V110, P20176, DOI 10.1073/pnas.1304291110
   Krivoruchko A, 2010, J COMP PHYSIOL B, V180, P403, DOI 10.1007/s00360-009-0414-9
   Li Y, 2012, TOXICOL LETT, V215, P1, DOI 10.1016/j.toxlet.2012.09.019
   YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3
   Aguiar AS, 2009, BRAIN RES BULL, V79, P452, DOI 10.1016/j.brainresbull.2009.05.005
   BOVERIS A, 1973, BIOCHEM J, V134, P707
   Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028
   Willeumier K, 2006, J NEUROSCI, V26, P11333, DOI 10.1523/JNEUROSCI.1684-06.2006
   Puram SV, 2013, CELL REP, V4, P19, DOI 10.1016/j.celrep.2013.06.006
   Elkharaz J, 2013, BBA-MOL BASIS DIS, V1832, P1930, DOI 10.1016/j.bbadis.2013.07.002
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI [10.1038/nchembio.497, 10.1038/NCHEMBIO.497]
   Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056
   Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006
   HARMAN D, 1972, AM J CLIN NUTR, V25, P839
   Kesaraju S, 2009, J NEUROCHEM, V109, P1413, DOI 10.1111/j.1471-4159.2009.06068.x
   Manzanero S, 2013, NEUROCHEM INT, V62, P712, DOI 10.1016/j.neuint.2012.11.009
   Larson J, 2009, NEUROREPORT, V20, P1634, DOI 10.1097/WNR.0b013e32833370cf
   Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.0022-3042.2003.01580.x
   Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152
   Baker PJ, 2007, J COMP PHYSIOL B, V177, P875, DOI 10.1007/s00360-007-0185-0
   Xu G, 2008, MECH AGEING DEV, V129, P366, DOI 10.1016/j.mad.2008.03.001
   Morrison SJ, 2000, J NEUROSCI, V20, P7370
   Woodcock J, 2008, ANNU REV MED, V59, P1, DOI 10.1146/annurev.med.59.090506.155819
   Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812
   Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
   Wang YX, 2000, NEUROBIOL AGING, V21, P525, DOI 10.1016/S0197-4580(00)00114-7
   Edrey YH, 2012, AGING CELL, V11, P213, DOI 10.1111/j.1474-9726.2011.00772.x
   Dowd WW, 2010, PHYSIOL GENOMICS, V42, P93, DOI 10.1152/physiolgenomics.00176.2009
   Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451
   Storey KB, 2007, COMP BIOCHEM PHYS A, V147, P263, DOI 10.1016/j.cbpa.2006.03.019
   Mao PZ, 2012, HUM MOL GENET, V21, P2973, DOI 10.1093/hmg/dds128
   Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4
   Lushchak VI, 2005, INT J BIOCHEM CELL B, V37, P1319, DOI 10.1016/j.biocel.2005.01.006
   Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI [10.1016/j.neuropharm.2008.01.005, 10.1016/j.neurophann.2008.01.005]
   Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106
   Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0
   Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582
   Massaad CA, 2009, AGING-US, V1, P758
   Borgesius NZ, 2011, J NEUROSCI, V31, P12543, DOI 10.1523/JNEUROSCI.1589-11.2011
   Orr ME, 2014, NEUROBIOL AGING, V35, P1233, DOI 10.1016/j.neurobiolaging.2013.12.006
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Mamady H, 2008, ARCH BIOCHEM BIOPHYS, V477, P77, DOI 10.1016/j.abb.2008.05.006
   Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801
   Currais A, 2013, ANTIOXID REDOX SIGN, V19, P813, DOI 10.1089/ars.2012.4996
   Buffenstein R, 2014, AGING-US, V6, P913
   Hamilton AM, 2013, NEURAL PLAST, DOI 10.1155/2013/196848
   Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087
   Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031
   Edrey YH, 2014, J NEUROSCI RES, V92, P195, DOI 10.1002/jnr.23320
   Carey HV, 2000, J COMP PHYSIOL B, V170, P551, DOI 10.1007/s003600000135
   Arrieta-Cruz I, 2007, EXP NEUROL, V205, P449, DOI 10.1016/j.expneurol.2007.03.005
   Bagnyukova TV, 2003, J THERM BIOL, V28, P21, DOI 10.1016/S0306-4565(02)00031-1
   Bitner B. R., 2012, MAGN RESON INSIGHTS, V5, P1, DOI DOI 10.4137/MRI.S9352
   Brennan-Minnella A. M., 2014, ANTIOXID REDOX SIGNA
   Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5
   Buzadzic B, 1997, COMP BIOCHEM PHYS C, V117, P141, DOI 10.1016/S0742-8413(97)00061-3
   Cai M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111938
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   Chung DJ, 2014, VET J, V199, P123, DOI 10.1016/j.tvjl.2013.10.020
   Dave KR, 2006, STROKE, V37, P1261, DOI 10.1161/01.STR.0000217409.60731.38
   Dave KR, 2012, COMP BIOCHEM PHYS B, V162, P1, DOI 10.1016/j.cbpb.2012.01.008
   Dong Y, 2013, BRAIN RES, V1535, P115, DOI 10.1016/j.brainres.2013.08.039
   Drew KL, 1999, BRAIN RES, V851, P1, DOI 10.1016/S0006-8993(99)01969-1
   Grimm S, 2012, AMINO ACIDS, V42, P23, DOI 10.1007/s00726-010-0646-8
   Grune T, 2011, FREE RADICAL BIO MED, V51, P1355, DOI 10.1016/j.freeradbiomed.2011.06.015
   Hochachka P. W., 2002, BIOCH ADAPTATION MEC, Vxi, P466
   Hochachka PW, 2000, ADV EXP MED BIOL, V475, P25
   HORTON TM, 1995, NEUROLOGY, V45, P1879
   Hou QM, 2011, NEURON, V72, P806, DOI 10.1016/j.neuron.2011.10.011
   Jung T, 2006, FREE RADICAL BIO MED, V40, P1303, DOI 10.1016/j.freeradbiomed.2005.11.023
   Kim BM, 2014, COMP BIOCHEM PHYS C, V166, P65, DOI 10.1016/j.cbpc.2014.07.005
   Kim HC, 2002, BEHAV BRAIN RES, V131, P211, DOI 10.1016/S0166-4328(01)00382-5
   Kraytsberg Y, 2003, MECH AGEING DEV, V124, P49, DOI 10.1016/S0047-6374(02)00169-0
   Lei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107746
   Linnane AW, 2007, BIOGERONTOLOGY, V8, P445, DOI 10.1007/s10522-007-9096-4
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   Liu YY, 2014, J NEUROSCI, V34, P2813, DOI 10.1523/JNEUROSCI.3541-13.2014
   Lutz P. L, 2003, BRAIN OXYGEN CAUSES
   Mamady H, 2006, MOL CELL BIOCHEM, V292, P89, DOI 10.1007/s11010-006-9221-8
   Martin LB, 2007, ECOLOGY, V88, P2516, DOI 10.1890/07-0060.1
   Nathaniel TI, 2009, J INTEGR NEUROSCI, V8, P123, DOI 10.1142/S0219635209002149
   OHTA A, 1989, BRAIN RES, V498, P195, DOI 10.1016/0006-8993(89)90421-6
   Oksala NKJ, 2014, REDOX BIOL, V3, P25, DOI 10.1016/j.redox.2014.10.003
   Page MM, 2009, COMP BIOCHEM PHYS A, V152, P115, DOI 10.1016/j.cbpa.2008.09.032
   Page MM, 2010, J COMP PHYSIOL B, V180, P361, DOI 10.1007/s00360-009-0416-7
   Peterson BL, 2012, NEUROSCI LETT, V506, P342, DOI 10.1016/j.neulet.2011.11.042
   Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145
   Renshaw GMC, 2004, FRONT BIOSCI, V9, P110, DOI 10.2741/1206
   Rodriguez K. A., 2014, MOL BASIS DIS
   Rodriguez KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035890
   Rodriguez KA, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00083
   Rut T., 2014, BIOL REV CAMB PHILOS
   STEVENS CF, 1993, NATURE, V364, P147, DOI 10.1038/364147a0
   Sureda FX, 2006, EXP GERONTOL, V41, P360, DOI 10.1016/j.exger.2006.01.015
   Swain U, 2012, MECH AGEING DEV, V133, P186, DOI 10.1016/j.mad.2012.01.001
   Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005
   Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006
   Vadhvani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057530
   VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352
   Wang Xinkun, 2005, Brain Res Mol Brain Res, V140, P120
   Wang XK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-12
   Wrobel M, 2001, ACTA NEUROBIOL EXP, V61, P69
   Yasui F, 2002, NEUROSCI LETT, V334, P177, DOI 10.1016/S0304-3940(02)01127-8
   ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368
NR 137
TC 1
Z9 1
U1 14
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2015
VL 576
BP 8
EP 16
DI 10.1016/j.abb.2015.01.029
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3LQ
UT WOS:000356118000003
PM 25841340
ER

PT J
AU Tower, J
AF Tower, John
TI Mitochondrial maintenance failure in aging and role of sexual dimorphism
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE UPRmt; Sexual antagonistic pleiotropy; Sexual conflict; Mother's curse;
   Heteroplasmy; Dosage compensation
ID UNFOLDED-PROTEIN RESPONSE; LIFE-SPAN EXTENSION; GENE-EXPRESSION CHANGES;
   DNA COPY NUMBER; ADULT DROSOPHILA-MELANOGASTER; GENDER-SPECIFIC ASPECTS;
   HEAT-SHOCK PROTEINS; CELL-DEATH PATHWAY; CAENORHABDITIS-ELEGANS;
   OXIDATIVE STRESS
AB Gene expression changes during aging are partly conserved across species, and suggest that oxidative stress, inflammation and proteotoxicity result from mitochondrial malfunction and abnormal mitochondrial nuclear signaling. Mitochondrial maintenance failure may result from trade-offs between mitochondrial turnover versus growth and reproduction, sexual antagonistic pleiotropy and genetic conflicts resulting from uni-parental mitochondrial transmission, as well as mitochondrial and nuclear mutations and loss of epigenetic regulation. Aging phenotypes and interventions are often sex-specific, indicating that both male and female sexual differentiation promote mitochondrial failure and aging. Studies in mammals and invertebrates implicate autophagy, apoptosis, AKT, PARP, p53 and FOX in mediating sex-specific differences in stress resistance and aging. The data support a model where the genes Sxl in Drosophila, sdc-2 in Caenorhabditis elegans, and Xist in mammals regulate mitochondrial maintenance across generations and in aging. Several interventions that increase life span cause a mitochondrial unfolded protein response (UPRmt), and UPRmt is also observed during normal aging, indicating hormesis. The UPRmt may increase life span by stimulating mitochondrial turnover through autophagy, and/or by inhibiting the production of hormones and toxic metabolites. The data suggest that metazoan life span interventions may act through a common hormesis mechanism involving liver UPRmt, mitochondrial maintenance and sexual differentiation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Tower, John] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.
RP Tower, J (reprint author), Univ So Calif, 1050 Childs Way,RRI201, Los Angeles, CA 90089 USA.
EM jtower@usc.edu
FU Department of Health and Human Services, National Institute on Aging
   [AG011833]; Southern California Environmental Health Sciences Center
   [5P30ES007048]
FX Thank you to Laura Corrales-Diaz Pomatto and the anonymous reviewers for
   comments on the manuscript. This work was supported by a Grant from the
   Department of Health and Human Services, National Institute on Aging
   (AG011833) and by pilot project funding from the Southern California
   Environmental Health Sciences Center (5P30ES007048).
CR Abramowitz Lara K, 2014, J Genomics, V2, P77, DOI 10.7150/jgen.8123
   Adham IM, 2004, INT J ANDROL, V27, P257, DOI 10.1111/j.1365-2605.2004.00481.x
   Amador-Noguez D, 2005, BIOCHEM BIOPH RES CO, V332, P1086, DOI 10.1016/j.bbrc.2005.05.063
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Wolff JN, 2013, BIOESSAYS, V35, P93, DOI 10.1002/bies.201200141
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   Perez-Crespo M, 2005, MOL REPROD DEV, V72, P502, DOI 10.1002/mrd.20366
   Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004
   Sorensen JG, 2007, EXP GERONTOL, V42, P1123, DOI 10.1016/j.exger.2007.09.001
   Reichelt ME, 2013, J MOL CELL CARDIOL, V65, P67, DOI 10.1016/j.yjmcc.2013.09.014
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Cypser JR, 2006, EXP GERONTOL, V41, P935, DOI 10.1016/j.exger.2006.09.004
   Madeo F, 2010, NAT CELL BIOL, V12, P842, DOI 10.1038/ncb0910-842
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Zhao SY, 2011, CANCER SCI, V102, P1553, DOI 10.1111/j.1349-7006.2011.01968.x
   Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170
   Kanamori H, 2011, AM J PHYSIOL-HEART C, V300, pH2261, DOI 10.1152/ajpheart.01056.2010
   Magkos F, 2010, NUTRITION, V26, P686, DOI 10.1016/j.nut.2009.10.013
   Ritzel RM, 2013, HORM BEHAV, V63, P238, DOI 10.1016/j.yhbeh.2012.04.007
   Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105
   Calvani R, 2013, BIOL CHEM, V394, P393, DOI 10.1515/hsz-2012-0247
   Wolff JN, 2013, HEREDITY, V110, P57, DOI 10.1038/hdy.2012.60
   Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7
   Wu CC, 2006, CANCER RES, V66, P8287, DOI 10.1158/0008-5472.CAN-05-4247
   Gasparre G, 2008, HUM MOL GENET, V17, P986, DOI 10.1093/hmg/ddm371
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388
   Tricoire H, 2009, MECH AGEING DEV, V130, P547, DOI 10.1016/j.mad.2009.05.004
   Epel ES, 2014, J GERONTOL A-BIOL, V69, pS10, DOI 10.1093/gerona/glu055
   WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.2307/2406060
   Brewer AC, 2013, ANTIOXID REDOX SIGN, V18, P1114, DOI 10.1089/ars.2012.4914
   Rattan SIS, 2008, AGEING RES REV, V7, P63, DOI 10.1016/j.arr.2007.03.002
   Vasconsuelo A, 2011, STEROIDS, V76, P1223, DOI 10.1016/j.steroids.2011.08.001
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2006.02.002
   Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920
   KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206
   Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7
   Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Parrella E, 2008, METHODS, V46, P256, DOI 10.1016/j.ymeth.2008.10.004
   Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006
   Katewa SD, 2011, EXP GERONTOL, V46, P382, DOI 10.1016/j.exger.2010.11.036
   Yui R, 2003, GENES GENET SYST, V78, P245
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Rochet JC, 2012, PROG MOL BIOL TRANSL, V107, P125, DOI 10.1016/B978-0-12-385883-2.00011-4
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Ren CL, 2009, EXP GERONTOL, V44, P228, DOI 10.1016/j.exger.2008.10.002
   Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986
   Zhang YC, 2013, MOL BIOL EVOL, V30, P2588, DOI 10.1093/molbev/mst148
   Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345
   Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105
   Hartfield M, 2012, INTEGR ZOOL, V7, P192, DOI 10.1111/j.1749-4877.2012.00284.x
   Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645
   Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006
   Tower J, 2012, WIRES DEV BIOL, V1, P789, DOI 10.1002/wdev.56
   Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054
   Calabrese V, 2004, MECH AGEING DEV, V125, P325, DOI 10.1016/j.mad.2004.01.003
   Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   Wu JJ, 2013, CELL REP, V4, P913, DOI 10.1016/j.celrep.2013.07.030
   Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101
   Tilly JL, 2013, CELL METAB, V17, P838, DOI 10.1016/j.cmet.2013.05.007
   Allen JF, 1996, J THEOR BIOL, V180, P135, DOI 10.1006/jtbi.1996.0089
   Guarner-Lans V, 2011, EXP GERONTOL, V46, P517, DOI 10.1016/j.exger.2011.02.007
   Oukka M, 2008, ANN RHEUM DIS, V67, P26, DOI 10.1136/ard.2008.098004
   Lu Q, 2007, J IMMUNOL, V179, P6352
   Hadji P, 2013, CRIT REV ONCOL HEMAT, V87, P101, DOI 10.1016/j.critrevonc.2013.05.015
   Katewa SD, 2012, CELL METAB, V16, P97, DOI 10.1016/j.cmet.2012.06.005
   Jung T, 2010, METHODS MOL BIOL, V594, P173, DOI 10.1007/978-1-60761-411-1_13
   McKinney EA, 2013, GENET MOL BIOL, V36, P308, DOI 10.1590/S1415-47572013000300002
   Morrow Genevieve, 2008, Biotechnology Journal, V3, P728, DOI 10.1002/biot.200800015
   Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056
   Migliaccio E, 1999, NATURE, V402, P309
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Mattila J, 2009, MOL CELL BIOL, V29, P5357, DOI 10.1128/MCB.00302-09
   Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016
   Rotter D, 2012, PHARMACOL RES, V66, P494, DOI 10.1016/j.phrs.2012.10.001
   Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Waskar M, 2009, AGING-US, V1, P903
   Pellegrini P, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/819724
   WHEELER JC, 1995, P NATL ACAD SCI USA, V92, P10408, DOI 10.1073/pnas.92.22.10408
   Regitz-Zagrosek V, 2007, GENDER MED, V4, pS162, DOI 10.1016/S1550-8579(07)80056-8
   Ventura N, 2009, AGING CELL, V8, P380, DOI 10.1111/j.1474-9726.2009.00482.x
   Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495
   Nunes MDS, 2013, MOL ECOL, V22, P2106, DOI 10.1111/mec.12256
   Sun JT, 2002, GENETICS, V161, P661
   Murray SM, 2010, CURR OPIN CELL BIOL, V22, P722, DOI 10.1016/j.ceb.2010.09.006
   Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x
   Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780
   Renolleau S, 2008, NEUROSCIENTIST, V14, P46, DOI 10.1177/1073858407308889
   King V, 1999, DEV BIOL, V207, P107, DOI 10.1006/dbio.1998.9147
   Rand DM, 2011, GENETICA, V139, P685, DOI 10.1007/s10709-011-9576-y
   Payne BAI, 2013, HUM MOL GENET, V22, P384, DOI 10.1093/hmg/dds435
   Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130
   Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707
   Ingleby FC, 2014, J EVOLUTION BIOL, V27, P1721, DOI 10.1111/jeb.12429
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Antebi A, 2013, CURR TOP DEV BIOL, V105, P181, DOI 10.1016/B978-0-12-396968-2.00007-5
   Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539
   Paik D, 2012, MECH AGEING DEV, V133, P234, DOI 10.1016/j.mad.2012.02.001
   Weis SN, 2014, NEUROSCIENCE, V256, P201, DOI 10.1016/j.neuroscience.2013.10.046
   Tower J, 2009, TRENDS ENDOCRIN MET, V20, P216, DOI 10.1016/j.tem.2008.12.005
   Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Owen BM, 2013, NAT MED, V19, P1153, DOI 10.1038/nm.3250
   Clayton JA, 2014, NATURE, V509, P282
   Tufi R, 2014, NAT CELL BIOL, V16, P157, DOI 10.1038/ncb2901
   Tower J, 2006, MECH AGEING DEV, V127, P705, DOI 10.1016/j.mad.2006.05.001
   Promislow D, 2003, BEHAV GENET, V33, P191, DOI 10.1023/A:1022562103669
   Simonsen A, 2008, AUTOPHAGY, V4, P176
   Bennett CF, 2014, EXP GERONTOL, V56, P142, DOI 10.1016/j.exger.2014.02.002
   Orozco-Solis R, 2014, CURR OPIN GENET DEV, V26, P66, DOI 10.1016/j.gde.2014.06.003
   Chen C, 2013, LIFE SCI, V93, P265, DOI 10.1016/j.lfs.2013.06.019
   Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220
   Moskalev AA, 2014, CELL CYCLE, V13, P1063, DOI 10.4161/cc.28433
   Connallon T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2123
   Yuan R, 2012, P NATL ACAD SCI USA, V109, P8224, DOI 10.1073/pnas.1121113109
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651
   Cabreiro F, 2011, FREE RADICAL BIO MED, V51, P1575, DOI 10.1016/j.freeradbiomed.2011.07.020
   Maglioni S, 2014, EXP GERONTOL, V56, P89, DOI 10.1016/j.exger.2014.03.026
   Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002
   Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919
   Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063
   Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015
   Matson CK, 2012, NAT REV GENET, V13, P163, DOI 10.1038/nrg3161
   Lin J, 2009, CIRCULATION, V120, P245, DOI 10.1161/CIRCULATIONAHA.109.868729
   Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x
   Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002
   Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211
   Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
   Waterson MJ, 2014, P NATL ACAD SCI USA, V111, P8137, DOI 10.1073/pnas.1315461111
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200
   Manley S, 2013, EXP BIOL MED, V238, P525, DOI 10.1177/1535370213489446
   Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032
   Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Haynes CM, 2013, TRENDS CELL BIOL, V23, P311, DOI 10.1016/j.tcb.2013.02.002
   Lippai M, 2014, BIOMED RES INT, DOI 10.1155/2014/832704
   Rand DM, 2001, GENETICS, V159, P173
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Yan L, 2004, J MOL CELL CARDIOL, V37, P921, DOI 10.1016/j.yjmcc.2004.06.012
   Gioti A, 2012, P ROY SOC B-BIOL SCI, V279, P4423, DOI 10.1098/rspb.2012.1634
   Yamamoto R, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-85
   Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   McGee MD, 2012, AGING-US, V4, P256
   Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje
   Baggio G, 2013, CLIN CHEM LAB MED, V51, P713, DOI 10.1515/cclm-2012-0849
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Hagstrom E, 2014, NUCLEIC ACIDS RES, V42, P1111, DOI 10.1093/nar/gkt969
   Girardot F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-69
   Salminen A, 2010, AGEING RES REV, V9, P211, DOI 10.1016/j.arr.2010.04.003
   Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003
   Brown-Borg HM, 2012, J GERONTOL A-BIOL, V67, P652, DOI 10.1093/gerona/gls086
   Salz HK, 2011, CURR OPIN GENET DEV, V21, P395, DOI 10.1016/j.gde.2011.03.001
   Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193
   Landis G, 2012, AGING-US, V4, P768
   Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021
   De Haes W, 2014, P NATL ACAD SCI USA, V111, pE2501, DOI 10.1073/pnas.1321776111
   Honda Y, 1999, FASEB J, V13, P1385
   Vellai T, 2006, GENETICS, V174, P309, DOI 10.1534/genetics.106.061499
   Pennell TM, 2013, ECOL EVOL, V3, P1819, DOI 10.1002/ece3.540
   Yacobi-Sharon K, 2013, DEV CELL, V25, P29, DOI 10.1016/j.devcel.2013.02.002
   Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Palomar-Morales M, 2010, PANCREAS, V39, P193, DOI 10.1097/MPA.0b013e3181c156d9
   McCormick MA, 2011, PHILOS T R SOC B, V366, P17, DOI 10.1098/rstb.2010.0198
   Garigan D, 2002, GENETICS, V161, P1101
   Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2
   McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291
   Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382
   Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200
   Lee SH, 2011, METABOLISM, V60, P1677, DOI 10.1016/j.metabol.2011.04.010
   Maklakov AA, 2013, BIOESSAYS, V35, P717, DOI 10.1002/bies.201300021
   Pulliam DA, 2014, BIOCHEM J, V462, P359, DOI 10.1042/BJ20140291
   Cheng X, 2010, AGING CELL, V9, P919, DOI 10.1111/j.1474-9726.2010.00607.x
   Marzetti E, 2013, AM J PHYSIOL-HEART C, V305, pH459, DOI 10.1152/ajpheart.00936.2012
   Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801
   Yasuda K, 2006, MECH AGEING DEV, V127, P763, DOI 10.1016/j.mad.2006.07.002
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X
   Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428
   Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034
   Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108
   Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004
   Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013
   Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014
   Liu FD, 2011, STROKE, V42, P1090, DOI 10.1161/STROKEAHA.110.594861
   Camus MF, 2012, CURR BIOL, V22, P1717, DOI 10.1016/j.cub.2012.07.018
   Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Munkacsy E, 2014, EXP GERONTOL, V56, P221, DOI 10.1016/j.exger.2014.03.016
   Deng XX, 2014, NAT REV GENET, V15, P367, DOI 10.1038/nrg3687
   de Paula WBM, 2013, GENOME BIOL EVOL, V5, P1969, DOI 10.1093/gbe/evt147
   Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002
   Serra C, 2013, ENDOCRINOLOGY, V154, P4594, DOI 10.1210/en.2013-1004
   ANTONERXLEBEN F, 1983, MECH AGEING DEV, V23, P265, DOI 10.1016/0047-6374(83)90027-1
   Applebaum M. A., 2014, INT J RADIAT BIOL, P1
   Arnold A. P., 2014, EXP NEUROL
   Arslan-Ergul A, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-29
   Babcock CS, 1996, GENETICS, V144, P839
   Babcock CS, 1998, GENETICS, V149, P2063
   Bai H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003941
   Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760
   Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004
   Barford A, 2006, BRIT MED J, V332, P808, DOI 10.1136/bmj.332.7545.808
   Baruah A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004097
   Basualto-Alarcon C, 2013, MED SCI SPORT EXER, V45, P1712, DOI 10.1249/MSS.0b013e31828cf5f3
   Bell G, 1982, MASTERPIECE NATURE E
   Bennett CF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4483
   Berghella AM, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-3
   Berletch JB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-213
   Bhole D, 2004, MECH AGEING DEV, V125, P651, DOI 10.1016/j.mad.2004.08.010
   Bitto A, 2014, AGE, V36, P1123, DOI 10.1007/s11357-014-9626-3
   Bojesen SE, 2008, CELL CYCLE, V7, P158
   Bonduriansky R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000255
   Broue F, 2007, AGING CELL, V6, P87, DOI 10.1111/j.1474-9726.2006.00268.x
   Bubb KJ, 2012, BRIT J PHARMACOL, V167, P298, DOI 10.1111/j.1476-5381.2012.02036.x
   Burger J. M., 2004, SCI AGING KNOWLEDGE, ppe30, DOI DOI 10.1126/SAGEKE.2004.28.PE30
   Callies F, 2003, ENDOCRINOLOGY, V144, P4478, DOI 10.1210/en.2003-0058
   Campesi I, 2013, LIFE SCI, V93, P145, DOI 10.1016/j.lfs.2013.06.001
   Caro P, 2010, MITOCHONDRION, V10, P479, DOI 10.1016/j.mito.2010.05.004
   Chamseddin KH, 2012, MECH AGEING DEV, V133, P637, DOI 10.1016/j.mad.2012.08.004
   Chen XQ, 2008, DEV NEUROBIOL, V68, P265, DOI 10.1002/dneu.20581
   Cho J, 2011, EXP GERONTOL, V46, P331, DOI 10.1016/j.exger.2010.08.010
   Contasta I, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-223
   de Castro IP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.394
   Courtois F, 2013, CURR PHARM DESIGN, V19, P4341
   Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056
   Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262
   Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209
   de Paula WBM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0263
   Di Pietro F., 2012, J GERONTOL A
   Dubessay P, 2007, BIOCHIMIE, V89, P988, DOI 10.1016/j.biochi.2007.03.018
   Dumas KJ, 2013, GENETICS, V194, P619, DOI 10.1534/genetics.113.149948
   Dumas KJ, 2013, G3-GENES GENOM GENET, V3, P841, DOI 10.1534/g3.112.005116
   Dunlay Shannon M, 2012, Curr Heart Fail Rep, V9, P267, DOI 10.1007/s11897-012-0107-7
   Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010
   Extermann Martine, 2013, Critical Reviews in Oncogenesis, V18, P515
   Fagegaltier D., 2014, GENETICS
   Fekete A, 2004, J PHYSIOL-LONDON, V555, P471, DOI 10.1113/jphysiol.2003.054825
   Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549
   Finch CE, 2014, CELL, V156, P398, DOI 10.1016/j.cell.2014.01.028
   Findlay GD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004108
   Amadoro G, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00018
   Forman HJ, 2010, ANN NY ACAD SCI, V1203, P35, DOI 10.1111/j.1749-6632.2010.05551.x
   Galikova M, 2011, EXP GERONTOL, V46, P141, DOI 10.1016/j.exger.2010.08.021
   Gems D, 2000, GENETICS, V154, P1597
   Gendron CM, 2014, SCIENCE, V343, P544, DOI 10.1126/science.1243339
   Gerisch B, 2007, P NATL ACAD SCI USA, V104, P5014, DOI 10.1073/pnas.0700847104
   Giampietri C, 2013, J CELL MOL MED, V17, P550, DOI 10.1111/jcmm.12047
   Gil EMC, 2014, CANCER TREAT REV, V40, P862, DOI 10.1016/j.ctrv.2014.03.004
   Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75
   Golden TR, 2008, AGING CELL, V7, P850, DOI 10.1111/j.1474-9726.2008.00433.x
   Golden TR, 2001, MECH AGEING DEV, V122, P1577, DOI 10.1016/S0047-6374(01)00288-3
   Guarente Leonard, 2011, Cold Spring Harb Symp Quant Biol, V76, P81, DOI 10.1101/sqb.2011.76.010629
   Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024
   Harada H, 2003, P NATL ACAD SCI USA, V100, P739, DOI 10.1073/pnas.0235680100
   Hartman PS, 2007, MECH AGEING DEV, V128, P437, DOI 10.1016/j.mad.2007.06.001
   Hauser F., 2014, GEN COMP ENDOCRINOL
   Herrera VLM, 2008, PHYSIOL GENOMICS, V35, P316, DOI 10.1152/physiolgenomics.00044.2008
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Hughes BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026116
   Hur JH, 2014, J BIOENERG BIOMEMBR, V46, P329, DOI 10.1007/s10863-014-9553-0
   Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335
   Isensee J, 2008, J MOL MED, V86, P61, DOI 10.1007/s00109-007-0240-z
   Jacobs HT, 2004, BBA-BIOENERGETICS, V1659, P190, DOI 10.1016/j.bbabio.2004.07.004
   Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001
   Jazwinski SM, 2014, PROG MOL BIOL TRANSL, V127, P133, DOI 10.1016/B978-0-12-394625-6.00005-2
   Jokinen R, 2011, SMALL GTPASES, V2, P31
   Juhasz G., 2008, AUTOPHAGY, V4
   Jumbo-Lucioni P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-659
   Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004
   Khraiwesh H., 2013, J GERONTOL A
   Kim JH, 2012, J RHEUMATOL, V39, P1465, DOI 10.3899/jrheum.111444
   Koenig A, 2014, J CARDIOVASC TRANSL, V7, P182, DOI 10.1007/s12265-013-9525-5
   Kolesar J. E., 2014, FREE RADIC BIOL MED
   Kujoth GC, 2008, EXP GERONTOL, V43, P20, DOI 10.1016/j.exger.2007.09.010
   Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684
   Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552
   Lane N, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015982
   Lang JT, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-33
   Lapierre LR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3267
   Laurent M, 2014, ASIAN J ANDROL, V16, P213, DOI 10.4103/1008-682X.122356
   Li H, 2005, ANN NEUROL, V58, P317, DOI 10.1002/ana.20538
   Li JY, 2014, CARDIOVASC RES, V102, DOI 10.1093/cvr/cvu064
   Li RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048581
   Liu CS, 2005, ANN NY ACAD SCI, V1042, P70, DOI 10.1196/annals.1338.008
   Liu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085272
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Lively CM, 2014, J EVOLUTION BIOL, V27, P1292, DOI 10.1111/jeb.12354
   Lopez S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042711
   Ma D, 2012, TRENDS ENDOCRIN MET, V23, P319, DOI 10.1016/j.tem.2012.03.004
   Magner DB, 2013, CELL METAB, V18, P212, DOI 10.1016/j.cmet.2013.07.007
   Magwire MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001037
   Maiello M, 1998, GERONTOLOGY, V44, P15, DOI 10.1159/000021977
   Malik A. N., 2012, MITOCHONDRION
   Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007
   Maures TJ, 2014, SCIENCE, V343, P541, DOI 10.1126/science.1244160
   McCulloch D, 2007, ANN NY ACAD SCI, V1119, P253, DOI 10.1196/annals.1404.018
   McCulloch D, 2003, AGING CELL, V2, P165, DOI 10.1046/j.1474-9728.2003.00047.x
   Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008
   Miguel J., 1979, AGE, V2, P78
   Morrow EH, 2013, EVOL APPL, V6, P1208, DOI 10.1111/eva.12097
   Morrow EH, 2008, J EVOLUTION BIOL, V21, P1046, DOI 10.1111/j.1420-9101.2008.01542.x
   Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200
   Moskalev A, 2009, BIOGERONTOLOGY, V10, P3, DOI 10.1007/s10522-008-9147-5
   Moskalev AA, 2011, BIOGERONTOLOGY, V12, P253, DOI 10.1007/s10522-011-9320-0
   Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059
   Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005
   Oertelt-Prigione S, 2009, ARCH INTERN MED, V169, P1740, DOI 10.1001/archinternmed.2009.353
   Osiewacz HD, 2010, ANN NY ACAD SCI, V1197, P54, DOI 10.1111/j.1749-6632.2010.05190.x
   Partridge L., 2008, MOL BIOL AG, P267
   Pickering A. M., 2012, J EXP BIOL
   Pierdominici M, 2011, CURR PHARM DESIGN, V17, P1046
   Pimenta de Castro I., 2012, CELL DEATH DIFFER, V19, P1308, DOI DOI 10.1038/CDD.2012.5
   Pitetti JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003160
   Pronsato L, 2012, J ENDOCRINOL, V212, P371, DOI 10.1530/JOE-11-0234
   Purdue MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043149
   Regmi S. G., 2014, AGING
   Runkel ED, 2014, EXP GERONTOL, V56, P194, DOI 10.1016/j.exger.2014.02.013
   Sachdeva UM, 2008, AUTOPHAGY, V4, P581
   SACKTOR B, 1972, J CELL BIOL, V52, P465, DOI 10.1083/jcb.52.2.465
   Scherfer C, 2013, AGING-US, V5, P276
   Schwarze SR, 1998, FREE RADICAL BIO MED, V25, P740, DOI 10.1016/S0891-5849(98)00153-1
   Seney ML, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-20
   Sevini F., 2014, EXP GERONTOL
   Shaposhnikov M V, 2011, Adv Gerontol, V24, P405
   Shen J, 2010, EXP GERONTOL, V45, P97, DOI 10.1016/j.exger.2009.10.009
   Shen Jie, 2009, Discov Med, V8, P223
   Shen Jie, 2009, BMC Geriatr, V9, P56, DOI 10.1186/1471-2318-9-56
   Shen J, 2013, CELL CYCLE, V12, P3237, DOI 10.4161/cc.26354
   Shi C, 2014, SCIENCE, V343, P536, DOI 10.1126/science.1242958
   Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168
   Siegel C, 2011, ACTA PHYSIOL, V203, P225, DOI 10.1111/j.1748-1716.2010.02229.x
   Siegel C, 2010, J NEUROSCI RES, V88, P2765, DOI 10.1002/jnr.22406
   Siegel CS, 2013, NEUROSCIENCE, V237, P223, DOI 10.1016/j.neuroscience.2013.01.068
   Snell-Rood EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034857
   Soares P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058993
   SOHAL RS, 1975, J MORPHOL, V145, P337, DOI 10.1002/jmor.1051450307
   SOHAL RS, 1970, EXP GERONTOL, V5, P213, DOI 10.1016/0531-5565(70)90040-9
   Straface E, 2009, FEBS LETT, V583, P3448, DOI 10.1016/j.febslet.2009.09.052
   Sun XP, 2014, CELL REP, V8, P1781, DOI 10.1016/j.celrep.2014.08.022
   Takacs-Vellai K, 2006, BIOESSAYS, V28, P1126, DOI 10.1002/bies.20489
   TAKAHASHI A, 1970, J GERONTOL, V25, P218
   TAKAHASHI A, 1970, J GERONTOL, V25, P222
   Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011
   Tang HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002373
   Thondamal M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5879
   Tower J., 2013, J GERONTOL A
   Tower J, 2010, CELL CYCLE, V9, P3840, DOI 10.4161/cc.9.19.13464
   Walker DW, 2004, P NATL ACAD SCI USA, V101, P10290, DOI 10.1073/pnas.0403767101
   Wang FF, 2010, HYPERTENSION, V55, P1172, DOI 10.1161/HYPERTENSIONAHA.110.150839
   Webster CM, 2013, DEVELOPMENT, V140, P3601, DOI 10.1242/dev.094292
   Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002
   Wolff JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020522
   Xie H., 2013, CARCINOGENESIS
   Yoshida K, 2006, GENE, V385, P64, DOI 10.1016/j.gene.2006.06.031
   Yuan M, 2009, EXP NEUROL, V217, P210, DOI 10.1016/j.expneurol.2009.02.012
   Yuan R., 2014, MED SCI
   Yui R, 2006, MUTAT RES-FUND MOL M, V594, P155, DOI 10.1016/j.mrfmmm.2005.08.003
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
   Zarkower David, 2006, WormBook, P1
   Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x
   Zheng Jie, 2005, Proc Natl Acad Sci U S A, V102, P12083, DOI 10.1073/pnas.0503374102
   Zhu CT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004354
   Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x
   Zuo W, 2013, EUR J PHARMACOL, V711, P73, DOI 10.1016/j.ejphar.2013.04.024
NR 390
TC 1
Z9 2
U1 32
U2 32
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2015
VL 576
BP 17
EP 31
DI 10.1016/j.abb.2014.10.008
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3LQ
UT WOS:000356118000004
PM 25447815
ER

PT J
AU Cunningham, GM
   Roman, MG
   Flores, LC
   Hubbard, GB
   Salmon, AB
   Zhang, YQ
   Gelfond, J
   Ikeno, Y
AF Cunningham, Geneva M.
   Roman, Madeline G.
   Flores, Lisa C.
   Hubbard, Gene B.
   Salmon, Adam B.
   Zhang, Yiqiang
   Gelfond, Jonathan
   Ikeno, Yuji
TI The paradoxical role of thioredoxin on oxidative stress and aging
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Thioredoxin; Transgenic mouse; Knockout mouse; Oxidative stress; Cancer;
   Aging
ID MN-SUPEROXIDE-DISMUTASE; METHIONINE SULFOXIDE REDUCTASE; ADULT
   DROSOPHILA-MELANOGASTER; EARLY EMBRYONIC LETHALITY; LONGEST-LIVING
   RODENT; NAKED MOLE-RAT; LIFE-SPAN; TRANSGENIC MICE; DIETARY RESTRICTION;
   PROTEIN OXIDATION
AB In spite of intensive study, there is still controversy about the free radical or oxidative stress theory of aging, particularly in mammals. Our laboratory has conducted the first detailed studies on the role of thioredoxin (Trx) in the cytosol (Trx1) and in mitochondria (Trx2) on oxidative stress and aging using unique mouse models either overexpressing or down-regulating Trx1 or Trx2. The results generated from our lab and others indicate that: (1) oxidative stress and subsequent changes in signaling pathways could have different pathophysiological impacts at different stages of life; (2) changes in redox-sensitive signaling controlled by levels of oxidative stress and redox state could play more important roles in pathophysiology than accumulation of oxidative damage; (3) changes in oxidative stress and redox state in different cellular compartments (cytosol, mitochondria, or nucleus) could play different roles in pathophysiology during aging, and their combined effects show more impact on aging than changes in either oxidative stress or redox state alone; and (4) the roles of oxidative stress and redox state could have different pathophysiological consequences in different organs/tissues/cells or pathophysiological conditions. To critically test the role of oxidative stress on aging and investigate changes in redox-sensitive signaling pathways, further study is required. Published by Elsevier Inc.
C1 [Cunningham, Geneva M.; Roman, Madeline G.; Flores, Lisa C.; Hubbard, Gene B.; Salmon, Adam B.; Zhang, Yiqiang; Ikeno, Yuji] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA.
   [Hubbard, Gene B.; Ikeno, Yuji] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA.
   [Salmon, Adam B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA.
   [Gelfond, Jonathan] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA.
   [Ikeno, Yuji] Audie L Murphy VA Hosp South Texas Vet Hlth Care, Res Serv, San Antonio, TX 78229 USA.
   [Salmon, Adam B.; Ikeno, Yuji] Audie L Murphy VA Hosp South Texas Vet Hlth Care, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA.
RP Ikeno, Y (reprint author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA.
EM Ikeno@uthscsa.edu
FU VA Merit Review from the Biomedical Laboratory Research & Development
   Service of the Veteran's Affairs Office of Research and Development -
   United States [1 I01BX001023]; NIH - United States [AG13319]; American
   Federation for Aging Research (AFAR) - United States; Glenn Foundation -
   United States
FX This research was supported by the VA Merit Review Grant 1 I01BX001023
   from the Biomedical Laboratory Research & Development Service of the
   Veteran's Affairs Office of Research and Development - United States
   (Y.I.), NIH - United States Grant AG13319 (Y.I.), The American
   Federation for Aging Research (AFAR) - United States Grant (Y.I.), and a
   Grant from the Glenn Foundation - United States (Y.I.).
CR Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003
   Aksenova MV, 1998, MECH AGEING DEV, V100, P157, DOI 10.1016/S0047-6374(97)00133-4
   RAO G, 1990, J NUTR, V120, P602
   SOHAL RS, 1992, ANN NY ACAD SCI, V663, P74, DOI 10.1111/j.1749-6632.1992.tb38651.x
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x
   Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x
   KIM KW, 1988, J BIOL CHEM, V263, P4704
   BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207
   Brot N, 2000, BIOPOLYMERS, V55, P288, DOI 10.1002/1097-0282(2000)55:4<288::AID-BIP1002>3.0.CO;2-M
   Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208
   Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje
   Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534
   Sun JT, 2002, GENETICS, V161, P661
   TAGAYA Y, 1989, EMBO J, V8, P757
   Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com
   Chae HZ, 1999, METHOD ENZYMOL, V300, P219
   ORR WC, 1993, ARCH BIOCHEM BIOPHYS, V301, P34, DOI 10.1006/abbi.1993.1111
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044
   Sun JT, 1999, MOL CELL BIOL, V19, P216
   Perez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Spyrou G, 1997, J BIOL CHEM, V272, P2936
   Powis G, 2000, FREE RADICAL BIO MED, V29, P312, DOI 10.1016/S0891-5849(00)00313-0
   Widder JD, 2009, HYPERTENSION, V54, P338, DOI 10.1161/HYPERTENSIONAHA.108.127928
   Dubey A, 1996, ARCH BIOCHEM BIOPHYS, V333, P189, DOI 10.1006/abbi.1996.0380
   Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019
   Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com
   Go YM, 2013, CRIT REV BIOCHEM MOL, V48, P173, DOI 10.3109/10409238.2013.764840
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Ishii N, 2002, FREE RADICAL BIO MED, V33, P1021, DOI 10.1016/S0891-5849(02)00857-2
   Takagi Y, 1999, P NATL ACAD SCI USA, V96, P4131, DOI 10.1073/pnas.96.7.4131
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106
   Perez VI, 2008, FREE RADICAL BIO MED, V44, P882, DOI 10.1016/j.freeradbiomed.2007.11.018
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   Honda Y, 1999, FASEB J, V13, P1385
   Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498
   SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199
   Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3
   Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132
   BOHR VA, 1995, MUTAT RES-DNAGING G, V338, P25, DOI 10.1016/0921-8734(95)00008-T
   Chavous DA, 2000, FASEB J, V14, pA1488
   CHEN LH, 1992, ARCH GERONTOL GERIAT, V14, P17, DOI 10.1016/0167-4943(92)90003-M
   CHIPALKATTI S, 1983, J NUTR, V113, P944
   DAVIS LJ, 1993, MECH AGEING DEV, V72, P155
   DE AK, 1983, MECH AGEING DEV, V21, P37, DOI 10.1016/0047-6374(83)90014-3
   ENESCO HE, 1981, EXP GERONTOL, V16, P357, DOI 10.1016/0531-5565(81)90056-5
   Flores Lisa C, 2012, Longev Healthspan, V1, P4, DOI 10.1186/2046-2395-1-4
   GALTER D, 1994, EUR J BIOCHEM, V221, P639, DOI 10.1111/j.1432-1033.1994.tb18776.x
   Go Y.-M., 2011, PLOS ONE, V6, P18918
   Hamilton ML, 2001, NUCLEIC ACIDS RES, V29, P2117, DOI 10.1093/nar/29.10.2117
   Huang TT, 2000, J GERONTOL A-BIOL, V55, pB5
   Kaiser M., 1996, HEREDITY, V78, P1
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LEVIN G, 1992, MECH AGEING DEV, V62, P137, DOI 10.1016/0047-6374(92)90050-N
   Mahlke M. A., 2011, PATHOBIOL AGING AGE, V1, P7189, DOI DOI 10.3402/PBA.V1I0.7189
   Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885
   Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201
   Murakami K, 1997, STROKE, V28, P1797
   Nakamura H, 2002, METHOD ENZYMOL, V347, P436
   Nakamura H, 2002, IMMUNOL LETT, V82, P165, DOI 10.1016/S0165-2478(02)00033-0
   ORR WC, 1992, MECH AGEING DEV, V63, P287, DOI 10.1016/0047-6374(92)90006-Y
   Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200
   Perez VI, 2011, J GERONTOL A-BIOL, V66, P1286, DOI 10.1093/gerona/glr125
   PIERI C, 1992, ARCH GERONTOL GERIAT, V14, P93, DOI 10.1016/0167-4943(92)90010-2
   REVEILLAUD I, 1991, MOL CELL BIOL, V11, P632
   Saitoh M., 1998, EMBO J, V17, P2569
   Salmon A.B., 2012, PATHOBIOL AGING AGE, V2, P17101
   SETO NOL, 1990, P NATL ACAD SCI USA, V87, P4270, DOI 10.1073/pnas.87.11.4270
   SOHAL RS, 1995, J BIOL CHEM, V270, P15671
   STADTMAN ER, 1988, EXP GERONTOL, V23, P327, DOI 10.1016/0531-5565(88)90036-8
   STEARNS SC, 1993, GENETICA, V91, P167, DOI 10.1007/BF01435996
   TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328
   WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9
   Yoshihara E., 2013, FRONT IMMUNOL, V4, P514
   Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423
   Zhang HF, 2007, AM J PATHOL, V170, P1108, DOI 10.2353/ajpath.2007.060960
NR 89
TC 1
Z9 1
U1 13
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2015
VL 576
BP 32
EP 38
DI 10.1016/j.abb.2015.02.025
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3LQ
UT WOS:000356118000005
PM 25726727
ER

PT J
AU Zhang, YQ
   Fischer, KE
   Soto, V
   Liu, YH
   Sosnowska, D
   Richardson, A
   Salmon, AB
AF Zhang, Yiqiang
   Fischer, Kathleen E.
   Soto, Vanessa
   Liu, Yuhong
   Sosnowska, Danuta
   Richardson, Arlan
   Salmon, Adam B.
TI Obesity-induced oxidative stress, accelerated functional decline with
   age and increased mortality in mice
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Obesity; Rotarod; Longevity; Oxidation; Grip strength; Respirometry;
   Gait
ID MN-SUPEROXIDE-DISMUTASE; INSULIN-RESISTANCE; LIFE-SPAN; COGNITIVE
   IMPAIRMENT; ADIPOSE-TISSUE; HEALTH; MUSCLE; OVEREXPRESSION; RESTRICTION;
   LONGEVITY
AB Obesity is a serious chronic disease that increases the risk of numerous co-morbidities including metabolic syndrome, cardiovascular disease and cancer as well as increases risk of mortality, leading some to suggest this condition represents accelerated aging. Obesity is associated with significant increases in oxidative stress in vivo and, despite the well-explored relationship between oxidative stress and aging, the role this plays in the increased mortality of obese subjects remains an unanswered question. Here, we addressed this by undertaking a comprehensive, longitudinal study of a group of high fat-fed obese mice and assessed both their changes in oxidative stress and in their performance in physiological assays known to decline with aging. In female C57BL/6J mice fed a high-fat diet starting in adulthood, mortality was significantly increased as was oxidative damage in vivo. High fat-feeding significantly accelerated the decline in performance in several assays, including activity, gait, and rotarod. However, we also found that obesity had little effect on other markers of function and actually improved performance in grip strength, a marker of muscular function. Together, this first comprehensive assessment of longitudinal, functional changes in high fat-fed mice suggests that obesity may induce segmental acceleration of some of the aging process. Published by Elsevier Inc.
C1 [Zhang, Yiqiang; Soto, Vanessa; Liu, Yuhong; Salmon, Adam B.] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   [Zhang, Yiqiang] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.
   [Salmon, Adam B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA.
   [Salmon, Adam B.] South Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX USA.
   [Fischer, Kathleen E.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.
   [Sosnowska, Danuta; Richardson, Arlan] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK USA.
   [Sosnowska, Danuta; Richardson, Arlan] Oklahoma City VA Med Ctr, Oklahoma City, OK USA.
RP Salmon, AB (reprint author), 15355 Lambda Dr, San Antonio, TX 78245 USA.
EM salmona@uthscsa.edu
FU American Federation for Aging Research; Biomedical Laboratory Research &
   Development Service of the Veteran's Affairs Office of Research and
   Development [1I01BX000547]; Geriatric Research Education and Clinical
   Center of the South Texas Veterans Healthcare System
FX Animal studies were performed in the Healthspan and Functional
   Assessment Core of the San Antonio Nathan Shock Center of Excellence in
   the Basic Biology of Aging. This research was supported in part by
   funding from the American Federation for Aging Research (Y.Z. and
   A.B.S.), the Biomedical Laboratory Research & Development Service of the
   Veteran's Affairs Office of Research and Development (1I01BX000547 to
   A.R.) and Geriatric Research Education and Clinical Center of the South
   Texas Veterans Healthcare System (A.B.S.).
CR HARRISON DE, 1984, P NATL ACAD SCI-BIOL, V81, P1835, DOI 10.1073/pnas.81.6.1835
   Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100
   SILBERBERG M, 1954, AM J PHYSIOL, V177, P23
   Fahlstrom A, 2011, NEUROBIOL AGING, V32, P1868, DOI 10.1016/j.neurobiolaging.2009.11.003
   Heaberlin JR, 2013, CARDIOVASC PATHOL, V22, P481, DOI 10.1016/j.carpath.2013.06.002
   Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415
   Peeters A, 2003, ANN INTERN MED, V138, P24
   Muzumdar R, 2008, AGING CELL, V7, P438, DOI 10.1111/j.1474-9726.2008.00391.x
   Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI200421625]
   Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722
   GIUGLIANO D, 1995, METABOLISM, V44, P363, DOI 10.1016/0026-0495(95)90167-1
   Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   Styskal J, 2013, FREE RADICAL BIO MED, V56, P123, DOI 10.1016/j.freeradbiomed.2012.10.544
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   [Anonymous], 2014, MOUS PHEN DAT WEB SI, V2014
   Masters RK, 2013, AM J PUBLIC HEALTH, V103, P1895, DOI 10.2105/AJPH.2013.301379
   Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308
   Prescott HC, 2014, CRIT CARE MED, V42, P1766, DOI 10.1097/CCM.0000000000000336
   Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Keipert S, 2011, AGING CELL, V10, P122, DOI 10.1111/j.1474-9726.2010.00648.x
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1
   Morrison CD, 2010, J NEUROCHEM, V114, P1581, DOI 10.1111/j.1471-4159.2010.06865.x
   Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106
   Zhang YQ, 2014, J GERONTOL A-BIOL, V69, P119, DOI 10.1093/gerona/glt056
   Boumat JC, 2010, CURR OPIN ENDOCRINOL, V17, P446
   Burnett Colin M L, 2014, Mol Metab, V3, P460, DOI 10.1016/j.molmet.2014.03.003
   Goldman DP, 2013, HEALTH AFFAIR, V32, P1698, DOI 10.1377/hlthaff.2013.0052
   Huffman DM, 2010, INTERD TOP GERONTOL, V37, P1, DOI 10.1159/000319991
   Kitahara CM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001673
   Koga S, 2014, NEUROBIOL DIS, V71, P180, DOI 10.1016/j.nbd.2014.08.015
   KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205
   List EO, 2013, INT J OBESITY, V37, P1088, DOI 10.1038/ijo.2012.203
   Liu YH, 2013, BIOCHEM BIOPH RES CO, V438, P78, DOI 10.1016/j.bbrc.2013.07.029
   Menshikova EV, 2005, AM J PHYSIOL-ENDOC M, V288, pE818, DOI 10.1152/ajpendo.00322.2004
   Muscogiuri G, 2013, DIABETES, V62, P4201, DOI 10.2337/db13-0314
   Park S, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/984643
   Piers LS, 1998, J APPL PHYSIOL, V85, P2196
   Rame JE, 2011, PHYSIOL GENOMICS, V43, P726, DOI 10.1152/physiolgenomics.00088.2010
   U.S. Department of Agriculture, 2012, NHANES 2009 2010
NR 45
TC 1
Z9 1
U1 6
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2015
VL 576
BP 39
EP 48
DI 10.1016/j.abb.2014.12.018
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3LQ
UT WOS:000356118000006
PM 25558793
ER

PT J
AU Rehman, SU
   Sarwar, T
   Husain, MA
   Ishqi, HM
   Tabish, M
AF Rehman, Sayeed Ur
   Sarwar, Tarique
   Husain, Mohammed Amir
   Ishqi, Hassan Mubarak
   Tabish, Mohammad
TI Studying non-covalent drug-DNA interactions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Drug-DNA binding; Intercalation; Groove binding; Electrostatic
   interactions
ID CALF-THYMUS DNA; ATOMIC-FORCE MICROSCOPY; ENERGY-TRANSFER AMPLIFICATION;
   IN-VITRO; MOLECULAR DOCKING; CRYSTAL-STRUCTURE; FLUORESCENT-PROBE;
   SPECTROSCOPIC TECHNIQUES; DEOXYRIBONUCLEIC-ACID; CAUSES PHOTOCLEAVAGE
AB Drug-DNA interactions have been extensively studied in the recent past. Various techniques have been employed to decipher these interactions. DNA is a major target for a wide range of drugs that may specifically or non-specifically interact with DNA and affect its functions. Interaction between small molecules and DNA are of two types, covalent interactions and non-covalent interactions. Three major modes of non-covalent interactions are electrostatic interactions, groove binding and intercalative binding. This review primarily focuses on discussing various techniques used to study non-covalent interactions that occur between drugs and DNA. Additionally, we report several techniques that may be employed to analyse the binding mode of a drug with DNA. These techniques provide data that are reliable and simple to interpret. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Rehman, Sayeed Ur; Sarwar, Tarique; Husain, Mohammed Amir; Ishqi, Hassan Mubarak; Tabish, Mohammad] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India.
RP Tabish, M (reprint author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India.
EM tabish.bcmlab@gmail.com
FU CSIR, New Delhi [09/112(0470)/2011-EMR1]; UGC; DBT, New Delhi
   [BT/PR8032/BID/7/443/2013]
FX Authors are thankful to CSIR, New Delhi, for the award of CSIR-SRF
   fellowship to SUR (File no - 09/112(0470)/2011-EMR1) and UGC for the
   award of MANF to TS and MAH. Department of Biochemistry, Faculty of Life
   Sciences, AMU, Aligarh is also acknowledged for providing the necessary
   facilities. We are also thankful to DBT, New Delhi for providing
   generous funding to MT (Project number: BT/PR8032/BID/7/443/2013).
CR Akdi K, 2005, J INORG BIOCHEM, V99, P1360, DOI 10.1016/j.jinorgbio.2005.03.010
   Anantharaman A, 2015, SPECTROCHIM ACTA A, V144, P163, DOI 10.1016/j.saa.2015.02.049
   Agarwal S, 2013, J PHOTOCH PHOTOBIO B, V120, P177, DOI 10.1016/j.jphotobiol.2012.11.001
   Chakrabarty A, 2007, BIOMACROMOLECULES, V8, P920, DOI 10.1021/bm061084s
   Cui FL, 2014, J FLUORESC, V24, P189, DOI 10.1007/s10895-013-1285-8
   Perez-Arnaiz C, 2014, J PHYS CHEM B, V118, P1288, DOI 10.1021/jp411429g
   Ni YN, 2006, ANAL BIOCHEM, V352, P231, DOI 10.1016/j.ab.2006.02.031
   Hu W, 2013, J INORG BIOCHEM, V127, P90, DOI 10.1016/j.jinorgbio.2013.07.034
   Shahabadi N, 2012, SPECTROCHIM ACTA A, V96, P278, DOI 10.1016/j.saa.2012.05.045
   Kakkar R, 2002, J MOL STRUC-THEOCHEM, V579, P109, DOI 10.1016/S0166-1280(01)00721-7
   Fotouhi L, 2014, SPECTROCHIM ACTA A, V121, P152, DOI 10.1016/j.saa.2013.10.067
   ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017
   Wang Q, 2014, SPECTROCHIM ACTA A, V117, P754, DOI 10.1016/j.saa.2013.09.039
   Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s
   Husain MA, 2015, PHYS CHEM CHEM PHYS, V17, P13837, DOI 10.1039/c5cp00272a
   Yaseen Z, 2014, SPECTROCHIM ACTA A, V122, P553, DOI 10.1016/j.saa.2013.11.030
   Shahabadi N, 2014, APPL BIOCHEM BIOTECH, V172, P2436, DOI 10.1007/s12010-013-0695-z
   Tarushi A, 2014, EUR J MED CHEM, V74, P187, DOI 10.1016/j.ejmech.2013.12.019
   Jana B, 2012, J PHYS CHEM B, V116, P639, DOI 10.1021/jp2094824
   Li XL, 2012, BIOMACROMOLECULES, V13, P873, DOI 10.1021/bm2017959
   Husain MA, 2013, FEBS J, V280, P6569, DOI 10.1111/febs.12558
   Das A, 2012, J CHEM THERMODYN, V54, P421, DOI 10.1016/j.jct.2012.05.028
   Pulimamidi RR, 2014, EUR J MED CHEM, V79, P117, DOI 10.1016/j.ejmech.2014.03.084
   Lyubchenko YL, 2009, METHODS, V47, P206, DOI 10.1016/j.ymeth.2008.09.002
   Rafique B, 2013, BIOSENS BIOELECTRON, V44, P21, DOI 10.1016/j.bios.2012.12.028
   Rauf S, 2005, J PHARMACEUT BIOMED, V37, P205, DOI 10.1016/j.jpba.2004.10.037
   Lyubchenko YL, 2014, METHODS MOL BIOL, V1117, P367, DOI 10.1007/978-1-62703-776-1_17
   Hampshire AJ, 2007, METHODS, V42, P128, DOI 10.1016/j.ymeth.2007.01.002
   Zhong WY, 2004, SPECTROCHIM ACTA A, V60, P2985, DOI 10.1016/j.saa.2004.02.012
   Mallick A, 2005, J PHYS CHEM B, V109, P14683, DOI 10.1021/jp051367z
   Zhang GW, 2011, J AGR FOOD CHEM, V59, P8944, DOI 10.1021/jf2019006
   Shah A, 2013, J PHOTOCH PHOTOBIO B, V120, P90, DOI 10.1016/j.jphotobiol.2012.12.015
   Xu LG, 2011, J PHYS CHEM C, V115, P16315, DOI 10.1021/jp2036263
   Agudelo D, 2014, INT J BIOL MACROMOL, V66, P144, DOI 10.1016/j.ijbiomac.2014.02.028
   Arjmand F, 2012, EUR J MED CHEM, V49, P141, DOI 10.1016/j.ejmech.2012.01.005
   Shahabadi N, 2014, MOL BIOSYST, V10, P338, DOI 10.1039/c3mb70340a
   Grueso E, 2012, J INORG BIOCHEM, V106, P1, DOI 10.1016/j.jinorgbio.2011.09.028
   CARTER MT, 1987, J AM CHEM SOC, V109, P7528, DOI 10.1021/ja00258a046
   Zhao TT, 2014, SPECTROCHIM ACTA A, V132, P198, DOI 10.1016/j.saa.2014.04.158
   KUMAR CV, 1993, J PHOTOCH PHOTOBIO A, V74, P231, DOI 10.1016/1010-6030(93)80121-O
   Suzuki Y, 2011, WIRES NANOMED NANOBI, V3, P574, DOI 10.1002/wnan.150
   Wei CY, 2010, BIOPHYS CHEM, V148, P51, DOI 10.1016/j.bpc.2010.02.009
   Parveen M, 2014, J PHOTOCH PHOTOBIO B, V130, P179, DOI 10.1016/j.jphotobiol.2013.11.019
   Ahmadi F, 2013, TOXICOL IN VITRO, V27, P641, DOI 10.1016/j.tiv.2012.11.004
   Wu HL, 2011, TRANSIT METAL CHEM, V36, P847, DOI 10.1007/s11243-011-9539-2
   Lyubchenko YL, 2011, METHODS, V54, P274, DOI 10.1016/j.ymeth.2011.02.001
   Shi Y, 2011, BIOMACROMOLECULES, V12, P797, DOI 10.1021/bm101414w
   Bhadra K, 2011, BBA-GEN SUBJECTS, V1810, P485, DOI 10.1016/j.bbagen.2011.01.011
   Hossain M, 2009, MOL BIOSYST, V5, P1311, DOI 10.1039/b909563b
   Arakawa H, 2000, J BIOL CHEM, V275, P10150, DOI 10.1074/jbc.275.14.10150
   Haq I, 2002, ARCH BIOCHEM BIOPHYS, V403, P1, DOI 10.1016/S0003-9861(02)00202-3
   Basu A, 2013, INT J BIOL MACROMOL, V62, P257, DOI 10.1016/j.ijbiomac.2013.09.003
   Blair Rebecca H, 2013, Methods Mol Biol, V977, P203, DOI 10.1007/978-1-62703-284-1_16
   Cassina V, 2011, EUR BIOPHYS J BIOPHY, V40, P59, DOI 10.1007/s00249-010-0627-6
   Coats JE, 2013, NUCLEIC ACIDS RES, V41, P1372, DOI 10.1093/nar/gks1208
   De S, 2014, J PHOTOCH PHOTOBIO B, V140, P130, DOI 10.1016/j.jphotobiol.2014.07.014
   Fei B., 2014, J PHOTOCHEM PHOT B C, V142C, P77
   Ganeshpandian M, 2014, J INORG BIOCHEM, V140, P202, DOI 10.1016/j.jinorgbio.2014.07.021
   Gomez-Segura J, 2006, INORG CHEM, V45, P10031, DOI 10.1021/ic061292t
   Guo LH, 2007, ANAL CHIM ACTA, V588, P123, DOI 10.1016/j.aca.2007.01.083
   Icsel C., 2013, J PHOTOCH PHOTOBIO B, V130, P115
   Jalali F, 2012, J PHARMACEUT BIOMED, V70, P598, DOI 10.1016/j.jpba.2012.06.005
   Jangir DK, 2011, J PHOTOCH PHOTOBIO B, V105, P143, DOI 10.1016/j.jphotobiol.2011.08.003
   Kabir A, 2014, MOL BIOSYST, V10, P1172, DOI 10.1039/c3mb70616h
   Khorasani-Motlagh M, 2010, SPECTROCHIM ACTA A, V75, P598, DOI 10.1016/j.saa.2009.11.024
   KUMAR CV, 1992, J CHEM SOC CHEM COMM, P470, DOI 10.1039/c39920000470
   Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P278
   Ling X, 2008, J PHOTOCH PHOTOBIO B, V93, P172, DOI 10.1016/j.jphotobiol.2008.07.008
   Liu HK, 2011, ACCOUNTS CHEM RES, V44, P349, DOI 10.1021/ar100140e
   Ma YD, 2013, J PHOTOCH PHOTOBIO B, V126, P112, DOI 10.1016/j.jphotobiol.2013.07.011
   Masum Abdulla Al, 2014, J Phys Chem B, V118, P13151, DOI 10.1021/jp509326r
   McCann M, 2013, CHEM COMMUN, V49, P2341, DOI 10.1039/c3cc38710k
   McKnight RE, 2013, ISOTHERMAL TITRATION, DOI [10.5772/54061, DOI 10.5772/54061]
   Nejedly K., 2005, NUCLEIC ACIDS RES, V33, P1
   Ozluer C, 2014, J PHOTOCH PHOTOBIO B, V138, P36, DOI 10.1016/j.jphotobiol.2014.05.015
   Paul P, 2010, BIOPHYS CHEM, V148, P93, DOI 10.1016/j.bpc.2010.02.015
   Rehman SU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093913
   Rehman SU, 2015, ARCH BIOCHEM BIOPHYS, V566, P7, DOI 10.1016/j.abb.2014.12.013
   Rescifina A, 2014, EUR J MED CHEM, V74, P95, DOI 10.1016/j.ejmech.2013.11.029
   Saito ST, 2012, J PHOTOCH PHOTOBIO B, V111, P59, DOI 10.1016/j.jphotobiol.2012.03.012
   Sanju KS, 2011, CHEM COMMUN, V47, P1288, DOI 10.1039/c0cc04173d
   Sarwar T, 2015, INT J BIOL MACROMOL, V73, P9, DOI 10.1016/j.ijbiomac.2014.10.017
   Sarwar T, 2015, MOL BIOSYST, V11, P522, DOI 10.1039/c4mb00636d
   Sasikala WD, 2012, J PHYS CHEM B, V116, P12208, DOI 10.1021/jp307911r
   Shahabadi N, 2011, BIOINORG CHEM APPL, DOI 10.1155/2011/687571
   Shahabadi N, 2015, SPECTROCHIM ACTA A, V138, P840, DOI 10.1016/j.saa.2014.10.104
   Sobha S, 2012, SPECTROCHIM ACTA A, V92, P175, DOI 10.1016/j.saa.2012.02.063
   Song YH, 2014, LUMINESCENCE, V29, P1141, DOI 10.1002/bio.2674
   Tabassum S, 2014, EUR J MED CHEM, V74, P509, DOI 10.1016/j.ejmech.2013.12.046
   Urbach AR, 2005, MOL BIOSYST, V1, P287, DOI 10.1039/b509471m
   van Noort J, 1999, NUCLEIC ACIDS RES, V27, P3875, DOI 10.1093/nar/27.19.3875
   van Noort SJT, 1998, BIOPHYS J, V74, P2840
   Wang LH, 2013, INT J BIOL MACROMOL, V52, P1, DOI 10.1016/j.ijbiomac.2012.08.015
   Wu FY, 2008, J FLUORESC, V18, P175, DOI 10.1007/s10895-007-0261-6
   Zhang GW, 2011, SPECTROCHIM ACTA A, V78, P687, DOI 10.1016/j.saa.2010.11.050
NR 95
TC 1
Z9 1
U1 22
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2015
VL 576
BP 49
EP 60
DI 10.1016/j.abb.2015.03.024
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3LQ
UT WOS:000356118000007
PM 25951786
ER

PT J
AU Machado-Oliveira, G
   Guerreiro, E
   Matias, AC
   Facucho-Oliveira, J
   Pacheco-Leyva, I
   Braganca, J
AF Machado-Oliveira, Gisela
   Guerreiro, Eduarda
   Matias, Ana Catarina
   Facucho-Oliveira, Joao
   Pacheco-Leyva, Ivette
   Braganca, Jose
TI FBXL5 modulates HIF-1 alpha transcriptional activity by degradation of
   CITED2
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE FBXL5; CITED2; HIF-1 alpha; TFAP2; Proteasome; Mouse embryonic stem
   cells
ID EMBRYONIC STEM-CELLS; HYPOXIA-INDUCIBLE FACTORS; CONGENITAL
   HEART-DEFECTS; PROTEIN 5 FBXL5; F-BOX PROTEINS; IRON HOMEOSTASIS;
   TRANSACTIVATION DOMAIN; UBIQUITIN LIGASE; BINDING-PROTEIN;
   GENE-EXPRESSION
AB CITED2 is a ubiquitously expressed nuclear protein exhibiting a high affinity for the cysteine-histidine-rich domain 1 (CH1) of the transcriptional co-activators CBP/p300. CITED2 is particularly efficient in the inhibition of the hypoxia-inducible factor-1 alpha (HIF-1 alpha) dependent transcription by competing with it for the interaction with the CH1 domain. Here we report a direct and specific interaction between CITED2 and the F-box and leucine rich repeat protein 5 (FBXL5), a substrate adaptor protein which is part of E3 ubiquitin ligase complexes mediating protein degradation by the proteasome. We demonstrated that depletion of FBXL5 by RNA interference led to an increase of CITED2 protein levels. Conversely, overexpression of FBXL5 caused the decrease of CITED2 protein levels in a proteasome-dependent manner, and impaired the interaction between CITED2 and the CH1 domain of p300 in living cells. In undifferentiated mouse embryonic stem cells, the overexpression of FBXL5 also reduced Cited2 protein levels. Finally, we evidenced that FBXL5 overexpression and the consequent degradation of CITED2 enabled the transcriptional activity of the N-terminal transactivation domain of HIF-1 alpha. Collectively, our results highlighted a novel molecular interaction between CITED2 and FBXL5, which might regulate the steady state CITED2 protein levels and contribute to the modulation of gene expression by HIF-1 alpha. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Machado-Oliveira, Gisela; Guerreiro, Eduarda; Matias, Ana Catarina; Facucho-Oliveira, Joao; Pacheco-Leyva, Ivette; Braganca, Jose] Univ Algarve, Dept Biomed Sci & Med, P-8005139 Faro, Portugal.
   [Machado-Oliveira, Gisela; Guerreiro, Eduarda; Matias, Ana Catarina; Pacheco-Leyva, Ivette; Braganca, Jose] Univ Algarve, CBMR Ctr Biomed Res, P-8005139 Faro, Portugal.
RP Braganca, J (reprint author), Univ Algarve, Dept Biomed Sci & Med, Campus Gambelas, P-8005139 Faro, Portugal.
EM jebraganca@ualg.pt
RI Braganca, Jose/F-4410-2012; 
OI Braganca, Jose/0000-0001-9566-400X; Matias, Ana
   Catarina/0000-0002-6385-9117
FU FCT - Fundacao para a Ciencia e a Tecnologia [PEst-OE/EQB/LA0023/2013,
   PTDC/SAU-ENB/111702/2009, SFRH/BPD/74807/2010, SFRH/BD/62054/2009]
FX This work was supported by national Portuguese funding through FCT -
   Fundacao para a Ciencia e a Tecnologia, projects PEst-OE/EQB/LA0023/2013
   and PTDC/SAU-ENB/111702/2009 to JB and ACM, fellowships
   SFRH/BPD/74807/2010 to GMO and SFRH/BD/62054/2009 to IPL. The research
   project was started in Shoumo Bhattacharya's group (University of
   Oxford), to whom we are undoubtedly grateful. We thank Kohei Miyazono
   (JFCR Cancer Institute, Tokyo, Japan) for pcDNA3-flagFBXL5, Shoumo
   Bhattacharya (University of Oxford) for 3xHRE-Luc, Gal4-Luc,
   pcDNA3-HIF-1 alpha, pcDNA3-CITED2, GAL4-HIF-1 alpha at and GAL4-ODD
   plasmids, Raquel Andrade (University of Algarve) for templates to
   amplify VEN and VEC fragments, Helen Hurst (Queen Mary University of
   London) for p3xAP2-Bluc and pcDNA3-TFAP2A and pcDNA3-TFAP2C, Austin
   Smith (University of Cambridge) for E14/T cells and pPyCAGIP vector, and
   Rui Jian (Third Military Medical University) for pDoubNeo vector. We are
   undoubtedly grateful to Keiichi I. Nakayama and Masaaki Nishiyama
   (Kyushu University) for the vectors encoding flag-FBXL5 lacking the
   F-box region Delta 195-256 (FBXL5<SUP>Delta F-Box</SUP>), flag-FBXL5
   (1-297) lacking the LRR (FBXL5<SUP>Delta LRR</SUP>), small hairpin RNA
   against LacZ and FBXL5 and the CSII-EF-TetR-IRES-puro plasmid. We also
   thank Patricia Madureira and Richard Hill (University of Algarve) for
   sharing the ALDOLASE A, PGK1 and SLC2A1 primers for qPCR and the
   anti-HIF1 alpha antibody.
CR Chollangi S, 2012, J BIOL CHEM, V287, P23710, DOI 10.1074/jbc.M112.360404
   Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582
   Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333
   Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001
   Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419
   Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326
   Shin DH, 2008, ONCOGENE, V27, P1939, DOI 10.1038/sj.onc.1210826
   Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883
   Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253
   Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564
   Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370
   Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009
   Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592
   Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64
   Leung KW, 2011, ANGIOGENESIS, V14, P515, DOI 10.1007/s10456-011-9235-z
   Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h
   Bamforth SD, 2004, NAT GENET, V36, P1189, DOI 10.1038/ng1446
   Sakai M, 2012, NAT MED, V18, P612, DOI 10.1038/nm.2691
   Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144
   Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768
   Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1
   O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106
   Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799
   Peyssonnaux C, 2008, CELL CYCLE, V7, P28
   Moroishi T, 2014, J BIOL CHEM, V289, P16430, DOI 10.1074/jbc.M113.541490
   Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200
   Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011
   Vinas-Castells R, 2014, NUCLEIC ACIDS RES, V42, P1079, DOI 10.1093/nar/gkt935
   Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262
   Li Q, 2012, BIOCHEM BIOPH RES CO, V423, P895, DOI 10.1016/j.bbrc.2012.06.099
   Jian R, 2007, STEM CELLS, V25, P1904, DOI 10.1634/stemcells.2006-0448
   Ruiz JC, 2013, J BIOL CHEM, V288, P552, DOI 10.1074/jbc.M112.426171
   Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072
   Bhaskaran N, 2013, MOL CELL BIOL, V33, P85, DOI 10.1128/MCB.00288-12
   O'Hara A, 2014, J CELL SCI, V127, P3659, DOI 10.1242/jcs.149328
   Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304
   Braganca J, 2002, J BIOL CHEM, V277, P8559, DOI 10.1074/jbc.M110850200
   Brahimi-Horn MC, 2007, ESSAYS BIOCHEM, V43, P165
   Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552
   Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936
   Fukuchi M, 2001, MOL BIOL CELL, V12, P1431
   Glenn DJ, 1999, J BIOL CHEM, V274, P36159, DOI 10.1074/jbc.274.51.36159
   Kranc KR, 2015, STEM CELLS, V33, P699, DOI 10.1002/stem.1889
   Lee BL, 2008, CARCINOGENESIS, V29, P44, DOI 10.1093/carcin/bgm232
   Lichner Z, 2011, DIFFERENTIATION, V81, P11, DOI 10.1016/j.diff.2010.08.002
   Lou XW, 2011, J IMMUNOL, V186, P539, DOI 10.4049/jimmunol.1001650
   Masson Norma, 2014, Cancer Metab, V2, P3, DOI 10.1186/2049-3002-2-3
   Masson N, 1998, MOL CELL BIOL, V18, P3502
   Shah YM, 2014, GASTROENTEROLOGY, V146, P630, DOI 10.1053/j.gastro.2013.12.031
   Shioda T, 1997, GENE, V204, P235, DOI 10.1016/S0378-1119(97)00551-9
   Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200
   Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67
   Wu ZZ, 2011, J CELL PHYSIOL, V226, P2415, DOI 10.1002/jcp.22589
   Yahata T, 2002, GENOMICS, V80, P601, DOI 10.1006/geno.2002.7005
   Yoon H., 2011, BIOCHIM BIOPHYS ACTA, V43, P2008
   Zhang N, 2007, BIOCHEM BIOPH RES CO, V359, P34, DOI 10.1016/j.bbrc.2007.05.068
NR 56
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2015
VL 576
BP 61
EP 72
DI 10.1016/j.abb.2015.04.012
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3LQ
UT WOS:000356118000008
PM 25956243
ER

PT J
AU Korkmaz, F
   van Pee, K
   Yildiz, O
AF Korkmaz, Filiz
   van Pee, Katharina
   Yildiz, Oezkan
TI IR-spectroscopic characterization of an elongated OmpG mutant
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Outer membrane protein (OMP); IR spectroscopy; Protein engineering;
   Porin; beta-Barrel
ID TRANSFORM INFRARED-SPECTROSCOPY; MONOMERIC PORIN; PROTEINS; FTIR;
   ABSORPTION; COLI
AB OmpG is a nonselective, pH dependent outer membrane protein from Escherichia coli. It consists of 281 residues, forming a 14-stranded beta-sheet structure. In this study, OmpG is extended by 38 amino acids to produce a 16-stranded beta-barrel (OmpG-16S). The resulting protein is investigated by IR-spectroscopy. The secondary structure, pH-dependent opening/closing mechanism, buffer accessibility and thermal stability of OmpG-16S are compared to OmpG-WT. The results show that OmpG-16S is responsive to pH change as indicated by the Amide I band shift upon a switch from acidic to neutral pH. This spectral shift is consistent with that observed in OmpG-WT, which confirms the existence of structural differences consistent with the presence of the open or closed state. Secondary structure analysis after curve-fitting of Amide I band revealed that the additional residues do not fold into beta-sheet; rather they are in the form of turns and unordered structure. In thermal stability experiments, OmpG-16S is found to be as stable as OmpG-WT. Additionally, H/D exchange experiments showed no difference in the exchange rate of OmpG-16S between the acidic and alkaline pH, suggesting that the loop L6 is no longer sufficient to block the pore entrance at acidic pH. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Korkmaz, Filiz] Atilim Univ, Phys Unit, Biophys Lab, TR-06836 Ankara, Turkey.
   [van Pee, Katharina; Yildiz, Oezkan] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany.
RP Korkmaz, F (reprint author), Atilim Univ, Phys Unit, Biophys Lab, TR-06836 Ankara, Turkey.
EM filiz.korkmaz@atilim.edu.tr
FU Atilim University [ATU-ALP-1011-01]; TUBITAK [211T179]
FX This work is supported by the grant ATU-ALP-1011-01 provided by Atilim
   University and the grant 211T179 provided by TUBITAK.
CR Damaghi M, 2010, J MOL BIOL, V397, P878, DOI 10.1016/j.jmb.2010.02.023
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Conlan S, 2000, BIOCHEMISTRY-US, V39, P11845, DOI 10.1021/bi001065h
   Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011
   Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815
   Yildiz O, 2006, EMBO J, V25, P3702, DOI 10.1038/sj.emboj.7601237
   VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309
   GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521
   Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3
   Goormaghtigh E, 1994, Subcell Biochem, V23, P405
   Conlan S, 2003, BIOCHEMISTRY-US, V42, P9453, DOI 10.1021/bi0344228
   Dzafic E, 2009, SPECTROCHIM ACTA A, V72, P102, DOI 10.1016/j.saa.2008.08.015
   Grosse W, 2010, BIOORGAN MED CHEM, V18, P7716, DOI 10.1016/j.bmc.2010.03.044
   Hirsch A, 1997, FEBS LETT, V404, P208, DOI 10.1016/S0014-5793(97)00131-2
   Korkmaz F, 2012, SPECTROCHIM ACTA A, V91, P395, DOI 10.1016/j.saa.2012.01.025
   Korkmaz F, 2008, BIOCHEMISTRY-US, V47, P12126, DOI 10.1021/bi801224y
   Korkmaz-Ozkan F, 2010, J MOL BIOL, V401, P56, DOI 10.1016/j.jmb.2010.06.015
   MANTELE W, 1993, TRENDS BIOCHEM SCI, V18, P197, DOI 10.1016/0968-0004(93)90186-Q
   Mari SA, 2010, J MOL BIOL, V396, P610, DOI 10.1016/j.jmb.2009.12.034
NR 19
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2015
VL 576
BP 73
EP 79
DI 10.1016/j.abb.2015.04.010
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CK3LQ
UT WOS:000356118000009
PM 25958106
ER

PT J
AU Han, S
   Pham, TV
   Kim, JH
   Lim, YR
   Park, HG
   Cha, GS
   Yun, CH
   Chun, YJ
   Kang, LW
   Kim, D
AF Han, Songhee
   Tan-Viet Pham
   Kim, Joo-Hwan
   Lim, Young-Ran
   Park, Hyoung-Goo
   Cha, Gun-Su
   Yun, Chul-Ho
   Chun, Young-Jin
   Kang, Lin-Woo
   Kim, Donghak
TI Functional characterization of CYP107W1 from Streptomyces avermitilis
   and biosynthesis of macrolide oligomycin A
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE P450; CYP; CYP107W1; Streptomyces avermitilis; Oligomycin; X-ray crystal
   structure
ID COMPLETE GENOME SEQUENCE; COELICOLOR A3(2); CYTOCHROME-P450 COMPLEMENT;
   HYDROXYLATION; FERMENTATION; COELIBACTIN; ORGANISM; STRAIN; MODEL
AB Streptomyces avermitilis contains 33 cytochrome P450 genes in its genome, many of which play important roles in the biosynthesis process of antimicrobial agents. Here, we characterized the biochemical function and structure of CYP107W1 from S. avermitilis, which is responsible for the 12-hydroxylation reaction of oligomycin C. CYP107W1 was expressed and purified from Escherichia coli.. Purified proteins exhibited the typical CO-binding spectrum of P450. Interaction of oligomycin C and oligomycin A (12-hydroxylated oligomycin C) with purified CYP107W1 resulted in a type I binding with K-d values of 14.4 +/- 0.7 mu M and 2.0 +/- 0.1 mu M, respectively. LC-mass spectrometry analysis showed that CYP107W1 produced oligomycin A by regioselectively hydroxylating C12 of oligomycin C. Steady-state kinetic analysis yielded a k(cat) value of 0.2 min(-1) and a K-m value of 18 mu M. The crystal structure of CYP107W1 was determined at 2.1 angstrom resolution. The overall P450 folding conformations are well conserved, and the open access binding pocket for the large macrolide oligomycin C was observed above the distal side of heme. This study of CYP107W1 can help a better understanding of clinically important P450 enzymes as well as their optimization and engineering for synthesizing novel antibacterial agents and other pharmaceutically important compounds. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Han, Songhee; Tan-Viet Pham; Kim, Joo-Hwan; Lim, Young-Ran; Park, Hyoung-Goo; Kang, Lin-Woo; Kim, Donghak] Konkuk Univ, Dept Biol Sci, Seoul 143701, South Korea.
   [Cha, Gun-Su; Yun, Chul-Ho] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea.
   [Chun, Young-Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.
RP Kang, LW (reprint author), Konkuk Univ, Dept Biol Sci, 120 Neungdong Ro, Seoul 143701, South Korea.
EM lkang@konkuk.ac.kr; donghak@konkuk.ac.kr
FU National Research Foundation of Korea (NRF) grant - Korea government
   [2011-0016509, 2009-0088150]; Cooperative Research Program for
   Agriculture Science & Technology Development, Rural Development
   Administration, Korea [PJ01127901]
FX This work was supported by a National Research Foundation of Korea (NRF)
   grant funded by the Korea government (Nos. 2011-0016509, 2009-0088150)
   and a grant from the Cooperative Research Program for Agriculture
   Science & Technology Development (PJ01127901), Rural Development
   Administration, Korea.
CR Symersky J, 2012, P NATL ACAD SCI USA, V109, P13961, DOI 10.1073/pnas.1207912109
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Urlacher VB, 2012, TRENDS BIOTECHNOL, V30, P26, DOI 10.1016/j.tibtech.2011.06.012
   Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a
   Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820
   Oliynyk M, 2007, NAT BIOTECHNOL, V25, P447, DOI 10.1038/nbt1297
   Xu LH, 2009, J BACTERIOL, V191, P1211, DOI 10.1128/JB.01276-08
   Lamb DC, 2002, J BIOL CHEM, V277, P24000, DOI 10.1074/jbc.M111109200
   Choi S, 2013, BIOMOL THER, V21, P487, DOI 10.4062/biomolther.2013.086
   Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361
   Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/bse0470053, 10.1042/BSE0470053]
   Ikeda H, 1999, P NATL ACAD SCI USA, V96, P9509, DOI 10.1073/pnas.96.17.9509
   CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144
   Dyson P, 2011, STREPTOMYCES: MOLECULAR BIOLOGY AND BIOTECHNOLOGY, P1
   Kelly SL, 2005, CYTOCHROME P450 STRU, P585, DOI 10.1007/0-387-27447-2_13
   Kim D, 2006, BIOCHEMISTRY-US, V45, P14772, DOI 10.1021/bi061429r
   Kim D, 2004, BIOCHEMISTRY-US, V43, P981, DOI 10.1021/bi035593f
   Lamb DC, 2010, APPL ENVIRON MICROB, V76, P1975, DOI 10.1128/AEM.03000-09
   Lamb DC, 2011, STREPTOMYCES: MOLECULAR BIOLOGY AND BIOTECHNOLOGY, P233
   Lamb DC, 2006, EXPERT OPIN DRUG MET, V2, P27, DOI 10.1517/17425255.2.1.27
   Li SY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.410340
   Lim YR, 2012, ARCH BIOCHEM BIOPHYS, V528, P111, DOI 10.1016/j.abb.2012.09.001
   Lin XP, 2009, APPL MICROBIOL BIOT, V81, P839, DOI 10.1007/s00253-008-1684-y
   Otwinowski Z., 1997, ENZYMOLOGY, V276, P307
   Parajuli N, 2004, ARCH BIOCHEM BIOPHYS, V425, P233, DOI 10.1016/j.abb.2004.03.011
   Quaderer R, 2006, J AM CHEM SOC, V128, P13036, DOI 10.1021/ja0639214
   SCHENKMA.JB, 1967, MOL PHARMACOL, V3, P113
   Schrodinger L. L. C., 2010, PYMOL MOL GRAPHICS S
   SMITH RM, 1954, ANTIBIOT CHEMOTHER, V4, P962
   Wu H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-337
   Xu LH, 2010, J BIOL CHEM, V285, P16844, DOI 10.1074/jbc.M109.092460
   YAMAZAKI M, 1992, J ANTIBIOT, V45, P171
   Yang PW, 2010, FOLIA MICROBIOL, V55, P10, DOI 10.1007/s12223-010-0002-0
   Zhao B, 2012, INT J MOL SCI, V13, P8500, DOI 10.3390/ijms13078500
NR 36
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 1
PY 2015
VL 575
BP 1
EP 7
DI 10.1016/j.abb.2015.03.025
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CI8OI
UT WOS:000355031200001
PM 25849761
ER

PT J
AU Verma, AK
   Bule, P
   Ribeiro, T
   Bras, JLA
   Mukherjee, J
   Gupta, MN
   Fontes, CMGA
   Goyal, A
AF Verma, Anil Kumar
   Bule, Pedro
   Ribeiro, Teresa
   Bras, Joana L. A.
   Mukherjee, Joyeeta
   Gupta, Munishwar N.
   Fontes, Carlos M. G. A.
   Goyal, Arun
TI The family 6 Carbohydrate Binding Module (CtCBM6) of glucuronoxylanase
   (CtXynGH30) of Clostridium thermocellum binds decorated and undecorated
   xylans through cleft A
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Clostridium thermocellum; Binding cleft; Ligand binding affinity and
   isothermal; titration calorimetry
ID ALPHA-L-ARABINOFURANOSIDASE; LIGAND-BINDING; OLIGOSACCHARIDE
   RECOGNITION; AFFINITY ELECTROPHORESIS; 3-DIMENSIONAL STRUCTURES;
   AUTOMATED DOCKING; ENZYME COMPLEXES; PROTEINS; CELLULOSE; DOMAINS
AB CtCBM6 of glucuronoxylan-xylanohydrolase (CtXynGH30) from Clostridium thermocellum was cloned, expressed and purified as a soluble similar to 14 kDa protein. Quantitative binding analysis with soluble polysaccharides by affinity electrophoresis and ITC revealed that CtCBM6 displays similar affinity towards decorated and undecorated xylans by binding wheat- and rye-arabinoxylans, beechwood-, birchwood- and oatspelt-xylan. Protein melting studies confirmed thermostable nature of CtCBM6 and that Ca2+ ions did not affect its structure stability and binding affinity significantly. The CtCBM6 structure was modeled and refined and CD spectrum displayed 44% beta-strands supporting the predicted structure. CtCBM6 displays a jelly roll beta-sandwich fold presenting two potential carbohydrate binding clefts, A and B. The cleft A, is located between two loops connecting beta 4-beta 5 and beta 8-beta 9 strands. Tyr28 and Phe84 present on these loops make a planar hydrophobic binding surface to accommodate sugar ring of ligand. The cleft B, is located on concave surface of beta-sandwich fold. Tyr34 and Tyr104 make a planar hydrophobic platform, which may be inaccessible to ligand due to hindrance by Pro68. Site-directed mutagenesis revealed Tyr28 and Phe84 in cleft A, playing a major role in ligand binding. The results suggest that CtCBM6 interacts with carbohydrates through cleft A, which recognizes equally well both decorated and un-decorated xylans. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Verma, Anil Kumar; Goyal, Arun] Indian Inst Technol, Dept Biotechnol, Gauhati 781039, Assam, India.
   [Bule, Pedro; Ribeiro, Teresa; Bras, Joana L. A.; Fontes, Carlos M. G. A.] CIISA, Fac Med Vet, P-1300477 Lisbon, Portugal.
   [Mukherjee, Joyeeta; Gupta, Munishwar N.] Indian Inst Technol Delhi, Dept Chem, New Delhi, India.
RP Goyal, A (reprint author), Indian Inst Technol, Dept Biotechnol, Gauhati 781039, Assam, India.
EM arungoyl@iitg.ernet.in
OI Fontes, Carlos/0000-0002-1219-9753
FU Cutting-edge Research Enhancement and Scientific Training (CREST)
   Fellowship from Department of Biotechnology, Ministry of Science and
   Technology; IIT Guwahati
FX The authors thank Arun Dhillon for his help with CD spectroscopy
   experiment. We thankfully acknowledged Dr. P. Saravanan for his help
   with the MD simulation study. The funder has no role in designing the
   experiments, preparation of this manuscript and bearing any further
   publication charges. The research work in part, was supported by
   Cutting-edge Research Enhancement and Scientific Training (CREST)
   Fellowship from Department of Biotechnology, Ministry of Science and
   Technology to Arun Goyal. The scholarships from IIT Guwahati to AKV are
   gratefully acknowledged.
CR Abbott DW, 2009, BIOCHEMISTRY-US, V48, P10395, DOI 10.1021/bi9013424
   Abbott DW, 2014, CURR OPIN STRUC BIOL, V28, P32, DOI 10.1016/j.sbi.2014.07.004
   Ahmed S, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1272, DOI 10.1134/S0006297913110072
   Ahmed S, 2013, BIOCATAL BIOTRANSFOR, V31, P217, DOI 10.3109/10242422.2013.828047
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005
   Bae HJ, 2003, FEMS MICROBIOL LETT, V227, P175, DOI 10.1016/S0378-1097(03)00593-7
   Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Wang AJA, 2002, APPL ENVIRON MICROB, V68, P1684, DOI 10.1128/AEM.68.4.1684-1689.2002
   Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4
   Levy I, 2002, BIOTECHNOL ADV, V20, P191, DOI 10.1016/S0734-9750(02)00006-X
   FRANCISCO JA, 1993, BIO-TECHNOL, V11, P491, DOI 10.1038/nbt0493-491
   Abou-Hachem M, 2002, BIOCHEMISTRY-US, V41, P5720, DOI 10.1021/bi012094a
   Boraston AB, 2004, BIOCHEM J, V382, P769
   Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05
   SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306
   RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95
   MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G
   Fiser A, 2000, PROTEIN SCI, V9, P1753
   Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200
   GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302
   Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y
   Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366
   Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200
   Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925
   BAYDOUN EAH, 1991, BIOCHEM SOC T, V19, pS250
   Boraston AB, 2003, J MOL BIOL, V327, P659, DOI 10.1016/S0022-2836(03)00152-9
   Boraston AB, 2001, PROTEIN EXPRES PURIF, V21, P417, DOI 10.1006/prep.2001.1393
   Boraston AB, 2000, BIOCHEM J, V350, P933, DOI 10.1042/0264-6021:3500933
   Correia MAS, 2009, FEMS MICROBIOL LETT, V300, P48, DOI 10.1111/j.1574-6968.2009.01764.x
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Dvortsov IA, 2009, MICROBIOL-SGM, V155, P2442, DOI 10.1099/mic.0.026930-0
   Fernandes AC, 1999, BIOCHEM J, V342, P105, DOI 10.1042/0264-6021:3420105
   Fires V. M. R., 2004, J BIOL CHEM, V279, P21560
   Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646
   GILKES NR, 1992, J BIOL CHEM, V267, P6743
   Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3
   Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200
   Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200
   Johansson R, 2006, J MOL RECOGNIT, V19, P275, DOI 10.1002/jmr.794
   Louis-Jeune C., 2011, PROTEINS
   Notenboom V, 2001, J MOL BIOL, V314, P797, DOI 10.1006/jmbi.2001.5153
   Novy R, 1997, FASEB J, V11, pA1151
   PHELPS MR, 1995, BIOTECHNOL BIOENG, V46, P514, DOI 10.1002/bit.260460604
   Rodriguez B, 2004, BIOTECHNOL PROGR, V20, P1479, DOI 10.1021/bp0341904
   Sainz-Polo MA, 2014, J BIOL CHEM, V289, P31088, DOI 10.1074/jbc.M114.597732
   SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404
   TAKEO K, 1995, J CHROMATOGR A, V698, P89, DOI 10.1016/0021-9673(94)01265-G
   Tomme P, 2000, ENZYME MICROB TECH, V27, P453, DOI 10.1016/S0141-0229(00)00246-5
   van Bueren AL, 2005, J BIOL CHEM, V280, P530, DOI 10.1074/jbc.M410113200
   van Bueren AL, 2004, J MOL BIOL, V340, P869, DOI 10.1016/j.jbm.2004.05.038
   Wang AA, 2001, BIOTECHNOL PROGR, V17, P407, DOI 10.1021/bp0100225
   ZHOU MY, 1995, BIOTECHNIQUES, V19, P34
NR 59
TC 0
Z9 0
U1 5
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 1
PY 2015
VL 575
BP 8
EP 21
DI 10.1016/j.abb.2015.03.026
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CI8OI
UT WOS:000355031200002
PM 25857803
ER

PT J
AU Zhan, YA
   Ytreberg, FM
AF Zhan, Yingqian Ada
   Ytreberg, F. Marty
TI The cis conformation of proline leads to weaker binding of a p53 peptide
   to MDM2 compared to trans
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Intrinsically disordered protein; cis-trans isomerization; Binding
   affinity; Molecular dynamics; Potential of mean force
ID FREE-ENERGY CALCULATIONS; PROTEIN-LIGAND-BINDING; MOLECULAR-DYNAMICS;
   COMPUTER-SIMULATIONS; PROLYL ISOMERIZATION; ALPHA-HELIX; DRUG DESIGN;
   AFFINITY; PHOSPHORYLATION; STABILITY
AB The cis and trans conformations of the Xaa Pro (Xaa: any amino acid) peptide bond are thermodynamically stable while other peptide bonds strongly prefer trans. The effect of proline cis trans isomerization on protein binding has not been thoroughly investigated. In this study, computer simulations were used to calculate the absolute binding affinity for a p53 peptide (residues 17-29) to MDM2 for both cis and trans isomers of the p53 proline in position 27. Results show that the cis isomer of p53(17-29) binds more weakly to MDM2 than the trans isomer, and that this is primarily due to the difference in the free energy cost associated with the loss of conformational entropy of p53(17-29) when it binds to MDM2. The population of cis p53(17-29) was estimated to be 0.8% of the total population in the bound state. The stronger binding of trans p53(17-29) to MDM2 compared to cis may leave a minimal level of p53 available to respond to cellular stress. This study demonstrates that it is feasible to estimate the absolute binding affinity for an intrinsically disordered protein fragment binding to an ordered protein that are in good agreement with experimental results. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Zhan, Yingqian Ada; Ytreberg, F. Marty] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83844 USA.
   [Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID 83844 USA.
RP Ytreberg, FM (reprint author), Univ Idaho, Dept Phys, Moscow, ID 83844 USA.
EM ytreberg@uidaho.edu
FU National Institutes of Health [NIH R21 GM83827]; INBRE Program (NIH)
   [P20 GM103408]; IBEST Computing Core (NIH) [P30 GM103324]
FX The authors would like to thank Dr. Francois-Xavier Theillet for
   providing NMR data and analysis (In-cell NMR Laboratory, Department of
   NMR-supported Structural Biology, Leibniz Institute of Molecular
   Pharmacology, Berlin, Germany). This project was supported by the
   National Institutes of Health (NIH R21 GM83827 to F.M.Y.), the INBRE
   Program (NIH Grant P20 GM103408), and the IBEST Computing Core (NIH
   Grant P30 GM103324). The contents of this manuscript are solely the
   responsibility of the authors and do not necessarily represent the
   official views of NIH.
CR MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H
   Kim MK, 1999, PROTEIN SCI, V8, P1492
   Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056
   Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543
   FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648
   GRATHWOHL C, 1981, BIOPOLYMERS, V20, P2623, DOI 10.1002/bip.1981.360201209
   KEMP DS, 1988, TETRAHEDRON LETT, V29, P4931, DOI 10.1016/S0040-4039(00)80644-9
   Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004
   Weiss MS, 1998, NAT STRUCT BIOL, V5, P676, DOI 10.1038/1368
   Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h
   BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4
   Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4
   Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102
   Wlodawer A, 2002, ANNU REV MED, V53, P595, DOI 10.1146/annurev.med.53.052901.131947
   Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723
   Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948
   Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207
   Gumbart JC, 2013, J CHEM THEORY COMPUT, V9, P794, DOI 10.1021/ct3008099
   Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657
   Ytreberg FM, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3119261
   ZIMMERMAN SS, 1976, MACROMOLECULES, V9, P408, DOI 10.1021/ma60051a005
   Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026
   Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4
   STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J
   Elcock AH, 2001, J PHYS CHEM B, V105, P1504, DOI 10.1021/jp003602d
   ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420
   Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571
   KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d
   AQVIST J, 1994, PROTEIN ENG, V7, P385, DOI 10.1093/protein/7.3.385
   Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103
   Lee C, 2014, BBA-GEN SUBJECTS, V1840, P993, DOI 10.1016/j.bbagen.2013.10.042
   Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j
   Sandhu KS, 2009, J MOL RECOGNIT, V22, P1, DOI 10.1002/jmr.915
   Craveur P, 2013, AMINO ACIDS, V45, P279, DOI 10.1007/s00726-013-1511-3
   RAMACHANDRAN GN, 1976, J MOL BIOL, V107, P85, DOI 10.1016/S0022-2836(76)80019-8
   Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0
   Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cpba.2003.12.008
   Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739
   Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0
   Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130
   Borcherds W, 2014, NAT CHEM BIOL, V10, P1000, DOI 10.1038/nchembio.1668
   Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078
   Chen Jiandong, 2012, Genes Cancer, V3, P274, DOI 10.1177/1947601912454733
   Chipot C., 2007, FREE ENERGY CALCULAT, VSpringer
   Dadarlat VM, 2011, BIOPHYS J, V100, P469, DOI 10.1016/j.bpj.2010.11.053
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g
   Deng H, 2001, BIOCHEMISTRY-US, V40, P3767, DOI 10.1021/bi0026268
   Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068
   Fischer G, 2003, Rev Physiol Biochem Pharmacol, V148, P105, DOI 10.1007/s10254-003-0011-3
   Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299
   Gracia L., CLUSTERING PLUGIN VM
   Grossfield A., WHAM WEIGHTED HISTOG
   Torbeev VY, 2013, P NATL ACAD SCI USA, V110, P20051, DOI 10.1073/pnas.1310414110
   KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P6475, DOI 10.1021/bi00479a020
   lakoucheva L. M., 2002, J MOL BIOL, P573
   Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200
   LEVITT M, 1981, J MOL BIOL, V145, P251, DOI 10.1016/0022-2836(81)90342-9
   Lu K.P., 2007, NAT CHEM BIOL, V3, P617
   MacKerell JAD, 1998, J PHYS CHEM B, V102, P3586, DOI DOI 10.1021/JP973084F
   McClendon S., 2005, BIOPHYS J, V89, pL07
   Mobley DL, 2007, J CHEM THEORY COMPUT, V3, P1231, DOI 10.1021/ct700032n
   Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7
   SCHMID FX, 1978, P NATL ACAD SCI USA, V75, P4764, DOI 10.1073/pnas.75.10.4764
   Schroeder D. V., 2000, INTRO THERMAL PHYS
   Suizu F, 2006, MOL CELL BIOL, V26, P1463, DOI 10.1128/MCB.26.4.1463-1479.2006
   Theillet F-X, 2013, INTRINSICALLY DISORD, V1, P5
   Tony P., 2003, SCIENCE, V300, P445
   Vousden K.H., 2009, CELL, V13, P413
   Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b
   Weng ZP, 1997, PROTEIN SCI, V6, P1976
   Xu Yang, 2003, Cell Death and Differentiation, V10, P400, DOI 10.1038/sj.cdd.4401182
   YUN RH, 1991, PROTEINS, V10, P219, DOI 10.1002/prot.340100306
   Zhan Y.A., 2013, PROTEINS
   Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026
   Zondlo SC, 2006, BIOCHEMISTRY-US, V45, P11945, DOI 10.1021/bi060309g
NR 87
TC 0
Z9 0
U1 13
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 1
PY 2015
VL 575
BP 22
EP 29
DI 10.1016/j.abb.2015.03.021
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CI8OI
UT WOS:000355031200003
PM 25840370
ER

PT J
AU Villavicencio-Queijeiro, A
   Pardo, JP
   Gonzalez-Halphen, D
AF Villavicencio-Queijeiro, Alexa
   Pablo Pardo, Juan
   Gonzalez-Halphen, Diego
TI Kinetic and hysteretic behavior of ATP hydrolysis of the highly stable
   dimeric ATP synthase of Polytomella sp.
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Mitochondrial F1Fo-ATP synthase; Dimeric complex V; Chlorophycean algae;
   Hysteresis; Polytomella sp.
ID MITOCHONDRIAL OXIDATIVE-PHOSPHORYLATION; NUCLEOTIDE-BINDING-SITES;
   STEADY-STATE KINETICS; ESCHERICHIA-COLI; CHLAMYDOMONAS-REINHARDTII;
   SACCHAROMYCES-CEREVISIAE; F1FO-ATP SYNTHASE; COUPLING FACTOR;
   PHOTOSYNTHETIC PHOSPHORYLATION; PROTEOLIPID SUBUNIT
AB The F1Fo -ATP synthase of the colorless alga Polytomella sp. exhibits a robust peripheral arm constituted by nine atypical subunits only present in chlorophycean algae. The isolated dimeric enzyme exhibits a latent ATP hydrolytic activity which can be activated by some detergents. To date, the kinetic behavior of the algal ATPase has not been studied. Here we show that while the soluble F-1 sector exhibits Michaelis-Menten kinetics, the dimer exhibits a more complex behavior. The kinetic parameters (V-max and K-m) were obtained for both the F-1 sector and the dimeric enzyme as isolated or activated by detergent, and this activation was also seen on the enzyme reconstituted in liposomes. Unlike other ATP synthases, the algal dimer hydrolyzes ATP on a wide range of pH and temperature. The enzyme was inhibited by oligomycin, DCCD and Mg-ADP, although oligomycin induced a peculiar inhibition pattern that can be attributed to structural differences in the algal subunit-c. The hydrolytic activity was temperature-dependent and exhibited activation energy of 4 kcal/mol. The enzyme also exhibited a hysteretic behavior with a lag phase strongly dependent on temperature but not on pH, that may be related to a possible regulatory role in vivo. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Villavicencio-Queijeiro, Alexa; Gonzalez-Halphen, Diego] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.
   [Pablo Pardo, Juan] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico.
RP Gonzalez-Halphen, D (reprint author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Apartado Postal 70-600, Mexico City 04510, DF, Mexico.
EM dhalphen@ifc.unam.mx
FU Consejo Nacional de Ciencia y Tecnologia (CONACyT) [239219, 229468];
   Direccion General de Asuntos del Personal Academico (DGAPA-UNAM, Mexico)
   [IN203114]
FX This manuscript is dedicated to the memory of Professor Armando
   Gomez-Puyou, whose scientific contributions and teachings inspired us
   and many generations of Mexican bioenergeticists. We are grateful for
   the suggestions and criticisms made to our manuscript by our colleagues
   at IFC (UNAM): Professors Marietta Tuena and Georges Dreyfus. We are
   indebted to Professor Marina Gavilanes-Ruiz (Facultad de Quimica, UNAM)
   for teaching us the calorimetric technique for ATP hydrolysis. We
   acknowledge the technical expertise of M. Vazquez-Acevedo (IFC-UNAM) and
   J. De la Mora (Georges Dreyfus laboratory, IFC-UNAM). This research was
   supported by grant 239219 from the Consejo Nacional de Ciencia y
   Tecnologia (CONACyT). Additional support was received from grants,
   IN203114 from the Direccion General de Asuntos del Personal Academico
   (DGAPA-UNAM, Mexico). CONACyT also supported A.V.-Q with the fellowship
   229468 during her graduate studies at the Biomedical Sciences Ph.D.
   Program at UNAM (Posgrado en Ciencias Biomedicas). This manuscript
   partially fulfils the requirements of A.V-Q. to obtain her Ph.D. degree.
CR ADOLFSEN R, 1976, BIOCHEMISTRY-US, V15, P4163, DOI 10.1021/bi00664a005
   ADOLFSEN R, 1976, ARCH BIOCHEM BIOPHYS, V172, P425, DOI 10.1016/0003-9861(76)90094-1
   ADOLFSEN R, 1975, BIOCHEMISTRY-US, V14, P1727, DOI 10.1021/bi00679a027
   ALFONZO M, 1981, J BIOENERG BIOMEMBR, V13, P375, DOI 10.1007/BF00743211
   Allegretti M, 2015, NATURE
   HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871
   Symersky J, 2012, P NATL ACAD SCI USA, V109, P13961, DOI 10.1073/pnas.1207912109
   Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753
   Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065
   Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698
   Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109
   Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5
   CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4
   Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106
   Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620
   Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678
   Atteia A, 2005, EUKARYOT CELL, V4, P2087, DOI 10.1128/EC.4.12.2087-2097.2005
   MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x
   FRIEDEN C, 1970, J BIOL CHEM, V245, P5788
   PULLMAN ME, 1960, J BIOL CHEM, V235, P3322
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006
   Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Cook GM, 2003, J BACTERIOL, V185, P4442, DOI 10.1128/JB.185.15.4442-4449.2003
   Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170
   Haagsma AC, 2010, FEMS MICROBIOL LETT, V313, P68, DOI 10.1111/j.1574-6968.2010.02123.x
   PERLIN DS, 1985, BIOCHIM BIOPHYS ACTA, V807, P238, DOI 10.1016/0005-2728(85)90254-3
   Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200
   Atteia A, 1997, BBA-BIOENERGETICS, V1320, P275, DOI 10.1016/S0005-2728(97)00031-5
   Cano-Estrada A, 2010, BBA-BIOENERGETICS, V1797, P1439, DOI 10.1016/j.bbabio.2010.02.024
   Cardol P, 2005, PLANT PHYSIOL, V137, P447, DOI 10.1104/pp.104.054148
   DIPIETRO A, 1980, BIOCHEMISTRY-US, V19, P5671, DOI 10.1021/bi00566a002
   DROBINSKAYA IY, 1985, FEBS LETT, V182, P419, DOI 10.1016/0014-5793(85)80346-X
   Dudkina N. V., 1797, BIOCHIM BIOPHYS ACTA, P272
   DUNHAM KR, 1981, J BIOL CHEM, V256, P212
   FELDMAN RI, 1985, J BIOL CHEM, V260, P3088
   FITIN AF, 1979, BIOCHEM BIOPH RES CO, V86, P434, DOI 10.1016/0006-291X(79)90884-2
   FOSTER DL, 1980, J BIOL CHEM, V255, P2037
   Futai M., 2004, HDB ATPASES BIOCH CE
   GALANIS M, 1989, FEBS LETT, V249, P333, DOI 10.1016/0014-5793(89)80653-2
   GLASER E, 1982, EUR J BIOCHEM, V121, P525, DOI 10.1111/j.1432-1033.1982.tb05818.x
   Golden TR, 1998, BIOCHEMISTRY-US, V37, P13871, DOI 10.1021/bi981120a
   GOMEZPUYOU A, 1979, BIOCHIM BIOPHYS ACTA, V547, P252, DOI 10.1016/0005-2728(79)90008-2
   GONZALEZROMO P, 1992, ANAL BIOCHEM, V200, P235, DOI 10.1016/0003-2697(92)90458-J
   HAMMES GG, 1971, BIOCHIM BIOPHYS ACTA, V233, P580, DOI 10.1016/0005-2736(71)90156-8
   HERMOLIN J, 1989, J BIOL CHEM, V264, P3896
   LAGET PP, 1979, ARCH BIOCHEM BIOPHYS, V192, P474, DOI 10.1016/0003-9861(79)90117-6
   Lapaille M, 2010, MOL BIOL EVOL, V27, P1630, DOI 10.1093/molbev/msq049
   Markwell M. A., 1978, ANAL BIOCHEM, V87, P206
   Neet K E, 1980, Methods Enzymol, V64, P192
   Nurani G, 1996, PLANT MOL BIOL, V31, P1105, DOI 10.1007/BF00040828
   OOI BG, 1985, EUR J BIOCHEM, V152, P709, DOI 10.1111/j.1432-1033.1985.tb09251.x
   PENEFSKY HS, 1974, J BIOL CHEM, V249, P3579
   Petrella S, 2006, ANTIMICROB AGENTS CH, V50, P2853, DOI 10.1128/AAC.00244-06
   SCHAGGER H, 1988, ANAL BIOCHEM, V173, P201, DOI 10.1016/0003-2697(88)90179-0
   SEBALD W, 1980, P NATL ACAD SCI-BIOL, V77, P785, DOI 10.1073/pnas.77.2.785
   SWANLJUN.P, 1973, BIOCHIM BIOPHYS ACTA, V305, P519, DOI 10.1016/0005-2728(73)90073-X
   Toei M, 2013, J BIOL CHEM, V288, P25717, DOI 10.1074/jbc.M113.482455
   van Lis R, 2003, PLANT PHYSIOL, V132, P318, DOI 10.1104/pp.102.018325
   van Lis R, 2007, PLANT PHYSIOL, V144, P1190, DOI 10.1104/pp.106.094060
   Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x
   Villavicencio-Queijeiro A, 2009, J BIOENERG BIOMEMBR, V41, P1, DOI 10.1007/s10863-009-9203-0
   Vinogradov AD, 2000, J EXP BIOL, V203, P41
   Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001
   YOSHIDA M, 1983, J BIOL CHEM, V258, P4407
   Zanotti F, 2009, BIOCHEM BIOPH RES CO, V384, P43, DOI 10.1016/j.bbrc.2009.04.046
NR 69
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 1
PY 2015
VL 575
BP 30
EP 37
DI 10.1016/j.abb.2015.03.018
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CI8OI
UT WOS:000355031200004
PM 25843420
ER

PT J
AU Chen, J
   Lan, T
   Zhang, WM
   Dong, LJ
   Kang, N
   Fu, M
   Liu, B
   Liu, KT
   Zhang, CX
   Hou, JC
   Zhan, QM
AF Chen, Jie
   Lan, Tian
   Zhang, Weimin
   Dong, Lijia
   Kang, Nan
   Fu, Ming
   Liu, Bing
   Liu, Kangtai
   Zhang, Cuixiang
   Hou, Jincai
   Zhan, Qimin
TI Dasatinib enhances cisplatin sensitivity in human esophageal squamous
   cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3
   pathways
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE ESCC; Dasatinib; Cisplatin; AKT; Stat3
ID OVARIAN-CANCER CELLS; SRC FAMILY KINASES; UP-REGULATION; INHIBITION;
   RESISTANCE; GROWTH
AB The clinical efficacy of cisplatin in esophageal squamous cell carcinoma (ESCC) treatment remains undesirable. Src, a non-receptor tyrosine kinase involved in multiple fields of tumorigenesis, recently has been indicated as a promising therapeutic target in the treatment of solid tumors including ESCC. However, whether inhibition of Src activity can increase cisplatin efficacy in ESCC cells remains unknown. The present study found that inhibition of Src by its inhibitor-dasatinib sensitized ESCC cells to cisplatin in vitro. Our data also suggest a likely mechanism for this synergy that dasatinib reduces expression of critical oncogenic members of the signaling pathways, such as AKT or Stat3, and cisplatin-resistant molecules, such as ERCC1 and BRCA1, under the control of Src. Furthermore, dasatinib could sensitize ESCC cells to another platin-based agent, carboplatin. Therefore, this study provides a potential target for improving cisplatin efficacy in ESCC therapy. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Chen, Jie; Lan, Tian; Zhang, Weimin; Dong, Lijia; Kang, Nan; Fu, Ming; Zhan, Qimin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100191, Peoples R China.
   [Chen, Jie; Lan, Tian; Zhang, Weimin; Dong, Lijia; Kang, Nan; Fu, Ming; Zhan, Qimin] Peking Union Med Coll, Beijing 100191, Peoples R China.
   [Lan, Tian] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing 100191, Peoples R China.
   [Liu, Bing] Guangdong Pharmaceut Univ, Sch Pharm, Dept Pharmacol, Guangzhou 510006, Guangdong, Peoples R China.
   [Liu, Kangtai] Tsinghua Univ, Peking Union Med Coll, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China.
   [Liu, Kangtai] Chinese Acad Med Sci, Beijing 100005, Peoples R China.
   [Zhang, Cuixiang; Hou, Jincai] China Acad Chinese Med Sci, Xiyuan Hosp, Inst Basic Med Sci, Beijing 110300, Peoples R China.
RP Zhan, QM (reprint author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100191, Peoples R China.
EM zhanqimin@pumc.edu.cn
FU National Natural Fund of China [81021061, 81230047]; China Postdoctoral
   Science Foundation [2013M530555]
FX This work is supported by the National Natural Fund of China (81021061,
   81230047) and China Postdoctoral Science Foundation (2013M530555).
CR Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308
   Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425
   Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079
   Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185
   Yao XY, 2011, J CELL BIOCHEM, V112, P2837, DOI 10.1002/jcb.23198
   Geletu M, 2012, ANTICANCER RES, V32, P4245
   Kim EMH, 2013, J SURG RES, V185, P231, DOI 10.1016/j.jss.2013.06.041
   Tang MKS, 2010, NEOPLASIA, V12, P128, DOI 10.1593/neo.91438
   Ceppi P, 2009, MOL CANCER THER, V8, P3066, DOI 10.1158/1535-7163.MCT-09-0151
   Sun CY, 2013, JNCI-J NATL CANCER I, V105, P1750, DOI 10.1093/jnci/djt302
   Tiseo M, 2013, BRIT J CANCER, V108, P1695, DOI 10.1038/bjc.2013.127
   YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555
   Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366
   Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002
   Bharthuar Anubha, 2014, J Gastrointest Oncol, V5, P253, DOI 10.3978/j.issn.2078-6891.2014.018
   Chen J, 2012, INT J BIOCHEM CELL B, V44, P759, DOI 10.1016/j.biocel.2012.01.015
   Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052589
   Kim Won Ho, 1993, Yonsei Medical Journal, V34, P45
   Lee MW, 2008, INT J CANCER, V122, P2380, DOI 10.1002/ijc.23371
   Li H., 2013, ONCOGENE, V25, P1
   Li W, 2014, MOL MED REP, V9, P2423, DOI 10.3892/mmr.2014.2112
   McCarthy N, 2012, NAT REV CANCER, V12, DOI [10.1038/nrc3208, 10.1038/nrc3222]
   Rossman Joanne F, 2011, Gastrointest Cancer Res, V4, P9
   Song Y, 2013, EUR ARCH OTO-RHINO-L, V270, P1397, DOI 10.1007/s00405-013-2394-3
   Ueda Y, 2009, INT J ONCOL, V34, P689, DOI 10.3892/ijo_00000195
   Wang L, 2012, CLIN SCI, V122, P13, DOI 10.1042/CS20110230
NR 26
TC 0
Z9 0
U1 7
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 1
PY 2015
VL 575
BP 38
EP 45
DI 10.1016/j.abb.2014.11.008
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CI8OI
UT WOS:000355031200005
PM 25843419
ER

PT J
AU Martina, CE
   Lapenta, F
   Silva, AM
   Hochkoeppler, A
AF Martina, Cristina Elisa
   Lapenta, Fabio
   Silva, Alejandro Monton
   Hochkoeppler, Alejandro
TI HoLaMa: A Klenow sub-fragment lacking the 3 '-5 ' exonuclease domain
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Klenow enzyme; Exonuclease domain; Polymerase domain; HoLaMa; Klenow
   sub-fragment
ID DNA-POLYMERASE-I; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES;
   DEOXYRIBONUCLEIC-ACID; III HOLOENZYME; ACTIVE-SITE; AMINO-ACID;
   FLUORESCENCE; SUBUNIT; MECHANISM
AB The design, construction, overexpression, and purification of a Klenow sub-fragment lacking the 3'-5' exonuclease domain is presented here. In particular, a synthetic gene coding for the residues 515-928 of Escherichia coli DNA polymerase I was constructed. To improve the solubility and stability of the corresponding protein, the synthetic gene was designed to contain 11 site-specific substitutions. The gene was inserted into the pBADHis expression vector, generating 2 identical Klenow sub-fragments, bearing or not a hexahistidine tag. Both these Klenow sub-fragments, denominated HoLaMa and HoLaMaHis, were purified, and their catalytic properties were compared to those of Klenow enzyme. When DNA polymerase activity was assayed under processive conditions, the Klenow enzyme performed much better than HoLaMa and HoLaMaHis. However, when DNA polymerase activity was assayed under distributive conditions, the initial velocity of the reaction catalyzed by HoLaMa was comparable to that observed in the presence of Klenow enzyme. In particular, under distributive conditions HoLaMa was found to strongly prefer dsDNAs bearing a short template overhang, to the length of which the Klenow enzyme was relatively insensitive. Overall, our observations indicate that the exonuclease domain of the Klenow enzyme, besides its proofreading activity, does significantly contribute to the catalytic efficiency of DNA elongation. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Martina, Cristina Elisa; Lapenta, Fabio; Silva, Alejandro Monton; Hochkoeppler, Alejandro] Univ Bologna, Dept Pharm & Biotechnol, I-40136 Bologna, Italy.
   [Hochkoeppler, Alejandro] Univ Florence, CSGI, I-50019 Sesto Fiorentino, FI, Italy.
RP Hochkoeppler, A (reprint author), Dept Pharm & Biotechnol, Viale Risorgimento 4, I-40136 Bologna, Italy.
EM a.hochkoeppler@unibo.it
CR BRUTLAG D, 1972, J BIOL CHEM, V247, P241
   JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.biochem.63.1.777
   MORGAN AR, 1979, NUCLEIC ACIDS RES, V7, P547, DOI 10.1093/nar/7.3.547
   BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004
   Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096
   Li Y, 1999, P NATL ACAD SCI USA, V96, P9491, DOI 10.1073/pnas.96.17.9491
   Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304
   Teplova M, 1999, P NATL ACAD SCI USA, V96, P14240, DOI 10.1073/pnas.96.25.14240
   DERBYSHIRE V, 1991, EMBO J, V10, P17
   BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987
   Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593
   Brautigam CA, 1999, BIOCHEMISTRY-US, V38, P696, DOI 10.1021/bi981537g
   BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001
   DELUCIA P, 1969, NATURE, V224, P1164, DOI 10.1038/2241164a0
   DERBYSHIRE V, 1993, NUCLEIC ACIDS RES, V21, P5439, DOI 10.1093/nar/21.23.5439
   FREEMONT P S, 1986, Proteins Structure Function and Genetics, V1, P66, DOI 10.1002/prot.340010111
   Guilten Suare A.S., 2012, BIOTECHNIQUES, V53, P99
   Huang YP, 1997, FEBS LETT, V400, P94, DOI 10.1016/S0014-5793(96)01361-0
   JACOBSEN H, 1974, EUR J BIOCHEM, V45, P623, DOI 10.1111/j.1432-1033.1974.tb03588.x
   JOYCE CM, 1989, J BIOL CHEM, V264, P10858
   Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848
   KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057
   MCCLURE WR, 1975, J BIOL CHEM, V250, P4073
   MIZRAHI V, 1986, P NATL ACAD SCI USA, V83, P5769, DOI 10.1073/pnas.83.16.5769
   Mo JY, 1996, J BIOL CHEM, V271, P18947
   MORGAN AR, 1979, NUCLEIC ACIDS RES, V7, P571, DOI 10.1093/nar/7.3.571
   OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0
   POLESKY AH, 1990, J BIOL CHEM, V265, P14579
   Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206
   STUDWELL PS, 1990, J BIOL CHEM, V265, P1171
   Wang HY, 2013, ACS NANO, V7, P3876, DOI 10.1021/nn401180j
NR 35
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 1
PY 2015
VL 575
BP 46
EP 53
DI 10.1016/j.abb.2015.04.003
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CI8OI
UT WOS:000355031200006
PM 25906742
ER

PT J
AU Makino, J
   Nii, M
   Kamiya, T
   Hara, H
   Adachi, T
AF Makino, Junya
   Nii, Miyuki
   Kamiya, Tetsuro
   Hara, Hirokazu
   Adachi, Tetsuo
TI Oxidized low-density lipoprotein accelerates the destabilization of
   extracellular-superoxide dismutase mRNA during foam cell formation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Extracellular-superoxide dismutase; Oxidized low-density lipoprotein; 3
   '-Untranslated region; mRNA; Destabilization
ID SMOOTH-MUSCLE-CELLS; EC-SOD; OXIDATIVE STRESS; COBALT CHLORIDE; LDL
   OXIDATION; U937 CELLS; EXPRESSION; DISEASE; ATHEROSCLEROSIS; SP1
AB Extracellular-superoxide dismutase (EC-SOD) is one of the main anti-oxidative enzymes that protect cells against the damaging effects of superoxide. In the present study, we investigated the regulation of EC-SOD expression during the oxidized low density lipoprotein (oxLDL)-induced foam cell formation of THP-1-derived macrophages. The uptake of oxLDL into THP-1-derived macrophages was increased and EC-SOD expression was decreased in a time-dependent manner by oxLDL. Furthermore, EC-SOD suppression by oxLDL was mediated by the binding to scavenger receptors, especially CD36, from the results with siRNA experience. EC-SOD expression is known to be regulated by histone acetylation and binding of the transcription factor Sp1/3 to the EC-SOD promoter region in human cell lines. However, oxLDL did not affect these processes. On the other hand, the stability of EC-SOD mRNA was decreased by oxLDL. Moreover, oxLDL promoted destabilization of ectopically expressed mRNA from EC-SOD or chimeric Cu,Zn-SOD gene with the sequence corresponding to 3'UTR of EC-SOD mRNA, whereas oxLDL had no effect on ectopic mRNA produced from EC-SOD gene lacking the sequence. These results suggested that oxLDL decreased the expression of EC-SOD, which, in turn, accelerated the destabilization of EC-SOD mRNA, leading to weaker protection against oxidative stress and atherosclerosis. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Makino, Junya; Nii, Miyuki; Kamiya, Tetsuro; Hara, Hirokazu; Adachi, Tetsuo] Gifu Pharmaceut Univ, Dept Biomed Pharmaceut, Lab Clin Pharmaceut, Gifu 5011196, Japan.
RP Kamiya, T (reprint author), Gifu Pharmaceut Univ, Dept Biomed Pharmaceut, Lab Clin Pharmaceut, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.
EM tekamiya@gifu-pu.ac.jp
FU Japan Society for the Promotion for Science [26460070]; Gifu
   Pharmaceutical University
FX This study was supported in part by a Grant-in-Aid for Scientific
   Research from the Japan Society for the Promotion for Science (T.K.: No.
   26460070) and a grant for the encouragement of young scientists from
   Gifu Pharmaceutical University (T.K.).
CR ADACHI T, 1989, J BIOL CHEM, V264, P8537
   Adachi T, 2006, BIOL PHARM BULL, V29, P2095, DOI 10.1248/bpb.29.2095
   EMILI A, 1994, MOL CELL BIOL, V14, P1582
   Watanabe K, 2013, ATHEROSCLEROSIS, V227, P51, DOI 10.1016/j.atherosclerosis.2012.12.020
   Li QH, 2001, CIRCULATION, V103, P1893
   Wright E, 2006, INT J CLIN PRACT, V60, P308, DOI 10.1111/j.1368-5031.2006.00825.x
   Lappalainen J, 2011, ATHEROSCLEROSIS, V214, P357, DOI 10.1016/j.atherosclerosis.2010.11.024
   Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691
   Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005
   Laukkanen MO, 2000, GENE, V254, P173, DOI 10.1016/S0378-1119(00)00272-9
   MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634
   Kamiya T, 2008, FREE RADICAL RES, V42, P949, DOI 10.1080/10715760802566566
   Kiyan Y, 2014, J MOL CELL CARDIOL, V66, P72, DOI 10.1016/j.yjmcc.2013.11.005
   Makino J, 2012, FREE RADICAL RES, V46, P637, DOI 10.3109/10715762.2012.664841
   Kamiya T, 2010, REDOX REP, V15, P131, DOI 10.1179/174329210X12650506623483
   Zelko IN, 2004, FREE RADICAL BIO MED, V37, P1256, DOI 10.1016/j.freeradbiomed.2004.06.022
   Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033
   Kamiya T, 2011, J CELL BIOCHEM, V112, P244, DOI 10.1002/jcb.22917
   Chavez-Sanchez L, 2014, HUM IMMUNOL, V75, P322, DOI 10.1016/j.humimm.2014.01.012
   CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954
   Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067
   Hagmeister U, 2012, J DERMATOL SCI, V67, P44, DOI 10.1016/j.jdermsci.2012.03.001
   Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
   Heistad DD, 2006, ARTERIOSCL THROM VAS, V26, P689, DOI 10.1161/01.ATV.0000203525.62147.28
   Itabe H, 2000, BBA-MOL CELL BIOL L, V1487, P233, DOI 10.1016/S1388-1981(00)00098-6
   Jerome WG, 2008, MICROSC MICROANAL, V14, P138, DOI 10.1017/S1431927608080069
   Kamiya T, 2013, FREE RADICAL BIO MED, V61, P197, DOI 10.1016/j.freeradbiomed.2013.04.013
   Laurila JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005786
   Lu Z, 2008, HYPERTENSION, V51, P19, DOI 10.1161/HYPERTENSIONAHA.107.098186
   Michael D. T., 2013, BIOMACROMOLECULES, V14, P2499
   Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/01.mol.0000092631.86399.49
   Mukai E, 2004, ATHEROSCLEROSIS, V176, P289, DOI 10.1016/j.athersclerosis.2004.03.028
   Ookawara T, 1998, AM J PHYSIOL-CELL PH, V275, pC840
   Osawa M, 2012, RNA, V18, P1957, DOI 10.1261/rna.035311.112
   Rios FJO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076893
   Ross R, 1999, NEW ENGL J MED, V340, P115
   Takatsu H, 2001, BIOCHEM BIOPH RES CO, V285, P84, DOI 10.1006/bbrc.2001.5114
   VACHIER I, 1994, EUR RESPIR J, V7, P1585, DOI 10.1183/09031936.94.07091585
   Wang JH, 2013, CELL PHYSIOL BIOCHEM, V32, P121, DOI 10.1159/000350130
   Yamamoto M, 2002, ATHEROSCLEROSIS, V163, P223, DOI 10.1016/S0021-9150(02)00007-2
   Zelko IN, 2008, AM J RESP CELL MOL, V39, P243, DOI 10.1165/rcmb.2007-0378OC
   Zelko IN, 2003, BIOCHEM J, V369, P375, DOI 10.1042/BJ20021431
NR 42
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 1
PY 2015
VL 575
BP 54
EP 60
DI 10.1016/j.abb.2015.04.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CI8OI
UT WOS:000355031200007
PM 25906743
ER

PT J
AU Ogawa, T
   Kimura, A
   Sakuyama, H
   Tamoi, M
   Ishikawa, T
   Shigeoka, S
AF Ogawa, Takahisa
   Kimura, Ayako
   Sakuyama, Harumi
   Tamoi, Masahiro
   Ishikawa, Takahiro
   Shigeoka, Shigeru
TI Characterization and physiological role of two types of chloroplastic
   fructose-1,6-bisphosphatases in Euglena gracilis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Fructose-1,6-bisphosphatase; Photosynthesis; Euglena gracilis
ID HYDROGEN-PEROXIDE; MOLECULAR CHARACTERIZATION; RESISTANCE; ENZYME;
   ACTIVATION; BINDING; OVEREXPRESSION; PHOTOSYNTHESIS; THIOREDOXIN;
   SEQUENCES
AB The chloroplastic fructose-1,6-bisphosphatase (FBPase) is a late-limiting enzyme in the Calvin cycle. In the present study, we isolated and characterized the cDNAs encoding two types of chloroplastic FBPase isoforms (EgFBPaseI and II) from Euglena gracilis. The K-m values of recombinant EgFBPaseI and EgFBPaseII for fructose 1,6-bisphosphate (Fru 1,6-P-2) were 165 +/- 17 and 2200 +/- 200 mu M, respectively. The activity of EgFBPaseI was inhibited by 1 mM H2O2 and recovered when incubated with DTT. The activity of EgFBPaseII was resistant to concentrations of H2O2 up to 1 mM, which was distinct from those of EgFBPaseI and spinach chloroplastic FBPase. The suppression of EgFBPaseI gene expression by gene silencing markedly decreased photosynthetic activity and inhibited cell growth. The results of the present study clearly demonstrated that EgFBPaseI played a critical role in photosynthesis in Euglena chloroplasts. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ogawa, Takahisa; Kimura, Ayako; Sakuyama, Harumi; Tamoi, Masahiro; Shigeoka, Shigeru] Kinki Univ, Fac Agr, Dept Adv Biosci, Nara 6318505, Japan.
   [Ogawa, Takahisa; Kimura, Ayako; Sakuyama, Harumi; Tamoi, Masahiro; Ishikawa, Takahiro; Shigeoka, Shigeru] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan.
   [Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan.
RP Tamoi, M (reprint author), Kinki Univ, Fac Agr, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.
EM tamoi@nara.kindai.ac.jp
CR TESSIER LH, 1991, EMBO J, V10, P2621
   KAISER WM, 1979, PLANTA, V145, P377, DOI 10.1007/BF00388364
   TAKEDA T, 1995, PLANT CELL PHYSIOL, V36, P1089
   Tamoi M, 1996, ARCH BIOCHEM BIOPHYS, V334, P27, DOI 10.1006/abbi.1996.0425
   INUI H, 1982, FEBS LETT, V150, P89, DOI 10.1016/0014-5793(82)81310-0
   Serrato AJ, 2009, PLANT CELL ENVIRON, V32, P811, DOI 10.1111/j.1365-3040.2009.01960.x
   INUI H, 1984, EUR J BIOCHEM, V142, P121, DOI 10.1111/j.1432-1033.1984.tb08258.x
   Durnford DG, 2006, EUKARYOT CELL, V5, P2079, DOI 10.1128/EC.00222-06
   Ishikawa T, 2010, BIOCHEM J, V426, P125, DOI 10.1042/BJ20091406
   CRAMER M, 1952, ARCH MIKROBIOL, V17, P384, DOI 10.1007/BF00410835
   Miyagawa Y, 2001, NAT BIOTECHNOL, V19, P965, DOI 10.1038/nbt1001-965
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Tamoi M, 1998, BBA-PROTEIN STRUCT M, V1383, P232, DOI 10.1016/S0167-4838(97)00208-2
   CHARDOT T, 1991, BIOCHEM J, V278, P787
   Chueca A, 2002, PHOTOSYNTH RES, V74, P235, DOI 10.1023/A:1021243110495
   CSEKE C, 1984, TRENDS BIOCHEM SCI, V9, P533, DOI 10.1016/0968-0004(84)90284-6
   Hermoso R, 1996, PLANT MOL BIOL, V30, P455, DOI 10.1007/BF00049324
   HUPPE HC, 1989, Z NATURFORSCH C, V44, P487
   Kitaoka S., 1989, BIOL EUGLENA, VIV, P2
   PLA A, 1981, BIOCHIM BIOPHYS ACTA, V636, P113, DOI 10.1016/0005-2728(81)90082-7
   Reichert A, 2003, BBA-PROTEINS PROTEOM, V1645, P212, DOI 10.1016/S1570-9639(02)00539-3
   Smillie R.M., 1968, BIOL EUGLENA, VII, P2
   Tamoi M, 1996, BIOCHEM J, V316, P685
   Tang GL, 2000, PROTEIN EXPRES PURIF, V19, P411, DOI 10.1006/prep.2000.1267
   Wangensteen OS, 2001, BBA-PROTEIN STRUCT M, V1547, P156, DOI 10.1016/S0167-4838(01)00178-9
NR 25
TC 1
Z9 1
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 1
PY 2015
VL 575
BP 61
EP 68
DI 10.1016/j.abb.2015.04.002
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CI8OI
UT WOS:000355031200008
PM 25906744
ER

PT J
AU Oh, S
   Ju, JH
   Yang, W
   Lee, KM
   Nam, K
   Shin, I
AF Oh, Sunhwa
   Ju, Ji-hyun
   Yang, Wonseok
   Lee, Kyung-min
   Nam, KeeSoo
   Shin, Incheol
TI EGFR negates the proliferative effect of oncogenic HER2 in MDA-MB-231
   cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE EGFR; HER2; Triple negative breast cancer; Breast cancer cell
ID BREAST EPITHELIAL-CELLS; ERBB SIGNALING NETWORK; CANCER PROGRESSION;
   PHOSPHATASE; RECEPTORS; HETERODIMERIZATION; OVEREXPRESSION; INHIBITION;
   ACTIVATION; CARCINOMA
AB Members of the EGFR family are potent mediators of normal cell growth and development. HER2 possesses an active tyrosine kinase domain, but no direct ligand has been identified. To investigate the differential effect of HER2 in breast cell lines, HER2 was overexpressed in MCF-10A, MCF7 and MDA-MB-231 cells. HER2 overexpression promoted proliferation, survival and migration in MCF-10A and MCF-7 cells. No significant differences were seen in proliferation, survival or migration between MDA-MB-231 vec and HER2 cells. The activity of downstream HER2 proteins increased in MCF-10A HER2 and MCF-7 HER2 cells but not in MDA-MB-231 HER2 cells. Exogenously expressed HER2 failed to associate with EGFR or HER3 in MDA-MB-231 cells, while overexpression of HER2 enhanced HER family dimerization in MCF-10A and MCF-7 cells. (C) 2015 Published by Elsevier Inc.
C1 [Oh, Sunhwa; Ju, Ji-hyun; Yang, Wonseok; Lee, Kyung-min; Nam, KeeSoo; Shin, Incheol] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea.
   [Shin, Incheol] Hanyang Univ, Inst Nat Sci, Seoul 133791, South Korea.
RP Shin, I (reprint author), Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea.
EM incheol@hanyang.ac.kr
FU National Research Foundation of Korea (NRF) Grant from the Korea
   Research Foundation [2013-059143]; Converging Research Center Program -
   Ministry of Education, Science and Technology [2011-K000897]
FX This work was supported by an National Research Foundation of Korea
   (NRF) Grant (2013-059143) from the Korea Research Foundation and by the
   Converging Research Center Program funded by the Ministry of Education,
   Science and Technology (2011-K000897).
CR Lee CH, 1999, IUBMB LIFE, V48, P585, DOI 10.1080/152165499306450
   Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54
   Lonne GK, 2009, J BIOL CHEM, V284, P33456, DOI 10.1074/jbc.M109.036186
   Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200
   Arias-Romero LE, 2009, CANCER RES, V69, P4582, DOI 10.1158/0008-5472.CAN-08-4001
   Mersin H, 2008, BREAST, V17, P341, DOI 10.1016/j.breast.2007.11.031
   Yuan TC, 2010, J BIOL CHEM, V285, P14861, DOI 10.1074/jbc.M109.099879
   Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839
   GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647
   Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759
   Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208
   Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159
   Gensler M, 2004, J BIOL CHEM, V279, P12110, DOI 10.1074/jbc.M309527200
   Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609
   Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X
   Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003
   Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073
   Menard S, 2000, J CELL PHYSIOL, V182, P150, DOI 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E
   Ross JS, 1998, STEM CELLS, V16, P413
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   DAVIES RL, 1980, P NATL ACAD SCI-BIOL, V77, P4188, DOI 10.1073/pnas.77.7.4188
   Shin I, 2006, IUBMB LIFE, V58, P664, DOI 10.1080/15216540601001681
   Tan AR, 2008, CANCER J, V14, P343, DOI 10.1097/PPO.0b013e31818d839b
   Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361
   Yang W, 2011, CELL SIGNAL, V23, P19, DOI 10.1016/j.cellsig.2010.07.016
   Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922
NR 26
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 1
PY 2015
VL 575
BP 69
EP 76
DI 10.1016/j.abb.2015.04.008
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CI8OI
UT WOS:000355031200009
PM 25935365
ER

PT J
AU Obinger, C
AF Obinger, Christian
TI A protein fold with multiple functions: Chlorite dismutase, HemQ and
   DyP-type peroxidase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
ID PURIFICATION; EVOLUTION
C1 Univ Nat Resources & Life Sci, Vienna Inst BioTechnol BOKU, Dept Chem, Div Biochem, A-1190 Vienna, Austria.
RP Obinger, C (reprint author), Univ Nat Resources & Life Sci, Vienna Inst BioTechnol BOKU, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria.
EM christian.obinger@boku.ac.at
CR Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029
   Mendes S, 2015, ARCH BIOCHEM BIOPHYS, V574, P99, DOI 10.1016/j.abb.2015.03.009
   Rahmanpour R, 2015, ARCH BIOCHEM BIOPHYS, V574, P93, DOI 10.1016/j.abb.2014.12.022
   Linde D, 2015, ARCH BIOCHEM BIOPHYS, V574, P66, DOI 10.1016/j.abb.2015.01.018
   Singh R, 2015, ARCH BIOCHEM BIOPHYS, V574, P56, DOI 10.1016/j.abb.2015.01.014
   Zamocky M, 2010, ARCH BIOCHEM BIOPHYS, V500, P45, DOI 10.1016/j.abb.2010.03.024
   Strittmatter E, 2015, ARCH BIOCHEM BIOPHYS, V574, P75, DOI 10.1016/j.abb.2014.12.016
   Yoshida T, 2015, ARCH BIOCHEM BIOPHYS, V574, P49, DOI 10.1016/j.abb.2015.01.022
   Obinger C, 2006, ARCH BIOCHEM BIOPHYS, V445, P197, DOI 10.1016/j.abb.2005.10.015
   Zamocky M, 2012, ARCH BIOCHEM BIOPHYS, V525, P131, DOI 10.1016/j.abb.2012.01.017
   Buttner E, 2015, ARCH BIOCHEM BIOPHYS, V574, P86, DOI 10.1016/j.abb.2015.03.003
   Celis AI, 2015, ARCH BIOCHEM BIOPHYS, V574, P3, DOI 10.1016/j.abb.2015.03.004
   Dailey HA, 2015, ARCH BIOCHEM BIOPHYS, V574, P27, DOI 10.1016/j.abb.2015.02.017
   Hofbauer S, 2015, ARCH BIOCHEM BIOPHYS, V574, P36, DOI 10.1016/j.abb.2015.01.010
   Obinger C, 2010, ARCH BIOCHEM BIOPHYS, V500, P1, DOI 10.1016/j.abb.2010.06.022
   Obinger C, 2012, ARCH BIOCHEM BIOPHYS, V525, P93, DOI 10.1016/j.abb.2012.07.005
   Schaffner I, 2015, ARCH BIOCHEM BIOPHYS, V574, P18, DOI 10.1016/j.abb.2015.02.031
   vanGlinkel CG, 1996, ARCH MICROBIOL, V166, P321, DOI 10.1007/s002030050390
   Zamocky M., 2008, PROTEINS, V71, P589
   Zamocky M, 2015, ARCH BIOCHEM BIOPHYS, V574, P108, DOI 10.1016/j.abb.2014.12.025
NR 20
TC 0
Z9 0
U1 9
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 1
EP 2
DI 10.1016/j.abb.2015.03.023
PG 2
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500001
PM 25841895
ER

PT J
AU Celis, AI
   DuBois, JL
AF Celis, Arianna I.
   DuBois, Jennifer L.
TI Substrate, product, and cofactor: The extraordinarily flexible
   relationship between the CDE superfamily and heme
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Heme; Chlorite dismutase; Heme biosynthesis; Aldoxime dehydratase; EfeB;
   IsdG; Heme oxygenase
ID DYE-DECOLORIZING PEROXIDASE; CANDIDUM DEC 1; STAPHYLOCOCCUS-AUREUS ISDG;
   RHODOCOCCUS-JOSTII RHA1; NITROGEN TRIPLE-BOND; CHLORITE DISMUTASE;
   CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; ALDOXIME DEHYDRATASE;
   CATALYTIC MECHANISM
AB PFam Clan 0032, also known as the CDE superfamily, is a diverse group of at least 20 protein families sharing a common alpha,beta-barrel domain. Of these, six different groups bind heme inside the barrel's interior, using it alternately as a cofactor, substrate, or product. Focusing on these six, an integrated picture of structure, sequence, taxonomy, and mechanism is presented here, detailing how a single structural motif might be able to mediate such an array of functions with one of nature's most important small molecules. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Celis, Arianna I.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.
RP DuBois, JL (reprint author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.
EM jdubois@chemistry.montana.edu
FU National Institutes of Health [U54GM093342-05, R01GM090260, GM110732]
FX Professor John Gent (University of Illinois Department of Biochemistry)
   and the Enzyme Function Initiative team (funded by National Institutes
   of Health Grant U54GM093342-05) are gratefully acknowledged for
   providing training in the generation and manipulation of sequence
   similarity networks, for access to tools now publically available at the
   Enzyme Function Initiative website (enzymefunction.org), and for their
   generous assistance with the large sequence set required for generating
   Fig. 1. We thank the National Institutes of Health for funding
   (R01GM090260 and GM110732) and Garrett Moraski for helpful
   conversations.
CR Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x
   Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200
   Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029
   Yoshida T, 2012, FEBS LETT, V586, P4351, DOI 10.1016/j.febslet.2012.10.049
   Sawai H, 2009, J BIOL CHEM, V284, P32089, DOI 10.1074/jbc.M109.018762
   Liu Y, 1997, J BIOL CHEM, V272, P6909
   Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673
   Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176
   Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171
   Rao B, 2010, ENVIRON SCI TECHNOL, V44, P2961, DOI 10.1021/es903065f
   Bali S, 2011, P NATL ACAD SCI USA, V108, P18260, DOI 10.1073/pnas.1108228108
   Sugano Y, 2000, APPL ENVIRON MICROB, V66, P1754, DOI 10.1128/AEM.66.4.1754-1758.2000
   Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675
   Streit BR, 2010, J AM CHEM SOC, V132, P5711, DOI 10.1021/ja9082182
   ERMAN JE, 1993, BIOCHEMISTRY-US, V32, P9798, DOI 10.1021/bi00088a035
   Coates JD, 2004, NAT REV MICROBIOL, V2, P569, DOI 10.1038/nrmicro926
   Rao B, 2010, ENVIRON SCI TECHNOL, V44, P8429, DOI 10.1021/es1024228
   Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399
   Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047
   Sugano Y, 1999, J BIOSCI BIOENG, V87, P411, DOI 10.1016/S1389-1723(99)80087-5
   Wilks A, 2014, ARCH BIOCHEM BIOPHYS, V544, P87, DOI 10.1016/j.abb.2013.10.013
   Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z
   Sugano Y, 2006, APPL MICROBIOL BIOT, V73, P862, DOI 10.1007/s00253-006-0545-9
   STEWART V, 1988, MICROBIOL REV, V52, P190
   Graves AB, 2014, INORG CHEM, V53, P5931, DOI 10.1021/ic500033b
   Maixner F, 2008, ENVIRON MICROBIOL, V10, P3043, DOI 10.1111/j.1462-2920.2008.01646.x
   Bender KS, 2004, APPL ENVIRON MICROB, V70, P5651, DOI 10.1128/AEM.70.9.5651-5658.2004
   Miethke M, 2013, BBA-MOL CELL RES, V1833, P2267, DOI 10.1016/j.bbamcr.2013.05.027
   TERAOKA J, 1981, J BIOL CHEM, V256, P3969
   Goblirsch BR, 2010, J BIOL INORG CHEM, V15, P879, DOI 10.1007/s00775-010-0651-0
   Mlynek G, 2011, J BACTERIOL, V193, P2408, DOI 10.1128/JB.01262-10
   Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017
   Pinakoulaki E, 2011, J PHYS CHEM B, V115, P13012, DOI 10.1021/jp205944e
   Blanc B, 2012, BIOCHEMISTRY-US, V51, P1895, DOI 10.1021/bi2017377
   Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0
   Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780
   Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h
   de Geus DC, 2009, J MOL BIOL, V387, P192, DOI 10.1016/j.jmb.2009.01.036
   Ruiz-Duenas FJ, 2013, MYCOLOGIA, V105, P1428, DOI 10.3852/13-059
   Singh R, 2013, ACS CHEM BIOL, V8, P700, DOI 10.1021/cb300608x
   Kostan J, 2010, J STRUCT BIOL, V172, P331, DOI 10.1016/j.jsb.2010.06.014
   Coates JD, 1999, APPL ENVIRON MICROB, V65, P5234
   Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550
   Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018
   Yoshida T, 2011, FEBS J, V278, P2387, DOI 10.1111/j.1742-4658.2011.08161.x
   Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345
   Bamford V.A., EFEB PEROXIDAS UNPUB
   Blanc B, 2013, DALTON T, V42, P3156, DOI 10.1039/c2dt32312e
   Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x
   Celis AI, 2015, BIOCHEMISTRY-US, V54, P434, DOI 10.1021/bi501184c
   Chang C., CRYSTAL STRUCT UNPUB
   Chim N, 2010, J MOL BIOL, V395, P595, DOI 10.1016/j.jmb.2009.11.025
   Clark IC, 2013, MBIO, V4, DOI 10.1128/mBio.00379-13
   Dailey H. A., 2011, MBIO, V2
   Dailey HA, 2015, P NATL ACAD SCI USA, V112, P2210, DOI 10.1073/pnas.1416285112
   Dailey TA, 2010, J BIOL CHEM, V285, P25978, DOI 10.1074/jbc.M110.142604
   Danielsson H, 2003, APPL ENVIRON MICROB, V69, P5585, DOI 10.1128/AEM.69.9.5585-5592.2003
   de Montellano PR Ortiz, 1998, ACCOUNTS CHEM RES, V31, P543
   De Montellano PRO, 2001, ADV INORG CHEM, V51, P359
   Dunford H. B., 1999, HEME PEROXIDASES
   Ebihara Akio, 2005, Journal of Structural and Functional Genomics, V6, P21, DOI 10.1007/s10969-005-1103-x
   FARBER GK, 1990, TRENDS BIOCHEM SCI, V15, P228, DOI 10.1016/0968-0004(90)90035-A
   Ferraroni M, 2013, J STRUCT BIOL, V182, P44, DOI 10.1016/j.jsb.2013.01.006
   Fox NK, 2014, NUCLEIC ACIDS RES, V42, pD304, DOI 10.1093/nar/gkt1240
   Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209
   Gilski M., CRYSTAL STRUCT UNPUB
   Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b
   Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851
   Hofbauer S, 2012, BBA-PROTEINS PROTEOM, V1824, P1031, DOI 10.1016/j.bbapap.2012.05.012
   Hofbauer S, 2014, BIOCHEMISTRY-US, V53, P77, DOI 10.1021/bi401042z
   Hofbauer S, 2015, ARCH BIOCHEM BIOPHYS, V574, P36, DOI 10.1016/j.abb.2015.01.010
   KATTI SK, 1989, J MOL BIOL, V205, P557, DOI 10.1016/0022-2836(89)90226-X
   Kuhner M., 2014, ARCHAEA
   Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200
   Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106
   Linde D, 2015, BIOCHEM J, V466, P253, DOI 10.1042/BJ20141211
   Lukk T., DYP TYPE PEROX UNPUB
   Marion GM, 2010, ICARUS, V207, P675, DOI 10.1016/j.icarus.2009.12.003
   Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p
   Matsui T, 2010, INORG CHEM, V49, P3602, DOI 10.1021/ic901869t
   Mayfield JA, 2013, BIOCHEMISTRY-US, V52, P6982, DOI 10.1021/bi4005599
   Mayfield JA, 2013, J BIOL CHEM, V288, P23488, DOI 10.1074/jbc.M112.442335
   Nomura J, 2013, P NATL ACAD SCI USA, V110, P2810, DOI 10.1073/pnas.1200338110
   Ocarra P., 1970, BIOCHEM J, V119, p42P
   OCARRA P, 1969, BIOCHEM J, V115, pP13
   POULOS TL, 1994, MET IONS BIOL SYST, V30, P25
   Rahmanpour R., 2015, ARCH BIOCH BIOPHYS
   Rajasekaran MB, 2010, BIOMETALS, V23, P1, DOI 10.1007/s10534-009-9262-z
   Reniere ML, 2011, BIOCHEMISTRY-US, V50, P6730, DOI 10.1021/bi200999q
   Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x
   Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031
   Sigman JA, 2001, J AM CHEM SOC, V123, P6945, DOI 10.1021/ja015776u
   Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200
   Streit BR, 2008, BIOCHEMISTRY-US, V47, P5271, DOI 10.1021/bi800163x
   Strittmatter E., 2014, ARCH BIOCHEM BIOPHYS, VS0003-9861, P00432
   Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200
   Sugano Y., DYE DECOLOR IN PRESS
   Tan K., CRYSTAL STRUCT UNPUB
   Turlin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056529
   Ukpabi G, 2012, J BIOL CHEM, V287, P34179, DOI 10.1074/jbc.M112.393249
   Veith A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00037
   Wu R., 2010, MOL MICROBIOL, V75, P1529
   Wyckoff EE, 2006, J BACTERIOL, V188, P6515, DOI 10.1128/JB.00626-06
NR 103
TC 2
Z9 2
U1 10
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 3
EP 17
DI 10.1016/j.abb.2015.03.004
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500002
PM 25778630
ER

PT J
AU Schaffner, I
   Hofbauer, S
   Krutzler, M
   Pirker, KF
   Furtmuller, PG
   Obinger, C
AF Schaffner, Irene
   Hofbauer, Stefan
   Krutzler, Michael
   Pirker, Katharina F.
   Furtmueller, Paul G.
   Obinger, Christian
TI Mechanism of chlorite degradation to chloride and dioxygen by the enzyme
   chlorite dismutase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Chlorite dismutase; Heme enzyme; Chlorite; Chloride; O-O bond formation;
   Hypochlorous acid
ID CANDIDATUS-NITROSPIRA-DEFLUVII; HORSERADISH-PEROXIDASE;
   MOLECULAR-OXYGEN; HEME; REACTIVITY; CHLOROPEROXIDASE; CHLORINATION;
   PURIFICATION; REDUCTION; RESIDUES
AB Heme b containing chlorite dismutase (Cld) catalyses the conversion of chlorite to chloride and dioxygen which includes an unusual O-O bond formation. This review summarizes our knowledge about the interaction of chlorite with heme enzymes and introduces the biological role, phylogeny and structure of functional chlorite dismutases with differences in overall structure and subunit architecture. The paper sums up the available experimental and computational studies on chlorite degradation by water soluble porphyrin complexes as well as a model based on the active site of Cld. Finally, it reports the available biochemical and biophysical data of Clds from different organisms which allow the presentation of a general reaction mechanism. It includes binding of chlorite to ferric Cld followed by subsequent heterolytic O-Cl bond cleavage leading to the formation of Compound I and hypochlorite, which finally recombine for production of chloride and O-2. The role of the Cld-typical distal arginine in catalysis is discussed together with the pH dependence of the reaction and the role of transiently produced hypochlorite in irreversible inactivation of the enzyme. (C) 2015 The Authors. Published by Elsevier Inc.
C1 [Schaffner, Irene; Hofbauer, Stefan; Krutzler, Michael; Pirker, Katharina F.; Furtmueller, Paul G.; Obinger, Christian] Univ Nat Resources & Life Sci, BOKU, Div Biochem, Dept Chem, A-1190 Vienna, Austria.
   [Hofbauer, Stefan] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, A-1030 Vienna, Austria.
RP Obinger, C (reprint author), Univ Nat Resources & Life Sci, BOKU, Div Biochem, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria.
EM christian.obinger@boku.ac.at
RI Hofbauer, Stefan/I-3889-2014; 
OI Hofbauer, Stefan/0000-0003-3375-7715
FU Austrian Science Foundation, FWF [W1224, P25270-B22]
FX This project was supported by the Austrian Science Foundation, FWF
   [Doctoral program BioToP - Molecular Technology of Proteins (W1224) and
   the FWF-project P25270-B22].
CR Rikken GB, 1996, APPL MICROBIOL BIOT, V45, P420
   Hagedoorn PL, 2002, EUR J BIOCHEM, V269, P4905, DOI 10.1046/j.1432-1033.2002.03208.x
   Jakopitsch C, 2014, J INORG BIOCHEM, V135, P10, DOI 10.1016/j.jinorgbio.2014.02.010
   Stenklo K, 2001, J BIOL INORG CHEM, V6, P601, DOI 10.1007/s007750100237
   Bardiya N, 2011, MICROBIOL RES, V166, P237, DOI 10.1016/j.micres.2010.11.005
   FRENCH CL, 1995, J APPL TOXICOL, V15, P167, DOI 10.1002/jat.2550150306
   Streit BR, 2010, J AM CHEM SOC, V132, P5711, DOI 10.1021/ja9082182
   Coates JD, 2004, NAT REV MICROBIOL, V2, P569, DOI 10.1038/nrmicro926
   Mehboob F, 2009, FEMS MICROBIOL LETT, V293, P115, DOI 10.1111/j.1574-6968.2009.01517.x
   Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047
   HRYCAY EG, 1975, FEBS LETT, V56, P161, DOI 10.1016/0014-5793(75)80132-3
   Jakopitsch C, 2008, J INORG BIOCHEM, V102, P293, DOI 10.1016/j.jinorgbio.2007.09.002
   Maixner F, 2008, ENVIRON MICROBIOL, V10, P3043, DOI 10.1111/j.1462-2920.2008.01646.x
   Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950
   Goblirsch BR, 2010, J BIOL INORG CHEM, V15, P879, DOI 10.1007/s00775-010-0651-0
   Mlynek G, 2011, J BACTERIOL, V193, P2408, DOI 10.1128/JB.01262-10
   Hofbauer S, 2012, BIOCHEMISTRY-US, V51, P9501, DOI 10.1021/bi3013033
   Blanc B, 2012, BIOCHEMISTRY-US, V51, P1895, DOI 10.1021/bi2017377
   de Geus DC, 2009, J MOL BIOL, V387, P192, DOI 10.1016/j.jmb.2009.01.036
   Hofbauer S, 2014, BIOTECHNOL J, V9, P461, DOI 10.1002/biot.201300210
   Kostan J, 2010, J STRUCT BIOL, V172, P331, DOI 10.1016/j.jsb.2010.06.014
   Lee AQ, 2008, P NATL ACAD SCI USA, V105, P15654, DOI 10.1073/pnas.0804279105
   Hofbauer S, 2014, BIOCHEMISTRY-US, V53, P3145, DOI 10.1021/bi500401k
   Blanc B, 2013, DALTON T, V42, P3156, DOI 10.1039/c2dt32312e
   Celis A.I., 2015, BIOCHEMISTR IN PRESS
   Dailey H., 2015, ARCH BIOCH BIO UNPUB
   Ebihara Akio, 2005, Journal of Structural and Functional Genomics, V6, P21, DOI 10.1007/s10969-005-1103-x
   Eriksen G.E., 1983, AM SCI, V71, P366
   Ettwig K.F., 2010, NATURE, V264, P543
   GEORGE P, 1953, J BIOL CHEM, V201, P413
   HEWSON WD, 1979, J BIOL CHEM, V254, P3175
   HEWSON WD, 1979, J BIOL CHEM, V254, P3182
   Hofbauer S, 2012, BBA-PROTEINS PROTEOM, V1824, P1031, DOI 10.1016/j.bbapap.2012.05.012
   Hofbauer S, 2014, BIOCHEMISTRY-US, V53, P77, DOI 10.1021/bi401042z
   Hofbauer S, 2015, ARCH BIOCHEM BIOPHYS, V574, P36, DOI 10.1016/j.abb.2015.01.010
   HOLLENBE.PF, 1974, J BIOL CHEM, V249, P5816
   Keith JM, 2011, INORG CHEM, V50, P7928, DOI 10.1021/ic2009732
   Mayfield JA, 2013, BIOCHEMISTRY-US, V52, P6982, DOI 10.1021/bi4005599
   Mayfield JA, 2013, J BIOL CHEM, V288, P23488, DOI 10.1074/jbc.M112.442335
   Schaffner I., 2015, J MOL MICRO IN PRESS
   SHAHANGIAN S, 1981, J BIOL CHEM, V256, P6034
   SHAHANGIAN S, 1982, J BIOL CHEM, V257, P1529
   Singh R., 2015, ARCH BIOCH IN PRESS
   Streit BR, 2008, BIOCHEMISTRY-US, V47, P5271, DOI 10.1021/bi800163x
   Sun S, 2014, DALTON T, V43, P973, DOI 10.1039/c3dt52171k
   Sundermann A, 2014, BIOCHEMISTRY-US, V53, P4869, DOI 10.1021/bi500467h
   Ueno H, 2000, ARCH ENVIRON CON TOX, V38, P1
   vanGlinkel CG, 1996, ARCH MICROBIOL, V166, P321, DOI 10.1007/s002030050390
   Yoshida T., 2015, ARCH BIOCH IN PRESS
   Zamocky M., 2015, ARCH BIOCHEM BIOPHYS, V574, P108
   Zdilla M.J., 2008, ANGEW CHEM, V47, P7700
NR 51
TC 1
Z9 1
U1 14
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 18
EP 26
DI 10.1016/j.abb.2015.02.031
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500003
PM 25748001
ER

PT J
AU Dailey, HA
   Gerdes, S
AF Dailey, Harry A.
   Gerdes, Svetlana
TI HemQ: An iron-coproporphyrin oxidative decarboxylase for protoheme
   synthesis in Firmicutes and Actinobacteria
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE HemQ; Heme synthesis; Coproheme decarboxylase; Chlorite dismutase-like
   protein
ID PROTOPORPHYRINOGEN OXIDASE ACTIVITY; CHLORITE DISMUTASE;
   RHODOPSEUDOMONAS-SPHEROIDES; HUMAN FERROCHELATASE; CRYSTAL-STRUCTURE;
   UROPORPHYRINOGEN DECARBOXYLASE; PORPHOBILINOGEN DEAMINASE;
   5-AMINOLEVULINIC ACID; MYXOCOCCUS-XANTHUS; BACILLUS-SUBTILIS
AB Genes for chlorite dismutase-like proteins are found widely among heme-synthesizing bacteria and some Archaea. It is now known that among the Firmicutes and Actinobacteria these proteins do not possess chlorite dismutase activity but instead are essential for heme synthesis. These proteins, named HemQ are iron-coproporphyrin (coproheme) decarboxylases that catalyze the oxidative decarboxylation of coproheme III into protoheme IX. As purified, HemQs do not contain bound heme, but readily bind exogeneously supplied heme with low micromolar affinity. The heme-bound form of HemQ has low peroxidase activity and in the presence of peroxide the bound heme may be destroyed. Thus, it is possible that HemQ may serve a dual role as a decarboxylase in heme biosynthesis and a regulatory protein in heme homeostasis. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Dailey, Harry A.] Univ Georgia, Dept Microbiol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA.
   [Dailey, Harry A.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.
   [Gerdes, Svetlana] Argonne Natl Lab, Math & Comp Sci Div, Argonne, IL 60439 USA.
RP Dailey, HA (reprint author), Univ Georgia, Dept Microbiol, Biomed & Hlth Sci Inst, Athens, GA 30602 USA.
EM hdailey@uga.edu
FU NIH [DK096051]
FX During this work H.A.D. was supported by NIH grant DK096051. We
   acknowledge the contribution of T.A. Dailey in manuscript editing and
   preparation.
CR BATTERSBY AR, 1980, NATURE, V285, P17, DOI 10.1038/285017a0
   Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102
   Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658
   Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004
   Dailey HA, 1996, J BIOL CHEM, V271, P8714
   Bali S, 2011, P NATL ACAD SCI USA, V108, P18260, DOI 10.1073/pnas.1108228108
   Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598
   Mobius K, 2010, P NATL ACAD SCI USA, V107, P10436, DOI 10.1073/pnas.1000956107
   Panek H, 2002, MICROBIOL-SGM, V148, P2273
   Erskine PT, 1997, NAT STRUCT BIOL, V4, P1025, DOI 10.1038/nsb1297-1025
   Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240
   Buan NR, 2006, J BIOL CHEM, V281, P16971, DOI 10.1074/jbc.M603069200
   Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009
   Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405
   Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158
   Blanc B, 2012, BIOCHEMISTRY-US, V51, P1895, DOI 10.1021/bi2017377
   ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x
   Medlock AE, 2009, J MOL BIOL, V393, P308, DOI 10.1016/j.jmb.2009.08.042
   Phillips JD, 2003, EMBO J, V22, P6225, DOI 10.1093/emboj/cdg606
   Kostan J, 2010, J STRUCT BIOL, V172, P331, DOI 10.1016/j.jsb.2010.06.014
   Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792
   Bab-Dinitz E, 2006, BIOINFORMATICS, V22, P671, DOI 10.1093/bioinformatics/bti043
   Bali S, 2014, CELL MOL LIFE SCI, V71, P2837, DOI 10.1007/s00018-014-1563-x
   Boynton TO, 2011, APPL ENVIRON MICROB, V77, P4795, DOI 10.1128/AEM.00171-11
   Boynton TO, 2009, BIOCHEMISTRY-US, V48, P6705, DOI 10.1021/bi900850y
   Breckau D, 2003, J BIOL CHEM, V278, P46625, DOI 10.1074/jbc.M308553200
   Dailey H. A., 2003, PORPHYRIN HDB, V12, P93
   Dailey HA, 2007, BIOCHEMISTRY-US, V46, P7973, DOI 10.1021/bi700151f
   Dailey H.A., 2015, P NATL ACAD SCI US
   Dailey TA, 2010, J BIOL CHEM, V285, P25978, DOI 10.1074/jbc.M110.142604
   DAILEY TA, 1994, J BIOL CHEM, V269, P813
   Dailey TA, 2002, J BACTERIOL, V184, P2460, DOI 10.1128/JB.184.9.2460-2464.2002
   Fan J, 2007, J BACTERIOL, V189, P3573, DOI 10.1128/JB.01083-06
   HANSSON M, 1994, J BACTERIOL, V176, P5962
   Hofbauer S, 2014, BIOCHEMISTRY-US, V53, P77, DOI 10.1021/bi401042z
   Holliday GL, 2007, NAT PROD REP, V24, P972, DOI 10.1039/b703107f
   Ishida T, 1998, P NATL ACAD SCI USA, V95, P4853, DOI 10.1073/pnas.95.9.4853
   JACOBS NJ, 1971, J BACTERIOL, V107, P203
   Jahn Dieter, 2009, P29, DOI 10.1007/978-0-387-78518-9_2
   JAHN D, 1992, TRENDS BIOCHEM SCI, V17, P215, DOI 10.1016/0968-0004(92)90380-R
   KANNANGARA CG, 1988, TRENDS BIOCHEM SCI, V13, P139
   Kato K, 2010, P NATL ACAD SCI USA, V107, P16649, DOI 10.1073/pnas.1000771107
   Kobayashi K, 2014, GENOME BIOL EVOL, V6, P2141, DOI 10.1093/gbe/evu170
   Kuhner M., 2014, ARCHAEA, V2014
   Labbe-Bois R., 1990, BIOSYNTHESIS HEME CH, P235
   Lacelles J., 1964, TETRAPYRROLE BIOSYNT
   LASCELLES J, 1960, J GEN MICROBIOL, V23, P487
   Layer G, 2005, J BIOL CHEM, V280, P29038, DOI 10.1074/jbc.M501275200
   Lewis CA, 2008, P NATL ACAD SCI USA, V105, P17328, DOI 10.1073/pnas.0809838105
   LOUIE GV, 1992, NATURE, V359, P33, DOI 10.1038/359033a0
   Mayfield JA, 2013, J BIOL CHEM, V288, P23488, DOI 10.1074/jbc.M112.442335
   Medlock A, 2007, P NATL ACAD SCI USA, V104, P1789, DOI 10.1073/pnas.0606144104
   Medlock AE, 2007, J MOL BIOL, V373, P1006, DOI 10.1016/j.jmb.2007.08.040
   Mira A, 2005, MOL BIOL EVOL, V22, P2135, DOI 10.1093/molbev/msi209
   Munro Andrew W., 2009, P160, DOI 10.1007/978-0-387-78518-9_10
   Raux E, 2003, BIOCHEM J, V370, P505, DOI 10.1042/BJ20021443
   SANDY JD, 1975, BIOCHEM J, V150, P245
   Schubert Heidi L., 2009, P43, DOI 10.1007/978-0-387-78518-9_3
   Schulze JO, 2006, J MOL BIOL, V358, P1212, DOI 10.1016/j.jmb.2006.02.064
   TAIT GH, 1972, BIOCHEM J, V128, P1159
   Terry Matthew J., 2009, P250, DOI 10.1007/978-0-387-78518-9_15
   TOWNSLEY PM, 1957, J BIOL CHEM, V224, P695
   Wyckoff EE, 2004, J BACTERIOL, V186, P4142, DOI 10.1128/JB.186.13.4142-4151.2004
NR 63
TC 1
Z9 1
U1 11
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 27
EP 35
DI 10.1016/j.abb.2015.02.017
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500004
PM 25711532
ER

PT J
AU Hofbauer, S
   Hagmuller, A
   Schaffner, I
   Mlynek, G
   Krutzler, M
   Stadlmayr, G
   Pirker, KF
   Obinger, C
   Daims, H
   Djinoyic-Carugo, K
   Furtmuller, PG
AF Hofbauer, Stefan
   Hagmueller, Andreas
   Schaffner, Irene
   Mlynek, Georg
   Krutzler, Michael
   Stadlmayr, Gerhard
   Pirker, Katharina F.
   Obinger, Christian
   Daims, Holger
   Djinoyic-Carugo, Kristina
   Furtmueller, Paul G.
TI Structure and heme-binding properties of HemQ (chlorite dismutase-like
   protein) from Listeria monocytogenes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Chlorite dismutase; HemQ; Heme binding; Heme biosynthesis; Protein
   stability; X-ray crystallography
ID CANDIDATUS-NITROSPIRA-DEFLUVII; MOLECULAR-OXYGEN; ENZYME; PURIFICATION;
   PEROXIDASE; REACTIVITY; RESIDUES; FEATURES
AB Chlorite dismutase-like proteins are structurally closely related to functional chlorite dismutases which are heme b-dependent oxidoreductases capable of reducing chlorite to chloride with simultaneous production of dioxygen. Chlorite dismutase-like proteins are incapable of performing this reaction and their biological role is still under discussion. Recently, members of this large protein family were shown to be involved in heme biosynthesis in Gram-positive bacteria, and thus the protein was renamed HemQ in these organisms. In the present work the structural and heme binding properties of the chlorite dismutase-like protein from the Gram-positive pathogen Listeria monocytogenes (LmCld) were analyzed in order to evaluate its potential role as a regulatory heme sensing protein. The homopentameric crystal structure (2.0 angstrom) shows high similarity to chlorite-degrading chlorite dismutases with an important difference in the structure of the putative substrate and heme entrance channel. In solution LmCld is a stable hexamer able to bind the low-spin ligand cyanide. Heme binding is reversible with K-D-values determined to be 7.2 mu M (circular dichroism spectroscopy) and 16.8 mu M (isothermal titration calorimetry) at pH 7.0. Both acidic and alkaline conditions promote heme release. Presented biochemical and structural data reveal that the chlorite dismutase-like protein from L monocytogenes could act as a potential regulatory heme sensing and storage protein within heme biosynthesis. (C) 2015 The Authors. Published by Elsevier Inc.
C1 [Hofbauer, Stefan; Schaffner, Irene; Krutzler, Michael; Stadlmayr, Gerhard; Pirker, Katharina F.; Obinger, Christian; Furtmueller, Paul G.] Univ Nat Resources & Life Sci, BOKU, Div Biochem, Dept Chem, A-1190 Vienna, Austria.
   [Hofbauer, Stefan; Hagmueller, Andreas; Mlynek, Georg; Krutzler, Michael; Djinoyic-Carugo, Kristina] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, A-1030 Vienna, Austria.
   [Djinoyic-Carugo, Kristina] Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, Ljubljana 1000, Slovenia.
   [Daims, Holger] Univ Vienna, Div Microbial Ecol, Dept Microbiol & Ecosyst Sci, A-1090 Vienna, Austria.
RP Djinoyic-Carugo, K (reprint author), Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, A-1030 Vienna, Austria.
EM kristina.djinovic@univie.ac.at; paul.furt-mueller@boku.ac.at
RI Hofbauer, Stefan/I-3889-2014; Daims, Holger/I-8410-2012; 
OI Daims, Holger/0000-0002-4195-0913; Obinger,
   Christian/0000-0002-7133-3430; Hofbauer, Stefan/0000-0003-3375-7715
FU Austrian Science Foundation, FWF [W1224, P25270, P22276]; Federal
   Ministry of Economy, Family and Youth through the initiative "Laura
   Bassi Centres of Expertise", Center of Optimized Structural Studies
   [253275]
FX This project was supported by the Austrian Science Foundation, FWF
   [Doctoral program BioToP - Molecular Technology of Proteins (W1224) and
   the projects P25270 and P22276]. We thank Daniel Kracher and Alfons
   Felice for technical assistance concerning ITC measurements. MG was
   supported by Federal Ministry of Economy, Family and Youth through the
   initiative "Laura Bassi Centres of Expertise", funding Center of
   Optimized Structural Studies, No 253275.
CR Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172
   Stenklo K, 2001, J BIOL INORG CHEM, V6, P601, DOI 10.1007/s007750100237
   Mehboob F, 2009, FEMS MICROBIOL LETT, V293, P115, DOI 10.1111/j.1574-6968.2009.01517.x
   Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047
   Liers C, 2013, APPL MICROBIOL BIOT, V97, P5839, DOI 10.1007/s00253-012-4521-2
   Maixner F, 2008, ENVIRON MICROBIOL, V10, P3043, DOI 10.1111/j.1462-2920.2008.01646.x
   TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X
   Goblirsch BR, 2010, J BIOL INORG CHEM, V15, P879, DOI 10.1007/s00775-010-0651-0
   Mlynek G, 2011, J BACTERIOL, V193, P2408, DOI 10.1128/JB.01262-10
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Blanc B, 2012, BIOCHEMISTRY-US, V51, P1895, DOI 10.1021/bi2017377
   de Geus DC, 2009, J MOL BIOL, V387, P192, DOI 10.1016/j.jmb.2009.01.036
   Hofbauer S, 2014, BIOTECHNOL J, V9, P461, DOI 10.1002/biot.201300210
   Kostan J, 2010, J STRUCT BIOL, V172, P331, DOI 10.1016/j.jsb.2010.06.014
   Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413
   Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550
   Hofbauer S, 2014, BIOCHEMISTRY-US, V53, P3145, DOI 10.1021/bi500401k
   Bab-Dinitz E, 2006, BIOINFORMATICS, V22, P671, DOI 10.1093/bioinformatics/bti043
   Barcroft J, 1910, J PHYSIOL-LONDON, V39, P411
   Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708
   Dailey TA, 2010, J BIOL CHEM, V285, P25978, DOI 10.1074/jbc.M110.142604
   Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k
   Ebihara Akio, 2005, Journal of Structural and Functional Genomics, V6, P21, DOI 10.1007/s10969-005-1103-x
   Hofbauer S, 2012, BBA-PROTEINS PROTEOM, V1824, P1031, DOI 10.1016/j.bbapap.2012.05.012
   Hofbauer S, 2014, BIOCHEMISTRY-US, V53, P77, DOI 10.1021/bi401042z
   Howes BD, 2000, J BIOL INORG CHEM, V5, P227, DOI 10.1007/s007750050367
   Le P, 2014, BIOCHEMISTRY-US, V53, P6863, DOI 10.1021/bi5005975
   Mayfield JA, 2013, J BIOL CHEM, V288, P23488, DOI 10.1074/jbc.M112.442335
   Schaffner I., 2015, MOL MICROBIOL UNPUB
   Streit BR, 2008, BIOCHEMISTRY-US, V47, P5271, DOI 10.1021/bi800163x
   Sundermann A, 2014, BIOCHEMISTRY-US, V53, P4869, DOI 10.1021/bi500467h
   vanGlinkel CG, 1996, ARCH MICROBIOL, V166, P321, DOI 10.1007/s002030050390
NR 35
TC 4
Z9 4
U1 9
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 36
EP 48
DI 10.1016/j.abb.2015.01.010
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500005
PM 25602700
ER

PT J
AU Yoshida, T
   Sugano, Y
AF Yoshida, Toru
   Sugano, Yasushi
TI A structural and functional perspective of DyP-type peroxidase family
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Dye-decolorizing peroxidase; DyP; DyP-type peroxidase family
ID RHODOCOCCUS-JOSTII RHA1; DECOLORIZING PEROXIDASE; ESCHERICHIA-COLI;
   CRYSTAL-STRUCTURES; HEME-BINDING; IDENTIFICATION; NANOCOMPARTMENT;
   ENZYME; ACID; IRON
AB Dye-decolorizing peroxidase from the basidiomycete Bjerkandera adusta Dec 1 (DyP) is a heme peroxidase. This name reflects its ability to degrade several anthraquinone dyes. The substrate specificity, the amino acid sequence, and the tertiary structure of DyP are different from those of the other heme peroxidase (super)families. Therefore, many proteins showing the similar amino acid sequences to that of DyP are called DyP-type peroxidase which is a new family of heme peroxidase identified in 2007. In fact, all structures of this family show a similar structure fold. However, this family includes many proteins whose amino acid sequence identity to DyP is lower than 15% and/or whose catalytic efficiency (k(cat)/K-m) is a few orders of magnitude less than that of DyP. A protein showing an activity different from peroxidase activity (dechelatase activity) has been also reported. In addition, the precise physiological roles of DyP-type peroxidases are unknown. These facts raise a question of whether calling this family DyP-type peroxidase is suitable. Here, we review the differences and similarities of structure and function among this family and propose the reasonable new classification of DyP-type peroxidase family, that is, class P, I and V. In this contribution, we discuss the adequacy of this family name. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Yoshida, Toru] Kyoto Sangyo Univ, Fac Life Sci, Dept Bioresource & Environm Sci, Kita Ku, Kyoto 6038555, Japan.
   [Sugano, Yasushi] Japan Womens Univ, Fac Sci, Dept Chem & Biol Sci, Bunkyo Ku, Tokyo 1128681, Japan.
RP Sugano, Y (reprint author), Japan Womens Univ, Fac Sci, Dept Chem & Biol Sci, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.
EM suganoy@fc.jwu.ac.jp
CR Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200
   Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029
   Yoshida T, 2012, FEBS LETT, V586, P4351, DOI 10.1016/j.febslet.2012.10.049
   Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673
   Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171
   Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Biswas L, 2009, J BACTERIOL, V191, P5921, DOI 10.1128/JB.00642-09
   Ogola HJO, 2009, APPL ENVIRON MICROB, V75, P7509, DOI 10.1128/AEM.01121-09
   Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047
   Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y
   Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7
   Li J, 2012, APPL BIOCHEM BIOTECH, V166, P774, DOI 10.1007/s12010-011-9466-x
   Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006
   Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z
   Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x
   Fawal N, 2013, NUCLEIC ACIDS RES, V41, pD441, DOI 10.1093/nar/gks1083
   Liers C, 2013, APPL MICROBIOL BIOT, V97, P5839, DOI 10.1007/s00253-012-4521-2
   Santos A, 2014, APPL MICROBIOL BIOT, V98, P2053, DOI 10.1007/s00253-013-5041-4
   Mlynek G, 2011, J BACTERIOL, V193, P2408, DOI 10.1128/JB.01262-10
   Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h
   Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581
   Johjima T, 2003, APPL MICROBIOL BIOT, V61, P220, DOI 10.1007/s00253-003-1236-4
   Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366
   Salvachua D, 2013, APPL ENVIRON MICROB, V79, P4316, DOI 10.1128/AEM.00699-13
   van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x
   Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550
   Scheibner M, 2008, APPL MICROBIOL BIOT, V77, P1241, DOI 10.1007/s00253-007-1261-9
   Sugano Y, 2009, BIODEGRADATION, V20, P433, DOI 10.1007/s10532-008-9234-y
   Yoshida T, 2011, FEBS J, V278, P2387, DOI 10.1111/j.1742-4658.2011.08161.x
   Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x
   Contreras H, 2014, J BIOL CHEM, V289, P18279, DOI 10.1074/jbc.M114.570119
   Dailey H.A., 2011, MBIO, V2
   Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x
   Kaur A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.50
   Kellner H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095557
   Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106
   Rahmanpour R, 2013, FEBS J, V280, P2097, DOI 10.1111/febs.12234
   Rajasekaran MB, 2010, BIOMETALS, V23, P1, DOI 10.1007/s10534-009-9262-z
   Rost B, 1997, FOLD DES, V2, pS19, DOI 10.1016/S1359-0278(97)00059-X
   Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200
   Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473
   Turlin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056529
   Zamocky M, 2014, CELL MOL LIFE SCI, V71, P4681, DOI 10.1007/s00018-014-1643-y
NR 44
TC 3
Z9 3
U1 9
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 49
EP 55
DI 10.1016/j.abb.2015.01.022
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500006
PM 25655348
ER

PT J
AU Singh, R
   Eltis, LD
AF Singh, Rahul
   Eltis, Lindsay D.
TI The multihued palette of dye-decolorizing peroxidases
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Enzymology; Compound I; Biotechnology; Heme-proteins;
   Structure-function; Lignin
ID RHODOCOCCUS-JOSTII RHA1; CANDIDUM DEC 1; CRYSTAL-STRUCTURE;
   ESCHERICHIA-COLI; PHANEROCHAETE-CHRYSOSPORIUM; HORSERADISH-PEROXIDASE;
   HEME-BINDING; EXPRESSION; ENZYME; NANOCOMPARTMENT
AB Dye-decolorizing peroxidases (DyPs; EC 1.11.1.19) are heme enzymes that comprise a family of the dimeric alpha+beta barrel structural superfamily of proteins. The first DyP, identified relatively recently in the fungus Bjerkandera adusta, was characterized for its ability to catalyze the decolorization of anthraquinone-based industrial dyes. These enzymes are now known to be present in all three domains of life, but do not appear to occur in plants or animals. They are involved in a range of physiological processes, although in many cases their roles remain unknown. This has not prevented the development of their biocatalytic potential, which includes the transformation of lignin. This review highlights the functional diversity of DyPs in the light of phylogenetic, structural and biochemical data. The phylogenetic analysis reveals the existence of at least five classes of DyPs. Their potential physiological roles are discussed based in part on synteny analyses. Finally, the considerable biotechnological potential of DyPs is summarized. Crown Copyright (C) 2015 Published by Elsevier Inc. All rights reserved.
C1 [Singh, Rahul; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.
   [Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.
RP Eltis, LD (reprint author), Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.
EM rahuls@mail.ubc.ca; leltis@mail.ubc.ca
RI Eltis, Lindsay/J-8272-2015
OI Eltis, Lindsay/0000-0002-6774-8158
FU Genome Canada; Natural Sciences and Engineering Research Council (NSERC)
   of Canada Strategic Network (LignoWorks); NSERC
FX This work was supported by funding to LDE from a Genome Canada
   Large-Scale Research Project, a Natural Sciences and Engineering
   Research Council (NSERC) of Canada Strategic Network (LignoWorks), and
   an NSERC Discovery grant. We thank past and present members of the Eltis
   lab, particularly Mr. Joseph N. Roberts, and our collaborators Drs.
   Timothy D. Bugg, Jason C. Grigg and Michael E. Murphy, for their
   valuable contributions to our research on DyPs.
CR Alvarado Berenize, 2009, Recent Pat Biotechnol, V3, P88, DOI 10.2174/187220809788700210
   Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X
   Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200
   Poulos TL, 2010, ARCH BIOCHEM BIOPHYS, V500, P3, DOI 10.1016/j.abb.2010.02.008
   Yoshida T, 2012, FEBS LETT, V586, P4351, DOI 10.1016/j.febslet.2012.10.049
   Poulos TL, 2014, CHEM REV, V114, P3919, DOI 10.1021/cr400415k
   Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673
   Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524
   Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762
   Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092
   Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151
   Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176
   Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171
   SCHELLHORN HE, 1995, FEMS MICROBIOL LETT, V131, P113, DOI 10.1111/j.1574-6968.1995.tb07764.x
   Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Sugano Y, 2000, APPL ENVIRON MICROB, V66, P1754, DOI 10.1128/AEM.66.4.1754-1758.2000
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201
   Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913
   Sundaramoorthy M, 2010, J INORG BIOCHEM, V104, P683, DOI 10.1016/j.jinorgbio.2010.02.011
   Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x
   Ogola HJO, 2009, APPL ENVIRON MICROB, V75, P7509, DOI 10.1128/AEM.01121-09
   Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047
   Strittmatter E, 2015, ARCH BIOCHEM BIOPHYS, V574, P75, DOI 10.1016/j.abb.2014.12.016
   Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y
   Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7
   Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z
   Wilson AW, 2005, MYCOLOGIA, V97, P667, DOI 10.3852/mycologia.97.3.667
   Liers C, 2013, APPL MICROBIOL BIOT, V97, P5839, DOI 10.1007/s00253-012-4521-2
   Santos A, 2014, APPL MICROBIOL BIOT, V98, P2053, DOI 10.1007/s00253-013-5041-4
   Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h
   Ruiz-Duenas FJ, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P37, DOI 10.1007/978-3-642-12627-7_3
   RodriguezLopez JN, 1996, J BIOL CHEM, V271, P4023
   Miethke M, 2013, BBA-MOL CELL RES, V1833, P2267, DOI 10.1016/j.bbamcr.2013.05.027
   Kaur P, 1997, J BACTERIOL, V179, P569
   Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780
   Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h
   Singh R, 2013, ACS CHEM BIOL, V8, P700, DOI 10.1021/cb300608x
   Salvachua D, 2013, APPL ENVIRON MICROB, V79, P4316, DOI 10.1128/AEM.00699-13
   van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x
   Kim SJ, 1999, BIOTECHNOL BIOENG, V62, P114, DOI 10.1002/(SICI)1097-0290(19990105)62:1<114::AID-BIT13>3.0.CO;2-T
   Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550
   Scheibner M, 2008, APPL MICROBIOL BIOT, V77, P1241, DOI 10.1007/s00253-007-1261-9
   CAI DY, 1993, J BIOTECHNOL, V30, P79, DOI 10.1016/0168-1656(93)90029-M
   Cells Arianna I., 2014, ARCH BIOCH BIOPHYS
   Colpa DI, 2014, J IND MICROBIOL BIOT, V41, P1, DOI 10.1007/s10295-013-1371-6
   Contreras H, 2014, J BIOL CHEM, V289, P18279, DOI 10.1074/jbc.M114.570119
   Dailey H. A., 2011, MBIO, V2
   Dunford H. B., 1999, HEME PEROXIDASES
   Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD364, DOI 10.1093/nar/gkt1210
   Gaigalat L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-104
   Kaur A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.50
   Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106
   Linde D., 2014, BIOCHEM J, V466, P253
   MAYFIELD MB, 1994, APPL ENVIRON MICROB, V60, P4303
   Rahmanpour R, 2013, FEBS J, V280, P2097, DOI 10.1111/febs.12234
   Rajasekaran MB, 2010, BIOMETALS, V23, P1, DOI 10.1007/s10534-009-9262-z
   Savenkova MI, 1996, J BIOL CHEM, V271, P24598
   Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200
   Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473
   vanGlinkel CG, 1996, ARCH MICROBIOL, V166, P321, DOI 10.1007/s002030050390
   WELINDER KG, 1991, BIOCHIM BIOPHYS ACTA, V1080, P215
   Yim G, 2014, CHEMBIOCHEM, V15, P2613, DOI 10.1002/cbic.201402179
   Zamocky M, 2015, ARCH BIOCHEM BIOPHYS, V574, P108, DOI 10.1016/j.abb.2014.12.025
NR 65
TC 2
Z9 2
U1 8
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 56
EP 65
DI 10.1016/j.abb.2015.01.014
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500007
PM 25743546
ER

PT J
AU Linde, D
   Ruiz-Duenas, FJ
   Fernandez-Fueyo, E
   Guallar, V
   Hammel, KE
   Pogni, R
   Martinez, AT
AF Linde, Dolores
   Ruiz-Duenas, Francisco J.
   Fernandez-Fueyo, Elena
   Guallar, Victor
   Hammel, Kenneth E.
   Pogni, Rebecca
   Martinez, Angel T.
TI Basidiomycete DyPs: Genomic diversity, structural-functional aspects,
   reaction mechanism and environmental significance
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Dye-decolorizing peroxidases; CDE superfamily; Molecular structure;
   Reaction mechanism; Catalytic tryptophan; Long-range electron transfer;
   Substituted anthraquinone breakdown; Ligninolysis
ID DYE-DECOLORIZING PEROXIDASE; THANATEPHORUS-CUCUMERIS DEC-1;
   ELECTRON-TRANSFER PATHWAYS; RHODOCOCCUS-JOSTII RHA1; LIGNIN PEROXIDASE;
   HETEROLOGOUS EXPRESSION; VERSATILE PEROXIDASE; CRYSTAL-STRUCTURES;
   MARASMIUS-SCORODONIUS; MANGANESE PEROXIDASE
AB The first enzyme with dye-decolorizing peroxidase (DyP) activity was described in 1999 from an arthroconidial culture of the fungus Bjerkandera adusta. However, the first DyP sequence had been deposited three years before, as a peroxidase gene from a culture of an unidentified fungus of the family Polyporaceae (probably Irpex lacteus). Since the first description, fewer than ten basidiomycete DyPs have been purified and characterized, but a large number of sequences are available from genomes. DyPs share a general fold and heme location with chlorite dismutases and other DyP-type related proteins (such as Escherichia coli EfeB), forming the CDE superfamily. Taking into account the lack of an evolutionary relationship with the catalase-peroxidase superfamily, the observed heme pocket similarities must be considered as a convergent type of evolution to provide similar reactivity to the enzyme cofactor. Studies on the Auricularia auricula-judae DyP showed that high-turnover oxidation of anthraquinone type and other DyP substrates occurs via long-range electron transfer from an exposed tryptophan (Trp377, conserved in most basidiomycete DyPs), whose catalytic radical was identified in the H2O2-activated enzyme. The existence of accessory oxidation sites in DyP is suggested by the residual activity observed after site-directed mutagenesis of the above tryptophan. DyP degradation of substituted anthraquinone dyes (such as Reactive Blue 5) most probably proceeds via typical one-electron peroxidase oxidations and product breakdown without a DyP-catalyzed hydrolase reaction. Although various DyPs are able to break down phenolic lignin model dimers, and basidiomycete DyPs also present marginal activity on non-phenolic dimers, a significant contribution to lignin degradation is unlikely because of the low activity on high redox-potential substrates. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
C1 [Linde, Dolores; Ruiz-Duenas, Francisco J.; Fernandez-Fueyo, Elena; Martinez, Angel T.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain.
   [Guallar, Victor] Barcelona Supercomp Ctr, Res Program Computat Biol, Joint BSC CRG IRB, E-08034 Barcelona, Spain.
   [Guallar, Victor] Passeig Lluis Co 23, ICREA, E-08010 Barcelona, Spain.
   [Hammel, Kenneth E.] US Forest Serv, Madison, WI 53726 USA.
   [Pogni, Rebecca] Univ Siena, Dept Biotechnol Chem & Pharm, I-53100 Siena, Italy.
RP Martinez, AT (reprint author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, E-28040 Madrid, Spain.
EM ATMartinez@cib.csic.es
RI Hammel, Kenneth/G-1890-2011; Ruiz-Duenas, Francisco/L-9837-2015;
   Partearroyo, CIB-Biblioteca/L-3262-2014
OI Hammel, Kenneth/0000-0002-2935-5847; Partearroyo,
   CIB-Biblioteca/0000-0002-1692-4481
FU INDOX European project [KBBE-2013-7-613549]; Spanish Ministry of Economy
   and Competitiveness (MINECO) [BIO2011-26694, CTQ2013-48287]; Italian
   Ministry of Education, University and Research (MIUR); MINECO
FX This work was supported by the INDOX (KBBE-2013-7-613549;
   www.indoxproject.eu) European project, the BIO2011-26694 (HIPOP) and
   CTQ2013-48287 projects of the Spanish Ministry of Economy and
   Competitiveness (MINECO), and the PRIN 2009-STNWX3 project of the
   Italian Ministry of Education, University and Research (MIUR). FJR-D
   thanks a Ramon y Cajal contract of MINECO. The authors thank Veronica
   Saez-Jimenez for data on Reactive Blue 5 decolorization by VP and its
   heme-channel variants.
CR Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200
   Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029
   Yoshida T, 2012, FEBS LETT, V586, P4351, DOI 10.1016/j.febslet.2012.10.049
   Rahmanpour R, 2015, ARCH BIOCHEM BIOPHYS, V574, P93, DOI 10.1016/j.abb.2014.12.022
   Liers C, 2014, J MOL CATAL B-ENZYM, V103, P41, DOI 10.1016/j.molcatb.2013.09.025
   Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0
   Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673
   Mandelman D, 1998, BIOCHEMISTRY-US, V37, P17610, DOI 10.1021/bi981958y
   Ruiz-Duenas FJ, 2009, J BIOL CHEM, V284, P7986, DOI 10.1074/jbc.M808069200
   Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176
   Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171
   Faraco V, 2007, WORLD J MICROB BIOT, V23, P889, DOI 10.1007/s11274-006-9303-5
   Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X
   Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004
   HARRIMAN A, 1987, J PHYS CHEM-US, V91, P6102, DOI 10.1021/j100308a011
   Nousiainen P, 2009, HOLZFORSCHUNG, V63, P699, DOI 10.1515/HF.2009.066
   Blodig W, 2001, J MOL BIOL, V305, P851, DOI 10.1006/jmbi.2000.4346
   Ogola HJO, 2009, APPL ENVIRON MICROB, V75, P7509, DOI 10.1128/AEM.01121-09
   Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047
   Miki Y, 2011, J BIOL CHEM, V286, P15525, DOI 10.1074/jbc.M111.220996
   Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y
   Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7
   Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002
   Sugano Y, 1999, J BIOSCI BIOENG, V87, P411, DOI 10.1016/S1389-1723(99)80087-5
   Daniel G, 2007, APPL ENVIRON MICROB, V73, P6241, DOI 10.1128/AEM.00977-07
   Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z
   Hunt CG, 2013, ENVIRON MICROBIOL, V15, P956, DOI 10.1111/1462-2920.12039
   Enoki M, 1999, FEMS MICROBIOL LETT, V180, P205, DOI 10.1016/S0378-1097(99)00487-5
   Sugano Y, 2006, APPL MICROBIOL BIOT, V73, P862, DOI 10.1007/s00253-006-0545-9
   Perez-Boada M, 2005, J MOL BIOL, V354, P385, DOI 10.1016/j.jmb.2005.09.047
   HAMMEL KE, 1993, J BIOL CHEM, V268, P12274
   Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748
   Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200
   Santos A, 2014, APPL MICROBIOL BIOT, V98, P2053, DOI 10.1007/s00253-013-5041-4
   Gold MH, 2000, MET IONS BIOL SYST, V37, P559
   Warren JJ, 2012, FEBS LETT, V586, P596, DOI 10.1016/j.febslet.2011.12.014
   Baciocchi E, 2003, J ORG CHEM, V68, P9061, DOI 10.1021/jo035052w
   Ruiz-Duenas FJ, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P37, DOI 10.1007/978-3-642-12627-7_3
   BAO WL, 1994, FEBS LETT, V354, P297, DOI 10.1016/0014-5793(94)01146-X
   Strittmatter E, 2013, ARCH BIOCHEM BIOPHYS, V537, P161, DOI 10.1016/j.abb.2013.07.007
   Hofrichter M, 2014, CURR OPIN CHEM BIOL, V19, P116, DOI 10.1016/j.cbpa.2014.01.015
   Goblirsch BR, 2010, J BIOL INORG CHEM, V15, P879, DOI 10.1007/s00775-010-0651-0
   Sato T, 2004, ACTA CRYSTALLOGR D, V60, P149, DOI 10.1107/S0907444903025472
   Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780
   Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h
   SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632
   Hofbauer S, 2014, BIOTECHNOL J, V9, P461, DOI 10.1002/biot.201300210
   Piontek K, 2013, J BIOL CHEM, V288, P34767, DOI 10.1074/jbc.M113.514521
   Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002
   Ruiz-Duenas FJ, 2013, MYCOLOGIA, V105, P1428, DOI 10.3852/13-059
   Johjima T, 2003, APPL MICROBIOL BIOT, V61, P220, DOI 10.1007/s00253-003-1236-4
   Singh R, 2013, ACS CHEM BIOL, V8, P700, DOI 10.1021/cb300608x
   Kostan J, 2010, J STRUCT BIOL, V172, P331, DOI 10.1016/j.jsb.2010.06.014
   Salvachua D, 2013, APPL ENVIRON MICROB, V79, P4316, DOI 10.1128/AEM.00699-13
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x
   Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550
   del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Zelena K, 2009, ARCH MICROBIOL, V191, P397, DOI 10.1007/s00203-009-0462-2
   Scheibner M, 2008, APPL MICROBIOL BIOT, V77, P1241, DOI 10.1007/s00253-007-1261-9
   Sugano Y, 2009, BIODEGRADATION, V20, P433, DOI 10.1007/s10532-008-9234-y
   Yoshida T, 2011, FEBS J, V278, P2387, DOI 10.1111/j.1742-4658.2011.08161.x
   Blanc B, 2013, DALTON T, V42, P3156, DOI 10.1039/c2dt32312e
   Blodig W, 1999, ARCH BIOCHEM BIOPHYS, V370, P86, DOI 10.1006/abbi.1999.1365
   Colpa DI, 2014, J IND MICROBIOL BIOT, V41, P1, DOI 10.1007/s10295-013-1371-6
   Dimroth O., 1916, LIEBIGS ANN CHEM, V411, P345, DOI 10.1002/jlac.19164110305
   Guallar V, 2008, J R SOC INTERFACE, V5, pS233, DOI 10.1098/rsif.2008.0061.focus
   HARVEY PJ, 1986, FEBS LETT, V195, P242, DOI 10.1016/0014-5793(86)80168-5
   Jiao K, 2000, ANAL CHIM ACTA, V413, P71, DOI 10.1016/S0003-2670(00)00820-5
   Kellner H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095557
   KIM SJ, 1995, J FERMENT BIOENG, V79, P601, DOI 10.1016/0922-338X(95)94755-G
   Liers C, 2013, APPL MICROBIOL BIOT, V87, P5839
   Linde D, 2014, PROTEIN EXPRES PURIF, V103, P28, DOI 10.1016/j.pep.2014.08.007
   Linde D., 2014, BIOCH J
   Miki Y, 2013, BIOCHEM J, V452, P575, DOI 10.1042/BJ20130251
   Reece SY, 2005, BBA-BIOENERGETICS, V1706, P232, DOI 10.1016/j.bbabio.2004.11.011
   RUIZDUENAS FJ, 2009, EXP BOT, V60, P441
   Salvachua D, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-115
   Smith MB, 2007, MARCHS ADV ORGANIC C
   Strittmatter E., 2014, ARCH BIOCH BIOPHYS
   Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200
   Sugano Y., 2009, LIFE SCI, V66, P1387
   Sugano Y, 2004, BIOCHEM BIOPH RES CO, V322, P126, DOI 10.1016/j.bbrc.2004.07.090
   TIEN M, 1986, J BIOL CHEM, V261, P1687
   Wallrapp F. H., 2013, PLOS COMPUT BIOL, V9
   Yu WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110319
   Zamocky M, 2015, ARCH BIOCHEM BIOPHYS, V574, P108, DOI 10.1016/j.abb.2014.12.025
   Zarnocky M., 2014, CELL MOL LIFE SCI, V71, P4681
NR 89
TC 4
Z9 4
U1 22
U2 27
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 66
EP 74
DI 10.1016/j.abb.2015.01.018
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500008
PM 25637654
ER

PT J
AU Strittmatter, E
   Serrer, K
   Liers, C
   Ullrich, R
   Hofrichter, M
   Piontek, K
   Schleicher, E
   Plattner, DA
AF Strittmatter, Eric
   Serrer, Kerstin
   Liers, Christiane
   Ullrich, Rene
   Hofrichter, Martin
   Piontek, Klaus
   Schleicher, Erik
   Plattner, Dietmar A.
TI The toolbox of Auricularia auricula-judae dye-decolorizing peroxidase -
   Identification of three new potential substrate-interaction sites
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Aspartate; Catalysis; Crystal structure; Dye-decolorizing peroxidases
   (DyPs); Electron paramagnetic resonance (EPR) spectroscopy; Heme; Mass
   spectrometry; Spin trapping; Tryptophan; Tyrosine
ID DENSITY-FUNCTIONAL THEORY; TRYPTOPHAN RADICALS; RIBONUCLEOTIDE
   REDUCTASE; VERSATILE PEROXIDASE; MULTIFREQUENCY EPR; HEME; RESIDUE;
   REFINEMENT; BACTERIUM; CATALASE
AB Dye-decolorizing peroxidases (DyPs) such as AauDyPI from the fungus Auricularia auricula-judae are able to oxidize substrates of different kinds and sizes. A crystal structure of an AauDyPI-imidazole complex gives insight into the binding patterns of organic molecules within the heme cavity of a DyP. Several small N-containing heterocyclic aromatics are shown to bind in the AauDyPI heme cavity, hinting to susceptibility of DyPs to azole-based inhibitors similar to cytochromes P450. Imidazole is confirmed as a competitive inhibitor with regard to peroxide binding. In contrast, bulky substrates such as anthraquinone dyes are converted at the enzyme surface. In the crystal structure a substrate analog, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), binds to a tyrosine-rich hollow harboring Y25, Y147, and Y337. Spin trapping with a nitric oxide donor uncovers Y229 as an additional tyrosine-based radical center in AauDyPI. Multi-frequency EPR spectroscopy further reveals the presence of at least one intermediate tryptophanyl radical center in activated AauDyPI with W377 as the most likely candidate. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Strittmatter, Eric; Piontek, Klaus; Plattner, Dietmar A.] Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany.
   [Serrer, Kerstin; Schleicher, Erik] Univ Freiburg, Inst Phys Chem, D-79104 Freiburg, Germany.
   [Liers, Christiane; Ullrich, Rene; Hofrichter, Martin] Tech Univ Dresden, Int Inst Zittau, Dept Bio & Environm Sci, D-02763 Zittau, Germany.
RP Plattner, DA (reprint author), Univ Freiburg, Inst Organ Chem, Albertstr 21, D-79104 Freiburg, Germany.
EM dietmar.plattner@chemie.uni-freiburg.de
RI Schleicher, Erik/C-9951-2010
CR Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029
   McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617
   Ruiz-Duenas FJ, 2009, J BIOL CHEM, V284, P7986, DOI 10.1074/jbc.M808069200
   Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176
   Bernini C, 2011, PHYS CHEM CHEM PHYS, V13, P5078, DOI 10.1039/c0cp02151b
   Bernini C, 2013, J AM CHEM SOC, V135, P4822, DOI 10.1021/ja400464n
   Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374
   Un S, 2005, MAGN RESON CHEM, V43, pS229, DOI 10.1002/mrc.1660
   Miki Y, 2011, J BIOL CHEM, V286, P15525, DOI 10.1074/jbc.M111.220996
   Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y
   DOLPHIN D, 1971, P NATL ACAD SCI USA, V68, P614, DOI 10.1073/pnas.68.3.614
   Liers C, 2013, APPL MICROBIOL BIOT, V97, P5839, DOI 10.1007/s00253-012-4521-2
   MCCONNELL HM, 1956, J CHEM PHYS, V24, P764, DOI 10.1063/1.1742605
   Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200
   Strittmatter E, 2013, ARCH BIOCHEM BIOPHYS, V537, P161, DOI 10.1016/j.abb.2013.07.007
   Piontek K, 2010, ACTA CRYSTALLOGR F, V66, P693, DOI 10.1107/S1744309110013515
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d
   Piontek K, 2013, J BIOL CHEM, V288, P34767, DOI 10.1074/jbc.M113.514521
   Singh R, 2013, ACS CHEM BIOL, V8, P700, DOI 10.1021/cb300608x
   Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013
   Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e
   POULOS TL, 1980, J BIOL CHEM, V255, P8199
   Yoshida T, 2011, FEBS J, V278, P2387, DOI 10.1111/j.1742-4658.2011.08161.x
   Blodig W, 1999, ARCH BIOCHEM BIOPHYS, V370, P86, DOI 10.1006/abbi.1999.1365
   BOLLAG JM, 1979, CAN J MICROBIOL, V25, P229, DOI 10.1139/m79-035
   Buttner E, 2015, ARCH BIOCHEM BIOPHYS, V574, P86, DOI 10.1016/j.abb.2015.03.003
   Colpa DI, 2014, J IND MICROBIOL BIOT, V41, P1, DOI 10.1007/s10295-013-1371-6
   Dailey H. A., 2011, MBIO, V2
   Delano W. L., 2001, PYMOL MOL GRAPHICS S
   Fitzpatrick JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000543
   Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49
   KIM SJ, 1995, J FERMENT BIOENG, V79, P601, DOI 10.1016/0922-338X(95)94755-G
   Kong LY, 2010, ARCH MICROBIOL, V192, P585, DOI 10.1007/s00203-010-0585-5
   Lendzian F, 1996, J AM CHEM SOC, V118, P8111, DOI 10.1021/ja960917r
   Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106
   Pogni R, 2007, APPL MAGN RESON, V31, P509, DOI 10.1007/BF03166599
   Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679
   Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079
   Strittmatter E., 2014, ENCY INORGANIC BIOIN
   Svistunenko DA, 2009, PHYS CHEM CHEM PHYS, V11, P6600, DOI 10.1039/b905522c
   Zhao XB, 2004, J BIOL CHEM, V279, P7606, DOI 10.1074/jbc.M311884200
NR 45
TC 5
Z9 5
U1 15
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 75
EP 85
DI 10.1016/j.abb.2014.12.016
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500009
PM 25542606
ER

PT J
AU Buttner, E
   Ullrich, R
   Strittmatter, E
   Piontek, K
   Plattner, DA
   Hofrichter, M
   Liers, C
AF Buettner, Enrico
   Ullrich, Rene
   Strittmatter, Eric
   Piontek, Klaus
   Plattner, Dietmar A.
   Hofrichter, Martin
   Liers, Christiane
TI Oxidation and nitration of mononitrophenols by a DyP-type peroxidase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Dye-decolorizing peroxidases; Nitration; Nitrophenol; Nitrite;
   One-electron oxidation
ID HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; DECOLORIZING PEROXIDASE;
   ENZYMATIC NITRATION; CATALYZED NITRATION; AROMATIC-COMPOUNDS; LIGNIN
   PEROXIDASE; NITRITE; PHENOLS; DEGRADATION
AB Substantial conversion of nitrophenols, typical high-redox potential phenolic substrates, by heme peroxidases has only been reported for lignin peroxidase (LiP) so far. But also a dye-decolorizing peroxidase of Auricularia auricula-judae (AauDyP) was found to be capable of acting on (i) ortho-nitrophenol (oNP), (ii) meta-nitrophenol (mNP) and (iii) para-nitrophenol (pNP). The pH dependency for pNP oxidation showed an optimum at pH 4.5, which is typical for phenol conversion by DyPs and other heme peroxidases. In the case of oNP and pNP conversion, dinitrophenols (2,4-DNP and 2,6-DNP) were identified as products and for pNP additionally p-benzoquinone. Moreover, indications were found for the formation of random polymerization products originating from initially formed phenoxy radical intermediates. Nitration was examined using N-15-labeled pNP and (NaNO2)-N-14 as an additional source of nitro-groups. Products were identified by HPLC-MS, and mass-to-charge ratios were evaluated to clarify the origin of nitro-groups. The additional nitrogen in DNPs formed during enzymatic conversion was found to originate both from N-15-pNP and (NO2Na)-N-14. Based on these results, a hypothetical reaction scheme and a catalytically responsible confine of the enzyme's active site are postulated. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Buettner, Enrico; Ullrich, Rene; Hofrichter, Martin; Liers, Christiane] Tech Univ Dresden, Int Inst Zittau, D-02763 Zittau, Germany.
   [Strittmatter, Eric; Piontek, Klaus; Plattner, Dietmar A.] Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany.
RP Liers, C (reprint author), Tech Univ Dresden, Int Inst Zittau, Markt 23, D-02763 Zittau, Germany.
EM christiane.liers@tu-dresden.de
FU European Union
FX The work was financially supported by the European Union (integrated
   project PEROXICATS and INDOX). We are also grateful to our research team
   and Stefan Franzle for useful comments and their know-how and to F.
   Hahn, who participated in this study.
CR Yoshida T, 2012, FEBS LETT, V586, P4351, DOI 10.1016/j.febslet.2012.10.049
   Sampson JB, 1998, ARCH BIOCHEM BIOPHYS, V356, P207, DOI 10.1006/abbi.1998.0772
   Ullrich R, 2007, CELL MOL LIFE SCI, V64, P271, DOI 10.1007/s00018-007-6362-1
   Liers C, 2014, J MOL CATAL B-ENZYM, V103, P41, DOI 10.1016/j.molcatb.2013.09.025
   Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0
   Hollmann F, 2012, POLYMERS-BASEL, V4, P759, DOI 10.3390/polym4010759
   Ayala M, 2007, BIOCHEM BIOPH RES CO, V357, P804, DOI 10.1016/j.bbrc.2007.04.020
   Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176
   Budde CL, 2001, J MOL CATAL B-ENZYM, V15, P55, DOI 10.1016/S1381-1177(01)00004-2
   Strittmatter E, 2015, ARCH BIOCHEM BIOPHYS, V574, P75, DOI 10.1016/j.abb.2014.12.016
   Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7
   Sugano Y, 1999, J BIOSCI BIOENG, V87, P411, DOI 10.1016/S1389-1723(99)80087-5
   Liers C, 2013, APPL MICROBIOL BIOT, V97, P5839, DOI 10.1007/s00253-012-4521-2
   Liers C, 2011, FEMS MICROBIOL ECOL, V78, P91, DOI 10.1111/j.1574-6941.2011.01144.x
   Ricoux R, 2001, EUR J BIOCHEM, V268, P3783, DOI 10.1046/j.1432-1327.2001.02288.x
   Li C, 1999, J PHYS CHEM B, V103, P6653, DOI 10.1021/jp983819w
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e
   Lopes GR, 2014, RSC ADV, V4, P37244, DOI 10.1039/c4ra06094f
   Casella L, 2002, ENVIRON HEALTH PERSP, V110, P709
   DeLano W. L., 2010, PYMOL MOL GRAPHICS S, P1
   Gebicka L, 1999, ACTA BIOCHIM POL, V46, P919
   Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49
   MASSEY IJ, 1994, ENVIRON TOXICOL CHEM, V13, P1743, DOI 10.1897/1552-8618(1994)13[1743:MSORPF]2.0.CO;2
   Monzani E, 2004, EUR J BIOCHEM, V271, P895, DOI 10.1111/j.1432-1033.2004.03992.x
   Nicolis S, 2007, BIOCHEM J, V407, P89, DOI 10.1042/BJ12007072
   Sakihama Y, 2003, FEBS LETT, V553, P377, DOI 10.1016/S0014-5793(03)01059-7
   SASAKI K, 1969, J ELECTROANAL CHEM, V20, P137, DOI 10.1016/S0022-0728(69)80015-X
   Sheng DW, 1998, ARCH BIOCHEM BIOPHYS, V352, P121, DOI 10.1006/abbi.1997.0570
   Teramoto H, 2004, APPL MICROBIOL BIOT, V66, P312, DOI 10.1007/s00253-004-1637-z
   Van Dalen CJ, 2006, BIOCHEM J, V394, P707, DOI 10.1042/BJ20051470
   Ward G, 2003, J CHEM TECHNOL BIOT, V78, P1239, DOI 10.1002/jctb.933
NR 32
TC 2
Z9 2
U1 8
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 86
EP 92
DI 10.1016/j.abb.2015.03.003
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500010
PM 25796533
ER

PT J
AU Rahmanpour, R
   Bugg, TDH
AF Rahmanpour, Rahman
   Bugg, Timothy D. H.
TI Characterisation of Dyp-type peroxidases from Pseudomonas fluorescens
   Pf-5: Oxidation of Mn(II) and polymeric lignin by Dyp1B
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Dye decolourising peroxidase; Lignin; Pseudomonas fluorescens
ID RHODOCOCCUS-JOSTII RHA1; DECOLORIZING PEROXIDASES; HEME; IDENTIFICATION;
   BACTERIUM
AB Members of the DyP family of peroxidases in Gram-positive bacteria have recently been shown to oxidise Mn(II) and lignin model compounds. Gram-negative pseudomonads, which also show activity for lignin oxidation, also contain dyp-type peroxidase genes. Pseudomonas fluorescens Pf-5 contains three dyp-type peroxidases (35, 40 and 55 kDa), each of which has been overexpressed in Escherichia coli, purified, and characterised. Each of the three enzymes shows activity for oxidation of phenol substrates, but the 35 kDa Dyp1B enzyme also shows activity for oxidation of Mn(II) and Kraft lignin. Treatment of powdered lignocellulose with Dyp1B in the presence of Mn(II) and hydrogen peroxide leads to the release of a low molecular weight lignin fragment, which has been identified by mass spectrometry as a beta-aryl ether lignin dimer containing one G unit and one H unit bearing a benzylic ketone. A mechanism for release of this fragment from lignin oxidation is proposed. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Rahmanpour, Rahman; Bugg, Timothy D. H.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.
RP Bugg, TDH (reprint author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.
EM T.D.Bugg@warwick.ac.uk
FU University of Warwick
FX We thank the University of Warwick for the award of a Chancellor's
   International Scholarship to Rahman Rahmanpour, and we thank Dr. Derren
   Heyes (University of Manchester) for assistance with stopped flow
   kinetic measurements.
CR Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200
   Kim SJ, 1999, APPL ENVIRON MICROB, V65, P1029
   RAMACHANDRA M, 1988, APPL ENVIRON MICROB, V54, P3057
   Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009
   Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8
   Ogola HJO, 2009, APPL ENVIRON MICROB, V75, P7509, DOI 10.1128/AEM.01121-09
   Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y
   Ahmad M, 2010, MOL BIOSYST, V6, P815, DOI 10.1039/b908966g
   Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7
   Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z
   Wong DWS, 2009, APPL BIOCHEM BIOTECH, V157, P174, DOI 10.1007/s12010-008-8279-z
   Santos A, 2014, APPL MICROBIOL BIOT, V98, P2053, DOI 10.1007/s00253-013-5041-4
   Ruiz-Duenas FJ, 2007, BIOCHEMISTRY-US, V46, P66, DOI 10.1021/bi061542h
   Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780
   Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u
   Taylor CR, 2012, J APPL MICROBIOL, V113, P521, DOI 10.1111/j.1365-2672.2012.05352.x
   Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h
   Singh R, 2013, ACS CHEM BIOL, V8, P700, DOI 10.1021/cb300608x
   Ghasempur S, 2007, ENVIRON SCI TECHNOL, V41, P7073, DOI 10.1021/es070626q
   van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x
   Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550
   POULOS TL, 1980, J BIOL CHEM, V255, P8199
   Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106
   Rahmanpour R., 2012, FEBS J, V280, P2097
NR 24
TC 6
Z9 6
U1 14
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 93
EP 98
DI 10.1016/j.abb.2014.12.022
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500011
PM 25558792
ER

PT J
AU Mendes, S
   Brissos, V
   Gabriel, A
   Catarino, T
   Turner, DL
   Todorovic, S
   Martins, LO
AF Mendes, Sonia
   Brissos, Vania
   Gabriel, Antonieta
   Catarino, Teresa
   Turner, David L.
   Todorovic, Smilja
   Martins, Ligia O.
TI An integrated view of redox and catalytic properties of B-type PpDyP
   from Pseudomonas putida MET94 and its distal variants
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Dye decolourising peroxidase; Pseudomonas putida; Site directed
   mutagenesis; Kinetics; Spectroscopy; Redox properties
ID DYE-DECOLORIZING PEROXIDASE; CYTOCHROME-C PEROXIDASE; COMPOUND-I
   FORMATION; HYDROGEN-PEROXIDE; ACTIVE-SITE; HORSERADISH-PEROXIDASE;
   CATALASE-PEROXIDASE; RAMAN-SPECTROSCOPY; SUBSTRATE-BINDING; HEME
   PEROXIDASES
AB PpDyP from Pseudomonas putida MET94 is an extremely versatile B-type dye-decolourising peroxidase (DyP) capable of efficient oxidation of a wide range of anthraquinonic and azo dyes, phenolic substrates, the non-phenolic veratryl alcohol and even manganese and ferrous ions. In reaction with H2O2 it forms a stable Compound I at a rate of (1.4 +/- 0.3) x 10(6) M-1 s(-1), comparable to those of classical peroxidases and other DyPs. We provide the first report of standard redox potential (En of the Compound I/Native redox couple in a DyP-type peroxidase. The value of E-Cpd(0') (I/N) = 1.10 +/- 0.04 (V) is similar to those found in peroxidases from the mammalian superfamily but higher than in peroxidases from the plant superfamily. Site-directed mutagenesis has been used to investigate the role of conserved distal residues, i.e. to replace aspartate 132 by asparagine, and arginine 214 and asparagine 136 by leucine. The structural, redox and catalytic properties of variants are addressed by spectroscopic, electrochemical and kinetic measurements. Our data point to the importance of the distal arginine in the catalytic mechanism of PpDyP, as also observed in DyPB from Rhodococcus jostii RHA1 but not in DyPs from the A and D subfamilies. This work reinforces the idea of existence of mechanistic variations among members of the different sub-families of DyPs with direct implications for their enzymatic properties and potential for biotechnological applications. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Mendes, Sonia; Brissos, Vania; Gabriel, Antonieta; Catarino, Teresa; Turner, David L.; Todorovic, Smilja; Martins, Ligia O.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal.
   [Catarino, Teresa] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, P-2829516 Caparica, Portugal.
RP Martins, LO (reprint author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ, P-2780157 Oeiras, Portugal.
EM lmartins@itqb.unl.pt
RI Todorovic, Smilja/F-7612-2010; Brissos, Vania/M-5789-2013; Turner,
   David/B-9061-2011; Mendes, Sonia/L-1224-2014; Martins, Ligia
   O./C-2513-2009
OI Todorovic, Smilja/0000-0002-0219-6743; Brissos,
   Vania/0000-0002-8171-0113; Mendes, Sonia/0000-0003-0568-204X; Martins,
   Ligia O./0000-0003-0082-9591
FU FCT-Fundacao para a Ciencia e Tecnologia, Portugal
   [PEst-OE/QUI/UI0100/2013, EXP/BBB-BIO/1932/2013, REEQ/336/BIO/2005]
FX The authors thank Celia Silveira for the help with CV experiments.
   FCT-Fundacao para a Ciencia e Tecnologia, Portugal, is acknowledged for
   funding (PEst-OE/QUI/UI0100/2013, EXP/BBB-BIO/1932/2013 and
   REEQ/336/BIO/2005).
CR Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200
   Poulos TL, 2010, ARCH BIOCHEM BIOPHYS, V500, P3, DOI 10.1016/j.abb.2010.02.008
   Liers C, 2014, J MOL CATAL B-ENZYM, V103, P41, DOI 10.1016/j.molcatb.2013.09.025
   Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0
   Haladjian J, 1996, TALANTA, V43, P1125, DOI 10.1016/0039-9140(96)01874-7
   RodriguezLopez JN, 1996, J BIOL INORG CHEM, V1, P136, DOI 10.1007/s007750050032
   DiCarlo CM, 2007, J INORG BIOCHEM, V101, P603, DOI 10.1016/j.jinorgbio.2006.12.006
   Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176
   Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171
   Hiner ANP, 2002, J INORG BIOCHEM, V91, P27, DOI 10.1016/S0162-0134(02)00390-2
   Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002
   Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8
   Sezer M, 2013, BIOCHEMISTRY-US, V52, P3074, DOI 10.1021/bi301630a
   Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g
   Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y
   Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7
   Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x
   Sezer M, 2012, SOFT MATTER, V8, P10314, DOI 10.1039/c2sm26310f
   Liers C, 2013, APPL MICROBIOL BIOT, V97, P5839, DOI 10.1007/s00253-012-4521-2
   Zamocky M, 2012, BIOCHIMIE, V94, P673, DOI 10.1016/j.biochi.2011.09.020
   Santos A, 2014, APPL MICROBIOL BIOT, V98, P2053, DOI 10.1007/s00253-013-5041-4
   RodriguezLopez JN, 1996, J BIOL CHEM, V271, P4023
   VITELLO LB, 1993, BIOCHEMISTRY-US, V32, P9807, DOI 10.1021/bi00088a036
   Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780
   Smulevich G, 2005, ACCOUNTS CHEM RES, V38, P433, DOI 10.1021/ar020112q
   Salvachua D, 2013, APPL ENVIRON MICROB, V79, P4316, DOI 10.1128/AEM.00699-13
   van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x
   Yoshida T, 2011, FEBS J, V278, P2387, DOI 10.1111/j.1742-4658.2011.08161.x
   Arnhold J, 2001, EUR J BIOCHEM, V268, P5142, DOI 10.1046/j.0014-2956.2001.02449.x
   BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9
   Colpa DI, 2014, J IND MICROBIOL BIOT, V41, P1, DOI 10.1007/s10295-013-1371-6
   Dunford H.B., 2010, PEROXIDASES CATALASE, P107
   Efimov I, 2007, BIOCHEMISTRY-US, V46, P8017, DOI 10.1021/bi7006492
   ERMAN JE, 1992, J AM CHEM SOC, V114, P6592, DOI 10.1021/ja00042a068
   FARHANGRAZI ZS, 1994, BIOCHEMISTRY-US, V33, P5647, DOI 10.1021/bi00184a038
   Furtmuller PG, 2005, J INORG BIOCHEM, V99, P1220, DOI 10.1016/j.jinorgbio.2005.02.021
   Furtmuller PG, 2003, BIOCHEM BIOPH RES CO, V301, P551, DOI 10.1016/S0006-291X(02)03075-9
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Kapetanaki S, 2003, BIOCHEMISTRY-US, V42, P3835, DOI 10.1021/bi026992y
   KOPPENOL WH, 1987, BIOELECTROCH BIOENER, V18, P3, DOI 10.1016/0302-4598(87)85002-X
   Mondal MS, 1996, J AM CHEM SOC, V118, P263, DOI 10.1021/ja952489f
   NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4
NR 42
TC 2
Z9 2
U1 4
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 99
EP 107
DI 10.1016/j.abb.2015.03.009
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500012
PM 25797439
ER

PT J
AU Zamocky, M
   Hofbauer, S
   Schaffner, I
   Gasselhuber, B
   Nicolussi, A
   Soudi, M
   Pirker, KF
   Furamuller, PG
   Obinger, C
AF Zamocky, Marcel
   Hofbauer, Stefan
   Schaffner, Irene
   Gasselhuber, Bernhard
   Nicolussi, Andrea
   Soudi, Monika
   Pirker, Katharina F.
   Furamueller, Paul G.
   Obinger, Christian
TI Independent evolution of four heme peroxidase superfamilies
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Heme peroxidase; Peroxidase-catalase superfamily;
   Peroxidase-cyclooxygenase superfamily; Peroxidase-chlorite dismutase
   superfamily; Peroxidase-peroxygenase superfamily
ID CHLORITE DISMUTASES; BACTERIAL PEROXIDASE; ASCORBATE-PEROXIDASE;
   CATALASE-PEROXIDASE; ALPHA-DIOXYGENASE; CRYSTAL-STRUCTURE; CLASS-I;
   FUNGAL; REDOX; CYCLOOXYGENASE
AB Four heme peroxidase superfamilies (peroxidase-catalase, peroxidase-cyclooxygenase, peroxidase-chlorite dismutase and peroxidase-peroxygenase superfamily) arose independently during evolution, which differ in overall fold, active site architecture and enzymatic activities. The redox cofactor is heme b or posttranslationally modified heme that is ligated by either histidine or cysteine. Heme peroxidases are found in all kingdoms of life and typically catalyze the one- and two-electron oxidation of a myriad of organic and inorganic substrates. In addition to this peroxidatic activity distinct (sub)families show pronounced catalase, cyclooxygenase, chlorite dismutase or peroxygenase activities. Here we describe the phylogeny of these four superfamilies and present the most important sequence signatures and active site architectures. The classification of families is described as well as important turning points in evolution. We show that at least three heme peroxidase superfamilies have ancient prokaryotic roots with several alternative ways of divergent evolution. In later evolutionary steps, they almost always produced highly evolved and specialized clades of peroxidases in eukaryotic kingdoms with a significant portion of such genes involved in coding various fusion proteins with novel physiological functions. (C) 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
C1 [Zamocky, Marcel; Hofbauer, Stefan; Schaffner, Irene; Gasselhuber, Bernhard; Nicolussi, Andrea; Soudi, Monika; Pirker, Katharina F.; Furamueller, Paul G.; Obinger, Christian] Univ Nat Resources & Life Sci, VIBT, Div Biochem, Dept Chem, A-1190 Vienna, Austria.
   [Zamocky, Marcel] Slovak Acad Sci, Inst Mol Biol, SK-84551 Bratislava, Slovakia.
   [Hofbauer, Stefan] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, A-1030 Vienna, Austria.
RP Zamocky, M (reprint author), Univ Nat Resources & Life Sci, VIBT, Div Biochem, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria.
EM marcel.zamocky@boku.ac.at
RI Hofbauer, Stefan/I-3889-2014; 
OI Obinger, Christian/0000-0002-7133-3430; Hofbauer,
   Stefan/0000-0003-3375-7715
FU Austrian Science Fund (FWF) [P23855, P25270, P25538, P27474, W1224];
   Slovak Grant Agency VEGA [2/0021/14]
FX This work was supported by the Austrian Science Fund (FWF projects
   P23855, P25270, P25538, P27474 & W1224) as well as by the Slovak Grant
   Agency VEGA (Grant 2/0021/14).
CR Adak S, 2005, BIOCHEM J, V390, P465, DOI 10.1042/BJ20050311
   Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X
   Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061
   Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436
   Kessler J, 2008, THYROID, V18, P769, DOI 10.1089/thy.2007.0310
   Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581
   Su C, 1996, J BIOL CHEM, V271, P14112
   Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0
   Hofrichter M, 2006, APPL MICROBIOL BIOT, V71, P276, DOI 10.1007/s00253-006-0417-3
   Singh R, 2012, J BIOL CHEM, V287, P10623, DOI 10.1074/jbc.M111.332171
   Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/nchembio.1038, 10.1038/NCHEMBIO.1038]
   Kawamura M, 2014, PROSTAG OTH LIPID M, V109, P14, DOI 10.1016/j.prostaglandins.2014.03.002
   Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8
   Passardi F, 2007, GENOMICS, V89, P567, DOI 10.1016/j.ygeno.2007.01.006
   Jerneren F, 2010, J BIOL CHEM, V285, P5308, DOI 10.1074/jbc.M109.062810
   Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g
   Singh R, 2008, ARCH BIOCHEM BIOPHYS, V471, P207, DOI 10.1016/j.abb.2007.12.008
   Goulah CC, 2013, BIOCHEMISTRY-US, V52, P1364, DOI 10.1021/bi400013k
   Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047
   Zamocky M, 2010, ARCH BIOCHEM BIOPHYS, V500, P45, DOI 10.1016/j.abb.2010.03.024
   Yoshida T, 2015, ARCH BIOCHEM BIOPHYS, V574, P49, DOI 10.1016/j.abb.2015.01.022
   Zamocky M, 2012, BIOCHIMIE, V94, P673, DOI 10.1016/j.biochi.2011.09.020
   Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748
   Hofrichter M, 2014, CURR OPIN CHEM BIOL, V19, P116, DOI 10.1016/j.cbpa.2014.01.015
   Ishikawa T, 2010, BIOCHEM J, V426, P125, DOI 10.1042/BJ20091406
   Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950
   Mlynek G, 2011, J BACTERIOL, V193, P2408, DOI 10.1128/JB.01262-10
   Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017
   Hofbauer S, 2012, BIOCHEMISTRY-US, V51, P9501, DOI 10.1021/bi3013033
   Hofbauer S, 2014, BIOTECHNOL J, V9, P461, DOI 10.1002/biot.201300210
   Piontek K, 2013, J BIOL CHEM, V288, P34767, DOI 10.1074/jbc.M113.514521
   Mathe C, 2010, ARCH BIOCHEM BIOPHYS, V500, P58, DOI 10.1016/j.abb.2010.04.007
   Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003
   Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111
   van Bloois E, 2010, APPL MICROBIOL BIOT, V86, P1419, DOI 10.1007/s00253-009-2369-x
   Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Hofbauer S, 2014, BIOCHEMISTRY-US, V53, P3145, DOI 10.1021/bi500401k
   Auer M, 2013, J BIOL CHEM, V288, P27181, DOI 10.1074/jbc.M113.477067
   Auer M, 2014, J BIOL CHEM, V289, P31480, DOI 10.1074/jbc.M114.595157
   Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063
   Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154
   Chothia C, 2009, BIOCHEM J, V419, P15, DOI 10.1042/BJ20090122
   Dailey TA, 2010, J BIOL CHEM, V285, P25978, DOI 10.1074/jbc.M110.142604
   Erman JE, 2002, BBA-PROTEIN STRUCT M, V1597, P193, DOI 10.1016/S0167-4838(02)00317-5
   Fraaije MW, 1996, EUR J BIOCHEM, V235, P192, DOI 10.1111/j.1432-1033.1996.00192.x
   Gui-Qin S., 2012, ARCH INSECT BIOCH PH, V79, P87
   Hofbauer S, 2015, ARCH BIOCHEM BIOPHYS, V574, P36, DOI 10.1016/j.abb.2015.01.010
   Kellner H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095557
   Lazzarotto F, 2011, NEW PHYTOL, V191, P234, DOI 10.1111/j.1469-8137.2011.03659.x
   Loughran NB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-101
   Mayfield JA, 2013, J BIOL CHEM, V288, P23488, DOI 10.1074/jbc.M112.442335
   Mimuro M, 2011, BIOENERGETIC PROCESSES OF CYANOBACTERIA: FROM EVOLUTIONARY SINGULARITY TO ECOLOGICAL DIVERSITY, P211, DOI 10.1007/978-94-007-0388-9_9
   Peraza L, 2002, BIOL CHEM, V383, P569, DOI 10.1515/BC.2002.058
   Sammut SJ, 2008, BRIEF BIOINFORM, V9, P210, DOI 10.1093/bib/bbn010
   Santamaria-Hernando S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040698
   Schaffner I., MOL MICROBIOL UNPUB
   Soudi M., 2012, CHEM BIODIVERS, P1776
   Sundermann A, 2014, BIOCHEMISTRY-US, V53, P4869, DOI 10.1021/bi500467h
   Vizzini A., 2013, DEV COMPUT IMMUNOL, V41, P59
   Welinder KG, 1992, CURR OPIN STRUC BIOL, V2, P388, DOI 10.1016/0959-440X(92)90230-5
   Zamocky M, 2006, FEBS LETT, V580, P6655, DOI 10.1016/j.febslet.2006.11.017
   Zamocky M, 2004, EUR J BIOCHEM, V271, P3297, DOI 10.1111/j.1432-1033.2004.04262.x
   Zamocky M, 2013, ARCH MICROBIOL, V195, P393, DOI 10.1007/s00203-013-0887-5
   Zamocky M, 2014, CELL MOL LIFE SCI, V71, P4681, DOI 10.1007/s00018-014-1643-y
   Zhu GY, 2013, PROTEIN SCI, V22, P1432, DOI 10.1002/pro.2327
NR 66
TC 5
Z9 5
U1 17
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2015
VL 574
SI SI
BP 108
EP 119
DI 10.1016/j.abb.2014.12.025
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH6MA
UT WOS:000354149500013
PM 25575902
ER

PT J
AU Silva-Filho, JL
   Souza, MC
   Henriques, MG
   Morrot, A
   Savino, W
   Caruso-Neves, C
   Pinheiro, AAS
AF Silva-Filho, J. L.
   Souza, M. C.
   Henriques, M. G.
   Morrot, A.
   Savino, W.
   Caruso-Neves, C.
   Pinheiro, A. A. S.
TI Renin-angiotensin system contributes to naive T-cell migration in vivo
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Renin-angiotensin system; Angiotensin receptors; Adaptive immunity;
   Lymphoid organs; Chemokine
ID HOMEOSTATIC CHEMOKINES CCL19; SECONDARY LYMPHOID ORGANS; KAPPA-B
   ACTIVATION; II TYPE-1 RECEPTOR; DENDRITIC CELLS; L-SELECTIN; ADHESION
   MOLECULE-1; BINDING-SITES; UP-REGULATION; EXPRESSION
AB Angiotensin II (Ang II) plays an important role in the regulation of the T-cell response during inflammation. However, the cellular mechanisms underlying the regulation of lymphocytes under physiologic conditions have not yet been studied. Here, we tested the influence of Ang II on T-cell migration using T cells from BALB/c mice. The results obtained in vivo showed that when Ang II production or the AT(1) receptor were blocked, T-cell counts were enhanced in blood but decreased in the spleen. The significance of these effects was confirmed by observing that these cells migrate, through fibronectin to Ang II via the AT(1) receptor. We also observed a gradient of Ang II from peripheral blood to the spleen, which explains its chemotactic effect on this organ. The following cellular mechanisms were identified to mediate the Ang II effect: upregulation of the chemokine receptor CCR9; upregulation of the adhesion molecule CD62L; increased production of the chemokines CCL19 and CCL25 in the spleen. These results indicate that the higher levels of Ang II in the spleen and AT(1) receptor activation contribute to migration of naive T cells to the spleen, which expands our understanding on how the Ang II/AT(1) receptor axis contributes to adaptive immunity. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Silva-Filho, J. L.; Caruso-Neves, C.; Pinheiro, A. A. S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Souza, M. C.; Henriques, M. G.] Inst Tecnol Farmacos, Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Morrot, A.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo Goes, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Savino, W.] Fundacao Oswaldo Cruz, Dept Imunol, Rio De Janeiro, RJ, Brazil.
   [Caruso-Neves, C.] Conselho Nacl Desenvolvimento Cient & Tecnol, MCT, Inst Nacl Ciencia & Tecnol Biol & Bioimagem, Sao Paulo, Brazil.
   [Pinheiro, A. A. S.] Conselho Nacl Desenvolvimento Cient & Tecnol, MCT, Inst Nacl Pesquisa Translac Saude & Ambiente Reg, Sao Paulo, Brazil.
RP Pinheiro, AAS (reprint author), Univ Fed Rio de Janeiro, CCS, Bloco C,Sala 34, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM acacia@biof.ufrj.br
RI Henriques, Maria das Gracas/G-2998-2013
OI Henriques, Maria das Gracas/0000-0003-3065-0541
FU Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - INCT/INPeTAm/CNPq/MCT [57.3695/2008-3]; Brazilian agency:
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   INCT-INBEB/CNPq/MCT [57.3767/2008-4]; Brazilian agency: Fundacao Carlos
   Chagas Filho de Amparo Pesquisa do Estado do Rio de Janeiro - FAPERJ
   [E-26/110.085/2014, E-26/110.605/2012]
FX This work was supported by Grants from the following Brazilian agencies:
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   INCT/INPeTAm/CNPq/MCT [Grant Number 57.3695/2008-3], INCT-INBEB/CNPq/MCT
   [Grant Number 57.3767/2008-4]; and Fundacao Carlos Chagas Filho de
   Amparo Pesquisa do Estado do Rio de Janeiro - FAPERJ [Grant Numbers
   E-26/110.085/2014, E-26/110.605/2012].
CR Abd Alla J, 2010, J BIOL CHEM, V285, P23494, DOI 10.1074/jbc.M110.117481
   Ahmed NA, 1996, CLIN INVEST MED, V19, P427
   Ahn KO, 2007, TRANSPLANTATION, V83, P938, DOI 10.1097/01.tp.0000258589.39006.94
   Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005
   Ruiz-Ortega M, 2001, CURR OPIN NEPHROL HY, V10, P321, DOI 10.1097/00041552-200105000-00005
   Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669
   Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6
   Bono MR, 2007, CYTOKINE GROWTH F R, V18, P33, DOI 10.1016/j.cytogfr.2007.01.004
   Zaballos A, 1999, J IMMUNOL, V162, P5671
   Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106
   Damas JK, 2007, ARTERIOSCL THROM VAS, V27, P614, DOI 10.1161/01.ATV.0000255581.38523.7c
   Kumar R, 2007, TRENDS ENDOCRIN MET, V18, P208, DOI 10.1016/j.term.2007.05.001
   Jurewicz M, 2007, J AM SOC NEPHROL, V18, P1093, DOI 10.1681/ASN.2006070707
   Lapteva N, 2001, BIOCHEM BIOPH RES CO, V285, P1059, DOI 10.1006/bbrc.2001.5215
   Engelhardt B, 2004, EUR J IMMUNOL, V34, P2955, DOI 10.1002/eji.200425327
   PABST R, 1988, IMMUNOL TODAY, V9, P43, DOI 10.1016/0167-5699(88)91258-3
   Kvakan H, 2009, CIRCULATION, V119, P2904, DOI 10.1161/CIRCULATIONAHA.108.832782
   Muller DN, 2002, AM J PATHOL, V161, P1679, DOI 10.1016/S0002-9440(10)64445-8
   Pickens SR, 2012, ARTHRITIS RHEUM-US, V64, P2471, DOI 10.1002/art.34452
   Kaur D, 2006, AM J RESP CRIT CARE, V174, P1179, DOI 10.1164/rccm.200603-394OC
   Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60
   Basso N, 2001, HYPERTENSION, V38, P1246, DOI 10.1161/hy1201.101214
   Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645
   Navar LG, 2002, HYPERTENSION, V39, P316, DOI 10.1161/hy0202.103821
   Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019
   Damas JK, 2009, CLIN EXP IMMUNOL, V157, P400, DOI 10.1111/j.1365-2249.2009.03976.x
   Piqueras L, 2000, CIRCULATION, V102, P2118
   Liu J, 2012, INT J MOL MED, V29, P269, DOI 10.3892/ijmm.2011.818
   Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430
   Engwerda CR, 2005, TRENDS PARASITOL, V21, P75, DOI 10.1016/j.pt.2004.11.008
   Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040
   Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje
   Nie WC, 2009, MOL IMMUNOL, V46, P355, DOI 10.1016/j.molimm.2008.10.022
   Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8
   Astrup E., 2014, BMC INFECT DIS, V9, P70
   Besedovsky L, 2014, EUR J IMMUNOL, V44, P1759, DOI 10.1002/eji.201344265
   Blann AD, 1996, BRIT J HAEMATOL, V95, P192, DOI 10.1046/j.1365-2141.1996.7562378.x
   Carramolino L, 2001, BLOOD, V97, P850, DOI 10.1182/blood.V97.4.850
   CASTREN E, 1987, PEPTIDES, V8, P737, DOI 10.1016/0196-9781(87)90050-7
   Coppo M, 2008, REGUL PEPTIDES, V151, P1, DOI 10.1016/j.regpep.2008.07.010
   Costerousse, 1993, J BIOCH, V290, P33
   Crowley S. D., 2008, AM J PHYSIOL-RENAL, V295, P515
   CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581
   DEGANDARIAS JM, 1988, REV ESP FISIOL, V44, P191
   Del Portillo H.A., 2005, CELL MICROBIOL, V14, P343
   EKKER M, 1989, P NATL ACAD SCI USA, V86, P5155, DOI 10.1073/pnas.86.13.5155
   FORD WL, 1969, BRIT J EXP PATHOL, V50, P257
   Hoch N.E., 2009, AM J PHYSIOL-REG I, V296, P208
   KUNERTRADEK J, 1994, BIOCHEM BIOPH RES CO, V198, P1034, DOI 10.1006/bbrc.1994.1147
   Lee HS, 2012, IMMUNOBIOLOGY, V217, P402, DOI 10.1016/j.imbio.2011.10.014
   Mills PJ, 2002, J HYPERTENS, V20, P311, DOI 10.1097/00004872-200202000-00022
   Moschovakis GL, 2012, EUR J IMMUNOL, V42, P1949, DOI 10.1002/eji.201242614
   Nabah Yafa Naim Abu, 2004, Circulation, V110, P3581, DOI 10.1161/01.CIR.0000148824.93600.F3
   Nahmod K, 2010, J PHARMACOL EXP THER, V334, P854, DOI 10.1124/jpet.109.161760
   Nataraj C, 1999, J CLIN INVEST, V104, P1693, DOI 10.1172/JCI7451
   Noor S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-77
   Okamura A, 1999, J HYPERTENS, V17, P537, DOI 10.1097/00004872-199917040-00012
   Pavel J, 2009, REGUL PEPTIDES, V158, P156, DOI 10.1016/j.regpep.2009.09.004
   PHILLIPS MI, 1993, REGUL PEPTIDES, V43, P1
   Prasad A, 2001, AM HEART J, V142, P248, DOI 10.1067/mhj.2001.116699
   Rasini E, 2006, REGUL PEPTIDES, V134, P69, DOI 10.1016/j.regpep.2006.01.007
   Sanchez-Lemus E., 2009, AM J PHYSIOL-REG I, V296, P1376
   Seidelin JB, 1998, AM J GASTROENTEROL, V93, P1854
   SHIMADA K, 1978, J BIOCHEM-TOKYO, V84, P1013
   Silva JL, 2011, MOL IMMUNOL, V48, P1835, DOI 10.1016/j.molimm.2011.05.008
   Silva-Filho J.L., 2013, PLOS ONE, V8, P62999
   Soloski M.J., 2014, PLOS ONE, V9, P93243
   Sun PY, 2009, INFLAMMATION, V32, P347, DOI 10.1007/s10753-009-9141-3
   von Andrian UH, 2000, NEW ENGL J MED, V343, P1020
   Weninger W, 2003, J IMMUNOL, V170, P4638
   Zapolska-Downar D, 2006, J HYPERTENS, V24, P1565, DOI 10.1097/01.hjh.0000239292.32883.38
NR 71
TC 0
Z9 0
U1 9
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 1
EP 13
DI 10.1016/j.abb.2015.02.035
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100001
PM 25752953
ER

PT J
AU Tsai, CY
   Chen, YJ
   Fu, YS
   Chang, LS
AF Tsai, Chia-Yu
   Chen, Ying-Jung
   Fu, Yaw-Syan
   Chang, Long-Sen
TI Antibacterial and membrane-damaging activities of mannosylated bovine
   serum albumin
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Mannosylated BSA; Bactericidal effect; Membrane-damaging activity;
   Fusogenicity
ID INDUCED LUNG INFLAMMATION; ANTIMICROBIAL PEPTIDES;
   STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; OUTER-MEMBRANE; MOLECULAR
   CHARACTERIZATION; BETA-LACTOGLOBULIN; LACTOFERRIN; PERMEABILITY;
   BACTERIA
AB The aim of this study was to test whether mannosylated BSA (Man-BSA) exerts antibacterial activity on Escherichia coli (gram-negative bacteria) and Staphylococcus aureus (gram-positive bacteria) via its membrane-damaging effect. Man-BSA caused inhibition of growth of E. coli and S. aureus. Moreover, bactericidal action of Man-BSA on E. coli and S. aureus positively correlated with the increase in membrane permeability of the bacterial cells. Morphological examination showed that Man-BSA disrupted bacterial membrane integrity. Destabilization of the lipopolysaccharide (LPS) layer and inhibition of lipoteichoic acid (LTA) biosynthesis in the cell wall increased the bactericidal effect of Man-BSA on E. coli and S. aureus. Man-BSA also induced leakage and fusion of membrane-mimicking liposomes in E. coli and S. aureus. Man-BSA showed similar binding affinity for LPS and LTA. LPS and LTA strongly suppressed the membrane-damaging activity of Man-BSA, whereas an increase in the Man-BSA concentration attenuated the inhibitory action of LPS and LTA. Taken together, our data indicate that Man-BSA's bactericidal activity depends strongly on its ability to induce membrane permeability. Moreover, the bactericidal action of Man-BSA proven in this study suggests that Man-BSA may serve as a prototype for the development of anti-infective agents targeting E. coli and S. aureus. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Tsai, Chia-Yu; Chen, Ying-Jung; Chang, Long-Sen] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan.
   [Fu, Yaw-Syan] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan.
   [Chang, Long-Sen] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung 807, Taiwan.
RP Chang, LS (reprint author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan.
EM lschang@mail.nsysu.edu.tw
FU Ministry of Science and Technology, Taiwan, ROC [MOST
   103-2320-B110-002-MY2]
FX This work was supported by Grant MOST 103-2320-B110-002-MY2 from the
   Ministry of Science and Technology, Taiwan, ROC (to L.S. Chang).
CR Torrent M, 2009, BIOCHEM J, V421, P425, DOI 10.1042/BJ20082330
   Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637
   Pan Y, 2007, INT DAIRY J, V17, P606, DOI 10.1016/j.idairyj.2006.08.005
   Epand RF, 2008, J MOL BIOL, V379, P38, DOI 10.1016/j.jmb.2008.03.047
   Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Koprivnjak T, 2008, INFECT IMMUN, V76, P2169, DOI 10.1128/IAI.01705-07
   Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015
   Haney EF, 2009, BIOCHIMIE, V91, P141, DOI 10.1016/j.biochi.2008.04.013
   PIERS KL, 1994, ANTIMICROB AGENTS CH, V38, P2311
   Knapp S, 2008, J IMMUNOL, V180, P3478
   Arcidiacono S, 2009, J PEPT SCI, V15, P398, DOI 10.1002/psc.1125
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   van den Bogaart G, 2007, BIOPHYS J, V93, P154, DOI 10.1529/biophysj.107.106005
   Pan Y, 2007, INT DAIRY J, V17, P1450, DOI 10.1016/j.idairyj.2007.04.006
   Brown KL, 2011, J IMMUNOL, V186, P5497, DOI 10.4049/jimmunol.1002508
   Orsi N, 2004, BIOMETALS, V17, P189, DOI 10.1023/B:BIOM.0000027691.86757.e2
   Hoek KS, 1997, ANTIMICROB AGENTS CH, V41, P54
   Ruan Y, 2013, INT IMMUNOPHARMACOL, V15, P575, DOI 10.1016/j.intimp.2013.01.012
   Abreu MSC, 2003, BIOPHYS J, V84, P386
   Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026
   Chaneton L, 2011, J DAIRY SCI, V94, P138, DOI 10.3168/jds.2010-3319
   Chen LW, 2011, TOXICON, V58, P46, DOI 10.1016/j.toxicon.2011.04.021
   Chiou YL, 2011, TOXICON, V58, P518, DOI 10.1016/j.toxicon.2011.08.013
   Dessing MC, 2008, J INFECT DIS, V197, P245, DOI 10.1086/524873
   Gurr MI, 2002, LIPID BIOCH
   Isogai E, 2003, ADV EXP MED BIOL, V528, P195
   Kao PH, 2012, TOXICON, V60, P367, DOI 10.1016/j.toxicon.2012.04.345
   Laganas V, 2003, ANTIMICROB AGENTS CH, V47, P2682, DOI 10.1128/AAC.47.8.2682-2684.2003
   Lin QP, 2008, EUR J PHARMACOL, V596, P160, DOI 10.1016/j.ejphar.2008.08.017
   MARVIN HJP, 1989, J BACTERIOL, V171, P5262
   Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067
   Pan Y, 2007, LETT APPL MICROBIOL, V44, P229, DOI 10.1111/j.1472-765X.2006.02081.x
   VAARA M, 1992, MICROBIOL REV, V56, P395
   Yang SY, 2014, ARCH BIOCHEM BIOPHYS, V564, P43, DOI 10.1016/j.abb.2014.10.001
NR 35
TC 0
Z9 0
U1 8
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 14
EP 22
DI 10.1016/j.abb.2015.02.034
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100002
PM 25752952
ER

PT J
AU An, P
   Brodsky, JL
   Pipas, JM
AF An, Ping
   Brodsky, Jeffrey L.
   Pipas, James M.
TI The conserved core enzymatic activities and the distinct dynamics of
   polyomavirus large T antigens
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Polyomavirus; ATPase; DNA helicase; Protein-protein interaction; p53
ID SIMIAN-VIRUS-40 LARGE T; LARGE TUMOR-ANTIGEN; MOLECULAR CHAPERONE
   FUNCTION; POLYMERASE ALPHA-PRIMASE; J-DOMAIN; ATPASE ACTIVITY;
   EVOLUTIONARY CONSERVATION; REPLICATIVE HELICASE; STRUCTURAL BASIS;
   DNA-REPLICATION
AB Several human polyomaviruses including JCV, BKV and TSV are associated with diseases, particularly in immunosuppressed patients. While the large T antigen (LT) encoded by the monkey polyomavirus SV40 is well studied, and possesses intrinsic ATPase and DNA helicase activities, the LTs of the human polyomaviruses are relatively uncharacterized. In order to evaluate whether these enzymatic activities, which are required for viral DNA replication, are conserved between polyomaviruses, we performed a comparative study using the LTs from JCV, TSV and SV40. The ATPase and DNA helicase activities and the interaction with the cellular tumor suppressor p53 were assayed for the purified Zn-ATPase domains of the three LTs. We found that all Zn-ATPases were active ATPases. The Zn-ATPase domains also functioned as DNA helicases, although the measured kinetic constants differed among the three proteins. In addition, when tested against four small molecule ATPase inhibitors, the Zn-ATPase domains of TSV was more resistant than that of SV40 and JCV. Our results show that, while LTs from JCV and TSV share the core ATPase and DNA helicase activities, they possess important functional differences that might translate into their respective abilities to infect and replicate in hosts. (C) 2015 Elsevier Inc. All rights reserved.
C1 [An, Ping; Brodsky, Jeffrey L.; Pipas, James M.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.
RP Pipas, JM (reprint author), Univ Pittsburgh, Dept Biol Sci, 4249 Fifth Ave, Pittsburgh, PA 15260 USA.
EM pipas@pitt.edu
FU National Institutes of Health [R21 AI109339]; Pittsburgh Center for
   Kidney Research [GM75061, DK79307]
FX This work was supported by National Institutes of Health (R21 AI109339)
   and the Pittsburgh Center for Kidney Research (GM75061 and DK79307).
CR Ahuja D, 2009, J VIROL, V83, P8781, DOI 10.1128/JVI.00621-09
   Hickman AB, 2005, CURR OPIN STRUC BIOL, V15, P77, DOI 10.1016/j.sbi.2004.12.001
   WAGA S, 1994, J BIOL CHEM, V269, P10923
   An P, 2012, ANNU REV MICROBIOL, V66, P213, DOI 10.1146/annurev-micro-092611-150154
   Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6
   Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684
   Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370
   Huryn DM, 2011, P NATL ACAD SCI USA, V108, P6757, DOI 10.1073/pnas.1015251108
   Pipas JM, 2001, SEMIN CANCER BIOL, V11, P23, DOI 10.1006/scbi.2000.0343
   Harris KF, 1996, J VIROL, V70, P2378
   WALKER JE, 1982, EMBO J, V1, P945
   Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381
   Sheppard HM, 1999, MOL CELL BIOL, V19, P2746
   Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399
   LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9
   Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017
   Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002
   Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916
   Bochkareva E, 2006, EMBO J, V25, P5961, DOI 10.1038/sj.emboj.7601452
   Calabrese L.H., 2014, NAT REV RHEUMATOL
   Cantalupo P, 2005, J VIROL, V79, P13094, DOI 10.1128/JVI.79.20.13094-13104.2005
   Castellino AM, 1997, J VIROL, V71, P7549
   CUNNINGHAM TP, 1985, J VIROL, V54, P483
   DELUCIA AL, 1983, J VIROL, V46, P143
   Fewell SW, 2002, P NATL ACAD SCI USA, V99, P2002, DOI 10.1073/pnas.042670999
   Greenleaf WB, 2008, J VIROL, V82, P6017, DOI 10.1128/JVI.00387-08
   Huang H, 2010, J BIOL CHEM, V285, P33475, DOI 10.1074/jbc.M110.156240
   van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024
   Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679
   Khopde S, 2008, J VIROL, V82, P1136, DOI 10.1128/JVI.01314-07
   Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295
   Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691
   Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad1456306
   Seguin SP, 2012, ANTIVIR RES, V96, P70, DOI 10.1016/j.antiviral.2012.07.012
   Seguin SP, 2012, J BIOMOL SCREEN, V17, P194, DOI 10.1177/1087057111421630
   Seneca NTM, 2014, VIROLOGY, V468, P47, DOI 10.1016/j.virol.2014.07.038
   Srinivasan A, 1997, MOL CELL BIOL, V17, P4761
   STAHL H, 1986, EMBO J, V5, P1939
   Stubdal H, 1997, MOL CELL BIOL, V17, P4979
   Sullivan CS, 2000, MOL CELL BIOL, V20, P6233, DOI 10.1128/MCB.20.17.6233-6243.2000
   TROWBRIDGE PW, 1993, VIROLOGY, V196, P458, DOI 10.1006/viro.1993.1502
   WIEKOWSKI M, 1988, J BIOL CHEM, V263, P436
   Wright CM, 2009, VIRUS RES, V141, P71, DOI 10.1016/j.virusres.2008.12.018
   Wright CM, 2008, BIOORGAN MED CHEM, V16, P3291, DOI 10.1016/j.bmc.2007.12.014
   Zalvide J, 1998, MOL CELL BIOL, V18, P1408
   Zhou B, 2012, J BIOL CHEM, V287, P26854, DOI 10.1074/jbc.M112.363655
NR 48
TC 2
Z9 2
U1 4
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 23
EP 31
DI 10.1016/j.abb.2015.02.033
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100003
PM 25752954
ER

PT J
AU LaFountain, AM
   Frank, HA
   Yuan, YW
AF LaFountain, Amy M.
   Frank, Harry A.
   Yuan, Yao-Wu
TI Carotenoid composition of the flowers of Mimulus lewisii and related
   species: Implications regarding the prevalence and origin of two unique,
   allenic pigments
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Carotenoid biosynthesis; High performance liquid chromatography;
   Mimulaxanthin; Monkeyflowers
ID MONKEYFLOWERS MIMULUS; REPRODUCTIVE ISOLATION; FLORAL TRAITS; EVOLUTION;
   PHOTOPROTECTION; MIMULAXANTHIN; XANTHOPHYLL; NEOXANTHIN; PHRYMACEAE;
   GUTTATUS
AB The genus Mimulus has been used as a model system in a wide range of ecological and evolutionary studies and contains many species with carotenoid pigmented flowers. However, the detailed carotenoid composition of these flowers has never been reported. In this paper the floral carotenoid composition of 11 Mimulus species are characterized using high-performance liquid chromatography, mass spectrometry and chemical methods with a particular focus on the genetic model species, Mimulus lewisii. M. lewisii flowers have five major carotenoids: antheraxanthin, violaxanthin, neoxanthin, and the unique allenic carotenoids, deepoxyneoxanthin and mimulaxanthin. This carotenoid profile is consistent with the expression levels of putative carotenoid biosynthetic genes in the M. lewisii flower. The other 10 species possess the same five carotenoids or a subset of these. Comparison of the carotenoid profiles among species in a phylogenetic context provides new insights into the biosynthesis and evolution of deepoxyneoxanthin and mimulaxanthin. This work also lays the foundation for future studies regarding transcriptional control of the carotenoid biosynthesis pathway in Mimulus flowers. (C) 2015 Elsevier Inc. All rights reserved.
C1 [LaFountain, Amy M.; Frank, Harry A.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA.
   [Yuan, Yao-Wu] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.
   [Yuan, Yao-Wu] Univ Connecticut, Inst Syst Genom, Storrs, CT 06269 USA.
RP LaFountain, AM (reprint author), Univ Connecticut, Dept Chem, 55 North Eagleville Rd, Storrs, CT 06269 USA.
EM amy.lafountain@uconn.edu
OI Yuan, Yaowu/0000-0003-1376-0028
FU University of Connecticut Research Foundation; University of Connecticut
   start-up funds
FX The authors would like to thank Dr. Shigeo Katsumura for providing
   synthetic mimulaxanthin, and Clinton Morse and Matt Opel for plant care.
   We are grateful to Dena Grossenbacher and Matt Streisfeld for kindly
   providing flower images used in Fig. 1. This work was supported by the
   University of Connecticut Research Foundation to H.A.F. and the
   University of Connecticut start-up funds to Y-W.Y.
CR Al-Babili A., 2000, FEBS LETT, V485, P168
   Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106
   BRADSHAW HD, 1995, NATURE, V376, P762, DOI 10.1038/376762a0
   Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002
   Baroli I, 2000, PHILOS T ROY SOC B, V355, P1385, DOI 10.1098/rstb.2000.0700
   Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333
   Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324
   Hellsten U, 2013, P NATL ACAD SCI USA, V110, P19478, DOI 10.1073/pnas.1319032110
   Yuan YW, 2013, GENETICS, V194, P255, DOI 10.1534/genetics.112.146852
   Ramsey J, 2003, EVOLUTION, V57, P1520
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Yuan YW, 2014, NEW PHYTOL, V204, P1013, DOI 10.1111/nph.12968
   Moise AR, 2014, CHEM REV, V114, P164, DOI 10.1021/cr400106y
   Dall'Osto L, 2007, J BIOL CHEM, V282, P35056, DOI 10.1074/jbc.M704729200
   Sweigart AL, 2006, GENETICS, V172, P2465, DOI 10.1534/genetics.105.053686
   Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910
   Beardsley PM, 2004, AM J BOT, V91, P474, DOI 10.3732/ajb.91.3.474
   Angert AL, 2005, EVOLUTION, V59, P1671
   MACNAIR MR, 1989, NEW PHYTOL, V112, P269, DOI 10.1111/j.1469-8137.1989.tb02383.x
   Brandvain Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004410
   Britton G, 1995, CAROTENOIDS A, V1A
   Britton G., 2004, CAROTENOIDS HDB
   BUCHECKER R, 1980, HELV CHIM ACTA, V63, P2531, DOI 10.1002/hlca.19800630848
   Cooley AM, 2009, NEW PHYTOL, V183, P729, DOI 10.1111/j.1469-8137.2009.02858.x
   DemmigAdams B, 1996, FASEB J, V10, P403
   Fishman L., 2008, SCIENCE, V322, P1599
   Glover B.J., 2007, UNDERSTANDING FLOWER
   Goodwin T. W, 1980, BIOCH CAROTENOIDS, V1
   Goodwin T.W., 1982, BIOCH CAROTENOIDS
   GOODWIN TW, 1964, PHYTOCHEMISTRY, V3, P47, DOI 10.1016/S0031-9422(00)83993-X
   Grossenbacher DL, 2011, EVOLUTION, V65, P2712, DOI 10.1111/j.1558-5646.2011.01306.x
   Hiesey W. M., 1971, CARNEGIE I WASHINGTO
   Kajikawa T, 2009, ORG BIOMOL CHEM, V7, P4586, DOI 10.1039/b915390j
   Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500
   Neue U.D., 2002, HPLC TROUBLESHOOTING
   NITSCHE H, 1972, PHYTOCHEMISTRY, V11, P3383, DOI 10.1016/S0031-9422(00)86413-4
   NITSCHE H, 1973, Z NATURFORSCH C, VC 28, P481
   NITSCHE H, 1972, PHYTOCHEMISTRY, V11, P401, DOI 10.1016/S0031-9422(00)90023-2
   NITSCHE H, 1969, TETRAHEDRON LETT, P2999
   Owen CR, 2011, ARTHROPOD-PLANT INTE, V5, P235, DOI 10.1007/s11829-011-9133-8
   Ruiz-Sola M.A., 2012, THE ARABIDOPSIS BOOK, V10
   Schiedt K., 1995, CAROTENOIDS A, V1A
   SCHIMMER BP, 1966, BIOCHEMISTRY-US, V5, P3649, DOI 10.1021/bi00875a038
   Streisfeld MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003385
   Takaichi S, 1998, PLANT CELL PHYSIOL, V39, P968
   Vickery P.K., 1992, AM NAT, V52, P145
   Weedon B.C.L., 1995, CAROTENOIDS A, V1A
   Yamamoto H.Y., 1978, BIOCHEMISTRY-US, V190, P514
   Young A. J., 1993, CAROTENOIDS PHOTOSYN, P16
   Yuan YW, 2013, GENETICS, V194, P523, DOI 10.1534/genetics.113.151225
   Zechmeister L., 1942, ARCH BIOCHEM, V1, P231
NR 51
TC 1
Z9 1
U1 7
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 32
EP 39
DI 10.1016/j.abb.2015.03.006
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100004
PM 25778629
ER

PT J
AU Ismael, FO
   Proudfoot, JM
   Brown, BE
   van Reyk, DM
   Croft, KD
   Davies, MJ
   Hawkins, CL
AF Ismael, Fahd O.
   Proudfoot, Julie M.
   Brown, Bronwyn E.
   van Reyk, David M.
   Croft, Kevin D.
   Davies, Michael J.
   Hawkins, Clare L.
TI Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and
   HOSCN with low-density lipoprotein (LDL): Implications for foam cell
   formation in atherosclerosis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Myeloperoxidase; Low-density lipoprotein; Thiocyanate; Cholesterol;
   Oxidation; Atherosclerosis
ID LACTOPEROXIDASE-CATALYZED OXIDATION; MAMMALIAN HEME PEROXIDASES;
   HYPOCHLOROUS ACID; LIPID-PEROXIDATION; THIOCYANATE LEVELS; YOUNG-PEOPLE;
   SMOKING; LESIONS; ENZYME; PLASMA
AB Atherosclerosis is characterised by the accumulation of lipids within macrophages in the artery wall. Low-density lipoprotein (LDL) is the source of this lipid, owing to the uptake of oxidised LDL by scavenger receptors. Myeloperoxidase (MPO) released by leukocytes during inflammation produces oxidants that are implicated in atherosclerosis. Modification of LDL by the MPO oxidant hypochlorous acid (Hod), results in extensive lipid accumulation by macrophages. However, the reactivity of the other major MPO oxidant, hypothiocyanous acid (HOSCN) with LDL is poorly characterised, which is significant given that thiocyanate is the favoured substrate for MPO. In this study, we comprehensively compare the reactivity of HOC and HOSCN with LDL, and show key differences in the profile of oxidative damage observed. HOSCN selectively modifies Cys residues on apolipoprotein B100, and oxidises cholesteryl esters resulting in formation of lipid hydroperoxides, 9-hydroxy-10,12-octadecadienoic acid (9-HODE) and F-2-isoprostanes. The modification of LDL by HOSCN results macrophage lipid accumulation, though generally to a lesser extent than HOCl-modified LDL. This suggests that a change in the ratio of HOSCN:HOCl formation by MPO from variations in plasma thiocyanate levels, will influence the nature of LDL oxidation in vivo, and has implications for the progression of atherosclerosis. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ismael, Fahd O.; Brown, Bronwyn E.; Davies, Michael J.; Hawkins, Clare L.] Heart Res Inst, Newtown, NSW 2042, Australia.
   [Ismael, Fahd O.; Brown, Bronwyn E.; Davies, Michael J.; Hawkins, Clare L.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Proudfoot, Julie M.; Croft, Kevin D.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6000, Australia.
   [van Reyk, David M.] Univ Technol Sydney, Fac Sci, Broadway, NSW 2007, Australia.
   [Davies, Michael J.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark.
RP Hawkins, CL (reprint author), Heart Res Inst, 7 Eliza St, Newtown, NSW 2042, Australia.
EM hawkinsc@hri.org.au
RI Davies, Michael/H-4939-2011
OI Davies, Michael/0000-0002-5196-6919
FU Australian National Health and Medical Research Council [570829];
   National Heart Foundation of Australia [CR 08S 3959]; Australian
   Research Council [FT120100682, CE0561607, DP0988311]
FX This work was supported by the Australian National Health and Medical
   Research Council [Grant No. 570829], National Heart Foundation of
   Australia [Grant No. CR 08S 3959] and the Australian Research Council
   [Grant Nos. FT120100682, CE0561607, DP0988311].
CR Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7
   Spalteholz H, 2005, BIOFACTORS, V24, P67
   Proudfoot J, 1999, ANAL BIOCHEM, V272, P209, DOI 10.1006/abio.1999.4187
   Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436
   Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927
   Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003
   Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379
   Hawkins CL, 2008, BIOCHEM J, V416, P441, DOI 10.1042/BJ20070941
   THOMAS EL, 1981, BIOCHEMISTRY-US, V20, P3273, DOI 10.1021/bi00514a045
   Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637
   Brown BE, 2005, DIABETOLOGIA, V48, P361, DOI 10.1007/s00125-004-1648-4
   Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x
   Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3
   Hawkins CL, 2005, CHEM RES TOXICOL, V18, P1600, DOI 10.1021/tx050207b
   vanDalen CJ, 1997, BIOCHEM J, V327, P487
   Hawkins CL, 2009, FREE RADICAL BIO MED, V46, P965, DOI 10.1016/j.freeradbiomed.2009.01.007
   Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003
   DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342
   Zhang RL, 2002, BLOOD, V99, P1802
   Tabas I, 2009, ANTIOXID REDOX SIGN, V11, P2333, DOI 10.1089/ARS.2009.2469
   Talib J, 2012, FREE RADICAL BIO MED, V53, P20, DOI 10.1016/j.freeradbiomed.2012.04.018
   Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733
   Botti TP, 1996, ATHEROSCLEROSIS, V124, P191, DOI 10.1016/0021-9150(96)05825-X
   Han KH, 2000, J CLIN INVEST, V106, P793, DOI 10.1172/JCI10052
   Hadfield KA, 2013, BIOCHEM J, V449, P531, DOI 10.1042/BJ20121210
   Apostolov EO, 2010, J AM SOC NEPHROL, V21, P1852, DOI 10.1681/ASN.2010040365
   Barrett TJ, 2012, CHEM RES TOXICOL, V25, P263, DOI 10.1021/tx200219s
   Barrett TJ, 2012, FREE RADICAL BIO MED, V52, P1075, DOI 10.1016/j.freeradbiomed.2011.12.024
   Basnakian AG, 2010, ADV CLIN CHEM, V51, P25, DOI 10.1016/S0065-2423(10)51002-3
   Bonifay V, 2014, ARCH BIOCHEM BIOPHYS, V564, P1, DOI 10.1016/j.abb.2014.08.014
   Calay D, 2010, ANTIOXID REDOX SIGN, V13, P1491, DOI 10.1089/ars.2009.2971
   Davies MJ, 2000, FREE RADICAL RES, V33, P719, DOI 10.1080/10715760000301241
   Delporte C, 2014, J LIPID RES, V55, P747, DOI 10.1194/jlr.M047449
   Ermak N, 2010, BIOCHEM BIOPH RES CO, V393, P783, DOI 10.1016/j.bbrc.2010.02.082
   Exner M, 2004, FREE RADICAL BIO MED, V37, P146, DOI 10.1016/j.freeradbiomed.2004.04.039
   Furtmuller PG, 2003, BIOCHEM BIOPH RES CO, V301, P551, DOI 10.1016/S0006-291X(02)03075-9
   HAZELL LJ, 1993, BIOCHEM J, V290, P165
   Hazell LJ, 1999, BIOCHEM J, V339, P489, DOI 10.1042/0264-6021:3390489
   HAZELL LJ, 1994, BIOCHEM J, V302, P297
   HUSGAFVELPURSIAINEN K, 1987, INT ARCH OCC ENV HEA, V59, P337, DOI 10.1007/BF00405277
   Kopprasch S, 2004, INT J BIOCHEM CELL B, V36, P460, DOI 10.1016/j.biocel.2003.08.001
   Maitra D, 2011, FREE RADICAL BIO MED, V51, P364, DOI 10.1016/j.freeradbiomed.2011.03.040
   Malle E, 2006, BBA-MOL CELL BIOL L, V1761, P392, DOI 10.1016/j.bbalip.2006.03.024
   Malle E, 2000, EUR J BIOCHEM, V267, P4495, DOI 10.1046/j.1432-1327.2000.01498.x
   Marsche G, 2003, J BIOL CHEM, V278, P47562, DOI 10.1074/jbc.M308428200
   Nagy P, 2006, BIOCHEMISTRY-US, V45, P12610, DOI 10.1021/bi061015y
   Pattison DI, 2012, FREE RADICAL RES, V46, P975, DOI 10.3109/10715762.2012.667566
   Pattison DI, 2009, CHEM RES TOXICOL, V22, P807, DOI 10.1021/tx800372d
   Scanlon CEO, 1996, ATHEROSCLEROSIS, V121, P23, DOI 10.1016/0021-9150(95)05672-6
   Sokolov AV, 2010, CHEM PHYS LIPIDS, V163, P347, DOI 10.1016/j.chemphyslip.2010.02.002
   Sokolov AV, 2014, CHEM PHYS LIPIDS, V180, P72, DOI 10.1016/j.chemphyslip.2014.02.006
   Zhang Renliang, 2001, JAMA (Journal of the American Medical Association), V286, P2136, DOI 10.1001/jama.286.17.2136
NR 52
TC 1
Z9 1
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 40
EP 51
DI 10.1016/j.abb.2015.03.008
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100005
PM 25795019
ER

PT J
AU Ma, XF
   Zhang, J
   Shuai, HL
   Guan, BZ
   Luo, X
   Yan, RL
AF Ma, Xue-Feng
   Zhang, Jie
   Shuai, Han-Lin
   Guan, Bao-Zhang
   Luo, Xin
   Yan, Rui-Ling
TI IKK beta/NF-kappa B mediated the low doses of bisphenol A induced
   migration of cervical cancer cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE BPA; Cervical cancer; Migration; NF-kappa B
ID PI3K/AKT SIGNALING PATHWAYS; ACTIVATED PROTEIN-KINASES; COUPLED RECEPTOR
   30; OVARIAN-CANCER; UP-REGULATION; PROMOTES INVASION; INDUCED APOPTOSIS;
   GAP-JUNCTIONS; GROWTH-FACTOR; ESTROGEN
AB Cervical cancer is considered as the second most common female malignant disease. There is an urgent need to illustrate risk factors which can trigger the motility of cervical cancer cells. Our present study revealed that nanomolar concentration of bisphenol A (BPA) significantly promoted the in vitro migration and invasion of cervical cancer HeLa, SiHa, and C-33A cells. Further, BPA treatment increased the expression of metalloproteinase-9 (MMP-9) and fibronectin (FN) in both HeLa and SiHa cells, while did not obviously change the expression of MMP-2, vimentin (Vim) or N-Cadherin (N-Cad). BAY 11-7082, the inhibitor of NF-kappa B, significantly abolished BPA induced up regulation of FN and MMP-9 in cervical cancer cells. While the inhibitors of PICA (H89), ERK1/2 (PD 98059), EGFR (AG1478), or PI3K/Akt (LY294002) had no effect on the expression of either FN or MMP-9. BPA treatment rapidly increased the phosphorylation of both I kappa B alpha and p65, stimulated nuclear translocation, and up regulated the promoter activities of NF-kappa B. The BPA induced up regulation of MMP-9 and FN and activation of NF-kappa B were mediated by phosphorylation of IKK beta via PKC signals. Collectively, our study found for the first time that BPA stimulated the cervical cancer migration via IKK-beta/NF-kappa B signals. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ma, Xue-Feng; Shuai, Han-Lin; Guan, Bao-Zhang; Luo, Xin; Yan, Rui-Ling] Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou 510630, Guangdong, Peoples R China.
   [Ma, Xue-Feng; Zhang, Jie] Baoan Maternal & Child Hlth Hosp, Dept Gynecol & Obstet, Shenzhen, Peoples R China.
RP Yan, RL (reprint author), Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou 510630, Guangdong, Peoples R China.
EM yanrljnu@163.com
FU Fundamental Research Funds of the Central Universities [21613316]
FX This research was supported by the Fundamental Research Funds of the
   Central Universities (Grant No. 21613316).
CR Sheng ZG, 2011, ENVIRON HEALTH PERSP, V119, P1775, DOI 10.1289/ehp.1103781
   Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866
   Lee S, 2008, J NEUROSCI RES, V86, P2932, DOI 10.1002/jnr.21739
   Liu R, 2013, FOOD CHEM TOXICOL, V52, P76, DOI 10.1016/j.fct.2012.10.033
   Ptak A, 2011, TOXICOL LETT, V202, P30, DOI 10.1016/j.toxlet.2011.01.015
   Geens T, 2012, FOOD CHEM TOXICOL, V50, P3725, DOI 10.1016/j.fct.2012.07.059
   Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608
   Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/mrc839
   Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016
   Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2
   Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367
   Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234
   Mori T, 2011, INT J GYNECOL CANCER, V21, P609, DOI 10.1097/IGC.0b013e3182017e9b
   Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537
   Mo MS, 2013, NEUROSCIENCE, V228, P1, DOI 10.1016/j.neuroscience.2012.10.002
   Steenbergen RDM, 2004, J NATL CANCER I, V96, P294, DOI 10.1093/jnci/djh031
   Wang KH, 2013, TAIWAN J OBSTET GYNE, V52, P246, DOI 10.1016/j.tjog.2013.04.016
   Chang MC, 2012, BIOCHEM J, V442, P293, DOI 10.1042/BJ20110282
   Long HX, 2012, STEM CELLS, V30, P2309, DOI 10.1002/stem.1194
   Alonso-Magdalena P, 2012, MOL CELL ENDOCRINOL, V355, P201, DOI 10.1016/j.mce.2011.12.012
   Rogers JA, 2013, MOL IMMUNOL, V53, P421, DOI 10.1016/j.molimm.2012.09.013
   Ptak A, 2012, TOXICOL LETT, V210, P332, DOI 10.1016/j.toxlet.2012.02.003
   Song LB, 2012, J PATHOL, V226, P534, DOI 10.1002/path.3008
   Defamie N, 2014, FEBS LETT, V588, P1331, DOI 10.1016/j.febslet.2014.01.012
   Yan Y, 2013, MOL CELL BIOCHEM, V378, P1, DOI 10.1007/s11010-013-1579-9
   Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V291, P76, DOI 10.1006/bbrc.2002.6407
   Ben-Jonathan N, 2009, MOL CELL ENDOCRINOL, V304, P49, DOI 10.1016/j.mce.2009.02.022
   Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015
   Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087
   Ptak A, 2014, TOXICOL LETT, V229, P357, DOI 10.1016/j.toxlet.2014.07.001
   Dong S, 2011, ENVIRON POLLUT, V159, P212, DOI 10.1016/j.envpol.2010.09.004
   Aasen T, 2003, ONCOGENE, V22, P7969, DOI 10.1038/sj.onc.1206709
   Ge LC, 2014, TOXICOL LETT, V226, P81, DOI 10.1016/j.toxlet.2014.01.035
   Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065
   Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010
   Derouiche S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-54
   Dominguez MA, 2008, REPROD TOXICOL, V25, P420, DOI 10.1016/j.reprotox.2008.05.059
   Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012
   Ken RA, 2007, REPROD TOXICOL, V24, P240
   Labrecque MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029545
   Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103904
   Park SH, 2009, J REPROD DEVELOP, V55, P23, DOI 10.1262/jrd.20094
   Petrier C, 2010, ULTRASON SONOCHEM, V17, P111, DOI 10.1016/j.ultsonch.2009.05.010
   POTTER ME, 1990, GYNECOL ONCOL, V37, P78, DOI 10.1016/0090-8258(90)90312-9
   Shi T., 2014, ENV TOXICOL
   Shingleton HM, 1996, J AM COLL SURGEONS, V183, P393
   Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87
   Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716
   Zhang KS, 2014, BIOMED PHARMACOTHER, V68, P1037, DOI 10.1016/j.biopha.2014.09.003
NR 49
TC 0
Z9 0
U1 8
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 52
EP 58
DI 10.1016/j.abb.2015.03.010
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100006
PM 25797437
ER

PT J
AU Ng, TK
   Gahan, LR
   Schenk, G
   Ollis, DL
AF Ng, Tee-Kheang
   Gahan, Lawrence R.
   Schenk, Gerhard
   Ollis, David L.
TI Altering the substrate specificity of methyl parathion hydrolase with
   directed evolution
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Organophosphate pesticides; Bioremediation; Methyl parathion hydrolase;
   Substrate specificity; Directed evolution
ID METALLO-BETA-LACTAMASE; EXTENSION PROCESS STEP; CRYSTAL-STRUCTURE;
   SWISS-MODEL; GLYOXALASE II; ACETYLCHOLINESTERASE; PURIFICATION;
   ENVIRONMENT; INSIGHTS; DOCKING
AB Many organophosphates (OPs) are used as pesticides in agriculture. They pose a severe health hazard due to their inhibitory effect on acetylcholinesterase. Therefore, detoxification of water and soil contaminated by OPs is important. Metalloenzymes such as methyl parathion hydrolase (MPH) from Pseudomonas sp. WBC-3 hold great promise as bioremediators as they are able to hydrolyze a wide range of OPs. MPH is highly efficient towards methyl parathion (1 x 10(6) s(-1) M-1), but its activity towards other OPs is more modest. Thus, site saturation mutagenesis (SSM) and DNA shuffling were performed to find mutants with improved activities on ethyl paraxon (6.1 x 10(3) s(-1) M-1). SSM was performed on nine residues lining the active site. Several mutants with modest activity enhancement towards ethyl paraoxon were isolated and used as templates for DNA shuffling. Ultimately, 14 multiple-site mutants with enhanced activity were isolated. One mutant, R2F3, exhibited a nearly 100-fold increase in the k(cat)/K-m value for ethyl paraoxon (5.9 x 10(5) s(-1) M-1). These studies highlight the 'plasticity' of the MPH active site that facilitates the finetuning of its active site towards specific substrates with only minor changes required. MPH is thus an ideal candidate for the development of an enzyme-based bioremediation system. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ng, Tee-Kheang; Ollis, David L.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia.
   [Gahan, Lawrence R.; Schenk, Gerhard] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.
RP Ollis, DL (reprint author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia.
EM ollis@rsc.anu.edu.au
RI Ollis, David/I-5967-2014
FU Australian Research Council, Discovery Projects Scheme [DP120104263];
   Australian National University PhD Scholarship; Australian National
   University Research Scholarship
FX This work was financially supported by the Australian Research Council,
   Discovery Projects Scheme (DP120104263). T.-K.N. is supported by an
   Australian National University PhD Scholarship and an Australian
   National University Research Scholarship. G.S. also acknowledges the
   receipt of an ARC Future Fellowship (FT120100694).
CR Stevenson BJ, 2008, BIOCHEMISTRY-US, V47, P3013, DOI 10.1021/bi701858u
   Sanchis J, 2008, APPL MICROBIOL BIOT, V81, P387, DOI 10.1007/s00253-008-1678-9
   Yang H, 2003, PROTEIN ENG, V16, P135, DOI 10.1093/proeng/gzg015
   Fu GP, 2004, PROTEIN EXPRES PURIF, V36, P170, DOI 10.1016/j.pep.2004.04.019
   Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258
   Zhang RF, 2006, BIODEGRADATION, V17, P465, DOI 10.1007/s10532-005-9018-6
   WILSON IB, 1955, BIOCHIM BIOPHYS ACTA, V18, P168, DOI 10.1016/0006-3002(55)90040-8
   Weinbroum AA, 2005, BRIT MED BULL, V72, P119, DOI 10.1093/bmb/ldh038
   Worek F, 2004, BIOCHEM PHARMACOL, V68, P2237, DOI 10.1016/j.bcp.2004.07.038
   Neuwald AF, 1997, NUCLEIC ACIDS RES, V25, P1665, DOI 10.1093/nar/25.9.1665
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298
   Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070
   Cameron AD, 1999, STRUCT FOLD DES, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9
   Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2
   Jeong YS, 2012, PROTEIN ENG DES SEL, V25, P725, DOI 10.1093/protein/gzs071
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148
   Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006
   Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Campos-Bermudez VA, 2007, BIOCHEMISTRY-US, V46, P11069, DOI 10.1021/bi7007245
   Carfi A., 1998, BIOL CRYSTALLOGR D, V54, P313
   Dong YJ, 2005, J MOL BIOL, V353, P655, DOI 10.1016/j.jmb.2005.08.057
   Ekkhunnatham A, 2012, WORLD J MICROB BIOT, V28, P1739, DOI 10.1007/s11274-011-0985-y
   Ely F, 2007, CURR TOP BIOCH RES, V9, P63
   Gotthard G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077995
   JEYARATNAM J, 1990, World Health Statistics Quarterly, V43, P139
   Kim MH, 2005, P NATL ACAD SCI USA, V102, P17606, DOI 10.1073/pnas.0504996102
   Leiros HKS, 2012, ANTIMICROB AGENTS CH, V56, P4341, DOI 10.1128/AAC.00448-12
   Liu JW, 2006, PROTEIN EXPRES PURIF, V47, P258, DOI 10.1016/j.pep.2005.11.019
   POST, 1998, ORG, P122
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Tseng WC, 2008, ANAL BIOCHEM, V375, P376, DOI 10.1016/j.ab.2007.12.013
   WILSON IB, 1966, ANN NY ACAD SCI, V135, P177, DOI 10.1111/j.1749-6632.1966.tb45471.x
   Zhao HM, 2006, NAT PROTOC, V1, P1865, DOI 10.1038/nprot.2006.309
NR 36
TC 0
Z9 0
U1 10
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 59
EP 68
DI 10.1016/j.abb.2015.03.012
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100007
PM 25797441
ER

PT J
AU Zhang, L
   Nan, CL
   Chen, Y
   Tian, J
   Jean-Charles, PY
   Getfield, C
   Wang, XQ
   Huang, XP
AF Zhang, Lei
   Nan, Changlong
   Chen, Yuan
   Tian, Jie
   Jean-Charles, Pierre-Yves
   Getfield, Cecile
   Wang, Xiaoqing
   Huang, Xupei
TI Calcium desensitizer catechin reverses diastolic dysfunction in mice
   with restrictive cardiomyopathy
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Diastolic dysfunction; Calcium hypersensitivity; Catechins; Calcium
   desensitizer; Myocardial cells; Transgenic mice
ID CARDIAC TROPONIN-I; HEART-FAILURE; MOUSE MODEL; TRANSGENIC MICE; TEA
   CATECHINS; MUTATIONS; SENSITIVITY; RELAXATION; POLYPHENOL; MANAGEMENT
AB Diastolic dysfunction refers to an impaired relaxation and an abnormality in ventricular blood filling during diastole while systolic function is preserved. Cardiac myofibril hypersensitivity to Ca2+ is a major factor that causes impaired relaxation of myocardial cells. The present study investigates the effect of the green tea extract catechins on myofibril calcium desensitization and restoration of diastolic function in a restrictive cardiomyopathy (RCM) mouse model with cardiac troponin mutations. Wild type (WT) and RCM mice were treated daily with catechin (epigallocatechin-3-gallate, EGCg, 50 mg/kg body weight) for 3 months. Echocardiography and cell based assays were performed to measure cardiac structure and flow-related variables including chamber dimensions, fraction shortening, trans-mitral flow patterns in the experimental mice. In addition, myocyte contractility and calcium dynamics were measured in WT and RCM cardiomyocytes treated in vitro with 5 mu M EGCg. Our data indicated that RCM mice treated with EGCg showed an improved diastolic function while systolic function remained unchanged. At the cellular level, sarcomere relaxation and calcium decay were accelerated in RCM myocardial cells treated with EGCg. These results suggest that catechin is effective in reversing the impaired relaxation in RCM myocardial cells and rescuing the RCM mice with diastolic dysfunction. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Zhang, Lei; Chen, Yuan; Tian, Jie; Huang, Xupei] Chongqing Med Univ, Div Cardiol, Childrens Hosp, Boca Raton, FL 33431 USA.
   [Nan, Changlong; Jean-Charles, Pierre-Yves; Getfield, Cecile; Wang, Xiaoqing; Huang, Xupei] Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA.
   [Nan, Changlong; Huang, Xupei] Florida Atlantic Univ, Ctr Mol Biol & Biotechnol, Boca Raton, FL 33431 USA.
RP Huang, XP (reprint author), Chongqing Med Univ, Div Cardiol, 777 Glades Rd, Boca Raton, FL 33431 USA.
EM xhuang@fau.edu
FU NIH [HL112130-01]; NSFC [31271218]; American Heart Association
   [11GRNT7860030]; American Physiological Society
FX The authors would like to thank Dr. Herbert Weissbach, Professor and
   Director of the Center of Molecular Biology and Biotechnology at Florida
   Atlantic University for reviewing the manuscript. This work was
   supported by grants from the NIH (HL112130-01), NSFC (31271218) and the
   American Heart Association (11GRNT7860030) to X.P. Huang. P.Y.
   Jean-Charles is a recipient of William Townsend Porter Pre-doctoral
   Fellowship from the American Physiological Society.
CR Chen G, 2012, J CELL BIOCHEM, V113, P3559, DOI 10.1002/jcb.24233
   Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017
   Huang XP, 1999, CIRC RES, V84, P1
   Liou YM, 2008, PFLUG ARCH EUR J PHY, V456, P787, DOI 10.1007/s00424-008-0456-y
   Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336
   Dou Y, 2007, AM J PHYSIOL-CELL PH, V293, pC1148, DOI 10.1152/ajpcell.00551.2006
   Ammash NM, 2000, CIRCULATION, V101, P2490
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Robertson IM, 2009, J BIOL CHEM, V284, P23012, DOI 10.1074/jbc.M109.021352
   Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50
   BONOW RO, 1992, ANN INTERN MED, V117, P502
   Chang AN, 2008, BIOCHEM BIOPH RES CO, V369, P74, DOI 10.1016/j.bbrc.2007.12.081
   Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200
   Kettlewell S, 2004, EXP PHYSIOL, V89, P163, DOI 10.1113/expphysiol.2003.026732
   Tadano N, 2010, BRIT J PHARMACOL, V161, P1034, DOI 10.1111/j.1476-5381.2010.00942.x
   Artz G, 2000, CURR TREAT OPTIONS C, V2, P431, DOI 10.1007/s11936-000-0038-6
   Braunwald E, 2008, CIRC-HEART FAIL, V1, P58, DOI 10.1161/CIRCHEARTFAILURE.107.752162
   Davis J, 2008, J MOL CELL CARDIOL, V44, P891, DOI 10.1016/j.yjmcc.2008.02.274
   Du J, 2006, ARCH BIOCHEM BIOPHYS, V456, P143, DOI 10.1016/j.abb.2006.08.018
   Du JF, 2008, AM J PHYSIOL-HEART C, V294, pH2604, DOI 10.1152/ajpheart.91506.2007
   Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287300
   Griffin B.P., 2004, MANUAL CARDIOVASULAR, Vsecond
   GWATHMEY JK, 1991, CIRC RES, V69, P1280
   Jean-Charles P.Y., 2014, TROPONIN REGULATOR M, P259
   Li YJ, 2013, J MOL CELL CARDIOL, V62, P227, DOI 10.1016/j.yjmcc.2013.06.007
   Ligi I, 2003, ARCH PEDIATRIE, V10, P432, DOI 10.1016/S0929-693X(03)00036-8
   Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1273, DOI 10.1152/ajpheart.01379.2006
   Palka P, 2003, CARDIOL YOUNG, V13, P469
   Reuter Hannes, 2012, Wien Med Wochenschr, V162, P297
   Rivenes SM, 2000, CIRCULATION, V102, P876
   SIEGEL RJ, 1984, CIRCULATION, V70, P165
   Yumoto F, 2005, BIOCHEM BIOPH RES CO, V338, P1519, DOI 10.1016/j.bbrc.2005.10.116
   Zhang C, 2011, J CELL BIOCHEM, V112, P98, DOI 10.1002/jcb.22876
NR 33
TC 1
Z9 1
U1 3
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 69
EP 76
DI 10.1016/j.abb.2015.03.015
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100008
PM 25813360
ER

PT J
AU Warepam, M
   Singh, LR
AF Warepam, Marina
   Singh, Laishram Rajendrakumar
TI Osmolyte mixtures have different effects than individual osmolytes on
   protein folding and functional activity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Chemical denaturation; Preferential hydration; Synergistic effect;
   Refolding efficiency; Enzyme activity
ID ORGANIC OSMOLYTES; COMPATIBLE OSMOLYTES; ELASMOBRANCH FISHES;
   ALPHA-CHYMOTRYPSIN; WATER-STRUCTURE; UREA; STABILITY; AGGREGATION;
   OXIDE; RIBONUCLEASE
AB Osmolytes are small organic molecules accumulated by organisms under stress conditions to protect macromolecular structure and function. In the present study, we have investigated the effect of several binary osmolyte mixtures on the protein folding/stability and function of RNase-A. For this, we have measured Delta(D)degrees (Gibbs free energy change at 25 degrees C) and specific activity of RNase-A mediated hydrolysis of cytidine 2'-3' cyclic monophosphate in the presence and absence of individual and osmolyte mixtures. It was found that the osmolyte mixtures have different effect on protein stability and function than that of individual osmolytes. Refolding studies of RNase-A in the presence of osmolyte mixtures and individual osmolytes also revealed that osmolyte mixtures have a poor refolding efficiency relative to the individual osmolytes. (C) 2015 Published by Elsevier Inc.
C1 [Warepam, Marina; Singh, Laishram Rajendrakumar] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.
RP Singh, LR (reprint author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.
EM lairksingh@gmail.com
FU Department of Science and Technology [SR/SO/BB-0003/2011]; Council of
   Scientific and Industrial Research [09/045(0992)/2010-EMR-1]
FX This work was supported by the grant from the Department of Science and
   Technology (Ref. No.: SR/SO/BB-0003/2011). LRS and MW acknowledge
   Council of Scientific and Industrial Research for the financial
   assistance provided in the form of research fellowship (File. no.
   09/045(0992)/2010-EMR-1).
CR YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124
   GREENE RF, 1974, J BIOL CHEM, V249, P5388
   YANCEY PH, 1979, BIOCHEM J, V183, P317
   Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831
   Wang AJ, 1996, BIOPHYS J, V71, P2117
   BOWLUS RD, 1979, J EXP ZOOL, V208, P137, DOI 10.1002/jez.1402080202
   Leandro P, 2001, MOL GENET METAB, V73, P173, DOI 10.1006/mgme.2001.3172
   Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970
   Yancey PH, 2004, CELL MOL BIOL, V50, P371
   Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819
   Mello CC, 2003, PROTEIN SCI, V12, P1522, DOI 10.1110/ps.0372903
   Samuel D, 2000, PROTEIN SCI, V9, P344
   Haque I, 2005, FEBS LETT, V579, P3891, DOI 10.1016/j.febslet.2005.06.005
   Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730
   Qu YX, 1998, P NATL ACAD SCI USA, V95, P9268, DOI 10.1073/pnas.95.16.9268
   Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985
   Ratnaparkhi GS, 2001, J BIOL CHEM, V276, P28789, DOI 10.1074/jbc.M101906200
   Ou WB, 2002, INT J BIOCHEM CELL B, V34, P136, DOI 10.1016/S1357-2725(01)00113-3
   Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711
   Holthauzen LMF, 2007, PROTEIN SCI, V16, P293, DOI 10.1110/ps.062610407
   Haque I, 2006, BIOPHYS CHEM, V119, P224, DOI 10.1016/j.bpc.2005.09.016
   Uversky VN, 2001, FEBS LETT, V509, P31, DOI 10.1016/S0014-5793(01)03121-0
   BAGNASCO S, 1986, J BIOL CHEM, V261, P5872
   Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399
   Bruzdziak P, 2013, J PHYS CHEM B, V117, P11502, DOI 10.1021/jp404780c
   Mishra R, 2005, J BIOL CHEM, V280, P15553, DOI 10.1074/jbc.M410947200
   FRANK HS, 1968, J CHEM PHYS, V48, P4746, DOI 10.1063/1.1668057
   YANCEY PH, 1980, J EXP ZOOL, V212, P205, DOI 10.1002/jez.1402120207
   Baskakov I, 1998, BIOPHYS J, V74, P2666
   Jamal S, 2009, FEBS J, V276, P6024, DOI 10.1111/j.1742-4658.2009.07317.x
   Qu YX, 2003, BIOCHEMISTRY-US, V42, P5837, DOI 10.1021/bi0206457
   BIGELOW C C, 1960, C R Trav Lab Carlsberg, V31, P305
   BOLEN DW, 1969, BIOCHEMISTRY-US, V8, P4239, DOI 10.1021/bi00839a003
   Burg M B, 1996, Kidney Int Suppl, V57, pS100
   CROOK EM, 1960, BIOCHEM J, V74, P234
   Francesca S., 2006, BIOCHEMISTRY-US, V45, P3684
   GARCIAPEREZ A, 1990, HYPERTENSION, V16, P595
   Leandro P, 2008, MINI-REV MED CHEM, V8, P901, DOI 10.2174/138955708785132783
   LEE JH, 1994, NEW ENGL J MED, V331, P439, DOI 10.1056/NEJM199408183310704
   LIN TY, 1994, BIOCHEMISTRY-US, V33, P12695, DOI 10.1021/bi00208a021
   Monterroso B, 2007, J BIOL CHEM, V282, P33452, DOI 10.1074/jbc.M705157200
   Natalello A., 2008, PROTEINS, V75, P509
   Nozaki Y, 1972, Methods Enzymol, V26, P43
   PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551
   Petersen CR, 2008, J EXP BIOL, V211, P1903, DOI 10.1242/jeb.017558
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011
   SIZELAND PCB, 1993, KIDNEY INT, V43, P448, DOI 10.1038/ki.1993.66
   Takahashi T, 2001, ANAL SCI, V17, P847, DOI 10.2116/analsci.17.847
   Tanaka M, 2005, J MOL MED-JMM, V83, P343, DOI 10.1007/s00109-004-0632-2
   Warskulat U, 2004, J INVEST DERMATOL, V123, P516, DOI 10.1111/j.0022-202X.2004.23313.x
   WITHERS PC, 1994, J EXP BIOL, V188, P175
   Yancey Paul H., 2004, Science Progress, V87, P1, DOI 10.3184/003685004783238599
   Yancey PH, 2003, BIOLOGIST, V50, P126
NR 54
TC 0
Z9 0
U1 4
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 77
EP 83
DI 10.1016/j.abb.2015.03.017
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100009
PM 25817170
ER

PT J
AU Contreras, TC
   Ricciardi, E
   Cremonini, E
   Oteiza, PI
AF Contreras, Telma C.
   Ricciardi, Elisabetta
   Cremonini, Eleonora
   Oteiza, Patricia I.
TI (-)-Epicatechin in the prevention of tumor necrosis alpha-induced loss
   of Caco-2 cell barrier integrity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE (-)-Epicatechin; NADPH oxidase; Intestinal barrier; Inflammation; Tight
   junction; Intestinal permeability
ID TIGHT JUNCTION PERMEABILITY; GRAPE SEED EXTRACT; NF-KAPPA-B; TNF-ALPHA;
   CROHNS-DISEASE; INTESTINAL PERMEABILITY; EXPERIMENTAL COLITIS;
   EPITHELIAL BARRIER; HEALTHY HUMANS; NADPH OXIDASE
AB An increased permeability of the intestinal barrier is proposed as a major event in the pathophysiology of inflammatory bowel diseases (IBD). Tumor necrosis alpha (TNE alpha) plays a central role in IBD pathogenesis, in part promoting tight function (TJ) barrier dysfunction. Food extracts enriched in (-)-epicatechin (EC) prevent the development or improve the progression of IBD in animal models. This study investigated the capacity of EC to inhibit TNF alpha-induced permeabilization of Caco-2 cell monolayers, characterizing the underlying mechanisms. Caco-2 cells differentiated into intestinal epithelial cells were incubated in the absence/presence of TNF alpha, with or without the addition of 0.5-5 mu M EC. TNF alpha triggered cell monolayer permeabilization, decreasing transepithelial electrical resistance (TEER) and increasing the paracellular transport of fluorescein sulfonic acid. The permeabilizing effects of TNF alpha were not due to Caco-2 cell apoptosis as evaluated by DNA fragmentation, caspase 3 and 9 activation, and cell morphology. EC prevented TNF alpha-triggered Caco-2 monolayer permeabilization and acted inhibiting the associated: (i) NADPH oxidase (NOX)-mediated increased oxidant production, (ii) NF-kappa B (I kappa B alpha, phosphorylation, p50 and RelA nuclear transport, and nuclear NF-kappa B-DNA binding) and ERK1/2 activation, (iii) increased myosin light kinase expression, and decreased TJ protein ZO-1 levels. In summary, EC prevented TNF alpha-mediated Caco-2 cell barrier permeabilization in part through the inhibition of NOX/NF-kappa B activation and downstream TJ disruption. Diets rich in EC could contribute to ameliorate IBD-associated increased intestinal permeability. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Oteiza, Patricia I.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.
   Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.
RP Oteiza, PI (reprint author), Univ Calif Davis, Dept Nutr, One Shields Av, Davis, CA 95616 USA.
EM poteiza@ucdavis.edu
FU CHNR-State of California Vitamin Price Fixing Consumer Settlement Fund,
   NIFA-USDA [CA-D*-xxx-7244-H]; University of California, Davis
FX This work was supported by the CHNR-State of California Vitamin Price
   Fixing Consumer Settlement Fund, NIFA-USDA (CA-D*-xxx-7244-H) and the
   University of California, Davis. We thank Magdalena Fraga for her work
   in obtaining fluorescence microscopy images. PIO is correspondent
   researcher from CONICET, Argentina.
CR Actis-Goretta L, 2012, FREE RADICAL BIO MED, V53, P787, DOI 10.1016/j.freeradbiomed.2012.05.023
   WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   VanDeventer SJH, 1997, GUT, V40, P443
   Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011
   HOLLANDER D, 1986, ANN INTERN MED, V105, P883
   Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320
   Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003
   Actis-Goretta L, 2013, AM J CLIN NUTR, V98, P924, DOI 10.3945/ajcn.113.065789
   Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316
   Steffen Y, 2008, ARCH BIOCHEM BIOPHYS, V469, P209, DOI 10.1016/j.abb.2007.10.012
   Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653
   Baba S, 2000, FREE RADICAL RES, V33, P635, DOI 10.1080/10715760000301151
   Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373
   Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027
   Mohamed RH, 2011, BRAIN RES BULL, V86, P22, DOI 10.1016/j.brainresbull.2011.07.001
   Da Silva M, 2012, FREE RADICAL BIO MED, V52, P151, DOI 10.1016/j.freeradbiomed.2011.10.436
   Mackenzie GG, 2004, FASEB J, V18, P167, DOI 10.1096/fj.03-0402fje
   Al-Sadi R, 2013, AM J PATHOL, V183, P1871, DOI 10.1016/j.ajpath.2013.09.001
   Erlejman AG, 2006, FREE RADICAL BIO MED, V41, P1247, DOI 10.1016/j.freeradbiomed.2006.07.002
   Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114
   Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081
   Fraga CG, 2011, FREE RADICAL BIO MED, V51, P813, DOI 10.1016/j.freeradbiomed.2011.06.002
   Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403
   Tsang C, 2005, BRIT J NUTR, V94, P170, DOI 10.1079/BJN20051480
   Donovan JL, 2006, FREE RADICAL RES, V40, P1029, DOI 10.1080/10715760600868545
   Droge W, 2002, PHYSIOL REV, V82, P47
   Steffen Y, 2007, BIOCHEM BIOPH RES CO, V359, P828, DOI 10.1016/j.bbrc.2007.05.200
   Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002
   Ottaviani JI, 2011, FREE RADICAL BIO MED, V50, P237, DOI 10.1016/j.freeradbiomed.2010.11.005
   Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Bettaieb A., 2014, FREE RADICAL BIOL ME
   Choy YY, 2013, J AGR FOOD CHEM, V61, P121, DOI 10.1021/jf301939e
   Erlejman A.G., 2008, ARCH BIOCH BIOPHYS
   Gitter AH, 2001, GASTROENTEROLOGY, V121, P1320, DOI 10.1053/gast.2001.29694
   Hammerstone JF, 2000, J NUTR, V130, p2086S
   Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004
   Schmitz H, 1999, J CELL SCI, V112, P137
   Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147
   Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x
   Unno N, 1996, AM J PHYSIOL-GASTR L, V270, pG1010
   Vazquez-Prieto M.A., 2012, ARCH BIOCH BIOPHYS
   Ye D, 2008, J CELL MOL MED, V12, P1331, DOI 10.1111/j.1582-4934.2008.00302.x
NR 44
TC 0
Z9 0
U1 5
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 84
EP 91
DI 10.1016/j.abb.2015.01.024
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100010
PM 25795020
ER

PT J
AU Marques, AF
   Gomes, PSFC
   Oliveira, PL
   Rosenthal, PJ
   Pascutti, PG
   Lima, LMTR
AF Marques, Adriana Fonseca
   Gomes, Priscila S. F. C.
   Oliveira, Pedro L.
   Rosenthal, Philip J.
   Pascutti, Pedro G.
   Lima, Luis Mauricio T. R.
TI Allosteric regulation of the Plasmodium falciparum cysteine protease
   falcipain-2 by heme
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Falcipain; Heme; Ferriprotoporphyrin IX; Allostery; Malaria
ID MOLECULAR-DYNAMICS SIMULATIONS; HEMOZOIN FORMATION; MALARIA PIGMENT;
   BETA-HEMATIN; HEMOGLOBIN DEGRADATION; INHIBITION; POLYMERIZATION;
   PROTEINASE; ALGORITHM; PARASITES
AB During the erythrocytic cycle of Plasmodium falciparum malaria parasites break down host hemoglobin, resulting in the release of free heme (ferriprotoporphyrin IX). Heme is a generator of free radicals that cause oxidative stress, but it is detoxified by crystallization into hemozoin inside the food vacuole. We evaluated the interaction of heme and heme analogues with falcipain-2, a P. falciparum food vacuole cysteine protease that plays a key role in hemoglobin digestion. Heme bound to falcipain-2 with a 1:1 stoichiometry, and heme inhibited falcipain-2 activity against both human hemoglobin and chromogenic peptide substrates through a noncompetitive-like mechanism. A series of porphyrin analogues was screened for inhibition of falcipain-2, demonstrating a minor contribution of iron to heme-falcipain-2 interaction, and revealing dependence on both propionic and vinyl groups for inhibition of falcipain-2 by heme. Docking and molecular dynamics simulation unveiled a novel, inducible heme-binding moiety in falcipain-2 adjacent to the catalytic site. Kinetic data suggested that the noncompetitive-like inhibition was substrate inhibition induced by heme. Collectively these data suggest that binding of heme to falcipain-2 may limit the accumulation of free heme in the parasite food vacuole, providing a means of heme detoxification in addition to crystallization into hemozoin. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Marques, Adriana Fonseca; Lima, Luis Mauricio T. R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Marques, Adriana Fonseca; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Gomes, Priscila S. F. C.; Pascutti, Pedro G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil.
   [Oliveira, Pedro L.] INCT EM, Sao Paulo, Brazil.
   [Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA.
   [Pascutti, Pedro G.; Lima, Luis Mauricio T. R.] Brazilian Natl Inst Metrol Qual & Technol, INMETRO, DIMAV, Lab Macromol, BR-25250020 Rio De Janeiro, Brazil.
   [Lima, Luis Mauricio T. R.] Univ Fed Rio de Janeiro, Natl Inst Sci & Technol Struct Biol & Bioimaging, BR-21941590 Rio De Janeiro, Brazil.
RP Lima, LMTR (reprint author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM LML@UFRJ.BR
RI Oliveira, Pedro/A-9438-2010
OI Oliveira, Pedro/0000-0003-0307-354X
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   INCT-CNPq; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   Carlos Chagas Filho (FAPERJ); Instituto Nacional de Metrologia,
   Normalizacao e Qualidade Industrial (INMETRO)
FX The authors thank Jennifer Legac and Jiri Gut for assistance with enzyme
   expression and purification. This research was supported by the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   INCT-CNPq; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   Carlos Chagas Filho (FAPERJ), and Instituto Nacional de Metrologia,
   Normalizacao e Qualidade Industrial (INMETRO). Funding agencies had no
   involvement in study design, data collection, analysis or
   interpretation, writing the report and decision on submission.
CR Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X
   Sijwali PS, 2001, PROTEIN EXPRES PURIF, V22, P128, DOI 10.1006/prep.2001.1416
   Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97
   DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0
   Ekland EH, 2008, INT J PARASITOL, V38, P743, DOI 10.1016/j.ijpara.2008.03.004
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273
   Hogg T, 2006, J BIOL CHEM, V281, P25425, DOI 10.1074/jbc.M60377200
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0
   Fitch CD, 1999, BBA-MOL BASIS DIS, V1454, P31, DOI 10.1016/S0925-4439(99)00017-4
   Patsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866
   Lin Y, 2001, DRUG METAB DISPOS, V29, P368
   Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197
   SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325
   Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783
   Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200
   Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102
   Lara FA, 2009, J CEREBR BLOOD F MET, V29, P1109, DOI 10.1038/jcbfm.2009.34
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103
   GOLDBERG DE, 1990, P NATL ACAD SCI USA, V87, P2931, DOI 10.1073/pnas.87.8.2931
   Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3
   Egan TJ, 2008, J INORG BIOCHEM, V102, P1288, DOI 10.1016/j.jinorgbio.2007.12.004
   Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941
   Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793
   Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103
   WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2
   Francis SE, 1996, MOL BIOCHEM PARASIT, V83, P189, DOI 10.1016/S0166-6851(96)02772-7
   Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219
   Gomes DEB, 2010, J PHYS CHEM B, V114, P531, DOI 10.1021/jp9083635
   Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5
   Chugh M, 2013, P NATL ACAD SCI USA, V110, P5392, DOI 10.1073/pnas.1218412110
   Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123
   Marques AF, 2013, BIOORGAN MED CHEM, V21, P3667, DOI 10.1016/j.bmc.2013.04.047
   Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972
   Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132
   Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013
   Basilico N, 1997, FEBS LETT, V409, P297, DOI 10.1016/S0014-5793(97)00533-4
   Batista PR, 2006, CELL BIOCHEM BIOPHYS, V44, P395, DOI 10.1385/CBB:44:3:395
   BENDRAT K, 1995, NATURE, V378, P138, DOI 10.1038/378138a0
   Berendsen H., 1981, INTERMOLECULAR FORCE, V331, P331
   Bisswanger H, 2008, ENZYME KINETICS PRIN
   Caiaffa CD, 2010, INSECT BIOCHEM MOLEC, V40, P855, DOI 10.1016/j.ibmb.2010.08.005
   Cole KA, 2000, J INORG BIOCHEM, V78, P109, DOI 10.1016/S0162-0134(99)00216-0
   DARDEN TA, 1993, ENVIRON HEALTH PERSP, V101, P410, DOI 10.2307/3431897
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Dronamraju K.R., 2012, J HUM GENET, V18, P3
   Hendrick P.W., 2012, MALARIA J, V11, P349
   Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053
   Lima LMTR, 2004, J BIOL CHEM, V279, P47968, DOI 10.1074/jbc.M407696200
   Marques A.F., 2013, BIOORG MED CHEM, V21
   Martiney JA, 1996, MOL MED, V2, P236
   Morris G. M., 2009, J COMPUT CHEM, V16, P2785, DOI DOI 10.1002/JCC.21256
   Pandey KC, 2005, P NATL ACAD SCI USA, V102, P9138, DOI 10.1073/pnas.0502368102
   Rosenthal PJ, 2013, MOL MICROBIOL, V89, P1025, DOI 10.1111/mmi.12349
   ROSENTHAL PJ, 1991, J CLIN INVEST, V88, P1467, DOI 10.1172/JCI115456
   ROSENTHAL PJ, 1993, J CLIN INVEST, V91, P1052, DOI 10.1172/JCI116262
   Rosenthal PJ, 1996, ANTIMICROB AGENTS CH, V40, P1600
   Saotome C, 2000, BIOORGAN MED CHEM, V8, P2249, DOI 10.1016/S0968-0896(00)00170-X
   Saraiva VB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017174
   Sartorello R, 2010, CELL BIOL INT, V34, P859, DOI 10.1042/CBI20090427
   Sijwali PS, 2002, J BIOL CHEM, V277, P14910, DOI 10.1074/jbc.M109680200
   SLATER AFG, 1992, NATURE, V355, P167, DOI 10.1038/355167a0
   Subramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005156
   World Health Organization, WORLD MAL REP 2013
NR 72
TC 0
Z9 0
U1 4
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 92
EP 99
DI 10.1016/j.abb.2015.03.007
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100011
PM 25791019
ER

PT J
AU Onodera, T
   Kuriyama, I
   Sakamoto, Y
   Kawamura, M
   Kuramochi, K
   Tsubaki, K
   Tabata, A
   Naganune, H
   Mizushina, Y
AF Onodera, Takefumi
   Kuriyama, Isoko
   Sakamoto, Yuka
   Kawamura, Moe
   Kuramochi, Kouji
   Tsubaki, Kazunori
   Tabata, Atsushi
   Naganune, Hideaki
   Mizushina, Yoshiyuki
TI 5-O-Acyl plumbagins inhibit DNA polymerase activity and suppress the
   inflammatory response
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE 5-O-Acyl plumbagins; C22:6-acyl plumbagin; DNA polymerase lambda; Enzyme
   inhibitor; Anti-inflammation
ID NF-KAPPA-B; INDUCED OXIDATIVE STRESS; BASE-EXCISION-REPAIR; FATTY-ACIDS;
   ESCHERICHIA-COLI; TUMOR PROMOTER; CANCER-CELLS; CALF THYMUS; IN-VITRO;
   LAMBDA
AB We previously found that vitamin K-3 (menadione, 2-methyl-1,4-naphthoquinone) inhibits the activity of human mitochondrial DNA polymerase (pol) gamma. In this study, we focused on plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), and chemically synthesized novel plumbagins conjugated with C2:0 to C22:6 fatty acids (5-O-acyl plumbagins). These chemically modified plumbagins displayed enhanced mammalian pol inhibition, with plumbagin conjugated to docosahexaenoic acid (C22:6-acyl plumbagin) exhibiting the strongest inhibition of pol lambda among the ten 5-O-acyl plumbagins synthesized. C22:6-acyl plumbagin selectively inhibited the activities of mammalian pol species, but did not influence the activities of other pols or DNA metabolic enzymes tested. The inhibition of pol lambda, a DNA repair/recombination pol, by these compounds was significantly correlated with both their suppression of lipopolysaccharide (LPS) induced tumor necrosis factor-alpha (TNF-alpha) production by mouse RAW264.7 macrophages and the reduction of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in the mouse ear. These data indicate that 5-O-acyl plumbagins act as anti-inflammatory agents by inhibiting mammalian pol gamma. These results further suggest that C22:6-acyl plumbagin is a promising anti-inflammatory candidate and that acylation could be an effective chemical modification to improve the anti-inflammatory activity of vitamin K-3 derivatives, such as plumbagin. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Onodera, Takefumi; Kuriyama, Isoko; Sakamoto, Yuka] Kobe Gakuin Univ, Fac Nutr, Lab Food & Nut Sci, Nishi Ku, Kobe, Hyogo 6512180, Japan.
   [Onodera, Takefumi; Tabata, Atsushi; Naganune, Hideaki; Mizushina, Yoshiyuki] Kobe Gakuin Univ, Cooperat Res Ctr Life Sci, Chuo Ku, Kobe, Hyogo 6518586, Japan.
   [Kawamura, Moe; Kuramochi, Kouji; Tsubaki, Kazunori] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan.
   [Tabata, Atsushi; Naganune, Hideaki] Univ Tokushima, Grad Sch, Inst Sci & Technol, Dept Biol Sci & Technol Life Syst, Tokushima 7708506, Japan.
   [Mizushina, Yoshiyuki] Shinshu Univ, Grad Sch Agr, Nagano 3994598, Japan.
RP Mizushina, Y (reprint author), Shinshu Univ, Grad Sch Agr, Nagano 3994598, Japan.
EM mizushina@shinshu-u.ac.jp
FU MEXT (Ministry of Education, Culture, Sports, Science and Technology,
   Japan)-Supported Program for the Strategic Research Foundation at
   Private Universities (Japan); MEXT (Japan) [24580205]; Cosmetology
   Research Foundation (Japan); JST (Japan Science and Technology Agency)
   (Japan)
FX This study was supported in part by the MEXT (Ministry of Education,
   Culture, Sports, Science and Technology, Japan)-Supported Program for
   the Strategic Research Foundation at Private Universities, 2012-2016
   (Japan). Y.M. acknowledges Grants-in-Aid for Scientific Research (C)
   (No. 24580205) from MEXT (Japan), and the 25th (2014) Cosmetology
   Research Foundation (Japan). K.K and Y.M. acknowledge a Grant-in-Aid for
   A-STEP (Adaptable and Seamless Technology Transfer Program through
   target-driven R&D) (Exploratory Research) from JST (Japan Science and
   Technology Agency) (Japan).
CR Aggarwal B.B., 2003, REV IMMUNOL, V3, P745
   Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704
   Mizushina Y, 1999, J BIOL CHEM, V274, P25599, DOI 10.1074/jbc.274.36.25599
   Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1365-2443.2004.00747.x
   Sasaki R, 2008, CANCER SCI, V99, P1040, DOI 10.1111/j.1349-7006.2008.00771.x
   Checker R, 2011, FREE RADICAL RES, V45, P975, DOI 10.3109/10715762.2011.585647
   Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200
   Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998
   Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397
   Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345
   Kusumoto R, 2004, GENES CELLS, V9, P1139, DOI 10.1111/j.1365-2443.2004.00797.x
   Nakamura Y, 1998, CANCER RES, V58, P4832
   Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518
   Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196
   Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200
   Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0
   Srinivas P, 2004, MOL CARCINOGEN, V40, P201, DOI 10.1002/mc.20031
   Luo P, 2010, J PHARMACOL EXP THER, V335, P735, DOI 10.1124/jpet.110.170852
   Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041
   MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801
   Ogawa A, 1998, JPN J CANCER RES, V89, P1154
   Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137
   Bertocci B, 2002, J IMMUNOL, V168, P3702
   Checker R, 2014, INFLAMMATION, V37, P542, DOI 10.1007/s10753-013-9768-y
   DATE T, 1988, BIOCHEMISTRY-US, V27, P2983, DOI 10.1021/bi00408a048
   Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397
   Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005
   Garcia-Diaz M, 2001, J BIOL CHEM, V276, P34659, DOI 10.1074/jbc.M106336200
   GSCHWENDT M, 1984, CANCER LETT, V25, P177, DOI 10.1016/S0304-3835(84)80043-9
   HIROSE F, 1989, EXP CELL RES, V181, P169, DOI 10.1016/0014-4827(89)90191-2
   Kawamura M., 2014, PLOS ONE, V9
   Kornberg K., 1992, DNA REPLICATION, P197
   LU BC, 1991, J BIOL CHEM, V266, P21060
   Mizushina Y., 2007, CURR ENZYME INHIB, V3, P61, DOI 10.2174/157340807779815422
   Mizushina Y, 1996, BBA-GENE STRUCT EXPR, V1308, P256, DOI 10.1016/0167-4781(96)00121-2
   Mizushina Y., 2011, Journal of Japanese Society of Nutrition and Food Science, V64, P377
   Mizushina Y, 2007, BIOCHIMIE, V89, P581, DOI 10.1016/j.biochi.2007.01.009
   Mizushina Y, 2002, BIOCHEMISTRY-US, V41, P14463, DOI 10.1021/bi020476q
   Mizushina Y, 1997, BBA-GEN SUBJECTS, V1336, P509, DOI 10.1016/S0304-4165(97)00067-6
   Mizushina Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1239, DOI 10.1271/bbb.90121
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NAKAYAMA C, 1985, J BIOCHEM-TOKYO, V97, P1385
   Ohsugi T, 2005, CARCINOGENESIS, V26, P1382, DOI 10.1093/carcin/bgi095
   Oshige M, 2004, PROTEIN EXPRES PURIF, V35, P248, DOI 10.1016/j.pep.2004.02.001
   Ramadan K, 2002, J BIOL CHEM, V277, P18454, DOI 10.1074/jbc.M200421200
   SAKAGUCHI K, 1980, CELL STRUCT FUNCT, V5, P323
   Shimazaki N, 2002, GENES CELLS, V7, P639, DOI 10.1046/j.1365-2443.2002.00547.x
   SINGHAL RK, 1993, J BIOL CHEM, V268, P15906
   SOLTIS DA, 1982, J BIOL CHEM, V257, P1332
   Takeuchi T, 2006, GENES CELLS, V11, P223, DOI 10.1111/j.1365-2443.2006.00937.x
   TAMAI K, 1988, BIOCHIM BIOPHYS ACTA, V950, P263, DOI 10.1016/0167-4781(88)90122-4
   TamiyaKoizumi K, 1997, BIOCHEM MOL BIOL INT, V41, P1179
   Umeda S, 2000, EUR J BIOCHEM, V267, P200, DOI 10.1046/j.1432-1327.2000.00990.x
   Wang TY, 2014, FOOD CHEM TOXICOL, V64, P177, DOI 10.1016/j.fct.2013.11.027
   Zucca E, 2013, NUCLEIC ACIDS RES, V41, P229, DOI 10.1093/nar/gks1016
NR 55
TC 0
Z9 0
U1 5
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 100
EP 110
DI 10.1016/j.abb.2015.02.032
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100012
PM 25748000
ER

PT J
AU Spolitak, T
   Ballou, DP
AF Spolitak, Tatyana
   Ballou, David P.
TI Evidence for catalytic intermediates involved in generating the
   chromopyrrolic acid scaffold of rebeccamycin by RebO and RebD
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Peroxidase; Indolocarbazoles; Rebeccamycin; RebD; Chromopyrrolic acid;
   Cpd II
ID CYTOCHROME-C PEROXIDASE; LECHEVALIERIA-AEROCOLONIGENES ATCC-39243;
   BIOSYNTHETIC GENE-CLUSTER; TYROSYL RADICAL FORMATION;
   CATALASE-PEROXIDASE; COMPOUND-ES; WILD-TYPE; INDOLOCARBAZOLE
   BIOSYNTHESIS; MULTIFREQUENCY EPR; TOPOISOMERASE-I
AB We provide the first experimental evidence for intermediates being involved in catalysis by RebD in generating the chromopyrrolic acid (CPA) scaffold of rebeccamycin. In the presence of its substrates (indole pyruvate imine - IPAI - and H2O2 both produced by the flavoprotein oxidase RebO that oxidizes tryptophan), RebD reacts as a peroxidase forming two IPAI radicals that recombine as a C-C bond in the CPA. When catalase is included to remove H2O2, CPA can still be formed because the IPAI rapidly reduces RebD, which reacts with O-2, utilizing oxidase-peroxidase chemistry to produce CPA. Reduced RebD can also react with H2O2 forming Cpd II directly, which can oxidize IPAI. Stopped-flow spectrophotometric studies demonstrated that during the reaction of RebO and RebD with Trp and oxygen, a species with a red-shifted Soret band at 424.5 nm appeared. This species can react with either guaiacol or ABTS to form ferric RebD, suggesting that it is Cpd II of RebD involved in the formation of CPA. In summary, the studies reveal new and unusual aspects peroxidase and peroxygenase chemistry used by RebD in catalyzing carbon-carbon oxidative coupling reactions that are involved in biosynthesis of indolocarbazoles. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Spolitak, Tatyana; Ballou, David P.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.
RP Ballou, DP (reprint author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.
EM dballou@umich.edu
FU National Institutes of Health, United States [GM20877]
FX Support for this work was provided by a Grant from the National
   Institutes of Health, United States, GM20877, to D.P.B.
CR Schunemann V, 2002, J INORG BIOCHEM, V91, P586, DOI 10.1016/S0162-0134(02)00476-2
   Schunemann V, 2000, FEBS LETT, V479, P149, DOI 10.1016/S0014-5793(00)01886-X
   Raner GM, 2006, J INORG BIOCHEM, V100, P2045, DOI 10.1016/j.jinorgbio.2006.09.025
   Salas AP, 2005, MOL MICROBIOL, V58, P17, DOI 10.1111/j.1365-2958.2005.04777.x
   Sanchez C, 2005, P NATL ACAD SCI USA, V102, P461, DOI 10.1073/pnas.0407809102
   Spolitak T, 2008, J BIOL INORG CHEM, V13, P599, DOI 10.1007/s00775-008-0348-9
   YAMASHITA Y, 1992, BIOCHEMISTRY-US, V31, P12069, DOI 10.1021/bi00163a015
   Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200
   Howard-Jones AR, 2005, BIOCHEMISTRY-US, V44, P15652, DOI 10.1021/bi051706e
   Howard-Jones AR, 2006, J AM CHEM SOC, V128, P12289, DOI 10.1021/ja063898m
   Jung C, 2005, BIOCHEM BIOPH RES CO, V338, P355, DOI 10.1016/j.bbrc.2005.08.166
   Spolitak T, 2010, ARCH BIOCHEM BIOPHYS, V493, P184, DOI 10.1016/j.abb.2009.10.014
   Ryan KS, 2007, P NATL ACAD SCI USA, V104, P15311, DOI 10.1073/pnas.0707190104
   Singh R, 2007, J AM CHEM SOC, V129, P15954, DOI 10.1021/ja075108u
   Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200
   Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d
   Spolitak T, 2006, J INORG BIOCHEM, V100, P2034, DOI 10.1016/j.jinorgbio.2006.09.026
   Onaka H, 2003, BIOSCI BIOTECH BIOCH, V67, P127
   SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632
   Prudhomme M, 2003, EUR J MED CHEM, V38, P123, DOI 10.1016/S0223-5234(03)00011-4
   HUYETT JE, 1995, J AM CHEM SOC, V117, P9033, DOI 10.1021/ja00140a021
   Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303
   Ivancich A, 2001, BIOCHEMISTRY-US, V40, P6860, DOI 10.1021/bi002826j
   Sanchez C, 2006, CHEMBIOCHEM, V7, P1231, DOI 10.1002/cbic.200600029
   Sanchez C, 2002, CHEM BIOL, V9, P519, DOI 10.1016/S1074-5521(02)00126-6
   Asamizu S, 2007, TETRAHEDRON LETT, V48, P2923, DOI 10.1016/j.tetlet.2007.02.062
   Asamizu S, 2006, TETRAHEDRON LETT, V47, P473, DOI 10.1016/j.tetlet.2005.11.061
   Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z
   Blodig W, 1999, ARCH BIOCHEM BIOPHYS, V370, P86, DOI 10.1006/abbi.1999.1365
   Chouchane S, 2002, J BIOL CHEM, V277, P42633, DOI 10.1074/jbc.M207916200
   Dorlet P, 2002, BIOCHEMISTRY-US, V41, P6107, DOI 10.1021/bi015871f
   Dunford H. B., 1999, HEME PEROXIDASES
   ERMAN JE, 1989, BIOCHEMISTRY-US, V28, P7992, DOI 10.1021/bi00446a004
   Fruton JS, 1934, J BIOL CHEM, V105, P79
   Gunsalus I C, 1978, Methods Enzymol, V52, P166
   HOUSEMAN ALP, 1993, BIOCHEMISTRY-US, V32, P4430, DOI 10.1021/bi00067a036
   Howard-Jones AR, 2007, J AM CHEM SOC, V129, P11016, DOI 10.1021/ja0743801
   Ivancich A, 2003, J AM CHEM SOC, V125, P14093, DOI 10.1021/ja035582+
   Makino M, 2007, P NATL ACAD SCI USA, V104, P11591, DOI 10.1073/pnas.0702946104
   Moreau P, 2003, BIOORGAN MED CHEM, V11, P4871, DOI 10.1016/j.bmc.2003.09.014
   Moreau P, 2005, ANTI-CANCER DRUG, V16, P145, DOI 10.1097/00001813-200502000-00005
   Nishizawa T, 2005, J BACTERIOL, V187, P2084, DOI 10.1128/JB.187.6.2084-2092.2005
   Nishizawa T, 2006, J AM CHEM SOC, V128, P724, DOI 10.1021/ja056749x
   Onaka H, 2005, BIOSCI BIOTECH BIOCH, V69, P1753, DOI 10.1271/bbb.69.1753
   Poulos TL, 2007, NAT PROD REP, V24, P504, DOI 10.1039/b604195g
   Reipa V, 2002, CHEM COMMUN, P318, DOI 10.1039/b111436k
   Ryan K.S., J BIOL CHEM, V283, P1240
   Tsai AL, 1999, J BIOL CHEM, V274, P21695, DOI 10.1074/jbc.274.31.21695
   Valton O., 2000, STRCUT FUNCT GENET, V38, P95
   Wang Y, 2008, J AM CHEM SOC, V130, P7170, DOI 10.1021/ja711426y
   Wang Y, 2009, J AM CHEM SOC, V131, P6748, DOI 10.1021/ja9003365
   Zhao XB, 2004, J BIOL CHEM, V279, P7606, DOI 10.1074/jbc.M311884200
NR 52
TC 0
Z9 0
U1 4
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2015
VL 573
BP 111
EP 119
DI 10.1016/j.abb.2015.03.020
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CH2OI
UT WOS:000353864100013
PM 25837855
ER

PT J
AU Bernstein, PS
   Khachik, F
   Frank, HA
AF Bernstein, Paul S.
   Khachik, Frederick
   Frank, Harry A.
TI Highlights of carotenoid research from the 17th International Carotenoid
   Symposium
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
C1 [Bernstein, Paul S.] Univ Utah, Sch Med, John A Moran Eye Ctr, Mary Boesche Prof Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA.
   [Khachik, Frederick] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.
   [Frank, Harry A.] Univ Connecticut, Dept Chem, U 3060, Storrs, CT 06269 USA.
RP Bernstein, PS (reprint author), Univ Utah, Sch Med, John A Moran Eye Ctr, Mary Boesche Prof Ophthalmol & Visual Sci, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.
EM paul.bernstein@hsc.utah.edu
NR 0
TC 0
Z9 0
U1 3
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 1
EP 1
DI 10.1016/j.abb.2015.03.016
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900001
PM 25817377
ER

PT J
AU Wang, CX
   Jiang, HF
   Yuen, JSJ
   Lee, SA
   Narayanasamy, S
   Curley, RW
   Harrison, EH
   Blaner, WS
AF Wang, Cynthia X.
   Jiang, Hongfeng
   Yuen, Jason J.
   Lee, Seung-Ah
   Narayanasamy, Sureshbabu
   Curley, Robert W., Jr.
   Harrison, Earl H.
   Blaner, William S.
TI Actions of beta-apo-carotenoids in differentiating cells: Differential
   effects in P19 cells and 3T3-L1 adipocytes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Retinoid; All-trans-retinoic acid; Adipose differentiation; Obesity;
   Transcription; Gene expression
ID RETINOIC ACID RECEPTORS; BINDING-PROTEIN 4; INSULIN-RESISTANCE;
   ACTIVATED RECEPTOR; LIPID-METABOLISM; GENE-EXPRESSION; X-RECEPTOR;
   VITAMIN-A; CLEAVAGE; IDENTIFICATION
AB beta-Apo-carotenoids, including beta-apo-13-carotenone and beta-apo-14'-carotenal, are potent retinoic acid receptor (RAR) antagonists in transactivation assays. We asked how these influence RAR-dependent processes in living cells. Initially, we explored the effects of beta-apo-13-carotenone and beta-apo-14'-carotenal on P19 cells, a mouse embryonal carcinoma cell line that differentiates into neurons when treated with all-trans-retinoic acid. Treatment of P19 cells with either compound failed to block all-trans-retinoic acid induced differentiation. Liquid chromatography tandem mass spectrometry studies, however, established that neither of these beta-apo-carotenoids accumulates in P19 cells. All-trans-retinoic acid accumulated to high levels in P19 cells. This suggests that the uptake and metabolism of beta-apo-carotenoids by some cells does not involve the same processes used for retinoids and that these may be cell type specific. We also investigated the effects of two beta-apo-carotenoids on 3T3-L1 adipocyte marker gene expression during adipocyte differentiation. Treatment of 3T3-L1 adipocytes with either beta-apo-13-carotenone or beta-apo-10'-carotenoic acid, which lacks RAR antagonist activity, stimulated adipocyte marker gene expression. Neither blocked the inhibitory effects of a relatively large dose of exogenous all-trans-retinoic acid on adipocyte differentiation. Our data suggest that in addition to acting as transcriptional antagonists, some beta-apo-carotenoids act through other mechanisms to influence 3T3-L1 adipocyte differentiation. Published by Elsevier Inc.
C1 [Wang, Cynthia X.] Columbia Univ, Columbia Coll, New York, NY 10032 USA.
   [Jiang, Hongfeng; Yuen, Jason J.; Lee, Seung-Ah; Blaner, William S.] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.
   [Narayanasamy, Sureshbabu; Curley, Robert W., Jr.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA.
   [Narayanasamy, Sureshbabu; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA.
RP Blaner, WS (reprint author), Columbia Univ, Coll Phys & Surg, Dept Med, 650 W 168th St, New York, NY 10032 USA.
EM wsb2@columbia.edu
FU U.S. Public Health Services, National Institutes of Health [R01
   DK068437, R01 HL049879, R21 AA021336]
FX This work was supported by U.S. Public Health Services, National
   Institutes of Health grants R01 DK068437(W.S.B.), R01 HL049879 (E.H.H.),
   and R21 AA021336 (W.S.B).
CR Amengual J, 2013, J BIOL CHEM, V288, P3408
   Amengual J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020644
   Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200
   von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915
   Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081
   Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862
   Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08
   Kiefer C, 2001, J BIOL CHEM, V276, P14110
   MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135
   Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2002-0210
   Wood RJ, 2008, NUTR REV, V66, P40, DOI 10.1111/j.1753-4887.2007.00004.x
   Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200
   Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906
   Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711
   Clugston RD, 2011, J LIPID RES, V52, P2021, DOI 10.1194/jlr.M017368
   Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833
   Eroglu A, 2013, J LIPID RES, V54, P1719, DOI 10.1194/jlr.R039537
   Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552
   Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303
   Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142
   Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571
   Bobbert P, 2009, EUR J HEART FAIL, V11, P1163, DOI 10.1093/eurjhf/hfp153
   Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309
   von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027
   Yan WM, 2001, GENOMICS, V72, P193, DOI 10.1006/geno.2000.6476
   Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.RI00015-JLR200
   WANG XD, 1991, ARCH BIOCHEM BIOPHYS, V285, P8, DOI 10.1016/0003-9861(91)90322-A
   BENDICH A, 1989, FASEB J, V3, P1927
   Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938
   Blaner William S., 1994, P229
   Brun P.J., 2014, FASEB J
   Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015
   Chavarria N., 2013, CIRC J, V76, P2148
   Chen YL, 2011, J CELL BIOCHEM, V112, P2865, DOI 10.1002/jcb.23200
   Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025
   Harrison E.H., 1821, BIOCHIM BIOPHYS ACTA, V70-77, P2012
   Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907
   HORST RL, 1995, ARCH BIOCHEM BIOPHYS, V322, P235, DOI 10.1006/abbi.1995.1457
   Kaulmann A, 2014, NUTR RES, V34, P907, DOI 10.1016/j.nutres.2014.07.010
   Kim YK, 2011, FASEB J, V25, P1641, DOI 10.1096/fj.10-175448
   Klöting Nora, 2007, Cell Metab, V6, P79, DOI 10.1016/j.cmet.2007.06.002
   Lee SA, 2014, AM J PHYSIOL-HEART C, V307, pH1675, DOI 10.1152/ajpheart.00548.2014
   Maher JJ, 2013, HEPATOLOGY, V58, P477, DOI 10.1002/hep.26507
   Mangelsdorf David J., 1994, P319
   Osth M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085610
   Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200
   Prakash P, 2004, J NUTR, V134, P667
   SHARMA RV, 1977, BIOCHIM BIOPHYS ACTA, V486, P183, DOI 10.1016/0005-2760(77)90083-2
   Sun J, 2014, J BIOL CHEM, V289, P33118, DOI 10.1074/jbc.M114.610501
   Wei Li-Na, 2013, Transcription, V4, P158
   Wongsiriroj N, 2014, J LIPID RES, V55, P104, DOI 10.1194/jlr.M043844
   Wyss A, 2001, BIOCHEM J, V354, P521, DOI 10.1042/0264-6021:3540521
   Xia M, 2013, HEPATOLOGY, V58, P564, DOI 10.1002/hep.26227
   Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225
NR 54
TC 0
Z9 0
U1 5
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 2
EP 10
DI 10.1016/j.abb.2015.01.009
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900002
PM 25602703
ER

PT J
AU Kim, YK
   Zuccaro, MV
   Costabile, BK
   Rodas, R
   Quadro, L
AF Kim, Youn-Kyung
   Zuccaro, Michael V.
   Costabile, Brianna K.
   Rodas, Rebeka
   Quadro, Loredana
TI Tissue- and sex-specific effects of beta-carotene 15,15 ' oxygenase
   (BCO1) on retinoid and lipid metabolism in adult and developing mice
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE beta-Carotene 15,15' oxygenase (BCO1 or CMOI or BCMO1); Embryonic
   organs; Adult organs; Retinoid metabolism; beta-Carotene metabolism
ID VITAMIN-A METABOLISM; ACYLTRANSFERASE GENE; EARLY-LIFE; MOUSE; ACID;
   DEFICIENCY; PROVITAMIN; LECITHIN; RECEPTOR; SUPPLEMENTATION
AB In mammals, beta-carotene-15,15'-oxygenase (BCO1) is the main enzyme that cleaves beta-carotene, the most abundant vitamin A precursor, to generate retinoids (vitamin A derivatives), both in adult and developing tissues. We previously reported that, in addition to this function, BCO1 can also influence the synthesis of retinyl esters, the storage form of retinoids, in the mouse embryo at mid-gestation. Indeed, lack of embryonic BCO1 impaired both lecithin-dependent and acyl CoA-dependent retinol esterification, mediated by lecithin:retinol acyltransferase (LRAT) and acyl CoA:retinol acyltransferase (ARAT), respectively. Furthermore, embryonic BCO1 also influenced the ester pools of cholesterol and diacylglycerol. In this report, we gained novel insights into this alternative function of BCO1 by investigating whether BCO1 influenced embryonic retinoid and lipid metabolism in a tissue-dependent manner. To this end, livers and brains from wild-type and BCO1-/- embryos at mid-gestation were analyzed for retinoid and lipid content, as well as gene expression levels. We also asked whether or not the role of BCO1 as a regulator of lecithin- and acyl CoA-dependent retinol esterification was exclusively restricted to the developing tissues. Thus, a survey of retinol and retinyl ester levels in adult tissues of wild-type, BCO1-/-, LRAT / and LRAT-/-BCO1-/- mice was performed. We showed that the absence of BCO1 affects embryonic retinoid and lipid homeostasis in a tissue-specific manner and that retinyl ester formation is also influenced by BCO1 in a few adult tissues (pancreas, lung, heart and adipose) in a sex-dependent manner. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Quadro, Loredana] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.
   Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA.
RP Quadro, L (reprint author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.
EM quadro@aesop.rutgers.edu
FU U.S. National Institute of Health [R01HD057493, R01HD057493-02S1,
   R01HD057493-05S1]
FX We are indebted to Dr. Anita Brinker and the Core LC-MS Facility of the
   Institute of Food, Nutrition and Health (IFNH) at Rutgers University for
   the invaluable assistance and support in performing quantitative lipid
   analysis in various mouse tissues. We would also like to thank Dr.
   Elizabeth Spiegler for her critical reading of the manuscript. This work
   was supported by grants R01HD057493, R01HD057493-02S1 and
   R01HD057493-05S1 from the U.S. National Institute of Health.
CR Amengual J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020644
   Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002
   Lindqvist A, 2007, J NUTR, V137, P2346
   Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632
   Reichert B, 2011, MOL ENDOCRINOL, V25, P799, DOI 10.1210/me.2010-0465
   Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008
   Shmarakov I, 2010, ARCH BIOCHEM BIOPHYS, V504, P3, DOI 10.1016/j.abb.2010.05.010
   Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200
   Shete V, 2013, NUTRIENTS, V5, P4849, DOI 10.3390/nu5124849
   Kiefer C, 2001, J BIOL CHEM, V276, P14110
   Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158
   Lindqvist A, 2005, J HISTOCHEM CYTOCHEM, V53, P1403, DOI 10.1369/jhc.5A6705.2005
   Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142
   Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200
   Tourniaire F, 2009, GENES NUTR, V4, P179, DOI 10.1007/s12263-009-0128-3
   Spiegler E, 2012, BBA-MOL CELL BIOL L, V1821, P88, DOI 10.1016/j.bbalip.2011.05.003
   Granados N, 2013, INT J OBESITY, V37, P1169, DOI 10.1038/ijo.2012.190
   D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063
   Lobo GP, 2012, BBA-MOL CELL BIOL L, V1821, P78, DOI 10.1016/j.bbalip.2011.04.010
   Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571
   Wassef L, 2011, J BIOL CHEM, V286, P32198, DOI 10.1074/jbc.M111.253070
   O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648
   Chen F, 2014, J CLIN INVEST, V124, P801, DOI 10.1172/JCI70291
   Innis SM, 2011, MATERN CHILD NUTR, V7, P112, DOI 10.1111/j.1740-8709.2011.00318.x
   Amengual J, 2013, J BIOL CHEM, V288, P34081, DOI 10.1074/jbc.M113.501049
   Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028
   Bharadwaj KG, 2010, J BIOL CHEM, V285, P37976, DOI 10.1074/jbc.M110.174458
   Dixon JL, 2014, BBA-MOL CELL BIOL L, V1841, P34, DOI [10.1016/j.bbalip.2013.08.013, 10.1016/Lbbalip2013.08.013]
   Gil-Sanchez Alfonso, 2011, Frontiers in Genetics, V2, P57, DOI 10.3389/fgene.2011.00057
   Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200
   Kim YK, 2011, FASEB J, V25, P1641, DOI 10.1096/fj.10-175448
   Kim YK, 2010, METHODS MOL BIOL, V652, P263, DOI 10.1007/978-1-60327-325-1_15
   Lee S.A., 2014, AM J PHYSIOL-HEART C, DOI DOI 10.1152/AJPHEART.00548.2014.EPUB
   Li Yang, 2014, Hepatobiliary Surg Nutr, V3, P126, DOI 10.3978/j.issn.2304-3881.2014.05.04
   Lietz G, 2010, ARCH BIOCHEM BIOPHYS, V502, P8, DOI 10.1016/j.abb.2010.06.032
   Lindqvist A, 2004, J HISTOCHEM CYTOCHEM, V52, P491
   Liu LM, 2008, BIOCHEM PHARMACOL, V75, P2316, DOI 10.1016/j.bcp.2008.03.012
   O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200
   Palczewski G, 2014, FASEB J, V28, P4457, DOI 10.1096/fj.14-252411
   Petrosino JM, 2014, NUTRIENTS, V6, P950, DOI 10.3390/nu6030950
   Quadro L, 2003, MOL ASPECTS MED, V24, P421, DOI 10.1016/S0098-2997(03)00038-4
   ROSS AC, 1982, J LIPID RES, V23, P133
   Sun J, 2014, J BIOL CHEM, V289, P33118, DOI 10.1074/jbc.M114.610501
   Trasino S.E., 2014, J BIOL CHEM
   van Helden YGJ, 2011, MOL NUTR FOOD RES, V55, P1466, DOI 10.1002/mnfr.201100194
   von Lintig J, 2012, AM J CLIN NUTR, V96, p1234S, DOI 10.3945/ajcn.112.034629
   Wassef L, 2012, J NUTR, V142, P1456, DOI 10.3945/jn.112.162677
   Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200
   Yasmeen R, 2013, DIABETES, V62, P124, DOI 10.2337/db11-1779
   Zolfaghari R, 2000, J LIPID RES, V41, P2024
NR 50
TC 0
Z9 0
U1 4
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 11
EP 18
DI 10.1016/j.abb.2015.01.002
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900003
PM 25602705
ER

PT J
AU Raghuvanshi, S
   Reed, V
   Blaner, WS
   Harrison, EH
AF Raghuvanshi, Shiva
   Reed, Vanessa
   Blaner, William S.
   Harrison, Earl H.
TI Cellular localization of beta-carotene 15,15 ' oxygenase-1 (BCO1) and
   beta-carotene 9 ',10 ' oxygenase-2 (BCO2) in rat liver and intestine
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Vitamin A; beta-Carotene; beta-Carotene 15,15 '-oxygenase (BCO1);
   beta-Carotene 9 ',10 ' oxygenase (BCO2); Hepatic stellate cells;
   Immunohistochemistry
ID HEPATIC STELLATE CELLS; VITAMIN-A; RETINOIC ACID; BETA,BETA-CAROTENE
   15,15'-DIOXYGENASE; BRUNNERS GLANDS; HUMAN TISSUES; EXPRESSION;
   METABOLISM; STORAGE; ACYLTRANSFERASE
AB The intestine and liver are crucial organs for vitamin A uptake and storage. Liver accounts for 70% of total body retinoid stores. Vitamin A deficiency (VAD) is a major micronutrient deficiency around the world. The provitamin A carotenoid, beta-carotene, is a significant source of vitamin A in the diet. beta-Carotene 15,15' oxygenase-1 (BCO1) and beta-carotene 9',10' oxygenase-2 (BCO2) are the two known carotenoid cleavage enzymes in humans. BCO1 and BCO2 are highly expressed in liver and intestine. Hepatocytes and hepatic stellate cells are two main cell types involved in the hepatic metabolism of retinoids. Stellate-like cells in the intestine also show ability to store vitamin A. Liver is also known to accumulate carotenoids, however, their uptake, retention and metabolism in specific liver and intestinal cell types is still unknown. Hence, we studied the cellular and subcellular expression and localization of BCO1 and BCO2 proteins in rat liver and intestine. We demonstrate that both BCO1 and BCO2 proteins are localized in hepatocytes and mucosal epithelium. We also show that BCO1 is also highly expressed in hepatic stellate cells (HSC) and portal endothelial cells in liver. At the subcellular level in liver, BCO1 is found in cytosol, while BCO2 is found in mitochondria. In intestine, immunohistochemistry showed strong BCO1 immunoreactivity in the duodenum, particularly in Brunner's glands. Both BCO1 and BCO2 showed diffuse presence along epithelia with strong immunoreactivity in endothelial cells and in certain epithelial cells which warrant further investigation as possible intestinal retinoid storage cells. (C) 2015 Published by Elsevier Inc.
C1 [Raghuvanshi, Shiva; Reed, Vanessa; Harrison, Earl H.] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA.
   [Blaner, William S.] Columbia Univ, Dept Med, New York, NY 10032 USA.
RP Harrison, EH (reprint author), Ohio State Univ, Dept Human Sci, 314 Campbell Hall,1787 Neil Ave, Columbus, OH 43210 USA.
EM Harrison.304@osu.edu
FU National Institutes of Health [R01-DK044498, R01-HL049879,
   R01-DK068437]; services of Veterinary Histology Laboratory, The Ohio
   State University (Columbus, OH, USA)
FX The authors gratefully acknowledge support from the National Institutes
   of Health through research grants R01-DK044498 (EHH), R01-HL049879
   (EHH), R01-DK068437 (WSB) and the services of Veterinary Histology
   Laboratory, The Ohio State University (Columbus, OH, USA). We also thank
   Dr. Helen Everts for the use of her Olympus BX51 light microscope.
CR Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200
   Saari JC, 2012, ANNU REV NUTR, V32, P125, DOI 10.1146/annurev-nutr-071811-150748
   Shmarakov I, 2010, ARCH BIOCHEM BIOPHYS, V504, P3, DOI 10.1016/j.abb.2010.05.010
   Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z
   Kiefer C, 2001, J BIOL CHEM, V276, P14110
   During A, 2004, ARCH BIOCHEM BIOPHYS, V430, P77, DOI 10.1016/j.abb.2004.03.024
   Teodoro AJ, 2009, EUR J NUTR, V48, P261, DOI 10.1007/s00394-009-0001-6
   Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906
   Sommer A, 1998, PROG RETIN EYE RES, V17, P9, DOI 10.1016/S1350-9462(97)00001-3
   Harrison EH, 2012, BBA-MOL CELL BIOL L, V1821, P70, DOI 10.1016/j.bbalip.2011.06.002
   Lindqvist A, 2005, J HISTOCHEM CYTOCHEM, V53, P1403, DOI 10.1369/jhc.5A6705.2005
   Chambon P, 1996, FASEB J, V10, P940
   O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648
   Collaco AM, 2013, AM J PHYSIOL-GASTR L, V305, pG258, DOI 10.1152/ajpgi.00485.2012
   Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.RI00015-JLR200
   BENDICH A, 1989, FASEB J, V3, P1927
   Apte MV, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00344
   Bohnsack BL, 2004, GENE DEV, V18, P1345, DOI 10.1101/gad.1184904
   During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400
   FRIEND DS, 1965, J CELL BIOL, V25, P563, DOI 10.1083/jcb.25.3.563
   Grune T., 2010, J NUTR, V140, P2268
   Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002
   HARRISON EH, 1987, J LIPID RES, V28, P973
   Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200
   Krause W J, 2000, Prog Histochem Cytochem, V35, P259
   Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200
   Lindqvist A, 2004, J HISTOCHEM CYTOCHEM, V52, P491
   Martucci RB, 2004, J CELL BIOCHEM, V92, P414, DOI 10.1002/jcb.20073
   Nagatsuma K, 2009, LIVER INT, V29, P47, DOI 10.1111/j.1478-3231.2008.01773.x
   Nagy NE, 1997, J LIPID RES, V38, P645
   Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200
   Palczewski G, 2014, FASEB J, V28, P4457, DOI 10.1096/fj.14-252411
   Ross A.C., 2014, HDB VITAMINS, V5th, P1
   Sato K., 2012, ANN OTO RHINOL LARYN, V2012, P51
   Senoo H, 2013, CELL BIOL INT, V37, P1171, DOI 10.1002/cbin.10140
   Shmarakov IO, 2013, J LIPID RES, V54, P893, DOI 10.1194/jlr.M029801
   U.S. Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT VIT VIT
   Wake K, 1999, J ELECTRON MICROSC, V48, P89
   Wyss A, 2001, BIOCHEM J, V354, P521, DOI 10.1042/0264-6021:3540521
   Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619
NR 40
TC 0
Z9 0
U1 4
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 19
EP 27
DI 10.1016/j.abb.2014.12.024
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900004
PM 25575786
ER

PT J
AU Linnewiel-Hermoni, K
   Khanin, M
   Danilenko, M
   Zango, G
   Amosi, Y
   Levy, J
   Sharoni, Y
AF Linnewiel-Hermoni, Karin
   Khanin, Marina
   Danilenko, Michael
   Zango, Gabriel
   Amosi, Yaara
   Levy, Joseph
   Sharoni, Yoav
TI The anti-cancer effects of carotenoids and other phytonutrients resides
   in their combined activity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Synergy; Carotenoids; Polyphenols; Prostate cancer; Androgen signaling
ID PROSTATE-CANCER CELLS; MEDITERRANEAN DIET; BETA-CAROTENE;
   APO-10'-LYCOPENOIC ACID; LYCOPENE INHIBITION; CYCLE PROGRESSION; GROWTH;
   PROLIFERATION; PREVENTION; PHYTOCHEMICALS
AB Epidemiological studies have consistently shown that regular consumption of fruits and vegetables is strongly associated with reduced risk of developing chronic diseases, such as cancer. It is now accepted that the actions of any specific phytonutrient alone do not explain the observed health benefits of diets rich in fruits and vegetables as nutrients that were taken alone in clinical trials did not show consistent preventive effects. The considerable cost and complexity of such clinical trials requires prudent selection of combinations of ingredients rather than single compounds. Indeed, synergistic inhibition of prostate and mammary cancer cell growth was evident when using combinations of low concentrations of various carotenoids or carotenoids with retinoic acid and the active metabolite of vitamin-D. In this study we aimed to develop simple and sensitive in vitro methods which provide information on potent combinations suitable for inclusion in clinical studies for cancer prevention. We, thus, used reporter gene assays of the transcriptional activity of the androgen receptor in hormone-dependent prostate cancer cells and of the electrophile/antioxidant response element (EpRE/ARE) transcription system. We found that combinations of several carotenoids (e.g., lycopene, phytoene and phytofluene), or carotenoids and polyphenols (e.g., carnosic acid and curcumin) and/or other compounds (e.g., vitamin E) synergistically inhibit the androgen receptor activity and activate the EpRE/ARE system. The activation of EpRE/ARE was up to four fold higher than the sum of the activities of the single ingredients, a robust hallmark of synergy. Such combinations can further be tested in the more complex in vivo models and human studies. (C) 2015 Elsevier Inc. All rights reserved.
C1 Ben Gurion Univ Negev, Fac Hlth Sci, Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel.
   Soroka Med Ctr, IL-84101 Beer Sheva, Israel.
RP Sharoni, Y (reprint author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, 1 Ben Gurion Blvd, IL-84105 Beer Sheva, Israel.
EM yoav@bgu.ac.il
FU Lycored Ltd., Beer Sheva, Israel
FX We thank Dr. M. Hannink (University of Missouri-Columbia, Columbia, MO)
   and Dr. H.P. Koeffler (Cedars-Sinai Medical Center, Los Angeles) for
   donating the plasmids used in this study. We thank Dr. Andrzej Kutner
   (Pharmaceutical Research Institute, Warsaw, Poland) for donating
   1,25vitD<INF>3</INF>. We thank Dr. S.A. Lamprecht for his help in
   language editing, proofreading and revising the manuscript. This
   research was supported in part by a grant from Lycored Ltd., Beer Sheva,
   Israel (to Y. Sharoni and J. Levy). LycoRed Ltd. did not have any role
   in the performance of the experiments or in the analysis and
   interpretation of the data presented in this paper.
CR Hadad N, 2012, FREE RADICAL BIO MED, V53, P1381, DOI 10.1016/j.freeradbiomed.2012.07.078
   Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009
   Nahum A, 2001, ONCOGENE, V20, P3428, DOI 10.1038/sj.onc.1204452
   Bommareddy A, 2013, ANTICANCER RES, V33, P4163
   Aftab N, 2010, PHYTOTHER RES, V24, P500, DOI 10.1002/ptr.2960
   Palozza P, 2010, CARCINOGENESIS, V31, P1813, DOI 10.1093/carcin/bgq157
   Guo H, 2013, PHARMAZIE, V68, P431, DOI 10.1691/ph.2013.2861
   Kotake-Nara E, 2001, J NUTR, V131, P3303
   Giovannucci E, 1999, J NATL CANCER I, V91, P317, DOI 10.1093/jnci/91.4.317
   Ip BC, 2013, CANCER PREV RES, V6, P1304, DOI 10.1158/1940-6207.CAPR-13-0178
   Tabrez S, 2013, J ENVIRON SCI HEAL C, V31, P67, DOI 10.1080/10590501.2013.763577
   Eroglu A, 2013, J LIPID RES, V54, P1719, DOI 10.1194/jlr.R039537
   Karas M, 2000, NUTR CANCER, V36, P101, DOI 10.1207/S15327914NC3601_14
   Nahum A, 2006, EUR J NUTR, V45, P275, DOI 10.1007/s00394-006-0595-x
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Schwingshackl L, 2014, INT J CANCER, V135, P1884, DOI 10.1002/ijc.28824
   LEVY J, 1995, NUTR CANCER, V24, P257
   Linnewiel K, 2009, FREE RADICAL BIO MED, V47, P659, DOI 10.1016/j.freeradbiomed.2009.06.008
   Kenfield SA, 2014, EUR UROL, V65, P887, DOI 10.1016/j.eururo.2013.08.009
   Ivanov NI, 2007, CLIN NUTR, V26, P252, DOI 10.1016/j.clnu.2007.01.002
   Holzapfel NP, 2013, INT J MOL SCI, V14, P14620, DOI 10.3390/ijms140714620
   Tognon G, 2012, J NUTR, V142, P1547, DOI 10.3945/jn.112.160499
   BLOCK G, 1992, NUTR CANCER, V18, P1
   Catalano A, 2013, FOOD CHEM TOXICOL, V51, P71, DOI 10.1016/j.fct.2012.08.050
   Cutts SM, 2001, CANCER RES, V61, P8194
   GIOVANNUCCI E, 1995, J NATL CANCER I, V87, P1767, DOI 10.1093/jnci/87.23.1767
   Goel A., BIOCH PHARM, V75, P787
   Gu ZN, 2013, BIOMED RES INT, DOI 10.1155/2013/824563
   Kaarbo M, 2007, BIOESSAYS, V29, P1227, DOI 10.1002/bies.20676
   Kim Linda, 2002, Journal of Medicinal Food, V5, P181, DOI 10.1089/109662002763003320
   Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459, DOI 10.1016/j.mam.2005.10.001
   Kristal A.R., CANC EPIDEMIOL BIOMA, V20, P638
   Landis-Piwowar Kristin R, 2014, Cancer Growth Metastasis, V7, P19, DOI 10.4137/CGM.S11288
   Limpens J, 2006, J NUTR, V136, P1287
   Linnewiel-Hermoni K, 2014, FREE RADICAL BIO MED, V75, P105, DOI 10.1016/j.freeradbiomed.2014.07.024
   Liu RH, 2003, AM J CLIN NUTR, V78, p517S
   Magbanua MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024004
   Omenn G.S., N ENGL J MED, V334, P1150
   Pastori M, 1998, BIOCHEM BIOPH RES CO, V250, P582, DOI 10.1006/bbrc.1998.9351
   Prakash P, 2001, J NUTR, V131, P1574
   Riboli E., 2003, AM J CLIN NUTR, V78, P559
   Sharoni Y, 2012, AM J CLIN NUTR, V96, p1173S, DOI 10.3945/ajcn.112.034645
   Yang CM, 2012, J NUTR BIOCHEM, V23, P8, DOI 10.1016/j.jnutbio.2010.10.006
   Zinov'eva V. N., 2012, Biomeditsinskaya Khimiya, V58, P257
   Zu K, 2014, JNCI-J NATL CANCER I, V106, P430, DOI DOI 10.1093/JNCI/DJT430
NR 45
TC 1
Z9 1
U1 20
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 28
EP 35
DI 10.1016/j.abb.2015.02.018
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900005
PM 25711533
ER

PT J
AU Sahin, K
   Cross, B
   Sahin, N
   Ciccone, K
   Suleiman, S
   Osunkoya, AO
   Master, V
   Harris, W
   Carthon, B
   Mohammad, R
   Bilir, B
   Wertz, K
   Moreno, CS
   Walker, CL
   Kucuk, O
AF Sahin, Kazim
   Cross, Brian
   Sahin, Nurhan
   Ciccone, Karina
   Suleiman, Shadeah
   Osunkoya, Adeboye O.
   Master, Viraj
   Harris, Wayne
   Carthon, Bradley
   Mohammad, Ramzi
   Bilir, Birdal
   Wertz, Karin
   Moreno, Carlos S.
   Walker, Cheryl L.
   Kucuk, Omer
TI Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker
   rat model
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Renal cell cancer; Lycopene; Eker rat
ID PROSTATE-CANCER; CARCINOMA; RISK; CAROTENOIDS; GENE; CONSUMPTION;
   VITAMIN; SUPPLEMENTATION; DIET
AB Renal cell carcinoma (RCC) is the most frequent upper urinary tract cancer in humans and accounts for 80-85% of malignant renal tumors. Eker rat represents a unique animal model to study RCC since these rats develop spontaneous renal tumors and leiomyoma, which may be due to tuberous sclerosis 2 (TSC2) mutation resulting in the activation of the mammalian target of rapamycin (mTOR) pathway. This study examines the role of a lycopene-rich diet in the development of RCC in the TSC2 mutant Eker rat model. Ten-week old female Eker rats (n = 90) were assigned in equal numbers to receive 0, 100 or 200 mg/kg of lycopene as part of their daily diet. After 18 months the rats were sacrificed and the kidneys were removed. Immunohistochemical staining with antibodies against mTOR, phospho-S6 and EGFR were performed, as well as hematoxylin-eosin staining for histologic examination of the tumors. Tumors were counted and measured in individual kidneys. Presence of tumor decreased from 94% in control animals to 65% in the experimental group, but the difference was not statistically significant (P < 0.12). However, mean numbers of renal carcinomas were statistically significantly decreased in the lycopene-treated rats (P < 0.008) when compared to untreated controls. In the lycopene group, tumor numbers decreased (P < 0.002) and the numbers tended to decrease linearly (P < 0.003) as supplemental lycopene increased from 0 to 200. Control rats fed only basal diet had a greater length of tumors (23.98 mm) than rats fed lycopene supplement groups (12.90 mm and 11.07 mm) (P < 0.05). Moreover tumor length decreased (P < 0.02) and tumor length tended to decrease linearly (P < 0.03) as supplemental lycopene increased from 0 to 200 mg/kg. All tumors showed strong staining with antibodies against mTOR, phospho-S6 and EGER. In conclusion, dietary supplementation with lycopene attenuates the development of renal cell cancers in the predisposed TSC2 mutant Eker rat model. These results suggest that lycopene may play a role in the prevention of RCC. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Sahin, Kazim; Sahin, Nurhan] Firat Univ, Dept Anim Nutr, Fac Vet, TR-23169 Elazig, Turkey.
   [Cross, Brian; Ciccone, Karina; Suleiman, Shadeah; Osunkoya, Adeboye O.; Master, Viraj; Harris, Wayne; Carthon, Bradley; Bilir, Birdal; Moreno, Carlos S.; Kucuk, Omer] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.
   [Mohammad, Ramzi] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA.
   [Wertz, Karin] DSM, Basel, Switzerland.
   [Walker, Cheryl L.] Univ Texas MD Anderson Canc Ctr, Div Sci Pk Res, Mol Carcinogenesis, Smithville, TX USA.
RP Kucuk, O (reprint author), Emory Univ, Winship Canc Inst, 1365-B Clifton Rd NE,Room B-4301, Atlanta, GA 30322 USA.
EM okucuk@emory.edu
FU DSM, Basel, Switzerland; Georgia Cancer Coalition Carpenter Fellowship
   Fund (Karma Ciccone)
FX This research was supported in part by funds from DSM, Basel,
   Switzerland, and Georgia Cancer Coalition Carpenter Fellowship Fund
   (Karma Ciccone). Dr. Omer Kucuk is a Georgia Cancer Coalition
   Distinguished Cancer Scholar.
CR Siler U, 2004, FASEB J, V18, P1019, DOI 10.1096/fj.03-1116fje
   van Dijk BAC, 2008, CANCER CAUSE CONTROL, V19, P125, DOI 10.1007/s10552-007-9078-5
   Hu JF, 2009, CANCER CAUSE CONTROL, V20, P1451, DOI 10.1007/s10552-009-9371-6
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]
   Faramawi MF, 2007, CANCER CAUSE CONTROL, V18, P125, DOI 10.1007/s10552-006-0104-9
   Hu JF, 2003, CANCER CAUSE CONTROL, V14, P705, DOI 10.1023/A:1026310323882
   Yuan JM, 1998, INT J CANCER, V77, P211, DOI 10.1002/(SICI)1097-0215(19980717)77:2<211::AID-IJC7>3.3.CO;2-0
   Olson JA, 1995, FASEB J, V9, P1547
   DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0
   Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839
   Lindblad P, 1997, CANCER EPIDEM BIOMAR, V6, P215
   Tang FY, 2011, J AGR FOOD CHEM, V59, P9011, DOI 10.1021/jf2017644
   Bosetti C, 2007, INT J CANCER, V120, P892, DOI 10.1002/ijc.22374
   Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899
   Giovannucci E, 2002, EXP BIOL MED, V227, P852
   ZHANG LX, 1991, CARCINOGENESIS, V12, P2109, DOI 10.1093/carcin/12.11.2109
   Bertram JS, 1999, NUTR REV, V57, P182
   Mellemgaard A, 1996, EUR J CANCER, V32A, P673, DOI 10.1016/0959-8049(95)00633-8
   Arsanious A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-20
   Chew BP, 2004, J NUTR, V134, P257
   EKER R, 1961, NATURE, V189, P858, DOI 10.1038/189858b0
   Giovannucci E., 1999, HORM RES, V51, pS34
   Hazai E, 2006, BIOORGAN MED CHEM, V14, P6859, DOI 10.1016/j.bmc.2006.06.045
   Hino O, 2003, CANCER SCI, V94, P142, DOI 10.1111/j.1349-7006.2003.tb01410.x
   Jewell C, 1999, BRIT J NUTR, V81, P235
   Kucuk O, 2002, CANCER METAST REV, V21, P189, DOI 10.1023/A:1021298508095
   Lee E., 2006, CANCER EPIDEM BIOMAR, V15, P2445
   Maclure M, 1990, Epidemiology, V1, P430, DOI 10.1097/00001648-199011000-00004
   Riso P, 1999, AM J CLIN NUTR, V69, P712
   Sahin K, 2004, NUTR CANCER, V50, P181, DOI 10.1207/s15327914nc5002_8
   TALAMINI R, 1990, CANCER CAUSE CONTROL, V1, P125, DOI 10.1007/BF00053163
   Tavani A, 1997, J NEPHROL, V10, P93
NR 32
TC 0
Z9 0
U1 4
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 36
EP 39
DI 10.1016/j.abb.2015.01.006
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900006
PM 25602702
ER

PT J
AU Gong, XM
   Rubin, LP
AF Gong, Xiaoming
   Rubin, Lewis P.
TI Role of macular xanthophylls in prevention of common neovascular
   retinopathies: Retinopathy of prematurity and diabetic retinopathy
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Lutein; Zeaxanthin; Xanthophylls; Retina; Diabetes; Prematurity;
   Retinopathy; Oxidative stress; Prevention
ID MITOCHONDRIAL SUPEROXIDE-DISMUTASE; RETINAL-PIGMENT EPITHELIUM;
   FACTOR-KAPPA-B; OXIDATIVE STRESS; BETA-CAROTENE; POLY(ADP-RIBOSE)
   POLYMERASE; PRIMATE RETINAS; NITRIC-OXIDE; PKC-DELTA; ZEAXANTHIN
   SUPPLEMENTATION
AB Retinopathy of prematurity (ROP) and diabetic retinopathy (DR) are important causes of blindness among children and working-age adults, respectively. The development of both diseases involves retinal microvascular degeneration, vessel loss and consequent hypoxic and inflammatory pathologic retinal neovascularization. Mechanistic studies have shown that oxidative stress and subsequent derangement of cell signaling are important factors in disease progression. In eye and vision research, role of the dietary xanthophyll carotenoids, lutein and zeaxanthin, has been more extensively studied in adult onset macular degeneration than these other retinopathies. These carotenoids also may decrease severity of ROP in preterm infants and of DR in working-age adults. A randomized controlled clinical trial of carotenoid supplementation in preterm infants indicated that lutein has functional effects in the neonatal eye and is anti-inflammatory. Three multicenter clinical trials all showed a trend of decreased ROP severity in the lutein supplemented group. Prospective studies on patients with non-proliferative DR indicate serum levels of lutein and zeaxanthin are significantly lower in these patients compared to normal subjects. The present review describes recent advances in lutein and zeaxanthin modulation of oxidative stress and inflammation related to ROP and DR and discusses potential roles of lutein/zeaxanthin in preventing or lessening the risks of disease initiation or progression. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Gong, Xiaoming; Rubin, Lewis P.] Texas Tech Univ, Dept Pediat, Hlth Sci Ctr, Paul L Foster Sch Med, El Paso, TX 79905 USA.
RP Rubin, LP (reprint author), Texas Tech Univ, Dept Pediat, Hlth Sci Ctr, Paul L Foster Sch Med, 4800 Alberta Ave, El Paso, TX 79905 USA.
EM Lewis.rubin@ttuhsc.edu
FU Muma Family Endowment; Laura W. Bush Institute for Women's Health at
   Texas Tech University
FX This work was supported by the Muma Family Endowment and the Laura W.
   Bush Institute for Women's Health at Texas Tech University.
CR Abdelsaid MA, 2010, J PHARMACOL EXP THER, V332, P125, DOI 10.1124/jpet.109.157941
   Acar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035102
   OLSON JA, 1989, J NUTR, V119, P105
   Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606
   Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200
   SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P674
   Klinger G, 2010, PEDIATRICS, V125, pE736, DOI 10.1542/peds.2009-2017
   Yeum KJ, 2002, ANNU REV NUTR, V22, P483, DOI 10.1146/annurev.nutr.22.010402.102834
   Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632
   Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915
   Ates O, 2009, EUR J OPHTHALMOL, V19, P80
   Zheng L, 2004, DIABETES, V53, P2960, DOI 10.2337/diabetes.53.11.2960
   Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129
   Leung IYF, 2004, INVEST OPHTH VIS SCI, V45, P3244, DOI 10.1167/iovs.02-1233
   Muriach M, 2006, FREE RADICAL BIO MED, V41, P979, DOI 10.1016/j.freeradbiomed.2006.06.023
   Niesman MR, 1997, NEUROCHEM RES, V22, P597, DOI 10.1023/A:1022474120512
   Obrosova IG, 2005, DIABETES, V54, P3435, DOI 10.2337/diabetes.54.12.3435
   Moscuzza F, 2011, GYNECOL ENDOCRINOL, V27, P319, DOI 10.3109/09513590.2010.487619
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Landrum JT, 1999, METHOD ENZYMOL, V299, P457
   Abdel-Aal EM, 2013, NUTRIENTS, V5, P1169, DOI 10.3390/nu5041169
   [Anonymous], 2013, JAMA J AM MED ASS, V309, P2005
   Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje
   Smith LE, 2013, CLIN PERINATOL, V40, P201, DOI 10.1016/j.clp.2013.02.002
   Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6
   Perrone S, 2014, OXID MED CELL LONGEV, DOI 10.1155/2014/781454
   Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963
   Pacher P, 2005, ANTIOXID REDOX SIGN, V7, P1568, DOI 10.1089/ars.2005.7.1568
   Khachik F, 1997, INVEST OPHTH VIS SCI, V38, P1802
   Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052
   Bhosale P, 2009, BIOCHEMISTRY-US, V48, P4798, DOI 10.1021/bi9004478
   Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938
   Wang W, 2007, AM J CLIN NUTR, V85, P762
   Mares JA, 2006, AM J CLIN NUTR, V84, P1107
   Kowluru RA, 2006, FREE RADICAL BIO MED, V41, P1191, DOI 10.1016/j.freeadbiomed.2006.01.012
   Kiefer C, 2001, J BIOL CHEM, V276, P14110
   Khachik F, 2002, INVEST OPHTH VIS SCI, V43, P3383
   Joussen AM, 2002, AM J PATHOL, V160, P501, DOI 10.1016/S0002-9440(10)64869-9
   Woo SJ, 2012, GRAEF ARCH CLIN EXP, V250, P915, DOI 10.1007/s00417-011-1648-2
   Sato T, 2009, OPHTHALMOLOGY, V116, P2165, DOI 10.1016/j.ophtha.2009.04.026
   Tolsma KW, 2011, ARCH OPHTHALMOL-CHIC, V129, P1555, DOI 10.1001/archophthalmol.2011.319
   Schram MT, 2005, DIABETOLOGIA, V48, P370, DOI 10.1007/s00125-004-1628-8
   BONE RA, 1993, INVEST OPHTH VIS SCI, V34, P2033
   Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H
   Cui Y, 2006, EXP EYE RES, V83, P807, DOI 10.1016/j.exer.2006.03.024
   Li SY, 2010, INT J MOL SCI, V11, P2109, DOI 10.3390/ijms11052109
   Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906
   Sato M, 2011, J OBSTET GYNAECOL RE, V37, P1313, DOI 10.1111/j.1447-0756.2010.01519.x
   SUBCZYNSKI WK, 1991, BIOCHIM BIOPHYS ACTA, V1068, P68, DOI 10.1016/0005-2736(91)90061-C
   Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111
   Chew EY, 2014, JAMA OPHTHALMOL, V132, P142, DOI 10.1001/jamaophthalmol.2013.7376
   Qin XH, 2011, ACTA BIOCH BIOPH SIN, V43, P703, DOI 10.1093/abbs/gmr069
   Ozturk BT, 2009, MOL VIS, V15, P1906
   Hellstrom A, 2003, PEDIATRICS, V112, P1016, DOI 10.1542/peds.112.5.1016
   Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222
   Lindqvist A, 2005, J HISTOCHEM CYTOCHEM, V53, P1403, DOI 10.1369/jhc.5A6705.2005
   Zhong Q, 2011, INVEST OPHTH VIS SCI, V52, P8739, DOI 10.1167/iovs.11-8045
   MALINOW MR, 1980, INVEST OPHTH VIS SCI, V19, P857
   Ma L, 2012, OPHTHALMOLOGY, V119, P2290, DOI 10.1016/j.ophtha.2012.06.014
   Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0
   Sujak A, 1999, ARCH BIOCHEM BIOPHYS, V371, P301, DOI 10.1006/abbi.1999.1437
   Kaur C, 2009, INVEST OPHTH VIS SCI, V50, P5364, DOI 10.1167/iovs.09-3552
   Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217
   Lee J, 2012, SEMIN FETAL NEONAT M, V17, P26, DOI 10.1016/j.siny.2011.08.007
   Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6
   Li BX, 2011, BIOCHEMISTRY-US, V50, P2541, DOI 10.1021/bi101906y
   Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909
   Boscia F, 2000, INVEST OPHTH VIS SCI, V41, P2461
   Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310
   Mein JR, 2011, ARCH BIOCHEM BIOPHYS, V506, P109, DOI 10.1016/j.abb.2010.11.005
   Rivera JC, 2011, NEONATOLOGY, V100, P343, DOI 10.1159/000330174
   Johnson EJ, 2005, INVEST OPHTH VIS SCI, V46, P692, DOI 10.1167/iovs.02-1192
   Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171
   Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138
   Soriano FG, 2001, NAT MED, V7, P108
   Li BX, 2014, P NATL ACAD SCI USA, V111, P10173, DOI 10.1073/pnas.1402526111
   Qanungo S, 2000, MOL CELL BIOCHEM, V215, P11, DOI 10.1023/A:1026511420505
   Granado F, 2003, BRIT J NUTR, V90, P487, DOI 10.1079/BJN2003927
   Bone RA, 1997, EXP EYE RES, V64, P211, DOI 10.1006/exer.1996.0210
   Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002
   Musch DC, 2014, JAMA OPHTHALMOL, V132, P139, DOI 10.1001/jamaophthalmol.2013.7443
   Rapp LM, 2000, INVEST OPHTH VIS SCI, V41, P1200
   Graven SN, 2011, CLIN PERINATOL, V38, P671, DOI 10.1016/j.clp.2011.08.006
   Kowluru RA, 2005, ANTIOXID REDOX SIGN, V7, P1581, DOI 10.1089/ars.2005.7.1581
   Sood BG, 2010, PEDIATR RES, V67, P394, DOI 10.1203/PDR.0b013e3181d01a36
   Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591
   Cavallaro G, 2014, ACTA OPHTHALMOL, V92, P2, DOI 10.1111/aos.12049
   Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615
   Kowluru RA, 2008, INVEST OPHTH VIS SCI, V49, P1645, DOI 10.1167/iovs.07-0764
   Chew EY, 2013, JAMA OPHTHALMOL, V131, P843, DOI 10.1001/jamaophthalmol.2013.4412
   Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044
   Zeng HY, 2008, ARCH OPHTHALMOL-CHIC, V126, P227, DOI 10.1001/archophthalmol.2007.65
   Kowluru RA, 2006, INVEST OPHTH VIS SCI, V47, P1594, DOI 10.1167/iovs.05-1276
   Arden Geoffrey B, 2011, Curr Diabetes Rev, V7, P291
   Arnal E., 2010, NEUROSCIENCE, P271
   Arnal E, 2009, CURR EYE RES, V34, P928, DOI 10.3109/02713680903205238
   BIRCH EE, 1992, INVEST OPHTH VIS SCI, V33, P3242
   Brazionis L., 2009, BR J NUTR, V101, P277
   Byfield G, 2009, INVEST OPHTH VIS SCI, V50, P3360, DOI 10.1167/iovs.08-3256
   Dani C., 2011, J MATERN FETAL NEONA
   DAVIS MD, 1992, DIABETES CARE, V15, P1844, DOI 10.2337/diacare.15.12.1844
   El-Remessy AB, 2011, DIABETOLOGIA, V54, P1567, DOI 10.1007/s00125-011-2061-4
   Feeney-Burns L, 1989, Prog Clin Biol Res, V314, P601
   Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0
   HANDELMAN GJ, 1992, METHOD ENZYMOL, V213, P220
   Hardy P, 2000, CARDIOVASC RES, V47, P489, DOI 10.1016/S0008-6363(00)00084-5
   Hartnett M.E., 2010, ADV OPHTHALMOL, V120, P25
   Hartnett Mary Elizabeth, 2010, Trans Am Ophthalmol Soc, V108, P96
   Heidary G, 2009, SEMIN OPHTHALMOL, V24, P77, DOI 10.1080/08820530902800314
   Hellstrom A, 2001, P NATL ACAD SCI USA, V98, P5804, DOI 10.1073/pnas.101113998
   Hu BJ, 2011, INT J OPHTHALMOL-CHI, V4, P303, DOI 10.3980/j.issn.2222-3959.2011.03.19
   Kaul Kirti, 2010, Curr Diabetes Rev, V6, P294, DOI 10.2174/157339910793360851
   Kermorvant-Duchemin E, 2010, DOC OPHTHALMOL, V120, P51, DOI 10.1007/s10633-009-9201-x
   Koleva-Georgieva Desislava N, 2011, Folia Med (Plovdiv), V53, P44
   Kowluru RA, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-8
   Krinsky NI, 2002, J NUTR, V132, p540S
   Landrum J T, 1997, Adv Pharmacol, V38, P537
   Lee JW, 2011, CURR OPIN PEDIATR, V23, P161, DOI 10.1097/MOP.0b013e3283423e51
   Lima VC, 2010, INVEST OPHTH VIS SCI, V51, P5840, DOI 10.1167/iovs.09-4695
   Manzoni P, 2013, AM J PERINAT, V30, P25, DOI 10.1055/s-0032-1321494
   Miranda M, 2006, Arch Soc Esp Oftalmol, V81, P27
   Miranda S, 2012, J CELL PHYSIOL, V227, P2352, DOI 10.1002/jcp.22970
   Mitra S, 2014, NEONATOLOGY, V105, P189, DOI 10.1159/000357556
   Nitti M, 2007, NEUROSCI LETT, V416, P261, DOI 10.1016/j.neulet.2007.02.013
   Nitti M, 2005, FREE RADICAL BIO MED, V38, P846, DOI 10.1016/j.freeradbiomed.2004.12.002
   Nyengaard JR, 2004, DIABETES, V53, P2931, DOI 10.2337/diabetes.53.11.2931
   OJIMA F, 1993, FREE RADICAL BIO MED, V15, P377, DOI 10.1016/0891-5849(93)90037-U
   Ozawa Y, 2011, EXP DIABETES RES, DOI 10.1155/2011/108328
   Parker RS, 1999, P NUTR SOC, V58, P155, DOI 10.1079/PNS19990021
   Penn JS, 1997, FREE RADICAL BIO MED, V22, P977, DOI 10.1016/S0891-5849(96)00479-0
   Perrone S, 2010, NEONATOLOGY, V97, P36, DOI 10.1159/000227291
   Picone S, 2012, CLIN BIOCHEM, V45, P1558, DOI 10.1016/j.clinbiochem.2012.07.109
   Pollan Charlene, 2009, Neonatal Netw, V28, P93
   Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554
   Romagnoli C, 2009, EARLY HUM DEV, V85, pS79, DOI 10.1016/j.earlhumdev.2009.08.026
   Romagnoli C, 2011, J MATERN-FETAL NEO M, V24, P147, DOI 10.3109/14767058.2011.607618
   Rubin L.P., 2011, J PERINATOL
   SanGiovanni JP, 2012, AM J CLIN NUTR, V96, p1223S, DOI 10.3945/ajcn.112.038240
   Silveira RC, 2011, INVEST OPHTH VIS SCI, V52, P1297, DOI 10.1167/iovs.10-6279
   Smith L.E., 2004, IGF RES SA, V14, pS140
   SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448
   Subczynski WK, 2014, J CLIN EXP OPHTHALMO, V5, P326
   TANG GW, 1991, BIOCHEMISTRY-US, V30, P9829, DOI 10.1021/bi00105a003
   van het Hof Karin H., 2000, Journal of Nutrition, V130, P503
   WANG XD, 1994, ARCH BIOCHEM BIOPHYS, V313, P150, DOI 10.1006/abbi.1994.1371
   Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619
   Yang Y, 2010, OXID MED CELL LONGEV, V3, P392, DOI 10.4161/oxim.3.6.14786
   Yao LH, 2000, LIPIDS, V35, P339, DOI 10.1007/s11745-000-0531-0
   Yeum KJ, 1998, J AM COLL NUTR, V17, P442
NR 155
TC 2
Z9 3
U1 6
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 40
EP 48
DI 10.1016/j.abb.2015.02.004
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900007
PM 25701588
ER

PT J
AU Tian, Y
   Kijlstra, A
   Webers, CAB
   Berendschot, TTJM
AF Tian, Yuan
   Kijlstra, Aize
   Webers, Carroll A. B.
   Berendschot, Tos T. J. M.
TI Lutein and Factor D: Two intriguing players in the field of age-related
   macular degeneration
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Lutein; Age-related macular degeneration; Factor D; Complement system
ID COMPLEMENT FACTOR-D; INDUCED CHOROIDAL NEOVASCULARIZATION; ALTERNATIVE
   PATHWAY CONVERTASE; MEMBRANE ATTACK COMPLEX; FACTOR-H POLYMORPHISM;
   ADIPOSE-TISSUE; OXIDATIVE STRESS; CAROTENOID CONCENTRATIONS;
   DIETARY-INTAKE; RISK-FACTORS
AB Age-related macular degeneration (AMD) is a progressive eye disease that impairs central vision among elderly populations in Western, industrialized countries. In this review we will focus on the role of factor D (FD) and lutein in AMD. FD is a rate-limiting enzyme of the alternative complement activation pathway that may play an important role in the development of AMD. Several independent studies have shown a significant increase in the level of a number of complement factors of the alternative pathway, including factor D in the blood of AMD patients as compared to healthy individuals, which suggests a systemic involvement in the pathogenesis of AMD.
   FD, also called adipsin, is mainly produced by adipose tissue. Besides playing a role in the activation of the alternative pathway, FD is also known to regulate the immune system. Of interest is our preliminary finding that lutein supplementation of early AMD cases was shown to lower the level of systemic FD. If confirmed, these findings provide further support for the application of anti-factor D intervention as a new approach to control the development of this disease. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Tian, Yuan; Kijlstra, Aize; Webers, Carroll A. B.; Berendschot, Tos T. J. M.] Univ Eye Clin Maastricht, NL-6202 AZ Maastricht, Netherlands.
RP Berendschot, TTJM (reprint author), Univ Eye Clin Maastricht, POB 5800, NL-6202 AZ Maastricht, Netherlands.
EM tberendschot@maastrichtuniversity.nl
CR Troutbeck R, 2012, CLIN EXP OPHTHALMOL, V40, P18, DOI 10.1111/j.1442-9071.2011.02581.x
   PASCUAL M, 1988, KIDNEY INT, V34, P529, DOI 10.1038/ki.1988.214
   Sivaprasad S, 2006, EYE, V20, P867, DOI 10.1038/sj.eye.6702176
   Dwyer JH, 2001, CIRCULATION, V103, P2922
   Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069
   Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P785, DOI 10.1001/archopht.121.6.785
   Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578
   van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101
   Bora NS, 2006, J IMMUNOL, V177, P1872
   WHITE RT, 1992, J BIOL CHEM, V267, P9210
   Ma L, 2012, BRIT J NUTR, V107, P350, DOI 10.1017/S0007114511004260
   Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003
   Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0
   Izumi-Nagai K, 2007, ARTERIOSCL THROM VAS, V27, P2555, DOI 10.1161/ATVBAHA.107.151431
   Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103
   Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321
   Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013
   Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557
   Brantley MA, 2007, OPHTHALMOLOGY, V114, P2168, DOI 10.1016/j.ophtha.2007.09.008
   YANG A, 1992, AUST J AGR RES, V43, P1809, DOI 10.1071/AR9921809
   Delcourt C, 2006, INVEST OPHTH VIS SCI, V47, P2329, DOI 10.1167/iovs.05-1235
   Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056
   Aronow ME, 2014, CURR OPIN OPHTHALMOL, V25, P186, DOI 10.1097/ICU.0000000000000046
   Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
   Yang PZ, 2005, CURR EYE RES, V30, P943, DOI 10.1080/02713680500263606
   MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.bi.57.070188.001541
   BARNUM SR, 1984, J IMMUNOL METHODS, V67, P303, DOI 10.1016/0022-1759(84)90470-8
   Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113
   Stanton CM, 2011, INVEST OPHTH VIS SCI, V52, P8828, DOI 10.1167/iovs.11-7933
   Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7
   Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222
   El-Sohemy A, 2002, AM J CLIN NUTR, V76, P172
   Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166
   Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928
   Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359
   Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5
   Sparrow JR, 2012, MOL ASPECTS MED, V33, P436, DOI 10.1016/j.mam.2012.03.007
   LESAVRE PH, 1978, J EXP MED, V148, P1498, DOI 10.1084/jem.148.6.1498
   Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472
   Katschke KJ, 2012, J BIOL CHEM, V287, P12886, DOI 10.1074/jbc.M112.345082
   Barker FM, 2011, INVEST OPHTH VIS SCI, V52, P3934, DOI 10.1167/iovs.10-5898
   Halberg N, 2008, ENDOCRIN METAB CLIN, V37, P753, DOI 10.1016/j.ecl.2008.07.002
   Rohrer B, 2007, INVEST OPHTH VIS SCI, V48, P5282, DOI 10.1167/iovs.07-0282
   Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189
   Loyet KM, 2012, INVEST OPHTH VIS SCI, V53, P6628, DOI 10.1167/iovs.12-9587
   Lee EH, 2004, J INVEST DERMATOL, V122, P510, DOI 10.1046/j.0022-202X.2004.22227.x
   Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937
   CHONN A, 1991, J IMMUNOL, V146, P4234
   SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413
   Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310
   Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728
   Morgan BP, 1997, CLIN EXP IMMUNOL, V107, P1, DOI 10.1046/j.1365-2249.1997.d01-890.x
   Bora PS, 2005, J IMMUNOL, V174, P491
   Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002
   Do DV, 2014, RETINA-J RET VIT DIS, V34, P313, DOI 10.1097/IAE.0b013e3182979ddd
   Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821
   Bamashmus MA, 2004, EYE, V18, P257, DOI 10.1038/sj.eye.6700606
   Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7
   Chew EY, 2013, JAMA OPHTHALMOL, V131, P843, DOI 10.1001/jamaophthalmol.2013.4412
   Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899
   Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618
   Awh CC, 2015, OPHTHALMOLOGY, V122, P162, DOI 10.1016/j.ophtha.2014.07.049
   BAUDOUIN C, 1992, JPN J OPHTHALMOL, V36, P443
   Birke K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076766
   Chen L, 2003, CURR EYE RES, V26, P291, DOI 10.1076/ceyr.26.4.291.15432
   Chucair AJ, 2007, INVEST OPHTH VIS SCI, V48, P5168, DOI 10.1167/iovs.07-0037
   Johnson LR, 2000, IEEE ANN HIST COMPUT, V22, P70
   Kuno Noriyuki, 2011, Curr Mol Pharmacol, V4, P196
   Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720
   Mayne ST, 2003, J NUTR, V133, P933
   Mousavi M, 2013, J OPTOM, V6, P176
   Mozaffarieh M., 2003, J NUTR, V2, P20
   Mullins RF, 2014, AM J PATHOL, V184, P3142, DOI 10.1016/j.ajpath.2014.07.017
   Pangburn M.K., 1984, ALTERNATIVE PATHWAY, P163
   Querques G, 2014, OPHTHALMIC RES, V52, P107, DOI 10.1159/000363187
   REID KBM, 1986, ESSAYS BIOCHEM, V22, P27
   Rohrer Bärbel, 2011, Mol Immunol, V48, pe1, DOI 10.1016/j.molimm.2010.12.016
   ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615
   Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593
   Tian Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073387
   Tian Y., ACTA OPHTHA IN PRESS
   Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106
   Tucker KL, 1999, J NUTR, V129, P438
   VANDERSCHAFT TL, 1993, BRIT J OPHTHALMOL, V77, P657, DOI 10.1136/bjo.77.10.657
   Williams M.A., 2014, COCHRANE DB SYST REV, V1
   Xu YY, 2001, IMMUNOL REV, V180, P123, DOI 10.1034/j.1600-065X.2001.1800111.x
   Yehoshua Z., 2013, AGE RELATED MACULAR, P263
NR 87
TC 1
Z9 1
U1 9
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 49
EP 53
DI 10.1016/j.abb.2015.01.019
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900008
PM 25637656
ER

PT J
AU Bovier, ER
   Hammond, BR
AF Bovier, Emily R.
   Hammond, Billy R.
TI A randomized placebo-controlled study on the effects of lutein and
   zeaxanthin on visual processing speed in young healthy subjects
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Lutein; Zeaxanthin; CFF; Visual processing speed
ID PIGMENT OPTICAL-DENSITY; CRITICAL FLICKER FREQUENCY; MACULAR PIGMENT;
   OLDER-ADULTS; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; PRACTICAL METHOD;
   CAROTENOIDS; SUPPLEMENTATION; DAMAGE
AB Speed of processing is a particularly important characteristic of the visual system. Often a behavioral reaction to a visual stimulus must be faster than the conscious perception of that stimulus, as is the case with many sports (e.g., baseball). Visual psychophysics provides a relatively simple and precise means of measuring visual processing speed called the temporal contrast sensitivity function (tCSF). Past study has shown that macular pigment (a collection of xanthophylls, lutein (L), meso-zeaxanthin (MZ) and zeaxanthin (Z), found in the retina) optical density (MPOD) is positively correlated with the tCSF. In this study, we found similar correlations when testing 102 young healthy subjects. As a follow-up, we randomized 69 subjects to receive a placebo (n = 15) or one of two L and Z supplements (n = 54). MPOD and tCSF were measured psychophysically at baseline and 4 months. Neither MPOD nor tCSF changed for the placebo condition, but both improved significantly as a result of supplementation. These results show that an intervention with L and Z can increase processing speed even in young healthy subjects. (C) 2014 The Authors. Published by Elsevier Inc.
C1 [Bovier, Emily R.] SUNY Coll Oswego, Dept Psychol, Oswego, NY 13126 USA.
   [Bovier, Emily R.; Hammond, Billy R.] Univ Georgia, Brain & Behav Sci, Athens, GA 30602 USA.
RP Hammond, BR (reprint author), Univ Georgia, Brain & Behav Sci, Athens, GA 30602 USA.
EM bhammond@uga.edu
FU ZeaVision, LLC.
FX This study was funded by ZeaVision, LLC.
CR Hammond BR, 2005, OPHTHAL PHYSL OPT, V25, P315, DOI 10.1111/j.1475-1313.2005.00271.x
   Johnson EJ, 2008, NUTR NEUROSCI, V11, P75, DOI 10.1179/147683008X301450
   Wells EF, 2001, EXP BRAIN RES, V139, P106, DOI 10.1007/s002210100721
   Lucas A, 2014, J EXP BIOL, V217, P1253, DOI 10.1242/jeb.098004
   Wang MX, 2013, ATHEROSCLEROSIS, V227, P380, DOI 10.1016/j.atherosclerosis.2013.01.021
   Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003
   Romero-Gomez M, 2007, HEPATOLOGY, V45, P879, DOI 10.1002/hep.21586
   Bian QN, 2012, FREE RADICAL BIO MED, V53, P1298, DOI 10.1016/j.freeradbiomed.2012.06.024
   Wooten BR, 2010, BIOMED OPT EXPRESS, V1, P47
   Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC
   Curran S, 2000, HUM PSYCHOPHARM CLIN, V15, P103, DOI 10.1002/(SICI)1099-1077(200003)15:2<103::AID-HUP149>3.0.CO;2-7
   Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403
   Johnson EJ, 2014, NUTR REV, V72, P605, DOI 10.1111/nure.12133
   Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083
   Renzi LM, 2010, OPHTHAL PHYSL OPT, V30, P351, DOI 10.1111/j.1475-1313.2010.00720.x
   Renzi LM, 2013, NUTR NEUROSCI, V16, P262, DOI 10.1179/1476830513Y.0000000054
   Renzi LM, 2014, NEUROBIOL AGING, V35, P1695, DOI 10.1016/j.neurobiolaging.2013.12.024
   Vishwanathan R, 2013, NUTR NEUROSCI, V16, P21, DOI 10.1179/1476830512Y.0000000024
   Wooten BR, 1999, INVEST OPHTH VIS SCI, V40, P2481
   Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19
   Bovier ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108178
   Ciccone M.M., 2013, MEDIAT INFLAMM, V2013, P1
   DALEY ML, 1979, ARCH NEUROL-CHICAGO, V36, P292
   Feeney J, 2013, NEUROBIOL AGING, V34, P2449, DOI 10.1016/j.neurobiolaging.2013.05.007
   Garcia-de Blas E, 2013, PHYSIOL BIOCHEM ZOOL, V86, P483, DOI 10.1086/671812
   Hammond BR, 2012, AM J CLIN NUTR, V96, p1207S, DOI 10.3945/ajcn.112.034876
   Hammond BR, 2013, INVEST OPHTH VIS SCI, V54, P476, DOI 10.1167/iovs.12-10411
   JACKSON MD, 1979, J EXP PSYCHOL GEN, V108, P151, DOI 10.1037//0096-3445.108.2.151
   Kuchan M., 2013, ADV CONTR CLIN NUTR
   Nolan JM, 2014, J ALZHEIMERS DIS, V42, P1191, DOI 10.3233/JAD-140507
   Roberts R. L., 2013, American Journal of Lifestyle Medicine, V7, P182
   Serpeloni J.M., 2014, FOOD CHEM TOXICOL
   SMITH JM, 1976, PSYCHOPHARMACOLOGY, V47, P175, DOI 10.1007/BF00735818
   Vishwanathan R., 2014, J PEDIAT GASTROENTER
   Wong J.C., 2014, NUTR NEUROSCI
   Zimmer J Paul, 2007, Clin Ophthalmol, V1, P25
NR 36
TC 2
Z9 2
U1 8
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 54
EP 57
DI 10.1016/j.abb.2014.11.012
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900009
PM 25483230
ER

PT J
AU Apanasenko, IE
   Selyutina, OY
   Polyakov, NE
   Suntsova, LP
   Meteleva, ES
   Dushkin, AV
   Vachali, P
   Bernstein, PS
AF Apanasenko, Irina E.
   Selyutina, Olga Yu.
   Polyakov, Nikolay E.
   Suntsova, Lyubov P.
   Meteleva, Elizaveta S.
   Dushkin, Alexander V.
   Vachali, Preejith
   Bernstein, Paul S.
TI Solubilization and stabilization of macular carotenoids by water soluble
   oligosaccharides and polysaccharides
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Lutein; Zeaxanthin; Water-soluble complexes; Arabinogalactan;
   Glycyrrhizic acid; Ozone; Oxygen radicals; Carotenoid oxidation; NMR
   relaxation; Surface plasmon resonance
ID BETA-GLYCYRRHIZIC ACID; CYCLOMALTOOLIGOSACCHARIDES CYCLODEXTRINS;
   SUPRAMOLECULAR COMPLEXES; NONCOVALENT ASSOCIATIONS; INCLUSION COMPLEXES;
   LIGHT-SCATTERING; LIPID-MEMBRANES; FENTON REACTION; FREE-RADICALS;
   ZEAXANTHIN
AB Xanthophyll carotenoids zeaxanthin and lutein play a special role in the prevention and treatment of visual diseases. These carotenoids are not produced by the human body and must be consumed in the diet. On the other hand, extremely low water solubility of these carotenoids and their instability restrict their practical application as components of food or medicinal formulations. Preparation of supramolecular complexes of zeaxanthin and lutein with glycyrrhizic acid, its disodium salt and the natural polysaccharide arabinogalactan allows one to minimize the aforementioned disadvantages when carotenoids are used in food processing as well as for production of therapeutic formulations with enhanced solubility and stability. In the present study, the formation of supramolecular complexes was investigated by NMR relaxation, surface plasmon resonance (SPR) and optical absorption techniques. The complexes increase carotenoid solubility more than 1000-fold. The kinetics of carotenoid decay in reactions with ozone molecules, hydroperoxyl radicals and metal ions were measured in water and organic solutions, and significant increases in oxidation stability of lutein and zeaxanthin in arabinogalactan and glycyrrhizin complexes were detected. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Apanasenko, Irina E.; Selyutina, Olga Yu.; Polyakov, Nikolay E.] Russian Acad Sci, Inst Chem Kinet & Combust, Novosibirsk 630090, Russia.
   [Apanasenko, Irina E.; Selyutina, Olga Yu.] Novosibirsk State Univ, Novosibirsk 630090, Russia.
   [Suntsova, Lyubov P.; Meteleva, Elizaveta S.; Dushkin, Alexander V.] Inst Solid State Chem & Mechanochem, Novosibirsk, Russia.
   [Vachali, Preejith; Bernstein, Paul S.] Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Moran Eye Ctr, Salt Lake City, UT USA.
RP Polyakov, NE (reprint author), Inst Str 3, Novosibirsk 630090, Russia.
EM polyakov@kinetics.nsc.ru
FU United States (US) Civilian Research & Development Foundation (CRDF
   Global) [RUC-7067-NO-12]; United States Department of State; US Grant
   from National Institute of Health (NIH) [EY-11600]; Research to Prevent
   Blindness; Russian Academy of Science [V.48.1.8]
FX This work was supported by Grant RUC-7067-NO-12 from the United States
   (US) Civilian Research & Development Foundation (CRDF Global) with
   funding from the United States Department of State, by US Grant EY-11600
   from National Institute of Health (NIH), by unrestricted departmental
   funds from Research to Prevent Blindness, and by research project of
   Russian Academy of Science V.48.1.8. The development of drug delivery
   systems based on mechanochemically synthesized supramolecular systems.
CR Li BX, 2010, PHOTOCH PHOTOBIO SCI, V9, P1418, DOI 10.1039/c0pp00126k
   BAILEY PS, 1958, CHEM REV, V58, P925, DOI 10.1021/cr50023a005
   Gale CR, 2003, INVEST OPHTH VIS SCI, V44, P2461, DOI 10.1167/iovs.02-0929
   Polyakov NE, 2013, J PHYS CHEM B, V117, P10173, DOI 10.1021/jp4062708
   RUBAN AV, 1993, J PHOTOCH PHOTOBIO B, V21, P229, DOI 10.1016/1011-1344(93)80188-F
   Wang C, 2010, J AM CHEM SOC, V132, P13988, DOI 10.1021/ja102851m
   Polyakov NE, 2004, FREE RADICAL BIO MED, V36, P872, DOI 10.1016/j.freeradbiomed.2004.12.009
   KRINSKY NI, 1989, FREE RADICAL BIO MED, V7, P617, DOI 10.1016/0891-5849(89)90143-3
   Henry LK, 2000, J AGR FOOD CHEM, V48, P5008, DOI 10.1021/jf000503o
   Wang C, 2012, J PHYS CHEM B, V116, P10617, DOI 10.1021/jp3069514
   El-Agamey A, 2004, ARCH BIOCHEM BIOPHYS, V430, P37, DOI 10.1016/j.abb.2004.03.007
   Tachaprutinun A, 2009, INT J PHARMACEUT, V374, P119, DOI 10.1016/j.ijpharm.2009.03.001
   Woodall AA, 1997, BBA-GEN SUBJECTS, V1336, P33, DOI 10.1016/S0304-4165(97)00006-8
   Edge R, 1997, J PHOTOCH PHOTOBIO B, V41, P189, DOI 10.1016/S1011-1344(97)00092-4
   McHale JL, 2012, J PHYS CHEM LETT, V3, P587, DOI 10.1021/jz3000678
   Goulinet S, 1997, ARTERIOSCL THROM VAS, V17, P786
   Sujak A, 1999, ARCH BIOCHEM BIOPHYS, V371, P301, DOI 10.1006/abbi.1999.1437
   KIRSCHFELD K, 1982, PROC R SOC SER B-BIO, V216, P71, DOI 10.1098/rspb.1982.0061
   Kornievskaya VS, 2007, J PHYS CHEM B, V111, P11447, DOI 10.1021/jp0739770
   HAM WT, 1976, NATURE, V260, P153, DOI 10.1038/260153a0
   Gluschenko OY, 2011, APPL MAGN RESON, V41, P283, DOI 10.1007/s00723-011-0258-9
   ODONMAZIG P, 1994, CARBOHYD RES, V252, P317
   Polyakov NE, 2009, J PHYS CHEM B, V113, P275, DOI 10.1021/jp805531q
   Martin HD, 1999, PURE APPL CHEM, V71, P2253, DOI 10.1351/pac199971122253
   Billsten HH, 2005, J PHYS CHEM A, V109, P1521, DOI 10.1021/jp044847j
   Polyakov NE, 2006, FREE RADICAL BIO MED, V40, P1804, DOI 10.1016/j.freeradbiomed.2006.01.015
   Polyakov NE, 2008, J PHYS CHEM B, V112, P4435, DOI 10.1021/jp076850j
   Barbusinski K, 2009, ECOL CHEM ENG S, V16, P347
   Borisenko S. N., 2013, CHEM PLANT MAT, V2, P85
   Chistyachenko Y.S., 2014, DRUG DELIV, P1
   D'Adamo P., 1996, J NATUROPATH MED, V6, P32
   Dushkin AV, 2013, DOKL BIOCHEM BIOPHYS, V451, P180, DOI 10.1134/S1607672913040030
   Dushkin A.V., 2010, HIGH ENERGY BALL MIL, P249
   Dushkin A.V., 2008, RUSS CHEM B, V6, P1299
   Higuchi T, 1965, ADV ANAL CHEM INSTRU, V4, P117
   JORGENSEN K, 1993, Z LEBENSM UNTERS FOR, V196, P423, DOI 10.1007/BF01190806
   Kondratenko R. M., 2001, PHARM CHEM J, V35, P101, DOI 10.1023/A:1010481123359
   Krinsky N.I., 1989, CAROTENOIDS CHEM BIO
   Krinsky NI, 2004, CAROTENOIDS HLTH DIS
   Lancrajan I, 2001, CHEM PHYS LIPIDS, V112, P1, DOI 10.1016/S0009-3084(01)00138-4
   Loftsson T, 1996, J PHARM SCI, V85, P1017, DOI 10.1021/js950534b
   Mazza G.O., 2000, HERBS BOT TEAS
   Medvedeva EN, 2003, CHEM PLANT STOCK, V1, P27
   Mele A, 1998, CARBOHYD RES, V310, P261, DOI 10.1016/S0008-6215(98)00193-1
   Mele A, 2002, CARBOHYD RES, V337, P1129, DOI 10.1016/S0008-6215(02)00097-6
   Mosquera M.I.M., 1999, PIGMENTS FOOD TECHNO
   Nicolescu C, 2010, FARMACIA, V58, P620
   Perez-Benito JF, 2004, J PHYS CHEM A, V108, P4853, DOI 10.1021/jp0313391
   Polyakov N. E., 2011, OPEN C P J, V2
   Polyakov NE, 2010, J PHYS CHEM B, V114, P14200, DOI 10.1021/jp908578j
   Polyakov NE, 2001, FREE RADICAL BIO MED, V31, P398, DOI 10.1016/S0891-5849(01)00598-6
   Polyakov NE, 2006, J PHYS CHEM B, V110, P6991, DOI 10.1021/jp0560381
   Polyakov NE, 2001, FREE RADICAL BIO MED, V31, P43, DOI 10.1016/S0891-5849(01)00547-0
   Poole C.P., 1971, RELAXATION MAGNETIC, P392
   Sujak A, 2000, BBA-BIOMEMBRANES, V1509, P255, DOI 10.1016/S0005-2736(00)00299-6
   Szejtli J., 1988, CYCLODEXTRIN TECHNOL, V1
   Szente L, 1998, J INCLUS PHENOM MOL, V32, P81, DOI 10.1023/A:1007970501916
   Tolstikov GA, 1997, BIOORG KHIM+, V23, P691
   Vachali P, 2012, ARCH BIOCHEM BIOPHYS, V519, P32, DOI 10.1016/j.abb.2012.01.006
NR 59
TC 3
Z9 3
U1 11
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 58
EP 65
DI 10.1016/j.abb.2014.12.010
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900010
PM 25527162
ER

PT J
AU Vachali, PP
   Li, BX
   Bartschi, A
   Bernstein, PS
AF Vachali, Preejith P.
   Li, Binxing
   Bartschi, Alexis
   Bernstein, Paul S.
TI Surface plasmon resonance (SPR)-based biosensor technology for the
   quantitative characterization of protein-carotenoid interactions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Age-related macular degeneration; Biosensor; Carotenoid-binding
   proteins; GSTP1; IRBP; Macula; Retina; StARD3; Xanthophylls
ID VITAMIN-A PRODUCTION; MACULAR DEGENERATION; BINDING PROTEIN;
   INVERTEBRATE CAROTENOPROTEINS; DIETARY CAROTENOIDS; OPTICAL BIOSENSORS;
   DRUG DISCOVERY; IDENTIFICATION; PIGMENT; METABOLISM
AB The surface plasmon resonance (SPR) biosensor method is a highly sensitive, label-free technique to study the non-covalent interactions of biomolecules, especially protein-protein and protein-small molecule interactions. We have explored this robust biosensor platform to study the interactions of carotenoid-binding proteins and their carotenoid ligands to assess the specificity of interaction, kinetics, affinity, and stoichiometry. These characterizations are important to further study uptake and transport of carotenoids to targeted tissues such as the macula of the human eye. In this review, we present an overview of the SPR method and optimization of assay conditions, and we discuss the particular challenges in studying carotenoid-protein interactions using SPR. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Vachali, Preejith P.; Li, Binxing; Bartschi, Alexis; Bernstein, Paul S.] Univ Utah, Moran Eye Ctr, Sch Med, Salt Lake City, UT 84132 USA.
RP Bernstein, PS (reprint author), Univ Utah, Moran Eye Ctr, Sch Med, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.
EM paul.bernstein@hsc.utah.edu
FU NIH [R01 EY11600]; core grant [EY14800]; Lowy Medical Research
   Foundation; Research to Prevent Blindness to the Department of
   Ophthalmology at Moran Eye Center, University of Utah
FX This work was supported by NIH grant R01 EY11600 (P.S.B.) and core grant
   EY14800, Lowy Medical Research Foundation (P.S.B.), and Unrestricted
   Research Grants from Research to Prevent Blindness to the Department of
   Ophthalmology at Moran Eye Center, University of Utah.
CR ZAGALSKY PF, 1985, METHOD ENZYMOL, V111, P216
   During A, 2008, J LIPID RES, V49, P1715, DOI 10.1194/jlr.M700580-JLR200
   Apanasenko IE, 2015, ARCH BIOCHEM BIOPHYS, V572, P58, DOI 10.1016/j.abb.2014.12.010
   Bhosale P, 2004, J BIOL CHEM, V279, P49447, DOI 10.1074/jbc.M405334200
   Baird CL, 2002, ANAL BIOCHEM, V310, P93, DOI 10.1016/S0003-2697(02)00278-6
   Li BX, 2010, PHOTOCH PHOTOBIO SCI, V9, P1418, DOI 10.1039/c0pp00126k
   OLSON JA, 1994, PURE APPL CHEM, V66, P1011, DOI 10.1351/pac199466051011
   Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3
   Tabunoki H, 2004, FEBS LETT, V567, P175, DOI 10.1016/j.febslet.2004.04.067
   Piliarik Marek, 2009, V503, P65, DOI 10.1007/978-1-60327-567-5_5
   Lobo GP, 2013, J BIOL CHEM, V288, P9017, DOI 10.1074/jbc.M112.444240
   LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7
   Bhosale P, 2007, ARCH BIOCHEM BIOPHYS, V458, P121, DOI 10.1016/j.abb.2006.10.005
   Quinn JG, 2012, ANAL BIOCHEM, V421, P401, DOI 10.1016/j.ab.2011.11.023
   BONE RA, 1993, INVEST OPHTH VIS SCI, V34, P2033
   Willander M, 2009, METHODS MOL BIOL, V544, P201, DOI 10.1007/978-1-59745-483-4_14
   Snellen ELM, 2002, ACTA OPHTHALMOL SCAN, V80, P368, DOI 10.1034/j.1600-0420.2002.800404.x
   Zhang H, 2014, BIOCHEMISTRY-US, V53, P13, DOI 10.1021/bi401539w
   Bone RA, 2001, INVEST OPHTH VIS SCI, V42, P235
   Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838
   Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307
   KHACHIK F, 1991, PURE APPL CHEM, V63, P71, DOI 10.1351/pac199163010071
   Li BX, 2011, BIOCHEMISTRY-US, V50, P2541, DOI 10.1021/bi101906y
   SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413
   Guo XW, 2012, J BIOPHOTONICS, V5, P483, DOI 10.1002/jbio.201200015
   Khachik F, 1997, ANAL CHEM, V69, P1873, DOI 10.1021/ac961085i
   Britton G, 1997, PURE APPL CHEM, V69, P2075, DOI 10.1351/pac199769102075
   Li BX, 2014, P NATL ACAD SCI USA, V111, P10173, DOI 10.1073/pnas.1402526111
   Fang Y, 2006, ASSAY DRUG DEV TECHN, V4, P583, DOI 10.1089/adt.2006.4.583
   BONE RA, 1985, VISION RES, V25, P1531, DOI 10.1016/0042-6989(85)90123-3
   Beatty S, 1999, BRIT J OPHTHALMOL, V83, P867, DOI 10.1136/bjo.83.7.867
   Frank H., 1999, PHOTOCHEMISTRY CAROT, P1
   Gedig ET, 2008, HANDBOOK OF SURFACE PLASMON RESONANCE, P173
   GOMEZ R, 1984, REV ESP FISIOL, V40, P319
   Gonzalez-Fernandez Federico, 2012, J Ophthalmic Vis Res, V7, P100
   KRETSCHM.E, 1971, Z PHYS, V241, P313, DOI 10.1007/BF01395428
   KRETSCHM.E, 1968, Z NATURFORSCH PT A, VA 23, P2135
   Krinsky N I, 1995, Biochem Soc Symp, V61, P117
   Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995
   Mares-Perlman JA, 2002, J NUTR, V132, P518
   Marquart J.A., 2008, SURFACE PLASMON RESO
   McGlennen RC, 2001, CLIN CHEM, V47, P393
   MURIANA FJG, 1993, J BIOCHEM-TOKYO, V114, P223
   Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3
   Nagao A, 2011, BIOFACTORS, V37, P83, DOI 10.1002/biof.151
   Pfander Hanspeter, 1992, V213, P3
   Rich RL, 2010, ANAL BIOCHEM, V407, P270, DOI 10.1016/j.ab.2010.08.024
   Schasfoort RBM, 2008, HANDBOOK OF SURFACE PLASMON RESONANCE, P35
   Sestak Z., 1999, PHOTOSYNTHETICA, V37, P60, DOI 10.1023/A:1007035400662
   SIMPSON KL, 1981, ANNU REV NUTR, V1, P351, DOI 10.1146/annurev.nu.01.070181.002031
   Vachali P, 2012, ARCH BIOCHEM BIOPHYS, V519, P32, DOI 10.1016/j.abb.2012.01.006
   Vachali PP, 2013, ARCH BIOCHEM BIOPHYS, V539, P181, DOI 10.1016/j.abb.2013.07.008
   Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086594
   Zagalsky PF, 2003, ACTA CRYSTALLOGR D, V59, P1529, DOI 10.1107/S0907444903013416
   ZAGALSKY PF, 1990, COMP BIOCHEM PHYS B, V97, P1, DOI 10.1016/0305-0491(90)90171-O
NR 55
TC 2
Z9 2
U1 14
U2 27
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 66
EP 72
DI 10.1016/j.abb.2014.12.005
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900011
PM 25513962
ER

PT J
AU Nguyen, LM
   Scherr, RE
   Linnell, JD
   Ermakov, IV
   Gellermann, W
   Jahns, L
   Keen, CL
   Miyamoto, S
   Steinberg, FM
   Young, HM
   Zidenberg-Cherr, S
AF Nguyen, Lori M.
   Scherr, Rachel E.
   Linnell, Jessica D.
   Ermakov, Igor V.
   Gellermann, Werner
   Jahns, Lisa
   Keen, Carl L.
   Miyamoto, Sheridan
   Steinberg, Francene M.
   Young, Heather M.
   Zidenberg-Cherr, Sheri
TI Evaluating the relationship between plasma and skin carotenoids and
   reported dietary intake in elementary school children to assess fruit
   and vegetable intake
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Carotenoids; Raman spectroscopy; Validation; Dietary assessment;
   Biomarkers
ID RESONANCE RAMAN-SPECTROSCOPY; BIOMARKER; ADOLESCENTS; VALIDATION;
   INTERVENTION; ANTIOXIDANTS; QUESTIONNAIRE; CONSUMPTION; OVERWEIGHT
AB Accurate assessment of dietary intake of children can be challenging due to the limited reliability of current dietary assessment methods. Plasma carotenoid concentration has been used to assess fruit and vegetable intake, but this testing is rarely conducted in school settings in children. Resonance Raman spectroscopy (RRS) is emerging as a useful method to objectively assess fruit and vegetable intake. This methodology has been validated in adults, but limited work has been done in children, particularly in the school setting. The purpose of this research is to further validate the RRS methodology in children. Children (9-12 year) participating in a school-based intervention were recruited. Plasma carotenoids were quantified using HPLC, skin carotenoid status was measured using RRS, and dietary intake of carotenoids was measured with the Block Food Frequency Questionnaire Ages 8-17. Total plasma carotenoid concentrations and skin carotenoid intensities were strongly correlated (r = 0.62, p < 0.001, n = 38). Reported total carotenoid intake correlated with skin carotenoids (r = 0.40, p < 0.0001, n = 128). Skin carotenoid status as measured by RRS can be a strong predictor of plasma carotenoid status and dietary intake of carotenoids in children. RRS may be used as a valid, non-invasive, and useful method to assess fruit and vegetable intakes in this population. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Nguyen, Lori M.; Scherr, Rachel E.; Linnell, Jessica D.; Keen, Carl L.; Steinberg, Francene M.; Zidenberg-Cherr, Sheri] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.
   [Nguyen, Lori M.; Scherr, Rachel E.; Linnell, Jessica D.; Zidenberg-Cherr, Sheri] Ctr Nutr Sch, San Francisco, CA USA.
   [Ermakov, Igor V.; Gellermann, Werner] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA.
   [Jahns, Lisa] USDA ARS, Grand Forks, ND USA.
   [Keen, Carl L.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA.
   [Miyamoto, Sheridan; Young, Heather M.] Univ Calif Davis, Betty Irene Moore Sch Nursing, Davis, CA 95616 USA.
   [Zidenberg-Cherr, Sheri] Univ Calif Cooperat Extens, Univ Calif Agr & Nat Resources, Davis, CA USA.
RP Scherr, RE (reprint author), Univ Calif Davis, One Shields Ave, Davis, CA 95616 USA.
EM lmnguyen@ucdavis.edu; rescherr@ucdavis.edu; ermakov@physics.utah.edu;
   werner@physics.utah.edu; Lisadahns@ars.usda.gov; clkeen@ucdavis.edu;
   sheridan.miyamoto@ucdmc.ucdavis.edu; fmsteinberg@ucdavis.edu;
   heather.young@ucdmc.ucdavis.edu; sazidenbergcherr@ucdavis.edu
FU University of California Agriculture and Natural Resources Competitive
   Grant [11-1018]; United States Department of Agriculture Cooperative
   State Research, Education, and Extension Service Fellowship
   [2011-38420-20082]; Henry A. Jastro Research Award; Kosuna Doctoral
   Fellowship; Campbell Research and Travel Award; Barbara Schneeman
   Research and Travel Award
FX Funding was provided by University of California Agriculture and Natural
   Resources Competitive Grant #11-1018 and United States Department of
   Agriculture Cooperative State Research, Education, and Extension Service
   Fellowship #2011-38420-20082. Additional funding was provided by the
   Henry A. Jastro Research Award, Kosuna Doctoral Fellowship, Campbell
   Research and Travel Award, and Barbara Schneeman Research and Travel
   Award. The sponsoring agencies have no role in study design, data
   collection, or subsequent analyses. The authors would like to thank all
   of the students, parents, and registered nurses participating in the
   study, and the school and district administration for their assistance.
   In addition, the authors would like to acknowledge Jodi Ensunsa and
   Reedmond Fong for their assistance in HPLC data analysis and the many
   undergraduate interns for their assistance in data collection and entry.
CR Burrows TL, 2009, OBESITY, V17, P162, DOI 10.1038/oby.2008.495
   Brevik A, 2004, EUR J CLIN NUTR, V58, P1166, DOI 10.1038/sj.ejcn.1601945
   Scarmo S, 2013, BRIT J NUTR, V110, P911, DOI 10.1017/S000711451200582X
   Scarmo S, 2012, EUR J CLIN NUTR, V66, P555, DOI 10.1038/ejcn.2012.31
   Mayne ST, 2013, ARCH BIOCHEM BIOPHYS, V539, P163, DOI 10.1016/j.abb.2013.06.007
   Cullen KW, 2008, J AM DIET ASSOC, V108, P862, DOI 10.1016/j.jada.2008.02.015
   Zidichouski JA, 2009, J AM COLL NUTR, V28, P687
   Aguilar SS, 2014, J ACAD NUTR DIET, V114, P1174, DOI 10.1016/j.jand.2014.04.026
   Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169
   Jahns L, 2014, AM J CLIN NUTR, V100, P930, DOI 10.3945/ajcn.114.086900
   Baldrick FR, 2011, CRIT REV FOOD SCI, V51, P795, DOI 10.1080/10408398.2010.482217
   Fiedor J, 2014, NUTRIENTS, V6, P466, DOI 10.3390/nu6020466
   Block G, 2001, AM J EPIDEMIOL, V154, P1113, DOI 10.1093/aje/154.12.1113
   Collins CE, 2010, INT J OBESITY, V34, P1103, DOI 10.1038/ijo.2009.241
   Ermakov IV, 2001, OPT LETT, V26, P1179, DOI 10.1364/OL.26.001179
   Ermakov IV, 2010, ARCH BIOCHEM BIOPHYS, V504, P40, DOI 10.1016/j.abb.2010.07.023
   Fernandez J.R., J PEDIAT, V145, P439
   Gellermann W., 2005, CAROTENOIDS RETINOID, P86
   Gueguen S, 2002, J CHROMATOGR SCI, V40, P69
   Kaaks RJ, 1997, AM J CLIN NUTR, V65, P1232
   Kaulmann A., 2014, NUTR RES NEW YORK
   Mayne ST, 2010, AM J CLIN NUTR, V92, P794, DOI 10.3945/ajcn.2010.29707
   Molnar D, 2004, INT J OBESITY, V28, P1197, DOI 10.1038/sj.ijo.0802719
   Rerksuppaphol S, 2012, PEDIAT REP, V4, P12
   Scherr RE, 2014, J NUTR EDUC BEHAV, V46, pE13, DOI 10.1016/j.jneb.2014.08.010
   Slater B, 2010, CAD SAUDE PUBLICA, V26, P2090, DOI 10.1590/S0102-311X2010001100010
   US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010
   U.S. Department of Agriculture ChooseMyPlate.gov Website Food Groups Washington DC, 2010, FOOD GROUPS
   Wolfenden L, 2012, COCHRANE DB SYST REV, V11
NR 29
TC 0
Z9 0
U1 4
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 73
EP 80
DI 10.1016/j.abb.2015.02.015
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900012
PM 25765187
ER

PT J
AU Stice, CP
   Liu, C
   Aizawa, K
   Greenberg, AS
   Ausman, LM
   Wang, XD
AF Stice, Camilla P.
   Liu, Chun
   Aizawa, Koichi
   Greenberg, Andrew S.
   Ausman, Lynne M.
   Wang, Xiang-Dong
TI Dietary tomato powder inhibits alcohol-induced hepatic injury by
   suppressing cytochrome p450 2E1 induction in rodent models
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Tomato; Lycopene; CYP2E1; Alcohol; Liver disease
ID ENDOPLASMIC-RETICULUM STRESS; PROSTATE-CANCER; LIVER-DISEASE;
   HEPATOCELLULAR-CARCINOMA; OXIDATIVE STRESS; CHRONIC ETHANOL; FED RATS;
   LYCOPENE; CARCINOGENESIS; PRODUCTS
AB Chronic and excessive alcohol consumption leads to the development of alcoholic liver disease (ALD) and greatly increases the risk of liver cancer. Induction of the cytochrome p450 2E1 (CYP2E1) enzyme by chronic and excessive alcohol intake is known to play a role in the pathogenesis of ALD. High intake of tomatoes, rich in the carotenoid lycopene, is associated with a decreased risk of chronic disease. We investigated the effects of whole tomato (tomato powder, TP), partial tomato (tomato extract, TE), and purified lycopene (LYC) against ALD development in rats. Of the three supplements, only TP reduced the severity of alcohol-induced steatosis, hepatic inflammatory foci, and CYP2E1 protein levels. TE had no effect on these outcomes and LYC greatly increased inflammatory foci in alcohol-fed rats. To further support the protective effect of TP against ALD, TP was supplemented in a carcinogen (diethylnitrosamine, DEN)-initiated alcohol-promoted mouse model. In addition to reduced steatosis and inflammatory foci, TP abolished the presence of preneoplastic foci of altered hepatocytes in DEN-injected mice fed alcohol. These reductions were associated with decreased hepatic CYP2E1 protein levels, restored levels of peroxisome proliferator-activated receptor-a and downstream gene expression, decreased inflammatory gene expression, and reduced endoplasmic reticulum stress markers. These data provide strong evidence for TP as an effective whole food prevention strategy against ALD. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Stice, Camilla P.; Liu, Chun; Aizawa, Koichi; Ausman, Lynne M.; Wang, Xiang-Dong] Tufts Univ, Nutr & Canc Biol Lab, Jean Mayer USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA.
   [Greenberg, Andrew S.] Tufts Univ, Obes & Metab Lab, Jean Mayer USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA.
   [Stice, Camilla P.; Greenberg, Andrew S.; Ausman, Lynne M.; Wang, Xiang-Dong] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.
RP Wang, XD (reprint author), Tufts Univ, Nutr & Canc Biol Lab, Jean Mayer USDA, Human Nutr Res Ctr Aging, 711 Washington St,Room 514, Boston, MA 02111 USA.
EM xiang-dong.wang@tufts.edu
FU USDA/ARS CRIS grant [1950-51000-074S]; NIH/NCI [CA176256]
FX This study was supported by the USDA/ARS CRIS grant 1950-51000-074S and
   NIH/NCI CA176256 grant. Any opinions, findings, conclusions, and
   recommendations expressed in this publication are those of the author(s)
   and do not necessarily reflect the views of the sponsors. The authors
   would like to thank Dr. Donald Smith for his assistance in designing and
   conducting the animal protocols included in this manuscript. The authors
   would also like to thank Junrui Cheng for her assistance on this
   manuscript.
CR Alshatwi AA, 2010, NUTR RES, V30, P66, DOI 10.1016/j.nutres.2009.12.002
   Etminan M, 2004, CANCER EPIDEM BIOMAR, V13, P340
   Boileau TWM, 2002, EXP BIOL MED, V227, P914
   Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   Boileau TWM, 2003, J NATL CANCER I, V95, P1578, DOI 10.1093/jnci/djg081
   La Vecchia C, 2002, EXP BIOL MED, V227, P860
   Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780
   Esfandiari F, 2005, AM J PHYSIOL-GASTR L, V289, pG54, DOI 10.1152/ajpgi.00542.2004
   Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2
   Wu DF, 2010, BIOCHEM BIOPH RES CO, V402, P116, DOI 10.1016/j.bbrc.2010.09.127
   Hoek JB, 2002, ALCOHOL, V27, P63, DOI 10.1016/S0741-8329(02)00215-X
   Canene-Adams K, 2005, J NUTR, V135, P1226
   Sesso HD, 2003, J NUTR, V133, P2336
   Basu A, 2007, EUR J CLIN NUTR, V61, P295, DOI 10.1038/sj.ejcn.1602510
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Giovannucci E, 2002, EXP BIOL MED, V227, P852
   Wang Y, 2010, ALCOHOL CLIN EXP RES, V34, P567, DOI 10.1111/j.1530-0277.2009.01122.x
   Giovannucci E, 2002, J NATL CANCER I, V94, P391, DOI 10.1093/jnci/94.5.391
   Wang Y, 2010, INT J CANCER, V126, P1788, DOI 10.1002/ijc.24689
   Cederbaum AI, 2010, DIGEST DIS, V28, P802, DOI 10.1159/000324289
   Chung JY, 2002, ONCOGENE, V21, P1539, DOI 10.1038/sj/onc/1205023
   Fang C, 1998, HEPATOLOGY, V27, P1304, DOI 10.1002/hep.510270516
   Kim Y, 2004, PHYTOMEDICINE, V11, P152, DOI 10.1078/0944-7113-00282
   Lu Y., 2010, FREE RADIC BIOL MED, P1406
   Melendez-Martinez A. J., 2013, HEPATOBILIARY SURG N, V2, P198
   Morgan K, 2002, HEPATOLOGY, V36, P122, DOI 10.1053/jhep.2002.33720
   Narisawa T, 1998, JPN J CANCER RES, V89, P1003
   Porrini M, 2005, J NUTR, V135, p2042S
   PORTER TD, 1989, MOL PHARMACOL, V36, P61
   RONIS MJJ, 1993, J PHARMACOL EXP THER, V264, P944
   SCHMITZ HH, 1991, J NUTR, V121, P1613
   Seitz Helmut K, 2013, Subcell Biochem, V67, P131, DOI 10.1007/978-94-007-5881-0_3
   Tsuchishima M, 2013, DIGEST DIS SCI, V58, P1923, DOI 10.1007/s10620-013-2574-4
   Veeramachaneni S, 2008, J NUTR, V138, P1329
   Wang Y, 2009, HEPATOLOGY, V50, P453, DOI 10.1002/hep.22978
   Ye QY, 2013, HEPATOL RES, V43, P1115, DOI 10.1111/hepr.12063
   Ye Q, 2012, HEPATOBILIARY SURG N, V1, P5
NR 38
TC 1
Z9 1
U1 6
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 81
EP 88
DI 10.1016/j.abb.2015.01.004
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900013
PM 25592162
ER

PT J
AU Sy, C
   Dangles, O
   Borel, P
   Caris-Veyrat, C
AF Sy, Charlotte
   Dangles, Olivier
   Borel, Patrick
   Caris-Veyrat, Catherine
TI Stability of bacterial carotenoids in the presence of iron in a model of
   the gastric compartment - Comparison with dietary reference carotenoids
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE beta-Carotene; Lycopene; Astaxanthin; Carotenoids from bacteria;
   Transition metal; Metmyoglobin; Gastric model; Degradation; Oxidation
ID BETA-CAROTENE; LIPID-PEROXIDATION; ANTIOXIDANT ACTIVITY;
   FERRIC-CHLORIDE; FREE-RADICALS; HUMAN HEALTH; OXIDATION; AUTOXIDATION;
   PRODUCTS; DEGRADATION
AB Recently isolated spore-forming pigmented marine bacteria, Bacillus indicus HU36 and Bacillus firmus GB1 are sources of carotenoids (similar to fifteen distinct yellow and orange pigments and similar to thirteen distinct pink pigments, respectively). They are glycosides of oxygenated lycopene derivatives (apo-lycopenoids) and are assumed to be more heat- and gastric-stable than common carotenoids. In this study, the oxidation by O-2 of the bacterial carotenoids was initiated by free iron (Fe-II and Fe-III) or by heme iron (metmyoglobin) in a mildly acidic aqueous solution mimicking the gastro-intestinal compartment and compared to the oxidation of the common dietary carotenoids beta-carotene, lycopene and astaxanthin. Under these conditions, all bacterial carotenoids appear more stable in the presence of heme iron vs. free iron. Carotenoid autoxidation initiated by Fe-II is relatively fast and likely involves reactive oxygen-iron species derived from Fe-II and O-2. By contrast, the corresponding reaction with Fe-III is kinetically blocked by the slow preliminary reduction of Fe-III into Fe-II by the carotenoids. The stability of carotenoids toward autoxidation increases as follows: beta-carotene < lycopene < astaxanthin < HU36 and GB1. In particular, bacterial carotenoids react more quickly than reference carotenoids with Fe-III, but much more slowly than the reference carotenoids with Fe-II. This reaction is correlated with the structure of the carotenoids, which can have opposite effects in a micellar system: bacterial carotenoids with electro-attracting terminal groups have a lower reducing capacity than beta-carotene and lycopene. However, their polar head favours their location close to the interface of micelles, in closer contact with oxidative species. Kinetic analyses of the iron-induced autoxidation of astaxanthin and HU36 carotenoids has been performed and gives insights in the underlying mechanisms. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Sy, Charlotte; Dangles, Olivier; Caris-Veyrat, Catherine] INRA, Securite & Qualite Prod Origine Vegetale UMR408, F-84000 Avignon, France.
   [Sy, Charlotte; Dangles, Olivier; Caris-Veyrat, Catherine] Univ Avignon & Pays Vaucluse, Securite & Qualite Prod Origine Vegetale UMR408, F-84000 Avignon, France.
   [Sy, Charlotte; Borel, Patrick] INRA, Nutr Obesite & Risque Thrombot UMR1260, F-13385 Marseille, France.
   [Sy, Charlotte; Borel, Patrick] INSERM, UMR 1062, F-13385 Marseille, France.
   [Sy, Charlotte; Borel, Patrick] Aix Marseille Univ, Fac Med, F-13385 Marseille, France.
RP Caris-Veyrat, C (reprint author), INRA, Ctr Rech PACA, Securite & Qualite Prod Origine Vegetale UMR408, 228 Route Aerodrome,CS 40509, F-84914 Avignon 9, France.
EM catherine.caris@avignon.inra.fr
FU European Community [207948, KBBE-2007-2-3-03]
FX This work was supported by a grant from the European Community's Seventh
   Framework Program (Colorspore, No. 207948, "New sources of natural,
   gastric stable, food additives, colorants and novel functional foods",
   which was a small collaborative project coordinated by Simon Cutting,
   Royal Holloway University of London, within the work program topic
   "(Bio)Technologies for the production of food additives, and flavours
   (KBBE-2007-2-3-03)"). This publication reflects only the authors' view.
   The Colorspore community is not liable for any use that may be made of
   the results. Special thanks are given to Paul Fraser, Laura Perez-Fons
   and Reena Khaneja (Royal Holloway University of London, UK) for
   providing carotenoid-rich bacterial extracts. We thank the company
   Conesa (Conservas Vegetales de Extremadura, Badajoz, Spain) for its gift
   of (all-E)-lycopene. We also thank Michel Carail (INRA) for his
   technical assistance with the UPLC-DAD-MS analysis, Christian Ginies
   (INRA) for his help with the GC-MS analysis and Rachel Kopec for the
   critical reading of the manuscript.
CR Perez-Fons L, 2011, BBA-MOL CELL BIOL L, V1811, P177, DOI 10.1016/j.bbalip.2010.12.009
   Mancuso JR, 1999, J AGR FOOD CHEM, V47, P4146, DOI 10.1021/jf990453r
   Duc LH, 2006, FEMS MICROBIOL LETT, V255, P215, DOI 10.1111/j.1574-6968.2005.00091.x
   Khaneja R, 2010, J APPL MICROBIOL, V108, P1889, DOI 10.1111/j.1365-2672.2009.04590.x
   Sy C, 2013, FOOD FUNCT, V4, P698, DOI 10.1039/c3fo30334a
   Hong HA, 2009, RES MICROBIOL, V160, P134, DOI 10.1016/j.resmic.2008.11.002
   Skibsted LH, 2012, J AGR FOOD CHEM, V60, P2409, DOI 10.1021/jf2051416
   Baron CP, 2002, J AGR FOOD CHEM, V50, P3887, DOI 10.1021/jf011394w
   MARSHALL JH, 1981, J BACTERIOL, V147, P900
   MORDI RC, 1993, TETRAHEDRON, V49, P911, DOI 10.1016/S0040-4020(01)80333-1
   Stahl W, 2002, BIOL CHEM, V383, P553, DOI 10.1515/BC.2002.056
   Henry LK, 2000, J AGR FOOD CHEM, V48, P5008, DOI 10.1021/jf000503o
   Goupy P, 2012, NEW J CHEM, V36, P575, DOI 10.1039/c1nj20437h
   Mortensen A, 2001, ARCH BIOCHEM BIOPHYS, V385, P13, DOI 10.1006/abbi.2000.2172
   El-Agamey A, 2004, ARCH BIOCHEM BIOPHYS, V430, P37, DOI 10.1016/j.abb.2004.03.007
   Woodall AA, 1997, BBA-GEN SUBJECTS, V1336, P33, DOI 10.1016/S0304-4165(97)00006-8
   Kim SJ, 2004, FOOD SCI BIOTECHNOL, V13, P202
   Edge R, 1997, J PHOTOCH PHOTOBIO B, V41, P189, DOI 10.1016/S1011-1344(97)00092-4
   Goupy P, 2007, FREE RADICAL BIO MED, V43, P933, DOI 10.1016/j.freeradbiomed.2007.06.013
   Realini CE, 2013, MEAT SCI, V94, P408, DOI 10.1016/j.meatsci.2013.03.009
   Borel P, 2003, CLIN CHEM LAB MED, V41, P979, DOI 10.1515/CCLM.2003.151
   Faustman C, 2010, MEAT SCI, V86, P86, DOI 10.1016/j.meatsci.2010.04.025
   Mortensen A, 1997, J AGR FOOD CHEM, V45, P2970, DOI 10.1021/jf970010s
   Lombardi-Boccia G, 2002, J FOOD SCI, V67, P1738, DOI 10.1111/j.1365-2621.2002.tb08715.x
   Kanner J, 2001, FREE RADICAL BIO MED, V31, P1388, DOI 10.1016/S0891-5849(01)00718-3
   Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012
   Rodriguez EB, 2007, FOOD CHEM, V101, P563, DOI 10.1016/j.foodchem.2006.02.015
   Lapidot T, 2005, J AGR FOOD CHEM, V53, P3383, DOI 10.1021/jf040402g
   Bohm F, 2012, MOL NUTR FOOD RES, V56, P205, DOI 10.1002/mnfr.201100222
   Boon CS, 2010, CRIT REV FOOD SCI, V50, P515, DOI 10.1080/10408390802565889
   Martin HD, 1999, PURE APPL CHEM, V71, P2253, DOI 10.1351/pac199971122253
   Miller NJ, 1996, FEBS LETT, V384, P240, DOI 10.1016/0014-5793(96)00323-7
   Tyssandier V, 2003, AM J PHYSIOL-GASTR L, V284, pG913, DOI 10.1152/ajpgi.00410.2002
   Boon CS, 2009, J AGR FOOD CHEM, V57, P2993, DOI 10.1021/jf803747j
   Britton G., 1994, CAROTENOIDS B, V1B
   Britton G., 2004, CAROTENOIDS HDB
   Burke M, 2001, FEBS LETT, V500, P132, DOI 10.1016/S0014-5793(01)02601-1
   Burton GW, 2014, CAN J CHEM, V92, P305, DOI 10.1139/cjc-2013-0494
   Dufosse L., 2009, CAROTENOIDS, V5, P363
   Finkelshtein EI, 1996, J PHYS ORG CHEM, V9, P411, DOI 10.1002/(SICI)1099-1395(199606)9:6<411::AID-POC800>3.3.CO;2-5
   Gao GQ, 1997, J PHYS CHEM B, V101, P7844, DOI 10.1021/jp970630w
   Gao YL, 2003, J PHYS CHEM B, V107, P5333, DOI 10.1021/jp034063q
   HANDELMAN GJ, 1991, FREE RADICAL BIO MED, V10, P427, DOI 10.1016/0891-5849(91)90051-4
   Johnson EJ, 2009, CAROTENOIDS SER, V5, P287, DOI 10.1007/978-3-7643-7501-0_14
   Johnson E.J., 2013, J AGEING RES
   Mikkelsen A., 1995, UNTERS FORSCH, V200, P171
   Mortensen A, 2009, CAROTENOIDS SER, V5, P67, DOI 10.1007/978-3-7643-7501-0_4
   Palozza P, 2009, CAROTENOIDS SER, V5, P211, DOI 10.1007/978-3-7643-7501-0_11
   Chew BP, 2009, CAROTENOIDS SER, V5, P363, DOI 10.1007/978-3-7643-7501-0_17
   Perez-Galvez A, 2001, J AGR FOOD CHEM, V49, P4864, DOI 10.1021/jf010547c
   Rock CL, 2009, CAROTENOIDS SER, V5, P269, DOI 10.1007/978-3-7643-7501-0_13
   Rodrigues E, 2012, FOOD CHEM, V135, P2103, DOI 10.1016/j.foodchem.2012.06.074
   Sabour-Pickett S, 2012, MOL NUTR FOOD RES, V56, P270, DOI 10.1002/mnfr.201100219
   Schalch W., 2009, CAROTENOIDS, V5, P287
   Stahl W, 2003, MOL ASPECTS MED, V24, P345, DOI 10.1016/S0098-2997(03)00030-X
   Sy C, 2013, FREE RADICAL BIO MED, V63, P195, DOI 10.1016/j.freeradbiomed.2013.05.017
   Takahashi A, 1999, J AM OIL CHEM SOC, V76, P897, DOI 10.1007/s11746-999-0104-5
   Wei C-C, 1997, J CHEM SOC PERK T, V2, P783, DOI 10.1039/A605027A
NR 58
TC 1
Z9 1
U1 8
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 89
EP 100
DI 10.1016/j.abb.2014.12.030
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900014
PM 25595845
ER

PT J
AU Ermakov, IV
   Gellermann, W
AF Ermakov, Igor V.
   Gellermann, Werner
TI Optical detection methods for carotenoids in human skin
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Carotenoids; Antioxidants; Human skin; Raman spectroscopy; Reflection
   spectroscopy
ID RESONANCE RAMAN-SPECTROSCOPY; VEGETABLE INTAKE; MACULAR PIGMENT; HUMAN
   RETINA; DERMAL CAROTENOIDS; VITAMIN-A; FRUIT; PLASMA; BIOMARKER;
   CHILDREN
AB Resonance Raman spectroscopy and reflection spectroscopy are non-invasive optical quantitative methods for the measurement of carotenoid antioxidant levels in human skin in vivo. Since all tissue carotenoids are derived from the diet, optical monitoring in skin may serve as an objective indicator for fruit and vegetable intake, and more broadly also as an effective biomarker for integrative health. The two optical methods have already found enthusiastic application in the Nutritional Supplement Industry where they are used with large populations to measure skin carotenoid uptake upon consumption of carotenoid-containing dietary supplements. Applications in medical fields such as nutrition science and epidemiology have been awaiting rigorous correlation studies between the optical carotenoid detection methods and the established gold standard detection method of high-performance liquid chromatography, which requires excised tissue samples. In this article we review the principles of the methods along with the current status of validations so the reader can assess the merits of the optical methods in their respective fields of interest. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ermakov, Igor V.; Gellermann, Werner] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA.
RP Ermakov, IV (reprint author), Dept Phys & Astron, 115 S 1400 E RM 201, Salt Lake City, UT 84112 USA.
EM ermakov@physics.utah.edu
FU Image Technologies Inc., Salt Lake City, UT
FX This work was supported by Image Technologies Inc., Salt Lake City, UT.
CR Age-related eye disease study research group, 2007, Arch. Ophthalmol, V125, P1225, Patent No. [20128260402, US 2012/8260402 B2]
   Alaluf S, 2002, J NUTR, V132, P399
   Bernstein PS, 1998, INVEST OPHTH VIS SCI, V39, P2003
   Scarmo S, 2012, EUR J CLIN NUTR, V66, P555, DOI 10.1038/ejcn.2012.31
   Sahni S, 2009, J BONE MINER RES, V24, P1086, DOI [10.1359/jbmr.090102, 10.1359/JBMR.090102]
   Hata TR, 2000, J INVEST DERMATOL, V115, P441, DOI 10.1046/j.1523-1747.2000.00060.x
   Giovannucci E, 1999, J NATL CANCER I, V91, P317, DOI 10.1093/jnci/91.4.317
   Bernstein PS, 2013, INVEST OPHTH VIS SCI, V54, P4034, DOI 10.1167/iovs.13-11891
   Sugiura M, 2008, OSTEOPOROSIS INT, V19, P211, DOI 10.1007/s00198-007-0457-2
   Aguilar SS, 2014, J ACAD NUTR DIET, V114, P1174, DOI 10.1016/j.jand.2014.04.026
   Ermakov IV, 2004, J BIOMED OPT, V9, P332, DOI [10.1117/1.1646172, 10.1117/1.16461721]
   KHACHIK F, 1991, PURE APPL CHEM, V63, P71, DOI 10.1351/pac199163010071
   Liu S, 2000, AM J CLIN NUTR, V72, P922
   Jahns L, 2014, AM J CLIN NUTR, V100, P930, DOI 10.3945/ajcn.114.086900
   Tohill BC, 2004, NUTR REV, V62, P365, DOI [10.1301/nr.2004.oct.365-374, 10.1301/nr.2004.oct.365374]
   Bergeson SD, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2952075
   Betz B.B., 2010, CANC PREV RES, V3, P529
   Canene-Adams K, 2009, CAROTENOIDS SER, V5, P115, DOI 10.1007/978-3-7643-7501-0_7
   Chan GM, 2013, J PEDIATR GASTR NUTR, V56, P556, DOI 10.1097/MPG.0b013e318282a8fe
   Cho EY, 2004, ARCH OPHTHALMOL-CHIC, V122, P883, DOI 10.1001/archopht.122.6.883
   Ermakov IV, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2139974
   Ermakov IV, 2013, J BIOPHOTONICS, V6, P793, DOI 10.1002/jbio.201200195
   Ermakov I.V., 2007, ARCH OPHTHALMOL, Patent No. US 2012/8260402 B2
   Ermakov IV, 2001, OPT LETT, V26, P1179, DOI 10.1364/OL.26.001179
   Ermakov IV, 2012, J BIOPHOTONICS, V5, P559, DOI 10.1002/jbio.201100122
   Ermakov IV, 2001, OPT LETT, V26, P202, DOI 10.1364/OL.26.000202
   Ermakov IV, 2010, CAROTENOIDS: PHYSICAL, CHEMICAL, AND BIOLOGICAL FUNCTIONS AND PROPERTIES, P87
   Ermakov IV, 2010, ARCH BIOCHEM BIOPHYS, V504, P40, DOI 10.1016/j.abb.2010.07.023
   Ermakov I.V., 2013, J BIOMED OPT, V18
   Gellermann W., 2005, CAROTENOIDS RETINOID, P86
   Henriksen BS, 2013, INVEST OPHTH VIS SCI, V54, P5568, DOI 10.1167/iovs.13-12331
   Holt EW, 2014, NUTR RES, V34, P821, DOI 10.1016/j.nutres.2014.08.017
   Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459, DOI 10.1016/j.mam.2005.10.001
   Krutmann J., 2006, SKIN AGING, P103, DOI 10.1007/3-540-32953-6_9
   Lin S, 2000, BIOPOLYMERS, V57, P249, DOI 10.1002/1097-0282(2000)57:4<249::AID-BIP6>3.0.CO;2-1
   LUTZ M, 1987, BIOCHIM BIOPHYS ACTA, V894, P423, DOI 10.1016/0005-2728(87)90121-6
   Mayne ST, 2010, AM J CLIN NUTR, V92, P794, DOI 10.3945/ajcn.2010.29707
   Meinke MC, 2010, EUR J PHARM BIOPHARM, V76, P269, DOI 10.1016/j.ejpb.2010.06.004
   Niedorf F, 2005, MED PHYS, V32, P1297, DOI 10.1118/1.1851917
   PENG YM, 1995, NUTR CANCER, V23, P233
   Rerksuppaphol S., 2012, PEDIAT REP, V4, P44
   RIMAI L, 1971, J AM CHEM SOC, V93, P1353, DOI 10.1021/ja00735a006
   Sharifzadeh M, 2008, J OPT SOC AM A, V25, P947, DOI 10.1364/JOSAA.25.000947
   Smidt CR, 2004, FASEB J, V18, pA480
   Stahl W, 1998, J NUTR, V128, P903
   Stahl W, 2000, METHOD ENZYMOL, V319, P494
   World Cancer Research Fund American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P
NR 47
TC 2
Z9 2
U1 9
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 101
EP 111
DI 10.1016/j.abb.2015.01.020
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900015
PM 25637655
ER

PT J
AU Bonet, ML
   Canas, JA
   Ribot, J
   Palou, A
AF Luisa Bonet, M.
   Canas, Jose A.
   Ribot, Joan
   Palou, Andreu
TI Carotenoids and their conversion products in the control of adipocyte
   function, adiposity and obesity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Carotenoids; Apocarotenoids; Obesity; Adiposity; Energy metabolism;
   White adipose tissue browning
ID HIGH-FAT-DIET; VITAMIN-A SUPPLEMENTATION; RETINOIC ACID-TREATMENT;
   ACTIVATED RECEPTOR-GAMMA; 6-MONTH DAILY SUPPLEMENTATION; UNCOUPLING
   PROTEIN GENE; RECENT NATIONAL SURVEYS; NECROSIS-FACTOR-ALPHA; ORAL
   BETA-CAROTENE; PEROXISOME PROLIFERATOR
AB A novel perspective of the function of carotenoids and carotenoid-derived products - including, but not restricted to, the retinoids - is emerging in recent years which connects these compounds to the control of adipocyte biology and body fat accumulation, with implications for the management of obesity, diabetes and cardiovascular disease. Cell and animal studies indicate that carotenoids and carotenoids derivatives can reduce adiposity and impact key aspects of adipose tissue biology including adipocyte differentiation, hypertrophy, capacity for fatty acid oxidation and thermogenesis (including browning of white adipose tissue) and secretory function. Epidemiological studies in humans associate higher dietary intakes and serum levels of carotenoids with decreased adiposity. Specifically designed human intervention studies, though still sparse, indicate a beneficial effect of carotenoid supplementation in the accrual of abdominal adiposity. The objective of this review is to summarize recent findings in this area, place them in physiological contexts, and provide likely regulatory schemes whenever possible. The focus will be on the effects of carotenoids as nutritional regulators of adipose tissue biology and both animal and human studies, which support a role of carotenoids and retinoids in the prevention of abdominal adiposity. (C) 2015 The Authors. Published by Elsevier Inc.
C1 [Luisa Bonet, M.; Ribot, Joan; Palou, Andreu] Univ Illes Balears, Lab Mol Biol Nutr & Biotechnol Nutrigen, Palma De Mallorca 07122, Spain.
   [Canas, Jose A.] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Palma De Mallorca, Spain.
   [Canas, Jose A.] Nemours Childrens Clin, Metab & Diabet, Jacksonville, FL 32207 USA.
RP Bonet, ML (reprint author), Univ Illes Balears, Lab Mol Biol Nutr & Biotechnol, Cra Valldemossa Km 7-5, Palma De Mallorca 07122, Spain.
EM luisabonet@uib.es
RI Bonet, M.Luisa/H-6722-2015; Palou, Andreu/K-9881-2014; Ribot,
   Joan/L-2224-2014
OI Bonet, M.Luisa/0000-0002-8698-0630; Palou, Andreu/0000-0002-0295-4452; 
FU European Union's Seventh Framework Programme FP7 [244995, 278373];
   Spanish Government [AGL2012-33692]; Fundacion Ramon Areces; Instituto de
   Salud Carlos III, Centro de Investigacion Biomedica en Red
   Fisiopatologia de la Obesidad y Nutricion, CIBERobn; Nemours Research
   Foundation; Players Center for Child Health at Wolfson Children's
   Hospital in Jacksonville, Florida
FX The authors acknowledge funding support from the European Union's
   Seventh Framework Programme FP7 under Grant agreements No. 244995
   (BIOCLAIMS Project) and No. 278373 (DIABAT project), the Spanish
   Government (Grant AGL2012-33692), Fundacion Ramon Areces, and the
   Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red
   Fisiopatologia de la Obesidad y Nutricion, CIBERobn. The authors are
   also grateful to The Nemours Research Foundation and The Players Center
   for Child Health at Wolfson Children's Hospital in Jacksonville, Florida
   for their generous support. The UIB group is a member of the European
   Nutrigenomics Organization and the network IBERCAROT (CYTED, Spanish
   Government, No. 112RT0445).
CR ALVAREZ R, 1995, J BIOL CHEM, V270, P5666
   Alvarez R, 2000, BIOCHEM J, V345, P91, DOI 10.1042/0264-6021:3450091
   Amengual J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020644
   Amengual J, 2012, INT J BIOCHEM CELL B, V44, P2019, DOI 10.1016/j.biocel.2012.07.026
   Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21
   Gunanti IR, 2014, J NUTR, V144, P489, DOI 10.3945/jn.113.183137
   Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632
   Reichert B, 2011, MOL ENDOCRINOL, V25, P799, DOI 10.1210/me.2010-0465
   Zhang Y, 2002, BBA-MOL CELL BIOL L, V1584, P115, DOI 10.1016/S1388-1981(02)00298-6
   Burrows TL, 2009, OBESITY, V17, P162, DOI 10.1038/oby.2008.495
   Decsi T, 1997, J PEDIATR-US, V130, P653, DOI 10.1016/S0022-3476(97)70253-1
   Jeyakumar SM, 2008, BIOCHEM BIOPH RES CO, V370, P243, DOI 10.1016/j.bbrc.2008.03.073
   Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65
   Mercader J, 2008, CELL PHYSIOL BIOCHEM, V22, P363, DOI 10.1159/000149815
   Lai CS, 2012, J AGR FOOD CHEM, V60, P1094, DOI 10.1021/jf204862d
   Kesse-Guyot E, 2013, NUTR METAB CARDIOVAS, V23, P677, DOI 10.1016/j.numecd.2012.02.005
   Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003
   Lucas EA, 2011, BRIT J NUTR, V106, P1495, DOI 10.1017/S0007114511002066
   Takayanagi K, 2011, J AGR FOOD CHEM, V59, P12342, DOI 10.1021/jf202821u
   Kang SI, 2011, BIOCHEM BIOPH RES CO, V409, P769, DOI 10.1016/j.bbrc.2011.05.086
   Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200
   Sheng L, 2008, BRIT J PHARMACOL, V154, P1016, DOI 10.1038/bjp.2008.160
   Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045
   Sliwa A, 2012, ACTA BIOCHIM POL, V59, P39
   Maeda H, 2009, MOL MED REP, V2, P897, DOI 10.3892/mmr_00000189
   Mercader J, 2007, CELL PHYSIOL BIOCHEM, V20, P1061, DOI 10.1159/000110717
   Hu XJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P59, DOI 10.1016/j.abb.2012.01.011
   Kritchevsky SB, 2000, AM J EPIDEMIOL, V152, P1065, DOI 10.1093/aje/152.11.1065
   TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805
   Lee CM, 1999, J NUTR, V129, P2271
   Neuhouser ML, 2001, J NUTR, V131, P2184
   Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08
   Beydoun MA, 2012, J NUTR, V142, P1693, DOI 10.3945/jn.112.160416
   Ford ES, 1999, AM J EPIDEMIOL, V149, P168
   Redonnet A, 2008, BRIT J NUTR, V100, P722, DOI 10.1017/S0007114508967568
   Beydoun MA, 2011, J NUTR, V141, P903, DOI 10.3945/jn.110.136580
   Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923
   Miyashita K, 2011, J SCI FOOD AGR, V91, P1166, DOI 10.1002/jsfa.4353
   Kumar MV, 1998, J ENDOCRINOL, V157, P237, DOI 10.1677/joe.0.1570237
   Arner P, 2010, BIOCHEM BIOPH RES CO, V396, P101, DOI 10.1016/j.bbrc.2010.02.165
   Gorocica-Buenfil MA, 2007, J ANIM SCI, V85, P3355, DOI 10.2527/jas.2007-0172
   Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760
   Menendez C, 2001, J ENDOCRINOL, V170, P425, DOI 10.1677/joe.0.1700425
   Sugiura M, 2006, J EPIDEMIOL, V16, P71, DOI 10.2188/jea.16.71
   Amengual J, 2008, OBESITY, V16, P585, DOI 10.1038/oby.2007.104
   MURRAY T, 1980, J SUPRAMOL STR CELL, V14, P255, DOI 10.1002/jss.400140214
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001
   Strauss RS, 1999, J PEDIATR-US, V134, P160, DOI 10.1016/S0022-3476(99)70409-9
   Yasmeen R, 2012, BBA-MOL CELL BIOL L, V1821, P190, DOI 10.1016/j.bbalip.2011.06.004
   Teas J, 2009, ASIA PAC J CLIN NUTR, V18, P145
   Abidov M, 2010, DIABETES OBES METAB, V12, P72, DOI 10.1111/j.1463-1326.2009.01132.x
   Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906
   Aranda A, 2001, PHYSIOL REV, V81, P1269
   Mercader J, 2010, OBESITY, V18, P655, DOI 10.1038/oby.2009.330
   Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5
   Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje
   Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552
   van Helden YGJ, 2009, CARCINOGENESIS, V30, P2070, DOI 10.1093/carcin/bgp186
   El-Sohemy A, 2002, AM J CLIN NUTR, V76, P172
   Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002
   Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x
   Kim KN, 2010, EUR J PHARMACOL, V649, P369, DOI 10.1016/j.ejphar.2010.09.032
   SAFONOVA I, 1994, MOL CELL ENDOCRINOL, V104, P201, DOI 10.1016/0303-7207(94)90123-6
   Bays HE, 2011, J AM COLL CARDIOL, V57, P2461, DOI 10.1016/j.jacc.2011.02.038
   Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107
   Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142
   Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006
   Tourniaire F, 2009, GENES NUTR, V4, P179, DOI 10.1007/s12263-009-0128-3
   Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621
   Peinado JR, 2010, PROTEOMICS, V10, P3356, DOI 10.1002/pmic.201000350
   Jeyakumar SM, 2006, OBESITY, V14, P52, DOI 10.1038/oby.2006.7
   PARKER RS, 1989, J NUTR, V119, P101
   Kang SI, 2012, J AGR FOOD CHEM, V60, P3389, DOI 10.1021/jf2047652
   Johnson EJ, 2014, NUTR REV, V72, P605, DOI 10.1111/nure.12133
   Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012
   STAHL W, 1992, ARCH BIOCHEM BIOPHYS, V294, P173, DOI 10.1016/0003-9861(92)90153-N
   Granados N, 2013, INT J OBESITY, V37, P1169, DOI 10.1038/ijo.2012.190
   Felipe F, 2005, BBA-MOL BASIS DIS, V1740, P258, DOI 10.1016/j.bbadis.2004.11.014
   Chung HY, 2009, AM J CLIN NUTR, V90, P533, DOI 10.3945/ajcn.2009.27712
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571
   Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f
   Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001
   Wang L, 2008, AM J CLIN NUTR, V88, P747
   Teruel T, 2003, J BIOL CHEM, V278, P263, DOI 10.1074/jbc.M207200200
   Landrier JF, 2012, NUTRIENTS, V4, P1622, DOI 10.3390/nu4111622
   Hosokawa M, 2010, ARCH BIOCHEM BIOPHYS, V504, P17, DOI 10.1016/j.abb.2010.05.031
   Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Andersen LF, 2006, BRIT J NUTR, V95, P358, DOI 10.1079/BJN20051638
   Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587
   Emek SC, 2010, PREP BIOCHEM BIOTECH, V40, P13, DOI 10.1080/10826060903413057
   Sluijs I, 2009, J NUTR, V139, P987, DOI 10.3945/jn.108.101451
   Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403
   Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005
   Esteban-Pretel G, 2010, J NUTR, V140, P792, DOI 10.3945/jn.109.119388
   Maeda H, 2006, INT J MOL MED, V18, P147
   Amengual J, 2010, CELL PHYSIOL BIOCHEM, V25, P657, DOI 10.1159/000315085
   Gerhard GS, 2014, INT J OBESITY, V38, P371, DOI 10.1038/ijo.2013.152
   Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002
   Ikeuchi M, 2007, BIOSCI BIOTECH BIOCH, V71, P893, DOI 10.1271/bbb.60521
   Fiedor J, 2014, NUTRIENTS, V6, P466, DOI 10.3390/nu6020466
   Berry DC, 2012, DIABETES, V61, P1112, DOI 10.2337/db11-1620
   Arunkumar E, 2012, FOOD FUNCT, V3, P120, DOI 10.1039/c1fo10161g
   Bairras C, 2005, J PHYSIOL BIOCHEM, V61, P353
   Beck J, 2008, NUTRITION, V24, P964, DOI 10.1016/j.nut.2008.04.006
   Bonet ML, 2003, CELL MOL LIFE SCI, V60, P1311, DOI 10.1007/s00018-003-2290-x
   Bonet ML, 2000, J ENDOCRINOL, V166, P511, DOI 10.1677/joe.0.1660511
   Borel P, 2012, MOL NUTR FOOD RES, V56, P228, DOI 10.1002/mnfr.201100322
   Botella-Carretero JI, 2010, OBES SURG, V20, P69, DOI 10.1007/s11695-008-9686-5
   Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje
   Breitman TR, 1996, BIOCHEM SOC T, V24, P723
   Calder PC, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511005460
   Canas J., 2014, FASEB J, V28
   Canas J. A., 2012, J PEDIAT, V161, pe51
   CHAWLA A, 1994, P NATL ACAD SCI USA, V91, P1786, DOI 10.1073/pnas.91.5.1786
   Collard F, 2007, BIOCHIMIE, V89, P369, DOI 10.1016/j.biochi.2006.11.005
   Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243
   Da Silva LDV, 2007, NUTRITION, V23, P392, DOI 10.1016/j.nut.2007.02.009
   Dave S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100862
   Erlinger TP, 2001, ARCH INTERN MED, V161, P1903, DOI 10.1001/archinte.161.15.1903
   Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025
   Felipe F, 2004, DIABETES, V53, P882, DOI 10.2337/diabetes.53.4.882
   Felipe F, 2003, INT J OBESITY, V27, P60, DOI 10.1038/sj.ijo.0802188
   Ford ES, 2002, AM J CLIN NUTR, V76, P818
   Ford ES, 2003, EUR J CLIN NUTR, V57, P1157, DOI 10.1038/sj.ejcn.1601667
   Frey SK, 2011, NUTRIENTS, V3, P27, DOI 10.3390/nu3010027
   Fuster A, 2008, J NUTR BIOCHEM, V19, P295, DOI 10.1016/j.jnutbio.2007.03.004
   Goto T, 2013, MOL NUTR FOOD RES, V57, P20, DOI 10.1002/mnfr.201200522
   Gouranton E, 2008, FOOD CHEM TOXICOL, V46, P3832, DOI 10.1016/j.fct.2008.10.006
   Gouranton E, 2011, BBA-MOL CELL BIOL L, V1811, P1105, DOI 10.1016/j.bbalip.2011.09.002
   Gouranton E., 2010, J NUTR BIOCH, V22, P642
   Grune T., 2010, J NUTR, V140, P2268
   Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200
   Hozawa A, 2007, CLIN CHEM, V53, P447, DOI 10.1373/clinchem.2006.074930
   Inoue M, 2012, BIOCHEM PHARMACOL, V84, P692, DOI 10.1016/j.bcp.2012.05.021
   Iwamoto M, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-52
   Jiang WY, 2013, J BIOL CHEM, V288, P589, DOI 10.1074/jbc.M112.402883
   Jiang WY, 2012, BBA-GEN SUBJECTS, V1820, P859, DOI 10.1016/j.bbagen.2012.03.016
   Kabagambe EK, 2005, J NUTR, V135, P1763
   Kameji H, 2010, NUTRITION, V26, P1151, DOI 10.1016/j.nut.2009.09.006
   Kaulmann A, 2014, NUTR RES, V34, P907, DOI 10.1016/j.nutres.2014.07.010
   Kawada T, 2000, BIOFACTORS, V13, P103
   Kawada T, 1996, INT J OBESITY, V20, pS52
   Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757
   Kim HS, 2000, EXP MOL MED, V32, P197
   Kimmons Joel E, 2006, MedGenMed, V8, P59
   KLYDE BJ, 1979, J LIPID RES, V20, P705
   Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459, DOI 10.1016/j.mam.2005.10.001
   Kumar MV, 1999, J LIPID RES, V40, P824
   Le Lay S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/908539
   Lederman JD, 1998, J NUTR, V128, P271
   Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483
   Luvizotto R., 2015, HUM EXP TOXICOL
   Maeda H., 2013, ISRN INFLAMMATION, V2013, DOI 10.1155/2013/76375824049664
   Manolescu DC, 2010, J NUTR, V140, P311, DOI 10.3945/jn.109.115147
   Marchildon F, 2010, J BIOL CHEM, V285, P13274, DOI 10.1074/jbc.M109.054536
   Marcotorchino J, 2012, MOL NUTR FOOD RES, V56, P725, DOI 10.1002/mnfr.201100623
   Murano I, 2005, BBA-MOL BASIS DIS, V1740, P305, DOI 10.1016/j.bbadis.2004.10.012
   Murholm M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-41
   Murri M, 2013, MOL CELL ENDOCRINOL, V376, P99, DOI 10.1016/j.mce.2013.06.010
   Musinovic H, 2014, MOL NUTR FOOD RES, V58, P2157, DOI 10.1002/mnfr.201400457
   Okada T, 2008, J OLEO SCI, V57, P345, DOI 10.5650/jos.57.345
   Osth M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085610
   Palou A, 2013, CURR OPIN CLIN NUTR, V16, P650, DOI 10.1097/MCO.0b013e328365980f
   Palou A, 2013, NUTR HOSP, V28, P144, DOI 10.3305/nh.2013.28.sup5.6930
   Palozza P, 1998, NUTR REV, V56, P257
   Perez-Perez R, 2009, J PROTEOME RES, V8, P1682, DOI 10.1021/pr800942k
   Pico C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00255
   Puigserver P, 1996, BIOCHEM J, V317, P827
   Rabelo R, 1996, ENDOCRINOLOGY, V137, P3488, DOI 10.1210/en.137.8.3488
   Rde A. Luvizotto, 2013, BR J NUTR, V110, P1803
   Rodriguez AM, 2005, BBA-MOL BASIS DIS, V1740, P132, DOI 10.1016/j.bbadis.2004.01.004
   Saito Masayuki, 2013, Diabetes Metab J, V37, P22, DOI 10.4093/dmj.2013.37.1.22
   Sakamuri VPSS, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-70
   Sanchez J, 2009, BRIT J NUTR, V102, P1686, DOI 10.1017/S0007114509991024
   Sarni ROS, 2005, MED SCI MONITOR, V11, pCR510
   Serra F, 1999, INT J OBESITY, V23, P650, DOI 10.1038/sj.ijo.0800897
   Shirakura Y, 2011, J NUTR SCI VITAMINOL, V57, P426
   Siems W, 2005, J NUTR BIOCHEM, V16, P385, DOI 10.1016/j.jnutbio.2005.01.009
   Sima A, 2011, BIOCHEM CELL BIOL, V89, P578, DOI [10.1139/o11-062, 10.1139/O11-062]
   Suzuki K, 2010, CLIN CHIM ACTA, V411, P1330, DOI 10.1016/j.cca.2010.05.029
   Takayanagi K, 2014, NUTRITION IN THE PREVENTION AND TREATMENT OF ABDOMINAL OBESITY, P381, DOI 10.1016/B978-0-12-407869-7.00034-9
   Tan CP, 2014, INFLAMMATION, V37, P443, DOI 10.1007/s10753-013-9757-1
   Tang GW, 2003, AM J CLIN NUTR, V78, P259
   Tanoury Al., 2013, J LIPID RES, V54, P1761
   Tourniaire F., 2014, EUR J NUTR
   Tsuchida T, 2008, JPN PHARMACOL THER, V36, P247
   Viroonudomphol D, 2003, ASIA PAC J CLIN NUTR, V12, P73
   van Herpen-Broekmans WMR, 2004, EUR J EPIDEMIOL, V19, P915, DOI 10.1007/s10654-004-5760-z
   Virtanen SM, 1996, AM J EPIDEMIOL, V144, P968
   von Lintig J, 2012, AM J CLIN NUTR, V96, p1234S, DOI 10.3945/ajcn.112.034629
   Wise JA, 2009, INT J FOOD SCI NUTR, V60, P65, DOI 10.1080/09637480902852553
   Xi L, 2007, BRIT J PHARMACOL, V151, P610, DOI 10.1038/sj.bjp.0707276
   Yeum K J, 1998, J Nutr Health Aging, V2, P79
   Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225
   Zulet MA, 2008, J NUTR SCI VITAMINOL, V54, P347, DOI 10.3177/jnsv.54.347
NR 198
TC 2
Z9 2
U1 12
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 112
EP 125
DI 10.1016/j.abb.2015.02.022
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900016
PM 25721497
ER

PT J
AU Bruno, M
   Beyer, P
   Al-Babili, S
AF Bruno, Mark
   Beyer, Peter
   Al-Babili, Salim
TI The potato carotenoid cleavage dioxygenase 4 catalyzes a single cleavage
   of beta-ionone ring-containing carotenes and non-epoxidated xanthophylls
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Apocarotenoids; Carotenoids; Carotenoid cleavage dioxygenases; Potato
ID IN-VITRO CHARACTERIZATION; RETINAL BIOSYNTHESIS; CROCUS-SATIVUS;
   CITRUS-FRUIT; OXYGENASE; ENZYME; ARABIDOPSIS; INHIBITION; ROLES;
   APOCAROTENOIDS
AB Down-regulation of the potato carotenoid cleavage dioxygenase 4 (StCCD4) transcript level led to tubers with altered morphology and sprouting activity, which also accumulated higher levels of violaxanthin and lutein leading to elevated carotenoid amounts. This phenotype indicates a role of this enzyme in tuber development, which may be exerted by a cleavage product. In this work, we investigated the enzymatic activity of StCCD4, by expressing the corresponding cDNA in carotenoid accumulating Escherichia coli strains and by performing in vitro assays with heterologously expressed enzyme. StCCD4 catalyzed the cleavage of all-trans-beta-carotene at the C9'-C10' double bond, leading to beta-ionone and all-trans-beta-apo-10'-carotenal, both in vivo and in vitro. The enzyme also cleaved beta,beta-cryptoxanthin, zeaxanthin and lutein either at the C9'-C10' or the C9-C10 double bond in vitro. In contrast, we did not observe any conversion of violaxanthin and only traces of activity with 9-cis-beta-carotene, which led to 9-cis-beta-apo-10'-carotenal. Our data indicate that all-trans-beta-carotene is the likely substrate of StCCD4 in planta, and that this carotene may be precursor of an unknown compound involved in tuber development. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Al-Babili, Salim] KAUST, BESE Div, Ctr Desert Agr, Thuwal 239556900, Saudi Arabia.
   [Bruno, Mark; Beyer, Peter; Al-Babili, Salim] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany.
RP Al-Babili, S (reprint author), 4700 King Abdullah Univ Sci & Technol KAUST, Div Biol & Environm Sci & Engn, Ctr Desert Agr, Thuwal 239556900, Saudi Arabia.
EM salim.babili@kaust.edu.sa
OI Al-Babili, Salim/0000-0003-4823-2882
FU European Union (METAPRO) [FP7 KBBE-2009-3-1-01]; King Abdullah
   University of Science and Technology (KAUST)
FX We thank Dr. Hansgeorg Ernst for providing the synthetic substrates and
   Erdmann Scheffer for skillful technical assistance. This work was
   supported by the European Union (METAPRO; FP7 KBBE-2009-3-1-01) and by
   the King Abdullah University of Science and Technology (KAUST).
CR Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272
   von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915
   Alder A, 2008, BIOCHEM J, V416, P289, DOI 10.1042/BJ20080568
   Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002
   Rubio A, 2008, J BIOL CHEM, V283, P24816, DOI 10.1074/jbc.M804000200
   Schwartz SH, 2001, J BIOL CHEM, V276, P25208, DOI 10.1074/jbc.M102146200
   Ma G, 2013, PLANT PHYSIOL, V163, P682, DOI 10.1104/pp.113.223297
   Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271
   Ruyter-Spira C, 2013, TRENDS PLANT SCI, V18, P72, DOI 10.1016/j.tplants.2012.10.003
   Alder A, 2012, SCIENCE, V335, P1348, DOI 10.1126/science.1218094
   Sui XW, 2014, J BIOL CHEM, V289, P12286, DOI 10.1074/jbc.M114.552836
   Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061
   Auldridge ME, 2006, PLANT J, V45, P982, DOI 10.1111/j.1365-313X.2006.02666.x
   Avendano-Vazquez AO, 2014, PLANT CELL, V26, P2524, DOI 10.1105/tpc.114.123349
   Walter MH, 2010, PLANTA, V232, P1, DOI 10.1007/s00425-010-1156-3
   Huang FC, 2009, J EXP BOT, V60, P3011, DOI 10.1093/jxb/erp137
   Kloer DP, 2006, CELL MOL LIFE SCI, V63, P2291, DOI 10.1007/s00018-006-6176-6
   Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106
   Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965
   Rodrigo MJ, 2013, J EXP BOT, V64, P4461, DOI 10.1093/jxb/ert260
   Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815
   Kachanovsky DE, 2012, P NATL ACAD SCI USA, V109, P19021, DOI 10.1073/pnas.1214808109
   Gonzalez-Jorge S, 2013, PLANT CELL, V25, P4812, DOI 10.1105/tpc.113.119677
   Bouvier F, 2005, TRENDS PLANT SCI, V10, P187, DOI 10.1016/j.tplants.2005.02.007
   Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a
   Al-Babili S, 2015, ANNU REV PLANT BIOL, V66, P161, DOI 10.1146/annurev-arplant-043014-114759
   Ohmiya A, 2006, PLANT PHYSIOL, V142, P1193, DOI 10.1104/pp.106.087130
   Harrison PJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P105, DOI 10.1016/j.abb.2013.10.005
   Floss DS, 2008, PLANT PHYSIOL, V148, P1267, DOI 10.1104/pp.108.125062
   Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012
   Ahrazem O, 2010, GENOMICS, V96, P239, DOI 10.1016/j.ygeno.2010.07.003
   Vogel JT, 2008, J BIOL CHEM, V283, P11364, DOI 10.1074/jbc.M710106200
   Auldridge ME, 2006, CURR OPIN PLANT BIOL, V9, P315, DOI 10.1016/j.pbi.2006.03.005
   Brandi F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-24
   Brefort T, 2011, FUNGAL GENET BIOL, V48, P132, DOI 10.1016/j.fgb.2010.10.009
   Bruno M., 2014, FEBS LETT
   Campbell R, 2010, PLANT PHYSIOL, V154, P656, DOI 10.1104/pp.110.158733
   DAVIES BH, 1976, CHEM BIOCH PLANT PIG, V2, P150
   IIg A., 2009, FEBS J, V276, P736
   IIg A., 2014, FEBS OPEN BIO, V4, P584
   Ilg A, 2010, PLANTA, V232, P691, DOI 10.1007/s00425-010-1205-y
   Medina HR, 2011, MOL MICROBIOL, V82, P199, DOI 10.1111/j.1365-2958.2011.07805.x
   Moise A.R., 2013, CHEM REV
   Naested H, 2004, J CELL SCI, V117, P4807, DOI 10.1242/jcs.01360
   Prado-Cabrero A, 2007, EUKARYOT CELL, V6, P650, DOI 10.1128/EC.00392-06
   Ruch S, 2005, MOL MICROBIOL, V55, P1015, DOI 10.1111/j.1365-2958.2004.00460.x
   Scherzinger D, 2010, FEBS J, V277, P4662, DOI 10.1111/j.1742-4658.2010.07873.x
   Scherzinger D, 2008, MOL MICROBIOL, V69, P231, DOI 10.1111/j.1365-2958.2008.06282.x
   Scherzinger D, 2006, BIOCHEM J, V398, P361, DOI 10.1042/BJ20060592
   Schlicht M, 2008, PLANT J, V55, P709, DOI 10.1111/j.1365-313X.2008.03543.x
   Schmidt Holger, 2006, J Biol Chem, V281, P9845, DOI 10.1074/jbc.M511668200
   Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872
   Vogel JT, 2010, PLANT J, V61, P300, DOI 10.1111/j.1365-313X.2009.04056.x
   Van Norman JM, 2014, P NATL ACAD SCI USA, V111, pE1300, DOI 10.1073/pnas.1403016111
NR 54
TC 2
Z9 2
U1 14
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 126
EP 133
DI 10.1016/j.abb.2015.02.011
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900017
PM 25703194
ER

PT J
AU Autenrieth, C
   Ghosh, R
AF Autenrieth, Caroline
   Ghosh, Robin
TI Random mutagenesis and overexpression of rhodopin-3,4-desaturase allows
   the production of highly conjugated carotenoids in Rhodospirillum rubrum
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Carotenoids; Photosynthesis; Purple bacteria; Light-harvesting
   complexes; Spirilloxanthin; Mass spectroscopy
ID ESCHERICHIA-COLI; CLONING; RHODOBACTER; COMBINATION; DESATURASE;
   COMPLEXES; LYCOPENE; PROTEIN; VECTOR; DNA
AB The crtD gene of the purple bacterium Rhodospirillum rubrum, encoding rhodopin desaturase, was cloned into a broad-host range expression plasmid (pRKCAG53) and transferred to the R. rubrum crtD(-) mutant, ST4, which restored the wild-type phenotype and produced the carotenoid spirilloxanthin. pRKCAG53 was randomly mutated in an Escherichia coli mutator strain and then transferred to ST4 for selection of non-wild-type phenotypes. Strains containing the mutated expression plasmid exhibited two coloured phenotypes: a "brown" phenotype, corresponding to 3,4,3',4'-tetrahydrospirilloxanthin, arising from plasmids containing an inactivated crtD gene, and secondly, a "dark pink" phenotype. Absorption and mass spectra and HPLC analysis obtained from hexane extracts of brown mutants, confirmed the carotenoid assignment above. DNA sequence analysis of the crtD genes from the brown transconjugants showed frameshifts at the extreme C-terminus, suggesting that this domain forms part of the active site. Spectral analysis of the dark pink strains showed an additional, non-natural double bond formed at the carotenoid end, yielding the asymmetric carotenoids, 3,4,3',4'-tetradehydrorhodopin - and 3',4'-didehydroanhydrorhodovibrin, each containing 14 conjugated double bonds. For only two dark pink strains, was a mutation in crtD detected, in both cases at the N-terminus of CrtD. Otherwise, the higher conjugation was ascribed to an elevated plasmid copy number. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Autenrieth, Caroline; Ghosh, Robin] Univ Stuttgart, Dept Bioenerget, Inst Biomat & Biomol Syst, D-70569 Stuttgart, Germany.
RP Autenrieth, C (reprint author), Univ Stuttgart, Dept Bioenerget, Inst Biomat & Biomol Syst, Pfaffenwaldring 57, D-70569 Stuttgart, Germany.
EM caroline.autenrieth@bio.uni-stuttgart.de
FU BMBF FORSYS-partner program [0315282]
FX We thank Katrin Wohlbold and Joachim Trinkner (Service Department of the
   Institute of Organic Chemistry, University of Stuttgart) for performing
   the mass spectroscopy measurements. The BMBF FORSYS-partner program
   (grant 0315282) is acknowledged for generous financial support.
CR DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X
   FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648
   SISTROM WR, 1960, J GEN MICROBIOL, V22, P778
   Albrecht M, 2000, NAT BIOTECHNOL, V18, P843, DOI 10.1038/78443
   Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347
   Wang GS, 2012, APPL ENVIRON MICROB, V78, P7205, DOI 10.1128/AEM.00545-12
   Takaichi Shinichi, 2009, V28, P97
   Bóna-Lovász Judit, 2013, Metabolites, V3, P912, DOI 10.3390/metabo3040912
   DAVIES BH, 1970, BIOCHEM J, V116, P93
   Fiedor L, 2004, BIOCHEMISTRY-US, V43, P16487, DOI 10.1021/bi0481587
   Garcia-Asua G, 2002, MOL MICROBIOL, V44, P233, DOI 10.1046/j.1365-2958.2002.02871.x
   HENNECKE H, 1982, GENE, V19, P231, DOI 10.1016/0378-1119(82)90011-7
   KARRASCH S, 1995, EMBO J, V14, P631
   Komori M, 1998, BIOCHEMISTRY-US, V37, P8987, DOI 10.1021/bi9730947
   Mohamed HE, 2004, J BACTERIOL, V186, P5621, DOI 10.1128/JB.186.17.5621.5628.2004
   SAEGESSER R, 1992, FEMS MICROBIOL LETT, V95, P7
   Sambrook J., 2001, MOL CLONING LAB MANU
   SCHWERZMANN RU, 1989, PLANT CELL PHYSIOL, V30, P497
   Stahlberg H, 1998, J MOL BIOL, V282, P819, DOI 10.1006/jmbi.1998.1975
   Steiger S, 2002, J BIOTECHNOL, V97, P51, DOI 10.1016/S0168-1656(02)00055-X
   Willetts N., 1984, METHOD MICROBIOL, V17, P33
NR 23
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 134
EP 141
DI 10.1016/j.abb.2015.01.023
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900018
PM 25655347
ER

PT J
AU Choi, J
   Oh, ET
   Koo, S
AF Choi, Jeongae
   Oh, Eun-Taek
   Koo, Sangho
TI A chain extension method for apocarotenoids; lycopene and lycophyll
   syntheses
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Carotenoids; Apocarotenoids; Julia-Kocienski olefination; Sulfone;
   Lycopene; Lycophyll
ID CAROTENOID NATURAL-PRODUCTS; MODIFIED JULIA OLEFINATION;
   (+)-THIAZINOTRIENOMYCIN E; EFFICIENT SYNTHESES; CARBONYL-COMPOUNDS;
   CAROTINOID-REIHE; VITAMIN-A; SULFONES; SULFIDES; ASTAXANTHIN
AB The novel C-5 benzothiazolyl (BT) sulfone containing an acetal group was prepared as a building block for the chain-extension of apocarotenoids. The double Julia-Kocienski olefination of the BT-sulfone with C-10 2,7-dimethy1-2,4,6-octatrienedial and deprotection of the resulting acetal groups efficiently produced C-20 crocetin dial. The higher homologues of C-30 and C-40 apocarotenoids were prepared from C-20 crocetin dial by the repeated application of the Julia-Kocienski olefination of the C-5 BT-sulfone and hydrolysis. The scopes of the Julia-Kocienski olefination in the total synthesis of carotenoid natural products were evaluated using the C-10 + C-20 + C-10 coupling protocol. The olefination was sensitive to the steric factor and bulky C-10 beta-cyclogeranyl BT-sulfone was not able to react with C-20 crocetin dial, however, lycopene and lycophyll were efficiently produced by the Julia-Kocienski olefination of C-10 geranyl BT-sulfone and hydroxygeranyl BT-sulfone, in which protection of the hydroxyl group was not necessary. (C) 201 5 Elsevier Inc. All rights reserved.
C1 [Choi, Jeongae; Koo, Sangho] Myong Ji Univ, Dept Energy & Biotechnol, Yongin 449728, Gyeonggi Do, South Korea.
   [Oh, Eun-Taek; Koo, Sangho] Myong Ji Univ, Dept Nano Sci & Engn, Yongin 449728, Gyeonggi Do, South Korea.
   [Koo, Sangho] Myong Ji Univ, Dept Chem, Yongin 449728, Gyeonggi Do, South Korea.
RP Koo, S (reprint author), Myong Ji Univ, Dept Chem, Myongji Ro 116, Yongin 449728, Gyeonggi Do, South Korea.
EM sangkoo@mju.ac.kr
FU National Research Foundation of Korea [2012R1A2A2A01045344,
   2009-0093816]
FX This research was supported by Basic Science Research Program (Grant No.
   2012R1A2A2A01045344) and by Priority Research Centers Program (Grant No.
   2009-0093816) both through the National Research Foundation of Korea.
CR ISLER O, 1956, HELV CHIM ACTA, V39, P463, DOI 10.1002/hlca.19560390217
   KRINSKY NI, 1994, PURE APPL CHEM, V66, P1003, DOI 10.1351/pac199466051003
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   ISLER O, 1956, HELV CHIM ACTA, V39, P249, DOI 10.1002/hlca.19560390128
   BAUDIN JB, 1991, TETRAHEDRON LETT, V32, P1175, DOI 10.1016/S0040-4039(00)92037-9
   Zeeshan M, 2012, ORG LETT, V14, P5496, DOI 10.1021/ol302577d
   Deming DM, 1999, PURE APPL CHEM, V71, P2213, DOI 10.1351/pac199971122213
   Trost BM, 2004, J AM CHEM SOC, V126, P12565, DOI 10.1021/ja048084p
   Ritz T, 2002, CHEMPHYSCHEM, V3, P243, DOI 10.1002/1439-7641(20020315)3:3<243::AID-CPHC243>3.0.CO;2-Y
   BALICKI R, 1993, J PRAK CHEM-CHEM ZTG, V335, P209, DOI 10.1002/prac.19933350218
   BERNHARD K, 1991, PURE APPL CHEM, V63, P35, DOI 10.1351/pac199163010035
   Blakemore PR, 2002, J CHEM SOC PERK T 1, P2563, DOI 10.1039/b208078h
   Cane D.E., 1999, COMPREHENSIVE NATURA, V2
   Charette AB, 2001, TETRAHEDRON LETT, V42, P5149, DOI 10.1016/S0040-4039(01)00941-8
   Choi E, 2008, ADV SYNTH CATAL, V350, P365, DOI 10.1002/adsc.200700484
   Choi HJ, 1999, J ORG CHEM, V64, P8051, DOI 10.1021/jo990987r
   Choi S, 2005, J ORG CHEM, V70, P3328, DOI 10.1021/jo0501011
   Choi S, 2001, J ORG CHEM, V66, P8192, DOI 10.1021/jo016013s
   ELETTIBIANCHI G, 1976, J ORG CHEM, V41, P1648, DOI 10.1021/jo00871a039
   Fontan N, 2013, CHEM COMMUN, V49, P2694, DOI 10.1039/c3cc38676g
   Frederico D, 2003, J ORG CHEM, V68, P9126, DOI 10.1021/jo034545y
   GIAM CS, 1981, ORG PREP PROCED INT, V13, P137
   Guha SK, 2005, J ORG CHEM, V70, P9662, DOI 10.1021/jo0516335
   ISLER O, 1979, PURE APPL CHEM, V51, P447, DOI 10.1351/pac197951030447
   Jackson HL, 2005, ORG PROCESS RES DEV, V9, P830, DOI 10.1021/op050137f
   Jeong YC, 2004, TETRAHEDRON, V60, P10181, DOI 10.1016/j.tet.2004.009.002
   Ji MK, 2001, ANGEW CHEM INT EDIT, V40, P3627, DOI 10.1002/1521-3773(20011001)40:19<3627::AID-ANIE3627>3.0.CO;2-E
   JULIA M, 1973, B SOC CHIM FR, P746
   JULIA M, 1973, B SOC CHIM FR, P743
   KARRER P, 1950, HELV CHIM ACTA, V33, P1349, DOI 10.1002/hlca.19500330534
   Kocienski PJ, 2000, SYNLETT, P365
   Kryshtal GV, 2012, TETRAHEDRON LETT, V53, P4971, DOI 10.1016/j.tetlet.2012.07.015
   Oh ET, 2014, J ORG CHEM, V79, P4712, DOI 10.1021/jo500478u
   OROSHNIK W, 1950, J AM CHEM SOC, V72, P4608, DOI 10.1021/ja01166a076
   PAUST J, 1991, PURE APPL CHEM, V63, P45, DOI 10.1351/pac199163010045
   POMMER H, 1960, ANGEW CHEM INT EDIT, V72, P911, DOI 10.1002/ange.19600722307
   Pommer H., 1977, ANGEW CHEM, V89, P437, DOI 10.1002/ange.19770890704
   Smith AB, 1999, ORG LETT, V1, P1491, DOI 10.1021/ol991049g
   Smith AB, 2000, J ORG CHEM, V65, P3738, DOI 10.1021/jo991958j
   Stahl W, 1997, CARCINOGENESIS, V18, P89, DOI 10.1093/carcin/18.1.89
   WIDMER E, 1985, PURE APPL CHEM, V57, P741, DOI 10.1351/pac198557050741
   Zeeshan M, 2012, TETRAHEDRON LETT, V53, P4522, DOI 10.1016/j.tetlet.2012.06.029
NR 42
TC 0
Z9 0
U1 6
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 142
EP 150
DI 10.1016/j.abb.2014.12.028
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900019
PM 25579882
ER

PT J
AU Tsuchida, K
   Sakudoh, T
AF Tsuchida, Kozo
   Sakudoh, Takashi
TI Recent progress in molecular genetic studies on the carotenoid transport
   system using cocoon-color mutants of the silkworm
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Selective transfer of carotenoid; Lipophorin receptor; CD36; SR-BI;
   START protein; Silkworm
ID LIPID TRANSFER PARTICLE; I SR-BI; REGULATORY PROTEIN STAR;
   LOW-DENSITY-LIPOPROTEIN; LUTEIN-BINDING PROTEIN; LARVAL MANDUCA-SEXTA;
   BOMBYX-MORI LARVAE; X-RAY-SCATTERING; FAT-BODY; DIACYLGLYCEROL EXCHANGE
AB The existence of tissue-specific delivery for certain carotenoids is supported by genetic evidence from the silkworm Bombyx mori and the identification of cocoon color mutant genes, such as Yellow blood (Y), Yellow cocoon (C), and Flesh cocoon (F). Mutants with white cocoons are defective in one of the steps involved in transporting carotenoids from the midgut lumen to the middle silk gland via the hemolymph lipoprotein, lipophorin, and the different colored cocoons are caused by the accumulation of specific carotenoids into the middle silk gland. The Y gene encodes carotenoid-binding protein (CBP), which is expected to function as the cytosolic transporter of carotenoids across the enterocyte and epithelium of the middle silk gland. The C and F genes encode the C locus-associated membrane protein, which is homologous to a mammalian high-density lipoprotein receptor-2 (Cameo2) and scavenger receptor class B member 15 (SCRB15), respectively: these membrane proteins are expected to function as non-internalizing lipophorin receptors in the middle silk gland. Cameo2 and SCRB15 belong to the cluster determinant 36 (CD36) family, with Cameo2 exhibiting specificity not only for lutein, but also for zeaxanthin and astaxanthin, while SCRB15 seems to have specificity toward carotene substrates such as alpha-carotene and beta-carotene. These findings suggest that Cameo2 and SCRB15 can discriminate the chemical structure of lutein and beta-carotene from circulating lipophorin during uptake. These data provide the first evidence that CD36 family proteins can discriminate individual carotenoid molecules in lipophorin. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Tsuchida, Kozo; Sakudoh, Takashi] Natl Inst Infect Dis, Div Radiol Protect & Biol, Shinjuku Ku, Tokyo 1628640, Japan.
RP Tsuchida, K (reprint author), Natl Inst Infect Dis, Div Radiol Protect & Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
EM kozo@niid.go.jp; sakudoh@niid.go.jp
CR SOULAGES JL, 1994, ADV PROTEIN CHEM, V45, P371
   During A, 2008, J LIPID RES, V49, P1715, DOI 10.1194/jlr.M700580-JLR200
   MoogLutz C, 1997, INT J CANCER, V71, P183, DOI 10.1002/(SICI)1097-0215(19970410)71:2<183::AID-IJC10>3.0.CO;2-J
   During A, 2005, J NUTR, V135, P2305
   Li BX, 2010, PHOTOCH PHOTOBIO SCI, V9, P1418, DOI 10.1039/c0pp00126k
   Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104
   Tabunoki H, 2004, FEBS LETT, V567, P175, DOI 10.1016/j.febslet.2004.04.067
   Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006
   Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193
   Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI14006
   Bhosale P, 2009, BIOCHEMISTRY-US, V48, P4798, DOI 10.1021/bi9004478
   During A, 2002, J LIPID RES, V43, P1086, DOI 10.1194/jlr.M200068-JLR200
   Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485
   Voolstra O, 2006, BIOCHEMISTRY-US, V45, P13429, DOI 10.1021/bi060701u
   [Anonymous], 1908, NATURE, V79, P265
   Tabunoki H, 2002, J BIOL CHEM, V277, P32133, DOI 10.1074/jbc.M204507200
   Shen WJ, 2014, METABOLISM, V63, P875, DOI 10.1016/j.metabol.2014.03.011
   [Anonymous], 1917, NATURE, V99, P174
   Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408
   Li BX, 2011, BIOCHEMISTRY-US, V50, P2541, DOI 10.1021/bi101906y
   Ryan RO, 2000, ANNU REV ENTOMOL, V45, P233, DOI 10.1146/annurev.ento.45.1.233
   CLARK BJ, 1994, J BIOL CHEM, V269, P28314
   Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200
   Li BX, 2014, P NATL ACAD SCI USA, V111, P10173, DOI 10.1073/pnas.1402526111
   Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8
   Neculai D, 2013, NATURE, V504, P172, DOI 10.1038/nature12684
   Tamura T, 2000, NAT BIOTECHNOL, V18, P81
   Imamura M, 2003, GENETICS, V165, P1329
   RYAN RO, 1988, J BIOL CHEM, V263, P14140
   Banno Y, 2010, EXP ANIM TOKYO, V59, P139
   BLACKLOCK BJ, 1995, J LIPID RES, V36, P108
   Canavoso LE, 2004, J LIPID RES, V45, P456, DOI 10.1194/jlr.M300242-JLR200
   Canavoso LE, 2001, INSECT BIOCHEM MOLEC, V31, P783, DOI 10.1016/S0965-1748(00)00183-1
   Chai CL, 2014, GENE, V534, P119, DOI 10.1016/j.gene.2013.10.030
   CHINO H, 1969, BIOCHIM BIOPHYS ACTA, V176, P1
   CHINO H, 1964, SCIENCE, V143, P359, DOI 10.1126/science.143.3604.359
   Cleghorn M. L., 1918, P ZOOL SOC LOND 1, V12, P133
   During A., 2007, J LIPID RES, V48, P2284
   FERNANDOWARNAKULASURIYA GJP, 1988, INSECT BIOCHEM, V18, P211, DOI 10.1016/0020-1790(88)90025-X
   Fruttero LL, 2011, J INSECT PHYSIOL, V57, P475, DOI 10.1016/j.jinsphys.2011.01.009
   FUJII H, 1988, Journal of Sericultural Science of Japan, V57, P94
   FUJII H, 1988, Journal of Sericultural Science of Japan, V57, P398
   Fujimoto N., 1949, J SERIC SCI JAP, V18, P82
   Fujimoto N., 1949, J SERIC SCI JPN, V18, P73
   Hanada Y, 2011, J BIOL CHEM, V286, P39360, DOI 10.1074/jbc.M111.278416
   Hara Wajiro, 2007, Journal of Insect Biotechnology and Sericology, V76, P149
   Harizuka M., 1948, J SERIC SCI JAP, V17, P1
   Harizuka M., 1956, J SERIC SCI JPN, V25, P152
   HARIZUKA MASAKI, 1953, BULL SERICUL EXPT STA [JAPAN], V14, P141
   Harizuka M., 1940, J SERIC SCI JPN, V11, P267
   Herboso L, 2011, INT J DEV BIOL, V55, P603, DOI 10.1387/ijdb.103254lh
   HIRAYAMA Y, 1990, J LIPID RES, V31, P793
   Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI 10.1016/j.ibmb.2008.11.004
   Jouni ZE, 2003, INSECT BIOCHEM MOLEC, V33, P145, DOI 10.1016/S0965-1748(02)00102-9
   Jouni ZE, 1996, J BIOL CHEM, V271, P14722
   KATAGIRI C, 1991, BIOCHEMISTRY-US, V30, P9675, DOI 10.1021/bi00104a015
   KATAGIRI C, 1985, J BIOL CHEM, V260, P3490
   KATAGIRI C, 1987, J BIOL CHEM, V262, P15857
   Kellogg V. L., 1908, U SER, V1, P89
   Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899
   LAW JH, 1992, ANNU REV BIOCHEM, V61, P87
   Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003
   Niu Yan-Shan, 2010, Yichuan, V32, P942, DOI 10.3724/SP.J.1005.2010.00942
   Palm W, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002828
   Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554
   RYAN RO, 1990, J BIOL CHEM, V265, P10551
   RYAN RO, 1986, BIOCHEM BIOPH RES CO, V136, P260, DOI 10.1016/0006-291X(86)90903-4
   RYAN RO, 1988, BIOCHIM BIOPHYS ACTA, V962, P143, DOI 10.1016/0005-2760(88)90105-1
   RYAN RO, 1990, J BIOL CHEM, V265, P546
   Sakudoh T, 2010, CAROTENOIDS: PHYSICAL, CHEMICAL, AND BIOLOGICAL FUNCTIONS AND PROPERTIES, P511
   Sakudoh T, 2005, BIOCHEM BIOPH RES CO, V336, P1125, DOI 10.1016/j.bbrc.2005.08.241
   Sakudoh T, 2010, J BIOL CHEM, V285, P7739, DOI 10.1074/jbc.M109.074435
   Sakudoh T, 2013, J LIPID RES, V54, P482, DOI 10.1194/jlr.M032771
   Sakudoh T, 2011, GENETICS, V187, P965, DOI 10.1534/genetics.110.124982
   SINGH TKA, 1992, J BIOL CHEM, V267, P9275
   SOULAGES JL, 1991, J LIPID RES, V32, P407
   Sundermeyer K, 1996, INSECT BIOCHEM MOLEC, V26, P735, DOI 10.1016/S0965-1748(96)00060-4
   Takeuchi N., 1993, J LIPID RES, V34, P543
   Tanaka Y., 1916, J COLL AGR TOHOKU IM, V7, P129
   Tanaka Y., 1913, J COLL AGR TOHOKU IM, V4, P1
   Tazima Y., 1964, GENETICS SILKWORM
   Tazima Y., 1978, SILKWORM IMPORTANT L
   Toyama K., 1906, BIOL ZBL, V26, P320
   Toyama K., 1906, B COLL AGR TOKYO U, V7, P259
   Tsuchida K, 2004, J INSECT PHYSIOL, V50, P363, DOI 10.1016/j.jinphys.2004.02.006
   Tsuchida K, 2004, J INSECT PHYSIOL, V50, P975, DOI 10.1016/j.jinsphys.2004.08.001
   TSUCHIDA K, 1988, INSECT BIOCHEM, V18, P263, DOI 10.1016/0020-1790(88)90090-X
   Tsuchida K, 1998, INSECT BIOCHEM MOLEC, V28, P927, DOI 10.1016/S0965-1748(98)00036-8
   Tsuchida K, 1997, BBA-PROTEIN STRUCT M, V1337, P57, DOI 10.1016/S0167-4838(96)00149-5
   Uda H, 1919, GENETICS, V4, P395
   VANHEUSDEN MC, 1989, J BIOL CHEM, V264, P17287
   Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086594
   WEERS PMM, 1993, J BIOL CHEM, V268, P4300
   Yoda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5936
   Yokoyama H, 2013, J LIPID RES, V54, P2379, DOI 10.1194/jlr.M037093
   Yuasa M., 2014, Journal of Insect Biotechnology and Sericology, V83, P1
NR 96
TC 0
Z9 0
U1 10
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 151
EP 157
DI 10.1016/j.abb.2014.12.029
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900020
PM 25579881
ER

PT J
AU Horibe, T
   Qian, P
   Hunter, CN
   Hashimoto, H
AF Horibe, Tomoko
   Qian, Pu
   Hunter, C. Neil
   Hashimoto, Hideki
TI Stark absorption spectroscopy on the carotenoids bound to B800-820 and
   B800-850 type LH2 complexes from a purple photosynthetic bacterium,
   Phaeospirillum molischianum strain DSM120
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Stark absorption spectroscopy; Carotenoids; B800-820 LH2 complex;
   B800-850 LH2 complex; Purple photosynthetic bacteria
ID LIGHT-HARVESTING COMPLEX; BACTERIOCHLOROPHYLL BINDING-SITE;
   RHODOBACTER-SPHAEROIDES; RHODOSPIRILLUM-MOLISCHIANUM; CRYSTAL-STRUCTURE;
   DIRECTED MUTANTS; BETA-CAROTENE; ANTENNA; CONFORMATION; XANTHOPHYLLS
AB Stark absorption spectroscopy was applied to clarify the structural differences between carotenoids bound to the B800-820 and B800-850 LH2 complexes from a purple photosynthetic bacterium Phaeospirillum (Phs.) molischianum DSM120. The former complex is produced when the bacteria are grown under stressed conditions of low temperature and dim light. These two LH2 complexes bind carotenoids with similar composition, 10% lycopene and 80% rhodopin, each with the same number of conjugated C=C double bonds (n = 11). Quantitative classical and semi-quantum chemical analyses of Stark absorption spectra recorded in the carotenoid absorption region reveal that the absolute values of the difference dipole moments vertical bar Delta mu vertical bar have substantial differences (2 [D/f]) for carotenoids bound to either B800-820 or B800-850 complexes. The origin of this striking difference in the vertical bar Delta mu vertical bar values was analyzed using the X-ray crystal structure of the B800-850 LH2 complex from Phs. molischianum DSM119. Semi-empirical molecular orbital calculations predict structural deformations of the major carotenoid, rhodopin, bound within the B800-820 complex. We propose that simultaneous rotations around neighboring C=C and C-C bonds account for the differences in the 2 [D/f] of the vertical bar Delta mu vertical bar value. The plausible position of the rotation is postulated to be located around C21-C24 bonds of rhodopin. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Horibe, Tomoko; Hashimoto, Hideki] Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, Osaka 5588585, Japan.
   [Qian, Pu; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.
   [Hashimoto, Hideki] Osaka City Univ, Adv Res Inst Nat Sci & Technol OCARINA, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Hashimoto, H (reprint author), Osaka City Univ, Adv Res Inst Nat Sci & Technol OCARINA, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
EM hassy@ocarina.osaka-cu.ac.jp
FU CREST from Japan Science and Technology Agency; Japan Society for the
   Promotion of Science (JSPS) [24107002]; Biotechnology and Biological
   Sciences Research Council (UK)
FX This work is financially supported by CREST from Japan Science and
   Technology Agency. H.H. thanks for the financial support of Scientific
   Research on Innovative Areas "All Nippon Artificial photosynthesis
   Project for Living Earth (An Apple)" (No. 24107002) from the Japan
   Society for the Promotion of Science (JSPS). P.Q. and C.N.H. acknowledge
   financial support from the Biotechnology and Biological Sciences
   Research Council (UK).
CR Mizoguchi T, 2008, PHOTOCH PHOTOBIO SCI, V7, P492, DOI 10.1039/b719272j
   Polivka T, 2010, ACCOUNTS CHEM RES, V43, P1125, DOI 10.1021/ar100030m
   Cogdell RJ, 2000, PHILOS T ROY SOC B, V355, P1345
   Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050
   Bublitz GU, 1997, ANNU REV PHYS CHEM, V48, P213, DOI 10.1146/annurev.physchem.48.1.213
   Fowler GJS, 1997, BIOCHEMISTRY-US, V36, P11282, DOI 10.1021/bi9626315
   Nakagawa K, 2008, J PHYS CHEM B, V112, P9467, DOI 10.1021/jp801773j
   GOTTFRIED DS, 1991, BIOCHIM BIOPHYS ACTA, V1059, P63, DOI 10.1016/S0005-2728(05)80188-4
   Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   FOWLER GJS, 1992, NATURE, V355, P848, DOI 10.1038/355848a0
   Papiz MZ, 2003, J MOL BIOL, V326, P1523, DOI 10.1016/S0022-2836(03)00024-X
   Hashimoto H, 2002, J MOL STRUCT, V604, P125, DOI 10.1016/S0022-2860(01)00648-2
   Fraser NJ, 2001, PHOTOSYNTH RES, V70, P249, DOI 10.1023/A:1014715114520
   Yanagi K, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.195118
   Premvardhan L, 2005, J PHYS CHEM B, V109, P15589, DOI 10.1021/jp052027g
   Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9
   Cogdell RJ, 2012, PHILOS T R SOC A, V370, P3819, DOI 10.1098/rsta.2011.0422
   MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0
   Yanagi K, 2005, J PHYS CHEM B, V109, P992, DOI 10.1021/jp046929d
   COGDELL RJ, 1987, BIOCHIM BIOPHYS ACTA, V895, P63, DOI 10.1016/S0304-4173(87)80008-3
   CRIELAARD W, 1994, BBA-BIOENERGETICS, V1183, P473, DOI 10.1016/0005-2728(94)90074-4
   FOWLER GJS, 1994, BIOCHEM J, V299, P695
   Fujii R, 2001, J LUMIN, V92, P213, DOI 10.1016/S0022-2313(00)00260-X
   Fujii R, 1998, SPECTROCHIM ACTA A, V54, P727, DOI 10.1016/S1386-1425(98)00011-0
   Gall A, 1997, BIOCHEMISTRY-US, V36, P16282, DOI 10.1021/bi9717237
   Garcia-Martin A, 2008, J MOL BIOL, V382, P154, DOI 10.1016/j.jmb.2008.07.002
   Georgakopoulou S, 2004, BIOPHYS J, V87, P3010, DOI 10.1529/biophysj.104.047498
   GOTTFRIED DS, 1991, BIOCHIM BIOPHYS ACTA, V1059, P76, DOI 10.1016/S0005-2728(05)80189-6
   Green B. R., 2003, LIGHT HARVESTING ANT
   Hashimoto H, 2001, J PHYS-CONDENS MAT, V13, pL529, DOI 10.1088/0953-8984/13/23/101
   INAGAKI F, 1974, J MOL SPECTROSC, V50, P286, DOI 10.1016/0022-2852(74)90236-7
   KRAWCZYK S, 1995, CHEM PHYS LETT, V236, P431, DOI 10.1016/0009-2614(95)00251-X
   Kusumoto T, 2010, CHEM PHYS, V373, P71, DOI 10.1016/j.chemphys.2010.01.018
   Liptay W., 1974, EXCITED STATES, V1, P129
   Maoka T., 2003, FOODS FOOD INGREDIEN, V208, P623
   Mascle-Allemand C, 2010, P NATL ACAD SCI USA, V107, P5357, DOI 10.1073/pnas.0914854107
   McLuskey K, 2001, BIOCHEMISTRY-US, V40, P8783, DOI 10.1021/bi010309a
   Phillip D, 2002, J BIOL CHEM, V277, P25160, DOI 10.1074/jbc.M202002200
   Sauer PRR, 1996, BIOCHEMISTRY-US, V35, P6500, DOI 10.1021/bi9528255
   VISSCHERS RW, 1995, BBA-BIOENERGETICS, V1230, P147, DOI 10.1016/0005-2728(95)00046-L
   VISSCHERS RW, 1994, BBA-BIOENERGETICS, V1183, P483, DOI 10.1016/0005-2728(94)90075-2
   Wang YL, 2002, J AM CHEM SOC, V124, P8445, DOI 10.1021/ja025618l
   Yanagi K, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.205103
   Yanagi K, 2004, J PHYS CHEM B, V108, P10334, DOI 10.1021/jp037863+
   Yanagi K, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.115122
   Young AJ, 2002, J MOL STRUCT, V642, P137, DOI 10.1016/S0022-2860(02)00444-1
   Zhang Y., 2008, BMC BIOINFORMATICS, V9
NR 48
TC 0
Z9 0
U1 8
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 158
EP 166
DI 10.1016/j.abb.2014.12.015
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900021
PM 25536050
ER

PT J
AU Focsan, AL
   Magyar, A
   Kispert, LD
AF Focsan, A. Ligia
   Magyar, Adam
   Kispert, Lowell D.
TI Chemistry of carotenoid neutral radicals
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Carotenoid neutral radicals; Quenching; Zeaxanthin radical cation;
   Photoprotection
ID ELECTRON-PARAMAGNETIC-RESONANCE; LIGHT-HARVESTING COMPLEXES; PROTON
   HYPERFINE COUPLINGS; DENSITY-FUNCTIONAL THEORY; NUCLEAR
   DOUBLE-RESONANCE; BETA-GLYCYRRHIZIC ACID; I=1/2 SPIN SYSTEMS; CATION
   RADICALS; MOLECULAR-SIEVES; SILICA-ALUMINA
AB Proton loss from the carotenoid radical cations (Car) to form neutral radicals (#Car) was investigated by numerous electrochemical, EPR, ENDOR and DFT studies described herein. The radical cation and neutral radicals were formed in solution electrochemically and stabilized on solid silica-alumina and MCM-41 matrices. Carotenoid neutral radicals were recently identified in Arabidopsis thaliana plant and photosystem II samples. Deprotonation at the terminal ends of a zeaxanthin radical cation could provide a secondary photoprotection pathway which involves quenching excited state chlorophyll by the long-lived zeaxanthin neutral radicals formed. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Focsan, A. Ligia] Valdosta State Univ, Dept Chem, Valdosta, GA 31698 USA.
   [Magyar, Adam; Kispert, Lowell D.] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA.
RP Focsan, AL (reprint author), Valdosta State Univ, Dept Chem, Valdosta, GA 31698 USA.
EM alfocsan@valdosta.edu
FU Chemical Sciences, Geosciences and Biosciences Division, Office of Basic
   Sciences, United States Department of Energy [DEFG02-86ER-13465];
   Natural Science Foundation [CHE-0342921, CHE-0079498]; Faculty Research
   Seed Grants (FRSG) Program at Valdosta State University
FX We thank Prof. Michael Bowman (UA) for extensive discussions on
   photoprotection. This work was supported by The Chemical Sciences,
   Geosciences and Biosciences Division, Office of Basic Sciences, United
   States Department of Energy, Grant DEFG02-86ER-13465 that provided the
   RA support for Adam Magyar, summer stipend for L.D.K. and laboratory
   supplies, and by the Natural Science Foundation for EPR instrument
   Grants CHE-0342921 and CHE-0079498. This work was also supported by
   Faculty Research Seed Grants (FRSG) Program at Valdosta State University
   for A. L. F.
CR Amarie S, 2009, BBA-BIOENERGETICS, V1787, P747, DOI 10.1016/j.bbabio.2009.02.006
   Liu DZ, 2000, J ELECTROANAL CHEM, V488, P140, DOI 10.1016/S0022-0728(00)00205-9
   Hapiot PF, 2001, J AM CHEM SOC, V123, P6669, DOI 10.1021/ja0106063
   Konovalova TA, 2001, J PHYS CHEM B, V105, P7459, DOI 10.1021/jp0108519
   Polyakov NE, 2013, J PHYS CHEM B, V117, P10173, DOI 10.1021/jp4062708
   JEEVARAJAN AS, 1994, J PHYS CHEM-US, V98, P7777, DOI 10.1021/j100083a006
   Hideg E, 2002, PLANT CELL PHYSIOL, V43, P1154, DOI 10.1093/pcp/pcf145
   Polyakov NE, 2004, FREE RADICAL BIO MED, V36, P872, DOI 10.1016/j.freeradbiomed.2004.12.009
   Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262
   Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800
   Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200
   Kim CH, 2010, J PHYS CHEM A, V114, P5618, DOI 10.1021/jp909438p
   Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008
   Kim CH, 2009, PHYS CHEM CHEM PHYS, V11, P10266, DOI 10.1039/b915768a
   Gao YL, 2002, J PHYS CHEM B, V106, P10808, DOI 10.1021/jp025978s
   Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200
   Barbatti M, 2009, PHYS CHEM CHEM PHYS, V11, P1406, DOI 10.1039/b814255f
   Jeevarajan JA, 1996, J PHYS CHEM-US, V100, P5637, DOI 10.1021/jp9530663
   Polyakov NE, 2009, J PHYS CHEM B, V113, P275, DOI 10.1021/jp805531q
   GREEN JA, 1973, J CHEM PHYS, V58, P2690, DOI 10.1063/1.1679569
   Gao YL, 2006, J PHYS CHEM B, V110, P24750, DOI 10.1021/jp0643707
   Jeevarajan JA, 1996, J ELECTROANAL CHEM, V411, P57, DOI 10.1016/0022-0728(96)04572-X
   Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833
   FORMOSINHO SJ, 1993, J PHOTOCH PHOTOBIO A, V75, P21, DOI 10.1016/1010-6030(93)80158-6
   Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044
   Polyakov NE, 2006, FREE RADICAL BIO MED, V40, P1804, DOI 10.1016/j.freeradbiomed.2006.01.015
   Kispert LD, 2010, CHEM LETT, V39, P148, DOI 10.1246/cl.2010.148
   Deng Y, 2000, J PHYS CHEM B, V104, P5651, DOI 10.1021/jp994436g
   DIKANOV SA, 1995, J MAGN RESON SER A, V116, P125, DOI 10.1006/jmra.1995.1199
   Dikanov SA, 1998, J BIOL INORG CHEM, V3, P18, DOI 10.1007/s007750050204
   Dikanov SA, 2000, J MAGN RESON, V144, P228, DOI 10.1006/jmre.2000.2055
   DING R, 1988, J PHYS CHEM-US, V92, P4600, DOI 10.1021/j100327a010
   Focsan AL, 2009, J PHYS CHEM B, V113, P6087, DOI 10.1021/jp810604s
   Focsan AL, 2014, J PHYS CHEM B, V118, P2331, DOI 10.1021/jp4121436
   Focsan AL, 2011, J PHYS CHEM B, V115, P9495, DOI 10.1021/jp204787b
   Focsan AL, 2012, J PHYS CHEM B, V116, P13200, DOI 10.1021/jp307421e
   Focsan AL, 2008, J PHYS CHEM B, V112, P1806, DOI 10.1021/jp0765650
   Gao FG, 2000, J PHOTOCH PHOTOBIO A, V130, P49, DOI 10.1016/S1010-6030(99)00193-8
   Gao G, 1996, J ELECTROANAL CHEM, V411, P51, DOI 10.1016/0022-0728(96)04573-1
   Gao GQ, 1999, J CHEM SOC PERK T 2, P1225, DOI 10.1039/a809706b
   Gao GQ, 1997, J PHYS CHEM B, V101, P2038, DOI 10.1021/jp963741o
   Gao Y., 2004, RECENT RESEARCH DEVE, V7, P63
   Gao YL, 2005, J PHYS CHEM B, V109, P18289, DOI 10.1021/jp052550v
   Gao YL, 2009, J PHYS CHEM B, V113, P9901, DOI 10.1021/jp8075832
   Gao YL, 2003, J PHYS CHEM B, V107, P2459, DOI 10.1021/jp027164h
   GRANT JL, 1988, J AM CHEM SOC, V110, P2151, DOI 10.1021/ja00215a025
   Hasjim PL, 2010, CHEMPHYSCHEM, V11, P1258, DOI 10.1002/cphc.200900896
   Hasjim PL, 2010, J PHYS CHEM LETT, V1, P1687, DOI 10.1021/jz100471z
   He ZF, 1999, J PHYS CHEM B, V103, P10524, DOI 10.1021/jp991904d
   He ZF, 1999, J PHYS CHEM B, V103, P9038, DOI 10.1021/jp992167o
   JEEVARAJAN AS, 1993, CHEM PHYS LETT, V209, P269, DOI 10.1016/0009-2614(93)80106-Y
   JEEVARAJAN AS, 1993, Z PHYS CHEM, V182, P51
   JEEVARAJAN AS, 1994, J CHEM SOC PERK T 2, P861, DOI 10.1039/p29940000861
   Jeevarajan JA, 1996, J CHEM SOC FARADAY T, V92, P1757, DOI 10.1039/ft9969201757
   Kevan L., 1976, ELECTRON SPIN DOUBLE
   KHALED M, 1990, J PHYS CHEM-US, V94, P5164, DOI 10.1021/j100375a072
   KHALED M, 1991, J PHYS CHEM-US, V95, P2438, DOI 10.1021/j100159a060
   Kispert L. D., 2009, CAROTENOIDS PHYS CHE, P159, DOI 10.1201/9781420052312-c9
   Kispert L. D., 2006, HANDBOOK OF APPLIED
   Kispert LD, 2004, ARCH BIOCHEM BIOPHYS, V430, P49, DOI 10.1016/j.abb.2004.03.036
   Kolbasoy D, 2003, J PHYS CHEM B, V107, P2386, DOI 10.1021/jp0265079
   Konovalov V.V., 2002, ORGANIC ELECTROCHEMI, P93
   Konovalova TA, 2009, J PHYS CHEM B, V113, P8704, DOI 10.1021/jp811369h
   Konovalova TA, 2004, J PHYS CHEM B, V108, P11820, DOI 10.1021/jp0313425
   Konovalova TA, 1997, J PHYS CHEM B, V101, P7858, DOI 10.1021/jp9708761
   Konovalova TA, 2003, J PHYS CHEM B, V107, P1006, DOI 10.1021/jp021565f
   Konovalova TA, 2001, J PHYS CHEM B, V105, P8361, DOI 10.1021/jp010960n
   Konovalova TA, 1998, J CHEM SOC FARADAY T, V94, P1465, DOI 10.1039/a709049h
   Konovalova TA, 1999, J PHYS CHEM B, V103, P5782, DOI 10.1021/jp990579r
   Lawrence J, 2008, J PHYS CHEM B, V112, P5449, DOI 10.1021/jp711310u
   Liu D., 1999, RECENT RES DEV ELECT, V2, P139
   Liu DZ, 2002, J PHYS CHEM B, V106, P2933, DOI 10.1021/jp011876a
   Liu DZ, 2001, J PHYS CHEM B, V105, P975, DOI 10.1021/jp0022860
   Magyar A, 2013, J PHYS CHEM B, V117, P2239, DOI 10.1021/jp306387e
   NORRIS JR, 1975, ANN NY ACAD SCI, V244, P260, DOI 10.1111/j.1749-6632.1975.tb41535.x
   Ostafin AE, 2003, PHOTOSYNTH RES, V77, P53, DOI 10.1023/A:1024921115267
   Petrenko A, 2005, CHEM PHYS LETT, V406, P327, DOI 10.1016/j.cplett.2005.03.012
   PIEKARASADY L, 1995, J CHEM SOC FARADAY T, V91, P2881, DOI 10.1039/ft9959102881
   PIEKARASADY L, 1991, CHEM PHYS LETT, V186, P143, DOI 10.1016/S0009-2614(91)85120-L
   PIEKARASADY L, 1993, CHEM PHYS LETT, V207, P173, DOI 10.1016/0009-2614(93)87010-Z
   Polyakov N., 2010, NSTI NANOTECH, V3, P312
   Polyakov NE, 2004, J PHOTOCH PHOTOBIO A, V161, P261, DOI 10.1016/j.nainr.2003.08.007
   Polyakov NE, 2009, NUTR DIET RES PROG, P191
   Polyakov NE, 2002, J PHOTOCH PHOTOBIO A, V153, P113, DOI 10.1016/S1010-6030(02)00267-8
   Polyakov NE, 2001, J PHOTOCH PHOTOBIO A, V141, P117, DOI 10.1016/S1010-6030(01)00429-4
   Polyakov NE, 2001, FREE RADICAL BIO MED, V31, P398, DOI 10.1016/S0891-5849(01)00598-6
   Polyakov NE, 2006, J PHYS CHEM B, V110, P6991, DOI 10.1021/jp0560381
   Polyakov NE, 2010, J PHYS CHEM B, V114, P16968, DOI 10.1021/jp109039v
   Polyakov NE, 2001, FREE RADICAL BIO MED, V31, P43, DOI 10.1016/S0891-5849(01)00547-0
   Srivatsan N, 2003, J PHYS CHEM B, V107, P7867, DOI 10.1021/jp027736y
   Srivatsan N, 2003, J PHYS CHEM B, V107, P2127, DOI 10.1021/jp0255233
   Srivatsan N, 2001, J PHYS CHEM B, V105, P12391, DOI 10.1021/jp011676z
   WU Y, 1991, CHEM PHYS LETT, V180, P573, DOI 10.1016/0009-2614(91)85012-L
NR 93
TC 0
Z9 0
U1 5
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 167
EP 174
DI 10.1016/j.abb.2015.02.005
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900022
ER

PT J
AU Beck, WF
   Bishop, MM
   Roscioli, JD
   Ghosh, S
   Frank, HA
AF Beck, Warren F.
   Bishop, Michael M.
   Roscioli, Jerome D.
   Ghosh, Soumen
   Frank, Harry A.
TI Excited state conformational dynamics in carotenoids: Dark intermediates
   and excitation energy transfer
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Carotenoids; Chlorophylls; Energy transfer; Photosynthesis;
   Radiationless decay
ID PERIDININ-CHLOROPHYLL-PROTEIN; TRANSIENT GRATING SPECTROSCOPY;
   LIGHT-HARVESTING COMPLEXES; DIFFRACTIVE OPTICS METHOD; STOKES-RAMAN
   SCATTERING; CONICAL INTERSECTIONS; ABSORPTION-SPECTROSCOPY;
   AMPHIDINIUM-CARTERAE; PURPLE BACTERIA; BETA-CAROTENE
AB A consideration of the excited state potential energy surfaces of carotenoids develops a new hypothesis for the nature of the conformational motions that follow optical preparation of the S-2 (1(1)B(u)(+)) state. After an initial displacement from the Franck-Condon geometry along bond length alternation coordinates, it is suggested that carotenoids pass over a transition-state barrier leading to twisted conformations. This hypothesis leads to assignments for several dark intermediate states encountered in femtosecond spectroscopic studies. The Sx state is assigned to the structure reached upon the onset of torsional motions near the transition state barrier that divides planar and twisted structures on the S-2 state potential energy surface. The X state, detected recently in two-dimensional electronic spectra, corresponds to a twisted structure well past the barrier and approaching the S-2 state torsional minimum. Lastly, the S-x state is assigned to a low lying S-1 state structure with intramolecular charge transfer character (ICT) and a pyramidal conformation. It follows that the bent and twisted structures of carotenoids that are found in photosynthetic light-harvesting proteins yield excited-state structures that favor the development of an ICT character and optimized energy transfer yields to (bacterio)chlorophyll acceptors. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Beck, Warren F.; Bishop, Michael M.; Roscioli, Jerome D.; Ghosh, Soumen; Frank, Harry A.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
RP Beck, WF (reprint author), Michigan State Univ, Dept Chem, 578 S Shaw Lane, E Lansing, MI 48824 USA.
EM beckw@msu.edu
RI Ghosh, Soumen/O-2091-2015
FU Photosynthetic Systems Program of Chemical Sciences, Geosciences and
   Biosciences Division, Office of Basic Energy Sciences, Office of
   Science, U.S. Department of Energy [DE-SC0010847]; National Science
   Foundation [MCB-1243565]; University of Connecticut Research Foundation
FX This work was supported by the Photosynthetic Systems Program of
   Chemical Sciences, Geosciences and Biosciences Division, Office of Basic
   Energy Sciences, Office of Science, U.S. Department of Energy under
   Award Number DE-SC0010847. Work in the laboratory of HAF is supported by
   grants from the National Science Foundation (MCB-1243565) and the
   University of Connecticut Research Foundation. We thank Professor
   Benjamin Levine (Michigan State University) for several helpful
   discussions.
CR Frank HA, 2000, J PHYS CHEM B, V104, P4569, DOI 10.1021/jp000079u
   Niedzwiedzki D, 2007, J PHYS CHEM B, V111, P5984, DOI 10.1021/jp070500f
   ORLANDI G, 1979, J AM CHEM SOC, V101, P3492, DOI 10.1021/ja00507a012
   Cong H, 2008, J PHYS CHEM B, V112, P10689, DOI 10.1021/jp711946w
   Malhado JP, 2011, J PHYS CHEM A, V115, P3720, DOI 10.1021/jp106096m
   Christensson N, 2009, J PHYS CHEM B, V113, P16409, DOI 10.1021/jp906604j
   Kosumi D, 2006, CHEM PHYS LETT, V425, P66, DOI 10.1016/j.cplett.2006.05.023
   Lukes V, 2011, CHEM PHYS LETT, V506, P122, DOI 10.1016/j.cplett.2011.02.060
   HOHLNEICHER G, 1984, J PHOTOCHEM, V27, P215, DOI 10.1016/0047-2670(84)85039-X
   Garavelli M, 1999, J AM CHEM SOC, V121, P1023, DOI 10.1021/ja981719y
   Dietzek B, 2007, J PHYS CHEM B, V111, P4520, DOI 10.1021/jp066471a
   Ostroumov EE, 2013, J PHYS CHEM B, V117, P11349, DOI 10.1021/jp403028x
   Vaswani HM, 2003, J PHYS CHEM B, V107, P7940, DOI 10.1021/jp030086t
   OLIVUCCI M, 1993, J AM CHEM SOC, V115, P3710, DOI 10.1021/ja00062a042
   Fuss W, 2000, CHEM PHYS, V259, P273, DOI 10.1016/S0301-0104(00)00200-7
   Shima S, 2003, J PHYS CHEM A, V107, P8052, DOI 10.1021/jp022648z
   Cerullo G, 2002, SCIENCE, V298, P2395, DOI 10.1126/science.1074685
   ANDERSSON PO, 1995, J CHEM PHYS, V103, P2509, DOI 10.1063/1.469672
   Kosumi D, 2014, J PHYS CHEM LETT, V5, P792, DOI 10.1021/jz5000287
   Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429
   WALDECK DH, 1991, CHEM REV, V91, P415, DOI 10.1021/cr00003a007
   Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811
   de Weerd FL, 2002, CHEM PHYS LETT, V354, P38, DOI 10.1016/S0009-2614(02)00095-7
   Xu QH, 2002, J CHEM PHYS, V116, P9333, DOI 10.1063/1.1473653
   SHREVE AP, 1992, J LUMIN, V53, P179, DOI 10.1016/0022-2313(92)90133-T
   ABERG U, 1994, CHEM PHYS, V183, P269, DOI 10.1016/0301-0104(94)00022-0
   Ruiz DS, 2002, PHOTOCHEM PHOTOBIOL, V76, P622
   Kosumi D, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3147008
   Fleming GR, 2004, NATURE, V431, P256, DOI 10.1038/431256a
   Niedzwiedzki DM, 2009, CHEM PHYS, V357, P4, DOI 10.1016/j.chemphys.2008.07.011
   Levine BG, 2006, MOL PHYS, V104, P1039, DOI 10.1080/00268970500417762
   Papiz MZ, 2003, J MOL BIOL, V326, P1523, DOI 10.1016/S0022-2836(03)00024-X
   YARTSEV A, 1995, CHEM PHYS LETT, V243, P281, DOI 10.1016/0009-2614(95)00858-2
   Sanchez-Galvez A, 2000, J AM CHEM SOC, V122, P2911, DOI 10.1021/ja993985x
   Xu QH, 2001, J PHYS CHEM A, V105, P10187, DOI 10.1021/jp011924r
   Pang Y, 2010, J AM CHEM SOC, V132, P2264, DOI 10.1021/ja908472y
   Polivka T, 2009, CHEM PHYS LETT, V477, P1, DOI 10.1016/j.cplett.2009.06.011
   Frank HA, 1997, J PHYS CHEM A, V101, P149, DOI 10.1021/jp962373l
   Wohlleben W, 2003, BIOPHYS J, V85, P442
   Garavelli M, 1997, J AM CHEM SOC, V119, P6891, DOI 10.1021/ja9610895
   Weigel A, 2012, PHYS CHEM CHEM PHYS, V14, P13350, DOI 10.1039/c2cp41522d
   Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142
   Niedzwiedzki DM, 2006, J PHYS CHEM B, V110, P22872, DOI 10.1021/jp0622738
   Levine BG, 2009, J PHYS CHEM A, V113, P12815, DOI 10.1021/jp907111u
   Scholes GD, 2000, J PHYS CHEM B, V104, P1854, DOI 10.1021/jp993435l
   Premvardhan L, 2005, J PHYS CHEM B, V109, P15589, DOI 10.1021/jp052027g
   Polivka T, 2004, CHEM REV, V104, P2021, DOI 10.1021/cr020674n
   LONGUETHIGGINS HC, 1959, PROC R SOC LON SER-A, V251, P172, DOI 10.1098/rspa.1959.0100
   CLOSS GL, 1988, SCIENCE, V240, P440, DOI 10.1126/science.240.4851.440
   Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907
   ORLANDI G, 1991, CHEM REV, V91, P867, DOI 10.1021/cr00005a012
   Read EL, 2007, P NATL ACAD SCI USA, V104, P14203, DOI 10.1073/pnas.0701201104
   Xu QH, 2002, J PHYS CHEM A, V106, P10755, DOI 10.1021/jp014714n
   Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x
   Papagiannakis E, 2002, P NATL ACAD SCI USA, V99, P6017, DOI 10.1073/pnas.092626599
   Cong H, 2008, J PHYS CHEM B, V112, P3558, DOI 10.1021/jp0763681
   Levine BG, 2007, ANNU REV PHYS CHEM, V58, P613, DOI 10.1146/annurev.physchem.57.032905.104612
   Hofmann E, 1996, SCIENCE, V272, P1788, DOI 10.1126/science.272.5269.1788
   Garavelli M, 1998, J AM CHEM SOC, V120, P1285, DOI 10.1021/ja972695i
   Ostroumov EE, 2013, SCIENCE, V340, P52, DOI 10.1126/science.1230106
   Gradinaru CC, 2001, P NATL ACAD SCI USA, V98, P2364, DOI 10.1073/pnas.051501298
   Christensen RL, 1999, ADV PHOTOSYNTH, V8, P137
   Wohlleben W, 2004, J PHYS CHEM B, V108, P3320, DOI 10.1021/jp036145k
   Damjanovic A, 2000, BIOPHYS J, V79, P1695
   BIRGE RR, 1986, ACCOUNTS CHEM RES, V19, P138, DOI 10.1021/ar00125a003
   Buckup T, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2388274
   Calhoun TR, 2012, CHEM PHYS LETT, V523, P1, DOI 10.1016/j.cplett.2011.10.051
   CELANI P, 1995, J CHEM PHYS, V102, P5733, DOI 10.1063/1.469304
   Dolan PM, 2001, J PHYS CHEM B, V105, P12134, DOI 10.1021/jp010271b
   FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55
   Frank HA, 2004, BIOCHEMISTRY-US, V43, P8607, DOI 10.1021/bi0492096
   Kim J, 2009, ACCOUNTS CHEM RES, V42, P1375, DOI 10.1021/ar9000795
   Klessinger M., 1995, EXCITED STATES PHOTO
   Kosumi D, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.104715
   Kosumi D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.213601
   Kosumi D, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4737129
   Kreuger B.P., 1998, J PHYS CHEM B, V102, P2284
   Kusumoto T, 2010, CHEM PHYS, V373, P71, DOI 10.1016/j.chemphys.2010.01.018
   Li B, 2010, OPT EXPRESS, V18, P25825, DOI 10.1364/OE.18.025825
   Orlandi G., 1975, CHEM PHYS LETT, V30, P353
   Polli D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.163002
   Robb MA, 2001, J PHOTOCH PHOTOBIO A, V144, P237, DOI 10.1016/S1010-6030(01)00453-1
   Rohlfing F, 1997, CHEM PHYS LETT, V277, P406, DOI 10.1016/S0009-2614(97)00959-7
   Sundstrom V., 2007, PHOTOBIOLOGY SCI LIF, P289
   TRULSON MO, 1990, J PHYS CHEM-US, V94, P5741, DOI 10.1021/j100378a026
   Wei ZR, 2011, J AM CHEM SOC, V133, P8205, DOI 10.1021/ja110716b
   Xu QH, 2001, CHEM PHYS LETT, V338, P254, DOI 10.1016/S0009-2614(01)00281-0
NR 87
TC 3
Z9 3
U1 18
U2 32
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 175
EP 183
DI 10.1016/j.abb.2015.02.016
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900023
PM 25731863
ER

PT J
AU O'Hare, TJ
   Fanning, KJ
   Martin, IF
AF O'Hare, Tim J.
   Fanning, Kent J.
   Martin, Ian F.
TI Zeaxanthin biofortification of sweet-corn and factors affecting
   zeaxanthin accumulation and colour change
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Macula; Lutein; Carotenoid; Breeding; Zea mays; Hue angle; Harvest
   maturity
ID MACULAR PIGMENT; CAROTENOID FORMULATIONS; LUTEIN; AGE; SUPPLEMENTATION;
   DEGENERATION; HPLC; EYE
AB Zeaxanthin, along with its isomer lutein, are the major carotenoids contributing to the characteristic colour of yellow sweet-corn. From a human health perspective, these two carotenoids are also specifically accumulated in the human macula, and are thought to protect the photoreceptor cells of the eye from blue light oxidative damage and to improve visual acuity. As humans cannot synthesise these compounds, they must be accumulated from dietary components containing zeaxanthin and lutein. In comparison to most dietary sources, yellow sweet-corn (Zea mays var. rugosa) is a particularly good source of zeaxanthin, although the concentration of zeaxanthin is still fairly low in comparison to what is considered a supplementary dose to improve macular pigment concentration (2 mg/person/day). In our present project, we have increased zeaxanthin concentration in sweet-corn kernels from 0.2 to 0.3 mg/100 g FW to greater than 2.0 mg/100 g FW at sweet-corn eating-stage, substantially reducing the amount of corn required to provide the same dosage of zeaxanthin. This was achieved by altering the carotenoid synthesis pathway to more than double total carotenoid synthesis and to redirect carotenoid synthesis towards the beta-arm of the pathway where zeaxanthin is synthesised. This resulted in a proportional increase of zeaxanthin from 22% to 70% of the total carotenoid present. As kernels increase in physiological maturity, carotenoid concentration also significantly increases, mainly due to increased synthesis but also due to a decline in moisture content of the kernels. When fully mature, dried kernels can reach zeaxanthin and carotene concentrations of 8.7 mg/100 g and 2.6 mg/100 g, respectively. Although kernels continue to increase in zeaxanthin when harvested past their normal harvest maturity stage, the texture of these 'over-mature' kernels is tough, making them less appealing for fresh consumption. Increase in zeaxanthin concentration and other orange carotenoids such as p-carotene also results in a decline in kernel hue angle of fresh sweet-corn from approximately 90 (yellow) to as low as 75 (orange-yellow). This enables high-zeaxanthin sweet-corn to be visually-distinguishable from standard yellow sweet-corn, which is predominantly pigmented by lutein. (C) 2015 Elsevier Inc. All rights reserved.
C1 [O'Hare, Tim J.] Univ Queensland, QAAFI, Ctr Nutr & Food Sci, Brisbane, Qld 4072, Australia.
   [Fanning, Kent J.; Martin, Ian F.] Agrisci Queensland, Dept Agr Fisheries & Forestry, Brisbane, Qld, Australia.
RP O'Hare, TJ (reprint author), Univ Queensland, QAAFI, Ctr Nutr & Food Sci, Brisbane, Qld 4072, Australia.
EM t.ohare@uq.edu.au
CR Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997
   Davies NP, 2004, PROG RETIN EYE RES, V23, P533, DOI 10.1016/j.preteyeres.2004.05.004
   Sabour-Pickett S, 2014, RETINA-J RET VIT DIS, V34, P1757, DOI 10.1097/IAE.0000000000000174
   BONE RA, 1988, INVEST OPHTH VIS SCI, V29, P843
   Scott CE, 2005, J FOOD COMPOS ANAL, V18, P551, DOI 10.1016/j.jfca.2004.04.001
   Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255
   Loughman J, 2012, INVEST OPHTH VIS SCI, V53, P7871, DOI 10.1167/iovs.12-10690
   Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d
   BONE RA, 1993, INVEST OPHTH VIS SCI, V34, P2033
   Perry A, 2009, J FOOD COMPOS ANAL, V22, P9, DOI 10.1016/j.jfca.2008.07.006
   Li QR, 2010, TRANSGENIC RES, V19, P1053, DOI 10.1007/s11248-010-9381-x
   Whitehead AJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1038, DOI 10.1001/archopht.124.7.1038
   Moros EE, 2002, J AGR FOOD CHEM, V50, P5787, DOI [10.1021/jf020109l, 10.1021/jf0201909l]
   Fanning KJ, 2010, J SCI FOOD AGR, V90, P91, DOI 10.1002/jsfa.3787
   Krinsky NI, 2003, ANNU REV NUTR, V23, P171, DOI 10.1146/annurev.nutr.23.011702.073307
   Bone RA, 2003, J NUTR, V133, P992
   HarvestPlus, 2012, HARVESTPLUS NUTR TAR
   Holden Joanne M., 1999, Journal of Food Composition and Analysis, V12, P169, DOI 10.1006/jfca.1999.0827
   Kopsell DA, 2009, J AGR FOOD CHEM, V57, P6362, DOI 10.1021/jf9013313
   Leibowitz H M, 1980, Surv Ophthalmol, V24, P335
   Melendez-Martinez AJ, 2007, FOOD CHEM, V101, P1145, DOI 10.1016/j.foodchem.2006.03.015
   Murray IJ, 2013, INVEST OPHTH VIS SCI, V54, P1781, DOI 10.1167/iovs.12-10715
   Plate AYA, 2005, CEREAL FOOD WORLD, V50, P305
NR 23
TC 0
Z9 0
U1 9
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 184
EP 187
DI 10.1016/j.abb.2015.01.015
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900024
PM 25637659
ER

PT J
AU Melendez-Martinez, AJ
   Mapelli-Brahm, P
   Benitez-Gonzalez, A
   Stinco, CM
AF Melendez-Martinez, Antonio J.
   Mapelli-Brahm, Paula
   Benitez-Gonzalez, Ana
   Stinco, Carla M.
TI A comprehensive review on the colorless carotenoids phytoene and
   phytofluene
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Colorless carotenoids; Phytoene; Phytofluene; Health; Food; Nutrition
ID INCREASES PLASMA-CONCENTRATIONS; TRANSGENIC TOMATO PLANTS; SYNTHASE GENE
   FAMILY; BETA-CAROTENE; IN-VITRO; ZETA-CAROTENE; BIOSYNTHETIC-PATHWAY;
   ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; PHOTOSYNTHETIC BACTERIA
AB Carotenoids and their derivatives are versatile isoprenoids involved in many varied actions, hence their importance in the agri-food industry, nutrition, health and other fields. All carotenoids are derived from the colorless carotenes phytoene and phytofluene, which are oddities among carotenoids due to their distinct chemical structure. They occur together with lycopene in tomato and other lycopene-containing foods. Furthermore, they are also present in frequently consumed products like oranges and carrots, among others. The intake of phytoene plus phytofluene has been shown to be higher than that of lycopene and other carotenoids in Luxembourg. This is likely to be common in other countries. However, they are not included in food carotenoid databases, hence they have not been linked to health benefits in epidemiological studies. Interestingly, there are evidences in vitro, animal models and humans indicating that they may provide health benefits. In this sense, the study of these colorless carotenes in the context of food science, nutrition and health should be further encouraged. In this work, we review much of the existing knowledge concerning their chemical characteristics, physico-chemical properties, analysis, distribution in foods, bioavailability and likely biological activities. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Melendez-Martinez, Antonio J.; Mapelli-Brahm, Paula; Benitez-Gonzalez, Ana; Stinco, Carla M.] Univ Seville, Dept Nutr & Food Sci, Food Colour & Qual Lab, E-41012 Seville, Spain.
RP Melendez-Martinez, AJ (reprint author), Univ Seville, Fac Farm, Dept Nutr & Food Sci, Food Colour & Qual Lab, E-41012 Seville, Spain.
EM ajmelendez@us.es
RI Stinco, Carla/M-8621-2014
OI Stinco, Carla/0000-0003-2743-9016
FU Andalusian Coundil of Economy, Innovation, Science and Employment
   [CAROTINCO-P12-AGR-1287]; Spanish State Secretariat of Research,
   Development and Innovation (Ministry of Economy and Competitiveness
   [AGL2012-37610]; FEDER; National Program for the Mobility of Human
   Resources [JC-2009-00176]; CYTED [112RT0445]
FX A.J.M.M. acknowledges funding from the Andalusian Coundil of Economy,
   Innovation, Science and Employment (project ref.
   CAROTINCO-P12-AGR-1287), the Spanish State Secretariat of Research,
   Development and Innovation (Ministry of Economy and Competitiveness,
   project ref. AGL2012-37610, co-funded by FEDER) and the National Program
   for the Mobility of Human Resources (ref. JC-2009-00176). The authors
   are members of the IBERCAROT network, funded by CYTED (ref. 112RT0445).
CR Engelmann NJ, 2011, ADV NUTR, V2, P51, DOI 10.3945/an.110.000075
   Campbell JK, 2007, NUTR RES, V27, P794, DOI 10.1016/j.nutres.2007.09.015
   FRAY RG, 1993, PLANT MOL BIOL, V22, P589, DOI 10.1007/BF00047400
   Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI 10.1104/PP.107.098996
   Boileau TWM, 2003, J NATL CANCER I, V95, P1578, DOI 10.1093/jnci/djg081
   Rivera S, 2011, ANAL BIOANAL CHEM, V400, P1339, DOI 10.1007/s00216-011-4825-6
   Frigaard NU, 2004, J BACTERIOL, V186, P5210, DOI 10.1128/JB.186.16.5210-5220.2004
   Rodrigo MJ, 2003, J EXP BOT, V54, P727, DOI 10.1093/jxb/erg083
   Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002
   Schieber A, 2005, TRENDS FOOD SCI TECH, V16, P416, DOI 10.1016/j.tifs.2005.03.018
   Shixian Q, 2005, FOOD REV INT, V21, P295, DOI 10.1080/FRI-200061612
   Xu CJ, 2006, J AGR FOOD CHEM, V54, P5474, DOI 10.1021/jf060702t
   Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003
   Khachik F, 2002, EXP BIOL MED, V227, P845
   PECKER I, 1992, P NATL ACAD SCI USA, V89, P4962, DOI 10.1073/pnas.89.11.4962
   Busch M, 2002, PLANT PHYSIOL, V128, P439, DOI 10.1104/pp.128.2.439
   Ben-Dor A, 2005, MOL CANCER THER, V4, P177
   Engelmann NJ, 2010, J AGR FOOD CHEM, V58, P9979, DOI 10.1021/jf101942x
   Lange BM, 2003, PLANT MOL BIOL, V51, P925, DOI 10.1023/A:1023005504702
   Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622
   Takaichi S, 2007, CELL MOL LIFE SCI, V64, P2607, DOI 10.1007/s00018-007-7190-z
   Romer S, 2000, NAT BIOTECHNOL, V18, P666, DOI 10.1038/76523
   Liu AG, 2009, J AGR FOOD CHEM, V57, P7304, DOI 10.1021/jf901926b
   FRASER PD, 1994, PLANT PHYSIOL, V105, P405
   Bohm V, 2002, J AGR FOOD CHEM, V50, P221, DOI 10.1021/jf010888q
   Kotake-Nara E, 2001, J NUTR, V131, P3303
   Sandmann G, 2009, ARCH BIOCHEM BIOPHYS, V483, P169, DOI 10.1016/j.abb.2008.10.004
   Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303
   TONUCCI LH, 1995, J AGR FOOD CHEM, V43, P579, DOI 10.1021/jf00051a005
   AlBabili S, 1996, PLANT J, V9, P601, DOI 10.1046/j.1365-313X.1996.9050601.x
   Basu A, 2007, EUR J CLIN NUTR, V61, P295, DOI 10.1038/sj.ejcn.1602510
   Alquezar B, 2008, PHYTOCHEMISTRY, V69, P1997, DOI 10.1016/j.phytochem.2008.04.020
   Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200
   Sambanthamurthi R, 2000, PROG LIPID RES, V39, P507, DOI 10.1016/S0163-7827(00)00015-1
   KUNTZ M, 1992, PLANT J, V2, P25
   Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x
   Borguini RG, 2009, FOOD REV INT, V25, P313, DOI 10.1080/87559120903155859
   Isaacson T, 2004, PLANT PHYSIOL, V136, P4246, DOI 10.1104/pp.104.052092
   Britton G, 2009, CAROTENOIDS SER, V5, P45, DOI 10.1007/978-3-7643-7501-0_3
   Tran D, 2009, PLANTA, V229, P723, DOI 10.1007/s00425-008-0866-2
   Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120
   Giuliano G, 2008, TRENDS BIOTECHNOL, V26, P139, DOI 10.1016/j.tibtech.2007.12.003
   Britton G, 1995, FASEB J, V9, P1551
   Martinez A, 2014, J PHYS CHEM B, V118, P9819, DOI 10.1021/jp503227j
   Chaudhary N, 2010, MOL GENET GENOMICS, V283, P13, DOI 10.1007/s00438-009-0495-x
   Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303
   Farre G, 2011, TRENDS PLANT SCI, V16, P532, DOI 10.1016/j.tplants.2011.08.001
   Shumskaya M, 2012, PLANT CELL, V24, P3725, DOI 10.1105/tpc.112.104174
   CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348
   Fraser PD, 2002, P NATL ACAD SCI USA, V99, P1092, DOI 10.1073/pnas.241374598
   Fu XM, 2012, J EXP BOT, V63, P341, DOI 10.1093/jxb/err284
   [Anonymous], 2007, J AGR FOOD CHEM
   Lohr M, 2005, PLANT PHYSIOL, V138, P490, DOI 10.1104/pp.104.056069
   Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028
   Howitt CA, 2009, FUNCT INTEGR GENOMIC, V9, P363, DOI 10.1007/s10142-009-0121-3
   Ishida BK, 2004, J AGR FOOD CHEM, V52, P274, DOI 10.1021/jf030616i
   Khachik F, 1997, ANAL CHEM, V69, P1873, DOI 10.1021/ac961085i
   Nishino H, 2002, CANCER METAST REV, V21, P257, DOI 10.1023/A:1021206826750
   Shumskaya M, 2013, PLANT SCI, V208, P58, DOI 10.1016/j.plantsci.2013.03.012
   Lu S, 2008, J INTEGR PLANT BIOL, V50, P778, DOI 10.1111/j.1744-7909.2008.00708.x
   Breitenbach J, 2005, PLANTA, V220, P785, DOI 10.1007/s00425-004-1395-2
   Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082
   Rodriguez-Amaya DB, 2008, J FOOD COMPOS ANAL, V21, P445, DOI 10.1016/j.jfca.2008.04.001
   GRANGER P, 1973, J MAGN RESON, V10, P43, DOI 10.1016/0022-2364(73)90233-3
   Moehs CP, 2001, PLANT MOL BIOL, V45, P281, DOI 10.1023/A:1006417009203
   Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI [10.1104/pp.108.122119, 10.1104/pp.108.12219]
   Salvini M, 2005, J PLANT PHYSIOL, V162, P479, DOI 10.1016/j.jplph.2004.04.011
   ARMSTRONG GA, 1989, MOL GEN GENET, V216, P254, DOI 10.1007/BF00334364
   Aust, 2005, INT J VITAM NUTR RES, V75, P54
   BARTLEY GE, 1989, J BIOL CHEM, V264, P13109
   BARTLEY GE, 1991, P NATL ACAD SCI USA, V88, P6532, DOI 10.1073/pnas.88.15.6532
   BARTLEY GE, 1993, J BIOL CHEM, V268, P25718
   BEYER P, 1985, EUR J BIOCHEM, V153, P341, DOI 10.1111/j.1432-1033.1985.tb09308.x
   Biehler E, 2012, J FOOD COMPOS ANAL, V25, P56, DOI 10.1016/j.jfca.2011.07.005
   BRITTON G, 1977, PHYTOCHEMISTRY, V16, P1253, DOI 10.1016/S0031-9422(00)94368-1
   Britton G., 1995, CAROTENOIDS, V1B, P13
   Britton G., 2004, CAROTENOIDS HDB
   BUBB FA, 1973, CLIN CHIM ACTA, V48, P329, DOI 10.1016/0009-8981(73)90204-0
   Campbell JK, 2006, J NUTR, V136, P2813
   Campbell JK, 2006, J AGR FOOD CHEM, V54, P747, DOI 10.1021/jf0581269
   CHAMOVITZ D, 1991, PLANT MOL BIOL, V16, P967, DOI 10.1007/BF00016069
   CHAMOVITZ D, 1992, FEBS LETT, V296, P305, DOI 10.1016/0014-5793(92)80310-D
   CHAMOVITZ D, 1990, Z NATURFORSCH C, V45, P482
   Chisato T., 2009, J SEP SCI, V32, P3659
   Choo YM, 1996, J AM OIL CHEM SOC, V73, P599, DOI 10.1007/BF02518114
   CLOUGH JM, 1983, J CHEM SOC PERK T 1, P3011, DOI 10.1039/p19830003011
   COGDELL RJ, 1994, PURE APPL CHEM, V66, P1041
   de Faria AF, 2009, J FOOD COMPOS ANAL, V22, P196, DOI 10.1016/j.jfca.2008.10.014
   Dhuique-Mayer C, 2009, J AGR FOOD CHEM, V57, P9160, DOI 10.1021/jf901668d
   Edwards AJ, 2003, J NUTR, V133, P1043
   Engelmann NJ, 2009, J AGR FOOD CHEM, V57, P4614, DOI 10.1021/jf803905d
   Fraser PD, 2007, PLANT J, V49, P552, DOI 10.1111/j.1365-313X.2006.02949.x
   Fraser PD, 2007, PLANT CELL, V19, P3194, DOI 10.1105/tpc.106.049817
   Fuller Bryan, 2006, J Cosmet Dermatol, V5, P30, DOI 10.1111/j.1473-2165.2006.00220.x
   Gallagher C.E., 2004, PLANT PHYSL, V135
   Gijsbers L, 2013, J AGR FOOD CHEM, V61, P3419, DOI 10.1021/jf304790a
   Goodwin TW, 1976, CHEMISTRY BIOCHEMIST, V2, P38, DOI DOI 10.1590/S0101-20612001000200017
   GRANADO F, 1991, J LIQ CHROMATOGR, V14, P2457, DOI 10.1080/01483919108049333
   Hamano PS, 2001, J FOOD COMPOS ANAL, V14, P335, DOI 10.1006/jfca.2000.0975
   Hausmann A, 2000, FUNGAL GENET BIOL, V30, P147, DOI 10.1006/fgbi.2000.1212
   Hirsch K, 2007, BREAST CANCER RES TR, V104, P221, DOI 10.1007/s10549-006-9405-7
   Hugueney P., 1992, EUR J BIOCH, V209
   Jacques P.F., 2013, BR J NUTR, P1
   KARVOUNI Z, 1995, PLANT MOL BIOL, V27, P1153, DOI 10.1007/BF00020888
   KHACHIK F, 1989, J AGR FOOD CHEM, V37, P1465, DOI 10.1021/jf00090a003
   KOE BK, 1953, ARCH BIOCHEM BIOPHYS, V46, P100, DOI 10.1016/0003-9861(53)90172-6
   Kuemmel H.W., 1975, Z NATURFORSCH C, P333
   Leon R, 2005, BIOTECHNOL BIOENG, V92, P695, DOI 10.1002/bit.20660
   Li Faqiang, 2009, Plant Signal Behav, V4, P208
   Lu CH, 2011, J AGR FOOD CHEM, V59, P9996, DOI 10.1021/jf202599z
   MACKINNEY G, 1947, ANAL CHEM, V19, P614, DOI 10.1021/ac60008a008
   MARTINEZFEREZ I, 1994, BBA-GENE STRUCT EXPR, V1218, P145, DOI 10.1016/0167-4781(94)90003-5
   MATHEWSROTH M, 1975, PHOTOCHEM PHOTOBIOL, V21, P261, DOI 10.1111/j.1751-1097.1975.tb06666.x
   MATHEWSROTH MM, 1982, ONCOLOGY, V39, P33
   Melendez-Martinez A. J., 2013, HEPATOBILIARY SURG N, V2, P198
   Melendez-Martinez AJ, 2014, J AGR FOOD CHEM, V62, P12399, DOI 10.1021/jf5041965
   Melendez-Martinez AJ, 2010, PHYTOCHEMISTRY, V71, P1104, DOI 10.1016/j.phytochem.2010.03.021
   Melendez-Martinez AJ, 2013, FOOD CHEM, V138, P1341, DOI 10.1016/j.foodchem.2012.10.067
   Melendez-Martinez AJ, 2007, FOOD CHEM, V101, P1145, DOI 10.1016/j.foodchem.2006.03.015
   Mercadante AZ, 1998, J AGR FOOD CHEM, V46, P4102, DOI 10.1021/jf9801724
   Moran NE, 2013, J NUTR, V143, P1920, DOI 10.3945/jn.113.181461
   Muller H, 1999, EUR J NUTR, V38, P35, DOI 10.1007/s003940050044
   Muller H., 1997, UNTERS FORSCH A, V204, P88
   NAKAYAMA T, 1957, ARCH BIOCHEM BIOPHYS, V66, P310, DOI 10.1016/S0003-9861(57)80006-X
   Nara E, 2001, NUTR CANCER, V39, P273, DOI 10.1207/S15327914nc392_18
   Paetau I, 1998, AM J CLIN NUTR, V68, P1187
   Paniagua-Michel J, 2012, Methods Mol Biol, V892, P1, DOI 10.1007/978-1-61779-879-5_1
   Porrini M, 2005, BRIT J NUTR, V93, P93, DOI 10.1079/BJN20041315
   Porter J.W., 1953, ARCH BIOCHEM BIOPHYS, P252
   POWLS R, 1977, ARCH MICROBIOL, V115, P175, DOI 10.1007/BF00406372
   Richelle M, 2002, J NUTR, V132, P404
   Robertson FP, 2012, J EXP BOT, V63, P6035, DOI 10.1093/jxb/ers252
   Rodriguez-Amaya D.B., 2001, LIFE SCI
   ROSS MA, 1995, EUR J CLIN NUTR, V49, P861
   Rosso V. V. de, 2007, Journal of Agricultural and Food Chemistry, V55, P5062, DOI 10.1021/jf0705421
   de Rosso VV, 2007, J AGR FOOD CHEM, V55, P5062, DOI 10.1021/jf0705421
   ROUSEFF RL, 1992, J AGR FOOD CHEM, V40, P47, DOI 10.1021/jf00013a009
   Ruiz D, 2008, J AGR FOOD CHEM, V56, P4916, DOI 10.1021/jf7036032
   Sandmann G, 2001, J AGR FOOD CHEM, V49, P138, DOI 10.1021/jf0010432
   SANDMANN G, 1994, EUR J BIOCHEM, V223, P7, DOI 10.1111/j.1432-1033.1994.tb18961.x
   Schledz M, 1996, PLANT J, V10, P781, DOI 10.1046/j.1365-313X.1996.10050781.x
   SCHMITZ HH, 1995, J AGR FOOD CHEM, V43, P1212, DOI 10.1021/jf00053a017
   Schneider C, 1997, PROTEIN EXPRES PURIF, V10, P175, DOI 10.1006/prep.1997.0730
   Shaish A, 2008, PLANT FOOD HUM NUTR, V63, P83, DOI 10.1007/s11130-008-0075-y
   Simkin AJ, 2000, J AGR FOOD CHEM, V48, P4676, DOI 10.1021/jf006426
   Spirt S., 2010, CURR NUTR FOOD SCI, V6, P36
   Stahl W, 2012, AM J CLIN NUTR, V96, P1179
   Steiger S, 2005, ARCH MICROBIOL, V184, P207, DOI 10.1007/s00203-005-0004-5
   Stinco CM, 2014, J CHROMATOGR A, V1370, P162, DOI 10.1016/j.chroma.2014.10.044
   THAN A, 1972, PHYTOCHEMISTRY, V11, P3187, DOI 10.1016/S0031-9422(00)86370-0
   Tiziani S, 2006, J AGR FOOD CHEM, V54, P6094, DOI 10.1021/jf061154m
   Tsuchiya T, 2005, FEBS LETT, V579, P2125, DOI 10.1016/j.febslet.2005.02.066
   WALLACE V, 1952, ARCH BIOCHEM BIOPHYS, V36, P468, DOI 10.1016/0003-9861(52)90434-7
   Werman MJ, 2002, J NUTR BIOCHEM, V13, P585, DOI 10.1016/S0955-2863(02)00210-3
   ZECHMEISTER L, 1954, J AM CHEM SOC, V76, P2923, DOI 10.1021/ja01640a020
   ZECHMEISTER L, 1946, J AM CHEM SOC, V68, P197, DOI 10.1021/ja01206a014
   Zhou-Hui Li., 1996, PLANT MOL BIOL, V30, P269
NR 157
TC 3
Z9 3
U1 16
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 188
EP 200
DI 10.1016/j.abb.2015.01.003
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900025
PM 25615528
ER

PT J
AU LaFountain, AM
   Prum, RO
   Frank, HA
AF LaFountain, Amy M.
   Prum, Richard O.
   Frank, Harry A.
TI Diversity, physiology, and evolution of avian plumage carotenoids and
   the role of carotenoid-protein interactions in plumage color appearance
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Carotenoid metabolism; Evolution; Plumage coloration; Resonance Raman
   spectroscopy
ID RESONANCE RAMAN-SPECTROSCOPY; COTINGA XIPHOLENA-PUNICEA; BIRD PLUMAGE;
   DIETARY CAROTENOIDS; METABOLIC PATHWAYS; RED PIGMENTS; RHODOXANTHIN;
   FEATHERS; ECOLOGY; PATTERN
AB The diversity of vibrant plumage colors in birds has evolved as a direct result of social and environmental pressures. To fully understand these underlying pressures it is necessary to elucidate the mechanisms for the creation of novel plumage colors which include the metabolic transformations of dietary carotenoids and spectral tuning of the molecules within the feather protein environment. Recent advances in this field have greatly expanded the number and breadth of avian species for which plumage pigmentation has been characterized, making it possible to reconstruct the phylogenetic history of carotenoid usage in plumage. Resonance Raman and classical Raman spectroscopic techniques have been employed with great effect in the study of carotenoids in situ. The application of these methods have two benefits: to identify carotenoids in feathers that are unavailable for destructive sampling; and to study the spectral tuning resulting from the interaction between the carotenoids and the proteins to which they are bound. This review presents a summary of recent advances in the understanding of the molecular factors controlling the coloration of avian carotenoid plumage obtained through the application of both bioanalytical and spectroscopic methodologies. (C) 2015 Elsevier Inc. All rights reserved.
C1 [LaFountain, Amy M.; Frank, Harry A.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA.
   [Prum, Richard O.] Yale Univ, Dept Ecol & Evolutionary Biol, Peabody Museum Nat Hist, New Haven, CT 06511 USA.
RP LaFountain, AM (reprint author), Univ Connecticut, Dept Chem, 55 North Eagleville Rd, Storrs, CT 06269 USA.
EM amy.lafountain@uconn.edu
FU University of Connecticut Research Foundation; W.R. Coe Fund of Yale
   University
FX The authors would like to thank Profs. Ronald Christensen and George
   Britton for helpful discussions. Work by H.A.F. and A.M.L. was supported
   by the University of Connecticut Research Foundation. Work by R.O.P. was
   supported by the W.R. Coe Fund of Yale University.
CR Andersson S, 2007, FUNCT ECOL, V21, P272, DOI 10.1111/j.1365-2435.2007.01233.x
   SCHIEDT K, 1993, METHOD ENZYMOL, V214, P148
   MATSUNO T, 1986, COMP BIOCHEM PHYS B, V84, P477, DOI 10.1016/0305-0491(86)90110-0
   Hill GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1314
   Thomas DB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0806
   Robert B, 1999, ADV PHOTOSYNTH, V8, P189
   Scarmo S, 2012, EUR J CLIN NUTR, V66, P555, DOI 10.1038/ejcn.2012.31
   Chabera P, 2009, PHYS CHEM CHEM PHYS, V11, P8795, DOI 10.1039/b909924g
   Fuciman M, 2015, J PHYS CHEM B, V119, P1457, DOI 10.1021/jp512354r
   McGraw KJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P391, DOI 10.1007/s00265-004-0853-y
   Mendes-Pinto MM, 2013, J PHYS CHEM B, V117, P11015, DOI 10.1021/jp309908r
   Hill GE, 2002, P ROY SOC B-BIOL SCI, V269, P1119, DOI 10.1098/rspb.2002.1980
   LaFountain AM, 2010, ARCH BIOCHEM BIOPHYS, V504, P142, DOI 10.1016/j.abb.2010.08.006
   Mendes-Pinto MM, 2012, J R SOC INTERFACE, V9, P3338, DOI [10.1098/rsif.2012.0471, 10.1098/rsif.2012.0171]
   Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X
   Johnson JD, 2013, BIOCHIMIE, V95, P436, DOI 10.1016/j.biochi.2012.10.021
   Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x
   Prum RO, 2010, EVOLUTION, V64, P3085, DOI 10.1111/j.1558-5646.2010.01054.x
   Stradi R, 2001, COMP BIOCHEM PHYS B, V130, P57, DOI 10.1016/S1096-4959(01)00402-X
   Pryke SR, 2001, ANIM BEHAV, V62, P695, DOI 10.1006/anbe.2001.1804
   VERONELLI M, 1995, J RAMAN SPECTROSC, V26, P683, DOI 10.1002/jrs.1250260815
   Svensson PA, 2011, BEHAVIOUR, V148, P131, DOI 10.1163/000579510X548673
   Stoddard MC, 2011, BEHAV ECOL, V22, P1042, DOI 10.1093/beheco/arr088
   Negro JJ, 2002, NATURE, V416, P807, DOI 10.1038/416807a
   CHIOU CT, 1977, ENVIRON SCI TECHNOL, V11, P475, DOI 10.1021/es60128a001
   McGraw KJ, 2003, CONDOR, V105, P587, DOI 10.1650/7281
   ARPIN N, 1969, PHYTOCHEMISTRY, V8, P185, DOI 10.1016/S0031-9422(00)85811-2
   Bart I.C.J., 1968, ACTA CRYSTALLOGR B, V24, P1587
   Beaulieu J.M., 2013, SYST BIOL, V65, P725
   Berg CJ, 2013, ARCH BIOCHEM BIOPHYS, V539, P142, DOI 10.1016/j.abb.2013.09.009
   Bernhard K., 1995, CAROTENOIDS B, V1B, P117
   Blount JD, 2002, FUNCT ECOL, V16, P445, DOI 10.1046/j.1365-2435.2002.00648.x
   Britton George, 2008, V4, P99, DOI 10.1007/978-3-7643-7499-0_6
   Britton G., 2009, NUTR HLTH
   Britton G., 2004, CAROTENOIDS HDB
   Brockmann H., 1934, PHYSIOL CHEM PHYS M, V224, P193
   Canene-Adams K, 2009, CAROTENOIDS SER, V5, P115, DOI 10.1007/978-3-7643-7501-0_7
   Christensen R.L., 1999, PHOTOCHEMISTRY CAROT, P137
   Friedman NR, 2014, COMP BIOCHEM PHYS B, V172, P1, DOI 10.1016/j.cbpb.2014.03.004
   Friedman NR, 2014, EVOLUTION, V68, P791, DOI 10.1111/evo.12304
   Garcia-de Blas E, 2014, NATURWISSENSCHAFTEN, V101, P407, DOI 10.1007/s00114-014-1169-z
   Garda-de Bias E., 2013, PHYSIOL BIOCHEM ZOOL, V86, P483
   Goodwin T.W., 1982, BIOCH CAROTENOIDS
   Goodwin TW, 1984, BIOCH CAROTENOIDS
   Gornitz K., 1924, Journal fuer Ornithologie Berlin, V72, P113, DOI 10.1007/BF02119504
   Hill G. E., 2006, BIRD COLORATION, V2
   Hill G. E., 2006, BIRD COLORATION, V1
   Hill GE, 2006, BIRD COLORATION, V1, P507
   HUDON J, 1989, J FIELD ORNITHOL, V60, P361
   Hudon J, 2012, AUK, V129, P491, DOI 10.1525/auk.2012.11235
   Hudon J, 2007, COMP BIOCHEM PHYS B, V147, P402, DOI 10.1016/j.cbpb.2007.02.004
   HUDON J, 1991, CAN J ZOOL, V69, P2311, DOI 10.1139/z91-325
   Hudon J, 2013, WILSON J ORNITHOL, V125, P88, DOI 10.1676/11-161.1
   HUDON J, 1994, BIOTECHNOL ADV, V12, P49, DOI 10.1016/0734-9750(94)90290-9
   Ikuno Y., 1985, B JAPANESE SOC SCI F
   Isler O, 1971, CAROTENOIDS
   Kaisuyama M, 1988, COMP BIOCH PHYSL B, V90, P131, DOI 10.1016/0305-0491(88)90049-1
   Kohn S., 2008, CAROTENOIDS, V4
   Koyama Y, 1995, CAROTENOIDS B, V1, P135
   Krinsky NI, 2004, CAROTENOIDS HLTH DIS
   Kritzler Henry, 1943, PHYSIOL ZOOL, V16, P241
   LaFountain AM, 2013, ARCH BIOCHEM BIOPHYS, V539, P133, DOI 10.1016/j.abb.2013.08.012
   LaFountain AM, 2013, ARCH BIOCHEM BIOPHYS, V539, P126, DOI 10.1016/j.abb.2013.07.001
   MATSUNO T, 1985, COMP BIOCHEM PHYS B, V80, P779, DOI 10.1016/0305-0491(85)90461-4
   MATTERN I, 1955, NATURWISSENSCHAFTEN, V42, P612
   Mattern I., 1956, Z ZELLFORCH, V45
   McGraw K. J., 2006, BIRD COLORATION, V1, P243
   McGraw KJ, 2004, COMP BIOCHEM PHYS B, V139, P45, DOI 10.1016/j.cbpc.2004.06.006
   McGraw KJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P843, DOI 10.1086/323797
   McGraw KJ, 2006, BIRD COLORATION, V1, P177
   McGraw KJ, 2006, BIRD COLORATION, V1
   McGraw KJ, 2002, COMP BIOCHEM PHYS B, V132, P811, DOI 10.1016/S1096-4959(02)00100-8
   McGraw KJ, 2004, J AVIAN BIOL, V35, P543, DOI 10.1111/j.0908-8857.2004.03345.x
   McGraw KJ, 2003, COMP BIOCHEM PHYS B, V135, P689, DOI 10.1016/S1096-4959(03)00164-7
   Mori Y, 2001, J RAMAN SPECTROSC, V32, P543, DOI 10.1002/jrs.715
   MULVIHILL RS, 1992, J FIELD ORNITHOL, V63, P212
   Prager M, 2009, COMP BIOCHEM PHYS B, V154, P373, DOI 10.1016/j.cbpb.2009.06.015
   Prum RO, 2012, J COMP PHYSIOL B, V182, P1095, DOI 10.1007/s00360-012-0677-4
   Prum RO, 2014, J COMP PHYSIOL B, V184, P651, DOI 10.1007/s00360-014-0816-1
   Prum RO, 2006, BIRD COLORATION, V1, P295
   Pryke SR, 2001, EVOLUTION, V55, P1452
   Robert B, 2009, PHOTOSYNTH RES, V101, P147, DOI 10.1007/s11120-009-9440-4
   RODRIGUE.DB, 1973, INT J BIOCHEM, V4, P213, DOI 10.1016/0020-711X(73)90042-6
   Saranathan V., 2012, J R SOC INTERFACE
   Schiedt K., 1998, CAROTENOIDS, V3, P285
   SCHMIDT WJ, 1956, Z ZELLFORSCH MIK ANA, V45, P152
   Stradi R, 1997, COMP BIOCHEM PHYS B, V117, P85, DOI 10.1016/S0305-0491(96)00271-4
   Stradi R, 1998, COMP BIOCHEM PHYS B, V120, P223, DOI 10.1016/S0305-0491(98)10033-0
   STRADI R, 1995, COMP BIOCHEM PHYS B, V110, P131, DOI 10.1016/0305-0491(94)00136-I
   STRADI R, 1995, J CHROMATOGR B, V670, P337, DOI 10.1016/0378-4347(95)00173-5
   Stradi R, 2001, COMP BIOCHEM PHYS B, V128, P529, DOI 10.1016/S1096-4959(00)00353-5
   Stradi R, 1996, COMP BIOCHEM PHYS B, V113, P427, DOI 10.1016/0305-0491(95)02064-0
   Thomas D. B., 2014, SCI REPORTS, V4, P1
   Thomas DB, 2014, ANAL METHODS-UK, V6, P1301, DOI 10.1039/c3ay41870g
   Volker O., 1964, Journal fuer Ornithologie Leipzig, V105, P186, DOI 10.1007/BF01670990
   Volker O., 1952, Journal fuer Ornithologie Berlin, V93, P122
   VOLKER O, 1951, NATURWISSENSCHAFTEN, V38, P565
   VOLKER OTTO, 1955, JOUR ORNITHOL, V96, P54
   Volker O., 1953, Journal fuer Ornithologie, V94, P263
   Weedon B.C.L., 1995, CAROTENOIDS A, V1A
   Witmer MC, 1996, AUK, V113, P735
NR 101
TC 2
Z9 2
U1 12
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2015
VL 572
SI SI
BP 201
EP 212
DI 10.1016/j.abb.2015.01.016
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG5XJ
UT WOS:000353368900026
PM 25637658
ER

PT J
AU Koyani, CN
   Flemmig, J
   Malle, E
   Arnhold, J
AF Koyani, Chintan N.
   Flemmig, Joerg
   Malle, Ernst
   Arnhold, Juergen
TI Myeloperoxidase scavenges peroxynitrite: A novel anti-inflammatory
   action of the heme enzyme
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE APF; Flavonoids; Hypochlorite; MPO-H2O2-Cl- system; Nitric oxide;
   Superoxide
ID NITRIC-OXIDE SYNTHASE; DECOMPOSITION CATALYSTS; COMPOUNDS I;
   CHLORINATING ACTIVITY; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; COMPOUND-I;
   OXIDATION; THIOCYANATE; MECHANISMS
AB Peroxynitrite, a potent pro-inflammatory and cytotoxic species, interacts with a variety of heme containing proteins. We addressed the question whether (i) the interaction of myeloperoxidase (MPO, an enzyme generating hypochlorous acid from hydrogen peroxide and chloride ions) with peroxynitrite affects the clearance of peroxynitrite, and (ii) if peroxynitrite could modulate the chlorinating activity of MPO. Our results show that this interaction promotes the decomposition of the highly reactive pro-inflammatory oxidant, whereby MPO Compound II (but not Compound I) is formed. The efficiency of MPO to remove peroxynitrite was enhanced by L-tyrosine, nitrite and (-)-epicatechin, substances known to reduce Compound II with high reaction rate. Next, peroxynitrite (added as reagent) diminished the chlorinating activity of MPO in the presence of hydrogen peroxide. Alternatively, SIN-1, a peroxynitrite donor, reduced hypochlorous acid formation by MPO, as measured by aminophenyl fluorescein oxidation (time kinetics) and taurine chloramine formation (end point measurement). At inflammatory loci, scavenging of peroxynitrite by MPO may overcome the uncontrolled peroxynitrite decomposition and formation of reactive species, which lead to cell/tissue damage. (C) 2015 The Authors. Published by Elsevier Inc.
C1 [Koyani, Chintan N.; Malle, Ernst] Med Univ Graz, Inst Mol Biol & Biochem, A-8010 Graz, Austria.
   [Flemmig, Joerg; Arnhold, Juergen] Univ Leipzig, Translat Ctr Regenerat Med Leipzig, D-04103 Leipzig, Germany.
   [Flemmig, Joerg; Arnhold, Juergen] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04107 Leipzig, Germany.
RP Arnhold, J (reprint author), Univ Leipzig, Fac Med, Inst Med Phys & Biophys, Haertelstr 16-18, D-04107 Leipzig, Germany.
EM juergen.arnhold@medizin.uni-leipzig.de
FU Austrian Science Fund [FWF DK-W1226-B18, P19074]; Sachsische Aufbaubank
   via European Regional Development Fund (ERDF) (SAB Project) [100116526];
   German Federal Ministry of Education and Research [BMBF 1315883]
FX This study was supported by grants from the Austrian Science Fund (FWF
   DK-W1226-B18 and P19074), the Sachsische Aufbaubank via funding of the
   European Regional Development Fund (ERDF) (SAB Project Nr: 100116526)
   and the German Federal Ministry of Education and Research (BMBF
   1315883).
CR Alvarez MN, 2004, ARCH BIOCHEM BIOPHYS, V432, P222, DOI 10.1016/j.abb.2004.09.015
   Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936
   Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222
   Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460
   Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358
   Kuzkaya N, 2003, J BIOL CHEM, V278, P22546, DOI 10.1074/jbc.M302227200
   Keng T, 2000, MOL MED, V6, P779
   Kettle AJ, 1997, BIOCHEM J, V321, P503
   Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411
   Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375
   Salvemini D, 1998, P NATL ACAD SCI USA, V95, P2659, DOI 10.1073/pnas.95.5.2659
   Martin-Romero FJ, 2004, J FLUORESC, V14, P17, DOI 10.1023/B:JOFL.0000014655.89256.bd
   Gebicka L, 2000, IUBMB LIFE, V49, P11
   Gaupels F, 2011, NITRIC OXIDE-BIOL CH, V25, P222, DOI 10.1016/j.niox.2011.01.009
   Marquez LA, 1995, J BIOL CHEM, V270, P30434
   Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921
   Radi R, 2001, FREE RADICAL BIO MED, V30, P463, DOI 10.1016/S0891-5849(00)00373-7
   SJOBACK R, 1995, SPECTROCHIM ACTA A, V51, pL7, DOI 10.1016/0584-8539(95)01421-P
   Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI [10.1007/s10787-007-0013-x, 10.1007/s10787-007-0013-2]
   RUBBO H, 1994, J BIOL CHEM, V269, P26066
   Heiss C, 2003, JAMA-J AM MED ASSOC, V290, P1030, DOI 10.1001/jama.290.8.1030
   Marla SS, 1997, P NATL ACAD SCI USA, V94, P14243, DOI 10.1073/pnas.94.26.14243
   BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   BOHLE DS, 1994, J AM CHEM SOC, V116, P7423, DOI 10.1021/ja00095a062
   Levonen AL, 2001, ANTIOXID REDOX SIGN, V3, P215, DOI 10.1089/152308601300185188
   Heiss C, 2005, J AM COLL CARDIOL, V46, P1276, DOI 10.1016/j.jacc.2005.06.055
   Denicola A, 1998, P NATL ACAD SCI USA, V95, P3566, DOI 10.1073/pnas.95.7.3566
   Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017
   Su J, 2010, INORG CHEM, V49, P6317, DOI 10.1021/ic902157z
   Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8
   Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200
   Gebicka L, 2009, J INORG BIOCHEM, V103, P1375, DOI 10.1016/j.jinorgbio.2009.07.011
   Malle E, 2003, KIDNEY INT, V64, P1956, DOI 10.1046/j.1523-1755.2003.00336.x
   Li YN, 2010, MOL MED, V16, P335, DOI 10.2119/molmed.2010.00034
   Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008
   Burner U, 1999, FEBS LETT, V443, P290, DOI 10.1016/S0014-5793(98)01727-X
   HARRISON JE, 1976, J BIOL CHEM, V251, P1371
   Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697
   Furtmuller PG, 2005, BIOCHEM BIOPH RES CO, V337, P944, DOI 10.1016/j.bbrc.2005.09.138
   BIELSKI BHJ, 1985, PHILOS T ROY SOC B, V311, P473, DOI 10.1098/rstb.1985.0158
   Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808
   BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V784, P189, DOI 10.1016/0167-4838(84)90127-4
   BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5
   Botti H, 2005, IUBMB LIFE, V57, P407, DOI 10.1080/15216540500137701
   Burner U, 2000, J BIOL CHEM, V275, P20597, DOI 10.1074/jbc.M000181200
   Chakraborti S, 2004, BBA-GEN SUBJECTS, V1671, P70, DOI 10.1016/j.bbagen.2004.01.005
   Daphna EM, 1998, MOL CELL BIOCHEM, V183, P55, DOI 10.1023/A:1006848730927
   Deeb RS, 2006, J LIPID RES, V47, P898, DOI 10.1194/jlr.M500384-JLR200
   Dunford HB, 1999, BIOCHEM CELL BIOL, V77, P449, DOI 10.1139/bcb-77-5-449
   Flemmig J, 2012, J BIOL CHEM, V287, P27913, DOI 10.1074/jbc.M112.364299
   Flemmig J, 2008, CELL PHYSIOL BIOCHEM, V21, P287, DOI 10.1159/000129387
   Furtmuller PG, 2000, FEBS LETT, V484, P139, DOI 10.1016/S0014-5793(00)02143-8
   Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772
   Gagnon C, 1998, FEBS LETT, V431, P107, DOI 10.1016/S0014-5793(98)00741-8
   Galijasevic S, 2009, FREE RADICAL BIO MED, V47, P431, DOI 10.1016/j.freeradbiomed.2009.05.017
   Grover AK, 2003, AM J PHYSIOL-CELL PH, V284, pC294, DOI 10.1152/ajpcell.00297.2002
   Jantschko W, 2002, ARCH BIOCHEM BIOPHYS, V398, P12, DOI 10.1006/abbi.2001.2674
   Jensen MP, 2002, INORG CHEM, V41, P4788, DOI 10.1021/ic011089s
   KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502
   Lancel S, 2004, J AM COLL CARDIOL, V43, P2348, DOI 10.1016/j.jacc.2004.01.047
   Latal P, 2004, INORG CHEM, V43, P6519, DOI 10.1021/ic049161k
   Lee JB, 1998, J AM CHEM SOC, V120, P7493, DOI 10.1021/ja980507y
   Marechal A, 2007, J BIOL CHEM, V282, P14101, DOI 10.1074/jbc.M609237200
   Mehl M, 1999, NITRIC OXIDE-BIOL CH, V3, P142, DOI 10.1006/niox.1999.0217
   Mehta TR, 2001, AMINO ACIDS, V20, P419, DOI 10.1007/s007260170038
   Migita K, 2002, CLIN EXP RHEUMATOL, V20, P59
   Misko TP, 1998, J BIOL CHEM, V273, P15646, DOI 10.1074/jbc.273.25.15646
   ODAJIMA T, 1972, BIOCHIM BIOPHYS ACTA, V284, P368, DOI 10.1016/0005-2744(72)90132-5
   Soriano FG, 2011, SHOCK, V35, P560, DOI 10.1097/SHK.0b013e31820fe5d5
   Spalteholz H, 2008, BIOCHEM BIOPH RES CO, V371, P810, DOI 10.1016/j.bbrc.2008.04.139
   Starodubtseva M. N., 2010, BIOCHEMISTRY MOS A S, V4, P332, DOI 10.1134/S1990747810040021
   Tiruppathi C, 2004, P NATL ACAD SCI USA, V101, P7699, DOI 10.1073/pnas.0401712101
   Torres-Duenas D, 2007, BRIT J PHARMACOL, V152, P341, DOI 10.1038/sj.bjp.0707393
   Zederbauer M, 2007, BIOCHEM BIOPH RES CO, V356, P450, DOI 10.1016/j.bbrc.2007.02.157
   ZGLICZYNSKI JM, 1977, P SOC EXP BIOL MED, V154, P418
NR 76
TC 0
Z9 0
U1 11
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2015
VL 571
BP 1
EP 9
DI 10.1016/j.abb.2015.02.028
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF9ZQ
UT WOS:000352926800001
PM 25731855
ER

PT J
AU Lehman, W
   Medlock, G
   Li, XC
   Suphamungmee, W
   Tu, AY
   Schmidtmann, A
   Ujfalusi, Z
   Fischer, S
   Moore, JR
   Geeves, MA
   Regnier, M
AF Lehman, William
   Medlock, Greg
   Li, Xiaochuan (Edward)
   Suphamungmee, Worawit
   Tu, An-Yue
   Schmidtmann, Anja
   Ujfalusi, Zoltan
   Fischer, Stefan
   Moore, Jeffrey R.
   Geeves, Michael A.
   Regnier, Michael
TI Phosphorylation of Ser283 enhances the stiffness of the tropomyosin
   head-to-tail overlap domain
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Actin; Tropomyosin; Phosphorylation; Cardiomyopathy; Muscle regulation;
   Molecular Dynamics
ID RABBIT SKELETAL-MUSCLE; ALPHA-TROPOMYOSIN; STRIATED-MUSCLE;
   SARCOPLASMIC-RETICULUM; MOLECULAR-DYNAMICS; ACTIN-FILAMENTS;
   SMOOTH-MUSCLE; TROPONIN-T; F-ACTIN; CONTRACTION
AB The ends of coiled-coil tropomyosin molecules are joined together by nine to ten residue-long head-to-tail "overlapping domains". These short four-chained interconnections ensure formation of continuous tropomyosin cables that wrap around actin filaments. Molecular Dynamics simulations indicate that the curvature and bending flexibility at the overlap is 10-20% greater than over the rest of the molecule, which might affect head-to-tail filament assembly on F-actin. Since the penultimate residue of striated muscle tropomyosin, Ser283, is a natural target of phosphorylating enzymes, we have assessed here if phosphorylation adjusts the mechanical properties of the tropomyosin overlap domain. MD simulations show that phosphorylation straightens the overlap to match the curvature of the remainder of tropomyosin while stiffening it to equal or exceed the rigidity of canonical coiled-coil regions. Corresponding EM data on phosphomimetic tropomyosin S283D corroborate these findings. The phosphorylation-induced change in mechanical properties of tropomyosin likely results from electrostatic interactions between C-terminal phosphoSer283 and N-terminal Lysl 2 in the four-chain overlap bundle, while promoting stronger interactions among surrounding residues and thus facilitating tropomyosin cable assembly. The stiffening effect of D283-tropomyosin noted correlates with previously observed enhanced actin-tropomyosin activation of myosin S1-ATPase, suggesting a role for the tropomyosin phosphorylation in potentiating muscle contraction. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Lehman, William; Li, Xiaochuan (Edward); Suphamungmee, Worawit; Moore, Jeffrey R.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.
   [Medlock, Greg; Tu, An-Yue; Regnier, Michael] Univ Washington, Dept Bioengn, Seattle, WA 98109 USA.
   [Schmidtmann, Anja; Ujfalusi, Zoltan; Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.
   [Fischer, Stefan] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Computat Biochem Grp, D-69120 Heidelberg, Germany.
RP Lehman, W (reprint author), Boston Univ, Sch Med, Dept Physiol & Biophys, 72 East Concord St, Boston, MA 02118 USA.
EM wlehman@bu.edu
FU NIH [R37HL036153, R01HL077280, R01HL011197, R01HD048895]; Wellcome Trust
   [085309]; British Heart Foundation [30200]
FX These studies were supported by NIH grants R37HL036153 (to W.L.),
   R01HL077280 (to J.R.M.), R01HL011197 (to M.R.), R01HD048895 (to M.R.;
   M.J. Bamshad, P.I.) and by Wellcome Trust grant 085309 and British Heart
   Foundation grant 30200 (to M.A.G). The Massachusetts Green High
   Performance Computing Center provided computational resources.
CR Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447
   Schulz EM, 2013, J BIOL CHEM, V288, P28925, DOI 10.1074/jbc.M113.466466
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461
   Linke WA, 2014, CIRC RES, V114, P1052, DOI 10.1161/CIRCRESAHA.114.301286
   Solaro RJ, 2011, J BIOL CHEM, V286, P9935, DOI 10.1074/jbc.R110.197731
   Lehman W, 2008, ADV EXP MED BIOL, V644, P95
   Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697
   Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   Li XC, 2010, J STRUCT BIOL, V170, P313, DOI 10.1016/j.jsb.2010.01.016
   Rao VS, 2009, CELL MOTIL CYTOSKEL, V66, P10, DOI 10.1002/cm.20321
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001
   Chen FH, 2000, J MOL CELL CARDIOL, V32, P745, DOI 10.1006/jmcc.2000.1116
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   SPUDICH JA, 1971, J BIOL CHEM, V246, P4866
   Li XE, 2014, BIOCHEM BIOPH RES CO, V446, P304, DOI 10.1016/j.bbrc.2014.02.097
   Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9
   Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672
   Pfuhl M, 2012, J MUSCLE RES CELL M, V33, P83, DOI 10.1007/s10974-012-9291-z
   Peng Y, 2013, J MUSCLE RES CELL M, V34, P199, DOI 10.1007/s10974-013-9352-y
   BARANY M, 1981, AM J PHYSIOL, V241, pH117
   Coulton A, 2006, BIOCHEMISTRY-US, V45, P12853, DOI 10.1021/bi0613224
   Coulton AT, 2008, BIOCHEMISTRY-US, V47, P388, DOI 10.1021/bi701144g
   Geeves M. A., 2014, J MUSCLE RE IN PRESS
   GLYN H, 1985, J PHYSIOL-LONDON, V365, P259
   Greenfield NJ, 2003, BIOCHEMISTRY-US, V42, P614, DOI 10.1021/bi026989e
   HEELEY DA, 1982, FEBS LETT, V146, P115, DOI 10.1016/0014-5793(82)80716-3
   HEELEY DH, 1989, J BIOL CHEM, V264, P2424
   Heeley DH, 2013, J MUSCLE RES CELL M, V34, P233, DOI 10.1007/s10974-013-9351-z
   Hitchcock-DeGregori SE, 2008, ADV EXP MED BIOL, V644, P60
   Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6
   Katz A. M., 2001, PHYSL HEART
   Kawamura Y, 2010, CIRC J, V74, P1442, DOI 10.1253/circj.CJ-09-0793
   Lehman W, 2014, ARCH BIOCHEM BIOPHYS, V552, P68, DOI 10.1016/j.abb.2013.09.011
   LEHRER SS, 1982, J BIOL CHEM, V257, P8073
   LeWinter MM, 2014, J CARDIOVASC PHARM, V63, P207, DOI 10.1097/FJC.0000000000000007
   Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060
   Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999
   LIM MS, 1986, BIOCHEM CELL BIOL, V64, P622
   MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55
   Marston SB, 2013, J MUSCLE RES CELL M, V34, P189, DOI 10.1007/s10974-013-9347-8
   Orzechowski M, 2014, BIOPHYS J, V107, P694, DOI 10.1016/j.bpj.2014.06.034
   Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020
   Sano K, 2000, J BIOCHEM-TOKYO, V127, P1095
   Schulz EM, 2012, J BIOL CHEM, V287, P44478, DOI 10.1074/jbc.M112.402040
   Sousa D., 2010, BIOPHYS J, V99, P1
   Streng AS, 2013, J MOL CELL CARDIOL, V63, P47, DOI 10.1016/j.yjmcc.2013.07.004
   Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2
   WEGNER A, 1980, FEBS LETT, V119, P245, DOI 10.1016/0014-5793(80)80263-8
NR 53
TC 0
Z9 0
U1 1
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2015
VL 571
BP 10
EP 15
DI 10.1016/j.abb.2015.02.026
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF9ZQ
UT WOS:000352926800002
PM 25726728
ER

PT J
AU Mexia, N
   Gaitanis, G
   Velegrald, A
   Soshilov, A
   Denison, MS
   Magiatis, P
AF Mexia, Nikitia
   Gaitanis, Georgios
   Velegrald, Aristea
   Soshilov, Anatoly
   Denison, Michael S.
   Magiatis, Prokopios
TI Pityriazepin and other potent AhR ligands isolated from Malassezia
   furfur yeast
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Malassezia furfur; Aryl-hydrocarbon receptor; Indole metabolites;
   Pityriacitrin; Pityriazepin
ID ARYL-HYDROCARBON RECEPTOR; CYCLIN-DEPENDENT KINASES; DIOXIN RECEPTOR;
   HYMENIALDISINE; INDIRUBINS; SKIN
AB Malassezia furfur yeast strains isolated from diseased human skin preferentially biosynthesize indole alkaloids which can be detected in the human skin and are highly potent activators of the aryl hydrocarbon receptor (AhR) and AhR-dependent gene expression. Chemical analysis of an EtOAc extract of a M. furfur strain obtained from diseased human skin and grown on L-tryptophan agar revealed several known AhR active tryptophan metabolites along with a previously unidentified compound, pityriazepin. While its structure resembled that of the known alkaloid pityriacitrin, the comprised pyridine ring had been transformed into an azepinone. The indoloazepinone scaffold of pityriazepin is extremely rare in nature and has only been reported once previously. Pityriazepin, like the other isolated compounds, was found to be a potent activator of the AhR-dependent reporter gene assay in recombinant cell lines derived from four different species, although significant species differences in relative potency were observed. The ability of pityriazepin to competitively bind to the AhR and, directly stimulate AhR DNA binding classified it as a new naturally-occurring potent AhR agonist. M. furfur produces an expanded collection of extremely potent naturally occurring AhR agonists, which produce their biological effects in a species-specific manner. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Mexia, Nikitia; Magiatis, Prokopios] Univ Athens, Fac Pharm, Dept Pharmacognosy & Nat Prod Chem, Athens 15771, Greece.
   [Gaitanis, Georgios] Univ Ioannina, Sch Hlth Sci, Fac Med, Dept Skin & Venereal Dis, GR-45110 Ioannina, Greece.
   [Velegrald, Aristea] Univ Athens, Sch Med, Dept Microbiol, Mycol Lab, GR-10679 Athens, Greece.
   [Soshilov, Anatoly; Denison, Michael S.; Magiatis, Prokopios] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.
RP Magiatis, P (reprint author), Univ Athens, Fac Pharm, Dept Pharmacognosy & Nat Prod Chem, Athens 15771, Greece.
EM magiatis@pharm.uoa.gr
FU National Institute of Environmental Health Sciences [R01ES07685];
   California Agricultural Experiment Station
FX This research was supported in part by a grant (to MSD) from the
   National Institute of Environmental Health Sciences (R01ES07685) and the
   California Agricultural Experiment Station. The authors are grateful to
   Dr. Eleni Melliou for recording the MS spectra, Stavroula Kritikou for
   expert technical assistance in Malassezia cultures and Prof. A.L
   Skaltsounis for his interest on this work.
CR Knockaert M, 2004, ONCOGENE, V23, P4400, DOI 10.1038/sj.onc.1207535
   Gaitanis G, 2008, J INVEST DERMATOL, V128, P1620, DOI 10.1038/sj.jid.5701252
   Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI [10.1128/​CMR.00021-11, 10.1128/CMR.00021-11]
   Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218
   Mizuoka T, 2010, ORG BIOMOL CHEM, V8, P3157, DOI 10.1039/c003837g
   Sharma V, 2004, J MED CHEM, V47, P3700, DOI 10.1021/jm040013d
   White AW, 2012, EUR J MED CHEM, V56, P246, DOI 10.1016/j.ejmech.2012.08.022
   Magiatis P, 2013, J INVEST DERMATOL, V133, P2023, DOI 10.1038/jid.2013.92
   Korashy HM, 2011, CHEM RES TOXICOL, V24, P1540, DOI 10.1021/tx200141p
   He GC, 2011, TOXICOL SCI, V123, P511, DOI 10.1093/toxsci/kfr189
   DeGroot D., 2011, AH RECEPTOR BIOL TOX, P63
   He G., 2013, OPTIMIZATION DRUG DI, P221
   Polychronopoulos P, 2004, J MED CHEM, V47, P935, DOI 10.1021/jm031016d
   Potewar TM, 2008, ARKIVOC, P100
   Soshilov A. A., 2014, OPTIMIZATION DRUG DI, V18, P207
   Tholander J, 1999, TETRAHEDRON, V55, P6243, DOI 10.1016/S0040-4020(99)00268-9
   Vlachos C, 2012, BRIT J DERMATOL, V167, P496, DOI 10.1111/j.1365-2133.2012.11014.x
   Wille G, 2001, BIOORGAN MED CHEM, V9, P955, DOI 10.1016/S0968-0896(00)00319-9
NR 18
TC 2
Z9 2
U1 5
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2015
VL 571
BP 16
EP 20
DI 10.1016/j.abb.2015.02.023
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF9ZQ
UT WOS:000352926800003
PM 25721496
ER

PT J
AU Larsen, MC
   Bushkofsky, JR
   Gorman, T
   Adhami, V
   Mukhtar, H
   Wang, SQ
   Reeder, SB
   Sheibani, N
   Jefcoate, CR
AF Larsen, Michele Campaigne
   Bushkofsky, Justin R.
   Gorman, Tyler
   Adhami, Vaqar
   Mukhtar, Hasan
   Wang, Suqing
   Reeder, Scott B.
   Sheibani, Nader
   Jefcoate, Colin R.
TI Cytochrome P450 1B1: An unexpected modulator of liver fatty acid
   homeostasis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cytochrome P450 1b1; Diet-induced obesity; Liver steatosis; Sexual
   dimorphism; PPARalpha
ID ACTIVATED RECEPTOR-ALPHA; STEAROYL-COA DESATURASE-1; HEPATIC STEATOSIS;
   LIPID-METABOLISM; MOUSE-LIVER; PPAR-ALPHA; GENE-EXPRESSION;
   ADIPOSE-TISSUE; TRIGLYCERIDE CLEARANCE; ENDOTHELIAL FUNCTION
AB Cytochrome P450 1b1 (Cyp1b1) expression is absent in mouse hepatocytes, but present in liver endothelia and activated stellate cells. Increased expression during adipogenesis suggests a role of Cyp1b1 metabolism in fatty acid homeostasis. Wild-type C57BL/6j (WT) and Cyp1b1-null (Cyp1b1-ko) mice were provided low or high fat diets (LFD and HFD, respectively). Cyp1b1-deletion suppressed HFD-induced obesity, improved glucose tolerance and prevented liver steatosis. Suppression of lipid droplets in sinusoidal hepatocytes, concomitant with enhanced glycogen granules, was a consistent feature of Cyp1b1-ko mice. Cyp1b1 deletion altered the in vivo expression of 560 liver genes, including suppression of PPAR gamma, stearoyl CoA desaturase 1 (Scd1) and many genes stimulated by PPAR alpha, each consistent with this switch in energy storage mechanism. Ligand activation of PPARa in Cyp1b1-ko mice by WY-14643 was, nevertheless, effective. Seventeen gene changes in Cyp1b1-ko mice correspond to mouse transgenic expression that attenuated diet-induced diabetes. The absence of Cyp1b1 in mouse hepatocytes indicates participation in energy homeostasis through extra-hepatocyte signaling. Extensive sexual dimorphism in hepatic gene expression suggests a developmental impact of estrogen metabolism by Cyp1b1. Suppression of Scd1 and increased leptin turnover support enhanced leptin participation from the hypothalamus. Cyp1b1-mediated effects on vascular cells may underlie these changes. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Larsen, Michele Campaigne; Gorman, Tyler; Wang, Suqing; Jefcoate, Colin R.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.
   [Bushkofsky, Justin R.; Jefcoate, Colin R.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA.
   [Bushkofsky, Justin R.; Jefcoate, Colin R.] Univ Wisconsin, Endocrinol & Reprod Physiol Program, Madison, WI 53706 USA.
   [Adhami, Vaqar; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA.
   [Reeder, Scott B.] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA.
   [Reeder, Scott B.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA.
   [Reeder, Scott B.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Reeder, Scott B.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA.
   [Reeder, Scott B.] Univ Wisconsin, Dept Emergency Med, Madison, WI 53706 USA.
   [Sheibani, Nader] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.
RP Jefcoate, CR (reprint author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, 1111 Highland Ave, Madison, WI 53792 USA.
EM jefcoate@wisc.edu
FU NIH [R01 DK090249, R01 DK072749, R01 EY018179, R01 EY016695, R01 RCA
   EY021357, T32 HD041921, T32 ES007015]; Department of Defense [PC050578];
   University of Wisconsin George M O'Brien Urology Research Center
FX This research was supported by NIH grants: R01 DK090249 (C.R.J. and
   N.S.), R01 DK072749 (C.R.J.), R01 EY018179 (N.S. and C.R.J.), R01
   EY016695 (N.S.), R01 RCA EY021357 (N.S.), T32 HD041921, T32 ES007015,
   the Department of Defense grant PC050578 (C.RJ) and the University of
   Wisconsin George M O'Brien Urology Research Center (C.R.J.).
CR Al-Dwairi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046716
   Anderson SP, 2004, MOL PHARMACOL, V66, P1440, DOI 10.1124/mol.104.005496
   Jeannot E, 2007, CANCER RES, V67, P2611, DOI 10.1158/00087-5472.CAN-06-3947
   Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977
   Lopez-Garrido MP, 2013, OPHTHALMOLOGY, V120, P716, DOI 10.1016/j.ophtha.2012.09.016
   Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729
   Farrell GC, 2008, ANAT REC, V291, P684, DOI 10.1002/ar.20715
   Lasar D, 2013, BBA-MOL CELL BIOL L, V1831, P960, DOI 10.1016/j.bbalip.2013.01.016
   Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0
   Kim E, 2011, EUR J PHARMACOL, V672, P38, DOI 10.1016/j.ejphar.2011.09.172
   Addison ML, 2012, ENDOCRINOLOGY, V153, P1898, DOI 10.1210/en.2011-1982
   Stauber AJ, 2005, MOL PHARMACOL, V67, P681, DOI 10.1124/mol.104.007278
   Jennings BL, 2014, HYPERTENSION, V64, P134, DOI 10.1161/HYPERTENSIONAHA.114.03275
   Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012
   Desaulniers D, 2005, TOXICOL SCI, V86, P175, DOI 10.1093/toxsci/kfi178
   Hsuchou H, 2013, J CELL PHYSIOL, V228, P1610, DOI 10.1002/jcp.24325
   Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200
   Miyamoto L, 2012, J BIOL CHEM, V287, P40441, DOI 10.1074/jbc.M112.384545
   Hu HH, 2012, MAGN RESON IMAGING, V20, P323, DOI 10.1016/j.mri.2011.12.004
   Tripathy S, 2014, J LIPID RES, V55, P1448, DOI 10.1194/jlr.M050062
   Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132
   Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036
   Dashty M, 2013, CLIN BIOCHEM, V46, P1339, DOI 10.1016/j.clinbiochem.2013.04.027
   Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099
   Shawahna R, 2011, MOL PHARMACEUT, V8, P1332, DOI 10.1021/mp200129p
   Tang YX, 2009, BLOOD, V113, P744, DOI 10.1182/blood-2008-03-145219
   Casanueva FF, 1999, FRONT NEUROENDOCRIN, V20, P317, DOI 10.1006/frne.1999.0187
   Jeong S, 2009, EXP MOL MED, V41, P397, DOI 10.3858/emm.2009.41.6.045
   Pashkov V, 2011, J BIOL CHEM, V286, P15116, DOI 10.1074/jbc.M110.216234
   Misso ML, 2003, ENDOCRINOLOGY, V144, P1474, DOI 10.1210/en.2002-221123
   Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001
   Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352
   Hines CDG, 2010, RADIOLOGY, V254, P119, DOI [10.1148/radiol.09090131, 10.1148/radiol.2531090131]
   Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422
   Bechmann LP, 2013, J HEPATOL, V58, P1000, DOI 10.1016/j.jhep.2013.01.020
   Lovren F, 2010, CIRCULATION, V122, pS185, DOI 10.1161/CIRCULATIONAHA.109.931782
   Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224
   Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699
   Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522
   Reilly SJ, 2008, J BIOCHEM, V144, P655, DOI 10.1093/jb/mvn114
   Li F, 2014, J PROTEOME RES, V13, P2679, DOI 10.1021/pr500145n
   Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527
   de Meijer VE, 2010, METABOLISM, V59, P1092, DOI 10.1016/j.metabol.2009.11.006
   Viswakarma N, 2010, PPAR RES, DOI 10.1155/2010/250126
   Houten SM, 2009, CELL MOL LIFE SCI, V66, P1283, DOI 10.1007/s00018-009-9066-x
   Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200
   Chen LH, 2014, PPAR RES, DOI 10.1155/2014/653017
   Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386
   Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011
   Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200
   Abu-Elheiga L, 2012, J BIOL CHEM, V287, P12578, DOI 10.1074/jbc.M111.309559
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Rettberg JR, 2014, FRONT NEUROENDOCRIN, V35, P8, DOI 10.1016/j.yfrne.2013.08.001
   Hines CDG, 2012, J MAGN RESON IMAGING, V35, P844, DOI 10.1002/jmri.22890
   Palenski TL, 2013, LAB INVEST, V93, P646, DOI 10.1038/labinvest.2013.55
   Kordes C, 2013, J CLIN INVEST, V123, P1874, DOI 10.1172/JCI66027
   Childs GV, 2011, ENDOCRINOLOGY, V152, P69, DOI 10.1210/en.2010-0498
   Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003
   Chambers D, 2007, DEVELOPMENT, V134, P1369, DOI 10.1242/dev.02815
   Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058
   Chambers D, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-6
   Cherkaoui-Malki M, 2001, GENE EXPRESSION, V9, P291
   Cho YC, 2005, ARCH BIOCHEM BIOPHYS, V439, P139, DOI 10.1016/j.abb.2005.04.024
   Choudhary D, 2003, ARCH BIOCHEM BIOPHYS, V414, P91, DOI 10.1016/S0003-9861(03)00174-7
   Cocos S., 2007, BMC MOL BIOL, V8, P113
   Conforto TL, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-9
   Cui JY, 2012, DRUG METAB DISPOS, V40, P1226, DOI 10.1124/dmd.111.042697
   D'Ambrosio D. N., 2011, PLOS ONE, V6, P1
   Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034
   Fourcot A, 2011, AM J PHYSIOL-GASTR L, V300, pG1043, DOI 10.1152/ajpgi.00311.2010
   Fu SN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002902
   Galjda A. M., 2007, ANIM LAB NEWS
   Giometti CS, 2000, ELECTROPHORESIS, V21, P2162
   Goto T, 2013, MOL NUTR FOOD RES, V57, P20, DOI 10.1002/mnfr.201200522
   Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200
   Jefcoate CR, 2000, J NATL CANC I MONOGR, V27, P95
   Jiang F, 2011, DIABETES RES CLIN PR, V93, P43, DOI 10.1016/j.diabres.2011.03.028
   Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126
   Kang HW, 2010, TRENDS ENDOCRIN MET, V21, P449, DOI 10.1016/j.tem.2010.02.001
   Li XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025177
   Luo XL, 2011, DIABETES, V60, P1435, DOI 10.2337/db10-1663
   McMinn JE, 2005, AM J PHYSIOL-ENDOC M, V289, pE403, DOI 10.1152/ajpendo.00535.2004
   Palenski TL, 2013, AM J PHYSIOL-CELL PH, V305, pC1170, DOI 10.1152/ajpcell.00139.2013
   Piscaglia F, 1999, BIOCHEM PHARMACOL, V58, P157, DOI 10.1016/S0006-2952(99)00066-0
   Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005
   Sun K., 2013, J CLIN INVEST, V121, P2094
   Tacken PJ, 2001, CURR OPIN LIPIDOL, V12, P275, DOI 10.1097/00041433-200106000-00006
   Tang YX, 2010, AM J PHYSIOL-CELL PH, V298, pC665, DOI 10.1152/ajpcell.00153.2009
   Tao R., 2013, PLOS ONE, V88
   Vila-Brau A, 2013, J LIPID RES, V54, P592, DOI 10.1194/jlr.M028472
   Vollrath AL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-280
   Wauthier Valerie, 2010, Mol Endocrinol, V24, P667, DOI 10.1210/me.2009-0454
   Wheatcroft SB, 2003, DIABETES, V52, P2075, DOI 10.2337/diabetes.52.8.2075
   Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583
NR 96
TC 2
Z9 2
U1 4
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2015
VL 571
BP 21
EP 39
DI 10.1016/j.abb.2015.02.010
PG 19
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF9ZQ
UT WOS:000352926800004
PM 25703193
ER

PT J
AU Suzuki, M
   Matsushima-Nishiwaki, R
   Kuroyanagi, G
   Suzuki, N
   Takamatsu, R
   Furui, T
   Yoshimi, N
   Kozawa, O
   Morishige, K
AF Suzuki, Mariko
   Matsushima-Nishiwaki, Rie
   Kuroyanagi, Gen
   Suzuki, Noriko
   Takamatsu, Reika
   Furui, Tatsuro
   Yoshimi, Naoki
   Kozawa, Osamu
   Morishige, Ken-ichirou
TI Regulation by heat shock protein 22 (HSPB8) of transforming growth
   factor-alpha-induced ovary cancer cell migration
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE HSP22; Ovary cancer; TGF-alpha; Migration
ID SURFACE EPITHELIUM; KINASE PATHWAY; EXPRESSION; METASTASIS; INHIBITOR;
   RECEPTOR; PROLIFERATION; CARCINOMA
AB Accumulating evidence suggests that heat shock proteins (HSPs) are implicated in progression of cancer. HSP22 (HSPB8), a small HSP, is recognized to be ubiquitously expressed in various tissues. However, the expression and the role of HSP22 in ovarian cancer remain to be clarified. In the present study, we investigated the involvement of HSP22 in transforming growth factor (TGF)-alpha-induced migration of ovarian cancer cells. The expression of HSP22 was detected in a serous ovarian cancer cell line, SKOV3.ip1. The migration was reduced by down-regulation of HSP22 expression. The TGF-alpha-induced migration was reduced by SB203580 (a p38 MAP kinase inhibitor), SP600125 (a SAPK/JNK inhibitor) and Y27632 (a Rho-kinase inhibitor). However, down-regulation of HSP22 had little effect on the TGF-alpha-induced phosphorylation of p38 MAP kinase, SAPK/JNK and MYPT, a target protein of Rho-kinase. The HSP22 expression was further analyzed in 20 resected specimens of human ovarian serous carcinoma. The expression of HSP22 was detected in-all the twenty tissues (8.24-109.22 pg/mg protein), and the cases with highly expression of HSP22 showed a tendency to acquire the progressive ability. Our results strongly suggest that HSP22 acts as a positive regulator in TGF-alpha-induced migration of ovarian cancer cells, subsequently directing ovarian cancer toward progression. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Suzuki, Mariko; Suzuki, Noriko; Furui, Tatsuro; Morishige, Ken-ichirou] Gifu Univ, Grad Sch Med, Dept Obstet & Gynecol, Gifu 5011194, Japan.
   [Suzuki, Mariko; Matsushima-Nishiwaki, Rie; Kuroyanagi, Gen; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan.
   [Takamatsu, Reika; Yoshimi, Naoki] Univ Ryukyus, Grad Sch Med, Dept Pathol & Oncol, Okinawa 9030215, Japan.
RP Kozawa, O (reprint author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan.
EM okozawa@gifu-u.ac.jp
CR Amadori D., 1997, FRONT BIOSCI, V2, P8
   Kyriakis JM, 2001, PHYSIOL REV, V81, P807
   Modem S, 2011, J CELL PHYSIOL, V226, P2747, DOI 10.1002/jcp.22868
   Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7
   Hudson LG, 2009, FUTURE ONCOL, V5, P323, DOI [10.2217/fon.09.10, 10.2217/FON.09.10]
   Sawada K, 2002, GYNECOL ONCOL, V87, P252, DOI 10.1006/gyno.2002.6831
   Doraiswamy V, 2000, BIOL REPROD, V63, P789, DOI 10.1095/biolreprod63.3.789
   Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006
   Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001
   ALESSI DR, 1995, J BIOL CHEM, V270, P27489
   Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842
   Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298
   Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409
   Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010
   Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611
   Gui T, 2012, CANCER EPIDEMIOL, V36, P490, DOI 10.1016/j.canep.2012.06.005
   Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1
   Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0
   Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615
   Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255
   HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025
   English DP, 2013, MOL DIAGN THER, V17, P85, DOI 10.1007/s40291-013-0024-9
   YU DH, 1993, CANCER RES, V53, P891
   [Anonymous], 1970, NATURE, DOI DOI 10.1038/227680A0
   CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F
   Balcan E, 2012, INT J GYNECOL CANCER, V22, P1138, DOI 10.1097/IGC.0b013e31825b7dcc
   Charpentier AH, 2000, CANCER RES, V60, P5977
   DERYNCK R, 1990, MOL REPROD DEV, V27, P3, DOI 10.1002/mrd.1080270104
   Hu YH, 2000, J MED CHEM, V43, P3045, DOI 10.1021/jm000117y
   Kurman R.J., 2014, WHO CLASSIFICATION T, P21
   Matsushima-Nishiwaki R, 2008, J BIOL CHEM, V283, P18852, DOI 10.1074/jbc.M801301200
   Pavan S, 2014, INT J CANCER, V134, P1289, DOI 10.1002/ijc.28464
   PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182
   Sewell JM, 2005, EXP CELL RES, V304, P305, DOI 10.1016/j.yexcr.2004.11.007
   Smith CC, 2000, J BIOL CHEM, V275, P25690, DOI 10.1074/jbc.M002140200
   Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014
   Wang YY, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0379-8
   Zhao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113478
   Zhao M, 2012, REPROD SCI, V19, P748, DOI 10.1177/1933719111432875
NR 39
TC 0
Z9 0
U1 2
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2015
VL 571
BP 40
EP 49
DI 10.1016/j.abb.2015.02.030
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF9ZQ
UT WOS:000352926800005
PM 25731856
ER

PT J
AU Pekarova, M
   Kuhn, H
   Bezakova, L
   Ufer, C
   Heydeck, D
AF Pekarova, Maria
   Kuhn, Hartmut
   Bezakova, Lydia
   Ufer, Christoph
   Heydeck, Dagmar
TI Mutagenesis of triad determinants of rat Alox15 alters the specificity
   of fatty acid and phospholipid oxygenation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Eicosanoids; ALOX15; Biomembranes; Lipoproteins; Oxidative stress;
   Reaction mechanism
ID POSITIONAL SPECIFICITY; ACTIVE-SITE; LIPOXYGENASE; 15-LIPOXYGENASE;
   12-LIPOXYGENASE; 12/15-LIPOXYGENASE; EXPRESSION; STEREOCONTROL;
   PURIFICATION; DISRUPTION
AB Among lipoxygenases ALOX15 orthologs are somewhat peculiar because of their capability of oxygenating polyenoic fatty acids even if they are incorporated in complex lipid-protein assemblies. ALOX15 orthologs of different species have been characterized before, but little is known about the corresponding rat enzyme. Since rats are frequently employed as models in biomedical research we expressed rat Alox15 as recombinant protein in pro- and eukaryotic expression systems and characterized the enzyme with respect to its enzymatic properties. The enzyme oxygenated free arachidonic acid mainly to 12S-HpETE with 15S-HpETE only contributing 10% to the product mixture. Multiple directed mutagenesis studies indicated applicability of the triad concept with particular importance of Leu353 and Ile593 as specificity determinants. Ala404Gly exchange induced subtle alterations in enantioselectivity suggesting partial applicability of the Coffa/Brash concept. Wildtype rat Alox15 and its 15-lipoxygenating Leu353Phe mutant are capable of oxygenating ester lipids of biomembranes and high-density lipoproteins. For the wildtype enzyme 13S-HODE and 12S-HETE were identified as major oxygenation products but for the Leu353Phe mutant 135-HODE and 15S-HETE prevailed. These data indicate for the first time that mutagenesis of triad determinants modifies the reaction specificity of ALOX15 orthologs with free fatty acids and complex ester lipids in a similar way. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Pekarova, Maria; Kuhn, Hartmut; Ufer, Christoph; Heydeck, Dagmar] Charite, Inst Biochem, D-10117 Berlin, Germany.
   [Pekarova, Maria; Bezakova, Lydia] Comenius Univ, Fac Pharm, Dept Cell & Mol Biol Drugs, Bratislava 83232, Slovakia.
RP Heydeck, D (reprint author), Charite, Inst Biochem, Charitepl 1, D-10117 Berlin, Germany.
EM dagmar.heydeck@charite.de
FU Slovak Grant Agency VEGA [1/0392/14]; Deutsche Forschungsgemeinschaft
   [GRK1673-1]
FX This work was supported in part by research Grants of Slovak Grant
   Agency VEGA 1/0392/14 (to M.P.) and Deutsche Forschungsgemeinschaft
   (GRK1673-1, to H.K.).
CR WATANABE T, 1993, BIOCHEM BIOPH RES CO, V192, P1023, DOI 10.1006/bbrc.1993.1519
   Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016
   Berger M, 1998, J MOL BIOL, V278, P935, DOI 10.1006/jmbi.1998.1737
   HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182
   SCHEWE T, 1975, FEBS LETT, V60, P149, DOI 10.1016/0014-5793(75)80439-X
   DEMARZO N, 1992, AM J PHYSIOL, V262, pL198
   Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003
   Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d
   Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345
   Sun DX, 1996, J BIOL CHEM, V271, P24055
   Mikule K, 2002, J NEUROSCI, V22, P4932
   Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802
   Jansen C, 2011, J BIOL CHEM, V286, P37804, DOI 10.1074/jbc.M111.259242
   Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Haas U, 2011, P NATL ACAD SCI USA, V108, P20479, DOI 10.1073/pnas.1117094108
   Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9
   Shureiqi I, 2003, P NATL ACAD SCI USA, V100, P9968, DOI 10.1073/pnas.1631086100
   Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101
   Borngraber S, 1996, J MOL BIOL, V264, P1145, DOI 10.1006/jmbi.1996.0702
   Gregus AM, 2013, FASEB J, V27, P1939, DOI 10.1096/fj.12-217414
   KUHN H, 1990, J BIOL CHEM, V265, P18351
   Ganini D, 2014, FREE RADICAL BIO MED, V76, P61, DOI 10.1016/j.freeradbiomed.2014.07.031
   TAKAHASHI Y, 1993, EUR J BIOCHEM, V218, P165, DOI 10.1111/j.1432-1033.1993.tb18362.x
   CRANE FL, 1956, BIOCHIM BIOPHYS ACTA, V22, P475, DOI 10.1016/0006-3002(56)90058-0
   KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N
   Horn T., 2014, PROG LIPID RES C, V57C, P13
   Kuhn H., 2014, BIOCH BIOPHYS ACTA
   Schewe T, 1981, Methods Enzymol, V71 Pt C, P430
   YOKOYAMA C, 1986, J BIOL CHEM, V261, P6714
NR 30
TC 1
Z9 1
U1 3
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2015
VL 571
BP 50
EP 57
DI 10.1016/j.abb.2015.02.029
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF9ZQ
UT WOS:000352926800006
PM 25731857
ER

PT J
AU Furukawa, K
   Ohmi, Y
   Kondo, Y
   Ohkawa, Y
   Tajima, O
   Furukawa, K
AF Furukawa, Koichi
   Ohmi, Yuhsuke
   Kondo, Yuji
   Ohkawa, Yuki
   Tajima, Orie
   Furukawa, Keiko
TI Regulatory function of glycosphingolipids in the inflammation and
   degeneration
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Inflammation; Glycosphingolipid; Neurodegeneration
ID AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; GLOBO-SERIES
   GLYCOSPHINGOLIPIDS; LYMPHOMA-ASSOCIATED ANTIGEN; ALZHEIMERS-DISEASE
   BRAIN; TUMOR-NECROSIS-FACTOR; GD3 SYNTHASE GENE; COMPLEX GANGLIOSIDES;
   MUTANT MICE; SPINAL-CORD
AB Recent progress in the biological sciences has revealed that a number of extrinsic and intrinsic environmental factors may cause chronic inflammation. When these insults are persistent or intermittently repeated, regardless of extrinsic or intrinsic origins, homeostasis of our bodies would be disturbed and undergo long-term impact. These situations might give rise to chronic inflammation, leading to various diseases as results of accumulative effects of various inflammatory reactions. Complex carbohydrates expressed mainly on the cell surface have been demonstrated to play roles in fine-tuning of various biological processes to maintain homeostasis of cells, organs and our bodies. When abnormal physicochemical insults and harmful pathogens invade, the fine-tuning including modification of the glycosylation patterns is continuously exerted. Therefore, defects in the proper response with proper glycosylation lead to chronic inflammation and subsequent deterioration of individual tissues and organs. Genetic depletion of sialic acid-containing glycolipids, gangliosides resulted in the inflammation of CNS and neurodegeneration. Lactosylceramide was also reported to mediate neuroinflammation, leading to chronic inflammatory diseases. Defects of globoseries glycolipids resulted in the increased sensitivity to LPS toxicity. Thus, possibilities that manipulation of synthesis and expression of glycosphingolipids may be applicable for the disease control are now proposed. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Furukawa, Koichi; Ohmi, Yuhsuke; Kondo, Yuji; Ohkawa, Yuki; Tajima, Orie; Furukawa, Keiko] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4648601, Japan.
   [Tajima, Orie; Furukawa, Keiko] Chubu Univ, Fac Life & Hlth Sci, Dept Life & Med Sci, Kasugai, Aichi 487, Japan.
RP Furukawa, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4648601, Japan.
EM koichi@med.nagoya-u.ac.jp
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   (MEXT) [21390076, 23590371, 23110008, 24111519]
FX We would like to thank Ms. Yoshiko Shibagaki for editorial assistance.
   These studies were supported by a Grant-in-Aid for Scientific Research
   (#21390076) and partly by a Grant-in-Aid for Scientific Research
   (#23590371) and by Grants-in-Aid for Scientific Research on Innovative
   Areas (#23110008) (#24111519, "Brain Environment") from the Ministry of
   Education, Culture, Sports, Science, and Technology of Japan (MEXT).
CR Way EE, 2013, EUR J IMMUNOL, V43, P3116, DOI 10.1002/eji.201343713
   Miyake K, 2004, SEMIN IMMUNOL, V16, P11, DOI 10.1016/j.smim.2003.10.007
   JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   SCHNEIDER JS, 1992, SCIENCE, V256, P843, DOI 10.1126/science.1350379
   ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016
   McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8
   Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147
   Strohmeyer R, 2000, MOL BRAIN RES, V81, P7, DOI 10.1016/S0169-328X(00)00149-2
   Miyata M, 2014, BIOCHEM BIOPH RES CO, V445, P504, DOI 10.1016/j.bbrc.2014.02.038
   Truedsson L, 2007, AUTOIMMUNITY, V40, P560, DOI 10.1080/08916930701510673
   Van Beek J, 2003, ANN NY ACAD SCI, V992, P56
   KARLSSON KA, 1995, CURR OPIN STRUC BIOL, V5, P622, DOI 10.1016/0959-440X(95)80054-9
   Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662
   Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200
   Wu GS, 2012, J NEUROSCI RES, V90, P1997, DOI 10.1002/jnr.23090
   Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8
   Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809
   Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199
   Rogers J, 2000, ANN NY ACAD SCI, V924, P132
   Furukawa K, 2012, J BIOCHEM, V151, P573, DOI 10.1093/jb/mvs043
   Woodruff TM, 2008, ADV EXP MED BIOL, V632, P143, DOI 10.1007/978-0-387-78952-1_11
   Shen Y, 2001, NEUROSCI LETT, V305, P165, DOI 10.1016/S0304-3940(01)01842-0
   Schneider JS, 2013, J NEUROL SCI, V324, P140, DOI 10.1016/j.jns.2012.10.024
   Tokuda N, 2013, GLYCOBIOLOGY, V23, P1175, DOI 10.1093/glycob/cwt054
   Dong Y, 2010, CANCER SCI, V101, P2039, DOI 10.1111/j.1349-7006.2010.01613.x
   Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0
   Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004
   Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090
   Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4
   Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111
   Boukhris A, 2013, AM J HUM GENET, V93, P118, DOI 10.1016/j.ajhg.2013.05.006
   Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299
   Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102
   Chapman-Kiddell CA, 2010, INFLAMM BOWEL DIS, V16, P137, DOI 10.1002/ibd.20968
   Barnum SR, 2002, IMMUNOL RES, V26, P7, DOI 10.1385/IR:26:1-3:007
   Benard M, 2004, J BIOL CHEM, V279, P43487, DOI 10.1074/jbc.M404124200
   Cazet A, 2012, GLYCOBIOLOGY, V22, P806, DOI 10.1093/glycob/cws049
   Christen U, 2014, INT REV IMMUNOL, V33, P296, DOI 10.3109/08830185.2014.921162
   DAWSON G, 1984, J NEUROSCI RES, V12, P213, DOI 10.1002/jnr.490120209
   Farkas I, 2003, J IMMUNOL, V170, P5764
   Fujii Y, 2005, GLYCOBIOLOGY, V15, P1257, DOI 10.1093/glycob/cwj015
   Furukawa K., 1990, HUMAN MELANOMA BASIC, P15
   FURUKAWA K, 1993, P NATL ACAD SCI USA, V90, P1972, DOI 10.1073/pnas.90.5.1972
   Furukawa Koichi, 2014, Adv Neurobiol, V9, P307, DOI 10.1007/978-1-4939-1154-7_14
   GEISLER FH, 1990, ACTA NEUROBIOL EXP, V50, P515
   Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102
   Harlalka GV, 2013, BRAIN, V136, P3618, DOI 10.1093/brain/awt270
   Inoue M, 2002, J BIOL CHEM, V277, P29881, DOI 10.1074/jbc.M201631200
   Kane BA, 2014, J INNATE IMMUN, V6, P727, DOI 10.1159/000363449
   Karasawa F, 2012, J CLIN INVEST, V122, P923, DOI 10.1172/JCI59087
   KIJIMOTOOCHIAI S, 1977, P NATL ACAD SCI USA, V74, P5407, DOI 10.1073/pnas.74.12.5407
   Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199
   Kumagai T, 2009, BIOCHEM BIOPH RES CO, V379, P456, DOI 10.1016/j.bbrc.2008.12.078
   Kumagai T, 2010, GLYCOCONJUGATE J, V27, P685, DOI 10.1007/s10719-010-9313-2
   Mason JC, 1999, BLOOD, V94, P1673
   Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681
   McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006
   MERRITT WD, 1987, CANCER RES, V47, P1724
   Miyamoto K, 2008, GLYCOBIOLOGY, V18, P408, DOI 10.1093/glycob/cwn017
   MURRAY LJ, 1985, INT J CANCER, V36, P561, DOI 10.1002/ijc.2910360508
   NAIKI M, 1975, BIOCHEMISTRY-US, V14, P4837, DOI 10.1021/bi00693a010
   Nishie T, 2010, GLYCOBIOLOGY, V20, P1311, DOI 10.1093/glycob/cwq098
   Ohkawa Y, 2010, J BIOL CHEM, V285, P27213, DOI 10.1074/jbc.M109.087791
   Ohmi Y, 2009, P NATL ACAD SCI USA, V106, P22405, DOI 10.1073/pnas.0912336106
   Ohmi Y, 2011, J NEUROCHEM, V116, P926, DOI 10.1111/j.1471-4159.2010.07067.x
   Ohmi Y, 2012, NEUROCHEM RES, V37, P1185, DOI 10.1007/s11064-012-0764-7
   Ohmi Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-61
   Okuda T, 2010, GLYCOCONJUGATE J, V27, P287, DOI 10.1007/s10719-009-9277-2
   RAPPORT MM, 1990, ACTA NEUROBIOL EXP, V50, P505
   Rasch Sebastian, 2014, Clin Exp Gastroenterol, V7, P261, DOI 10.2147/CEG.S43457
   Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597
   SIDDIQUI B, 1984, CANCER RES, V44, P5262
   Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460
   Smith DC, 2002, TRAFFIC, V3, P697, DOI 10.1034/j.1600-0854.2002.31001.x
   Sugiura Y, 2005, NEUROSCIENCE, V135, P1167, DOI 10.1016/j.neuroscience.2005.07.035
   Tajima O, 2009, BEHAV BRAIN RES, V198, P74, DOI 10.1016/j.bbr.2008.10.024
   Tajima O, 2010, BEHAV BRAIN RES, V206, P101, DOI 10.1016/j.bbr.2009.09.005
   Tenner AJ, 2001, NEUROBIOL AGING, V22, P849, DOI 10.1016/S0197-4580(01)00301-3
   Terai K, 1997, BRAIN RES, V769, P385, DOI 10.1016/S0006-8993(97)00849-4
   Van de Kar N.C., 1993, BEHRING I MITT, V92, P202
   VANDEKAR NCAJ, 1992, BLOOD, V80, P2755
   Wang JQ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00367
   Watanabe Y, 2012, DIABETES, V61, P1199, DOI 10.2337/db11-1182
   WIELS J, 1981, P NATL ACAD SCI-BIOL, V78, P6485, DOI 10.1073/pnas.78.10.6485
   Won JS, 2007, J NEUROCHEM, V103, P180, DOI 10.1111/j.1471-4159.2007.04822.x
   Woodruff TM, 2008, J IMMUNOL, V181, P8727
   Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0
   YAMASHIRO S, 1995, GLYCOCONJUGATE J, V12, P894, DOI 10.1007/BF00731251
   Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142
   Yang LB, 2000, J NEUROSCI, V20, P7505
   Yao DG, 2014, J NEUROSCI, V34, P880, DOI 10.1523/JNEUROSCI.3996-13.2014
NR 94
TC 1
Z9 1
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2015
VL 571
BP 58
EP 65
DI 10.1016/j.abb.2015.02.007
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF9ZQ
UT WOS:000352926800007
PM 25688919
ER

PT J
AU De Moliner, K
   Wolfson, ML
   Perrone-Bizzozero, N
   Adamo, AM
AF De Moliner, Karina
   Wolfson, Manuel Luis
   Perrone-Bizzozero, Nora
   Adamo, Ana M.
TI GAP-43 slows down cell cycle progression via sequences in its 3 ' UTR
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE GAP-43; RNA-binding protein; Cell cycle control; 3 ' UTR
ID PROTEIN-KINASE-C; MESSENGER-RNA DEGRADATION; POSTTRANSCRIPTIONAL
   REGULATION; GENE-EXPRESSION; NERVOUS-SYSTEM; PC12 CELLS; NEURONAL
   DIFFERENTIATION; UNTRANSLATED REGION; BIPHASIC ACTIVATION; NEURAL
   DEVELOPMENT
AB Growth-associated protein 43 (GAP-43) is a neuronal phosphoprotein associated with initial axonal outgrowth and synaptic remodeling and recent work also suggests its involvement in cell cycle control. The complex expression of GAP-43 features transcriptional and posttranscriptional components. However, in some conditions, GAP-43 gene expression is controlled primarily by the interaction of stabilizing or destabilizing RNA-binding proteins (RBPs) with adenine and uridine (AU)-rich instability elements (AREs) in its 3 ' UTR. Like GAP-43, many proteins involved in cell proliferation are encoded by ARE-containing mRNAs, some of which codify cell-cycle-regulating proteins including cyclin D1. Considering that GAP-43 and cyclin D1 mRNA stabilization may depend on similar RBPs, this study evaluated the participation of GAP-43 in cell cycle control and its underlying mechanisms, particularly the possible role of its 3 ' UTR, using GAP-43-transfected NIH-3T3 fibroblasts. Our results show an arrest in cell cycle progression in the G(0)/G(1), phase. This arrest may be mediated by the competition of GAP-43 3 ' UTR with cyclin D1 3 ' UTR for the binding of Hu proteins such as HuR, which may lead to a decrease in cyclin D1 expression. These results might lead to therapeutic applications involving the use of sequences in the B region of GAP-43 3 ' UTR to slow down cell cycle progression. (C) 2015 Elsevier Inc. All rights reserved.
C1 [De Moliner, Karina; Wolfson, Manuel Luis; Adamo, Ana M.] Univ Buenos Aires, Sch Pharm & Biochem, Dept Biol Chem, IQUIFIB UBA CONICET, Buenos Aires, DF, Argentina.
   [Perrone-Bizzozero, Nora] Univ New Mexico, Sch Med, Dept Neurosci & Psychiat, Albuquerque, NM 87131 USA.
RP Adamo, AM (reprint author), Univ Buenos Aires, Sch Pharm & Biochem, Dept Biol Chem, IQUIFIB UBA CONICET, Junin 956,C1113AAD, Buenos Aires, DF, Argentina.
EM amadamo@qb.ffyb.uba.ar
FU University of Buenos Aires, Argentina [20020090100281]; CONICET,
   Argentina [PIP830]
FX Supported by grants from the University of Buenos Aires (20020090100281)
   and CONICET (PIP830), Argentina.
CR ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108
   Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   TAMEMOTO H, 1992, J BIOL CHEM, V267, P20293
   Neve RL, 1998, J NEUROSCI, V18, P7757
   MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845
   Kanazir S, 1996, MOL BRAIN RES, V38, P145, DOI 10.1016/0169-328X(96)00008-3
   CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1
   Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5
   Dou CL, 1999, CEREB CORTEX, V9, P543, DOI 10.1093/cercor/9.6.543
   SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7
   SZABO A, 1991, CELL, V67, P325
   Tarui T, 2005, CEREB CORTEX, V15, P1343, DOI 10.1093/cercor/bhi017
   Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044
   Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046
   KAHAN C, 1992, J BIOL CHEM, V267, P13369
   Mobarak CD, 2000, MOL BIOL CELL, V11, P3191
   BELL RM, 1991, J BIOL CHEM, V266, P4661
   BRITTIS PA, 1995, EXP NEUROL, V134, P1, DOI 10.1006/exnr.1995.1031
   Chiaramello A, 1996, J BIOL CHEM, V271, P22035
   Cremisi F, 2003, CURR OPIN NEUROBIOL, V13, P26, DOI 10.1016/S0959-4388(03)00005-9
   Dyer MA, 2000, DEVELOPMENT, V127, P3593
   EGGEN BJL, 1994, MOL BRAIN RES, V23, P221, DOI 10.1016/0169-328X(94)90229-1
   Esdar C, 1999, EUR J NEUROSCI, V11, P503, DOI 10.1046/j.1460-9568.1999.00455.x
   Gilardini A, 2008, CURR MED CHEM, V15, P3025, DOI 10.2174/092986708786848622
   Huang ZY, 2003, CANCER RES, V63, P2933
   Kinney WR, 1996, MOL BRAIN RES, V38, P25, DOI 10.1016/0169-328X(95)00287-3
   Lange C, 2010, CELL CYCLE, V9, P1893
   Mani S, 2001, MOL CELL NEUROSCI, V17, P54, DOI 10.1006/mcne.2000.0931
   Meiri KF, 1998, J NEUROSCI, V18, P10429
   MEIRI KF, 1990, J NEUROSCI, V10, P256
   Mishra R, 2008, CELL CYCLE, V7, P348
   Nakayama T, 2009, JPN J CLIN ONCOL, V39, P251, DOI 10.1093/jjco/hyp011
   Namgung U, 2000, EUR J NEUROSCI, V12, P3124, DOI 10.1046/j.1460-9568.2000.00196.x
   Neve R L, 1987, Brain Res, V388, P177, DOI 10.1016/S0006-8993(87)80012-4
   Nguyen L, 2006, CELL CYCLE, V5, P2314, DOI 10.4161/cc.5.20.3381
   Ohnuma S, 2001, CURR OPIN NEUROBIOL, V11, P66, DOI 10.1016/S0959-4388(00)00175-6
   Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175
   PERRONE-BIZZOZERO N I, 1991, Molecular and Cellular Neuroscience, V2, P402
   PERRONEBIZZOZERO NI, 1993, J CELL BIOL, V120, P1263, DOI 10.1083/jcb.120.5.1263
   ROSS J, 1995, MICROBIOL REV, V59, P423
   Shen YP, 2008, CEREBELLUM, V7, P451, DOI 10.1007/s12311-008-0049-5
   Shen YP, 2004, MOL CELL NEUROSCI, V26, P390, DOI 10.1016/j.mcn.2004.03.004
   STARR RG, 1994, BRAIN RES, V638, P211, DOI 10.1016/0006-8993(94)90652-1
   STRITTMATTER SM, 1994, J CELL SCI, V107, P195
   Tsai KC, 1997, J NEUROSCI, V17, P1950
   VANHOOFF COM, 1989, J CELL BIOL, V108, P1115, DOI 10.1083/jcb.108.3.1115
   Zhao JP, 2009, INT J DEV NEUROSCI, V27, P531, DOI 10.1016/j.ijdevneu.2009.06.013
   ZWIERS H, 1990, PEPTIDES, V11, P951, DOI 10.1016/0196-9781(90)90015-W
NR 49
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2015
VL 571
BP 66
EP 75
DI 10.1016/j.abb.2015.02.024
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF9ZQ
UT WOS:000352926800008
PM 25721498
ER

PT J
AU Gianulis, EC
   Pakhomov, AG
AF Gianulis, Elena C.
   Pakhomov, Andrei G.
TI Gadolinium modifies the cell membrane to inhibit permeabilization by
   nanosecond electric pulses
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Electroporation; Nanosecond electric pulses; Gadolinium; Lanthanide ions
ID RABBIT VENTRICULAR MYOCYTES; PHOSPHATIDYLSERINE MEMBRANES;
   CALCIUM-CHANNELS; ION CHANNELS; CATIONS; FUSION; PHASE; BLOCK; PORE;
   FLUORESCENCE
AB Lanthanide ions are the only known blockers of permeabilization by electric pulses of nanosecond duration (nsEP), but the underlying mechanisms are unknown. We employed timed applications of Gd3+ before or after nsEP (600-ns, 20 kV/cm) to investigate the mechanism of inhibition, and measured the uptake of the membrane-impermeable YO-PRO-1 (YP) and propidium (Pr) dyes. Gd3+ inhibited dye uptake in a concentration-dependent manner. The inhibition of Pr uptake was always about 2-fold stronger. Gd3+ was effective when added after nsEP, as well as when it was present during nsEP exposure and removed afterward. Pores formed by nsEP in the presence of Gd3+ remained quiescent unless Gd3+ was promptly washed away. Such pores resealed (or shrunk) shortly after the wash despite the absence of Gd3+. Finally, a brief (3 s) Gd3+ perfusion was equally potent at inhibiting dye uptake when performed either immediately before or after nsEP, or early before nsEP. The persistent protective effect of Gd3+ even in its absence proves that inhibition by Gd3+ does not result from simple pore obstruction. Instead, Gd3+ causes lasting modification of the membrane, occurring promptly and irrespective of pore presence; it makes the membrane less prone to permeabilization and/or reduces the stability of electropores. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Gianulis, Elena C.; Pakhomov, Andrei G.] Old Dominion Univ, Frank Reidy Ctr Bioelect, Norfolk, VA 23508 USA.
RP Gianulis, EC (reprint author), Old Dominion Univ, Frank Reidy Ctr Bioelect, 4211 Monarch Way,Suite 300, Norfolk, VA 23508 USA.
EM egianulis@odu.edu
FU National Institute of General Medical Sciences [R01GM088303]
FX This work was supported by R01GM088303 from the National Institute of
   General Medical Sciences (to A.G.P.). We thank Dr. S. Xiao (Old Dominion
   University, Norfolk, VA) for continued help with nsEP exposure and
   dosimetry.
CR Akuzawa-Tateyama M, 1998, J PHYSIOL-LONDON, V513, P775, DOI 10.1111/j.1469-7793.1998.775ba.x
   Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423
   Andre FM, 2010, BIOELECTROCHEMISTRY, V79, P95, DOI 10.1016/j.bioelechem.2009.12.007
   Ermakov YA, 2001, BIOPHYS J, V80, P1851
   Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008
   Lerner I, 2006, J NEUROCHEM, V97, P116, DOI 10.1111/j.1471-4159.2006.03709.x
   LANSMAN JB, 1990, J GEN PHYSIOL, V95, P679, DOI 10.1085/jgp.95.4.679
   YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333
   Pakhomova ON, 2014, BBA-BIOMEMBRANES, V1838, P2547, DOI 10.1016/j.bbamem.2014.06.015
   Nesin OM, 2011, BBA-BIOMEMBRANES, V1808, P792, DOI 10.1016/j.bbamem.2010.12.012
   MLINAR B, 1993, J PHYSIOL-LONDON, V469, P639
   Bowman AM, 2010, J MEMBRANE BIOL, V236, P15, DOI 10.1007/s00232-010-9269-y
   Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468
   Palasz A, 2000, ACTA BIOCHIM POL, V47, P1107
   Pakhomova ON, 2013, J CELL MOL MED, V17, P154, DOI 10.1111/j.1582-4934.2012.01658.x
   Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354
   Tanaka T, 2001, BBA-BIOMEMBRANES, V1515, P189, DOI 10.1016/S0005-2736(01)00413-8
   CHANTURIYA AN, 1994, J MEMBRANE BIOL, V137, P71
   Vernier PT, 2009, LANGMUIR, V25, P1020, DOI 10.1021/la8025057
   Martin-Molina A, 2012, BIOPHYS J, V102, P2095, DOI 10.1016/j.bpj.2012.03.009
   Alexy T, 2007, BIORHEOLOGY, V44, P361
   Suzuki T, 1997, J HISTOCHEM CYTOCHEM, V45, P49
   Ermakov YA, 2010, BIOPHYS J, V98, P1018, DOI 10.1016/j.bpj.2009.11.044
   Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035
   Sinn CG, 2006, COLLOID SURFACE A, V282, P410, DOI 10.1016/j.colsurfa.2005.10.014
   BENTZ J, 1988, BIOPHYS J, V53, P593
   Dyachok O, 2010, J MEMBRANE BIOL, V238, P69, DOI 10.1007/s00232-010-9320-z
   Hamill OP, 1996, PHARMACOL REV, V48, P231
   Levine ZA, 2012, J MEMBRANE BIOL, V245, P599, DOI 10.1007/s00232-012-9471-1
   Li GR, 2001, AM J PHYSIOL-HEART C, V280, pH272
   LI XM, 1994, J INORG BIOCHEM, V53, P139, DOI 10.1016/0162-0134(94)85028-3
   Lipski J, 2006, BRAIN RES, V1077, P187, DOI 10.1016/j.brainres.2006.01.016
   Malasics A, 2010, BBA-BIOMEMBRANES, V1798, P2013, DOI 10.1016/j.bbamem.2010.08.001
   Martin-Molina A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168103
   Morotomi-Yano K, 2013, BIOCHEM BIOPH RES CO, V438, P557, DOI 10.1016/j.bbrc.2013.07.083
   Mussauer H, 1999, J MEMBRANE BIOL, V170, P121, DOI 10.1007/s002329900542
   OHKI S, 1986, BIOCHIM BIOPHYS ACTA, V861, P177, DOI 10.1016/0005-2736(86)90416-5
   Pakhomov A.G., 2010, ADV ELECTROPORATION, P177
   Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003
   Pakhomova ON, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017100
   Song YM, 2002, J PHYSIOL-LONDON, V545, P463, DOI 10.1113/jphysiol.2002.031039
   Tsai HHG, 2012, BBA-BIOMEMBRANES, V1818, P2742, DOI 10.1016/j.bbamem.2012.05.029
   Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37
   Verstraeten SV, 1997, ARCH BIOCHEM BIOPHYS, V338, P121, DOI 10.1006/abbi.1996.9810
   Wu SN, 2011, BIOCHEM BIOPH RES CO, V405, P508, DOI 10.1016/j.bbrc.2011.01.066
NR 45
TC 3
Z9 3
U1 3
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2015
VL 570
BP 1
EP 7
DI 10.1016/j.abb.2015.02.013
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF1UC
UT WOS:000352332400001
PM 25707556
ER

PT J
AU Chen, YL
   Chen, C
   Feng, C
   Tang, AL
   Ma, YD
   He, X
   Li, YH
   He, JG
   Dong, YG
AF Chen, Yili
   Chen, Cong
   Feng, Cong
   Tang, Anli
   Ma, Yuedong
   He, Xin
   Li, Yanhui
   He, Jiangui
   Dong, Yugang
TI AVE 3085, a novel endothelial nitric oxide synthase enhancer, attenuates
   cardiac remodeling in mice through the Smad signaling pathway
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE AVE 3085; Cardiac remodeling; Smad signaling; Pressure overload; eNOS
ID LEFT-VENTRICULAR HYPERTROPHY; MYOCARDIAL-INFARCTION; PRESSURE-OVERLOAD;
   INHIBITION; APOPTOSIS
AB AVE 3085 is a novel endothelial nitric oxide synthase enhancer. Although AVE 3085 treatment has been shown to be effective in spontaneously restoring endothelial function in hypertensive rats, little is known about the effects and mechanisms of AVE 3085 with respect to cardiac remodeling. The present study was designed to examine the effects of AVE 3085 on cardiac remodeling and the mechanisms underlying the effects of this compound. Mice were subjected to aortic banding to induce cardiac remodeling and were then administered AVE 3085 (10 mg kg day(-1), orally) for 4 weeks. At the end of the treatment, the aortic banding-treated mice exhibited significant elevations in cardiac remodeling, characterized by an increase in left ventricular weight relative to body weight, an increase in the area of collagen deposition, an increase in the mean myocyte diameter, and increases in the gene expressions of the hypertrophic markers atrial natriuretic peptide (ANP) and beta-MHC. These indexes were significantly decreased in the AVE 3085-treated mice. Furthermore, AVE 3085 treatment reduced the expression and activation of the Smad signaling pathway in the aortic banding-treated mice. Our data showed that AVE 3085 attenuated cardiac remodeling, and this effect was possibly mediated through the inhibition of Smad signaling. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Chen, Yili; Chen, Cong; Feng, Cong; Tang, Anli; Ma, Yuedong; Li, Yanhui; He, Jiangui; Dong, Yugang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510080, Guangdong, Peoples R China.
   [Chen, Yili; Chen, Cong; Feng, Cong; Tang, Anli; Ma, Yuedong; Li, Yanhui; He, Jiangui; Dong, Yugang] Minist Hlth, Key Lab Assisted Circulat, Guangzhou 510080, Guangdong, Peoples R China.
   [He, Xin] Sun Yat Sen Univ, Fac Clin Med, Zhongshan Sch Med, Year Programme 8, Guangzhou 510080, Guangdong, Peoples R China.
RP He, JG (reprint author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, 58 Zhongshan II Rd, Guangzhou 510080, Guangdong, Peoples R China.
EM hejiangui@163.com; ylinter@163.com
FU National Science Foundation of China [81100171, 81270318, 81200173];
   5010 Research Program for Clinical Medicine, Sun Yat-sen University
   [2007011]
FX This work was supported by the National Science Foundation of China
   [grants 81100171, 81270318 and 81200173] and the 5010 Research Program
   for Clinical Medicine, Sun Yat-sen University (2007011).
CR Cheang WS, 2011, CARDIOVASC RES, V92, P267, DOI 10.1093/cvr/cvr233
   Forstermann U, 2011, BRIT J PHARMACOL, V164, P213, DOI 10.1111/j.1476-5381.2010.01196.x
   Pu J, 2013, EUR HEART J, V34, P1834, DOI 10.1093/eurheartj/ehs011
   Fraccarollo D, 2008, CIRCULATION, V118, P818, DOI 10.1161/CIRCULATIONAHA.107.717702
   Westermann D, 2009, BASIC RES CARDIOL, V104, P499, DOI 10.1007/s00395-009-0014-6
   Pu J, 2014, J AM COLL CARDIOL, V63, P2220, DOI 10.1016/j.jacc.2014.02.576
   Kwon JS, 2014, LIFE SCI, V101, P15, DOI 10.1016/j.lfs.2014.02.009
   Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006
   Chen LL, 2007, CARDIOVASC PATHOL, V16, P221, DOI 10.1016/j.carpath.2007.02.007
   Bjornstad JL, 2012, CARDIOVASC RES, V93, P100, DOI 10.1093/cvr/cvr294
   Chu Y, 2002, ARTERIOSCL THROM VAS, V22, P611, DOI 10.1161/01.ATV.0000012663.85364.FA
   He JG, 2009, EUR J PHARMACOL, V602, P132, DOI 10.1016/j.ejphar.2008.10.064
   He JG, 2010, CLIN EXP PHARMACOL P, V37, P283, DOI 10.1111/j.1440-1681.2009.05281.x
   He Q., 2014, CIRC HEART FAIL
   Li A.H., 2014, CIRC RES, V28, P916
   Li Y., 2014, ARCH BIOCH BIOPHYS
   Saura M, 2002, CIRC RES, V91, P806, DOI 10.1161/01.RES.0000040397.23817.E5
   Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882
   Sun G, 2014, ARCH BIOCHEM BIOPHYS, V542, P1, DOI 10.1016/j.abb.2013.11.011
   Yagi S, 2008, CIRC RES, V102, P68, DOI 10.1161/CIRCRESAHA.107.163493
   Yang Q, 2011, BRIT J PHARMACOL, V163, P1078, DOI 10.1111/j.1476-5381.2011.01308.x
   Zhang Y, 2014, HYPERTENS RES, V37, P43, DOI 10.1038/hr.2013.119
NR 22
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2015
VL 570
BP 8
EP 13
DI 10.1016/j.abb.2015.02.020
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF1UC
UT WOS:000352332400002
PM 25712222
ER

PT J
AU Huang, JS
   Smith, F
   Panizzi, JR
   Goodwin, DC
   Panizzi, P
AF Huang, Jiansheng
   Smith, Forrest
   Panizzi, Jennifer R.
   Goodwin, Douglas C.
   Panizzi, Peter
TI Inactivation of myeloperoxidase by benzoic acid hydrazide
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Myeloperoxidase; Inflammation; Benzoic acid hydrazide
ID PROTEIN COVALENT BONDS; PROSTHETIC HEME GROUP; HORSERADISH-PEROXIDASE;
   CATALASE-PEROXIDASE; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE;
   LACTOPEROXIDASE; MECHANISM; OXIDATION; CLEAVAGE
AB Myeloperoxidase (MPO) is expressed by myeloid cells for the purpose of catalyzing the formation of hypochlorous acid, from chloride ions and reaction with a hydrogen peroxide-charged heme covalently bound to the enzyme. Most peroxidase enzymes both plant and mammalian are inhibited by benzoic acid hydrazide (BAH)-containing compounds, but the mechanism underlying MPO inhibition by BAH compounds is largely unknown. Recently, we reported MPO inhibition by BAH and 4-(trifluoromethyl)-BAH was due to hydrolysis of the ester bond between MPO heavy chain glutamate 242 ((HC)Glu(242)) residue and the heme pyrrole A ring, freeing the heme linked light chain MPO subunit from the larger remaining heavy chain portion. Here we probed the structure and function relationship behind this ester bond cleavage using a panel of BAH analogs to gain insight into the constraints imposed by the MPO active site and channel leading to the buried protoporphyrin IX ring. In addition, we show evidence that destruction of the heme ring does not occur by tracking the heme prosthetic group and provide evidence that the mechanism of hydrolysis follows a potential attack of the (HC)Glu(242) carbonyl leading to a rearrangement causing the release of the vinyl-sulfonium linkage between (HC)Met(243) and the pyrrole A ring. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Huang, Jiansheng; Smith, Forrest; Panizzi, Peter] Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, Auburn, AL 36849 USA.
   [Panizzi, Jennifer R.] Auburn Univ, Coll Vet Med, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA.
   [Goodwin, Douglas C.] Auburn Univ, Coll Sci & Math, Dept Chem & Biochem, Auburn, AL 36849 USA.
RP Panizzi, P (reprint author), Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, 3211-J Walker Bldg, Auburn, AL 36849 USA.
EM panizzi@auburn.edu
OI Panizzi, Peter/0000-0003-0141-8807
FU National Institutes of Health through National Heart, Lung, and Blood
   Institute [R00HL094533, R01HL114477]; National Institute of Allergy and
   Infectious Diseases [2R44AI085840-02]; Auburn University Research
   Initiative Cancer Graduate Fellowship
FX Supported by the National Institutes of Health through grants provided
   by the National Heart, Lung, and Blood Institute, R00HL094533 (to P.P.)
   and R01HL114477 (to P.P.), the National Institute of Allergy and
   Infectious Diseases grant 2R44AI085840-02 (to P.P.) and Auburn
   University Research Initiative Cancer Graduate Fellowship (to J.H.)
CR ANDREWS PC, 1982, J BIOL CHEM, V257, P13240
   ANDREWS PC, 1982, ANAL BIOCHEM, V127, P346, DOI 10.1016/0003-2697(82)90185-3
   Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834
   Kettle AJ, 1997, REDOX REP, V3, P257
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]
   Paumann-Page M, 2013, ARCH BIOCHEM BIOPHYS, V539, P51, DOI 10.1016/j.abb.2013.09.004
   Kettle AJ, 1997, BIOCHEM J, V321, P503
   Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Colas C, 2004, J BIOL CHEM, V279, P24131, DOI 10.1074/jbc.M401687200
   Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017
   Wojciechowski G, 2005, J AM CHEM SOC, V127, P15871, DOI 10.1021/ja054084t
   ATOR MA, 1987, J BIOL CHEM, V262, P1542
   Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303
   Arvadia P, 2011, ARCH BIOCHEM BIOPHYS, V515, P120, DOI 10.1016/j.abb.2011.07.015
   ATOR MA, 1987, J BIOL CHEM, V262, P14954
   Baker RD, 2006, BIOCHEMISTRY-US, V45, P7113, DOI 10.1021/bi052392y
   Colas C, 2002, J BIOL CHEM, V277, P7191, DOI 10.1074/jbc.M109523200
   Everse J, 1998, FREE RADICAL BIO MED, V24, P1338, DOI 10.1016/S0891-5849(97)00451-6
   Forman HJ, 2015, FREE RADICAL BIO MED, V78, P233, DOI 10.1016/j.freeradbiomed.2014.10.504
   HARRISON JE, 1980, BIOCHEM BIOPH RES CO, V94, P34, DOI 10.1016/S0006-291X(80)80183-5
   Huang JS, 2014, ARCH BIOCHEM BIOPHYS, V548, P74, DOI 10.1016/j.abb.2014.02.014
   Huang LS, 2006, J BIOL CHEM, V281, P18983, DOI 10.1074/jbc.M602307200
   Huang LS, 2006, ARCH BIOCHEM BIOPHYS, V446, P77, DOI 10.1016/j.abb.2005.11.011
   LANGE M, 1981, TETRAHEDRON LETT, V22, P2561, DOI 10.1016/S0040-4039(01)90520-9
   PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4331, DOI 10.1021/bi00013a023
   POULOS TL, 1993, J BIOL CHEM, V268, P4429
   TAYLOR KL, 1992, J BIOL CHEM, V267, P25282
NR 28
TC 0
Z9 0
U1 6
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2015
VL 570
BP 14
EP 22
DI 10.1016/j.abb.2015.01.028
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF1UC
UT WOS:000352332400003
PM 25688920
ER

PT J
AU Ochi, A
   Nakao, R
   Yamamoto, Y
   Kitahata, K
   Takagi, M
   Hirasaka, K
   Ohno, A
   Teshima-Kondo, S
   Taesik, G
   Choi, I
   Kawamura, T
   Nemoto, H
   Mukai, R
   Terao, J
   Nikawa, T
AF Ochi, Arisa
   Nakao, Reiko
   Yamamoto, Yoriko
   Kitahata, Kanako
   Takagi, Marina
   Hirasaka, Katsuya
   Ohno, Ayako
   Teshima-Kondo, Shigetada
   Taesik, Gwag
   Choi, Inho
   Kawamura, Tomoyuki
   Nemoto, Hisao
   Mukai, Rie
   Terao, Junji
   Nikawa, Takeshi
TI N-myristoylated ubiquitin ligase Cbl-b inhibitor prevents on
   glucocorticoid-induced atrophy in mouse skeletal muscle
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cbl-b; IRS-1; Mice; Skeletal muscle atrophy; Ubiquitin ligase inhibitor
ID PROTEASOME PATHWAY; GENE-EXPRESSION; DENERVATION; TRANSPORT; ACTIVATION;
   CELL
AB A DGpYMP peptide mimetic of tyrosine (608)-phosphorylated insulin receptor substrate-1 (IRS-1), named Cblin, was previously shown to significantly inhibit Cbl-b-mediated IRS-1 ubiquitination. In the present study, we developed N-myristoylated Cblin and investigated whether it was effective in preventing glucocorticoid-induced muscle atrophy. Using HEK293 cells overexpressing Cbl-b, IRS-1 and ubiquitin, we showed that the 50% inhibitory concentrations of Cbl-b-mediated IRS-1 ubiquitination by N-myristoylated Cblin and Cblin were 30 and 120 mu M, respectively. Regarding the DEX-induced atrophy of C2C12 myotubes, N-myristoylated Cblin was more effective than Cblin for inhibiting the DEX-induced decreases in C2C12 myotube diameter and IRS-1 degradation. The inhibitory efficacy of N-myristoylated Cblin on IRS-1 ubiquitination in C2C12 myotubes was approximately fourfold larger than that of Cblin. Furthermore, N-myristoylation increased the incorporation of Cblin into HEK293 cells approximately 10-folds. Finally, we demonstrated that N-myristoylated Cblin prevented the wet weight loss, IRS-1 degradation, and MAFbx/atrogin-1 and MuRF-1 expression in gastrocnemius muscle of DEX-treated mice approximately fourfold more effectively than Cblin. Taken together, these results suggest that N-myristoylated Cblin prevents DEX-induced skeletal muscle atrophy in vitro and in vivo, and that N-myristoylated Cblin more effectively prevents muscle atrophy than unmodified Cblin. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ochi, Arisa; Nakao, Reiko; Yamamoto, Yoriko; Kitahata, Kanako; Takagi, Marina; Hirasaka, Katsuya; Ohno, Ayako; Teshima-Kondo, Shigetada; Nikawa, Takeshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nutr Physiol, Tokushima 7708503, Japan.
   [Yamamoto, Yoriko] Natl Inst Adv Ind Sci & Technol, Tsukuba 3058566, Japan.
   [Taesik, Gwag; Choi, Inho] Yonsei Univ, Coll Sci & Technol, Div Biol Sci & Technol, Yonsei 3058566, South Korea.
   [Kawamura, Tomoyuki; Nemoto, Hisao] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmaceut Chem, Tokushima 7708503, Japan.
   [Mukai, Rie; Terao, Junji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Food Sci, Tokushima 7708503, Japan.
RP Nikawa, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nutr Physiol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.
EM nikawa@tokushima-u.ac.jp
FU Promotion of Basic Research Activities for Innovative Biosciences from
   the Bio-Oriented Technology Research Advancement Institution of Japan;
   Japan Aerospace Exploration Agency
FX We thank Dr. Kishi for providing pLX2-IRS-1, Dr. Lipkowitz for providing
   pCEFL-Cbl-b-HA, and Dr. Suzuki for providing pcDNA3-FLAG-Ubiquitin. This
   work was supported in part by a grant from the Promotion of Basic
   Research Activities for Innovative Biosciences from the Bio-Oriented
   Technology Research Advancement Institution of Japan to T. N. and J.T.
   This study was also supported by a grant (to T.N.) provided by the Japan
   Aerospace Exploration Agency, which sponsored this study as part of a
   space-related biological experiment, known as the "MyoLab" (T.N. is the
   principal investigator of this).
CR Ananth S, 2012, J PHARM SCI-US, V101, P154, DOI 10.1002/jps.22733
   CLANDININ MT, 1991, FASEB J, V5, P2761
   Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4
   Nelson AR, 2007, BIOCHEMISTRY-US, V46, P14771, DOI 10.1021/bi701295k
   Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08
   Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036
   Ogawa T, 2006, MUSCLE NERVE, V34, P463, DOI 10.1002/mus.20611
   MEDINA R, 1991, BIOMED BIOCHIM ACTA, V50, P347
   Robinson LE, 2007, APPL PHYSIOL NUTR ME, V32, P1008, DOI 10.1139/H07-087
   GOLDBERG AL, 1969, AM J PHYSIOL, V216, P1116
   Hirasaka K., 2005, BIOCHIM BIOPHYS ACTA, V743, P130
   Ikemoto M, 2001, FASEB J, V15, P1279
   Lecker SH, 1999, J NUTR, V129, p227S
   Nakao R, 2014, CHRONOBIOL INT, V31, P506, DOI 10.3109/07420528.2013.872654
   Nikawa T, 2004, FASEB J, V18, P522, DOI 10.1096/fj.03-0419fje
   Parag P., 2010, MOL CELL BIOL, V17, P4094
   Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541
   SCHULTZ AM, 1988, ANNU REV CELL BIOL, V4, P611, DOI 10.1146/annurev.cb.04.110188.003143
   Suzue N, 2006, J BONE MINER RES, V21, P722, DOI 10.1359/JBMR.060207
NR 19
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2015
VL 570
BP 23
EP 31
DI 10.1016/j.abb.2015.02.006
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF1UC
UT WOS:000352332400004
PM 25689493
ER

PT J
AU Xu, XL
   Chen, SW
   Salinas, ND
   Tolia, NH
   Grant, GA
AF Xu, Xiao Lan
   Chen, Shawei
   Salinas, Nichole D.
   Tolia, Niraj H.
   Grant, Gregory A.
TI Comparison of Type 1 D-3-phosphoglycerate dehydrogenases reveals unique
   regulation in pathogenic Mycobacteria
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Phosphoglycerate; Dehydrogenase; L-Serine; Mycobacteria; Feedback
   inhibition
ID 3-PHOSPHOGLYCERATE DEHYDROGENASE; SUBSTRATE-INHIBITION; ANIMAL TISSUES;
   BINDING; SERINE; PATHWAYS; DOMAIN
AB D-3-phosphoglycerate dehydrogenases (PGDH) from all organisms catalyze the conversion of D-3-phosphoglycerate to phosphohydroxypyruvate as the first step in the biosynthesis of L-serine. This investigation compares the properties of Type 1 PGDHs from seven different species and demonstrates that conserved residues in the ACT and ASB domains of some allow L-serine to act as a feedback inhibitor at low micromolar concentrations. In addition, the serine sensitivity is dependent on the presence of phosphate ions. These residues are most highly conserved among PGDHs from the actinomycetales family, but only certain pathogenic mycobacteria appear to have the full complement of residues required for high sensitivity to serine. These basic residues are also responsible for the presence of dual pH optima in the acidic region that is also phosphate dependent. Analytical ultracentrifugation analysis demonstrates that the dual pH optima do not require changes in oligomeric state. This study also demonstrates that substrate inhibition is a common feature of Type 1 PGDHs and that it is suppressed by phosphate, indicating that phosphate likely interacts at both the catalytic and regulatory sites. The unique features resulting from the complement of basic residues conserved in pathogenic mycobacteria may impart important metabolic advantages to these organisms. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Xu, Xiao Lan; Chen, Shawei; Grant, Gregory A.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.
   [Salinas, Nichole D.; Tolia, Niraj H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Grant, Gregory A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
RP Grant, GA (reprint author), Washington Univ, Sch Med, Dept Med & Dev Biol, St Louis, MO 63110 USA.
EM ggrant@wustl.edu
FU Department of Developmental Biology
FX We thank the following for providing chromosomal DNA used to clone PGDH
   enzymes by PCR: Christina Stallings for M. marinum and M. smegmatis,
   Joseph R. McCormick for S. coelicolor, Petra Levin for B. subtilis, and
   Hazel Holden for C. glutamicum. We thank Burton Wice for cloning and
   providing the gene encoding human liver PGDH. Support for this research
   was provided by the Department of Developmental Biology.
CR Ali V, 2004, EUR J BIOCHEM, V271, P2670, DOI 10.1111/j.1432-1033.2004.04195.x
   Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210
   LiCata VJ, 1997, BIOPHYS CHEM, V64, P225, DOI 10.1016/S0301-4622(96)02204-1
   Achouri Y, 1997, BIOCHEM J, V323, P365
   Burton RL, 2007, J BIOL CHEM, V282, P31517, DOI 10.1074/jbc.M704032200
   [Anonymous], 1992, ANAL CENTRIFUGATION
   Peters-Wendisch P, 2002, APPL MICROBIOL BIOT, V60, P437, DOI 10.1007/s00253-002-1161-y
   Burton RL, 2009, BIOCHEMISTRY-US, V48, P4808, DOI 10.1021/bi900172q
   Dey S, 2005, J BIOL CHEM, V280, P14892, DOI 10.1074/jbc.M414489200
   Dey S, 2008, BIOCHEMISTRY-US, V47, P8271, DOI 10.1021/bi800212b
   Grant GA, 2012, ARCH BIOCHEM BIOPHYS, V519, P175, DOI 10.1016/j.abb.2011.10.005
   Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200
   ROSENBLU.IY, 1970, ARCH BIOCHEM BIOPHYS, V137, P91, DOI 10.1016/0003-9861(70)90414-5
   SASKI R, 1975, EUR J BIOCHEM, V51, P415, DOI 10.1111/j.1432-1033.1975.tb03941.x
   Slaughter J C, 1975, Methods Enzymol, V41, P278
   WALSH DA, 1966, J BIOL CHEM, V241, P4068
   Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094829
   WILLIS JE, 1964, BIOCHIM BIOPHYS ACTA, V81, P39, DOI 10.1016/0926-6569(64)90333-5
   Xu XL, 2014, BIOCHEMISTRY-US, V53, P4239, DOI 10.1021/bi500469d
   Zubay G., 1998, BIOCHEMISTRY-US, P572
NR 20
TC 0
Z9 0
U1 3
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2015
VL 570
BP 32
EP 39
DI 10.1016/j.abb.2015.02.008
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF1UC
UT WOS:000352332400005
PM 25698123
ER

PT J
AU Fernandez-Sierra, M
   Quinones, E
AF Fernandez-Sierra, Monica
   Quinones, Edwin
TI Assays for the determination of the activity of DNA nucleases based on
   the fluorometric properties of the YOYO dye
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE DNA intercalator; Fluorescence; Kinetics; Exonuclease; Endonuclease;
   Single-stranded DNA binding protein
ID SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; BINDING-PROTEIN;
   LAMBDA-EXONUCLEASE; RECA PROTEIN; PHOTOPHYSICAL PROPERTIES;
   FLUORESCENCE; INTERCALATORS; KINETICS; LIGANDS
AB Here we characterize the fluorescence of the YOYO dye as a tool for studying DNA-protein interactions in real time and present two continuous YOYO-based assays for sensitively monitoring the kinetics of DNA digestion by lambda-exonuclease and the endonuclease EcoRV. The described assays rely on the different fluorescence intensities between single- and double-stranded DNA-YOYO complexes, allowing straightforward determination of nuclease activity and quantitative determination of reaction products. The assays were also employed to assess the effect of single-stranded DNA-binding proteins on the lambda-exonuclease reaction kinetics, showing that the extreme thermostable single-stranded DNA-binding protein (ET-SSB) significantly reduced the reaction rate, while the recombination protein A (RecA) displayed no effect. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Fernandez-Sierra, Monica; Quinones, Edwin] Univ Puerto Rico, Dept Chem, Rio Piedras, PR 00936 USA.
RP Quinones, E (reprint author), Univ Puerto Rico, Dept Chem, Rio Piedras Campus, Rio Piedras, PR 00936 USA.
EM edwin.quinones3@upr.edu
FU NIH-RISE program
FX We received financial support through the NIH-RISE program.
CR Kunzelmann S, 2010, BIOCHEMISTRY-US, V49, P843, DOI 10.1021/bi901743k
   Gunther K, 2010, NUCLEIC ACIDS RES, V38, P6526, DOI 10.1093/nar/gkq434
   Mitsis PG, 1999, NUCLEIC ACIDS RES, V27, P3057, DOI 10.1093/nar/27.15.3057
   Murade CU, 2009, BIOPHYS J, V97, P835, DOI 10.1016/j.bpj.2009.05.024
   RYE HS, 1995, NUCLEIC ACIDS RES, V23, P1215, DOI 10.1093/nar/23.7.1215
   LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527
   MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X
   Furstenberg A, 2007, CHEM-EUR J, V13, P8600, DOI 10.1002/chem.200700665
   LITTLE JW, 1967, J BIOL CHEM, V242, P679
   Matsuura S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e79
   Cosa G, 2001, PHOTOCHEM PHOTOBIOL, V73, P585, DOI 10.1562/0031-8655(2001)073<0585:PPOFDD>2.0.CO;2
   Subramanian K, 2003, NUCLEIC ACIDS RES, V31, P1585, DOI 10.1093/nar/gkg266
   GLAZER AN, 1992, NATURE, V359, P859, DOI 10.1038/359859a0
   LARSSON A, 1994, J AM CHEM SOC, V116, P8459, DOI 10.1021/ja00098a004
   Bianco PR, 1996, NUCLEIC ACIDS RES, V24, P4933, DOI 10.1093/nar/24.24.4933
   CARLSSON C, 1994, J PHYS CHEM-US, V98, P10313, DOI 10.1021/j100091a055
   CHABBERT M, 1987, BIOCHEMISTRY-US, V26, P2218, DOI 10.1021/bi00382a022
   FADDEJEVA MD, 1991, TSITOLOGIYA+, V33, P3
   GEORGE JW, 1992, J BIOL CHEM, V267, P10683
   Han ES, 2006, NUCLEIC ACIDS RES, V34, P1084, DOI 10.1093/nar/gkj503
   Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z
   KUNKEL TA, 1979, P NATL ACAD SCI USA, V76, P6331, DOI 10.1073/pnas.76.12.6331
   LARSSON A, 1995, BIOPOLYMERS, V36, P153, DOI 10.1002/bip.360360205
   MCENTEE K, 1980, P NATL ACAD SCI-BIOL, V77, P857, DOI 10.1073/pnas.77.2.857
   Mishra N.C., 1995, MOL BIOL NUCLEASES
   Nishino T, 2002, ONCOGENE, V21, P9022, DOI 10.1038/sj.onc.1206135
   PRITCHAR.NJ, 1966, NATURE, V212, P1360, DOI 10.1038/2121360a0
   RADDING CM, 1971, J BIOL CHEM, V246, P2513
   Schein C. H, 2001, NUCLEASE METHODS PRO
   Tolun G, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng111
NR 30
TC 0
Z9 0
U1 7
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2015
VL 570
BP 40
EP 46
DI 10.1016/j.abb.2015.02.012
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF1UC
UT WOS:000352332400006
PM 25711531
ER

PT J
AU Kolawole, AO
   Hixon, BP
   Dameron, LS
   Chrisman, IM
   Smirnov, VV
AF Kolawole, Ayodele O.
   Hixon, Brian P.
   Dameron, Laura S.
   Chrisman, Ian M.
   Smirnov, Valeriy V.
TI Catalytic activity of human indoleamine 2,3-dioxygenase (hIDO1) at low
   oxygen
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Indoleamine dioxygenase; Oxygen electrode; Enzyme kinetics; Substrate
   analog; Inhibition; Global fit
ID SUPEROXIDE ANION; CYTOCHROME B(5); TRYPTOPHAN 2,3-DIOXYGENASE; EFFECTOR
   INTERACTIONS; SUBSTRATE-INHIBITION; MAJOR REDUCTANT; METHYLENE-BLUE;
   BINDING-SITE; IN-VITRO; ENZYME
AB A cytokine-inducible extrahepatic human indoleamine 2,3-dioxygenase (hIDO1) catalyzes the first step of the kynurenine pathway. Immunosuppressive activity of hIDO1 in tumor cells weakens host T-cell immunity, contributing to the progression of cancer. Here we report on enzyme kinetics and catalytic mechanism of hIDO1, studied at varied levels of dioxygen (O-2) and L-tryptophan (L-Trp). Using a cytochrome b(5)-based activating system, we measured the initial rates of O-2 decay with a Clark-type oxygen electrode at physiologically-relevant levels of both substrates. Kinetics was also studied in the presence of two substrate analogs: 1-methyl-L-tryptophan and norharmane. Quantitative analysis supports a steady-state rather than a rapid equilibrium kinetic mechanism, where the rates of individual pathways, leading to a ternary complex, are significantly different, and the overall rate of catalysis depends on contributions of both routes. One path, where O2 binds to ferrous hIDO1 first, is faster than the second route, which starts with the binding of L-Trp. However, L-Trp complexation with free ferrous hIDO1 is more rapid than that of O2. As the level of L-Trp increases, the slower route becomes a significant contributor to the overall rate, resulting in observed substrate inhibition. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Kolawole, Ayodele O.; Hixon, Brian P.; Dameron, Laura S.; Chrisman, Ian M.; Smirnov, Valeriy V.] Univ Montana, Ctr Biomol Struct & Dynam, Dept Chem & Biochem, Missoula, MT 59812 USA.
RP Smirnov, VV (reprint author), Univ Montana, Ctr Biomol Struct & Dynam, Dept Chem & Biochem, Missoula, MT 59812 USA.
EM valeriy.smirnov@umontana.edu
FU National Institute of General Medical Sciences of the National
   Institutes of Health [P20GM103546]; University of Montana; NSF
   [CHE-1039814]; NSF EPSCoR program under at the University of Montana
   [EPS-0701906]
FX We gratefully acknowledge Prof. A. Grant Mauk for the generous gift of
   hIDO1, cytochrome b<INF>5</INF>, and cytochrome b<INF>5</INF> reductase
   expression vectors and helpful discussions; Profs. Bruce E. Bowler and
   Stephen R. Sprang for the use of stopped-flow systems and other major
   biochemical equipment in their laboratories, and helpful discussions.
   Research reported in this publication was supported by the National
   Institute of General Medical Sciences of the National Institutes of
   Health under Award Number P20GM103546 and the University of Montana. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health. Acquisition of the Bruker Microflex MALDI-ToF mass spectrometer
   was supported by the NSF CHE-1039814 award. Purchase of the AVIV Model
   14 Spectrophotometer was supported by the NSF EPSCoR program under Grant
   # EPS-0701906 at the University of Montana.
CR Poulos TL, 2014, CHEM REV, V114, P3919, DOI 10.1021/cr400415k
   Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500
   Pearson JT, 2010, BIOCHEMISTRY-US, V49, P2647, DOI 10.1021/bi100022c
   CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6
   Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491
   YAMAMOTO S, 1967, J BIOL CHEM, V242, P5260
   Lu CY, 2009, J AM CHEM SOC, V131, P12866, DOI 10.1021/ja9029768
   CARLIN JM, 1987, J IMMUNOL, V139, P2414
   Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958
   Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802
   Roth A, 2010, P NATL ACAD SCI USA, V107, P19502, DOI 10.1073/pnas.1008178107
   Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x
   Davydov RM, 2010, J AM CHEM SOC, V132, P5494, DOI 10.1021/ja100518z
   Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066
   Weber B, 2014, J PHYS CHEM LETT, V5, P756, DOI 10.1021/jz500220k
   SONO M, 1980, J BIOL CHEM, V255, P1339
   Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103
   Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196
   Widner B, 1997, CLIN CHEM, V43, P2424
   Bertazzo A, 2001, BBA-GEN SUBJECTS, V1527, P167, DOI 10.1016/S0304-4165(01)00165-9
   Chauhan N, 2009, J AM CHEM SOC, V131, P4186, DOI 10.1021/ja808326g
   Chauhan N, 2008, BIOCHEMISTRY-US, V47, P4761, DOI 10.1021/bi702405a
   Cleland W.W., 1970, THE ENZYMES, VII, P1
   Cook PJ, 2007, ADV AUSTRIAN ECON, V10, P157, DOI 10.1016/S1529-2134(07)10007-7
   Cook P.F., 2007, ENZYME KINETICS MECH, P76
   CORNISHB.A, 1974, BIOCHEM J, V137, P143
   Dawson R.M.C., 1989, DATA BIOCH RES, P122
   Efimov I, 2012, J AM CHEM SOC, V134, P3034, DOI 10.1021/ja208694g
   FERDINAND W, 1966, BIOCHEM J, V98, P278
   Fromm H.J., 1975, INITIAL RATE ENZYME, P94
   Fromm H.J., 1975, INITIAL RATE ENZYME, P49
   Grant Mauk A., COMMUNICATION
   Herbert A, 2011, BRIT J DERMATOL, V164, P308, DOI 10.1111/j.1365-2133.2010.10086.x
   Hood BD, 1999, J BIOL CHEM, V274, P32547, DOI 10.1074/jbc.274.46.32547
   ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593
   Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106
   LLOYD E, 1994, BIOCHEMISTRY-US, V33, P11432, DOI 10.1021/bi00204a005
   Lu CY, 2010, BIOCHEMISTRY-US, V49, P5028, DOI 10.1021/bi1005078
   MADRAS BK, 1974, METABOLISM, V23, P1107, DOI 10.1016/0026-0495(74)90027-4
   Maghzal GJ, 2008, J BIOL CHEM, V283, P12014, DOI 10.1074/jbc.M710266200
   Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232
   Novitskiy SV, 2012, CANCER DISCOV, V2, P673, DOI 10.1158/2159-8290.CD-12-0311
   Rosell FI, 2011, J BIOL CHEM, V286, P29273, DOI 10.1074/jbc.M111.262139
   Schmidt SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063301
   Segel I.H., 1975, ENZYME KINETICS BEHA, P646
   Segel I.H., 1975, ENZYME KINETICS, P657
   SONO M, 1989, BIOCHEMISTRY-US, V28, P5400, DOI 10.1021/bi00439a013
   SONO M, 1989, BIOCHEMISTRY-US, V28, P5392, DOI 10.1021/bi00439a012
   SONO M, 1989, J BIOL CHEM, V264, P1616
   SONO M, 1986, BIOCHEMISTRY-US, V25, P6089, DOI 10.1021/bi00368a038
   TANIGUCHI T, 1979, J BIOL CHEM, V254, P3288
   Trepanier L.A., 2005, CURRENT PROTOCOL S24, DOI [10.1002/0471140856.tx0416s24, DOI 10.1002/0471140856.TX0416S24]
   Vazquez S, 2002, J BIOL CHEM, V277, P4867, DOI 10.1074/jbc.M107529200
   Voet D., 2004, BIOCHEMISTRY-US, P1098
   Vottero E, 2006, FEBS LETT, V580, P2265, DOI 10.1016/j.febslet.2006.03.034
   Wirleitner B, 2003, CURR MED CHEM, V10, P1581, DOI 10.2174/0929867033457179
   WOLF H, 1974, Scandinavian Journal of Clinical and Laboratory Investigation Supplement, V33, P11, DOI 10.3109/00365517409104201
   Yanagisawa S, 2010, CHEM LETT, V39, P36, DOI 10.1246/cl.2010.36
   Yanagisawa S, 2011, FARADAY DISCUSS, V148, P239, DOI 10.1039/c004552g
   Yanagisawa S, 2013, CHEM PHYS, V419, P178, DOI 10.1016/j.chemphys.2013.02.032
   YSI Inc, 2009, DISS OX HDB PRACT GU, P46
NR 61
TC 0
Z9 0
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2015
VL 570
BP 47
EP 57
DI 10.1016/j.abb.2015.02.014
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF1UC
UT WOS:000352332400007
PM 25712221
ER

PT J
AU Vieira, SM
   de Oliveir, VH
   Valente, RD
   Moreira, OD
   Fontes, CFL
   Mignaco, JA
AF Vieira, Saulo Martins
   de Oliveir, Vanessa Honorato
   Valente, Raphael do Carmo
   Moreira, Otacilio da Cruz
   Leite Fontes, Carlos Frederico
   Mignaco, Julio Alberto
TI Chelerythrine inhibits the sarco/endoplasmic reticulum Ca2+-ATPase and
   results in cell Ca2+ imbalance
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE SERCA; ATPase; Chelerythrine; PBMC; Cytotoxicity; Calcium
ID PROTEIN-KINASE-C; SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; SKELETAL-MUSCLE;
   ADENOSINE-TRIPHOSPHATASE; ALKALOID SANGUINARINE; MULTIDRUG-RESISTANCE;
   CARDIAC MYOCYTES; ION-TRANSPORT; ACTIVE-SITE
AB The isoquinoline alkaloid chelerythrine is described as an inhibitor of SERCA. The ATPase inhibition presented two non-competitive components, K-i1 = 1, 2 mu M and K-i2 = 26 mu M. Conversely, chelerythrine presented a dual effect on the p-nitrophenylphosphatase (pNPPase) of SERCA. Ca2+-dependent pNPPase was activated up to similar to 5 mu M chelerythrine with inhibition thereafter. Ca2+-independent pNPPase was solely inhibited. The phospholylation of SERCA with ATP reached half-inhibition with 10 mu M chelerythrine and did not parallel the decrease of ATPase activity. In contrast, chelerythrine up to 50 mu M increased the phosphorylation by P-i. Cross-linking of SERCA with glutaraldehyde was counteracted by high concentrations of chelerythrine. The controlled tryptic digestion of SERCA shows that the low-affinity binding of chelerythrine evoked an E-2-like pattern. Our data indicate a non-competitive inhibition of ATP hydrolysis that favors buildup of the E-2-conformers of the enzyme. Chelerythrine as low as 0.5-1.5 mu M resulted in an increase of intracellular Ca2+ on cultured PBMC cells. The inhibition of SERCA and the loss of cell Ca2+ homeostasis could in part be responsible for some described cytotoxic effects of the alkaloid. Thus, the choice of chelerythrine as a PKC-inhibitor should consider its potential cytotoxicity due to the alkaloid's effects on SERCA. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Vieira, Saulo Martins; de Oliveir, Vanessa Honorato; Valente, Raphael do Carmo; Leite Fontes, Carlos Frederico; Mignaco, Julio Alberto] Univ Fed Rio de Janeiro, CCS, Inst Bioquim Med Leopoldo Meis, BR-21941590 Rio de Janeiro, RJ, Brazil.
   [Valente, Raphael do Carmo] Univ Fed Rio de Janeiro, CCS, Inst Bies Carlos Chagas Filho, BR-21941590 Rio de Janeiro, RJ, Brazil.
   [Vieira, Saulo Martins] Fiocruz MS, Inst Oswaldo Cruz, Lab Toxinol, Rio De Janeiro, Brazil.
   [Moreira, Otacilio da Cruz] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol & Doengas Endem, Rio De Janeiro, Brazil.
RP Vieira, SM (reprint author), Univ Fed Rio de Janeiro, CCS, Inst Bioquim Med Leopoldo Meis, Lab Estrut & Regulacao Prote & ATPases, Sala H2-026,Ave Brigadeiro Trompowsky S-N, BR-21941590 Rio de Janeiro, RJ, Brazil.
EM saulomvieira@gmail.com; cfontes@bioqmed.ufrj.br;
   jmignaco@bioqmed.ufrj.br
RI Mignaco, Julio/J-3469-2013; fontes, carlos frederico/G-2343-2014
OI Mignaco, Julio/0000-0002-8491-092X; fontes, carlos
   frederico/0000-0002-9384-0898
FU CNPq; CAPES; FAPERJ
FX The helpful technical assistance of M.Sc. Monica M. Freire and Geiza L.
   Fraga is greatly acknowledged. We also thank the formerly undergraduate
   students Ana Paula Carvalho and Catarina C. P. Prima for their
   contribution in the beginning of this project. A.P.C. and C.C.P.P. were
   recipients of undergraduate fellowships from CNPq. V.H.O. and O.C.M.
   were recipients of graduate fellowships from CNPq. C.F.L.F. is recipient
   of a research fellowship from CNPq. This work was supported by grants
   from CNPq, CAPES and FAPERJ.
CR ANDERSEN JP, 1986, BIOCHEMISTRY-US, V25, P6439, DOI 10.1021/bi00369a015
   Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358
   Wan KF, 2008, J BIOL CHEM, V283, P8423, DOI 10.1074/jbc.M707687200
   Lewis D, 2012, J BIOL CHEM, V287, P32717, DOI 10.1074/jbc.M112.373472
   ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5
   Brini M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004168
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Yamamoto S, 2001, J MOL CELL CARDIOL, V33, P1829, DOI 10.1006/jmcc.2001.1446
   Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638
   WALTEROVA D, 1981, J MED CHEM, V24, P1100, DOI 10.1021/jm00141a019
   CARAFOLI E, 1991, ANNU REV PHYSIOL, V53, P531, DOI 10.1146/annurev.physiol.53.1.531
   HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3
   Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289
   DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275
   Lee AG, 2001, BIOCHEM J, V356, P665, DOI 10.1042/0264-6021:3560665
   Ding ZH, 2002, BIOCHEM PHARMACOL, V63, P1415, DOI 10.1016/S0006-2952(02)00902-4
   Dong Z, 2006, ANNU REV PATHOL-MECH, V1, P405, DOI 10.1146/annurev.pathol.1.110304.100218
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017
   Malikova Jana, 2006, Biomedical Papers (Olomouc), V150, P5
   Zhang YH, 2006, J MOL BIOL, V364, P536, DOI 10.1016/j.jmb.2006.09.023
   Autry JM, 2012, J BIOL CHEM, V287, P39070, DOI 10.1074/jbc.M112.404434
   Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286
   Bartak P, 2003, J PHYS ORG CHEM, V16, P803, DOI 10.1003/poc.659
   CALA PM, 1982, J MEMBRANE BIOL, V64, P23, DOI 10.1007/BF01870765
   Carraway RE, 2008, REGUL PEPTIDES, V147, P96, DOI 10.1016/j.regpep.2008.01.009
   CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288
   Chmura SJ, 2000, CLIN CANCER RES, V6, P737
   Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1
   DOSTAL J, 1995, J NAT PRODUCTS, V58, P723, DOI 10.1021/np50119a010
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   Janovska M, 2010, TOXICOL LETT, V196, P56, DOI 10.1016/j.toxlet.2010.03.1114
   Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135
   Kaminskyy V, 2008, CELL BIOL INT, V32, P271, DOI 10.1016/j.cellbi.2007.09.004
   Kohro S, 2004, ANESTH ANALG, V99, P1316, DOI 10.1213/01.ANE.0000135636.45389.E6
   Kovar J., 1986, COLL CZECH CHEM COMM, V51
   Maia J.C.C., 1983, GENES ANTIGENES PARA, P145
   MCINTOSH DB, 1992, J BIOL CHEM, V267, P22328
   MEIS LD, 1971, J BIOL CHEM, V246, P4759
   MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P246, DOI 10.1016/0005-2736(73)90355-6
   Mignaco JA, 1996, BIOCHEMISTRY-US, V35, P3886, DOI 10.1021/bi9518353
   Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8
   Moubarak AS, 2003, IN VITRO CELL DEV-AN, V39, P395
   RIBEIRO JMC, 1980, AN ACAD BRAS CIENC, V52, P403
   RIZZOLO LJ, 1978, BIOCHEMISTRY-US, V17, P4049, DOI 10.1021/bi00612a028
   ROSS DC, 1987, J BIOL CHEM, V262, P12977
   Shrivastava A, 2007, INDIAN J EXP BIOL, V45, P755
   Slaninova I, 2007, CYTOM PART A, V71A, P700, DOI 10.1002/cyto.a.20423
   Slaninova I, 2001, CELL BIOL TOXICOL, V17, P51, DOI 10.1023/A:1010907231602
   TAYLOR JS, 1979, J BIOL CHEM, V254, P4402
   Ushimaru M, 2007, BIOCHEM BIOPH RES CO, V353, P799, DOI 10.1016/j.bbrc.2006.12.107
   VALENTE APC, 1990, BIOCHIM BIOPHYS ACTA, V1039, P297, DOI 10.1016/0167-4838(90)90262-E
   VERJOVSKIALMEIDA S, 1979, BIOCHIM BIOPHYS ACTA, V558, P119, DOI 10.1016/0005-2736(79)90321-3
   Vlckova M, 2004, J CHROMATOGR A, V1040, P141, DOI 10.1016/j.chroma.2004.03.064
   Vrba J, 2008, CELL BIOL TOXICOL, V24, P39, DOI 10.1007/s10565-007-9014-1
   Vrba J, 2008, TOXICOL IN VITRO, V22, P1008, DOI 10.1016/j.tiv.2008.02.007
   WALSETH TF, 1979, BIOCHIM BIOPHYS ACTA, V562, P11, DOI 10.1016/0005-2787(79)90122-9
   Weerasinghe P, 2006, EXP TOXICOL PATHOL, V58, P21, DOI 10.1016/j.etp.2006.01.008
   Wink M, 1998, ALKALOIDS, P265
   Zdarilova A, 2006, FOOD CHEM TOXICOL, V44, P242, DOI 10.1016/j.fct.2005.07.006
   Zhang ZS, 2001, J BIOL CHEM, V276, P15232, DOI 10.1074/jbc.M010813200
NR 61
TC 0
Z9 0
U1 5
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2015
VL 570
BP 58
EP 65
DI 10.1016/j.abb.2015.02.019
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF1UC
UT WOS:000352332400008
PM 25721495
ER

PT J
AU Breydo, L
   Sales, AE
   Ferreira, L
   Fedotoff, O
   Shevelyova, MP
   Permyakov, SE
   Kroeck, KG
   Permyakov, EA
   Zaslavsky, BY
   Uversky, VN
AF Breydo, Leonid
   Sales, Amanda E.
   Ferreira, Luisa
   Fedotoff, Olga
   Shevelyova, Marina P.
   Permyakov, Sergei E.
   Kroeck, Kyle G.
   Permyakov, Eugene A.
   Zaslavsky, Boris Y.
   Uversky, Vladimir N.
TI Effects of osmolytes on protein-solvent interactions in crowded
   environment: Analyzing the effect of TMAO on proteins in crowded
   solutions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Partitioning; Macromolecular crowding; Protein structure; Protein
   stability; Aqueous two-phase system; Structural changes; Solvent
   interaction analysis
ID TRIMETHYLAMINE-N-OXIDE; AQUEOUS 2-PHASE SYSTEMS; WATER-STRUCTURE; SALT
   ADDITIVES; STABILITY; STABILIZATION; PARTITION; SOLUTES; COEFFICIENTS;
   VOLUME
AB We analyzed the effect of a natural osmolyte, trimethylamine N-oxide (TMAO), on structural properties and conformational stabilities of several proteins under macromolecular crowding conditions by a set of biophysical techniques. We also used the solvent interaction analysis method to look at the peculiarities of the TMAO-protein interactions under crowded conditions. To this end, we analyzed the partitioning of these proteins in TMAO-free and TMAO-containing aqueous two-phase systems (ATPSs). These ATPSs had the same polymer composition of 6.0 wt.% PEG-8000 and 12.0 wt.% dextran-75, and same ionic composition of 0.01 M K/NaPB, pH 7.4. These analyses revealed that there is no direct interaction of TMAO with proteins, suggesting that the TMAO effects on the protein structure in crowded solutions occur via the effects of this osmolyte on solvent properties of aqueous media. The effects of TMAO on protein structure in the presence of polymers were rather complex and protein-specific. Curiously, our study revealed that in highly concentrated polymer solutions, TMAO does not always act to promote further protein folding. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Breydo, Leonid; Sales, Amanda E.; Kroeck, Kyle G.; Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA.
   [Breydo, Leonid; Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL 33612 USA.
   [Sales, Amanda E.] Univ Fed Rural Pernambuco, Dept Morphol & Anim Physiol, BR-52171900 Recife, PE, Brazil.
   [Ferreira, Luisa; Fedotoff, Olga; Zaslavsky, Boris Y.] Analiza Inc, Cleveland, OH USA.
   [Shevelyova, Marina P.; Permyakov, Sergei E.; Permyakov, Eugene A.; Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia.
   [Uversky, Vladimir N.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah 21589, Saudi Arabia.
   [Uversky, Vladimir N.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg 196140, Russia.
RP Uversky, VN (reprint author), Univ S Florida, VNU, Dept Mol Med, 12901 Bruce B Downs Blvd,MDC07, Tampa, FL 33612 USA.
EM vuversky@health.usf.edu
RI Fac Sci,  KAU,  Biol Sci Dept/L-4228-2013; Permyakov,
   Sergei/B-8156-2011; 
OI Permyakov, Sergei/0000-0003-4086-3137; Zaslavsky,
   Boris/0000-0003-0771-6696; Breydo, Leonid/0000-0003-4666-2301
FU Russian Science Foundation RSCF [14-24-00131]; Russian Academy of
   Sciences "Molecular and Cellular Biology"
FX This work was supported in part by a grant from Russian Science
   Foundation RSCF No. 14-24-00131 (V.N.U.). This work was also supported
   by a grant from the Program of the Russian Academy of Sciences
   "Molecular and Cellular Biology" (E.A.P.).
CR Schellman JA, 2003, BIOPHYS J, V85, P108
   Cho SS, 2011, J PHYS CHEM B, V115, P13401, DOI 10.1021/jp207289b
   Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9
   ZASLAVSKY BY, 1981, J CHROMATOGR, V216, P103, DOI 10.1016/S0021-9673(00)82339-0
   Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819
   Konopka MC, 2007, METHOD ENZYMOL, V428, P487, DOI 10.1016/S0076-6879(07)28027-9
   Shalaeva M, 2013, J MED CHEM, V56, P4870, DOI 10.1021/jm301850m
   Singh R, 2005, J BIOL CHEM, V280, P11035, DOI 10.1074/jbc.M410716200
   Canchi DR, 2013, ANNU REV PHYS CHEM, V64, P273, DOI 10.1146/annurev-physchem-040412-110156
   Madeira PP, 2012, J CHROMATOGR A, V1229, P38, DOI 10.1016/j.chroma.2012.01.029
   Matyus L, 2006, J PHOTOCH PHOTOBIO B, V83, P223, DOI 10.1016/j.jphotobiol.2005.12.017
   Ferreira LA, 2011, J CHROMATOGR A, V1218, P5031, DOI 10.1016/j.chroma.2011.05.068
   Ma JQ, 2014, P NATL ACAD SCI USA, V111, P8476, DOI 10.1073/pnas.1403224111
   Madeira PP, 2013, J CHROMATOGR A, V1271, P10, DOI 10.1016/j.chroma.2012.11.028
   LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001
   Daggett V, 2006, CHEM REV, V106, P1898, DOI 10.1021/cr0404242
   Sagle LB, 2011, J AM CHEM SOC, V133, P18707, DOI 10.1021/ja205106e
   Hackel M, 1999, BIOPHYS CHEM, V82, P35, DOI 10.1016/S0301-4622(99)00104-0
   Ellis RJ, 2007, ADV EXP MED BIOL, V594, P1
   Miyawaki O, 2014, BIOPHYS CHEM, V185, P19, DOI 10.1016/j.bpc.2013.10.004
   Sharp KA, 2001, J CHEM PHYS, V114, P1791, DOI 10.1063/1.1334678
   Meersman F, 2009, BIOPHYS J, V97, P2559, DOI 10.1016/j.bpj.2009.08.017
   Roesgen Joerg, 2009, V490, P195, DOI 10.1007/978-1-59745-367-7_9
   Bruzdziak P, 2013, J PHYS CHEM B, V117, P11502, DOI 10.1021/jp404780c
   Ferreira L, 2013, BBA-PROTEINS PROTEOM, V1834, P2859, DOI 10.1016/j.bbapap.2013.07.014
   Larini L, 2013, J PHYS CHEM B, V117, P13268, DOI 10.1021/jp403635g
   EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7
   Breydo L, 2014, BBA-PROTEINS PROTEOM, V1844, P346, DOI 10.1016/j.bbapap.2013.11.004
   Strambini GB, 2010, J PHYS CHEM B, V114, P1089, DOI 10.1021/jp909567q
   Paul S, 2007, J AM CHEM SOC, V129, P4476, DOI 10.1021/ja0685506
   Bolen DW, 2008, ANNU REV BIOCHEM, V77, P339, DOI 10.1146/annurev.biochem.77.061306.131357
   Breydo L, 2013, MOL BIOSYST, V9, P3068, DOI 10.1039/c3mb70329k
   Choudhary S, 2011, J CHEM THERMODYN, V43, P1541, DOI 10.1016/j.jct.2011.05.012
   COLLANDER R, 1947, ACTA PHYSIOL SCAND, V13, P363
   Foglia F, 2008, J THERM ANAL CALORIM, V91, P67, DOI 10.1007/s10973-007-8555-0
   Hansch C., 1995, EXPLORING QSAR FUNDA
   HANSCH C, 1972, J PHARM SCI, V61, P1, DOI 10.1002/jps.2600610102
   Kestranek Aimee, 2013, Curr Protoc Chem Biol, V5, P269, DOI 10.1002/9780470559277.ch130145
   LEO A, 1971, J ORG CHEM, V36, P1539, DOI 10.1021/jo00810a023
   Madeira PP, 2008, J CHROMATOGR A, V1190, P39, DOI 10.1016/j.chroma.2008.03.003
   Madeira PP, 2008, FLUID PHASE EQUILIBR, V267, P150, DOI 10.1016/j.fluid.2008.03.003
   Mikheeva Larissa, 2012, Methods Mol Biol, V896, P351, DOI 10.1007/978-1-4614-3704-8_23
   Privalov P L, 1986, Methods Enzymol, V131, P4
   Schellman JA, 2005, Q REV BIOPHYS, V38, P351, DOI 10.1017/S0033583505004099
   Spitzer J, 2011, MICROBIOL MOL BIOL R, V75, P491, DOI 10.1128/MMBR.00010-11
   Treberg JR, 2002, J EXP ZOOL, V293, P39, DOI 10.1002/jez.10109
   Zaslavsky A, 2013, BBA-PROTEINS PROTEOM, V1834, P583, DOI 10.1016/j.bbapap.2012.11.004
   Zaslavsky B. Y., 1994, AQUEOUS 2 PHASE PART
NR 48
TC 5
Z9 5
U1 12
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2015
VL 570
BP 66
EP 74
DI 10.1016/j.abb.2015.02.021
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CF1UC
UT WOS:000352332400009
PM 25712220
ER

PT J
AU Onopiuk, M
   Brutkowski, W
   Young, C
   Krasowska, E
   Rog, J
   Ritso, M
   Wojciechowska, S
   Arkle, S
   Zablocki, K
   Gorecki, DC
AF Onopiuk, Marta
   Brutkowski, Wojciech
   Young, Christopher
   Krasowska, Elzbieta
   Rog, Justyna
   Ritso, Morten
   Wojciechowska, Sylwia
   Arkle, Stephen
   Zablocki, Krzysztof
   Gorecki, Dariusz C.
TI Store-operated calcium entry contributes to abnormal Ca2+ signalling in
   dystrophic mdx mouse myoblasts
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Duchenne muscular dystrophy; mdx; Myoblasts; Store-operated calcium
   entry; STIM1 protein
ID DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; EXTRACELLULAR ATP;
   SATELLITE CELLS; EXPRESSION; MICE; RECEPTOR; INFLUX; DIFFERENTIATION;
   ACTIVATION
AB Sarcolemma damage and activation of various calcium channels are implicated in altered Ca2+ homeostasis in muscle fibres of both Duchenne muscular dystrophy (DMD) sufferers and in the mdx mouse model of DMD. Previously we have demonstrated that also in mdx myoblasts extracellular nucleotides trigger elevated cytoplasmic Ca2+ concentrations due to alterations of both ionotropic and metabotropic purinergic receptors. Here we extend these findings to show that the mdx mutation is associated with enhanced store-operated calcium entry (SOCE). Substantially increased rate of SOCE in mdx myoblasts in comparison to that in control cells correlated with significantly elevated STIM1 protein levels. These results reveal that mutation in the dystrophin-encoding Dmd gene may significantly impact cellular calcium response to metabotropic stimulation involving depletion of the intracellular calcium stores followed by activation of the store-operated calcium entry, as early as in undifferentiated myoblasts. These data are in agreement with the increasing number of reports showing that the dystrophic pathology resulting from dystrophin mutations may be developmentally regulated. Moreover, our results showing that aberrant responses to extracellular stimuli may contribute to DMD pathogenesis suggest that treatments inhibiting such responses might alter progression of this lethal disease. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Brutkowski, Wojciech; Young, Christopher; Krasowska, Elzbieta; Arkle, Stephen; Gorecki, Dariusz C.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England.
   [Onopiuk, Marta; Brutkowski, Wojciech; Krasowska, Elzbieta; Rog, Justyna; Wojciechowska, Sylwia; Zablocki, Krzysztof] Nencki Inst Expt Biol, Warsaw, Poland.
   [Ritso, Morten] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
RP Zablocki, K (reprint author), Inst Expt Biol, 3 Pasteur Str, PL-02093 Warsaw, Poland.
EM k.zablocki@nencki.gov.pl
FU Interreg IV (TC2N); Duchenne Parents Project (The Netherlands);
   Institute of Biomedical and Biomolecular Sciences; National Science
   Centre, Poland [N 301 530338]; Foundation For Polish Science; European
   Union Regional Development Fund [MPD4-109]
FX This work was supported by the Interreg IV (TC2N) and the Duchenne
   Parents Project (The Netherlands) grants to DCG, Ph.D. bursary from the
   Institute of Biomedical and Biomolecular Sciences to CY, the National
   Science Centre grant number N 301 530338, Poland (to KZ) and the
   'International PhD Studies in Neurobiology' project (MPD/2009/4) from
   the Foundation For Polish Science to EK, co-financed from the European
   Union Regional Development Fund (grant number MPD4-109) to KZ and DCG.
CR Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200
   Young CNJ, 2012, J CELL MOL MED, V16, P1026, DOI 10.1111/j.1582-4934.2011.01397.x
   KOLB HA, 1983, NATURE, V303, P621, DOI 10.1038/303621a0
   PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6
   Martinello T, 2011, MOL CELL BIOCHEM, V351, P183, DOI 10.1007/s11010-011-0726-4
   Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003
   MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103
   Yeung D, 2006, FASEB J, V20, P610, DOI 10.1096/fj.05-4022com
   Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104
   Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200
   Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819
   Li TY, 2012, MOL CELL BIOL, V32, P3009, DOI 10.1128/MCB.06599-11
   Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x
   Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0
   Onopiuk M, 2009, BIOCHEM BIOPH RES CO, V386, P463, DOI 10.1016/j.bbrc.2009.06.053
   Prins KW, 2009, J CELL BIOL, V186, P363, DOI 10.1083/jcb.200905048
   Trimarchi F, 2006, CELLS TISSUES ORGANS, V183, P87, DOI 10.1159/000095513
   Jiang TW, 2005, NEUROMUSCULAR DISORD, V15, P225, DOI 10.1016/j.nmd.2004.11.008
   FERRARI D, 1994, AM J PHYSIOL-CELL PH, V267, pC886
   Rawat R, 2010, AM J PATHOL, V176, P2891, DOI 10.2353/ajpath.2010.090058
   Musaro A, 2010, METHODS MOL BIOL, V633, P101, DOI 10.1007/978-1-59745-019-5_8
   Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091
   Seno MMG, 2008, HUM MOL GENET, V17, P2622, DOI 10.1093/hmg/ddn162
   Sabourin J, 2012, CELL CALCIUM, V52, P445, DOI 10.1016/j.ceca.2012.08.003
   Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106
   Gudlur A, 2013, CURR TOP MEMBR, V71, P33, DOI 10.1016/B978-0-12-407870-3.00002-0
   Patel A, 2010, PFLUG ARCH EUR J PHY, V460, P571, DOI 10.1007/s00424-010-0847-8
   Ryten M, 2001, DEV DYNAM, V221, P331, DOI 10.1002/dvdy.1147
   Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315
   Merrick D, 2009, DIS MODEL MECH, V2, P374, DOI 10.1242/dmm.001008
   MIRANDA AF, 1988, AM J PATHOL, V132, P410
   Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602
   Vandebrouck A, 2007, FASEB J, V21, P608, DOI 10.1096/fj.06-6683com
   Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025
   Balghi H, 2006, J GEN PHYSIOL, V128, P219, DOI 10.1085/jgp.200609559
   Brun C, 2003, CELL MOL LIFE SCI, V60, P557, DOI 10.1007/s000180300047
   Constantin B, 2006, J MUSCLE RES CELL M, V27, P375, DOI 10.1007/s10974-006-9085-2
   Edwards J. N., 2010, AM J PHYSIOL-CELL PH, V299, P42
   Glynkiewicz G., 1985, J BIOL CHEM, V260, P3440
   Harisseh R, 2013, AM J PHYSIOL-CELL PH, V304, pC881, DOI 10.1152/ajpcell.00182.2012
   Jorgensen LH, 2009, HUM GENE THER, V20, P641, DOI 10.1089/hum.2008.162
   Kiviluoto S., 2011, SKELET MUSCLE, V1
   PARKMATSUMOTO YC, 1991, BRAIN RES, V565, P280, DOI 10.1016/0006-8993(91)91660-S
   Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x
   Szigeti GP, 2007, PFLUG ARCH EUR J PHY, V453, P509, DOI 10.1007/s00424-006-0145-7
   Vandebrouck A, 2006, FASEB J, V20, P136
   Wang L, 2006, GLYCOCONJUGATE J, V23, P303, DOI 10.1007/s10719-006-5742-3
   Young C., 2014, AUTOPHAGY IN PRESS
   Young C., 2013, SIGNAL
   Zablocki K, 2003, CELL CALCIUM, V33, P91, DOI 10.1016/S0143-4160(02)00202-6
NR 50
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2015
VL 569
BP 1
EP 9
DI 10.1016/j.abb.2015.01.025
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CE9NI
UT WOS:000352170300001
PM 25659883
ER

PT J
AU Cho, SA
   Rohn-Glowacki, KJ
   Jaffar, YB
   Yi, M
   Kim, WY
   Shin, JG
   Lee, SJ
AF Cho, Sun-Ah
   Rohn-Glowacki, Katie Jo
   Jaffar, Yazun B.
   Yi, Myeongjin
   Kim, Woo-Young
   Shin, Jae-Gook
   Lee, Su-Jun
TI Analysis of genetic polymorphism and biochemical characterization of a
   functionally decreased variant in prostacyclin synthase gene (CYP8A1) in
   humans
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Prostacyclin; CYP8A1; Polymorphism; SNP; Cytochrome P450
ID SINGLE-NUCLEOTIDE POLYMORPHISMS; MYOCARDIAL-INFARCTION; KOREAN
   POPULATION; PROMOTER REGION; IDENTIFICATION; HYPERTENSION; ASSOCIATION;
   PURIFICATION; HEMOPROTEIN; SEQUENCE
AB Prostacyclin synthase (CYP8A1) is an enzyme responsible for the biosynthesis of prostacyclin (PGI(2)) which inhibits platelet activation and exhibits anti-inflammatory effect. The objectives of this study were to identify CYP8A1 genetic variants and characterize functional consequences of CYP8A1 variants. In total, 27 variants including four previously unidentified single-nucleotide polymorphisms (SNPs) were identified by direct DNA sequencing in Koreans (n = 48). Among them, CYP8A1 A447T and E314Stop were newly assigned as CYP8A1*5 and CYP8A1*6 by the Human Cytochrome P450 Allele Nomenclature Committee, respectively. CYP8A1*5 was found in the heme binding area in three individuals as a heterozygous mutation. To investigate the functional change of CYP8A1*5, CYP8A1*5 and wild-type CYP8A1 protein were overexpressed in an Escherichia coil expression system and purified. Metabolism of PGH(2) by the CYP8A1*5 protein exhibited significantly decreased activity, resulting in a 45% decrease in V-max and a 1.8-fold decrease in intrinsic clearance compared to the wild-type. Based on the predicted crystal structure of CYP8A1*5 using the Molecular Operating Environment platform, the distance from CYP8A1 Cys441 to the heme was altered with a significantly changed binding free energy for the mutant protein. Further studies would be needed to determine the effect of CYP8A1*5 on PGI(2) levels in humans. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Cho, Sun-Ah; Jaffar, Yazun B.; Yi, Myeongjin; Kim, Woo-Young; Shin, Jae-Gook; Lee, Su-Jun] Inje Univ, Coll Med, Dept Pharmacol, Pharmacogen Res Ctr, Busan 614735, South Korea.
   [Shin, Jae-Gook] Inje Univ, Coll Med, Busan Paik Hosp, Dept Clin Pharmacol, Busan 614735, South Korea.
   [Rohn-Glowacki, Katie Jo] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL USA.
RP Shin, JG (reprint author), Inje Univ, Coll Med, Dept Pharmacol, 633-165 Gaegum Dong, Busan 614735, South Korea.
EM phshinjg@gmail.com; 2sujun@inje.ac.kr
FU National Research Foundation of Korea (NRF) - Korea government (MSIP)
   [R13-2007-023-00000-0]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (No.
   R13-2007-023-00000-0).
CR Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Amano S, 2004, RESPIROLOGY, V9, P184, DOI 10.1111/j.1440-1843.2004.00568.x
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597
   MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006
   Yokoyama C, 2002, CIRCULATION, V106, P2397, DOI 10.1161/01.CIR.0000034733.93020.BC
   Xie X, 2009, CLIN CHEM LAB MED, V47, P347, DOI 10.1515/CCLM.2009.078
   Lee SJ, 2003, PHARMACOGENETICS, V13, P461, DOI 10.1097/01.fpc.0000054117.14659.ac
   HARA S, 1994, J BIOL CHEM, V269, P19897
   Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711
   Iwai N, 1999, CIRCULATION, V100, P2231
   Lee SJ, 2010, J HUM GENET, V55, P189, DOI 10.1038/jhg.2010.6
   Lee SS, 2007, DRUG METAB DISPOS, V35, P623, DOI 10.1124/dmd.106.012302
   Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926
   Chevalier D, 2001, HUM GENET, V108, P148, DOI 10.1007/s004390000444
   Chevalier D, 2002, PROSTAG OTH LIPID M, V70, P31, DOI 10.1016/S0090-6980(02)00016-3
   Chiang CW, 2006, J MOL BIOL, V364, P266, DOI 10.1016/j.jmb.2006.09.039
   DEWITT DL, 1983, J BIOL CHEM, V258, P3285
   Feher M, 2000, J CHEM INF COMP SCI, V40, P495, DOI 10.1021/ci9900682
   FITZGERALD GA, 1984, NEW ENGL J MED, V310, P1065, DOI 10.1056/NEJM198404263101701
   Lee SJ, 2009, DRUG METAB DISPOS, V37, P2262, DOI 10.1124/dmd.109.028175
   Matys V., 2006, NUCLEIC ACIDS RES, V34, P108
   Nakayama T, 1997, LANCET, V349, P1887, DOI 10.1016/S0140-6736(05)63878-0
   Nakayama T, 1996, BIOCHEM BIOPH RES CO, V224, P281, DOI 10.1006/bbrc.1996.1021
   Nakayama T, 2000, AM J HYPERTENS, V13, P1263, DOI 10.1016/S0895-7061(00)01216-4
   Nakayama T, 2002, BIOCHEM BIOPH RES CO, V297, P1135, DOI 10.1016/S0006-291X(02)02341-0
   Nakayama T, 2002, AM HEART J, V143, P797, DOI 10.1067/mhj.2002.122171
   OATES JA, 1988, NEW ENGL J MED, V319, P689, DOI 10.1056/NEJM198809153191106
   ROSENKRANZ B, 1980, BIOCHIM BIOPHYS ACTA, V619, P207, DOI 10.1016/0005-2760(80)90069-7
   SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025
   Smyth EM, 2002, VITAM HORM, V65, P149, DOI 10.1016/S0083-6729(02)65063-0
   ULLRICH V, 1981, BIOCHEM PHARMACOL, V30, P2033, DOI 10.1016/0006-2952(81)90218-5
   Vane J. R., 1995, AM J CARDIOL, V75, P3
   Wada M, 2004, J BIOCHEM, V135, P455, DOI 10.1093/jb/mvh059
   Wildman SA, 2001, J CHEM INF COMP SCI, V41, P446, DOI 10.1021/ci0000880
   Xiang Xie, 2009, Clin Appl Thromb Hemost, V15, P574, DOI 10.1177/1076029608329581
   Yokoyama C, 1996, GENOMICS, V36, P296, DOI 10.1006/geno.1996.0465
NR 39
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2015
VL 569
BP 10
EP 18
DI 10.1016/j.abb.2015.01.012
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CE9NI
UT WOS:000352170300002
PM 25623425
ER

PT J
AU Endo, S
   Matsunaga, T
   Ikari, A
   El-Kabbani, O
   Hara, A
   Kitade, Y
AF Endo, Satoshi
   Matsunaga, Toshiyuki
   Ikari, Akira
   El-Kabbani, Ossama
   Hara, Akira
   Kitade, Yukio
TI Identification of a determinant for strict NADP(H)-specificity and high
   sensitivity to mixed-type steroid inhibitor of rabbit aldo-keto
   reductase 1C33 by site-directed mutagenesis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Aldo-keto reductase; Bile acid synthesis; Coenzyme specificity
   determinant; Conformational change; Deoxycorticosterone; Hydroxysteroid
   dehydrogenase
ID BROAD SUBSTRATE-SPECIFICITY; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE;
   20-ALPHA-HYDROXYSTEROID DEHYDROGENASE; ALDEHYDE REDUCTASE;
   CRYSTAL-STRUCTURE; BINDING-SITE; DIHYDRODIOL DEHYDROGENASE; MOLECULAR
   DETERMINANTS; CARBONYL-COMPOUNDS; COENZYME BINDING
AB In rabbit tissues, hydroxysteroid dehydrogenase belonging to the aldo-keto reductase (AKR) superfamily exists in six isoforms (AKRs: 105 and 1C29-1C33), sharing >73% amino acid sequence identity. AKR1C33 is strictly NADPH-specific, in contrast to dual NADPH/NADH specificity of the other isoforms. All coenzyme-binding residues of the structurally elucidated AKR1C5 are conserved in other isoforms, except that S217 (interacting with the pyrophosphate moiety) and T273 (interacting with the 2'-phosphate moiety) are replaced with F217 and N272, respectively, in AKR1C33. To explore the determinants for the NADPH specificity of AKR1C33, we prepared its F217S and N272T mutant enzymes. The mutation of F217S, but not N272T, converted AKR1C33 into a dually coenzyme-specific form that showed similar k(cat) values for NAD(P)H to those of AKR1C32. The reverse mutation (S217F) in dually coenzyme-specific AKR1C32 produced a strictly NADPH-specific form. The F2175 mutation also abolished the activity towards 3-keto-5 beta-cholestanes that are substrates specific to AKR1C33, and markedly decreased the sensitivity to 4-pregnenes (such as deoxycorticosterone and medroxyprogesterone acetate) that were found to be potent mixed-type inhibitors of the wild-type enzyme. The results indicate the important role of F217 in the strict NADPH-dependency, as well as its involvement in the unique catalytic properties of AKR1C33. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Endo, Satoshi; Matsunaga, Toshiyuki; Ikari, Akira] Gifu Pharmaceut Univ, Biochem Lab, Gifu 5028585, Japan.
   [El-Kabbani, Ossama] Monash Univ, Monash Inst Pharmaceut Sci, Clayton, Vic 3800, Australia.
   [Hara, Akira; Kitade, Yukio] Gifu Univ, Fac Engn, Gifu 50111, Japan.
RP Endo, S (reprint author), Gifu Pharmaceut Univ, Biochem Lab, Gifu 5028585, Japan.
EM sendo@gifu-pu.ac.jp
RI Endo, Satoshi/F-8059-2011
OI Endo, Satoshi/0000-0003-0578-9672
FU Japan Society for the Promotion of Science [24790114]; Japan Science
   Society [24-413]
FX We thank Dr. Nobutada Tanaka (University of Showa) for discussing the
   structure of AKR1C33. This work was partly founded by grant-in-aid for
   Young Scientists (B) [24790114] from the Japan Society for the Promotion
   of Science, and by a Sasakawa Scientific Research Grant [24-413] from
   Japan Science Society.
CR Jez JM, 1996, J BIOL CHEM, V271, P30190
   Ishikura S, 2006, J BIOCHEM, V139, P1053, DOI 10.1093/jb/mvj109
   Endo S, 2007, ARCH BIOCHEM BIOPHYS, V467, P76, DOI 10.1016/j.abb.2007.08.011
   Sanai M, 2007, ARCH BIOCHEM BIOPHYS, V464, P122, DOI 10.1016/j.abb.2007.04.003
   Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337
   Ratnam K, 1999, BIOCHEMISTRY-US, V38, P7856, DOI 10.1021/bi982838t
   Endo S, 2013, BIOCHEM PHARMACOL, V86, P1366, DOI 10.1016/j.bcp.2013.08.024
   BORHANI DW, 1992, J BIOL CHEM, V267, P24841
   Endo S, 2013, BIOL PHARM BULL, V36, P1514
   Penning TM, 1999, J STEROID BIOCHEM, V69, P211, DOI 10.1016/S0960-0760(99)00038-2
   Jez JM, 1997, BIOCHEM J, V326, P625
   Jin Y, 2001, BIOCHEMISTRY-US, V40, P10161, DOI 10.1021/bi010919a
   Jin Y, 2006, BIOCHEMISTRY-US, V45, P13054, DOI 10.1021/bi060591r
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Endo S, 2012, ARCH BIOCHEM BIOPHYS, V527, P23, DOI 10.1016/j.abb.2012.07.012
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Couture JF, 2003, J MOL BIOL, V331, P593, DOI 10.1016/S0022-2836(03)00762-9
   Couture JF, 2004, J MOL BIOL, V339, P89, DOI 10.1016/j.jmb.2004.03.035
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Barski S. M., 2008, DRUG METAB REV, V40, P553
   BOHREN KM, 1991, J BIOL CHEM, V266, P24031
   Di Luccio E, 2006, BIOCHEM J, V400, P105, DOI 10.1042/BJ20060660
   ELKABBANI O, 1995, NAT STRUCT BIOL, V2, P687, DOI 10.1038/nsb0895-687
   ElKabbani O, 1997, PROTEINS, V29, P186, DOI 10.1002/(SICI)1097-0134(199710)29:2<186::AID-PROT6>3.0.CO;2-B
   Endo S, 2009, CHEM-BIOL INTERACT, V178, P151, DOI 10.1016/j.cbi.2008.09.010
   Endo S, 2013, ARCH BIOCHEM BIOPHYS, V529, P131, DOI 10.1016/j.abb.2012.11.013
   Endo S, 2014, DRUG METAB DISPOS, V42, P803, DOI 10.1124/dmd.113.056044
   Faucher F, 2006, J MOL BIOL, V364, P747, DOI 10.1016/j.jmb.2006.09.030
   FLYNN TG, 1975, J BIOL CHEM, V250, P2933
   GRIMSHAW CE, 1995, BIOCHEMISTRY-US, V34, P14356, DOI 10.1021/bi00044a012
   Heredia VV, 2004, BIOCHEMISTRY-US, V43, P12028, DOI 10.1021/bi0489762
   Ikeda S, 1999, FEBS LETT, V459, P433, DOI 10.1016/S0014-5793(99)01243-0
   Ishikura S, 2005, BIOL PHARM BULL, V28, P1075, DOI 10.1248/bpb.28.1075
   KUBISESKI TJ, 1995, J BIOL CHEM, V270, P16911
   KUBISESKI TJ, 1992, J BIOL CHEM, V267, P6510
   Li B, 1996, EUR J BIOCHEM, V235, P180, DOI 10.1111/j.1432-1033.1996.00180.x
   Ma HC, 1999, BIOCHEM J, V341, P853, DOI 10.1042/0264-6021:3410853
   Ma HC, 2000, BIOCHEMISTRY-US, V39, P102, DOI 10.1021/bi991659o
   Matsuura K, 1997, BIOCHEM J, V322, P89
   Matsuura K, 1998, BIOCHEM J, V336, P429
   Rees-Milton KJ, 1998, ARCH BIOCHEM BIOPHYS, V355, P137, DOI 10.1006/abbi.1998.0721
   Sanli G, 2003, CELL BIOCHEM BIOPHYS, V38, P79, DOI 10.1385/CBB:38:1:79
   Segel I., 1975, ENZYME KINETICS BEHA, P161
   Srivastava S, 1998, BIOCHEMISTRY-US, V37, P12909, DOI 10.1021/bi9804333
NR 44
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2015
VL 569
BP 19
EP 25
DI 10.1016/j.abb.2015.01.026
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CE9NI
UT WOS:000352170300003
PM 25660042
ER

PT J
AU Butler, J
   Smyth, N
   Broadbridge, R
   Council, CE
   Lee, AG
   Stocker, CJ
   Hislop, DC
   Arch, JRS
   Cawthorne, MA
   East, JM
AF Butler, John
   Smyth, Neil
   Broadbridge, Robert
   Council, Claire E.
   Lee, Anthony G.
   Stocker, Claire J.
   Hislop, David C.
   Arch, Jonathan R. S.
   Cawthorne, Michael A.
   East, J. Malcolm
TI The effects of sarcolipin over-expression in mouse skeletal muscle on
   metabolic activity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Sarcolipin; SERCA; Thermogenesis; Energy expenditure; Obesity; High fat
   diet
ID SARCOPLASMIC-RETICULUM CA2+-ATPASE; CA2+ TRANSPORT; PHOSPHOLAMBAN;
   THERMOGENESIS; RELAXATION; BINDING; PROTEIN; CALCIUM; MICE; ATP
AB Studies in sarcolipin knockout mice have led to the suggestion that skeletal muscle sarcolipin plays a role in thermogenesis. The mechanism proposed is uncoupling of the sarcoplasmic reticulum calcium pump. However, in other work sarcolipin was not detected in mouse skeletal tissue. We have therefore measured sarcolipin levels in mouse skeletal muscle using semi-quantitative western blotting and synthetic mouse sarcolipin. Sarcolipin levels were so low that it is unlikely that knocking out sarcolipin would have a measurable effect on thermogenesis by SERCA. In addition, overexpression of neither wild type nor FLAG-tagged variants of mouse sarcolipin in transgenic mice had any major significant effects on body mass, energy expenditure, even when mice were fed on a high fat diet. (C) 2015 The Authors. Published by Elsevier Inc.
C1 [Butler, John; Smyth, Neil; Lee, Anthony G.; East, J. Malcolm] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England.
   [Broadbridge, Robert; Council, Claire E.] Peptide Prot Res Ltd, Fareham PO15 6DP, England.
   [Stocker, Claire J.; Hislop, David C.; Arch, Jonathan R. S.; Cawthorne, Michael A.] Univ Buckingham, Clore Lab, Buckingham MK18 1EG, England.
RP East, JM (reprint author), Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England.
EM jme1@soton.ac.uk
FU Wellcome Trust, UK [086171/Z/08/Z]
FX We gratefully acknowledge the technical assistance of Bhavwanti Sheth
   and Caroline Smith, University of Southampton for the production of the
   transgenic mice; Ed Wargent, University of Buckingham, for the
   physiological analyses and the Wellcome Trust, UK (Grant #
   086171/Z/08/Z) for funding the study.
CR Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200
   Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897
   Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5
   Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277
   Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068
   Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360
   BRENNAN KJ, 1993, J BIOL CHEM, V268, P719
   Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009
   Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010
   Bombardier E, 2013, FEBS LETT, V587, P1687, DOI 10.1016/j.febslet.2013.04.019
   Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100
   Ottenheijm CAC, 2008, FASEB J, V22, P2912, DOI 10.1096/fj.07-104372
   Bombardier E, 2013, FASEB J, V27, P3871, DOI 10.1096/fj.13-230631
   Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006
   DAIHO T, 1993, BIOCHEMISTRY-US, V32, P10021, DOI 10.1021/bi00089a018
   JORGENSEN AO, 1986, J BIOL CHEM, V261, P3775
   Stocker C.J., 2007, AM J PHYSIOL, V292
NR 17
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2015
VL 569
BP 26
EP 31
DI 10.1016/j.abb.2015.01.027
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CE9NI
UT WOS:000352170300004
PM 25660043
ER

PT J
AU Patananan, AN
   Budenholzer, LM
   Pedraza, ME
   Torres, ER
   Adler, LN
   Clarke, SG
AF Patananan, Alexander N.
   Budenholzer, Lauren M.
   Pedraza, Maria E.
   Torres, Eric R.
   Adler, Lital N.
   Clarke, Steven G.
TI The invertebrate Caenorhabditis elegans biosynthesizes ascorbate
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Ascorbic acid; Vitamin C; Caenorhabditis elegans; Biosynthetic pathway;
   Invertebrates
ID L-GALACTOSE PHOSPHORYLASE; D-ERYTHROASCORBIC ACID; OXIDATIVE DNA-DAMAGE;
   VITAMIN-C; SACCHAROMYCES-CEREVISIAE; PROLYL 4-HYDROXYLASE;
   ARABIDOPSIS-THALIANA; LIFE-SPAN; CARNITINE BIOSYNTHESIS; DEHYDROASCORBIC
   ACID
AB L-Ascorbate, commonly known as vitamin C, serves as an antioxidant and cofactor essential for many biological processes. Distinct ascorbate biosynthetic pathways have been established for animals and plants, but little is known about the presence or synthesis of this molecule in invertebrate species. We have investigated ascorbate metabolism in the nematode Caenorhabditis elegans, where this molecule would be expected to play roles in oxidative stress resistance and as cofactor in collagen and neurotransmitter synthesis. Using high-performance liquid chromatography and gas-chromatography mass spectrometry, we determined that ascorbate is present at low amounts in the egg stage, L1 larvae, and mixed animal populations, with the egg stage containing the highest concentrations. Incubating C elegans with precursor molecules necessary for ascorbate synthesis in plants and animals did not significantly alter ascorbate levels. Furthermore, bioinformatic analyses did not support the presence in C. elegans of either the plant or the animal biosynthetic pathway. However, we observed the complete C-13-labeling of ascorbate when C elegans was grown with C-13-labeled Escherichia coli as a food source. These results support the hypothesis that ascorbate biosynthesis in invertebrates may proceed by a novel pathway and lay the foundation for a broader understanding of its biological role. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.
RP Clarke, SG (reprint author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.
EM clarke@mbi.ucla.edu
FU Ruth L. Kirschstein National Research Service Award [GM007185]; NIH
   [GM026020]; Ellison Medical Foundation; Elizabeth and Thomas Plott Chair
   in Gerontology of the UCLA Longevity Center
FX This work was supported by a Ruth L. Kirschstein National Research
   Service Award GM007185 to ANP, and by NIH grant GM026020, a Senior
   Scholar in Aging Award from the Ellison Medical Foundation, and funds
   from the Elizabeth and Thomas Plott Chair in Gerontology of the UCLA
   Longevity Center to SGC. We would like to acknowledge Gregory Khitrov
   from the UCLA Molecular Instrumentation Center, Kym Faull, and
   Christopher Ryan for their help and advice on GC-MS analysis. We would
   also like to thank Brian Young and Carole Linster for their
   contributions to the early stages of this work, and Alison Frand for
   helpful discussions.
CR Adler L. N., 2012, THESIS UCLA
   Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774
   Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375
   RICE ME, 1995, J NEUROCHEM, V64, P1790
   COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7
   Gruber J, 2009, FEBS LETT, V583, P3377, DOI 10.1016/j.febslet.2009.09.051
   Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200
   Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193
   Cabreiro F, 2013, EMBO MOL MED, V5, P1300, DOI 10.1002/emmm.201100972
   Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147
   Drouin G, 2011, CURR GENOMICS, V12, P371, DOI 10.2174/138920211796429736
   HARRINGTON LA, 1988, MECH AGEING DEV, V43, P71, DOI 10.1016/0047-6374(88)90098-X
   Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x
   Conklin PL, 2000, GENETICS, V154, P847
   Gest N, 2013, J EXP BOT, V64, P33, DOI 10.1093/jxb/ers297
   Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897
   Tulipani S, 2008, J AGR FOOD CHEM, V56, P696, DOI 10.1021/jf0719959
   Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863
   OBERBACHER MF, 1963, NATURE, V197, P1203, DOI 10.1038/1971203a0
   Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005
   Valpuesta V, 2004, TRENDS PLANT SCI, V9, P573, DOI 10.1016/j.tplants.2004.10.002
   Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653
   ENGLARD S, 1986, ANNU REV NUTR, V6, P365
   Rajan TV, 2003, J PARASITOL, V89, P868, DOI 10.1645/GE-3137RN
   Barth C, 2006, J EXP BOT, V57, P1657, DOI 10.1093/jxb/erj198
   Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185
   FRAGA CG, 1991, P NATL ACAD SCI USA, V88, P11003, DOI 10.1073/pnas.88.24.11003
   Winter AD, 2000, MOL CELL BIOL, V20, P4084, DOI 10.1128/MCB.20.11.4084-4093.2000
   Justi KC, 2000, ARCH LATINOAM NUTR, V50, P405
   Gao Q, 2008, J PLANT PHYSIOL, V165, P138, DOI 10.1016/j.jplph.2007.04.002
   TSAO CS, 1987, J NUTR, V117, P291
   McGregor GP, 2006, CURR OPIN CLIN NUTR, V9, P697, DOI 10.1097/01.mco.0000247478.79779.8f
   Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271
   Dhawan R, 1999, J TOXICOL ENV HEAL A, V58, P451, DOI 10.1080/009841099157179
   Carr AC, 1999, AM J CLIN NUTR, V69, P1086
   DABROWSKI K, 1994, EXPERIENTIA, V50, P745, DOI 10.1007/BF01919376
   Shibamura A, 2009, MECH AGEING DEV, V130, P652, DOI 10.1016/j.mad.2009.06.008
   Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936
   Urzica EI, 2012, J BIOL CHEM, V287, P14234, DOI 10.1074/jbc.M112.341982
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/i.cmet.2007.08.011
   Pignocchi C, 2003, CURR OPIN PLANT BIOL, V6, P379, DOI 10.1016/S1369-5266(03)00069-4
   Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437
   Pallauf K, 2013, FOOD CHEM TOXICOL, V58, P255, DOI 10.1016/j.fct.2013.04.046
   Goodyear-Bruch C, 2002, AM J CRIT CARE, V11, P543
   Olson SK, 2012, J CELL BIOL, V198, P731, DOI 10.1083/jcb.201206008
   Merchie G, 1997, AQUACULTURE, V155, P165, DOI 10.1016/S0044-8486(97)00115-4
   Hendriks GJ, 2014, MOL CELL, V53, P380, DOI 10.1016/j.molcel.2013.12.013
   Du J, 2012, BBA-REV CANCER, V1826, P443, DOI 10.1016/j.bbcan.2012.06.003
   Wintergerst ES, 2006, ANN NUTR METAB, V50, P85, DOI 10.1159/000090495
   Badejo AA, 2012, J EXP BOT, V63, P229, DOI 10.1093/jxb/err275
   Baroja-Mazo A, 2005, FUNGAL GENET BIOL, V42, P390, DOI 10.1016/fgb.2005.01.005
   Brooks K. K., 2009, PLOS ONE, V4
   Carr B. S., 1983, ANAL CHEM, V55, P1229
   CARR RS, 1980, ANAL CHEM, V52, P2428, DOI 10.1021/ac50064a046
   CHATTERJ.IB, 1973, SCIENCE, V182, P1271, DOI 10.1126/science.182.4118.1271
   CHIPPENDALE GM, 1975, J NUTR, V105, P499
   DABROWSKI K, 1989, ANALYST, V114, P83, DOI 10.1039/an9891400083
   DAWSON CR, 1975, ANN NY ACAD SCI, V258, P209, DOI 10.1111/j.1749-6632.1975.tb29281.x
   DUMBRAVA VA, 1987, BIOCHIM BIOPHYS ACTA, V926, P331, DOI 10.1016/0304-4165(87)90219-4
   DUNN WA, 1984, J BIOL CHEM, V259, P764
   Duthie SJ, 1996, CANCER RES, V56, P1291
   Esselen WB, 1939, J BACTERIOL, V37, P501
   FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208
   Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312
   Friedman L, 2000, P NATL ACAD SCI USA, V97, P4736, DOI 10.1073/pnas.97.9.4736
   Gomez F., 2012, BMC MICROBIOL, V12
   Goumas C., 2008, MOL BIOSYST, V4, P404
   GUPTA SD, 1972, ARCH BIOCHEM BIOPHYS, V152, P889, DOI 10.1016/0003-9861(72)90287-1
   Huang JZ, 2009, J MOL BIOL, V387, P559, DOI 10.1016/j.jmb.2009.02.028
   Huh WK, 1998, MOL MICROBIOL, V30, P895, DOI 10.1046/j.1365-2958.1998.01133.x
   Khare S, 2009, MECH AGEING DEV, V130, P670, DOI 10.1016/j.mad.2009.08.002
   Lachapelle MY, 2011, GENETICA, V139, P199, DOI 10.1007/s10709-010-9537-x
   Linster CL, 2008, J BIOL CHEM, V283, P18483, DOI 10.1074/jbc.M802594200
   Linster G. L., 2008, TRENDS PLANT SCI, V13, P567
   Lykkesfeldt J, 1998, FASEB J, V12, P1183
   MASSIE HR, 1991, EXP GERONTOL, V26, P487, DOI 10.1016/0531-5565(91)90037-M
   Moreau R, 2000, J FISH BIOL, V57, P733, DOI 10.1006/jfbi.2000.1350
   NICK JA, 1986, PLANT SCI, V46, P181, DOI 10.1016/0168-9452(86)90190-1
   Obinger C, 1998, PHYSIOL PLANTARUM, V104, P693, DOI 10.1034/j.1399-3054.1998.1040425.x
   Paciolla C, 2003, BIOL PLANTARUM, V47, P387
   Pang SS, 2014, CELL METAB, V19, P221, DOI 10.1016/j.cmet.2013.12.005
   Pang SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6048
   REBOUCHE CJ, 1991, AM J CLIN NUTR, V54, pS1147
   RICHTER HE, 1988, CAN J MICROBIOL, V34, P822
   Riihimaa P, 2002, J BIOL CHEM, V277, P18238, DOI 10.1074/jbc.M200895200
   SASAKI R, 1983, J GERONTOL, V38, P26
   SAXENA PN, 1966, NATURE, V209, P535, DOI 10.1038/209535b0
   Smirnoff Nicholas, 2003, Nat Biotechnol, V21, P134, DOI 10.1038/nbt0203-134
   Spickett CM, 2000, FREE RADICAL BIO MED, V28, P183, DOI 10.1016/S0891-5849(99)00214-2
   Streb P, 2003, J EXP BOT, V54, P405, DOI 10.1093/jxb/erg048
   SUMMERS CB, 1993, BIOCHIM BIOPHYS ACTA, V1156, P235, DOI 10.1016/0304-4165(93)90142-U
   TELOR E, 1986, ARCH BIOCHEM BIOPHYS, V246, P396, DOI 10.1016/0003-9861(86)90485-6
   The C. elegans Sequencing Consortium, 1999, SCIENCE, V283, P35
   Wang SY, 2007, J AM SOC HORTIC SCI, V132, P647
   Wong S. Z. H., 2013, PLOS ONE, V8
   Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556
   Yilmaz LS, 2014, TRENDS GENET, V30, P496, DOI 10.1016/j.tig.2014.07.010
   Young RM, 1942, J BACTERIOL, V44, P75
   Zhang WY, 2009, PLANT PHYSIOL, V150, P942, DOI 10.1104/pp.109.138453
   Zhang ZG, 2003, J BACTERIOL, V185, P2243, DOI 10.1128/JB.185.7.2243-2250.2003
NR 102
TC 1
Z9 1
U1 3
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2015
VL 569
BP 32
EP 44
DI 10.1016/j.abb.2015.02.002
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CE9NI
UT WOS:000352170300005
PM 25668719
ER

PT J
AU Kojic, S
   Nestorovic, A
   Rakicevic, L
   Protic, O
   Jasnic-Savovic, J
   Faulkner, G
   Radojkovic, D
AF Kojic, Snezana
   Nestorovic, Aleksandra
   Rakicevic, Ljiljana
   Protic, Olga
   Jasnic-Savovic, Jovana
   Faulkner, Georgine
   Radojkovic, Dragica
TI Cardiac transcription factor Nkx2.5 interacts with p53 and modulates its
   activity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE p53; Nkx2.5; Ankrd2; Stress response; Apoptosis; Heart
ID CONGENITAL HEART-DISEASE; ANKYRIN REPEAT PROTEIN; DOXORUBICIN-INDUCED
   APOPTOSIS; DNA-BINDING TARGETS; GENE-EXPRESSION; IN-VIVO; MUSCLE
   DIFFERENTIATION; FACTOR CSX/NKX2-5; TRANSGENIC MICE; UP-REGULATION
AB Transcription factor Nkx2.5, essential for heart development, regulates cardiomyocyte-specific gene expression through combinatorial interactions with other cardiac-restricted (GATA4 and dHAND) or ubiquitous (p300) transcription regulators. Here we demonstrate that Nkx2.5 and p53 synergistically activate the promoter of the striated muscle stress responsive transcriptional cofactor Ankrd2, involved in coordination of proliferation and apoptosis during myogenic differentiation. Moreover, the p53 protein is able to interact with both wild type Nkx2.5 and its mutant Delta Nkx2.5 (aa 1-198) found in patients with diverse cardiac malformations. Nkx2.5 interaction site of p53 maps to the C terminal region, while p53 binding site on Nkx2.5 lies outside its C terminus. In addition, overexpression of Nkx2.5 has a modulatory, promoter dependent effect on p53 transactivation, while the mutant significantly abolished p53 activity on the Mdm2, p21(WAF1/CIP1) and Box promoters. Their physical interaction contributes to the observed behavior in the case of the Mdm2 promoter. Our data provide a new evidence for the role of p53 in cardiac function through interaction with Nkx2.5. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Kojic, Snezana; Nestorovic, Aleksandra; Rakicevic, Ljiljana; Protic, Olga; Jasnic-Savovic, Jovana; Radojkovic, Dragica] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia.
   [Faulkner, Georgine] Univ Padua, CRIBI, Padua, Italy.
RP Kojic, S (reprint author), Inst Mol Genet & Genet Engn, Vojvode Stepe 444a,POB 23, Belgrade 11010, Serbia.
EM snezanakojic@imgge.bg.ac.rs
FU Collaborative Research Programme, ICGEB, Italy [CRP/YUG-05-01]; Ministry
   of Education, Science and Technological Development of the Republic of
   Serbia [173008]
FX This work was supported by Collaborative Research Programme, ICGEB,
   Italy (CRP/YUG-05-01) and Ministry of Education, Science and
   Technological Development of the Republic of Serbia (Project No.
   173008). We are grateful to C. Kuhne and G. Del Sal for p53 constructs.
CR Matsusaka H, 2006, CARDIOVASC RES, V70, P457, DOI 10.1016/j.cardiores.2006.02.001
   Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700
   Kojic S, 2011, CRIT REV CL LAB SCI, V48, P269, DOI 10.3109/10408363.2011.643857
   Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8
   Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154
   Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263
   Long XL, 1997, J CLIN INVEST, V99, P2635, DOI 10.1172/JCI119452
   Kasahara H, 2004, CARDIOVASC RES, V64, P40, DOI 10.1016/j.cardiores.2004.06.004
   Gottlieb E, 1997, EMBO J, V16, P1381, DOI 10.1093/emboj/16.6.1381
   Leri A, 1998, CIRCULATION, V97, P194
   CHEN CY, 1995, J BIOL CHEM, V270, P15628
   Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687
   Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910
   Toko H, 2002, J BIOL CHEM, V277, P24735, DOI 10.1074/jbc.M107669200
   Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115
   Naito AT, 2010, CIRC RES, V106, P1692, DOI 10.1161/CIRCRESAHA.109.214346
   Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391
   Olson EN, 1996, SCIENCE, V272, P671, DOI 10.1126/science.272.5262.671
   Mohamed JS, 2013, J BIOL CHEM, V288, P24560, DOI 10.1074/jbc.M112.434423
   Tamir Y, 1998, ONCOGENE, V17, P347, DOI 10.1038/sj.onc.1201929
   KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145
   Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101
   Tanaka M, 1999, DEVELOPMENT, V126, P1269
   Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008
   Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864
   Ikeda Y, 2002, CIRC J, V66, P561, DOI 10.1253/circj.66.561
   Fishman MC, 1997, DEVELOPMENT, V124, P2099
   Chen CY, 1996, MOL CELL BIOL, V16, P6372
   Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405
   Okamoto T, 2000, ONCOGENE, V19, P6194, DOI 10.1038/sj.onc.1204029
   Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108
   McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/S0735-1097(03)01082-9
   Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054
   Kuo HC, 1999, DEVELOPMENT, V126, P4223
   ROGEL A, 1985, MOL CELL BIOL, V5, P2851
   Choi J, 1999, CELL MOL LIFE SCI, V55, P38, DOI 10.1007/s000180050268
   Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037
   Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716
   Takimoto E, 2000, BIOCHEM BIOPH RES CO, V270, P1074, DOI 10.1006/bbrc.2000.2561
   Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6
   Liu XW, 2004, AM J PHYSIOL-HEART C, V286, pH933, DOI 10.1152/ajpheart.00759.2003
   Zhu WD, 2000, J BIOL CHEM, V275, P35291, DOI 10.1074/jbc.M000525200
   Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804
   Monzen K, 2002, BIOCHEM BIOPH RES CO, V298, P493, DOI 10.1016/S0006-291X(02)02497-X
   Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123
   Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0
   Thompson JT, 1998, AM J PHYSIOL-HEART C, V274, pH1569
   Song H, 1999, J HEART LUNG TRANSPL, V18, P744, DOI 10.1016/S1053-2498(98)00039-4
   Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012
   Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417
   Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005
   Zou YM, 1997, DEVELOPMENT, V124, P793
   Bean C, 2008, BBA-MOL CELL RES, V1783, P1023, DOI 10.1016/j.bbamcr.2008.01.027
   Belgrano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025519
   Caprioli A, 2011, CIRCULATION, V123, P1633, DOI 10.1161/CIRCULATIONAHA.110.008185
   Das B, 2010, CARDIOVASC RES, V87, P524, DOI 10.1093/cvr/cvq068
   Durocher D, 1998, DEV GENET, V22, P250, DOI 10.1002/(SICI)1520-6408(1998)22:3<250::AID-DVG7>3.0.CO;2-5
   Feridooni T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022801
   Gutierrez-Roelens Ilse, 2002, Hum Mutat, V20, P75, DOI 10.1002/humu.9041
   Imamura T, 2001, J BIOL CHEM, V276, P7534, DOI 10.1074/jbc.M008143200
   Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200
   Kasahara H, 1999, MOL CELL BIOL, V19, P526
   Lee Y, 1998, MOL CELL BIOL, V18, P3120
   Len A., 1998, J CLIN INVEST, V101, P1326
   [李涛 Li Tao], 2012, [生物工程学报, Chinese Journal of Biotechnology], V28, P1253
   Li T, 2007, J MOL BIOL, V370, P976, DOI 10.1016/j.jmb.2007.05.033
   LINTS TJ, 1993, DEVELOPMENT, V119, P969
   LOUIS JM, 1988, BIOCHIM BIOPHYS ACTA, V950, P395, DOI 10.1016/0167-4781(88)90136-4
   LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654
   MacCallum DE, 1996, ONCOGENE, V13, P2575
   Maeda T, 2002, GENE, V297, P1, DOI 10.1016/S0378-1119(02)00924-1
   Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950
   Pallavicini A, 2001, BIOCHEM BIOPH RES CO, V285, P378, DOI 10.1006/bbrc.2001.5131
   Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000
   Poyurovsky MV, 2006, GENE DEV, V20, P125, DOI 10.1101/gad.1397506
   Saadane N, 1999, BRIT J PHARMACOL, V127, P1165, DOI 10.1038/sj.bjp.0702676
   SCHMID P, 1991, DEVELOPMENT, V113, P857
   Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M50930200
   Watanabe Y, 2002, J MED GENET, V39, P807, DOI 10.1136/jmg.39.11.807
   Zaffran S, 2005, BIOCHEM BIOPH RES CO, V334, P361, DOI 10.1016/j.bbrc.2005.06.090
   Zheng W, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0364-y
NR 81
TC 0
Z9 0
U1 5
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2015
VL 569
BP 45
EP 53
DI 10.1016/j.abb.2015.02.001
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CE9NI
UT WOS:000352170300006
PM 25677450
ER

PT J
AU Qiao, C
   Jiang, YJ
   Deng, CL
   Huang, ZB
   Teng, KX
   Chen, L
   Liu, X
AF Qiao, Cheng
   Jiang, Yajie
   Deng, Cuilan
   Huang, Zebo
   Teng, Kaixuan
   Chen, Lan
   Liu, Xin
TI Characterization of the transcriptional activation domains of human
   TEF3-1 (transcription enhancer factor 3 isoform 1)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Transcription enhancer factor 3 isoform 1; Transcriptional activation
   domains; Yeast; HUVEC; Angiogenesis
ID ENDOTHELIAL-CELLS; GASTRIC-CANCER; YAP; BINDING; EXPRESSION; PATHWAY;
   RTEF-1; GROWTH; TEAD4; PROLIFERATION
AB TEF3-1 (transcription enhancer factor 3 isoform 1) is a human transcriptional factor, which has a N-terminal TEA/ATTS domain supposedly for DNA binding and C-terminal PRD and STY domains for transcriptional activation. Taking advantage of the efficient reporter design of yeast two-hybrid system, we characterized the TEF3-1 domains in activating gene expression. Previously study usually mentioned that the C-terminal domain of TEF3-1 has the transcriptional activity, however, our data shows that the peptides TEF3-1(1-66) and TEF3-1(197-434) functioned as two independent activation domains, suggesting that N-terminal domain of TEF3-1 also has transcriptional activation capacity. Additionally, more deletions of amino acids 197-434 showed that only the peptides TEF3-1 197-265 contained the minimum sequences for the C-terminal transcriptional activation domain. The protein structure is predicted to contain a helix-turn-helix structure in TEF3-1(1-66) and four beta sheets in TEF3-1(197-265). Finally, after the truncated fragments of TEF3-1 were expressed in HUVEC cells, the whole TEF3-1 and the two activation domains could increase F-actin stress fiber, cell proliferation, migration and targeted gene expression. Further analysis and characterization of the activation domains in TEF3-1 may broaden our understanding of the gene involved in angiogenesis and other pathological processes. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Qiao, Cheng; Jiang, Yajie; Deng, Cuilan; Huang, Zebo; Teng, Kaixuan; Chen, Lan; Liu, Xin] Wuhan Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovery, Wuhan 430071, Peoples R China.
RP Liu, X (reprint author), Wuhan Univ, Sch Pharmaceut Sci, 185 East Lake Rd, Wuhan 430071, Peoples R China.
EM lx@whu.edu.cn
FU National Program on Key Basic Research Project (973 Program)
   [2010CB529804]; National Natural Science Foundation of China [30971456,
   81273540, 81472550, 31400155]; Wuhan University School of Medicine
FX This study was supported by National Program on Key Basic Research
   Project (973 Program, No. 2010CB529804), the National Natural Science
   Foundation of China (Grant Nos. 30971456, 81273540, 81472550 and
   31400155), and by Innovation Seed Fund of Wuhan University School of
   Medicine. We would like to thank Professor Zan Huang, college of life
   science in Wuhan University for his support in recombinant lentivirus
   production.
CR Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010
   Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999
   Stewart AFR, 1998, CIRC RES, V83, P43
   Shie JL, 2004, J BIOL CHEM, V279, P25010, DOI 10.1074/jbc.M403103200
   Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810
   Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434
   Home P, 2012, P NATL ACAD SCI USA, V109, P7362, DOI 10.1073/pnas.1201595109
   Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310
   Jacquemin P, 1996, J BIOL CHEM, V271, P21775
   Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200
   Wang K, 2013, CANCER LETT, V340, P63, DOI 10.1016/j.canlet.2013.06.026
   Pourgholami MH, 2010, BIOCHEM BIOPH RES CO, V397, P729, DOI 10.1016/j.bbrc.2010.06.019
   Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151
   Borneman AR, 2000, MOL MICROBIOL, V38, P1034, DOI 10.1046/j.1365-2958.2000.02202.x
   Tao L, 2011, MICROBIOL-SGM, V157, P313, DOI 10.1099/mic.0.044271-0
   Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.femsre.2004.12.008
   Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210
   Rayon T, 2014, DEV CELL, V30, P410, DOI 10.1016/j.devcel.2014.06.019
   Lim B, 2014, CARCINOGENESIS, V35, P1020, DOI 10.1093/carcin/bgt409
   Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310
   Naye F, 2007, INT J DEV BIOL, V51, P745, DOI 10.1387/ijdb.072375fn
   Appukuttan B, 2007, INVEST OPHTH VIS SCI, V48, P3775, DOI 10.1167/iovs.06-1172
   BURGLIN TR, 1991, CELL, V66, P11, DOI 10.1016/0092-8674(91)90132-I
   Cheng Z., 2012, MOL MICROBIOL
   Farrance IKG, 1996, J BIOL CHEM, V271, P8266
   Hayashi S, 2014, DEV BIOL, V396, P31, DOI 10.1016/j.ydbio.2014.09.018
   He P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088143
   Herring BP, 2007, CIRC RES, V101, P856, DOI 10.1161/CIRCRESAHA.107.164053
   Jacquemin P, 1997, J BIOL CHEM, V272, P12928, DOI 10.1074/jbc.272.20.12928
   Jacquemin P, 1999, GENOMICS, V55, P127, DOI 10.1006/geno.1998.5628
   Liu X, 2008, J BIOL CHEM, V283, P34159, DOI 10.1074/jbc.M806338200
   Liu X, 2011, FASEB J, V25, P1188, DOI 10.1096/fj.10-167619
   Shultzaberger RK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002614
   STEWART AFR, 1994, J BIOL CHEM, V269, P3147
   Thompson M, 2003, BIOCHEM BIOPH RES CO, V301, P267, DOI 10.1016/S0006-291X(02)03024-3
   Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997
   Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091770
   Zhang YX, 2002, CELL, V109, P849, DOI 10.1016/S0092-8674(02)00805-X
NR 38
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2015
VL 569
BP 54
EP 61
DI 10.1016/j.abb.2015.02.003
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CE9NI
UT WOS:000352170300007
PM 25687649
ER

PT J
AU Zhang, HQ
   Davies, KJA
   Forman, HJ
AF Zhang, Hongqiao
   Davies, Kelvin J. A.
   Forman, Henry Jay
TI TGF beta 1 rapidly activates Src through a non-canonical redox signaling
   mechanism
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Sit; TGF-beta; Hydrogen peroxide; Oxidative modification; Redox
   signaling
ID GROWTH-FACTOR-BETA; PROTEIN-TYROSINE-PHOSPHATASE; EPITHELIAL-MESENCHYMAL
   TRANSITION; C-SRC; KINASE-ACTIVITY; HYDROGEN-PEROXIDE; CYSTEINE
   RESIDUES; FAMILY KINASES; REVERSIBLE INACTIVATION; NADPH OXIDASE
AB Transforming growth factor-beta (TGF-beta) is involved in multiple cellular processes through Src activation. In the canonical pathway, Src activation is initiated by pTyr530 dephosphorylation followed by a conformational change allowing Tyr419 auto-phosphorylation. A non-canonical pathway in which oxidation of cysteine allows bypassing of pTyr530 dephosphorylation has been reported. Here, we examined how TGF-beta activates Src in H358 cells, a small cell lung carcinoma cell line. TGF-beta increased Src Tyr419 phosphorylation, but surprisingly, Tyr530 phosphorylation was increased rather than decreased. Vanadate, a protein tyrosine phosphatase inhibitor, stimulated Src activation itself, but rather than inhibiting Src activation by TGF-beta, activation by vanadate was additive with TGF-beta showing that pTyr530 dephosphorylation was not required. Thus, the involvement of the non-canonical oxidative activation was suspected. TGF-beta increased extracellular H2O2 transiently while GSH-ester and catalase abrogated Src activation by TGF-beta. Apocynin, a NADPH oxidase inhibitor, inhibited TGF-beta-stimulated H2O2 production. Furthermore, mutation of cysteines to alanine, 248C/A, 277C/A, or 501 C/A abrogated, while 490C/A significantly reduced, TGF-beta-mediated Src activation. Taken together, the results indicate that TGF-beta-mediated Src activation operates largely through a redox dependent mechanism, resulting from enhanced H2O2 production through an NADPH oxidase and that cysteines 248, 277, 490, and 501 are critical for this activation. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Zhang, Hongqiao; Davies, Kelvin J. A.; Forman, Henry Jay] Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA.
   [Davies, Kelvin J. A.] Univ So Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Div Mol & Computat Biol, Los Angeles, CA 90089 USA.
   [Forman, Henry Jay] Univ Calif, Sch Nat Sci, Merced, CA USA.
RP Forman, HJ (reprint author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA.
EM peroxideman@gmail.com
OI Forman, Henry/0000-0001-5838-2791
FU United States NIH [R21-ES020942, R01-ES003598]
FX This research was supported by United States NIH Grants R21-ES020942 and
   R01-ES003598.
CR Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821
   Chiarugi P, 2001, J BIOL CHEM, V276, P33478, DOI 10.1074/jbc.M102302200
   Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005
   Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t
   Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371
   Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003
   Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655
   Gharaee-Kermani M, 2009, CURR MED CHEM, V16, P1400
   Zhang HQ, 2012, FREE RADICAL BIO MED, V52, P1437, DOI 10.1016/j.freeradbiomed.2012.01.024
   Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611
   Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973
   Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001
   Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6
   Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005
   Raugei G, 2002, CELL MOL LIFE SCI, V59, P941, DOI 10.1007/s00018-002-8481-z
   Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366
   Mallozzi C, 1999, FEBS LETT, V456, P201, DOI 10.1016/S0014-5793(99)00945-X
   Wang SE, 2005, MOL CELL BIOL, V25, P4703, DOI 10.1128/MCB.11.4703-4715.2005
   Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160
   Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v
   Parasassi T, 2010, THESCIENTIFICWORLDJO, V10, P1192, DOI 10.1100/tsw.2010.104
   Schwartz EA, 2005, BIOCHEM J, V390, P199, DOI 10.1042/BJ20041182
   Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005
   Ungefroren H, 2011, INT J ONCOL, V38, P797, DOI 10.3892/ijo.2011.897
   Byeon SE, 2013, FREE RADICAL BIO MED, V57, P105, DOI 10.1016/j.freeradbiomed.2012.12.013
   Martinez-Orozco R, 2010, EUR J CELL BIOL, V89, P476, DOI 10.1016/j.ejcb.2009.12.005
   Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141
   Giannoni E, 2010, FREE RADICAL BIO MED, V49, P516, DOI 10.1016/j.freeradbiomed.2010.04.025
   Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106
   Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336
   Krejsa CM, 1997, J BIOL CHEM, V272, P11541
   Meng D, 2007, FREE RADICAL BIO MED, V42, P1651, DOI 10.1016/j.freeradbiomed.2007.01.037
   Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202
   Bartscht T, 2012, CANCER CHEMOTH PHARM, V70, P221, DOI 10.1007/s00280-012-1904-0
   Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1
   Murillo MM, 2007, BIOCHEM J, V405, P251, DOI 10.1042/BJ20061846
   Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011
   Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214
   Zhang HQ, 2006, FREE RADICAL BIO MED, V40, P1281, DOI 10.1016/j.freeradbiomed.2005.11.005
   Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378
   Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935
   Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje
   Mills JE, 2007, J MOL BIOL, V365, P1460, DOI 10.1016/j.jmb.2006.10.076
   Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492
   Zuo W, 2009, MOL BIOL CELL, V20, P1020, DOI 10.1091/mbc.E08-09-0898
   Barford D, 1995, CURR OPIN STRUC BIOL, V5, P728, DOI 10.1016/0959-440X(95)80004-2
   FUKAZAWA H, 1990, BIOCHEM BIOPH RES CO, V173, P276, DOI 10.1016/S0006-291X(05)81053-8
   Krasnowska EK, 2008, FREE RADICAL BIO MED, V45, P1566, DOI 10.1016/j.freeradbiomed.2008.09.012
   Li S, 2003, ARCH BIOCHEM BIOPHYS, V410, P269, DOI 10.1016/S0003-9861(02)00696-3
   Mehdi MZ, 2005, ANTIOXID REDOX SIGN, V7, P1014, DOI 10.1089/ars.2005.7.1014
   Nauphar D., 2013, INT J SCI ADV TECHNO, V3, P9
   Neel B., 1997, CURR OPIN CELL BIOL, V2, P193
   OKADA M, 1989, J BIOL CHEM, V264, P20886
   Oo ML, 2003, ONCOGENE, V22, P1411, DOI 10.1038/sj.onc.1206286
   Pu MY, 1996, ONCOGENE, V13, P2615
   Sato M, 2005, ARTERIOSCL THROM VAS, V25, P341, DOI 10.1161/01.ATV.0000152608.29351.8f
   Sen B, 2011, J SIGNAL TRANSDUCT, V2011, DOI [10.1155/2011/865819, DOI 10.1155/2011/865819]
   Senga T, 2000, ONCOGENE, V19, P273, DOI 10.1038/sj.onc.1203296
   Wang DX, 2002, J BIOL CHEM, V277, P40428, DOI 10.1074/jbc.M206467200
   Wang LF, 2011, AM J PHYSIOL-CELL PH, V301, pC171, DOI 10.1152/ajpcell.00363.2010
   Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007
   Xiao YQ, 2006, J IMMUNOL, V176, P1209
   Xu KP, 2006, INVEST OPHTH VIS SCI, V47, P2832, DOI 10.1167/iovs.05-1361
   Yan SR, 1996, J BIOL CHEM, V271, P23464
   Yang SZ, 2009, BIOCHEM BIOPH RES CO, V382, P555, DOI 10.1016/j.bbrc.2009.03.079
   Zhang Y, 2010, ANTIOXID REDOX SIGN, V13, P959, DOI 10.1089/ars.2009.2908
   Zhuang Shougang, 2004, Am J Physiol Renal Physiol, V286, pF858
NR 67
TC 2
Z9 2
U1 3
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 2015
VL 568
BP 1
EP 7
DI 10.1016/j.abb.2015.01.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CC7GN
UT WOS:000350535800001
PM 25585026
ER

PT J
AU Gani, AR
   Uppala, JK
   Ramaiah, KVA
AF Gani, Amina R.
   Uppala, Jagadeesh Kumar
   Ramaiah, Kolluru V. A.
TI Tauroursodeoxycholic acid prevents stress induced aggregation of
   proteins in vitro and promotes PERK activation in HepG2 cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE TUDCA; PERK; UPR; BSA; Protein aggregation; LC-MS/MS; COX1; EcoR1
ID ENDOPLASMIC-RETICULUM STRESS; URSODEOXYCHOLIC ACID; RAT HEPATOCYTES;
   BILE-ACID; INDUCED APOPTOSIS; ER-STRESS; PHARMACOLOGICAL CHAPERONES;
   MECHANISMS; DISEASE; PROTECTS
AB Tauroursodeoxycholic acid (TUDCA) a bile salt and chemical chaperone reduces stress-induced 'aggregation of proteins; activates PERK [PKR (RNA-dependent protein kinase)-like ER (endoplasmic reticulum) kinasel or ElF2AK3, one of the hallmarks of ER stress induced unfolded protein response (UPR) in human hepatoblastoma HepG2 cells; prevents heat and dithiothreitol (DTT) induced aggregation of BSA (bovine serum albumin), and reduces ANS (1-anilino-naphthalene-8-sulfonate) bound BSA fluorescence in vitro. TUDCA inactivates heat treated, but not the native EcoR1 enzyme, and reduces heat-induced aggregation and activity of COX-1 (cyclooxygenase enzyme-1) in vitro. These findings suggest that TUDCA binds to the hydrophobic regions of proteins and prevents their subsequent aggregation. This may stabilize unfolded proteins that can mount UPR or facilitate their degradation through cellular degradation pathways. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Gani, Amina R.; Uppala, Jagadeesh Kumar; Ramaiah, Kolluru V. A.] Univ Hyderabad, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India.
RP Ramaiah, KVA (reprint author), Univ Hyderabad, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India.
EM kvarsl@uohyd.ernet.in
FU CSIR - India; UGC - India; DST - India, New-Delhi
FX ARG, UJK and KVAR acknowledge CSIR - India, UGC - India and DST - India,
   New-Delhi respectively for financial assistance in the form of
   fellowships and research grant respectively. The authors thank DST-FIST
   for the infrastructural facilities.
CR Aarti I, 2010, APOPTOSIS, V15, P679, DOI 10.1007/s10495-010-0474-z
   Reddy CM, 2000, BIOCHEM BIOPH RES CO, V277, P599, DOI 10.1006/bbrc.2000.3725
   Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299
   Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056
   Sola S, 2005, HEPATOLOGY, V42, P925, DOI 10.1002/hep.20870
   Beuers U, 1996, GASTROENTEROLOGY, V110, P1553, DOI 10.1053/gast.1996.v110.pm8613063
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387
   Ramalho RM, 2008, TRENDS MOL MED, V14, P54, DOI 10.1016/j.molmed.2007.12.001
   Cui WJ, 2011, ACTA CRYSTALLOGR D, V67, P423, DOI 10.1107/S0907444911006445
   Rodrigues CMP, 1999, CELL DEATH DIFFER, V6, P842, DOI 10.1038/sj.cdd.4400560
   Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020
   KullakUblick GA, 1996, HEPATOLOGY, V23, P1053
   Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200
   Schliess F, 1997, GASTROENTEROLOGY, V113, P1306, DOI 10.1053/gast.1997.v113.pm9322526
   Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755
   Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738
   Beuers U, 2006, NAT CLIN PRACT GASTR, V3, P318, DOI 10.1038/ncpgasthep0521
   Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317
   Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317
   Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113
   Kraskiewicz H, 2012, TRENDS PHARMACOL SCI, V33, P53, DOI 10.1016/j.tips.2011.10.002
   Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246
   Berger E, 2011, BIOCHEM BIOPH RES CO, V409, P610, DOI 10.1016/j.bbrc.2011.05.043
   Haussinger D, 2003, GASTROENTEROLOGY, V124, P1476, DOI 10.1016/S0016-5085(03)00274-9
   Amaral JD, 2009, J LIPID RES, V50, P1721, DOI 10.1194/jlr.R900011-JLR200
   Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100
   Loo Tip W., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000361
   Aparna G, 2003, BIOCHEMISTRY-US, V42, P15352, DOI 10.1021/bi0349423
   Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526
   BEUERS U, 1993, J CLIN INVEST, V92, P2984, DOI 10.1172/JCI116921
   BOUSCAREL B, 1993, AM J PHYSIOL, V264, pG243
   Castro RE, 2005, J HEPATOL, V42, P897, DOI 10.1016/j.jhep.2005.01.026
   Duan WM, 2002, CELL TRANSPLANT, V11, P195
   Glasova H, 2002, EUR J CLIN INVEST, V32, P437, DOI 10.1046/j.1365-2362.2002.01002.x
   Hussain SG, 2007, CURR SCI INDIA, V93, P1684
   Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507
   Lazaridis KN, 2001, J HEPATOL, V35, P134, DOI 10.1016/S0168-8278(01)00092-7
   Leandro P, 2008, MINI-REV MED CHEM, V8, P901, DOI 10.2174/138955708785132783
   Mannack G, 2008, CELL PHYSIOL BIOCHEM, V21, P137, DOI 10.1159/000113756
   Paumgartner Gustav, 2004, Clin Liver Dis, V8, P67, DOI 10.1016/S1089-3261(03)00135-1
   Rajan RS, 2011, CURR MED CHEM, V18, P1
   Sano R., 1833, BIOCHIM BIOPHYS ACTA, V2013, P3460
   Seyhun E, 2011, AM J PHYSIOL-GASTR L, V301, pG773, DOI 10.1152/ajpgi.00483.2010
   Sola S, 2006, MOL ENDOCRINOL, V20, P2292, DOI 10.1210/me.2006.0063
   Wang LF, 2005, HEPATOLOGY, V41, P1241, DOI 10.1002/hep.20697
NR 47
TC 2
Z9 2
U1 5
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 2015
VL 568
BP 8
EP 15
DI 10.1016/j.abb.2014.12.031
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CC7GN
UT WOS:000350535800002
PM 25579883
ER

PT J
AU Yuan, CC
   Ma, WK
   Schemmel, P
   Cheng, YS
   Liu, JM
   Tsaprailis, G
   Feldman, S
   Southgate, AA
   Irving, TC
AF Yuan, Chen-Ching
   Ma, Weikang
   Schemmel, Peter
   Cheng, Yu-Shu
   Liu, Jiangmin
   Tsaprailis, George
   Feldman, Samuel
   Southgate, Agnes Ayme
   Irving, Thomas C.
TI Elastic proteins in the flight muscle of Manduca sexta
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Insect flight muscle; Passive tension; Elastic proteins
ID TANDEM MASS-SPECTROMETRY; PEVK DOMAIN; TEMPERATURE-GRADIENTS; DROSOPHILA
   PROJECTIN; MYOFIBRILLAR PROTEIN; ASYNCHRONOUS MUSCLE; STATISTICAL-MODEL;
   TITIN ISOFORMS; CARDIAC-MUSCLE; Z-BAND
AB The flight muscles (DLK) of the Hawkmoth, Manduca sexta are synchronous, requiring a neural spike for each contraction. Stress/strain curves of skinned DLM1, showed hysteresis indicating the presence of titin-like elastic proteins. Projectin and kettin are titin-like proteins previously identified in Lethocerus and Drosophila flight muscles. Analysis of Manduca muscles with 1% SDS-agarose gels and western blots showed two bands near 1 MDa that cross-reacted with antibodies to Drosophila projectin. Antibodies to Drosophila kettin cross-reacted to bands at similar to 500 and similar to 700 kDa, but also to bands at similar to 1.6 and similar to 2.1 MDa, that had not been previously observed in insect flight muscles. Mass spectrometry identified the 2.1 MDa protein as a product of the Sallimus (sis) gene. Analysis of the gene sequence showed that all 4 putative Sallimus and kettin isoforms could be explained as products of alternative splicing of the single sls gene. Both projectin and sallimus isoforms were expressed to higher levels in ventrally located DLM1 subunits, primarily responsible for active work production, as compared to dorsally located subunits, which may act as damped springs. The different expression levels of the 2 projectin isoforms and 4 sallimus/kettin isoforms may be adaptations to the specific requirements of individual muscle subunits. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Yuan, Chen-Ching; Ma, Weikang; Schemmel, Peter; Cheng, Yu-Shu; Liu, Jiangmin; Irving, Thomas C.] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA.
   [Tsaprailis, George] Univ Arizona, Ctr Toxicol, Tucson, AZ USA.
   [Feldman, Samuel; Southgate, Agnes Ayme] Coll Charleston, Dept Biol, Charleston, SC 29401 USA.
RP Irving, TC (reprint author), IIT, Dept Biol & Chem Sci, 3101 S Dearborn St, Chicago, IL 60616 USA.
EM irving@iit.edu
FU NSF [IOS-1022058]; NIEHS [ES06694]; NIH/NCI [CA023074]; BIO5 Institute
   of the University of Arizona; NIH/NCRR [1S10 RR028868-01]; College of
   Charleston
FX We would like to thank Prof. T. Daniel (U. Washington) for providing
   Manduca sexta samples. Research was supported by NSF IOS-1022058
   (Irving). Mass spectrometry and proteomics data were acquired by the
   Arizona Proteomics Consortium supported by NIEHS grant ES06694 to the
   SWEHSC, NIH/NCI grant CA023074 to the AZCC and by the BIO5 Institute of
   the University of Arizona. The Thermo Fisher LTQ OrbitrapVelos mass
   spectrometer was provided by grant 1S10 RR028868-01 from NIH/NCRR. AAS
   and SF were supported by the College of Charleston.
CR Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261
   Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Junier T, 2000, BIOINFORMATICS, V16, P178, DOI 10.1093/bioinformatics/16.2.178
   HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D
   Bullard B, 2005, J MUSCLE RES CELL M, V26, P479, DOI 10.1007/s10974-005-9032-7
   C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012
   Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4
   GRANZIER HL, 1995, BIOPHYS J, V68, P1027
   Burkart C, 2007, J MOL BIOL, V367, P953, DOI 10.1016/j.jmb/2007.01.059
   Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092
   Cazorla O, 2000, CIRC RES, V86, P59
   Josephson RK, 2000, J EXP BIOL, V203, P2713
   Linke WA, 1996, J MOL BIOL, V261, P62, DOI 10.1006/jmbi.1996.0441
   Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h
   George NT, 2013, SCIENCE, V340, P1217, DOI 10.1126/science.1229573
   Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638
   HOROWITS R, 1992, BIOPHYS J, V61, P392
   AYMESOUTHGATE A, 1995, J CELL BIOL, V128, P393, DOI 10.1083/jcb.128.3.393
   Ayme-Southgate A., 2012, J PROTEOMICS GENOME, V1, P21
   Ayme-Southgate A, 2005, J MUSCLE RES CELL M, V26, P467, DOI 10.1007/s10974-005-9031-8
   Ayme-Southgate A, 2011, INSECT MOL BIOL, V20, P347, DOI 10.1111/j.1365-2583.2011.01069.x
   Ayme-Southgate A. J., 2013, J INSECT SCI, V13
   Ayme-Southgate AJ, 2008, J MOL EVOL, V67, P653, DOI 10.1007/s00239-008-9177-2
   Bullard B., 2006, NATURES VERSATILE EN, P177, DOI 10.1007/0-387-31213-7_14
   Bullard B, 2006, P NATL ACAD SCI USA, V103, P4451, DOI 10.1073/pnas.0509016103
   Bullard B, 2002, J MUSCLE RES CELL M, V23, P435, DOI 10.1023/A:1023454305437
   Dudley R., 2000, BIOMECHANICS INSECT
   Gautel M, 1996, FEBS LETT, V385, P11, DOI 10.1016/0014-5793(96)00338-9
   George NT, 2012, J EXP BIOL, V215, P471, DOI 10.1242/jeb.062901
   George NT, 2011, J EXP BIOL, V214, P894, DOI 10.1242/jeb.047969
   Granzier H, 2002, J PHYSIOL-LONDON, V541, P335, DOI 10.1113/jphysiol.2001.014381
   Granzier HL, 2005, ADV PROTEIN CHEM, V71, P89, DOI 10.1016/S0065-3233(04)71003-7
   Kreiskother N, 2006, J MUSCLE RES CELL M, V27, P93, DOI 10.1007/s10974-006-9060-y
   Kulke M, 2001, J CELL BIOL, V154, P1045, DOI 10.1083/jcb.200104016
   Linke WA, 1999, J CELL BIOL, V146, P631, DOI 10.1083/jcb.146.3.631
   Machado C, 2000, J CELL BIOL, V151, P639
   NAVE R, 1990, J CELL SCI, V95, P535
   Nedrud J, 2011, BIOPHYS J, V101, P1385, DOI 10.1016/j.bpj.2011.06.054
   Perz-Edwards R. J., 2011, P NATL ACAD SCI US, V108
   PRINGLE JWS, 1978, PROC R SOC SER B-BIO, V201, P107, DOI 10.1098/rspb.1978.0035
   Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-6-405, 10.1186/gb-2013-14-7-405]
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   SIEGMAN MJ, 1976, SCIENCE, V191, P383, DOI 10.1126/science.128819
   Southgate R, 2001, J MOL BIOL, V313, P1035, DOI 10.1006/jmbi.2001.5115
   STEVENSON RD, 1990, J EXP BIOL, V149, P61
   Trombitas K, 2000, ADV EXP MED BIOL, V481, P1
   Trombitas K, 1998, J STRUCT BIOL, V122, P188, DOI 10.1006/jsbi.1998.3984
   Tu MS, 2004, J EXP BIOL, V207, P2455, DOI 10.1242/jeb.01039
   Weitkamp B, 1998, J BIOL CHEM, V273, P19802, DOI 10.1074/jbc.273.31.19802
NR 50
TC 1
Z9 1
U1 3
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 2015
VL 568
BP 16
EP 27
DI 10.1016/j.abb.2014.12.033
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CC7GN
UT WOS:000350535800003
PM 25602701
ER

PT J
AU Boehlein, SK
   Shaw, JR
   Stewart, JD
   Sullivan, B
   Hannah, LC
AF Boehlein, Susan K.
   Shaw, Janine R.
   Stewart, Jon D.
   Sullivan, Bradford
   Hannah, L. Curtis
TI Enhancing the heat stability and kinetic parameters of the maize
   endosperm ADP-glucose pyrophosphorylase using iterative saturation
   mutagenesis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE ADP-glucose pyrophosphorylase; Heat stability; Iterative saturation
   mutagenesis; Starch biosynthesis; Grain yield
ID SINGLE-POINT MUTATIONS; POTATO-TUBER; SEED WEIGHT; INCREASES;
   THERMOSTABILITY; STARCH; YIELD; STABILIZATION; EXPRESSION; PROTEINS
AB Iterative saturation mutagenesis (ISM) has been used to improve the thermostability of maize endosperm ADP-glucose pyrophosphorylase (AGPase), a highly-regulated, rate-limiting and temperature-sensitive enzyme essential for starch biosynthesis. The thermo-sensitivity of heterotetrameric AGPase has been linked to grain loss in cereals and improving this property might therefore have direct impacts on grain yield. Nine amino acids were selected for site-saturation mutagenesis on the basis of elevated B-factors in the crystal structure of the closest available homolog (a small subunit homotetramer of potato AGPase). After each round of mutagenesis, iodine staining and antibody capture activity assays at varying temperatures were used to select the optimum positions and amino acid changes for the next rounds of mutagenesis. After three iterations, the signals from whole-colony iodine staining were saturated and a heat stable AGPase variant was obtained. Kinetic studies of the heat stable mutant showed that it also had an unexpected increased affinity for the activator, 3-PGA. This is particularly valuable as both the temperature stability and allosteric properties of AGPase significantly influence grain yield. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Boehlein, Susan K.; Shaw, Janine R.; Hannah, L. Curtis] Univ Florida, Program Plant Mol & Cellular Biol, Gainesville, FL 32611 USA.
   [Stewart, Jon D.; Sullivan, Bradford] Univ Florida, Dept Chem, Gainesville, FL 32611 USA.
RP Hannah, LC (reprint author), Univ Florida, Program Plant Mol & Cellular Biol, POB 110690,1253 Fifield Hall, Gainesville, FL 32611 USA.
EM lchannah@ufl.edu
FU National Science Foundation [IBM 0444031, IOS 0815104]; USDA
   [2006-35100-17220, 2008-35318-18649]; National Institute of Food and
   Agriculture [2010-04228]
FX We gratefully acknowledge support from the National Science Foundation
   (L.C.H. IBM 0444031 and IOS 0815104) and the USDA Competitive Grants
   Program (L.C.H. 2006-35100-17220 and 2008-35318-18649) and from the
   National Institute of Food and Agriculture (L.C.H. 2010-04228).
CR STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287
   Giroux MJ, 1996, P NATL ACAD SCI USA, V93, P5824, DOI 10.1073/pnas.93.12.5824
   Ballicora MA, 2005, J BIOL CHEM, V280, P10189, DOI 10.1074/mbc.M413540200
   Smidansky ED, 2003, PLANTA, V216, P656, DOI 10.1007/s00425-002-0897-z
   Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026
   Silva IR, 2014, APPL MICROBIOL BIOT, V98, P4521, DOI 10.1007/s00253-013-5483-8
   Smidansky ED, 2002, P NATL ACAD SCI USA, V99, P1724, DOI 10.1073/pnas.022635299
   O'Fagain C, 2003, ENZYME MICROB TECH, V33, P137, DOI 10.1016/S0141-0229(03)00160-1
   Smidansky ED, 2007, PLANTA, V225, P965, DOI 10.1007/s00425-006-0400-3
   Sakulsingharoj C, 2004, PLANT SCI, V167, P1323, DOI 10.1016/j.plantsci.2004.06.028
   Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795
   Lehmann M, 2002, PROTEIN ENG, V15, P403, DOI 10.1093/protein/15.5.403
   Li N, 2011, PLANTA, V233, P241, DOI 10.1007/s00425-010-1296-5
   Rader AJ, 2011, MOL BIOSYST, V7, P464, DOI 10.1039/c0mb00054j
   Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551
   Boehlein S., 2009, PLANT PHYSIOL, P318
   Boehlein S., 2008, PLANT PHYSIOL, P289
   Boehlein SK, 2013, ARCH BIOCHEM BIOPHYS, V537, P210, DOI 10.1016/j.abb.2013.07.019
   Boehlein SK, 2005, PLANT PHYSIOL, V138, P1552, DOI 10.1104/pp.105.060699
   Boehlein SK, 2010, PLANT PHYSIOL, V152, P1056, DOI 10.1104/pp.109.149450
   Boehlein SK, 2013, ARCH BIOCHEM BIOPHYS, V535, P215, DOI 10.1016/j.abb.2013.04.003
   Boehlein SK, 2014, ARCH BIOCHEM BIOPHYS, V543, P1, DOI 10.1016/j.abb.2013.12.018
   Cross J., 2004, PLANT PHYSIOL, P137
   Georgelis N., 2008, PLANT SCI, P247
   Georgelis N., 2009, PLANT PHYSIOL, P67
   Greene T., 1998, PLANT CELL, P1295
   Hannah LC, 2012, PLANT CELL, V24, P2352, DOI 10.1105/tpc.112.100602
   IGLESIAS AA, 1993, J BIOL CHEM, V268, P1081
   Kavakli IH, 2001, J BIOL CHEM, V276, P40834, DOI 10.1074/jbc.M106310200
   Kumar R, 2014, BIOCHEM BIOPH RES CO, V447, P626, DOI 10.1016/j.bbrc.2014.04.051
   LIU TTY, 1981, PLANT PHYSIOL, V67, P525, DOI 10.1104/pp.67.3.525
   OSHIMA T, 1994, CURR OPIN STRUC BIOL, V4, P623, DOI 10.1016/S0959-440X(94)90228-3
   PREISS J, 1971, PLANT PHYSIOL, V47, P104, DOI 10.1104/pp.47.1.104
   Segel I., 1975, ENZYME KINETICS BEHA, P161
   Sullivan B, 2013, ENZYME MICROB TECH, V53, P70, DOI 10.1016/j.enzmictec.2013.02.012
   Sushmita R., 2000, BIOCHEMISTRY-US, V39, P4603
NR 36
TC 1
Z9 1
U1 8
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 2015
VL 568
BP 28
EP 37
DI 10.1016/j.abb.2015.01.008
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CC7GN
UT WOS:000350535800004
PM 25600571
ER

PT J
AU Aguayo, D
   Pacheco, N
   Morales, EH
   Collao, B
   Luraschi, R
   Cabezas, C
   Calderon, P
   Gonzalez-Nilo, F
   Gil, F
   Calderon, IL
   Saavedra, CP
AF Aguayo, Daniel
   Pacheco, Nicolas
   Morales, Eduardo H.
   Collao, Bernardo
   Luraschi, Roberto
   Cabezas, Carolina
   Calderon, Paulina
   Gonzalez-Nilo, Fernando
   Gil, Fernando
   Calderon, Ivan L.
   Saavedra, Claudia P.
TI Hydrogen peroxide and hypochlorous acid influx through the major S.
   Typhimurium porin OmpD is affected by substitution of key residues of
   the channel
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE OmpD porin; Hydrogen peroxide; Hypochlorous acid; Homology modeling;
   Molecular simulations
ID MOLECULAR-DYNAMICS SIMULATION; ESCHERICHIA-COLI; SALMONELLA-ENTERICA;
   MEMBRANE-PROTEIN; GENE; PERMEABILITY; SELECTIVITY; SYSTEMS; EFFLUX;
   REGION
AB OmpD is the major Salmonella enterica serovar Typhimurium (S. Typhimurium) porin and mediates hydrogen peroxide (H2O2) influx. The results described herein extend this finding to hypochlorous acid (HOCI), another reactive oxygen species that is also part of the oxidative burst generated by the phagosome. S. Typhimurium cells lacking OmpD show decreased HOCI influx, and OmpD-reconstituted proteoliposomes show an increase in the uptake of the toxic compound. To understand this physiologically relevant process, we investigated the role of key OmpD residues in H2O2 and NaOCl transport. Using a theoretical approach, residue K16 was defined as a major contributor to the channel electrostatic properties, and E1 II was shown to directly participate in the size-exclusion limit of the channel. Together, we provide theoretical, genetic, and biochemical evidence that OmpD mediates H2O2 and NaOCl uptake, and that key residues of the channel are implicated in this process. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Pacheco, Nicolas; Collao, Bernardo; Luraschi, Roberto; Cabezas, Carolina; Calderon, Paulina; Gil, Fernando; Calderon, Ivan L.; Saavedra, Claudia P.] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Lab Microbiol Mol, Santiago, Chile.
   [Aguayo, Daniel; Gonzalez-Nilo, Fernando] Univ Andres Bello, Fac Ciencias Biol, Ctr Bioinformat & Integrat Biol, Santiago, Chile.
   [Morales, Eduardo H.] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Lab Microbiol Mol, Santiago, Chile.
   [Aguayo, Daniel; Gonzalez-Nilo, Fernando] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso 2366103, Chile.
RP Saavedra, CP (reprint author), Univ Andres Bello, Dept Ciencias Biol, Lab Microbiol Mol, Republ 217, Santiago, Chile.
EM csaavedra@unab.cl
OI Gonzalez-Nilo, Fernando/0000-0001-6857-3575
FU FONDECYT [1120384, 11130576]; Millenium Initiative [09-022-F]
FX This work was supported in part by FONDECYT grants CS #1120384 and DA
   #11130576 and Millenium Initiative 09-022-F (FGN).
CR Aguilella VM, 2011, INTEGR BIOL-UK, V3, P159, DOI 10.1039/c0ib00048e
   Aksimentiev A, 2005, BIOPHYS J, V88, P3745, DOI 10.1529/biophysj.104.058727
   Alcaraz A, 2004, BIOPHYS J, V87, P943, DOI 10.1529/biophysj.104/043414
   FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648
   Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X
   HASSETT DJ, 1989, FASEB J, V3, P2574
   Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x
   Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137
   Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457
   Ziervogel BK, 2013, STRUCTURE, V21, P76, DOI 10.1016/j.str.2012.10.014
   Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732
   Bredin J, 2002, BIOCHEM J, V363, P521, DOI 10.1042/0264-6021:3630521
   Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354
   Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1
   Aguilella-Arzo M, 2009, PHYS CHEM CHEM PHYS, V11, P358, DOI 10.1039/b812775a
   COWAN SW, 1995, STRUCTURE, V3, P1041, DOI 10.1016/S0969-2126(01)00240-4
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082
   Simonet V, 2000, ANTIMICROB AGENTS CH, V44, P311, DOI 10.1128/AAC.44.2.311-315.2000
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x
   Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.022
   Calderon IL, 2011, RES MICROBIOL, V162, P214, DOI 10.1016/j.resmic.2010.11.001
   Cubillos MA, 2001, CHEM PHYS LIPIDS, V112, P41, DOI 10.1016/S0009-3084(01)00161-X
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   De la Cruz MA, 2010, J MOL MICROB BIOTECH, V18, P24, DOI 10.1159/000274309
   Delcour AH, 2003, FRONT BIOSCI, V8, pD1055, DOI 10.2741/1132
   Domenech-Sanchez A, 1999, J BACTERIOL, V181, P2726
   Garcia-Gimenez E., 2012, BIOCH RES INT, V2012, P1
   Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7
   Ipinza F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111062
   JEANTEUR D, 1994, P NATL ACAD SCI USA, V91, P10675, DOI 10.1073/pnas.91.22.10675
   Lou HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025825
   Masi Muriel, 2013, Open Microbiol J, V7, P22, DOI 10.2174/1874285801307010022
   McDonald SM, 2009, J VIROL, V83, P6135, DOI 10.1128/JVI.00409-09
   Miedema H, 2007, NANO LETT, V7, P2886, DOI 10.1021/nl0716808
   Morales EH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-63
   NIKAIDO H, 1983, J BACTERIOL, V153, P232
   Panasenko I. V., 2014, BIOCH MOSC, V78, P1466
   Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k
   Saint N, 1996, J BIOL CHEM, V271, P20676
   Santiviago CA, 2002, MOL MICROBIOL, V46, P687, DOI 10.1046/j.1365-2958.2002.03204.x
   Santiviago CA, 2003, J BACTERIOL, V185, P5901, DOI 10.1128/JB.185.19.5901-5905.2003
   Schweizer HP, 2012, EXPERT OPIN DRUG DIS, V7, P633, DOI 10.1517/17460441.2012.688949
   TUCKERMAN ME, 1991, J CHEM PHYS, V94, P1465, DOI 10.1063/1.460004
   Vrouenraets M, 2006, BIOPHYS J, V90, P1202, DOI 10.1529/biophysj.105.072298
   Webb B., 2014, METHODS MOL BIOL
   Wibbenmeyer JA, 2002, INFECT IMMUN, V70, P121, DOI 10.1128/IAI.70.1.121-126.2002
NR 56
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 2015
VL 568
BP 38
EP 45
DI 10.1016/j.abb.2015.01.005
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CC7GN
UT WOS:000350535800005
PM 25600570
ER

PT J
AU Huang, LQ
   Liu, XR
   Cheng, BA
   Huang, K
AF Huang, Lianqi
   Liu, Xinran
   Cheng, Biao
   Huang, Kun
TI How our bodies fight amyloidosis: Effects of physiological factors on
   pathogenic aggregation of amyloidogenic proteins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Amyloidosis; Amyloidogenic aggregation; Biological factors;
   Physicochemical factors
ID INSULIN-DEGRADING ENZYME; HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN;
   A-BETA AGGREGATION; AMYOTROPHIC-LATERAL-SCLEROSIS;
   CREUTZFELDT-JAKOB-DISEASE; PEPTIDE FIBRIL FORMATION; C-REACTIVE PROTEIN;
   ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E
AB The process of protein aggregation from soluble amyloidogenic proteins to insoluble amyloid fibrils plays significant roles in the onset of over 30 human amyloidogenic diseases, such as Prion disease, Alzheimer's disease and type 2 diabetes mellitus. Amyloid deposits are commonly found in patients suffered from amyloidosis; however, such deposits are rarely seen in healthy individuals, which may be largely attributed to the self-regulation in vivo. A vast number of physiological factors have been demonstrated to directly affect the process of amyloid formation in vivo. In this review, physiological factors that influence amyloidosis, including biological factors (chaperones, natural antibodies, enzymes, lipids and saccharides) and physicochemical factors (metal ions, pH environment, crowding and pressure, etc.), together with the mechanisms underlying these proteostasis effects, are summarized. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Huang, Lianqi; Liu, Xinran; Huang, Kun] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China.
   [Cheng, Biao] Cent Hosp, Dept Pharm, Wuhan 430014, Hubei, Peoples R China.
   [Huang, Kun] Wuhan Inst Biotechnol, Ctr Biomed Res, Wuhan 430075, Hubei, Peoples R China.
RP Huang, K (reprint author), Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430030, Hubei, Peoples R China.
EM kunhuang2008@hotmail.com
FU Natural Science Foundation of China [81172971, 31471208, 81202557,
   81222043]; Program for New Century Excellent Talents in University,
   China [NECT11-0170]; Municipal Key Technology Program of Wuhan (Wuhan
   Bureau of Science Technology) [201260523174]; Natural Science Foundation
   of Hubei Province, China [2011BCB012, 2014CFA021]
FX This work was supported by the Natural Science Foundation of China (Nos.
   81172971, 31471208, 81202557 and 81222043), the Program for New Century
   Excellent Talents in University, China (NECT11-0170), the Municipal Key
   Technology Program of Wuhan (Wuhan Bureau of Science & Technology, No.
   201260523174), the Natural Science Foundation of Hubei Province, China
   (2011BCB012 and 2014CFA021).
CR Andersson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055766
   Rivera-Mancia S, 2010, CHEM-BIOL INTERACT, V186, P184, DOI 10.1016/j.cbi.2010.04.010
   Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010
   Ahmad E, 2011, BIOCHIMIE, V93, P793, DOI 10.1016/j.biochi.2010.12.012
   Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728
   Lazarev VF, 2013, ACTA NATURAE, V5, P81
   Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021
   Wei X, 2012, J BIOL CHEM, V287, P12858, DOI 10.1074/jbc.M111.255836
   Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734
   Narayan P, 2012, BIOCHEMISTRY-US, V51, P9270, DOI 10.1021/bi301277k
   Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200
   Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21
   Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x
   Pluta R, 2013, MOL NEUROBIOL, V47, P425, DOI 10.1007/s12035-012-8360-z
   Witt SN, 2013, MOL NEUROBIOL, V47, P552, DOI 10.1007/s12035-012-8325-2
   Ly S, 2013, J BIOL CHEM, V288, P11628, DOI 10.1074/jbc.M112.411900
   Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339
   Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191
   Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018
   Paulsson JF, 2005, DIABETES, V54, P2117, DOI 10.2337/diabetes.54.7.2117
   Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253
   Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006
   Yu X, 2012, J MOL BIOL, V421, P561, DOI 10.1016/j.jmb.2011.11.006
   Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje
   Fantini J, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001602
   Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085
   Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010
   Jones CE, 2004, J BIOL CHEM, V279, P32018, DOI 10.1074/jbc.M403467200
   Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389
   Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com
   CHOI NH, 1990, J IMMUNOL METHODS, V131, P159, DOI 10.1016/0022-1759(90)90186-Y
   Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012
   Yokel RA, 2006, J ALZHEIMERS DIS, V10, P223
   Molina-Holgado F, 2007, BIOMETALS, V20, P639, DOI 10.1007/s10534-006-9033-z
   Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021
   Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345
   Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008
   Chaudhuri TK, 2006, FEBS J, V273, P1331, DOI 10.1111/j.1742-4658.2006.05181.x
   Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4
   Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003
   Caillon L, 2013, BBA-BIOMEMBRANES, V1828, P2091, DOI 10.1016/j.bbamem.2013.05.014
   Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058
   Ariga T, 2010, J NEUROSCI RES, V88, P2303, DOI 10.1002/jnr.22393
   RENKAWEK K, 1992, ACTA NEUROPATHOL, V83, P324
   Guzhova IV, 2011, HUM MOL GENET, V20, P3953, DOI 10.1093/hmg/ddr314
   Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699
   Mattoo RUH, 2014, CELL MOL LIFE SCI, V71, P3311, DOI 10.1007/s00018-014-1627-y
   Deng J, 2012, J NEUROCHEM, V120, P732, DOI 10.1111/j.1471-4159.2011.07629.x
   Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107
   Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8
   Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017
   Liu GJ, 2006, J STRUCT BIOL, V155, P45, DOI 10.1016/jjsb.2005.12.011
   Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106
   Irizarry MC, 2004, J NEUROCHEM, V90, P1132, DOI 10.1111/j.1471-4159.2004.02581.x
   Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116
   Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805
   Authier F, 1996, CLIN INVEST MED, V19, P149
   Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095
   Barnett A, 2006, INT J CLIN PRACT, V60, P1454, DOI 10.1111/j.1742-1241.2006.01178.x
   Zhou Y, 2004, J BIOL CHEM, V279, P39155, DOI 10.1074/jbc.M405456200
   Healy EF, 2014, CELL BIOCHEM BIOPHYS, V69, P275, DOI 10.1007/s12013-013-9795-1
   McCord LA, 2013, P NATL ACAD SCI USA, V110, P13827, DOI 10.1073/pnas.1304575110
   Bekard IB, 2011, BIOPOLYMERS, V95, P733, DOI 10.1002/bip.21646
   NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F
   Frenkel D, 2000, J NEUROIMMUNOL, V106, P23, DOI 10.1016/S0165-5728(99)00232-5
   SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L
   Du YS, 1998, J NEUROCHEM, V70, P1182
   Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288
   Bokvist M, 2007, J AM CHEM SOC, V129, P14848, DOI 10.1021/ja076059o
   SNOW AD, 1985, LAB INVEST, V53, P37
   Zhou HX, 2013, FEBS LETT, V587, P1053, DOI 10.1016/j.febslet.2013.01.064
   van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927
   King M, 2009, J NEUROSCI RES, V87, P3161, DOI 10.1002/jnr.22145
   French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f
   McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x
   Weibezahn J, 2005, BIOL CHEM, V386, P739, DOI 10.1515/BC.2005.086
   Biringer Roger G., 2006, Briefings in Functional Genomics & Proteomics, V5, P144, DOI 10.1093/bfgp/ell026
   Kim YS, 2006, METHOD ENZYMOL, V413, P237, DOI 10.1016/S0076-6879(06)13013-X
   Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263
   Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616
   Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408
   Fung J, 2005, BIOCHEM BIOPH RES CO, V328, P1067, DOI 10.1016/j.bbrc.2005.01.068
   COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169
   Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200
   Scott LE, 2009, CHEM REV, V109, P4885, DOI 10.1021/cr9000176
   Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004
   Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875
   Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897
   Neff F, 2008, AUTOIMMUN REV, V7, P501, DOI 10.1016/j.autrev.2008.04.010
   CHARGE SBP, 1995, BIOCHEMISTRY-US, V34, P14588, DOI 10.1021/bi00044a038
   TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299
   Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10
   Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770
   Relini A, 2014, ADV COLLOID INTERFAC, V207, P81, DOI 10.1016/j.cis.2013.10.015
   Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s
   Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640
   Binger KJ, 2013, FASEB J, V27, P1214, DOI 10.1096/fj.12-220657
   Pedersen JT, 2011, J BIOL CHEM, V286, P26952, DOI 10.1074/jbc.M111.220863
   McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x
   Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X
   SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539
   Huang CJ, 2006, J MOL BIOL, V364, P323, DOI 10.1016/j.jmb.2006.08.062
   Du Y, 2001, NEUROLOGY, V57, P801
   Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a
   MURPHY BF, 1988, J CLIN INVEST, V81, P1858, DOI 10.1172/JCI113531
   Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860
   Wang AM, 2013, NAT CHEM BIOL, V9, P112, DOI [10.1038/nchembio.1140, 10.1038/NCHEMBIO.1140]
   Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262
   Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2
   Hay DG, 2004, HUM MOL GENET, V13, P1389, DOI 10.1093/hmg/ddh144
   HUTCHINSON WL, 1994, J CLIN INVEST, V94, P1390, DOI 10.1172/JCI117474
   Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4
   Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x
   Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200
   Weksler ME, 2002, EXP GERONTOL, V37, P943
   Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005
   Cheng B, 2013, BBA-GEN SUBJECTS, V1830, P4860, DOI 10.1016/j.bbagen.2013.06.029
   Leal SS, 2013, J BIOL CHEM, V288, P25219, DOI 10.1074/jbc.M113.470740
   Ellis RJ, 2002, NATURE, V416, P483, DOI 10.1038/416483a
   PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119
   Brender JR, 2010, J AM CHEM SOC, V132, P8973, DOI 10.1021/ja1007867
   Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0
   JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4
   Mayer MP, 2000, NAT STRUCT BIOL, V7, P586
   Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200
   Hatters DM, 2002, EUR J BIOCHEM, V269, P2789, DOI 10.1046/j.1432-1033.2002.02957.x
   Jeong JS, 2013, J MOL BIOL, V425, P1765, DOI 10.1016/j.jmb.2013.02.005
   Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100
   Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v
   Gu ZZ, 2010, MOL NEUROBIOL, V41, P55, DOI 10.1007/s12035-010-8113-9
   Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191
   Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233
   Baumann MH, 2000, BIOCHEM J, V349, P77, DOI 10.1042/0264-6021:3490077
   Bourassa Megan W, 2014, Front Aging Neurosci, V6, P110, DOI 10.3389/fnagi.2014.00110
   BOWMAN BH, 1982, ADV HUM GENET, V12, P453
   Buchet R, 2000, ACTA BIOCHIM POL, V47, P725
   Buell A.K., 2014, P NATL ACAD SCI US
   Caillon L., 2014, MOL MEMBR BIOL, P1
   Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697
   Castillo GM, 1997, J NEUROCHEM, V69, P2452
   Chabrier PE, 1999, CELL MOL LIFE SCI, V55, P1029, DOI 10.1007/s000180050353
   Chaulagain CP, 2013, CURR HEMATOL MALIG R, V8, P291, DOI 10.1007/s11899-013-0175-0
   Chien V, 2010, BIOCHEM J, V432, P113, DOI 10.1042/BJ20100434
   Cristovao JS, 2013, INT J MOL SCI, V14, P19128, DOI 10.3390/ijms140919128
   Daturpalli S., 2013, J MOL BIOL
   Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4
   Falsone SF, 2009, J BIOL CHEM, V284, P31190, DOI 10.1074/jbc.M109.057240
   Fernandez M.S., 2014, CELL CALCIUM
   GLENNER GG, 1989, BIOCHEM BIOPH RES CO, V159, P402, DOI 10.1016/0006-291X(89)90005-3
   Gomes RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050123
   Gong H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054198
   Gralka E, 2008, DALTON T, P5207, DOI 10.1039/b806192k
   Gruys E, 2006, AMYLOID, V13, P13, DOI 10.1080/13506120500535768
   Hane F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059005
   Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179
   JANCIAUSKIENE S, 1995, J BIOL CHEM, V270, P26041
   JENSEN PEH, 1986, J BIOL CHEM, V261, P5863
   Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com
   Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k
   Kolstoe SE, 2010, BIOCHEM SOC T, V38, P466, DOI 10.1042/BST0380466
   Langlois MR, 1996, CLIN CHEM, V42, P1589
   Lao A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-74
   Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24
   Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036288
   McHattie S, 1999, BIOCHEM BIOPH RES CO, V259, P336, DOI 10.1006/bbrc.1999.0781
   Meng FJ, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-34
   Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x
   Morris RJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2909
   NASLUND J, 1995, NEURON, V15, P219, DOI 10.1016/0896-6273(95)90079-9
   Panza G, 2008, REJUV RES, V11, P365, DOI 10.1089/rej.2008.0698
   PHILLIPS NR, 1983, J LIPID RES, V24, P1525
   Qi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046834
   Sanders CR, 2000, CURR OPIN STRUC BIOL, V10, P438, DOI 10.1016/S0959-440X(00)00112-3
   Sasaki K, 2002, ACTA NEUROPATHOL, V104, P225, DOI 10.1007/s00401-002-0546-4
   Sharoyan S, 2013, NEUROCHEM INT, V62, P1048, DOI 10.1016/j.neuint.2013.03.017
   Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319
   Sobek O, 2003, J NEUROL, V250, P371, DOI 10.1007/s00415-003-0991-6
   Sobek O., 2003, J NEUROL, V250, P372
   Sultan A, 2013, J BIOL CHEM, V288, P32326, DOI 10.1074/jbc.M113.498337
   Tabner Brian J., 2001, Current Topics in Medicinal Chemistry, V1, P507, DOI 10.2174/1568026013394822
   Takeda A., 2004, J PHARM SOC JAPAN, V124, P577
   Torrent J, 2004, BIOCHEMISTRY-US, V43, P7162, DOI 10.1021/bi049939d
   Torricelli C, 2004, J MOL ENDOCRINOL, V33, P335, DOI 10.1677/jme.101530
   Walter J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-34
   Wyatt AR, 2013, FEBS LETT, V587, P398, DOI 10.1016/j.febslet.2013.01.020
   Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x
   Yi CW, 2013, ACTA BIOCH BIOPH SIN, V45, P520, DOI 10.1093/abbs/gmt052
   Zhang Y, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-4
NR 188
TC 2
Z9 2
U1 17
U2 30
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 2015
VL 568
BP 46
EP 55
DI 10.1016/j.abb.2015.01.007
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CC7GN
UT WOS:000350535800006
PM 25615529
ER

PT J
AU Ball, J
   Bui, QVV
   Gannavaram, S
   Gadda, G
AF Ball, Jacob
   Bui, Quan V. V.
   Gannavaram, Swathi
   Gadda, Giovanni
TI Importance of glutamate 87 and the substrate a-amine for the reaction
   catalyzed by D-arginine dehydrogenase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Flavoprotein; Sticky proton; pH effects; Amino acid oxidation;
   Dehydrogenase; Isotope effects
ID REDUCTIVE HALF-REACTION; TRANSFORM INFRARED-SPECTROSCOPY; D-ASPARTATE
   OXIDASE; ACID OXIDASE; TRYPTOPHAN 2-MONOOXYGENASE;
   PSEUDOMONAS-AERUGINOSA; ACTIVE-SITE; PH; MECHANISM; BACTERIORHODOPSIN
AB Pseudomonas aeruginosa D-arginine dehydrogenaie (PaDADH) catalyzes the oxidation of b-arginine to iminoarginine, which is non-enzymatically hydrolyzed to 2-ketoarginine and ammonia. Here, sitedirected mutagenesis and pH effects were used to investigate binding and catalysis of zwitterionic and cationic substrates for the enzyme. An unprotonated group with apparent pK(a) value >= 7.9 is required for binding D-arginine or D-lysine, but not D-methionine or D-leucine. This group is E87, as suggested by its replacement with leucine. An unprotonated group with pK(a) of 9.5, which persists in the H48F and E87L variants, is required for amine oxidation with all substrates. Since Y53 and Y249 were previously ruled out, the pK(a) is assigned to the substrate alpha-NH3+ group, which previous QM/MM and K-d pH-profile demonstrated to be protonated for preferred binding to the enzyme. Lack of pH effects on the Dk(red) with D-leucine established 9.5 as the intrinsic pK(a), and D-leucine as a non-sticky substrate. D-Arginine, D-lysine and D-methionine and their corresponding iminoproducts were significantly stickier than D-leucine, as indicated by apparent pK(a) values <9.5 in both k(cat)/K-m and k(cat). Restricted proton movements in catalysis were established from hollowed k(cat) pH profiles in wild-type PaDADH with D-lysine and in the H48F and E87L enzymes with D-arginine. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Ball, Jacob; Bui, Quan V. V.; Gannavaram, Swathi; Gadda, Giovanni] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA.
   [Gadda, Giovanni] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA.
   [Gadda, Giovanni] Georgia State Univ, Ctr Biotechnol & Drug Design, Atlanta, GA 30302 USA.
   [Gadda, Giovanni] Georgia State Univ, Ctr Diag & Therapeut, Atlanta, GA 30302 USA.
   [Bui, Quan V. V.] Georgia Perimeter Coll, Decatur, GA 30034 USA.
RP Gadda, G (reprint author), Georgia State Univ, Dept Chem, POB 3965, Atlanta, GA 30302 USA.
EM ggadda@gsu.edu
FU NSF [MCB-1121695]; Georgia State University Molecular Basis of Disease
   Fellowships; Georgia Perimeter College (GPC) STEP DUE [1067896]
FX This work was supported in part by Grant MCB-1121695 from the NSF
   (G.G.), Georgia State University Molecular Basis of Disease Fellowships
   (J.B., Q.V.V.B., S.G.), and Georgia Perimeter College (GPC) STEP DUE:
   1067896 (Q,V.V.B.; PI Pamela Leggett-Robinson).
CR Yuan H, 2010, BIOCHEMISTRY-US, V49, P9542, DOI 10.1021/bi101420w
   DANIELLO A, 1993, J BIOL CHEM, V268, P26941
   Li C, 2009, P NATL ACAD SCI USA, V106, P906, DOI 10.1073/pnas.0808269106
   Fu GX, 2010, BIOCHEMISTRY-US, V49, P8535, DOI 10.1021/bi1005865
   DENU JM, 1992, BIOCHEMISTRY-US, V31, P8207, DOI 10.1021/bi00150a013
   Ralph EC, 2006, BIOCHEMISTRY-US, V45, P15844, DOI 10.1021/bi061894o
   Yuan HL, 2011, J AM CHEM SOC, V133, P18957, DOI 10.1021/ja2082729
   Fitzpatrick PF, 2010, ARCH BIOCHEM BIOPHYS, V493, P13, DOI 10.1016/j.abb.2009.07.019
   Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319
   SZARAZ S, 1994, BIOPHYS J, V67, P1706
   Zscherp C, 1999, P NATL ACAD SCI USA, V96, P5498, DOI 10.1073/pnas.96.10.5498
   McIntosh LP, 1996, BIOCHEMISTRY-US, V35, P9958, DOI 10.1021/bi9613234
   Richter HT, 1996, BIOCHEMISTRY-US, V35, P4054, DOI 10.1021/bi952883q
   Qin J, 1996, BIOCHEMISTRY-US, V35, P7, DOI 10.1021/bi952299h
   Boselli A, 2002, EUR J BIOCHEM, V269, P4762, DOI 10.1046/j.1432-1033.2002.03173.x
   CLELAND WW, 1982, CRC CR REV BIOCH MOL, V13, P385
   CLELAND WW, 1982, METHOD ENZYMOL, V87, P390
   CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104
   Cook P., 2007, ENZYME KINETICS MECH
   COOK PF, 1981, BIOCHEMISTRY-US, V20, P1204, DOI 10.1021/bi00508a023
   EMANUELE JJ, 1995, BIOCHEMISTRY-US, V34, P3716, DOI 10.1021/bi00011a029
   Fu GX, 2011, BIOCHEMISTRY-US, V50, P6292, DOI 10.1021/bi200831a
   Gadda G, 2003, APPL ENVIRON MICROB, V69, P2126, DOI 10.1128/AEM.69.4.2126-2132.2003
   Gannavaram S, 2014, BIOCHEMISTRY-US, V53, P6574, DOI 10.1021/bi500917q
   Geueke B, 2007, APPL MICROBIOL BIOT, V74, P1240, DOI 10.1007/s00253-006-0776-9
   Harris CM, 2001, EUR J BIOCHEM, V268, P5504, DOI 10.1046/j.1432-1033.2001.02462.x
   Jeng MF, 1996, BIOCHEMISTRY-US, V35, P1, DOI 10.1021/bi952404n
   NEGRI A, 1987, J BIOL CHEM, V262, P10026
   PORTER DJT, 1980, J BIOL CHEM, V255, P2969
   Press W. H., 1992, NUMERICAL RECIPES C
   Serrano H., 2013, BIOCHEMISTRY
   Zhao GH, 2005, BIOCHEMISTRY-US, V44, P16866, DOI 10.1021/bi051898d
NR 32
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 2015
VL 568
BP 56
EP 63
DI 10.1016/j.abb.2015.01.017
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CC7GN
UT WOS:000350535800007
PM 25637657
ER

PT J
AU Whittaker, MM
   Penmatsa, A
   Whittaker, JW
AF Whittaker, Mei M.
   Penmatsa, Aravind
   Whittaker, James W.
TI The Mtm1p carrier and pyridoxal 5 '-phosphate cofactor trafficking in
   yeast mitochondria
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Mitochondrial carrier protein; Pyridoxal 5 '-phosphate; Iron
   homeostasis; Heme biosynthesis
ID SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; 5-AMINOLEVULINATE
   SYNTHASE; MANGANESE ACTIVATION; ESCHERICHIA-COLI; SERUM-ALBUMIN;
   BINDING; PROTEIN; PURIFICATION; EXPRESSION
AB Biochemical communication between the cytoplasmic and mitochondrial subsystems of the cell depends on solute carriers in the mitochondrial inner membrane that transport metabolites between the two compartments. We have expressed and purified a yeast mitochondrial carrier protein (Mtm1p, YGR257cp), originally identified as a manganese ion carrier, for biochemical characterization aimed at resolving its function. High affinity, stoichiometric pyridoxal 5'-phosphate (PLP) cofactor binding was characterized by fluorescence titration and calorimetry, and the biochemical effects of mtm1 gene deletion on yeast mitochondria were investigated. The PLP status of the mitochondria! proteome (the mitochondrial 'PLP-ome') was probed by immunoblot analysis of mitochondria isolated from wild type (MTM1(+)) and knockout (MTM1(-)) yeast, revealing depletion of mitochondrial PLP in the latter. A direct activity assay of the enzyme catalyzing the first committed step of heme biosynthesis, the PLP-dependent mitochondrial enzyme 5-aminolevulinate synthase, extends these results, providing a specific example of PLP cofactor limitation. Together, these experiments support a role for Mtm1p in mitochondrial PLP trafficking and highlight the link between PLP cofactor transport and iron metabolism, a remarkable illustration of metabolic integration. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Whittaker, Mei M.; Whittaker, James W.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Portland, OR 97239 USA.
   [Penmatsa, Aravind] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.
RP Whittaker, JW (reprint author), Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Portland, OR 97239 USA.
EM whittakj@ohsu.edu
FU NIH [R01 GM42680]; OHSU Presidential Bridge Fund
FX This work was supported by NIH Grant R01 GM42680 and the OHSU
   Presidential Bridge Fund to J.W.W.
CR Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914
   Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200
   Luk E, 2003, P NATL ACAD SCI USA, V100, P10353, DOI 10.1073/pnas.1632471100
   Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012
   Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3
   Yang M, 2006, EMBO J, V25, P1775, DOI 10.1038/sj.emboj.7601064
   Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635
   Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914
   Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005
   MAUZERALL D, 1956, J BIOL CHEM, V219, P435
   McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054
   FONDA ML, 1991, ARCH BIOCHEM BIOPHYS, V288, P79, DOI 10.1016/0003-9861(91)90167-H
   Palmieri L, 2000, J BIOENERG BIOMEMBR, V32, P67, DOI 10.1023/A:1005564429242
   Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008
   Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   AOKI Y, 1978, J BIOL CHEM, V253, P2026
   Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X
   Boldogh IR, 2007, METHOD CELL BIOL, V80, P45, DOI 10.1016/S0091-679X(06)80002-6
   BRANDON DL, 1985, J IMMUNOL METHODS, V78, P87, DOI 10.1016/0022-1759(85)90331-X
   Bueno C, 2010, PHOTOCHEM PHOTOBIOL, V86, P39, DOI 10.1111/j.1751-1097.2009.00643.x
   Chang Jennifer, 2008, V457, P141, DOI 10.1007/978-1-59745-261-8_10
   CORDOBA F, 1966, BIOCHIM BIOPHYS ACTA, V127, P151, DOI 10.1016/0304-4165(66)90485-5
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   GIARTOSIO A, 1982, J BIOL CHEM, V257, P8163
   Gregg C., 2009, J VIS EXP, V30, pe1417
   HILAK MC, 1975, INT J PEPT PROT RES, V7, P411
   Kaur J, 2014, J BIOL CHEM, V289, P1377, DOI 10.1074/jbc.M113.510743
   Nishio K, 2010, FEBS J, V277, P2157, DOI 10.1111/j.1742-4658.2010.07631.x
   Oppenheim EW, 2001, J BIOL CHEM, V276, P19855, DOI 10.1074/jbc.M100039200
   Palmieri F, 2010, ESSAYS BIOCHEM, V47, P37, DOI [10.1042/bse0470037, 10.1042/BSE0470037]
   Park J, 2013, METALLOMICS, V5, P656, DOI 10.1039/c3mt00041a
   Percudani R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-273
   RELIMPIO A, 1981, J BIOL CHEM, V256, P4478
   Schatz G, 2007, ANNU REV BIOCHEM, V76, P673, DOI 10.1146/annurev.biochem.76.060806.091141
   ShoolinginJordan PM, 1997, METHOD ENZYMOL, V281, P309
   Treco DA, 2008, CURR PROT MOL BIOL, V82, DOI DOI 10.1002/0471142727.MB1302S82
   Vazquez M.A., 1991, PERKIN T, V2, P275
   VOLLAND C, 1984, EUR J BIOCHEM, V142, P551, DOI 10.1111/j.1432-1033.1984.tb08321.x
   von der Haar T., 2007, PLOS ONE, V10, P1
   Whittaker MM, 2012, ARCH BIOCHEM BIOPHYS, V523, P191, DOI 10.1016/j.abb.2012.04.016
   Whittaker MM, 2014, PROTEIN EXPRES PURIF, V93, P77, DOI 10.1016/j.pep.2013.10.014
   Woeller CF, 2007, J BIOL CHEM, V282, P29927, DOI 10.1074/jbc.M706264200
   Wohlrab H, 2009, IUBMB LIFE, V61, P40, DOI 10.1002/iub.139
   Yang B I, 1979, Methods Enzymol, V62, P528
   Zhou M, 1999, BIOCHEMISTRY-US, V38, P2636, DOI 10.1021/bi9823737
NR 49
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 2015
VL 568
BP 64
EP 70
DI 10.1016/j.abb.2015.01.021
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CC7GN
UT WOS:000350535800008
PM 25637770
ER

PT J
AU Simoes, B
   Conceicao, N
   Matias, AC
   Braganca, J
   Kelsh, RN
   Cancela, ML
AF Simoes, B.
   Conceicao, N.
   Matias, A. C.
   Braganca, J.
   Kelsh, R. N.
   Cancela, M. L.
TI Molecular characterization of cbf beta gene and identification of new
   transcription variants: Implications for function
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Transcription factor; Alternative splicing; cbf beta; Runx2; Functional
   analysis; Zebrafish
ID CORE-BINDING-FACTOR; X COLLAGEN GENE; OSTEOBLAST DIFFERENTIATION;
   CLEIDOCRANIAL DYSPLASIA; CHONDROCYTE DIFFERENTIATION; SKELETAL
   DEVELOPMENT; BONE-DEVELOPMENT; IN-VIVO; CBFA1-DEFICIENT MICE; ZEBRAFISH
AB The CBF beta gene encodes a transcription factor that, in combination with CBF alpha (also called Runx, runtrelated transcription factor) regulates expression of several target genes. CBF beta interacts with all Runx family members, such as RUNX2, a regulator of bone-related gene transcription that contains a conserved DNA-binding domain. CBF beta stimulates DNA binding of the Runt domain, and is essential for most of the known functions of RUNX2.
   A comparative analysis of the zebrafish cbf beta gene and protein, and of its orthologous identified homologous proteins in different species indicates a highly conserved function. We cloned eleven zebrafish cbf beta gene transcripts, one resulting in the known Cbf beta protein (with 187 aa), and three additional variants resulting from skipping exon 5a (resulting in a protein with 174 aa) or exon 5b (resulting in a protein with 201 aa), both observed for the first time in zebrafish, and a completely novel isoform containing both exon 5a and 5b (resulting in a protein with 188 aa). Functional analysis of these isoforms provides insight into their role in regulating gene transcription. From the other variants two are premature termination Cbf beta forms, while the others show in-frame exon-skipping causing changes in the Cbf beta domain that may affect its function. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Simoes, B.; Matias, A. C.; Braganca, J.; Cancela, M. L.] Univ Algarve, Dept Biomed Sci & Med DCBM, P-8005139 Faro, Portugal.
   [Simoes, B.] Univ Algarve, PhD Program Biomed Sci, P-8005139 Faro, Portugal.
   [Simoes, B.; Conceicao, N.; Cancela, M. L.] Univ Algarve, Ctr Marine Sci, P-8005139 Faro, Portugal.
   [Kelsh, R. N.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.
   [Kelsh, R. N.] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.
   [Matias, A. C.; Braganca, J.] Univ Algarve, Ctr Mol & Struct Biomed, P-8005139 Faro, Portugal.
RP Cancela, ML (reprint author), Univ Algarve, DCBM CCMAR, Campus Gambelas, P-8005139 Faro, Portugal.
EM lcancela@ualg.pt
RI Cancela, M. Leonor/F-4665-2012; Braganca, Jose/F-4410-2012; Conceicao,
   Natercia/F-1737-2011; 
OI Cancela, M. Leonor/0000-0003-3114-6662; Braganca,
   Jose/0000-0001-9566-400X; Conceicao, Natercia/0000-0002-5057-0912;
   Matias, Ana Catarina/0000-0002-6385-9117
FU European Regional Development Fund (ERDF) through the COMPETE -
   Operational Competitiveness Program; National Funds through FCT -
   Foundation for Science and Technology [PEst-C/MAR/LA0015/2011]; FCT
   [SFRH/BPD/48206/2008, SFRH/BD/38083/2007]
FX This research was partially supported by the European Regional
   Development Fund (ERDF) through the COMPETE - Operational
   Competitiveness Program and National Funds through FCT - Foundation for
   Science and Technology, under the project "PEst-C/MAR/LA0015/2011. NC
   and BS were supported, respectively, by a postdoctoral and doctoral
   grant from FCT (SFRH/BPD/48206/2008 and SFRH/BD/38083/2007).
CR Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189
   BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025
   Shigesada K, 2004, ONCOGENE, V23, P4297, DOI 10.1038/sj.onc.1207748
   Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8
   Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4
   Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210
   Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X
   Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154
   Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972
   Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143
   Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049
   Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695
   Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6
   Martin J. W., 2011, Sarcoma, P282745, DOI 10.1155/2011/282745
   Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720
   Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597
   LIU PP, 1995, BLOOD, V85, P2289
   OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262
   Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x
   ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5
   MUNDLOS S, 1995, HUM MOL GENET, V4, P71
   Stothard P, 2000, BIOTECHNIQUES, V28, P1102
   Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/job.200211089
   Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09
   Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041
   Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015
   Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674
   Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359
   Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101
   Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016
   Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039
   Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7
   Adya N, 1998, MOL CELL BIOL, V18, P7432
   Blake T, 2000, BLOOD, V96, P4178
   Bresciani E, 2014, BLOOD, V124, P70, DOI 10.1182/blood-2013-10-531988
   Dourado G, 1998, J CELL BIOCHEM, V70, P507, DOI 10.1002/(SICI)1097-4644(19980915)70:4<507::AID-JCB7>3.0.CO;2-N
   Du J, 2013, J VIROL, V87, P1906, DOI 10.1128/JVI.02199-12
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Han MS, 2010, J CELL BIOCHEM, V110, P97, DOI 10.1002/jcb.22516
   Higashikawa A, 2009, ARTHRITIS RHEUM, V60, P166, DOI 10.1002/art.24243
   Hinoi E, 2006, GENE DEV, V20, P2937, DOI 10.1101/gad.1482906
   Kagoshima H, 1996, J BIOL CHEM, V271, P33074
   Li LH, 1999, DEVELOPMENT, V126, P3313
   Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838
   Simoes B, 2006, CALCIFIED TISSUE INT, V79, P230, DOI 10.1007/s00223-006-0111-6
   Speck NA, 1999, CANCER RES, V59, p1789S
   Spoorendonk KM, 2010, J APPL ICHTHYOL, V26, P219, DOI 10.1111/j.1439-0426.2010.01409.x
   Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640
   Taniuchi I, 2012, EMBO J, V31, P4098, DOI 10.1038/emboj.2012.282
   Tu QS, 2007, WOUND REPAIR REGEN, V15, P404, DOI 10.1111/j.1524-475X.2007.00243.x
   Vijayakumar P, 2013, ZEBRAFISH, V10, P500, DOI 10.1089/zeb.2012.0833
   WANG SW, 1993, MOL CELL BIOL, V13, P3324
   ZAIMAN AL, 1995, J VIROL, V69, P2898
   Zheng QP, 2005, AM J HUM GENET, V77, P305, DOI 10.1086/432261
   Zhou XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033495
NR 59
TC 0
Z9 0
U1 3
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 2015
VL 567
BP 1
EP 12
DI 10.1016/j.abb.2014.12.023
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CA5UV
UT WOS:000348974200001
PM 25575784
ER

PT J
AU Padrao, AI
   Moreira-Goncalves, D
   Oliveira, PA
   Teixeira, C
   Faustino-Rocha, AI
   Helguero, L
   Vitorino, R
   Santos, LL
   Arnado, F
   Duarte, JA
   Ferreira, R
AF Padrao, Ana Isabel
   Moreira-Goncalves, Daniel
   Oliveira, Paula A.
   Teixeira, Catarina
   Faustino-Rocha, Ana I.
   Helguero, Luisa
   Vitorino, Rui
   Santos, Lucio Lara
   Arnado, Francisco
   Duarte, Jose Alberto
   Ferreira, Rita
TI Endurance training prevents TWEAK but not myostatin-mediated cardiac
   remodelling in cancer cachexia
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Mammary tumours; Physical activity; Wasting; Pro-inflammatory cytokines
ID EXERCISE-INDUCED CARDIOPROTECTION; SKELETAL-MUSCLE; HEART-FAILURE;
   MOLECULAR-MECHANISMS; APOPTOSIS TWEAK; WEAK INDUCER; RATS; EXPRESSION;
   MITOCHONDRIA; PROTEOLYSIS
AB Strategies to prevent tumour burden-induced cardiac remodelling that might progress to heart failure are necessary to improve patients' health outcomes and tolerability to cancer therapies. Exercise has been suggested as a measure to prevent cardiac damage; however, its effectiveness on regulating cardiac remodelling secondary to cancer was never addressed. Using an animal model of mammary tumorigenesis, we studied the impact of 35 weeks of endurance training on heart, focusing on the signalling pathways modulated by pro-inflammatory and wasting cytokines.
   The cardiac fibrosis and myofiber disorganization induced by tumour burden was paralleled by the increase of myostatin and TWEAK with the activation of signalling pathways involving Smad-3, NF-kappa B, TRAF-6 and atrogin-1. The activation of Akt/mTOR was observed in heart from rats with tumours, for which contributed the extracellular matrix. Endurance training prevented the increase of serum and cardiac TWEAK promoted by cancer, as well as the activation of NF-kappa B, TRAF6, atrogin-1 and p70S6K in heart. Data highlight the impact of exercise in the modulation of signalling pathways activated by wasting cytokines and the resulting outcomes on heart adaptation. Future studies focused on the cellular pathways underlying cardiac remodelling will assist in the development of exercise programs targeting cancer-related cardiac alterations. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Padrao, Ana Isabel; Helguero, Luisa; Vitorino, Rui; Ferreira, Rita] Univ Aveiro, QOPNA, Dept Chem, Aveiro, Portugal.
   [Moreira-Goncalves, Daniel; Duarte, Jose Alberto] Univ Porto, CIAFEL, Fac Sport, P-4100 Oporto, Portugal.
   [Moreira-Goncalves, Daniel] Univ Porto, Fac Med, Dept Physiol & Cardiothorac Surg, P-4100 Oporto, Portugal.
   [Oliveira, Paula A.; Teixeira, Catarina; Faustino-Rocha, Ana I.] Univ Tras Os Montes & Alto Douro, CITAB, Dept Vet Sci, Vila Real, Portugal.
   [Santos, Lucio Lara] Inst Oncol, Expt Pathol & Therapeut Grp, Oporto, Portugal.
   [Arnado, Francisco] Univ Aveiro, QOPNA, Sch Hlth Sci, Aveiro, Portugal.
RP Ferreira, R (reprint author), Univ Aveiro, Dept Chem, Campus Santiago, P-3810193 Aveiro, Portugal.
EM ritaferreira@ua.pt
RI Vitorino, Rui/G-7356-2014; PTMS, RNEM/C-1589-2014; Helguero,
   Luisa/B-1221-2013; Ferreira, Rita/C-4020-2014; Duarte, Jose
   Alberto/F-1443-2013; Oliveira, Paula/F-2510-2013
OI Vitorino, Rui/0000-0003-3636-5805; Helguero, Luisa/0000-0001-8237-2390;
   Lara Santos, Lucio/0000-0002-0521-5655; Ferreira,
   Rita/0000-0002-6872-4051; Duarte, Jose Alberto/0000-0003-4756-5917;
   Goncalves, Daniel/0000-0002-7404-7405; Oliveira,
   Paula/0000-0001-9519-4044
FU Portuguese Foundation for Science and Technology (FCT); European Union;
   QREN; FEDER; COMPETE [PEst-C/QUI/ UI0062/2013, EXPL/DTP-DES/1010/2013,
   FCOMP-01-0124-FEDER-041115, PTDC/DES/114122/2009,
   FCOMP-01-0124-FEDER-014707, SFRH/BPD/94312/2013, SFRH/BPD/ 90010/2012]
FX This work was supported by Portuguese Foundation for Science and
   Technology (FCT), European Union, QREN, FEDER and COMPETE for funding
   the QOPNA research unit (project PEst-C/QUI/ UI0062/2013), the research
   projects (EXPL/DTP-DES/1010/2013, FCOMP-01-0124-FEDER-041115,
   PTDC/DES/114122/2009 and FCOMP-01-0124-FEDER-014707) and post-graduation
   students (grant number SFRH/BPD/94312/2013 to A.I.P. and SFRH/BPD/
   90010/2012 to D.M.G.). The authors would like to thank Celeste Resende
   and Ligia Bento for their assistance in sample preparation for
   morphological analysis. The authors would like to thank Doctor Adelina
   Gama for her support in rat mammary tumours classification.
CR Tian M, 2011, INT J ONCOL, V39, P1321, DOI 10.3892/ijo.2011.1150
   Michaelson JS, 2005, ONCOGENE, V24, P2613, DOI 10.1038/sj.onc.1208208
   Manne NDPK, 2013, INT J ONCOL, V42, P2134, DOI 10.3892/ijo.2013.1893
   Frasier CR, 2011, J APPL PHYSIOL, V111, P905, DOI 10.1152/japplphysiol.00004.2011
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Ascensao A, 2007, INT J CARDIOL, V117, P16, DOI 10.1016/j.ijcard.2006.04.076
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Ren MY, 2012, MOL BIOL REP, V39, P9971, DOI 10.1007/s11033-012-1867-6
   Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307
   Tian M, 2010, INT J ONCOL, V37, P347, DOI 10.3892/ijo_00000683
   Padrao AI, 2013, INT J BIOCHEM CELL B, V45, P1399, DOI 10.1016/j.biocel.2013.04.014
   Powers SK, 2008, FREE RADICAL BIO MED, V44, P193, DOI 10.1016/j.freeradbiomed.2007.02.006
   Argiles JM, 2012, DRUG DISCOV TODAY, V17, P702, DOI 10.1016/j.drudis.2012.02.001
   Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286
   Matsakas A, 2006, EXP PHYSIOL, V91, P983, DOI 10.1113/expphysiol.2006.033571
   Attaix D, 2010, CURR OPIN CLIN NUTR, V13, P223, DOI 10.1097/MCO.0b013e328338b9a6
   Xu H, 2011, LIFE SCI, V88, P406, DOI 10.1016/j.lfs.2010.12.010
   Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014
   Russo J, 2000, J MAMMARY GLAND BIOL, V5, P187, DOI 10.1023/A:1026443305758
   Marin-Corral J, 2010, ANTIOXID REDOX SIGN, V12, P365, DOI 10.1089/ars.2009.2818
   Argiles JM, 2012, J CACHEXIA SARCOPENI, V3, P73, DOI 10.1007/s13539-012-0067-5
   Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639
   Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011
   Scott JM, 2011, CIRCULATION, V124, P642, DOI 10.1161/CIRCULATIONAHA.111.021774
   Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com
   Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389
   Breitbart A, 2011, AM J PHYSIOL-HEART C, V300, pH1973, DOI 10.1152/ajpheart.00200.2011
   Lenk K, 2009, EUR J HEART FAIL, V11, P342, DOI 10.1093/eurjhf/hfp020
   Wold LE, 2005, CANCER DETECT PREV, V29, P294, DOI 10.1016/j.cdp.2004.07.008
   Ascensao A, 2005, AM J PHYSIOL-HEART C, V289, pH722, DOI 10.1152/ajpheart.01249.2004
   COORE HG, 1971, BIOCHEM J, V125, P115
   Kadaja L, 2010, EXP CLIN CARDIOL, V15, pE116
   LAWLER JM, 1993, MED SCI SPORT EXER, V25, P1259
   Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044946
   Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200
   Moreira-Goncalves D, 2011, AM J PHYSIOL-HEART C, V300, pH1044, DOI 10.1152/ajpheart.01008.2010
   Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11
   Roomi MW, 2005, BREAST CANCER RES, V7, pR291, DOI 10.1186/bcr989
   Schuenemann M, 2008, NAT CLIN PRACT ONCOL, V5, P632, DOI 10.1038/ncponc1226
   Springer J, 2010, CIRCULATION, V121, P354, DOI 10.1161/CIR.0b013e3181d0ba8b
   Waring CD, 2014, EUR HEART J, V35, P2722, DOI 10.1093/eurheartj/ehs338
NR 41
TC 0
Z9 0
U1 3
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 2015
VL 567
BP 13
EP 21
DI 10.1016/j.abb.2014.12.026
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CA5UV
UT WOS:000348974200002
PM 25575785
ER

PT J
AU Semenyuk, PI
   Moiseeva, EV
   Stroylova, YY
   Lotti, M
   Izumrudov, VA
   Muronetz, VI
AF Semenyuk, Pavel I.
   Moiseeva, Evgeniya V.
   Stroylova, Yulia Yu.
   Lotti, Marina
   Izumrudov, Vladimir A.
   Muronetz, Vladimir I.
TI Sulfated and sulfonated polymers are able to solubilize efficiently the
   protein aggregates of different nature
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Protein aggregation; Inclusion bodies solubilization; Protein
   disaggregation; Polyanions; Poly(styrenesulfonate); Dextran sulfate
ID ALPHA-SYNUCLEIN OLIGOMERS; AMYLOID FIBRIL FORMATION; INCLUSION-BODY
   PROTEINS; OVINE PRION PROTEIN; COMPLEXING POLYANIONS; PARKINSON DISEASE;
   BASIC-PROTEINS; PURIFICATION; ENZYMES; HSP104
AB The search for new ways to suppress unwanted protein aggregation represents an important problem in modern biochemistry, bioengineering, and even medicine. Recently we succeeded in preventing the aggregation using synthetic polyelectrolytes. The present work describes a new approach to solubilizing pre-formed protein aggregates with sulfated or sulfonated polymers (polysulfoanions). For the first time it was shown that polysulfoanions are capable of solubilizing amorphous and amyloid protein inclusion bodies as well as thermal aggregates. Treatment of prion protein inclusion bodies with sulfonated polymers was shown to cause significant decrease in amyloid structure content, whereas in case of thermal aggregates of glyceraldehyde-3-phosphate dehydrogenase the observed solubilization was accompanied by a partial recovery of enzymatic activity. The suggested approach could be relevant in the task of extracting recombinant proteins from inclusion bodies and also useful in the development of amyloid disease therapy. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Semenyuk, Pavel I.; Stroylova, Yulia Yu.; Muronetz, Vladimir I.] Moscow MV Lomonosov State Univ, Belozersky Inst Physico Chem Biol, Moscow 119234, Russia.
   [Moiseeva, Evgeniya V.; Stroylova, Yulia Yu.; Muronetz, Vladimir I.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119234, Russia.
   [Lotti, Marina] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.
   [Izumrudov, Vladimir A.] Moscow MV Lomonosov State Univ, Fac Chem, Moscow 119234, Russia.
RP Semenyuk, PI (reprint author), Moscow MV Lomonosov State Univ, Belozersky Inst Physico Chem Biol, Leninskye Gory 1,Bld 40, Moscow 119234, Russia.
EM psemenyuk@belozersky.msu.ru
RI Yulia, Stroylova /E-6828-2012; Semenyuk, Pavel/E-2974-2012
OI Yulia, Stroylova /0000-0001-6542-2552; 
FU Russian Foundation for Basic Research [14-04-00331]; Award from The
   Landau Network-Centro Volta (The Cariplo Foundation); Russian Federation
   President Fellowship for young scientists
FX The work was supported by Russian Foundation for Basic Research, project
   No. 14-04-00331, as well as Award from The Landau Network-Centro Volta
   (The Cariplo Foundation) for Vladimir Muronetz and Russian Federation
   President Fellowship for young scientists for Pavel Semenyuk.
CR Ivinova ON, 2003, MACROMOL BIOSCI, V3, P210, DOI 10.1002/mabi.200390024
   Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2004.01.043
   Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746
   Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200
   Klajnert B, 2006, BIOCHEM BIOPH RES CO, V345, P21, DOI 10.1016/j.bbrc.2006.04.041
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   CARNALI JO, 1993, LANGMUIR, V9, P2933, DOI 10.1021/la00035a034
   Ashe KH, 2013, PRION, V7, P55, DOI 10.4161/pri.23061
   Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200
   Carrio MM, 2002, J BIOTECHNOL, V96, P3, DOI 10.1016/S0168-1656(02)00032-9
   Xu YS, 2011, BIOMACROMOLECULES, V12, P1512, DOI 10.1021/bm101465y
   Cooper CL, 2005, CURR OPIN COLLOID IN, V10, P52, DOI 10.1016/j.cocis.2005.05.007
   Wang SY, 2013, BIOMACROMOLECULES, V14, P818, DOI 10.1021/bm301865g
   Kazantsev AG, 2008, ARCH NEUROL-CHICAGO, V65, P1577, DOI 10.1001/archneur.65.12.1577
   SCOPES RK, 1982, METHOD ENZYMOL, V90, P479
   Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303
   Newnam GP, 1999, MOL CELL BIOL, V19, P1325
   Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   McDonald P, 2009, BIOTECHNOL BIOENG, V102, P1141, DOI 10.1002/bit.22127
   Jaru-Ampornpan P, 2013, J BIOL CHEM, V288, P13431, DOI 10.1074/jbc.M113.462861
   Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352
   Burgess RR, 2009, METHOD ENZYMOL, V463, P259, DOI 10.1016/S0076-6879(09)63017-2
   Izumrudov V. A., 2008, RUSS CHEM REV, V77, P401, DOI 10.1070/RC2008v077n04ABEH003767
   KABANOV V A, 1980, Molekulyarnaya Biologiya (Moscow), V14, P64
   Kiselev GG, 2011, BBA-PROTEINS PROTEOM, V1814, P1730, DOI 10.1016/j.bbapap.2011.08.006
   Kondo N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2417
   Ojha B, 2013, J PHYS CHEM B, V117, P13975, DOI 10.1021/jp4065467
   Paul S, 2014, MOL CELL BIOCHEM, V386, P45, DOI 10.1007/s11010-013-1844-y
   Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x
   Semenyuk PI, 2013, BBA-GEN SUBJECTS, V1830, P4800, DOI 10.1016/j.bbagen.2013.06.024
   Serb T. R., 2000, SCIENCE, V289, P1317, DOI DOI 10.1126/SCIENCE.289.5483.1317
   Shalova IN, 2005, MACROMOL BIOSCI, V5, P1184, DOI 10.1002/mabi.200500142
   Shalova IN, 2007, MACROMOL BIOSCI, V7, P929, DOI 10.1002/mabi.200700052
   Stogov S.V., 2010, BIOCH MOSC, V75, P47
   Swietnicki W, 2006, CURR OPIN BIOTECH, V17, P367, DOI 10.1016/j.copbio.2006.05.011
   Thuring CMA, 2005, J COMP PATHOL, V132, P59, DOI 10.1016/j.jcpa.2004.06.004
   Ventura S, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-11
NR 38
TC 1
Z9 1
U1 5
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 2015
VL 567
BP 22
EP 29
DI 10.1016/j.abb.2014.12.021
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CA5UV
UT WOS:000348974200003
PM 25562403
ER

PT J
AU Sudhani, HPK
   Moreno, J
AF Sudhani, Hemanth P. K.
   Moreno, Joaquin
TI Control of the ribulose 1,5-bisphosphate carboxylase/oxygenase activity
   by the chloroplastic glutathione pool
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Chlamydomonas reinhardtii; Cysteine disulfide exchange; Glutathione;
   Redox control; Ribulose 1,5-bisphosphate carboxylase/oxygenase; Rubisco
ID RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; REDOX-REGULATION; LARGE-SUBUNIT;
   CHLAMYDOMONAS-REINHARDTII; OXIDATIVE STRESS; BISPHOSPHATE CARBOXYLASE;
   PHOTOSYNTHETIC ORGANISMS; REDUCTIVE ACTIVATION; EUGLENA-GRACILIS;
   THIOREDOXIN
AB The CO2-fixing activity of ribulose 1,5-bisphosphate carboxylase/oxygenase depends on the redox state of its cysteines. Disulfides like cystamine or 5,5'-dithio-bis(2-nitrobenzoic acid), but not oxidized glutathione, switch the enzyme to the inactive oxidized form. Conversely, thiols like cysteamine, cysteine, dithiotreitol or 2-mercaptoethanol, but not reduced glutathione, recover enzymatic activity after a previous oxidation. Direct regulation of the carboxylase activity by the chloroplastic glutathione pool is hindered by kinetic barriers impeding access to the critical residues. However, reduced glutathione can drive the recovery of activity by means of minute amounts of smaller intermediary thiol/disulfide exchangers. In contrast, oxidized glutathione does not inactivate the enzyme even in the presence of these intermediaries. This asymmetrical effect should help to maintain the enzyme in the active form in vivo. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Sudhani, Hemanth P. K.; Moreno, Joaquin] Univ Valencia, Fac Biol, Dept Biochem & Mol Biol, E-46100 Valencia, Spain.
RP Moreno, J (reprint author), Univ Valencia, Fac Biol, Dept Biochem & Mol Biol, Dr Moliner 50, E-46100 Valencia, Spain.
EM joaquin.moreno@uv.es
FU Spanish Ministry of Science and Research [MCeI-DGI] [BFU2009-11965];
   fellowship for doctoral studies from Spanish Ministry of Foreign Affairs
   and Cooperation (MAEC-AECID)
FX This work was supported by the Spanish Ministry of Science and Research
   [Grant BFU2009-11965 from MCeI-DGI]. H.P.K.S. received a fellowship for
   doctoral studies from the Spanish Ministry of Foreign Affairs and
   Cooperation (MAEC-AECID).
CR Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200
   Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811
   Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101
   MEHTA RA, 1992, J BIOL CHEM, V267, P2810
   Flohe L, 2013, BBA-GEN SUBJECTS, V1830, P3139, DOI 10.1016/j.bbagen.2012.10.020
   Taylor TC, 2001, J BIOL CHEM, V276, P48159, DOI 10.1074/jbc.M107765200
   Baier M, 2005, J EXP BOT, V56, P1449, DOI 10.1093/jxb/eri161
   Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569
   Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11-008
   Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003
   SPREITZER RJ, 1981, PLANT PHYSIOL, V67, P565, DOI 10.1104/pp.67.3.565
   Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200
   Danon A, 2002, TRENDS BIOCHEM SCI, V27, P197, DOI 10.1016/S0968-0004(02)02066-2
   Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336
   Schurmann P, 2000, ANNU REV PLANT PHYS, V51, P371, DOI 10.1146/annurev.arplant.51.1.371
   Balmer Y, 2004, PHOTOSYNTH RES, V79, P275, DOI 10.1023/B:PRES.0000017207.88257.d4
   CLANCEY CJ, 1987, J BIOL CHEM, V262, P13545
   Cohen I, 2005, PLANT PHYSIOL, V137, P738, DOI 10.1104/pp.104.056341
   Cohen I, 2006, PLANT PHYSIOL, V141, P1089, DOI 10.1104/pp.106.079046
   Couturier J., 2013, FRONT PLANT SCI, V4, pe105
   CRAWFORD NA, 1989, ARCH BIOCHEM BIOPHYS, V271, P223, DOI 10.1016/0003-9861(89)90273-7
   FERREIRA RB, 2000, CURR TOP PHYTOCHEM, V3, P129
   FERREIRA RB, 1989, PLANTA, V179, P456, DOI 10.1007/BF00397585
   GARCIAFERRIS C, 1993, PHOTOSYNTH RES, V35, P55, DOI 10.1007/BF02185411
   GARCIAFERRIS C, 1994, PLANTA, V193, P208
   Genkov T, 2006, ARCH BIOCHEM BIOPHYS, V451, P167, DOI 10.1016/j.abb.2006.04.012
   Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101
   Marin-Navarro J, 2006, PLANT CELL ENVIRON, V29, P898, DOI 10.1111/j.1365-3040.2005.01469.x
   Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1
   Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2
   Michelet L., 2013, FRONT PLANT SCI, V4, pe470
   Moreno J, 2008, J EXP BOT, V59, P1605, DOI 10.1093/jxb/erm310
   Moreno J, 1999, J BIOL CHEM, V274, P26789, DOI 10.1074/jbc.274.38.26789
   PENARRUBIA L, 1990, ARCH BIOCHEM BIOPHYS, V281, P319, DOI 10.1016/0003-9861(90)90450-D
   PICKERSGILL RW, 1986, BIOCHEM J, V236, P311
   Ranty B., 1991, EUR J BIOCHEM, V200, P342
   Sudhani HPK, 2013, PLANT CELL ENVIRON, V36, P1160, DOI 10.1111/pce.12050
   SUGIYAMA T, 1968, ARCH BIOCHEM BIOPHYS, V125, P98, DOI 10.1016/0003-9861(68)90643-7
   TENAUD M, 1987, J PLANT PHYSIOL, V130, P315
   Torchinsky Y.M., 1981, SULPHUR IN PROTEINS
   Yosef I, 2004, J BIOL CHEM, V279, P10148, DOI 10.1074/jbc.M308602200
   Zaffagnini M., 2012, MOL CELL PROTEOMICS, V11
NR 42
TC 0
Z9 0
U1 3
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 2015
VL 567
BP 30
EP 34
DI 10.1016/j.abb.2014.12.032
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CA5UV
UT WOS:000348974200004
PM 25579884
ER

PT J
AU Barry, KP
   Ngu, A
   Cohn, EF
   Cote, JM
   Burroughs, AM
   Gerbino, JP
   Taylor, EA
AF Barry, Kevin Patrick
   Ngu, Abraham
   Cohn, Erin Frances
   Cote, Joy Marie
   Burroughs, A. Maxwell
   Gerbino, Jason Paul
   Taylor, Erika Anne
TI Exploring allosteric activation of LigAB from Sphingobium sp strain
   SYK-6 through kinetics, mutagenesis and computational studies
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Protocatechuate 4,5-dioxygenase; Dioxygenase; Vanillin; Allosteric
   activation; Lignin; PCAD superfamily
ID SPHINGOMONAS-PAUCIMOBILIS SYK-6; EXTRADIOL CATECHOL DIOXYGENASE;
   PROTOCATECHUATE 4,5-DIOXYGENASE; INDOLEAMINE 2,3-DIOXYGENASE;
   SUBSTRATE-SPECIFICITY; 2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE;
   ESCHERICHIA-COLI; TRYPTOPHAN 2,3-DIOXYGENASE; FRUCTOSE 2,6-BISPHOSPHATE;
   EFFECTOR INTERACTIONS
AB The protocatechuate 4,5-dioxygenase (LigAB) from Sphingobium sp. strain SYK-6 is the defining member of the Type II extradiol dioxygenase superfamily (a.k.a. PCA Dioxygenase Superfamily or PCADSF) and plays a key aromatic ring-opening role in the metabolism of several lignin derived aromatic compounds. In our search for alternate substrates and inhibitors of LigAB, we discovered allosteric rate enhancement in the presence of non-substrate protocatechuate-like aldehydes such as vanillin. LigAB has the broadest substrate utilization profile of all protocatechuate (PCA) 4,5-dioxygenase described in the literature, however, the rate enhancement is only observed with PCA, with vanillin increasing k(cat) for LigAB by 36%. Computational docking has identified a potential site of allosteric binding near the entrance to the active site. Examination of a multiple sequence alignment reveals that many of the residues contributing to this newly identified allosteric pocket are highly conserved within the LigB family of the PCADSF. Point mutants of Phe103 alpha and Ala18 beta, two residues located in the putative allosteric pocket, display altered rate enhancement as compared to LigAB-WT, providing support for the computationally identified allosteric binding site. Further investigation of this binding site may provide insight into the mechanism of this never before observed allosteric activation in extradiol dioxygenases. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Barry, Kevin Patrick; Ngu, Abraham; Cohn, Erin Frances; Cote, Joy Marie; Gerbino, Jason Paul; Taylor, Erika Anne] Wesleyan Univ, Dept Chem, Middletown, CT 06459 USA.
   [Burroughs, A. Maxwell] NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA.
RP Taylor, EA (reprint author), Wesleyan Univ, Dept Chem, Middletown, CT 06459 USA.
EM eataylor@wesleyan.edu
RI Taylor, Erika/F-5635-2015
FU Intramural Research Program of the NIH, National Library of Medicine;
   Wesleyan University
FX We would like to thank Carlos A. Ramirez-Mondragon for calculating the
   surface accessibility of the tryptophan residues of LigAB and Ishita
   Mukerji for providing us access to her Horiba SPEX Fluoromax-4
   spectrofluorometer. Support for this research project was provided by
   Wesleyan University. AMB is supported by the Intramural Research Program
   of the NIH, National Library of Medicine.
CR Adina-Zada A, 2011, ARCH BIOCHEM BIOPHYS, V509, P117, DOI 10.1016/j.abb.2011.03.006
   Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887
   Martinez AT, 2001, J ANAL APPL PYROL, V58, P401, DOI 10.1016/S0165-2370(00)00116-9
   EGUCHI N, 1984, ARCH BIOCHEM BIOPHYS, V232, P602, DOI 10.1016/0003-9861(84)90579-4
   Gosselink RJA, 2004, IND CROP PROD, V20, P121, DOI 10.1016/j.indcrop.2004.04.015
   Mendel S, 2004, BIOCHEMISTRY-US, V43, P13390, DOI 10.1021/bi048518
   Raj A, 2007, BIODEGRADATION, V18, P783, DOI 10.1007/s10532-007-9107-9
   CAIN RB, 1962, NATURE, V193, P842, DOI 10.1038/193842a0
   Azadi P, 2013, RENEW SUST ENERG REV, V21, P506, DOI 10.1016/j.rser.2012.12.022
   Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892
   QUE L, 1977, BIOCHIM BIOPHYS ACTA, V485, P60
   Masai E, 1999, J IND MICROBIOL BIOT, V23, P364, DOI 10.1038/sj.jim.2900747
   Mampel J, 2005, ARCH MICROBIOL, V183, P130, DOI 10.1007/s00203-004-0755-4
   Nogales J, 2005, J BIOL CHEM, V280, P35382, DOI 10.1074/jbc.M502585200
   Feng YM, 1999, APPL ENVIRON MICROB, V65, P946
   Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437
   KATAYAMA Y, 1987, MOKUZAI GAKKAISHI, V33, P77
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Wisastra R, 2013, BIOORGAN MED CHEM, V21, P7763, DOI 10.1016/j.bmc.2013.10.015
   Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104
   Machonkin TE, 2011, BIOCHEMISTRY-US, V50, P8899, DOI 10.1021/bi200855m
   Davis JR, 2013, NUCLEIC ACIDS RES, V41, P3888, DOI 10.1093/nar/gkt009
   Vaillancourt FH, 2002, J BIOL CHEM, V277, P2019, DOI 10.1074/jbc.M106890200
   ELTIS LD, 1993, J BIOL CHEM, V268, P2727
   Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006
   ONO K, 1970, BIOCHIM BIOPHYS ACTA, V220, P224, DOI 10.1016/0005-2744(70)90008-2
   Miller MA, 1996, J BIOL CHEM, V271, P5524
   Hocking MB, 1997, J CHEM EDUC, V74, P1055
   Beauchet R, 2012, BIORESOURCE TECHNOL, V121, P328, DOI 10.1016/j.biortech.2012.06.061
   PILKIS SJ, 1981, J BIOL CHEM, V256, P3171
   Ehara K, 2005, J WOOD SCI, V51, P256, DOI 10.1007/s10086-004-0653-z
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Dominy JE, 2008, J BIOL CHEM, V283, P12188, DOI 10.1074/jbc.M800044200
   Vishtal A, 2011, BIORESOURCES, V6, P3547
   ZABINSKI R, 1972, BIOCHEMISTRY-US, V11, P3212, DOI 10.1021/bi00767a012
   ARCIERO DM, 1990, METHOD ENZYMOL, V188, P89
   Briganti F, 1997, FEBS LETT, V416, P61, DOI 10.1016/S0014-5793(97)01167-8
   SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9
   Kamimura N, 2010, APPL ENVIRON MICROB, V76, P8093, DOI 10.1128/AEM.01863-10
   MASAI E, 1989, FEBS LETT, V249, P348, DOI 10.1016/0014-5793(89)80656-8
   Kamimura N, 2010, J BACTERIOL, V192, P3394, DOI 10.1128/JB.00215-10
   Yun SH, 2004, J MICROBIOL, V42, P152
   Barry KP, 2013, BIOCHEMISTRY-US, V52, P6724, DOI 10.1021/bi400665t
   Bogolitsyna A, 2011, J CHROMATOGR A, V1218, P8561, DOI 10.1016/j.chroma.2011.09.063
   Cho JH, 2009, J BIOL CHEM, V284, P34321, DOI 10.1074/jbc.M109.031054
   Cornish-Bowden A., 2004, PURSUIT PERFECTION A
   DAGLEY S, 1968, Biochemical Journal, V109, P559
   DEVILLEBONNE D, 1991, BIOCHEMISTRY-US, V30, P5750, DOI 10.1021/bi00237a017
   Di Nardo G, 2009, DALTON T, P6507, DOI 10.1039/b903105g
   DURHAM DR, 1980, BIOCHEMISTRY-US, V19, P149, DOI 10.1021/bi00542a023
   GIBELLO A, 1994, BIOCHEM J, V301, P145
   Sonnad JR, 2004, MATH COMPUT MODEL, V40, P573, DOI 10.1016/j.mcm.2003.10.051
   Hines JK, 2007, J BIOL CHEM, V282, P11696, DOI 10.1074/jbc.M611104200
   Ishida T, 2004, J BIOCHEM, V135, P721, DOI 10.1093/jb/mvh089
   Kasai D, 2004, J BACTERIOL, V186, P4951, DOI 10.1128/JB.186.4951-4959.2004
   Kasai D, 2005, J BACTERIOL, V187, P5067, DOI 10.1128/JB.187.15.5067-5074.2005
   KATAYAMA Y, 1988, FEBS LETT, V233, P129, DOI 10.1016/0014-5793(88)81369-3
   Macchiarulo A, 2007, BBA-PROTEINS PROTEOM, V1774, P1058, DOI 10.1016/j.bbapap.2007.06.007
   NAKANISHI Y, 1991, AGR BIOL CHEM TOKYO, V55, P1281
   NOZAKI M, 1970, BIOCHIM BIOPHYS ACTA, V220, P213, DOI 10.1016/0005-2744(70)90007-0
   PILKIS SJ, 1981, J BIOL CHEM, V256, P1489
   Providenti MA, 2006, J BACTERIOL, V188, P3862, DOI 10.1128/JB.01675-05
   SONO M, 1989, BIOCHEMISTRY-US, V28, P5400, DOI 10.1021/bi00439a013
   SONO M, 1989, BIOCHEMISTRY-US, V28, P5392, DOI 10.1021/bi00439a012
   SONO M, 1990, BIOCHEMISTRY-US, V29, P1451, DOI 10.1021/bi00458a016
   Lendenmann U, 1996, J BACTERIOL, V178, P6227
   Sugimoto K, 1999, STRUCTURE, V7, P953, DOI 10.1016/S0969-2126(99)80122-1
   Sugimoto K., 2014, PLOS ONE, V9
   Tomlinson GH, 1936, J AM CHEM SOC, V58, P345, DOI 10.1021/ja01293a046
   UCHIDA K, 1985, J BIOL CHEM, V260, P1400
   Vaillancourt FH, 2005, BIOCHEM BIOPH RES CO, V338, P215, DOI 10.1016/j.bbrc.2005.08.219
   Vane CH, 2003, INT BIODETER BIODEGR, V51, P67, DOI 10.1016/S0964-8305(02)00089-6
   Veldhuizen EJA, 2005, BIOCHEM J, V386, P305, DOI 10.1042/BJ20041370
   Villar P.C., 1971, FED PROC, V30, pA219
   Walsh R., MED CHEM DRUG DESIGN, P357
   Whiting AK, 1996, BIOCHEMISTRY-US, V35, P160, DOI 10.1021/bi951979h
   WOLGEL SA, 1993, J BACTERIOL, V175, P4414
NR 77
TC 1
Z9 1
U1 6
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 2015
VL 567
BP 35
EP 45
DI 10.1016/j.abb.2014.12.019
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CA5UV
UT WOS:000348974200005
PM 25562402
ER

PT J
AU Profit, AA
   Vedad, J
   Saleh, M
   Desamero, RZB
AF Profit, Adam A.
   Vedad, Jayson
   Saleh, Mohamad
   Desamero, Rue Z. B.
TI Aromaticity and amyloid formation: Effect of pi-electron distribution
   and aryl substituent geometry on the self-assembly of peptides derived
   from hIAPP(22-29)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Amyloid formation; beta-Sheet; pi-Stacking; Aggregation; Raman
   spectroscopy; Thioflavin T fluorescence
ID PROTEIN SECONDARY STRUCTURE; FORMATION IN-VITRO; SOLID-STATE NMR; FIBRIL
   FORMATION; POLYPEPTIDE IAPP; STACKING INTERACTIONS; MEMBRANE DISRUPTION;
   CIRCULAR-DICHROISM; ATOMIC STRUCTURES; HUMAN AMYLIN
AB A comprehensive investigation of peptides derived from the 22-29 region of human islet amyloid polypeptide (hIAPP) that contain phenylalanine analogs at position 23 with a variety of electron donating and withdrawing groups, along with heteroaromatic surrogates, has been employed to interrogate how pi-electron distribution effects amyloid formation. Kinetic aggregation studies using turbidity measurements indicate that electron rich aromatic ring systems consistently abolish the amyloidogenic propensity of hIAPP(22-29). Electron poor systems modulate the rate of aggregation. Raman and Fourier transform infrared spectroscopy confirm the parallel beta-sheet secondary structure of aggregates derived from peptides containing electron poor phenylalanine analogs and provide direct evidence of ring stacking. Transmission electron microscopy confirms the presence of amyloid fibrils. The effect of aryl substituent geometry on peptide self-assembly reveals that the electronic nature of substituents and not their steric profile is responsible for failure of the electron donating group peptides to aggregate. Non-aggregating hIAPP(22-29) peptides were found to inhibit the self-assembly of full-length hIAPP(1-37). The most potent inhibitory peptides contain phenylalanine with the p-amino and p-formamido functionalities. These novel peptides may serve as leads for the development of future aggregation inhibitors. A potential mechanism for inhibition of amylin self-assembly by electron rich hIAPP(22-29) peptides is proposed. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Profit, Adam A.] CUNY, York Coll, Inst Macromol Assemblies, Jamaica, NY 11451 USA.
   CUNY, Grad Ctr, Jamaica, NY 11451 USA.
RP Profit, AA (reprint author), CUNY, York Coll, Inst Macromol Assemblies, Jamaica, NY 11451 USA.
EM aprofit@york.cuny.edu; rdesamero@york.cuny.edu
FU Institute of General Medicine of the National Institutes of Health
   [5SC3GM89624-2]
FX This work was supported in part by the Institute of General Medicine of
   the National Institutes of Health, Grant No. 5SC3GM89624-2. We would
   like to thank Hsin-Pin Ho from York College of CUNY for providing
   MALDI-TOF mass spectrometric analysis. We are grateful to Ms. Jennifer
   Desamero for careful reading of this manuscript.
CR Hughes SR, 1996, P NATL ACAD SCI USA, V93, P2065, DOI 10.1073/pnas.93.5.2065
   Tracz SM, 2004, BIOCHEMISTRY-US, V43, P15901, DOI 10.1021/bi0488121
   Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005
   Marek P, 2007, BIOCHEMISTRY-US, V46, P3255, DOI 10.1021/bi0621967
   Cockroft SL, 2005, J AM CHEM SOC, V127, P8594, DOI 10.1021/ja050880n
   Shim SH, 2009, P NATL ACAD SCI USA, V106, P6614, DOI 10.1073/pnas.0805957106
   Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108
   Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x
   Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q
   Cao P, 2013, FEBS LETT, V587, P1106, DOI 10.1016/j.febslet.2013.01.046
   Higham CE, 2000, FEBS LETT, V470, P55, DOI 10.1016/S0014-5793(00)01287-4
   Tjernberg LO, 1996, J BIOL CHEM, V271, P8545
   Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp
   Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601
   Ryan DM, 2011, LANGMUIR, V27, P4029, DOI 10.1021/la1048375
   Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c
   Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012
   Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422
   Nanga RPR, 2008, BIOCHEMISTRY-US, V47, P12689, DOI 10.1021/bi8014357
   Lutz TA, 2012, CELL MOL LIFE SCI, V69, P1947, DOI 10.1007/s00018-011-0905-1
   Nielsen JT, 2009, ANGEW CHEM INT EDIT, V48, P2118, DOI 10.1002/anie.200804198
   WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881
   Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036
   CLARK A, 1987, LANCET, V2, P231
   Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579
   Montane J, 2012, DIABETES OBES METAB, V14, P68, DOI 10.1111/j.1463-1326.2012.01657.x
   Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008
   WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036
   FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269
   Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320
   Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095
   Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066
   Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x
   Tu LH, 2013, BIOCHEMISTRY-US, V52, P333, DOI 10.1021/bi3014278
   Cao P, 2013, CURR OPIN STRUC BIOL, V23, P82, DOI 10.1016/j.sbi.2012.11.003
   COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628
   Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d
   Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z
   Brender JR, 2011, BIOPHYS J, V100, P685, DOI 10.1016/j.bpj.2010.09.070
   Wiltzius JJW, 2009, PROTEIN SCI, V18, P1521, DOI 10.1002/pro.145
   Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a
   Cao P, 2013, P NATL ACAD SCI USA, V110, P19279, DOI 10.1073/pnas.1305517110
   Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853
   Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009
   Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817
   Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695
   Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a
   Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107
   HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016
   Abedini A, 2013, FEBS LETT, V587, P1119, DOI 10.1016/j.febslet.2013.01.017
   Jameson LP, 2012, ACS CHEM NEUROSCI, V3, P807, DOI 10.1021/cn300076x
   ASHBURN TT, 1993, J AM CHEM SOC, V115, P11012, DOI 10.1021/ja00076a078
   Azami-Movahed M, 2013, INT J BIOCHEM CELL B, V45, P299, DOI 10.1016/j.biocel.2012.10.004
   Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200
   BOURN AJR, 1964, TETRAHEDRON, V20, P1811, DOI 10.1016/S0040-4020(01)98450-9
   Buxbaum J.N., 2012, J MOL BIOL, V421, P231
   Cao P, 2012, J MOL BIOL, V421, P282, DOI 10.1016/j.jmb.2011.12.032
   Chiti F., 2006, ANNU REV BIOCHEM, V75, P222
   Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3
   Desamero R., FOR RESUBMISSION
   Doran T.M., 2011, PROTEINS, V80, P1053
   Fandrich M, 2006, ACTA HISTOCHEM, V108, P215, DOI 10.1016/j.acthis.2006.03.012
   Hamley IW, 2010, J PHYS CHEM B, V114, P10674, DOI 10.1021/jp105508g
   Kapurniotu A, 2001, BIOPOLYMERS, V60, P438, DOI 10.1002/bip.10182
   Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646
   Levy-Sakin M, 2009, ISLETS, V1, P210, DOI 10.4161/isl.1.3.9609
   Manea VP, 1997, J AM CHEM SOC, V119, P2033, DOI 10.1021/ja962809a
   Milardi D, 2011, EUR BIOPHYS J BIOPHY, V40, P1, DOI 10.1007/s00249-010-0623-x
   Omondi B., 2008, ACTA CRYSTALLOGR C, V64, P137
   Ortiz C, 2007, BIOPHYS CHEM, V128, P150, DOI 10.1016/j.bpc.2007.03.012
   Porat Y, 2003, BIOPOLYMERS, V69, P161, DOI 10.1002/bip.10386
   Profit AA, 2013, PROTEINS, V81, P690, DOI 10.1002/prot.24229
   Rodriguez-Ropero F, 2009, BIOMACROMOLECULES, V10, P2338, DOI 10.1021/bm900524v
   Scherzer-Attali R., 2012, PROTEINS, V8, P162
NR 74
TC 0
Z9 0
U1 10
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 2015
VL 567
BP 46
EP 58
DI 10.1016/j.abb.2014.12.008
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CA5UV
UT WOS:000348974200006
PM 25524740
ER

PT J
AU Mahajan, S
   Sanejouand, YH
AF Mahajan, Swapnil
   Sanejouand, Yves-Henri
TI On the relationship between low-frequency normal modes and the
   large-scale conformational changes of proteins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Flexibility; Conformational transition; Elastic network model;
   Low-frequency modes; Structure-function relationship
ID PANCREATIC TRYPSIN-INHIBITOR; ELASTIC NETWORK MODELS; MOLECULAR-DYNAMICS
   SIMULATIONS; ELECTRON-DENSITY MAPS; HINGE-BENDING MODE;
   ASPARTATE-TRANSCARBAMYLASE; OPEN-STATE; TEMPERATURE-DEPENDENCE;
   MACROMOLECULAR MOTIONS; PRINCIPAL COMPONENT
AB Normal mode analysis is a computational technique that allows to study the dynamics of biological macromolecules. It was first applied to small protein cases, more than thirty years ago. The interest in this technique then raised when it was realized that it can provide insights about the large-scale conformational changes a protein can experience, for instance upon ligand binding. As it was also realized that studying highly simplified protein models can provide similar insights, meaning that this kind of analysis can be both quick and simple to handle, several applications were proposed, in the context of various structural biology techniques. This review focuses on these applications, as well as on how the functional relevance of the lowest-frequency modes of proteins was established. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Mahajan, Swapnil; Sanejouand, Yves-Henri] Univ Nantes, UFIP, CNRS, UMR 6286, F-44035 Nantes, France.
RP Sanejouand, YH (reprint author), Univ Nantes, UFIP, CNRS, UMR 6286, F-44035 Nantes, France.
EM yves-henri.sanejouand@univ-nantes.fr
OI Mahajan, Swapnil/0000-0003-2136-1801
FU Investissement d'Avenir (BIP:BIP project) [ANR-10-BINF-03-04]
FX This work has been supported by an Investissement d'Avenir (BIP:BIP
   project, ANR-10-BINF-03-04).
CR Abergel C, 2005, ACTA CRYSTALLOGR F, V61, P212, DOI 10.1107/S174430910500062X
   Alexandrov V, 2005, PROTEIN SCI, V14, P633, DOI 10.1110/ps.04882105
   Andrabi M, 2014, PROTEINS, V82, P841, DOI 10.1002/prot.24462
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   ELBER R, 1990, J AM CHEM SOC, V112, P9161, DOI 10.1021/ja00181a020
   Hinsen K, 2000, CHEM PHYS, V261, P25, DOI 10.1016/S0301-0104(00)00222-6
   Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102
   Miloshevsky GV, 2007, STRUCTURE, V15, P1654, DOI 10.1016/j.str.2007.09.022
   Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1
   Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351
   Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082
   Schaefer M, 1996, J PHYS CHEM-US, V100, P1578, DOI 10.1021/jp9521621
   Petrone P, 2006, BIOPHYS J, V90, P1583, DOI 10.1529/biophysj.105.070045
   Kim MK, 2002, BIOPHYS J, V83, P1620
   Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542
   Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009
   Tama F, 2006, ANNU REV BIOPH BIOM, V35, P115, DOI 10.1146/annurev.biophys.35.040405.102010
   Kondrashov DA, 2006, BIOPHYS J, V91, P2760, DOI 10.1529/biophysj.106.085894
   BROOKS BR, 1995, J COMPUT CHEM, V16, P1522, DOI 10.1002/jcc.540161209
   Skjaerven L, 2011, PROTEINS, V79, P232, DOI 10.1002/prot.22875
   Skjaerven L, 2009, J MOL STRUC-THEOCHEM, V898, P42, DOI 10.1016/j.theochem.2008.09.024
   Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613
   ELBER R, 1987, SCIENCE, V235, P318, DOI 10.1126/science.3798113
   JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051
   Lu MY, 2005, BIOPHYS J, V89, P2395, DOI 10.1529/biophysj.105.065904
   Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604
   MCCAMMON JA, 1976, NATURE, V262, P325, DOI 10.1038/262325a0
   Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005
   Ming D, 2002, P NATL ACAD SCI USA, V99, P8620, DOI 10.1073/pnas.082148899
   Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100
   Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090
   SENO Y, 1990, J MOL BIOL, V216, P95, DOI 10.1016/S0022-2836(05)80063-4
   Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406
   Kundu S, 2002, BIOPHYS J, V83, P723
   Cavasotto CN, 2005, J AM CHEM SOC, V127, P9632, DOI 10.1021/ja042260c
   Gohlke H, 2006, BIOPHYS J, V91, P2115, DOI 10.1529/biophysj.106.083568
   DURAND P, 1994, BIOPOLYMERS, V34, P759, DOI 10.1002/bip.360340608
   Rueda M, 2007, STRUCTURE, V15, P565, DOI 10.1016/j.str.2007.03.013
   Grant BJ, 2010, CURR OPIN STRUC BIOL, V20, P142, DOI 10.1016/j.sbi.2009.12.004
   May A, 2008, PROTEINS, V70, P794, DOI 10.1002/prot.21579
   Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121
   Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007
   Kirillova S, 2008, PROTEINS, V70, P131, DOI 10.1002/prot.21570
   Franklin J, 2007, NUCLEIC ACIDS RES, V35, pW477, DOI 10.1093/nar/gkm342
   Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821
   Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011
   Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012
   Delarue M, 2002, J MOL BIOL, V320, P1011, DOI 10.1016/S0022-2836(02)00562-4
   Riccardi D, 2009, BIOPHYS J, V96, P464, DOI [10.1016/j.bpj.2008.10.010, 10.1016/j.bpj.2008.l0.010]
   Ghysels A, 2010, J COMPUT CHEM, V31, P994, DOI 10.1002/jcc.21386
   KIDERA A, 1990, P NATL ACAD SCI USA, V87, P3718, DOI 10.1073/pnas.87.10.3718
   Li GH, 2002, BIOPHYS J, V83, P2457
   Zacharias M, 2010, CURR OPIN STRUC BIOL, V20, P180, DOI 10.1016/j.sbi.2010.02.001
   Dobbins SE, 2008, P NATL ACAD SCI USA, V105, P10390, DOI 10.1073/pnas.0802496105
   Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007
   Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098
   Thomas A, 1996, J MOL BIOL, V257, P1070, DOI 10.1006/jmbi.1996.0224
   Garzon JI, 2007, BIOINFORMATICS, V23, P901, DOI 10.1093/bioinformatics/btm014
   Rodgers TL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001651
   Micheletti C, 2004, PROTEINS, V55, P635, DOI 10.1002/prot.20049
   Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092
   BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571
   CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2
   Marques O, 1995, PROTEINS, V23, P557, DOI 10.1002/prot.340230410
   Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407
   BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995
   SENO Y, 1990, J MOL BIOL, V216, P111, DOI 10.1016/S0022-2836(05)80064-6
   Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.0.CO;2-M
   Tama F, 2000, PROTEINS, V41, P1
   Zheng WJ, 2006, P NATL ACAD SCI USA, V103, P7664, DOI 10.1073/pnas.0510426103
   Doruker P, 2002, J COMPUT CHEM, V23, P119, DOI 10.1002/jcc.1160
   Kolossvary I, 1996, J AM CHEM SOC, V118, P5011, DOI 10.1021/ja952478m
   Soheilifard R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026008
   Ahmed A, 2006, PROTEINS, V63, P1038, DOI 10.1002/prot.20907
   Zheng WJ, 2007, PROTEINS, V69, P43, DOI 10.1002/prot.21465
   Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961
   Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2
   Roh JH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.038101
   Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002
   PERAHIA D, 1995, COMPUT CHEM, V19, P241, DOI 10.1016/0097-8485(95)00011-G
   Uyar A, 2014, BIOPHYS J, V106, P2656, DOI 10.1016/j.bpj.2014.05.017
   Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445
   Ma JP, 1998, P NATL ACAD SCI USA, V95, P8502, DOI 10.1073/pnas.95.15.8502
   Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133
   Ghysels A, 2012, J COMPUT CHEM, V33, P2250, DOI 10.1002/jcc.23076
   Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics./btl.448
   Suhre K, 2006, ACTA CRYSTALLOGR D, V62, P1098, DOI 10.1107/S090744490602244X
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905
   Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N
   PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0
   Rader AJ, 2005, STRUCTURE, V13, P413, DOI 10.1016/j.str.2004.12.015
   Poon BK, 2007, P NATL ACAD SCI USA, V104, P7869, DOI 10.1073/pnas.0701204104
   Song G, 2007, J MOL BIOL, V369, P880, DOI 10.1016/j.jmb.2007.03.059
   Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8
   Gerstein M, 1998, NUCLEIC ACIDS RES, V26, P4280, DOI 10.1093/nar/26.18.4280
   Hinsen K, 2008, BIOINFORMATICS, V24, P521, DOI 10.1093/bioinformatics/btm625
   Hinsen K, 1999, PROTEINS, V34, P369, DOI 10.1002/(SICI)1097-0134(19990215)34:3<369::AID-PROT9>3.0.CO;2-F
   Mouawad L, 1996, J MOL BIOL, V258, P393, DOI 10.1006/jmbi.1996.0257
   Tama F, 2004, J MOL BIOL, V337, P985, DOI 10.1016/j.jmb.2004.01.048
   HAYWARD S, 1995, PROTEINS, V23, P177, DOI 10.1002/prot.340230207
   Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258
   LEVITT M, 1985, J MOL BIOL, V181, P423, DOI 10.1016/0022-2836(85)90230-X
   Halle B, 2002, P NATL ACAD SCI USA, V99, P1274, DOI 10.1073/pnas.032522499
   Tama F, 2003, P NATL ACAD SCI USA, V100, P9319, DOI 10.1073/pnas.1632476100
   Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368
   Nguyen H, 2014, J AM CHEM SOC, V136, P13959, DOI 10.1021/ja5032776
   Bahar I., 2005, C HCRC MATH COMPUTAT, V9
   Bathe M, 2008, PROTEINS, V70, P1595, DOI 10.1002/prot.21708
   Batista PR, 2010, PHYS CHEM CHEM PHYS, V12, P2850, DOI 10.1039/b919148h
   BENAVRAHAM D, 1993, PHYS REV B, V47, P14559, DOI 10.1103/PhysRevB.47.14559
   Bohnuud T, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003872
   Brink J, 2004, STRUCTURE, V12, P185, DOI 10.1016/j.str.2004.01.015
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Chacon P, 2003, J MOL BIOL, V326, P485, DOI 10.1016/S0022-2836(02)01426-2
   CHANGEUX JP, 1968, BIOCHEMISTRY-US, V7, P553, DOI 10.1021/bi00842a601
   Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107
   Chennubhotla C, 2005, PHYS BIOL, V2, pS173, DOI 10.1088/1475-3975/2/4/S12
   De Los Rios P, 2005, BIOPHYS J, V89, P14, DOI 10.1529/biophysj.104.055004
   Delarue M., 2007, ACTA CRYSTALLOGR D, V64, P40, DOI 10.1107/S0907444907053516
   Delarue M, 2004, P NATL ACAD SCI USA, V101, P6957, DOI 10.1073/pnas.0400301101
   DIAMOND R, 1990, ACTA CRYSTALLOGR A, V46, P425, DOI 10.1107/S0108767390002082
   Elezgaray J, 2000, J COMPUT CHEM, V21, P1274
   Floquet N, 2006, FEBS LETT, V580, P5130, DOI 10.1016/j.febslet.2006.08.037
   Fuglebakk Edvin, 2013, J Chem Theory Comput, V9, P5618, DOI 10.1021/ct400399x
   Goldstein H, 1950, CLASSICAL MECH
   Gorba Christian, 2010, Bioinform Biol Insights, V4, P43
   Guilbert C, 1996, CHEM PHYS, V204, P327, DOI 10.1016/0301-0104(95)00293-6
   HAO MH, 1992, BIOPOLYMERS, V32, P1393, DOI 10.1002/bip.360321012
   HARRISON RW, 1984, BIOPOLYMERS, V23, P2943, DOI 10.1002/bip.360231216
   Hinsen K, 2005, BIOPHYS J, V88, P818, DOI 10.1529/biophysj.104.050716
   Hollup SM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-52
   Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102
   Jeong JI, 2006, ACTA CRYSTALLOGR D, V62, P398, DOI 10.1107/S0907444906002204
   KNAPP EW, 1982, J PHYS CHEM-US, V86, P5042, DOI 10.1021/j100223a002
   Kondrashov DA, 2007, STRUCTURE, V15, P169, DOI 10.1016/j.str.2006.12.006
   Krebs WG, 2002, PROTEINS, V48, P682, DOI 10.1002/prot.10168
   Lamy AV, 1996, BIOPOLYMERS, V39, P471, DOI 10.1002/(SICI)1097-0282(199609)39:3<471::AID-BIP18>3.0.CO;2-E
   LEVITT M, 1983, INT J QUANTUM CHEM, P181
   LEVY RM, 1979, BIOPOLYMERS, V18, P2465, DOI 10.1002/bip.1979.360181008
   LEVY RM, 1982, P NATL ACAD SCI USA, V79, P1346, DOI 10.1073/pnas.79.4.1346
   Li GH, 2004, BIOPHYS J, V86, P743
   Micheletti C, 2002, J MOL BIOL, V321, P909, DOI 10.1016/S0022-2836(02)00710-6
   Miloshevsky GV, 2006, STRUCTURE, V14, P1241, DOI 10.1016/j.str.2006.006.007
   Mitternacht S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002301
   Mouawad L., 1993, BIOPOLYMERS, V33, P569
   Mousseau N, 2005, ACCOUNTS CHEM RES, V38, P885, DOI 10.1021/ar050045a
   Nicolay S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.078104
   NOGUTI T, 1982, NATURE, V296, P776, DOI 10.1038/296776a0
   Phan J, 2005, J MOL BIOL, V353, P104, DOI 10.1016/j.jmb.2005.08.037
   Ramaswamy A, 2005, PROTEINS, V58, P683, DOI 10.1002/prot.20357
   Sanejouand Y.-H., 2012, ELASTIC NETWORK MODE, P601
   Sanejouand YH, 1996, PROTEIN ENG, V9, P671, DOI 10.1093/protein/9.8.671
   Sanejouand Y.-H., 2004, ADV SERIES NONLINEAR, P273
   Sanejouand YH, 1997, CR ACAD SCI III-VIE, V320, P163, DOI 10.1016/S0764-4469(97)85008-1
   Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409
   SIMONSON T, 1992, BIOPHYS J, V61, P410
   Suhre K, 2004, ACTA CRYSTALLOGR D, V60, P796, DOI 10.1107/S0907444904001982
   SWAMINATHAN S, 1982, BIOCHEMISTRY-US, V21, P5230, DOI 10.1021/bi00264a019
   Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229
   Tama F, 2002, J MOL BIOL, V318, P733, DOI 10.1016/S0022-2836(02)00135-3
   Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6
   Thomas A, 1996, J MOL BIOL, V261, P490, DOI 10.1006/jmbi.1996.0478
   Thorpe MF, 2007, PHYS BIOL, V4, P60, DOI 10.1088/1478-3975/4/1/N01
   TIRION MM, 1995, BIOPHYS J, V68, P5
   Trapani S, 2006, ACTA CRYSTALLOGR D, V62, P467, DOI 10.1107/S0907444906005361
   Valadie H, 2003, J MOL BIOL, V332, P657, DOI 10.1016/S0022-2836(03)00851-9
   van Vlijmen HWT, 1999, J PHYS CHEM B, V103, P3009, DOI 10.1021/jp983452v
   van Vlijmen HWT, 2005, J MOL BIOL, V350, P528, DOI 10.1016/j.jmb.2005.03.028
   Wilson E., 1955, CROSS MOL VIBRATIONS
   Zheng WJ, 2005, BIOPHYS J, V88, P3109, DOI 10.1529/biophysj.104.058453
   Zheng WJ, 2003, P NATL ACAD SCI USA, V100, P13253, DOI 10.1073/pnas.2235686100
NR 172
TC 1
Z9 1
U1 10
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 2015
VL 567
BP 59
EP 65
DI 10.1016/j.abb.2014.12.020
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CA5UV
UT WOS:000348974200007
PM 25562404
ER

PT J
AU House, AJ
   Daye, LR
   Tarpley, M
   Addo, K
   Lamson, DS
   Parker, MK
   Bealer, WE
   Williams, KP
AF House, Alan J.
   Daye, Laura R.
   Tarpley, Michael
   Addo, Kezia
   Lamson, David S.
   Parker, Margie K.
   Bealer, Warren E.
   Williams, Kevin P.
TI Design and characterization of a photo-activatable hedgehog probe that
   mimics the natural lipidated form
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Sonic hedgehog; Benzophenone; Crosslinking; Photoactivatable; Heparin;
   Palmitoyl
ID HEPARAN-SULFATE INTERACTIONS; HUMAN SONIC HEDGEHOG; SIGNALING PATHWAY;
   CHOLESTEROL MODIFICATION; INTRACELLULAR-TRANSPORT; STRUCTURAL INSIGHTS;
   ANIMAL DEVELOPMENT; DUAL ROLES; DALLY-LIKE; PROTEIN
AB We have generated a photoactivatable form of sonic hedgehog protein by modifying the N-terminal cysteine with the heterobifunctional photocrosslinker 4-maleimidobenzophenone (Bzm). The Bzm modification on ShhN imparted a significant increase in activity as assessed in the C3H10T1/2 functional assay with potency comparable to that of the endogenous dual-lipidated form of ShhN (ShhNp). Reversedphase HPLC analysis indicated that the increase in activity compared to unmodified ShhN may be due in part to the hydrophobic nature of the benzophenone group. In contrast to the fully processed ShhNp, Bzm-ShhN is monomeric as assessed by analytical SEC and does not require detergent to be soluble. Further, we demonstrated that the Bzm-ShhN was able to crosslink in vitro in the presence of a known binding partner, heparin. We suggest that Bzm-ShhN can serve as a relatively facile and preferred source of ShhNp for in vitro assays and as a probe to identify novel Hh protein interactions. (C) 2014 Elsevier Inc. All rights reserved.
C1 [House, Alan J.; Daye, Laura R.; Tarpley, Michael; Addo, Kezia; Lamson, David S.; Parker, Margie K.; Bealer, Warren E.; Williams, Kevin P.] N Carolina Cent Univ, BRITE, Dept Pharmaceut Sci, Durham, NC 27707 USA.
RP Williams, KP (reprint author), N Carolina Cent Univ, BRITE, Dept Pharmaceut Sci, 1801 Fayetteville St, Durham, NC 27707 USA.
EM kpwilliams@nccu.edu
FU National Cancer Institute of the NIH [U54AA019765, R15CA159209,
   U54CA156735]; Golden LEAF Foundation; BIOIMPACT Initiative of the State
   of North Carolina through the Biomanufacturing Research Institute &
   Technology Enterprise (BRITE) Center for Excellence at North Carolina
   Central University; National Institute on Alcohol Abuse and Alcoholism
FX This work was supported by the National Institute on Alcohol Abuse and
   Alcoholism and the National Cancer Institute of the NIH under award
   numbers U54AA019765, R15CA159209 and U54CA156735 (KPW). Additional
   funding was from the Golden LEAF Foundation and the BIOIMPACT Initiative
   of the State of North Carolina through the Biomanufacturing Research
   Institute & Technology Enterprise (BRITE) Center for Excellence at North
   Carolina Central University. The authors thank Robert Ndoyi, Willietta
   Gibson, Khalia Williams and Shalonda Ingram (BRITE, NCCU) for technical
   assistance, and acknowledge Blake Pepinslcy for initial discussions.
CR Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107
   ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2
   Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037
   Varjosalo M, 2007, J CELL SCI, V120, P3, DOI 10.1242/jcs.03309
   Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0
   Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0
   Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437
   Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086
   Patten I, 2000, CELL MOL LIFE SCI, V57, P1695, DOI 10.1007/PL00000652
   Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603
   Taipale J, 2000, NATURE, V406, P1005
   Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255
   MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0
   Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157
   Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026
   Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004
   Wittelsberger A, 2008, CHEM BIOL DRUG DES, V71, P380, DOI [10.1111/j.1747-0285.2008.00646.x, 10.1111/j.1747.0285.2008.00646.x]
   Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21
   Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033
   Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006
   Kim MS, 2011, P NATL ACAD SCI USA, V108, P13112, DOI 10.1073/pnas.1109877108
   Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u
   Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804
   Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710
   Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017
   Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607
   Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632
   BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294
   Callejo A, 2006, DEVELOPMENT, V133, P471, DOI 10.1242/dev.02217
   Chang SC, 2011, J BIOL CHEM, V286, P44391, DOI 10.1074/jbc.M111.285361
   Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4
   Cleveland T.E., 2014, PROTEIN EXPR PURIF
   Daye L., 2010, INT J HIGH THROUGHPU, V2010, P69
   Dierker T, 2009, J BIOL CHEM, V284, P32562, DOI 10.1074/jbc.M109.044867
   DIGARD P, 1995, P NATL ACAD SCI USA, V92, P1456, DOI 10.1073/pnas.92.5.1456
   Farshi P, 2011, J BIOL CHEM, V286, P23608, DOI 10.1074/jbc.M110.206474
   Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200
   Grover VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021353
   Hu D, 1999, DEVELOPMENT, V126, P4873
   Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601
   JOHNSON RL, 1994, BIOCHEM SOC T, V22, P569
   Kang J.-S., 2007, SCI SIGNAL, ppe50
   Kavran JM, 2010, J BIOL CHEM, V285, P24584, DOI 10.1074/jbc.M110.131680
   Kohtz JD, 2001, DEVELOPMENT, V128, P2351
   Kornberg TB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002447
   Kornberg TB, 2014, DEV BIOL, V394, P1, DOI 10.1016/j.ydbio.2014.07.015
   Li YX, 2007, LAB INVEST, V87, P231, DOI 10.1038/labinvest.3700516
   Mao H, 2009, LAB INVEST, V89, P290, DOI 10.1038/labinvest.2008.163
   McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358
   McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103
   Ohlig S, 2012, J BIOL CHEM, V287, P43708, DOI 10.1074/jbc.M112.356667
   Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010
   OLSZEWSKI S, 1994, J BIOL CHEM, V269, P27987
   Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0
   Rhodes DG, 2009, METHOD ENZYMOL, V463, P691, DOI 10.1016/S0076-6879(09)63039-1
   RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2
   Rubin JB, 2002, DEVELOPMENT, V129, P2223
   Toedt GH, 2003, NUCLEIC ACIDS RES, V31, P819, DOI 10.1093/nar/gkg191
   Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x
   Whalen DM, 2013, P NATL ACAD SCI USA, V110, P16420, DOI 10.1073/pnas.1310097110
   Williams K.P., J CELL SCI, V112
   WILLIAMS KP, 1993, J BIOL CHEM, V268, P5361
   Wojcinski A, 2011, DEV BIOL, V358, P168, DOI 10.1016/j.ydbio.2011.07.027
   Zhang FM, 2007, BIOCHEMISTRY-US, V46, P3933, DOI 10.1021/bi6025424
NR 64
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 2015
VL 567
BP 66
EP 74
DI 10.1016/j.abb.2014.12.014
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CA5UV
UT WOS:000348974200008
PM 25529135
ER

PT J
AU Wang, YP
   Marling, SJ
   Beaver, EF
   Severson, KS
   Deluca, HF
AF Wang, Yanping
   Marling, Steven J.
   Beaver, Emily F.
   Severson, Kyle S.
   Deluca, Hector F.
TI UV light selectively inhibits spinal cord inflammation and demyelination
   in experimental autoimmune encephalomyelitis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Multiple sclerosis; Ultraviolet light; Chemokine CCL5; IL-10
ID ULTRAVIOLET-B IRRADIATION; RANTES MESSENGER-RNA; MULTIPLE-SCLEROSIS;
   T-CELLS; VITAMIN-D; IMMUNE-RESPONSES; HUMAN-SKIN; CHEMOKINES;
   EXPRESSION; LESIONS
AB Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). The incidence of MS is inversely related to sun light exposure or ultraviolet radiation (UVR). UVR was found to suppress experimental autoimmune encephalomyelitis (EAE), an animal model of MS, independent of vitamin D production. The mechanism of this suppression remains to be elucidated. To this end, several elements of an immune response in the spinal cord, spleen and skin during development of EAE were studied. As expected, UVR (10 kJ/m(2)) inhibits inflammation and demyelination of the spinal cord. Most significant, UVR dramatically reduced spinal cord chemokine CCL5 mRNA and protein levels. UVR also suppressed IL-10 in skin and spleen but not the spinal cord. As expected from the UVR action on skin, macrophage population and IFN-gamma levels are increased in that organ. UVR had no effect on lymphocyte proliferation and IFN-gamma in spleen. From these measurements, we suggest that UVR suppression of EAE prevents the migration of inflammatory cells into the CNS by a focal inhibition of chemokine CCL-5 in the CNS and a systemic elevation of immunosuppressive IL-10. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wang, Yanping; Marling, Steven J.; Beaver, Emily F.; Severson, Kyle S.; Deluca, Hector F.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.
RP Deluca, HF (reprint author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.
EM deluca@biochem.wisc.edu
RI Wang, Yanping/A-4452-2013
OI Wang, Yanping/0000-0002-5934-7717
FU Wisconsin Alumni Research Foundation, Madison, WI
FX This work was supported by a fund from the Wisconsin Alumni Research
   Foundation, Madison, WI. The authors thank William Blaser and Wendy
   Hellwig for their technical support and Pat Mings for her assistance in
   preparing the manuscript.
CR Opdenakker G, 2011, CYTOKINE GROWTH F R, V22, P359, DOI 10.1016/j.cytogfr.2011.11.005
   dos Santos AC, 2005, J NEUROIMMUNOL, V162, P122, DOI 10.1016/j.jneuroim.2005.01.020
   Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2
   Becklund BR, 2010, P NATL ACAD SCI USA, V107, P6418, DOI 10.1073/pnas.1001119107
   Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045
   Subileau EA, 2009, J NEUROPATH EXP NEUR, V68, P227, DOI 10.1097/NEN.0b013e318197eca7
   Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194
   Ascherio A, 2013, EXPERT REV NEUROTHER, V13, P3, DOI 10.1586/14737175.2013.865866
   Schwarz T, 2008, PHOTOCHEM PHOTOBIOL, V84, P10, DOI 10.1111/j.1751-1097.2007.00223.x
   Elhofy A, 2002, IMMUNOL RES, V25, P167, DOI 10.1385/IR:25:2:167
   Zang YCQ, 2000, BRAIN, V123, P1874, DOI 10.1093/brain/123.9.1874
   Piskin G, 2003, EXP DERMATOL, V12, P172, DOI 10.1034/j.1600-0625.2003.120208.x
   Hvas J, 1997, SCAND J IMMUNOL, V46, P195, DOI 10.1046/j.1365-3083.1997.d01-100.x
   Glass WG, 2004, J IMMUNOL, V172, P4018
   Skuljec J, 2011, CELL IMMUNOL, V270, P164, DOI 10.1016/j.cellimm.2011.05.001
   Cantorna MT, 1999, J NUTR, V129, P1966
   MACLAUGHLIN JA, 1982, SCIENCE, V216, P1001, DOI 10.1126/science.6281884
   Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873
   Choi SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092325
   Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861
   Arakawa S, 2006, ARCH DERMATOL RES, V297, P377, DOI 10.1007/s00403-005-0620-6
   Boonstra A, 2000, INT IMMUNOL, V12, P1531, DOI 10.1093/intimm/12.11.1531
   Boven LA, 2000, CLIN EXP IMMUNOL, V122, P257, DOI 10.1046/j.1365-2249.2000.01334.x
   Byrne SN, 2005, PHOTOCHEM PHOTOBIOL, V81, P1366, DOI 10.1562/2005-04-20-Ra-495
   Garssen J, 1999, IMMUNOLOGY, V97, P506
   Holmøy T, 2008, Minerva Med, V99, P119
   KANG KF, 1994, J IMMUNOL, V153, P5256
   Kang KF, 1998, J INVEST DERMATOL, V111, P31, DOI 10.1046/j.1523-1747.1998.00121.x
   Khaskhely NM, 2002, CLIN DIAGN LAB IMMUN, V9, P677, DOI 10.1128/CDLI.9.3.677.686.2002
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Platten M, 2005, NAT MED, V11, P252, DOI 10.1038/nm0305-252
   Rateb AA, 2012, EUR J DERMATOL, V22, P481, DOI 10.1684/ejd.2012.1730
   Schwarz Thomas, 2005, Keio Journal of Medicine, V54, P165, DOI 10.2302/kjm.54.165
   Walters IB, 2003, ARCH DERMATOL, V139, P155, DOI 10.1001/archderm.139.2.155
   Wang YJ, 2010, ARCH BIOCHEM BIOPHYS, V494, P166, DOI 10.1016/j.abb.2009.11.029
   Wang YP, 2013, ARCH BIOCHEM BIOPHYS, V536, P81, DOI 10.1016/j.abb.2013.05.010
NR 36
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 2015
VL 567
BP 75
EP 82
DI 10.1016/j.abb.2014.12.017
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CA5UV
UT WOS:000348974200009
PM 25541149
ER

PT J
AU Kostomoiri, M
   Zikos, C
   Benaki, D
   Triantis, C
   Sagnou, M
   Paravatou-Petsotas, M
   Papadaki, A
   Boleti, H
   Papadopoulos, M
   Pirmettis, I
   Pelecanou, M
   Livaniou, E
AF Kostomoiri, Myrta
   Zikos, Christos
   Benaki, Dimitra
   Triantis, Charalampos
   Sagnou, Marina
   Paravatou-Petsotas, Maria
   Papadaki, Amalia
   Boleti, Haralabia
   Papadopoulos, Minas
   Pirmettis, Ioannis
   Pelecanou, Maria
   Livaniou, Evangelia
TI New labeled derivatives of the neuroprotective peptide colivelin:
   Synthesis, characterization, and first in vitro and in vivo applications
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Colivelin; Synthetic colivelin probes; NMR; Tc-99m-radiolabeling; FITC
   labeling; Biotin labeling
ID DEPENDENT NEUROTROPHIC FACTOR; DISEASE-RELEVANT INSULTS; NEURONAL
   CELL-DEATH; ALZHEIMERS-DISEASE; BIOLOGICAL EVALUATION; MEMORY
   IMPAIRMENT; MEDIATED NEUROPROTECTION; HUMANIN ANALOGS; RESCUE FACTOR;
   AMINO-ACIDS
AB Colivelin (CL), first reported in 2005, is the most potent member of the humanin family of neuroprotective peptides with in vitro and in vivo rescuing action against insults associated with Alzheimer's disease (AD). The objective of the present work is the design, synthesis and characterization of specific CL derivatives that can be used as molecular probes in the investigation of the unknown mechanism of CL action. Within this framework, three CL derivatives bearing suitable tags, i.e., the fluorescent moiety FITC, the streptavidin-counterpart biotinyl-group, and the Tc-99m-radiometal chelating unit dimethylGly-Ser-Cys, were developed and subsequently applied in biological evaluation experiments. Specifically, the FITC-labeled derivative of CL was used in confocal microscopy, where specific binding at the periphery of F11 cells was observed; the biotin-labeled derivative of CL was used in an in-house developed ELISA-type assay, where specific and concentration-dependent binding with the beta-amyloid peptide of AD was shown; finally, the Tc-99m-radiolabeled derivative of CL was used in in vivo biodistribution studies in healthy Swiss Albino mice, where 0.58% of the radioactivity administered was measured in the mouse brain 2 min after injection. The above first successful applications of the CL probes demonstrate their potential to contribute in the field of neuroprotective peptides. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Kostomoiri, Myrta; Benaki, Dimitra; Sagnou, Marina; Pelecanou, Maria] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens 15310, Greece.
   [Zikos, Christos; Triantis, Charalampos; Paravatou-Petsotas, Maria; Papadopoulos, Minas; Pirmettis, Ioannis; Livaniou, Evangelia] Natl Ctr Sci Res Demokritos, Inst Nucl & Radiol Sci & Technol Energy & Safety, Athens 15310, Greece.
   [Benaki, Dimitra] Univ Athens, Dept Pharm, GR-15771 Athens, Greece.
   [Papadaki, Amalia; Boleti, Haralabia] Hellenic Pasteur Inst, Intracellular Parasitism Grp, Athens 11521, Greece.
   [Boleti, Haralabia] Hellenic Pasteur Inst, Light Microscopy Unit, Athens 11521, Greece.
RP Pelecanou, M (reprint author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens 15310, Greece.
EM pelmar@bio.demokritos.gr
FU National Funding to NCSR "Demokritos"; Hellenic Postbank
FX This work was financially supported by National Funding to NCSR
   "Demokritos" and by a Grant from Hellenic Postbank. The authors wish to
   express their gratitude to Professor Masaaki Matsuoka, Tokyo Medical
   University, for his prompt and instructive response, and the kind supply
   of the F11 neurohybrid cells. The authors also thank Ms. Zoe Tsialla,
   MSc, for obtaining the ESI-MS spectra at the Immunoassay-Immunosensors
   Laboratory of the Institute of Nuclear 82 Radiological Sciences 82
   Technology, Energy 82 Safety, National Center for Scientific Research
   "Demokritos" and Dr. E. Xingi at the Light Microscopy Unit of the
   Hellenic Pasteur Institute (HPI-LMU) for her help in the quantitative
   analysis of the microscopy digital images.
CR Alves ID, 2010, BBA-BIOMEMBRANES, V1798, P2231, DOI 10.1016/j.bbamem.2010.02.009
   FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x
   Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8
   Arakawa T, 2008, CURR MED CHEM, V15, P2086, DOI 10.2174/092986708785747616
   Boturyn D, 2004, J AM CHEM SOC, V126, P5730, DOI 10.1021/ja049926n
   Zhang WJ, 2012, PHARMACOL BIOCHEM BE, V100, P361, DOI 10.1016/j.pbb.2011.09.012
   Sahoo H, 2012, RSC ADV, V2, P7017, DOI 10.1039/c2ra20389h
   WUTHRICH K, 1982, J MOL BIOL, V155, P311, DOI 10.1016/0022-2836(82)90007-9
   Huang NP, 2002, LANGMUIR, V18, P220, DOI 10.1021/la010913m
   Jullian M, 2009, TETRAHEDRON LETT, V50, P260, DOI 10.1016/j.tetlet.2008.10.141
   Chiba T, 2007, MOL NEUROBIOL, V35, P55, DOI 10.1007/BF02700624
   Amblard M, 2006, MOL BIOTECHNOL, V33, P239, DOI 10.1385/MB:33:3:239
   Cyr JE, 2007, J MED CHEM, V50, P4295, DOI 10.1021/jm060887v
   Chiba T, 2006, BIOCHEM BIOPH RES CO, V343, P793, DOI 10.1016/j.bbrc.2006.02.184
   Matsuoka M, 2006, CNS DRUG REV, V12, P113, DOI 10.1111/j.1527-3458.2006.00113.x
   GREEN NM, 1990, METHOD ENZYMOL, V184, P51
   Chiba T, 2005, J NEUROSCI, V25, P10252, DOI 10.1523/JNEUROSCI.3348-05.2005
   Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168
   Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z
   Yamada M, 2008, NEUROPSYCHOPHARMACOL, V33, P2020, DOI 10.1038/sj.npp.1301591
   Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200
   Chiba T, 2009, EXPERT OPIN THER TAR, V13, P1155, DOI 10.1517/14728220903213426
   Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627
   Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498
   Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031
   Benaki D, 2012, CHEM BIOL DRUG DES, V80, P545, DOI 10.1111/j.1747-0285.2012.01425.x
   Brenneman DE, 1998, J PHARMACOL EXP THER, V285, P619
   Evangelou A, 2009, PEPTIDES, V30, P2409, DOI 10.1016/j.peptides.2009.07.028
   Evangelou A, 2004, J PEPT SCI, V10, P631, DOI 10.1002/psc.572
   Fani E., 2012, EUR J NUCL MED MOL I, V39, pS11
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161
   Gourni E, 2009, J MED CHEM, V52, P4234, DOI 10.1021/jm900360d
   Krejcova G, 2004, J PEPT SCI, V10, P636, DOI 10.1002/psc.569
   Kunesova G, 2008, PEPTIDES, V29, P1982, DOI 10.1016/j.peptides.2008.06.019
   MacGillavry HD, 2011, MOL CELL NEUROSCI, V46, P460, DOI 10.1016/j.mcn.2010.11.011
   Madani Fatemeh, 2011, Journal of Biophysics, DOI 10.1155/2011/414729
   Maftei M, 2012, J PEPT SCI, V18, P373, DOI 10.1002/psc.2404
   Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429
   Niikura T, 2002, J NEUROSCI RES, V70, P380, DOI 10.1002/jnr.10354
   Niikura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016259
   PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499
   Sari Y, 2009, NEUROSCIENCE, V164, P1653, DOI 10.1016/j.neuroscience.2009.09.049
   SARIN VK, 1981, ANAL BIOCHEM, V117, P147, DOI 10.1016/0003-2697(81)90704-1
   Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391
   Trippier PC, 2013, CHEMMEDCHEM, V8, P190, DOI 10.1002/cmdc.201200498
   Wieringa P, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/27/275102
   Yamagishi Y, 2003, PEPTIDES, V24, P585, DOI 10.1016/S0196-9781(03)00106-2
   Yen K, 2013, J MOL ENDOCRINOL, V50, pR11, DOI 10.1530/JME-12-0203
   Zou P, 2003, PEPTIDES, V24, P679, DOI 10.1016/S0196-9781(03)00131-1
NR 51
TC 1
Z9 1
U1 5
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 2015
VL 567
BP 83
EP 93
DI 10.1016/j.abb.2014.12.027
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CA5UV
UT WOS:000348974200010
PM 25575783
ER

PT J
AU Skaff, DA
   McWhorter, WJ
   Geisbrecht, BV
   Wyckoff, GJ
   Miziorko, HM
AF Skaff, D. Andrew
   McWhorter, William J.
   Geisbrecht, Brian V.
   Wyckoff, Gerald J.
   Miziorko, Henry M.
TI Inhibition of bacterial mevalonate diphosphate decarboxylase by
   eriochrome compounds
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Mevalonate diphosphate decarboxylase; Mevalonate pathway; Isoprenoid
   biosynthesis; Enzyme inhibitors
ID 5-PYROPHOSPHATE DECARBOXYLASE; STAPHYLOCOCCUS-AUREUS; SCORING FUNCTION;
   BINDING; EXPRESSION; CATALYSIS; RESIDUES; ANALOGS; SITE
AB Mevalonate diphosphate decarboxylase (MDD; EC 4.1.1.33) catalyzes the irreversible decarboxylation of mevalonate diphosphate in the mevalonate pathway to form isopentenyl diphosphate, which is a precursor in the biosynthesis of many essential polyisoprenoid natural products, including sterols. In low G/C Gram-positive bacteria, which utilize the mevalonate pathway, MDD is required for cell viability and thus is a potential target for development of antibiotic drugs. To identify potential inhibitors of the enzyme, the National Cancer Institute's Mechanistic Diversity Set library of compounds was screened for inhibitors of Staphylococcus epidermidis MDD. From this screen, the compound Eriochrome Black A (EBA), an azo dye, was found to inhibit the enzyme with an IC50 value < 5 mu M. Molecular docking of EBA into a crystal structure of S. epidermidis MDD suggested binding at the active site. EBA, along with the related Eriochrome B and T compounds, was evaluated for its ability to not only inhibit enzymatic activity but to inhibit bacterial growth as well. These compounds exhibited competitive inhibition towards the substrate mevalonate diphosphate, with K-i values ranging from 0.6 to 2.7 mu M. Non-competitive inhibition was observed versus ATP indicating binding of the inhibitor in the mevalonate diphosphate binding site, consistent with molecular docking predictions. Fluorescence quenching analyses also supported active site binding of EBA. These eriochrome compounds are effective at inhibiting S. epidermidis cell growth on both solid media and in liquid culture (MIC50 from 31 to 350 mu M) raising the possibility that they could be developed into antibiotic leads targeting pathogenic low-G/C Gram-positive cocci. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Skaff, D. Andrew; Wyckoff, Gerald J.; Miziorko, Henry M.] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, Kansas City, MO 64110 USA.
   [McWhorter, William J.; Geisbrecht, Brian V.] Univ Missouri, Div Cell Biol & Biophys, Kansas City, MO 64110 USA.
RP Miziorko, HM (reprint author), Univ Missouri, Sch Biol Sci, 5100 Rockhill Rd, Kansas City, MO 64110 USA.
EM miziorkoh@umkc.edu
FU University of Missouri System Interdisciplinary Intercampus grant;
   Marion-Merrell-Dow foundation; NIH [AI071028, AI090149]
FX The authors acknowledge support from a University of Missouri System
   Interdisciplinary Intercampus grant, from the Marion-Merrell-Dow
   foundation (H.M.M.), and from NIH (AI071028 and AI090149; B.V.G.).
CR Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g
   Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77
   Durrant JD, 2011, J CHEM INF MODEL, V51, P2897, DOI 10.1021/ci2003889
   Tiemersma EW, 2004, EMERG INFECT DIS, V10, P1627
   Wilding EI, 2000, J BACTERIOL, V182, P5147, DOI 10.1128/JB.182.18.5147-5152.2000
   Barta ML, 2011, J BIOL CHEM, V286, P23900, DOI 10.1074/jbc.M111.242016
   Voynova NE, 2008, ARCH BIOCHEM BIOPHYS, V480, P58, DOI 10.1016/j.abb.2008.08.024
   Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.01725204
   REARDON JE, 1987, BIOCHEMISTRY-US, V26, P4717, DOI 10.1021/bi00389a018
   Lefurgy ST, 2010, J BIOL CHEM, V285, P20654, DOI 10.1074/jbc.M109.098350
   Sezgin Z, 2013, ARCH BIOCHEM BIOPHYS, V532, P32, DOI 10.1016/j.abb.2013.01.003
   Atlas R.M., 2004, HDB MICROBIOLOGICAL, P1226
   Barta ML, 2012, BIOCHEMISTRY-US, V51, P5611, DOI 10.1021/bi300591x
   BLOCH K, 1959, J BIOL CHEM, V234, P2595
   CARDEMIL E, 1985, METHOD ENZYMOL, V110, P86
   Dassanayake RS, 2002, MOL GENET GENOMICS, V267, P281, DOI 10.1007/s00438-002-0648-7
   Krepkiy DV, 2005, BIOCHEMISTRY-US, V44, P2671, DOI 10.1021/bi0484217
   Moldover Brian, 2012, Open Med Chem J, V6, P29, DOI 10.2174/1874104501206010029
   Moran G.J., 2007, ANN EMERG MED, V50, P356
   Qiu YG, 2006, ORG LETT, V8, P1013, DOI 10.1021/ol052573s
   Skaff D.A., BIOL, P17
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Vlattas I, 1996, BIOORG MED CHEM LETT, V6, P2091, DOI 10.1016/0960-894X(96)00374-5
NR 23
TC 0
Z9 0
U1 2
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 1
EP 6
DI 10.1016/j.abb.2014.12.002
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000001
PM 25499551
ER

PT J
AU Rehman, SU
   Sarwar, T
   Ishqi, HM
   Husain, MA
   Hasan, Z
   Tabish, M
AF Rehman, Sayeed Ur
   Sarwar, Tarique
   Ishqi, Hassan Mubarak
   Husain, Mohammed Amir
   Hasan, Ziaul
   Tabish, Mohammad
TI Deciphering the interactions between chlorambucil and calf thymus DNA: A
   multi-spectroscopic and molecular docking study
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Chlorambucil; Calf thymus DNA; Non-covalent interactions; Groove
   binding; Molecular docking
ID HERRING SPERM DNA; BINDING CHARACTERISTICS; DRUG; MECHANISMS; PROBE
AB Non-covalent interactions of chlorambucil with calf thymus DNA was investigated using multi-spectroscopic techniques and molecular docking study. Binding constant calculated was found to be 1.54 x 10(4) M-1 at 290 K, significantly lower than various known intercalators. Quenching process was found to be static as evident by biomolecular quenching constant. Thermodynamic parameters revealed the involvement of hydrophobic interactions and hydrogen bonds in the binding. Chlorambucil was found to interact via external binding mode and follow groove binding as it replaces Hoechst (a typical groove binder) from the groove of DNA but does not replace intercalating dyes including ethidium bromide and acridine orange from the DNA helix. These results were further supported by KI quenching experiments, DNA melting studies, CD spectroscopy and molecular docking. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Rehman, Sayeed Ur; Sarwar, Tarique; Ishqi, Hassan Mubarak; Husain, Mohammed Amir; Hasan, Ziaul; Tabish, Mohammad] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India.
RP Tabish, M (reprint author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India.
EM tabish.bcmlab@gmail.com
FU CSIR, New Delhi [09/112(0470)/2011-EMR1]; UGC; DBT, New Delhi
FX Authors are thankful to CSIR, New Delhi, for the award of CSIR-SRF
   fellowship to SUR (File no. 09/112(0470)/2011-EMR1) and Department of
   Biochemistry, Faculty of Life Sciences, AMU, Aligarh for providing the
   necessary facilities. We also thank UGC and DBT, New Delhi for providing
   financial assistance. CD experiments were performed at AIRF, JNU, New
   Delhi.
CR Zhao N, 2010, SPECTROCHIM ACTA A, V75, P1435, DOI 10.1016/j.saa.2010.01.013
   Kandagal PB, 2006, J PHARMACEUT BIOMED, V41, P393, DOI 10.1016/j.jpba.2005.11.037
   Mohamed D, 2009, CHEM RES TOXICOL, V22, P1435, DOI 10.1021/tx900123r
   Polavarapu A, 2012, J ORG CHEM, V77, P5914, DOI 10.1021/jo300351g
   Zhang GW, 2014, J AGR FOOD CHEM, V62, P991, DOI 10.1021/jf405085g
   Husain MA, 2013, FEBS J, V280, P6569, DOI 10.1111/febs.12558
   Ding YH, 2010, J PHYS CHEM B, V114, P2033, DOI 10.1021/jp9104757
   Kashanian S, 2010, EUR FOOD RES TECHNOL, V230, P821, DOI 10.1007/s00217-010-1226-6
   Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k
   Liu YJ, 2008, SPECTROCHIM ACTA A, V70, P171, DOI 10.1016/j.saa.2007.07.029
   Shahabadi N, 2014, MOL BIOSYST, V10, P338, DOI 10.1039/c3mb70340a
   Sirajuddin M, 2013, J PHOTOCH PHOTOBIO B, V124, P1, DOI 10.1016/j.jphotobiol.2013.03.013
   Margison GP, 2002, MUTAGENESIS, V17, P483, DOI 10.1093/mutage/17.6.483
   KUMAR CV, 1993, J PHOTOCH PHOTOBIO A, V74, P231, DOI 10.1016/1010-6030(93)80121-O
   Sanderson BJS, 1996, MUTAT RES-FUND MOL M, V355, P41, DOI 10.1016/0027-5107(96)00021-8
   Charak S, 2012, INT J BIOL MACROMOL, V51, P406, DOI 10.1016/j.ijbiomac.2012.06.012
   Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749
   Shi Y, 2011, BIOMACROMOLECULES, V12, P797, DOI 10.1021/bm101414w
   Bi SY, 2008, SPECTROCHIM ACTA A, V69, P123, DOI 10.1016/j.saa.2007.03.017
   Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027
   Chen ZW, 2009, BIOELECTROCHEMISTRY, V75, P13, DOI 10.1016/j.bioelechem.2008.12.003
   Elder RM, 2011, BIOMACROMOLECULES, V12, P3870, DOI 10.1021/bm201113y
   FAGUET GB, 1994, J CLIN ONCOL, V12, P1974
   Ilanchelian M, 2011, J FLUORESC, V21, P1439, DOI 10.1007/s10895-010-0829-4
   Khan SN, 2010, BIOSCIENCE REP, V30, P331, DOI 10.1042/BSR20090083
   Ling X, 2008, J PHOTOCH PHOTOBIO B, V93, P172, DOI 10.1016/j.jphotobiol.2008.07.008
   Long J, 2014, J MOL RECOGNIT, V27, P131, DOI 10.1002/jmr.2341
   Rehman SU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093913
   Sarwar T., 2014, INT J BIOL MACROMOL
   Sarwar T., 2014, MOL BIOSYST
   Shahabadi N, 2014, SPECTROCHIM ACTA A, V120, P1, DOI 10.1016/j.saa.2013.10.008
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Wu FY, 2008, J FLUORESC, V18, P175, DOI 10.1007/s10895-007-0261-6
NR 33
TC 3
Z9 3
U1 4
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 7
EP 14
DI 10.1016/j.abb.2014.12.013
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000002
PM 25528167
ER

PT J
AU Kumar, V
   Murugeson, S
   Vithani, N
   Prakash, B
   Gowda, LR
AF Kumar, Vinod
   Murugeson, Saravanan
   Vithani, Neha
   Prakash, Balaji
   Gowda, Lalitha R.
TI A salt-bridge stabilized C-terminal hook is critical for the
   dimerization of a Bowman Birk inhibitor
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Knob-in-the-hole; Site-directed mutagenesis; Molecular dynamics
   simulations; Salt bridge; Substrate-induced monomerisation;
   Trypsin/chymotrypsin inhibitor
ID HORSEGRAM DOLICHOS-BIFLORUS; BEANS PHASEOLUS-VULGARIS;
   PROTEINASE-INHIBITORS; PROTEASE INHIBITOR; CHYMOTRYPSIN-INHIBITOR;
   TRYPSIN-INHIBITORS; CRYSTAL-STRUCTURE; FORCE-FIELD; PURIFICATION; SEEDS
AB Legume Bowman-Birk inhibitors (BBIs) that inhibit mammalian proteases exist as dimers in solution. The structural basis governing dimerization of HGI-III (horsegram seed BBI) was investigated. An intramonomer salt bridge (D76-K71) stabilizes an atypical hook-like conformation at the C-terminus. We postulate that this hook, positions D75 to enable an inter-monomer salt-bridge D75(a)-K24(b), which results in dimerization. We verify this by K71A and D76A mutations of HGI-III. The mutants were both monomers, likely due to destabilization of the C-terminal hook. Dimerization was sustained in a double mutant K71D/D76K that was anticipated to form a similar hook critical for dimerization. Conversely, K24(b) that interacts with D75(a) of the loop is the specificity determining residue that interacts with trypsin to inhibit its activity. The inter-monomer salt bridge D75(a)-K24(b) must be disrupted for the inhibition of trypsin, requiring HGI-III to transition into a monomer. Size exclusion studies and a model of HGI-III-trypsin complex support this notion. Interestingly, isoforms of the inhibitor present in germinated seeds (HGGIs) are monomers; and most strikingly, the C-termini of these inhibitors are truncated with the loss the C-terminal hook critical for dimerization. The tendency of HGI-III to self-associate seems to relate to its physiological function of a storage protein. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kumar, Vinod; Gowda, Lalitha R.] Cent Food Technol Res Inst, CSIR, Dept Prot Chem & Technol, Mysore 570020, Karnataka, India.
   [Murugeson, Saravanan; Vithani, Neha; Prakash, Balaji] Indian Inst Technol, Dept Biol Sci & BioEngn, Kanpur 208016, Uttar Pradesh, India.
   [Prakash, Balaji] Indian Inst Technol, Ctr Excellence Chem Biol, Kanpur 208016, Uttar Pradesh, India.
RP Gowda, LR (reprint author), Cent Food Technol Res Inst, CSIR, Dept Prot Chem & Technol, Mysore 570020, Karnataka, India.
EM lrgowda2k11@gmail.com
FU Council of Scientific and Industrial Research (CSIR), New Delhi, India;
   MHRD IIT, Kanpur [MLP-0087]
FX We are grateful to Director, CSIR-Central Food Technological Research
   Institute (CFTRI), Mysore for his support and encouragement. We
   acknowledge the help of (1) K.S. Rakesh and Susheelendra Vaidys, Waters
   India Pvt. Ltd, Bangalore, India, for technical assistance in ESI-MS MS
   and (2) Dr. Ravikumar Muttineni, Schrodinger, Bangalore for help in
   modelling. BP acknowledges Ministry of Human Resources and Development,
   India, for establishing a 'Center of Excellence for Chemical Biology' at
   IIT Kanpur. VK is the recipient of a Senior Research Fellowship from
   Council of Scientific and Industrial Research (CSIR), New Delhi, India.
   SM and NV. acknowledge financial support from MHRD & IIT, Kanpur This
   work was carried out under the institutional project MLP-0087.
CR Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106
   Li ZM, 2013, J BIOL CHEM, V288, P31447, DOI 10.1074/jbc.M113.467753
   RICHARDSON M, 1977, PHYTOCHEMISTRY, V16, P159, DOI 10.1016/S0031-9422(00)86777-1
   Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   McBride JD, 2001, CURR MED CHEM, V8, P909
   Kumar P, 2004, J BIOL CHEM, V279, P30425, DOI 10.1074/jbc.M402972200
   KAKADE ML, 1969, CEREAL CHEM, V46, P518
   De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023
   Koiwa H, 1997, TRENDS PLANT SCI, V2, P379, DOI 10.1016/S1360-1385(97)90052-2
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y
   Barbosa JARG, 2007, BIOPHYS J, V92, P1638, DOI 10.1529/biophysj.106.090555
   Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036
   Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102
   Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845
   Prakash B, 1996, J MOL EVOL, V42, P560, DOI 10.1007/BF02352286
   LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113
   DIXON M, 1953, BIOCHEM J, V55, P170
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D
   Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9
   WU C, 1990, J AGR FOOD CHEM, V38, P1523, DOI 10.1021/jf00097a021
   Mosolov VV, 2005, APPL BIOCHEM MICRO+, V41, P227, DOI 10.1007/s10438-005-0040-6
   BERGERON D, 1993, J AGR FOOD CHEM, V41, P1544, DOI 10.1021/jf00034a003
   BIRK Y, 1985, INT J PEPT PROT RES, V25, P113
   Cetinbas N, 2013, J BIOL CHEM, V288, P27940, DOI 10.1074/jbc.M113.475301
   Eswar N, 2006, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0506S15
   GODBOLE SA, 1994, J SCI FOOD AGR, V64, P87, DOI 10.1002/jsfa.2740640113
   Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107
   Kennedy AR, 1998, AM J CLIN NUTR, V68, p1406S
   Kumar P, 2002, PHYTOCHEMISTRY, V60, P581, DOI 10.1016/S0031-9422(02)00178-4
   Kumar V, 2013, ARCH BIOCHEM BIOPHYS, V537, P49, DOI 10.1016/j.abb.2013.06.002
   Kumar V, 2013, PROTEIN EXPRES PURIF, V89, P16, DOI 10.1016/j.pep.2013.02.002
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lawrence Paulraj K., 2002, Electron. J. Biotechnol., V5, P5
   Losso JN, 2008, CRIT REV FOOD SCI, V48, P94, DOI 10.1080/10408390601177589
   Malkowicz SB, 2001, PROSTATE, V48, P16
   Muricken DG, 2010, BBA-PROTEINS PROTEOM, V1804, P1413, DOI 10.1016/j.bbapap.2010.02.012
   ODANI S, 1978, J BIOCHEM-TOKYO, V83, P737
   Reeck G. R., 1997, ADV INSECT CONTROL R, P157
   SEIDL DS, 1972, J BIOL CHEM, V247, P3533
   de la Sierra IL, 1999, J MOL BIOL, V285, P1195
   Silva LP, 2005, PROTEINS, V61, P642, DOI 10.1002/prot.20646
   Sreerama YN, 1997, J FOOD BIOCHEM, V21, P461, DOI 10.1111/j.1745-4514.1997.tb00200.x
   TERADA S, 1994, BIOSCI BIOTECH BIOCH, V58, P371
   Tiffin P, 2001, MOL BIOL EVOL, V18, P2092
   TSUNOGAE Y, 1986, J BIOCHEM-TOKYO, V100, P243
   VENTURA MM, 1984, AN ACAD BRAS CIENC, V56, P217
   Yang H, 2013, FEBS LETT, V587, P1610, DOI 10.1016/j.febslet.2013.04.009
NR 52
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 15
EP 25
DI 10.1016/j.abb.2014.12.011
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000003
PM 25527163
ER

PT J
AU Ishii, M
   Maeda, A
   Tani, S
   Akagawa, M
AF Ishii, Megumi
   Maeda, Ayumi
   Tani, Shuji
   Akagawa, Mitsugu
TI Palmitate induces insulin resistance in human HepG2 hepatocytes by
   enhancing ubiquitination and proteasomal degradation of key insulin
   signaling molecules
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Insulin resistance; Free fatty acids; Palmitate; Ubiquitin; Proteasome
ID RECEPTOR SUBSTRATE 1; FREE FATTY-ACIDS; DIABETIC KK-A(Y) MICE; C2C12
   MYOTUBES; DIETARY-FAT; GLUCOSE-PRODUCTION; PROTEIN; EXPRESSION;
   MECHANISM; OBESITY
AB Obesity-associated insulin resistance is a major pathogenesis of type 2 diabetes mellitus and is characterized by defects in insulin signaling. High concentrations of plasma free fatty acids (FFAs) are involved in the etiology of obesity-associated insulin resistance. However, the detailed mechanism by which FFAs contribute to the development of insulin resistance is not yet fully understood. We investigated the molecular basis of insulin resistance elicited by FFAs using the human hepatocyte cell line HepG2. Among major human FFAs, palmitate markedly inhibited insulin-stimulated phosphorylation of key insulin signaling molecules such as insulin receptor, insulin receptor substrate-1, and Akt, indicating that palmitate is the principal inducer of insulin resistance. We revealed that palmitate facilitates ubiquitination of the key insulin signaling molecules, and subsequently elicits their proteasomal degradation. Furthermore, we demonstrated that inhibition of ubiquitination by the ubiquitin-activating enzyme El inhibitor PYR41 significantly prevents palmitate-inducible insulin resistance but not by the proteasome inhibitor MG132, implying that ubiquitinated signaling molecules may be dysfunctional. In conclusion, inhibition of ubiquitination of the key insulin signaling molecules may be a potential strategy for preventing and treating obesity-associated insulin resistance. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Ishii, Megumi; Maeda, Ayumi; Tani, Shuji; Akagawa, Mitsugu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Dept Biol Chem, Sakai, Osaka 5998531, Japan.
   [Maeda, Ayumi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan.
RP Akagawa, M (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Dept Biol Chem,Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.
EM akagawa@biochem.osakafu-u.ac.jp
RI Tani, Shuji/E-2309-2011
FU Kieikai Research Foundation; JSPS KAKENHI [22780124]
FX This work was supported by a Grant from Kieikai Research Foundation (to
   M.A.) and in part by JSPS KAKENHI Grant Number 22780124 (to M.A.).
CR Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x
   Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63
   Schinner S, 2005, DIABETIC MED, V22, P674, DOI 10.1111/j.1464-5491.2005.01566.x
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007
   Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09
   Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006
   Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808
   Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568
   Takada M, 2012, BIOCHEM BIOPH RES CO, V428, P315, DOI 10.1016/j.bbrc.2012.10.055
   Boden G, 2001, DIABETES, V50, P810, DOI 10.2337/diabetes.50.4.810
   Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351
   Liu JF, 2011, PHYTOTHER RES, V25, P588, DOI 10.1002/ptr.3305
   Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974
   Dasgupta S, 2011, BBA-MOL BASIS DIS, V1812, P495, DOI 10.1016/j.bbadis.2011.01.001
   Rieser E, 2013, TRENDS BIOCHEM SCI, V38, P94, DOI 10.1016/j.tibs.2012.11.007
   Rondinone CM, 1997, P NATL ACAD SCI USA, V94, P4171, DOI 10.1073/pnas.94.8.4171
   DELPRATO S, 1994, DIABETOLOGIA, V37, P1025
   Liang HY, 2013, J PHYSIOL-LONDON, V591, P2897, DOI 10.1113/jphysiol.2012.247510
   Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4
   Chevalier S, 2006, J GERONTOL A-BIOL, V61, P156
   Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478
   Ou HY, 2012, ENDOCRINOLOGY, V153, P2974, DOI 10.1210/en.2011-2043
   SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060
   Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017
   Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200
   Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694
   Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834
   Leng SH, 2010, J ENDOCRINOL, V206, P171, DOI 10.1677/JOE-09-0456
   Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254
   Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002
   Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200
   Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2
   Maeda A, 2014, MOL NUTR FOOD RES, V58, P1177, DOI 10.1002/mnfr.201300675
   Pupim LB, 2005, KIDNEY INT, V68, P1857, DOI 10.1111/j.1523-1755.2005.00605.x
   Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9
   GOUGEON R, 1994, DIABETES, V43, P318, DOI 10.2337/diabetes.43.2.318
   Bhattacharya S, 2007, J BIOSCIENCES, V32, P405, DOI 10.1007/s12038-007-0038-8
   Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x
   Araya J, 2002, AM J PHYSIOL-LUNG C, V283, pL849, DOI 10.1152/ajplung.00422.2001
   Bonala S, 2014, J BIOL CHEM, V289, P7654, DOI 10.1074/jbc.M113.529925
   Chevalier S, 2006, DIABETES, V55, P675, DOI 10.2337/diabetes.55.03.06.db05-1117
   Choukem SP, 2008, DIABETES METAB, V34, P664, DOI 10.1016/S1262-3636(08)74602-0
   Galgani JE, 2008, BRIT J NUTR, V100, P471, DOI 10.1017/S0007114508894408
   Koopmans SJ, 1997, DIABETES, V46, P1572, DOI 10.2337/diabetes.46.10.1572
   Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000
   McGarry JD, 2001, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7
   Medina EA, 2005, ENDOCRINOLOGY, V146, P2726, DOI 10.1210/en.2004-1074
   MohammadTaghvaei N, 2012, CELL SIGNAL, V24, P1964, DOI 10.1016/j.cellsig.2012.04.019
   MohammadTaghvaei N, 2011, INFLAMMATION, V34, P43, DOI 10.1007/s10753-010-9206-3
   Parvaneh L, 2010, BIOCHEM BIOPH RES CO, V396, P467, DOI 10.1016/j.bbrc.2010.04.118
   Scheufele F, 2014, CELL SIGNAL, V26, P233, DOI 10.1016/j.cellsig.2013.11.005
   Seely B.L., 1994, INSULIN RESISTANCE, P187
   Yang M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-104
   Yi JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3354
   Zhande R, 2006, J BIOL CHEM, V281, P39071, DOI 10.1074/jbc.M605251200
NR 56
TC 4
Z9 4
U1 4
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 26
EP 35
DI 10.1016/j.abb.2014.12.009
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000004
PM 25527164
ER

PT J
AU Yamamoto, K
   Higashiura, A
   Hossain, MT
   Yamada, N
   Shiotsuki, T
   Nakagawa, A
AF Yamamoto, Kohji
   Higashiura, Akifumi
   Hossain, Md Tofazzal
   Yamada, Naotaka
   Shiotsuki, Takahiro
   Nakagawa, Atsushi
TI Structural characterization of the catalytic site of a Nilaparvata
   lugens delta-class glutathione transferase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Crystal structure; Glutathione; Glutathione transferase; Nilaparvata
   lugens; Site-directed mutagenesis
ID S-TRANSFERASE; MACROMOLECULAR STRUCTURES; BROWN PLANTHOPPER;
   ACTIVE-SITE; EXPRESSION; RESISTANCE; MECHANISM; EVOLUTION; SILKWORM;
   RESIDUES
AB Glutathione transferases (GSTs) are a major class of detoxification enzymes that play a central role in the defense against environmental toxicants and oxidative stress. Here, we studied the crystal structure of a delta-class glutathione transferase from Nilaparvata lugens, nlGSTD, to gain insights into its catalytic mechanism. The structure of nlGSTD in complex with glutathione, determined at a resolution of 1.7 A, revealed that it exists as a dimer and its secondary and tertiary structures are similar to those of other delta-class GSTs. Analysis of a complex between nIGSTD and glutathione showed that the bound glutathione was localized to the glutathione-binding site. Site-directed mutagenesis of nlGSTD mutants indicated that amino acid residues Ser11, His52, Glu66, and Phe119 contribute to catalytic activity. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Yamamoto, Kohji; Hossain, Md Tofazzal; Yamada, Naotaka] Kyushu Univ, Grad Sch, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan.
   [Higashiura, Akifumi; Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan.
   [Shiotsuki, Takahiro] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan.
RP Yamamoto, K (reprint author), Kyushu Univ, Grad Sch, Fac Agr, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.
EM yamamok@agr.kyushu-u.ac.jp
FU Ministry of Education, Science, Sports and Culture of Japan; Research
   Grant for Young Investigators of Faculty of Agriculture, Kyushu
   University
FX This work was supported in part by a Grant-in-Aid for Scientific
   Research from the Ministry of Education, Science, Sports and Culture of
   Japan, and a Research Grant for Young Investigators of Faculty of
   Agriculture, Kyushu University. This work was performed under the
   auspices of the Cooperative Research Program of Institute for Protein
   Research, Osaka University. The synchrotron radiation experiments were
   carried out at the BL44XU of SPring-8 with the approval of the Japan
   Synchrotron Radiation Research Institute (JASRI) (Proposal Nos.
   2013A6862 and 201386862).
CR Yamamoto K, 2005, COMP BIOCHEM PHYS B, V141, P340, DOI 10.1016/j.cpbc.2005.04.012
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Wongsantichon J, 2006, BIOCHEM J, V394, P135, DOI 10.1042/BJ20050915
   Miyazaki N, 2008, J VIROL, V82, P11344, DOI 10.1128/JVI.02375-07
   LISTOWSKY I, 1988, DRUG METAB REV, V19, P305, DOI 10.3109/03602538808994138
   Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x
   Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005
   Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/0264-6021:3620329
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3
   Chen BY, 2011, J MOL BIOL, V412, P204, DOI 10.1016/j.jmb.2011.07.019
   Hossain MDT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097740
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kakuta Y., 1810, BIOCHIM BIOPHYS ACTA, V2011, P1355
   Lerksuthirat T, 2008, ARCH BIOCHEM BIOPHYS, V479, P97, DOI 10.1016/j.abb.2008.08.006
   Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477
   Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117
   Otwinowski Z., 1997, ENZYMOLOGY, V276, P307
   Satoh K, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00313
   Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x
   Tu CPD, 2005, METHOD ENZYMOL, V401, P204, DOI 10.1016/S0076-6879(05)01013-X
   Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780
   Vararattanavech A, 2006, BIOCHEM J, V393, P89, DOI 10.1042/BJ20050555
   Winayanuwattikun P, 2005, J BIOL CHEM, V280, P31776, DOI 10.1074/jbc.M502612200
   Winayanuwattikun P, 2007, BIOCHEM J, V402, P339, DOI 10.1042/BJ20061253
   Wongsantichon J, 2010, BIOCHEM J, V428, P25, DOI 10.1042/BJ20091939
   Yamamoto K., 1830, BIOCHIM BIOPHYS ACTA, V2013, P3711
   Yamamoto K, 2009, COMP BIOCHEM PHYS C, V149, P461, DOI 10.1016/j.cbpc.2008.10.108
   Yamamoto K., 1820, BIOCHIM BIOPHYS ACTA, V2012, P1469
   Zhou HN, 2012, J MOL BIOL, V420, P190, DOI 10.1016/j.jmb.2012.04.014
NR 34
TC 0
Z9 0
U1 8
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 36
EP 42
DI 10.1016/j.abb.2014.12.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000005
PM 25497345
ER

PT J
AU Kitagawa, M
   Shiozaki, A
   Ichikawa, D
   Nakashima, S
   Kosuga, T
   Konishi, H
   Komatsu, S
   Fujiwara, H
   Okamoto, K
   Otsuji, E
AF Kitagawa, Maki
   Shiozaki, Atsushi
   Ichikawa, Daisuke
   Nakashima, Shingo
   Kosuga, Toshiyuki
   Konishi, Hirotaka
   Komatsu, Shuhei
   Fujiwara, Hitoshi
   Okamoto, Kazuma
   Otsuji, Eigo
TI Tumor necrosis factor-alpha-induced apoptosis of gastric cancer MKN28
   cells: Accelerated degradation of the inhibitor of apoptosis family
   members
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Apoptosis; Gastric cancer; Inhibitor of apoptosis; Tumor necrosis
   factor-alpha
ID CASPASE-8 ACTIVATION; DEPENDENT APOPTOSIS; SURVIVIN; RECEPTOR; IAPS;
   INDUCTION; TARGET; C-IAP2; DEATH
AB The role of the inhibitor of apoptosis (IAP) family members in tumor necrosis factor-alpha (TNF-alpha)-induced apoptosis of human gastric cancer MKN28 cells was explored. TNF-alpha induced up-regulation of clAP2, whereas cycloheximide (CHX) induced down-regulation of XIAP and survivin. Degradation of cIAP1 and XIAP, but not survivin, was accelerated by co-treatment of cells with TNF-alpha and CHX, and TNF-alpha-induced up-regulation of clAP2 was inhibited by BMS-345541 (NF-kappa B inhibitor). Treatment of MKN28 cells with TNF-alpha plus CHX induced degradation of survivin and activation of caspase-8 and -3, followed by degradation of cIAP1 and XIAP and apoptosis. Proteasome inhibitors (MG132 and epoxomicin) suppressed TNF-alpha plus CHX-induced degradation of survivin, clAP1, and XIAP as well as apoptosis. A caspase inhibitor (z-VAD-fmk) suppressed TNF-alpha plus CHX-induced apoptosis, but allowed degradation of survivin, cIAP1 and XIAP. TNF-alpha receptor 1 and 2 were expressed on MKN28 cells. The magnitude of apoptosis induced by TNF-alpha plus BMS-345541 was much less than that induced by TNF-alpha plus CHX. These findings suggest that TNF-alpha plus CHX-induced apoptosis of gastric cancer MKN28 cells may be caused by accelerated degradation of the IAP family members (survivin, cIAP1, and XIAP), in addition to inhibition of NF-kappa B-dependent synthesis of anti-apoptotic molecules. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kitagawa, Maki; Shiozaki, Atsushi; Ichikawa, Daisuke; Nakashima, Shingo; Kosuga, Toshiyuki; Konishi, Hirotaka; Komatsu, Shuhei; Fujiwara, Hitoshi; Okamoto, Kazuma; Otsuji, Eigo] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kamigyo Ku, Kyoto 6028566, Japan.
RP Kitagawa, M (reprint author), Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kamigyo Ku, Kajii Cho, Kyoto 6028566, Japan.
EM icam-s@koto.kpu-m.ac.jp; shiozaki@koto.kpu-m.ac.jp
FU Japan Society of the Promotion of Science [25-3299]
FX This work was supported by Grants-in-Aid from Japan Society of the
   Promotion of Science (25-3299 to M. Kitagawa).
CR Darding M, 2012, CELL DEATH DIFFER, V19, P58, DOI 10.1038/cdd.2011.163
   Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030
   Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200
   Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X
   Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037
   Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001
   Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057
   Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680
   Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4
   Liu ZH, 2000, NATURE, V408, P1004
   Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537
   Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036
   Nachmias B, 2004, SEMIN CANCER BIOL, V14, P231, DOI 10.1016/j.semcancer.2004.04.002
   Faustman DL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00478
   Hasegawa T, 2003, BLOOD, V101, P1164, DOI 10.1182/blood-2002-05-1505
   Hinnis AR, 2007, BRIT J CANCER, V96, P639, DOI 10.1038/sj.bjc.6603616
   Kelly RJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-35
   Kitagawa M, 2013, ARCH BIOCHEM BIOPHYS, V539, P92, DOI 10.1016/j.abb.2013.06.014
   Tanimura Y, 2005, CANCER LETT, V219, P205, DOI 10.1016/j.canlet.2004.07.027
NR 19
TC 0
Z9 1
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 43
EP 48
DI 10.1016/j.abb.2014.12.003
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000006
PM 25513960
ER

PT J
AU Xiao, X
   Huang, CQ
   Zhao, CL
   Gou, XX
   Senavirathna, LK
   Hinsdale, M
   Lloyd, P
   Liu, L
AF Xiao, Xiao
   Huang, Chaoqun
   Zhao, Chunling
   Gou, Xuxu
   Senavirathna, Lakmini K.
   Hinsdale, Myron
   Lloyd, Pamela
   Liu, Lin
TI Regulation of myofibroblast differentiation by miR-424 during
   epithelial-to-mesenchymal transition
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Epithelial-to-mesenchymal transition; Idiopathic pulmonary fibrosis;
   miR-424; TGF-beta; Smurf2; Myofibroblast differentiation
ID IDIOPATHIC PULMONARY-FIBROSIS; MUSCLE ACTIN EXPRESSION; E3 UBIQUITIN
   LIGASE; TGF-BETA; GROWTH-FACTOR; LATENT TGF-BETA-1; TUMOR PROGRESSION;
   LUNG FIBROSIS; ALPHA-ACTIN; RAT LUNG
AB Idiopathic pulmonary fibrosis (IPF) is one of the most common and severe interstitial lung diseases. Epithelial-to-mesenchymal transition (EMT) is a process whereby epithelial cells undergo transition to a mesenchymal phenotype. This process has been shown to contribute to IPF. MicroRNAs (miRNAs) are small non-coding RNAs of 18-24 nucleotides in length which regulate gene expression. Several studies have implicated miRNAs in EMT; however, specific miRNAs that regulate EMT in IPF have not yet been identified. In this study, we identified 6 up-regulated and 3 down-regulated miRNAs in a human lung epithelial cell EMT model using miRNA microarray and real-time PCR. Overexpression of one of these upregulated miRNAs, miR-424, increased the expression of a-smooth muscle actin, an indicator of myofibroblast differentiation, but had no effects on the epithelial or mesenchymal cell markers. miR-424 enhanced the activity of the TGF-beta signaling pathway, as demonstrated by a luciferase reporter assay. Further experiments showed that miR-424 decreased the protein expression of Smurf2, a negative regulator of TGF-beta signaling, indicating that miR-424 exerts a forward regulatory loop in the TGF-beta signaling pathway. Our results suggest that miR-424 regulates the myofibroblast differentiation during EMT by potentiating the TGF-beta signaling pathway, likely through Smurf2. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Xiao, Xiao; Huang, Chaoqun; Zhao, Chunling; Gou, Xuxu; Senavirathna, Lakmini K.; Hinsdale, Myron; Lloyd, Pamela; Liu, Lin] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.
   [Zhao, Chunling] Luzhou Med Coll, Dept Physiol, Luzhou, Sichuan, Peoples R China.
RP Liu, L (reprint author), Oklahoma State Univ, Ctr Vet Hlth Sci, 264 McElroy Hall, Stillwater, OK 74078 USA.
EM lin.liu@okstate.edu
FU National Heart, Lung, and Blood Institute [R01 HL116876, R03 HL-95383];
   National Institute of General Medical Sciences [P20GM103648]; Oklahoma
   Center for Adult Stem Cell Research; American Heart Association
   [12PRE12060188]
FX This work was supported by the National Heart, Lung, and Blood Institute
   under Award Number R01 HL116876 and R03 HL-95383 (to L.L.), and the
   National Institute of General Medical Sciences under Award number
   P20GM103648 (Molecular Biology Core) and grants from Oklahoma Center for
   Adult Stem Cell Research (to L.L., M.H. and P.L.). The content is solely
   the responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. X.X. was supported
   by a pre-doctoral fellowship from the American Heart Association
   (12PRE12060188).
CR Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9
   Pandit KV, 2011, TRANSL RES, V157, P191, DOI 10.1016/j.trsl.2011.01.012
   Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753
   Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997
   Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC
   Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822
   Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Baumgartner KB, 1997, AM J RESP CRIT CARE, V155, P242
   Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722
   Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035
   Hinz B, 2001, MOL BIOL CELL, V12, P2730
   Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x
   Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170
   Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705
   Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC
   Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347
   Cogan JG, 2002, J BIOL CHEM, V277, P36433, DOI 10.1074/jbc.M203232200
   Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.55.091902.103810
   Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.813257.26
   Sun W, 2010, ANNU REV BIOMED ENG, V12, P1, DOI 10.1146/annurev-bioeng-070909-105314
   Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058
   Yao HW, 2004, LIFE SCI, V76, P29, DOI 10.1016/j.lfs.2004.06.019
   Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011
   Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530
   Hodgson U, 2006, AM J HUM GENET, V79, P149, DOI 10.1086/504639
   Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794
   Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835
   Hubbard R, 1996, LANCET, V347, P284, DOI 10.1016/S0140-6736(96)90465-1
   Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907
   Yang SZ, 2012, AM J PATHOL, V180, P484, DOI 10.1016/j.ajpath.2011.10.005
   Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC
   Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103
   Yang SZ, 2012, FASEB J, V26, P3790, DOI 10.1096/fj.11-202366
   Selman M, 2001, ANN INTERN MED, V134, P136
   Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613
   Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131
   Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393
   Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487
   Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200
   Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225
   Duffy HS, 2011, J CARDIOVASC PHARM, V57, P373, DOI 10.1097/FJC.0b013e3182155a38
   Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC
   Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6
   Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505
   Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018
   Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974
   WAKEFIELD LM, 1995, CLIN CANCER RES, V1, P129
   Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   Araya J, 2010, ANNU REV PATHOL-MECH, V5, P77, DOI 10.1146/annurev.pathol.4.110807.092217
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518
   Banyard J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03151
   Chen ZM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-47
   Chen ZM, 2005, PHYSIOL GENOMICS, V21, P284, DOI 10.1152/physiolgenomics.00236.2004
   Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010
   Cushing L., 2010, AM J RESP CELL MOL B, V45, P287
   Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200
   Hu B, 2007, J PATHOL, V211, P455, DOI 10.1002/path.2119
   Kis K, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001967
   Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152
   Marmai C., 2011, AM J PHYSIOL-LUNG C, V301, P71
   Miyazono K, 2000, J CELL SCI, V113, P1101
   Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0
   Nakao A, 1997, NATURE, V389, P631
   Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718
   Ramirez AM, 2006, AM J TRANSPLANT, V6, P2080, DOI 10.1111/j.1600-6143.2006.01430.x
   Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660
   Wang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-29
   Warner DR, 2005, FEBS LETT, V579, P3539, DOI 10.1016/j.febslet.2005.05.024
   Weng TT, 2012, BIOCHEM BIOPH RES CO, V422, P586, DOI 10.1016/j.bbrc.2012.05.030
   Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007
   Xu YD, 2003, AM J PHYSIOL-LUNG C, V285, pL527, DOI 10.1152/ajplung.00298.2002
NR 77
TC 2
Z9 2
U1 3
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 49
EP 57
DI 10.1016/j.abb.2014.12.007
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000007
PM 25524739
ER

PT J
AU Ghorbani, A
   Jeddi-Tehrani, M
   Saidpour, A
   Safa, M
   Bayat, AA
   Zand, H
AF Ghorbani, Arman
   Jeddi-Tehrani, Mahmood
   Saidpour, Atoosa
   Safa, Majid
   Bayat, Ahmad Ali
   Zand, Hamid
TI PI3K/AKT and Mdm2 activation are associated with inhibitory effect of
   cAMP increasing agents on DNA damage-induced cell death in human pre-B
   NALM-6 cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE DNA damage response (DDR); Cyclic adenosine monophosphate (cAMP); AKT
   (PKB); Mdm2; p53; NF-kappa B
ID NF-KAPPA-B; PROTEIN-KINASE B; SIGNALING PATHWAYS; HUMAN CANCER;
   CROSS-TALK; AKT; P53; APOPTOSIS; SURVIVAL; EXPRESSION
AB DNA damage response (DDR) consists of both proapoptotic and prosurvival signaling branches. Superiority of each signaling branch determines the outcome of DNA damage: death or allowing the repair. The present authors have previously shown that an increased intracellular level of cAMP disrupts p53-mediated apoptosis in human pre-B NALM-6 cells and inhibition of NF-kappa B prevents prosurvival effect of cAMP during DNA damage. AKT/PKB (protein kinase B) is a general mediator of survival signaling. ART signaling inhibits p53-mediated transcription and apoptosis. The results of present study showed that cAMP disrupted DNA damage/p53-mediated apoptosis through AKT and subsequent NF-kappa B activation. These results suggested that AKT may be found as part of a complex with scaffolding proteins, beta-arrestins and PDE4D. cAMP disarticulated the complex through binding to PDE4D compartment. It seems that release of ART protein potentiated DDR activated pro-survival AKT in NALM-6 cells. Taken together, the present data indicated that regulation of AKT signaling may determine the fate of cells exposed to genotoxic stress. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Saidpour, Atoosa; Zand, Hamid] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Tehran, Iran.
   [Jeddi-Tehrani, Mahmood; Bayat, Ahmad Ali] ACECR, Avicenna Res Inst, Monoclonal Antibody Res Ctr, Tehran, Iran.
   [Ghorbani, Arman] Univ Tehran Med Sci, Dept Cellular & Mol Nutr, Fac Nutr & Diet Therapy, Tehran, Iran.
   [Safa, Majid] Iran Univ Med Sci, Fac Allied Med, Cellular & Mol Res Ctr, Dept Hematol, Tehran, Iran.
RP Zand, H (reprint author), Shahid Beheshti Univ Med Sci, Dept Basic Med Sci, Fac Nutr Sci & Food Technol, Natl Nutr & Food Technol Res Inst, POB 19395-4741, Tehran, Iran.
EM hamid_zand@sbmu.ac.ir
FU Avicenna Research Institute (Tehran, Iran)
FX Authors would like to express their gratitude to Avicenna Research
   Institute (Tehran, Iran) for supporting this study.
CR Bjorgo E, 2010, MOL CELL BIOL, V30, P1660, DOI 10.1128/MCB.00696-09
   SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363
   Safa M, 2010, APOPTOSIS, V15, P196, DOI 10.1007/s10495-009-0417-8
   Kim HW, 2010, MOL CELL BIOL, V30, P5406, DOI 10.1128/MCB.00217-10
   Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085
   Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200
   Safa M, 2010, FEBS LETT, V584, P3492, DOI 10.1016/j.febslet.2010.07.009
   Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010
   Gustin JA, 2004, J BIOL CHEM, V279, P1615, DOI 10.1074/jbc.M306976200
   Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911
   Brognard J, 2001, CANCER RES, V61, P3986
   Sun ZJ, 2010, APOPTOSIS, V15, P850, DOI 10.1007/s10495-010-0497-5
   Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185
   Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140
   Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj/onc/1205181
   Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x
   Naderi EH, 2009, BLOOD, V114, P608, DOI 10.1182/blood-2009-02-204883
   SCUDIERO DA, 1988, CANCER RES, V48, P4827
   Khalil A, 2011, CELL CYCLE, V10, P481, DOI 10.4161/cc.10.3.14713
   Factor V, 2001, HEPATOLOGY, V34, P32, DOI 10.1053/jhep.2001.25270
   Alessi DR, 1996, EMBO J, V15, P6541
   Zhuang JG, 2010, HAEMATOL-HEMATOL J, V95, P110, DOI 10.3324/haematol.2009.010272
   Barki-Harrington L, 2008, PHYSIOLOGY, V23, P17, DOI 10.1152/physiol.00042.2007
   Bers DM, 2007, J PHYSIOL-LONDON, V583, P415, DOI 10.1113/jphysiol.2007.140764
   Butch ER, 1996, J BIOL CHEM, V271, P4230
   Calvin HI, 2003, CURR EYE RES, V27, P269
   Kloster MM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-45
   Lerner A, 2000, LEUKEMIA LYMPHOMA, V37, P39, DOI 10.3109/10428190009057627
   Li Min, 2008, Zhonghua Xue Ye Xue Za Zhi, V29, P289
   Miles PD, 2007, AM J PHYSIOL-ENDOC M, V293, pE70, DOI 10.1152/ajpendo.00259.2006
   Sandnes D, 1996, PHARMACOL TOXICOL, V79, P15
   Shen Quan, 2005, Zhonghua Xue Ye Xue Za Zhi, V26, P493
   Surucu B, 2008, J BIOL CHEM, V283, P30025, DOI 10.1074/jbc.M803053200
   Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184
   Weston VJ, 2004, BLOOD, V104, P1465, DOI 10.1182/blood-2003-11-4039
   Zhou J, 2013, EXP CLIN CARDIOL, V18, pE95
NR 36
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 58
EP 66
DI 10.1016/j.abb.2014.11.010
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000008
PM 25524737
ER

PT J
AU Diaz-Vasquez, WA
   Abarca-Lagunas, MJ
   Cornejo, FA
   Pinto, CA
   Arenas, FA
   Vasquez, CC
AF Diaz-Vasquez, Waldo A.
   Abarca-Lagunas, Maria J.
   Cornejo, Fabian A.
   Pinto, Camilo A.
   Arenas, Felipe A.
   Vasquez, Claudio C.
TI Tellurite-mediated damage to the Escherichia coli NDH-dehydrogenases and
   terminal oxidases in aerobic conditions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE E. coli; NADH; Enzyme inactivation; Bacterial metabolism; Membrane
   protein; Tellurite; NADH:ubiquinone oxidoreductase I; Terminal oxidase;
   Electron transport chain; Oxidative damage
ID NADH-UBIQUINONE OXIDOREDUCTASE; IRON-SULFUR CLUSTERS; HYDROGEN-PEROXIDE
   FORMATION; COMPLEX-I; OXIDATIVE STRESS; REDUCTASE-ACTIVITY;
   RESPIRATORY-CHAIN; SUCCINATE-DEHYDROGENASE; RHODOBACTER-CAPSULATUS;
   POTASSIUM TELLURITE
AB Escherichia coli exposed to tellurite shows augmented membrane lipid peroxidation and ROS content. Also, reduced thiols, protein carbonylation, [Fe-S] center dismantling, and accumulation of key metabolites occur in these bacteria. In spite of this, not much is known about tellurite effects on the E. coli electron transport chain (ETC).
   In this work, tellurite-mediated damage to the E. coli ETC's NADH dehydrogenases and terminal oxidases was assessed. Mutant lacking ETC components showed delayed growth, decreased oxygen consumption and increased ROS in the presence of the toxicant.
   Membranes from tellurite-exposed E. coli exhibited decreased oxygen consumption and dNADH/NADH dehydrogenase activity, showing an impairment of NDH-I but not of NDH-II activity. Regarding terminal oxidases, only the bo oxidase complex was affected by tellurite. When assaying NDH-I and NDH-II activity in the presence of superoxide, the NDH-I complex was preferentially damaged. The activity was partly restored in the presence of reducing agents, sulfide and Fe2+ under anaerobic conditions, suggesting that damage affects NDH-I [4Fe-4S] centers.
   Finally, augmented membrane protein oxidation along with reduced oxidase activity was observed in the presence of the toxicant. Also, the increased expression of genes encoding alternative terminal oxidases probably reflects a cell's change towards anaerobic respiration when facing tellurite. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Diaz-Vasquez, Waldo A.; Abarca-Lagunas, Maria J.; Cornejo, Fabian A.; Pinto, Camilo A.; Arenas, Felipe A.; Vasquez, Claudio C.] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile.
   [Diaz-Vasquez, Waldo A.] Univ San Sebastian, Fac Ciencia, Santiago, Chile.
RP Vasquez, CC (reprint author), Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Mol Microbiol Lab, Casilla 40,Correo 33, Santiago, Chile.
EM claudio.vasquez@usach.cl
FU FONDECYT (Fondo Nacional de Ciencia y Tecnologia) [1130362, 1090097];
   DICYT (Direccion de Investigacion en Ciencia y Tecnologia, Universidad
   de Santiago de Chile); CONICYT (Comision Nacional de Ciencia y
   Tecnologia) [24121087]
FX The authors thank Dr. J.A. Imlay for providing some of the
   microorganisms detailed in Table S1 and critical reading of the
   manuscript. This work received financial support from FONDECYT (Fondo
   Nacional de Ciencia y Tecnologia) grants 1130362 and 1090097 and DICYT
   (Direccion de Investigacion en Ciencia y Tecnologia, Universidad de
   Santiago de Chile) (CCV). A doctoral fellowship and Grant # 24121087
   from CONICYT (Comision Nacional de Ciencia y Tecnologia) to WAD-V is
   also acknowledged.
CR Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Borsetti F, 2005, RES MICROBIOL, V156, P807, DOI 10.1016/j.resmic.2005.03.011
   Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200
   Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938
   Tremaroli V, 2009, APPL ENVIRON MICROB, V75, P719, DOI 10.1128/AEM.01771-08
   Lindqvist A, 2000, ANTON LEEUW INT J G, V78, P23, DOI 10.1023/A:1002779201379
   WALL D, 1992, J BACTERIOL, V174, P6554
   Pradenas GA, 2012, MICROBIOL-SGM, V158, P1279, DOI 10.1099/mic.0.056903-0
   GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587
   Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002
   Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7
   Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066
   Pradenas GA, 2013, BIOMED RES INT, DOI 10.1155/2013/563756
   Avazeri C, 1997, MICROBIOL-SGM, V143, P1181
   Refsgaard HHF, 2000, P NATL ACAD SCI USA, V97, P611, DOI 10.1073/pnas.97.2.611
   Flemming D, 2006, J BIOL CHEM, V281, P24781, DOI 10.1074/jbc.M602499200
   Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144
   Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200
   Chasteen TG, 2003, CHEM REV, V103, P1, DOI 10.1021/cr010210+
   Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016
   Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x
   Borsetti F, 2003, FEBS LETT, V554, P315, DOI 10.1016/S0014-5793(03)01180-3
   Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055
   Seaver LC, 2004, J BIOL CHEM, V279, P48742, DOI 10.1074/jbc.M408754200
   Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119
   Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2005.05028.x
   Hellwig P, 2000, BIOCHEMISTRY-US, V39, P10884, DOI 10.1021/bi000842a
   DASSA J, 1991, MOL GEN GENET, V229, P341, DOI 10.1007/BF00267454
   Cabiscol Elisa, 2000, International Microbiology, V3, P3
   Calderon IL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000070
   Calderon IL, 2009, MICROBIOL-SGM, V155, P1840, DOI 10.1099/mic.0.026260-0
   Castro ME, 2009, BIOCHEM BIOPH RES CO, V380, P148, DOI 10.1016/j.bbrc.2009.01.078
   Castro ME, 2008, BIOCHEM BIOPH RES CO, V375, P91, DOI 10.1016/j.bbrc.2008.07.119
   Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9
   Contreras ND, 2010, ARCH MICROBIOL, V192, P969, DOI 10.1007/s00203-010-0624-2
   Diaz-Vasquez WA, 2014, BIOMETALS, V27, P237, DOI 10.1007/s10534-013-9701-8
   Elias AO, 2012, MICROBIOLOGYOPEN, V1, P259, DOI 10.1002/mbo3.26
   Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b
   Fernandes AS, 2002, J BIOENERG BIOMEMBR, V34, P413, DOI 10.1023/A:1022509907553
   Flemming D, 2003, J BIOL CHEM, V278, P47602, DOI 10.1074/jbc.M308967200
   Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3
   GENNIS RB, 1987, FEMS MICROBIOL LETT, V46, P387
   HADDOCK BA, 1977, BACTERIOL REV, V41, P47
   INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222
   LLOYDJONES G, 1994, FEMS MICROBIOL LETT, V118, P113
   Lohmeier-Vogel EM, 2004, APPL ENVIRON MICROB, V70, P7342, DOI 10.1128/AEM.70.12.7342-7347.2004
   Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979
   MATSUSHITA K, 1984, BIOCHEMISTRY-US, V23, P4703, DOI 10.1021/bi00315a028
   Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004
   Molina-Quiroz RC, 2014, RES MICROBIOL, V165, P566, DOI 10.1016/j.resmic.2014.07.003
   Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9
   Perez JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000211
   Reinoso CA, 2012, BIOCHEM BIOPH RES CO, V421, P721, DOI 10.1016/j.bbrc.2012.04.069
   Requena JR, 2003, AMINO ACIDS, V25, P221, DOI 10.1007/s00726-003-0012-1
   Sousa PMF, 2011, BIOCHIMIE, V93, P418, DOI 10.1016/j.biochi.2010.10.014
   Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2
   Tantalean JC, 2003, J BACTERIOL, V185, P5831, DOI 10.1128/JB.185.19.5831-5837.2003
   TAYLOR DE, 1988, J ULTRA MOL STRUCT R, V99, P18, DOI 10.1016/0889-1605(88)90029-8
   Tremaroli V, 2007, ARCH MICROBIOL, V187, P127, DOI 10.1007/s00203-006-0179-4
   Trutko SM, 1998, DOKL AKAD NAUK+, V358, P836
   Turner RJ, 2001, CAN J MICROBIOL, V47, P33, DOI 10.1139/cjm-47-1-33
   Turner RJ, 1999, MICROBIOL-UK, V145, P2549
   Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0
   Valdivia-Gonzalez M, 2012, BIOMETALS, V25, P451, DOI 10.1007/s10534-012-9518-x
   WEIDNER U, 1993, J MOL BIOL, V233, P109, DOI 10.1006/jmbi.1993.1488
   Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104
NR 68
TC 0
Z9 0
U1 3
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 67
EP 75
DI 10.1016/j.abb.2014.10.011
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000009
PM 25447814
ER

PT J
AU Uruno, A
   Yagishita, Y
   Yamamoto, M
AF Uruno, Akira
   Yagishita, Yoko
   Yamamoto, Masayuki
TI The Keap1-Nrf2 system and diabetes mellitus
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Nrf2; Keap1; Diabetes mellitus; Glucose metabolism; Pancreatic
   beta-cells
ID PANCREATIC BETA-CELLS; SMALL MAF PROTEINS; HIGH-FAT DIET; STIMULATED
   INSULIN-SECRETION; TRANSCRIPTION FACTOR NRF2; ELEMENT-DEPENDENT GENES;
   OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; ANTIOXIDANT RESPONSE;
   BARDOXOLONE METHYL
AB Nrf2 (NF-E2-related factor 2) plays a key role in the protection of vertebrates against environmental stress by contributing to the inducible expression of detoxification and antioxidant enzymes. Keap1 (Kelch-like ECH-associated protein 1) is a sensor for oxidative and electrophilic stresses. Keap1 also acts as an E3 ubiquitin ligase substrate-recognition subunit that specifically targets Nrf2. Keap1 causes Nrf2 to be degraded through the ubiquitin-proteasome pathway and thus ensures that Nrf2 is constitutively suppressed under unstressed conditions. Upon exposure to oxidative or electrophilic stress, Keap1 loses its ability to ubiquitinate Nrf2. Many lines of evidence have recently clarified that the Keap1-Nrf2 system also plays critical roles in the maintenance of cellular homeostasis. One of the most salient examples is the contribution of Keap1-Nrf2 to metabolic and energy-balance regulation. In particular, how the Keap1-Nrf2 system protects the body against diabetes mellitus and how perturbations in this system provoke the disease condition are now under intense investigation. This review will summarize the recent progress made in this area. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Uruno, Akira; Yagishita, Yoko; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Uruno, Akira] Tohoku Univ, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan.
RP Uruno, A (reprint author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM uruno@med.tohoku.ac.jp; masiyamamoto@med.tohoku.ac.jp
FU Ministry of Education, Science, Sports and Culture (MEXT); Create
   Revolutionary Technological Seeds for Science and Technology Innovation
   program (CREST) of the Japanese Technology Agency (JST); Japan Society
   for the Promotion of Science (JSPS) [24249015, 90396474, 26893008];
   Takeda Foundation; Naito Foundation; Japanese Foundation for Applied
   Enzymology
FX This work was supported by the Grants-in-Aids for Scientific Research on
   Innovative Areas and Scientific Research from the Ministry of Education,
   Science, Sports and Culture (MEXT) (M.Y.), the Create Revolutionary
   Technological Seeds for Science and Technology Innovation program
   (CREST) of the Japanese Technology Agency (JST) (M.Y.), Grants-in-Aids
   for Scientific Research from the Japan Society for the Promotion of
   Science (JSPS) (Grant Numbers 24249015 (M.Y.), 90396474 (A.U.) and
   26893008 (Y.Y.)), the Takeda Foundation (M.Y.), the Naito Foundation
   (M.Y.) and the Japanese Foundation for Applied Enzymology (A.U.).
CR Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589
   Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200
   Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013
   Bae EJ, 2007, HEPATOLOGY, V46, P730, DOI 10.1002/hep.21769
   Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927
   Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200
   Song MY, 2009, TOXICOL APPL PHARM, V235, P57, DOI 10.1016/j.taap.2008.11.007
   Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10
   Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   GRANKVIST K, 1981, NATURE, V294, P158, DOI 10.1038/294158a0
   Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601
   Zhang YKJ, 2012, TOXICOL APPL PHARM, V264, P305, DOI 10.1016/j.taap.2012.09.014
   GRANKVIST K, 1981, BIOCHEM J, V199, P393
   Cho HY, 2004, FASEB J, V18, P1258
   Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2
   Uruno A, 2011, NITRIC OXIDE-BIOL CH, V25, P153, DOI 10.1016/j.niox.2011.02.007
   Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248
   Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481
   IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0
   Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071
   Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584
   Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545
   Hirotsu Y, 2014, GENES CELLS, V19, P650, DOI 10.1111/gtc.12165
   Meher AK, 2012, FREE RADICAL BIO MED, V52, P1708, DOI 10.1016/j.freeradbiomed.2012.02.022
   Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955
   Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708
   RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632
   Soriano FX, 2008, J NEUROCHEM, V107, P533, DOI 10.1111/j.1471-4159.2008.05648.x
   ITOH K, 1995, MOL CELL BIOL, V15, P4184
   Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164
   Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76
   Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022
   Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002
   Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029
   Nishikawa T, 2000, NATURE, V404, P787
   Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799
   Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004
   Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392
   Bonora E, 2008, NUTR METAB CARDIOVAS, V18, P74, DOI 10.1016/j.numecd.2007.05.004
   Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169
   Fukutomi T, 2014, MOL CELL BIOL, V34, P832, DOI 10.1128/MCB.01191-13
   RUDERMAN NB, 1992, FASEB J, V6, P2905
   Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13
   Chartoumpekis DV, 2011, DIABETES, V60, P2465, DOI 10.2337/db11-0112
   Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827
   Yagishita Y, 2014, DIABETES, V63, P605, DOI 10.2337/db13-0909
   Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388
   Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5
   Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023
   Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005
   de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033
   FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258
   Xu ZH, 2014, DIABETOLOGIA, V57, P204, DOI 10.1007/s00125-013-3093-8
   Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z
   Thimmulappa RK, 2002, CANCER RES, V62, P5196
   Zheng HT, 2011, DIABETES, V60, P3055, DOI 10.2337/db11-0807
   Yoh K, 2008, GENES CELLS, V13, P1159, DOI 10.1111/j.1365-2443.2008.01234.x
   Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443
   Sugimoto H, 2010, AM J PHYSIOL-GASTR L, V298, pG283, DOI 10.1152/ajpgi.00296.2009
   Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11
   Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101
   Mukai E, 2011, DIABETES, V60, P218, DOI 10.2337/db10-0021
   Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853
   Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200
   Hayashi A, 2003, BIOCHEM BIOPH RES CO, V310, P824, DOI 10.1016/j.bbrc.2003.09.086
   Cho HY, 2002, AM J RESP CELL MOL, V26, P175
   Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x
   Yu Z, 2011, DIABETOLOGIA, V54, P922, DOI 10.1007/s00125-010-2001-8
   Yamazaki H, 2012, MOL CELL BIOL, V32, P808, DOI 10.1128/MCB.06543-11
   Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398
   Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08
   Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950
   Fujii S, 2010, J BIOL CHEM, V285, P23970, DOI 10.1074/jbc.M110.145441
   Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056
   Taguchi K, 2010, MOL CELL BIOL, V30, P3016, DOI 10.1128/MCB.01591-09
   Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246
   Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351
   Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006
   Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016
   Li WJ, 2014, FEBS LETT, V588, P2115, DOI 10.1016/j.febslet.2014.04.046
   Chartoumpekis Dionysios V, 2013, Curr Diabetes Rev, V9, P137
   Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029
   Chin M, 2013, AM J PHYSIOL-RENAL, V304, pF1438, DOI 10.1152/ajprenal.00387.2012
   Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6
   Fu JQ, 2013, PHARM RES-DORDR, V30, P2248, DOI 10.1007/s11095-013-1013-8
   Fujimoto S, 2011, PROG BIOPHYS MOL BIO, V107, P304, DOI 10.1016/j.pbiomolbio.2011.07.013
   Furusawa Y., 2014, GENES CELLS
   GRANKVIST K, 1979, BIOCHEM J, V182, P17
   Heiss EH, 2013, REDOX BIOL, V1, P359, DOI 10.1016/j.redox.2013.06.001
   Held IM, 2010, NAT GENET, V42, P949
   Kubisch HM, 1997, DIABETES, V46, P1563, DOI 10.2337/diabetes.46.10.1563
   Lee S, 2012, TOXICOL APPL PHARM, V264, P431, DOI 10.1016/j.taap.2012.08.021
   Lee YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050412
   Meakin P.J., 2014, MOL CELL BIOL
   Portha Bernard, 2012, Methods Mol Biol, V933, P125, DOI 10.1007/978-1-62703-068-7_9
   Rebelato E, 2010, METABOLISM, V59, P409, DOI 10.1016/j.metabol.2009.08.010
   Rebelato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024507
   Saadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030200
   Sasaki M, 2013, DIABETES, V62, P1996, DOI 10.2337/db12-0903
   Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579
   Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3
   Tsujita T, 2014, MOL CELL BIOL, V34, P3800, DOI 10.1128/MCB.00110-14
   Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231
   Xu B, 1999, FREE RADICAL BIO MED, V27, P830, DOI 10.1016/S0891-5849(99)00130-6
   Xu JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079841
   Yang B, 2012, TOXICOL APPL PHARM, V264, P315, DOI 10.1016/j.taap.2012.09.012
NR 111
TC 10
Z9 10
U1 9
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 76
EP 84
DI 10.1016/j.abb.2014.12.012
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000010
PM 25528168
ER

PT J
AU Peek, J
   Christendat, D
AF Peek, James
   Christendat, Dinesh
TI The shikimate dehydrogenase family: Functional diversity within a
   conserved structural and mechanistic framework
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Shikimate dehydrogenase; Quinate dehydrogenase; Oxidoreductase; Enzyme
   kinetics; Crystal structure; Enzyme family
ID PENTAFUNCTIONAL AROM POLYPEPTIDE; AMYCOLATOPSIS-MEDITERRANEI S699;
   AMINO-ACID BIOSYNTHESIS; QA-GENE-CLUSTER; NEUROSPORA-CRASSA;
   ESCHERICHIA-COLI; QUINIC ACID; CORYNEBACTERIUM-GLUTAMICUM;
   3-AMINO-5-HYDROXYBENZOIC ACID; QUINATE DEHYDROGENASE
AB Shikimate dehydrogenase (SDH) catalyzes the NADPH-dependent reduction of 3-deydroshikimate to shikimate, an essential reaction in the biosynthesis of the aromatic amino acids and a large number of other secondary metabolites in plants and microbes. The indispensible nature of this enzyme makes it a potential target for herbicides and antimicrobials. SDH is the archetypal member of a large protein family, which contains at least four additional functional classes with diverse metabolic roles. The different members of the SDH family share a highly similar three-dimensional structure and utilize a conserved catalytic mechanism, but exhibit distinct substrate preferences, making the family a particularly interesting system for studying modes of substrate recognition used by enzymes. Here, we review our current understanding of the biochemical and structural properties of each of the five previously identified SDH family functional classes. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Peek, James; Christendat, Dinesh] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3B2, Canada.
   [Christendat, Dinesh] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON M5S 3B2, Canada.
RP Christendat, D (reprint author), 25 Willcocks St, Toronto, ON M5S 3B2, Canada.
EM dinesh.christendat@utoronto.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
   [RGPIN 250203]
FX D.C. is supported by a grant from the Natural Sciences and Engineering
   Research Council of Canada (NSERC; grant number RGPIN 250203).
CR Adachi O, 2006, BIOSCI BIOTECH BIOCH, V70, P2786, DOI 10.1271/bbb.60305
   Adachi O, 2003, BIOSCI BIOTECH BIOCH, V67, P2124, DOI 10.1271/bbb.67.2124
   Adachi O, 2006, BIOSCI BIOTECH BIOCH, V70, P2579, DOI 10.1271/bbb.60259
   Teramoto H, 2009, APPL ENVIRON MICROB, V75, P3461, DOI 10.1128/AEM.00163-09
   Kim CG, 1996, J AM CHEM SOC, V118, P7486, DOI 10.1021/ja9601292
   Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131
   Barco A, 1997, TETRAHEDRON-ASYMMETR, V8, P3515, DOI 10.1016/S0957-4166(97)00471-0
   Floss HG, 2011, J ANTIBIOT, V64, P35, DOI 10.1038/ja.2010.139
   SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0
   MITSUHASHI S, 1954, BIOCHIM BIOPHYS ACTA, V15, P268, DOI 10.1016/0006-3002(54)90069-4
   DEWICK PM, 1969, BIOCHEM J, V113, P537
   Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376
   Diaz J, 1997, PHYSIOL PLANTARUM, V100, P147, DOI 10.1034/j.1399-3054.1997.1000116.x
   Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297
   Kim CG, 1998, J BIOL CHEM, V273, P6030, DOI 10.1074/jbc.273.11.6030
   Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413
   YANIV H, 1955, J BIOL CHEM, V213, P787
   Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473
   August PR, 1998, CHEM BIOL, V5, P69, DOI 10.1016/S1074-5521(98)90141-7
   Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723
   STEINRUCKEN HC, 1980, BIOCHEM BIOPH RES CO, V94, P1207, DOI 10.1016/0006-291X(80)90547-1
   Goel AK, 2001, APPL ENVIRON MICROB, V67, P245, DOI 10.1128/AEM.67.1.245-250.2001
   ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0
   Zhang XL, 2005, J BIOCHEM MOL BIOL, V38, P624
   Lim S, 2004, FEMS MICROBIOL LETT, V238, P101, DOI 10.1016/j.femsle.2004.07.023
   Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938
   Han C, 2006, FEBS J, V273, P4682, DOI 10.1111/j.1742-4658.2006.05469.x
   Ding L, 2007, J EXP BOT, V58, P2053, DOI 10.1093/jxb/erm059
   Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200
   PITTARD J, 1966, J BACTERIOL, V91, P1494
   Campbell SA, 2004, INT J PARASITOL, V34, P5, DOI 10.1016/j.ipara.2003.10.006
   Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439
   Draths KM, 1999, J AM CHEM SOC, V121, P1603, DOI 10.1021/ja9830243
   Balskus EP, 2010, SCIENCE, V329, P1653, DOI 10.1126/science.1193637
   GILES NH, 1985, MICROBIOL REV, V49, P338
   Kramer M, 2003, METAB ENG, V5, P277, DOI 10.1016/j.ymben.2003.09.001
   WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012
   Avitia-Dominguez C, 2014, MOLECULES, V19, P4491, DOI 10.3390/molecules19044491
   Bagautdinov B, 2007, J MOL BIOL, V373, P424, DOI 10.1016/j.jmb.2007.08.017
   BAILLIE AC, 1972, BIOCHEM J, V126, pP21
   BAKER PJ, 1992, J MOL BIOL, V228, P662, DOI 10.1016/0022-2836(92)90848-E
   BALINSKY D, 1961, BIOCHEM J, V80, P296
   BALINSKY D, 1961, BIOCHEM J, V80, P292
   BALINSKY D, 1971, BIOCHEMISTRY-US, V10, P1947
   BAREA JL, 1978, BIOCHIM BIOPHYS ACTA, V524, P1, DOI 10.1016/0005-2744(78)90097-9
   Benach J, 2003, J BIOL CHEM, V278, P19176, DOI 10.1074/jbc.M301348200
   Bischoff M, 2001, PLANT PHYSIOL, V125, P1891, DOI 10.1104/pp.125.4.1891
   BONNER CA, 1994, BIOCHEM J, V302, P11
   BOUDET AM, 1974, PLANTA, V119, P71, DOI 10.1007/BF00390823
   BRUCE NC, 1990, ARCH MICROBIOL, V154, P179, DOI 10.1007/BF00423330
   Bugg T.D.H., 1988, TETRAHEDRON LETT, V51, P6779
   CAIN RB, 1972, BIOCHEM J, V127, pP15
   CHALEFF RS, 1974, J GEN MICROBIOL, V81, P337
   CHALEFF RS, 1974, J GEN MICROBIOL, V81, P357
   CHAUDHURI S, 1985, BIOCHEM J, V226, P217
   Chen XZ, 2014, BIORESOURCE TECHNOL, V166, P64, DOI 10.1016/j.biortech.2014.05.035
   Choorapoikayil S, 2012, OMICS, V16, P668, DOI 10.1089/omi.2012.0055
   COGGINS JR, 1987, METHOD ENZYMOL, V142, P325, DOI 10.1016/S0076-6879(87)42044-2
   DAVIS BD, 1953, J BACTERIOL, V66, P129
   DENNIS AW, 1972, INT J BIOCHEM, V3, P93, DOI 10.1016/0020-711X(72)90031-6
   Dong CJ, 2003, STRUCTURE, V11, P715, DOI 10.1016/S0969-2126(03)00098-4
   DOWSETT JR, 1972, BIOCHIM BIOPHYS ACTA, V276, P344, DOI 10.1016/0005-2744(72)90994-1
   DUNCAN K, 1988, FEBS LETT, V241, P83, DOI 10.1016/0014-5793(88)81036-6
   ELSEMORE DA, 1994, J BACTERIOL, V176, P7659
   FIEDLER E, 1985, PLANT PHYSIOL, V79, P212, DOI 10.1104/pp.79.1.212
   Fonseca IO, 2006, PROTEIN EXPRES PURIF, V46, P429, DOI 10.1016/j.pep.2005.10.004
   Gamborg O.L., 1966, BIOCHIM BIOPHYS ACTA, V126, P483
   GAMBORG OL, 1966, CAN J BIOCHEM CELL B, V44, P791
   GAMBORG OL, 1967, PHYTOCHEMISTRY, V6, P1067, DOI 10.1016/S0031-9422(00)86063-X
   Gan JH, 2007, BIOCHEMISTRY-US, V46, P9513, DOI 10.1021/bi602601e
   GEEVER RF, 1989, J MOL BIOL, V207, P15, DOI 10.1016/0022-2836(89)90438-5
   GOLLUB E, 1967, J BIOL CHEM, V242, P5323
   GRAZIANA A, 1980, PLANT CELL PHYSIOL, V21, P1163
   Graziana A., 1983, FEBS LETT, V163
   Guo J, 2014, J BIOL CHEM, V289, P23846, DOI 10.1074/jbc.M114.558536
   Guo JT, 2004, ORG LETT, V6, P1585, DOI 10.1021/ol049666e
   Han C, 2009, FEBS J, V276, P1125, DOI 10.1111/j.1742-4658.2008.06856.x
   HAWKINS AR, 1993, BIOCHEM J, V296, P451
   HAWKINS AR, 1988, MOL GEN GENET, V214, P224, DOI 10.1007/BF00337715
   HAWKINS AR, 1991, EUR J BIOCHEM, V196, P717, DOI 10.1111/j.1432-1033.1991.tb15870.x
   HAWKINS AR, 1993, J GEN MICROBIOL, V139, P2891
   Hoppner A, 2013, BIOL CHEM, V394, P1505, DOI 10.1515/hsz-2013-0170
   Hsu KC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003127
   HUANG XP, 1995, J CHEM ECOL, V21, P1601, DOI 10.1007/BF02035155
   INGLEDEW WM, 1972, CAN J MICROBIOL, V18, P1817
   Johansson L, 2006, J BIOTECHNOL, V126, P528, DOI 10.1016/j.jbiotec.2006.05.007
   Juminaga D., 2011, APPL ENVIRON MICROB, V78, P89
   KANG XB, 1993, PHYTOCHEMISTRY, V33, P769, DOI 10.1016/0031-9422(93)85272-S
   Kim BG, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-15
   KIM CG, 1992, J AM CHEM SOC, V114, P4941, DOI 10.1021/ja00038a090
   Knop DR, 2001, J AM CHEM SOC, V123, P10173, DOI 10.1021/ja0109444
   Kubota T, 2013, APPL MICROBIOL BIOT, V97, P8139, DOI 10.1007/s00253-012-4659-y
   Kubota T, 2014, MOL MICROBIOL, V92, P356, DOI 10.1111/mmi.12560
   LAMB HK, 1991, MOL GEN GENET, V227, P187
   LAMBERT JM, 1985, BIOCHEM J, V226, P817
   LARIMER FW, 1983, MOL CELL BIOL, V3, P1609
   Lee HH, 2012, MOL CELLS, V33, P229, DOI 10.1007/s10059-012-2200-x
   Lee HH, 2011, ACTA CRYSTALLOGR F, V67, P1556, DOI 10.1107/S1744309111041194
   Lindner HA, 2005, J BIOL CHEM, V280, P7162, DOI 10.1074/jbc.M412028200
   Liu DF, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-40
   Liu XL, 2014, WORLD J MICROB BIOT, V30, P2543, DOI 10.1007/s11274-014-1679-z
   LOURENCO EJ, 1991, J AGR FOOD CHEM, V39, P458, DOI 10.1021/jf00003a006
   LUMSDEN J, 1977, BIOCHEM J, V161, P599
   Marsh KB, 2009, FUNCT PLANT BIOL, V36, P463, DOI 10.1071/FP08240
   Michel G, 2003, J BIOL CHEM, V278, P19463, DOI 10.1074/jbc.M300794200
   Minamikawa T., 1968, PLANT CELL PHYSL, V10, P283
   MINAMIKA.T, 1966, PLANT CELL PHYSIOL, V7, P583
   MOUSDALE DM, 1987, PHYTOCHEMISTRY, V26, P2665
   Muir RM, 2011, PLANT MOL BIOL, V75, P555, DOI 10.1007/s11103-011-9739-3
   Muller M, 1998, J ORG CHEM, V63, P9753, DOI 10.1021/jo981291l
   NANDY M, 1961, ARCH BIOCHEM BIOPHYS, V92, P399, DOI 10.1016/0003-9861(61)90378-2
   NISHIOKA Y, 1967, GENETICS, V56, P341
   Ossipov V, 2000, PLANT PHYSIOL BIOCH, V38, P923, DOI 10.1016/S0981-9428(00)01203-1
   OSSIPOV V, 1995, TREES-STRUCT FUNCT, V10, P46
   Ossipov V., 2003, BIOCH SYST ECOL, V31
   Padyana AK, 2003, STRUCTURE, V11, P1005, DOI 10.1016/S0969-2126(03)00159-X
   Park A, 2004, PROTEIN SCI, V13, P2108, DOI 10.1110/ps.04705404
   PATEL VB, 1981, P NATL ACAD SCI-BIOL, V78, P5783, DOI 10.1073/pnas.78.9.5783
   Peek J, 2011, BIOCHEMISTRY-US, V50, P8616, DOI 10.1021/bi200586y
   Peek J, 2014, J BIOMOL SCREEN, V19, P1090, DOI 10.1177/1087057114527127
   Peek J., 1834, BIOCHIM BIOPHYS ACTA, V2013, P516
   Peek J, 2014, MOL BIOCHEM PARASIT, V194, P16, DOI 10.1016/j.molbiopara.2014.04.002
   POLLEY LD, 1978, BIOCHIM BIOPHYS ACTA, V526, P259, DOI 10.1016/0005-2744(78)90310-8
   Rodrigues Valnês S Jr, 2009, BMC Res Notes, V2, P227, DOI 10.1186/1756-0500-2-227
   Rodrigues Vda Jr S., 2009, INT J BIOL MACROMOL, V45, P200
   SANDERSO.GW, 1966, BIOCHEM J, V98, P248
   SCHMIDT CL, 1991, J PLANT PHYSIOL, V138, P51
   Schoepe J, 2008, ACTA CRYSTALLOGR D, V64, P803, DOI 10.1107/S090744490801411X
   Singh S, 2008, MOL BIOL EVOL, V25, P2221, DOI 10.1093/molbev/msn170
   Singh S, 2005, J BIOL CHEM, V280, P17101, DOI 10.1074/jbc.M412753200
   Singh SA, 2007, CRYST GROWTH DES, V7, P2153, DOI 10.1021/cg7007107
   Singh SA, 2006, BIOCHEMISTRY-US, V45, P7787, DOI 10.1021/bi060366+
   Subramaniam PS, 1998, J BACTERIOL, V180, P119
   TRESGUERRES M E F, 1970, Archiv fuer Mikrobiologie, V70, P110, DOI 10.1007/BF00412202
   Vangnai A.S., 2009, BIOCHEMISTRY-MOSCOW, V75, P452
   VANKLEEF MAG, 1988, ARCH MICROBIOL, V150, P32
   WELCH GR, 1975, P NATL ACAD SCI USA, V72, P4218, DOI 10.1073/pnas.72.11.4218
   Werner RA, 2004, PHYTOCHEMISTRY, V65, P2809, DOI 10.1016/j.phytochem.2004.08.020
   WHEELIS ML, 1970, GENETICS, V66, P245
   WHITING GC, 1971, ANTON VAN LEE J M S, V37, P33, DOI 10.1007/BF02218465
   WHITING GC, 1974, BIOCHEM J, V141, P35
   WHITING GC, 1973, J SCI FOOD AGR, V24, P897, DOI 10.1002/jsfa.2740240806
   Wu X, 2007, CHEMBIOCHEM, V8, P239, DOI 10.1002/cbic.200600446
   Yan DZ, 2009, ANN MICROBIOL, V59, P789
   Ye S, 2003, J BACTERIOL, V185, P4144, DOI 10.1128/JB.185.14.4144-4151.2003
   Yu TW, 2001, J BIOL CHEM, V276, P12546, DOI 10.1074/jbc.M009667200
NR 146
TC 0
Z9 0
U1 10
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 85
EP 99
DI 10.1016/j.abb.2014.12.006
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000011
PM 25524738
ER

PT J
AU Massberg, D
   Simon, A
   Haussinger, D
   Keitel, V
   Gisselmann, G
   Conrad, H
   Hatt, H
AF Massberg, Desiree
   Simon, Annika
   Haeussinger, Dieter
   Keitel, Verena
   Gisselmann, Guenter
   Conrad, Heike
   Hatt, Hanns
TI Monoterpene (-)-citronellal affects hepatocarcinoma cell signaling via
   an olfactory receptor
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Olfactory receptor; (-)-Citronellal; Hepatocellular carcinoma; Calcium;
   p38 MAPK; Proliferation
ID PROSTATE-CANCER CELLS; PROTEIN-COUPLED RECEPTORS; HUMAN HEPATOMA-CELLS;
   PERILLYL ALCOHOL; D-LIMONENE; HEPATOCELLULAR-CARCINOMA; INHIBITS
   PROLIFERATION; VOLATILE COMPONENTS; INDUCE APOPTOSIS; OLEANOLIC ACID
AB Terpenes are the major constituents of essential oils in plants. In recent years, terpenes have become of clinical relevance due to their ability to suppress cancer development. Their effect on cellular proliferation has made them promising agents in the prevention or treatment of many types of cancer. In the present study, a subset of different monoterpenes was investigated for their molecular effects on the hepatocellular carcinoma cell line Huh7. Using fluorometric calcium imaging, acyclic monoterpene (-)-citronellal was found to induce transient Ca2+ signals in Huh7 cells by activating a cAMP-dependent signaling pathway. Moreover, we detected the (-)-citronellal-activated human olfactory receptor OR1A2 at the mRNA and protein levels and demonstrated its potential involvement in (-)-citronellal-induced calcium signaling in Huh7 cells. Furthermore, activation of OR1A2 results in phosphorylation of p38 MAPK and reduced cell proliferation, indicating an effect on hepatocellular carcinoma progression. Here, we provide for the first time data on the molecular mechanism evoked by (-)-citronellal in human hepatocellular carcinoma cells. The identified olfactory receptor could serve as a potential therapeutic target for cancer diagnosis and treatment. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Massberg, Desiree; Simon, Annika; Gisselmann, Guenter; Conrad, Heike; Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, D-44801 Bochum, Germany.
   [Haeussinger, Dieter; Keitel, Verena] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany.
RP Gisselmann, G (reprint author), Ruhr Univ Bochum, Dept Cell Physiol, ND-4-16,Univ Str 150, D-44780 Bochum, Germany.
EM desireemassberg@gmx.de; a.simon-mail@web.de;
   haeussin@uni-duesseldorf.de; verena.keitel@med.uni-duesseldorf.de;
   guenter.gisselmann@rub.de; heike.benecke@med.uni-goettingen.de;
   hanns.hatt@rub.de
FU DFG [Sonderforschungsbereich 642]
FX Desiree Massberg was funded by the Heinrich und Alma Vogelsang Stiftung
   Hanns Hatt was funded by the DFG-Sonderforschungsbereich 642 "GTP- and
   ATP dependent membrane processes". The funders had no role in study
   design, in the collection, analysis and interpretation of data, decision
   to publish, or preparation of the manuscripts.
CR Chang WJ, 2010, J INVEST SURG, V23, P228, DOI 10.3109/08941939.2010.496036
   De la Cruz O, 2009, MOL BIOL EVOL, V26, P491, DOI 10.1093/molbev/msn294
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Chung BH, 2006, CANCER LETT, V236, P222, DOI 10.1016/j.canlet.2005.05.023
   DeOliveira ACAX, 1997, TOXICOL LETT, V92, P39, DOI 10.1016/S0378-4274(97)00034-9
   Lin CC, 2011, J AGR FOOD CHEM, V59, P755, DOI 10.1021/jf103904b
   Aghemo A, 2013, SEMIN IMMUNOPATHOL, V35, P111, DOI 10.1007/s00281-012-0330-z
   Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021
   Spehr J, 2011, J BIOL CHEM, V286, P13184, DOI 10.1074/jbc.M110.183525
   Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8
   WEINRYB I, 1974, BIOCHEM PHARMACOL, V23, P2411, DOI 10.1016/0006-2952(74)90232-9
   Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7
   Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096
   Babu LH, 2012, MOL CELL BIOCHEM, V369, P183, DOI 10.1007/s11010-012-1381-0
   Patlolla JMR, 2012, CURR PHARM BIOTECHNO, V13, P147
   Burke YD, 1997, LIPIDS, V32, P151, DOI 10.1007/s11745-997-0019-y
   Gaspers LD, 2005, CELL CALCIUM, V38, P329, DOI 10.1016/j.ceca.2005.06.009
   Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320
   Veitinger T, 2011, J BIOL CHEM, V286, P17311, DOI 10.1074/jbc.M110.211524
   Wang YG, 2012, CHEM-BIOL INTERACT, V200, P11, DOI 10.1016/j.cbi.2012.08.023
   Mansoor TA, 2009, BIOORG MED CHEM LETT, V19, P4255, DOI 10.1016/j.bmcl.2009.05.104
   Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232
   Wiseman DA, 2007, J PHARMACOL EXP THER, V320, P1163, DOI 10.1124/jpet.106.111666
   Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105
   Vigushin DM, 1998, CANCER CHEMOTH PHARM, V42, P111, DOI 10.1007/s002800050793
   Yan SL, 2010, TOXICOL IN VITRO, V24, P842, DOI 10.1016/j.tiv.2009.12.008
   Murthy KNC, 2012, LIFE SCI, V91, P429, DOI 10.1016/j.lfs.2012.08.016
   Iyoda K, 2003, CANCER, V97, P3017, DOI 10.1002/cncr.11425
   Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036
   Jayaprakasha GK, 2012, PLANTA MED, V78, P974, DOI 10.1055/s-0031-1298619
   Arunasree KM, 2010, PHYTOMEDICINE, V17, P581, DOI 10.1016/j.phymed.2009.12.008
   Ong TP, 2006, CARCINOGENESIS, V27, P1194, DOI 10.1093/carcin/bgi291
   Kenakin T, 2003, TRENDS PHARMACOL SCI, V24, P346, DOI 10.1016/S0165-6147(03)00167-6
   Bardon S, 2002, CANCER LETT, V181, P187, DOI 10.1016/S0304-3835(02)00047-2
   Barritt GJ, 2008, BBA-MOL CELL RES, V1783, P651, DOI 10.1016/j.bbamcr.2008.01.016
   CROWELL PL, 1992, CANCER CHEMOTH PHARM, V31, P205, DOI 10.1007/BF00685549
   Deb DD, 2011, CHEM-BIOL INTERACT, V193, P97, DOI 10.1016/j.cbi.2011.05.009
   Enfissi A, 2004, CELL CALCIUM, V36, P459, DOI 10.1016/j.ceca.2004.04.004
   Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121
   Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368
   Foster S.R., 2013, PHARM THER
   Gaspers LD, 2012, CELL CALCIUM, V52, P93, DOI 10.1016/j.ceca.2012.04.009
   IGIMI H, 1974, XENOBIOTICA, V4, P77
   Jiang LH, 2004, J AGR FOOD CHEM, V52, P4197, DOI 10.1021/jf030663a
   Kenakin T, 2002, TRENDS PHARMACOL SCI, V23, P403, DOI 10.1016/S0165-6147(02)02046-1
   Kim SH, 2012, INT J ONCOL, V40, P1683, DOI 10.3892/ijo.2011.1318
   KODAMA R, 1976, XENOBIOTICA, V6, P377
   Krelle A., 2013, J CANC THER, P606
   Lin SY, 2010, BIOSCI BIOTECH BIOCH, V74, P806, DOI 10.1271/bbb.90891
   Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024
   Liu L, 2012, EUR J PHARMACOL, V691, P61, DOI 10.1016/j.ejphar.2012.07.031
   Mainland J.D., 2013, NAT NEUROSCI
   Melo MS, 2011, BIOL RES, V44, P363, DOI [/S0716-97602011000400008, 10.4067/S0716-97602011000400008]
   Murren JR, 2002, CANCER BIOL THER, V1, P130
   NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0
   Paik SY, 2005, BIOL PHARM BULL, V28, P802, DOI 10.1248/bpb.28.802
   Quintans L, 2011, J MED FOOD, V14, P630, DOI 10.1089/jmf.2010.0125
   Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016
   Sanz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085110
   Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013
   Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200
   Siegel W.N.L., 1976, GASTROENTEROLOGY, P937
   Thoppil Roslin J, 2011, World J Hepatol, V3, P228, DOI 10.4254/wjh.v3.i9.228
   Wang H, 2010, ONCOL REP, V24, P647, DOI 10.3892/or_00000903
   Xu M, 2004, TOXICOL APPL PHARM, V195, P232, DOI 10.1016/j.taap.2003.11.013
   Yeruva Laxmi, 2007, Cancer Lett, V257, P216, DOI 10.1016/j.canlet.2007.07.020
   Yuri T, 2004, BREAST CANCER RES TR, V84, P251, DOI 10.1023/B:BREA.0000019966.97011.4d
   Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055
   Zhao W., 2012, J ALZHEIMERS DIS
NR 71
TC 2
Z9 2
U1 3
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2015
VL 566
BP 100
EP 109
DI 10.1016/j.abb.2014.12.004
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ8SD
UT WOS:000348484000012
PM 25513961
ER

PT J
AU Nagasawa, T
   Matsushima-Nishiwaki, R
   Yasuda, E
   Matsuura, J
   Toyoda, H
   Kaneoka, Y
   Kumada, T
   Kozawa, O
AF Nagasawa, Tomoaki
   Matsushima-Nishiwaki, Rie
   Yasuda, Eisuke
   Matsuura, Junya
   Toyoda, Hidenori
   Kaneoka, Yuji
   Kumada, Takashi
   Kozawa, Osamu
TI Heat shock protein 20 (HSPB6) regulates TNF-alpha-induced intracellular
   signaling pathway in human hepatocellular carcinoma cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE HSP20; TNF-alpha; HCC; IKK-alpha; Cell proliferation
ID NF-KAPPA-B; TUMOR PROGRESSION; EXPRESSION LEVELS; LIVER-CANCER;
   IKK-BETA; HSP20; PHOSPHORYLATION; INHIBITION; APOPTOSIS; KINASES
AB We previously demonstrated that the expression of HSP20, a small heat shock protein, is inversely correlated with the progression of HCC. Inflammation is associated with HCC, and numerous cytokines, including TNF-alpha, act as key mediators in the progression of HCC. In the present study, we investigated whether HSP20 is implicated in the TNF-alpha-stimulated intracellular signaling in HCC using human HCC-derived HuH7 cells in the presence of TNF-alpha. In HSP20-overexpressing HCC cells, the cell growth was retarded compared with that in the control cells under long-term exposure of TNF-alpha. Because NF-kappa B pathway is the main intracellular signaling system activated by TNF-alpha, we investigated the effects of HSP20-overexpression of this pathway. The protein levels of but not IKK-beta, in the HSP20-overexpressing cells were decreased. Short-term exposure to TNF-alpha-induced phosphorylation and degradation of 1 kappa B, and the phosphorylation and transactivational activity of NF-kappa B were suppressed in the HSP20-overexpressing HCC cells. Furthermore, the increase in IKK-alpha levels was accompanied by a decrease in the HSP20 levels in human HCC tissues. These findings strongly suggest that HSP20 might decrease the IKK-alpha protein level and that it down-regulates the TNF-alpha-stimulated intracellular signaling in HCC, thus resulting in the suppression of HCC progression. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Nagasawa, Tomoaki; Matsushima-Nishiwaki, Rie; Matsuura, Junya; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan.
   [Yasuda, Eisuke; Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Gifu 5038502, Japan.
   [Kaneoka, Yuji] Ogaki Municipal Hosp, Dept Surg, Gifu 5038502, Japan.
   [Yasuda, Eisuke] Suzuka Univ Med Sci, Dept Radiol Technol, Suzuka 5138670, Japan.
RP Kozawa, O (reprint author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan.
EM okozawa@gifu-u.ac.jp
FU Ministry of Education, Science, Sports and Culture of Japan [25460989]
FX We are very grateful to Yumiko Kurokawa for her skillful technical
   assistance. This work was supported in part by a Grant-in-Aid for
   Scientific Research (25460989 to O.K.) from the Ministry of Education,
   Science, Sports and Culture of Japan.
CR Edwards HV, 2011, CELL SIGNAL, V23, P1447, DOI 10.1016/j.cellsig.2011.05.009
   Jiang RQ, 2010, INT J CANCER, V126, P1263, DOI 10.1002/ijc.24854
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x
   Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937
   Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780
   Lee DF, 2008, CLIN CANCER RES, V14, P5656, DOI 10.1158/1078-0432.CCR-08-0123
   Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2
   Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006
   Dreiza CM, 2010, CELL STRESS CHAPERON, V15, P1, DOI 10.1007/s12192-009-0127-8
   Wang XH, 2009, J MOL CELL CARDIOL, V47, P382, DOI 10.1016/j.yjmcc.2009.05.016
   Schattenberg JM, 2011, J GASTROEN HEPATOL, V26, P213, DOI 10.1111/j.1440-1746.2010.06582.x
   Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010
   Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020
   Campbell KJ, 2004, BIOCHEM SOC T, V32, P1087
   Oakley F, 2005, AM J PATHOL, V166, P695, DOI 10.1016/S0002-9440(10)62291-2
   KATO K, 1994, J BIOL CHEM, V269, P15302
   Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200
   Cui RW, 2006, CIRC RES, V99, P723, DOI 10.1161/01.RES.0000244015.10655.3f
   Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007
   Kozawa O, 2002, LIFE SCI, V72, P113, DOI 10.1016/S0024-3205(02)02144-6
   Matsuno H, 1998, FEBS LETT, V429, P327, DOI 10.1016/S0014-5793(98)00626-7
   Matsushima-Nishiwaki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078440
   Matsushima-Nishiwaki R, 2011, J CELL BIOCHEM, V112, P3430, DOI 10.1002/jcb.23270
   Moles A, 2013, HEPATOLOGY, V57, P817, DOI 10.1002/hep.26068
   Nagasawa T., 2014, ONCOL REP
   Nishimura D, 2006, INT J ONCOL, V29, P713
   Noda T, 2007, ONCOL REP, V17, P1309
   Yasuda E, 2005, BIOCHEM BIOPH RES CO, V337, P337, DOI 10.1016/j.bbrc.2005.08.273
NR 29
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2015
VL 565
BP 1
EP 8
DI 10.1016/j.abb.2014.10.010
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ1OL
UT WOS:000348008000001
PM 25447820
ER

PT J
AU Patthy, A
   Molnar, T
   Porrogi, P
   Naude, R
   Graf, L
AF Patthy, Andras
   Molnar, Tamas
   Porrogi, Palma
   Naude, Ryno
   Graf, Laszlo
TI Isolation and characterization of a protease inhibitor from Acacia
   karroo with a common combining loop and overlapping binding sites for
   chymotrypsin and trypsin
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Acacia karroo; Kunitz-type protease inhibitor; Combining loop; Trypsin;
   Chymotrypsin
ID AMINO-ACID-SEQUENCE; SERINE PROTEINASE-INHIBITOR; TETRAGONOLOBUS L DC;
   SCHISTOCERCA-GREGARIA; REACTIVE SITE; SEEDS; KUNITZ; PURIFICATION;
   MUTAGENESIS; JULIFLORA
AB By using affinity and reversed-phase HPLC (RP-HPLC) chromatographies two chymotrypsin-trypsin inhibitors were isolated from seeds of Acacia karroo, a legume of the subfamily Mimosoideae. The primary structure of one of these inhibitors, named AkCI/1, was determined. The inhibitor consists of two polypeptide chains, 139 and 44 residues respectively, which are linked by a single disulfide bridge. The amino acid sequence of AkCI/1 is homologous to and showed more than 60% sequence similarity with other protease inhibitors isolated earlier from the group of Mimosoideae. AkCl/1 inhibits both chymotrypsin (EC 3.4.21.1) and trypsin (EC 3.4.21.4) in a 1:1 M ratio with K-i values of 2.8 x 10(-12) M and 1.87 x 10(-12) M, respectively. The P1-P1' residues for trypsin were identified as Arg68-Ile69 by selective hydrolysis of the inhibitor at this site, with bovine trypsin and human trypsin IV. The cleavage did not affect the inhibition of trypsin, but fully abolished the chymotrypsin inhibitory activity of AkCI/1. This finding together with our studies on competition of the two enzymes for the same combining loop suggests that the same loop has to contain the binding sites for both proteases. The most likely P1 residue of AkCI/1 for chymotrypsin is Tyr67. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Patthy, Andras; Molnar, Tamas; Porrogi, Palma; Graf, Laszlo] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary.
   [Naude, Ryno] Nelson Mandela Metropolitan Univ, Dept Biochem & Microbiol, ZA-6031 Port Elizabeth, South Africa.
   [Graf, Laszlo] Hungarian Acad Sci, Mol Biophys Res Grp, H-1117 Budapest, Hungary.
   [Graf, Laszlo] Eotvos Lorand Univ, H-1117 Budapest, Hungary.
RP Graf, L (reprint author), Eotvos Lorand Univ, Dept Biochem, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.
EM graf@elte.hu
FU Hungarian Scientific Research Fund [OTKA NK81950]; Hungarian Academy of
   Sciences (HAS-ELTE research group) [01055]; National Office for Research
   and Technology (Hungary); Nelson Mandela Metropolitan University;
   National Research Foundation (South Africa)
FX This work was supported by the Hungarian Scientific Research Fund OTKA
   NK81950, the Hungarian Academy of Sciences (HAS-ELTE research group ID
   01055), the National Office for Research and Technology (Hungary),
   Nelson Mandela Metropolitan University and the National Research
   Foundation (South Africa). We would like to thank Gergely Katona
   (Department of Chemistry and Molecular Biology, University of
   Gothenburg) and Andras Malnasi-Csizmadia (Molecular Biophysics Research
   Group, Hungarian Academy of Sciences) for the helpful discussions. We
   also thank the staff of the mass spectrometry laboratory (MTA-ELTE
   Research Group of Peptide Chemistry) for the expert technical
   assistance.
CR RICHARDSON M, 1977, PHYTOCHEMISTRY, V16, P159, DOI 10.1016/S0031-9422(00)86777-1
   Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8
   Malik Z, 1999, BBA-PROTEIN STRUCT M, V1434, P143, DOI 10.1016/S0167-4838(99)00167-3
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   JAMESON GW, 1973, BIOCHEM J, V131, P107
   Di Ciero L, 1998, J PROTEIN CHEM, V17, P827
   Oliva MLV, 2000, BBA-PROTEIN STRUCT M, V1477, P64, DOI 10.1016/S0167-4838(99)00285-X
   Oliva MLV, 2011, CURR PROTEIN PEPT SC, V12, P348
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Szilagyi L, 2001, J BIOL CHEM, V276, P24574, DOI 10.1074/jbc.M011374200
   Apostoluk W, 1998, PROTEINS, V32, P459, DOI 10.1002/(SICI)1097-0134(19980901)32:4<459::AID-PROT5>3.0.CO;2-B
   ARGALL ME, 1994, BBA-PROTEIN STRUCT M, V1204, P189, DOI 10.1016/0167-4838(94)90008-6
   Batista IFC, 1996, PHYTOCHEMISTRY, V41, P1017, DOI 10.1016/0031-9422(95)00710-5
   Ee KY, 2009, J AGR FOOD CHEM, V57, P7022, DOI 10.1021/jf900923t
   EMPIE MW, 1982, BIOCHEMISTRY-US, V21, P2274, DOI 10.1021/bi00539a002
   Franco OL, 2002, PROTEINS, V49, P335, DOI 10.1002/prot.10228
   HUBER R, 1970, NATURWISSENSCHAFTEN, V57, P389
   HUNG CH, 1994, FEBS LETT, V353, P312, DOI 10.1016/0014-5793(94)01066-8
   JOUBERT FJ, 1985, J BIOL CHEM, V260, P2948
   JOUBERT FJ, 1987, INT J BIOCHEM, V19, P601, DOI 10.1016/0020-711X(87)90225-4
   KOIDE T, 1973, EUR J BIOCHEM, V32, P401, DOI 10.1111/j.1432-1033.1973.tb02622.x
   KORTT AA, 1979, BIOCHIM BIOPHYS ACTA, V577, P371, DOI 10.1016/0005-2795(79)90040-0
   KORTT AA, 1981, EUR J BIOCHEM, V115, P551
   KOUZUMA Y, 1992, BIOSCI BIOTECH BIOCH, V56, P1819
   KUNITZ M, 1945, SCIENCE, V101, P668, DOI 10.1126/science.101.2635.668
   LIN JY, 1991, J BIOCHEM-TOKYO, V110, P879
   Macedo MLR, 2004, J AGR FOOD CHEM, V52, P2533, DOI 10.1021/jf035389z
   Odei-Addo F, 2014, J ENZYM INHIB MED CH, V29, P633, DOI 10.3109/14756366.2013.836642
   OZAWA K, 1966, J BIOL CHEM, V241, P3955
   Patthy A, 2002, ARCH BIOCHEM BIOPHYS, V398, P179, DOI 10.1006/abbi.2001.2686
   NEGREIROS ANM, 1991, PHYTOCHEMISTRY, V30, P2829
   SASAKI T, 1984, FEBS LETT, V168, P227, DOI 10.1016/0014-5793(84)80251-3
   Schechter I, 1967, BIOCHEM BIOPH RES CO, V425, P497, DOI [10.1016/j.bbrc.2012.08.015, DOI 10.1016/J.BBRC.2012.08.015]
   SCHELLENBERGER V, 1994, BIOCHEMISTRY-US, V33, P4251, DOI 10.1021/bi00180a020
   SEALOCK RW, 1969, BIOCHEMISTRY-US, V8, P3703, DOI 10.1021/bi00837a032
   SHIBATA H, 1986, J BIOCHEM-TOKYO, V99, P1147
   Szenthe B, 2007, J MOL BIOL, V370, P63, DOI 10.1016/j.jmb.2007.04.029
   YAMAMOTO M, 1983, J BIOCHEM-TOKYO, V94, P849
NR 38
TC 0
Z9 0
U1 5
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2015
VL 565
BP 9
EP 16
DI 10.1016/j.abb.2014.11.001
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ1OL
UT WOS:000348008000002
PM 25447841
ER

PT J
AU Adel, S
   Kakularam, KR
   Horn, T
   Reddanna, P
   Kuhn, H
   Heydeck, D
AF Adel, Susan
   Kakularam, Kumar Reddy
   Horn, Thomas
   Reddanna, Pallu
   Kuhn, Hartmut
   Heydeck, Dagmar
TI Leukotriene signaling in the extinct human subspecies Homo denisovan and
   Homo neanderthalensis. Structural and functional comparison with Homo
   sapiens
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Eicosanoids; Leukotrienes; Prostaglandins; H. denisovan; H.
   neanderthalensis; Evolution
ID PLATELET-TYPE 12-LIPOXYGENASE; MAMMALIAN LIPOXYGENASES;
   CYSTEINYL-LEUKOTRIENES; RECEPTOR ANTAGONISTS; HUMAN 5-LIPOXYGENASE;
   MOLECULAR-CLONING; ARACHIDONIC-ACID; GENOME SEQUENCE; DEFICIENT MICE;
   DISRUPTION
AB Mammalian lipoxygenases (LOXs) have been implicated in cell differentiation and in the biosynthesis of pro- and anti-inflammatory lipid mediators. The initial draft sequence of the Homo neanderthalensis genome (coverage of 1.3-fold) suggested defective leukotriene signaling in this archaic human subspecies since expression of essential proteins appeared to be corrupted. Meanwhile high quality genomic sequence data became available for two extinct human subspecies (H. neanderthalensis, Homo denisovan) and completion of the human 1000 genome project provided a comprehensive database characterizing the genetic variability of the human genome. For this study we extracted the nucleotide sequences of selected eicosanoid relevant genes (ALOX5, ALOX15, ALOX12, ALOX15B, ALOX12B, ALOXE3, COX1, COX2, LTA4H, LTC4S, ALOX5AP, CYSLTR1, CYSLTR2, BLTR1, BLTR2) from the corresponding databases. Comparison of the deduced amino acid sequences in connection with site-directed mutagenesis studies and structural modeling suggested that the major enzymes and receptors of leukotriene signaling as well as the two cyclooxygenase isoforms were fully functional in these two extinct human subspecies. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Adel, Susan; Kakularam, Kumar Reddy; Horn, Thomas; Kuhn, Hartmut; Heydeck, Dagmar] Charite, Inst Biochem, D-10117 Berlin, Germany.
   [Kakularam, Kumar Reddy; Reddanna, Pallu] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad 500046, Andhra Pradesh, India.
   [Reddanna, Pallu] Natl Inst Anim Biotechnol, Hyderabad 500046, Andhra Pradesh, India.
RP Kuhn, H (reprint author), Charite, Inst Biochem, Charitepl 1, D-10117 Berlin, Germany.
EM hartmut.kuehn@charite.de
FU Deutsche Forschungsgemeinschaft [GRK 1673/1]
FX This work was supported in part by a research grant of Deutsche
   Forschungsgemeinschaft (GRK 1673/1). The authors would like to thank Dr.
   Niyaz Ahmed for interesting discussion and valuable advice. The authors
   would like to thank CLC bio for providing a 15 day free trial version of
   CLC Genomics Workbench 7.
CR Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Yokomizo T, 2011, ADV ENZYME REGUL, V51, P59, DOI 10.1016/j.advenzreg.2010.08.002
   Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016
   Devi NS, 2012, CURR DRUG TARGETS, V13, P1107
   HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400
   Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886
   Walther M, 2011, ARCH BIOCHEM BIOPHYS, V516, P1, DOI 10.1016/j.abb.2011.09.004
   Kobe MJ, 2014, J BIOL CHEM, V289, P8562, DOI 10.1074/jbc.M113.543777
   George J, 2001, CIRCULATION, V104, P1646, DOI 10.1161/hc3901.095772
   Hansen J, 2013, APPL MICROBIOL BIOT, V97, P4737, DOI 10.1007/s00253-013-4887-9
   Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d
   FUNK CD, 1989, P NATL ACAD SCI USA, V86, P2587, DOI 10.1073/pnas.86.8.2587
   Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021
   Singh RK, 2010, PHARMACOLOGY, V85, P336, DOI 10.1159/000312669
   Sun DX, 1996, J BIOL CHEM, V271, P24055
   Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590
   Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710
   Berger W, 2007, INT J CLIN PRACT, V61, P663, DOI 10.1111/j.1742-1241.2007.01320.x
   Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976
   Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462
   Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344
   Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003
   Vahlquist A, 2010, J INVEST DERMATOL, V130, P438, DOI 10.1038/jid.2009.346
   Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008
   Krieg P, 2013, J INVEST DERMATOL, V133, P172, DOI 10.1038/jid.2012.250
   Chaitidis P, 2013, J LIPID RES, V54, P1397, DOI 10.1194/jlr.M035626
   Fanning LB, 2013, ANN ALLERG ASTHMA IM, V111, P155, DOI 10.1016/j.anai.2013.06.031
   Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148
   CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0
   Singh RK, 2013, J ASTHMA, V50, P922, DOI 10.3109/02770903.2013.823447
   Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106
   Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203
   Haeggstrom JZ, 2007, PROSTAG OTH LIPID M, V83, P198, DOI 10.1016/j.prostaglandins.2007.01.006
   Matsuse H, 2014, EXPERT OPIN PHARMACO, V15, P353, DOI 10.1517/14656566.2014.872241
   KUHN H, 1990, J BIOL CHEM, V265, P16300
   Eckl KM, 2009, J INVEST DERMATOL, V129, P1421, DOI 10.1038/jid.2008.409
   Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116
   Boeglin WE, 1998, P NATL ACAD SCI USA, V95, P6744, DOI 10.1073/pnas.95.12.6744
   Bosse Y, 2009, ANN ALLERG ASTHMA IM, V102, P16, DOI 10.1016/S1081-1206(10)60102-0
   Crofford L J, 1997, J Rheumatol Suppl, V49, P15
   FUNK CD, 1990, P NATL ACAD SCI USA, V87, P5638, DOI 10.1073/pnas.87.15.5638
   Garcia Rodriguez LA, 2013, RECENT RESULTS CANC, V191, P67, DOI DOI 10.1007/978-3-642-30331-9_
   GOLDYNE ME, 1984, J BIOL CHEM, V259, P8815
   Hicks A, 2007, EXPERT OPIN INV DRUG, V16, P1909, DOI 10.1517/13543784.16.12.1909
   Horn T, 2013, REDOX BIOL, V1, P566, DOI 10.1016/j.redox.2013.11.001
   Johnson EN, 1999, J INVEST DERMATOL, V112, P861, DOI 10.1046/j.1523-1747.1999.00595.x
   Johnson EN, 1998, P NATL ACAD SCI USA, V95, P3100, DOI 10.1073/pnas.95.6.3100
   Kinzig A, 1999, GENOMICS, V58, P158, DOI 10.1006/geno.1999.5816
   Le Bel M., 2013, J INNATE IMMUN
   Lu Dongsheng, 2013, Frontiers in Genetics, V4, P127, DOI 10.3389/fgene.2013.00127
   Mednikova MB, 2011, ARCHAEOL ETHNOL ANTH, V39, P129
   Mortimer M, 2006, ARCH BIOCHEM BIOPHYS, V445, P147, DOI 10.1016/j.abb.2005.10.023
   Oliw EH, 2002, PROSTAG OTH LIPID M, V68-9, P313, DOI 10.1016/S0090-6980(02)00037-0
   Patrono C, 2012, HDB EXP PHARM, V210, P137
   Sampson AP, 2009, CURR OPIN INVEST DR, V10, P1163
   SIGAL E, 1988, J BIOL CHEM, V263, P5328
   Stringer C, 2012, NATURE, V485, P33, DOI 10.1038/485033a
   Walther M, 2009, BBA-MOL CELL BIOL L, V1791, P827, DOI 10.1016/j.bbalip.2009.05.007
   Yu Z., 2007, ARCH BIOCHEM BIOPHYS, V455, P188
NR 59
TC 1
Z9 1
U1 9
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2015
VL 565
BP 17
EP 24
DI 10.1016/j.abb.2014.10.012
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ1OL
UT WOS:000348008000003
PM 25447821
ER

PT J
AU Watanabe-Matsui, M
   Matsumoto, T
   Matsui, T
   Ikeda-Saito, M
   Muto, A
   Murayama, K
   Igarashi, K
AF Watanabe-Matsui, Miki
   Matsumoto, Takashi
   Matsui, Toshitaka
   Ikeda-Saito, Masao
   Muto, Akihiko
   Murayama, Kazutaka
   Igarashi, Kazuhiko
TI Heme binds to an intrinsically disordered region of Bach2 and alters its
   conformation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Intrinsically disordered protein; Heme binding; Small-angle X-ray
   scattering; Chemical modification; Conformation change
ID SMALL-ANGLE SCATTERING; ANTIBODY CLASS SWITCH; REV-ERB-ALPHA;
   TRANSCRIPTION FACTOR; CIRCULAR-DICHROISM; B-CELLS; X-RAY; REPRESSOR
   BACH2; PROTEINS; BLIMP-1
AB The transcriptional repressor Bach2 regulates humoral and cellular immunity, including antibody class switching. It possesses a basic leucine zipper domain that mediates DNA binding. Heme inhibits the DNA-binding activity of Bach2 in vitro and induces the degradation of Bach2 in B cells. However, the structural basis of the heme-Bach2 interaction has not been identified. Spectroscopic analyses revealed that Bach2(331-52) is the heme-binding domain, as it includes three Cys-Pro motifs known to be important for heme binding. Heme-titration experiments demonstrated the presence of 5- and 6-coordinated heme-binding modes. Circular dichroism measurements indicated that Bach2(331-52) exists mostly in a random-coil conformation. However, dynamic light scattering analyses showed that, upon heme binding to Bach2331-520, this region becomes denatured at a lower temperature, as compared with unbound Bach2(331-520). In addition, small-angle X-ray scattering and chemical modification analyses revealed that heme binding induces conformational alterations within the unstructured region. A GAL4-based luciferase assay in 293T cells showed that heme alters the protein interactions mediated by Bach2(331-520). These observations suggested that the unstructured region of Bach2 is important for heme binding, and consequently for its functional regulation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Watanabe-Matsui, Miki; Muto, Akihiko; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 980, Japan.
   [Matsumoto, Takashi] Rigaku Corp, Akishima, Tokyo, Japan.
   [Matsui, Toshitaka; Ikeda-Saito, Masao] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 980, Japan.
   [Murayama, Kazutaka] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Measurements & Diagnost, Sendai, Miyagi 980, Japan.
   [Murayama, Kazutaka] RIKEN Yokohama Inst, Div Struct & Synthet Biol, Yokohama, Kanagawa, Japan.
   [Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi 980, Japan.
   [Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi, Japan.
RP Igarashi, K (reprint author), Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.
EM kmura@bme.tohoku.ac.jp; igarashi@med.tohoku.ac.jp
RI Matsui, Toshitaka/B-1570-2008
FU JSPS [24570175, 23790320, 21249014, 24350081]
FX We thank our technical scientist, Ryogo Akasaka (RIKEN Systems and
   Structural Biology Center, Systems and Structural Biology Research
   Team), for assistance with the analytical ultracentrifugation
   experiments. We acknowledge the support of the Biomedical Research Core
   of Tohoku University, Graduate School of Medicine, and TAMRIC (Tohoku
   Advanced Medical Research and Incubation Center). This work was
   supported by a JSPS Grant-in-Aid for Scientific Research (C) Number
   24570175 (K. M.), a Grant-in-Aid for Young Scientists (B) Number
   23790320 (M. W.-M.), a Grant-inAid for Scientific Research (A) Number
   21249014 (K. I.), a Grantin-Aid for Scientific Research (B) Number
   24350081 (M. I.-S.), and a Grant-in-Aid for Scientific Research (C)
   Number 23550186 (T. M.). M. W.-M. was also supported by the Naito
   Foundation Subsidy for Female Researchers. This research was also
   supported by the Network Medicine Global COE Program from the Ministry
   of Education, Culture, Sports, Science, and Technology (MEXT) and Takeda
   Science Foundation (K. M. and K. I.), as well as by Grantsin-Aid for
   Scientific Research on Innovative Areas, Numbers 23117702 (A. M.),
   2412006 (M. I.-S.) and 25109504 (T. M.).
CR Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+
   Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005
   Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012
   TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2
   Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100
   Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q
   Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.0241-06
   Nakamura A, 2013, J EXP MED, V210, P2191, DOI 10.1084/jem.20130028
   Kallies A, 2007, CURR OPIN IMMUNOL, V19, P156, DOI 10.1016/j.coi.2007.01.003
   Ranjbar B, 2009, CHEM BIOL DRUG DES, V74, P101, DOI 10.1111/j.1747-0285.2009.00847.x
   Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483
   Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835
   Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1
   Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351
   Svergun DI, 2010, BIOL CHEM, V391, P737, DOI 10.1515/BC.2010.093
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200
   Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jcm.20040973
   Szollosi E, 2008, J PROTEOME RES, V7, P2291, DOI 10.1021/pr700720c
   Schuck P, 2000, BIOPHYS J, V78, P1606
   Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101
   Oyake T, 1996, MOL CELL BIOL, V16, P6083
   Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596
   Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734
   Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537
   Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200
   Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724
   Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344
   Muto A, 2010, EMBO J, V29, P4048, DOI 10.1038/emboj.2010.257
   Bernado P, 2012, MOL BIOSYST, V8, P151, DOI DOI 10.1039/C1MB05275F
   Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006
   Hira S, 2007, IUBMB LIFE, V59, P542, DOI 10.1080/15216540701225941
   Igarashi K, 2014, TOHOKU J EXP MED, V232, P229
   Ito N, 2009, GENES CELLS, V14, P167, DOI 10.1111/j.1365-2443.2008.01259.x
   Laue T.M., 1992, COMPUTER AIDED INTER, P90
   Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853
   Rogers PM, 2008, BIOCHEM BIOPH RES CO, V368, P955, DOI 10.1016/j.bbrc.2008.02.031
   Roychoudhuri K.H.R., 2013, NATURE, V498, P506
   Schneidman-Duhovny D, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-17
   Shiba K, 2010, ANAL SCI, V26, P659
   Swaminathan S, 2013, NAT MED, V19, P1014, DOI 10.1038/nm.3247
   Woody R. W., 2010, INSTRUMENTAL ANAL IN, P303
NR 44
TC 0
Z9 0
U1 5
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2015
VL 565
BP 25
EP 31
DI 10.1016/j.abb.2014.11.005
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ1OL
UT WOS:000348008000004
PM 25444856
ER

PT J
AU Rocha, BAM
   Barroso-Neto, IL
   Teixeira, CS
   Santiago, MQ
   Pires, AF
   Souza, LAG
   Nascimento, KS
   Sampaio, AH
   Delatorre, P
   Assreuy, AMS
   Cavada, BS
AF Rocha, Bruno A. M.
   Barroso-Neto, Ito L.
   Teixeira, Claudener S.
   Santiago, Mayara Q.
   Pires, Alana F.
   Souza, Luiz A. G.
   Nascimento, Kyria S.
   Sampaio, Alexandre H.
   Delatorre, Plinio
   Assreuy, Ana M. S.
   Cavada, Benildo S.
TI CRLI induces vascular smooth muscle relaxation and suggests a dual
   mechanism of eNOS activation by legume lectins via muscarinic receptors
   and shear stress
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Lectin; Heparan sulfate; Nitric oxide; Endothelial cell; Molecular
   docking; Protein crystallography
ID RAY DIFFRACTION ANALYSIS; CYMBOSEMA-ROSEUM SEEDS; NITRIC-OXIDE SYNTHASE;
   ENDOTHELIAL-CELLS; CARBOHYDRATE-RECOGNITION; STRUCTURAL-ANALYSIS;
   CRYSTAL-STRUCTURE; BINDING-SITES; RABBIT AORTA; CALCIUM
AB Lectins are proteins able to recognize carbohydrates, without modifying their structure, via the carbohydrate-recognition domain (CRD). Here, the three-dimensional structure of the mannose-binding lectin isolated from Cymbosema roseum (CRLI) was determined with X-man molecule modeled into the carbohydrate recognition domain. CRLI relaxant activity in thoracic rat aorta was also investigated, and based on the results, a molecular docking of CRLI with heparan sulfate was performed to investigate the possible interaction with mechanoreceptors involved in vasorelaxation. CRLI (IC50=12.4 mu g mL(-1)) elicited vasorelaxant response (96%) in endothelialized rat aorta contracted with phenylephrine. Endothelium-derived relaxant factors, extracellular calcium (Ca-e(2+)) and muscarinic receptors were also evaluated as putative participants in the CRLI relaxant effect. CRLI relaxant effect was blocked by L-NAME, a nonselective inhibitor of nitric oxide synthase (NOS), and partially inhibited in a calcium-free solution (0Ca) and by atropine, but it remained unchanged in the presence of indomethacin and TEA. In summary, our data suggest interaction between CRLI and muscarinic receptors located in vascular endothelial cells leading to NOS activation triggered by a mechanism that involves Ca-e(2+) along with the ability of CRLI to interact with heparan sulfate, a highly rated mechanoreceptor involved in eNOS activation. (C) 2014 Published by Elsevier Inc.
C1 [Rocha, Bruno A. M.; Barroso-Neto, Ito L.; Teixeira, Claudener S.; Santiago, Mayara Q.; Nascimento, Kyria S.; Cavada, Benildo S.] Univ Fed Ceara, Lab Mol Biologicamente Ativas, Fortaleza, Ceara, Brazil.
   [Teixeira, Claudener S.] Univ Reg Cariri, Dept Ciencias Biol, Campos Sales, Brazil.
   [Teixeira, Claudener S.] Univ Estadual Ceara, Inst Super Ciencias Biomed, Fortaleza, Ceara, Brazil.
   [Souza, Luiz A. G.] INPA, Manaus, Amazonas, Brazil.
   [Sampaio, Alexandre H.] Univ Fed Ceara, Dept Engn Pesca, Fortaleza, Ceara, Brazil.
   [Delatorre, Plinio] Univ Fed Paraiba, Dept Biol Mol, BR-58059900 Joao Pessoa, Paraiba, Brazil.
RP Delatorre, P (reprint author), Univ Fed Paraiba, Dept Biol Mol, BR-58059900 Joao Pessoa, Paraiba, Brazil.
EM pldelatorre@gmail.com; bscavada@ufc.br
RI Rocha, Bruno /E-2919-2015
FU Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico -
   FUNCAP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -
   CAPES; National Synchrotron Light Laboratory - LNLS, Brazil;
   Universidade Regional do Cariri - URCA
FX This work was supported by the Fundacao Cearense de Apoio ao
   Desenvolvimento Cientifico e Tecnologico - FUNCAP, Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq, Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - CAPES, National
   Synchrotron Light Laboratory - LNLS, Brazil, and Universidade Regional
   do Cariri - URCA. BAMR, PD, AMSA, KSN, AHS and BSC are senior
   investigators of CNPq. We thank David Martin for helping with the
   English language editing of the manuscript.
CR Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   LUCKHOFF A, 1988, BRIT J PHARMACOL, V95, P189
   FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Cavada BS, 2001, CURR PROTEIN PEPT SC, V2, P123, DOI 10.2174/1389203013381152
   Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81
   Gadelha CAD, 2005, J STRUCT BIOL, V152, P185, DOI 10.1016/j.jsb.2005.07.012
   Assreuy AMS, 2009, N-S ARCH PHARMACOL, V380, P509, DOI 10.1007/s00210-009-0465-1
   Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   KLEHA JF, 1991, BRIT J PHARMACOL, V104, P287
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Bezerra MJB, 2013, INT J BIOCHEM CELL B, V45, P807, DOI 10.1016/j.biocel.2013.01.012
   Ayajiki K, 1996, CIRC RES, V78, P750
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   Komath SS, 2006, ORG BIOMOL CHEM, V4, P973, DOI 10.1039/b515446d
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e
   Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9
   BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U
   Mochizuki S, 2003, AM J PHYSIOL-HEART C, V285, pH722, DOI 10.1152/ajpheart.00691.2002
   White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128
   Quartara L, 1997, NEUROPEPTIDES, V31, P537, DOI 10.1016/S0143-4179(97)90001-9
   Assreuy AMS, 2011, PROTEIN PEPTIDE LETT, V18, P1107
   Babosha AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P812, DOI 10.1134/S0006297908070109
   Barroso-Neto IL, 2014, ARCH BIOCHEM BIOPHYS, V543, P31, DOI 10.1016/j.abb.2013.12.006
   Bezerra EHS, 2011, BIOCHEM BIOPH RES CO, V408, P566, DOI 10.1016/j.bbrc.2011.04.061
   BUSSE R, 1995, ANN MED, V27, P331, DOI 10.3109/07853899509002586
   Cavada BS, 2006, ACTA CRYSTALLOGR F, V62, P235, DOI 10.1107/S174430910600371X
   Chen PF, 1997, J BIOL CHEM, V272, P6114
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Delatorre P., 2007, BMC STRUCT BIOL, V7, P1
   Fleming R., 2003, AM J PHYSIOL-REG I, V284, P1
   Florian JA, 2003, CIRC RES, V93, P136
   Forst T, 2004, EXP DIABESITY RES, V5, P51, DOI 10.1080/15438600490424532
   Kuchan M., 1994, AM J PHYSL 1, V266, P628
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Laurie R.M., 2005, BIOINFORMATICS, V21, P1908
   Luzzati P.V., 1952, ACTA CRYSTALLOGR, V5, P802
   Murshudov G., 2011, ACTA CRYSTALLOGR D, V67, P335
   Nagano C., 2008, BIOCHEM J, V409, P1
   Nascimento A., 2012, J MOL RECOGNIT, V25, P657
   Nobrega RB, 2012, BIOCHIMIE, V94, P900
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   ROBERTS DD, 1983, J BIOL CHEM, V258, P3820
   Rocha B, 2009, APPL BIOCHEM BIOTECH, V152, P383, DOI 10.1007/s12010-008-8334-9
   Rocha BAM, 2011, BIOCHIMIE, V93, P806, DOI 10.1016/j.biochi.2011.01.006
   Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679
   Sharon N, 2001, ADV EXP MED BIOL, V491, P1
   SINGER HA, 1982, HYPERTENSION, V4, P19
   Van Damme E. J., 1998, HDB PLANT LECTINS PR
NR 53
TC 0
Z9 0
U1 5
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2015
VL 565
BP 32
EP 39
DI 10.1016/j.abb.2014.11.003
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ1OL
UT WOS:000348008000005
PM 25444858
ER

PT J
AU Deacon, JC
   Engelman, DM
   Barrera, FN
AF Deacon, John C.
   Engelman, Donald M.
   Barrera, Francisco N.
TI Targeting acidity in diseased tissues: Mechanism and applications of the
   membrane-inserting peptide, pHLIP
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Membrane insertion; Tumor targeting; Transmembrane; Tumor
   microenvironment
ID CELL-PENETRATING PEPTIDES; TOXIN T-DOMAIN; DIPHTHERIA-TOXIN;
   DRUG-DELIVERY; TRANSMEMBRANE HELIX; CANCER-CELLS; LIPID-BILAYER;
   LUNG-CANCER; IN-VIVO; PH
AB pHLIPs are a family of soluble similar to 36 amino acid peptides, which bind to membrane surfaces. If the environment is acidic, a pHLIP folds and inserts across the membrane to form a stable transmembrane helix, thus preferentially locating itself in acidic tissues. Since tumors and other disease tissues are acidic, pHLIPs' low-pH targeting behavior leads to applications as carriers for diagnostic and surgical imaging agents. The energy of membrane insertion can also be used to promote the insertion of modestly polar, normally cell-impermeable cargos across the cell membrane into the cytosol of targeted cells, leading to applications in tumor-targeted delivery of therapeutic molecules. We review the biochemical and biophysical basis of pHLIPs' unique properties, diagnostic and therapeutic applications, and the principles upon which translational applications are being developed. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Deacon, John C.; Engelman, Donald M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.
   [Barrera, Francisco N.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.
RP Barrera, FN (reprint author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.
EM fbarrera@utk.edu
FU NIH [R01-GM073857-08]
FX We are grateful to Yana Reshetnyak, Haden Scott and Alexander
   Karabadzhak for helpful comments on the manuscript. This research was
   partially funded by NIH R01-GM073857-08 (DME).
CR Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796
   Sosunov EA, 2013, P NATL ACAD SCI USA, V110, P82, DOI 10.1073/pnas.1220038110
   Pan JJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021931
   Reshetnyak YK, 2006, P NATL ACAD SCI USA, V103, P6460, DOI 10.1073/pnas.0601463103
   Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   Barrera FN, 2008, BIOCHEMISTRY-US, V47, P2123, DOI 10.1021/bi700778c
   Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766
   Fu L, 2011, J AM CHEM SOC, V133, P8094, DOI 10.1021/ja201575e
   Emmetiere F, 2013, BIOCONJUGATE CHEM, V24, P1784, DOI 10.1021/bc400322h
   Foged C, 2008, EXPERT OPIN DRUG DEL, V5, P105, DOI 10.1517/17425247.5.1.105
   Barrera FN, 2011, J MOL BIOL, V413, P359, DOI 10.1016/j.jmb.2011.08.010
   Booth PJ, 2012, CURR OPIN STRUC BIOL, V22, P469, DOI 10.1016/j.sbi.2012.03.008
   Weerakkody D, 2013, P NATL ACAD SCI USA, V110, P5834, DOI 10.1073/pnas.1303708110
   Trehin R, 2004, EUR J PHARM BIOPHARM, V58, P209, DOI 10.1016/j.ejpb.2004.02.018
   Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104
   An M, 2010, P NATL ACAD SCI USA, V107, P20246, DOI 10.1073/pnas.1014403107
   Nasrollahi SA, 2012, CHEM BIOL DRUG DES, V80, P639, DOI 10.1111/cbdd.12008
   Reshetnyak YK, 2008, P NATL ACAD SCI USA, V105, P15340, DOI 10.1073/pnas.0804746105
   Yamashita F, 2013, ADV DRUG DELIVER REV, V65, P139, DOI 10.1016/j.addr.2012.11.006
   Andreev OA, 2007, P NATL ACAD SCI USA, V104, P7893, DOI 10.1073/pnas.0702439104
   Barrera FN, 2012, P NATL ACAD SCI USA, V109, P14422, DOI 10.1073/pnas.1212665109
   Torchilin VP, 2007, PHARM RES, V24, P1, DOI 10.1007/s11095-006-9132-0
   Lyass O, 2000, CANCER, V89, P1037, DOI 10.1002/1097-0142(20000901)89:5<1037::AID-CNCR13>3.0.CO;2-Z
   Jakes KS, 2012, ANNU REV GENET, V46, P209, DOI 10.1146/annurev-genet-110711-155427
   Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806
   Daumar P, 2012, BIOCONJUGATE CHEM, V23, P1557, DOI 10.1021/bc3000222
   Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531
   Reshetnyak YK, 2011, MOL IMAGING BIOL, V13, P1146, DOI 10.1007/s11307-010-0457-z
   Adochite RC, 2014, MOL PHARMACEUT, V11, P2896, DOI 10.1021/mp5002526
   Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730
   Hendrich AB, 2003, CURR DRUG TARGETS, V4, P23, DOI 10.2174/1389450033347172
   Andreev OA, 2009, CHIM OGGI, V27, P34
   Fendos J, 2013, BIOCHEMISTRY-US, V52, P4595, DOI 10.1021/bi400252k
   Andreev OA, 2010, MOL MEMBR BIOL, V27, P341, DOI 10.3109/09687688.2010.509285
   Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15177, DOI 10.1021/bi970147b
   Harms MJ, 2009, J MOL BIOL, V389, P34, DOI 10.1016/j.jmb.2009.03.039
   Kucerka N, 2007, EUR PHYS J E, V23, P247, DOI 10.1140/epje/i2007-10202-8
   Musial-Siwek M, 2010, BBA-BIOMEMBRANES, V1798, P1041, DOI 10.1016/j.bbamem.2009.08.023
   Kurnikov IV, 2013, J MOL BIOL, V425, P2752, DOI 10.1016/j.jmb.2013.04.030
   Loja MN, 2013, INT J CANCER, V132, P1613, DOI 10.1002/ijc.27837
   van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218
   TARABOLETTI G, 1989, INT J CANCER, V44, P707, DOI 10.1002/ijc.2910440426
   Booth PJ, 2006, CURR OPIN STRUC BIOL, V16, P480, DOI 10.1016/j.sbi.2006.06.004
   Zoonens M, 2008, BIOPHYS J, V95, P225, DOI 10.1529/biophysj.107.124156
   Yao L, 2013, P NATL ACAD SCI USA, V110, P465, DOI 10.1073/pnas.1219665110
   Andreev OA, 2010, P NATL ACAD SCI USA, V107, P4081, DOI 10.1073/pnas.0914330107
   Sok M, 1999, CANCER LETT, V139, P215, DOI 10.1016/S0304-3835(99)00044-0
   Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395
   Macholl S, 2012, MOL IMAGING BIOL, V14, P725, DOI 10.1007/s11307-012-0549-z
   Davies A, 2012, P NATL ACAD SCI USA, V109, P1862, DOI 10.1073/pnas.1112132109
   Reshetnyak YK, 2007, BIOPHYS J, V93, P2363, DOI 10.1529/biophysj.107.109967
   Choi YS, 2014, CURR PHARM BIOTECHNO, V15, P192
   Viola-Villegas NT, 2014, P NATL ACAD SCI USA, V111, P7254, DOI 10.1073/pnas.1405240111
   Yao L, 2013, J CONTROL RELEASE, V167, P228, DOI 10.1016/j.jconrel.2013.01.037
   Vavere AL, 2009, CANCER RES, V69, P4510, DOI 10.1158/0008-5472.CAN-08-3781
   Baritaki S, 2007, ADV CANCER RES, V98, P149, DOI 10.1016/S0065-230X(06)98005-1
   BRAUNFALCO O, 1986, HAUTARZT, V37, P126
   Brown MC, 2014, BIOPHYS CHEM, V187, P1, DOI 10.1016/j.bpc.2013.12.004
   Cheng CJ, 2014, NATURE
   Cruz-Monserrate Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep04410
   Deng YH, 2013, INT J MOL SCI, V14, P14532, DOI 10.3390/ijms140714532
   Findlay HE, 2010, P NATL ACAD SCI USA, V107, P18451, DOI 10.1073/pnas.1005729107
   Guo L, 2010, BIOPHYS J, V98, P2914, DOI 10.1016/j.bpj.2010.03.050
   Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15156, DOI 10.1021/bi970146j
   Karabadzhak A. G., 2014, ACS CHEM BIOL
   Karabadzhak AG, 2012, BIOPHYS J, V102, P1846, DOI 10.1016/j.bpj.2012.03.021
   Ladokhin AS, 2009, METHOD ENZYMOL, V466, P19, DOI 10.1016/S0076-6879(09)66002-X
   Ladokhin AS, 2005, BIOCHEMISTRY-US, V44, P3402, DOI 10.1021/bi047805u
   Ladokhin AS, 2004, BIOCHEMISTRY-US, V43, P7451, DOI 10.1021/bi036157w
   Langen R, 1998, P NATL ACAD SCI USA, V95, P14060, DOI 10.1073/pnas.95.24.14060
   Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j
   Li N, 2013, FUTURE MICROBIOL, V8, P257, DOI [10.2217/fmb.12.134, 10.2217/FMB.12.134]
   Luo Z., 2014, CANC PREV RES
   Marti DN, 2005, BIOPHYS CHEM, V118, P88, DOI 10.1016/j.bpc.2005.06.011
   Moshnikova A, 2013, BIOCHEMISTRY-US, V52, P1171, DOI 10.1021/bi301647y
   Musial-Siwek M., 2009, BIOCH BIOPHYS ACTA
   Otzen DE, 2013, ARCH BIOCHEM BIOPHYS, V531, P34, DOI 10.1016/j.abb.2012.10.008
   Preetha A, 2007, COLLOID SURFACE B, V60, P12, DOI 10.1016/j.colsurfb.2007.05.015
   Renthal R, 2006, BIOCHEMISTRY-US, V45, P14559, DOI 10.1021/bi0620454
   Segala J, 2009, INT J MOL SCI, V10, P3478, DOI 10.3390/ijms10083478
   Sok M, 2002, ANN THORAC SURG, V73, P1567, DOI 10.1016/S0003-4975(02)03458-6
   Tang J, 2008, BIOCHEMISTRY-US, V47, P8250, DOI 10.1021/bi801103x
   Tang J., 2008, BIOCHEMISTRY
   Vargas-Uribe M, 2013, BIOCHEMISTRY-US, V52, P7901, DOI 10.1021/bi400926k
   VOLK T, 1993, BRIT J CANCER, V68, P492, DOI 10.1038/bjc.1993.375
   Wijesinghe D, 2011, BIOCHEMISTRY-US, V50, P10215, DOI 10.1021/bi2009773
   Wijesinghe D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03560
   Zakharov SD, 1999, BIOCHEMISTRY-US, V38, P11325, DOI 10.1021/bi9903087
   ZHAN HJ, 1995, BIOCHEMISTRY-US, V34, P4856, DOI 10.1021/bi00014a043
NR 90
TC 3
Z9 3
U1 6
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2015
VL 565
BP 40
EP 48
DI 10.1016/j.abb.2014.11.002
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ1OL
UT WOS:000348008000006
PM 25444855
ER

PT J
AU Li, W
   Pierce, BS
AF Li, Wei
   Pierce, Brad S.
TI Steady-state substrate specificity and O-2-coupling efficiency of mouse
   cysteine dioxygenase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Non-heme iron; Cysteine; Dioxygenase; Specificity; Coupling; Thiols
ID NONHEME IRON ENZYMES; CROSS-LINK FORMATION; MECHANISTIC IMPLICATIONS;
   VARIOVORAX-PARADOXUS; OXIDATION; INTERMEDIATE; PROTEIN; PURIFICATION;
   METABOLISM; ACTIVATION
AB Cysteine dioxygenase (CDO) is a non-heme mononuclear iron enzyme that catalyzes the oxygendependent oxidation of L-cysteine (Cys) to produce L-cysteine sulfinic acid (CSA). Sequence alignment of mammalian COO with recently discovered thiol dioxygenase enzymes suggests that the mononuclear iron site within all enzymes in this class share a common 3-His first coordination sphere. This implies a similar mechanistic paradigm among thiol dioxygenase enzymes. Although steady-state studies were first reported for mammalian CDO over 45 years ago, detailed analysis of the specificity for alternative thiol-bearing substrates and their oxidative coupling efficiencies have not been reported for this enzyme. Assuming a similar mechanistic theme among this class of enzymes, characterization of the CDO substrate specificity may provide valuable insight into substrate-active site intermolecular during thiol oxidation. In this work, the substrate-specificity for wild-type Mus musculus CDO was investigated using NMR spectroscopy and LC-MS for a variety of thiol-bearing substrates. Tandem mass spectrometry was used to confirm dioxygenase activity for each non-native substrate investigated. Steady-state MichaelisMenten parameters for sulfinic acid product formation and O-2-consumption were compared to establish the coupling efficiency for each reaction. In light of these results, the minimal substrate requirements for CDO catalysis and O-2-activation are discussed. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Li, Wei; Pierce, Brad S.] Univ Texas Arlington, Dept Chem & Biochem, Coll Sci, Arlington, TX 76019 USA.
RP Pierce, BS (reprint author), Univ Texas Arlington, Dept Chem & Biochem, 700 Planetarium Pl,Room 130, Arlington, TX 76019 USA.
EM bspierce@uta.edu
FU NSF (CHE) [1213655]; NSF (CRIF:MU) [CHE-0840509]
FX This work was supported by NSF (CHE) 1213655 to B.S.P. We would also
   like to acknowledge NSF financial support (CRIF:MU CHE-0840509) for the
   purchase of the JEOL ECA500 500 MHz FT-NMR spectrometers and the UTA
   Shimadzu Center for Advanced Analytical Chemistry for the use of HPLC
   and LC-MS/MS instrumentation.
CR Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418
   Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200
   Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200
   Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n
   Siakkou E, 2010, ANAL BIOCHEM, V405, P127, DOI 10.1016/j.ab.2010.06.013
   Chai SC, 2005, J BIOL CHEM, V280, P9865, DOI 10.1074/jbc.M413733200
   Dominy JE, 2006, J BACTERIOL, V188, P5561, DOI 10.1128/JB.00291-06
   Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275
   Siakkou E, 2011, BBA-PROTEINS PROTEOM, V1814, P2003, DOI 10.1016/j.bbapap.2011.07.019
   Li W, 2013, BIOCHEMISTRY-US, V52, P9104, DOI 10.1021/bi4010232
   Bantan-Polak T, 2001, ANAL BIOCHEM, V297, P128, DOI 10.1006/abio.2001.5338
   HEAFIELD MT, 1990, NEUROSCI LETT, V110, P216, DOI 10.1016/0304-3940(90)90814-P
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001
   GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521
   Driggers CM, 2013, J MOL BIOL, V425, P3121, DOI 10.1016/j.jmb.2013.05.028
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Dominy J, 2007, J BIOL CHEM, V282, P25189, DOI 10.1074/jbc.M703089200
   Easson LH, 1933, BIOCHEM J, V27, P1257
   Simmons CR, 2006, PROTEIN EXPRES PURIF, V47, P74, DOI 10.1016/j.pep.2005.10.025
   Bruland N, 2009, J BIOL CHEM, V284, P660, DOI 10.1074/jbc.M806762200
   Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d
   Dominy JE, 2008, J BIOL CHEM, V283, P12188, DOI 10.1074/jbc.M800044200
   Kasperova A, 2011, MYCOSES, V54, pE456, DOI 10.1111/j.1439-0507.2010.01948.x
   Simmons CR, 2008, BIOCHEMISTRY-US, V47, P11390, DOI 10.1021/bi801546n
   Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028
   Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803
   BAGLEY PJ, 1995, ANAL BIOCHEM, V227, P40, DOI 10.1006/abio.1995.1250
   Behave D. P., 2007, INFECT DISORD DRUG T, V7, P140
   Brandt U, 2014, APPL MICROBIOL BIOT, V98, P6039, DOI 10.1007/s00253-014-5811-7
   Corder AL, 2013, BIOCHEMISTRY-US, V52, P6182, DOI 10.1021/bi4000832
   Crawford JA, 2011, BIOCHEMISTRY-US, V50, P10241, DOI 10.1021/bi2011724
   Crowell J.K., 2014, BIOCHEMISTR IN PRESS
   Dean J.A., 1992, LANGES HDB CHEM
   EWETZ L, 1966, BIOCHIM BIOPHYS ACTA, V128, P296, DOI 10.1016/0926-6593(66)90176-7
   Gardner JD, 2010, BIOCHEMISTRY-US, V49, P6033, DOI 10.1021/bi100189h
   GORDON C, 1992, LANCET, V339, P25, DOI 10.1016/0140-6736(92)90144-R
   Heron S, 2007, J CHROMATOGR A, V1161, P152, DOI 10.1016/j.chroma.2007.05.101
   Hillas PJ, 1996, BIOCHEMISTRY-US, V35, P6969, DOI 10.1021/bi9606861
   LOMBARDI.JB, 1969, J BIOL CHEM, V244, P1172
   MISRA CH, 1983, NEUROCHEM RES, V8, P1497, DOI 10.1007/BF00965005
   Njeri CW, 2014, ARCH BIOCHEM BIOPHYS, V558, P61, DOI 10.1016/j.abb.2014.06.001
   SOERBO B, 1965, Biochem Biophys Res Commun, V18, P359
   Solomon EI, 2003, P NATL ACAD SCI USA, V100, P3589, DOI 10.1073/pnas.0336792100
   Stipanuk M., 2010, AMINO ACIDS, P1
   YOST RA, 1983, MASS SPECTROM REV, V2, P1, DOI 10.1002/mas.1280020102
NR 46
TC 1
Z9 1
U1 5
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2015
VL 565
BP 49
EP 56
DI 10.1016/j.abb.2014.11.004
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ1OL
UT WOS:000348008000007
PM 25444857
ER

PT J
AU Seraphim, TV
   Gava, LM
   Mokry, DZ
   Cagliari, TC
   Barbosa, LRS
   Ramos, CHI
   Borges, JC
AF Seraphim, Thiago V.
   Gava, Lisandra M.
   Mokry, David Z.
   Cagliari, Thiago C.
   Barbosa, Leandro R. S.
   Ramos, Carlos H. I.
   Borges, Julio C.
TI The C-terminal region of the human p23 chaperone modulates its structure
   and function
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE p23; p19; Hsp90; Sba1; Molecular chaperone
ID HSP90 COCHAPERONE P23; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE;
   PROGESTERONE-RECEPTOR; PROTEIN P23; CELL-DEATH; IN-VIVO; COMPLEX;
   CANCER; PHOSPHORYLATION
AB The p23 protein is a chaperone widely involved in protein homeostasis, well known as an Hsp90 cochaperone since it also controls the Hsp90 chaperone cycle. Human p23 includes a 13-sheet domain, responsible for interacting with Hsp90; and a charged C-terminal region whose function is not clear, but seems to be natively unfolded. p23 can undergo caspase-dependent proteolytic cleavage to form p19 (p231-142), which is involved in apoptosis, while p23 has anti-apoptotic activity. To better elucidate the function of the human p23 C-terminal region, we studied comparatively the full-length human p23 and three C-terminal truncation mutants: p231_117; p231-131 and p231_142. Our data indicate that p23 and p19 have distinct characteristics, whereas the other two truncations behave similarly, with some differences to p23 and p19. We found that part of the C-terminal region can fold in an a-helix conformation and slightly contributes to p23 thermal-stability, suggesting that the C-terminal interacts with the 13-sheet domain. As a whole, our results suggest that the C-terminal region of p23 is critical for its structure-function relationship. A mechanism where the human p23 C-terminal region behaves as an activation/inhibition module for different p23 activities is proposed. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Seraphim, Thiago V.; Borges, Julio C.] Univ Sao Paulo, Inst Chem Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
   [Gava, Lisandra M.] Fed Univ Sao Carlos UFSCar, Dept Genet & Evolut, BR-13565905 Sao Carlos, SP, Brazil.
   [Mokry, David Z.; Cagliari, Thiago C.; Ramos, Carlos H. I.] Univ Campinas UNICAMP, Inst Chem, BR-13083970 Campinas, SP, Brazil.
   [Cagliari, Thiago C.] Univ Campinas UNICAMP, Inst Biol, BR-13083970 Campinas, SP, Brazil.
   [Barbosa, Leandro R. S.] Univ Sao Paulo, Inst Phys, BR-05508090 Sao Paulo, Brazil.
RP Ramos, CHI (reprint author), Univ Campinas UNICAMP, Inst Chem, POB 6154, BR-13083970 Campinas, SP, Brazil.
EM cramos@iqm.unicamp.br; borgesjc@iqsc.usp.br
RI Borges, Julio/C-6160-2008; Barbosa, Leandro/E-6577-2012; Ramos,
   Carlos/C-1571-2012; 
OI Borges, Julio/0000-0003-4856-748X; Ramos, Carlos/0000-0002-7246-9081;
   Barbosa, Leandro/0000-0001-5997-2160
FU FAPESP - Brazil [2011/23110-0, 2012/50161-8]
FX CHIR, JCB and LRSB are CNPq Research Fellows and thank FAPESP - Brazil
   (2011/23110-0; 2012/50161-8) and CNPq - Brazil for financial support. We
   thank the LNBio/CNPEM-ABTLuS (Campinas, Brazil) for making the AUC
   device available. We also thank the LNLS/CNPEM-ABTLuS (Campinas, Brazil)
   staff for use of the SAXS beamline.
CR Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y
   Felts SJ, 2003, CELL STRESS CHAPERON, V8, P108, DOI 10.1379/1466-1268(2003)008<0108:PASPWC>2.0.CO;2
   Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Weikl T, 1999, J MOL BIOL, V293, P685, DOI 10.1006/jmbi.1999.3172
   Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200
   Woo SH, 2009, J BIOL CHEM, V284, P30871, DOI 10.1074/jbc.M109.052720
   Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206
   Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715
   Simpson NE, 2010, CANCER RES, V70, P8446, DOI 10.1158/0008-5472.CAN-10-1590
   Echtenkamp FJ, 2011, MOL CELL, V43, P229, DOI 10.1016/j.molcel.2011.05.029
   Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2
   Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108
   Trudeau T, 2013, STRUCTURE, V21, P332, DOI 10.1016/j.str.2012.12.013
   ELBLE R, 1992, BIOTECHNIQUES, V13, P18
   Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716
   SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X
   Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085
   Deleage G, 2001, COMPUT BIOL MED, V31, P259, DOI 10.1016/S0010-4825(01)00008-7
   Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Borges JC, 2011, CURR MED CHEM, V18, P1276
   Kroll ES, 1996, GENETICS, V143, P95
   Schuck P, 2000, BIOPHYS J, V78, P1606
   Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200
   Tosoni K, 2011, MOL CELL BIOCHEM, V356, P245, DOI 10.1007/s11010-011-0969-0
   Martinez-Yamout MA, 2006, J BIOL CHEM, V281, P14457, DOI 10.1074/jbc.M601759200
   Patwardhan CA, 2013, J BIOL CHEM, V288, P7313, DOI 10.1074/jbc.M112.427328
   Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064
   Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B
   Bohen SP, 1998, MOL CELL BIOL, V18, P3330
   Correcirc DH, 2009, AFR J BIOCH RES, V3, P164
   da Silva VCH, 2012, J PROTEOMICS, V75, P2790, DOI 10.1016/j.jprot.2011.12.028
   Echtenkamp F.J., 2014, MOL CHAPERONES INTER, P207
   Forafonov F, 2008, MOL CELL BIOL, V28, P3446, DOI 10.1128/MCB.02246-07
   Gausdal G, 2004, LEUKEMIA, V18, P1989, DOI 10.1038/sj.leu.2403508
   Gaya L.M., 2009, CURR CHEM BIOL, V3, P10
   Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06
   JOHNSON JL, 1994, J BIOL CHEM, V269, P24989
   JOHNSON JL, 1995, MOL ENDOCRINOL, V9, P670, DOI 10.1210/me.9.6.670
   JOHNSON JL, 1994, MOL CELL BIOL, V14, P1956
   Kobayashi T, 2004, BIOCHEM J, V381, P59, DOI 10.1042/BJ20040118
   Mollerup J, 2005, FEBS LETT, V579, P4187, DOI 10.1016/j.febslet.2005.06.045
   Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2
   Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157
   Poksay K., 2011, J MOL NEUROSCI, P1
   Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761
   Song D., 2014, J BIOL CHEM
   Toogun OA, 2007, P NATL ACAD SCI USA, V104, P5765, DOI 10.1073/pnas.0701442104
   Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930
NR 52
TC 3
Z9 3
U1 4
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2015
VL 565
BP 57
EP 67
DI 10.1016/j.abb.2014.10.015
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ1OL
UT WOS:000348008000008
PM 25447839
ER

PT J
AU Tang, YL
   Yin, Y
   Miao, L
   Wei, B
   Zhai, K
   Ji, GJ
AF Tang, Yinglong
   Yin, Yin
   Miao, Lin
   Wei, Bin
   Zhai, Kui
   Ji, Guangju
TI Nitric oxide enhances extracellular ATP induced Ca2+ oscillation in He
   La cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Nitric oxide; Calcium oscillation; eNOS; Phospholamban
ID ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELLS; ENOS
   PHOSPHORYLATION; SPATIAL CONFINEMENT; SIGNAL-TRANSDUCTION;
   SMOOTH-MUSCLE; ACTIVATION; SYNTHASE; TRANSLOCATION; RECEPTORS
AB Calcium (Ca2+) oscillations play a central role in varieties of cellular processes including fertilization and immune response, but controversy over the regulation mechanisms still exists. It has been known that nitric oxide (NO) dependently regulates Ca2+ signaling in most physiopathological processes. Previous study indicated that eNOS translocation during some pathological process influences intracellular Ca2+ homeostasis. In this study, we investigated the role and mechanism of NO on Ca2+ release by overexpressing eNOS in cytoplasm (Cyto-eNOS) and endoplasmic reticulum (ER-eNOS) of HeLa cells. We found that the properties of Ca2+ release were altered by the overexpression of eNOS. The amplitude and frequency of extracellular ATP (eATP)-induced Ca2+ oscillation were enhanced in both Cyto-eNOS and ER-eNOS cells, respectively. Especially, the enhancement of the amplitude and frequency of the Ca2+ oscillation was much more significant in the ER-eNOS cells than that of Cyto-eNOS cells. Further study indicated that this effect was abrogated by NO inhibitor, 1..-NAME, suggesting it was not an artificial result induced by ER stress. Furthermore, an up-regulated phosphorylation of phospholamban (PLB) was observed and the sarco-endoplasmic reticulum Ca2tATPase (SERCA) function was activated followed by the significant increase in the ER Ca2+ load. Taken together, we revealed a novel regulatory mechanism of Ca2+ oscillation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Tang, Yinglong; Miao, Lin; Zhai, Kui; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
   [Yin, Yin] Gen Hosp Air Force, Beijing, Peoples R China.
   [Wei, Bin] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA.
   [Tang, Yinglong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Ji, GJ (reprint author), Chinese Acad Sci, Inst Biophys, Beijing Datun Rd 15, Beijing 100101, Peoples R China.
EM gj28@ibp.ac.cn
FU National Basic Research Program of China [2011CB809104]; National
   Foundation of Sciences and Technology [31271228]
FX This work was supported by Grants from the National Basic Research
   Program of China (2011CB809104 to GJ) and the National Foundation of
   Sciences and Technology (31271228 to GJ).
CR Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6
   Siow NL, 2010, MOL PHARMACOL, V78, P1059, DOI 10.1124/mol.110.066506
   Barouch LA, 2002, NATURE, V416, P337
   Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048
   Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013
   Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907
   Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JC126373
   Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028
   Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2
   Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007
   Belke DD, 2004, CURR HYPERTENS REP, V6, P424, DOI 10.1007/s11906-004-0035-3
   Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200
   Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421
   Massion PB, 2003, CIRC RES, V93, P388, DOI 10.1161/01.RES.0000088351.58510.21
   Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220
   Cardozo AK, 2005, DIABETES, V54, P452
   Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC
   Chen Z, 2009, BIOCHEM BIOPH RES CO, V382, P381, DOI 10.1016/j.bbrc.2009.03.030
   Colella M, 2008, P NATL ACAD SCI USA, V105, P2859, DOI 10.1073/pnas.0712316105
   Colyer J, 1998, ANN NY ACAD SCI, V853, P79, DOI 10.1111/j.1749-6632.1998.tb08258.x
   Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005
   Dui W., 2013, MOL BIOL CELL, V24, pS1671
   Hare JM, 2004, LANCET, V363, P1338, DOI 10.1016/S0140-6736(04)16083-2
   Ott SR, 2007, EUR J NEUROSCI, V25, P181, DOI 10.1111/j.1460-9568.2006.05271.x
   Pott C, 2006, AM J PHYSIOL-CELL PH, V290, pC1437, DOI 10.1152/ajpcell.00005.2005
   Ruiz-Holst C, 2010, CAN J PHYSIOL PHARM, V88, P121, DOI 10.1139/Y09-115
   Sakurai A, 1999, MOL HUM REPROD, V5, P132, DOI 10.1093/molehr/5.2.132
   Schreiber F, 2008, ANAL CHEM, V80, P1152, DOI 10.1021/ac071563x
   Shah JH, 2007, ADV EXP MED BIOL, V599, P133
   Wei B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002526
   Wei B, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-12
   Welter-Stahl L, 2009, BBA-BIOMEMBRANES, V1788, P1176, DOI 10.1016/j.bbamem.2009.03.006
   Wenzel S, 2007, HYPERTENSION, V49, P193, DOI 10.1161/01.HYP.0000250468.02084.ce
   Yang Y, 2004, CELL BIOL INT, V28, P577, DOI 10.1016/j.cellbi.2004.05.001
   Zhu Y, 2003, BBA-MOL CELL BIOL L, V1635, P117, DOI 10.1016/j.bbalip.2003.10.011
NR 35
TC 0
Z9 0
U1 1
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2015
VL 565
BP 68
EP 75
DI 10.1016/j.abb.2014.11.006
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ1OL
UT WOS:000348008000009
PM 25461674
ER

PT J
AU Gao, H
   Peng, XJ
   Li, ZM
   Li, M
   Gao, S
   He, YH
   Wang, JJ
   Zeng, SY
   Liu, XP
   Huang, XY
   Chen, SR
   Liu, PQ
AF Gao, Hui
   Peng, Xiao-jun
   Li, Zhuo-ming
   Li, Min
   Gao, Si
   He, Yan-hong
   Wang, Jiao-jiao
   Zeng, Si-yu
   Liu, Xue-ping
   Huang, Xiao-yang
   Chen, Shao-rui
   Liu, Pei-qing
TI Downregulation of adipose triglyceride lipase promotes cardiomyocyte
   hypertrophy by triggering the accumulation of ceramides
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Adipose triglyceride lipase; Ceramide; Fatty acid uptake; Fatty acid
   oxidation; Cardiac hypertrophy
ID TANDEM MASS-SPECTROMETRY; NECROSIS-FACTOR-ALPHA; FATTY-ACID OXIDATION;
   RECEPTOR PPAR-ALPHA; PRESSURE-OVERLOAD; CARDIAC-HYPERTROPHY;
   LIPID-METABOLISM; INSULIN-RESISTANCE; DYSFUNCTION; HEART
AB Adipose triglyceride lipase (ATGL), the rate-limiting enzyme of triglyceride (TG) hydrolysis, plays an important role in TG metabolism. ATGL knockout mice suffer from TG accumulation and die from heart failure. However, the mechanisms underlying cardiac hypertrophy caused by ATGL dysfunction remain unknown. In this study, we found that ATGL expression declined in pressure overload-induced cardiac hypertrophy in vivo and phenylephrine (PE)-induced cardiomyocyte hypertrophy in vitro. ATGL knockdown led to cardiomyocyte hypertrophy, while ATGL overexpression prevented PE-induced hypertrophy. In addition, ATGL downregulation increased but ATGL overexpression reduced the contents of ceramide, which has been proved to be closely associated with cardiac hypertrophy. Moreover, the accumulation of ceramide was due to elevation of free fatty acids in ATGL-knockdown cardiomyocytes, which could be explained by the reduced activity of peroxisome proliferator-activated receptor (PPAR) a leading to imbalance of fatty acid uptake and oxidation. These observations suggest that downregulation of ATGL causes the decreased PPAR alpha activity which results in the imbalance of FA uptake and oxidation, elevating intracellular FFA contents to promote the accumulation of ceramides, and finally inducing cardiac hypertrophy. Upregulation of ATGL could be a strategy for ameliorating lipotoxic damage in cardiac hypertrophy. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Gao, Hui; Peng, Xiao-jun; Li, Zhuo-ming; Li, Min; Gao, Si; He, Yan-hong; Wang, Jiao-jiao; Liu, Xue-ping; Huang, Xiao-yang; Chen, Shao-rui; Liu, Pei-qing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Guangzhou 510006, Guangdong, Peoples R China.
   [Gao, Hui] Jishou Univ, Sch Med, Dept Pharmacol, Jishou, Peoples R China.
   [Zeng, Si-yu] Seconds People Hosp Guangdong Prov, Dept Pharmaceut, Guangzhou, Guangdong, Peoples R China.
RP Chen, SR (reprint author), Sun Yat Sen Univ, Higher Educ Mega Ctr, Dept Pharmacol & Toxicol, Sch Pharmaceut Sci, 132 E Wai Huan Rd, Guangzhou 510006, Guangdong, Peoples R China.
EM chshaor@mail.sysu.edu.cn; liupq@mail.sysu.edu.cn
FU National Natural Science Foundation of China [81072641, 81273499];
   National Science and Technology Major Project of China "Key New Drug
   Creation and Manufacturing Program" [2011ZX09401-307]; Team item of
   Natural Science Foundation of Guangdong Province [S2011030003190]; Major
   Project of Guangdong Province [2008A030201013, 2012 A080201007]; Major
   Project of Department of Education of Guangdong Province [CXZD1006]
FX This work was supported by Grants from the National Natural Science
   Foundation of China (No. 81072641 and 81273499); the National Science
   and Technology Major Project of China "Key New Drug Creation and
   Manufacturing Program" (No. 2011ZX09401-307), Team item of Natural
   Science Foundation of Guangdong Province (No. S2011030003190), Major
   Project of Guangdong Province (No. 2008A030201013 and 2012 A080201007)
   and Major Project of Department of Education of Guangdong Province (No.
   CXZD1006).
CR Aflaki E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.17
   Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002
   Kienesberger PC, 2013, J MOL CELL CARDIOL, V55, P101, DOI 10.1016/j.yjmcc.2012.06.018
   Obrowsky S, 2013, J LIPID RES, V54, P425, DOI 10.1194/jlr.M031716
   Banke NH, 2010, CIRC RES, V107, P233, DOI 10.1161/CIRCRESAHA.110.221713
   Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888
   SADDIK M, 1991, J BIOL CHEM, V266, P8162
   Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Kemp S, 2004, CLIN CHEM, V50, P1824, DOI 10.1373/clinchem.2004.038539
   Phrommintikul A, 2008, AM J PHYSIOL-HEART C, V294, pH1804, DOI 10.1152/ajpheart.01078.2007
   Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006
   Kienesberger PC, 2012, MOL CELL BIOL, V32, P740, DOI 10.1128/MCB.06470-11
   Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494
   Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459
   Turpin SM, 2011, DIABETOLOGIA, V54, P146, DOI 10.1007/s00125-010-1895-5
   Badin PM, 2011, DIABETES, V60, P1734, DOI 10.2337/db10-1364
   Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100
   Li H, 2014, MOL CELL ENDOCRINOL, V382, P998, DOI 10.1016/j.mce.2013.11.012
   Jensen BC, 2011, J MOL CELL CARDIOL, V51, P518, DOI 10.1016/j.yjmcc.2010.11.014
   Corda S, 2001, AM J RESP CELL MOL, V24, P762
   KWON DY, 1986, J AM OIL CHEM SOC, V63, P89, DOI 10.1007/BF02676129
   Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200
   Kienesberger PC, 2013, CARDIOVASC RES, V99, P442, DOI 10.1093/cvr/cvt124
   Eichmann TO, 2012, J BIOL CHEM, V287, P41446, DOI 10.1074/jbc.M112.400416
   Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439
   Liu L, 2009, J BIOL CHEM, V284, P36312, DOI 10.1074/jbc.M109.049817
   Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006
   Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004
   GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369
   Ruiz JI, 1997, J LIPID RES, V38, P1482
   Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965
   Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F
   Szczepaniak LS, 2003, MAGNET RESON MED, V49, P417, DOI 10.1002/mrm.10372
   Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005
   Dobrzyn P, 2013, AM J PHYSIOL-ENDOC M, V304, pE1348, DOI 10.1152/ajpendo.00603.2012
   Brindley DN, 2010, AM J PHYSIOL-ENDOC M, V298, pE897, DOI 10.1152/ajpendo.00509.2009
   Dai ZY, 2013, MOL CELL ENDOCRINOL, V377, P123, DOI 10.1016/j.mce.2013.07.001
   Gagne S, 2007, J LIPID RES, V48, P252, DOI 10.1194/jlr.D600037-JLR200
   Hammer S, 2008, J CLIN ENDOCR METAB, V93, P497, DOI 10.1210/jc.2007-2015
   Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200
   Kuzmicic J, 2014, BIOCHEM PHARMACOL, V91, P323, DOI 10.1016/j.bcp.2014.07.022
   LEGER C, 1977, LIPIDS, V12, P538, DOI 10.1007/BF02533378
   Li RF, 2007, FEBS LETT, V581, P3311, DOI 10.1016/j.febslet.2007.06.017
   LOWRY RR, 1976, J AM OIL CHEM SOC, V53, P470, DOI 10.1007/BF02636814
   Rijzewijk L.J., 2008, AM COLL CARDIOL, V52, P1793
   Schrammel A, 2013, BBA-MOL CELL BIOL L, V1831, P1600, DOI 10.1016/j.bbalip.2013.07.004
   SOMA MR, 1992, J BIOL CHEM, V267, P11168
   Steinbusch LKM, 2011, AM J PHYSIOL-ENDOC M, V301, pE618, DOI 10.1152/ajpendo.00106.2011
NR 49
TC 1
Z9 1
U1 4
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2015
VL 565
BP 76
EP 88
DI 10.1016/j.abb.2014.11.009
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ1OL
UT WOS:000348008000010
PM 25436917
ER

PT J
AU Weis, S
   Bielow, T
   Sommerer, I
   Iovanna, J
   Malicet, C
   Mossner, J
   Hoffmeister, A
AF Weis, Sebastian
   Bielow, Tobias
   Sommerer, Ines
   Iovanna, Juan
   Malicet, Cedric
   Moessner, Joachim
   Hoffmeister, Albrecht
TI P8 deficiency increases cellular ROS and induces HO-1
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE p8; HO-1; Reactive oxygen species; Mouse embryonic fibroblasts
ID HEME OXYGENASE-1 EXPRESSION; ACUTE-PANCREATITIS; OXIDATIVE STRESS;
   FLOW-CYTOMETRY; PROTEIN P8; NUCLEAR-PROTEIN; GENE-EXPRESSION;
   BREAST-CANCER; IN-VITRO; CELLS
AB The gene p8 encodes for a small cytoprotective protein with no apparent enzymatic activity being proposed to act as co-transcription factor whose expression is increased during inflammation. Recent data from astrocytes demonstrates that p8 suppression leads to induction of heme oxygenase 1 (HO-1). Here, we assessed the cross-talk between p8 and HO-1 in mouse embryonic fibroblasts (MEF) observing an increased expression of HO-1 in p8-deficient (p8(-/-)) MEFs in non-treated and treated conditions. This effect was independent of the cell cycle. Our findings revealed that generation of reactive oxygen species (ROS) was higher in p8(-/-) MEFs. Mitochondria and NADPH oxidases were not the origin of ROS. This observation was not restricted to MEF as suppression of p8 gene transcription in MiaPaCa-2 cells also led to increased intracellular ROS. Additionally, p8 deficiency did not affect the Rac1 dependant NADPH oxidase complex. Our data shows that p8 deficiency increases ROS and subsequently the expression of anti-oxidative enzymes, such as HO-1, suggesting an involvement in the anti-oxidative defense. Moreover, we suggest that the severity of AP observed in p8(-/-) mice is induced by an impaired anti oxidative capacity of the pancreas, which is caused by increased generation of ROS. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Weis, Sebastian; Bielow, Tobias; Sommerer, Ines; Moessner, Joachim; Hoffmeister, Albrecht] Univ Hosp Leipzig, Dept Internal Med Neurol & Dermatol, Div Gastroenterol & Rheumatol, Leipzig, Germany.
   [Weis, Sebastian] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany.
   [Weis, Sebastian] Jena Univ Hosp, Ctr Infect Dis & Infect Control, Jena, Germany.
   [Iovanna, Juan] Aix Marseille Univ, CRCM, INSERM U1068, CNRS UMR 7258, Marseille, France.
   [Iovanna, Juan] Inst J Paoli I Calmettes, Marseille, France.
   [Malicet, Cedric] Vect Horus SAS, F-13344 Marseille, France.
RP Weis, S (reprint author), Univ Klinikum Leipzig, Dept Internal Med Neurol & Dermatol, AoR, Liebigstr 20, D-04103 Leipzig, Germany.
EM sebastian.weis@med.uni-jena.de
FU Formel 1 Grant of the University of Leipzig
FX This study was funded by the Formel 1 Grant of the University of
   Leipzig. No other funding was obtained.
CR Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104
   Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119
   TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748
   Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240
   Sundaresan M, 1996, BIOCHEM J, V318, P379
   Sah RP, 2012, CURR OPIN GASTROEN, V28, P507, DOI 10.1097/MOG.0b013e3283567f52
   Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473
   Sandi MJ, 2011, J CELL PHYSIOL, V226, P3442, DOI 10.1002/jcp.22702
   Trnka J, 2008, FREE RADICAL BIO MED, V44, P1406, DOI 10.1016/j.freeradbiomed.2007.12.036
   Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032
   Morse D, 2002, AM J RESP CELL MOL, V27, P8
   PETRONE WF, 1980, P NATL ACAD SCI-BIOL, V77, P1159, DOI 10.1073/pnas.77.2.1159
   Vasseur S, 2002, ONCOGENE, V21, P1685, DOI 10.1038/sj/onc/1205222
   Vasseur S, 2004, J BIOL CHEM, V279, P7199, DOI 10.1074/jbc.M309152200
   Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887
   Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200
   Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327
   Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912
   Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109
   Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4
   Han ZS, 2009, J PHARMACOL EXP THER, V329, P94, DOI 10.1124/jpet.108.145557
   Hamidi T, 2012, J CLIN INVEST, V122, P2092, DOI 10.1172/JCI60144
   Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360
   Jiang YF, 1999, BIOCHEM BIOPH RES CO, V260, P686, DOI 10.1006/bbrc.1999.0953
   Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25
   Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638
   Encinar JA, 2001, J BIOL CHEM, V276, P2742, DOI 10.1074/jbc.M008594200
   Bratland A, 2000, CANCER RES, V60, P5578
   Cano CE., 2010, J CELL PHYSL, V226, P1439
   Carracedo A, 2006, FEBS LETT, V580, P1571, DOI 10.1016/j.febslet.2006.01.084
   Chu YW, 1999, CYTOMETRY, V36, P333, DOI 10.1002/(SICI)1097-0320(19990801)36:4<333::AID-CYTO8>3.0.CO;2-F
   Colombrita C, 2003, BIOCHEM BIOPH RES CO, V308, P1001, DOI 10.1016/S0006-291X(03)01509-2
   Cosen-Binker LI, 2007, CAN J GASTROENTEROL, V21, P19
   Escobar J., 2011, FREE RADICAL BIO MED, V52, P819
   Garcia-Montero AC, 2001, BIOCHEM J, V357, P249, DOI 10.1042/0264-6021:3570249
   Habtezion A., 2010, GUT, V60, P671
   JACKMAN J, 2001, CURR PROTOC CELL BIO, pCH8, DOI DOI 10.1002/0471143030.CB0803S00
   Maines MD, 2005, BIOCHEM BIOPH RES CO, V338, P568, DOI 10.1016/j.bbrc.2005.08.121
   Malicet C, 2006, BIOCHEM BIOPH RES CO, V339, P284, DOI 10.1016/j.bbrc.2005.11.018
   Malicet Cédric, 2003, Mol Cancer, V2, P37, DOI 10.1186/1476-4598-2-37
   Path G, 2006, AM J PHYSIOL-ENDOC M, V291, pE1168, DOI 10.1152/ajpendo.00436.2005
   Ree AH, 2000, CLIN CANCER RES, V6, P1778
   Vasseur S, 1999, EUR J BIOCHEM, V259, P670, DOI 10.1046/j.1432-1327.1999.00092.x
   Weis S., 2014, PANCREAS
   Zhang FH, 2014, AM J MED SCI, V348, P224, DOI 10.1097/MAJ.0000000000000225
NR 45
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2015
VL 565
BP 89
EP 94
DI 10.1016/j.abb.2014.11.007
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AZ1OL
UT WOS:000348008000011
PM 25475530
ER

PT J
AU Bonifay, V
   Barrett, TJ
   Pattison, DI
   Davies, MJ
   Hawkins, CL
   Ashby, MT
AF Bonifay, Vincent
   Barrett, Tessa J.
   Pattison, David I.
   Davies, Michael J.
   Hawkins, Clare L.
   Ashby, Michael T.
TI Tryptophan oxidation in proteins exposed to thiocyanate-derived oxidants
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Tryptophan; Hypothiocyanite; Lactoperoxidase; Myeloperoxidase;
   Oxidation; Biomarker
ID AMINO-ACID-ANALYSIS; APOLIPOPROTEIN-A-I; HYPOTHIOCYANOUS ACID;
   ORTHO-PHTHALDIALDEHYDE; PHYSIOLOGICAL FLUIDS; CATALYZED OXIDATION;
   HYDROGEN-PEROXIDE; MASS-SPECTROMETRY; HYPOCHLOROUS ACID; HYPOBROMOUS
   ACID
AB Human defensive peroxidases, including lactoperoxidase (LPO) and myeloperoxidase (MPO), are capable of catalyzing the oxidation of halides (X-) by H2O2 to give hypohalous acids (HOX) for the purpose of cellular defense. Substrate selectivity depends upon the relative abundance of the halides, but the pseudohalide thiocyanate (SCN-) is a major substrate, and sometimes the exclusive substrate, of all defensive peroxidases in most physiologic fluids. The resulting hypothiocyanous acid (HOSCN) has been implicated in cellular damage via thiol oxidation. While thiols are believed to be the primary target of HOSCN in vivo, Trp residues have also been implicated as targets for HOSCN. However, the mechanism involved in HOSCN-mediated Trp oxidation was not established. Trp residues in proteins appeared to be susceptible to oxidation by HOSCN, whereas free Trp and Trp residues in small peptides were found to be unreactive. We show that HOSCN-induced Trp oxidation is dependent on pH, with oxidation of free Trp, and Trp-containing peptides observed when the pH is below 2. These conditions mimic those employed previously to precipitate proteins after treatment with HOSCN, which accounts for the discrepancy in the results reported for proteins versus free Trp and small peptides. The reactant in these cases may be thiocyanogen ((SCN)(2)), which is produced by comproportionation of HOSCN and SCN- at low pH. Reaction of thiocyanate-derived oxidants with protein Trp residues at low pH results in the formation of a number of oxidation products, including mono- and di-oxygenated derivatives, which are also formed with other hypohalous acids. Our data suggest that significant modification of Trp by HOSCN in vivo is likely to have limited biological relevance. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Bonifay, Vincent; Ashby, Michael T.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.
   [Barrett, Tessa J.; Pattison, David I.; Davies, Michael J.; Hawkins, Clare L.] Heart Res Inst, Newtown, NSW 2042, Australia.
   [Barrett, Tessa J.; Pattison, David I.; Davies, Michael J.; Hawkins, Clare L.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
RP Ashby, MT (reprint author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.
EM mashby@ou.edu
RI Davies, Michael/H-4939-2011
OI Davies, Michael/0000-0002-5196-6919
FU National Science Foundation [CHE-0911328]; National Health and Medical
   Research Council of Australia [570829]; Australian Research Council
   [FT120100682, CE0561607, DP0988311]
FX This research was supported by the National Science Foundation
   (CHE-0911328), the National Health and Medical Research Council of
   Australia (570829), and Australian Research Council (FT120100682,
   CE0561607, DP0988311).
CR Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7
   Ashby MT, 2004, J AM CHEM SOC, V126, P15976, DOI 10.1021/ja0438361
   Ashby MT, 2004, J AM CHEM SOC, V126, P10216, DOI 10.1021/ja048585a
   Todorovski T, 2011, J MASS SPECTROM, V46, P1030, DOI 10.1002/jms.1984
   Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927
   Hawkins CL, 2008, BIOCHEM J, V416, P441, DOI 10.1042/BJ20070941
   Skaff O, 2009, BIOCHEM J, V422, P111, DOI 10.1042/BJ20090276
   Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637
   Salavej P, 2006, FREE RADICAL BIO MED, V40, P516, DOI 10.1016/j.freeradbiomed.2005.09.007
   Hamblin M, 2007, J MOL CELL CARDIOL, V42, P884, DOI 10.1016/j.yjmcc.2006.12.018
   Taylor SW, 2003, J BIOL CHEM, V278, P19587, DOI 10.1074/jbc.C300135200
   Chandler JD, 2012, BIOCHEM PHARMACOL, V84, P1381, DOI 10.1016/j.bcp.2012.07.029
   Ronsein GE, 2008, CHEM RES TOXICOL, V21, P1271, DOI 10.1021/tx800026g
   Ding YS, 2002, J CHROMATOGR A, V982, P237, DOI 10.1016/S0021-9673(02)01650-3
   Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459
   PAPAYANNOPOULOS IA, 1995, MASS SPECTROM REV, V14, P49, DOI 10.1002/mas.1280140104
   Gracanin M, 2009, FREE RADICAL BIO MED, V47, P92, DOI 10.1016/j.freeradbiomed.2009.04.015
   Botti TP, 1996, ATHEROSCLEROSIS, V124, P191, DOI 10.1016/0021-9150(96)05825-X
   Hadfield KA, 2013, BIOCHEM J, V449, P531, DOI 10.1042/BJ20121210
   Ashby MT, 2012, ADV INORG CHEM, V64, P263, DOI 10.1016/B978-0-12-396462-5.00008-8
   Ashby MT, 2008, J DENT RES, V87, P900
   AUNE TM, 1977, BIOCHEMISTRY-US, V16, P4611, DOI 10.1021/bi00640a013
   AUNE TM, 1978, BIOCHEMISTRY-US, V17, P1005, DOI 10.1021/bi00599a010
   Barrett TJ, 2012, CHEM RES TOXICOL, V25, P263, DOI 10.1021/tx200219s
   DAS D, 1995, BIOCHEM J, V305, P59
   Davies M.J., 2012, ENCY RADICALS CHEM B, V3, P1425
   DRESCHER DG, 1978, ANAL BIOCHEM, V84, P559, DOI 10.1016/0003-2697(78)90075-1
   Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772
   Hawkins CL, 2005, FREE RADICAL BIO MED, V39, P900, DOI 10.1016/j.freeradbiomed.2005.05.011
   Henderson John W., 2000, CLIFF WOODWARD
   Kalmar J, 2011, J AM CHEM SOC, V133, P19911, DOI 10.1021/ja2083152
   LEE KS, 1978, INT J BIOCHEM, V9, P457, DOI 10.1016/0020-711X(78)90075-7
   MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007
   Nagy P, 2006, BIOCHEMISTRY-US, V45, P12610, DOI 10.1021/bi061015y
   Nagy P, 2006, CHEM RES TOXICOL, V19, P587, DOI 10.1021/tx050338c
   Nagy P, 2007, INORG CHEM, V46, P285, DOI 10.1021/ic061470i
   NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4
   Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815
   Pruitt K.M., 1985, IMMUNOLOGY SERIES, V27
   Ronsein GE, 2009, J AM SOC MASS SPECTR, V20, P188, DOI 10.1016/j.jasms.2008.08.016
   ROXBOROUGH HE, 1995, MED HYPOTHESES, V45, P125, DOI 10.1016/0306-9877(95)90059-4
   Scanlon CEO, 1996, ATHEROSCLEROSIS, V121, P23, DOI 10.1016/0021-9150(95)05672-6
   SLUNGAARD A, 1991, J BIOL CHEM, V266, P4903
   STEWART M, 1972, AUST J CHEM, V25, P2139
   Wood J.L., 1946, ORG REACT N Y, P240
NR 45
TC 2
Z9 2
U1 5
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 1
EP 11
DI 10.1016/j.abb.2014.08.014
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600001
PM 25172223
ER

PT J
AU Naddaf, L
   Sayyed-Ahmad, A
AF Naddaf, Lamis
   Sayyed-Ahmad, Abdallah
TI Intracellular crowding effects on the self-association of the bacterial
   cell division protein FtsZ
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Brownian dynamics; Macromolecular crowding; Protein-protein interaction;
   FtsZ protein
ID ESCHERICHIA-COLI; BROWNIAN DYNAMICS; MOLECULAR-DYNAMICS; BIOCHEMICAL
   REACTIONS; GLOBULAR-PROTEINS; EXCLUDED-VOLUME; IN-VITRO; SOLVENT;
   DIFFUSION; BINDING
AB The dimerization rate of the bacterial cell division protein FtsZ is strongly affected by the intracellular crowding. Yet the complexity of the intracellular environment makes it difficult to investigate via all-atom molecular dynamics or other detailed theoretical methods. We study the crowding effect on FtsZ dimerization which is the first step of an oligomerization process that results in more elaborate supramolecular structures. In particular, we consider the effect of intracellular crowding on the reaction rates, and their dependence on the different concentrations of crowding agents. We achieved this goal by using Brownian dynamics (BD) simulation techniques and a modified post-processing approach in which we decompose the rate constant in crowded media as a product of the rate constant in the dilute solution times a factor that incorporates the crowding effect. The latter factor accounts for the diffusion reduction and crowder induced energy. In addition we include the crowding effects on water viscosity in the BD simulations of crowded media. We finally show that biomolecular crowding has a considerable effect on the FtsZ dimerization by increasing the dimerization rate constant from 2.6 x 10(7) M-1 s(-1) in the absence of crowders to 1.0 x 10(8) M-1 s(-1) at crowding level of 0.30. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Naddaf, Lamis; Sayyed-Ahmad, Abdallah] Birzeit Univ, Dept Phys, Birzeit, Israel.
RP Sayyed-Ahmad, A (reprint author), Birzeit Univ, Dept Phys, Birzeit, Israel.
EM asayyeda@birzeit.edu
CR Allen M. P., 1989, COMPUTER SIMULATION
   Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a
   Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200
   Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7
   MURPHY LD, 1994, BBA-GENE STRUCT EXPR, V1219, P277, DOI 10.1016/0167-4781(94)90049-3
   de la Torre JG, 2000, BIOPHYS J, V78, P719
   Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y
   del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005
   Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855
   Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102
   Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5
   ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761
   FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8
   Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w
   Baker N, 2000, J COMPUT CHEM, V21, P1343, DOI 10.1002/1096-987X(20001130)21:15<1343::AID-JCC2>3.0.CO;2-K
   Huber GA, 2010, COMPUT PHYS COMMUN, V181, P1896, DOI 10.1016/j.cpc.2010.07.022
   Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660
   ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V
   Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063
   Makarov VA, 1998, BIOPHYS J, V75, P150
   Qin SB, 2009, BIOPHYS J, V97, P12, DOI 10.1016/j.bpj.2009.03.066
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05
   ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331
   Zheng KW, 2010, NUCLEIC ACIDS RES, V38, P327, DOI 10.1093/nar/gkp898
   Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286
   Qin SB, 2010, J PHYS CHEM LETT, V1, P107, DOI 10.1021/jz900023w
   Kim JS, 2009, BIOPHYS J, V96, P1333, DOI 10.1016/j.bpj.2008.11.030
   LOUNNAS V, 1994, BIOPHYS J, V66, P601
   ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871
   Dlugosz M, 2011, J COMPUT CHEM, V32, P2734, DOI 10.1002/jcc.21847
   Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200
   Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520
   WIDOM B, 1963, J CHEM PHYS, V39, P2808, DOI 10.1063/1.1734110
   Dan T.G., 2007, J CHEM PHYS, V126
   Gabdoulline RR, 1996, J PHYS CHEM-US, V100, P3868, DOI 10.1021/jp953109f
   Harada R, 2012, J AM CHEM SOC, V134, P4842, DOI 10.1021/ja211115q
   Kim JS, 2010, BIOPHYS J, V98, P951, DOI 10.1016/j.bpj.2009.11.022
   Konopka MC, 2009, J BACTERIOL, V191, P231, DOI 10.1128/JB.00536-08
   Lampoudi S, 2009, J COMPUT PHYS, V228, P3656, DOI 10.1016/j.jcp.2009.02.002
   Lindner RA, 1997, BIOPHYS CHEM, V66, P57, DOI 10.1016/S0301-4622(97)00011-2
   MacKerell Alexander D. Jr., 2000, Biopolymers, V56, P257, DOI 10.1002/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W
   McGuffee S.R., 2010, PLOS COMPUT BIOL, V6
   Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7
   Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006
   Phillip Y, 2012, BIOPHYS J, V103, P1011, DOI 10.1016/j.bpj.2012.08.009
   Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136
   Qin SB, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/066008
   Qu YX, 2002, BIOPHYS CHEM, V101, P155, DOI 10.1016/S0301-4622(02)00148-5
   Rivas G, 2001, P NATL ACAD SCI USA, V98, P3150, DOI 10.1073/pnas.051634398
   Sun J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2789434
   Tzvia Selzer S.A., 1999, J MOL BIOL, V287, P409
   Wieczorek G, 2008, BIOPHYS J, V95, P5030, DOI 10.1529/biophysj.108.136291
   ZIMMERMAN SB, 1988, NUCLEIC ACIDS RES, V16, P6309, DOI 10.1093/nar/16.14.6309
NR 54
TC 1
Z9 1
U1 2
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 12
EP 19
DI 10.1016/j.abb.2014.08.016
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600002
PM 25218002
ER

PT J
AU Lee, EH
   Kim, HY
   Hwang, KY
AF Lee, Eun Hye
   Kim, Hwa-Young
   Hwang, Kwang Yeon
TI The GSH- and GSSG-bound structures of glutaredoxin from Clostridium
   oremlandii
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Glutaredoxin; Crystal structure; Glutathione; GSSG-bound
ID ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; MONOTHIOL GLUTAREDOXIN;
   PROTEIN INTERACTION; NMR STRUCTURE; GLUTATHIONE; REDUCTASE; THIOREDOXIN;
   THIOLTRANSFERASE; MECHANISM
AB Glutaredoxin (Grx) is a major redox enzyme that reduces disulfide bonds using glutathione (GSH) as an electron donor. The anaerobic bacterium Clostridium oremlandii possesses a selenocysteine-containing Grx (cGrx1) and a cysteine-containing homolog (cGrx2). Here, the crystal structure of the GSSG-bound form of cGrx2 was determined for the first time at a resolution of 1.95 angstrom. In addition, its monothiol variant cGrx2/C15S in complex with GSH was also determined at a resolution of 1.58 angstrom. cGrx2 is a monomeric protein with an overall structure that consists of the typical thioredoxin fold composed of four gamma-helices and four beta-strands. Two ligands, GSH and GSSG, share a conserved binding site consisting of CPYC, TVP, and CDD motifs. The cysteinyl and gamma-glutamyl moieties show similar binding interactions in the two structures, whereas the glycine moiety shows different interactions. Interestingly, the structures revealed that only one GSH moiety of GSSG is sufficient for its binding to the protein. The GSSG-bound structure of cGrx2 was obtained as an oxidized form with a disulfide bond at the CPYC motif. Comparison of the GSH-binding mode in cGrx2 to other known Grxs revealed similarities as well as some diversity. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Lee, Eun Hye; Hwang, Kwang Yeon] Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul, South Korea.
   [Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea.
RP Kim, HY (reprint author), Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, 170 Hyeonchungno, Taegu 705717, South Korea.
EM hykim@ynu.ac.kr; chahong@korea.ac.kr
FU National Research Foundation of Korea [2011-0028166]
FX The authors thank the staff of beamline BL-5C at the Pohang Light Source
   (Korea) for technical support. This work was supported by a grant from
   the National Research Foundation of Korea (2011-0028166).
CR Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623
   Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Fernandes AP, 2005, J BIOL CHEM, V280, P24544, DOI 10.1074/jbc.M500678200
   VANBLADEREN PJ, 1988, TRENDS PHARMACOL SCI, V9, P295, DOI 10.1016/0165-6147(88)90014-4
   Luo M, 2010, J MOL BIOL, V398, P614, DOI 10.1016/j.jmb.2010.03.029
   Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5
   WELLS WW, 1990, J BIOL CHEM, V265, P15361
   Holmgren A, 2005, BIOCHEM SOC T, V33, P1375
   Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200
   Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003
   Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Iwema T, 2009, BIOCHEMISTRY-US, V48, P6041, DOI 10.1021/bi900440m
   Couto N, 2013, J PROTEOME RES, V12, P2885, DOI 10.1021/pr4001948
   Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200
   Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851
   CIRIOLO MR, 1990, J BIOL CHEM, V265, P11030
   HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275
   Kim MJ, 2011, MOL MICROBIOL, V79, P1194, DOI 10.1111/j.1365-2958.2010.07500.x
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Mesecke N, 2008, BIOCHEMISTRY-US, V47, P1452, DOI 10.1021/bi7017865
   Noguera V, 2005, J MOL BIOL, V353, P629, DOI 10.1016/j.jmb.2005.08.035
   Nordstrand K, 2000, J MOL BIOL, V303, P423, DOI 10.1006/jmbi.2000.4145
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Porras P, 2002, BIOCHEM BIOPH RES CO, V295, P1046, DOI 10.1016/S0006-291X(02)00771-4
   Vlamis-Gardikas A, 2002, METHOD ENZYMOL, V347, P286
   Vlamis-Gardikas A, 2002, J BIOL CHEM, V277, P10861, DOI 10.1074/jbc.M111024200
   Yu J, 2008, PROTEINS, V72, P1077, DOI 10.1002/prot.22096
NR 36
TC 0
Z9 0
U1 4
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 20
EP 25
DI 10.1016/j.abb.2014.09.001
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600003
PM 25218089
ER

PT J
AU Moretti, D
   Del Bello, B
   Allavena, G
   Maellaro, E
AF Moretti, Daniele
   Del Bello, Barbara
   Allavena, Giulia
   Maellaro, Emilia
TI Calpains and cancer: Friends or enemies?
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Calpain; Cancer; Cell migration; Apoptosis; Autophagy; Anticancer
   therapy
ID CISPLATIN-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM STRESS; DIFFERENTIAL
   GENE-EXPRESSION; CALCIUM-DEPENDENT PROTEASE; EPIDERMAL-GROWTH-FACTOR;
   DRUG-INDUCED APOPTOSIS; RENAL-CELL CARCINOMA; BREAST-CANCER;
   PROSTATE-CANCER; MESSENGER-RNA
AB Calpains are a complex family of ubiquitous or tissue-specific cysteine proteases that proteolyze a variety of substrates (leading to their degradation or functional modulation) and are implicated in several pathophysiological phenomena. In tumor cell biology, calpains are implicated in a triple way: they are involved in different processes crucial for tumor progression, including cell proliferation, apoptotic cell death, survival mechanisms, migration and invasiveness; they have aberrant expression in several human cancers; a variety of anticancer drugs induce cytotoxicity through activation of calpains or the latter can influence response to therapy. This review covers established and recent literature showing these diverse aspects in tumor cells. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Maellaro, Emilia] Univ Siena, Dept Mol & Dev Med, I-53100 Siena, Italy.
   Ist Toscano Tumori, I-50139 Florence, Italy.
RP Maellaro, E (reprint author), Univ Siena, Dept Mol & Dev Med, Via A Moro, I-53100 Siena, Italy.
EM dmonline@gmail.com; barbara.delbello@unisi.it; giulia.allavena@unisi.it;
   emilia.maellaro@unisi.it
FU Istituto Toscano Tumori (ITT) - Italy
FX We wish to thank Istituto Toscano Tumori (ITT) - Italy for financial
   support.
CR Angka L, 2014, CANCER LETT, V348, P29, DOI 10.1016/j.canlet.2014.03.003
   Anguissola S., 2009, MOL PHARM, V276, P998
   Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5
   Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1
   Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI 10.2183/pjab/85.12
   Gao G, 2000, J CELL BIOCHEM, V80, P53
   Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562
   Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007
   Yeh TC, 2007, BIOCHEM PHARMACOL, V73, P782, DOI 10.1016/j.bcp.2006.11.027
   McGrath MJ, 2013, CANCER RES, V73, P5066, DOI 10.1158/0008-5472.CAN-12-4520
   Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064
   Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
   Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532
   Nanduri J, 2009, P NATL ACAD SCI USA, V106, P1199, DOI 10.1073/pnas.0811018106
   Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337
   Lau JK, 2014, APOPTOSIS, V19, P1190, DOI 10.1007/s10495-014-1007-y
   Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001
   Ojima K, 2011, J MOL BIOL, V407, P439, DOI 10.1016/j.jmb.2011.01.057
   Weeraratna AT, 2004, ONCOGENE, V23, P2264, DOI 10.1038/sj.onc.1207337
   Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998
   Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746
   OHNO S, 1986, NUCLEIC ACIDS RES, V14, P5559
   Kimura Y, 1998, NAT MED, V4, P915, DOI 10.1038/nm0898-915
   SORIMACHI H, 1989, J BIOL CHEM, V264, P20106
   Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072
   Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200
   Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614
   Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294
   Libertini SJ, 2005, CANCER RES, V65, P10700, DOI 10.1158/008-5472.CAN-05-1666
   Sergeev IN, 2012, ANTICANCER RES, V32, P299
   Zhou X, 2013, ANTI-CANCER DRUG, V24, P920, DOI 10.1097/CAD.0b013e328364a109
   Rios-Doria J, 2003, J BIOL CHEM, V278, P1372, DOI 10.1074/jbc.M208772200
   Kato M, 2000, J BIOCHEM-TOKYO, V127, P297
   Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032
   Wang HM, 2005, BIOCHEM BIOPH RES CO, V333, P496, DOI 10.1016/j.bbrc.2005.05.143
   Xu LJ, 2006, J BIOL CHEM, V281, P4457, DOI 10.1074/jbc.M510721200
   Skubitz KM, 2003, CANCER, V98, P1029, DOI 10.1002/cncr.11586
   Raveendran NN, 2008, J PHARMACOL EXP THER, V325, P389, DOI 10.1124/jpet.107.127720
   Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014
   Gollob JA, 2005, CANCER RES, V65, P8869, DOI 10.1158/008-5472.can-05-1387
   Sergeev IN, 2004, BIOCHEM BIOPH RES CO, V321, P462, DOI 10.1016/j.bbrc.2004.06.173
   Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048
   Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002
   Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200
   Mo XG, 2011, MICROVASC RES, V81, P160, DOI 10.1016/j.mvr.2010.12.004
   Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1
   Frances CP, 2007, J GASTROEN HEPATOL, V22, P2298, DOI 10.1111/j.1440-1746.2007.04843.x
   Lal S, 2012, J NEUROSCI RES, V90, P769, DOI 10.1002/jnr.22794
   Camilli TC, 2011, PIGM CELL MELANOMA R, V24, P175, DOI 10.1111/j.1755-148X.2010.00792.x
   Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120
   CROALL DE, 1991, PHYSIOL REV, V71, P813
   Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183
   Carragher NO, 2004, NEOPLASIA, V6, P53
   Woo MG, 2012, J BIOL CHEM, V287, P3963, DOI 10.1074/jbc.M111.314765
   Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200
   Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200
   Kiss R, 2008, BIOCHEMISTRY-US, V47, P6936, DOI 10.1021/bi800201a
   Shiraha H, 2002, MOL CELL BIOL, V22, P2716, DOI 10.1128/MCB.22.8.2716-2727.2002
   Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175
   Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006
   Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200
   Dave JM, 2014, MICROCIRCULATION, V21, P333, DOI 10.1111/micc.12111
   Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134
   Yoshikawa Y, 2000, JPN J CANCER RES, V91, P459
   Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001
   Moretti D, 2009, CARCINOGENESIS, V30, P960, DOI 10.1093/carcin/bgp098
   Roperto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010299
   Zhuang QF, 2014, J INT MED RES, V42, P282, DOI 10.1177/0300060513505524
   Bai DS, 2009, HEPATOLOGY, V49, P460, DOI 10.1002/hep.22638
   Marion A, 2012, INT J CANCER, V130, P2514, DOI 10.1002/ijc.26246
   Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040
   Sorimachi H, 2011, J BIOCHEM, V150, P23, DOI 10.1093/jb/mvr070
   Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037
   Panaretakis T, 2002, J BIOL CHEM, V277, P44317, DOI 10.1074/jbc.M205273200
   Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200
   GUROFF G, 1964, J BIOL CHEM, V239, P149
   Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482
   Yang HJ, 2008, J CELL PHYSIOL, V217, P569, DOI 10.1002/jcp.21565
   Chan D, 2013, WORLD J GASTROENTERO, V19, P2772, DOI 10.3748/wjg.v19.i18.2772
   Storr SJ, 2012, ANN ONCOL, V23, P2289, DOI 10.1093/annonc/mds176
   Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887
   Chen B, 2013, CELL BIOL INT, V37, P643, DOI 10.1002/cbin.10062
   Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4
   Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003
   Hata S, 2007, J BIOL CHEM, V282, P27847, DOI 10.1074/jbc.M703168200
   De Tullio R, 1999, BIOCHEM J, V343, P467
   Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004
   Carragher NO, 2002, INT J BIOCHEM CELL B, V34, P1539, DOI 10.1016/S1357-2725(02)00069-9
   Tonami K, 2007, MOL CELL BIOL, V27, P2548, DOI 10.1128/MCB.00992-06
   Vaish V, 2012, BIOMED PHARMACOTHER, V66, P116, DOI 10.1016/j.biopha.2011.11.019
   Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604
   Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021
   Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054
   Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451
   Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211
   Kumar B, 2012, BIOCHEM BIOPH RES CO, V417, P903, DOI 10.1016/j.bbrc.2011.12.072
   Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005
   Baghdiguian S, 1999, NAT MED, V5, P503
   Huynh KM, 2009, GENE, V433, P32, DOI 10.1016/j.gene.2008.11.013
   Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880
   Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x
   Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004
   Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200
   Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003
   Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1
   Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200
   Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79
   Storr SJ, 2011, BREAST, V20, P413, DOI 10.1016/j.breast.2011.04.002
   Kar P, 2010, ARCH BIOCHEM BIOPHYS, V495, P1, DOI 10.1016/j.abb.2009.12.020
   Liu YL, 2011, CELL SIGNAL, V23, P827, DOI 10.1016/j.cellsig.2011.01.005
   Mukhopadhyay S, 2014, APOPTOSIS, V19, P555, DOI 10.1007/s10495-014-0967-2
   Wood DE, 1999, J BIOL CHEM, V274, P8309, DOI 10.1074/jbc.274.12.8309
   Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702
   Rios-Doria J, 2004, CANCER RES, V64, P7237, DOI 10.1158/0008-5472.CAN-04-1048
   Ruffini F, 2013, ONCOL REP, V30, P2887, DOI 10.3892/or.2013.2791
   Pagliarini V, 2012, CELL DEATH DIFFER, V19, P1495, DOI 10.1038/cdd.2012.27
   Choi KS, 2012, EXP MOL MED, V44, P109, DOI 10.3858/emm.2012.44.2.033
   Conacci-Sorrell M, 2014, GENE DEV, V28, P689, DOI 10.1101/gad.231894.113
   McGinnis KM, 1999, BIOCHEM BIOPH RES CO, V263, P94, DOI 10.1006/bbrc.1999.1315
   Horikawa Y, 2000, NAT GENET, V26, P163
   Zheng XW, 2014, P NATL ACAD SCI USA, V111, P2560, DOI 10.1073/pnas.1320815111
   Sivanandam A, 2011, J CELL PHYSIOL, V226, P1889, DOI 10.1002/jcp.22516
   Perrin BJ, 2006, MOL BIOL CELL, V17, P239
   Atencio IA, 2000, CELL GROWTH DIFFER, V11, P247
   Baki A, 1996, BIOCHEM J, V318, P897
   Branca D, 2004, BIOCHEM BIOPH RES CO, V322, P1098, DOI 10.1016/j.bbrc.2004.07.126
   Braun C, 1999, INT J CANCER, V84, P6, DOI 10.1002/(SICI)1097-0215(19990219)84:1<6::AID-IJC2>3.0.CO;2-T
   Busquets S, 2000, BBA-GEN SUBJECTS, V1475, P5, DOI 10.1016/S0304-4165(00)00050-7
   Cai JJ, 2014, CNS NEUROSCI THER, V20, P521, DOI 10.1111/cns.12248
   Castiglioni S, 2012, BIOCHEM BIOPH RES CO, V421, P380, DOI 10.1016/j.bbrc.2012.04.024
   Chia JS, 2013, INTEGR CANCER THER, V12, P248, DOI 10.1177/1534735412458828
   Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131
   Colunga A, 2014, GENE THER, V21, P371, DOI 10.1038/gt.2014.6
   Conacci-Sorrell M, 2011, CELL CYCLE, V10, P604, DOI 10.4161/cc.10.4.14794
   Daniel KG, 2003, INT J MOL MED, V12, P247
   Das A, 2006, INT J CANCER, V119, P2575, DOI 10.1002/ijc.22228
   Dear N, 1997, GENOMICS, V45, P175, DOI 10.1006/geno.1997.4870
   Dear TN, 1999, MECH DEVELOP, V89, P201, DOI 10.1016/S0925-4773(99)00214-2
   Del Bello B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057236
   Del Bello B, 2004, EXP CELL RES, V293, P302, DOI 10.1016/j.yexcr.2003.10.024
   Del Bello B, 2007, ONCOGENE, V26, P2717, DOI 10.1038/sj.onc.1210079
   De Tullio R, 2003, BIOCHEM J, V375, P689, DOI 10.1042/BJ20030706
   Dho SH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001588
   EMORI Y, 1987, P NATL ACAD SCI USA, V84, P3590, DOI 10.1073/pnas.84.11.3590
   Esteban F, 2008, EJSO-EUR J SURG ONC, V34, P94, DOI 10.1016/j.ejso.2007.02.004
   Fan DG, 2009, CELL BIOL INT, V33, P1263, DOI 10.1016/j.cellbi.2009.08.014
   Fullerton SM, 2002, AM J HUM GENET, V70, P1096, DOI 10.1086/339930
   Gafni J, 2009, J BIOL CHEM, V284, P25441, DOI 10.1074/jbc.M109.038174
   Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004
   Gonen H, 1997, FEBS LETT, V406, P17, DOI 10.1016/S0014-5793(97)00225-1
   Gu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090151
   Hata S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001040
   Jeong J.C., 2011, J EXP CLIN CANC RES, V30, P30
   Kawabata Y, 2003, FEBS LETT, V555, P623, DOI 10.1016/S0014-5793(03)01324-3
   Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200
   Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460
   Kulkarni S, 2010, ONCOGENE, V29, P1339, DOI 10.1038/onc.2009.422
   Kulkarni S., 2012, INT J CANCER, V15, P2420
   Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604
   Lee HJ, 1999, ARCH BIOCHEM BIOPHYS, V362, P22, DOI 10.1006/abbi.1998.1021
   Lee HJ, 1998, BIOL CHEM, V379, P175, DOI 10.1515/bchm.1998.379.2.175
   Lee SJ, 2008, ONCOL REP, V19, P859
   Lee S.J., 2007, GYNECOL CANC, V17, P248
   Lepine S, 2011, J BIOL CHEM, V286, P44380, DOI 10.1074/jbc.M111.257519
   Li HB, 2012, EXP HEMATOL, V40, P548, DOI 10.1016/j.exphem.2012.02.002
   Ling C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006558
   Liu KY, 2000, J BIOL CHEM, V275, P31093, DOI 10.1074/jbc.M005451200
   Liu L, 2009, INT J CANCER, V125, P2757, DOI 10.1002/ijc.24626
   Liu L, 2008, INT J CANCER, V122, P2210, DOI 10.1002/ijc.23378
   Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043711
   Liu TC, 2014, INT J ONCOL, V44, P467, DOI 10.3892/ijo.2013.2196
   Liu XL, 2003, J PHARMACOL EXP THER, V304, P63, DOI 10.1124/jpet.102.043406
   Lu T, 2002, BBA-MOL CELL RES, V1590, P16, DOI 10.1016/S0167-4889(02)00193-3
   Maki M, 1997, BIOCHEM J, V328, P718
   Mamoune A, 2003, CANCER RES, V63, P4632
   Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002
   Matthew A., 2012, CARDIOVASC RES, V96, P32
   Melloni E, 2000, J BIOL CHEM, V275, P82, DOI 10.1074/jbc.275.1.82
   MINAMI Y, 1987, J BIOCHEM-TOKYO, V101, P889
   Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353
   Molinari M, 1997, J MEMBRANE BIOL, V156, P1, DOI 10.1007/s002329900181
   Moreno-Luna R, 2011, HEAD NECK-J SCI SPEC, V33, P72, DOI 10.1002/hed.21404
   Munarriz E, 2005, BIOCHEM BIOPH RES CO, V333, P954, DOI 10.1016/j.bbrc.2005.05.188
   Niapour M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2011.50
   Niapour M, 2008, J BIOL CHEM, V283, P21371, DOI 10.1074/jbc.M801462200
   O'Connell MP, 2009, J INVEST DERMATOL, V129, P1782, DOI 10.1038/jid.2008.433
   Pariat M, 1997, MOL CELL BIOL, V17, P2806
   Phillips-Mason P.J., 2014, J CELL BIOCH
   Porn-Ares MI, 1998, CELL DEATH DIFFER, V5, P1028, DOI 10.1038/sj.cdd.4400424
   Postovit LM, 2002, BIOCHEM BIOPH RES CO, V297, P294, DOI 10.1016/S0006-291X(02)02187-3
   Rho SB, 2008, CANCER LETT, V271, P306, DOI 10.1016/j.canlet.2008.06.020
   RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2
   Ruiz-Vela, 1999, EMBO J, V18, P4988
   Saini M.K., 2014, BIOMED PHARMACOTHER, DOI DOI 10.1016/J.BOIPHA.2014.03.007
   Salehin D, 2010, ANTICANCER RES, V30, P2837
   Sato K, 2004, J BIOCHEM, V136, P777, DOI 10.1093/jb/mvh187
   Serrano K, 2004, CELL MOTIL CYTOSKEL, V58, P242, DOI 10.1002/cm.20011
   Shi M, 2013, APOPTOSIS, V18, P435, DOI 10.1007/s10495-012-0786-2
   Skubitz KM, 2003, J LAB CLIN MED, V141, P297, DOI 10.1016/S0022-2143(03)00007-6
   Small GW, 2002, ARCH BIOCHEM BIOPHYS, V400, P151, DOI 10.1016/S0003-9861(02)00005-X
   Sobhan PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059350
   Sorimachi H, 1997, BIOCHEM J, V328, P721
   Sorimachi H, 2012, BIOL CHEM, V393, P853, DOI 10.1515/hsz-2012-0143
   SORIMACHI H, 1993, J BIOL CHEM, V268, P19476
   Storr SJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-511
   Storr SJ, 2012, J CELL MOL MED, V16, P2422, DOI 10.1111/j.1582-4934.2012.01559.x
   Storr SJ, 2011, INT J CANCER, V129, P1773, DOI 10.1002/ijc.25832
   Storr SJ, 2013, J GASTROENTEROL, V48, P1213, DOI 10.1007/s00535-012-0743-4
   Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12
   Suzuki K, 1998, FEBS LETT, V433, P1, DOI 10.1016/S0014-5793(98)00856-4
   Tonami K, 2011, J CELL SCI, V124, P1214, DOI 10.1242/jcs.072561
   Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748
   Waterhouse NJ, 1998, CELL DEATH DIFFER, V5, P1051, DOI 10.1038/sj.cdd.4400425
   Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034
   Xia HG, 2010, AUTOPHAGY, V6, P61
   Ye Y, 2013, ONCOGENE, V32, P1702, DOI 10.1038/onc.2012.180
   Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054619
   Zheng PC, 2014, CANCER SCI, V105, P630, DOI 10.1111/cas.12416
   Zhou HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086195
   Zhou J, 2006, MOL BIOL CELL, V17, P1549, DOI 10.1091/mbc.E05-08-0770
NR 221
TC 2
Z9 2
U1 6
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 26
EP 36
DI 10.1016/j.abb.2014.09.018
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600004
PM 25305531
ER

PT J
AU Lindqvist, J
   Hardeman, EC
   Ochala, J
AF Lindqvist, Johan
   Hardeman, Edna C.
   Ochala, Julien
TI Sexually dimorphic myofilament function in a mouse model of nemaline
   myopathy
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Myopathy; Mutation; Force production; Contractility; Myosin heavy chain;
   Skeletal alpha-actin
ID SKELETAL-MUSCLE FIBERS; ACTIN GENE; MUTATIONS; MECHANISMS; PROTEIN;
   LENGTH
AB Nemaline myopathy, the most common congenital myopathy, is characterized by mutations in genes encoding myofilament proteins such as skeletal a-actin. These mutations are thought to ultimately lead to skeletal muscle weakness. Interestingly, some of the mutations appear to be more potent in males than in females. The underlying mechanisms remain obscure but may be related to sex-specific differences in the myofilament function of both limb and respiratory muscles. To verify this, in the present study, we used skeletal muscles (tibialis anterior and diaphragm) from a transgenic mouse model harbouring the His40Tyr amino acid substitution in skeletal a-actin. In this animal model, 60% of males die by 13 weeks of age (the underlying causes of death are obscure but probably due to respiratory insufficiency) whereas females have a normal lifespan. By recording and analysing the mechanics of membrane-permeabilized myofibres, we only observed sex-related differences in the tibialis anterior muscles. Indeed, the concomitant deficits in maximal steady-state isometric force and stiffness of myofibres were less exacerbated in transgenic females than in males, potentially explaining the lower potency in limb muscles. However, the absence of sex-difference in the diaphragm muscles was rather unexpected and suggests that myofilament dysfunction does not solely underlie the sexually dimorphic phenotypes. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Lindqvist, Johan] Uppsala Univ, Dept Neurosci, Uppsala, Sweden.
   [Hardeman, Edna C.] Univ New S Wales, Sch Med Sci, Neuromuscular & Regenerat Med Unit, Sydney, NSW, Australia.
   [Ochala, Julien] Kings Coll London, Ctr Human & Aerosp Physiol Sci, London SE1 1UL, England.
RP Ochala, J (reprint author), Kings Coll London, Ctr Human & Aerosp Physiol Sci, Room 3-3,Shepherds House,Guys Campus, London SE1 1UL, England.
EM julien.ochala@kcl.ac.uk
FU Swedish Research Council; Harald och Greta Jeanssons Stiftelse
FX We wish to thank Yvette Hedstrom from the Department of Neuroscience,
   Clinical Neurophysiology at Uppsala University for excellent technical
   support. We are very grateful to Prof. Lars Larsson for providing lab
   space and equipments to perform the study. This study was supported by
   Grants from the Swedish Research Council and Harald och Greta Jeanssons
   Stiftelse to J.O.
CR Nowak KJ, 2013, ACTA NEUROPATHOL, V125, P19, DOI 10.1007/s00401-012-1019-z
   Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242
   LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   Frontera WR, 1997, MUSCLE NERVE, V20, P948, DOI 10.1002/(SICI)1097-4598(199708)20:8<948::AID-MUS3>3.0.CO;2-6
   Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5
   Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128
   Nowak KJ, 1999, NAT GENET, V23, P208
   BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542
   COOKE R, 1980, BIOCHEMISTRY-US, V19, P2265, DOI 10.1021/bi00551a042
   Feng JJ, 2009, NEUROMUSCULAR DISORD, V19, P6, DOI 10.1016/j.nmd.2008.09.005
   Ilkovski B, 2001, AM J HUM GENET, V68, P1333, DOI 10.1086/320605
   Kim J, 2008, TRENDS CELL BIOL, V18, P264, DOI 10.1016/j.tcb.2008.03.007
   Lindqvist J, 2013, J NEUROPATH EXP NEUR, V72, P472, DOI 10.1097/NEN.0b013e318293b1cc
   McKee LAK, 2013, ARCH BIOCHEM BIOPHYS, V535, P39, DOI 10.1016/j.abb.2012.12.023
   MOSS RL, 1979, J PHYSIOL-LONDON, V292, P177
   Najafi A., 2014, PFLUGERS AR IN PRESS
   Nguyen MAT, 2011, BRAIN, V134, P3513, DOI 10.1093/brain/awr274
   Norman H, 2006, PFLUG ARCH EUR J PHY, V453, P53, DOI 10.1007/s00424-006-0110-5
   Ochala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020558
   Ochala J., 2013, PLOS ONE, V7
   Ochala J, 2014, FASEB J, V28, P408, DOI 10.1096/fj.13-239640
   Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004
NR 23
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 37
EP 42
DI 10.1016/j.abb.2014.09.011
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600005
PM 25261348
ER

PT J
AU Yang, SY
   Chen, YJ
   Kao, PH
   Chang, LS
AF Yang, Shin-Yi
   Chen, Ying-Jung
   Kao, Pei-Hsiu
   Chang, Long-Sen
TI Bovine serum albumin with glycated carboxyl groups shows
   membrane-perturbing activities
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Bovine serum albumin; Glycation; Carboxyl group; Membrane-damaging
   activity; Fusogenicity
ID CARBOHYDRATE-LIPID INTERACTIONS; SECRETORY PHOSPHOLIPASES A(2);
   ANTIMICROBIAL PEPTIDES; SECONDARY STRUCTURE; REVERSE MICELLES;
   AQUEOUS-SOLUTION; LIGAND-BINDING; CELL-FUSION; RECEPTOR; ASSAY
AB The aim of the present study aimed to investigate whether glycated bovine serum albumin (BSA) showed novel activities on the lipid water interface. Mannosylated BSA (Man-BSA) was prepared by modification of the carboxyl groups with p-aminophenyl alpha-D-mannopyranoside. In contrast to BSA, Man-BSA notably induced membrane permeability of egg yolk phosphatidylcholine (EYPC)/egg yolk sphingomyelin (EYSM)/cholesterol (Chol) and EYPC/EYSM vesicles. Noticeably, Man-BSA induced the fusion of EYPC/ EYSM/Chol vesicles, but not of EYPC/EYSM vesicles. Although BSA and Man-BSA showed similar binding affinity for lipid vesicles, the lipid-bound conformation of Man-BSA was distinct from that of BSA. Moreover, Man-BSA adopted distinct structure upon binding with the EYPC/EYSM/Chol and EYPC/EYSM vesicles. Man-BSA could induce the fusion of EYPC/EYSM/Chol vesicles with 1(562 and MCF-7 cells, while Man-BSA greatly induced the leakage of Chol-depleted 1(562 and MCF-7 cells. The modified BSA prepared by conjugating carboxyl groups with p-aminophenyl alpha-D-glucopyranoside also showed membrane-perturbing activities. Collectively, our data indicate that conjugation of carboxyl groups with monosaccharide generates functional BSA with membrane-perturbing activities on the lipid water interface. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Yang, Shin-Yi; Chen, Ying-Jung; Kao, Pei-Hsiu; Chang, Long-Sen] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan.
   [Chang, Long-Sen] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung 807, Taiwan.
RP Chang, LS (reprint author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan.
EM lschang@mail.nsysu.edu.tw
FU National Science Council, ROC [NSC102-2633-B110-001]
FX This work was supported by grant NSC102-2633-B110-001 from the National
   Science Council, ROC (to L.S. Chang).
CR GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x
   Hashida M, 2005, CHEM PHARM BULL, V53, P871, DOI 10.1248/cpb.53.871
   Dong AC, 1997, ARCH BIOCHEM BIOPHYS, V347, P213, DOI 10.1006/abbi.1997.0349
   Maccarrone M, 1996, EUR J BIOCHEM, V241, P297, DOI 10.1111/j.1432-1033.1996.0297t.x
   Kolusheva S, 2000, NAT BIOTECHNOL, V18, P225, DOI 10.1038/72697
   El Kadi N, 2006, BIOPHYS J, V91, P3397, DOI 10.1529/biophysj.106.088963
   LIFSON J, 1986, J EXP MED, V164, P2101, DOI 10.1084/jem.164.6.2101
   Meersman F, 2003, BIOCHEMISTRY-US, V42, P14234, DOI 10.1021/bi035623e
   Todor I. N., 2012, Experimental Oncology, V34, P97
   Churchward MA, 2008, BIOPHYS J, V94, P3976, DOI 10.1529/biophysj.107.123984
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Churchward MA, 2005, J CELL SCI, V118, P4833, DOI 10.1242/jcs.02601
   Sassi P, 2011, BIOPHYS CHEM, V158, P46, DOI 10.1016/j.bpc.2011.05.002
   Kolusheva S, 2000, BIOCHEMISTRY-US, V39, P15851, DOI 10.1021/bi000570b
   Abreu MSC, 2003, BIOPHYS J, V84, P386
   Bo T, 2006, ANAL BIOCHEM, V350, P91, DOI 10.1016/j.ab.2005.11.039
   Carter C.D., 1994, ADV PROTEIN CHEM, VV, P153
   Celej MS, 2003, PROTEIN SCI, V12, P1496, DOI 10.1110/ps.0240003
   CHEN CH, 1981, BIOPHYS J, V36, P359
   Chiou YL, 2010, TOXICON, V56, P1362, DOI 10.1016/j.toxicon.2010.08.001
   Choi YA, 2010, BIOL CELL, V102, P107, DOI 10.1042/BC20090073
   Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043
   DESFOSSES B, 1991, EUR J BIOCHEM, V199, P79, DOI 10.1111/j.1432-1033.1991.tb16094.x
   DESFOSSES B, 1992, BIOCHEM INT, V26, P257
   Fernandez N, 2005, J IMMUNOL, V174, P8154
   Gurr MI, 2002, LIPID BIOCH
   Hernandez M, 1998, J BIOL CHEM, V273, P606, DOI 10.1074/jbc.273.1.606
   Janin Joël, 2013, F1000 Biol Rep, V5, P2, DOI 10.3410/B5-2
   Kao PH, 2009, TOXICON, V53, P512, DOI 10.1016/j.toxicon.2009.01.018
   Kolusheva S, 2008, PEPTIDES, V29, P1620, DOI 10.1016/j.peptides.2008.05.012
   Kumar R, 2001, J BIOSCIENCE, V26, P325, DOI 10.1007/BF02703741
   Lau WL, 2004, BIOPHYS J, V86, P272, DOI 10.1016/S0006-3495(04)74103-X
   Liu L, 2012, CHEM-EUR J, V18, P12059, DOI 10.1002/chem.201201222
   MATTHEWS TJ, 1987, P NATL ACAD SCI USA, V84, P5424, DOI 10.1073/pnas.84.15.5424
   NICOLAS JP, 1995, J BIOL CHEM, V270, P28869
   Poon IKH, 2014, ELIFE, V3, DOI 10.7554/eLife.01808
   REED RG, 1989, J BIOL CHEM, V264, P9867
   Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6
   Triggiani M, 2000, J IMMUNOL, V164, P4908
   WALL J, 1995, MOL MEMBR BIOL, V12, P183, DOI 10.3109/09687689509027506
   Wang WC, 2007, BIOPHYS J, V92, P2819, DOI 10.1529/biophysj.106.097923
   Yang J, 2004, BIOPHYS J, V87, P1951, DOI 10.1529/biophysj.103.028530
NR 43
TC 1
Z9 1
U1 5
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 43
EP 51
DI 10.1016/j.abb.2014.10.001
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600006
PM 25449061
ER

PT J
AU Xie, XY
   Yu, HT
   Wang, YZ
   Zhou, YW
   Li, GL
   Ruan, Z
   Li, FY
   Wang, XH
   Liu, HX
   Zhang, J
AF Xie, Xinyou
   Yu, Haitao
   Wang, Yanzhong
   Zhou, Yanwen
   Li, Guiling
   Ruan, Zhi
   Li, Fengying
   Wang, Xiuhong
   Liu, Huixing
   Zhang, Jun
TI Nicotinamide N-methyltransferase enhances the capacity of tumorigenesis
   associated with the promotion of cell cycle progression in human
   colorectal cancer cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Nicotinamide N-methyltransferase; Colorectal cancer; Cell cycle;
   Apoptosis; 1-Methylnicotinamide; Tumorigenesis
ID PI3K/AKT PATHWAY; CARCINOMA-CELLS; TUMOR-MARKER; EXPRESSION;
   IDENTIFICATION; DIFFERENTIATION; APOPTOSIS; PROTEIN; OVEREXPRESSION;
   DISCOVERY
AB Nicotinamide N-methyltransferase (NNMT), an enzyme involved in the biotransformation and detoxification of many drugs and xenobiotic compounds, has been found to be overexpressed in several malignancies, including colorectal cancer. However, the biological function of NNMT and the related mechanisms in colorectal cancer have not been elucidated. In the present study, we investigated the effects of NNMT on tumorigenesis by overexpressing NNMT in the human colorectal cancer cells line SW480 which lacks constitutive NNMT expression, and downregulating NNMT expression in HT-29 cells, which exhibit high endogenous expression of NNMT. We found that NNMT significantly accelerates cell proliferation, enhances colony formation in vitro and tumorigenicity in mice; it also inhibits apoptosis, promotes cell cycle progression, increases ATP and 1-methylnicotinamide level and decreases ROS level. We also showed that 1-methylnicotinamide accelerates cell growth, inhibits apoptosis, promotes cell cycle progression, attenuates ROS production and increases ATP level. Our results indicate that NNMT enhances the capacity of tumorigenesis associated with the inhibition of cell apoptosis and the promotion of cell cycle progression in human colorectal cancer cells and the 1-methylnicotinamide increased by NNMT mediates the cellular effects of NNMT in cells. NNMT may play a vital role in energy balance and ROS induction. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Xie, Xinyou; Yu, Haitao; Wang, Yanzhong; Li, Guiling; Li, Fengying; Wang, Xiuhong; Zhang, Jun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Clin Lab, Hangzhou 310016, Zhejiang, Peoples R China.
   [Xie, Xinyou; Yu, Haitao; Wang, Yanzhong; Zhou, Yanwen; Ruan, Zhi; Liu, Huixing; Zhang, Jun] Zhejiang Univ, Key Lab Biotherapy Zhejiang Prov, Hangzhou 310016, Zhejiang, Peoples R China.
RP Zhang, J (reprint author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Clin Lab, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China.
EM jameszhang2000@163.com
RI Ruan, Zhi/P-3987-2015
OI Ruan, Zhi/0000-0001-8648-4592
FU National Natural Science Foundation of China [81271914]; Zhejiang
   Provincial Natural Science Foundation [LY12H16025]; Science Foundation
   of Health Bureau of Zhejiang Province [20088114, 2011KYA081]; Science
   Foundation of Education Bureau of Zhejiang Province [Y201121182]; Key
   Program of the Science Technology Department Zhejiang Province
   [2012C13019-2]
FX We thank Dr Chen, Gong-Xiang and Dr Hu, Xiao-Tong for English editing.
   This study was supported partly by the grants from National Natural
   Science Foundation of China (81271914), Zhejiang Provincial Natural
   Science Foundation (LY12H16025), Science Foundation of Health Bureau of
   Zhejiang Province (Nos. 20088114 and 2011KYA081), Science Foundation of
   Education Bureau of Zhejiang Province (Y201121182), funds for Key
   Program of the Science Technology Department Zhejiang Province
   (2012C13019-2).
CR Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Verbon EH, 2012, GENE, V511, P1, DOI 10.1016/j.gene.2012.08.038
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Liao KA, 2011, J PROTEOME RES, V10, P2347, DOI 10.1021/pr101146w
   Xu JM, 2003, J CLIN ENDOCR METAB, V88, P4990, DOI 10.1210/jc.2002-021843
   Roessler M, 2005, CLIN CANCER RES, V11, P6550, DOI 10.1158/1078-0432.CCR-05-0983
   Sartini D, 2006, J UROLOGY, V176, P2248, DOI 10.1016/j.juro.2006.07.046
   Lim BH, 2006, EXP MOL MED, V38, P455
   Sartini D, 2007, MOL MED, V13, P415, DOI 10.2119/2007-00035.Sartini
   Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824
   Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693
   Rogers CD, 2006, CANCER BIOL THER, V5, P1383, DOI 10.4161/cbt.5.10.3323
   Bhattarai G, 2012, BIOL PHARM BULL, V35, P1711
   Zhang J, 2010, J ZHEJIANG UNIV-SC B, V11, P136, DOI 10.1631/jzus.B0900249
   Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902
   Jang JS, 2004, ONCOL RES, V14, P491
   Tang SW, 2011, CARCINOGENESIS, V32, P138, DOI 10.1093/carcin/bgq225
   Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398
   Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X
   Wu Y, 2008, ONCOGENE, V27, P6679, DOI 10.1038/onc.2008.264
   Parsons RB, 2011, BIOCHEM J, V436, P145, DOI 10.1042/BJ20101685
   Emanuelli M, 2010, HISTOL HISTOPATHOL, V25, P15
   Tomida M, 2008, J CANCER RES CLIN, V134, P551, DOI 10.1007/s00432-007-0318-6
   Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/nchembio.1204, 10.1038/NCHEMBIO.1204]
   Creeke PI, 2005, J CHROMATOGR B, V817, P247, DOI 10.1016/j.jchromb.2004.12.012
   D'Andrea FP, 2011, RADIOTHER ONCOL, V99, P373, DOI 10.1016/j.radonc.2011.05.086
   Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P1239, DOI 10.1016/S0002-9440(10)62551-5
   Kim J, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-20
   Pozzi V, 2011, INT J IMMUNOPATH PH, V24, P69
   Pozzi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071272
   RINI J, 1990, CLIN CHIM ACTA, V186, P359, DOI 10.1016/0009-8981(90)90322-J
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Tomida M, 2009, J CANCER RES CLIN, V135, P1223, DOI 10.1007/s00432-009-0563-y
   Yamada K, 2010, J NUTR SCI VITAMINOL, V56, P83
   Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089202
NR 36
TC 2
Z9 2
U1 5
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 52
EP 66
DI 10.1016/j.abb.2014.08.017
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600007
PM 25201588
ER

PT J
AU Dergunov, AD
AF Dergunov, Alexander D.
TI Prediction of the influences of missense mutations on cholesteryl ester
   transfer protein structure
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Missense mutation; Cholesteryl ester transfer protein; Reverse
   cholesterol transport; Hyperalphalipoproteinemia; Structure prediction;
   Cholesterol recognition amino acid consensus; Cholesterol consensus
   motif
ID HIGH-DENSITY-LIPOPROTEINS; JAPANESE HYPERALPHALIPOPROTEINEMIC SUBJECTS;
   CORONARY-HEART-DISEASE; LIPID TRANSFER PROTEIN; HDL CHOLESTEROL; CETP
   GENE; PHOSPHATIDYLCHOLINE; ATHEROSCLEROSIS; POLYMORPHISMS; DISTRIBUTIONS
AB The structure of human plasma cholesteryl ester transfer protein (CETP) was mapped in silica by a search of the structural effects of missense mutations in the CETP gene. Sixteen deleterious substitutions were chosen among 54 known missense mutations and further ranked by stability change score into six structural and ten functional mutations with large and small stability changes, respectively. A cluster of eight mutations in a central region spanning residues 184-296 with exclusively destabilizing effects was evident. Moreover, the mutations were differently distributed between ordered and highly fluctuating regions. Putative cholesterol-binding regions, mostly unique for CETP in a whole CETP-including protein family, were identified. Three of six structural mutations influence cholesteryl ester and phosphatidylcholine binding by CETP. The local partially disordered structure of some putative cholesterol-binding regions is suggested to be differently influenced by cholesterol binding. This may underlie the impairment of the local ordering effect of cholesterol by the L261R substitution. Also, cholesterol may competitively inhibit cholesteryl ester binding to the CETP molecule, with triglyceride binding being largely undisturbed. This analysis may contribute to the ongoing design and mechanistic studies of new CETP inhibitors.(C) 2014 Elsevier Inc. All rights reserved.
C1 Natl Res Ctr Prevent Med, Moscow 101990, Russia.
RP Dergunov, AD (reprint author), Natl Res Ctr Prevent Med, 10 Petroverigsky St, Moscow 101990, Russia.
EM dergunov@img.ras.ru
FU Russian Foundation for Basic Research [13-04-00474]
FX The financial support of the Russian Foundation for Basic Research
   (Grant # 13-04-00474) is greatly acknowledged. I would like to thank
   Prof. Michael C. Phillips, The Children's Hospital of Philadelphia,
   University of Pennsylvania Perelman School of Medicine, Philadelphia,
   USA, for help in language improvement.
CR Agerholm-Larsen B, 2000, CIRCULATION, V102, P2197
   Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799
   Pirillo A, 2013, CARDIOLOGY, V124, P116, DOI 10.1159/000346463
   Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610
   Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001
   Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991
   Liu SP, 2012, J BIOL CHEM, V287, P37321, DOI 10.1074/jbc.M112.380063
   Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197
   Kumpula LS, 2008, CHEM PHYS LIPIDS, V155, P57, DOI 10.1016/j.chemphyslip.2008.06.003
   Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   [Anonymous], 2013, DAT SINGL NUCL POL D
   MORTON RE, 1988, J BIOL CHEM, V263, P12235
   Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/nchembio.796, 10.1038/NCHEMBIO.796]
   Spirin V, 2007, AM J HUM GENET, V81, P1298, DOI 10.1086/522497
   Charles MA, 2012, J LIPID RES, V53, P1451, DOI 10.1194/jlr.R027011
   DEMEL RA, 1972, BIOCHIM BIOPHYS ACTA, V255, P311, DOI 10.1016/0005-2736(72)90030-2
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189
   BARTER PJ, 1980, J LIPID RES, V21, P238
   Barter PJ, 1996, ATHEROSCLEROSIS, V121, P1, DOI 10.1016/0021-9150(95)05675-0
   BRUCE C, 1995, J BIOL CHEM, V270, P11532, DOI 10.1074/jbc.270.19.11532
   Clark RW, 2006, J LIPID RES, V47, P537, DOI 10.1194/jlr.M500349-JLR200
   Connolly DT, 1996, BIOCHEM J, V320, P39
   Dergunov A.D., 1834, BIOCHIM BIOPHYS ACTA, V2013, P2030
   Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI DOI 10.1093/BIOINF0RMATICS/BTS209
   Eickholt J., 2013, BMC BIOINFORMATICS, V14
   EPPS DE, 1995, BIOCHEMISTRY-US, V34, P12560, DOI 10.1021/bi00039a010
   Golovin A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-312
   IHM J, 1982, J LIPID RES, V23, P1328
   Koivuniemi A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002299
   Lei DS, 2013, PROTEINS, V81, P415, DOI 10.1002/prot.24200
   MILLER KW, 1983, J BIOL CHEM, V258, P3772
   Nagano M, 2002, J LIPID RES, V43, P1011, DOI 10.1194/jlr.M200024-JLR200
   Ohtani R, 2012, CLIN CHIM ACTA, V413, P537, DOI 10.1016/j.cca.2011.11.010
   Radovica I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064191
   RAJARAM OV, 1994, BIOCHEM J, V304, P423
   Schrodinger LLC, 2010, PYMOL MOL GRAPHICS S
   SPOONER PJR, 1986, BIOCHIM BIOPHYS ACTA, V860, P345, DOI 10.1016/0005-2736(86)90531-6
   Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13
   Tall AR, 2010, J CLIN LIPIDOL, V4, P389, DOI 10.1016/j.jacl.2010.08.006
   Tsai MY, 2008, ATHEROSCLEROSIS, V200, P359, DOI 10.1016/j.atherosclerosis.2007.12.038
   Vacic V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002709
   Worth C.L., 2011, NUCLEIC ACIDS RES, V39, pW222
   Yamashita S, 2000, BBA-MOL CELL BIOL L, V1529, P257, DOI 10.1016/S1388-1981(00)00164-5
   Zheng KQ, 2004, ACTA BIOCH BIOPH SIN, V36, P33
NR 46
TC 0
Z9 0
U1 2
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 67
EP 73
DI 10.1016/j.abb.2014.08.018
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600008
PM 25201589
ER

PT J
AU Yu, N
   Jiang, JM
   Yu, Y
   Li, H
   Huang, XY
   Ma, YZ
   Zhang, LK
   Zou, J
   Zhang, BY
   Chen, SR
   Liu, PQ
AF Yu, Na
   Jiang, Jianmin
   Yu, Yang
   Li, Hong
   Huang, Xiaoyang
   Ma, Yunzi
   Zhang, Luankun
   Zou, Jian
   Zhang, Boyu
   Chen, Shaorui
   Liu, Peiqing
TI SLC41A1 knockdown inhibits angiotensin II-induced cardiac fibrosis by
   preventing Mg2+ efflux and Ca2+ signaling in cardiac fibroblasts
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE SLC41A1; Cardiac fibrosis; Calcium; Magnesium; Ne+/Mg2+ exchanger
ID SMOOTH-MUSCLE-CELLS; HUMAN SOLUTE CARRIER; INTRACELLULAR CALCIUM;
   EXTRACELLULAR-MATRIX; MYOFIBROBLAST DIFFERENTIATION; MEDIATED
   REGULATION; NA+/MG2+ EXCHANGER; HYPERTENSIVE-RATS; NUCLEAR-FACTOR;
   KAPPA-B
AB Ne+/Mg2+ exchanger plays an important role in cardiovascular system, but the molecular mechanisms still largely remain unknown. The Solute Carrier family 41A1 (SLC41A1), a novel Mg2+ transporter, recently was found to function as Na+/Mg2+ exchanger, which mainly regulates the intracellular Mg2+ ([Mg2+](i)) homeostasis. Our present studies were designed to investigate whether SLC41A1 impacts on the fibrogenesis of cardiac fibroblasts under Ang II stimulation. Our results showed that quinidine, a prototypical inhibitor of Na+/Mg2+ exchanger, inhibited Ang II-induced cardiac fibrosis via attenuating the overexpression of vital biomarkers of fibrosis, including connective tissue growth factor (CTGF), fibronectin (FN) and alpha-smooth muscle actin (alpha-SMA). In addition, quinidine also decreased the Ang ll-mediated elevation of concentration of intracellular Ca2+ ([Ca2+](i)) and extrusion of intracellular Mg2+. Meanwhile, silencing SLC41A1 by RNA interference also impaired the elevation of [Ca2+](i), [Mg2+](i) efflux and the upregulation of CTGF, FN and alpha-SMA provoked by Ang II. Furthermore, we found that Ang II-mediated activation of NFATc4 translocation decreased in SLC41A1-s1RNA cells. These results support the notion that rapid extrusion of intracellular Mg2+ mediated by SLC41A1 and provide the evidence that the intracellular free Ca2+ concentration is influenced by extrusion of intracellular Mg2+ which facilitates fibrosis reaction in cardiac fibroblasts.(C) 2014 Elsevier Inc. All rights reserved.
C1 [Yu, Na; Jiang, Jianmin; Yu, Yang; Li, Hong; Huang, Xiaoyang; Ma, Yunzi; Zhang, Luankun; Zou, Jian; Zhang, Boyu; Chen, Shaorui; Liu, Peiqing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Guangzhou 510006, Guangdong, Peoples R China.
   [Liu, Peiqing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Natl & Local Joint Engn Lab Druggabil Assessment, Guangzhou 510006, Guangdong, Peoples R China.
RP Chen, SR (reprint author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou Higher Educ Mega Ctr, 132 East,Waihuan Rd, Guangzhou 510006, Guangdong, Peoples R China.
EM chshaor@mail.sysu.edu.cn; liupq@mail.sysu.edu.cn
FU National Natural Science Foundation of China [30670837, 81072641,
   81273499]; NSFC-CIHR Joint Health Research Programs [30811120434];
   National Science and Technology Major Project of China Key New Drug
   Creation and Manufacturing Program [2011ZX09401-307]; Team Item of
   Natural Science Foundation of Guangdong Province [S2011030003190]; Major
   Project of Guangdong Province [2008A030201013, 2012A080201007]; Major
   Project of Guangzhou City [2008Z1-E571]; Major Project of Department of
   Education of Guangdong Province [CXZD1006]; Natural Science Foundation
   of Guangdong Province [S2012040006327]
FX This study was supported by the National Natural Science Foundation of
   China (Nos. 30670837, 81072641, 81273499), and NSFC-CIHR Joint Health
   Research Programs (No. 30811120434); the National Science and Technology
   Major Project of China Key New Drug Creation and Manufacturing Program
   (No. 2011ZX09401-307); Team Item of Natural Science Foundation of
   Guangdong Province (No. S2011030003190); Major Project of Guangdong
   Province (Nos. 2008A030201013, 2012A080201007) and Major Project of
   Guangzhou City (No. 2008Z1-E571); Major Project of Department of
   Education of Guangdong Province (No. CXZD1006); the Natural Science
   Foundation of Guangdong Province (No. S2012040006327).
CR AGUS ZS, 1991, ANNU REV PHYSIOL, V53, P299, DOI 10.1146/annurev.physiol.53.1.299
   AGUS ZS, 1989, AM J PHYSIOL, V256, pC452
   Altura BM, 2003, AM J HYPERTENS, V16, P701, DOI 10.1016/S0895-7061(03)00987-7
   Zhang W, 2010, J CARDIOVASC PHARM, V55, P96, DOI 10.1097/FJC.0b013e3181c9548b
   Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322
   Sontia B, 2007, ARCH BIOCHEM BIOPHYS, V458, P33, DOI 10.1016/j.abb.2006.05.005
   Herum KM, 2013, J MOL CELL CARDIOL, V54, P73, DOI 10.1016/j.yjmcc.2012.11.006
   Deason-Towne F, 2011, FEBS LETT, V585, P2275, DOI 10.1016/j.febslet.2011.05.052
   Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155
   Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246
   Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004
   Kolisek M, 2012, AM J PHYSIOL-CELL PH, V302, pC318, DOI 10.1152/ajpcell.00289.2011
   Ahokas RA, 2005, CIRCULATION, V111, P51, DOI 10.1161/01.CIR.0000151516.84238.37
   Schweigel M, 2006, AM J PHYSIOL-GASTR L, V290, pG56, DOI 10.1152/ajpgi.00014.2005
   Olson ER, 2008, HYPERTENSION, V51, P704, DOI 10.1161/HYPERTENSIONAHA.107.098459
   Du JY, 2010, CIRC RES, V106, P992, DOI 10.1161/CIRCRESAHA.109.206771
   Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158
   Mubagwa K, 2007, ARCH BIOCHEM BIOPHYS, V458, P73, DOI 10.1016/j.abb.2006.10.014
   Yu Y, 2014, CELL CALCIUM, V55, P252, DOI 10.1016/j.ceca.2014.02.019
   Kawano H, 2000, CIRCULATION, V101, P1130
   Wabakken T, 2003, BIOCHEM BIOPH RES CO, V306, P718, DOI 10.1016/S0006-291X(03)01030-1
   Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004
   Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020
   Lei B, 2011, J PHARMACOL SCI, V117, P98, DOI 10.1254/jphs.11065FP
   Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729
   Liu W, 2013, CIRC-HEART FAIL, V6, P833, DOI 10.1161/CIRCHEARTFAILURE.112.000123
   Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737
   Deb A, 2014, J MOL CELL CARDIOL, V70, P47, DOI 10.1016/j.yjmcc.2014.02.017
   Aromolaran AS, 2007, AM J PHYSIOL-CELL PH, V293, pC106, DOI 10.1152/ajpcell.00543.2006
   Brilla CG, 1998, J MOL CELL CARDIOL, V30, P1237, DOI 10.1006/jmcc.1998.0689
   Chakraborti S, 2002, MOL CELL BIOCHEM, V238, P163, DOI 10.1023/A:1019998702946
   Colston JT, 2002, J BIOL CHEM, V277, P23477, DOI 10.1074/jbc.M108676200
   Cunha AR, 2013, J AM SOC HYPERTENS, V7, P344, DOI 10.1016/j.jash.2013.04.008
   Goytain A, 2005, BIOCHEM BIOPH RES CO, V330, P701, DOI 10.1016/j.bbrc.2005.03.037
   Gwanyanya A, 2004, J PHYSIOL-LONDON, V559, P761, DOI 10.1113/jphysiol.2004.067637
   Nakajima T, 1997, EUR J PHARMACOL, V320, P81, DOI 10.1016/S0014-2999(96)00873-4
   PICADO MJ, 1994, HYPERTENSION, V23, P987
   Runyan AL, 2005, J LAB CLIN MED, V146, P76, DOI 10.1016/j.lab.2005.04.008
   Sapna S, 2006, AM J PHYSIOL-HEART C, V291, pH436, DOI 10.1152/ajpheart.01185.2005
   Tashiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073171
   Touyz RM, 2003, CLIN SCI, V105, P235, DOI 10.1042/CS20030033
   Touyz R. M., 2003, Molecular Aspects of Medicine, V24, P107, DOI 10.1016/S0098-2997(02)00094-8
   Touyz RM, 2003, J HYPERTENS, V21, P337, DOI 10.1097/01.hjh.0000052419.12292.99
   VANDELDEN C, 1993, J BIOL CHEM, V268, P12443
   VOLPE P, 1990, AM J PHYSIOL, V258, pC1077
   Wang M, 2004, J PHYSIOL-LONDON, V555, P383, DOI 10.1113/jphysiol.2003.048538
   Yamaoka K, 2003, MOL CELL BIOCHEM, V253, P3, DOI 10.1023/A:1026036931170
   Zafar S, 2008, ARCH BIOCHEM BIOPHYS, V476, P87, DOI 10.1016/j.abb.2008.04.035
NR 48
TC 2
Z9 2
U1 9
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 74
EP 82
DI 10.1016/j.abb.2014.09.013
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600009
PM 25263961
ER

PT J
AU Orzechowski, M
   Fischer, S
   Moore, JR
   Lehman, W
   Farman, GP
AF Orzechowski, Marek
   Fischer, Stefan
   Moore, Jeffrey R.
   Lehman, William
   Farman, Gerrie P.
TI Energy landscapes reveal the myopathic effects of tropomyosin mutations
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Actin; Myosin; Tropomyosin; Cardiomyopathy; Muscle regulation
ID SKELETAL-MUSCLE; ALPHA-TROPOMYOSIN; F-ACTIN; HYPERTROPHIC
   CARDIOMYOPATHY; CAUSE GAIN; MYOSIN; FLEXIBILITY; CONTRACTION;
   ACTIVATION; TROPONIN
AB Striated muscle contraction is regulated by an interaction network connecting the effects of troponin, Ca2+, and myosin-heads to the azimuthal positioning of tropomyosin along thin filaments. Many missense mutations, located at the actin-tropomyosin interface, however, reset the regulatory switching mechanism either by weakening or strengthening residue-specific interactions, leading to hyper- or hypo-contractile pathologies. Here, we compute energy landscapes for the actin-tropomyosin interface and quantify contributions of single amino acid residues to actin-tropomyosin binding. The method is a useful tool to assess effects of actin and tropomyosin mutations, potentially relating initial stages of myopathy to alterations in thin filament stability and regulation. Landscapes for mutant filaments linked to hyper-contractility provide a simple picture that describes a decrease in actin-tropomyosin interaction energy. Destabilizing the blocked (relaxed)-state parallels previously noted enhanced Ca2+-sensitivity conferred by these mutants. Energy landscapes also identify post-translational modifications that can rescue regulatory imbalances. For example, cardiomyopathy-associated E62Q tropomyosin mutation weakens actin-tropomyosin interaction, but phosphorylation of neighboring S61 rescues the binding-deficit, results confirmed experimentally by in vitro motility assays. Unlike results on hyper-contractility-related mutants, landscapes for tropomyosin mutants tied to hypo-contractility do not present a straightforward picture. These mutations may affect other components of the regulatory network, e.g., troponin-tropomyosin signaling. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Orzechowski, Marek; Moore, Jeffrey R.; Lehman, William; Farman, Gerrie P.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.
   [Orzechowski, Marek; Fischer, Stefan] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Computat Biochem Grp, D-69120 Heidelberg, Germany.
RP Lehman, W (reprint author), Boston Univ, Sch Med, Dept Physiol & Biophys, 72 East Concord St, Boston, MA 02118 USA.
EM wlehman@bu.edu
FU NIH [R37HL036153, R01HL077280]
FX These studies were supported by NIH Grants R37HL036153 (to W.L.) and
   R01HL077280 (to J.R.M.). The Massachusetts Green High Performance
   Computing Center provided computational resources.
CR Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447
   Prasad SVN, 2005, NAT CELL BIOL, V7, P785, DOI 10.1038/ncb1278
   PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5
   Chang AN, 2005, J BIOL CHEM, V280, P34343, DOI 10.1074/jbc.M505014200
   Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685
   Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   Marston S, 2013, HUM MOL GENET, V22, P4978, DOI 10.1093/hmg/ddt345
   Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Lehman W, 2009, J MOL BIOL, V388, P673, DOI 10.1016/j.jmb.2009.03.060
   Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011
   Loong CKP, 2012, FEBS LETT, V586, P3503, DOI 10.1016/j.febslet.2012.08.005
   Li XE, 2014, BIOCHEM BIOPH RES CO, V446, P304, DOI 10.1016/j.bbrc.2014.02.097
   Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9
   Ochala J, 2012, HUM MOL GENET, V21, P4473, DOI 10.1093/hmg/dds289
   Bai F, 2013, J MUSCLE RES CELL M, V34, P295, DOI 10.1007/s10974-013-9343-z
   Clarke NF, 2012, NEUROMUSCULAR DISORD, V22, P955, DOI 10.1016/j.nmd.2012.06.002
   Coulton AT, 2008, BIOCHEMISTRY-US, V47, P388, DOI 10.1021/bi701144g
   Greenberg MJ, 2010, P NATL ACAD SCI USA, V107, P17403, DOI 10.1073/pnas.1009619107
   Greenberg MJ, 2009, AM J PHYSIOL-REG I, V297, pR265, DOI 10.1152/ajpregu.00171.2009
   Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341
   Hitchcock-DeGregori SE, 2008, ADV EXP MED BIOL, V644, P60
   Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361
   Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080
   LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0
   Lehman W, 2013, J MUSCLE RES CELL M, V34, P155, DOI 10.1007/s10974-013-9342-0
   Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060
   Li XC, 2012, BIOCHEM BIOPH RES CO, V424, P493, DOI 10.1016/j.bbrc.2012.06.141
   Margaret Sunitha S., 2012, BIOINFORM BIOL INSIG, V6, P203
   MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55
   Memo M, 2013, J MUSCLE RES CELL M, V34, P165, DOI 10.1007/s10974-013-9344-y
   Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842
   Orzechowski M, 2014, BIOPHYS J, V107, P694, DOI 10.1016/j.bpj.2014.06.034
   Orzechowski M, 2014, ARCH BIOCHEM BIOPHYS, V545, P63, DOI 10.1016/j.abb.2014.01.001
   Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020
   POTTER JD, 1982, METHOD ENZYMOL, V85, P241
   Redwood C, 2013, J MUSCLE RES CELL M, V34, P285, DOI 10.1007/s10974-013-9358-5
   Sousa DR, 2013, J MOL BIOL, V425, P4544, DOI 10.1016/j.jmb.2013.08.020
NR 39
TC 3
Z9 3
U1 2
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 89
EP 99
DI 10.1016/j.abb.2014.09.007
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600011
PM 25241052
ER

PT J
AU Halama, A
AF Halama, Anna
TI Metabolomics in cell culture-A strategy to study crucial metabolic
   pathways in cancer development and the response to treatment
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Metabolomics; Metabolic alterations; Cell culture; Cancer cell lines;
   Drug screening
ID MULTIVARIATE STATISTICAL-ANALYSIS; BREAST-CANCER; PANCREATIC-CANCER;
   COLORECTAL-CANCER; MASS-SPECTROMETRY; PROSTATE-CANCER; OVARIAN-CANCER;
   HEPATOCELLULAR-CARCINOMA; URINARY NUCLEOSIDES; SERUM METABOLOMICS
AB Metabolomics is a comprehensive tool for monitoring processes within biological systems. Thus, metabolomics may be widely applied to the determination of diagnostic biomarkers for certain diseases or treatment outcomes. There is significant potential for metabolomics to be implemented in cancer research because cancer may modify metabolic pathways in the whole organism. However, not all biological questions can be answered solely by the examination of small molecule composition in biofluids; in particular, the study of cellular processes or preclinical drug testing requires ex vivo models. The major objective of this review was to summarise the current achievement in the field of metabolomics in cancer cell culture focusing on the metabolic pathways regulated in different cancer cell lines and progress that has been made in the area of drug screening and development by the implementation of metabolomics in cell lines. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Halama, Anna] Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar.
RP Halama, A (reprint author), Qatar Fdn Educ City, Weill Cornell Med Coll Qatar, POB 24144, Doha, Qatar.
EM amh2025@qatar-med.cornell.edu
FU 'Biomedical Research Program' funds at Weill Cornell Medical College in
   Qatar; Qatar Foundation
FX This work was supported by 'Biomedical Research Program' funds at Weill
   Cornell Medical College in Qatar, a program funded by the Qatar
   Foundation. The statements made herein are solely the responsibility of
   the author. I am thankful to Dr. Michal Kulinski for the critical
   reading of the manuscript.
CR Abramov Yoram, 2013, Oncol Res, V20, P529, DOI 10.3727/096504013X13747716581372
   Adamski J., 2012, GENOME MED, V4, P1
   Alcarraz-Vizan G., 2013, BIOCH BIPHYS ACTA GE
   Velazquez OC, 1996, DIGEST DIS SCI, V41, P727, DOI 10.1007/BF02213129
   Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146
   Wyss M, 2000, PHYSIOL REV, V80, P1107
   Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875
   Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650
   Patterson AD, 2011, CANCER RES, V71, P6590, DOI 10.1158/0008-5472.CAN-11-0885
   Hjarnaa PJV, 1999, CANCER RES, V59, P5751
   Boss EA, 2000, NMR BIOMED, V13, P297, DOI 10.1002/1099-1492(200008)13:5<297::AID-NBM648>3.3.CO;2-9
   Qiu YP, 2009, J PROTEOME RES, V8, P4844, DOI 10.1021/pr9004162
   Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a
   Hori S, 2011, LUNG CANCER, V74, P284, DOI 10.1016/j.lungcan.2011.02.008
   Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012
   Ressom HW, 2012, ANAL CHIM ACTA, V743, P90, DOI 10.1016/j.aca.2012.07.013
   Doria ML, 2012, BREAST CANCER RES TR, V133, P635, DOI 10.1007/s10549-011-1823-5
   Teng Q, 2009, METABOLOMICS, V5, P199, DOI 10.1007/s11306-008-0137-z
   Nordstrom A, 2010, J NEUROIMMUNE PHARM, V5, P4, DOI 10.1007/s11481-009-9156-4
   Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456
   Fujitani N, 2013, P NATL ACAD SCI USA, V110, P2105, DOI 10.1073/pnas.1214233110
   Sitter B, 2010, NMR BIOMED, V23, P424, DOI 10.1002/nbm.1478
   Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911
   Griffiths WJ, 2009, CHEM SOC REV, V38, P1882, DOI 10.1039/b618553n
   Leichtle AB, 2012, METABOLOMICS, V8, P643, DOI 10.1007/s11306-011-0357-5
   Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016
   Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012
   Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356
   Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021
   Qiu YP, 2014, CLIN CANCER RES, V20, P2136, DOI 10.1158/1078-0432.CCR-13-1939
   Beger RD, 2006, METABOLOMICS, V2, P125, DOI 10.1007/s11306-006-0026-2
   Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7
   Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879
   Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137
   Weljie AM, 2011, J BIOMOL NMR, V49, P185, DOI 10.1007/s10858-011-9486-4
   HAGUE A, 1993, INT J CANCER, V55, P498, DOI 10.1002/ijc.2910550329
   Dettmer K, 2011, ANAL BIOANAL CHEM, V399, P1127, DOI 10.1007/s00216-010-4425-x
   Averna TA, 2005, J UROLOGY, V173, P433, DOI 10.1097/01.ju.0000148949.72314.d7
   Lv WW, 2012, CLIN BIOCHEM, V45, P127, DOI 10.1016/j.clinbiochem.2011.10.011
   Halama A, 2011, OMICS, V15, P325, DOI 10.1089/omi.2010.0121
   Lesko LJ, 2001, ANNU REV PHARMACOL, V41, P347, DOI 10.1146/annurev.pharmtox.41.1.347
   Nishiumi S, 2010, METABOLOMICS, V6, P518, DOI 10.1007/s11306-010-0224-9
   Slupsky CM, 2010, CLIN CANCER RES, V16, P5835, DOI 10.1158/1078-0432.CCR-10-1434
   Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220
   Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755
   Watson DG, 2013, CELL SIGNAL, V25, P1011, DOI 10.1016/j.cellsig.2013.01.002
   Nicholson JK, 1999, XENOBIOTICA, V29, P1181
   Halama A, 2013, J INTERN MED, V274, P425, DOI 10.1111/joim.12117
   Carrola J, 2011, J PROTEOME RES, V10, P221, DOI 10.1021/pr100899x
   Harrison RG, 1907, ANAT REC, V1, P116, DOI 10.1002/ar.1090010503
   Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016
   Asiago VM, 2010, CANCER RES, V70, P8309, DOI 10.1158/0008-5472.CAN-10-1319
   Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896
   Parker WB, 2009, CHEM REV, V109, P2880, DOI 10.1021/cr900028p
   Bathe OF, 2011, CANCER EPIDEM BIOMAR, V20, P140, DOI 10.1158/1055-9965.EPI-10-0712
   Silva LP, 2013, ANAL CHEM, V85, P9536, DOI 10.1021/ac401559v
   Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09
   Odunsi K, 2005, INT J CANCER, V113, P782, DOI 10.1002/ijc.20651
   Leon Z, 2013, ELECTROPHORESIS, V34, P2762, DOI 10.1002/elps.201200605
   Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217
   OuYang D, 2011, APPL BIOCHEM BIOTECH, V165, P148, DOI 10.1007/s12010-011-9240-0
   Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666
   Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155
   Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1
   Zimmermann D, 2007, METABOLOMICS, V3, P13, DOI 10.1007/s11306-006-0038-y
   Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194
   Garcia E, 2011, J PROTEOME RES, V10, P1765, DOI 10.1021/pr101050d
   Katajamaa M, 2006, BIOINFORMATICS, V22, P634, DOI 10.1093/bioinformatics/btk039
   Batista U, 2010, CELL BIOL INT, V34, P663, DOI 10.1042/CBI20090276
   YAMASHITA SI, 1994, BRIT J CANCER, V69, P1166, DOI 10.1038/bjc.1994.229
   Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519
   Cholewinski G, 2011, PHARMACOL REP, V63, P305
   Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007
   Miller TL, 1996, APPL ENVIRON MICROB, V62, P1589
   Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776
   Dietmair S, 2010, ANAL BIOCHEM, V404, P155, DOI 10.1016/j.ab.2010.04.031
   Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113
   Warskulat U, 2007, ARCH BIOCHEM BIOPHYS, V462, P202, DOI 10.1016/j.abb.2007.03.022
   Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525
   Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102
   Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762
   Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775
   Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039
   Vermeer LS, 2012, J PROTEOME RES, V11, P2996, DOI 10.1021/pr300111x
   Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102
   Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992
   Zhang T, 2012, CLIN CHIM ACTA, V413, P861, DOI 10.1016/j.cca.2012.01.026
   Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178
   Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838
   Ceglarek U, 2010, J STEROID BIOCHEM, V121, P479, DOI 10.1016/j.jsbmb.2010.07.002
   Artati A., 2012, GENETICS MEETS METAB, P13
   Babina I.S., 2011, SEMIN CELL DEV BIOL
   Baselga J., 2011, ONCOLOGIST S, V16, P12
   Basu M, 2014, J BIOL CHEM, V289, P1415, DOI 10.1074/jbc.M113.535427
   Beger Richard D, 2013, Metabolites, V3, P552, DOI 10.3390/metabo3030552
   Bergnes G, 1996, ONCOL RES, V8, P121
   Berlicki L, 2008, MINI-REV MED CHEM, V8, P869, DOI 10.2174/138955708785132800
   Booth S.C., 2013, COMPUT STRUCT BIOTEC, P4
   Boren J, 2003, J BIOL CHEM, V278, P28395, DOI 10.1074/jbc.M302932200
   Bullinger Dino, 2007, BMC Biochemistry, V8, P25, DOI 10.1186/1471-2091-8-25
   Cano KE, 2010, J PROTEOME RES, V9, P5382, DOI 10.1021/pr100614a
   Cheng Y., 2011, J PROTEOME RES, V11, P1354
   Dayon A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008048
   DeBerardinis R.J., 2007, P NATL ACAD SCI USA, V104, P19345
   Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72
   DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203
   Di Gangi I.M., 2014, TRAC TRENDS ANAL CHE
   Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126
   Earle W.R., 1943, J NATL CANCER I, V4, P122
   Ertel A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-55
   FDA, 2004, INN STAGN CHALL OPP
   Fernandez-Albert F., 2014, BIOINFORMATICS
   Fujimura Y, 2014, PANCREAS, V43, P311, DOI 10.1097/MPA.0000000000000092
   Gey C., 1952, CANC RES
   Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282
   Jordan KW, 2007, EXPERT REV PROTEOMIC, V4, P389, DOI 10.1586/14789450.4.3.389
   Kastenmuller G., 2010, J BIOMED BIOTECHNOL, V2011
   KOVACEVI.Z, 1972, CANCER RES, V32, P326
   Krumsiek J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003005
   Krumsiek J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-21
   Lu B., 2010, PLOS ONE, V6
   Ludwig C, 2009, MAGN RESON CHEM, V47, pS68, DOI 10.1002/mrc.2519
   Mirbahai L., 2010, INT J BIOCH CELL BIO
   Mirbahai L, 2012, NMR BIOMED, V25, P1253, DOI 10.1002/nbm.2796
   Nair M, 2014, CURR CANC DRUG TARGE
   PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374
   Putluri N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021417
   Rainaldi G, 2008, RADIAT RES, V169, P170, DOI 10.1667/RR0958.1
   Ritchie SA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-13
   Sasco AJ, 1996, CANCER LETT, V108, P157, DOI 10.1016/S0304-3835(96)04393-5
   SCHAEFFER WI, 1984, IN VITRO CELL DEV B, V20, P19
   Sellick C.A., 2008, ANAL CHEM, V81, P174
   Shi Z., 2014, CANC LETT, V344, P47
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   SOERGEL KH, 1994, CLIN INVESTIGATOR, V72, P742
   Stein WD, 2004, CANCER RES, V64, P2805, DOI 10.1158/0008-5472.CAN-03-3383
   Struck W, 2011, ANAL BIOANAL CHEM, V401, P2039, DOI 10.1007/s00216-011-4789-6
   Takatani T., 2004, AM J PHYSIOL-CELL PH, V287, pC949
   Teahan O, 2011, INT J BIOCHEM CELL B, V43, P1002, DOI 10.1016/j.biocel.2010.07.003
   Tiziani S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1562
   Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251
   Vander Heiden MG, 2009, SCIENCE, V324, P1029, DOI DOI 10.1126/SCIENCE.1160809
   Volmer M., 2011, BMC P
   WAGLE SR, 1963, CANCER RES, V23, P1003
   Wang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063572
   Watanabe M., 2012, J MOL BIOMARK DIAGN, V3, P2
   Webber MM, 2001, PROSTATE, V47, P1
   Xia JG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-507
   Xiao Yang, 2013, Neoplasia, V15, P1151
   Yang L., 2014, MOL SYST BIOL, V10
   Zhang HP, 2011, ELECTROPHORESIS, V32, P340, DOI 10.1002/elps.201000431
   Zhang X., 1998, SEMINARS CELL DEV BI
   Zheng YF, 2005, CLIN BIOCHEM, V38, P24, DOI 10.1016/j.clinbiochem.2004.09.021
NR 155
TC 3
Z9 3
U1 19
U2 65
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 100
EP 109
DI 10.1016/j.abb.2014.09.002
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600012
PM 25218088
ER

PT J
AU Zhang, YF
   Weiner, JH
AF Zhang, Yanfei
   Weiner, Joel H.
TI Characterization of the kinetics and electron paramagnetic resonance
   spectroscopic properties of Acidithiobacillus ferrooxidans
   sulfide:quinone oxidoreductase (SQR)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Flavoprotein; Flavin radical; Oxidative respiration; Ubiquinone
ID QUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI; FUMARATE REDUCTASE; OXIDATION;
   BINDING; PROTEIN; ENZYME; PURIFICATION; MITOCHONDRIA; COMPONENT
AB Acidithiobacillus ferrooxidans sulfide:quinone oxidoreductase (SQR) catalyzes the oxidation of sulfide to polysulfide chains or elemental sulfur coupled to quinone reduction via a non-covalent FAD cofactor. We investigated the role of the FAD using kinetics and EPR spectroscopy. The properties of the enzyme were compared with alanine and/or serine variants of conserved cysteine residues (Cys128, Cys160, Cys356) structurally close to the FAD cofactor and histidine residues (His132, His198) implicated in function. When the pre-steady state reduction of FAD was monitored, variants of Cys128 and His132 had similar rates to wild-type enzyme confirming they do not participate in the reductive half reaction whereas variants of Cys160, Cys356 and His198 had greatly reduced activity. Using steady state kinetics of Na2S-dependent decylubiquinone (DUQ) reduction we measured a kat of 6.5 s(-1) and a K-m (Na2S) of 3.0 mu M and a K-m (DUQ) of 3.4 mu M. Variants of Cys160, Cys356 and His198 had greatly diminished DUQ reduction activity whereas variants of Cys128 and His132 were less affected. A neutral flavin semiquinone was observed in the EPR spectrum of SQR reduced with Na2S which was enhanced in the Cys160Ala variant suggesting the presence of a Cys356-S-gamma-S-C-4A-FAD adduct. Potentiometric titrations of the FAD semiquinone revealed an E-m of -139 +/- 4 mV at pH 7.0. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Zhang, Yanfei; Weiner, Joel H.] Univ Alberta, Dept Biochem, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada.
RP Weiner, JH (reprint author), Univ Alberta, Dept Biochem, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada.
EM joel.weiner@ualberta.ca
FU Canadian Institutes of Health Research (CIHR) [MOP89735]
FX The authors thank Justin G. Fedor for reviewing this manuscript and
   helpful discussions. This work was funded by the Canadian Institutes of
   Health Research (CIHR MOP89735). We thank Dr. Richard A. Rothery for
   help with the EPR analysis.
CR Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com
   Cherney MM, 2012, J STRUCT BIOL, V178, P319, DOI 10.1016/j.jsb.2012.04.007
   Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200
   MULLER F, 1972, EUR J BIOCHEM, V25, P573, DOI 10.1111/j.1432-1033.1972.tb01730.x
   Hastings SF, 1998, EUR J BIOCHEM, V255, P317, DOI 10.1046/j.1432-1327.1998.2550317.x
   ARIELI B, 1994, J BIOL CHEM, V269, P5705
   Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047
   Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013
   Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m
   Cherney MM, 2010, J MOL BIOL, V398, P292, DOI 10.1016/j.jmb.2010.03.018
   Olson GJ, 2003, APPL MICROBIOL BIOT, V63, P249, DOI 10.1007/s00253-003-1404-6
   Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Chakrabarti MH, 2008, J CHEM SOC PAKISTAN, V30, P817
   Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708
   Griesbeck C, 2002, BIOCHEMISTRY-US, V41, P11552, DOI 10.1021/bi026032b
   Griesbeck G., 2000, RECENT RES DEV MICRO, V4, P179
   Harris D.C., 2010, QUANTITATIVE CHEM AN
   Holmes D.S., 2007, BIOMINING, P281, DOI 10.1007/978-3-540-34911-2_14
   Lencina AM, 2013, BBA-BIOENERGETICS, V1827, P266, DOI 10.1016/j.bbabio.2012.10.010
   Morton R.A., 1965, SPECTROSCOPY QUINONE
   Moxley MA, 2012, BIOCHEMISTRY-US, V51, P511, DOI 10.1021/bi201603f
   Murataliev M.B., 1999, FLAVOPROTEIN PROTOCO, P97
   Parrino V, 2000, J EXP BIOL, V203, P2209
   Pham VH, 2008, MICROBIOL-SGM, V154, P3112, DOI 10.1099/mic.0.2008/018580-0
   Sambrook J., 1989, MOL CLONING LAB MANU
   Schrodinger L. L. C., 2010, PYMOL MOL GRAPHICS S
   SHAHAK Y, 1994, PHOTOSYNTH RES, V39, P175, DOI 10.1007/BF00029384
   Shahak Yosepha, 2008, V27, P319
   Shibata H, 2006, CAN J MICROBIOL, V52, P724, DOI 10.1139/W06-022
   SODEOKA M, 1993, BIOORG MED CHEM LETT, V3, P1089, DOI 10.1016/S0960-894X(00)80293-0
   Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174
   Theissen U, 2008, FEBS J, V275, P1131, DOI 10.1111/j.1742-4658.2008.06273.x
   Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597
   Vande Weghe JG, 1999, J BIOL CHEM, V274, P13250, DOI 10.1074/jbc.274.19.13250
   Wakai S, 2007, BIOSCI BIOTECH BIOCH, V71, P2735, DOI 10.1271/bbb.70332
   Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp
   WEINER JH, 1979, J BIOL CHEM, V254, P8590
   Yong R, 2001, COMP BIOCHEM PHYS B, V129, P129, DOI 10.1016/S1096-4959(01)00309-8
   Zhang YF, 2009, ACTA CRYSTALLOGR F, V65, P839, DOI 10.1107/S1744309109027535
NR 40
TC 0
Z9 0
U1 7
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 110
EP 119
DI 10.1016/j.abb.2014.09.016
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600013
PM 25303790
ER

PT J
AU Kumar, G
   Guan, SQ
   Frantom, PA
AF Kumar, Garima
   Guan, Siqi
   Frantom, Patrick A.
TI Biochemical characterization of the retaining glycosyltransferase
   glucosyl-3-phosphoglycerate synthase from Mycobacterium tuberculosis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Retaining glycosyltransferase; Glucosyl-3-phosphoglycerate synthase;
   GT-A fold; Substrate inhibition; Kinetic mechanism; Methylated
   polysaccharides
ID METHYLGLUCOSE LIPOPOLYSACCHARIDE BIOSYNTHESIS;
   MANNOSYL-3-PHOSPHOGLYCERATE SYNTHASE; CRYSTAL-STRUCTURE; ENZYME;
   ALPHA-1,3-GALACTOSYLTRANSFERASE; GLUCOSYLGLYCERATE; POLYSACCHARIDES;
   SPECIFICITY; MECHANISM; CATALYSIS
AB Glucosyl-3-phosphoglycerate synthase (GpgS) catalyzes the first step in the biosynthesis of glucosyl glycerate, the putative precursor used in building methylated polysaccharides in mycobacteria. Enzymes from Mycobacterium tuberculosis (MtGpgS) and related species have been structurally characterized and subjected to basic kinetic analyses, but more in-depth kinetic analysis is currently lacking. Dead-end inhibition studies with MtGpgS suggest an ordered kinetic mechanism with 3-phosphoglycerate (3-PGA) binding first, followed by UDP-glucose, in contrast to previous reports. At higher concentrations, 3-PGA exhibits competitive substrate inhibition vs. UDP-glucose, suggesting 3-PGA can bind to either binding site on the enzyme. Parabolic noncompetitive inhibition plots by a 3-PGA analog also support this conclusion. The effect of varying pH on the catalytic parameters indicates single ionizable residue involved catalysis (pK(a) = 6.3) that must be deprotonated for full activity. A solvent kinetic isotope effect of 2.0 +/- 0.3 on k(cat) is consistent with a proton in flight during the rate-determining step. Site-directed mutagenesis studies identify several residues critical for interactions with substrates. Although the residues are conserved among other glycosyltransferase families catalyzing similar reactions, the effect of substitutions varies between families suggesting that conserved areas play different catalytic roles in each family. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kumar, Garima; Guan, Siqi; Frantom, Patrick A.] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA.
RP Frantom, PA (reprint author), Univ Alabama, Dept Chem, Box 870336, Tuscaloosa, AL 35487 USA.
EM pfrantom@ua.edu
FU University of Alabama by a Graduate Council Fellowship
FX This work was supported by The University of Alabama by a Graduate
   Council Fellowship (G.K.) and start-up funding (P.A.F.).
CR Costa J, 2007, J BACTERIOL, V189, P1648, DOI 10.1128/JB.00841-06
   Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   [Anonymous], FACT SHEET TUB
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/nchembio.628, 10.1038/NCHEMBIO.628]
   Quiros LM, 2000, J BIOL CHEM, V275, P11713, DOI 10.1074/jbc.275.16.11713
   Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322
   SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551
   Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x
   Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096
   Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200
   Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200
   Costa J, 2006, J BACTERIOL, V188, P1022, DOI 10.1128/JB.188.3.1022-1030.2006
   Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x
   Empadinhas N, 2011, MOL MICROBIOL, V79, P76, DOI 10.1111/j.1365-2958.2010.07432.x
   Fulton Z, 2008, J BIOL CHEM, V283, P27881, DOI 10.1074/jbc.M801853200
   Goncalves S, 2010, J BIOL CHEM, V285, P17857, DOI 10.1074/jbc.M109.095976
   ILTON M, 1971, P NATL ACAD SCI USA, V68, P87, DOI 10.1073/pnas.68.1.87
   Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200
   Kaur D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005447
   MACHIDA Y, 1973, P NATL ACAD SCI USA, V70, P1146, DOI 10.1073/pnas.70.4.1146
   Mathlouthi M., 1994, SUCROSE PROPERTIES A, P126
   Mendes V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00177
   Nielsen MM, 2011, J BIOL CHEM, V286, P15155, DOI 10.1074/jbc.M110.199844
   Pereira PJB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003748
   Urresti S, 2012, J BIOL CHEM, V287, P24649, DOI 10.1074/jbc.M112.368191
   Xu HY, 2006, BIOCHEMISTRY-US, V45, P12156, DOI 10.1021/bi0610808
   Zhang YN, 2003, BIOCHEMISTRY-US, V42, P13512, DOI 10.1021/bi035430r
NR 29
TC 1
Z9 1
U1 5
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 120
EP 127
DI 10.1016/j.abb.2014.10.002
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600014
PM 25317963
ER

PT J
AU Nahalkova, J
   Tomkinson, B
AF Nahalkova, Jarmila
   Tomkinson, Birgitta
TI TPPII, MYBBP1A and CDK2 form a protein-protein interaction network
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE TPPII; MYBBP1A; CDK2; Cell cycle; Apoptosis
ID TRIPEPTIDYL-PEPTIDASE-II; ANTIGEN PRESENTATION; CELLS; ACTIVATION;
   APOPTOSIS; PATHWAYS; COMPLEX; DOMAIN; SILVER; 1A
AB Tripeptidyl-peptidase II (TPPII) is an aminopeptidase with suggested regulatory effects on cell cycle, apoptosis and senescence. A protein-protein interaction study revealed that TPPII physically interacts with the tumor suppressor MYBBP1A and the cell cycle regulator protein CDK2. Mutual protein-protein interaction was detected between MYBBP1A and CDK2 as well. In situ Proximity Ligation Assay (PLA) using HEK293 cells overexpressing TPPII forming highly enzymatically active oligomeric complexes showed that the cytoplasmic interaction frequency of TPPII with MYBBP1A increased with the protein expression of TPPII and using serum-free cell growth conditions. A specific reversible inhibitor of TPPII, butabindide, suppressed the cytoplasmic interactions of TPPII and MYBBP1A both in control HEK293 and the cells overexpressing murine TPPII. The interaction of MYBBP1A with CDK2 was confirmed by in situ PLA in two different mammalian cell lines. Functional link between TPPII and MYBBP1A has been verified by gene expression study during anoikis, where overexpression of TPP II decreased mRNA expression level of MYBBP1A at the cell detachment conditions. All three interacting proteins TPPII, MYBBP1A and CDK2 have been previously implicated in the research for development of tumor-suppressing agents. This is the first report presenting mutual protein-protein interaction network of these proteins. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Nahalkova, Jarmila; Tomkinson, Birgitta] Uppsala Univ, Dept Med Biochem & Microbiol IMBIM, BMC, SE-75123 Uppsala, Sweden.
RP Nahalkova, J (reprint author), Uppsala Univ, Dept Med Biochem & Microbiol IMBIM, BMC, Box 582, SE-75123 Uppsala, Sweden.
EM jarmila.nahalkova@imbim.uu.se; jarmila.nahalkova@gmail.com
FU Forsakringskassan, O. E. och Edla Johanssons vetenskapliga stiftelse and
   Stiftelsen Sigurd och Elsa Goljes Minne
FX We would like to acknowledge Eva Andersson and Dr. Lars Tjernberg for
   valuable assistance with performance of LC-MS/MS analysis. The
   experimental research was financially supported by Forsakringskassan, O.
   E. och Edla Johanssons vetenskapliga stiftelse and Stiftelsen Sigurd och
   Elsa Goljes Minne. The funding sources did not have any role in the
   experimental design, analysis, and data interpretation or in making
   publishing decisions.
CR Akaogi K, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-65
   Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099
   Levy F, 2002, J IMMUNOL, V169, P4161
   Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844
   Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013
   Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3
   Owa T, 2001, CURR MED CHEM, V8, P1487
   Rose C, 1996, NATURE, V380, P403, DOI 10.1038/380403a0
   York IA, 2006, J IMMUNOL, V177, P1434
   Gavioli R, 2001, NAT CELL BIOL, V3, P283, DOI 10.1038/35060076
   Huai J, 2008, P NATL ACAD SCI USA, V105, P5177, DOI 10.1073/pnas.0801413105
   MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935
   Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620
   Tomkinson B, 2002, EUR J BIOCHEM, V269, P1438, DOI 10.1046/j.1432-1033.2002.02783.x
   Preta G, 2009, BIOCHEM BIOPH RES CO, V389, P575, DOI 10.1016/j.bbrc.2009.09.021
   Tomkinson B, 1997, FEBS LETT, V405, P277, DOI 10.1016/S0014-5793(97)00173-7
   BALOW RM, 1983, J BIOL CHEM, V258, P1622
   Duensing Stefan, 2010, Genes Cancer, V1, P883, DOI 10.1177/1947601910389605
   Hilbi H, 2000, INFECT IMMUN, V68, P5502, DOI 10.1128/IAI.68.10.5502-5508.2000
   Hiromura K, 2002, ONCOGENE, V21, P1750, DOI 10.1038/sj/onc/1205238
   Keough RA, 2003, EXP CELL RES, V289, P108, DOI 10.1016/S0014-4827(03)00262-3
   Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23
   Mori S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039723
   Perrera C, 2010, J BIOL CHEM, V285, P11775, DOI 10.1074/jbc.M109.068312
   Sanhueza G.A.A., 2012, BMC CANCER, V12, P1
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Stavropoulou V, 2005, CANCER RES, V65, P1361, DOI 10.1158/0008-5472.CAN-04-2085
   Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294
   TOMKINSON B, 1990, BIOCHEM J, V267, P149
NR 29
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 128
EP 135
DI 10.1016/j.abb.2014.09.017
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600015
PM 25303791
ER

PT J
AU Yoneda, JS
   Rigos, CF
   de Lourenco, TFA
   Sebinelli, HG
   Ciancaglini, P
AF Yoneda, Juliana Sakamoto
   Rigos, Carolina Fortes
   Aranda de Lourenco, Thais Fernanda
   Sebinelli, Heitor Gobbi
   Ciancaglini, Pietro
TI Na,K-ATPase reconstituted in ternary liposome: The presence of
   cholesterol affects protein activity and thermal stability
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Na,K-ATPase; Detergent solubilized; Proteoliposome; Thermal
   inactivation; Unfolding; Differential scanning calorimetry
ID THERMOTROPIC PHASE-BEHAVIOR; DIPALMITOYLPHOSPHATIDYLCHOLINE
   BILAYER-MEMBRANES; SODIUM-POTASSIUM PUMP; NA+/K+-ATPASE ACTIVITY;
   CRYSTAL-STRUCTURE; SCANNING CALORIMETRY; CARDIOTONIC STEROIDS; BINDING
   SITE; NA+,K+-ATPASE; ORGANIZATION
AB Differential scanning calorimetry (DSC) was applied to investigate the effect of cholesterol on the thermotropic properties of the lipid membrane (DPPC and DPPE). The thermostability and unfolding of solubilized and reconstituted Na,K-ATPase in DPPC:DPPE:cholesterol-liposomes was also studied to gain insight into the role of cholesterol in the Na,K-ATPase modulation of enzyme function and activity. The tertiary system (DPPC:DPPE:cholesterol) (molar ratio DPPC:DPPE equal 1:1) when cholesterol content was increased from 0% up to 40% results in a slight decrease in the temperature of transition and enthalpy, and an increase in width.
   We observed that, without heating treatment, at 37 degrees C, the activity was higher for 20 mol% cholesterol. However, thermal inactivation experiments showed that the enzyme activity loss time depends on the cholesterol membrane content.
   The unfolding of the enzyme incorporated to liposomes of DPPC:DPPE (1:1 mol) with different cholesterol contents, ranging from 0% to 40% mol was also studied by DSC.
   Some differences between the thermograms indicate that the presence of lipids promotes a conformational change in protein structure and this change is enough to change the way Na,K-ATPase thermally unfolds. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Yoneda, Juliana Sakamoto; Rigos, Carolina Fortes; Aranda de Lourenco, Thais Fernanda; Sebinelli, Heitor Gobbi; Ciancaglini, Pietro] Univ Sao Paulo, Fac Filosofia Ciancias & Letras Ribeirao Preto, Dept Quim, BR-14040901 Ribeirao Preto, SP, Brazil.
RP Ciancaglini, P (reprint author), Univ Sao Paulo, Fac Filosofia Ciancias & Letras Ribeirao Preto, Dept Quim, BR-14040901 Ribeirao Preto, SP, Brazil.
EM pietro@ffclrp.usp.br
FU FAPESP; CNPq; CAPES; FAPESP fellowship; CNPq fellowship
FX The authors thank Priscila Cerviglieri for Linguistic advice. They also
   thank FAPESP, CNPq, CAPES for the financial support given. CFR received
   a FAPESP fellowship and JSY received CNPq fellowship.
CR Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725
   Biruss B, 2007, CHEM PHYS LIPIDS, V148, P84, DOI 10.1016/j.chemphyslip.2007.04.009
   Tian J, 2008, PHYSIOLOGY, V23, P205, DOI 10.1152/physiol.00008.2008
   Demetzos C, 2008, J LIPOSOME RES, V18, P159, DOI 10.1080/08982100802310261 
   Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578
   Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g
   Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106
   Mannock DA, 2010, BBA-BIOMEMBRANES, V1798, P376, DOI 10.1016/j.bbamem.2009.09.002
   Benesch MGK, 2011, BIOCHEMISTRY-US, V50, P9982, DOI 10.1021/bi200721j
   Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6
   Fajardo VA, 2011, J MEMBRANE BIOL, V244, P97, DOI 10.1007/s00232-011-9401-7
   Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939
   Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711
   Mannock DA, 2008, BBA-BIOMEMBRANES, V1778, P2191, DOI 10.1016/j.bbamem.2008.05.004
   SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249
   Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110
   Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967
   Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004
   Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419
   Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250
   Benesch M.G., 1838, BIOCHIM BIOPHYS ACTA, V2014, P1941
   BLUME A, 1980, BIOCHEMISTRY-US, V19, P4908, DOI 10.1021/bi00562a032
   CHETVERIN AB, 1986, FEBS LETT, V205, P185, DOI 10.1016/0014-5793(86)80894-8
   Cornelius F, 2008, BIOCHEMISTRY-US, V47, P1652, DOI 10.1021/bi702128x
   Cuevas FJ, 2006, BIOCHEMISTRY-US, V45, P13855, DOI 10.1021/bi061351e
   Santos HD, 2005, COLLOID SURFACE B, V41, P239, DOI 10.1016/j.colsurfb.2004.12.013
   Fodor E, 2008, BBA-BIOMEMBRANES, V1778, P835, DOI 10.1016/j.bbamem.2007.12.006
   Franzin CM, 2007, J BIOENERG BIOMEMBR, V39, P379, DOI 10.1007/s10863-007-9105-y
   Grinberg AV, 2001, EUR J BIOCHEM, V268, P5027, DOI 10.1046/j.0014-2956.2001.02436.x
   Heinonen S.K., 1981, ANAL BIOCHEM, V113, P313
   Korkmaz F, 2005, ARCH BIOCHEM BIOPHYS, V440, P141, DOI 10.1016/j.abb.2005.06.013
   Levi V, 2000, J MEMBRANE BIOL, V173, P215, DOI 10.1007/s002320001021
   Mannock DA, 2006, BIOPHYS J, V91, P3327, DOI 10.1529/biophysj.106.084368
   MCMULLEN TPW, 1995, BIOPHYS J, V69, P169
   Reinhard L., 2012, CELL MOL LIFE SCI, V70, P205
   Rigos CF, 2010, BIOPHYS CHEM, V146, P36, DOI 10.1016/j.bpc.2009.10.002
   Santos HL, 2002, BRAZ J MED BIOL RES, V35, P277, DOI 10.1590/S0100-879X2002000300002
   SHULL GE, 1986, NATURE, V321, P429, DOI 10.1038/321429a0
   Sotomayor CP, 2000, BIOCHEMISTRY-US, V39, P10928, DOI 10.1021/bi000717z
   Stolz M, 2003, ANN NY ACAD SCI, V986, P245
   Yoneda JS, 2013, ARCH BIOCHEM BIOPHYS, V530, P93, DOI 10.1016/j.abb.2012.12.022
NR 41
TC 0
Z9 0
U1 5
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 136
EP 141
DI 10.1016/j.abb.2014.09.015
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600016
PM 25286376
ER

PT J
AU Yu, CP
   Luo, CC
   Qu, B
   Khudhair, N
   Gu, XY
   Zang, YL
   Wang, CM
   Zhang, N
   Li, QZ
   Gao, XJ
AF Yu, Cuiping
   Luo, Chaochao
   Qu, Bo
   Khudhair, Nagam
   Gu, Xinyu
   Zang, Yanli
   Wang, Chunmei
   Zhang, Na
   Li, Qingzhang
   Gao, Xuejun
TI Molecular network including eIF1AX, RPS7, and 14-3-3 gamma regulates
   protein translation and cell proliferation in bovine mammary epithelial
   cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE 14-3-3 gamma; Bovine mammary epithelial cells; Protein translation; Cell
   proliferation; eIF1AX; RPS7
ID CYCLIN D1 EXPRESSION; INITIATION-FACTOR 4E; SIGNALING PATHWAY; PROTEOMIC
   ANALYSIS; MESSENGER-RNA; CANCER CELLS; IN-VIVO; GROWTH; GENE; ACTIVATION
AB 14-3-3 gamma, an isoform of the 14-3-3 protein family, was proved to be a positive regulator of mTOR pathway. Here, we analyzed the function of 14-3-3 gamma in protein synthesis using bovine mammary epithelial cells (BMECs). We found that 14-3-3 gamma interacted with eIF1AX and RPS7 by 14-3-3 gamma coimmunoprecipitation (CoIP) and matrix-assisted laser desorption/ionization-time-of-flight/time-of-flight (MALDI-TOF/TOF) peptide mass fingerprinting analysis. These interactions of 14-3-3 gamma with eIF1AX and RPS7 were further confirmed by colocalization and fluorescence resonance energy transfer (FRET) analysis. We also found that methionine could promote protein synthesis and trigger the protein expression levels of 14-3-3 gamma, eIF1AX and RPS7. Analysis of overexpression and inhibition of 14-3-3 gamma confirmed that it positively affected the protein expression levels of eIF1AX, RPS7, Stat5 and mTOR pathway to promote protein synthesis and cell proliferation in BMECs. We further showed that overexpression of eIF1AX and RPS7 also triggered protein translation and cell proliferation. From these results, we conclude that molecular network including eIF1AX, RPS7, and 14-3-3 gamma regulates protein translation and cell proliferation in BMECs. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Yu, Cuiping; Luo, Chaochao; Qu, Bo; Khudhair, Nagam; Gu, Xinyu; Zang, Yanli; Wang, Chunmei; Zhang, Na; Li, Qingzhang; Gao, Xuejun] Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin 150030, Peoples R China.
RP Gao, XJ (reprint author), Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin 150030, Peoples R China.
EM yuguiyan@126.com; luochaohao839505@163.com; qb5172@163.com;
   nagam1980_2005@yahoo.com; 18045181998@163.com; yanlizang@163.com;
   wangcm-1@163.com; nazhang1981@126.com; qingzhangli2004@163.com;
   gaoxj5390@sina.com
FU Major State Basic Research Development Program of China (973 Program)
   [2011CB100804]; 863 Project of Ministry of Science and Technology of
   China [2013AA102504-03]
FX This study was financially supported by Major State Basic Research
   Development Program of China (973 Program, No. 2011CB100804), 863
   Project of Ministry of Science and Technology of China (No.
   2013AA102504-03).
CR Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5
   Beck T, 1999, NATURE, V402, P689
   Jung IH, 2013, NEURO-ONCOLOGY, V15, P290, DOI 10.1093/neuonc/nos387
   CLARK RM, 1978, J DAIRY SCI, V61, P408
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367
   Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5
   Ajjappala BS, 2009, J IMMUNOL, V182, P1050
   Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/BJ20031797
   van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134
   Spilka R, 2013, CANCER LETT, V340, P9, DOI 10.1016/j.canlet.2013.06.019
   Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3
   Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103
   ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358
   Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004
   Lu LM, 2013, MOLECULES, V18, P263, DOI 10.3390/molecules18010263
   Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055
   Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5
   Wang LN, 2014, INT J MOL SCI, V15, P5952, DOI 10.3390/ijms15045952
   Geng Y, 2001, P NATL ACAD SCI USA, V98, P194, DOI 10.1073/pnas.011522998
   Takuwa N, 1999, MOL CELL BIOL, V19, P1346
   Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800
   Wang H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-91
   Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045
   Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0
   Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200
   Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065
   Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327
   Zhang X, 2014, MOLECULES, V19, P9435, DOI 10.3390/molecules19079435
   Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03
   Wu CT, 2011, CARCINOGENESIS, V32, P1890, DOI 10.1093/carcin/bgr221
   Huang YL, 2013, MOLECULES, V18, P12987, DOI 10.3390/molecules181012987
   Hamaguchi I, 2003, MOL THER, V7, P613, DOI 10.1016/S1525-0016(03)00091-1
   Khatib H, 2008, J DAIRY SCI, V91, P784, DOI 10.3168/jds.2007-0669
   Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631
   Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005
   Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051
   Huang JG, 2012, IN VITRO CELL DEV-AN, V48, P449, DOI 10.1007/s11626-012-9531-y
   Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075
   Autieri MV, 1996, CELL GROWTH DIFFER, V7, P1453
   Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715
   Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0
   Ghosh AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039586
   Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010
   Kasahara K., 2013, NAT COMMUN, V4
   Lai H., 2000, ONCOGENE, V19
   Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200
   Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200
   Magne S, 2003, MOL CELL BIOL, V23, P8934, DOI 10.1128/MCB.23.24.8934-8945.2003
   McManus EJ, 2002, NAT CELL BIOL, V4, pE214, DOI 10.1038/ncb0902-e214
   Mori H, 2000, FEBS LETT, V467, P61, DOI 10.1016/S0014-5793(00)01126-1
   MORRISON D, 1994, SCIENCE, V266, P56, DOI 10.1126/science.7939645
   Ozpolat B., 2012, LEUKEMIA RES TREAT, V2012
   RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669
   ROSENWALD IB, 1995, J BIOL CHEM, V270, P21176
   Shumway SD, 2003, J BIOL CHEM, V278, P2089, DOI 10.1074/jbc.C200499200
   Topisirovic I, 2003, MOL CELL BIOL, V23, P8992, DOI 10.1128/MCB.23.24.8992-9002.2003
   Wang C, 2010, J DAIRY SCI, V93, P3661, DOI 10.3168/jds.2009-2750
   Wang ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102118
   Wang ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079117
   Wang Z, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-119
   Yoo H, 2011, BIOCHEM BIOPH RES CO, V415, P567, DOI 10.1016/j.bbrc.2011.10.103
NR 62
TC 3
Z9 3
U1 12
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 142
EP 155
DI 10.1016/j.abb.2014.09.014
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600017
PM 25281768
ER

PT J
AU Preugschat, F
   Carter, LH
   Boros, EE
   Porter, DJT
   Stewart, EL
   Shewchuk, LM
AF Preugschat, Frank
   Carter, Luke H.
   Boros, Eric E.
   Porter, David J. T.
   Stewart, Eugene L.
   Shewchuk, Lisa M.
TI A pre-steady state and steady state kinetic analysis of the N-ribosyl
   hydrolase activity of hCD157
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Nicotinamide riboside; NAD(+) salvage; CD38; CD157
ID NICOTINAMIDE RIBOSIDE; NAD(+) METABOLISM; CD38; INTERMEDIATE; BST-1;
   CD157; CYCLIZATION; ACTIVATION; LONGEVITY; MECHANISM
AB hCD157 catalyzes the hydrolysis of nicotinamide riboside (NR) and nicotinic acid riboside (NAR). The release of nicotinamide or nicotinic acid from NR or NAR was confirmed by spectrophotometric, HPLC and NMR analyses. hCD157 is inactivated by a mechanism-based inhibitor, 2'-deoxy-2'-fluoro-nicotin-amide arabinoside (fNR). Modification of the enzyme during the catalytic cycle by NR, NAR, or fNR increased the intrinsic protein fluorescence by approximately 50%. Pre-steady state and steady state data were used to derive a minimal kinetic scheme for the hydrolysis of NR. After initial complex formation a reversible step (360 and 30 s(-1)) is followed by a slow irreversible step (0.1 s(-1)) that defined the rate limiting step, or k(cat). The calculated K-Mapp value for NR in the hydrolytic reaction is 6 nM. The values of the kinetic constants suggest that one biological function of cell-surface hCD157 is to bind and slowly hydrolyze NR, possibly converting it to a ligand-activated receptor. Differences in substrate preference between hCD157 and hCD38 were rationalized through a comparison of the crystal structures of the two proteins. This comparison identified several residues in hCD157 (F108 and F173) that can potentially hinder the binding of dinucleotide substrates (NAD(+)). (C) 2014 Elsevier Inc. All rights reserved.
C1 [Preugschat, Frank; Boros, Eric E.] GlaxoSmithKline, Muscle Metab Discovery Performance Unit, Res Triangle Pk, NC 27709 USA.
   [Carter, Luke H.] GlaxoSmithKline, Biol Sci, Mol Discovery Res, Platform Technol & Sci, Res Triangle Pk, NC 27709 USA.
   [Stewart, Eugene L.; Shewchuk, Lisa M.] GlaxoSmithKline, Chem Sci, Mol Discovery Res, Platform Technol & Sci, Res Triangle Pk, NC 27709 USA.
   [Porter, David J. T.] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA.
RP Preugschat, F (reprint author), GlaxoSmithKline, Muscle Metab Discovery Performance Unit, 5 Moore Dr,3-2094, Res Triangle Pk, NC 27709 USA.
EM Frank.X.Preugschat@gsk.com
CR Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500
   Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034
   Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095
   Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024
   Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006
   Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7
   Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Quarona V, 2013, CYTOM PART B-CLIN CY, V84B, P207, DOI 10.1002/cyto.b.21092
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689
   Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Escande C, 2013, DIABETES, V62, P1084, DOI 10.2337/db12-1139
   Aomatsu E., 2014, SCI REP, V4, P1
   Buono N.L., 2011, J BIOL CHEM, V286, P18681
   Chi Y., 2013, CURR OPIN CLIN NUTR, V60, P741
   Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2
   GLICK DL, 1991, CELL REGUL, V2, P211
   Goldberger J., 1916, SOUTH MED J, V8, P1043
   ITOH M, 1994, BIOCHEM BIOPH RES CO, V203, P1309, DOI 10.1006/bbrc.1994.2325
   KAISHO T, 1994, P NATL ACAD SCI USA, V91, P5325, DOI 10.1073/pnas.91.12.5325
   Lee HC, 1997, J BIOL CHEM, V272, P20378, DOI 10.1074/jbc.272.33.20378
   Liang F, 2001, FEBS LETT, V506, P207, DOI 10.1016/S0014-5793(01)02912-X
   Okuyama Y, 1996, BIOCHEM BIOPH RES CO, V228, P838, DOI 10.1006/bbrc.1996.1741
   Ortolan E, 2010, J NATL CANCER I, V102, P1160, DOI 10.1093/jnci/djq256
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Preugschat F, 2008, ARCH BIOCHEM BIOPHYS, V479, P114, DOI 10.1016/j.abb.2008.09.005
   Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s
   Sauve AA, 2000, J AM CHEM SOC, V122, P7855, DOI 10.1021/ja001139c
   SCHLENK F., 1940, Noturwis-senschaften, V28, P46
   Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263
   WielgusKutrowska B, 1997, EUR J BIOCHEM, V243, P408, DOI 10.1111/j.1432-1033.1997.0408a.x
   Yamamoto-Katayama S, 2002, J MOL BIOL, V316, P711, DOI 10.1006/jmbi.2001.5386
   Yamamoto-Katayama S., 2000, BIOCHEM J, V357, P385
   ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410
NR 42
TC 1
Z9 1
U1 5
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 156
EP 163
DI 10.1016/j.abb.2014.09.008
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600018
PM 25250980
ER

PT J
AU Bjornberg, O
   Efler, P
   Ebong, ED
   Svensson, B
   Hagglund, P
AF Bjornberg, Olof
   Efler, Petr
   Ebong, Epie Denis
   Svensson, Birte
   Hagglund, Per
TI Lactococcus lactis TrxD represents a subgroup of thioredoxins prevalent
   in Gram-positive bacteria containing WCXDC active site motifs
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Thioredoxin; Lactic acid bacteria; Redox potential; Disulfide reduction;
   Thiol-disulfide exchange
ID ESCHERICHIA-COLI THIOREDOXIN; PROTEIN DISULFIDE-ISOMERASE;
   BACILLUS-SUBTILIS; BOND FORMATION; RIBONUCLEOTIDE REDUCTASE;
   SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER;
   GLUTATHIONE-REDUCTASE; OXIDIZED GLUTATHIONE; REDOX POTENTIALS
AB Three protein disulfide reductases of the thioredoxin superfamily from the industrially important Gram-positive Lactococcus lactis (LlTrxA, LlTrxD and LlNrdH) are compared to the "classical" thioredoxin from Escherichia coli (EcTrx1). LlTrxA resembles EcTrx1 with a WCGPC active site motif and other key residues conserved. By contrast, LlTrxD is more distantly related and contains a WCGDC motif. Bioinformatics analysis suggests that LlTrxD represents a subgroup of thioredoxins from Gram-positive bacteria. LlNrdH is a glutaredoxin-like electron donor for ribonucleotide reductase class Ib. Based on protein-protein equilibria LlTrxA (E-o' = -259 mV) and LlNrdH (E-o' = -238 my) show approximately 10 mV higher standard state redox potentials than the corresponding E. coli homologues, while E' of LlTrxD is -243 mV, more similar to glutaredoxin than "classical" thioredoxin. EcTrx1 and LlTrxA have high capacity to reduce insulin disulfides and their exposed active site thiol is alkylated at a similar rate at pH 7.0. LlTrxD on the other hand, is alkylated by iodoacetamide at almost 100 fold higher rate and shows no activity towards insulin disulfides. LlTrxA, LlTrxD and L1NrdH are all efficiently reduced by NADPH dependent thioredoxin reductase (TrxR) from L lactis and good cross-reactivity towards E. coli TrxR was observed with LITrxD as the notable exception. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Bjornberg, Olof; Efler, Petr; Ebong, Epie Denis; Svensson, Birte; Hagglund, Per] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.
RP Hagglund, P (reprint author), Tech Univ Denmark, Dept Syst Biol, Bldg 224, DK-2800 Lyngby, Denmark.
EM ph@bio.dtu.dk
FU Danish Council for Independent Research \ Technology and Production
   Sciences (FTP) [274-08-0413]; Carlsberg Foundation; Technical University
   of Denmark
FX Aida Curovic is acknowledged for technical assistance. Anne Blicher is
   thanked for performing amino acid analysis and we are grateful to
   Alexander Viborg for constructing algorithms to extract lists of
   phylogenetic information from large datasets of Uniprot entries. The
   work was supported by the Danish Council for Independent Research
   vertical bar Technology and Production Sciences (FTP, Grant nr
   274-08-0413) and the Carlsberg Foundation. The PhD Grant to PE was in
   part financed by the Technical University of Denmark.
CR Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853
   HOLMGREN A, 1989, J BIOL CHEM, V264, P13963
   Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189
   MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X
   Chartron J, 2007, BIOCHEMISTRY-US, V46, P3942, DOI 10.1021/bi700130e
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x
   Maeda K, 2010, FEBS LETT, V584, P3376, DOI 10.1016/j.febslet.2010.06.028
   EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103
   Sagemark J, 2007, PROTEINS, V68, P879, DOI 10.1002/prot.21416
   KRAUSE G, 1991, J BIOL CHEM, V266, P9494
   Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580
   Jeong W, 2004, J BIOL CHEM, V279, P3142, DOI 10.1074/jbc.M307932200
   Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a
   Li Y, 2003, APPL ENVIRON MICROB, V69, P5739, DOI 10.1128/AEM.69.10.5739-5745.2003
   HOLMGREN A, 1979, J BIOL CHEM, V254, P9627
   Uziel O, 2004, J BACTERIOL, V186, P326, DOI 10.1128/JB.2.326-334.2004
   Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643
   Collet JF, 2003, J BIOL CHEM, V278, P45325, DOI 10.1074/jbc.M307818200
   Vido K, 2005, J BACTERIOL, V187, P601, DOI 10.1128/JB.187.2.601-610.2005
   Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200
   Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100
   Marco S, 2013, BIOCHIMIE, V95, P2145, DOI 10.1016/j.biochi.2013.08.008
   Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200
   SZAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011, DOI 10.1021/ja00526a042
   Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012
   Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841
   Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06
   Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780
   Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844
   Jensen KS, 2009, ANTIOXID REDOX SIGN, V11, P1047, DOI 10.1089/ARS.2008.2297
   Pader I, 2014, P NATL ACAD SCI USA, V111, P6964, DOI 10.1073/pnas.1317320111
   Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985
   Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044
   Baker LMS, 2001, J BACTERIOL, V183, P1961, DOI 10.1128/JB.183.6.1961-1973.2001
   Björnberg Olof, 2012, Biochemistry, V51, P9930, DOI 10.1021/bi301051b
   Brown JR, 2001, SYST BIOL, V50, P497
   Cheng ZY, 2007, BIOCHEMISTRY-US, V46, P7875, DOI 10.1021/bi700442r
   Cheng ZY, 2011, CHEM REV, V111, P5768, DOI 10.1021/cr100006x
   Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l
   de Lamotte-Guery F, 1997, PROTEIN ENG, V10, P1425, DOI 10.1093/protein/10.12.1425
   Eckers E, 2009, BIOCHEMISTRY-US, V48, P1410, DOI 10.1021/bi801859b
   EKLUND H, 1984, EMBO J, V3, P1443
   Greetham D, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-3
   Gustafsson TN, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.413427
   HAWKINS HC, 1991, BIOCHEM J, V275, P335
   Jensen JM, 2012, FEBS LETT, V586, P2479, DOI 10.1016/j.febslet.2012.06.009
   Jordan A, 1996, J BIOL CHEM, V271, P8779
   KALLIS GB, 1980, J BIOL CHEM, V255, P261
   KRAUSE G, 1991, J BIOL CHEM, V266, P4056
   LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018
   Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106
   Moller MC, 2008, J BACTERIOL, V190, P4660, DOI 10.1128/JB.00252-08
   NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039
   Nordlund Pär, 2006, Annu Rev Biochem, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   PRONGAY AJ, 1989, J BIOL CHEM, V264, P2656
   Roos G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000461
   Scharf C, 1998, J BACTERIOL, V180, P1869
   SNYDER GH, 1987, BIOCHEMISTRY-US, V26, P688, DOI 10.1021/bi00377a005
   Woo JR, 2004, J BIOL CHEM, V279, P48120, DOI 10.1074/jbc.M407079200
   ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016
NR 61
TC 1
Z9 1
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 164
EP 172
DI 10.1016/j.abb.2014.09.010
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600019
PM 25255970
ER

PT J
AU Roberto, VP
   Tiago, DM
   Silva, IAL
   Cancela, ML
AF Roberto, V. P.
   Tiago, D. M.
   Silva, I. A. L.
   Cancela, M. L.
TI MiR-29a is an enhancer of mineral deposition in bone-derived systems
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE MiR-29; Extracellular matrix mineralization; beta-Catenin; SPARC;
   Conservation
ID MATRIX GLA PROTEIN; IN-SILICO ANALYSIS; GENE-EXPRESSION; SPARUS-AURATA;
   OSTEOBLAST DIFFERENTIATION; CONSERVED FEATURES; IDENTIFICATION;
   OSTEOCALCIN; MICRORNAS; FISH
AB MicroRNAs (miRNAs) provide a mechanism for fine-tuning of intricate cellular processes through post-transcriptional regulation. Emerging evidences indicate that miRNAs play key roles in regulation of osteogenesis. The miR-29 family was previously implicated in mammalian osteoblast differentiation by targeting extracellular matrix molecules and modulating Wnt signaling. Nevertheless, the function of miR-29 in bone formation and homeostasis is not completely understood. Here, we provide novel insights into the biological effect of miR-29a overexpression in a mineralogenic cell system (ABSa15). MiR-29a gain-of-function resulted in significant increase of extracellular matrix mineralization, probably due to accelerated differentiation. We also demonstrated for the first time that miR-29a induced beta-catenin protein levels, implying a stimulation of canonical Wnt signaling. Our data also suggests that SPARC is a conserved target of miR-29a, and may contribute to the phenotype observed in ABSa15 cells. Finally, we provide evidences for miR-29a conservation throughout evolution based on sequence homology, synteny analysis and expression patterns. Concluding, miR-29a is a key player in osteogenic differentiation, leading to increased mineralization in vitro, and this function seems to be conserved throughout vertebrate evolution by interaction with canonical Wnt signaling and conservation of targets. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Roberto, V. P.; Tiago, D. M.; Silva, I. A. L.; Cancela, M. L.] Univ Algarve, Ctr Marine Sci, P-8005139 Faro, Portugal.
   [Roberto, V. P.; Silva, I. A. L.] Univ Algarve, DCBM, PhD Program Biomed Sci, P-8005139 Faro, Portugal.
   [Cancela, M. L.] Univ Algarve, Dept Biomed Sci & Med, P-8005139 Faro, Portugal.
RP Tiago, DM (reprint author), Univ Algarve, Campus Gambelas,Edf 7,Lab 2-13, P-8005139 Faro, Portugal.
EM vroberto@ualg.pt; dtiago@ualg.pt; irissepol@gmail.com; lcancela@ualg.pt
RI Cancela, M. Leonor/F-4665-2012; Tiago, Daniel/A-4820-2013; 
OI Cancela, M. Leonor/0000-0003-3114-6662; Tiago,
   Daniel/0000-0001-8418-6292; Roberto, Vania/0000-0002-8134-4045
FU Calouste Gulbenkian Foundation (program "Na Fronteira das Ciencias da
   Vida"); European Regional Development Fund (ERDF) through COMPETE
   Program; FCT - Foundation for Science and Technology
   [PEst-C/MAR/LA0015/2011]; FCT [SFRH/BD/38607/2007, SFRH/BD/77227/2011,
   SFRH/BPD/45034/2008]
FX Authors are grateful to Doctor Dominique Modrowski from INSERM U606
   Unit, Paris, France, for kindly providing the beta-catenin antibody.
   This work was supported by grants from the Calouste Gulbenkian
   Foundation (program "Na Fronteira das Ciencias da Vida"; to D.M.T.).
   This work was co-funded by The European Regional Development Fund (ERDF)
   through COMPETE Program and by national funds through FCT - Foundation
   for Science and Technology, under the project "PEst-C/MAR/LA0015/2011".
   V.P.R., I.A.L.S and D.M.T. were the recipients of doctoral
   (SFRH/BD/38607/2007, SFRH/BD/77227/2011) and post-doctoral
   (SFRH/BPD/45034/2008) fellowships, respectively, from FCT.
CR Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243
   Zhao X, 2014, J BONE MINER METAB, V32, P221, DOI 10.1007/s00774-013-0537-7
   Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308
   STANFORD CM, 1995, J BIOL CHEM, V270, P9420
   Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0
   Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625
   Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832
   Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044
   Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137
   Delany AM, 2009, J CELL COMMUN SIGNAL, V3, P227, DOI 10.1007/s12079-009-0076-0
   Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428
   Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533
   Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC
   Pombinho AR, 2004, CELL TISSUE RES, V315, P393, DOI 10.1007/s00441-003-0830-1
   Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6
   Gavaia PJ, 2006, GENE EXPR PATTERNS, V6, P637, DOI 10.1016/j.modgep.2005.11.010
   Tetreault N, 2013, CLIN BIOCHEM, V46, P842, DOI 10.1016/j.clinbiochem.2013.02.009
   Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Franceschetti T, 2013, J BIOL CHEM, V288, P33347, DOI 10.1074/jbc.M113.484568
   He XJ, 2011, DEV BIOL, V357, P463, DOI 10.1016/j.ydbio.2011.07.014
   Marques CL, 2007, CYTOTECHNOLOGY, V55, P9, DOI 10.1007/s10616-007-9098-8
   Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0
   Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026
   Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25
   Mansergh FC, 2007, PHYSIOL GENOMICS, V32, P64, DOI 10.1152/physiolgenomics.00151.2007
   Rossi M, 2013, J CELL PHYSIOL, V228, P1506, DOI 10.1002/jcp.24306
   Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200
   Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108
   PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7
   Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30
   Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105
   Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079
   Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929
   Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106
   Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377
   Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105
   Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437
   HALE JE, 1988, J BIOL CHEM, V263, P5820
   Ouyang YB, 2014, NEUROSCI LETT, V565, P53, DOI 10.1016/j.neulet.2013.11.015
   Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008
   Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147
   Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630
   Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205
   Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001
   Guarnieri DJ, 2008, ANN MED, V40, P197, DOI 10.1080/07853890701771823
   Li Y, 2011, J PATHOL, V224, P484, DOI 10.1002/path.2873
   Bensimon-Brito A, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-28
   Bodine P.V., 2007, BONEKEY OSTEOVISION, V4, P108
   Cavaco S, 2014, FISH PHYSIOL BIOCHEM, V40, P731, DOI 10.1007/s10695-013-9880-9
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Estevao MD, 2011, CELL TISSUE RES, V343, P619, DOI 10.1007/s00441-010-1109-y
   Estevao MD, 2005, GEN COMP ENDOCR, V142, P155, DOI 10.1016/j.ygcen.2004.11.018
   Kaartinen MT, 1997, J BIOL CHEM, V272, P22736, DOI 10.1074/jbc.272.36.22736
   Laize V, 2005, BIOCHIMIE, V87, P411, DOI 10.1016/j.biochi.2005.01.008
   Laize V, 2006, J BIOL CHEM, V281, P15037, DOI 10.1074/jbc.M600373200
   Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Luna C, 2011, INVEST OPHTH VIS SCI, V52, P3567, DOI 10.1167/iovs.10-6448
   Oliveira P.T.D., 2003, J HISTOCHEM CYTOCHEM, V51, P633
   Pinto JP, 2003, BONE, V32, P201, DOI 10.1016/S8756-3282(02)00981-X
   Rafael MS, 2006, BONE, V39, P1373, DOI 10.1016/j.bone.2006.06.021
   Roberto VP, 2009, AQUACULTURE, V294, P202, DOI 10.1016/j.aquaculture.2009.06.020
   Smith SS, 2013, ENDOCRINOLOGY, V154, P253, DOI 10.1210/en.2012-1476
   Spoorendonk B.K.M., 2010, J ANAT, V26, P219
   Tiago DM, 2014, ARCH BIOCHEM BIOPHYS, V543, P23, DOI 10.1016/j.abb.2013.12.009
   Trompeter HI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-111
NR 67
TC 6
Z9 6
U1 6
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 173
EP 183
DI 10.1016/j.abb.2014.09.006
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600020
PM 25241053
ER

PT J
AU Li, J
   Li, Y
   Cao, YY
   Yuan, MF
   Gao, ZF
   Guo, XM
   Zhu, FH
   Wang, YF
   Xu, J
AF Li, Jian
   Li, Yang
   Cao, Yinyin
   Yuan, Meifen
   Gao, Zhengfeng
   Guo, Xuemei
   Zhu, Fenhua
   Wang, Yunfeng
   Xu, Jin
TI Polycomb chromobox (Cbx) 7 modulates activation-induced CD4(+) T cell
   apoptosis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE T lymphocyte; Apoptosis; Fas ligand; Chromobox homolog 7; Methylation
ID GROUP PROTEINS; DEATH; EXPRESSION; LIGAND; GENE; FASL; LYMPHOCYTES;
   RECEPTORS; DISEASE
AB CD4(+) T cell polarization plays a critical role in a number of immune disorders; the pathogenesis is unclear. Chromobox homolog 7 (Cbx7) is involved in the gene transcription of several cell types. This study aims to investigate the mechanism by which Cbx7 modulates the CD4(+) T cell polarization. Expression of Cbx7 was assessed by quantitative RT-PCR and Western blotting. Apoptosis of CD4(+) T cell was analyzed by flow cytometry. The FasL promoter methylation was evaluated by the methylation specific PCR. The results showed that CD4(+) CD25(-) T cells express Cbx7 that was increased significantly after activation by exposing to anti-CD3/CD28 Ab, but suppressed by exposing to specific antigens. More apoptotic cells were detected in CD4(+) T cells with the Cbx7 gene knockdown. Exposure to insulin-like growth factor-1 up regulated the expression of Cbx7 in CD4(+) T cells. After antigen-specific TCR activation, Cbx7-deficient CD4(+) T cells expressed more FasL and showed the FasL gene promoter hyper demethylation than wild CD4(+) T cells. In addition, CD4(+) T cells with overexpression of Cbx7 showed lower levels of FasL gene promoter demethylation. We conclude that CD4(+) T cells express Cbx7; the latter prevents FasL expression and the activation-induced CD4(+) T cell apoptosis. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Li, Jian; Yuan, Meifen; Gao, Zhengfeng; Guo, Xuemei; Zhu, Fenhua; Xu, Jin] Fudan Univ, Childrens Hosp, Ctr Clin Lab, Shanghai 201102, Peoples R China.
   [Cao, Yinyin] Fudan Univ, Childrens Hosp, Ctr Cardiovasc, Shanghai 201102, Peoples R China.
   [Wang, Yunfeng] Fudan Univ, Affiliated Eye & ENT Hosp, Dept Otolaryngol, Shanghai 200031, Peoples R China.
   [Li, Yang] Kunming Med Univ, Kunming 650101, Peoples R China.
RP Wang, YF (reprint author), Fudan Univ, Affiliated Eye & ENT Hosp, Dept Otolaryngol, Shanghai 200031, Peoples R China.
EM xujinngg@126.com
FU National Nature Science Found of China [81273204]; National Natural
   Science Fund for Youth of China [81400240]; Shanghai Health and Family
   Planning Commission Scientific Reseach Project [201440632]; National
   Nature Science Found for Youth of China [81100721]; "Zhuoxue Plan" Funds
   of the Fudan University
FX This study was supported by research grants from National Nature Science
   Found of China (81273204) to Jin Xu, National Natural Science Fund for
   Youth of China (81400240) and Shanghai Health and Family Planning
   Commission Scientific Reseach Project (201440632) to Jian Li, National
   Nature Science Found for Youth of China (81100721) and "Zhuoxue Plan"
   Funds of the Fudan University to Yunfeng Wang.
CR Adachi Y, 2014, TUMOR BIOL, V35, P973, DOI 10.1007/s13277-013-1131-2
   Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115
   Maher S, 2002, IMMUNOL CELL BIOL, V80, P131, DOI 10.1046/j.1440-1711.2002.01068.x
   Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117
   Waring P, 1999, IMMUNOL CELL BIOL, V77, P312, DOI 10.1046/j.1440-1711.1999.00837.x
   JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0
   Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692
   Overhoff MG, 2014, NUCLEIC ACIDS RES, V42, P1606, DOI 10.1093/nar/gkt1096
   Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095
   Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305
   Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x
   von Rossum A, 2011, J BIOL CHEM, V286, P21137, DOI 10.1074/jbc.M110.197657
   FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6
   Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603
   Weiss EM, 2011, J IMMUNOL, V187, P1684, DOI 10.4049/jimmunol.1002321
   Cippitelli M, 2002, J IMMUNOL, V168, P1154
   Deng L.J., 2014, CHEM BIOL INTERACT
   Dong C.X., 2013, ENDOCRINOLOGY, V155, P370
   Donskow K, 2011, PARASITE IMMUNOL, V33, P158, DOI 10.1111/j.1365-3024.2010.01262.x
   Hamad A R, 2001, Int Rev Immunol, V20, P535, DOI 10.3109/08830180109045577
   Kottilil S, 2001, CELL IMMUNOL, V214, P1, DOI 10.1006/cimm.2001.1876
   Lee H., 2013, AM J RESP CELL MOL B, V50, P667
   Lettau M, 2009, RESULTS PROBL CELL D, V49, P49, DOI 10.1007/400_2008_21
   Sax A. T., 2014, CANC EPIDEMIOL
   Tabet S, 2013, BIOORGAN MED CHEM, V21, P7004, DOI 10.1016/j.bmc.2013.09.024
   Xu MD, 2013, J IMMUNOL, V190, P5436, DOI 10.4049/jimmunol.1203576
NR 26
TC 0
Z9 0
U1 2
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 184
EP 188
DI 10.1016/j.abb.2014.10.004
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600021
PM 25449062
ER

PT J
AU Huddleston, JP
   Burks, EA
   Whitman, CP
AF Huddleston, Jamison P.
   Burks, Elizabeth A.
   Whitman, Christian P.
TI Identification and characterization of new family members in the
   tautomerase superfamily: Analysis and implications
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Tautomerase superfamily; 4-Oxalocrotonate tautomerase; Malonate
   semialdehyde decarboxylase beta-alpha-beta fold; Catalytic amino
   terminal praline; Hydratase activity; Catalytic promiscuity
ID MALONATE SEMIALDEHYDE DECARBOXYLASE; TRANS-3-CHLOROACRYLIC ACID
   DEHALOGENASE; ACTIVE-SITE RESIDUES; BIOSYNTHETIC GENE-CLUSTER;
   AMINO-TERMINAL PROLINE; 4-OXALOCROTONATE TAUTOMERASE; MECHANISTIC
   CHARACTERIZATION; PHENYLPYRUVATE TAUTOMERASE; ENZYMATIC KETONIZATION;
   3-CHLOROACRYLIC ACID
AB Tautomerase superfamily members are characterized by a beta-alpha-beta building block and a catalytic amino terminal proline. 4-Oxalocrotonate tautomerase (4-OT) and malonate semialdehyde decarboxylase (MSAD) are the title enzymes of two of the five known families in the superfamily. Two recent developments in these families indicate that there might be more metabolic diversity in the tautomerase superfamily than previously thought. 4-OT homologues have been identified in three biosynthetic pathways, whereas all previously characterized 4-OTs are found in catabolic pathways. In the MSAD family, homologues have been characterized that lack decarboxylase activity, but have a modest hydratase activity using 2-oxo-3-pentynoate. This observation stands in contrast to the first characterized MSAD, which is a proficient decarboxylase and a less efficient hydratase. The hydratase activity was thought to be a vestigial and promiscuous activity. However, this recent discovery suggests that the hydratase activity might reflect a new activity in the MSAD family for an unknown substrate. These discoveries open up new avenues of research in the tautomerase superfamily. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Huddleston, Jamison P.; Burks, Elizabeth A.; Whitman, Christian P.] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.
RP Whitman, CP (reprint author), Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.
EM whitman@austin.utexas.edu
FU National Institutes of Health [R01 GM41239, R01 GM65324]; Robert A.
   Welch Foundation [F-1334]
FX This research was supported by the National Institutes of Health (Grants
   R01 GM41239 and R01 GM65324) and the Robert A. Welch Foundation (Grant
   F-1334).
CR Almrud JJ, 2005, BIOCHEMISTRY-US, V44, P14818, DOI 10.1021/bi051383m
   Gerratana B, 2012, MED RES REV, V32, P254, DOI 10.1002/med.20212
   Li W, 2009, APPL ENVIRON MICROB, V75, P2958, DOI 10.1128/AEM.02325-08
   Huang TT, 2011, J BIOL CHEM, V286, P20648, DOI 10.1074/jbc.M110.180000
   Whitman CP, 2002, ARCH BIOCHEM BIOPHYS, V402, P1, DOI 10.1016/S0003-9861(02)00052-8
   Colabroy KL, 2008, ARCH BIOCHEM BIOPHYS, V479, P131, DOI 10.1016/j.abb.2008.08.022
   Sakai A, 2006, BIOCHEMISTRY-US, V45, P4455, DOI 10.1021/bi060230b
   Li W, 2009, APPL ENVIRON MICROB, V75, P2869, DOI 10.1128/AEM.02326-08
   Yebra MJ, 2007, APPL ENVIRON MICROB, V73, P3850, DOI 10.1128/AEM.00243-07
   Taylor AB, 1998, BIOCHEMISTRY-US, V37, P14692, DOI 10.1021/bi981607j
   Burks EA, 2010, BIOCHEMISTRY-US, V49, P5016, DOI 10.1021/bi100502z
   Poelarends GJ, 1998, APPL ENVIRON MICROB, V64, P2931
   Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m
   Subramanya HS, 1996, BIOCHEMISTRY-US, V35, P792, DOI 10.1021/bi951732k
   Mast Y, 2011, MICROB BIOTECHNOL, V4, P192, DOI 10.1111/j.1751-7915.2010.00213.x
   Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1
   Wang SC, 2007, BIOCHEMISTRY-US, V46, P11919, DOI 10.1021/bi701231a
   Atschul S.F., 1990, J MOL BIOL, V215, P403
   Azurmendi HF, 2004, BIOCHEMISTRY-US, V43, P4082, DOI 10.1021/bi030241u
   Burks EA, 2011, BIOCHEMISTRY-US, V50, P7600, DOI 10.1021/bi200947w
   Czerwinski RM, 1999, BIOCHEMISTRY-US, V38, P12358, DOI 10.1021/bi9911177
   Czerwinski RM, 2001, BIOCHEMISTRY-US, V40, P1984, DOI 10.1021/bi0024714
   Czerwinski RM, 1997, BIOCHEMISTRY-US, V36, P14551, DOI 10.1021/bi971545h
   Dagley S., 1978, BACTERIA TREATISE ST, P305
   de Jong RM, 2004, J BIOL CHEM, V279, P11546, DOI 10.1074/jbc.M311966200
   Glasner ME, 2006, J MOL BIOL, V360, P228, DOI 10.1016/j.jmb.2006.04.055
   Guo YZ, 2013, BIOCHEMISTRY-US, V52, P4830, DOI 10.1021/bi400567a
   Harris TK, 1999, BIOCHEMISTRY-US, V38, P12343, DOI 10.1021/bi991116e
   HARTMANS S, 1991, J GEN MICROBIOL, V137, P2025
   Horvat CM, 2005, P NATL ACAD SCI USA, V102, P16199, DOI 10.1073/pnas.0508176102
   JENKINS JR, 1988, J BACTERIOL, V170, P5317
   Johnson WH, 1997, BIOCHEMISTRY-US, V36, P15724
   Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100
   Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5
   Odokonyero D, 2013, BIOCHEMISTRY-US, V52, P7512, DOI 10.1021/bi401176d
   Poelarends GJ, 2005, BIOCHEMISTRY-US, V44, P9375, DOI 10.1021/bi050296r
   Poelarends GJ, 2008, CELL MOL LIFE SCI, V65, P3606, DOI 10.1007/s00018-008-8285-x
   Poelarends GJ, 2001, J BACTERIOL, V183, P4269, DOI 10.1128/JB.183.14.4269-4277.2001
   Poelarends GJ, 2006, BIOCHEMISTRY-US, V45, P7700, DOI 10.1021/bi0600603
   Poelarends GJ, 2004, BIOCHEMISTRY-US, V43, P759, DOI 10.1021/bi0355948
   Poelarends GJ, 2003, J BIOL CHEM, V278, P48674, DOI 10.1074/jbc.M306706200
   Poelarends GJ, 2004, J AM CHEM SOC, V126, P15658, DOI 10.1021/ja044304n
   Poelarends GJ, 2004, BIOORG CHEM, V32, P376, DOI 10.1016/j.bioorg.2004.05.006
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Stivers JT, 1996, BIOCHEMISTRY-US, V35, P803, DOI 10.1021/bi951077g
   Stivers JT, 1996, BIOCHEMISTRY-US, V35, P814, DOI 10.1021/bi9510789
   van Hylckama Vlieg J.E.T., 1992, BIODEGRADATION, V2, P139
   Wang SC, 2003, J AM CHEM SOC, V125, P14282, DOI 10.1021/ja.0370948
   Wang SC, 2003, BIOCHEMISTRY-US, V42, P8762, DOI 10.1021/bi034598+
   WHITMAN CP, 1991, J AM CHEM SOC, V113, P3154, DOI 10.1021/ja00008a052
   WHITMAN CP, 1992, J AM CHEM SOC, V114, P10104, DOI 10.1021/ja00052a002
NR 51
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 189
EP 196
DI 10.1016/j.abb.2014.08.019
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600022
PM 25219626
ER

PT J
AU Bu, SY
   Zhu, YC
   Peng, CD
   Cai, X
   Cao, CX
   Tan, H
   Cheng, JQ
   Zhang, J
   Liu, JM
   Li, H
   Wang, KJ
AF Bu, Siyuan
   Zhu, Yuchun
   Peng, Chuandu
   Cai, Xiang
   Cao, Chenxi
   Tan, Hong
   Cheng, Jingqiu
   Zhang, Jie
   Liu, Jiaming
   Li, Hong
   Wang, Kunjie
TI Simulated physiological stretch-induced proliferation of human bladder
   smooth muscle cells is regulated by MMPs
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Urinary bladder; Smooth muscle cell; Matrix metalloproteinases; Cell
   proliferation; Stretch
ID ACTIVATED PROTEIN-KINASE; FLUID SHEAR-STRESS; EXTRACELLULAR-MATRIX;
   METALLOPROTEINASE ACTIVITY; GROWTH-FACTOR; III COLLAGEN; CANCER; TISSUE;
   RAT; OBSTRUCTION
AB Mechanical stimulation is an essential factor for organisms to develop normally. In bladder development matrix metalloproteinases (MMPs) play an important role through structure remodeling and regulating the cell proliferation. In this study, we investigated the simulated physiological stretch induced proliferation of HBSMCs; MMPs/TIMPs expression in stretch and non-stretch groups. HBSMCs were exposed to cyclic stretch with defined parameters (5%, 10% and 15% elongation). The expression of MMPs and TIMPs in each parameter and non-stretch groups was examined at the transcriptional and translational levels respectively. 5-Ethynyl-2'-deoxyuridine (EdU) assay was used to assess cell proliferation. In the presence of the broad spectrum MMPs inhibitor (Batimastat), cells proliferation, MMPs and tissue inhibitors of metalloproteinases (TIMPs) expression were assessed again. Compared with non-stretch group, HBSMCs in stretch groups showed higher proliferation. The expression of MMP-1, 2, 3, 7 was up-regulated in stretch groups, and it remained at the same high level in 10% and 15% stretch groups. TIMP-1, 2 expression only increased under 15% stretch. Stretch resulted in elevated cell proliferation was abolished by Batimastat. In conclusion, the proliferation of HBSMCs induced by stretch was resulted from the stretch-induced MMPs expression and release. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Bu, Siyuan; Zhu, Yuchun; Peng, Chuandu; Cai, Xiang; Cao, Chenxi; Liu, Jiaming; Li, Hong; Wang, Kunjie] Sichuan Univ, West China Hosp, Dept Urol, Chengdu 610041, Sichuan, Peoples R China.
   [Tan, Hong] Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
   [Cheng, Jingqiu; Zhang, Jie] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Key Lab Transplant Engn & Immunol,Minist Hlth, Chengdu 610041, Sichuan, Peoples R China.
RP Wang, KJ (reprint author), Sichuan Univ, West China Hosp, Dept Urol, Guoxue Alley 37, Chengdu 610041, Sichuan, Peoples R China.
EM wzwzlscu@qq.com
FU National Natural Science Foundation of China [31370951, 31170907];
   National Science Foundation for Young Scholars of China [81300579,
   81100494]; Ph.D. Programs Foundation of Ministry of Education of China
   [20110181110028, 20110181130003]; Science and Technology Bureau of
   Chengdu City [12PPYB030SF-002]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 31370951 and 31170907), the National Science
   Foundation for Young Scholars of China (Grant Nos. 81300579 and
   81100494), the Ph.D. Programs Foundation of Ministry of Education of
   China (Grant No. 20110181110028), the Ph.D. Programs Foundation of
   Ministry of Education of China (Priority area) (Grant No.
   20110181130003), and the Science and Technology Bureau of Chengdu City
   (Grant No. 12PPYB030SF-002).
CR Aitken KJ, 2006, AM J PATHOL, V169, P459, DOI 10.2353/ajpath.2006.050969
   Chen L, 2012, J UROLOGY, V188, P661, DOI 10.1016/j.juro.2012.03.112
   GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Di Carlo A, 2006, ONCOL REP, V15, P1321
   COTTAM DW, 1993, INT J ONCOL, V2, P861
   Yu YM, 2009, J IMMUNOL METHODS, V350, P29, DOI 10.1016/j.jim.2009.07.008
   Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006
   Farhat WA, 2008, WORLD J UROL, V26, P301, DOI 10.1007/s00345-008-0318-4
   Lee AA, 2002, J BIOMECH ENG-T ASME, V124, P37, DOI 10.1115/1.1427697
   Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058
   Hasaneen NA, 2005, FASEB J, V19, P1507, DOI 10.1096/fj.04-3350fje
   Ye S, 1996, J BIOL CHEM, V271, P13055
   Fowlkes JL, 2002, CYTOKINE GROWTH F R, V13, P277, DOI 10.1016/S1359-6101(02)00005-9
   Black JL, 2003, RESP PHYSIOL NEUROBI, V137, P339, DOI 10.1016/S1569-9048(03)00157-5
   Defawe OD, 2005, CARDIOVASC RES, V66, P402, DOI 10.1016/j.cardiores.2004.11.025
   Evans JD, 1997, DIGESTION, V58, P520
   Ewalt D.H., 1992, J UROLOGY, V147, P438
   GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600
   Jones JL, 1997, J PATHOL, V183, P377, DOI 10.1002/(SICI)1096-9896(199712)183:4<377::AID-PATH951>3.0.CO;2-R
   Kim JC, 2000, NEUROUROL URODYNAM, V19, P29, DOI 10.1002/(SICI)1520-6777(2000)19:1<29::AID-NAU5>3.0.CO;2-#
   Lee DY, 2008, J BONE MINER RES, V23, P1140, DOI [10.1359/jbmr.080302, 10.1359/JBMR.080302]
   Luo DY, 2013, J UROLOGY, V190, P1421, DOI 10.1016/j.juro.2013.04.027
   Mohammed A, 2008, EXPERT REV MOL DIAGN, V8, P63, DOI 10.1586/14737159.8.1.63
   Nakopoulou L, 2001, APPL IMMUNOHISTO M M, V9, P130, DOI 10.1097/00022744-200106000-00005
   Peters CA, 1997, AM J PHYSIOL-REG I, V272, pR1960
   Ramachandran A, 2011, AM J PATHOL, V179, P2977, DOI 10.1016/j.ajpath.2011.08.034
   Sabha N, 2006, IN VITRO CELL DEV-AN, V42, P124
   Stevenson K, 2006, MOL CELL BIOCHEM, V283, P107, DOI 10.1007/s11010-006-2388-1
   Sutherland RS, 1997, PEDIATR RES, V41, P430, DOI 10.1203/00006450-199703000-00021
   Tian Y, 2013, MOL MED REP, V8, P294, DOI 10.3892/mmr.2013.1473
   UVELIUS B, 1984, J UROLOGY, V131, P173
   Wei Tangqiang, 2012, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V29, P691
   Wei WJ, 2012, J UROLOGY, V188, P1306, DOI 10.1016/j.juro.2012.06.041
   WEI X, 2011, CHINESE MED J PEKING, V124, P568
   Wu T, 2012, INT J UROL, V19, P867, DOI 10.1111/j.1442-2042.2012.03043.x
NR 36
TC 0
Z9 1
U1 2
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 197
EP 202
DI 10.1016/j.abb.2014.09.012
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600023
PM 25263962
ER

PT J
AU Lee, JR
   Lee, MH
   Eo, HJ
   Park, GH
   Song, HM
   Kim, MK
   Lee, JW
   Jeong, JB
AF Lee, Jeong Rak
   Lee, Man Hyo
   Eo, Hyun Ji
   Park, Gwang Hun
   Song, Hun Min
   Kim, Mi Kyoung
   Lee, Jin Wook
   Jeong, Jin Boo
TI The contribution of activating transcription factor 3 to apoptosis of
   human colorectal cancer cells by Protocatechualdehyde, a naturally
   occurring phenolic compound
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Protocatechualdehyde; Chemoprevention; Colorectal cancer; Activating
   transcription factor 3; Apoptosis
ID ADAPTIVE-RESPONSE GENE; CYCLIN D1; PROSTATE-CANCER; FACTOR ATF3;
   EXPRESSION; 3,4-DIHYDROXYBENZALDEHYDE; ANTIOXIDANT; TEA
AB Protocatechualdehyde (PCA) is one of the important compounds found in barley, green cavendish bananas and grapevine leaves. PCA shows anti-cancer activities in breast, leukemia and colorectal cancer cells. Previous study reported that PCA exerts anti-cancer activity through down-regulating cyclin D1 and HDAC2 in human colorectal cancer cells. However, the underlying mechanisms for the expression of activating transcription factor 3 (ATF3) by PCA has not been studied. Thus, we performed in vitro study to investigate if treatment of PCA affects ATF3 expression and ATF3-mediated apoptosis in human colorectal cancer cells. PCA decreased cell viability in a dose-dependent manner in HCT116 and SW480 cells. In addition, PCA reduced cell viability in MCF-7, MDA-MB-231 and HepG-2 cells. Exposure of PCA activated the levels of ATF3 protein and mRNA in HCT116 and SW480 cells. Inhibition of ERK1/2/ by PD98059 and p38 by SB203580 inhibited PCA-induced ATF3 expression and transcriptional activation. ATF3-knockdown inhibited PCA-induced apoptosis and cell viability. In addition, ATF3 overexpression enhanced PCA-mediated cleavage of PARP. These findings suggest that inhibition of cell viability and apoptosis by PCA may be result of ATF3 expression through ERK1/2 and p38-mediated transcriptional activation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Lee, Jeong Rak; Lee, Man Hyo] Gyeongbuk Inst Bioind, Andong 760380, South Korea.
   [Eo, Hyun Ji; Park, Gwang Hun; Song, Hun Min; Kim, Mi Kyoung; Lee, Jin Wook; Jeong, Jin Boo] Andong Natl Univ, Dept Bioresource Sci, Andong 760749, South Korea.
   [Jeong, Jin Boo] Andong Natl Univ, Inst Agr Sci & Technol, Andong 760749, South Korea.
RP Jeong, JB (reprint author), Andong Natl Univ, Dept Bioresource Sci, Andong 760749, South Korea.
EM jjb0403@anu.ac.kr
FU BK21 PLUS program of Ministry of Education; Research Fund of Andong
   National University [2014-0169]
FX This work was supported by the BK21 PLUS program of Ministry of
   Education and by a grant from 2014 Research Fund of Andong National
   University (2014-0169).
CR Cho KN, 2007, EUR J CANCER, V43, P2404, DOI 10.1016/j.ejca.2007.07.020
   Araujo JR, 2011, NUTR RES, V31, P77, DOI 10.1016/j.nutres.2011.01.006
   Yin X, 2010, J CELL SCI, V123, P3558, DOI 10.1242/jcs.064915
   Allan AL, 2001, J BIOL CHEM, V276, P27272, DOI 10.1074/jbc.M103196200
   Kim KJ, 2008, ARCH PHARM RES, V31, P1572, DOI 10.1007/s12272-001-2153-7
   Chang ZQ, 2011, J NUTR SCI VITAMINOL, V57, P118, DOI 10.3177/jnsv.57.118
   Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5742.CAN-06-0943
   Jeong JB, 2013, BIOCHEM BIOPH RES CO, V430, P381, DOI 10.1016/j.bbrc.2012.11.018
   Lee SH, 2005, BIOCHEM BIOPH RES CO, V328, P63, DOI 10.1016/j.bbrc.2004.12.138
   Yan CH, 2005, MOL CANCER THER, V4, P233
   Zhang YJ, 2011, J ETHNOPHARMACOL, V136, P129, DOI 10.1016/j.jep.2011.04.023
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   WEBER B, 1995, PHYTOCHEMISTRY, V40, P433, DOI 10.1016/0031-9422(95)00314-W
   Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200
   Bottone FG, 2005, MOL CANCER THER, V4, P693, DOI 10.1158/1535-7163.MCT-04-0337
   Mashima T, 2001, J CELL PHYSIOL, V188, P352, DOI 10.1002/jcp.1130
   Etoh H, 2004, BIOSCI BIOTECH BIOCH, V68, P2616, DOI 10.1271/bbb.68.2616
   Ishiguro T, 2000, JPN J CANCER RES, V91, P833
   James CG, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-30
   Lee BH, 2008, NAT PROD RES, V22, P1441, DOI 10.1080/14786410802076333
   Lee SH, 2010, ONCOGENE, V29, P5182, DOI 10.1038/onc.2010.251
   Lee SH, 2013, J NUTR BIOCHEM, V24, P664, DOI 10.1016/j.jnutbio.2012.03.016
   罗世英, 2009, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V25, P44
   MULVENA D, 1969, PHYTOCHEMISTRY, V8, P393, DOI 10.1016/S0031-9422(00)85436-9
   Wang H, 2012, ANTI-CANCER AGENT ME, V12, P1281
   Xing YL, 2012, PHYTOTHER RES, V26, P1334, DOI 10.1002/ptr.3720
   Yamaguchi K, 2006, CANCER RES, V66, P2376, DOI 10.1158/0008-5472.CAN-05-1987
   Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861
   Zhou Z, 2005, EUR J PHARMACOL, V513, P1, DOI 10.1016/j.ejphar.2005.01.059
NR 29
TC 1
Z9 1
U1 2
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 203
EP 210
DI 10.1016/j.abb.2014.10.005
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600024
PM 25447816
ER

PT J
AU Dergunov, AD
   Shabrova, EV
   Dobretsov, GE
AF Dergunov, Alexander D.
   Shabrova, Elena V.
   Dobretsov, Gennady E.
TI Cholesteryl ester diffusion, location and self-association constraints
   determine CETP activity with discoidal HDL: Excimer probe study
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Apolipoprotein A-I; Cholesteryl ester; CETP and reverse cholesterol
   transport; Discoidal HDL; Enzyme kinetics; Excimer
ID HIGH-DENSITY-LIPOPROTEINS; LIPID TRANSFER PROTEIN; LECITHIN/CHOLESTEROL
   ACYLTRANSFERASE ACTIVITY; APOLIPOPROTEIN-A-I; LATERAL DIFFUSION;
   PLASMA-LIPOPROTEINS; FLUORESCENCE; PYRENE; MEMBRANES; MODEL
AB The transfer of cholesteryl ester by recombinant cholesteryl ester transfer protein (CETP) between reconstituted discoidal high-density lipoprotein (rHDL) was studied. Particles contained apolipoprotein A-I, unsaturated POPC or saturated DPPC and cholesteryl ester as cholesteryl 1-pyrenedecanoate (CPD) or cholestelyl laurate (CL) in donor and acceptor rHDL, respectively. Probe dynamics fulfilled the quenching sphere-of-action model. The cholesteryl ester exchange between donor and acceptor particles was characterized by a heterogeneous kinetics; the fast exchanging CPD pool was much higher in a case of POPC compared to DPPC complexes. Probe fraction accessible to CETP increased with temperature, suggesting a more homogeneous probe distribution. Noncompetitive inhibition of probe transfer by acceptor particles was observed. The values of V-max (0.063 mu M min(-1)) and catalytic rate constant kat (0.42 s(-1)) together with a similarity of Km (0.9 mu M CPD) and K-1(2.8 mu M CL) values for POPC-containing rHDL suggest the efficient cholesteryl ester transfer between nascent HDL with unsaturated phosphatidylcholine in vivo. The phospholipid matrix in discoidal HDL may underlie CETP activity through the self-association, diffusivity and location of cholesteryl ester in the bilayer, the accessibility of cholesteryl ester to cholesterol-binding site in apoA-I structure and the binding of cholesteryl ester, positionable by apoA-I, to CETP. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Dergunov, Alexander D.; Shabrova, Elena V.] Natl Res Ctr Prevent Med, Moscow 101990, Russia.
   [Dobretsov, Gennady E.] Res Inst Phys Chem Med, Moscow 119828, Russia.
RP Dergunov, AD (reprint author), Natl Res Ctr Prevent Med, 10 Petroverigsky St, Moscow 101990, Russia.
EM dergunov@img.ras.ru
FU Russian Fund for Basic Research [13-04-00474]
FX This research was supported by the Russian Fund for Basic Research
   (13-04-00474). We are grateful to Dr. A. Tall (Columbia University, New
   York, USA) for providing the recombinant CETP. We are grateful to Dr. M.
   Rosseneu (Gent University, Belgium) for allowing us to use the
   facilities in her laboratory. The excellent technical assistance of H.
   Caster is acknowledged.
CR Pirillo A, 2013, CARDIOLOGY, V124, P116, DOI 10.1159/000346463
   HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182
   Vergeer M, 2010, J LIPID RES, V51, P2058, DOI 10.1194/jlr.R001610
   Filippov A, 2003, BIOPHYS J, V84, P3079
   Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197
   BIRKS JB, 1963, PROC R SOC LON SER-A, V275, P575, DOI 10.1098/rspa.1963.0187
   Castanho MARB, 1998, BBA-BIOMEMBRANES, V1373, P1, DOI 10.1016/S0005-2736(98)00081-9
   EISINGER J, 1986, BIOPHYS J, V49, P987
   Melo E, 2006, BIOPHYS CHEM, V123, P77, DOI 10.1016/j.bpc.2006.05.003
   Catte A, 2008, BIOPHYS J, V94, P2306, DOI 10.1529/biophysj.107.115857
   Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0
   Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/nchembio.796, 10.1038/NCHEMBIO.796]
   Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5
   MORTON RE, 1990, J LIPID RES, V31, P1559
   OHNISHI T, 1995, BBA-LIPID LIPID MET, V1254, P117, DOI 10.1016/0005-2760(94)00164-T
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Charles MA, 2012, J LIPID RES, V53, P1451, DOI 10.1194/jlr.R027011
   SHIN YK, 1989, BIOPHYS J, V55, P537
   Attia N, 2008, ATHEROSCLEROSIS, V198, P49, DOI 10.1016/j.atherosclerosis.2007.09.023
   ATZEL A, 1993, BIOCHEMISTRY-US, V32, P10444, DOI 10.1021/bi00090a021
   Barenholz Y, 1996, J BIOL CHEM, V271, P3085
   BARTER PJ, 1980, J LIPID RES, V21, P238
   Barter PJ, 1996, ATHEROSCLEROSIS, V121, P1, DOI 10.1016/0021-9150(95)05675-0
   BINDER H, 1987, STUD BIOPHYS, V120, P59
   BLACKWELL MF, 1986, BIOCHIM BIOPHYS ACTA, V858, P221, DOI 10.1016/0005-2736(86)90327-5
   BRUCE C, 1995, J BIOL CHEM, V270, P11532, DOI 10.1074/jbc.270.19.11532
   DAEMS D, 1985, EUR BIOPHYS J BIOPHY, V12, P97
   Dergunov AD, 2000, CHEM PHYS LIPIDS, V104, P161, DOI 10.1016/S0009-3084(99)00125-5
   Dergunov AD, 2011, LIPIDS, V46, P1075, DOI 10.1007/s11745-011-3613-6
   Dergunov AD, 1997, BBA-LIPID LIPID MET, V1346, P131, DOI 10.1016/S0005-2760(97)00025-8
   Dergunov A.D., 1834, BIOCHIM BIOPHYS ACTA, V2013, P2030
   Dergunov AD, 2012, ARCH BIOCHEM BIOPHYS, V520, P81, DOI 10.1016/j.abb.2012.02.006
   Dergunov AD, 2010, SPECTROCHIM ACTA A, V75, P1100, DOI 10.1016/j.saa.2009.12.064
   Dergunov AD, 2001, CHEM PHYS LIPIDS, V113, P67, DOI 10.1016/S0009-3084(01)00176-1
   Frank I.M., 1931, Z PHYS, V69, P100
   GUYARDDANGREMONT V, 1994, J LIPID RES, V35, P982
   GWYNNE J, 1974, J BIOL CHEM, V249, P2411
   IHM J, 1982, J LIPID RES, V23, P1328
   Koivuniemi A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002299
   MACKAY AL, 1981, BIOPHYS J, V35, P301
   Main LA, 1996, BBA-LIPID LIPID MET, V1300, P17, DOI 10.1016/0005-2760(95)00228-6
   Mazeres S, 2001, SPECTROCHIM ACTA A, V57, P2297, DOI 10.1016/S1386-1425(01)00486-3
   MORTON RE, 1985, J BIOL CHEM, V260, P2593
   Nakamura Y, 2004, BIOCHEMISTRY-US, V43, P14811, DOI 10.1021/bi0485629
   NEMZEK TL, 1975, J CHEM PHYS, V62, P477, DOI 10.1063/1.430501
   OWEN CS, 1975, J CHEM PHYS, V62, P3204, DOI 10.1063/1.430870
   PATTNAIK NM, 1979, J BIOL CHEM, V254, P2782
   Radovica I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064191
   SMABY JM, 1987, J LIPID RES, V28, P1078
   Tall AR, 2010, J CLIN LIPIDOL, V4, P389, DOI 10.1016/j.jacl.2010.08.006
   VANDERKO.JM, 1974, BIOCHEMISTRY-US, V13, P4000, DOI 10.1021/bi00716a028
   Yamashita S, 2000, BBA-MOL CELL BIOL L, V1529, P257, DOI 10.1016/S1388-1981(00)00164-5
NR 52
TC 1
Z9 1
U1 7
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 211
EP 218
DI 10.1016/j.abb.2014.09.019
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600025
PM 25449063
ER

PT J
AU Ning, CX
   Su, EZ
   Wei, DZ
AF Ning, Chenxi
   Su, Erzheng
   Wei, Dongzhi
TI Characterization and identification of three novel aldo-keto reductases
   from Lodderomyces elongisporus for reducing ethyl 4-chloroacetoacetate
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Lodderomyces elongisporus; Aldo-keto reductase; Characterization;
   Identification; Ethyl 4-chloroacetoacetate
ID ALDEHYDE REDUCTASE; STEREOSELECTIVE REDUCTION; ASYMMETRIC REDUCTION;
   CRYSTAL-STRUCTURE; SUPERFAMILY; DEHYDROGENASE; NADPH;
   4-CHLORO-3-OXOBUTANOATE; BIOCATALYSIS; PURIFICATION
AB Lodderomyces elongisporus LH703 isolated from soil samples contained three novel aldo-keto reductases (AKRs) (LEAKR 48, LEAKR 49, and LEAKR 50). The three enzymes were cloned, expressed, and purified to homogeneity for characterization. These three AKRs shared <40% amino acid identity with each other. LEAKR 50 was identified as a member of AKR3 family, whereas the other two LEAKRs were identified as members of two novel AKR families, respectively. All the three AKRs required nicotinamide adenine dinucleotide phosphate as a cofactor. However, they showed diverse characteristics, including optimum catalyzing conditions, resistance to adverse reaction conditions, and substrate specificity. LEAKR 50 was estimated to be a promising biocatalyst that could reduce ethyl 4-chloroacetoacetate with high enantiomeric excess (98% e. e.) and high activity residue under adverse conditions. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Ning, Chenxi; Wei, Dongzhi] E China Univ Sci & Technol, New World Inst Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.
   [Su, Erzheng] Nanjing Forestry Univ, Coll Light Ind Sci & Engn, Enzyme & Fermentat Technol Lab, Nanjing 210037, Jiangsu, Peoples R China.
RP Su, EZ (reprint author), E China Univ Sci & Technol, New World Inst Biotechnol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.
EM ezhsu@njfu.edu.cn; dzhwei@ecust.edu.cn
FU Natural Science Foundation of China [21276084]; National Major Science
   and Technology Projects of China [2012ZX09304009]
FX This work was supported by the Natural Science Foundation of China (No.
   21276084) and the National Major Science and Technology Projects of
   China (No. 2012ZX09304009).
CR Jez JM, 2001, CHEM-BIOL INTERACT, V130, P499, DOI 10.1016/S0009-2797(00)00295-7
   Jez JM, 1997, BIOCHEM PHARMACOL, V54, P639, DOI 10.1016/S0006-2952(97)84253-0
   Ellis EM, 2002, FEMS MICROBIOL LETT, V216, P123, DOI 10.1111/j.1574-6968.2002.tb11425.x
   Goldberg K, 2007, APPL MICROBIOL BIOT, V76, P237, DOI 10.1007/s00253-007-1002-0
   Jez JM, 1997, BIOCHEM J, V326, P625
   Breuer M, 2004, ANGEW CHEM INT EDIT, V43, P788, DOI 10.1002/anie.200300599
   Champion E, 2012, J AM CHEM SOC, V134, P18677, DOI 10.1021/ja306845b
   Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117
   Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   BRUCE NC, 1994, BIOCHEM J, V299, P805
   Fessner WD, 2011, ADV SYNTH CATAL, V353, P2189, DOI 10.1002/adsc.201100679
   Hur E, 2001, CHEM-BIOL INTERACT, V130, P527, DOI 10.1016/S0009-2797(00)00296-9
   Ishihara K, 2000, J MOL CATAL B-ENZYM, V10, P419, DOI 10.1016/S1381-1177(99)00114-9
   Itoh N, 2004, APPL MICROBIOL BIOT, V66, P53, DOI 10.1007/s00253-004-1702-7
   Jing KJ, 2005, PREP BIOCHEM BIOTECH, V35, P203, DOI 10.1081/PB-200065622
   Kataoka M, 1999, APPL MICROBIOL BIOT, V51, P486
   Khurana S, 1998, P NATL ACAD SCI USA, V95, P6768, DOI 10.1073/pnas.95.12.6768
   Machielsen R, 2006, APPL ENVIRON MICROB, V72, P233, DOI 10.1128/AEM.72.1.233-238.2006
   Penning TM, 1996, STEROIDS, V61, P508, DOI 10.1016/S0039-128X(96)00093-1
   PETRASH JM, 1994, DIABETES, V43, P955, DOI 10.2337/diabetes.43.8.955
   Sanli G, 2001, J MOL BIOL, V309, P1209, DOI 10.1006/jmbi.2001.4739
   SHIMIZU S, 1990, APPL ENVIRON MICROB, V56, P2374
NR 23
TC 3
Z9 3
U1 9
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 219
EP 228
DI 10.1016/j.abb.2014.10.007
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600026
PM 25447817
ER

PT J
AU Wang, X
   Zhu, YH
   Tao, HR
   Jin, C
   Liu, YZ
   Lu, XW
   Hu, XP
   Fan, CY
AF Wang, Xiang
   Zhu, Yanhui
   Tao, Hairong
   Jin, Chen
   Liu, Yonzhang
   Lu, Xiongwei
   Hu, Xiaopeng
   Fan, Cunyi
TI Interaction of ERK1/2 and Smad2/3 signaling pathways in TGF-beta
   1-induced TIMP-3 expression in rat chondrocytes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Transforming growth factor beta1; TIMP-3; ERK1/2; Smad2/3; Chondrocytes
ID GROWTH-FACTOR-BETA; TGF-BETA; ARTICULAR CHONDROCYTES; TISSUE INHIBITOR;
   CROSS-TALK; TNF-ALPHA; METALLOPROTEINASES-3 GENE; MAP KINASE; CELLS;
   CARTILAGE
AB Tissue inhibitor of metalloproteinase-3 (TIMP-3) is an important natural inhibitor of matrix metalloproteinases (MMPs) and of a disintegrin and metalloproteinase with thrombospondin motif (ADAMTs), which can cleave cartilage extracellular matrix components to cause cartilage degradation. In this study, our data suggest TGF-beta 1 induces TIMP-3 expression through activations of both the ERKI/2 and Smad2/3 signaling pathways. TGF-beta 1-stimulated TIMP-3 expression was significantly inhibited by SB525334 (TGF11 beta receptor I kinase inhibitor), accompanied by a reduction in ERKI/2 and Smad3 phosphorylation. We used P098059 (MEK inhibitor) and SIS3 (inhibitor of Smad3 phosphorylation) to investigate the respective roles of ERKI/2 and Smad2/3 signaling pathways in TGF-beta 1-induced TIMP-3 expression. The results show PD98059 treatment significantly suppressed TGF-beta 1-induced ERKI/2 phosphorylation and TIMP-3 expression. Under these conditions, the degree of Smad3 phosphorylation correlated with ERK1/2 activation, which suggests that ERK1/2 may activate Smad3 phosphorylation. SIS3 significantly inhibited TGF-beta 1-induced Smad3 phosphorylation and TIMP-3 expression. ERKI/2 phosphorylation alone had no effect on TGF-beta 1-induced TIMP-3 expression, which suggests ERKI/2 via Smad3 phosphorylation regulates TGF-beta 1 -induced TIMP-3 expression. Here, we demonstrate that ERKI/2 may be capable of activating the Smad2/3 signaling pathway to result in TGF-beta 1-induced TIMP-3 up-regulation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wang, Xiang; Zhu, Yanhui; Tao, Hairong; Jin, Chen; Liu, Yonzhang; Lu, Xiongwei; Hu, Xiaopeng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 3, Dept Orthopaed, Shanghai 200030, Peoples R China.
   [Wang, Xiang; Fan, Cunyi] Shanghai Jiao Tong Univ, Affiliated Hosp 6, Dept Orthopaed, Shanghai 200030, Peoples R China.
RP Fan, CY (reprint author), Shanghai Jiao Tong Univ, Affiliated Hosp 6, Dept Orthopaed, 600 Yishan Rd, Shanghai 200030, Peoples R China.
EM fancunyi888@yeah.net
CR Sawaji Y, 2008, ARTHRITIS RHEUM, V58, P3498, DOI 10.1002/art.24025
   Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427
   Qureshi HY, 2008, BBA-MOL CELL RES, V1783, P1605, DOI 10.1016/j.bbamcr.2008.04.005
   Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje
   Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483
   Miyazaki Y, 2000, OSTEOARTHR CARTILAGE, V8, P378, DOI 10.1053/joca.1999.0313
   Roman-Blas JA, 2007, OSTEOARTHR CARTILAGE, V15, P1367, DOI 10.1016/j.joca.2007.04.011
   Qureshi HY, 2005, J CELL PHYSIOL, V203, P345, DOI 10.1002/jcp.20228
   Morris KJ, 2010, CONNECT TISSUE RES, V51, P478, DOI 10.3109/03008201003686958
   Prasadam I, 2010, ARTHRITIS RHEUM-US, V62, P1349, DOI 10.1002/art.27397
   Qureshi HY, 2007, CELL SIGNAL, V19, P1643, DOI 10.1016/j.cellsig.2007.02.007
   Kretzschmar M, 1997, NATURE, V389, P618
   Takahashi N, 2005, OSTEOARTHR CARTILAGE, V13, P426, DOI 10.1016/j.joca.2004.12.010
   van der Kraan PM, 2012, CELL TISSUE RES, V347, P257, DOI 10.1007/s00441-011-1194-6
   Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x
   Watanabe H, 2001, J BIOL CHEM, V276, P14466
   Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541
   Moon MH, 2013, OSTEOARTHR CARTILAGE, V21, P470, DOI 10.1016/j.joca.2012.11.017
   Blanchette F, 2001, J BIOL CHEM, V276, P33986, DOI 10.1074/jbc.M100093200
   Blaney Davidson E N, 2005, Arthritis Res Ther, V7, pR1338, DOI 10.1186/ar1833
   Blaney Davidson E N, 2007, Osteoarthritis Cartilage, V15, P597, DOI 10.1016/j.joca.2007.02.005
   de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587
   Grimm OH, 2002, NAT CELL BIOL, V4, P519, DOI 10.1038/ncb812
   Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513
   Hui W, 2001, CYTOKINE, V16, P31, DOI 10.1006/cyto.2001.0950
   Leivonen SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057474
   Raymond L, 2006, J CELL PHYSIOL, V207, P683, DOI 10.1002/jcp.20608
   Shen J., 2013, ARTHRITIS RHEUM
   Shi SL, 2013, J CELL BIOCHEM, V114, P908, DOI 10.1002/jcb.24430
   Thomas M, 2009, AM J PATHOL, V174, P380, DOI 10.2353/ajpath.2009.080565
   Torzilli PA, 2011, CARTILAGE, V2, P364, DOI 10.1177/1947603511407484
   Tsai SH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-97
   Wang GN, 2005, BIOCHEM J, V386, P29, DOI 10.1042/BJ200041820
   Xiang Y, 2006, OSTEOARTHR CARTILAGE, V14, P1163, DOI 10.1016/j.joca.2006.04.015
   Zhang M, 2006, AM J PATHOL, V169, P1282, DOI 10.2353/ajpath.2006.050921
NR 35
TC 0
Z9 0
U1 2
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 229
EP 236
DI 10.1016/j.abb.2014.09.009
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600027
PM 25245272
ER

PT J
AU King, JD
   Harrington, L
   Lada, BM
   He, GN
   Cooley, JW
   Blankenship, RE
AF King, Jeremy D.
   Harrington, Lucas
   Lada, Bryan M.
   He, Guannan
   Cooley, Jason W.
   Blankenship, Robert E.
TI Site-directed mutagenesis of the highly perturbed copper site of
   auracyanin D
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Metalloproteins; Blue copper proteins; Cupredoxins; Electron transport;
   Chloroflexus aurantiacus
ID BACTERIUM CHLOROFLEXUS-AURANTIACUS; PSEUDOMONAS-AERUGINOSA;
   ACHROMOBACTER-CYCLOCLASTES; ALCALIGENES-DENITRIFICANS;
   THIOBACILLUS-FERROOXIDANS; NITRITE REDUCTASE; EXOGENOUS LIGANDS; BLUE;
   AZURIN; PROTEINS
AB Type-1 copper proteins participate in redox reactions and biological catalysis. Significant variation exists within the electronic structure of type-1 copper sites, producing both blue and green proteins. Classical, "blue" sites have been extensively studied, but "green" sites have been poorly characterized. We recently discovered a green copper protein, called auracyanin D. Here, we report a series of axial ligand mutations in auracyanin D, and characterize the resulting spectral and redox changes. The resulting mutants appear blue, green, and red and vary in redox potential from +56 mV to +786 mV. This is the largest change in redox potential to date for any type-1 center. We found that in this green protein, modifications of the axial ligand produce significantly larger changes than similar mutations in blue type-1 copper sites. (C) 2014 Elsevier Inc. All rights reserved.
C1 [King, Jeremy D.] Washington Univ, Grad Program Plant Biol, St Louis, MO 63130 USA.
   [Blankenship, Robert E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA.
   [Harrington, Lucas; He, Guannan; Blankenship, Robert E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA.
   [Lada, Bryan M.; Cooley, Jason W.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA.
   [Blankenship, Robert E.] Washington Univ, Photosynthet Antenna Res Ctr, St Louis, MO 63130 USA.
RP Blankenship, RE (reprint author), Washington Univ, Dept Chem, Dept Biol, St Louis, MO 63130 USA.
EM Blankenship@wustl.edu
FU Molecular Biochemistry Program of NSF [MCB-0646621]; Monsanto Graduate
   Fellowship
FX This work was funded by grant MCB-0646621 to R.E.B. from the Molecular
   Biochemistry Program of NSF and the Monsanto Graduate Fellowship to
   J.D.K.
CR Hall JF, 1999, BIOCHEMISTRY-US, V38, P12675, DOI 10.1021/bi990983g
   Vijgenboom E, 1997, MICROBIOL-SGM, V143, P2853
   Arciero DM, 2002, BIOCHEMISTRY-US, V41, P1703, DOI 10.1021/bi015908w
   Clark KM, 2010, J AM CHEM SOC, V132, P10093, DOI 10.1021/ja102632p
   Gray HB, 2010, BBA-BIOENERGETICS, V1797, P1563, DOI 10.1016/j.bbabio.2010.05.001
   Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d
   Xu F, 1999, J BIOL CHEM, V274, P12372, DOI 10.1074/jbc.274.18.12372
   Solomon EI, 2004, CHEM REV, V104, P419, DOI 10.1021/cr0206317
   Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y
   Ellis PJ, 2001, STRUCTURE, V9, P125, DOI 10.1016/S0969-2126(01)00566-4
   Warren JJ, 2012, J INORG BIOCHEM, V115, P119, DOI 10.1016/j.jinorgbio.2012.05.002
   Kanbi LD, 2002, J MOL BIOL, V320, P263, DOI 10.1016/S0022-2836(02)00443-6
   King JD, 2013, BIOCHEMISTRY-US, V52, P8267, DOI 10.1021/bi401163g
   Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002
   Hall JF, 1998, BIOCHEMISTRY-US, V37, P11451, DOI 10.1021/bi980960m
   Gray HB, 2000, J BIOL INORG CHEM, V5, P551, DOI 10.1007/s007750000146
   Basumallick L, 2005, J AM CHEM SOC, V127, P3531, DOI 10.1021/ja044412+
   ADMAN ET, 1995, J BIOL CHEM, V270, P27458
   Tsukatani Y, 2009, ARCH BIOCHEM BIOPHYS, V490, P57, DOI 10.1016/j.abb.2009.08.003
   DENBLAAUWEN T, 1993, BIOCHEMISTRY-US, V32, P12455, DOI 10.1021/bi00097a025
   Marshall NM, 2009, NATURE, V462, P113, DOI 10.1038/nature08551
   Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013
   HANADA S, 1995, INT J SYST BACTERIOL, V45, P676
   PASCHER T, 1993, EUR J BIOCHEM, V212, P289, DOI 10.1111/j.1432-1033.1993.tb17661.x
   Berry SM, 2011, J BIOL INORG CHEM, V16, P473, DOI 10.1007/s00775-010-0746-7
   Bonander N, 1996, BIOCHEMISTRY-US, V35, P2429, DOI 10.1021/bi9522110
   Ghosh S, 2009, P NATL ACAD SCI USA, V106, P4969, DOI 10.1073/pnas.0900995106
   GROSSMANN JG, 1995, BIOCHEMISTRY-US, V34, P8406, DOI 10.1021/bi00026a023
   GUSS JM, 1992, ACTA CRYSTALLOGR B, V48, P790, DOI 10.1107/S0108768192004270
   Hira D, 2007, J BIOCHEM, V142, P335, DOI 10.1093/jb/mvm136
   HOITINK CWG, 1992, J BIOL CHEM, V267, P13836
   INGLEDEW WJ, 1980, BIOCHIM BIOPHYS ACTA, V590, P141, DOI 10.1016/0005-2728(80)90020-1
   KARLSSON BG, 1991, PROTEIN ENG, V4, P343, DOI 10.1093/protein/4.3.343
   Kataoka K, 2003, BIOCHEM BIOPH RES CO, V303, P519, DOI 10.1016/S0006-291X(03)00381-4
   Kataoka K, 1998, BIOCHEM BIOPH RES CO, V250, P409, DOI 10.1006/bbrc.1998.9310
   Kataoka K, 2000, J INORG BIOCHEM, V82, P79, DOI 10.1016/S0162-0134(00)00146-X
   Kroes SJ, 1996, EUR J BIOCHEM, V240, P342, DOI 10.1111/j.1432-1033.1996.0342h.x
   LaCroix L., 1998, J AM CHEM SOC, V7863, P9621
   Lieberman R., 2001, BIOCHEMISTRY-US, P5674
   Machonkin TE, 1998, BIOCHEMISTRY-US, V37, P9570, DOI 10.1021/bi980434v
   Majumder ELW, 2013, BBA-BIOENERGETICS, V1827, P1383, DOI 10.1016/j.bbabio.2013.01.008
   MCMANUS JD, 1992, J BIOL CHEM, V267, P6531
   Roger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098941
   SOLOMON E I, 1992, Journal of Inorganic Biochemistry, V47, P29, DOI 10.1016/0162-0134(92)84100-2
   TROST JT, 1988, BIOCHEMISTRY-US, V27, P7858, DOI 10.1021/bi00420a041
   Vanngard T, 1972, BIOL APPLICATIONS EL, P411
   Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110
NR 47
TC 1
Z9 1
U1 7
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 237
EP 243
DI 10.1016/j.abb.2014.10.003
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600028
PM 25317962
ER

PT J
AU Pugh, CP
   Pouncey, DL
   Hartman, JH
   Nshimiyimana, R
   Desrochers, LP
   Goodwin, TE
   Boysen, G
   Miller, GP
AF Pugh, C. Preston
   Pouncey, Dakota L.
   Hartman, Jessica H.
   Nshimiyimana, Robert
   Desrochers, Linda P.
   Goodwin, Thomas E.
   Boysen, Gunnar
   Miller, Grover P.
TI Multiple UDP-glucuronosyltransferases in human liver microsomes
   glucuronidate both R-and S-7-hydroxywarfarin into two metabolites
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Glucuronidation; UGT (UDP-glucuronosyltransferase); Metabolism;
   Warfarin; 7-Hydroxywarfarin; In vitro
ID CHROMATOGRAPHY-MASS SPECTROMETRY; NUCLEAR-MAGNETIC-RESONANCE; WARFARIN
   METABOLISM; HUMAN PLASMA; IN-VITRO; KINETIC-DATA; S-WARFARIN;
   ENANTIOMERS; 4-HYDROXYCOUMARINS; CYTOCHROME-P450
AB The widely used anticoagulant Coumadin (R/S-warfarin) undergoes oxidation by cytochromes P450 into hydroxywarfarins that subsequently become conjugated for excretion in urine. Hydroxywarfarins may modulate warfarin metabolism transcriptionally or through direct inhibition of cytochromes P450 and thus, UGT action toward hydroxywarfarin elimination may impact levels of the parent drugs and patient responses. Nevertheless, relatively little is known about conjugation by UDP-glucuronosyltransferases in warfarin metabolism. Herein, we identified probable conjugation sites, kinetic mechanisms and hepatic UGT isoforms involved in microsomal glucuronidation of R-and S-7-hydroxywarfarin. Both compounds underwent glucuronidation at C4 and C7 hydroxyl groups based on elution properties and spectral characteristics. Their formation demonstrated regio-and enantioselectivity by UGTs and resulted in either Michaelis-Menten or substrate inhibition kinetics. Glucuronidation at the C7 hydroxyl group occurred more readily than at the C4 group, and the reaction was overall more efficient for R-7-hydroxywarfarin due to higher affinity and rates of turnover. The use of these mechanisms and parameters to model in vivo clearance demonstrated that contributions of substrate inhibition would lead to underestimation of metabolic clearance than that predicted by Michaelis-Menten kinetics. Lastly, these processes were driven by multiple UGTs indicating redundancy in glucuronidation pathways and ultimately metabolic clearance of R-and S-7-hydroxywarfarin. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Pugh, C. Preston; Pouncey, Dakota L.; Hartman, Jessica H.; Miller, Grover P.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.
   [Pouncey, Dakota L.; Nshimiyimana, Robert; Desrochers, Linda P.; Goodwin, Thomas E.] Hendrix Coll, Dept Chem, Conway, AR USA.
   [Boysen, Gunnar] Univ Arkansas Med Sci, Dept Environm & Occupat Hlth, Little Rock, AR 72205 USA.
RP Miller, GP (reprint author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, 4301 W Markham,Slot 516, Little Rock, AR 72205 USA.
EM MillerGroverP@uams.edu
OI Boysen, Gunnar/0000-0001-8364-9881
FU Summer Undergraduate Research Fellowship - Biochemistry and Molecular
   Biology Department at the University of Arkansas for Medical Sciences;
   NIH National Heart, Lung and Blood Institute (National Heart, Lung, and
   Blood Institute) (DLP) [R25HL108825]; NIH National Institute of General
   Medical Sciences (NIGMS) [P2003429, P20RR016460]; SouthWest Affiliate of
   the American Heart Association [13GRNT16960043]; NIH [UL1 TR000039]
FX Financial support for undergraduate research was provided in part by the
   Summer Undergraduate Research Fellowship program sponsored by the
   Biochemistry and Molecular Biology Department at the University of
   Arkansas for Medical Sciences (CPP and DLP), the UAMS Summer
   Undergraduate Research Program to Increase Diversity in Research under
   award number R25HL108825 from the NIH National Heart, Lung and Blood
   Institute (National Heart, Lung, and Blood Institute) (DLP), and the
   Arkansas INBRE program, supported by Grant funding from the NIH National
   Institute of General Medical Sciences (NIGMS) (P2003429, formerly
   P20RR016460) (CPP). In addition, financial support was provided to GPM
   through a Grant-in-Aid from the SouthWest Affiliate of the American
   Heart Association (13GRNT16960043) and a pilot study Grants provided by
   the NIH (UL1 TR000039) awarded to the University of Arkansas for Medical
   Sciences awarded to GB and GPM. The content of this publication is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the University of Arkansas for Medical
   Sciences, the American Heart Association, or National Institutes of
   Health. TEG gratefully acknowledges funding from the Hendrix College
   Odyssey and Rwanda Presidential Scholars Programs, as well as from John
   and Laura Byrd. Funding was provided by the U.S. National Science
   Foundation for the NMR spectrometer (NSF MRI Grant to Hendrix College,
   Award No. 1040470). Nick Heathscott, Doug Hammon, Jake Leffert, Kenyon
   Plummer, Robert Rurangwa, and Aline Umuhire-Juru contributed to the
   early stages of the research at Hendrix College.
CR Zielinska A, 2008, J PHARMACOL EXP THER, V324, P139, DOI 10.1124/jpet.107.129858
   Jones DR, 2011, EXPERT OPIN DRUG MET, V7, P857, DOI 10.1517/17425255.2011.576247
   Houston JB, 2000, DRUG METAB DISPOS, V28, P246
   Doerge DR, 2000, DRUG METAB DISPOS, V28, P298
   Rulcova A, 2010, J THROMB HAEMOST, V8, P2708, DOI 10.1111/j.1538-7836.2010.04036.x
   Uchaipichat V, 2004, DRUG METAB DISPOS, V32, P413, DOI 10.1124/dmd.32.4.413
   Miller GP, 2009, CHEM RES TOXICOL, V22, P1239, DOI 10.1021/tx900031z
   Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247
   Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238
   Jones DR, 2010, CHEM RES TOXICOL, V23, P939, DOI 10.1021/tx1000283
   VALENTE EJ, 1977, J MED CHEM, V20, P1489, DOI 10.1021/jm00221a025
   BOSMA PJ, 1994, J BIOL CHEM, V269, P17960
   Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670
   Kim H, 2006, ORG LETT, V8, P5239, DOI 10.1021/ol062000v
   Michaelis L, 1913, BIOCHEM Z, V49, P333
   HOUSTON JB, 1994, BIOCHEM PHARMACOL, V47, P1469
   Jones DR, 2011, J CHROMATOGR B, V879, P1056, DOI 10.1016/j.jchromb.2011.03.022
   Williams JA, 2004, DRUG METAB DISPOS, V32, P1201, DOI 10.1124/dmd.104.000794
   Krishnaswamy S, 2003, DRUG METAB DISPOS, V31, P133, DOI 10.1124/dmd.31.1.133
   Bratton SM, 2012, J PHARMACOL EXP THER, V340, P46, DOI 10.1124/jpet.111.184721
   BRECKENR.A, 1974, CLIN PHARMACOL THER, V15, P424
   CHAN E, 1994, BRIT J CLIN PHARMACO, V37, P563
   CHAN E, 1993, CHIRALITY, V5, P610, DOI 10.1002/chir.530050808
   Crespi C., 2009, OPTIMIZING DONOR NUM
   Gaganis P, 2007, BIOCHEM PHARMACOL, V73, P1683, DOI 10.1016/j.bcp.2007.01.030
   GIANNINI DD, 1974, P NATL ACAD SCI USA, V71, P4221, DOI 10.1073/pnas.71.10.4221
   GREENLEE WF, 1978, J PHARMACOL EXP THER, V205, P596
   Guo YY, 2006, NAT BIOTECHNOL, V24, P531, DOI 10.1038/nbt1195
   Hartman JH, 2014, BIOCHEM PHARMACOL, V87, P523, DOI 10.1016/j.bcp.2013.12.003
   HERMODSO.MA, 1971, J MED CHEM, V14, P167
   Ishii Y, 2005, FRONT BIOSCI, V10, P887, DOI 10.2741/1583
   Ishii Y, 2010, DRUG METAB REV, V42, P145, DOI 10.3109/03602530903208579
   JANSING RL, 1992, MOL PHARMACOL, V41, P209
   Jones D.R., 2010, DRUG METAB REV, V42, P53
   Jorgensen AL, 2009, PHARMACOGENET GENOM, V19, P800, DOI 10.1097/FPC.0b013e3283317ab5
   Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4
   Luukkanen L, 2005, DRUG METAB DISPOS, V33, P1017, DOI 10.1124/dmd.105.004093
   Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433
   Ufer M, 2004, J CHROMATOGR B, V809, P217, DOI 10.1016/j.jchromb.2004.06.023
   VALENTE EJ, 1978, J MED CHEM, V21, P231, DOI 10.1021/jm00200a019
   Wong TC, 2010, J CHEM EDUC, V87, P194, DOI 10.1021/ed800040m
   Zhou J, 2014, METHODS MOL BIOL, V1113, P203, DOI 10.1007/978-1-62703-758-7_11
   Zuo Z, 2010, J PHARMACEUT BIOMED, V52, P305, DOI 10.1016/j.jpba.2010.01.005
NR 43
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 244
EP 253
DI 10.1016/j.abb.2014.10.006
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600029
PM 25447818
ER

PT J
AU Soderberg, KL
   Guterstam, P
   Langel, U
   Graslund, A
AF Soderberg, Kajsa Lofgren
   Guterstam, Peter
   Langel, Ulo
   Graslund, Astrid
TI Targeting prion propagation using peptide constructs with signal
   sequence motifs
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Prion; Signal peptide; Polycationic motif; Cell penetrating peptide
ID CELL-PENETRATING PEPTIDES; HUMAN IMMUNODEFICIENCY VIRUS; TRANSMEMBRANE
   PH GRADIENT; PROTEASE-RESISTANT STATE; TAT PROTEIN; LIPID RAFTS;
   ANCHORED PROTEINS; ENDOSOMAL ESCAPE; SCRAPIE; CONVERSION
AB Synthetic peptides with sequences derived from the cellular prion protein (PrPc) unprocessed N-terminus are able to counteract the propagation of proteinase K resistant prions (PrPRes, indicating the presence of the prion isoform of the prion protein) in cell cultures (Lofgren et al., 2008). The anti-prion peptides have characteristics like cell penetrating peptides (CPPs) and consist of the prion protein hydrophobic signal sequence followed by a polycationic motif (residues KKRPKP), in mouse PrPc corresponding to residues 1-28. Here we analyze the sequence elements required for the anti-prion effect of KKRPKP-conjugates. Neuronal GT1-1 cells were infected with either prion strain RML or 22L Variable peptide constructs originating from the mPrP(1-28) sequence were analyzed for anti-prion effects, measured as disappearance of proteinase K resistant prions (PrPRes) in the infected cell cultures. We find that even a 5 amino acid N-terminal shortening of the signal peptide abolishes the anti-prion effect. We show that the signal peptide from PrPc can be replaced with the signal peptide from the Neural cell adhesion molecule-1; NCAMl(1-19), with a retained capacity to reduce PrPRes levels. The anti-prion effect is lost if the polycationic N-terminal PrPc-motif is conjugated to any conventional CPP, such as TAT(48-60), transportan-10 or penetratin. We propose a mechanism by which a signal peptide from a secretory or cell surface protein acts to promote the transport of a prion-binding polycationic PrPc-motif to a subcellular location where prion conversion occurs (most likely the Endosome Recycling Compartment), thereby targeting prion propagation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Soderberg, Kajsa Lofgren; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.
   [Guterstam, Peter; Langel, Ulo] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden.
RP Soderberg, KL (reprint author), Stockholm Univ, Arrhenius Labs, Dept Biochem & Biophys, Svante Arrhenius Vag 16 C, SE-10691 Stockholm, Sweden.
EM k.l.soderberg@live.com; astrid@dbb.su.se
CR Abid K, 2010, FEBS LETT, V584, P2409, DOI 10.1016/j.febslet.2010.04.040
   Viet MH, 2011, J PHYS CHEM B, V115, P7433, DOI 10.1021/jp1116728
   Magzoub M, 2005, BIOCHEMISTRY-US, V44, P14890, DOI 10.1021/bi051356w
   Lofgren K, 2008, FASEB J, V22, P2177, DOI 10.1096/fj.07-099549
   Zou WQ, 2002, J BIOL CHEM, V277, P43942, DOI 10.1074/jbc.M203611200
   Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006
   CAUGHEY B, 1991, J VIROL, V65, P6597
   Magzoub M, 2006, BIOCHEM BIOPH RES CO, V348, P379, DOI 10.1016/j.bbrc.2006.07.065
   Deriziotis P, 2011, EMBO J, V30, P3065, DOI 10.1038/emboj.2011.224
   Tjernberg LO, 1996, J BIOL CHEM, V271, P8545
   Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200
   ARNOLD JE, 1995, J PATHOL, V176, P403, DOI 10.1002/path.1711760412
   Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114
   Gerber R, 2008, PROTEIN SCI, V17, P537, DOI 10.1110/ps.073163308
   DEROSSI D, 1994, J BIOL CHEM, V269, P10444
   Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344
   Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945
   Lewis V, 2011, FRONT BIOSCI-LANDMRK, V16, P151, DOI 10.2741/3681
   Godsave SF, 2008, J NEUROSCI, V28, P12489, DOI 10.1523/JNEUROSCI.4474-08.2008
   Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140
   Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2001.5183
   Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x
   Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358
   Race R, 1998, J INFECT DIS, V178, P949, DOI 10.1086/515669
   Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104
   Li XY, 2012, PROG NEUROBIOL, V97, P127, DOI 10.1016/j.pneurobio.2011.10.002
   Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010
   Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012
   Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4
   Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x
   Kretzschmar H, 2013, BRAIN PATHOL, V23, P321, DOI 10.1111/bpa.12045
   BORCHELT DR, 1992, J BIOL CHEM, V267, P16188
   Ostapchenko VG, 2008, J MOL BIOL, V383, P1210, DOI 10.1016/j.jmb.2008.08.073
   Maeda Y, 2011, PROG LIPID RES, V50, P411, DOI 10.1016/j.plipres.2011.05.002
   Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481
   Madani F, 2013, BBA-BIOMEMBRANES, V1828, P1198, DOI 10.1016/j.bbamem.2012.12.008
   FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2
   Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989
   Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031
   Chen KC, 2011, BIOPHYS J, V101, P1221, DOI 10.1016/j.bpj.2011.07.024
   Jen A, 2010, J CELL SCI, V123, P246, DOI 10.1242/jcs.058099
   Barmada SJ, 2005, J NEUROSCI, V25, P5824, DOI 10.1523/JNEUROSCI.1192-05.2005
   Biverstahl H, 2004, BIOCHEMISTRY-US, V43, P14940, DOI 10.1021/bi0485070
   Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200
   Ersdal C, 2009, NEUROPATH APPL NEURO, V35, P259, DOI 10.1111/j.1365-2990.2008.00988.x
   Ghibaudi E, 2005, J PEPT SCI, V11, P401, DOI 10.1002/psc.633
   Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282
   GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0
   Gyllberg H, 2006, FEBS LETT, V580, P2603, DOI 10.1016/j.febslet.2006.03.092
   Huang P., 2013, ACTA BIOCH BIOPHYS S
   Jeffrey M, 2009, BRAIN PATHOL, V19, P1, DOI 10.1111/j.1750-3639.2008.00150.x
   Kappel K., 2009, PROTEIN TRANSPORT EN, P1, DOI 10.1145/1541948.1541984
   Kim C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002835
   Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139
   Langel T., 1992, INT J PEPT PROT RES, V39, P516
   Lau AL, 2007, P NATL ACAD SCI USA, V104, P11551, DOI 10.1073/pnas.0704260104
   Linden R., 2011, CELL MOL LIFE SCI, V69, P1105
   Lofgren K, 2008, EUR J NEUROSCI, V28, P964, DOI 10.1111/j.1460-9568.2008.06386.x
   Lundberg P, 2002, BIOCHEM BIOPH RES CO, V299, P85, DOI 10.1016/S0006-291X(02)02595-0
   Madani Fatemeh, 2011, Journal of Biophysics, DOI 10.1155/2011/414729
   Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426
   MCKINLEY MP, 1991, LAB INVEST, V65, P622
   Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x
   Rigter A, 2010, VACCINE, V28, P7810, DOI 10.1016/j.vaccine.2010.09.012
   Sajnani G, 2012, PRION, V6, DOI 10.4161/pri.22309
   Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829
   Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973
   Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666
   Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012
   Vendruscolo M., 2011, PERSPECT BIOL, V3
   Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314
   Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192
   Yam AY, 2011, BIOCHEMISTRY-US, V50, P4322, DOI 10.1021/bi200215j
   Younan N.D., 2013, FASEB J
NR 74
TC 2
Z9 2
U1 2
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 254
EP 261
DI 10.1016/j.abb.2014.10.009
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600030
PM 25447819
ER

PT J
AU Otzen, D
AF Otzen, Daniel
TI Membrane protein folding and stability
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
C1 Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark.
RP Otzen, D (reprint author), Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr iNANO, Gustav Wieds Vej 14, DK-8000 Aarhus C, Denmark.
CR McMorran LM, 2014, ARCH BIOCHEM BIOPHYS, V564, P265, DOI 10.1016/j.abb.2014.02.011
   Neumann J, 2014, ARCH BIOCHEM BIOPHYS, V564, P281, DOI 10.1016/j.abb.2014.07.017
   Kleinschmidt JH, 2014, ARCH BIOCHEM BIOPHYS, V564, P327, DOI 10.1016/j.abb.2014.10.013
   Hong H, 2014, ARCH BIOCHEM BIOPHYS, V564, P297, DOI 10.1016/j.abb.2014.07.031
   Popot JL, 2014, ARCH BIOCHEM BIOPHYS, V564, P314, DOI 10.1016/j.abb.2014.06.029
NR 5
TC 0
Z9 0
U1 9
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 262
EP 264
DI 10.1016/j.abb.2014.10.014
PG 3
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600031
PM 25447840
ER

PT J
AU McMorran, LM
   Brockwell, DJ
   Radford, SE
AF McMorran, Lindsay M.
   Brockwell, David J.
   Radford, Sheena E.
TI Mechanistic studies of the biogenesis and folding of outer membrane
   proteins in vitro and in vivo: What have we learned to date?
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Protein folding; Outer membrane protein; Periplasmic chaperone; BAM
   complex; Phi-Value analysis; Protein stability
ID BARREL ASSEMBLY MACHINERY; TRANSMEMBRANE BETA-BARREL; PERIPLASMIC
   CHAPERONE SKP; GRAM-NEGATIVE BACTERIA; FRUSTRATED ENERGY LANDSCAPE;
   PEPTIDYL-PROLYL ISOMERASE; ESCHERICHIA-COLI BAMB; TRANSITION-STATE;
   CRYSTAL-STRUCTURE; MOLECULAR CHAPERONE
AB Research into the mechanisms by which proteins fold into their native structures has been on-going since the work of Anfinsen in the 1960s. Since that time, the folding mechanisms of small, water-soluble proteins have been well characterised. By contrast, progress in understanding the biogenesis and folding mechanisms of integral membrane proteins has lagged significantly because of the need to create a membrane mimetic environment for folding studies in vitro and the difficulties in finding suitable conditions in which reversible folding can be achieved. Improved knowledge of the factors that promote membrane protein folding and disfavour aggregation now allows studies of folding into lipid bilayers in vitro to be performed. Consequently, mechanistic details and structural information about membrane protein folding are now emerging at an ever increasing pace. Using the panoply of methods developed for studies of the folding of water-soluble proteins. This review summarises current knowledge of the mechanisms of outer membrane protein biogenesis and folding into lipid bilayers in vivo and in vitro and discusses the experimental techniques utilised to gain this information. The emerging knowledge is beginning to allow comparisons to be made between the folding of membrane proteins with current understanding of the mechanisms of folding of water-soluble proteins. (C) 2014 Published by Elsevier Inc.
C1 [Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.
   Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.
RP Radford, SE (reprint author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.
EM s.e.radford@leeds.ac.uk
FU UK Biotechnology and Biological Sciences Research Council [BB/F01614X/1]
FX We thank G.H.M. Huysmans, A.I. Bartlett, B. Schiffrin and S.A. Baldwin
   for helpful discussions and many critical insights. We also acknowledge,
   with grateful thanks, members of the Radford and Brockwell groups as
   well as our collaborators past and present. L.M.M. is supported by the
   UK Biotechnology and Biological Sciences Research Council
   (BB/F01614X/1).
CR Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892
   Raschle T, 2010, CURR OPIN STRUC BIOL, V20, P471, DOI 10.1016/j.sbi.2010.05.006
   Pashley CL, 2012, J MOL BIOL, V416, P300, DOI 10.1016/j.jmb.2011.12.041
   Geitner AJ, 2013, J MOL BIOL, V425, P4089, DOI 10.1016/j.jmb.2013.06.038
   Damaghi M, 2010, J MOL BIOL, V397, P878, DOI 10.1016/j.jmb.2010.02.023
   Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110
   Hartl FU, 2011, NAT MED, V17, P1206, DOI 10.1038/nm.2467
   ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223
   Lazar SW, 1996, J BACTERIOL, V178, P1770
   Schobert B, 2002, J MOL BIOL, V321, P715, DOI 10.1016/S0022-2836(02)00681-2
   Banachewicz W, 2011, P NATL ACAD SCI USA, V108, P5596, DOI 10.1073/pnas.1101752108
   Cota E, 2001, J MOL BIOL, V305, P1185, DOI 10.1006/jmbi.2000.4378
   Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351
   MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0
   Rigel NW, 2012, J BACTERIOL, V194, P1002, DOI 10.1128/JB.06426-11
   McMorran LM, 2013, J MOL BIOL, V425, P3178, DOI 10.1016/j.jmb.2013.06.017
   Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184
   Curnow P, 2011, P NATL ACAD SCI USA, V108, P14133, DOI 10.1073/pnas.1012594108
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200
   Voulhoux R, 2004, RES MICROBIOL, V155, P129, DOI 10.1016/j.resmic.2003.11.007
   Wu S, 2011, BIOCHEM J, V438, P505, DOI 10.1042/BJ20110264
   Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521
   Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101
   Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202
   Olofsson M, 2007, J MOL BIOL, V365, P237, DOI 10.1016/j.jmb.2006.09.016
   Nickson AA, 2010, METHODS, V52, P38, DOI 10.1016/j.ymeth.2010.06.003
   Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P5006, DOI 10.1021/bi982465w
   Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983
   Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973
   Anil B, 2006, BIOCHEMISTRY-US, V45, P10110, DOI 10.1021/bi060636o
   Zoldak G, 2013, CURR OPIN STRUC BIOL, V23, P48, DOI 10.1016/j.sbi.2012.11.007
   Naeem A, 2011, CELL BIOCHEM BIOPHYS, V61, P237, DOI 10.1007/s12013-011-9200-x
   Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023
   Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107
   Huysmans GHM, 2007, J MOL BIOL, V373, P529, DOI 10.1016/j.jmb.2007.07.072
   Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137
   Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102
   Korndorfer IP, 2004, NAT STRUCT MOL BIOL, V11, P1015, DOI 10.1038/nsmb828
   Hagan CL, 2011, BIOCHEMISTRY-US, V50, P7444, DOI 10.1021/bi2010784
   Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020
   Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103
   BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026
   SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457
   Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1
   Danoff EJ, 2011, BIOPHYS CHEM, V159, P194, DOI 10.1016/j.bpc.2011.06.013
   Booth PJ, 2012, CURR OPIN STRUC BIOL, V22, P469, DOI 10.1016/j.sbi.2012.03.008
   Raman P, 2006, CELL MOL LIFE SCI, V63, P36, DOI 10.1007/s00018-005-5350-6
   Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009
   SURREY T, 1995, J BIOL CHEM, V270, P28199
   Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071
   Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002
   Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567
   Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200
   Stanley AM, 2008, ARCH BIOCHEM BIOPHYS, V469, P46, DOI 10.1016/j.abb.2007.09.024
   Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285
   Francis CJ, 2006, PROTEINS, V65, P145, DOI 10.1002/prot.21077
   Kim S, 2012, P NATL ACAD SCI USA, V109, P7263, DOI 10.1073/pnas.1204791109
   Braselmann E, 2013, TRENDS BIOCHEM SCI, V38, P337, DOI 10.1016/j.tibs.2013.05.001
   Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003
   Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109
   KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331
   Kim KH, 2011, BIOCHEMISTRY-US, V50, P1081, DOI 10.1021/bi101659u
   Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002
   Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384
   Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757
   Patel GJ, 2009, BIOCHEMISTRY-US, V48, P10235, DOI 10.1021/bi901403c
   Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004
   Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x
   Pocanschi CL, 2013, EUR BIOPHYS J BIOPHY, V42, P103, DOI 10.1007/s00249-013-0887-z
   Huysmans GHM, 2012, J MOL BIOL, V416, P453, DOI 10.1016/j.jmb.2011.12.039
   Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267
   RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0
   Behrens-Kneip S, 2010, INT J MED MICROBIOL, V300, P421, DOI 10.1016/j.ijmm.2010.04.012
   Dong C, 2012, ACTA CRYSTALLOGR D, V68, P1134, DOI 10.1107/S0907444912023141
   ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309
   Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414
   Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101
   Burmann BM, 2012, CHIMIA, V66, P759, DOI 10.2533/chimia.2012.759
   Schwalm J, 2013, J BACTERIOL, V195, P3734, DOI 10.1128/JB.00431-13
   Gruss F, 2013, NAT STRUCT MOL BIOL, V20, P1318, DOI 10.1038/nsmb.2689
   Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442
   Denoncin K, 2012, PROTEOMICS, V12, P1391, DOI 10.1002/pmic.201100633
   Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x
   Otzen DE, 2011, PROTEIN ENG DES SEL, V24, P139, DOI 10.1093/protein/gzq079
   Qu J, 2007, J MOL BIOL, V374, P91, DOI 10.1016/j.jmb.2007.09.020
   Hennecke G, 2005, J BIOL CHEM, V280, P23540, DOI 10.1074/jbc.M413742200
   Lappalainen I, 2008, J MOL BIOL, V375, P547, DOI 10.1016/j.jmb.2007.09.088
   Zhou HX, 2013, FEBS LETT, V587, P1053, DOI 10.1016/j.febslet.2013.01.064
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a
   BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524
   Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591
   Maslennikov I, 2013, CURR OPIN STRUC BIOL, V23, P555, DOI 10.1016/j.sbi.2013.05.002
   Webb CT, 2012, J MOL BIOL, V422, P545, DOI 10.1016/j.jmb.2012.05.035
   Wensley BG, 2010, NATURE, V463, P685, DOI 10.1038/nature08743
   Piana S, 2013, P NATL ACAD SCI USA, V110, P5915, DOI 10.1073/pnas.1218321110
   Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919
   Burmann BM, 2013, NAT STRUCT MOL BIOL, V20, P1265, DOI 10.1038/nsmb.2677
   Booth PJ, 2009, CURR OPIN STRUC BIOL, V19, P8, DOI 10.1016/j.sbi.2008.12.005
   Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104
   HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W
   Schuler B, 2013, CURR OPIN STRUC BIOL, V23, P36, DOI 10.1016/j.sbi.2012.10.008
   Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10
   Saul FA, 2004, J MOL BIOL, V335, P595, DOI 10.1016/j.jmb.2003.10.056
   Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245
   Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro.1322
   Kim KH, 2012, PROTEIN SCI, V21, P751, DOI 10.1002/pro.2069
   Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003
   Ternstrom T, 1999, P NATL ACAD SCI USA, V96, P14854, DOI 10.1073/pnas.96.26.14854
   Bulieris PV, 2003, J BIOL CHEM, V278, P9092, DOI 10.1074/jbc.M211177200
   Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842
   Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o
   Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499
   Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005
   Nam HJ, 2009, BMB REP, V42, P697
   Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001
   Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611
   Cox K, 2009, MOL MEMBR BIOL, V26, P205, DOI 10.1080/09687680902788967
   Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x
   Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860
   Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b
   Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747
   Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066
   Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06
   Gluck JM, 2009, J AM CHEM SOC, V131, P12060, DOI 10.1021/ja904897p
   Nickson AA, 2013, CURR OPIN STRUC BIOL, V23, P66, DOI 10.1016/j.sbi.2012.11.009
   FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W
   Damaghi M, 2011, ANGEW CHEM INT EDIT, V50, P7422, DOI 10.1002/anie.201101450
   ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616
   Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166
   Popot JL, 2010, ANNU REV BIOCHEM, V79, P737, DOI 10.1146/annurev.biochem.052208.114057
   Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042
   Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4
   Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X
   Wensley BG, 2012, J MOL BIOL, V423, P273, DOI 10.1016/j.jmb.2012.08.003
   Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592
   Khan MA, 2007, BIOCHEMISTRY-US, V46, P4565, DOI 10.1021/bi602526k
   Mallam AL, 2006, J MOL BIOL, V359, P1420, DOI 10.1016/j.jmb.2006.04.032
   MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131
   Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323
   Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993
   White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200
   Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395
   Friel CT, 2009, NAT STRUCT MOL BIOL, V16, P318, DOI 10.1038/nsmb.1562
   Quan S, 2011, NAT STRUCT MOL BIOL, V18, P262, DOI 10.1038/nsmb.2016
   Neuweiler H, 2005, P NATL ACAD SCI USA, V102, P16650, DOI 10.1073/pnas.0507351102
   Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1
   Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007
   Piana S, 2012, P NATL ACAD SCI USA, V109, P17845, DOI 10.1073/pnas.1201811109
   Smith LJ, 1996, FOLD DES, V1, pR95, DOI 10.1016/S1359-0278(96)00046-6
   Schug A, 2010, CURR OPIN PHARMACOL, V10, P709, DOI 10.1016/j.coph.2010.09.012
   Bitto E, 2002, STRUCTURE, V10, P1489, DOI 10.1016/S0969-2126(02)00877-8
   Sapra KT, 2009, ANGEW CHEM INT EDIT, V48, P8306, DOI 10.1002/anie.200904361
   Marsh JA, 2009, J MOL BIOL, V391, P359, DOI 10.1016/j.jmb.2009.06.001
   Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110
   Kleinschmidt JH, 2002, J MOL BIOL, V324, P319, DOI 10.1016/S0022-2836(02)01071-9
   Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925
   Stansfeld PJ, 2013, STRUCTURE, V21, P810, DOI 10.1016/j.str.2013.03.005
   Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170
   Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944
   Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035
   Andersen KK, 2012, BIOCHEMISTRY-US, V51, P8371, DOI 10.1021/bi300974y
   Cuesta-Seijo JA, 2010, STRUCTURE, V18, P1210, DOI 10.1016/j.str.2010.06.014
   BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302
   Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106
   Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320
   Hamill SJ, 2000, J MOL BIOL, V297, P165, DOI 10.1006/jmbi.2000.3517
   Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X
   Bitto E, 2004, FEBS LETT, V568, P94, DOI 10.1016/j.febslet.2004.05.014
   Booth PJ, 2010, P NATL ACAD SCI USA, V107, P3947, DOI 10.1073/pnas.0914478107
   Clark PL, 2011, J MOL BIOL, V406, P543, DOI 10.1016/j.jmb.2011.01.023
   Curnow P, 2009, P NATL ACAD SCI USA, V106, P773, DOI 10.1073/pnas.0806953106
   DIEDRICH DL, 1974, J BACTERIOL, V119, P1006
   Entzminger KC, 2012, BIOCHEMISTRY-US, V51, P4822, DOI 10.1021/bi300412y
   Ferreon ACM, 2011, BBA-PROTEINS PROTEOM, V1814, P1021, DOI 10.1016/j.bbapap.2011.01.011
   Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446
   Fersht AR, 1999, STRUCTURE MECH PROTE
   Friel CT, 2004, J MOL BIOL, V342, P261, DOI 10.1016/j.jmb.2004.06.076
   Friel CT, 2003, J MOL BIOL, V326, P293, DOI 10.1016/S0022-2836(02)01249-4
   Geierhaas CD, 2004, J MOL BIOL, V343, P1111, DOI 10.1016/j.jmb.2004.08.100
   Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100
   Gianni S, 2003, J MOL BIOL, V330, P1145, DOI 10.1016/S0022-2836(03)00689-2
   GUIDOTTI G, 1972, ARCH INTERN MED, V129, P194, DOI 10.1001/archinte.129.2.194
   Hagan CL, 2013, BIOCHEMISTRY-US, V52, P6108, DOI 10.1021/bi400865z
   Harms N, 2001, J BIOL CHEM, V276, P18804, DOI 10.1074/jbc.M011194200
   HELLER KB, 1978, J BACTERIOL, V134, P1181
   Hiller S, 2008, ANGEW CHEM INT EDIT, V47, P977, DOI 10.1002/anie.200703367
   Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827
   Huysmans G.H.M., 2008, THESIS U LEEDS UK
   JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010
   JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10436, DOI 10.1021/bi00107a011
   KENNEDY SJ, 1978, J MEMBRANE BIOL, V42, P265, DOI 10.1007/BF01870362
   Kielec JM, 2010, BBA-BIOMEMBRANES, V1798, P150, DOI 10.1016/j.bbamem.2009.07.027
   Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P4996, DOI 10.1021/bi9824644
   Kleinschmidt JH, 2011, J MOL BIOL, V407, P316, DOI 10.1016/j.jmb.2011.01.021
   Kleinschmidt JH, 2006, CHEM PHYS LIPIDS, V141, P30, DOI 10.1016/j.chemphyslip.2006.02.004
   Lam AR, 2007, J MOL BIOL, V373, P1348, DOI 10.1016/j.jmb.2007.08.032
   Le Duff CS, 2006, J MOL BIOL, V364, P824, DOI 10.1016/j.jmb.2006
   Levinthal C., 1969, U ILLINOIS B, V67, P22
   LEVINTHA.C, 1968, J CHIM PHYS PCB, V65, P44
   Li Y, 2005, J MOL BIOL, V349, P839, DOI 10.1016/j.jmb.2005.04.017
   Lyu ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046068
   Mari SA, 2010, J MOL BIOL, V396, P610, DOI 10.1016/j.jmb.2009.12.034
   Maurya S.R., 2013, SCI REP, V3
   Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x
   Moon CP, 2011, J MOL BIOL, V413, P484, DOI 10.1016/j.jmb.2011.08.041
   Otzen DE, 2013, ARCH BIOCHEM BIOPHYS, V531, P34, DOI 10.1016/j.abb.2012.10.008
   Ozenne V, 2014, J MOL BIOL, V426, P722, DOI 10.1016/j.jmb.2013.10.031
   Patel GJ, 2013, BIOCHEMISTRY-US, V52, P3974, DOI 10.1021/bi400103t
   Piana S, 2013, J PHYS CHEM B, V117, P12935, DOI 10.1021/jp4020993
   Pocanschi CL, 2006, BIOPHYS J, V91, pL75, DOI 10.1529/biophysj.106.091439
   Pocanschi CL, 2006, J MOL BIOL, V355, P548, DOI 10.1016/j.jmb.2005.10.060
   PTITSYN OB, 1973, DOKL AKAD NAUK SSSR+, V210, P1213
   Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033
   Ricci D.P., 2013, MBIO, V4
   Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377
   Sawa J, 2010, CURR OPIN STRUC BIOL, V20, P253, DOI 10.1016/j.sbi.2010.01.014
   SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x
   Scott KA, 2004, J MOL BIOL, V344, P195, DOI 10.1016/j.jmb.2004.09.037
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084
   Snijder HJ, 1999, NATURE, V401, P717, DOI 10.1038/44890
   Sohn J, 2009, STRUCTURE, V17, P1411, DOI 10.1016/j.str.2009.07.017
   Surrey T, 1996, BIOCHEMISTRY-US, V35, P2283, DOI 10.1021/bi951216u
   Tafer H, 2004, BIOCHEMISTRY-US, V43, P860, DOI 10.1021/bi0356606
   Tan AE, 2010, MACROMOL BIOSCI, V10, P763, DOI 10.1002/mabi.200900479
   TORMO A, 1990, J BACTERIOL, V172, P4339
   TSONG TY, 1972, P NATL ACAD SCI USA, V69, P1809, DOI 10.1073/pnas.69.7.1809
   Tsytlonok M, 2013, ARCH BIOCHEM BIOPHYS, V531, P14, DOI 10.1016/j.abb.2012.10.006
   Vabulas R.M., 2010, COLD SPRING HARB PER, V2
   Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033
   Vendruscolo M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a010454
   Wensley BG, 2012, P NATL ACAD SCI USA, V109, P17795, DOI 10.1073/pnas.1201793109
   Wensley BG, 2009, J MOL BIOL, V390, P1074, DOI 10.1016/j.jmb.2009.05.010
   Wright CF, 2003, NAT STRUCT BIOL, V10, P658, DOI 10.1038/nsb947
   Wright CF, 2004, J MOL BIOL, V338, P445, DOI 10.1016/j.jmb.2004.02.062
NR 242
TC 3
Z9 3
U1 13
U2 45
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 265
EP 280
DI 10.1016/j.abb.2014.02.011
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600032
PM 24613287
ER

PT J
AU Neumann, J
   Klein, N
   Otzen, DE
   Schneider, D
AF Neumann, Jennifer
   Klein, Noreen
   Otzen, Daniel E.
   Schneider, Dirk
TI Folding energetics and oligomerization of polytopic alpha-helical
   transmembrane proteins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Membrane protein; Protein folding; Oligomerization; Folding energetics
ID INTEGRAL MEMBRANE-PROTEIN; COLI DIACYLGLYCEROL KINASE; POTASSIUM CHANNEL
   KCSA; DISULFIDE BOND FORMATION; SODIUM DODECYL-SULFATE; COUPLED RECEPTOR
   OLIGOMERIZATION; EFFLUX PUMP ACRB; ESCHERICHIA-COLI; LACTOSE PERMEASE;
   CRYSTAL-STRUCTURE
AB While interactions of single-span transmembrane helices have been studied to a significant extent in the past years, the folding of polytopic alpha-helical transmembrane proteins, as well as their oligomerization, are far less analyzed and understood. The goal of the few thus far performed thermodynamic studies, in which unfolding of polytopic TM proteins was described, was to achieve a mild, potentially reversible unfolding process, to finally derive thermodynamic parameters for the reverse folding pathway. In the first part of this review, we summarize the studies analyzing the thermodynamic stability and folding pathways of polytopic transmembrane proteins. Based on these studies, we deduce some common principles, guiding transmembrane protein unfolding and folding, important for the design of future folding/unfolding studies. Furthermore, the discussed observations can conceptually guide an experimental search for proper in vitro transmembrane protein refolding conditions. In many of the resolved membrane protein structures, individual monomers interact to form higher ordered oligomers. In most cases, oligomerization of those monomeric units appears to be intimately linked to the protein function, and folding of the individual protomers might even occur only after interaction. In the second part of this review, we discuss folding pathways of oligomeric alpha-helical transmembrane proteins as well as causes and consequences of alpha-helical transmembrane protein oligomerization. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Neumann, Jennifer; Klein, Noreen; Schneider, Dirk] Johannes Gutenberg Univ Mainz, Dept Biochem & Pharm, D-55128 Mainz, Germany.
   [Otzen, Daniel E.] Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark.
RP Schneider, D (reprint author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Johann Joachim Becher Weg 30, D-55128 Mainz, Germany.
EM Dirk.Schneider@uni-mainz.de
OI Otzen, Daniel/0000-0002-2918-8989
FU Deutsche Forschungsgemeinschaft; Stiftung Rheinland-Pfalz fur
   Innovation; Danish Research Council\Natural Sciences (FNU); Danish
   Research Foundation; German Chemical Industry Fund
FX D.S. is supported by grants of the Deutsche Forschungsgemeinschaft and
   of the "Stiftung Rheinland-Pfalz fur Innovation". D.E.O. is supported by
   the Danish Research Council vertical bar Natural Sciences (FNU) and the
   Danish Research Foundation (inSPIN). N.K. is supported by a fellowship
   from the German Chemical Industry Fund.
CR Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037
   Ali SA, 2003, BIOPHYS J, V85, P2606, DOI 10.1016/S0006-3495(03)74683-9
   Anbazhagan V, 2010, ARCH BIOCHEM BIOPHYS, V495, P159, DOI 10.1016/j.abb.2010.01.006
   Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011
   Hansen JS, 2011, BBA-BIOMEMBRANES, V1808, P2600, DOI 10.1016/j.bbamem.2011.05.021
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   Xu D, 1998, PROTEIN SCI, V7, P533
   Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105
   Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402
   Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452
   Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348
   Jensen MO, 2001, STRUCTURE, V9, P1083, DOI 10.1016/S0969-2126(01)00668-2
   Papoian GA, 2003, BIOPOLYMERS, V68, P333, DOI 10.1002/bip.10286
   Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104
   Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   MATOUSCHEK A, 1990, NATURE, V346, P440, DOI 10.1038/346440a0
   Barrera FN, 2008, BIOCHEMISTRY-US, V47, P2123, DOI 10.1021/bi700778c
   BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038
   Hubbard SR, 2007, CURR OPIN CELL BIOL, V19, P117, DOI 10.1016/j.ceb.2007.02.010
   van Dalen A, 2002, FEBS LETT, V525, P33, DOI 10.1016/S0014-5793(02)03061-2
   Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003
   KHORANA HG, 1979, P NATL ACAD SCI USA, V76, P5046, DOI 10.1073/pnas.76.10.5046
   Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699
   Marti T, 1998, J BIOL CHEM, V273, P9312, DOI 10.1074/jbc.273.15.9312
   Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107
   Bogdanov M, 1996, J BIOL CHEM, V271, P11615
   Booth PJ, 1997, BIOCHEMISTRY-US, V36, P197, DOI 10.1021/bi962200m
   Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201
   Frillingos S, 1998, FASEB J, V12, P1281
   Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798
   CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940
   Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167
   LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002
   PARSELL DA, 1989, J BIOL CHEM, V264, P7590
   Cymer F, 2012, BIOL CHEM, V393, P1215, DOI 10.1515/hsz-2012-0231
   Curran AR, 1999, BIOCHEMISTRY-US, V38, P9328, DOI 10.1021/bi982322+
   Otzen DE, 1999, P NATL ACAD SCI USA, V96, P11746, DOI 10.1073/pnas.96.21.11746
   Booth PJ, 2012, CURR OPIN STRUC BIOL, V22, P469, DOI 10.1016/j.sbi.2012.03.008
   Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200
   Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7
   Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104
   SMITH RL, 1994, J BACTERIOL, V176, P5459
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   SCHREMPF H, 1995, EMBO J, V14, P5170
   Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007
   Zhou YF, 2001, PROTEIN SCI, V10, P378, DOI 10.1110/ps.34201
   Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13
   Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027
   Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050
   Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098
   Lau FW, 1999, BIOCHEMISTRY-US, V38, P5521, DOI 10.1021/bi982763t
   POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001
   Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497
   Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103
   Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104
   REYNOLDS JA, 1970, J BIOL CHEM, V245, P5161
   LEMMON MA, 1992, J BIOL CHEM, V267, P7683
   Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196
   Sun J, 2014, NATURE, V507, P73, DOI 10.1038/nature13074
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Sehgal P, 2006, PROTEIN SCI, V15, P890, DOI 10.1110/ps.052031306
   Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083
   MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084
   GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258
   Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7
   Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/nchembio.1021, 10.1038/NCHEMBIO.1021]
   Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006
   Tsai CJ, 2011, J MOL BIOL, V407, P368, DOI 10.1016/j.jmb.2011.01.028
   Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843
   SAHINTOTH M, 1994, P NATL ACAD SCI USA, V91, P5421, DOI 10.1073/pnas.91.12.5421
   Otzen DE, 2011, PROTEIN ENG DES SEL, V24, P139, DOI 10.1093/protein/gzq079
   Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406
   Gorzelle BM, 1999, BIOCHEMISTRY-US, V38, P16373, DOI 10.1021/bi991292n
   Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/b0206215y
   Kauko A, 2010, J MOL BIOL, V397, P190, DOI 10.1016/j.jmb.2010.01.042
   SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0
   HUANG KS, 1981, J BIOL CHEM, V256, P3802
   Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716
   Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034
   Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004
   Barrera FN, 2005, BIOCHEMISTRY-US, V44, P14344, DOI 10.1021/b050845t
   BOOTH PJ, 1995, NAT STRUCT BIOL, V2, P139, DOI 10.1038/nsb0295-139
   Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005
   Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752
   Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107
   Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15177, DOI 10.1021/bi970147b
   POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7
   Lee SP, 2003, LIFE SCI, V74, P173, DOI 10.1016/j.lfs.2003.09.028
   Sehgal P, 2005, BBA-BIOMEMBRANES, V1716, P59, DOI 10.1016/j.bbamem.2005.08.006
   Chang YC, 2014, P NATL ACAD SCI USA, V111, P219, DOI 10.1073/pnas.1318576111
   Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467
   AGRE P, 1993, AM J PHYSIOL, V265, pF461
   George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913
   Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978
   Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011
   Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2
   Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101
   FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W
   Zhou YF, 2000, J BIOL CHEM, V275, P6975, DOI 10.1074/jbc.275.10.6975
   Anbazhagan V, 2010, BBA-BIOMEMBRANES, V1798, P1899, DOI 10.1016/j.bbamem.2010.06.027
   Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   Verkman AS, 2013, CURR BIOL, V23, pR52, DOI 10.1016/j.cub.2012.11.025
   Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619
   Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200
   Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X
   Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028
   MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131
   Fujiyoshi Y, 2002, CURR OPIN STRUC BIOL, V12, P509, DOI 10.1016/S0959-440X(02)00355-X
   Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2
   Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524
   JUNG JS, 1994, J BIOL CHEM, V269, P14648
   Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395
   Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067
   MATTICE WL, 1976, BIOCHEMISTRY-US, V15, P4264, DOI 10.1021/bi00664a020
   Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279
   RIETVELD AG, 1995, EMBO J, V14, P5506
   Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489
   Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008
   Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200
   Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076
   JANDER G, 1994, EMBO J, V13, P5121
   Triano I, 2010, BIOCHEMISTRY-US, V49, P5397, DOI 10.1021/bi1003712
   Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1
   Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373
   van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472
   Albright RA, 1996, BIOCHEMISTRY-US, V35, P735, DOI 10.1021/bi951958n
   Rochet JC, 2000, BIOCHEMISTRY-US, V39, P11291, DOI 10.1021/bi0003184
   Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8
   Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827
   Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7
   Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542
   Miller D, 2009, J MOL BIOL, V393, P815, DOI 10.1016/j.jmb.2009.08.039
   Harris NJ, 2014, J MOL BIOL, V426, P1812, DOI 10.1016/j.jmb.2014.01.012
   Guan L, 2001, J BACTERIOL, V183, P1734, DOI 10.1128/JB.183.5.1734-1739.2001
   Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302
   Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154
   Becker CFW, 2004, J MOL BIOL, V343, P747, DOI 10.1016/j.jmb.2004.08.062
   Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339
   Bogdanov M, 2009, J BIOL CHEM, V284, P9637, DOI 10.1074/jbc.R800081200
   Booth PJ, 2000, BBA-BIOENERGETICS, V1460, P4, DOI 10.1016/S0005-2728(00)00125-0
   Booth PJ, 2010, P NATL ACAD SCI USA, V107, P3947, DOI 10.1073/pnas.0914478107
   Booth PJ, 1997, FOLD DES, V2, pR85, DOI 10.1016/S1359-0278(97)00045-X
   BRAIMAN MS, 1987, J BIOL CHEM, V262, P9271
   Bron P, 1999, J STRUCT BIOL, V128, P287, DOI 10.1006/jsbi.1999.4196
   Charalambous Kalypso, 2008, BMC Biochemistry, V9, P31, DOI 10.1186/1471-2091-9-31
   Cumow P., 2011, P NATL ACAD SCI USA, V108, P14133
   Curnow P, 2009, P NATL ACAD SCI USA, V106, P773, DOI 10.1073/pnas.0806953106
   Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035
   Cymer F, 2010, BIOCHEMISTRY-US, V49, P279, DOI 10.1021/bi901660t
   Cymer F, 2010, CELL ADHES MIGR, V4, P299, DOI 10.4161/cam.4.2.11191
   Deal S.S., 2006, BIOPHYS J, V90, P822
   de Cock H, 2001, EUR J BIOCHEM, V268, P865, DOI 10.1046/j.1432-1327.2001.01975.x
   Di Bartolo ND, 2011, J BIOL CHEM, V286, P18807, DOI 10.1074/jbc.M110.176891
   Dobrowolski A, 2010, BIOCHEMISTRY-US, V49, P5972, DOI 10.1021/bi100918j
   Duchesne L, 2001, KIDNEY INT, V60, P422, DOI 10.1046/j.1523-1755.2001.060002422.x
   DUNN R, 1981, P NATL ACAD SCI-BIOL, V78, P6744, DOI 10.1073/pnas.78.11.6744
   Eicher T, 2009, BIOL CHEM, V390, P693, DOI 10.1515/BC.2009.090
   Sachs JN, 2006, ANNU REV BIOCHEM, V75, P707, DOI 10.1146/annurev.biochem.75.110105.142336
   Escher C, 2009, J MOL BIOL, V389, P10, DOI 10.1016/j.jmb.2009.04.002
   Findlay HE, 2010, P NATL ACAD SCI USA, V107, P18451, DOI 10.1073/pnas.1005729107
   Finger C, 2006, J MOL BIOL, V358, P1221, DOI 10.1016/j.jmb.2006.02.065
   Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799
   Galka JJ, 2008, BIOCHEMISTRY-US, V47, P3513, DOI 10.1021/bi7021409
   Gonen T., 2006, REV BIOPHYS, V39, P361
   GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z
   Hara-Chikuma M, 2006, CELL MOL LIFE SCI, V63, P1386, DOI 10.1007/s00018-006-6028-4
   He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044
   He MM, 1998, MOL MEMBR BIOL, V15, P15, DOI 10.3109/09687689809027513
   Jensen MO, 2007, BIOPHYS J, V93, P92, DOI 10.1529/biophysj.107.103994
   JUBB JS, 1984, EMBO J, V3, P1455
   Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077
   Killian JA, 1998, PURE APPL CHEM, V70, P75
   KOUYAMA T, 1981, J MOL BIOL, V153, P337, DOI 10.1016/0022-2836(81)90282-5
   Laage R, 1997, EUR J BIOCHEM, V249, P540, DOI 10.1111/j.1432-1033.1997.00540.x
   Lagree V, 1999, J BIOL CHEM, V274, P6817, DOI 10.1074/jbc.274.11.6817
   Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j
   LeCoutre J, 1997, P NATL ACAD SCI USA, V94, P10167, DOI 10.1073/pnas.94.19.10167
   Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031
   Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200
   LIAO MJ, 1983, J BIOL CHEM, V258, P9949
   LONDON E, 1982, J BIOL CHEM, V257, P7003
   Lorch M, 2004, J MOL BIOL, V344, P1109, DOI 10.1016/j.jmb.2004.09.090
   Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246
   MacBeath G, 1998, PROTEIN SCI, V7, P1757
   Maggio R, 2005, FEBS J, V272, P2939, DOI 10.1111/j.1742-4658.2005.04729.x
   Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x
   Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780
   Nagy JK, 2002, BIOCHEMISTRY-US, V41, P9021, DOI 10.1021/bi020318z
   Nagy JK, 2001, BIOCHEMISTRY-US, V40, P8971, DOI 10.1021/bi010202n
   Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046
   Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c
   OESTERHE.D, 1971, NATURE-NEW BIOL, V233, P149
   ORR JW, 1992, BIOCHEMISTRY-US, V31, P4667, DOI 10.1021/bi00134a019
   Otzen DE, 2002, ROY SOC CH, P208, DOI 10.1039/9781847550255-00208
   Oxenoid K, 2004, J AM CHEM SOC, V126, P5048, DOI 10.1021/ja049916m
   Oxenoid K, 2001, BIOCHEMISTRY-US, V40, P5111, DOI 10.1021/bi0029090
   Pace C N, 1986, Methods Enzymol, V131, P266
   PALADE GE, 1955, J BIOPHYS BIOCHEM CY, V1, P59, DOI 10.1083/jcb.1.1.59
   Partridge AW, 2003, J BIOL CHEM, V278, P22056, DOI 10.1074/jbc.M210685200
   Paslawski W., 2014, UNPUB
   Patzlaff JS, 1998, BIOCHEMISTRY-US, V37, P15363, DOI 10.1021/bi981142x
   Pei XY, 1997, P NATL ACAD SCI USA, V94, P9637, DOI 10.1073/pnas.94.18.9637
   Perez C, 2011, EMBO REP, V12, P804, DOI 10.1038/embor.2011.102
   Plasencia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014674
   POPOT JL, 1986, EMBO J, V5, P3039
   Raja M, 2007, FEBS LETT, V581, P5715, DOI 10.1016/j.febslet.2007.11.039
   Renthal R, 2010, CELL MOL LIFE SCI, V67, P1077, DOI 10.1007/s00018-009-0234-9
   Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042
   SAHINTOTH M, 1992, P NATL ACAD SCI USA, V89, P10547, DOI 10.1073/pnas.89.21.10547
   Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257
   Sanders CR, 1996, BIOCHEMISTRY-US, V35, P8610, DOI 10.1021/bi9604892
   Sanders CR, 2000, CURR OPIN STRUC BIOL, V10, P438, DOI 10.1016/S0959-440X(00)00112-3
   Schneider D, 2004, FEBS LETT, V577, P5, DOI 10.1016/j.febslet.2004.10.029
   Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200
   Schulz R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000806
   SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x
   Skach WR, 2007, J CELL BIOL, V179, P1333, DOI 10.1083/jcb.200711107
   Stangl M, 2012, BIOPHYS J, V103, P2455, DOI 10.1016/j.bpj.2012.11.004
   Subramaniam S, 1999, CURR OPIN STRUC BIOL, V9, P462, DOI 10.1016/S0959-440X(99)80065-7
   Sukharev SI, 1999, J MEMBRANE BIOL, V171, P183, DOI 10.1007/s002329900570
   Takatsuka Y, 2009, J BACTERIOL, V191, P1729, DOI 10.1128/JB.01441-08
   Tastan O, 2014, BBA-BIOENERGETICS, V1837, P656, DOI 10.1016/j.bbabio.2013.11.021
   TREUTLEIN HR, 1992, BIOCHEMISTRY-US, V31, P12726, DOI 10.1021/bi00166a003
   van den Brink-van der Laan E, 2004, BIOCHEMISTRY-US, V43, P4240, DOI 10.1021/bi036129d
   van den Brink-van der Laan E, 2004, BIOCHEMISTRY-US, V43, P5937, DOI 10.1021/bi0496079
   van Dalen A, 2000, EMBO REP, V1, P340, DOI 10.1093/embo-reports/kvd067
   Veerappan A, 2011, BIOCHEMISTRY-US, V50, P10223, DOI 10.1021/bi201266m
   Verkman A.S., 2000, AM J PHYSIOL-RENAL, V278, pF13
   Vinogradova O, 1997, BIOPHYS J, V72, P2688
   Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255
   Weber M, 2011, J MOL BIOL, V407, P594, DOI 10.1016/j.jmb.2011.02.005
   Wen JA, 1996, NAT STRUCT BIOL, V3, P141, DOI 10.1038/nsb0296-141
   White SH, 2005, CURR OPIN STRUC BIOL, V15, P378, DOI 10.1016/j.sbi.2005.07.004
   Yang CH, 2003, BIOCHEMISTRY-US, V42, P4527, DOI 10.1021/bi0273157
   Zheng HJ, 2010, J MOL BIOL, V396, P593, DOI 10.1016/j.jmb.2009.12.010
NR 239
TC 3
Z9 3
U1 6
U2 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 281
EP 296
DI 10.1016/j.abb.2014.07.017
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600033
PM 25057769
ER

PT J
AU Hong, H
AF Hong, Heedeok
TI Toward understanding driving forces in membrane protein folding
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Membrane protein folding; Membrane protein stability; Packing
   interaction; Hydrogen bonding; Salt-bridge; Aromatic-aromatic
   interaction; Cation-pi interaction
ID CATION-PI INTERACTIONS; TRANSMEMBRANE ALPHA-HELICES; SIDE-CHAIN
   INTERACTIONS; SURFACE SALT BRIDGES; DOUBLE-MUTANT CYCLES; INSIDE-OUT
   PROTEINS; MOLECULAR-DYNAMICS SIMULATIONS; AROMATIC AROMATIC
   INTERACTIONS; GLYCOPHORIN-A DIMERIZATION; CELL RECEPTOR-CD3 COMPLEX
AB alpha-Helical membrane proteins are largely composed of nonpolar residues that are embedded in the lipid bilayer. An enigma in the folding of membrane proteins is how a polypeptide chain can be condensed into the compact folded state in the environment where the hydrophobic effect cannot strongly drive molecular interactions. Probably other forces such as van der Waals packing, hydrogen bonding, and weakly polar interactions, which are regarded less important in the folding of water-soluble proteins, should emerge. However, it is not clearly understood how those individual forces operate and how they are balanced for stabilizing membrane proteins. Studying this problem is not a trivial task mainly because of the methodological challenges in controlling the reversible folding of membrane proteins in the lipid bilayer. Overcoming the hurdles, meaningful progress has been made in the field in the last few decades. This review will focus on recent studies tackling the problem of driving forces in membrane protein folding. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Hong, Heedeok] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.
   [Hong, Heedeok] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.
RP Hong, H (reprint author), Michigan State Univ, 578 S Shaw Lane,Chem Bldg Rm325, E Lansing, MI 48824 USA.
EM honghd@msu.edu
FU Michigan State University
FX This work was supported by start-up fund from Michigan State University.
   H.H. thanks Dr. Miyeon Kim in helping the preparation of figures and
   Hong group for critical readings. The author appreciates the truly
   helpful comments from anonymous reviewers.
CR ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024
   Aliste MP, 2003, BIOCHEMISTRY-US, V42, P8976, DOI 10.1021/bi027001j
   Allen SJ, 2004, J MOL BIOL, V342, P1293, DOI 10.1016/j.jmb.2004.07.041
   Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643
   ANDERSON DE, 1993, PROTEIN SCI, V2, P1285
   Andrew CD, 2002, J AM CHEM SOC, V124, P12706, DOI 10.1021/ja027629h
   Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488
   Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898
   Dutta A, 2010, BIOCHEMISTRY-US, V49, P6329, DOI 10.1021/bi100339x
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110
   Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863
   Takano K, 2003, J BIOL CHEM, V278, P31790, DOI 10.1074/jbc.M304177200
   DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492
   ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223
   Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102
   BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686
   Schobert B, 2002, J MOL BIOL, V321, P715, DOI 10.1016/S0022-2836(02)00681-2
   SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006
   Hong H, 2010, P NATL ACAD SCI USA, V107, P19802, DOI 10.1073/pnas.1010348107
   Oberai A, 2006, PROTEIN SCI, V15, P1723, DOI 10.1110/ps.062109706
   Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225
   Cantor RS, 1997, BIOCHEMISTRY-US, V36, P2339, DOI 10.1021/bi9627323
   Bowie JU, 2011, CURR OPIN STRUC BIOL, V21, P42, DOI 10.1016/j.sbi.2010.10.003
   Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348
   Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881
   Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218
   Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101
   ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543
   White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319
   YEATES TO, 1987, P NATL ACAD SCI USA, V84, P6438, DOI 10.1073/pnas.84.18.6438
   Gromiha MM, 2003, BIOPHYS CHEM, V103, P251, DOI 10.1016/S0301-4622(02)00318-6
   Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796
   Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107
   Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163
   Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216
   Tsuzuki S, 2006, J PHYS CHEM A, V110, P2027, DOI 10.1021/jp054461o
   Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399
   MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388
   LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0
   Schlebach JP, 2011, J MOL BIOL, V406, P545, DOI 10.1016/j.jmb.2010.12.018
   Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c
   Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798
   Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740
   Joh NH, 2009, J AM CHEM SOC, V131, P10846, DOI 10.1021/ja904711k
   LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002
   FernandezRecio J, 1997, J MOL BIOL, V267, P184, DOI 10.1006/jmbi.1996.0831
   Oberai A, 2009, P NATL ACAD SCI USA, V106, P17747, DOI 10.1073/pnas.0906390106
   COX EG, 1958, REV MOD PHYS, V30, P159, DOI 10.1103/RevModPhys.30.159
   Curran AR, 1999, BIOCHEMISTRY-US, V38, P9328, DOI 10.1021/bi982322+
   Engelman DM, 2003, MOL CELL, V11, P5, DOI 10.1016/S1097-2765(03)00016-9
   Hong H, 2011, J AM CHEM SOC, V133, P11389, DOI 10.1021/ja204524c
   Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861
   Stanley AM, 2008, ARCH BIOCHEM BIOPHYS, V469, P46, DOI 10.1016/j.abb.2007.09.024
   HONIG BH, 1986, ANNU REV BIOPHYS BIO, V15, P163
   Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007
   KELLIS JT, 1989, BIOCHEMISTRY-US, V28, P4914, DOI 10.1021/bi00437a058
   Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671
   Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104
   WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122
   Cubberley MS, 2001, J AM CHEM SOC, V123, P7560, DOI 10.1021/ja015817m
   Chen KYM, 2012, P NATL ACAD SCI USA, V109, P13284, DOI 10.1073/pnas.1205512109
   STEED JM, 1979, J CHEM PHYS, V70, P4940, DOI 10.1063/1.437383
   Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001
   Fleming KG, 2001, P NATL ACAD SCI USA, V98, P14340, DOI 10.1073/pnas.251367498
   MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653
   HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4
   Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384
   Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1
   ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025
   Gurezka R, 2001, J BIOL CHEM, V276, P45580, DOI 10.1074/jbc.M105362200
   Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985
   Adamian L, 2005, PROTEINS, V59, P496, DOI 10.1002/prot.20456
   Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x
   Tissot AC, 1996, BIOCHEMISTRY-US, V35, P6786, DOI 10.1021/bi952930e
   LEMMON MA, 1992, J BIOL CHEM, V267, P7683
   BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5
   Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047
   HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7
   Senes A, 2011, CURR OPIN STRUC BIOL, V21, P460, DOI 10.1016/j.sbi.2011.06.004
   Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196
   Kim S, 2004, P NATL ACAD SCI USA, V101, P5988, DOI 10.1073/pnas.0308694101
   Scott DJ, 2013, CURR OPIN CHEM BIOL, V17, P427, DOI 10.1016/j.cbpa.2013.04.002
   Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782
   MARQUSEE S, 1994, PROTEIN SCI, V3, P2217
   Hong H, 2009, METHOD ENZYMOL, V455, P213, DOI 10.1016/S0076-6879(08)04208-0
   Schlinkmann KM, 2012, J MOL BIOL, V422, P414, DOI 10.1016/j.jmb.2012.05.039
   Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106
   LOEWENTHAL R, 1992, J MOL BIOL, V224, P759, DOI 10.1016/0022-2836(92)90560-7
   Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7
   Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/nchembio.1021, 10.1038/NCHEMBIO.1021]
   Song YL, 2014, PROTEIN SCI, V23, P1, DOI 10.1002/pro.2385
   Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101
   Mueller BK, 2014, P NATL ACAD SCI USA, V111, pE888, DOI 10.1073/pnas.1319944111
   Shi ZS, 2002, J AM CHEM SOC, V124, P3284, DOI 10.1021/ja0174938
   WIENER MC, 1992, BIOPHYS J, V61, P434
   Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205
   Cymer F, 2013, P NATL ACAD SCI USA, V110, P14640, DOI 10.1073/pnas.1306787110
   Hertel B, 2010, EUR BIOPHYS J BIOPHY, V39, P1057, DOI 10.1007/s00249-009-0451-z
   McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458
   Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387
   Kauko A, 2010, J MOL BIOL, V397, P190, DOI 10.1016/j.jmb.2010.01.042
   Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880
   SUNNER J, 1981, J PHYS CHEM-US, V85, P1814, DOI 10.1021/j150613a011
   HUANG KS, 1981, J BIOL CHEM, V256, P3802
   Chae PS, 2010, NAT METHODS, V7, P1003, DOI [10.1038/nmeth.1526, 10.1038/NMETH.1526]
   Pace CN, 2009, NAT STRUCT MOL BIOL, V16, P681, DOI 10.1038/nsmb0709-681
   Massey-Gendel E, 2009, PROTEIN SCI, V18, P372, DOI 10.1002/pro.39
   Fleming KG, 1997, J MOL BIOL, V272, P266, DOI 10.1006/jmbi.1997.1236
   Hong H, 2013, METHODS MOL BIOL, V1063, P37, DOI 10.1007/978-1-62703-583-5_3
   BOOTH PJ, 1995, NAT STRUCT BIOL, V2, P139, DOI 10.1038/nsb0295-139
   KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0
   SALI D, 1991, J MOL BIOL, V220, P779, DOI 10.1016/0022-2836(91)90117-O
   Blois TM, 2009, J AM CHEM SOC, V131, P13914, DOI 10.1021/ja905725n
   Gao JM, 2009, NAT STRUCT MOL BIOL, V16, P684, DOI 10.1038/nsmb.1610
   Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101
   POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7
   HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W
   Walmsley AR, 1998, TRENDS BIOCHEM SCI, V23, P476, DOI 10.1016/S0968-0004(98)01326-7
   Bayburt TH, 1998, J STRUCT BIOL, V123, P37, DOI 10.1006/jsbi.1998.4007
   BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125
   Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737
   Chang YC, 2014, P NATL ACAD SCI USA, V111, P219, DOI 10.1073/pnas.1318576111
   CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0
   Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111
   Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459
   BenTal N, 1997, J PHYS CHEM B, V101, P450, DOI 10.1021/jp961825r
   Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744
   Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60
   Eriksson UK, 2013, SCIENCE, V340, P1346, DOI 10.1126/science.1234306
   Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7
   BROCCHIERI L, 1994, P NATL ACAD SCI USA, V91, P9297, DOI 10.1073/pnas.91.20.9297
   ENGELMAN DM, 1980, P NATL ACAD SCI-BIOL, V77, P5894, DOI 10.1073/pnas.77.10.5894
   Meindl-Beinker NM, 2006, EMBO REP, V7, P1111, DOI 10.1038/sj.embor.7400818
   Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842
   Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o
   RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055
   Schulze RJ, 2014, P NATL ACAD SCI USA, V111, P4844, DOI 10.1073/pnas.1315901111
   Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020
   Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2
   Baldwin RL, 2003, J BIOL CHEM, V278, P17581, DOI 10.1074/jbc.X200009200
   JORGENSEN WL, 1990, J AM CHEM SOC, V112, P4768, DOI 10.1021/ja00168a022
   Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c
   FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W
   HENDSCH ZS, 1994, PROTEIN SCI, V3, P211
   Zhou YF, 2000, J BIOL CHEM, V275, P6975, DOI 10.1074/jbc.275.10.6975
   Korendovych IV, 2010, J AM CHEM SOC, V132, P15516, DOI 10.1021/ja107487b
   ERIKSSON AE, 1992, NATURE, V355, P371, DOI 10.1038/355371a0
   Anbazhagan V, 2010, BBA-BIOMEMBRANES, V1798, P1899, DOI 10.1016/j.bbamem.2010.06.027
   Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542
   LAW KS, 1984, J CHEM PHYS, V81, P4871, DOI 10.1063/1.447514
   Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295
   You M, 2005, ANAL BIOCHEM, V340, P154, DOI 10.1016/j.ab.2.01.035
   Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977
   MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131
   Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524
   Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395
   Ojemalm K, 2012, MOL CELL, V45, P529, DOI 10.1016/j.molcel.2011.12.024
   KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7
   McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022
   Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067
   Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927
   Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071
   Baker D, 2014, BIOCHEM SOC T, V42, P225, DOI 10.1042/BST20130055
   DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P7142
   REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138
   Zhou FX, 2000, NAT STRUCT BIOL, V7, P154
   Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524
   HONIG BH, 1984, P NATL ACAD SCI-BIOL, V81, P5412, DOI 10.1073/pnas.81.17.5412
   HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016
   White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904
   Hedin LE, 2010, J MOL BIOL, V396, P221, DOI 10.1016/j.jmb.2009.11.036
   Schlebach JP, 2012, PROTEIN SCI, V21, P97, DOI 10.1002/pro.766
   Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908
   Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768
   Wallin E, 1998, PROTEIN SCI, V7, P1029
   Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251
   Harris NJ, 2014, J MOL BIOL, V426, P1812, DOI 10.1016/j.jmb.2014.01.012
   Arbely E, 2004, J AM CHEM SOC, V126, P5362, DOI 10.1021/ja049826h
   Arkin IT, 1998, BBA-PROTEIN STRUCT M, V1429, P113, DOI 10.1016/S0167-4838(98)00225-8
   Arora A, 2000, J BIOL CHEM, V275, P1594, DOI 10.1074/jbc.275.3.1594
   Balashov SP, 1996, BIOPHYS J, V71, P1973
   Barth P, 2007, CURR OPIN STRUC BIOL, V17, P460, DOI 10.1016/j.sbi.2007.08.006
   Battaglia M. R., 1981, Chemical Physics Letters, V78, DOI 10.1016/0009-2614(81)85228-1
   BAYLEY H, 1982, METHOD ENZYMOL, V88, P74
   Beevers AJ, 2012, BIOCHEMISTRY-US, V51, P2558, DOI 10.1021/bi201269w
   Bowie JU, 2013, SCIENCE, V339, P398, DOI 10.1126/science.1228655
   BURLEY SK, 1986, J AM CHEM SOC, V108, P7995, DOI 10.1021/ja00285a019
   Campos LA, 2005, BIOPHYS J, V88, P1311, DOI 10.1529/biophysj.104.050203
   Cao Z, 2012, P NATL ACAD SCI USA, V109, P8121, DOI 10.1073/pnas.1201298109
   Chamberlain AK, 2003, ADV PROTEIN CHEM, V63, P19
   Choma C, 2000, NAT STRUCT BIOL, V7, P161
   CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1
   Cui GY, 2013, J BIOL CHEM, V288, P20758, DOI 10.1074/jbc.M113.476226
   Curnow P, 2009, P NATL ACAD SCI USA, V106, P773, DOI 10.1073/pnas.0806953106
   DAVIES M, 1956, J PHYS CHEM-US, V60, P767, DOI 10.1021/j150540a014
   DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001
   Doura AK, 2004, J MOL BIOL, V343, P1487, DOI 10.1016/j.jmb.2004.09.011
   Doura AK, 2004, J MOL BIOL, V341, P991, DOI 10.1016/j.jmb.2004.06.042
   EDSALL JT, 1992, PROTEIN SCI, V1, P1526
   EISENSTEIN L, 1987, J AM CHEM SOC, V109, P6860, DOI 10.1021/ja00256a055
   Faham S, 2004, J MOL BIOL, V335, P297, DOI 10.1016/j.jmb.2003.10.041
   Fernandez-Recio J, 1999, J MOL BIOL, V290, P319, DOI 10.1006/jmbi.1999.2863
   Findlay HE, 2010, P NATL ACAD SCI USA, V107, P18451, DOI 10.1073/pnas.1005729107
   Fu YW, 2006, J AM CHEM SOC, V128, P15948, DOI 10.1021/ja065303t
   Gromiha MM, 2005, INT J BIOL MACROMOL, V35, P55, DOI 10.1016/j.ijbiomac.2004.12.001
   Hausmann R, 2013, MOL PHARMACOL, V83, P73, DOI 10.1124/mol.112.081489
   He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036
   He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044
   He MM, 1998, MOL MEMBR BIOL, V15, P15, DOI 10.3109/09687689809027513
   He U., 2012, PLOS ONE, V7
   Hildebrand PW, 2005, BIOPHYS J, V88, P1970, DOI 10.1529/biophysj.104.049585
   Hong H, 2013, BIOCHEMISTRY-US, V52, P4413, DOI 10.1021/bi400344b
   Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827
   Honig B., 1992, CURR OPIN STRUC BIOL, V2, P40, DOI 10.1016/0959-440X(92)90174-6
   HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829
   HUANG KS, 1980, P NATL ACAD SCI-BIOL, V77, P323, DOI 10.1073/pnas.77.1.323
   Hunter CA, 2001, J CHEM SOC PERK T 2, P651, DOI 10.1039/b008495f
   Jackups R, 2005, J MOL BIOL, V354, P979, DOI 10.1016/j.jmb.2005.09.094
   Jang DS, 2004, BIOCHEM J, V382, P967
   Johnson RM, 2007, BIOCHEMISTRY-US, V46, P9208, DOI 10.1021/bi7008773
   KAHN TW, 1992, BIOCHEMISTRY-US, V31, P6144, DOI 10.1021/bi00141a027
   KAHN TW, 1992, BIOCHEMISTRY-US, V31, P8829, DOI 10.1021/bi00152a020
   Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753
   Kim S, 2003, J MOL BIOL, V329, P831, DOI 10.1016/S0022-2836(03)00521-7
   KLOTZ IM, 1962, J AM CHEM SOC, V84, P3461, DOI 10.1021/ja00877a009
   Kong FR, 2011, PROTEIN SCI, V20, P513, DOI 10.1002/pro.583
   Kuznetsov G, 1998, NEW ENGL J MED, V339, P1688
   Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j
   LeCoutre J, 1997, P NATL ACAD SCI USA, V94, P10167, DOI 10.1073/pnas.94.19.10167
   le Coutre J, 1998, P NATL ACAD SCI USA, V95, P6114, DOI 10.1073/pnas.95.11.6114
   LEE JI, 1992, J BIOL CHEM, V267, P20758
   LONDON E, 1982, J BIOL CHEM, V257, P7003
   Luisi DL, 2003, BIOCHEMISTRY-US, V42, P7050, DOI 10.1021/bi027202n
   MacKenzie KR, 2008, CURR OPIN STRUC BIOL, V18, P412, DOI 10.1016/j.sbi.2008.04.007
   MacKenzie KR, 1998, P NATL ACAD SCI USA, V95, P3583, DOI 10.1073/pnas.95.7.3583
   Mahalakshmi R, 2006, J AM CHEM SOC, V128, P1125, DOI 10.1021/ja054040k
   MARTI T, 1991, J BIOL CHEM, V266, P18674
   Mirsky AE, 1929, J GEN PHYSIOL, V13, P133, DOI 10.1085/jgp.13.2.133
   Mohan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014217
   Moon CP, 2011, J MOL BIOL, V413, P484, DOI 10.1016/j.jmb.2011.08.041
   North B, 2006, J MOL BIOL, V359, P930, DOI 10.1016/j.jmb.2006.04.001
   Olson CA, 2001, J AM CHEM SOC, V123, P6451, DOI 10.1021/ja015590v
   Pace CN, 2001, BIOCHEMISTRY-US, V40, P310, DOI 10.1021/bi001574j
   Park H, 2008, J PHYS CHEM B, V112, P1041, DOI 10.1021/jp077285n
   Patel GJ, 2013, BIOCHEMISTRY-US, V52, P3974, DOI 10.1021/bi400103t
   Pervushin K, 1996, J MOL BIOL, V264, P1002, DOI 10.1006/jmbi.1996.0692
   Placone J., 2012, PLOS ONE, V7
   POPOT JL, 1986, EMBO J, V5, P3039
   Rees DC, 2000, PROTEINS, V38, P121, DOI 10.1002/(SICI)1097-0134(20000201)38:2<121::AID-PROT1>3.0.CO;2-M
   Renthal R, 2006, BIOCHEMISTRY-US, V45, P14559, DOI 10.1021/bi0620454
   REYNOLDS JA, 1974, P NATL ACAD SCI USA, V71, P2925, DOI 10.1073/pnas.71.8.2925
   Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084
   Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200
   Schlebach JP, 2013, BIOCHEMISTRY-US, V52, P3229, DOI 10.1021/bi301635f
   Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200
   SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L
   Sheu SY, 2009, J PHYS CHEM B, V113, P5318, DOI 10.1021/jp810772a
   Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239
   HUNTER CA, 1991, J MOL BIOL, V218, P837, DOI 10.1016/0022-2836(91)90271-7
   SINGH UC, 1988, P NATL ACAD SCI USA, V85, P4280, DOI 10.1073/pnas.85.12.4280
   SMITH CK, 1995, SCIENCE, V270, P980, DOI 10.1126/science.270.5238.980
   Stanley AM, 2007, J MOL BIOL, V370, P912, DOI 10.1016/j.jmb.2007.05.009
   Stevens TJ, 1999, PROTEINS, V36, P135, DOI 10.1002/(SICI)1097-0134(19990701)36:1<135::AID-PROT11>3.0.CO;2-I
   Stevens TJ, 2000, PROTEINS, V40, P463, DOI 10.1002/1097-0134(20000815)40:3<463::AID-PROT120>3.0.CO;2-D
   Su PC, 2012, J BIOL CHEM, V287, P31515, DOI 10.1074/jbc.M112.396895
   Tatko CD, 2003, PROTEIN SCI, V12, P2443, DOI 10.1110/ps.03284003
   Tatko CD, 2002, J AM CHEM SOC, V124, P9372, DOI 10.1021/ja0262481
   Theobald DL, 2010, NAT STRUCT MOL BIOL, V17, P2, DOI 10.1038/nsmb0110-2
   Tieleman DP, 1999, BIOPHYS J, V76, P40
   Ting AY, 1998, J AM CHEM SOC, V120, P7135, DOI 10.1021/ja981520l
   Torrice MM, 2009, P NATL ACAD SCI USA, V106, P11919, DOI 10.1073/pnas.0903260106
   Unterreitmeier S, 2007, J MOL BIOL, V374, P705, DOI 10.1016/j.jmb.2007.09.056
   Veerappan A, 2011, BIOCHEMISTRY-US, V50, P10223, DOI 10.1021/bi201266m
   Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200
   Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255
   WARME PK, 1978, J MOL BIOL, V118, P289, DOI 10.1016/0022-2836(78)90229-2
   Weber M, 2011, J MOL BIOL, V407, P594, DOI 10.1016/j.jmb.2011.02.005
   Wen JA, 1996, NAT STRUCT BIOL, V3, P141, DOI 10.1038/nsb0296-141
   Zhou YF, 1997, NAT STRUCT BIOL, V4, P986, DOI 10.1038/nsb1297-986
   Zhu L, 2013, J BIOL CHEM, V288, P28180, DOI 10.1074/jbc.M113.491613
NR 285
TC 4
Z9 4
U1 15
U2 52
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 297
EP 313
DI 10.1016/j.abb.2014.07.031
PG 17
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600034
PM 25107533
ER

PT J
AU Popot, JL
AF Popot, Jean-Luc
TI Folding membrane proteins in vitro: A table and some comments
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Membrane proteins; Surfactants; Folding; Biochemistry; Biophysics
ID CELL-FREE SYNTHESIS; FREE EXPRESSION SYSTEM; MULTIDRUG TRANSPORTER EMRE;
   SODIUM-PROTON ANTIPORTER; A TRANSMEMBRANE DOMAIN; LARGE-SCALE
   PRODUCTION; BETA-BARREL PROTEINS; OUTER-MEMBRANE; ESCHERICHIA-COLI;
   COUPLED RECEPTORS
AB Thirty-three years have elapsed since the first membrane protein (MP) was brought back in vitro to its native state starting from the completely unfolded polypeptide. Folding MPs is as useful from a practical point of view as it is thought-provoking from a theoretical one. Yet, this activity is considered as a high-risk, time-consuming endeavor, full of pitfalls, its path littered with the broken careers of graduate students sacrificed on the altar of a long shot that never paid off. In fact, a surprisingly high number of MPs have actually been folded or refolded in vitro. Analysis of the literature indicates (i) that the endeavor is not as desperate as it may seem, (ii) that techniques are diversifying and improving, and (iii) that many MPs do not need the cellular biosynthetic apparatus, nor even a membrane environment, to reach a functional 3D structure. A compilation, hopefully close to complete, is presented of MPs that have been (re)folded in vitro to-date, with the conditions of their synthesis, the denaturant(s) used, if any, and the (re)folding conditions, along with a few comments. The hope is that this analysis will encourage membrane protein biochemists to consider producing their target proteins in this way, help them decide about an experimental course, and stimulate the reflection about which environments favor membrane protein folding and why. (C) 2014 Elsevier Inc. All rights reserved.
C1 Univ Paris 07, CNRS, Inst Biol Phys Chim FRC 550, UMR 7099, F-75005 Paris, France.
RP Popot, JL (reprint author), Univ Paris 07, CNRS, Inst Biol Phys Chim FRC 550, UMR 7099, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.
EM jean-luc.popot@ibpc.fr
CR Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008
   Aly KA, 2013, MICROBIOLOGYOPEN, V2, P94, DOI 10.1002/mbo3.51
   Anfinsen C B, 1975, Adv Protein Chem, V29, P205, DOI 10.1016/S0065-3233(08)60413-1
   Shimono K, 2009, PROTEIN SCI, V18, P2160, DOI 10.1002/pro.230
   Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609
   Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106
   PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146
   Dewald AH, 2011, BIOPHYS J, V100, P2131, DOI 10.1016/j.bpj.2011.03.025
   ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223
   Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881
   Junge F, 2011, NEW BIOTECHNOL, V28, P262, DOI 10.1016/j.nbt.2010.07.002
   Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200
   Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214
   Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200
   Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011
   Jarecki BW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01040
   Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983
   Shenkarev ZO, 2013, BBA-BIOMEMBRANES, V1828, P776, DOI 10.1016/j.bbamem.2012.11.005
   Rajesh S, 2011, NEW BIOTECHNOL, V28, P250, DOI 10.1016/j.nbt.2010.07.011
   Huysmans GHM, 2007, J MOL BIOL, V373, P529, DOI 10.1016/j.jmb.2007.07.072
   Koppel DA, 1998, J BIOL CHEM, V273, P13794, DOI 10.1074/jbc.273.22.13794
   Deniaud A, 2010, BBA-BIOMEMBRANES, V1798, P1540, DOI 10.1016/j.bbamem.2010.04.010
   Kedrov A, 2004, J MOL BIOL, V340, P1143, DOI 10.1016/j.jmb.2004.05.026
   SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457
   Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324
   Schmidt P, 2009, BIOTECHNOL PROGR, V25, P1732, DOI 10.1002/btpr.266
   Schmid B, 1996, FEBS LETT, V381, P111, DOI 10.1016/0014-5793(96)00080-4
   Fiedler S, 2010, CELL MOL LIFE SCI, V67, P1779, DOI 10.1007/s00018-010-0259-0
   Svensson G, 2009, BIOCHEMISTRY-US, V48, P9994, DOI 10.1021/bi901402x
   Wang JZ, 2011, SPECTROCHIM ACTA A, V78, P142, DOI 10.1016/j.saa.2010.09.013
   Pocanschi CL, 2006, BIOCHEMISTRY-US, V45, P13954, DOI 10.1021/bi0616706
   Hill K, 1998, NATURE, V395, P516
   Albrecht R, 2006, ACTA CRYSTALLOGR F, V62, P415, DOI 10.1107/S1744309106010190
   Stanley AM, 2008, ARCH BIOCHEM BIOPHYS, V469, P46, DOI 10.1016/j.abb.2007.09.024
   Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671
   Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104
   PAULSEN H, 1990, PLANTA, V181, P204, DOI 10.1007/BF02411539
   Rath A, 2013, P NATL ACAD SCI USA, V110, P15668, DOI 10.1073/pnas.1311305110
   Leney AC, 2012, ANAL CHEM, V84, P9841, DOI 10.1021/ac302223s
   REYNOLDS JA, 1970, J BIOL CHEM, V245, P5161
   Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104
   Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219
   Wang XQ, 2011, P NATL ACAD SCI USA, V108, P9049, DOI 10.1073/pnas.1018185108
   Baneres JL, 2011, TRENDS BIOTECHNOL, V29, P314, DOI 10.1016/j.tibtech.2011.03.002
   Vogt J, 1999, STRUCT FOLD DES, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5
   Pocanschi CL, 2013, EUR BIOPHYS J BIOPHY, V42, P103, DOI 10.1007/s00249-013-0887-z
   Bhuyan AK, 2010, BIOPOLYMERS, V93, P186, DOI 10.1002/bip.21318
   ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309
   Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7
   Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/nchembio.1021, 10.1038/NCHEMBIO.1021]
   Akazawa-Ogawa Y, 2014, J BIOL CHEM, V289, P15666, DOI 10.1074/jbc.M113.534222
   Kramer RA, 2000, EUR J BIOCHEM, V267, P885, DOI 10.1046/j.1432-1327.2000.01073.x
   Gorzelle BM, 1999, BIOCHEMISTRY-US, V38, P16373, DOI 10.1021/bi991292n
   Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/b0206215y
   Katzen F, 2009, TRENDS BIOTECHNOL, V27, P455, DOI 10.1016/j.tibtech.2009.05.005
   HUANG KS, 1981, J BIOL CHEM, V256, P3802
   DORNMAIR K, 1990, J BIOL CHEM, V265, P18907
   Bazzacco P, 2012, BIOCHEMISTRY-US, V51, P1416, DOI 10.1021/bi201862v
   Weiss HM, 2002, EUR J BIOCHEM, V269, P82, DOI 10.1046/j.0014-2956.2002.02618.x
   Kiefer H, 2003, BBA-BIOMEMBRANES, V1610, P57, DOI 10.1016/S0005-2736(02)00717-4
   Kessler M, 2006, J MOL BIOL, V357, P644, DOI 10.1016/j.jmb.2005.12.065
   Schneider B, 2010, METHODS MOL BIOL, V601, P165, DOI 10.1007/978-1-60761-344-2_11
   Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255
   POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7
   Arcemisbehere L, 2010, J BIOL CHEM, V285, P6337, DOI 10.1074/jbc.M109.083477
   Berrier C, 2004, BIOCHEMISTRY-US, V43, P12585, DOI 10.1021/bi049049y
   Harris NJ, 2012, BBA-BIOMEMBRANES, V1818, P1055, DOI 10.1016/j.bbamem.2011.11.006
   Bosshart PD, 2012, STRUCTURE, V20, P121, DOI 10.1016/j.str.2011.11.002
   Dahmane T, 2009, BIOCHEMISTRY-US, V48, P6516, DOI 10.1021/bi801729z
   Engelhardt H, 2007, J MEMBRANE BIOL, V216, P93, DOI 10.1007/s00232-007-9038-8
   Rogl H, 1998, FEBS LETT, V432, P21, DOI 10.1016/S0014-5793(98)00825-4
   Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499
   Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367
   Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x
   Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148
   Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066
   Damaghi M, 2011, ANGEW CHEM INT EDIT, V50, P7422, DOI 10.1002/anie.201101450
   PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x
   Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395
   Periasamy A, 2013, BBA-BIOMEMBRANES, V1828, P743, DOI 10.1016/j.bbamem.2012.10.003
   Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019
   Buchanan SK, 1999, BIOCHEM SOC T, V27, P903
   Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5
   Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x
   Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8
   Michaux C, 2008, J MOL BIOL, V375, P1477, DOI 10.1016/j.jmb.2007.11.026
   Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7
   Miller D, 2009, J MOL BIOL, V393, P815, DOI 10.1016/j.jmb.2009.08.039
   Armstrong N, 1999, PROTEIN SCI, V8, P1475
   Babavali M, 2009, BIOCHEMISTRY-US, V48, P9022, DOI 10.1021/bi901124j
   Baldermann C, 2000, J STRUCT BIOL, V131, P96, DOI 10.1006/jsbi.2000.4261
   Baldwin V, 2011, BBA-BIOMEMBRANES, V1808, P2206, DOI 10.1016/j.bbamem.2011.05.013
   Bannwarth M, 2003, BBA-BIOMEMBRANES, V1610, P37, DOI 10.1016/S0005-2736(02)00711-3
   Beebe ET, 2011, NEW BIOTECHNOL, V28, P239, DOI 10.1016/j.nbt.2010.07.003
   Booth PJ, 2003, BBA-BIOMEMBRANES, V1610, P51, DOI 10.1016/S0005-2736(02)00714-9
   Buchanan S.K., 2012, MEMBRANES, P139
   Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200
   Conlan S, 2003, BIOCHEMISTRY-US, V42, P9453, DOI 10.1021/bi0344228
   Curnow P, 2004, J MOL BIOL, V343, P213, DOI 10.1016/j.jmb.2004.08.032
   Dahan D, 1996, FEBS LETT, V392, P304, DOI 10.1016/0014-5793(96)00841-1
   Dahmane T, 2011, BIOPOLYMERS, V95, P811, DOI 10.1002/bip.21683
   Dahmane T, 2013, EUR BIOPHYS J BIOPHY, V42, P85, DOI 10.1007/s00249-012-0839-z
   Debnath DK, 2010, BIOPHYS CHEM, V152, P80, DOI 10.1016/j.bpc.2010.08.003
   DEKKER N, 1995, EUR J BIOCHEM, V232, P214, DOI 10.1111/j.1432-1033.1995.tb20801.x
   Devaraneni PK, 2011, BIOCHEMISTRY-US, V50, P10442, DOI 10.1021/bi2012965
   EISELE JL, 1990, J BIOL CHEM, V265, P10217
   Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101
   Elter S., 2014, J MEMBR BIOL
   Fernandez C, 2001, P NATL ACAD SCI USA, V98, P2358, DOI 10.1073/pnas.051629298
   Gao TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044911
   Genji T, 2010, BIOCHEM BIOPH RES CO, V400, P638, DOI 10.1016/j.bbrc.2010.08.119
   Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002
   Gourdon P, 2008, PROTEIN EXPRES PURIF, V58, P103, DOI 10.1016/j.pep.2007.10.017
   Guild K, 2011, ACTA CRYSTALLOGR F, V67, P1027, DOI 10.1107/S1744309111032143
   He MM, 1998, MOL MEMBR BIOL, V15, P15, DOI 10.3109/09687689809027513
   Hearn EM, 2008, P NATL ACAD SCI USA, V105, P8601, DOI 10.1073/pnas.0801264105
   Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393
   IBEL K, 1990, EUR J BIOCHEM, V190, P311, DOI 10.1111/j.1432-1033.1990.tb15578.x
   Ishihara G, 2005, PROTEIN EXPRES PURIF, V41, P27, DOI 10.1016/j.pep.2005.01.013
   Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5
   Kai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056637
   Kaiser L, 2008, P NATL ACAD SCI USA, V105, P15726, DOI 10.1073/pnas.0804766105
   Kalmbach R, 2007, J MOL BIOL, V371, P639, DOI 10.1016/j.jmb.2007.05.087
   Katzen Federico, 2008, Biotechniques, V45, P469, DOI 10.2144/000112996
   Kedrov A, 2006, J MOL BIOL, V355, P2, DOI 10.1016/j.jmb.2005.10.028
   Kiefer H, 1996, BIOCHEMISTRY-US, V35, P16077, DOI 10.1021/bi9612069
   Klammt C, 2006, FEBS J, V273, P4141, DOI 10.1111/j.1742-4658.2006.05432.x
   Klammt C., 2007, FEBS J, V274, P3259
   Klammt C, 2007, J STRUCT BIOL, V158, P482, DOI 10.1016/j.jsb.2007.01.006
   Klammt C, 2011, PROTEIN SCI, V20, P1030, DOI 10.1002/pro.636
   Kleinschmidt JH, 2003, CELL MOL LIFE SCI, V60, P1547, DOI 10.1007/s00018-003-3170-0
   KLUG CS, 1995, BIOCHEMISTRY-US, V34, P14230, DOI 10.1021/bi00043a030
   Krautler V, 2010, EUR BIOPHYS J BIOPHY, V39, P1421, DOI 10.1007/s00249-010-0596-9
   Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j
   LIND C, 1981, J BIOL CHEM, V256, P8298
   Linke D, 2004, BIOPHYS J, V86, P1479, DOI 10.1016/S0006-3495(04)74216-2
   LONDON E, 1982, J BIOL CHEM, V257, P7003
   Lyukmanova EN, 2012, BBA-BIOMEMBRANES, V1818, P349, DOI 10.1016/j.bbamem.2011.10.020
   Mari SA, 2010, J MOL BIOL, V396, P610, DOI 10.1016/j.jmb.2009.12.034
   Mary S., 2014, J MEMBR BIOL
   Matzen F., 2008, J PROTEOME RES, V7, P3535
   Michalke K, 2010, ANAL BIOCHEM, V401, P74, DOI 10.1016/j.ab.2010.02.017
   Mogensen JE, 2005, BIOCHEMISTRY-US, V44, P4533, DOI 10.1021/bi0475121
   Nagy JK, 2001, BIOCHEMISTRY-US, V40, P8971, DOI 10.1021/bi010202n
   Ni D, 2011, PROTEIN EXPRES PURIF, V80, P157, DOI 10.1016/j.pep.2011.08.004
   Nozawa A, 2007, PLANT CELL PHYSIOL, V48, P1815, DOI 10.1093/pcp/pcm150
   Otzen DE, 2013, ARCH BIOCHEM BIOPHYS, V531, P34, DOI 10.1016/j.abb.2012.10.008
   Pace C N, 1986, Methods Enzymol, V131, P266
   Park KH, 2011, NEW BIOTECHNOL, V28, P255, DOI 10.1016/j.nbt.2010.08.008
   Park KH, 2007, BIOCHEM J, V403, P183, DOI 10.1042/BJ20061473
   Park SH, 2012, BBA-BIOMEMBRANES, V1818, P584, DOI 10.1016/j.bbamem.2011.10.008
   Pautsch A, 1999, PROTEINS, V34, P167, DOI 10.1002/(SICI)1097-0134(19990201)34:2<167::AID-PROT2>3.0.CO;2-H
   PERVUSHIN KV, 1992, FEBS LETT, V308, P190, DOI 10.1016/0014-5793(92)81272-N
   PERVUSHIN KV, 1994, EUR J BIOCHEM, V219, P571, DOI 10.1111/j.1432-1033.1994.tb19973.x
   Plesniak LA, 2011, BBA-BIOMEMBRANES, V1808, P482, DOI 10.1016/j.bbamem.2010.09.017
   Pocanschi CL, 2006, J MOL BIOL, V355, P548, DOI 10.1016/j.jmb.2005.10.060
   Popot J.-L., UNPUB
   POPOT JL, 1990, ANNU REV BIOPHYS BIO, V19, P369
   POPOT JL, 1995, CURR OPIN BIOTECH, V6, P394, DOI 10.1016/0958-1669(95)80068-9
   Popot J.-L., 2015, ARCH BIOCH BIOPHYS, V564, P327
   POPOT JL, 1986, EMBO J, V5, P3039
   Popp B, 1997, BIOCHEMISTRY-US, V36, P2844, DOI 10.1021/bi961745d
   Prince SM, 2001, ACTA CRYSTALLOGR D, V57, P1164, DOI 10.1107/S0907444901009416
   Proverbio D, 2013, BBA-BIOMEMBRANES, V1828, P2182, DOI 10.1016/j.bbamem.2013.05.031
   PULLEN JK, 1995, GENE, V152, P85, DOI 10.1016/0378-1119(94)00706-X
   QI HL, 1994, INFECT IMMUN, V62, P2432
   RACKER E, 1977, J SUPRAMOL STR CELL, V6, P215, DOI 10.1002/jss.400060207
   Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377
   Rutten L, 2009, P NATL ACAD SCI USA, V106, P1960, DOI 10.1073/pnas.0813064106
   Salmannejad F, 2014, IRAN J PHARM RES, V13, P27
   Sansuk K, 2008, J PROTEOME RES, V7, P621, DOI 10.1021/pr7005654
   Schimmer S, 2010, PROTEIN PEPTIDE LETT, V17, P605
   Schroder-Tittmann K, 2010, BIOCHEMISTRY-US, V49, P7956, DOI 10.1021/bi101159s
   Schwarz D, 2008, PROTEOMICS, V8, P3933, DOI 10.1002/pmic.200800171
   Sevova ES, 2010, J BIOL CHEM, V285, P20580, DOI 10.1074/jbc.M110.127662
   Shadiac N, 2013, MOL MEMBR BIOL, V30, P229, DOI 10.3109/09687688.2012.762125
   Shimada Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1942, DOI 10.1271/bbb.68.1942
   Siritapetawee J, 2004, BIOCHEM J, V384, P609
   SONAR S, 1993, BIOCHEMISTRY-US, V32, P13777, DOI 10.1021/bi00213a004
   STOECKENIUS W, 1982, ANNU REV BIOCHEM, V51, P587, DOI 10.1146/annurev.bi.51.070182.003103
   Surrey T, 1996, BIOCHEMISTRY-US, V35, P2283, DOI 10.1021/bi951216u
   Tanabe M, 2009, ACTA CRYSTALLOGR F, V65, P996, DOI 10.1107/S1744309109032333
   Vandeputte-Rutten L, 2003, J BIOL CHEM, V278, P24825, DOI 10.1074/jbc.M302803200
   VANGELDER P, 1994, EUR J BIOCHEM, V226, P783
   Visudtiphole V, 2005, BIOCHEM J, V392, P375, DOI 10.1042/BJ20051257
   Wang XQ, 2013, PROTEIN PEPTIDE LETT, V20, P1272
   White SH, 2003, FEBS LETT, V555, P116, DOI 10.1016/S0014-5793(03)01153-0
   Wirth C, 2009, J MOL BIOL, V394, P718, DOI 10.1016/j.jmb.2009.09.054
   Yang CH, 2003, BIOCHEMISTRY-US, V42, P4527, DOI 10.1021/bi0273157
   Yang JP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-57
   Zoonens M., 2014, J MEMBR BIOL
NR 191
TC 4
Z9 4
U1 10
U2 36
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 314
EP 326
DI 10.1016/j.abb.2014.06.029
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600035
PM 24997361
ER

PT J
AU Kleinschmidt, JH
   Popot, JL
AF Kleinschmidt, Joerg H.
   Popot, Jean-Luc
TI Folding and stability of integral membrane proteins in amphipols
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Membrane protein; Folding; Amphipols; Kinetics; Thermodynamic stability;
   Outer membrane proteins; Bacteriorhodopsin; G protein-coupled receptors;
   A8-35
ID MOLECULAR-DYNAMICS SIMULATIONS; THERMALLY-INDUCED AGGREGATION; RESONANCE
   ENERGY-TRANSFER; A TRANSMEMBRANE DOMAIN; BETA-BARREL PROTEINS; CELL-FREE
   SYNTHESIS; OUTER-MEMBRANE; ESCHERICHIA-COLI; IN-VITRO; LIPID-BILAYERS
AB Amphipols (APols) are a family of amphipathic polymers designed to keep transmembrane proteins (TMPs) soluble in aqueous solutions in the absence of detergent. APols have proven remarkably efficient at (i) stabilizing TMPs, as compared to detergent solutions, and (ii) folding them from a denatured state to a native, functional one. The underlying physical chemical mechanisms are discussed. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kleinschmidt, Joerg H.] Univ Kassel, Inst Biol, Biophys Abt, D-34132 Kassel, Germany.
   [Kleinschmidt, Joerg H.] Ctr Interdisciplinary Nanostruct Sci & Technol CI, D-34132 Kassel, Germany.
   [Popot, Jean-Luc] Univ Paris 07, CNRS, Inst Biol Phys Chim FRC 550, Lab Phys Chim Mol Prot Membranaires,UMR 7099, F-75005 Paris, France.
RP Kleinschmidt, JH (reprint author), Univ Kassel, Inst Biol, Biophys Abt, FB 10, D-34132 Kassel, Germany.
EM jhk@uni-kassel.de; jean-luc.popot@ibpc.fr
FU Deutsche Forschungsgemeinschaft; University of Konstanz; University of
   Kassel; French Centre National de la Recherche Scientifique, University
   Paris-7 Denis Diderot; Human Frontier Scientific Program Organization;
   European Community; Agence Nationale pour la Recherche; US National
   Institutes of Health
FX Particular thanks are due to Jean-Louis Baneres, Laurent Catoire,
   Melanie Cocco, Tassadite Dahmane, Yann Gohon, Jason Perlmutter, Cosmin
   Pocanschi, and Manuela Zoonens for discussions and/or comments on the
   manuscript. Work performed in JHK's laboratory was funded by the
   Deutsche Forschungsgemeinschaft, the University of Konstanz and the
   University of Kassel. Work performed in JLP's laboratory was funded
   principally by the French Centre National de la Recherche Scientifique,
   University Paris-7 Denis Diderot, the Human Frontier Scientific Program
   Organization, the European Community, the Agence Nationale pour la
   Recherche and the US National Institutes of Health.
CR Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008
   Anbazhagan V, 2008, BIOCHEMISTRY-US, V47, P8414, DOI 10.1021/bi800750s
   Tribet C, 2009, LANGMUIR, V25, P12623, DOI 10.1021/la9018772
   Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881
   Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200
   Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214
   Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200
   Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P5006, DOI 10.1021/bi982465w
   Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983
   Huysmans GHM, 2007, J MOL BIOL, V373, P529, DOI 10.1016/j.jmb.2007.07.072
   Leyris JP, 2011, ANAL BIOCHEM, V408, P253, DOI 10.1016/j.ab.2010.09.030
   Puntervoll P, 2002, MICROBIOL-SGM, V148, P3395
   BROUILLETTE CG, 1989, PROTEINS, V5, P38, DOI 10.1002/prot.340050106
   Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105
   SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457
   Sanders CR, 2004, CHEMBIOCHEM, V5, P423, DOI 10.1002/cbic.200300830
   Booth PJ, 2012, CURR OPIN STRUC BIOL, V22, P469, DOI 10.1016/j.sbi.2012.03.008
   Pocanschi CL, 2006, BIOCHEMISTRY-US, V45, P13954, DOI 10.1021/bi0616706
   Zoonens M, 2007, BIOCHEMISTRY-US, V46, P10392, DOI 10.1021/bi7007596
   Sharma KS, 2008, LANGMUIR, V24, P13581, DOI 10.1021/la8023056
   Stanley AM, 2008, ARCH BIOCHEM BIOPHYS, V469, P46, DOI 10.1016/j.abb.2007.09.024
   Picard M, 2006, BIOCHEMISTRY-US, V45, P1861, DOI 10.1021/bi051954a
   Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X
   Champeil P, 2000, J BIOL CHEM, V275, P18623, DOI 10.1074/jbc.M000470200
   PAULSEN H, 1990, PLANTA, V181, P204, DOI 10.1007/BF02411539
   POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001
   Patel GJ, 2009, BIOCHEMISTRY-US, V48, P10235, DOI 10.1021/bi901403c
   Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104
   Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047
   Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219
   Baneres JL, 2011, TRENDS BIOTECHNOL, V29, P314, DOI 10.1016/j.tibtech.2011.03.002
   Pocanschi CL, 2013, EUR BIOPHYS J BIOPHY, V42, P103, DOI 10.1007/s00249-013-0887-z
   Huysmans GHM, 2012, J MOL BIOL, V416, P453, DOI 10.1016/j.jmb.2011.12.039
   Popot JL, 2003, CELL MOL LIFE SCI, V60, P1559, DOI 10.1007/s00018-003-3169-6
   Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101
   Kramer RA, 2000, EUR J BIOCHEM, V267, P885, DOI 10.1046/j.1432-1327.2000.01073.x
   Gorzelle BM, 1999, BIOCHEMISTRY-US, V38, P16373, DOI 10.1021/bi991292n
   Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068
   Qu J, 2007, J MOL BIOL, V374, P91, DOI 10.1016/j.jmb.2007.09.020
   Tsybovsky Y, 2013, STRUCTURE, V21, P854, DOI 10.1016/j.str.2013.03.001
   HUANG KS, 1981, J BIOL CHEM, V256, P3802
   DORNMAIR K, 1990, J BIOL CHEM, V265, P18907
   Caffrey M, 2011, BIOCHEM SOC T, V39, P725, DOI 10.1042/BST0390725
   Bazzacco P, 2012, BIOCHEMISTRY-US, V51, P1416, DOI 10.1021/bi201862v
   Kiefer H, 2003, BBA-BIOMEMBRANES, V1610, P57, DOI 10.1016/S0005-2736(02)00717-4
   Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823
   POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7
   Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993
   Harris NJ, 2012, BBA-BIOMEMBRANES, V1818, P1055, DOI 10.1016/j.bbamem.2011.11.006
   Tifrea DF, 2014, J IMMUNOL, V192, P5201, DOI 10.4049/jimmunol.1303392
   Sharma KS, 2012, LANGMUIR, V28, P4625, DOI 10.1021/la205026r
   Dahmane T, 2009, BIOCHEMISTRY-US, V48, P6516, DOI 10.1021/bi801729z
   Engelhardt H, 2007, J MEMBRANE BIOL, V216, P93, DOI 10.1007/s00232-007-9038-8
   Rogl H, 1998, FEBS LETT, V432, P21, DOI 10.1016/S0014-5793(98)00825-4
   Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003
   Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499
   Warschawski DE, 2011, BBA-BIOMEMBRANES, V1808, P1957, DOI 10.1016/j.bbamem.2011.03.016
   Giusti F, 2012, LANGMUIR, V28, P10372, DOI 10.1021/la300774d
   Moosavi-Movahedi AA, 2003, J BIOCHEM, V133, P93, DOI 10.1093/jb/mvg008
   Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2
   Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b
   Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822
   Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066
   Zhou YF, 2000, J BIOL CHEM, V275, P6975, DOI 10.1074/jbc.275.10.6975
   Miller JL, 2011, J MOL BIOL, V413, P628, DOI 10.1016/j.jmb.2011.08.057
   Damaghi M, 2011, ANGEW CHEM INT EDIT, V50, P7422, DOI 10.1002/anie.201101450
   Popot JL, 2010, ANNU REV BIOCHEM, V79, P737, DOI 10.1146/annurev.biochem.052208.114057
   Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324
   Buchanan SK, 1999, BIOCHEM SOC T, V27, P903
   Kleinschmidt JH, 2002, J MOL BIOL, V324, P319, DOI 10.1016/S0022-2836(02)01071-9
   Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5
   Stansfeld PJ, 2013, STRUCTURE, V21, P810, DOI 10.1016/j.str.2013.03.005
   Kevany BM, 2013, J BIOL CHEM, V288, P36272, DOI 10.1074/jbc.M113.520700
   Valiyaveetil FI, 2002, J AM CHEM SOC, V124, P9113, DOI 10.1021/ja0266722
   Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8
   Andersen KK, 2012, BIOCHEMISTRY-US, V51, P8371, DOI 10.1021/bi300974y
   Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7
   Arunmanee W, 2014, J MEMBRANE BIOL, V247, P949, DOI 10.1007/s00232-014-9640-5
   Basit H., 2012, CHEM COMMUN
   Bay DC, 2008, BIOPHYS J, V94, P457, DOI 10.1529/biophysj.107.115196
   Bazzacco P, 2009, BIOMACROMOLECULES, V10, P3317, DOI 10.1021/bm900938w
   Breyton C, 1997, J BIOL CHEM, V272, P21892, DOI 10.1074/jbc.272.35.21892
   Aponte-Santamaria C, 2012, P NATL ACAD SCI USA, V109, P9887, DOI 10.1073/pnas.1121054109
   Buchanan SK, 2012, COMPREHENSIVE BIOPHY, P139, DOI DOI 10.1016/B978-0-12-374920-8.00514-2
   Catoire LJ, 2010, J AM CHEM SOC, V132, P9049, DOI 10.1021/ja101868c
   Catoire LJ, 2009, J MAGN RESON, V197, P91, DOI 10.1016/j.jmr.2008.11.017
   Catoire LJ, 2010, EUR BIOPHYS J BIOPHY, V39, P623, DOI 10.1007/s00249-009-0513-2
   Catoire L.J., 2014, MEMBRANE PROTEIN PRO, P315
   Changeux Jean-Pierre, 2013, Drug Discov Today Technol, V10, pe223, DOI 10.1016/j.ddtec.2012.07.007
   Charvolin D, 2014, J MEMBRANE BIOL, V247, P981, DOI 10.1007/s00232-014-9694-4
   Charvolin D, 2009, P NATL ACAD SCI USA, V106, P405, DOI 10.1073/pnas.0807132106
   Cherezov V, 2011, CURR OPIN STRUC BIOL, V21, P559, DOI 10.1016/j.sbi.2011.06.007
   Dahmane T, 2011, BIOPOLYMERS, V95, P811, DOI 10.1002/bip.21683
   Dahmane T, 2013, EUR BIOPHYS J BIOPHY, V42, P85, DOI 10.1007/s00249-012-0839-z
   Dahmane T., 2007, PROTEINES MEMBRANAIR
   Damian M, 2007, FEBS LETT, V581, P1944, DOI 10.1016/febslet.2007.03.091
   Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449
   Debnath D, 2010, BIOPHYS CHEM, V148, P112, DOI 10.1016/j.bpc.2010.03.004
   Della Pia EA, 2014, J MEMBRANE BIOL, V247, P815, DOI 10.1007/s00232-014-9663-y
   Della Pia EA, 2014, ACS NANO, V8, P1844, DOI 10.1021/nn406252h
   Diab C, 2007, BBA-BIOMEMBRANES, V1768, P2737, DOI 10.1016/j.bbmem.2007.07.007
   Diab C, 2007, LANGMUIR, V23, P3025, DOI 10.1021/la062522j
   Elter S, 2014, J MEMBRANE BIOL, V247, P957, DOI 10.1007/s00232-014-9669-5
   Etzkorn M, 2014, J MEMBRANE BIOL, V247, P965, DOI 10.1007/s00232-014-9657-9
   Feher VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068934
   Feinstein HE, 2014, J MEMBRANE BIOL, V247, P1053, DOI 10.1007/s00232-014-9693-5
   Ferrandez Y, 2014, J MEMBRANE BIOL, V247, P925, DOI 10.1007/s00232-014-9707-3
   Gohon Y, 2006, LANGMUIR, V22, P1281, DOI 10.1021/la052243g
   Gohon Y, 2004, ANAL BIOCHEM, V334, P318, DOI 10.1016/j.ab.2004.07.033
   Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848
   HENNING U, 1978, EUR J BIOCHEM, V92, P491, DOI 10.1111/j.1432-1033.1978.tb12771.x
   Huynh KW, 2014, J MEMBRANE BIOL, V247, P843, DOI 10.1007/s00232-014-9684-6
   Ishchenko E., 2014, MEMBRANE PROTEIN PRO, P289
   JACKSON MB, 1978, BIOCHEMISTRY-US, V17, P911, DOI 10.1021/bi00598a026
   Kiefer H, 1996, BIOCHEMISTRY-US, V35, P16077, DOI 10.1021/bi9612069
   Kiefer H, 1999, BIOCHEM SOC T, V27, P908
   Kleinschmidt JH, 2011, J MOL BIOL, V407, P316, DOI 10.1016/j.jmb.2011.01.021
   Kleinschmidt JH, 2006, CHEM PHYS LIPIDS, V141, P30, DOI 10.1016/j.chemphyslip.2006.02.004
   Kleinschmidt JH, 1999, PROTEIN SCI, V8, P2065
   Kleinschmidt JH, 2003, CELL MOL LIFE SCI, V60, P1547, DOI 10.1007/s00018-003-3170-0
   KLUG CS, 1995, BIOCHEMISTRY-US, V34, P14230, DOI 10.1021/bi00043a030
   Koebnik R, 1996, EMBO J, V15, P3529
   Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j
   Le Bon C, 2014, J MEMBRANE BIOL, V247, P797, DOI 10.1007/s00232-014-9655-y
   Le Bon C., 2014, NUCL ACIDS RES
   Lee A.G., 2010, STRUCTURE BIOL MEMBR, P273
   Leney A.C., 2012, ANAL CHEM
   Liao MF, 2014, CURR OPIN STRUC BIOL, V27, P1, DOI 10.1016/j.sbi.2014.02.005
   LONDON E, 1982, J BIOL CHEM, V257, P7003
   Lorch M, 2004, J MOL BIOL, V344, P1109, DOI 10.1016/j.jmb.2004.09.090
   Lu P, 2014, NATURE
   Ma DW, 2012, CHEM LETT, V41, P1380, DOI 10.1246/cl.2012.1380
   Marie E, 2014, J MEMBRANE BIOL, V247, P861, DOI 10.1007/s00232-014-9679-3
   Martin N, 2014, BIOMACROMOLECULES, V15, P2952, DOI 10.1021/bm5005756
   Martinez KL, 2002, FEBS LETT, V528, P251, DOI 10.1016/S0014-5793(02)03306-9
   Maurya SR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01989
   Maurya SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087701
   McMorran L.M., 2014, ARCH BIOCH BIOPHYS
   MERINO JM, 1994, FEBS LETT, V343, P155, DOI 10.1016/0014-5793(94)80309-9
   Michalke K, 2010, ANAL BIOCHEM, V401, P74, DOI 10.1016/j.ab.2010.02.017
   Mogensen JE, 2005, PROTEIN SCI, V14, P2814, DOI 10.1110/ps.051628705
   Mogensen JE, 2005, BIOCHEMISTRY-US, V44, P4533, DOI 10.1021/bi0475121
   Moller J.V., 2010, METHOD MOL BIOL, V604, P119
   Nagy JK, 2001, FEBS LETT, V501, P115, DOI 10.1016/S0014-5793(01)02627-8
   Nagy JK, 2001, BIOCHEMISTRY-US, V40, P8971, DOI 10.1021/bi010202n
   OESTERHE.D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853
   OESTERHE.D, 1971, NATURE-NEW BIOL, V233, P149
   Otzen DE, 2013, ARCH BIOCHEM BIOPHYS, V531, P34, DOI 10.1016/j.abb.2012.10.008
   Park KH, 2011, NEW BIOTECHNOL, V28, P255, DOI 10.1016/j.nbt.2010.08.008
   Patel GJ, 2013, BIOCHEMISTRY-US, V52, P3974, DOI 10.1021/bi400103t
   Pautsch A, 1999, PROTEINS, V34, P167, DOI 10.1002/(SICI)1097-0134(19990201)34:2<167::AID-PROT2>3.0.CO;2-H
   Perlmutter JD, 2011, LANGMUIR, V27, P10523, DOI 10.1021/la202103v
   Planchard N, 2014, J MEMBRANE BIOL, V247, P827, DOI 10.1007/s00232-014-9654-z
   Pocanschi CL, 2006, BIOPHYS J, V91, pL75, DOI 10.1529/biophysj.106.091439
   Pocanschi CL, 2006, J MOL BIOL, V355, P548, DOI 10.1016/j.jmb.2005.10.060
   Polovinkin V, 2014, J MEMBRANE BIOL, V247, P997, DOI 10.1007/s00232-014-9700-x
   Perlmutter JD, 2014, J MEMBRANE BIOL, V247, P883, DOI 10.1007/s00232-014-9690-8
   Popot J.-L., 2015, ARCH BIOPHYS BIOCH, V564, P314
   SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x
   Stangl M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110970
   Surrey T, 1996, BIOCHEMISTRY-US, V35, P2283, DOI 10.1021/bi951216u
   Sverzhinsky A, 2014, J MEMBRANE BIOL, V247, P1005, DOI 10.1007/s00232-014-9678-4
   Tastan O, 2014, BBA-BIOENERGETICS, V1837, P656, DOI 10.1016/j.bbabio.2013.11.021
   Tehei M, 2014, J MEMBRANE BIOL, V247, P897, DOI 10.1007/s00232-014-9725-1
   Tifrea DF, 2011, VACCINE, V29, P4623, DOI 10.1016/j.vaccine.2011.04.065
   Vahedi-Faridi A, 2013, MICROSCOPY-JPN, V62, P95, DOI 10.1093/jmicro/dfs091
   Vandeputte-Rutten L, 2001, EMBO J, V20, P5033, DOI 10.1093/emboj/20.18.5033
   Zoonens M, 2014, J MEMBRANE BIOL, V247, P759, DOI 10.1007/s00232-014-9666-8
   Zoonens M, 2005, P NATL ACAD SCI USA, V102, P8893, DOI 10.1073/pnas.0503750102
   Zoonens M., 2014, MEMBRANE PROTEIN PRO, P173
NR 170
TC 4
Z9 4
U1 5
U2 24
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 327
EP 343
DI 10.1016/j.abb.2014.10.013
PG 17
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600036
PM 25449655
ER

PT J
AU Naito, Y
   Takagi, T
   Higashimura, Y
AF Naito, Yuji
   Takagi, Tomohisa
   Higashimura, Yasuki
TI Heme oxygenase-1 and anti-inflammatory M2 macrophages
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Heme oxygenase; Macrophage; Polarization; Inflammation
ID TRANSCRIPTION REPRESSOR BACH1; ACUTE LIVER-FAILURE;
   AGARO-OLIGOSACCHARIDES; OXIDATIVE STRESS; IN-VIVO; INTESTINAL
   INFLAMMATION; MYOCARDIAL PROTECTION; DEPENDENT PATHWAY; GENETIC
   ABLATION; CARBON-MONOXIDE
AB Heme oxygenase-1 (HO-1) catalyzes the first and rate-limiting enzymatic step of heme degradation and produces carbon monoxide, free iron, and biliverdin. HO-1, a stress-inducible protein, is induced by various oxidative and inflammatory signals. Consequently, HO-1 expression has been regarded as an adaptive cellular response against inflammatory response and oxidative injury. Although several transcriptional factors and signaling cascades are involved in HO-1 regulation, the two main pathways of Nrf2/Bach1 system and IL-10/HO-1 axis exist in monocyte/macrophage. Macrophages are broadly divisible into two groups: pro-inflammatory M1 macrophages and anti-inflammatory M2 macrophages. More recently, several novel macrophage subsets have been identified including Mhem. Mox, and M4 macrophages. Of these, M2 macrophages, Mhem, and Mox are HO-1 highly expressing macrophages. HO-1 has been recognized as having major immunomodulatory and anti-inflammatory properties, which have been demonstrated in HO-1 deficient mice and human cases of genetic HO-1 deficiency. However, the mechanism underlying the immunomodulatory actions of HO-1 remains poorly defined. This review specifically addresses macrophage polarization. The present current evidence indicates that HO-1 induction mediated by multiple pathways can drive the phenotypic shift to M2 macrophages and suggests that HO-1 induction in macrophages is a potential therapeutic approach to immunomodulation in widely diverse human diseases. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Naito, Yuji; Takagi, Tomohisa; Higashimura, Yasuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto 6028566, Japan.
   [Higashimura, Yasuki] Kyoto Prefectural Univ Med, Dept Food Factor Sci, Kyoto 6028566, Japan.
RP Naito, Y (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto 6028566, Japan.
EM ynaito@koto.kpu-m.ac.jp
FU Japan Society for the Promotion of Science [25460958, 25460959,
   25750050]; Japan Science and Technology Agency
FX This work was supported by Grants-in-Aid for Scientific Research to Yuji
   Naito (No. 25460958), Tomohisa Takagi (No. 25460959), and Yasuki
   Higashimura (No. 25750050) from the Japan Society for the Promotion of
   Science; an Adaptable and Seamless Technology Transfer Program through
   target-driven R&D to Yuji Naito from Japan Science and Technology
   Agency.
CR Alam J, 2003, AM J PHYSIOL-RENAL, V284, pF743, DOI 10.1152/ajprenal.00376.2002
   ALAM J, 1992, J BIOL CHEM, V267, P21894
   Choi AMK, 1996, AM J RESP CELL MOL, V15, P9
   Boyle JJ, 2009, AM J PATHOL, V174, P1097, DOI 10.2353/ajpath.2009.080431
   MAINES MD, 1988, FASEB J, V2, P2557
   Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104
   Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905
   Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004
   Hayashi S, 2004, GENE, V336, P241, DOI 10.1016/j.gene.2004.04.002
   Boyle JJ, 2012, CIRC RES, V110, P20, DOI 10.1161/CIRCRESAHA.111.247577
   David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053
   Jadhav A, 2013, J PHARMACOL EXP THER, V345, P239, DOI 10.1124/jpet.112.200808
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Ricchetti GA, 2004, J LEUKOCYTE BIOL, V76, P719, DOI 10.1189/jlb.0104046
   MAINES MD, 1986, J BIOL CHEM, V261, P411
   Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.0241-06
   Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920
   Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240
   Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200
   Ndisang JF, 2013, AM J HYPERTENS, V26, P1123, DOI 10.1093/ajh/hpt082
   Ogborne RM, 2004, BIOCHEM SOC T, V32, P1003
   TENHUNEN R, 1972, BIOCHEMISTRY-US, V11, P1716, DOI 10.1021/bi00759a029
   Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071
   Lee PJ, 1997, J BIOL CHEM, V272, P5375
   Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005
   Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644
   Kim SJ, 2013, FREE RADICAL BIO MED, V65, P997, DOI 10.1016/j.freeradbiomed.2013.08.178
   ALAM J, 1995, J BIOL CHEM, V270, P11977
   Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014
   Chiang N, 2013, J IMMUNOL, V190, P6378, DOI 10.4049/jimmunol.1202969
   Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835
   Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0
   Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014
   Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165
   Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107
   HAIN R, 1990, PLANT MOL BIOL, V15, P325, DOI 10.1007/BF00036918
   Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036
   Harusato A, 2013, INFLAMM BOWEL DIS, V19, P740, DOI 10.1097/MIB.0b013e3182802968
   Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163
   Immenschuh S, 2000, BIOCHEM PHARMACOL, V60, P1121, DOI 10.1016/S0006-2952(00)00443-3
   Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR
   Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6
   Alam J, 2003, CURR PHARM DESIGN, V9, P2499, DOI 10.2174/1381612033453730
   Higashimura Y, 2013, J GASTROENTEROL, V48, P897, DOI 10.1007/s00535-012-0719-4
   Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715
   Drechsler Y, 2006, J IMMUNOL, V177, P2592
   Onyiah JC, 2013, GASTROENTEROLOGY, V144, P789, DOI 10.1053/j.gastro.2012.12.025
   Fantuzzi G, 2008, J ALLERGY CLIN IMMUN, V121, P326, DOI 10.1016/j.jaci.2007.10.018
   Yokota T, 2000, BLOOD, V96, P1723
   Watari Y, 2008, HYPERTENS RES, V31, P783, DOI 10.1291/hypres.31.783
   TENHUNEN R, 1969, J BIOL CHEM, V244, P6388
   Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912
   Chen SF, 2005, P NATL ACAD SCI USA, V102, P7251, DOI 10.1073/pnas.050240710
   Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR
   Son Y, 2014, BIOFACTORS, V40, P138, DOI 10.1002/biof.1108
   Higashimura Y, 2014, J GASTROEN HEPATOL, V29, P310, DOI 10.1111/jgh.12373
   Jang DS, 1999, BIOCHEM PHARMACOL, V57, P705, DOI 10.1016/S0006-2952(98)00350-5
   Wiesel P, 2000, CIRCULATION, V102, P3015
   Lin PH, 2008, BBA-MOL CELL RES, V1783, P1826, DOI 10.1016/j.bbamcr.2008.05.008
   Junttila IS, 2008, J EXP MED, V205, P2595, DOI 10.1084/jem.20080452
   Wolf AM, 2006, J HEPATOL, V44, P537, DOI 10.1016/j.jhep.2005.08.019
   Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930
   CRUSE I, 1988, J BIOL CHEM, V263, P3348
   Cheung K, 2009, PHARM RES-DORD, V26, P224, DOI 10.1007/s11095-008-9734-9
   Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368
   Lang R, 2002, J IMMUNOL, V169, P2253
   Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919
   Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119
   Chen HM, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-31
   Chen HM, 2005, BBA-GEN SUBJECTS, V1722, P103, DOI 10.1016/j.bbagen.2004.11.016
   Dobashi K, 2001, CLIN EXP IMMUNOL, V124, P290, DOI 10.1046/j.1365-2249.2001.01535.x
   Enoki T, 2010, BIOSCI BIOTECH BIOCH, V74, P766, DOI 10.1271/bbb.90803
   Harusato A, 2009, J PHYSIOL PHARMACOL, V60, P149
   Harusato A, 2011, FREE RADICAL RES, V45, P717, DOI 10.3109/10715762.2011.574287
   Hull TD, 2014, ANTIOXID REDOX SIGN, V20, P1770, DOI 10.1089/ars.2013.5673
   Iida A, 2009, TOHOKU J EXP MED, V217, P223
   Kanno H, 2009, J NEUROTRAUM, V26, P31, DOI 10.1089/neu.2008.0667
   Kawashima A, 2002, HUM PATHOL, V33, P125, DOI 10.1053/hupa.2002.30217
   Kazlowski B, 2008, CARBOHYD RES, V343, P2443, DOI 10.1016/j.carres.2008.06.019
   Kobayashi M, 2010, J IMMUNOL, V185, P7174, DOI 10.4049/jimmunol.0903935
   Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427
   Mito S, 2008, HYPERTENSION, V51, P1570, DOI 10.1161/HYPERTENSIONAHA.107.102566
   Naidu S, 2008, J IMMUNOL, V181, P4113
   Radhakrishnan N, 2011, J PEDIAT HEMATOL ONC, V33, P74, DOI 10.1097/MPH.0b013e3181fd2aae
   Salinas M, 2004, FEBS LETT, V578, P90, DOI 10.1016/j.febslet.2004.10.077
   Takagi T, 2009, J PHARMACOL EXP THER, V331, P255, DOI 10.1124/jpet.109.152702
   Takagi T, 2008, J GASTROEN HEPATOL, V23, pS229, DOI 10.1111/j.1440-1746.2008.05443.x
   Tanimoto T, 2009, FREE RADICAL BIO MED, V46, P1119, DOI 10.1016/j.freeradbiomed.2009.01.017
   Tenhunen R, 1969, Trans Assoc Am Physicians, V82, P363
   Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607
   Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130
   Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x
   Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016
NR 96
TC 12
Z9 12
U1 6
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 15
PY 2014
VL 564
BP 83
EP 88
DI 10.1016/j.abb.2014.09.005
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AW3ZY
UT WOS:000346222600010
PM 25241054
ER

PT J
AU Mukhtar, H
   Setaluri, V
AF Mukhtar, Hasan
   Setaluri, Vijayasaradhi
TI Advances in melanocyte and melanoma biology
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
C1 [Mukhtar, Hasan; Setaluri, Vijayasaradhi] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA.
RP Mukhtar, H (reprint author), Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA.
EM hmukhtar@dermatology.wisc.edu; vsetaluri@dermatology.wisc.edu
NR 0
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 1
EP 3
DI 10.1016/j.abb.2014.09.003
PG 3
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000001
PM 25369182
ER

PT J
AU Abdel-Malek, ZA
   Swope, VB
   Starner, RJ
   Koikov, L
   Cassidy, P
   Leachman, S
AF Abdel-Malek, Zalfa A.
   Swope, Viki B.
   Starner, Renny J.
   Koikov, Leonid
   Cassidy, Pamela
   Leachman, Sancy
TI Melanocortins and the melanocortin 1 receptor, moving translationally
   towards melanoma prevention
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Melanocortins; Melanocortin 1 receptor; Human melanocytes; DNA damage;
   DNA repair; Ultraviolet radiation; Melanoma; Melanocortin analogs
ID CULTURED HUMAN MELANOCYTES; STIMULATING-HORMONE-RECEPTOR; INDUCED
   DNA-DAMAGE; AGOUTI SIGNALING PROTEIN; NONMELANOMA SKIN-CANCER; MINIMAL
   ACTIVE SEQUENCE; RED HAIR; ALPHA-MELANOTROPIN; ULTRAVIOLET-RADIATION;
   OXIDATIVE STRESS
AB Beginning in the last decade of the twentieth century, the fields of pigment cell research and melanoma have witnessed major breakthroughs in the understanding of the role of melanocortins in human pigmentation and the DNA damage response of human melanocytes to solar ultraviolet radiation (UV). This began with the cloning of the melanocortin 1 receptor (MC1R) gene from human melanocytes and the demonstration that the encoded receptor is functional. Subsequently, population studies found that the MC1R gene is highly polymorphic, and that some of its variants are associated with red hair phenotype, fair skin and poor tanning ability. Using human melanocytes cultured from donors with different MC1R genotypes revealed that the alleles associated with red hair color encode for a non-functional receptor. Epidemiological studies linked the MC1R red hair color variants to increased melanoma risk. Investigating the impact of different MC1R variants on the response of human melanocytes to UV led to the important discovery that the MC1R signaling activates antioxidant, DNA repair and survival pathways, in addition to stimulation of eumelanin synthesis. These effects of MC1R were absent in melanocytes expressing 2 MC1R red hair color variants that result in loss of function of the receptor. The importance of the MC1R in reducing UV-induced genotoxicity in melanocytes led us to design small peptide analogs of the physiological MC1R agonist alpha-melanocortin (alpha-melanocyte stimulating hormone; alpha-MSH) for the goal of utilizing them for melanoma chemoprevention. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Abdel-Malek, Zalfa A.; Swope, Viki B.; Starner, Renny J.; Koikov, Leonid] Univ Cincinnati, Dept Dermatol, Cincinnati, OH 45267 USA.
   [Cassidy, Pamela; Leachman, Sancy] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97239 USA.
RP Abdel-Malek, ZA (reprint author), Univ Cincinnati, Dept Dermatol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.
EM abdelmza@uc.edu
CR Abdel-Malek ZA, 2001, J CELL SCI, V114, P1019
   Abdel Malek Z A, 1985, Cancer Res, V45, P4735
   Abdel-Malek ZA, 2006, FASEB J, V20, P1561, DOI 10.1096/fj.05-5655fje
   Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711
   ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789
   CASTRUCCI AML, 1989, GEN COMP ENDOCR, V73, P157, DOI 10.1016/0016-6480(89)90066-X
   Smith AG, 2008, J BIOL CHEM, V283, P12564, DOI 10.1074/jbc.M800480200
   Abdel-Malek ZA, 2001, CELL MOL LIFE SCI, V58, P434, DOI 10.1007/PL00000868
   Suzuki I, 1997, J INVEST DERMATOL, V108, P838, DOI 10.1111/1523-1747.ep12292572
   D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098
   SCHAUER E, 1994, J CLIN INVEST, V93, P2258, DOI 10.1172/JCI117224
   LERNER AB, 1961, NATURE, V189, P176, DOI 10.1038/189176a0
   Abdel-Malek ZA, 2009, PIGM CELL MELANOMA R, V22, P635, DOI 10.1111/j.1755-148X.2009.00598.x
   Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500
   IMOKAWA G, 1992, J BIOL CHEM, V267, P24675
   Hauser JE, 2006, PIGM CELL RES, V19, P303, DOI 10.1111/j.1600-0749.2006.00315.x
   Slominski A, 2000, PHYSIOL REV, V80, P979
   Hennessy A, 2005, PIGM CELL RES, V18, P220, DOI 10.1111/j.1600-0749.2005.00233.x
   KOBAYASHI T, 1995, J CELL SCI, V108, P2301
   MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670
   Voisey J, 2001, PIGM CELL RES, V14, P264, DOI 10.1034/j.1600-0749.2001.140406.x
   BUSTAMANTE J, 1993, PIGM CELL RES, V6, P348, DOI 10.1111/j.1600-0749.1993.tb00612.x
   Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891
   Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x
   Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341
   Wakamatsu K, 1997, PIGM CELL RES, V10, P288, DOI 10.1111/j.1600-0749.1997.tb00688.x
   Song XZ, 2009, PIGM CELL MELANOMA R, V22, P809, DOI 10.1111/j.1755-148X.2009.00615.x
   Sanchez-Laorden BL, 2009, J CELL PHYSIOL, V220, P640, DOI 10.1002/jcp.21804
   HUNT G, 1995, PIGM CELL RES, V8, P202, DOI 10.1111/j.1600-0749.1995.tb00664.x
   RANSON M, 1988, J INVEST DERMATOL, V91, P593, DOI 10.1111/1523-1747.ep12477126
   Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624
   ABDELMALEK Z, 1992, J CELL PHYSIOL, V150, P416, DOI 10.1002/jcp.1041500226
   MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454
   Kadekaro AL, 2005, CANCER RES, V65, P4292, DOI 10.1158/0008-5472.CAN-04-4535
   Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200
   Rana BK, 1999, GENETICS, V151, P1547
   BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4
   Beaumont KA, 2005, HUM MOL GENET, V14, P2145, DOI 10.1093/hmg/ddi219
   HRUBY VJ, 1987, J MED CHEM, V30, P2126, DOI 10.1021/jm00394a033
   Wong SS, 2012, J INVEST DERMATOL, V132, P1452, DOI 10.1038/jid.2011.473
   Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8
   Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509
   Kauser S, 2003, J INVEST DERMATOL, V120, P1073, DOI 10.1046/j.1523-1747.2003.12242.x
   Xu XL, 1996, NAT GENET, V14, P384, DOI 10.1038/ng1296-384
   LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0
   KAIDBEY KH, 1979, J AM ACAD DERMATOL, V1, P249, DOI 10.1016/S0190-9622(79)70018-1
   Kadekaro AL, 2012, MOL CANCER RES, V10, P778, DOI 10.1158/1541-7786.MCR-11-0436
   Kadekaro AL, 2010, FASEB J, V24, P3850, DOI 10.1096/fj.10-158485
   Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863
   SAWYER TK, 1980, P NATL ACAD SCI-BIOL, V77, P5754, DOI 10.1073/pnas.77.10.5754
   Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200
   VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328
   Rousseau K, 2007, FASEB J, V21, P1844, DOI 10.1096/fj.06-7398com
   Wakamatsu K, 2006, PIGM CELL RES, V19, P154, DOI 10.1111/j.1600-0749.2006.00293.x
   Bigliardi-Qi M, 2004, DERMATOLOGY, V209, P183, DOI 10.1159/000079887
   Eller MS, 2008, PHOTOCHEM PHOTOBIOL, V84, P339, DOI 10.1111/j.1751-1097.2007.00264.x
   Cotter MA, 2007, CLIN CANCER RES, V13, P5952, DOI 10.1158/1078-0432.CCR-07-1187
   Jenkins NC, 2011, ONCOGENE, V30, P265, DOI 10.1038/onc.2010.419
   ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8
   BLANCHARD SG, 1995, BIOCHEMISTRY-US, V34, P10406, DOI 10.1021/bi00033a012
   Suzuki I, 1996, ENDOCRINOLOGY, V137, P1627, DOI 10.1210/en.137.5.1627
   Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166
   Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880
   Barnetson RS, 2006, J INVEST DERMATOL, V126, P1869, DOI 10.1038/sj.jid.5700317
   Bohm M, 2005, J BIOL CHEM, V280, P5795, DOI 10.1074/jbc.M406334200
   Box NF, 2001, AM J HUM GENET, V69, P765, DOI 10.1086/323412
   CHEDEKEL MR, 1977, PHOTOCHEM PHOTOBIOL, V26, P651, DOI 10.1111/j.1751-1097.1977.tb07546.x
   Chen HQ, 2006, PEPTIDES, V27, P931, DOI 10.1016/j.peptides.2005.08.018
   Demenais F, 2010, J NATL CANCER I, V102, P1568, DOI 10.1093/jnci/djq363
   Denat L., 2014, J INVEST DERMATOL
   DONATIEN PD, 1992, ARCH DERMATOL RES, V284, P424, DOI 10.1007/BF00372074
   EISINGER M, 1982, P NATL ACAD SCI-BIOL, V79, P2018, DOI 10.1073/pnas.79.6.2018
   Fabrikant J, 2013, J DRUGS DERMATOL, V12, P775
   Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024
   Gerstenblith MR, 2007, HUM MUTAT, V28, P495, DOI 10.1002/humu.20476
   Geschwind I.I., 1972, Recent Progress Hormone Res, V28, P91
   Haider RM, 1995, CANCER, V75, P667
   HALABAN R, 1993, ANN NY ACAD SCI, V680, P290, DOI 10.1111/j.1749-6632.1993.tb19691.x
   Han J., 2006, INT J CANC
   HUNT G, 1995, J INVEST DERMATOL, V104, P83, DOI 10.1111/1523-1747.ep12613565
   HUNT G, 1994, PIGM CELL RES, V7, P217, DOI 10.1111/j.1600-0749.1994.tb00052.x
   Hyter S, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12063
   Ito S., 1993, PIGMENTATION PIGMENT, P33
   Jagirdar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078075
   Jones BH, 1996, AM J PHYSIOL-ENDOC M, V270, pE192
   Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076
   Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x
   Koppula SV, 1997, HUM MUTAT, V9, P30, DOI 10.1002/(SICI)1098-1004(1997)9:1<30::AID-HUMU5>3.0.CO;2-T
   KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018
   KWON HY, 1994, P NATL ACAD SCI USA, V91, P9760, DOI 10.1073/pnas.91.21.9760
   LERNER AB, 1964, NEW ENGL J MED, V270, P539, DOI 10.1056/NEJM196403122701101
   LEVINE N, 1991, JAMA-J AM MED ASSOC, V266, P2730, DOI 10.1001/jama.266.19.2730
   Lipton JM, 1999, ANN NY ACAD SCI, V885, P173
   Luger TA, 1998, ANN NY ACAD SCI, V840, P381, DOI 10.1111/j.1749-6632.1998.tb09577.x
   MARCINKIEWICZ M, 1993, P NATL ACAD SCI USA, V90, P4922, DOI 10.1073/pnas.90.11.4922
   MARWAN MM, 1985, MOL CELL ENDOCRINOL, V41, P171, DOI 10.1016/0303-7207(85)90020-6
   Menon I.A., 1985, BIOL MOL CLIN ASPECT, P77
   Novellino L, 1999, CHEM RES TOXICOL, V12, P985, DOI 10.1021/tx990020i
   Ozen S, 2012, GENET COUNSEL, V23, P493
   Pathak MA, 1980, PHENOTYPIC EXPRESSIO, P655
   PEARSON OP, 1977, COMP BIOCHEM PHYS A, V58, P353
   Peters EMJ, 2000, J INVEST DERMATOL, V114, P430, DOI 10.1046/j.1523-1747.2000.00913.x
   Ringholm A, 2004, J INVEST DERMATOL, V123, P917, DOI 10.1111/j.0022-202X.2004.23444.x
   Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544
   Sanchez-Mas J, 2005, MOL ENDOCRINOL, V19, P1035, DOI 10.1210/me.2004-0227
   Sarkar Soumya Brata, 2012, Contemp Clin Dent, V3, P484, DOI 10.4103/0976-237X.107450
   Sarkar-Agrawal P, 2004, J NATL CANCER I, V96, P1790, DOI 10.1093/jnci/djh307
   Sawyer T K, 1988, Synapse, V2, P289
   SAWYER TK, 1983, AM ZOOL, V23, P529
   Scott MC, 2002, J CELL SCI, V115, P2349
   SEIDAH NG, 1993, ANN NY ACAD SCI, V680, P135, DOI 10.1111/j.1749-6632.1993.tb19680.x
   Sherbrooke Wade C., 1997, Amphibia-Reptilia, V18, P155, DOI 10.1163/156853897X00044
   Sherbrooke W.C., 1988, MELANOTROPIC PEPTIDE, P175
   Silvers WK, 1979, COAT COLORS MICE MOD
   Smith R, 1998, J INVEST DERMATOL, V111, P119, DOI 10.1046/j.1523-1747.1998.00252.x
   Stratigos AJ, 2006, J INVEST DERMATOL, V126, P1842, DOI 10.1038/sj.jid.5700292
   Supp DM, 2004, BURNS, V30, P643, DOI 10.1016/j.burns.2004.03.012
   Suzuki I, 2002, J INVEST DERMATOL, V118, P73, DOI 10.1046/j.1523-1747.2002.01647.x
   Swope V., 2014, PIGMENT CELL MELANOM
   SWOPE VB, 1995, EXP CELL RES, V217, P453, DOI 10.1006/excr.1995.1109
   Swope V.B., 2012, J INVEST DERMATOL
   Tada A, 1998, CELL GROWTH DIFFER, V9, P575
   Tadokoro T., 2003, FASEB J
   TAMATE HB, 1984, SCIENCE, V224, P1241, DOI 10.1126/science.6328651
   Thody AJ, 1998, PIGM CELL RES, V11, P265, DOI 10.1111/j.1600-0749.1998.tb00735.x
   Wei QY, 2003, J NATL CANCER I, V95, P308
   WILSON JF, 1979, GEN COMP ENDOCR, V38, P172, DOI 10.1016/0016-6480(79)90204-1
   YEN TT, 1994, FASEB J, V8, P479
   Zanello SB, 1999, ANN NY ACAD SCI, V885, P85
NR 129
TC 4
Z9 4
U1 5
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 4
EP 12
DI 10.1016/j.abb.2014.07.002
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000002
PM 25017567
ER

PT J
AU Liu, JL
   Fukunaga-Kalabis, M
   Li, L
   Herlyn, M
AF Liu, Jianglan
   Fukunaga-Kalabis, Mizuho
   Li, Ling
   Herlyn, Meenhard
TI Developmental pathways activated in melanocytes and melanoma
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Melanocytes; Melanoma; Signaling pathways; Notch; Wnt; Beta-catenin;
   Endothelin; Sox9; Sox10; MITF
ID ENDOTHELIN-B RECEPTOR; NEURAL CREST DEVELOPMENT; BETA-CATENIN
   EXPRESSION; MALIGNANT-MELANOMA; TRANSCRIPTION FACTOR; CELL-FATE;
   METASTATIC MELANOMA; CUTANEOUS MELANOMA; SIGNALING PATHWAY; TUMOR
   PROGRESSION
AB Cutaneous malignant melanomas originate primarily within epidermal melanocytic cells. Melanoma cells share many characteristics with melanocyte precursors, suggesting that melanoma cells utilize the developmental programs of their normal counterpart for their own progression. The pigmentation system provides an advantageous model to assess survival pathway interactions in the melanocytic lineage, as genetic alterations controlling melanocyte development can be easily detectable by coat color phenotype that do not affect the viability of an animal. By integrating combinatorial gene knockout approaches, cell-based assays and immunohistochemical observations, recent studies have illustrated several genes and pathways that play important roles both in melanocyte specification and maintenance and in melanoma formation and progression. We are reviewing those genes and pathways to understand the connection between normal and cancerous development and to reveal therapeutic potential of targeting developmental pathways for melanoma therapy. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Liu, Jianglan; Fukunaga-Kalabis, Mizuho; Li, Ling; Herlyn, Meenhard] Wistar Inst Anat & Biol, Melanoma Res Ctr, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA.
RP Herlyn, M (reprint author), Wistar Inst Anat & Biol, Melanoma Res Ctr, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.
EM herlynm@Wistar.org
FU NIH [CA 025874-33]
FX These studies were funded by NIH Grants CA 025874-33.
CR Ikeya M, 1997, NATURE, V389, P966
   Maelandsmo GM, 2003, CLIN CANCER RES, V9, P3383
   Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758
   Christensen C, 2005, ONCOGENE, V24, P6292, DOI 10.1038/sj.onc.1208758
   Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054
   Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x
   Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200511124
   Bandarchi B, 2013, J CLIN PATHOL, V66, P644, DOI 10.1136/jclinpath-2013-201471
   Pinnix CC, 2007, PIGM CELL RES, V20, P458, DOI 10.1111/j.1600-0749.2007.00410.x
   Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200
   Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001
   Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767
   Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664
   Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907
   SAKURAI T, 1992, TRENDS PHARMACOL SCI, V13, P103
   Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432
   Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050
   Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049
   Spinella F, 2007, CANCER RES, V67, P1725, DOI 10.1158/0008-5472.CAN-06-2006
   Howard JD, 2013, PIGM CELL MELANOMA R, V26, P697, DOI 10.1111/pcmr.12131
   Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115
   Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011
   Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200
   Kumano K, 2008, PIGM CELL MELANOMA R, V21, P70, DOI 10.1111/j.1755-148X.2007.00423.x
   Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3
   Imokawa G, 1996, BIOCHEM J, V314, P305
   Graf SA, 2014, J INVEST DERMATOL, V134, P2212, DOI 10.1038/jid.2014.128
   Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831
   Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092
   Guth SIE, 2008, CELL MOL LIFE SCI, V65, P3000, DOI 10.1007/s00018-008-8138-7
   Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/job.200303158
   You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227
   Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106
   Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000
   Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107
   Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620
   Hendrix MJC, 2002, CANCER RES, V62, P665
   Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157
   Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030
   Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4
   HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5
   Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589
   Cronin JC, 2013, CANCER RES, V73, P5709, DOI 10.1158/0008-5472.CAN-12-4620
   Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121
   Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731
   Cui H, 2013, CANCER RES, V73, P3451, DOI 10.1158/0008-5472.CAN-12-3902
   Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104
   Lister JA, 1999, DEVELOPMENT, V126, P3757
   BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3
   Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6
   Charbel C, 2014, J INVEST DERMATOL, V134, P1067, DOI 10.1038/jid.2013.429
   Hardy KM, 2010, CANCER RES, V70, P10340, DOI 10.1158/0008-5472.CAN-10-0705
   Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X
   Cichorek M, 2013, POSTEP DERM ALERGOL, V30, P30, DOI 10.5114/pdia.2013.33376
   Asnaghi L, 2012, CLIN CANCER RES, V18, P654, DOI 10.1158/1078-0432.CCR-11-1406
   Aubin-Houzelstein G, 2008, J INVEST DERMATOL, V128, P2686, DOI 10.1038/jid.2008.120
   Bagnato A, 2004, CANCER RES, V64, P1436, DOI 10.1158/0008-5472.CAN-03-2344
   Bakos RM, 2010, EXP DERMATOL, V19, pE89, DOI 10.1111/j.1600-0625.2009.00991.x
   Bedogni B, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12194
   Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274
   BOHM M, 1995, CELL GROWTH DIFFER, V6, P291
   Cook AL, 2005, EXP CELL RES, V308, P222, DOI 10.1016/j.yexcr.2005.04.019
   Da Forno P.D., 2008, CLIN CANCER RES, V2008, P5825
   Demunter A, 2001, VIRCHOWS ARCH, V438, P485, DOI 10.1007/s004280000362
   Dupin E, 2000, P NATL ACAD SCI USA, V97, P7882, DOI 10.1073/pnas.97.14.7882
   Grossmann AH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003398
   Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039
   HERLYN M, 1985, CANCER RES, V45, P5670
   Hornyak TJ, 2001, MECH DEVELOP, V101, P47, DOI 10.1016/S0925-4773(00)00569-4
   IOZZO RV, 1995, CANCER RES, V55, P3495
   Kellerer S, 2006, DEVELOPMENT, V133, P2875, DOI 10.1242/dev.02477
   Lahav R, 1998, P NATL ACAD SCI USA, V95, P14214, DOI 10.1073/pnas.95.24.14214
   Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X
   Li G, 2002, CRIT REV ORAL BIOL M, V13, P62
   Lim X, 2013, COLD SPRING HARB PER, V5
   Niederleithner H, 2012, J INVEST DERMATOL, V132, P2235, DOI 10.1038/jid.2012.138
   Opdecamp K, 1998, BIOCHEM CELL BIOL, V76, P1093, DOI 10.1139/bcb-76-6-1093
   Passeron T., 2009, J CLIN INVEST, V2009, P954
   Pham K, 2003, J CLIN PATHOL-MOL PA, V56, P280
   Rao G.N., 2010, AM J DERMATOPATH, V32, P262
   Reid K, 1996, DEVELOPMENT, V122, P3911
   Shakhova O., 2012, NAT CELL BIOL, V14
   Shin MK, 1999, NATURE, V402, P496
   Tang L, 2008, J CUTAN MED SURG, V12, P64, DOI 10.2310/7750.2008.06164
   Webster M.R., 2013, SCI SIGNAL, V6
NR 85
TC 3
Z9 3
U1 8
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 13
EP 21
DI 10.1016/j.abb.2014.07.023
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000003
PM 25109840
ER

PT J
AU Rodriguez, CI
   Setaluri, V
AF Rodriguez, Carlos Ivan
   Setaluri, Vijayasaradhi
TI Cyclic AMP (cAMP) signaling in melanocytes and melanoma
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Melanocortin-1 receptor (MC1R); Adenylate cyclases (ADCYs);
   Phosphodiesterases (PDEs); cAMP Responsive Element Binding Protein
   (CREB); MAPK signaling; Drug resistance
ID SOLUBLE ADENYLYL-CYCLASE; PROTEIN-COUPLED RECEPTORS; MELANOCORTIN 1
   RECEPTOR; MALIGNANT-MELANOMA; RED HAIR; NUCLEOTIDE PHOSPHODIESTERASES;
   TRANSCRIPTION FACTOR; HORMONE RESISTANCE; MUTATIONS; CELLS
AB G-protein coupled receptors (GPCRs), which include melanocortin-1 receptor (MC1R), play a crucial role in melanocytes development, proliferation and differentiation. Activation of the MC1R by the cc-melanocyte stimulating hormone (alpha-MSH) leads to the activation of the cAMP signaling pathway that is mainly associated with differentiation and pigment production. Some MC1R polymorphisms produce cAMP signaling impairment and pigmentary phenotypes such as the red head color and fair skin phenotype (RHC) that is usually associated with higher risk for melanoma development. Despite its importance in melanocyte biology, the role of cAMP signaling cutaneous melanoma is not well understood. Melanoma is primarily driven by mutations in the components of mitogen-activated protein kinases (MAPK) pathway. Increasing evidence, however, now suggests that cAMP signaling also plays an important role in melanoma even though genetic alterations in components of this pathway are note commonly found in melanoma. Here we review these new roles for cAMP in melanoma including its contribution to the notorious treatment resistance of melanoma. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Setaluri, Vijayasaradhi] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53706 USA.
   Univ Wisconsin, Sch Med & Publ Hlth, Mol & Environm Toxicol Grad Program, Madison, WI 53706 USA.
RP Setaluri, V (reprint author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, 1300 Univ Ave,B-25, Madison, WI 53706 USA.
EM vsetaluri@dermatology.wisc.edu
FU Science and Medicine Graduate Research Scholars (SciMed GRS)
FX Science and Medicine Graduate Research Scholars (SciMed GRS).
CR Abdel-Malek ZA, 2010, ADV EXP MED BIOL, V681, P126, DOI 10.1007/978-1-4419-6354-3_10
   Abdel-Malek ZA, 2006, FASEB J, V20, P1561, DOI 10.1096/fj.05-5655fje
   Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711
   ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789
   Ong S, 2012, AUSTRALAS J DERMATOL, V53, P301, DOI 10.1111/j.1440-0960.2012.00915.x
   Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200
   Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827
   Linglart A, 2011, NEW ENGL J MED, V364, P2218, DOI 10.1056/NEJMoa1012717
   Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003
   Linglart A, 2012, J CLIN ENDOCR METAB, V97, pE2328, DOI 10.1210/jc.2012-2326
   D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098
   Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843
   Box NF, 1997, HUM MOL GENET, V6, P1891, DOI 10.1093/hmg/6.11.1891
   Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069
   Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358
   Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688
   Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935
   Herraiz C, 2011, MOL ENDOCRINOL, V25, P138, DOI 10.1210/me.2010-0217
   Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95
   Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908
   Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836
   Lin DC, 2013, P NATL ACAD SCI USA, V110, P6109, DOI 10.1073/pnas.1218206110
   Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x
   Cardones AR, 2009, ARCH DERMATOL, V145, P441, DOI 10.1001/archdermatol.2008.623
   Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002
   Salama AKS, 2013, CLIN CANCER RES, V19, P4326, DOI 10.1158/1078-0432.CCR-13-0779
   Dessauer CW, 1997, J BIOL CHEM, V272, P22272, DOI 10.1074/jbc.272.35.22272
   Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227
   Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024
   Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443
   Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620
   Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149
   Kirschner LS, 2009, ENDOCR-RELAT CANCER, V16, P773, DOI 10.1677/ERC-09-0068
   Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008
   Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112
   Kadekaro AL, 2010, FASEB J, V24, P3850, DOI 10.1096/fj.10-158485
   Su F, 2012, CANCER RES, V72, P969, DOI 10.1158/0008-5472.CAN-11-1875
   VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328
   Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038
   GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5
   Hemesath TJ, 1998, NATURE, V391, P298
   Rosenkranz AA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1228, DOI 10.1134/S0006297913110035
   Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228
   Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498
   Tesmer JJG, 2000, BIOCHEMISTRY-US, V39, P14464, DOI 10.1021/bi0015562
   Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359
   BEAVO JA, 1995, PHYSIOL REV, V75, P725
   BEEBE SJ, 1993, CELL GROWTH DIFFER, V4, P1005
   Box NF, 2001, J INVEST DERMATOL, V116, P224, DOI 10.1046/j.1523-1747.2001.01224.x
   Carlson JA, 2007, DERMATOL CLIN, V25, P541, DOI 10.1016/j.det.2007.06.005
   Cho DH, 2000, EXP MOL MED, V32, P235
   DeSantis C E, 2014, CA CANC J CLIN
   Dumaz N, 2011, SMALL GTPASES, V2, P289
   Flaherty KT, 2012, ANNU REV MED, V63, P171, DOI 10.1146/annurev-med-050410-105655
   Halaban R, 2000, PIGM CELL RES, V13, P4, DOI 10.1034/j.1600-0749.2000.130103.x
   Hiramoto K., 2014, CELL SIGNAL
   Hu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.441
   Jang S., 2013, CLIN PHARM THER
   Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998
   JOHNSON RA, 1989, MOL PHARMACOL, V35, P681
   Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x
   Khaled M, 2010, GENE DEV, V24, P2276, DOI 10.1101/gad.1937710
   Krayem M, 2014, EUR J CANCER, V50, P1310, DOI 10.1016/j.ejca.2014.01.021
   Li Y., 2013, J BIOL CHEM
   Lin Hsi-Hsien, 2012, Chang Gung Med J, V35, P15
   Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003
   Lyons J, 2013, P NATL ACAD SCI USA, V110, P13845, DOI 10.1073/pnas.1201917110
   Magro CM, 2012, ARCH PATHOL LAB MED, V136, P1558, DOI 10.5858/arpa.2011-0617-OA
   Magro CM, 2012, ARCH DERMATOL, V148, P335, DOI 10.1001/archdermatol.2011.338
   Marquette A, 2011, NAT STRUCT MOL BIOL, V18, P584, DOI 10.1038/nsmb.2022
   Melnikova VO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012452
   Morita H, 2013, ONCOL REP, V29, P1275, DOI 10.3892/or.2013.2260
   Narita M, 2007, ONCOL REP, V17, P1133
   Paurobally D, 2011, BRIT J DERMATOL, V164, P1403, DOI 10.1111/j.1365-2133.2011.10273.x
   Reid C, 2013, Ir Med J, V106, P148
   Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935
   Scott MC, 2002, J CELL SCI, V115, P2349
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Tada A, 2002, J INVEST DERMATOL, V118, P316, DOI 10.1046/j.0022-202x.2001.01694.x
   Vultur Adina, 2013, Cancer Cell, V23, P706, DOI 10.1016/j.ccr.2013.05.001
   Weeraratna AT, 2005, CANCER METAST REV, V24, P237, DOI 10.1007/s10555-005-1574-z
   WOLFF J, 1981, ADV CYCL NUCL RES<D>, V14, P199
   Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119
NR 83
TC 3
Z9 3
U1 5
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 22
EP 27
DI 10.1016/j.abb.2014.07.003
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000004
PM 25017568
ER

PT J
AU Hsiao, JJ
   Fisher, DE
AF Hsiao, Jennifer J.
   Fisher, David E.
TI The roles of microphthalmia-associated transcription factor and
   pigmentation in melanoma
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE MITF; Melanoma; Melanocyte; Pigmentation
ID CELL-CYCLE ARREST; BRAF MUTATIONS; METASTATIC MELANOMA;
   MALIGNANT-MELANOMA; LINEAGE SURVIVAL; FACTOR MITF; B-RAF; MELANOCYTES;
   TARGET; EXPRESSION
AB MITF and pigmentation play important roles in both normal melanocyte and transformed melanoma cell biology. MITF is regulated by many pathways and it also regulates many targets, some of which are still being discovered and functionally validated. MITF is involved in a wide range of processes in melanocytes, including pigment synthesis and lineage survival. Pigmentation itself plays an important role as the interface between genetic and environmental factors that contribute to melanoma. (C) 2014 Elsevier Inc. All rights reserved.
C1 Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Fisher, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr,Dept Dermatol, Charlestown, MA 02129 USA.
RP Fisher, DE (reprint author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr,Dept Dermatol, Bldg 149,13th St, Charlestown, MA 02129 USA.
EM dfisher3@partners.org
FU NIH [P01 CA163222, R01 AR043369, R01CA150226]; Dr. Miriam and Sheldon G.
   Adelson Medical Research Foundation
FX We thank Marcelo Pereira da Silva for his generous help with rendering
   the figures. We also thank Dr. Roydon Price and Dr. Katey Robinson for
   insightful comments on the manuscript. This work was supported by grants
   to DEF from NIH (P01 CA163222; R01 AR043369; R01CA150226) and the Dr.
   Miriam and Sheldon G. Adelson Medical Research Foundation.
CR Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054
   Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406
   Dorsky RI, 2000, GENE DEV, V14, P158
   Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231
   D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098
   Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200
   Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658
   Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664
   Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539
   Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292
   Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622
   Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491
   Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x
   Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003
   Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049
   McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200
   Loercher AE, 2005, J CELL BIOL, V168, P35
   Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011
   Samokhvalov A, 2005, PHOTOCHEM PHOTOBIOL, V81, P145, DOI 10.1562/2004-07-23-RC-245.1
   Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433
   Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95
   Levy C, 2010, CELL, V141, P994, DOI 10.1016/j.cell.2010.05.004
   Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269
   Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183
   Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031
   Shoag J, 2013, MOL CELL, V49, P145, DOI 10.1016/j.molcel.2012.10.027
   Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092
   Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356
   Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118
   Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x
   Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145
   Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045
   Liu F, 2009, J INVEST DERMATOL, V129, P422, DOI 10.1038/jid.2008.255
   Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053
   Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411
   TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251
   Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200
   Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x
   Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x
   Wu M, 2000, GENE DEV, V14, P301
   Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110
   Hemesath TJ, 1998, NATURE, V391, P298
   Pollock PM, 2002, CANCER CELL, V2, P5, DOI 10.1016/S1535-6108(02)00089-2
   [Anonymous], 2013, MEL SKIN CANC
   Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799
   Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022
   Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612
   McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6
   Young C, 2009, OCCUP MED-OXFORD, V59, P82, DOI 10.1093/occmed/kqn170
   Giuliano S, 2010, CANCER RES, V70, P3813, DOI 10.1158/0008-5472.CAN-09-2913
   Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067
   Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785
   Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200
   Feige E, 2011, P NATL ACAD SCI USA, V108, pE924, DOI 10.1073/pnas.1106351108
   Fuse N, 1996, BIOCHEM BIOPH RES CO, V219, P702, DOI 10.1006/bbrc.1996.0298
   Goding CR, 2011, ONCOGENE, V30, P2304, DOI 10.1038/onc.2010.641
   Hershey CL, 2005, GENE, V347, P73, DOI 10.1016/j.gene.2004.12.002
   Hoeflich Klaus P, 2006, Cancer Res, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720
   Huber WE, 2003, J BIOL CHEM, V278, P45224, DOI 10.1074/jbc.M309036200
   Jacobs A.L., 2011, CHROMOSOMA, V121, P1
   Johannessen C.M., 2014, NATURE, V504, P138
   Kadekaro AL, 2006, FRONT BIOSCI, V11, P2157, DOI 10.2741/1958
   Khaled M, 2010, GENE DEV, V24, P2276, DOI 10.1101/gad.1937710
   Kobi D, 2010, PIGM CELL MELANOMA R, V23, P404, DOI 10.1111/j.1755-148X.2010.00697.x
   Kudchadkar RR, 2013, CANCER CONTROL, V20, P282
   Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200
   Mitra D., 2012, NATURE, V491, P413
   Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059
   Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734
   Yokoyama S., 2011, NATURE, V480, P1
NR 74
TC 8
Z9 8
U1 4
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 28
EP 34
DI 10.1016/j.abb.2014.07.019
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000005
PM 25111671
ER

PT J
AU Bellono, NW
   Oancea, EV
AF Bellono, Nicholas W.
   Oancea, Elena V.
TI Ion transport in pigmentation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Melanocyte; Pigmentation; Ion channel; Transporter; Melanosome
ID II OCULOCUTANEOUS ALBINISM; PROTEIN-COUPLED RECEPTOR;
   X-RAY-MICROANALYSIS; EYED DILUTION GENE; HUMAN MELANOCYTES; OCULAR
   ALBINISM; ULTRAVIOLET-LIGHT; MELANOSOMAL PH; MELANOMA-CELLS;
   TRANSCRIPTIONAL REGULATION
AB Skin melanocytes and ocular pigment cells contain specialized organelles called melanosomes, which are responsible for the synthesis of melanin, the major pigment in mammals. Defects in the complex mechanisms involved in melanin synthesis and regulation result in vision and pigmentation deficits, impaired development of the visual system, and increased susceptibility to skin and eye cancers. Ion transport across cellular membranes is critical for many biological processes, including pigmentation, but the molecular mechanisms by which it regulates melanin synthesis, storage, and transfer are not understood. In this review we first discuss ion channels and transporters that function at the plasma membrane of melanocytes; in the second part we consider ion transport across the membrane of intracellular organelles, with emphasis on melanosomes. We discuss recently characterized lysosomal and endosomal ion channels and transporters associated with pigmentation phenotypes. We then review the evidence for melanosomal channels and transporters critical for pigmentation, discussing potential molecular mechanisms mediating their function. The studies investigating ion transport in pigmentation physiology open new avenues for future research and could reveal novel molecular mechanisms underlying melanogenesis. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Bellono, Nicholas W.; Oancea, Elena V.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.
RP Oancea, EV (reprint author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, 171 Meeting St,Box G-E304, Providence, RI 02912 USA.
EM elena_oancea@brown.edu
CR Ancans J, 2001, EXP CELL RES, V268, P26, DOI 10.1006/excr.2001.5251
   Ancans J, 2000, FEBS LETT, V478, P57, DOI 10.1016/S0014-5793(00)01795-6
   Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023
   Duncan LM, 1998, CANCER RES, V58, P1515
   Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j
   Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236
   Oancea E, 2011, ADV EXP MED BIOL, V704, P135, DOI 10.1007/978-94-007-0265-3_7
   Inaba M, 2012, SCIENCE, V335, P677, DOI 10.1126/science.1212821
   Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809
   Bates-Withers C, 2011, ADV EXP MED BIOL, V704, P173, DOI 10.1007/978-94-007-0265-3_9
   Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340
   Meyer H, 2011, J CELL SCI, V124, P1984, DOI 10.1242/jcs.082024
   Chen K, 2002, MOL BIOL CELL, V13, P1953, DOI 10.1091/mbc.02-02-0022
   Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535
   Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58
   IMOKAWA G, 1992, J BIOL CHEM, V267, P24675
   ROSEMBLAT S, 1994, P NATL ACAD SCI USA, V91, P12071, DOI 10.1073/pnas.91.25.12071
   Altimimi HF, 2007, CHANNELS, V1, P62
   Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014
   LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056
   Paravicini TM, 2012, INT J BIOCHEM CELL B, V44, P1381, DOI 10.1016/j.biocel.2012.05.010
   Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013
   Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009
   Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807
   Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036
   Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009
   Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842
   Weinert S, 2014, EMBO REP, V15, P784, DOI 10.15252/embr.201438553
   Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200
   Park HY, 2004, J INVEST DERMATOL, V122, P159, DOI 10.1046/j.0022-202X.2003.22134.x
   Ancans J, 2001, J INVEST DERMATOL, V117, P158, DOI 10.1046/j.0022-202x.2001.01397.x
   Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200
   Wu H, 2003, BIOCHEM BIOPH RES CO, V311, P948, DOI 10.1016/j.bbrc.2003.10.092
   Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106
   Park HY, 2006, BIOCHEM J, V395, P571, DOI 10.1042/BJ20051388
   Innamorati G, 2006, PIGM CELL RES, V19, P125, DOI 10.1111/j.1600-0749.2006.00292.x
   Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584
   Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311
   Berson JF, 2001, MOL BIOL CELL, V12, P3451
   Reissmann M, 2013, SEMIN CELL DEV BIOL, V24, P576, DOI 10.1016/j.semcdb.2013.03.014
   Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003
   Gilchrest BA, 1996, PHOTOCHEM PHOTOBIOL, V63, P1, DOI 10.1111/j.1751-1097.1996.tb02988.x
   Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x
   DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816
   Park HY, 1999, J BIOL CHEM, V274, P16470, DOI 10.1074/jbc.274.23.16470
   Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104
   Jin J, 2012, P NATL ACAD SCI USA, V109, pE225, DOI 10.1073/pnas.1120033109
   Li XR, 2013, J PHYSIOL-LONDON, V591, P4389, DOI 10.1113/jphysiol.2013.258301
   Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717
   Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238
   Lu YY, 2013, J BIOL CHEM, V288, P24247, DOI 10.1074/jbc.M113.484253
   Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003
   McNeill MS, 2007, J INVEST DERMATOL, V127, P2020, DOI 10.1038/sj.jid.5700710
   Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907
   Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137
   MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663
   Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030
   Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005
   Puri N, 2000, J INVEST DERMATOL, V115, P607, DOI 10.1046/j.1523-1747.2000.00108.x
   Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200
   RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0
   Ishida Y, 2013, J GEN PHYSIOL, V141, P705, DOI 10.1085/jgp.201210930
   Gees M, 2012, COMPR PHYSIOL, V2, P563, DOI 10.1002/cphy.c110026
   PARK HY, 1993, J BIOL CHEM, V268, P11742
   IMOKAWA G, 1995, J INVEST DERMATOL, V105, P32, DOI 10.1111/1523-1747.ep12312500
   Costin GE, 2003, J CELL SCI, V116, P3203, DOI 10.1242/jcs.00598
   van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012
   Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667
   Bellono NW, 2013, P NATL ACAD SCI USA, V110, P2383, DOI 10.1073/pnas.1215555110
   Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003
   Stanisz H, 2012, J INVEST DERMATOL, V132, P1443, DOI 10.1038/jid.2011.478
   Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072
   Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702
   Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163
   Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x
   Boissy RE, 2003, EXP DERMATOL, V12, P5, DOI 10.1034/j.1600-0625.12.s2.1.x
   Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107
   Beirl AJ, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12205
   Bellono NW, 2013, CHANNELS AUSTIN, V7
   Bellono NW, 2014, J GEN PHYSIOL, V143, P203, DOI 10.1085/jgp.201311094
   BRILLIANT MH, 1994, PIGM CELL RES, V7, P398, DOI 10.1111/j.1600-0749.1994.tb00068.x
   Bush WD, 2007, PIGM CELL RES, V20, P134, DOI 10.1111/j.1600-0749.2007.00362.x
   Cang CL, 2014, NAT CHEM BIOL, V10, P463, DOI [10.1038/nchembio.1522, 10.1038/j.NCHEMBIO.1522]
   Cortese K, 2005, INVEST OPHTH VIS SCI, V46, P4358, DOI 10.1167/iovs.05-0834
   Daniele T, 2014, CURR BIOL, V24, P393, DOI 10.1016/j.cub.2014.01.007
   Devi S, 2009, AM J PHYSIOL-CELL PH, V297, pC679, DOI 10.1152/ajpcell.00092.2009
   Dooley CM, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12053
   Du JY, 2002, J BIOL CHEM, V277, P402, DOI 10.1074/jbc.M110229200
   Giordano F, 2009, HUM MOL GENET, V18, P4530, DOI 10.1093/hmg/ddp415
   Hill K, 2009, CELL CALCIUM, V45, P155, DOI 10.1016/j.ceca.2008.08.001
   Ho HA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200543
   Irie S, 2014, HANDB EXP PHARMACOL, V222, P387, DOI 10.1007/978-3-642-54215-2_15
   Iwashita M, 2006, PLOS GENET, V2, P1861, DOI 10.1371/journal.pgen.0020197
   Jeffery G, 1998, EYE, V12, P499
   Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035
   Joshi PG, 2007, PIGM CELL RES, V20, P380, DOI 10.1111/j.1600-0749.2007.00397.x
   Kiselyov KK, 2012, CHANNELS, V6, P344, DOI 10.4161/chan.21723
   LEE ST, 1995, GENOMICS, V26, P354, DOI 10.1016/0888-7543(95)80220-G
   Lehman AL, 2000, J INVEST DERMATOL, V115, P601, DOI 10.1046/j.1523-1747.2000.00107.x
   Manga P, 2001, PIGM CELL RES, V14, P362, DOI 10.1034/j.1600-0749.2001.140508.x
   Matsui M. S., 1990, CARCINOGENESIS, V11, P229
   Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440
   Montoliu L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12167
   Ni-Komatsu L, 2006, EXP EYE RES, V82, P519, DOI 10.1016/j.exer.2005.08.013
   Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146
   Oehler B, 2012, N-S ARCH PHARMACOL, V385, P555, DOI 10.1007/s00210-012-0747-x
   Russ M., 2010, CURR BIOL, V20, P703
   Salceda R, 2000, CELL CALCIUM, V27, P223, DOI 10.1054/ceca.2000.0111
   SAMUELSON DA, 1993, EXP EYE RES, V56, P63, DOI 10.1006/exer.1993.1009
   Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715
   Sulem P., NAT GENET, V40
   SZEKERES L, 1975, ARCH DERMATOL FORSCH, V252, P297, DOI 10.1007/BF00560369
   TAKAYA K, 1977, CELL TISSUE RES, V178, P169
   Tsetskhladze Z. R., 2012, PLOS ONE, V7
   ULSHAFER RJ, 1990, ARCH OPHTHALMOL-CHIC, V108, P113
   Wicks NL, 2011, CURR BIOL, V21, P1906, DOI 10.1016/j.cub.2011.09.047
   YADA Y, 1991, J BIOL CHEM, V266, P18352
NR 119
TC 3
Z9 3
U1 7
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 35
EP 41
DI 10.1016/j.abb.2014.06.020
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000006
PM 25034214
ER

PT J
AU Nosrati, A
   Wei, ML
AF Nosrati, Adi
   Wei, Maria L.
TI Sex disparities in melanoma outcomes: The role of biology
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Melanoma; Outcome disparities; Sexual dimorphism
ID CUTANEOUS MALIGNANT-MELANOMA; HUMAN ESTROGEN-RECEPTOR; CELL-LINES;
   X-CHROMOSOME; VITAMIN-D; GENDER-DIFFERENCES; OXIDATIVE STRESS;
   IMMUNE-RESPONSE; GENE-EXPRESSION; POOLED ANALYSIS
AB Melanoma outcomes differ between men and women even when adjusted for prognostic factors such as age, Breslow thickness, body site, ulceration, lymph node dissection, and for treatment, with men having poorer outcomes compared to women. The mechanisms underlying this disparity are not well understood. Behavioral differences between the sexes such as ultraviolet light exposure and health care services utilization have been suggested as contributing, and differences in endogenous biological processes such as immune function, hormonal regulation, oxidative stress response, vitamin D metabolism and sex chromosome gene expression have also been proposed as mechanisms. This review examines the cumulative evidence for biologically based processes that lead to differences in melanoma biology, including inherent sex-based differences in immune function, oxidative stress response and vitamin D metabolism; the complex interplay between sex hormones, the immune system and oxidative stress response; the effect of non-random X chromosome inactivation on tumorigenesis; and the potential contribution of recently identified oncogenes on the Y chromosome. Published by Elsevier Inc.
C1 Vet Affairs Med Ctr, Dermatol Serv, San Francisco, CA 94121 USA.
   Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.
RP Wei, ML (reprint author), 1700 Owens St, San Francisco, CA 94158 USA.
EM weim@derm.ucsf.edu
FU Werner Kohnstamm Family Foundation
FX Many thanks Drs. Jeffrey Schneider and Timothy Berger for critical
   reading of the manuscript and to Jerelyn Magnusson for superb technical
   assistance. This work was supported by the Werner Kohnstamm Family
   Foundation.
CR MORVILLO V, 1995, PIGM CELL RES, V8, P135, DOI 10.1111/j.1600-0749.1995.tb00654.x
   Brewer JD, 2012, J CLIN ONCOL, V30, P843, DOI 10.1200/JCO.2011.34.9605
   Allil PAA, 2008, MED CHEM, V4, P100, DOI 10.2174/157340608783789185
   MERINO R, 1994, EMBO J, V13, P683
   Dreumont N, 2010, J CELL SCI, V123, P40, DOI 10.1242/jcs.055889
   Micheli A, 2009, EUR J CANCER, V45, P1017, DOI 10.1016/j.ejca.2008.11.008
   Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766
   Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015
   Sander CS, 2003, BRIT J DERMATOL, V148, P913, DOI 10.1046/j.1365-2133.2003.05303.x
   McMurray RW, 2001, PATHOBIOLOGY, V69, P44, DOI 10.1159/000048757
   COLSTON K, 1981, ENDOCRINOLOGY, V108, P1083
   Joosse A, 2012, J CLIN ONCOL, V30, P2240, DOI 10.1200/JCO.2011.38.0584
   Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9
   VanBrocklin MW, 2010, PIGM CELL MELANOMA R, V23, P531, DOI 10.1111/j.1755-148X.2010.00717.x
   Joosse A, 2013, J CLIN ONCOL, V31, P2337, DOI 10.1200/JCO.2012.44.5031
   Erdei E, 2010, EXPERT REV ANTICANC, V10, P1811, DOI [10.1586/era.10.170, 10.1586/ERA.10.170]
   Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709
   Lin PY, 2010, J IMMUNOL, V185, P2747, DOI 10.4049/jimmunol.1000496
   Kanda N, 1996, CLIN EXP IMMUNOL, V106, P410, DOI 10.1046/j.1365-2249.1996.d01-842.x
   STHOEGER ZM, 1988, J IMMUNOL, V141, P91
   BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M
   GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0
   Meyskens FL, 2001, FREE RADICAL BIO MED, V31, P799, DOI 10.1016/S0891-5849(01)00650-5
   Kanda N, 2001, J INVEST DERMATOL, V117, P274, DOI 10.1046/j.1523-1747.2001.01422.x
   Elsheikh M, 2002, ENDOCR REV, V23, P120, DOI 10.1210/er.23.1.120
   Kanda N, 1999, J ALLERGY CLIN IMMUN, V103, P282, DOI 10.1016/S0091-6749(99)70503-8
   Giltay EJ, 2000, J CLIN ENDOCR METAB, V85, P1648, DOI 10.1210/jc.85.4.1648
   Joosse A, 2011, J INVEST DERMATOL, V131, P719, DOI 10.1038/jid.2010.354
   Schmidt AN, 2006, EXP DERMATOL, V15, P971, DOI 10.1111/j.1600-0625.2006.00502.x
   Ruteshouser EC, 2008, GENE CHROMOSOME CANC, V47, P461, DOI 10.1002/gcc.20553
   Sato S, 1998, SEMIN IMMUNOL, V10, P287, DOI 10.1006/smim.1998.0121
   LIEL Y, 1992, ENDOCRINOLOGY, V130, P2597, DOI 10.1210/en.130.5.2597
   Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721
   Streicher KL, 2012, ONCOGENE, V31, P1558, DOI 10.1038/onc.2011.345
   Sondak VK, 2012, J CLIN ONCOL, V30, P2177, DOI 10.1200/JCO.2011.41.3849
   Polanczyk MJ, 2007, INT IMMUNOL, V19, P337, DOI 10.1093/intimm/dxl151
   De Vries E, 2008, ANN ONCOL, V19, P583, DOI 10.1093/annonc/mdm498
   Scoggins CR, 2006, ANN SURG, V243, P693, DOI 10.1097/01.sla.0000216771.81362.6b
   Chang C, 2014, ONCOGENE, V33, P3225, DOI 10.1038/onc.2013.274
   de Giorgi V, 2009, ARCH DERMATOL, V145, P30, DOI 10.1001/archdermatol.2008.537
   Lasithiotakis K, 2008, CANCER, V112, P1795, DOI 10.1002/cncr.23359
   Micheli A, 1998, EUR J CANCER, V34, P2271, DOI 10.1016/S0959-8049(98)00324-4
   McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884
   Grimaldi CM, 2002, J CLIN INVEST, V109, P1625, DOI 10.1172/JCI200214873
   Caballero OL, 2013, ONCOTARGET, V4, P531
   Matin RN, 2008, AM J TRANSPLANT, V8, P1891, DOI 10.1111/j.1600-6143.2008.02326.x
   Thomas-Ahner JM, 2007, CANCER RES, V67, P3468, DOI 10.1158/0008-5472.CAN-06-3798
   Hsueh EC, 2003, J SURG RES, V110, P393, DOI 10.1006/jsre.2002.6608
   Nishikawa M, 2008, CANCER LETT, V266, P53, DOI 10.1016/j.canlet.2008.02.031
   Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008
   Cho JL, 2010, PHOTOCH PHOTOBIO SCI, V9, P608, DOI 10.1039/b9pp00168a
   Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024
   Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479
   Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509
   Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790
   Malorni W, 2007, ANTIOXID REDOX SIGN, V9, P1779, DOI 10.1089/ars.2007.1596
   O'Meara AT, 2005, CANCER, V103, P1217, DOI 10.1002/cncr.20925
   CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6
   Karagas MR, 2002, BRIT J CANCER, V86, P1085, DOI 10.1038/sj/bjc/6600196
   Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3
   Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506
   Fisher DE, 2013, JAMA DERMATOL, V149, P903, DOI 10.1001/jamadermatol.2013.4437
   Edgren G, 2012, EUR J EPIDEMIOL, V27, P187, DOI 10.1007/s10654-011-9647-5
   Borras C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Polanczyk MJ, 2006, J NEUROSCI RES, V84, P370, DOI 10.1002/jnr.20881
   Hino R, 2010, CANCER-AM CANCER SOC, V116, P1757, DOI 10.1002/cncr.24899
   PINTO RE, 1969, BIOCHEM J, V112, P109
   Gamba CS, 2013, JAMA DERMATOL, V149, P912, DOI 10.1001/jamadermatol.2013.4408
   Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661
   FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0
   Lens M, 2008, CANCER CAUSE CONTROL, V19, P437, DOI 10.1007/s10552-008-9110-4
   FRAMPTON RJ, 1983, CANCER RES, V43, P4443
   Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669
   Cotter MA, 2007, CLIN CANCER RES, V13, P5952, DOI 10.1158/1078-0432.CCR-07-1187
   Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133
   Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799
   Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394
   MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252
   Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034
   Smith MA, 1998, INT J EPIDEMIOL, V27, P751, DOI 10.1093/ije/27.5.751
   Hamid O, 2013, EXPERT OPIN BIOL TH, V13, P847, DOI 10.1517/14712598.2013.770836
   RAMPEN FHJ, 1980, LANCET, V1, P562
   Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664
   Tsuei DJ, 2004, ONCOGENE, V23, P5815, DOI 10.1038/sj.onc.1207773
   Brewer JD, 2011, ARCH DERMATOL, V147, P790, DOI 10.1001/archdermatol.2011.159
   Mahadevaiah SK, 1998, HUM MOL GENET, V7, P715, DOI 10.1093/hmg/7.4.715
   BARSONY J, 1990, J CELL BIOL, V111, P2385, DOI 10.1083/jcb.111.6.2385
   Berwick M, 2013, PIGM CELL MELANOMA R, V26, P9, DOI 10.1111/pcmr.12015
   Bokov AF, 2009, ENDOCR RES, V34, P43, DOI 10.1080/07435800902913600
   Borras C, 2010, BBA-MOL BASIS DIS, V1802, P205, DOI 10.1016/j.bbadis.2009.09.007
   Bouman A, 2004, AM J REPROD IMMUNOL, V52, P19, DOI 10.1111/j.1600-0897.2004.00177.x
   Busch E., 1998, AM J SURG, V175, P444
   Bynoe MS, 2000, P NATL ACAD SCI USA, V97, P2703, DOI 10.1073/pnas.040577497
   Danielsson C, 1998, CELL DEATH DIFFER, V5, P946, DOI 10.1038/sj.cdd.4400437
   Dobos J, 2004, INT J CANCER, V112, P771, DOI 10.1002/ijc.20473
   Dorak M. Tevfik, 2012, Frontiers in Genetics, V3, P268, DOI 10.3389/fgene.2012.00268
   Duffy DL, 2000, BEHAV ECOL, V11, P654, DOI 10.1093/beheco/11.6.654
   Essa S, 2010, J STEROID BIOCHEM, V121, P110, DOI 10.1016/j.jsbmb.2010.02.003
   Evans SRT, 1996, J SURG RES, V61, P127, DOI 10.1006/jsre.1996.0092
   FRAMPTON RJ, 1982, CANCER RES, V42, P1116
   Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152
   Gefeller O, 1998, BRIT J DERMATOL, V138, P122
   Ghosh R, 2003, MELANOMA RES, V13, P119, DOI 10.1097/01.cmr.0000056211.78713.b9
   Grin CM, 1998, SEMIN CUTAN MED SURG, V17, P167, DOI 10.1016/S1085-5629(98)80010-2
   Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97
   Homsi Jade, 2005, Cancer Control, V12, P223
   Indsto JO, 2003, CLIN CANCER RES, V9, P6476
   Johnson JA, 1995, EXP GERONTOL, V30, P631, DOI 10.1016/0531-5565(95)00014-3
   Joosse A, 2010, PIGM CELL MELANOMA R, V23, P352, DOI 10.1111/j.1755-148X.2010.00694.x
   Kandalaft LE, 2008, CARCINOGENESIS, V29, P1282, DOI 10.1093/carcin/bgn087
   Kemeny M.M., 1998, AM J SURG, V175, P437
   Kido T, 2008, INT J CANCER, V123, P1573, DOI 10.1002/ijc.23697
   Kido T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022979
   Lasithiotakis KG, 2006, CANCER, V107, P1331, DOI 10.1002/cncr.22126
   Lau YFC, 2011, SYST BIOL REPROD MED, V57, P27, DOI 10.3109/19396368.2010.499157
   Lens MB, 2004, J CLIN ONCOL, V22, P4369, DOI 10.1200/JCO.2004.02.096
   Li Y, 2008, ONCOGENE, V27, P6141, DOI 10.1038/onc.2008.206
   Liu YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000707
   MacKie RM, 2004, BRIT J CANCER, V90, P770, DOI 10.1038/sj.bjc.6601595
   Malorni W, 2008, FEBS LETT, V582, P635, DOI 10.1016/j.febslet.2008.01.034
   MCMILLEN MM, 1979, SCIENCE, V204, P89, DOI 10.1126/science.571144
   Naldi L, 2005, ANN EPIDEMIOL, V15, P545, DOI 10.1016/j.annepidem.2004.10.005
   Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135
   Oram SW, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-154
   PACK GT, 1951, CANCER, V4, P324, DOI 10.1002/1097-0142(195103)4:2<324::AID-CNCR2820040218>3.0.CO;2-G
   Renault NKE, 2013, EUR J HUM GENET, V21, P1396, DOI 10.1038/ejhg.2013.84
   Richardson B, 1999, BRIT J CANCER, V80, P2025, DOI 10.1038/sj.bjc.6690637
   Roy S, 2011, MOL PHARMACEUT, V8, P350, DOI 10.1021/mp2000346
   RuizLarrea MB, 1997, J PHYSIOL BIOCHEM, V53, P225
   Scanlan Matthew J, 2004, Cancer Immun, V4, P1
   Schoemaker MJ, 2008, LANCET ONCOL, V9, P239, DOI 10.1016/S1470-2045(08)70033-0
   Schwartz B, 2000, MOL CELL BIOCHEM, V203, P87, DOI 10.1023/A:1007015027268
   Scoggins CR, 2006, ANN SURG, V243, P698
   Seifert M, 2004, J STEROID BIOCHEM, V89-90, P375, DOI 10.1016/j.jsbmb.2004.03.002
   Shier, HOLES HUMAN ANATOMY
   Spolarics Z, 2007, SHOCK, V27, P597, DOI 10.1097/SHK.0b013e31802e40bd
   SUTHERLAND CM, 1983, SURG GYNECOL OBSTET, V157, P443
   Tan B, 2013, ONCOTARGET, V5, P264
   Tan BS, 2012, PIGM CELL MELANOMA R, V25, P398, DOI 10.1111/j.1755-148X.2012.00993.x
   Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035
   TRAPEZNIKOV NN, 1987, VOP ONKOL+, V33, P40
   Trouba KJ, 2002, ANTIOXID REDOX SIGN, V4, P665, DOI 10.1089/15230860260220175
   Tsuei DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026948
   Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200
   Verthelyi D, 1997, J AUTOIMMUN, V10, P115, DOI 10.1006/jaut.1996.0121
   Vina J, 2005, FEBS LETT, V579, P2541, DOI 10.1016/j.febslet.2005.03.090
   Wu H, 2014, NEURON, V81, P103, DOI 10.1016/j.neuron.2013.10.051
   Yin YH, 2005, BRIT J CANCER, V93, P458, DOI 10.1038/sj.bjc.6602716
   Yudoh K, 1999, J LAB CLIN MED, V133, P120, DOI 10.1016/S0022-2143(99)90004-5
   Zhang Julie S., 1992, Human Molecular Genetics, V1, P717, DOI 10.1093/hmg/1.9.717
NR 151
TC 2
Z9 2
U1 4
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 42
EP 50
DI 10.1016/j.abb.2014.06.018
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000007
PM 25057772
ER

PT J
AU Liu-Smith, F
   Dellinger, R
   Meyskens, FL
AF Liu-Smith, Feng
   Dellinger, Ryan
   Meyskens, Frank L., Jr.
TI Updates of reactive oxygen species in melanoma etiology and progression
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Reactive oxygen species; ROS; RNS; Mitochondria; NADPH oxidase; Nox1;
   Nox4; Melanoma
ID NADPH OXIDASE INHIBITOR; HUMAN HAIR PHEOMELANIN; HUMAN COLON CANCERS;
   PROTEIN-KINASE-C; SMALL GTPASE RAC; HUMAN MELANOCYTES; NITRIC-OXIDE;
   METASTATIC MELANOMA; OXIDATIVE STRESS; MELANOCORTIN-1 RECEPTOR
AB Reactive oxygen species (ROS) play crucial roles in all aspects of melanoma development, however, the source of ROS is not well defined. In this review we summarize recent advancement in this rapidly developing field. The cellular ROS pool in melanocytes can be derived from mitochondria, melanosomes, NADPH oxidase (NOX) family enzymes, and uncoupling of nitric oxide synthase (NOS). Current evidence suggests that Nox1, Nox4 and Nox5 are expressed in melanocytic lineage. While there is no difference in Nox1 expression levels in primary and metastatic melanoma tissues, Nox4 expression is significantly higher in a subset of metastatic melanoma tumors as compared to the primary tumors; suggesting distinct and specific signals and effects for NOX family enzymes in melanoma. Targeting these NOX enzymes using specific NOX inhibitors may be effective for a subset of certain tumors. ROS also play important roles in BRAF inhibitor induced drug resistance; hence identification and blockade of the source of this ROS may be an effective way to enhance efficacy and overcome resistance. Furthermore, ROS from different sources may interact with each other and interact with reactive nitrogen species (RNS) and drive the melanomagenesis process at all stages of disease. Further understanding ROS and RNS in melanoma etiology and progression is necessary for developing new prevention and therapeutic approaches. Published by Elsevier Inc.
C1 [Liu-Smith, Feng; Meyskens, Frank L., Jr.] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92697 USA.
   [Liu-Smith, Feng; Dellinger, Ryan; Meyskens, Frank L., Jr.] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92697 USA.
   [Meyskens, Frank L., Jr.] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA.
   [Meyskens, Frank L., Jr.] Univ Calif Irvine, Sch Med, Dept Publ Hlth, Irvine, CA 92697 USA.
   [Liu-Smith, Feng; Dellinger, Ryan; Meyskens, Frank L., Jr.] Univ Calif Irvine, Sch Med, Chao Family Comprehens Canc Ctr, Irvine, CA 92697 USA.
RP Liu-Smith, F (reprint author), Univ Calif Irvine, Sch Med, Dept Epidemiol, B200 Sprague Hall, Irvine, CA 92697 USA.
EM liufe@uci.edu
FU Chao Family Cancer Center Seed Grant (CCSG) [P30 CA 62230]; Alan Hubbell
   Education [P20 CA174188]; NCI [CA160756]; Waltmar Foundation
FX This work is supported by Chao Family Cancer Center Seed Grant (CCSG,
   P30 CA 62230, to F.L.M. and F.L.S.), the Alan Hubbell Education Grant
   (CSUF and UCI-CFCCC Partnership for Cancer Health Disparities Research
   P20 CA174188 to Hubbell and sub-grant to F.L.S.), NCI K07 (CA160756 to
   F.L.S.) and Waltmar Foundation (to F.L.M. and F.L.S.). The authors thank
   Dr. Sun Yang for critical scientific discussions.
CR Abdel-Mallek ZA, 2008, PHOTOCHEM PHOTOBIOL, V84, P501, DOI 10.1111/j.1751-1097.2008.00294.x
   Ahmed B, 1999, BRIT J DERMATOL, V141, P12
   Alan Jamie K, 2013, Small GTPases, V4, P159, DOI 10.4161/sgtp.26530
   Altenhofer S., 2014, ANTIOXID RE IN PRESS
   Panzella L, 2010, PHOTOCHEM PHOTOBIOL, V86, P757, DOI 10.1111/j.1751-1097.2010.00726.x
   Kinnula VL, 2004, FREE RADICAL BIO MED, V36, P718, DOI 10.1016/j.freeradbiomed.2003.12.010
   Gray SP, 2013, CIRCULATION, V127, P1888, DOI 10.1161/CIRCULATIONAHA.112.132159
   Yang S, 2005, MOL CANCER THER, V4, P1923, DOI 10.1158/1535-7163.MCT-05-0229
   Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8
   Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586
   Meyskens FL, 1997, PIGM CELL RES, V10, P184, DOI 10.1111/j.1600-0749.1997.tb00482.x
   Meyskens FL, 1999, CLIN CANCER RES, V5, P1197
   Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200
   Antony S, 2013, FREE RADICAL BIO MED, V65, P497, DOI 10.1016/j.freeradbiomed.2013.07.005
   Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421
   Garufi A, 2014, INT J ONCOL, V44, P1084, DOI 10.3892/ijo.2014.2304
   Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028
   SIMONS JM, 1990, FREE RADICAL BIO MED, V8, P251, DOI 10.1016/0891-5849(90)90070-Y
   Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804
   Laurent E, 2008, INT J CANCER, V123, P100, DOI 10.1002/ijc.23423
   Meyskens FL, 2001, PIGM CELL RES, V14, P148, DOI 10.1034/j.1600-0749.2001.140303.x
   McNulty SE, 2001, PIGM CELL RES, V14, P456, DOI 10.1034/j.1600-0749.2001.140606.x
   Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833
   Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5
   Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003
   Huang H, 2014, J MED CHEM, V57, P686, DOI 10.1021/jm401252e
   Sikora AG, 2010, CLIN CANCER RES, V16, P1834, DOI 10.1158/1078-0432.CCR-09-3123
   Moan J, 1999, PHOTOCHEM PHOTOBIOL, V70, P243, DOI 10.1111/j.1751-1097.1999.tb07995.x
   Maccioni L, 2013, INT J CANCER, V132, P42, DOI 10.1002/ijc.27648
   Song XZ, 2009, PIGM CELL MELANOMA R, V22, P809, DOI 10.1111/j.1755-148X.2009.00615.x
   Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007
   Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745
   Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624
   Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011
   Meyskens FL, 2001, FREE RADICAL BIO MED, V31, P799, DOI 10.1016/S0891-5849(01)00650-5
   Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728
   Lopez-Rivera E, 2014, CANCER RES, V74, P1067, DOI 10.1158/0008-5472.CAN-13-0588
   Perry BN, 2006, J INVEST DERMATOL, V126, P2316, DOI 10.1038/sj.jid.5700413
   Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29
   Ortega A, 2008, NITRIC OXIDE-BIOL CH, V19, P107, DOI 10.1016/j.niox.2008.04.010
   Swope VB, 2012, J INVEST DERMATOL, V132, P2255, DOI 10.1038/jid.2012.135
   Powis G, 2007, CURR OPIN PHARMACOL, V7, P392, DOI 10.1016/j.coph.2007.04.003
   Sun QA, 2012, FREE RADICAL BIO MED, V52, P1897, DOI 10.1016/j.freeradbiomed.2012.02.046
   Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI 10.1089/ARS.2009.2541
   Wittgen HGM, 2007, MELANOMA RES, V17, P400
   Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020
   Zhang YX, 2011, ANTIOXID REDOX SIGN, V15, P2867, DOI 10.1089/ars.2010.3685
   Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003
   Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200
   Liu F, 2009, J INVEST DERMATOL, V129, P422, DOI 10.1038/jid.2008.255
   Abdel-Malek Z, 1999, ANN NY ACAD SCI, V885, P117
   Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782
   Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032
   Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024
   Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e
   Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344
   Corcoran RB, 2011, ONCOTARGET, V2, P336
   Wingler K, 2012, CELL MOL LIFE SCI, V69, P3159, DOI 10.1007/s00018-012-1107-1
   Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082
   Ishikawa K, 2010, ANN NY ACAD SCI, V1201, P40, DOI 10.1111/j.1749-6632.2010.05616.x
   Bhandarkar SS, 2009, J CLIN INVEST, V119, P2359, DOI 10.1172/JCI33877
   Arbiser JL, 2012, J AM ACAD DERMATOL, V67, pE81, DOI 10.1016/j.jaad.2011.10.028
   Valencia A, 2008, J INVEST DERMATOL, V128, P214, DOI 10.1038/sj.jid.5700960
   Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044
   Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009
   Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868
   Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161
   Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365
   Armitage ME, 2009, J MOL MED-JMM, V87, P1071, DOI 10.1007/s00109-009-0544-2
   Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3
   Wingler K, 2011, BRIT J PHARMACOL, V164, P866, DOI 10.1111/j.1476-5381.2011.01249.x
   Flaherty KT, 2011, NAT REV DRUG DISCOV, V10, P811, DOI 10.1038/nrd3579
   Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015
   Chan EC, 2009, PHARMACOL THERAPEUT, V122, P97, DOI 10.1016/j.pharmthera.2009.02.005
   Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221
   de Carvalho DD, 2008, INT J CANCER, V122, P1757, DOI 10.1002/ijc.23300
   Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626
   Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068
   Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n
   Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003
   Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330
   Godoy LC, 2012, P NATL ACAD SCI USA, V109, P20373, DOI 10.1073/pnas.1218938109
   Briones AM, 2011, J AM SOC HYPERTENS, V5, P137, DOI 10.1016/j.jash.2011.02.001
   Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006
   Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803
   Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067
   ten Freyhaus H, 2006, CARDIOVASC RES, V71, P331, DOI 10.1016/j.cardiores.2006.01.022
   Brar SS, 2002, AM J PHYSIOL-CELL PH, V282, pC1212, DOI 10.1152/ajpcell.00496.2001
   Dellinger RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047696
   Dworakowski R, 2006, BIOCHEM SOC T, V34, P960
   Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878
   Ewton DZ, 2011, MOL CANCER THER, V10, P2104, DOI 10.1158/1535-7163.MCT-11-0498
   Farmer PJ, 2003, PIGM CELL RES, V16, P273, DOI 10.1034/j.1600-0749.2003.00046.x
   Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P732, DOI 10.1111/pcmr.12000
   Frazziano G, 2014, AM J PHYSIOL-HEART C, V306, pH197, DOI 10.1152/ajpheart.00977.2012
   Fried L, 2008, PIGM CELL MELANOMA R, V21, P117, DOI 10.1111/j.1755-148X.2008.00451.x
   Garrido-Urbani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014665
   Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JC130102
   Greco G, 2011, J NAT PROD, V74, P675, DOI 10.1021/np100740n
   Greco G, 2012, PIGM CELL MELANOMA R, V25, P110, DOI 10.1111/j.1755-148X.2011.00896.x
   Henri P, 2012, J CELL PHYSIOL, V227, P2578, DOI 10.1002/jcp.22996
   Hiramoto K, 2012, CLIN EXP DERMATOL, V37, P65, DOI 10.1111/j.1365-2230.2011.04149.x
   Jha J.C., 2014, J AM SOC NE IN PRESS
   Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x
   Kelkka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084148
   Kroviarski Y, 2010, FASEB J, V24, P2077, DOI 10.1096/fj.09-147629
   Liu F, 2012, J INVEST DERMATOL, V132, P2033, DOI 10.1038/jid.2012.119
   Liu GS, 2012, FREE RADICAL BIO MED, V52, P1835, DOI 10.1016/j.freeradbiomed.2012.02.040
   Liu GS, 2014, FREE RADICAL BIO MED, V70, P14, DOI 10.1016/j.freeradbiomed.2013.12.024
   Maybury BD, 2013, ANTICANCER RES, V33, P3543
   Mehdi MZ, 2007, CELL BIOCHEM BIOPHYS, V47, P1
   Melo FHM, 2011, FREE RADICAL BIO MED, V50, P1263, DOI 10.1016/j.freeradbiomed.2011.02.022
   Meyskens Frank L. Jr., 2007, V174, P191
   Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003
   Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200
   Morre DJ, 1996, EUR J CANCER, V32A, P1995, DOI 10.1016/0959-8049(96)00234-1
   Opitz N, 2007, FREE RADICAL BIO MED, V42, P175, DOI 10.1016/j.freeadbiomed.2006.11.003
   Panzella L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12199
   Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004
   Park SJ, 2012, MOL CELLS, V33, P363, DOI 10.1007/s10059-012-2285-2
   Quast SA, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.344
   Schildknecht S, 2013, CURR MED CHEM, V21, P365, DOI DOI 10.2174/09298673113209990179
   Sturm RA, 2002, MELANOMA RES, V12, P405, DOI 10.1097/00008390-200209000-00001
   Sun Z, 2013, CANCER INVEST, V31, P273, DOI 10.3109/07357907.2013.789897
   Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2
   Tanese K, 2012, INT J CANCER, V131, P891, DOI 10.1002/ijc.26451
   Tazzeo T, 2009, BRIT J PHARMACOL, V158, P790, DOI 10.1111/j.1476-5381.2009.00394.x
   Turgeon D, 2003, J LIPID RES, V44, P1182, DOI 10.1194/jlr.M300010-JLR200
   Wang R, 2011, INT J CANCER, V128, P2581, DOI 10.1002/ijc.25610
   Winer I, 2002, MELANOMA RES, V12, P429, DOI 10.1097/00008390-200209000-00003
   Wu SL, 2008, MOL IMMUNOL, V45, P2288, DOI 10.1016/j.molimm.2007.11.019
   YAMANISHI DT, 1994, CRIT REV ONCOGENESIS, V5, P429
   Yang Z., 2014, ANTIOXID REDOX SIGN, V57, P686
   Yang Z, 2008, MOL CANCER THER, V7, P3751, DOI 10.1158/1535-7163.MCT-08-0562
NR 134
TC 5
Z9 5
U1 6
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 51
EP 55
DI 10.1016/j.abb.2014.04.007
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000008
PM 24780245
ER

PT J
AU Theodosakis, N
   Micevic, G
   Kelly, DP
   Bosenberg, M
AF Theodosakis, Nicholas
   Micevic, Goran
   Kelly, Daniel P.
   Bosenberg, Marcus
TI Mitochondrial function in melanoma
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Melanoma; Mitochondria; Metabolism; PGC-1; MITF; Apoptosis
ID PROLIFERATOR-ACTIVATED RECEPTOR; HIF-1-ALPHA STABILIZATION;
   OXIDATIVE-PHOSPHORYLATION; COACTIVATOR PGC-1-ALPHA; PGC-1 COACTIVATORS;
   ENERGY-METABOLISM; LINEAGE SURVIVAL; CANCER-CELLS; LUNG-CANCER; IN-VIVO
AB Melanoma is the most lethal form of skin cancer and its incidence is rapidly rising. Breakthroughs in the understanding of the basic biology of melanoma in the past decade have yielded several new treatments, and advances continue to be made on a variety of fronts. One such area involves the delineation of changes in mitochondria that occur during melanoma formation, and how these changes affect responses to therapy. In this review, we summarize recent developments on the multiple functions that mitochondria play in melanoma, and how these roles are currently being evaluated as new targets for clinical intervention. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Theodosakis, Nicholas; Micevic, Goran; Bosenberg, Marcus] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.
   [Kelly, Daniel P.] Sanford Burnham Med Res Inst, Lake Nona, FL USA.
   [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.
RP Theodosakis, N (reprint author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.
EM nicholas.theodosakis@yale.edu
FU NIH - United States [R01 DK045416, R01 HL058493]
FX Daniel P. Kelly is supported by NIH - United States grants R01 DK045416
   and R01 HL058493.
CR Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188
   Brahimi-Horn MC, 2012, CANCER RES, V72, P2140, DOI 10.1158/0008-5472.CAN-11-3940
   BALABAN RS, 1990, AM J PHYSIOL, V258, pC377
   Luo CL, 2013, J INVEST DERMATOL, V133, P768, DOI 10.1038/jid.2012.357
   Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623
   Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001
   Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766
   Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003
   Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006
   Lizama-Manibusan B, 2013, FEBS LETT, V587, P2291, DOI 10.1016/j.febslet.2013.06.007
   Liu H, 2013, SEMIN CANCER BIOL, V23, P352, DOI 10.1016/j.semcancer.2013.06.008
   Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5
   Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603
   Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745
   Salem AF, 2012, CELL CYCLE, V11, P4174, DOI 10.4161/cc.22376
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918
   Held MA, 2013, CANCER DISCOV, V3, P52, DOI 10.1158/2159-8290.CD-12-0408
   Plotz M, 2013, CANCER LETT, V335, P100, DOI 10.1016/j.canlet.2013.02.005
   Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020
   Lai L, 2014, J BIOL CHEM, V289, P2250, DOI 10.1074/jbc.M113.523654
   Shoag J, 2013, MOL CELL, V49, P145, DOI 10.1016/j.molcel.2012.10.027
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Mohamed A, 2014, CLIN LUNG CANCER, V15, P7, DOI 10.1016/j.cllc.2013.09.001
   Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI 10.1089/ARS.2008.2270
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028
   WARBURG O, 1956, SCIENCE, V124, P269
   Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111
   Kluza J, 2012, CANCER RES, V72, P5035, DOI 10.1158/0008-5472.CAN-12-0979
   Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038
   Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110
   Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046
   Galluzzi L, 2008, ONCOGENE, V27, P4633, DOI 10.1038/onc.2008.114
   McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6
   Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004
   Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359
   Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004
   Comito G, 2011, FREE RADICAL BIO MED, V51, P893, DOI 10.1016/j.freeradbiomed.2011.05.042
   de Moura MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040690
   Cai Q, 2013, ONCOGENE, V32, P2079, DOI 10.1038/onc.2012.221
   Corazao-Rozas P, 2013, ONCOTARGET, V4, P1986
   Feng YM, 2013, PIGM CELL MELANOMA R, V26, P136, DOI 10.1111/pcmr.12033
   Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P732, DOI 10.1111/pcmr.12000
   Girnun GD, 2012, SEMIN CELL DEV BIOL, V23, P381, DOI 10.1016/j.semcdb.2012.01.007
   Ho JH, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-76
   Howlader N, 2012, SEER CANC STAT REV
   Kim M. J., 2013, INT J CLIN EXP PATHO, V7, P301
   Li YN, 2014, TOXICOL LETT, V224, P165, DOI 10.1016/j.toxlet.2013.10.029
   McGuirk Shawn, 2013, Cancer Metab, V1, P22, DOI 10.1186/2049-3002-1-22
   Meierjohann S., 2013, EURO J CELL BIOL
   Nessling M, 1999, CYTOGENET CELL GENET, V87, P286, DOI 10.1159/000015451
   Quast SA, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.344
   Soengas MS, 2012, PIGM CELL MELANOMA R, V25, P721, DOI 10.1111/pcmr.12021
   Sullivan RJ, 2013, ONCOGENE, V32, P2373, DOI 10.1038/onc.2012.345
   URABE K, 1994, BBA-MOL CELL RES, V1221, P272, DOI 10.1016/0167-4889(94)90250-X
   Vander Heiden Matthew G, 2009, Science, V324, P1029, DOI 10.1126/science.1160809
NR 61
TC 3
Z9 3
U1 3
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 56
EP 59
DI 10.1016/j.abb.2014.06.028
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000009
PM 24997363
ER

PT J
AU Aftab, MN
   Dinger, ME
   Perera, RJ
AF Aftab, Muhammad Nauman
   Dinger, Marcel E.
   Perera, Ranjan J.
TI The role of microRNAs and long non-coding RNAs in the pathology,
   diagnosis, and management of melanoma
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Noncoding RNAs; MicroRNAs; Melanoma; Molecular function
ID CELL-CYCLE PROGRESSION; FACTOR-KAPPA-B; CUTANEOUS MALIGNANT-MELANOMA;
   ENDOTHELIAL GROWTH-FACTOR; TRANSCRIPTION FACTOR; TUMOR PROGRESSION;
   DOWN-REGULATION; PROSTATE-CANCER; GENE-EXPRESSION; BREAST-CANCER
AB Melanoma is frequently lethal and its global incidence is steadily increasing. Despite the rapid development of different modes of targeted treatment, durable clinical responses remain elusive. A complete understanding of the molecular mechanisms that drive melanomagenesis is required, both genetic and epigenetic, in order to improve prevention, diagnosis, and treatment. There is increased appreciation of the role of microRNAs (miRNAs) in melanoma biology, including in proliferation, cell cycle, migration, invasion, and immune evasion. Data are also emerging on the role of long non-coding RNAs (IncRNAs), such as SPRY4-IT1, BANCR, and HOTAIR, in melanomagenesis. Here we review the data on the miRNAs and IncRNAs implicated in melanoma biology. An overview of these studies will be useful for providing insights into mechanisms of melanoma development and the miRNAs and IncRNAs that might be useful biomarkers or future therapeutic targets. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Aftab, Muhammad Nauman; Perera, Ranjan J.] Sanford Burnham Med Res Inst, Orlando, FL 32827 USA.
   [Dinger, Marcel E.] Univ New S Wales, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia.
   [Dinger, Marcel E.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia.
   [Aftab, Muhammad Nauman] Govt Coll Univ, Inst Ind Biotechnol, Lahore 54000, Pakistan.
RP Perera, RJ (reprint author), Sanford Burnham Med Res Inst, Orlando, FL 32827 USA.
EM rperera@sanfordburnham.org
FU National Institutes of Health [NCI 5P30CA030199, CA165184, CA172847]
FX This work was supported by National Institutes of Health Grants NCI
   5P30CA030199, CA165184, and CA172847 to RJP. We also thank Ms. Debbie
   McFadden (Sanford-Burnham Medical Research Institute) for formatting the
   manuscript.
CR Ahonen M, 1998, CANCER RES, V58, P2310
   Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106
   Sakurai E, 2011, INT J ONCOL, V39, P665, DOI 10.3892/ijo.2011.1084
   Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376
   Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030
   Worley LA, 2008, MELANOMA RES, V18, P184, DOI 10.1097/CMR.0b013e3282feeac6
   Tang LH, 2013, BIOMED RES INT, DOI 10.1155/2013/251098
   Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10
   Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112
   Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406
   Alexeev V, 2006, J INVEST DERMATOL, V126, P1102, DOI 10.1038/sj.jid.5700125
   Zinkernagel AS, 2007, J MOL MED-JMM, V85, P1339, DOI 10.1007/s00109-007-0282-2
   Migliore C, 2008, CANCER RES, V68, P10128, DOI 10.1158/0008-5472.CAN-08-2148
   Sotillo R, 2001, P NATL ACAD SCI USA, V98, P13312, DOI 10.1073/pnas.241338598
   Luo CL, 2013, J INVEST DERMATOL, V133, P768, DOI 10.1038/jid.2012.357
   Lodygin D, 2008, CELL CYCLE, V7, P2591
   Redova M, 2013, FUTURE ONCOL, V9, P387, DOI [10.2217/fon.12.192, 10.2217/FON.12.192]
   Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001
   Noguchi S, 2012, J VET MED SCI, V74, P1, DOI 10.1292/jvms.11-0264
   Glud M, 2009, J INVEST DERMATOL, V129, P1219, DOI 10.1038/jid.2008.347
   Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004
   Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006
   Levati L, 2009, INT J ONCOL, V35, P393, DOI 10.3892/ijo_00000352
   Karst AM, 2009, INT J CANCER, V124, P494, DOI 10.1002/ijc.23973
   Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102
   Boissier S, 2000, CANCER RES, V60, P2949
   Mazar J, 2011, FEBS LETT, V585, P2467, DOI 10.1016/j.febslet.2011.06.025
   Noguchi S, 2014, J INVEST DERMATOL, V134, P461, DOI 10.1038/jid.2013.310
   Kanemaru H, 2011, J DERMATOL SCI, V61, P187, DOI 10.1016/j.jdermsci.2010.12.010
   Jiang L, 2012, ACTA HISTOCHEM, V114, P582, DOI 10.1016/j.acthis.2011.11.001
   Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111
   Alonso SR, 2004, AM J PATHOL, V164, P193, DOI 10.1016/S0002-9440(10)63110-0
   Noguchi S, 2012, J BIOL CHEM, V287, P11769, DOI 10.1074/jbc.M111.325027
   Levati L, 2011, PIGM CELL MELANOMA R, V24, P538, DOI 10.1111/j.1755-148X.2011.00857.x
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128
   Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020
   Ohashi S, 2011, CANCER BIOL THER, V11, P184, DOI 10.4161/cbt.11.2.14140
   Nelson MA, 2006, CANCER BIOL THER, V5, P407
   BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0
   Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1
   Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913
   Kivisaari AK, 2010, BRIT J DERMATOL, V163, P726, DOI 10.1111/j.1365-2133.2010.09924.x
   Montone KT, 1997, MODERN PATHOL, V10, P939
   Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018
   BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I
   Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5
   Otsuka T, 1998, CANCER RES, V58, P5157
   Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538
   BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M
   Jiang CC, 2014, ONCOGENE, V33, P2577, DOI 10.1038/onc.2013.237
   Liu AH, 2009, INT J CLIN EXP PATHO, V2, P519
   Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061
   Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3
   Tonelli F, 2010, CELL SIGNAL, V22, P1536, DOI 10.1016/j.cellsig.2010.05.022
   Satzger I, 2010, INT J CANCER, V126, P2553, DOI 10.1002/ijc.24960
   Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634
   Cruz J, 2003, ONCOLOGY-BASEL, V65, P72, DOI 10.1159/000071207
   Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452
   Igoucheva O, 2009, BIOCHEM BIOPH RES CO, V379, P790, DOI 10.1016/j.bbrc.2008.12.152
   Muller DW, 2008, ONCOGENE, V27, P6698, DOI 10.1038/onc.2008.282
   Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005
   Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911
   Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x
   Huynh C, 2011, ONCOGENE, V30, P1481, DOI 10.1038/onc.2010.523
   Heinemann A, 2012, CANCER RES, V72, P460, DOI 10.1158/0008-5472.CAN-11-1977
   Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705
   Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005
   Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981
   Mueller DW, 2011, INT J CANCER, V129, P1064, DOI 10.1002/ijc.25768
   Satzger I, 2012, EXP DERMATOL, V21, P509, DOI 10.1111/j.1600-0625.2012.01510.x
   Braig S, 2010, CELL MOL LIFE SCI, V67, P3535, DOI 10.1007/s00018-010-0394-7
   Shiiyama R, 2013, MELANOMA RES, V23, P366, DOI 10.1097/CMR.0b013e328363e485
   Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628
   Kasemeier-Kulesa JC, 2008, DEV DYNAM, V237, P2657, DOI 10.1002/dvdy.21613
   Alla V, 2012, CELL CYCLE, V11, P3067, DOI 10.4161/cc.21476
   Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875
   Dynoodt P, 2013, INT J ONCOL, V42, P1443, DOI 10.3892/ijo.2013.1823
   Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x
   Chi SM, 2012, CELL SIGNAL, V24, P1222, DOI 10.1016/j.cellsig.2012.02.004
   Smedley D, 2000, GENE CHROMOSOME CANC, V28, P121, DOI 10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O
   Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349
   WATANABE N, 1995, EMBO J, V14, P1878
   Wegner M, 2005, PIGM CELL RES, V18, P74, DOI 10.1111/j.1600-0749.2005.00218.x
   Liu SJ, 2012, J PATHOL, V226, P61, DOI 10.1002/path.2964
   Bhattacharya A, 2013, ONCOGENE, V32, P3175, DOI 10.1038/onc.2012.324
   Maddodi N, 2008, PHOTOCHEM PHOTOBIOL, V84, P528, DOI 10.1111/j.1751-1097.2007.00283.x
   Verastegui C, 2000, J BIOL CHEM, V275, P30757, DOI 10.1074/jbc.C000445200
   Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45
   Noman MZ, 2012, CANCER RES, V72, P4629, DOI 10.1158/0008-5472.CAN-12-1383
   Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251
   Flockhart RJ, 2012, GENOME RES, V22, P1006, DOI 10.1101/gr.140061.112
   Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934
   Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014
   Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460
   Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611
   Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104
   Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4
   Reuland SN, 2013, J INVEST DERMATOL, V133, P1286, DOI 10.1038/jid.2012.400
   Dhawan P, 2002, CANCER RES, V62, P7335
   Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014
   Zhang KM, 2013, PIGM CELL MELANOMA R, V26, P408, DOI 10.1111/pcmr.12089
   Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027
   Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731
   Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020
   Sauter ER, 2002, CANCER RES, V62, P3200
   SEFTOR REB, 1992, P NATL ACAD SCI USA, V89, P1557, DOI 10.1073/pnas.89.5.1557
   Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171
   Bevona C, 2003, ARCH DERMATOL, V139, P1620, DOI 10.1001/archderm.139.12.1620
   Dar AA, 2013, JNCI-J NATL CANCER I, V105, P433, DOI 10.1093/jnci/djt003
   Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x
   Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840
   Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698
   Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912
   Nguyen T, 2011, EPIGENETICS-US, V6, P388
   Bell RE, 2014, J INVEST DERMATOL, V134, P441, DOI 10.1038/jid.2013.340
   Asangani IA, 2012, ONCOTARGET, V3, P1011
   Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x
   Palazon A, 2012, CLIN CANCER RES, V18, P1207, DOI 10.1158/1078-0432.CCR-11-1591
   Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726
   Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108
   Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x
   Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69
   Felicetti F, 2008, EXPERT REV ANTICANC, V8, P1759, DOI 10.1586/14737140.8.11.1759
   Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1
   Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x
   Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24
   Bashir T., 2004, CELL CYCLE, V3, pe27
   Berger AJ, 2005, CANCER RES, V65, P11185, DOI 10.1158/0008-5472.CAN-05-2300
   BHAVANANDAN V P, 1991, Glycobiology, V1, P493, DOI 10.1093/glycob/1.5.493
   Chattopadhyay C, 2012, INT J CANCER, V131, pE56, DOI 10.1002/ijc.26487
   Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8
   Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190
   Chen XY, 2011, INVEST OPHTH VIS SCI, V52, P1193, DOI 10.1167/iovs.10-5272
   Elson-Schwab I, 2010, PLOS ONE, V5
   Ernfors P, 2010, EXP CELL RES, V316, P1397, DOI 10.1016/j.yexcr.2010.02.042
   Estrada-Bernal A, 2009, J CELL SCI, V122, P2300, DOI 10.1242/jcs.047860
   Felli N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056824
   Fernandez-Messina L, 2010, J BIOL CHEM, V285, P8543, DOI 10.1074/jbc.M109.045906
   Friedman EB, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-155
   Fu TY, 2011, EXP CELL RES, V317, P445, DOI 10.1016/j.yexcr.2010.11.004
   Georgantas RW, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12200
   Greenberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018936
   John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363
   Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27
   Kozubek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072699
   Kyrgidis Athanassios, 2010, J Carcinog, V9, P3, DOI 10.4103/1477-3163.62141
   Larsson E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.89
   Leidinger P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-262
   Li JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02962
   Liang XQ, 2004, FEBS LETT, V569, P94, DOI 10.1016/j.febslet.2004.05.057
   Liu NF, 2001, CANCER RES, V61, P1022
   Liu SH, 2013, ANN SURG ONCOL, V20, P1745, DOI 10.1245/s10434-012-2467-3
   Liu XM, 2009, J GASTROENTEROL, V44, P460, DOI 10.1007/s00535-009-0030-1
   Liu Y., 2013, BIOCHEM BIOPH RES CO, V4, P4
   Ma ZH, 2009, J MOL DIAGN, V11, P420, DOI 10.2353/jmoldx.2009.090041
   Madonna G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-53
   Margue C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073473
   Mateyak MK, 1999, MOL CELL BIOL, V19, P4672
   Mazar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024922
   Mazar J., 2014, ONCOTARGET
   Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779
   Medgyesi D, 2014, J EXP MED, V211, P427, DOI 10.1084/jem.20131196
   Medic S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009977
   Molhoek KR, 2008, CANCER RES, V68, P4392, DOI 10.1158/0008-5472.CAN-07-5844
   Morris L, 2000, NAT CELL BIOL, V2, P232
   Mueller D.W., 2009, J INVEST DERMATOL, P1740
   O'Rahilly R, 2007, J ANAT, V211, P335, DOI 10.1111/j.1469-7580.2007.00773.x
   Qi M., 2014, INT J MOL MED
   Rigel DS, 2008, J AM ACAD DERMATOL, V58, pS129, DOI 10.1016/j.jaad.2007.04.034
   ROSS J, 1995, MICROBIOL REV, V59, P423
   Schwimmer J, 2000, Q J NUCL MED, V44, P153
   Shonukan Oluwatoyin, 2003, Oncogene, V22, P3616, DOI 10.1038/sj.onc.1206561
   Tao HF, 2007, J HUAZHONG U SCI-MED, V27, P326, DOI 10.1007/s11596-007-0328-2
   Umemura S, 2009, BRIT J CANCER, V100, P764, DOI 10.1038/sj.bjc.6604900
   Wagenseller AG, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-218
   Walter KA, 2002, MOL CELL BIOL, V22, P2703, DOI 10.1128/MCB.22.8.2703-2715.2002
   Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064396
   Westerhof W, 2006, PIGM CELL RES, V19, P183, DOI 10.1111/j.1600-0749.2006.00313.x
   Wu C.F., 2013, YI CHUAN XUE BAO, V40, P179
   Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568
   Yajima I, 2011, J SKIN CANC, V2011
   Zabierowski SE, 2011, STEM CELLS, V29, P1752, DOI 10.1002/stem.740
   Zhang B., 2007, DEV BIOL, V301, P1
   Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103
   Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100
   Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735
NR 187
TC 4
Z9 4
U1 7
U2 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 60
EP 70
DI 10.1016/j.abb.2014.07.022
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000010
PM 25065585
ER

PT J
AU Bonchak, JG
   Eby, JM
   Willenborg, KA
   Chrobak, D
   Henning, SW
   Krzywiec, A
   Johnson, SL
   Le Poole, IC
AF Bonchak, Jonathan G.
   Eby, Jonathan M.
   Willenborg, Kristin A.
   Chrobak, David
   Henning, Steven W.
   Krzywiec, Anna
   Johnson, Steven L.
   Le Poole, I. Caroline
TI Targeting melanocyte and melanoma stem cells by
   8-hydroxy-2-dipropylaminotetralin
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE MBEH; 8-DPAT; Melanocyte; Melanoma; Stem cells; Viability; Pigmentation
ID METASTATIC MELANOMA; MALIGNANT-MELANOMA; IMATINIB MESYLATE; CD34
   EXPRESSION; PAX3 FUNCTIONS; PHASE-II; KIT; DIFFERENTIATION;
   PIGMENTATION; AUTOIMMUNITY
AB Monobenzyl ether of hydroquinone (MBEH) is cytotoxic towards melanocytes. Its treatment efficacy is limited by an inability to eradicate stem cells. By contrast, 8-hydroxy-N,N-dipropyl-2-aminotetralin (8-DPAT) affects melanocyte stem cell survival. MBEH and 8-DPAT were added to melanocytes and melanoma cells to compare cytotoxicity. Stem cell content among viable cells was determined by fluorocytometry using markers CD34, Pax3, and CD271. Immunostaining was used to identify stem cells in skin explants treated with MBEH or 8-DPAT ex vivo. Mice were exposed to MBEH or 8-DPAT and scanned for depigmentation before harvesting skin. MBEH exposure prompted a relative increase in stem cells among cultured melanocytes and melanoma cells, as treatment preferentially eliminated differentiated cells and spared the stem cells. Viability of this remaining, enriched stem cell population was however rapidly reduced by exposure to 8-DPAT within melanocyte and melanoma cell cultures. In human skin explants, the abundance of melanocyte stem cells was also visibly reduced after 8-DPAT treatment, in contrast to tissue exposed to MBEH. Meanwhile, significant depigmentation of the mouse pelage and loss of differentiated melanocytes was observed in vivo in response to topical application of MBEH, but not 8-DPAT. Prolonged application of the latter agent instead appeared to effectively reduce the abundance of melanocyte stem cells in the dermis. This furthers the idea that MBEH and 8-DPAT target complementary cell populations. Results indicate that combination treatment may demonstrate superior therapeutic activity by eliminating both differentiated and tumor initiating populations. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Bonchak, Jonathan G.] Loyola Univ, Med Ctr, Dept Med, Maywood, IL 60153 USA.
   [Bonchak, Jonathan G.] Loyola Univ, Med Ctr, Dept Radiol, Maywood, IL 60153 USA.
   [Eby, Jonathan M.; Willenborg, Kristin A.; Chrobak, David; Henning, Steven W.; Le Poole, I. Caroline] Loyola Univ, Med Ctr, Oncol Res Inst, Maywood, IL 60153 USA.
   [Krzywiec, Anna] Illinois Math & Sci Acad, Aurora, IL USA.
   [Johnson, Steven L.] Washington Univ, Sch Med, Dept Genet, St Louis, MA USA.
   [Le Poole, I. Caroline] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA.
   [Le Poole, I. Caroline] Loyola Univ, Med Ctr, Dept Microbiol, Maywood, IL 60153 USA.
   [Le Poole, I. Caroline] Loyola Univ, Med Ctr, Dept Immunol, Maywood, IL 60153 USA.
RP Le Poole, IC (reprint author), Oncol Res Inst, Dept Pathol, Rm 203,2160 South 1st Ave, Maywood, IL 60153 USA.
EM ilepool@luc.edu
FU NIH/NCI [RO3 CA128068]
FX Support by NIH/NCI RO3 CA128068 to CLP is gratefully acknowledged.
CR Ackaert OW, 2010, J PHARM SCI-US, V99, P275, DOI 10.1002/jps.21833
   Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454
   Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466
   Guo J, 2011, J CLIN ONCOL, V29, P2904, DOI 10.1200/JCO.2010.33.9275
   Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997
   Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x
   Lotti T, 2008, DERMATOL THER, V21, P110, DOI 10.1111/j.1529-8019.2008.00178.x
   Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292
   Nishimura EK, 2011, PIGM CELL MELANOMA R, V24, P401, DOI 10.1111/j.1755-148X.2011.00855.x
   Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567
   Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343
   Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161
   Engelhard VH, 2002, IMMUNOL REV, V188, P136, DOI 10.1034/j.1600-065X.2002.18812.x
   Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a
   Schatton T, 2008, PIGM CELL MELANOMA R, V21, P39, DOI 10.1111/j.1755-148X.2007.00427.x
   Bhatia S, 2009, ONCOLOGY-NY, V23, P488
   Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x
   Westerhof W, 2007, PIGM CELL RES, V20, P345, DOI 10.1111/j.1600-0749.2007.00399.x
   Benninghoff J, 2010, NEUROPSYCHOPHARMACOL, V35, P893, DOI 10.1038/npp.2009.181
   Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746
   Held MA, 2010, CANCER RES, V70, P388, DOI 10.1158/0008-5472.CAN-09-2153
   Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102
   Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465
   Little EG, 2012, DERMATOL CLIN, V30, P355, DOI 10.1016/j.det.2012.04.001
   Lang D, 2013, CLIN DERMATOL, V31, P166, DOI 10.1016/j.clindermatol.2012.08.014
   Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661
   Assie MB, 1996, BRIT J PHARMACOL, V119, P845
   Kim KB, 2008, BRIT J CANCER, V99, P734, DOI 10.1038/sj.bjc.6604482
   Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304
   Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x
   Bolognia JL, 2001, DERMATOL THER, V14, P29, DOI 10.1046/j.1529-8019.2001.014001029.x
   Breza TS, 2005, J CUTAN PATHOL, V32, P685, DOI 10.1111/j.0303-6987.2005.00367.x
   Buzaid AC, 2001, CLIN CANCER RES, V7, P2611
   Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
   DEROOY ECH, 1990, PHARMACOL BIOCHEM BE, V36, P937, DOI 10.1016/0091-3057(90)90103-O
   Grichnik JM, 2006, J INVEST DERMATOL, V126, P945, DOI 10.1038/sj.jid.5700164
   Hariharan V, 2011, MELANOMA RES, V21, P115, DOI 10.1097/CMR.0b013e328343f542
   Hariharan V, 2010, J INVEST DERMATOL, V130, P211, DOI 10.1038/jid.2009.214
   Hoang MP, 2001, J CUTAN PATHOL, V28, P508, DOI 10.1034/j.1600-0560.2001.281003.x
   Hoerter J. D., 2012, J SKIN CANC, V2012
   Hoerter J.D., 2012, STEM CELLS INT, V2
   Hultman KA, 2008, ZEBRAFISH, V5, P279, DOI 10.1089/zeb.2008.0542
   Lee N, 2014, LAB INVEST, V94, P13, DOI 10.1038/labinvest.2013.116
   Medic S, 2011, BIOCHEM BIOPH RES CO, V411, P832, DOI 10.1016/j.bbrc.2011.07.053
   Michalowicz J., 2007, POL J ENV STUD, V16
   Ohta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016182
   Osawa M, 2009, STEMBOOK
   Scorza MC, 2012, BRIT J PHARMACOL, V167, P1021, DOI 10.1111/j.1476-5381.2011.01770.x
   van den Boorn JG, 2011, J INVEST DERMATOL, V131, P1240, DOI 10.1038/jid.2011.16
   Zabierowski SE, 2011, PIGM CELL MELANOMA R, V24, P422, DOI 10.1111/j.1755-148X.2011.00847.x
NR 50
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 71
EP 78
DI 10.1016/j.abb.2014.07.033
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000011
PM 25132642
ER

PT J
AU Slominski, A
   Kim, TK
   Brozyna, AA
   Janjetovic, Z
   Brooks, DLP
   Schwab, LP
   Skobowiat, C
   Jozwicki, W
   Seagroves, TN
AF Slominski, A.
   Kim, T. -K.
   Brozyna, A. A.
   Janjetovic, Z.
   Brooks, D. L. P.
   Schwab, L. P.
   Skobowiat, C.
   Jozwicki, W.
   Seagroves, T. N.
TI The role of melanogenesis in regulation of melanoma behavior:
   Melanogenesis leads to stimulation of HIF-1 alpha expression and
   HIF-dependent attendant pathways
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Melanoma; Melanogenesis; HIF-1; Metabolism; Glycolysis; Melanoma
   progression
ID GROWTH-FACTOR EXPRESSION; INDUCIBLE FACTOR 1-ALPHA; PRIMARY-CELL
   CULTURE; HAMSTER MELANOMA; L-TYROSINE; L-DOPA; METASTATIC MELANOMA;
   CANCER-CELLS; VITAMIN-D; GLUCOSE TRANSPORTERS
AB To study the effect of melanogenesis on HIF-1 alpha expression and attendant pathways, we used stable human and hamster melanoma cell lines in which the amelanotic vs. melanotic phenotypes are dependent upon the concentration of melanogenesis precursors in the culture media. The induction of melanin pigmentation led to significant up-regulation of HIF-1 alpha, but not HIF-2 alpha, protein in melanized cells for both lines. Similar upregulation of nuclear HIF-1 alpha was observed in excisions of advanced melanotic vs. amelanotic melanomas. In cultured cells, melanogenesis also significantly stimulated expression of classical HIF-1-dependent target genes involved in angiogenesis and cellular metabolism, including glucose metabolism and stimulation of activity of key enzymes in the glycolytic pathway. Several other stress related genes containing putative HRE consensus sites were also upregulated by melanogenesis, concurrently with modulation of expression of HIF-1-independent genes encoding for steroidogenic enzymes, cytokines and growth factors. Immunohistochemical studies using a large panel of pigmented lesions revealed that higher levels of HIF-1 alpha and GLUT-1 were detected in advanced melanomas in comparison to melanocytic nevi or thin melanomas localized to the skin. However, the effects on overall or disease free survival in melanoma patients were modest or absent for GLUT-1 or for HIF-1 alpha, respectively. In conclusion, induction of the melanogenic pathway leads to robust upregulation of HIF-1-dependent and independent pathways in cultured melanoma cells, suggesting a key role for melanogenesis in regulation of cellular metabolism. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Slominski, A.; Kim, T. -K.; Janjetovic, Z.; Brooks, D. L. P.; Schwab, L. P.; Skobowiat, C.; Seagroves, T. N.] Univ Tennessee HSC, Dept Pathol & Lab Med, Memphis, TN USA.
   [Slominski, A.] Univ Tennessee HSC, Dept Med, Div Rheumatol, Memphis, TN USA.
   [Slominski, A.; Kim, T. -K.; Janjetovic, Z.; Brooks, D. L. P.; Schwab, L. P.; Skobowiat, C.; Seagroves, T. N.] Univ Tennessee HSC, Ctr Canc Res, Memphis, TN USA.
   [Brozyna, A. A.; Jozwicki, W.] Nicholas Copernicus Univ, Ludwik Rydygier Coll Med, Prof Franciszek Lukaszczyk Mem Hosp, Dept Tumor Pathol & Pathomorphol,Oncol Ctr, Bydgoszcz, Poland.
RP Slominski, A (reprint author), Dept Pathol, 930 Madison Ave,RM525, Memphis, TN 38163 USA.
EM aslominski@uthsc.edu
RI Skobowiat, Cezary/J-5007-2012; Jozwicki, Wojciech/I-1948-2014; Brozyna,
   Anna/D-4902-2014
OI Skobowiat, Cezary/0000-0002-3881-0231; Brozyna, Anna/0000-0002-3195-9965
FU NIH/NIAMS [2R06 AR052190, 1R01AR056666]; NIH/NCI [1R01CA138488]; West
   Clinic Cancer Foundation
FX This work was supported by grants from NIH/NIAMS (2R06 AR052190 and
   1R01AR056666 to AS), NIH/NCI (1R01CA138488 to TS) and the West Clinic
   Cancer Foundation awards to AS and TS. The paper is dedicated to Dr.
   Andrzej Bomirski, who established Bomirski melanomas that are
   transplantable to Syrian golden hamsters [110]. We thank Dr. Zbigniew
   Pawlowicz, Director of Oncology Centre - Prof. Franciszek Lukaszczyk
   Memorial Hospital for generously supporting collaborations advantageous
   for our research.
CR Chen PJ, 2012, EMBO J, V31, P959, DOI 10.1038/emboj.2011.448
   Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695
   SLOMINSKI A, 1991, FEBS LETT, V291, P165, DOI 10.1016/0014-5793(91)81274-C
   Lee JH, 2009, ANN SURG ONCOL, V16, P2834, DOI 10.1245/s10434-009-0583-5
   Slominski AT, 2014, ANTI-CANCER AGENT ME, V14, P77, DOI 10.2174/18715206113139990308
   [Anonymous], 2012, ADV ANAT EMBRYOL CEL
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003
   Wood JM, 1999, EXP DERMATOL, V8, P153, DOI 10.1111/j.1600-0625.1999.tb00365.x
   Slominski A, 1998, ANTICANCER RES, V18, P3709
   Slominski A, 2000, PHYSIOL REV, V80, P979
   Johnson DB, 2013, CANCER IMMUNOL RES, V1, P373, DOI 10.1158/2326-6066.CIR-13-0092
   Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338
   Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x
   Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005
   SLOMINSKI A, 1993, J THEOR BIOL, V164, P103, DOI 10.1006/jtbi.1993.1142
   Gaber T, 2011, J IMMUNOL, V186, P764, DOI 10.4049/jimmunol.0903421
   Slominski A, 2013, J STEROID BIOCHEM, V137, P107, DOI 10.1016/j.jsbmb.2013.02.006
   Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001
   Kobayashi M, 2005, BIOL PHARM BULL, V28, P1197, DOI 10.1248/bpb.28.1197
   Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x
   Weber JS, 2013, J CLIN ONCOL, V31, P4311, DOI 10.1200/JCO.2013.51.4802
   Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005
   SLOMINSKI A, 1989, PIGM CELL RES, V2, P109, DOI 10.1111/j.1600-0749.1989.tb00170.x
   Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055
   Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106
   Bikle DD, 2011, EXP DERMATOL, V20, P7, DOI 10.1111/j.1600-0625.2010.01202.x
   Schadendorf D, 2014, NAT REV CLIN ONCOL, V11, P75, DOI 10.1038/nrclinonc.2013.246
   Tonon L, 2010, NUCLEIC ACIDS RES, V38, pW286, DOI 10.1093/nar/gkq473
   Wachsberger PR, 2002, MELANOMA RES, V12, P35, DOI 10.1097/00008390-200202000-00006
   Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006
   Iervolino A, 2002, FASEB J, V16, P1453, DOI 10.1096/fj.02-0122fje.
   Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427
   Bailey KM, 2012, ADV PHARMACOL, V65, P63, DOI 10.1016/B978-0-12-397927-8.00004-X
   Giatromanolaki A, 2003, MELANOMA RES, V13, P493, DOI 10.1097/01.cmr.0000056268.56735.4c
   Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
   Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092
   Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006
   SLOMINSKI A, 1988, J CELL SCI, V89, P287
   Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093
   Shah DJ, 2014, MAYO CLIN PROC, V89, P504, DOI 10.1016/j.mayocp.2014.02.002
   Janjetovic Z, 2011, BRIT J CANCER, V105, P1874, DOI 10.1038/bjc.2011.458
   Kauser S, 2003, J INVEST DERMATOL, V120, P1073, DOI 10.1046/j.1523-1747.2003.12242.x
   Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143
   Stiehl DP, 2012, ONCOGENE, V31, P2283, DOI 10.1038/onc.2011.417
   Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143
   Sowter HM, 2003, CANCER RES, V63, P6130
   Slominski AT, 2014, MAYO CLIN PROC, V89, P429, DOI 10.1016/j.mayocp.2014.02.009
   Zhong H, 1999, CANCER RES, V59, P5830
   Bohm M, 2006, J INVEST DERMATOL, V126, P1966, DOI 10.1038/sj.jid.5700421
   Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev
   Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874
   Slominski A, 2005, ENDOCRINE, V27, P137, DOI 10.1385/ENDO:27:2:137
   Dang NHT, 2014, CURR PHARM DESIGN, V20, P2637
   Park SG, 2012, NUCL MED BIOL, V39, P1167, DOI 10.1016/j.nucmedbio.2012.07.003
   Robert C, 2013, LANCET ONCOL, V14, P733, DOI 10.1016/S1470-2045(13)70237-7
   Nosjean O, 2000, J BIOL CHEM, V275, P31311, DOI 10.1074/jbc.M005141200
   Kuphal S, 2010, EUR J CANCER, V46, P1159, DOI 10.1016/j.ejca.2010.01.031
   SLOMINSKI A, 1985, J CANCER RES CLIN, V109, P29, DOI 10.1007/BF01884251
   BOMIRSKI A, 1988, CANCER METAST REV, V7, P95, DOI 10.1007/BF00046481
   Brozyna AA, 2013, HUM PATHOL, V44, P374, DOI 10.1016/j.humpath.2012.03.031
   Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664
   Brozyna AA, 2011, HUM PATHOL, V42, P618, DOI 10.1016/j.humpath.2010.09.014
   Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955
   Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033
   Deng Q, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.324
   Grisouard J, 2010, BIOCHEM PHARMACOL, V80, P1736, DOI 10.1016/j.bcp.2010.08.021
   Hu JM, 2011, MOL CANCER RES, V9, P1520, DOI 10.1158/1541-7786.MCR-11-0090
   Joshi M.D., 1966, METHOD ENZYMOL, V9, P371
   Kauser S, 2004, J INVEST DERMATOL, V123, P184, DOI 10.1111/j.0022-202X.2004.22724.x
   Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707
   KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464
   Kwong LN, 2014, ONCOGENE, V33, P1, DOI 10.1038/onc.2013.34
   Lerner A.B., 1950, PHYSIOL REV, V30, P1
   Levine D, 2014, METHODS MOL BIOL, V1102, P177, DOI 10.1007/978-1-62703-727-3_11
   Li W, 2009, ANAL BIOCHEM, V386, P282, DOI 10.1016/j.ab.2008.12.017
   Lindsey JD, 2001, ARCH OPHTHALMOL-CHIC, V119, P853
   Liu L, 2011, J CELL PHYSIOL, V226, P1702, DOI 10.1002/jcp.22501
   Mihic-Probst D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033571
   Mills CN, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-104
   Murai M, 2005, CLIN CANCER RES, V11, P1021
   Parente P, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-34
   PAWELEK J, 1980, NATURE, V286, P617, DOI 10.1038/286617a0
   PAWELEK JM, 1982, AM SCI, V70, P136
   Prota G, 1995, Fortschr Chem Org Naturst, V64, P93
   Rutter W.J., 1966, METHOD ENZYMOL, V9, P479
   Schodel J, 2013, BIOL CHEM, V394, P507, DOI 10.1515/hsz-2012-0351
   Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087
   SCISLOWSKI PWD, 1983, NEOPLASMA, V30, P239
   SCISLOWSKI PWD, 1985, NEOPLASMA, V32, P593
   SCISLOWSKI PWD, 1984, INT J BIOCHEM, V16, P327, DOI 10.1016/0020-711X(84)90107-1
   Semenza Gregg L, 2007, Sci STKE, V2007, pcm8, DOI 10.1126/stke.4072007cm8
   Shi Q, 2010, GENE THER, V17, P1085, DOI 10.1038/gt.2010.55
   Slominski A, 1999, IN VITRO CELL DEV-AN, V35, P564
   SLOMINSKI A, 1987, BIOSCIENCE REP, V7, P949, DOI 10.1007/BF01122128
   SLOMINSKI A, 1991, LIFE SCI, V48, P2075, DOI 10.1016/0024-3205(91)90164-7
   SLOMINSKI A, 1983, BIOSCIENCE REP, V3, P189, DOI 10.1007/BF01121951
   SLOMINSKI A, 1991, ANTICANCER RES, V11, P257
   SLOMINSKI A, 1992, PIGM CELL RES, V5, P396, DOI 10.1111/j.1600-0749.1992.tb00569.x
   SLOMINSKI A, 1983, BIOSCIENCE REP, V3, P1027, DOI 10.1007/BF01121029
   SLOMINSKI A, 1991, EXPERIENTIA, V47, P721, DOI 10.1007/BF01958826
   SLOMINSKI A, 1989, BIOSCIENCE REP, V9, P579, DOI 10.1007/BF01119801
   Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003
   Stolzenbach F., 1966, METHOD ENZYMOL, V9, P278
   Valencak J, 2009, CLIN EXP DERMATOL, V34, pE962, DOI 10.1111/j.1365-2230.2009.03706.x
   Victor N, 2006, CLIN EXP METASTAS, V23, P87, DOI 10.1007/s10585-006-9024-z
   Yamada K, 2005, J DERMATOL, V32, P316
   Zbytek Blazej, 2013, Dermatoendocrinol, V5, P239, DOI 10.4161/derm.22678
NR 110
TC 14
Z9 14
U1 3
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 79
EP 93
DI 10.1016/j.abb.2014.06.030
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000012
PM 24997364
ER

PT J
AU Wilking, MJ
   Singh, C
   Nihal, M
   Zhong, WX
   Ahmad, N
AF Wilking, Melissa J.
   Singh, Chandra
   Nihal, Minakshi
   Zhong, Weixiong
   Ahmad, Nihal
TI SIRT1 deacetylase is overexpressed in human melanoma and its small
   molecule inhibition imparts anti-proliferative response via p53
   activation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE SIRT1; Melanoma; p53; p21; Tenovin-1
ID PROSTATE-CANCER CELLS; MALIGNANT-MELANOMA; IN-VITRO; APOPTOSIS;
   EXPRESSION; ACETYLATION; SENESCENCE; SIRTUINS; INSIGHTS; ROLES
AB Melanoma causes more deaths than any other skin cancer, and its incidence in the US continues to rise. Current medical therapies are insufficient to control this deadly neoplasm, necessitating the development of new target-based approaches. The objective of this study was to determine the role and functional significance of the class III histone deacetylase SIRT1 in melanoma. We have found that SIRT1 is overexpressed in clinical human melanoma tissues and human melanoma cell lines (Sk-Mel-2, WM35, G361, A375, and Hs294T) compared to normal skin and normal melanocytes, respectively. In addition, treatment of melanoma cell lines A375, Hs294T, and G361 with Tenovin-1, a small molecule SIRT1 inhibitor, resulted in a significant decrease in cell growth and cell viability. Further, Tenovin-1 treatment also resulted in a marked decrease in the clonogenic survival of melanoma cells. Further experiments showed that the anti-proliferative response of Tenovin-1 was accompanied by an increase in the protein as well as activity of the tumor suppressor p53. This increase in p53 activity was substantiated by an increase in the protein level of its downstream target p21. Overall, these data suggest that small molecule inhibition of SIRT1 causes anti-proliferative effects in melanoma cells. SIRT1 appears to be acting through the activity of the tumor suppressor p53, which is not mutated in the majority of melanomas. However, future detailed studies are needed to further explore the role and mechanism of SIRT1 in melanoma development and progression and its usefulness in melanoma treatment. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wilking, Melissa J.; Singh, Chandra; Nihal, Minakshi; Ahmad, Nihal] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA.
   [Zhong, Weixiong] Univ Wisconsin, Dept Pathol, Madison, WI 53706 USA.
   [Ahmad, Nihal] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA.
RP Ahmad, N (reprint author), Univ Wisconsin, Med Sci Ctr, Dept Dermatol, 1300 Univ Ave,Room 423, Madison, WI 53706 USA.
EM nahmad@wisc.edu
FU NIH [R01AR059130, R01CA176748]; Department of Veterans Affairs
   [1I01BX001008]
FX This work was partially supported by funding from the NIH (R01AR059130
   and R01CA176748 and the Department of Veterans Affairs (VA Merit Review
   Award 1I01BX001008).
CR Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454
   Jemal A, 2011, J AM ACAD DERMATOL, V65, pS17, DOI 10.1016/j.jaad.2011.04.032
   Byles V, 2010, INT J BIOL SCI, V6, P599
   GIARD DJ, 1973, J NATL CANCER I, V51, P1417
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Stunkel W, 2011, J BIOMOL SCREEN, V16, P1153, DOI 10.1177/1087057111422103
   Chen X, 2006, CANCER RES, V66, P11323, DOI 10.1158/0008-5472.CAN-06-1536
   Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
   Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004
   Choi HN, 2011, ONCOL REP, V26, P503, DOI 10.3892/or.2011.1301
   Dahl C, 2007, APMIS, V115, P1161, DOI 10.1111/j.1600-0463.2007.apm_855.xml.x
   Jung-Hynes B, 2010, J PINEAL RES, V49, P60, DOI 10.1111/j.1600-079X.2010.00767.x
   Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140
   Yuan HF, 2013, ONCOTARGETS THER, V6, P1399, DOI 10.2147/OTT.S37750
   Fok JY, 2006, MOL CANCER THER, V5, P1493, DOI 10.1158/1535-7163.MCT-06-0083
   Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872
   Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020
   Zhao G, 2011, GENE THER, V18, P920, DOI 10.1038/gt.2011.81
   Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200
   Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584
   Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581
   Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025
   Ahmad I, 2013, TOXICOL APPL PHARM, V270, P70, DOI 10.1016/j.taap.2013.03.027
   Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935
   CREASEY AA, 1979, IN VITRO CELL DEV B, V15, P342
   Fogh J., 1975, HUMAN TUMOR CELLS IN, P120
   HERLYN M, 1990, CANCER METAST REV, V9, P101, DOI 10.1007/BF00046337
   Hide Y., 2007, ARCH DERMATOL RES, V299, P103
   Kalle AM, 2010, BIOCHEM BIOPH RES CO, V401, P13, DOI 10.1016/j.bbrc.2010.08.118
   Kunimoto R., 2014, J INVEST DERMATOL
   Looi CY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-166
   Ma JX, 2013, NEUROPATHOLOGY, V33, P7, DOI 10.1111/j.1440-1789.2012.01318.x
   PEEBLES PT, 1978, PEDIATR RES, V12, P485, DOI 10.1203/00006450-197804001-00732
   Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276
   Satyamoorthy K, 2000, CELL GROWTH DIFFER, V11, P467
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Vanleeuwen I., 2009, ADV CANCER RES, P171
NR 37
TC 7
Z9 8
U1 3
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 94
EP 100
DI 10.1016/j.abb.2014.04.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000013
PM 24751483
ER

PT J
AU Nihal, M
   Wu, JQ
   Wood, GS
AF Nihal, Minakshi
   Wu, Jianqiang
   Wood, Gary S.
TI Methotrexate inhibits the viability of human melanoma cell lines and
   enhances Fas/Fas-ligand expression, apoptosis and response to
   interferon-alpha: Rationale for its use in combination therapy
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Melanoma; Methotrexate; Fas/FasL; Apoptosis; DNA methylation
ID BRAF-MUTANT MELANOMA; FAS-LIGAND; DIHYDROFOLATE-REDUCTASE;
   DOWN-REGULATION; UP-REGULATION; CANCER CELLS; RESISTANCE;
   3-O-(3,4,5-TRIMETHOXYBENZOYL)-(-)-EPICATECHIN; CHEMOTHERAPY; ACTIVATION
AB Melanoma, a highly aggressive form of cancer, is notoriously resistant to available therapies. Methotrexate (MTX), an antifolate, competitively inhibits DNA synthesis and is effective for several types of cancer. In cutaneous T-cell lymphoma (CTCL), MTX increases Fas death receptor by decreasing Fas promoter methylation by blocking the synthesis of SAM, the principal methyl donor for DNMTs, resulting in enhanced Fas-mediated apoptosis. The objective of this study was to explore the effects of MTX in human melanoma. MTX variably inhibited the survival of melanoma cells and induced apoptosis as evident by annexin V positivity and senescence associated beta-galactosidase activity induction. Furthermore, MTX caused increased transcript and protein levels of extrinsic apoptotic pathway factors Fas and Fas-ligand, albeit at different levels in different cell lines. Our pyrosequencing studies showed that this increased expression of Fas was associated with Fas promoter demethylation. Overall, the ability of MTX to up-regulate Fas/FasL and enhance melanoma apoptosis through extrinsic as well as intrinsic pathways might make it a useful component of novel combination therapies designed to affect multiple melanoma targets simultaneously. In support of this concept, combination therapy with MTX and interferon-alpha (IFN alpha) induced significantly greater apoptosis in the aggressive A375 cell line than either agent alone. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Nihal, Minakshi; Wu, Jianqiang; Wood, Gary S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53706 USA.
   [Nihal, Minakshi; Wood, Gary S.] Paul P Carbone Comprehens Canc Ctr, Madison, WI USA.
   [Wood, Gary S.] Wm S Middleton VA Med Ctr, Madison, WI USA.
RP Wood, GS (reprint author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, 1300 Univ Ave,Room B25, Madison, WI 53706 USA.
EM gwood@dermatology.wisc.edu
FU Department of Veterans Affairs; NCI [P30CA014520]
FX Supported by Merit Review funding from the Department of Veterans
   Affairs (GSW) and NCI Grant is P30CA014520 (UWCCC).
CR Jang S, 2014, CLIN PHARMACOL THER, V95, P24, DOI 10.1038/clpt.2013.197
   Wu JQ, 2011, ARCH DERMATOL, V147, P443, DOI 10.1001/archdermatol.2010.376
   Jang S, 2013, LANCET ONCOL, V14, pE60, DOI 10.1016/S1470-2045(12)70539-9
   Chan H, 1999, MOL CELL BIOL, V19, P2098
   Sanchez-del-Campo L, 2009, MOL PHARMACEUT, V6, P883, DOI 10.1021/mp800259k
   Richards S, 2013, PEDIATR BLOOD CANCER, V60, P185, DOI 10.1002/pbc.24228
   Porcelli L, 2011, CURR DRUG METAB, V12, P975
   Wu JQ, 2009, J INVEST DERMATOL, V129, P1165, DOI 10.1038/jid.2008.309
   Helmbach H, 2001, INT J CANCER, V93, P617, DOI 10.1002/ijc.1378
   OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075
   Wu JQ, 2011, ARCH BIOCHEM BIOPHYS, V508, P185, DOI 10.1016/j.abb.2010.10.020
   Salva K, 2014, J INVEST DERMATOL, V134, pS117
   Barker CA, 2014, INT J RADIAT ONCOL, V88, P986, DOI 10.1016/j.ijrobp.2013.08.035
   Martin M, 2003, ANN ONCOL, V14, P833, DOI 10.1093/annonc/mdg260
   Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363
   Sinha AK, 2006, BRIT J CANCER, V95, P485, DOI 10.1038/sj.bjc.6603273
   Aviles A, 2007, CANCER BIOTHER RADIO, V22, P836, DOI 10.1089/cbr.2007.0402
   Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574
   Ivanov VN, 2003, ONCOGENE, V22, P3152, DOI 10.1038/sj.onc.1206456
   SCHIMKE RT, 1984, CELL, V37, P705, DOI 10.1016/0092-8674(84)90406-9
   Saez-Ayala M, 2013, CANCER CELL, V24, P105, DOI 10.1016/j.ccr.2013.05.009
   Bullani RR, 2002, MELANOMA RES, V12, P263, DOI 10.1097/00008390-200206000-00010
   CAMARGO M, 1980, HUM GENET, V54, P47, DOI 10.1007/BF00279048
   Ekmekcioglu S, 1999, MELANOMA RES, V9, P261, DOI 10.1097/00008390-199906000-00008
   Kainthla Radhika, 2014, Pharmgenomics Pers Med, V7, P21, DOI 10.2147/PGPM.S37220
   Kim K B, 2001, Expert Rev Anticancer Ther, V1, P99, DOI 10.1586/14737140.1.1.99
   Owen-Schaub LB, 1998, J EXP MED, V188, P1717, DOI 10.1084/jem.188.9.1717
   Philips M.R., 2004, SCI STKE, V2004, ppe13
   PORCILE G, 1979, TUMORI, V65, P237
   ROTHENBERG M, 1989, JNCI-J NATL CANCER I, V81, P907, DOI 10.1093/jnci/81.12.907
   Saez-Ayala M, 2012, EXP CELL RES, V318, P1146, DOI 10.1016/j.yexcr.2012.03.022
   Sanchez-del-Campo L, 2009, PIGM CELL MELANOMA R, V22, P588, DOI 10.1111/j.1755-148X.2009.00586.x
   Sanchez-del-Campo L, 2010, J CELL BIOCHEM, V110, P1399, DOI 10.1002/jcb.22656
   Sanchez-del-Campo L, 2008, INT J CANCER, V123, P2446, DOI 10.1002/ijc.23813
   SORENSEN JB, 1988, CANCER CHEMOTH PHARM, V21, P103
   Takahashi K, 2013, WORLD J GASTROENTERO, V19, P5187, DOI 10.3748/wjg.v19.i31.5187
   Ugurel S, 1999, INT J CANCER, V82, P727, DOI 10.1002/(SICI)1097-0215(19990827)82:5<727::AID-IJC17>3.0.CO;2-E
   Ugurel S, 2001, CLIN CANCER RES, V7, P1282
   Voskoboynik M, 2014, BIOCH RES INT, V2014
   Wu J, 2014, J INVEST DERMATOL, V134, pS32
NR 40
TC 1
Z9 1
U1 2
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 101
EP 107
DI 10.1016/j.abb.2014.04.019
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000014
PM 24862567
ER

PT J
AU Syed, DN
   Lall, RK
   Chamcheu, JC
   Haidar, O
   Mukhtar, H
AF Syed, Deeba N.
   Lall, Rahul K.
   Chamcheu, Jean Christopher
   Haidar, Omar
   Mukhtar, Hasan
TI Involvement of ER stress and activation of apoptotic pathways in fisetin
   induced cytotoxicity in human melanoma
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Fisetin; Cytotoxicity; Melanoma
ID DIETARY FLAVONOID FISETIN; PROTEIN-KINASE; CANCER-CELLS;
   MALIGNANT-MELANOMA; SIGNALING PATHWAYS; PROSTATE-CANCER; AUTOPHAGY;
   INHIBITION; SURVIVAL; THERAPY
AB The prognosis of malignant melanoma remains poor in spite of recent advances in therapeutic strategies for the deadly disease. Fisetin, a dietary flavonoid is currently being investigated for its growth inhibitory properties in various cancer models. We previously showed that fisetin inhibited melanoma growth in vitro and in vivo. Here, we evaluated the molecular basis of fisetin induced cytotoxicity in metastatic human melanoma cells. Fisetin treatment induced endoplasmic reticulum (ER) stress in highly aggressive A375 and 451Lu human melanoma cells, as revealed by up-regulation of ER stress markers including IRE1 alpha, XBP1s, ATF4 and GRP78. Time course analysis indicated that the ER stress was associated with activation of the extrinsic and intrinsic apoptotic pathways. Fisetin treated 2-D melanoma cultures displayed autophagic response concomitant with induction of apoptosis. Prolonged treatment (16 days) with fisetin in a 3-D reconstituted melanoma model resulted in inhibition of melanoma progression with significant apoptosis, as evidenced by increased staining of cleaved Caspase-3 in the treated constructs. However, no difference in the expression of autophagic marker LC-3 was noted between treated and control groups. Fisetin treatment to 2-D melanoma cultures resulted in phosphorylation and activation of the multifunctional AMP-activated protein kinase (AMPK) involved in the regulation of diverse cellular processes, including autophagy and apoptosis. Silencing of AMPK failed to prevent cell death indicating that fisetin induced cytotoxicity is mediated through both AMPK-dependent and -independent mechanisms. Taken together, our studies confirm apoptosis as the primary mechanism through which fisetin inhibits melanoma cell growth and that activation of both extrinsic and intrinsic pathways contributes to fisetin induced cytotoxicity. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Syed, Deeba N.; Lall, Rahul K.; Chamcheu, Jean Christopher; Haidar, Omar; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA.
RP Mukhtar, H (reprint author), Univ Wisconsin, Med Sci Ctr, Dept Dermatol, Room 4385,1300 Univ Ave, Madison, WI 53706 USA.
EM hmukhtar@wisc.edu
FU United States Public Health Service [R01CA160867, T32 ES007015]
FX This work was supported by United States Public Health Service Grants
   R01CA160867 and T32 ES007015. The authors thank Brendan T. Boylan for
   his assistance in 3-D immunostaining.
CR Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763
   Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833
   Benbrook D. M., 2012, Experimental Oncology, V34, P286
   Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454
   Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a
   Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746
   Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003
   Fried LE, 2009, ANTIOXID REDOX SIGN, V11, P1139, DOI 10.1089/ARS.2009.2440
   Liang XH, 1999, NATURE, V402, P672
   Jang KY, 2012, CANCER LETT, V319, P197, DOI 10.1016/j.canlet.2012.01.008
   Kundu JK, 2005, MUTAT RES-FUND MOL M, V591, P123, DOI 10.1016/j.mrfmmm.2005.04.019
   Logue SE, 2013, APOPTOSIS, V18, P537, DOI 10.1007/s10495-013-0818-6
   Go YM, 2004, J BIOL CHEM, V279, P5837, DOI 10.1074/jbc.M307547200
   Nagalingam A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3128
   Martinon F, 2012, ACTA ONCOL, V51, P822, DOI 10.3109/0284186X.2012.689113
   Khan N, 2013, ANTIOXID REDOX SIGN, V19, P151, DOI 10.1089/ars.2012.4901
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Jiang CC, 2008, CANCER RES, V68, P6708, DOI 10.1158/0008-5472.CAN-08-0349
   Syed DN, 2011, J INVEST DERMATOL, V131, P1291, DOI 10.1038/jid.2011.6
   Tripathi DN, 2013, P NATL ACAD SCI USA, V110, pE2950, DOI 10.1073/pnas.1307736110
   Droge W, 2002, PHYSIOL REV, V82, P47
   He Y, 2010, GENE EXPRESSION, V15, P13, DOI 10.3727/105221610X12819686555051
   Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005
   Prasath GS, 2013, FOOD CHEM TOXICOL, V59, P249, DOI 10.1016/j.fct.2013.05.062
   Martin S, 2013, BRIT J CANCER, V109, P433, DOI 10.1038/bjc.2013.325
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x
   Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x
   Suh Y, 2010, CARCINOGENESIS, V31, P1424, DOI 10.1093/carcin/bgq115
   Syed DN, 2008, CANCER LETT, V265, P167, DOI 10.1016/j.canlet.2008.02.050
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803
   Woodard J, 2010, BIOCHEM BIOPH RES CO, V398, P135, DOI 10.1016/j.bbrc.2010.06.052
   Hersey P, 2008, PIGM CELL MELANOMA R, V21, P358, DOI 10.1111/j.1755-148X.2008.00467.x
   Bonini MG, 2013, IUBMB LIFE, V65, P889, DOI 10.1002/iub.1213
   Filomeni G, 2010, AUTOPHAGY, V6, P202
   Hartman ML, 2013, CANCER LETT, V331, P24, DOI 10.1016/j.canlet.2013.01.010
   Kang KA, 2014, IN VITRO CELL DEV-AN, V50, P66, DOI 10.1007/s11626-013-9681-6
   Liu W Y, 2013, Pak J Biol Sci, V16, P1459
   Oberley TD, 2002, AM J PATHOL, V160, P403, DOI 10.1016/S0002-9440(10)64857-2
   Sarasin A, 2010, CURR MOL MED, V10, P413
   Steinberg G.R., 2009, PHYSL APPL NUTR META, V34, P315
   Syed DN, 2013, ANTI-CANCER AGENT ME, V13, P995
   Syed DN, 2014, BIOCHEM PHARMACOL, V89, P349, DOI 10.1016/j.bcp.2014.03.007
   Voskoboynik M, 2014, BIOCH RES INT, V2014
   Wu MS, 2014, MOL CARCINOGEN, V53, pE119, DOI 10.1002/mc.22053
   Yang ZNJ, 2011, CANCER BIOL THER, V11, P169, DOI 10.4161/cbt.11.2.14663
NR 47
TC 1
Z9 1
U1 2
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 108
EP 117
DI 10.1016/j.abb.2014.06.034
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000015
PM 25016296
ER

PT J
AU Strong, AMP
   Setaluri, V
   Spiegelman, VS
AF Strong, Ashley M. Poenitzsch
   Setaluri, Vijayasaradhi
   Spiegelman, Vladimir S.
TI microRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE microRNA; miR-340; Melanoma; Tumor suppressor; Proliferation; Invasion;
   RAS; RAF; MAPK
ID IN-VITRO; TARGETS; CANCER; GROWTH; BRAF; IDENTIFICATION; INHIBITION;
   PREDICTION; DISEASE; KINASE
AB microRNA (miRNA)-dependent regulation of gene expression is increasingly linked to development and progression of melanoma. In this study we evaluated the functions of miR-340 in human melanoma cells. Here, we show that miR-340 inhibits the tumorigenic phenotype of melanoma cells. We also found that miR-340 regulates RAS-RAF-Mitogen Activated Protein Kinase (MAPK) signaling by modulating the expression of multiple components of this pathway. Given the importance of MAPK signaling in melanoma, these results provide further insight into the pathogenesis of melanoma. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Strong, Ashley M. Poenitzsch; Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53706 USA.
   [Strong, Ashley M. Poenitzsch; Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.] Univ Wisconsin, Sch Med & Publ Hlth, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA.
   [Setaluri, Vijayasaradhi; Spiegelman, Vladimir S.] Univ Wisconsin, Sch Med & Publ Hlth, UW Carbone Canc Ctr, Madison, WI 53792 USA.
RP Spiegelman, VS (reprint author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, 1300 Univ Ave,MSC 417, Madison, WI 53706 USA.
EM spiegelman@dermatology.wisc.edu
FU NIEHS [ES007015]; NIAMS [AR063361]
FX We would like to thank Edwarda Desouza and Emily Adochio for their
   technical assistance. We would also like to thank Drs. Meenhard Herlyn,
   Yiqun Shellman, Paul Robbins and Anja Katrin Bosserhoff for their
   generous gifts of reagents. This research is supported by NIEHS training
   Grant ES007015 (to A.M.P.) and NIAMS grant AR063361 (to V.S.S.).
CR Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397
   Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1
   Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044
   Sun Y, 2012, ONCOL REP, V28, P1346, DOI 10.3892/or.2012.1958
   Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766
   Zhou X, 2013, BIOCHEM BIOPH RES CO, V437, P653, DOI 10.1016/j.bbrc.2013.07.033
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641
   Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Davies MA, 2009, CLIN CANCER RES, V15, P7538, DOI 10.1158/1078-0432.CCR-09-1985
   Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115
   Krutovskikh VA, 2010, BIOESSAYS, V32, P894, DOI 10.1002/bies.201000040
   Medina PP, 2008, CELL CYCLE, V7, P2485
   [Anonymous], 2013, KYOTO ENCY GENES GEN
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Fedorenko IV, 2013, ONCOGENE, V32, P3009, DOI 10.1038/onc.2012.453
   Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002
   Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206
   Rovira C, 2010, IUBMB LIFE, V62, P859, DOI 10.1002/iub.399
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Bell RE, 2014, J INVEST DERMATOL, V134, P441, DOI 10.1038/jid.2013.340
   Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009
   Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995
   Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166
   Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031
   Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768
   Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90
   Dorn GW, 2013, CELL CYCLE, V12, P707, DOI 10.4161/cc.23858
   Haass NK, 2008, CLIN CANCER RES, V14, P230, DOI 10.1158/1078-0432.CCR-07-1440
   HERLYN D, 1990, CANCER RES, V50, P2296
   Hinselwood DC, 2005, ELECTROPHORESIS, V26, P2553, DOI 10.1002/elps.200410427
   John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363
   Maddodi N, 2010, J INVEST DERMATOL, V130, P1657, DOI 10.1038/jid.2010.26
   Megraw M., 2007, NUCLEIC ACIDS RES, V35, P0149
   Solus JF, 2013, ADV ANAT PATHOL, V20, P217, DOI 10.1097/PAP.0b013e3182976c94
   Surgucheva Irina, 2010, J Ocul Biol Dis Infor, V3, P41, DOI 10.1007/s12177-010-9054-2
   Wu ZS, 2011, CANCER-AM CANCER SOC, V117, P2842, DOI 10.1002/cncr.25860
NR 42
TC 6
Z9 6
U1 2
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 118
EP 124
DI 10.1016/j.abb.2014.07.012
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000016
ER

PT J
AU Mehrotra, A
   Saladi, SV
   Trivedi, AR
   Aras, S
   Qi, HL
   Jayanthy, A
   Setaluri, V
   de la Serna, IL
AF Mehrotra, Aanchal
   Saladi, Srinivas Vinod
   Trivedi, Archit R.
   Aras, Shweta
   Qi, Huiling
   Jayanthy, Ashika
   Setaluri, Vijayasaradhi
   de la Serna, Ivana L.
TI Modulation of BRAHMA expression by the mitogen-activated protein
   kinase/extracellular signal regulated kinase pathway is associated with
   changes in melanoma proliferation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE SWI/SNF chromatin remodeling enzymes; BRG1/BRM; Melanoma; BRAF(V600E);
   Mitogen-activated protein kinase/extracellular signal regulated kinase
   (ERK1/2) pathway; Vemurafenib
ID CHROMATIN REMODELING COMPLEX; TRANSCRIPTION FACTOR; CELL-LINES; BRM
   EXPRESSION; SWI/SNF; CANCER; BRG1; BRAF; SENESCENCE; INHIBITOR
AB ahma (BRM) and Brahma-related gene 1(BRG1) are catalytic subunits of SWItch/sucrose non-fermentable (SWI/SNF) chromatin remodeling complexes. BRM is epigenetically silenced in a wide-range of tumors. Mutations in the v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene occur frequently in melanoma and lead to constitutive activation of the mitogen-activated protein kinase (MAPK)/extracellular signal regulated kinase (ERK1/2) pathway. We tested the hypothesis that BRM expression is modulated by oncogenic BRAF and phosphorylation of ERK1/2 in melanocytes and melanoma cells. Expression of oncogenic BRAF in melanocytes and melanoma cells that are wild-type for BRAF decreased BRM expression and increased BRG1 expression. Inhibition of mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) or selective inhibition of BRAF in melanoma cells that harbor oncogenic BRAF increased BRM expression and decreased BRG1 expression. Increased BRM expression was associated with increased histone acetylation on the BRM promoter. Over-expression of BRM in melanoma cells that harbor oncogenic BRAF promoted changes in cell cycle progression and apoptosis consistent with a tumor suppressive role. Upon inhibition of BRAF(V600E) with PLX4032, BRM promoted survival. PLX4032 induced changes in BRM function were correlated with increased acetylation of the BRM protein. This study provides insights into the epigenetic consequences of inhibiting oncogenic BRAF in melanoma through modulation of SWI/SNF subunit expression and function. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Mehrotra, Aanchal; Saladi, Srinivas Vinod; Trivedi, Archit R.; Aras, Shweta; Qi, Huiling; de la Serna, Ivana L.] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43614 USA.
   [Jayanthy, Ashika; Setaluri, Vijayasaradhi] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA.
RP de la Serna, IL (reprint author), Univ Toledo, Coll Med, Dept Biochem & Canc Biol, 3035 Arlington Ave, Toledo, OH 43614 USA.
EM ivana.delaserna@utoledo.edu
FU Ohio Cancer Research Associates; Ohio Division of the American Cancer
   Society; National Institute of Health [R01(ARO59379)]
FX We would like to thank Dr. Christian Muchardt (Institut Pasteur) for the
   antisera to acetylated BRM. This work was supported by funding from the
   Ohio Cancer Research Associates, the Ohio Division of the American
   Cancer Society, and by funding from the National Institute of Health
   R01(ARO59379).
CR Reisman DN, 2003, CANCER RES, V63, P560
   Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223
   Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005
   Bourachot B, 2003, EMBO J, V22, P6505, DOI 10.1093/emboj/cdg621
   Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766
   Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200
   Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664
   Strober BE, 1996, MOL CELL BIOL, V16, P1576
   Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011
   Keenen B, 2010, ONCOGENE, V29, P81, DOI 10.1038/onc.2009.304
   Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882
   Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514
   Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433
   Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022
   Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008
   Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356
   Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024
   Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302
   Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283
   Liu G, 2011, ONCOGENE, V30, P3295, DOI 10.1038/onc.2011.81
   Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x
   Shen H, 2008, CANCER RES, V68, P10154, DOI 10.1158/0008-5472.CAN-08-1794
   Primot A, 2010, PIGM CELL MELANOMA R, V23, P93, DOI 10.1111/j.1755-148X.2009.00652.x
   Halliday GM, 2012, EXP DERMATOL, V21, P599, DOI 10.1111/j.1600-0625.2012.01522.x
   Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979
   Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x
   De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000
   Kahali B, 2014, ONCOGENE, V33, P653, DOI 10.1038/onc.2012.613
   Saladi SV, 2013, PIGM CELL MELANOMA R, V26, P377, DOI 10.1111/pcmr.12088
   Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361
   Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0
   Vachtenheim J, 2010, BIOCHEM BIOPH RES CO, V392, P454, DOI 10.1016/j.bbrc.2010.01.048
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359
   Bismuth K, 2005, PIGM CELL RES, V18, P349, DOI 10.1111/j.1600-0749.2005.00249.x
   Damiano L., 2013, ONCOGENE, V33, P2441
   Goodall J, 2004, MOL CELL BIOL, V24, P2923, DOI 10.1128/MCB.24.7.2923-2931.2004
   Gramling S, 2011, ONCOGENE, V30, P3289, DOI 10.1038/onc.2011.80
   Liu TF, 2001, J BIOL CHEM, V276, P35768, DOI 10.1074/jbc.M103585200
   Marshall TW, 2003, J BIOL CHEM, V278, P30605, DOI 10.1074/jbc.M304582200
   Moloney FJ, 2009, J INVEST DERMATOL, V129, P1012, DOI 10.1038/jid.2008.319
   Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593
   Saladi SV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-280
   Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842
   Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39
   Thakur MD, 2014, CLIN CANCER RES, V20, P1074
   Wong K.M., 2014, CANC MED, P426
   Yamamichi N, 2005, ONCOGENE, V24, P5471, DOI 10.1038/sj.onc.1208716
   Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601
NR 51
TC 0
Z9 0
U1 2
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 125
EP 135
DI 10.1016/j.abb.2014.07.004
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000017
PM 25026375
ER

PT J
AU Xiao, TZ
   Suh, Y
   Longley, BJ
AF Xiao, Tony Z.
   Suh, Yewseok
   Longley, B. Jack
TI MAGE proteins regulate KRAB zinc finger transcription factors and KAP1
   E3 ligase activity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Melanoma; KRAB; ZNF; MAGE
ID T-CELL RESPONSES; DNA VACCINATION; GENE-EXPRESSION; HUMAN-MELANOMA;
   CANCER; ANTIGEN; FAMILY; IDENTIFICATION; LINES; COREPRESSOR
AB Expression of Melanoma AntiGen Encoding (MAGE) genes, particularly MAGE-A3, has been correlated with aggressive clinical course, the acquisition of resistance to chemotherapy and poor clinical outcomes of melanoma and other malignancies. MAGE proteins bind to KAP1, a gene repressor and ubiquitin E3 ligase which also binds KRAB domain containing zinc finger transcription factors (KZNIFs), and MAGE expression may affect KZNF mediated gene regulation. To investigate mechanisms for these effects, we tested the hypothesis that differences in KRAB domain composition affect KZNF poly-ubiquitination and determine whether MACE expression increases, decreases, or has no effect on KZNFs mediated gene repression. Using an integrated reporter gene responsive to repression by KRAB domain fusion proteins, we found that MAGE-A3 relieved KZNF mediated repression and induced KZNF poly-ubiquitination and degradation in association with expression of the A+B box KRAB domain. In contrast, MAGE-A3 enhanced KAP1 mediated repression of KZNFs expressing A or A+b box KRAB domains but caused no increase in poly-ubiquitination or degradation. MAGE-A3 has no significant impact on KZNIFs with KRAB domains containing the Scan box motif. These data support our hypothesis by showing that the effects of MAGE-A3 on gene repression depend on the type of KZNF KRAB domain involved. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Xiao, Tony Z.; Suh, Yewseok; Longley, B. Jack] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53706 USA.
   [Longley, B. Jack] Univ Wisconsin, Sch Med & Publ Hlth, Paul P Carbone Comprehens Canc Ctr, Madison, WI 53706 USA.
RP Xiao, TZ (reprint author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Univ Wisconsin, Madison, WI 53706 USA.
EM Txiao@dermatology.wisc.edu; bjlongley@dermatol-ogy.wisc.edu
FU USPHS [R21 AR062773]
FX We thank Dr. Vladimir Spiegelman (University of Wisconsin School of
   Medicine and Public Health, Madison) for providing us the HA tagged
   ubiquitin plasmid. We also thank Dr. Vijay Setaluri, Dr. Nihal Ahmed,
   and Dr. Hasan Mukhtar (University of Wisconsin School of Medicine and
   Public Health, Madison) for useful discussions. This work was supported
   by USPHS Grant R21 AR062773 (BJL).
CR Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001
   Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203
   Jungbluth AA, 2005, BLOOD, V106, P167, DOI 10.1182/blood-2004-12-4931
   Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029
   Cammas F, 2000, DEVELOPMENT, V127, P2955
   Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2
   Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001
   Bhatia N, 2013, J INVEST DERMATOL, V133, P759, DOI 10.1038/jid.2012.355
   Bertram J, 1998, ANTI-CANCER DRUG, V9, P311, DOI 10.1097/00001813-199804000-00004
   Cheng YD, 2010, CANCER RES, V70, P6516, DOI 10.1158/0008-5472.CAN-09-4566
   VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703
   Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103
   Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231
   Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478
   Chomez P, 2001, CANCER RES, V61, P5544
   KNUTH A, 1989, P NATL ACAD SCI USA, V86, P2804, DOI 10.1073/pnas.86.8.2804
   Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731
   Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669
   Basarab T, 1999, BRIT J DERMATOL, V140, P106
   Bhatia N, 2011, ARCH BIOCHEM BIOPHYS, V508, P217, DOI 10.1016/j.abb.2011.01.007
   Brossart Peter, 2002, Transfus Apher Sci, V27, P183
   Coulie PG, 2002, IMMUNOL REV, V188, P33, DOI 10.1034/j.1600-065X.2002.18804.x
   Duan ZF, 2003, CLIN CANCER RES, V9, P2778
   Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067
   Gebelein B, 1998, J CLIN INVEST, V102, P1911, DOI 10.1172/JCI1919
   Godelaine D, 2003, J IMMUNOL, V171, P4893
   Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869
   Lonchay C, 2004, P NATL ACAD SCI USA, V101, P14631, DOI 10.1073/pnas.0405743101
   Lucas S, 1998, CANCER RES, V58, P743
   Park JH, 1999, MOL CELLS, V9, P384
   Park JW, 2002, J IMMUNOL METHODS, V266, P79, DOI 10.1016/S0022-1759(02)00105-9
   Pold M, 1999, GENOMICS, V59, P161, DOI 10.1006/geno.1999.5870
   Sun XL, 2002, VACCINE, V20, P1466, DOI 10.1016/S0264-410X(01)00476-5
   Xiao TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023747
   Zhang Y, 2003, J IMMUNOL, V171, P219
NR 35
TC 1
Z9 1
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD DEC 1
PY 2014
VL 563
SI SI
BP 136
EP 144
DI 10.1016/j.abb.2014.07.026
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AT8QT
UT WOS:000345198000018
PM 25107531
ER

PT J
AU Stifanese, R
   Averna, M
   De Tullio, R
   Pedrazzi, M
   Milanese, M
   Bonifacino, T
   Bonanno, G
   Salamino, F
   Pontremoli, S
   Melloni, E
AF Stifanese, R.
   Averna, M.
   De Tullio, R.
   Pedrazzi, M.
   Milanese, M.
   Bonifacino, T.
   Bonanno, G.
   Salamino, F.
   Pontremoli, S.
   Melloni, E.
TI Role of calpain-1 in the early phase of experimental ALS
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Ca2+-dependent proteolysis; Calpain; SOD1/G93A transgenic mice; ALS;
   Neurodegeneration; NR2B; NMDA-R; nNOS
ID AMYOTROPHIC-LATERAL-SCLEROSIS; OXIDE SYNTHASE ISOFORMS; NITRIC-OXIDE;
   TRANSGENIC MICE; FAMILIAL ALS; MOUSE MODEL; CALCIUM; GLUTAMATE; SUBUNIT;
   SYSTEM
AB Elevation in [Ca2+]; and activation of calpain-1 occur in central nervous system of SOD1(G93A) transgenic mice model of amyotrophic lateral sclerosis (ALS), but few data are available about the early stage of ALS. We here investigated the level of activation of the Ca2+-dependent protease calpain-1 in spinal cord of SOD1(G93A) mice to ascertain a possible role of the protease in the aetiology of ALS. Comparing the events occurring in the 120 day old mice, we found that [Ca2+]; and activation of calpain-1 were also increased in the spinal cord of 30 day old mice, as indicated by the digestion of some substrates of the protease such as nNOS, alpha II-spectrin, and the NR2B subunit of NMDA-R. However, the digestion pattern of these proteins suggests that calpain-1 may play different roles depending on the phase of ALS. In fact, in spinal cord of 30 day old mice, activation of calpain-1 produces high amounts of nNOS active species, while in 120 day old mice enhanced-prolonged activation of calpain-1 inactivates nNOS and down-regulates NR2B.
   Our data reveal a critical role of calpain-1 in the early phase and during progression of ALS, suggesting new therapeutic approaches to counteract its onset and fatal course. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Stifanese, R.] UOS Genoa, CNR, Inst Marine Sci ISMAR, I-16149 Genoa, Italy.
   [Stifanese, R.; Averna, M.; De Tullio, R.; Pedrazzi, M.; Milanese, M.; Bonifacino, T.; Bonanno, G.; Salamino, F.; Pontremoli, S.; Melloni, E.] Univ Genoa, Genoa, Italy.
   [Stifanese, R.; Averna, M.; De Tullio, R.; Pedrazzi, M.; Salamino, F.; Pontremoli, S.; Melloni, E.] Dept Expt Med DIMES, Biochem Sect, I-16132 Genoa, Italy.
   [Stifanese, R.; Averna, M.; De Tullio, R.; Pedrazzi, M.; Milanese, M.; Bonifacino, T.; Bonanno, G.; Salamino, F.; Pontremoli, S.; Melloni, E.] Ctr Excellence Biomed Res, I-16132 Genoa, Italy.
   [Milanese, M.; Bonifacino, T.; Bonanno, G.] Dept Pharm DIFAR, Pharmacol & Toxicol Unit, I-16147 Genoa, Italy.
RP Stifanese, R (reprint author), UOS Genoa, CNR, Inst Marine Sci ISMAR, Via De Marini 6, I-16149 Genoa, Italy.
EM roberto.stifanese@ge.ismar.cnr.it
RI CNR, Ismar/P-1247-2014; 
OI CNR, Ismar/0000-0001-5351-1486; Bonanno,
   Giambattista/0000-0003-3744-5786
FU University of Genoa
FX This work was supported by PRIN Project 2008 to Edon Melloni and by the
   University of Genoa (PRA 2012 to Monica Averna).
CR Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7
   Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936
   Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186
   Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x
   Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200
   Laine R, 1998, MOL PHARMACOL, V54, P305
   Tradewell ML, 2010, NEUROREPORT, V21, P976, DOI 10.1097/WNR.0b013e32833ddd45
   Averna M, 2009, J NEUROCHEM, V110, P412, DOI 10.1111/j.1471-4159.2009.06149.x
   Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1
   Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4
   Paluzzi S, 2007, J NEUROCHEM, V103, P1196, DOI 10.1111/j.1471-4159.2007.04826.x
   Kambe Y, 2010, J NEUROSCI RES, V88, P2177, DOI 10.1002/jnr.22388
   Stifanese R, 2010, J BIOL CHEM, V285, P631, DOI 10.1074/jbc.M109.031674
   Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002
   Saxena S, 2013, NEURON, V80, P80, DOI 10.1016/j.neuron.2013.07.027
   Simpkins KL, 2003, J NEUROSCI, V23, P11322
   Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x
   Wootz H, 2006, EXP CELL RES, V312, P1890, DOI 10.1016/j.yexcr.2006.02.021
   Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304
   Urushitani M, 2001, AMYOTROPH LATERAL SC, V2, P71
   Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003
   Siklos L, 1996, ANN NEUROL, V39, P203, DOI 10.1002/ana.410390210
   Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001
   Milanese M, 2011, J NEUROCHEM, V116, P1028, DOI 10.1111/j.1471-4159.2010.07155.x
   Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Rao MV, 2014, J NEUROSCI, V34, P9222, DOI 10.1523/JNEUROSCI.1132-14.2014
   Mulligan VK, 2012, J MOL BIOL, V421, P631, DOI 10.1016/j.jmb.2012.04.016
   ALEXIANU ME, 1994, ANN NEUROL, V36, P846, DOI 10.1002/ana.410360608
   Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Araujo Ines M., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P319, DOI 10.2174/1568007054546126
   Averna M, 2007, FEBS J, V274, P6116, DOI 10.1111/j.1742-4658.2007.06133.x
   Cleveland D.W., 1996, NEUROLOGY, V47, P54
   Dainese E, 2002, J BIOL CHEM, V277, P40296, DOI 10.1074/jbc.M204471200
   Evangelopoulos ME, 2010, NEUROSCI LETT, V468, P28, DOI 10.1016/j.neulet.2009.10.054
   Fuller PI, 2006, NEUROSCI LETT, V399, P157, DOI 10.1016/j.neulet.2006.01.051
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   Kim HJ, 2007, EXP MOL MED, V39, P574
   Li HQ, 2004, BBA-MOL CELL RES, V1691, P91, DOI 10.1016/j.bbamer.2003.12.006
   Pedrazzi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044518
   Pritt M.L., 2014, TOXICOL SCI
   Shaw PJ, 2000, J NEUROL, V247, pI17
   Shibata N, 2001, NEUROPATHOLOGY, V21, P82, DOI 10.1046/j.1440-1789.2001.00361.x
   Siklos L, 1998, J NEUROPATH EXP NEUR, V57, P571
   Sorimachi H, 1997, BIOCHEM J, V328, P721
   Stifanese R, 2008, ARCH BIOCHEM BIOPHYS, V479, P145, DOI 10.1016/j.abb.2008.09.002
   Sukati S., 2012, PLOS ONE, V7, pe3713
   Swerdlow RH, 1998, EXP NEUROL, V153, P135, DOI 10.1006/exnr.1998.6866
   Uccelli A, 2012, MOL MED, V18, P794, DOI 10.2119/molmed.2011.00498
   Wu H.Y., 2006, MUSCLE NERVE, V26, P438
NR 51
TC 0
Z9 0
U1 1
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 1
EP 8
DI 10.1016/j.abb.2014.08.006
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400001
PM 25151305
ER

PT J
AU Sawada, T
   Nakamura, Y
   Ohdan, T
   Saitoh, A
   Francisco, PB
   Suzuki, E
   Fujita, N
   Shimonaga, T
   Fujiwara, S
   Tsuzuki, M
   Colleoni, C
   Ball, S
AF Sawada, Takayuki
   Nakamura, Yasunori
   Ohdan, Takashi
   Saitoh, Asami
   Francisco, Perigio B., Jr.
   Suzuki, Eiji
   Fujita, Naoko
   Shimonaga, Takahiro
   Fujiwara, Shoko
   Tsuzuki, Mikio
   Colleoni, Christophe
   Ball, Steven
TI Diversity of reaction characteristics of glucan branching enzymes and
   the fine structure of alpha-glucan from various sources
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Glucan branching enzyme; Chain-length distribution; Phosphorylase limit
   dextrin; Amylopectin; Glycogen; Starch
ID RICE ENDOSPERM; STARCH COMPONENTS; RED ALGAE; AMYLOSE; AMYLOPECTIN;
   GLYCOGEN; ISOFORMS; FORMS; BIOSYNTHESIS; PURIFICATION
AB To investigate the functional properties of 10 alpha-glucan branching enzymes (BEs) from various sources, we determined the chain-length distribution of BE enzymatic products and their phosphorylase-limit dextrins (Phi-LD). All BEs could be classified into either of the three rice BE isozymes: OsBEI, OsBEIIa, or OsBEIIb. Escherichia coli BE (EcoBE) had the same enzymatic properties as OsBEI, while Synechococcus elongatus BE (ScoBE) and Chlorella kessleri BE (ChlBE) had BEIIb-type properties. Human BE (HosBE), yeast BE (SacBE), and two Porphyridium purpureum BEs (PopBE1 and PopBE2) exhibited the OsBEIIa-type properties. Analysis of chain-length profile of Phi-LD of the BE reaction products revealed that EcoBE, ScoBE, PopBE1, and PopBE2 preferred A-chains as acceptors, while OsBEIIb used B-chains more frequently than A-chains. Both EcoBE and ScoBE specifically formed the branch linkages at the third glucose residue from the reducing end of the acceptor chain. The present results provide evidence for the first time that great variation exists as to the preference of BEs for their acceptor chain, either A-chain or B-chain. In addition, EcoBE and ScoBE recognize the location of branching points in their acceptor chain during their branching reaction. Nevertheless, no correlation exists between the primary structure of BE proteins and their enzymatic characteristics. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Sawada, Takayuki; Nakamura, Yasunori; Ohdan, Takashi; Saitoh, Asami; Francisco, Perigio B., Jr.; Suzuki, Eiji; Fujita, Naoko] Akita Prefectural Univ, Fac Bioresource Sci, Shimoshinjo Nakano, Akita 0100195, Japan.
   [Nakamura, Yasunori] Akita Nat Sci Lab, Katagami, Akita 0100101, Japan.
   [Shimonaga, Takahiro; Fujiwara, Shoko; Tsuzuki, Mikio] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo 1920392, Japan.
   [Colleoni, Christophe; Ball, Steven] Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France.
RP Nakamura, Y (reprint author), Akita Nat Sci Lab, 25-44 Oiwake Nishi, Katagami, Akita 0100101, Japan.
EM nakayn@silver.plala.or.jp
OI Nakamura, Yasunori/0000-0001-7660-0078
FU Ministry of Education, Sports, Science and Technology [20248002];
   Research Project Fund of APU
FX This work was funded by the Ministry of Education, Sports, Science and
   Technology [Grant-in-Aid for Scientific Research (A), 20248002] and the
   Research Project Fund of APU President to Y.N. and N.F., respectively.
   The DNA sequence analysis was performed with the aid of the
   Biotechnology Center, APU.
CR Shimonaga T, 2007, MAR BIOTECHNOL, V9, P192, DOI 10.1007/s10126-006-6104-7
   Morell MK, 1997, PLANT PHYSIOL, V113, P201, DOI 10.1104/pp.113.1.201
   SMITH AM, 1988, PLANTA, V175, P270, DOI 10.1007/BF00392437
   Palomo M, 2011, J BIOL CHEM, V286, P3520, DOI 10.1074/jbc.M110.179515
   Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035
   TAKEDA Y, 1993, CARBOHYD RES, V240, P253, DOI 10.1016/0008-6215(93)84188-C
   Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI 10.1104/pp.127.2.459
   MARTIN C, 1995, PLANT CELL, V7, P971
   Deschamps P, 2008, MOL BIOL EVOL, V25, P536, DOI 10.1093/molbev/msm280
   Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115
   Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3
   Roussel X, 2013, BBA-GEN SUBJECTS, V1830, P2167, DOI 10.1016/j.bbagen.2012.09.022
   Devillers CH, 2003, ARCH BIOCHEM BIOPHYS, V418, P34, DOI 10.1016/S0003-9861(03)00341-2
   Murakami T, 2006, J BACTERIOL, V188, P5915, DOI 10.1128/JB.00390-06
   Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013
   Sun CX, 1997, NEW PHYTOL, V137, P215, DOI 10.1046/j.1469-8137.1997.00796.x
   Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091
   Palomo M, 2009, APPL ENVIRON MICROB, V75, P1355, DOI 10.1128/AEM.02141-08
   BOROVSKY D, 1975, EUR J BIOCHEM, V59, P615, DOI 10.1111/j.1432-1033.1975.tb02490.x
   Thompson DB, 2000, CARBOHYD POLYM, V43, P223, DOI 10.1016/S0144-8617(00)00150-8
   GIDLEY MJ, 1987, CARBOHYD RES, V161, P291, DOI 10.1016/S0008-6215(00)90086-7
   Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044
   Shimonaga T, 2008, PLANT CELL PHYSIOL, V49, P103, DOI 10.1093/pcp/pcm172
   BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4
   Nakamura Y, 2005, PLANT CELL PHYSIOL, V46, P539, DOI 10.1093/pcp/pci045
   Binderup Kim, 2002, Archives of Biochemistry and Biophysics, V397, P279, DOI 10.1006/abbi.2001.2544
   BOROVSKY D, 1975, FEBS LETT, V54, P201, DOI 10.1016/0014-5793(75)80074-3
   BOROVSKY D, 1979, ARCH BIOCHEM BIOPHYS, V198, P627, DOI 10.1016/0003-9861(79)90540-X
   BOROVSKY D, 1976, EUR J BIOCHEM, V62, P307, DOI 10.1111/j.1432-1033.1976.tb10162.x
   DANG PL, 1988, PHYTOCHEMISTRY, V27, P1255, DOI 10.1016/0031-9422(88)80174-2
   Fisher DK, 1996, PLANT PHYSIOL, V110, P611
   Hamada S, 2002, J BIOL CHEM, V277, P16538, DOI [10.1074/jbc.M110497200, 10.1074/jbc.M110467200]
   HAWKER JS, 1974, ARCH BIOCHEM BIOPHYS, V160, P530, DOI 10.1016/0003-9861(74)90430-5
   HIZUKURI S, 1986, CARBOHYD RES, V147, P342, DOI 10.1016/S0008-6215(00)90643-8
   KAINUMA K, 1972, BIOPOLYMERS, V11, P2241, DOI 10.1002/bip.1972.360111105
   Mizuno K, 2001, PLANT CELL PHYSIOL, V42, P349, DOI 10.1093/pcp/pce042
   MIZUNO K, 1993, J BIOL CHEM, V268, P19084
   Morell MK, 1998, ELECTROPHORESIS, V19, P2603, DOI 10.1002/elps.1150191507
   Mutisya J, 2003, J PLANT PHYSIOL, V160, P921, DOI 10.1078/0176-1617-00960
   Nakamura Y., 2014, MUTAGENESIS EXPLORIN, P251
   NAKAMURA Y, 1992, PHYSIOL PLANTARUM, V84, P329, DOI 10.1034/j.1399-3054.1992.840302.x
   Nakamura Y., 2011, J APPL GLYCOSCI, V58, P119
   Patron NJ, 2005, J PHYCOL, V41, P1131, DOI 10.1111/j.1529-8817.2005.00135.x
   Sawada T., 2013, J APPL GLYCOSCI, V60, P69
   Sawada T, 2009, PLANT CELL PHYSIOL, V50, P1062, DOI 10.1093/pcp/pcp058
   Suzuki E., 2013, J APPL GLYCOSCI, V60, P21
   Tetlow I., 2012, SEB ESSENTIAL REV SE, V5, P141
   YAMANOUCHI H, 1992, PLANT CELL PHYSIOL, V33, P985
NR 48
TC 3
Z9 3
U1 5
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 9
EP 21
DI 10.1016/j.abb.2014.07.032
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400002
PM 25107532
ER

PT J
AU Wang, JJ
   Liu, ZP
   Feng, XJ
   Gao, S
   Xu, SW
   Liu, PQ
AF Wang, Jiaojiao
   Liu, Zhiping
   Feng, Xiaojun
   Gao, Si
   Xu, Suowen
   Liu, Peiqing
TI Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via
   inhibition of AMPK and activation of p38 MAPK signaling
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE ING3; Cardiac hypertrophy; Signaling pathway; AMPK; p38 MAPK
ID COMPENSATORY CARDIAC-HYPERTROPHY; PROTEIN-KINASE PATHWAY; NF-KAPPA-B;
   PRESSURE-OVERLOAD; HEART-FAILURE; DOWN-REGULATION; CELL-GROWTH;
   EXPRESSION; APOPTOSIS; FAMILY
AB Cardiac hypertrophy, an adaptive growth process that occurs in response to various pathophysiological stimuli, constitutes an important risk factor for the development of heart failure. However, the molecular mechanisms that regulate this cardiac growth response are not completely understood. Here we revealed that ING3 (inhibitor of growth family, member 3), a type II tumor suppressor, plays a critical role in the regulation of cardiac hypertrophy. ING3 expression was present in relatively high abundance in the heart, and was prominently upregulated in hypertrophic agonists angiotensin II (Ang II), phenylephrine (PE), or isoproterenol (ISO)-stimulated cardiomyocytes and in hearts of rat undergoing abdominal aortic constriction (AAC) surgery. In cardiomyocytes, overexpression of ING3 caused an increase in ANP, BNP and beta-MHC mRNA levels and cell surface area, while depletion of ING3 attenuated PE-induced cardiomyocyte hypertrophy. Mechanistically, we have demonstrated that overexpression of ING3 could inactivate the AMPK and activate the canonical p38 MAPK signaling. Remarkably, AMPK agonist AICAR or p38 MAPK inhibitor SB203580 abrogated ING3-induced hypertrophic response in cardiomyocytes. In summary, our data disclose a novel role of ING3 as an inducer of pathological cardiac hypertrophy, suggesting that silencing of ING3 may be explored as a potential therapeutic target in preventing cardiac hypertrophy. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wang, Jiaojiao; Liu, Zhiping; Feng, Xiaojun; Gao, Si; Xu, Suowen; Liu, Peiqing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Guangzhou 510006, Guangdong, Peoples R China.
RP Liu, PQ (reprint author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Higher Educ Mega Ctr, Guangzhou 510006, Guangdong, Peoples R China.
EM Liupq_sysu@163.com
FU National Natural Science Foundation of China [81072641, 81273499];
   National Science and Technology Major Project of China "Key New Drug
   Creation and Manufacturing Program" [2011ZX09401-307]; Team Item of
   Natural Science Foundation of Guangdong Province [S2011030003190];
   Natural Science Foundation of Guangdong Province [S2013010016210]; Major
   Project of Guangdong Province [2008A030201013, 2012A080201007]; Major
   Project of Department of Education of Guangdong Province [CXZD1006]
FX The authors gratefully acknowledge financial support from National
   Natural Science Foundation of China (No. 81072641 and No. 81273499), the
   National Science and Technology Major Project of China "Key New Drug
   Creation and Manufacturing Program" (No. 2011ZX09401-307), Team Item of
   Natural Science Foundation of Guangdong Province (No. S2011030003190),
   Natural Science Foundation of Guangdong Province (No. S2013010016210),
   Major Project of Guangdong Province (No. 2008A030201013 and No.
   2012A080201007), and the Major Project of Department of Education of
   Guangdong Province (No. CXZD1006).
CR Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798
   Barry SP, 2010, INT REV CEL MOL BIO, V284, P113, DOI 10.1016/S1937-6448(10)84003-1
   Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200
   Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009
   Streicher JM, 2010, CIRC RES, V106, P1434, DOI 10.1161/CIRCRESAHA.109.213199
   Marber MS, 2011, J MOL CELL CARDIOL, V51, P485, DOI 10.1016/j.yjmcc.2010.10.021
   Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009
   Le K, 2012, ARCH BIOCHEM BIOPHYS, V518, P71, DOI 10.1016/j.abb.2011.11.024
   Zhang Y, 2014, CARDIOVASC RES, V102, P35, DOI 10.1093/cvr/cvu004
   Phrommintikul A, 2008, AM J PHYSIOL-HEART C, V294, pH1804, DOI 10.1152/ajpheart.01078.2007
   Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007
   Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137
   Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798
   Jaswal JS, 2007, AM J PHYSIOL-HEART C, V293, pH1107, DOI 10.1152/ajpheart.00455.2007
   Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200
   Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983
   Xu SW, 2011, ARCH BIOCHEM BIOPHYS, V515, P72, DOI 10.1016/j.abb.2011.08.006
   Lopez IP, 2013, MOL CELL BIOL, V33, P2903, DOI 10.1128/MCB.00031-13
   Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161
   Kang S, 2011, J BIOL CHEM, V286, P18465, DOI 10.1074/jbc.M110.200022
   Li D, 2010, J BIOL CHEM, V285, P33499, DOI 10.1074/jbc.M110.159772
   Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454
   Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006
   CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F
   Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103
   Coles AH, 2009, J CELL PHYSIOL, V218, P45, DOI 10.1002/jcp.21583
   Du X.J., 2007, BRIT J PHARMACOL, V152, P169
   Errami Mounir, 2010, Heart Int, V5, pe7, DOI 10.4081/hi.2010.e7
   Esposito G, 2001, CIRCULATION, V103, P1453
   Gao S, 2014, ARCH BIOCHEM BIOPHYS, V542, P46, DOI 10.1016/j.abb.2013.12.008
   Gunduz M, 2008, CANCER SCI, V99, P531, DOI 10.1111/j.1349-7006.2007.00708.x
   Han YS, 2013, ARCH BIOCHEM BIOPHYS, V538, P25, DOI 10.1016/j.abb.2013.08.002
   Jacquet S, 2007, CARDIOVASC RES, V76, P465, DOI 10.1016/j.cardiores.2007.08.001
   Jafarnejad SM, 2012, CANCER METAST REV, V31, P55, DOI 10.1007/s10555-011-9329-5
   Jin LT, 2013, MOL CELL BIOL, V33, P2574, DOI 10.1128/MCB.01677-12
   Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197
   Lu ML, 2012, ONCOL LETT, V4, P47, DOI 10.3892/ol.2012.685
   Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115
   Purcell NH, 2003, CIRCULATION, V108, P638, DOI 10.1161/01.CIR.0000085362.40608.DD
   Satpathy S, 2013, BIOCHEM J, V450, P433, DOI 10.1042/BJ20121632
   Schisler JC, 2013, J CLIN INVEST, V123, P3588, DOI 10.1172/JCI69080
   Shimano M, 2011, P NATL ACAD SCI USA, V108, pE899, DOI 10.1073/pnas.1108559108
   Taglieri DM, 2014, J MOL CELL CARDIOL, V66, P27, DOI 10.1016/j.yjmcc.2013.10.010
   Unoki M, 2009, CURR DRUG TARGETS, V10, P442
   Wang YM, 2007, CLIN CANCER RES, V13, P4111, DOI 10.1158/1078-0432.CCR-07-0408
   Wang YM, 2006, J BIOL CHEM, V281, P11887, DOI 10.1074/jbc.M511309200
   Yu HJ, 2013, INT J MOL SCI, V14, P21378, DOI 10.3390/ijms141121378
   Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115
   Zhang Weihua, 2003, Exp Clin Cardiol, V8, P173
NR 49
TC 1
Z9 1
U1 9
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 22
EP 30
DI 10.1016/j.abb.2014.08.007
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400003
PM 25151306
ER

PT J
AU Yan, LB
   Cai, QC
   Xu, Y
AF Yan, Libo
   Cai, Qingchun
   Xu, Yan
TI Hypoxic conditions differentially regulate TAZ and YAP in cancer cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Hypoxia; Hippo-YAP pathway; YAP (Yes-associated protein); TAZ
   (transcriptional co-activator with PDZ-binding motif)
ID HIPPO PATHWAY; TRANSCRIPTIONAL COACTIVATOR; COBALT CHLORIDE;
   BREAST-CANCER; EXPRESSION; APOPTOSIS; METASTASIS; MIGRATION; ONCOGENE;
   NECROSIS
AB The Hippo-YAP pathway is altered and implicated as an oncogenic signaling pathway in many human cancers. Hypoxia is an important microenvironmental factor that promotes tumorigenesis. However, the effects of hypoxia on the two most important Hippo-YAP effectors, YAP (Yes-associated protein) and TAZ (transcriptional co-activator with PDZ-binding motif), have not been reported. In this work, we demonstrated that TAZ was functionally involved in cell proliferation and/or migration in epithelial ovarian cancer (EOC) or human ovarian surface epithelial (HOSE) cells. Hypoxic conditions (1% O-2 or hypoxia mimics) induced a reduction of YAP phosphorylation (S127) and total YAP expression in EOC cell lines OVCAR5 and SKOV3. However, these conditions up-regulated levels of S69 phosphorylated TAZ in EOC cells. The known TAZ kinases, Lats1 and Akt, were unlikely to be involved in up-regulated pTAZ by hypoxic conditions. Together, our data revealed new and differential regulating mechanisms of TAZ and YAP in cancer cells by hypoxia conditions. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Yan, Libo; Cai, Qingchun; Xu, Yan] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA.
RP Xu, Y (reprint author), Indiana Univ Sch Med, Dept Obstet & Gynecol, 975 W Walnut St IB355A, Indianapolis, IN 46202 USA.
EM xu2@iupui.edu
RI Cai, Qingchun/B-6211-2015
FU National Institutes of Health [RO1 155145]; Mary Fendrich-Hulman
   Charitable Trust Fund
FX This work is supported in part by the National Institutes of Health (RO1
   155145 to YX); and the Mary Fendrich-Hulman Charitable Trust Fund to YX.
   We would like to thank Dr. Mircea Ivan, Indiana University for his
   support in hypoxic cell culture. We would like to thank Mr. Kevin J.
   McClelland for editing the manuscript.
CR Agani F, 1998, MOL PHARMACOL, V54, P749
   Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242
   Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1
   Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8
   Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111
   Nishio M, 2013, CANCER SCI, V104, P1271, DOI 10.1111/cas.12227
   Shimizu S, 1996, CANCER RES, V56, P2161
   Bendinelli P, 2013, EUR J CANCER, V49, P2608, DOI 10.1016/j.ejca.2013.03.002
   Asikainen TM, 2005, FREE RADICAL BIO MED, V38, P1002, DOI 10.1016/j.freeadbiomed.2004.12.004
   Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001
   Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112
   Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361
   Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458
   Azad MB, 2008, AUTOPHAGY, V4, P195
   Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871
   Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037
   Jeong GO, 2013, CELL PHYSIOL BIOCHEM, V32, P253, DOI 10.1159/000354434
   Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111
   de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008
   Kim KS, 2006, CANCER RES, V66, P7983, DOI 10.1158/0008-5472.CAN-05-4381
   Li WQ, 2011, CANCER RES, V71, P2162, DOI 10.1158/0008-5472.CAN-10-3268
   Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112
   Matteucci E, 2013, EUR J CANCER, V49, P231, DOI 10.1016/j.ejca.2012.05.006
   Xie M, 2012, J THORAC ONCOL, V7, P799, DOI 10.1097/JTO.0b013e318248240b
   BRADFORD DS, 1990, J BONE JOINT SURG AM, V72A, P536
   Cai H, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-31
   Dai Y, 2014, BRAIN DEV-JPN, V36, P228, DOI 10.1016/j.braindev.2013.04.007
   Yao SY, 2008, J NEUROSCI RES, V86, P2403, DOI 10.1002/jnr.21697
NR 28
TC 1
Z9 1
U1 1
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 31
EP 36
DI 10.1016/j.abb.2014.07.024
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400004
PM 25078107
ER

PT J
AU Yuen, SL
   Ogut, O
   Brozovich, FV
AF Yuen, Samantha L.
   Ogut, Ozgur
   Brozovich, Frank V.
TI Differential phosphorylation of LZ+/LZ-MYPT1 isoforms regulates MLC
   phosphatase activity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Nitric oxide; Vasodilatation; Vascular tone; Vascular reactivity
ID LIGHT-CHAIN PHOSPHATASE; SMOOTH-MUSCLE MYOSIN; PULMONARY
   ARTERIAL-HYPERTENSION; HEART-FAILURE; CA2+ SENSITIZATION;
   BLOOD-PRESSURE; NITRIC-OXIDE; CGMP; SUBUNIT; KINASE
AB The vascular response to NO is due, in part, to a Ca2+ independent activation of myosin light chain (MLC) phosphatase, a trimeric enzyme of 20 kDa, 38 kDa catalytic and 110-130 kDa myosin targeting (MYPT1) subunits. Alternative mRNA splicing produces MYPT1 isoforms that differ by the presence or absence of a central insert (CI) and a leucine zipper (12), and the presence of a LZ+ MYPT1 isoform is important for protein kinase G (PKG) mediated activation of MLC phosphatase. This study was designed to determine the molecular basis for the differential sensitivity of the vasculature to NO. Our results demonstrate that the presence of the MYPT1 LZ domain is required for PKG to both phosphorylate MYPT1 at S668 and activate MLC phosphatase. Further for LZ+ MYPT1 isoforms, an S668A MYPT1 mutation prevents the PKG mediated, Ca2+ independent activation of MLC phosphatase. These data demonstrate that differential PKG mediated S668 phosphorylation of LZ+/LZ- MYPT1 isoforms could be important for determining the diversity in the sensitivity of the vasculature to NO mediated vasodilatation. Thus, the relative expression of LZ+/LZ- MYPT1 isoforms, in part, defines the vascular response to NO and NO based vasodilators, and therefore, plays a role in the regulation of vascular tone in both health and disease. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Yuen, Samantha L.; Ogut, Ozgur; Brozovich, Frank V.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Div Cardiovasc Dis, Rochester, MN 55905 USA.
RP Brozovich, FV (reprint author), Mayo Clin, Stabile 5,200 1st St SW, Rochester, MN 55905 USA.
EM brozovich.frank@mayo.edu
CR McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S
   Furchgott RF, 1999, BIOSCIENCE REP, V19, P235, DOI 10.1023/A:1020537506008
   Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3
   TREASURE CB, 1993, CIRCULATION, V87, P86
   Crowley SD, 2005, J CLIN INVEST, V115, P1092, DOI 10.1172/JCI200523378
   Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064
   Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200
   Wegner Adam M., 2007, V365, P61
   Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105
   Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003
   Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0
   GONG MC, 1992, J BIOL CHEM, V267, P14662
   TREASURE CB, 1992, CIRC RES, V71, P776
   Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7
   Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200
   Chen FC, 2006, J MOL CELL CARDIOL, V41, P488, DOI 10.1016/j.yjmcc.2006.05.018
   Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200
   Dhaunsi GS, 1997, AM J PHYSIOL-HEART C, V272, pH1342
   Dou D, 2010, CARDIOVASC RES, V86, P151, DOI 10.1093/cvr/cvp376
   Fontal OI, 1999, ANAL BIOCHEM, V269, P289, DOI 10.1006/abio.1999.3099
   FRANCIS GS, 1990, FASEB J, V4, P3068
   Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006
   Grassie ME, 2012, J BIOL CHEM, V287, P36356, DOI 10.1074/jbc.M112.398479
   IKEBE M, 1985, J BIOL CHEM, V260, P3146
   Karim SM, 2004, CIRC RES, V95, P612, DOI 10.1161/01.RES.0000142736.39359.58
   Kitazawa T, 2003, J PHYSIOL-LONDON, V546, P879, DOI 10.1113/jphysiol.2002.029306
   KITAZAWA T, 1991, J BIOL CHEM, V266, P1708
   KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307
   Konik EA, 2013, J MOL CELL CARDIOL, V65, P147, DOI 10.1016/j.yjmcc.2013.10.009
   LINCOLN TM, 1989, PHARMACOL THERAPEUT, V41, P479, DOI 10.1016/0163-7258(89)90127-7
   Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007
   MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498
   Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055
   Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981
   Negrao CE, 2000, AM J PHYSIOL-HEART C, V278, pH168
   Payne MC, 2004, AM J PHYSIOL-HEART C, V286, pH1801, DOI 10.1152/ajpheart.00696.2003
   Payne MC, 2006, J MOL CELL CARDIOL, V40, P274, DOI 10.1016/j.yjmcc.2005.07.099
   SHI MM, 1980, CAN J BIOCHEM CELL B, V58, P1223
   Singh Dev K, 2011, Pulm Circ, V1, P487, DOI 10.4103/2045-8932.93548
   Sitbon O, 1998, EUR RESPIR J, V12, P265, DOI 10.1183/09031936.98.12020265
   Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583
   Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200
   Yuen S, 2011, J BIOL CHEM, V286, P37274, DOI 10.1074/jbc.M111.282905
   Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35
NR 44
TC 0
Z9 1
U1 3
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 37
EP 42
DI 10.1016/j.abb.2014.08.011
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400005
PM 25168281
ER

PT J
AU Manna, RN
   Dybala-Defratyka, A
AF Manna, Rabindra Nath
   Dybala-Defratyka, Agnieszka
TI A computational study of the dechlorination of
   beta-hexachlorocyclohexane (beta-HCH) catalyzed by the haloalkane
   dehalogenase LinB
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE LinB; beta-HCH; Dechlorination; DFT; QM/MM; MD
ID SPHINGOMONAS-PAUCIMOBILIS UT26; HISTOGRAM ANALYSIS METHOD; FREE-ENERGY
   CALCULATIONS; POTENTIAL FUNCTIONS; MOLECULAR-DYNAMICS; ACCURATE DOCKING;
   LARGE SYSTEMS; FORCE-FIELD; DEGRADATION; GLIDE
AB LinB, a haloalkane dehalogenase from Sphingomonas paucimobilis UT26, is known to metabolize halohydrocarbons to halide ions and the respective alcohols. Its broad substrate specificity allowed its consideration for bioremediation. Herein, we have shown its catalytic action toward beta-hexachlorocyclohexane (beta-HCH) - an example of large-size substrates that can be accommodated in its active site. We have analyzed the capability of combined QM/MM schemes to describe in detail the S(N)2 dechlorination reaction between beta-HCH and Asp108 in the active site of LinB. Free energy surfaces have been calculated using one and two dimensional potentials of mean force (PMF) obtained at the PM3/MM (MM = amberff99SB, TIP3P) level of theory. The overestimated energetic barriers by the PM3 Hamiltonian were corrected using a DFT functional (M06-2X). The resulted activation energies (16 and 19 kcal mol(-1) from 1D and 2D-PMF profiles, respectively) for the dechlorination reaction of beta-HCH in the active site of LinB enzyme are in qualitative agreement with the experimentally determined value of 17 kcal mol(-1). The binding of beta-HCH to the active site of LinB has been compared to the binding of smaller 1-chlorobutane (1-CB) and larger delta-hexabromocyclododecane (delta-HBCD). (C) 2014 Elsevier Inc. All rights reserved.
C1 [Manna, Rabindra Nath; Dybala-Defratyka, Agnieszka] Lodz Univ Technol, Fac Chem, Inst Appl Radiat Chem, PL-90924 Lodz, Poland.
RP Dybala-Defratyka, A (reprint author), Lodz Univ Technol, Inst Appl Radiat Chem, Zeromskiego 116, PL-90924 Lodz, Poland.
EM agnieszka.dybala-defratyka@p.lodz.pl
FU EU MCA-ITN grant "CSI-Environment" [FP7-264329]
FX RNM acknowledges the support from the EU MCA-ITN grant "CSI-Environment"
   (FP7-264329 2011-2014). Access to supercomputing facilities at the
   Computer Center of the Lodz University of Technology (Blue Ocean
   cluster) is gratefully acknowledged. We thank Anna Pabis for many useful
   insights on using Amber package as well as the fDYNAMO library and Pawel
   Adamczyk for a technical assistance. We are also grateful to Professor
   Inaki Tunon for providing a modified copy of the latter one and helpful
   comments.
CR Field MJ, 2000, J COMPUT CHEM, V21, P1088, DOI 10.1002/1096-987X(200009)21:12<1088::AID-JCC5>3.0.CO;2-8
   Marti S, 2005, J CHEM THEORY COMPUT, V1, P1008, DOI 10.1021/ct0501396
   Manna RN, 2013, J PHYS ORG CHEM, V26, P797, DOI 10.1002/poc.3163
   Brittain DRB, 2011, CHEM COMMUN, V47, P976, DOI 10.1039/c0cc02925d
   Lal R, 2010, MICROBIOL MOL BIOL R, V74, P58, DOI 10.1128/MMBR.00029-09
   Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x
   STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208
   Heeb NV, 2013, CHEMOSPHERE, V90, P1911, DOI 10.1016/j.chemosphere.2012.10.019
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   Heeb NV, 2012, ENVIRON SCI TECHNOL, V46, P6566, DOI 10.1021/es2046487
   Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
   KUMAR S, 1995, J COMPUT CHEM, V16, P1339, DOI 10.1002/jcc.540161104
   Koudelakova T, 2011, BIOCHEM J, V435, P345, DOI 10.1042/BJ20101405
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.3.CO;2-G
   Kaminski GA, 1998, J PHYS CHEM B, V102, P1787, DOI 10.1021/jp980314x
   Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   Oakley AJ, 2004, BIOCHEMISTRY-US, V43, P870, DOI 10.1021/bi034748g
   Hratchian HP, 2005, J CHEM THEORY COMPUT, V1, P61, DOI 10.1021/ct0499783
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Nagata Y, 2005, APPL ENVIRON MICROB, V71, P2183, DOI 10.1128/AEM.71.4.2183-2185.2005
   Turner AJ, 1999, PHYS CHEM CHEM PHYS, V1, P1323, DOI 10.1039/a808364i
   BEURSKENS JEM, 1991, ECOTOX ENVIRON SAFE, V21, P128, DOI 10.1016/0147-6513(91)90015-H
   Case D. A., 2012, AMBER 12, V12
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Frisch J., 2010, GAUSSIAN 09 REVISION
   FRISCH MJ, 1984, J CHEM PHYS, V80, P3265, DOI 10.1063/1.447079
   Glide, 2010, GLID VERS 5 0
   Grossfield A., WHAM WEIGHTED HISTOG
   Hur S, 2003, P NATL ACAD SCI USA, V100, P2215, DOI 10.1073/pnas.242721799
   Maestro, 2010, MAESTR VERS 9 1
   Negri A, 2007, J MOL GRAPH MODEL, V26, P643, DOI 10.1016/j.jmgm.2007.03.010
   Oakley AJ, 2002, BIOCHEMISTRY-US, V41, P4847, DOI 10.1021/bi015734i
NR 39
TC 1
Z9 1
U1 9
U2 36
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 43
EP 50
DI 10.1016/j.abb.2014.07.028
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400006
PM 25102308
ER

PT J
AU Bhat, SA
   Bano, B
AF Bhat, Sheraz Ahmad
   Bano, Bilqees
TI Conformational behaviour and aggregation of chickpea cystatin in
   trifluoroethanol: Effects of epicatechin and tannic acid
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Chick pea cystatin; Tannic acid; Trifluoroethanol; Secondary structure;
   Aggregation; Polyphenols
ID AMYLOID-FIBRIL FORMATION; IN-VITRO; FLUORESCENCE SPECTROSCOPY; INSULIN
   AGGREGATION; PROTEIN AGGREGATION; ALZHEIMERS-DISEASE; AQUEOUS-SOLUTIONS;
   BETA AGGREGATION; STEFIN-B; INHIBITION
AB Conformational alterations and aggregates of chickpea cystatin (CPC) were investigated upon sequential addition of trifluoroethanol (TFE) over a range of 0-70% v/v. CPC on 30% and 40% v/v TFE addition exhibited non-native beta-sheet, altered intrinsic fluorescence, increased thioflavin T fluorescence, prominent red shifted shoulder peak in Congo red absorbance, and enhanced turbidity as well as Rayleigh scattering, suggesting the aggregate formation. TEM results confirmed the formation of fibrillar aggregates at 30% and 40% v/v TFE. On increasing concentration of TFE to 70% v/v, CPC showed retention of native-like secondary structure, increased intrinsic and ANS fluorescence. Thus our results show that favourable condition for fibrillation of CPC is in the range of 30-40% TFE. Moreover, anti-aggregational effects of polyphenols, epicatechin (EC) and tannic acid (TA) were analysed using ThT binding assay and other biophysical assays. EC and TA produced a concentration dependent decline in ThT fluorescence suggesting inhibition of the fibril formation. Furthermore, TA in comparison to EC, served as a more effective inhibitor against amyloid fibril formation of CPC. This work supports the universality of the amyloid-like aggregation not restricted to some special categories of protein and the fact that this aggregation can be prevented. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Bhat, Sheraz Ahmad; Bano, Bilqees] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India.
RP Bano, B (reprint author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202002, Uttar Pradesh, India.
EM bilqeesbanos@gmail.com
FU Senior Research Fellow of the University Grants Commission (UGC), New
   Delhi, India; SAP-DRS programme; DST-FIST programme
FX The authors are highly thankful for the facilities obtained at AMU
   Aligarh. Financial support to S.A.B. as a Senior Research Fellow of the
   University Grants Commission (UGC), New Delhi, India is acknowledged. We
   are grateful to SAP-DRS and DST-FIST programmes for their generous
   research support.
CR Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752
   Goormaghtigh E, 2009, BBA-PROTEINS PROTEOM, V1794, P1332, DOI 10.1016/j.bbapap.2009.06.007
   KUNITZ M, 1947, J GEN PHYSIOL, V30, P291, DOI 10.1085/jgp.30.4.291
   Ladiwala ARA, 2012, J BIOL CHEM, V287, P24765, DOI 10.1074/jbc.M111.329763
   Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x
   Upchurch GR, 1998, J THROMB THROMBOLYS, V5, P9, DOI 10.1023/A:1008859729045
   Gast K, 1999, PROTEIN SCI, V8, P625
   Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445
   Fazili NA, 2014, INT J BIOL MACROMOL, V64, P36, DOI 10.1016/j.ijbiomac.2013.11.010
   Naeem A, 2011, CELL BIOCHEM BIOPHYS, V61, P237, DOI 10.1007/s12013-011-9200-x
   Ono K, 2002, J NEUROCHEM, V81, P434, DOI 10.1046/j.1471-4159.2002.00904.x
   Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013
   Lin SJ, 2004, BIOORG MED CHEM LETT, V14, P1173, DOI 10.1016/j.bmcl.2003.12.086
   Lee S, 2005, PROTEIN SCI, V14, P593, DOI 10.1110/ps.041020705
   SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377
   Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125
   Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590
   Pappolla M, 1998, J BIOL CHEM, V273, P7185, DOI 10.1074/jbc.273.13.7185
   Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101
   Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224
   De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com
   Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089
   STRYER L, 1968, SCIENCE, V162, P526, DOI 10.1126/science.162.3853.526
   Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9
   DONG AC, 1995, J PHARM SCI, V84, P415, DOI 10.1002/jps.2600840407
   Bhat SA, 2014, J FLUORESC, V24, P1107, DOI 10.1007/s10895-014-1391-2
   Amani S, 2013, INT J BIOL MACROMOL, V58, P104, DOI 10.1016/j.ijbiomac.2013.03.055
   SLUZKY V, 1992, BIOTECHNOL BIOENG, V40, P895, DOI 10.1002/bit.260400805
   Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9
   Morshedi D, 2010, BBA-PROTEINS PROTEOM, V1804, P714, DOI 10.1016/j.bbapap.2009.11.012
   Armen RS, 2004, P NATL ACAD SCI USA, V101, P11622, DOI 10.1073/pnas.0401781101
   Cheng BA, 2011, J AGR FOOD CHEM, V59, P13147, DOI 10.1021/jf201702h
   Chung HS, 2004, J PHYS CHEM B, V108, P15332, DOI 10.1021/jp0479926
   Ptitsyn Oleg B., 1992, P243
   Defelice FG, 2002, AN ACAD BRAS CIENC, V74, P265, DOI 10.1590/S0001-37652002000200006
   Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002
   Goncalves S, 2007, J PHOTOCH PHOTOBIO B, V86, P170, DOI 10.1016/j.jphotobiol.2006.09.001
   Huang K, 2001, BBA-PROTEIN STRUCT M, V1545, P305, DOI 10.1016/S0167-4838(00)00293-4
   Iram A, 2013, ARCH BIOCHEM BIOPHYS, V533, P69, DOI 10.1016/j.abb.2013.02.019
   Iram A, 2012, J FLUORESC, V22, P47, DOI 10.1007/s10895-011-0929-9
   Iram A, 2012, INT J BIOL MACROMOL, V50, P932, DOI 10.1016/j.ijbiomac.2012.02.012
   Jaenicke R, 1997, ADV PROTEIN CHEM, V50, P1, DOI 10.1016/S0065-3233(08)60318-6
   Lai Z., 1998, BIOOCHEMISTRY, V33
   Marcinowski KJ, 1998, J AM CHEM SOC, V120, P11082, DOI 10.1021/ja9738687
   MIRANKER A, 1991, NATURE, V349, P633, DOI 10.1038/349633a0
   Ono K, 2002, BIOL PSYCHIAT, V52, P880, DOI 10.1016/S0006-3223(02)01417-8
   Ono K., 2004, BIOCH BIOPHYS ACTA, V1690
   Povarova OI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015035
   Priyadarshini M, 2012, MOL BIOL REP, V39, P2945, DOI 10.1007/s11033-011-1056-z
   Rehman M.T., 2014, J BIOMOL STRUCT DYN
   Skerget K, 2009, PROTEINS, V74, P425, DOI 10.1002/prot.22156
   Thomas T, 2001, NEUROREPORT, V12, P3263, DOI 10.1097/00001756-200110290-00024
   Tyagi S., 2010, J PHARM SCI REV RES, V3, P53
   Uno K., 2004, J NEUROSCI RES, V75, P742
   Vondrasek J, 2005, J AM CHEM SOC, V127, P2615, DOI 10.1021/ja044607h
   Wang SSS, 2005, BBA-MOL BASIS DIS, V1741, P307, DOI 10.1016/j.bbadis.2005.05.004
   Wang SSS, 2006, J MOL CATAL B-ENZYM, V43, P49, DOI 10.1016/j.molcatb.2006.06.006
   Zerovnik E, 2007, AMYLOID, V14, P237, DOI 10.1080/13506120701461137
NR 58
TC 0
Z9 0
U1 3
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 51
EP 61
DI 10.1016/j.abb.2014.08.015
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400007
PM 25173679
ER

PT J
AU Valentine, RJ
   Coughlan, KA
   Ruderman, NB
   Saha, AK
AF Valentine, Rudy J.
   Coughlan, Kimberly A.
   Ruderman, Neil B.
   Saha, Asish K.
TI Insulin inhibits AMPK activity and phosphorylates AMPK Ser(485/491)
   through Akt in hepatocytes, myotubes and incubated rat skeletal muscle
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Insulin; Growth factors; AMPK; PKB; Ser(485/491)
ID ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; MALONYL-COA; S6
   KINASE; RESISTANCE; HEART; METABOLISM; EXPRESSION; ISCHEMIA; CELLS
AB Recent studies have highlighted the importance of an inhibitory phosphorylation site, Ser(485/491), on the alpha-subunit of AMP-activated protein kinase (AMPK); however, little is known about the regulation of this site in liver and skeletal muscle. We examined whether the inhibitory effects of insulin on AMPK activity may be mediated through the phosphorylation of this inhibitory Ser(485/491) site in hepatocytes, myotubes and incubated skeletal muscle. HepG2 and C2C12 cells were stimulated with or without insulin for 15-min. Similarly, rat extensor digitorum longus (EDL) muscles were treated +/- insulin for 10-min. Insulin significantly increased Ser(485/491) p-AMPK under all conditions, resulting in a subsequent reduction in AMPK activity, ranging from 40% to 70%, despite no change in p-AMPK Thr(172). Akt inhibition both attenuated the increase in Ser(485/491) p-AMPK caused by insulin, and prevented the decrease in AMPK activity. Similarly, the growth factor IGF-1 stimulated Ser(485/491) AMPK phosphorylation, and this too was blunted by inhibition of Akt. Inhibition of the mTOR pathway with rapamycin, however, had no effect on insulin-stimulated Ser(495/491) p-AMPK. These data suggest that insulin and IGF-1 diminish AMPK activity in hepatocytes and muscle, most likely through Akt activation and the inhibitory phosphorylation of Ser(485/491) on its alpha-subunit. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Valentine, Rudy J.; Coughlan, Kimberly A.; Ruderman, Neil B.; Saha, Asish K.] Boston Univ, Sch Med, Dept Med, Endocrinol Diabet & Nutr Sect, Boston, MA 02118 USA.
RP Saha, AK (reprint author), 650 Albany St,Room 827, Boston, MA 02118 USA.
EM aksaha@bu.edu
FU National Institutes of Health, USA [DK19514, DK67509, T32 HL70024, T32
   HL07969-06A1]
FX This work was supported by grants from the National Institutes of
   Health, USA (DK19514 and DK67509 to N.B.R. and A.K.S.), T32 HL70024 to
   R.V and T32 HL07969-06A1 to K.C.
CR Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200
   Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008
   Hegarty BD, 2009, ACTA PHYSIOL, V196, P129, DOI 10.1111/j.1748-1716.2009.01968.x
   Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200
   Pulinilkunnil T, 2011, J BIOL CHEM, V286, P8798, DOI 10.1074/jbc.M111.218719
   Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006
   Gauthier MS, 2011, BIOCHEM BIOPH RES CO, V404, P382, DOI 10.1016/j.bbrc.2010.11.127
   Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008
   WITTERS LA, 1992, J BIOL CHEM, V267, P2864
   Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187
   Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200
   Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155
   Gamble J, 1997, METABOLISM, V46, P1270, DOI 10.1016/S0026-0495(97)90229-8
   Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010
   Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344
   Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005
   Xu XJ, 2012, J LIPID RES, V53, P792, DOI 10.1194/jlr.P022905
   Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227
   Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200
   Beauloye C, 2001, FEBS LETT, V505, P348, DOI 10.1016/S0014-5793(01)02788-0
   Coughlan Kimberly A, 2014, Diabetes Metab Syndr Obes, V7, P241, DOI 10.2147/DMSO.S43731
   Coughlan K.A., 2014, PHARM PKC ACTIVATION
   Coughlan K.A., 2013, J ENDOCRINOL DIABETE, V1, P1008
   Hebbachi A, 2012, BIOSCIENCE REP, V33, P71
   KOZMA SC, 1989, EMBO J, V8, P4125
   Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005
   Pehmoller C, 2009, AM J PHYSIOL-ENDOC M, V297, pE665, DOI 10.1152/ajpendo.00115.2009
   Soltys CLM, 2006, AM J PHYSIOL-HEART C, V290, pH2472, DOI 10.1152/ajpheart.01206.2005
   Somwar R, 1998, AM J PHYSIOL-ENDOC M, V275, pE618
   Xu X Julia, 2014, Curr Obes Rep, V3, P248, DOI 10.1007/s13679-014-0095-x
NR 31
TC 7
Z9 7
U1 6
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 62
EP 69
DI 10.1016/j.abb.2014.08.013
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400008
PM 25172224
ER

PT J
AU Lietzan, AD
   Lin, Y
   St Maurice, M
AF Lietzan, Adam D.
   Lin, Yi
   St Maurice, Martin
TI The role of biotin and oxamate in the carboxyltransferase reaction of
   pyruvate carboxylase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Enzyme; Decarboxylation; Biotin; Oxaloacetate decarboxylase; Pyruvate
   carboxylase
ID ACETYL-COA CARBOXYLASE; SUBSTRATE-INDUCED SYNERGISM; ESCHERICHIA-COLI;
   OXALOACETATE DECARBOXYLASE; CARRIER PROTEIN; RHIZOBIUM-ETLI; COENZYME-A;
   PSEUDOMONAS-AERUGINOSA; TRANSFERASE DOMAIN; MECHANISM
AB Pyruvate carboxylase (PC) is a biotin-dependent enzyme that catalyzes the MgATP-dependent carboxylation of pyruvate to oxaloacetate, an important anaplerotic reaction in central metabolism. During catalysis, carboxybiotin is translocated to the carboxyltransferase domain where the carboxyl group is transferred to the acceptor substrate, pyruvate. Many studies on the carboxyltransferase domain of PC have demonstrated an enhanced oxaloacetate decarboxylation activity in the presence of oxamate and it has been shown that oxamate accepts a carboxyl group from carboxybiotin during oxaloacetate decarboxylation. The X-ray crystal structure of the carboxyltransferase domain from Rhizobium etli PC reveals that oxamate is positioned in the active site in an identical manner to the substrate, pyruvate, and kinetic data are consistent with the oxamate-stimulated decarboxylation of oxaloacetate proceeding through a simple ping-pong bi bi mechanism in the absence of the biotin carboxylase domain. Additionally, analysis of truncated PC enzymes indicates that the BCCP domain devoid of biotin does not contribute directly to the enzymatic reaction and conclusively demonstrates a biotin-independent oxaloacetate decarboxylation activity in PC. These findings advance the description of catalysis in PC and can be extended to the study of related biotin-dependent enzymes. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Lietzan, Adam D.; Lin, Yi; St Maurice, Martin] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53201 USA.
RP St Maurice, M (reprint author), Marquette Univ, Dept Biol Sci, POB 1881, Milwaukee, WI 53201 USA.
EM martin.stmaurice@marquette.edu
FU National Institute of Health [GM070455]; National Science Foundation
   MRI-R2 grant [DBI-0959442]; Arthur J. Schmitt Foundation; U.S.
   Department of Energy, Office of Science, Office of Basic Energy Sciences
   [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan
   Technology Tr-Corridor [085P1000817]
FX This work was supported by the National Institute of Health grant
   GM070455 to W.W. Cleland, John C. Wallace, Paul V. Attwood and Martin
   St. Maurice and National Science Foundation MRI-R2 grant DBI-0959442 to
   Martin St. Maurice. Adam D. Lietzan is supported by a Schmitt fellowship
   from the Arthur J. Schmitt Foundation. Use of the Advanced Photon Source
   was supported by U.S. Department of Energy, Office of Science, Office of
   Basic Energy Sciences, under contract No. DE-AC02-06CH11357. Use of the
   LS-CAT Sector 21 was supported by the Michigan Economic Development
   Corporation and the Michigan Technology Tr-Corridor for the support of
   this research program (Grant 085P1000817).
CR Adina-Zada A, 2008, INT J BIOCHEM CELL B, V40, P1743, DOI 10.1016/j.biocel.2008.01.001
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008
   Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2
   Schar J, 2010, J BACTERIOL, V192, P1774, DOI 10.1128/JB.01132-09
   Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393
   Tiwari V, 2014, J ALZHEIMERS DIS, V41, P387, DOI 10.3233/JAD-122449
   WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004
   Blanchard CZ, 1999, BIOCHEMISTRY-US, V38, P3393, DOI 10.1021/bi982660a
   Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709
   Kukavica-Ibrulj I, 2008, MICROBIOL-SGM, V154, P2106, DOI 10.1099/mic.0.2007/011239-0
   CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881
   MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200
   Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200
   ATTWOOD PV, 1986, BIOCHEMISTRY-US, V25, P8197, DOI 10.1021/bi00373a012
   ATTWOOD PV, 1986, BIOCHEM J, V235, P359
   ATTWOOD PV, 1986, BIOCHEMISTRY-US, V25, P8191, DOI 10.1021/bi00373a011
   Blanchard CZ, 1998, J BIOL CHEM, V273, P19140, DOI 10.1074/jbc.273.30.19140
   Blanchard CZ, 1999, J BIOL CHEM, V274, P31767, DOI 10.1074/jbc.274.45.31767
   Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108
   DIBERARDINO M, 1995, EUR J BIOCHEM, V231, P790
   Duangpan S, 2010, BIOCHEMISTRY-US, V49, P3296, DOI 10.1021/bi901894t
   Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41
   FRY DC, 1985, J AM CHEM SOC, V107, P7659, DOI 10.1021/ja00311a072
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   GOODALL GJ, 1981, BIOCHEM J, V199, P603
   GUCHHAIT RB, 1974, J BIOL CHEM, V249, P6633
   Han J, 2010, J ENDOCRINOL, V204, P143, DOI 10.1677/JOE-09-0391
   Islam MN, 2005, PROTEIN ENG DES SEL, V18, P71, DOI 10.1093/protein/gzi011
   Levert KL, 2000, BIOCHEMISTRY-US, V39, P4122, DOI 10.1021/bi992662a
   Lietzan AD, 2014, ARCH BIOCHEM BIOPHYS, V544, P75, DOI 10.1016/j.abb.2013.10.014
   Lietzan AD, 2013, BIOCHEM BIOPH RES CO, V441, P377, DOI 10.1016/j.bbrc.2013.10.066
   Lietzan AD, 2011, BIOCHEMISTRY-US, V50, P9708, DOI 10.1021/bi201277j
   Lietzan AD, 2013, J BIOL CHEM, V288, P19915, DOI 10.1074/jbc.M113.477828
   Lin TW, 2006, P NATL ACAD SCI USA, V103, P3072, DOI 10.1073/pnas.0510580103
   Marlier JF, 2013, BIOCHEMISTRY-US, V52, P2888, DOI 10.1021/bi400075t
   Mochalkin I, 2008, PROTEIN SCI, V17, P1706, DOI 10.1110/ps.035584.108
   Narayanan BC, 2008, BIOCHEMISTRY-US, V47, P167, DOI 10.1021/bi701954p
   OKEEFE SJ, 1986, BIOCHEMISTRY-US, V25, P6077, DOI 10.1021/bi00368a036
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   POLAKIS SE, 1974, J BIOL CHEM, V249, P6657
   SCRUTTON MC, 1968, BIOCHEMISTRY-US, V7, P1490, DOI 10.1021/bi00844a036
   Segel I. H., 1975, ENZYME KINETICS BEHA
   St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504
   Wolfenden R, 2011, J AM CHEM SOC, V133, P5683, DOI 10.1021/ja111457h
   Zeczycki T.N., 2011, BIOCHEMISTRY-US, P9694
   Zeczycki TN, 2009, BIOCHEMISTRY-US, V48, P4305, DOI 10.1021/bi9003759
   Zeczycki T.N., 2011, BIOCHEMISTRY-US, P9724
NR 52
TC 0
Z9 0
U1 2
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 70
EP 79
DI 10.1016/j.abb.2014.08.008
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400009
PM 25157442
ER

PT J
AU Corti, A
   Franzini, M
   Scataglini, I
   Pompella, A
AF Corti, Alessandro
   Franzini, Maria
   Scataglini, Ilenia
   Pompella, Alfonso
TI Mechanisms and targets of the modulatory action of S-nitrosoglutathione
   (GSNO) on inflammatory cytokines expression
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE S-nitrosoglutathione; S-nitrosothiols; Nitric oxide; Inflammation;
   Inflammatory cytokines; Signal transduction
ID NF-KAPPA-B; GAMMA-GLUTAMYL-TRANSFERASE; PROTEIN DISULFIDE-ISOMERASE;
   VASCULAR ENDOTHELIAL-CELLS; BLOOD MONONUCLEAR-CELLS; AIRWAY
   EPITHELIAL-CELLS; TRAUMATIC BRAIN-INJURY; RAW 264.7 MACROPHAGES;
   NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE DONORS
AB A number of experimental studies has documented that S-nitrosoglutathione (GSNO), the main endogenous low-molecular-weight S-nitrosothiol, can exert modulatory effects on inflammatory processes, thus supporting its potential employment in medicine for the treatment of important disease conditions. At molecular level, GSNO effects have been shown to modulate the activity of a series of transcription factors (notably NF-kappa B, AP-1, CREB and others) as well as other components of signal transduction chains (e.g. IKK-beta, caspase 1, calpain and others), resulting in the modulation of several cytokines and chemokines expression (TNF alpha, IL-1 beta, IFN-gamma, IL-4, IL-8, RANTES, MCP-1 and others). Results reported to date are however not univocal, and a single main mechanism of action for the observed anti-inflammatory effects of GSNO has not been identified. Conflicting observations can be explained by differences among the various cell types studies as to the relative abundance of enzymes in charge of GSNO metabolism (GSNO reductase, gamma-glutamyltransferase, protein disulfide isomerase and others), as well as by variables associated with the individual experimental models employed. Altogether, anti-inflammatory properties of GSNO seem however to prevail, and exploration of the therapeutic potential of GSNO and analogues appears therefore warranted. (C) 2014 Published by Elsevier Inc.
C1 [Corti, Alessandro; Scataglini, Ilenia; Pompella, Alfonso] Univ Pisa, Sch Med, Dept Translat Res & New Technol Med & Surg, I-56126 Pisa, Italy.
   [Franzini, Maria] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy.
   [Franzini, Maria] CNR, Fdn Toscana G Monasterio, Cardiol & Cardiovasc Med Div, I-56100 Pisa, Italy.
RP Corti, A (reprint author), Univ Pisa, Sch Med, Dept Translat Res & New Technol Med & Surg, Via Roma 55, I-56126 Pisa, Italy.
EM alessandro.corti@med.unipi.it
RI Franzini, Maria/L-5650-2013
OI Franzini, Maria/0000-0001-9496-9370
FU FFC - Fondazione Fibrosi Cistica (Verona, Italy)
FX The financial support by FFC - Fondazione Fibrosi Cistica (Verona,
   Italy) is kindly acknowledged.
CR Al-Sa'doni H, 2000, CLIN SCI, V98, P507, DOI 10.1042/CS19990267
   ANDREW PJ, 1995, BIOCHEM BIOPH RES CO, V214, P949, DOI 10.1006/bbrc.1995.2378
   Andrew PJ, 1999, BIOCHEM PHARMACOL, V57, P1423, DOI 10.1016/S0006-2952(99)00052-0
   Nikitovic D, 1996, J BIOL CHEM, V271, P19180
   Staab CA, 2011, CHEM-BIOL INTERACT, V191, P95, DOI 10.1016/j.cbi.2011.01.016
   Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200
   Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474
   Connelly L, 2001, J IMMUNOL, V166, P3873
   Jensen DE, 1998, BIOCHEM J, V331, P659
   Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436
   Angeli V, 2009, ARCH BIOCHEM BIOPHYS, V481, P191, DOI 10.1016/j.abb.2008.10.027
   Aleryani S, 1998, J BIOL CHEM, V273, P6041, DOI 10.1074/jbc.273.11.6041
   Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008
   Brune B, 2007, METHOD ENZYMOL, V435, P463, DOI 10.1016/S0076-6879(07)35024-6
   Hedberg JJ, 2003, EUR J BIOCHEM, V270, P1249, DOI 10.1046/j.1432-1033.2003.03486.x
   Kobayashi Y, 2010, J LEUKOCYTE BIOL, V88, P1157, DOI 10.1189/jlb.0310149
   Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969
   Lim SY, 2010, J BIOL CHEM, V285, P14377, DOI 10.1074/jbc.M109.075242
   DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074
   Zanini GM, 2012, J NEUROIMMUNE PHARM, V7, P477, DOI 10.1007/s11481-012-9343-6
   Giustizieri ML, 2002, AM J PATHOL, V161, P1409, DOI 10.1016/S0002-9440(10)64416-1
   Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007
   Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016
   Zaman K, 2006, MOL PHARMACOL, V70, P1435, DOI 10.1124/mol.106.023242
   Salas E, 1998, HEART, V80, P146
   Siednienko J, 2011, CYTOKINE, V54, P282, DOI 10.1016/j.cyto.2011.02.015
   Won JS, 2013, J ALZHEIMERS DIS, V34, P621, DOI 10.3233/JAD-121786
   Yasinska IM, 2003, FEBS LETT, V549, P105, DOI 10.1016/S0014-5793(03)00807-X
   Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003
   Foster MW, 2011, AM J PHYSIOL-LUNG C, V301, pL739, DOI 10.1152/ajplung.00134.2011
   Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x
   Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007
   Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051
   Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004
   Zhang HQ, 2012, SEMIN CELL DEV BIOL, V23, P722, DOI 10.1016/j.semcdb.2012.03.017
   Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930
   Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042
   Sandau KB, 2000, BIOCHEM BIOPH RES CO, V278, P263, DOI 10.1006/bbrc.2000.3789
   Macphail SE, 2003, J IMMUNOL, V171, P4809
   Root P, 2004, BIOCHEM J, V382, P575
   Martinez-Ruiz A, 2011, FREE RADICAL BIO MED, V51, P17, DOI 10.1016/j.freeradbiomed.2011.04.010
   Nath N, 2010, J NEUROIMMUNE PHARM, V5, P240, DOI 10.1007/s11481-009-9187-x
   KHALAF MR, 1987, HISTOCHEM J, V19, P385, DOI 10.1007/BF01680457
   GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957
   Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742
   Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101
   Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012
   Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.E02-12-0791
   Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024
   Sha YG, 2012, BBA-GEN SUBJECTS, V1820, P701, DOI 10.1016/j.bbagen.2011.05.008
   Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101
   Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828
   Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200
   Ramachandran N, 2001, P NATL ACAD SCI USA, V98, P9539, DOI 10.1073/pnas.171180998
   Bogdan C, 2001, TRENDS CELL BIOL, V11, P66, DOI 10.1016/S0962-8924(00)01900-0
   Sogawa K, 1998, P NATL ACAD SCI USA, V95, P7368, DOI 10.1073/pnas.95.13.7368
   Broniowska KA, 2012, ANTIOXID REDOX SIGN, V17, P969, DOI 10.1089/ars.2012.4590
   Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009
   Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101
   Hogg N, 1997, BIOCHEM J, V323, P477
   Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6
   Corti A, 2010, ANTICANCER RES, V30, P1169
   Staab CA, 2008, BIOCHEM J, V413, P493, DOI 10.1042/BJ20071666
   Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236
   STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674
   Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764
   Lipton AJ, 2001, NATURE, V413, P171, DOI 10.1038/35093117
   Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596
   Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200
   von Knethen A, 1999, MOL BIOL CELL, V10, P361
   Spiecker M, 1997, J BIOL CHEM, V272, P30969, DOI 10.1074/jbc.272.49.30969
   Mallis RJ, 2001, BIOCHEM J, V355, P145
   Cartwright JE, 1997, EXP CELL RES, V235, P431, DOI 10.1006/excr.1997.3723
   Bramanti E, 2009, ARCH BIOCHEM BIOPHYS, V487, P146, DOI 10.1016/j.abb.2009.05.012
   Brune B, 1996, BIOCHEM BIOPH RES CO, V229, P396, DOI 10.1006/bbrc.1996.1816
   Callapina M, 2005, EXP CELL RES, V306, P274, DOI 10.1016/j.yexer.2005.02.018
   Carver DJ, 2007, AM J RESP CELL MOL, V37, P255, DOI 10.1165/rcmb.2006-0289SM
   Corinti S, 2003, J INTERF CYTOK RES, V23, P423, DOI 10.1089/107999003322277838
   Corriveau CC, 1998, J INFECT DIS, V177, P116, DOI 10.1086/513829
   Corti A, 2013, FREE RADICAL BIO MED, V65, P360, DOI 10.1016/j.freeradbiomed.2013.06.015
   Davis BJ, 2004, J IMMUNOL, V173, P6914
   DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399
   DelaTorre A, 1997, BIOCHEM BIOPH RES CO, V238, P703, DOI 10.1006/bbrc.1997.7279
   del Fresno C, 2004, NITRIC OXIDE-BIOL CH, V10, P213, DOI 10.1016/j.niox.2004.04.007
   de Menezes AMA, 2012, J PERIODONTOL, V83, P514, DOI 10.1902/jop.2011.110332
   Deschoolmeester ML, 1999, IMMUNOLOGY, V96, P138
   Dominici S, 2003, TUMORI, V89, P426
   Duan SJ, 2007, CELL MOL IMMUNOL, V4, P353
   Eastmond NC, 1997, J IMMUNOL, V159, P1444
   Forsythe P, 2003, J IMMUNOL, V170, P287
   Fortenberry JD, 2001, INFLAMM RES, V50, P89
   Fowler AA, 1999, BIOCHEM CELL BIOL, V77, P201, DOI 10.1139/bcb-77-3-201
   Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP
   Gaston B, 1998, LANCET, V351, P1317, DOI 10.1016/S0140-6736(97)07485-0
   Gaston Benjamin M, 2003, Mol Interv, V3, P253, DOI 10.1124/mi.3.5.253
   Gilchrist M, 2008, IMMUNOLOGY, V123, P209, DOI 10.1111/j.1365-2567.2007.02688.x
   Giustarini D, 2007, J CHROMATOGR B, V851, P124, DOI 10.1016/j.jchromb.2006.09.031
   Matsumoto A, 2011, NITRIC OXIDE-BIOL CH, V25, P102, DOI 10.1016/j.niox.2011.02.006
   Granillo OM, 2008, AM J PHYSIOL-LUNG C, V295, pL38, DOI 10.1152/ajplung.00280.2007
   Habib A, 1997, J IMMUNOL, V158, P3845
   Haq E, 2007, J OCUL PHARMACOL TH, V23, P221, DOI 10.1089/jop.2007.0023
   Henson SE, 1999, J IMMUNOL, V163, P1845
   Hornyak I, 2011, CURR PHARM BIOTECHNO, V12, P1368
   Hou YC, 1996, BIOCHEM BIOPH RES CO, V228, P88, DOI 10.1006/bbrc.1996.1620
   Into T, 2008, MOL CELL BIOL, V28, P1338, DOI 10.1128/MCB.01412-07
   Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011
   Jourd'heuil D, 1999, ARCH BIOCHEM BIOPHYS, V361, P323, DOI 10.1006/abbi.1998.1010
   Keszler A, 2010, FREE RADICAL BIO MED, V48, P55, DOI 10.1016/j.freeradbiomed.2009.10.026
   Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32
   Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78
   Klatt P, 2000, BIOCHEM J, V349, P567, DOI 10.1042/0264-6021:3490567
   Kluge I, 1997, J NEUROCHEM, V69, P2599
   Liu DH, 2013, NEUROSCIENCE, V229, P36, DOI 10.1016/j.neuroscience.2012.10.055
   Ma PL, 2004, J LEUKOCYTE BIOL, V76, P278, DOI 10.1189/jlb.1203653
   Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y
   MERRYMAN PF, 1993, ARTHRITIS RHEUM, V36, P1414, DOI 10.1002/art.1780361014
   Miersch S, 2008, J BIOL CHEM, V283, P18513, DOI 10.1074/jbc.M800440200
   Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039
   Natarajan R, 2001, EXP CELL RES, V266, P203, DOI 10.1006/excr.2001.5218
   Nikitovic D, 1998, BIOCHEM BIOPH RES CO, V242, P109, DOI 10.1006/bbrc.1997.7930
   Okamoto T, 2002, AM J RESP CELL MOL, V27, P463, DOI 10.1165/rcmb-2002-0039OC
   Olson N, 2011, AM J RESP CELL MOL, V44, P813, DOI 10.1165/rcmb.2010-0035OC
   Palmer LA, 2000, MOL PHARMACOL, V58, P1197
   Park SW, 2005, MOL CELL PROTEOMICS, V4, P300, DOI 10.1074/mcp.M400195-MCP200
   PENG HB, 1995, J BIOL CHEM, V270, P14214
   PENG HB, 1995, J BIOL CHEM, V270, P17050
   PILZ RB, 1995, FASEB J, V9, P552
   Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011
   Priora R, 2011, PHARMACOL RES, V64, P289, DOI 10.1016/j.phrs.2011.03.014
   Romeo AA, 2003, J AM CHEM SOC, V125, P14370, DOI 10.1021/ja0289752
   Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200
   Shunmugavel A, 2012, NEUROSCI MED, V3, P294, DOI DOI 10.4236/NM.2012.33034
   Sliskovic I, 2005, J BIOL CHEM, V280, P8733, DOI 10.1074/jbc.M408080200
   Smith AW, 2011, J NEUROIMMUNOL, V232, P179, DOI 10.1016/j.jneuroim.2010.09.030
   Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/rccm.2105032
   So HS, 1998, BIOCHEM BIOPH RES CO, V247, P809, DOI 10.1006/bbrc.1998.8788
   Sundararajan S., 2013, AM J RESP CRIT CARE, pA1905
   TABUCHI A, 1994, FEBS LETT, V351, P123, DOI 10.1016/0014-5793(94)00839-6
   TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328
   Turpaev K, 2003, CYTOKINE, V23, P15, DOI 10.1016/S1043-4666(03)00114-5
   Umansky V, 1998, EUR J IMMUNOL, V28, P2276, DOI 10.1002/(SICI)1521-4141(199808)28:08<2276::AID-IMMU2276>3.0.CO;2-H
   Wang D, 2007, PROSTATE, V67, P1825, DOI 10.1002/pros.20669
   Wang F, 2002, BIOCHEM BIOPH RES CO, V295, P657, DOI 10.1016/S0006-291X(02)00729-5
   Wang SB, 1999, J BIOL CHEM, V274, P33190, DOI 10.1074/jbc.274.47.33190
   West MB, 2006, FASEB J, V20, P1715, DOI 10.1096/fj.06-5843fje
   Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200
   Zaman K, 2006, AM J RESP CELL MOL, V34, P387, DOI 10.1165/rcmb.2005-0336RC
   Zaman K, 2004, BIOCHEM J, V380, P67, DOI 10.1042/BJ.20031687
   Zeng H, 2001, AM J PHYSIOL-HEART C, V281, pH432
NR 149
TC 2
Z9 2
U1 3
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 80
EP 91
DI 10.1016/j.abb.2014.08.002
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400010
PM 25135357
ER

PT J
AU Tran, TA
   Ahn, KS
   Song, YW
   Moon, JY
   Cho, M
   Lim, Y
   Cho, SK
AF Thao Anh Tran
   Ahn, Kwang Seok
   Song, Yeon Woo
   Moon, Jeong Yong
   Cho, Moonjae
   Lim, Yoongho
   Cho, Somi Kim
TI Mechanism of 2 ',3 '-dimethoxyflavanone-induced apoptosis in breast
   cancer stem cells: Role of ubiquitination of caspase-8 and LC3
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Apoptosis; Breast cancer stem cells; Caspase-8; 2 ',3
   '-Dimethoxyflavanone; LC3; Ubiquitination
ID COLORECTAL-CANCER; CYCLE ARREST; HEAT-SHOCK; DUAL ROLE; AUTOPHAGY;
   ACTIVATION; PROTEASOME; FLAVONOIDS; DEATH; INHIBITION
AB Accumulating evidence has displayed that targeting cancer stem cells (CSCs) is a very promising way for anti-cancer therapies. 2',3'-Dimethoxyflavanone (2',3'-DMF) showed the most potent toxicity of a group of 42 flavonoids tested in MCF-7-SC breast cancer stem cells. 2',3'-DMF triggered intrinsic and extrinsic apoptosis by stimulating the cleavage of PARP and the activation of caspase-9, -8, and -3. Interestingly, 2',3'-DMF induces a dramatic increase in the conversion of LC3, a well-known marker for autophagy. However, acidic vesicular organelles (AVOs), one of the autophagic flux markers were not detected. Co-treatment with chloroquine, the lysosomal inhibitor that blocks autophagic degradation did not show any change in the degree of LC3 conversion, implying that LC3 could play a role in the non-autophagic cell death of MCF-7-SC. We found that 2',3'-DMF induces the ubiquitination of caspase-8, this resulted in an interaction between caspase-8 and LC3, which led to the aggregation and activation of caspase-8. Co-treating cells with 2',3'-DMF and 3-methyladenine, an inhibitor of LC3 lipidation, reduced the activation of caspase-8. These findings provide novel insights into the anti-cancer effects of 2',3'-DMF in breast cancer stem cells by revealing that it induced apoptosis in accompany with the activation of caspase-8 mediated by LC3 conversion. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Thao Anh Tran; Song, Yeon Woo; Moon, Jeong Yong; Cho, Somi Kim] Jeju Natl Univ, Coll Appl Life Sci, Fac Biotechnol, SARI, Cheju 690756, South Korea.
   [Ahn, Kwang Seok] Kyung Hee Univ, Coll Oriental Med, Dept Oriental Pathol, Seoul 130701, South Korea.
   [Moon, Jeong Yong; Cho, Somi Kim] Jeju Natl Univ, Subtrop Hort Res Inst, Cheju 690756, South Korea.
   [Cho, Moonjae] Jeju Natl Univ, Dept Med, Sch Med, Cheju 690756, South Korea.
   [Lim, Yoongho] Konkuk Univ, BMIC, Div Biosci & Biotechnol, Seoul 143701, South Korea.
RP Cho, SK (reprint author), Jeju Natl Univ, Coll Appl Life Sci, Fac Biotechnol, Cheju 690756, South Korea.
EM somikim@jejunu.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea (NFK) - Ministry of Education [2013R1A1A2A10012017]
FX We thank Pham Van Phuc MSc. and the Laboratory of Stem Cells (Ho Chi
   Minh, Vietnam) for providing the cancer stem-like cell line MCF-7-SC.
   This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NFK) funded by the Ministry
   of Education (2013R1A1A2A10012017).
CR Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104
   Cioce M, 2010, CELL CYCLE, V9, P2878, DOI 10.4161/cc.9.14.12371
   Namgoong GM, 2010, J BIOL CHEM, V285, P23829, DOI 10.1074/jbc.M109.092874
   HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2
   Walle T, 2007, SEMIN CANCER BIOL, V17, P354, DOI 10.1016/j.semcancer.2007.05.002
   Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047
   Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11
   Walle T, 2007, BIOCHEM PHARMACOL, V73, P1288, DOI 10.1016/j.bcp.2006.12.028
   Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9
   Pouget C, 2001, BIOORG MED CHEM LETT, V11, P3095, DOI 10.1016/S0960-894X(01)00617-5
   Huang SB, 2013, J BIOL CHEM, V288, P33654, DOI 10.1074/jbc.M113.518134
   Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001
   Zhao Y, 2010, J CELL PHYSIOL, V225, P316, DOI 10.1002/jcp.22276
   Ding WX, 2008, AUTOPHAGY, V4, P141
   Shin SY, 2013, INT J MOL SCI, V14, P16970, DOI 10.3390/ijms140816970
   Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8
   Paglin S, 2001, CANCER RES, V61, P439
   Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7
   Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028
   Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128
   Moll UM, 2001, FEBS LETT, V493, P65, DOI 10.1016/S0014-5793(01)02284-0
   Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026
   Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482
   Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300
   Wang AB, 2005, PHYTOCHEM ANALYSIS, V16, P272, DOI 10.1002/pca.838
   Fehrenbacher N, 2005, CANCER RES, V65, P2993
   Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099
   Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595
   Wen X, 2006, XENOBIOTICA, V36, P387, DOI 10.1080/00498250600630636
   Shin SY, 2013, BIOORGAN MED CHEM, V21, P7018, DOI 10.1016/j.bmc.2013.09.014
   Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361
   Wei YJ, 2008, AUTOPHAGY, V4, P949
   Frisch SM, 2008, CANCER RES, V68, P4491, DOI 10.1158/0008-5472.CAN-08-0952
   Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015
   Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053
   Wu WKK, 2010, CANCER LETT, V293, P15, DOI 10.1016/j.canlet.2009.12.002
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015
   Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254
   Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4
   Tasdemir E, 2008, AUTOPHAGY, V4, P810
   Atun S., 2013, INT J CHEM ANAL SCI, V4, P3
   Bekes M, 2009, CELL, V137, P604, DOI 10.1016/j.cell.2009.04.052
   Bergada L, 2013, MOL ONCOL, V7, P763, DOI 10.1016/j.molonc.2013.03.003
   Carew Jennifer S, 2008, Biologics, V2, P201
   Choi EJ, 2011, ARCH PHARM RES, V34, P2125, DOI 10.1007/s12272-011-1216-7
   Diéras V, 1997, Oncology (Williston Park), V11, P31
   Garcia J.A., 2007, AFRICAN AM BIOETHICS, V861807, P1
   Kar R, 2009, ONCOGENE, V28, P2556, DOI 10.1038/onc.2009.118
   Kaur K., 2013, STEM CELL RES THER, V4, P1
   Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002
   Levaj Branka, 2009, Agriculturae Conspectus Scientificus, V74, P221
   Li X, 2011, TOXICOL APPL PHARM, V251, P146, DOI 10.1016/j.taap.2010.12.007
   Mani A.S., 2008, CELL, V133, P704
   Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238
   Pan J.A., 2012, J BIOL CHEM, V288, P2952
   Pham P.V., 2011, J BIOTECHNOL, V9, P13
   Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b
   Sharma AK, 2013, BIO-TECHNOL, V3, P439
   Shin JY, 2012, J GINSENG RES, V36, P86, DOI 10.5142/jgr.2012.36.1.86
   Shin SY, 2011, TOXICOL APPL PHARM, V254, P288, DOI 10.1016/j.taap.2011.05.003
   Stolpe, 2013, AM J CANCER RES, V3, P107
   Toiyama Y, 2013, CARCINOGENESIS, V34, P2548, DOI 10.1093/carcin/bgt282
   Tomas-Navarro M., 2013, POLYPHENOLS HUM HLTH, V1, P537
   Wang AL, 2009, AUTOPHAGY, V5, P1190
   Wirawan E., 2010, CELL DEATH DIS, V1, P1038
   Yan W., 2013, CANCER CELL INT, V13, P1
NR 69
TC 3
Z9 5
U1 4
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 92
EP 102
DI 10.1016/j.abb.2014.08.001
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400011
PM 25132643
ER

PT J
AU Pey, AL
   Padin-Gonzalez, E
   Mesa-Torres, N
   Timson, DJ
AF Pey, Angel L.
   Padin-Gonzalez, Esperanza
   Mesa-Torres, Noel
   Timson, David J.
TI The metastability of human UDP-galactose 4 '-epimerase (GALE) is
   increased by variants associated with type III galactosemia but
   decreased by substrate and cofactor binding
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Protein conformational stability; Protein dynamics; Protein aggregation;
   Proteolysis; Type III galactosemia; Ligand binding
ID EPIMERASE-DEFICIENCY GALACTOSEMIA; DIFFERENTIAL SCANNING CALORIMETRY;
   HUMAN UDP-GALACTOSE-4-EPIMERASE; PHARMACOLOGICAL CHAPERONES; PROTEIN
   STABILITY; KINETIC STABILITY; MUTATIONS; 4-EPIMERASE; GENE;
   PHENYLKETONURIA
AB Type III galactosemia is an inherited disease caused by mutations which affect the activity of UDP-galactose 4'-epimerase (GALE). We evaluated the impact of four disease-associated variants (p.N34S, p.G90E, p.V94M and p.K161N) on the conformational stability and dynamics of GALE. Thermal denaturation studies showed that wild-type GALE denatures at temperatures close to physiological, and disease-associated mutations often reduce GALE's thermal stability. This denaturation is under kinetic control and results partly from dimer dissociation. The natural ligands, NAD(+) and UDP-glucose, stabilize GALE. Proteolysis studies showed that the natural ligands and disease-associated variations affect local dynamics in the N-terminal region of GALE. Proteolysis kinetics followed a two-step irreversible model in which the intact protein is cleaved at Ala38 forming a long-lived intermediate in the first step. NAD(+) reduces the rate of the first step, increasing the amount of undigested protein whereas UDP-glucose reduces the rate of the second step, increasing accumulation of the intermediate. Disease-associated variants affect these rates and the amounts of protein in each state. Our results also suggest communication between domains in GALE. We hypothesize that, in vivo, concentrations of natural ligands modulate GALE stability and that it should be possible to discover compounds which mimic the stabilising effects of the natural ligands overcoming mutation-induced destabilization. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Pey, Angel L.; Padin-Gonzalez, Esperanza; Mesa-Torres, Noel] Univ Granada, Dept Phys Chem, Fac Sci, E-18071 Granada, Spain.
   [Timson, David J.] Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland.
RP Pey, AL (reprint author), Univ Granada, Dept Phys Chem, Fac Sci, Av Fuentenueva S-N, E-18071 Granada, Spain.
EM angelpey@ugr.es; d.timson@qub.ac.uk
OI Mesa-Torres, Noel/0000-0001-6653-6260; Pey, Angel
   Luis/0000-0001-7706-3243; Timson, David/0000-0002-0985-8818
FU MINECO, Spain [BIO2012-34937, CSD2009-00088]; Junta de Andalucia, Spain
   [P11-CTS-07187]; Royal Society, UK [2004/R1]; FEDER Funds, EU; Ramon y
   Cajal research contract from MINECO [RyC-2009-04147]; FPI predoctoral
   fellowship from MINECO
FX We thank Dr. Jose Manuel Sanchez-Ruiz for support. This work was
   supported by grants from MINECO, Spain (BIO2012-34937 and
   CSD2009-00088), Junta de Andalucia, Spain (P11-CTS-07187), The Royal
   Society, UK (2004/R1) and FEDER Funds, EU. A.L.P. is supported by a
   Ramon y Cajal research contract from MINECO (RyC-2009-04147). N.M-T. is
   supported by a FPI predoctoral fellowship from MINECO.
CR Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200
   Thoden JB, 2000, BIOCHEMISTRY-US, V39, P5691, DOI 10.1021/bi000215l
   Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188
   Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085
   Pey AL, 2013, BIOCHEM J, V449, P109, DOI 10.1042/BJ20120731
   Pey AL, 2008, J CLIN INVEST, V118, P2858, DOI 10.1172/JCI34355
   Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c
   McCorvie TJ, 2013, GENE, V524, P95, DOI [10.1016/j.gene.2013.04.061, 10.1016/j.gene2013.04.061]
   Timson DJ, 2006, IUBMB LIFE, V58, P83, DOI 10.1080/15216540600644846
   SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921
   Goodman JL, 2000, J MOL BIOL, V295, P963, DOI 10.1006/jmbi.1999.3419
   [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760
   Rodrigues JV, 2012, CURR TOP MED CHEM, V12, P2546
   Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009
   Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y
   Antonarakis SE, 1998, HUM MUTAT, V11, P1
   SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9
   STROMINGER JL, 1957, J BIOL CHEM, V224, P79
   Chhay JS, 2008, J INHERIT METAB DIS, V31, P108, DOI 10.1007/s10545-007-0790-9
   CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1
   CONEJEROLARA F, 1991, BIOCHEMISTRY-US, V30, P2067, DOI 10.1021/bi00222a010
   Daenzer JMI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002721
   Fridovich-Keil JL, 2008, ONLINE METABOLIC MOL
   Maceratesi P, 1998, MOL GENET METAB, V63, P26, DOI 10.1006/mgme.1997.2645
   MAITRA US, 1971, P NATL ACAD SCI USA, V68, P2660, DOI 10.1073/pnas.68.11.2660
   Martinez A, 2008, PROG MOL BIOL TRANSL, V83, P89, DOI 10.1016/S0079-6603(08)00603-X
   McCorvie T.J., 2014, HDB GLYCOSYLTRANSFER
   McCorvie TJ, 2012, BBA-MOL BASIS DIS, V1822, P1516, DOI 10.1016/j.bbadis.2012.05.007
   PACE CN, 1995, PROTEIN SCI, V4, P2411
   Pey AL, 2013, AMINO ACIDS, V45, P1331, DOI 10.1007/s00726-013-1609-7
   Pey AL, 2013, BBA-PROTEINS PROTEOM, V1834, P2502, DOI 10.1016/j.bbapap.2013.07.011
   PILLER F, 1983, J BIOL CHEM, V258, P774
   Quimby BB, 1997, AM J HUM GENET, V61, P590, DOI 10.1086/515517
   SANCHEZRUIZ JM, 1988, EUR J BIOCHEM, V176, P225, DOI 10.1111/j.1432-1033.1988.tb14272.x
   Santos-Sierra S, 2012, HUM MOL GENET, V21, P1877, DOI 10.1093/hmg/dds001
   Timson DJ, 2005, FEBS J, V272, P6170, DOI 10.1111/j.1742-4658.2005.05017.x
   Timson DJ, 2013, GENE, V526, P318, DOI 10.1016/j.gene.2013.05.027
   Wohlers TM, 2000, J INHERIT METAB DIS, V23, P713, DOI 10.1023/A:1005682913784
   Wohlers TM, 1999, AM J HUM GENET, V64, P462, DOI 10.1086/302263
NR 39
TC 1
Z9 1
U1 3
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 103
EP 114
DI 10.1016/j.abb.2014.07.030
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400012
PM 25150110
ER

PT J
AU Masuda, M
   Ichikawa, Y
   Shimono, K
   Shimizu, M
   Tanaka, Y
   Nara, T
   Miyauchi, S
AF Masuda, Masayuki
   Ichikawa, Yukari
   Shimono, Kazumi
   Shimizu, Maki
   Tanaka, Yoshio
   Nara, Toshifumi
   Miyauchi, Seiji
TI Electrophysiological characterization of human Na+/taurocholate
   cotransporting polypeptide (hNTCP) heterologously expressed in Xenopus
   laevis oocytes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Bile acid; Electrogenicity; Hepatic uptake; Na+-dependent transporter;
   NTCP; SLC10A1; Xenopus laevis oocyte
ID ISOLATED RAT HEPATOCYTES; PLASMA-MEMBRANE VESICLES; BILE-ACID
   TRANSPORTERS; HEPATIC TAUROCHOLATE UPTAKE; NA+-COUPLED TRANSPORTER;
   ORGANIC ANION UPTAKE; HUMAN-LIVER; MONOCARBOXYLATE TRANSPORTER;
   SUBSTRATE-SPECIFICITY; SALT TRANSPORTERS
AB The Na+/taurocholate cotransporting polypeptide (NTCP) plays a major role in Na+-dependent bile acid uptake into hepatocytes. The purpose of the present study was to establish the heterologous expression of human NTCP (hNTCP) in Xenopus laevis oocytes and to elucidate whether the transport of bile acid via hNTCP is electrogenic using electrophysiological techniques. First, we evaluated the uptake of taurocholate (TCA) by hNTCP heterologously expressed in Xenopus oocytes utilizing [H-3]-labeled TCA. The uptake of 1.2 mu M TCA by cRNA-injected oocytes increased more than 100-fold compared to H2O-injected oocytes, indicating that hNTCP is robustly expressed in the oocytes. hNTCP-mediated transport of TCA is saturable with a Michaelis constant of 10.5 +/- 2.9 mu M. The Na+-activation kinetics describing the relationship between the concentration of Na+ and the magnitude of the TCA uptake rate by hNTCP were sigmoidal with a Hill coefficient of 2.3 +/- 0.4, indicating the involvement of more than one Na+ in the transport process. Ntcp in primary cultured hepatocytes from rats exhibited similar Na+-activation kinetics of TCA uptake rate with a Hill coefficient of 1.9 +/- 0.1, suggesting that hNTCP could be expressed properly in the oocytes and exhibit the electrogenic property of Na+-coupled TCA transport. The transport of TCA via hNTCP was subsequently determined in the oocytes by the inward currents induced via TCA uptake under voltage (-50 mV). Two hundred micromolar TCA induced significant inward currents that were entirely abolished by the substitution of Na+ with N-methyl-D-glucamine (NMDG) in the perfusate, indicating that the TCA-induced currents were obligatorily dependent on the presence of Na+. The TCA-induced currents were saturable, and the substrate concentration needed for half-maximal induction of the current was consistent with the Michaelis constant. Transportable substrates, such as rosuvastatin and fluvastatin, also induced currents. These results in the hNTCP heterologously expressed in Xenopus oocytes directly demonstrated that hNTCP is an electrogenic Na+-dependent transporter. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Masuda, Masayuki; Ichikawa, Yukari; Shimono, Kazumi; Shimizu, Maki; Tanaka, Yoshio; Miyauchi, Seiji] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan.
   [Nara, Toshifumi] Matsuyama Univ, Coll Pharmaceut Sci, Matsuyama, Ehime 7908578, Japan.
RP Miyauchi, S (reprint author), Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan.
EM seiji.miyauchi@phar.toho-u.ac.jp
FU Japanese Ministry of Education, Culture, Sports, Science, and Technology
   [23590062]
FX This work was supported by the grant from the Japanese Ministry of
   Education, Culture, Sports, Science, and Technology to Seiji Miyauchi
   (23590062).
CR Greupink R, 2012, TOXICOL SCI, V129, P35, DOI 10.1093/toxsci/kfs188
   SPIVEY JR, 1993, J CLIN INVEST, V92, P17, DOI 10.1172/JCI116546
   Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200
   de Graaf W, 2011, J HEPATOL, V54, P738, DOI 10.1016/j.jhep.2010.07.047
   Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300
   Ho RH, 2006, GASTROENTEROLOGY, V130, P1793, DOI 10.1053/j.gastro.2006.02.034
   Hata S, 2003, AM J PHYSIOL-GASTR L, V285, pG829, DOI 10.1152/ajpgi.00352.2002
   Alrefai WA, 2007, PHARM RES, V24, P1803, DOI 10.1007/s11095-007-9289-1
   Zhou XM, 2014, NATURE, V505, P569, DOI 10.1038/nature12811
   Yanni SB, 2011, BIOPHARM DRUG DISPOS, V32, P222, DOI 10.1002/bdd.752
   MURPHY GM, 1974, GUT, V15, P151, DOI 10.1136/gut.15.2.151
   Doring B, 2012, CURR TOP MEMBR, V70, P105, DOI 10.1016/B978-0-12-394316-3.00004-1
   Itagaki S, 2006, PHARM RES, V23, P1209, DOI 10.1007/s11095-006-0023-1
   Meier PJ, 1997, HEPATOLOGY, V26, P1667
   Abu-Hayyeh S, 2010, J BIOL CHEM, V285, P16504, DOI 10.1074/jbc.M109.072140
   Yanni SB, 2010, DRUG METAB DISPOS, V38, P1848, DOI 10.1124/dmd.110.033811
   Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005
   Gopal E, 2004, J BIOL CHEM, V279, P44522, DOI 10.1074/jbc.M405365200
   Pauli-Magnus C, 2006, HEPATOLOGY, V44, P778, DOI 10.1002/hep.21359
   Kuiper EMM, 2010, HEPATOLOGY, V52, P1334, DOI 10.1002/hep.23821
   Miyauchi S, 2010, BBA-BIOMEMBRANES, V1798, P1164, DOI 10.1016/j.bbamem.2010.03.002
   Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450
   Greupink R, 2011, EUR J PHARM SCI, V44, P487, DOI 10.1016/j.ejps.2011.09.009
   HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091
   Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200
   Kim RB, 1999, J PHARMACOL EXP THER, V291, P1204
   ANWER MS, 1978, H-S Z PHYSIOL CHEM, V359, P181
   AZER SA, 1993, BIOCHEM PHARMACOL, V46, P813, DOI 10.1016/0006-2952(93)90489-J
   BOUSCAREL B, 1995, AM J PHYSIOL-GASTR L, V268, pG908
   Dong ZQ, 2013, MOL PHARMACEUT, V10, P1008, DOI 10.1021/mp300453k
   DUFFY MC, 1983, J CLIN INVEST, V72, P1470, DOI 10.1172/JCI111103
   EBIHARA K, 1989, J NUTR, V119, P1100
   EDMONDSON JW, 1985, AM J PHYSIOL, V249, pG427
   FITZ JG, 1987, AM J PHYSIOL, V252, pG56
   Gopal E, 2007, AM J PHYSIOL-GASTR L, V292, pG402, DOI 10.1152/ajpgi.00371.2006
   Hagenbuch B, 1996, SEMIN LIVER DIS, V16, P129, DOI 10.1055/s-2007-1007226
   HOFMANN AF, 1965, GASTROENTEROLOGY, V48, P484
   IGA T, 1979, AM J PHYSIOL, V236, pC9
   INOUE M, 1982, HEPATOLOGY, V2, P572
   Lepist EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087548
   LIDOFSKY SD, 1993, AM J PHYSIOL, V264, pG478
   MEIER PJ, 1984, J BIOL CHEM, V259, P614
   Melgert BN, 2001, DRUG METAB DISPOS, V29, P361
   Meng JP, 2006, AM J PHYSIOL-CELL PH, V291, pC546, DOI 10.1152/ajpcell.00011.2006
   MIYAUCHI S, 1993, PHARMACEUT RES, V10, P434, DOI 10.1023/A:1018952709120
   Miyauchi S, 2006, PLACENTA, V27, P550, DOI 10.1016/j.placenta.2005.05.004
   NOVAK DA, 1989, HEPATOLOGY, V10, P447, DOI 10.1002/hep.1840100408
   SANDKER GW, 1994, BIOCHEM PHARMACOL, V47, P2193, DOI 10.1016/0006-2952(94)90255-0
   SCHARSCHMIDT BF, 1981, P NATL ACAD SCI-BIOL, V78, P986, DOI 10.1073/pnas.78.2.986
   Weinman SA, 1997, YALE J BIOL MED, V70, P331
   WEINMAN SA, 1993, AM J PHYSIOL, V265, pG73
   Bi YA, 2013, BIOPHARM DRUG DISPOS, V34, P452, DOI 10.1002/bdd.1861
NR 52
TC 0
Z9 0
U1 4
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 115
EP 121
DI 10.1016/j.abb.2014.08.010
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400013
PM 25168282
ER

PT J
AU Wooten, CJ
   Adcock, AF
   Agina-Obu, DI
   Lopez, D
AF Wooten, Catherine J.
   Adcock, Audrey F.
   Agina-Obu, DaTonye I.
   Lopez, Dayami
TI Having excess levels of PCSK9 is not sufficient to induce complex
   formation between PCSK9 and the LDL receptor (vol 545, pg 124, 2014)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Correction
C1 [Wooten, Catherine J.; Adcock, Audrey F.; Agina-Obu, DaTonye I.; Lopez, Dayami] N Carolina Cent Univ, Coll Arts & Sci, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise, Durham, NC 27707 USA.
RP Lopez, D (reprint author), N Carolina Cent Univ, Coll Arts & Sci, Dept Pharmaceut Sci, Biomfg Res Inst & Technol Enterprise, 1801 Fayetteville St, Durham, NC 27707 USA.
EM lopezd@nccu.edu
CR Wooten CJ, 2014, ARCH BIOCHEM BIOPHYS, V545, P124, DOI 10.1016/j.abb.2014.01.018
NR 1
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 122
EP 122
DI 10.1016/j.abb.2014.08.003
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400014
ER

PT J
AU Ward, HA
   Kuhnle, GGC
AF Ward, Heather A.
   Kuhnle, Gunter G. C.
TI Phytoestrogen consumption and association with breast, prostate and
   colorectal cancer in EPIC Norfolk (vol 501, pg 170, 2010)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Correction
C1 [Ward, Heather A.; Kuhnle, Gunter G. C.] Univ Cambridge, MRC, Ctr Nutr Epidemiol Canc Prevent & Survival, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England.
   [Kuhnle, Gunter G. C.] Univ Reading, Dept Food & Nutr Sci, Reading RG6 6AP, Berks, England.
RP Kuhnle, GGC (reprint author), Univ Reading, Dept Food & Nutr Sci, POB 226, Reading RG6 6AP, Berks, England.
EM g.g.kuhnle@reading.ac.uk
CR Ward HA, 2010, ARCH BIOCHEM BIOPHYS, V501, P170, DOI 10.1016/j.abb.2010.05.018
NR 1
TC 0
Z9 0
U1 3
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 123
EP 123
DI 10.1016/j.abb.2014.08.004
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400015
ER

PT J
AU Yamamoto, K
   Wilson, DK
AF Yamamoto, Kohji
   Wilson, David K.
TI Identification, characterization, and crystal structure of an aldo-keto
   reductase (AKR2E4) from the silkworm Bombyx mori (vol 538, pg 156, 2013)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Correction
C1 [Yamamoto, Kohji] Kyushu Univ, Grad Sch, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan.
   [Wilson, David K.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.
RP Yamamoto, K (reprint author), Kyushu Univ, Grad Sch, Fac Agr, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.
EM yamamok@agr.kyushu-u.ac.jp
CR Yamamoto K, 2013, ARCH BIOCHEM BIOPHYS, V538, P156, DOI 10.1016/j.abb.2013.08.018
NR 1
TC 0
Z9 0
U1 2
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2014
VL 562
BP 124
EP 124
DI 10.1016/j.abb.2014.08.005
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR1RN
UT WOS:000343362400016
ER

PT J
AU van der Eerden, BCJ
   Teti, A
   Zambuzzi, WF
AF van der Eerden, Bram C. J.
   Teti, Anna
   Zambuzzi, Willian F.
TI Bone, a dynamic and integrating tissue
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
C1 [van der Eerden, Bram C. J.] Erasmus MC, Dept Internal Med, NL-3015 CN Rotterdam, Netherlands.
   [Teti, Anna] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.
   [Zambuzzi, Willian F.] Sao Paulo State Univ, UNESP, Biosci Inst, Lab Bioassays & Cellular Dynam,Dept Chem & Bioche, BR-18618970 Botucatu, SP, Brazil.
RP van der Eerden, BCJ (reprint author), Erasmus MC, Dept Internal Med, Room Ee585b,Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.
EM b.vandereerden@erasmusmc.nl; teti@univaq.it; wzambuzzi@ibb.unesp.br
RI Zambuzzi, Willian/F-9519-2012
OI Zambuzzi, Willian/0000-0002-4149-5965
NR 0
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 1
EP 2
DI 10.1016/j.abb.2014.08.012
PG 2
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300001
PM 25157441
ER

PT J
AU Capulli, M
   Paone, R
   Rucci, N
AF Capulli, Mattia
   Paone, Riccardo
   Rucci, Nadia
TI Osteoblast and osteocyte: Games without frontiers
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Osteoblast; Osteocyte; Bone remodelling; Mechanosensing; Hormonal
   regulation
ID RECEPTOR-RELATED PROTEIN-5; MESENCHYMAL STEM-CELLS; BONE-FORMATION;
   PARATHYROID-HORMONE; GENE-EXPRESSION; OCULODENTODIGITAL DYSPLASIA;
   OSTEOGENIC DIFFERENTIATION; TARGETED ABLATION; BINDING PROTEIN; BMP
   ANTAGONIST
AB The portrait of osteoblasts and osteocytes has been subjected to a revision, since a large body of evidence is attributing these cells amazing roles both inside and outside the bone. The osteoblast, long confined to its bone building function, is actually a very eclectic cell, actively regulating osteoclast formation and function as well as hematopoietic stem cells homeostasis. It is also an endocrine cell, affecting energy metabolism, male fertility and cognition through the release of osteocalcin, a perfect definition-fitting hormone in its uncarboxylated state. As for the osteocytes, many evidence shows that they do not merely represent the final destination of the osteoblasts, but they are instead very active cells that, besides a mechanosensorial function, actively contribute to the bone remodelling by regulating bone formation and resorption. The regulation is exerted by the production of sclerostin (SOST), which in turn inhibits osteoblast differentiation by blocking Wnt/beta-catenin pathway. At the same time, osteocytes influence bone resorption both indirectly, by producing RANKL, which stimulates osteoclastogenesis, and directly by means of a local osteolysis, which is observed especially under pathological conditions. The great versatility of both these cells reflects the complexity of the bone tissue, which has not only a structural role, but influences and is influenced by different organs, taking part in homeostatic and adaptive responses affecting the whole organism. (C) 2014 Published by Elsevier Inc.
C1 [Capulli, Mattia; Paone, Riccardo; Rucci, Nadia] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.
RP Rucci, N (reprint author), Univ Aquila, Dept Biotechnol & Appl Clin Sci, Via Vetoio Coppito 2, I-67100 Laquila, Italy.
EM rucci@univaq.it
OI Paone, Riccardo/0000-0002-8688-9191; Rucci, Nadia/0000-0002-1371-8252;
   Capulli, Mattia/0000-0003-0449-6720
FU European Union, FP7 program - Marie Curie Actions International Research
   Staff Exchange Schem'e (IRSES) [INTERBONE-FP7-PEOPLE-2011-IRSES-295181]
FX We thank Marco Ponzetti and Rita Di Massimo for editing the manuscript.
   M.C. and R.P. were recipients of Marie Curie fellowships from the
   European Union funded, FP7 program - Marie Curie Actions International
   Research Staff Exchange Schem'e (IRSES),
   INTERBONE-FP7-PEOPLE-2011-IRSES-295181.
CR Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239
   Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599
   Roberts S, 2007, J BONE MINER RES, V22, P617, DOI 10.1359/JBMR.070108
   Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270
   Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200
   Lima F, 2009, MOL BIOL CELL, V20, P2697, DOI 10.1091/mbc.E08-10-1079
   Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308
   Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2
   Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3
   Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090
   Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200
   Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448
   Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058
   Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603
   Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315
   Franssen BBGM, 2008, J HAND SURG-EUR VOL, V33E, P363, DOI 10.1177/1753193408087104
   Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137
   Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6
   Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182
   Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452
   Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200
   Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236
   Hamidouche Z, 2010, J CELL PHYSIOL, V224, P509, DOI 10.1002/jcp.22152
   Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288
   Plotkin LI, 2008, J BONE MINER RES, V23, P1712, DOI [10.1359/jbmr.080617, 10.1359/JBMR.080617]
   Civitelli R, 2008, ARCH BIOCHEM BIOPHYS, V473, P188, DOI 10.1016/j.abb.2008.04.005
   Noble BS, 2003, AM J PHYSIOL-CELL PH, V284, pC934, DOI 10.1152/ajpcell.00234.2002
   Oury F, 2013, CELL, V155, P228, DOI 10.1016/j.cell.2013.08.042
   Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567
   Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003
   Marie PJ, 2012, GENE, V498, P1, DOI 10.1016/j.gene.2012.01.086
   Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022
   Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102
   DUDLEY HR, 1961, J BIOPHYS BIOCHEM CY, V11, P627, DOI 10.1083/jcb.11.3.627
   Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444
   Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311
   Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548
   Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390
   Shu B, 2011, J CELL SCI, V124, P3428, DOI 10.1242/jcs.083659
   Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304
   van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454
   Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108
   Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816
   Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200
   Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011
   Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515
   Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje
   Buo AM, 2014, FEBS LETT, V588, P1315, DOI 10.1016/j.febslet.2014.01.025
   Al-Dujaili SA, 2011, J CELL BIOCHEM, V112, P2412, DOI 10.1002/jcb.23164
   Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Komori T, 2013, CELL TISSUE RES, V352, P191, DOI 10.1007/s00441-012-1546-x
   Santos A, 2010, BIOCHEM BIOPH RES CO, V391, P364, DOI 10.1016/j.bbrc.2009.11.064
   Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200
   Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756
   Bivi N, 2012, CALCIFIED TISSUE INT, V91, P215, DOI 10.1007/s00223-012-9628-z
   Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641
   Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004
   Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001
   Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647
   Tome M, 2011, CELL DEATH DIFFER, V18, P985, DOI 10.1038/cdd.2010.167
   Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011
   GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139
   Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412
   Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834
   Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7
   Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011
   Bivi N, 2011, J CELL BIOCHEM, V112, P2920, DOI 10.1002/jcb.23208
   Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017
   Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623
   Stains JP, 2014, CALCIFIED TISSUE INT, V94, P55, DOI 10.1007/s00223-013-9742-6
   Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004
   Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105
   Shandala T, 2012, J CELL PHYSIOL, V227, P2889, DOI 10.1002/jcp.23034
   Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047
   Hebert C, 2013, J CELL BIOCHEM, V114, P2542, DOI 10.1002/jcb.24603
   Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216
   BAUD CA, 1962, ACTA ANAT, V51, P209
   BAUD CA, 1968, CLIN ORTHOP RELAT R, P227
   BIANCO P, 1988, CALCIFIED TISSUE INT, V43, P167, DOI 10.1007/BF02571315
   Boyde A., 1980, METAB BONE DIS RELAT, V25, P239
   Britanova O, 2006, AM J HUM GENET, V79, P668, DOI 10.1086/508214
   Colopy SA, 2004, BONE, V35, P881, DOI 10.1016/j.bone.2004.05.024
   Del Fattore Andrea, 2012, Inflammation & Allergy Drug Targets, V11, P181
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   EJIRI S, 1982, ARCH HISTOL JAPON, V45, P399, DOI 10.1679/aohc.45.399
   Fakhry Maya, 2013, World J Stem Cells, V5, P136, DOI 10.4252/wjsc.v5.i4.136
   FELIX R, 1990, J BONE MINER RES, V5, P781
   FROST HAROLD M., 1960, HENRY FORD HOSP MED BULL, V8, P208
   Gegenbauer C., 1864, UNTERSUCHUNGEN VERGL
   Han Y, 2011, BIOCHEM BIOPH RES CO, V407, P461, DOI 10.1016/j.bbrc.2011.03.034
   HANCOX N. M., 1965, CLIN ORTHOP RELAT RES, V40, P153
   Johnson L. C., 1966, BIRTH DEFECTS ORIG A, V2, P66
   Karsenty G., 2012, NATURE, V48, P314
   KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J
   Kode A., 2014, NATURE, V13, P240
   Kogianni G, 2008, J BONE MINER RES, V23, P915, DOI [10.1359/jbmr.080207, 10.1359/JBMR.080207]
   KREMPIEN B, 1976, VIRCHOWS ARCH A, V370, P55, DOI 10.1007/BF00427310
   LAZENBY RA, 1990, AM J PHYS ANTHROPOL, V82, P473, DOI 10.1002/ajpa.1330820408
   Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307
   Lee JS, 2011, BIOMATERIALS, V32, P760, DOI 10.1016/j.biomaterials.2010.09.042
   Lilly A.J., 2011, STEM CELLS INT, V274564, P2011
   Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052
   MAROTTI G, 1995, BONE, V16, P125, DOI 10.1016/8756-3282(95)80022-I
   Marotti G., 1990, ITAL J MINER ELECTRO, V4, P93
   McEwen DG, 2000, CURR BIOL, V10, pR562, DOI 10.1016/S0960-9822(00)00611-4
   Moriishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040143
   Mullender MG, 1996, BONE, V18, P109, DOI 10.1016/8756-3282(95)00444-0
   Noble BS, 2008, ARCH BIOCHEM BIOPHYS, V473, P106, DOI 10.1016/j.abb.2008.04.009
   O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942
   OWEN M, 1967, J CELL SCI, V2, P39
   RAMP WK, 1971, AM J PHYSIOL, V220, P270
   REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98
   Sato M, 2013, CELL METAB, V18, P749, DOI 10.1016/j.cmet.2013.09.014
   Semba T., 1966, 6 INT C EL MICR, P569
   TALMAGE RV, 1976, CALC TISS RES, V22, P117
   TONNA EA, 1966, J GERONTOL, V21, P124
   Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200
   Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07
   ZALLONE AZ, 1983, BASIC APPL HISTOCHEM, V27, P191
NR 126
TC 11
Z9 11
U1 7
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 3
EP 12
DI 10.1016/j.abb.2014.05.003
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300002
PM 24832390
ER

PT J
AU Cappariello, A
   Maurizi, A
   Veeriah, V
   Teti, A
AF Cappariello, Alfredo
   Maurizi, Antonio
   Veeriah, Vimal
   Teti, Anna
TI Reprint of: The Great Beauty of the osteoclast
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Osteoclast; Bone resorption; Bone formation; Immune system;
   Angiogenesis; Hematopoiesis
ID BONE-RESORBING OSTEOCLASTS; ENDOTHELIAL GROWTH-FACTOR; INTRACELLULAR
   MEMBRANE TRAFFICKING; RESISTANT ACID-PHOSPHATASE; HEMATOPOIETIC
   STEM-CELLS; IN-VITRO; T-CELLS; METALLOPROTEINASE MT1-MMP; MATRIX
   METALLOPROTEINASES; SUBCELLULAR-LOCALIZATION
AB Much has been written recently on osteoclast biology, but this cell type still astonishes scientists with its multifaceted functions and unique properties. The last three decades have seen a change in thinking about the osteoclast, from a cell with a single function, which just destroys the tissue it belongs to, to an "orchestrator" implicated in the concerted regulation of bone turnover. Osteoclasts have unique morphological features, organelle distribution and plasma membrane domain organization. They require polarization to cause extracellular bone breakdown and release of the digested bone matrix products into the circulation. Osteoclasts contribute to the control of skeletal growth and renewal. Alongside other organs, including kidney, gut, thyroid and parathyroid glands, they also affect calcemia and phosphatemia. Osteoclasts are very sensitive to pro-inflammatory stimuli, and studies in the '00s ascertained their tight link with the immune system, bringing about the question why bone needs a cell regulated by the immune system to remove the extracellular matrix components. Recently, osteoclasts have been demonstrated to contribute to the hematopoietic stem cell niche, controlling local calcium concentration and regulating the turnover of factors essential for hematopoietic stem cell mobilization. Finally, osteoclasts are important regulators of osteoblast activity and angiogenesis, both by releasing factors stored in the bone matrix, and secreting "clastokines" that regulate the activity of neighboring cells. All these facets will be discussed in this review article, with the aim of underscoring The Great Beauty of the osteoclast. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Cappariello, Alfredo] Bambino Gesu Pediat Hosp, Ist Ricovero & Cura Carattere Sci, Regenerat Med Unit, Rome, Italy.
   [Maurizi, Antonio; Veeriah, Vimal; Teti, Anna] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.
   [Veeriah, Vimal] Anna Univ, KB Chandrasekhar Res Ctr AU KBC, Madras 600025, Tamil Nadu, India.
RP Teti, A (reprint author), Dept Biotechnol & Appl Clin Sci, Via Vetoio Coppito 2, I-67100 Laquila, Italy.
EM teti@univaq.it
RI Veeriah, Vimal/H-5772-2015; 
OI Teti, Anna Maria/0000-0002-5887-4419
FU European Union [295181, 602300]; Associazione Italiana per la Ricerca
   sul Cancro (AIRC); Telethon [GGP09018]
FX The original work was performed with the financial support from the
   European Union (Programme "PEOPLE" - Call identifier:
   FP7-PEOPLE-2011-IRSES Proposal No. 295181 - Acronym: INTERBONE, and
   "Collaborative Project - Large-scale integrating project" - Call
   identifier: FP7-HEALTH.2012.2.1.1-1-C Proposal No. 602300 - Acronym:
   SYBIL), the Associazione Italiana per la Ricerca sul Cancro (AIRC), and
   Telethon (Grant GGP09018) to A.T. We are indebted to Dr. Rita Di Massimo
   for manuscript editing. Antonio Maurizi and Vimal Veeriah are Marie
   Curie Fellows involved in the INTERBONE-IRSES Project.
CR Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019
   Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1
   Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559
   Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003
   Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011
   Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x
   Sato T, 1997, J CELL SCI, V110, P589
   Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247
   Schachtner H, 2013, CYTOSKELETON, V70, P572, DOI 10.1002/cm.21119
   Hou P, 2004, BONE, V34, P37, DOI 10.1016/j.bone.2003.08.011
   Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514
   Vaaraniemi J, 2004, J BONE MINER RES, V19, P1432, DOI 10.1359/JBMR.040603
   Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917
   Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JC165952
   MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696
   Calvi LM, 2014, CALCIFIED TISSUE INT, V94, P112, DOI 10.1007/s00223-013-9805-8
   Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166
   Gay CV, 2000, CRIT REV EUKAR GENE, V10, P213
   Trebec-Reynolds DP, 2010, J CELL BIOCHEM, V110, P343, DOI 10.1002/jcb.22542
   Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5
   Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029
   Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2
   Sobacchi C, 2013, NAT REV ENDOCRINOL, V9, P522, DOI 10.1038/nrendo.2013.137
   Baud'huin M, 2013, CYTOKINE GROWTH F R, V24, P401, DOI 10.1016/j.cytogfr.2013.06.001
   Bertaud J, 2010, ACTA BIOMATER, V6, P2457, DOI 10.1016/j.actbio.2010.01.028
   Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008
   Frisch BJ, 2009, BLOOD, V114, P4054, DOI 10.1182/blood-2009-03-205823
   Kovesdy CP, 2013, NEPHROL DIAL TRANSPL, V28, P2228, DOI 10.1093/ndt/gft065
   Oury F, 2013, CELL, V155, P228, DOI 10.1016/j.cell.2013.08.042
   Barrow AD, 2011, J CLIN INVEST, V121, P3505, DOI 10.1172/JCI45913
   Ea HK, 2009, CURR OPIN RHEUMATOL, V21, P150, DOI 10.1097/BOR.0b013e3283257ba9
   Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822
   Zaidi M, 2001, J BONE MINER RES, V16, P1747, DOI 10.1359/jbmr.2001.16.10.1747
   Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374
   Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007
   Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196
   Panaroni C, 2013, CALCIFIED TISSUE INT, V93, P261, DOI 10.1007/s00223-013-9753-3
   Khan UA, 2013, J CELL BIOCHEM, V114, P1772, DOI 10.1002/jcb.24518
   Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328
   Miyamoto K, 2011, J EXP MED, V208, P2175, DOI 10.1084/jem.20101890
   Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200
   Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137
   Schett G, 2011, EUR J CLIN INVEST, V41, P1361, DOI 10.1111/j.1365-2362.2011.02545.x
   Supanchart C, 2008, ARCH BIOCHEM BIOPHYS, V473, P161, DOI 10.1016/j.abb.2008.03.029
   Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060
   Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001
   Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002
   Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070
   Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002
   Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1
   Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001
   Lee SH, 2008, BMB REP, V41, P495
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   Danks L, 2013, J BIOCHEM, V154, P29, DOI 10.1093/jb/mvt049
   Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011
   Boyce BF, 2013, J DENT RES, V92, P860, DOI 10.1177/0022034513500306
   Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106
   Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017
   Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840
   Dubyak GR, 2012, CELL MICROBIOL, V14, P1697, DOI 10.1111/cmi.12001
   BARON R, 1988, J CELL BIOL, V106, P1863, DOI 10.1083/jcb.106.6.1863
   BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220
   Baron R, 2004, NAT MED, V10, P458, DOI 10.1038/nm0504-458
   BARON R, 1989, CONNECT TISSUE RES, V20, P109, DOI 10.3109/03008208909023879
   BARON R, 1990, J CELL SCI, V97, P439
   BLAIR HC, 1986, J CELL BIOL, V102, P1164, DOI 10.1083/jcb.102.4.1164
   Bonar SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035979
   Buchwald ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038199
   Buchwald ZS, 2013, BONE, V56, P163, DOI 10.1016/j.bone.2013.05.024
   CHAMBERS TJ, 1980, CLIN ORTHOP RELAT R, P283
   Collin-Osdoby P, 2002, J BONE MINER RES, V17, P1859, DOI 10.1359/jbmr.2002.17.10.1859
   Coxon FP, 2008, SEMIN CELL DEV BIOL, V19, P424, DOI 10.1016/j.semcdb.2008.08.004
   Del Fattore A., 2011, HUMAN GENETIC DIS, P57
   Del Fattore A, 2008, J BONE MINER RES, V23, P380, DOI 10.1359/JBMR.071107
   Devlin M.J., 2014, LANCET DIABETES ENDO
   Domon T, 2002, TISSUE CELL, V34, P326, DOI 10.1016/S0040-8166(02)00013-7
   Dufour X., 2007, EXP CELL RES, V313, P394
   Fumoto T, 2014, J BONE MINER RES, V29, P830, DOI 10.1002/jbmr.2096
   Garimella R, 2008, J HISTOCHEM CYTOCHEM, V56, P569, DOI 10.1369/jhc.2008.950394
   Grol M.V., 2009, PURINERG SIGNAL, P205
   Gurevitch O, 2006, MED HYPOTHESES, V67, P729, DOI 10.1016/j.mehy.2006.03.051
   Hayman AR, 2003, J BONE MINER RES, V18, P1905, DOI 10.1359/jbmr.2003.18.10.1905
   He C, 2005, BIOCHEM BIOPH RES CO, V329, P324, DOI 10.1016/j.bbrc.2005.01.133
   Hirvonen Mirkka J, 2013, Bonekey Rep, V2, P306, DOI 10.1038/bonekey.2013.40
   HUNTER SJ, 1989, J HISTOCHEM CYTOCHEM, V37, P1529
   Irie K, 2001, TISSUE CELL, V33, P478
   JOYCE NC, 1995, CURR EYE RES, V14, P601, DOI 10.3109/02713689508998408
   Kiesel JR, 2009, J IMMUNOL, V182, P5477, DOI 10.4049/jimmunol.0803897
   Lei Zhu, 2009, Int J Exp Pathol, V90, P512, DOI 10.1111/j.1365-2613.2009.00661.x
   Liao Eryuan, 2013, Front Med, V7, P65, DOI 10.1007/s11684-013-0254-6
   LINDSEY AE, 1990, P NATL ACAD SCI USA, V87, P5278, DOI 10.1073/pnas.87.14.5278
   Lymperi S, 2008, BLOOD, V111, P1173, DOI 10.1182/blood-2007-03-082800
   Lymperi S, 2011, BLOOD, V117, P1540, DOI 10.1182/blood-2010-05-282855
   Mitic N, 2005, ARCH BIOCHEM BIOPHYS, V439, P154, DOI 10.1016/j.abb.2005.05.013
   Miyamoto T., 2013, J ORTHOP, V4, P198
   Motyckova Gabriela, 2002, Current Molecular Medicine (Hilversum), V2, P407, DOI 10.2174/1566524023362401
   Mulari M, 2003, MICROSC RES TECHNIQ, V61, P496, DOI 10.1002/jemt.10371
   MURRAY EJB, 1995, MINER ELECTROL METAB, V21, P184
   Nakamura H, 2004, BONE, V34, P48, DOI 10.1016/j.bone.2003.09.001
   Ng PY, 2013, J BONE MINER RES, V28, P119, DOI 10.1002/jbmr.1725
   Noble BS, 2008, ARCH BIOCHEM BIOPHYS, V473, P106, DOI 10.1016/j.abb.2008.04.009
   OKADA Y, 1995, LAB INVEST, V72, P311
   Otero K, 2012, J IMMUNOL, V188, P2612, DOI 10.4049/jimmunol.1102836
   Padera R, 1999, FASEB J, V13, P1677
   Peruzzi B., 2012, CLIN REV BONE MINER, V10, P71
   Porter RL, 2008, ARCH BIOCHEM BIOPHYS, V473, P193, DOI 10.1016/j.abb.2008.04.001
   Saijo M, 2003, HISTOCHEM CELL BIOL, V120, P493, DOI 10.1007/s00418-003-0589-1
   SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199
   Sheu TJ, 2003, J BIOL CHEM, V278, P438, DOI 10.1074/jbc.M208292200
   Stenbeck G, 2004, J CELL SCI, V117, P827, DOI 10.1242/jcs.00935
   Szewczyk KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060285
   Takamatsu Y, 1998, BLOOD, V92, P3465
   Teti Anna, 2013, Bonekey Rep, V2, P449, DOI 10.1038/bonekey.2013.183
   Teti Anna, 2012, Bonekey Rep, V1, P46, DOI 10.1038/bonekey.2012.46
   TETI A, 1989, J CLIN INVEST, V83, P227, DOI 10.1172/JCI113863
   Thammasitboon K, 2006, BONE, V38, P845, DOI 10.1016/j.bone.2005.10.013
   Ye SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027285
   Yi T, 2008, J CELL PHYSIOL, V217, P409, DOI 10.1002/jcp.21511
   Zaiss MM, 2010, ARTHRITIS RHEUM-US, V62, P2328, DOI 10.1002/art.27535
   ZALLONE AZ, 1983, J ANAT, V137, P57
   Zhao HB, 2002, BIOCHEM BIOPH RES CO, V293, P1060, DOI 10.1016/S0006-291X(02)00326-1
NR 121
TC 3
Z9 3
U1 3
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 13
EP 21
DI 10.1016/j.abb.2014.08.009
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300003
PM 25282390
ER

PT J
AU Sims, NA
   Vrahnas, C
AF Sims, Natalie A.
   Vrahnas, Christina
TI Regulation of cortical and trabecular bone mass by communication between
   osteoblasts, osteocytes and osteoclasts
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Osteoblast; Osteoclast; Osteocyte
ID LEUKEMIA INHIBITORY FACTOR; KAPPA-B LIGAND; PARATHYROID-HORMONE 1-34;
   RECEPTOR ACTIVATOR; ONCOSTATIN-M; POSTMENOPAUSAL OSTEOPOROSIS;
   1,25-DIHYDROXYVITAMIN D-3; TARGETED ABLATION; ANABOLIC ACTIONS;
   SEX-DIFFERENCES
AB The size and strength of bone is determined by two fundamental processes. One process, bone remodelling, renews the skeleton throughout life. In this process existing bone is resorbed by osteoclasts and replaced, in the same location, by osteoblasts. The other process is bone modelling, where bone formation and resorption occur at different sites so that the shape of bone is changed. Recent data suggests that both remodelling and modelling are controlled by signals between the cells that carry out these two processes. Osteoclasts both resorb bone, and provide inhibitory and stimulatory signals, including cardiotrophin-1 and sphingosine-1-kinase, to the osteoblast lineage thereby regulating their differentiation and activity on both trabecular and cortical surfaces. In addition, the osteoblast lineage, including osteoblast progenitors, matrix-producing osteoblasts, bone lining cells, and matrix-embedded osteocytes, produce both inhibitory and stimulatory factors that stimulate osteoclast differentiation. We will discuss the roles of osteoblast- and osteocyte-derived RANKL, and paracrine, autocrine and endocrine factors, such as ephrinB2, the IL-6/gp130 family of cytokines, parathyroid hormone, and its related peptide, PTHrP. These factors not only stimulate RANKL production, but also stimulate osteoblast differentiation and activity. This review will focus on recent data, generated from pharmacological and genetic studies of mouse models and what these data reveal about these pathways at different stages of osteoblast differentiation and their impact on both bone remodelling and modelling in trabecular and cortical bone. (C) 2014 Elsevier Inc. All rights reserved.
C1 St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia.
   Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia.
RP Sims, NA (reprint author), 9 Princes St, Fitzroy, Vic 3122, Australia.
EM nsims@svi.edu.au
CR ABE Y, 1993, CALCIFIED TISSUE INT, V52, P365, DOI 10.1007/BF00310201
   Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239
   Richards CD, 2000, CYTOKINE, V12, P613, DOI 10.1006/cyto.1999.0635
   Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975
   Sims NA, 2004, J CLIN INVEST, V113, P379, DOI 10.1172/JCI200419872
   Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3
   Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200
   Johnson RW, 2014, BONE, V64, P47, DOI 10.1016/j.bone.2014.03.053
   METCALF D, 1989, P NATL ACAD SCI USA, V86, P5948, DOI 10.1073/pnas.86.15.5948
   ECAROTCHARRIER B, 1983, J CELL BIOL, V96, P639, DOI 10.1083/jcb.96.3.639
   Finkelstein JS, 2010, J CLIN ENDOCR METAB, V95, P1838, DOI 10.1210/jc.2009-1703
   Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308
   Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8
   Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904
   Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448
   Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200
   TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924
   Fuller K, 2008, BONE, V42, P200, DOI 10.1016/j.bone.2007.09.044
   Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73
   Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797
   Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625
   Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI [10.1359/jbmr.080706, 10.1359/JBMR.080706]
   Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y
   TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600
   Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI [10.1359/jbmr.080324, 10.1359/JBMR.080324]
   Thomas GP, 2001, J ENDOCRINOL, V170, P451, DOI 10.1677/joe.0.1700451
   Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452
   Henriksen K, 2014, CALCIFIED TISSUE INT, V94, P88, DOI 10.1007/s00223-013-9741-7
   Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627
   Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493
   Koh AJ, 2005, ENDOCRINOLOGY, V146, P4584, DOI 10.1210/en.2005-0333
   O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301
   Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568
   Karsdal MA, 2008, BIOCHEM BIOPH RES CO, V366, P483, DOI 10.1016/j.bbrc.2007.11.168
   Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1
   Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890
   Kristensen HB, 2014, AM J PATHOL, V184, P778, DOI 10.1016/j.ajpath.2013.11.022
   Poulton IJ, 2012, J BONE MINER RES, V27, P586, DOI 10.1002/jbmr.1485
   Martin TJ, 2008, BEST PRACT RES CL EN, V22, P701, DOI 10.1016/j.beem.2008.07.006
   Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918
   Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610
   Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311
   Kim BT, 2003, J BONE MINER RES, V18, P150, DOI 10.1359/jbmr.2003.18.1.150
   Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835
   Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534
   Akhter MP, 2000, CALCIFIED TISSUE INT, V67, P337, DOI 10.1007/s002230001144
   Sheng MHC, 2013, BONE, V52, P133, DOI 10.1016/j.bone.2012.09.027
   Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299
   Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/jbmr.081248, 10.1359/JBMR.081248]
   RUFF CB, 1988, J ORTHOPAED RES, V6, P886, DOI 10.1002/jor.1100060613
   Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489
   Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018
   Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507
   Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012
   Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513
   Takyar FM, 2013, J BONE MINER RES, V28, P912, DOI 10.1002/jbmr.1820
   Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743
   Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09
   Sims NA, 2014, CURR OSTEOPOROS REP, V12, P98, DOI 10.1007/s11914-014-0196-1
   POLI V, 1994, EMBO J, V13, P1189
   McGregor NE, 2010, CALCIFIED TISSUE INT, V86, P261, DOI 10.1007/s00223-010-9337-4
   Gooi JH, 2014, J ENDOCRINOL, V221, P181, DOI 10.1530/JOE-13-0524
   Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001
   Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1259/JBMR.050209
   DOBNIG H, 1995, ENDOCRINOLOGY, V136, P3632, DOI 10.1210/en.136.8.3632
   Wong PKK, 2006, ARTHRITIS RHEUM, V54, P158, DOI 10.1002/art.21537
   RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454
   Johnson RW, 2014, J BONE MINER RES, V29, P1492, DOI 10.1002/jbmr.2159
   Martin TJ, 2010, ADV EXP MED BIOL, V658, P51, DOI 10.1007/978-1-4419-1050-9_6
   Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106
   Callewaert F, 2010, J BONE MINER RES, V25, P617, DOI 10.1359/jbmr.090828
   Leder BZ, 2003, J CLIN ENDOCR METAB, V88, P204, DOI 10.1210/jc.2002-021036
   Gooi JH, 2010, BONE, V46, P1486, DOI 10.1016/j.bone.2010.02.018
   Palmqvist P, 2002, J IMMUNOL, V169, P3353
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Perry MJ, 2008, BONE, V42, P216, DOI 10.1016/j.bone.2007.09.053
   Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840
   Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221
   Kong YY, 1999, NATURE, V397, P315
   Winkler IG, 2012, LEUKEMIA, V26, P1594, DOI 10.1038/leu.2012.17
   Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979
   Arthur A, 2013, J BONE MINER RES, V28, P926, DOI 10.1002/jbmr.1821
   Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6
   Cornish J, 1997, BONE, V21, P243, DOI 10.1016/S8756-3282(97)00144-0
   Dai XM, 2004, J BONE MINER RES, V19, P1441, DOI 10.1359/JBMR.040514
   DELMAS PD, 1995, BONE, V16, P603, DOI 10.1016/8756-3282(95)00113-R
   ERIKSEN EF, 1984, METAB BONE DIS RELAT, V5, P243, DOI 10.1016/0221-8747(84)90066-3
   Frost HM, 1964, BONE BIODYNAMICS, P315
   Fumoto T, 2014, J BONE MINER RES, V29, P830, DOI 10.1002/jbmr.2096
   Gerber I., 2001, European Cells & Materials, V2, P10
   Henriksen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027482
   HOLTROP ME, 1979, CALCIFIED TISSUE INT, V27, P129, DOI 10.1007/BF02441175
   HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204
   Kim S, 2007, MOL ENDOCRINOL, V21, P197, DOI 10.1210/me.2006-0315
   Kim S, 2007, J STEROID BIOCHEM, V103, P430, DOI 10.1016/j.jsbmb.2006.12.020
   Kogianni G, 2008, J BONE MINER RES, V23, P915, DOI [10.1359/jbmr.080207, 10.1359/JBMR.080207]
   LIAN JB, 1990, ENDOCRINOLOGY, V126, P955
   MALAVAL L, 1995, ENDOCRINOLOGY, V136, P1411, DOI 10.1210/en.136.4.1411
   PARFITT AM, 1984, CALCIFIED TISSUE INT, V36, pS37, DOI 10.1007/BF02406132
   Parfitt A.M., 2010, FUNDAMENTALS OSTEOPO, P35
   Sakagami N, 2005, MICRON, V36, P688, DOI 10.1016/j.micron.2005.06.008
   Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753
   Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215
   Stanislaus D, 2000, BONE, V27, P209, DOI 10.1016/S8756-3282(00)00309-4
   Tonna S, 2014, CALCIFIED TISSUE INT, V94, P35, DOI 10.1007/s00223-013-9738-2
   Turner CH, 2001, J BONE MINER RES, V16, P206, DOI 10.1359/jbmr.2001.16.2.206
NR 106
TC 4
Z9 4
U1 5
U2 35
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 22
EP 28
DI 10.1016/j.abb.2014.05.015
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300004
PM 24875146
ER

PT J
AU Blin-Wakkach, C
   Rouleau, M
   Wakkach, A
AF Blin-Wakkach, Claudine
   Rouleau, Matthieu
   Wakkach, Abdelilah
TI Roles of osteoclasts in the control of medullary hematopoietic niches
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Hematopoietic niches; Osteoclasts; Bone marrow; Osteopetrosis; Cell
   mobilization
ID COLONY-STIMULATING FACTOR; STEM-CELL NICHE; BONE-MARROW NICHE;
   OSTEOPETROTIC OP/OP MICE; SYMPATHETIC-NERVOUS-SYSTEM; MALIGNANT
   INFANTILE OSTEOPETROSIS; AUTOSOMAL RECESSIVE OSTEOPETROSIS;
   OSTEOSCLEROTIC OC MOUSE; FUNCTION IN-VITRO; CD8(+) T-CELLS
AB Bone marrow is the major site of hematopoiesis in mammals. The bone marrow environment plays an essential role in the regulation of hematopoietic stem and progenitor cells by providing specialized niches in which these cells are maintained. Many cell types participate to the composition and regulation of hematopoietic stem cell (HSC) niches, integrating complex signals from the bone, immune and nervous systems. Among these cells, the bone-resorbing osteoclasts (OCLs) have been described as main regulators of HSC niches. They are not limited to carving space for HSCs, but they also provide signals that affect the molecular and cellular niche components. However, their exact role in HSC niches remains unclear because of the variety of models, signals and conditions used to address the question. The present review will discuss the importance of the implication of OCLs focusing on the formation of HSC niches, the maintenance of HSCs in these niches and the mobilization of HSCs from the bone marrow. It will underline the importance of OCLs in HSC niches. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Blin-Wakkach, Claudine] CNRS, UMR7370, LP2M, Fac Med, F-06107 Nice, France.
   Univ Nice Sophia Antipolis, Fac Sci, F-06100 Nice, France.
RP Blin-Wakkach, C (reprint author), CNRS, UMR7370, LP2M, Fac Med, 28 Av Valombrose, F-06107 Nice, France.
EM blin@unice.fr
RI Blin, Claudine/P-6836-2015
FU "Fondation pour la Recherche Medicale" (FRM); "Agence Nationale de la
   Recherche" (ANR); Arthritis Fondation; Societe Francaise de Rhumatologie
FX The work of the authors was supported by the "Fondation pour la
   Recherche Medicale" (FRM), the "Agence Nationale de la Recherche" (ANR),
   the "Arthritis Fondation" and the "Societe Francaise de Rhumatologie".
CR Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x
   An J, 1996, EXP HEMATOL, V24, P768
   Widler L, 2002, J MED CHEM, V45, P3721, DOI 10.1021/jm020819i
   WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0
   Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833
   Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252
   Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639
   Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417
   Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002
   Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017
   Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685
   REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557
   Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845
   Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Chang MK, 2008, J IMMUNOL, V181, P1232
   Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289
   Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4
   Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593
   Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688
   Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8
   OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63
   Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247
   Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480
   Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146
   Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041
   Falanga A, 1999, BLOOD, V93, P2506
   Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984
   Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0
   Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145
   Kollet O, 2013, LEUKEMIA, V27, P2006, DOI 10.1038/leu.2013.154
   SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O
   Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X
   FREEDMAN MH, 1981, AM J HEMATOL, V11, P271, DOI 10.1002/ajh.2830110307
   Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053
   Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992
   Grassinger J, 2010, BLOOD, V116, P3185, DOI 10.1182/blood-2009-12-260703
   Arai M, 2003, BBA-MOL CELL RES, V1640, P137, DOI 10.1016/S0167-4889(03)00042-9
   Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132
   Takeuchi T, 2001, BIOCHEM PHARMACOL, V61, P579, DOI 10.1016/S0006-2952(00)00591-8
   Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046
   Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657
   Szumilas P, 2005, CELL PROLIFERAT, V38, P47, DOI 10.1111/j.1365-2184.2005.00329.x
   Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006
   Kunisaki Y, 2014, INT J HEMATOL, V99, P699, DOI 10.1007/s12185-014-1580-4
   MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0
   Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029
   Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191
   Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813
   Mansour A, 2011, CELL RES, V21, P1102, DOI 10.1038/cr.2011.21
   Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160
   Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7
   Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513
   Wang L, 2013, EMBO J, V32, P219, DOI 10.1038/emboj.2012.308
   Purton LE, 1996, BLOOD, V87, P1802
   Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242
   Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612
   Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026
   Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025
   Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4
   Mansour A, 2012, J EXP MED, V209, P537, DOI 10.1084/jem.20110994
   Levesque JP, 2003, EXP HEMATOL, V31, P109, DOI 10.1016/S0301-472X(02)01028-7
   Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547
   Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987
   Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037
   Kollet Orit, 2012, Inflammation & Allergy Drug Targets, V11, P170
   Pettit AR, 2008, BONE, V43, P976, DOI 10.1016/j.bone.2008.08.128
   Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534
   Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016
   GONG JK, 1978, SCIENCE, V199, P1443, DOI 10.1126/science.75570
   Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783
   Josien R, 1999, J IMMUNOL, V162, P2562
   Del Fattore A, 2010, ARCH BIOCHEM BIOPHYS, V503, P28, DOI 10.1016/j.abb.2010.07.020
   Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318
   Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028
   Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200
   Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885
   Miyamoto K, 2011, J EXP MED, V208, P2175, DOI 10.1084/jem.20101890
   Wiethe C, 2003, J IMMUNOL, V171, P4121
   Singh P, 2012, LEUKEMIA, V26, P2375, DOI 10.1038/leu.2012.117
   Goto T, 2003, J ELECTRON MICROSC, V52, P551, DOI 10.1093/jmicro/52.6.551
   Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Davey RA, 2013, J BONE MINER RES, V28, P973, DOI 10.1002/jbmr.1869
   Christopher MJ, 2011, J EXP MED, V208, P251, DOI 10.1084/jem.20101700
   Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926
   Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412
   Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje
   Fujihara Y, 2014, BONE, V61, P1, DOI 10.1016/j.bone.2013.12.026
   Jacenko O, 2002, AM J PATHOL, V160, P2019, DOI 10.1016/S0002-9440(10)61152-2
   Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004
   Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994
   Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730
   Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272
   Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434
   Lowell CA, 1996, BLOOD, V87, P1780
   Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011
   Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249
   Cackowski FC, 2010, BLOOD, V115, P140, DOI 10.1182/blood-2009-08-237628
   Itkin T, 2013, CURR OPIN HEMATOL, V20, P237, DOI 10.1097/MOH.0b013e3283606162
   Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398
   Kong YY, 1999, NATURE, V397, P315
   Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8
   Li HY, 2010, BLOOD, V116, P210, DOI 10.1182/blood-2009-11-255026
   Winkler IG, 2012, LEUKEMIA, V26, P1594, DOI 10.1038/leu.2012.17
   Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979
   Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422
   BANCO R, 1985, CLIN ORTHOP RELAT R, P238
   Barker JE, 1997, EXP HEMATOL, V25, P542
   Batard P, 2000, J CELL SCI, V113, P383
   Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6
   BEGG SK, 1993, J EXP MED, V177, P237, DOI 10.1084/jem.177.1.237
   Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139
   Blin-Wakkach C, 2006, EXP HEMATOL, V34, P851, DOI 10.1016/j.exphem.2006.04.003
   Blin-Wakkach C, 2004, LEUKEMIA, V18, P1505, DOI 10.1038/sj.leu.2403449
   Blin-Wakkach C, 2004, J BONE MINER RES, V19, P1137, DOI 10.1359/JBMR.040318
   BRAGA PC, 1994, AGENTS ACTIONS, V41, P121, DOI 10.1007/BF02001904
   Bruder E, 2003, PEDIATR PATHOL MOL M, V22, P3, DOI 10.1080/15227950390168138
   Burgess W, 2003, J NEUROIMMUNOL, V135, P82, DOI 10.1016/S0165-5728(02)00443-5
   Chen CJ, 2003, ANN HEMATOL, V82, P64, DOI 10.1007/s00277-002-0578-9
   Chiusaroli R, 2003, DEV BIOL, V261, P537, DOI 10.1016/S0012-1606(03)00299-9
   Chiusaroli R, 2004, MOL BIOL CELL, V15, P234
   Cho KA, 2010, INT J MOL MED, V26, P557, DOI 10.3892/ijmm_00000499
   Christopher MJ, 2008, J BONE MINER RES, V23, P1765, DOI [10.1359/jbmr.080612, 10.1359/JBMR.080612]
   Day CJ, 2004, J CELL BIOCHEM, V91, P303, DOI 10.1002/jcb.10780
   Deguchi K, 1999, BIOCHEM BIOPH RES CO, V255, P352, DOI 10.1006/bbrc.1999.0163
   Dini G, 2000, BONE MARROW TRANSPL, V26, P219, DOI 10.1038/sj.bmt.1702491
   Flores C, 2013, HAEMATOLOGICA, V98, P1848, DOI 10.3324/haematol.2013.089466
   Frattini A, 2005, P NATL ACAD SCI USA, V102, P14629, DOI 10.1073/pnas.0507637102
   Furthner D., 2009, KILN PADIATR, V222, P180
   Golan Karin, 2013, Pharmaceuticals (Basel), V6, P1145, DOI 10.3390/ph6091145
   GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702
   Gribi R, 2006, BLOOD, V108, P501, DOI 10.1182/blood-2005-10-4209
   Harrison DE, 1997, EXP HEMATOL, V25, P293
   Hirbe AC, 2007, BLOOD, V109, P3424, DOI 10.1182/blood-2006-09-048686
   Johansson M, 2006, EXP HEMATOL, V34, P242, DOI 10.1016/j.exphem.2005.11.010
   Judex S., 2002, FASEB J, V5, P9
   Kiesel JR, 2009, J IMMUNOL, V182, P5477, DOI 10.4049/jimmunol.0803897
   Kimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026918
   Kondo H, 2013, AM J PHYSIOL-ENDOC M, V304, pE507, DOI 10.1152/ajpendo.00191.2012
   Kook S, 2013, J CLIN INVEST, V123, P3420, DOI 10.1172/JCI64060
   Lapid K, 2008, EGRESS MOBILIZATION
   Lee HM, 2009, LEUKEMIA, V23, P2052, DOI 10.1038/leu.2009.158
   Li SD, 2011, TRANSPL P, V43, P3920, DOI 10.1016/j.transproceed.2011.09.020
   Li SD, 2013, J CELL PHYSIOL, V228, P1002, DOI 10.1002/jcp.24246
   Ludin A., 2014, ANTIOXID REDOX SIGNA
   Lymperi S, 2008, BLOOD, V111, P1173, DOI 10.1182/blood-2007-03-082800
   Lymperi S, 2011, BLOOD, V117, P1540, DOI 10.1182/blood-2010-05-282855
   Mansour A, 2012, CELL CYCLE, V11, P2045, DOI 10.4161/cc.20534
   Miyamoto Takeshi, 2013, World J Orthop, V4, P198, DOI 10.5312/wjo.v4.i4.198
   MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141
   Nagao M, 2011, P NATL ACAD SCI USA, V108, P17767, DOI 10.1073/pnas.1109402108
   Nakamichi Y, 2012, P NATL ACAD SCI USA, V109, P10006, DOI 10.1073/pnas.1207361109
   Nicholls BM, 2005, J BONE MINER RES, V20, P2264, DOI 10.1359/JBMR.050807
   NILSSON SK, 1994, DEV BIOL, V164, P456, DOI 10.1006/dbio.1994.1215
   NILSSON SK, 1994, EXP HEMATOL, V22, P377
   Roberts AW, 1997, BLOOD, V89, P2736
   Scadden DT, 2008, NATURE, V452, P416, DOI 10.1038/452416a
   SEIFERT MF, 1987, TISSUE CELL, V19, P29, DOI 10.1016/0040-8166(87)90054-1
   SEIFERT MF, 1985, AM J ANAT, V172, P141, DOI 10.1002/aja.1001720204
   SEXTON PM, 1991, MOL NEUROBIOL, V5, P251, DOI 10.1007/BF02935550
   Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072
   Steward CG, 2005, BIOL BLOOD MARROW TR, V11, P115, DOI 10.1016/j.bbmt.2004.11.001
   Suga S, 2010, J PHARMACOL SCI, V112, P184, DOI 10.1254/jphs.09283FP
   Tagaya H, 2000, BLOOD, V95, P3363
   Takamatsu Y, 1998, BLOOD, V92, P3465
   Tanaka M, 2012, BONE MARROW TRANSPL, V47, P1143, DOI 10.1038/bmt.2011.233
   Teti Anna, 2012, Bonekey Rep, V1, P46, DOI 10.1038/bonekey.2012.46
   Tolcos M, 2003, J COMP NEUROL, V456, P29, DOI 10.1002/cne.10478
   Wakkach A, 2008, BLOOD, V112, P5074, DOI 10.1182/blood-2008-01-132787
   Watanabe T, 2003, INT J HEMATOL, V77, P75, DOI 10.1007/BF02982606
   WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516
   Wilson CJ, 2000, ARCH DIS CHILD, V83, P449, DOI 10.1136/adc.83.5.449
NR 177
TC 3
Z9 3
U1 3
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 29
EP 37
DI 10.1016/j.abb.2014.06.032
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300005
PM 24998177
ER

PT J
AU Morhayim, J
   Baroncelli, M
   van Leeuwen, JP
AF Morhayim, Jess
   Baroncelli, Marta
   van Leeuwen, Johannes P.
TI Extracellular vesicles: Specialized bone messengers
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Extracellular vesicles; Intercellular communication; Bioactive cargo;
   Bone
ID MESENCHYMAL STEM-CELL; TUMOR-DERIVED EXOSOMES; PEPTIDE-BASED VACCINE;
   DENDRITIC CELLS; MEMBRANE-VESICLES; MATRIX VESICLES; HORIZONTAL
   TRANSFER; PROTEOMIC ANALYSIS; ENDOTHELIAL-CELLS; URINARY EXOSOMES
AB Mammalian cells actively secrete factors that contribute to shape their microenvironment. These factors either travel freely or they are enclosed within the lipid bilayer of extracellular vesicles (EVs), and regulate the function of neighboring and distant cells. EVs are secreted by a wide spectrum of cell types and are found in various biological fluids. They convey their message by mediating the horizontal transfer of bioactive molecules, such as proteins, mRNAs and miRNAs, between cells. Recent studies showed the vital roles of EVs in a wide range of physiological and pathophysiological processes. In this review, we highlight the recent developments in the newly emerging EV field, including their biogenesis, molecular content and function. Moreover, we discuss the role of EVs in bone biology and their promising applications in diagnosis, drug development and regenerative therapy. (C) 2014 Published by Elsevier Inc.
C1 [Morhayim, Jess; Baroncelli, Marta; van Leeuwen, Johannes P.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3015 CN Rotterdam, Netherlands.
RP van Leeuwen, JP (reprint author), Erasmus Univ, Med Ctr, Dept Internal Med, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.
EM j.morhayim@erasmusmc.nl; m.baroncelli@erasmusmc.nl;
   j.vanleeuwen@erasmusmusmc.nl
FU INTERBONE research program
FX We acknowledge the support from the INTERBONE research program. We thank
   Hector Hugo Perez Garza for help with atomic force microscopy imaging,
   and Gert-Jan Kremers for confocal imaging.
CR Alves RDAM, 2013, MOL CELL PROTEOMICS, V12, P2890, DOI 10.1074/mcp.M112.024927
   ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266
   Anderson H.C., 1984, SCANNING ELECTRON MI, V2, P953
   Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832
   Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887
   Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988
   Maumus M, 2013, BIOCHIMIE, V95, P2229, DOI 10.1016/j.biochi.2013.04.017
   Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014
   Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254
   ANDERSON HC, 1967, J CELL BIOL, V35, P81, DOI 10.1083/jcb.35.1.81
   RONQUIST G, 1985, BIOCHIM BIOPHYS ACTA, V822, P203, DOI 10.1016/0304-4157(85)90008-5
   Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200
   Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152
   Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]
   Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003
   Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162
   Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0
   Soleti R, 2012, VITAM HORM, V88, P395, DOI 10.1016/B978-0-12-394622-5.00018-3
   Kooijmans SAA, 2012, INT J NANOMED, V7, P1525, DOI 10.2147/IJN.S29661
   Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657
   Thery C, 2001, J IMMUNOL, V166, P7309
   Holmgren L, 1999, BLOOD, V93, P3956
   Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800
   Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043
   Balcerzak M, 2008, PROTEOMICS, V8, P192, DOI 10.1002/pmic.200700612
   Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x
   Katsuda T, 2013, PROTEOMICS, V13, P1637, DOI 10.1002/pmic.201200373
   Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138
   Bruno S, 2013, PEDIATR NEPHROL, V28, P2249, DOI 10.1007/s00467-013-2413-z
   Choi DS, 2013, PROTEOMICS, V13, P1554, DOI 10.1002/pmic.201200329
   van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065
   van Dommelen SM, 2012, J CONTROL RELEASE, V161, P635, DOI 10.1016/j.jconrel.2011.11.021
   Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594
   Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004
   Verderio C, 2012, ANN NEUROL, V72, P610, DOI 10.1002/ana.23627
   Giusti I, 2008, NEOPLASIA, V10, P481, DOI 10.1593/neo.08178
   Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109
   Renzulli JF, 2010, J UROLOGY, V184, P2165, DOI 10.1016/j.juro.2010.06.119
   Esser J, 2010, J ALLERGY CLIN IMMUN, V126, P1032, DOI 10.1016/j.jaci.2010.06.039
   Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998
   Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43
   Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161
   Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389
   Lai RC, 2013, BIOTECHNOL ADV, V31, P543, DOI 10.1016/j.biotechadv.2012.08.008
   Anderson HC, 1997, AM J PATHOL, V151, P1555
   Barres C, 2010, BLOOD, V115, P696, DOI 10.1182/blood-2009-07-231449
   Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234
   Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576
   van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jh/mvj128
   Jang SC, 2013, ACS NANO, V7, P7698, DOI 10.1021/nn402232g
   Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1
   van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x
   Perez-Casal M, 2009, HAEMATOL-HEMATOL J, V94, P387, DOI 10.3324/haematol.13547
   Mokarizadeh A, 2012, IMMUNOL LETT, V147, P47, DOI 10.1016/j.imlet.2012.06.001
   Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517
   Shifrin DA, 2013, MOL BIOL CELL, V24, P1253, DOI 10.1091/mbc.E12-08-0572
   Tetta C, 2011, ORGANOGENESIS, V7, P105, DOI 10.4161/org.7.2.15782
   Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X
   Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753
   Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273
   Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x
   BASTIDA E, 1984, BLOOD, V64, P177
   Bianco F, 2005, J IMMUNOL, V174, P7268
   Andre F, 2004, J IMMUNOL, V172, P2126
   Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596
   Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438
   Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857
   Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609
   Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102
   Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455
   Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010
   del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095
   Shedden K, 2003, CANCER RES, V63, P4331
   Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798
   Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043
   Dolo V, 1999, CLIN EXP METASTAS, V17, P131, DOI 10.1023/A:1006500406240
   Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132
   Castellana D, 2010, THROMB RES, V125, pS84, DOI 10.1016/S0049-3848(10)70021-9
   Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868
   Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709
   Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110
   Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351
   Sahoo S, 2011, CIRC RES, V109, P724, DOI 10.1161/CIRCRESAHA.111.253286
   Barry OP, 1999, J BIOL CHEM, V274, P7545, DOI 10.1074/jbc.274.11.7545
   Gonzales PA, 2010, METHODS MOL BIOL, V641, P89, DOI 10.1007/978-1-60761-711-2_6
   Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033
   Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307
   Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007
   STEGMAYR B, 1982, UROL RES, V10, P253
   Perez-Hernandez D, 2013, J BIOL CHEM, V288, P11649, DOI 10.1074/jbc.M112.445304
   Brouwers JF, 2013, PROTEOMICS, V13, P1660, DOI 10.1002/pmic.201200348
   Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267
   Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3
   Zheng Y, 2013, EXP CELL RES, V319, P1706, DOI 10.1016/j.yexcr.2012.10.006
   Chaput N, 2004, J IMMUNOL, V172, P2137
   Hristov M, 2004, BLOOD, V104, P2761, DOI 10.1182/blood-2003-10-3614
   Lachenal G, 2011, MOL CELL NEUROSCI, V46, P409, DOI 10.1016/j.mcn.2010.11.004
   Nolte-'t Hoen ENM, 2009, BLOOD, V113, P1977, DOI 10.1182/blood-2008-08-174094
   Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043
   Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807
   Hurley JH, 2012, NAT CELL BIOL, V14, P654, DOI 10.1038/ncb2530
   Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658
   Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002
   Zwicker JI, 2011, ARTERIOSCL THROM VAS, V31, P728, DOI 10.1161/ATVBAHA.109.200964
   Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1
   Zhang HG, 2011, CLIN CANCER RES, V17, P959, DOI 10.1158/1078-0432.CCR-10-1489
   Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010
   Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088
   Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x
   Admyre C, 2007, J IMMUNOL, V179, P1969
   Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124
   Bicalho B, 2013, BBA-BIOMEMBRANES, V1828, P317, DOI 10.1016/j.bbamem.2012.10.026
   Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567
   Hao SG, 2007, CANCER BIOTHER RADIO, V22, P692, DOI 10.1089/cbr.2007.368-R
   Kagiya T, 2013, J PERIODONTAL RES, V48, P373, DOI 10.1111/jre.12017
   Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579
   Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003
   Von Bartheld CS, 2011, PROG NEUROBIOL, V93, P313, DOI 10.1016/j.pneurobio.2011.01.003
   Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828
   Recht M, 2013, HAEMOPHILIA, V19, P908, DOI 10.1111/hae.12195
   Bebawy M, 2009, LEUKEMIA, V23, P1643, DOI 10.1038/leu.2009.76
   Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359
   Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9
   Benito-Martin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072387
   Bess JW, 1997, VIROLOGY, V230, P134, DOI 10.1006/viro.1997.8499
   Bhattacharyya S, 2008, J BONE MINER RES, V23, P1106, DOI [10.1359/jbmr.080235, 10.1359/JBMR.080235]
   Bobryshev YV, 2013, PATHOBIOLOGY, V80, P24, DOI 10.1159/000339430
   BONUCCI E, 1967, J ULTRA MOL STRUCT R, V20, P33, DOI 10.1016/S0022-5320(67)80034-0
   Bruno S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0304
   Castellano D, 2009, HAMOSTASEOLOGIE, V29, P51
   Chaput N, 2005, BLOOD CELL MOL DIS, V35, P111, DOI 10.1016/j.bcmd.2005.05.009
   Choi D. S., 2014, MASS SPECTROM REV
   Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803
   de Gassart A, 2004, TRAFFIC, V5, P896, DOI 10.1111/j.1600-0854.2004.00223.x
   Denzer K, 2000, J CELL SCI, V113, P3365
   Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227
   Garza-Licudine Edolfo, 2010, Conf Proc IEEE Eng Med Biol Soc, V2010, P5736, DOI 10.1109/IEMBS.2010.5627861
   Gill DJ, 2007, EMBO J, V26, P600, DOI 10.1038/sj.emboj.7601501
   Gonzalez Laurie J, 2009, PMC Biophys, V2, P7, DOI 10.1186/1757-5036-2-7
   Khan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046737
   Kim DK, 2013, J EXTRACELL VESICLES, V2
   Martinez MC, 2006, BLOOD, V108, P3012, DOI 10.1182/blood-2006-04-019109
   Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4
   Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285
   Muller G, 2010, BRIT J PHARMACOL, V160, P878, DOI 10.1111/j.1476-5381.2010.00724.x
   Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386
   Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059
   Ouyang L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0340-7
   Raimondo F, 2013, MOL BIOSYST, V9, P1139, DOI 10.1039/c2mb25396h
   Simpson R.J., 2012, J EXTRACELL VESICLES, V1
   Strassburg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033739
   Szajnik M., 2013, GYNECOL OBSTET SU S4, V29, P3
   Tetta Ciro, 2012, Muscles Ligaments Tendons J, V2, P212
   Thery C, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0322S30
   Turola E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00149
   Webster DJ, 2013, BONE, V54, P285, DOI 10.1016/j.bone.2013.01.004
   Woeckel VJ, 2010, J CELL PHYSIOL, V225, P593, DOI 10.1002/jcp.22244
   WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x
   Xiao Z, 2009, J PROTEOMICS, V72, P34, DOI 10.1016/j.jprot.2008.11.011
   Zakharova L, 2007, J CELL PHYSIOL, V212, P174, DOI 10.1002/jcp.21013
NR 162
TC 2
Z9 2
U1 3
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 38
EP 45
DI 10.1016/j.abb.2014.05.011
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300006
PM 24858341
ER

PT J
AU van der Eerden, BCJ
AF van der Eerden, Bram C. J.
TI MicroRNAs in the skeleton: Cell-restricted or potent intercellular
   communicators?
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Bone; MicroRNA; Osteoblast; Osteoclast; Osteogenesis;
   Osteoclastogenesis; Osteoporosis; Osteocyte; Mesenchymal stem cell; MSC
ID MESENCHYMAL STEM-CELLS; SUPPRESSES OSTEOGENIC DIFFERENTIATION;
   SMOOTH-MUSCLE-CELLS; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION;
   OSTEOCLAST DIFFERENTIATION; CIRCULATING MICRORNAS; REGULATES
   OSTEOCLASTOGENESIS; ADIPOGENIC DIFFERENTIATION; OSTEOPOROTIC FRACTURES
AB MicroRNAs (miRNAs) play a fundamental role in cell proliferation, differentiation and apoptosis and have been associated with many diseases and physiological states. Within the skeleton, both the bone forming cells, osteoblasts, and the bone degrading cells, osteoclasts, are mostly being stimulated by miRNAs through downregulation of inhibitors of bone cell differentiation. Besides miRNAs affecting master genes of bone cell differentiation and function in a cell-restricted manner, evidence is gathering that miRNAs are excreted into the local environment but also into the circulation, implicating a role for miRNAs in nearby or even distant target cells. In this review, the most recent novel miRNAs implicated in bone cell differentiation regulation will be described but also their potential paracrine or endocrine role, thus reinforcing the concept that miRNAs may function as powerful communicators between cell types or tissues. (C) 2014 Elsevier Inc. All rights reserved.
C1 [van der Eerden, Bram C. J.] Erasmus MC, Dept Internal Med, NL-3015 CN Rotterdam, Netherlands.
RP van der Eerden, BCJ (reprint author), Erasmus MC, Dept Internal Med, Calcium & Bone Metab Grp, Room Ee585b,Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.
EM b.vandereerden@erasmusmc.nl
CR Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335
   Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105
   Wen P, 2014, EXP CELL RES, V322, P302, DOI 10.1016/j.yexcr.2014.01.025
   Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200
   Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010
   Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601
   Lee Y, 2013, BONE, V56, P383, DOI 10.1016/j.bone.2013.07.007
   Dong SW, 2012, BIOCHEM BIOPH RES CO, V418, P587, DOI 10.1016/j.bbrc.2012.01.075
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138
   Lisse TS, 2013, CRIT REV EUKAR GENE, V23, P195
   Ell B, 2013, CANCER CELL, V24, P542, DOI 10.1016/j.ccr.2013.09.008
   Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832
   Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984
   Hu WH, 2013, MOL MED REP, V7, P689, DOI 10.3892/mmr.2012.1207
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Kim EJ, 2013, LIFE SCI, V92, P562, DOI 10.1016/j.lfs.2013.01.015
   Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234
   Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137
   Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604
   Bakhshandeh B, 2012, J GENET, V91, P171, DOI 10.1007/s12041-012-0168-0
   Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647
   Lisse TS, 2013, J BONE MINER RES, V28, P1478, DOI 10.1002/jbmr.1882
   Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517
   Tijsen AJ, 2012, AM J PHYSIOL-HEART C, V303, pH1085, DOI 10.1152/ajpheart.00191.2012
   Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021
   Guo L, 2011, EXP HEMATOL, V39, P608, DOI 10.1016/j.exphem.2011.01.011
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Wang FS, 2013, ARTHRITIS RHEUM-US, V65, P1530, DOI 10.1002/art.37948
   Taipaleenmaki H, 2012, EUR J ENDOCRINOL, V166, P359, DOI 10.1530/EJE-11-0646
   Seeliger C, 2014, J BONE MINER RES, V29, P1718, DOI 10.1002/jbmr.2175
   Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002
   Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110
   Bhushan R, 2013, INT J BIOCHEM CELL B, V45, P696, DOI 10.1016/j.biocel.2012.12.008
   Massy ZA, 2013, CURR OPIN NEPHROL HY, V22, P405, DOI 10.1097/MNH.0b013e328362155b
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   Gong M, 2014, MOL CANCER RES, V12, P101, DOI 10.1158/1541-7786.MCR-13-0136
   Sugatani T, 2014, J CELL BIOCHEM, V115, P1043, DOI 10.1002/jcb.24759
   Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372
   Guo LJ, 2014, EXP CELL RES, V321, P142, DOI 10.1016/j.yexcr.2013.12.001
   Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026
   Rossi M, 2013, J CELL PHYSIOL, V228, P1506, DOI 10.1002/jcp.24306
   Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200
   Cheng P, 2013, J BONE MINER RES, V28, P1180, DOI 10.1002/jbmr.1845
   Deng Y, 2014, EUR CELLS MATER, V27, P13
   Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108
   Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107
   Suh JS, 2013, BIOMATERIALS, V34, P4347, DOI 10.1016/j.biomaterials.2013.02.039
   Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617
   Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210
   Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515
   Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798
   Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106
   Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228
   Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007
   Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377
   Deng Y, 2013, BIOMATERIALS, V34, P6717, DOI 10.1016/j.biomaterials.2013.05.042
   Bae YJ, 2012, HUM MOL GENET, V21, P2991, DOI 10.1093/hmg/dds129
   Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057
   Liao XB, 2013, ENDOCRINOLOGY, V154, P3344, DOI 10.1210/en.2012-2236
   Huang S, 2012, STEM CELLS DEV, V21, P2531, DOI 10.1089/scd.2012.0014
   Kureel J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.4
   Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926
   Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008
   Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851
   Jia J, 2013, FEBS LETT, V587, P3027, DOI 10.1016/j.febslet.2013.07.030
   Gamez B, 2013, J BIOL CHEM, V288, P14264, DOI 10.1074/jbc.M112.432104
   Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405
   Li HL, 2013, STEM CELL RES, V10, P313, DOI 10.1016/j.scr.2012.11.007
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Guo L, 2013, J CELL SCI, V126, P978, DOI 10.1242/jcs.117515
   Lei SF, 2011, J BONE MINER RES, V26, P72, DOI 10.1002/jbmr.186
   Ko JY, 2013, BONE, V57, P468, DOI 10.1016/j.bone.2013.09.019
   Roccaro AM, 2009, BLOOD, V113, P6669, DOI 10.1182/blood-2009-01-198408
   Kagiya T, 2013, J PERIODONTAL RES, V48, P373, DOI 10.1111/jre.12017
   Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003
   Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105
   Chen C, 2014, J BONE MINER RES, V29, P338, DOI 10.1002/jbmr.2032
   Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803
   Eguchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058796
   Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227
   HE L, 2004, NAT REV GENET, V5, P522
   Hernlund E, 2013, Arch Osteoporos, V8, P136, DOI 10.1007/s11657-013-0136-1
   Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694
   Laine SK, 2012, GENE, V497, P1, DOI 10.1016/j.gene.2012.01.045
   Li EQ, 2014, MOL CELL BIOCHEM, V390, P69, DOI 10.1007/s11010-013-1957-3
   Liu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.65
   Moorthi A, 2013, INT J BIOL MACROMOL, V56, P181, DOI 10.1016/j.ijbiomac.2013.02.017
   Nugent Mary, 2014, Cancer Manag Res, V6, P15, DOI 10.2147/CMAR.S53928
   Mackay Eirinn W, 2013, Bonekey Rep, V2, P445, DOI 10.1038/bonekey.2013.179
   Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215
   Tamura M, 2013, MOL MED REP, V8, P1807, DOI 10.3892/mmr.2013.1713
   Tiago D.M., 2014, ARCH BIOCHEM BIOPHYS, V453, P23
   Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119
   van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6
   Vimalraj S, 2014, J CELL PHYSL
   Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072266
   Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034641
   Xia Zhuying, 2011, Front Med, V5, P414, DOI 10.1007/s11684-011-0168-0
   Zhang WB, 2014, BONE, V58, P59, DOI 10.1016/j.bone.2013.09.015
NR 101
TC 4
Z9 4
U1 7
U2 24
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 46
EP 55
DI 10.1016/j.abb.2014.04.016
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300007
PM 24832391
ER

PT J
AU Cancela, ML
   Laize, V
   Conceicao, N
AF Cancela, M. Leonor
   Laize, Vincent
   Conceicao, Natercia
TI Matrix Gla protein and osteocalcin: From gene duplication to
   neofunctionalization
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Matrix Gla protein; Osteocalcin; Protein structure; Gene architecture;
   Splicing variants; Gene duplication; Molecular evolution
ID GAMMA-CARBOXYGLUTAMIC ACID; BONE MORPHOGENETIC PROTEIN-2; HUMAN
   TRABECULAR MESHWORK; K-DEPENDENT PROTEINS; SMOOTH-MUSCLE-CELLS;
   VITAMIN-K; KEUTEL-SYNDROME; XENOPUS-LAEVIS; VASCULAR CALCIFICATION;
   ECTOPIC CALCIFICATION
AB Osteocalcin (OC or bone Gla protein, BGP) and matrix Gla protein (MGP) are two members of the growing family of vitamin K-dependent (VKD) proteins. They were the first VKD proteins found not to be involved in coagulation and synthesized outside the liver. Both proteins were isolated from bone although it is now known that only OC is synthesized by bone cells under normal physiological conditions, but since both proteins can bind calcium and hydroxyapatite, they can also accumulate in bone. Both OC and MGP share similar structural features, both in terms of protein domains and gene organization. OC gene is likely to have appeared from MGP through a tandem gene duplication that occurred concomitantly with the appearance of the bony vertebrates. Despite their relatively close relationship and the fact that both can bind calcium and affect mineralization, their functions are not redundant and they also have other unrelated functions. Interestingly, these two proteins appear to have followed quite different evolutionary strategies in order to acquire novel functionalities, with OC following a gene duplication strategy while MGP variability was obtained mostly by the use of multiple promoters and alternative splicing, leading to proteins with additional functional characteristics and alternative gene regulatory pathways. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Cancela, M. Leonor; Laize, Vincent; Conceicao, Natercia] Univ Algarve, Ctr Marine Sci, P-8005139 Faro, Portugal.
   [Cancela, M. Leonor] Univ Algarve, Dept Biomed Sci & Med, P-8005139 Faro, Portugal.
RP Cancela, ML (reprint author), Univ Algarve, Dept Biomed Sci & Med, Campus Gambelas, P-8005139 Faro, Portugal.
EM lcancela@ualg.pt
RI Laize, Vincent/B-4463-2008; Cancela, M. Leonor/F-4665-2012; Conceicao,
   Natercia/F-1737-2011; 
OI Laize, Vincent/0000-0001-9565-9198; Cancela, M.
   Leonor/0000-0003-3114-6662; Conceicao, Natercia/0000-0002-5057-0912
FU European Regional Development Fund (ERDF) through COMPETE Program;
   National Fund through the Portuguese Science and Technology Foundation
   (FCT) [PEst-C/MAR/LA0015/2011]; FCT [SFRH/BPD/48206/2008]
FX This work was co-funded by the European Regional Development Fund (ERDF)
   through COMPETE Program and by National Fund through the Portuguese
   Science and Technology Foundation (FCT) under PEst-C/MAR/LA0015/2011
   project. NC was supported by a post-doctoral grant (SFRH/BPD/48206/2008)
   from the FCT.
CR STENFLO J, 1974, P NATL ACAD SCI USA, V71, P2730, DOI 10.1073/pnas.71.7.2730
   Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1
   Munroe PB, 1999, NAT GENET, V21, P142, DOI 10.1038/5102
   Gundberg CM, 2012, ADV NUTR, V3, P149, DOI 10.3945/an.112.001834
   Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200
   Malashkevich VN, 2013, BIOCHEMISTRY-US, V52, P8387, DOI 10.1021/bi4010254
   Kruger MC, 2006, NUTRITION, V22, P1120, DOI 10.1016/j.nut.2006.08.008
   Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0
   Karsenty G, 2014, MOL CELL ENDOCRINOL, V382, P521, DOI 10.1016/j.mce.2013.10.008
   Roijers RB, 2011, AM J PATHOL, V178, P2879, DOI 10.1016/j.ajpath.2011.02.004
   Viegas CSB, 2013, J BIOL CHEM, V288, P27801, DOI 10.1074/jbc.M113.450213
   VANDELOO PGF, 1987, BIOCHEM BIOPH RES CO, V142, P113, DOI 10.1016/0006-291X(87)90458-X
   Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046
   Ueland T, 2011, CLIN SCI, V121, P119, DOI 10.1042/CS20100589
   van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3
   Price PA, 2009, J BIOL CHEM, V284, P17092, DOI 10.1074/jbc.M109.007013
   Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JC165952
   PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447
   Wajih N, 2004, J BIOL CHEM, V279, P43052, DOI 10.1074/jbc.M407180200
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   LINK KP, 1959, CIRCULATION, V19, P97
   Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x
   Xue W, 2006, INVEST OPHTH VIS SCI, V47, P997, DOI 10.1167/iovs.05-1106
   Oury F, 2013, CELL, V155, P228, DOI 10.1016/j.cell.2013.08.042
   Booth SL, 2013, NAT REV ENDOCRINOL, V9, P43, DOI 10.1038/nrendo.2012.201
   Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8
   Proudfoot D, 2000, CIRC RES, V87, P1055
   Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763
   Tomarev SI, 2003, INVEST OPHTH VIS SCI, V44, P2588, DOI 10.1167/iovs.02-1099
   O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k
   SHANAHAN CM, 1993, CIRC RES, V73, P193
   Albig Allan R., 2007, Angiogenesis, V10, P197, DOI 10.1007/s10456-007-9075-z
   Dalmeijer GW, 2013, J NUTR BIOCHEM, V24, P624, DOI 10.1016/j.jnutbio.2012.02.012
   Bostrom K, 2001, J BIOL CHEM, V276, P14044
   PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7
   Yagami K, 1999, J CELL BIOL, V147, P1097, DOI 10.1083/jcb.147.5.1097
   Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039
   van den Heuvel EGHM, 2014, MATURITAS, V77, P137, DOI 10.1016/j.maturitas.2013.10.008
   RICE JS, 1994, J BONE MINER RES, V9, P567
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   HALE JE, 1988, J BIOL CHEM, V263, P5820
   Gerdes S, 2014, EXP DERMATOL, V23, P322, DOI 10.1111/exd.12381
   Henneicke H, 2014, TRENDS ENDOCRIN MET, V25, P197, DOI 10.1016/j.tem.2013.12.006
   Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2
   Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004
   Danziger J, 2008, CLIN J AM SOC NEPHRO, V3, P1504, DOI 10.2215/CJN.00770208
   Jacobsen SE, 2013, J PHARMACOL EXP THER, V347, P298, DOI 10.1124/jpet.113.206276
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323
   Bensimon-Brito A, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-28
   Boraldi F, 2013, BBA-MOL BASIS DIS, V1832, P2077, DOI 10.1016/j.bbadis.2013.07.017
   BRONCKERS ALJJ, 1994, J BONE MINER RES, V9, P833
   CANCELA L, 1990, J BIOL CHEM, V265, P15040
   Cancela ML, 2001, J BONE MINER RES, V16, P1611, DOI 10.1359/jbmr.2001.16.9.1611
   CANCELA ML, 1992, ENDOCRINOLOGY, V130, P102, DOI 10.1210/en.130.1.102
   CANCELA ML, 1995, INT J PEPT PROT RES, V46, P419
   Cavaco S, 2014, FISH PHYSIOL BIOCHEM, V40, P731, DOI 10.1007/s10695-013-9880-9
   CHEN L, 1990, ONCOGENE, V5, P1391
   Conceicao N, 2005, FEBS J, V272, P1501, DOI 10.1111/j.1742-4658.2005.04590.x
   Dowd TL, 2003, BIOCHEMISTRY-US, V42, P7769, DOI 10.1021/bi034470s
   Fan CW, 2001, CANCER LETT, V165, P63, DOI 10.1016/S0304-3835(01)00416-5
   Frazao C, 2005, BIOCHEMISTRY-US, V44, P1234, DOI 10.1021/bi048336z
   Goiko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080344
   Gonzalez P, 2000, INVEST OPHTH VIS SCI, V41, P3678
   Guo Lei, 2010, Chinese Journal of Pathology, V39, P436, DOI 10.3760/cma.j.issn.0529-5807.2010.07.002
   HALE JE, 1991, J BIOL CHEM, V266, P21145
   Hashimoto F, 2001, ARCH ORAL BIOL, V46, P585, DOI 10.1016/S0003-9969(01)00022-X
   HAUSCHKA PV, 1989, ANAT REC, V224, P180, DOI 10.1002/ar.1092240208
   HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038
   HAUSCHKA PV, 1975, P NATL ACAD SCI USA, V72, P3925, DOI 10.1073/pnas.72.10.3925
   Heersche J N, 1992, Proc Finn Dent Soc, V88 Suppl 1, P173
   Hendig D, 2008, CLIN BIOCHEM, V41, P407, DOI 10.1016/j.clinbiochem.2007.12.023
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Hough C.D., 2001, CANCER, P3869
   Hur DJ, 2005, AM J MED GENET A, V135A, P36, DOI 10.1002/ajmg.a.30680
   JOHANSEN JS, 1988, J CLIN ENDOCR METAB, V67, P273
   Kuzontkoski PM, 2010, ONCOGENE, V29, P3793, DOI 10.1038/onc.2010.147
   Laize V, 2005, J BIOL CHEM, V280, P26659, DOI 10.1074/jbc.M500257200
   Laize V, 2006, J BIOL CHEM, V281, P15037, DOI 10.1074/jbc.M600373200
   LEVEDAKOU EN, 1992, INT J CANCER, V52, P534, DOI 10.1002/ijc.2910520406
   LIAN JB, 1988, CLIN ORTHOP RELAT R, P267
   Lu XL, 2013, KIDNEY BLOOD PRESS R, V37, P15, DOI 10.1159/000343396
   Meier M, 2001, EUR RESPIR J, V17, P566, DOI 10.1183/09031936.01.17305660
   Micke P, 2007, J INVEST DERMATOL, V127, P1516, DOI 10.1038/sj.jid.5700714
   Nanda A, 2006, AM J MED GENET A, V140A, P1487, DOI 10.1002/ajmg.a.31234
   Nishimoto SK, 2005, MATRIX BIOL, V24, P353, DOI 10.1016/j.matbio.2005.05.004
   NISHIMOTO SK, 1980, J BIOL CHEM, V255, P6579
   OTAWARA Y, 1986, J BIOL CHEM, V261, P828
   PAN LC, 1985, J BIOL CHEM, V260, P3398
   Porter WR, 2010, J COMPUT AID MOL DES, V24, P553, DOI 10.1007/s10822-010-9335-7
   PRICE PA, 1994, PROTEIN SCI, V3, P822
   PRICE PA, 1985, J BIOL CHEM, V260, P4971
   PRICE PA, 1987, P NATL ACAD SCI USA, V84, P8335, DOI 10.1073/pnas.84.23.8335
   PRICE PA, 1980, J BIOL CHEM, V255, P2938
   PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374
   Price P A, 1989, Connect Tissue Res, V21, P51, DOI 10.3109/03008208909049995
   Rishavy MA, 2005, J BIOL CHEM, V280, P34870, DOI 10.1074/jbc.M504345200
   Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194
   Sharma B, 2013, MICROVASC RES, V85, P24, DOI 10.1016/j.mvr.2012.10.005
   Silaghi CN, 2012, CLIN CHEM LAB MED, V50, P125, DOI 10.1515/CCLM.2011.713
   Wallin R, 2010, OSTEOARTHR CARTILAGE, V18, P1096, DOI 10.1016/j.joca.2010.05.013
   Willems B.A.G., 2014, MOL NUTR FOOD RES, V1, P1
   Yao YC, 2008, CIRC RES, V102, P1065, DOI 10.1161/CIRCRESAHA.107.166124
   Yoshimura K, 2009, MOL MED REP, V2, P549, DOI 10.3892/mmr_00000135
NR 106
TC 4
Z9 4
U1 5
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 56
EP 63
DI 10.1016/j.abb.2014.07.020
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300008
PM 25068814
ER

PT J
AU Carreira, AC
   Alves, GG
   Zambuzzi, WF
   Sogayar, MC
   Granjeiro, JM
AF Carreira, Ana Claudia
   Alves, Gutemberg Gomes
   Zambuzzi, William Fernando
   Sogayar, Mari Cleide
   Granjeiro, Jose Mauro
TI Bone Morphogenetic Proteins: Structure, biological function and
   therapeutic applications
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Bone Morphogenetic Proteins; Osteogenesis inducing proteins; Peptide
   growth factors; Bone repair; Extracellular matrix; Tissue engineering
ID MESENCHYMAL STEM-CELLS; ACTIVITY IN-VITRO; GROWTH-FACTORS; OSTEOBLAST
   DIFFERENTIATION; SIGNALING PATHWAYS; BETA SUPERFAMILY; TGF-BETA; BMP;
   EXPRESSION; RECOMBINANT
AB Bone Morphogenetic Proteins (BMPs) are multifunctional secreted cytokines, which belong to the TGF-beta superfamily. These glycoproteins act as a disulfide-linked homo- or heterodimers, being potent regulators of bone and cartilage formation and repair, cell proliferation during embryonic development and bone homeostasis in the adult. BMPs are promising molecules for tissue engineering and bone therapy. The present review discusses this family of proteins, their structure and biological function, their therapeutic applications and drawbacks, their effects on mesenchymal stem cells differentiation, and the cell signaling pathways involved in this process. (C) 2014 Published by Elsevier Inc.
C1 [Carreira, Ana Claudia; Sogayar, Mari Cleide] Univ Sao Paulo, Dept Biochem, Inst Chem, BR-05508000 Sao Paulo, Brazil.
   [Carreira, Ana Claudia; Sogayar, Mari Cleide] Univ Sao Paulo, Sch Med, Dept Clin Med, NUCEL NETCEM Cell & Mol Therapy Ctr, BR-05508000 Sao Paulo, Brazil.
   [Alves, Gutemberg Gomes] Univ Fed Fluminense, Inst Biol, Dept Cell & Mol Biol, Niteroi, RJ, Brazil.
   [Zambuzzi, William Fernando] Univ Estadual Paulista, UNESP, Biosci Inst, Dept Chem & Biochem, Botucatu, SP, Brazil.
   [Granjeiro, Jose Mauro] Natl Inst Metrol Qual & Technol, Bioengn Div, Duque De Caxias, RJ, Brazil.
   [Granjeiro, Jose Mauro] Univ Fed Fluminense, Sch Dent, Dept Dent Mat, Niteroi, RJ, Brazil.
RP Granjeiro, JM (reprint author), Diretoria DIPRO, Av Nossa Senhora das Gracas 50,Predio 6,2o Andar, BR-25250020 Duque De Caxias, RJ, Brazil.
EM ancoc@iq.usp.br; gutemberg.alves@id.uff.br; wzambuzzi@ibb.unesp.br;
   mcsoga@iq.usp.br; jmgranjeiro@inmetro.gov.br
RI Zambuzzi, Willian/F-9519-2012; Granjeiro, Jose/D-8289-2012
OI Zambuzzi, Willian/0000-0002-4149-5965; Granjeiro,
   Jose/0000-0002-8027-8293
FU Brazilian Federal agency; Sao Paulo State research agency
FX We thank all researches and technicians involved in our BMP projects
   over the years. The financial support of the following Brazilian Federal
   and Sao Paulo State research agencies was essential for generation of
   this review and development of the work carried out in our laboratory,
   namely: National Bank for Economical and Social Development (BNDES),
   National Council for Scientific and Technological Development (CNPq),
   Coordination for the Improvement of Higher Education Personnel (CAPES),
   Sao Paulo Research Foundation (FAPESP), Rio de Janeiro State Foundation
   Support Research (FAPERJ), Research and Projects Financier (FINEP),
   Ministry of Science, Technology and Innovation (MCTI) and Ministry of
   Health of Brazil/Department of Science and Technology (MS-DECIT).
CR URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Daluiski A, 2001, NAT GENET, V27, P84
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   Cui YZ, 2001, GENE DEV, V15, P2797
   WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582
   Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295
   Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X
   Bastida MF, 2009, DEVELOPMENT, V136, P3779, DOI 10.1242/dev.036418
   Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200
   Bowers RR, 2006, P NATL ACAD SCI USA, V103, P13022, DOI 10.1073/pnas.0605789103
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032
   Noel D, 2004, STEM CELLS, V22, P74, DOI 10.1634/stemcells.22-1-74
   Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345
   Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6
   Diefenderfer DL, 2003, CONNECT TISSUE RES, V44, P305, DOI 10.1080/03008200390181825
   Liao WX, 2003, J BIOL CHEM, V278, P3713, DOI 10.1074/jbc.M210958200
   Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148
   Sipe JB, 2004, BONE, V35, P1316, DOI 10.1016/j.bone.2004.08.020
   Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870
   Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014
   Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360
   Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074
   Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016
   Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356
   Davis SW, 2007, DEV BIOL, V305, P145, DOI 10.1016/j.ydbio.2007.02.001
   Giannoudis PV, 2011, INJURY, V42, P591, DOI 10.1016/j.injury.2011.03.036
   Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878
   Hussein KA, 2013, J ORAL MAXIL SURG, V71, P1107, DOI 10.1016/j.joms.2012.12.018
   Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003
   Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130
   Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x
   Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459
   Di Pasquale E, 2009, J BIOL CHEM, V284, P26127, DOI 10.1074/jbc.M109.036608
   Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Bivi N, 2013, J ORTHOP RES, V31, P1075, DOI 10.1002/jor.22341
   Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929
   Herpin A, 2007, FEBS J, V274, P2977, DOI 10.1111/j.1742-4658.2007.05840.x
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673
   MIYAZONO K, 1988, J BIOL CHEM, V263, P6407
   Bowers RR, 2007, CELL CYCLE, V6, P385
   Minina E, 2001, DEVELOPMENT, V128, P4523
   Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229
   ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110
   Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551
   Brondyk WH, 2009, METHOD ENZYMOL, V463, P131, DOI 10.1016/S0076-6879(09)63011-1
   Gamer LW, 2005, DEV BIOL, V285, P156, DOI 10.1016/j.ydbio.2005.06.012
   Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139
   Chen C, 2012, J CELL BIOCHEM, V113, P3672, DOI 10.1002/jcb.24240
   Kuroda R, 2006, ARTHRITIS RHEUM, V54, P433, DOI 10.1002/art.21632
   Du XL, 2012, J CELL PHYSIOL, V227, P3731, DOI 10.1002/jcp.24083
   Bessho K, 1999, BRIT J ORAL MAX SURG, V37, P2, DOI 10.1054/bjom.1998.0379
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   Buser D, 2008, INT J PERIODONT REST, V28, P441
   Aubin J, 2004, GENE DEV, V18, P1482, DOI 10.1101/gad.1202604
   Bessa PC, 2009, PROTEIN EXPRES PURIF, V63, P89, DOI 10.1016/j.pep.2008.09.014
   BESSHO K, 1991, J DENT RES, V70, P171, DOI 10.1177/00220345910700030301
   BESSHO K, 1991, CLIN ORTHOP RELAT R, P226
   Bustos-Valenzuela JC, 2010, MOL BIOTECHNOL, V46, P118, DOI 10.1007/s12033-010-9287-0
   Carreira AC, 2014, J DENT RES, V93, P335, DOI 10.1177/0022034513518561
   Dorman Lisa J, 2012, Biomed Sci Instrum, V48, P81
   Gao T, 1996, INT ORTHOP, V20, P321, DOI 10.1007/s002640050086
   Ghosh-Choudhury Nandini, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P345
   Hao RR, 2012, J PEDIATR ENDOCR MET, V25, P233, DOI 10.1515/jpem-2012-0029
   Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59
   Herzig S, 2013, BBA-MOL CELL BIOL L, V1831, P895, DOI 10.1016/j.bbalip.2013.03.009
   James AW, 2013, SCIENTIFICA, V2013, P1
   JOHNER R, 1972, HELV CHIR ACTA, V39, P409
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Kujala S, 2004, ARCH ORTHOP TRAUM SU, V124, P26, DOI 10.1007/s00402-003-0599-4
   Kusumoto K, 1997, BIOCHEM BIOPH RES CO, V239, P575, DOI 10.1006/bbrc.1997.7497
   Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15
   Lee DH, 2003, YONSEI MED J, V44, P593
   Lissenberg-Thunnissen S.N., 2012, INT ORTHOP, V35, P1271
   Long MW, 2001, BLOOD CELL MOL DIS, V27, P677, DOI 10.1006/bcmd.2001.0431
   Long SN, 2006, PROTEIN EXPRES PURIF, V46, P374, DOI 10.1016/j.pep.2005.09.025
   Lowery J.W., 2013, CELL MOL LIFE SCI, V71, P3165
   MARUOKA Y, 1995, BIOCHEM MOL BIOL INT, V35, P957
   MOHAN S, 1991, CLIN ORTHOP RELAT R, P30
   Mont MA, 1998, CLIN ORTHOP RELAT R, pS314
   Papakostidis C, 2008, SPINE, V33, pE680, DOI 10.1097/BRS.0b013e3181844eca
   Pecina M, 2007, INT ORTHOP, V31, P719, DOI 10.1007/s00264-007-0425-7
   Reid J, 1982, J R Coll Surg Edinb, V27, P228
   Shintani N, 2007, ARTHRITIS RHEUM, V56, P1869, DOI 10.1002/art.22701
   Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86
   Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219
   Takada I, 2012, PPAR RES, DOI 10.1155/2012/607141
   Valera E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011167
   Varkey M, 2006, CLIN ORTHOP RELAT R, P113, DOI 10.1097/01.blo.0000200236.84189.87
NR 95
TC 7
Z9 8
U1 7
U2 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 64
EP 73
DI 10.1016/j.abb.2014.07.011
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300009
PM 25043976
ER

PT J
AU Paiva, KBS
   Granjeiro, JM
AF Silva Paiva, Katiucia Batista
   Granjeiro, Jose Mauro
TI Bone tissue remodeling and development: Focus on matrix
   metalloproteinase functions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Bone development; Bone remodeling; Extracellular Matrix; Matrix
   metalloproteinases; Tissue inhibitor of matrix metalloproteinases; RECK,
   Bone Bioengineering
ID OSTEOBLAST-LIKE CELLS; MEMBRANE-TYPE MMPS; EXTRACELLULAR-MATRIX;
   ENDOCHONDRAL OSSIFICATION; SKELETAL DEVELOPMENT; HYPERTROPHIC
   CHONDROCYTES; INTERSTITIAL COLLAGENASE; MULTICENTRIC OSTEOLYSIS;
   WINCHESTER-SYNDROME; CYSTEINE SWITCH
AB Bone-forming cells originate from distinct embryological layers, mesoderm (axial and appendicular bones) and ectoderm (precursor of neural crest cells, which mainly form facial bones). These cells will develop bones by two principal mechanisms: intramembranous and endochondral ossification. In both cases, condensation of multipotent mesenchymal cells occurs, at the site of the future bone, which differentiate into bone and cartilage-forming cells. During long bone development, an initial cartilaginous template is formed and replaced by bone in a coordinated and refined program involving chondrocyte proliferation and maturation, vascular invasion, recruitment of adult stem cells and intense remodeling of cartilage and bone matrix. Matrix metalloproteinases (MMPs) are the most important enzymes for cleaving structural components of the extracellular matrix (ECM), as well as other non-ECM molecules in the ECM space, pericellular perimeter and intracellularly. Thus, the bioactive molecules generated act on several biological events, such as development, tissue remodeling and homeostasis. Since the discovery of collagenase in bone cells, more than half of the MMP members have been detected in bone tissues under both physiological and pathological conditions. Pivotal functions of MMPs during development and bone regeneration have been revealed by knockout mouse models, such as chondrocyte proliferation and differentiation, osteoclast recruitment and function, bone modeling, coupling of bone resorption and formation (bone remodeling), osteoblast recruitment and survival, angiogenesis, osteocyte viability and function (biomechanical properties); as such alterations in MMP function may alter bone quality. In this review, we look at the principal properties of MMPs and their inhibitors (TIMPs and RECK), provide an up-date on their known functions in bone development and remodeling and discuss their potential application to Bone Bioengineering. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Silva Paiva, Katiucia Batista] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Matrix Biol & Cellular Interact Grp GBMec, BR-05508000 Sao Paulo, Brazil.
   [Granjeiro, Jose Mauro] Natl Inst Metrol InMetro Qual & Technol, Bioengn Program, Xerem, RJ, Brazil.
   [Granjeiro, Jose Mauro] Univ Fed Fluminense, Cell Therapy Ctr, Unit Clin Res, Niteroi, RJ, Brazil.
RP Paiva, KBS (reprint author), Univ Sao Paulo, Inst Biomed Sci ICB 3, Dept Anat, Extracellular Matrix Biol & Cell Interact Grp, Ave Prof Lineu Prestes 2415, BR-05508000 Sao Paulo, Brazil.
EM katipaiva@usp.br
RI Paiva, Katiucia/C-3147-2012
OI Paiva, Katiucia/0000-0002-3583-625X
FU Sao Paulo Research Foundation (FAPESP) Grants [2010/08918-9]; K.B.S.P.
   Young Scientist Fellowship [2011/00204-0]
FX Our research group is supported by Sao Paulo Research Foundation
   (FAPESP) Grants no. 2010/08918-9 and K.B.S.P. Young Scientist Fellowship
   no. 2011/00204-0.
CR Accorsi-Mendonca T, 2008, J MOL HISTOL, V39, P201, DOI 10.1007/s10735-007-9152-z
   Accorsi-Mendonca T, 2005, J MOL HISTOL, V36, P311, DOI 10.1007/s10735-005-7018-9
   Aiken A, 2010, BBA-MOL CELL RES, V1803, P121, DOI 10.1016/j.bbamcr.2009.07.002
   Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x
   Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003
   SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364
   Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559
   Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017
   Kim J, 2010, J BIOMED MATER RES A, V95A, P673, DOI 10.1002/jbm.a.32884
   Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427
   Mavcic B, 2012, INT ORTHOP, V36, P689, DOI 10.1007/s00264-012-1487-8
   STRONGIN AY, 1995, J BIOL CHEM, V270, P5331
   LECO KJ, 1994, J BIOL CHEM, V269, P9352
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006
   Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001
   Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118
   Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603
   Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200
   Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197
   Wang XD, 2013, BONE, V52, P111, DOI 10.1016/j.bone.2012.09.018
   VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578
   Chung UI, 2004, J ORTHOP SCI, V9, P410, DOI 10.1007/s00776-004-0786-3
   Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147
   Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063
   Miki T, 2007, J BIOL CHEM, V282, P12341, DOI 10.1074/jbc.M610948200
   Lozito TP, 2014, MATRIX BIOL, V34, P132, DOI 10.1016/j.matbio.2013.10.003
   Boeckel DG, 2012, J ORAL IMPLANTOL, V38, P538, DOI 10.1563/AAID-JOI-D-11-00197
   Simizu S, 2005, CANCER RES, V65, P7455, DOI 10.1158/0008-5472.CAN-04-4446
   Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007
   Knauper V, 1996, J BIOL CHEM, V271, P17124
   Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015
   Gabison EE, 2009, PROG RETIN EYE RES, V28, P19, DOI 10.1016/j.preteyeres.2008.11.001
   Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1
   Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033
   Himeno-Ando A, 2012, BIOCHEM BIOPH RES CO, V417, P765, DOI 10.1016/j.bbrc.2011.12.031
   Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948
   Brizzi MF, 2012, CURR OPIN CELL BIOL, V24, P645, DOI 10.1016/j.ceb.2012.07.001
   Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0
   Takagi S, 2009, CANCER RES, V69, P1502, DOI 10.1158/0008-5472.CAN-08-2635
   Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344
   Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017
   STRONGIN AY, 1993, J BIOL CHEM, V268, P14033
   Hojo H, 2010, J BONE MINER METAB, V28, P489, DOI 10.1007/s00774-010-0199-7
   Shapiro F, 2008, EUR CELLS MATER, V15, P53
   Kondo S, 2007, J CELL SCI, V120, P849, DOI 10.1242/jcs.03388
   Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925
   Huang WS, 2002, J CELL BIOCHEM, V85, P295, DOI 10.1002/jcb.10138
   Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7
   Maes C, 2013, CALCIFIED TISSUE INT, V92, P307, DOI 10.1007/s00223-012-9689-z
   Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   Mannello F, 2012, PROG HISTOCHEM CYTO, V47, P27, DOI 10.1016/j.proghi.2011.12.002
   TAKINO T, 1995, J BIOL CHEM, V270, P23013
   Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011
   Velasco G, 2000, CANCER RES, V60, P877
   Nyman JS, 2011, J BONE MINER RES, V26, P1252, DOI 10.1002/jbmr.326
   Dirckx N, 2013, BIRTH DEFECTS RES C, V99, P170, DOI 10.1002/bdrc.21047
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Behonick DJ, 2003, MECH DEVELOP, V120, P1327, DOI 10.1016/j.mod.2003.05.002
   Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711
   Overall CM, 2000, J BIOL CHEM, V275, P39497, DOI 10.1074/jbc.M005932200
   Van den Steen PE, 2001, BBA-GEN SUBJECTS, V1528, P61, DOI 10.1016/S0304-4165(01)00190-8
   Ortega N, 2003, ANN NY ACAD SCI, V995, P109
   Nyman JS, 2005, MICRON, V36, P566, DOI 10.1016/j.micron.2005.07.004
   Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368
   Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f
   Villemure I, 2009, J BIOMECH, V42, P1793, DOI 10.1016/j.jbiomech.2009.05.021
   Hall BK, 2005, J EXP ZOOL PART B, V304B, P548, DOI 10.1002/jez.b.21057
   Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333
   Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060
   Franz-Odendaal TA, 2011, FRONT BIOSCI-LANDMRK, V16, P2734, DOI 10.2741/3882
   Young SRL, 2009, J BONE MINER RES, V24, P411, DOI [10.1359/jbmr.081102, 10.1359/JBMR.081102]
   PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0
   English WR, 2001, J BIOL CHEM, V276, P42018, DOI 10.1074/jbc.M107783200
   Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510
   Santos A, 2010, BIOCHEM BIOPH RES CO, V391, P364, DOI 10.1016/j.bbrc.2009.11.064
   Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   StahleBackdahl M, 1997, LAB INVEST, V76, P717
   Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013
   Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893
   Noguera R, 2012, HISTOL HISTOPATHOL, V27, P693
   Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221
   Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001
   Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048
   Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101
   Tang SY, 2012, J BONE MINER RES, V27, P1936, DOI 10.1002/jbmr.1646
   Staines KA, 2013, J ENDOCRINOL, V219, pR1, DOI 10.1530/JOE-13-0276
   Qing H, 2009, INT J ORAL SCI, V1, P59, DOI 10.4248/ijos.09019
   Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200
   Catalano V, 2013, SEMIN CANCER BIOL, V23, P522, DOI 10.1016/j.semcancer.2013.08.007
   Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9
   Omura A, 2009, J BIOL CHEM, V284, P3461, DOI 10.1074/jbc.M806212200
   Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x
   Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688
   Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389
   English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046
   Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511
   APTE SS, 1994, DEV DYNAM, V200, P177
   Blavier L, 1997, MOL BIOL CELL, V8, P1513
   Blumer MJF, 2008, ANN ANAT, V190, P305, DOI 10.1016/j.aanat.2008.02.004
   Bord S, 1999, BONE, V24, P229, DOI 10.1016/S8756-3282(98)00174-4
   Butler GS, 1997, EUR J BIOCHEM, V244, P653, DOI 10.1111/j.1432-1033.1997.t01-1-00653.x
   CAWSTON TE, 1981, BIOCHEM J, V195, P159
   Chellaiah MA, 2013, BIOMED RES INT, DOI 10.1155/2013/302392
   Eames BF, 2004, DEV DYNAM, V231, P4, DOI 10.1002/dvdy.20134
   Egeblad M, 2007, DEV DYNAM, V236, P1683, DOI 10.1002/dvdy.21159
   Evans BR, 2012, AM J HUM GENET, V91, P572, DOI 10.1016/j.ajhg.2012.07.022
   Fajardo M, 2010, J ORTHOP TRAUMA, V24, P557, DOI 10.1097/BOT.0b013e3181ed294c
   FLENNIKEN AM, 1990, GENE DEV, V4, P1094, DOI 10.1101/gad.4.7.1094
   FULLER K, 1995, J CELL SCI, V108, P2221
   GACK S, 1995, CELL GROWTH DIFFER, V6, P759
   Galliera E, 2010, INJURY, V41, P1204, DOI 10.1016/j.injury.2010.09.024
   Groma G, 2012, ARTHRITIS RHEUM-US, V64, P2644, DOI 10.1002/art.34435
   Hammani K, 1996, J BIOL CHEM, V271, P25498
   Hatch N.E., 2010, GENE EXPRESSION, V20, P295
   Henle P, 2005, BONE, V37, P791, DOI 10.1016/j.bone.2005.06.015
   Hernandez-Barrantes S, 2002, SEMIN CANCER BIOL, V12, P131, DOI 10.1006/scbi.2001.0421
   HIPPS DS, 1991, BIOL CHEM H-S, V372, P287, DOI 10.1515/bchm3.1991.372.1.287
   Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061
   HUGHES DE, 1994, J BONE MINER RES, V9, P39
   Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101
   Itagaki T, 2008, ANAT REC, V291, P1038, DOI 10.1002/ar.20717
   Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431
   Joronen K, 2000, HISTOCHEM CELL BIOL, V114, P157
   Kennedy AM, 2005, J CLIN INVEST, V115, P2832, DOI 10.1172/JCI22900
   Kim EJ, 2011, MOL THER, V19, P355, DOI 10.1038/mt.2010.262
   Kimura T, 2010, AM J PATHOL, V176, P2858, DOI 10.2353/ajpath.2010.091003
   Kojima T, 2013, BIOMED RES-TOKYO, V34, P119
   Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234
   Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020
   Kulkarni RN, 2012, BIOCHEM BIOPH RES CO, V417, P824, DOI 10.1016/j.bbrc.2011.12.045
   Laflamme C, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015008
   Lee ER, 1999, DEV DYNAM, V215, P190, DOI 10.1002/(SICI)1097-0177(199907)215:3<190::AID-AJA2>3.0.CO;2-B
   Lehmann W, 2005, BONE, V36, P300, DOI 10.1016/j.bone.2004.10.010
   Lei YG, 2010, MICROSC RES TECHNIQ, V73, P910, DOI 10.1002/jemt.20840
   Li LQ, 2013, CANCER BIOL THER, V14, P796, DOI 10.4161/cbt.25936
   Lieu S, 2011, DIS MODEL MECH, V4, P203, DOI 10.1242/dmm.006304
   Llano E, 1999, CANCER RES, V59, P2570
   MacLean HE, 2003, DEV BIOL, V262, P51, DOI 10.1016/S0012-1606(03)00324-5
   Madsen DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071261
   Malemud CJ, 2006, FRONT BIOSCI, V11, P1702, DOI 10.2741/1916
   Maquart F, 2005, BIOCHIMIE, V87, P353, DOI 10.1016/j.biochi.2004.10.006
   Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100
   MATTOT V, 1995, J CELL SCI, V108, P529
   McDonald MM, 2013, J BONE MINER RES, V28, P1550, DOI 10.1002/jbmr.1889
   MEIKLE MC, 1991, BONE MINER, V12, P41, DOI 10.1016/0169-6009(91)90120-O
   Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305
   Mosig RA, 2013, DIS MODEL MECH, V6, P397, DOI 10.1242/dmm.007914
   MUHLHAUSER J, 1986, J SUBMICR CYTOL PATH, V18, P717
   Ortega N, 2010, DIS MODEL MECH, V3, P224, DOI 10.1242/dmm.004226
   Ortega N, 2005, MOL BIOL CELL, V16, P3028, DOI 10.1091/mbc.E04-12-1119
   Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223
   Pei DQ, 1999, FEBS LETT, V457, P262, DOI 10.1016/S0014-5793(99)01046-7
   Piperi C, 2012, CURR TOP MED CHEM, V12, P1095
   Rietz A, 2012, BRIT J PHARMACOL, V166, P1225, DOI 10.1111/j.1476-5381.2012.01917.x
   RIFAS L, 1994, ENDOCRINOLOGY, V134, P213, DOI 10.1210/en.134.1.213
   Rocha C.A., 2014, J MOL HISTOL
   Rouzier C, 2006, CLIN GENET, V69, P271, DOI 10.1111/j.1399-0004.2006.00584.x
   Rozen N, 2007, CRIT REV EUKAR GENE, V17, P197
   Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985
   Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137
   SCOTTSAVAGE P, 1980, ACTA ANAT, V106, P129
   Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037
   Shen Y., 2010, PLOS ONE, V5
   Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215
   Song IW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092194
   Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461
   Su S, 1999, RHEUMATOL INT, V18, P183, DOI 10.1007/s002960050083
   Szabova L, 2009, J BONE MINER RES, V24, P1905, DOI [10.1359/jbmr.090510, 10.1359/JBMR.090510]
   Szabova L, 2010, BLOOD, V116, P5752, DOI [10.1182/blood-2009-10-249847, 10.1182/blood2009-10-249847]
   Teti Anna, 2011, Curr Osteoporos Rep, V9, P264, DOI 10.1007/s11914-011-0078-8
   Tuysuz B, 2009, EUR J HUM GENET, V17, P565, DOI 10.1038/ejhg.2008.204
   Uusitalo H, 2000, CALCIFIED TISSUE INT, V67, P382, DOI 10.1007/s002230001152
   Vincenti M P, 2001, Methods Mol Biol, V151, P121
   Wagenaar-Miller RA, 2007, MOL CELL BIOL, V27, P6309, DOI 10.1128/MCB.00291-07
   Wang K, 2006, MATRIX BIOL, V25, P271, DOI 10.1016/j.matbio.2006.02.001
   Welm B, 2002, CURR BIOL, V12, pR209, DOI 10.1016/S0960-9822(02)00752-2
   Wigner NA, 2012, INJURY, V43, P274, DOI 10.1016/j.injury.2011.05.038
   WOODS JF, 1965, J CELL BIOL, V26, P747, DOI 10.1083/jcb.26.3.747
   Wysolmerski John J, 2012, Bonekey Rep, V1, P229, DOI 10.1038/bonekey.2012.229
   Yamagiwa H, 1999, BONE, V25, P197, DOI 10.1016/S8756-3282(99)00157-X
   Zambuzzi WF, 2009, J MOL HISTOL, V40, P301, DOI 10.1007/s10735-009-9241-2
   Zankl A, 2005, CLIN GENET, V67, P261, DOI 10.1111/j.1399-0004.2004.00402.x
   Zeng Y, 1998, DEV DYNAM, V211, P228
   Zhao WG, 2000, J CLIN INVEST, V106, P941, DOI 10.1172/JCI10158
NR 189
TC 6
Z9 6
U1 10
U2 35
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 74
EP 87
DI 10.1016/j.abb.2014.07.034
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300010
PM 25157440
ER

PT J
AU Gemini-Piperni, S
   Takamori, ER
   Sartoretto, SC
   Paiva, KBS
   Granjeiro, JM
   de Oliveira, RC
   Zambuzzi, WF
AF Gemini-Piperni, Sara
   Takamori, Esther Rieko
   Sartoretto, Suelen Cristina
   Paiva, Katiucia B. S.
   Granjeiro, Jose Mauro
   de Oliveira, Rodrigo Cardoso
   Zambuzzi, Willian Fernando
TI Cellular behavior as a dynamic field for exploring bone bioengineering:
   A closer look at cell-biomaterial interface
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Bone; Bioengineering; Osteoblast; Signal transduction; Cell behavior;
   Biomaterials; Scaffolds; Regenerative medicine; Dentistry
ID MESENCHYMAL STEM-CELLS; INTERVERTEBRAL DISC CELLS; EXTRACELLULAR-MATRIX;
   OSTEOBLAST ADHESION; SIGNALING PATHWAYS; GROWTH-FACTORS; IN-VITRO;
   OSTEOCLAST DIFFERENTIATION; MORPHOGENETIC PROTEINS; REGULATORY
   MECHANISMS
AB Bone is a highly dynamic and specialized tissue, capable of regenerating itself spontaneously when afflicted by minor injuries. Nevertheless, when major lesions occur, it becomes necessary to use biomaterials, which are not only able to endure the cellular proliferation and migration, but also to substitute the original tissue or integrate itself to it. With the life expectancy growth, regenerative medicine has been gaining constant attention in the reconstructive field of dentistry and orthopedy. Focusing on broadening the therapeutic possibilities for the regeneration of injured organs, the development of biomaterials allied with the applicability of gene therapy and bone bioengineering has been receiving vast attention over the recent years. The progress of cellular and molecular biology techniques gave way to new-guided therapy possibilities. Supported by multidisciplinary activities, tissue engineering combines the interaction of physicists, chemists, biologists, engineers, biotechnologist, dentists and physicians with common goals: the search for materials that could promote and lead cell activity. A well-oriented combining of scaffolds, promoting factors, cells, together with gene therapy advances may open new avenues to bone healing in the near future. In this review, our target was to write a report bringing overall concepts on tissue bioengineering, with a special attention to decisive biological parameters for the development of biomaterials, as well as to discuss known intracellular signal transduction as a new manner to be explored within this field, aiming to predict in vitro the quality of the host cell/material and thus contributing with the development of regenerative medicine. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Gemini-Piperni, Sara; Zambuzzi, Willian Fernando] Univ Estadual Paulista, UNESP, Inst Biociencia, Lab Bioensaios & Dinam Celular,Dept Quim & Bioqui, Botucatu, SP, Brazil.
   [Gemini-Piperni, Sara] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.
   [Takamori, Esther Rieko] Excell Biomed Serv, Petropolis, RJ, Brazil.
   [Sartoretto, Suelen Cristina] Univ Fed Fluminense, Dept Oral Surg, Niteroi, RJ, Brazil.
   [Paiva, Katiucia B. S.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Extracellular Matrix Biol & Cellular Interact Grp, Sao Paulo, Brazil.
   [Granjeiro, Jose Mauro] Inst Nacl Metrol Normalizacao & Qualidade Ind INM, Diretoria Programas DIPRO Bioengn, Xerem, RJ, Brazil.
   [de Oliveira, Rodrigo Cardoso] Univ Sao Paulo, Baum Dent Sch, Dept Biol Sci, BR-17012901 Sao Paulo, Brazil.
RP Zambuzzi, WF (reprint author), Biosci Inst IBB UNESP, Dept Chem & Biochem, Bioassays & Cellular Dynam Lab, POB 510, BR-18618970 Botucatu, SP, Brazil.
EM wzambuzzi@ibb.unesp.br
RI Zambuzzi, Willian/F-9519-2012; Gemini Piperni, Sara/A-9858-2015; Paiva,
   Katiucia/C-3147-2012; Granjeiro, Jose/D-8289-2012
OI Zambuzzi, Willian/0000-0002-4149-5965; Paiva,
   Katiucia/0000-0002-3583-625X; Granjeiro, Jose/0000-0002-8027-8293
FU Marie Curie International Research Staff Exchange Scheme Fellowship;
   CNPq [PQ-2]; FAPESP; S.I.N. Sistema de Implantes (Sao Paulo, SP,
   Brazil); CNPq
FX The authors would like to thank FAPESP, CNPq and S.I.N. Sistema de
   Implantes (Sao Paulo, SP, Brazil). This research was supported by a
   Marie Curie International Research Staff Exchange Scheme Fellowship to
   S.G.P. and S.S. within the 7th European Community Framework Program.
   W.F.Z. is supported by fellowship at CNPq (PQ-2). The authors are
   grateful to Mileni S. Fernandes, Marcela M. Yanai, Paula K. Herrera and
   Andressa P. Z. Sabino, from Sao Paulo University, for helping with the
   pictures.
CR Garg T, 2012, CRIT REV THER DRUG, V29, P1
   Levi B, 2011, ORGANOGENESIS, V7, P242, DOI 10.4161/org.7.4.17926
   Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325
   Abukawa H, 2004, J ORAL MAXIL SURG, V62, P601, DOI 10.1016/j.joms.2003.11.010
   Sun XQ, 2013, BIOMATERIALS, V34, P4971, DOI 10.1016/j.biomaterials.2013.03.015
   Honma M, 2014, CURR OSTEOPOROS REP, V12, P115, DOI 10.1007/s11914-014-0189-0
   Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   Mannion RJ, 2011, SPINE J, V11, P527, DOI 10.1016/j.spinee.2010.07.005
   Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8
   Guthrie K, 2013, TRENDS BIOTECHNOL, V31, P505, DOI 10.1016/j.tibtech.2013.05.007
   Duailibi SE, 2008, J DENT RES, V87, P745
   Caplan MR, 2009, CELL BIOCHEM BIOPHYS, V54, P1, DOI 10.1007/s12013-009-9048-5
   Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/scd.2004.13.436
   McNamara LE, 2014, METHOD CELL BIOL, V119, P293, DOI 10.1016/B978-0-12-416742-1.00015-9
   Blokhuis TJ, 2013, INJURY, V44, pS40, DOI 10.1016/S0020-1383(13)70009-3
   Sekiya S, 2013, REGEN MED, V8, P371, DOI [10.2217/rme.13.16, 10.2217/RME.13.16]
   Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367
   Bertazzo S, 2010, LANGMUIR, V26, P3364, DOI 10.1021/la903140k
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Wegman F, 2013, TISSUE ENG PT A, V19, P2686, DOI [10.1089/ten.TEA.2012.0569, 10.1089/ten.tea.2012.0569]
   Traub S, 2013, BIOMATERIALS, V34, P5958, DOI 10.1016/j.biomaterials.2013.04.050
   Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193
   de la Rica R, 2010, CHEM SOC REV, V39, P3499, DOI 10.1039/b917574c
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   Kim YH, 2014, BIOMATERIALS, V35, P214, DOI 10.1016/j.biomaterials.2013.09.103
   Martin A, 2012, ADV EXP MED BIOL, V728, P65, DOI 10.1007/978-1-4614-0887-1_4
   Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264
   Antoniou MN, 2013, HUM GENE THER, V24, P363, DOI 10.1089/hum.2013.062
   Shapiro IM, 2014, AUTOPHAGY, V10, P7, DOI 10.4161/auto.26679
   Kinoshita Y, 2013, SCI WORLD J, DOI 10.1155/2013/863157
   Deshpande S, 2013, J SURG RES, V185, P278, DOI 10.1016/j.jss.2013.06.063
   Chung VHY, 2012, J CRANIOFAC SURG, V23, P1558, DOI 10.1097/SCS.0b013e31825e4e30
   Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260
   Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Bertazzo S, 2010, COLLOID SURFACE B, V78, P177, DOI 10.1016/j.colsurfb.2010.02.027
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Kam LC, 2013, ANNU REV BIOMED ENG, V15, P305, DOI 10.1146/annurev-bioeng-071811-150050
   Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017
   Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597
   Armentano Ilaria, 2013, Recent Pat Drug Deliv Formul, V7, P9
   Bakker A.D., 2014, J DENT RES
   Balint R., 2014, ACTA BIOMATER
   Bastos A.S., 2012, J ORAL IMPLANTOL
   Bertazzo S, 2010, CLIN ORAL IMPLAN RES, V21, P1411, DOI 10.1111/j.1600-0501.2010.01968.x
   Bertazzo S, 2009, CLIN ORAL IMPLAN RES, V20, P288, DOI 10.1111/j.1600-0501.2008.01642.x
   Bocelli-Tyndall C., 2013, ANN RHEUM DIS
   Boskey AL, 2008, BONE, V42, P1061, DOI 10.1016/j.bone.2008.01.016
   Carreira A.C., 2014, J DENT RES
   Cavagis A., 2013, ORAL DIS
   de Oliveira RC, 2008, CLIN ORAL IMPLAN RES, V19, P749, DOI 10.1111/j.1600-0501.2008.01521.x
   Ellman MB, 2013, GENE, V524, P282, DOI 10.1016/j.gene.2013.04.003
   Feng X., 2009, CURR CHEM BIOL, V3, P189
   Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550
   Garrison K.R., 2010, COCHRANE DB SYST REV, V6
   Girard PJ, 2013, J ORTHOP TRAUMA, V27, pe220, DOI 10.1097/BOT.0b013e31827069b9
   Gulan G, 2012, COLLEGIUM ANTROPOL, V36, P617
   Harada Hidemitsu, 2002, Odontology, V90, P1, DOI 10.1007/s102660200000
   Herlofsen SR, 2014, STEM CELLS, V32, P1629, DOI 10.1002/stem.1642
   Heydarkhan-Hagvall S, 2012, BIOMATERIALS, V33, P2032, DOI 10.1016/j.biomaterials.2011.11.065
   Hwang Yongyun, 2012, Commun Integr Biol, V5, P538, DOI 10.4161/cib.21633
   Kelleher CM, 2010, J R SOC INTERFACE, V7, pS717, DOI 10.1098/rsif.2010.0345.focus
   Kim Eun-Hee, 2014, World J Stem Cells, V6, P65, DOI 10.4252/wjsc.v6.i1.65
   Kim M, 2011, BMB REP, V44, P619, DOI 10.5483/BMBRep.2011.44.10.619
   Knight MN, 2013, ADV WOUND CARE NEW R, V2, P306, DOI DOI 10.1089/W0UND.2012.0420
   Kumar CY, 2013, J CLIN DIAGN RES, V7, P2926
   Lee HJ, 2013, BIOTECHNOL PROGR, V29, P432, DOI 10.1002/btpr.1685
   Leventis MD, 2014, IMPLANT DENT, V23, P37, DOI 10.1097/ID.0000000000000030
   Liu J, 2005, IN VITRO CELL DEV-AN, V41, P232
   Liu N., 2014, CURR STEM CELL RES T
   Marie PJ, 2012, CURR OSTEOPOROS REP, V10, P190, DOI 10.1007/s11914-012-0109-0
   Mathur Shivani, 2014, Int J Oral Maxillofac Implants, V29, pe210, DOI 10.11607/jomi.te57
   Michigami T, 2013, CELL MOL LIFE SCI, V70, P4213, DOI 10.1007/s00018-013-1346-9
   Michigami Toshimi, 2014, Clin Pediatr Endocrinol, V23, P1, DOI 10.1292/cpe.23.1
   Milani R, 2010, J CELL BIOCHEM, V109, P957, DOI 10.1002/jcb.22479
   Mishra R., 2014, J MAT SCI MAT MED
   Murray James I, 2013, J Chem Biol, V6, P175, DOI 10.1007/s12154-013-0100-y
   Muscari C., 2014, STEM CELLS INT
   Nakashima M, 2009, CYTOKINE GROWTH F R, V20, P435, DOI 10.1016/j.cytogfr.2009.10.012
   Neto AHC, 2011, J CELL BIOCHEM, V112, P71, DOI 10.1002/jcb.22763
   Ormsby R.T., 2013, J STEROID BIOCHEM, V13, pS0960
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   Panahi Y, 2014, J IMMUNOTOXICOL, V11, P72, DOI 10.3109/1547691X.2013.797525
   Park I.S., 2013, CYTOTHERAPY
   Park Justin J, 2013, Bull Hosp Jt Dis  (2013), V71, P39
   Petit A, 2011, TISSUE ENG PT A, V17, P899, DOI [10.1089/ten.TEA.2010.0494, 10.1089/ten.tea.2010.0494]
   Pham PV, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-56
   Piperni S.G., 2014, BIOTECHNOL BIOENG
   Ramiro-Gutierrez M.L., 2013, J BIOMED MAT RES A
   Romagnoli Cecilia, 2013, Clin Cases Miner Bone Metab, V10, P155
   Ronga M, 2013, INJURY, V44, pS34, DOI 10.1016/S0020-1383(13)70008-1
   Roorda BD, 2009, CANCER BIOL THER, V8, P1239, DOI 10.4161/cbt.8.13.8688
   Rosenberg Nahum, 2012, Rambam Maimonides Med J, V3, pe0013, DOI 10.5041/RMMJ.10080
   Russo V., 2014, BIOMATERIALS
   Satija NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055769
   Senoo M, 2013, ADV WOUND CARE NEW R, V2, P273
   Shilpashree H.S., 2013, DENT J, V79, P60
   Slavkin HC, 2014, AUST DENT J, V59, P186, DOI 10.1111/adj.12105
   SrinivasaBabu K., 2014, AM J THER
   Stasyk T, 2012, TRENDS MOL MED, V18, P43, DOI 10.1016/j.molmed.2011.11.001
   Tanaka S, 1998, J BONE MINER RES, V13, P1714, DOI 10.1359/jbmr.1998.13.11.1714
   Tang JB, 2014, WOUND REPAIR REGEN, V22, P111, DOI 10.1111/wrr.12129
   Trautvetter W, 2011, J ORAL MAXIL SURG, V69, P2753, DOI 10.1016/j.joms.2011.02.096
   Vrijens K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059045
   Wegman F, 2013, BIOTECHNOL GENET ENG, V29, P206, DOI 10.1080/02648725.2013.801227
   Wright JF, 2009, HUM GENE THER, V20, P698, DOI 10.1089/hum.2009.064
   Yadav MC, 2012, J BONE MINER RES, V27, P1722, DOI 10.1002/jbmr.1619
   Yamashita Teruhito, 2012, World J Orthop, V3, P175, DOI 10.5312/wjo.v3.i11.175
   Yang M., 2014, CURR STEM CELL RES T
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Zambuzzi WF, 2009, J CELL BIOCHEM, V108, P134, DOI 10.1002/jcb.22236
   Zambuzzi W.F., 2014, PLOS ONE
   Zambuzzi Willian F, 2012, Braz Dent J, V23, P315, DOI 10.1590/S0103-64402012000400002
   Zambuzzi WF, 2011, BIOTECHNOL BIOENG, V108, P1246, DOI 10.1002/bit.23117
   Zambuzzi Willian Fernando, 2006, Braz Dent J, V17, P274, DOI 10.1590/S0103-64402006000400002
   Zambuzzi WF, 2008, CELL PHYSIOL BIOCHEM, V22, P497, DOI 10.1159/000185506
   Zambuzzi WF, 2009, J MOL HISTOL, V40, P301, DOI 10.1007/s10735-009-9241-2
   Zhang WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088794
NR 123
TC 1
Z9 1
U1 8
U2 35
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 88
EP 98
DI 10.1016/j.abb.2014.06.019
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300011
PM 24976174
ER

PT J
AU Coelho, PG
   Jimbo, R
AF Coelho, Paulo G.
   Jimbo, Ryo
TI Osseointegration of metallic devices: Current trends based on implant
   hardware design
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Bone; Osseointegration; Metallic devices; Design
ID ROOT FORM IMPLANTS; BONE-FORMATION ADJACENT; HUMAN DENTAL IMPLANTS;
   IN-VIVO; HISTOMORPHOMETRIC EVALUATION; PRIMARY STABILITY; DRILL SPEED;
   BIOMECHANICAL STABILITY; MECHANICAL-PROPERTIES; ENDOSSEOUS IMPLANTS
AB Osseointegration of metallic devices has been one of the most successful treatments in rehabilitative dentistry and medicine over the past five decades. While highly successful, the quest for designing surgical instrumentation and associated implantable devices that hastens osseointegration has been perpetual and has often been approached as single variable preclinical investigations. The present manuscript presents how the interplay between surgical instrumentation and device macrogeometry not only plays a key role on both early and delayed stages of osseointegration, but may also be key in how efficient smaller length scale designing (at the micrometer and nanometer scale levels) may be in hastening early stages of osseointegration. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Coelho, Paulo G.] NYU, Coll Dent, Dept Biomat & Biomimet & Periodontol & Implantol, New York, NY USA.
   [Coelho, Paulo G.] NYU Abu Dhabi, Div Engn, Abu Dhabi, U Arab Emirates.
   [Jimbo, Ryo] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.
RP Coelho, PG (reprint author), 345 E 24th St Room 804s, New York, NY 10010 USA.
EM pc92@nyu.edu
CR Aegerter C.M., 2013, PLOS ONE, V8
   Coelho PG, 2010, CLIN IMPLANT DENT R, V12, P202, DOI 10.1111/j.1708-8208.2009.00153.x
   Raghavendra S, 2005, INT J ORAL MAX IMPL, V20, P425
   De Bruyn H, 2008, CLIN ORAL IMPLAN RES, V19, P717, DOI 10.1111/j.1600-0501.2008.01533.x
   Marin C, 2010, CLIN ORAL IMPLAN RES, V21, P577, DOI 10.1111/j.1600-0501.2009.01853.x
   Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6
   Masaki C, 2005, CLIN ORAL IMPLAN RES, V16, P650, DOI 10.1111/j.1600-0501.2005.01170.x
   Jimbo R, 2007, BIOMATERIALS, V28, P3469, DOI 10.1016/j.biomaterials.2007.04.029
   Abrahamsson I, 2009, CLIN ORAL IMPLAN RES, V20, P313, DOI 10.1111/j.1600-0501.2008.01646.x
   Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013
   dos Santos MV, 2011, CLIN IMPLANT DENT R, V13, P215, DOI 10.1111/j.1708-8208.2009.00202.x
   Tabassum A, 2010, CLIN ORAL IMPLAN RES, V21, P213, DOI 10.1111/j.1600-0501.2009.01823.x
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Vervaeke S, 2013, INT J ORAL MAX IMPL, V28, P1352, DOI 10.11607/jomi.3200
   Sharawy M, 2002, J ORAL MAXIL SURG, V60, P1160, DOI 10.1053/joms.2002.34992
   Gomes JB, 2013, INT J ORAL MAX IMPL, V28, pE128, DOI 10.11607/jomi.2885
   Vandeweghe S, 2013, INT J PROSTHODONT, V26, P458, DOI 10.11607/ijp.3075
   Freitas AC, 2012, CLIN ORAL IMPLAN RES, V23, P113, DOI 10.1111/j.1600-0501.2010.02142.x
   Klein-Nulend J, 2005, PATHOL BIOL, V53, P576, DOI 10.1016/j.patbio.2004.12.005
   Elias CN, 2012, J MECH BEHAV BIOMED, V16, P169, DOI 10.1016/j.jmbbm.2012.10.010
   Coelho PG, 2010, ORAL SURG ORAL MED O, V109, pE39, DOI 10.1016/j.tripleo.2010.01.004
   Coelho PG, 2013, J ORAL MAXIL SURG, V71, pE69, DOI 10.1016/j.joms.2012.10.008
   Jimbo R, 2013, J PERIODONTOL, V84, P1599, DOI 10.1902/jop.2012.120565
   Oh TJ, 2002, J PERIODONTOL, V73, P322, DOI 10.1902/jop.2002.73.3.322
   Buser D, 2004, J DENT RES, V83, P529
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Bucci-Sabattini V, 2010, ORAL SURG ORAL MED O, V109, P217, DOI 10.1016/j.tripleo.2009.09.007
   Norton M, 2013, INT J ORAL MAX IMPL, V28, P19
   Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5
   Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   Valencia S, 2009, INT J ORAL MAX IMPL, V24, P38
   Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264
   Petrie CS, 2005, CLIN ORAL IMPLAN RES, V16, P486, DOI 10.1111/j.1600-0501.2005.01132.x
   Huang HL, 2011, CLIN ORAL IMPLAN RES, V22, P691, DOI 10.1111/j.1600-0501.2010.01983.x
   Halldin A, 2011, BONE, V49, P783, DOI 10.1016/j.bone.2011.07.003
   Bonfante EA, 2013, CLIN ORAL IMPLAN RES, V24, P1375, DOI 10.1111/clr.12010
   Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x
   Leonard G, 2009, CLIN ORAL IMPLAN RES, V20, P232, DOI 10.1111/j.1600-0501.2008.01640.x
   ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Bashutski JD, 2009, J PERIODONTOL, V80, P700, DOI 10.1902/jop.2009.080581
   Isidor F, 2006, CLIN ORAL IMPLAN RES, V17, P8, DOI 10.1111/j.1600-0501.2006.01360.x
   Abouzgia MB, 1996, INT J ORAL MAX SURG, V25, P394, DOI 10.1016/S0901-5027(06)80040-8
   Bentolila V, 1998, BONE, V23, P275, DOI 10.1016/S8756-3282(98)00104-5
   Bosshardt DD, 2011, CLIN ORAL IMPLAN RES, V22, P357, DOI 10.1111/j.1600-0501.2010.02107.x
   Bonfante EA, 2011, INT J ORAL MAX IMPL, V26, P75
   Witek L, 2013, INT J ORAL MAX IMPL, V28, P694, DOI 10.11607/jomi.2952
   Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2
   Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60
   Jimbo R, 2012, J DENT RES, V91, P1172, DOI 10.1177/0022034512463240
   ERIKSSON A, 1982, INT J ORAL MAXILLOF, V11, P115, DOI 10.1016/S0300-9785(82)80020-3
   Coelho PG, 2011, J MECH BEHAV BIOMED, V4, P1974, DOI 10.1016/j.jmbbm.2011.06.016
   MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150
   ZIZIC TM, 1985, AM J MED, V79, P596, DOI 10.1016/0002-9343(85)90057-9
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P544
   Augustin G, 2008, ARCH ORTHOP TRAUM SU, V128, P71, DOI 10.1007/s00402-007-0427-3
   Campos FE, 2012, J ORAL MAXIL SURG, V70, pE43, DOI 10.1016/j.joms.2011.08.006
   Baldassarri M, 2012, J BIOMED MATER RES B, V100B, P2015, DOI 10.1002/jbm.b.32786
   Bonfante EA, 2013, INT J ORAL MAX IMPL, V28, P136, DOI [10.11607/jomi.2331, 10.11607jomi.2331]
   Brånemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Bronckers ALJJ, 1996, J BONE MINER RES, V11, P1281
   Browaeys H, 2014, CLIN IMPLANT DENT RE
   CHAMAY A, 1972, J BIOMECH, V5, P173, DOI 10.1016/0021-9290(72)90053-X
   Chowdhary R, 2013, CLIN IMPLANT DENT RE
   Chowdhary R, 2013, IMPLANT DENT, V22, P91, DOI 10.1097/ID.0b013e31827daf55
   Coelho PG, 2009, J BIOMED MATER RES B, V91B, P975, DOI 10.1002/jbm.b.31455
   Coelho PG, 2014, J BIOMED MATER RES B, V102, P430, DOI 10.1002/jbm.b.33020
   Coelho Paulo G, 2010, J Long Term Eff Med Implants, V20, P335
   Coelho PG, 2014, BONE, V65, P25, DOI 10.1016/j.bone.2014.05.004
   Davies John E, 2003, J Dent Educ, V67, P932
   Deporter DA, 2012, INT J PERIODONT REST, V32, P563
   Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659
   ERIKSSON RA, 1984, SCAND J PLAST RECONS, V18, P261
   Giro Gabriela, 2013, International Journal of Biomaterials, DOI 10.1155/2013/230310
   Giro G, 2011, J ORAL MAXIL SURG, V69, P2158, DOI 10.1016/j.joms.2011.01.029
   Gottlow J, 2012, CLIN IMPLANT DENT R, V14, pe204, DOI 10.1111/j.1708-8208.2012.00439.x
   Iezzi G, 2014, ODONTOLOGY, V102, P116, DOI 10.1007/s10266-012-0084-z
   Iezzi G, 2012, QUINTESSENCE INT, V43, P287
   Iezzi G, 2012, ODONTOLOGY, V102, P116
   Iyer S, 1997, INT J PROSTHODONT, V10, P411
   Iyer S, 1997, INT J PROSTHODONT, V10, P536
   Jimbo R, 2013, IMPLANT DENT, V22, P596, DOI 10.1097/ID.0b013e31829f1f4b
   Jimbo R, 2013, CLIN ORAL IMPLANTS R
   Jimbo R., 2014, INT J DENT, V2014
   Jimbo R., 2014, INT J ORAL MAXILLOFA
   Leclercq L, 2013, J BIOMAT SCI-POLYM E, V24, P1499, DOI 10.1080/09205063.2013.772045
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473
   LINDSTROM J, 1981, SCAND J PLAST RECONS, V15, P29
   Liu RH, 2013, J PROSTHODONT, V22, P641, DOI 10.1111/jopr.12063
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   Mangano C, 2013, INT J ORAL MAX IMPL, V28, P917, DOI 10.11607/jomi.2666
   Monjo M., 2012, INT J BIOMATER, V2012
   Piattelli A, 2014, J BIOMED MATER RES B, V102, P239, DOI 10.1002/jbm.b.33000
   Shibli JA, 2010, CLIN IMPLANT DENT R, V12, P281, DOI 10.1111/j.1708-8208.2009.00174.x
   Shigehara S, 2014, J ORAL IMPLANTOL
   Suzuki M, 2010, J ORAL MAXIL SURG, V68, P1631, DOI 10.1016/j.joms.2009.07.064
   Thalji G.N., 2013, CLIN ORAL IMPLANTS R
   Yeniyol S, 2013, OR SURG OR MED OR PA, V116, P550, DOI 10.1016/j.oooo.2013.07.001
   Zambuzzi WF, 2011, BIOTECHNOL BIOENG, V108, P1246, DOI 10.1002/bit.23117
NR 100
TC 7
Z9 7
U1 3
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 99
EP 108
DI 10.1016/j.abb.2014.06.033
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300012
PM 25010447
ER

PT J
AU Saran, U
   Piperni, SG
   Chatterjee, S
AF Saran, Uttara
   Piperni, Sara Gemini
   Chatterjee, Suvro
TI Role of angiogenesis in bone repair
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Angiogenesis; Endothelial cells; Endothelial progenitor cells; VEGF;
   Osteogenesis; Osteoblasts
ID ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS;
   FIBROBLAST-GROWTH-FACTOR; OSTEOCLASTOGENESIS-INHIBITORY FACTOR;
   STIMULATE CHEMOTACTIC MIGRATION; REGIONAL GENE-THERAPY; OSTEOBLAST-LIKE
   CELLS; MARROW STROMAL CELLS; SIZE DEFECT MODEL; DISTRACTION OSTEOGENESIS
AB Bone vasculature plays a vital role in bone development, remodeling and homeostasis. New blood vessel formation is crucial during both primary bone development as well as fracture repair in adults. Both bone repair and bone remodeling involve the activation and complex interaction between angiogenic and ostegenic pathways. Interestingly studies have demonstrated that angiogenesis precedes the onset of osteogenesis. Indeed reduced or inadequate blood flow has been linked to impaired fracture healing and old age related low bone mass disorders such as osteoporosis. Similarly the slow penetration of host blood vessels in large engineered bone tissue grafts has been cited as one of the major hurdle still impeding current bone construction engineering strategies. This article reviews the current knowledge elaborating the importance of vascularization during bone healing and remodeling, and the current therapeutic strategies being adapted to promote and improve angiogenesis. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Saran, Uttara; Chatterjee, Suvro] Anna Univ, AU KBC Res Ctr, Vasc Biol Lab, Madras 600044, Tamil Nadu, India.
   [Chatterjee, Suvro] Anna Univ, Dept Biotechnol, Madras 600044, Tamil Nadu, India.
   [Piperni, Sara Gemini] Univ Aquila, Dept Appl Clin Sci & Biotechnol, I-67100 Laquila, Italy.
RP Chatterjee, S (reprint author), Anna Univ, AU KBC Res Ctr, MIT Campus, Madras 600044, Tamil Nadu, India.
EM soovro@yahoo.ca
RI Gemini Piperni, Sara/A-9858-2015
FU University Grant Commission (UGC) Faculty Recharge Programme, Government
   of India;  [295181]
FX The authors would like to acknowledge the help of Saranya Rajendran,
   Prattusha Sengupta, Sneha Srinivas and Ilaria Salvati for editing the
   manuscript. This work was partially supported by FP7-PEOPLE-2011-IRSES;
   Grant No 295181 Acronym: INTERBONE, and a grant from University Grant
   Commission (UGC) Faculty Recharge Programme, Government of India to SC.
CR Andreshak JL, 1997, ANAT RECORD, V248, P198, DOI 10.1002/(SICI)1097-0185(199706)248:2<198::AID-AR6>3.0.CO;2-P
   Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8
   Popov VK, 2004, J MATER SCI-MATER M, V15, P123, DOI 10.1023/B:JMSM.0000011812.08185.2a
   Tomanek RJ, 1998, AM J PHYSIOL-HEART C, V274, pH1620
   Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209
   Rozen N, 2009, BONE, V45, P918, DOI 10.1016/j.bone.2009.07.085
   Clarkin CE, 2013, CELL BIOCHEM FUNCT, V31, P1, DOI 10.1002/cbf.2911
   Domaschke H, 2006, TISSUE ENG, V12, P949, DOI 10.1089/ten.2006.12.949
   Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1
   Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Kim YM, 2002, J BIOL CHEM, V277, P6799, DOI 10.1074/jbc.M109434200
   Kumar S, 2010, MOL THER, V18, P1026, DOI 10.1038/mt.2009.315
   Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559
   Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Jacobsen KA, 2008, J BONE MINER RES, V23, P596, DOI [10.1359/jbmr.080103, 10.1359/JBMR.080103]
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Barou O, 2002, BONE, V30, P604, DOI 10.1016/S8756-3282(02)00677-4
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   NASH TJ, 1994, BONE, V15, P203, DOI 10.1016/8756-3282(94)90709-9
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Hollinger JO, 2008, J BONE JOINT SURG AM, V90A, P48, DOI 10.2106/JBJS.G.01231
   Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146
   Sims NA, 2008, SEMIN CELL DEV BIOL, V19, P444, DOI 10.1016/j.semcdb.2008.07.016
   Moya ML, 2010, J SURG RES, V160, P208, DOI 10.1016/j.jss.2009.06.003
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   Fedorovich NE, 2010, TISSUE ENG PT A, V16, P2355, DOI 10.1089/ten.TEA.2009.0603
   Radomsky ML, 1999, J ORTHOPAED RES, V17, P607, DOI 10.1002/jor.1100170422
   Kim HH, 2003, FASEB J, V17, P2163, DOI 10.1096/fj.03-0215fje
   Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051
   Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116
   Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010
   Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Eckardt H, 2005, J BONE JOINT SURG BR, V87B, P1434, DOI 10.1302/0301-620X.87B10
   Gerber HP, 1999, NAT MED, V5, P623
   Zelzer E, 2002, DEVELOPMENT, V129, P1893
   Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9
   Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Yazar S, 2006, PLAST RECONSTR SURG, V117, P2468, DOI 10.1097/01.prs.0000224304.56885.c2
   Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905
   Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166
   Peterson B, 2005, TISSUE ENG, V11, P120, DOI 10.1089/ten.2005.11.120
   Trebec-Reynolds DP, 2010, J CELL BIOCHEM, V110, P343, DOI 10.1002/jcb.22542
   Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JC131581
   Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012
   Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Lieberman JR, 1998, J ORTHOP RES, V16, P330, DOI 10.1002/jor.1100160309
   Yang JW, 2001, NAT BIOTECHNOL, V19, P219, DOI 10.1038/85655
   Arman E, 1999, P NATL ACAD SCI USA, V96, P11895, DOI 10.1073/pnas.96.21.11895
   Veleva AN, 2008, BIOMATERIALS, V29, P3656, DOI 10.1016/j.biomaterials.2008.05.022
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659
   Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/ten.2004.10.1037
   Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008
   TRUETA J, 1963, J BONE JOINT SURG BR, V45, P402
   Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1
   Seebach C, 2010, TISSUE ENG PT A, V16, P1961, DOI 10.1089/ten.TEA.2009.0715
   Shen HC, 2004, J GENE MED, V6, P984, DOI 10.1002/jgm.588
   Geuze RE, 2009, TISSUE ENG PT A, V15, P3669, DOI 10.1089/ten.TEA.2009.0289
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100
   Shah NJ, 2011, BIOMATERIALS, V32, P6183, DOI 10.1016/j.biomaterials.2011.04.036
   Jabbarzadeh E, 2012, J BIOMED MATER RES B, V100B, P2187, DOI 10.1002/jbm.b.32787
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
   Kempen DHR, 2010, TISSUE ENG PART B-RE, V16, P551, DOI 10.1089/ten.teb.2010.0176
   Hankenson KD, 2011, INJURY, V42, P556, DOI 10.1016/j.injury.2011.03.035
   Peled A, 2000, BLOOD, V95, P3289
   Martin TJ, 2008, BEST PRACT RES CL EN, V22, P701, DOI 10.1016/j.beem.2008.07.006
   Maes C, 2013, CALCIFIED TISSUE INT, V92, P307, DOI 10.1007/s00223-012-9689-z
   Imai K, 1999, BRIT J HAEMATOL, V106, P905, DOI 10.1046/j.1365-2141.1999.01644.x
   Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   Min JK, 2003, J BIOL CHEM, V278, P39548, DOI 10.1074/jbc.M300539200
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Utting JC, 2010, CELL BIOCHEM FUNCT, V28, P374, DOI 10.1002/cbf.1660
   Keramaris NC, 2008, INJURY, V39, pS45, DOI 10.1016/S0020-1383(08)70015-9
   Hengartner NE, 2013, MOL MED, V19, P36, DOI 10.2119/molmed.2012.00058
   Tarkka T, 2003, J GENE MED, V5, P560, DOI 10.1002/jgm.392
   Li R, 2009, J ORTHOP RES, V27, P8, DOI 10.1002/jor.20658
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   Hristov M, 2003, TRENDS CARDIOVAS MED, V13, P201, DOI 10.1016/S1050-1738(03)00077-X
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Duneas N, 1998, GROWTH FACTORS, V15, P259
   Nakajima F, 2001, J ORTHOPAED RES, V19, P935, DOI 10.1016/S0736-0266(01)00024-9
   Dirckx N, 2013, BIRTH DEFECTS RES C, V99, P170, DOI 10.1002/bdrc.21047
   Yilgor P, 2010, J BIOMED MATER RES A, V93A, P528, DOI 10.1002/jbm.a.32520
   Hauge EM, 2001, J BONE MINER RES, V16, P1575, DOI 10.1359/jbmr.2001.16.9.1575
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   Uriel S, 2006, AM J SURG, V192, P604, DOI 10.1016/j.amjsurg.2006.08.012
   Laroche M, 2002, JOINT BONE SPINE, V69, P262, DOI 10.1016/S1297-319X(02)00391-3
   Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200
   Goad DL, 1996, ENDOCRINOLOGY, V137, P2262, DOI 10.1210/en.137.6.2262
   Kindle L, 2006, J BONE MINER RES, V21, P193, DOI 10.1359/JBMR.051027
   Komatsu DE, 2007, J BONE MINER RES, V22, P366, DOI 10.1359/JBMR.061207
   Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342
   Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671
   Rivron NC, 2008, EUR CELLS MATER, V15, P27
   Bax BE, 1999, CALCIFIED TISSUE INT, V65, P83, DOI 10.1007/s002239900662
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/jbmr.090602, 10.1359/JBMR.090602]
   Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053
   Eshkar-Oren I, 2009, DEVELOPMENT, V136, P1263, DOI 10.1242/dev.034199
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   Fang TD, 2005, J BONE MINER RES, V20, P1114, DOI 10.1359/JBMR.050301
   Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004
   Matsubara H, 2012, BONE, V51, P168, DOI 10.1016/j.bone.2012.02.017
   Atesok K, 2010, J ORTHOP RES, V28, P1007, DOI 10.1002/jor.21083
   Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383
   Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   Vogelin E, 2005, J BONE JOINT SURG AM, V87A, P1323, DOI 10.2106/JBJS.C.00913
   Faller DV, 1999, CLIN EXP PHARMACOL P, V26, P74, DOI 10.1046/j.1440-1681.1999.02992.x
   Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597
   Raida M, 2006, INT J MOL MED, V18, P735
   Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510
   Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979
   Yeh LCC, 1999, MOL CELL ENDOCRINOL, V153, P113, DOI 10.1016/S0303-7207(99)00076-3
   Baltzer AWA, 2000, GENE THER, V7, P734, DOI 10.1038/sj.gt.3301166
   Lee DY, 2008, BONE, V42, P932, DOI 10.1016/j.bone.2008.01.007
   Antonov EN, 2005, ADV MATER, V17, P327, DOI 10.1002/adma.200400838
   AURORI BF, 1985, CLIN ORTHOP RELAT R, P153
   Baltzer AWA, 2001, GENE THER, V8, P1770, DOI 10.1038/sj.gt.3301594
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Beamer Brandon, 2010, HSS J, V6, P85, DOI 10.1007/s11420-009-9129-4
   Bick T, 2007, J BONE MINER RES, V22, pS143
   Brandi M.L., 2006, J BONE MINER RES, V21, P2
   Burkhardt B., 1987, BONE, V8, P157
   Carvalho RS, 2004, BONE, V34, P849, DOI 10.1016/j.bone.2003.12.027
   Cetrulo CL, 2005, PLAST RECONSTR SURG, V116, P1053, DOI 10.1097/01.prs.0000178403.79051.70
   Chen WJ, 2004, J BONE MINER METAB, V22, P303, DOI 10.1007/s00774-004-0487-6
   Chen Y, 2001, J Orthop Sci, V6, P199, DOI 10.1007/s007760100072
   Ciarrocchi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001338
   Clemens Thomas L., 1996, P597
   Clines GA, 2010, CURR OPIN ORGAN TRAN, V15, P73, DOI 10.1097/MOT.0b013e328333d52c
   Colciago Alessandra, 2009, Int J Biomed Sci, V5, P380
   Collin-Osdoby P, 2002, J BONE MINER RES, V17, P1859, DOI 10.1359/jbmr.2002.17.10.1859
   COOK SD, 1994, CLIN ORTHOP RELAT R, P302
   Davies N, 2008, BIOMATERIALS, V29, P3531, DOI 10.1016/j.biomaterials.2008.05.007
   De Becker A, 2007, HAEMATOL-HEMATOL J, V92, P440, DOI 10.3324/haematol.10475
   Ding WG, 2011, CONNECT TISSUE RES, V52, P25, DOI 10.3109/03008201003783011
   Egermann M, 2005, OSTEOPOROSIS INT, V16, pS120, DOI 10.1007/s00198-004-1817-9
   Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264
   Erlebacher A, 1998, MOL BIOL CELL, V9, P1903
   Goldfarb Mitchell, 1996, Cytokine and Growth Factor Reviews, V7, P311, DOI 10.1016/S1359-6101(96)00039-1
   Groppe J, 2003, J BONE JOINT SURG AM, V85A, P52
   GRUNDNES O, 1993, ACTA ORTHOP SCAND, V64, P340, DOI 10.3109/17453679308993640
   Haigh JJ, 2000, DEVELOPMENT, V127, P1445
   Harper J, 2001, J CELL BIOCHEM, V81, P82, DOI 10.1002/1097-4644(20010401)81:1<82::AID-JCB1025>3.0.CO;2-P
   Hayashi K, 1992, Nihon Seikeigeka Gakkai Zasshi, V66, P548
   He C, 2005, BIOCHEM BIOPH RES CO, V329, P324, DOI 10.1016/j.bbrc.2005.01.133
   He XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060473
   He XN, 2013, TISSUE ENG PT A, V19, P508, DOI [10.1089/ten.TEA.2012.0244, 10.1089/ten.tea.2012.0244]
   Henrich D, 2009, TISSUE ENG PART C-ME, V15, P551, DOI 10.1089/ten.TEC.2008.0385
   Hing Karin A., 2004, PHIL T R SOC LOND A, P362
   Holder Walter D., 1997, TISSUE ENG, V3
   Holstein JH, 2008, BRIT J PHARMACOL, V154, P1055, DOI 10.1038/bjp.2008.167
   Horner A, 1999, J ANAT, V194, P519, DOI 10.1046/j.1469-7580.1999.19440519.x
   Hurley MM, 1998, BONE, V22, P309, DOI 10.1016/S8756-3282(97)00292-5
   Imai K, 1999, BLOOD, V93, P149
   Imura T, 2008, EUR J NEUROSCI, V27, P1596, DOI 10.1111/j.1460-9568.2008.06134.x
   Jr Cetrulo C.L., 2005, RECONSTR SURG, V116, P1065
   Kado M, 2008, BIOCHEM BIOPH RES CO, V377, P413, DOI 10.1016/j.bbrc.2008.09.160
   Kaigler D, 2006, J DENT RES, V85, P633
   Kaigler Darnell, 2006, J BONE MINER RES, V21, P5
   Karsenty G, 2000, NAT MED, V6, P970, DOI 10.1038/79655
   Kawaguchi H, 2000, J BONE MINER RES, V15, P466, DOI 10.1359/jbmr.2000.15.3.466
   Kawamura K, 2006, PLAST RECONSTR SURG, V117, P1471, DOI 10.1097/01.prs.0000197883.17428.22
   Klein S, 1996, J BIOL CHEM, V271, P22583
   KLEIN S, 1993, MOL BIOL CELL, V4, P973
   Lee DH, 2006, TISSUE ENG, V12, P1577, DOI 10.1089/ten.2006.12.1577
   Leu A., 2008, TISSUE ENG PART A, V15, P877, DOI DOI 10.1089/TEN.TEA.2008.0018
   Leu A., 2008, PHARM RES, V25, P1122, DOI DOI 10.1007/S11095-007-9508-9
   Li G, 2005, J ORTHOP RES, V23, P680, DOI 10.1016/j.orthres.2004.12.005
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Lu Chuanyong, 2006, Iowa Orthop J, V26, P17
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Lubiatowski P, 2006, TRANSPLANT P, V38, P320, DOI 10.1016/j.transproceed.2005.12.012
   Luttun A, 2002, TRENDS CARDIOVAS MED, V12, P88, DOI 10.1016/S1050-1738(01)00152-9
   Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3
   Maes C, 2012, J BONE MINER RES, V27, P596, DOI 10.1002/jbmr.1487
   Mathieu C, 2008, MOL CELL NEUROSCI, V38, P569, DOI 10.1016/j.mcn.2008.05.005
   Mehrotra M, 2004, J CELL BIOCHEM, V93, P741, DOI 10.1002/jcb.20138
   MIZUNO K, 1990, J BONE JOINT SURG BR, V72, P822
   Moldovan L, 2002, ARCH PATHOL LAB MED, V126, P310
   Murasawa S, 2007, CURR GENE THER, V7, P1, DOI 10.2174/156652307779940225
   Nakagawa N, 1999, BIOCHEM BIOPH RES CO, V265, P158, DOI 10.1006/bbrc.1999.1601
   Nakasa T, 2005, J BIOMED MATER RES A, V75A, P350, DOI 10.1002/jbm.a..30435
   Nomi Masashi, 2002, Molecular Aspects of Medicine, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Parfitt AM, 2000, BONE, V26, P319, DOI 10.1016/S8756-3282(00)80937-0
   Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708
   Rose FRAJ, 2004, J PHARM PHARMACOL, V56, P415, DOI 10.1211/0022357023312
   Sabbieti MG, 2005, CELL TISSUE RES, V319, P267, DOI 10.1007/s00441-004-0981-8
   Sanchez-Fernandez MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003537
   Seebach C, 2012, CELL TRANSPLANT, V21, P1667, DOI 10.3727/096368912X638937
   Smadja DM, 2008, ARTERIOSCL THROM VAS, V28, P2137, DOI 10.1161/ATVBAHA.108.168815
   Sobue T, 2002, J BONE MINER RES, V17, P502, DOI 10.1359/jbmr.2002.17.3.502
   Sojo K, 2005, J CRANIO MAXILL SURG, V33, P238, DOI 10.1016/j.jcms.2005.02.004
   Song XB, 2011, ACTA BIOCH BIOPH SIN, V43, P796, DOI 10.1093/abbs/gmr074
   Street J, 2000, J AM COLL SURGEONS, V191, pS91, DOI 10.1016/S1072-7515(00)00660-8
   Street J, 2000, CLIN ORTHOP RELAT R, P224
   Street JT, 2001, J ORTHOPAED RES, V19, P1057, DOI 10.1016/S0736-0266(01)00048-1
   Usami K, 2009, J BIOMED MATER RES A, V90A, P730, DOI 10.1002/jbm.a.32142
   Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46
   Wang H, 2010, MOL CELL BIOCHEM, V335, P19, DOI 10.1007/s11010-009-0236-9
   Young PP, 2002, P NATL ACAD SCI USA, V99, P11951, DOI 10.1073/pnas.182215799
   Zhao Qiang, 2012, BONE, V50, P763
   Zhou J, 2010, BIOMATERIALS, V31, P1171, DOI 10.1016/j.biomaterials.2009.10.043
   Zhou Jian, 2012, VASCULARIZATION BONE, DOI [10.5772/36325, DOI 10.5772/36325]
   Zigdon-Giladi H, 2013, CLIN IMPLANT DENT RE, DOI 10.1111/cid.12078
   Zigdon-Giladi H, 2013, J PERIODONTOL
NR 233
TC 10
Z9 11
U1 11
U2 49
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 109
EP 117
DI 10.1016/j.abb.2014.07.006
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300013
PM 25034215
ER

PT J
AU Guerrini, MM
   Takayanagi, H
AF Guerrini, Matteo M.
   Takayanagi, Hiroshi
TI The immune system, bone and RANKL
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Osteoimmunology; RANKL; Rheumatoid arthritis; T and B lymphocytes
ID TUMOR-NECROSIS-FACTOR; OSTEOCLASTOGENESIS-INHIBITORY FACTOR;
   DENDRITIC-CELL-FUNCTION; FACTOR FAMILY-MEMBER; REGULATORY T-CELLS; B
   LIGAND RANKL; RECEPTOR ACTIVATOR; ESTROGEN DEFICIENCY; IN-VIVO;
   DIFFERENTIATION FACTOR
AB Bone and immune systems are tightly linked. In the past years, many molecules originally believed to belong to the immune system were found to function in bone cells. It is now evident that the two systems are coregulated by many shared cytokines and signaling molecules. Here we exemplify the complex interaction between bone metabolism and immune response focusing on the multifaceted role of receptor activator of NF-kappa B ligand (RANKL). RANKL is expressed by cells of both systems, is an essential regulator of bone degradation and exerts either pro or anti-inflammatory effects on the immune response. In the present review, we summarize the multiple functions of RANKL in bone and in the immune systems, aiming to provide an overview of the field of osteoimmunology. (C) 2014 Published by Elsevier Inc.
C1 [Takayanagi, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan.
   [Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan.
   Japan Sci & Technol Agcy JST, Explorat Res Adv Technol ERATO Program, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo 1130033, Japan.
RP Takayanagi, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.
EM takayana@m.u-tokyo.ac.jp
CR Josien R, 2000, J EXP MED, V191, P495, DOI 10.1084/jem.191.3.495
   Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518
   Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417
   Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101
   Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075
   Williamson E, 2002, J IMMUNOL, V169, P3606
   Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593
   Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780
   Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6
   Gao YH, 2004, P NATL ACAD SCI USA, V101, P16618, DOI 10.1073/pnas.0404888101
   Yun TJ, 1998, J IMMUNOL, V161, P6113
   Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669
   Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761
   Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257
   Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165
   Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018
   Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497
   Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855
   MOSMANN TR, 1986, J IMMUNOL, V136, P2348
   Kim HJ, 2009, P NATL ACAD SCI USA, V106, P2325, DOI 10.1073/pnas.0806963106
   Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167
   Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015
   Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515
   Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444
   Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524
   Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707
   Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X
   Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698
   Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062
   Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107
   Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888
   Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037
   Xu YK, 2007, J IMMUNOL, V179, P7577
   Bachmann MF, 1999, J EXP MED, V189, P1025, DOI 10.1084/jem.189.7.1025
   Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203
   Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI [10.1016/j.ajhg.2008.06.015, 10.1016/j.ajhg.2008.06.01S]
   Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110
   Oda T, 2005, J ORTHOP SCI, V10, P70, DOI 10.1007/s00776-004-0851-y
   Perlot T, 2012, J IMMUNOL, V188, P1201, DOI 10.4049/jimmunol.1102063
   Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279
   Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015
   Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076
   Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405
   Gravallese EM, 1998, AM J PATHOL, V152, P943
   Miyamoto K, 2011, J EXP MED, V208, P2175, DOI 10.1084/jem.20101890
   Knoop KA, 2009, J IMMUNOL, V183, P5738, DOI 10.4049/jimmunol.0901563
   Ashcroft AJ, 2003, IMMUNITY, V19, P849, DOI 10.1016/S1074-7613(03)00326-1
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Takayanagi H, 2000, ARTHRITIS RHEUM, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W
   Hashizume M, 2008, RHEUMATOLOGY, V47, P1635, DOI 10.1093/rheumatology/ken363
   BROMLEY M, 1984, ARTHRITIS RHEUM, V27, P968, DOI 10.1002/art.1780270902
   Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748
   Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775
   Das S, 2013, DRUG DES DEV THER, V7, P435, DOI 10.2147/DDDT.S31504
   Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412
   Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004
   Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x
   Takayanagi H, 2000, NATURE, V408, P600
   Onal M, 2012, J BIOL CHEM, V287, P29851, DOI 10.1074/jbc.M112.377945
   Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066
   Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749
   Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697
   Kong YY, 1999, NATURE, V402, P304
   Maruyama K, 2012, J BIOL CHEM, V287, P29114, DOI 10.1074/jbc.M112.347799
   Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597
   Kong YY, 1999, NATURE, V397, P315
   Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921
   Green EA, 2002, IMMUNITY, V16, P183, DOI 10.1016/S1074-7613(02)00279-0
   HANAOKA H, 1979, CLIN ORTHOP RELAT R, P252
   Kanazawa K, 2005, J BONE MINER RES, V20, P2053, DOI 10.1359/JBMR.050706
   Kanematsu M, 2000, J BONE MINER RES, V15, P1321, DOI 10.1359/jbmr.2000.15.7.1321
   Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432
   Lee SK, 2006, J BONE MINER RES, V21, P1704, DOI 10.1359/JBMR.060726
   Li Y, 2007, J CELL BIOCHEM, V100, P1370, DOI 10.1002/jcb.21121
   Miyaura C, 1997, P NATL ACAD SCI USA, V94, P9360, DOI 10.1073/pnas.94.17.9360
   Onoe Y, 2000, J BONE MINER RES, V15, P541, DOI 10.1359/jbmr.2000.15.3.541
   Pangrazio A, 2012, J BONE MINER RES, V27, P342, DOI 10.1002/jbmr.559
   SHIOI A, 1991, J CELL BIOCHEM, V47, P272, DOI 10.1002/jcb.240470313
   Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200
   Yi T, 2008, J CELL PHYSIOL, V217, P409, DOI 10.1002/jcp.21511
NR 81
TC 5
Z9 6
U1 6
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 118
EP 123
DI 10.1016/j.abb.2014.06.003
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300014
PM 24929185
ER

PT J
AU Lecka-Czernik, B
   Stechschulte, LA
AF Lecka-Czernik, Beata
   Stechschulte, Lance A.
TI Bone and fat: A relationship of different shades
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Bone marrow; Adipocyte; WAT; BAT; Beige adipocytes; Bone remodeling;
   Energy homeostasis
ID BROWN ADIPOSE-TISSUE; TYPE-2 DIABETES-MELLITUS; MARROW FAT; MINERAL
   DENSITY; PPAR-GAMMA; ENERGY-METABOLISM; ANOREXIA-NERVOSA; VISCERAL FAT;
   WHITE FAT; ADIPOCYTES
AB Environmental and behavioral changes which occurred over the last century led simultaneously to a remarkable increase in human lifespan and to the development of health problems associated with functional impairment of organs either regulating or dependent on balanced energy metabolism. Diseases such as diabetes, obesity and osteoporosis are prevalent in our society and pose major challenges with respect to the overall health and economy. Therefore, better understanding of regulatory axes between bone and fat may provide the basis for development of strategies which will treat these diseases simultaneously and improve health and life quality of elderly. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Lecka-Czernik, Beata; Stechschulte, Lance A.] Univ Toledo, Dept Orthopaed Surg, Toledo, OH 43614 USA.
   [Lecka-Czernik, Beata] Univ Toledo, Dept Physiol & Pharmacol, Toledo, OH 43614 USA.
   [Lecka-Czernik, Beata; Stechschulte, Lance A.] Univ Toledo, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA.
RP Lecka-Czernik, B (reprint author), Univ Toledo, Hlth Sci Campus,3000 Arlington Ave,Mail Stop 1008, Toledo, OH 43614 USA.
EM beata.leckaczernik@utoledo.edu
OI Stechschulte, Lance/0000-0001-9783-6194
FU American Diabetes Association Award [7-13-BS-089]
FX This work was supported to BL-C by grant from the American Diabetes
   Association Award 7-13-BS-089.
CR Aguirre L., 2014, J CLIN ENDOCR METAB
   Wren TAL, 2011, J CLIN ENDOCR METAB, V96, P782, DOI 10.1210/jc.2010-1922
   Baker JM, 2011, FASEB J, V25, P4348, DOI 10.1096/fj.11-189043
   Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182
   Syed FA, 2008, OSTEOPOROSIS INT, V19, P1323, DOI 10.1007/s00198-008-0574-6
   Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108
   Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003
   Almeida M, 2009, J BIOL CHEM, V284, P27438, DOI 10.1074/jbc.M109.023572
   Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111
   Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x
   Di Iorgi N, 2010, J CLIN ENDOCR METAB, V95, P2977, DOI 10.1210/jc.2009-2336
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Griffith JF, 2005, RADIOLOGY, V236, P945, DOI 10.1148/radiol.2363041425
   Devlin MJ, 2010, J BONE MINER RES, V25, P2078, DOI 10.1002/jbmr.82
   Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008
   Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002
   Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363
   LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0
   Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112
   Shen W, 2012, J CLIN ENDOCR METAB, V97, P1337, DOI 10.1210/jc.2011-2605
   Rantalainen T, 2013, J CLIN ENDOCR METAB, V98, P2037, DOI 10.1210/jc.2012-3748
   Reyes-Garcia R, 2013, ACTA DIABETOL, V50, P47, DOI 10.1007/s00592-011-0347-0
   Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021
   Trudel G, 2012, J APPL PHYSIOL, V112, P1824, DOI 10.1152/japplphysiol.00029.2012
   Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070
   Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587
   Garcia-Martin A, 2012, J CLIN ENDOCR METAB, V97, P234, DOI 10.1210/jc.2011-2186
   Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890
   Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017
   Bredella MA, 2009, J CLIN ENDOCR METAB, V94, P2129, DOI 10.1210/jc.2008-2532
   Gennari L, 2012, J CLIN ENDOCR METAB, V97, P1737, DOI 10.1210/jc.2011-2958
   Krings A, 2012, BONE, V50, P546, DOI 10.1016/j.bone.2011.06.016
   Manavalan JS, 2012, J CLIN ENDOCR METAB, V97, P3240, DOI 10.1210/jc.2012-1546
   Olmsted-Davis E, 2007, AM J PATHOL, V170, P620, DOI 10.2353/ajpath.2007.060692
   Thrailkill KM, 2011, J CLIN ENDOCR METAB, V96, P142, DOI 10.1210/jc.2010-0980
   Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3
   Bredella MA, 2011, OBESITY, V19, P49, DOI 10.1038/oby.2010.106
   Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011
   Lecka-Czernik B, 2012, BONE, V50, P534, DOI 10.1016/j.bone.2011.06.032
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003
   Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264
   MOORE SG, 1990, RADIOLOGY, V175, P219
   Motyl KJ, 2013, J BONE MINER RES, V28, P1885, DOI 10.1002/jbmr.1943
   Styner M, 2014, BONE, V64, P39, DOI 10.1016/j.bone.2014.03.044
   Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271
   Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829
   Moyer-Mileur LJ, 2008, J BONE MINER RES, V23, P1884, DOI [10.1359/jbmr.080713, 10.1359/JBMR.080713]
   Rahman S, 2013, ENDOCRINOLOGY, V154, P2687, DOI 10.1210/en.2012-2162
   Botolin S, 2007, ENDOCRINOLOGY, V148, P198, DOI 10.1210/en.2006-1006
   Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007
   Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1
   Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x
   Bredella MA, 2012, J CLIN ENDOCR METAB, V97, pE584, DOI 10.1210/jc.2011-2246
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027
   Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367
   Shen W, 2007, OSTEOPOROSIS INT, V18, P641, DOI 10.1007/s00198-006-0285-9
   Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777
   Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398
   Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08
   Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019
   KRAKAUER JC, 1995, DIABETES, V44, P775, DOI 10.2337/diabetes.44.7.775
   Bredella Miriam A, 2013, Radiology, V269, P534, DOI 10.1148/radiol.13130375
   Bredella MA, 2014, BONE, V58, P55, DOI 10.1016/j.bone.2013.10.007
   Compston J, 2013, CURR OSTEOPOROS REP, V11, P30, DOI 10.1007/s11914-012-0127-y
   Cuevas-Ramos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038022
   Fernandez-Marcos PJ, 2010, DEV CELL, V19, P360, DOI 10.1016/j.devcel.2010.08.018
   Gasparrini M, 2009, EXP GERONTOL, V44, P613, DOI 10.1016/j.exger.2009.05.009
   Huang S, 2010, BONE, V46, P1138, DOI 10.1016/j.bone.2009.12.020
   Kawai M, 2009, NAT REV RHEUMATOL, V5, P365, DOI 10.1038/nrrheum.2009.102
   Lecka-Czernik Beata, 2010, Curr Osteoporos Rep, V8, P84, DOI 10.1007/s11914-010-0016-1
   Lecka-Czernik Beata, 2010, Curr Osteoporos Rep, V8, P178, DOI 10.1007/s11914-010-0027-y
   Levinger I, 2014, J BONE MINER RES
   Liu LC, 2012, CALCIFIED TISSUE INT, V91, P139, DOI 10.1007/s00223-012-9623-4
   Ouellet V., 2010, J CLIN ENDOCR METAB, V96, P192
   Ponrartana S, 2012, J CLIN ENDOCR METAB, V97, P2693, DOI 10.1210/jc.2012-1589
   Sage AP, 2011, J BONE MINER RES, V26, P1197, DOI 10.1002/jbmr.312
   Liu LF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-212
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011
   Wei Jianwen, 2014, J Clin Invest, V124, P1, DOI 10.1172/JCI72323
NR 83
TC 6
Z9 6
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 124
EP 129
DI 10.1016/j.abb.2014.06.010
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300015
PM 24956594
ER

PT J
AU Quiros-Gonzalez, I
   Yadav, VK
AF Quiros-Gonzalez, Isabel
   Yadav, Vijay K.
TI Central genes, pathways and modules that regulate bone mass
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Bone; Brain; Leptin; Serotonin; Sympathetic nervous system
ID ESTROGEN-RECEPTOR-ALPHA; GROWTH-FACTOR-I; FOLLICLE-STIMULATING-HORMONE;
   SYMPATHETIC-NERVOUS-SYSTEM; SEROTONERGIC NEURONS; HYPOTHALAMIC CONTROL;
   LEPTIN REGULATION; MINERAL DENSITY; THYROID-HORMONE; NEUROPEPTIDE-Y
AB Bones are structures that give the shape and defined features to vertebrates, protect several soft organs and perform multiple endocrine influences on other organs. To achieve these functions bones are first modeled early during life and then constantly remodeled throughout life. The process of bone (re)modeling happens simultaneously at multitude of locations in the skeleton and ensures that vertebrates have a mechanically strong yet a flexible skeleton to the most part of their life. Given the extent of its occurrence in the body, bone remodeling is a highly energy demanding process and is co-ordinated with other physiological processes as diverse as energy metabolism, sleep-wake cycle and reproduction. Neuronal circuits in the brain play a very important role in the coordination of bone remodeling with other organ system functions, and perform this function in sync with environmental and peripheral hormonal cues. In this review, we will focus on the roles of hormonal signals and neural circuits that originate in, or impinge on, the brain in the regulation of bone mass. We will provide herein an updated view of how advances in molecular genetics have refined the neural circuits involved in the regulation of bone mass, from the whole brain level to the specific neuronal populations and their neurotransmitters. This will help to understand the mechanisms whereby vertebrate brain regulates bone mass by fine-tuning metabolic signals that originate in the brain or elsewhere in the body. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Quiros-Gonzalez, Isabel; Yadav, Vijay K.] Wellcome Trust Sanger Inst, Dept Mouse & Zebrafish Genet, Syst Biol Bone Lab, Cambridge CB10 1SA, England.
   [Yadav, Vijay K.] Wellcome Trust Sanger Inst, Dept Mouse & Zebrafish Genet, Sanger Mouse Genet Project, Cambridge CB10 1SA, England.
RP Yadav, VK (reprint author), Wellcome Trust Sanger Inst, Dept Mouse & Zebrafish Genet, Sanger Mouse Genet Project, Cambridge CB10 1SA, England.
EM vy1@sanger.ac.uk
FU ERA-EDTA [ERA LTF-107/2012]; Wellcome Trust [098051]
FX I.Q.-G. is supported by the ERA-EDTA postdoctoral fellowship (ERA
   LTF-107/2012). We sincerely apologize to investigators whose work has
   not been discussed due to space constraints. This work was supported by
   the Wellcome Trust (Grant Number: 098051).
CR Albright F., 1941, JAMA-J AM MED ASSOC, V116, P10
   Allison SJ, 2006, J BIOL CHEM, V281, P23436, DOI 10.1074/jbc.M604839200
   Dietrich MO, 2013, TRENDS NEUROSCI, V36, P65, DOI 10.1016/j.tins.2012.12.005
   Camerino C, 2012, ENDOCRINOLOGY, V153, P5394, DOI 10.1210/en.2012-1378
   Ohlsson C, 2012, P NATL ACAD SCI USA, V109, P983, DOI 10.1073/pnas.1111436109
   Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001
   Singh MK, 2008, ENDOCRINOLOGY, V149, P3933, DOI 10.1210/en.2008-0109
   Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016
   Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523
   Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8
   Sowers MR, 2003, OSTEOPOROSIS INT, V14, P44, DOI 10.1007/s00198-002-1307-x
   Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005
   Lee NJ, 2010, J BONE MINER RES, V25, P1736, DOI 10.1002/jbmr.61
   Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051
   Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010
   Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975
   Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051
   Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463
   SHEN V, 1993, J CLIN INVEST, V91, P2479, DOI 10.1172/JCI116483
   Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358
   Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588
   Elabd C, 2008, STEM CELLS, V26, P2399, DOI 10.1634/stemcells.2008-0127
   Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200
   Ebeling PR, 1996, J CLIN ENDOCR METAB, V81, P3366, DOI 10.1210/jc.81.9.3366
   Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763
   Sims NA, 2003, J CLIN INVEST, V111, P1319, DOI 10.1172/JCI200317246
   Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910
   Shi YC, 2011, OBESITY, V19, P2137, DOI 10.1038/oby.2011.99
   Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025
   AITKEN JM, 1973, BRIT MED J, V3, P515
   Ahn JD, 2006, ENDOCRINOLOGY, V147, P3196, DOI 10.1210/en.2006-0281
   Bajayo A, 2012, P NATL ACAD SCI USA, V109, P15455, DOI 10.1073/pnas.1206061109
   Collin M, 2000, MOL BRAIN RES, V81, P51, DOI 10.1016/S0169-328X(00)00167-4
   HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777
   Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308
   Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174
   Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106
   Baldock PA, 2007, J BIOL CHEM, V282, P19092, DOI 10.1074/jbc.M700644200
   Kauffman AS, 2007, TRENDS NEUROSCI, V30, P504, DOI 10.1016/j.tins.2007.08.001
   Bassett JHD, 2007, MOL ENDOCRINOL, V21, P1095, DOI 10.1210/me.2007-0033
   Wojcicka A, 2013, BBA-GEN SUBJECTS, V1830, P3979, DOI 10.1016/j.bbagen.2012.05.005
   Shi Y, 2008, P NATL ACAD SCI USA, V105, P20529, DOI 10.1073/pnas.0808701106
   Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025
   Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537
   Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398
   Breuil V, 2011, JOINT BONE SPINE, V78, P611, DOI 10.1016/j.jbspin.2011.02.002
   Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5
   Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324
   Yadav VK, 2011, J EXP MED, V208, P41, DOI 10.1084/jem.20101940
   Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0
   Bajayo A, 2005, P NATL ACAD SCI USA, V102, P12956, DOI 10.1073/pnas.0502562102
   Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415
   Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004
   Baraban SC, 1998, REV NEUROSCIENCE, V9, P117
   Barake M., 2014, J CLIN ENDOCR METAB
   Cizza G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040894
   Cornish J, 2002, J ENDOCRINOL, V175, P405, DOI 10.1677/joe.0.1750405
   Danilovich N, 2000, ENDOCRINOLOGY, V141, P4295, DOI 10.1210/en.141.11.4295
   Ducy P, 2011, CURR OPIN PHARMACOL, V11, P34, DOI 10.1016/j.coph.2011.01.007
   Fernandez-Galaz MC, 2002, J NEUROENDOCRINOL, V14, P429, DOI 10.1046/j.1365-2826.2002.00783.x
   Finn PD, 2001, J CLIN ENDOCR METAB, V86, P422, DOI 10.1210/jc.86.1.422
   Gao JJ, 2007, ENDOCRINOLOGY, V148, P2613, DOI 10.1210/en.2006-1404
   Hosoi T, 2002, ENDOCRINOLOGY, V143, P3498, DOI 10.1210/en.2002-220077
   Kronenberg H., 2008, WILLIAMS TXB ENDOCRI, Vxix, P1911
   Lam DD, 2011, CELL METAB, V13, P584, DOI 10.1016/j.cmet.2011.03.016
   Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229
   Logan RW, 2012, MOL CELL ENDOCRINOL, V349, P82, DOI 10.1016/j.mce.2011.06.039
   Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   Nicks Kristy M, 2010, Curr Osteoporos Rep, V8, P60, DOI 10.1007/s11914-010-0014-3
   Oikonen M., 2013, INT J BEHAV MED
   Oz OK, 2001, J STEROID BIOCHEM, V79, P49, DOI 10.1016/S0960-0760(01)00130-3
   Qury F., 2010, GENE DEV, V24, P2330
   Riggs BL, 2003, NEW ENGL J MED, V348, P618
   Sullivan SD, 2002, BIOL REPROD, V66, P1702, DOI 10.1095/biolreprod66.6.1702
   Teixeira L, 2009, J CELL BIOCHEM, V107, P908, DOI 10.1002/jcb.22194
   Vestergaard P, 2002, THYROID, V12, P411, DOI 10.1089/105072502760043503
   Vestergaard P, 2003, THYROID, V13, P585, DOI 10.1089/105072503322238854
   Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730
   Xing WR, 2012, J BONE MINER RES, V27, P1067, DOI 10.1002/jbmr.1551
NR 82
TC 1
Z9 1
U1 2
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 130
EP 136
DI 10.1016/j.abb.2014.06.005
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300016
PM 24950023
ER

PT J
AU Ferron, M
   Lacombe, J
AF Ferron, Mathieu
   Lacombe, Julie
TI Regulation of energy metabolism by the skeleton: Osteocalcin and beyond
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Osteocalcin; Glucose metabolism; Energy metabolism; Osteoblast;
   Osteoclast; Insulin
ID PROTEIN-TYROSINE-PHOSPHATASE; TYPE-2 DIABETES-MELLITUS;
   POLYCYSTIC-OVARY-SYNDROME; FATTY LIVER-DISEASE; SERUM UNDERCARBOXYLATED
   OSTEOCALCIN; PANCREATIC BETA-CELL; DIET-INDUCED OBESITY; ABDOMINAL
   AORTIC CALCIFICATION; ENDOPLASMIC-RETICULUM STRESS; EARLY POSTMENOPAUSAL
   WOMEN
AB The skeleton has recently emerged as an endocrine organ implicated in the regulation of glucose and energy metabolism. This function of bone is mediated, at least in part, by osteocalcin, an osteoblast-derived protein acting as a hormone stimulating insulin sensitivity, insulin secretion and energy expenditure. Osteocalcin secretion and bioactivity is in turn regulated by several hormonal cues including insulin, leptin, the sympathetic nervous system and glucocorticoids. Recent findings support the notion that osteocalcin functions and regulations are conserved between mice and humans. Moreover, studies in mice suggest that osteocalcin could represent a viable therapeutic approach for the treatment of obesity and insulin resistance. In this review, we summarize the current knowledge on osteocalcin functions, its various modes of action and the mechanisms implicated in the control of this hormone. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Ferron, Mathieu; Lacombe, Julie] Inst Rech Clin Montreal, Lab Physiol Integrat & Mol, Montreal, PQ H2W 1R7, Canada.
   [Ferron, Mathieu] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada.
RP Ferron, M (reprint author), Inst Rech Clin Montreal, 110 Ave des Pins O, Montreal, PQ H2W 1R7, Canada.
EM mathieu.ferron@ircm.qc.ca; julie.lacombe@ircm.qc.ca
FU Canada Research Chair in Bone and Energy Metabolism; Canadian Institutes
   of Health Research
FX This work was supported by the Canada Research Chair in Bone and Energy
   Metabolism (M.F.) and by the Canadian Institutes of Health Research
   (M.F.).
CR Almqvist EG, 2012, SCAND J CLIN LAB INV, V72, P92, DOI 10.3109/00365513.2011.634432
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Bao YQ, 2013, J CLIN ENDOCR METAB, V98, P345, DOI 10.1210/jc.2012-2906
   Malashkevich VN, 2013, BIOCHEMISTRY-US, V52, P8387, DOI 10.1021/bi4010254
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Ma X, 2013, J BONE MINER RES, V28, P1641, DOI 10.1002/jbmr.1898
   Henriksen DB, 2009, BONE, V45, P833, DOI 10.1016/j.bone.2009.07.008
   Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003
   Oosterwerff MM, 2013, CLIN ENDOCRINOL, V78, P242, DOI 10.1111/j.1365-2265.2012.04391.x
   Stafford DW, 2005, J THROMB HAEMOST, V3, P1873, DOI 10.1111/j.1538-7836.2005.01419.x
   Bullo M, 2012, AM J CLIN NUTR, V95, P249, DOI 10.3945/ajcn.111.016642
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8
   Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002
   Lu CY, 2012, J CLIN ENDOCR METAB, V97, P4106, DOI 10.1210/jc.2012-2045
   Lucey AJ, 2013, NUTR RES, V33, P67, DOI 10.1016/j.nutres.2012.11.011
   Abseyi N, 2012, J CLIN RES PEDIATR E, V4, P182, DOI [10.4274/jcrpe.831, 10.4274/Jcrpe.831]
   Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295
   Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P237, DOI 10.1210/jc.2008-0270
   Liu JJ, 2013, INT J MOL SCI, V14, P19782, DOI 10.3390/ijms141019782
   Sumara G, 2012, CELL METAB, V16, P588, DOI 10.1016/j.cmet.2012.09.014
   Yeap BB, 2012, OSTEOPOROSIS INT, V23, P599, DOI 10.1007/s00198-011-1586-1
   Gower BA, 2013, J CLIN ENDOCR METAB, V98, pE1173, DOI 10.1210/jc.2013-1203
   Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046
   Zhou B, 2013, CELL CYCLE, V12, P1901, DOI 10.4161/cc.24929
   Pollock NK, 2011, J CLIN ENDOCR METAB, V96, pE1092, DOI 10.1210/jc.2010-2731
   Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JC165952
   Furusyo N, 2013, ENDOCRINE, V43, P635, DOI 10.1007/s12020-012-9803-z
   Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103
   Bao YQ, 2011, CLIN EXP PHARMACOL P, V38, P50, DOI 10.1111/j.1440-1681.2010.05463.x
   Boucher-Berry C, 2012, J BONE MINER RES, V27, P283, DOI 10.1002/jbmr.550
   Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797
   Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002
   Xita N, 2010, ANN NY ACAD SCI, V1205, P148, DOI 10.1111/j.1749-6632.2010.05658.x
   Kim SH, 2010, CLIN CHIM ACTA, V411, P2054, DOI 10.1016/j.cca.2010.08.046
   Reinehr T, 2010, INT J OBESITY, V34, P852, DOI 10.1038/ijo.2009.282
   Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005
   Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051
   Aonuma H, 2009, TOHOKU J EXP MED, V218, P201, DOI 10.1620/tjem.218.201
   Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301
   Ferron M, 2012, BONE, V50, P568, DOI 10.1016/j.bone.2011.04.017
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]
   Escobar-Morreale HF, 2007, TRENDS ENDOCRIN MET, V18, P266, DOI 10.1016/j.tem.2007.07.003
   Yun TJ, 2001, J IMMUNOL, V166, P1482
   Aller R, 2011, ANN HEPATOL, V10, P50
   Saleem U, 2010, ARTERIOSCL THROM VAS, V30, P1474, DOI 10.1161/ATVBAHA.110.204859
   Shea MK, 2009, AM J CLIN NUTR, V90, P1230, DOI 10.3945/ajcn.2009.28151
   Ravn P, 1999, J BONE MINER RES, V14, P1622, DOI 10.1359/jbmr.1999.14.9.1622
   Gillespie JR, 2013, ENDOCRINOLOGY, V154, P3702, DOI 10.1210/en.2013-1155
   Oury F, 2013, CELL, V155, P228, DOI 10.1016/j.cell.2013.08.042
   Chen L, 2013, DIABETIC MED, V30, P309, DOI 10.1111/j.1464-5491.2012.03769.x
   Bae SJ, 2011, OSTEOPOROSIS INT, V22, P2837, DOI 10.1007/s00198-010-1504-y
   Levinger I, 2011, OSTEOPOROSIS INT, V22, P1621, DOI 10.1007/s00198-010-1370-7
   Iki M, 2012, OSTEOPOROSIS INT, V23, P761, DOI 10.1007/s00198-011-1600-7
   Im JA, 2008, CLIN CHIM ACTA, V396, P66, DOI 10.1016/j.cca.2008.07.001
   Bao YQ, 2011, CLIN ENDOCRINOL, V75, P196, DOI 10.1111/j.1365-2265.2011.04065.x
   Smajilovic S, 2013, AMINO ACIDS, V44, P383, DOI 10.1007/s00726-012-1341-8
   Yoshikawa Y, 2011, J BONE MINER RES, V26, P2012, DOI 10.1002/jbmr.417
   Yang R, 2013, MENOPAUSE, V20, P548, DOI [10.1097/GME.0b013e318271b1da, 10.1097/gme.0b013e318271b1da]
   Ackermann AM, 2007, J MOL ENDOCRINOL, V38, P193, DOI 10.1677/JME-06-0053
   Ogawa-Furuya N, 2013, OSTEOPOROSIS INT, V24, P2223, DOI 10.1007/s00198-013-2289-6
   Winhofer Y, 2010, DIABETES CARE, V33, P139, DOI 10.2337/dc09-1237
   Brennan-Speranza TC, 2012, J CLIN INVEST, V122, P4172, DOI 10.1172/JCI63377
   Yeap BB, 2010, EUR J ENDOCRINOL, V163, P265, DOI 10.1530/EJE-10-0414
   Ferron M, 2010, BIOCHEM BIOPH RES CO, V397, P691, DOI 10.1016/j.bbrc.2010.06.008
   Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1
   Ngarmukos C, 2012, CLIN ENDOCRINOL, V77, P42, DOI 10.1111/j.1365-2265.2011.04215.x
   Polgreen LE, 2012, OBESITY, V20, P2194, DOI 10.1038/oby.2012.108
   O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990
   Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963
   Lee SW, 2012, GYNECOL ENDOCRINOL, V28, P472, DOI 10.3109/09513590.2011.633660
   Misra M, 2011, NEUROENDOCRINOLOGY, V93, P65, DOI 10.1159/000323771
   Schafer AL, 2011, J CLIN ENDOCR METAB, V96, pE1982, DOI 10.1210/jc.2011-0587
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Sarkar PD, 2013, EUR REV MED PHARMACO, V17, P1631
   Kanazawa I, 2011, OSTEOPOROSIS INT, V22, P187, DOI 10.1007/s00198-010-1184-7
   Weiler HA, 2013, J NUTR BIOCHEM, V24, P412, DOI 10.1016/j.jnutbio.2011.12.007
   Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366
   Zhou B, 2013, ENDOCRINOLOGY, V154, P1055, DOI 10.1210/en.2012-2144
   Hwang YC, 2012, OSTEOPOROSIS INT, V23, P1337, DOI 10.1007/s00198-011-1679-x
   Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910
   Yilmaz Y, 2011, SCAND J CLIN LAB INV, V71, P631, DOI 10.3109/00365513.2011.604427
   Movahed A, 2012, J BONE MINER METAB, V30, P683, DOI 10.1007/s00774-012-0367-z
   Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200
   Dowd TL, 2001, BBA-MOL BASIS DIS, V1535, P153, DOI 10.1016/S0925-4439(00)00094-6
   Hill HS, 2014, HORM METAB RES, V46, P341, DOI 10.1055/s-0034-1368709
   Wang QQ, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/842598
   Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335
   Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003
   Legro RS, 2003, ENDOCR REV, V24, P302, DOI 10.1210/er.2003-0004
   Buday B, 2013, BONE, V57, P98, DOI 10.1016/j.bone.2013.07.018
   Idelevich A, 2011, ARTERIOSCL THROM VAS, V31, pE55, DOI 10.1161/ATVBAHA.111.230904
   Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7
   Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422
   Diaz-Lopez A, 2013, J CLIN ENDOCR METAB, V98, P4524, DOI 10.1210/jc.2013-2472
   Choudhury AB, 2014, ARCH PHYSIOL BIOCHEM, V120, P73, DOI 10.3109/13813455.2013.877488
   Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901
   Zhang YF, 2010, AM J CARDIOL, V106, P1461, DOI 10.1016/j.amjcard.2010.07.013
   Garcia-Martin A, 2011, MENOPAUSE, V18, P537, DOI 10.1097/gme.0b013e3181f8565e
   Garanty-Bogacka B, 2013, ENDOKRYNOL POL, V64, P346, DOI 10.5603/EP.2013.0016
   Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113
   Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004
   Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5
   Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105
   Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045
   Alfadda AA, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/197519
   Prats-Puig A, 2010, DIABETES CARE, V33, P661, DOI 10.2337/dc09-1837
   Kajimura D, 2013, CELL METAB, V17, P901, DOI 10.1016/j.cmet.2013.04.009
   Dou JX, 2013, CLIN EXP PHARMACOL P, V40, P282, DOI 10.1111/1440-1681.12063
   Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.000025.2004
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047
   Hwang YC, 2012, DIABETES CARE, V35, P1919, DOI 10.2337/dc11-2471
   Confavreux CB, 2013, J CLIN ENDOCR METAB, V98, P1084, DOI 10.1210/jc.2012-3426
   Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455
   Kanazawa I, 2011, BONE, V48, P720, DOI 10.1016/j.bone.2010.12.020
   Suh HS, 2013, CLIN CHIM ACTA, V418, P17, DOI 10.1016/j.cca.2012.11.029
   Basu R, 2011, J CLIN ENDOCR METAB, V96, P1450, DOI 10.1210/jc.2010-2877
   Bergen HT, 1998, ENDOCRINOLOGY, V139, P4483, DOI 10.1210/en.139.11.4483
   Bozec A, 2013, J CELL SCI, V126, P5432, DOI 10.1242/jcs.134510
   Chen X., 2013, DIABETES METAB RES R
   Chengalvala MV, 2001, BIOCHEMISTRY-US, V40, P814, DOI 10.1021/bi0019996
   Chin KY, 2014, INT J MED SCI, V11, P151, DOI 10.7150/ijms.7152
   Confavreux CB, 2012, OSTEOPOROSIS INT, V23, P1645, DOI 10.1007/s00198-011-1684-0
   Cousin W, 2004, BIOCHEM BIOPH RES CO, V321, P259, DOI 10.1016/j.bbrc.2004.06.137
   Dacquin R, 2004, DEV DYNAM, V229, P826, DOI 10.1002/dvdy.20003
   Das SK, 2010, DIS MARKERS, V28, P281, DOI 10.3233/DMA-2010-0701
   Diamanti-Kandarakis E, 2011, J BONE MINER METAB, V29, P201, DOI 10.1007/s00774-010-0211-2
   Dubnov-Raz G, 2012, PEDIATR OBES, V7, P313, DOI 10.1111/j.2047-6310.2012.00058.x
   Fernandez-Real JM, 2010, OSTEOPOROSIS INT, V21, P2101, DOI 10.1007/s00198-010-1174-9
   Gianotti L, 2011, CALCIFIED TISSUE INT, V88, P231, DOI 10.1007/s00223-010-9453-1
   Gounarides JS, 2008, ENDOCRINOLOGY, V149, P758, DOI 10.1210/en.2007-1214
   Gravenstein KS, 2011, J CLIN ENDOCR METAB, V96, pE884, DOI 10.1210/jc.2010-2589
   HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Hong Seong-Hun, 2013, J Bone Metab, V20, P37, DOI 10.11005/jbm.2013.20.1.37
   Iglesias P, 2011, CLIN ENDOCRINOL, V75, P184, DOI 10.1111/j.1365-2265.2011.04035.x
   Iwamoto Jun, 2004, Keio Journal of Medicine, V53, P251, DOI 10.2302/kjm.53.251
   Jurimae J, 2011, J SPORT MED PHYS FIT, V51, P347
   Kajimura D, 2011, J EXP MED, V208, P841, DOI 10.1084/jem.20102608
   Kanazawa I, 2011, DIABETES RES CLIN PR, V92, P393, DOI 10.1016/j.diabres.2011.03.015
   Kim S, 2013, MENOPAUSE, V20, P1061, DOI [10.1097/GME.0b013e31828838e8, 10.1097/gme.0b013e31828838e8]
   Knapen MHJ, 2012, BRIT J NUTR, V108, P1017, DOI 10.1017/S000711451100626X
   Kode A, 2012, J BIOL CHEM, V287, P8757, DOI 10.1074/jbc.M111.282897
   Korostishevsky M, 2012, BONE, V51, P688, DOI 10.1016/j.bone.2012.07.010
   Lacombe Julie, 2013, Mol Metab, V2, P498, DOI 10.1016/j.molmet.2013.08.004
   Legroux-Gerot I., JOINT BONE SPINE, V72, P489
   Lenders CM, 2013, OBESITY, V21, P808, DOI 10.1002/oby.20131
   Luo Junming, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P1, DOI 10.3969/j.issn.1672-7347.2010.01.001
   Ma H, 2014, EUR J INTERN MED, V25, P259, DOI 10.1016/j.ejim.2014.01.017
   Maduro MR, 2002, J UROLOGY, V167, P2282, DOI 10.1016/S0022-5347(05)65143-9
   Mauro LJ, 1996, ENDOCRINOLOGY, V137, P925, DOI 10.1210/en.137.3.925
   MAURO LJ, 1994, J BIOL CHEM, V269, P30659
   Migliaccio S, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/182753
   Mizokami A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057375
   Mokuda S, 2012, J ENDOCRINOL INVEST, V35, P661, DOI 10.3275/7971
   Mori K, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-53
   Nohara K, 2013, AM J PHYSIOL-ENDOC M, V304, pE1321, DOI 10.1152/ajpendo.00620.2012
   Nohara K, 2013, J ENDOCRINOL, V219, P259, DOI 10.1530/JOE-13-0230
   Oury F, 2010, GENE DEV, V24, P2330, DOI 10.1101/gad.1977210
   Pepene CE, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-4
   Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390
   Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858
   Poomthavorn P., 2013, CLIN ENDOCRINOL OXF, V80, P516
   REID IR, 1986, J CLIN ENDOCR METAB, V62, P379
   Sarkar PD, 2012, ARCH PHYSIOL BIOCHEM, V118, P260, DOI 10.3109/13813455.2012.715651
   Sato M, 2013, CELL METAB, V18, P749, DOI 10.1016/j.cmet.2013.09.014
   Schwetz V, 2014, ENDOCR PRACT, V20, P5, DOI 10.4158/EP13110.OR
   White KE, 2000, NAT GENET, V26, P345
   Thrailkill KM, 2012, OSTEOPOROSIS INT, V23, P1799, DOI 10.1007/s00198-011-1807-7
   TREMOLLIERES FA, 1993, J CLIN ENDOCR METAB, V77, P683, DOI 10.1210/jc.77.3.683
   Villafan-Bernal JR, 2014, J INVEST MED, V62, P33, DOI 10.231/JIM.0000000000000015
   Wei J., 2013, DIABETES, V63, P1021
   Winhofer Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040947
   Yamashita T, 2013, INT UROL NEPHROL, V45, P207, DOI 10.1007/s11255-012-0156-6
   Zee T, 2012, MOL CELL BIOL, V32, P1080, DOI 10.1128/MCB.06279-11
NR 179
TC 12
Z9 12
U1 9
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 137
EP 146
DI 10.1016/j.abb.2014.05.022
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300017
PM 24893146
ER

PT J
AU Chamouni, A
   Oury, F
AF Chamouni, Alexandre
   Oury, Franck
TI Reciprocal interaction between bone and gonads
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Gonads; Bone; Sex steroid hormones; Osteocalcin; Prostate cancer
ID ADVANCED PROSTATE-CANCER; GENOME-WIDE ASSOCIATION; MATRIX GLA PROTEIN;
   SERUM OSTEOCALCIN; SEX STEROIDS; UNDERCARBOXYLATED OSTEOCALCIN;
   METABOLIC SYNDROME; ENERGY-METABOLISM; MINERAL DENSITY; POSTMENOPAUSAL
   WOMEN
AB The demonstration that the skeleton is an endocrine organ has enriched the physiological importance of this tissue and advanced our understanding of whole-organism homeostasis. Moreover, that bone affects powerful regulators of its own physiology such as glucose metabolism, energy expenditure, gonads and brain, reinforced the concept of interdependence between organs. This notion is particularly true for the interplay between bone and gonads. On one hand, gonads are essential for bone growth, maturation and maintenance via the secretion of the sex steroid hormones. On the other hand, bone returns this favor to the gonads, through the secretion of osteocalcin (Ocn), which promotes testosterone biosynthesis following its binding to Gprc6a, a G-protein-coupled receptor. Moreover, that a loss of function mutation in GPRC6A leads to glucose intolerance and male sterility in human, expands the biological relevance of the endocrine role of the skeleton and suggests to some extent its implication in the onset of reproductive and metabolic human diseases. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Chamouni, Alexandre; Oury, Franck] Inst Necker Enfants Malad, INSERM U1151, F-75014 Paris, France.
RP Oury, F (reprint author), Inst Necker Enfants Malad, INSERM U1151, 96 Rue Didot Batiment Leriche, F-75014 Paris, France.
EM franck.oury@inserm.fr
FU Fondation pour la Recherche Medicale (FRM) [FRM: AJE20130928594]; Human
   Frontier Scientific Program (HFSP) - CDA; Institut national de la sante
   et de la recherche medicale (Inserm) - France
FX This work was supported by the Fondation pour la Recherche Medicale
   (FRM) grants FRM: AJE20130928594, Human Frontier Scientific Program
   (HFSP) - CDA and the Institut national de la sante et de la recherche
   medicale (Inserm) - France (F.O. and A.C.).
CR Zallone A, 2006, ANN NY ACAD SCI, V1068, P173, DOI 10.1196/annals.1346.019
   Kirmani S, 2009, J BONE MINER RES, V24, P1033, DOI [10.1359/jbmr.081255, 10.1359/JBMR.081255]
   Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072
   Khosla S, 2010, J CLIN ENDOCR METAB, V95, P3569, DOI 10.1210/jc.2010-0856
   Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168
   Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003
   Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660
   Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9
   MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689
   Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P237, DOI 10.1210/jc.2008-0270
   Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046
   Katznelson L, 1996, J CLIN ENDOCR METAB, V81, P4358, DOI 10.1210/jc.81.12.4358
   Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101
   Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JC165952
   BUCHANAN JR, 1988, J CLIN ENDOCR METAB, V67, P937
   Karsenty G, 2012, ANNU REV PHYSIOL, V74, P87, DOI 10.1146/annurev-physiol-020911-153233
   Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975
   Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887
   Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551
   Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002
   Michael H, 2005, J BONE MINER RES, V20, P2224, DOI 10.1359/JBMR.050803
   Khosla S, 2005, ENDOCRIN METAB CLIN, V34, P1015, DOI 10.1016/j.ecl.2005.07.009
   Kirmani S, 2011, J BONE MINER RES, V26, P2212, DOI 10.1002/jbmr.421
   Aonuma H, 2009, TOHOKU J EXP MED, V218, P201, DOI 10.1620/tjem.218.201
   TURNER RT, 1990, J ORTHOPAED RES, V8, P612, DOI 10.1002/jor.1100080418
   Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Saleem U, 2010, ARTERIOSCL THROM VAS, V30, P1474, DOI 10.1161/ATVBAHA.110.204859
   Khosla S, 2010, J CLIN ENDOCR METAB, V95, P3, DOI 10.1210/jc.2009-1740
   Venken K, 2008, OSTEOPOROSIS INT, V19, P1517, DOI 10.1007/s00198-008-0609-z
   Oury F, 2013, CELL, V155, P228, DOI 10.1016/j.cell.2013.08.042
   Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91
   Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013
   Talbott EO, 2000, ARTERIOSCL THROM VAS, V20, P2414
   Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8
   Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763
   Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67
   Im JA, 2008, CLIN CHIM ACTA, V396, P66, DOI 10.1016/j.cca.2008.07.001
   Callewaert F, 2010, TRENDS ENDOCRIN MET, V21, P89, DOI 10.1016/j.tem.2009.09.002
   Ellem SJ, 2010, J STEROID BIOCHEM, V118, P246, DOI 10.1016/j.jsbmb.2009.10.015
   Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008
   Martin A, 2012, ADV EXP MED BIOL, V728, P65, DOI 10.1007/978-1-4614-0887-1_4
   Callewaert F, 2010, J ENDOCRINOL, V207, P127, DOI 10.1677/JOE-10-0209
   Yoshikawa Y, 2011, J BONE MINER RES, V26, P2012, DOI 10.1002/jbmr.417
   ALBRIGHT F, 1947, ANN INTERN MED, V27, P861
   Winhofer Y, 2010, DIABETES CARE, V33, P139, DOI 10.2337/dc09-1237
   Finkelstein JS, 1996, J CLIN ENDOCR METAB, V81, P1152, DOI 10.1210/jc.81.3.1152
   Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243
   Yeap BB, 2010, EUR J ENDOCRINOL, V163, P265, DOI 10.1530/EJE-10-0414
   Shafi AA, 2013, PHARMACOL THERAPEUT, V140, P223, DOI 10.1016/j.pharmthera.2013.07.003
   Pi M, 2012, ENDOCRINOLOGY, V153, P2062, DOI 10.1210/en.2011-2117
   Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025
   Clarke BL, 2010, RADIOL CLIN N AM, V48, P483, DOI 10.1016/j.rcl.2010.02.014
   Liao M, 2013, J CLIN ENDOCR METAB, V98, P3463, DOI 10.1210/jc.2013-1805
   Hori M, 2011, ENDOCRINOLOGY, V152, P4, DOI 10.1210/en.2010-0800
   Seeman E, 2001, J CLIN ENDOCR METAB, V86, P4576, DOI 10.1210/jc.86.10.4576
   Kumar TR, 2007, MOL CELL ENDOCRINOL, V269, P81, DOI 10.1016/j.mce.2006.10.020
   Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Wu HC, 2003, EUR UROL, V43, P197, DOI 10.1016/S0302-2838(02)00541-9
   Huggins C, 1940, J EXP MED, V72, P747, DOI 10.1084/jem.72.6.747
   Lorentzon M, 2005, J BONE MINER RES, V20, P1334, DOI 10.1359/JBMR.050404
   GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439
   Weitzmann MN, 2002, J CLIN INVEST, V110, P1643, DOI 10.1172/JCI200215687
   Khosla S, 2001, J CLIN ENDOCR METAB, V86, P3555, DOI 10.1210/jc.86.8.3555
   Kousteni S, 2002, SCIENCE, V298, P843, DOI 10.1126/science.1074935
   Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279
   Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422
   Callewaert F, 2010, J BONE MINER RES, V25, P617, DOI 10.1359/jbmr.090828
   Pi M, 2012, PROSTATE, V72, P399, DOI 10.1002/pros.21442
   Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385
   Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113
   Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004
   Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047
   Komaba H, 2010, KIDNEY INT, V77, P292, DOI 10.1038/ki.2009.466
   ARAI Y, 1992, PROSTATE, V20, P169, DOI 10.1002/pros.2990200302
   BERTELLONI S, 1995, J BONE MINER RES, V10, P1488
   BUCHANAN JR, 1988, J BONE MINER RES, V3, P673
   CURATOLO C, 1992, EUR UROL, V21, P105
   Fui MNT, 2013, ASIAN J ANDROL, V15, P445, DOI 10.1038/aja.2013.57
   Garcia AJ, 2013, J BONE MINER RES, V28, P283, DOI 10.1002/jbmr.1747
   Gardner TA, 2009, ONCOL REP, V21, P903, DOI 10.3892/or_00000302
   Gravholt CH, 2003, CLIN ENDOCRINOL, V59, P89, DOI 10.1046/j.1365-2265.2003.01807.x
   Grossmann M, 2013, BEST PRACT RES CL EN, V27, P603, DOI 10.1016/j.beem.2013.05.001
   Habuchi T, 2000, CANCER RES, V60, P5710
   Hannemann A, 2013, ANDROLOGY-US, V1, P469, DOI 10.1111/j.2047-2927.2012.00044.x
   Ho GYF, 2002, INT J CANCER, V98, P938, DOI 10.1002/ijc.10290
   Hwang Y.C., 2009, DIABETES-METAB RES, V25, P768
   Kanazawa I, 2013, OSTEOPOROSIS INT, V24, P1115, DOI 10.1007/s00198-012-2017-7
   KELLY PJ, 1990, J BONE MINER RES, V5, P1169
   Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1443, DOI 10.1210/jc.87.4.1443
   Krum SA, 2008, CELL CYCLE, V7, P1348, DOI 10.4161/cc.7.10.5892
   Lacombe Julie, 2013, Mol Metab, V2, P498, DOI 10.1016/j.molmet.2013.08.004
   LEVEDAKOU EN, 1992, INT J CANCER, V52, P534, DOI 10.1002/ijc.2910520406
   MARCELLINI M, 1992, EUR UROL, V21, P102
   MAURO LJ, 1994, J BIOL CHEM, V269, P30659
   Nimptsch K, 2009, CANCER EPIDEM BIOMAR, V18, P49, DOI 10.1158/1055-9965.EPI-08-0554
   Oades GM, 2002, PROSTATE CANCER P D, V5, P264, DOI 10.1038/sj.pcan.4500607
   Oury F, 2012, ANN NY ACAD SCI, V1260, P1, DOI 10.1111/j.1749-6632.2011.06360.x
   Pi M, 2013, CURR OSTEOPOROS REP, V11, P391, DOI 10.1007/s11914-013-0178-8
   Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858
   Samavat J, 2014, INT J OBESITY, V38, P357, DOI 10.1038/ijo.2013.228
   SHIH WJ, 1990, J NUCL MED, V31, P1486
   Ullen A, 2005, ACTA ONCOL, V44, P644, DOI 10.1080/02841860510029617
   Vandenput L, 2004, J BONE MINER RES, V19, P1462, DOI 10.1359/JBMR.040505
   Venken K, 2005, J BONE MINER RES, V20, P2138, DOI 10.1359/JBMR.050811
   Wei SY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-288
   Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776
   Yeung F, 2002, J BIOL CHEM, V277, P2468, DOI 10.1074/jbc.M105947200
   Zborowski JV, 2000, J CLIN ENDOCR METAB, V85, P3496, DOI 10.1210/jc.85.10.3496
NR 112
TC 2
Z9 2
U1 7
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 147
EP 153
DI 10.1016/j.abb.2014.06.016
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300018
PM 24998176
ER

PT J
AU Razzaque, MS
AF Razzaque, Mohammed Shawkat
TI Bone-kidney axis in systemic phosphate turnover
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Klotho; FGF23; Kidney; Bone; Vitamin-D
ID FIBROBLAST-GROWTH-FACTOR; SOFT-TISSUE CALCIFICATION; VITAMIN-D;
   PARATHYROID-HORMONE; IN-VIVO; PHOSPHORUS HOMEOSTASIS;
   HEMODIALYSIS-PATIENTS; INORGANIC-PHOSPHATE; TUMORAL CALCINOSIS; MISSENSE
   MUTATION
AB An adequate phosphate balance is essential for the maintenance of skeletal growth, development and function. It is also crucial in basic cellular functions, ranging from cell signaling to energy metabolism. Bone-derived fibroblast growth factor 23 (FGF23), through activating FGF receptor system, plays an important role in the systemic regulation of phosphate metabolism. Under physiological conditions, FGF23 exerts serum phosphate-lowering effects by inducing urinary phosphate excretion. Increased FGF23 activities are associated with hypophosphatemic diseases (i.e., rickets/osteomalacia), while reduced FGF23 activity are linked to hyperphosphatemic diseases (i.e., tumoral calcinosis). Unlike most of the FGF family members, FGF23 needs klotho, as a co-factor to activate its receptor system. In vivo studies have convincingly demonstrated that, in absence of klotho, FGF23 is unable to influence systemic phosphate metabolism. Available information suggests that interactions of FGF23, klotho, and FGFRs regulate renal phosphate metabolism by suppressing sodium-phosphate transporters in the proximal tubular epithelial cells. This article briefly summarizes how bone-kidney communication contributes to physiologic phosphate balance. (C) 2014 Elsevier Inc. All rights reserved.
C1 Forsyth Inst, Dept Appl Oral Sci, Cambridge, MA 02142 USA.
RP Razzaque, MS (reprint author), Forsyth Inst, Dept Appl Oral Sci, 245 First St, Cambridge, MA 02142 USA.
EM mrazzaque@hms.harvard.edu
CR Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034
   Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696
   Goetz R, 2012, J BIOL CHEM, V287, P29134, DOI 10.1074/jbc.M112.342980
   Lanske B, 2007, CURR OPIN NEPHROL HY, V16, P311, DOI 10.1097/MNH.0b013e3281c55eca
   Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059
   Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   Miyamoto K, 2005, THER APHER DIAL, V9, P331, DOI 10.1111/j.1744-9987.2005.00292.x
   Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC
   Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008
   Osuka S, 2012, J BONE MINER METAB, V30, P10, DOI 10.1007/s00774-011-0343-z
   Razzaque MS, 2013, CONTRIB NEPHROL, V180, P74, DOI 10.1159/000346784
   Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107
   Razzaque MS, 2009, AM J PHYSIOL-RENAL, V296, pF470, DOI 10.1152/ajprenal.90538.2008
   Tenenhouse HS, 2005, ANNU REV NUTR, V25, P197, DOI 10.1146/annurev.nutr.25.050304.092642
   Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83
   Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06
   Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330
   Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095
   Tagliabracci VS, 2014, P NATL ACAD SCI USA, V111, P5520, DOI 10.1073/pnas.1402218111
   Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275
   Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007
   WILLS MR, 1983, LANCET, V2, P29
   Medici D, 2008, J CELL BIOL, V182, P459, DOI 10.1083/jcb.200803024
   Ohnishi M, 2009, CIRC-CARDIOVASC GENE, V2, P583, DOI 10.1161/CIRCGENETICS.108.847814
   Ohnishi M, 2013, CONTRIB NEPHROL, V180, P1, DOI 10.1159/000346774
   Razzaque MS, 2011, IUBMB LIFE, V63, P240, DOI 10.1002/iub.437
   MARTIN RR, 1987, JAMA-J AM MED ASSOC, V257, P2190, DOI 10.1001/jama.257.16.2190
   Razzaque MS, 2011, KIDNEY INT, V79, P708, DOI 10.1038/ki.2010.432
   Segawa H, 2003, PFLUG ARCH EUR J PHY, V446, P585, DOI 10.1007/s00424-003-1084-1
   Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104
   Farrow EG, 2009, J AM SOC NEPHROL, V20, P955, DOI 10.1681/ASN.2008070783
   Forster IC, 2006, KIDNEY INT, V70, P1548, DOI 10.1038/sj.ki.5001813
   Fukagawa M, 2006, J BONE MINER METAB, V24, P434, DOI 10.1007/s00774-006-0719-7
   Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196
   Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10266
   Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559
   Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24
   Melamed ML, 2006, KIDNEY INT, V70, P351, DOI 10.1038/sj.ki.5001542
   Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765
   Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488
   Razzaque MS, 2011, CLIN SCI, V120, P91, DOI 10.1042/CS20100377
   Razzaque MS, 2009, NEPHROL DIAL TRANSPL, V24, P4, DOI 10.1093/ndt/gfn620
   Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264
   Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397
   Lindsay R, 1997, LANCET, V350, P550, DOI 10.1016/S0140-6736(97)02342-8
   Azari F, 2008, J STRUCT BIOL, V162, P468, DOI 10.1016/j.jsb.2008.03.003
   Bauer W, 1929, J EXP MED, V49, P145, DOI 10.1084/jem.49.1.145
   BERNER YN, 1988, ANNU REV NUTR, V8, P121, DOI 10.1146/annurev.nu.08.070188.001005
   BETTS F, 1975, P NATL ACAD SCI USA, V72, P2088, DOI 10.1073/pnas.72.6.2088
   Cheng C.-Y., 2011, ADV CHRONIC KIDNEY D
   Frazao JM, 2000, AM J KIDNEY DIS, V36, P550, DOI 10.1053/ajkd.2000.16193
   Fukagawa M., 2006, PEDIAT NEPHROL
   Ghosh Amit K, 2008, J Assoc Physicians India, V56, P613
   Goetz R, 2012, MOL CELL BIOL, V32, P1944, DOI 10.1128/MCB.06603-11
   Ismail EAR, 2000, J PEDIATR GASTR NUTR, V30, P220, DOI 10.1097/00005176-200002000-00025
   Ito M, 2005, AM J PHYSIOL-ENDOC M, V288, pE1101, DOI 10.1152/ajpendo.00502.2004
   Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005
   Kuro-o M, 2001, TRENDS MOL MED, V7, P179, DOI 10.1016/S1471-4914(01)01921-9
   Lutfioglu M, 2010, J PERIODONTOL, V81, P150, DOI 10.1902/jop.2009.090353
   Marraffa JM, 2004, PEDIATR EMERG CARE, V20, P453, DOI 10.1097/01.pec.0000132217.65600.52
   MORGAN JM, 1974, ARCH INTERN MED, V134, P549, DOI 10.1001/archinte.134.3.549
   Murer H, 1998, Kidney Int Suppl, V65, pS2
   Nabeshima Y, 2002, AGEING RES REV, V1, P627, DOI 10.1016/S1568-1637(02)00027-2
   Nabeshima Yo-ichi, 2006, Sci Aging Knowledge Environ, V2006, ppe11, DOI 10.1126/sageke.2006.8.pe11
   Nabeshima Y, 2008, CELL MOL LIFE SCI, V65, P3218, DOI 10.1007/s00018-008-8177-0
   Nakatani T, 2009, FASEB J, V23, P3702, DOI 10.1096/fj.08-123992
   NESBITT T, 1992, J CLIN INVEST, V89, P1453, DOI 10.1172/JCI115735
   OOI SW, 1981, CAN J MICROBIOL, V27, P267
   Perlman JM, 1997, AM J HEALTH-SYST PH, V54, P2488
   Razzaque M.S., 2010, NEPHROL DIAL TRANSPL, V26, P42
   Razzaque MS, 2010, EXPERT OPIN THER PAT, V20, P981, DOI 10.1517/13543771003774100
   REEVE J, 1976, CALC TISS RES, V21, P469
   Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025
   Rosen CJ, 2010, CELL, V142, P198, DOI 10.1016/j.cell.2010.07.001
   Segawa H., 2006, J AM SOC NEPHROL, V17, p355A
   Taylor JG, 2009, BLOOD PURIFICAT, V27, P387, DOI 10.1159/000209740
   White KE, 2000, NAT GENET, V26, P345
   Uchihashi K, 2013, CONTRIB NEPHROL, V180, P124, DOI 10.1159/000346792
   Yuan Q, 2011, ENDOCRINOLOGY, V152, P4053, DOI 10.1210/en.2011-1113
NR 80
TC 2
Z9 2
U1 2
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 154
EP 158
DI 10.1016/j.abb.2014.06.031
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300019
PM 24997362
ER

PT J
AU van Driel, M
   van Leeuwen, JPTM
AF van Driel, Marjolein
   van Leeuwen, Johannes P. T. M.
TI Cancer and bone: A complex complex
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Bone; Cancer; Metastases; Microenvironment; Therapy
ID ACUTE LYMPHOBLASTIC-LEUKEMIA; MARROW STROMAL CELLS; HUMAN MYELOMA CELLS;
   CHRONIC LYMPHOCYTIC-LEUKEMIA; HUMAN MULTIPLE-MYELOMA; ANTI-CS1
   MONOCLONAL-ANTIBODY; RESISTANT PROSTATE-CANCER; ESTROGEN-RECEPTOR-BETA;
   MESENCHYMAL STEM-CELLS; HUMAN BREAST-CANCER
AB Primary and secondary bone cancers are rare events. However, once settled, a complex process is started involving an extensive amount of factors and interactions. The bone micro-environment is a preferential site for (metastatic) tumor cells to enter, stay, colonize and expand. The fact that the tumor cells affect the complete bone environment involving many cell types and regulatory pathways to stimulate their own growth and escape from therapy is devastating for the patient. Many efforts have been made to get more insight into the mechanisms underlying the communication between bone cells and cancer cells and progress is made in therapeutic interventions. This review will discuss the biological mechanisms of primary bone malignancies (osteosarcoma, Ewing's sarcoma, chondrosarcoma, multiple myeloma) and secondary bone malignancies (bone metastases) and therapeutic interventions. (C) 2014 Elsevier Inc. All rights reserved.
C1 [van Driel, Marjolein; van Leeuwen, Johannes P. T. M.] Erasmus MC, Dept Internal Med, NL-3015 CN Rotterdam, Netherlands.
RP van Driel, M (reprint author), Erasmus MC, Dept Internal Med, Room Ee585c,Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.
EM m.vandriel@erasmusmc.nl
CR Agnelli L, 2013, EXPERT OPIN BIOL TH, V13, pS55, DOI 10.1517/14712598.2013.793305
   AHSMANN EJM, 1992, BLOOD, V79, P2068
   Tagliaferri P, 2012, CURR CANCER DRUG TAR, V12, P838
   Gill J, 2013, PHARMACOL THERAPEUT, V137, P89, DOI 10.1016/j.pharmthera.2012.09.003
   Roberson JR, 2009, LEUKEMIA, V23, P245, DOI 10.1038/leu.2008.289
   Ferrara F, 2013, LEUKEMIA, V27, P997, DOI 10.1038/leu.2012.303
   Browne G, 2014, TRENDS ENDOCRIN MET, V25, P320, DOI 10.1016/j.tem.2014.03.014
   Heider U, 2005, BIOCHEM BIOPH RES CO, V338, P687, DOI 10.1016/j.bbrc.2005.09.146
   Yang L, 2008, J CLIN ONCOL, V26, P1932, DOI 10.1200/JCO.2007.13.8404
   Lonial S, 2013, SEMIN ONCOL, V40, P652, DOI 10.1053/j.seminoncol.2013.07.004
   Yonou H, 2007, PROSTATE, V67, P840, DOI 10.1002/pros.20574
   Fowler JA, 2011, BLOOD, V118, P5872, DOI 10.1182/blood-2011-01-330407
   Lee GT, 2014, BRIT J CANCER, V110, P1634, DOI 10.1038/bjc.2014.23
   Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9
   Hadji P, 2012, ANN ONCOL, V23, P2782, DOI 10.1093/annonc/mds169
   Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498
   Smith DC, 2013, J CLIN ONCOL, V31, P412, DOI 10.1200/JCO.2012.45.0494
   Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004
   Abe M, 2002, BLOOD, V100, P2195
   Fruehauf S, 2007, CANCER, V109, P1543, DOI 10.1002/cncr.22535
   Raje N, 2011, CLIN CANCER RES, V17, P1278, DOI 10.1158/1078-0432.CCR-10-1804
   Standal T, 2007, BLOOD, V109, P3024, DOI 10.1182/blood-2006-07-034884
   Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414
   Noll JE, 2014, HAEMATOLOGICA, V99, P163, DOI 10.3324/haematol.2013.090977
   Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195
   Lee JW, 2004, BLOOD, V103, P2308, DOI 10.1182/blood-2003-06-1992
   Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247
   Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026
   Chesi M, 2013, INT J HEMATOL, V97, P313, DOI 10.1007/s12185-013-1291-2
   Ell B, 2013, CANCER CELL, V24, P542, DOI 10.1016/j.ccr.2013.09.008
   Jones TS, 2008, J CLIN ONCOL, V26, P3031, DOI 10.1200/JCO.2007.14.6399
   D'Souza S, 2011, BLOOD, V118, P6871, DOI 10.1182/blood-2011-04-346775
   Clezardin P, 2011, BONE, V48, P71, DOI 10.1016/j.bone.2010.07.016
   Terpos E, 2003, BRIT J HAEMATOL, V123, P106, DOI 10.1046/j.1365-2141.2003.04561.x
   Henry DH, 2011, J CLIN ONCOL, V29, P1125, DOI 10.1200/JCO.2010.31.3304
   Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883
   Seidel C, 2001, BLOOD, V98, P2269, DOI 10.1182/blood.V98.7.2269
   Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055
   Dimopoulos K, 2013, EUR J HAEMATOL, V91, P95, DOI 10.1111/ejh.12124
   Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032
   Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359
   Standal T, 2004, EXP ONCOL, V26, P179
   Chauhan D, 1997, BLOOD, V89, P227
   Keller ET, 2004, J CELL BIOCHEM, V91, P718, DOI 10.1002/jcb.10662
   van der Pluijm G, 2011, BONE, V48, P37, DOI 10.1016/j.bone.2010.07.023
   Coleman RE, 2013, BREAST, V22, pS50, DOI 10.1016/j.breast.2013.07.010
   Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3
   Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694
   Hideshima T, 2001, ONCOGENE, V20, P4519, DOI 10.1038/sj.onc.1204623
   Tai YT, 2006, CANCER RES, V66, P6675, DOI 10.1158/0008-5472.CAN-06-0190
   Giuliani N, 2001, BLOOD, V98, P3527, DOI 10.1182/blood.V98.13.3527
   Damiano JS, 1999, BLOOD, V93, P1658
   Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027
   Ferlin M, 2000, BRIT J HAEMATOL, V111, P626, DOI 10.1046/j.1365-2141.2000.02364.x
   Schaap FG, 2013, ADV ANAT PATHOL, V20, P32, DOI 10.1097/PAP.0b013e31827b654d
   Katz BZ, 2010, SEMIN CANCER BIOL, V20, P186, DOI 10.1016/j.semcancer.2010.04.003
   Yi B, 2002, CANCER RES, V62, P917
   Fowler JA, 2011, BONE, V48, P121, DOI 10.1016/j.bone.2010.06.029
   Terpos E, 2012, INT J CANCER, V131, P1466, DOI 10.1002/ijc.27342
   Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753
   Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568
   Vallet S, 2010, P NATL ACAD SCI USA, V107, P5124, DOI 10.1073/pnas.0911929107
   Chauhan D, 1996, BLOOD, V87, P1104
   Giuliani N, 2002, BLOOD, V100, P4615, DOI 10.1182/blood-2002-04-1121
   de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032
   Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7
   Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2
   Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346
   Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857
   Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002
   Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307
   Qiang YW, 2004, BLOOD, V103, P301, DOI 10.1182/blood-2003-06-2066
   MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752
   Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151
   Oba Y, 2005, EXP HEMATOL, V33, P272, DOI 10.1016/j.exphem.2004.11.015
   van Oosterwijk JG, 2013, HEMATOL ONCOL CLIN N, V27, P1021, DOI 10.1016/j.hoc.2013.07.012
   Dhodapkar MV, 1998, BLOOD, V91, P2679
   Rubnitz JE, 2008, J CLIN ONCOL, V26, P2186, DOI 10.1200/JCO.2007.14.3552
   KURIHARA N, 1990, J IMMUNOL, V144, P4226
   Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010
   Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004
   Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4
   Edwards CM, 2008, BONE, V42, P1007, DOI 10.1016/j.bone.2008.01.027
   Zannettino ACW, 2005, CANCER RES, V65, P1700, DOI 10.1158/0008-5472.CAN-04-1687
   Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009
   Metzgeroth G, 2007, CLIN CHEM LAB MED, V45, P1313, DOI 10.1515/CCLM.2007.287
   Buijs JT, 2007, CLIN EXP METASTAS, V24, P609, DOI 10.1007/s10585-007-9118-2
   Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004
   Terpos E, 2003, BLOOD, V102, P1064, DOI 10.1182/blood-2003-02-0380
   Farrugia AN, 2003, CANCER RES, V63, P5438
   Jarvinen TAH, 2000, AM J PATHOL, V156, P29, DOI 10.1016/S0002-9440(10)64702-5
   Urashima M, 1996, BLOOD, V87, P1928
   Oranger A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/289458
   Hehlmann R, 2007, LANCET, V370, P342, DOI 10.1016/S0140-6736(07)61165-9
   Dai X, 2011, MED SCI MONITOR, V17, pRA177
   Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710
   Jovanovic JV, 2007, BLOOD, V109, P4635, DOI 10.1182/blood-2006-10-050054
   Skliris GP, 2003, J PATHOL, V201, P213, DOI 10.1002/path.1436
   Castellano D, 2011, ONCOLOGIST, V16, P136, DOI [10.1634/theoncologist.2010-0154, 10.1634/theoncologist.20100154]
   Hehlmann R, 2007, BLOOD, V109, P4686, DOI 10.1182/blood-2006-11-055186
   Ma YM, 2013, BIOCHEM BIOPH RES CO, V431, P274, DOI 10.1016/j.bbrc.2012.12.118
   Stocco G, 2009, CLIN PHARMACOL THER, V85, P164, DOI 10.1038/clpt.2008.154
   Kaplan RN, 2006, CANCER METAST REV, V25, P521, DOI 10.1007/s10555-006-9036-9
   Coleman RE, 2012, CURR OPIN SUPPORT PA, V6, P322, DOI 10.1097/SPC.0b013e32835689cd
   Bovee JVMG, 2010, NAT REV CANCER, V10, P481, DOI 10.1038/nrc2869
   Kreil S, 2007, BLOOD, V110, P1283, DOI 10.1182/blood-2007-02-074252
   van der Deen M, 2013, J BIOL CHEM, V288, P21307, DOI 10.1074/jbc.M112.445890
   Jamil N, 2010, INT J EXP PATHOL, V91, P387, DOI 10.1111/j.1365-2613.2010.00749.x
   Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Jakubowiak AJ, 2012, J CLIN ONCOL, V30, P1960, DOI 10.1200/JCO.2011.37.7069
   Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237
   Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9
   Boyerinas B, 2013, BLOOD, V121, P4821, DOI 10.1182/blood-2012-12-475483
   Bord S, 2005, BONE, V36, P812, DOI 10.1016/j.bone.2004.12.006
   Schatton T, 2009, ANN NY ACAD SCI, V1176, P154, DOI 10.1111/j.1749-6632.2009.04568.x
   Giuliani N, 2005, BLOOD, V106, P2472, DOI 10.1182/blood-2004-12-4986
   Thorselius M, 2006, BLOOD, V107, P2889, DOI 10.1182/blood-2005-06-2227
   Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004
   ACHBAROU A, 1994, CANCER RES, V54, P2372
   Sawant A, 2013, CANCER RES, V73, P672, DOI 10.1158/0008-5472.CAN-12-2202
   Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004
   Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487
   Hajek R, 2013, BRIT J HAEMATOL, V163, P551, DOI 10.1111/bjh.12563
   Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847
   Kacena MA, 2006, BONE, V39, P991, DOI 10.1016/j.bone.2006.05.004
   Lonial S, 2013, EXPERT OPIN BIOL TH, V13, P1731, DOI 10.1517/14712598.2013.847919
   Boeuf S, 2010, HISTOPATHOLOGY, V56, P641, DOI 10.1111/j.1365-2559.2010.03528.x
   Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123
   Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63
   Walz C, 2007, HAEMATOL-HEMATOL J, V92, P163, DOI 10.3324/haematol.10980
   Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004
   Terpos E, 2013, J CLIN ONCOL, V31, P2347, DOI 10.1200/JCO.2012.47.7901
   Menoret E, 2008, J IMMUNOL, V181, P6837
   Xu GS, 2012, BLOOD, V119, P4205, DOI 10.1182/blood-2011-05-353300
   Roberson JR, 2008, PEDIATR BLOOD CANCER, V50, P1207, DOI 10.1002/pbc.21505
   Brunetti G, 2011, ANN NY ACAD SCI, V1237, P19, DOI 10.1111/j.1749-6632.2011.06196.x
   Morgan GJ, 2010, LANCET, V376, P1989, DOI 10.1016/S0140-6736(10)62051-X
   Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027
   D'Souza S, 2012, BLOOD, V119, P1888, DOI 10.1182/blood-2011-11-393348
   Basu-Roy U, 2013, CANCER LETT, V338, P158, DOI 10.1016/j.canlet.2012.05.028
   Cairoli R, 2013, AM J HEMATOL, V88, P594, DOI 10.1002/ajh.23461
   Chen YC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2781
   Chiorazzi N, 2005, ANN NY ACAD SCI, V1062, P1, DOI 10.1196/annals.1358.002
   Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720
   Choi SJ, 2000, BLOOD, V96, P671
   Clezardin P, 2007, CLIN EXP METASTAS, V24, P599, DOI 10.1007/s10585-007-9112-8
   Colucci S, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.22
   Cumming AP, 2011, PROSTATE CANCER P D, V14, P286, DOI 10.1038/pcan.2011.34
   De Leenheer E, 2004, CURR OPIN PHARMACOL, V4, P340, DOI 10.1016/j.coph.2004.03.011
   Eisterer W, 2001, LEUKEMIA RES, V25, P1051, DOI 10.1016/S0145-2126(01)00075-3
   Fabarius A, 2007, HAEMATOL-HEMATOL J, V92, P834, DOI 10.3324/haematol.11064
   Ferrara F, 2013, J CLIN ONCOL, V31, P820, DOI 10.1200/JCO.2012.45.2219
   Fuller K, 2000, BIOCHEM BIOPH RES CO, V268, P2, DOI 10.1006/bbrc.2000.2075
   Galson Deborah L, 2012, Bonekey Rep, V1, P135, DOI 10.1038/bonekey.2012.135
   GARRETT IR, 1987, NEW ENGL J MED, V317, P526, DOI 10.1056/NEJM198708273170902
   Giuliani N, 2004, HAEMATOLOGICA, V89, P1118
   Hansen MF, 2006, J BONE MINER RES, V21, pP58, DOI 10.1359/JBMR.06S211
   Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002
   Hiraga T, 2012, CANCER RES, V72, P4238, DOI 10.1158/0008-5472.CAN-11-3061
   Ibrahim Toni, 2013, Clin Cases Miner Bone Metab, V10, P121
   Kamdem LK, 2008, PHARMACOGENET GENOM, V18, P507, DOI 10.1097/FPC.0b013e3282fc5801
   Kaste S, 2009, LEUKEMIA, V23, P104, DOI 10.1038/leu.2008.269
   Kawano Y, 2012, INT J ONCOL, V41, P876, DOI 10.3892/ijo.2012.1545
   Kibler C, 1998, CELL ADHES COMMUN, V5, P307, DOI 10.3109/15419069809040300
   Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540
   Kitsoulis P, 2006, ANTICANCER RES, V26, P325
   KOENDERS PG, 1991, BREAST CANCER RES TR, V18, P27, DOI 10.1007/BF01975440
   Kumar S, 2004, BLOOD, V104, P1159, DOI 10.1182/blood-2003-11-3811
   Kyle RA, 2014, EXPERT REV HEMATOL, V7, P5, DOI 10.1586/17474086.2014.870030
   Li X, 2011, J BONE MINER RES, V26, P125, DOI 10.1002/jbmr.204
   Lynch CC, 2011, BONE, V48, P44, DOI 10.1016/j.bone.2010.06.007
   Matasar MJ, 2008, RADIOL CLIN N AM, V46, P175, DOI 10.1016/j.rcl.2008.03.005
   Matsumoto T, 2011, BONE, V48, P129, DOI 10.1016/j.bone.2010.05.036
   Munshi N.C., 2012, BLOOD, V120
   Mutsaers AJ, 2014, BONE
   Nugent Mary, 2014, Cancer Manag Res, V6, P15, DOI 10.2147/CMAR.S53928
   Okada T, 2003, CLIN EXP METASTAS, V20, P639, DOI 10.1023/A:1027362507683
   PELLATDECEUNYNCK C, 1995, CANCER RES, V55, P3647
   Power PF, 2013, J ORTHOP RES, V31, P493, DOI 10.1002/jor.22227
   RABBANI SA, 1990, BIOCHEM BIOPH RES CO, V173, P1058, DOI 10.1016/S0006-291X(05)80893-9
   Rai SN, 2008, CONTEMP CLIN TRIALS, V29, P711, DOI 10.1016/j.cct.2008.05.002
   Roodman GD, 2010, J BONE MINER METAB, V28, P244, DOI 10.1007/s00774-009-0154-7
   Rubio R, 2014, STEM CELLS, V32, P1136, DOI 10.1002/stem.1647
   Rucci Nadia, 2010, Front Biosci (Schol Ed), V2, P907
   Schwaninger R, 2007, AM J PATHOL, V170, P160, DOI 10.2353/ajpath.2007.051276
   Scullen T, 2013, LEUKEMIA, V27, P1715, DOI 10.1038/leu.2013.50
   Secondini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016078
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Silbermann Rebecca, 2011, Curr Opin Support Palliat Care, V5, P251, DOI 10.1097/SPC.0b013e328349c524
   Silbermann R, 2011, BLOOD, V118, P1681
   Stewart JP, 2006, J CELL BIOCHEM, V98, P1, DOI 10.1002/jcb.20774
   Terpos E, 2012, CURR HEMATOL MALIG R, V7, P249, DOI 10.1007/s11899-012-0135-0
   Under T.T., 2008, CANCER RES, V68, P3645
   Vadlamudi RK., 2012, INT J BREAST CANC, V2012
   van Driel M, 1998, LEUKEMIA, V12, P1821, DOI 10.1038/sj.leu.2401179
   Van Driel M, 2002, LEUKEMIA, V16, P135, DOI 10.1038/sj.leu.2402336
   Ward E, 2014, CA CANC J CLIN
   Wilson C, 2012, CANCER TREAT REV, V38, P877, DOI 10.1016/j.ctrv.2012.02.007
   Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031
   YANG L, 2010, J BONE MINER RES, V25, P1701
   Yang W, 2011, ENDOCRIN METAB CLIN, V40, P643, DOI 10.1016/j.ecl.2011.05.001
   Ye XZ, 2010, J GENET GENOMICS, V37, P423, DOI 10.1016/S1673-8527(09)60061-8
NR 203
TC 2
Z9 2
U1 3
U2 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 159
EP 166
DI 10.1016/j.abb.2014.07.013
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300020
PM 25046842
ER

PT J
AU Lee, Y
   Kim, K
   Kang, KT
   Lee, JS
   Yang, SS
   Chung, WH
AF Lee, Yoonna
   Kim, Kangil
   Kang, Kyu-Tae
   Lee, Jong-Soo
   Yang, Sang Sik
   Chung, Woo-Hyun
TI Atmospheric-pressure plasma jet induces DNA double-strand breaks that
   require a Rad51-mediated homologous recombination for repair in
   Saccharomyces cerevisiae
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Plasma jet; Rad51; Double-strand break; Homologous recombination;
   Reactive oxygen species
ID SUPEROXIDE-DISMUTASE MUTANTS; DAMAGE CHECKPOINT; OXIDATIVE STRESS;
   BUDDING YEAST; CANCER CELLS; APOPTOSIS; OXYGEN; MITOCHONDRIA;
   REPLICATION; PROTEIN
AB Non-thermal plasma generated under atmospheric pressure produces a mixture of chemically reactive molecules and has been developed for a number of biomedical applications. Recently, plasma jet has been proposed as novel cancer therapies based on the observation that free radicals generated by plasma jet induce mitochondria-mediated apoptotic cell death. We show here that air plasma jet induces DNA double-strand breaks (DSBs) in yeast chromosomes leading to genomic instability and loss of viability, which are alleviated by Rad51, the yeast homolog of Escherichia coli RecA recombinase, through DNA damage repair by a homologous recombination (HR) process. Hypersensitivity of rad51 mutant to air plasma was not restored by antioxidant treatment unlike sod1 mutant that was highly sensitive to reactive oxygen species (ROS) challenge, suggesting that plasma jet induces DSB-mediated cell death independent of ROS generation. These results may provide a new insight into the mechanism of air plasma jet-induced cell death. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Lee, Yoonna; Kang, Kyu-Tae; Chung, Woo-Hyun] Duksung Womens Univ, Coll Pharm, Seoul 132714, South Korea.
   [Kim, Kangil; Yang, Sang Sik] Ajou Univ, Dept Elect & Comp Engn, Suwon 443749, South Korea.
   [Lee, Jong-Soo] Ajou Univ, Dept Life Sci, Suwon 443749, South Korea.
RP Yang, SS (reprint author), Ajou Univ, Dept Elect & Comp Engn, Suwon 443749, South Korea.
EM ssyang@ajou.ac.kr; whchung23@duksung.ac.kr
FU National Research Foundation of Korea (NRF) - Ministry of Science, ICT
   and Future Planning [2012R1A1A1009917, 2012M3A9B2052872]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Science, ICT and Future Planning (2012R1A1A1009917 (W.H.
   Chung) and 2012M3A9B2052872 (S.S. Yang)).
CR Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064
   Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445
   Mao ZY, 2009, NEOPLASIA, V11, P683, DOI 10.1593/neo.09312
   Oehmigen K, 2010, PLASMA PROCESS POLYM, V7, P250, DOI 10.1002/ppap.200900077
   Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022
   Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4
   Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0
   Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037
   McManus KJ, 2009, P NATL ACAD SCI USA, V106, P3276, DOI 10.1073/pnas.0813414106
   Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899
   Lee K, 2006, J MICROBIOL, V44, P269
   Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023
   Kim K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3555434
   Uhm HS, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4817291
   Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955
   Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298
   Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386
   Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223
   Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964
   Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451
   Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351
   Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757
   Rupf S, 2010, J MED MICROBIOL, V59, P206, DOI 10.1099/jmm.0.013714-0
   Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012
   O'Connell D, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3521502
   Yang J, 2008, FREE RADICAL RES, V42, P492, DOI 10.1080/10715760802112791
   Kim SJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462293
   Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154
   Baik KY, 2013, PLASMA PROCESS POLYM, V10, P235, DOI 10.1002/ppap.201200076
   Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361
   OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314
   SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K
   Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154
   Kim CH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3449575
   Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500
   Choi J, 2010, PLASMA PROCESS POLYM, V7, P258, DOI 10.1002/ppap.200900079
   Spradling A, 2006, GENETICS, V172, P2025
   Longhese MP, 1998, EMBO J, V17, P5525, DOI 10.1093/emboj/17.19.5525
   CHANG EC, 1991, J BIOL CHEM, V266, P4417
   Chang XL, 2013, CHEM-BIOL INTERACT, V206, P248, DOI 10.1016/j.cbi.2013.09.010
   Hensel K, 2007, PLASMA PROCESS POLYM, V4, P682, DOI 10.1002/ppap.200700022
   Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206
   Liang HL, 2009, APOPTOSIS, V14, P1176, DOI 10.1007/s10495-009-0393-z
   Ma RN, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/28/285401
   Motegi A, 2007, METHODS, V41, P168, DOI 10.1016/j.ymeth.2006.07.025
   Nunes E, 1996, RADIAT ENVIRON BIOPH, V35, P55, DOI 10.1007/BF01211243
   Ryu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066231
   SANDSTROM PA, 1994, J LEUKOCYTE BIOL, V55, P221
   AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013
   Simon JA, 2000, CANCER RES, V60, P328
   Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427
   Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200
   WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652
NR 53
TC 2
Z9 2
U1 4
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2014
VL 560
BP 1
EP 9
DI 10.1016/j.abb.2014.07.029
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AP9JG
UT WOS:000342395500001
PM 25086216
ER

PT J
AU Kim, HS
   Kwak, GH
   Lee, K
   Jo, CH
   Hwang, KY
   Kim, HY
AF Kim, Hyun Sook
   Kwak, Geun-Hee
   Lee, Kitaik
   Jo, Chang-Hwa
   Hwang, Kwang Yeon
   Kim, Hwa-Young
TI Structural and biochemical analysis of a type II free
   methionine-R-sulfoxide reductase from Thermoplasma acidophilum
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Methionine sulfoxide reductase; fRMsr; Catalysis; ROS; Resolving Cys;
   Thermoplasma
ID SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; ESCHERICHIA-COLI; GAF
   DOMAIN; OVEREXPRESSION; IDENTIFICATION; RESISTANCE; MECHANISM; ENZYMES;
   SYSTEM
AB Free methionine-R-sulfoxide reductase (fRMsr) enzymes only reduce the free form of methionine-R-sulfoxide and can be grouped into two types with respect to the number of conserved Cys residues in the active sites. In this work, the crystal structures of type II fRMsr from Thermoplasma acidophilum (TafRMsr), which contains two conserved Cys, have been determined in native form and in a complex with the substrate. The overall structure of TafRMsr consists of a central beta-sheet encompassed by a two-alpha-helix bundle flanking on one side and one small alpha-helix on the other side. Based on biochemical and growth complementation assays, Cys(84) is demonstrated to be the catalytic Cys. The data also show that TafRMsr functions as an antioxidant protein. Structural analyses reveal insights into substrate recognition and orientation, conformational changes in the active site during substrate binding, and the role of active site residues in substrate binding. A model for the catalytic mechanism of type II TafRMsr is suggested, in which intramolecular disulfide bond formation is not involved. In addition, the biochemical, enzymatic, and structural properties of type II TafRMsr are compared with those of type I enzymes. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kim, Hyun Sook; Lee, Kitaik; Jo, Chang-Hwa; Hwang, Kwang Yeon] Korea Univ, Coll Life Sci & Biotechnol, Dept Biosyst & Biotechnol, Seoul 136701, South Korea.
   [Kwak, Geun-Hee; Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea.
RP Hwang, KY (reprint author), Korea Univ, Coll Life Sci & Biotechnol, Dept Biosyst & Biotechnol, 145 Anam Ro, Seoul 136701, South Korea.
EM chahong@korea.ac.kr; hykim@ynu.ac.kr
FU National Research Foundation of Korea [2011-0028166, 2013R1A1A2008404]
FX We thank the staff of beamline 5C-SBII at the Pohang Light Source
   (Korea) for technical support, the staff at the Korea Basic Science
   Institute (KBSI, Daejeon, Korea) for the use of a mosquito
   crystallization robot, and the members at beamline BL-17A of the Photon
   Factory for their assistance with data collection (2012G189; Tsukuba,
   Japan). This work was supported by grants from the National Research
   Foundation of Korea (2011-0028166 and 2013R1A1A2008404).
CR Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X
   Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200
   Ko JJ, 2005, PROTEINS, V59, P183, DOI 10.1002/prot.20418
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003
   Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664
   Kantorow M, 2004, P NATL ACAD SCI USA, V101, P9654, DOI 10.1073/pnas.0403532101
   Kim HY, 2013, ANTIOXID REDOX SIGN, V19, P958, DOI 10.1089/ars.2012.5081
   Cabreiro F, 2008, J BIOL CHEM, V283, P16673, DOI 10.1074/jbc.M708580200
   Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200
   Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071
   Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200
   Bong SM, 2010, J BIOL CHEM, V285, P25044, DOI 10.1074/jbc.M110.103119
   Dos Santos CV, 2007, FEBS LETT, V581, P4371, DOI 10.1016/j.febslet.2007.07.081
   Gruez A, 2010, J BIOL CHEM, V285, P25033, DOI 10.1074/jbc.M110.134528
   Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288
   Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101
   Kwak GH, 2009, BMB REP, V42, P113
   Kwak GH, 2010, BIOCHEM BIOPH RES CO, V395, P412, DOI 10.1016/j.bbrc.2010.04.036
   Kwak GH, 2012, ARCH BIOCHEM BIOPHYS, V527, P1, DOI 10.1016/j.abb.2012.07.009
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1
NR 27
TC 0
Z9 0
U1 1
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2014
VL 560
BP 10
EP 19
DI 10.1016/j.abb.2014.07.009
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AP9JG
UT WOS:000342395500002
PM 25043974
ER

PT J
AU Do, QT
   Nguyen, GT
   Celis, V
   Phillips, RS
AF Do, Quang T.
   Nguyen, Giang T.
   Celis, Victor
   Phillips, Robert S.
TI Inhibition of Escherichia coli tryptophan indole-lyase by tryptophan
   homologues
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE L-Homotryptophan; L-Bishomotryptophan; Pyridoxal-5 '-phosphate;
   Steady-state kinetics; Pre-steady-state kinetics
ID TYROSINE PHENOL-LYASE; STOPPED-FLOW SPECTROPHOTOMETRY; BIOFILM
   FORMATION; PROTEUS-VULGARIS; BOND-CLEAVAGE; AMINO-ACIDS; ACTIVE-SITE;
   MECHANISM; ANALOGS; SYNTHASE
AB We have designed, synthesized and evaluated homotryptophan analogues as possible mechanism-based inhibitors for Escherichia colt tryptophan indole-lyase (tryptophanase, TIL, E.C. 4.1.99.1). As a quinonoid structure is an intermediate in the reaction mechanism of TIL, we anticipated that homologation of the physiological substrate, L-Trp would provide analogues resembling the transition state for beta-elimination, and potentially inhibit TIL. Our results demonstrate that L-homotryptophan (1a) is a moderate competitive inhibitor of TIL, with K-i = 67 mu M, whereas L-bishomotryptophan (1b) displays more potent inhibition, with K-i = 4.7 mu M. Pre-steady-state kinetics indicated the formation of an external aldimine and quinonoid with 1a, but only the formation of an external aldimine for 1b, suggesting differences in the inhibition mechanism. These results demonstrate that formation of a quinonoid complex is not required for strong inhibition. In addition, the Trp analogues were evaluated as inhibitors of Salmonella typhimurium Trp synthase. Our results indicate that compound 1b is at least 25-fold more selective toward TIL than Trp synthase. We report that compound 1b is comparable to the most potent inhibitor previously reported, while displaying high selectivity for TIL. Thus, 1b is a potential lead for the development of novel antibacterials. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Do, Quang T.; Nguyen, Giang T.; Celis, Victor; Phillips, Robert S.] Univ Georgia, Dept Chem, Athens, GA 30602 USA.
   [Phillips, Robert S.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.
RP Phillips, RS (reprint author), Univ Georgia, Dept Chem, Athens, GA 30602 USA.
EM plp@uga.edu
CR Milic D, 2011, J AM CHEM SOC, V133, P16468, DOI 10.1021/ja203361g
   Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354
   PHILLIPS RS, 1990, BIOCHEMISTRY-US, V29, P8608, DOI 10.1021/bi00489a016
   WATANABE T, 1977, J BIOCHEM-TOKYO, V82, P733
   Anyanful A, 2005, MOL MICROBIOL, V57, P988, DOI 10.1111/j.1365-2958.2005.04739.x
   Phillips RS, 2003, BBA-PROTEINS PROTEOM, V1647, P167, DOI 10.1016/S1570-9636(03)00089-X
   Chant EL, 2007, MOL MICROBIOL, V63, P35, DOI 10.1111/j.1365-2958.2006.05481.x
   CHENAULT HK, 1989, J AM CHEM SOC, V111, P6354, DOI 10.1021/ja00198a055
   APPEL R, 1975, ANGEW CHEM INT EDIT, V14, P801, DOI 10.1002/anie.197508011
   Goswami K, 2012, TETRAHEDRON, V68, P280, DOI 10.1016/j.tet.2011.10.055
   Vega NM, 2012, NAT CHEM BIOL, V8, P431, DOI [10.1038/nchembio.915, 10.1038/NCHEMBIO.915]
   PHILLIPS RS, 1989, J BIOL CHEM, V264, P10627
   Schramm VL, 1998, ANNU REV BIOCHEM, V67, P693, DOI 10.1146/annurev.biochem.67.1.693
   Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056
   SUELTER CH, 1976, FEBS LETT, V66, P230, DOI 10.1016/0014-5793(76)80510-8
   Ku SY, 2006, ACTA CRYSTALLOGR D, V62, P814, DOI 10.1107/S0907444906019895
   PHILLIPS RS, 1989, ENZYME MICROB TECH, V11, P80, DOI 10.1016/0141-0229(89)90064-1
   Cleland W W, 1979, Methods Enzymol, V63, P103
   Collet A, 2007, ANTON LEEUW INT J G, V91, P71, DOI 10.1007/s10482-006-9097-3
   Davis L., 1972, ENZYMES, V7, P33, DOI 10.1016/S1874-6047(08)60446-1
   Demidkina TV, 2003, BIOCHEMISTRY-US, V42, P11161, DOI 10.1021/bi034348t
   Di Martino P, 2002, CAN J MICROBIOL, V48, P132, DOI 10.1139/W02-001
   Harris AP, 2013, FEBS J, V280, P1807, DOI 10.1111/febs.12205
   Kulikova VV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1181, DOI 10.1023/B:BIRY.0000009131.78603.8b
   Lee JT, 2009, APPL ENVIRON MICROB, V75, P1703, DOI 10.1128/AEM.02081-08
   LEE M, 1995, BIOORGAN MED CHEM, V3, P195, DOI 10.1016/0968-0896(95)00016-A
   LINGENS F, 1963, LIEBIGS ANN CHEM, V662, P139
   Ma CR, 2000, TETRAHEDRON LETT, V41, P2781, DOI 10.1016/S0040-4039(00)00263-X
   Phillips RS, 2000, J AM CHEM SOC, V122, P1008, DOI 10.1021/ja991647q
   PHILLIPS RS, 1985, J BIOL CHEM, V260, P4665
   PHILLIPS RS, 1991, BIOCHEMISTRY-US, V30, P5927, DOI 10.1021/bi00238a017
   PHILLIPS RS, 1991, J BIOL CHEM, V266, P18642
   PHILLIPS RS, 1984, BIOCHEMISTRY-US, V23, P6228, DOI 10.1021/bi00320a052
   PHILLIPS RS, 1990, FEBS LETT, V268, P213, DOI 10.1016/0014-5793(90)81011-C
   PHILLIPS RS, 1987, ARCH BIOCHEM BIOPHYS, V256, P302, DOI 10.1016/0003-9861(87)90450-4
   Scherzer R., 2009, J ENZYM INHIB MED CH, V24, P250
   SNELL EE, 1975, ADV ENZYMOL RAMB, V42, P287
   SNYDER HR, 1948, J AM CHEM SOC, V70, P1962, DOI 10.1021/ja01185a094
   Yang LH, 1996, PROTEIN EXPRES PURIF, V8, P126, DOI 10.1006/prep.1996.0082
NR 39
TC 0
Z9 0
U1 5
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2014
VL 560
BP 20
EP 26
DI 10.1016/j.abb.2014.07.027
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AP9JG
UT WOS:000342395500003
PM 25088962
ER

PT J
AU Pei, Z
   Yang, Y
   Kiess, W
   Sun, CJ
   Luo, FH
AF Pei, Zhou
   Yang, Yi
   Kiess, Wieland
   Sun, Chengjun
   Luo, Feihong
TI Dynamic profile and adipogenic role of growth differentiation factor 5
   (GDF5) in the differentiation of 3T3-L1 preadipocytes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Growth differentiation factor 5; Preadipocytes; Adipocyte;
   Differentiation
ID MITOTIC CLONAL EXPANSION; BROWN ADIPOGENESIS; ENERGY-EXPENDITURE; CDMP1
   GENE; STEM-CELL; MUTATION; OBESITY; HEIGHT; ADIPOCYTE; REGION
AB Adipocyte differentiation is key to determining the number of adipocytes during the development of obesity. Recent studies have shown that growth differentiation factor-5 (GDF5) promotes brown adipogenesis, however its role in white adipogenesis is still uncertain. The aim of the present study was to investigate the effect of GDF5 on white adipogenesis using 3T3-L1 preadipocyte model. In the present study, GDF5 was found to be differentially regulated during adipocyte differentiation. GDF5 protein increased the differentiation of 3T3-L1 preadipocytes, especially when these cells were exposed to hormone cocktails without insulin. During adipogenesis, GDF5 enhanced the expression of genes related to adipocyte differentiation and caused cells to enter the S phase. Short-hairpin-RNA knockdown of GDF5 in 3T3-L1 cells was found to prevent adipogenesis induced by a standard hormone cocktail and to down-regulate the expression of adipocyte genes and proteins, this impairment could be partly rescued by GDF5 protein. Collectively, these results suggest that GDF5 can promote progression of the cell-cycle and increase numbers of cells in S phase, GDF5 might play a critical role in 3T3-L1 preadipocyte differentiation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Pei, Zhou; Sun, Chengjun; Luo, Feihong] Fudan Univ, Childrens Hosp, Dept Pediat Endocrinol & Inherited Metab Dis, Shanghai 200433, Peoples R China.
   [Yang, Yi] Fudan Univ, Childrens Hosp, Inst Pediat, Shanghai 200433, Peoples R China.
   [Kiess, Wieland] Univ Leipzig, Ctr Pediat Res, Hosp Children & Adolescents, Dept Women & Child Hlth, D-04109 Leipzig, Germany.
   [Sun, Chengjun] Karolinska Inst, Dept Med, Stockholm, Sweden.
RP Luo, FH (reprint author), Fudan Univ, Childrens Hosp, Dept Pediat Endocrinol & Inherited Metab Dis, Shanghai 200433, Peoples R China.
EM luofh@fudan.edu.cn
FU Natural Science Foundation of China (NSFC) [81270929]; Science and
   Technology Commission of Shanghai Municipality (STCSM) [12410709700]
FX This work was supported by the Natural Science Foundation of China (NSFC
   81270929) and Science and Technology Commission of Shanghai Municipality
   (STCSM 12410709700).
CR Artaza JN, 2005, ENDOCRINOLOGY, V146, P3547, DOI 10.1210/en.2005-0362
   Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064
   Francis-West PH, 1999, DEVELOPMENT, V126, P1305
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Kiess W, 2008, BEST PRACT RES CL EN, V22, P135, DOI 10.1016/j.beem.2007.10.002
   Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189
   Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221
   Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231
   Hatakeyama Y, 2004, J CELL BIOCHEM, V91, P1204, DOI 10.1002/jcb.20019
   Faiyaz-Ul-Haque M, 2002, CLIN GENET, V61, P454, DOI 10.1034/j.1399-0004.2002.610610.x
   Faiyaz-Ul-Haque M, 2008, J BONE MINER METAB, V26, P648, DOI 10.1007/s00774-008-0853-5
   Hasselbalch AL, 2010, DAN MED BULL, V57
   Hinoi E, 2014, DIABETES, V63, P162, DOI 10.2337/db13-0808
   Johnson LM, 2011, METHODS MOL BIOL, V713, P227, DOI 10.1007/978-1-60327-416-6_17
   Oshin AO, 2007, VET COMP ORTHOPAED, V20, P185, DOI 10.1160/VCOT-07-07-0061
   Park Anna, 2014, World J Stem Cells, V6, P33, DOI 10.4252/wjsc.v6.i1.33
   Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74
   Sottile V, 2000, FEBS LETT, V475, P201, DOI 10.1016/S0014-5793(00)01655-0
   Suto J, 2006, J VET MED SCI, V68, P1121, DOI 10.1292/jvms.68.1121
   Szczaluba K, 2005, AM J MED GENET A, V138A, P379, DOI 10.1002/ajmg.a.30969
   Takahara M, 2004, BONE, V35, P1069, DOI 10.1016/j.bone.2004.06.020
   Vaes RBA, 2009, ANN RHEUM DIS, V68, P1754, DOI 10.1136/ard.2008.099655
   Zamani N., 2010, ENDOCR REV
   Zhao JH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-96
   Zhou P., 2012, CHIN J EVID BASED PE, V07, P274
NR 26
TC 0
Z9 0
U1 1
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2014
VL 560
BP 27
EP 35
DI 10.1016/j.abb.2014.07.025
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AP9JG
UT WOS:000342395500004
PM 25078108
ER

PT J
AU Kim, DI
   Park, MJ
   Lim, SK
   Choi, JH
   Kim, JC
   Han, HJ
   Kundu, TK
   Park, JI
   Yoon, KC
   Park, SW
   Park, JS
   Heo, YR
   Park, SH
AF Kim, Dong-il
   Park, Min-jung
   Lim, Seul-ki
   Choi, Joo-hee
   Kim, Jong-choon
   Han, Ho-jae
   Kundu, Tapas K.
   Park, Jae-il
   Yoon, Kyung-chul
   Park, Sang-woo
   Park, Jong-sung
   Heo, Young-ran
   Park, Soo-hyun
TI High-glucose-induced CARM1 expression regulates apoptosis of human
   retinal pigment epithelial cells via histone 3 arginine 17
   dimethylation: Role in diabetic retinopathy
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Diabetic retinopathy; Protein arginine methyltransferase;
   Coactivator-associated arginine methyltransferase 1; CARM1; Apoptosis;
   Retinal pigment epithelial cells
ID EXTERNAL LIMITING MEMBRANE; IN-VIVO; METHYLATION; METHYLTRANSFERASE-1;
   ASSOCIATION; GENE; H3; INVOLVEMENT; DISRUPTION; ACTIVATION
AB Hyperglycemia-induced apoptosis of retinal pigment epithelial (RPE) cells is considered to be involved in the progression of diabetic retinopathy. Histone arginine methylation catalyzed by protein arginine methyltransferases (PRMTs) has emerged as an important histone modification involved in gene regulation. However, the role of PRMTs in diabetic retinopathy has not been elucidated. Here, we found that expression of coactivator-associated arginine methyltransferase 1 (CARM1; also known as PRMT4) was increased in the high-glucose treated human RPE cell line ARPE-19 and in the RPE layer of streptozotocin-treated rats. In addition, high-glucose induced apoptosis in ARPE-19 cells. To determine the function of CARM1 on RPE cell apoptosis, we performed gain- and loss-of-function studies. CARM1 overexpression increased apoptosis of RPE cells. In contrast, silencing of CARM1 expression by siRNA and pharmacological inhibition of CARM1 activity abolished high-glucose-induced RPE cell apoptosis. Furthermore, we found that inhibition of histone 3 arginine 17 (H3R17) asymmetric dimethylation attenuates both CARM1- and high-glucose-induced apoptosis in RPE cells. Together, these results show that high-glucose-induced CARM1 expression increases RPE cell apoptosis via H3R17 asymmetric dimethylation. Strategies to reduce CARM1 expression or enzymatic activity could be used to prevent apoptosis of RPE cells in the progression of diabetic retinopathy. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kim, Dong-il; Park, Min-jung; Choi, Joo-hee; Kim, Jong-choon; Park, Soo-hyun] Chonnam Natl Univ, Coll Vet Med, Kwangju 500757, South Korea.
   [Lim, Seul-ki] World Inst Kimchi, R&D Div, Metab & Funct Res Grp, Kimchi 503360, South Korea.
   [Han, Ho-jae] Seoul Natl Univ, Coll Vet Med, Seoul 151741, South Korea.
   [Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bangalore 560064, Karnataka, India.
   [Park, Jae-il] Chonnam Natl Univ, Gwangju Ctr, Korea Basic Sci Inst, Kwangju 500757, South Korea.
   [Yoon, Kyung-chul; Park, Sang-woo] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Kwangju 500757, South Korea.
   [Park, Jong-sung] Chonnam Natl Univ, Med Sch & Hosp, Dept Physiol, Kwangju 501757, South Korea.
   [Heo, Young-ran] Chonnam Natl Univ, Dept Food & Nutr, Kwangju 500757, South Korea.
RP Heo, YR (reprint author), Chonnam Natl Univ, Coll Vet Med, Dept Vet Physiol, Biotherapy Human Resources Ctr, Kwangju 500757, South Korea.
EM yrhuh@jnu.ac.kr; parksh@chonnam.ac.kr
FU Forest Science 82 Technology Projects by Korea Forest Service
   [S121313L50100]; Next-Generation Bio-Green 21 Program, Rural Development
   Administration, Republic of Korea [PJ009090]
FX This work was supported by Forest Science 82 Technology Projects
   (Project No. S121313L50100) by Korea Forest Service. This work was also
   supported by a grant from the Next-Generation Bio-Green 21 Program (No.
   PJ009090), Rural Development Administration, Republic of Korea.
CR Kusari J, 2010, INVEST OPHTH VIS SCI, V51, P1044, DOI 10.1167/iovs.08-3293
   Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933
   Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004
   Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200
   Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006
   Yadav N, 2008, EMBO REP, V9, P193, DOI 10.1038/sj.embor.7401151
   Zhong Q, 2013, DIABETES, V62, P2559, DOI 10.2337/db12-1141
   Sharma A, 2008, ARCH BIOCHEM BIOPHYS, V480, P85, DOI 10.1016/j.abb.2008.09.016
   Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409
   Bhattacharya S, 2012, INVEST OPHTH VIS SCI, V53, P8350, DOI 10.1167/iovs.12-10495
   Kim D, 2014, CELL SIGNAL, V26, P1774, DOI 10.1016/j.cellsig.2014.04.008
   Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110
   Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786
   Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b
   Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013
   An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009
   El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103
   Pesonen M, 2012, TOXICOL LETT, V211, P239, DOI 10.1016/j.toxlet.2012.04.002
   Omri S, 2011, AM J PATHOL, V179, P942, DOI 10.1016/j.ajpath.2011.04.018
   Ito S, 2013, BRIT J OPHTHALMOL, V97, P228, DOI 10.1136/bjophthalmol-2011-301418
   Selvi BR, 2010, J BIOL CHEM, V285, P7143, DOI 10.1074/jbc.M109.063933
   Du M, 2013, DIABETOLOGIA, V56, P2318, DOI 10.1007/s00125-013-2986-x
   Jain A, 2013, MOL VIS, V19, P1760
   Jayne S, 2009, J MOL BIOL, V394, P485, DOI 10.1016/j.jmb.2009.09.032
   Krones-Herzig A, 2006, J BIOL CHEM, V281, P3025, DOI 10.1074/jbc.M509770200
   Lee YH, 2011, GENE DEV, V25, P176, DOI 10.1101/gad.1975811
   Lim SK, 2012, J CELL PHYSIOL, V227, P569, DOI 10.1002/jcp.22756
   Majumder S, 2006, PROSTATE, V66, P1292, DOI 10.1002/pros.20438
   Miranda S, 2012, J CELL PHYSIOL, V227, P2352, DOI 10.1002/jcp.22970
   Sawamiphak S, 2010, NAT PROTOC, V5, P1659, DOI 10.1038/nprot.2010.130
   Song MK, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/323784
   Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200
   Westlund B, 2009, APOPTOSIS, V14, P31, DOI 10.1007/s10495-008-0285-7
   Wu CH, 2011, ANTIOXID REDOX SIGN, V14, P353, DOI 10.1089/ars.2010.3134
   Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034692
NR 35
TC 2
Z9 3
U1 1
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2014
VL 560
BP 36
EP 43
DI 10.1016/j.abb.2014.07.021
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AP9JG
UT WOS:000342395500005
PM 25072916
ER

PT J
AU Guo, DD
   Du, YX
   Wu, QX
   Jiang, WJ
   Bi, HS
AF Guo, Dadong
   Du, Yuxiang
   Wu, Qiuxin
   Jiang, Wenjun
   Bi, Hongsheng
TI Disrupted calcium homeostasis is involved in elevated zinc ion-induced
   photoreceptor cell death
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Zinc chloride; Calcium homeostasis; Plasma membrane calcium ATPase;
   Reactive oxygen species; Cell cycle arrest
ID RETINAL GANGLION-CELLS; OXIDE NANOPARTICLES; GENE-EXPRESSION; EXOGENOUS
   ZINC; CANCER-CELLS; ATPASE; DAMAGE; APOPTOSIS; NEURONS; CYTOTOXICITY
AB Zinc (Zn), the second abundant trace element in living organisms, plays an important role in regulating cell metabolism, signaling, proliferation, gene expression and apoptosis. Meanwhile, the overload of Zn will disrupt the intracellular calcium homeostasis via impairing mitochondrial function. However, the specific molecular mechanism underlying zinc-induced calcium regulation remains poorly understood. In the present study, using zinc chloride (ZnCl2) as a stressor, we investigated the effect of exogenous Zn2+ in regulating murine photoreceptor cell viability, reactive oxygen species (ROS), cell cycle distribution and calcium homeostasis as well as plasma membrane calcium ATPase (PMCA) isoforms (PMCA1 and PMCA2, i.e., ATP2B1, ATP2B2) expression. We found that the exogenous Zn2+ in the exposure range (31.25-125.0 mu mol/L) results in the overgeneration of ROS, cell cycle arrest at G(2)/M phases, elevation of cytosolic [Ca2+], inactivation of Ca2+-ATPase and reduction of both PMCA1 and PMCA2 in 661 W cells, and thus induces cell death. In conclusion, ZnCl2 exposure can elevate the cytosolic [Ca2+], disrupt the intracellular calcium homeostasis, further initiate Ca2+-dependent signaling pathway in 661 W cells, and finally cause cell death. Our results will facilitate the understanding of cell death induced by the zinc ion-mediated calcium homeostasis disruption. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Guo, Dadong; Jiang, Wenjun; Bi, Hongsheng] Shandong Univ Tradit Chinese Med, Inst Eye, Key Lab Integrated Tradit Chinese & Western Med P, Shandong Prov Key Lab Integrated Tradit Chinese &, Jinan 250002, Peoples R China.
   [Du, Yuxiang] Shandong Univ Tradit Chinese Med, Jinan 250002, Peoples R China.
   [Wu, Qiuxin] Shandong Univ Tradit Chinese Med, Affiliated Eye Hosp, Jinan 250002, Peoples R China.
RP Bi, HS (reprint author), Shandong Univ Tradit Chinese Med, Inst Eye, Key Lab Integrated Tradit Chinese & Western Med P, Shandong Prov Key Lab Integrated Tradit Chinese &, Jinan 250002, Peoples R China.
EM azuresky1999@163.com
FU Natural Science Foundation of Shandong Province [ZR2010HM032];
   Development Project of Medicine and Health Science Technology of
   Shandong Province [2013WS0251]
FX This work was supported by the Natural Science Foundation of Shandong
   Province (ZR2010HM032) and the Development Project of Medicine and
   Health Science Technology of Shandong Province (2013WS0251).
CR Sargazi M, 2013, J TRACE ELEM MED BIO, V27, P242, DOI 10.1016/j.jtemb.2012.12.004
   Wang DG, 2013, TOXICOL IN VITRO, V27, P2117, DOI 10.1016/j.tiv.2013.09.015
   Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081
   Kozlova E, 2012, ACTA BIOENG BIOMECH, V14, P3
   Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456
   Dalghi MG, 2013, J BIOL CHEM, V288, P23380, DOI 10.1074/jbc.M113.470542
   Gee KR, 2002, J AM CHEM SOC, V124, P776, DOI 10.1021/ja011774y
   Krizaj D, 2002, J COMP NEUROL, V451, P1, DOI 10.1002/cne.10281
   Guo DD, 2013, TOXICOL IN VITRO, V27, P731, DOI 10.1016/j.tiv.2012.12.001
   BOROVANSKY J, 1989, CHEM-BIOL INTERACT, V69, P279, DOI 10.1016/0009-2797(89)90085-9
   Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003
   Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023
   Mato S, 2013, GLIA, V61, P750, DOI 10.1002/glia.22470
   Rink L, 2000, P NUTR SOC, V59, P541, DOI 10.1017/S0029665100000781
   Esterberg R, 2013, J NEUROSCI, V33, P7513, DOI 10.1523/JNEUROSCI.4559-12.2013
   James AM, 2002, J BIOMED SCI, V9, P475, DOI 10.1159/000064721
   Burdette SC, 2003, P NATL ACAD SCI USA, V100, P3605, DOI 10.1073/pnas.0637711100
   Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178
   Sekler I, 2012, GLIA, V60, P843, DOI 10.1002/glia.22286
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Green K, 2004, DIABETES, V53, pS110, DOI 10.2337/diabetes.53.2007.S110
   Baggott RR, 2012, CARCINOGENESIS, V33, P2362, DOI 10.1093/carcin/bgs282
   Bielefeldt K, 1997, AM J PHYSIOL-GASTR L, V272, pG1439
   Boczek T, 2012, CELL CALCIUM, V52, P433, DOI 10.1016/j.ceca.2012.08.002
   Celes MRN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068809
   Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337
   Empson RM, 2013, CEREBELLUM, V12, P667, DOI 10.1007/s12311-013-0472-0
   Garcia-Prieto C, 2013, J BIOL CHEM, V288, P3240, DOI 10.1074/jbc.M112.384776
   Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2
   Gronli O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082793
   Guo DD, 2013, INT J BIOCHEM CELL B, V45, P1849, DOI 10.1016/j.biocel.2013.06.002
   Guo DD, 2013, J NANOSCI NANOTECHNO, V13, P3769, DOI 10.1166/jnn.2013.7169
   Hara H, 2013, BIOL PHARM BULL, V36, P585
   Hillman DE, 1996, NEUROSCIENCE, V72, P315, DOI 10.1016/0306-4522(95)00518-8
   Inigo-Figueroa G, 2013, NUTRIENTS, V5, P3447, DOI 10.3390/nu5093447
   Li X., 2013, PLOS ONE, V8, P83638
   Maret W, 2013, BIOMETALS, V26, P197, DOI 10.1007/s10534-013-9613-7
   Martin JL, 2006, CELL CALCIUM, V40, P393, DOI 10.1016/j.ceca.2006.04.008
   Muylle FAR, 2006, BIOMETALS, V19, P437, DOI 10.1007/s10534-005-4576-y
   Nriagu J., 2007, ZINC TOXICITY HUMANS
   OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038
   Ostan R, 2006, BIOGERONTOLOGY, V7, P437, DOI 10.1007/s10522-006-9059-1
   Qadir M Imran, 2013, World J Clin Cases, V1, P140, DOI 10.12998/wjcc.v1.i4.140
   Rocha A.G., 2013, BIOCH J
   Roome CJ, 2010, METHODS MOL BIOL, V637, P343, DOI 10.1007/978-1-60761-700-6_19
   Sadli N, 2013, CELL PHYSIOL BIOCHEM, V32, P243, DOI 10.1159/000354433
   Srivastava SK, 1997, INVEST OPHTH VIS SCI, V38, P2300
   Stroh S., 2013, PLOS ONE, V8, P83076
   Tachibana T, 2004, MOL BRAIN RES, V131, P26, DOI 10.1016/j.molbrainres.2004.08.001
   Tellis M, 2013, AQUAT TOXICOL, V146, P220
   VALLEE BL, 1983, J INHERIT METAB DIS, V6, P31, DOI 10.1007/BF01811320
   Wang YH, 2013, BIOL TRACE ELEM RES, V154, P418, DOI 10.1007/s12011-013-9737-1
   Wu QX, 2013, MOL CELL BIOCHEM, V382, P263, DOI 10.1007/s11010-013-1743-2
   Yuan N, 2012, BIOSCI BIOTECH BIOCH, V76, P2014, DOI 10.1271/bbb.120216
   Zaidi A, 1999, FREE RADICAL BIO MED, V27, P810, DOI 10.1016/S0891-5849(99)00128-8
   Zaidi A, 2009, FREE RADICAL BIO MED, V47, P1507, DOI 10.1016/j.freeradbiomed.2009.08.018
   Zheng J, 2012, CELL PHYSIOL BIOCHEM, V29, P181, DOI 10.1159/000337599
NR 57
TC 1
Z9 1
U1 8
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2014
VL 560
BP 44
EP 51
DI 10.1016/j.abb.2014.07.014
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AP9JG
UT WOS:000342395500006
PM 25051343
ER

PT J
AU Dhayan, H
   Baydoun, AR
   Kukol, A
AF Dhayan, Hansraj
   Baydoun, Anwar R.
   Kukol, Andreas
TI G-quadruplex formation of FXYD1 pre-mRNA indicates the possibility of
   regulating expression of its protein product
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE G-quadruplex; Pre-mRNA; Splicing; Sodium-pump; Fluorescence;
   Bioinformatics
ID SODIUM-POTASSIUM PUMP; CARDIAC NA/K ATPASE; TRANSLATION REGULATION;
   NUCLEOTIDE-SEQUENCES; CRYSTAL-STRUCTURE; DOWN-REGULATION; HUMAN
   TELOMERE; PHOSPHOLEMMAN; DNA; PHOSPHORYLATION
AB G-quadruplexes are higher-order nucleic acid structures formed of square-planar arrangements of four guanine bases held together by Hoogsteen-type hydrogen bonds. Stacks of guanine tetrads are stabilised by intercalating potassium ions. FXYD1 encodes for phospholemman, a regulatory subunit of the cardiac Na+/K+-ATPase. Computational sequence analysis of FXYD1 pre-mRNA predicted the formation of stable intramolecular G-quadruplexes in human and orthologue sequences. Multiple sequence alignment indicated that G-rich sequences are conserved in evolution suggesting a potential role of G-quadruplexes in FXYD1 gene expression. The existence of a non-functional alternative splicing product indicated that the G-quadruplex formation may control alternative splicing. Quadruplex formation of human and bovine oligonucleotides was confirmed in vitro by native polyacrylamide gel electrophoresis and intrinsic fluorescence emission spectroscopy. Taking together the evolutionary conservation of G-quadruplex forming sequences with the confirmation of G-quadruplex formation in vitro by two FXYD1 homologues the results point to a potential role of these structures in regulating the expression of FXYD1 and thus regulate indirectly the activity of the cardiac Na+/K+-ATPase. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Dhayan, Hansraj; Baydoun, Anwar R.; Kukol, Andreas] Univ Hertfordshire, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England.
RP Kukol, A (reprint author), Univ Hertfordshire, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England.
EM a.kukol@herts.ac.uk
FU School of Life and Medical Sciences at the University of Hertfordshire,
   United Kingdom
FX This work was partially funded by the School of Life and Medical
   Sciences at the University of Hertfordshire, United Kingdom.
CR Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   Bryan TM, 2011, MOL BIOTECHNOL, V49, P198, DOI 10.1007/s12033-011-9395-5
   Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511
   Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253
   Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005
   Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088
   Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236
   GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013
   GRAY NK, 1994, EMBO J, V13, P3882
   Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b
   Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557
   Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068
   Kwok CK, 2013, BIOCHEMISTRY-US, V52, P3019, DOI 10.1021/bi400139e
   Menendez C, 2012, NUCLEIC ACIDS RES, V40, pW96, DOI 10.1093/nar/gks422
   Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864
   Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939
   Gomez D, 2004, NUCLEIC ACIDS RES, V32, P371, DOI 10.1093/nar/gkh181
   Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103
   Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5
   van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4
   Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253
   Lim KW, 2009, NUCLEIC ACIDS RES, V37, P6239, DOI 10.1093/nar/gkp630
   Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419
   WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7
   Beevers AJ, 2007, J BIOL CHEM, V282, P32742, DOI 10.1074/jbc.M703676200
   Beevers AJ, 2006, PROTEIN SCI, V15, P1127, DOI 10.1110/ps.051899406
   Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200
   Cheung JY, 2010, CTS-CLIN TRANSL SCI, V3, P189, DOI 10.1111/j.1752-8062.2010.00213.x
   Franceschin M, 2009, EUR J ORG CHEM, P2225, DOI 10.1002/ejoc.200801196
   Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje
   Huppert JL, 2007, PHILOS T R SOC A, V365, P2969, DOI 10.1098/rsta.2007.0011
   Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x
   Lorenz R., 2013, IEEE ACM T COMPUT BI, P832
   Lorenz R., 2011, ALGORITHM MOL BIOL, V6
   Moon IK, 2007, FRONT BIOSCI, V12, P4595, DOI 10.2741/2412
   Nguyen Thuan D., 2011, FEBS LETT, V585, P3969
   Onyshchenko MI, 2009, NUCLEIC ACIDS RES, V37, P7570, DOI 10.1093/nar/gkp840
   SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0
   Shattock MJ, 2009, CURR OPIN PHARMACOL, V9, P160, DOI 10.1016/j.coph.2008.12.015
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036
NR 41
TC 1
Z9 1
U1 2
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2014
VL 560
BP 52
EP 58
DI 10.1016/j.abb.2014.07.016
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AP9JG
UT WOS:000342395500007
PM 25051342
ER

PT J
AU Oenarto, J
   Gorg, B
   Moos, M
   Bidmon, HJ
   Haussinger, D
AF Oenarto, Jessica
   Goerg, Boris
   Moos, Michael
   Bidmon, Hans Juergen
   Haeussinger, Dieter
TI Expression of organic osmolyte transporters in cultured rat astrocytes
   and rat and human cerebral cortex
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Osmolyte transporter; Hepatic encephalopathy; Astrocytes; Ammonia
ID MACROPHAGES KUPFFER CELLS; BRAIN IN-VIVO; NF-KAPPA-B;
   HEPATIC-ENCEPHALOPATHY; OXIDATIVE STRESS; RESONANCE SPECTROSCOPY; MOUSE
   MACROPHAGES; AMMONIA TOXICITY; GENE-EXPRESSION; MYOINOSITOL
AB This study characterizes the expression of the osmolyte transporters betaine/gamma-amino-n-butyric acid (GABA) transporter (BGT-1), the taurine transporter (TauT) and the sodium-dependent myo-inositol transporter (SMIT) in various rat brain cells in culture and in rat and human cerebral cortex in situ. Osmolyte transporter expression greatly differed between cultured brain cells with highest mRNA expression levels for SMIT in astrocytes and TauT in neurons. BGT-1 mRNA and protein were expressed in microglia but not in astrocytes and neurons. In rat and human cerebral cortex, SMIT was expressed in astrocytes and TauT was found in neurons. Osmolyte transporter expression was subject to regulation by factors relevant for hepatic encephalopathy (HE). Hypoosmolarity, NH4Cl (0.5-5 mmol/l), diazepam (10 mu mol/l) and TNF alpha (10 ng/ml) time-dependently decreased mRNA expression of SMIT and/or TauT in cultured astrocytes. NH4Cl-induced SMIT/TauT mRNA expression changes were sensitive to inhibitors of glutamine synthetase and NADPH oxidase. In rat cerebral cortex, SMIT mRNA expression decreased after portal vein ligation or ammonium acetate injection probably due to astrocyte swelling in these HE animal models. It is concluded that osmolyte transporters are heterogeneously expressed in brain and are subject to regulation by HE-relevant factors. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Oenarto, Jessica; Goerg, Boris; Moos, Michael; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany.
   [Bidmon, Hans Juergen] Univ Dusseldorf, C&O Vogt Inst Brain Res, Dusseldorf, Germany.
RP Haussinger, D (reprint author), Univ Klinikum Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM haeussin@uni-duesseldorf.de
OI Oenarto, Jessica/0000-0001-6769-4201
FU Deutsche Forschungsgemeinschaft through Collaborative Research Center
   "Communication and Systems Relevance in Liver Injury and Regeneration"
   [SFB 974]
FX This study was supported by Deutsche Forschungsgemeinschaft through
   Collaborative Research Center SFB 974 "Communication and Systems
   Relevance in Liver Injury and Regeneration" (Dusseldorf). Expert
   technical assistance of Lilia Igdalova, Torsten Janssen, Ursula Kristek
   and Brigida Ziegler is gratefully acknowledged.
CR ALBRECHT J, 1994, BRAIN RES, V660, P288, DOI 10.1016/0006-8993(94)91301-3
   Butz M, 2013, ARCH BIOCHEM BIOPHYS, V536, P197, DOI 10.1016/j.abb.2013.04.004
   Lachmann V, 2013, ARCH BIOCHEM BIOPHYS, V536, P143, DOI 10.1016/j.abb.2013.05.004
   Haussinger D, 2008, GUT, V57, P1156, DOI 10.1136/gut.2007.122176
   Zemtsova I, 2011, HEPATOLOGY, V54, P204, DOI 10.1002/hep.24326
   MULLER HW, 1984, P NATL ACAD SCI-BIOL, V81, P1248, DOI 10.1073/pnas.81.4.1248
   Schliess F, 2007, FEBS J, V274, P5799, DOI 10.1111/j.1742-4658.2007-06100-x
   Gines P, 2008, HEPATOLOGY, V48, P1002, DOI 10.1002/hep.22418
   Haussinger D, 2000, J HEPATOL, V32, P1035, DOI 10.1016/S0168-8278(00)80110-5
   CHOJKIER M, 1981, AM J PHYSIOL, V240, pG371
   Pow DV, 2002, GLIA, V37, P153, DOI 10.1002/glia.10026
   Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730
   Cheong SH, 2013, ADV EXP MED BIOL, V776, P167, DOI 10.1007/978-1-4614-6093-0_17
   Lang F, 1998, PHYSIOL REV, V78, P247
   Schliess F, 1996, BIOCHEM J, V320, P167
   Gorg B, 2008, HEPATOLOGY, V48, P567, DOI 10.1002/hep.22345
   Coupland NJ, 2005, BIOL PSYCHIAT, V57, P1526, DOI 10.1016/j.biopsych.2005.02.027
   Shah NJ, 2008, NEUROIMAGE, V41, P706, DOI 10.1016/j.neuroimage.2008.02.057
   Nishimura T, 2010, PLACENTA, V31, P1003, DOI 10.1016/j.placenta.2010.08.003
   HAUSSINGER D, 1994, GASTROENTEROLOGY, V107, P1475
   Zhou Y, 2012, AM J PHYSIOL-RENAL, V302, pF316, DOI 10.1152/ajprenal.00464.2011
   Reinehr R, 2007, GLIA, V55, P758, DOI 10.1002/glia.20504
   Kumar R, 2009, ARCH BIOCHEM BIOPHYS, V491, P1, DOI 10.1016/j.abb.2009.09.007
   Gorg B, 2013, HEPATOLOGY, V57, P2436, DOI 10.1002/hep.26265
   Gorg B, 2013, ARCH BIOCHEM BIOPHYS, V536, P158, DOI 10.1016/j.abb.2013.03.010
   STRANGE K, 1994, GLIA, V12, P35, DOI 10.1002/glia.440120105
   Beetsch JW, 1996, BBA-GEN SUBJECTS, V1290, P141, DOI 10.1016/0304-4165(96)00011-6
   BERRY GT, 1995, GENOMICS, V25, P507, DOI 10.1016/0888-7543(95)80052-N
   Bitoun M, 2000, GLIA, V32, P165, DOI 10.1002/1098-1136(200011)32:2<165::AID-GLIA60>3.0.CO;2-2
   Chang RCC, 2001, NEUROCHEM INT, V38, P249, DOI 10.1016/S0197-0186(00)00082-6
   Cordoba J, 1996, HEPATOLOGY, V24, P919, DOI 10.1002/hep.510240427
   Denkert C, 1998, ARCH BIOCHEM BIOPHYS, V354, P172, DOI 10.1006/abbi.1998.0661
   Haussinger D, 2007, METHOD ENZYMOL, V428, P1
   ISAACKS RE, 1994, NEUROCHEM RES, V19, P331, DOI 10.1007/BF00971582
   Isaacks RE, 1999, NEUROCHEM RES, V24, P51, DOI 10.1023/A:1020928029845
   Jayakumar AR, 2004, GLIA, V46, P296, DOI 10.1002/glia.20003
   Koops A, 1996, MOL BRAIN RES, V41, P65, DOI 10.1016/0169-328X(96)00067-8
   Kruczek C, 2009, GLIA, V57, P79, DOI 10.1002/glia.20737
   MATTHIESSEN HP, 1989, GLIA, V2, P177, DOI 10.1002/glia.440020307
   Mongin AA, 2001, PATHOPHYSIOLOGY, V8, P77, DOI 10.1016/S0928-4680(01)00074-8
   MORAN J, 1994, NEUROCHEM RES, V19, P415, DOI 10.1007/BF00967318
   Nagaraja TN, 1998, AM J PHYSIOL-CELL PH, V274, pC883
   Pasantes Morales H, 1988, J NEUROSCI RES, V20, P503
   Rao KVR, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-66
   Roychoudhury A, 2013, BIOL CHEM, V394, P1465, DOI 10.1515/hsz-2013-0173
   Schliess F, 2002, FASEB J, V16, P739, DOI 10.1096/fj.01-0862fje
   Schliess F, 2006, BIOL CHEM, V387, P1363, DOI 10.1515/BC.2006.171
   Sinke AP, 2008, J NEUROCHEM, V106, P2302, DOI 10.1111/j.1471-4159.2008.05549.x
   TAKAHASHI H, 1991, AM J PHYSIOL, V261, pH825
   Warskulat U, 2002, GLIA, V40, P324, DOI 10.1002/glia.10128
   Warskulat U, 1995, FEBS LETT, V377, P47, DOI 10.1016/0014-5793(95)01317-2
   Warskulat U, 1996, FEBS LETT, V391, P287, DOI 10.1016/0014-5793(96)00753-3
   Yorek MA, 2000, AM J PHYSIOL-CELL PH, V278, pC1011
   Zhang F, 1996, GASTROENTEROLOGY, V110, P1543, DOI 10.1053/gast.1996.v110.pm8613062
   Zwingmann C, 2005, NEUROCHEM INT, V47, P39, DOI 10.1016/j.neuint.2005.04.005
NR 55
TC 0
Z9 0
U1 3
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2014
VL 560
BP 59
EP 72
DI 10.1016/j.abb.2014.06.024
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AP9JG
UT WOS:000342395500008
PM 25004465
ER

PT J
AU Catto, M
   Arnesano, F
   Palazzo, G
   De Stradis, A
   Calo, V
   Losacco, M
   Purgatorio, R
   Campagna, F
AF Catto, Marco
   Arnesano, Fabio
   Palazzo, Gerardo
   De Stradis, Angelo
   Calo, Vincenza
   Losacco, Maurizio
   Purgatorio, Rosa
   Campagna, Francesco
TI Investigation on the influence of
   (Z)-3-(2-(3-chlorophenyl)hydrazono)-5,6-dihydroxyindolin-2-one (PT2) on
   beta-amyloid(1-40) aggregation and toxicity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Alzheimer's disease; beta-Amyloid aggregation inhibitors; Dynamic light
   scattering; Heteronuclear single quantum coherence; NMR; Multi-target
   activity; Indolin-2-ones
ID SMALL-MOLECULE INHIBITORS; BETA-AMYLOID AGGREGATION; BIOLOGICAL
   EVALUATION; ALZHEIMERS-DISEASE; PEPTIDE 1-42; IN-VITRO; PROTEIN;
   FIBRILS; DESIGN; OLIGOMERIZATION
AB In Alzheimer's disease (AD), native A beta protein monomers aggregate through the formation of a variety of water-soluble, toxic oligomers, ultimately leading to insoluble fibrillar deposits. The inhibition of oligomers formation and/or their dissociation into non-toxic monomers, are considered an attractive strategy for the prevention and treatment of AD. A number of studies have demonstrated that small molecules, containing single or multiple (hetero)aromatic rings, can inhibit protein aggregation, being potentially effective in AD treatment.
   Starting from previously reported data on the antiamyloidogenic activity of a series of 3-hydrazonoindolinones, compound PT2 was selected to deeply investigate the inhibitory mechanism in the A beta aggregation cascade. We compared data from DLS, NMR, CD, TEM and ThT fluorescence measures to ascertain the interactions with amyloidogenic species formed in vitro during the aggregation process, and confirmed this feature with cell viability tests on HeLa cultured cells. PT2 was effective in disrupting toxic oligomers and mature amyloid fibrils, stabilizing A beta as non-toxic, beta-sheet arranged, ThT-insensitive protofilaments. It also strongly reduced cellular toxicity caused by A beta and showed good antioxidant properties in two radical scavenging tests. Taken together, these data confirmed that PT2 is a small molecule inhibitor of A beta oligomerization and toxicity, displaying also additional activity as antioxidant. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Catto, Marco; Campagna, Francesco] Univ Bari Aldo Moro, Dipartimento Farm Sci Farm, I-70125 Bari, Italy.
   [Arnesano, Fabio; Palazzo, Gerardo; Calo, Vincenza; Losacco, Maurizio] Univ Bari Aldo Moro, Dipartimento Chim, I-70125 Bari, Italy.
   [De Stradis, Angelo] Univ Bari Aldo Moro, CNR, Ist Virol Vegetale, I-70126 Bari, Italy.
   [Purgatorio, Rosa] Columbia Univ, Taub Inst, New York, NY 10032 USA.
RP Campagna, F (reprint author), Univ Bari Aldo Moro, Dipartimento Farm Sci Farm, Via E Orabona 4, I-70125 Bari, Italy.
EM francesco.campagna@uniba.it
RI Palazzo, Gerardo/G-9030-2011; 
OI Palazzo, Gerardo/0000-0001-5504-2177; Arnesano,
   Fabio/0000-0002-8399-0964; ANGELO, DE STRADIS/0000-0003-1624-2365
FU University of Bari; Consorzio Interuniversitario di Ricerca in Chimica
   dei Metalli nei Sistemi Biologici (CIRCMSB); Italian Ministero
   dell'Universita e della Ricerca [PRIN 2010M2JARJ]; Compagnia di San
   Paolo (Programma Neuroscienze) [2008.2510]
FX Authors thank the University of Bari, the Consorzio Interuniversitario
   di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCMSB), the
   Italian Ministero dell'Universita e della Ricerca (PRIN 2010M2JARJ), and
   Compagnia di San Paolo (Programma Neuroscienze 2008.2510) for financial
   support.
CR Fukuda T, 2010, BIOCONJUGATE CHEM, V21, P1079, DOI 10.1021/bc100053x
   Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200
   Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q
   LEVINE H, 1995, NEUROBIOL AGING, V16, P755, DOI 10.1016/0197-4580(95)00052-G
   Cellamare S, 2008, BIOORGAN MED CHEM, V16, P4810, DOI 10.1016/j.bmc.2008.03.052
   [Anonymous], 2007, ZET NAN MAN 0 317
   PIKE CJ, 1995, J BIOL CHEM, V270, P23895
   Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001
   Costantino L, 2012, CURR MED CHEM, V19, P3353
   Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200
   Campagna F, 2011, EUR J MED CHEM, V46, P275, DOI 10.1016/j.ejmech.2010.11.015
   VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084
   Yamaguchi T, 2011, FEBS LETT, V585, P1097, DOI 10.1016/j.febslet.2011.03.014
   Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499
   Catto M, 2010, EUR J MED CHEM, V45, P1359, DOI 10.1016/j.ejmech.2009.12.029
   Sakono M, 2013, BIOCHEM BIOPH RES CO, V430, P1259, DOI 10.1016/j.bbrc.2012.12.059
   Grosso C, 2013, CURR MED CHEM, V20, P4694
   Wahlstrom A, 2008, FEBS J, V275, P5117, DOI 10.1111/j.1742-4658.2008.06643.x
   Bitan Gal, 2005, Methods Mol Biol, V299, P3
   Catto M, 2012, EUR J MED CHEM, V58, P84, DOI 10.1016/j.ejmech.2012.10.003
   Cesari I, 2013, J ETHNOPHARMACOL, V146, P264, DOI 10.1016/j.jep.2012.12.041
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Levine H, 2007, AMYLOID, V14, P185, DOI 10.1080/13506120701461020
   Lopez LC, 2012, J MED CHEM, V55, P9521, DOI 10.1021/jm301186p
   Nishimura S, 2003, PHARMACOL TOXICOL, V93, P29, DOI 10.1034/j.1600-0773.2003.930104.x
   Palazzo G., 2014, COLLOIDAL FDN NANOSC, P199
   Peters R, 1998, ACTA CRYSTALLOGR D, V54, P873, DOI 10.1107/S0907444998002455
NR 29
TC 1
Z9 3
U1 1
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2014
VL 560
BP 73
EP 82
DI 10.1016/j.abb.2014.07.015
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AP9JG
UT WOS:000342395500009
PM 25051344
ER

PT J
AU Pivato, M
   Fabrega-Prats, M
   Masi, A
AF Pivato, Micaela
   Fabrega-Prats, Marta
   Masi, Antonio
TI Low-molecular-weight thiols in plants: Functional and analytical
   implications
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Cysteine; Glutathione; Redox; Sulfur; Thiolation; Thiols
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; ALPHA-LIPOIC ACID;
   GAMMA-GLUTAMYL-TRANSFERASE; LASER-INDUCED FLUORESCENCE; ACYL CARRIER
   PROTEIN; MASS-SPECTROMETRY; METHIONINE BIOSYNTHESIS;
   ARABIDOPSIS-THALIANA; S-GLUTATHIONYLATION; SULFHYDRYL-GROUPS
AB Low-molecular-weight (LMW) thiols are a class of highly reactive compounds massively involved in the maintenance of cellular redox homeostasis. They are implicated in plant responses to almost all stress factors, as well as in the regulation of cellular metabolism. The most studied LMW thiols are glutathione and its biosynthetically related compounds (cysteine, gamma-glutamylcysteine, cysteinylglycine, and phytochelatins). Other LMW thiols are described in the literature, such as thiocysteine, cysteamine, homocysteine, lipoic acid, and many species-specific volatile thiols. Here, we review the known LMW thiols in plants, briefly describing their physico-chemical properties, their relevance in post-translational protein modification, and recently-developed thiol detection methods. Current research points to a huge thiol biodiversity in plants and many species-specific and organ-specific thiols remain to be identified. Recent advances in technology should help researchers in this very challenging task, helping us to decipher the roles of thiols in plant metabolism. (C) 2014 Published by Elsevier Inc.
C1 [Pivato, Micaela; Fabrega-Prats, Marta; Masi, Antonio] Univ Padua, DAFNAE, I-35020 Legnaro, PD, Italy.
RP Masi, A (reprint author), Univ Padua, DAFNAE, Viale Univ 16, I-35020 Legnaro, PD, Italy.
EM antonio.masi@unipd.it
FU Cariparo PhD grant (Fondazione Cassa di Risparmio di Padova e Rovigo),
   Micaela Pivato; University of Padova-Italy grant
FX The Authors wish to thank Dr. Dinesh Prasad for critically reading the
   manuscript and providing advice, Dr. Anna Rita Trentin for technical
   support, and Frances Coburn for English grammar and style revision.
   Marta Fabrega-Prats was founded by the Cariparo PhD grant (Fondazione
   Cassa di Risparmio di Padova e Rovigo), Micaela Pivato by a University
   of Padova-Italy grant.
CR Akasaka K., 1986, ANAL SCI, V2, P443, DOI 10.2116/analsci.2.443
   Amarnath V, 2002, TALANTA, V56, P745, DOI 10.1016/S0039-9140(01)00631-2
   El-Zohri MHA, 2005, ANAL BIOANAL CHEM, V382, P1871, DOI 10.1007/s00216-005-3331-0
   Benkova B, 2008, J CHROMATOGR B, V870, P103, DOI 10.1016/j.jchromb.2008.06.015
   Reddy PY, 1998, SYNTHESIS-STUTTGART, P999
   Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200
   KLAPHECK S, 1988, PHYSIOL PLANTARUM, V74, P733, DOI 10.1111/j.1399-3054.1988.tb02045.x
   Glaser K, 2014, PLANT J, V77, P31, DOI 10.1111/tpj.12359
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141
   Satoh S, 2008, ANAL CHIM ACTA, V618, P210, DOI 10.1016/j.aca.2008.05.001
   Noctor G, 2002, J EXP BOT, V53, P1283, DOI 10.1093/jexbot/53.372.1283
   [Anonymous], 2010, EFSA J, V8, P1337
   Moini H, 2002, TOXICOL APPL PHARM, V182, P84, DOI 10.1006/taap.2002.9437
   Rebeille F, 2006, P NATL ACAD SCI USA, V103, P15687, DOI 10.1073/pnas.0606195103
   GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674
   Lindorff-Larsen K, 2000, ANAL BIOCHEM, V286, P308, DOI 10.1006/abio.2000.4807
   Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811
   Bindoli A, 2008, ANTIOXID REDOX SIGN, V10, P1549, DOI 10.1089/ars.2008.2063
   Wang H, 2004, ANAL CHIM ACTA, V512, P281, DOI 10.1016/j.aca.2004.03.002
   Hinterholzer A, 1998, FLAVOUR FRAG J, V13, P49, DOI 10.1002/(SICI)1099-1026(199801/02)13:1<49::AID-FFJ691>3.3.CO;2-J
   Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010
   Geu-Flores F, 2011, PLANT CELL, V23, P2456, DOI 10.1105/tpc.111.083998
   Roland A, 2011, CHEM REV, V111, P7355, DOI 10.1021/cr100205b
   REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9
   Olm E, 2009, P NATL ACAD SCI USA, V106, P11400, DOI 10.1073/pnas.0902204106
   Tausz M, 2004, J EXP BOT, V55, P1955, DOI 10.1093/jxb/erh194
   Pal R, 2010, APPL BIOCHEM BIOTECH, V160, P945, DOI 10.1007/s12010-009-8565-4
   Ruseva S, 2014, FOOD ANAL METHOD, V7, P865, DOI 10.1007/s12161-013-9693-6
   Spadaro D, 2010, PHYSIOL PLANTARUM, V138, P360, DOI 10.1111/j.1399-3054.2009.01307.x
   Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805
   Hesse H, 2004, J EXP BOT, V55, P1799, DOI 10.1093/jxb/erh139
   Guan XM, 2003, J PHARMACEUT BIOMED, V31, P251, DOI 10.1016/S0731-7085(02)00594-0
   MILLER SL, 1993, J MOL EVOL, V36, P302
   Navari-Izzo F, 2002, PLANT PHYSIOL BIOCH, V40, P463, DOI 10.1016/S0981-9428(02)01407-9
   Haugaard N, 2000, ANN NY ACAD SCI, V899, P148
   Starkenmann C, 2008, FLAVOUR FRAG J, V23, P369, DOI 10.1002/ffj.1907
   Hortin GL, 2006, CLIN CHEM, V52, P2258, DOI 10.1373/clinchem.2006.074302
   Ansong C, 2013, P NATL ACAD SCI USA, V110, P10153, DOI 10.1073/pnas.1221210110
   Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200
   El Msehli S, 2011, NEW PHYTOL, V192, P496, DOI 10.1111/j.1469-8137.2011.03810.x
   Tolin S, 2013, PROTEOMICS, V13, P2031, DOI 10.1002/pmic.201200479
   Durrani AI, 2007, J PHARMACEUT BIOMED, V45, P694, DOI 10.1016/j.jpba.2007.08.003
   Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623
   Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007
   Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046
   Ogawa K, 2005, ANTIOXID REDOX SIGN, V7, P973, DOI 10.1089/ars.2005.7.973
   Winther JR, 2014, BBA-GEN SUBJECTS, V1840, P838, DOI 10.1016/j.bbagen.2013.03.031
   Kand'ar R, 2007, J PHARMACEUT BIOMED, V43, P1382, DOI 10.1016/j.jpba.2006.11.028
   Chen X, 2010, CHEM SOC REV, V39, P2120, DOI 10.1039/b925092a
   Petraglia A, 2014, J EXP BOT, V65, P1153, DOI 10.1093/jxb/ert472
   Liang SC, 2005, ANAL BIOANAL CHEM, V381, P1095, DOI 10.1007/s00216-004-3006-2
   Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014
   Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609
   Diopan V, 2010, ELECTROANAL, V22, P1248, DOI 10.1002/elan.200900374
   Rafii M, 2007, ANAL BIOCHEM, V371, P71, DOI 10.1016/j.ab.2007.07.026
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   Saito K, 2004, PLANT PHYSIOL, V136, P2443, DOI 10.1104/pp.10.1104.046755
   Brzezinski K, 2008, ACTA CRYSTALLOGR F, V64, P671, DOI 10.1107/S1744309108017703
   Yasuno R, 2002, FEBS LETT, V517, P110, DOI 10.1016/S0014-5793(02)02589-9
   Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002
   Sgherri C, 2002, PLANT PHYSIOL BIOCH, V40, P591, DOI 10.1016/S0981-9428(02)01421-3
   Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x
   Potesil D, 2005, J CHROMATOGR A, V1084, P134, DOI 10.1016/j.chroma.2005.06.019
   Goraca A, 2011, PHARMACOL REP, V63, P849
   Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105
   Toyo'oka T, 2009, J CHROMATOGR B, V877, P3318, DOI 10.1016/j.jchromb.2009.03.034
   Kaniowska E, 1998, J CHROMATOGR A, V798, P27, DOI 10.1016/S0021-9673(97)01193-X
   Wood BA, 2012, ANAL BIOANAL CHEM, V402, P3299, DOI 10.1007/s00216-011-5649-0
   Hansen RE, 2009, ANAL BIOCHEM, V394, P147, DOI 10.1016/j.ab.2009.07.051
   Leustek T, 1999, PLANT PHYSIOL, V120, P637, DOI 10.1104/pp.120.3.637
   REED LJ, 1951, SCIENCE, V114, P93, DOI 10.1126/science.114.2952.93
   Lu C, 2007, J CHROMATOGR A, V1163, P328, DOI 10.1016/j.chroma.2007.07.045
   Su TB, 2011, PLANT CELL, V23, P364, DOI 10.1105/tpc.110.079145
   ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399
   Peng HJ, 2012, SENSORS-BASEL, V12, P15907, DOI 10.3390/s121115907
   Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249
   Jacob C, 2003, ANGEW CHEM INT EDIT, V42, P4742, DOI 10.1002/anie.200300573
   Yarmolinsky D, 2013, PLANT PHYSIOL, V161, P725, DOI 10.1104/pp.112.207712
   MEISTER A, 1988, J BIOL CHEM, V263, P17205
   Zagorchev L, 2013, INT J MOL SCI, V14, P7405, DOI 10.3390/ijms14047405
   Rhazi L, 2003, PLANT PHYSIOL BIOCH, V41, P895, DOI 10.1016/S0981-9428(03)00134-7
   SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945
   Bilska A, 2005, PHARMACOL REP, V57, P570
   ATTIEH JM, 1995, J BIOL CHEM, V270, P9250
   Bald E, 2001, J LIQ CHROMATOGR R T, V24, P1323, DOI 10.1081/JLC-100103450
   Baldacci-Cresp F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002471
   Bashir H, 2013, ENVIRON EXP BOT, V94, P19, DOI 10.1016/j.envexpbot.2012.05.004
   BELFAIZA J, 1986, P NATL ACAD SCI USA, V83, P867, DOI 10.1073/pnas.83.4.867
   BERGMANN L, 1993, SULFUR NUTRITION AND ASSIMILATION IN HIGHER PLANTS, P109
   Besouw M, 2013, DRUG DISCOV TODAY, V18, P785, DOI 10.1016/j.drudis.2013.02.003
   BUCHANAN BB, 1994, ARCH BIOCHEM BIOPHYS, V314, P257, DOI 10.1006/abbi.1994.1439
   Carru C, 2004, ELECTROPHORESIS, V25, P882, DOI 10.1002/elps.200305768
   Causse E, 2000, ELECTROPHORESIS, V21, P2074, DOI 10.1002/1522-2683(20000601)21:10<2074::AID-ELPS2074>3.0.CO;2-L
   Chen Y, 2014, BIOINFORMATICS, P1
   Clements A, 2005, ANAL CHEM, V77, P4495, DOI 10.1021/ac050247k
   Coloso RM, 2006, ADV EXP MED BIOL, V583, P25
   Colville L, 2010, PLANT GROWTH REGUL, V62, P241, DOI 10.1007/s10725-010-9482-9
   Corti A, 2005, ANTIOXID REDOX SIGN, V7, P911, DOI 10.1089/ars.2005.7.911
   Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00105
   DATKO AH, 1974, J BIOL CHEM, V249, P1139
   DATKO AH, 1977, J BIOL CHEM, V252, P3436
   Demirkol O, 2004, J AGR FOOD CHEM, V52, P8151, DOI 10.1021/jf040266f
   Dudev T., 2014, J COMPUT CHEM, V2, P19
   Eaton P, 2006, FREE RADICAL BIO MED, V40, P1889, DOI 10.1016/j.freeradbiomed.2005.12.037
   FAHEY RC, 1987, METHOD ENZYMOL, V143, P85
   Ferretti M, 2009, NEW PHYTOL, V181, P115, DOI 10.1111/j.1469-8137.2008.02653.x
   Frendo P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00376
   Fricker MD, 2000, J MICROSC-OXFORD, V198, P162, DOI 10.1046/j.1365-2818.2000.00696.x
   Gallaher CM, 2012, J AGR FOOD CHEM, V60, P1358, DOI 10.1021/jf2041142
   GOODSON RJ, 1990, BIO-TECHNOL, V8, P343, DOI 10.1038/nbt0490-343
   GRASSETT.DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2
   GREGORY JD, 1955, J AM CHEM SOC, V77, P3922, DOI 10.1021/ja01619a073
   Gueguen V, 2000, J BIOL CHEM, V275, P5016, DOI 10.1074/jbc.275.7.5016
   HAMAMOTO A, 1986, PLANT PHYSIOL, V80, P702, DOI 10.1104/pp.80.3.702
   Hartmann TN, 2003, PLANT CELL ENVIRON, V26, P965, DOI 10.1046/j.1365-3040.2003.01031.x
   Hassinen VH, 2010, PLANT BIOLOGY, V13, P225
   Hell Rüdiger, 2011, Arabidopsis Book, V9, pe0154, DOI 10.1199/tab.0154
   Hesse H, 2003, TRENDS PLANT SCI, V8, P259, DOI 10.1016/S1360-1385(03)00107-9
   Hsu CC, 2004, J NUTR, V134, P149
   Huang KJ, 2010, CHROMATOGRAPHIA, V72, P1049, DOI 10.1365/s10337-010-1793-5
   Huang TM, 2006, CHROMATOGRAPHIA, V63, P551, DOI 10.1365/s10337-006-0815-9
   Jeitner TM, 2001, TOXICOL SCI, V63, P57, DOI 10.1093/toxsci/63.1.57
   Jezek J, 1999, J AGR FOOD CHEM, V47, P4669, DOI 10.1021/jf9906026
   Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739
   Jones PR, 2003, J BIOL CHEM, V278, P10291, DOI 10.1074/jbc.M212207200
   Jozefczak M, 2012, INT J MOL SCI, V13, P3145, DOI 10.3390/ijms13033145
   Kaleta C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-116
   KANAOKA Y, 1970, BIOCHIM BIOPHYS ACTA, V207, P269, DOI 10.1016/0005-2795(70)90019-X
   Khan N.A., 2014, J PLANT BIOCH PHYSL, V2, P1
   KLAPHECK S, 1992, BOT ACTA, V105, P174
   Klein M, 2004, J EXP BOT, V55, P1809, DOI 10.1093/jxb/erh183
   KUNERT KJ, 1993, SULFUR NUTRITION AND ASSIMILATION IN HIGHER PLANTS, P139
   Kwon YH, 2001, AM J PHYSIOL-ENDOC M, V280, pE804
   LASZLO P, 1984, J ORG CHEM, V49, P2281, DOI 10.1021/jo00186a039
   Leustek Thomas, 2002, Arabidopsis Book, V1, pe0017, DOI 10.1199/tab.0017
   MACNICOL PK, 1981, PLANT PHYSIOL, V68, P619, DOI 10.1104/pp.68.3.619
   Maeda K, 2005, PROTEOMICS, V5, P1634, DOI 10.1002/pmic.200401050
   Masi A, 2002, J PLANT PHYSIOL, V159, P499, DOI 10.1078/0176-1617-00655
   McCoy E., 2012, TAURINE HLTH DIS, P5
   McDonagh B, 2011, J PROTEOMICS, V74, P2487, DOI 10.1016/j.jprot.2011.04.018
   Messens J., 2013, OXIDATIVE STRESS RED, P59
   Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1
   MILLER DM, 1985, PLANT PHYSIOL, V77, P162, DOI 10.1104/pp.77.1.162
   Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n
   Mishra S, 2008, AQUAT TOXICOL, V86, P205, DOI 10.1016/j.aquatox.2007.11.001
   Moldrup M.E., 2013, PLANT CELL, V2013, P360
   Moreno J, 2008, J EXP BOT, V59, P1605, DOI 10.1093/jxb/erm310
   Musenga A, 2007, ANAL BIOANAL CHEM, V387, P917, DOI 10.1007/s00216-006-0980-6
   NAKASHIMA K, 1985, TALANTA, V32, P167, DOI 10.1016/0039-9140(85)80050-3
   Noctor Graham, 2011, Arabidopsis Book, V9, pe0142, DOI 10.1199/tab.0142
   Oe T, 1998, J CHROMATOGR B, V708, P285, DOI 10.1016/S0378-4347(97)00676-2
   Pasternak T, 2014, PLANT PHYSIOL BIOCH, V74, P16, DOI 10.1016/j.plaphy.2013.10.028
   Pilon-Smits E.A.H., 2006, STRUCTURE FUNCTION P, P387
   Pucciariello C, 2009, PLANT PHYSIOL, V151, P1186, DOI 10.1104/pp.109.142034
   RENNENBERG H, 1982, PLANT PHYSIOL, V69, P766, DOI 10.1104/pp.69.4.766
   Rennenberg H., 1993, SULFUR NUTR SULFUR A, P53
   Roj S., 2006, PHYTOCHEMISTRY, V15, P1686
   ROMANO AH, 1954, J BIOL CHEM, V208, P409
   Sass JO, 1997, J CHROMATOGR A, V776, P342
   Shinohara Y, 2001, J CHROMATOGR B, V758, P283, DOI 10.1016/S0378-4347(01)00190-6
   Shung E., 1990, SULFUR NUTR SULFUR A, P179
   Skipsey M, 2005, PLANT BIOTECHNOL J, V3, P409, DOI 10.1111/j.1467-7652.2005.00134.x
   Su TB, 2013, PLANT CELL, V25, P367, DOI 10.1105/tpc.113.109975
   Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3
   TOYOOKA T, 1989, ANALYST, V114, P413, DOI 10.1039/an9891400413
   TOYOOKA T, 1984, ANAL CHEM, V56, P2461, DOI 10.1021/ac00277a044
   Vellasco AP, 2002, ANALYST, V127, P1050, DOI 10.1039/b203832c
   YANG JR, 1991, J HETEROCYCLIC CHEM, V28, P1177
   Yano H, 2014, MOL PLANT, V7, P4, DOI 10.1093/mp/sst124
   Yasuno R, 1998, PLANT PHYSIOL, V118, P935, DOI 10.1104/pp.118.3.935
   Yuan L, 1996, J BIOL CHEM, V271, P3417
   Zander T, 1998, METHOD ENZYMOL, V290, P59, DOI 10.1016/S0076-6879(98)90007-6
NR 173
TC 3
Z9 3
U1 9
U2 55
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2014
VL 560
BP 83
EP 99
DI 10.1016/j.abb.2014.07.018
PG 17
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AP9JG
UT WOS:000342395500010
PM 25057770
ER

PT J
AU Di Muzio, E
   Polticelli, F
   Trezza, V
   Fanali, G
   Fasano, M
   Ascenzi, P
AF Di Muzio, Elena
   Polticelli, Fabio
   Trezza, Viviana
   Fanali, Gabriella
   Fasano, Mauro
   Ascenzi, Paolo
TI Imatinib binding to human serum albumin modulates heme association and
   reactivity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Human serum albumin; Human serum heme-albumin; Imatinib binding;
   Peroxynitrite detoxification; Allosteric effects; Molecular docking
ID TYROSINE KINASE INHIBITORS; CHRONIC MYELOID-LEUKEMIA; SUDLOWS SITE-I;
   DRUG-BINDING; ALPHA-1-ACID GLYCOPROTEIN; PLASMA-CONCENTRATIONS;
   PEROXYNITRITE DETOXIFICATION; ALPHA(1)-ACID GLYCOPROTEIN; CLINICAL
   PHARMACOKINETICS; CARCINOEMBRYONIC ANTIGEN
AB Imatinib, an inhibitor of the Bcr-Abl tyrosine kinase, is approximately 95% bound to plasma proteins, alpha 1-acid glycoprotein (AGP) being the primary carrier. However, human serum albumin (HSA) may represent the secondary carrier of imatinib in pathological states characterized by low AGP levels, such as pancreatic cancer, hepatic cirrhosis, hepatitis, hyperthyroidism, nephrotic syndrome, malnutrition, and cachexia. Here, thermodynamics of imatinib binding to full-length HSA and its recombinant Asp1-Glu382 truncated form (containing only the FA1, FA2, FA6, and FA7 binding sites; trHSA), in the absence and presence of ferric heme (heme-Fe(III)), and the thermodynamics of heme-Fe(III) binding to RSA and trHSA, in the absence and presence of imatinib, has been investigated. Moreover, the effect of imatinib on kinetics of peroxynitrite detoxification by ferric human serum heme-albumin (HSA-heme-Fe(III)) and ferric truncated human serum heme-albumin (trHSA-heme-Fe(III)) has been explored. All data were obtained at pH 7.0, and 20.0 degrees C and 37.0 degrees C. Imatinib binding to the FA7 site of HSA and trHSA inhibits allosterically heme-Fe(III) association to the FA1 site and vice versa, according to linked functions. Moreover, imatinib binding to the secondary FA2 site of HSA-heme-Fe(III) inhibits allosterically peroxynitrite detoxification. Docking simulations and local structural comparison with other imatinib-binding proteins support functional data indicating the preferential binding of imatinib to the FA1 and FA7 sites of HSA, and to the FA2 and FA7 sites of HSA-heme-Fe(III). Present results highlight the allosteric coupling of the FA1, FA2, and FA7 sites of HSA, and may be relevant in modulating ligand binding and reactivity properties of HSA in vivo. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Di Muzio, Elena; Polticelli, Fabio; Trezza, Viviana] Roma Tre Univ, Dept Sci, I-00146 Rome, Italy.
   [Polticelli, Fabio] Natl Inst Nucl Phys, Roma Tre Sect, I-00146 Rome, Italy.
   [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Dept Theoret & Appl Sci, Biomed Res Div, I-21052 Busto Arsizio, VA, Italy.
   [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Ctr Neurosci, I-21052 Busto Arsizio, VA, Italy.
   [Ascenzi, Paolo] Roma Tre Univ, Interdept Lab Electron Microscopy, I-00146 Rome, Italy.
   [Ascenzi, Paolo] Natl Inst Biostruct & Biosyst, I-00136 Rome, Italy.
RP Ascenzi, P (reprint author), Roma Tre Univ, Interdept Lab Electron Microscopy, Via Vasca Navale 79, I-00146 Rome, Italy.
EM ascenzi@uniroma3.it
RI Fasano, Mauro/A-7100-2008
OI Fasano, Mauro/0000-0003-0628-5871
FU Roma Tre University, Roma, Italy (CLA)
FX This study was fully supported by a grant from Roma Tre University,
   Roma, Italy (CLA 2013 to P.A.).
CR Alwen S., 2004, J BIOL CHEM, V279, P55827
   SUDLOW G, 1976, MOL PHARMACOL, V12, P1052
   Haouala A, 2013, BRIT J CLIN PHARMACO, V75, P1007, DOI 10.1111/j.1365-2125.2012.04422.x
   Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439
   Boffi A, 1999, BIOPHYS J, V77, P1143
   Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158
   SUDLOW G, 1975, MOL PHARMACOL, V11, P824
   Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u
   Huang ZQ, 2013, CURR DRUG METAB, V14, P226
   Jacobs MD, 2008, PROTEINS, V70, P1451, DOI 10.1002/prot.21633
   Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4
   Widmer N, 2006, BRIT J CLIN PHARMACO, V62, P97, DOI 10.1111/j.1365-2125.2006.02719.x
   Nakajou K, 2003, BBA-GEN SUBJECTS, V1623, P88, DOI 10.1016/j.bbagen.2003.08.001
   Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002
   McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8
   Fitos I, 2006, BBA-GEN SUBJECTS, V1760, P1704, DOI 10.1016/j.bbagen.2006.08.015
   Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075
   Hartmann JT, 2009, CURR DRUG METAB, V10, P470
   Miller YI, 1999, BBA-MOL BASIS DIS, V1454, P153
   Lankheet NAG, 2014, THER DRUG MONIT, V36, P326, DOI 10.1097/FTD.0000000000000004
   Ascenzi P, 2006, MINI-REV MED CHEM, V6, P483, DOI 10.2174/138955706776361448
   Ascenzi P, 2009, IUBMB LIFE, V61, P1118, DOI 10.1002/iub.263
   Caprari S, 2014, BIOINFORMATICS, V30, P1022, DOI 10.1093/bioinformatics/btt664
   DOMENICI E, 1991, J PHARM SCI-US, V80, P164, DOI 10.1002/jps.2600800216
   Ascenzi P, 2005, BIOCHEM BIOPH RES CO, V334, P481, DOI 10.1016/j.bbrc.2005.06.127
   Goldstein S, 2005, CHEM REV, V105, P2457, DOI 10.1021/cr0307087
   Bolli A, 2010, BIOCHEM BIOPH RES CO, V398, P444, DOI 10.1016/j.bbrc.2010.06.096
   Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097
   Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013
   Hegde AH, 2012, J FLUORESC, V22, P521, DOI 10.1007/s10895-011-0986-0
   Ascenzi P, 2010, BIOPHYS CHEM, V148, P16, DOI 10.1016/j.bpc.2010.03.001
   WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4
   Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Nicoletti FP, 2008, J AM CHEM SOC, V130, P11677, DOI 10.1021/ja800966t
   Peng B, 2005, CLIN PHARMACOKINET, V44, P879, DOI 10.2165/00003088-200544090-00001
   Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, P123
   Ascenzi P, 2010, IUBMB LIFE, V62, P776, DOI 10.1002/iub.381
   Ascenzi P, 2007, BIOCHEM BIOPH RES CO, V353, P469, DOI 10.1016/j.bbrc.2006.12.041
   Ascenzi P, 2011, BIOCHEM BIOPH RES CO, V415, P463, DOI 10.1016/j.bbrc.2011.10.094
   Ascenzi P, 2011, BIOCHEM BIOPH RES CO, V404, P190, DOI 10.1016/j.bbrc.2010.11.091
   Ascenzi P, 2011, J BIOL INORG CHEM, V16, P97, DOI 10.1007/s00775-010-0706-2
   Ascenzi P, 2009, J BIOL CHEM, V284, P31006, DOI 10.1074/jbc.M109.010736
   Ascenzi P, 2013, IUBMB LIFE, V65, P836, DOI 10.1002/iub.1208
   ASCENZI P, 1987, BIOCHEM EDUC, V15, P134, DOI 10.1016/0307-4412(87)90043-4
   Ascenzi P, 2011, BIOCHEM BIOPH RES CO, V411, P185, DOI 10.1016/j.bbrc.2011.06.130
   Barber MD, 1999, NUTR CANCER, V35, P106, DOI 10.1207/S15327914NC352_2
   Basciani S, 2005, CANCER RES, V65, P1897, DOI 10.1158/0008-5472.CAN-04-2181
   Bocedi A, 2005, FEBS J, V272, P6287, DOI 10.1111/j.1742-4658.2005.05015.x
   Bocedi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058842
   Bohle DS, 1996, METHOD ENZYMOL, V269, P302
   Sun LC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-288
   Chuang VTG, 2002, PHARMACEUT RES, V19, P1458, DOI 10.1023/A:1020496314081
   di Masi A, 2011, FEBS J, V278, P654, DOI 10.1111/j.1742-4658.2010.07986.x
   Dixon MR, 2003, ARCH SURG-CHICAGO, V138, P962, DOI 10.1001/archsurg.138.9.962
   Fanali G, 2009, FEBS J, V276, P2241, DOI 10.1111/j.1742-4658.2009.06952.x
   Fanali G, 2012, J BIOMOL STRUCT DYN, V29, P691, DOI 10.1080/07391102.2011.672632
   Fanali G, 2013, BIOFACTORS, V39, P294, DOI 10.1002/biof.1070
   FITOS I, 1992, CHIRALITY, V4, P21, DOI 10.1002/chir.530040106
   Fitos I, 2012, INT J BIOL MACROMOL, V50, P788, DOI 10.1016/j.ijbiomac.2011.11.023
   Gambacorti-Passerini C, 2003, CLIN CANCER RES, V9, P625
   Gambacorti-Passerini C, 2000, J NATL CANCER I, V92, P1641, DOI 10.1093/jnci/92.20.1641
   Gambacorti-Passerini CB, 2002, BLOOD CELL MOL DIS, V28, P361, DOI 10.1006/bcmd.2002.0526
   Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2
   Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69
   Herold S, 2004, J AM CHEM SOC, V126, P6945, DOI 10.1021/ja0493300
   Herold S, 2003, BIOCHEMISTRY-US, V42, P14036, DOI 10.1021/bi0350349
   Jahnke W, 2010, J AM CHEM SOC, V132, P7043, DOI 10.1021/ja101837n
   Kaneko K, 2011, IUBMB LIFE, V63, P277, DOI 10.1002/iub.457
   Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o
   Koppenol WH, 1996, METHOD ENZYMOL, V269, P296
   KREMER JMH, 1988, PHARMACOL REV, V40, P1
   Kretz O, 2004, BRIT J CLIN PHARMACO, V58, P212, DOI 10.1111/j.1365-2125.2004.02117.x
   Kyail A.J., 2011, J STRUCT BIOL, V174, P84
   Leveque D, 2005, IN VIVO, V19, P77
   MULLEREB.U, 1968, BLOOD, V32, P811
   Namboodiri HV, 2010, BIOCHEMISTRY-US, V49, P3611, DOI 10.1021/bi100070r
   Seeliger M.A., 2007, J STRUCT, V15, P299
   Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540
   Winger JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-7
   Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6
NR 81
TC 1
Z9 1
U1 5
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 15
PY 2014
VL 560
BP 100
EP 112
DI 10.1016/j.abb.2014.07.001
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AP9JG
UT WOS:000342395500011
PM 25057771
ER

PT J
AU Terao, J
   Sies, H
AF Terao, Junji
   Sies, Helmut
TI Special issue "polyphenols and health"
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
C1 [Terao, Junji] Univ Tokushima, Grad Sch Nutr Sci, Grad Sch, Dept Food Sci,Inst Hlth Biosci, Tokushima 7708503, Japan.
   [Sies, Helmut] Univ Dusseldorf, Inst Biochem & Mol Biol 1, D-40225 Dusseldorf, Germany.
RP Terao, J (reprint author), Univ Tokushima, Grad Sch Nutr Sci, Grad Sch, Dept Food Sci,Inst Hlth Biosci, Tokushima 7708503, Japan.
EM terao@nutr.med.tokushima-u.ac.jp; sies@uni-duesseldorf.de
CR Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Rodriguez-Mateos A, 2014, ARCH BIOCHEM BIOPHYS, V559, P17, DOI 10.1016/j.abb.2014.03.014
   Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006
   Wilson L, 2014, ARCH BIOCHEM BIOPHYS, V559, P3, DOI 10.1016/j.abb.2014.06.014
   Ruotolo R, 2014, ARCH BIOCHEM BIOPHYS, V559, P62, DOI 10.1016/j.abb.2014.03.003
   de Pascual-Teresa S, 2014, ARCH BIOCHEM BIOPHYS, V559, P68, DOI 10.1016/j.abb.2014.04.012
   Terao J, 2014, ARCH BIOCHEM BIOPHYS, V559, P12, DOI 10.1016/j.abb.2014.04.002
   Qin S, 2014, ARCH BIOCHEM BIOPHYS, V559, P53, DOI 10.1016/j.abb.2014.03.011
   Sandoval-Acuna C, 2014, ARCH BIOCHEM BIOPHYS, V559, P75, DOI 10.1016/j.abb.2014.05.017
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Franke Adrian A., 2014, ARCH BIOCHEM BIOPHYS, V559, P24
   Hollman PCH, 2011, J NUTR, V141, p989S, DOI 10.3945/jn.110.131490
   Hollman Peter C.H., 2014, ARCH BIOCHEM BIOPHYS, V559, P100
   Kroon Paul A., 2014, ARCH BIOCHEM BIOPHYS, V559, P29
   Surh Y.-J., 2014, ARCH BIOCHEM BIOPHYS, V559, P38
NR 15
TC 1
Z9 1
U1 7
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 1
EP 2
DI 10.1016/j.abb.2014.06.015
PG 2
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100001
PM 24953178
ER

PT J
AU Wilson, L
   Arabshahi, A
   Simons, B
   Prasain, JK
   Barnes, S
AF Wilson, Landon
   Arabshahi, Ali
   Simons, Brigitte
   Prasain, Jeevan K.
   Barnes, Stephen
TI Improved high sensitivity analysis of polyphenols and their metabolites
   by nano-liquid chromatography-mass spectrometry
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Polyphenols; Nanoliquid chromatography-mass spectrometry; Sample
   volumes; Sensitivity; Quantification; Mass accuracy
ID CONJUGATED METABOLITES; DIETARY-SUPPLEMENTS; RAT PLASMA; LC-MS/MS;
   ISOFLAVONES; MS; QUANTIFICATION; PHYTOESTROGENS; PUERARIN; SERUM
AB This study was conducted to assess the value of a high resolution, high mass accuracy time-of-flight analyzer in combination with nanoliquid chromatography for the analysis of polyphenols and their metabolites. The goal was to create a method that utilizes small volumes of biological fluids and provides a significant improvement in sensitivity compared with existing methods. Accordingly, nanoLC-MS and nanoLC-pseudo-multiple reaction monitoring (MRM) methods were developed that had a lower limit of quantification of 0.5 nM for several polyphenols and were linear over 2-3 orders of magnitude (R-2 > 0.999). Using urine samples, the ability to observe and quantify polyphenols in such a complex biological fluid depended on much narrower mass windows (0.050 amu or less) on a TOF analyzer than those used on a quadrupole analyzer (0.7 amu). Although a greater selectivity was possible with the low mass resolution of a triple quadrupole instrument using the MRM approach, for the daidzein metabolite O-DMA, a chromatographically resolvable second peak could only be substantially reduced by using a 0.01 amu mass window. The advantage of a TOF analyzer for product ion data is that the whole MSMS spectrum is collected at high mass accuracy and MRM experiments are conducted in silica after the analysis. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Prasain, Jeevan K.; Barnes, Stephen] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA.
   [Wilson, Landon; Arabshahi, Ali; Prasain, Jeevan K.; Barnes, Stephen] Univ Alabama Birmingham, Targeted Metabol & Prote Lab, Birmingham, AL 35294 USA.
   [Prasain, Jeevan K.; Barnes, Stephen] Univ Alabama Birmingham, OBrien Acute Kidney Injury Ctr, Birmingham, AL 35294 USA.
   [Simons, Brigitte] AB Sciex, Concord, ON, Canada.
RP Barnes, S (reprint author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, McCallum Res Bldg,Room 452,1918 Univ Blvd, Birmingham, AL 35294 USA.
EM sbarnes@uab.edu
FU NIH/NCRR [S10 RR027822]; NIH/NIAMS [P30 AR50948]; NIH/NIDDK [P30
   DK079337]
FX The AB Sciex 5600 TripleTOF mass spectrometer was purchased with funds
   from a NIH/NCRR Shared Instrumentation Grant to SB (S10 RR027822). Core
   support for mass spectrometry at UAB is provided by grants from
   NIH/NIAMS to the UAB Skin Disease Research Center (Craig Elmets, PI; P30
   AR50948) and NIH/NIDDK to the O'Brien Acute Kidney Injury Research
   Center (Anupam Agarwal, PI; P30 DK079337).
CR Prasain JK, 2004, FREE RADICAL BIO MED, V37, P1324, DOI 10.1016/j.freeradbiomed.2004.07.026
   Quirantes-Pine R, 2012, ANAL BIOANAL CHEM, V404, P3081, DOI 10.1007/s00216-012-6402-z
   Churchwell MI, 2005, J CHROMATOGR B, V825, P134, DOI 10.1016/j.jchromb.2005.05.037
   Soucy NV, 2006, TOXICOL SCI, V90, P230, DOI 10.1093/toxsci/kfj077
   Prasain JK, 2003, J AGR FOOD CHEM, V51, P4213, DOI 10.1021/jf030174a
   Rybak ME, 2008, J CHROMATOGR B, V861, P145, DOI 10.1016/j.jchromb.2007.11.013
   Maskarinec G, 2008, BRIT J NUTR, V100, P424, DOI 10.1017/S0007114508898686
   Prasain JK, 2010, J CHROMATOGR B, V878, P994, DOI 10.1016/j.jchromb.2010.02.032
   Shen Y, 2004, ANAL CHEM, V76, P144, DOI 10.1021/ac030096q
   Aoki F, 2005, J CHROMATOGR B, V828, P70, DOI 10.1016/j.jchromb.2005.09.012
   Coward L, 1996, CLIN CHIM ACTA, V247, P121, DOI 10.1016/0009-8981(95)06242-4
   Prasain JK, 2009, PHYTOMEDICINE, V16, P233, DOI 10.1016/j.phymed.2008.08.006
   Prasain JK, 2007, BIOMED CHROMATOGR, V21, P410, DOI 10.1002/bmc.772
   Wang CC, 2002, J CHROMATOGR B, V777, P3, DOI 10.1016/S1570-0232(02)00341-0
   Legette LL, 2014, J AGR FOOD CHEM, V62, P1294, DOI 10.1021/jf400097m
   Barnes S, 1999, J Med Food, V2, P111, DOI 10.1089/jmf.1999.2.111
   Barnes S, 2006, LIFE SCI, V78, P2054, DOI 10.1016/j.lfs.2005.12.002
   Barnes S, 1998, P SOC EXP BIOL MED, V217, P254
   Boyd R.K., 2008, TRACE QUANTITATIVE A
   Gao S, 2011, J PHARMACEUT BIOMED, V55, P288, DOI 10.1016/j.jpba.2011.01.015
   Grace PB, 2007, J CHROMATOGR B, V853, P138, DOI 10.1016/j.jchromb.2007.03.011
   Grace PB, 2003, RAPID COMMUN MASS SP, V17, P1350, DOI 10.1002/rcm.1059
   Lin Qing, 2013, Zhong Yao Cai, V36, P589
   Plomley JB, 2011, J PHARMACEUT BIOMED, V55, P125, DOI 10.1016/j.jpba.2010.12.031
   Prasain JK, 2009, PHYTOMEDICINE, V16, P65, DOI 10.1016/j.phymed.2008.09.004
   Prasain JK, 2004, J AGR FOOD CHEM, V52, P3708, DOI 10.1021/jf040037t
   Prasain J.K., 2013, J CHROMATOGR B, V5, P913
   Rajbhandari R, 2011, J AGR FOOD CHEM, V59, P6682, DOI 10.1021/jf200673h
   Sepehr E, 2006, J AOAC INT, V89, P1158
   Shinkaruk S, 2012, FOOD CHEM, V135, P1104, DOI 10.1016/j.foodchem.2012.03.135
NR 30
TC 2
Z9 2
U1 2
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 3
EP 11
DI 10.1016/j.abb.2014.06.014
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100002
PM 24967696
ER

PT J
AU Terao, J
   Mukai, R
AF Terao, Junji
   Mukai, Rie
TI Prenylation modulates the bioavailability and bioaccumulation of dietary
   flavonoids
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Prenylflavonoids; Prenylation; Epithelial cells; Efflux; Uptake;
   Bioaccumulation
ID HOPS HUMULUS-LUPULUS; CACO-2 CELL MONOLAYERS; HUMAN LIVER-MICROSOMES;
   POTENT PHYTOESTROGEN; 8-PRENYLNARINGENIN; METABOLISM; QUERCETIN; L.;
   XANTHOHUMOL; ISOXANTHOHUMOL
AB Prenylflavonoids are distributed widely in the plant kingdom and have attracted appreciable attention because of their potential benefits for human health. Prenylation may be a promising tool for applying the biological functions of flavonoids to clinical uses. The bioavailability and bioaccumulation of prenylflavonoids have not been clarified, but extensive studies have been accomplished on their biological functions. This review provides current knowledge on the bioavailability of prenylflavonoids, including their absorption and metabolism in the intestine, as well as their bioaccumulation in specific tissues. Despite higher uptake into epithelial cells of the digestive tract, the bioavailability of single-dose prenylflavonoids seems to be lower than that of the parent flavonoids. Efflux from epithelial cells to the blood circulation is likely to be restricted by prenyl groups, resulting in insufficient increase in the plasma concentration. Rodent studies have revealed that prenylation enhances accumulation of naringenin in muscle tissue after long-term feeding; and that prenylation accelerates accumulation of quercetin in liver tissue. Efflux from hepatocytes to blood and enterohepatic circulations may be restricted by prenyl groups, thereby promoting slow excretion of prenylflavonoids from the blood circulation and efficient uptake to tissues. The hepatotoxicity and other deleterious effects, taken together with beneficial effects, should be considered because unexpectedly high accumulation may occur in some tissues after long-term supplementation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Terao, Junji; Mukai, Rie] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Food Sci, Tokushima 7708503, Japan.
RP Terao, J (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Food Sci, Kuramoto 3-18-15, Tokushima 7708503, Japan.
EM terao@nutr.med.tokushima-u.ac.jp
FU JSPS Kakenhi [25292075]
FX This work was supported by JSPS Kakenhi (Grant No. 25292075).
CR Jaganath IB, 2009, FREE RADICAL BIO MED, V47, P1180, DOI 10.1016/j.freeradbiomed.2009.07.031
   Possemiers S, 2006, J NUTR, V136, P1862
   Zhang L, 2007, EUR J PHARM SCI, V31, P221, DOI 10.1016/j.ejps.2007.04.001
   Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544
   Graefe EU, 2001, J CLIN PHARMACOL, V41, P492, DOI 10.1177/00912700122010366
   Nikolic D, 2005, J MASS SPECTROM, V40, P289, DOI 10.1002/jms.753
   Milligan SR, 1999, J CLIN ENDOCR METAB, V84, P2249, DOI 10.1210/jc.84.6.2249
   Murota K, 2010, ARCH BIOCHEM BIOPHYS, V501, P91, DOI 10.1016/j.abb.2010.06.036
   Botta B, 2005, CURR MED CHEM, V12, P713
   Simons R, 2012, FOOD FUNCT, V3, P810, DOI 10.1039/c2fo10290k
   Mukai R, 2013, J NUTR, V143, P1558, DOI 10.3945/jn.113.176818
   Brand W, 2008, DRUG METAB DISPOS, V36, P1794, DOI 10.1124/dmd.107.019943
   Williamson G, 2007, DRUG METAB DISPOS, V35, P1262, DOI 10.1124/dmd.106.014241
   Stevens JF, 2004, PHYTOCHEMISTRY, V65, P1317, DOI 10.1016/j.phytochem.2004.04.025
   Rechner AR, 2002, FREE RADICAL BIO MED, V33, P220, DOI 10.1016/S0891-5849(02)00877-8
   Guo J, 2006, DRUG METAB DISPOS, V34, P1152, DOI 10.1124/dmd.105.008250
   Day AJ, 2003, BIOCHEM PHARMACOL, V65, P1199, DOI 10.1016/S0006-2952(03)00039-X
   Takumi H, 2012, FOOD FUNCT, V3, P389, DOI 10.1039/c2fo10224b
   Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008
   Bolca S, 2010, MOL NUTR FOOD RES, V54, pS284, DOI 10.1002/mnfr.200900519
   Bolca S, 2007, BRIT J NUTR, V98, P950, DOI 10.1017/S0007114507749243
   Cattoor K, 2010, J AGR FOOD CHEM, V58, P4132, DOI 10.1021/jf904079h
   Legette L, 2014, MOL NUTR FOOD RES, V58, P248, DOI 10.1002/mnfr.201300333
   Metodiewa D, 1999, FREE RADICAL BIO MED, V26, P107, DOI 10.1016/S0891-5849(98)00167-1
   Kretzschmar G, 2010, J STEROID BIOCHEM, V118, P1, DOI 10.1016/j.jsbmb.2009.08.005
   Nikolic D, 2004, DRUG METAB DISPOS, V32, P272, DOI 10.1124/dmd.32.2.272
   Barron D, 1996, PHYTOCHEMISTRY, V43, P921, DOI 10.1016/S0031-9422(96)00344-5
   Jirasko R, 2010, J CHROMATOGR A, V1217, P4100, DOI 10.1016/j.chroma.2010.02.041
   Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023
   Milligan SR, 2000, J CLIN ENDOCR METAB, V85, P4912, DOI 10.1210/jc.85.12.4912
   Arung ET, 2010, FITOTERAPIA, V81, P640, DOI 10.1016/j.fitote.2010.03.011
   Ayabe Shin-ichi, 2006, Phytochemistry Reviews, V5, P271, DOI 10.1007/s11101-006-9007-3
   Bierger J., 2008, J NUTR, V138, P1417
   Chen X., 2013, PHARM BIOL
   De Boer VC, 2005, J NUTR, V135, P1617
   Hendrich AB, 2002, EUR J PHARM SCI, V16, P201, DOI 10.1016/S0928-0987(02)00106-9
   Konishi Y, 2005, J AGR FOOD CHEM, V53, P9928, DOI 10.1021/jf051962y
   Legette I., 2012, MOL NUTR FOOD RES, V56, P466
   Manach Claudine, 2005, Am J Clin Nutr, V81, p230S
   Mukai R., 2012, PLOS ONE, V9
   Piskula M.K., 2012, FLAVONOIDS RELATED C, P93
   Qian Q., 2012, J PHARM BIOMED ANAL, V66, P382
   Yilmazer M., 2001, DRUG METAB DISPOS, V29, P2223
NR 43
TC 7
Z9 7
U1 7
U2 33
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 12
EP 16
DI 10.1016/j.abb.2014.04.002
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100003
PM 24736381
ER

PT J
AU Rodriguez-Mateos, A
   Toro-Funes, N
   Cifuentes-Gomez, T
   Cortese-Krott, M
   Heiss, C
   Spencer, JPE
AF Rodriguez-Mateos, Ana
   Toro-Funes, Natalia
   Cifuentes-Gomez, Tania
   Cortese-Krott, Miriam
   Heiss, Christian
   Spencer, Jeremy P. E.
TI Uptake and metabolism of (-)-epicatechin in endothelial cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE (-)-Epicatechin; Uptake; Phase II metabolism; HUVEC; Endothelial cells;
   HepG2; Caco-2 monolayer
ID FLAVANOL-RICH COCOA; BLOOD-PRESSURE; PLATELET-FUNCTION; CHOCOLATE
   CONSUMPTION; DIETARY FLAVANOLS; VASCULAR FUNCTION; CONTROLLED-TRIAL;
   CELLULAR UPTAKE; NITRIC-OXIDE; BIOACTIVITY
AB Accumulating evidence suggest that diets rich in cocoa flavanols may have beneficial effects on cardiovascular health. The major cocoa flavanol monomer, (-)-epicatechin (EC), is readily absorbed and circulates primarily as glucuronidated, sulfated, and O-methylated metabolites in human plasma. However, cellular metabolism, for example in endothelial cells, is less well defined. In the present study we detail the uptake and cellular metabolism of EC and its major in vivo metabolites, (-)-epicatechin-3'-beta-D-glucuronide (E3G), (-)-epicatechin-3'-sulfate (E3S), 3'-O-methyl-(-)-epicatechin-5-sulfate (3ME5S), and 3'-O-methyl-(-)-epicatechin-7-sulfate (3ME7S) in human endothelial (HUVEC), liver (HepG2) and intestinal epithelial cells (Caco-2 monolayer). Our results indicate that EC associates with HUVECs, leading to its intracellular metabolism to 3ME7G and 3ME7S. In contrast, none of the metabolites were taken up by the cells. The metabolic rate and pattern of metabolism in HUVECs was similar to that observed in HepG2 cells, whilst in Caco-2 cells EC was metabolized to E3G, 3ME5G, 3ME7G, 4ME5G, 4ME7G and 3ME7S. Our data support the notion that endothelial cells may contribute significantly to EC metabolism. However, major human circulating metabolites are not accounted for in these model systems underscoring that caution should be taken when drawing conclusions on in vivo flavanol metabolism from in vitro experiments. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Rodriguez-Mateos, Ana; Cortese-Krott, Miriam; Heiss, Christian] Univ Dusseldorf, Fac Med, Div Cardiol Pulmonol & Vasc Med, D-40225 Dusseldorf, Germany.
   [Rodriguez-Mateos, Ana; Toro-Funes, Natalia; Cifuentes-Gomez, Tania; Spencer, Jeremy P. E.] Univ Reading, Sch Chem Food & Pharm, Mol Nutr Grp, Reading RG2 6AP, Berks, England.
   [Toro-Funes, Natalia] Univ Barcelona, Fac Pharm, Dept Nutr & Food Sci XaRTA, Barcelona 08921, Spain.
RP Rodriguez-Mateos, A (reprint author), Univ Dusseldorf, Fac Med, Div Cardiol Pulmonol & Vasc Med, D-40225 Dusseldorf, Germany.
EM ana.rodriguez-mateos@med.uni-duesseldorf.de
RI Spencer, Jeremy/F-4757-2010
FU European Union FP7 [FP7-KBBE-2008-2B]
FX This work was supported by a European Union FP7 research Grant
   (FP7-KBBE-2008-2B) entitled "Targeted delivery of dietary flavanols for
   optimal human cell function: effect on cardiovascular health
   (FLAVIOLA)".
CR Actis-Goretta L, 2012, FREE RADICAL BIO MED, V53, P787, DOI 10.1016/j.freeradbiomed.2012.05.023
   Engler MB, 2004, J AM COLL NUTR, V23, P197
   Vafeiadou K, 2008, ARCH BIOCHEM BIOPHYS, V478, P195, DOI 10.1016/j.abb.2008.07.014
   Pearson DA, 2002, THROMB RES, V106, P191, DOI 10.1016/S0049-3848(02)00128-7
   Steffen Y, 2008, ARCH BIOCHEM BIOPHYS, V469, P209, DOI 10.1016/j.abb.2007.10.012
   Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70
   Ostertag LM, 2010, MOL NUTR FOOD RES, V54, P60, DOI 10.1002/mnfr.200900172
   Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598
   Wong YC, 2009, EXPERT OPIN DRUG MET, V5, P1399, DOI 10.1517/17425250903179300
   Taubert D, 2007, JAMA-J AM MED ASSOC, V298, P49, DOI 10.1001/jama.298.1.49
   Kawai Y, 2008, J BIOL CHEM, V283, P9424, DOI 10.1074/jbc.M706571200
   Blount JW, 2012, BIOCHEM BIOPH RES CO, V417, P457, DOI 10.1016/j.bbrc.2011.11.139
   Heiss C, 2003, JAMA-J AM MED ASSOC, V290, P1030, DOI 10.1001/jama.290.8.1030
   Spencer JPE, 2004, ARCH BIOCHEM BIOPHYS, V423, P148, DOI 10.1016/j.abb.2003.11.010
   Wu BJ, 2011, J PHARM SCI-US, V100, P3655, DOI 10.1002/jps.22568
   Spencer JPE, 2001, FREE RADICAL BIO MED, V31, P1139, DOI 10.1016/S0891-5849(01)00704-3
   Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783
   Heiss C, 2007, J CARDIOVASC PHARM, V49, P74, DOI 10.1097/FJC.0b013e31802d0001
   Uhlenhut K, 2012, FREE RADICAL BIO MED, V53, P305, DOI 10.1016/j.freeradbiomed.2012.04.013
   Spencer JPE, 2003, BIOCHEM J, V372, P173, DOI 10.1042/BJ20021972
   Heiss C, 2010, J AM COLL CARDIOL, V56, P218, DOI 10.1016/j.jacc.2010.03.039
   Buijsse B, 2010, EUR HEART J, V31, P1616, DOI 10.1093/eurheartj/ehq068
   Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103
   Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059
   Spencer JPE, 2001, BIOCHEM J, V354, P493, DOI 10.1042/0264-6021:3540493
   Ottaviani JI, 2012, FREE RADICAL BIO MED, V52, P1403, DOI 10.1016/j.freeradbiomed.2011.12.010
   Murphy KJ, 2003, AM J CLIN NUTR, V77, P1466
   Barbier O, 2000, J CLIN ENDOCR METAB, V85, P4819, DOI 10.1210/jc.85.12.4819
   Galindo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032673
   Heiss C, 2010, EUR HEART J, V31, P1554, DOI 10.1093/eurheartj/ehq114
   Mochizuki M, 2004, BIOFACTORS, V22, P201
   Proteggente AR, 2003, PHOTOCHEM PHOTOBIOL, V78, P256, DOI 10.1562/0031-8655(2003)078<0256:HGAPAA>2.0.CO;2
   Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39
   Salucci M, 2002, BRIT J CANCER, V86, P1645, DOI 10.1038/sj/bjc/6600295
   Ziberna L, 2012, FREE RADICAL BIO MED, V52, P1750, DOI 10.1016/j.freeradbiomed.2012.02.027
NR 35
TC 6
Z9 6
U1 5
U2 41
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 17
EP 23
DI 10.1016/j.abb.2014.03.014
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100004
PM 24717599
ER

PT J
AU Franke, AA
   Lai, JF
   Halm, BM
AF Franke, Adrian A.
   Lai, Jennifer F.
   Halm, Brunhild M.
TI Absorption, distribution, metabolism, and excretion of isoflavonoids
   after soy intake
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Soy; Isoflavonoid; Bioavailability; Daidzein; Genistein; Equol
ID INFANTS FED SOY; BREAST-CANCER RISK; FOOD-FREQUENCY QUESTIONNAIRE;
   DIETARY PHYTOESTROGEN INTAKE; EQUOL PRODUCTION CHANGES; ASIAN-AMERICAN
   WOMEN; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; URINARY-EXCRETION;
   PROBIOTIC CONSUMPTION
AB Soy is the major source of dietary exposure to isoflavonoids (IFLs). Accumulating evidence supports a role for soy and IFLs in the protection against many chronic diseases including cancer. After soy intake we found a biphasic IFL appearance pattern in plasma as well as in urine that we suggest to be due to IFL absorption in the small intestine (ca. 10%) during the first 2 h after intake and IFL absorption in the large intestine (ca. 90%) 4-6 h after intake. While each IFL disappears from the circulation at different times excellent correlations between urinary and circulating IFL values were discovered and algorithms to convert urinary excretion values into circulating levels were established. We suggest the term 'apparent bioavailability' when using urinary data to describe IFL exposure. The IFL bioavailability was found to be influenced by gut bacteria, oral antibiotic treatment (OABX), and an individual's age and health status. While daidzein (DE) and genistein start to be absorbed minutes after intake, equol (EQ) appears in plasma only after a minimum of 8 h following soy intake owing to the required transit time of DE to the colon where the conversion of DE to EQ takes place by intestinal microbiota. We have also shown that the apparent IFL bioavailability is higher in children than adults, higher in healthy versus non-healthy individuals, and decreased in children but increased in adults during OABX. Finally, we propose to use a urinary EQ/DE ratio of 0.018 with a DE threshold to identify EQ producers. With this cutoff definition we observed that EQ production is inconsistent over time in 5-30% of both premenopausal and postmenopausal women. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Franke, Adrian A.; Lai, Jennifer F.; Halm, Brunhild M.] Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA.
RP Franke, AA (reprint author), Univ Hawaii, Ctr Canc, 1236 Lauhala St, Honolulu, HI 96813 USA.
EM adrian@cc.hawaii.edu
CR Day AJ, 2000, FEBS LETT, V468, P166, DOI 10.1016/S0014-5793(00)01211-4
   Setchell KDR, 2002, J NUTR, V132, P3577
   FRANKE AA, 1995, P SOC EXP BIOL MED, V208, P18
   Setchell KDR, 2003, J NUTR, V133, P1027
   Strom BL, 2001, JAMA-J AM MED ASSOC, V286, P807, DOI 10.1001/jama.286.7.807
   Messina M, 2010, J NUTR, V140, p1350S, DOI 10.3945/jn.109.118315
   Zubik L, 2003, AM J CLIN NUTR, V77, P1459
   Franke AA, 2009, DRUG TEST ANAL, V1, P14, DOI 10.1002/dta.12
   Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0
   Yu BS, 2002, J PHARMACEUT BIOMED, V30, P843, DOI 10.1016/S0731-7085(02)00326-6
   Walter ED, 1941, J AM CHEM SOC, V63, P3273, DOI 10.1021/ja01857a013
   Maskarinec G, 2008, BRIT J NUTR, V100, P424, DOI 10.1017/S0007114508898686
   [Anonymous], 1972, HDB CHEM PHYS
   Fanti P, 1999, J AM SOC NEPHROL, V10, P864
   Lampe JW, 1998, P SOC EXP BIOL MED, V217, P335
   Kim DH, 1998, BIOL PHARM BULL, V21, P628
   Setchell KDR, 2003, AM J CLIN NUTR, V77, P411
   Murphy PA, 2002, J CHROMATOGR B, V777, P129, DOI 10.1016/S1570-0232(02)00342-2
   King RA, 1998, AM J CLIN NUTR, V67, P867
   Grace PB, 2004, CANCER EPIDEM BIOMAR, V13, P698
   Walz E, 1931, LIEBIGS ANN CHEM, V489, P118
   Frankenfeld CL, 2005, BRIT J NUTR, V94, P873, DOI 10.1079/BJN20051565
   Morton MS, 2002, J NUTR, V132, P3168
   Franke AA, 2010, CANCER EPIDEM BIOMAR, V19, P1775, DOI 10.1158/1055-9965.EPI-10-0116
   Wu J, 2007, MENOPAUSE, V14, P866, DOI 10.1097/gme.0b013e3180305299
   Frankenfeld CL, 2004, EXP BIOL MED, V229, P902
   Umphress ST, 2005, J FOOD COMPOS ANAL, V18, P533, DOI 10.1016/j.jfca.2004.04.008
   Wiseman H, 2002, J AGR FOOD CHEM, V50, P1404, DOI 10.1021/jf011243t
   Wu AH, 2004, CARCINOGENESIS, V25, P77, DOI 10.1093/carcin/bgg189
   XU X, 1994, J NUTR, V124, P825
   Atkinson C, 2005, EXP BIOL MED, V230, P155
   Cotroneo MS, 2002, CARCINOGENESIS, V23, P1467, DOI 10.1093/carcin/23.9.1467
   Akaza H, 2004, JPN J CLIN ONCOL, V34, P86, DOI 10.1093/jjco/hyh015
   Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863
   Setchell KDR, 2006, J NUTR, V136, P2188
   Arai Y, 2000, J Epidemiol, V10, P127
   Atkinson C, 2002, CANCER EPIDEM BIOMAR, V11, P253
   AXELSON M, 1984, J ENDOCRINOL, V102, P49, DOI 10.1677/joe.0.1020049
   Benlhabib Elhabib, 2002, Journal of Medicinal Food, V5, P109, DOI 10.1089/10966200260398143
   Bonorden MJL, 2004, EUR J CLIN NUTR, V58, P1635, DOI 10.1038/sj.ejcn.1602020
   CHURELLA HR, 1994, J AM COLL NUTR, V13, P262
   Franke AA, 2006, AM J CLIN NUTR, V84, P406
   Franke A.A., 2009, PLANT PHENOLICS HUMA
   Franke AA, 2012, BRIT J NUTR, V107, P1201, DOI 10.1017/S0007114511004223
   Franke AA, 2008, NUTR CANCER, V60, P627, DOI 10.1080/01635580802065310
   Franke AA, 2004, NUTR CANCER, V50, P141, DOI 10.1207/s15327914nc5002_3
   FRANKE AA, 1994, J CHROMATOGR B, V662, P47, DOI 10.1016/0378-4347(94)00390-4
   Franke AA, 1999, BIOCHEM SOC T, V27, P308
   Franke AA, 2012, J NUTR BIOCHEM, V23, P573, DOI 10.1016/j.jnutbio.2011.03.002
   Frankenfeld CL, 2003, AM J CLIN NUTR, V77, P674
   Gilchrist JM, 2010, J PEDIATR-US, V156, P215, DOI 10.1016/j.jpeds.2009.08.043
   Halm BM, 2008, NUTR CANCER, V60, P14, DOI 10.1080/01635580701586747
   Halm BM, 2007, BRIT J NUTR, V98, P998, DOI 10.1017/S0007114507771866
   Hendrich S., 2001, HDB NUTRACEUTICALS F, P55
   Hodis HN, 2011, STROKE, V42, P3168, DOI 10.1161/STROKEAHA.111.620831
   Horn-Ross PL, 2000, CANCER CAUSE CONTROL, V11, P299, DOI 10.1023/A:1008968003575
   Irvine CHG, 1998, AM J CLIN NUTR, V68, p1462S
   Jaceldo-Siegl K, 2008, AM J CLIN NUTR, V87, P1422
   Jurd L., 1962, CHEM FLAVONOID COMPO, P107
   Ko TF, 2010, J FOOD SCI, V75, pH306, DOI 10.1111/j.1750-3841.2010.01860.x
   Korde LA, 2009, CANCER EPIDEM BIOMAR, V18, P1050, DOI 10.1158/1055-9965.EPI-08-0405
   Lampe J., 2009, AM J CLIN NUTR, V89, P1664
   Lampe JW, 2010, J NUTR, V140, p1369S, DOI 10.3945/jn.109.118323
   Lampe JW, 2001, J NUTR, V131, P740
   Lasekan JB, 1999, CLIN PEDIATR, V38, P563, DOI 10.1177/000992289903801001
   Lee SA, 2009, AM J CLIN NUTR, V89, P1920, DOI 10.3945/ajcn.2008.27361
   Liu BH, 2010, J EPIDEMIOL, V20, P377, DOI 10.2188/jea.JE20090185
   Lu LJW, 1996, NUTR CANCER, V26, P289
   LU LLW, 1995, NUTR CANCER, V24, P311
   Maskarinec G, 2005, NUTR CANCER, V52, P22, DOI 10.1207/s15327914nc5201_3
   Maskarinec G, 2005, EUR J CLIN NUTR, V59, P369, DOI 10.1038/sj.ejcn.1602083
   Maskarinec G, 2003, J AM DIET ASSOC, V103, P861, DOI [10.1016/S0002-8223(03)00377-8, 10.1053/jada.2002.50162]
   Nagata C, 2008, NUTR CANCER, V60, P49, DOI 10.1080/01635580701525885
   Nettleton JA, 2005, J NUTR, V135, P603
   Nettleton JA, 2004, J NUTR, V134, P1998
   Ollis W.D., 1962, CHEM FLAVONOID COMPO, P353
   Ritchie MR, 2004, BRIT J NUTR, V91, P447, DOI 10.1079/BJN20031062
   Setchell KDR, 2001, J NUTR, V131, p1362S
   Shu XO, 2001, CANCER EPIDEM BIOMAR, V10, P483
   Silbernagl S., 1983, TASCHENATLAS PHYSL
   Slavin JL, 1998, AM J CLIN NUTR, V68, p1492S
   STEICHEN JJ, 1987, J PEDIATR-US, V110, P687, DOI 10.1016/S0022-3476(87)80003-3
   Thanos J, 2006, CANCER CAUSE CONTROL, V17, P1253, DOI 10.1007/s10552-006-0062-2
   Vedrine N, 2006, EUR J CLIN NUTR, V60, P1039, DOI 10.1038/sj.ejcn.1602415
   Walker SE, 2008, ATHEROSCLEROSIS, V196, P106, DOI 10.1016/j.atherosclerosis.2007.02.007
   Wang Q, 2013, BIOMED REP, V1, P697
   WILLIAMS CA, 1989, METHODS PLANT BIOCH, V1, P421
   Wiseman H., 2006, Flavonoids: chemistry, biochemistry and applications, P371
   Wu AH, 2002, CARCINOGENESIS, V23, P1491, DOI 10.1093/carcin/23.9.1491
   Yan L., 2004, INT J CANC PREV, V1, P281
NR 90
TC 3
Z9 3
U1 7
U2 35
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 24
EP 28
DI 10.1016/j.abb.2014.06.007
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100005
PM 24946051
ER

PT J
AU Gasper, A
   Hollands, W
   Casgrain, A
   Saha, S
   Teucher, B
   Dainty, JR
   Venema, DP
   Hollman, PC
   Rein, MJ
   Nelson, R
   Williamson, G
   Kroon, PA
AF Gasper, Amy
   Hollands, Wendy
   Casgrain, Amelie
   Saha, Shikha
   Teucher, Birgit
   Dainty, Jack R.
   Venema, Dini P.
   Hollman, Peter C.
   Rein, Maarit J.
   Nelson, Rebecca
   Williamson, Gary
   Kroon, Paul A.
TI Consumption of both low and high (-)-epicatechin apple puree attenuates
   platelet reactivity and increases plasma concentrations of nitric oxide
   metabolites: A randomized controlled trial
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Platelet reactivity; Nitric oxide; Flavonoids
ID FLAVANOL-RICH COCOA; REDUCES BLOOD-PRESSURE; GREEN TEA CATECHINS; BLACK
   TEA; GRAPE JUICE; ENDOTHELIAL DYSFUNCTION; REGULAR INGESTION; FOOD
   SOURCES; RED WINE; IN-VIVO
AB We hypothesised that consumption of flavanol-containing apple puree would modulate platelet activity and increase nitric oxide metabolite status, and that high flavanol apple puree would exert a greater effect than low flavanol apple puree. 25 subjects consumed 230 g of apple puree containing 25 and 100 mg epicatechin (low and high flavanol apple puree, respectively) and aspirin (75 mg) in random order. Measurements were made at baseline, acutely after treatment (2, 6 and 24 h), and after 14 d of treatment. Low flavanol apple puree significantly attenuated ADP and epinephrine-induced integrin-beta 3 expression 2 h and 6 h after consumption and ADP and epinephrine-induced P-selectin expression within 2 h of consumption. High flavanol apple puree attenuated epinephrine and ADP-induced integrin-beta 3 expression after 2 and 6 h. ADP and epinephrine-induced integrin-beta 3 expression was significantly attenuated 2, 6 and 24 h after consumption of aspirin, whilst 14 d aspirin consumption attenuated collagen-induced P-selectin expression only. The plasma total nitric oxide metabolite conc. was significantly increased 6 h after consumption of both low and high flavanol apple purees. In conclusion, consumption of apple purees containing >= 25 or 100 mg flavanols transiently attenuated ex vivo integrin-beta 3 and P-selectin expression and increased plasma nitric oxide metabolite conc. in healthy subjects, but the effect was not enhanced for the high flavanol apple puree. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Gasper, Amy; Hollands, Wendy; Casgrain, Amelie; Saha, Shikha; Teucher, Birgit; Dainty, Jack R.; Kroon, Paul A.] Inst Food Res, Food & Hlth Programme, Norwich NR4 7UA, Norfolk, England.
   [Venema, Dini P.; Hollman, Peter C.] RIKILT Inst Food Safety, Wageningen, Netherlands.
   [Rein, Maarit J.; Nelson, Rebecca; Williamson, Gary] Nestle Res Ctr, CH-1000 Lausanne 26, Switzerland.
   [Williamson, Gary] Univ Leeds, Sch Food Sci & Nutr, Leeds LS2 9JT, W Yorkshire, England.
RP Kroon, PA (reprint author), Inst Food Res, Food & Hlth Programme, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.
EM paul.kroon@ifr.ac.uk
RI Hollman, Peter/I-7446-2013; Kroon, Paul/H-5384-2013; Williamson,
   Gary/C-9684-2010; Teucher, Birgit/J-6380-2015
OI Hollman, Peter/0000-0002-7510-6809; Kroon, Paul/0000-0002-9805-6947;
   Williamson, Gary/0000-0002-5624-6267; 
FU EU Grant [Food-CT-2004-513960]; UK Biotechnology and Biological Sciences
   Research Council (BBSRC)
FX This research was supported by an EU Grant (Food-CT-2004-513960) and
   funding from the UK Biotechnology and Biological Sciences Research
   Council (BBSRC).
CR Engler MB, 2004, J AM COLL NUTR, V23, P197
   Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227
   Loke WM, 2008, AM J CLIN NUTR, V88, P1018
   Pearson DA, 2002, THROMB RES, V106, P191, DOI 10.1016/S0049-3848(02)00128-7
   Schewe T, 2001, BIOL CHEM, V382, P1687, DOI 10.1515/BC.2001.204
   Keevil JG, 2000, J NUTR, V130, P53
   Ellinger S, 2012, AM J CLIN NUTR, V95, P1365, DOI 10.3945/ajcn.111.029330
   Holt RR, 2002, JAMA-J AM MED ASSOC, V287, P2212, DOI 10.1001/jama.287.17.2212
   Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411
   Osman HE, 1998, J NUTR, V128, P2307
   JOANNIDES R, 1995, CIRCULATION, V91, P1314
   Saha S, 2012, PHARMACOL RES, V65, P592, DOI 10.1016/j.phrs.2012.02.005
   Schramm DD, 2001, AM J CLIN NUTR, V73, P36
   PaceAsciak CR, 1996, CLIN CHIM ACTA, V246, P163, DOI 10.1016/0009-8981(96)06236-5
   Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/01.hjh.0000084783.15238.eb
   Richelle M, 1999, EUR J CLIN NUTR, V53, P22, DOI 10.1038/sj.ejcn.1600673
   Heiss C, 2003, JAMA-J AM MED ASSOC, V290, P1030, DOI 10.1001/jama.290.8.1030
   Mathur S, 2002, J NUTR, V132, P3663
   Del Rio D, 2010, NUTRITION, V26, P1110, DOI 10.1016/j.nut.2009.09.021
   Hooper L, 2008, AM J CLIN NUTR, V88, P38
   Alexopoulos N, 2008, EUR J CARDIOV PREV R, V15, P300, DOI 10.1097/HJR.0b013e3282f4832f
   Heiss C, 2005, J AM COLL CARDIOL, V46, P1276, DOI 10.1016/j.jacc.2005.06.055
   Rein D, 2000, AM J CLIN NUTR, V72, P30
   Cooper KA, 2008, BRIT J NUTR, V99, P1, DOI 10.1017/S0007114507795296
   Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523
   Freedman JE, 2001, CIRCULATION, V103, P2792
   Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103
   Hord NG, 2009, AM J CLIN NUTR, V90, P1, DOI 10.3945/ajcn.2008.27131
   Murphy KJ, 2003, AM J CLIN NUTR, V77, P1466
   Siervo M, 2013, J NUTR, V143, P818, DOI 10.3945/jn.112.170233
   BYDLOWSKI SP, 1987, INT J VITAM NUTR RES, V57, P217
   Chun OK, 2007, J NUTR, V137, P1244
   Ding EL, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-2
   Duffy SJ, 2001, ARTERIOSCL THROM VAS, V21, P1084
   Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com
   Folts JD, 1998, PHARM BIOL, V36, P21, DOI 10.1076/phbi.36.6.21.4558
   Grimm Tanja, 2006, BMC Clin Pharmacol, V6, P4, DOI 10.1186/1472-6904-6-4
   Hodgson JM, 2002, CLIN SCI, V102, P195, DOI 10.1042/CS20010120
   Hodgson JM, 2002, BRIT J NUTR, V87, P141, DOI 10.1079/BJN2001499
   Hodgson JM, 2001, EUR J CLIN NUTR, V55, P881, DOI 10.1038/sj.ejcn.1601231
   Jeong WS, 2004, PHARM BIOL, V42, P84, DOI 10.1080/13880200490893500
   Kang WS, 1999, THROMB RES, V96, P229, DOI 10.1016/S0049-3848(99)00104-8
   Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeadbiomed.2005.08.025
   Matsuo S, 2001, AM J CARDIOL, V87, P1029, DOI 10.1016/S0002-9149(01)01446-1
   McKenzie Marcus E., 2003, Blood Coagulation & Fibrinolysis, V14, P249, DOI 10.1097/00001721-200304000-00005
   Menet MC, 2004, J AGR FOOD CHEM, V52, P2455, DOI 10.1021/jf035427e
   Polagruto JA, 2007, J MED FOOD, V10, P725, DOI 10.1089/jmf.2007.402
   Rein D, 2000, J NUTR, V130, p2120S
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Urpi-Sarda M, 2009, J CHROMATOGR A, V1216, P7258, DOI 10.1016/j.chroma.2009.07.058
   van der Hooft JJJ, 2012, ANAL CHEM, V84, P7263, DOI 10.1021/ac3017339
NR 51
TC 2
Z9 2
U1 3
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 29
EP 37
DI 10.1016/j.abb.2014.05.026
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100006
PM 24929184
ER

PT J
AU Choi, KS
   Kundu, JK
   Chun, KS
   Na, HK
   Surh, YJ
AF Choi, Ki-Seok
   Kundu, Joydeb Kumar
   Chun, Kyung-Soo
   Na, Hye-Kyung
   Surh, Young-Joon
TI Rutin inhibits UVB radiation-induced expression of COX-2 and iNOS in
   hairless mouse skin: p38 MAP kinase and JNK as potential targets
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Rutin; Cyclooxygenase-2; Inducible nitric oxide synthase; Mouse skin
   carcinogenesis; UVB-induced skin cancer; AP-1
ID NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; ACTIVATED PROTEIN-KINASES;
   ESTER-INDUCED EXPRESSION; PHORBOL ESTER; CYCLOOXYGENASE-2 EXPRESSION;
   UPSTREAM TARGETS; HUMAN KERATINOCYTES; OXIDATIVE DAMAGE; TERMINAL KINASE
AB Exposure to ultraviolet B (UVB) radiation, a complete environmental carcinogen, induces oxidative and inflammatory skin damage, thereby increasing the risk of skin carcinogenesis. The antioxidant and anti-inflammatory activities of a wide variety of plant polyphenols have been reported. Rutin (3-rhamnosyl-glucosylquercetin), a polyphenol present in many edible plants, possesses diverse pharmacological properties including antioxidant, anti-inflammatory, antimutagenic and anticancer activities. The present study was aimed to investigate the effects of rutin on UVB-induced inflammation in mouse skin in vivo. Topical application of rutin onto the dorsal skin of female HR-1 hairless mice 30 min prior to UVB irradiation diminished epidermal hyperplasia and the levels of proteins modified by 4-hydroxynonenal, which is a biochemical hallmark of lipid peroxidation. Topical application of rutin also significantly inhibited UVB-induced expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), two representative inflammatory enzymes, in hairless mouse skin. Rutin inhibited the DNA binding of activator protein-1 (AP-1) and phosphorylation of signal transducer and activator of transcription-3 (STAT3) in mouse skin exposed to UVB. Moreover, rutin attenuated UVB-induced phosphorylation of p38 mitogen-activated protein (MAP) kinase and c-Jun-N-terminal kinase (JNK). Pharmacological inhibition of p38 MAP kinase and JNK decreased UVB-induced expression of COX-2 in mouse skin. Taken together, these findings suggest that rutin exerts anti-inflammatory effects in UVB-irradiated mouse skin by inhibiting expression of COX-2 and iNOS, which is attributable to its suppression of p38 MAP kinase and JNK signaling responsible for AP-1 activation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Choi, Ki-Seok; Surh, Young-Joon] Seoul Natl Univ, Coll Pharm, Tumor Microenvironm Global Core Res Ctr, Seoul 151742, South Korea.
   [Kundu, Joydeb Kumar; Chun, Kyung-Soo] Keimyung Univ, Coll Pharm, Taegu 704701, South Korea.
   [Na, Hye-Kyung] Sungsin Womens Univ, Dept Food & Nutr, Seoul 136742, South Korea.
   [Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea.
   [Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul 151742, South Korea.
RP Surh, YJ (reprint author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 151742, South Korea.
EM surh@snu.ac.kr
FU Global Core Research Center (GCRC) grant [2012-0001184]; National
   Research Foundation (NRF), Republic of Korea [2008-0093868]
FX This work was supported by the Global Core Research Center (GCRC) grant
   (No. 2012-0001184) and the grant (No. 2008-0093868) from the National
   Research Foundation (NRF), Republic of Korea.
CR Alonso-Castro AJ, 2013, ARCH MED RES, V44, P346, DOI 10.1016/j.arcmed.2013.06.002
   Chang HR, 2003, ARCH DERMATOL RES, V295, P293, DOI 10.1007/s00403-003-0433-4
   Kim SO, 2005, ONCOGENE, V24, P2558, DOI 10.1038/sj.onc.1208446
   Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x
   Tripp CS, 2003, J INVEST DERMATOL, V121, P853, DOI 10.1046/j.1523-1747.2003.12495.x
   Chun KS, 2003, CARCINOGENESIS, V24, P1515, DOI 10.1093/carcin/bgg107
   Chun KS, 2004, CARCINOGENESIS, V25, P713, DOI 10.1093/carcin/bgh076
   Hong JT, 2001, MOL CARCINOGEN, V31, P152, DOI 10.1002/mc.1050
   Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545
   Cho JW, 2005, EXP MOL MED, V37, P186
   Ziesche E, 2007, J BIOL CHEM, V282, P16006, DOI 10.1074/jbc.M611040200
   Afaq F, 2003, ONCOGENE, V22, P9254, DOI 10.1038/sj.onc.1207035
   Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012
   Allport VC, 2000, MOL HUM REPROD, V6, P561, DOI 10.1093/molehr/6.6.561
   Chen WX, 1999, ONCOGENE, V18, P7469, DOI 10.1038/sj.onc.1203210
   Liu Y, 2013, PHARM BIOL, V51, P914, DOI 10.3109/13880209.2013.771375
   Chang EJ, 2011, MOL CARCINOGEN, V50, P310, DOI 10.1002/mc.20646
   Kim GN, 2011, TOXICOL IN VITRO, V25, P138, DOI 10.1016/j.tiv.2010.10.005
   Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200
   Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3
   Sharma S, 2013, EXPERT OPIN INV DRUG, V22, P1063, DOI 10.1517/13543784.2013.805744
   Moretti E, 2012, REPROD TOXICOL, V34, P651, DOI 10.1016/j.reprotox.2012.10.002
   Tiano HF, 2002, CANCER RES, V62, P3395
   INOUE H, 1995, J BIOL CHEM, V270, P24965
   Kundu JK, 2012, FREE RADICAL BIO MED, V52, P2013, DOI 10.1016/j.freeradbiomed.2012.02.035
   Kim DJ, 2009, ONCOGENE, V28, P950, DOI 10.1038/onc.2008.453
   Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013
   Chan ED, 2001, AM J PHYSIOL-CELL PH, V280, pC441
   An KP, 2002, PHOTOCHEM PHOTOBIOL, V76, P73, DOI 10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2
   Afaq F, 2005, MUTAT RES-FUND MOL M, V571, P153, DOI 10.1016/j.mrfmmm.2004.07.019
   Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007
   Lee JC, 2007, CARCINOGENESIS, V28, P1491, DOI 10.1093/carcin/bgm054
   Turkson J, 1999, MOL CELL BIOL, V19, P7519
   Staniforth V, 2006, CARCINOGENESIS, V27, P1803, DOI 10.1093/carcin/bgl006
   Bachelor MA, 2005, MOL CANCER RES, V3, P90, DOI 10.1158/1541-7786.MCR-04-0065
   Bode A.M., 2003, SCI STKE, V2003
   Choi JK, 2013, EXP BIOL MED, V238, P410, DOI 10.1177/1535370213477975
   Choi S, 2013, BIOCHEM PHARMACOL, V86, P1468, DOI 10.1016/j.bcp.2013.08.066
   Chu SC, 1998, BIOCHEM BIOPH RES CO, V248, P871, DOI 10.1006/bbrc.1998.9062
   Chun KS, 2004, CARCINOGENESIS, V25, P445, DOI 10.1093/carcin/bgh021
   Dickinson SE, 2011, MOL CARCINOGEN, V50, P469, DOI 10.1002/mc.20734
   Fischer SM, 2007, MOL CARCINOGEN, V46, P363, DOI 10.1002/mc.20284
   Guan ZH, 1999, J BIOL CHEM, V274, P36200, DOI 10.1074/jbc.274.51.36200
   Guruvayoorappan C., 2007, Drug Metabolism and Drug Interactions, V22, P263
   Harborne J B, 1986, Prog Clin Biol Res, V213, P15
   Huang CS, 1999, ONCOGENE, V18, P2828, DOI 10.1038/sj.onc.1202639
   KATO R, 1983, CARCINOGENESIS, V4, P1301, DOI 10.1093/carcin/4.10.1301
   Koon HW, 2006, J IMMUNOL, V176, P5050
   Kundu JK, 2008, PHOTOCHEM PHOTOBIOL, V84, P399, DOI 10.1111/j.1751-1097.2007.00277.x
   Lin CF, 2012, EUR J PHARM SCI, V47, P857, DOI 10.1016/j.ejps.2012.04.024
   Lin JP, 2012, ENVIRON TOXICOL, V27, P480, DOI 10.1002/tox.20662
   Marin M, 2013, PLANTA MED, V79, P1392, DOI 10.1055/s-0033-1350710
   Medeiros R, 2009, BIOCHEM PHARMACOL, V78, P390, DOI 10.1016/j.bcp.2009.04.021
   Muller-Decker K, 2002, P NATL ACAD SCI USA, V99, P12483, DOI 10.1073/pnas.192323799
   Oberley TD, 2004, ANTIOXID REDOX SIGN, V6, P537, DOI 10.1089/152308604773934297
   Olszewska MA, 2012, NAT PROD RES, V26, P243, DOI 10.1080/14786419.2010.537271
   Patil Shrikant L, 2013, J Med Phys, V38, P87, DOI 10.4103/0971-6203.111321
   Tyrrell R M, 1995, Biochem Soc Symp, V61, P47
NR 58
TC 4
Z9 4
U1 2
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 38
EP 45
DI 10.1016/j.abb.2014.05.016
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100007
PM 24875145
ER

PT J
AU Cheong, JDLK
   Croft, KD
   Henry, PD
   Matthews, V
   Hodgson, JM
   Ward, NC
AF Cheong, J. D. Li Kwok
   Croft, K. D.
   Henry, P. D.
   Matthews, V.
   Hodgson, J. M.
   Ward, N. C.
TI Green coffee polyphenols do not attenuate features of the metabolic
   syndrome and improve endothelial function in mice fed a high fat diet
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Chlorogenic acid; Atherosclerosis; Metabolic syndrome; Endothelial
   dysfunction; Coffee
ID TYPE-2 DIABETES-MELLITUS; E-KNOCKOUT MICE; CHLOROGENIC ACID; OXIDATIVE
   STRESS; PHENOLIC-COMPOUNDS; MASS-SPECTROMETRY; TEA CONSUMPTION;
   DYSFUNCTION; OBESITY; RATS
AB We have investigated the effects of the major polyphenol in coffee, chlorogenic acid (CGA), on obesity, glucose intolerance, insulin resistance, systemic oxidative stress and endothelial dysfunction in a mouse model of the metabolic syndrome. Thirty C57BL6 mice were randomly divided into (n = 10/group) (i) normal diet (ND), (ii) high fat diet (HFD), or (iii) high fat diet supplemented with 0.5% w/w green coffee bean extract (GCE) rich in chlorogenic acid (HFD + GCE). The high fat diet consisted of 28% fat and all animals were maintained on their diets for 12 weeks. The mice fed a HFD and HFD + GCE displayed symptoms of the metabolic syndrome compared to their normal fed counterparts, although no endothelial dysfunction was detected in the abdominal aortas after 12 weeks. GCE did not attenuate HFD-induced obesity, glucose intolerance, insulin resistance or systemic oxidative stress. Furthermore, GCE did not protect against ex vivo oxidant (hypochlorous acid)-induced endothelial dysfunction. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Cheong, J. D. Li Kwok; Croft, K. D.; Henry, P. D.; Hodgson, J. M.; Ward, N. C.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6847, Australia.
   [Matthews, V.] Harry Perkins Inst Med Res, UWA Ctr Med Res, Lab Metab Dysfunct, Perth, WA, Australia.
RP Ward, NC (reprint author), Univ Western Australia, Sch Med & Pharmacol, GPO Box X2213, Perth, WA 6847, Australia.
EM natalie.ward@uwa.edu.au
FU Raine Medical Research Foundation; MRF/UWA Postdoctoral Fellowship;
   NHMRC
FX This study was supported by a Raine Medical Research Foundation Priming
   Grant. The authors acknowledge the A. Mubarak, A. Indrawan and Y. Shen
   for their valuable laboratory assistance. N.C. Ward acknowledges the
   support of a MRF/UWA Postdoctoral Fellowship. J.M. Hodgson acknowledges
   the support of a NHMRC Senior Research Fellowship. V. Matthews
   acknowledges the support of a NHMRC Career Development Fellowship.
CR Crozier TWM, 2012, FOOD FUNCT, V3, P30, DOI 10.1039/c1fo10240k
   de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0
   DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013
   Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, pE122, DOI 10.1152/ajpendo.00441.2010
   Kobayasi R, 2010, J HYPERTENS, V28, P2111, DOI 10.1097/HJH.0b013e32833ca68c
   Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a
   Perticone F, 2001, DIABETES, V50, P159, DOI 10.2337/diabetes.50.1.159
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   Gonthier MP, 2003, J NUTR, V133, P1853
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687
   Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238
   Monteiro M, 2007, J NUTR, V137, P2196
   Jaiswal R, 2012, FOOD FUNCT, V3, P976, DOI 10.1039/c2fo10260a
   Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11
   Ruhl CE, 2005, GASTROENTEROLOGY, V129, P1928, DOI 10.1053/j.gast.2005.08.056
   Shen Y, 2013, FREE RADICAL BIO MED, V65, P908, DOI 10.1016/j.freeradbiomed.2013.08.185
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Roberts CK, 2005, J APPL PHYSIOL, V98, P203, DOI 10.1152/japplphysiol.00463.2004
   Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Bondonno CP, 2012, FREE RADICAL BIO MED, V52, P95, DOI 10.1016/j.freeradbiomed.2011.09.028
   Mori TA, 1999, ANAL BIOCHEM, V268, P117, DOI 10.1006/abio.1998.3037
   Deckert V, 1999, CIRCULATION, V100, P1230
   Deedwania Prakash C, 2003, Curr Diab Rep, V3, P289, DOI 10.1007/s11892-003-0019-8
   DeFronzo R.A., 2004, MED CLIN N AM, V88, pix
   Esper RJ, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-4
   Hollman PCH, 2011, J NUTR, V141, p989S, DOI 10.3945/jn.110.131490
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Liu J., 2013, MAYO CLIN P, V88, P10
   Shen Y, 2012, BIOCHEM PHARMACOL, V84, P1036, DOI 10.1016/j.bcp.2012.07.016
   Stalmach Angelique, 2006, Brazilian Journal of Plant Physiology, V18, P253, DOI 10.1590/S1677-04202006000100018
   Stocker R, 2004, ARTERIOSCL THROM VAS, V24, P2028, DOI 10.1161/01.ATV.0000143388.20994.fa
NR 40
TC 2
Z9 2
U1 6
U2 50
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 46
EP 52
DI 10.1016/j.abb.2014.02.005
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100008
ER

PT J
AU Qin, S
   Deng, FM
   Wu, WG
   Jiang, LW
   Yamashiro, T
   Yano, S
   Hou, DX
AF Qin, Si
   Deng, Fangming
   Wu, Weiguo
   Jiang, Liwen
   Yamashiro, Takaaki
   Yano, Satoshi
   Hou, De-Xing
TI Baicalein modulates Nrf2/Keap1 system in both Keap1-dependent and
   Keap1-independent mechanisms
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Baicalein; Nrf2/Keap1 system; Nrf2 ubiquitination; Keap1 modification
ID PROTEIN-KINASE-C; NF-KAPPA-B; GENE-EXPRESSION; UP-REGULATION;
   PHOSPHATIDYLINOSITOL 3-KINASE; NF-E2-RELATED FACTOR-2; NUCLEAR
   TRANSLOCATION; MOLECULAR-MECHANISM; DETOXIFYING ENZYMES; SIGNALING
   PATHWAY
AB Baicalein, a major component of Scutellaria baicalensis Georgi (Huang Qin), is widely used in the traditional Chinese medicine. However, the mechanisms underlying cancer chemoprevention are still not clear. The present study aimed to clarify how baicalein modulate Nrf2/Keap1 system to exert its cytoprotection and cancer chemoprevention. In the upstream cellular signaling, baicalein stimulated the phosphorylation of MEK1/2, AKT and JNK1/2, which were demonstrated to be essential for baicalein-induced Nrf2 expression by their inhibitors. Immunoprecipitation with Nrf2 found that baicalein increased the amount of phosphorylated MEK1/2, AKT and JNK1/2 bound to Nrf2, and also stabilized Nrf2 protein by inhibiting the ubiquitination and proteasomal turnover of Nrf2. Simultaneously, baicalein down-regulated Keap1 by stimulating modification and degradation of Keap1 without affecting the dissociation of Keap1-Nrf2. Silencing Nrf2 using Nrf2 siRNA markedly reduced the ARE activity under both baseline and baicalein-induced conditions. Thus, baicalein positively modulate Nrf2/Keap1 system through both Keap1-independent and -dependent pathways. These finding provide an insight to understand the mechanisms of baicalein in cytoprotection and cancer chemoprevention. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Qin, Si; Deng, Fangming; Wu, Weiguo; Jiang, Liwen; Hou, De-Xing] Hunan Agr Univ, Coll Food Sci & Technol, Key Lab Food Sci & Biotechnol Hunan Prov, Changsha, Hunan, Peoples R China.
   [Qin, Si; Yamashiro, Takaaki; Yano, Satoshi; Hou, De-Xing] Kagoshima Univ, Fac Agr, Dept Biochem Sci & Technol, Kagoshima 8900065, Japan.
   [Hou, De-Xing] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900065, Japan.
RP Hou, DX (reprint author), Kagoshima Univ, Fac Agr, Dept Biochem Sci & Technol, Korimoto 1-21-24, Kagoshima 8900065, Japan.
EM hou@chem.agri.kagoshima-u.ac.jp
FU National Natural Science Foundation of China [31101268]; Scientific
   Research Fund of Hunan Provincial Education Department [138047]; Hunan
   Agriculture University; fund of Scholar Research of Kagoshima
   University, Japan
FX This work was partially supported by National Natural Science Foundation
   of China (31101268) and Scientific Research Fund of Hunan Provincial
   Education Department (138047) to S. Qin, and by Hunan Agriculture
   University Grant for 100 Intelligent Projects, and the fund of Scholar
   Research of Kagoshima University, Japan to D.X. Hou.
CR Akao T, 2000, J PHARM PHARMACOL, V52, P1563, DOI 10.1211/0022357001777621
   Martelli AM, 2003, LEUKEMIA, V17, P1794, DOI 10.1038/sj.leu.2403044
   Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003
   Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003
   Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5
   Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200
   Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003
   Rada P, 2012, MOL CELL BIOL, V32, P3486, DOI 10.1128/MCB.00180-12
   Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075
   Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664
   Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200
   Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817
   Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237
   Lin CW, 2010, J AGR FOOD CHEM, V58, P4477, DOI 10.1021/jf904061x
   Kang HJ, 2010, J BIOL CHEM, V285, P21258, DOI 10.1074/jbc.M109.084590
   Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899
   Pi JB, 2007, FREE RADICAL BIO MED, V42, P1797, DOI 10.1016/j.freeradbiomed.2007.03.001
   Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200
   Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035
   Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200
   Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X
   Xu CJ, 2006, MOL CANCER THER, V5, P1918, DOI 10.1158/1535-7163.MCT-05-0497
   Qin S, 2013, MOL NUTR FOOD RES, V57, P435, DOI 10.1002/mnfr.201200563
   Ninomiya-Tsuji J, 1999, NATURE, V398, P252
   Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545
   Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200
   Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221
   Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102
   Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388
   Rushworth SA, 2012, BLOOD, V120, P5188, DOI 10.1182/blood-2012-04-422121
   Shimoi K, 2001, DRUG METAB DISPOS, V29, P1521
   Kaspar JW, 2011, FASEB J, V25, P1076, DOI 10.1096/fj.10-171553
   Papp D, 2012, FEBS LETT, V586, P1795, DOI 10.1016/j.febslet.2012.05.016
   Donald G, 2012, CURR DRUG TARGETS, V13, P1772
   Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950
   Ohtsubo T, 1999, CELL DEATH DIFFER, V6, P865, DOI 10.1038/sj.cdd.4400566
   Pidgeon GP, 2002, CANCER RES, V62, P2721
   Lee JM, 2001, J BIOL CHEM, V276, P20011, DOI 10.1074/jbc.M100734200
   Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005
   Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9
   Lai MY, 2003, J PHARM PHARMACOL, V55, P205, DOI 10.1211/002235702522
   Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046
   Kumamoto T, 2009, CANCER LETT, V275, P17, DOI 10.1016/j.canlet.2008.09.027
   Belyanskaya LL, 2005, INT J CANCER, V117, P755, DOI 10.1002/ijc.21242
   De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189
   Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006
   Kang KW, 2002, MOL PHARMACOL, V62, P1001, DOI 10.1124/mol.62.5.1001
   Chao JI, 2007, MOL CANCER THER, V6, P3039, DOI 10.1158/1535-7163.MCT-07-0281
   Ishisaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080843
   Miyata Y, 2004, MOL CANCER THER, V3, P839
   Qin S, 2012, J ETHNOPHARMACOL, V140, P131, DOI 10.1016/j.jep.2011.12.046
   Sakai M, 2001, NUCLEIC ACIDS RES, V29, P1228, DOI 10.1093/nar/29.5.1228
   Spence JR, 2007, MOL VIS, V13, P57
   Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017
NR 54
TC 5
Z9 6
U1 4
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 53
EP 61
DI 10.1016/j.abb.2014.03.011
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100009
PM 24704364
ER

PT J
AU Ruotolo, R
   Calani, L
   Brighenti, F
   Crozier, A
   Ottonello, S
   Del Rio, D
AF Ruotolo, Roberta
   Calani, Luca
   Brighenti, Furio
   Crozier, Alan
   Ottonello, Simone
   Del Rio, Daniele
TI Glucuronidation does not suppress the estrogenic activity of quercetin
   in yeast and human breast cancer cell model systems
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Flavonols; Quercetin; Quercetin metabolites; Phytoestrogen
ID IN-VITRO; RECEPTOR-ALPHA; FLAVONOIDS; PHYTOESTROGENS; ANTIOXIDANT;
   GENISTEIN; QUERCETIN-3-O-GLUCURONIDE; IDENTIFICATION; METABOLITES;
   EXPRESSION
AB Several plant-derived molecules, referred to as phytoestrogens, are thought to mimic the actions of endogenous estrogens. Among these, quercetin, one of the most widespread flavonoids in the plant kingdom, has been reported as estrogenic in some occasions. However, quercetin occurs in substantial amounts as glycosides such as quercetin-3-O-glucoside (isoquercitrin) and quercetin-3-O-rutinoside (rutin) in dietary sources. It is now well established that quercetin undergoes substantial phase II metabolism after ingestion by humans, with plasma metabolites after a normal dietary intake rarely exceeding nmol/L concentrations. Therefore, attributing phytoestrogenic activity to flavonoids without taking into account the fact that it is their phase II metabolites that enter the circulatory system, will almost certainly lead to misleading conclusions. With the aim of clarifying the above issue, the goal of the present study was to determine if plant-associated quercetin glycosides and human phase II quercetin metabolites, actually found in human biological fluids after intake of quercetin containing foods, are capable of interacting with the estrogen receptors (ER). To this end, we used a yeast-based two-hybrid system and an estrogen response element-luciferase reporter assay in an ER-positive human cell line (MCF-7) to probe the ER interaction capacities of quercetin and its derivatives. Our results show that quercetin-3-O-glucuronide, one of the main human phase II metabolites produced after intake of dietary quercetin, displays ER alpha- and ER beta-dependent estrogenic activity, the functional consequences of which might be related to the protective activity of diets rich in quercetin glycosides. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Ruotolo, Roberta; Ottonello, Simone] Univ Parma, Dept Life Sci, Biochem & Mol Biol Unit, Lab Funct Genom & Prot Engn, I-43124 Parma, Italy.
   [Calani, Luca; Brighenti, Furio; Del Rio, Daniele] Univ Parma, Dept Food Sci, Human Nutr Unit, Lab Phytochem Physiol, I-43125 Parma, Italy.
   [Calani, Luca; Del Rio, Daniele] Univ Parma, Dept Food Sci, Interlab Grp, Bioact & Hlth LS9, I-43124 Parma, Italy.
   [Crozier, Alan] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Plant Prod & Human Nutr Grp, Glasgow G12 8QQ, Lanark, Scotland.
RP Ottonello, S (reprint author), Univ Parma, Dept Life Sci, Parco Area Sci 23-A, I-43124 Parma, Italy.
EM s.ottonello@unipr.it; daniele.delrio@unipr.it
RI Del Rio, Daniele/E-8696-2010; brighenti, furio/E-4174-2010
OI Del Rio, Daniele/0000-0001-5394-1259; brighenti,
   furio/0000-0001-8441-4611
FU Progetto AGER [2011-0283]
FX This study has been partly supported by "Progetto AGER" (grant No.
   2011-0283).
CR Zhang Y, 1999, J NUTR, V129, P399
   Ruotolo R, 2013, NUTR METAB CARDIOVAS, V23, P1086, DOI 10.1016/j.numecd.2013.01.002
   MOREL I, 1993, BIOCHEM PHARMACOL, V45, P13, DOI 10.1016/0006-2952(93)90371-3
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1
   Nishikawa J, 1999, TOXICOL APPL PHARM, V154, P76, DOI 10.1006/taap.1998.8557
   Day AJ, 2001, FREE RADICAL RES, V35, P941, DOI 10.1080/10715760100301441
   Mira L, 2002, FREE RADICAL RES, V36, P1199, DOI 10.1080/1071576021000016463
   Prouillet C, 2004, BIOCHEM PHARMACOL, V67, P1307, DOI 10.1016/j.bcp.2003.11.009
   Craig MC, 2010, ANN NY ACAD SCI, V1205, P245, DOI 10.1111/j.1749-6632.2010.05673.x
   Moon JH, 2001, FREE RADICAL BIO MED, V30, P1274, DOI 10.1016/S0891-5849(01)00522-6
   Maggiolini M, 2001, MOL PHARMACOL, V60, P595
   Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008
   Tsuji M, 2009, J BONE MINER METAB, V27, P673, DOI 10.1007/s00774-009-0088-0
   Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252
   Crozier A, 2010, MOL ASPECTS MED, V31, P446, DOI 10.1016/j.mam.2010.09.007
   Patisaul HB, 2010, FRONT NEUROENDOCRIN, V31, P400, DOI 10.1016/j.yfrne.2010.03.003
   Mullen W, 2006, BRIT J NUTR, V96, P107, DOI 10.1079/BJN20061809
   Pugazhendhi D, 2008, J ENDOCRINOL, V197, P503, DOI 10.1677/JOE-07-0384
   Derlindati E, 2012, FOOD FUNCT, V3, P1144, DOI 10.1039/c2fo30127j
   Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001
   Ho L, 2013, FASEB J, V27, P769, DOI 10.1096/fj.12-212118
   Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x
   BARRETTLEE PJ, 1987, CANCER RES, V47, P6653
   Boesch-Saadatmandi C, 2011, J NUTR BIOCHEM, V22, P293, DOI 10.1016/j.jnutbio.2010.02.008
   Ciana P, 2001, MOL ENDOCRINOL, V15, P1104, DOI 10.1210/me.15.7.1104
   Galluzzo P, 2009, MOL NUTR FOOD RES, V53, P699, DOI 10.1002/mnfr.200800239
   Guo XD, 2013, MOL NUTR FOOD RES, V57, P1037, DOI 10.1002/mnfr.201200569
   Han DH, 2002, BIOSCI BIOTECH BIOCH, V66, P1479
   Kang HK, 2012, FOOD CHEM TOXICOL, V50, P2751, DOI 10.1016/j.fct.2012.05.017
   Kim DS, 2007, J CELL BIOCHEM, V101, P790, DOI 10.1002/jcb.21233
   Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0
   Miodini P, 1999, BRIT J CANCER, V80, P1150, DOI 10.1038/sj.bjc.6690479
   Resende FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074881
   Totta P, 2005, J NUTR, V135, P2687
   van der Woude H, 2005, MOL NUTR FOOD RES, V49, P763, DOI 10.1002/mnfr.200500036
   Zava DT, 1997, NUTR CANCER, V27, P31
NR 37
TC 3
Z9 3
U1 6
U2 27
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 62
EP 67
DI 10.1016/j.abb.2014.03.003
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100010
PM 24657077
ER

PT J
AU de Pascual-Teresa, S
AF de Pascual-Teresa, Sonia
TI Molecular mechanisms involved in the cardiovascular and neuroprotective
   effects of anthocyanins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Anthocyanin; Molecular mechanisms; Cardiovascular; Neuroprotection
ID ENDOTHELIAL-CELLS; PATHWAY; FLAVONOIDS; MACROPHAGES; METABOLISM;
   CYANIDIN; ALPHA; ACID; NRF2
AB Anthocyanins are the main group of natural hydrosoluble pigments in plants. They introduce colouring to foods, with colours ranging from blue to red and orange. Nowadays, their importance for the Food and Pharmaceutical industries is mainly based in the existing scientific work evidencing their beneficial effects on the prevention of cardiovascular diseases and neurological conditions. Different mechanisms have been shown to be involved in those effects. The most consistent ones are related to their antihypertensive and endothelium protective activities, antiatherogenic activity and their interaction with the estrogenic receptor. In some of the existing work, studies on structure-activity relationship have been done, showing that modifications on the structure of anthocyanins, besides having an effect on their colours, have a clear incidence on their interaction with different steps in the principal pathways related to these diseases. Therefore, different colours might show different molecular mechanisms. However, in a normal diet most of these compounds are present simultaneously and, thus; they can act by different mechanisms but can rise to a common final action. Design of new food product or food supplements should take these potential synergies into consideration. (C) 2014 Elsevier Inc. All rights reserved.
C1 CSIC, Spanish Natl Res Council, Inst Food Sci Technol & Nutr ICTAN, Dept Metab & Nutr, Madrid 28008, Spain.
RP de Pascual-Teresa, S (reprint author), CSIC, Spanish Natl Res Council, Inst Food Sci Technol & Nutr ICTAN, Dept Metab & Nutr, Jose Antonio Novais 10,Ciudad Univ, Madrid 28008, Spain.
EM s.depascualteresa@csic.es
RI de Pascual-Teresa, Sonia/F-5321-2011
FU Spanish Ministry of Economy and Competitiveness [AGL2012-30803]; CSIC
   [i-link0502]
FX Thanks are due to Prof B. de Pascual-Teresa and Dr. S. Martin-Santamaria
   at CEU-San Pablo for docking studies. Part of this work was supported by
   the Spanish Ministry of Economy and Competitiveness (AGL2012-30803) and
   CSIC (i-link0502).
CR Paixao J, 2011, APOPTOSIS, V16, P976, DOI 10.1007/s10495-011-0632-y
   Hou DX, 2005, BIOCHEM PHARMACOL, V70, P417, DOI 10.1016/j.bcp.2005.05.003
   West ME, 2013, J AGR FOOD CHEM, V61, P4169, DOI 10.1021/jf400608b
   Hidalgo M, 2012, J AGR FOOD CHEM, V60, P3882, DOI 10.1021/jf3002153
   Jennings A, 2012, AM J CLIN NUTR, V96, P781, DOI 10.3945/ajcn.112.042036
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1063, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1063::AID-JSFA605>3.3.CO;2-H
   Hidalgo M, 2012, GENES NUTR, V7, P295, DOI 10.1007/s12263-011-0263-5
   Gao X, 2012, NEUROLOGY, V78, P1138, DOI 10.1212/WNL.0b013e31824f7fc4
   Zhang B, 2013, J AGR FOOD CHEM, V61, P8765, DOI 10.1021/jf4012399
   Czank C, 2013, AM J CLIN NUTR, V97, P995, DOI 10.3945/ajcn.112.049247
   Rodriguez-Mateos A, 2013, AM J CLIN NUTR, V98, P1179, DOI 10.3945/ajcn.113.066639
   Yi L, 2012, BIOCHIMIE, V94, P2035, DOI 10.1016/j.biochi.2012.05.027
   Poulose SM, 2012, J AGR FOOD CHEM, V60, P1084, DOI 10.1021/jf203989k
   Xia M, 2005, J BIOL CHEM, V280, P36792, DOI 10.1074/jbc.M505047200
   Ernst IMA, 2010, PHARMACOL RES, V61, P253, DOI 10.1016/j.phrs.2009.10.006
   Avila M, 2009, FOOD RES INT, V42, P1453, DOI 10.1016/j.foodres.2009.07.026
   Speciale A, 2013, MOL NUTR FOOD RES, V57, P1979, DOI 10.1002/mnfr.201300102
   Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024
   Jia YY, 2013, BBA-MOL CELL BIOL L, V1831, P698, DOI 10.1016/j.bbalip.2012.11.012
   Hassellund SS, 2013, J HUM HYPERTENS, V27, P100, DOI 10.1038/jhh.2012.4
   Cassidy A., 2013, CIRCULATION, V127
   Dreiseitel A, 2008, BIOCHEM BIOPH RES CO, V372, P57, DOI 10.1016/j.bbrc.2008.04.140
   Goto T., 1987, PROGR CHEM ORG NAT P, V52, P113
   Jakobsdottir G., 2013, J NUTR METAB, V2013
   Salucci M, 2002, BRIT J CANCER, V86, P1645, DOI 10.1038/sj/bjc/6600295
   Sas L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3196
   Wang L, 2013, J CHROMATOGR B, V937, P91, DOI 10.1016/j.jchromb.2013.08.024
   Ziberna L, 2012, FREE RADICAL BIO MED, V52, P1750, DOI 10.1016/j.freeradbiomed.2012.02.027
NR 28
TC 2
Z9 2
U1 8
U2 27
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 68
EP 74
DI 10.1016/j.abb.2014.04.012
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100011
PM 24791600
ER

PT J
AU Sandoval-Acuna, C
   Ferreira, J
   Speisky, H
AF Sandoval-Acuna, Cristian
   Ferreira, Jorge
   Speisky, Hernan
TI Polyphenols and mitochondria: An update on their increasingly emerging
   ROS-scavenging independent actions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Polyphenols; Mitochondria; Antioxidants; Mitochondrial biogenesis;
   Mitochondrial energetic; Mitochondrial electron transport chain
ID EPIGALLOCATECHIN GALLATE PROTECTS; QUERCETIN INDUCES APOPTOSIS;
   PROSTATE-CANCER CELLS; COLI ATP SYNTHASE; OXIDATIVE STRESS; COMPLEX-I;
   PARKINSONS-DISEASE; RESPIRATORY-CHAIN; ISCHEMIA/REPERFUSION INJURY;
   DEPENDENT APOPTOSIS
AB Polyphenols, ubiquitously present in fruits and vegetables, have been traditionally viewed as antioxidant molecules. Such contention emerged, mainly from their well established in vitro ability to scavenge free radicals and other reactive oxygen species (ROS). During the last decade, however, increasing evidence has emerged supporting the ability of certain polyphenols to also exert numerous ROS-scavenging independent actions. Although the latter can comprise the whole cell, particular attention has been placed on the ability of polyphenols to act, whether favorably or not, on a myriad of mitochondrial processes. Thus, some particular polyphenols are now recognized as molecules capable of modulating pathways that define mitochondrial biogenesis (i.e., inducing sirtuins), mitochondrial membrane potential (i.e., mitochondrial permeability transition pore opening and uncoupling effects), mitochondrial electron transport chain and ATP synthesis (i.e., modulating complexes I to V activity), intra-mitochondrial oxidative status (i.e., inhibiting/inducing ROS formation/removal enzymes), and ultimately mitochondrially-triggered cell death (i.e., modulating intrinsic-apoptosis). The present review describes recent evidence on the ability of some polyphenols to modulate each of the formerly mentioned pathways, and discusses on how, by acting on such mitochondrial processes, polyphenols may afford protection against those mitochondrial damaging events that appear to be key in the cellular toxicity induced by various xenobiotics as well as that seen during the development of several ROS-related diseases. (C) 2014 Published by Elsevier Inc.
C1 [Sandoval-Acuna, Cristian; Speisky, Hernan] Univ Chile, Nutr & Food Technol Inst, Santiago, Chile.
   [Sandoval-Acuna, Cristian; Ferreira, Jorge] Univ Chile, Fac Med, ICBM, Clin & Mol Pharmacol Program, Santiago 7, Chile.
   [Speisky, Hernan] Univ Chile, Fac Chem & Pharmaceut Sci, Santiago, Chile.
RP Speisky, H (reprint author), Univ Chile, Nutr & Food Technol Inst INTA, Macul 5540,POB 138-11, Santiago, Chile.
EM hspeisky@inta.uchile.cl
RI SPEISKY, HERNAN/E-6146-2013; Sandoval Acuna, Cristian/E-5741-2013
OI Sandoval Acuna, Cristian/0000-0002-5760-0985
FU FONDECYT-Chile [1130772, 1110018]; COPEC-UC-Chile [2012.R.008]
FX This work was supported by grants from FONDECYT-Chile 1130772 (to J.F.)
   and 1110018 (to H.S.) and from COPEC-UC-Chile 2012.R.008 (to H.S.).
CR Ahmad Z, 2012, INT J BIOL MACROMOL, V50, P476, DOI 10.1016/j.ijbiomac.2012.01.019
   James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200
   Bournival J, 2009, CELL MOL NEUROBIOL, V29, P1169, DOI 10.1007/s10571-009-9411-5
   Panickar KS, 2009, EXP NEUROL, V216, P420, DOI 10.1016/j.expneurol.2008.12.024
   Carrasco-Pozo C, 2011, J AGR FOOD CHEM, V59, P11501, DOI 10.1021/jf202621d
   Wang Q, 2005, J NEUROSCI RES, V82, P138, DOI 10.1002/jnr.20610
   Dabaghi-Barbosa P, 2005, FREE RADICAL RES, V39, P1305, DOI 10.1080/13561820500177659
   Trumbeckaite S, 2006, BIOMED PHARMACOTHER, V60, P245, DOI 10.1016/j.biopha.2006.04.003
   Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003
   De Marchi U, 2009, BBA-BIOENERGETICS, V1787, P1425, DOI 10.1016/j.bbabio.2009.06.002
   CLEETER MWJ, 1992, J NEUROCHEM, V58, P786, DOI 10.1111/j.1471-4159.1992.tb09789.x
   Strathearn KE, 2014, BRAIN RES, V1555, P60, DOI 10.1016/j.brainres.2014.01.047
   Santos AC, 1998, FREE RADICAL BIO MED, V24, P1455, DOI 10.1016/S0891-5849(98)00003-3
   PARTHASARATHY S, 1992, ANNU REV MED, V43, P219
   Anandhan A, 2012, BRAIN RES, V1433, P104, DOI 10.1016/j.brainres.2011.11.021
   Yao K, 2008, MOL VIS, V14, P217
   Chien SY, 2009, HUM EXP TOXICOL, V28, P493, DOI 10.1177/0960327109107002
   Gabrielova E, 2010, J BIOENERG BIOMEMBR, V42, P499, DOI 10.1007/s10863-010-9319-2
   Cevik O, 2013, FREE RADICAL RES, V47, P683, DOI 10.3109/10715762.2013.814912
   Im AR, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/517965
   Shankar S, 2007, CARCINOGENESIS, V28, P1277, DOI 10.1093/carcin/bgm024
   Amic D, 2007, CURR MED CHEM, V14, P827, DOI 10.2174/092986707780090954
   MacRae HSH, 2006, INT J SPORT NUTR EXE, V16, P405
   Ji LL, 2013, J NUTR BIOCHEM, V24, P1911, DOI 10.1016/j.jnutbio.2013.05.007
   Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200
   Biala A, 2010, BLOOD PRESSURE, V19, P196, DOI 10.3109/08037051.2010.481808
   Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009
   Fraga CG, 2010, MOL ASPECTS MED, V31, P435, DOI 10.1016/j.mam.2010.09.006
   LANG DR, 1974, BIOCHIM BIOPHYS ACTA, V333, P180, DOI 10.1016/0005-2728(74)90002-4
   Zini R, 1999, DRUG EXP CLIN RES, V25, P87
   Lee DH, 2008, BIOCHEM PHARMACOL, V75, P2345, DOI 10.1016/j.bcp.2008.03.013
   Yang EJ, 2013, PHARMACOGN MAG, V9, P302, DOI 10.4103/0973-1296.117824
   Zhang JY, 2013, J AGR FOOD CHEM, V61, P2188, DOI 10.1021/jf305263r
   Yang WH, 2011, J CELL BIOCHEM, V112, P1601, DOI 10.1002/jcb.23072
   Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882
   Eckert GP, 2013, NEUROCHEM INT, V62, P595, DOI 10.1016/j.neuint.2013.02.014
   Zhu L, 2010, J NUTR BIOCHEM, V21, P1089, DOI 10.1016/j.jnutbio.2009.09.006
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Ortega R, 2009, J BIOENERG BIOMEMBR, V41, P41, DOI 10.1007/s10863-009-9198-6
   Mladenka P, 2011, J INORG BIOCHEM, V105, P693, DOI 10.1016/j.jinorgbio.2011.02.003
   Nieman DC, 2010, MED SCI SPORT EXER, V42, P338, DOI 10.1249/MSS.0b013e3181b18fa3
   Feng ZH, 2011, FREE RADICAL BIO MED, V50, P1437, DOI 10.1016/j.freeradbiomed.2011.03.001
   Valdameri G, 2010, CHEM-BIOL INTERACT, V188, P52, DOI 10.1016/j.cbi.2010.07.016
   Biasutto L, 2008, BIOORG MED CHEM LETT, V18, P5594, DOI 10.1016/j.bmcl.2008.08.100
   Campos-Esparza MR, 2009, CELL CALCIUM, V45, P358, DOI 10.1016/j.ceca.2008.12.007
   Lagoa R, 2011, BBA-BIOENERGETICS, V1807, P1562, DOI 10.1016/j.bbabio.2011.09.022
   Bishayee K, 2013, CELL PROLIFERAT, V46, P153, DOI 10.1111/cpr.12017
   Carrasco-Pozo C, 2012, CHEM-BIOL INTERACT, V195, P199, DOI 10.1016/j.cbi.2011.12.007
   BORS W, 1990, METHOD ENZYMOL, V186, P343
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397
   Visioli F, 2011, CRIT REV FOOD SCI, V51, P524, DOI 10.1080/10408391003698677
   Rao AV, 2002, NUTR NEUROSCI, V5, P291, DOI 10.1080/1028415021000033767
   Taub PR, 2012, CTS-CLIN TRANSL SCI, V5, P43, DOI 10.1111/j.1752-8062.2011.00357.x
   Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010
   Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008
   Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110
   Dadi PK, 2009, INT J BIOL MACROMOL, V45, P72, DOI 10.1016/j.ijbiomac.2009.04.004
   Lv CF, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/928643
   Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4
   Gelinas S, 2002, J NEUROSCI RES, V70, P90, DOI 10.1002/jnr.10315
   Mercer LD, 2005, BIOCHEM PHARMACOL, V69, P339, DOI 10.1016/j.bcp.2004.09.018
   Karuppagounder SS, 2013, NEUROSCIENCE, V236, P136, DOI 10.1016/j.neuroscience.2013.01.032
   Mertens-Talcott SU, 2003, J NUTR, V133, P2669
   Lin J, 2009, J NATL CANCER I, V101, P14, DOI 10.1093/jnci/djn438
   Kikuno N, 2008, INT J CANCER, V123, P552, DOI 10.1002/ijc.23590
   Ma HJ, 2011, J PHYSIOL SCI, V61, P337, DOI 10.1007/s12576-011-0148-9
   Wang CZ, 2013, INT J ONCOL, V42, P1018, DOI 10.3892/ijo.2013.1777
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917
   Biasutto L, 2010, BBA-BIOENERGETICS, V1797, P189, DOI 10.1016/j.bbabio.2009.10.001
   Bjelakovic G., 2008, COCHRANE DB SYST REV, V16
   Carrasco-Pozo C, 2011, J AGR FOOD CHEM, V59, P6459, DOI 10.1021/jf200553s
   Chin D, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0397-3
   Dorta DJ, 2005, CHEM-BIOL INTERACT, V152, P67, DOI 10.1016/j.cbi.2005.02.004
   Du Y, 2008, EUR J PHARMACOL, V591, P96, DOI 10.1016/j.ejphar.2008.06.068
   Durante M, 2013, PLANTA MED, V79, P465, DOI 10.1055/s-0032-1328293
   Filomeni G, 2010, AUTOPHAGY, V6, P202
   GEY KF, 1989, ANN NY ACAD SCI, V570, P268, DOI 10.1111/j.1749-6632.1989.tb14926.x
   Halder B, 2008, CARCINOGENESIS, V29, P129, DOI 10.1093/carcin/bgm233
   Herrerias T, 2008, BIOORGAN MED CHEM, V16, P854, DOI 10.1016/j.bmc.2007.10.029
   HODNICK WF, 1994, BIOCHEM PHARMACOL, V47, P573, DOI 10.1016/0006-2952(94)90190-2
   HODNICK WF, 1987, BIOCHEM PHARMACOL, V36, P2873, DOI 10.1016/0006-2952(87)90282-6
   Hollman PCH, 2011, J NUTR, V141, p989S, DOI 10.3945/jn.110.131490
   Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08
   Kazi A, 2002, MOL PHARMACOL, V62, P765, DOI 10.1124/mol.62.4.765
   Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z
   Kris-Etherton Penny M., 2002, American Journal of Medicine, V113, p71S
   Lee JH, 2010, CANCER LETT, V290, P68, DOI 10.1016/j.canlet.2009.08.027
   Li B, 2012, J NUTR BIOCHEM, V23, P953, DOI 10.1016/j.jnutbio.2011.05.001
   Li WJ, 2009, J AGR FOOD CHEM, V57, P6685, DOI 10.1021/jf901396f
   Mattarei A, 2008, CHEMBIOCHEM, V9, P2633, DOI 10.1002/cbic.200800162
   McAnlis GT, 1999, EUR J CLIN NUTR, V53, P92, DOI 10.1038/sj.ejcn.1600682
   Modriansky M, 2009, J BIOENERG BIOMEMBR, V41, P133, DOI 10.1007/s10863-009-9212-z
   Moskaug JO, 2005, AM J CLIN NUTR, V81, p277S
   Mursu J, 2008, INT J CANCER, V123, P660, DOI 10.1002/ijc.23421
   Nadal-Serrano M, 2013, INT J BIOCHEM CELL B, V45, P2045, DOI 10.1016/j.biocel.2013.07.002
   Panickar K.S., 2011, NEUROSCIENCE, V2011, P1
   Park SY, 2013, J TOXICOL SCI, V38, P371
   Qanungo S, 2005, CARCINOGENESIS, V26, P958, DOI 10.1093/carcin/bgi040
   Ran ZH, 2007, WORLD J GASTROENTERO, V13, P4255
   Rehman H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065029
   Salvi M, 2002, BBA-BIOENERGETICS, V1556, P187, DOI 10.1016/S0005-2728(02)00361-4
   Sandoval-Acuna C, 2012, CHEM-BIOL INTERACT, V199, P18, DOI 10.1016/j.cbi.2012.05.006
   Sassi N, 2012, BBA-BIOENERGETICS, V1817, P1095, DOI 10.1016/j.bbabio.2012.03.007
   Sassi N., 2013, CURR PHARM DES
   Schaffer S, 2012, MOL NEUROBIOL, V46, P161, DOI 10.1007/s12035-012-8282-9
   Sekiya M, 2012, J BIOL CHEM, V287, P22771, DOI 10.1074/jbc.M112.374868
   Skulachev VP, 2013, BIOCHEM BIOPH RES CO, V441, P275, DOI 10.1016/j.bbrc.2013.10.063
   Tsuji PA, 2013, NUTR CANCER, V65, P1014, DOI 10.1080/01635581.2013.809127
   Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P542, DOI 10.1016/j.bbadis.2012.12.011
   van Dijk C, 2000, BIOCHEM PHARMACOL, V60, P1593, DOI 10.1016/S0006-2952(00)00488-3
   Wang Y, 2013, BRAZ J MED BIOL RES, V46, P861, DOI 10.1590/1414-431X20133036
   Xie XB, 2011, ONCOL REP, V26, P687, DOI 10.3892/or.2011.1328
   Ye QY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-82
NR 116
TC 12
Z9 13
U1 12
U2 40
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 75
EP 90
DI 10.1016/j.abb.2014.05.017
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100012
PM 24875147
ER

PT J
AU Gupta, SC
   Tyagi, AK
   Deshmukh-Taskar, P
   Hinojosa, M
   Prasad, S
   Aggarwal, BB
AF Gupta, Subash C.
   Tyagi, Amit K.
   Deshmukh-Taskar, Priya
   Hinojosa, Myriam
   Prasad, Sahdeo
   Aggarwal, Bharat B.
TI Downregulation of tumor necrosis factor and other proinflammatory
   biomarkers by polyphenols
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Cytokines; Inflammation; TNF; NF-kappa B; Polyphenols
ID NF-KAPPA-B; INFLAMMATORY CYTOKINE PRODUCTION; ACTIVATED PROTEIN-KINASES;
   DIABETIC NEUROPATHIC PAIN; TNF-ALPHA; NUCLEAR-FACTOR; ELLAGIC ACID;
   MOUSE MODEL; IN-VITRO; ENDOTHELIAL-CELLS
AB Human tumor necrosis factor (TNF), first isolated by our group as an anticancer agent, has been now shown to be a primary mediator of inflammation. Till today 19 different members of the TNF superfamily which interact with 29 different receptors, have been identified. Most members of this family exhibit pro-inflammatory activities, in part through the activation of the transcription factor, nuclear factor-kappaB (NF-kappa B). Thus TNF and the related pro-inflammatory cytokines have been shown to play a key role in most chronic diseases such as cancer, rheumatoid arthritis, cardiovascular diseases, psoriasis, neurologic diseases, Crohn's disease, and metabolic diseases. Therefore, agents that can modulate the TNF-mediated inflammatory pathways may have potential against these pro-inflammatory diseases. Although blockers of TNF-alpha, such as infliximab (antibody against TNF-alpha), adalimumab (humanized antibody against TNF-alpha), and etanercept (soluble form of TNFR2) have been approved for human use, these blockers exhibit numerous side effects. In this review, we describe various plant-derived polyphenols that can suppress TNF-alpha activated inflammatory pathways both in vitro and in vivo. These polyphenols include curcumin, resveratrol, genistein, epigallocatechin gallate, flavopiridol, silymarin, emodin, morin isoliquiritigenin, naringenin, ellagic acid, apigenin, kaempferol, catechins, myricetin, xanthohumol, flsetin, vitexin, escin, mangostin and others. Thus these polyphenols are likely to have potential against various pro-inflammatory diseases. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Gupta, Subash C.; Tyagi, Amit K.; Deshmukh-Taskar, Priya; Hinojosa, Myriam; Prasad, Sahdeo; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77054 USA.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013
FU Malaysian Palm Oil Board
FX We thank Arthur Gelmis, editor, Department of Scientific Publications
   for carefully proofreading the manuscript and providing valuable
   comments. Dr. Aggarwal is the Ransom Horne, Jr., Professor of Cancer
   Research. This work was supported in part by a grant from the Malaysian
   Palm Oil Board.
CR Anderson SE, 2010, TOXICOL SCI, V115, P453, DOI 10.1093/toxsci/kfq067
   Harikumar KB, 2010, MOL PHARMACOL, V77, P818, DOI 10.1124/mol.109.062760
   Chen XJ, 2012, INT IMMUNOPHARMACOL, V14, P209, DOI 10.1016/j.intimp.2012.07.007
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   Sharma S, 2007, FUND CLIN PHARMACOL, V21, P89, DOI 10.1111/j.1472-8206.2006.00455.x
   Abe Y, 1999, PHARMACOL RES, V39, P41, DOI 10.1006/phrs.1998.0404
   Peter S, 2007, DIGESTION, V75, P25, DOI 10.1159/000101564
   Carlson BA, 1996, CANCER RES, V56, P2973
   Yildirim A, 2013, EXP THER MED, V5, P596, DOI 10.3892/etm.2012.831
   Sharma S, 2007, PHYTOTHER RES, V21, P278, DOI 10.1002/ptr.2070
   Kim TH, 2012, INFLAMM RES, V61, P217, DOI 10.1007/s00011-011-0403-9
   Tewtrakul S, 2009, J ETHNOPHARMACOL, V121, P379, DOI 10.1016/j.jep.2008.11.007
   Zitelli KB, 2013, CUTIS, V92, P35
   Giorgi VSI, 2012, J REPROD IMMUNOL, V95, P67, DOI 10.1016/j.jri.2012.06.004
   Dong ZG, 1997, CANCER RES, V57, P4414
   Yen TL, 2012, J AGR FOOD CHEM, V60, P1937, DOI 10.1021/jf204909p
   Atzeni F, 2013, AUTOIMMUN REV, V12, P703, DOI 10.1016/j.autrev.2012.10.021
   Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026
   Yilma AN, 2013, INT J NANOMED, V8, P2421, DOI 10.2147/IJN.S44090
   Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2
   Jayaraman J, 2012, TOXICOL MECH METHOD, V22, P568, DOI 10.3109/15376516.2012.707255
   Orsu P, 2013, J NEURAL TRANSM, V120, P1217, DOI 10.1007/s00702-013-0982-4
   Yang CS, 1997, NATURE, V389, P134, DOI 10.1038/38154
   Rosillo MA, 2012, PHARMACOL RES, V66, P235, DOI 10.1016/j.phrs.2012.05.006
   Dong Z, 2011, MOL MED, V17, P1357, DOI 10.2119/molmed.2011.00186
   Nanji AA, 2003, AM J PHYSIOL-GASTR L, V284, pG321, DOI 10.1152/ajpgi.00230.2002
   Raffoul JJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-107
   Umesalma S, 2010, BASIC CLIN PHARMACOL, V107, P650, DOI 10.1111/j.1742-7843.2010.00565.x
   Li DP, 2013, EUR J PHARMACOL, V705, P79, DOI 10.1016/j.ejphar.2013.02.021
   Hsu CL, 2013, J AGR FOOD CHEM, V61, P602, DOI 10.1021/jf304487v
   Tiwari V, 2010, INT J NEUROPSYCHOPH, V13, P1053, DOI 10.1017/S146114571000060X
   Wingo PA, 1999, J NATL CANCER I, V91, P675, DOI 10.1093/jnci/91.8.675
   Jing YW, 2006, FREE RADICAL BIO MED, V40, P2183, DOI 10.1016/j.freeradbiomed.2006.02.016
   Kumar A, 1998, ONCOGENE, V17, P913, DOI 10.1038/sj.onc.1201998
   Ghanim H, 2010, J CLIN ENDOCR METAB, V95, pE1, DOI 10.1210/jc.2010-0482
   Siddiqui AM, 2006, CRIT CARE MED, V34, P1874, DOI 10.1097/01.CCM.0000221921.71300.BF
   Papoutsi Z, 2008, BRIT J NUTR, V99, P715, DOI 10.1017/S0007114507837421
   Khajehdehi P, 2011, SCAND J UROL NEPHROL, V45, P365, DOI 10.3109/00365599.2011.585622
   Koosirirat C, 2010, INT IMMUNOPHARMACOL, V10, P815, DOI 10.1016/j.intimp.2010.04.021
   Ha MK, 2011, BIOL PHARM BULL, V34, P1432, DOI 10.1248/bpb.34.1432
   Fang SH, 2003, LIFE SCI, V74, P743, DOI 10.1016/j.lfs.2003.07.017
   Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004
   Gupta SC, 2011, NAT PROD REP, V28, P1937, DOI 10.1039/c1np00051a
   Tome-Carneiro J, 2013, PHARMACOL RES, V72, P69, DOI 10.1016/j.phrs.2013.03.011
   Sithisarn P, 2013, ANTIVIR RES, V97, P41, DOI 10.1016/j.antiviral.2012.10.004
   Yoshida H, 2013, J NUTR BIOCHEM, V24, P1276, DOI 10.1016/j.jnutbio.2012.10.003
   Jin CY, 2007, ACTA PHARMACOL SIN, V28, P1645, DOI 10.1111/j.1745-7254.2007.00651.x
   Hanai H, 2009, CURR PHARM DESIGN, V15, P2087, DOI 10.2174/138161209788489177
   Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003
   Woo HM, 2007, LIFE SCI, V80, P926, DOI 10.1016/j.lfs.2006.11.030
   Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004
   Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165
   Valsecchi AE, 2011, EUR J PHARMACOL, V650, P694, DOI 10.1016/j.ejphar.2010.10.060
   Ung VYL, 2010, DIGEST DIS SCI, V55, P1272, DOI 10.1007/s10620-009-0843-z
   Masamune A, 2005, BIOCHEM PHARMACOL, V70, P869, DOI 10.1016/j.bcp.2005.06.008
   El-Moselhy MA, 2011, FOOD CHEM TOXICOL, V49, P1129, DOI 10.1016/j.fct.2011.02.004
   Gao XH, 2004, BIOCHEM PHARMACOL, V68, P51, DOI 10.1016/j.bcp.2004.03.015
   Fallahzadeh MK, 2012, AM J KIDNEY DIS, V60, P896, DOI 10.1053/j.ajkd.2012.06.005
   Borghi SM, 2013, J NAT PROD, V76, P1141, DOI 10.1021/np400222v
   Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218
   Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a
   Tian J, 2013, RHEUMATOL INT, V33, P1829, DOI 10.1007/s00296-012-2657-0
   Park SE, 2011, BRIT J PHARMACOL, V164, P1008, DOI 10.1111/j.1476-5381.2011.01389.x
   Miroliaee AE, 2011, TOXICOL MECH METHOD, V21, P200, DOI 10.3109/15376516.2010.547887
   He ZY, 2011, CANCER INVEST, V29, P208, DOI 10.3109/07357907.2010.550592
   Wang WR, 2013, APOPTOSIS, V18, P689, DOI 10.1007/s10495-013-0833-7
   Gao XJ, 2013, J NUTR BIOCHEM, V24, P222, DOI 10.1016/j.jnutbio.2012.05.008
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Lee IS, 2011, NEUROCHEM INT, V58, P153, DOI 10.1016/j.neuint.2010.11.008
   Ko SY, 2012, ARCH ORAL BIOL, V57, P1623, DOI 10.1016/j.archoralbio.2012.06.012
   Zhu XF, 2013, INFLAMMATION, V36, P1253, DOI 10.1007/s10753-013-9663-6
   Thuillier P, 2002, BIOCHEM J, V366, P901, DOI 10.1042/BJ20020377
   Gupta SC, 2013, BIOCHEM PHARMACOL, V85, P898, DOI 10.1016/j.bcp.2012.12.018
   Dou W, 2013, BRIT J NUTR, V110, P599, DOI 10.1017/S0007114512005594
   Park DK, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/914524
   Song ZC, 2012, TOHOKU J EXP MED, V227, P225, DOI 10.1620/tjem.227.225
   Kim JE, 2009, BIOCHEM PHARMACOL, V77, P412, DOI 10.1016/j.bcp.2008.10.027
   Juneja M, 2013, EUR J MED CHEM, V63, P474, DOI 10.1016/j.ejmech.2013.02.032
   Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200
   SINGH S, 1995, J BIOL CHEM, V270, P24995
   Wang PJ, 2012, PHARMAZIE, V67, P733, DOI 10.1691/ph.2012.1822
   Gadgeel SM, 2009, CANCER, V115, P2165, DOI 10.1002/cncr.24250
   Honda H, 2012, J LEUKOCYTE BIOL, V91, P967, DOI 10.1189/jlb.0112038
   Boeckenholt C, 2012, PLANTA MED, V78, P761, DOI 10.1055/s-0031-1298374
   Lee SY, 2009, BMB REP, V42, P574
   Armoza A, 2013, J HYPERTENS, V31, P521, DOI 10.1097/HJH.0b013e32835c1d01
   Bandgar BP, 2014, J ENZYM INHIB MED CH, V29, P7, DOI 10.3109/14756366.2012.743536
   Banskota AH, 2000, BIOL PHARM BULL, V23, P456
   Beserra AMSES, 2011, J AGR FOOD CHEM, V59, P6957, DOI 10.1021/jf2003267
   Brown J, 2003, CARCINOGENESIS, V24, P171, DOI 10.1093/carcin/24.2.171
   Chan Chung-Yin Stanley, 2008, Dermatol Online J, V14, P12
   Chao CY, 2010, MOL NUTR FOOD RES, V54, P388, DOI 10.1002/mnfr.200900087
   Chao PC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-33
   Chen YC, 2004, INT J ONCOL, V25, P661
   Choi HG, 2013, NAT PROD COMMUN, V8, P181
   Creţu Elena, 2012, Rev Med Chir Soc Med Nat Iasi, V116, P1223
   Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044
   Dominguez B, 2013, INT IMMUNOPHARMACOL, V15, P588, DOI 10.1016/j.intimp.2013.01.024
   Dorn GW, 2010, J CARDIOVASC PHARM, V56, P589, DOI 10.1097/FJC.0b013e3181f8d173
   Drummond EM, 2013, PHYTOTHER RES, V27, P588, DOI 10.1002/ptr.4753
   Esmat A, 2012, J MED FOOD, V15, P278, DOI 10.1089/jmf.2011.0099
   Ferreira LC, 2013, J ETHNOPHARMACOL, V145, P100, DOI 10.1016/j.jep.2012.10.037
   Gao Hui-Ling, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P458
   Gharagozloo M, 2013, INT IMMUNOPHARMACOL, V16, P243, DOI 10.1016/j.intimp.2013.04.016
   Goh FY, 2012, EUR J PHARMACOL, V679, P109, DOI 10.1016/j.ejphar.2012.01.002
   Gutierrez-Macias A, 2007, CLIN RHEUMATOL, V26, P452, DOI 10.1007/s10067-005-0164-3
   Hsiang CY, 2005, BIOCHEM PHARMACOL, V69, P1603, DOI 10.1016/j.bcp.2005.03.008
   Huang WT, 2008, EUR J PHARMACOL, V593, P105, DOI 10.1016/j.ejphar.2008.07.017
   Jang MK, 2001, PLANTA MED, V67, P550, DOI 10.1055/s-2001-16482
   Ji GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053101
   Jia ZQ, 2013, INT J CARDIOL, V168, P2637, DOI 10.1016/j.ijcard.2013.03.035
   Jiang N, 2011, PHYTOMEDICINE, V18, P1276, DOI 10.1016/j.phymed.2011.06.011
   Kang OH, 2011, IMMUNOPHARM IMMUNOT, V33, P473, DOI 10.3109/08923973.2010.538851
   Karieb S, 2013, BIOCHEM BIOPH RES CO, V436, P619, DOI 10.1016/j.bbrc.2013.05.140
   KOCHANEK S, 1990, P NATL ACAD SCI USA, V87, P8830, DOI 10.1073/pnas.87.22.8830
   KOCHANEK S, 1991, P NATL ACAD SCI USA, V88, P5759, DOI 10.1073/pnas.88.13.5759
   Kouklakis G, 2013, DRUG DES DEV THER, V7, P195, DOI 10.2147/DDDT.S41889
   Kunnumakkara AB, 2009, INT J CANCER, V125, P2187, DOI 10.1002/ijc.24593
   Lee G, 2012, IMMUNOPHARM IMMUNOT, V34, P454, DOI 10.3109/08923973.2011.619195
   Lee HS, 2008, ARCH PHARM RES, V31, P1160, DOI 10.1007/s12272-001-1283-5
   Lee SO, 2013, KOREAN J INTERN MED, V28, P159, DOI 10.3904/kjim.2013.28.2.159
   Leyon PV, 2003, J EXP CLIN CANC RES, V22, P77
   Li CY, 2006, AM J CHINESE MED, V34, P667, DOI 10.1142/S0192415X06004223
   Liu ST, 2012, MOL MED REP, V6, P1150, DOI 10.3892/mmr.2012.1031
   Llaneza P, 2011, PHYTOMEDICINE, V18, P245, DOI 10.1016/j.phymed.2010.07.011
   Ma Ming, 2007, Zhongguo Zhong Yao Za Zhi, V32, P1175
   Manna SK, 2007, CLIN CANCER RES, V13, P2290, DOI 10.1158/1078-0432.CCR-06-2394
   Marcotorchino J, 2012, MOL NUTR FOOD RES, V56, P725, DOI 10.1002/mnfr.201100623
   Mekhora C, 2012, ASIAN PAC J CANCER P, V13, P653, DOI 10.7314/APJCP.2012.13.1.653
   Meng L, 2012, INT J MOL MED, V29, P999, DOI 10.3892/ijmm.2012.940
   Messmann RA, 2003, CLIN CANCER RES, V9, P562
   Mo J, 2014, PHYTOTHER RES, V28, P629, DOI 10.1002/ptr.5039
   MUIZNIEKS I, 1994, FEBS LETT, V344, P251, DOI 10.1016/0014-5793(94)00394-7
   Nishida M, 2010, INT J MOL MED, V25, P761, DOI 10.3892/ijmm_00000402
   Park DS, 1996, J BIOL CHEM, V271, P8161
   Prabhakar O, 2013, N-S ARCH PHARMACOL, V386, P705, DOI 10.1007/s00210-013-0871-2
   Qureshi AA, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-76
   Ren H, 2014, BIOMATERIALS, V35, P6585, DOI 10.1016/j.biomaterials.2014.04.042
   Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1
   Rithidech KN, 2012, MUTAT RES-GEN TOX EN, V749, P29, DOI 10.1016/j.mrgentox.2012.08.001
   Rojanathammanee L, 2013, J NUTR, V143, P597, DOI 10.3945/jn.112.169516
   Sachdeva AK, 2010, BASIC CLIN PHARMACOL, V106, P490, DOI 10.1111/j.1742-7843.2009.00525.x
   Sae-Wong C, 2011, J ETHNOPHARMACOL, V136, P488, DOI 10.1016/j.jep.2011.01.013
   Senderowicz AM, 1998, J CLIN ONCOL, V16, P2986
   Singh JA, 2011, COCHRANE DB SYST REV, V2
   Sivaramakrishnan V, 2009, CHEM-BIOL INTERACT, V180, P353, DOI 10.1016/j.cbi.2009.02.004
   Smith ME, 2011, P NATL ACAD SCI USA, V108, P319, DOI 10.1073/pnas.0913297108
   Sreedharan V, 2009, INVEST NEW DRUG, V27, P21, DOI 10.1007/s10637-008-9136-1
   Suganuma M, 1999, MUTAT RES-FUND MOL M, V428, P339, DOI 10.1016/S1383-5742(99)00059-9
   Takei S, 1996, BIOCHEM BIOPH RES CO, V220, P606, DOI 10.1006/bbrc.1996.0450
   Tamashiro Filho P., 2012, J ETHNOPHARMACOL, V144, P497
   Tiwari V, 2013, NEUROCHEM INT, V62, P861, DOI 10.1016/j.neuint.2013.02.012
   Tran PLCHB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-276
   Tsushima H, 2001, PHARMACOL BIOCHEM BE, V69, P17, DOI 10.1016/S0091-3057(01)00500-7
   Usharani P, 2008, DRUGS R&D, V9, P243, DOI 10.2165/00126839-200809040-00004
   Valsecchi AE, 2008, J NEUROCHEM, V107, P230, DOI 10.1111/j.1471-4159.2008.05614.x
   Vogl S, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/395316
   Wang T, 2011, TOXICOL MECH METHOD, V21, P400, DOI 10.3109/15376516.2010.550337
   Wang WM, 2012, PHARMACOL REP, V64, P1216
   Wei Q, 2013, HEPATOB PANCREAT DIS, V12, P251, DOI 10.1016/S1499-3872(13)60041-7
   Wu D, 2013, CASE REP DERMATOL ME, V2013
   Wu MY, 2011, J AGR FOOD CHEM, V59, P10496, DOI 10.1021/jf202756f
   Wuaa S.T., 2010, INT J ENG SCI TECHNO, V2, P4263
   Xiao J., 2013, J DIABETES RES, V2013
   Xie CH, 2012, J NUTR BIOCHEM, V23, P1184, DOI 10.1016/j.jnutbio.2011.06.013
   Xin WY, 2011, PHYTOMEDICINE, V18, P272, DOI 10.1016/j.phymed.2010.08.013
   Yamagata K., 2010, STROKE RES TREAT, V2010
   Yon JM, 2013, BIRTH DEFECTS RES B, V98, P268, DOI 10.1002/bdrb.21061
   Zahedi Hoda Sadat, 2013, Int J Prev Med, V4, pS1
   Zaky A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-26
NR 170
TC 19
Z9 19
U1 13
U2 60
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 91
EP 99
DI 10.1016/j.abb.2014.06.006
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100013
PM 24946050
ER

PT J
AU Hollman, PCH
AF Hollman, Peter C. H.
TI Unravelling of the health effects of polyphenols is a complex puzzle
   complicated by metabolism
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Polyphenols; Flavonoids; Health effects; Cardiovascular diseases;
   Epidemiology; Human interventions; Antioxidant capacity; Metabolism;
   Metabolomics
ID CARDIOVASCULAR-DISEASE MORTALITY; FLAVONOID INTAKE; BLOOD-PRESSURE;
   PROSPECTIVE COHORT; ADHESION MOLECULE; VASCULAR FUNCTION; HEART-DISEASE;
   CANCER-RISK; DIET; CONSUMPTION
AB Plant metabolism creates complex mixtures of polyphenols in plant foods. Epidemiology and human trials reduced this complexity, by studying specific foods; subclasses of polyphenols; individual polyphenols, or total antioxidant capacity (TAC). This implies the following assumptions: (1) a limited number of potent polyphenols exists; (2) well-defined natural potent mixtures of polyphenols exist; (3) polyphenols share a common biological activity (e.g. antioxidant activity). To find potent polyphenols (1st assumption), in vitro screening has been widely applied, but most published results are of limited use because metabolism, changing biological activity profoundly, has frequently not been considered. The abundant anecdotal evidence for natural potent mixtures of polyphenols (2nd assumption) on the internet is very hard to verify. Additionally, cross-cultural studies have revealed the potency of e.g. cocoa. Polyphenols share the antioxidant phenolic group which inspired researchers to measure their antioxidant activity, thus greatly reducing complexity (3rd assumption). Unfortunately, the elegant antioxidant hypothesis has to be rejected, because poor absorption and extensive metabolism annihilate any contribution to the endogenous body antioxidants. In conclusion, the above assumptions are hard to verify, and no quick answers are to be expected. Future research should focus on structure-activity relations at nanomolar levels and explore metabolomics. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Hollman, Peter C. H.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands.
   [Hollman, Peter C. H.] RIKILT Wageningen UR, Wageningen, Netherlands.
RP Hollman, PCH (reprint author), Wageningen Univ, NL-6700 AP Wageningen, Netherlands.
EM peter.hollman@wur.nl
RI Hollman, Peter/I-7446-2013
OI Hollman, Peter/0000-0002-7510-6809
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Loke WM, 2008, AM J CLIN NUTR, V88, P1018
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Williamson G, 2005, FREE RADICAL RES, V39, P457, DOI 10.1080/10715760500053610
   Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01
   Wild CP, 2013, ENVIRON MOL MUTAGEN, V54, P480, DOI 10.1002/em.21777
   Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735
   Rubio-Aliaga I, 2012, J CLIN GASTROENTEROL, V46, P545, DOI 10.1097/MCG.0b013e3182548df2
   Smolinska A, 2012, ANAL CHIM ACTA, V750, P82, DOI 10.1016/j.aca.2012.05.049
   Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748
   Knekt P, 2002, AM J CLIN NUTR, V76, P560
   Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457
   Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882
   HERTOG MGL, 1992, J AGR FOOD CHEM, V40, P2379, DOI 10.1021/jf00024a011
   Liesenfeld DB, 2013, CANCER EPIDEM BIOMAR, V22, P2182, DOI 10.1158/1055-9965.EPI-13-0584
   Manach C, 2009, MOL NUTR FOOD RES, V53, P1303, DOI 10.1002/mnfr.200800516
   Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411
   [Anonymous], 2013, OFFIC J EUR UNION L, V235
   Parr AJ, 2000, J SCI FOOD AGR, V80, P985, DOI 10.1002/(SICI)1097-0010(20000515)80:7<985::AID-JSFA572>3.0.CO;2-7
   Rautiainen S, 2013, AM J MED, V126, P494, DOI 10.1016/j.amjmed.2013.01.006
   Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a
   Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5
   BANG HO, 1980, AM J CLIN NUTR, V33, P2657
   Mink PJ, 2007, AM J CLIN NUTR, V85, P895
   Spencer JPE, 2004, ARCH BIOCHEM BIOPHYS, V423, P148, DOI 10.1016/j.abb.2003.11.010
   Hedrick VE, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-109
   Steinberg D, 1997, CIRCULATION, V95, P1062
   Hollman PCH, 2010, J NUTR, V140, P600, DOI 10.3945/jn.109.116632
   Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113
   Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303
   Loke WM, 2008, BIOCHEM PHARMACOL, V75, P1045, DOI 10.1016/j.bcp.2007.11.002
   Mladenka P, 2010, FREE RADICAL BIO MED, V49, P963, DOI 10.1016/j.freeradbiomed.2010.06.010
   Buijsse B, 2010, EUR HEART J, V31, P1616, DOI 10.1093/eurheartj/ehq068
   Middleton E, 2000, PHARMACOL REV, V52, P673
   Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103
   Schewe T, 2008, ARCH BIOCHEM BIOPHYS, V476, P102, DOI 10.1016/j.abb.2008.03.004
   Di Castelnuovo A, 2012, EUR J INTERN MED, V23, P15, DOI 10.1016/j.ejim.2011.07.014
   HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U
   Lin J, 2006, AM J EPIDEMIOL, V164, P644, DOI 10.1093/aje/kwj296
   Arts ICW, 2001, INT J CANCER, V92, P298, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1187>3.0.CO;2-8
   Peterson JJ, 2012, NUTR REV, V70, P491, DOI 10.1111/j.1753-4887.2012.00508.x
   McCullough ML, 2012, AM J CLIN NUTR, V95, P454, DOI 10.3945/ajcn.111.016634
   KROMANN N, 1980, ACTA MED SCAND, V208, P401
   Arab L, 2009, STROKE, V40, P1786, DOI 10.1161/STROKEAHA.108.538470
   Archibald K, 2011, LANCET, V377, P1915, DOI 10.1016/S0140-6736(11)60802-7
   Benzie IFF, 1999, NUTR CANCER, V34, P83, DOI 10.1207/S15327914NC340112
   Boto-Ordonez M., 2013, MOL NUTR FOOD RES, V58, P466
   Carter P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4229
   DYERBERG J, 1978, LANCET, V2, P117
   European Food Safety Authority (EFSA), 2012, EFSA J, V10, P2809
   Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528
   Gey K. F, 1986, BIBLTHCA NUTR DIETA, V37, P53
   Harborne J. B., 1999, HDB NATURAL FLAVONOI, V1, P889
   Harborne J.B., 1999, HDB NATURAL FLAVONOI, V2, P879
   Hollman PCH, 2011, J NUTR, V141, p989S, DOI 10.3945/jn.110.131490
   Hollenberg NK, 2006, J CARDIOVASC PHARM, V47, pS99
   Kuijsten A, 2006, CANCER EPIDEM BIOMAR, V15, P1132, DOI 10.1158/1055-9965.EPI-05-0991
   Lodi F, 2009, ATHEROSCLEROSIS, V204, P34, DOI 10.1016/j.atherosclerosis.2008.08.007
   McCullough ML, 2006, J CARDIOVASC PHARM, V47, pS103, DOI 10.1097/00005344-200606001-00003
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Ottaviani J.I., 2010, FREE RADIC BIOL MED, V50, P237
   PORTER LJ, 1991, PHYTOCHEMISTRY, V30, P1657, DOI 10.1016/0031-9422(91)84228-K
   Qian GQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048090
   Ras RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016974
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Ried K, 2012, COCHRANE DB SYST REV, V8, DOI 10.1002/14651858.CD008893.pub2
   Tribolo S, 2008, ATHEROSCLEROSIS, V197, P50, DOI 10.1016/j.atherosclerosis.2007.07.040
   US Department of Agriculture, 2010, DIET GUID AM
   USDA, 2004, USDA DAT PROANTH CON
   USDA, 2012, OX RAD ABS CAP ORAC
   USDA, 2006, USDA DAT FLAV CONT S
   von Linne C., 1772, FRAGA VESCA
   Winterbone MS, 2009, ATHEROSCLEROSIS, V202, P431, DOI 10.1016/j.atherosclerosis.2008.04.040
   World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P
   Zhang A.H., 2013, J PHYSL BIOCH
NR 75
TC 6
Z9 6
U1 11
U2 54
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD OCT 1
PY 2014
VL 559
SI SI
BP 100
EP 105
DI 10.1016/j.abb.2014.04.013
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO1LH
UT WOS:000341073100014
PM 24796225
ER

PT J
AU Reddy, VS
   Kumar, CU
   Raghu, G
   Reddy, GB
AF Reddy, V. Sudhakar
   Kumar, Ch. Uday
   Raghu, G.
   Reddy, G. Bhanuprakash
TI Expression and induction of small heat shock proteins in rat heart under
   chronic hyperglycemic conditions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE sHsp; Diabetes; Diabetic cardiomyopathy; Streptozotocin;
   Phosphorylation; p38MAPK; p44/42MAPK; Apoptosis; Rat
ID ALPHA-B-CRYSTALLIN; DIABETIC CARDIOMYOPATHY; INSULIN-RESISTANCE;
   POTENTIAL ROLE; MIMICKING PHOSPHORYLATION; MYOGENIC DIFFERENTIATION;
   CHAPERONE FUNCTION; HUMAN MYOCARDIUM; STRESS-RESPONSE; A-CRYSTALLIN
AB The induction of small heat shock proteins (sHsp) is observed under various stress conditions to protect the cells and organisms from adverse events including diabetes. Diabetic cardiomyopathy is a common complication of diabetes. Therefore, in this study, we investigated the expression of sHsp under chronic hyperglycemic conditions in rat heart. Hyperglycemia was induced in WNIN rats by intraperitoneal injection of streptozotocin and maintained for a period of 12 weeks. Expression of sHsp, phosphorylation and translocation of phosphoforms of Hsp27 and alpha B-crystallin (alpha BC) from cytosolic fraction to cytoskeletal fraction was analyzed. While the expression of MKBP, HspB3, alpha BC was found to be increased in diabetic heart, expression of Hsp20 was decreased. Chronic hyperglycemia further induced phosphorylation of alpha BC at S59, S45, Hsp27 at S82, p38MAPK and p44/42MAPK. However, pS59-alpha BC and pS82-Hsp27 were translocated from detergent-soluble to detergent-insoluble fraction under hyperglycemic conditions. Furthermore, the interaction of pS82-Hsp27 and pS59-alpha BC with desmin was increased under hyperglycemia. However, the interaction of alpha BC and pS59-alpha BC with Bax was impaired by chronic hyperglycemia. These results suggest up regulation of sHsp (MKBP, HspB3 and alpha BC), phosphorylation and translocation of Hsp27 and alpha BC to striated sarcomeres and impaired interaction of alpha BC and pS59-alpha BC with Bax under chronic hyperglycemia. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Reddy, V. Sudhakar; Kumar, Ch. Uday; Raghu, G.; Reddy, G. Bhanuprakash] Natl Inst Nutr, Div Biochem, Hyderabad 500007, Andhra Pradesh, India.
RP Reddy, GB (reprint author), Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India.
EM geereddy@yahoo.com
FU Department of Science and Technology; University Grants Commission,
   Government of India; Department of Biotechnology, Government of India
FX This work was supported by grants from Department of Science and
   Technology and Department of Biotechnology, Government of India to
   G.B.R. V.S.R. was supported by a research fellowship from the University
   Grants Commission, Government of India. We thank Sneha Jakhotia for the
   help in editing the manuscript.
CR Cai L, 2006, FREE RADICAL BIO MED, V41, P851, DOI 10.1016/j.freeradbiomed.2006.06.007
   Perng MD, 1999, J CELL SCI, V112, P2099
   Picano E, 2003, J AM COLL CARDIOL, V42, P454, DOI 10.1016/S0735-1097(03)00647-8
   Avogaro A, 2004, AM J CARDIOL, V93, p13A, DOI 10.1016/j.amjcard.2003.11.003
   Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033
   Adeghate E, 2004, MOL CELL BIOCHEM, V261, P187, DOI 10.1023/B:MCBI.0000028755.86521.11
   Chis R, 2012, AM J PHYSIOL-HEART C, V303, pH967, DOI 10.1152/ajpheart.00040.2012
   Aragno M, 2008, ENDOCRINOLOGY, V149, P380, DOI 10.1210/en.2007-0877
   Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095
   Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4
   Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200
   Westermann D, 2009, DIABETES, V58, P1373, DOI 10.2337/db08-0329
   Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200
   Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384
   den Engelsman J, 2009, J MOL BIOL, V393, P1022, DOI 10.1016/j.jmb.2009.08.052
   [Anonymous], 2013, DIABETES ATLAS, V6th
   Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2
   Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x
   Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200
   Lee JH, 2013, BIOCHEM BIOPH RES CO, V430, P1109, DOI 10.1016/j.bbrc.2012.12.029
   Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z
   Losiewicz MK, 2011, INVEST OPHTH VIS SCI, V52, P5034, DOI 10.1167/iovs.10-6931
   LANDRY J, 1992, J BIOL CHEM, V267, P794
   Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113
   Koh TJ, 2004, AM J PHYSIOL-CELL PH, V286, pC713, DOI 10.1152/ajpcell.00341.2003
   Morrison LE, 2003, CIRC RES, V92, P203, DOI 10.1161/01.RES.0000052989.83995.A5
   Heling A, 2000, CIRC RES, V86, P846
   Zhu SG, 2012, J CELL MOL MED, V16, P950, DOI 10.1111/j.1582-4934.2011.01376.x
   Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263
   Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022
   Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981
   Hoover HE, 2000, J BIOL CHEM, V275, P23825, DOI 10.1074/jbc.M003864200
   Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev
   Cruz-Topete D, 2011, J PROTEOMICS, V74, P716, DOI 10.1016/j.jprot.2011.02.018
   Eaton P, 2001, J MOL CELL CARDIOL, V33, P1659, DOI 10.1006/jmcc.2001.1418
   AOYAMA A, 1993, MOL CELL BIOL, V13, P1824
   Arrigo AP, 2005, M S-MED SCI, V21, P619, DOI 10.1051/medsci/2005216-7619
   BENNARDINI F, 1992, CIRC RES, V71, P288
   Buriro R, 2013, GENET MOL RES, V12, P3003, DOI 10.4238/2013.August.20.2
   Cai L, 2001, Cardiovasc Toxicol, V1, P181, DOI 10.1385/CT:1:3:181
   Chen H, 2005, ACTA PHARMACOL SIN, V26, P806, DOI 10.1111/j.1745-7254.2005.00113.x
   Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105
   Clements RT, 2007, J THORAC CARDIOV SUR, V134, P1461, DOI 10.1016/j.jtcvs.2007.06.026
   Elliott JL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0375
   Golenhofen N, 2002, HISTOCHEM CELL BIOL, V117, P203, DOI 10.1007/s00418-001-0378-7
   Golenhofen N, 1998, AM J PHYSIOL-HEART C, V274, pH1457
   Golenhofen N, 2002, J MOL CELL CARDIOL, V34, P309, DOI 10.1006/jmcc.2001.1513
   Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492
   He B, 1998, MOL CELL BIOL, V18, P6624
   Hooper Philip L, 2005, Diabetes Technol Ther, V7, P204, DOI 10.1089/dia.2005.7.204
   Kim YH, 2007, NEUROBIOL DIS, V28, P293, DOI 10.1016/j.nbd.2007.07.017
   Kumar MS, 2005, J BIOL CHEM, V280, P21726, DOI 10.1074/jbc.M500405200
   Kumar PA, 2005, ARCH BIOCHEM BIOPHYS, V444, P77, DOI 10.1016/j.abb.2005.09.021
   MEHLEN P, 1995, J IMMUNOL, V154, P363
   Mitra A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.114
   Reddy GB, 2009, INVEST OPHTH VIS SCI, V50, P3456, DOI 10.1167/iovs.08-2498
   Reddy VS, 2013, INVEST OPHTH VIS SCI, V54, P7674, DOI 10.1167/iovs.13-12715
   Reddy VS, 2014, BIOCHEM BIOPH RES CO, V446, P602, DOI 10.1016/j.bbrc.2014.03.012
   Shama Kazi Mohammed Abu, 1999, Cell Structure and Function, V24, P1
   Taub PR, 2013, CLIN SCI, V125, P383, DOI 10.1042/CS20130023
   TONG P, 1995, LANCET, V345, P357, DOI 10.1016/S0140-6736(95)90343-7
NR 61
TC 2
Z9 3
U1 2
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 1
EP 9
DI 10.1016/j.abb.2014.06.008
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600001
PM 24950024
ER

PT J
AU Yuan, LQ
   Hassan, BA
AF Yuan, Liqun
   Hassan, Bassem A.
TI Neurogenins in brain development and disease: An overview
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Neurogenin; bHLH protein; Proneural gene; Anti-glia; Axon guidance;
   Dendrite morphology; Gliogenesis
ID CRANIAL SENSORY GANGLIA; NEURAL PRECURSOR CELLS; EMBRYONIC STEM-CELLS;
   DORSAL-ROOT GANGLIA; DOPAMINERGIC-NEURONS; DETERMINATION GENES;
   PYRAMIDAL NEURONS; PRONEURAL GENES; DEVELOPING CNS; BHLH PROTEIN
AB The production of neurons, astrocytes and oligodendrocytes is regulated by a group of transcription factors, which determine cell fates and specify subtype identities in the nervous system. Here we focus on profiling the distinct roles of Neurogenin (Ngn or Neurog) family members during the neuronal development. Ngn proteins are tightly regulated to be expressed at defined times and positions of different progenitor cell pools. In addition to their well-elucidated proneural function, Ngn proteins play various critical roles to specify or maintain cell fate and regulate neurite outgrowth and targeting in the central nervous system. Finally, Ngns have been associated with neuronal disorders. Therefore understanding the function and regulation of Ngns will not only improve the understanding of the molecular mechanism underlying the development of nervous system, but may also provide insight into neuronal disease. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Hassan, Bassem A.] VIB, Ctr Biol Dis, B-3000 Louvain, Belgium.
   Univ Louvain, Sch Med, Ctr Human Genet, B-3000 Louvain, Belgium.
RP Hassan, BA (reprint author), VIB, Ctr Biol Dis, B-3000 Louvain, Belgium.
EM bh@kuleuven.be
FU VIB; Fonds Wetenschaplijk Onderzoek (FWO); KU Leuven research council
   (DOC)
FX Work in the Hassan lab is funded by VIB, Grants from the Fonds
   Wetenschaplijk Onderzoek (FWO) and KU Leuven research council (DOC).
CR Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820
   Deng B, 2013, BIOMATERIALS, V34, P8786, DOI 10.1016/j.biomaterials.2013.07.076
   Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003
   Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008
   Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5
   Hassan BA, 2000, GENE DEV, V14, P1852
   Salama-Cohen P, 2006, J NEUROCHEM, V97, P1269, DOI 10.1111/j.1471-4159.2006.03783
   Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1
   Wilkinson G, 2013, NEUROSCIENCE, V253, P256, DOI 10.1016/j.neuroscience.2013.08.029
   Kim EJ, 2011, J COMP NEUROL, V519, P1355, DOI 10.1002/cne.22574
   Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118
   Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717
   Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5
   Kim SW, 2008, MOL CELLS, V26, P26
   Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032
   Ma QF, 2000, JARO, V1, P129, DOI 10.1007/sl01620010017
   Knuckles P, 2012, NAT NEUROSCI, V15, P962, DOI 10.1038/nn.3139
   Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0
   Ali F, 2011, DEVELOPMENT, V138, P4267, DOI 10.1242/dev.067900
   Ma QF, 1997, J NEUROSCI, V17, P3644
   Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874
   Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297
   Fode C, 2000, GENE DEV, V14, P67
   Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7
   Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223
   Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165
   Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060
   Begbie J, 2002, MOL CELL NEUROSCI, V21, P502, DOI 10.1006/mcne.2002.1197
   Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6
   Chan-Il Choi, 2013, Cell Transplant, V22, P855
   Fanous AH, 2007, AM J MED GENET B, V144B, P207, DOI 10.1002/ajmg.b.30423
   Furlong RF, 2005, DEV GENES EVOL, V215, P639, DOI 10.1007/s00427-005-0023-x
   Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115
   Hand R, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-30
   Ho BC, 2008, SCHIZOPHR RES, V106, P192, DOI 10.1016/j.schres.2008.08.009
   Jeong JY, 2006, P NATL ACAD SCI USA, V103, P5143, DOI 10.1073/pnas.0600337103
   Jo AY, 2007, EXP CELL RES, V313, P4066, DOI 10.1016/j.yexcr.2007.08.026
   Lee J, 2003, DEV BIOL, V253, P84, DOI 10.1006/dbio.2002.0868
   Ma WX, 2009, MOL CELL NEUROSCI, V40, P187, DOI 10.1016/j.mcn.2008.10.006
   Ma WX, 2006, MOL CELL NEUROSCI, V31, P463, DOI 10.1016/j.mcn.2005.10.018
   McGraw HF, 2008, J NEUROSCI, V28, P12558, DOI 10.1523/JNEUROSCI.2079-08.2008
   Nakada Y, 2004, DEV BIOL, V271, P479, DOI 10.1016/j.ybdio.2004.04.021
   Ribes V, 2008, DEV BIOL, V321, P470, DOI 10.1016/j.ydbio.2008.06.003
   Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779
   Roybon L, 2010, CEREB CORTEX, V20, P1234, DOI 10.1093/cercor/bhp187
   Shaker T, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-28
   Simmons AD, 2001, DEV BIOL, V229, P327, DOI 10.1006/dbio.2000.9984
   Simon-Areces J, 2010, J COMP NEUROL, V518, P1814, DOI 10.1002/cne.22304
   Thoma EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038651
   Thompson LH, 2006, EXP NEUROL, V198, P183, DOI 10.1016/j.expneurol.2005.11.025
   Uhrig M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006779
   Velkey JM, 2013, DEV DYNAM, V242, P230, DOI 10.1002/dvdy.23920
   Wang XK, 2001, GENE, V275, P47, DOI 10.1016/S0378-1119(01)00648-5
NR 53
TC 1
Z9 1
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 10
EP 13
DI 10.1016/j.abb.2014.05.028
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600002
PM 24950022
ER

PT J
AU Moraes, MS
   Costa, PE
   Batista, WL
   Paschoalin, T
   Curcio, MF
   Borges, RE
   Taha, MO
   Fonseca, FV
   Stern, A
   Monteiro, HP
AF Moraes, Miriam S.
   Costa, Paulo E.
   Batista, Wagner L.
   Paschoalin, Taysa
   Curcio, Marli F.
   Borges, Roberta E.
   Taha, Murched O.
   Fonseca, Fabio V.
   Stern, Arnold
   Monteiro, Hugo P.
TI Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth
   factor receptor-mediated signaling pathway in bradykinin-stimulated
   angiogenesis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Angiogenesis; Bradykinin; Endothelial cells; Epidermal growth factor
   receptor; Nitric oxide; S-nitrosylation
ID PROTEIN-TYROSINE PHOSPHATASES; HUMAN TUMOR-CELLS; S-NITROSYLATION; EGF
   RECEPTOR; COUPLED RECEPTORS; 3T3-F442A CELLS; MAP KINASE; IN-VITRO;
   PHOSPHORYLATION; MECHANISMS
AB Nitric oxide (NO) is involved in angiogenesis and stimulates the EGF-R signaling pathway. Stimulation of different endothelial cell lines with bradykinin (BK) activates the endothelial NO synthase (eNOS) and promotes EGF-R tyrosine phosphorylation. Increase in NO production correlated with enhanced phosphorylation of tyrosine residues and S-nitrosylation of the EGF-R. NO-mediated stimulatory effects on tyrosine phosphorylation of the EGF-R, where cGMP independent. Inhibition of soluble guanylyl cyclase followed by BK stimulation of human umbilical vein endothelial cells (HUVECs) did not change tyrosine phosphorylation levels of EGF-R. BK-stimulation of HUVEC promoted S-nitrosylation of the phosphatase SHP-1 and of p21Ras. Phosphorylation and activation of the ERK1/2 MAP kinases mediated by BK was dependent on the activation of the B2 receptor, of the EGF-R, and of p21 Ras. Inhibition of BK-stimulated S-nitrosylation prevented the activation of the ERK1/2 MAP kinases. Furthermore, activated ERK1/2 MAP kinases inhibited internalization of EGF-R by phosphorylating specific Thr residues of its cytoplasmic domain. BK-induced proliferation of endothelial cells was partially inhibited by the NOS inhibitor (L-NAME) and by the MEK inhibitor (PD98059). BK stimulated the expression of vascular endothelial growth factor (VEGF). VEGF expression was dependent on the activation of the EGF-R, the B2 receptor, p21Ras, and on NO generation. A Matrigel (R)-based in vitro assay for angiogenesis showed that BK induced the formation of capillary-like structures in HUVEC, but not in those cells expressing a mutant of the EGF-R lacking tyrosine kinase activity. Additionally, pre-treatment of BK-stimulated HUVEC with L-NAME, PD98059, and with SU5416, a specific inhibitor of VEGFR resulted in inhibition of in vitro angiogenesis. Our findings indicate that BK-mediated angiogenesis in endothelial cells involves the induction of the expression of VEGF associated with the activation of the NO/EGF-R/p21Ras/ERK1/2 MAP kinases signaling pathway. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Costa, Paulo E.; Curcio, Marli F.; Borges, Roberta E.; Monteiro, Hugo P.] Univ Fed Sao Paulo, Ctr Cellular & Mol Therapy CTCMol, Dept Biochem, BR-04044010 Sao Paulo, Brazil.
   [Batista, Wagner L.; Paschoalin, Taysa; Curcio, Marli F.] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, BR-04044010 Sao Paulo, Brazil.
   [Moraes, Miriam S.] Univ Sao Paulo, Inst Quim, Dept Biochem, Sao Paulo, Brazil.
   [Taha, Murched O.] Univ Fed Sao Paulo, Dept Surg, BR-04044010 Sao Paulo, Brazil.
   [Stern, Arnold] NYU, Sch Med, Dept Pharmacol, New York, NY USA.
   [Stern, Arnold] Univ Spiritu Santo Ecuador, Sch Med, Guayaquil, Ecuador.
   [Batista, Wagner L.] Univ Fed Sao Paulo, Dept Biol Sci, Sao Paulo, Brazil.
   [Fonseca, Fabio V.] Case Western Univ, Inst Transformat Mol Med, Dept Med, Cleveland, OH USA.
RP Monteiro, HP (reprint author), Univ Fed Sao Paulo, CTCMol, Rua Mirassol 207, BR-04044010 Sao Paulo, Brazil.
EM hpmonte@uol.com.br
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/Brazil)
   [2007/59617-6, 2010/19013-7, 2012/10470-1]; Conselho Nacional de
   Desenvolvimento Cientlfico e Tecnologico/Brazil (CNPq); FAPESP
FX This work was supported by grants from FAPESP (Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo/Brazil, Proc. 2007/59617-6,
   2010/19013-7, 2012/10470-1) and from Conselho Nacional de
   Desenvolvimento Cientlfico e Tecnologico/Brazil (CNPq) to H.P.M. M.S.M.
   received a doctorate fellowship from FAPESP.
CR Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034
   KNOWLES RG, 1994, BIOCHEM J, V298, P249
   Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100
   Tabernero J, 2007, MOL CANCER RES, V5, P203, DOI 10.1158/1541-7786.MCR-06-0404
   CASELLI A, 1994, J BIOL CHEM, V269, P24878
   MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536
   Monteiro HP, 2008, ANTIOXID REDOX SIGN, V10, P843, DOI 10.1089/ars.2007.1853
   FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664
   Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569
   Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8
   Hirata A, 2002, CANCER RES, V62, P2554
   Chen YY, 2007, METHODS, V42, P243, DOI 10.1016/j.ymeth.2007.03.002
   PEARSON RB, 1991, METHOD ENZYMOL, V200, P62
   Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3
   Switzer CH, 2012, MOL CANCER RES, V10, P1203, DOI 10.1158/1541-7786.MCR-12-0124
   ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557
   Li X, 2008, CELL SIGNAL, V20, P2145, DOI 10.1016/j.cellsig.2008.08.006
   Ishihara K, 2002, INT IMMUNOPHARMACOL, V2, P499, DOI 10.1016/S1567-5769(01)00193-X
   PERANOVICH TMS, 1995, BIOCHEM J, V305, P613
   Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019
   Thuringer D, 2002, J BIOL CHEM, V277, P2028, DOI 10.1074/jbc.M109493200
   Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011
   FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27
   LIAO JK, 1993, J CLIN INVEST, V92, P2168, DOI 10.1172/JCI116818
   Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6
   Bae SW, 2003, BIOCHEM BIOPH RES CO, V306, P981, DOI 10.1016/S0006-291X(03)01086-6
   Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0
   Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x
   LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563
   Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454
   Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200
   Batista WL, 2013, ANTIOXID REDOX SIGN, V18, P221, DOI 10.1089/ars.2011.4455
   Curcio MF, 2010, ANTIOXID REDOX SIGN, V13, P109, DOI 10.1089/ars.2009.2534
   Hampl V., 1996, METHODS NITRIC OXIDE, P309
   Huang Y, 2004, ENDOCRINOLOGY, V145, P3297, DOI 10.1210/en.2003-1658
   Huang Y, 2003, J BIOL CHEM, V278, P18902, DOI 10.1074/jbc.M300939200
   Kashles O., 1991, MOL CELL BIOL, V11, P1459
   Khur F., 2010, NEUROPEPTIDES, V44, P145
   Liebmann C, 2001, BIOL CHEM, V382, P49, DOI 10.1515/BC.2001.008
   MORRISON P, 1993, J BIOL CHEM, V268, P15536
   Murillo-Carretero M, 2009, FREE RADICAL BIO MED, V46, P471, DOI 10.1016/j.freeradbiomed.2008.10.048
   Oliveira CJR, 2008, NITRIC OXIDE-BIOL CH, V18, P241, DOI 10.1016/j.niox.2008.02.001
   Oliveira CJR, 2003, FREE RADICAL BIO MED, V35, P381, DOI 10.1016/S0891-5849(03)00311-3
   Paschoalin T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-44
   TOMIC S, 1995, J BIOL CHEM, V270, P21277
   Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8
NR 49
TC 3
Z9 3
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 14
EP 27
DI 10.1016/j.abb.2014.06.011
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600003
PM 24960080
ER

PT J
AU Jerome, M
   Paudel, HK
AF Jerome, Myrka
   Paudel, Hemant K.
TI 14-3-3 zeta regulates nuclear trafficking of protein phosphatase 1 alpha
   (PP1 alpha) in HEK-293 cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE PP1 alpha; 14-3-3 zeta; Nuclear trafficking; HEK-293 cells
ID SUBCELLULAR-LOCALIZATION; CATALYTIC SUBUNIT; MAMMALIAN-CELLS;
   EXOENZYME-S; PHOSPHORYLATION; BRAIN; SPERMATOZOA; INHIBITION; BINDING;
   KINASE
AB Protein phosphatase 1 (PP1) is one of the major Ser/Thr phosphatases in mammalian cells. There are four isoforms of PP1 namely, PP1 alpha, PP1 beta/delta, PP1 gamma(1) and PP1 gamma(2). PP1 gamma and PP1 beta translocate to the nucleus by binding to a co-transporter that contains a nuclear localization signal. The mechanism by which PP1 alpha shuttles between the nucleus and the cytosol is not known. In this study, we found that PP1 alpha co-immunoprecipitates with 14-3-3 zeta; from HEK-293 cell lysates. By co-immunoprecipitation and GST pull-down assay, we determined that 14-3-3 zeta; binds to both PP1 alpha (WT) and PP1 alpha (T320A), and that phosphorylation of PP1 alpha is not required for binding. Using PP1 alpha deletion mutants, we located the 14-3-3 zeta; binding region within PP1 alpha residues 159-279. An in vitro assay showed that 14-3-3 zeta; does not affect PP1 alpha activity. When HEK-293 cells expressing PP1 alpha and 14-3-3 zeta; were subjected to subcellular fractionation, the ratio of cytosolic vs. nuclear PP1 alpha was significantly higher in cells expressing PP1 alpha and 14-3-3 zeta; than those expressing PP1 alpha alone. In cells expressing a dominant negative 14-3-3 zeta; (K49E), PP1 alpha accumulated in the nucleus. Our results show that 14-3-3 zeta; binds to PP1 alpha and causes its retention in the cytosol which suggests that 14-3-3 zeta; regulates nuclear trafficking of PPla in mammalian cells. (C) 2014 Elsevier Inc. All rights reserved.
C1 McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada.
   McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3T 1E2, Canada.
RP Paudel, HK (reprint author), Jewish Gen Hosp, Lady Davis Inst Med Res, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.
EM hemant.paudel@mcgill.ca
FU Canadian Institute for Health Research; Alzheimer's Society of Canada
FX This work was supported by grants from Canadian Institute for Health
   Research and Alzheimer's Society of Canada.
CR Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207
   Qureshi HY, 2011, J BIOL CHEM, V286, P5055, DOI 10.1074/jbc.M110.178905
   Connor JH, 1999, J BIOL CHEM, V274, P22366, DOI 10.1074/jbc.274.32.22366
   Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6
   ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T
   Zhang LF, 1996, BIOCHEMISTRY-US, V35, P1606, DOI 10.1021/bi9521396
   Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200
   Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617
   Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501
   Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059
   Huang ZH, 2005, BIOL REPROD, V72, P384, DOI 10.1095/biolreprod.104.034140
   Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x
   Maynes JT, 2001, J BIOL CHEM, V276, P44078, DOI 10.1074/jbc.M107656200
   Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   Cohen PTW, 2002, J CELL SCI, V115, P241
   Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9
   Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x
   Huang ZH, 2004, BIOL REPROD, V71, P177, DOI 10.1095/biolreprod.104.027284
   Jagiello I, 2000, J CELL SCI, V113, P3761
   Kim YM, 2003, J BIOL CHEM, V278, P13819, DOI 10.1074/jbc.M209621200
   Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200
   Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200
   Liu CWY, 1999, J BIOL CHEM, V274, P29470, DOI 10.1074/jbc.274.41.29470
   Llorian M, 2005, J BIOL CHEM, V280, P38862, DOI 10.1074/jbc.M509185200
   Lu YF, 2011, J BIOL CHEM, V286, P20569, DOI 10.1074/jbc.M111.220962
   Okano K, 1997, GENOMICS, V45, P211, DOI 10.1006/geno.1997.4907
   Platholi J, 2008, J NEUROCHEM, V105, P2029, DOI 10.1111/j.1471-4159.2008.05300.x
   Qureshi HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084615
   Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219
   Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717
   Zhang SS, 1999, J BIOL CHEM, V274, P24865, DOI 10.1074/jbc.274.35.24865
NR 32
TC 0
Z9 0
U1 1
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 28
EP 35
DI 10.1016/j.abb.2014.06.012
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600004
PM 24956593
ER

PT J
AU Kadomatsu, K
   Sakamoto, K
AF Kadomatsu, Kenji
   Sakamoto, Kazuma
TI Mechanisms of axon regeneration and its inhibition: Roles of sulfated
   glycans
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Axon regeneration; Chondroitin sulfate; Dystrophic endball; Keratan
   sulfate; Neural injury; Receptor-type protein tyrosine phosphatase
ID SPINAL-CORD-INJURY; MYELIN-ASSOCIATED GLYCOPROTEIN; PROMOTES FUNCTIONAL
   RECOVERY; CHONDROITIN SULFATE; NEURITE OUTGROWTH; NERVE REGENERATION;
   GROWTH CONE; CYCLIC-AMP; PROTEOGLYCAN; PLASTICITY
AB Axons in the peripheral nervous system can regenerate after injury, whereas axons in the central nervous system (CNS) do not readily regenerate. Intrinsic regenerating capacity and emerging inhibitors could explain these contrasting phenotypes. Among the inhibitors, sulfated sugar chains including chondroitin sulfate and keratan sulfate have recently attracted attention, since these sugar chains strongly inhibit axon regeneration and also induce dystrophic endball formation, a hallmark of injured axons in the adult mammalian CNS. In addition, chondroitin sulfate is a negative regulator of synaptic plasticity. To overcome the inability of CNS axons to regenerate, a comprehensive understanding of both the positive and negative regulations of axon regeneration is required. These may include signaling waves from the injury site to the nucleus, intracellular signals for growth cone formation and axon regeneration, intracellular signals for the inhibition of axon regeneration, and extracellular inhibitory signals and their receptors. This review addresses these issues, with a focus on the roles of chondroitin sulfate and keratan sulfate. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kadomatsu, Kenji; Sakamoto, Kazuma] Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, Nagoya, Aichi 4668550, Japan.
RP Kadomatsu, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.
EM kkadoma@med.nagoya-u.ac.jp
RI Kadomatsu, Kenji/G-8083-2012
FU MEXT, Japan [23110002]
FX This work was supported in part by a Grant-in-Aid for Scientific
   Research on Innovative Areas (No. 23110002 to K.K.) from MEXT, Japan.
CR Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070
   Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7
   Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200
   Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737
   Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515
   MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6
   Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011
   Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2
   Imagama S, 2011, J NEUROSCI, V31, P17091, DOI 10.1523/JNEUROSCI.5120-10.2011
   Xie YM, 2006, J BIOL CHEM, V281, P16482, DOI 10.1074/jbc.M603131200
   Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011
   Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377
   Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527
   Ito Z, 2010, J NEUROSCI, V30, P5937, DOI 10.1523/JNEUROSCI.2570-09.2010
   Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021
   Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146
   Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9
   Cai D, 2001, J NEUROSCI, V21, P4731
   Zhang HQ, 2006, GLYCOBIOLOGY, V16, P702, DOI 10.1093/glycob/cwj115
   Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002
   Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011
   Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004
   Davies SJA, 1999, J NEUROSCI, V19, P5810
   SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5
   Orlando C, 2012, J NEUROSCI, V32, P18009, DOI 10.1523/JNEUROSCI.2406-12.2012
   Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609
   Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699
   Moon LDF, 2001, NAT NEUROSCI, V4, P465
   Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007
   Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310
   Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566
   Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176
   Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007
   Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338
   O'Donovan KJ, 2014, J EXP MED, V211, P801, DOI 10.1084/jem.20131780
   Cafferty WBJ, 2001, J NEUROSCI, V21, P7161
   Byrne AB, 2014, NEURON, V81, P561, DOI 10.1016/j.neuron.2013.11.019
   Brosius Lutz Amanda, 2014, Dev Cell, V28, P7, DOI 10.1016/j.devcel.2013.12.002
   Enes J, 2010, CURR BIOL, V20, P1154, DOI 10.1016/j.cub.2010.05.055
   Erez H, 2007, J CELL BIOL, V176, P497, DOI 10.1083/jcb.200607098
   Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957
   JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6
   Kadomatsu K, 2014, NEUROSCI RES, V78, P50, DOI 10.1016/j.neures.2013.10.005
   Kuboyama T, 2013, EXP NEUROL, V248, P157, DOI 10.1016/j.expneurol.2013.06.011
   Takeuchi K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3740
   Tauchi R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-53
   Williams KA, 2013, J BIOL CHEM, V288, P33156, DOI 10.1074/jbc.M113.472506
   Yang T, 2005, EUR J NEUROSCI, V22, P2159, DOI 10.1111/j.1460-9568.2005.04403.x
NR 50
TC 2
Z9 2
U1 2
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 36
EP 41
DI 10.1016/j.abb.2014.06.009
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600005
PM 24951877
ER

PT J
AU Hamann, I
   Petroll, K
   Grimm, L
   Hartwig, A
   Klotz, LO
AF Hamann, Ingrit
   Petroll, Kerstin
   Grimm, Larson
   Hartwig, Andrea
   Klotz, Lars-Oliver
TI Insulin-like modulation of Akt/FoxO signaling by copper ions is
   independent of insulin receptor
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Insulin signaling; PTPase (protein tyrosine phosphatase); ROS; Copper
   ions; Hepatoma cells; Linsitinib; Akt; FoxO
ID PROTEIN-TYROSINE PHOSPHATASES; GROWTH-FACTOR RECEPTOR; HUMAN
   HEPATOMA-CELLS; HYDROGEN-PEROXIDE; EGF RECEPTOR; ZINC IONS; AQUAPORINS
   FACILITATE; TRANSCRIPTION FACTORS; REVERSIBLE OXIDATION; PROMOTER
   ACTIVITY
AB Copper ions are known to induce insulin-like effects in various cell lines, stimulating the phosphoinositide 3'-kinase (PI3K)/Akt signaling cascade and leading to the phosphorylation of downstream targets, including FoxO transcription factors. The aim of this work was to study the role of insulin- and IGF1-receptors (IR and IGF1R) in insulin-like signaling induced by copper in HepG2 human hepatoma cells. Cells were exposed to Cu(II) at various concentrations for up to 60 min. While Akt and FoxO1a/FoxO3a were strongly phosphorylated in copper- and insulin-treated cells at all time points studied, only faint tyrosine phosphorylation of IR/IGF1R was detected in cells exposed to Cu(II) by either immunoprecipitation/immunoblot or by immunoblotting using phospho-specific antibodies, whereas insulin triggered strong phosphorylation at these sites. Pharmacological inhibition of IR/IGF1R modestly attenuated Cu-induced Akt and Fox() phosphorylation, whereas no attenuation of Cu-induced Akt activation was achieved by siRNA-mediated IR depletion. Cu(II)-induced FoxO1a nuclear exclusion was only slightly impaired by pharmacological inhibition of IR/IGF1R, whereas insulin-induced effects were blunted. In contrast, genistein, a broad-spectrum tyrosine kinase inhibitor, at concentrations not affecting IR/IGF1R, attenuated Cu(II)-induced Akt phosphorylation, pointing to the requirement of tyrosine kinases other than IR/IGF1R for Cu(II)-induced signaling. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Hamann, Ingrit; Petroll, Kerstin; Grimm, Larson; Klotz, Lars-Oliver] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.
   [Petroll, Kerstin; Hartwig, Andrea] Karlsruhe Inst Technol, D-76021 Karlsruhe, Germany.
   [Klotz, Lars-Oliver] Univ Jena, Dept Nutrigen, Inst Nutr, D-07743 Jena, Germany.
RP Klotz, LO (reprint author), Univ Jena, Dept Nutrigen, Inst Nutr, Dornburger Str 29, D-07743 Jena, Germany.
EM lars-oliver.klotz@uni-jena.de
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
   [RGPIN 402228-2011]; Canada Foundation for Innovation (CFI); Alberta
   Advanced Education and Technology (AET); Canada Research Chairs (CRC)
   Program
FX This study was supported by the Natural Sciences and Engineering
   Research Council of Canada (NSERC, Discovery Grant RGPIN 402228-2011 to
   LOK). LOK acknowledges support by Canada Foundation for Innovation
   (CFI), Alberta Advanced Education and Technology (AET), and the Canada
   Research Chairs (CRC) Program.
CR Abdelmohsen K, 2003, J BIOL CHEM, V278, P38360, DOI 10.1074/jbc.M306785200
   ABLER A, 1992, J BIOL CHEM, V267, P3946
   Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104
   AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
   Plum LM, 2014, METALLOMICS, V6, P1277, DOI 10.1039/c3mt00197k
   Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200
   von Montfort C, 2006, FREE RADICAL BIO MED, V41, P1478, DOI 10.1016/j.freeradbiomed.2006.08.005
   Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015
   Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200
   Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408
   Eckers A, 2009, REDOX REP, V14, P141, DOI 10.1179/135100009X392610
   Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11
   Walter PL, 2006, ARCH BIOCHEM BIOPHYS, V454, P107, DOI 10.1016/j.abb.2006.08.016
   Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107
   Monsalve M, 2011, CURR DRUG TARGETS, V12, P1322
   Speckmann B, 2008, HEPATOLOGY, V48, P1998, DOI 10.1002/hep.22526
   Klotz LO, 2002, BIOL CHEM, V383, P443, DOI 10.1515/BC.2002.047
   Kim JH, 2000, ARCH BIOCHEM BIOPHYS, V382, P72, DOI 10.1006/abbi.2000.1996
   Abdelmohsen K, 2005, BIOL CHEM, V386, P217, DOI 10.1515/BC.2005.027
   Barthel A, 2005, BIOL CHEM, V386, P207, DOI 10.1515/BC.2005.026
   Beier JI, 2006, FEBS LETT, V580, P1859, DOI 10.1016/j.febslet.2006.02.048
   Wu WD, 1999, AM J PHYSIOL-LUNG C, V277, pL924
   Leyendecker M, 2011, HORM METAB RES, V43, P268, DOI 10.1055/s-0031-1271692
   Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI [10.4155/fmc.09.89, 10.4155/FMC.09.89]
   Mattie MD, 2008, J MOL BIOL, V383, P1008, DOI 10.1016/j.jmb.2008.08.080
   Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y
   Walter PL, 2008, BIOCHEM BIOPH RES CO, V365, P316, DOI 10.1016/j.bbrc.2007.10.171
   Barthel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P175, DOI 10.1016/j.abb.2007.04.015
   Eckers A, 2009, BIOMETALS, V22, P307, DOI 10.1007/s10534-008-9167-2
   Klotz LO, 2000, BIOCHEM J, V352, P219, DOI 10.1042/0264-6021:3520219
   Knebel A, 1996, EMBO J, V15, P5314
   Korashy HM, 2008, FREE RADICAL BIO MED, V44, P795, DOI 10.1016/j.freeradbiomed.2007.11.003
   Kortylewski M, 2003, J BIOL CHEM, V278, P5242, DOI 10.1074/jbc.M205403200
   Larocca MC, 2009, AM J PHYSIOL-GASTR L, V296, pG93, DOI 10.1152/ajpgi.90410.2008
   Li Y, 2000, J BIOL CHEM, V275, P37443, DOI 10.1074/jbc.M004373200
   Ostrakhovitch EA, 2002, ARCH BIOCHEM BIOPHYS, V397, P232, DOI 10.1006/abbi.2001.2559
   Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200
   Dalla Sega FV, 2014, BBA-MOL CELL RES, V1843, P806, DOI 10.1016/j.bbamcr.2014.01.011
NR 38
TC 1
Z9 1
U1 1
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 42
EP 50
DI 10.1016/j.abb.2014.06.004
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600006
PM 24933099
ER

PT J
AU Yao, GD
   Qi, M
   Ji, XL
   Fan, SM
   Xu, L
   Hayashi, T
   Tashiro, S
   Onodera, S
   Ikejima, T
AF Yao, Guodong
   Qi, Min
   Ji, Xiaoling
   Fan, Simiao
   Xu, Lei
   Hayashi, Toshihiko
   Tashiro, Shin-ichi
   Onodera, Satoshi
   Ikejima, Takashi
TI ATM-p53 pathway causes G2/M arrest, but represses apoptosis in
   pseudolaric acid B-treated HeLa cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Pseudolaric acid B; G2/M arrest; Apoptosis; ATM; p53
ID FIBROSARCOMA L929 CELLS; COLON-CANCER CELLS; MITOTIC CATASTROPHE;
   REACTIVE OXYGEN; TUMOR-CELLS; CARCINOMA-CELLS; CYCLE ARREST; DNA-DAMAGE;
   DEATH; SENESCENCE
AB Pseudolaric acid B (PAB) is a diterpene acid, isolated from the root and trunk bark of Pseudolarix kaempferi Gordon (Pinaceae). Previous studies demonstrated that PAB induced G2/M arrest and apoptosis in several cancer cell lines, but the relationship between G2/M arrest and apoptosis is still unclear. We examined the relevant signaling pathways for human cervical carcinoma HeLa cells treated with 1 mu M PAB. Intriguingly, we found that activation of ATM-p53 signaling pathway by the treatment with 1 mu M PAB played a protective role for the subsequent apoptosis. Although the treatment with 1 mu M PAB up-regulated the expression of cyclin B1 and p-Histone 3 (mitotic markers) at 12 h, the expression decreased at 24 and 36 h along with the up-down expression of mitotic markers. The expressions of p-ATM and p-p53 that were involved in G2/M arrest increased at 12 h after treatment with PAB. However, a prolonged treatment with PAB (longer than 24 h) caused cell apoptosis. When the cells were arrested in G1 or S phase by the treatment with serum starvation, cytosine beta-D-arabinofuranoside (Ara-C) or hydroxyurea (Hu), the apoptotic ratio induced by PAB decreased. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Yao, Guodong; Qi, Min; Ji, Xiaoling; Fan, Simiao; Xu, Lei; Hayashi, Toshihiko; Ikejima, Takashi] Shenyang Pharmaceut Univ, China Japan Res Inst Med & Pharmaceut Sci, Shenyang 110016, Liaoning Provin, Peoples R China.
   [Tashiro, Shin-ichi] Inst Clin & Biomed Sci, Kyoto 6038072, Japan.
   [Onodera, Satoshi] Showa Pharmaceut Univ, Dept Clin & Biomed Sci, Tokyo 1948543, Japan.
   [Qi, Min] Tianjin Taiyang Pharmaceut Co Ltd, Tianjin 300457, Peoples R China.
   [Fan, Simiao] Tianjin Univ Tradit Chinese Med, Tianjin 300193, Peoples R China.
RP Ikejima, T (reprint author), Shenyang Pharmaceut Univ, China Japan Res Inst Med & Pharmaceut Sci, 103 Wenhua Rd, Shenyang 110016, Liaoning Provin, Peoples R China.
EM ikejimat@vip.sina.com
CR Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401
   Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627
   Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043
   Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256
   Farinelli SE, 1996, J NEUROSCI, V16, P1150
   Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037
   Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089
   Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178
   LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009
   Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027
   Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864
   Fan SM, 2011, FREE RADICAL RES, V45, P1307, DOI 10.3109/10715762.2011.618186
   Qi M, 2012, EUR J PHARMACOL, V683, P16, DOI 10.1016/j.ejphar.2012.02.035
   Zhang ZY, 2013, INT J ONCOL, V43, P289, DOI 10.3892/ijo.2013.1946
   Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672
   Erenpreisa J, 2005, CELL BIOL INT, V29, P1005, DOI 10.1016/j.cellbi.2005.10.008
   Yu JH, 2007, ACTA PHARMACOL SIN, V28, P1975, DOI 10.1111/j.1745-7254.2007.00706.x
   Oyagbemi AA, 2009, ASIAN PAC J CANCER P, V10, P535
   Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368
   Galan-Malo P, 2012, TOXICOL APPL PHARM, V258, P384, DOI 10.1016/j.taap.2011.11.021
   Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572
   HOPPESEYLER F, 1993, J VIROL, V67, P3111
   Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124
   Gewirtz DA, 2009, AUTOPHAGY, V5, P1232
   Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528
   Gartel AL, 2002, MOL CANCER THER, V1, P639
   Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677
   Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213
   Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682
   Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743
   Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973
   Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312
   Bataller M, 2005, ARCH BIOCHEM BIOPHYS, V437, P151, DOI 10.1016/j.abb.2005.03.008
   Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300
   Draetta G, 1997, BBA-REV CANCER, V1332, pM53, DOI 10.1016/S0304-419X(96)00049-2
   Duan WJ, 2010, J PHARMACOL SCI, V113, P48, DOI 10.1254/jphs.09315FP
   Filippi-Chiela EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020849
   Han C.R., 2013, APOPTOSIS, V19, P224
   Han CR, 2013, BBA-MOL CELL RES, V1833, P2220, DOI 10.1016/j.bbamcr.2013.05.016
   Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5
   Liu WW, 2013, FEBS J, V280, P4572, DOI 10.1111/febs.12426
   Meng AG, 2009, ACTA PHARMACOL SIN, V30, P442, DOI 10.1038/aps.2009.20
   Miyakoda M, 2002, ONCOGENE, V21, P1090, DOI 10.1038/sj/onc/1205196
   Nguyen L, 2003, INT J DEV NEUROSCI, V21, P321, DOI 10.1016/S0736-5748(03)00075-3
   Qi M, 2013, J PHARMACOL SCI, V121, P200, DOI 10.1254/jphs.12269FP
   Santi SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014614
   Sasnauskiene A, 2009, APOPTOSIS, V14, P276, DOI 10.1007/s10495-008-0292-8
   Shin SY, 2011, TOXICOL APPL PHARM, V254, P288, DOI 10.1016/j.taap.2011.05.003
   Yan ZM, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/106583
NR 49
TC 3
Z9 3
U1 4
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 51
EP 60
DI 10.1016/j.abb.2014.05.029
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600007
PM 24929187
ER

PT J
AU Njeri, CW
   Ellis, HR
AF Njeri, Catherine W.
   Ellis, Holly R.
TI Shifting redox states of the iron center partitions CDO between
   crosslink formation or cysteine oxidation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cysteine dioxygenase; Cys-Tyr thioether crosslink; Metalloprotein;
   L-Cysteine; L-Cysteine sulfinic acid; Cupin superfamily
ID AMINO-ACIDS; RAT-LIVER; CRYSTAL-STRUCTURE; DIOXYGENASE; METABOLISM;
   SUBSTRATE; MECHANISM; COFACTOR; OXIDASE; SULFUR
AB Cysteine dioxygenase (CDO) is a mononuclear iron-dependent enzyme that catalyzes the oxidation of L-cysteine to L-cysteine sulfinic acid. The mammalian COO enzymes contain a thioether crosslink between Cys93 and Tyr157, and purified recombinant CDO exists as a mixture of the crosslinked and non crosslinked isoforms. The current study presents a method of expressing homogenously non crosslinked CDO using a cell permeative metal chelator in order to provide a comprehensive investigation of the non crosslinked and crosslinked isoforms. Electron paramagnetic resonance analysis of purified non crosslinked CDO revealed that the iron was in the EPR silent Fe(II) form. Activity of non crosslinked CDO monitoring dioxygen utilization showed a distinct lag phase, which correlated with crosslink formation. Generation of homogenously crosslinked COO resulted in an similar to 5-fold higher k(cat)/K-m value compared to the enzyme with a heterogenous mixture of crosslinked and non crosslinked CDO isoforms. EPR analysis of homogenously crosslinked CDO revealed that this isoform exists in the Fe(III) form. These studies present a new perspective on the redox properties of the active site iron and demonstrate that a redox switch commits CDO towards either formation of the Cys93-Tyr157 crosslink or oxidation of the cysteine substrate. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Njeri, Catherine W.; Ellis, Holly R.] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA.
RP Ellis, HR (reprint author), Auburn Univ, Dept Chem & Biochem, 179 Chem Bldg, Auburn, AL 36849 USA.
EM ellishr@auburn.edu
CR ANDINE P, 1991, J NEUROCHEM, V57, P230, DOI 10.1111/j.1471-4159.1991.tb02120.x
   Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200
   Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200
   Schnell R, 2005, J BIOL CHEM, V280, P27319, DOI 10.1074/jbc.M502560200
   Chai SC, 2005, J BIOL CHEM, V280, P9865, DOI 10.1074/jbc.M413733200
   Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9
   Siakkou E, 2011, BBA-PROTEINS PROTEOM, V1814, P2003, DOI 10.1016/j.bbapap.2011.07.019
   Lee JI, 2004, J NUTR BIOCHEM, V15, P112, DOI 10.1016/j.jnutbio.2003.10.005
   Li W, 2013, BIOCHEMISTRY-US, V52, P9104, DOI 10.1021/bi4010232
   Fetzner S, 2012, APPL ENVIRON MICROB, V78, P2505, DOI 10.1128/AEM.07651-11
   Stipanuk MH, 2011, AMINO ACIDS, V41, P91, DOI 10.1007/s00726-010-0518-2
   Bella DL, 1999, AM J PHYSIOL-ENDOC M, V277, pE144
   Kleffmann T, 2009, J BIOL INORG CHEM, V14, P913, DOI 10.1007/s00775-009-0504-x
   Dominy JE, 2008, J BIOL CHEM, V283, P12188, DOI 10.1074/jbc.M800044200
   Bella DL, 1999, AM J PHYSIOL-ENDOC M, V276, pE326
   Simmons CR, 2008, BIOCHEMISTRY-US, V47, P11390, DOI 10.1021/bi801546n
   YAMAGUCHI K, 1978, J BIOCHEM-TOKYO, V83, P479
   Chaka G, 2007, J AM CHEM SOC, V129, P5217, DOI 10.1021/ja068960u
   CHURCH WB, 1986, J BIOL CHEM, V261, P234
   Crawford JA, 2011, BIOCHEMISTRY-US, V50, P10241, DOI 10.1021/bi2011724
   EWETZ L, 1966, BIOCHIM BIOPHYS ACTA, V128, P296, DOI 10.1016/0926-6593(66)90176-7
   Gardner JD, 2010, BIOCHEMISTRY-US, V49, P6033, DOI 10.1021/bi100189h
   Imsand EM, 2012, ARCH BIOCHEM BIOPHYS, V521, P10, DOI 10.1016/j.abb.2012.03.006
   LEHMANN A, 1987, NEUROSCIENCE, V22, P573, DOI 10.1016/0306-4522(87)90354-X
   LEHMANN A, 1993, EUR J NEUROSCI, V5, P1398, DOI 10.1111/j.1460-9568.1993.tb00926.x
   LOMBARDI.JB, 1969, J BIOL CHEM, V244, P1172
   McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103
   ORVILLE AM, 1993, J BIOL CHEM, V268, P8596
   Parkin SE, 1998, BIOCHEMISTRY-US, V37, P1124, DOI 10.1021/bi9723717
   Rogers MS, 2008, BIOCHEMISTRY-US, V47, P10428, DOI 10.1021/bi8010835
   SOERBO B, 1965, Biochem Biophys Res Commun, V18, P359
   Stipanuk MH, 2006, J NUTR, V136, p1652S
   WAINER A, 1965, BIOCHIM BIOPHYS ACTA, V104, P405, DOI 10.1016/0304-4165(65)90346-6
   Wasinger EC, 2003, INORG CHEM, V42, P365, DOI 10.1021/ic025906f
   Whittaker MM, 1996, J BIOL CHEM, V271, P681
NR 35
TC 3
Z9 3
U1 1
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 61
EP 69
DI 10.1016/j.abb.2014.06.001
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600008
PM 24929188
ER

PT J
AU Cappariello, A
   Maurizi, A
   Veeriah, V
   Teti, A
AF Cappariello, Alfredo
   Maurizi, Antonio
   Veeriah, Vimal
   Teti, Anna
TI The Great Beauty of the osteoclast
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Osteoclast; Bone resorption; Bone formation; Immune system;
   Angiogenesis; Hematopoiesis
ID BONE-RESORBING OSTEOCLASTS; ENDOTHELIAL GROWTH-FACTOR; INTRACELLULAR
   MEMBRANE TRAFFICKING; RESISTANT ACID-PHOSPHATASE; HEMATOPOIETIC
   STEM-CELLS; IN-VITRO; T-CELLS; METALLOPROTEINASE MT1-MMP; MATRIX
   METALLOPROTEINASES; SUBCELLULAR-LOCALIZATION
AB Much has been written recently on osteoclast biology, but this cell type still astonishes scientists with its multifaceted functions and unique properties. The last three decades have seen a change in thinking about the osteoclast, from a cell with a single function, which just destroys the tissue it belongs to, to an "orchestrator" implicated in the concerted regulation of bone turnover. Osteoclasts have unique morphological features, organelle distribution and plasma membrane domain organization. They require polarization to cause extracellular bone breakdown and release of the digested bone matrix products into the circulation. Osteoclasts contribute to the control of skeletal growth and renewal. Alongside other organs, including kidney, gut, thyroid and parathyroid glands, they also affect calcemia and phosphatemia. Osteoclasts are very sensitive to pro-inflammatory stimuli, and studies in the '00s ascertained their tight link with the immune system, bringing about the question why bone needs a cell regulated by the immune system to remove the extracellular matrix components. Recently, osteoclasts have been demonstrated to contribute to the hematopoietic stem cell niche, controlling local calcium concentration and regulating the turnover of factors essential for hematopoietic stem cell mobilization. Finally, osteoclasts are important regulators of osteoblast activity and angiogenesis, both by releasing factors stored in the bone matrix, and secreting "clastokines" that regulate the activity of neighboring cells. All these facets will be discussed in this review article, with the aim of underscoring The Great Beauty of the osteoclast. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Cappariello, Alfredo] Ist Ricovero & Cura Carattere Sci, Bambino Gesu Childrens Hosp, Regenerat Med Unit, Rome, Italy.
   [Maurizi, Antonio; Veeriah, Vimal; Teti, Anna] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.
   [Veeriah, Vimal] Anna Univ, KB Chandrasekhar Res Ctr AU KBC, Madras 600025, Tamil Nadu, India.
RP Teti, A (reprint author), Dept Biotechnol & Appl Clin Sci, Via Vetoio Coppito 2, I-67100 Laquila, Italy.
EM teti@univaq.it
RI Veeriah, Vimal/H-5772-2015; 
OI Teti, Anna Maria/0000-0002-5887-4419
FU Associazione Italiana per la Ricerca sul Cancro (AIRC); Telethon
   [GGP09018]; European Union (Programme "PEOPLE" - Call identifier:
   FP7-PEOPLE-2011-IRSES) [295181]; European Union ("Collaborative Project
   - Large-scale integrating project" - Call identifier:
   FP7-HEALTH.2012.2.1.1-1-C) [602300]
FX The original work was performed with the financial support from the
   European Union (Programme "PEOPLE" - Call identifier:
   FP7-PEOPLE-2011-IRSES Proposal No. 295181 - Acronym: INTER-BONE, and
   "Collaborative Project - Large-scale integrating project" - Call
   identifier: FP7-HEALTH.2012.2.1.1-1-C Proposal No. 602300 - Acronym:
   SYBIL), the Associazione Italiana per la Ricerca sul Cancro (AIRC), and
   Telethon (Grant GGP09018) to A.T. We are indebted to Dr. Rita Di Massimo
   for manuscript editing. Antonio Maurizi and Vimal Veeriah are Marie
   Curie Fellows involved in the INTERBONE-IRSES Project.
CR Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019
   Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1
   Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559
   Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003
   Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011
   Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x
   Sato T, 1997, J CELL SCI, V110, P589
   Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247
   Schachtner H, 2013, CYTOSKELETON, V70, P572, DOI 10.1002/cm.21119
   Hou P, 2004, BONE, V34, P37, DOI 10.1016/j.bone.2003.08.011
   Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514
   Vaaraniemi J, 2004, J BONE MINER RES, V19, P1432, DOI 10.1359/JBMR.040603
   Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917
   Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JC165952
   MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696
   Calvi LM, 2014, CALCIFIED TISSUE INT, V94, P112, DOI 10.1007/s00223-013-9805-8
   Shao ES, 2009, BLOOD, V114, P2197, DOI 10.1182/blood-2009-01-199166
   Gay CV, 2000, CRIT REV EUKAR GENE, V10, P213
   Trebec-Reynolds DP, 2010, J CELL BIOCHEM, V110, P343, DOI 10.1002/jcb.22542
   Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5
   Del Fattore A, 2008, BONE, V42, P19, DOI 10.1016/j.bone.2007.08.029
   Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2
   Sobacchi C, 2013, NAT REV ENDOCRINOL, V9, P522, DOI 10.1038/nrendo.2013.137
   Baud'huin M, 2013, CYTOKINE GROWTH F R, V24, P401, DOI 10.1016/j.cytogfr.2013.06.001
   Bertaud J, 2010, ACTA BIOMATER, V6, P2457, DOI 10.1016/j.actbio.2010.01.028
   Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008
   Frisch BJ, 2009, BLOOD, V114, P4054, DOI 10.1182/blood-2009-03-205823
   Kovesdy CP, 2013, NEPHROL DIAL TRANSPL, V28, P2228, DOI 10.1093/ndt/gft065
   Oury F, 2013, CELL, V155, P228, DOI 10.1016/j.cell.2013.08.042
   Barrow AD, 2011, J CLIN INVEST, V121, P3505, DOI 10.1172/JCI45913
   Ea HK, 2009, CURR OPIN RHEUMATOL, V21, P150, DOI 10.1097/BOR.0b013e3283257ba9
   Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822
   Zaidi M, 2001, J BONE MINER RES, V16, P1747, DOI 10.1359/jbmr.2001.16.10.1747
   Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374
   Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007
   Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196
   Panaroni C, 2013, CALCIFIED TISSUE INT, V93, P261, DOI 10.1007/s00223-013-9753-3
   Khan UA, 2013, J CELL BIOCHEM, V114, P1772, DOI 10.1002/jcb.24518
   Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328
   Miyamoto K, 2011, J EXP MED, V208, P2175, DOI 10.1084/jem.20101890
   Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200
   Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137
   Schett G, 2011, EUR J CLIN INVEST, V41, P1361, DOI 10.1111/j.1365-2362.2011.02545.x
   Supanchart C, 2008, ARCH BIOCHEM BIOPHYS, V473, P161, DOI 10.1016/j.abb.2008.03.029
   Mosig RA, 2007, HUM MOL GENET, V16, P1113, DOI 10.1093/hmg/ddm060
   Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001
   Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002
   Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070
   Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002
   Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1
   Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   Danks L, 2013, J BIOCHEM, V154, P29, DOI 10.1093/jb/mvt049
   Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011
   Boyce BF, 2013, J DENT RES, V92, P860, DOI 10.1177/0022034513500306
   Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106
   Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017
   Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840
   Dubyak GR, 2012, CELL MICROBIOL, V14, P1697, DOI 10.1111/cmi.12001
   BARON R, 1988, J CELL BIOL, V106, P1863, DOI 10.1083/jcb.106.6.1863
   BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220
   Baron R, 2004, NAT MED, V10, P458, DOI 10.1038/nm0504-458
   BARON R, 1989, CONNECT TISSUE RES, V20, P109, DOI 10.3109/03008208909023879
   BARON R, 1990, J CELL SCI, V97, P439
   BLAIR HC, 1986, J CELL BIOL, V102, P1164, DOI 10.1083/jcb.102.4.1164
   Bonar SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035979
   Buchwald ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038199
   Buchwald ZS, 2013, BONE, V56, P163, DOI 10.1016/j.bone.2013.05.024
   CHAMBERS TJ, 1980, CLIN ORTHOP RELAT R, P283
   Collin-Osdoby P, 2002, J BONE MINER RES, V17, P1859, DOI 10.1359/jbmr.2002.17.10.1859
   Coxon FP, 2008, SEMIN CELL DEV BIOL, V19, P424, DOI 10.1016/j.semcdb.2008.08.004
   Del Fattore A., 2011, HUMAN GENETIC DIS, P57
   Del Fattore A, 2008, J BONE MINER RES, V23, P380, DOI 10.1359/JBMR.071107
   Devlin M.J., 2014, LANCET DIABETES ENDO
   Domon T, 2002, TISSUE CELL, V34, P326, DOI 10.1016/S0040-8166(02)00013-7
   Dufour X., 2007, EXP CELL RES, V313, P394
   Fumoto T, 2014, J BONE MINER RES, V29, P830, DOI 10.1002/jbmr.2096
   Garimella R, 2008, J HISTOCHEM CYTOCHEM, V56, P569, DOI 10.1369/jhc.2008.950394
   Grol MW, 2009, PURINERG SIGNAL, V5, P205, DOI 10.1007/s11302-009-9139-1
   Gurevitch O, 2006, MED HYPOTHESES, V67, P729, DOI 10.1016/j.mehy.2006.03.051
   Hayman AR, 2003, J BONE MINER RES, V18, P1905, DOI 10.1359/jbmr.2003.18.10.1905
   He C, 2005, BIOCHEM BIOPH RES CO, V329, P324, DOI 10.1016/j.bbrc.2005.01.133
   Hirvonen Mirkka J, 2013, Bonekey Rep, V2, P306, DOI 10.1038/bonekey.2013.40
   HUNTER SJ, 1989, J HISTOCHEM CYTOCHEM, V37, P1529
   Irie K, 2001, TISSUE CELL, V33, P478
   JOYCE NC, 1995, CURR EYE RES, V14, P601, DOI 10.3109/02713689508998408
   Kiesel JR, 2009, J IMMUNOL, V182, P5477, DOI 10.4049/jimmunol.0803897
   Lei Zhu, 2009, Int J Exp Pathol, V90, P512, DOI 10.1111/j.1365-2613.2009.00661.x
   Liao Eryuan, 2013, Front Med, V7, P65, DOI 10.1007/s11684-013-0254-6
   LINDSEY AE, 1990, P NATL ACAD SCI USA, V87, P5278, DOI 10.1073/pnas.87.14.5278
   Lymperi S, 2008, BLOOD, V111, P1173, DOI 10.1182/blood-2007-03-082800
   Lymperi S, 2011, BLOOD, V117, P1540, DOI 10.1182/blood-2010-05-282855
   Mitic N, 2005, ARCH BIOCHEM BIOPHYS, V439, P154, DOI 10.1016/j.abb.2005.05.013
   Miyamoto T., 2013, J ORTHOP, V4, P198
   Motyckova Gabriela, 2002, Current Molecular Medicine (Hilversum), V2, P407, DOI 10.2174/1566524023362401
   Mulari M, 2003, MICROSC RES TECHNIQ, V61, P496, DOI 10.1002/jemt.10371
   MURRAY EJB, 1995, MINER ELECTROL METAB, V21, P184
   Nakamura H, 2004, BONE, V34, P48, DOI 10.1016/j.bone.2003.09.001
   Ng PY, 2013, J BONE MINER RES, V28, P119, DOI 10.1002/jbmr.1725
   Noble BS, 2008, ARCH BIOCHEM BIOPHYS, V473, P106, DOI 10.1016/j.abb.2008.04.009
   OKADA Y, 1995, LAB INVEST, V72, P311
   Otero K, 2012, J IMMUNOL, V188, P2612, DOI 10.4049/jimmunol.1102836
   Padera R, 1999, FASEB J, V13, P1677
   Peruzzi B., 2012, CLIN REV BONE MINER, V10, P71
   Porter RL, 2008, ARCH BIOCHEM BIOPHYS, V473, P193, DOI 10.1016/j.abb.2008.04.001
   Saijo M, 2003, HISTOCHEM CELL BIOL, V120, P493, DOI 10.1007/s00418-003-0589-1
   SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199
   Sheu TJ, 2003, J BIOL CHEM, V278, P438, DOI 10.1074/jbc.M208292200
   Stenbeck G, 2004, J CELL SCI, V117, P827, DOI 10.1242/jcs.00935
   Szewczyk KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060285
   Takamatsu Y, 1998, BLOOD, V92, P3465
   Teti Anna, 2013, Bonekey Rep, V2, P449, DOI 10.1038/bonekey.2013.183
   Teti Anna, 2012, Bonekey Rep, V1, P46, DOI 10.1038/bonekey.2012.46
   TETI A, 1989, J CLIN INVEST, V83, P227, DOI 10.1172/JCI113863
   Thammasitboon K, 2006, BONE, V38, P845, DOI 10.1016/j.bone.2005.10.013
   Ye SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027285
   Yi T, 2008, J CELL PHYSIOL, V217, P409, DOI 10.1002/jcp.21511
   Zaiss MM, 2010, ARTHRITIS RHEUM-US, V62, P2328, DOI 10.1002/art.27535
   ZALLONE AZ, 1983, J ANAT, V137, P57
   Zhao HB, 2002, BIOCHEM BIOPH RES CO, V293, P1060, DOI 10.1016/S0006-291X(02)00326-1
NR 120
TC 4
Z9 4
U1 2
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 70
EP 78
DI 10.1016/j.abb.2014.06.017
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600009
PM 24976175
ER

PT J
AU Li, Y
   Chen, C
   Yao, F
   Su, Q
   Liu, D
   Xue, R
   Dai, G
   Fang, R
   Zeng, J
   Chen, Y
   Huang, H
   Ma, Y
   Li, W
   Zhang, L
   Liu, C
   Dong, Y
AF Li, Yanh
   Chen, Cong
   Yao, Fengj
   Su, Qiao
   Liu, Dan
   Xue, Ruic
   Dai, Gang
   Fang, Rong
   Zeng, Juny
   Chen, Yil
   Huang, Huil
   Ma, Yued
   Li, Wenw
   Zhang, Lil
   Liu, Chen
   Dong, Yug
TI AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cardiac hypertrophy; Autophagy; AMPK; mTORC1
ID ACTIVATED PROTEIN-KINASE; PRESSURE-OVERLOAD; SIGNALING PATHWAY;
   HEMODYNAMIC STRESS; IN-VIVO; DYSFUNCTION; PHOSPHORYLATION; CELLS;
   CARDIOMYOCYTES; DEFICIENCY
AB AMPK, a serine/threonine protein kinase, has proven to be an important positive regulator of autophagy, which is a key factor in the regulation of cardiac hypertrophy. Thus, we explored whether AMPK could inhibit cardiac hypertrophy by regulating autophagy. In pressure overload induced cardiac hypertrophy, decreased autophagy was detected. Administration of AMPK activators (AICAR and metformin) significantly blocked hypertrophy, accompanied by enhanced autophagy level in the hearts. Furthermore, AMPK activation resulted in enhanced autophagosome formation and unimpaired lysosomal function. In vitro studies demonstrated adenoviral overexpression of constitutively activated AMPK increased autophagy and blunted PE-induced cardiomyocyte hypertrophy. Additionally, we found AICAR reduced the phosphorylation of the mTORC1 downstream effectors 4EBP1 and p70S6K, but AKT, which is a downstream signal of mTORC2, was not affected. Furthermore, activation by AMPK failed to lead to an additive effect on autophagy induced by the mTORC1 inhibitor rapamycin, indicating AMPK activates autophagy through the inhibition of mTORC1 but not of mTORC2. This study proved that AMPK can inhibit cardiac hypertrophy by stimulating autophagy through mTORC1 signaling. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Li, Yanh; Chen, Cong; Yao, Fengj; Liu, Dan; Xue, Ruic; Dai, Gang; Fang, Rong; Zeng, Juny; Chen, Yil; Huang, Huil; Ma, Yued; Zhang, Lil; Liu, Chen; Dong, Yug] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510080, Guangdong, Peoples R China.
   [Li, Yanh; Chen, Cong; Yao, Fengj; Liu, Dan; Xue, Ruic; Dai, Gang; Fang, Rong; Zeng, Juny; Chen, Yil; Huang, Huil; Ma, Yued; Zhang, Lil; Liu, Chen; Dong, Yug] Minist Hlth, Key Lab Assisted Circulat, Guangzhou 510080, Guangdong, Peoples R China.
   [Su, Qiao; Li, Wenw] Sun Yat Sen Univ, Affiliated Hosp 1, Anim Res Ctr, Guangzhou 510080, Guangdong, Peoples R China.
RP Liu, C (reprint author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.
EM liuch75@mail.sysu.edu.cn; dongxg@mail.sysu.edu.cn
FU National Natural Science Foundation of China [81170226, 81270318,
   81100172, 81100173, 81200173]; Guangdong Natural Science Foundation
   [S2011040003614]; Guangdong Scientific Program Foundation [B2011071]
FX This work is supported by funding provided by the National Natural
   Science Foundation of China (Nos. 81170226, 81270318, 81100172, 81100173
   and 81200173), Guangdong Natural Science Foundation (No. S2011040003614)
   and Guangdong Scientific Program Foundation (No. B2011071).
CR Ahmad M, 2002, ARTERIOSCL THROM VAS, V22, P759, DOI 10.1161/01.ATV.0000015884.61894.DC
   Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7
   Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017
   Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050
   Turdi S, 2011, J MOL CELL CARDIOL, V50, P712, DOI 10.1016/j.yjmcc.2010.12.007
   Meng RS, 2011, ARCH BIOCHEM BIOPHYS, V511, P1, DOI 10.1016/j.abb.2011.04.010
   Tian R, 2001, CIRCULATION, V104, P1664, DOI 10.1161/hc4001.097183
   McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45
   Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Kienesberger PC, 2012, MOL CELL BIOL, V32, P740, DOI 10.1128/MCB.06470-11
   Guo R, 2012, CARDIOVASC RES, V94, P480, DOI 10.1093/cvr/cvs127
   Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574
   Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001
   Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384
   Chen BL, 2010, ACTA PHARMACOL SIN, V31, P798, DOI 10.1038/aps.2010.73
   Chen DH, 2013, BIOCHEM BIOPH RES CO, V432, P226, DOI 10.1016/j.bbrc.2013.02.010
   He CY, 2013, DIABETES, V62, P1270, DOI 10.2337/db12-0533
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967
   Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523
   Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200
   Meng RS, 2009, EUR J PHARMACOL, V620, P63, DOI 10.1016/j.ejphar.2009.08.024
   Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585
   Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C
   Liu C, 2010, J NUTR BIOCHEM, V21, P1238, DOI 10.1016/j.jnutbio.2009.11.001
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Stapleton D, 1996, J BIOL CHEM, V271, P611
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Kuzman JA, 2007, ENDOCRINOLOGY, V148, P3477, DOI 10.1210/en.2007-0099
   Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702
   Chen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064757
   Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123
   Elsasser A, 2004, J AM COLL CARDIOL, V43, P2191, DOI 10.1016/j.jacc.2004.02.053
   Ha TZ, 2005, FREE RADICAL BIO MED, V39, P1570, DOI 10.1016/j.freeradbiomed.2005.08.002
   Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197
   Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455
   Stuck BJ, 2008, J BIOL CHEM, V283, P32562, DOI 10.1074/jbc.M801904200
   Sugden PH, 1999, CIRC RES, V84, P633
   Sun M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000191
NR 40
TC 8
Z9 8
U1 5
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 79
EP 86
DI 10.1016/j.abb.2014.06.023
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600010
PM 25009141
ER

PT J
AU Azarashvili, T
   Baburina, Y
   Grachev, D
   Krestinina, O
   Papadopoulos, V
   Lemasters, JJ
   Odinokova, I
   Reiser, G
AF Azarashvili, Tamara
   Baburina, Yulia
   Grachev, Dmitry
   Krestinina, Olga
   Papadopoulos, Vassilios
   Lemasters, John J.
   Odinokova, Irina
   Reiser, Georg
TI Carbenoxolone induces permeability transition pore opening in rat
   mitochondria via the translocator protein TSPO and connexin43
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Carbenoxolone; Protoporphyrin IX; TSPO; Connexins; Mitochondria;
   Permeability transition pore
ID PERIPHERAL BENZODIAZEPINE-RECEPTOR; MYELIN BASIC-PROTEIN; BRAIN
   MITOCHONDRIA; ATP SYNTHASE; CHOLESTEROL TRANSPORT; GLYCYRRHETINIC ACID;
   LIVER-MITOCHONDRIA; SUBUNIT-C; STEROID-BIOSYNTHESIS; P-I
AB Ca2+-induced permeability transition pore (mPTP) opening in isolated rat brain mitochondria is promoted through targeting of connexin43. After a threshold Ca2+ load, mitochondrial membrane potential drops and efflux of accumulated Ca2+ from the mitochondrial matrix occurs, indicating the mPTP opening. Specific antibodies were used to assess the role of the translocator protein (18 kDa; TSPO) and connexin43 in swelling of isolated rat liver and brain mitochondria induced by carbenoxolone and the endogenous TSPO ligand protoporphyrin IX. Mitochondrial membrane potential, Ca2+ transport and oxygen consumption were determined using selective electrodes. All the parameters were detected simultaneously in a chamber with the selective electrodes. The phosphorylation state of mitochondrial protein targets was assessed. We report that Ca2+-induced mitochondrial swelling was strengthened in the presence of both carbenoxolone and protoporphyrin IX. The carbenoxolone- and protoporphyrin IX-accelerated mPTP induction in brain mitochondria was completely prevented by antibodies specific for the mitochondrial translocator protein (TSPO). The anti-TSPO antibodies were more effective than anti-connexin43 antibodies. Moreover, carbenoxolone-stimulated phosphorylation of mitochondrial proteins was inhibited by anti-TSPO antibodies. Taken together, the data suggests that, in addition to acting via connexion43, carbenoxolone may exert its effect on mPTP via mitochondrial outer membrane TSPO. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Azarashvili, Tamara; Baburina, Yulia; Grachev, Dmitry; Krestinina, Olga; Lemasters, John J.; Odinokova, Irina] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142290, Moscow Region, Russia.
   [Azarashvili, Tamara; Reiser, Georg] Univ Magdeburg, Inst Neurobiochem, D-39120 Magdeburg, Germany.
   [Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3H 2R9, Canada.
   [Lemasters, John J.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.
   [Lemasters, John J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.
RP Azarashvili, T (reprint author), Russian Acad Sci, Inst Theoret & Expt Biophys, Inst Skaya Str 3, Pushchino 142290, Moscow Region, Russia.
EM tamara.azarashvili@gmail.com; byul@rambler.ru; grachew@rambler.ru;
   krestinina@rambler.ru; vassilios.papadopoulos@mcgill.ca;
   JJLemasters@musc.edu; odinokova@rambler.ru; georg.reiser@med.ovgu.de
FU RFBR [13-04-00935]; Russian Federation Government [N14.Z50.0028];
   Bundesministerium fur Bildung und Forschung [RUS 09/030]; Canadian
   Institutes of Health Research [MOP102647]; Canada Research Chair in
   Biochemical Pharmacology
FX This study was supported by RFBR grant (13-04-00935 to T.A.), grant from
   Russian Federation Government (N14.Z50.0028 to J.L.), the
   Bundesministerium fur Bildung und Forschung (RUS 09/030 to G.R.), the
   Canadian Institutes of Health Research (MOP102647 to V.P.) and a Canada
   Research Chair in Biochemical Pharmacology (to V.P.).
CR Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007
   Issop L, 2013, MOL CELL ENDOCRINOL, V371, P34, DOI 10.1016/j.mce.2012.12.003
   Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002
   Sagar GDV, 2006, J CELL BIOCHEM, V98, P1543, DOI 10.1002/jcb.20870
   Galiegue S, 2003, CURR MED CHEM, V10, P1563, DOI 10.2174/0929867033457223
   Liu J, 2003, J STEROID BIOCHEM, V85, P275, DOI 10.1016/S0960-0760(03)00213-9
   DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104
   Boengler K, 2006, HEART, V92, P1724, DOI 10.1136/hrt.2005.066878
   Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004
   KRUEGER KE, 1990, J BIOL CHEM, V265, P15015
   Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005
   Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200
   Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991
   Ruiz-Meana M, 2008, CARDIOVASC RES, V77, P325, DOI 10.1093/cvr/cvm062
   Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599
   Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.M200703200
   SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x
   Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159
   Baburina YL, 2014, BIOCHEMISTRY-MOSCOW+, V79, P555, DOI 10.1134/S0006297914060091
   Krestinina OV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P421, DOI 10.1134/S0006297909040105
   Boengler K, 2005, CARDIOVASC RES, V67, P234, DOI 10.1016/j.cardiores.2005.04.014
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Azarashvily TS, 2000, BIOCHEM BIOPH RES CO, V270, P741, DOI 10.1006/bbrc.2000.2488
   MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170
   Armanini D, 2002, EXP CLIN ENDOCR DIAB, V110, P257, DOI 10.1055/s-2002-34587
   Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598
   Bernardi P, 1999, PHYSIOL REV, V79, P1127
   Azarashvili T, 2010, BIOL CHEM, V391, P619, DOI 10.1515/BC.2010.070
   Azarashvili TS, 2002, J BIOENERG BIOMEMBR, V34, P279, DOI 10.1023/A:1020204518513
   Sileikyte J, 2011, J BIOL CHEM, V286, P1046, DOI 10.1074/jbc.M110.172486
   Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021
   Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575
   Baines CP, 2009, J MOL CELL CARDIOL, V46, P850, DOI 10.1016/j.yjmcc.2009.02.007
   Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200
   Fan JJ, 2010, PROG LIPID RES, V49, P218, DOI 10.1016/j.plipres.2009.12.003
   Azarashvili T, 2005, J NEUROCHEM, V94, P1054, DOI 10.1111/j.1741-4159.2005.03260.x
   Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115
   Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004
   Schubert AL, 2002, BIOCHEMISTRY-US, V41, P5754, DOI 10.1021/bi0121656
   Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6
   Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110
   ARMANINI D, 1983, CLIN ENDOCRINOL, V19, P609, DOI 10.1111/j.1365-2265.1983.tb00038.x
   Azarashvili T, 2014, J BIOENERG BIOMEMBR, V46, P135, DOI 10.1007/s10863-014-9541-4
   Azarashvili T, 2011, AM J PHYSIOL-CELL PH, V300, pC707, DOI 10.1152/ajpcell.00061.2010
   Azarashvili T, 2014, CELL CALCIUM, V55, P69, DOI 10.1016/j.ceca.2013.12.002
   Azarashvili T, 2003, CELL CALCIUM, V34, P253, DOI 10.1016/S0143-4160(03)00107-6
   Castedo M, 2002, J EXP MED, V196, P1121, DOI 10.1084/jem.20021758
   Fiore C, 2004, BBA-BIOENERGETICS, V1658, P195, DOI 10.1016/j.bbabio.2004.05.012
   Gamier M., 1994, MOL PHARM, V45, P201
   Herve JC, 2005, CURR PHARM DESIGN, V11, P1941, DOI 10.2174/1381612054021060
   Krestinina OV, 2013, NEUROCHEM J+, V7, P284, DOI 10.1134/S1819712413040053
   KUSANO A, 1991, CHEM PHARM BULL, V39, P930
   Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de
   Salvi M, 2003, BIOCHEM PHARMACOL, V66, P2375, DOI 10.1016/j.bcp.2003.08.023
   Salvi M, 2005, ENDOCRINOLOGY, V146, P2306, DOI 10.1210/en.2004-1128
   WHALIN ME, 1994, J RECEPTOR RES, V14, P217, DOI 10.3109/10799899409066033
NR 56
TC 2
Z9 2
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 87
EP 94
DI 10.1016/j.abb.2014.06.027
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600011
PM 24995971
ER

PT J
AU Jeong, M
   Lee, AR
   Kim, HE
   Choi, YG
   Choi, BS
   Lee, JH
AF Jeong, Minjee
   Lee, Ae-Ree
   Kim, Hee-Eun
   Choi, Yong-Geun
   Choi, Byong-Seok
   Lee, Joon-Hwa
TI NMR study of the Z-DNA binding mode and B-Z transition activity of the Z
   alpha domain of human ADAR1 when perturbed by mutation on the alpha 3
   helix and beta-hairpin
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE NMR; Z-DNA; Hydrogen exchange; ADAR1; B-Z transition; DNA-protein
   interactions
ID HANDED Z-DNA; HUMAN EDITING ENZYME; CRYSTAL-STRUCTURE;
   ADENOSINE-DEAMINASE; REVEALS; COMPLEX; PROTEINS; EXCHANGE; DUPLEX;
   FAMILY
AB The Z alpha domains of human ADAR1 (Z alpha(ADAR-1)) bind to Z-DNA via interaction mediated by the alpha 3-core and beta-hairpin. Five residues in the alpha 3 helix and four residues in the beta-hairpin play important roles in Z alpha function, forming direct or water-mediated hydrogen bonds with DNA backbone phosphates or interacting hydrophobically with DNA bases. To understand the roles of these residues during B-Z transition of duplex DNA, we performed NMR experiments on complexes of various Z alpha(ADAR1) mutants with a 6-bp DNA duplex at various protein-to-DNA molar ratios. Our study suggests that single mutations at residues K169, N173, or Y177 cause unusual conformational changes in the hydrophobic faces of helices alpha 1, alpha 2, and alpha 3, which dramatically decrease the Z-DNA binding affinity. ID imino proton spectra and chemical shift perturbation showed that single mutations at residues K170, R174, T191, P192, P193, or W195 slightly affected the Z-DNA binding affinity. A hydrogen exchange study proved that the K170A- and R174A-Z alpha(ADAR1) proteins could efficiently change B-DNA to left-handed Z-DNA via an active B-Z transition pathway, whereas the G2.C5 base pair was significantly destabilized compared to wild-type Z alpha(ADAR1). (C) 2014 Elsevier Inc. All rights reserved.
C1 [Jeong, Minjee; Lee, Ae-Ree; Kim, Hee-Eun; Choi, Yong-Geun; Lee, Joon-Hwa] Gyeongsang Natl Univ, Dept Chem, Jinju 660701, Gyeongnam, South Korea.
   [Jeong, Minjee; Lee, Ae-Ree; Kim, Hee-Eun; Choi, Yong-Geun; Lee, Joon-Hwa] Gyeongsang Natl Univ, Res Inst Nat Sci, Jinju 660701, Gyeongnam, South Korea.
   [Choi, Byong-Seok] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.
RP Lee, JH (reprint author), Gyeongsang Natl Univ, Dept Chem, Jinju 660701, Gyeongnam, South Korea.
EM joonhwa@gnu.ac.kr
RI Choi, Byong-Seok/C-1937-2011
FU National Research Foundation of Korea (NRF) - Korean Government (MSIP)
   [2010-0020480, 2013R1A2A2A05003837, 2012R1A4A1027750]; Next-Generation
   BioGreen 21 Program (SSAC) [PJ009041]; Rural Development Administration,
   Korea
FX This work was supported by several National Research Foundation of Korea
   (NRF) grants funded by the Korean Government (MSIP) [2010-0020480,
   2013R1A2A2A05003837, 2012R1A4A1027750 (BRL)]. This work was also
   supported by a grant from the Next-Generation BioGreen 21 Program (SSAC,
   No. PJ009041), Rural Development Administration, Korea. We thank the GNU
   Central Instrument Facility for performing the NMR experiments and Dr.
   Melissa Stauffer, of Scientific Editing Solutions, for editing the
   manuscript.
CR Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100
   Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841
   Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Bae S, 2011, J AM CHEM SOC, V133, P668, DOI 10.1021/ja107498y
   Ha SC, 2005, NATURE, V437, P1183, DOI 10.1038/nature04088
   Athanasiadis A, 2005, J MOL BIOL, V351, P496, DOI 10.1016/j.jmb.2005.06.028
   Goddard TD, 2003, SPARKY 3
   Ha SC, 2004, P NATL ACAD SCI USA, V101, P14367, DOI 10.1073/pnas.0405586101
   Ha SC, 2008, P NATL ACAD SCI USA, V105, P20671, DOI 10.1073/pnas.0810463106
   Herbert Alan, 1996, Journal of Biological Chemistry, V271, P11595
   Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421
   Herbert A, 1999, GENETICA, V106, P37, DOI 10.1023/A:1003768526018
   Kang YM, 2009, J AM CHEM SOC, V131, P11485, DOI 10.1021/ja902654u
   Kim D, 2014, NUCLEIC ACIDS RES, V42, P5937, DOI 10.1093/nar/gku189
   Kim HE, 2011, FEBS LETT, V585, P772, DOI 10.1016/j.febslet.2011.01.043
   Kim YG, 2004, P NATL ACAD SCI USA, V101, P1514, DOI 10.1073/pnas.0308260100
   Lee EH, 2010, FEBS LETT, V584, P4453, DOI 10.1016/j.febslet.2010.10.003
   Lee JH, 2007, NUCLEIC ACIDS RES, V35, P2965, DOI 10.1093/nar/gkm184
   Lee JH, 2008, FEBS LETT, V582, P1835, DOI 10.1016/j.febslet.2008.05.003
   Quyen Dong Van, 2007, Nucleic Acids Res, V35, P7714
   Schade M, 1999, P NATL ACAD SCI USA, V96, P12465, DOI 10.1073/pnas.96.22.12465
   Schade M, 1999, EMBO J, V18, P470, DOI 10.1093/emboj/18.2.470
   Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761
NR 24
TC 1
Z9 1
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 95
EP 103
DI 10.1016/j.abb.2014.06.026
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600012
PM 25010446
ER

PT J
AU Ramos-Martin, F
   Hervas, R
   Carrion-Vazquez, M
   Laurents, DV
AF Ramos-Martin, Francisco
   Hervas, Ruben
   Carrion-Vazquez, Mariano
   Laurents, Douglas V.
TI NMR spectroscopy reveals a preferred conformation with a defined
   hydrophobic cluster for polyglutamine binding peptide 1
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Protein misfolding & aggregation; CAG-expansion diseases; Nuclear
   magnetic resonance; Amyloid inhibitor
ID NEURODEGENERATIVE DISEASES; PROTEIN; AGGREGATION; QBP1; ZIPPERS;
   DISPLAY; SIZE
AB Several important human inherited neurodegenerative diseases are caused by "polyQ expansions", which are aberrant long repeats of glutamine residues in proteins. PolyQ binding peptide 1 (QBP1), whose minimal active core sequence is Trp-Lys-Trp-Trp-Pro-Gly-Ile-Phe, binds to expanded polyQs and blocks their beta-structure transition, aggregation and in vivo neurodegeneration. Whereas QBP1 is a widely used, commercially available product, its structure is unknown. Here, we have characterized the conformations of QBP1 and a scrambled peptide (Trp-Pro-Ile-Trp-Lys-Gly-Trp-Phe) in aqueous solution by CD, fluorescence and NMR spectroscopies. A CD maximum at 227 nm suggests the presence of rigid Trp side chains in QBP1. Based on 41 NOE-derived distance constraints, the 3D structure of QBP1 was determined. The side chains of Trp 4 and Ile 7, and to a lesser extent, those of Lys 2, Trp 3 and Phe 8, form a small hydrophobic cluster. Pro 5 and Gly 6 adopt a type II tight turn and Lys 2's zeta-NH3+; is positioned to form a favorable cation-pi interaction with Trp 4's indole ring. In contrast, the scrambled QBP1 peptide, which lacks inhibitory activity, does not adopt a preferred structure. These results provide a basis for future structure-based design approaches to further optimize QBP1 for therapy. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Ramos-Martin, Francisco; Hervas, Ruben; Carrion-Vazquez, Mariano] CSIC, Inst Cajal, E-28002 Madrid, Spain.
   [Ramos-Martin, Francisco; Hervas, Ruben; Carrion-Vazquez, Mariano] Inst Madrileno Estudios Avanzados Nanociencia IMD, E-28049 Madrid, Spain.
   [Laurents, Douglas V.] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain.
RP Laurents, DV (reprint author), CSIC, Inst Quim Fis Rocasolano, Serrano 119, E-28006 Madrid, Spain.
EM dlaurents@iqfr.csic.es
RI Laurents, Douglas/E-7527-2015
OI Laurents, Douglas/0000-0002-4187-165X
FU Ministerio de Ciencia e Innovacion (MICINN)/Ministerio de Economia y
   Competitividad (MINECO) [CTQ2010-21567-C02-02, SAF 2013-49179-C2-2-R,
   BIO2010-22275, SAF 2013-49179-C2-1-R]; Consejeria de Educacion de la
   Comunidad de Madrid
FX This work was funded by grants from the Ministerio de Ciencia e
   Innovacion (MICINN)/Ministerio de Economia y Competitividad (MINECO)
   (CTQ2010-21567-C02-02 & SAF 2013-49179-C2-2-R) to D.V.L. and
   (BIO2010-22275 & SAF 2013-49179-C2-1-R) to M.C.-V. as well as grant
   (S-0505/MAT/0283) from the Consejeria de Educacion de la Comunidad de
   Madrid to M.C.-V. We are grateful to Dr. M<SUP>a</SUP>. Angeles Jimenez
   and Dr. David Pantoja-Uceda for help with CYANA scripts and to Prof.
   Marta Bruix for critically reading the manuscript.
CR Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898
   Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3
   Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215
   Landrum E, 2014, J BIOL CHEM, V289, P10254, DOI 10.1074/jbc.C114.552943
   PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099
   Sreerama N, 1999, PROTEIN SCI, V8, P370
   SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111
   Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437
   Nagai Y, 2003, HUM MOL GENET, V12, P1253, DOI 10.1093/hmg/ddg144
   Armen RS, 2005, P NATL ACAD SCI USA, V102, P13433, DOI 10.1073/pnas.0502068102
   Bauer P.O., 2010, NAT BIOTECHNOL, V2010, P256
   Diez-Garcia F, 2013, ARCH BIOCHEM BIOPHYS, V537, P62, DOI 10.1016/j.abb.2013.06.009
   Güntert Peter, 2004, Methods Mol Biol, V278, P353
   Hamuro L, 2007, ASSAY DRUG DEV TECHN, V5, P629, DOI 10.1089/adt.2007.083
   Hervas R, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001335
   Kier BL, 2008, J AM CHEM SOC, V130, P14675, DOI 10.1021/ja804656h
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Nagai Y., 2008, CURR PHARM DESIGN, V13, P3267
   PACE CN, 1995, PROTEIN SCI, V4, P2411
   Provencher S.W., 1981, BIOCHEMISTRY-US, V20, P1085
   Tomita K, 2009, BIOORGAN MED CHEM, V17, P1259, DOI 10.1016/j.bmc.2008.12.018
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
NR 26
TC 0
Z9 0
U1 2
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 104
EP 110
DI 10.1016/j.abb.2014.06.025
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600013
PM 25009140
ER

PT J
AU Krondorfer, I
   Brugger, D
   Paukner, R
   Scheiblbrandner, S
   Pirker, KF
   Hofbauer, S
   Furtmuller, PG
   Obinger, C
   Haltrich, D
   Peterbauer, CK
AF Krondorfer, Iris
   Brugger, Dagmar
   Paukner, Regina
   Scheiblbrandner, Stefan
   Pirker, Katharina F.
   Hofbauer, Stefan
   Furtmueller, Paul G.
   Obinger, Christian
   Haltrich, Dietmar
   Peterbauer, Clemens K.
TI Agaricus meleagris pyranose dehydrogenase: Influence of covalent FAD
   linkage on catalysis and stability
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Pyranose dehydrogenase; Covalent flavinylation; FAD; Thermal stability;
   Conformational stability; Semiquinone radical
ID VANILLYL-ALCOHOL OXIDASE; BOUND FLAVIN; CHOLESTEROL OXIDASE;
   FLAVINYLATION; BINDING; DISCOVERY; OXIDATION; 2-OXIDASE; EPR
AB Pyranose dehydrogenase (PDH) is a monomeric flavoprotein belonging to the glucose-methanol-choline (GMC) family of oxidoreductases. It catalyzes the oxidation of free, non-phosphorylated sugars to the corresponding keto sugars. The enzyme harbors an FAD cofactor that is covalently attached to histidine 103 via an 8 alpha-N(3) histidyl linkage. Our previous work showed that variant H103Y was still able to bind FAD (non-covalently) and perform catalysis but steady-state kinetic parameters for several substrates were negatively affected. In order to investigate the impact of the covalent FAD attachment in Agaricus meleagris PDH in more detail, pre-steady-state kinetics, reduction potential and stability of the variant H103Y in comparison to the wild-type enzyme were probed. Stopped-flow analysis revealed that the mutation slowed down the reductive half-reaction by around three orders of magnitude whereas the oxidative half-reaction was affected only to a minor degree. This was reflected by a decrease in the standard reduction potential of variant H103Y compared to the wild-type protein. The existence of an anionic semiquinone radical in the resting state of both the wild-type and variant H103Y was demonstrated using electron paramagnetic resonance (EPR) spectroscopy and suggested a higher mobility of the cofactor in the variant H103Y. Unfolding studies showed significant negative effects of the disruption of the covalent bond on thermal and conformational stability. The results are discussed with respect to the role of covalently bound FAD in catalysis and stability. (C) 2014 The Authors. Published by Elsevier Inc.
C1 [Krondorfer, Iris; Brugger, Dagmar; Paukner, Regina; Scheiblbrandner, Stefan; Haltrich, Dietmar; Peterbauer, Clemens K.] BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Food Biotechnol Lab, A-1190 Vienna, Austria.
   [Pirker, Katharina F.; Hofbauer, Stefan; Furtmueller, Paul G.; Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, A-1190 Vienna, Austria.
RP Peterbauer, CK (reprint author), BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Food Biotechnol Lab, Muthgasse 11, A-1190 Vienna, Austria.
EM clemens.peterbauer@boku.ac.at
RI Hofbauer, Stefan/I-3889-2014; 
OI Obinger, Christian/0000-0002-7133-3430; Hofbauer,
   Stefan/0000-0003-3375-7715
FU Austrian Science Fund FWF [P22094]; Austrian Science Fund [W1224]
FX The authors thank Cindy Lorenz for technical assistance. This work was
   supported by the Austrian Science Fund FWF (grant P22094 to CKP), IK, DB
   and SH are member of the doctoral program BioToP (Biomolecular
   Technology of Proteins) of the Austrian Science Fund (W1224).
CR Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803
   Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005
   Jin J, 2008, FEBS J, V275, P5191, DOI 10.1111/j.1742-4658.2008.06649.x
   Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x
   Peterbauer CK, 2010, APPL MICROBIOL BIOT, V85, P837, DOI 10.1007/s00253-009-2226-y
   Sygmund C, 2012, APPL MICROBIOL BIOT, V94, P695, DOI 10.1007/s00253-011-3667-7
   Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514
   Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200
   Volc J, 1997, ARCH MICROBIOL, V167, P119, DOI 10.1007/s002030050424
   Heuts DPHM, 2007, J BIOL CHEM, V282, P20283, DOI 10.1074/jbc.M610849200
   Motteran L, 2001, J BIOL CHEM, V276, P18024, DOI 10.1074/jbc.M010953200
   REEVE CD, 1990, BIOCHEM J, V269, P815
   Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922
   Tasca F, 2010, BIOSENS BIOELECTRON, V25, P1710, DOI 10.1016/j.bios.2009.12.017
   Macheroux P, 1999, METH MOL B, V131, P1
   Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013
   Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x
   Hassan-Abdallah A, 2005, BIOCHEMISTRY-US, V44, P6452, DOI 10.1021/bi047271x
   Caldinelli L, 2005, J BIOL CHEM, V280, P22572, DOI 10.1074/jbc.M500549200
   Fraaije MW, 2000, J BIOL CHEM, V275, P38654, DOI 10.1074/jbc.M004753200
   Halada P, 2003, ANAL BIOCHEM, V314, P235, DOI 10.1016/S0003-2697(02)00661-9
   Heuts DPHM, 2008, BIOCHEM J, V413, P175, DOI 10.1042/BJ20071591
   Hofbauer S, 2012, BBA-PROTEINS PROTEOM, V1824, P1031, DOI 10.1016/j.bbapap.2012.05.012
   Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200
   HYDE JS, 1970, BIOCHIM BIOPHYS ACTA, V222, P688, DOI 10.1016/0304-4165(70)90202-3
   Krondorfer I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091145
   Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027
   Mathews S.F., 1991, BIOCHEMISTRY-US, V30, P238
   Staudigl Petra, 2013, Biomolecules, V3, P535, DOI 10.3390/biom3030535
   Tan TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053567
NR 30
TC 1
Z9 1
U1 6
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 111
EP 119
DI 10.1016/j.abb.2014.07.008
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600014
PM 25043975
ER

PT J
AU Lim, J
   Lee, KM
   Shim, J
   Shin, I
AF Lim, Juyeon
   Lee, Kyung-min
   Shim, Jaekyung
   Shin, Incheol
TI CD24 regulates stemness and the epithelial to mesenchymal transition
   through modulation of Notch1 mRNA stability by p38MAPK
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Breast cancer; CD24; CSC; EMT; Notch1
ID BREAST-CARCINOMA CELLS; P-SELECTIN; PROGNOSTIC MARKER; OVARIAN-CANCER;
   LIGAND; CYCLOOXYGENASE-2; PROLIFERATION; TRANSCRIPTION; ACTIVATION;
   EXPRESSION
AB We report here that CD24 knockdown resulted in decreased expression of Notch1 in MCF-7 cells. CD24-downstream p38MAPK was shown to regulate Notch1 at the level of mRNA stability. We also found that CD24-mediated cell migration, invasion, mammosphere formation, and drug resistance was regulated by its downstream target Notch1. Together, our results indicate that CD24 may regulate the epithelial to mesenchymal transition and sternness through Notch1 signaling in breast cancer cells. (C) 2014 Elsevier Inc. All rights reserved,
C1 [Lim, Juyeon; Lee, Kyung-min; Shin, Incheol] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea.
   [Shim, Jaekyung] Sejong Univ, Dept Mol Biol, Seoul 143747, South Korea.
   [Shin, Incheol] Hanyang Univ, Inst Nat Sci, Seoul 133791, South Korea.
RP Shin, I (reprint author), Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea.
EM incheol@hanyang.ac.kr
FU NRF from the Korea Research Foundation [2013-059143]; Ministry of
   Education, Science and Technology [2011-K000897]
FX This work was supported by an NRF grant (2013-059143) from the Korea
   Research Foundation and by the Converging Research Center Program funded
   by the Ministry of Education, Science and Technology (2011-K000897).
CR Abdullah Lissa Nurrul, 2013, Clin Transl Med, V2, P3, DOI 10.1186/2001-1326-2-3
   Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
   Shutter JR, 2000, GENE DEV, V14, P1313
   SAMMAR M, 1994, INT IMMUNOL, V6, P1027, DOI 10.1093/intimm/6.7.1027
   Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004
   Kristiansen G, 2004, PROSTATE, V58, P183, DOI 10.1002/pros.10324
   Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006
   Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619
   Krantz SB, 2012, J SURG RES, V173, P105, DOI 10.1016/j.jss.2011.09.020
   JACKSON D, 1992, CANCER RES, V52, P5264
   Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406
   Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2
   Schabath H, 2006, J CELL SCI, V119, P314, DOI 10.1242/jcs.02741
   Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001
   Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7
   Wang WF, 2010, CANCER SCI, V101, P112, DOI 10.1111/j.1349-7006.2009.01370.x
   Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6
   Wang ZW, 2010, CURR DRUG TARGETS, V11, P745
   Aigner S, 1998, FASEB J, V12, P1241
   Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100
   LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598
   Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850
   Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854
   Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35
   Kristiansen G, 2003, CLIN CANCER RES, V9, P4906
   Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003
   LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5
   Aigner S, 1997, BLOOD, V89, P3385
   Go MJ, 1998, DEVELOPMENT, V125, P2031
   Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590
   Lee KM, 2012, CELL SIGNAL, V24, P2132, DOI 10.1016/j.cellsig.2012.07.005
   Oswald F, 1998, MOL CELL BIOL, V18, P2077
   Dean JLE, 2003, J BIOL CHEM, V278, P39470, DOI 10.1074/jbc.M306345200
   Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264
   Du R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030771
   Gonsalves FC, 2007, P NATL ACAD SCI USA, V104, P531, DOI 10.1073/pnas.0609851104
   Harrison H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3396
   Kristoffersen K., 2013, CANCER BIOL THER, V14, P2
   Lundell MJ, 2003, DEVELOPMENT, V130, P4109, DOI 10.1242/dev.00593
   Nistico P., 2012, COLD SPRING HARB PER, V4
   Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831
   Tang ZY, 2001, NUCLEIC ACIDS RES, V29, P2284, DOI 10.1093/nar/29.11.2284
   Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803
   Zheng YY, 2013, CANCER CELL, V24, P59, DOI 10.1016/j.ccr.2013.05.021
NR 44
TC 3
Z9 3
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 120
EP 126
DI 10.1016/j.abb.2014.06.022
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600015
PM 24977325
ER

PT J
AU Wang, XY
   Guo, YQ
   Shao, XX
   Liu, YL
   Xu, ZG
   Guo, ZY
AF Wang, Xin-Yi
   Guo, Yu-Qi
   Shao, Xiao-Xia
   Liu, Ya-Li
   Xu, Zeng-Guang
   Guo, Zhan-Yun
TI Identification of important residues of insulin-like peptide 5 and its
   receptor RXFP4 for ligand-receptor interactions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE INSL5; RXFP4; Ligand-receptor interaction; Electrostatic interaction;
   Mutagenesis
ID ELECTROSTATIC INTERACTIONS; RELAXIN-3; SUPERFAMILY; GPCR142; INSL5
AB Insulin-like peptide 5 (INSL5) is an insulin/relaxin superfamily peptide involved in the regulation of glucose homeostasis by activating its receptor RXFP4, which can also be activated by relaxin-3 in vitro. To determine the interaction mechanism of INSL5 with its receptor RXFP4, we studied their electrostatic interactions using a charge-exchange mutagenesis approach. First, we identified three negatively charged extracellular residues (Glul 00, Asp104 and Glul 82) in human RXFP4 that were important for receptor activation by wild-type INSL5. Second, we demonstrated that two positively charged B-chain Arg residues (B13Arg and B23Arg) in human INSL5 were involved in receptor binding and activation. Third, we proposed probable electrostatic interactions between INSL5 and RXFP4: the B-chain central B13Arg of INSL5 interacts with both Asp104 and Glu182 of RXFP4, meanwhile the B-chain C-terminal B23Arg of INSL5 interacts with both Glu100 and Asp104 of RXFP4. The present electrostatic interactions between INSL5 and RXFP4 were similar to our previously identified interactions between relaxin-3 and RXFP4, but had subtle differences that might be caused by the different B-chain C-terminal conformations of relaxin-3 and INSL5 because a dipeptide exchange at the B-chain C-terminus significantly decreased the activity of INSL5 and relaxin-3 to receptor RXFP4. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wang, Xin-Yi; Guo, Yu-Qi; Shao, Xiao-Xia; Liu, Ya-Li; Guo, Zhan-Yun] Tongji Univ, Inst Prot Res, Coll Life Sci & Technol, Shanghai 200092, Peoples R China.
   [Wang, Xin-Yi; Liu, Ya-Li; Xu, Zeng-Guang; Guo, Zhan-Yun] Tongji Univ, Sch Med, Cent Lab, Shanghai East Hosp, Shanghai 200120, Peoples R China.
RP Guo, ZY (reprint author), Tongji Univ, Inst Prot Res, Coll Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China.
EM zhan-yun.guo@tongji.edu.cn
FU National Natural Science Foundation of China [31270824, 30970609];
   National Basic Research Program of China (973 Program) [2010CB912604];
   Fundamental Research Funds from Tongji University
FX This work was supported by grants from the National Natural Science
   Foundation of China (31270824, 30970609), the National Basic Research
   Program of China (973 Program, No. 2010CB912604), and the Fundamental
   Research Funds from Tongji University.
CR Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012
   Shabanpoor F, 2009, VITAM HORM, V80, P1, DOI 10.1016/S0083-6729(08)00601-8
   Conklin D, 1999, GENOMICS, V60, P50, DOI 10.1006/geno.1999.5899
   Bathgate Ross A D, 2013, Front Endocrinol (Lausanne), V4, P13, DOI 10.3389/fendo.2013.00013
   Burnicka-Turek O, 2012, ENDOCRINOLOGY, V153, P4655, DOI 10.1210/en.2012-1161
   Haugaard-Jonsson LM, 2009, BIOCHEM J, V419, P619, DOI 10.1042/BJ20082353
   Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163
   Liu CL, 2005, J BIOL CHEM, V280, P292, DOI 10.1074/jbc.M409916200
   Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200
   Luo XA, 2010, AMINO ACIDS, V39, P1343, DOI 10.1007/s00726-010-0586-3
   Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200
   Wang XY, 2014, FEBS J, V281, P2927, DOI 10.1111/febs.12830
   Zhang WJ, 2014, AMINO ACIDS, V46, P1393, DOI 10.1007/s00726-014-1705-3
   Zhang WJ, 2013, J PEPT SCI, V19, P350, DOI 10.1002/psc.2507
NR 14
TC 0
Z9 0
U1 3
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 127
EP 132
DI 10.1016/j.abb.2014.07.010
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600016
PM 25043977
ER

PT J
AU Neira, JL
AF Neira, Jose L.
TI Structural dissection of the C-terminal sterile alpha motif (SAM) of
   human p73
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Circular dichroism; Aggregation; Flexibility; Interactions; NMR;
   Peptides
ID SECONDARY STRUCTURE ANALYSES; LIPID PHOSPHATASE SHIP2;
   CIRCULAR-DICHROISM; HYDRODYNAMIC RADII; SPONTANEOUS TUMORS;
   NMR-SPECTROSCOPY; FOLDING PROBLEM; HUMAN P73-ALPHA; EPHA2 RECEPTOR;
   DOMAIN
AB The alpha splice variant of p73 (p73 alpha), a homologue of the tumour suppressor p53, has at its C terminus a sterile alpha motif (SAM); this domain, SAMp73, is involved in lipid binding and it is thought to mediate in protein protein interactions. SAMp73 is composed of five helices (alpha 1-alpha 5). In this work, we dissected SAMp73 in fragments encompassing the different helices, to study the conformational stability of the isolated elements of secondary structure. There was no evidence of stable residual helical structure in the isolated alpha 1, alpha 4 and alpha 5 helices in aqueous solution, as shown by 2D-H-1 NMR and far-UV CD spectroscopies; those helices acquired native-like helical structure in the presence of 40% trifluoroethanol (TFE). The population of helical structure in alpha 5 seemed to be driven by the indole moiety of Trp542, and it was enhanced by the presence of alpha 4. On the other hand, helices alpha 2 and 3(10)(alpha 3) had a tendency to self-associate even in TFE water solutions. However, the short, aggregation-prone 3(10)(alpha 3) helix was key to attain the native-like fold of SAMp73, as suggested by experiments with non-covalent complexes among the peptides. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Neira, Jose L.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche 03202, Alicante, Spain.
   [Neira, Jose L.] Inst Biocomputac & Fis Sistemas Complejos, Zaragoza, Spain.
RP Neira, JL (reprint author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Avda Ferrocarril S-N, Elche 03202, Alicante, Spain.
EM jlneira@umh.es
FU Spanish Ministerio de Economia y Competitividad [CTQ2013-4493,
   CSD2008-00005]; Generalitat Valenciana [Prometeo 2013/018]
FX We thank both reviewers for all their suggestions, ideas and
   corrections. We thank Prof. Paul F. Fitzpatrick for handling the
   manuscript. This work was supported by the Spanish Ministerio de
   Economia y Competitividad (CTQ2013-4493, and CSD2008-00005) and
   Generalitat Valenciana (Prometeo 2013/018). We thank Dr. Martina
   Palomino from Centro de Investigacion Principe Felipe (Valencia, Spain)
   for acquisition of the 1D-<SUP>1</SUP>H NMR spectra of alpha 2 alpha 3
   alpha 4 at very low concentrations in a 600 MHz (Bruker magnet) equipped
   with a cryoprobe.
CR Danielsson J, 2002, MAGN RESON CHEM, V40, pS89, DOI 10.1002/mrc.1132
   Ueda Y, 1999, ONCOGENE, V18, P4993, DOI 10.1038/sj.onc.1202817
   Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371
   Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i
   Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q
   Schultz J, 1997, PROTEIN SCI, V6, P249
   Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133
   Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962
   Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127
   Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X
   Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253
   Rajakulendran T, 2008, P NATL ACAD SCI USA, V105, P2836, DOI 10.1073/pnas.0709705105
   WISHART DS, 1995, J BIOMOL NMR, V6, P135
   Hoang TX, 2004, P NATL ACAD SCI USA, V101, P7960, DOI 10.1073/pnas.0402525101
   MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8
   Wang WG, 2006, P NATL ACAD SCI USA, V103, P11003, DOI 10.1073/pnas.0604507103
   Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3
   Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607
   Kravchenko JE, 2008, P NATL ACAD SCI USA, V105, P6302, DOI 10.1073/pnas.0802091105
   RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1
   Zawacka-Pankau J, 2010, CELL CYCLE, V9, P720, DOI 10.4161/cc.9.4.10668
   BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6
   De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763
   MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399
   Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a
   Inoue S, 2014, P NATL ACAD SCI USA, V111, P1843, DOI 10.1073/pnas.1323416111
   Melino G, 2003, TRENDS BIOCHEM SCI, V28, P663, DOI 10.1016/j.tibs.2003.10.004
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853
   Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147
   DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0
   Niklison-Chirou MV, 2013, P NATL ACAD SCI USA, V110, P18952, DOI 10.1073/pnas.1221172110
   Parra RG, 2013, J PHYS CHEM B, V117, P12887, DOI 10.1021/jp402105j
   Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145
   McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221
   Avid T., 2003, NAT STRUCT BIOL, V10, P614
   Barrera FN, 2003, J BIOL CHEM, V278, P46878, DOI 10.1074/jbc.M307846200
   Barrera FN, 2002, BIOCHEMISTRY-US, V41, P5743, DOI 10.1021/bi0159478
   BUCK M, 1995, BIOCHEMISTRY-US, V34, P13219, DOI 10.1021/bi00040a038
   Cavanagh J., 1996, PROTEIN NMR SPECTROS
   CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027
   Chi SW, 1999, EMBO J, V18, P4438, DOI 10.1093/emboj/18.16.4438
   de Prat Gay G, 1996, Arch Biochem Biophys, V335, P1, DOI 10.1006/abbi.1996.0475
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521
   Falconi M, 2004, BIOCHEM BIOPH RES CO, V316, P1037, DOI 10.1016/j.bbrc.2004.02.146
   GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7
   Hollstein M, 1996, NUCLEIC ACIDS RES, V24, P141, DOI 10.1093/nar/24.1.141
   HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840
   JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020
   KEMMINK J, 1993, J MOL BIOL, V234, P861, DOI 10.1006/jmbi.1993.1631
   Kurabi A, 2009, J MOL BIOL, V392, P1168, DOI 10.1016/j.jmb.2009.08.004
   Lee HJ, 2012, STRUCTURE, V20, P41, DOI 10.1016/j.str.2011.11.013
   Leone M, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-59
   Leone M, 2008, BIOCHEMISTRY-US, V47, P12721, DOI 10.1021/bi801713f
   Liu G., 2005, J BIOL CHEM, V280, P2111
   Mercurio FA, 2012, BIOCHEMISTRY-US, V51, P2136, DOI 10.1021/bi300141h
   Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.44014914
   Neira JL, 2012, PHYS CHEM CHEM PHYS, V14, P10308, DOI 10.1039/c2cp41179b
   Qiao F., 2005, SCI STKE, pre7, DOI DOI 10.1126/STKE.2862005RE7
   RICO M, 1986, BIOPOLYMERS, V25, P1031, DOI 10.1002/bip.360250605
   Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890
   SANCHO J, 1992, J MOL BIOL, V224, P749, DOI 10.1016/0022-2836(92)90559-3
   Sathyamurthy A, 2011, FEBS J, V278, P2680, DOI 10.1111/j.1742-4658.2011.08194.x
   Tanaka-Hall T.M., 2003, NAT STRUCT BIOL, V10, P677
   Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833
   Wang WK, 2000, ACTA CRYSTALLOGR D, V56, P769, DOI 10.1107/S0907444900005059
   Wang W.K., 2001, ACTA CRYSTALLOGR D, V57, P249
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
NR 71
TC 1
Z9 1
U1 4
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 133
EP 142
DI 10.1016/j.abb.2014.07.005
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600017
PM 25034213
ER

PT J
AU Dickinson, SE
   Olson, ER
   Levenson, C
   Janda, J
   Rusche, JJ
   Alberts, DS
   Bowden, GT
AF Dickinson, Sally E.
   Olson, Erik R.
   Levenson, Corey
   Janda, Jaroslav
   Rusche, Jadrian J.
   Alberts, David S.
   Bowden, G. Timothy
TI A novel chemopreventive mechanism for a traditional medicine: East
   Indian sandalwood oil induces autophagy and cell death in proliferating
   keratinocytes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Sandalwood oil; Ultraviolet light; Cell death; Autophagy
ID SKIN TUMOR-DEVELOPMENT; ALPHA-SANTALOL; ACTIVATOR PROTEIN-1; CANCER;
   MICE; EXPRESSION; MUTATIONS; PATHWAYS; BINDING; AGENT
AB One of the primary components of the East Indian sandalwood oil (EISO) is alpha-santalol, a molecule that has been investigated for its potential use as a chemopreventive agent in skin cancer. Although there is some evidence that alpha-santalol could be an effective chemopreventive agent, to date, purified EISO has not been extensively investigated even though it is widely used in cultures around the world for its health benefits as well as for its fragrance and as a cosmetic. In the current study, we show for the first time that EISO-treatment of HaCaT keratinocytes results in a blockade of cell cycle progression as well as a concentration-dependent inhibition of UV-induced AP-1 activity, two major cellular effects known to drive skin carcinogenesis. Unlike many chemopreventive agents, these effects were not mediated through an inhibition of signaling upstream of AP-1, as EISO treatment did not inhibit UV-induced Akt or MAPK activity. Low concentrations of EISO were found to induce HaCaT cell death, although not through apoptosis as annexin V and PARP cleavage were not found to increase with EISO treatment. However, plasma membrane integrity was severely compromised in EISO-treated cells, which may have led to cleavage of LC3 and the induction of autophagy. These effects were more pronounced in cells stimulated to proliferate with bovine pituitary extract and EGF prior to receiving EISO. Together, these effects suggest that EISO may exert beneficial effects upon skin, reducing the likelihood of promotion of pre-cancerous cells to actinic keratosis (AK) and skin cancer. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Dickinson, Sally E.; Olson, Erik R.; Janda, Jaroslav; Rusche, Jadrian J.; Alberts, David S.; Bowden, G. Timothy] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA.
   [Dickinson, Sally E.] Univ Arizona, Dept Pharmacol, Tucson, AZ USA.
   [Olson, Erik R.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.
   [Bowden, G. Timothy] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA.
   [Alberts, David S.] Univ Arizona, Dept Med, Tucson, AZ USA.
   [Levenson, Corey] Santalis Pharmaceut Inc, San Antonio, TX USA.
RP Dickinson, SE (reprint author), 1515 N Campbell Ave, Tucson, AZ 85724 USA.
EM sdickinson@uacc.arizona.edu
FU NIH grant: Arizona Cancer Center Support Grant [CA23074]; NIH grant:
   Chemoprevention of Skin Cancer Program Porject Grant [CA27502]; NIH
   grant: Southwest Environmental Health Sciences Center Support Grant
   [ES06694]; Santalis Pharmaceuticals, Inc.
FX This work was supported by NIH grants: Arizona Cancer Center Support
   Grant CA23074, Chemoprevention of Skin Cancer Program Project Grant
   CA27502, Southwest Environmental Health Sciences Center Support Grant
   ES06694. This work was also supported by Santalis Pharmaceuticals, Inc.
CR Olson ER, 2008, CANCER PREV RES, V1, P362, DOI 10.1158/1940-6207.CAPR-08-0101
   Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009
   Arasada BL, 2008, ANTICANCER RES, V28, P129
   Bommareddy A, 2012, PHYTOMEDICINE, V19, P804, DOI 10.1016/j.phymed.2012.04.003
   Bommareddy A, 2007, ANTICANCER RES, V27, P2185
   Dwivedi C, 2006, CARCINOGENESIS, V27, P1917, DOI 10.1093/carcin/bgl058
   Dwivedi C, 1999, EUR J CANCER PREV, V8, P449, DOI 10.1097/00008469-199910000-00011
   Dwivedi C, 2003, CANCER EPIDEM BIOMAR, V12, P151
   Cooper SJ, 2003, MOL CANCER RES, V1, P848
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833
   Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253
   Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3
   Dwivedi C, 1997, EUR J CANCER PREV, V6, P399, DOI 10.1097/00008469-199708000-00013
   Dickinson SE, 2009, CANCER RES, V69, P7103, DOI 10.1158/0008-5472.CAN-09-0770
   Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047
   Chen WX, 1998, J BIOL CHEM, V273, P32176, DOI 10.1074/jbc.273.48.32176
   Chilampalli C, 2013, Drug Discov Ther, V7, P109
   Ehrhart JC, 2003, PHOTOCH PHOTOBIO SCI, V2, P825, DOI 10.1039/b302281a
   Gonzales M, 2002, GENE, V293, P169, DOI 10.1016/S0378-1119(02)00723-0
   Kaur M, 2005, CARCINOGENESIS, V26, P369, DOI 10.1093/carcin/bgh325
   Priest D.B., 2004, COSMET NEWS, V27, P107
   Santha S, 2013, PHOTOCHEM PHOTOBIOL, V89, P919, DOI 10.1111/php.12070
   Santha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056982
   Sharma M., 2013, PHYTOTHER RES, V28, P925
   Steeves MA, 2010, CURR OPIN CELL BIOL, V22, P218, DOI 10.1016/j.ceb.2009.12.013
   Wu WKK, 2010, DRUG RESIST UPDATE, V13, P87, DOI 10.1016/j.drup.2010.04.003
   Zhang Xiaoying, 2011, Front Biosci (Schol Ed), V3, P777, DOI 10.2741/s186
   Zhang Xiaoying, 2010, BMC Res Notes, V3, P220, DOI 10.1186/1756-0500-3-220
NR 29
TC 3
Z9 3
U1 5
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2014
VL 558
BP 143
EP 152
DI 10.1016/j.abb.2014.06.021
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AN6JU
UT WOS:000340701600018
PM 25004464
ER

PT J
AU Miyamoto, S
   Terao, J
AF Miyamoto, Sayuri
   Terao, Junji
TI Antioxidants and Redox Processes in Health - Bilateral Meeting
   Brazil-Japan
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
C1 [Miyamoto, Sayuri] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil.
   [Terao, Junji] Univ Tokushima, Grad Sch Nutr Sci, Grad Sch, Dept Food Sci,Inst Hlth Biosci, Tokushima 7708503, Japan.
RP Miyamoto, S (reprint author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Av Prof Lineu Prestes 748, BR-05508000 Sao Paulo, Brazil.
EM miyamoto@iq.usp.br; terao@nutr.med.tokushima-u.ac.jp
RI Miyamoto, Sayuri/A-2144-2008; CEPID, Redoxoma/J-2971-2015
OI Miyamoto, Sayuri/0000-0002-5714-8984; 
CR Ishisaka A, 2014, ARCH BIOCHEM BIOPHYS, V557, P11, DOI 10.1016/j.abb.2014.05.025
   Cuevas A, 2014, ARCH BIOCHEM BIOPHYS, V557, P28, DOI 10.1016/j.abb.2014.04.009
   Zhang TS, 2014, ARCH BIOCHEM BIOPHYS, V557, P36, DOI 10.1016/j.abb.2014.05.023
   SIES H, 1986, ANGEW CHEM INT EDIT, V25, P1058, DOI 10.1002/anie.198610581
   Cadet J, 2014, ARCH BIOCHEM BIOPHYS, V557, P47, DOI 10.1016/j.abb.2014.05.001
   Droge W, 2002, PHYSIOL REV, V82, P47
   Murakami A, 2014, ARCH BIOCHEM BIOPHYS, V557, P3, DOI 10.1016/j.abb.2014.04.018
   Yamazaki S, 2014, ARCH BIOCHEM BIOPHYS, V557, P18, DOI 10.1016/j.abb.2014.05.030
   Demasi M, 2014, ARCH BIOCHEM BIOPHYS, V557, P65, DOI 10.1016/j.abb.2014.05.002
   Iqbal A, 2014, ARCH BIOCHEM BIOPHYS, V557, P72, DOI 10.1016/j.abb.2014.06.013
   Pellosi MC, 2014, ARCH BIOCHEM BIOPHYS, V557, P55, DOI 10.1016/j.abb.2014.05.024
   Sies H., 2007, ENCY STRESS, V3, P45
NR 12
TC 0
Z9 0
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2014
VL 557
SI SI
BP 1
EP 2
DI 10.1016/j.abb.2014.07.007
PG 2
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AM1ZA
UT WOS:000339646600001
PM 25047742
ER

PT J
AU Murakami, A
AF Murakami, Akira
TI Dose-dependent functionality and toxicity of green tea polyphenols in
   experimental rodents
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT Brazil-Japan Bilateral Meeting on Antioxidants and Redox Proc in Hlth /
   6th Int Conf of Polyphenols and Hlth / 8th Meeting of the
   Soc-for-Free-Rad-Biol-and-Med-S-Amer
CY OCT 21-22, 2013
CL Univ Sao Paulo, Sao Paulo, BRAZIL
HO Univ Sao Paulo
DE Green tea polyphenol; Colitis; Nephrotoxicity; Heat shock protein;
   Molecular chaperone; Pro-oxidation
ID HEAT-SHOCK PROTEINS; OXIDATIVE STRESS; HEME OXYGENASE-1;
   NEURODEGENERATIVE DISEASES; NRF2-MEDIATED ANTIOXIDANT; INDUCED
   HEPATOTOXICITY; COLON CARCINOGENESIS; LIPID-PEROXIDATION; CANCER
   PREVENTION; REDOX PROTEOMICS
AB A large number of physiologically functional foods are comprised of plant polyphenols. Their antioxidative activities have been intensively studied for a long period and proposed to be one of the major mechanisms of action accounting for their health promotional and disease preventive effects. Green tea polyphenols (GTPs) are considered to possess marked anti-oxidative properties and versatile beneficial functions, including anti-inflammation and cancer prevention. On the other hand, some investigators, including us, have uncovered their toxicity at high doses presumably due to pro-oxidative properties. For instance, both experimental animal studies and epidemiological surveys have demonstrated that GTPs may cause hepatotoxicity. We also recently showed that diets containing high doses (0.5-1%) of a GTP deteriorated dextran sodium sulfate (DSS)-induced intestinal inflammation and carcinogenesis. In addition, colitis mode mice fed a 1% GTP exhibited symptoms of nephrotoxicity, as indicated by marked elevation of serum creatinine level. This diet also increased thiobarbituric acid-reactive substances, a reliable marker of oxidative damage, in both kidneys and livers even in normal mice, while the expression levels of antioxidant enzymes and heat shock proteins (HSPs) were diminished in colitis and normal mice. Intriguingly, GTPs at 0.01% and 0.1% showed hepato-protective activities, i.e., they significantly suppressed DSS-increased serum aspartate aminotransferase and alanine aminotransferase levels. Moreover, those diets remarkably restored DSS-down-regulated expressions of heme oxygenase-1 and HSP70 in livers and kidneys. Taken together, while low and medium doses of GTPs are beneficial in colitis model mice, unwanted side-effects occasionally emerge with high doses. This dose-dependent functionality and toxicity of GTPs are in accordance with the concept of hormesis, in which mild, but not severe, stress activates defense systems for adaptation and survival. (C) 2014 Elsevier Inc. All rights reserved.
C1 Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan.
RP Murakami, A (reprint author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan.
EM cancer@kais.kyoto-u.ac.jp
CR Akatsuka S, 2006, AM J PATHOL, V169, P1328, DOI 10.2353/ajpath.2006.051280
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Song WC, 2012, TOXICOL PATHOL, V40, P174, DOI 10.1177/0192623311428478
   Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025
   Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030
   Jacobs AT, 2007, J BIOL CHEM, V282, P33412, DOI 10.1074/jbc.M706799200
   Kim M, 2005, CARCINOGENESIS, V26, P1553, DOI 10.1093/carcin/bgi104
   Saleh IG, 2013, FITOTERAPIA, V90, P151, DOI 10.1016/j.fitote.2013.07.014
   Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje
   Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006
   Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957
   Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100
   Imai K, 1997, PREV MED, V26, P769, DOI 10.1006/pmed.1997.0242
   Naeem A, 2011, CELL BIOCHEM BIOPHYS, V61, P237, DOI 10.1007/s12013-011-9200-x
   Chen C, 2003, CARCINOGENESIS, V24, P1369, DOI 10.1093/carcin/bgg091
   Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003
   Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693
   Calabrese EJ, 2002, TRENDS PHARMACOL SCI, V23, P331, DOI 10.1016/S0165-6147(02)02034-5
   Kim HJ, 2007, MOL CELLS, V23, P123
   Yang CS, 2011, MOL NUTR FOOD RES, V55, P819, DOI 10.1002/mnfr.201100036
   Kajiya K, 2001, BIOSCI BIOTECH BIOCH, V65, P2638, DOI 10.1271/bbb.65.2638
   Li YY, 2009, MOL PHARMACEUT, V6, P1152, DOI 10.1021/mp900037p
   Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069
   Singh M, 2010, J ALZHEIMERS DIS, V21, P741, DOI 10.3233/JAD-2010-100405
   Ishii T, 2011, BIOSCI BIOTECH BIOCH, V75, P100, DOI 10.1271/bbb.100600
   Thavanesan N, 2011, BRIT J NUTR, V106, P1297, DOI 10.1017/S0007114511003849
   OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694
   Gates KS, 2009, CHEM RES TOXICOL, V22, P1747, DOI 10.1021/tx900242k
   Perluigi M, 2012, ANTIOXID REDOX SIGN, V17, P1590, DOI 10.1089/ars.2011.4406
   Na HK, 2008, FOOD CHEM TOXICOL, V46, P1271, DOI 10.1016/j.fct.2007.10.006
   Inoue H, 2011, CELL STRESS CHAPERON, V16, P653, DOI 10.1007/s12192-011-0280-8
   Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013
   Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7
   Calabrese EJ, 2012, BIOGERONTOLOGY, V13, P215, DOI 10.1007/s10522-012-9374-7
   Mandel SA, 2011, J ALZHEIMERS DIS, V25, P187, DOI 10.3233/JAD-2011-101803
   Mori T, 2010, BIOSCI BIOTECH BIOCH, V74, P2451, DOI 10.1271/bbb.100509
   Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002
   Moyers SB, 2004, NUTR REV, V62, P204, DOI 10.1301/nr.2004.may.204-211
   Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106
   Beck R, 2009, BIOCHEM PHARMACOL, V77, P375, DOI 10.1016/j.bcp.2008.10.019
   Christian P, 2013, BBA-MOL CELL BIOL L, V1831, P819, DOI 10.1016/j.bbalip.2012.12.009
   Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385
   Shen GX, 2005, PHARM RES-DORDR, V22, P1805, DOI 10.1007/s11095-005-7546-8
   Nezis IP, 2012, ANTIOXID REDOX SIGN, V17, P786, DOI 10.1089/ars.2011.4394
   Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027
   Inoue H, 2013, BIOSCI BIOTECH BIOCH, V77, P1223, DOI 10.1271/bbb.121003
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Kweon MH, 2006, J BIOL CHEM, V281, P33761, DOI 10.1074/jbc.M604748200
   Bhattacharyya S, 2009, INFLAMM BOWEL DIS, V15, P673, DOI 10.1002/ibd.20821
   Cookson MR, 2002, AMYOTROPH LATERAL SC, V3, P75, DOI 10.1080/146608202760196048
   Desbuards N, 2009, NEPHRON EXP NEPHROL, V113, pE35, DOI 10.1159/000228081
   Fan Y.C, 2013, DRUG CHEM TOXICOL
   Feng J, 2011, J CELL BIOCHEM, V112, P1524, DOI 10.1002/jcb.23065
   Hirose M, 2001, CANCER LETT, V168, P23, DOI 10.1016/S0304-3835(01)00502-X
   Kim M, 2010, BIOFACTORS, V36, P43, DOI 10.1002/biof.69
   Kohlmeier L, 1997, NUTR CANCER, V27, P1
   Lim J.H., 2013, DIABETOLOGIA
   Ohnishi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058641
   Ohnishi K, 2013, BIOCHEM BIOPH RES CO, V430, P616, DOI 10.1016/j.bbrc.2012.11.104
   Okushio K, 1999, BIOSCI BIOTECH BIOCH, V63, P430, DOI 10.1271/bbb.63.430
   Patterson A. D, 2013, CHEM RES TOXICOL
   Salminen WF, 2012, FOOD CHEM TOXICOL, V50, P1439, DOI 10.1016/j.fct.2012.01.027
   Shi Q, 2007, CELL MOL IMMUNOL, V4, P53
   Strober W, 1998, ANN INTERN MED, V128, P848
   Turturici G., 2011, BIOCH RES INT, V2011, DOI DOI 10.1155/2011/618127
   Vydra N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-504
   Weisburger JH, 1998, CARCINOGENESIS, V19, P229, DOI 10.1093/carcin/19.1.229
   YAMANE T, 1991, JPN J CANCER RES, V82, P1336
   Yellapu Radha K, 2011, Can J Gastroenterol, V25, P157
   Yuan JH, 2007, PHARMACOLOGY, V80, P269, DOI 10.1159/000106447
NR 71
TC 3
Z9 4
U1 9
U2 46
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2014
VL 557
SI SI
BP 3
EP 10
DI 10.1016/j.abb.2014.04.018
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AM1ZA
UT WOS:000339646600002
PM 24814373
ER

PT J
AU Ishisaka, A
   Mukai, R
   Terao, J
   Shibata, N
   Kawai, Y
AF Ishisaka, Akari
   Mukai, Rie
   Terao, Junji
   Shibata, Noriyuki
   Kawai, Yoshichika
TI Specific localization of quercetin-3-O-glucuronide in human brain
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT Brazil-Japan Bilateral Meeting on Antioxidants and Redox Proc in Hlth /
   6th Int Conf of Polyphenols and Hlth / 8th Meeting of the
   Soc-for-Free-Rad-Biol-and-Med-S-Amer
CY OCT 21-22, 2013
CL Univ Sao Paulo, Sao Paulo, BRAZIL
HO Univ Sao Paulo
DE Quercetin; Glucuronide; Brain; Blood-cerebrospinal fluid barrier;
   Macrophage; Inflammation
ID POTENTIALLY ANTICARCINOGENIC FLAVONOIDS; TISSUE DISTRIBUTION; DIETARY
   FLAVONOIDS; LIPID-PEROXIDATION; ALZHEIMERS-DISEASE; IN-VIVO; QUERCETIN;
   CELLS; RATS; IDENTIFICATION
AB In recent years, many papers have suggested that dietary flavonoids may exert beneficial effects in the brain tissue for the protection of neurons against oxidative stress and inflammation. However, the bioavailability of flavonoids across the blood-brain baffler and the localization in the brain remain controversial. Thus, we examined the localization of quercetin-3-O-glucuronide (Q3GA), a major phase-II metabolite of quercetin, in the human brain tissues with or without cerebral infarction by immunohistochemical staining using anti-Q3GA antibody. A significant immunoreactivity was observed in the epithelial cells of the choroid plexus, which constitute the structural basis of the blood-cerebrospinal fluid (CSF) barrier, and in the foamy macrophages of recent infarcts. The cellular accumulation of Q3GA was also reproduced in vitro in macrophage-like RAW264, microglial MG6, and brain capillary endothelial RBEC1. It is of interest that a common feature of these cell lines is the deconjugation of Q3GA, resulting in the cellular accumulation of non-conjugated quercetin and the methylated forms. We then examined the anti-inflammatory activity of Q3GA and the deconjugated forms in the lipopolysaccharide-stimulated macrophage cells and revealed that the deconjugated forms (quercetin and a methylated form isorhamnetin), but not Q3GA itself, exhibited inhibitory effects on the inflammatory responses through attenuation of the c-Jun N-terminal kinase pathway. These results suggested that a quercetin glucuronide can pass through the blood-brain barrier, perhaps the CSF barrier, accumulate in specific types of cells, such as macrophages, and act as anti-inflammatory agents in the brain through deconjugation into the bioactive non-conjugated forms. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Ishisaka, Akari] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6700092, Japan.
   [Mukai, Rie; Terao, Junji] Univ Tokushima, Grad Sch Nutr & Biosci, Dept Food Sci, Tokushima 7708503, Japan.
   [Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Pathol, Tokyo 1628666, Japan.
   [Kawai, Yoshichika] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan.
RP Kawai, Y (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan.
EM kawaiy@agr.nagoya-u.ac.jp
CR Williamson G, 2005, FREE RADICAL RES, V39, P457, DOI 10.1080/10715760500053610
   Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766
   Day AJ, 2001, FREE RADICAL RES, V35, P941, DOI 10.1080/10715760100301441
   Youdim KA, 2004, FREE RADICAL BIO MED, V37, P1683, DOI 10.1016/j.freeradbiomed.2004.08.002
   Kawabata K, 2010, J NUTR BIOCHEM, V21, P374, DOI 10.1016/j.jnutbio.2009.01.008
   de Boer VCJ, 2005, J NUTR, V135, P1718
   Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001
   HERTOG MGL, 1992, J AGR FOOD CHEM, V40, P2379, DOI 10.1021/jf00024a011
   Moon JH, 2001, FREE RADICAL BIO MED, V30, P1274, DOI 10.1016/S0891-5849(01)00522-6
   Kawai Y, 2008, J BIOL CHEM, V283, P9424, DOI 10.1074/jbc.M706571200
   Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008
   Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046
   HERTOG MGL, 1993, NUTR CANCER, V20, P21
   Kido Y, 2000, PHARMACEUT RES, V17, P55, DOI 10.1023/A:1007518525161
   Ishisaka A, 2011, FREE RADICAL BIO MED, V51, P1329, DOI 10.1016/j.freeradbiomed.2011.06.017
   Derlindati E, 2012, FOOD FUNCT, V3, P1144, DOI 10.1039/c2fo30127j
   Wang J, 2012, J NEUROSCI, V32, P5144, DOI 10.1523/JNEUROSCI.6437-11.2012
   Bieger J, 2008, J NUTR, V138, P1417
   da Silva EL, 1998, ARCH BIOCHEM BIOPHYS, V349, P313, DOI 10.1006/abbi.1997.0455
   Ishisaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080843
   Kamada C, 2005, FREE RADICAL RES, V39, P185, DOI 10.1080/10715760400019638
   Sakakibara H, 2008, BIOSCI BIOTECH BIOCH, V72, P94, DOI 10.1271/bbb.70454
   Shirai M, 2006, FREE RADICAL RES, V40, P1047, DOI 10.1080/10715760600794287
   Strazielle N, 1999, J NEUROSCI, V19, P6275
NR 24
TC 11
Z9 11
U1 3
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2014
VL 557
SI SI
BP 11
EP 17
DI 10.1016/j.abb.2014.05.025
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AM1ZA
UT WOS:000339646600003
PM 24893148
ER

PT J
AU Yamazaki, S
   Miyoshi, N
   Kawabata, K
   Yasuda, M
   Shimoi, K
AF Yamazaki, Shunsuke
   Miyoshi, Noriyuki
   Kawabata, Kyuichi
   Yasuda, Michiko
   Shimoi, Kayoko
TI Quercetin-3-O-glucuronide inhibits noradrenaline-promoted invasion of
   MDA-MB-231 human breast cancer cells by blocking beta(2)-adrenergic
   signaling
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT Brazil-Japan Bilateral Meeting on Antioxidants and Redox Proc in Hlth /
   6th Int Conf of Polyphenols and Hlth / 8th Meeting of the
   Soc-for-Free-Rad-Biol-and-Med-S-Amer
CY OCT 21-22, 2013
CL Univ Sao Paulo, Sao Paulo, BRAZIL
HO Univ Sao Paulo
DE Noradrenaline; beta(2)-Adrenergic signaling; ROS; MMP; Invasion;
   Quercetin-3-O-glucuronide; MDA-MB-231
ID NF-KAPPA-B; MATRIX-METALLOPROTEINASE EXPRESSION; INDUCED UP-REGULATION;
   OXIDATIVE STRESS; EPITHELIAL-CELLS; OVARIAN-CARCINOMA;
   ALZHEIMERS-DISEASE; ACTIVATION; RECEPTOR; QUERCETIN
AB Endogenous catecholamines such as adrenaline (A) and noradrenaline (NA) are released from the adrenal gland and sympathetic nervous system during exposure to stress. The adrenergic system plays a central role in stress signaling, and excessive stress was found to be associated with increased production of reactive oxygen species (ROS). Overproduction of ROS induces oxidative damage in tissues and causes the development of diseases such as cancer. In this study, we investigated the effects of quercetin-3-O-glucuronide (Q3G), a circulating metabolite of quercetin, which is a type of natural flavonoid, on the catecholamine-induced beta(2)-adrenergic receptor (beta(2)-AR)-mediated response in MDA-MB-231 human breast cancer cells expressing beta(2)-AR. Treatment with A or NA at concentrations above 1 mu M generated significant levels of ROS, and NA treatment induced the gene expression of heme oxygenase-1 (HMOX1), and matrix metalloproteinase-2 (MMP-2) and -9 (MMP9). Inhibitors of p38 MAP kinase (SB203580), cAMP-dependent protein kinase (PKA) (H-89), activator protein-1 (AP-1) transcription factor (SR11302), and NF-kappa B and AP-1 (Tanshinone IIA) decreased MMP2 and MMP9 gene expression. NA also enhanced cAMP induction, RAS activation and phosphorylation of ERK1/2. These results suggested that the cAMP-PKA, MAPK, and ROS-NF-kappa B pathways are involved in beta(2)-AR signaling. Treatment with 0.1 mu M Q3G suppressed ROS generation, CAMP and RAS activation, phosphorylation of ERK1/2 and the expression of HMOX1, MMP2, and MMP9 genes. Furthermore, Q3G (0.1 mu M) suppressed invasion of MDA-MB-231 breast cancer cells and MMP-9 induction, and inhibited the binding of [H-3]-NA to beta(2)-AR. These results suggest that Q3G may function to suppress invasion of breast cancer cells by controlling beta(2)-adrenergic signaling, and may be a dietary chemopreventive factor for stress-related breast cancer. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Yamazaki, Shunsuke; Shimoi, Kayoko] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Suruga Ku, Shizuoka 4228526, Japan.
   [Miyoshi, Noriyuki; Yasuda, Michiko; Shimoi, Kayoko] Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Suruga Ku, Shizuoka 4228526, Japan.
   [Kawabata, Kyuichi] Fukui Prefectural Univ, Dept Biosci, Fukui 9101195, Japan.
RP Shimoi, K (reprint author), Univ Shizuoka, Grad Sch Nutr & Environm Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.
EM shimoi@u-shizuoka-ken.ac.jp
CR BOS JL, 1989, CANCER RES, V49, P4682
   Jagtap S, 2009, CURR MED CHEM, V16, P1451
   Hwang MK, 2009, INT J BIOCHEM CELL B, V41, P1592, DOI 10.1016/j.biocel.2009.01.014
   KELSEY JL, 1993, EPIDEMIOL REV, V15, P36
   Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7
   Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641
   Day AJ, 2001, FREE RADICAL RES, V35, P941, DOI 10.1080/10715760100301441
   Terao J, 2011, FOOD FUNCT, V2, P11, DOI 10.1039/c0fo00106f
   Shahzad MMK, 2010, J BIOL CHEM, V285, P35462, DOI 10.1074/jbc.M110.109579
   Vijayababu MR, 2006, MOL CELL BIOCHEM, V287, P109, DOI 10.1007/s11010-005-9085-3
   Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200
   Chakroborty D, 2009, CANCER RES, V69, P3727, DOI 10.1158/0008-5472.CAN-08-4289
   Day AJ, 1998, FEBS LETT, V436, P71, DOI 10.1016/S0014-5793(98)01101-6
   Gong KZ, 2008, J BIOL CHEM, V283, P29028, DOI 10.1074/jbc.M801313200
   Baker JG, 2011, TRENDS PHARMACOL SCI, V32, P227, DOI 10.1016/j.tips.2011.02.010
   Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447
   Sauer CG, 2004, VIRCHOWS ARCH, V444, P518, DOI 10.1007/s00428-004-1016-2
   Herschbach P, 2004, BRIT J CANCER, V91, P504, DOI 10.1038/sj.bjc.6601986
   Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5
   Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698
   Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134
   Jiang ZH, 2013, BIOL PSYCHIAT, V73, P1024, DOI 10.1016/j.biopsych.2012.12.004
   Lutgendorf SK, 2003, CLIN CANCER RES, V9, P4514
   LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C
   PIKE MC, 1993, EPIDEMIOL REV, V15, P17
   Li J, 2010, J PHYSIOL-LONDON, V588, P2987, DOI 10.1113/jphysiol.2010.190900
   Thaker PH, 2007, CELL CYCLE, V6, P430
   Sood AK, 2010, J CLIN INVEST, V120, P1515, DOI 10.1172/JCI40802
   Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200
   Takemura H, 2013, CURR PHARM DESIGN, V19, P6125, DOI 10.2174/1381612811319340006
   Schuller HM, 2010, ONCOTARGET, V1, P466
   Nilsson MB, 2007, J BIOL CHEM, V282, P29919, DOI 10.1074/jbc.M611539200
   Kim JH, 2006, FEBS LETT, V580, P385, DOI 10.1016/j.febslet.2005.12.051
   Cavalieri E, 2006, ANN NY ACAD SCI, V1089, P286, DOI 10.1196/annals.1386.042
   Iaccarino G, 2005, CIRC RES, V97, P1182, DOI 10.1161/01.RES.0000191541.06788.bb
   Sprehn GC, 2009, CANCER, V115, P5108, DOI 10.1002/cncr.24547
   Kroenke CH, 2006, J CLIN ONCOL, V24, P1105, DOI 10.1200/JCO.2005.04.2846
   McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006
   URA H, 1989, CANCER RES, V49, P4615
   HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U
   Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100
   Ho L, 2013, FASEB J, V27, P769, DOI 10.1096/fj.12-212118
   Lutgendorf SK, 2008, CLIN CANCER RES, V14, P6839, DOI 10.1158/1078-0432.CCR-08-0230
   Kroon PA, 2004, AM J CLIN NUTR, V80, P15
   Wang M, 2009, J AGR FOOD CHEM, V57, P5106, DOI 10.1021/jf900194s
   Daly CJ, 2011, TRENDS PHARMACOL SCI, V32, P219, DOI 10.1016/j.tips.2011.02.008
   Deryugina EI, 1998, CANCER RES, V58, P3743
   Deryugina EI, 1997, ANTICANCER RES, V17, P3201
   Guo XD, 2013, MOL NUTR FOOD RES, V57, P1037, DOI 10.1002/mnfr.201200569
   Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88
   Ishisaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080843
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   JANSSON CC, 1994, BIOCHEM BIOPH RES CO, V199, P869, DOI 10.1006/bbrc.1994.1309
   Kawai Y, 2011, BIOSCI BIOTECH BIOCH, V75, P609, DOI 10.1271/bbb.100785
   Lai KB, 2013, INT J CARDIOL, V163, P183, DOI 10.1016/j.ijcard.2011.06.003
   Lee KJ, 2008, CANCER LETT, V268, P233, DOI 10.1016/j.canlet.2008.03.058
   Lee KW, 2006, INT J CANCER, V119, P1767, DOI 10.1002/ijc.22056
   LIOTTA LA, 1992, SCI AM, V266, P54
   Miyashita T, 2006, BIOCHEM BIOPH RES CO, V349, P775, DOI 10.1016/j.bbrc.2006.08.098
   Moniri NH, 2007, BIOCHEM PHARMACOL, V74, P64, DOI 10.1016/j.bcp.2007.01.016
   Murota Kaeko, 2007, J Med Invest, V54, P370, DOI 10.2152/jmi.54.370
   Nishio Y, 2007, GENES ENV, V29, P17, DOI 10.3123/jemsge.29.17
   Perez Pifiero C., 2012, BRIT J PHARMACOL, V166, P721
   Pocernich CB, 2011, CURR ALZHEIMER RES, V8, P452
   Rang P.H., 2012, RANG RANG DALES PHAR
   Saja K, 2004, INDIAN J BIOCHEM BIO, V41, P294
   SALO T, 1994, LAB INVEST, V70, P176
   Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200
   Shayo C, 2001, MOL PHARMACOL, V60, P1049
   Stetler-Stevenson W G, 2001, Surg Oncol Clin N Am, V10, P383
   Vazquez S, 2006, CANCER CHEMOTH PHARM, V58, P50, DOI 10.1007/s00280-005-0130-4
   VOGEL WH, 1985, NEUROPSYCHOBIOLOGY, V13, P129, DOI 10.1159/000118175
   Xu Q, 2011, BRIT J PHARMACOL, V162, P1012, DOI 10.1111/j.1476-5381.2010.01043.x
   Yamazaki S, 2014, J STEROID BIOCHEM, V143, P122, DOI 10.1016/j.jsbmb.2014.02.014
   Yang EV, 2002, J NEUROIMMUNOL, V133, P144, DOI 10.1016/S0165-5728(02)00270-9
NR 75
TC 6
Z9 7
U1 5
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2014
VL 557
SI SI
BP 18
EP 27
DI 10.1016/j.abb.2014.05.030
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AM1ZA
UT WOS:000339646600004
PM 24929186
ER

PT J
AU Cuevas, A
   Saavedra, N
   Cavalcante, MF
   Salazar, LA
   Abdalla, DSP
AF Cuevas, Alejandro
   Saavedra, Nicolas
   Cavalcante, Marcela F.
   Salazar, Luis A.
   Abdalla, Dulcineia S. P.
TI Identification of microRNAs involved in the modulation of pro-angiogenic
   factors in atherosclerosis by a polyphenol-rich extract from propolis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT Brazil-Japan Bilateral Meeting on Antioxidants and Redox Proc in Hlth /
   6th Int Conf of Polyphenols and Hlth / 8th Meeting of the
   Soc-for-Free-Rad-Biol-and-Med-S-Amer
CY OCT 21-22, 2013
CL Univ Sao Paulo, Sao Paulo, BRAZIL
HO Univ Sao Paulo
DE Polyphenols; Propolis; microRNAs; Atherosclerosis
ID OXIDATIVE STRESS; IN-VIVO; ENDOTHELIAL DYSFUNCTION; CHILEAN PROPOLIS;
   KNOCKOUT MICE; CANCER CELLS; EXPRESSION; INFLAMMATION; HYPOXIA; VEGF
AB New vessel formation plays a critical role in the progression and vulnerability of atherosclerotic lesions. It has been shown that polyphenols from propolis attenuate the progression of atherosclerosis and also exert inhibitory effects on angiogenic factors. However, the mechanisms underlying these effects are not completely understood. Thus, this study aimed to identify microRNAs (miRNAs) involved in the modulation of pro-angiogenic factors in the atherosclerotic plaques of LDL receptor gene knockout mice treated with a polyphenol-rich extract of Chilean propolis. The progression of the atherosclerotic lesions was significantly attenuated in treated mice compared with control mice. Using microarray analysis and a bioinformatic approach, we identified 29 differentially expressed miRNAs. Many of these miRNAs were involved in biological processes associated with angiogenesis, such as the cell cycle, cell migration, cell growth and proliferation. Among them, three miRNAs (miR-181a, miR-106a and miR-20b) were over-expressed and inversely related to the expression of Vegfa (vascular endothelial growth factor A) and Hif1a (hypoxia inducible factor 1 alpha). In addition, VEGF-A protein expression was attenuated in histological sections obtained from the aortic sinuses of treated mice. VEGFA is a key pro-angiogenic factor in atherosclerotic plaques, and Hif1a, which is expressed in the necrotic nucleus of the atheroma, is its main inducer. We found a correlation between the over-expression of miR-181a, miR-106a and miR-20b and their target genes, Hif1a and Vegfa, which is consistent with attenuation of the atherosclerotic lesion. In conclusion, our data analysis provides evidence that the anti-angiogenic effects of polyphenols from Chilean propolis can be modulated by miRNAs, in particular miR-181a, miR-106a and miR-20b. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Cuevas, Alejandro; Saavedra, Nicolas; Salazar, Luis A.] Univ La Frontera, Sci & Technol Bioresource Nucleus BIOREN, Ctr Mol Biol & Pharmacogenet, Temuco 01145, Chile.
   [Cavalcante, Marcela F.; Abdalla, Dulcineia S. P.] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
RP Abdalla, DSP (reprint author), Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Av Prof Lineu Prestes 580, Sao Paulo, Brazil.
EM dspa@usp.br
CR Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870
   Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003
   Semenza GL, 2007, J CELL BIOCHEM, V102, P840, DOI 10.1002/jcb.21523
   Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126
   Lim CS, 2013, J VASC SURG, V58, P219, DOI 10.1016/j.jvs.2013.02.240
   PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4
   Alyane M, 2008, PAK J PHARM SCI, V21, P201
   Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003
   Krupinski J, 2008, FRONT BIOSCI, V13, P6472, DOI 10.2741/3167
   Howell JC, 2013, MOL VIS, V19, P544
   Zhou Q, 2007, CARCINOGENESIS, V28, P28, DOI 10.1093/carcin/bg1085
   Zhu DH, 2013, J ALLERGY CLIN IMMUN, V132, P426, DOI 10.1016/j.jaci.2013.02.005
   Daleprane JB, 2012, J NUTR BIOCHEM, V23, P557, DOI 10.1016/j.jnutbio.2011.02.012
   Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187
   Cuevas A, 2013, NUTRIENTS, V5, P2314, DOI 10.3390/nu5072314
   Mano T, 1996, AM HEART J, V131, P231, DOI 10.1016/S0002-8703(96)90346-4
   Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74
   Machado JL, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/157652
   Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644
   Madanecki P, 2013, CELL MOL BIOL LETT, V18, P47, DOI 10.2478/s11658-012-0037-0
   Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687
   Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855
   Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042
   Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025
   Demir R, 2010, ACTA HISTOCHEM, V112, P203, DOI 10.1016/j.acthis.2009.04.004
   Morrison M, 2014, ATHEROSCLEROSIS, V233, P149, DOI 10.1016/j.atherosclerosis.2013.12.027
   Bidzhekov K, 2012, THROMB HAEMOSTASIS, V107, P619, DOI 10.1160/TH11-09-0607
   Zhu M, 2014, FEBS LETT, V588, P600, DOI 10.1016/j.febslet.2013.12.028
   Sawicka D, 2012, FOLIA HISTOCHEM CYTO, V50, P25, DOI [10.2478/18693, 10.5603/FHC.2012.0004]
   Jeon TI, 2013, MOL NUTR FOOD RES, V57, P1931, DOI 10.1002/mnfr.201300071
   Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047
   Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002
   Paul SAM, 2004, J CELL PHYSIOL, V200, P20, DOI 10.1002/jcp.10479
   Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002
   Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449
   Gao N, 2002, J BIOL CHEM, V277, P31963, DOI 10.1074/jbc.M200082200
   Milenkovic D, 2013, FREE RADICAL BIO MED, V64, P40, DOI 10.1016/j.freeradbiomed.2013.05.046
   Kim YW, 2013, J MOL MED, V91, P323, DOI 10.1007/s00109-013-1007-3
   Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18
   Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003
   Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323
   Boesch-Saadatmandi C, 2011, J NUTR BIOCHEM, V22, P293, DOI 10.1016/j.jnutbio.2010.02.008
   Castaldo S, 2002, FITOTERAPIA, V73, pS1, DOI 10.1016/S0367-326X(02)00185-5
   Chikaraishi Y, 2010, MOL NUTR FOOD RES, V54, P566, DOI 10.1002/mnfr.200900115
   Coban J, 2013, BIOSCI BIOTECH BIOCH, V77, P389, DOI 10.1271/bbb.120722
   Crawford Talia N, 2009, Curr Diabetes Rev, V5, P8
   Curifuta M, 2012, CIENC INVESTIG AGRAR, V39, P347, DOI 10.4067/S0718-16202012000200011
   de Moura S.A., 2011, EVID-BASED COMPL ALT, V54
   Habauzit Vèronique, 2012, Ther Adv Chronic Dis, V3, P87, DOI 10.1177/2040622311430006
   Han H, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.31
   Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116
   Izuta H, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-45
   Juan-Babot JO, 2003, REV ESP CARDIOL, V56, P978, DOI 10.1157/13052386
   Keshavarz M, 2009, ARCH MED RES, V40, P59, DOI 10.1016/j.arcmed.2008.10.004
   Khalil Mahmoud Lotfy, 2006, Asian Pac J Cancer Prev, V7, P22
   Kurek-Gorecka AM, 2012, Z NATURFORSCH C, V67, P545
   Li P, 2014, FEBS LETT, V588, P705, DOI 10.1016/j.febslet.2014.01.007
   Li SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069818
   Libby P, 2006, AM J CARDIOL, V98, p3Q, DOI 10.1016/j.amjcard.2006.09.020
   Lin WJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-48
   Liu XH, 2014, ATHEROSCLEROSIS, V233, P349, DOI 10.1016/j.atherosclerosis.2014.01.039
   Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390
   Maruotti N, 2006, HISTOL HISTOPATHOL, V21, P557
   McCarthy M.J., 1999, BRIT J SURG, V86, P707
   Meneghelli C, 2013, MICROVASC RES, V88, P1, DOI 10.1016/j.mvr.2013.03.003
   Milenkovic D, 2012, PLOS ONE, V7, P156, DOI 10.1371/journal.pone.0029837
   Moreno PR, 2006, CURR MOL MED, V6, P457, DOI 10.2174/156652406778018635
   Mukhopadhyay P, 2012, J CELL MOL MED, V16, P2504, DOI 10.1111/j.1582-4934.2011.01480.x
   Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268
   Pousa ID, 2008, EUR J CLIN INVEST, V38, P73, DOI 10.1111/j.1365-2362.2007.01914.x
   Saavedra N, 2011, CIENC INVESTIG AGRAR, V38, P117, DOI 10.4067/S0718-16202011000100011
   Sforcin JM, 2005, J ETHNOPHARMACOL, V98, P301, DOI 10.1016/j.jep.2005.01.042
   Tresserra-Rimbau A., 2014, NUTR METAB CARDIOVAS
   Waterhouse A.L., 2001, CURRENT PROTOCOLS FO
   Yeo A-Reum, 2012, Prev Nutr Food Sci, V17, P1, DOI 10.3746/pnf.2012.17.1.001
   Zhi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072390
NR 76
TC 6
Z9 6
U1 11
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2014
VL 557
SI SI
BP 28
EP 35
DI 10.1016/j.abb.2014.04.009
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AM1ZA
UT WOS:000339646600005
PM 24792245
ER

PT J
AU Zhang, TS
   Kimura, Y
   Jiang, SY
   Harada, K
   Yamashita, Y
   Ashida, H
AF Zhang, Tianshun
   Kimura, Yuki
   Jiang, Songyan
   Harada, Kiyonari
   Yamashita, Yoko
   Ashida, Hitoshi
TI Luteolin modulates expression of drug-metabolizing enzymes through the
   AhR and Nrf2 pathways in hepatic cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT Brazil-Japan Bilateral Meeting on Antioxidants and Redox Proc in Hlth /
   6th Int Conf of Polyphenols and Hlth / 8th Meeting of the
   Soc-for-Free-Rad-Biol-and-Med-S-Amer
CY OCT 21-22, 2013
CL Univ Sao Paulo, Sao Paulo, BRAZIL
HO Univ Sao Paulo
DE Luteolin; Drug-metabolizing enzymes; Aryl hydrocarbon receptor; Nuclear
   factor-erythroid-2-related factor 2
ID ARYL-HYDROCARBON RECEPTOR; GLUTATHIONE-S-TRANSFERASE; TRANSCRIPTIONAL
   REGULATION; ANTIOXIDANT RESPONSE; PHASE-II; MOLECULAR-MECHANISMS;
   OXIDATIVE STRESS; GENE BATTERY; MUSCLE-CELLS; HEPG2 CELLS
AB Drugs, xenobiotics including environmental pollutants, and certain food components modulate expression of drug-metabolizing enzymes. An aryl hydrocarbon receptor (AhR) possesses possible expression of phase I and phase II enzymes directly by binding of its ligands such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and indirectly by regulating expression of nuclear factor-erythroid-2-related factor 2 (Nrf2). Previous our result demonstrated that luteolin, a natural flavonoid existing in vegetables and herbs, competed the binding of TCDD to AhR. In the present study, we investigated the effect of luteolin on the expression of drug-metabolizing enzymes through the AhR and Nrf2 pathways. Luteolin inhibited TCDD-induced protein expression of phase I enzyme cytochrome P450 1A1 (CYP1A1), phase II enzymes NAD(P)H:quinone oxidoreductase-1 (NQO1) and glutathione-S-transferase P1 (GSTP1) in HepG2, Hepa1c1c7 and RL-34 cells in a dose-dependent manner. Luteolin suppressed TCDD- and tert-butylhydroquinone-induced Nrf2 protein by decreasing its stability in HepG2 cells. In tert-butylhydroquinone treated cells, luteolin dose-dependently inhibited NQO1, GSTP1 and aldo-keto reductases (AKRs). Of these, protein expression of CYP1A1 and GSTP1 was mainly dominated by the AhR pathway, while that of NQO1 and AKRs was by the Nrf2 pathway. In conclusion, luteolin inhibits expression of phase I and phase II drug-metabolizing enzymes by modulating the AhR and Nrf2 pathways. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Zhang, Tianshun; Kimura, Yuki; Jiang, Songyan; Harada, Kiyonari; Yamashita, Yoko; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan.
RP Ashida, H (reprint author), Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan.
EM ashida@kobe-u.ac.jp
CR Mukai R, 2010, ARCH BIOCHEM BIOPHYS, V501, P134, DOI 10.1016/j.abb.2010.05.002
   Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3
   Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200
   Ashida H, 2000, FEBS LETT, V476, P213, DOI 10.1016/S0014-5793(00)01730-0
   Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115
   Vogel CFA, 2005, ENVIRON HEALTH PERSP, V113, P1536, DOI 10.1289/ehp.8094
   Lu H, 2011, TOXICOL APPL PHARM, V256, P122, DOI 10.1016/j.taap.2011.07.019
   Hayes JD, 2009, TOXICOL SCI, V111, P199, DOI 10.1093/toxsci/kfp168
   Ciolino HP, 1999, BIOCHEM J, V340, P715, DOI 10.1042/0264-6021:3400715
   Nishinaka T, 2007, TOXICOL LETT, V170, P238, DOI 10.1016/j.toxlet.2007.03.011
   Lin CW, 2010, J AGR FOOD CHEM, V58, P4477, DOI 10.1021/jf904061x
   HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307
   Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8
   Ashida H, 2008, EXPERT OPIN DRUG MET, V4, P1429, DOI [10.1517/17425255.4.11.1429 , 10.1517/17425250802479207]
   Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103
   MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176
   Kohle C, 2006, BIOCHEM PHARMACOL, V72, P795, DOI 10.1016/j.bcp.2006.04.017
   ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8
   Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465
   Tang XW, 2011, FREE RADICAL BIO MED, V50, P1599, DOI 10.1016/j.freeradbiomed.2011.03.008
   FAVREAU LV, 1991, J BIOL CHEM, V266, P4556
   Shi RX, 2007, MOL CANCER THER, V6, P1338, DOI 10.1158/1535-7163.MCT-06-0638
   Granado-Serrano AB, 2012, CHEM-BIOL INTERACT, V195, P154, DOI 10.1016/j.cbi.2011.12.005
   Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7
   Thimmulappa RK, 2002, CANCER RES, V62, P5196
   Dean M, 2001, J LIPID RES, V42, P1007
   Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828
   Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965
   Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058
   Ma Q, 2004, BIOCHEM J, V377, P205, DOI 10.1042/BJ20031123
   Eggler AL, 2008, MOL NUTR FOOD RES, V52, pS84, DOI 10.1002/mnfr.200700249
   POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505
   Nakata K, 2006, DRUG METAB PHARMACOK, V21, P437, DOI 10.2133/dmpk.21.437
   Lang YS, 2012, J PHARM PHARMACOL, V64, P597, DOI 10.1111/j.2042-7158.2011.01438.x
   SAFE SH, 1986, ANNU REV PHARMACOL, V26, P371, DOI 10.1146/annurev.pa.26.040186.002103
   Funakoshi-Tago M, 2011, INT IMMUNOPHARMACOL, V11, P1150, DOI 10.1016/j.intimp.2011.03.012
   Lee JM, 2001, BIOCHEM BIOPH RES CO, V280, P286, DOI 10.1006/bbrc.2000.4106
   Ashida H, 2000, BIOCHEM PHARMACOL, V59, P741, DOI 10.1016/S0006-2952(99)00387-1
   Ciolino HP, 1998, CANCER RES, V58, P2754
   DENISON MS, 1986, J BIOL CHEM, V261, P189
   ELFERINK CJ, 1990, J BIOL CHEM, V265, P20708
   Hamada M, 2006, J AGR FOOD CHEM, V54, P8891, DOI 10.1021/jf060944t
   Hawas UW, 2009, Z NATURFORSCH C, V64, P831
   Kanazawa K., 2011, FOOD SCI TECHNOL, V22, P655
   Kawabata K, 2011, MOL NUTR FOOD RES, V55, P467, DOI 10.1002/mnfr.201000267
   Kusinmore I.H., 1990, P NATL ACAD SCI USA, V87, P3826
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ohtake F, 2009, BIOCHEM PHARMACOL, V77, P474, DOI 10.1016/j.bcp.2008.08.034
   Pandurangan AK, 2014, TOXICOL MECH METHOD, V24, P13, DOI 10.3109/15376516.2013.843111
   Simmons RA, 2012, BEST PRACT RES CL EN, V26, P701, DOI 10.1016/j.beem.2012.03.012
   Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017
   Tsai CW, 2007, J AGR FOOD CHEM, V55, P1019, DOI 10.1021/jf061874t
   Zhang TS, 2013, MUTAT RES-GEN TOX EN, V752, P34, DOI 10.1016/j.mrgentox.2013.01.002
   Zhang YC, 2013, FOOD CHEM TOXICOL, V59, P272, DOI 10.1016/j.fct.2013.05.058
NR 56
TC 7
Z9 7
U1 6
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2014
VL 557
SI SI
BP 36
EP 46
DI 10.1016/j.abb.2014.05.023
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AM1ZA
UT WOS:000339646600006
PM 24914470
ER

PT J
AU Cadet, J
   Wagner, JR
AF Cadet, Jean
   Wagner, J. Richard
TI Oxidatively generated base damage to cellular DNA by hydroxyl radical
   and one-electron oxidants: Similarities and differences
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT Brazil-Japan Bilateral Meeting on Antioxidants and Redox Proc in Hlth /
   6th Int Conf of Polyphenols and Hlth / 8th Meeting of the
   Soc-for-Free-Rad-Biol-and-Med-S-Amer
CY OCT 21-22, 2013
CL Univ Sao Paulo, Sao Paulo, BRAZIL
HO Univ Sao Paulo
DE Oxidized nucleobases; Radical cations; Tandem base lesions; Intrastrand
   cross-links; Interstrand cross-links; DNA-protein cross-links; Clustered
   DNA damage
ID PROTEIN CROSS-LINKING; TANDEM MASS-SPECTROMETRY; C4'-OXIDIZED ABASIC
   SITE; FENTON-TYPE REAGENTS; GUANINE OXIDATION; EXCISION-REPAIR;
   HUMAN-CELLS; DUPLEX DNA; GAMMA-RADIATION; SINGLET OXYGEN
AB Hydroxyl radical (center dot OH) and one-electron oxidants that may be endogenously formed through oxidative metabolism, phagocytosis, inflammation and pathological conditions constitute the main sources of oxidatively generated damage to cellular DNA. It is worth mentioning that exposure of cells to exogenous physical agents (UV light, high intensity UV laser, ionizing radiation) and chemicals may also induce oxidatively generated damage to DNA. Emphasis is placed in this short review article on the mechanistic aspects of center dot OH and one-electron oxidant-mediated formation of single and more complex damage (tandem lesions, intra- and interstrand cross-links, DNA-protein cross-links) in cellular DNA arising from one radical hit. This concerns DNA modifications that have been accurately measured using suitable analytical methods such as high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Evidence is provided that center dot OH and one-electron oxidants after generating neutral radicals and base radical cations respectively may partly induce common degradation pathways. In addition, selective oxidative reactions giving rise to specific degradation products of center dot OH and one-electron oxidation reactions that can be used as representative biomarkers of these oxidants have been identified. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Cadet, Jean] CEA Grenoble, Inst Nanosci & Cryogenie, F-38054 Grenoble 9, France.
   [Cadet, Jean; Wagner, J. Richard] Univ Sherbrooke, Fac Med Sci Sante, Dept Med Nucl & Radiobiol, Sherbrooke, PQ J1H 5N4, Canada.
RP Cadet, J (reprint author), CEA Grenoble, Inst Nanosci & Cryogenie, F-38054 Grenoble 9, France.
EM jean.cadet@cea.fr
OI Cadet, Jean/0000-0003-2594-9485
CR Angelov D, 2003, PHOTOCHEM PHOTOBIOL, V77, P592, DOI 10.1562/0031-8655(2003)077<0592:SSOTNP>2.0.CO;2
   Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x
   Frelon S, 2003, CHEM RES TOXICOL, V16, P191, DOI 10.1021/tx025650q
   Borghini A, 2013, ATHEROSCLEROSIS, V230, P202, DOI 10.1016/j.atherosclerosis.2013.07.038
   San Pedro JMN, 2014, J AM CHEM SOC, V136, P3928, DOI 10.1021/ja412562p
   Murata M, 2001, CHEM RES TOXICOL, V14, P678, DOI 10.1021/tx000209q
   Cadet J, 2011, MUTAT RES-FUND MOL M, V711, P3, DOI 10.1016/j.mrfmmm.2011.02.004
   Roginskaya M, 2014, RADIAT RES, V181, P131, DOI 10.1667/RR12993.1
   Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i
   Belmadoui N, 2010, ORG BIOMOL CHEM, V8, P3211, DOI 10.1039/c004531d
   Chatgilialoglu C, 2011, CHEM RES TOXICOL, V24, P2200, DOI 10.1021/tx2003245
   Wang J, 2012, AGING CELL, V11, P714, DOI 10.1111/j.1474-9726.2012.00828.x
   Pouget JP, 2002, RADIAT RES, V157, P589, DOI 10.1667/0033-7587(2002)157[0589:FOMDBI]2.0.CO;2
   Douki T, 2002, CHEM RES TOXICOL, V15, P445, DOI 10.1021/tx0155909
   Hong HH, 2007, ANAL CHEM, V79, P322, DOI 10.1021/ac061465w
   Wang YS, 2008, CHEM RES TOXICOL, V21, P276, DOI 10.1021/tx700411g
   Chatgilialoglu C, 2009, ANGEW CHEM INT EDIT, V48, P2214, DOI 10.1002/anie.200805372
   D'Errico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277
   Azqueta A, 2013, ARCH TOXICOL, V87, P949, DOI 10.1007/s00204-013-1070-0
   Cadet J, 2012, CANCER LETT, V327, P5, DOI 10.1016/j.canlet.2012.04.005
   OLINSKI R, 1992, ARCH BIOCHEM BIOPHYS, V297, P139, DOI 10.1016/0003-9861(92)90651-C
   Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250
   O'Neill P, 2009, INT J RADIAT BIOL, V85, P9, DOI 10.1080/09553000802640401
   KASAI H, 1992, J AM CHEM SOC, V114, P9692, DOI 10.1021/ja00050a078
   Cao HC, 2007, NUCLEIC ACIDS RES, V35, P4833, DOI 10.1093/nar/gkm497
   Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547
   Wang J, 2012, NUCLEIC ACIDS RES, V40, P7368, DOI 10.1093/nar/gks357
   Sczepanski JT, 2011, BIOORGAN MED CHEM, V19, P5788, DOI 10.1016/j.bmc.2011.08.024
   Cuesta-Lopez S, 2011, NUCLEIC ACIDS RES, V39, P5276, DOI 10.1093/nar/gkr096
   Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003
   Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200
   Epe B, 2012, PHOTOCH PHOTOBIO SCI, V11, P98, DOI 10.1039/c1pp05190c
   D'Errico M, 2007, ONCOGENE, V26, P4336, DOI 10.1038/sj.onc.1210232
   Hong HZ, 2007, NUCLEIC ACIDS RES, V35, P7118, DOI 10.1093/nar/gkm851
   Sheng ZJ, 2012, J CLIN INVEST, V122, P4344, DOI 10.1172/JCI65053
   Cui L, 2013, CHEM RES TOXICOL, V26, P195, DOI 10.1021/tx300294d
   Pratviel G, 2006, CHEM-EUR J, V12, P6018, DOI 10.1002/chem.200600539
   Pitie M, 2010, CHEM REV, V110, P1018, DOI 10.1021/cr900247m
   Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738
   Dedon PC, 2008, CHEM RES TOXICOL, V21, P206, DOI 10.1021/tx700283c
   Wagner JR, 2010, ACCOUNTS CHEM RES, V43, P564, DOI 10.1021/ar9002637
   Nikjoo H, 2012, INT J RADIAT BIOL, V88, P87, DOI 10.3109/09553002.2011.640860
   Ravanat JL, 2000, J BIOL CHEM, V275, P40601, DOI 10.1074/jbc.M006681200
   Boussicault F, 2008, J AM CHEM SOC, V130, P8377, DOI 10.1021/ja800763j
   Badouard C, 2005, J CHROMATOGR B, V827, P26, DOI 10.1016/j.jchromb.2005.03.025
   Fleming AM, 2013, CHEM RES TOXICOL, V26, P593, DOI 10.1021/tx400028y
   Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597
   Shafirovich V, 2001, J BIOL CHEM, V276, P24621, DOI 10.1074/jbc.M101131200
   Bauer G, 2013, ANTICANCER RES, V33, P3589
   Bergeron F, 2010, P NATL ACAD SCI USA, V107, P5528, DOI 10.1073/pnas.1000193107
   Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s
   Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85
   Cadet J, 2008, ACCOUNTS CHEM RES, V41, P1075, DOI 10.1021/ar700245e
   Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015
   Regulus P, 2007, P NATL ACAD SCI USA, V104, P14032, DOI 10.1073/pnas.0706044104
   Perrier S, 2006, J AM CHEM SOC, V128, P5703, DOI 10.1021/ja057656i
   Canugovi C, 2013, DNA REPAIR, V12, P578, DOI 10.1016/j.dnarep.2013.04.010
   Georgakilas AG, 2013, RADIAT RES, V180, P100, DOI 10.1667/RR3041.1
   Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445
   Chatgilialoglu C, 2011, CHEM SOC REV, V40, P1368, DOI 10.1039/c0cs00061b
   Labet V, 2008, ORG BIOMOL CHEM, V6, P3300, DOI 10.1039/b805589k
   Kropachev K, 2014, NUCLEIC ACIDS RES, V42, P5020, DOI 10.1093/nar/gku162
   Sczepanski JT, 2009, J AM CHEM SOC, V131, P11132, DOI 10.1021/ja903404v
   Toyokuni S, 2008, IUBMB LIFE, V60, P441, DOI 10.1002/iub.61
   Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200
   Agnez-Lima LF, 2012, MUTAT RES-REV MUTAT, V751, P15, DOI 10.1016/j.mrrev.2011.12.005
   Attard NR, 2011, PHOTOCHEM PHOTOBIOL, V11, P62
   Bellon S, 2002, CHEM RES TOXICOL, V15, P598, DOI 10.1021/tx015594d
   BESSHO T, 1993, CARCINOGENESIS, V14, P1069, DOI 10.1093/carcin/14.5.1069
   Bourdat AG, 2000, J AM CHEM SOC, V122, P4549, DOI 10.1021/ja994282i
   BOX HC, 1995, RADIAT RES, V141, P91, DOI 10.2307/3579095
   Box HC, 1996, RADIAT RES, V145, P641, DOI 10.2307/3579285
   Brem R, 2012, PHOTOCHEM PHOTOBIOL, V88, P5, DOI 10.1111/j.1751-1097.2011.01043.x
   Brem R, 2011, DNA REPAIR, V10, P869, DOI 10.1016/j.dnarep.2011.05.010
   BUDZINSKI EE, 1995, RADIAT RES, V142, P107, DOI 10.2307/3578973
   Cadet J, 1997, Rev Physiol Biochem Pharmacol, V131, P1
   Cadet J, 2009, PHOTOCH PHOTOBIO SCI, V8, P903, DOI 10.1039/b905343n
   Cadet J., 2012, FREE RADICAL RES, V48, P367
   Cadet J., 2010, FREE RADIC BIOL MED, V40, P9
   Cadet J., 2012, BIOANAL REV, V4, P55, DOI DOI 10.1007/S12566-012-0029-6
   Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012
   Chan W, 2010, J AM CHEM SOC, V132, P6145, DOI 10.1021/ja910928n
   Collins A.R., 2013, BIOCHIM BIOPHYS ACTA, V1840, P794
   Collins AR, 2013, ADV FOOD NUTR RES, V68, P283, DOI 10.1016/B978-0-12-394294-4.00016-X
   Crean C, 2008, NUCLEIC ACIDS RES, V36, P742, DOI 10.1093/nar/gkm1092
   Dizdaroglu M., 2012, FREE RADICAL RES, V46, P387
   Douki T, 2001, J AM CHEM SOC, V123, P11360, DOI 10.1021/ja016426a
   Douki T., 2004, TOP CURR CHEM, V236, P1
   Douki T, 2006, INT J RADIAT BIOL, V82, P119, DOI 10.1080/09553000600573788
   Dupont C, 2013, ORG BIOMOL CHEM, V11, P3038, DOI 10.1039/c3ob40280k
   Dutta S, 2007, J AM CHEM SOC, V129, P1852, DOI 10.1021/ja067294u
   Ghosh A, 2008, ORG BIOMOL CHEM, V6, P916, DOI 10.1039/b717437c
   Greenberg MM, 2014, ACCOUNTS CHEM RES, V47, P646, DOI 10.1021/ar400229d
   Guerrero CR, 2013, CHEM RES TOXICOL, V26, P1361, DOI 10.1021/tx400221w
   Hecht S.M., 2000, J NAT PRODUCTS, V63, P156
   Hong IS, 2007, J AM CHEM SOC, V129, P4089, DOI 10.1021/ja0692276
   Hong S., 2007, J AM CHEM SOC, V129, P4089
   Huang HD, 2009, BIOCHEMISTRY-US, V48, P7833, DOI 10.1021/bi900927d
   Jiang Y, 2007, BIOCHEMISTRY-US, V46, P12757, DOI 10.1021/bi7042195
   Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014
   Kurbanyan K, 2003, BIOCHEMISTRY-US, V42, P10269, DOI 10.1021/bi020713p
   Madison AL, 2012, BIOCHEMISTRY-US, V51, P362, DOI 10.1021/bi201087q
   Madugundu GS, 2013, CHEM RES TOXICOL, V26, P1031, DOI 10.1021/tx400158g
   Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511
   Misiaszek R, 2004, J BIOL CHEM, V279, P32106, DOI 10.1074/jbc.M313904200
   Nakano T, 2012, BIOSCI BIOTECH BIOCH, V76, P2208, DOI 10.1271/bbb.120482
   Nguyen KL, 2000, J AM CHEM SOC, V122, P3585, DOI 10.1021/ja993502p
   Parker H., 2013, FRONT IMMUNOL, V3, P1
   Price CS, 2010, RADIAT RES, V174, P645, DOI 10.1667/RR2263.1
   Price N.E., 2014, J AM CHEM SOC, V136, P3485
   Purkayastha S, 2007, RADIAT RES, V168, P357, DOI 10.1667/RR0964.1
   Regulus P, 2004, RAPID COMMUN MASS SP, V18, P2223, DOI 10.1002/rcm.1612
   Rokhlenko Y., 2014, J AM CHEM SOC, V136, P4955
   Samson-Thibault F, 2012, CHEM RES TOXICOL, V25, P1902, DOI 10.1021/tx300195f
   Shoulkamy MI, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks601
   TavernaPorro M.L., 2013, J AM CHEM SOC, V135, P16268
   von Sonntag C., 2006, FREE RADICAL INDUCED
   Cadet J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012559
   Watanabe T, 2005, J AM CHEM SOC, V127, P44, DOI 10.1021/ja0454743
   Xu Y, 2007, NAT PROTOC, V2, P78, DOI 10.1038/nprot.2006.467
   Yun BH, 2011, CHEM RES TOXICOL, V24, P1144, DOI 10.1021/tx200139c
   Zhang Q., 2003, J AM CHEM SOC, V125, P12595
   Zhang QB, 2005, CHEM RES TOXICOL, V18, P1897, DOI 10.1021/tx050195u
   Zhang QB, 2005, NUCLEIC ACIDS RES, V33, P1593, DOI 10.1093/nar/gki301
   Zhang QB, 2004, J AM CHEM SOC, V126, P13287, DOI 10.1021/ja048492t
NR 125
TC 11
Z9 11
U1 8
U2 53
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2014
VL 557
SI SI
BP 47
EP 54
DI 10.1016/j.abb.2014.05.001
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AM1ZA
UT WOS:000339646600007
PM 24820329
ER

PT J
AU Pellosi, MC
   Suzukawa, AA
   Scalfo, AC
   Di Mascio, P
   Pereira, CPM
   Pinto, NCD
   Martins, DD
   Martinez, GR
AF Pellosi, Maria Carolina
   Suzukawa, Andreia Akemi
   Scalfo, Alexsandra Cristina
   Di Mascio, Paolo
   Martins Pereira, Carolina Parga
   de Souza Pinto, Nadja Cristhina
   Martins, Daniela de Luna
   Martinez, Glaucia Regina
TI Effects of the melanin precursor 5,6-dihydroxy-indole-2-carboxylic acid
   (DHICA) On DNA damage and repair in the presence of reactive oxygen
   species
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT Brazil-Japan Bilateral Meeting on Antioxidants and Redox Proc in Hlth /
   6th Int Conf of Polyphenols and Hlth / 8th Meeting of the
   Soc-for-Free-Rad-Biol-and-Med-S-Amer
CY OCT 21-22, 2013
CL Univ Sao Paulo, Sao Paulo, BRAZIL
HO Univ Sao Paulo
DE DHICA; Singlet oxygen; Hydroxyl radical; Strand breaks; DNA damage; Fpg;
   DNA repair
ID SINGLET MOLECULAR-OXYGEN; 5,6-DIHYDROXYINDOLE-2-CARBOXYLIC ACID;
   OXIDATIVE DAMAGE; UVA IRRADIATION; FENTON REACTION; MAJOR PRODUCT;
   STRAND BREAKS; HUMAN-CELLS; EUMELANIN; SPIROIMINODIHYDANTOIN
AB Eumelanin is a heterogeneous polymer composed of 5,6-dihydroxyindole-2-carboxylic acid (DHICA) and 5,6-dihydroxyindole (DHI). Studies have shown that DHICA promotes single strand breaks in plasmid DNA exposed to ultraviolet B radiation (UVB, 313 nm) and in DNA from human keratinocytes exposed to ultraviolet A radiation (UVA, 340-400 nm). Singlet molecular oxygen (102) is the main reactive species formed by UVA radiation on the skin. In this context, we now report that DHICA can cause single strand breaks in plasmid DNA even in the absence of light radiation. Interestingly, when DHICA was pre-oxidized by 102, it lost this harmful capacity. It was also found that DHICA could interact with DNA, disturbing Fpg activity and decreasing its recognition of lesions by similar to 50%. Additionally, the free nucleoside deoxyguanosine (dGuo) was used to evaluate whether DHICA would interfere with the formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGuo) and spiroiminodihydantoin (dSp) by 102 or with the formation of 8-oxodGuo by hydroxyl radical ((OH)-O-center dot). We observed that when dGuo was oxidized by 102 in the presence of DHICA, 8-oxodGuo formation was increased. However, when dGuo was oxidized by (OH)-O-center dot in the presence of DHICA, 8-oxodGuo levels were lower than in the absence of the precursor. Overall, our data reveal an important role for this eumelanin precursor in both the promotion and the protection of DNA damage and imply that it can impair DNA repair. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Pellosi, Maria Carolina; Suzukawa, Andreia Akemi; Martinez, Glaucia Regina] Univ Fed Parana, Dept Bioquim & Biol Mol, Programa Posgrad Ciencias Bioquim, Curitiba, PR, Brazil.
   [Scalfo, Alexsandra Cristina; Di Mascio, Paolo; Martins Pereira, Carolina Parga; de Souza Pinto, Nadja Cristhina] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.
   [Martins, Daniela de Luna] Univ Fed Fluminense, Inst Quim, Rio De Janeiro, RJ, Brazil.
RP Martinez, GR (reprint author), UFPR, Setor Ciencias Biol, Dept Bioquim & Biol Mol, CP 19046, BR-81531980 Curitiba, Parana, Brazil.
EM grmartinez@pq.cnpq.br
CR LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   Gauden M, 2008, J AM CHEM SOC, V130, P17038, DOI 10.1021/ja806345q
   Martinez GR, 2007, J MASS SPECTROM, V42, P1326, DOI 10.1002/jms.1213
   Martinez GR, 2000, J AM CHEM SOC, V122, P10212, DOI 10.1021/ja0016452
   LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1
   Kobayashi N, 1998, J INVEST DERMATOL, V110, P806, DOI 10.1046/j.1523-1747.1998.00178.x
   RAVANAT JL, 1995, CHEM RES TOXICOL, V8, P379, DOI 10.1021/tx00045a009
   Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408
   McNeill DR, 2004, ENVIRON HEALTH PERSP, V112, P799, DOI 10.1289/txg.7038
   Aitken GR, 2007, CLIN EXP DERMATOL, V32, P722, DOI 10.1111/j.1365-2230.2007.02474.x
   Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605
   Pierlot C, 2000, METHOD ENZYMOL, V319, P3
   Shimizu M, 2007, BIOCHEMISTRY-US, V46, P5515, DOI 10.1021/bi062238r
   KORYTOWSKI W, 1987, PHOTOCHEM PHOTOBIOL, V45, P185, DOI 10.1111/j.1751-1097.1987.tb05362.x
   Bravard A, 2010, MUTAT RES-FUND MOL M, V685, P61, DOI 10.1016/j.mrfmmm.2009.09.013
   BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016
   Cadet J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1219, DOI 10.1562/2006-06-09-IR-914
   Delaney MO, 2002, ANGEW CHEM INT EDIT, V41, P771, DOI 10.1002/1521-3773(20020301)41:5<771::AID-ANIE771>3.0.CO;2-V
   Niles JC, 2001, ORG LETT, V3, P963, DOI 10.1021/ol006993n
   PROTA G, 1980, J INVEST DERMATOL, V75, P122, DOI 10.1111/1523-1747.ep12521344
   Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803
   Charkoudian LK, 2006, INORG CHEM, V45, P3657, DOI 10.1021/ic060014r
   Henderson PT, 2003, BIOCHEMISTRY-US, V42, P9257, DOI 10.1021/bi0347252
   Martinez GR, 2002, BIOL CHEM, V383, P607, DOI 10.1515/BC.2002.063
   Wiederholt CJ, 2002, J AM CHEM SOC, V124, P7278, DOI 10.1021/ja026522r
   Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704
   Eblin KE, 2006, TOXICOL APPL PHARM, V217, P7, DOI 10.1016/j.taap.2006.07.004
   Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466
   Baier J, 2007, J INVEST DERMATOL, V127, P1498, DOI 10.1038/sj.jid.5700741
   BOROVANSKY J, 1991, NEOPLASMA, V38, P393
   Cadet J, 2012, ENCY RADICALS CHEM B
   Duarte V, 2000, J AM CHEM SOC, V122, P12622, DOI 10.1021/ja002218r
   EPE B, 1994, METHOD ENZYMOL, V234, P122
   Frelon S, 2002, J CHEM SOC PERK T 1, P2866, DOI 10.1039/b207532f
   GAJEWSKI E, 1990, BIOCHEMISTRY-US, V29, P7876, DOI 10.1021/bi00486a014
   HALLIWELL B., 2007, FREE RADICALS BIOL M
   HILL HZ, 1987, PIGM CELL RES, V1, P163, DOI 10.1111/j.1600-0749.1987.tb00408.x
   JIMBOW K, 1993, J INVEST DERMATOL, V100, pS259, DOI 10.1038/jid.1993.47
   Kipp C, 1999, PHOTOCHEM PHOTOBIOL, V70, P191, DOI 10.1111/j.1751-1097.1999.tb07989.x
   Kovacs D, 2012, J INVEST DERMATOL, V132, P1196, DOI 10.1038/jid.2011.457
   Mendes GLQ, 2010, J TOXICOL ENV HEAL A, V73, P850, DOI 10.1080/15287391003744757
   Novellino L, 1999, CHEM RES TOXICOL, V12, P985, DOI 10.1021/tx990020i
   Ravanat JL, 2003, J AM CHEM SOC, V125, P2030, DOI 10.1021/ja028608q
   Ravanat JL, 2004, ARCH BIOCHEM BIOPHYS, V423, P23, DOI 10.1016/j.abb.2003.10.018
   RHODES AR, 1988, CANCER, V61, P358, DOI 10.1002/1097-0142(19880115)61:2<358::AID-CNCR2820610227>3.0.CO;2-#
   ROUTABOUL C, 1995, PHOTOCHEM PHOTOBIOL, V62, P469, DOI 10.1111/j.1751-1097.1995.tb02370.x
   SARNA T, 1980, ARCH BIOCHEM BIOPHYS, V200, P140, DOI 10.1016/0003-9861(80)90340-9
   Suzukawa AA, 2012, FREE RADICAL BIO MED, V52, P1945, DOI 10.1016/j.freeradbiomed.2012.02.039
   Suzuki Tetsuya, 2007, Nucleic Acids Symp Ser (Oxf), P51
   URABE K, 1994, BBA-MOL CELL RES, V1221, P272, DOI 10.1016/0167-4889(94)90250-X
NR 50
TC 3
Z9 3
U1 8
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2014
VL 557
SI SI
BP 55
EP 64
DI 10.1016/j.abb.2014.05.024
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AM1ZA
UT WOS:000339646600008
PM 24893147
ER

PT J
AU Demasi, M
   Hand, A
   Ohara, E
   Oliveira, CLP
   Bicev, RN
   Bertoncini, CA
   Netto, LES
AF Demasi, Marilene
   Hand, Adrian
   Ohara, Erina
   Oliveira, Cristiano L. P.
   Bicev, Renata N.
   Bertoncini, Clelia A.
   Netto, Luis E. S.
TI 20S proteasome activity is modified via S-glutathionylation based on
   intracellular redox status of the yeast Saccharomyces cerevisiae:
   Implications for the degradation of oxidized proteins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT Brazil-Japan Bilateral Meeting on Antioxidants and Redox Proc in Hlth /
   6th Int Conf of Polyphenols and Hlth / 8th Meeting of the
   Soc-for-Free-Rad-Biol-and-Med-S-Amer
CY OCT 21-22, 2013
CL Univ Sao Paulo, Sao Paulo, BRAZIL
HO Univ Sao Paulo
DE 20S proteasome; S-glutathionylation; S. cerevisiae; Redox modulation;
   Oxidized proteins; Proteolysis
ID OXIDATIVE STRESS; 26S PROTEASOME; SELECTIVE DEGRADATION; ATP;
   ADAPTATION; COMPLEX; CELLS
AB Protein S-glutathionylation is a post-translational modification that controls many cellular pathways. Recently, we demonstrated that the alpha 5-subunit of the 20S proteasome is S-glutathionylated in yeast cells grown to the stationary phase in rich medium containing glucose, stimulating 20S core gate opening and increasing the degradation of oxidized proteins. In the present study, we evaluated the correlation between proteasomal S-glutathionylation and the intracellular redox status. The redox status was controlled by growing yeast cells in distinct carbon sources which induced respiratory (glycerol/ethanol) or fermentative (glucose) metabolism. Cells grown under glycerol/ethanol displayed higher reductive power when compared to cells grown under glucose. When purified from cells grown in glucose, 20S proteasome alpha 5-subunit exhibited an intense anti-glutathione labeling. A higher frequency of the open catalytic chamber gate was observed in the S-glutathionylated preparations as demonstrated by transmission electron microscopy. Therefore, cells that had been grown in glucose displayed an increased ability to degrade oxidized proteins. The results of the present study suggest that 20S proteasomal S-glutathionylation is a relevant adaptive response to oxidative stress that is capable to sense the intracellular redox environment, leading to the removal of oxidized proteins via a process that is not dependent upon ubiquitylation and ATP consumption. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Demasi, Marilene; Hand, Adrian; Ohara, Erina] Inst Butantan, Lab Bioquim & Biofis, BR-05503001 Sao Paulo, Brazil.
   [Oliveira, Cristiano L. P.; Bicev, Renata N.] Univ Sao Paulo, Inst Fis, BR-05508 Sao Paulo, Brazil.
   [Bertoncini, Clelia A.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Netto, Luis E. S.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, BR-05508 Sao Paulo, Brazil.
RP Demasi, M (reprint author), Inst Butantan, Lab Bioquim & Biofis, Ave Vital Brasil, BR-05503001 Sao Paulo, Brazil.
EM marimasi@butantan.gov.br
RI Oliveira, Cristiano/B-4403-2008; Demasi, Marilene/E-5873-2012
OI Oliveira, Cristiano/0000-0002-3426-6507; 
CR Andersen KM, 2011, ANTIOXID REDOX SIGN, V14, P1601, DOI 10.1089/ars.2010.3329
   Demasi M, 2003, J BIOL CHEM, V278, P679, DOI 10.1074/jbc.M209282200
   Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J
   Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200
   DAVIES KJA, 1987, J BIOL CHEM, V262, P8227
   Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6
   PACIFICI RE, 1993, J BIOL CHEM, V268, P15405
   Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200
   Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009
   Silva GM, 2008, FEBS J, V275, P2942, DOI 10.1111/j.1742-4658.2008.06441.x
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001
   Wiseman RL, 2009, J BIOL CHEM, V284, P15233, DOI 10.1074/jbc.M109.002121
   Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285
   Hill BG, 2012, J MOL CELL CARDIOL, V52, P559, DOI 10.1016/j.yjmcc.2011.07.009
   Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002
   Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336
   Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081
   DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680
   Dixon DP, 2005, PLANT PHYSIOL, V138, P2233, DOI 10.1104/pp.104.058917
   Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200
   Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003
   Verma R, 2000, MOL BIOL CELL, V11, P3425
   Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0
   Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334
   Hendil KB, 1998, BIOCHEM J, V332, P749
   Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717
   Pickering AM, 2013, FREE RADICAL BIO MED, V55, P109, DOI 10.1016/j.freeradbiomed.2012.11.001
   Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028
   Besh-Otschir D., 2009, NAT STRUCT MOL BIOL, V16, P219
   Demasi M, 2001, ARCH BIOCHEM BIOPHYS, V389, P254, DOI 10.1006/abbi.2001.2332
   Grune T, 2011, FREE RADICAL BIO MED, V51, P1355, DOI 10.1016/j.freeradbiomed.2011.06.015
   Hohn A., 2013, J PROTEOMICS
   Inai Y, 2002, ARCH BIOCHEM BIOPHYS, V404, P279, DOI 10.1016/S0003-9861(02)00336-3
   Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528
   Monteiro G, 2004, ARCH BIOCHEM BIOPHYS, V425, P14, DOI 10.1016/j.abb.2004.03.005
   Netto LES, 2007, COMP BIOCHEM PHYS C, V146, P180, DOI 10.1016/j.cbpc.2006.07.014
   Niture SK, 2005, ARCH BIOCHEM BIOPHYS, V444, P174, DOI 10.1016/j.abb.2005.10.013
   Silva GM, 2012, ANTIOXID REDOX SIGN, V16, P1183, DOI 10.1089/ars.2011.4210
   Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232
NR 40
TC 3
Z9 3
U1 0
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2014
VL 557
SI SI
BP 65
EP 71
DI 10.1016/j.abb.2014.05.002
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AM1ZA
UT WOS:000339646600009
PM 24813691
ER

PT J
AU Iqbal, A
   Paviani, V
   Moretti, AI
   Laurindo, FRM
   Augusto, O
AF Iqbal, Asif
   Paviani, Veronica
   Moretti, Ana Iochabel
   Laurindo, Francisco R. M.
   Augusto, Ohara
TI Oxidation, inactivation and aggregation of protein disulfide isomerase
   promoted by the bicarbonate-dependent peroxidase activity of human
   superoxide dismutase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT Brazil-Japan Bilateral Meeting on Antioxidants and Redox Proc in Hlth /
   6th Int Conf of Polyphenols and Hlth / 8th Meeting of the
   Soc-for-Free-Rad-Biol-and-Med-S-Amer
CY OCT 21-22, 2013
CL Univ Sao Paulo, Sao Paulo, BRAZIL
HO Univ Sao Paulo
DE Protein disulfide isomerase; Superoxide dismutase 1; Protein oxidation;
   Protein aggregation; Protein radicals; Dityrosine; Neurodegenerative
   diseases; Carbonate radical; UV light
ID AMYOTROPHIC-LATERAL-SCLEROSIS; INTRAMOLECULAR ELECTRON-TRANSFER;
   CU,ZN-SUPEROXIDE DISMUTASE; COVALENT AGGREGATION; ALZHEIMER-DISEASE;
   CYSTEINE RESIDUE; TRYPTOPHAN; TYROSINE; FAMILY; COPPER
AB Protein disulfide isomerase (PDI) is a dithiol-disulfide oxidoreductase that has essential roles in redox protein folding. PDI has been associated with protective roles against protein aggregation, a hallmark of neurodegenerative diseases. Intriguingly, PDI has been detected in the protein inclusions found in the central nervous system of patients of neurodegenerative diseases. Oxidized proteins are also consistently detected in such patients, but the agents that promote these oxidations remain undefined. A potential trigger of protein oxidation is the bicarbonate-dependent peroxidase activity of the human enzyme superoxide dismutase 1 (hSOD1). Therefore, we examined the effects of this activity on PDI structure and activity. The results showed that PDI was oxidized to radicals that lead to PDI inactivation and aggregation. The aggregates are huge and apparently produced by covalent cross-links. Spin trapping experiments coupled with MS analysis indicated that at least 3 residues of PDI are oxidized to tyrosyl radicals (Y-63, Y-116 and Y-327) Parallel experiments showed that PDI is also oxidized to radicals, inactivated and aggregated by the action of photolytically generated carbonate radical and by UV light. PDI is prone to inactivation and aggregation by one-electron oxidants and UV light probably because of its high content of aromatic amino acids. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Iqbal, Asif; Paviani, Veronica; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil.
   [Moretti, Ana Iochabel; Laurindo, Francisco R. M.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Vasc Biol Lab, BR-05403000 Sao Paulo, Brazil.
RP Augusto, O (reprint author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Caixa Postal 26077, BR-05513970 Sao Paulo, Brazil.
EM oaugusto@iq.usp.br
RI moretti, ana/J-9064-2012; Laurindo, Francisco/J-6575-2015; CEPID,
   Redoxoma/J-2971-2015
CR FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8
   Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439
   Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001
   Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416
   Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408
   Bhattacharjee S, 2007, J AM CHEM SOC, V129, P13493, DOI 10.1021/ja073349w
   Zhang H, 2005, J BIOL CHEM, V280, P40684, DOI 10.1074/jbc.M504503200
   Kim HT, 2000, ANTIOXID REDOX SIGN, V2, P485, DOI 10.1089/15230860050192260
   Pattison DI, 2012, PHOTOCH PHOTOBIO SCI, V11, P38, DOI 10.1039/c1pp05164d
   PRUTZ WA, 1980, BIOCHEM BIOPH RES CO, V96, P408
   Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037
   Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782
   Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017
   Bonini MG, 2004, BIOCHEMISTRY-US, V43, P344, DOI 10.1021/bi035606p
   Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200
   AUST SD, 1993, TOXICOL APPL PHARM, V120, P168, DOI 10.1006/taap.1993.1100
   Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Karala AR, 2010, FEBS J, V277, P2454, DOI 10.1111/j.1742-4658.2010.07660.x
   Ehrenshaft M, 2009, FREE RADICAL BIO MED, V46, P1260, DOI 10.1016/j.freeradbiomed.2009.01.020
   Mulligan VK, 2012, J MOL BIOL, V421, P631, DOI 10.1016/j.jmb.2012.04.016
   Conn KJ, 2004, BRAIN RES, V1022, P164, DOI 10.1016/j.brainres.2004.07.026
   Poon HF, 2005, FREE RADICAL BIO MED, V39, P453, DOI 10.1016/j.freeradbiomed.2005.03.030
   Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200
   Goss SPA, 1999, J BIOL CHEM, V274, P28233, DOI 10.1074/jbc.274.40.28233
   Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010
   Arenas A, 2013, CHEM RES TOXICOL, V26, P67, DOI 10.1021/tx300372t
   Augusto O., 2007, AMINO ACIDS, V32, P535
   Baber S.C., 2010, FREE RADIC BIOL MED, V48, P629
   Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130
   BUTLER J, 1986, J CHEM SOC CHEM COMM, P348, DOI 10.1039/c39860000348
   Chandran K, 2010, BIOCHEMISTRY-US, V49, P10616, DOI 10.1021/bi1010305
   CHEN SN, 1973, RADIAT RES, V56, P40, DOI 10.2307/3573789
   Cheng H, 2010, CELL STRESS CHAPERON, V15, P415, DOI 10.1007/s12192-009-0157-2
   Davies D.J., 2004, FREE RADIC BIOL MED, V36, P1072
   Estey T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015218
   FREEDMAN RB, 1984, BIOCHEM SOC T, V12, P929
   Gunther MR, 2007, FREE RADICAL RES, V41, P1005, DOI 10.1080/10715760701516308
   Honjo Y, 2010, BRAIN RES, V1349, P90, DOI 10.1016/j.brainres.2010.06.016
   Khan MMG, 2011, ONCOL RES, V19, P445, DOI 10.3727/096504011X13123323849717
   Leo G, 2013, RAPID COMMUN MASS SP, V27, P1660, DOI 10.1002/rcm.6610
   Medinas DB, 2009, CHEM RES TOXICOL, V22, P639, DOI 10.1021/tx800287m
   Medinas DB, 2010, FREE RADICAL BIO MED, V49, P1046, DOI 10.1016/j.freeradbiomed.2010.06.018
   Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511
   Queiroz RF, 2013, BIOCHEM J, V455, P37, DOI 10.1042/BJ20130180
   Ramirez DC, 2009, BIOCHEM J, V417, P341, DOI 10.1042/BJ20070722
   SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x
   Tanner C, 1998, FREE RADICAL BIO MED, V24, P671, DOI 10.1016/S0891-5849(97)00340-7
   Toledo JC, 2011, FREE RADICAL BIO MED, V50, P1032, DOI 10.1016/j.freeradbiomed.2011.02.020
   Vaz SM, 2009, ARCH BIOCHEM BIOPHYS, V484, P127, DOI 10.1016/j.abb.2008.12.017
   Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267
   Walker K.A., 2011, NEUROL RES INT, V2011
   Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630
   WANG CC, 1993, FASEB J, V7, P1515
   Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200
   Zhang H, 2004, FREE RADICAL BIO MED, V36, P1355, DOI 10.1016/j.freeradbiomed.2004.02.038
NR 56
TC 1
Z9 1
U1 2
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2014
VL 557
SI SI
BP 72
EP 81
DI 10.1016/j.abb.2014.06.013
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AM1ZA
UT WOS:000339646600010
PM 24956592
ER

PT J
AU Chen, SY
   Lin, JS
   Yang, BC
AF Chen, Sheng-Yi
   Lin, Jo-Shi
   Yang, Bei-Chang
TI Modulation of tumor cell stiffness and migration by type IV collagen
   through direct activation of integrin signaling pathway
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Col4A1; Integrin; Cell stiffness; Migration
ID EXTRACELLULAR-MATRIX; CANCER-DETECTION; FIBROBLASTS; INVOLVEMENT;
   MORPHOLOGY; RIGIDITY; INVASION; CHANNELS; RECEPTOR; TENSION
AB Excessive collagen deposition plays a critical role in tumor progression and metastasis. To understand how type IV collagen affects mechanical stiffness and migration, low-collagen-IV-expressing transfectants of B16F10, U118MG, and Huh7 (denoted shCol cells) were established by the lentiviral-mediated delivery of small interfering RNA against type IV-alpha 1 collagen (Col4A1). Although having similar growth rates, shCol cells showed a flatter morphology compared to that of the corresponding controls. Notably, knocking down the Col4A1 gene conferred the cells with higher levels of elasticity and lower motility. Exposure to blocking antibodies against human beta 1 integrin or alpha 2 beta 1 integrin or the pharmacological inhibition of Src and ERK activity by PP1 and U0126, respectively, effectively reduced cell motility and raised cell stiffness. Reduced Src and ERK activities in shCol cells indicate the involvement of a collagen IV/integrin signaling pathway. The forced expression of beta 1 integrin significantly stimulated Src and ERK phosphorylation, reduced cell stiffness, and accelerated cell motility. In an experimental metastasis assay using C57BL/6 mice, B16F10 shCol cells formed significantly fewer and smaller lung nodules, confirming the contribution of collagen to metastasis. In summary, the integrin signaling pathway activated in a tumor environment with collagen deposition is responsible for low cell elasticity and high metastatic ability. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Chen, Sheng-Yi; Yang, Bei-Chang] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan.
   [Lin, Jo-Shi; Yang, Bei-Chang] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan.
   [Yang, Bei-Chang] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan.
RP Yang, BC (reprint author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan.
EM wilson1211983@gmail.com; dutyzoe@gmail.com; y1357@mail.ncku.edu.tw
FU National Science Council of Taiwan [NSC 962-320-B00-6021-MY3, NSC
   992-320-B006-007]; Center for the Infectious Disease and Signaling
   Research of National Cheng Kung University (2012 Aim for the Top
   University Project)
FX The authors are thankful to Mr. Hans Ham and Prof. M.J. Tang for their
   valuable hands-on help with AFM measurements. This work was supported by
   the National Science Council of Taiwan (under grants NSC
   962-320-B00-6021-MY3 and NSC 992-320-B006-007 to B.-C. Yang) and the
   Center for the Infectious Disease and Signaling Research of National
   Cheng Kung University (2012 Aim for the Top University Project).
CR Fuhrmann A, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015007
   Fleischmajer R, 1998, ANN NY ACAD SCI, V857, P212, DOI 10.1111/j.1749-6632.1998.tb10118.x
   Lekka M, 2009, NAT NANOTECHNOL, V4, P72, DOI 10.1038/nnano.2009.004
   Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009
   Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Iyer S, 2009, NAT NANOTECHNOL, V4, P389, DOI [10.1038/nnano.2009.77, 10.1038/NNANO.2009.77]
   Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147
   Suresh S, 2007, NAT NANOTECHNOL, V2, P748, DOI 10.1038/nnano.2007.397
   Nasser NJ, 2008, CELL MOL LIFE SCI, V65, P1706, DOI 10.1007/s00018-008-7584-6
   Guo QQ, 2012, J BIOMECH, V45, P304, DOI 10.1016/j.jbiomech.2011.10.031
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Burnier JV, 2011, ONCOGENE, V30, P3766, DOI 10.1038/onc.2011.89
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050
   Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Castells M, 2012, INT J MOL SCI, V13, P9545, DOI 10.3390/ijms13089545
   Kauppila S, 1998, J PATHOL, V186, P262, DOI 10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3
   Tee SY, 2011, BIOPHYS J, V100, pL25, DOI 10.1016/j.bpj.2010.12.3744
   Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877
   Mierke CT, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015003
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247
   Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078
   Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760
   Li HY, 2011, CELL TRANSPLANT, V20, P893, DOI 10.3727/096368910X550206
   Chiu WT, 2008, MOL BIOL CELL, V19, P2220, DOI 10.1091/mbc.E07-11-1170
   Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808
   KAINZ C, 1995, EUR J CANCER, V31A, P1706, DOI 10.1016/0959-8049(95)00353-K
   Kolacna L, 2007, PHYSIOL RES, V56, pS51
   Lin HC, 2012, J BIOL CHEM, V287, P20664, DOI 10.1074/jbc.M111.326058
   Nagayama M, 2001, CELL MOTIL CYTOSKEL, V50, P173, DOI 10.1002/cm.10008
   Neira RE, 2012, INT J BIOCHEM CELL B, V44, P2194, DOI 10.1016/j.biocel.2012.08.018
   Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38
   Sanders MA, 2004, AM J PHYSIOL-GASTR L, V286, pG547, DOI 10.1152/ajpgi.00262.2003
   Stroka KM, 2011, CELL MOL BIOENG, V4, P9, DOI 10.1007/s12195-010-0142-y
   Wei WC, 2008, J CELL BIOCHEM, V103, P1111, DOI 10.1002/jcb.21482
   ZHU GG, 1995, CANCER, V75, P1010, DOI 10.1002/1097-0142(19950215)75:4<1010::AID-CNCR2820750417>3.0.CO;2-O
   Zou CY, 2013, CELL BIOCHEM BIOPHYS, V65, P455, DOI 10.1007/s12013-012-9449-8
NR 40
TC 1
Z9 2
U1 4
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG
PY 2014
VL 555
BP 1
EP 8
DI 10.1016/j.abb.2014.05.004
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AL0NR
UT WOS:000338824100001
PM 24823860
ER

PT J
AU Wennman, A
   Karkehabadi, S
   Oliw, EH
AF Wennman, Anneli
   Karkehabadi, Saeid
   Oliw, Ernst H.
TI Kinetic investigation of the rate-limiting step of manganese- and
   iron-lipoxygenases
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Arrhenius plot; Deuterium kinetic isotope effect; Hydrogen abstraction;
   Site-directed mutagenesis; Hydrogen tunneling
ID COUPLED ELECTRON-TRANSFER; UNSATURATED FATTY-ACIDS; SOYBEAN
   LIPOXYGENASE-1; PROTEIN DYNAMICS; CATALYSIS; SPECIFICITY; OXIDATION;
   INSIGHTS; PURIFICATION; OXYGENATION
AB Lipoxygenases (LOX) oxidize polyunsaturated fatty acids to hydroperoxides, which are generated by proton coupled electron transfer to the metal center with (FeOH-)-O-III or (MnOH-)-O-III. Hydrogen abstraction by (FeOH-)-O-III of soybean LOX-1 (sLOX-1) is associated with a large deuterium kinetic isotope effect (D-KIE). Our goal was to compare the D-KIE and other kinetic parameters at different temperatures of sLOX-1 with 13R-LOX with catalytic manganese (13R-MnLOX). The reaction rate and the D-KIE of sLOX-1 with unlabeled and [11-H-2(2)]18:2n-6 were almost temperature independent with an apparent D-KIE of similar to 56 at 30 degrees C, which is in agreement with previous studies. In contrast, the reaction rate of 13R-MnLOX increased 7-fold with temperature (8-50 degrees C), and the apparent D-KIE decreased linearly from similar to 38 at 8 degrees C to similar to 20 at 50 degrees C. The kinetic lag phase of 13R-MnLOX was consistently extended at low temperatures. The Phe337Ile mutant of 13R-MnLOX, which catalyzes antarafacial hydrogen abstraction and oxygenation in analogy with sLOX-1, retained the large D-KIE and its temperature-dependent reaction rate. The kinetic differences between 13R-MnLOX and sLOX-1 may be due to protein dynamics, hydrogen donor-acceptor distances, and to the metal ligands, which may not equalize the 0.7 V-gap between the redox potentials of the free metals. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wennman, Anneli; Karkehabadi, Saeid; Oliw, Ernst H.] Uppsala Univ, Dept Pharmaceut Biosci, Biomed Ctr, Div Biochem Pharmacol, SE-75124 Uppsala, Sweden.
RP Oliw, EH (reprint author), Uppsala Univ, Dept Pharmaceut Biosci, Div Biochem Pharmacol, POB 591, SE-75124 Uppsala, Sweden.
EM Ernst.Oliw@farmbio.uu.se
OI Oliw, Ernst/0000-0002-7986-8130
FU VR [03X-06523]; Knut and Alice Wallenberg Foundation [KAW 2004.0123]
FX This research was supported by VR (03X-06523) and the Knut and Alice
   Wallenberg Foundation (KAW 2004.0123).
CR Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016
   Hatcher E, 2007, J AM CHEM SOC, V129, P187, DOI 10.1021/ja0667211
   Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072
   Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d
   Su C, 2000, J BIOL CHEM, V275, P18830, DOI 10.1074/jbc.M001408200
   Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x
   Gupta A, 2008, J AM CHEM SOC, V130, P11274, DOI 10.1021/ja8042273
   Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008
   Rickert KW, 1999, BIOCHEMISTRY-US, V38, P12218, DOI 10.1021/bi990834y
   Hatcher E, 2004, J AM CHEM SOC, V126, P5763, DOI 10.1021/ja039606o
   Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002
   Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t
   Vance CK, 2001, BIOCHEMISTRY-US, V40, P13079, DOI 10.1021/bi0113317
   Miller AF, 2012, FEBS LETT, V586, P585, DOI 10.1016/j.febslet.2011.10.048
   Cristea M, 2005, ARCH BIOCHEM BIOPHYS, V434, P201, DOI 10.1016/j.abb.2004.10.026
   Segraves EN, 2003, BIOCHEMISTRY-US, V42, P5236, DOI 10.1021/bi0273462
   Wennman A, 2013, J LIPID RES, V54, P762, DOI 10.1194/jlr.M033787
   Heshof R, 2014, APPL MICROBIOL BIOT, V98, P1261, DOI 10.1007/s00253-013-5392-x
   Klinman JP, 2006, PHILOS T R SOC B, V361, P1323, DOI 10.1098/rstb.2006.1870
   Meyer MP, 2008, P NATL ACAD SCI USA, V105, P1146, DOI 10.1073/pnas.0710643105
   Pratt DA, 2003, J AM CHEM SOC, V125, P5801, DOI 10.1021/ja034182j
   Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x
   Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080
   Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884
   Brodhun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064919
   BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074
   DEGROOT JJM, 1975, BIOCHIM BIOPHYS ACTA, V377, P71, DOI 10.1016/0005-2744(75)90287-9
   GLICKMAN MH, 1995, BIOCHEMISTRY-US, V34, P14077, DOI 10.1021/bi00043a013
   GLICKMAN MH, 1994, J AM CHEM SOC, V116, P793, DOI 10.1021/ja00081a060
   GRAFF G, 1990, ANAL BIOCHEM, V188, P38, DOI 10.1016/0003-2697(90)90525-E
   HAMBERG M, 1967, J BIOL CHEM, V242, P5329
   Hoffmann I, 2012, BBA-MOL CELL BIOL L, V1821, P1508, DOI 10.1016/j.bbalip.2012.09.001
   Hornsten L, 2002, EUR J BIOCHEM, V269, P2690, DOI 10.1046/j.1432-1033.2002.02936.x
   Jacquot C, 2008, BIOORG MED CHEM LETT, V18, P5959, DOI 10.1016/j.bmcl.2008.08.108
   Jacquot C, 2008, BIOCHEMISTRY-US, V47, P7295, DOI 10.1021/bi800308q
   Klinman JP, 2013, BIOCHEMISTRY-US, V52, P2068, DOI 10.1021/bi301504m
   Kryvohuz M, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4754660
   Moiseyev N, 1997, J AM CHEM SOC, V119, P3853, DOI 10.1021/ja9632825
   Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m
   NELSON MJ, 1988, BIOCHEMISTRY-US, V27, P4273, DOI 10.1021/bi00412a011
   Oliw EH, 2011, J LIPID RES, V52, P1995, DOI 10.1194/jlr.M018259
   Oliw EH, 2008, J LIPID RES, V49, P420, DOI 10.1194/jlr.M700514-JLR200
   SCHILSTRA MJ, 1993, BIOCHEMISTRY-US, V32, P7686, DOI 10.1021/bi00081a012
   Sharma SC, 2008, J AM CHEM SOC, V130, P17632, DOI 10.1021/ja806354w
   SMITH WL, 1972, J BIOL CHEM, V247, P1038
   Wennman A, 2014, ACTA CRYSTALLOGR F, V70, P522, DOI 10.1107/S2053230X14005548
   Wennman A, 2012, J BIOL CHEM, V287, P31757, DOI 10.1074/jbc.M112.364331
NR 47
TC 3
Z9 3
U1 4
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG
PY 2014
VL 555
BP 9
EP 15
DI 10.1016/j.abb.2014.05.014
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AL0NR
UT WOS:000338824100002
PM 24857825
ER

PT J
AU Wang, QY
   Wang, YF
   Yu, ZJ
   Li, DL
   Jia, B
   Li, JJ
   Guan, KL
   Zhou, YB
   Chen, YL
   Kan, QC
AF Wang, Qiongye
   Wang, Yanfang
   Yu, Zujiang
   Li, Duolu
   Jia, Bin
   Li, Jingjing
   Guan, Kelei
   Zhou, Yubing
   Chen, Yanling
   Kan, Quancheng
TI Ammonia-induced energy disorders interfere with bilirubin metabolism in
   hepatocytes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Hyperammonemia; Mitochondria; Energy; Bilirubin metabolism
ID MITOCHONDRIAL PERMEABILITY TRANSITION; MULTIDRUG-RESISTANCE PROTEIN;
   HEPATIC-ENCEPHALOPATHY; CULTURED ASTROCYTES; CANALICULAR ISOFORM;
   OXIDATIVE STRESS; MRP2; TRANSPORT; CELLS; PATHOGENESIS
AB Hyperammonemia and jaundice are the most common clinical symptoms of hepatic failure. Decreasing the level of ammonia in the blood is often accompanied by a reduction in bilirubin in patients with hepatic failure. Previous studies have shown that hyperammonemia can cause bilirubin metabolism disorders, however it is unclear exactly how hyperammonemia interferes with bilirubin metabolism in hepatocytes. The purpose of the current study was to determine the mechanism or mechanisms by which hyperammonemia interferes with bilirubin metabolism in hepatocytes. Cell viability and apoptosis were analyzed in primary hepatocytes that had been exposed to ammonium chloride. Mitochondrial morphology and permeability were observed and analyzed, intermediates of the tricarboxylic acid (TCA) cycle were determined and changes in the expression of enzymes related to bilirubin metabolism were analyzed after ammonia exposure. Hyperammonemia inhibited cell growth, induced apoptosis, damaged the mitochondria and hindered the TCA cycle in hepatocytes. This led to a reduction in energy synthesis, eventually affecting the expression of enzymes related to bilirubin metabolism, which then caused further problems with bilirubin metabolism. These effects were significant, but could be reversed with the addition of adenosine triphosphate (ATP). This study demonstrates that ammonia can cause problems with bilirubin metabolism by interfering with energy synthesis. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wang, Qiongye; Wang, Yanfang; Li, Duolu; Jia, Bin; Li, Jingjing; Guan, Kelei; Zhou, Yubing; Kan, Quancheng] Zhengzhou Univ, Affiliated Hosp 1, Dept Pharmacol, Zhengzhou 450052, Peoples R China.
   [Yu, Zujiang; Chen, Yanling] Zhengzhou Univ, Affiliated Hosp 1, Dept Infect Dis, Zhengzhou 450052, Peoples R China.
RP Kan, QC (reprint author), Zhengzhou Univ, Affiliated Hosp 1, 40 Daxue Rd, Zhengzhou 450052, Peoples R China.
EM kanqc@outlook.com
CR Jones EA, 2012, CLIN LIVER DIS, V16, P7, DOI 10.1016/j.cld.2011.12.010
   Nies AT, 2007, PFLUG ARCH EUR J PHY, V453, P643, DOI 10.1007/s00424-006-0109-y
   Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357
   Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012
   Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5
   Cui YH, 1999, MOL PHARMACOL, V55, P929
   Rao KVR, 2001, METAB BRAIN DIS, V16, P67, DOI 10.1023/A:1011666612822
   Sung KC, 2013, AM J CARDIOL, V112, P1873, DOI 10.1016/j.amjcard.2013.08.018
   Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1
   Leier I, 2000, KIDNEY INT, V57, P1636, DOI 10.1046/j.1523-1755.2000.00007.x
   Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9
   Shawcross DL, 2010, HEPATOLOGY, V51, P1062, DOI 10.1002/hep.23367
   Rowland A, 2013, INT J BIOCHEM CELL B, V45, P1121, DOI 10.1016/j.biocel.2013.02.019
   Kruh GD, 2007, CANCER METAST REV, V26, P5, DOI 10.1007/s10555-007-9039-1
   Rao KVR, 2003, J NEUROSCI RES, V74, P891, DOI 10.1002/jnr.10755
   Jedlitschky G, 1997, BIOCHEM J, V327, P305
   Zoratti M, 2005, BBA-BIOENERGETICS, V1706, P40, DOI 10.1016/j.bbabio.2004.10.006
   Rao KVR, 2004, J BIOL CHEM, V279, P32333, DOI 10.1074/jbc.M402096200
   Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250
   Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095
   Bernardi Paolo, 2007, Novartis Found Symp, V287, P157
   Bhatia V, 2006, GUT, V55, P98, DOI 10.1136/gut.2004.061754
   Coltart I., 2013, ARCH BIOCHEM BIOPHYS, V534, P71
   DUBIN IN, 1954, MEDICINE, V33, P155
   HASSELL T, 1991, APPL BIOCHEM BIOTECH, V30, P29, DOI 10.1007/BF02922022
   Jayakumar AR, 2006, NEUROCHEM INT, V48, P623, DOI 10.1016/j.neuint.2005.11.017
   Jia B., 2013, LIVER INT, V34, P748
   Kartenbeck J, 1996, HEPATOLOGY, V23, P1061
   Kawabe T, 1999, FEBS LETT, V456, P327, DOI 10.1016/S0014-5793(99)00979-5
   Keppler D, 2014, DRUG METAB DISPOS, V42, P561, DOI 10.1124/dmd.113.055772
   Kinnally K.W., 1813, BIOCH BIOPHYS ACTA B, V2011, P616
   Nicotra A, 2002, NEUROTOXICOL TERATOL, V24, P599, DOI 10.1016/S0892-0362(02)00213-1
   Oakes GH, 2005, J BIOCHEM MOL TOXIC, V19, P244, DOI 10.1002/jbt.20086
   Reddy PVB, 2009, J NEUROSCI RES, V87, P2677, DOI 10.1002/jnr.22097
   SKANDALAKIS J E, 1958, J Med Assoc Ga, V47, P392
   Wang Y., 2007, J CLIN INTERN MED, V4
   Yin H.-k., 2007, CHIN J CLIN HEPATOL, V4
NR 37
TC 1
Z9 1
U1 4
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG
PY 2014
VL 555
BP 16
EP 22
DI 10.1016/j.abb.2014.05.019
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AL0NR
UT WOS:000338824100003
PM 24878366
ER

PT J
AU Zblewska, K
   Krajewska, J
   Zolkiewski, M
   Kedzierska-Mieszkowska, S
AF Zblewska, Kamila
   Krajewska, Joanna
   Zolkiewski, Michal
   Kedzierska-Mieszkowska, Sabina
TI Role of the disaggregase ClpB in processing of proteins aggregated as
   inclusion bodies
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE ClpB; Inclusion bodies; Molecular chaperone; Protein aggregation
ID ESCHERICHIA-COLI; MOLECULAR CHAPERONES; BETA-GALACTOSIDASE;
   QUALITY-CONTROL; SOLUBILITY; COOPERATION; DOMAIN; CELLS; DNAK
AB Overproduction of heterologous proteins in bacterial systems often results in the formation of insoluble inclusion bodies (IBs), which is a major impediment in biochemical research and biotechnology. In principle, the activity of molecular chaperones could be employed to gain control over the IB formation and to improve the recombinant protein yields, but the potential of each of the major bacterial chaperones (DnaK/J, GroEL/ES, and ClpB) to process IBs has not been fully established yet. We investigated the formation of inclusion bodies (IBs) of two aggregation-prone proteins, VP1LAC and VP1GFP, overproduced in Escherichia coli in the presence and absence of the chaperone ClpB. We found that both ClpB isoforms, ClpB95 and ClpB80 accumulated in E. coli cells during the production of IBs. The amount of IB proteins increased in the absence of ClpB. ClpB supported the resolubilization and reactivation of the aggregated VP1LAC and VP1GFP in E. coli cells. The IB disaggregation was optimal in the presence of both ClpB95 and ClpB80. Our results indicate an essential role of ClpB in controlling protein aggregation and inclusion body formation in bacteria. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Zblewska, Kamila; Krajewska, Joanna; Kedzierska-Mieszkowska, Sabina] Univ Gdansk, Dept Biochem, PL-80308 Gdansk, Poland.
   [Zolkiewski, Michal] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.
RP Kedzierska-Mieszkowska, S (reprint author), Univ Gdansk, Dept Biochem, PL-80308 Gdansk, Poland.
EM sabina.kedzierska-mieszkowska@biol.ug.edu.pl
CR SQUIRES CL, 1991, J BACTERIOL, V173, P4254
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x
   Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412
   Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862
   Rokney A, 2009, J MOL BIOL, V392, P589, DOI 10.1016/j.jmb.2009.07.009
   CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5
   Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27
   Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9
   de Marco A, 2007, NAT PROTOC, V2, P2632, DOI 10.1038/nprot.2007.400
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200
   Carrio MM, 2003, FEBS LETT, V537, P215, DOI 10.1016/S0014-5793(03)00126-1
   Chow IT, 2005, FEBS LETT, V579, P4235, DOI 10.1016/j.febslet.2005.06.054
   Corchero JL, 1996, J BIOTECHNOL, V48, P191, DOI 10.1016/0168-1656(96)01508-8
   Garcia-Fruitos E, 2007, APPL ENVIRON MICROB, V73, P289, DOI 10.1128/AEM.01952-06
   Guenther I, 2012, BIOCHEM BIOPH RES CO, V426, P596, DOI 10.1016/j.bbrc.2012.08.135
   Kedzierska S, 2003, BIOCHEMISTRY-US, V42, P14242, DOI 10.1021/bi035573d
   Kedzierska S, 2001, FEMS MICROBIOL LETT, V204, P355
   Martinez-Alonso M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-64
   Martinez-Alonso M, 2007, FEMS MICROBIOL LETT, V273, P187, DOI 10.1111/j.1574-6968.2007.00788.x
   Miller J. H., 1972, EXPT MOL GENETICS
   Nagy M, 2010, J MOL BIOL, V396, P697, DOI 10.1016/j.jmb.2009.11.059
   Platas G, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-79
   Sambrook J., 1989, MOL CLONING LAB MANU
NR 25
TC 0
Z9 0
U1 2
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG
PY 2014
VL 555
BP 23
EP 27
DI 10.1016/j.abb.2014.05.012
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AL0NR
UT WOS:000338824100004
PM 24943258
ER

PT J
AU Cai, WS
   Shen, F
   Li, JL
   Feng, Z
   Wang, YC
   Xiao, HQ
   Xu, B
AF Cai, Wen-song
   Shen, Fei
   Li, Jiang-lin
   Feng, Zhe
   Wang, Ying-cheng
   Xiao, Huan-qing
   Xu, Bo
TI Activated protease receptor-2 induces GATA6 expression to promote
   survival in irradiated colon cancer cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Colorectal cancer; Irradiation; Protease-activated receptor-2; GATA
   binding protein 6; Apoptosis
ID RBL-2H3 MAST-CELLS; COLORECTAL-CANCER; THERAPEUTIC TARGET
AB Background and aims: The resistance to irradiation is common and a great drawback in the treatment of cancer with radiotherapy; the underlying mechanism is unclear. GATA binding protein 6 (GATA6) is associated with the pathogenesis of cancer. This study aims to investigate the role of GATA6 on compromising irradiation effect on HT55 and HT29 cells, 2 colorectal cancer cell lines.
   Methods: Human colon cancer cell lines, HT55 and HT29 cells, were treated with irradiation in the culture. Apoptosis of HT55 and HT29 cells was determined by flow cytometry. The expression of PAR2 and GATA6 in HT55 and HT29 cells was analyzed by real time RT-PCR and Western blotting. The gene silence and gene over expression were employed to observe the effect of GATA6 on p53 expression in HT55 and HT29 cells.
   Results: The results showed that HT55 and HT29 cells expressed protease-activated receptor-2 (PAR2). Irradiation induced 38.6% HT55 cell and 33.8% HT29 cell apoptosis, which reduced to 4.2% and 5.6%, respectively after activation of PAR2. Exposure to irradiation increased the expression of GATA6; the latter played a critical role in suppression of p53 expression in HT55 and HT29 cells. Inhibition of GATA6 significantly increased the effect of irradiation on HT55 and HT29 cells.
   Conclusions: Activation of PAR2 compromises the effect of irradiation on inducing colorectal cancer cell apoptosis, which can be prevented by inhibition of GATA6 expression. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Cai, Wen-song; Shen, Fei; Li, Jiang-lin; Feng, Zhe; Wang, Ying-cheng; Xiao, Huan-qing; Xu, Bo] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China.
RP Xu, B (reprint author), Guangzhou First Peoples Hosp, Dept Gen Surg, 1 Panfu Rd, Guangzhou 510180, Guangdong, Peoples R China.
EM BoXu44@163.com
FU Guangdong Province Science and Technology Plan Project; Guangzhou City
   Medical Science and Technology Key Project [201102A212018]
FX This work was supported by the Guangdong Province Science and Technology
   Plan Project and Guangzhou City Medical Science and Technology Key
   Project (201102A212018).
CR Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399
   Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143
   Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200
   Belaguli NS, 2010, NEOPLASIA, V12, P856, DOI 10.1593/neo.10224
   Mikkelsen HB, 2010, J CELL MOL MED, V14, P818, DOI 10.1111/j.1582-4934.2010.01025.x
   Shen F, 2013, ONCOL REP, V30, P1355, DOI 10.3892/or.2013.2544
   Schaffner F, 2009, ARTERIOSCL THROM VAS, V29, P1999, DOI 10.1161/ATVBAHA.108.177428
   Wu ZH, 2010, LASER SURG MED, V42, P503, DOI 10.1002/lsm.20924
   Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641
   Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200
   Chen WB, 2013, DIGEST DIS SCI, V58, P2518, DOI 10.1007/s10620-013-2752-4
   He S, 2012, CURR MOL MED, V12, P1329
   Heijmans J, 2012, BBA-MOL BASIS DIS, V1822, P9, DOI 10.1016/j.bbadis.2010.12.001
   Hoogwater FJH, 2012, BBA-REV CANCER, V1826, P189, DOI 10.1016/j.bbcan.2012.03.007
   Joo HM, 2012, J BIOL CHEM, V287, P27789, DOI 10.1074/jbc.M112.378497
   Khan Z, 2013, BBA-REV CANCER, V1836, P123, DOI 10.1016/j.bbcan.2013.04.002
   Liang GQ, 2012, J ALLERGY CLIN IMMUN, V129, P1377, DOI 10.1016/j.jaci.2012.02.035
   Ma YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072383
   MacGlashan DW, 2012, TRENDS PHARMACOL SCI, V33, P502, DOI 10.1016/j.tips.2012.06.002
   Reck M., 1924, LANCET, V382, P709
   Skiriute D, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-218
NR 21
TC 1
Z9 1
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG
PY 2014
VL 555
BP 28
EP 32
DI 10.1016/j.abb.2014.05.021
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AL0NR
UT WOS:000338824100005
PM 24887481
ER

PT J
AU Sucharitakul, J
   Tinikul, R
   Chaiyen, P
AF Sucharitakul, Jeerus
   Tinikul, Ruchanok
   Chaiyen, Pimchai
TI Mechanisms of reduced flavin transfer in the two-component
   flavin-dependent monooxygenases
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Reduced flavin; Enzyme kinetics; Enzyme mechanisms; Oxygen; Transfer of
   unstable metabolite; Transient kinetics; Reductase; Oxygenase
ID P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; PROTEIN-PROTEIN INTERACTIONS;
   RESONANCE ENERGY-TRANSFER; NADPH-FMN OXIDOREDUCTASE;
   THERMUS-THERMOPHILUS HB8; STREPTOMYCES-COELICOLOR;
   ACINETOBACTER-BAUMANNII; VIBRIO-HARVEYI; ESCHERICHIA-COLI;
   4-HYDROXYPHENYLACETATE 3-MONOOXYGENASE
AB Two-component flavin-dependent enzymes are abundant in nature and are involved in a wide variety of biological reactions. These enzymes consist of a reductase which generates a reduced flavin and a monooxygenase that utilizes the reduced flavin as a substrate for monooxygenation. As reduced flavin is unstable and can be oxidized by oxygen, these enzymes must have a means to efficiently coordinate the transfer of the reduced flavin such that auto-oxidation can be minimized. Various types of experiments and methodologies have been used to probe the mode of reduced flavin transfer. Results from many systems have indicated that the transfer can be achieved by free diffusion and that the presence of one component has no influence on the kinetics of the other component. Contradicting results indicating that the transfer of the reduced flavin may be achieved via protein-protein mediation also exist. Regardless of the mode of reduced flavin transfer, these enzymes have a means to control their overall kinetics such that the reaction rate is slow when the demand for oxygenation is not high. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Sucharitakul, Jeerus] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok 10300, Thailand.
   [Tinikul, Ruchanok] Mahidol Univ, Nakhonsawan 60130, Thailand.
   [Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand.
   [Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand.
RP Chaiyen, P (reprint author), Mahidol Univ, Fac Sci, Dept Biochem, Rama 6 Rd, Bangkok 10400, Thailand.
EM pimchai.cha@mahidol.ac.th
FU Thailand Research fund [RSA5580050, RTA5680001]; Mahidol University
FX The authors acknowledge research support from the Thailand Research fund
   no. RSA5580050 (to J.S.) and no. RTA5680001 (to P.C.) and Mahidol
   University (to R.T. and P.C.).
CR AHMAD I, 1982, BIOCHEMISTRY-US, V21, P3122, DOI 10.1021/bi00256a014
   Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836
   Tongsook C, 2011, J BIOL CHEM, V286, P44491, DOI 10.1074/jbc.M111.284463
   Gao BL, 2005, BIOCHEM BIOPH RES CO, V331, P1137, DOI 10.1016/j.bbrc.2005.04.033
   Lei BF, 1998, BIOCHEMISTRY-US, V37, P14623, DOI 10.1021/bi981841+
   Kantz A, 2005, ARCH BIOCHEM BIOPHYS, V442, P102, DOI 10.1016/j.abb.2005.07.020
   Filisetti L, 2003, J BIOL CHEM, V278, P296, DOI 10.1074/jbc.M209689200
   Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028
   Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005
   HASTINGS JW, 1963, J BIOL CHEM, V238, P2537
   Hastings JW, 1996, GENE, V173, P5, DOI 10.1016/0378-1119(95)00676-1
   Phongsak T, 2012, J BIOL CHEM, V287, P26213, DOI 10.1074/jbc.M112.354472
   Low JC, 2003, PHOTOCHEM PHOTOBIOL, V77, P446, DOI 10.1562/0031-8655(2003)077<0446:ETEFIV>2.0.CO;2
   Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u
   Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104
   Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200
   Yan YL, 2003, CURR OPIN CHEM BIOL, V7, P635, DOI 10.1016/j.cbpa.2003.08.017
   Campbell ZT, 2009, J BIOL CHEM, V284, P8322, DOI 10.1074/jbc.M808977200
   Nijvipakul S, 2008, J BACTERIOL, V190, P1531, DOI 10.1128/JB.01660-07
   Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881
   Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000
   Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639
   Valton J, 2004, J BIOL CHEM, V279, P44362, DOI 10.1074/jbc.M407722200
   Dresen C, 2010, J BIOL CHEM, V285, P22264, DOI 10.1074/jbc.M109.099028
   Dijkman WP, 2013, APPL MICROBIOL BIOT, V97, P5177, DOI 10.1007/s00253-013-4925-7
   Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510
   Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200
   Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003
   Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841
   Wongnate T, 2013, FEBS J, V280, P3009, DOI 10.1111/febs.12280
   Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e
   Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005
   KENDREW SG, 1995, J BIOL CHEM, V270, P17339
   Jeffers CE, 2003, BIOCHEMISTRY-US, V42, P529, DOI 10.1021/bi026877n
   Campbell ZT, 2009, BIOCHEMISTRY-US, V48, P6085, DOI 10.1021/bi900003t
   Xia ZY, 2009, CURR OPIN BIOTECH, V20, P37, DOI 10.1016/j.copbio.2009.01.001
   Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004
   Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.0014-2956.2001.02490.x
   Tischler D, 2010, J BACTERIOL, V192, P5220, DOI 10.1128/JB.00723-10
   Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007
   Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614
   TU SC, 1979, ARCH BIOCHEM BIOPHYS, V193, P110, DOI 10.1016/0003-9861(79)90013-4
   Abdurachim K, 2006, J BACTERIOL, V188, P8153, DOI 10.1128/JB.00966-06
   ARUNACHALAM U, 1992, J BIOL CHEM, V267, P25848
   CABALLERO JL, 1991, MOL GEN GENET, V230, P401, DOI 10.1007/BF00280297
   COLE SP, 1987, J ANTIBIOT, V40, P340
   FERNANDEZMORENO MA, 1992, J BIOL CHEM, V267, P19278
   GIBIAN MJ, 1969, BIOCHEM BIOPH RES CO, V34, P594, DOI 10.1016/0006-291X(69)90779-7
   Gong F., 2006, PROTOC EXCH
   GUNSALUS.A, 1972, J BIOL CHEM, V247, P398
   Hollmann F, 2005, J AM CHEM SOC, V127, P6540, DOI 10.1021/ja050997b
   Jeffers CE, 2001, BIOCHEMISTRY-US, V40, P1749, DOI 10.1021/bi0024310
   Kantz A, 2011, BIOCHEMISTRY-US, V50, P523, DOI 10.1021/bi101328r
   Kim SH, 2008, PROTEINS, V70, P718, DOI 10.1002/prot.21534
   Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200
   Lakowicz JR, 2006, PRINCIPLES FLUORESCE, P1
   LEI BF, 1994, J BACTERIOL, V176, P3552
   MCELROY WD, 1955, ARCH BIOCHEM BIOPHYS, V56, P240, DOI 10.1016/0003-9861(55)90353-2
   Morrison E, 2013, BIOCHEMISTRY-US, V52, P6063, DOI 10.1021/bi400763h
   Nijvipakul S, 2010, BIOCHEMISTRY-US, V49, P9241, DOI 10.1021/bi1009985
   Reddy Chichili V. P., 2013, INTRINSICALLY DISORD, V1
   Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P30, DOI 10.1142/9789812773647_0002
   Suadee C, 2007, J BIOCHEM, V142, P539, DOI 10.1093/jb/mvm155
   Tinikul R, 2012, J BIOTECHNOL, V162, P346, DOI 10.1016/j.jbiotec.2012.08.018
   Tinikul R, 2013, BIOCHEMISTRY-US, V52, P6834, DOI 10.1021/bi4006545
   Tu SC, 2008, PHOTOCH PHOTOBIO SCI, V7, P183, DOI 10.1039/b713462b
   Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135
   Westerlund-Karlsson A, 2002, BIOCHEM BIOPH RES CO, V296, P1072, DOI 10.1016/S0006-291X(02)02052-1
   Wright GJ, 2009, MOL BIOSYST, V5, P1405, DOI [10.1039/B903580J, 10.1039/b903580j]
   ZENNO S, 1994, J BACTERIOL, V176, P3544
NR 70
TC 3
Z9 3
U1 10
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG
PY 2014
VL 555
BP 33
EP 46
DI 10.1016/j.abb.2014.05.009
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AL0NR
UT WOS:000338824100006
PM 24857824
ER

PT J
AU Morotomi-Yano, K
   Akiyama, H
   Yano, K
AF Morotomi-Yano, Keiko
   Akiyama, Hidenori
   Yano, Ken-ichi
TI Different involvement of extracellular calcium in two modes of cell
   death induced by nanosecond pulsed electric fields
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Nanosecond pulsed electric field; Apoptosis; Necrosis; Calcium
ID POLY(ADP-RIBOSE) POLYMERASE; MEMBRANE PERMEABILIZATION;
   MOLECULAR-MECHANISMS; JURKAT CELLS; APOPTOSIS; NECROSIS; INHIBITION;
   ACTIVATION; PATHWAYS; THERAPY
AB Exposure of cultured cells to nanosecond pulsed electric fields (nsPEFs) induces various cellular responses, including the influx of extracellular Ca2+ and cell death. Recently, nsPEFs have been regarded as a novel means of cancer therapy, but their molecular mechanism of action remains to be fully elucidated. Here, we demonstrate the involvement of extracellular Ca2+ in nsPEF-induced cell death. Extracellular Ca2+ was essential for necrosis and consequent poly(ADP-ribose) (PAR) formation in HeLa S3 cells. Treatment with a Ca2+ ionophore enhanced necrosis as well as PAR formation in nsPEF-exposed HeLa S3 cells. In the absence of extracellular Ca2+, HeLa S3 cells were less susceptible to nsPEFs and exhibited apoptotic proteolysis of caspase 3 and PARP-1. HeLa S3 cells retained the ability to undergo apoptosis even after nsPEF exposure but instead underwent necrosis, suggesting that necrosis is the preferential mode of cell death. In K562 and HEK293 cells, exposure to nsPEFs resulted in the formation of necrosis-associated PAR, whereas Jurkat cells exclusively underwent apoptosis independently of extracellular Ca2+. These observations demonstrate that the mode of cell death induced by nsPEFs is cell-type dependent and that extracellular Ca2+ is a critical factor for nsPEF-induced necrosis. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Morotomi-Yano, Keiko; Yano, Ken-ichi] Kumamoto Univ, Inst Pulsed Power Sci, Dept Bioelect, Kumamoto 8608555, Japan.
   [Akiyama, Hidenori] Kumamoto Univ, Inst Pulsed Power Sci, Dept Pulsed Power Infrastruct, Kumamoto 8608555, Japan.
RP Yano, K (reprint author), Kumamoto Univ, Inst Pulsed Power Sci, Dept Bioelect, 2-39-1 Kurokami, Kumamoto 8608555, Japan.
EM yanoken@kumamoto-u.ac.jp
FU Japan Society for the Promotion of Science; Suzuken Memorial Foundation
FX This study was supported by Grants-in-Aid for Scientific Research from
   Japan Society for the Promotion of Science and by Suzuken Memorial
   Foundation.
CR Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723
   Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y
   Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312
   Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496
   Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506
   Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140
   Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013
   Frandsen SK, 2012, CANCER RES, V72, P1336, DOI 10.1158/0008-5472.CAN-11-3782
   Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003
   Lemaire C, 1998, FEBS LETT, V425, P266, DOI 10.1016/S0014-5793(98)00252-X
   Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016
   Schildkopf P, 2010, BIOCHEM BIOPH RES CO, V391, P1014, DOI 10.1016/j.bbrc.2009.12.008
   Dorn GW, 2013, TOXICOL PATHOL, V41, P227, DOI 10.1177/0192623312466961
   Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269
   Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345
   Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476
   Morotomi-Yano K, 2011, ARCH BIOCHEM BIOPHYS, V515, P99, DOI 10.1016/j.abb.2011.09.002
   Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111
   Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978
   Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354
   Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009
   Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02.0859fje
   McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002
   Silve A, 2012, BIOELECTROCHEMISTRY, V87, P260, DOI 10.1016/j.bioelechem.2011.10.002
   Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012
   Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103
   Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x
   Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379
   White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200
   Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264
   Pakhomova ON, 2012, ARCH BIOCHEM BIOPHYS, V527, P55, DOI 10.1016/j.abb.2012.08.004
   Teissie J, 2005, BBA-GEN SUBJECTS, V1724, P270, DOI 10.1016/j.bbagen.2005.05.006
   Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006
   TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3
   Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164
   Beier HT, 2012, BIOCHEM BIOPH RES CO, V423, P863, DOI 10.1016/j.bbrc.2012.06.055
   Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150
   Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001
   Ford WE, 2010, ARCH BIOCHEM BIOPHYS, V497, P82, DOI 10.1016/j.abb.2010.03.008
   Mir LM, 2006, EJC SUPPL, V4, P38, DOI 10.1016/j.ejcsup.2006.08.005
   Morotomi-Yano K, 2012, BIOCHEM BIOPH RES CO, V428, P371, DOI 10.1016/j.bbrc.2012.10.061
   Morotomi-Yano K, 2011, BIOCHEM BIOPH RES CO, V408, P471, DOI 10.1016/j.bbrc.2011.04.056
   Morotomi-Yano K, 2012, EXP CELL RES, V318, P1733, DOI 10.1016/j.yexcr.2012.04.016
   Morotomi-Yano K, 2013, BIOCHEM BIOPH RES CO, V438, P557, DOI 10.1016/j.bbrc.2013.07.083
   Nuccitelli R, 2013, BIOCHEM BIOPH RES CO, V435, P580, DOI 10.1016/j.bbrc.2013.05.014
   Nuccitelli R, 2012, BIOCHEM BIOPH RES CO, V424, P446, DOI 10.1016/j.bbrc.2012.06.129
   Pakhomova ON, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070278
   Ren W, 2012, BIOCHEM BIOPH RES CO, V421, P808, DOI 10.1016/j.bbrc.2012.04.094
   Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342
   Sato T, 2008, J IMMUNOL, V181, P197
   Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37
   Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007
NR 52
TC 2
Z9 2
U1 1
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG
PY 2014
VL 555
BP 47
EP 54
DI 10.1016/j.abb.2014.05.020
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AL0NR
UT WOS:000338824100007
PM 24893145
ER

PT J
AU Terashima, Y
   Nishiumi, S
   Minami, A
   Kawano, Y
   Hoshi, N
   Azuma, T
   Yoshida, M
AF Terashima, Yoshihiko
   Nishiumi, Shin
   Minami, Akihiro
   Kawano, Yuki
   Hoshi, Namiko
   Azuma, Takeshi
   Yoshida, Masaru
TI Metabolomics-based search for therapeutic agents for non-alcoholic
   steatohepatitis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE NASH; Hypotaurine; GC/MS; Metabolome analysis
ID FATTY LIVER-DISEASE; PLACEBO-CONTROLLED TRIAL; HEPATIC STEATOSIS;
   OXIDATIVE STRESS; MICE; ACID; HYPOTAURINE; PROGRESSION; TAURINE;
   PENTOXIFYLLINE
AB Background: Non-alcoholic fatty liver disease (NAFLD) is the commonest form of chronic liver disease in developed countries. Non-alcoholic steatohepatitis (NASH), which represents advanced stage NAFLD, is increasingly being recognized as a major cause of liver-related morbidity and mortality. However, no effective drugs against NASH have yet been developed. Therefore, we searched for candidate therapeutic agents based on the changes in levels of hepatic metabolites via gas chromatography mass spectrometry (GC/MS)-based metabolome analysis of livers from methionine-choline deficient (MCD) diet-fed mice, a mouse model of NASH.
   Methods: The metabolites were extracted from the livers of the MCD diet-fed mice and then analyzed using GC/MS. Subsequently, the MCD diet-fed mice were supplemented with hypotaurine, and the therapeutic effects of hypotaurine against steatohepatitis were evaluated.
   Results: Ninety-nine metabolites were detected in the livers of the MCD diet-induced steatohepatitis model mice. Among these metabolites, hypotaurine exhibited the greatest decrease in its concentration in the mice. Supplementation with 2 mmol/kg BW hypotaurine attenuated liver injuries and fat accumulation caused by the MCD diet-induced steatohepatitis. Furthermore, 10 mmol/kg BW hypotaurine supplementation ameliorated fibrosis and oxidative stress induced by the MCD diet.
   Conclusion: The present metabolome analysis-based study demonstrated that hypotaurine is a novel candidate therapeutic agent for NASH. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Terashima, Yoshihiko; Nishiumi, Shin; Minami, Akihiro; Kawano, Yuki; Hoshi, Namiko; Azuma, Takeshi; Yoshida, Masaru] Kobe Univ, Grad Sch Med, Div Gastroenterol,Dept Internal Med, Chuo Ku, Kobe, Hyogo 6500017, Japan.
   [Yoshida, Masaru] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Kobe, Hyogo 6500017, Japan.
   [Yoshida, Masaru] Kobe Univ, Grad Sch Med, Div Metabol Res, Kobe, Hyogo 6500017, Japan.
RP Nishiumi, S (reprint author), Kobe Univ, Grad Sch Med, Div Gastroenterol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.
EM nishiums@med.kobe-u.ac.jp; myoshida@med.kobe-u.ac.jp
FU Ministry of Education, Culture, Sports, Science, and Technology (MEXT)
   of Japan; MEXT of Japan; Japan Society for the Promotion of Science
   (JSPS)
FX This study was partially supported by Grant for the Global COE Program,
   Global Center of Excellence for Education and Research on Signal
   Transduction Medicine in the Coming Generation, from the Ministry of
   Education, Culture, Sports, Science, and Technology (MEXT) of Japan
   [T.A., M.Y.], Special Coordination Funds for Promoting Science and
   Technology, Creation of Innovation Centers for Advanced
   Interdisciplinary Research Areas (Innovative Bioproduction Kobe), from
   MEXT of Japan [T.A., M.Y.], and a Grant-in-Aid for Young Scientists (B)
   from the Japan Society for the Promotion of Science (JSPS) [S.N.].
CR Acharya M, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S35
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047
   Hirata T, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/587140
   Younossi ZM, 2008, ALIMENT PHARM THER, V28, P2, DOI 10.1111/j.1365-2036.2008.03710.x
   Musso G, 2011, CURR OPIN LIPIDOL, V22, P489, DOI 10.1097/MOL.0b013e32834c37ee
   Tsugawa H, 2011, J BIOSCI BIOENG, V112, P292, DOI 10.1016/j.jbiosc.2011.05.001
   Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068
   Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003
   Kawano Y, 2010, ARCH BIOCHEM BIOPHYS, V504, P221, DOI 10.1016/j.abb.2010.09.001
   Staels B, 2013, HEPATOLOGY, V58, P1941, DOI 10.1002/hep.26461
   Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001
   Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1016/j.amjgastroenterol.2003.08.005
   Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013
   Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Gentile CL, 2011, AM J PHYSIOL-REG I, V301, pR1710, DOI 10.1152/ajpregu.00677.2010
   Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007
   Claudino WM, 2007, J CLIN ONCOL, V25, P2840, DOI 10.1200/JCO.2006.09.7550
   Abdelmalek MF, 2009, HEPATOLOGY, V50, P1818, DOI 10.1002/hep.23239
   Yoshida M, 2012, J GASTROENTEROL, V47, P9, DOI 10.1007/s00535-011-0493-8
   Kobayashi T, 2013, CANCER EPIDEM BIOMAR, V22, P571, DOI 10.1158/1055-9965.EPI-12-1033
   Tanaka N, 2012, HEPATOLOGY, V56, P118, DOI 10.1002/hep.25630
   Ito T, 2012, AMINO ACIDS, V42, P1529, DOI 10.1007/s00726-011-0883-5
   ARUOMA OI, 1988, BIOCHEM J, V256, P251
   Oliver SG, 1998, TRENDS BIOTECHNOL, V16, P373, DOI 10.1016/S0167-7799(98)01214-1
   Kudo H, 2009, LIVER INT, V29, P988, DOI 10.1111/j.1478-3231.2009.02006.x
   Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051
   Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042
   Dohil R, 2011, ALIMENT PHARM THER, V33, P1036, DOI 10.1111/j.1365-2036.2011.04626.x
   Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016
   Duvnjak M, 2009, J PHYSIOL PHARMACOL, V60, P57
   Li H, 2011, J PROTEOME RES, V10, P2797, DOI 10.1021/pr200047c
   Li WJ, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-49
   Malloy VL, 2013, METABOLISM, V62, P1651, DOI 10.1016/j.metabol.2013.06.012
   Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719
   Nishiumi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040459
   Quentin M., 2006, INT J EXP PATHOL, V87, P1
   Sakai A, 2012, ARCH BIOCHEM BIOPHYS, V522, P107, DOI 10.1016/j.abb.2012.03.025
   Sakuragawa T, 2010, J CLIN BIOCHEM NUTR, V46, P126, DOI 10.3164/jcbn.09-91
   Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616
   Tsugawa H., 2001, BMC BIOINFORMATICS, V12, P131
   Yalniz M, 2007, DIGEST DIS SCI, V52, P2380, DOI 10.1007/s10620-006-9194-1
   Yun KU, 2013, FOOD CHEM TOXICOL, V53, P180, DOI 10.1016/j.fct.2012.11.046
NR 44
TC 1
Z9 1
U1 2
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG
PY 2014
VL 555
BP 55
EP 65
DI 10.1016/j.abb.2014.05.013
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AL0NR
UT WOS:000338824100008
PM 24857839
ER

PT J
AU Rosas-Lemus, M
   Uribe-Alvarez, C
   Chiquete-Felix, N
   Uribe-Carvajal, S
AF Rosas-Lemus, Monica
   Uribe-Alvarez, Cristina
   Chiquete-Felix, Natalia
   Uribe-Carvajal, Salvador
TI In Saccharomyces cerevisiae fructose-1,6-bisphosphate contributes to the
   Crabtree effect through closure of the mitochondrial unspecific channel
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Fructose-1,6-bisphosphate; Glucose-6-phosphate; Crabtree effect;
   Mitochondria; Saccharomyces cerevisiae; Permeability transition
ID PERMEABILITY TRANSITION PORE; YEAST MITOCHONDRIA; UNSELECTIVE CHANNEL;
   CELL-DEATH; KLUYVEROMYCES-LACTIS; METABOLISM; MEMBRANE; GLUCOSE;
   MECHANISM; PHOSPHATE
AB In Saccharomyces cerevisiae addition of glucose inhibits oxygen consumption, i.e. S. cerevisiae is Crabtree-positive. During active glycolysis hexoses-phosphate accumulate, and probably interact with mitochondria. In an effort to understand the mechanism underlying the Crabtree effect, the effect of two glycolysis-derived hexoses-phosphate was tested on the S. cerevisiae mitochondrial unspecific channel (ScMUC). Glucose-6-phosphate (G6P) promoted partial opening of ScMUC, which led to proton leakage and uncoupling which in turn resulted in, accelerated oxygen consumption. In contrast, fructose-1,6-bisphosphate (F1,6BP) closed ScMUC and thus inhibited the rate of oxygen consumption. When added together, F1,6BP reverted the mild G6P-induced effects. F1,6BP is proposed to be an important modulator of ScMUC, whose closure contributes to the "Crabtree effect". (C) 2014 Elsevier Inc. All rights reserved.
C1 [Rosas-Lemus, Monica; Uribe-Alvarez, Cristina; Chiquete-Felix, Natalia; Uribe-Carvajal, Salvador] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico.
RP Uribe-Carvajal, S (reprint author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico.
EM suribe@ifc.unam.mx
FU PAPIIT-DGAPA/UNAM [IN202612]
FX M.R.L. and C.U.A. are CONACYT fellows enrolled in the Biochemistry PhD
   program at UNAM. Partially funded by PAPIIT-DGAPA/UNAM (grant IN202612).
   The authors thank Dr. Roberto Coria and Dr. Rocio Navarro for the kind
   donation of the K. lactis 12/8 strain. Dr. Diego Gonzalez Halphen
   critically read the manuscript and participated in discussion of the
   data.
CR URIBE S, 1985, J BACTERIOL, V161, P1195
   THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0
   Huberts DHEW, 2012, FEMS YEAST RES, V12, P118, DOI 10.1111/j.1567-1364.2011.00767.x
   Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1
   Perez-Vazquez V, 2003, J BIOENERG BIOMEMBR, V35, P231, DOI 10.1023/A:1024659615022
   Castrejon V, 1997, ARCH BIOCHEM BIOPHYS, V346, P37, DOI 10.1006/abbi.1997.0273
   Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233
   AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6
   HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2
   GUERIN B, 1994, J BIOL CHEM, V269, P25406
   PRIETO S, 1992, EUR J BIOCHEM, V208, P487, DOI 10.1111/j.1432-1033.1992.tb17212.x
   Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465
   Bernardi P, 1999, PHYSIOL REV, V79, P1127
   Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200
   GREINER EF, 1994, J BIOL CHEM, V269, P31484
   Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x
   Crabtree HG, 1929, BIOCHEM J, V23, P536
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662
   Manon S, 1998, J BIOENERG BIOMEMBR, V30, P419, DOI 10.1023/A:1020533928491
   VEECH RL, 1979, J BIOL CHEM, V254, P6538
   Uribe-Carvajal S, 2011, MITOCHONDRION, V11, P382, DOI 10.1016/j.mito.2011.02.004
   Manon S, 1998, BIOCHEM MOL BIOL INT, V44, P565
   Averet N, 2002, J BIOENERG BIOMEMBR, V34, P499, DOI 10.1023/A:1022526411188
   Averet N, 1998, MOL CELL BIOCHEM, V184, P67, DOI 10.1023/A:1006830810440
   BEAUVOIT B, 1993, EUR J BIOCHEM, V214, P163, DOI 10.1111/j.1432-1033.1993.tb17909.x
   Bernardi Paolo, 2007, Novartis Found Symp, V287, P157
   Castrejon V, 2002, J BIOENERG BIOMEMBR, V34, P299, DOI 10.1023/A:1020208619422
   Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200
   Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010
   Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003
   Ernandes JR, 1998, YEAST, V14, P255, DOI 10.1002/(SICI)1097-0061(199802)14:3<255::AID-YEA228>3.0.CO;2-N
   FIEK C, 1982, BIOCHIM BIOPHYS ACTA, V688, P429, DOI 10.1016/0005-2736(82)90354-6
   FRANCOIS J, 1984, EUR J BIOCHEM, V145, P187, DOI 10.1111/j.1432-1033.1984.tb08539.x
   Gutierrez-Aguilar M, 2010, ARCH BIOCHEM BIOPHYS, V494, P184, DOI 10.1016/j.abb.2009.12.002
   Halestrap A.P., 2004, NATURE, V430
   KOOBS DH, 1972, SCIENCE, V178, P127, DOI 10.1126/science.178.4057.127
   Mates N, 2014, MOL CELL PROTEOMICS, V13, P860, DOI 10.1074/mcp.M113.032714
   MUSTEA I, 1967, CANCER, V20, P1499, DOI 10.1002/1097-0142(196709)20:9<1499::AID-CNCR2820200917>3.0.CO;2-Q
   Navarro-Olmos R, 2010, MOL BIOL CELL, V21, P489, DOI 10.1091/mbc.E09-06-0472
   PENA A, 1977, FEBS LETT, V80, P209, DOI 10.1016/0014-5793(77)80441-9
   Rodriguez-Enriquez S, 2001, EUR J BIOCHEM, V268, P2512, DOI 10.1046/j.1432-1327.2001.02140.x
   Stefan C., 2011, FEMS YEAST RES, V11, P263
NR 43
TC 2
Z9 2
U1 10
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG
PY 2014
VL 555
BP 66
EP 70
DI 10.1016/j.abb.2014.05.027
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AL0NR
UT WOS:000338824100009
PM 24924491
ER

PT J
AU Groom, H
   Lee, M
   Patil, P
   Josephy, PD
AF Groom, Hilary
   Lee, Moses
   Patil, Pravin
   Josephy, P. David
TI Inhibition of human glutathione transferases by dinitronaphthalene
   derivatives
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Glutathione transferase; 1-Chloro-2,4-dinitronaphthalene; Meisenheimer
   complex
ID AROMATIC-SUBSTITUTION REACTIONS; S-TRANSFERASE; MEISENHEIMER COMPLEX;
   MUTAGENICITY TEST; SENSITIVE METHOD; ACTIVE-SITE; DRUGS;
   1-CHLORO-2,4-DINITROBENZENE; DETOXICATION; GENOTOXICITY
AB Glutathione transferase (GST) enzymes catalyze the conjugation of glutathione with reactive functional groups of endogenous compounds and xenobiotics, including halonitroaromatics. 1-Chloro-2, 4-dinitrobenzene (CDNB) is one of the most commonly used substrates for GST activity assays. We have studied the interactions of dinitronaphthalene analogues of CDNB with recombinant human GST enzymes (Alpha, Mu, and Pi classes) expressed in Escherichia coli. Dinitronaphthalene derivatives were found to be GST inhibitors. The highest potency of inhibition was observed towards Mu-class GSTs, M1-1 and M2-2; IC50 values for 1-methoxy- and 1-ethoxy-2,4-dinitronaphthalene were in the high nanomolar to low micromolar range. Inhibition accompanies the formation, at the enzyme active site, of very stable Meisenheimer complex intermediates. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Groom, Hilary; Josephy, P. David] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.
   [Lee, Moses; Patil, Pravin] Hope Coll, Dept Chem, Holland, MI 49423 USA.
RP Josephy, PD (reprint author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.
EM djosephy@uoguelph.ca
FU Natural Sciences and Engineering Research Council of Canada; National
   Science Foundation, USA [CHE 0809162]
FX This work was supported by a grant from the Natural Sciences and
   Engineering Research Council of Canada (Josephy) and by National Science
   Foundation, USA, grant CHE 0809162 (Lee). We wish to thank Dr. Matt
   Kimber for assistance with preparation of Fig. 7.
CR Cacciatore I, 2005, AMINO ACIDS, V29, P255, DOI 10.1007/s00726-005-0232-7
   Clarke ML, 2010, CYTOM PART A, V77A, P790, DOI 10.1002/cyto.a.20864
   Mukanganyama S, 2002, INT J CANCER, V97, P700, DOI 10.1002/ijc.10054
   ROSENKRANZ HS, 1983, MUTAT RES, V114, P217, DOI 10.1016/0165-1110(83)90034-9
   MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9
   WATANABE M, 1990, MUTAT RES, V234, P337, DOI 10.1016/0165-1161(90)90044-O
   Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019
   Pushparajah DS, 2008, MUTAGENESIS, V23, P299, DOI 10.1093/mutage/gen012
   KEEN JH, 1976, J BIOL CHEM, V251, P6183
   Mahajan S, 2005, CELL MOL LIFE SCI, V62, P1221, DOI 10.1007/s00018-005-4524-6
   SCHRAMM VL, 1984, J BIOL CHEM, V259, P714
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3
   Honaker MT, 2013, J BIOL CHEM, V288, P18599, DOI 10.1074/jbc.M112.445767
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Beuckmann CT, 2000, NEUROCHEM RES, V25, P733, DOI 10.1023/A:1007579507804
   BICO P, 1994, BIOCHEM MOL BIOL INT, V33, P887
   Blikstad C, 2008, BBA-GEN SUBJECTS, V1780, P1458, DOI 10.1016/j.bbagen.2008.07.007
   Bowman AL, 2007, BIOCHEMISTRY-US, V46, P6353, DOI 10.1021/bi0622827
   CLARK AG, 1973, BIOCHEM J, V135, P385
   CLARK AG, 1988, BIOCHEM PHARMACOL, V37, P259, DOI 10.1016/0006-2952(88)90727-7
   Wu BJ, 2012, TRENDS PHARMACOL SCI, V33, P656, DOI 10.1016/j.tips.2012.09.007
   Dreij K, 2002, CHEM RES TOXICOL, V15, P825, DOI 10.1021/tx025519i
   FENDLER JH, 1968, J ORG CHEM, V33, P977, DOI 10.1021/jo01267a009
   FOSTER R, 1967, TETRAHEDRON, V23, P227, DOI 10.1016/S0040-4020(01)83304-4
   Terrier F, 2013, MODERN NUCLEOPHILIC AROMATIC SUBSTITUTION, P1, DOI 10.1002/9783527656141
   GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P6252, DOI 10.1021/bi00441a017
   Griswold KE, 2006, J MOL BIOL, V364, P400, DOI 10.1016/j.jmb.2006.09.012
   HEALY MJR, 1972, BIOCHEM J, V130, P207
   Hurst R, 1998, BIOCHEM J, V332, P97
   Jemth P, 1997, ARCH BIOCHEM BIOPHYS, V348, P247, DOI 10.1006/abbi.1997.0357
   JI X, 1993, BIOCHEMISTRY-US, V32, P12949, DOI 10.1021/bi00211a001
   Josephy Philip David, 2013, Front Biosci (Schol Ed), V5, P341
   Josephy PD, 1997, MUTAT RES-REV MUTAT, V386, P1
   Kunze T, 2000, BIOCHEM PHARMACOL, V59, P973, DOI 10.1016/S0006-2952(99)00401-3
   Mannervik B, 1996, BIOCHEM SOC T, V24, P878
   Mannervik B, 1995, ADV DRUG METABOLISM, P407
   MCCOY EC, 1981, ENVIRON MUTAGEN, V3, P499, DOI 10.1002/em.2860030502
   MCGREGOR D, 1984, ENVIRON MUTAGEN, V6, P545, DOI 10.1002/em.2860060408
   Musdal Y, 2013, CHEM-BIOL INTERACT, V205, P53, DOI 10.1016/j.cbi.2013.06.003
   Norrgard MA, 2011, J MOL BIOL, V412, P111, DOI 10.1016/j.jmb.2011.07.039
   Patskovsky Y, 2006, BIOCHEMISTRY-US, V45, P3852, DOI 10.1021/bi051823+
   Prade L, 1997, STRUCTURE, V5, P1287, DOI 10.1016/S0969-2126(97)00281-5
   Rowe JD, 1997, BIOCHEM J, V325, P481
   Sajan M, 2000, INT J TOXICOL, V19, P285
   Sato A, 2006, J ORG CHEM, V71, P4692, DOI 10.1021/jo060501o
   SCHECHTER RL, 1992, BIOCHEM CELL BIOL, V70, P349
   Sekine I, 2007, JPN J CLIN ONCOL, V37, P329, DOI 10.1093/jjco/hym035
   SHIOTSUKI T, 1990, PESTIC BIOCHEM PHYS, V37, P121, DOI 10.1016/0048-3575(90)90117-K
   SUMMER KH, 1980, MUTAT RES, V70, P269, DOI 10.1016/0027-5107(80)90018-4
   Talen HW, 1928, RECL TRAV CHIM PAY-B, V47, P329
   Townsend Danyelle, 2003, Am J Pharmacogenomics, V3, P157, DOI 10.2165/00129785-200303030-00002
   Ullmann F, 1908, BER DTSCH CHEM GES, V41, P3932, DOI 10.1002/cber.19080410392
   Wei L, 2008, INT J BIOCHEM CELL B, V40, P1616, DOI 10.1016/j.biocel.2007.12.019
   Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130
NR 55
TC 1
Z9 1
U1 1
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG
PY 2014
VL 555
BP 71
EP 76
DI 10.1016/j.abb.2014.06.002
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AL0NR
UT WOS:000338824100010
PM 24929189
ER

PT J
AU Tong, JJ
   Zweier, JR
   Huskey, RL
   Ismail, RS
   Hemann, C
   Zweier, JL
   Liu, XP
AF Tong, Jianjing
   Zweier, Joseph R.
   Huskey, Rachael L.
   Ismail, Raed S.
   Hemann, Craig
   Zweier, Jay L.
   Liu, Xiaoping
TI Effect of temperature, pH and heme ligands on the reduction of
   Cygb(Fe3+) by ascorbate
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cytoglobin; Ascorbate; Temperature; pH; Heme ligand
ID NITRIC-OXIDE; CYTOGLOBIN; NEUROGLOBIN; OXYGEN; ACID; HEMOGLOBINS;
   MYOGLOBIN; CONFORMATIONS; REGULATOR; MECHANISM
AB Cytoglobin (Cygb) plays a role in regulating vasodilation in response to changes in local oxygen concentration by altering the rate of nitric oxide (NO) metabolism. Because the reduction of Cygb(Fe3+) by a reductant is the control step for Cygb-mediated NO metabolism, we examined the effects of temperature, pH, and heme ligands on the Cygb(Fe3+) reduction by ascorbate (Asc) under anaerobic conditions. The standard enthalpy of Cygb(Fe3+) reduction by Asc was determined to be 42.4 +/- 3.1 kj/mol. The rate of Cygb(Fe3+) reduction increased similar to 6% per C when temperature varied from 35 degrees C to 40 degrees C. The yield and the rate of Cygb(Fe3+) reduction significantly increases with pH (2-3 times per pH unit), paralleling the formation of the Asc ion (A(2-)) and the increased stability of reduced state of heme iron at high pH values. Heme ligand cyanide (CN-) decreased the yield and the rate of Cygb(Fe3+) reduction, but ligands CO and NO allowed the process of Cygb(Fe3+)reduction to continue to completion. Critical information is provided for modeling and prediction of the process of Cygb-mediated NO metabolism in vessels in a range of temperature and pH values. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Tong, Jianjing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Emergency Dept, Shanghai 200025, Peoples R China.
   [Tong, Jianjing; Zweier, Joseph R.; Huskey, Rachael L.; Ismail, Raed S.; Hemann, Craig; Zweier, Jay L.; Liu, Xiaoping] Ohio State Univ, Coll Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.
   [Zweier, Jay L.; Liu, Xiaoping] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA.
RP Zweier, JL (reprint author), 473 West 12th Ave, Columbus, OH 43210 USA.
EM jay.zweier@osumc.edu; Xiaoping.liu@osumc.edu
FU US National Institutes of Health [HL063744, HL065608, HL38324, EB016096]
FX This work was supported by US National Institutes of Health grants
   HL063744, HL065608, HL38324 and EB016096.
CR Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.011379598
   Qiao H, 2009, J VASC RES, V46, P15, DOI 10.1159/000135661
   Liu XP, 2012, BIOCHEMISTRY-US, V51, P5072, DOI 10.1021/bi300291h
   van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151
   Evelson P, 2001, ARCH BIOCHEM BIOPHYS, V388, P261, DOI 10.1006/abbi.2001.2292
   Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200
   Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102
   Gardner AM, 2010, J BIOL CHEM, V285, P23850, DOI 10.1074/jbc.M110.132340
   Li HT, 2012, J BIOL CHEM, V287, P36623, DOI 10.1074/jbc.M112.342378
   Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200
   Burmester T, 2002, MOL BIOL EVOL, V19, P416
   May JM, 2009, AM J PHYSIOL-CELL PH, V297, pC169, DOI 10.1152/ajpcell.00674.2008
   GIARDINA B, 1995, CRIT REV BIOCHEM MOL, V30, P165, DOI 10.3109/10409239509085142
   Lechauve C, 2010, FEBS J, V277, P2696, DOI [10.1111/j.1742-464X.2010.07686.x, 10.1111/j.1742-4658.2010.07686.x]
   Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200
   Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381
   Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200
   Weber RE, 2004, RESP PHYSIOL NEUROBI, V144, P141, DOI 10.1016/j.resp.2004.04.018
   Taylor CT, 2010, ARTERIOSCL THROM VAS, V30, P643, DOI 10.1161/ATVBAHA.108.181628
   Hendgen-Cotta UB, 2008, P NATL ACAD SCI USA, V105, P10256, DOI 10.1073/pnas.0801336105
   Bobrowicz E, 2001, CLIN CHIM ACTA, V314, P237, DOI 10.1016/S0009-8981(01)00577-0
   Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200
   Fago A, 2004, IUBMB LIFE, V56, P689, DOI 10.1080/15216540500037299
   FREI B, 1990, ADV EXP MED BIOL, V264, P155
   Hardison R, 1998, J EXP BIOL, V201, P1099
   Jurgens KD, 2000, NEWS PHYSIOL SCI, V15, P269
   KHAW KT, 1995, BRIT MED J, V310, P1559
   Liu X, 2007, CIRCULATION, V116, P27
   Liu XP, 2010, NITRIC OXIDE-BIOL CH, V23, P311, DOI 10.1016/j.niox.2010.09.002
   Liu XP, 2013, FEBS J, V280, P3621, DOI 10.1111/febs.12352
   Pazicni S, 2004, BIOCHEMISTRY-US, V43, P14684, DOI 10.1021/bi0488496
   Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-repots/kvf248
   Rahaman MM, 2013, REDOX BIOL, V1, P405, DOI 10.1016/j.redox.2013.08.001
   Saha R, 2013, BIOCHEMISTRY-US, V52, P8878, DOI 10.1021/bi401343t
   Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039
   TSUKAHARA K, 1983, J BIOCHEM-TOKYO, V93, P15
   Wajcman H, 2009, CR BIOL, V332, P273, DOI 10.1016/j.crvi.2008.07.026
   WELCH RW, 1993, BIOCHEM J, V294, P505
NR 38
TC 0
Z9 0
U1 2
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL 15
PY 2014
VL 554
BP 1
EP 5
DI 10.1016/j.abb.2014.04.011
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AJ8ZK
UT WOS:000337996400001
PM 24780244
ER

PT J
AU Raczynski, P
   Gorny, K
   Dawid, A
   Gburski, Z
AF Raczynski, Przemyslaw
   Gorny, Krzysztof
   Dawid, Aleksander
   Gburski, Zygmunt
TI Delivery of nitric oxide to the interior of mammalian cell by carbon
   nanotube: MD simulation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Molecular dynamics; Phospholipid bilayer; Carbon nanotube; Nitric oxide;
   Nanoindentation
ID SYNTHASE GENE-THERAPY; FREE-ENERGY DIFFERENCES; MOLECULAR-DYNAMICS;
   PROSTATE-CANCER; DRUG-DELIVERY; INOS GENE; PROMOTER; WATER; MICE;
   RADIOSENSITIZATION
AB Computer simulations have been performed to study the nanoindentation of phospholipid bilayer by the single-walled armchair carbon nanotube, filled with the nitric oxide molecules. The process has been simulated by means of molecular dynamics (MD) technique at physiological temperature T = 310 K with a constant pulling velocity of the nanotube. The force acting on the nanotube during membrane penetration has been calculated. We show that the indentation by carbon nanotube does not permanently destroy the membrane structure (self-sealing of the membrane occurs). The mobility of nitric oxide molecules during the membrane nanoindentation is discussed. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Raczynski, Przemyslaw; Gorny, Krzysztof; Dawid, Aleksander; Gburski, Zygmunt] Silesian Univ, Inst Phys, PL-40007 Katowice, Poland.
RP Raczynski, P (reprint author), Silesian Univ, Inst Phys, Uniwersytecka 4, PL-40007 Katowice, Poland.
EM przemyslaw.raczynski@us.edu.pl
RI Gorny, Krzysztof/G-9406-2014
OI Gorny, Krzysztof/0000-0001-9472-0620
FU ICM University of Warsaw [G53-6]
FX Calculations were performed at ICM University of Warsaw, Grant No.
   G53-6.
CR Adams C, 2009, J GENE MED, V11, P160, DOI 10.1002/jgm.1280
   Akita S, 2000, JPN J APPL PHYS 1, V39, P7086, DOI 10.1143/JJAP.39.7086
   Alberts B, 2008, MOL BIOL CELL
   Xie KP, 1998, CANCER METAST REV, V17, P55, DOI 10.1023/A:1005956721457
   Coulter JA, 2008, NITRIC OXIDE-BIOL CH, V19, P192, DOI 10.1016/j.niox.2008.04.023
   De Ridder M, 2008, NITRIC OXIDE-BIOL CH, V19, P164, DOI 10.1016/j.niox.2008.04.015
   Henin J, 2006, CHEM PHYS LETT, V425, P329, DOI 10.1016/j.cplett.2006.04.115
   Alexiadis A, 2008, CHEM REV, V108, P5014, DOI 10.1021/cr078140f
   Bhirde AA, 2009, ACS NANO, V3, P307, DOI 10.1021/nn800551s
   Luo XL, 2011, BIOMATERIALS, V32, P6316, DOI 10.1016/j.biomaterials.2011.05.020
   Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690
   Saito N, 2009, CHEM SOC REV, V38, P1897, DOI 10.1039/b804822n
   Wilson NR, 2009, NAT NANOTECHNOL, V4, P483, DOI [10.1038/nnano.2009.154, 10.1038/NNANO.2009.154]
   Fitzpatrick B, 2008, NITRIC OXIDE-BIOL CH, V19, P217, DOI 10.1016/j.niox.2008.05.001
   Keren S, 2008, P NATL ACAD SCI USA, V105, P5844, DOI 10.1073/pnas.0710575105
   Ali-Boucetta H, 2013, ADV DRUG DELIVER REV, V65, P1897, DOI 10.1016/j.addr.2013.11.002
   Pogodin S, 2010, ACS NANO, V4, P5293, DOI 10.1021/nn1016549
   Kotchey GP, 2013, ADV DRUG DELIVER REV, V65, P1921, DOI 10.1016/j.addr.2013.07.007
   Wong BS, 2013, ADV DRUG DELIVER REV, V65, P1964, DOI 10.1016/j.addr.2013.08.005
   Zhang Y, 2010, DRUG DISCOV TODAY, V15, P428, DOI 10.1016/j.drudis.2010.04.005
   Bianco A, 2011, CHEM COMMUN, V47, P10182, DOI 10.1039/c1cc13011k
   McCarthy HO, 2011, INT J PHARMACEUT, V405, P196, DOI 10.1016/j.ijpharm.2010.11.051
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Battigelli A, 2013, ADV DRUG DELIVER REV, V65, P1899, DOI 10.1016/j.addr.2013.07.006
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Delogu LG, 2012, P NATL ACAD SCI USA, V109, P16612, DOI 10.1073/pnas.1208312109
   Lu FS, 2009, ADV MATER, V21, P139, DOI 10.1002/adma.200801491
   Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241
   De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231
   Welsher K, 2011, P NATL ACAD SCI USA, V108, P8943, DOI 10.1073/pnas.1014501108
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.006
   Tong L, 2012, NAT NANOTECHNOL, V7, P56, DOI [10.1038/nnano.2011.210, 10.1038/NNANO.2011.210]
   Singh S, 2011, CANCER CHEMOTH PHARM, V67, P1211, DOI 10.1007/s00280-011-1654-4
   Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201
   Coulter JA, 2010, J GENE MED, V12, P755, DOI 10.1002/jgm.1495
   Cox M.M., 2013, LEHNINGER PRINCIPLES
   Dawid A, 2011, NITRIC OXIDE-BIOL CH, V25, P373, DOI 10.1016/j.niox.2011.08.004
   Gburski Z, 2010, SOLID STATE COMMUN, V150, P415, DOI 10.1016/j.ssc.2009.12.005
   Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018
   MacKerell A.D.J., 2000, BIOPOLYMERS, V56
   McCarthy HO, 2007, J GENE MED, V9, P511, DOI 10.1002/jgm.1045
   Price S, 2011, VET REC, V168, P445, DOI 10.1136/vr.d2617
   Raczynski P, 2013, COMP MATER SCI, V70, P13, DOI 10.1016/j.commatsci.2012.12.031
   Sperelakis N., 2012, CELL PHYSL SOURCEBOO
   Wallace EJ, 2008, NANO LETT, V8, P2751, DOI 10.1021/nl801217f
   Worthington J, 2005, GENE THER, V12, P1417, DOI 10.1038/sj.gt.3302552
   Worthington J, 2004, J GENE MED, V6, P673, DOI 10.1002/jgm.567
   Worthington J, 2002, GENE THER, V9, P263, DOI 10.1038/sj/gt/3301609
NR 49
TC 0
Z9 0
U1 4
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL 15
PY 2014
VL 554
BP 6
EP 10
DI 10.1016/j.abb.2014.04.014
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AJ8ZK
UT WOS:000337996400002
PM 24796224
ER

PT J
AU Wijnker, PJM
   Sequeira, V
   Witjas-Paalberends, ER
   Foster, DB
   dos Remedios, CG
   Murphy, AM
   Stienen, GJM
   van der Velden, J
AF Wijnker, Paul J. M.
   Sequeira, Vasco
   Witjas-Paalberends, E. Rosalie
   Foster, D. Brian
   dos Remedios, Cristobal G.
   Murphy, Anne M.
   Stienen, Ger J. M.
   van der Velden, Jolanda
TI Phosphorylation of protein kinase C sites Ser42/44 decreases
   Ca2+-sensitivity and blunts enhanced length-dependent activation in
   response to protein kinase A in human cardiomyocytes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Myofilament function; Protein phosphorylation; Cardiomyocyte; Troponin
   I; Protein kinase C
ID CARDIAC TROPONIN-I; FAILING HUMAN HEART; HYPERTROPHIC CARDIOMYOPATHY;
   HUMAN MYOCARDIUM; CA2+ ACTIVATION; ACTOMYOSIN S-1; MUSCLE; FAILURE;
   MUTANTS; TENSION
AB Protein kinase C (PKC)-mediated phosphorylation of troponin I (cTnI) at Ser42/44 is increased in heart failure. While studies in rodents demonstrated that PKC-mediated Ser42/44 phosphorylation decreases maximal force and ATPase activity, PKC incubation of human cardiomyocytes did not affect maximal force. We investigated whether Ser42/44 pseudo-phosphorylation affects force development and ATPase activity using troponin exchange in human myocardium. Additionally, we studied if pseudo-phosphorylated Ser42/44 modulates length-dependent activation of force, which is regulated by protein kinase A (PKA)-mediated cTnI-Ser23/24 phosphorylation. Isometric force was measured in membrane-permeabilized cardiomyocytes exchanged with human recombinant wild-type troponin or troponin mutated at Ser42/44 or Ser23/24 into aspartic acid (D) or alanine (A) to mimic phosphorylation and dephosphorylation, respectively. In troponin-exchanged donor cardiomyocytes experiments were repeated after PKA incubation. ATPase activity was measured in troponin-exchanged cardiac muscle strips. Compared to wild-type, 42D/44D decreased Ca2+-sensitivity without affecting maximal force in failing and donor cardiomyocytes. In donor myocardium, 42D/44D did not affect maximal ATPase activity or tension cost. Interestingly, 42D/44D blunted the length-dependent increase in Ca2+-sensitivity induced upon PKA mediated phosphorylation. Since the drop in Ca2+-sensitivity at physiological ca(2+)-concentrations is relatively large phosphorylation of Ser42/44 may result in a decrease of force and associated ATP utilization in the human heart. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wijnker, Paul J. M.; Sequeira, Vasco; Witjas-Paalberends, E. Rosalie; Stienen, Ger J. M.; van der Velden, Jolanda] Vrije Univ Amsterdam Med Ctr, Physiol Lab, Inst Cardiovasc Res, NL-1081 BT Amsterdam, Netherlands.
   [Wijnker, Paul J. M.] Univ Med Ctr Hamburg Eppendorf, Cardiovasc Res Ctr, Dept Expt Pharmacol & Toxicol, Hamburg, Germany.
   [Foster, D. Brian; Murphy, Anne M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Cardiol, Baltimore, MD 21205 USA.
   [dos Remedios, Cristobal G.] Univ Sydney, Bosch Inst, Muscle Res Unit, Sydney, NSW 2006, Australia.
   [Stienen, Ger J. M.] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands.
   [van der Velden, Jolanda] ICIN Netherlands Heart Inst, Utrecht, Netherlands.
RP Wijnker, PJM (reprint author), Vrije Univ Amsterdam Med Ctr, Physiol Lab, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.
EM p.wijnker@vumc.nl; v.sequeiraoliveira@vumc.nl; e.paalberends@vumc.nl;
   dbrianfoster@jhmi.edu; cris.dosremedios@sydney.edu.au; murphy@jhmi.edu;
   g.stienen@vumc.nl; j.vandervelden@vumc.nl
FU National Institute of Health (NIH) [R01 HL063038, NIH R01 HL76038];
   Netherlands Organization for Scientific Research (NWO); European Society
   of Cardiology Research Grant
FX This work was supported by National Institute of Health (NIH) R01
   HL063038 and NIH R01 HL76038, the Netherlands Organization for
   Scientific Research (NWO; VIDI grant) and a European Society of
   Cardiology Research Grant.
CR SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0
   de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017
   Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388
   Kooij V, 2010, BASIC RES CARDIOL, V105, P289, DOI 10.1007/s00395-009-0053-z
   NOLAND TA, 1995, J BIOL CHEM, V270, P25445
   Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071
   Zhang J, 2011, J PROTEOME RES, V10, P4054, DOI [10.1021/pr200258m, 10.1021/pr2002S8m]
   Takimoto E, 2004, CIRC RES, V94, P496, DOI 10.1161/01.RES.0000117307.57798.F5
   Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436
   Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025
   ALLEN DG, 1985, J MOL CELL CARDIOL, V17, P821, DOI 10.1016/S0022-2828(85)80097-3
   Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114
   SCHWINGER RHG, 1994, CIRC RES, V74, P959
   TERKEURS HEDJ, 1980, CIRC RES, V46, P703
   Bowling N, 1999, CIRCULATION, V99, P384
   Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780
   Fuchs F, 2005, J MUSCLE RES CELL M, V26, P199, DOI 10.1007/s10974-005-9011-z
   van der Velden J, 2011, PFLUG ARCH EUR J PHY, V462, P155, DOI 10.1007/s00424-011-0960-3
   van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5
   Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017
   Lang SE, 2013, ARCH BIOCHEM BIOPHYS, V535, P49, DOI 10.1016/j.abb.2012.12.021
   Sumandea MP, 2004, ANN NY ACAD SCI, V1015, P39, DOI 10.1196/annals.1302.004
   Dong XT, 2012, J BIOL CHEM, V287, P848, DOI 10.1074/jbc.M111.293258
   Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200
   Christopher B, 2009, J MUSCLE RES CELL M, V30, P111, DOI 10.1007/s10974-009-9180-2
   FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457
   Finley NL, 2004, J BIOL CHEM, V279, P54833, DOI 10.1074/jbc.M408304200
   Hamdani N, 2010, J MUSCLE RES CELL M, V31, P289, DOI 10.1007/s10974-010-9231-8
   Kobayashi T, 2004, BIOCHEMISTRY-US, V43, P5996, DOI 10.1021/bi036073n
   Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117
   Kooij V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074847
   MacGowan GA, 2001, AM J PHYSIOL-HEART C, V280, pH835
   MERCADIER JJ, 1983, CIRC RES, V53, P52
   Montgomery DE, 2002, AM J PHYSIOL-HEART C, V282, pH2397, DOI 10.1152/ajpheart.00714.2001
   Montgomery DE, 2001, AM J PHYSIOL-HEART C, V280, pH1011
   Narolska NA, 2005, CARDIOVASC RES, V65, P221, DOI 10.1016/j.cardiores.2004.09.029
   Narolska N.A., CIRC RES, V99
   Noguchi T, 2004, CIRCULATION, V110, P982, DOI 10.1161/01.CIR.0000139334.43109.F9
   NOLAND TA, 1989, J BIOL CHEM, V264, P20778
   Noland TA, 1996, BIOCHEMISTRY-US, V35, P14923
   Nowak G, 2007, J MUSCLE RES CELL M, V28, P415, DOI 10.1007/s10974-008-9136-y
   Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F
   POTMA EJ, 1994, J PHYSIOL-LONDON, V474, P303
   Pyle WG, 2002, AM J PHYSIOL-HEART C, V283, pH1215, DOI 10.1152/ajpheart.00128.2002
   van der Velden J, 2006, CARDIOVASC RES, V69, P876, DOI 10.1016/j.cardiores.2005.11.021
   Walker LA, 2010, J MOL CELL CARDIOL, V48, P1180, DOI 10.1016/j.yjmcc.2009.09.010
   Wijnker PJM, 2014, AM J PHYSIOL-HEART C, V306, pH1171, DOI 10.1152/ajpheart.00580.2013
   Wijnker PJM, 2013, AM J PHYSIOL-HEART C, V304, pH260, DOI 10.1152/ajpheart.00498.2012
   Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891
NR 49
TC 4
Z9 4
U1 1
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL 15
PY 2014
VL 554
BP 11
EP 21
DI 10.1016/j.abb.2014.04.017
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AJ8ZK
UT WOS:000337996400003
PM 24814372
ER

PT J
AU Zhang, LK
   Chen, YF
   Yue, ZB
   He, YH
   Zou, J
   Chen, SR
   Liu, M
   Chen, X
   Liu, ZP
   Liu, XP
   Feng, XJ
   Li, M
   Liu, PQ
AF Zhang, Luankun
   Chen, Yanfang
   Yue, Zhongbao
   He, Yanhong
   Zou, Jian
   Chen, Shaorui
   Liu, Min
   Chen, Xi
   Liu, Zhiping
   Liu, Xueping
   Feng, Xiaojun
   Li, Min
   Liu, Peiqing
TI The p65 subunit of NF-kappa B involves in RIP140-mediated inflammatory
   and metabolic dysregulation in cardiomyocytes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE RIP140; NF-kappa B; Inflammation; Cardiac energy metabolism;
   Mitochondria
ID TRANSCRIPTIONAL COREPRESSOR RIP140; CYTOCHROME-C-OXIDASE; FATTY-ACID
   OXIDATION; CARDIAC LIPID-METABOLISM; HEART-FAILURE; SKELETAL-MUSCLE;
   NEONATAL-RAT; PPAR-ALPHA; EXPRESSION; RESPIRATION
AB The transcription factor NF-kappa B regulates expression of many genes that are involved in inflammation, fatty acid and glucose metabolism, and plays a crucial role in cardiac pathological processes. RIP140 is a corepressor that down-regulates expression of genes involved in the cellular substrate uptake and mitochondrial beta-oxidation. In addition to this, RIP140 also acts as a coactivator for p65-NF-kappa B, potentiating the secretion of proinflammatory cytokines in macrophages, but the effects in cardiomyocytes are still unknown. In this study, overexpression of RIP140 induced proinflammatory gene expression and cytokine release in neonatal rat cardiomyocytes, which could be reversed by p65-NF-kappa B inhibition. Furthermore, RIP140-mediated repression of metabolic-related genes, mitochondrial biogenesis and metabolic function were weakened after knocking down of p65-NF-kappa B. These findings suggest that p65-NF-kappa B plays an important role in RIP140-mediated proinflammatory response and energy metabolism in cardiomyocytes, and provide evidence for the crosstalk between proinflammatory processes and metabolic dysregulation in the heart. (C) 2014 Published by Elsevier Inc.
C1 [Zhang, Luankun; Yue, Zhongbao; He, Yanhong; Chen, Shaorui; Liu, Min; Liu, Zhiping; Liu, Xueping; Feng, Xiaojun; Li, Min; Liu, Peiqing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Guangzhou 510006, Guangdong, Peoples R China.
   [Chen, Yanfang] Guangzhou Med Univ, Affiliated Hosp 2, Dept Pharm, Guangzhou 510260, Guangdong, Peoples R China.
   [Zou, Jian] Chengdu Fifth Peoples Hosp, Dept Pharm, Chengdu 611130, Peoples R China.
   [Chen, Xi] Changsha Cent Hosp, Dept Pharm, Changsha 410004, Hunan, Peoples R China.
RP Liu, PQ (reprint author), Sun Yat Sen Univ, Higher Educ Mega Ctr, Dept Pharmacol & Toxicol, Sch Pharmaceut Sci, 132 East,Wai Huan Rd, Guangzhou 510006, Guangdong, Peoples R China.
EM liupq@mail.sysu.edu.cn
FU National Science Foundation of China [81072641, 81273499]; National
   Science and Technology Major Project of China "Key New Drug Creation and
   Manufacturing Program" [2011ZX09401-307]; Team item of Natural Science
   Foundation of Guangdong Province [S2011030003190]; Medical Scientific
   Research Foundation of Guangdong Province [A2012166]; Natural Science
   Foundation of Guangdong Province [S2012040006327]; Major Project of
   Guangdong Province [2008A030201013, 2012A080 201007]; Major Project of
   Department of Education of Guangdong Province [CXZD1006]; Startup
   Project Fund for the Doctoral Scientific Research of Guangzhou Medical
   University [2012C41]
FX This work was supported by grants from the National Science Foundation
   of China (No. 81072641; No. 81273499); the National Science and
   Technology Major Project of China "Key New Drug Creation and
   Manufacturing Program" (No. 2011ZX09401-307); Team item of Natural
   Science Foundation of Guangdong Province (No. S2011030003190); Medical
   Scientific Research Foundation of Guangdong Province (No. A2012166);
   Natural Science Foundation of Guangdong Province (No. S2012040006327);
   Major Project of Guangdong Province (No. 2008A030201013, No. 2012A080
   201007); Major Project of Department of Education of Guangdong Province
   (No. CXZD1006); and Startup Project Fund for the Doctoral Scientific
   Research of Guangzhou Medical University (No. 2012C41).
CR Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721
   Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001
   Kalsi KK, 1999, EUR J CLIN INVEST, V29, P469, DOI 10.1046/j.1365-2362.1999.00468.x
   Li YY, 2001, CIRCULATION, V104, P2492, DOI 10.1161/hc4501.098944
   Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240
   Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080
   Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E
   Fu JJ, 2005, CYTOTECHNOLOGY, V49, P109, DOI 10.1007/s10616-006-6334-6
   Chen YF, 2012, MOL CELL ENDOCRINOL, V362, P11, DOI 10.1016/j.mce.2012.03.023
   Ide T, 2001, CIRC RES, V88, P529
   Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200
   Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014
   BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0
   Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610
   Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004
   Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116
   Fritah A, 2010, AM J PHYSIOL-ENDOC M, V299, pE335, DOI 10.1152/ajpendo.00243.2010
   Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040
   Fritah A, 2010, CARDIOVASC RES, V86, P443, DOI 10.1093/cvr/cvp418
   Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023
   Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253
   Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327
   Djouadi F, 1999, PROSTAG LEUKOTR ESS, V60, P339, DOI 10.1016/S0952-3278(99)80009-X
   Takano H, 2000, CIRC RES, V87, P596
   Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C
   Cheng LH, 2004, BIOCHEM BIOPH RES CO, V313, P277, DOI 10.1016/j.bbrc.2003.11.127
   Cook GA, 2001, J MOL CELL CARDIOL, V33, P317, DOI 10.1006/jmcc.2000.1304
   Ding GL, 2006, J MOL CELL CARDIOL, V40, P821, DOI 10.1016/j.yjmcc.2006.03.422
   Martin MA, 2000, BBA-MOL BASIS DIS, V1502, P330, DOI 10.1016/S0925-4439(00)00061-2
   Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052
   Pacelli C, 2011, MITOCHONDRION, V11, P334, DOI 10.1016/j.mito.2010.12.004
   Palomer X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019724
   Rosell M, 2011, BBA-MOL BASIS DIS, V1812, P919, DOI 10.1016/j.bbadis.2010.12.016
   Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166
   Watanabe K, 2000, J BIOL CHEM, V275, P22293, DOI 10.1074/jbc.M000248200
   Zschiedrich I, 2008, BLOOD, V112, P264, DOI 10.1182/blood-2007-11-121699
NR 36
TC 3
Z9 5
U1 3
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL 15
PY 2014
VL 554
BP 22
EP 27
DI 10.1016/j.abb.2014.05.005
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AJ8ZK
UT WOS:000337996400004
PM 24823858
ER

PT J
AU Michalec, K
   Mysiorek, C
   Kuntz, M
   Berezowski, V
   Szczepankiewicz, AA
   Wilczynski, GM
   Cecchelli, R
   Nalecz, KA
AF Michalec, Katarzyna
   Mysiorek, Caroline
   Kuntz, Melanie
   Berezowski, Vincent
   Szczepankiewicz, Andrzej A.
   Wilczynski, Grzegorz M.
   Cecchelli, Romeo
   Nalecz, Katarzyna A.
TI Protein kinase C restricts transport of carnitine by amino acid
   transporter ATB(0,+) apically localized in the blood-brain barrier
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Amino acid transporter (ATB(0,+)); Organic cation transporter (OCTN2);
   L-Carnitine; Blood-brain barrier; Protein kinase C
ID ORGANIC CATION/CARNITINE TRANSPORTER; ENDOTHELIAL-CELLS; RAT-BRAIN;
   FUNCTIONAL EXPRESSION; TIGHT JUNCTIONS; DRUG TARGET; MOUSE-BRAIN; HUMAN
   NA+; OCTN2; MODEL
AB Carnitine (3-hydroxy-4-trimethylammoniobutyrate) is necessary for transfer of fatty acids through the inner mitochondrial membrane. Carnitine, not synthesized in the brain, is delivered there through the strongly polarized blood-brain barrier (BBB). Expression and presence of two carnitine transporters - organic cation/carnitine transporter (OCTN2) and amino acid transporter B-0,B-+ (ATB(0,+)) have been demonstrated previously in an in vitro model of the BBB. Due to potential protein kinase C (PKC) phosphorylation sites within ATB(0,+) sequence, the present study verified effects of this kinase on transporter function and localization in the BBB. ATB(0,+) can be regulated by estrogen receptor a and up-regulated in vitro, therefore its presence in vivo was verified with the transmission electron microscopy. The analyses of brain slices demonstrated ATB(0,+) luminal localization in brain capillaries, confirmed by biotinylation experiments in an in vitro model of the BBB. Brain capillary endothelial cells were shown to control carnitine gradient. ATB(0,+) was phosphorylated by PKC, what correlated with inhibition of carnitine transport. PKC activation did not change the amount of ATB(0,+) present in the apical membrane of brain endothelial cells, but resulted in transporter exclusion from raft microdomains. ATB" inactivation by a lateral movement in plasma membrane after transporter phosphorylation has been postulated. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Michalec, Katarzyna; Nalecz, Katarzyna A.] M Nencki Inst Expt Biol, Lab Mech Transport Biomembranes, PL-02093 Warsaw, Poland.
   [Mysiorek, Caroline; Kuntz, Melanie; Berezowski, Vincent; Cecchelli, Romeo] Univ Lille Nord France, Lille, France.
   [Mysiorek, Caroline; Kuntz, Melanie; Berezowski, Vincent; Cecchelli, Romeo] LBHE, UArtois, Lens, France.
   [Mysiorek, Caroline; Kuntz, Melanie; Berezowski, Vincent; Cecchelli, Romeo] IMPRT IFR114, Lille, France.
   [Szczepankiewicz, Andrzej A.; Wilczynski, Grzegorz M.] M Nencki Inst Expt Biol, Lab Mol & System Neuromorphol, PL-02093 Warsaw, Poland.
RP Nalecz, KA (reprint author), M Nencki Inst Expt Biol, 3 Pasteur St, PL-02093 Warsaw, Poland.
EM k.nalecz@nencki.gov.pl
FU International PhD Studies in Neurobiology; International PhD Project
   Programme of the Foundation for Polish Science; European Union,
   Innovative Economy Operational Programme
FX The study was co-funded by the "International PhD Studies in
   Neurobiology" for Katarzyna Michalec, a project realized within the
   International PhD Project Programme of the Foundation for Polish
   Science, co-financed from the European Union, Innovative Economy
   Operational Programme.
CR Kido Y, 2001, J NEUROCHEM, V79, P959, DOI 10.1046/j.1471-4159.2001.00621.x
   Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007
   Kato Y, 2005, MOL PHARMACOL, V67, P734, DOI 10.1124/mol.104.002212
   Karunakaran S, 2011, J BIOL CHEM, V286, P31830, DOI 10.1074/jbc.M111.229518
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   PARDRIDGE WM, 1983, PHYSIOL REV, V63, P1481
   Leino RL, 2001, NEUROCHEM INT, V38, P519, DOI 10.1016/S0197-0186(00)00102-9
   Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200
   Duelli R, 2000, J CEREBR BLOOD F MET, V20, P1557
   Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5
   Hori S, 2004, J NEUROCHEM, V90, P526, DOI 10.1111/j.1471-4159.2004.02537.x
   Karunakaran S, 2008, BIOCHEM J, V414, P343, DOI 10.1042/BJ20080622
   Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006
   Lanz TV, 2013, P NATL ACAD SCI USA, V110, P14735, DOI 10.1073/pnas.1302569110
   Sloan JL, 1999, J BIOL CHEM, V274, P23740, DOI 10.1074/jbc.274.34.23740
   Nakanishi T, 2001, J PHYSIOL-LONDON, V532, P297, DOI 10.1111/j.1469-7793.2001.0297f.x
   Wakayama K, 2002, NEUROSCI RES, V44, P173, DOI 10.1016/S0168-0102(02)00120-7
   Januszewicz E, 2009, INT J BIOCHEM CELL B, V41, P2599, DOI 10.1016/j.biocel.2009.08.020
   Beaulieu E, 1997, BIOCHEM J, V326, P539
   Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x
   FARRELL CL, 1991, P NATL ACAD SCI USA, V88, P5779, DOI 10.1073/pnas.88.13.5779
   Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x
   Sakai K, 2003, J NEUROSCI, V23, P550
   Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378
   Samluk L, 2012, BIOCHEM BIOPH RES CO, V422, P64, DOI 10.1016/j.bbrc.2012.04.106
   Miecz D, 2008, J NEUROCHEM, V104, P113, DOI 10.1111/j.1471-4159.2007.05024.x
   Berezowski V, 2004, J NEUROCHEM, V91, P860, DOI 10.1111/j.1471-4159.2004.02752.x
   Boeckers TM, 1999, J NEUROSCI, V19, P6506
   Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x
   Buratta S, 2007, J NEUROCHEM, V103, P942, DOI 10.1111/j.1471-4159.2007.04783.x
   Cuddy LK, 2014, J NEUROCHEM, V128, P725, DOI 10.1111/jnc.12490
   Culot M, 2008, TOXICOL IN VITRO, V22, P799, DOI 10.1016/j.tiv.2007.12.016
   Czeredys M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082105
   Czeredys M, 2008, BIOCHEM BIOPH RES CO, V376, P267, DOI 10.1016/j.bbrc.2008.08.122
   Ebert D, 2003, J NEUROSCI, V23, P5928
   Elfeber K, 2004, HISTOCHEM CELL BIOL, V121, P201, DOI 10.1007/s00418-004-0633-9
   Filippo CADS, 2011, BBA-MOL BASIS DIS, V1812, P312, DOI 10.1016/j.bbadis.2010.11.007
   Ganapathy M. E., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P357, DOI 10.2174/156800805774912953
   Geier EG, 2013, CLIN PHARMACOL THER, V94, P636, DOI 10.1038/clpt.2013.175
   Hatanaka T, 2004, J PHARMACOL EXP THER, V308, P1138, DOI 10.1124/jpet.103.057109
   Hatanaka T, 2002, BIOCHEM BIOPH RES CO, V291, P291, DOI 10.1006/bbrc.2002.6441
   Helms HC, 2012, GLIA, V60, P882, DOI 10.1002/glia.22321
   Jones KT, 2012, J NEUROCHEM, V123, P700, DOI 10.1111/jnc.12007
   Kaido M, 1997, EUR NEUROL, V38, P302, DOI 10.1159/000113399
   KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K
   Kwok B, 2006, AM J PHYSIOL-REG I, V290, pR793, DOI 10.1152/ajpregu.00087.2005
   Lamhonwah AM, 2005, BIOCHEM BIOPH RES CO, V338, P1966, DOI 10.1016/j.bbrc.2005.10.170
   Lyck R, 2009, J CEREBR BLOOD F MET, V29, P1491, DOI 10.1038/jcbfm.2009.72
   MERESSE S, 1989, J NEUROCHEM, V53, P1363, DOI 10.1111/j.1471-4159.1989.tb08526.x
   Mroczkowska JE, 2000, BIOCHEM BIOPH RES CO, V267, P433, DOI 10.1006/bbrc.1999.1923
   NALECZ KA, 1995, ARCH BIOCHEM BIOPHYS, V322, P214, DOI 10.1006/abbi.1995.1454
   O'Kane RL, 2006, AM J PHYSIOL-ENDOC M, V291, pE412, DOI 10.1152/ajpendo.00007.2006
   O'Kane RL, 2003, AM J PHYSIOL-ENDOC M, V285, pE1167, DOI 10.1152/ajpendo.00193.2003
   Ramsay RR, 2000, BIOCHEM SOC T, V28, P182
   Rodriguez CM, 2002, BIOL REPROD, V67, P314, DOI 10.1095/biolreprod67.1.314
   Rytting E, 2008, BIOCHEM PHARMACOL, V75, P745, DOI 10.1016/j.bcp.2007.09.015
   Samluk L, 2010, J NEUROCHEM, V115, P1386, DOI 10.1111/j.1471-4159.2010.07040.x
   Shinawi M, 1998, NEUROLOGY, V50, P1869
   Srivastava K, 2013, J CEREBR BLOOD F MET, V33, P1928, DOI 10.1038/jcbfm.2013.151
   Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006
   Wagner CA, 2000, AM J PHYSIOL-RENAL, V279, pF584
   Watanabe C, 2006, DRUG METAB DISPOS, V34, P1927, DOI 10.1124/dmd.106.010207
NR 62
TC 0
Z9 0
U1 2
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL 15
PY 2014
VL 554
BP 28
EP 35
DI 10.1016/j.abb.2014.05.006
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AJ8ZK
UT WOS:000337996400005
PM 24823859
ER

PT J
AU Ashe, D
   Alleyne, T
   Wilson, M
   Svistunenko, D
   Nicholls, P
AF Ashe, Damian
   Alleyne, Trevor
   Wilson, Michael
   Svistunenko, Dimitri
   Nicholls, Peter
TI Redox equilibration after one-electron reduction of cytochrome c
   oxidase: Radical formation and a possible hydrogen relay mechanism
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Tryptophan; Tyrosine; Cytochrome c oxidase; Electron transfer; Amino
   acid radical; DMPO; Cyanide; Spin trap
ID EPR SPECTROSCOPY; PARAMAGNETIC-RES; PARACOCCUS-DENITRIFICANS;
   ARYLAZIDOCYTOCHROME-C; PROTON TRANSLOCATION; TYROSYL RADICALS;
   OXIDATION-STATES; ENZYME CATALYSIS; DERIVATIVES; SITE
AB Kinetic studies using UV/visible and EPR spectroscopy were carried out to follow the distribution of electrons within beef heart cytochrome c oxidase (CcO), both active and cyanide-inhibited, following addition of reduced cytochrome c as electron donor. In the initial one-electron reduced state the electron is shared between three redox centers, heme a, CuA and a third site, probably CuB. Using a rapid freeze system and the spin trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO) a protein radical was also detected. The EPR spectrum of the DMPO adduct of this radical was consistent with tyrosyl radical capture. This may be a feature of a charge relay mechanism involved in some part of the CcO electron transfer system from bound cytochrome c via CuA and heme a to the alpha 3CuB binuclear center. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Ashe, Damian; Alleyne, Trevor] Univ W Indies, Fac Med Sci, Biochem Unit, Dept Preclin Sci, St Augustine, Trinid & Tobago.
   [Wilson, Michael; Svistunenko, Dimitri; Nicholls, Peter] Univ Essex, Sch Biol Sci, Mol Biophys Res Grp, Colchester CO4 3SQ, Essex, England.
RP Nicholls, P (reprint author), Univ W Indies, Fac Med Sci, Biochem Unit, Dept Preclin Sci, St Augustine, Trinid & Tobago.
EM pnicholl@essex.ac.uk
CR Alleyne T, 2009, W INDIAN MED J, V58, P499
   Alleyne T, 2013, W INDIAN MED J, V62, P3
   ALLEYNE TA, 1992, BIOCHEM J, V287, P951
   Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875
   Gray HB, 2010, BBA-BIOENERGETICS, V1797, P1563, DOI 10.1016/j.bbabio.2010.05.001
   Yu MA, 2012, J AM CHEM SOC, V134, P4753, DOI 10.1021/ja210535w
   BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0
   Yu MA, 2011, BBA-BIOENERGETICS, V1807, P1295, DOI 10.1016/j.bbabio.2011.06.012
   GILCHRIST ML, 1995, P NATL ACAD SCI USA, V92, P9545, DOI 10.1073/pnas.92.21.9545
   Schwans JP, 2013, BIOCHEMISTRY-US, V52, P7840, DOI 10.1021/bi401083b
   FERGUSONMILLER S, 1978, J BIOL CHEM, V253, P149
   DOOLEY DM, 1991, NATURE, V349, P262, DOI 10.1038/349262a0
   Gunther MR, 1998, BIOCHEM J, V330, P1293
   Chen YR, 2000, BIOCHEMISTRY-US, V39, P4415, DOI 10.1021/bi992652+
   TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.biochem.63.1.675
   WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0
   HUYETT JE, 1995, J AM CHEM SOC, V117, P9033, DOI 10.1021/ja00140a021
   MacMillan F, 1999, BIOCHEMISTRY-US, V38, P9179, DOI 10.1021/bi9911987
   SARASTE M, 1990, Q REV BIOPHYS, V23, P331
   UNKRIG V, 1989, EUR J BIOCHEM, V184, P723, DOI 10.1111/j.1432-1033.1989.tb15072.x
   Babcock GT, 1997, ACTA CHEM SCAND, V51, P533, DOI 10.3891/acta.chem.scand.51-0533
   BEINERT H, 1976, BIOCHIM BIOPHYS ACTA, V423, P339, DOI 10.1016/0005-2728(76)90190-0
   BISSON R, 1977, FEBS LETT, V81, P147, DOI 10.1016/0014-5793(77)80948-4
   BISSON R, 1978, J BIOL CHEM, V253, P1874
   BISSON R, 1980, BIOCHEMISTRY-US, V19, P4173, DOI 10.1021/bi00559a006
   Brzezinski P, 1996, BIOCHEMISTRY-US, V35, P5611, DOI 10.1021/bi960260m
   Capaldi R.A., 1990, BIOCH BIOPHYS ARCH, V280, P252
   Chen YR, 1999, J BIOL CHEM, V274, P24611, DOI 10.1074/jbc.274.35.24611
   Chen YR, 1999, J BIOL CHEM, V274, P3308, DOI 10.1074/jbc.274.6.3308
   Chen YR, 2002, BIOCHEM J, V365, P461, DOI 10.1042/BJ20020170
   Gerfen GJ, 1996, J PHYS CHEM-US, V100, P16739, DOI 10.1021/jp960709l
   HARTZELL CR, 1976, BIOCHIM BIOPHYS ACTA, V423, P323, DOI 10.1016/0005-2728(76)90189-4
   HARTZELL CR, 1974, BIOCHIM BIOPHYS ACTA, V368, P318, DOI 10.1016/0005-2728(74)90178-9
   HILL BC, 1983, BIOCHEM J, V215, P57
   HILL BC, 1991, J BIOL CHEM, V266, P2219
   HILL BC, 1994, J BIOL CHEM, V269, P2419
   HILL BC, 1980, BIOCHEM J, V187, P809
   JENSEN P, 1984, BIOCHEM J, V224, P829
   KARTHEIN R, 1988, EUR J BIOCHEM, V171, P313, DOI 10.1111/j.1432-1033.1988.tb13792.x
   Mason MG, 2009, BIOCHEM J, V422, P237, DOI 10.1042/BJ20082220
   PAN LP, 1993, BIOCHEMISTRY-US, V32, P8492, DOI 10.1021/bi00084a014
   SMITH HT, 1977, BIOCHEMISTRY-US, V16, P4971, DOI 10.1021/bi00642a005
   Song AX, 2003, PROTEIN ENG, V16, P435, DOI 10.1093/protein/gzg059
   Svistunenko DA, 2004, BBA-BIOENERGETICS, V1655, P372, DOI 10.1016/j.bbabio.2003.06.006
   VANGELDE.BF, 1969, BIOCHIM BIOPHYS ACTA, V189, P1, DOI 10.1016/0005-2728(69)90219-9
   Wiertz FGM, 2007, J BIOL CHEM, V282, P31580, DOI 10.1074/jbc.M705520200
   WILSON MT, 1975, BIOCHEM J, V147, P145
   WILSON MT, 1982, BIOCHEM J, V203, P483
   Witt H, 1998, J BIOL CHEM, V273, P5132, DOI 10.1074/jbc.273.9.5132
   YONETANI T, 1960, J BIOL CHEM, V235, P845
   Yu M, 1992, FEBS LETT, V297, P63
NR 51
TC 0
Z9 0
U1 3
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL 15
PY 2014
VL 554
BP 36
EP 43
DI 10.1016/j.abb.2014.04.015
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AJ8ZK
UT WOS:000337996400006
PM 24811894
ER

PT J
AU Zhang, T
   Yamamoto, N
   Yamashita, Y
   Ashida, H
AF Zhang, Tianshun
   Yamamoto, Norio
   Yamashita, Yoko
   Ashida, Hitoshi
TI The chalcones cardamonin and flavokawain B inhibit the differentiation
   of preadipocytes to adipocytes by activating ERK
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cardamonin; Flavokawain B; CCAAT/enhancer-binding proteins; Peroxisome
   proliferator-activated receptor-gamma; Extracellular signal-regulated
   kinase
ID ALPINIA-PRICEI HAYATA; PPAR-GAMMA; GLUCOSE-INTOLERANCE; ADIPOSE
   CONVERSION; VASCULAR-DISEASES; DOWN-REGULATION; TEA CATECHIN; 3T3-L1
   CELLS; C/EBP-ALPHA; MAP KINASE
AB Aim: We searched for polyphenols capable of inhibiting the lipid accumulation in 3T3-L1 cells, and investigated the mechanisms of two effective chalcones cardamonin and flavokawain B on differentiation of preadipocytes.
   Method and results: We treated 3T3-L1 cells with a panel of 46 polyphenols and measured intracellular lipid accumulation by Sudan II staining. Four of them, including cardamonin and flavokawain B, inhibited lipid accumulation. In the further study, cardamonin and flavokawain B inhibited lipid accumulation by downregulating the expression of CCAAT/enhancer binding protein (C/EBP)-beta. C/EBP alpha, and peroxisome proliferator-activated receptor-gamma (PPAR gamma) at both mRNA and protein levels. Cardamonin and flavokawain B also increased phosphorylation of extracellular signal-regulated kinase (ERK) in the early phase of adipocyte differentiation. PD98059, an ERK inhibitor, restored C/EBP beta, PPAR gamma expression and intracellular lipid accumulation in adipocytes. Moreover, cardamonin and flavokawain B also modulated the secretion of C-reactive protein, dipeptidyl peptidase IV, interleukin-6, tumor necrosis factor-alpha and fibroblast growth factor-21 in mature adipocytes.
   Conclusions: These results indicate that ERk activation and consequent downregulation of adipocyte-specific transcription factors are involved in the inhibitory effects of the chalcones cardamonin and flavokawain B on adipocyte differentiation. Moreover, cardamonin and flavokawain B are able to modulate secretion of adipokines in mature adipocytes. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Zhang, Tianshun; Yamashita, Yoko; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan.
   [Yamamoto, Norio] House Wellness Foods Corp, Food Sci Res Ctr, Itami, Hyogo 6640011, Japan.
RP Ashida, H (reprint author), Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan.
EM ashida@kobe-u.ac.jp
FU Coordination Funds for Promoting Science and Technology; Creation of
   Innovation Centers for Advanced Interdisciplinary Research Areas
   (Innovative Bioproduction Kobe); MEXT, Japan
FX This study was supported by Coordination Funds for Promoting Science and
   Technology, Creation of Innovation Centers for Advanced
   Interdisciplinary Research Areas (Innovative Bioproduction Kobe, URL:
   http://www.org.kobe-u.acjp/bioproduction/en/ index.html), MEXT, Japan.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alexei K., 2005, J CLIN INVEST, V115, P1627
   Chen HJ, 2013, INT IMMUNOPHARMACOL, V17, P26, DOI 10.1016/j.intimp.2013.04.030
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538
   Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387
   Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160
   Tang B, 2012, ONCOL REP, V27, P1090, DOI 10.3892/or.2011.1580
   Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966
   GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2
   Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007
   Dimmock JR, 1999, CURR MED CHEM, V6, P1125
   He WY, 2005, BIOORGAN MED CHEM, V13, P1837, DOI 10.1016/j.bmc.2004.11.038
   Kim EH, 2006, BIOCHEM PHARMACOL, V72, P1516, DOI 10.1016/j.bcp.2006.07.030
   Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095
   Yamashita Y, 2012, ARCH BIOCHEM BIOPHYS, V527, P95, DOI 10.1016/j.abb.2012.03.018
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Sakaue H, 2004, J BIOL CHEM, V279, P39951, DOI 10.1074/jbc.M407353200
   Wang T, 2009, FEBS LETT, V583, P3655, DOI 10.1016/j.febslet.2009.10.046
   Bandgar BP, 2009, BIOORGAN MED CHEM, V17, P8168, DOI 10.1016/j.bmc.2009.10.035
   Wang T, 2008, ENDOCRINOLOGY, V149, P358, DOI 10.1210/en.2007-0467
   Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100
   Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x
   Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06
   Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013
   KUROYANAGI M, 1983, CHEM PHARM BULL, V31, P1544
   Zhou P, 2010, FASEB J, V24, P4722, DOI 10.1096/fj.10-163311
   Kanamoto Y, 2011, J AGR FOOD CHEM, V59, P8985, DOI 10.1021/jf201471p
   Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353
   Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001
   Zhang TS, 2013, MOL NUTR FOOD RES, V57, P1729, DOI 10.1002/mnfr.201300020
   Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200
   Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005
   Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392
   Gonzalez-Castejon M, 2011, PHARMACOL RES, V64, P438, DOI 10.1016/j.phrs.2011.07.004
   Green Brian D, 2006, Diab Vasc Dis Res, V3, P159, DOI 10.3132/dvdr.2006.024
   Green Brian D, 2006, Expert Opin Emerg Drugs, V11, P525, DOI 10.1517/14728214.11.3.525
   KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251
   Kao Y, 2000, AM J CLIN NUTR, V72, P1232
   Kaul Kirti, 2012, Adv Exp Med Biol, V771, P1
   Kim J, 2009, CELL MOL LIFE SCI, V66, P1766, DOI 10.1007/s00018-009-9169-4
   Ligibel J, 2011, ONCOLOGY-NY, V25, P994
   Lii CK, 2012, FOOD CHEM TOXICOL, V50, P478, DOI 10.1016/j.fct.2011.11.020
   Lin CT, 2009, J AGR FOOD CHEM, V57, P6060, DOI 10.1021/jf900517d
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   SALE EM, 1995, EMBO J, V14, P674
   Shao WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028784
   Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213
   Vernooij JWP, 2012, OBESITY, V20, P2118, DOI 10.1038/oby.2012.76
   Williamson G, 2005, AM J CLIN NUTR, V81, p243S
   Yamamoto N, 2011, PHYTOTHER RES, V25, P1218, DOI 10.1002/ptr.3416
   Yu YS, 2009, J AGR FOOD CHEM, V57, P7673, DOI 10.1021/jf901327g
NR 54
TC 1
Z9 1
U1 2
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL 15
PY 2014
VL 554
BP 44
EP 54
DI 10.1016/j.abb.2014.05.008
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AJ8ZK
UT WOS:000337996400007
PM 24845100
ER

PT J
AU Chen, X
   Miles, R
   Snyder, C
   Truksa, M
   Zhang, J
   Shah, S
   Weselake, RJ
AF Chen, Xue
   Miles, Robin
   Snyder, Crystal
   Truksa, Martin
   Zhang, Jian
   Shah, Saleh
   Weselake, Randall J.
TI Possible allostery and oligomerization of recombinant plastidial
   sn-glycerol-3-phosphate acyltransferase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE GPAT; Biochemical regulation; Glycerolipid biosynthesis; Substrate
   selectivity; Homotrimer; Erysimum asperum
ID SQUASH GLYCEROL-3-PHOSPHATE (1)-ACYLTRANSFERASE; CHILLING-SENSITIVE
   PLANT; SUBSTRATE SELECTIVITY; ARABIDOPSIS-THALIANA; NUCLEOTIDE-SEQUENCE;
   CUCURBITA-MOSCHATA; ENVELOPE MEMBRANES; IN-VITRO; CHLOROPLASTS;
   SPECIFICITY
AB Plastidial acyl-acyl carrier protein:sn-glycerol-3-phosphate acyltransferase (GPAT; EC 2.3.1.15) catalyzes the acyl-acyl carrier protein-dependent sn-1 acylation of sn-glycerol 3-phosphate (G3P) to produce lysophosphatic acid. Functional recombinant Erysimum asperum GPAT (EaGPAT), devoid of transit peptide, was produced in yeast. Analysis of the dependence of EaGPAT activity on increasing G3P concentration resulted in a hyperbolic response. EaGPAT exhibited a preference for 18-carbon unsaturated acyl-CoAs. Assays with concentrations of oleoyl-CoA up to 90 mu M revealed an exponential response to increasing concentrations of acyl donor, and the introduction of increasing concentrations of unlabeled linoleoyl-CoA into the standard reaction mixture resulted in increased incorporation of radiolabeled oleoyl moieties into lysophosphatidic acid. Collectively, the kinetic results suggest that acyl-CoA may act as both substrate and allosteric effector. EaGPAT was also shown to oligomerize to form higher molecular mass multimers, with the monomer and trimer being the predominant forms of the enzyme. Since most allosteric enzyme exhibit quaternary structure, the self-associating properties of EaGPAT are consistent with those of an allosteric enzyme. These results could have important regulatory implications when plastidial GPAT is introduced into a cytoplasmic environment where acyl-CoA is the acyl donor supporting cytoplasmic glycerolipid assembly. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Chen, Xue; Miles, Robin; Snyder, Crystal; Truksa, Martin; Weselake, Randall J.] Univ Alberta, Dept Agr Food & Nutr Sci, Agr Lipid Biotechnol Program, Edmonton, AB T6G 2P5, Canada.
   [Zhang, Jian; Shah, Saleh] Alberta Innovates Technol Futures, Plant Biotechnol, Vegreville, AB T9C 1T4, Canada.
RP Weselake, RJ (reprint author), Univ Alberta, Dept Agr Food & Nutr Sci, Agr Lipid Biotechnol Program, Edmonton, AB T6G 2P5, Canada.
EM randall.weselake@ualberta.ca
FU Alberta Innovates Bio Solution; Alberta Canola Producers Commission;
   Natural Sciences and Engineering Research Council of Canada; Canada
   Foundation for Innovation; Alberta Enterprise and Advanced Education;
   Canada Research Chairs Program
FX This work was supported by Alberta Innovates Bio Solutions, the Alberta
   Canola Producers Commission, the Natural Sciences and Engineering
   Research Council of Canada, the Canada Foundation for Innovation,
   Alberta Enterprise and Advanced Education and the Canada Research Chairs
   Program. The authors have no conflict of interest regarding the
   publication of this paper.
CR Hashimoto K, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035007
   Slabas AR, 2002, J BIOL CHEM, V277, P43918, DOI 10.1074/jbc.M206429200
   Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482
   Jain RK, 2000, BIOCHEM SOC T, V28, P958, DOI 10.1042/0300-5127:0280958
   OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957
   Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139
   NISHIDA I, 1993, PLANT MOL BIOL, V21, P267, DOI 10.1007/BF00019943
   MONOD J, 1965, J MOL BIOL, V12, P88
   Weiss JN, 1997, FASEB J, V11, P835
   BERTRAMS M, 1981, PLANT PHYSIOL, V68, P653, DOI 10.1104/pp.68.3.653
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005
   Birrell GB, 2003, BIOPHYS J, V84, P3264
   Block M.A., 2013, ADV PHOTOSYNTHESIS R, P131
   Chen Xue, 2011, Plant Signal Behav, V6, P1695, DOI 10.4161/psb.6.11.17777
   CRONAN JE, 1987, PLANT PHYSIOL, V83, P676, DOI 10.1104/pp.83.3.676
   Ferri SR, 1997, ARCH BIOCHEM BIOPHYS, V337, P202, DOI 10.1006/abbi.1996.9769
   FRENTZEN M, 1987, PLANT CELL PHYSIOL, V28, P1195
   FRENTZEN M, 1983, EUR J BIOCHEM, V129, P629
   HAMPP R, 1980, PLANT PHYSIOL, V65, P663, DOI 10.1104/pp.65.4.663
   Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107
   HAUSER M, 1995, PLANT PHYSIOL, V108, P1059
   Hayman MW, 2002, FEBS LETT, V514, P281, DOI 10.1016/S0014-5793(02)02381-5
   HERSHENSON S, 1983, ARCH BIOCHEM BIOPHYS, V223, P76, DOI 10.1016/0003-9861(83)90573-8
   Horton P, 2007, NUCLEIC ACIDS RES, V35, P585
   ISHIZAKI O, 1988, FEBS LETT, V238, P424, DOI 10.1016/0014-5793(88)80525-8
   JOHNSON TC, 1992, PLANT PHYSIOL, V99, P771, DOI 10.1104/pp.99.2.771
   Joyard J, 1998, PLANT PHYSIOL, V118, P715, DOI 10.1104/pp.118.3.715
   KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471
   Liu J, 2005, BIOCHEM J, V391, P389, DOI 10.1042/BJ20050428
   Motulsky H.J., 2003, FITTING MODELS BIOL
   Murata N, 1997, BBA-LIPID LIPID MET, V1348, P10, DOI 10.1016/S0005-2760(97)00115-X
   MURATA N, 1992, NATURE, V356, P710, DOI 10.1038/356710a0
   Onorato TM, 2005, J BIOL CHEM, V280, P19527, DOI 10.1074/jbc.M410422200
   Turnbull AP, 2001, STRUCTURE, V9, P347, DOI 10.1016/S0969-2126(01)00595-0
   WEBER S, 1991, PLANT MOL BIOL, V17, P1067, DOI 10.1007/BF00037145
   Weselake R.J., 2005, BMC BIOCH, V7, P24
   WOLTER FP, 1992, EMBO J, V11, P4685
   Xu C, 2007, PROTEIN PEPTIDE LETT, V14, P505, DOI 10.2174/092986607780782812
   Xu CC, 2006, PLANT J, V47, P296, DOI 10.1111/j.1365-313X.2006.02790.x
   Yokoi S, 1998, MOL BREEDING, V4, P269, DOI 10.1023/A:1009671231614
   Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200
   Zheng ZF, 2003, PLANT CELL, V15, P1872, DOI 10.1105/tpc.012427
   Zhu SQ, 2009, J INTEGR PLANT BIOL, V51, P1040, DOI 10.1111/j.1744-7909.2009.00876.x
NR 44
TC 0
Z9 0
U1 2
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL 15
PY 2014
VL 554
BP 55
EP 64
DI 10.1016/j.abb.2014.05.007
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AJ8ZK
UT WOS:000337996400008
PM 24841490
ER

PT J
AU Andreani, J
   Guerois, R
AF Andreani, Jessica
   Guerois, Raphael
TI Evolution of protein interactions: From interactomes to interfaces
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Co-evolution; Protein-protein interaction; Interactome; Interface;
   Computational methods; Bioinformatics; Prediction; Docking
ID MOLECULAR INTERACTION DATABASE; INTERACTION-SITE PREDICTION; INTERACTION
   NETWORKS; BINDING-SITES; CONTACT PREDICTION; 3-DIMENSIONAL STRUCTURES;
   STRUCTURAL SIMILARITIES; COMPREHENSIVE DATABASE; FUNCTIONAL SPECIFICITY;
   CORRELATED MUTATIONS
AB Protein-protein interactions lie at the heart of most cellular processes. Many experimental and computational studies aim to deepen our understanding of these interactions and improve our capacity to predict them. In this respect, the evolutionary perspective is most interesting, since the preservation of structure and function puts constraints on the evolution of proteins and their interactions. However, uncovering these constraints remains a challenge, and the description and detection of evolutionary signals in protein-protein interactions is currently a very active field of research. Here, we review recent works dissecting the mechanisms of protein-protein interaction evolution and exploring how to use evolutionary information to predict interactions, both at the global level of the interactome and at the detailed level of protein-protein interfaces. We first present to what extent protein-protein interactions are found to be conserved within interactomes and which properties can influence their conservation. We then discuss the evolutionary and co-evolutionary pressures applied on protein-protein interfaces. Finally, we describe how the computational prediction of interfaces can benefit from evolutionary inputs. (C) 2014 Elsevier Inc. All rights reserved.
C1 CEA, IBiTecS, F-91191 Gif Sur Yvette, France.
   Univ Paris 11, F-91191 Gif Sur Yvette, France.
   CNRS, UMR 8221, F-91191 Gif Sur Yvette, France.
RP Andreani, J (reprint author), CEA, IBiTecS, UMR 8221, F-91191 Gif Sur Yvette, France.
EM jessica.andreani@mines.org; guerois@cea.fr
FU French Infrastructure for Integrated Structural Biology (FRISBI)
   [ANR-10-INSB-05-01];  [ANR-IAB-2011-BIP:BIP]
FX This work was supported by the French Infrastructure for Integrated
   Structural Biology (FRISBI) ANR-10-INSB-05-01 and by the
   ANR-IAB-2011-BIP:BIP.
CR Andreani J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002677
   Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044
   Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830
   Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105
   Park SY, 2004, P NATL ACAD SCI USA, V101, P11646, DOI 10.1073/pnas.0401038101
   Keskin O, 2008, METHODS MOL BIOL, V484, P505, DOI 10.1007/978-1-59745-398-1_30
   Andreani J, 2013, BIOINFORMATICS, V29, P1742, DOI 10.1093/bioinformatics/btt260
   Hwang H, 2010, PROTEINS, V78, P3104, DOI 10.1002/prot.22764
   Thomas J, 2009, PROTEINS, V76, P911, DOI 10.1002/prot.22398
   Henschel A, 2006, BIOINFORMATICS, V22, P550, DOI 10.1093/bioinformatics/bti782
   Levy ED, 2012, P NATL ACAD SCI USA, V109, P20461, DOI 10.1073/pnas.1209312109
   Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107
   Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604
   Halperin I, 2004, STRUCTURE, V12, P1027, DOI 10.1016/j.str.2004.04.009
   Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040
   Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286
   Scannell DR, 2008, GENOME RES, V18, P137, DOI 10.1101/gr.6341207
   Franzosa EA, 2011, P NATL ACAD SCI USA, V108, P10538, DOI 10.1073/pnas.1101440108
   Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214
   Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301
   Valdar WSJ, 2001, PROTEINS, V42, P108
   Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102
   Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850
   Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144
   Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X
   von Mering C, 2002, NATURE, V417, P399
   Shoemaker BA, 2012, NUCLEIC ACIDS RES, V40, pD834, DOI 10.1093/nar/gkr997
   Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008
   Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105
   Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524
   Moal IH, 2012, BIOINFORMATICS, V28, P2600, DOI 10.1093/bioinformatics/bts489
   Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004
   Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j
   Keskin O, 2004, PROTEIN SCI, V13, P1043, DOI 10.1110/ps.03484604
   Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106
   Moal IH, 2013, CURR OPIN STRUC BIOL, V23, P862, DOI 10.1016/j.sbi.2013.06.017
   Levy ED, 2008, CURR OPIN STRUC BIOL, V18, P349, DOI 10.1016/j.sbi.2008.03.003
   Venkatesan K, 2009, NAT METHODS, V6, P83, DOI [10.1038/nmeth.1280, 10.1038/NMETH.1280]
   Juan D, 2008, FEBS LETT, V582, P1225, DOI 10.1016/j.febslet.2008.02.017
   Hooda Y, 2012, PROTEOMICS, V12, P1697, DOI 10.1002/pmic.201100597
   Res I, 2005, BIOINFORMATICS, V21, P2496, DOI 10.1093/bioinformatics/bti340
   Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025
   Zamir L, 2012, P NATL ACAD SCI USA, V109, pE406, DOI 10.1073/pnas.1108633109
   Faure G, 2012, NUCLEIC ACIDS RES, V40, pD847, DOI 10.1093/nar/gkr845
   Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419
   Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930
   Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198
   Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284
   Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107
   Teichmann SA, 2002, J MOL BIOL, V324, P399, DOI 10.1016/S0022-2836(02)01144-0
   Mosca R, 2014, NUCLEIC ACIDS RES, V42, pD374, DOI 10.1093/nar/gkt887
   Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012
   Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819
   Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604
   Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106
   Franzosa EA, 2009, MOL BIOL EVOL, V26, P2387, DOI 10.1093/molbev/msp146
   Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934
   Stein A, 2011, CURR OPIN STRUC BIOL, V21, P200, DOI 10.1016/j.sbi.2011.01.005
   Wass MN, 2011, CURR OPIN STRUC BIOL, V21, P382, DOI 10.1016/j.sbi.2011.03.013
   Vreven T, 2012, PROTEIN SCI, V21, P396, DOI 10.1002/pro.2027
   Reinke AW, 2013, SCIENCE, V340, P730, DOI 10.1126/science.1233465
   Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999
   Qian WF, 2011, P NATL ACAD SCI USA, V108, P8725, DOI 10.1073/pnas.1104695108
   ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V
   Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323
   Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356
   Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069
   de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712
   Andrusier N, 2008, PROTEINS, V73, P271, DOI 10.1002/prot.22170
   Zacharias M, 2010, CURR OPIN STRUC BIOL, V20, P180, DOI 10.1016/j.sbi.2010.02.001
   Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059
   Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854
   Lensink MF, 2013, PROTEINS, V81, P2082, DOI 10.1002/prot.24428
   Sacquin-Mora S, 2008, J MOL BIOL, V382, P1276, DOI 10.1016/j.jmb.2008.08.002
   Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108
   Pons C, 2010, PROTEINS, V78, P95, DOI 10.1002/prot.22564
   Levin KB, 2009, NAT STRUCT MOL BIOL, V16, P1049, DOI 10.1038/nsmb.1670
   de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414
   Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/nmeth.1284, 10.1038/NMETH.1284]
   Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638
   Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115
   Barrault MB, 2012, P NATL ACAD SCI USA, V109, pE1001, DOI 10.1073/pnas.1116538109
   Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P10340, DOI 10.1073/pnas.1207864109
   Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107
   Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973
   Meenan NAG, 2010, P NATL ACAD SCI USA, V107, P10080, DOI 10.1073/pnas.0910756107
   Mewes HW, 2011, NUCLEIC ACIDS RES, V39, pD220, DOI 10.1093/nar/gkq1157
   Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106
   Chen YC, 2010, NAT METHODS, V7, P667, DOI 10.1038/nmeth0910-667
   Ghoorah AW, 2014, NUCLEIC ACIDS RES, V42, pD389, DOI 10.1093/nar/gkt1199
   Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747
   Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006
   Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040
   Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010
   Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503
   Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787
   Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367
   Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116
   Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158
   Vakser IA, 2013, CURR OPIN STRUC BIOL, V23, P198, DOI 10.1016/j.sbi.2012.12.003
   Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942
   Wagner A, 2001, MOL BIOL EVOL, V18, P1283
   Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477
   Yang JR, 2012, P NATL ACAD SCI USA, V109, pE831, DOI 10.1073/pnas.1117408109
   Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189
   Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007
   Sandler I, 2013, PROTEINS, V81, P1997, DOI 10.1002/prot.24360
   Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077
   Elcock AH, 2001, P NATL ACAD SCI USA, V98, P2990, DOI 10.1073/pnas.061411798
   Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174
   Davis FP, 2005, BIOINFORMATICS, V21, P1901, DOI 10.1093/bioinformatics/bti277
   Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273
   Aucher W, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.003319
   Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025
   Beltrao P, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304521
   Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002
   Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95
   Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633
   Capra EJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001220
   Dago AE, 2012, P NATL ACAD SCI USA, V109, pE1733, DOI 10.1073/pnas.1201301109
   Das J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003350
   de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695
   de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842
   Eames M, 2007, STRUCTURE, V15, P1442, DOI 10.1016/j.str.2007.09.010
   Engelen S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000267
   Ezkurdia Iakes, 2009, Brief Bioinform, V10, P233, DOI 10.1093/bib/bbp021
   Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD364, DOI 10.1093/nar/gkt1210
   Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031
   Ghoorah AW, 2011, BIOINFORMATICS, V27, P2820, DOI 10.1093/bioinformatics/btr493
   Hamer R, 2010, PROTEINS, V78, P2781, DOI 10.1002/prot.22792
   Han JH, 2006, STRUCTURE, V14, P935, DOI 10.1016/j.str.2006.01.016
   Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120
   Heo MY, 2011, P NATL ACAD SCI USA, V108, P4258, DOI 10.1073/pnas.1009392108
   Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911
   Janin J, 2013, PROTEINS, V81, P2075, DOI 10.1002/prot.24375
   Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234
   Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088
   Keskin O, 2005, PROTEIN ENG DES SEL, V18, P11, DOI 10.1093/protein/gzh095
   Kim WK, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000232
   Korkin D, 2006, PLOS COMPUT BIOL, V2, P1365, DOI 10.1371/journal.pcbi.0020153
   Kundrotas PJ, 2012, P NATL ACAD SCI USA, V109, P9438, DOI 10.1073/pnas.1200678109
   Kundrotas PJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000727
   Kundrotas PJ, 2008, INT J BIOL MACROMOL, V43, P198, DOI 10.1016/j.ijbiomac.2008.05.004
   Lapedes AS, 1999, P AMS SIAM C STAT MO, P236
   Leducq JB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003161
   Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155
   Lewis ACF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002645
   Lewis ACF, 2010, MOL BIOSYST, V6, P55, DOI 10.1039/b916371a
   Lo YS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S7
   Lopes A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003369
   Madaoui H, 2008, P NATL ACAD SCI USA, V105, P7708, DOI 10.1073/pnas.0707032105
   Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208
   Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766
   Martin J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000821
   Martin J, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-7
   McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694
   Melquiond ASJ, 2012, WIRES COMPUT MOL SCI, V2, P642, DOI 10.1002/wcms.91
   Mika S, 2006, PLOS COMPUT BIOL, V2, P698, DOI 10.1371/journal.pcbi.0020079
   Mosca R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000490
   Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303
   Oliveira L, 2002, CHEMBIOCHEM, V3, P1010, DOI 10.1002/1439-7633(20021004)3:10<1010::AID-CBIC1010>3.0.CO;2-T
   Pons C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-378
   Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248
   Procaccini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019729
   Reece-Hoyes JS, 2013, MOL CELL, V51, P116, DOI 10.1016/j.molcel.2013.05.018
   Sambourg L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-605
   Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106
   Shapiro L, 2000, CELL, V100, P89, DOI 10.1016/S0092-8674(00)81686-4
   Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050
   Stumpf MPH, 2007, TRENDS ECOL EVOL, V22, P366, DOI 10.1016/j.tree.2007.04.004
   Sun MGF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-235
   Teyra J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-398
   van Dam TJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000132
   Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473
   Xin XF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.9
   Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904
   Zellner H, 2012, PROTEINS, V80, P154, DOI 10.1002/prot.23172
NR 177
TC 8
Z9 8
U1 17
U2 50
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL 15
PY 2014
VL 554
BP 65
EP 75
DI 10.1016/j.abb.2014.05.010
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AJ8ZK
UT WOS:000337996400009
PM 24853495
ER

PT J
AU Regnier, M
AF Regnier, Michael
TI Biophysical and biomechanical properties of myofilament proteins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
C1 [Regnier, Michael] Univ Washington, Sch Med, Dept Bioengn, Seattle, WA 98195 USA.
   [Regnier, Michael] Coll Engn, Seattle, WA 98195 USA.
RP Regnier, M (reprint author), Univ Washington, Sch Med, Dept Bioengn, Seattle, WA 98195 USA.
EM mregnier@uw.edu
NR 0
TC 0
Z9 0
U1 3
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 1
EP 2
DI 10.1016/j.abb.2014.05.018
PG 2
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300001
PM 24890820
ER

PT J
AU Akhter, S
   Bueltmann, K
   Huang, X
   Jin, JP
AF Akhter, Shirin
   Bueltmann, Kenneth, Jr.
   Huang, Xupei
   Jin, J. -P.
TI Restrictive cardiomyopathy mutations demonstrate functions of the
   C-terminal end-segment of troponin I
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Troponin I; C-terminal end-segment; Myofilament regulation; Restrictive
   cardiomyopathy; Striated muscle
ID HUMAN CARDIAC TROPONIN; MUSCLE-CONTRACTION; HYPERTROPHIC CARDIOMYOPATHY;
   CONFORMATIONAL MODULATION; MOLECULAR-CONFORMATION; DIASTOLIC
   DYSFUNCTION; ALPHA-TROPOMYOSIN; STRUCTURAL BASIS; TRANSGENIC MICE;
   STRIATED-MUSCLE
AB The C-terminal end-segment of Troponin I (TnI) corresponding to the last 27-33 amino acids is the most conserved structure of TnI and interacts with tropomyosin in a Ca2+-regulated manner, suggesting a role in muscle relaxation. Mutations in the C-terminal end-segment of cardiac TnI cause restrictive cardiomyopathy. Here we demonstrate that mouse cardiac TnI containing R193H or R205H mutation have significantly conformational changes in the region interfacing with troponin T (TnT) and increased binding affinity for TnT. These restrictive cardiomyopathy mutations also exhibit increased binding affinity for troponin Cat pCa 4. The effects of R193H mutation were more profound than that of R205H. Tertiary troponin complex was reconstituted using the TnI mutants and a mini TnT lacking tropomyosin-binding sites to examine the interaction between the C-terminal end-segment of TnI and tropomyosin. The results showed that, R193H, but not R205H, caused a moderate but statistically significant increase in the binding affinity for tropomyosin at pCa 9. Similar trend was observed at pCa 5.5 but not pCa 4. These results provide novel evidence for the function of the C-terminal end-segment of TnI, where mutations with conformational effects alter TnI's interaction with other troponin subunits and tropomyosin to cause diastolic dysfunction. (C) 2013 Published by Elsevier Inc.
C1 [Akhter, Shirin; Bueltmann, Kenneth, Jr.; Jin, J. -P.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA.
   [Huang, Xupei] Florida Atlantic Univ, Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA.
RP Jin, JP (reprint author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.
EM jjin@med.wayne.edu
FU National Heart, Lung and Blood Institute and National Institute of
   Arthritis and Musculoskeletal and Skin Diseases of the National
   Institutes of Health [HL098945, AR048816]; Office of Vice President for
   Research, Wayne State University
FX We thank Ms. Hui Wang for technical assistance and Dr. Jim Lin at the
   University of Iowa for CH1 mAb. Dr. Kenneth Bueltmann participated in
   this study during his research elective in Dr. Jin's laboratory at the
   Evanston Northwestern Healthcare Research Institute, Northwestern
   University Feinberg School of Medicine. This study was supported by the
   National Heart, Lung and Blood Institute and National Institute of
   Arthritis and Musculoskeletal and Skin Diseases of the National
   Institutes of Health under Award Numbers HL098945 and AR048816, and a
   Multidisciplinary Incubator Grant from the Office of Vice President for
   Research, Wayne State University (to J.-P.J).
CR Galinska A, 2010, CIRC RES, V106, P705, DOI 10.1161/CIRCRESAHA.109.210047
   Morner S, 2000, J MOL CELL CARDIOL, V32, P521, DOI 10.1006/jmcc.1999.1099
   Kostareva A, 2009, INT J CARDIOL, V131, P410, DOI 10.1016/j.ijcard.2007.07.108
   Julien O, 2011, PROTEINS, V79, P1240, DOI 10.1002/prot.22959
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336
   Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0
   Wei B, 2010, J BIOL CHEM, V285, P27806, DOI 10.1074/jbc.M110.137844
   Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031
   Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114
   Lehman W, 2009, J MOL BIOL, V388, P673, DOI 10.1016/j.jmb.2009.03.060
   Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379
   Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102
   Gambarin FI, 2008, HEART, V94, P1257, DOI 10.1136/hrt.2008.154203
   Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780
   Zhou ZQ, 2012, J BIOL CHEM, V287, P7661, DOI 10.1074/jbc.M111.281600
   McDonough JL, 1999, CIRC RES, V84, P9
   Akhter S, 2012, AM J PHYSIOL-HEART C, V302, pH923, DOI 10.1152/ajpheart.00637.2011
   Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200
   Jin JP, 2007, ARCH BIOCHEM BIOPHYS, V466, P1, DOI 10.1016/j.abb.2007.07.021
   Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715
   Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200
   Biesiadecki BJ, 2004, J BIOL CHEM, V279, P13825, DOI 10.1074/jbc.M314225200
   Chen SC, 2001, J HEART LUNG TRANSPL, V20, P90, DOI 10.1016/S1053-2498(00)00162-5
   Doolan Alessandra, 2005, J Mol Cell Cardiol, V38, P387, DOI 10.1016/j.yjmcc.2004.12.006
   Du J, 2006, ARCH BIOCHEM BIOPHYS, V456, P143, DOI 10.1016/j.abb.2006.08.018
   Du JF, 2008, AM J PHYSIOL-HEART C, V294, pH2604, DOI 10.1152/ajpheart.91506.2007
   Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062
   GOLDBERG ME, 1991, TRENDS BIOCHEM SCI, V16, P358, DOI 10.1016/0968-0004(91)90148-O
   Huang XP, 2004, ACTA PHARMACOL SIN, V25, P1569
   Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j
   Jin JP, 2000, AM J PHYSIOL-CELL PH, V279, pC1067
   Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93
   JIN JP, 1988, J BIOL CHEM, V263, P7309
   Jin JP, 2000, BIOCHEM J, V350, P579, DOI 10.1042/0264-6021:3500579
   Kimberlin MT, 2002, J HEART LUNG TRANSPL, V21, P455, DOI 10.1016/S1053-2498(01)00400-4
   Murphy AM, 2000, SCIENCE, V287, P488, DOI 10.1126/science.287.5452.488
   PEARLSTONE JR, 1983, J BIOL CHEM, V258, P2534
   Peddy SB, 2006, PEDIATRICS, V117, P1830, DOI 10.1542/peds.2005-2301
   Rivenes SM, 2000, CIRCULATION, V102, P876
   SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234
   Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050420
   Wang J, 1998, BIOCHEMISTRY-US, V37, P14519, DOI 10.1021/bi9812322
   Zhang ZL, 2011, FEBS J, V278, P3348, DOI 10.1111/j.1742-4658.2011.08250.x
NR 44
TC 2
Z9 2
U1 5
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 3
EP 10
DI 10.1016/j.abb.2013.12.001
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300002
PM 24326031
ER

PT J
AU Brunet, NM
   Chase, PB
   Mihajlovic, G
   Schoffstall, B
AF Brunet, Nicolas M.
   Chase, P. Bryant
   Mihajlovic, Goran
   Schoffstall, Brenda
TI Ca2+-regulatory function of the inhibitory peptide region of cardiac
   troponin I is aided by the C-terminus of cardiac troponin T: Effects of
   familial hypertrophic cardiomyopathy mutations cTnI R145G and cTnT
   R278C, alone and in combination, on filament sliding
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Thin filament; Motility assay; Temperature; Evolution
ID MYOFILAMENT CALCIUM SENSITIVITY; RABBIT SKELETAL-MUSCLE; THIN FILAMENT;
   REGULATORY DOMAIN; ALPHA-TROPOMYOSIN; STRUCTURAL TRANSITION; CA2+
   SENSITIZATION; HEAVY-MEROMYOSIN; STRIATED-MUSCLE; TRANSGENIC MICE
AB Investigations of cardiomyopathy mutations in Ca2+ regulatory proteins troponin and tropomyosin provide crucial information about cardiac disease mechanisms, and also provide insights into functional domains in the affected polypeptides. Hypertrophic cardiomyopathy-associated mutations TnI R145G, located within the inhibitory peptide (Ip) of human cardiac troponin I (hcTnI), and TnT R278C, located immediately C-terminal to the IT arm in human cardiac troponin T (hcTnT), share some remarkable features: structurally, biochemically, and pathologically. Using bioinformatics, we find compelling evidence that TnI and TnT, and more specifically the affected regions of hcTnI and hcTnT, may be related not just structurally but also evolutionarily. To test for functional interactions of these mutations on Ca2+-regulation, we generated and characterized Tn complexes containing either mutation alone, or both mutations simultaneously. The most important results from in vitro motility assays (varying [Ca2+], temperature or HMM density) show that the TnT mutant "rescued" some deleterious effects of the Till mutant at high Ca2+, but exacerbated the loss of function, i.e., switching off the actomyosin interaction, at low Ca2+. Taken together, our experimental results suggest that the C-terminus of cTnT aids Ca2+-regulatory function of cTnI I-p within the troponin complex. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Brunet, Nicolas M.; Chase, P. Bryant; Schoffstall, Brenda] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.
   [Chase, P. Bryant] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.
   [Mihajlovic, Goran] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA.
RP Chase, PB (reprint author), Florida State Univ, Dept Biol Sci, Biol Unit 1, 81 Chieftain Way,Box 3064370, Tallahassee, FL 32306 USA.
EM chase@bio.fsu.edu
FU NIH/NHLBI [HL63974]; American Heart Association FL/PR Affiliate
   Predoctoral Fellowship [0315097B]; NSF NIRT Grant [ECS-0210332]
FX This work was supported by NIH/NHLBI HL63974 (PBC), American Heart
   Association FL/PR Affiliate Predoctoral Fellowship 0315097B (NMB), and
   NSF NIRT Grant ECS-0210332 (PX).
CR THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X
   KRON SJ, 1991, METHOD ENZYMOL, V196, P399, DOI 10.1016/0076-6879(91)96035-P
   Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200
   Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382
   Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031
   Westfall MV, 2002, CIRC RES, V91, P525, DOI 10.1161/01.RES.0000034710.46739.C0
   MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461
   Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017
   Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216
   Hernandez OM, 2005, J BIOL CHEM, V280, P37183, DOI 10.1074/jbc.M508114200
   Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715
   UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmce.2001.1471
   Chong SM, 2009, J MOL EVOL, V68, P448, DOI 10.1007/s00239-009-9202-0
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d
   Wei B, 2010, J BIOL CHEM, V285, P27806, DOI 10.1074/jbc.M110.137844
   Kruger M, 2005, J PHYSIOL-LONDON, V564, P347, DOI 10.1113/jphysiol.2004.079095
   Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642
   Franklin AJ, 2012, BIOPHYS J, V102, P2536, DOI 10.1016/j.bpj.2012.04.037
   Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200
   Kohler J, 2003, PHYSIOL GENOMICS, V14, P117, DOI 10.1152/physiolgenomics.00101.2002
   Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001
   Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132
   Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624
   Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379
   Lindhout DA, 2002, BIOCHEMISTRY-US, V41, P7267, DOI 10.1021/bi020100c
   Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003
   Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102
   Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780
   Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170
   Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834
   Van Driest SL, 2003, CIRCULATION, V108, P445, DOI 10.1161/01.CIR.0000080896.52003.DF
   Mihajlovic G, 2004, APPL PHYS LETT, V85, P1060, DOI 10.1063/1.1777815
   Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200
   Asumda FZ, 2012, DIFFERENTIATION, V83, P106, DOI 10.1016/j.diff.2011.10.002
   Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399
   Brunet NM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/657523
   Loong CKP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039676
   Chase PB, 2000, AM J PHYSIOL-CELL PH, V278, pC1088
   Chase PB, 2013, J MUSCLE RES CELL M, V34, P275, DOI 10.1007/s10974-013-9356-7
   Davis J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009140
   Dong WJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P135, DOI 10.1016/j.abb.2006.08.007
   Dong WJ, 2001, J MOL BIOL, V314, P51, DOI 10.1006/jmbi.2001.5118
   Gafurov B, 2004, BIOCHEMISTRY-US, V43, P15276, DOI 10.1021/bi048646h
   Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018
   Gordon AM, 1997, BIOPHYS J, V72, P1295
   Gordon AM, 1998, ADV EXP MED BIOL, V453, P187
   Grove TJ, 2005, J MUSCLE RES CELL M, V26, P191, DOI 10.1007/s10974-005-9010-0
   HEALD RW, 1988, J BIOL CHEM, V263, P5254
   Hill A. V., 1910, J PHYSIOL-LONDON, V40, piv
   Homsher E, 2003, BIOPHYS J, V85, P1046, DOI 10.1016/S0006-3495(03)74543-3
   Huang QQ, 1999, J MOL EVOL, V49, P780, DOI 10.1007/PL00006600
   James J, 2000, CIRC RES, V87, P805
   Jha PK, 1996, BIOCHEMISTRY-US, V35, P16573, DOI 10.1021/bi9622433
   Kataoka A, 2007, J BIOMECH, V40, P2044, DOI 10.1016/j.jbiomech.2006.09.026
   Liang B, 2003, BIOPHYS J, V85, P1775, DOI 10.1016/S0006-3495(03)74607-4
   Loong CKP, 2013, CELL MOL BIOENG, V6, P183, DOI 10.1007/s12195-013-0269-8
   MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55
   MOERLAND TS, 1986, J EXP ZOOL, V238, P287, DOI 10.1002/jez.1402380303
   Morimoto S, 1999, BIOCHEM BIOPH RES CO, V261, P79, DOI 10.1006/bbrc.1999.1000
   PARDEE JD, 1982, METHOD ENZYMOL, V85, P164
   Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316
   Schoffstall B, 2005, J PHARMACOL EXP THER, V312, P12, DOI 10.1124/jpet.104.073445
   Schoffstall B, 2011, DNA CELL BIOL, V30, P653, DOI 10.1089/dna.2010.1163
   Schoffstall B, 2006, BIOPHYS J, V91, P2216, DOI [10.1529/biophysj.105.079061, 10.1529/biophysj.107.079061]
   Sirenko SG, 2006, J PHYSIOL-LONDON, V575, P201, DOI 10.1113/jphysiol.2006.107557
   Stefancsik R, 1998, P NATL ACAD SCI USA, V95, P957, DOI 10.1073/pnas.95.3.957
   Tsoutsman T, 2008, CLIN EXP PHARMACOL P, V35, P1349, DOI 10.1111/j.1440-1681.2008.05037.x
   Tung CS, 2000, PROTEIN SCI, V9, P1312
   VANEYK JE, 1988, J BIOL CHEM, V263, P1726
   Wang F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/435271
   WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603
   Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806
NR 76
TC 1
Z9 1
U1 2
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 11
EP 20
DI 10.1016/j.abb.2013.12.021
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300003
PM 24418317
ER

PT J
AU Moore, RK
   Abdullah, S
   Tardiff, JC
AF Moore, Rachel K.
   Abdullah, Salwa
   Tardiff, Jil C.
TI Allosteric effects of cardiac troponin TNT1 mutations on actomyosin
   binding: A novel pathogenic mechanism for hypertrophic cardiomyopathy
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Troponin; Thin filaments; Hypertrophic cardiomyopathy; Weak binding
ID THIN FILAMENT; T MUTATIONS; ALPHA-TROPOMYOSIN; SKELETAL-MUSCLE;
   TRANSGENIC MICE; IN-VITRO; SHORTENING VELOCITY; CALCIUM REGULATION;
   HEAVY-MEROMYOSIN; TAIL DOMAIN
AB The majority of hypertrophic cardiomyopathy mutations in (cTnT) occur within the alpha-helical tropomyosin binding TNT1 domain. A highly charged region at the C-terminal end of TNT1 unwinds to create a flexible "hinge". While this region has not been structurally resolved, it likely acts as an extended linker between the two cTnT functional domains. Mutations in this region cause phenotypically diverse and often severe forms of HCM. Mechanistic insight, however, has been limited by the lack of structural information. To overcome this limitation, we evaluated the effects of cTnT 160-163 mutations using regulated in vitro motility (R-IVM) assays and transgenic mouse models. R-IVM revealed that cTnT mutations Delta 160E, E163R and E163K disrupted weak electrostatic actomyosin binding. Reducing the ionic strength or decreasing Brownian motion rescued function. This is the first observation of HCM-linked mutations in cTnT disrupting weak interactions between the thin filament and myosin. To evaluate the in vivo effects of altering weak actomyosin binding we generated transgenic mice expressing Delta 160E and E163R mutant cTnT and observed severe cardiac remodeling and profound myofilament disarray. The functional changes observed in vitro may contribute to the structural impairment seen in vivo by destabilizing myofilament structure and acting as a constant pathophysiologic stress. (C) 2014 Published by Elsevier Inc.
C1 [Moore, Rachel K.; Tardiff, Jil C.] Univ Arizona, Dept Med, Tucson, AZ 85724 USA.
   [Abdullah, Salwa; Tardiff, Jil C.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA.
RP Tardiff, JC (reprint author), Univ Arizona, 1656 East Mabel St,Med Res Bldg 312,MS 245217, Tucson, AZ 85724 USA.
EM jtardiff@email.arizona.edu
FU NIH (Medical Scientist Training Grant) [GM007288]; Gootter Foundation;
   NIH [R01-HL075619, R01-HL107046]
FX This work was supported by grants from the NIH (R01-HL075619 and
   R01-HL107046 to J.C.T. and Medical Scientist Training Grant GM007288 to
   R.K.M.) and support from the Gootter Foundation.
CR HOMSHER E, 1992, AM J PHYSIOL, V262, pC714
   KRON SJ, 1991, METHOD ENZYMOL, V196, P399, DOI 10.1016/0076-6879(91)96035-P
   Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005
   Ferrante MI, 2011, J CELL SCI, V124, P565, DOI 10.1242/jcs.071274
   UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V
   SHEETZ MP, 1984, J CELL BIOL, V99, P1867, DOI 10.1083/jcb.99.5.1867
   Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800
   Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037
   Hinkle A, 2003, J BIOL CHEM, V278, P506, DOI 10.1074/jbc.M209194200
   Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875
   Pasquale F, 2012, CIRC-CARDIOVASC GENE, V5, P10, DOI 10.1161/CIRCGENETICS.111.959973
   Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624
   KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272
   Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200
   Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780
   Xu C, 1999, BIOPHYS J, V77, P985
   Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067
   Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170
   Huang W, 2009, DEV BIOL, V331, P237, DOI 10.1016/j.ydbio.2009.04.039
   Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x
   Tardiff JC, 1998, J CLIN INVEST, V101, P2800, DOI 10.1172/JCI2389
   Moore RK, 2013, J MOL CELL CARDIOL, V58, P188, DOI 10.1016/j.yjmcc.2013.02.004
   Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200
   Capek P, 2006, METHOD INFORM MED, V45, P169
   Ertz-Berger BR, 2005, P NATL ACAD SCI USA, V102, P18219, DOI 10.1073/pnas.0509181102
   Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0
   Gordon AM, 1997, BIOPHYS J, V72, P1295
   Guinto PJ, 2007, J THEOR COMPUT CHEM, V6, P413, DOI 10.1142/S0219633607003271
   Haim TE, 2007, J MOL CELL CARDIOL, V42, P1098, DOI 10.1016/j.yjmcc.2007.03.906
   Harada K, 2004, J BIOL CHEM, V279, P14488, DOI 10.1074/jbc.M309355200
   Harada K, 2000, J BIOCHEM-TOKYO, V127, P263
   Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157
   Homsher E, 1996, BIOPHYS J, V70, P1881
   Lin D, 1996, J CLIN INVEST, V97, P2842, DOI 10.1172/JCI118740
   Manning EP, 2012, J BIOL CHEM, V287, P14515, DOI 10.1074/jbc.M111.257436
   MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55
   MCKILLOP DFA, 1993, BIOPHYS J, V65, P693
   Nirody J., 2010, BIOPHYS J, V98, P1
   Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007
   Palm T, 2001, BIOPHYS J, V81, P2827
   Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050
   Regnier M, 1995, AM J PHYSIOL-CELL PH, V269, pC1532
   SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658
   SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234
   WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603
   Yar S, 2013, J BIOL CHEM, V288, P16235, DOI 10.1074/jbc.M113.458695
NR 46
TC 1
Z9 1
U1 4
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 21
EP 28
DI 10.1016/j.abb.2014.01.016
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300004
PM 24480310
ER

PT J
AU Muthu, P
   Liang, JS
   Schmidt, W
   Moore, JR
   Szczesna-Cordary, D
AF Muthu, Priya
   Liang, Jingsheng
   Schmidt, William
   Moore, Jeffrey R.
   Szczesna-Cordary, Danuta
TI In vitro rescue study of a malignant familial hypertrophic
   cardiomyopathy phenotype by pseudo-phosphorylation of myosin regulatory
   light chain
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cardiomyopathy; Muscle contraction; Mutation; Myosin phosphorylation; In
   vitro motility; Reconstituted cardiac system
ID CONTRACTILE PROTEINS; RLC PHOSPHORYLATION; CARDIAC-PERFORMANCE;
   MOLECULAR MOTORS; TRANSGENIC MICE; BINDING; MUTATIONS; INCREASES;
   TROPONIN; DISEASE
AB Pseudo-phosphorylation of cardiac myosin regulatory light chain (RLC) has never been examined as a rescue method to alleviate a cardiomyopathy phenotype brought about by a disease causing mutation in the myosin RLC. This study focuses on the aspartic acid to valine substitution (D166V) in the myosin RLC shown to be associated with a malignant phenotype of familial hypertrophic cardiomyopathy (FHC). The mutation has also been demonstrated to cause severe functional abnormalities in transgenic mice expressing D166V in the heart. To explore this novel rescue strategy, pseudo-phosphorylation of D166V was used to determine whether the D166V-induced detrimental phenotype could be brought back to the level of wild-type (WT) RLC. The S15D substitution at the phosphorylation site of RLC was inserted into the recombinant WT and D166V mutant to mimic constitutively phosphorylated RLC proteins. Non-phosphorylatable (S15A) constructs were used as controls. A multi-faceted approach was taken to determine the effect of pseudo-phosphorylation on the ability of myosin to generate force and motion. Using mutant reconstituted porcine cardiac muscle preparations, we showed an S15D-induced rescue of both the enzymatic and binding properties of D166V-myosin to actin. A significant increase in force production capacity was noted in the in vitro motility assays for S15D-D166V vs. D166V reconstituted myosin. A similar pseudo-phosphorylation induced effect was observed on the D166V-elicited abnormal Ca2+ sensitivity of force in porcine papillary muscle strips reconstituted with phosphomimic recombinant RLCs. Results from this study demonstrate a novel in vitro rescue strategy that could be utilized in vivo to ameliorate a malignant cardiomyopathic phenotype. We show for the first time that pseudo-RLC phosphorylation can reverse the majority of the mutation-induced phenotypes highlighting the importance of RLC phosphorylation in combating cardiac disease. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Muthu, Priya; Liang, Jingsheng; Szczesna-Cordary, Danuta] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.
   [Schmidt, William; Moore, Jeffrey R.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.
RP Szczesna-Cordary, D (reprint author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave,RMSB 6113 R-189, Miami, FL 33136 USA.
EM dszczesna@med.miami.edu
FU National Institutes of Health [HL071778, HL108343, HL077280]; American
   Heart Association [10POST3420009]
FX We thank Dr. Katarzyna Kazmierczak and Ms. Michelle Jones for their help
   in cloning, protein purification and stopped-flow experiments. This work
   was supported by National Institutes of Health Grants HL071778 and
   HL108343 (to D.S.-C.), HL077280 (to J.R.M.) and American Heart
   Association Grant 10POST3420009 (to P.M.).
CR Marston SB, 2011, J CARDIOVASC TRANSL, V4, P245, DOI 10.1007/s12265-011-9266-2
   Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697
   Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54
   Kazmierczak K, 2012, BIOCHEM J, V442, P95, DOI 10.1042/BJ20111145
   Teekakirikul P, 2012, J CELL BIOL, V199, P417, DOI 10.1083/jcb.201207033
   Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499
   van der Velden J, 2003, CARDIOVASC RES, V57, P505, DOI 10.1016/S0008-6363(02)00662-4
   CRAIG R, 1992, J MOL BIOL, V228, P474, DOI 10.1016/0022-2836(92)90836-9
   HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186
   Schober T, 2012, CIRC RES, V111, P170, DOI 10.1161/CIRCRESAHA.112.270041
   Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134
   Morano I, 1999, J MOL MED-JMM, V77, P544, DOI 10.1007/s001099900031
   Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897
   Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670
   Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5
   Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x
   Harada K, 1999, CIRCULATION, V100, P2093
   Olivotto I, 2009, J CARDIOVASC TRANSL, V2, P349, DOI 10.1007/s12265-009-9137-2
   Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200
   Ausubel F.M., 1995, CURR PROTOC MOL BIOL, V1
   Borejdo Julian, 2012, Methods Mol Biol, V875, P311, DOI 10.1007/978-1-61779-806-1_17
   Cooke R, 2011, BIOPHYS REV, V3, P33, DOI DOI 10.1007/S12551-011-0044-9
   Cooper A., 1983, J MUSCLE RES CELL M, V4, P253
   Drabikowski W., 1964, BIOCH MUSCLE CONTRAC, P125
   Geeves MA, 2002, NATURE, V415, P129, DOI 10.1038/415129a
   Greenberg MJ, 2010, P NATL ACAD SCI USA, V107, P17403, DOI 10.1073/pnas.1009619107
   HANSON KR, 1967, BIOCHEM BIOPH RES CO, V29, P194, DOI 10.1016/0006-291X(67)90586-4
   HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688
   Houdusse A, 1996, STRUCTURE, V4, P21, DOI 10.1016/S0969-2126(96)00006-8
   Kerrick WGL, 2009, FASEB J, V23, P855, DOI 10.1096/fj.08-118182
   Midde K, 2013, J BIOL CHEM, V288, P7012, DOI 10.1074/jbc.M112.434209
   MORANO I, 1992, BASIC RES CARDIOL, V87, P129
   Muthu P, 2012, J CELL MOL MED, V16, P911, DOI 10.1111/j.1582-4934.2011.01371.x
   Muthu P, 2012, CARDIOMYOPATHIES BAS, P383
   NADALGINARD B, 1989, J CLIN INVEST, V84, P1693, DOI 10.1172/JCI114351
   Pant K, 2009, FASEB J, V23, P3571, DOI 10.1096/fj.08-126672
   PARDEE JD, 1982, METHOD ENZYMOL, V85, P164
   RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857
   Richard P, 2004, CIRCULATION, V109, P3258
   ROBERTSON SP, 1981, BIOPHYS J, V34, P559
   Straub F.B., 1942, I MED CHEM U SZEGED, V2, P3
   Szczesna Danuta, 2003, Current Drug Targets - Cardiovascular & Haematological Disorders, V3, P187, DOI 10.2174/1568006033481474
   Toepfer C, 2013, J BIOL CHEM, V288, P13446, DOI 10.1074/jbc.M113.455444
   Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085
   van der Velden J, 2003, ADV EXP MED BIOL, V538, P3
NR 49
TC 4
Z9 4
U1 1
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 29
EP 39
DI 10.1016/j.abb.2013.12.011
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300005
PM 24374283
ER

PT J
AU Robertson, IM
   Pineda-Sanabria, SE
   Holmes, PC
   Sykes, BD
AF Robertson, Ian M.
   Pineda-Sanabria, Sandra E.
   Holmes, Peter C.
   Sykes, Brian D.
TI Conformation of the critical pH sensitive region of troponin depends
   upon a single residue in troponin I
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Troponin C; Troponin I; Histidine button; Ischemia; Acidosis; NMR
   spectroscopy
ID HUMAN CARDIAC TROPONIN; N-TERMINAL EXTENSION; MOLECULAR-STRUCTURE
   DETERMINATION; PROTEIN SECONDARY STRUCTURE; REGULATORY DOMAIN;
   SKELETAL-MUSCLE; THIN FILAMENT; NMR-SPECTROSCOPY; STRIATED-MUSCLE;
   CRYSTAL-STRUCTURE
AB The calcium sensitivity of cardiac and skeletal muscle is reduced during cytosolic acidosis, and this inhibition is more pronounced in cardiac muscle. Replacing cardiac troponin I with skeletal troponin I reduces the pH sensitivity of cardiac muscle. This diminished pH sensitivity depends on a single amino acid difference in troponin I: an alanine in cardiac and a histidine in skeletal. Studies suggested that when this histidine is protonated, it forms an electrostatic interaction with glutamate 19 on the surface of cardiac troponin C. Structures of the skeletal and cardiac troponin complexes show very different conformations for the region of troponin I surrounding this residue. In this study, we determined the structure of skeletal troponin I bound to cardiac troponin C. Skeletal troponin I is found to bind to cardiac troponin C with histidine 130 in close proximity to glutamate 19. This conformation is homologous to the crystal structure of the skeletal troponin complex; but different than in the cardiac complex. We show that an A162H variant of cardiac troponin I adopts a conformation similar to the skeletal structure. The implications of these structural differences in the context of cardiac muscle regulation are discussed. Crown Copyright (C) 2013 Published by Elsevier Inc. All rights reserved.
C1 [Robertson, Ian M.; Pineda-Sanabria, Sandra E.; Holmes, Peter C.; Sykes, Brian D.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.
RP Sykes, BD (reprint author), Univ Alberta, Dept Biochem, 4-19 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.
EM brian.sykes@ualberta.ca
RI Robertson, Ian/D-8266-2013
OI Robertson, Ian/0000-0001-9561-1418
FU CIHR [37769]; CIHR fellowship; AIHS studentship; NSERC studentship
FX The authors thank Drs. Pascal Mercier and Craig Markin for discussion
   about the skeletal TnC-TnI structures, Dr. Yin-Biao Sun for helpful
   comments on the manuscript and for atomic coordinates of the
   thin-filament based on fluorescence data, Dave Corson for help in
   protein expression and purification and Drs. Monica Li, Peter Hwang,
   Brian Lee, and John Glaves for general discussion. This work is
   supported by CIHR operating grant 37769. IMR is the recipient of a CIHR
   fellowship, SEPS is the recipient of an AIHS studentship, and PCH is the
   recipient of an NSERC studentship.
CR Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375
   Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730
   Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216
   Mercier P, 2003, BIOCHEMISTRY-US, V42, P4333, DOI 10.1021/bi027041n
   Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6
   GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784
   Clore GM, 2000, P NATL ACAD SCI USA, V97, P9021, DOI 10.1073/pnas.97.16.9021
   Galinska A, 2010, CIRC RES, V106, P705, DOI 10.1161/CIRCRESAHA.109.210047
   WISHART DS, 1994, METHOD ENZYMOL, V239, P363
   Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035
   Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887
   Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2
   Westfall MV, 1997, P NATL ACAD SCI USA, V94, P5444, DOI 10.1073/pnas.94.10.5444
   Baryshnikova OK, 2008, J BIOMOL NMR, V41, P5, DOI 10.1007/s10858-008-9234-6
   Julien O, 2011, PROTEINS, V79, P1240, DOI 10.1002/prot.22959
   Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200
   Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216
   Solaro RJ, 2011, J BIOL CHEM, V286, P9935, DOI 10.1074/jbc.R110.197731
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   Li MX, 2002, EUR BIOPHYS J BIOPHY, V31, P245, DOI 10.1007/s00249-002-0227-1
   Robertson IM, 2010, J MOL CELL CARDIOL, V49, P1031, DOI 10.1016/j.yjmcc.2010.08.019
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d
   Day SM, 2006, NAT MED, V12, P181, DOI 10.1038/nm1346
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
   Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116
   Pineda-Sanabria SE, 2013, CARDIOVASC RES, V97, P481, DOI 10.1093/cvr/cvs348
   Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031
   JENNINGS RB, 1991, ANNU REV MED, V42, P225, DOI 10.1146/annurev.med.42.1.225
   HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0
   Wang X, 2002, J BIOL CHEM, V277, P31124, DOI 10.1074/jbc.M203896200
   Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003
   Ward DG, 2004, BIOCHEMISTRY-US, V43, P4020, DOI 10.1021/bi0361281
   Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102
   Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   Li Y, 2000, P NATL ACAD SCI USA, V97, P5140, DOI 10.1073/pnas.090098997
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Slupsky CM, 2003, J BIOMOL NMR, V27, P313, DOI 10.1023/A:1025870122182
   Ward DG, 2003, BIOCHEMISTRY-US, V42, P10324, DOI 10.1021/bi034495r
   Zhou ZQ, 2012, J BIOL CHEM, V287, P7661, DOI 10.1074/jbc.M111.281600
   Ramos CHI, 1999, J BIOL CHEM, V274, P18189, DOI 10.1074/jbc.274.26.18189
   Dargis R, 2002, J BIOL CHEM, V277, P34662, DOI 10.1074/jbc.C200419200
   Warren CM, 2009, J BIOL CHEM, V284, P14258, DOI 10.1074/jbc.M807621200
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Oleszczuk M, 2010, J MOL CELL CARDIOL, V48, P925, DOI 10.1016/j.yjmcc.2010.01.016
   Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005
   Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679
   Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001
   Westfall MV, 2007, J MOL CELL CARDIOL, V43, P107, DOI 10.1016/j.yjmcc.2007.05.017
   Robertson IM, 2011, J BIOMOL NMR, V51, P115, DOI 10.1007/s10858-011-9546-9
   Blumenschein TMA, 2005, J BIOL CHEM, V280, P21924, DOI 10.1074/jbc.M500574200
   FARAH CS, 1994, J BIOL CHEM, V269, P5230
   Ferguson RE, 2003, MOL CELL, V11, P865, DOI 10.1016/S1097-2765(03)00096-0
   Hoffman RMB, 2009, BIOCHEMISTRY-US, V48, P5541, DOI 10.1021/bi9001826
   IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019
   Kirkpatrick KP, 2011, J EXP BIOL, V214, P1981, DOI 10.1242/jeb.052860
   Knowles AC, 2012, J MOL BIOL, V421, P125, DOI 10.1016/j.jmb.2012.05.005
   Kobayashi T, 2008, PFLUG ARCH EUR J PHY, V457, P37, DOI 10.1007/s00424-008-0511-8
   LEE JA, 1991, J CLIN INVEST, V88, P361, DOI 10.1172/JCI115311
   LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3
   Li G, 2001, J MOL CELL CARDIOL, V33, P1309, DOI 10.1006/jmcc.2001.1392
   Makinde AO, 1998, MOL CELL BIOCHEM, V188, P49, DOI 10.1023/A:1006860104840
   Palpant NJ, 2010, PHYSIOL GENOMICS, V42, P287, DOI 10.1152/physiolgenomics.00033.2010
   Palpant NJ, 2012, BIOPHYS J, V102, P1570, DOI 10.1016/j.bpj.2012.01.024
   Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050
   Robertson IM, 2009, NATO SCIENCE PEACE S, P101, DOI 10.1007/978-90-481-2368-1_7
   Robertson IM, 2012, J BIOL CHEM, V287, P4996, DOI 10.1074/jbc.M111.301499
   ROBERTSON SP, 1982, J BIOL CHEM, V257, P260
   Shaffer JF, 2010, PHYSIOL GENOMICS, V42, P406, DOI 10.1152/physiolgenomics.00055.2010
   Tanford C., 1961, PHYS CHEM MACROMOLEC
   Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847
   Whitby FG, 2000, PROTEINS, V38, P49
   Wolska BM, 2001, J PHYSIOL-LONDON, V536, P863, DOI 10.1111/j.1469-7793.2001.00863.x
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
NR 75
TC 3
Z9 3
U1 2
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 40
EP 49
DI 10.1016/j.abb.2013.12.003
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300006
PM 24333682
ER

PT J
AU Puglisi, JL
   Goldspink, PH
   Gomes, AV
   Utter, MS
   Bers, DM
   Solaro, RJ
AF Puglisi, Jose L.
   Goldspink, Paul H.
   Gomes, Aldrin V.
   Utter, Megan S.
   Bers, Donald M.
   Solaro, R. John
TI Influence of a constitutive increase in myofilament Ca2+-sensitivity on
   Ca2+-fluxes and contraction of mouse heart ventricular myocytes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Troponin I; Arrhythmia; Ca-sensitizer; Hypertrophic cardiomyopathy
ID FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; SKELETAL TROPONIN-I;
   BETA-ADRENERGIC RESPONSIVENESS; GENETIC-DETERMINANTS; CALCIUM
   SENSITIVITY; INTRACELLULAR CA2+; DIASTOLIC FUNCTION; ISOMETRIC TENSION;
   CARDIAC MYOCYTES; TRANSGENIC MICE
AB Chronic increases in myofilament Ca2+-sensitivity in the heart are known to alter gene expression potentially modifying Ca2+-homeostasis and inducing arrhythmias. We tested age-dependent effects of a chronic increase in myofilament Ca2+-sensitivity on induction of altered alter gene expression and activity of Ca2+ transport systems in cardiac myocytes. Our approach was to determine the relative contributions of the major mechanisms responsible for restoring Ca2+ to basal levels in field stimulated ventricular myocytes. Comparisons were made from ventricular myocytes isolated from non-transgenic (NTG) controls and transgenic mice expressing the fetal, slow skeletal troponin I (TG-ssTnI) in place of cardiac TnI (cTnI). Replacement of cTnI by ssTnI induces an increase in myofilament Ca2+-sensitivity. Comparisons included myocytes from relatively young (5-7 months) and older mice (11-13 months). Employing application of caffeine in normal Tyrode and in 0Na(+) 0Ca(2+) solution, we were able to dissect the contribution of the sarcoplasmic reticulum Ca2+ pump (SR Ca2+-ATPase), the Na+/Ca2+ exchanger (NCX), and "slow mechanisms" representing the activity of the sarcolemmal Ca2+ pump and the mitochondrial Ca2+ uniporter. The relative contribution of the SR Ca2+-ATPase to restoration of basal Ca2+ levels in younger TG-ssTnI myocytes was lower than in NTG (81.12 +/- 2.8% vs 92.70 +/- 1.02%), but the same in the older myocytes. Younger and older NTG myocytes demonstrated similar contributions from the SR Ca2+-ATPase and NCX to restoration of basal Ca2+. However, the slow mechanisms for Ca2+ removal were increased in the older NTG (3.4 +/- 0.3%) vs the younger NTG myocytes (1.4 +/- 0.1%). Compared to NTG, younger TG-ssTnI myocytes demonstrated a significantly bigger contribution of the NCX (16 +/- 2.7% in TG vs 6.9 +/- 0.9% in NTG) and slow mechanisms (3.3 +/- 0.4% in TG vs 1.4 +/- 0.1% in NTG). In older TG-ssTnI myocytes the contributions were not significantly different from NTG (NCX: 4.9 +/- 0.6% in TG vs 5.5 +/- 0.7% in NTG; slow mechanisms: 2.5 +/- 0.3% in TG vs 3.4 +/- 0.3% in NTG). Our data indicate that constitutive increases in myofilament Ca2+-sensitivity alter the relative significance of the NCX transport system involved in Ca2+-homeostasis only in a younger group of mice. This modification may be of significance in early changes in altered gene expression and electrical stability hearts with increased myofilament Ca-sensitivity. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Puglisi, Jose L.; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.
   [Goldspink, Paul H.; Utter, Megan S.; Solaro, R. John] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA.
   [Gomes, Aldrin V.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.
RP Solaro, RJ (reprint author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott,Ave M-C 901,E202 Med Sci Bldg, Chicago, IL 60612 USA.
EM solarorj@uic.edu
OI Gomes, Aldrin/0000-0002-9819-3036
FU NIH [RO1 HL 022231, PO1 HL 062426, R37 HL 030077, R01 HL 096819];
   American Heart Association
FX The authors are grateful to Drs. Lynn Wang and Anne Martin for their
   help in management of the mouse colonies and for help with the early
   phases of the experiments. Grant support was NIH RO1 HL 022231 and PO1
   HL 062426 (RJS), R37 HL 030077 (DMB), R01 HL 096819 (AVG), and American
   Heart Association (JLP).
CR Alden KJ, 2002, AM J PHYSIOL-CELL PH, V282, pC768, DOI 10.1152/ajpcell.00494.2001
   Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B
   Marston SB, 2011, J CARDIOVASC TRANSL, V4, P245, DOI 10.1007/s12265-011-9266-2
   F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x
   Lombardi R, 2008, CARDIOVASC RES, V79, P109, DOI 10.1093/cvr/cvn078
   Kokado H, 2000, CIRCULATION, V102, P663
   Marian AJ, 2008, CURR OPIN CARDIOL, V23, P199, DOI 10.1097/HCO.0b013e3282fc27d9
   Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5
   Keren A, 2008, NAT CLIN PRACT CARD, V5, P158, DOI 10.1038/ncpcardio1110
   Puglisi JL, 1996, AM J PHYSIOL-HEART C, V270, pH1772
   Dias FAL, 2006, J MOL CELL CARDIOL, V41, P330, DOI 10.1016/j.yjmcc.2006.05.012
   Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436
   Montgomery DE, 2001, J PHYSIOL-LONDON, V536, P583, DOI 10.1111/j.1469-7793.2001.0583c.xd
   Baudenbacher F, 2008, J CLIN INVEST, V118, P3893, DOI 10.1172/JCI36642
   Pogwizd SM, 1999, CIRC RES, V85, P1009
   Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132
   Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379
   Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193
   Pound KM, 2011, J MOL CELL CARDIOL, V51, P236, DOI 10.1016/j.yjmcc.2011.05.014
   Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170
   LeWinter MM, 2005, HEART FAIL REV, V10, P249, DOI 10.1007/s10741-005-5254-4
   Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x
   Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007
   Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672
   Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012
   Bahrudin U, 2011, J MOL BIOL, V413, P857, DOI 10.1016/j.jmb.2011.09.006
   BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279
   BASSANI RA, 1995, PFLUG ARCH EUR J PHY, V430, P573, DOI 10.1007/BF00373894
   Bassani RA, 2002, AM J PHYSIOL-HEART C, V282, pH2406, DOI 10.1152/ajpheart.00320.2001
   Bers DM, 2005, ANN NY ACAD SCI, V1047, P86, DOI 10.1196/annals.1341.008
   Biesiadecki BJ, 2010, J BIOL CHEM, V285, P19688, DOI 10.1074/jbc.M109.086892
   Chu GX, 1998, ANN NY ACAD SCI, V853, P49, DOI 10.1111/j.1749-6632.1998.tb08256.x
   Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018
   Guinto PJ, 2009, AM J PHYSIOL-HEART C, V297, pH614, DOI 10.1152/ajpheart.01143.2008
   Hasenfuss G, 1999, CIRCULATION, V99, P641
   HOFMANN PA, 1993, CIRC RES, V72, P50
   Hudsmith LE, 2006, INT J CARDIOVAS IMAG, V22, P493, DOI 10.1007/s10554-005-9034-y
   Huke S, 2013, CIRC RES, V112, P1334, DOI 10.1161/CIRCRESAHA.113.301055
   Jagatheesan G, 2007, AM J PHYSIOL-HEART C, V293, pH949, DOI 10.1152/ajpheart.01341.2006
   Kawai M, 2000, CLIN SCI, V99, P547, DOI 10.1042/CS20000063
   Kranias E. G., 2007, V45, P523
   KURIHARA S, 1990, JPN J PHYSIOL, V40, P915, DOI 10.2170/jjphysiol.40.915
   Kusakari Y, 2006, J PHYSIOL SCI, V56, P219, DOI 10.2170/physiolsci.RP003706
   Li L, 1998, AM J PHYSIOL-HEART C, V274, pH1335
   Ly HQ, 2005, CAN J CARDIOL, V21, P441
   Michele DE, 2000, J MOL MED-JMM, V78, P543, DOI 10.1007/s001090000161
   Pierce KE, 2000, MOL HUM REPROD, V6, P1155, DOI 10.1093/molehr/6.12.1155
   POWERS FM, 1995, AM J PHYSIOL-CELL PH, V268, pC1348
   SAEKI Y, 1993, J PHYSIOL-LONDON, V463, P291
   Solaro R.J., 2002, BASIC RES CARDIOL S1, V97, pI102
   Solaro RJ, 2002, J NUCL CARDIOL, V9, P523, DOI 10.1067/mnc.2002.127626
   Suematsu N, 2002, BASIC RES CARDIOL, V97, P137, DOI 10.1007/s003950200004
   Urboniene D, 2005, CIRC RES, V97, P70, DOI 10.1161/01.RES.0000173849.68636.1e
   Wei SK, 2003, CIRC RES, V92, P897, DOI 10.1161/01.RES.0000069701.19660.14
   WESTFALL MV, 1992, CIRC RES, V70, P302
   WOLFF MR, 1995, CIRC RES, V76, P781
   Wolska BM, 2001, J PHYSIOL-LONDON, V536, P863, DOI 10.1111/j.1469-7793.2001.00863.x
   Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250
NR 58
TC 2
Z9 2
U1 2
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 50
EP 59
DI 10.1016/j.abb.2014.01.019
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300007
PM 24480308
ER

PT J
AU Brandt, PW
   Poggesi, C
AF Brandt, Philip W.
   Poggesi, Corrado
TI Clusters of bound Ca2+ initiate contraction in fast skeletal muscle
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Skeletal muscle; Myofilaments; Contraction regulation; Troponin C;
   Calcium binding; Fluorescent probes
ID LABELED TROPONIN-C; CYCLING CROSS-BRIDGES; RABBIT PSOAS MUSCLE;
   X-RAY-DIFFRACTION; THIN-FILAMENTS; STRUCTURAL-CHANGES; REGULATORY SITES;
   COOPERATIVE ACTIVATION; RIGOR CROSSBRIDGES; MAGNESIUM BINDING
AB Ca2+-binding to troponin C ultimately controls force in muscle leading to the expectation that the two curves, pCa/force and pCa/Ca2+ binding, will coincide. Using an improved fluorescence apparatus to measure Ca2+-binding, we confirm a displacement between the position and shape of the pCa/Ca2+-binding and pCa/force curves. This displacement may be part of a mechanism that reduces the noise inherent in the control process. There must always be some Ca2+-binding events even at 10 or 100 nM, well below threshold for muscle contraction. To minimize the response to such random binding events we suggest that clusters of adjacent Ca2+-binding sites must be filled before contraction is initiated. Clusters promote the reconfiguration of the thin filament to the "On" state; this simultaneously increases thin filaments' affinity for myosin heads and of troponin C for Ca2+ producing the highly cooperative pCa/force curve. The cluster requirement displaces the Ca2+-binding from the force curve as observed. The thin filament conformational changes and the accompanying affinity increases introduce a discontinuity in the pCa/Ca2+-binding curve. The curve, therefore, is most appropriately fit by two separate Hill equations, a simple non-cooperative one (midpoint, pK(1), n(1) similar to 1) for the foot and a second cooperative one (pK(2), n(2) similar to 2.5) for the upper part. With this fit pK(2) is larger than pK(1) as our argument requires, in contrast to fitting to the sum of two Hill equations. It also expresses the idea that there may be three states of the thin filament. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Brandt, Philip W.] Columbia Univ, Dept Pathol, New York, NY 10032 USA.
   [Poggesi, Corrado] Univ Firenze, Dipartimento Med Sperimentale & Clin, I-50134 Florence, Italy.
RP Poggesi, C (reprint author), Univ Firenze, Dipartimento Med Sperimentale & Clin, Viale Morgagni 63, I-50134 Florence, Italy.
EM corrado.poggesi@unifi.it
CR Adhikari BB, 2001, FEBS LETT, V497, P95, DOI 10.1016/S0014-5793(01)02444-9
   ALLEN TS, 1992, BIOPHYS J, V61, P399
   JOHNSON JD, 1978, J BIOL CHEM, V253, P6451
   Dobesh DP, 2002, AM J PHYSIOL-HEART C, V282, pH1055
   POTTER JD, 1975, J BIOL CHEM, V250, P4628
   BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707
   KRESS M, 1986, J MOL BIOL, V188, P325, DOI 10.1016/0022-2836(86)90158-0
   Davis JP, 2002, J BIOL CHEM, V277, P49716, DOI 10.1074/jbc.M208488200
   Matsuo T, 2010, BIOPHYS J, V99, P193, DOI [10.1016/j.bpj.2010.04.021, 10.1016/j.bpj.2010.04.02]
   Tesi C, 2002, BIOPHYS J, V83, P2142
   Grabarek Z, 2011, BBA-MOL CELL RES, V1813, P913, DOI 10.1016/j.bbamcr.2011.01.017
   Bell MG, 2006, BIOPHYS J, V90, P531, DOI 10.1529/biophysj.105.072769
   BRANDT PW, 1980, P NATL ACAD SCI-BIOL, V77, P4717, DOI 10.1073/pnas.77.8.4717
   Brandt PW, 2010, BIOPHYS J, V98, p150A
   BRANDT PW, 1982, J GEN PHYSIOL, V79, P997, DOI 10.1085/jgp.79.6.997
   BRANDT PW, 1984, CARLSBERG RES COMMUN, V49, P155, DOI 10.1007/BF02913943
   BRANDT PW, 1987, J MOL BIOL, V195, P885, DOI 10.1016/0022-2836(87)90492-X
   BRANDT PW, 1972, J GEN PHYSIOL, V59, P305, DOI 10.1085/jgp.59.3.305
   BRANDT PW, 1984, J MOL BIOL, V180, P379, DOI 10.1016/S0022-2836(84)80010-8
   BRANDT PW, 1990, J MOL BIOL, V212, P473, DOI 10.1016/0022-2836(90)90326-H
   Cantino ME, 2007, BIOPHYS J, V92, P525, DOI 10.1529/biophysj.106.093757
   Caremani M, 2008, BIOPHYS J, V95, P5798, DOI 10.1529/biophysj.108.130435
   Caremani M, 2011, BIOPHYS J, V100, P665, DOI 10.1016/j.bpj.2010.12.3723
   DONALDSON SKB, 1975, J GEN PHYSIOL, V66, P427, DOI 10.1085/jgp.66.4.427
   EBASHI S, 1988, ANN NY ACAD SCI, V522, P51, DOI 10.1111/j.1749-6632.1988.tb33343.x
   EBASHI S, 1980, PROC R SOC SER B-BIO, V207, P259, DOI 10.1098/rspb.1980.0024
   FUCHS F, 1982, BIOCHIM BIOPHYS ACTA, V679, P110, DOI 10.1016/0005-2728(82)90261-4
   GUTH K, 1987, J BIOL CHEM, V262, P13627
   HANNON JD, 1992, CIRC RES, V71, P984
   Huang M, 2001, J MUSCLE RES CELL M, V22, P635, DOI 10.1023/A:1016381627438
   Huang M, 1998, BIOPHYS J, V74, pA346
   IIO T, 1981, J BIOCHEM-TOKYO, V90, P163
   Kawai M., 1981, BIOPHYS J BIOPHYS J, P885
   Linari M, 2009, BIOPHYS J, V96, P583, DOI 10.1016/j.bpj.2008.09.026
   MCKILLOP DFA, 1993, BIOPHYS J, V65, P693
   MOSS RL, 1984, BIOPHYS J, V45, P733
   MOSS RL, 1985, J GEN PHYSIOL, V86, P585, DOI 10.1085/jgp.86.4.585
   MOSS RL, 1983, BIOPHYS J, V43, P115
   Natori R., 1954, JIKEIKAI MED J, V1, P119
   Putkey JA, 1997, BIOCHEMISTRY-US, V36, P970, DOI 10.1021/bi9617466
   REUBEN JP, 1971, J GEN PHYSIOL, V57, P385, DOI 10.1085/jgp.57.4.385
   Schachat F., 2013, J MUSCLE RES CELL MO
   Sun YB, 2010, J MOL CELL CARDIOL, V48, P859, DOI 10.1016/j.yjmcc.2009.11.019
   Sun YB, 2006, P NATL ACAD SCI USA, V103, P17771, DOI 10.1073/pnas.0605430103
   TAKEMORI S, 1995, J BIOCHEM, V117, P603
   WEBER A, 1969, BIOCHEMISTRY-US, V8, P2266, DOI 10.1021/bi00834a005
   WEBER A, 1963, J BIOL CHEM, V238, P599
   WINEGRAD S, 1971, J GEN PHYSIOL, V58, P71, DOI 10.1085/jgp.58.1.71
   Wood D.S., 1975, SCIENCE, V187, P187
   ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031
   ZOT HG, 1986, J BIOL CHEM, V261, P5883
   ZOT HG, 1987, J MUSCLE RES CELL M, V8, P428, DOI 10.1007/BF01578432
   ZOT HG, 1982, J BIOL CHEM, V257, P7678
NR 55
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 60
EP 67
DI 10.1016/j.abb.2013.12.013
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300008
PM 24374032
ER

PT J
AU Lehman, W
   Li, XC
   Orzechowski, M
   Fischer, S
AF Lehman, William
   Li, Xiaochuan (Edward)
   Orzechowski, Marek
   Fischer, Stefan
TI The structural dynamics of alpha-tropomyosin on F-actin shape the
   overlap complex between adjacent tropomyosin molecules
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Actin; Coiled-coil; Molecular dynamics; Thin filaments; Tropomyosin
ID HELICAL COILED COILS; MUSCLE TROPOMYOSIN; CRYSTAL-STRUCTURE;
   GESTALT-BINDING; STRIATED-MUSCLE; AMINO TERMINUS; THIN-FILAMENTS;
   ISOFORMS; TROPONIN; REVEALS
AB Coiled-coil tropomyosin, localized on actin filaments in virtually all eukaryotic cells, serves as a gatekeeper regulating access of the motor protein myosin and other actin-binding proteins onto the thin filament surface. Tropomyosin's modular pseudo-repeating pattern of approximately 39 amino acid residues is designed to allow binding of the coiled-coil to successive actin subunits along thin filaments. Even though different tropomyosin isoforms contain varying numbers of repeat modules, the pseudo-repeat length, in all cases, matches that of a single actin subunit. Thus, the seven pseudo-repeats of 42 nm long muscle tropomyosin bind to seven successive actin subunits along thin filaments, while simultaneously bending into a super-helical conformation that is preshaped to the actin filament helix. In order to form a continuous cable on thin filaments that is free of gaps, adjacent tropomyosin molecules polymerize head-to-tail by means of a short (similar to 9 residue) overlap. Several laboratories have engineered peptides to mimic the N- and C-terminal tropomyosin association and to characterize the overlap structure. All overlapping domains examined show a compact N-terminal coiled-coil inserting into a partially opened C-terminal partner, where the opposing coiled-coils at the overlap junction face each other at up to similar to 90 twist angles. Here, Molecular Dynamics (MD) simulations were carried out to determine constraints on the formation of the tropomyosin overlap complex and to assess the amount of twisting exhibited by full-length tropomyosin when bound to actin. With the exception of the last 20-40 Cand N-terminal residues, we find that the average tropomyosin structure closely resembles a "canonical" model proposed in the classic work of McLachlan and Stewart, displaying perfectly symmetrical supercoil geometry matching the F-actin helix with an integral number of coiled-coil turns, a coiled-coil helical pitch of 137 angstrom, a superhelical pitch of 770 angstrom, and no localized pseudo-rotation. Over the middle 70% of tropomyosin, the average twisting of the coiled-coil deviates only by 10 degrees from the canonical model and the torsional freedom is very small (std. dev. of 7 degrees). This small degree of twisting cannot yield the orthogonal N- and C-termini configuration observed experimentally. In marked contrast, considerable coiled-coil unfolding, splaying and twisting at N- and C-terminal ends is observed, providing the conformational plasticity needed for head-to-tail nexus formation. 2013 Elsevier Inc. All rights reserved.
C1 [Lehman, William; Li, Xiaochuan (Edward); Orzechowski, Marek] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.
   [Li, Xiaochuan (Edward); Orzechowski, Marek; Fischer, Stefan] Heidelberg Univ, IWR, Computat Biochem Grp, D-69120 Heidelberg, Germany.
RP Lehman, W (reprint author), Boston Univ, Sch Med, Dept Physiol & Biophys, 72 East Concord St, Boston, MA 02118 USA.
EM wlehman@bu.edu; stefan.fischer@iwr.uni-heidelberg.de
FU NIH [R37-HL036153, P01-HL086655]
FX This work was supported by grants from the NIH (R37-HL036153 to W.L. and
   P01-HL086655 to W.L. and Kathleen G. Morgan). We thank Dr. Stefan
   Raunser for providing coordinates of structures in Ref. [38].
CR Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5
   PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5
   Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862
   Creed SJ, 2011, EXP CELL RES, V317, P249, DOI 10.1016/j.yexcr.2010.10.019
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461
   Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685
   Lehman W, 2008, ADV EXP MED BIOL, V644, P95
   Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697
   Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800
   Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   ISHIKAWA R, 1989, J BIOL CHEM, V264, P7490
   Frye J, 2010, BIOCHEMISTRY-US, V49, P4908, DOI 10.1021/bi100349a
   Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   Barua B, 2013, J BIOL CHEM, V288, P9602, DOI 10.1074/jbc.M113.451161
   Barua B, 2012, P NATL ACAD SCI USA, V109, P18425, DOI 10.1073/pnas.1212754109
   Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102
   CHO YJ, 1990, J BIOL CHEM, V265, P538
   Creed SJ, 2008, EUR J CELL BIOL, V87, P709, DOI 10.1016/j.ejcb.2008.03.004
   Greenfield NJ, 2003, BIOCHEMISTRY-US, V42, P614, DOI 10.1021/bi026989e
   Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341
   HEALD RW, 1988, J BIOL CHEM, V263, P5254
   Hitchcock-DeGregori SE, 2010, J STRUCT BIOL, V170, P319, DOI 10.1016/j.jsb.2009.12.013
   Hitchcock-DeGregori SE, 2008, ADV EXP MED BIOL, V644, P60
   Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6
   Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361
   Ishikawa R, 1998, J BIOL CHEM, V273, P26991, DOI 10.1074/jbc.273.41.26991
   JOHNSON P, 1977, BIOCHEMISTRY-US, V16, P2264, DOI 10.1021/bi00629a035
   Kuhn TB, 2008, ADV EXP MED BIOL, V644, P232
   Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080
   LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0
   Lehman W, 2013, J MUSCLE RES CELL M, V34, P155, DOI 10.1007/s10974-013-9342-0
   Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060
   Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999
   LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070
   MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2
   Paulucci AA, 2004, EUR J BIOCHEM, V271, P589, DOI 10.1111/j.1432-1033.2003.03961.x
   Rao JN, 2012, J BIOL CHEM, V287, P3165, DOI 10.1074/jbc.M111.307330
   Schevzov G, 2011, BIOARCHITECTURE, V1, P135, DOI DOI 10.4161/BIOA.1.4.17897
   Schevzov G, 2012, INT REV CEL MOL BIO, V298, P33, DOI 10.1016/B978-0-12-394309-5.00002-X
   Skau C.T., 2011, CURR BIOL, V20, P1415
   Sousa D., 2010, BIOPHYS J, V99, P1
   WEGNER A, 1980, FEBS LETT, V119, P245, DOI 10.1016/0014-5793(80)80263-8
   Whitby FG, 2000, PROTEINS, V38, P49
NR 48
TC 4
Z9 4
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 68
EP 73
DI 10.1016/j.abb.2013.09.011
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300009
PM 24071513
ER

PT J
AU Jackson, DR
   Webb, M
   Stewart, TJ
   Phillips, T
   Carter, M
   Cremo, CR
   Baker, JE
AF Jackson, Del R., Jr.
   Webb, Milad
   Stewart, Travis J.
   Phillips, Travis
   Carter, Michael
   Cremo, Christine R.
   Baker, Josh E.
TI Sucrose increases the activation energy barrier for actin-myosin strong
   binding
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Sucrose; Actin; Myosin; ATPase; Motility; Binding
ID SKELETAL-MUSCLE MYOSIN; ACTOMYOSIN INTERACTION; MUSCULAR-CONTRACTION;
   HEAVY-MEROMYOSIN; STRIATED-MUSCLE; MECHANISM; FIBERS; ATPASE; VISCOSITY;
   SUBFRAGMENTS
AB To determine the mechanism by which sucrose slows in vitro actin sliding velocities, V, we used stopped flow kinetics and a single molecule binding assay, SiMBA. We observed that in the absence of ATP, sucrose (880 mM) slowed the rate of actin-myosin (A-M) strong binding by 71 +/- 8% with a smaller inhibitory effect observed on spontaneous rigor dissociation (21 +/- 3%). Similarly, in the presence of ATP, sucrose slowed strong binding associated with P-1 release by 85 +/- 9% with a smaller inhibitory effect on ATP-induced A-M dissociation, k(T) (39 +/- 2%). Sucrose had no noticeable effect on any other step in the ATPase reaction. In SiMBA, sucrose had a relatively small effect on the diffusion coefficient for actin fragments (25 +/- 2%), and with stopped flow we showed that sucrose increased the activation energy barrier for A-M strong binding by 37 +/- 3%, indicating that sucrose inhibits the rate of A-M strong binding by slowing bond formation more than diffusional searching. The inhibitory effects of sucrose on the rate of A-M rigor binding (71%) are comparable in magnitude to sucrose's effects on both V(79 +/- 33% decrease) and maximal actin-activated ATPase, k(cat), (81 +/- 16% decrease), indicating that the rate of A-M strong bond formation significantly influences both k(cat) and V. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Jackson, Del R., Jr.; Webb, Milad] Univ Nevada, Dept Biomed Engn, Reno, NV 89557 USA.
   [Stewart, Travis J.; Phillips, Travis; Cremo, Christine R.; Baker, Josh E.] Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA.
   [Carter, Michael] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA.
RP Baker, JE (reprint author), Univ Nevada, Sch Med, Dept Biochem & Mol Biol, Reno, NV 89557 USA.
EM jebaker@unr.edu
FU  [5P20RR018751];  [1R21AR055749];  [1R01HL090938];  [AR040917]
FX Grants: 5P20RR018751, 1R21AR055749, and 1R01HL090938 (JEB) and AR040917
   (CRC). Thanks to Karolina Balkenbush, Alan Stickney, and Patricia
   Ellison for contributing experimental assistance and to Kevin Facemyer
   for helpful discussions.
CR ANDO T, 1977, J BIOENERG BIOMEMBR, V9, P283, DOI 10.1007/BF00743215
   Shaw MA, 2003, BIOCHEMISTRY-US, V42, P6128, DOI 10.1021/bi026964f
   LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004
   Prochniewicz E, 2008, AM J PHYSIOL-CELL PH, V294, pC613, DOI 10.1152/ajpcell.00232.2007
   HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356
   Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200
   Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240
   Stewart TJ, 2013, CELL MOL BIOENG, V6, P26, DOI 10.1007/s12195-013-0274-y
   Yengo CM, 2012, J MUSCLE RES CELL M, V33, P385, DOI 10.1007/s10974-012-9316-7
   HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0
   BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197
   Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395
   Astle Robert C., 1984, CRC HDB CHEM PHYS
   Baker JE, 2002, BIOPHYS J, V82, P2134
   Baker JE, 1998, P NATL ACAD SCI USA, V95, P2944, DOI 10.1073/pnas.95.6.2944
   Chase PB, 2000, AM J PHYSIOL-CELL PH, V278, pC1088
   Chase PB, 1998, BIOPHYS J, V74, P1428
   COOKE R, 1985, BIOPHYS J, V48, P789
   Cooke R, 1997, PHYSIOL REV, V77, P671
   CRIDDLE AH, 1985, BIOCHEM J, V232, P343
   De La Cruz E.M., 2009, KINETIC EQUILIBRIUM
   Frederick KB, 2008, J MOL BIOL, V378, P540, DOI 10.1016/j.jmb.2008.02.022
   GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P637
   HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4
   Hooft AM, 2007, BIOCHEMISTRY-US, V46, P3513, DOI 10.1021/bi0614840
   HUXLEY AF, 1974, J PHYSIOL-LONDON, V243, P1
   MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55
   Nelson SR, 2009, BIOPHYS J, V97, P509, DOI 10.1016/j.bpj.2009.04.052
   Ostap EM, 2002, J MUSCLE RES CELL M, V23, P305, DOI 10.1023/A:1022047102064
   PARDEE JD, 1982, METHOD ENZYMOL, V85, P164
   Qian H, 1991, BIOPHYS J, V60, P910
   Robblee JP, 2005, BIOCHEMISTRY-US, V44, P10238, DOI 10.1021/bi050232g
   STEIN LA, 1985, BIOCHEMISTRY-US, V24, P1357, DOI 10.1021/bi00327a013
   Takacs B, 2011, FASEB J, V25, P111, DOI 10.1096/fj.10-164871
   Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085
   WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0
NR 36
TC 2
Z9 2
U1 2
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 74
EP 82
DI 10.1016/j.abb.2013.12.012
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300010
ER

PT J
AU Hanft, LM
   Greaser, ML
   McDonald, KS
AF Hanft, Laurin M.
   Greaser, Marion L.
   McDonald, Kerry S.
TI Titin-mediated control of cardiac myofibrillar function
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Titin; Cardiac myocyte; Sarcomere length; Power output; Rate of force
   development
ID BINDING-PROTEIN-C; SKELETAL-MUSCLE FIBERS; SARCOMERE-LENGTH DEPENDENCE;
   POWER OUTPUT; FORCE REDEVELOPMENT; DILATED CARDIOMYOPATHY;
   MECHANICAL-PROPERTIES; PASSIVE TENSION; CMYBP-C; F-ACTIN
AB According to the Frank Starling relationship, ventricular pressure or stroke volume increases with end-diastolic volume. This is regulated, in large part, by the sarcomere length (SL) dependent changes in cardiac myofibrillar force, loaded shortening, and power. Consistent with this, both cardiac myofibrillar force and absolute power fall at shorter SL However, when Ca2+ activated force levels are matched between short and long SL (by increasing the activator [Ca2+]), short SL actually yields faster loaded shortening and greater peak normalized power output (PNPO). A potential mechanism for faster loaded shortening at short SL is that, at short SL, titin becomes less taut, which increases the flexibility of the cross-bridges, a process that may be mediated by titin's interactions with thick filament proteins. We propose a more slackened titin yields greater myosin head radial and azimuthal mobility and these flexible cross-bridges are more likely to maintain thin filament activation, which would allow more force-generating cross-bridges to work against a fixed load resulting in faster loaded shortening. We tested this idea by measuring SL-dependence of power at matched forces in rat skinned cardiac myocytes containing either N2B titin or a longer, more compliant N2BA titin. We predicted that, in N2BA titin containing cardiac myocytes, power-load curves would not be shifted upward at short SL compared to long SL (when force is matched). Consistent with this, peak normalized power was actually less at short SL versus long SL (at matched force) in N2BA-containing myocytes (N2BA titin: Delta PNPO (Short SL peak power minus long SL peak power) = -0.057 +/- 0.049 (n = 5) versus N2B titin: Delta PNPO = +0.012 +/- 0.012 (n = 5). These findings support a model whereby SL per se controls mechanical properties of cross-bridges and this process is mediated by titin. This myofibrillar mechanism may help sustain ventricular power during periods of low preloads, and perhaps a breakdown of this mechanism is involved in impaired function of failing hearts. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Hanft, Laurin M.; McDonald, Kerry S.] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA.
   [Greaser, Marion L.] Univ Wisconsin, Muscle Biol Lab, Madison, WI 53706 USA.
RP McDonald, KS (reprint author), Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA.
EM mcdonaldks@missouri.edu
FU National Heart, Lung, and Blood Institute [R01-HL-057852, R01 HL-077196]
FX The authors would like to acknowledge Patra A. Mierzwa for technical
   assistance. This work was supported by a National Heart, Lung, and Blood
   Institute Grants R01-HL-057852 to K.S.M. and R01 HL-077196 to M.L.G. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Hanft LM, 2010, J PHYSIOL-LONDON, V588, P2891, DOI 10.1113/jphysiol.2010.190504
   Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A
   Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200
   Campbell K, 1997, BIOPHYS J, V72, P254
   Guo W, 2012, NAT MED, V18, P766, DOI 10.1038/nm.2693
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   GRANZIER HL, 1995, BIOPHYS J, V68, P1027
   Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050
   Herron TJ, 2001, CIRC RES, V89, P1184, DOI 10.1161/hh2401.101908
   Adhikari BB, 2004, BIOPHYS J, V87, P1784, DOI 10.1529/biophysj.103.039131
   Mun JY, 2011, J MOL BIOL, V410, P214, DOI 10.1016/j.jmb.2011.05.010
   Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013
   Neagoe C, 2002, CIRCULATION, V106, P1333, DOI 10.1161/01.CIR.0000029803.93022.93
   BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265
   Fuchs F, 2005, J MUSCLE RES CELL M, V26, P199, DOI 10.1007/s10974-005-9011-z
   LeWinter MM, 2013, CIRCULATION, V127, P938, DOI 10.1161/CIRCULATIONAHA.112.139717
   Colson BA, 2007, J MOL BIOL, V367, P36, DOI 10.1016/j.jmb.2006.12.063
   Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f
   Cazorla O, 2001, CIRC RES, V88, P1028, DOI 10.1161/hh1001.090876
   Colson B.A., 2008, CIRC RES, V103
   Edes I.F., 2007, AM J PHYSL
   Fitzsimons DP, 2001, J PHYSIOL-LONDON, V530, P263, DOI 10.1111/j.1469-7793.2001.0263l.x
   FORD LE, 1991, CIRC RES, V68, P621
   Fukuda N, 2001, CIRCULATION, V104, P1639, DOI 10.1161/hc3901.095898
   Greaser ML, 2008, J MOL CELL CARDIOL, V44, P983, DOI 10.1016/j.yjmcc.2008.02.272
   Hanft LM, 2009, AM J PHYSIOL-HEART C, V296, pH1524, DOI 10.1152/ajpheart.00864.2008
   Hinken AC, 2004, AM J PHYSIOL-CELL PH, V287, pC500, DOI 10.1152/ajpcell.00049.2004
   Korte FS, 2007, J PHYSIOL-LONDON, V581, P725, DOI 10.1113/jphysiol.2007.128199
   Kulke M, 2001, CIRC RES, V89, P874, DOI 10.1161/hh2201.099453
   LeWinter MM, 2004, CIRCULATION, V110, P109, DOI 10.1161/01.CIR.0000137284.17083.93
   McDonald KS, 2000, J PHYSIOL-LONDON, V525, P169, DOI 10.1111/j.1469-7793.2000.00169.x
   McDonald KS, 2000, CIRC RES, V87, P768
   McDonald K.S., 2012, BIOCH RES INT
   METZGER JM, 1990, SCIENCE, V247, P1088, DOI 10.1126/science.2309121
   Patel JR, 2012, AM J PHYSIOL-HEART C, V302, pH697, DOI 10.1152/ajpheart.00800.2011
   ROME LC, 1988, NATURE, V335, P824, DOI 10.1038/335824a0
   Stelzer JE, 2006, CIRC RES, V99, P884, DOI 10.1161/01.RES.0000245191.34690.66
   SWARTZ DR, 1992, J BIOL CHEM, V267, P20497
   Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683
   Voelkel T, 2011, PFLUG ARCH EUR J PHY, V462, P143, DOI 10.1007/s00424-011-0938-1
   Woledge R.C., 1985, ENERGETIC ASPECTS MU
   WOLFF MR, 1995, CIRC RES, V76, P154
NR 42
TC 2
Z9 2
U1 5
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 83
EP 91
DI 10.1016/j.abb.2013.11.005
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300011
PM 24269766
ER

PT J
AU Chung, CS
   Mitov, MI
   Callahan, LA
   Campbell, KS
AF Chung, Charles S.
   Mitov, Mihail I.
   Callahan, Leigh Ann
   Campbell, Kenneth S.
TI Increased myocardial short-range forces in a rodent model of diabetes
   reflect elevated content of beta myosin heavy chain
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Diastole; Biomechanics; Myocardial stiffness
ID MECHANICAL-PROPERTIES; CONTRACTILE PROPERTIES; ISOFORM EXPRESSION;
   CARDIAC MYOCYTES; CARDIOMYOPATHY; RAT; HEART; TITIN; STIFFNESS; TENSION
AB Diastolic dysfunction is a clinically significant problem for patients with diabetes and often reflects increased ventricular stiffness. Attached cross-bridges contribute to myocardial stiffness and produce short-range forces, but it is not yet known whether these forces are altered in diabetes. In this study, we tested the hypothesis that cross-bridge-based short-range forces are increased in the streptozotocin (STZ) induced rat model of type I diabetes. Chemically permeabilized myocardial preparations were obtained from 12 week old rats that had been injected with STZ or vehicle 4 weeks earlier, and activated in solutions with pCa (=-log(10)[Ca2+) values ranging from 9.0 to 4.5. The short-range forces elicited by controlled length changes were similar to 67% greater in the samples from the diabetic rats than in the control preparations. This change was mostly due to an increased elastic limit (the length change at the peak short-range force) as opposed to increased passive muscle stiffness. The STZ-induced increase in short-ranges forces is thus unlikely to reflect changes to titin and/or collagen filaments. Gel electrophoresis showed that STZ increased the relative expression of beta myosin heavy chain. This molecular mechanism can explain the increased short-ranges forces observed in the diabetic tissue if beta myosin molecules remain bound between the filaments for longer durations than alpha molecules during imposed movements. These results suggest that interventions that decrease myosin attachment times may be useful treatments for diastolic dysfunction associated with diabetes. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Chung, Charles S.; Mitov, Mihail I.; Campbell, Kenneth S.] Univ Kentucky, Dept Physiol Crit Care & Sleep Med, Lexington, KY 40536 USA.
   [Chung, Charles S.; Mitov, Mihail I.; Callahan, Leigh Ann; Campbell, Kenneth S.] Univ Kentucky, Ctr Muscle Biol Crit Care & Sleep Med, Lexington, KY 40536 USA.
   [Callahan, Leigh Ann] Univ Kentucky, Div Pulm Crit Care & Sleep Med, Lexington, KY 40536 USA.
RP Campbell, KS (reprint author), Dept Physiol, MS508 Chandler Med Ctr,800 Rose St, Lexington, KY 40536 USA.
EM k.s.campbell@uky.edu
RI Campbell, Kenneth/C-3285-2008; 
OI Campbell, Kenneth/0000-0001-5615-5958; Chung,
   Charles/0000-0001-9180-3236
FU AHA [09POST223406]; NIH [HL090749, TR000117]; University of Kentucky
   Research Challenge Trust Fund
FX Supported by AHA 09POST223406, NIH HL090749, NIH TR000117, and the
   University of Kentucky Research Challenge Trust Fund. The authors thank
   Premi Haynes (Campbell lab) for helpful discussions and Arnold J
   Stromberg (Statistics, University of Kentucky) for statistical advice.
CR Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392
   Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597
   Campbell KS, 2003, BIOPHYS J, V84, P3807
   Agrawal GK, 2005, PROTEOMICS, V5, P4684, DOI 10.1002/pmic.200500021
   Irving T, 2011, BIOPHYS J, V100, P1499, DOI 10.1016/j.bpj.2011.01.059
   KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035
   LITWIN SE, 1990, J CLIN INVEST, V86, P481, DOI 10.1172/JCI114734
   Devereux RB, 2000, CIRCULATION, V101, P2271
   Guo W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/753675
   Schannwell CM, 2002, CARDIOLOGY, V98, P33, DOI 10.1159/000064682
   Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2
   King NMP, 2011, J GEN PHYSIOL, V137, P81, DOI 10.1085/jgp.201010499
   Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012
   Chung CS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/310791
   Metzger JM, 1999, CIRC RES, V84, P1310
   AKELLA AB, 1995, CIRC RES, V76, P600
   Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7
   Reiser PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1814
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Chung CS, 2011, J MOL CELL CARDIOL, V51, P428, DOI 10.1016/j.yjmcc.2011.06.006
   Miyata S, 2000, CIRC RES, V86, P386
   Bupha-Intr T, 2011, AM J PHYSIOL-HEART C, V300, pH1661, DOI 10.1152/ajpheart.00411.2010
   Campbell KS, 2010, ADV EXP MED BIOL, V682, P223, DOI 10.1007/978-1-4419-6366-6_13
   Campbell KS, 2002, BIOPHYS J, V82, P929
   HOFMANN PA, 1995, AM J PHYSIOL-HEART C, V269, pH1656
   Ishikawa T, 1999, AM J PHYSIOL-HEART C, V277, pH2185
   Joseph T, 2005, BASIC RES CARDIOL, V100, P231, DOI 10.1007/s00395-005-0512-5
   Kruger M, 2010, J MOL CELL CARDIOL, V48, P910, DOI 10.1016/j.yjmcc.2010.02.012
   Lowey S, 2013, J BIOL CHEM, V288, P14780, DOI 10.1074/jbc.M113.450668
   Malhotra A, 1997, CIRC RES, V81, P1027
   Mitov MI, 2009, J MOL CELL CARDIOL, V46, P39, DOI 10.1016/j.yjmcc.2008.10.004
   Mitov MI, 2009, ELECTROPHORESIS, V30, P848, DOI 10.1002/elps.200800583
   Morris GS, 1996, LIFE SCI, V58, P833, DOI 10.1016/0024-3205(96)00016-1
   Noguchi T, 2003, J MOL CELL CARDIOL, V35, P91, DOI 10.1016/S0022-2828(02)00282-1
   Rundell VLM, 2004, AM J PHYSIOL-HEART C, V287, pH408, DOI 10.1152/ajpheart.00049.2004
   Steinberg TH, 2009, METHOD ENZYMOL, V463, P541, DOI 10.1016/S0076-6879(09)63031-7
   Syme DA, 2013, AM J PHYSIOL-REG I, V305, pR864, DOI 10.1152/ajpregu.00055.2013
   Trombitas K, 2000, BIOPHYS J, V79, P3226
   VanBuren P., 1995, BIOPHYS J, V68, p256S
   VanBuren P., 1995, BIOPHYS J, V68, p258S
   van der Velden J, 2003, ADV EXP MED BIOL, V538, P3
   Wang Y, 2013, J MOL CELL CARDIOL, V54, P1, DOI 10.1016/j.yjmcc.2012.10.010
NR 42
TC 3
Z9 3
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 92
EP 99
DI 10.1016/j.abb.2013.08.013
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300012
PM 24012810
ER

PT J
AU Hidalgo, C
   Saripalli, C
   Granzier, HL
AF Hidalgo, Carlos
   Saripalli, Chandra
   Granzier, Henk L.
TI Effect of exercise training on post-translational and
   post-transcriptional regulation of titin stiffness in striated muscle of
   wild type and IG KO mice
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Titin-based stiffness; Diastolic function; Exercise; Phosphorylation;
   Differential splicing
ID PRESERVED EJECTION FRACTION; DIASTOLIC HEART-FAILURE; RAT CARDIAC
   MYOCYTES; PROTEIN-KINASE-II; PASSIVE STIFFNESS; DILATED CARDIOMYOPATHY;
   SKELETAL-MUSCLE; VENTRICULAR-FUNCTION; RESPIRATORY MUSCLES;
   HALF-SARCOMERE
AB Exercise has beneficial effects on diastolic dysfunction but the underlying mechanisms are not well understood. Here we studied the effects of exercise on the elastic protein titin, an important determinant of diastolic stiffness, in both the left ventricle and the diaphragm. We used wild type mice and genetically engineered mice with HFpEF symptoms (IG KO mice), including diastolic dysfunction. In the diaphragm muscle, exercise increased the expression level of titin (increased titin:MHC ratio) which is expected to increase titin-based stiffness. This effect was absent in the LV. We also studied the constitutively expressed titin residues S11878 and S12022 that are known targets of CaMKII delta and PKC alpha with increased phosphorylation resulting in an increase in titin-based passive stiffness. The phosphorylation level of S11878 was unchanged whereas S12022 responded to exercise with a reduction in the phosphorylation level in the LV and, interestingly, an increase in the diaphragm. These changes are expected to lower titin's stiffness in the LV and increase stiffness in the diaphragm. We propose that these disparate effects reflect the unique physiological needs of the two tissue types and that both effects are beneficial. (C) 2014 Published by Elsevier Inc.
C1 [Granzier, Henk L.] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA.
   Univ Arizona, Sarver Mol Cardiovasc Res Program, Tucson, AZ 85724 USA.
RP Granzier, HL (reprint author), Univ Arizona, Dept Physiol, POB 245051, Tucson, AZ 85724 USA.
EM granzier@email.arizona.edu
FU NIH [R01AR060697, R01HL062881]
FX We are grateful to members of the Granzier lab for helpful discussions
   and assistance with experiments (especially undergraduate researcher
   Javier Saldana Perez). Funding support from NIH Grants R01AR060697 and
   R01HL062881 and a gift from Alan and Alfie Norville.
CR Anderson BR, 2010, J STRUCT BIOL, V170, P270, DOI 10.1016/j.jsb.2010.02.002
   Yamasaki R, 2001, BIOPHYS J, V81, P2297
   Hidalgo C, 2013, TRENDS CARDIOVAS MED, V23, P165, DOI 10.1016/j.tcm.2012.10.005
   Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99
   Natali AJ, 2002, J PHYSIOL-LONDON, V541, P863, DOI 10.1113/jphysiol.2001.013415
   Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392
   Ottenheijm CAC, 2012, J APPL PHYSIOL, V112, P1157, DOI 10.1152/japplphysiol.01166.2011
   Freiburg A, 2000, CIRC RES, V86, P1114
   Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222
   LeWinter MM, 2010, CIRCULATION, V121, P2137, DOI 10.1161/CIRCULATIONAHA.109.860171
   FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563
   Brenner DA, 2001, CIRCULATION, V104, P221
   Borbely A, 2009, CIRC RES, V104, P780, DOI 10.1161/CIRCRESAHA.108.193326
   LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293
   Richards M, 2012, HUM GENET, V131, P325, DOI 10.1007/s00439-011-1100-z
   Ratnovsky A, 2008, RESP PHYSIOL NEUROBI, V163, P82, DOI 10.1016/j.resp.2008.04.019
   Borbely A, 2005, CIRCULATION, V111, P774, DOI 10.1161/01.CIR.0000155257.33485.6D
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Hamdani N, 2013, CIRC RES, V112, P664, DOI 10.1161/CIRCRESAHA.111.300105
   GRANZIER HL, 1995, BIOPHYS J, V68, P1027
   Hudson B, 2011, CIRC RES, V109, P858, DOI 10.1161/CIRCRESAHA.111.246819
   Cazorla O, 2000, CIRC RES, V86, P59
   Konhilas JP, 2004, AM J PHYSIOL-HEART C, V287, pH2768, DOI 10.1152/ajpheart.00292.2004
   Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86
   Chung CS, 2013, CIRCULATION, V128, P19, DOI 10.1161/CIRCULATIONAHA.112.001268
   Hidalgo C, 2009, CIRC RES, V105, P631, DOI 10.1161/CIRCRESAHA.109.198465
   Marshall KD, 2013, J APPL PHYSIOL, V114, P131, DOI 10.1152/japplphysiol.01059.2012
   Helmes M, 1996, CIRC RES, V79, P619
   Neagoe C, 2002, CIRCULATION, V106, P1333, DOI 10.1161/01.CIR.0000029803.93022.93
   Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408
   HOROWITS R, 1988, BIOPHYS J, V54, P165
   Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185
   Buck D, 2010, J STRUCT BIOL, V170, P325, DOI 10.1016/j.jsb.2010.02.014
   Hamdani N, 2013, CARDIOVASC RES, V97, P464, DOI 10.1093/cvr/cvs353
   Edelmann F, 2011, J AM COLL CARDIOL, V58, P1780, DOI 10.1016/j.jacc.2011.06.054
   Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f
   Bellafiore M, 2007, EUR J HISTOCHEM, V51, P119
   Borbely A, 2009, CIRC RES, V104, P12, DOI 10.1161/CIRCRESAHA.108.191130
   Buck D, 2014, J GEN PHYSIOL, V143, P215, DOI 10.1085/jgp.201311129
   Budiono BP, 2012, AM J PHYSIOL-REG I, V302, pR1091, DOI 10.1152/ajpregu.00406.2011
   De Troyer A, 2011, COMPR PHYSIOL, V1, P1273, DOI 10.1002/cphy.c100009
   Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010
   Hidalgo CG, 2013, J MOL CELL CARDIOL, V54, P90, DOI 10.1016/j.yjmcc.2012.11.012
   Hudson B.D., 2009, J MOL CELL CARDIOL
   Joho S, 2007, AM J PHYSIOL-HEART C, V292, pH369, DOI 10.1152/ajpheart.00704.2006
   Lassche S, 2013, NEUROLOGY, V80, P733, DOI 10.1212/WNL.0b013e318282513b
   Lujan HL, 2012, AM J PHYSIOL-REG I, V302, pR68, DOI 10.1152/ajpregu.00340.2011
   Malfatto G, 2009, J CARD FAIL, V15, P327, DOI 10.1016/j.cardfail.2008.10.032
   Moore AJ, 2006, J APPL PHYSIOL, V101, P1400, DOI 10.1152/japplphysiol.01614.2005
   Ottenheijm CAC, 2009, BIOPHYS J, V97, P2277, DOI 10.1016/j.bpj.2009.07.041
   Ottenheijm CAC, 2006, AM J RESP CRIT CARE, V173, P527, DOI 10.1164/rccm.200507-10560C
   Paulus W.J., 2013, J AM COLL CARDIOL, V62, P262
   Sorimachi H, 2012, BIOL CHEM, V393, P853, DOI 10.1515/hsz-2012-0143
   Trombitas K, 2001, AM J PHYSIOL-HEART C, V281, pH1793
   Trombitas K, 2000, BIOPHYS J, V79, P3226
   Wu YM, 2007, J MOL CELL CARDIOL, V42, P186, DOI 10.1016/j.yjmcc.2006.09.017
NR 56
TC 4
Z9 4
U1 5
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 100
EP 107
DI 10.1016/j.abb.2014.02.010
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300013
PM 24603287
ER

PT J
AU Piazzesi, G
   Dolfi, M
   Brunello, E
   Fusi, L
   Reconditi, M
   Bianco, P
   Linari, M
   Lombardi, V
AF Piazzesi, Gabriella
   Dolfi, Mario
   Brunello, Elisabetta
   Fusi, Luca
   Reconditi, Massimo
   Bianco, Pasquale
   Linari, Marco
   Lombardi, Vincenzo
TI The myofilament elasticity and its effect on kinetics of force
   generation by the myosin motor
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Skeletal muscle; Muscle contraction; Myofilament elasticity; Myosin
   motor; Cross-bridge kinetics
ID FROG-MUSCLE-FIBERS; RAY-DIFFRACTION MEASUREMENTS; SKELETAL-MUSCLE;
   WORKING STROKE; CONTRACTING MUSCLE; C-PROTEIN; ISOMETRIC CONTRACTION;
   MUSCULAR-CONTRACTION; INORGANIC-PHOSPHATE; TENSION TRANSIENTS
AB The half-sarcomere is the functional unit of striated muscle, in which, according to a "linear" mechanical model, myosin motors are parallel force generators with an average strain s acting between the opposing myosin and actin filaments that behave as a series elastic element with compliance C-f. Thus the definition of the mechanism of force generation by myosin motors in muscle requires integration of the crystallographic model of the working stroke with the mechanical constraints provided by the organization of motors in the half-sarcomere. The relation between half-sarcomere compliance and force (C-hs-T) during the development of isometric contraction deviates, at low forces, from that predicted by the linear model, indicating the presence of an elastic element in parallel with the myosin motors, which may influence the estimate of s. A working stroke model, kinetically constrained by the early phase of the isotonic velocity transient following a force step, predicts that the rate of quick force recovery following a length step is reduced to the observed value by a C-f of 12.6 nm/MPa. With this value of C-f, the fit of C-hs-T relation during the isometric force rise gives s = 1.8-1.9 nm, similar to the values estimated using the linear model. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Piazzesi, Gabriella; Dolfi, Mario; Brunello, Elisabetta; Fusi, Luca; Reconditi, Massimo; Bianco, Pasquale; Linari, Marco; Lombardi, Vincenzo] Univ Florence, Dept Biol, Physiol Lab, I-50019 Sesto Fiorentino, FI, Italy.
RP Lombardi, V (reprint author), Univ Florence, Dept Biol, Physiol Lab, Via G Sansone 1, I-50019 Sesto Fiorentino, FI, Italy.
EM gabriella.piazzesi@unifi.it; mario.dolfi@unifi.it;
   elisabetta.brunello@unifi.it; luca.fusi@kcl.ac.uk;
   massimo.reconditi@unifi.it; pasquale.bianco@unifi.it;
   marco.linari@unifi.it; vincenzo.lombardi@unifi.it
CR Reconditi M, 2004, NATURE, V428, P578, DOI 10.1038/nature02380
   Huxley H, 2006, J MOL BIOL, V363, P743, DOI 10.1016/j.jmb.2006.08.075
   PIAZZESI G, 1995, BIOPHYS J, V68, P1966
   HUXLEY HE, 1994, BIOPHYS J, V67, P2411
   FORD LE, 1977, J PHYSIOL-LONDON, V269, P441
   FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563
   Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549
   Reconditi M, 2014, J PHYSIOL-LONDON, V592, P1119, DOI 10.1113/jphysiol.2013.267849
   WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422
   Kaya M, 2010, SCIENCE, V329, P686, DOI 10.1126/science.1191484
   Barclay CJ, 2010, PROG BIOPHYS MOL BIO, V102, P53, DOI 10.1016/j.pbiomolbio.2009.10.003
   Piazzesi G, 2007, CELL, V131, P784, DOI 10.1016/j.cell.2007.09.045
   WANG K, 1979, P NATL ACAD SCI USA, V76, P3698, DOI 10.1073/pnas.76.8.3698
   HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0
   Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108
   Brunello E, 2006, J PHYSIOL-LONDON, V577, P971, DOI 10.1113/jphysiol.2006.115394
   Caremani M, 2013, J PHYSIOL-LONDON, V591, P5187, DOI 10.1113/jphysiol.2013.257410
   Capitanio M, 2012, NAT METHODS, V9, P1013, DOI [10.1038/nmeth.2152, 10.1038/NMETH.2152]
   RACK PMH, 1984, J PHYSIOL-LONDON, V347, P479
   Brunello E, 2007, P NATL ACAD SCI USA, V104, P20114, DOI 10.1073/pnas.0707626104
   Caremani M, 2008, BIOPHYS J, V95, P5798, DOI 10.1529/biophysj.108.130435
   CECCHI G, 1987, PFLUG ARCH EUR J PHY, V409, P39, DOI 10.1007/BF00584747
   Colombini B, 2010, BIOPHYS J, V98, P2582, DOI 10.1016/j.bpj.2010.02.014
   Decostre V, 2005, P NATL ACAD SCI USA, V102, P13927, DOI 10.1073/pnas.0506795102
   Dobbie I, 1998, NATURE, V396, P383
   FORD LE, 1985, J PHYSIOL-LONDON, V361, P131
   FORD LE, 1981, J PHYSIOL-LONDON, V311, P219
   Fusi L, 2010, J PHYSIOL-LONDON, V588, P495, DOI 10.1113/jphysiol.2009.178137
   Huxley A. F., 1980, REFLECTIONS MUSCLE
   HUXLEY AF, 1974, J PHYSIOL-LONDON, V243, P1
   Huxley A.F., 1980, J PHYSL, V305, P15
   Huxley AF, 1996, J MUSCLE RES CELL M, V17, P507, DOI 10.1007/BF00123366
   IRVING M, 1992, NATURE, V357, P156, DOI 10.1038/357156a0
   JULIAN FJ, 1974, BIOPHYS J, V14, P546
   Linari M, 2010, P R SOC B, V277, P19, DOI 10.1098/rspb.2009.1498
   Linari M, 2009, BIOPHYS J, V96, P583, DOI 10.1016/j.bpj.2008.09.026
   LOMBARDI V, 1992, NATURE, V355, P638, DOI 10.1038/355638a0
   LOMBARDI V, 1995, NATURE, V374, P553, DOI 10.1038/374553a0
   MARUYAMA K, 1977, J BIOCHEM-TOKYO, V82, P317
   MOOS C, 1981, J CELL BIOL, V90, P25, DOI 10.1083/jcb.90.1.25
   Offer G, 2010, J MUSCLE RES CELL M, V31, P245, DOI 10.1007/s10974-010-9232-7
   Offer G., 1972, COLD SPRING HARB SYM, V37, P87
   Park-Holohan S, 2012, J PHYSIOL-LONDON, V590, P1973, DOI 10.1113/jphysiol.2011.217133
   Piazzesi G, 2002, NATURE, V415, P659, DOI 10.1038/415659a
   Piazzesi G, 2002, J PHYSIOL-LONDON, V545, P145, DOI 10.1113/jphysiol.2002.028969
   PODOLSKY RJ, 1960, NATURE, V188, P666, DOI 10.1038/188666a0
   SLAWNYCH MP, 1994, BIOPHYS J, V67, P1669
   Squire JM, 2004, J MOL BIOL, V343, P1345, DOI 10.1016/j.jmb.2004.08.084
   Woledge RC, 2009, P R SOC B, V276, P2685, DOI 10.1098/rspb.2009.0177
   YAMAMOTO K, 1986, FEBS LETT, V208, P123, DOI 10.1016/0014-5793(86)81545-9
NR 50
TC 4
Z9 4
U1 7
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 108
EP 116
DI 10.1016/j.abb.2014.02.017
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300014
PM 24631572
ER

PT J
AU Tanner, BCW
   McNabb, M
   Palmer, BM
   Toth, MJ
   Miller, MS
AF Tanner, Bertrand C. W.
   McNabb, Mark
   Palmer, Bradley M.
   Toth, Michael J.
   Miller, Mark S.
TI Random myosin loss along thick-filaments increases myosin attachment
   time and the proportion of bound myosin heads to mitigate force decline
   in skeletal muscle
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Muscle mechanics; Sarcomere structure; Thick-filaments; Computational
   modeling; Cross-bridge kinetics
ID OBSTRUCTIVE PULMONARY-DISEASE; CROSS-BRIDGE KINETICS; CHRONIC
   HEART-FAILURE; SARCOMERE-LENGTH; 3D STRUCTURE; IN-VIVO; FIBERS;
   MECHANISMS; BINDING; MODEL
AB Diminished skeletal muscle performance with aging, disuse, and disease may be partially attributed to the loss of myofilament proteins. Several laboratories have found a disproportionate loss of myosin protein content relative to other myofilament proteins, but due to methodological limitations, the structural manifestation of this protein loss is unknown. To investigate how variations in myosin content affect ensemble cross-bridge behavior and force production we simulated muscle contraction in the half-sarcomere as myosin was removed either (i) uniformly, from the Z-line end of thick-filaments, or (ii) randomly, along the length of thick-filaments. Uniform myosin removal decreased force production, showing a slightly steeper force-to-myosin content relationship than the 1:1 relationship that would be expected from the loss of cross-bridges. Random myosin removal also decreased force production, but this decrease was less than observed with uniform myosin loss, largely due to increased myosin attachment time (t(on)) and fractional cross-bridge binding with random myosin loss. These findings support our prior observations that prolonged t(on) may augment force production in single fibers with randomly reduced myosin content from chronic heart failure patients. These simulations also illustrate that the pattern of myosin loss along thick-filaments influences ensemble cross-bridge behavior and maintenance of force throughout the sarcomere. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Tanner, Bertrand C. W.; McNabb, Mark] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA.
   [Palmer, Bradley M.; Toth, Michael J.; Miller, Mark S.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.
   [Toth, Michael J.] Univ Vermont, Dept Med, Burlington, VT 05405 USA.
RP Tanner, BCW (reprint author), Washington State Univ, Dept Integrat Physiol & Neurosci, 255 VBR,1815 Ferdinands Lane, Pullman, WA 99164 USA.
EM btanner@vetmed.wsu.edu
FU state of Washington; National Institutes of Health [T32-HL007647,
   P01-HL59408, R01-HL077418, R01-AG033547, K01-AG031303]
FX This work was supported by start-up funds from the state of Washington
   (BCWT) and National Institutes of Health grants T32-HL007647 (BCWT),
   P01-HL59408 (BMP), R01-HL077418 (MJT), R01-AG033547 (MJT), and
   K01-AG031303 (MSM).
CR Ahn AN, 2003, J PHYSIOL-LONDON, V549, P877, DOI 10.1113/jphysiol.2003.038018
   Al-Khayat HA, 2004, J MUSCLE RES CELL M, V25, P635, DOI 10.1007/s10974-004-5333-5
   Al-Khayat HA, 2008, J STRUCT BIOL, V163, P117, DOI 10.1016/j.jsb.2008.03.011
   Ottenheijm CAC, 2005, AM J RESP CRIT CARE, V172, P200, DOI 10.1164/rccm.200502-262OC
   GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170
   Miller MS, 2009, CIRC-HEART FAIL, V2, P700, DOI 10.1161/CIRCHEARTFAILURE.109.876433
   Miller MS, 2010, J PHYSIOL-LONDON, V588, P4039, DOI 10.1113/jphysiol.2010.191957
   Campbell K, 1997, BIOPHYS J, V72, P254
   JAKUBIECPUKA A, 1992, COMP BIOCHEM PHYS A, V102, P93, DOI 10.1016/0300-9629(92)90017-K
   D'Antona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276
   HOPPELER H, 1973, PFLUG ARCH EUR J PHY, V344, P217, DOI 10.1007/BF00588462
   Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059
   Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549
   Adams GR, 2003, J APPL PHYSIOL, V95, P2185, DOI 10.1152/japplphysiol.00346.2003
   Campbell KS, 2006, BIOPHYS J, V91, P4102, DOI 10.1529/biophysj.106.087312
   Geiger PC, 2000, J APPL PHYSIOL, V89, P695
   Toth MJ, 2010, INT J CARDIOL, V143, P276, DOI 10.1016/j.ijcard.2009.02.040
   Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174
   LIEBER RL, 1994, J NEUROPHYSIOL, V71, P874
   Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2
   HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   van Hees HWH, 2007, AM J PHYSIOL-HEART C, V293, pH819, DOI 10.1152/ajpheart.00085.2007
   Gosker HR, 2000, AM J CLIN NUTR, V71, P1033
   Campbell KS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000560
   Chase P.B., 2004, ANN BIOMED ENG, V32, P1556
   Daniel TL, 1998, BIOPHYS J, V74, P1611
   ETTINGER WH, 1994, J AM GERIATR SOC, V42, P1035
   FRANCHI LL, 1990, J MUSCLE RES CELL M, V11, P227, DOI 10.1007/BF01843576
   Geeves M, 2011, BIOPHYS J, V100, P2679, DOI 10.1016/j.bpj.2011.04.020
   Haddad F, 2003, J APPL PHYSIOL, V95, P781, DOI 10.1152/japplphysiol.00317.2003
   Howard J, 2001, MECH MOTOR PROTEINS
   HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255
   Larsson L, 2000, CRIT CARE MED, V28, P34, DOI 10.1097/00003246-200001000-00006
   Luther PK, 1996, J MORPHOL, V229, P325, DOI 10.1002/(SICI)1097-4687(199609)229:3<325::AID-JMOR7>3.0.CO;2-X
   PATE E, 1989, J MUSCLE RES CELL M, V10, P181, DOI 10.1007/BF01739809
   Piazzesi G, 2002, J PHYSIOL-LONDON, V545, P145, DOI 10.1113/jphysiol.2002.028969
   Squire J., 1986, MUSCLE DESIGN DIVERS
   Tanner BCW, 2007, PLOS COMPUT BIOL, V3, P1195, DOI 10.1371/journal.pcbi.0030115
   Tanner BCW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002506
   Toth MJ, 2013, J APPL PHYSIOL, V114, P858, DOI 10.1152/japplphysiol.01474.2012
   WENDEROTH MP, 1987, J CELL BIOL, V105, P2771, DOI 10.1083/jcb.105.6.2771
   Williams CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001018
   Williams CD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0697
   Williams CD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002770
NR 45
TC 1
Z9 1
U1 2
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 2014
VL 552
SI SI
BP 117
EP 127
DI 10.1016/j.abb.2014.01.015
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI8ZU
UT WOS:000337216300015
PM 24486373
ER

PT J
AU Schlecht, W
   Zhou, ZQ
   Li, KL
   Rieck, D
   Ouyang, YX
   Dong, WJ
AF Schlecht, William
   Zhou, Zhiqun
   Li, King-Lun
   Rieck, Daniel
   Ouyang, Yexin
   Dong, Wen-Ji
TI FRET study of the structural and kinetic effects of PKC phosphomimetic
   cardiac troponin T mutants on thin filament regulation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE PKC phosphorylation; Cardiac troponin T; FRET; Thin filament regulation
ID PROTEIN-KINASE-C; RESONANCE ENERGY-TRANSFER; ACTOMYOSIN MGATPASE
   ACTIVITY; CONFORMATIONAL TRANSITIONS; MUSCLE-CONTRACTION; INHIBITORY
   REGION; CA2+ REGULATION; CROSS-BRIDGES; PHOSPHORYLATION; TROPOMYOSIN
AB FRET was used to investigate the structural and kinetic effects that PKC phosphorylations exert on Ca2+ and myosin subfragment-1 dependent conformational transitions of the cardiac thin filament. PKC phosphorylations of cTnT were mimicked by glutamate substitution. Ca2+ and S1-induced distance changes between the central linker of cTnC and the switch region of cTnI (cTnI-Sr) were monitored in reconstituted thin filaments using steady state and time resolved FRET, while kinetics of structural transitions were determined using stopped flow. Thin filament Ca2+ sensitivity was found to be significantly blunted by the presence of the cTnT(T204E) mutant, whereas pseudo-phosphorylation at additional sites increased the Ca2+-sensitivity. The rate of Ca2+-dissociation induced structural changes was decreased in the C-terminal end of cTnI-Sr in the presence of pseudo-phosphorylations while remaining unchanged at the N-terminal end of this region. Additionally, the distance between cTnI-Sr and cTnC was decreased significantly for the triple and quadruple phosphomimetic mutants cTnT(T195E/S199E/T204E) and cTnT(T195E/S199E/T204E/T285E), which correlated with the Ca2+-sensitivity increase seen in these same mutants. We conclude that significant changes in thin filament Ca2+-sensitivity, structure and kinetics are brought about through PKC phosphorylation of cTnT. These changes can either decrease or increase Ca2+-sensitivity and likely play an important role in cardiac regulation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Schlecht, William; Li, King-Lun; Rieck, Daniel; Dong, Wen-Ji] Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA.
   [Zhou, Zhiqun; Ouyang, Yexin; Dong, Wen-Ji] Washington State Univ, Dept Integrated Neurosci & Physiol, Pullman, WA 99164 USA.
RP Dong, WJ (reprint author), Washington State Univ, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA.
EM wdong@vetmed.wsu.edu
FU National Institutes of Health [HL80186, IR21HL109693]; M.J. Murdock
   Charitable Trust; NIH/NIGMS [T32-GM008336]
FX This work was partially supported by the National Institutes of Health
   Grant HL80186 and IR21HL109693 (W.-J. D.), as well as by the M.J.
   Murdock Charitable Trust (W.-J. D.). Partial support for this
   publication came from the NIH/NIGMS through an institutional training
   Grant award T32-GM008336. Its contents are solely the responsibility of
   the authors and do not necessarily represent the official views of the
   NIGMS or NIH.
CR Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200
   PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5
   Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382
   Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5
   Rieck DC, 2013, ARCH BIOCHEM BIOPHYS, V537, P198, DOI 10.1016/j.abb.2013.07.013
   Xing J, 2009, J BIOL CHEM, V284, P16432, DOI 10.1074/jbc.M808075200
   Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003
   Montgomery DE, 2001, J PHYSIOL-LONDON, V536, P583, DOI 10.1111/j.1469-7793.2001.0583c.xd
   Oliveira DM, 2000, J BIOL CHEM, V275, P27513
   Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmp.2004.04.046
   Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031
   Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001
   Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200
   Gollapudi SK, 2013, J MOL BIOL, V425, P1565, DOI 10.1016/j.jmb.2013.01.028
   Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200
   Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780
   Chandra M, 2006, BIOPHYS J, V90, P2867, DOI 10.1529/biophysj.105.076950
   Mudalige WAKA, 2009, J MOL BIOL, V389, P575, DOI 10.1016/j.jmb.2009.04.027
   Zhou ZQ, 2012, J BIOL CHEM, V287, P7661, DOI 10.1074/jbc.M111.281600
   FARAH CS, 1995, FASEB J, V9, P755
   Perry SV, 1998, J MUSCLE RES CELL M, V19, P575
   Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679
   Malnic B, 1998, J BIOL CHEM, V273, P10594, DOI 10.1074/jbc.273.17.10594
   Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n
   Dong WJ, 2003, J BIOL CHEM, V278, P42394, DOI 10.1074/jbc.M304858200
   Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6745, DOI 10.1021/bi962226d
   Dong WJ, 2001, J MOL BIOL, V314, P51, DOI 10.1006/jmbi.2001.5118
   EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351
   Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0
   Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341
   Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361
   Jin J.P., 2013, CONFORMATIONAL STATE
   Kaminsky RA, 2001, ARCH PATHOL LAB MED, V125, P573
   Kobayashi T, 2000, BIOCHEMISTRY-US, V39, P86, DOI 10.1021/bi991903b
   LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0
   LIAO RL, 1992, BIOPHYS J, V63, P986
   Noguchi T, 2004, CIRCULATION, V110, P982, DOI 10.1161/01.CIR.0000139334.43109.F9
   NOLAND TA, 1993, J MOL CELL CARDIOL, V25, P53, DOI 10.1006/jmcc.1993.1007
   NOLAND TA, 1991, J BIOL CHEM, V266, P4974
   NOLAND TA, 1989, J BIOL CHEM, V264, P20778
   NOLAND TA, 1992, BIOCHEM J, V288, P123
   Ouyang YX, 2010, J MOL BIOL, V400, P1036, DOI 10.1016/j.jmb.2010.06.007
   PARDEE JD, 1982, METHOD ENZYMOL, V85, P164
   POTTER JD, 1995, J BIOL CHEM, V270, P2557
   POTTER JD, 1994, J MUSCLE RES CELL M, V15, P209
   Reinach FC, 1997, CELL STRUCT FUNCT, V22, P219
   SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234
   Stelzer JE, 2004, AM J PHYSIOL-HEART C, V287, pH1756, DOI 10.1152/ajpheart.00172.2004
   Streng AS, 2013, J MOL CELL CARDIOL, V63, P47, DOI 10.1016/j.yjmcc.2013.07.004
   Wei B, 2011, ARCH BIOCHEM BIOPHYS, V505, P144, DOI 10.1016/j.abb.2010.10.013
   XING J, 1994, ARCH BIOCHEM BIOPHYS, V313, P229, DOI 10.1006/abbi.1994.1381
   Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x
NR 52
TC 1
Z9 1
U1 3
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2014
VL 550
BP 1
EP 11
DI 10.1016/j.abb.2014.03.013
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI3RT
UT WOS:000336780300001
PM 24708997
ER

PT J
AU Sasaki, H
   Toyomura, K
   Matsuzaki, W
   Okamoto, A
   Yamaguchi, N
   Nakamura, H
   Murayama, T
AF Sasaki, Hirotsune
   Toyomura, Kaori
   Matsuzaki, Wataru
   Okamoto, Aya
   Yamaguchi, Naoto
   Nakamura, Hiroyuki
   Murayama, Toshihiko
TI Regulation of alkaline ceramidase activity by the c-Src-mediated pathway
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Ceramidase; Sphingolipid metabolism; c-Src; Lyn; Vanadate
ID PROTEIN-KINASE-C; CYTOSOLIC PHOSPHOLIPASE A(2)ALPHA; NEUTRAL CERAMIDASE;
   LYN KINASE; SPHINGOLIPID METABOLISM; ACID SPHINGOMYELINASE;
   CELL-PROLIFERATION; SPHINGOSINE KINASE; INDUCED ACTIVATION; TYROSINE
   KINASE
AB Ceramidase hydrolyzes ceramide to fatty acids and sphingosine, and sphingosine is then converted to sphingosine-1-phosphate. Ceramide and sphingosine-1-phosphate act as signaling molecules. Although stimuli coupling to protein kinases-dependent systems have been shown to regulate ceramidase activity, the exact role of c-Src-mediated signal has not been elucidated. We examined the effects of the downregulation of c-Src activity and c-Src overexpression on ceramidase activity in cells. In A549, CHO, and HeLa cells labeled with a fluorescent ceramide, 4-nitrobenzo-2-oxa-1,3-diazole-labeled C5-ceramide (NBD-ceramide), the downregulation of c-Src by c-Src-shRNA and pharmacological inhibitors including SU6656 decreased levels of NBD-caproic acid. The overexpression of c-Src increased NBD-caproic acid levels in CHO and HeLa cells. Similar results were obtained in Na3VO4-treated cells having higher NBD-caproic acid levels. The downregulation and overexpression of c-Src decreased and increased ceramidase activity, respectively, in the lysates of A549 cells at pH 8.8. The ceramidase sensitivity to substrates, pH, and Ca2+ suggest that the c-Src- and SU6656-sensitive ceramidase is alkaline ceramidase (ACER), possibly Ca2+-activated ACER2. Serum starvation increased both ceramidase activity at pH 8.8 and expression of ACER2. Our data suggest that c-Src-mediated signal positively regulates ACER activity in a Ca2+-independent manner. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Sasaki, Hirotsune; Toyomura, Kaori; Matsuzaki, Wataru; Nakamura, Hiroyuki; Murayama, Toshihiko] Chiba Univ, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Chiba 2608675, Japan.
   [Okamoto, Aya; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Mol Cell Biol Lab, Chiba 2608675, Japan.
RP Murayama, T (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.
EM murayama-toshi@faculty.chiba-u.jp
RI Nakamura, Hiroyuki/B-4089-2015
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [23590106]
FX This work was supported in part by a Grant (23590106 to T.M.) from the
   Ministry of Education, Culture, Sports, Science and Technology, Japan.
CR Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002
   Auge N, 1999, J BIOL CHEM, V274, P21533, DOI 10.1074/jbc.274.31.21533
   Gangoiti P, 2010, PROG LIPID RES, V49, P316, DOI 10.1016/j.plipres.2010.02.004
   Hu W, 2010, J BIOL CHEM, V285, P7964, DOI 10.1074/jbc.M109.063586
   Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200
   Sun W, 2010, J BIOL CHEM, V285, P8995, DOI 10.1074/jbc.M109.069203
   Galadari S, 2006, BIOCHEM J, V393, P687, DOI 10.1042/BJ200550682
   Mao ZH, 2010, J BIOL CHEM, V285, P29078, DOI 10.1074/jbc.M110.105296
   Tani M, 1999, J BIOCHEM-TOKYO, V125, P746
   Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626
   Urtz N, 2004, MOL CELL BIOL, V24, P8765, DOI 10.1128/MCB.24.19.8765-8777.2004
   Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277
   Olsson M, 2004, AM J PHYSIOL-GASTR L, V287, pG929, DOI 10.1152/ajpgi.00155.2004
   Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com
   Canals D, 2011, BRIT J PHARMACOL, V163, P694, DOI 10.1111/j.1476-5381.2011.01279.x
   Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001
   O'Neill SM, 2011, ARCH BIOCHEM BIOPHYS, V511, P31, DOI 10.1016/j.abb.2011.04.009
   Bauer J, 2009, FEBS LETT, V583, P915, DOI 10.1016/j.febslet.2009.02.008
   Bielawska A, 1996, J BIOL CHEM, V271, P12646
   BJORGE JD, 1995, J BIOL CHEM, V270, P24222
   Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200
   Cinq-Frais C, 2013, BBA-MOL CELL BIOL L, V1831, P1344, DOI 10.1016/j.bbalip.2013.04.014
   CORONEOS E, 1995, J BIOL CHEM, V270, P23305
   Dobierzewska A, 2011, J BIOL CHEM, V286, P32064, DOI 10.1074/jbc.M111.238030
   Franzen R, 2002, J BIOL CHEM, V277, P46184, DOI 10.1074/jbc.M204034200
   Gracia-Barros M., 2013, BIOCHIM BIOPHYS ACTA
   Graf C, 2008, MOL PHARMACOL, V74, P925, DOI 10.1124/mol.108.048652
   Grazide S, 2002, FASEB J, V16, P1685, DOI 10.1096/fje.01-0794fje
   Kajiwara K, 2014, BIOCHEM J, V458, P81, DOI 10.1042/BJ20130527
   Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011
   Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f
   Matsuzawa Y, 2009, J PHARMACOL SCI, V111, P182, DOI 10.1254/jphs.09201FP
   Mitsutake S, 2001, J BIOL CHEM, V276, P26249, DOI 10.1074/jbc.M102233200
   NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718
   Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266
   Ohlsson L, 2007, BIOCHIMIE, V89, P950, DOI 10.1016/j.biochi.2007.03.009
   Tada E, 2010, J PHARMACOL SCI, V114, P420, DOI 10.1254/jphs.10181FP
   Tani M, 2000, J BIOL CHEM, V275, P3462, DOI 10.1074/jbc.275.5.3462
   Taniguchi T, 2007, BIOCHEM PHARMACOL, V73, P854, DOI 10.1016/j.bcp.2006.11.026
   Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012
   Zhu Q, 2009, FEBS LETT, V583, P2136, DOI 10.1016/j.febslet.2009.05.047
NR 41
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2014
VL 550
BP 12
EP 19
DI 10.1016/j.abb.2014.03.012
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI3RT
UT WOS:000336780300002
PM 24708996
ER

PT J
AU Dow, BA
   Sukumar, N
   Matos, JO
   Choi, M
   Schulte, A
   Tatulian, SA
   Davidson, VL
AF Dow, Brian A.
   Sukumar, Narayanasami
   Matos, Jason O.
   Choi, Moonsung
   Schulte, Alfons
   Tatulian, Suren A.
   Davidson, Victor L.
TI The sole tryptophan of amicyanin enhances its thermal stability but does
   not influence the electronic properties of the type 1 copper site
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Amicyanin; Cupredoxin; Hydrogen bond; Protein structure
ID TRANSFER PROTEIN COMPLEX; METHYLAMINE DEHYDROGENASE;
   PARACOCCUS-DENITRIFICANS; X-RAY; DIRECTED MUTAGENESIS;
   CRYSTAL-STRUCTURE; SPECTROSCOPIC PROPERTIES; STRUCTURAL DETERMINANTS;
   ANGSTROM RESOLUTION; MOLECULAR-GRAPHICS
AB The cupredoxin amicyanin possesses a single tryptophan residue, Trp45. Its fluorescence is quenched when copper is bound even though it is separated by 10.1 angstrom. Mutation of Trp45 to Ala, Phe, Leu and Lys resulted in undetectable protein expression. A W45Y amicyanin variant was isolated. The W45Y mutation did not alter the spectroscopic properties or intrinsic redox potential of amicyanin, but increased the pK(a) value for the pH-dependent redox potential by 0.5 units. This is due to a hydrogen-bond involving the His95 copper ligand which is present in reduced W45Y amicyanin but not in native amicyanin. The W45Y mutation significantly decreased the thermal stability of amicyanin, as determined by changes in the visible absorbance of oxidized amicyanin and in the circular dichroism spectra for oxidized, reduced and apo forms of amicyanin. Comparison of the crystal structures suggests that the decreased stability of W45Y amicyanin may be attributed to the loss of a strong interior hydrogen bond between Trp45 and Tyr90 in native amicyanin which links two of the beta-sheets that comprise the overall structure of amicyanin. Thus, Trp45 is critical for stabilizing the structure of amicyanin but it does not influence the electronic properties of the copper which quenches its fluorescence. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Dow, Brian A.; Matos, Jason O.; Davidson, Victor L.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA.
   [Sukumar, Narayanasami] Cornell Univ, Argonne Natl Lab, NE CAT, Argonne, IL 60439 USA.
   [Sukumar, Narayanasami] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA.
   [Matos, Jason O.; Schulte, Alfons; Tatulian, Suren A.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA.
   [Choi, Moonsung] Seoul Natl Univ Sci & Technol, Coll Energy & Biotechnol, Dept Optometry, Seoul 139743, South Korea.
RP Sukumar, N (reprint author), Cornell Univ, Argonne Natl Lab, APS, Bldg 436E,9700 S Cass Ave, Argonne, IL 60439 USA.
EM sukumar@anl.gov; victor.davidson@ucf.edu
FU National Institute of General Medical Sciences (NIGMS) of the National
   Institutes of Health (NIH) [R37GM41574, GM103403]; National Institute of
   Allergy and Infectious Disease, NIH [1R03AI097591]; U.S. DOE, Office of
   Science, Office of Basic Energy Science [DE-AC02-06CH1 1357]
FX This research was supported by the National Institute of General Medical
   Sciences (NIGMS) of the National Institutes of Health (NIH) under award
   number R37GM41574 (V.L.D.) and the National Institute of Allergy and
   Infectious Disease, NIH, under award number 1R03AI097591 (S.A.T). This
   work and the beamlines 24lD-E and 24lD-C used to collect data and
   fluorescence scan are supported by award GM103403 from NIGMS at the NIH.
   Use of the APS is supported by the U.S. DOE, Office of Science, Office
   of Basic Energy Science, and Contract No. DE-AC02-06CH1 1357.
CR Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Choi M, 2011, METALLOMICS, V3, P140, DOI 10.1039/c0mt00061b
   CHEN LY, 1994, SCIENCE, V264, P86, DOI 10.1126/science.8140419
   Solomon EI, 2004, CHEM REV, V104, P419, DOI 10.1021/cr0206317
   Hart PJ, 1996, PROTEIN SCI, V5, P2175
   CHEN LY, 1992, BIOCHEMISTRY-US, V31, P4959, DOI 10.1021/bi00136a006
   Zhu ZY, 1998, BIOCHEMISTRY-US, V37, P17128, DOI 10.1021/bi9817919
   Battistuzzi G, 2005, BIOCHEMISTRY-US, V44, P9944, DOI 10.1021/bi050261r
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   DURLEY R, 1993, PROTEIN SCI, V2, P739
   Chothia C, 1998, J MOL BIOL, V278, P457, DOI 10.1006/jmbi.1998.1653
   Delfino I, 2009, BIOPHYS CHEM, V139, P1, DOI 10.1016/j.bpc.2008.09.016
   Sun DP, 2005, BIOCHEMISTRY-US, V44, P7200, DOI 10.1021/bi050288a
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460
   Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716
   Sukumar N, 2010, P NATL ACAD SCI USA, V107, P6817, DOI 10.1073/pnas.0912672107
   Paltrinieri L, 2013, BIOCHEMISTRY-US, V52, P7397, DOI 10.1021/bi400860n
   BAKER EN, 1988, J MOL BIOL, V203, P1071, DOI 10.1016/0022-2836(88)90129-5
   BROOKS HB, 1993, BIOCHEMISTRY-US, V32, P2725, DOI 10.1021/bi00061a034
   Cammack R., 1995, BIOENERGETICS PRACTI, P85
   Carrell CJ, 2007, BIOCHEMISTRY-US, V46, P1900, DOI 10.1021/bi0619674
   CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112
   CHISTOSERDOV AY, 1992, BIOCHEM BIOPH RES CO, V184, P1181, DOI 10.1016/S0006-291X(05)80007-5
   Choi M, 2009, BIOCHEMISTRY-US, V48, P9174, DOI 10.1021/bi900836h
   Cunane LM, 1996, ACTA CRYSTALLOGR D, V52, P676, DOI 10.1107/S0907444996001072
   Davidson VL, 1998, BIOCHEMISTRY-US, V37, P7371, DOI 10.1021/bi973020v
   DAVIDSON VL, 1993, BIOCHIM BIOPHYS ACTA, V1144, P39, DOI 10.1016/0005-2728(93)90028-E
   DAVIDSON VL, 1991, ANAL CHIM ACTA, V249, P235, DOI 10.1016/0003-2670(91)87028-6
   DAVIDSON VL, 1990, METHOD ENZYMOL, V188, P241
   Davidson VL, 1997, BIOCHEMISTRY-US, V36, P12733, DOI 10.1021/bi971353m
   Dennison C, 2005, COORDIN CHEM REV, V249, P3025, DOI 10.1016/j.ccr.2005.04.021
   Engman KC, 2004, PROTEIN SCI, V13, P2706, DOI 10.1110/ps.04849004
   Gough J, 2004, STRUCTURE, V12, P917, DOI 10.1016/j.str.2004.03.029
   Hira D, 2009, ACTA CRYSTALLOGR D, V65, P85, DOI 10.1107/S0907444908040195
   HUSAIN M, 1986, J BIOL CHEM, V261, P8577
   HUSAIN M, 1986, BIOCHEMISTRY-US, V25, P2431, DOI 10.1021/bi00357a020
   HUSAIN M, 1985, J BIOL CHEM, V260, P4626
   HUSAIN M, 1987, J BACTERIOL, V169, P1712
   KUMAR MA, 1992, BIOTECHNIQUES, V12, P198
   La Rosa C, 2002, EUR BIOPHYS J BIOPHY, V30, P559, DOI 10.1007/s00249-001-0193-z
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LIM LW, 1986, J MOL BIOL, V189, P257, DOI 10.1016/0022-2836(86)90398-0
   Ma JK, 2005, ARCH BIOCHEM BIOPHYS, V444, P27, DOI 10.1016/j.abb.2005.09.016
   Ma JK, 2007, BIOCHEMISTRY-US, V46, P8561, DOI 10.1021/bi700303e
   Ma JK, 2007, BIOCHEMISTRY-US, V46, P11137, DOI 10.1021/bi7012307
   MORPURGO L, 1972, BIOCHIM BIOPHYS ACTA, V271, P292, DOI 10.1016/0005-2795(72)90203-6
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PETRICH JW, 1987, BIOCHEMISTRY-US, V26, P2711, DOI 10.1021/bi00384a010
   SHARMA KD, 1988, J BIOL CHEM, V263, P3303
   Shih C, 2008, SCIENCE, V320, P1760, DOI 10.1126/science.1158241
   Sreerama N., 2000, CIRCULAR DICHROISM P, P601
   Sun DP, 2003, BIOCHEMISTRY-US, V42, P1772, DOI 10.1021/bi0271594
   SWEENEY JA, 1991, J AM CHEM SOC, V113, P7531, DOI 10.1021/ja00020a013
   SZABO AG, 1983, BIOPHYS J, V41, P233
   Wilson CJ, 2005, P NATL ACAD SCI USA, V102, P3984, DOI 10.1073/pnas.0501038102
   Woodruff W.H., 1988, BIOL APPLICATIONS RA, P413
   Woody R. W., 1996, CIRCULAR DICHROISM C, P109
NR 59
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2014
VL 550
BP 20
EP 27
DI 10.1016/j.abb.2014.03.010
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI3RT
UT WOS:000336780300003
PM 24704124
ER

PT J
AU Chow, ML
   Shaffer, JF
   Harris, SP
   Dawson, JF
AF Chow, Melissa L.
   Shaffer, Justin F.
   Harris, Samantha P.
   Dawson, John F.
TI Altered interactions between cardiac myosin binding protein-c and
   alpha-cardiac actin variants associated with cardiomyopathies
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cardiac actin; Myosin binding protein-C; Heart disease; Cardiomyopathy
ID FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; F-ACTIN; GENE-MUTATIONS; DILATED
   CARDIOMYOPATHY; DISEASE; PHOSPHORYLATION; TROPOMYOSIN; PREVALENCE;
   CHILDREN; MUTANTS
AB The two genes most commonly associated with mutations linked to hypertrophic or dilated cardiomyopathies are beta-myosin and cardiac myosin binding protein-C (cMyBP-C). Both of these proteins interact with cardiac actin (ACTC). Currently there are 16 ACTC variants that have been found in patients with HCM or DCM. While some of these ACTC variants exhibit protein instability or polymerization-deficiencies that might contribute to the development of disease, other changes could cause changes in protein-protein interactions between sarcomere proteins and ACTC. To test the hypothesis that changes in ACTC disrupt interactions with cMyBP-C, we examined the interactions between seven ACTC variants and the N-terminal C0C2 fragment of cMyBP-C. We found there was a significant decrease in binding affinity (increase in K-d values) for the A331P and Y166C variants of ACTC. These results suggest that a change in the ability of cMyBP-C to bind actin filaments containing these ACTC protein variants might contribute to the development of disease. These results also provide clues regarding the binding site of the C0C2 fragment of cMyBP-C on F-actin. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Chow, Melissa L.; Dawson, John F.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.
   [Shaffer, Justin F.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.
   [Harris, Samantha P.] Univ Arizona, Sch Med, Dept Cellular & Mol Med, Tucson, AZ 85724 USA.
RP Dawson, JF (reprint author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.
EM jdawso01@uoguelph.ca
FU NIH [HL080367]; Heart and Stroke Foundation of Canada [NA6469]
FX This work was supported by NIH HL080367 (to S.P.H.) and a Grant in aid
   from the Heart and Stroke Foundation of Canada NA6469 (to J.F.D.).
CR Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630
   Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750
   Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014
   FRITZ JD, 1989, ANAL BIOCHEM, V180, P205, DOI 10.1016/0003-2697(89)90116-4
   Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200
   Lu YL, 2011, J MOL BIOL, V413, P908, DOI 10.1016/j.jmb.2011.09.026
   Lakdawala NK, 2012, J CARD FAIL, V18, P296, DOI 10.1016/j.cardfail.2012.01.013
   Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037
   Orlova A, 2011, J MOL BIOL, V412, P379, DOI 10.1016/j.jmb.2011.07.056
   Muller M, 2012, CELL MOL LIFE SCI, V69, P3457, DOI 10.1007/s00018-012-1030-5
   Mun JY, 2011, J MOL BIOL, V410, P214, DOI 10.1016/j.jmb.2011.05.010
   Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463
   Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834
   Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x
   Kaski JP, 2009, CIRC-CARDIOVASC GENE, V2, P436, DOI 10.1161/CIRCGENETICS.108.821314
   Van Driest SL, 2003, CIRCULATION, V108, P445, DOI 10.1161/01.CIR.0000080896.52003.DF
   Barua B, 2013, J BIOL CHEM, V288, P9602, DOI 10.1074/jbc.M113.451161
   Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200
   Dijk S.J., 2014, PFLUG ARCH EUR J PHY, V466, P445
   Gaziano TA, 2007, HEALTH AFFAIR, V26, P13, DOI 10.1377/hlthaff.26.1.13
   Kensler RW, 2008, BIOPHYS J, V94, P1707, DOI 10.1529/biophysj.107.115899
   Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460
   Mogensen J, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010447
   Mundia MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036821
   Oda T, 2007, ADV EXP MED BIOL, V592, P385
   Olson TM, 2000, J MOL CELL CARDIOL, V32, P1687, DOI 10.1006/jmcc.2000.1204
   Rutkevich LA, 2006, CAN J PHYSIOL PHARM, V84, P111, DOI 10.1139/Y05-140
   Smith ER, 2009, CAN J CARDIOL, V25, P451
   Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105
   Wong WNW, 2001, J MUSCLE RES CELL M, V22, P665, DOI 10.1023/A:1016354308436
   Yates SP, 2007, ARCH BIOCHEM BIOPHYS, V466, P58, DOI 10.1016/j.abb.2007.07.018
NR 31
TC 2
Z9 2
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2014
VL 550
BP 28
EP 32
DI 10.1016/j.abb.2014.04.003
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI3RT
UT WOS:000336780300004
PM 24736382
ER

PT J
AU Katagiri, F
   Takagi, M
   Nakamura, M
   Tanaka, Y
   Hozumi, K
   Kikkawa, Y
   Nomizu, M
AF Katagiri, Fumihiko
   Takagi, Masaharu
   Nakamura, Minako
   Tanaka, Yoichiro
   Hozumi, Kentaro
   Kikkawa, Yamato
   Nomizu, Motoyoshi
TI Screening of integrin-binding peptides in a laminin peptide library
   derived from the mouse laminin beta chain short arm regions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Human dermal fibroblast; Integrin; Laminin; Synthetic peptide library
ID CELL ADHESIVE SEQUENCES; S-LAMININ; G-DOMAIN; NEUROMUSCULAR-JUNCTION;
   SYNTHETIC PEPTIDES; IDENTIFICATION; CLONING; NOMENCLATURE; METASTASIS;
   EXPRESSION
AB Laminins, major components of basement membrane, consist of three different subunits, alpha, beta, and gamma chains, and so far, five alpha, three beta, and three gamma chains have been identified. We have constructed synthetic peptide libraries derived from the laminin sequences and identified various cell-adhesive peptides. Ten active peptides from the laminin a chain sequences (alpha 1-alpha 5) were found to promote integrin-mediated cell adhesion. Previously, we found fourteen cell-adhesive peptides from the beta 1 chain sequence but their receptors have not been analyzed. Here, we expanded the synthetic peptide library to add peptides from the short arm regions of the laminin beta 2 and beta 3 chains and screened for integrin-binding peptides. Twenty-seven peptides promoted human dermal fibroblast (HDF) attachment in a peptide-coated plate assay. The morphological appearance of HDFs on the peptide-coated plates differed depending on the peptides. B34 (REKYYYAVYDMV, mouse laminin beta 1 chain, 255-266), B67 (IPYSMEYEILIRY, mouse laminin beta 1 chain, 604-616), B2-105 (APNFWNFTSGRG, mouse laminin beta 2 chain, 1081-1092), and B3-19 (GHLTGGINQLNL, mouse laminin beta 3 chain, 182-193) promoted HDF spreading and HDF attachment was inhibited by EDTA, suggesting that the peptides interact with integrins. Immunostaining analyses revealed that B67 induced well-organized actin stress fibers and focal contacts containing vinculin, however, B34, B2-105, and B3-19 did not exhibit stress fiber formation or focal contacts. The inhibition assay using anti-integrin antibodies indicated that B67 interacts with alpha 3, alpha 6, and beta 1 integrins, and B34 and B3-19 interact with in integrin. Based on adhesion analysis of peptides modified with an alanine scan and on switching analysis with the homologous inactive sequence B2-64 (LPRAMDYDLLLRW, mouse laminin beta 2 chain, 618-630), the Glu(8) residue in the B67 peptide was critical for HDF adhesion. These findings are useful for identifying an integrin binding motif. The B67 peptide has potential for use as a molecular probe for integrins. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Katagiri, Fumihiko; Takagi, Masaharu; Nakamura, Minako; Tanaka, Yoichiro; Hozumi, Kentaro; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Hachioji, Tokyo 1920392, Japan.
RP Nomizu, M (reprint author), Tokyo Univ Pharm & Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.
EM nomizu@toyaku.ac.jp
CR Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685
   Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8
   HUNTER DD, 1991, J NEUROSCI, V11, P3960
   Iwamoto Y, 1996, BRIT J CANCER, V73, P589, DOI 10.1038/bjc.1996.102
   Mercurio AM, 2002, AM J PATHOL, V161, P3, DOI 10.1016/S0002-9440(10)64149-1
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583
   Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Kreidberg JA, 1996, DEVELOPMENT, V122, P3537
   KLEINMAN HK, 1988, P NATL ACAD SCI USA, V85, P1282, DOI 10.1073/pnas.85.4.1282
   Champliaud MF, 1996, J CELL BIOL, V132, P1189, DOI 10.1083/jcb.132.6.1189
   CHARONIS AS, 1988, J CELL BIOL, V107, P1253, DOI 10.1083/jcb.107.3.1253
   Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525
   Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   Durkin ME, 1996, J BIOL CHEM, V271, P13407
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hozumi K, 2012, J BIOL CHEM, V287, P25111, DOI 10.1074/jbc.M112.348151
   Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012
   Hozumi K, 2010, FEBS LETT, V584, P3381, DOI 10.1016/j.febslet.2010.06.032
   HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0
   HUNTER DD, 1989, CELL, V59, P905, DOI 10.1016/0092-8674(89)90613-2
   Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200
   IGNATIUS MJ, 1988, NEURON, V1, P713, DOI 10.1016/0896-6273(88)90170-5
   Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107
   Ivins JK, 1998, J NEUROSCI, V18, P9703
   Katagiri F, 2010, ARCH BIOCHEM BIOPHYS, V500, P189, DOI 10.1016/j.abb.2010.05.004
   Katagiri F, 2012, ARCH BIOCHEM BIOPHYS, V521, P32, DOI 10.1016/j.abb.2012.02.017
   Kuster JE, 1997, MAMM GENOME, V8, P673, DOI 10.1007/s003359900535
   MATSUI C, 1995, J BIOL CHEM, V270, P23496
   Meyer A, 2006, CURR PHARM DESIGN, V12, P2723, DOI 10.2174/138161206777947740
   NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0
   NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719
   SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Urushibata S, 2009, BIOCHEMISTRY-US, V48, P10522, DOI 10.1021/bi901421t
   Urushibata S, 2010, ARCH BIOCHEM BIOPHYS, V497, P43, DOI 10.1016/j.abb.2010.03.006
   UTANI A, 1995, LAB INVEST, V72, P300
   Wang YF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-84
NR 45
TC 0
Z9 0
U1 3
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2014
VL 550
BP 33
EP 41
DI 10.1016/j.abb.2014.04.008
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI3RT
UT WOS:000336780300005
PM 24785228
ER

PT J
AU Noy, T
   Xu, H
   Blanchard, JS
AF Noy, Tahel
   Xu, Hua
   Blanchard, John S.
TI Acetylation of acetyl-CoA synthetase from Mycobacterium tuberculosis
   leads to specific inactivation of the adenylation reaction
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Tuberculosis; Enzyme kinetics; Enzyme regulation; Central carbon
   metabolism
ID STATE KINETIC-ANALYSIS; SALMONELLA-ENTERICA; SUBSTRATE-BINDING;
   STEADY-STATE; AMP; CATABOLISM; ACETATE; ENZYME; LYSINE
AB Acetyl-CoA synthetase (ACS) catalyzes the formation of AcCoA from acetate, ATP and Coenzyme A, allowing the organism to grow on acetate as the sole carbon source. ACS was the first enzyme in Mycobacterium tuberculosis shown to be regulated by posttranslational acetylation by the cAMP-dependent protein acetyltransferase. This modification results in the inactivation of the enzyme and can be reversed in the presence of NAD(+) and a mycobacterial sirtuin-like deacetylase. In this study we characterize the kinetic mechanism of MtACS, where the overall reaction can be divided into two half-reactions: the acetyl-adenylate forming reaction and the thiol-ligation reaction. We also provide evidence for the existence of the acetyl-adenylate intermediate via P-31 NMR spectroscopy. Furthermore, we dissect the regulatory role of K617 acetylation and show that acetylation inhibits only the first, adenylation half-reaction while leaving the second half reaction unchanged. Finally, we demonstrate that the chemical mechanism of the enzyme relies on a conformational change which is controlled by the protonation state of aspartate 525. Together with our earlier results, this suggests a degree of regulation of enzyme activity that is appropriate for the role of the enzyme in central carbon metabolism. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Noy, Tahel; Xu, Hua; Blanchard, John S.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.
RP Blanchard, JS (reprint author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM john.blanchard@einstein.yu.edu
FU National Institutes of Health [AI060899]
FX This work was supported by the National Institutes of Health Grant
   AI060899.
CR Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005
   Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105
   Zheng RJ, 2001, BIOCHEMISTRY-US, V40, P12904, DOI 10.1021/bi011522+
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t
   Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004
   Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352
   BERG P, 1956, J BIOL CHEM, V222, P1015
   Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506
   Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x
   Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010
   Boshoff HI, 2005, NAT MED, V11, P599, DOI 10.1038/nm0605-599
   de Carvalho LPS, 2010, CHEM BIOL, V17, P1122, DOI 10.1016/j.chembiol.2010.08.009
   Devlin T.M., 1986, TXB BIOCH CLIN CORRE, P211
   Fan F, 2007, BIOCHEMISTRY-US, V46, P11421, DOI 10.1021/bi7011492
   Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q
   Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a
   SANTI DV, 1971, FEBS LETT, V13, P157, DOI 10.1016/0014-5793(71)80224-7
   Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650
   Vergnolle O, 2013, J BIOL CHEM, V288, P28116, DOI 10.1074/jbc.M113.495549
NR 20
TC 3
Z9 3
U1 2
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2014
VL 550
BP 42
EP 49
DI 10.1016/j.abb.2014.04.004
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI3RT
UT WOS:000336780300006
PM 24751484
ER

PT J
AU Le, RK
   Harris, BJ
   Iwuchukwu, IJ
   Bruce, BD
   Cheng, XL
   Qian, S
   Heller, WT
   O'Neill, H
   Frymier, PD
AF Le, Rosemary K.
   Harris, Bradley J.
   Iwuchukwu, Ifeyinwa J.
   Bruce, Barry D.
   Cheng, Xiaolin
   Qian, Shuo
   Heller, William T.
   O'Neill, Hugh
   Frymier, Paul D.
TI Analysis of the solution structure of Thermosynechococcus elongatus
   photosystem I in n-dodecyl-beta-D-maltoside using small-angle neutron
   scattering and molecular dynamics simulation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Small-angle neutron scattering; Membrane protein; Dummy-atom
   reconstruction; Detergent monolayer
ID MEMBRANE-PROTEIN CRYSTALLIZATION; X-RAY-SCATTERING; DETERGENT STRUCTURE;
   CONTRAST VARIATION; MICELLE STRUCTURE; COMPLEXES; BIOLOGY; SURFACE;
   SHAPE; WATER
AB Small-angle neutron scattering (SANS) and molecular dynamics (MD) simulation were used to investigate the structure of trimeric photosystem I (PSI) from Thermosynechococcus elongatus (T. elongatus) stabilized in n-dodecyl-beta-D-maltoside (DDM) detergent solution. Scattering curves of detergent and protein-detergent complexes were measured at 18% D2O, the contrast match point for the detergent, and 100% D2O, allowing observation of the structures of protein/detergent complexes. It was determined that the maximum dimension of the PSI-DDM complex was consistent with the presence of a monolayer belt of detergent around the periphery of PSI. A dummy-atom reconstruction of the shape of the complex from the SANS data indicates that the detergent envelope has an irregular shape around the hydrophobic periphery of the PSI trimer rather than a uniform, toroidal belt around the complex. A 50 ns MD simulation model (a DDM ring surrounding the PSI complex with extra interstitial DDM) of the PSI-DDM complex was developed for comparison with the SANS data. The results suggest that DDM undergoes additional structuring around the membrane-spanning surface of the complex instead of a simple, relatively uniform belt, as is generally assumed for studies that use detergents to solubilize membrane proteins. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Le, Rosemary K.; Harris, Bradley J.; Iwuchukwu, Ifeyinwa J.; Frymier, Paul D.] Univ Tennessee, Dept Chem & Biomol Engn, Knoxville, TN 37996 USA.
   [Bruce, Barry D.; Cheng, Xiaolin] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.
   [Bruce, Barry D.; Frymier, Paul D.] Univ Tennessee, Sustainable Energy Educ & Res Ctr, Knoxville, TN 37996 USA.
   [Cheng, Xiaolin] Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN 37831 USA.
   [Qian, Shuo; Heller, William T.; O'Neill, Hugh] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA.
RP Frymier, PD (reprint author), Univ Tennessee, Dept Chem & Biomol Engn, 419 Dougherty Engn Bldg, Knoxville, TN 37996 USA.
EM pdf@utk.edu
FU National Science Foundation's IGERT program [DGE-0801470]; NSF-EPSCoR
   [NSF EPS-1004083]; Photosynthetic Antenna Research Center (PARC), an
   Energy Frontier Research Center - U.S. Department of Energy, Office of
   Science, Office of Basic Energy Sciences [DE-SC 0001035]; U.S. DOE,
   Office of Science, Office of Biological and Environmental Research
   Project [ERKP291]; Scientific User Facilities Division, Basic Energy
   Sciences; U.S. Department of Energy (DOE) [DE-AC05-00OR22725]; National
   Science Foundation [0711134, 0933959, 1041709, 1041710]; University of
   Tennessee
FX The authors would like to acknowledge financial support for Rosemary Le
   and Ifeyinwa Iwuchukwu from the National Science Foundation's IGERT
   program (DGE-0801470), Bradley Harris from the NSF-EPSCoR sponsored
   TN-SCORE (NSF EPS-1004083) and the University of Tennessee Sustainable
   Energy Education and Research Center (SEERC) for materials. HON
   acknowledges the support of Photosynthetic Antenna Research Center
   (PARC), an Energy Frontier Research Center funded by the U.S. Department
   of Energy, Office of Science, Office of Basic Energy Sciences under
   Award Number DE-SC 0001035. The Center for Structural Molecular Biology
   operates BioSANS and is supported by the U.S. DOE, Office of Science,
   Office of Biological and Environmental Research Project ERKP291. The
   High Flux Isotope Reactor is sponsored by the Scientific User Facilities
   Division, Basic Energy Sciences. Oak Ridge National Laboratory (ORNL) is
   managed by UT-Battelle, LLC, for the U.S. Department of Energy (DOE)
   under contract No. DE-AC05-00OR22725. This material is based upon work
   supported by the National Science Foundation under Grant numbers
   0711134, 0933959, 1041709, and 1041710 and the University of Tennessee
   through the use of the Kraken computing resource at the National
   Institute for Computational Sciences (http://www.nics.tennessee.edu).
CR Abel S.p., 2010, J PHYS CHEM B, V115, P487
   KREMER K, 1990, J CHEM PHYS, V92, P5057, DOI 10.1063/1.458541
   Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200
   Tjioe E, 2007, J APPL CRYSTALLOGR, V40, P782, DOI 10.1107/S002188980702420X
   Scholes GD, 2011, NAT CHEM, V3, P763, DOI [10.1038/nchem.1145, 10.1038/NCHEM.1145]
   KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0
   Grotjohann I, 2005, PHOTOSYNTH RES, V85, P51, DOI 10.1007/s11120-005-1440-4
   TUCKERMAN M, 1995, J CHEM PHYS, V103, P150, DOI 10.1063/1.469654
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268
   Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102
   Hong XG, 2004, BIOPHYS J, V86, P1082
   Heller WT, 2010, ACTA CRYSTALLOGR D, V66, P1213, DOI [10.1107/S0907444910017658, 10.1107/S090744491001]
   Iwuchukwu IJ, 2010, NAT NANOTECHNOL, V5, P73, DOI [10.1038/nnano.2009.315, 10.1038/NNANO.2009.315]
   Hauser H, 2000, BBA-BIOMEMBRANES, V1508, P164, DOI 10.1016/S0304-4157(00)00008-3
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   TIMMINS PA, 1988, FEBS LETT, V238, P361, DOI 10.1016/0014-5793(88)80513-1
   Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0
   Lubner CE, 2011, P NATL ACAD SCI USA, V108, P20988, DOI 10.1073/pnas.1114660108
   Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   RAPPE AK, 1991, J PHYS CHEM-US, V95, P3358, DOI 10.1021/j100161a070
   Zhang L, 2012, J COMPUT CHEM, V33, P1969, DOI 10.1002/jcc.23016
   Utschig LM, 2011, J PHYS CHEM LETT, V2, P236, DOI 10.1021/jz101728v
   Nelson N, 2009, J NANOSCI NANOTECHNO, V9, P1709, DOI [10.1166/jnn.2009.S101, 10.1166/jnn.2009.SI01]
   Dupuy C, 1997, LANGMUIR, V13, P3965, DOI 10.1021/la9604285
   le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082
   Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338
   Svergun DI, 2002, CURR OPIN STRUC BIOL, V12, P654, DOI 10.1016/S0959-440X(02)00363-9
   Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646
   Muh F, 2008, BBA-BIOMEMBRANES, V1778, P2298, DOI 10.1016/j.bbamem.2008.05.016
   Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j
   Forster S, 1996, PHYS REV LETT, V77, P95, DOI 10.1103/PhysRevLett.77.95
   Badura A, 2006, PHOTOCHEM PHOTOBIOL, V82, P1385, DOI 10.1562/2006-07-14-RC-969
   O'Neill H, 2007, J PHYS CHEM B, V111, P4211, DOI 10.1021/jp067463x
   Grimme RA, 2008, J AM CHEM SOC, V130, P6308, DOI 10.1021/ja800923y
   Ciesielski PN, 2008, ACS NANO, V2, P2465, DOI 10.1021/nn800389k
   Abel S, 2011, J PHYS CHEM B, V115, P487, DOI 10.1021/jp109545v
   LeBlanc G, 2012, LANGMUIR, V28, P7952, DOI 10.1021/la301019t
   Iwuchukwu IJ, 2011, INT J HYDROGEN ENERG, V36, P11684, DOI 10.1016/j.ijhydene.2011.06.068
   BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.biophys.18.1.431
   Chang CH, 2009, J CHEM THEORY COMPUT, V5, P1137, DOI 10.1021/ct800342w
   Smith DMA, 2012, J CHEM THEORY COMPUT, V8, P2103, DOI 10.1021/ct300185u
   Faulkner CJ, 2008, LANGMUIR, V24, P8409, DOI 10.1021/la800670b
   Das R, 2004, NANO LETT, V4, P1079, DOI 10.1021/nl049579f
   Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123
   Auer M, 1998, NATURE, V392, P840
   BaggerJorgensen H, 1997, LANGMUIR, V13, P1413, DOI 10.1021/la960788s
   Barret LA, 2013, J PHYS CHEM B, V117, P8770, DOI 10.1021/jp403483q
   BORGIS D, 1991, J CHEM PHYS, V94, P3619, DOI 10.1063/1.459733
   Ceccarelli M, 2003, J PHYS CHEM B, V107, P1423, DOI 10.1021/jp0270001
   Ciesielski PN, 2010, BIORESOURCE TECHNOL, V101, P3047, DOI 10.1016/j.biortech.2009.12.045
   Ciesielski PN, 2011, J PHYS CHEM A, V115, P3326, DOI 10.1021/jp200134h
   Crest G., 1986, PHYS REV A, V33, P3628
   Fahey M.R., 2013, CONT HIGH PERFORMANC, P453
   FORD RC, 1988, EMBO J, V7, P2287
   Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5
   Fromme P, 1998, BBA-BIOENERGETICS, V1365, P175, DOI 10.1016/S0005-2728(98)00059-0
   Gau-Racine J, 2007, J PHYS CHEM B, V111, P9900, DOI 10.1021/jp0687302
   GOGOL EP, 1984, BIOPHYS J, V46, P491
   GOLBECK JH, 1992, ANNU REV PLANT PHYS, V43, P293
   Grimme R. A., 2009, DALTON T, V45, P10106
   Guinier A., 1955, SMALL ANGLE SCATTERI
   Hall D. O., 1999, PHOTOSYNTHESIS
   Ihara M., 2006, PHOTOCHEM PHOTOBIOL, V82, P676
   Ihara M., 2006, PHOTOCHEM PHOTOBIOL, V82, P1677
   Jeng US, 2006, PHYSICA B, V385-86, P865, DOI 10.1016/j.physb.2006.05.128
   Kiley P, 2005, PLOS BIOL, V3, P1180, DOI 10.1371/journal.pbio.0030230
   Lipfert J, 2007, J PHYS CHEM B, V111, P12427, DOI 10.1021/jp073016l
   Lubner C.E., 2009, BIOCHEMISTRY-US, V49, P404
   Lynn GW, 2006, PHYSICA B, V385-86, P880, DOI 10.1016/j.physb.2006.05.133
   MCCONNELL GA, 1994, FARADAY DISCUSS, V98, P121, DOI 10.1039/fd9949800121
   Mershin A., 2012, SCI REP, P2
   MOLLER JV, 1993, J BIOL CHEM, V268, P18659
   Mukherjee D, 2011, J COLLOID INTERF SCI, V358, P477, DOI 10.1016/j.jcis.2011.03.070
   Mutch KJ, 2008, LANGMUIR, V24, P3053, DOI 10.1021/la702913y
   Nelson MT, 1996, INT J SUPERCOMPUT AP, V10, P251, DOI 10.1177/109434209601000401
   PEBAYPEYROULA E, 1995, STRUCTURE, V3, P1051, DOI 10.1016/S0969-2126(01)00241-6
   Qian S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052690
   ROTH M, 1989, NATURE, V340, P659, DOI 10.1038/340659a0
   Rowicka M, 2002, ACTA CRYSTALLOGR A, V58, P574, DOI 10.1107/S0108767302016744
   Santonicola MG, 2008, BIOPHYS J, V94, P3647, DOI 10.1529/biophysj.107.113258
   Schrodinger LLC, 2010, PYMOL MOL GRAPHICS S
   Scott S.P., 2013, APPL MOL MODELING CH, V1133, P177
   Stone J., 1998, EFFICIENT LIB PARALL
   Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805
   STROUD RM, 1979, BIOPHYS J, V25, P495
   Tanford C., 1980, HYDROPHOBIC EFFECT F
   THIYAGARAJAN P, 1994, J PHYS CHEM-US, V98, P10343, DOI 10.1021/j100091a058
   VANAKEN T, 1986, METHOD ENZYMOL, V125, P27
   ZILBER AL, 1992, PLANT PHYSIOL, V99, P901, DOI 10.1104/pp.99.3.901
NR 96
TC 5
Z9 5
U1 5
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2014
VL 550
BP 50
EP 57
DI 10.1016/j.abb.2014.04.005
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI3RT
UT WOS:000336780300007
PM 24769336
ER

PT J
AU Robinson, RM
   Rodriguez, PJ
   Sobrado, P
AF Robinson, Reeder M.
   Rodriguez, Pedro J.
   Sobrado, Pablo
TI Mechanistic studies on the flavin-dependent N-6-lysine monooxygenase
   MbsG reveal an unusual control for catalysis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Flavin-dependent monooxygenases; pH studies; Rapid reaction kinetics;
   Conformational changes; Viscosity effects; Siderophores
ID P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; L-ORNITHINE N-5-OXYGENASE;
   PSEUDOMONAS-AERUGINOSA; MYCOBACTERIUM-TUBERCULOSIS; NUCLEOTIDE-SEQUENCE;
   KINETIC MECHANISM; OXYGEN ACTIVATION; SOLVENT ISOTOPE; STEADY-STATE;
   IRON
AB The mechanism of Mycobacterium smegmatis G (MbsG), a flavin-dependent L-lysine monooxygenase, was investigated under steady-state and rapid reaction conditions using primary and solvent kinetic isotope effects, substrate analogs, pH and solvent viscosity effects as mechanistic probes. The results suggest that L-lysine binds before NAD(P)H, which leads to a decrease in the rate constant for flavin reduction. L-lysine binding has no effect on the rate of flavin oxidation, which occurs in a one-step process without the observation of a C4a-hydroperoxyflavin intermediate. Similar effects were determined with several substrate analogs. Flavin oxidation is pH independent while the k(cat)/K-m and k(red)/K-D pH profiles for NAD(P)H exhibit single pK(a) values of similar to 6.0, with increasing activity as the pH decreases. At lower pH, the enzyme becomes more uncoupled, producing more hydrogen peroxide and superoxide. Hydride transfer is partially rate-limiting at neutral pH and becomes more rate-limiting at low pH. An inverse solvent viscosity effect on k(cat)/K-m for NAD(P)H was observed at neutral pH whereas a normal solvent viscosity effect was observed at lower pH. Together, the results indicate a unique mechanism where a rate-limiting and pH-sensitive conformational change occurs in the reductive half-reaction, which affects the efficiency of lysine hydroxylation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Robinson, Reeder M.; Rodriguez, Pedro J.; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.
   [Robinson, Reeder M.; Rodriguez, Pedro J.; Sobrado, Pablo] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.
   [Sobrado, Pablo] Virginia Tech, Ctr Drug Discovery, Blacksburg, VA 24061 USA.
RP Sobrado, P (reprint author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.
EM psobrado@vt.edu
FU National Science Foundation [MCB 1021384]
FX This work was supported by a Grant from the National Science Foundation
   (MCB 1021384).
CR Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5
   Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a
   Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372
   Robinson R, 2011, BIOCHEMISTRY-US, V50, P8489, DOI 10.1021/bi200933h
   Dhatwalia R, 2012, J AM CHEM SOC, V134, P18132, DOI 10.1021/ja308188z
   Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028
   van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044
   Sobrado P, 2001, BIOCHEMISTRY-US, V40, P994, DOI 10.1021/bi002283d
   NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435
   Madigan CA, 2012, P NATL ACAD SCI USA, V109, P1257, DOI 10.1073/pnas.1109958109
   Olucha J, 2011, J BIOL CHEM, V286, P31789, DOI 10.1074/jbc.M111.265876
   Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004
   Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881
   Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z
   Ward PP, 2002, BIOCHEM CELL BIOL, V80, P95, DOI 10.1139/o01-214
   De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252
   Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n
   Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578
   Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075
   Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613
   Harris CM, 1997, J BIOL CHEM, V272, P8370
   Takase H, 2000, INFECT IMMUN, V68, P1834, DOI 10.1128/IAI.68.4.1834-1839.2000
   VISCA P, 1994, J BACTERIOL, V176, P1128
   JEONG SS, 1994, ANAL BIOCHEM, V221, P273, DOI 10.1006/abio.1994.1411
   Kang HY, 1996, J BACTERIOL, V178, P4877
   Barona-Gomez F, 2004, J AM CHEM SOC, V126, P16282, DOI 10.1021/ja045774k
   SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551
   Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w
   Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e
   Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105
   Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X
   Robinson R, 2013, BIOCHEMISTRY-US, V52, P9089, DOI 10.1021/bi4014903
   Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005
   Pierre JL, 1999, BIOMETALS, V12, P195, DOI 10.1023/A:1009252919854
   CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450
   Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627
   Lynch D, 2001, J BACTERIOL, V183, P2576, DOI 10.1128/JB.183.8.2576-2585.2001
   HERRERO M, 1988, J BACTERIOL, V170, P56
   Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578
   BEATY NB, 1980, J BIOL CHEM, V255, P3817
   Dawson R.M.C., 1986, DATA BIOCH RES, P427
   Gadda G, 2013, FEBS LETT, V587, P2785, DOI 10.1016/j.febslet.2013.04.021
   Romero E., 2013, FLAVINS FLAVOPROTEIN, P289
   Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k
   VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6
   Weast R.C., 1982, HDB CHEM PHYS 1982 1, pD239
NR 46
TC 3
Z9 3
U1 3
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2014
VL 550
BP 58
EP 66
DI 10.1016/j.abb.2014.04.006
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI3RT
UT WOS:000336780300008
PM 24769337
ER

PT J
AU Xu, YQ
   Zhang, L
   Xu, JD
   Wei, YP
   Xu, X
AF Xu, Yanqing
   Zhang, Liang
   Xu, Jiandong
   Wei, Yuping
   Xu, Xia
TI Membrane permeability of the human pluripotent stem cells to Me2SO,
   glycerol and 1,2-propanediol
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Human embryonic stem cells; Human induced pluripotent stem cells;
   Cryoprotectant permeability; Hydraulic permeability; Cryopreservation
ID RATIONALLY OPTIMIZED CRYOPRESERVATION; INTRACELLULAR ICE FORMATION;
   FREEZING-INJURY; ROCK INHIBITOR; HUMAN OOCYTES; WATER; KINETICS; LINES;
   DIMETHYLSULFOXIDE; HYPOTHESIS
AB Due to the unlimited capacity of self-renew and ability to differentiate into derivatives of three germ layers, human pluripotent stem cells, including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), have a great potential in regenerative medicine. A major challenge we are facing during the long-term storage of human pluripotent stem cells with the conventional slow cooling rate is the low cell recovery rate after cryopreservation which cannot meet the requirements for the future clinical applications. Evaluating the cell membrane permeability and the corresponding activation energy of hESCs and hiPSCs for water and different cryoprotective agents (CPA), including dimethyl sulfoxide (Me2SO), 1,2-propandiol and glycerol, is important for facilitating the development of cryopreservation protocol to enhance cell recovery after the cryopreservation. The osmotically inactive volume of hESCs and hiPSCs determined using the Boyle-van't Hoff model was 0.32V(0) and 0.42V(0), respectively. The membrane permeability was assessed from the volume changes of cells exposed to Me2SO, 1,2-propanediol and glycerol at the temperatures ranging from 8 to 30 degrees C. These results showed the biophysical differences between hESCs and hiPSCs. Their activation energy for water and CPAs extrapolated from the Arrhenius relationship indicated that the water transport was probably not through the channel-mediated mechanism. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Xu, Yanqing; Zhang, Liang; Xu, Jiandong; Wei, Yuping; Xu, Xia] Chinese Acad Sci, Inst Proc Engn, State Key Lab Biochem Engn, Beijing 100190, Peoples R China.
   [Xu, Yanqing; Zhang, Liang; Wei, Yuping] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Xu, X (reprint author), Chinese Acad Sci, Inst Proc Engn, State Key Lab Biochem Engn, 1 Beiertiao, Beijing 100190, Peoples R China.
EM xuxia@home.ipe.ac.cn
FU Chinese Academy of Sciences; National Natural Science Foundation of
   China [21176238]
FX This research was supported by the Chinese Academy of Sciences, and the
   National Natural Science Foundation of China (21176238).
CR Akhoondi M., 1808, BIOCHIM BIOPHYS ACTA, V2011, P642
   MULDREW K, 1990, BIOPHYS J, V57, P525
   Ameen C, 2008, CRIT REV ONCOL HEMAT, V65, P54, DOI 10.1016/j.critrevonc.2007.06.012
   Benson JD, 2012, CRYOBIOLOGY, V64, P144, DOI 10.1016/j.cryobiol.2012.01.001
   Li XY, 2008, STEM CELLS DEV, V17, P1079, DOI 10.1089/scd.2007.0247
   Smith DJ, 1998, J BIOMECH ENG-T ASME, V120, P549, DOI 10.1115/1.2834744
   Kashuba CM, 2014, CRYOBIOLOGY, V68, P166, DOI [10.1016/j.cryobiol.2013.12.007, 10.1016/j.cryobio1.2013.12.007]
   MULDREW K, 1994, BIOPHYS J, V66, P532
   Karlsson JOM, 1996, HUM REPROD, V11, P1296
   MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5
   TONER M, 1990, J APPL PHYS, V67, P1582, DOI 10.1063/1.345670
   GAO DY, 1995, HUM REPROD, V10, P1109
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Heng BC, 2009, TISSUE CELL, V41, P376, DOI 10.1016/j.tice.2009.01.004
   Malpique R, 2012, BIOTECHNOL PROGR, V28, P1079, DOI 10.1002/btpr.1572
   Karlsson JOM, 2009, MOL REPROD DEV, V76, P321, DOI 10.1002/mrd.20956
   Benson CMK, 2008, CRYOBIOLOGY, V56, P120, DOI 10.1016/j.cryobiol.2007.12.002
   Elmoazzen HY, 2002, CRYOBIOLOGY, V45, P68, DOI 10.1016/S0011-2240(02)00107-4
   Heng BC, 2006, ZYGOTE, V14, P341, DOI 10.1017/S0967199406003893
   Hunt CJ, 2007, TRANSFUS MED HEMOTH, V34, P293, DOI 10.1159/000104458
   Kashuba CM, 2014, CRYOBIOLOGY, V68, P176, DOI 10.1016/j.cryobiol.2013.12.003
   Kleinhans FW, 1998, CRYOBIOLOGY, V37, P271, DOI 10.1006/cryo.1998.2135
   Levin R.L., 1988, LOW TEMPERATURE BIOT, P177
   Marlow D.C., 1994, ADV HEAT MASS TRANSF, P71
   Martin-Ibanez R, 2008, HUM REPROD, V23, P2744, DOI 10.1093/humrep/den316
   MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347
   MAZUR P, 1990, CELL BIOPHYS, V17, P53
   MERYMAN H. T., 1985, CRYOPRESERVATION PLA, P13
   Muino L, 2011, MOL BIOCHEM PARASIT, V179, P80, DOI 10.1016/j.molbiopara.2011.06.003
   Paynter SJ, 2001, FERTIL STERIL, V75, P532, DOI 10.1016/S0015-0282(00)01757-X
   Paynter SJ, 1999, HUM REPROD, V14, P2338, DOI 10.1093/humrep/14.9.2338
   Pegg D.E., 1988, LOW TEMPERATURE BIOT, P3
   Taylor M.J., 1987, P3
   Thirumala S., 2004, THESIS LOUISIANA STA
   Thirumala S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/19/195104
   Valbuena D, 2008, REPROD BIOMED ONLINE, V17, P127
   Vian AM, 2014, CRYOBIOLOGY, V68, P35, DOI 10.1016/j.cryobiol.2013.11.004
   Xu X, 2003, MED ENG PHYS, V25, P573, DOI 10.1016/S1350-4533(03)00073-0
   Xu X, 2010, BIOTECHNOL PROGR, V26, P781, DOI 10.1002/btpr.358
NR 39
TC 0
Z9 0
U1 6
U2 24
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 2014
VL 550
BP 67
EP 76
DI 10.1016/j.abb.2014.04.010
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI3RT
UT WOS:000336780300009
PM 24780243
ER

PT J
AU Mikles, DC
   Schuchardt, BJ
   Bhat, V
   McDonald, CB
   Farooq, A
AF Mikles, David C.
   Schuchardt, Brett J.
   Bhat, Vikas
   McDonald, Caleb B.
   Farooq, Amjad
TI Role of promoter DNA sequence variations on the binding of EGR1
   transcription factor
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Zinc fingers; Protein-DNA thermodynamics; Enthalpy-entropy compensation;
   Single nucleotide polymorphisms
ID ENTHALPY-ENTROPY COMPENSATION; SP1/EGR1-TANDEM REPEAT POLYMORPHISM;
   PROTEIN-LIGAND INTERACTIONS; PROSTATE CARCINOMA-CELLS; GROWTH RESPONSE-1
   GENE; SITE-SPECIFIC BINDING; HEAT-CAPACITY CHANGES; ZINC-FINGER
   PROTEINS; SMOOTH-MUSCLE-CELLS; TARGET GENES
AB In response to a wide variety of stimuli such as growth factors and hormones, EGR1 transcription factor is rapidly induced and immediately exerts downstream effects central to the maintenance of cellular homeostasis. Herein, our biophysical analysis reveals that DNA sequence variations within the target gene promoters tightly modulate the energetics of binding of EGR1 and that nucleotide substitutions at certain positions are much more detrimental to EGR1-DNA interaction than others. Importantly, the reduction in binding affinity poorly correlates with the loss of enthalpy and gain of entropy-a trend indicative of a complex interplay between underlying thermodynamic factors due to the differential role of water solvent upon nucleotide substitution. We also provide a rationale for the physical basis of the effect of nucleotide substitutions on the EGR1-DNA interaction at atomic level. Taken together, our study bears important implications on understanding the molecular determinants of a key protein-DNA interaction at the cross-roads of human health and disease. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Mikles, David C.; Schuchardt, Brett J.; Bhat, Vikas; McDonald, Caleb B.; Farooq, Amjad] Univ Miami, Leonard Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.
RP Farooq, A (reprint author), Univ Miami, Leonard Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.
EM amjad@farooqlab.net
FU National Institutes of Health [R01-GM083897, T32-CA119929]; USylvester
   Braman Family Breast Cancer Institute
FX This work was supported by funds from the National Institutes of Health
   (Grant# R01-GM083897) and the USylvester Braman Family Breast Cancer
   Institute to A.F. C.B.M. is a recipient of a postdoctoral fellowship
   from the National Institutes of Health (Award# T32-CA119929).
CR Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711
   Alvarez V, 2008, ALZ DIS ASSOC DIS, V22, P177, DOI 10.1097/WAD.0b013e3181572046
   Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809
   CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909
   Wolfe SA, 1999, J MOL BIOL, V285, P1917, DOI 10.1006/jmbi.1998.2421
   LUMRY R, 1970, BIOPOLYMERS, V9, P1125, DOI 10.1002/bip.1970.360091002
   LEVIN WJ, 1995, ONCOGENE, V11, P1261
   Privalov PL, 2009, TRENDS BIOCHEM SCI, V34, P464, DOI 10.1016/j.tibs.2009.05.005
   Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178
   CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168
   Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291
   Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168
   Hamilton TB, 1998, BIOCHEMISTRY-US, V37, P2051, DOI 10.1021/bi9717993
   Zagurovskaya M, 2009, ONCOGENE, V28, P1121, DOI 10.1038/onc.2008.461
   Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124
   Bergqvist S, 2004, J MOL BIOL, V336, P829, DOI 10.1016/j.jmb.2003.12.061
   Olsson TSG, 2011, PROTEIN SCI, V20, P1607, DOI 10.1002/pro.692
   Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.one.1206560
   Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896
   Baron V, 2003, ANN NY ACAD SCI, V1002, P197, DOI 10.1196/annals.1281.024
   Ahmed MM, 2004, CURR CANCER DRUG TAR, V4, P43, DOI 10.2174/1568009043481704
   WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0
   MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664
   Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L
   Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318
   Munteanu MG, 1998, TRENDS BIOCHEM SCI, V23, P341, DOI 10.1016/S0968-0004(98)01265-1
   Liu CT, 1999, J BIOL CHEM, V274, P4400, DOI 10.1074/jbc.274.7.4400
   Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255
   SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294
   Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742
   Cooper A, 2005, BIOPHYS CHEM, V115, P89, DOI 10.1016/j.bpc.2004.12.011
   Eid MA, 1998, CANCER RES, V58, P2461
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
   EFTINK MR, 1983, BIOCHEMISTRY-US, V22, P3884, DOI 10.1021/bi00285a025
   PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256
   Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8
   Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W
   Bae SK, 1999, CANCER RES, V59, P5989
   Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273
   Berger C, 1996, BIOCHEMISTRY-US, V35, P14984, DOI 10.1021/bi961312a
   Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698
   Calogero A, 2001, CLIN CANCER RES, V7, P2788
   CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240
   Chavelas EA, 2009, BIOCHEM J, V420, P239, DOI 10.1042/BJ20082171
   DESJARLAIS JR, 1994, P NATL ACAD SCI USA, V91, P11099, DOI 10.1073/pnas.91.23.11099
   Edgcomb SP, 2000, CURR OPIN BIOTECH, V11, P62, DOI 10.1016/S0958-1669(99)00055-5
   FOGUEL D, 1994, P NATL ACAD SCI USA, V91, P8244, DOI 10.1073/pnas.91.17.8244
   FREIRE E, 1993, ARCH BIOCHEM BIOPHYS, V303, P181, DOI 10.1006/abbi.1993.1271
   Fu MG, 2002, J BIOL CHEM, V277, P26808, DOI 10.1074/jbc.M203748200
   Fu MG, 2003, BIOCHEM J, V370, P1019, DOI 10.1042/BJ20021503
   Fu MG, 2003, GENE, V315, P33, DOI 10.1016/S0378-1119(03)00730-3
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   Geiger EV, 2009, PROSTAG LEUKOTR ESS, V80, P255, DOI 10.1016/j.plefa.2009.04.001
   Gonzalez P, 2007, INT J IMMUNOGENET, V34, P127, DOI 10.1111/j.1744-313X.2007.00671.x
   Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429
   Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41
   Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200
   LADBURY JE, 1994, J MOL BIOL, V238, P669, DOI 10.1006/jmbi.1994.1328
   Liu CT, 2000, J BIOL CHEM, V275, P20315, DOI 10.1074/jbc.M909046199
   MERABET E, 1995, BIOCHEMISTRY-US, V34, P8554, DOI 10.1021/bi00027a005
   Mikles DC, 2013, FEBS J, V280, P3669, DOI 10.1111/febs.12360
   Milev S, 2005, BIOCHEMISTRY-US, V44, P285, DOI 10.1021/bi048907n
   Minc E, 1999, J BIOL CHEM, V274, P503, DOI 10.1074/jbc.274.1.503
   Morton CJ, 1996, PROTEIN SCI, V5, P2115
   Murphy KP, 1999, MED RES REV, V19, P333, DOI 10.1002/(SICI)1098-1128(199907)19:4<333::AID-MED6>3.0.CO;2-5
   MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2
   PETRI V, 1995, BIOCHEMISTRY-US, V34, P9977, DOI 10.1021/bi00031a020
   Renbaum P, 2003, GENE, V318, P113, DOI 10.1016/S0378-1119(03)00766-2
   Seldeen KL, 2008, ARCH BIOCHEM BIOPHYS, V480, P75, DOI 10.1016/j.abb.2008.10.010
   Seldeen KL, 2008, ARCH BIOCHEM BIOPHYS, V473, P48, DOI 10.1016/j.abb.2008.02.024
   Starikov EB, 2007, J PHYS CHEM B, V111, P14431, DOI 10.1021/jp075784i
   Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200
   Thigpen AE, 1996, J UROLOGY, V155, P975, DOI 10.1016/S0022-5347(01)66361-4
   Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200
   XIE D, 1994, PROTEINS, V19, P291, DOI 10.1002/prot.340190404
NR 75
TC 0
Z9 0
U1 2
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2014
VL 549
BP 1
EP 11
DI 10.1016/j.abb.2014.03.005
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AG3BZ
UT WOS:000335292100001
PM 24657079
ER

PT J
AU Karpicheva, OE
   Redwood, CS
   Borovikov, YS
AF Karpicheva, Olga E.
   Redwood, Charles S.
   Borovikov, Yurii S.
TI The E117K mutation in beta-tropomyosin disturbs concerted conformational
   changes of actomyosin in muscle fibers
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE beta-Tropomyosin; Congenital myopathy; Conformational change; ATPase
   cycle
ID CARDIOMYOPATHY-CAUSING MUTATIONS; THIN FILAMENT ACTIVATION; RABBIT
   SKELETAL-MUSCLE; F-ACTIN; REGULATORY PROTEINS; ALPHA-TROPOMYOSIN;
   STRIATED-MUSCLE; MYOSIN SUBFRAGMENT-1; CONTRACTILE FUNCTION; NEMALINE
   MYOPATHY
AB The effect of the skeletal myopathy-causing E117K mutation in human beta-tropomyosin on actomyosin structure during the ATPase cycle was studied using fluorescent probes bound to actin subdomain I and the myosin head. Multistep changes in flexural rigidity of actin filament and in spatial arrangement of actin subdomain 1 and myosin SHI helix in troponin-free ghost muscle fibers were revealed. During the ATPase cycle E117K tropomyosin inhibited the rotation of subdomain 1 by 46% and the tilt of the SH1 helix by 49% compared with wild-type. At strong-binding stages the proportion of strong binding sub-states in the actomyosin population is decreased by the mutation. At weak-binding stages abnormally high numbers of switched-on actin monomers were observed, thus indicating a disturbance in concerted conformational changes of actomyosin. These structural alterations are likely to underlie the contractile deficit observed with this mutation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Karpicheva, Olga E.; Borovikov, Yurii S.] Russian Acad Sci, Inst Cytol, Lab Mech Cell Motil, St Petersburg 194064, Russia.
   [Redwood, Charles S.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.
RP Borovikov, YS (reprint author), Russian Acad Sci, Inst Cytol, Lab Mech Cell Motil, 4 Tikhoretsky Ave, St Petersburg 194064, Russia.
EM borovikov@incras.ru
RI Karpicheva, Olga/D-8520-2014; Borovikov, Yurii/O-7433-2015
OI Karpicheva, Olga/0000-0003-0601-5978; 
FU FEBS Collaboration Scholarship; Russian Fund for Fundamental Research
   [14-0400454a]; Programme of Presidium of RAS; Muscular Dystrophy
   Campaign
FX This work was funded by a personal FEBS Collaboration Scholarship, the
   Russian Fund for Fundamental Research (No. 14-0400454a), the Programme
   of Presidium of RAS (theme No.7) and the Muscular Dystrophy Campaign.
CR Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781
   Chang AN, 2005, J BIOL CHEM, V280, P34343, DOI 10.1074/jbc.M505014200
   MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   Marston S, 2013, HUM MOL GENET, V22, P4978, DOI 10.1093/hmg/ddt345
   Lawlor MW, 2010, HUM MUTAT, V31, P176, DOI 10.1002/humu.21157
   Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930
   SPUDICH JA, 1971, J BIOL CHEM, V246, P4866
   Robinson P, 2007, FASEB J, V21, P896, DOI 10.1096/fj.06-6899com
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8
   BOREJDO J, 1977, BIOCHIM BIOPHYS ACTA, V459, P578, DOI 10.1016/0005-2728(77)90056-1
   Borejdo J, 2006, EXP BIOL MED, V231, P28
   Borejdo J, 2004, BIOPHYS J, V86, P2308
   Borovikov YS, 2009, ARCH BIOCHEM BIOPHYS, V489, P20, DOI 10.1016/j.abb.2009.07.018
   Borovikov YS, 1999, INT REV CYTOL, V189, P267, DOI 10.1016/S0074-7696(08)61389-3
   BOROVIKOV YS, 1983, EUR J BIOCHEM, V136, P363, DOI 10.1111/j.1432-1033.1983.tb07750.x
   Borovikov YS, 2009, BBA-PROTEINS PROTEOM, V1794, P985, DOI 10.1016/j.bbapap.2008.11.014
   Borovikov YS, 2000, BBA-PROTEIN STRUCT M, V1478, P138, DOI 10.1016/S0167-4838(00)00005-4
   Brandis A, 2008, NEUROMUSCULAR DISORD, V18, P1005, DOI 10.1016/j.nmd.2008.07.007
   Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102
   Chalovich JM, 2002, J MUSCLE RES CELL M, V23, P353, DOI 10.1023/A:1022066922922
   Egelman E H, 2001, Results Probl Cell Differ, V32, P95
   Fujita H, 2004, J PHYSIOL-LONDON, V556, P637, DOI 10.1113/jphysiol.2003.059956
   GOODY R S, 1980, Journal of Muscle Research and Cell Motility, V1, P101, DOI 10.1007/BF00711928
   Gordon AM, 1998, ADV EXP MED BIOL, V453, P187
   Greenfield NJ, 2002, BIOPHYS J, V83, P2754
   Holmes KC, 2000, PHILOS T ROY SOC B, V355, P419
   Homsher E, 2000, J PHYSIOL-LONDON, V524, P233, DOI 10.1111/j.1469-7793.2000.00233.x
   HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019
   Karpicheva OE, 2013, ARCH BIOCHEM BIOPHYS, V536, P25, DOI 10.1016/j.abb.2013.05.001
   Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200
   Lehman W, 2013, J MUSCLE RES CELL M, V34, P155, DOI 10.1007/s10974-013-9342-0
   MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55
   Marttila M, 2012, BIOCHEM J, V442, P231, DOI 10.1042/BJ20111030
   Mathur MC, 2011, BIOCHEM BIOPH RES CO, V406, P74, DOI 10.1016/j.bbrc.2011.01.112
   MCKILLOP DFA, 1993, BIOPHYS J, V65, P693
   Miki M, 2012, J MOL BIOL, V420, P40, DOI 10.1016/j.jmb.2012.03.029
   Ochala J, 2010, P NATL ACAD SCI USA, V107, P9807, DOI 10.1073/pnas.1001733107
   Ochala J, 2008, J PHYSIOL-LONDON, V586, P2993, DOI 10.1113/jphysiol.2008.153650
   OKAMOTO Y, 1985, J BIOCHEM-TOKYO, V98, P1143
   Pronina O, 2007, BIOPHYS J, p625A
   Roopnarine O, 1996, BIOPHYS J, V70, P2795
   Rysev NA, 2012, BBA-PROTEINS PROTEOM, V1824, P366, DOI 10.1016/j.bbapap.2011.11.004
   TAWADA K, 1978, EUR J BIOCHEM, V88, P411, DOI 10.1111/j.1432-1033.1978.tb12463.x
   TREGEAR RT, 1975, BIOPHYS J, V15, P455, DOI 10.1016/S0006-3495(75)85830-9
   YANAGIDA T, 1978, J MOL BIOL, V126, P507, DOI 10.1016/0022-2836(78)90056-6
   Yasuda R, 1996, J MOL BIOL, V263, P227, DOI 10.1006/jmbi.1996.0571
NR 48
TC 2
Z9 2
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2014
VL 549
BP 12
EP 16
DI 10.1016/j.abb.2014.03.007
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AG3BZ
UT WOS:000335292100002
PM 24657080
ER

PT J
AU Flemmig, J
   Rusch, D
   Czerwinska, ME
   Rauwald, HW
   Arnhold, J
AF Flemmig, Joerg
   Rusch, Dorothea
   Czerwinska, Monika Ewa
   Rauwald, Hans-Wilhelm
   Arnhold, Juergen
TI Components of a standardised olive leaf dry extract (Ph. Eur.) promote
   hypothiocyanite production by lactoperoxidase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Olive leaf dry extract; Olea europaea; Phenolic components;
   Hydroxytyrosol; Lactoperoxidase
ID ANAEROBIC STOPPED-FLOW; HYDROGEN-PEROXIDE; HUMAN MYELOPEROXIDASE;
   ANTIOXIDANT ACTIVITIES; HYPOCHLOROUS ACID; HOST-DEFENSE; IN-VITRO;
   THIOCYANATE; OXIDATION; SALIVA
AB We investigated in vitro the ability of a standardised olive leaf dry extract (Ph. Eur.) (OLE) as well as of its single components to circumvent the hydrogen peroxide-induced inhibition of the hypothiocyanite-producing activity of lactoperoxidase (LPO). The rate of hypothiocyanite (-OSCN) formation by LPO was quantified by spectrophotometric detection of the oxidation of 5-thio-2-nitrobenzoic acid (TNB).
   By using excess hydrogen peroxide, we forced the accumulation of inactive enzymatic intermediates which are unable fo promote the two-electronic oxidation of thiocyanate. Both OLE and certain extract components showed a strong LPO-reactivating effect. Thereby an 0-hydroxyphenolic moiety emerged to be essential for a good reactivity with the inactive LPO redox states. This basic moiety is found in the main OLE components oleuropein, oleacein, hydroxytyrosol, caffeic acid as well as in different other constituents including the OLE flavone luteolin.
   As LPO is a key player in the humoral immune response, these results propose a new mode of action regarding the well-known bacteriostatic and anti-inflammatory properties of the leaf extract of Olea europaea L. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Flemmig, Joerg] Translat Ctr Regenerat Med TRM Leipzig, D-04103 Leipzig, Germany.
   [Flemmig, Joerg; Rusch, Dorothea; Arnhold, Juergen] Univ Leipzig, Fac Med, Inst Med Phys & Biophys, D-04107 Leipzig, Germany.
   [Czerwinska, Monika Ewa] Med Univ Warsaw, Fac Pharm, Dept Pharmacognosy & Mol Basis Phytotherapy, PL-02097 Warsaw, Poland.
   [Rauwald, Hans-Wilhelm] Univ Leipzig, Dept Pharmaceut Biol, D-04103 Leipzig, Germany.
RP Flemmig, J (reprint author), Univ Leipzig, Fac Med, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.
EM joerg.flemmig@medizin.uni-leipzig.de; dr.rusch@googlemail.com;
   monika.czerwinska@wum.edu.pl; rauwald@rz.uni-leipzig.de;
   juergen.arnhold@medizin.uni-leipzig.de
FU German Federal Ministry of Education and Research [1315883]; European
   Regional Development Fund [100116526]; SAB
FX This work was made possible by funding from the German Federal Ministry
   of Education and Research (BMBF, 1315883) as well as by the SAB
   (Sachsische Aufbaubank) project 100116526 from a funding of the European
   Regional Development Fund (ERDF). We thank Kenny Kuchta and Anna Kiss
   for the practical work on isolation and characterization of OLE
   components and the revision of the manuscript, respectively.
CR Flemmig J, 2011, PHYTOMEDICINE, V18, P561, DOI 10.1016/j.phymed.2010.10.021
   FLORIS R, 1993, EUR J BIOCHEM, V215, P767, DOI 10.1111/j.1432-1033.1993.tb18091.x
   Tripoli E, 2005, NUTR RES REV, V18, P98, DOI 10.1079/NRR200495
   Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358
   Briante R, 2002, J AGR FOOD CHEM, V50, P4934, DOI 10.1021/jf025540p
   THOMAS EL, 1994, J DENT RES, V73, P544
   Czerwinska M, 2012, FOOD CHEM, V131, P940, DOI 10.1016/j.foodchem.2011.09.082
   Lavelli V, 2002, J AGR FOOD CHEM, V50, P7704, DOI 10.1021/jf020749o
   Yan JJ, 2004, BIOL PHARM BULL, V27, P2024, DOI 10.1248/bpb.27.2024
   vanDalen CJ, 1997, BIOCHEM J, V327, P487
   Chandler JD, 2012, BIOCHEM PHARMACOL, V84, P1381, DOI 10.1016/j.bcp.2012.07.029
   Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Omar Syed Haris, 2010, Sci Pharm, V78, P133, DOI 10.3797/scipharm.0912-18
   Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017
   Benavente-Garcia O, 2000, FOOD CHEM, V68, P457, DOI 10.1016/S0308-8146(99)00221-6
   Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008
   Lloyd MM, 2008, BIOCHEM J, V414, P271, DOI 10.1042/BJ20080468
   Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004
   Cecchini T., 1992, ENCICLOPEDIA HIERBAS, P348
   Dunford HB, 1999, BIOCHEM CELL BIOL, V77, P449, DOI 10.1139/bcb-77-5-449
   Fielding AJ, 2008, BIOCHEMISTRY-US, V47, P9781, DOI 10.1021/bi801032k
   Flemmig J, 2014, J INORG BIOCHEM, V130, P84, DOI 10.1016/j.jinorgbio.2013.10.002
   Furtmuller PG, 2000, FEBS LETT, V484, P139, DOI 10.1016/S0014-5793(00)02143-8
   Furtmuller PG, 2002, BIOCHEMISTRY-US, V41, P11895, DOI 10.1021/bi026326x
   Jantschko W, 2005, ARCH BIOCHEM BIOPHYS, V434, P51, DOI 10.1016/j.abb.2004.10.014
   Jantschko W, 2003, BIOCHEM BIOPH RES CO, V312, P292, DOI 10.1016/j.bbrc.2003.10.117
   Kiss AK, 2008, J ETHNOPHARMACOL, V120, P220, DOI 10.1016/j.jep.2008.08.015
   Koelsch M, 2010, BIOCHEM PHARMACOL, V79, P1156, DOI 10.1016/j.bcp.2009.11.024
   Kooter IM, 1999, J BIOL CHEM, V274, P26794, DOI 10.1074/jbc.274.38.26794
   Landino LM, 2008, NITRIC OXIDE-BIOL CH, V18, P11, DOI 10.1016/j.niox.2007.09.087
   Lane AE, 2010, BIOCHEM J, V430, P161, DOI 10.1042/BJ20100082
   LEPORATTI ML, 1985, J ETHNOPHARMACOL, V14, P65, DOI 10.1016/0378-8741(85)90029-7
   Nagy P, 2009, CHEM RES TOXICOL, V22, P1833, DOI 10.1021/tx900249d
   Ozdemir H, 2005, J ENZYM INHIB MED CH, V20, P491, DOI 10.1080/14756360500225045
   Paiva-Martins F, 2001, J AGR FOOD CHEM, V49, P4214, DOI 10.1021/jf010373z
   PRUITT KM, 1986, BIOCHIM BIOPHYS ACTA, V870, P385, DOI 10.1016/0167-4838(86)90245-1
   Rauwald H. W., 1991, PHARM PHARM LETT, V1, P78
   Ritter M, 2010, PLANTA MED, V76, P572, DOI 10.1055/s-0029-1240602
   Scheffler A., 2008, J ETHNOPHARMACOL, V20, P233
   Somova LI, 2004, PHYTOMEDICINE, V11, P121, DOI 10.1078/0944-7113-00329
   Spalteholz H, 2008, BIOCHEM BIOPH RES CO, V371, P810, DOI 10.1016/j.bbrc.2008.04.139
   Stiti N., 2012, J LIPIDS, V2012, P1
   TENOVUO J, 1976, J DENT RES, V55, P661, DOI 10.1177/00220345760550042001
   Valnet J., 1983, PHYTOTHERAPIE, P587
   Wang JG, 2006, ARCH BIOCHEM BIOPHYS, V445, P256, DOI 10.1016/j.abb.2005.10.008
   Wilson IR, 1960, J AM CHEM SOC, V82, P4515, DOI 10.1021/ja01502a017
NR 47
TC 3
Z9 3
U1 4
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2014
VL 549
BP 17
EP 25
DI 10.1016/j.abb.2014.03.006
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AG3BZ
UT WOS:000335292100003
PM 24657078
ER

PT J
AU Li, X
   Li, M
   Bai, XZ
AF Li, Xi
   Li, Miao
   Bai, Xizhuang
TI Upregulation of TLR2 expression is induced by estrogen via an
   estrogen-response element (ERE)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE TLR2; Gene expression; 17 beta-Estradiol; ERE
ID EARLY RHEUMATOID-ARTHRITIS; RECEPTORS; PATHWAYS; BINDING; CELLS
AB TLR2 and estrogen are both thought to be involved in the pathogenesis of RA; however, it is unknown if there is an association between estrogen and TLR2. In this report, we treated PMA-differentiated THP-1 cells with 17 beta-estradiol (E2) and observed increases in TLR2 mRNA and protein levels by real-time quantitative PCR and western blot. Transfection of THP-1 cells with a series of 5 '-deleted TLR2 promoter-luciferase constructs revealed that E2 enhanced TLR2 transcriptional activity in an estrogen receptor alpha (ERot)-dependent pattern. An estrogen receptor response element (ERE) was identified 251 bases upstream of the TLR2 promoter, and electrophoretic mobility shift assay and chromatin immunoprecipitations showed ER alpha binding was increased by E2. In summary, this work demonstrated that TLR2 is a new estrogen-regulated gene whose expression is upregulated through the interaction of ERot with an ERE in the promoter region. (C) 2014 Published by Elsevier Inc.
C1 [Li, Xi] China Med Univ, Affiliated Hosp 4, Dept Orthoped Surg, Shenyang 110032, Peoples R China.
   [Li, Miao] China Med Univ, Coll Basic Med Sci, Dept Pathogen Biol, Shenyang 110001, Peoples R China.
   [Li, Xi; Bai, Xizhuang] China Med Univ, Affiliated Hosp 1, Dept Sports Med & Joint Surg, Shenyang 110001, Peoples R China.
RP Bai, XZ (reprint author), China Med Univ, Affiliated Hosp 1, Dept Sports Med & Joint Surg, 155 Nanjing St, Shenyang 110001, Peoples R China.
EM baixizhuangcmu@sina.com
FU National Nature Science Foundation of China [81201333]
FX This project is supported by grants from the National Nature Science
   Foundation of China (No. 81201333).
CR Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657
   Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9
   O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802
   Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5
   Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7
   Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4
   Ospelt C, 2008, ARTHRITIS RHEUM, V58, P3684, DOI 10.1002/art.24140
   Kvien TK, 2006, ANN NY ACAD SCI, V1069, P212, DOI 10.1196/annals.1351.019
   Hoekstra M, 2003, ANN RHEUM DIS, V62, P423, DOI 10.1136/ard.62.5.423
   Cutolo M, 2004, LUPUS, V13, P635, DOI 10.1191/0961203304lu1094oa
   Jakacka M, 2001, J BIOL CHEM, V276, P13615
   Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062
   CROMARTIE WJ, 1977, J EXP MED, V146, P1585, DOI 10.1084/jem.146.6.1585
   Cutolo M, 2001, EUR CYTOKINE NETW, V12, P368
   CUTOLO M, 1993, ARTHRITIS RHEUM, V36, P1087, DOI 10.1002/art.1780360809
   Drexler Stefan K, 2006, Expert Rev Clin Immunol, V2, P585, DOI 10.1586/1744666X.2.4.585
   Dubey RK, 2004, J PHARMACOL EXP THER, V308, P403, DOI 10.1124/jpet.103.058057
   Liu ZQ, 2001, ARTHRITIS RES, V3, P375, DOI 10.1186/ar330
   Sacre Sandra M., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009488
   Verschueren P, 2009, SCAND J RHEUMATOL, V38, P166, DOI 10.1080/03009740802484846
   [张玉芬 ZHANG Yu-fen], 2009, [西安建筑科技大学学报, Journal of Xi'an University of Architecture & Technology], V41, P41
NR 21
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2014
VL 549
BP 26
EP 31
DI 10.1016/j.abb.2014.01.028
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AG3BZ
UT WOS:000335292100004
PM 24508688
ER

PT J
AU Sluchanko, NN
   Roman, SG
   Chebotareva, NA
   Gusev, NB
AF Sluchanko, Nikolai N.
   Roman, Svetlana G.
   Chebotareva, Natalia A.
   Gusev, Nikolai B.
TI Chaperone-like activity of monomeric human 14-3-3 zeta on different
   protein substrates
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE 14-3-3 monomer; Small heat shock proteins; bis-ANS fluorescence;
   Aggregation; Moonlight proteins; Hydrophobicity
ID HEAT-SHOCK PROTEINS; ENDOPLASMIC-RETICULUM STRESS; ERS-INITIATED
   APOPTOSIS; PHOSPHORYLASE-KINASE; MOLECULAR CHAPERONE; LIGAND-BINDING;
   PHYSICOCHEMICAL CHANGES; AGGREGATED PROTEINS; CROWDING CONDITIONS;
   ALPHA-CRYSTALLIN
AB Members of the 14-3-3 protein family interact with hundreds of different, predominantly phosphorylated, proteins. 14-3-3 dimers are prevalent but exist at the equilibrium with the monomers. Our previous studies using the engineered monomeric 14-3-3 zeta (14-3-3 zeta(m)) showed that 14-3-3 zeta monomer retained binding activity towards selected phosphorylated partners and, in addition, it prevented heat-induced aggregation of myosin subfragment 1. Since the chaperone-like activity of 14-3-3 monomers has been insufficiently studied, here we have analyzed the effect of 14-3-3 zeta(m) on the aggregation of different model proteins. We found that 14-3-3 zeta(m) demonstrated considerable chaperone-like activity by inhibiting the DTT-induced aggregation of insulin and thermally-induced aggregation of alcohol dehydrogenase and phosphorylase kinase. Importantly, the anti-aggregating activity of 14-3-3 zeta(m) was concentration-dependent and overall, was more pronounced than that of its dimeric counterpart. In some cases, the chaperone-like effect of 14-3-3 zeta(m) was comparable, or even higher, than that of the small heat shock proteins, HspB6 and HspB5. We suggest that 14-3-3s not only can bind and regulate the activity of multiple phosphoproteins, but also possess moonlighting chaperone-like activity, which is especially pronounced in the case of monomeric forms of 14-3-3 which can be present under certain stress conditions. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Sluchanko, Nikolai N.; Roman, Svetlana G.; Chebotareva, Natalia A.] Russian Acad Sci, AN Bach Inst Biochem, Moscow 119071, Russia.
   [Gusev, Nikolai B.] Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow 119991, Russia.
RP Sluchanko, NN (reprint author), Russian Acad Sci, AN Bach Inst Biochem, Leninsky Prospect 33, Moscow 119071, Russia.
EM nikolai.sluchanko@mail.ru
FU Russian Foundation for Basic Research [14-04-00146-a, 14-0401530-a,
   13-04-00015-a]
FX We are thankful to Prof. D.I. Levitsky and Dr. A.S. Seit-Nebi for
   fruitful discussions and for the help with manuscript preparation, to
   Dr. V.F. Makeeva for her help in PhK purification, to Dr. T.B. EronMa
   for her help with DLS measurements, to Dr. K.A. Markossian and Dr. M.O.
   Agaphonov for the provided substrate proteins (insulin and lysozyme).
   This investigation was supported by the Russian Foundation for Basic
   Research (14-04-00146-a to N.N.S., 14-0401530-a to N.A.C. and S.G.R.,
   13-04-00015-a to N.B.G.) and the program "Molecular and Cell Biology" of
   the Presidium of the Russian Academy of Sciences (N.N.S., S.G.R., and
   N.A.C.).
CR Hochgrebe T, 2000, BIOCHEMISTRY-US, V39, P1411, DOI 10.1021/bi991581b
   LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0
   Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102
   PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253
   Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106
   Yano M, 2006, MOL BIOL CELL, V17, P4769, DOI 10.1091/mbc.E06-03-0229
   Invernizzi G, 2012, INT J BIOCHEM CELL B, V44, P1541, DOI 10.1016/j.biocel.2012.05.023
   Murphy N, 2008, J NEUROCHEM, V106, P978, DOI 10.1111/j.1471-4159.2008.05447.x
   Vincenz C, 1996, J BIOL CHEM, V271, P20029
   Nadeau OW, 2002, STRUCTURE, V10, P23, DOI 10.1016/S0969-2126(01)00678-5
   Zhou Y, 2003, J BIOL CHEM, V278, P10073, DOI 10.1074/jbc.M211907200
   Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007
   Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9
   Scranton MA, 2012, J BIOL CHEM, V287, P18408, DOI 10.1074/jbc.M111.309500
   Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010
   Xu Z, 2013, J CELL SCI, V126, P4173, DOI 10.1242/jcs.126102
   Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317
   Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003
   Sluchanko NN, 2012, BIOCHEMISTRY-US, V51, P6127, DOI 10.1021/bi300674e
   Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019
   Sari FR, 2010, J PHARMACOL SCI, V113, P325, DOI 10.1254/jphs.10047FP
   Sari FR, 2010, CELL PHYSIOL BIOCHEM, V26, P167, DOI 10.1159/000320548
   Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j
   Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002
   Zhang BW, 2011, J AM CHEM SOC, V133, P19393, DOI 10.1021/ja2060066
   Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005
   ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1
   Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044
   de Thonel A, 2012, INT J BIOCHEM CELL B, V44, P1593, DOI 10.1016/j.biocel.2012.06.012
   Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06
   Brennan GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054491
   Bukach OV, 2004, EUR J BIOCHEM, V271, P291, DOI 10.1046/j.1432-1033.2003.03928.x
   Chebotareva NA, 2006, PROG COLL POL SCI S, V131, P83, DOI 10.1007/2882_007
   Chebotareva NA, 2010, MACROMOL BIOSCI, V10, P783, DOI 10.1002/mabi.200900397
   Chebotareva NA, 2008, BIOPHYS CHEM, V133, P45, DOI 10.1016/j.bpc.2007.12.001
   Chernik IS, 2007, MOL CELL BIOCHEM, V295, P9, DOI 10.1007/s11010-006-9266-8
   Dong Y, 2010, MOL NEUROBIOL, V41, P218, DOI 10.1007/s12035-010-8142-4
   ENGEL K, 1995, J CELL BIOCHEM, V57, P321, DOI 10.1002/jcb.240570216
   Kovacs D, 2009, FEBS LETT, V583, P88, DOI 10.1016/j.febslet.2008.11.049
   Lindner RA, 2001, BIOCHEM J, V354, P79, DOI 10.1042/0264-6021:3540079
   Liu WY, 2008, PROTEIN SCI, V17, P2111, DOI 10.1110/ps.037895.108
   Liu WY, 2013, PROTEIN SCI, V22, P444, DOI 10.1002/pro.2226
   Markov DI, 2008, FEBS LETT, V582, P1407, DOI 10.1016/j.febslet.2008.03.035
   Meredith SC, 2005, ANN NY ACAD SCI, V1066, P181, DOI 10.1196/annals.1363.030
   MOORE BW, 1968, J NEUROCHEM, V15, P265, DOI 10.1111/j.1471-4159.1968.tb11610.x
   Mymrikov EV, 2010, CELL STRESS CHAPERON, V15, P365, DOI 10.1007/s12192-009-0151-8
   Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200
   Reddy GB, 2006, IUBMB LIFE, V58, P632, DOI 10.1080/15216540601010096
   Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200
   Sluchanko NN, 2011, BIOCHEMISTRY-US, V50, P9797, DOI 10.1021/bi201374s
   Sluchanko NN, 2011, ARCH BIOCHEM BIOPHYS, V506, P24, DOI 10.1016/j.abb.2010.11.003
   Sluchanko NN, 2012, FEBS LETT, V586, P4249, DOI 10.1016/j.febslet.2012.10.048
   Sluchanko NN, 2008, ARCH BIOCHEM BIOPHYS, V477, P305, DOI 10.1016/j.abb.2008.05.020
   Sluchanko NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072597
   Suragani M., 2013, P NATL ACAD SCI US
   Uhart M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055703
   Velichko A.K., 2013, CELL MOL LIFE SCI
   Wang HN, 1998, J BIOL CHEM, V273, P16297, DOI 10.1074/jbc.273.26.16297
   Wilkinson DA, 1999, J PROTEIN CHEM, V18, P157, DOI 10.1023/A:1020667720565
   Williams DM, 2011, BIOCHEM J, V437, P493, DOI 10.1042/BJ20102178
   Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56
NR 63
TC 3
Z9 3
U1 4
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2014
VL 549
BP 32
EP 39
DI 10.1016/j.abb.2014.03.008
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AG3BZ
UT WOS:000335292100005
PM 24681339
ER

PT J
AU Wielgus-Kutrowska, B
   Modrak-Wojcik, A
   Dyzma, A
   Breer, K
   Zolkiewski, M
   Bzowska, A
AF Wielgus-Kutrowska, Beata
   Modrak-Wojcik, Anna
   Dyzma, Alicja
   Breer, Katarzyna
   Zolkiewski, Michal
   Bzowska, Agnieszka
TI Purine nucleoside phosphorylase activity decline is linked to the decay
   of the trimeric form of the enzyme
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Analytical ultracentrifugation; Protein stability; Protein association;
   Oligomeric proteins; Differential scanning calorimetry; Circular
   dichroism
ID CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE; ANALYTICAL ULTRACENTRIFUGATION;
   PROTEIN STABILITY; TRANSITION-STATE; HOT-SPOTS; MECHANISM;
   FIBRILLOGENESIS; DIMERIZATION; AGGREGATION
AB Homotrimeric mammalian purine nucleoside phosphorylase (PNP) plays a key role in the nucleoside and nucleotide metabolic salvage pathway. Each monomer in the active PNP trimer is composed of a central beta-sheet flanked by several alpha-helices. We investigated the stability of calf PNP using analytical ultracentrifugation, differential scanning calorimetry, circular dichroism, and UV absorption spectroscopy. The results demonstrate that the activity decline (due to protein aging after isolation from cells) of wild type PNP and its two mutants with point mutations in the region of monomer-monomer interface, is accompanied by a decrease of the population of the trimeric enzyme and an increase of the population of its aggregated forms. The data do not indicate a significant population of either folded or unfolded PNP monomers. The enzyme with specific activity lower than the maximal shows a decrease of the helical structure, which can make it prone to aggregation. The presence of phosphate stabilizes the enzyme but leads to a more pronounced aggregation above the melting temperature. These results suggest that the biological role of packing of the PNP monomers into a trimeric structure is to provide the stability of the enzyme since the monomers are not stable in solution. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wielgus-Kutrowska, Beata; Modrak-Wojcik, Anna; Dyzma, Alicja; Breer, Katarzyna; Bzowska, Agnieszka] Univ Warsaw, Inst Expt Phys, Div Biophys, PL-02089 Warsaw, Poland.
   [Dyzma, Alicja] Univ Warsaw, Coll Interfac Individual Studies Math & Nat Sci, PL-02089 Warsaw, Poland.
   [Zolkiewski, Michal] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.
RP Wielgus-Kutrowska, B (reprint author), Univ Warsaw, Inst Expt Phys, Div Biophys, Zwirki & Wigury 93, PL-02089 Warsaw, Poland.
EM beata@biogeo.uw.edu.pl
FU Polish Ministry for Science and Higher Education [NN 301 044939];
   Physics facing challenges of XXI century; European Union within European
   Social Fund, under the Human Capital Operational Programme; European
   Regional Development Fund [POIG.02.02.00-00-025/09]; Priority axis IV;
   European Social Fund [UDA-POKL.04.01.01-00-072/09-00]
FX We are indebted to Mrs. Lucyna Magnowska for the excellent technical
   assistance. This work was supported by the Polish Ministry for Science
   and Higher Education (Grant NN 301 044939), and, in part, by the
   projects: "Physics facing challenges of XXI century" co-financed by
   European Union within European Social Fund, under the Human Capital
   Operational Programme 2007-2013, Priority axis IV, and the European
   Social Fund, contract number UDA-POKL.04.01.01-00-072/09-00. The
   analytical ultracentrifugation experiments were performed in the NanoFun
   laboratories co-financed by the European Regional Development Fund
   within the Innovation Economy Operational Program, Project No.
   POIG.02.02.00-00-025/09.
CR Al-Kali A, 2010, FUTURE ONCOL, V6, P1211, DOI [10.2217/fon.10.83, 10.2217/FON.10.83]
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Xu D, 1998, PROTEIN SCI, V7, P533
   Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371
   Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474
   Hashimoto K, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035007
   Mao C, 1998, BIOCHEMISTRY-US, V37, P7135, DOI 10.1021/bi9723919
   Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684
   Bzowska A, 2000, PHARMACOL THERAPEUT, V88, P349, DOI 10.1016/S0163-7258(00)00097-8
   de la Torre JG, 2000, BIOPHYS J, V78, P719
   Wang JZ, 2012, SPECTROCHIM ACTA A, V98, P199, DOI 10.1016/j.saa.2012.07.105
   Takacs E, 2004, FEBS LETT, V566, P48, DOI 10.1016/j.febslet.2004.04.039
   Behlke J, 2005, Z NATURFORSCH C, V60, P927
   Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3
   Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240
   Modrak-Wojcik A, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/285219
   Modrak-Wojcik A, 2006, PROTEIN SCI, V15, P1794, DOI 10.1110/ps.062183206
   Arutyunyan AM, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1378, DOI 10.1023/A:1013337930104
   Miles RW, 1998, BIOCHEMISTRY-US, V37, P8615, DOI 10.1021/bi980658d
   Bzowska A, 2004, J MOL BIOL, V342, P1015, DOI 10.1016/j.jmb.2004.07.017
   Chojnowski G, 2010, BIOCHEM BIOPH RES CO, V391, P703, DOI 10.1016/j.bbrc.2009.11.124
   Koellner G, 1997, J MOL BIOL, V265, P202, DOI 10.1006/jmbi.1996.0730
   Larda ST, 2013, J AM CHEM SOC, V135, P10533, DOI 10.1021/ja404584s
   Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0
   Schuck P, 2000, BIOPHYS J, V78, P1606
   Thoma R, 2000, STRUCT FOLD DES, V8, P265, DOI 10.1016/S0969-2126(00)00106-4
   Breer K, 2008, PROTEIN EXPRES PURIF, V61, P122, DOI 10.1016/j.pep.2008.06.002
   Mehboob S, 2009, BIOCHEMISTRY-US, V48, P7045, DOI 10.1021/bi9005072
   Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604
   Beernink PT, 1996, P NATL ACAD SCI USA, V93, P5374, DOI 10.1073/pnas.93.11.5374
   Bertosa B, 2014, FEBS J, V281, P1860, DOI 10.1111/febs.12746
   Bzowska A, 2002, BBA-PROTEIN STRUCT M, V1596, P293, DOI 10.1016/S0167-4838(02)00218-2
   Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s
   de Giuseppe PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044282
   Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151
   Erion MD, 1997, BIOCHEMISTRY-US, V36, P11725, DOI 10.1021/bi961969w
   Furman R.R., 2007, SEMIN ONCOL, V34, P29
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571
   GIBLETT ER, 1975, LANCET, V1, P1010
   Griko Y, 2001, PROTEIN SCI, V10, P845, DOI 10.1110/ps.39701
   Hayes D., 1995, PROGRAM SEDNTERP SED
   KALCKAR HM, 1947, J BIOL CHEM, V167, P429
   Ogura M, 2012, CANCER SCI, V103, P1290, DOI 10.1111/j.1349-7006.2012.02287.x
   ROPP PA, 1991, J BIOL CHEM, V266, P7682
   Stoeckler J D, 1978, Methods Enzymol, V51, P530
   Tahirov TH, 2004, J MOL BIOL, V337, P1149, DOI 10.1016/j.jmb.2004.02.016
   Wielgus-Kutrowska B, 2012, BIOORGAN MED CHEM, V20, P6758, DOI 10.1016/j.bmc.2012.08.045
NR 47
TC 0
Z9 0
U1 9
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 1
PY 2014
VL 549
BP 40
EP 48
DI 10.1016/j.abb.2014.03.009
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AG3BZ
UT WOS:000335292100006
PM 24686197
ER

PT J
AU Robaszkiewicz, A
   Bartosz, G
   Pitt, AR
   Thakker, A
   Armstrong, RA
   Spickett, CM
   Soszynski, M
AF Robaszkiewicz, Agnieszka
   Bartosz, Grzegorz
   Pitt, Andrew R.
   Thakker, Alpesh
   Armstrong, Richard A.
   Spickett, Corinne M.
   Soszynski, Miroslaw
TI HOCl-modified phosphatidylcholines induce apoptosis and redox imbalance
   in HUVEC-ST cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Phosphatidylcholine; Hypochlorous acid; Apoptosis; Redox imbalance;
   Atherosclerosis
ID HUMAN ATHEROSCLEROTIC LESIONS; ENDOTHELIAL-CELLS; REACTIVE OXYGEN;
   HYPOCHLOROUS ACID; OXIDIZED LDL; FATTY-ACID; LC-MS; LIPIDS;
   CHLOROHYDRINS; OXIDATION
AB Electrophilic attack of hypochlorous acid on unsaturated bonds of fatty acyl chains is known to result mostly in chlorinated products that show cytotoxicity to some cell lines and were found in biological systems exposed to HOC. This study aimed to investigate more deeply the products and the mechanism underlying cytotoxicity of phospholipid-HOCl oxidation products, synthesized by the reaction of HOCl with 1-stearoyl-2-oleoyl-, 1-stearoyl-2-linoleoyl-, and 1-stearoyl-2-arachidonyl-phosphatidylcholine. Phospholipid chlorohydrins were found to be the most abundant among obtained products. HOCl-modified lipids were cytotoxic towards HUVEC-ST (endothelial cells), leading to a decrease of mitochondrial potential and an increase in the number of apoptotic cells. These effects were accompanied by an increase of the level of active caspase-3 and caspase-7, while the caspase-3/-7 inhibitor Ac-DEVD-CHO dramatically decreased the number of apoptotic cells. Phospholipid-HOCl oxidation products were shown to affect cell proliferation by a concentration-dependent cell cycle arrest in the G(0)/G(1) phase and activating redox sensitive p38 kinase. The redox imbalance observed in HUVEC-ST cells exposed to modified phosphatidylcholines was accompanied by an increase in ROS level, and a decrease in glutathione content and antioxidant capacity of cell extracts. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Robaszkiewicz, Agnieszka] Univ Lodz, Dept Environm Pollut Biophys, Fac Biol & Environm Protect, PL-90236 Lodz, Poland.
   [Bartosz, Grzegorz; Soszynski, Miroslaw] Univ Lodz, Fac Biol & Environm Protect, Dept Mol Biophys, PL-90236 Lodz, Poland.
   [Bartosz, Grzegorz] Univ Rzeszow, Dept Biochem & Cell Biol, PL-35959 Rzeszow, Poland.
   [Pitt, Andrew R.; Thakker, Alpesh; Spickett, Corinne M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.
   [Armstrong, Richard A.] Aston Univ, Sch Optometry, Sch Life & Hlth Sci, Ophthalm Res Grp, Birmingham B4 7ET, W Midlands, England.
RP Robaszkiewicz, A (reprint author), Univ Lodz, Dept Environm Pollut Biophys, Fac Biol & Environm Protect, Pomorska 141-143, PL-90236 Lodz, Poland.
EM robaszkiewicz.agnieszkaz@gmail.com; grzegorz.bartosz@gmail.com;
   a.r.pitt@aston.ac.uk; thakkera@aston.ac.uk; r.a.armstrong@aston.ac.uk;
   c.m.spickett@aston.ac.uk; sosmirek@biol.uni.lodz.pl
RI Armstrong, Richard/H-4557-2012; 
OI Armstrong, Richard/0000-0002-5046-3199; Pitt, Andrew
   R/0000-0003-3619-6503
CR LIZARD G, 1995, CYTOMETRY, V21, P275, DOI 10.1002/cyto.990210308
   Landar A, 2006, AM J PHYSIOL-HEART C, V290, pH1777, DOI 10.1152/ajpheart.01087.2005
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Robbesyn F, 2004, FREE RADICAL RES, V38, P541, DOI 10.1080/10715760410001665244
   Stefanec T, 2000, CHEST, V117, P841, DOI 10.1378/chest.117.3.841
   Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379
   Bulat N, 2009, J LIPID RES, V50, P81, DOI 10.1194/jlr.M800119-JLR200
   Giovannini C, 2011, J MOL CELL BIOL, V3, P316, DOI 10.1093/jmcb/mjr019
   Carr AC, 1997, REDOX REP, V3, P263
   Messner MC, 2008, LIPIDS, V43, P243, DOI 10.1007/s11745-008-3151-z
   Pitt AR, 2008, BIOCHEM SOC T, V36, P1077, DOI 10.1042/BST0361077
   SZOKA F, 1980, BIOCHIM BIOPHYS ACTA, V601, P559, DOI 10.1016/0005-2736(80)90558-1
   Robaszkiewicz A, 2009, BIOCHEM BIOPH RES CO, V390, P659, DOI 10.1016/j.bbrc.2009.10.023
   Bedner E, 1999, CYTOMETRY, V35, P181, DOI 10.1002/(SICI)1097-0320(19990301)35:3<181::AID-CYTO1>3.0.CO;2-5
   DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342
   STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9
   Robaszkiewicz A, 2010, TOXICOLOGY, V270, P112, DOI 10.1016/j.tox.2010.02.003
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Dimmeler S, 1998, EUR CYTOKINE NETW, V9, P697
   SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671
   Spickett CM, 2011, FREE RADICAL BIO MED, V51, P2133, DOI 10.1016/j.freeradbiomed.2011.09.003
   Jerlich A, 2000, FREE RADICAL BIO MED, V28, P673, DOI 10.1016/S0891-5849(99)00273-7
   Itabe H, 2009, CLIN REV ALLERG IMMU, V37, P4, DOI 10.1007/s12016-008-8095-9
   Bai X, 2010, VASC PHARMACOL, V52, P224, DOI 10.1016/j.vph.2010.02.001
   But P G, 2003, Izv Akad Nauk Ser Biol, P261
   Cheng JZ, 2007, ENDOCRINOLOGY, V148, P2085, DOI 10.1210/en.2006-1709
   Chisolm GM, 2000, FREE RADICAL BIO MED, V28, P1697, DOI 10.1016/S0891-5849(00)00227-6
   Cullen P, 2005, Handb Exp Pharmacol, P3
   Darzynkiewicz Z., 2001, CURR PROTOC CELL BIO
   Dever G, 2003, FEBS LETT, V540, P245, DOI 10.1016/S0014-5793(03)00271-0
   Dever G, 2006, ACTA BIOCHIM POL, V53, P761
   Dever GJ, 2008, FREE RADICAL BIO MED, V44, P452, DOI 10.1016/j.freeradbiomed.2007.10.038
   Franco-Pons N, 2013, ANN SURG, V257, P943, DOI 10.1097/SLA.0b013e318269d536
   Inai Y, 1997, CELL STRUCT FUNCT, V22, P555
   LEUNG KP, 1989, CELL TISSUE RES, V257, P653, DOI 10.1007/BF00221477
   Liu S, 2010, AM J PHYSIOL-ENDOC M, V299, pE351, DOI 10.1152/ajpendo.00005.2010
   Robaszkiewicz A, 2010, CHEM PHYS LIPIDS, V163, P639, DOI 10.1016/j.chemphyslip.2010.05.201
   Robaszkiewicz A, 2011, J IMMUNOL METHODS, V369, P141, DOI 10.1016/j.jim.2011.05.006
   Robaszkiewicz A, 2011, TOXICOL IN VITRO, V25, P1328, DOI 10.1016/j.tiv.2011.04.025
   Solarska-Sciuk K, 2013, BIOTECHNOL APPL BIOC, V60, P259, DOI 10.1002/bab.1071
   Spickett CM, 2013, REDOX BIOL, V1, P145, DOI 10.1016/j.redox.2013.01.007
   Spickett CM, 2007, PHARMACOL THERAPEUT, V115, P400, DOI 10.1016/j.pharmthera.2007.06.002
   STAPPER NJ, 1995, INT J CANCER, V62, P58
   Tentori L, 2005, INT J ONCOL, V27, P525
   Traikia M, 2005, CHEM-BIOL INTERACT, V151, P83, DOI 10.1016/j.cbi.2004.12.005
   Vissers MCM, 2001, REDOX REP, V6, P49, DOI 10.1179/135100001101536030
   Wallgren M, 2012, BBA-BIOMEMBRANES, V1818, P2718, DOI 10.1016/j.bbamem.2012.06.005
   Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X
   Zmijewski JW, 2005, BIOCHEM SOC T, V33, P1385
NR 49
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2014
VL 548
BP 1
EP 10
DI 10.1016/j.abb.2014.02.013
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AF8OK
UT WOS:000334975300001
PM 24607806
ER

PT J
AU Voma, C
   Barfell, A
   Croniger, C
   Romani, A
AF Voma, Chesinta
   Barfell, Andrew
   Croniger, Colleen
   Romani, Andrea
TI Reduced cellular Mg2+ content enhances hexose 6-phosphate dehydrogenase
   activity and expression in HepG2 and HL-60 cells
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Magnesium; Hepatic Mg2+ homeostasis; Glucose 6 phosphate; Hexose 6
   phosphate dehydrogenase; HL-60
ID FATTY LIVER-DISEASE; HEXOSE-6-PHOSPHATE DEHYDROGENASE;
   ENDOPLASMIC-RETICULUM; RAT-LIVER; INSULIN-RESISTANCE; METABOLIC
   SYNDROME; MAGNESIUM HOMEOSTASIS; GLUCOSE-6-PHOSPHATASE; ACTIVATION;
   GLUCOSE
AB We have reported that Mg2+ dynamically regulates glucose 6-phosphate entry into the endoplasmic reticulum and its hydrolysis by the glucose 6-phosphatase in liver cells. In the present study, we report that by modulating glucose 6-phosphate entry into the endoplasmic reticulum of HepG2 cells, Mg2+ also regulates the oxidation of this substrate via hexose 6-phosphate dehydrogenase (H6PD). This regulatory effect is dynamic as glucose 6-phosphate entry and oxidation can be rapidly down-regulated by the addition of exogenous Mg2+. In addition, HepG2 cells growing in low Mg2+ show a marked increase in hexose 6-phosphate dehydrogenase mRNA and protein expression. Metabolically, these effects on hexose 6-phosphate dehydrogenase are important as this enzyme increases intra-reticular NADPH production, which favors fatty acid and cholesterol synthesis. Similar effects of Mg2+ were observed in HL-60 cells.
   These and previously published results suggest that in an hepatocyte culture model changes in cytoplasmic Mg2+ content regulates glucose 6-phosphate utilization via glucose 6 phosphatase and hexose-6 phosphate dehydrogenase in alternative to glycolysis and glycogen synthesis. This alternative regulation might be of relevance in the transition from fed to fasted state. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Voma, Chesinta; Barfell, Andrew; Romani, Andrea] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.
   [Voma, Chesinta] Cleveland State Univ, Dept Clin Chem, Cleveland, OH 44115 USA.
   [Croniger, Colleen] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA.
RP Romani, A (reprint author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM amr5@po.cwru.edu
FU  [NIAAA-11593];  [HL 090969]
FX This study was supported by NIAAA-11593 and HL 090969 to Dr. A. Romani.
CR Marcolongo P, 2007, ENDOCRINOLOGY, V148, P2487, DOI 10.1210/en.2006-1472
   Tarantino G, 2013, WORLD J GASTROENTERO, V19, P6735, DOI 10.3748/wjg.v19.i40.6735
   Fatholahi M, 2000, ARCH BIOCHEM BIOPHYS, V374, P395, DOI 10.1006/abbi.1999.1619
   Rahimi RS, 2013, NUTR CLIN PRACT, V28, P40, DOI 10.1177/0884533612470464
   Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005
   Gupte SA, 2010, DRUG DEVELOP RES, V71, P161, DOI 10.1002/ddr.20359
   Barbagallo M, 2007, ARCH BIOCHEM BIOPHYS, V458, P40, DOI 10.1016/j.abb.2006.05.007
   Mazur A, 2007, ARCH BIOCHEM BIOPHYS, V458, P48, DOI 10.1016/j.abb.2006.03.031
   Romani AMP, 2008, MAGNESIUM RES, V21, P197
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Banhegyi G, 2004, J BIOL CHEM, V279, P27017, DOI 10.1074/jbc.M404159200
   Barfell A, 2011, ARCH BIOCHEM BIOPHYS, V509, P157, DOI 10.1016/j.abb.2011.03.003
   BOND M, 1987, J BIOL CHEM, V262, P15630
   Clarke JL, 2003, ARCH BIOCHEM BIOPHYS, V415, P229, DOI 10.1016/S0003-9861(03)00229-7
   CORKEY BE, 1986, J BIOL CHEM, V261, P2567
   Doleh L, 2007, ARCH BIOCHEM BIOPHYS, V467, P283, DOI 10.1016/j.abb.2007.09.001
   Fagan TE, 2004, AM J PHYSIOL-ENDOC M, V286, pE184, DOI 10.1152/ajpendo.00200.2003
   Fagan TE, 2000, AM J PHYSIOL-GASTR L, V279, pG943
   Foster JA, 2002, EXP BIOL MED, V227, P601
   Gerin I, 2002, FEBS LETT, V517, P257, DOI 10.1016/S0014-5793(02)02640-6
   HENNE V, 1986, FEBS LETT, V202, P267, DOI 10.1016/0014-5793(86)80699-8
   Joosen AMCP, 2006, INT J OBESITY, V30, P302, DOI 10.1038/sj.ijo.0803146
   Kardon T, 2008, FEBS LETT, V582, P1809, DOI 10.1016/j.febslet.2008.04.045
   Marcolongo P, 2011, J STEROID BIOCHEM, V126, P57, DOI 10.1016/j.jsbmb.2011.05.006
   MITHIEUX G, 1990, J BIOL CHEM, V265, P20364
   RAGNOTTI G, 1971, BIOCHEM J, V125, P1057
   Romani Andrea M P, 2013, Met Ions Life Sci, V13, P49, DOI 10.1007/978-94-007-7500-8_3
   Romani AMP, 2000, CIRC RES, V86, P326
   Romani AMP, 2013, METAL IONS LIFE SCI, V12, P69, DOI 10.1007/978-94-007-5561-1_4
   Rubin H, 2005, ADV CANCER RES, V93, P1, DOI 10.1016/S0065-230X(05)93001-7
   Senesi S, 2010, ENDOCRINOLOGY, V151, P4830, DOI 10.1210/en.2010-0614
   Senesi S, 2010, BIOL CHEM, V391, P1, DOI 10.1515/BC.2009.146
   Senesi S, 2008, J MOL ENDOCRINOL, V41, P125, DOI 10.1677/JME-08-0028
   Szaraz P, 2010, INT J BIOCHEM CELL B, V42, P157, DOI 10.1016/j.biocel.2009.10.004
   Tessman PA, 1998, AM J PHYSIOL-GASTR L, V275, pG1106
   Torres LM, 2010, ALCOHOL CLIN EXP RES, V34, P1659, DOI 10.1111/j.1530-0277.2010.01252.x
   Torres LM, 2005, AM J PHYSIOL-GASTR L, V288, pG195, DOI 10.1152/ajpgi.00488.2003
   VOLPE P, 1990, AM J PHYSIOL, V258, pC1077
   Wilkes JJ, 1996, ALCOHOL CLIN EXP RES, V20, P1016, DOI 10.1111/j.1530-0277.1996.tb01940.x
NR 39
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2014
VL 548
BP 11
EP 19
DI 10.1016/j.abb.2014.02.016
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AF8OK
UT WOS:000334975300002
PM 24631573
ER

PT J
AU Novo, E
   Cannito, S
   Patemostro, C
   Bocca, C
   Miglietta, A
   Parola, M
AF Novo, Erica
   Cannito, Stefania
   Patemostro, Claudia
   Bocca, Claudia
   Miglietta, Antonella
   Parola, Maurizio
TI Cellular and molecular mechanisms in liver fibrogenesis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Liver fibrogenesis; Hepatic myofibroblasts; Chronic liver injury;
   Fibrogenic mechanisms; Chronic inflammation; Extracellular matrix
ID HEPATIC STELLATE CELLS; EPITHELIAL-MESENCHYMAL TRANSITION;
   PLATELET-DERIVED SEROTONIN; IL-1 RECEPTOR ANTAGONIST; TOLL-LIKE
   RECEPTOR-4; INVARIANT NKT CELLS; KILLER T-CELLS; NF-KAPPA-B;
   NATURAL-KILLER; NONALCOHOLIC STEATOHEPATITIS
AB Liver fibrogenesis is a dynamic and highly integrated molecular, tissue and cellular process, potentially reversible, that drives the progression of chronic liver diseases (CLD) towards liver cirrhosis and hepatic failure. Hepatic myofibroblasts (MFs), the pro-fibrogenic effector cells, originate mainly from activation of hepatic stellate cells and portal fibroblasts being characterized by a proliferative and survival attitude. MFs also contract in response to vasoactive agents, sustain angiogenesis and recruit and modulate activity of cells of innate or adaptive immunity. Chronic activation of wound healing and oxidative stress as well as derangement of epithelial mesenchymal interactions are "major" pro-fibrogenic mechanisms, whatever the etiology. However, literature has outlined a complex network of pro-fibrogenic factors and mediators proposed to modulate CLD progression, with some of them being at present highly debated in the field, including the role of epithelial to mesenchymal transition and Hedgehog signaling pathways. Hypoxia and angiogenesis as well as inflammasomes are recently emerged as ubiquitous pro-inflammatory and pro-fibrogenic determinants whereas adipokines are mostly involved in CLD related to metabolic disturbances (metabolic syndrome and/or obesity and type 2 diabetes). Finally, autophagy as well as natural killer and natural killer-T cells have been recently proposed to significantly affect fibrogenic CLD progression. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Novo, Erica; Cannito, Stefania; Patemostro, Claudia; Bocca, Claudia; Miglietta, Antonella; Parola, Maurizio] Univ Turin, Dept Clin & Biol Sci, Unit Expt Med & Clin Pathol, I-10125 Turin, Italy.
RP Parola, M (reprint author), Univ Turin, Sch Med, Unit Expt Med & Clin Pathol, Dept Clin & Biol Sci, Corso Raffaello 30, I-10125 Turin, Italy.
EM maurizio.parola@unito.it
FU Italian Ministero dell'Universita e della Ricerca (MIUR, Rome - PRIN
   Project) [2009ARYX4T]; Regione Piemonte (Torino); Fondazione CRT
   (Torino); Fondazione CariPLO (Milan); University of Torino
FX Financial support was from the Italian Ministero dell'Universita e della
   Ricerca (MIUR, Rome - PRIN 2009 Project 2009ARYX4T, to M.P.), the
   Regione Piemonte (Torino, to M.P. and E.N), the Fondazione CRT (Torino,
   to M.P.), the Fondazione CariPLO (Milan, to MP), the University of
   Torino (to EN, CB, AM, MP).
CR Aleffi S, 2011, AM J PHYSIOL-GASTR L, V301, pG210, DOI 10.1152/ajpgi.00047.2010
   Diehl AM, 2002, AM J PHYSIOL-GASTR L, V282, pG1
   El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061
   Ding XK, 2005, AM J PATHOL, V166, P1655, DOI 10.1016/S0002-9440(10)62476-5
   Quintana FJ, 2005, J IMMUNOL, V175, P2777
   Desmet VJ, 2004, J HEPATOL, V40, P860, DOI 10.1016/j.jhep.2004.03.007
   Ouchi N, 2000, CIRCULATION, V102, P1296
   Dranoff JA, 2010, HEPATOLOGY, V51, P1438, DOI 10.1002/hep.23405
   Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021
   Forbes SJ, 2011, BEST PRACT RES CL GA, V25, P207, DOI 10.1016/j.bpg.2011.02.006
   Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122
   Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831
   Nocito A, 2007, HEPATOLOGY, V45, P369, DOI 10.1002/hep.21516
   Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400
   Syn WK, 2010, HEPATOLOGY, V51, P1998, DOI 10.1002/hep.23599
   Ouyang XS, 2013, BBA-MOL BASIS DIS, V1832, P979, DOI 10.1016/j.bbadis.2013.03.020
   Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011
   Novo E, 2006, GUT, V55, P1174, DOI 10.1136/gut.2005.082701
   Parola M, 2008, MOL ASPECTS MED, V29, P58, DOI 10.1016/j.mam.2007.09.002
   Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006
   Thoen LFR, 2011, J HEPATOL, V55, P1353, DOI 10.1016/j.jhep.2011.07.010
   Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965
   Zhu CB, 2006, NEUROPSYCHOPHARMACOL, V31, P2121, DOI 10.1038/sj.npp.1301029
   Tanida I, 2005, AUTOPHAGY, V1, P84
   Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6
   Bertolani C, 2006, AM J PATHOL, V169, P2042, DOI 10.2353/ajpath.2006.060081
   Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667
   Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405
   Asano T, 2009, J GASTROEN HEPATOL, V24, P1669, DOI 10.1111/j.1440-1746.2009.06039.x
   Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068
   Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780
   Rosselli M, 2013, GUT, V62, P1234, DOI 10.1136/gutjnl-2012-302826
   de Lalla C, 2004, J IMMUNOL, V173, P1417
   Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427
   Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003
   Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802
   Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029
   Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044
   Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038
   Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI [10.1146/annurev.immunol.021908.132715, 10.1146/annurev.immunol.021908.132532]
   Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/S0016-5085(03)01509-9
   Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008
   Novo E, 2007, AM J PATHOL, V170, P1942, DOI 10.2353/ajpath.2007.060887
   Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033
   Petrasek J, 2011, GASTROENTEROLOGY, V140, P697, DOI 10.1053/j.gastro.2010.08.020
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o
   Hernandez-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016
   Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005
   Lonardo A, 2004, GASTROENTEROLOGY, V126, P586, DOI 10.1053/j.gastro.2003.11.020
   Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526
   Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Scheibner KA, 2006, J IMMUNOL, V177, P1272
   Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777
   Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842
   Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341
   Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007
   Witek RP, 2009, GASTROENTEROLOGY, V136, P320, DOI 10.1053/j.gastro.2008.09.066
   Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708
   Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019
   Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004
   Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4
   Scholten D, 2010, GASTROENTEROLOGY, V139, P987, DOI 10.1053/j.gastro.2010.05.005
   Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200
   Kasai A, 2004, BIOCHEM BIOPH RES CO, V325, P395, DOI 10.1016/j.bbrc.2004.10.042
   Semela D, 2008, GASTROENTEROLOGY, V135, P671, DOI 10.1053/j.gastro.2008.04.010
   Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683
   Melgar-Lesmes P, 2011, GUT, V60, P1404, DOI 10.1136/gut.2010.234690
   Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368
   Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747
   Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Osterreicher CH, 2011, P NATL ACAD SCI USA, V108, P308, DOI 10.1073/pnas.1017547108
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   De Minicis S, 2008, HEPATOLOGY, V48, P2016, DOI 10.1002/hep.22560
   Xie GH, 2013, AM J PHYSIOL-GASTR L, V305, pG881, DOI 10.1152/ajpgi.00289.2013
   Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742
   Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266
   Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003
   Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014
   Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670
   Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737
   Wang JH, 2009, GASTROENTEROLOGY, V137, P713, DOI 10.1053/j.gastro.2009.04.011
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Katoh Y, 2009, CURR MOL MED, V9, P873
   Caligiuri A, 2008, HEPATOLOGY, V47, P668, DOI 10.1002/hep.21995
   Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861
   Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046
   Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Rosmorduc O, 2010, SEMIN LIVER DIS, V30, P258, DOI 10.1055/s-0030-1255355
   Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804
   Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005
   Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581
   Kendall TJ, 2009, HEPATOLOGY, V49, P901, DOI 10.1002/hep.22701
   Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797
   Gao B, 2013, BBA-MOL BASIS DIS, V1832, P1061, DOI 10.1016/j.bbadis.2012.09.008
   Cao Q, 2004, J BIOL CHEM, V279, P4292, DOI 10.1074/jbc.M308351200
   Chen YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046512
   Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964
   Ebrahimkhani MR, 2011, NAT MED, V17, P1668, DOI 10.1038/nm.2490
   Eisenhardt M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038846
   Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772
   El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683
   Hilscher M, 2013, BBA-MOL BASIS DIS, V1832, P972, DOI 10.1016/j.bbadis.2012.11.001
   Iredale JP, 2013, BBA-MOL BASIS DIS, V1832, P876, DOI 10.1016/j.bbadis.2012.11.002
   Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419
   Kamada Y, 2007, J HEPATOL, V47, P556, DOI 10.1016/j.jhep.2007.03.020
   Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journals.pmed.0010045
   Liu XW, 2012, HEPATOL RES, V42, P1024, DOI 10.1111/j.1872-034X.2012.01011.x
   Mann A.D., 2013, BIOCHIM BIOPHYS ACTA, V1832, P905
   Marra F, 2007, J HEPATOL, V46, P12, DOI 10.1016/j.jhep.2006.10.002
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Melgar-Lesmes P, 2010, ENDOCRINOLOGY, V151, P5306, DOI 10.1210/en.2010-0754
   Miura K, 2010, GASTROENTEROLOGY, V139, pe327
   Novo E, 2008, FIBROGENESIS TISSUE, V1, P1
   Novo E, 2011, J HEPATOL, V54, P964, DOI 10.1016/j.jhep.2010.09.022
   Omenetti A, 2009, HEPATOLOGY, V50, P518, DOI 10.1002/hep.23019
   Omenetti A, 2011, AM J PHYSIOL-GASTR L, V300, pG303, DOI 10.1152/ajpgi.00368.2010
   Principe A, 2008, HEPATOLOGY, V48, P1193, DOI 10.1002/hep.22467
   Ruddell RG, 2006, AM J PATHOL, V169, P861, DOI 10.2353/ajpath.2006.050767
   Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V290, pG859, DOI 10.1152/ajpgi.00456.2005
   SLAUSON DO, 1984, CELL IMMUNOL, V84, P240, DOI 10.1016/0008-8749(84)90096-0
   Soga F, 2007, J INVEST DERMATOL, V127, P1947, DOI 10.1038/sj.jid.5700824
   Syn WK, 2009, EUR J IMMUNOL, V39, P1879, DOI 10.1002/eji.200838890
   Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365
   Valfre di Bonzo L., 2009, HISTOL HISTOPATHOL, V23, P1324
   Watanabe A, 2009, AM J PHYSIOL-GASTR L, V296, pG1248, DOI 10.1152/ajpgi.90223.2008
   Watson MR, 2008, J HEPATOL, V48, P589, DOI 10.1016/j.jhep.2007.12.019
   Xie GH, 2013, HEPATOLOGY, V58, P1801, DOI 10.1002/hep.26511
   YOUNG MRI, 1993, IMMUNOLOGY, V80, P395
NR 148
TC 23
Z9 25
U1 3
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2014
VL 548
BP 20
EP 37
DI 10.1016/j.abb.2014.02.015
PG 18
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AF8OK
UT WOS:000334975300003
PM 24631571
ER

PT J
AU Maciel, E
   Neves, BM
   Santinha, D
   Reis, A
   Domingues, P
   Cruz, MT
   Pitt, AR
   Spickett, CM
   Domingues, MRM
AF Maciel, Elisabete
   Neves, Bruno M.
   Santinha, Deolinda
   Reis, Ana
   Domingues, Pedro
   Teresa Cruz, M.
   Pitt, Andrew R.
   Spickett, Corinne M.
   Domingues, M. Rosario M.
TI Detection of phosphatidylserine with a modified polar head group in
   human keratinocytes exposed to the radical generator AAPH
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Phosphatidylserine; Keratinocytes; AAPH; Oxidative stress; Mass
   spectrometry; Shotgun lipidomic
ID MASS-SPECTROMETRIC CHARACTERIZATION; STAUROSPORINE-INDUCED APOPTOSIS;
   HUMAN EPIDERMAL-KERATINOCYTES; OXIDATIVE STRESS; DERMAL FIBROBLASTS;
   CELLS; PEROXIDATION; EXTERNALIZATION; CARDIOLIPIN; LIPIDOMICS
AB Phosphatidylserine (PS) is preferentially located in the inner leaflet of the cell membrane, and translocation of PS oxidized in fatty acyl chains to the outside of membrane has been reported as signaling to macrophage receptors to clear apoptotic cells. It was recently shown that PS can be oxidized in serine moiety of polar head-group. In the present work, a targeted lipidomic approach was applied to detecting OxPS modified at the polar head-group in keratinocytes that were exposed to the radical generator AAPH. Glycerophosphoacetic acid derivatives (GPAA) were found to be the major oxidation products of OxPS modified at the polar head-group during oxidation induced by AAPH-generated radicals, similarly to previous observations for the oxidation induced by OH center dot radical. The neutral loss scan of 58 Da and a novel precursor ion scan of m/z 137.1 (HOPO3CH2COOH) allowed the recognition of GPAA derivatives in the total lipid extracts obtained from HaCaT cells treated with AAPH. The positive identification of serine head group oxidation products in cells under controlled oxidative conditions opens new perspectives and justifies further studies in other cellular environments in order to understand fully the role of PS polar head-group oxidation in cell homeostasis and disease. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Maciel, Elisabete; Neves, Bruno M.; Santinha, Deolinda; Domingues, Pedro; Domingues, M. Rosario M.] Univ Aveiro, Dept Chem, Mass Spectrometry Ctr, UI QOPNA, P-3810193 Aveiro, Portugal.
   [Teresa Cruz, M.] Univ Coimbra, Fac Pharm, P-3000548 Coimbra, Portugal.
   [Teresa Cruz, M.] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, P-3004517 Coimbra, Portugal.
   [Reis, Ana; Pitt, Andrew R.; Spickett, Corinne M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.
RP Domingues, MRM (reprint author), Univ Aveiro, Dept Chem, Mass Spectrometry Ctr, UI QOPNA, P-3810193 Aveiro, Portugal.
EM mrd@ua.pt
RI Reis, Ana/F-8937-2014; Domingues, Rosario/K-7444-2014; Domingues,
   Pedro/E-5202-2010; 
OI Reis, Ana/0000-0002-4537-9902; Domingues, Rosario/0000-0001-5357-3601;
   Domingues, Pedro/0000-0002-8060-7675; Pitt, Andrew
   R/0000-0003-3619-6503; Maciel, Elisabete/0000-0003-3637-6854
FU Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)
   [PEst-C/QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296, REDE/1504/REM/2005,
   PTDC/SAL/OSM/099762/2008, PTDC/QUI-BIQJ104968/2008]; European Union
   [PEst-C/QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296, REDE/1504/REM/2005,
   PTDC/SAL/OSM/099762/2008, PTDC/QUI-BIQJ104968/2008]; QREN
   [PEst-C/QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296, REDE/1504/REM/2005,
   PTDC/SAL/OSM/099762/2008, PTDC/QUI-BIQJ104968/2008]; FEDER
   [PEst-C/QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296, REDE/1504/REM/2005,
   PTDC/SAL/OSM/099762/2008, PTDC/QUI-BIQJ104968/2008]; COMPETE
   [PEst-C/QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296, REDE/1504/REM/2005,
   PTDC/SAL/OSM/099762/2008, PTDC/QUI-BIQJ104968/2008]; European Social
   Fund; MEC; Marie-Curie IEF FP7-PEOPLE-IEF Project [255076]; 
   [SFRH/BD/73203/2010]
FX Thanks are due to Fundacao para a Ciencia e a Tecnologia (FCT,
   Portugal), European Union, QREN, FEDER, and COMPETE for funding the
   QOPNA research unit (project PEst-C/QUI/UI0062/2013;
   FCOMP-01-0124-FEDER-037296), RNEM (REDE/1504/REM/2005 regarding the
   Portuguese Mass Spectrometry Network) and to Grant number
   PTDC/SAL/OSM/099762/2008 and PTDC/QUI-BIQJ104968/2008. Ph.D. grants to
   Elisabete Maciel (SFRH/BD/73203/2010) funded POPH-advanced formation,
   subsidized by the European Social Fund and by national funds of MEC. CMS
   and AR acknowledge support from Marie-Curie IEF FP7-PEOPLE-2009-IEF
   Project ID 255076. All authors would like to thank the COST Action
   CM1001.
CR Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2
   Betigeri S, 2005, PHARM RES-DORDR, V22, P310, DOI 10.1007/s11095-004-1199-x
   Shvedova AA, 2000, J INVEST DERMATOL, V114, P354, DOI 10.1046/j.1523-1747.2000.00865.x
   Tyurina YY, 2008, FREE RADICAL BIO MED, V44, P299, DOI [10.1016/j.freeradbiomed.2007.08.021, 10.1016/j.frecradbiorned.2007.08.021]
   Davies MJ, 1996, ARCH BIOCHEM BIOPHYS, V336, P163, DOI 10.1006/abbi.1996.0545
   Yoshida Y, 2004, FREE RADICAL RES, V38, P375, DOI 10.1080/1071576042000191763
   Melo T, 2012, J NEUROCHEM, V120, P998, DOI 10.1111/j.1471-4159.2011.07636.x
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Cho S, 2008, J LIPID RES, V49, P1235, DOI 10.1194/jlr.M700581-JLR200
   Maciel E, 2013, CHEM PHYS LIPIDS, V174, P1, DOI 10.1016/j.chemphyslip.2013.05.005
   Kagan VE, 2002, J IMMUNOL, V169, P487
   Tyurin VA, 2009, J CHROMATOGR B, V877, P2863, DOI 10.1016/j.jchromb.2009.03.007
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Tyurina YY, 2000, TOXICOLOGY, V148, P93, DOI 10.1016/S0300-483X(00)00199-2
   Tyurin VA, 2008, J NEUROCHEM, V107, P1614, DOI 10.1111/j.1471-4159.2008.05728.x
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Fadeel B, 2010, BIOCHEM BIOPH RES CO, V396, P7, DOI 10.1016/j.bbrc.2010.02.106
   Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Hsu FF, 2005, J AM SOC MASS SPECTR, V16, P1510, DOI 10.1016/j.jasms.2005.04.018
   Tyurina YY, 2010, AM J PHYSIOL-LUNG C, V299, pL73, DOI 10.1152/ajplung.00035.2010
   Santinha DR, 2013, ARCH BIOCHEM BIOPHYS, V533, P33, DOI 10.1016/j.abb.2013.02.012
   Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370
   Tyurina YY, 2011, RADIAT RES, V175, P610, DOI 10.1667/RR2297.1
   Maciel E, 2011, J AM SOC MASS SPECTR, V22, P1804, DOI 10.1007/s13361-011-0194-9
   Cui Y, 2004, CHEM PHYS LIPIDS, V129, P43, DOI 10.1016/j.chemphyslip.2003.11.004
   da Silva RN, 2012, ARCH BIOCHEM BIOPHYS, V525, P9, DOI 10.1016/j.abb.2012.05.022
   Maciel E, 2013, J CHROMATOGR B, V929, P76, DOI 10.1016/j.jchromb.2013.04.009
   Matsura T, 2002, FEBS LETT, V524, P25, DOI 10.1016/S0014-5793(02)02990-3
   Matsura T, 2005, BBA-MOL CELL BIOL L, V1736, P181, DOI 10.1016/j.bbalip.2005.08.011
   Orciani M, 2010, FREE RADICAL BIO MED, V49, P830, DOI 10.1016/j.freeradbiomed.2010.06.007
   Shvedova AA, 2002, J INVEST DERMATOL, V118, P1008, DOI 10.1046/j.1523-1747.2002.01759.x
   Tyurina YY, 2004, BIOCHEM BIOPH RES CO, V324, P1059, DOI 10.1016/j.bbrc.2004.09.102
   Tyurina Y Y, 2002, Subcell Biochem, V36, P79
NR 34
TC 1
Z9 1
U1 2
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2014
VL 548
BP 38
EP 45
DI 10.1016/j.abb.2014.02.002
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AF8OK
UT WOS:000334975300004
PM 24560783
ER

PT J
AU Swindle, N
   Albury, ANJ
   Baroud, B
   Burney, M
   Tikunova, SB
AF Swindle, Nicholas
   Albury, Acchia N. J.
   Baroud, Belal
   Burney, Maryam
   Tikunova, Svetlana B.
TI Molecular and functional consequences of mutations in the central helix
   of cardiac troponin C
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Troponin C; Troponin I; Central helix; Fluorescence; Calcium binding
ID CALCIUM-SENSITIZING MUTATIONS; AMINO-ACID-SEQUENCE; THIN-FILAMENTS;
   DILATED CARDIOMYOPATHY; INHIBITORY REGION; REGULATORY FUNCTION;
   MUSCLE-CONTRACTION; BINDING; EXCHANGE; COMPLEX
AB The objective of this work was to investigate the role of acidic residues within the exposed middle segment of the central helix of cTnC in (I) cTnC-cTnI interactions, (2) Ca2+ binding and exchange with the regulatory N-domain of cTnC in increasingly complex biochemical systems, and (3) ability of the cTn complex to regulate actomyosin ATPase. In order to achieve this objective, we introduced the D87A/D88A and E94A/E95A/E96A mutations into the central helix of cTnC. The D87A/D88A and E94A/E95A/E96A mutations decreased affinity of cTnC for the regulatory region of cTnI. The Ca2+ sensitivity of the regulatory N-domain of isolated cTnC was decreased by the D87A/D88A, but not E94A/E95A/E96A mutation. However, both the D87A/D88A and E94A/E95A/E96A mutations desensitized the cTn complex and reconstituted thin filaments to Ca2+. Decreases in the Ca2+ sensitivity of the cTn complex and reconstituted thin filaments were, at least in part, due to faster rates of Ca2+ dissociation. In addition, the D87A/D88A and E94A/E95A/E96A mutations desensitized actomyosin ATPase to Ca2+, and decreased maximal actomyosin ATPase activity. Thus, our results indicate that conserved acidic residues within the exposed middle segment of the central helix of cTnC are important for the proper regulatory function of the cTn complex. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Swindle, Nicholas; Baroud, Belal; Burney, Maryam; Tikunova, Svetlana B.] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77004 USA.
   [Albury, Acchia N. J.] Wingate Univ, Dept Biol, Wingate, NC 28174 USA.
RP Tikunova, SB (reprint author), Univ Houston, Dept Pharmacol & Pharmaceut Sci, 521 Sci & Res Bldg 2, Houston, TX 77204 USA.
EM sbtikunova@uh.edu
FU NHLBI institute of NIH [R15HL117034]
FX We thank Dr. Lawrence Smillie (University of Alberta) for the generous
   gift of the human cTnC plasmid. We also thank Dr. Darl Swartz (Delaware
   Valley College) for the generous gift of actin, cTm and myosin S1.
   Research reported in this publication was supported by the NHLBI
   institute of NIH under Award Number R15HL117034 (to S.B.T.). The content
   is solely the responsibility of the authors, and does not necessarily
   represent the official views of the NIH.
CR POLLESELLO P, 1994, J BIOL CHEM, V269, P28584
   Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447
   Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382
   VANEERD JP, 1975, BIOCHEM BIOPH RES CO, V64, P122, DOI 10.1016/0006-291X(75)90227-2
   Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2
   POTTER JD, 1975, J BIOL CHEM, V250, P4628
   Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380
   Guharoy M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-286
   JOHNSON JD, 1980, J BIOL CHEM, V255, P9635
   Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025
   Albury ANJ, 2012, BIOCHEMISTRY-US, V51, P3614, DOI 10.1021/bi300187k
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114
   Davis JP, 2008, CARDIOVASC RES, V77, P619, DOI 10.1093/cvr/cvm098
   Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200
   HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0
   Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406
   SUNDARALINGAM M, 1985, SCIENCE, V227, P945, DOI 10.1126/science.3969570
   Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102
   Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780
   Pinto JR, 2011, J BIOL CHEM, V286, P34404, DOI 10.1074/jbc.M111.267211
   Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170
   Lindhout DA, 2005, BIOCHEMISTRY-US, V44, P14750, DOI 10.1021/bi0515801
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200
   FARAH CS, 1995, FASEB J, V9, P755
   Sorsa T, 2004, EUR J PHARMACOL, V486, P1, DOI 10.1016/j.ejphar.2003.12.006
   Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679
   Swindle N, 2010, BIOCHEMISTRY-US, V49, P4813, DOI 10.1021/bi100400h
   Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200
   BABU A, 1993, J BIOL CHEM, V268, P19232
   COLLINS JH, 1991, J MUSCLE RES CELL M, V12, P3, DOI 10.1007/BF01781170
   DING XL, 1994, PROTEIN SCI, V3, P2089
   DOBROWOLSKI Z, 1991, J BIOL CHEM, V266, P5703
   Filatov VL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P969
   FUJIMORI K, 1990, NATURE, V345, P182, DOI 10.1038/345182a0
   Gillis TE, 2003, BIOCHEMISTRY-US, V42, P6418, DOI 10.1021/bi0340494
   GODZIK A, 1989, PROTEIN ENG, V2, P589, DOI 10.1093/protein/2.8.589
   Gordon AM, 2001, NEWS PHYSIOL SCI, V16, P49
   Kobayashi T, 2009, J BIOL CHEM, V284, P20052, DOI 10.1074/jbc.M109.001396
   Kobayashi T, 2008, PFLUG ARCH EUR J PHY, V457, P37, DOI 10.1007/s00424-008-0511-8
   Kobayashi T, 1999, BBA-PROTEIN STRUCT M, V1430, P214, DOI 10.1016/S0167-4838(99)00002-3
   Kowlessur D, 2010, J BIOL CHEM, V285, P2686, DOI 10.1074/jbc.M109.062349
   Liu B, 2012, J BIOL CHEM, V287, P20027, DOI 10.1074/jbc.M111.334953
   Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038259
   Matsumoto F, 2004, J MOL BIOL, V342, P1209, DOI 10.1016/j.jmb.2004.07.086
   Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899
   Ramakrishnan S, 1995, BIOCHEMISTRY-US, V34, P16789, DOI 10.1021/bi00051a029
   Ramakrishnan S, 1996, BIOCHEMISTRY-US, V35, P15515, DOI 10.1021/bi961788u
   Reinach FC, 1997, CELL STRUCT FUNCT, V22, P219
   Robertson S. R, 1984, METHOD PHARMACOL, V5, P63
   Sommese RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083403
   Sorsa T, 2003, J MOL CELL CARDIOL, V35, P1055, DOI 10.1016/S0022-2828(03)00178-0
   SUNDARALINGAM M, 1985, P NATL ACAD SCI USA, V82, P7944, DOI 10.1073/pnas.82.23.7944
   Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s
   Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h
NR 56
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2014
VL 548
BP 46
EP 53
DI 10.1016/j.abb.2014.03.004
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AF8OK
UT WOS:000334975300005
PM 24650606
ER

PT J
AU Kriznik, A
   Boschi-Muller, S
   Branlant, G
AF Kriznik, Alexandre
   Boschi-Muller, Sandrine
   Branlant, Guy
TI Kinetic evidence that methionine sulfoxide reductase A can reveal its
   oxidase activity in the presence of thioredoxin
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Methionine sulfoxide reductase A; Oxidase activity; Kinetic reductase
   parameters; Thioredoxin; Regulatory process
ID ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; CATALYTIC MECHANISM; SULFENIC
   ACID; DYNAMICS; PROTEIN
AB The mouse methionine sulfoxide reductase A (MsrA) belongs to the subclass of MsrAs with one catalytic and two recycling Cys corresponding to Cys51, Cys198 and Cys206 in Escherichia coli MsrA, respectively. It was previously shown that in the absence of thioredoxin, the mouse and the E. coli MsrAs, which reduce two mol of methionine-O substrate per mol of enzyme, displays an in vitro S-stereospecific methionine oxidase activity.
   In the present study carried out with E. coli MsrA, kinetic evidence are presented which show that formation of the second mol of Ac-L-Met-NHMe is rate-limiting in the absence of thioredoxin. In the presence of thioredoxin, the overall rate-limiting step is associated with the thioredoxin-recycling process. Kinetic arguments are presented which support the accumulation of the E. coli MsrA under Cys51 sulfenic acid state in the presence of Trx. Thus, the methionine oxidase activity could be operative in vivo without the action of a regulatory protein in order to block the action of Trx as previously proposed. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Kriznik, Alexandre; Boschi-Muller, Sandrine; Branlant, Guy] Univ Lorraine, CNRS, UMR 7365, IMoPA, F-54506 Vandoeuvre Les Nancy, France.
RP Branlant, G (reprint author), Univ Lorraine, CNRS, UMR 7365, IMoPA, CS 50184, F-54506 Vandoeuvre Les Nancy, France.
EM guy.branlant@univ-lorraine.fr
FU Centre National de la Recherche Scientifique; Universite de Lorraine;
   Service Commun de Biophysicochimie des Interactions Moleculaires;
   Federation de Recherche [3209]; PRST Bioingenierie
FX This work was financially supported by the Centre National de la
   Recherche Scientifique, the Universite de Lorraine, the Service Commun
   de Biophysicochimie des Interactions Moleculaires, the Federation de
   Recherche 3209, and the PRST Bioingenierie. Dr. S. Azza is acknowledged
   for his efficient technical help, Dr. M. Antoine to have initiated this
   work and A. Bersweiler for his graphical skills.
CR Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007
   Lim JC, 2013, FREE RADICAL BIO MED, V61, P257, DOI 10.1016/j.freeradbiomed.2013.04.004
   Ma XX, 2011, J BIOL CHEM, V286, P13430, DOI 10.1074/jbc.M110.205161
   Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104
   Boschi-Muller S, 2001, PROTEIN SCI, V10, P2272, DOI 10.1110/ps.10701
   Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200
   Antoine M, 2003, J BIOL CHEM, V278, P45352, DOI 10.1074/jbc.M307471200
   Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108
   Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200
   Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016
   Balta B, 2006, J PHYS CHEM A, V110, P7628, DOI 10.1021/jp0573036
   Coudevylle N, 2007, J MOL BIOL, V366, P193, DOI 10.1016/j.jmb.2006.11.042
   Dokainish HM, 2013, BIOCHEMISTRY-US, V52, P1814, DOI 10.1021/bi301168p
   PORQUE P G, 1970, Journal of Biological Chemistry, V245, P2371
   Jacob C, 2011, FEBS LETT, V585, P1905, DOI 10.1016/j.febslet.2011.04.070
   Lin TY, 1999, BIOCHEMISTRY-US, V38, P15508, DOI 10.1021/bi9907678
   Olry A, 2004, BIOCHEMISTRY-US, V43, P11616, DOI 10.1021/bi049306z
   Olry A, 2002, J BIOL CHEM, V277, P12016, DOI 10.1074/jbc.M112350200
   RUSSEL M, 1986, J BIOL CHEM, V261, P4997
   Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1
   Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8
   Thiriot E, 2011, THEOR CHEM ACC, V129, P93, DOI 10.1007/s00214-011-0901-4
NR 22
TC 4
Z9 4
U1 4
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2014
VL 548
BP 54
EP 59
DI 10.1016/j.abb.2014.03.002
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AF8OK
UT WOS:000334975300006
PM 24632144
ER

PT J
AU Schaefer-Ramadan, S
   Thorpe, C
   Rozovsky, S
AF Schaefer-Ramadan, Stephanie
   Thorpe, Colin
   Rozovsky, Sharon
TI Site-specific insertion of selenium into the redox-active disulfide of
   the flavoprotein augmenter of liver regeneration
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Augmenter of liver regeneration; Charge-transfer; Disulfide; Flavin;
   Selenium; Selenocysteine insertion sequence
ID DEPENDENT SULFHYDRYL OXIDASE; ELONGATION-FACTOR SELB; ESCHERICHIA-COLI;
   MESSENGER-RNA; SELENOCYSTEINE INSERTION; INTERMEMBRANE SPACE;
   SECIS-ELEMENTS; IN-VIVO; EXPRESSION; PROTEIN
AB Augmenter of liver regeneration (sfALR) is a small disulfide-bridged homodimeric flavoprotein with sulfhydryl oxidase activity. Here, we investigate the catalytic and spectroscopic consequences of selectively replacing C145 by a selenocysteine to complement earlier studies in which random substitution of similar to 90% of the 6 cysteine residues per sfALR monomer was achieved growing Escherichia coli on selenite. A selenocysteine insertion sequence (SECIS) element was installed within the gene for human sfALR. SecALR2 showed a spectrum comparable to that of wild-type sfALR. The catalytic efficiency of SecALR2 towards dithiothreitol was 6.8-fold lower than a corresponding construct in which position 145 was returned to a cysteine residue while retaining the additional mutations introduced with the SECIS element. This all-cysteine control enzyme formed a mixed disulfide between C142 and beta-mercaptoethanol releasing C145 to form a thiolate-flavin charge transfer absorbance band at similar to 530 nm. In contrast, SecALR2 showed a prominent long-wavelength absorbance at 585 nm consistent with the expectation that a selenolate would be a better charge-transfer donor to the isoalloxazine ring. These data show the robustness of the ALR protein fold towards the multiple mutations required to insert the SECIS element and provide the first example of a selenolate to flavin charge-transfer complex. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Schaefer-Ramadan, Stephanie; Thorpe, Colin; Rozovsky, Sharon] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.
RP Rozovsky, S (reprint author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.
EM rozovsky@udel.edu
FU NIH [P30 GM103519]; NSF [MCB-1054447, GM26643, 1-T32-GM008550]
FX This work was supported in part by NIH P30 GM103519 and NSF MCB-1054447
   "CAREER: Reactivity of Selenoproteins" (S.R.), GM26643 (C.T.) and
   1-T32-GM008550 (S.S.-R.). We acknowledge service from the University of
   Delaware's protein characterization core facility. We thank Ms. Brittany
   Riggio, Yuliya Pepelyayeva, Fei Li and Dr. Shawn Gannon for help during
   the early phase of this work. Professor Elias Arner generously provided
   the pSUABC plasmid used in this work.
CR Aldag C, 2009, P NATL ACAD SCI USA, V106, P5481, DOI 10.1073/pnas.0810503106
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188
   BARON C, 1993, P NATL ACAD SCI USA, V90, P4181, DOI 10.1073/pnas.90.9.4181
   Banci L, 2011, P NATL ACAD SCI USA, V108, P4811, DOI 10.1073/pnas.1014542108
   Hazebrouck S, 2000, J BIOL CHEM, V275, P28715, DOI 10.1074/jbc.M004985200
   Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v
   Wu CK, 2003, PROTEIN SCI, V12, P1109, DOI 10.1110/ps.0238103
   ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660
   HEIDER J, 1992, EMBO J, V11, P3759
   Liu ZS, 1998, NUCLEIC ACIDS RES, V26, P896, DOI 10.1093/nar/26.4.896
   Rozovsky S, 2013, ACS SYM SER, V1152, P127
   Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678
   Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085
   Busch A, 2005, BIOINFORMATICS, V21, P3312, DOI 10.1093/bioinformatics/bti507
   Bar-Noy S, 2002, BIOCHEM BIOPH RES CO, V297, P956, DOI 10.1016/S0006-291X(02)02314-8
   Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629
   Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z
   GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x
   Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555
   Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010
   Band L., 2012, J AM CHEM SOC, V134, P1442
   Bock A, 2006, SELENIUM ITS MOL BIO, P9, DOI 10.1007/0-387-33827-6_2
   Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m
   Gandhi Chandrashekhar R, 2012, Fibrogenesis Tissue Repair, V5, P10, DOI 10.1186/1755-1536-5-10
   Huttenhofer A, 1996, RNA, V2, P354
   Jiang ZH, 2004, BIOCHEM BIOPH RES CO, V321, P94, DOI 10.1016/j.bbrc.2004.06.110
   Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010
   Klug SJ, 1997, P NATL ACAD SCI USA, V94, P6676, DOI 10.1073/pnas.94.13.6676
   Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8
   Pawlowski R, 2006, MOL CELL BIOCHEM, V288, P159, DOI 10.1007/s11010-006-9133-7
   Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004
   Schaefer SA, 2013, J MOL BIOL, V425, P222, DOI 10.1016/j.jmb.2012.11.011
   Schaefer-Ramadan S, 2013, BIOCHEMISTRY-US, V52, P8323, DOI 10.1021/bi401305w
   Singh R., 2003, CHEM SULPHUR CONTAIN, P633
   Su D, 2005, NUCLEIC ACIDS RES, V33, P2486, DOI 10.1093/nar/gki547
   Suppmann S, 1999, EMBO J, V18, P2284, DOI 10.1093/emboj/18.8.2284
NR 36
TC 0
Z9 0
U1 4
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2014
VL 548
BP 60
EP 65
DI 10.1016/j.abb.2014.02.001
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AF8OK
UT WOS:000334975300007
PM 24582598
ER

PT J
AU Wang, QZ
   Viola, RE
AF Wang, Qinzhe
   Viola, Ronald E.
TI Reexamination of aspartoacylase: Is this human enzyme really a
   glycoprotein?
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Aspartoacylase; Glycoprotein; Deglycosylation
ID CANAVAN-DISEASE; BRAIN ASPARTOACYLASE; POLYACRYLAMIDE-GELS;
   N-GLYCOSYLATION; IDENTIFICATION; PURIFICATION; DEFICIENCY; PROTEINS;
   BINDING
AB Aspartoacylase catalyzes the metabolism of an important amino acid in the brain, with the release acetate serving as the source for fatty acid biosynthesis. Defects in this enzyme lead to a loss of activity and the symptoms of a fatal neurological disorder called Canavan disease. Extensive evidence, including deglycosylation studies, differential activity upon eukaryotic host expression and site directed mutagenesis, have supported the presence of a glycan that plays an essential role in the stability and catalytic activity of mammalian aspartoacylase. However, the structure of this enzyme did not show the presence of any non-amino acid components at the putative glycosylation site. A more extensive study specifically designed to resolve this discrepancy has now shown that recombinantly-expressed human aspartoacylase is not glycosylated, but is still fully functional and stable even when produced from a bacterial expression system. Alternative interpretations of the prior experiments now present a consistent picture of the structural components of this essential brain enzyme. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wang, Qinzhe; Viola, Ronald E.] Univ Toledo, Dept Chem & Biochem, Toledo, OH 43606 USA.
RP Viola, RE (reprint author), Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA.
EM ron.viola@utoledo.edu
FU Jacobs Cure Foundation
FX This work was partially supported by a grant from the Jacobs Cure
   Foundation. The authors thank Dr. Dragan Isailovic (University of
   Toledo) for assistance with the design and interpretation of the mass
   spectrometry studies.
CR Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771
   Canavan MM, 1931, ARCH NEURO PSYCHIATR, V25, P299
   Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827
   MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646
   DADAMO AF, 1977, J NEUROCHEM, V28, P739, DOI 10.1111/j.1471-4159.1977.tb10621.x
   MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2
   An HJ, 2003, ANAL CHEM, V75, P5628, DOI 10.1021/ac034414x
   Harvey DJ, 2000, J AM SOC MASS SPECTR, V11, P564, DOI 10.1016/S1044-0305(00)00122-7
   Bitto E, 2007, P NATL ACAD SCI USA, V104, P456, DOI 10.1073/pnas.0607817104
   DUBRAY G, 1982, ANAL BIOCHEM, V119, P325, DOI 10.1016/0003-2697(82)90593-0
   JAY GD, 1990, ANAL BIOCHEM, V185, P324, DOI 10.1016/0003-2697(90)90302-P
   Le Coq J, 2006, BIOCHEMISTRY-US, V45, P5878, DOI 10.1021/bi052608w
   Le Coq J, 2008, BIOCHEMISTRY-US, V47, P3484, DOI 10.1021/bi702400x
   MATALON R, 1989, J INHERIT METAB DIS, V12, P329
   Moore RA, 2003, ARCH BIOCHEM BIOPHYS, V413, P1, DOI 10.1016/S0003-9861(03)00055-9
   Rodig JV, 2013, BIOTECHNOL BIOENG, V110, P1691, DOI 10.1002/bit.24834
   Zano S, 2013, J INHERIT METAB DIS, V36, P1, DOI 10.1007/s10545-012-9520-z
NR 19
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2014
VL 548
BP 66
EP 73
DI 10.1016/j.abb.2014.03.001
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AF8OK
UT WOS:000334975300008
PM 24632142
ER

PT J
AU Huang, JS
   Smith, F
   Panizzi, P
AF Huang, Jiansheng
   Smith, Forrest
   Panizzi, Peter
TI Ordered cleavage of myeloperoxidase ester bonds releases active site
   heme leading to inactivation of myeloperoxidase by benzoic acid
   hydrazide analogs
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Myeloperoxidase; Inflammation; Reactive oxygen species
ID HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; SPECTRAL PROPERTIES;
   AUTOLYTIC CLEAVAGE; PROTEIN NITRATION; COMPOUNDS I; SUPEROXIDE;
   INHIBITION; MECHANISM; IDENTIFICATION
AB Myeloperoxidase (MPO) catalyzes the breakdown of hydrogen peroxide and the formation of the potent oxidant hypochlorous acid. We present the application of the fluorogenic peroxidase substrate 10-acetyl-3,7-dihydroxyphenoxazine(ADHP) in steady-state and transient kinetic studies of MPO function. Using initial kinetic parameters for the MPO system, we characterized under the same conditions a number of gold standards for MPO inhibition, namely 4-amino benzoic acid hydrazide (4-ABAH), isoniazid and NaN3 before expanding our focus to isomers of 4-ABAH and benzoic acid hydrazide analogs. We determined that in the presence of hydrogen peroxide that 4-ABAH and its isomer 2-ABAH are both slow-tight binding inhibitors of MPO requiring at least two steps, whereas NaN3 and isoniazid-based inhibition has a single observable step. We also determined that MPO inhibition by benzoic acid hydrazide and 4-(trifluoromethyl) benzoic acid hydrazide was due to hydrolysis of the ester bond between MPO heavy chain Glu 242 residue and the heme pyrrole A ring, freeing the light chain and heme b fragment from the larger remaining MPO heavy chain. This new mechanism would essentially indicate that the benzoic acid hydrazide analogs impart inhibition through initial ejection of the heme catalytic moiety without prior loss of the active site iron. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Huang, Jiansheng; Smith, Forrest; Panizzi, Peter] Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, Auburn, AL 36849 USA.
RP Panizzi, P (reprint author), Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, 3211-J Walker Bldg, Auburn, AL 36849 USA.
EM panizzi@auburn.edu
OI Panizzi, Peter/0000-0003-0141-8807
FU National Institutes of Health through National Heart, Lung, and Blood
   Institute [R00HL094533, R01HL114477]; National Institute of Allergy and
   Infectious Diseases [2R44AI085840-02]
FX Supported by the National Institutes of Health through grants provided
   by the National Heart, Lung, and Blood Institute, R00HL094533 (to P.P.)
   & R01HL114477 (to P.P.), and the National Institute of Allergy and
   Infectious Diseases grant 2R44AI085840-02 (to P.P.).
CR ANDREWS PC, 1981, J BIOL CHEM, V256, P4211
   ANDREWS PC, 1982, J BIOL CHEM, V257, P13240
   ANDREWS PC, 1982, ANAL BIOCHEM, V127, P346, DOI 10.1016/0003-2697(82)90185-3
   Forbes LV, 2012, BIOCHEM PHARMACOL, V84, P949, DOI 10.1016/j.bcp.2012.07.020
   Hampton MB, 1996, INFECT IMMUN, V64, P3512
   Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482
   Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358
   Kettle AJ, 1997, REDOX REP, V3, P257
   Nahrendorf M, 2008, CIRCULATION, V117, P1153, DOI 10.1161/CIRCULATIONAHA.107.756510
   Paumann-Page M, 2013, ARCH BIOCHEM BIOPHYS, V539, P51, DOI 10.1016/j.abb.2013.09.004
   Kettle AJ, 1997, BIOCHEM J, V321, P503
   Tiden AK, 2011, J BIOL CHEM, V286, P37578, DOI 10.1074/jbc.M111.266981
   Marquez LA, 1995, J BIOL CHEM, V270, P30434
   Swirski FK, 2010, J CLIN INVEST, V120, P2627, DOI 10.1172/JCI42304
   Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238
   Gorris HH, 2009, J AM CHEM SOC, V131, P6277, DOI 10.1021/ja9008858
   Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200
   Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017
   ATOR MA, 1987, J BIOL CHEM, V262, P1542
   Su HS, 2012, RADIOLOGY, V262, P181, DOI 10.1148/radiol.11110040
   WILKS A, 1995, BIOCHEMISTRY-US, V34, P4421, DOI 10.1021/bi00013a034
   Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964
   Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970
   Forbes LV, 2013, J BIOL CHEM, V288, P36636, DOI 10.1074/jbc.M113.507756
   Meng Y, 2005, ANAL BIOCHEM, V345, P227, DOI 10.1016/j.ab.2005.07.026
   Arvadia P, 2011, ARCH BIOCHEM BIOPHYS, V515, P120, DOI 10.1016/j.abb.2011.07.015
   ATOR MA, 1987, J BIOL CHEM, V262, P14954
   BOZEMAN PM, 1992, BIOCHEM PHARMACOL, V44, P553, DOI 10.1016/0006-2952(92)90449-S
   Burnham K, 2002, MODEL SELECTION MULT
   Cortez-Retamozo V, 2013, IMMUNITY, V38, P296, DOI 10.1016/j.immuni.2012.10.015
   Everse J, 1998, FREE RADICAL BIO MED, V24, P1338, DOI 10.1016/S0891-5849(97)00451-6
   FLISS H, 1988, MOL CELL BIOCHEM, V84, P177, DOI 10.1007/BF00421053
   Galijasevic S, 2008, BIOCHEMISTRY-US, V47, P2668, DOI 10.1021/bi702016q
   HARRISON JE, 1980, BIOCHEM BIOPH RES CO, V94, P34, DOI 10.1016/S0006-291X(80)80183-5
   IKEDASAITO M, 1991, J BIOL CHEM, V266, P3611
   Kooter IM, 1999, J BIOL INORG CHEM, V4, P684, DOI 10.1007/s007750050340
   Kooter IM, 1999, EUR J BIOCHEM, V264, P211, DOI 10.1046/j.1432-1327.1999.00606.x
   LANGE M, 1981, TETRAHEDRON LETT, V22, P2561, DOI 10.1016/S0040-4039(01)90520-9
   NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4
   Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976
   Sharma Sujata, 2013, Int J Biochem Mol Biol, V4, P108
   Smith M.B., 2006, ADV ORGANIC CHEM REA
   TAYLOR KL, 1995, ARCH BIOCHEM BIOPHYS, V316, P635, DOI 10.1006/abbi.1995.1083
   TAYLOR KL, 1992, J BIOL CHEM, V267, P25282
   Vaz SM, 2008, P NATL ACAD SCI USA, V105, P8191, DOI 10.1073/pnas.0708211105
   VISSERS MCM, 1987, BIOCHEM J, V245, P277
   WEVER R, 1981, BIOCHIM BIOPHYS ACTA, V661, P235, DOI 10.1016/0005-2744(81)90009-7
   Winterbourn CC, 2004, JPN J INFECT DIS, V57, pS31
NR 48
TC 2
Z9 2
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2014
VL 548
BP 74
EP 85
DI 10.1016/j.abb.2014.02.014
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AF8OK
UT WOS:000334975300009
PM 24632143
ER

PT J
AU Lee, E
   Kwak, GH
   Kamble, K
   Kim, HY
AF Lee, Eujin
   Kwak, Geun-Hee
   Kamble, Kranti
   Kim, Hwa-Young
TI Methionine sulfoxide reductase B3 deficiency inhibits cell growth
   through the activation of p53-p21 and p27 pathways
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Methionine sulfoxide reductase; MsrB3; Cell cycle arrest; p53; p21
ID OXIDATIVE STRESS; ENDOPLASMIC-RETICULUM; RESISTANCE; DROSOPHILA; P53;
   OVEREXPRESSION; PROTECTS; MSRB1; ROLES; ACTIN
AB Methionine sulfoxide reductase B3 (MsrB3) is an oxidoreductase in the endoplasmic reticulum that catalyzes the stereospecific reduction of methionine-R-sulfoxide to methionine. Here, we report the critical role and mechanisms of MsrB3 in cell proliferation. The deletion of MsrB3 led to a significant decrease in cell proliferation in mouse embryonic fibroblast (MEF) cells. MsrB3-knockout MEF cells showed increased p53 protein levels, compared to wild-type MEF cells, which subsequently elevated the protein level of cyclin-dependent kinase inhibitor p21. In addition, MsrB3 deficiency enhanced the protein level of p27, another cell cycle regulator, and caused cell cycle arrest at the G (1) stage. The inhibitory effect of MsrB3 deficiency on cell proliferation through the activation of p53-p21 and p27 pathways was also confirmed in primary human dermal fibroblasts. Collectively, the data suggest that MsrB3 is a regulator of cell growth through the p53-p21 and p27 pathways. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Lee, Eujin; Kwak, Geun-Hee; Kamble, Kranti; Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea.
RP Kim, HY (reprint author), Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, 170 Hyeonchungno, Taegu 705717, South Korea.
EM hykim@ynu.ac.kr
FU National Research Foundation of Korea [2005-0049417, 2011-0028166]
FX This work was supported by the National Research Foundation of Korea
   Grants 2005-0049417 and 2011-0028166 (to H.Y.K.).
CR Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   Cao G, 2010, J BIOL CHEM, V285, P26081, DOI 10.1074/jbc.M110.103655
   Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048
   XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0
   Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481
   AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493
   Ahmed ZM, 2011, AM J HUM GENET, V88, P19, DOI 10.1016/j.ajhg.2010.11.010
   Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P3205, DOI 10.1073/pnas.93.8.3205
   Lee BC, 2013, MOL CELL, V51, P397, DOI 10.1016/j.molcel.2013.06.019
   Kasaikina MV, 2011, J BIOL CHEM, V286, P33203, DOI 10.1074/jbc.M111.259218
   Hung RJ, 2013, NAT CELL BIOL, V15, P1445, DOI 10.1038/ncb2871
   Tarrago L, 2012, J BIOL CHEM, V287, P24448, DOI 10.1074/jbc.M112.374520
   Kwon TJ, 2014, HUM MOL GENET, V23, P1591, DOI 10.1093/hmg/ddt549
   Ciorba MA, 1997, P NATL ACAD SCI USA, V94, P9932, DOI 10.1073/pnas.94.18.9932
   Choi SH, 2011, BIOCHEM BIOPH RES CO, V416, P70, DOI 10.1016/j.bbrc.2011.10.145
   Kantorow M, 2004, P NATL ACAD SCI USA, V101, P9654, DOI 10.1073/pnas.0403532101
   Kim HY, 2013, ANTIOXID REDOX SIGN, V19, P958, DOI 10.1089/ars.2012.5081
   Cabreiro F, 2008, J BIOL CHEM, V283, P16673, DOI 10.1074/jbc.M708580200
   Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629
   Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I
   Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071
   Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726
   Kim HY, 2004, BIOCHEM BIOPH RES CO, V320, P1277, DOI 10.1016/j.bbrc.2004.06.078
   Kim J, 2013, SPACE, P18
   Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200
   Kwak GH, 2012, BIOCHEM BIOPH RES CO, V420, P130, DOI 10.1016/j.bbrc.2012.02.128
   Lim DH, 2012, BIOCHEM BIOPH RES CO, V419, P20, DOI 10.1016/j.bbrc.2012.01.099
   Sun HY, 1999, BIOCHEMISTRY-US, V38, P105, DOI 10.1021/bi981295k
   TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8
NR 30
TC 2
Z9 2
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2014
VL 547
BP 1
EP 5
DI 10.1016/j.abb.2014.02.0080003-9861
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AE7AI
UT WOS:000334148700001
PM 24583268
ER

PT J
AU Piovesan, AR
   Martinelli, AHS
   Ligabue-Braun, R
   Schwartz, JL
   Carlini, CR
AF Piovesan, Angela R.
   Martinelli, Anne H. S.
   Ligabue-Braun, Rodrigo
   Schwartz, Jean-Louis
   Carlini, Celia R.
TI Canavalia ensiformis urease, Jaburetox and derived peptides form ion
   channels in planar lipid bilayers
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Canavalia ensiformis urease; Insecticidal protein; Ion channel;
   Pore-forming toxin; Planar lipid bilayer; Membrane permeabilization
ID BACILLUS-THURINGIENSIS TOXIN; HELICOBACTER-PYLORI UREASE; UREOLYTIC
   ACTIVITY; EC 3.5.1.5; PROTEOLYTIC ACTIVATION; BLOOD-PLATELETS;
   CHOLERA-TOXIN; CANATOXIN; PROTEIN; PORE
AB Ureases catalyze the hydrolysis of urea into NH3 and CO2. They are synthesized by plants, fungi and bacteria but not by animals. Ureases display biological activities unrelated to their enzymatic activity, i.e., platelet and neutrophil activation, fungus inhibition and insecticidal effect. Urease from Canavalia ensiformis (jack bean) is toxic to several hemipteran and coleopteran insects. Jaburetox is an insecticidal fragment derived from jack bean urease. Among other effects, Jaburetox has been shown to interact with lipid vesicles. In this work, the ion channel activity of C ensiformis urease, Jaburetox and three deletion mutants of Jaburetox (one lacking the N-terminal region, one lacking the C-terminal region and one missing the central ss-hairpin) were tested on planar lipid bilayers. All proteins formed well resolved, highly cation-selective channels exhibiting two conducting states whose conductance ranges were 7-18 pS and 32-79 pS, respectively. Urease and the N-terminal mutant of Jaburetox were more active at negative potentials, while the channels of the other peptides did not display voltage-dependence. This is the first direct demonstration of the capacity of C ensiformis urease and Jaburetox to permeabilize membranes through an ion channel-based mechanism, which may be a crucial step of their diverse biological activities, including host defense. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Piovesan, Angela R.; Martinelli, Anne H. S.; Ligabue-Braun, Rodrigo; Carlini, Celia R.] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Grad Program Cellular & Mol Biol, BR-91501970 Porto Alegre, RS, Brazil.
   [Martinelli, Anne H. S.; Carlini, Celia R.] Univ Fed Rio Grande do Sul, Dept Biophys, BR-91501970 Porto Alegre, RS, Brazil.
   [Schwartz, Jean-Louis] Univ Montreal, Fac Med, Grp Etud Prot Membranaires, GEPROM,FQR S, Montreal, PQ H3C 3J7, Canada.
   [Schwartz, Jean-Louis] Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada.
   [Schwartz, Jean-Louis] Univ Sherbrooke, Ctr SEVE FQR NT, Sherbrooke, PQ J1K 2R, Canada.
RP Schwartz, JL (reprint author), Univ Montreal, Fac Med, Dept Physiol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.
EM jean-louis.schwartz@umontreal.ca; ccarlini@ufrgs.br
RI Carlini, Celia/H-4017-2011
OI Carlini, Celia/0000-0002-7027-2445
FU Government of Canada (DFAIT-SEP); Government of Canada (NSERC);
   Government of Quebec (FRQ-NT-IIP (Centre SEVE)); Government of Quebec
   (FQRNT-RS/CR); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNN); Fundacao de Amparo a Pesquisa do Estado do Rio Grande
   do Sul (FAPERGS)
FX This work was supported by grants from the Government of Canada
   (DFAIT-SEP to AP and NSERC Discovery to JLS), the Government of Quebec
   (FRQ-NT-IIP (Centre SEVE) to AP and FQRNT-RS/CR to JLS) and the
   Brazilian agencies Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNN) and Fundacao de Amparo a Pesquisa do Estado do Rio
   Grande do Sul (FAPERGS).
CR ALVES EW, 1992, TOXICON, V30, P1411, DOI 10.1016/0041-0101(92)90516-8
   Andreeva-Kovalevskaya ZI, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1473, DOI 10.1134/S0006297908130087
   ZERNER B, 1991, BIOORG CHEM, V19, P116, DOI 10.1016/0045-2068(91)90048-T
   Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0
   Fahrner RL, 1996, CHEM BIOL, V3, P543, DOI 10.1016/S1074-5521(96)90145-3
   Follmer C, 2004, EUR J BIOCHEM, V271, P1357, DOI 10.1111/j.1432-1033.2004.04046.x
   Follmer C, 2008, PHYTOCHEMISTRY, V69, P18, DOI 10.1016/j.phytochem.2007.06.034
   Stec B, 2006, CELL MOL LIFE SCI, V63, P1370, DOI 10.1007/s00018-005-5574-5
   Follmer C, 2005, ARCH BIOCHEM BIOPHYS, V435, P15, DOI 10.1016/j.abb.2004.12.001
   Sumner JB, 1926, J BIOL CHEM, V69, P435
   Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001
   Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009
   Thevissen K, 1999, APPL ENVIRON MICROB, V65, P5451
   Kruger V, 2012, J BIOL CHEM, V287, P33314, DOI 10.1074/jbc.M112.387563
   Krajewska B, 2009, J MOL CATAL B-ENZYM, V59, P9, DOI 10.1016/j.molcatb.2009.01.003
   Sirko A, 2000, ACTA BIOCHIM POL, V47, P1189
   DIXON NE, 1975, J AM CHEM SOC, V97, P4131, DOI 10.1021/ja00847a045
   Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572
   BONTEMS F, 1992, BIOCHEMISTRY-US, V31, P7756, DOI 10.1021/bi00149a003
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Follmer C, 2004, PLANT SCI, V167, P241, DOI 10.1016/j.plantsci.2004.03.019
   Balasubramanian A, 2010, J MOL BIOL, V400, P274, DOI 10.1016/j.jmb.2010.05.009
   Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005
   Carlini CR, 1997, J ECON ENTOMOL, V90, P340, DOI 10.1093/jee/90.2.340
   Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444
   Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n
   Corzo G, 2002, J BIOL CHEM, V277, P23627, DOI 10.1074/jbc.M200511200
   Balasubramanian A., 2012, MOL SIMULAT, V39, P357
   Barros PR, 2009, BBA-PROTEINS PROTEOM, V1794, P1848, DOI 10.1016/j.bbapap.2009.09.001
   Becker-Ritt AB, 2012, BIOPOLYMERS, V98, P367, DOI 10.1002/bip.22097
   Becker-Ritt AB, 2007, TOXICON, V50, P971, DOI 10.1016/j.toxicon.2007.07.008
   BENJAMIN CF, 1992, TOXICON, V30, P879, DOI 10.1016/0041-0101(92)90386-J
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551
   Carlini CR, 2008, CROP SCI, V48, P1665, DOI 10.2135/cropsci2007.10.0576
   CARLINI CR, 1991, TOXICON, V29, P791, DOI 10.1016/0041-0101(91)90216-E
   Defferrari MS, 2011, INSECT BIOCHEM MOLEC, V41, P388, DOI 10.1016/j.ibmb.2011.02.008
   Ferreira-DaSilva CT, 2000, ARCH INSECT BIOCHEM, V44, P162, DOI 10.1002/1520-6327(200008)44:4<162::AID-ARCH3>3.3.CO;2-R
   Follmer C, 2001, BIOCHEM J, V360, P217, DOI 10.1042/0264-6021:3600217
   Ghazaleh FA, 1997, ARCH BIOCHEM BIOPHYS, V339, P362, DOI 10.1006/abbi.1997.9898
   GRIFFITHS SL, 1986, BIOCHEM J, V238, P313
   Groulx N, 2011, J BIOL CHEM, V286, P42274, DOI 10.1074/jbc.M111.296103
   Hille B., 2001, IONIC CHANNELS EXCIT
   Hughes P, 2000, J BIOL CHEM, V275, P823, DOI 10.1074/jbc.275.2.823
   Iacovache I., 2012, COMPREHENSIVE BIOPHY, P164
   Llanos P, 2004, EUR BIOPHYS J BIOPHY, V33, P283, DOI 10.1007/s00249-003-0353-4
   Martinelli A.H.S., 1840, BIOCH BIOPHYS ACTA G, V2014, P935
   Mello EO, 2011, CURR MICROBIOL, V62, P1209, DOI 10.1007/s00284-010-9847-3
   Mulinari F, 2007, PEPTIDES, V28, P2042, DOI 10.1016/j.peptides.2007.08.009
   Muller P., 1963, J PHYS CHEM-US, V67, P534
   Olivera-Severo D, 2006, ARCH BIOCHEM BIOPHYS, V452, P149, DOI 10.1016/j.abb.2006.06.001
   Peyronnet O, 2002, BBA-BIOMEMBRANES, V1567, P113, DOI 10.1016/S0005-2736(02)00605-3
   Peyronnet O, 2001, J MEMBRANE BIOL, V184, P45, DOI 10.1007/s00232-001-0071-8
   Piovesan A.R., 2013, UREASE CANAVALIA ENS
   Piovesan AR, 2008, INSECT BIOCHEM MOLEC, V38, P1023, DOI 10.1016/j.ibmb.2008.09.004
   Postal M, 2012, PEPTIDES, V38, P22, DOI 10.1016/j.peptides.2012.08.010
   Puntheeranurak T, 2004, MOL MEMBR BIOL, V21, P67, DOI 10.1080/09687680310001625792
   Saslowsky DE, 2013, J BIOL CHEM, V288, P25804, DOI 10.1074/jbc.M113.474957
   Schwartz J.L., 2000, ENTOMOPATHOGENIC BAC, P199
   SCHWARTZ JL, 1993, J MEMBRANE BIOL, V132, P53
   Sobko AA, 2009, BBA-BIOMEMBRANES, V1788, P1962, DOI 10.1016/j.bbamem.2009.06.017
   Staniscuaski F, 2012, TOXINS, V4, P55, DOI 10.3390/toxins4020055
   Staniscuaski F, 2009, J INSECT PHYSIOL, V55, P255, DOI 10.1016/j.jinsphys.2008.12.002
   Uberti AF, 2013, TOXICON, V69, P240, DOI 10.1016/j.toxicon.2013.02.009
   Wassermann GE, 2010, J CELL MOL MED, V14, P2025, DOI 10.1111/j.1582-4934.2009.00901.x
   Zeilinger C, 2005, BBA-BIOMEMBRANES, V1720, P35, DOI 10.1016/j.bbamem.2005.10.015
NR 65
TC 3
Z9 3
U1 5
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2014
VL 547
BP 6
EP 17
DI 10.1016/j.abb.2014.02.0060003-9861
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AE7AI
UT WOS:000334148700002
PM 24583269
ER

PT J
AU Meints, CE
   Parke, SM
   Wolthers, KR
AF Meints, Carla E.
   Parke, Sarah M.
   Wolthers, Kirsten R.
TI Proximal FAD histidine residue influences interflavin electron transfer
   in cytochrome P450 reductase and methionine synthase reductase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Methionine synthase reductase; Cytochrome P450 reductase; Electron
   transfer; Flavin; Stopped-flow spectroscopy
ID FERREDOXIN-NADP(+) REDUCTASE; P450 OXIDOREDUCTASE; CRYSTAL-STRUCTURE;
   COENZYME BINDING; REDOX PROPERTIES; STRUCTURAL BASIS; CATALYTIC CYCLE;
   NADPH; MECHANISM; P-450
AB Cytochrome P450 reductase (CPR) and methionine synthase reductase (MSR) transfer reducing equivalents from NADPH to FAD to FMN. In CPR, hydride transfer and interflavin electron transfer are kinetically coupled steps, but in MSR the two catalytic steps are represented by two distinct kinetic phases leading to transient formation of the FAD hydroquinone. In human CPR, His(322) forms a hydrogen-bond with the highly conserved Asp(677), a member of the catalytic triad. The catalytic triad is present in MSR, but Ala(312) replaces the histidine residue. To examine if this structural variation accounts for differences in their kinetic behavior, reciprocal substitutions were created. Substitution of His322 for Ala in CPR does not affect the rate of NADPH hydride transfer or the FAD redox potentials, but does impede interflavin electron transfer. For MSR, swapping Ala312 for a histidine residue resulted in the kinetic coupling of hydride and interflavin electron transfer, and eliminated the formation of the FAD hydroquinone intermediate. For both enzymes, placement of the His residue in the active site weakens coenzyme binding affinity. The data suggest that the proximal FAD histidine residue accelerates proton-coupled electron transfer from FADH(2) to the higher potential FMN; a mechanism for this catalytic role is discussed. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Meints, Carla E.; Parke, Sarah M.; Wolthers, Kirsten R.] Univ British Columbia Okanagan, Dept Chem, Kelowna, BC V1V 1V7, Canada.
RP Wolthers, KR (reprint author), Univ British Columbia Okanagan, Dept Chem, 3333 Univ Way, Kelowna, BC V1V 1V7, Canada.
EM kirsten.wolthers@ubc.ca
FU Natural Sciences and Engineering Research Council of Canada
FX This work is supported by a Grant from the Natural Sciences and
   Engineering Research Council of Canada.
CR Matthews RG, 2001, ACCOUNTS CHEM RES, V34, P681, DOI 10.1021/ar0000051
   Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200
   Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411
   Deng Z, 1999, NAT STRUCT BIOL, V6, P847
   Brenner S, 2008, FEBS J, V275, P4540, DOI 10.1111/j.1742-4658.2008.06597.x
   Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097
   OPRIAN DD, 1982, J BIOL CHEM, V257, P8935
   Dumit VI, 2010, J MOL BIOL, V397, P814, DOI 10.1016/j.jmb.2010.01.063
   SHEN AL, 1991, J BIOL CHEM, V266, P19976
   Wolthers KR, 2003, BIOCHEMISTRY-US, V42, P3911, DOI 10.1021/bi027290b
   Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206
   Shen AL, 1996, BIOCHEMISTRY-US, V35, P9451, DOI 10.1021/bi960587n
   IYANAGI T, 1974, BIOCHEMISTRY-US, V13, P1701, DOI 10.1021/bi00705a023
   Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200
   Shen AL, 1999, J BIOL CHEM, V274, P5391, DOI 10.1074/jbc.274.9.5391
   Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s
   Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304
   Meints CE, 2011, BIOCHEMISTRY-US, V50, P11131, DOI 10.1021/bi2012228
   Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003
   Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200
   Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u
   Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059
   Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m
   BRUNS CM, 1995, J MOL BIOL, V247, P125, DOI 10.1006/jmbi.1994.0127
   Aliverti A, 1998, J BIOL CHEM, V273, P34008, DOI 10.1074/jbc.273.51.34008
   Jenner M, 2011, ANGEW CHEM INT EDIT, V50, P8291, DOI 10.1002/anie.201101077
   Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108
   Grunau A, 2006, BIOCHEMISTRY-US, V45, P1421, DOI 10.1021/bi052115r
   Dutton P L, 1978, Methods Enzymol, V54, P411
   Guengerich F. P., 2005, HUMAN CYTOCHROME P45
   Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022
   Medina M, 1998, BIOCHEMISTRY-US, V37, P2715, DOI 10.1021/bi971795y
   Meints CE, 2013, FEBS J, V280, P1460, DOI 10.1111/febs.12141
   Pudney CR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001222
   VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6
   Wolthers KR, 2004, BIOCHEMISTRY-US, V43, P490, DOI 10.1021/bi0356303
   Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P11833, DOI 10.1021/bi701209p
   Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532
NR 38
TC 1
Z9 1
U1 4
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2014
VL 547
BP 18
EP 26
DI 10.1016/j.abb.2014.02.0090003-9861
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AE7AI
UT WOS:000334148700003
PM 24589657
ER

PT J
AU Fischer, K
   von Brunneck, AC
   Hornung, D
   Denkert, C
   Ufer, C
   Schiebel, H
   Kuhn, H
   Borchert, A
AF Fischer, Katharina
   von Bruenneck, Ann-Christin
   Hornung, Daniela
   Denkert, Carsten
   Ufer, Christoph
   Schiebel, Heike
   Kuhn, Hartmut
   Borchert, Astrid
TI Differential expression of secretoglobins in normal ovary and in ovarian
   carcinoma - Overexpression of mammaglobin-1 is linked to tumor
   progression
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Secretoglobins; Oncogenes; Expression regulation; lmmunohistochemistry;
   Tumor growth; Quantitative real time PCR; Ovarian cancer
ID UTEROGLOBIN GENE FAMILY; HUMAN BREAST-CANCER; LIPOPHILIN-B; ENDOMETRIAL
   PROTEIN; DIAGNOSTIC MARKER; G-QUADRUPLEXES; IDENTIFICATION; CELLS;
   COEXPRESSION; MICROARRAYS
AB Secretoglobins (SCGB), such as mammaglobin 1 (MGB1, SCGB2A2), mammaglobin 2 (MGB2, SCGB2A1) and lipophilin B (LIPB, SCGB1D2), have been related to carcinogenesis. We profiled expression of MGB1, MGB2 and LIPB in human tissues and ovarian carcinoma and explored the impact of SCGB overexpression on cell proliferation. MGB1, MGB2 and LIPB mRNA are expressed at variable levels in most human tissues and we observed significant bilateral correlations between the different secretoglobins. Concerted overexpression of MGB1 and LIPB resulted in significant increase in cell proliferation. In clinical specimens of ovarian carcinoma we measured elevated concentrations of secretoglobin mRNA and for MGB1 this up-regulation was confirmed on the protein level. Overexpression of MGB1 positively correlated with the FIGO stage, the tumor grade and the mitotic index suggesting a patho-physiological role of the protein. Our data indicate that MGB1, MGB2 and LIPB mRNAs are expressed at low levels in human tissues but basal expression is upregulated in ovarian cancer. The in vivo correlation between nuclear MGB1 localization and the mitotic rate in ovarian cancer as well as the increased cell proliferation induced by secretoglobin overexpression in ovarian cancer cell lines suggest a pathophysiological role of these proteins in ovarian cancer. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Fischer, Katharina; Ufer, Christoph; Schiebel, Heike; Kuhn, Hartmut; Borchert, Astrid] Charite, Inst Biochem, ChariteCrossOver, D-10117 Berlin, Germany.
   [von Bruenneck, Ann-Christin; Denkert, Carsten] Charite, Inst Pathol, D-10117 Berlin, Germany.
   [Hornung, Daniela] Univ Schleswig Holstein, Dept Gynecol & Obstet, D-23538 Lubeck, Germany.
   [Hornung, Daniela] Diakonissen Hosp, Dept Gynecol & Obstet, D-76199 Karlsruhe, Germany.
RP Kuhn, H (reprint author), Charite, Inst Biochem, ChariteCrossOver, Charitepl 1,Virchowweg 6, D-10117 Berlin, Germany.
EM hartmut.kuehn@charite.de
FU European Commission [LSHM-CT-2004-0050333]
FX This work was supported in part by a research grant of the European
   Commission (FP6, LSHM-CT-2004-0050333) to H.K.
CR Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806
   Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3
   Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902
   Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511
   Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027
   Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001
   Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253
   Bignotti E, 2006, GYNECOL ONCOL, V103, P405, DOI 10.1016/j.ygyno.2006.03.056
   Klug J, 2000, ANN NY ACAD SCI, V923, P348
   Jackson Brian C., 2011, Human Genomics, V5, P691
   Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904
   Chan LWC, 2012, CURR TOP MED CHEM, V12, P920
   Culleton J, 2007, INT J CANCER, V120, P1087, DOI 10.1002/ijc.22471
   Adib TR, 2004, BRIT J CANCER, V90, P686, DOI 10.1038/sj.bjc.6601603
   Silverberg SG, 2000, INT J GYNECOL PATHOL, V19, P7, DOI 10.1097/00004347-200001000-00003
   Sjodin A, 2003, LUNG CANCER-J IASLC, V41, P49, DOI 10.1016/S0169-5002(03)00126-0
   Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037
   Watson MA, 1996, CANCER RES, V56, P860
   Becker RM, 1998, GENOMICS, V54, P70, DOI 10.1006/geno.1998.5539
   BEIER HM, 1968, BIOCHIM BIOPHYS ACTA, V160, P289, DOI 10.1016/0005-2795(68)90108-6
   Bignotti E, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-162
   Carter D, 2002, BIOCHEMISTRY-US, V41, P6714, DOI 10.1021/bi0159884
   Classen-Linke I, 2012, HISTOPATHOLOGY, V61, P955, DOI 10.1111/j.1365-2559.2012.04290.x
   Colpitts TL, 2001, BIOCHEMISTRY-US, V40, P11048, DOI 10.1021/bi010284f
   ESWORTHY RS, 1995, CANCER RES, V55, P957
   Hagemann IS, 2013, HUM PATHOL, V44, P628, DOI 10.1016/j.humpath.2012.07.013
   Hesselbrock DR, 2005, BREAST CANCER RES TR, V89, P289, DOI 10.1007/s10549-004-2622-z
   Jiang YQ, 2002, ONCOGENE, V21, P2270, DOI 10.1038/sj/onc/1205278
   Koga T, 2004, J MOL DIAGN, V6, P90, DOI 10.1016/S1525-1578(10)60495-3
   Masuda M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-S1-S2
   Ni J, 2000, ANN NY ACAD SCI, V923, P25
   Nunez-Villar MJ, 2003, BREAST CANCER RES, V5, pR65, DOI 10.1186/bcr587
   Shi CX, 2004, MOL THER, V10, P758, DOI 10.1016/j.ymthe.2004.06.849
   Sjodin A, 2003, J INVEST DERMATOL, V121, P428, DOI 10.1046/j.1523-1747.2003.12374.x
   Sjodin A, 2008, ANTICANCER RES, V28, P1493
   Tassi RA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-253
   Tassi RA, 2007, GYNECOL ONCOL, V105, P578, DOI 10.1016/j.ygyno.2007.01.043
   Tazawa H, 2011, EXPERT OPIN BIOL TH, V11, P145, DOI 10.1517/14712598.2011.542749
   TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184
   Wallwiener CW, 2011, BREAST CANCER RES TR, V130, P833, DOI 10.1007/s10549-011-1710-0
   Wu ZS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-542
   Xiao F, 2005, MOL ENDOCRINOL, V19, P2964, DOI 10.1210/me.2004-0408
   Zafrakas M, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-88
   Zehentner BK, 2004, CLIN BIOCHEM, V37, P249, DOI 10.1016/j.clinbiochem.2003.11.005
NR 44
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2014
VL 547
BP 27
EP 36
DI 10.1016/j.abb.2014.02.0120003-9861
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AE7AI
UT WOS:000334148700004
PM 24603286
ER

PT J
AU Halm, BM
   Lai, JF
   Morrison, CM
   Pagano, I
   Custer, LJ
   Cooney, RV
   Franke, AA
AF Halm, Brunhild M.
   Lai, Jennifer F.
   Morrison, Cynthia M.
   Pagano, Ian
   Custer, Laurie J.
   Cooney, Robert V.
   Franke, Adrian A.
TI In vivo changes in plasma coenzyme Q10, carotenoid, tocopherol, and
   retinol levels in children after computer tomography
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Computer tomography; Children; Coenzyme Q10; Carotenoids; Tocopherols;
   Retinol
ID HUMAN BLOOD-PLASMA; OXIDATIVE STRESS; VITAMIN-E; LIPID-PEROXIDATION;
   DENSITY-LIPOPROTEIN; IONIZING-RADIATION; ALPHA-TOCOPHEROL;
   HEART-DISEASE; BETA-CAROTENE; ANTIOXIDANT
AB Background: Low dose X-irradiation (IR) from computer tomography (CT) can generate free radicals, which can damage biologically relevant molecules and ultimately lead to cancer. These effects are especially concerning for children owing to their higher radiosensitivity and longer life expectancy than adults. The lipid phase micronutrients (LPM) coenzyme Q10, carotenoids, E vitamers, and vitamin A are potent radical scavengers that can act as intracellular antioxidants.
   Methods: We investigated changes in circulating levels of these LPM in 17 children (0.25-6 y) undergoing medically indicated CT scans involving relatively low IR doses. Blood was drawn before and 1 h after CT scans and analyzed using HPLC with electrochemical and UV/V1S detection.
   Results: We found significant decreases (p < 0.05) in post-CT plasma levels in several LPM which suggests that these LPM can serve as biodosimeters and may protect against damage from IR during clinical procedures such as CT. The strongest predictors for pre- to post-CT changes for many LPM were their baseline levels.
   Conclusion: Future larger studies are warranted to confirm our findings and to test whether high circulating antioxidant levels protect against IR damage in vivo with an ultimate goal of establishing prophylactic modalities for CT-induced IR damage.(C) 2014 Elsevier Inc. All rights reserved.
C1 [Halm, Brunhild M.; Lai, Jennifer F.; Morrison, Cynthia M.; Pagano, Ian; Custer, Laurie J.; Franke, Adrian A.] Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA.
   [Cooney, Robert V.] Univ Hawaii, Dept Publ Hlth Sci & Epidemiol, Honolulu, HI 96813 USA.
RP Halm, BM (reprint author), Univ Hawaii, Ctr Canc, 1236 Lauhala St, Honolulu, HI 96813 USA.
EM hhalm@cc.hawaii.edu; adrian@cc.hawaii.edu
FU University of Hawai'i Cancer Center Developmental Fund, National Cancer
   Institute [P30 CA71789]
FX University of Hawai'i Cancer Center Developmental Fund, National Cancer
   Institute P30 CA71789.
CR [Anonymous], 2012, HLTH DEVICES, V41, P332
   Weiss JF, 2003, TOXICOLOGY, V189, P1, DOI 10.1016/S0300-483X(03)00149-5
   Ames BN, 1999, ANN NY ACAD SCI, V889, P87, DOI 10.1111/j.1749-6632.1999.tb08727.x
   Lin AMY, 2005, ANN NY ACAD SCI, V1053, P319, DOI 10.1196/annals.1344.028
   TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0
   WEBER C, 1994, INT J VITAM NUTR RES, V64, P311
   Valentin J, 2007, Ann ICRP, V37, P1
   Mattila P, 2001, J FOOD COMPOS ANAL, V14, P409, DOI 10.1006/jfca.2000.0983
   Weiss JF, 2000, ANN NY ACAD SCI, V899, P44
   Frush DP, 1998, RADIOLOGY, V209, P37
   Halliwell B, 1999, NUTR REV, V57, P104
   Yamamoto Y, 1998, BIOCHEM BIOPH RES CO, V247, P166, DOI 10.1006/bbrc.1998.8752
   Debier C, 2005, BRIT J NUTR, V93, P153, DOI 10.1079/BJN20041308
   Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100
   Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548
   Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4
   PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657
   Crane FL, 2001, J AM COLL NUTR, V20, P591
   Turner ND, 2002, NUTRITION, V18, P904, DOI 10.1016/S0899-9007(02)00945-0
   NIERENBERG DW, 1987, AM J MED SCI, V294, P187, DOI 10.1097/00000441-198709000-00010
   STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646
   Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012
   Palace VP, 1999, FREE RADICAL BIO MED, V26, P746, DOI 10.1016/S0891-5849(98)00266-4
   Kleinerman RA, 2006, PEDIATR RADIOL, V36, P121, DOI 10.1007/s00247-006-0191-5
   Cooper DA, 1999, NUTR REV, V57, P201
   WISEMAN H, 1993, FEBS LETT, V326, P285, DOI 10.1016/0014-5793(93)81809-E
   Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451
   Barshop BA, 2007, MITOCHONDRION, V7, pS89, DOI 10.1016/j.mito.2007.04.002
   Berrington de González Amy, 2009, Arch Intern Med, V169, P2071, DOI 10.1001/archinternmed.2009.440
   Borek C, 2004, J NUTR, V134, p3207S
   BOVERIS A, 1984, METHOD ENZYMOL, V105, P429
   BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316
   Brenner DJ, 2001, AM J ROENTGENOL, V176, P289
   Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149
   CANTILENA LR, 1992, AM J CLIN NUTR, V55, P659
   Chevion S, 1999, BIOCHEM MOL BIOL INT, V47, P1019
   CLEMENS MR, 1990, AM J CLIN NUTR, V51, P216
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   FORSMARKANDREE P, 1995, FREE RADICAL BIO MED, V19, P749, DOI 10.1016/0891-5849(95)00076-A
   Franke A., 2013, J CHROMATOGR A, V2013, P1
   Franke AA, 2013, FREE RADICAL RES, V47, P757, DOI 10.3109/10715762.2013.822495
   FRANKE AA, 1993, J CHROMATOGR-BIOMED, V614, P43, DOI 10.1016/0378-4347(93)80222-P
   Franke AA, 2010, FREE RADICAL BIO MED, V48, P1610, DOI 10.1016/j.freeradbiomed.2010.03.002
   Gille L, 2008, BIOCHEM PHARMACOL, V76, P289, DOI 10.1016/j.bcp.2008.04.003
   Halliwell B., 1997, NUTR REV, V55, pS49
   Hosseinimehr SM, 2007, DRUG DISCOV TODAY, V12, P794, DOI 10.1016/j.drudis.2007.07.017
   KAGAN V, 1990, BIOCHEM BIOPH RES CO, V169, P851, DOI 10.1016/0006-291X(90)91971-T
   Kagan VE, 1998, SUB CELL BIOCHEM, V30, P491
   Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459, DOI 10.1016/j.mam.2005.10.001
   Lagendijk J, 1996, J LIPID RES, V37, P67
   Laguna TA, 2008, J PEDIATR-US, V153, P402, DOI 10.1016/j.jpeds.2008.03.028
   Lass A, 1998, ARCH BIOCHEM BIOPHYS, V352, P229, DOI 10.1006/abbi.1997.0606
   Menke T, 2008, PEDIATR DIABETES, V9, P540, DOI 10.1111/j.1399-5448.2008.00389.x
   Nohl H, 1999, BIOFACTORS, V9, P155
   PACKER L, 1993, ANN NY ACAD SCI, V691, P48, DOI 10.1111/j.1749-6632.1993.tb26156.x
   Rock C. L., 1996, J AM DIET ASSOC, V96, P703
   Rock CL, 1996, J AM DIET ASSOC, V96, P693, DOI 10.1016/S0002-8223(96)00190-3
   Society A.N., 2012, RAD DOS CHART
   Tang PH, 2001, CLIN CHEM, V47, P256
   UNSCEAR, 2013, UN SCI COMM EFF AT R
   White KS, 1996, PEDIATR RADIOL, V26, P5, DOI 10.1007/BF01403695
   Yamamoto Y, 1997, MOL ASPECTS MED, V18, pS79
NR 62
TC 1
Z9 1
U1 2
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2014
VL 547
BP 37
EP 43
DI 10.1016/j.abb.2014.02.0070003-9861
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AE7AI
UT WOS:000334148700005
PM 24583267
ER

PT J
AU Valez, V
   Cassina, A
   Batinic-Haberle, I
   Kalyanaraman, B
   Ferrer-Sueta, G
   Radi, R
AF Valez, Valeria
   Cassina, Adriana
   Batinic-Haberle, Ines
   Kalyanaraman, Balaraman
   Ferrer-Sueta, Gerardo
   Radi, Rafael
TI Peroxynitrite formation in nitric oxide-exposed submitochondrial
   particles: Detection, oxidative damage and catalytic removal by
   Mn-porphyrins [Arch. Biochem. Biophys. 529 (2013) 45-54]
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Correction
C1 [Valez, Valeria; Cassina, Adriana; Ferrer-Sueta, Gerardo; Radi, Rafael] Univ Republica, Ctr Free Radical & Biomed Res, Montevideo 11800, Uruguay.
   [Valez, Valeria; Cassina, Adriana; Radi, Rafael] Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay.
   [Batinic-Haberle, Ines] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA.
   [Kalyanaraman, Balaraman] Med Coll Wisconsin, Biophys Res Inst, Milwaukee, WI 53226 USA.
   [Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA.
   [Ferrer-Sueta, Gerardo] Univ Republica, Fac Ciencias, Lab Fisicoquim Biol, Montevideo 11400, Uruguay.
RP Radi, R (reprint author), Univ Republica, Fac Med, Dept Bioquim, Avda Gen Flores 2125, Montevideo 11800, Uruguay.
EM rradi@fmed.edu.uy
RI Ferrer-Sueta, Gerardo/C-3316-2011
OI Ferrer-Sueta, Gerardo/0000-0002-8663-8480
CR Valez V, 2013, ARCH BIOCHEM BIOPHYS, V529, P45, DOI 10.1016/j.abb.2012.10.012
NR 1
TC 0
Z9 0
U1 0
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 1
PY 2014
VL 547
BP 44
EP 44
DI 10.1016/j.abb.2014.02.004
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AE7AI
UT WOS:000334148700006
ER

PT J
AU Bertoldi, M
AF Bertoldi, Mariarita
TI Mammalian dopa decarboxylase: Structure, catalytic activity and
   inhibition
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Mammalian Dope decarboxylase; Mechanism; Kinetic analysis;
   Decarboxylation; Oxidative deamination; Inhibitors
ID AMINO-ACID DECARBOXYLASE; PIG-KIDNEY; 3,4-DIHYDROXYPHENYLALANINE
   DECARBOXYLASE; PARKINSONS-DISEASE; RAT-LIVER; SUBSTRATE-SPECIFICITY;
   ANAEROBIC CONDITIONS; OXIDATIVE DEAMINASE; CRYSTAL-STRUCTURE; COENZYME
AB Mammalian Dopa decarboxylase catalyzes the conversion of L-Dopa and L-5-hydroxytryptophan to dopamine and serotonin, respectively. Both of them are biologically active neurotransmitters whose levels should be finely tuned. In fact, an altered concentration of dopamine is the cause of neurodegenerative diseases, such as Parkinson's disease. The chemistry of the enzyme is based on the features of its coenzyme pyridoxal 5'-phosphate (PLP). The cofactor is highly reactive and able to perform multiple reactions, besides decarboxylation, such as oxidative deamination, half-transamination and Pictet-Spengler cyclization. The structure resolution shows that the enzyme has a dimeric arrangement and provides a molecular basis to identify the residues involved in each catalytic activity. This information has been combined with kinetic studies under steady-state and pre-steady-state conditions as a function of pH to shed light on residues important for catalysis. A great effort in DDC research is devoted to design efficient and specific inhibitors in addition to those already used in therapy that are not highly specific and are responsible for the side effects exerted by clinical approach to either Parkinson's disease or aromatic amino acid decarboxylase deficiency. (C) 2014 Elsevier Inc. All rights reserved.
C1 Univ Verona, Biochem Sect, Dept Life & Reprod Sci, I-37134 Verona, Italy.
RP Bertoldi, M (reprint author), Univ Verona, Biochem Sect, Dept Life & Reprod Sci, Str Le Grazie 8, I-37134 Verona, Italy.
EM mita.bertoldi@univr.it
FU FUR, University of Verona
FX The research reviewed in this paper is partly supported by FUR2012,
   University of Verona.
CR AMINOFF MJ, 1994, WESTERN J MED, V161, P303
   ANDOYAMAMOTO M, 1987, J BIOCHEM-TOKYO, V101, P405
   Kaminaga Y, 2006, J BIOL CHEM, V281, P23357, DOI 10.1074/jbc.M602708200
   Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403
   Bertoldi M, 2005, FEBS LETT, V579, P5175, DOI 10.1016/j.febslet.2005.08.029
   Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472
   Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265
   Hauser RA, 2009, EUR NEUROL, V62, P1, DOI 10.1159/000215875
   Bertoldi M, 2000, BIOCHEM J, V352, P533, DOI 10.1042/0264-6021:3520533
   Bertoldi M, 1998, BIOCHEMISTRY-US, V37, P6552, DOI 10.1021/bi9718898
   Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963
   Hayashi H, 1999, BIOCHEMISTRY-US, V38, P15615, DOI 10.1021/bi9909795
   Bertoldi M, 2003, BBA-PROTEINS PROTEOM, V1647, P42, DOI 10.1016/S1570-9639(03)00046-3
   Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9
   Bertoldi M, 2008, BIOCHEMISTRY-US, V47, P7187, DOI 10.1021/bi800478s
   Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510
   Giardina G, 2011, P NATL ACAD SCI USA, V108, P20514, DOI 10.1073/pnas.1111456108
   Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074
   Bertoldi M, 1996, J BIOL CHEM, V271, P23954
   Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228
   Bertoldi M, 2001, BIOCHEM BIOPH RES CO, V284, P90, DOI 10.1006/bbrc.2001.4945
   Bertoldi M, 2001, EUR J BIOCHEM, V268, P2975, DOI 10.1046/j.1432-1327.2001.02187.x
   Bertoldi M, 2001, PROTEIN SCI, V10, P1178
   Bertoldi M, 1999, J BIOL CHEM, V274, P5514, DOI 10.1074/jbc.274.9.5514
   Bertoldi M, 2002, J BIOL CHEM, V277, P36357, DOI 10.1074/jbc.M204867200
   Bertoldi M, 2009, ARCH BIOCHEM BIOPHYS, V488, P130, DOI 10.1016/j.abb.2009.06.019
   Borglum AD, 1999, MOL PSYCHIATR, V4, P545, DOI 10.1038/sj.mp.4000559
   Borri Voltattorni C., 2001, ENCY MOL MED
   Cellini B, 2005, BIOCHEMISTRY-US, V44, P13970, DOI 10.1021/bi051433n
   Cellini Barbara, 2012, Open Biochem J, V6, P131, DOI 10.2174/1874091X01206010131
   Chen XM, 2011, J PLANT PHYSIOL, V168, P88, DOI 10.1016/j.jplph.2010.06.011
   Crisp KM, 2004, J EXP BIOL, V207, P4535, DOI 10.1242/jeb.01315
   Daidone F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031610
   DOMINICI P, 1987, EUR J BIOCHEM, V169, P209, DOI 10.1111/j.1432-1033.1987.tb13599.x
   DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712
   HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P812, DOI 10.1021/bi00054a011
   Hodgetts RB, 2006, ANNU REV ENTOMOL, V51, P259, DOI 10.1146/annurev.ento.51.110104.151143
   Hoefig CS, 2012, MOL CELL ENDOCRINOL, V349, P195, DOI 10.1016/j.mce.2011.10.024
   JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P
   Komori H, 2012, J BIOL CHEM, V287, P29175, DOI 10.1074/jbc.M112.381897
   MARDER E, 1984, J NEUROPHYSIOL, V51, P1362
   MOMANY C, 1995, PROTEIN SCI, V4, P849
   Montioli R, 2013, HUM MOL GENET, V22, P1615, DOI 10.1093/hmg/ddt011
   Montioli R, 2013, BIOMED RES INT, DOI 10.1155/2013/161456
   Montioli R, 2011, J INHERIT METAB DIS, V34, P1213, DOI 10.1007/s10545-011-9340-6
   Moore PS, 1996, BIOCHEM J, V315, P249
   ORLACCHIO A, 1980, BIOCHEM J, V185, P41
   REITH J, 1994, P NATL ACAD SCI USA, V91, P11651, DOI 10.1073/pnas.91.24.11651
   SCHOTLAND J, 1995, NATURE, V374, P266, DOI 10.1038/374266a0
   Shih DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071741
   TANCINI B, 1988, ARCH BIOCHEM BIOPHYS, V260, P569, DOI 10.1016/0003-9861(88)90483-3
   Vavricka C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016124
   VOLTATTORNI CB, 1983, BIOCHEMISTRY-US, V22, P2249, DOI 10.1021/bi00278a030
   VOLTATTO.CB, 1971, FEBS LETT, V17, P231, DOI 10.1016/0014-5793(71)80153-9
NR 54
TC 4
Z9 4
U1 5
U2 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2014
VL 546
BP 1
EP 7
DI 10.1016/j.abb.2013.12.020
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AD4NT
UT WOS:000333228500001
PM 24407024
ER

PT J
AU Schneider, H
   Staudacher, S
   Poppelreuther, M
   Stremmel, W
   Ehehalt, R
   Fullekrug, J
AF Schneider, Hannah
   Staudacher, Sarah
   Poppelreuther, Margarete
   Stremmel, Wolfgang
   Ehehalt, Robert
   Fuellekrug, Joachim
TI Protein mediated fatty acid uptake: Synergy between CD36/FAT-facilitated
   transport and acyl-CoA synthetase-driven metabolism
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE CD36/FAT; Acyl-CoA synthetases; Fatty acid uptake; Protein
   quantification
ID CELLULAR UPTAKE; MEMBRANE-TRANSPORT; BINDING PROTEINS; PLASMA-MEMBRANE;
   RECOMBINANT ADENOVIRUSES; INTESTINAL-ABSORPTION; CELLS; CD36;
   CAVEOLIN-1; FATP4
AB The mechanism of cellular fatty acid uptake is highly relevant for basic and clinical research. Previous work has demonstrated that fatty acid uptake is facilitated by cell surface membrane proteins as well as by intracellularly localized enzymes. Here, the exogenous expression of the CD36/FAT glycoprotein and the acyl-CoA synthetases FATP4 and ACSL1 in MDCK cells was quantified by comparison to recombinant proteins, and related to the corresponding increases of fatty acid uptake. At the molecular level, CD36/FAT was 30-fold more efficient than either FATP4 or ACSL1 in enhancing fatty acid uptake. Remarkably, co-expression of CD36/FAT with FATP4 or ACSL1 led to a higher increase of fatty acid uptake than expected from the combined individual contributions, whereas co-expression of FATP4 and ACSL1 did not. Immunofluorescence microscopy confirmed the plasma membrane localization of CD36/FAT and the intracellular localization of FATP4 to the endoplasmic reticulum, and of ACSL1 to mitochondria. Concluding, we suggest that fatty acid uptake in our model system is organized by two spatially distinct but synergistic mechanisms: the cell surface protein CD36/FAT directly facilitates fatty acid transport across the plasma membrane, whereas the intracellular acyl-CoA synthetases FATP4 and ACSL1 enhance fatty acid uptake indirectly by metabolic trapping. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Schneider, Hannah; Staudacher, Sarah; Poppelreuther, Margarete; Stremmel, Wolfgang; Ehehalt, Robert; Fuellekrug, Joachim] Univ Heidelberg Hosp, Mol Cell Biol Lab, D-69120 Heidelberg, Germany.
RP Fullekrug, J (reprint author), Univ Heidelberg Hosp, Mol Cell Biol Lab, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.
EM hannah.schneider@gu.se; sarahstaudacher@gmx.de;
   M.Poppelreuther@med.uni-heidelberg.de;
   Wolfgang.Stremmel@med.uni-heidelberg.de; re@hd-gastro.de;
   Joachim.Fuellekrug@med.uni-heidelberg.de
RI Fullekrug, Joachim/A-6581-2008
FU German Research Foundation DFG [PO 1767/3-1, EH 196/5-1, FU 340/5-1];
   Stiftung Nephrologie
FX Funding by the German Research Foundation DFG (PO 1767/3-1 to M.P., EH
   196/5-1 to R.E., FU 340/5-1 to J.F.) and the Stiftung Nephrologie (to
   M.P.) is gratefully acknowledged.
CR Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001
   Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200
   Bonen A, 2007, PHYSIOLOGY, V22, P15
   Murphy EJ, 1998, AM J PHYSIOL-GASTR L, V275, pG244
   Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788
   Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200
   Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135
   Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.2004.07.072
   Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280
   Gao J, 1999, J BIOL CHEM, V274, P16825, DOI 10.1074/jbc.274.24.16825
   Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200
   McArthur MJ, 1999, J LIPID RES, V40, P1371
   Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9
   ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665
   Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625
   Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200
   Abumrad N, 1999, BBA-MOL CELL BIOL L, V1441, P4, DOI 10.1016/S1388-1981(99)00137-7
   Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846
   Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200
   Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009
   Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001
   Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003
   Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287
   Luiken JJFP, 2002, DIABETES, V51, P3113, DOI 10.2337/diabetes.51.10.3113
   Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9
   Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011
   Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200
   Hamilton JA, 2002, MOL CELL BIOCHEM, V239, P17, DOI 10.1023/A:1020542220599
   Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501
   Digel M, 2011, AM J PHYSIOL-ENDOC M, V301, pE785, DOI 10.1152/ajpendo.00079.2011
   Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006
   Fuellekrug J., 2012, FRONT PHYSL, V3
   Fullekrug J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00401
   Glatz JFC, 2001, CURR OPIN LIPIDOL, V12, P267, DOI 10.1097/00041433-200106000-00005
   Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006
   Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200
   Krammer J, 2011, INT J MED SCI, V8, P599
   Manninen A, 2005, MOL CELL BIOL, V25, P10087, DOI 10.1128/MCB.25.22.10087-10096.2005
   Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b
   Mashek DG, 2004, J LIPID RES, V45, P1958, DOI 10.1194/jlr.E4000002-JLR200
   Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b
   Niot I, 2009, PROG LIPID RES, V48, P101, DOI 10.1016/j.plipres.2009.01.001
   Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016
   Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101
   Simard JR, 2010, J LIPID RES, V51, P914, DOI 10.1194/jlr.M900251
   Tran Thi Thu Trang, 2011, J Biol Chem, V286, P25201, DOI 10.1074/jbc.M111.233551
   Trigatti BL, 1999, BIOCHEM BIOPH RES CO, V255, P34, DOI 10.1006/bbrc.1998.0123
   van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524
   Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200
   Weiss KH, 2008, AM J PATHOL, V173, P1783, DOI 10.2353/ajpath.2008.071134
   Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200
   Zhan TZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045087
NR 54
TC 4
Z9 4
U1 4
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2014
VL 546
BP 8
EP 18
DI 10.1016/j.abb.2014.01.025
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AD4NT
UT WOS:000333228500002
PM 24503477
ER

PT J
AU Finney, J
   Moon, HJ
   Ronnebaum, T
   Lantz, M
   Mure, M
AF Finney, Joel
   Moon, Hee-Jung
   Ronnebaum, Trey
   Lantz, Mason
   Mure, Minae
TI Human copper-dependent amine oxidases
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Copper amine oxidase; Lysyl oxidase; Quinoprotein
ID VASCULAR ADHESION PROTEIN-1; HUMAN LYSYL OXIDASE; SQUAMOUS-CELL
   CARCINOMAS; BREAST-CANCER CELLS; ACTIVE-SITE BASE; DIFFERENTIALLY
   EXPRESSED GENES; TO-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR ACTIVITY;
   POLYMERASE-CHAIN-REACTION; HUMAN UMBILICAL ARTERY
AB Copper amine oxidases (CAOs) are a class of enzymes that contain Cu2+ and a tyrosine-derived quinone cofactor, catalyze the conversion of a primary amine functional group to an aldehyde, and generate hydrogen peroxide and ammonia as byproducts. These enzymes can be classified into two non-homologous families: 2,4,5-trihydroxyphenylalanine quinone (TPQ)-dependent CAOs and the lysine tyrosylquinone (LTQ)-dependent lysyl oxidase (LOX) family of proteins. In this review, we will focus on recent developments in the field of research concerning human CAOs and the LOX family of proteins. The aberrant expression of these enzymes is linked to inflammation, fibrosis, tumor metastasis/invasion and other diseases. Consequently, there is a critical need to understand the functions of these proteins at the molecular level, so that strategies targeting these enzymes can be developed to combat human diseases. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Finney, Joel; Moon, Hee-Jung; Ronnebaum, Trey; Lantz, Mason; Mure, Minae] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA.
RP Mure, M (reprint author), Univ Kansas, Dept Chem, 1251 Wescoe Hall Dr,2054 Malott Hall, Lawrence, KS 66045 USA.
EM mmure@ku.edu
CR Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093
   Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695
   Murray JM, 2001, BIOCHEMISTRY-US, V40, P12808, DOI 10.1021/bi011187p
   Klutke J, 2008, ACTA OBSTET GYN SCAN, V87, P111, DOI 10.1080/00016340701819247
   Herranz N, 2012, MOL CELL, V46, P369, DOI 10.1016/j.molcel.2012.03.002
   Mure M, 2005, BIOCHEMISTRY-US, V44, P1568, DOI 10.1021/bi047988k
   Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052
   Borel A, 2001, J BIOL CHEM, V276, P48944, DOI 10.1074/jbc.M109499200
   Asuncion L, 2001, MATRIX BIOL, V20, P487, DOI 10.1016/S0945-053X(01)00161-5
   Boomsma F, 2005, MED SCI MONITOR, V11, pRA122
   Sebban S, 2013, CLIN EXP METASTAS, V30, P103, DOI 10.1007/s10585-012-9514-0
   Jourdan-Le Saux C, 2001, GENOMICS, V74, P211, DOI 10.1006/geno.2001.6545
   Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012
   Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Wilce MCJ, 1997, BIOCHEMISTRY-US, V36, P16116, DOI 10.1021/bi971797i
   Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776
   Gorogh T, 2007, J PATHOL, V212, P74, DOI 10.1002/path.2137
   Kaneda A, 2002, CANCER RES, V62, P6645
   Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170
   Maki JM, 2001, BIOCHEM J, V355, P381, DOI 10.1042/0264-6021:3550381
   Zhao BH, 2012, J OBSTET GYNAECOL RE, V38, P925, DOI 10.1111/j.1447-0756.2011.01814.x
   Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078
   Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998
   Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107
   Klema VJ, 2012, INT J MOL SCI, V13, P5375, DOI 10.3390/ijms13055375
   Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208
   Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432
   Kirschmann DA, 2002, CANCER RES, V62, P4478
   Young AN, 2001, AM J PATHOL, V158, P1639, DOI 10.1016/S0002-9440(10)64120-X
   Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8
   Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297
   Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178
   Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705
   KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898
   Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17
   Mure M, 2005, BIOCHEMISTRY-US, V44, P1583, DOI 10.1021/bi0479860
   Akiri G, 2003, CANCER RES, V63, P1657
   Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985
   Kishishita S, 2003, J AM CHEM SOC, V125, P1041, DOI 10.1021/ja017899k
   Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487
   TANG SS, 1983, J BIOL CHEM, V258, P4331
   Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345
   Panchenko MV, 1996, J BIOL CHEM, V271, P7113
   Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1
   Chiu YC, 2006, BIOCHEMISTRY-US, V45, P4105, DOI 10.1021/bi0524641
   Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200
   Rodriguez C, 2008, DRUG NEWS PERSPECT, V21, P218, DOI 10.1358/dnp.2008.21.4.1213351
   Sano M, 2010, INT J ONCOL, V36, P321, DOI 10.3892/ijo_00000503
   Busnadiego O, 2013, MOL CELL BIOL, V33, P2388, DOI 10.1128/MCB.00036-13
   McGrath AP, 2009, BIOCHEMISTRY-US, V48, P9810, DOI 10.1021/bi9014192
   Helleman J, 2008, CLIN CANCER RES, V14, P5555, DOI 10.1158/1078-0432.CCR-08-0555
   Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b
   MATSUZAKI R, 1994, FEBS LETT, V351, P360, DOI 10.1016/0014-5793(94)00884-1
   Airenne TT, 2005, PROTEIN SCI, V14, P1964, DOI 10.1110/ps.051438105
   Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212
   Jakobsson E, 2005, ACTA CRYSTALLOGR D, V61, P1550, DOI 10.1107/S0907444905028805
   PARSONS MR, 1995, STRUCTURE, V3, P1171, DOI 10.1016/S0969-2126(01)00253-2
   Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202
   Jaakkola K, 2000, AM J PATHOL, V157, P463, DOI 10.1016/S0002-9440(10)64558-0
   CAI DY, 1994, J BIOL CHEM, V269, P32039
   Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781
   Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130
   Sato S, 2011, MOL CELL BIOL, V31, P2683, DOI 10.1128/MCB.01148-10
   Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200
   Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136
   Montel V, 2005, AM J PATHOL, V166, P1565, DOI 10.1016/S0002-9440(10)62372-3
   Alarab M, 2010, INT UROGYNECOL J, V21, P1397, DOI 10.1007/s00192-010-1199-9
   Lugassy J, 2012, J BIOL CHEM, V287, P3541, DOI 10.1074/jbc.M111.261016
   Lee JE, 2006, J BIOL CHEM, V281, P37282, DOI 10.1074/jbc.M600977200
   Jung HJ, 2009, EUR J OBSTET GYN R B, V145, P117, DOI 10.1016/j.ejogrb.2009.03.026
   Kurkijarvi R, 1998, J IMMUNOL, V161, P1549
   Baker AM, 2011, J NATL CANCER I, V103, P407, DOI 10.1093/jnci/djq569
   Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101
   Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156
   BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345
   Chung CH, 2006, CANCER RES, V66, P8210, DOI 10.1158/0008-5472.CAN-06-1213
   Albinger-Hegyi A, 2010, INT J CANCER, V126, P2653, DOI 10.1002/ijc.24948
   Maintz L, 2007, AM J CLIN NUTR, V85, P1185
   Cano A, 2012, FUTURE ONCOL, V8, P1095, DOI [10.2217/fon.12.105, 10.2217/FON.12.105]
   Murray JM, 1999, BIOCHEMISTRY-US, V38, P8217, DOI 10.1021/bi9900469
   Wong CCL, 2012, J MOL MED, V90, P803, DOI 10.1007/s00109-011-0855-y
   Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274
   Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424
   Zhan P, 2012, MED ONCOL, V29, P648, DOI 10.1007/s12032-011-9959-z
   Jalkanen S, 2007, BLOOD, V110, P1864, DOI 10.1182/blood-2007-01-069674
   Kirschmann DA, 1999, BREAST CANCER RES TR, V55, P127
   Kobak W, 2005, J REPROD MED, V50, P827
   Mariadason JM, 2002, CANCER RES, V62, P4791
   Autio Anu, 2013, J Nucl Med, V54, P1315, DOI 10.2967/jnumed.113.120295
   Bais MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031188
   Ban S, 2005, J RADIAT RES, V46, P43, DOI 10.1269/jrr.46.43
   Best CH, 1929, J PHYSIOL-LONDON, V67, P256
   Borczuk AC, 2005, AM J RESP CRIT CARE, V172, P729, DOI 10.1164/rccm.200504-615OC
   Bouez C, 2006, CLIN CANCER RES, V12, P1463, DOI 10.1158/1078-0432.CCR-05-1456
   Bour S, 2007, BIOCHIMIE, V89, P916, DOI 10.1016/j.biochi.2007.02.013
   Brekhman V, 2011, FASEB J, V25, P55, DOI 10.1096/fj.10-162677
   Cai DY, 1997, BIOCHEMISTRY-US, V36, P11472, DOI 10.1021/bi970812g
   Cai DY, 1997, J BIOL CHEM, V272, P19277, DOI 10.1074/jbc.272.31.19277
   Contente S, 2009, BBA-MOL CELL RES, V1793, P1272, DOI 10.1016/j.bbamcr.2009.04.013
   Csiszar K, 2002, INT J CANCER, V97, P636, DOI 10.1002/ijc.10035
   DuBois JL, 2005, ARCH BIOCHEM BIOPHYS, V433, P255, DOI 10.1016/j.abb.2004.08.036
   Elmore BO, 2002, J BIOL INORG CHEM, V7, P565, DOI 10.1007/s00775-001-0331-1
   Elovaara H, 2011, BIOCHEMISTRY-US, V50, P5507, DOI 10.1021/bi200117z
   Ernberg K, 2010, ACTA CRYSTALLOGR F, V66, P1572, DOI 10.1107/S1744309110041515
   Flores I, 2006, FERTIL STERIL, V85, P1676, DOI 10.1016/j.fertnstert.2005.11.076
   Fuchs B, 2000, ANAL BIOCHEM, V286, P91, DOI 10.1006/abio.2000.4792
   GACHERU SN, 1988, J BIOL CHEM, V263, P16704
   Gilad GM, 2005, NEUROSCI LETT, V376, P210, DOI 10.1016/j.neulet.2004.11.054
   Grimsby JL, 2010, J CELL BIOCHEM, V111, P1231, DOI 10.1002/jcb.22845
   HAMALAINEN ER, 1995, J BIOL CHEM, V270, P21590
   Le QT, 2009, J CLIN ONCOL, V27, P4281, DOI 10.1200/JCO.2008.20.6003
   He Jie, 2002, Ai Zheng, V21, P671
   Heniquez A, 2003, INFLAMM RES, V52, pS74, DOI 10.1007/s000110300061
   Heuts DPHM, 2011, J BIOL CHEM, V286, P29584, DOI 10.1074/jbc.M111.232850
   Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308
   Holtmeier C, 2003, ANTICANCER RES, V23, P2585
   Imamura Y, 1997, GENOMICS, V40, P277, DOI 10.1006/geno.1996.4570
   Jakobsson E, 2005, ACTA CRYSTALLOGR F, V61, P274, DOI 10.1107/S1744309105002678
   JALKANEN S, 1993, RES IMMUNOL, V144, P746, DOI 10.1016/0923-2494(93)80060-C
   Jalkanen S, 2001, EMBO J, V20, P3893, DOI 10.1093/emboj/20.15.3893
   Jalkanen S., 1993, RES IMMUNOL, V144, P754
   JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581
   Jourdan-Le Saux C, 1999, J BIOL CHEM, V274, P12939
   KAGAN HM, 1994, PATHOL RES PRACT, V190, P910
   Kaitaniemi S, 2009, CELL MOL LIFE SCI, V66, P2743, DOI 10.1007/s00018-009-0076-5
   Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543
   Kemppainen R, 1996, ARCH BIOCHEM BIOPHYS, V328, P101, DOI 10.1006/abbi.1996.0148
   Khakoo A, 1997, CLIN GENET, V51, P109
   Kim DJ, 2008, BIOCHEM BIOPH RES CO, V373, P521, DOI 10.1016/j.bbrc.2008.06.071
   Kim M, 2002, NAT STRUCT BIOL, V9, P591, DOI 10.1038/nsb824
   Kim Y, 2009, ONCOL REP, V22, P799, DOI 10.3892/or_00000502
   KIM YH, 1995, J BIOL CHEM, V270, P7176
   Kirton CM, 2005, EUR J IMMUNOL, V35, P3119, DOI 10.1002/eji.200535300
   Klinman JP, 2003, BBA-PROTEINS PROTEOM, V1647, P131, DOI 10.1016/S1570-9639(03)00077-3
   Klinman JP, 1996, J BIOL CHEM, V271, P27189
   Klutke J, 2010, INT UROGYNECOL J, V21, P869, DOI 10.1007/s00192-010-1108-2
   KUIVANIEMI H, 1986, FEBS LETT, V195, P261, DOI 10.1016/0014-5793(86)80172-7
   LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P
   Macartney-Coxson DP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-187
   Maintz L, 2008, HUM REPROD UPDATE, V14, P485, DOI 10.1093/humupd/dmn014
   Maki JM, 2001, MATRIX BIOL, V20, P493, DOI 10.1016/S0945-053X(01)00157-3
   Maula SM, 2005, EUR J IMMUNOL, V35, P2718, DOI 10.1002/eji.200526351
   McGrath AP, 2010, ACTA CRYSTALLOGR F, V66, P137, DOI 10.1107/S1744309109052130
   Mercier N, 2007, HYPERTENSION, V50, P234, DOI 10.1161/HYPERTENSIONAHA.107.089292
   Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867
   Moore RH, 2007, J AM CHEM SOC, V129, P11524, DOI 10.1021/ja0731165
   MURE M, 1995, J AM CHEM SOC, V117, P8707, DOI 10.1021/ja00139a003
   Mure M, 2003, J AM CHEM SOC, V125, P6113, DOI 10.1021/ja0214274
   Mure M, 2004, ACCOUNTS CHEM RES, V37, P131, DOI 10.1021/ar9703342
   Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265
   Nakamura N, 1996, J BIOL CHEM, V271, P4718
   Ng MR, 2009, CANCER CELL, V16, P455, DOI 10.1016/j.ccr.2009.11.013
   NOVOTNY WF, 1994, J BIOL CHEM, V269, P9921
   O'Rourke AM, 2008, J PHARMACOL EXP THER, V324, P867, DOI 10.1124/jpet.107.131672
   O'Sullivan J, 2004, NEUROTOXICOLOGY, V25, P303, DOI 10.1016/S0161-813X(03)00117-7
   Patani Neill, 2010, J Carcinog, V9, P9, DOI 10.4103/1477-3163.72505
   Plastino J, 1999, BIOCHEMISTRY-US, V38, P8204, DOI 10.1021/bi9826660
   PRECIOUS E, 1988, BIOCHEM PHARMACOL, V37, P707, DOI 10.1016/0006-2952(88)90145-1
   Rebecchi KR, 2011, ANAL CHEM, V83, P8484, DOI 10.1021/ac2017037
   Salmi M, 1998, J IMMUNOL, V160, P5629
   Sanchez-Morgan N, 2011, MOL CELL BIOL, V31, P3286, DOI 10.1128/MCB.01426-10
   Schwartz B, 1998, BIOCHEMISTRY-US, V37, P16591, DOI 10.1021/bi981541s
   Schwelberger HG, 2007, J NEURAL TRANSM, V114, P757, DOI 10.1007/s00702-007-0684-x
   Scola N, 2010, ANTICANCER RES, V30, P4567
   Sebban S, 2009, VIRCHOWS ARCH, V454, P71, DOI 10.1007/s00428-008-0694-6
   SHAH MA, 1993, J BIOL CHEM, V268, P11573
   Shen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029270
   Sibon I, 2005, HEART, V91, DOI 10.1136/hrt.2004.053074
   SIEGEL RC, 1970, BIOCHIM BIOPHYS ACTA, V222, P552, DOI 10.1016/0304-4165(70)90154-6
   Stassar MJJG, 2001, BRIT J CANCER, V85, P1372, DOI 10.1054/bjoc.2001.2074
   TANG SS, 1989, CONNECT TISSUE RES, V19, P93, DOI 10.3109/03008208909016817
   Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200
   Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554
   TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831
   Tsuchiya MI, 2005, ONCOL REP, V13, P1033
   Uzel MI, 2000, J BONE MINER RES, V15, P1189, DOI 10.1359/jbmr.2000.15.6.1189
   Wilgus ML, 2011, CANCER-AM CANCER SOC, V117, P2186, DOI 10.1002/cncr.25768
   Wu GJ, 2007, CANCER RES, V67, P4123, DOI 10.1158/0008-5472.CAN-07-0012
   Xu HL, 2006, J PHARMACOL EXP THER, V317, P19, DOI 10.1124/jpet.105.096958
   Xu L, 2013, J BIOL CHEM, V288, P5357, DOI 10.1074/jbc.C112.421768
   Yraola F, 2007, CHEMMEDCHEM, V2, P173, DOI 10.1002/cmd.200600245
   Zhou Yang, 2013, J Biomed Res, V27, P23, DOI 10.7555/JBR.27.20110142
NR 184
TC 11
Z9 11
U1 5
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2014
VL 546
BP 19
EP 32
DI 10.1016/j.abb.2013.12.022
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AD4NT
UT WOS:000333228500003
PM 24407025
ER

PT J
AU Orlando, BJ
   McDougle, DR
   Lucido, MJ
   Eng, ET
   Graham, LA
   Schneider, C
   Stokes, DL
   Das, A
   Malkowski, MG
AF Orlando, Benjamin J.
   McDougle, Daniel R.
   Lucido, Michael J.
   Eng, Edward T.
   Graham, Leigh Ann
   Schneider, Claus
   Stokes, David L.
   Das, Aditi
   Malkowski, Michael G.
TI Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscs
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cyclooxygenase; Nanodisc; Arachidonic acid; Nonsteroidal
   anti-inflammatory drugs; Phospholipid; Aspirin
ID PROSTAGLANDIN ENDOPEROXIDE SYNTHASES-1; ARACHIDONIC-ACID;
   SELECTIVE-INHIBITION; MEMBRANE ASSOCIATION; STRUCTURAL BASIS; H
   SYNTHASES-1; ACTIVE-SITE; SUBSTRATE; ASPIRIN; BINDING
AB Cyclooxygenases (COX-1 and COX-2) oxygenate arachidonic acid (AA) to generate prostaglandins. The enzymes associate with one leaflet of the membrane bilayer. We utilized nanodisc technology to investigate the function of human (hu) COX-2 and murine (mu) COX-2 in a lipid bilayer environment. huCOX-2 and muCOX-2 were incorporated into nanodiscs composed of POPC, POPS, DOPC, or DOPS phospholipids. Size-exclusion chromatography and negative stain electron microscopy confirm that a single COX-2 homodimer is incorporated into the nanodisc scaffold. Nanodisc-reconstituted COX-2 exhibited similar kinetic profiles for the oxygenation of AA, eicosapentaenoic acid, and 1-arachidonoyl glycerol compared to those derived using detergent solubilized enzyme. Moreover, changing the phospholipid composition of the nanodisc did not alter the ability of COX-2 to oxygenate AA or to be inhibited by various nonselective NSAIDs or celecoxib. The cyclooxygenase activity of nanodisc-reconstituted COX-2 was reduced by aspirin acetylation and potentiated by the nonsubstrate fatty acid palmitic acid to the same extent as detergent solubilized enzyme, independent of phospholipid composition. The stabilization and maintenance of activity afforded by the incorporation of the enzyme into nanodiscs generates a native-like lipid bilayer environment to pursue studies of COX utilizing solution-based techniques that are otherwise not tractable in the presence of detergents. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Orlando, Benjamin J.; Lucido, Michael J.; Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA.
   [McDougle, Daniel R.; Das, Aditi] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61802 USA.
   [McDougle, Daniel R.; Das, Aditi] Univ Illinois, Dept Biochem, Urbana, IL 61802 USA.
   [McDougle, Daniel R.; Das, Aditi] Univ Illinois, Dept Bioengn, Urbana, IL 61802 USA.
   [McDougle, Daniel R.; Das, Aditi] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61802 USA.
   [Eng, Edward T.; Stokes, David L.] New York Struct Biol Ctr, New York, NY 10027 USA.
   [Graham, Leigh Ann; Schneider, Claus] Vanderbilt Univ, Sch Med, Dept Pharmacol, Div Clin Pharmacol, Nashville, TN 37232 USA.
   [Malkowski, Michael G.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA.
RP Malkowski, MG (reprint author), Hauptman Woodward Med Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.
EM malkowski@hwi.buffalo.edu
FU NIH [R01 GM077176, R01 GM076592, RR017528]; UIUC; KeyBank; Block Grant;
   NYSTAR; Research Board
FX This research was supported by NIH Grant R01 GM077176 to M.G.M., R01
   GM076592 to C.S., and UIUC start-up funds and a Research Board Grant to
   A.D. B.J.O. is supported by graduate fellowships from KeyBank. D.R.M. is
   supported by a Block Grant. Cryo EM data collection at the NYSBC was
   made possible by a grant from NYSTAR and NIH RR017528.
CR Boldog T, 2006, P NATL ACAD SCI USA, V103, P11509, DOI 10.1073/pnas.0604988103
   Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982
   Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003
   Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969
   Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s
   Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z
   McDougle DR, 2013, PROTEIN SCI, V22, P964, DOI 10.1002/pro.2280
   Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166
   Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886
   Gierse JK, 1999, BIOCHEM J, V339, P607, DOI 10.1042/0264-6021:3390607
   Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847
   Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129
   Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106
   Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200
   Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8
   Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984
   Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867
   Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0
   Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026
   Nunes C, 2011, LANGMUIR, V27, P10847, DOI 10.1021/la201600y
   LECOMTE M, 1994, J BIOL CHEM, V269, P13207
   Boggara MB, 2010, BIOPHYS J, V98, P586, DOI 10.1016/j.bpj.2009.10.046
   Denisov I.G., 2004, J AM CHEM SOC, V126, P3477
   DeWitt DL, 1999, MOL PHARMACOL, V55, P625
   Rand Doyen J, 2008, Prostaglandins Other Lipid Mediat, V85, P134, DOI 10.1016/j.prostaglandins.2007.12.001
   Li Y, 1998, J BIOL CHEM, V273, P29830, DOI 10.1074/jbc.273.45.29830
   Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933
   MirAfzali Z, 2005, ARCH BIOCHEM BIOPHYS, V443, P60, DOI 10.1016/j.abb.2005.08.014
   MirAfzali Z, 2006, J BIOL CHEM, V281, P28354, DOI 10.1074/jbc.M605206200
   Nunes C, 2011, J PHYS CHEM B, V115, P8024, DOI 10.1021/jp2025158
   OTTO JC, 1993, J BIOL CHEM, V268, P18234
   Otto JC, 1996, J BIOL CHEM, V271, P9906
   PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0
   Schneider C, 2000, J BIOL CHEM, V275, P4743, DOI 10.1074/jbc.275.7.4743
   Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115
   Smith T, 2000, ARCH BIOCHEM BIOPHYS, V375, P195, DOI 10.1006/abbi.1999.1659
   Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243
   Vecchio AJ, 2011, J STRUCT BIOL, V176, P254, DOI 10.1016/j.jsb.2011.07.019
   Wan SZ, 2009, J COMPUT CHEM, V30, P1038, DOI 10.1002/jcc.21130
   Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200
   Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103
NR 43
TC 4
Z9 4
U1 4
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2014
VL 546
BP 33
EP 40
DI 10.1016/j.abb.2014.01.026
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AD4NT
UT WOS:000333228500004
PM 24503478
ER

PT J
AU Fillat, MF
AF Fillat, Maria F.
TI The FUR (ferric uptake regulator) superfamily: Diversity and versatility
   of key transcriptional regulators
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Ferric uptake regulator superfamily
ID ZINC UPTAKE REGULATOR; SP PCC 7120; ANABAENA-SP PCC-7120;
   MICROCYSTIS-AERUGINOSA PCC7806; SYMBIOTIC BACTERIUM RHIZOBIUM;
   STREPTOMYCES-COELICOLOR A3(2); PATHOGEN HELICOBACTER-PYLORI;
   IRON-RESPONSIVE REGULATOR; UPTAKE REGULATION PROTEIN; BACILLUS-SUBTILIS
   ZUR
AB Control of metal homeostasis is essential for life in all kingdoms. In most prokaryotic organisms the FUR (ferric uptake regulator) family of transcriptional regulators is involved in the regulation of iron and zinc metabolism through control by Fur and Zur proteins. A third member of this family, the peroxide-stress response PerR, is present in most Gram-positives, establishing a tight functional interaction with the global regulator Fur. These proteins play a pivotal role for microbial survival under adverse conditions and in the expression of virulence in most pathogens. In this paper we present the current state of the art in the knowledge of the FUR family, including those members only present in more reduced numbers of bacteria, namely Mur, Nur and Irr. The huge amount of work done in the two last decades shows that FUR proteins present considerable diversity in their regulatory mechanisms and interesting structural differences. However, much work needs to be done to obtain a more complete picture of this family, especially in connection with the roles of some members as gas and redox sensors as well as to fully characterize their participation in bacterial adaptative responses. (C) 2014 Elsevier Inc. All rights reserved.
C1 Univ Zaragoza, Dept Biochem & Mol & Cell Biol, Inst Biocomputat & Phys Complex Syst BIFI, E-50009 Zaragoza, Spain.
RP Fillat, MF (reprint author), Univ Zaragoza, Dept Biochem & Mol & Cell Biol, Inst Biocomputat & Phys Complex Syst BIFI, Pedro Cerbuna 12, E-50009 Zaragoza, Spain.
EM fillat@unizar.es
FU Ibercaja-Universidad de Zaragoza; Obra Social La Caixa; Gobierno de
   Aragon;  [BFU2009-07424];  [BFU2012-31458]
FX Research in our laboratory was supported by grants BFU2009-07424 and
   BFU2012-31458, Ibercaja-Universidad de Zaragoza, Obra Social La Caixa
   and Gobierno de Aragon. M.F. Fillat thanks all the former and present
   members of our research team for all their efforts to gain a better
   understanding of Fur proteins.
CR Ahn BE, 2006, MOL MICROBIOL, V59, P1848, DOI 10.1111/j.1365-2958.2006.05065.x
   Alamuri P, 2006, J BACTERIOL, V188, P5325, DOI 10.1128/JB.00104-06
   An YJ, 2009, NUCLEIC ACIDS RES, V37, P3442, DOI 10.1093/nar/gkp198
   Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101
   Diaz-Mireles E, 2004, MICROBIOL-SGM, V150, P1447, DOI 10.1099/mic.0.26961-0
   Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651
   Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09
   Crawford MJ, 1998, J BIOL CHEM, V273, P34028, DOI 10.1074/jbc.273.51.34028
   Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x
   Todd JD, 2002, MICROBIOL-SGM, V148, P4059
   Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109
   Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002
   Johnston AWB, 2007, BIOMETALS, V20, P501, DOI 10.1007/s10534-007-9085-8
   Danielli A, 2006, J BACTERIOL, V188, P4654, DOI 10.1128/JB.00120-06
   Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3
   Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215
   Lewin AC, 2002, MICROBIOL-SGM, V148, P2449
   Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001
   Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518
   Sevilla E, 2011, MICROBIOL-SGM, V157, P3398, DOI 10.1099/mic.0.048231-0
   Gonzalez A, 2010, PLANT CELL PHYSIOL, V51, P1900, DOI 10.1093/pcp/pcq148
   Althaus EW, 1999, BIOCHEMISTRY-US, V38, P6559, DOI 10.1021/bi982788s
   Singh AK, 2003, PLANT PHYSIOL, V132, P1825, DOI 10.1104/pp.103.024018
   Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004
   Huang DL, 2008, NUCLEIC ACIDS RES, V36, P4295, DOI 10.1093/nar/gkn328
   Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7
   Hall HK, 1996, J BACTERIOL, V178, P5683
   Vecerek B, 2007, EMBO J, V26, P965, DOI 10.1038/sj.emboj.7601553
   BAGG A, 1987, BIOCHEMISTRY-US, V26, P5471, DOI 10.1021/bi00391a039
   Puri S, 2010, P NATL ACAD SCI USA, V107, P10691, DOI 10.1073/pnas.1002342107
   Lee JW, 2006, J BIOL CHEM, V281, P23567, DOI 10.1074/jbc.M603968200
   Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0
   Santander J, 2012, INFECT IMMUN, V80, P2689, DOI 10.1128/IAI.00013-12
   Benoit RM, 2011, RNA BIOL, V8, P18, DOI 10.4161/rna.8.1.13555
   White GF, 2011, FEBS J, V278, P2011, DOI 10.1111/j.1742-4658.2011.08117.x
   Fuangthong M, 2003, J BACTERIOL, V185, P6348, DOI 10.1128/JB.185.21.6348-6357.2003
   Napolitano M, 2012, J BACTERIOL, V194, P2426, DOI 10.1128/JB.00090-12
   Gonzalez A, 2011, J PROTEOMICS, V74, P660, DOI 10.1016/j.jprot.2011.02.001
   Maret W, 2006, ANTIOXID REDOX SIGN, V8, P1419, DOI 10.1089/ars.2006.8.1419
   Hohle TH, 2009, MOL MICROBIOL, V72, P399, DOI 10.1111/j.1365-2958.2009.06650.x
   Feng YJ, 2008, J BACTERIOL, V190, P7567, DOI 10.1128/JB.01532-07
   Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2
   Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e
   Lopez-Gomollon S, 2009, BIOCHEM J, V418, P201, DOI 10.1042/BJ20081066
   Hohle TH, 2010, J BIOL CHEM, V285, P26074, DOI 10.1074/jbc.M110.145979
   Campoy S, 2002, INFECT IMMUN, V70, P4721, DOI 10.1128/IAI.70.8.4721-4725.2002
   Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242
   Deng X, 2012, J BACTERIOL, V194, P1753, DOI 10.1128/JB.06582-11
   Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0
   Lopez-Gomollon S, 2007, J MOL BIOL, V374, P267, DOI 10.1016/j.jmb.2007.09.010
   Zheng M, 1999, J BACTERIOL, V181, P4639
   Bellini P, 2006, BIOCHEMISTRY-US, V45, P2686, DOI 10.1021/bi052081n
   Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x
   Palyada K, 2004, J BACTERIOL, V186, P4714, DOI 10.1128/JB.186.14.4714-4729.2004
   Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x
   Carpenter BM, 2013, J BACTERIOL, V195, P5526, DOI 10.1128/JB.01026-13
   Ernst FD, 2005, J BACTERIOL, V187, P3687, DOI 10.1128/JB.187.11.3687-3692.2005
   Bender KS, 2007, APPL ENVIRON MICROB, V73, P5389, DOI 10.1128/AEM.00276-07
   D'Autreaux B, 2002, P NATL ACAD SCI USA, V99, P16619, DOI 10.1073/pnas.252591299
   Gancz H, 2006, INFECT IMMUN, V74, P602, DOI 10.1128/IAI.74.1.602-614.2006
   Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w
   Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102
   FARR SB, 1991, MICROBIOL REV, V55, P561
   Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599
   Allard KA, 2006, J BACTERIOL, V188, P1351, DOI 10.1128/JB.188.4.1351-1363.2005
   Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x
   Pecqueur L, 2006, J BIOL CHEM, V281, P21286, DOI 10.1074/jbc.M601278200
   Lostao A, 2010, BBA-PROTEINS PROTEOM, V1804, P1723, DOI 10.1016/j.bbapap.2010.04.002
   Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09
   Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301
   Parent A, 2013, ANGEW CHEM INT EDIT, V52, P10339, DOI 10.1002/anie.201304021
   McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200
   Platero R, 2007, APPL ENVIRON MICROB, V73, P4832, DOI 10.1128/AEM.00686-07
   Smith KF, 2009, J BACTERIOL, V191, P1595, DOI 10.1128/JB.01392-08
   Delany I, 2005, J BACTERIOL, V187, P7703, DOI 10.1128/JB.187.22.7703-7715.2005
   Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X
   Ernst FD, 2005, MICROBIOL-SGM, V151, P533, DOI 10.1099/mic.0.27404-0
   Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200
   Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x
   Rudolph G, 2006, FEMS MICROBIOL REV, V30, P631, DOI 10.1111/j.1574-6976.2006.00030.x
   Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105
   Hernandez JA, 2006, BIOMETALS, V19, P259, DOI 10.1007/s10534-005-7750-3
   Delany I, 2001, MOL MICROBIOL, V42, P1297, DOI 10.1046/j.1365-2958.2001.02696.x
   Zhang ZG, 2005, J BACTERIOL, V187, P980, DOI 10.1128/JB.187.3.980-990.2005
   Shin JH, 2011, P NATL ACAD SCI USA, V108, P5045, DOI 10.1073/pnas.1017744108
   Friedman YE, 2003, J BIOL CHEM, V278, P38395, DOI 10.1074/jbc.M306710200
   Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x
   Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100
   Shin JH, 2007, J BACTERIOL, V189, P4070, DOI 10.1128/JB.01851-06
   Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200
   Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x
   Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x
   Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x
   Yang WF, 2007, CURR MICROBIOL, V54, P307, DOI 10.1007/s00284-006-0485-8
   Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100
   Igarashi J, 2011, HANDB PORPHYR SCI, V15, P399
   Delany I, 2006, J BACTERIOL, V188, P2483, DOI 10.1128/JB.188.7.2483-2492.2006
   Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x
   Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002
   Becerra G, 2011, BIOCHEM SOC T, V39, P1854, DOI 10.1042/BST20110706
   Bijlsma JJE, 2002, INFECT IMMUN, V70, P606, DOI 10.1128/IAI.70.2.606-611.2002
   Boer J.L., 2013, ARCH BIOCH BIOPHYS
   Botello-Morte L, 2013, ADV BOT RES, V65, P107, DOI 10.1016/B978-0-12-394313-2.00004-4
   Botello-Morte L., 2014, ANTIOXID RE IN PRESS
   Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x
   Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188
   Craig SA, 2011, J BACTERIOL, V193, P6505, DOI 10.1128/JB.05681-11
   Crossley RA, 2007, APPL ENVIRON MICROB, V73, P7819, DOI 10.1128/AEM.01919-07
   D'Autreaux B, 2007, BIOCHEMISTRY-US, V46, P1329, DOI 10.1021/bi061636r
   Delany I, 2003, MOL MICROBIOL, V50, P1329, DOI 10.1046/j.1365-2958.2003.03757.x
   DELORENZO V, 1988, J MOL BIOL, V203, P875, DOI 10.1016/0022-2836(88)90113-1
   Diaz-Mireles E, 2005, MICROBIOL-SGM, V151, P4071, DOI 10.1099/mic.0.28342-0
   Dowd GC, 2012, FEMS MICROBIOL LETT, V327, P118, DOI 10.1111/j.1574-6968.2011.02472.x
   Ducey TF, 2009, MICROB PATHOGENESIS, V46, P166, DOI 10.1016/j.micpath.2008.12.003
   Earhart CF, 1996, ESCHERICHIA COLI SAL, P1075
   Ebanks RO, 2013, VET MICROBIOL, V162, P831, DOI 10.1016/j.vetmic.2012.10.038
   Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119
   Gaballa A, 1998, J BACTERIOL, V180, P5815
   Gaballa A, 2002, J BACTERIOL, V184, P6508, DOI 10.1128/JB.184.23.6508-6514.2002
   Gabriel SE, 2008, J BACTERIOL, V190, P3482, DOI 10.1128/JB.01978-07
   Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07
   Gilbreath JJ, 2012, J BACTERIOL, V194, P6490, DOI 10.1128/JB.01226-12
   Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x
   Gonzalez A, 2013, FEBS LETT, V587, P2682, DOI 10.1016/j.febslet.2013.07.007
   Gonzalez A, 2012, ENVIRON MICROBIOL, V14, P3175, DOI 10.1111/j.1462-2920.2012.02897.x
   Graham AI, 2012, MICROBIOL-SGM, V158, P284, DOI 10.1099/mic.0.053843-0
   Hahn JS, 2000, J BACTERIOL, V182, P3767, DOI 10.1128/JB.182.13.3767-3774.2000
   HASSAN HM, 1992, P NATL ACAD SCI USA, V89, P3217, DOI 10.1073/pnas.89.8.3217
   Hernandez JA, 2006, J MOL BIOL, V355, P325, DOI 10.1016/j.jmb.2005.10.079
   Hernandez JA, 2004, FEMS MICROBIOL LETT, V236, P275, DOI 10.1016/j.femsle.2004.05.050
   Hernandez JA, 2002, BIOCHEM J, V366, P315
   Hernandez JA, 2010, J PLANT PHYSIOL, V167, P430, DOI 10.1016/j.jplph.2009.10.009
   Hernandez JA, 2004, FEBS LETT, V577, P35, DOI 10.1016/j.febslet.2004.09.060
   Isabella V, 2008, MICROBIOL-SGM, V154, P226, DOI 10.1099/mic.0.2007/010470-0
   Jung YS, 2008, CURR MICROBIOL, V57, P593, DOI 10.1007/s00284-008-9248-z
   Katigbak J, 2012, J PHYS CHEM LETT, V3, P3503, DOI 10.1021/jz301689b
   Kim IH, 2013, INFECT IMMUN, V81, P2888, DOI 10.1128/IAI.00375-13
   Kim JS, 2006, J BACTERIOL, V188, P8586, DOI 10.1128/JB.01084-06
   Kim M, 2011, J BACTERIOL, V193, P6171, DOI 10.1128/JB.05493-11
   Latifi A, 2005, J BACTERIOL, V187, P6596, DOI 10.1128/JB.187.18.6596-6598.2005
   Lavrrar JL, 2003, J BACTERIOL, V185, P2194, DOI 10.1128/JB.185.7.2194-2202.2003
   Ledala N, 2007, MICROBIOL-SGM, V153, P1103, DOI 10.1099/mic.0.2006/000620-0
   Ledala N, 2010, APPL ENVIRON MICROB, V76, P406, DOI 10.1128/AEM.01389-09
   Lee HJ, 2003, J BACTERIOL, V185, P5891, DOI 10.1128/JB.185.19.591-5896.2003
   Lee HJ, 2007, J BACTERIOL, V189, P2629, DOI 10.1128/JB.01791-06
   Lelong C, 2007, MOL CELL PROTEOMICS, V6, P660, DOI 10.1074/mcp.M600192-MCP200
   Li YL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-128
   Lindsay JA, 2001, MICROBIOL-SGM, V147, P1259
   LITWIN CM, 1992, J BACTERIOL, V174, P1897
   Lo M, 2010, INFECT IMMUN, V78, P4850, DOI 10.1128/IAI.00435-10
   Lopez-Gomollon S, 2007, MICROBIOL-SGM, V153, P42, DOI 10.1099/mic.0.2006/000091-0
   Loprasert S, 2000, GENE, V254, P129, DOI 10.1016/S0378-1119(00)00279-1
   Louvel H, 2009, FEMS MICROBIOL LETT, V295, P117, DOI 10.1111/j.1574-6968.2009.01594.x
   Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200
   Ma Z, 2011, NUCLEIC ACIDS RES, V39, P9130, DOI 10.1093/nar/gkr625
   Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06
   Makthal N, 2013, J BIOL CHEM, V288, P18311, DOI 10.1074/jbc.M113.456590
   Martin-Luna B, 2006, FEMS MICROBIOL LETT, V254, P63, DOI 10.1111/j.1574-6968.2005.00015.x
   Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06
   Metruccio MME, 2009, J BACTERIOL, V191, P1330, DOI 10.1128/JB.00849-08
   Mey AR, 2005, INFECT IMMUN, V73, P8167, DOI 10.1128/IAI.73.12.8167-8178.2005
   Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004
   Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x
   Nandal A, 2010, MOL MICROBIOL, V75, P637, DOI 10.1111/j.1365-2958.2009.06977.x
   OCHSNER UA, 1995, J BACTERIOL, V177, P7194
   Oglesby-Sherrouse AG, 2013, METALLOMICS, V5, P276, DOI 10.1039/c3mt20224k
   Ortiz de Orué Lucana D, 2000, Mol Gen Genet, V264, P341
   Owen GA, 2007, J BACTERIOL, V189, P4078, DOI 10.1128/JB.01901-06
   Patzer SI, 2001, J BACTERIOL, V183, P4806, DOI 10.1128/JB.183.16.4806-4813.2001
   Pawlik MC, 2012, J BACTERIOL, V194, P6594, DOI 10.1128/JB.01091-12
   Pellicer S, 2012, FEBS J, V279, P2231, DOI 10.1111/j.1742-4658.2012.08606.x
   Pich OQ, 2012, MOL MICROBIOL, V84, P921, DOI 10.1111/j.1365-2958.2012.08066.x
   Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005
   Rea RB, 2004, INFECT IMMUN, V72, P717, DOI 10.1128/IAI.72.2.717-727.2004
   Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x
   Schroder J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-12
   Sebastian S, 2002, J BACTERIOL, V184, P3965, DOI 10.1128/JB.184.14.3965-3974.2002
   Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x
   Smith A, 1996, J PROTEIN CHEM, V15, P575, DOI 10.1007/BF01908539
   Spiro S, 2012, ANTIOXID REDOX SIGN, V17, P1264, DOI 10.1089/ars.2012.4533
   Sridhar J, 2013, GENE, V516, P335, DOI 10.1016/j.gene.2012.12.057
   Sun K, 2008, J MICROBIOL, V46, P670, DOI 10.1007/s12275-008-0113-3
   Tang DJ, 2005, MOL PLANT MICROBE IN, V18, P652, DOI 10.1094/MPMI-18-0652
   Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711
   Teixido L, 2010, INT MICROBIOL, V13, P33, DOI 10.2436/20.1501.01.109
   Thompson DK, 2002, APPL ENVIRON MICROB, V68, P881, DOI 10.1128/AEM.68.2.881-892.2002
   Troxell B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00059
   van Vliet AHM, 2000, FEMS MICROBIOL LETT, V188, P115, DOI 10.1016/S0378-1097(00)00222-6
   Wang HR, 2009, VACCINE, V27, P4047, DOI 10.1016/j.vaccine.2009.04.023
   Wang SN, 2011, J BACTERIOL, V193, P563, DOI 10.1128/JB.01062-10
   Yang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075588
   Yu CX, 2012, J BACTERIOL, V194, P6372, DOI 10.1128/JB.00262-12
   Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x
   Zheleznova EE, 2000, J BACTERIOL, V182, P6264, DOI 10.1128/JB.182.21.6264-6267.2000
   Zhu YX, 2013, J BACTERIOL, V195, P2400, DOI 10.1128/JB.02280-12
NR 195
TC 22
Z9 23
U1 10
U2 40
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2014
VL 546
BP 41
EP 52
DI 10.1016/j.abb.2014.01.029
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AD4NT
UT WOS:000333228500005
PM 24513162
ER

PT J
AU Frese, M
   Schatschneider, S
   Voss, J
   Vorholter, FJ
   Niehaus, K
AF Frese, Marcel
   Schatschneider, Sarah
   Voss, Julia
   Vorhoelter, Frank-Joerg
   Niehaus, Karsten
TI Characterization of the pyrophosphate-dependent 6-phosphofructokinase
   from Xanthomonas campestris pv. campestris
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Glucose metabolism; Glycolysis; Embden-Meyerhof-Parnas pathway;
   Pyrophosphate-dependent; phosphofructokinase; Two-substrate enzyme
   kinetics
ID ACTINOMYCETE AMYCOLATOPSIS-METHANOLICA; PROTEIN FAMILIES DATABASE;
   COMPLETE GENOME SEQUENCE; XANTHAN GUM; PHYTOPATHOGENIC BACTERIA;
   ENTAMOEBA-HISTOLYTICA; BORRELIA-BURGDORFERI; GLUCOSE-METABOLISM;
   ESCHERICHIA-COLI; UDP-GLUCOSE
AB Xanthomonads are plant pathogenic proteobacteria that produce the polysaccharide xanthan. They are assumed to catabolize glucose mainly via the Entner-Doudoroff pathway. Whereas previous studies have demonstrated no phosphofructokinase (PFK) activity in xanthomonads, detailed genome analysis revealed in Xanthomonas campestris pathovar campestris (Xcc) genes for all Embden-Meyerhof-Parnas pathway (glycolysis) enzymes, including a conserved pfkA gene similar to 6-phosphofructokinase genes. To address this discrepancy between genetic and physiological properties, the pfkA gene of Xcc strain B100 was cloned into the expression vector pET28a+. The 45-kDa pfkA gene product exhibited no conventional PFK activity. Bioinformatic analysis of the Xcc PfkA amino acid sequence suggested utilization of pyrophosphate as an alternative cosubstrate. Pyrophosphate-dependent PFK activity was shown in an in vitro enzyme assay for purified Xcc PfkA, as well as in the Xcc B100 crude protein extract. Kinetic constants were determined for the forward and reverse reactions. Primary structure conservation indicates the global presence of similar enzymes among Xanthomonadaceae. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Frese, Marcel; Schatschneider, Sarah; Voss, Julia; Vorhoelter, Frank-Joerg; Niehaus, Karsten] Univ Bielefeld, Fak Biol, Abt Proteom & Metabolomforsch, D-33615 Bielefeld, Germany.
RP Niehaus, K (reprint author), Univ Bielefeld, Fak Biol, Abt Proteom & Metabolomforsch, POB 100 131, D-33501 Bielefeld, Germany.
EM kniehaus@CeBiTec.Uni-Bielefeld.DE
FU GenoMik-Plus program of the German federal Ministry of Education and
   Research (BMBF); NRW Ministry for Innovation, Science and Research for
   the CLIB-Graduate Cluster Industrial Biotechnology; German National
   Academic Foundation (Studienstiftung des Deutschen Volkes); Hans Bockler
   Foundation scholarship
FX This work benefited from a grant of the GenoMik-Plus program of the
   German federal Ministry of Education and Research (BMBF) and from
   support of the NRW Ministry for Innovation, Science and Research for the
   CLIB-Graduate Cluster Industrial Biotechnology. Marcel Frese was
   supported by a scholarship of the German National Academic Foundation
   (Studienstiftung des Deutschen Volkes), while Sarah Schatschneider
   received a Hans Bockler Foundation scholarship.
CR Aldon D, 2000, EMBO J, V19, P2304, DOI 10.1093/emboj/19.10.2304
   ALVES AMCR, 1994, J BACTERIOL, V176, P6827
   Alves AMCR, 2001, J BACTERIOL, V183, P7231, DOI 10.1128/JB.183.24.7231-7240.2001
   Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847
   Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005
   Siebers B, 1998, J BACTERIOL, V180, P2137
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   CARNAL NW, 1983, PLANT PHYSIOL, V71, P150, DOI 10.1104/pp.71.1.150
   Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616
   Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948
   OBRIEN WE, 1975, J BIOL CHEM, V250, P8690
   Rademaker JLW, 2005, PHYTOPATHOLOGY, V95, P1098, DOI 10.1094/PHYTO-95-1098
   RAHME LG, 1992, J BACTERIOL, V174, P3499
   Serrano A, 2007, IUBMB LIFE, V59, P76, DOI 10.1080/15216540701258132
   Parkinson N, 2009, INT J SYST EVOL MICR, V59, P264, DOI 10.1099/ijs.0.65825-0
   Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705
   Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558
   Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115
   MERTENS E, 1993, PARASITOL TODAY, V9, P122, DOI 10.1016/0169-4758(93)90169-G
   Deng ZH, 1999, ARCH BIOCHEM BIOPHYS, V371, P326, DOI 10.1006/abbi.1999.1446
   Bapteste E, 2003, GENE, V318, P185, DOI 10.1016/S0378-1119(03)00797-2
   da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a
   Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206
   Mertens E, 1998, J MOL EVOL, V47, P739, DOI 10.1007/PL00006433
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Frias JA, 2011, J BIOL CHEM, V286, P10930, DOI 10.1074/jbc.M110.216127
   Chi A, 2000, J BIOL CHEM, V275, P35677, DOI 10.1074/jbc.C000581200
   Becker A, 1998, APPL MICROBIOL BIOT, V50, P145, DOI 10.1007/s002530051269
   MERTENS E, 1991, FEBS LETT, V285, P1, DOI 10.1016/0014-5793(91)80711-B
   KOPLIN R, 1992, J BACTERIOL, V174, P191
   Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985
   Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154
   REEVES RE, 1974, J BIOL CHEM, V249, P7737
   Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x
   Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11
   Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189
   Garcia-Ochoa F, 2000, BIOTECHNOL ADV, V18, P549, DOI 10.1016/S0734-9750(00)00050-1
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   Attwood T.K., 2012, DATABASE J BIOL DATA
   Baltscheffsky M, 1999, FEBS Lett, V457, P527, DOI 10.1016/S0014-5793(99)90617-8
   Blanch M, 2008, MICROBIOL RES, V163, P362, DOI 10.1016/j.micres.2006.07.011
   Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224
   Brito B, 2002, MOL PLANT MICROBE IN, V15, P109, DOI 10.1094/MPMI.2002.15.2.109
   Claustre S, 2002, BIOCHEMISTRY-US, V41, P10183, DOI 10.1021/bi020082z
   Cleland W W, 1979, Methods Enzymol, V63, P103
   CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P188
   DECRECYLAGARD V, 1991, J BIOL CHEM, V266, P18154
   Deng ZH, 1998, BIOCHEM J, V329, P659
   DOW JM, 1989, J CELL SCI, P59
   Eltayeb M.M., 2013, BIOTECHNOL LETT, P1
   FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z
   Garrity GM, 2005, BERGEYS MANUAL SYSTE
   Guo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031855
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   KATZNELSON H, 1955, J BACTERIOL, V70, P469
   KATZNELSON H, 1958, J BACTERIOL, V75, P540
   Kim SY, 2010, BIOTECHNOL LETT, V32, P527, DOI 10.1007/s10529-009-0193-0
   KRUGER NJ, 1987, ARCH BIOCHEM BIOPHYS, V256, P273, DOI 10.1016/0003-9861(87)90446-2
   Letisse F, 2002, J BIOTECHNOL, V99, P307, DOI 10.1016/S0168-1656(02)00221-3
   LI ZJ, 1995, PROTEIN EXPRES PURIF, V6, P319, DOI 10.1006/prep.1995.1042
   Lu GT, 2009, MICROBIOL-SGM, V155, P1602, DOI 10.1099/mic.0.023762-0
   Mertens F., 1990, MOL BIOCHEM PARASIT, V40, P147
   MIYATAKE K, 1984, AGR BIOL CHEM TOKYO, V48, P2857
   Moore SA, 2002, STRUCTURE, V10, P659, DOI 10.1016/S0969-2126(02)00760-8
   Musa YR, 2013, J BIOTECHNOL, V167, P111, DOI 10.1016/j.jbiotec.2013.06.009
   Ochiai H, 2005, JARQ-JPN AGR RES Q, V39, P275
   PIELKEN P, 1988, CAN J MICROBIOL, V34, P1333
   Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065
   Saavedra E, 2005, FEBS J, V272, P1767, DOI 10.1111/j.1742-4658.2005.04610.x
   Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schatschneider S, 2013, J BIOTECHNOL, V167, P123, DOI 10.1016/j.jbiotec.2013.01.023
   SCHULTE R, 1992, J BACTERIOL, V174, P815
   Serrania J, 2008, J BIOTECHNOL, V135, P309, DOI 10.1016/j.jbiotec.2008.04.011
   SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3
   SHU CH, 1990, BIOTECHNOL BIOENG, V35, P454, DOI 10.1002/bit.260350503
   Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87
   Sutherland I.W., 1977, EXTRACELLULAR MICROB, P40
   Swings J.G., 1993, XANTHOMONAS
   Talker-Huiber D, 2003, APPL MICROBIOL BIOT, V61, P479, DOI 10.1007/s00253-003-1227-5
   Tang DJ, 2005, J BACTERIOL, V187, P6231, DOI 10.1128/JB.187.17.6231-6237.2005
   Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068
   Tung SY, 1999, APPL ENVIRON MICROB, V65, P5564
   Vorhoelter FJ, 2008, J BIOTECHNOL, V134, P33, DOI 10.1016/j.jbiotec.2007.12.013
   Watt SA, 2005, PROTEOMICS, V5, P153, DOI 10.1002/pmic.200400905
   Watt TF, 2009, J BIOTECHNOL, V140, P59, DOI 10.1016/j.jbiotec.2008.12.003
   WHITFIELD C, 1982, J GEN MICROBIOL, V128, P981
   XU J, 1994, J BIOL CHEM, V269, P15553
   ZAGALLO AC, 1967, J BACTERIOL, V93, P970
NR 89
TC 1
Z9 1
U1 5
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2014
VL 546
BP 53
EP 63
DI 10.1016/j.abb.2014.01.023
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AD4NT
UT WOS:000333228500006
PM 24508689
ER

PT J
AU Shisler, KA
   Broderick, JB
AF Shisler, Krista A.
   Broderick, Joan B.
TI Glycyl radical activating enzymes: Structure, mechanism, and substrate
   interactions
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Radical S-adenosylmethionine (SAM) enzyme; Glycyl radical enzyme
   activating enzyme (GRE-AE); Glycyl radical enzyme (GRE); Pyruvate
   formate lyase activating enzyme (PFL-AE)
ID PYRUVATE FORMATE-LYASE; ANAEROBIC RIBONUCLEOTIDE REDUCTASE;
   P-HYDROXYPHENYLACETATE DECARBOXYLASE; UNIQUE IRON SITE; X-RAY-STRUCTURE;
   SP STRAIN-T; S-ADENOSYLMETHIONINE; ESCHERICHIA-COLI; BENZYLSUCCINATE
   SYNTHASE; CRYSTAL-STRUCTURE
AB The glycyl radical enzyme activating enzymes (GRE-AEs) are a group of enzymes that belong to the radical S-adenosylmethionine (SAM) superfamily and utilize a [4Fe-4S] cluster and SAM to catalyze H-atom abstraction from their substrate proteins. GRE-AEs activate homodimeric proteins known as glycyl radical enzymes (GREs) through the production of a glycyl radical. After activation, these GREs catalyze diverse reactions through the production of their own substrate radicals. The GRE-AE pyruvate formate lyase activating enzyme (PFL-AE) is extensively characterized and has provided insights into the active site structure of radical SAM enzymes including GRE-AEs, illustrating the nature of the interactions with their corresponding substrate GREs and external electron donors. This review will highlight research on PFL-AE and will also discuss a few GREs and their respective activating enzymes. (C) 2014 Published by Elsevier Inc.
C1 [Broderick, Joan B.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.
   Montana State Univ, Astrobiol Biogeocatalysis Res Ctr, Bozeman, MT 59717 USA.
RP Broderick, JB (reprint author), Montana State Univ, Dept Chem & Biochem, 103 CBB, Bozeman, MT 59717 USA.
EM jbroderick@chemistry.montana.edu
FU National Institutes of Health [GM54608]
FX Research on radical SAM activating enzymes in the Broderick laboratory
   is supported by the National Institutes of Health (GM54608).
CR Andrei PI, 2004, EUR J BIOCHEM, V271, P2225, DOI 10.1111/j.1432-1033.2004.04152.x
   Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103
   Becker A, 1999, NAT STRUCT BIOL, V6, P969
   Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102
   Leuthner B, 1998, MOL MICROBIOL, V28, P615, DOI 10.1046/j.1365-2958.1998.00826.x
   Shisler KA, 2012, CURR OPIN STRUC BIOL, V22, P701, DOI 10.1016/j.sbi.2012.10.005
   Arragain S, 2010, J BIOL CHEM, V285, P5792, DOI 10.1074/jbc.M109.065516
   Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200
   Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71
   Li L, 2009, BIOCHEMISTRY-US, V48, P1284, DOI 10.1021/bi801766g
   Luttringer F, 2009, J BIOL INORG CHEM, V14, P923, DOI 10.1007/s00775-009-0505-9
   Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007
   Feliks M, 2012, J PHYS CHEM B, V116, P7076, DOI 10.1021/jp301165b
   Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598
   Goto-Ito S, 2007, ACTA CRYSTALLOGR D, V63, P1059, DOI 10.1107/S0907444907040668
   Wang SC, 2007, BIOCHEMISTRY-US, V46, P12889, DOI 10.1021/bi701745h
   Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505
   Martins BM, 2011, J AM CHEM SOC, V133, P14666, DOI 10.1021/ja203344x
   Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493
   Dey A, 2011, J AM CHEM SOC, V133, P18656, DOI 10.1021/ja203780t
   Becker A, 2002, J BIOL CHEM, V277, P40036, DOI 10.1074/jbc.M205821200
   Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105
   Fugate CJ, 2012, BBA-PROTEINS PROTEOM, V1824, P1213, DOI 10.1016/j.bbapap.2012.01.010
   Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121
   Benjdia A, 2012, NUCLEIC ACIDS RES, V40, P9308, DOI 10.1093/nar/gks603
   Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186
   Feliks M, 2013, J AM CHEM SOC, V135, P14574, DOI 10.1021/ja402379q
   Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x
   Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/nchembio.1091, 10.1038/NCHEMBIO.1091]
   Taylor AM, 2011, BIOCHEMISTRY-US, V50, P7953, DOI 10.1021/bi201042r
   Raynaud C, 2003, P NATL ACAD SCI USA, V100, P5010, DOI 10.1073/pnas.0734105100
   O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k
   FREY M, 1994, J BIOL CHEM, V269, P12432
   Broderick JB, 2010, NATURE, V465, P877, DOI 10.1038/465877a
   Krebs C, 2002, J AM CHEM SOC, V124, P912, DOI 10.1021/ja017562i
   Selmer T, 2005, BIOL CHEM, V386, P981, DOI 10.1515/BC.2005.114
   Hinckley GT, 2006, BIOCHEMISTRY-US, V45, P3219, DOI 10.1021/bi0519497
   Lanz ND, 2012, BBA-PROTEINS PROTEOM, V1824, P1196, DOI 10.1016/j.bbapap.2012.07.009
   Yang J, 2009, BIOCHEMISTRY-US, V48, P9234, DOI 10.1021/bi9010286
   Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358
   Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499
   Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616
   Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138
   Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109
   Thibodeaux CJ, 2012, P NATL ACAD SCI USA, V109, P21184, DOI 10.1073/pnas.1219534110
   Anton BP, 2010, NUCLEIC ACIDS RES, V38, P6195, DOI 10.1093/nar/gkq364
   Beller HR, 1999, FEMS MICROBIOL LETT, V178, P147, DOI 10.1111/j.1574-6968.1999.tb13771.x
   Benjdia A, 2010, FEBS J, V277, P1906, DOI 10.1111/j.1742-4658.2010.07613.x
   Bharadwaj VS, 2013, J AM CHEM SOC, V135, P12279, DOI 10.1021/ja404842r
   BIANCHI V, 1993, BIOCHEM BIOPH RES CO, V197, P792, DOI 10.1006/bbrc.1993.2548
   BLASCHKOWSKI HP, 1982, EUR J BIOCHEM, V123, P563
   Broderick JB, 1997, J AM CHEM SOC, V119, P7396, DOI 10.1021/ja9711425
   Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313
   Cho KB, 2001, J PHYS CHEM B, V105, P6445, DOI 10.1021/jp0107614
   Crain AV, 2013, BBA-PROTEINS PROTEOM, V1834, P2512, DOI 10.1016/j.bbapap.2013.08.014
   Demick JM, 2011, BIOCHEMISTRY-US, V50, P440, DOI 10.1021/bi101255e
   Eklund H, 1999, STRUCT FOLD DES, V7, pR257, DOI 10.1016/S0969-2126(00)80019-2
   Fontecave M, 2002, PROG NUCLEIC ACID RE, V72, P95, DOI 10.1016/S0079-6603(02)72068-0
   Grove TL, 2010, BIOCHEMISTRY-US, V49, P3783, DOI 10.1021/bi9022126
   Heider J, 2007, CURR OPIN CHEM BIOL, V11, P188, DOI 10.1016/j.cbpa.2007.02.027
   Hilberg M, 2012, J BIOL INORG CHEM, V17, P49, DOI 10.1007/s00775-011-0828-1
   IFUKU O, 1994, EUR J BIOCHEM, V224, P173, DOI 10.1111/j.1432-1033.1994.tb20009.x
   Kampmeier JA, 2010, BIOCHEMISTRY-US, V49, P10770, DOI 10.1021/bi101509u
   KNAPPE J, 1984, P NATL ACAD SCI-BIOL, V81, P1332, DOI 10.1073/pnas.81.5.1332
   KNAPPE J, 1976, BIOCHEM BIOPH RES CO, V71, P1110, DOI 10.1016/0006-291X(76)90768-3
   KNAPPE J, 1993, BIOCHEM SOC T, V21, P731
   Krebs C, 2000, J AM CHEM SOC, V122, P12497, DOI 10.1021/ja003335p
   Krieger CJ, 2001, J BIOL CHEM, V276, P12924, DOI 10.1074/jbc.M009453200
   Larsson KM, 2001, STRUCTURE, V9, P739, DOI 10.1016/S0969-2126(01)00627-X
   Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w
   Lees NS, 2009, J AM CHEM SOC, V131, P9184, DOI 10.1021/ja903978u
   Logan DT, 2003, P NATL ACAD SCI USA, V100, P3826, DOI 10.1073/pnas.0736456100
   McGlynn SE, 2010, J BACTERIOL, V192, P595, DOI 10.1128/JB.01125-09
   Nnyepi MR, 2007, ARCH BIOCHEM BIOPHYS, V459, P1, DOI 10.1016/j.abb.2006.12.024
   Ollagnier S, 1996, J BIOL CHEM, V271, P9410
   PARAST CV, 1995, BIOCHEMISTRY-US, V34, P2393, DOI 10.1021/bi00008a001
   Peng Y, 2010, J BIOL CHEM, V285, P27224, DOI 10.1074/jbc.M109.096875
   Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200
   Plaga W, 2000, FEBS LETT, V466, P45, DOI 10.1016/S0014-5793(99)01752-4
   PLAGA W, 1988, EUR J BIOCHEM, V178, P445, DOI 10.1111/j.1432-1033.1988.tb14468.x
   Selvaraj B., 2013, J BIO INORG CHEM, P1
   Stubbe J, 2001, TRENDS BIOCHEM SCI, V26, P93, DOI 10.1016/S0968-0004(00)01764-3
   Walsby CJ, 2005, INORG CHEM, V44, P727, DOI 10.1021/ic0484811
   Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v
   Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s
   Walters EM, 2005, J AM CHEM SOC, V127, P9612, DOI 10.1021/ja051909q
   Yu L, 2006, BIOCHEMISTRY-US, V45, P9584, DOI 10.1021/bi060840b
NR 87
TC 11
Z9 11
U1 6
U2 32
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2014
VL 546
BP 64
EP 71
DI 10.1016/j.abb.2014.01.020
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AD4NT
UT WOS:000333228500007
PM 24486374
ER

PT J
AU Krajewski, WA
AF Krajewski, Wladyslaw A.
TI Yeast Isw1a and Isw1b exhibit similar nucleosome mobilization capacities
   for mononucleosomes, but differently mobilize dinucleosome templates
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Chromatin; Histones; Nucleosomes; Chromatin remodeling; Transcription;
   Gene activity
ID CHROMATIN REMODELING COMPLEXES; RNA-POLYMERASE-II;
   SACCHAROMYCES-CEREVISIAE; EXTRANUCLEOSOMAL DNA; ANGSTROM RESOLUTION;
   CORE PARTICLE; HISTONE; TRANSCRIPTION; ORGANIZATION; ELONGATION
AB Nucleosome remodeling studies in vitro have primarily focused on the use of mononucleosome templates, which, however, can provide only limited information on how nucleosome mobilization occurs in the context of chromatin, in which internucleosome interactions might influence remodeling. We tried to evaluate whether nucleosome mobilization by yeast Isw1a, Isw1b and Isw2 could be affected by neighboring nucleosomes. We compared mono-and dinucleosomes positioned by the '601' sequence, the studied constructs contain variation in linker length between nucleosomes and variation in the length of flanking sequences. The data characterizing the remodeling were based on gel retardation of the mono and dinucleosomes, keeping in mind the observation that the relative position of the nucleosome will change the mobility of the complex in well defined ways. We found that Isw1a, Isw1b and Isw2 process nucleosomes differently whether they exist as mononucleosomes or dinucleosomes, such as, the Isw1a and Isw1b nucleosome repositioning patterns, which were very similar for mononucleosomes, appeared to be profoundly different in case of dinucleosome templates. We also examined the DNase I protection patterns of remodeled mono-and dinucleosomes. The data suggest that nucleosome mobilizing activity of Isw1a, Isw1b and Isw2 complexes could be significantly influenced by neighboring nucleosomes. (C) 2014 Elsevier Inc. All rights reserved.
C1 Russian Acad Sci, Inst Dev Biol, Moscow 119334, Russia.
RP Krajewski, WA (reprint author), Russian Acad Sci, Inst Dev Biol, Ul Vavilova 26, Moscow 119334, Russia.
EM wkrajewski@hotmail.com
FU Russian Foundation for Basic Research [11-04-00527/14-04-00718]
FX This work was in part supported by the Russian Foundation for Basic
   Research, Grants 11-04-00527/14-04-00718. We are very grateful to Dr.
   Oleg Vassiliev (Shemyakin Institute of Bioorganic Chemistry RAS, Moscow)
   for the help with the preparation of this manuscript.
CR Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32
   Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015
   Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8
   Hota SK, 2011, BBA-GENE REGUL MECH, V1809, P476, DOI 10.1016/j.bbagrm.2011.05.007
   Owen-Hughes T, 1999, METH MOL B, V119, P319
   WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0
   Krajewski WA, 2013, BIOCHEMISTRY-US, V52, P6940, DOI 10.1021/bi400634r
   Clark DJ, 2010, J BIOMOL STRUCT DYN, V27, P781
   Arya G, 2010, J BIOMOL STRUCT DYN, V27, P803
   MEERSSEMAN G, 1992, EMBO J, V11, P2951
   Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947
   Mellor J, 2004, BBA-GENE STRUCT EXPR, V1677, P100, DOI 10.1016/j.bbaexp.2003.10.014
   Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012
   Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223
   Luger K, 1997, NATURE, V389, P251
   Lorch Y, 2001, MOL CELL, V7, P89, DOI 10.1016/S1097-2765(01)00157-5
   Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032
   Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003
   Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8
   Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071
   BLANK TA, 1995, J MOL BIOL, V252, P305, DOI 10.1006/jmbi.1995.0498
   Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312
   PENNINGS S, 1991, J MOL BIOL, V220, P101, DOI 10.1016/0022-2836(91)90384-I
   Zheng CY, 2003, BIOPOLYMERS, V68, P539, DOI 10.1002/bip.10303
   Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018
   Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06
   Gangaraju VK, 2007, MOL CELL BIOL, V27, P3217, DOI 10.1128/MCB.01731-06
   Krajewski WA, 2010, BIOCHEMISTRY-US, V49, P6531, DOI 10.1021/bi1006157
   Krajewski WA, 2014, J BIOMOL STRUCT DYN, V32, P523, DOI 10.1080/07391102.2013.782823
   Lafon A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002994
   Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200
   Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686
   Ulyanova NP, 2005, MOL CELL BIOL, V25, P11156, DOI 10.1128/MCB.25.24.11156-11170.2005
   Xella B, 2006, MOL MICROBIOL, V59, P1531, DOI 10.1111/j.1365-2958.05031.x
   Zofall M, 2004, MOL CELL BIOL, V24, P10047, DOI 10.1128/MCB.24.22.10047-10057.2004
NR 35
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 15
PY 2014
VL 546
BP 72
EP 80
DI 10.1016/j.abb.2014.02.003
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AD4NT
UT WOS:000333228500008
PM 24530316
ER

PT J
AU Lee, EH
   Kwak, GH
   Kim, MJ
   Kim, HY
   Hwang, KY
AF Lee, Eun Hye
   Kwak, Geun-Hee
   Kim, Moon-Jung
   Kim, Hwa-Young
   Hwang, Kwang Yeon
TI Structural analysis of 1-Cys type selenoprotein methionine sulfoxide
   reductase A
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Methionine sulfoxide reductase; MsrA; Selenoprotein; Selenocysteine;
   Catalysis; Clostridium
ID PROTEIN-BOUND METHIONINE; CATALYTIC MECHANISM; ESCHERICHIA-COLI;
   NEISSERIA-MENINGITIDIS; ANTIOXIDANT DEFENSE; SULFENIC ACID; AMINO-ACIDS;
   MSRA; SELENOCYSTEINE; OXIDATION
AB Methionine sulfoxide reductase A (MsrA) reduces free and protein-based methionine-S-sulfoxide to methionine. Structures of 1-Cys MsrAs lacking a resolving Cys, which interacts with catalytic Cys, are unknown. In addition, no structural information on selenocysteine (Sec)-containing MsrA enzymes has been reported. In this work, we determined the crystal structures of 1-Cys type selenoprotein MsrA from Clostridium oremlandii at 1.6-1.8 angstrom, including the reduced, oxidized (sulfenic acid), and substrate-bound forms. The overall structure of Clostridium MsrA, consisting of ten alpha-helices and six beta-strands, folds into a catalytic domain and a novel helical domain absent from other known MsrA structures. The helical domain, containing five helices, tightly interacts with the catalytic domain, and is likely critical for catalytic activity due to its association with organizing the active site. This helical domain is also conserved in several selenoprotein MsrAs. Our structural analysis reveals that the side chain length of Glu55 is critical for the proton donor function of this residue. Our structures also provide insights into the architecture of the 1-Cys MsrA active site and the roles of active site residues in substrate recognition and catalysis. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Lee, Eun Hye; Hwang, Kwang Yeon] Korea Univ, Coll Life Sci & Biotechnol, Div Biotechnol, Seoul 136701, South Korea.
   [Kwak, Geun-Hee; Kim, Moon-Jung; Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea.
RP Kim, HY (reprint author), Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, 170 Hyeonchungno, Taegu 705717, South Korea.
EM hykim@ynu.ac.kr; chahong@korea.ac.kr
FU National Research Foundation of Korea [2011-0028166, 2013-044795]
FX We thank the staff of beamlines 4A at the Pohang Accelerator Laboratory
   and BL1A at the Photon Factory for technical support. We are also
   grateful to the staff at the Korea Basic Science Institute (Daejeon,
   Korea) for the use of a mosquito crystallization robot and the Rigaku
   MicroMax-007HF X-ray generator. This work was supported by grants from
   the National Research Foundation of Korea (2011-0028166 and
   2013-044795).
CR Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007
   Kryukov GV, 2004, EMBO REP, V5, P538, DOI 10.1038/sj.embor.7400126
   Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056
   Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155
   Moskovitz J, 2000, J BIOL CHEM, V275, P14167, DOI 10.1074/jbc.275.19.14167
   Boschi-Muller S, 2001, PROTEIN SCI, V10, P2272, DOI 10.1110/ps.10701
   Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477
   Lim JC, 2011, P NATL ACAD SCI USA, V108, P10472, DOI 10.1073/pnas.1101275108
   Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239
   Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Kim HY, 2013, ANTIOXID REDOX SIGN, V19, P958, DOI 10.1089/ars.2012.5081
   Kim HY, 2006, BIOCHEMISTRY-US, V45, P13697, DOI 10.1021/bi06111614
   Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629
   Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200
   Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269
   Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516
   Antoine M, 2006, J BIOL CHEM, V281, P39062, DOI 10.1074/jbc.M608844200
   Dokainish HM, 2013, BIOCHEMISTRY-US, V52, P1814, DOI 10.1021/bi301168p
   Gand A, 2007, J BIOL CHEM, V282, P20484, DOI 10.1074/jbc.M702350200
   Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.bpio.0030375
   Kim HY, 2009, PROTEINS, V74, P1008, DOI 10.1002/prot.22212
   Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lim JC, 2012, J BIOL CHEM, V287, P25589, DOI 10.1074/jbc.M112.368936
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Ranaivoson FM, 2008, J MOL BIOL, V377, P268, DOI 10.1016/j.jmb.2008.01.021
   Rother M, 2001, BIOFACTORS, V14, P75
   Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200
   Tarrago L, 2009, MOL PLANT, V2, P202, DOI 10.1093/mp/ssn067
   Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003
   Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8
NR 35
TC 4
Z9 4
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 1
EP 8
DI 10.1016/j.abb.2013.12.024
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700001
PM 24412203
ER

PT J
AU Anwer, K
   Parmar, A
   Rahman, S
   Kaushal, A
   Madamwar, D
   Islam, A
   Hassan, MI
   Ahmad, F
AF Anwer, Khalid
   Parmar, Asha
   Rahman, Safikur
   Kaushal, Avani
   Madamwar, Datta
   Islam, Asimul
   Hassan, Md. Imtaiyaz
   Ahmad, Faizan
TI Folding and stability studies on C-PE and its natural N-terminal
   truncant
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Biliproteins; C-phycoerythrin; Chromophore; Protein denaturation;
   Folding and stability
ID PROTEIN STABILITY; GUANIDINE HYDROCHLORIDE; SOLVENT DENATURATION;
   R-PHYCOERYTHRIN; ENERGY-TRANSFER; RIBONUCLEASE-A; PHYCOBILISOMES; UREA;
   THERMODYNAMICS; PURIFICATION
AB The conformational and functional state of biliproteins can be determined by optical properties of the covalently linked chromophores. alpha-Subunit of most of the phycoerythrin contains 164 residues. Recently determined crystal structure of the naturally truncated form of alpha-subunit of cyanobacterial phycoerythrin (Tr-alpha C-PE) lacks 31 N-terminal residues present in its full length form (FL-alpha C-PE). This provides an opportunity to investigate the structure-function relationship between these two natural forms. We measured guanidinium chloride (GdmCl)-induced denaturation curves of FL-alpha C-PE and Tr-alpha C-PE proteins, followed by observing changes in absorbance at 565 nm, fluorescence at 350 and 573 nm, and circular dichroism at 222 nm. The denaturation curve of each protein was analyzed for Delta G(D)degrees, the value of Gibbs free energy change on denaturation (Delta G(D)) in the absence of GdmCl. The main conclusions of the this study are: (i) GdmCl-induced denaturation (native state <-> denatured state) of FL-alpha C-PE and Tr-alpha C-PE is reversible and follows a two-state mechanism, (ii) FL-alpha C-PE is 1.4 kcal mol(-1) more stable than Tr-alpha C-PE, (iii) truncation of 31-residue long fragment that contains two alpha-helices, does not alter the 3-D structure of the remaining protein polypeptide chain, protein-chromophore interaction, and (iv) amino acid sequence of Tr-alpha C-PE determines the functional structure of the phycoerythrin. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Anwer, Khalid; Rahman, Safikur; Islam, Asimul; Hassan, Md. Imtaiyaz; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
   [Parmar, Asha; Kaushal, Avani; Madamwar, Datta] Sardar Patel Univ, BRD Sch Biosci, Vallabh Vidyanagar 388120, Gujarat, India.
RP Hassan, MI (reprint author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
EM mihassan@jmi.ac.in
OI Hassan, Imtaiyaz/0000-0002-3663-4940
FU Department of Science and Technology (DST) [SR/SO/BB-0124/2010A];
   University Grant Commission (UGC) for Maulana Azad National Fellowship
   (MANF)
FX M.I.H. and F.A. are thankful to the Department of Science and Technology
   (DST) for financial support (Project No. SR/SO/BB-0124/2010A). K.A. is
   thankful to University Grant Commission (UGC) for providing Maulana Azad
   National Fellowship (MANF).
CR AHMAD F, 1982, J BIOL CHEM, V257, P2935
   AHMAD F, 1978, CAN J BIOCHEM CELL B, V56, P1003
   Parmar A, 2011, PROCESS BIOCHEM, V46, P1793, DOI 10.1016/j.procbio.2011.06.006
   Vivian JT, 2001, BIOPHYS J, V80, P2093
   Singh NK, 2009, BIORESOURCE TECHNOL, V100, P1663, DOI 10.1016/j.biortech.2008.09.021
   Rahaman H, 2013, J CHEM THERMODYN, V58, P351, DOI 10.1016/j.jct.2012.11.024
   Soni BR, 2010, J STRUCT BIOL, V171, P247, DOI 10.1016/j.jsb.2010.05.008
   Pace CN, 1999, PROTEIN SCI, V8, P1500
   BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015
   Joo K, 2009, PROTEINS, V75, P1010, DOI 10.1002/prot.22312
   MacColl R, 2004, BBA-BIOENERGETICS, V1657, P73, DOI 10.1016/j.bbabio.2004.04.005
   GLAZER AN, 1982, ANNU REV MICROBIOL, V36, P173, DOI 10.1146/annurev.mi.36.100182.001133
   Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8
   MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062
   Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390
   AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4579, DOI 10.1021/bi00839a052
   Yokono M, 2008, BBA-BIOENERGETICS, V1777, P55, DOI 10.1016/j.bbabio.2007.11.001
   Bolen DW, 2004, METHODS, V34, P312, DOI 10.1016/j.ymeth.2004.03.022
   Creamer TP, 1997, BIOCHEMISTRY-US, V36, P2832, DOI 10.1021/bi962819o
   MYERS JK, 1995, PROTEIN SCI, V4, P2138
   FRENCH CS, 1952, J GEN PHYSIOL, V35, P873, DOI 10.1085/jgp.35.6.873
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7
   Anwer K., 2013, J BIOMOL STRUCT DYN, V31, P1
   Chang WR, 1996, J MOL BIOL, V262, P721, DOI 10.1006/jmbi.1996.0547
   CORNEJO J, 1992, J BIOL CHEM, V267, P14790
   Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200
   DeLano W.L., 2004, DELANO SCI, P1
   DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.biochem.60.1.795
   DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001
   Freilder D., 1982, PHYS BIOCH ED, V2, P86
   GRAY BH, 1973, J BACTERIOL, V116, P471
   Gupta R, 1999, BIOCHEMISTRY-US, V38, P2471, DOI 10.1021/bi982078m
   Gupta R, 1996, BIOCHEMISTRY-US, V35, P11925, DOI 10.1021/bi961079g
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kupka M, 2008, BBA-BIOENERGETICS, V1777, P94, DOI 10.1016/j.bbabio.2007.10.009
   Liu LN, 2009, BBA-BIOENERGETICS, V1787, P939, DOI 10.1016/j.bbabio.2009.02.018
   MacColl R, 1999, POLAR BIOL, V22, P384, DOI 10.1007/s003000050433
   PACE CN, 1995, PROTEIN SCI, V4, P2411
   PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551
   PACE NC, 1968, BIOCHEMISTRY-US, V7, P198
   Parmar A, 2011, BIORESOURCE TECHNOL, V102, P1795, DOI 10.1016/j.biortech.2010.09.025
   Parmar A, 2010, J PHYCOL, V46, P285, DOI 10.1111/j.1529-8817.2009.00798.x
   Schellman JA, 2002, BIOPHYS CHEM, V96, P91, DOI 10.1016/S0301-4622(02)00009-1
   SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515
   Shah G.N., 2001, ACTA BOT MAL, V26, P188
   TANFORD C, 1970, BIOCHEMISTRY-US, V9, P206, DOI 10.1021/bi00804a003
   Thompson J.D., 2002, CURR PROTOC BIOINFOR, V56, P59
   White A., 1958, BIOCHEMISTRY-US, V71, P217
NR 49
TC 0
Z9 0
U1 7
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 9
EP 21
DI 10.1016/j.abb.2014.01.005
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700002
PM 24434005
ER

PT J
AU Oliver, JC
   Gudihal, R
   Burgner, JW
   Pedley, AM
   Zwierko, AT
   Davisson, VJ
   Linger, RS
AF Oliver, Justin C.
   Gudihal, Ravidra
   Burgner, John W.
   Pedley, Anthony M.
   Zwierko, Alexander T.
   Davisson, V. Jo
   Linger, Rebecca S.
TI Conformational changes involving ammonia tunnel formation and allosteric
   control in GMP synthetase
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Glutamine amidotransferase; Substrate channeling; Ammonia tunnel;
   Allosteric control; Conformational change; Purine biosynthesis
ID GLYCEROL PHOSPHATE SYNTHASE; GUANOSINE 5'-MONOPHOSPHATE SYNTHETASE;
   XANTHOSINE 5'-PHOSPHATE AMINASE; ENZYME-CATALYZED REACTIONS;
   CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION; GLUTAMINE
   AMIDOTRANSFERASE; LIMITED PROTEOLYSIS; PROTEIN-STRUCTURE; ACTIVE-SITE
AB GMP synthetase is the glutamine amidotransferase that catalyzes the final step in the guanylate branch of de novo purine biosynthesis. Conformational changes are required to efficiently couple distal active sites in the protein; however, the nature of these changes has remained elusive. Structural information derived from both limited proteolysis and sedimentation velocity experiments support the hypothesis of nucleotide-induced loop- and domain-closure in the protein. These results were combined with information from sequence conservation and precedents from other glutamine amidotransferases to develop the first structural model of GMPS in a closed, active state. In analyzing this Catalytic model, an interdomain salt bridge was identified residing in the same location as seen in other triad glutamine amidotransferases. Using mutagenesis and kinetic analysis, the salt bridge between H186 and E383 was shown to function as a connection between the two active sites. Mutations at these residues uncoupled the two half-reactions of the enzyme. The chemical events of nucleotide binding initiate a series of conformational changes that culminate in the establishment of a tunnel for ammonia as well as an activated glutaminase catalytic site. The results of this study provide a clearer understanding of the allostery of GMPS, where, for the first time, key substrate binding and interdomain contacts are modeled and analyzed. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Oliver, Justin C.; Gudihal, Ravidra; Pedley, Anthony M.; Davisson, V. Jo] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.
   [Burgner, John W.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA.
   [Zwierko, Alexander T.; Linger, Rebecca S.] Univ Charleston, Dept Pharmaceut & Adm Sci, Charleston, WV 25304 USA.
RP Linger, RS (reprint author), Univ Charleston, Dept Pharmaceut & Adm Sci, 2300 MacCorkle Ave SE, Charleston, WV 25304 USA.
EM rebeccalinger@ucwv.edu
FU National Institutes of Health [GM067195, P20RR016477, P20GM103434,
   T32GM008296]; National Science Foundation [NSF-IGERT 9987576]
FX The research was supported by grants from the National Institutes of
   Health [GM067195] (V.J.D), [P20RR016477] (R.S.L), [P20GM103434] (R.S.L),
   [T32GM008296] (J.C.O), and a National Science Foundation grant
   [NSF-IGERT 9987576] (J.C.O).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Amaro RE, 2005, BIOPHYS J, V89, P475, DOI 10.1529/biophysj.104.058651
   Deras ML, 1999, BIOCHEMISTRY-US, V38, P303, DOI 10.1021/bi981980r
   ZALKIN H, 1985, METHOD ENZYMOL, V113, P273
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333
   de la Torre JG, 2000, BIOPHYS J, V78, P719
   Quemeneur L, 2003, J IMMUNOL, V170, P4986
   Liang J, 1998, PROTEIN SCI, V7, P1884
   Kudo M, 2009, DRUG METAB PHARMACOK, V24, P557
   Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945
   RANSOM JT, 1995, THER DRUG MONIT, V17, P681, DOI 10.1097/00007691-199512000-00023
   Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034
   Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370
   Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Amaro RE, 2007, BIOCHEMISTRY-US, V46, P2156, DOI 10.1021/bi061708e
   Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103
   FUKUYAMA TT, 1966, J BIOL CHEM, V241, P4745
   Errington N, 2003, EUR BIOPHYS J BIOPHY, V32, P511, DOI 10.1007/s00249-003-0315-x
   Tesmer JG, 1996, NAT STRUCT BIOL, V3, P74, DOI 10.1038/nsb0196-74
   Chaudhuri BN, 2001, STRUCTURE, V9, P987, DOI 10.1016/S0969-2126(01)00661-X
   ZYK N, 1969, BIOCHEMISTRY-US, V8, P2787, DOI 10.1021/bi00835a015
   Ali R, 2013, BIOCHEMISTRY-US, V52, P4308, DOI 10.1021/bi400472e
   Pearcy JO, 2001, J AM SOC MASS SPECTR, V12, P599, DOI 10.1016/S1044-0305(01)00208-2
   Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768
   Mouilleron S, 2007, CURR OPIN STRUC BIOL, V17, P653, DOI 10.1016/j.sbi.2007.09.003
   Fontana A, 2004, ACTA BIOCHIM POL, V51, P299
   Yon JM, 1998, BIOCHIMIE, V80, P33, DOI 10.1016/S0300-9084(98)80054-0
   Anand R, 2004, BIOCHEMISTRY-US, V43, P10328, DOI 10.1021/bi0491301
   Maruoka S, 2010, J MOL BIOL, V395, P417, DOI 10.1016/j.jmb.2009.10.053
   List F, 2012, CHEM BIOL, V19, P1589, DOI 10.1016/j.chembiol.2012.10.012
   Schuck P, 2000, BIOPHYS J, V78, P1606
   ZALKIN H, 1977, J BIOL CHEM, V252, P5431
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149
   Knochel T, 1999, P NATL ACAD SCI USA, V96, P9479, DOI 10.1073/pnas.96.17.9479
   Crivelli S, 2004, J COMPUT AID MOL DES, V18, P271, DOI 10.1023/B:JCAM.0000046822.54719.4f
   Bhat JY, 2011, BIOCHEMISTRY-US, V50, P3346, DOI 10.1021/bi1017057
   SAKAMOTO N, 1972, J BIOL CHEM, V247, P5880
   Bhat JY, 2011, FEBS J, V278, P3756, DOI 10.1111/j.1742-4658.2011.08296.x
   Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011
   Chaudhuri BN, 2003, BIOCHEMISTRY-US, V42, P7003, DOI 10.1012/bi034320h
   Chen SH, 1999, BIOCHEMISTRY-US, V38, P11659, DOI 10.1021/bi991060o
   Drenth J., 1994, PRINCIPLES PROTEIN X
   Franklin M.C., STRUCTURE GMP SYNTHA, DOI [10.2210/pdb3tqi/pdb, DOI 10.2210/PDB3TQI/PDB]
   Gutteridge A, 2004, FEBS LETT, V567, P67, DOI 10.1016/j.febslet.2004.03.067
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X
   Holden HM, 1998, CURR OPIN STRUC BIOL, V8, P679, DOI 10.1016/S0959-440X(98)80086-9
   Karim H, 2011, BIOCHEM BIOPH RES CO, V411, P156, DOI 10.1016/j.bbrc.2011.06.120
   Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468
   Krahn JM, 1997, BIOCHEMISTRY-US, V36, P11061, DOI 10.1021/bi9714114
   Li A. -A., 2011, J BIOL CHEM, V286, P18213
   LOU L, 1995, PROTEIN EXPRES PURIF, V6, P487, DOI 10.1006/prep.1995.1065
   Manley G, 2013, J PHYS CHEM B, V117, P3063, DOI 10.1021/jp312576v
   Myers RS, 2003, BIOCHEMISTRY-US, V42, P7013, DOI 10.1021/bi034314l
   Myers RS, 2005, BIOCHEMISTRY-US, V44, P11974, DOI 10.1021/bi050706b
   NAKAMURA J, 1995, J BIOL CHEM, V270, P7347
   Oliver JC, 2013, BIOCHEMISTRY-US, V52, P5225, DOI 10.1021/bi3017075
   Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k
   Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109
   Sakamoto N, 1978, Methods Enzymol, V51, P213
   Smith JL, 1998, CURR OPIN STRUC BIOL, V8, P686, DOI 10.1016/S0959-440X(98)80087-0
   Teplyakov A, 2001, J MOL BIOL, V313, P1093, DOI 10.1006/jmbi.2001.5094
   Tesmer J.J.G., 1995, CRYSTAL STRUCTURE PA
   TESMER JJG, 1994, PROTEINS, V18, P394, DOI 10.1002/prot.340180410
   Thoden JB, 1998, BIOCHEMISTRY-US, V37, P8825, DOI 10.1021/bi9807761
   Weeks A, 2006, CURR OPIN CHEM BIOL, V10, P465, DOI 10.1016/j.cbpa.2006.08.008
   Welin M., 2013, J MOL BIOL, V423, P4323
   Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87
NR 70
TC 1
Z9 1
U1 2
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 22
EP 32
DI 10.1016/j.abb.2014.01.004
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700003
PM 24434004
ER

PT J
AU Yao, SG
   Westphal, D
   Babon, JJ
   Thompson, GV
   Robin, AY
   Adams, JM
   Colman, PM
   Czabotar, PE
AF Yao, Shenggen
   Westphal, Dana
   Babon, Jeffrey J.
   Thompson, Geoff V.
   Robin, Adeline Y.
   Adams, Jerry M.
   Colman, Peter M.
   Czabotar, Peter E.
TI NMR studies of interactions between Bax and BH3 domain-containing
   peptides in the absence and presence of CHAPS
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Apoptosis; Bax; BH3 domains; CHAPS; Dimerization; NMR
ID BIOLOGICAL MACROMOLECULES; DIFFUSION MEASUREMENTS; BINDING-SITE;
   PROTEIN; RELAXATION; ACTIVATION; APOPTOSIS; OLIGOMERIZATION;
   SPECTROSCOPY; ASSOCIATION
AB Activation and oligomerisation of Bax, a key pro-apoptotic Bcl-2 family protein, are key steps in the mitochondrial pathway to apoptosis. The signals for apoptosis are conveyed by the distantly related BH3-only proteins, which use their short BH3 domain, an amphipathic alpha-helix, to interact with other Bcl-2 family members. Here we report an NMR study of interactions between Bax Delta C and BH3 domain-containing peptides in the absence and presence of CHAPS, a zwitterionic detergent. We find for the first time that CHAPS interacts weakly with Bax Delta C (fast exchange on the NMR chemical shift timescale), at concentrations below micelle formation and with an estimated K-d in the tens of mM. Direct and relatively strong-interactions (slow exchange on the NMR chemical shift timescale) were also observed for Bax Delta C with BaxBH3 (estimated K-d of circa 150 mu M) or BimBH3 in the absence of CHAPS. The interaction with either peptide alone induced widespread chemical shift perturbations to Bax Delta C in solution which implies that Bax Delta C might have undergone significant conformation change upon binding the BH3 peptide. However, Bax Delta C remained monomeric upon binding either CHAPS or a BH3 peptide alone, but the presence of both provoked it to form a dimer. Crown Copyright (C) 2014 Published by Elsevier Inc. All rights reserved.
C1 [Yao, Shenggen; Westphal, Dana; Babon, Jeffrey J.; Thompson, Geoff V.; Robin, Adeline Y.; Adams, Jerry M.; Colman, Peter M.; Czabotar, Peter E.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.
   [Yao, Shenggen; Westphal, Dana; Babon, Jeffrey J.; Robin, Adeline Y.; Adams, Jerry M.; Colman, Peter M.; Czabotar, Peter E.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia.
   [Yao, Shenggen] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.
RP Yao, SG (reprint author), Univ Melbourne, 30 Flemington Rd, Melbourne, Vic 3010, Australia.
EM shyao@unimelb.edu.au
RI babon, jeffrey/B-9170-2013
OI babon, jeffrey/0000-0002-5408-6239
FU NHMRC; ACRF; ARC; Victorian State Government; Australian Government
   NHMRC IRIISS
FX All NMR data were acquired at the NMR Facility, Bio21 Molecular Science
   and Biotechnology Institute, University of Melbourne. We thank Dr. Mark
   Hinds for helpful discussions, Eden Whitlock, and Ahmad Wardak for
   technical support and Motoshi Suzuki and Nico Tjandra for NMR chemical
   shift data of the full-length Bax. This work was supported by the NHMRC,
   ACRF, ARC (fellowship to P.E.C.), Victorian State Government Operational
   Infrastructure Support, and the Australian Government NHMRC IRIISS.
CR Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7
   BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486
   Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019
   Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031
   Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539
   ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039
   Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829
   Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020
   Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001
   WISHART DS, 1995, J BIOMOL NMR, V6, P135
   Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019
   Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777
   Leshchiner ES, 2013, P NATL ACAD SCI USA, V110, pE986, DOI 10.1073/pnas.1214313110
   Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307
   Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7
   Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366
   Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396
   de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170
   Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104
   FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040
   Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091
   Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014
   GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052
   Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6
   Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e
   Moldoveanu T, 2013, NAT STRUCT MOL BIOL, V20, P589, DOI 10.1038/nsmb.2563
   CALLAGHAN PT, 1983, J CHEM PHYS, V79, P6372, DOI 10.1063/1.445745
   Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027
   Ivashyna O, 2009, J BIOL CHEM, V284, P23935, DOI 10.1074/jbc.M109.023853
   Liu QA, 2010, J BIOL CHEM, V285, P41202, DOI 10.1074/jbc.M110.144857
   MEYERHOFFER SM, 1992, J PHYS CHEM-US, V96, P1961, DOI 10.1021/j100183a078
   Qin XG, 2010, J PHYS CHEM B, V114, P3863, DOI 10.1021/jp911720w
   Teller D C, 1979, Methods Enzymol, V61, P103
   Weast R. C., 1984, CRC HDB CHEM PHYS
   Yao S, 2008, BIOPHYS CHEM, V136, P145, DOI 10.1016/j.bpc.2008.06.002
   Yao SG, 2000, J BIOMOL NMR, V16, P109, DOI 10.1023/A:1008382624724
NR 37
TC 4
Z9 4
U1 2
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 33
EP 43
DI 10.1016/j.abb.2014.01.003
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700004
PM 24434006
ER

PT J
AU Brown, AM
   Lemkul, JA
   Schaum, N
   Bevan, DR
AF Brown, Anne M.
   Lemkul, Justin A.
   Schaum, Nicholas
   Bevan, David R.
TI Simulations of monomeric amyloid beta-peptide (1-40) with varying
   solution conditions and oxidation state of Met35: Implications for
   aggregation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Molecular dynamics simulations; Modeling; Protein folding; Amyloid-beta;
   Methionine oxidation
ID ALZHEIMERS-DISEASE BRAIN; MOLECULAR-DYNAMICS SIMULATIONS; MILD COGNITIVE
   IMPAIRMENT; PARTICLE MESH EWALD; FORCE-FIELD; BIOLOGICAL MOLECULES;
   SECONDARY STRUCTURE; LIPID-PEROXIDATION; PROTEIN OXIDATION; IN-VITRO
AB The amyloid beta-peptide (A beta) is a 40-42 residue peptide that is the principal toxic species in Alzheimer's disease (AD). The oxidation of methionine-35 (Met35) to the sulfoxide form (Met35(ox)) has been identified as potential modulator of A beta aggregation. The role Met35(ox) plays in A beta neurotoxicity differs among experimental studies, which may be due to inconsistent solution conditions (pH, buffer, temperature). We applied atomistic molecular dynamics (MD) simulations as a means to probe the dynamics of the monomeric 40-residue alloform of A beta (A beta(40)) containing Met35 or Met35(ox) in an effort to resolve the conflicting experimental results. We found that Met35 oxidation decreases the beta-strand content of the C-terminal hydrophobic region (residues 29-40), with a specific effect on the secondary structure of residues 33-35, thus potentially impeding aggregation. Further, there is an important interplay between oxidation state and solution conditions, with pH and salt concentration augmenting the effects of oxidation. The results presented here serve to rationalize the conflicting results seen in experimental studies and provide a fundamental biophysical characterization of monomeric A beta(40) dynamics in both reduced and oxidized forms, providing insight into the biochemical mechanism of A beta(40) and oxidative stress related to AD. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Brown, Anne M.; Lemkul, Justin A.; Schaum, Nicholas; Bevan, David R.] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.
RP Bevan, DR (reprint author), 201 Fralin Life Sci Ctr, Blacksburg, VA 24061 USA.
EM drbevan@vt.edu
OI Lemkul, Justin/0000-0001-6661-8653
FU Institute for Critical Technology and Applied Science (ICTAS) at
   Virginia Tech
FX The authors thank Advanced Research Computing at Virginia Tech for
   computing time on the SystemX and Athena supercomputers. This work was
   supported by the Institute for Critical Technology and Applied Science
   (ICTAS) at Virginia Tech.
CR Alzheimer's Association, 2012, ALZH DIS FACTS FIG
   Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D
   Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093
   Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200
   Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200
   Sarroukh R, 2011, CELL MOL LIFE SCI, V68, P1429, DOI 10.1007/s00018-010-0529-x
   Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200
   SUBBARAO KV, 1990, J NEUROCHEM, V55, P342, DOI 10.1111/j.1471-4159.1990.tb08858.x
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693
   Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895
   Kollman PA, 1996, ACCOUNTS CHEM RES, V29, P461, DOI 10.1021/ar9500675
   Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200
   Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6
   Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200
   Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699
   PIKE CJ, 1995, J NEUROCHEM, V64, P253
   Hewitt N, 2009, J PHYS CHEM B, V113, P1202, DOI 10.1021/jp807327a
   Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x
   Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f
   Guilloreau L, 2007, CHEMBIOCHEM, V8, P1317, DOI 10.1002/cbic.200700111
   Olubiyi OO, 2012, J PHYS CHEM B, V116, P3280, DOI 10.1021/jp2076337
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d
   Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3
   Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102
   Nymeyer H, 2003, P NATL ACAD SCI USA, V100, P13934, DOI 10.1073/pnas.2232868100
   CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   Watson AA, 1998, BIOCHEMISTRY-US, V37, P12700, DOI 10.1021/bi9810757
   Palmblad M, 2002, J BIOL CHEM, V277, P19506, DOI 10.1074/jbc.M112218200
   SIMMONS LK, 1994, MOL PHARMACOL, V45, P373
   HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133
   Markesbery WR, 2005, ANN NEUROL, V58, P730, DOI 10.1002/ana.20629
   Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z
   NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851
   Nose S, 2002, MOL PHYS, V100, P191, DOI 10.1080/00268970110089108
   Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9
   SNYDER SW, 1994, BIOPHYS J, V67, P1216
   Garcia AE, 2002, P NATL ACAD SCI USA, V99, P2782, DOI 10.1073/pnas.042496899
   Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090
   Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349
   Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037
   Smith MA, 1997, J NEUROSCI, V17, P2653
   Lauderback CM, 2001, J NEUROCHEM, V78, P413, DOI 10.1046/j.1471-4159.2001.00451.x
   Triguero L, 2008, J PHYS CHEM B, V112, P7123, DOI 10.1021/jp801168v
   Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288
   Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123
   Geerke DP, 2004, J PHYS CHEM B, V108, P1436, DOI 10.1021/jp035034i
   Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F
   Berendsen HJC, 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X
   Best RB, 2008, BIOPHYS J, V95, pL7, DOI 10.1529/biophysj.108.132696
   Bousejra-ElGarah F, 2011, INORG CHEM, V50, P9024, DOI 10.1021/ic201233b
   BURDICK D, 1992, J BIOL CHEM, V267, P546
   Butterfield D.A., 2011, J AMINO ACIDS, V2011
   Ciccotosto GD, 2004, J BIOL CHEM, V279, P42528, DOI 10.1074/jbc.M406465200
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Gerben S.R., 2013, J BIOMOL STRUCT DYN, P1
   HENSLEY K, 1995, J NEUROCHEM, V65, P2146
   JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kanski, 2002, BIOCHIM BIOPHYS ACTA, V1586, P190
   Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200
   Klug GMJA, 2003, EUR J BIOCHEM, V270, P4282, DOI 10.1046/j.1432-1033.2003.03815.x
   Ma K, 1999, J AM CHEM SOC, V121, P8698, DOI 10.1021/ja990864o
   Schoneich C, 2002, ARCH BIOCHEM BIOPHYS, V397, P370, DOI 10.1006/abbi.2001.2621
   Valerio M, 2008, CHEMMEDCHEM, V3, P833, DOI 10.1002/cmdc.200700324
   Wang Q, 2013, J RAMAN SPECTROSC, V44, P670, DOI 10.1002/jrs.4253
NR 78
TC 5
Z9 5
U1 8
U2 31
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 44
EP 52
DI 10.1016/j.abb.2014.01.002
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700005
PM 24418316
ER

PT J
AU Mompean, M
   Buratti, E
   Guarnaccia, C
   Brito, RMM
   Chakrabartty, A
   Baralle, FE
   Laurents, DV
AF Mompean, Miguel
   Buratti, Emanuele
   Guarnaccia, Corrado
   Brito, Rui M. M.
   Chakrabartty, Avijit
   Baralle, Francisco E.
   Laurents, Douglas V.
TI "Structural characterization of the minimal segment of TDP-43 competent
   for aggregation"
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Frontotemportal lobar degeneration (FTLD); Amyotrophic lateral sclerosis
   (ALS); NMR; Molecular dynamics; Circular dichroism; Protein misfolding &
   aggregation
ID AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NMR
   CHEMICAL-SHIFTS; MUTANT TDP-43; RICH REGION; BETA-SHEETS; IN-VIVO;
   PROTEINS; INCLUSIONS; MUTATIONS
AB TDP-43 is a nuclear protein whose abnormal aggregates are implicated in ALS and FTLD. Recently, an Asn/Gln rich C-terminal segment of TDP-43 has been shown to produce aggregation in vitro and reproduce most of the protein's pathological hallmarks in cells, but little is known about this segment's structure. Here, CD and 2D heteronuclear NMR spectroscopies provide evidence that peptides corresponding to the wild type and mutated sequences of this segment adopt chiefly disordered conformations that, in the case of the wild type sequence, spontaneously forms a beta-sheet rich oligomer. Moreover, MD simulation provides evidence for a structure consisting of two beta-strands and a well-defined, yet non-canonical structural element. Furthermore, MD simulations of four pathological mutations (Q343R, N345K, G348V and N352S) occurring in this segment predict that all of them could affect this region's structure. In particular, the Q343R variant tends to stabilize disordered conformers, N345K permits the formation of longer, more stable beta-strands, and G348V tends to shorten and destabilize them. Finally, N352S acts to alter the beta-stand register and when S352 is phosphorylated, it induces partial unfolding. Our results provide a better understanding of TDP-43 aggregation process and will be useful to design effectors capable to modulate its progression. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Mompean, Miguel; Laurents, Douglas V.] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain.
   [Buratti, Emanuele; Guarnaccia, Corrado; Baralle, Francisco E.] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy.
   [Brito, Rui M. M.] Univ Coimbra, Fac Sci & Technol, Dept Chem, Coimbra, Portugal.
   [Brito, Rui M. M.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.
   [Brito, Rui M. M.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1L7, Canada.
RP Baralle, FE (reprint author), Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy.
EM baralle@icgeb.org; dlaurents@iqfr.csic.es
RI Laurents, Douglas/E-7527-2015; 
OI Laurents, Douglas/0000-0002-4187-165X; Buratti,
   Emanuele/0000-0002-1356-9074; Brito, Rui/0000-0001-9128-2557
FU Spanish Ministerio de Ciencia e Innovacion [CTQ 2010-21567-C02-02];
   AriSLA (TARMA); Thierry-Latran Foundation (REHNPALS)
FX We thank Dr. D. Pantoja-Uceda for assistance with NMR spectrometers and
   Prof. M. Bruix for critically reading the MS. The authors state no
   conflict of interests. This work was funded by Grants CTQ
   2010-21567-C02-02 to DVL from the Spanish Ministerio de Ciencia e
   Innovacion and AriSLA (TARMA) to FEB and the Thierry-Latran Foundation
   (REHNPALS). The funders played no role in the experimental design or
   execution.
CR Cheng PN, 2013, J AM CHEM SOC, V135, P5477, DOI 10.1021/ja3088407
   [Anonymous], PYMOL PYMOL MOL GRAP
   King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016
   Bigio EH, 2013, ACTA NEUROPATHOL, V125, P463, DOI 10.1007/s00401-013-1089-6
   Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109
   Budini M, 2012, J BIOL CHEM, V287, P7512, DOI 10.1074/jbc.M111.288720
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055
   D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342
   Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004
   Gendron TF, 2013, J ALZHEIMERS DIS, V33, pS35, DOI 10.3233/JAD-2012-129036
   Kamada M, 2009, J NEUROL SCI, V284, P69, DOI 10.1016/j.jns.2009.04.017
   Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022
   Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207
   Zhang YJ, 2013, HUM MOL GENET, V22, P3112, DOI 10.1093/hmg/ddt166
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Robinson JL, 2013, ACTA NEUROPATHOL, V125, P121, DOI 10.1007/s00401-012-1055-8
   Guo M, 2005, FEBS LETT, V579, P3574, DOI 10.1016/j.febslet.2005.05.036
   Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388
   Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392
   Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093
   Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003
   Watanabe S, 2013, J BIOL CHEM, V288, P3641, DOI 10.1074/jbc.M112.433615
   Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774
   Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427
   WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471
   Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319
   Kirby J, 2010, NEUROGENETICS, V11, P217, DOI 10.1007/s10048-009-0218-9
   Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Krishnan R, 2012, P NATL ACAD SCI USA, V109, P11172, DOI 10.1073/pnas.1209527109
   Shaw KL, 2001, PROTEIN SCI, V10, P1206, DOI 10.1110/ps.440101
   Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f
   Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013
   Budini M, 2012, BRAIN RES, V1462, P139, DOI 10.1016/j.brainres.2012.02.031
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927
   Crierpicki T., 2001, J BIOMOL NMR, V21, P249
   Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039
   Kühnlein Peter, 2008, Arch Neurol, V65, P1185, DOI 10.1001/archneur.65.9.1185
   Rutherford N.J., 2008, PLOS GENET, V4
   Shodai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052776
   Teng PK, 2012, PROTEIN SCI, V21, P26, DOI 10.1002/pro.754
   Tsuiji H., 2013, EMBO MOL MED, P221
NR 44
TC 5
Z9 5
U1 1
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 53
EP 62
DI 10.1016/j.abb.2014.01.007
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700006
PM 24440310
ER

PT J
AU Orzechowski, M
   Moore, JR
   Fischer, S
   Lehman, W
AF Orzechowski, Marek
   Moore, Jeffrey R.
   Fischer, Stefan
   Lehman, William
TI Tropomyosin movement on F-actin during muscle activation explained by
   energy landscapes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Actin; Coiled-coil; Energy landscape; Myosin; Muscle regulation; Thin
   filaments
ID THIN FILAMENT; CONTRACTION; MODEL; TROPONIN; DIFFRACTION; MUTATIONS;
   DYNAMICS; BINDING; PROTEIN
AB Muscle contraction is regulated by tropomyosin movement across the thin filament surface, which exposes or blocks myosin-binding sites on actin. Recent atomic structures of F-actin-tropomyosin have yielded the positions of tropomyosin on myosin-free and myosin-decorated actin. Here, the repositioning of a-tropomyosin between these locations on F-actin was systematically examined by optimizing the energy of the complex for a wide range of tropomyosin positions on F-actin. The resulting energy landscape provides a full-map of the F-actin surface preferred by tropomyosin, revealing a broad energy basin associated with the tropomyosin position that blocks myosin-binding. This is consistent with previously proposed low-energy oscillations of semi-rigid tropomyosin, necessary for shifting of tropomyosin following troponin-binding. In contrast, the landscape shows much less favorable energies when tropomyosin locates near its myosin-induced "open-state" position. This indicates that spontaneous movement of tropomyosin away from its energetic "ground-state" to the open-state is unlikely in absence of myosin. Instead, myosin-binding must drive tropomyosin toward the open-state to activate the thin filament. Additional energy landscapes were computed for disease-causing actin mutants that distort the topology of the actin-tropomyosin energy landscape, explaining their phenotypes. Thus, the computation of such energy landscapes offers a sensitive way to estimate the impact of mutations. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Orzechowski, Marek; Moore, Jeffrey R.; Lehman, William] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.
   [Orzechowski, Marek; Fischer, Stefan] Heidelberg Univ, IWR, Interdisciplinary Ctr Sci Comp, Computat Biochem Grp, D-69120 Heidelberg, Germany.
RP Fischer, S (reprint author), Heidelberg Univ, IWR, Interdisciplinary Ctr Sci Comp, Computat Biochem Grp, Neuenheimer Feld 368, D-69120 Heidelberg, Germany.
EM stefan.fischer@iwr.uni-heidelberg.de; wlehman@bu.edu
FU NIH [R37HL036153]
FX We thank Drs. Xiaochuan (Edward) Li, Stefan Raunser, Steven Marston and
   Edyta Malolepsza for insightful discussions and helpful suggestions.
   These studies were supported by NIH Grant R37HL036153 (to W.L.). The
   Massachusetts Green High Performance Computing Center and the IWR
   (University of Heidelberg) provided computational resources.
CR Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685
   Lehman W, 2008, ADV EXP MED BIOL, V644, P95
   Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800
   Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321
   Marston S, 2013, HUM MOL GENET, V22, P4978, DOI 10.1093/hmg/ddt345
   Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037
   Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Lehman W, 2009, J MOL BIOL, V388, P673, DOI 10.1016/j.jmb.2009.03.060
   Perz-Edwards RJ, 2011, P NATL ACAD SCI USA, V108, P120, DOI 10.1073/pnas.1014599107
   Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9
   Barua B, 2013, J BIOL CHEM, V288, P9602, DOI 10.1074/jbc.M113.451161
   Barua B, 2012, P NATL ACAD SCI USA, V109, P18425, DOI 10.1073/pnas.1212754109
   Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061
   Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080
   Lehman W, 2014, ARCH BIOCHEM BIOPHYS, V552, P68, DOI 10.1016/j.abb.2013.09.011
   Lehman W, 2013, J MUSCLE RES CELL M, V34, P155, DOI 10.1007/s10974-013-9342-0
   Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654
   Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060
   LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070
   Maytum R, 2008, J BIOL CHEM, V283, P1902, DOI 10.1074/jbc.M708593200
   Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e
   MCKILLOP DFA, 1993, BIOPHYS J, V65, P693
   Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013
   Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020
   Redwood C, 2013, J MUSCLE RES CELL M, V34, P285, DOI 10.1007/s10974-013-9358-5
   WEGNER A, 1980, FEBS LETT, V119, P245, DOI 10.1016/0014-5793(80)80263-8
   Wu S., 2010, PLOS ONE, V5, P9
NR 33
TC 2
Z9 2
U1 3
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 63
EP 68
DI 10.1016/j.abb.2014.01.001
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700007
PM 24412204
ER

PT J
AU Guillaumond, F
   Iovanna, JL
   Vasseur, S
AF Guillaumond, Fabienne
   Iovanna, Juan Lucio
   Vasseur, Sophie
TI Pancreatic tumor cell metabolism: Focus on glycolysis and its connected
   metabolic pathways
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Pancreatic cancer; Metabolism; Hypoxia; Glycolysis; Glutaminolysis;
   Hexosamine
ID CANCER-CELLS; GLUCOSE-METABOLISM; MESENCHYMAL TRANSITION; IDH2
   MUTATIONS; HYPOXIA; PROGRESSION; MECHANISMS; LACTATE; GROWTH; METASTASIS
AB Because of lack of effective treatment, pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of death by cancer in Western countries, with a very weak improvement of survival rate over the last 40 years. Defeat of numerous conventional therapies to cure this cancer makes urgent to develop new tools usable by clinicians for a better management of the disease. Aggressiveness of pancreatic cancer relies on its own hallmarks: a low vascular network as well as a prominent stromal compartment (desmoplasia), which creates a severe hypoxic environment impeding correct oxygen and nutrients diffusion to the tumoral cells. To survive and proliferate in those conditions, pancreatic cancer cells set up specific metabolic pathways to meet their tremendous energetic and biomass demands. However, as PDAC is a heterogenous tumor, a complex reprogramming of metabolic processes is engaged by cancer cells according to their level of oxygenation and nutrients supply. In this review, we focus on the glycolytic activity of PDAC and the glucose-connected metabolic pathways which contribute to the progression and dissemination of this disease. We also discuss possible therapeutic strategies targeting these pathways in order to cure this disease which still until now is resistant to numerous conventional treatments. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Vasseur, Sophie] INSERM, Ctr Rech Cancerol Marseille, U1068, F-13009 Marseille, France.
   Inst J Paoli I Calmettes, Marseille, France.
   CNRS, UMR7258, F-13009 Marseille, France.
   Univ Aix Marseille, F-13284 Marseille, France.
RP Vasseur, S (reprint author), INSERM, U1068, Ave Luminy, F-13009 Marseille, France.
EM sophie.vasseur@inserm.fr
FU INSERM; Fondation pour la Recherche, le Sport et la Sante; Fondation de
   France; Plan Cancer; "Institut National du Cancer" (INCa); "canceropole
   Provence-Alpes Cote d'Azur"; "Ligue contre le Cancer"
FX Research on pancreatic cancer cell metabolism in the CRCM laboratory is
   supported by INSERM, by grants from the "Fondation pour la Recherche, le
   Sport et la Sante", the "Fondation de France", the "Plan Cancer", the
   "Institut National du Cancer" (INCa), the "canceropole Provence-Alpes
   Cote d'Azur", and the "Ligue contre le Cancer".
CR Almaraz RT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.017558
   Park MS, 2009, RADIOLOGY, V250, P110, DOI 10.1148/radiol.2493080226
   Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8
   Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071
   Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216
   Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741
   Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710
   Zhou WD, 2012, J PROTEOME RES, V11, P554, DOI 10.1021/pr2009274
   Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373
   Christiansen MN, 2014, PROTEOMICS, V14, P525, DOI 10.1002/pmic.201300387
   Vaupel P, 2004, METHOD ENZYMOL, V381, P335
   Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114
   Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843
   Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460
   Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344
   Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368
   Granovsky M, 2000, NAT MED, V6, P306
   Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334
   Bapat AA, 2011, NAT REV CANCER, V11, P695, DOI 10.1038/nrc3131
   Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023
   Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278
   Spivak-Kroizman TR, 2013, CANCER RES, V73, P3235, DOI 10.1158/0008-5472.CAN-11-1433
   Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949
   Cao XH, 2007, CANCER CHEMOTH PHARM, V59, P495, DOI 10.1007/s00280-006-0291-9
   Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515
   Diersch S, 2013, ONCOTARGET, V4, P277
   Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981
   Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058
   Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617
   Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107
   Chaika NV, 2012, P NATL ACAD SCI USA, V109, P13787, DOI 10.1073/pnas.1203339109
   Yamada S, 2013, SURGERY, V154, P946, DOI 10.1016/j.surg.2013.05.004
   Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008
   Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043
   Bayley JP, 2010, CURR OPIN GENET DEV, V20, P324, DOI 10.1016/j.gde.2010.02.008
   Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083
   Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110
   Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177
   Aubert M, 2000, CANCER RES, V60, P1449
   Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762
   Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230
   Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228
   Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910
   Chaika NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032996
   Chang Q, 2006, PANCREAS, V32, P297, DOI 10.1097/00006676-200604000-00010
   Dong XQ, 2011, CANCER-AM CANCER SOC, V117, P480, DOI 10.1002/cncr.25612
   Dong XQ, 2011, CANCER PREV RES, V4, P758, DOI 10.1158/1940-6207.CAPR-10-0247
   Fardini Yann, 2013, Front Endocrinol (Lausanne), V4, P99, DOI 10.3389/fendo.2013.00099
   Finley LWS, 2013, CELL METAB, V17, P466, DOI 10.1016/j.cmet.2013.02.016
   Guillaumond F, 2013, CELL CYCLE, V12, P1155, DOI 10.4161/cc.24489
   Han Haiyong, 2013, Cancer Cell, V23, P424, DOI 10.1016/j.ccr.2013.03.008
   Heiden Vander, 2013, J CLIN INVEST, V123, P3648
   Kamata S, 2007, CANCER BIOL THER, V6, P1036
   Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13
   Ma JM, 2013, FUTURE ONCOL, V9, P917, DOI [10.2217/fon.13.76, 10.2217/FON.13.76]
   Martineau Y., 2013, ONCOGENE, DOI DOI 10.1038/0NC.2013.100
   Sakuma K, 2006, BIOCHEM BIOPH RES CO, V340, P829, DOI 10.1016/j.bbrc.2005.12.072
   Vasseur Sophie, 2010, Cancers (Basel), V2, P2138, DOI 10.3390/cancers2042138
   Zhang JJ, 2010, WORLD J GASTROENTERO, V16, P2881, DOI 10.3748/wjg.v16.i23.2881
   Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065218
   Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60
NR 65
TC 7
Z9 7
U1 4
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 69
EP 73
DI 10.1016/j.abb.2013.12.019
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700008
PM 24393743
ER

PT J
AU Jung, HJ
   Seo, I
   Jha, BK
   Suh, SIS
   Suh, MH
   Baek, WK
AF Jung, Hui-Jung
   Seo, Incheol
   Jha, Bijay Kumar
   Suh, Seong-Il Suh
   Suh, Min-Ho
   Baek, Won-Ki
TI Minocycline inhibits angiogenesis in vitro through the translational
   suppression of HIF-1 alpha
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE HIF-1; VEGF; Minocycline; mTOR
ID HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR;
   STRESS-INDUCED APOPTOSIS; CANCER-CELLS; TUMOR PROGRESSION;
   STAPHYLOCOCCUS-AUREUS; PROTEIN TRANSLATION; GENE-EXPRESSION;
   BREAST-CANCER; ACTIVATION
AB Minocycline was recently found to be effective against cancer. However, the precise molecular mechanisms of minocycline in cancer are poorly understood. Hypoxia-inducible factor-1 (HIF-1, a heterodimeric transcription factor composed of HIF-1 alpha and beta) activates the transcription of genes that are involved in angiogenesis in cancer. In this study, we found that minocycline significantly inhibits HIF-1 alpha protein expression and suppresses HIF-1 transcriptional activity. The tube formation assay showed that minocydine has anti-angiogenic activity and suppresses hypoxia-induced vascular endothelial growth factor (VEGF) expression. The metabolic labeling assay showed that minocycline reduces HIF-1 alpha protein translation and global protein synthesis. In addition, minocycline suppresses mTOR signaling and increases the phosphorylation of eIF2 alpha, which is known to be related to the translational regulation of HIF-1 alpha expression. These findings collectively indicate that minocycline is a potential inhibitor of HIF-1 alpha and provide new insight into the discovery of drugs for cancer treatment. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Jung, Hui-Jung; Seo, Incheol; Jha, Bijay Kumar; Suh, Seong-Il Suh; Suh, Min-Ho; Baek, Won-Ki] Keimyung Univ, Sch Med, Dept Microbiol, Taegu 704701, South Korea.
RP Baek, WK (reprint author), Keimyung Univ, Sch Med, Dept Microbiol, 1095 Dalgubeol Daero, Taegu 704701, South Korea.
EM wonki@dsmc.or.kr
OI Seo, Incheol/0000-0002-3271-381X
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF); Ministry of Education, Science and Technology
   [NRF-2011-0013913]
FX We would like to thank Dr. Giovanni Melillo (National Cancer Institute,
   Frederick, MD, USA) for providing the pGL2-TK-HRE plasmid. This research
   was supported by Basic Science Research Program through the National
   Research Foundation of Korea (NRF) funded by the Ministry of Education,
   Science and Technology (NRF-2011-0013913).
CR Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002
   Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3
   Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200
   Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867
   Ruas JL, 2005, SEMIN CELL DEV BIOL, V16, P514, DOI 10.1016/j.semcdb.2005.04.001
   Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221
   Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441
   Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1
   Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439
   Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075
   Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082
   Beretta L, 1996, EMBO J, V15, P658
   Pourgholami MH, 2012, GYNECOL ONCOL, V125, P433, DOI 10.1016/j.ygyno.2012.01.006
   Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015
   Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.E02-12-0791
   Oh HJ, 2007, BIOCHEM BIOPH RES CO, V360, P840, DOI 10.1016/j.bbrc.2007.06.137
   Higashimura Y, 2011, ARCH BIOCHEM BIOPHYS, V509, P1, DOI 10.1016/j.abb.2011.02.011
   Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139
   Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015
   Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005
   Schindl M, 2002, CLIN CANCER RES, V8, P1831
   Behrooz A, 1997, J BIOL CHEM, V272, P5555
   Wang YX, 2011, AM J PHYSIOL-CELL PH, V301, pC695, DOI 10.1152/ajpcell.00322.2010
   Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200
   Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779
   Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3
   Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x
   Bowker KE, 2008, ANTIMICROB AGENTS CH, V52, P4370, DOI 10.1128/AAC.00922-07
   Zhong H, 1999, CANCER RES, V59, P5830
   Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201
   Petersen PJ, 1999, ANTIMICROB AGENTS CH, V43, P738
   Powis G, 2004, MOL CANCER THER, V3, P647
   Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI123865
   Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019
   Alkhalaf M, 2007, PHARMACOLOGY, V80, P134, DOI 10.1159/000103253
   Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103
   TAMARGO RJ, 1991, CANCER RES, V51, P672
   Williamson DL, 2006, AM J PHYSIOL-ENDOC M, V291, pE80, DOI 10.1152/ajpendo.00566.2005
   Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398
   Baay-Guzman GJ, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-60
   Fernandez A, 2001, J NATL CANCER I, V93, P208, DOI 10.1093/jnci/93.3.208
   Furumai R, 2010, CANCER SCI, V101, P2483, DOI 10.1111/j.1349-7006.2010.01686.x
   Gale DP, 2010, INT J BIOCHEM CELL B, V42, P486, DOI 10.1016/j.biocel.2009.10.012
   GILBERTSONBEADLING S, 1995, CANCER CHEMOTH PHARM, V36, P418, DOI 10.1007/BF00686191
   Hashimoto K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015430, 10.1371/journal.pone.0015430`]
   Kielian T, 2007, AM J PATHOL, V171, P1199, DOI 10.2353/ajpath.2007.070231
   Kizaka-Kondoh S, 2009, ADV DRUG DELIVER REV, V61, P623, DOI 10.1016/j.addr.2009.01.006
   Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604
   KROON AM, 1984, CANCER LETT, V25, P33, DOI 10.1016/S0304-3835(84)80023-3
   Li C.H., 2013, ARCH TOXICOL
   Liang YX, 2002, J BIOL CHEM, V277, P20087, DOI 10.1074/jbc.M201766200
   Liu WT, 2013, NEURO-ONCOLOGY, V15, P1127, DOI 10.1093/neuonc/not073
   Lokeshwar BL, 2002, INT J CANCER, V98, P297, DOI 10.1002/ijc.10168
   Markovic DS, 2011, BRAIN BEHAV IMMUN, V25, P624, DOI 10.1016/j.bbi.2011.01.015
   Palakurthi SS, 2000, CANCER RES, V60, P2919
   Palakurthi SS, 2001, CANCER RES, V61, P6213
   Park JY, 2009, BIOCHEM BIOPH RES CO, V382, P96, DOI 10.1016/j.bbrc.2009.02.129
   Ranasinghe WKB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054251
   Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714
   Shieh JM, 2010, BRIT J PHARMACOL, V160, P1171, DOI 10.1111/j.1476-5381.2010.00746.x
   VANDENBOGERT C, 1985, LEUKEMIA RES, V9, P617, DOI 10.1016/0145-2126(85)90142-0
   Wei J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016195
   Yao JHS, 2004, CIRC RES, V95, P364, DOI 10.1161/01.RES.0000138581.04174.2f
NR 65
TC 3
Z9 3
U1 1
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 74
EP 82
DI 10.1016/j.abb.2013.12.023
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700009
PM 24412777
ER

PT J
AU Salvi, M
   Raiborg, C
   Hanson, PI
   Campsteijn, C
   Stenmark, H
   Pinna, LA
AF Salvi, Mauro
   Raiborg, Camilla
   Hanson, Phyllis I.
   Campsteijn, Coen
   Stenmark, Harald
   Pinna, Lorenzo A.
TI CK2 involvement in ESCRT-III complex phosphorylation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Protein kinase CK2; ESCRT; CHMP2B; CHMP3; VPS4
ID PROTEIN-KINASE CK2; MAMMALIAN-CELLS; SPECIFICITY; MECHANISMS
AB The multivesicular body (MVB) sorting pathway is a mechanism for delivering transmembrane proteins into the lumen of the lysosome for degradation. ESCRT-III is the final complex in the pathway that assembles on endosomes and executes membrane scission of intraluminal vesicles. In addition, proteins of this complex are involved in other topologically similar processes such as cytokinesis, virus egress and autophagy. Here we show that protein kinase CK2 alpha is involved in the phosphorylation of the ESCRT-III subunits CHMP3 and CHMP2B, as well as of VPS4B/SKD1, an ATPase that mediates ESCRT-III disassembly. This phosphorylation is observed both in vitro and in cells. While we do not observe recruitment of CK2 alpha to endosomes, we demonstrate the localization of CK2 alpha to midbodies during cytokinesis. Phosphomimetic and non-phosphorylatable mutants of ESCRT-III proteins can still bind endosomes and localize to midbodies, indicating that CK2 alpha does not regulate ESCRT-III localization. Finally, we analyzed two cellular functions where CHMP3, CHMP2B and VPS4 are known to be involved, epidermal growth factor degradation and cytokinetic abscission. We demonstrate that the former is impaired by CK2 alpha downregulation whereas the latter is not affected. Taken together, our results indicate that CK2 alpha regulates the function of ESCRT-III proteins in MVB sorting. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Salvi, Mauro; Pinna, Lorenzo A.] Univ Padua, Dept Biomed Sci, Padua, Italy.
   [Raiborg, Camilla; Campsteijn, Coen; Stenmark, Harald] Oslo Univ Hosp, Inst Canc Res, Dept Biochem, Montebello, Norway.
   [Hanson, Phyllis I.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.
   [Pinna, Lorenzo A.] CNR, Inst Neurosci, Padua, Italy.
   [Pinna, Lorenzo A.] VIMM, I-35129 Padua, Italy.
RP Salvi, M (reprint author), Univ Padua, Dept Biomed Sci, Vle G Colombo 3, Padua, Italy.
EM mauro.salvi@unipd.it
OI Salvi, Mauro/0000-0003-3448-6048
FU Progetto Ateneo [CPDA089591/08]; Associazione Italiana per la Ricerca
   sul Cancro, AIRC [IG10312]; EMBO [ASTF 524-2012]
FX CK2 alpha-HA plasmid was a kind gift by D.W. Litchfield. The peptide
   RRRADDSDDDDD was a kind gift by Professor O. Mann (Padova, Italy). This
   work was supported by Progetto Ateneo (CPDA089591/08) (to M.S.) and
   Associazione Italiana per la Ricerca sul Cancro, AIRC (Grant no.
   IG10312) (to L.A.P.). M.S. was supported by an EMBO short-term
   Fellowship (ASTF 524-2012) to visit Stenmark's lab. We also thank Ellen
   Skarpen, the core facility Manager, and the confocal microscopy core
   facility at the Institute for Cancer Research (Oslo) for providing
   access to microscopes.
CR Yamane K, 2005, CANCER RES, V65, P4362, DOI 10.1158/0008-5472.CAN-04-3941
   Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152
   Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013
   Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203
   Salvi M, 2006, FEBS LETT, V580, P3948, DOI 10.1016/j.febslet.2006.06.031
   Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122
   Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931
   Schulenberg B, 2003, J BIOL CHEM, V278, P27251, DOI 10.1074/jbc.C300189200
   Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180
   van der Zee J, 2008, HUM MOL GENET, V17, P313, DOI 10.1093/hmg/ddm309
   Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604
   Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev
   Cesaro L.A., 2013, WILEY IUBMB SERIES B, P117
   Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200
   Piazza F, 2012, LEUKEMIA, V26, P1174, DOI 10.1038/leu.2011.385
   Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3
   Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9
   Pinna L.A., 2013, WILEY IUBMB SERIES B, pXV
   Pinna LA, 2003, ACCOUNTS CHEM RES, V36, P378, DOI 10.1021/ar020164f
   Rusten T. E., 2011, NAT CELL BIOL, V14, P38
   Salvi M., 2012, BIOTECHNIQUES, DOI DOI 10.2144/000113866
   Salvi M, 2012, BIOCHEM BIOPH RES CO, V418, P156, DOI 10.1016/j.bbrc.2011.12.152
   Salvi M., 2010, BIOMOL CONCEPTS, V2, P185
   Toppo S, 2010, CURR BIOINFORM, V5, P141
   Vilk G, 1999, J BIOL CHEM, V274, P14406, DOI 10.1074/jbc.274.20.14406
NR 27
TC 0
Z9 0
U1 1
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 83
EP 91
DI 10.1016/j.abb.2014.01.006
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700010
PM 24440309
ER

PT J
AU Doan, TTN
   Kim, JK
   Ngo, HPT
   Tran, HT
   Cha, SS
   Chung, KM
   Huynh, KH
   Ahn, YJ
   Kang, LW
AF Thanh Thi Ngoc Doan
   Kim, Jin-Kwang
   Ho-Phuong-Thuy Ngo
   Huyen-Thi Tran
   Cha, Sun-Shin
   Chung, Kyung Min
   Huynh, Kim-Hung
   Ahn, Yeh-Jin
   Kang, Lin-Woo
TI Crystal structures of D-alanine-D-alanine ligase from Xanthomonas oryzae
   pv. oryzae alone and in complex with nucleotides
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE D-Alanine-D-alanine ligase (DDL); Drug target; Bacterial cell wall
   synthesis; Xanthomonas oryzae pv. oryzae (Xoo); X-ray crystallography
ID CYSTATHIONINE BETA-LYASE; ALANYL-D-ALANINE; ESCHERICHIA-COLI;
   CRYSTALLIZATION; PHOSPHATE; REFMAC5
AB D-Alanine-D-alanine ligase (DDL) catalyzes the biosynthesis of D-alanyl-D-alanine, an essential bacterial peptidoglycan precursor, and is an important drug target for the development of antibacterials. We determined four different crystal structures of DDL from Xanthomonas oryzae pv. myzae (Xoo) causing Bacteria Blight (BB), which include apo, ADP-bound, ATP-bound, and AMPPNP-bound structures at the resolution between 2.3 and 2.0 angstrom. Similarly with other DDLs, the active site of XoDDL is formed by three loops from three domains at the center of enzyme. Compared with D-alanyl-D-alanine and ATP-bound TtDDL structure, the gamma-phosphate of ATP in XoDDL structure was shifted outside toward solution. We swapped the omega-loop (loop3) of XoDDL with those of Escherichia coli and Helicobacter pylori DDLs, and measured the enzymatic kinetics of wild-type XoDDL and two mutant XoDDLs with the swapped omega-loops. Results showed that the direct interactions between omega-loop and other two loops are essential for the active ATP conformation for D-ala-phosphate formation. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Thanh Thi Ngoc Doan; Kim, Jin-Kwang] Konkuk Univ, Dept Adv Technol Fus, Seoul 14301, South Korea.
   [Ho-Phuong-Thuy Ngo; Huyen-Thi Tran; Huynh, Kim-Hung; Kang, Lin-Woo] Konkuk Univ, Dept Biol Sci, Seoul 143701, South Korea.
   [Cha, Sun-Shin] Korea Inst Ocean Sci & Technol, Marine Biotechnol Res Div, Ansan 426744, South Korea.
   [Chung, Kyung Min] Chonbuk Natl Univ, Sch Med, Dept Microbiol & Immunol, Jeonju 551755, South Korea.
   [Ahn, Yeh-Jin] Sangmyung Univ, Coll Convergence, Dept Green Life Sci, Seoul 110743, South Korea.
   [Kang, Lin-Woo] Sun Yat Sen Univ, Inst Cellular & Struct Bioloy, Guangzhou, Guangdong, Peoples R China.
RP Kang, LW (reprint author), Konkuk Univ, Dept Biol Sci, Seoul 143701, South Korea.
EM Ikang@konkuk.ac.kr
FU Next-Generation BioGreen 21 Program [PJ009082]; Rural Development
   Administration, Republic of Korea; Korean National Research Foundation
   (NRF) [NRF-2012R1A2A2A02005978]; Introduced Innovative R&D Team
   Leadership of Guangdong Province, People's Republic of China
FX We are grateful to Dr. Kunio Hirata at beamline XU32 in RIKEN/SPring-8
   center, JAPAN, and the staff members at beamline 17A in KEK/Photon
   factory for their assistance, respectively. This work was supported by
   Grants from the Next-Generation BioGreen 21 Program (No. PJ009082), the
   Rural Development Administration, Republic of Korea, the Korean National
   Research Foundation (NRF) (NRF-2012R1A2A2A02005978), and the Introduced
   Innovative R&D Team Leadership of Guangdong Province, People's Republic
   of China.
CR Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975
   Fan C, 1997, BIOCHEMISTRY-US, V36, P2531, DOI 10.1021/bi962431t
   Liu SP, 2006, P NATL ACAD SCI USA, V103, P15178, DOI 10.1073/pnas.0604905103
   Breitinger U, 2001, PLANT PHYSIOL, V126, P631, DOI 10.1104/pp.126.2.631
   Kitamura Y, 2009, ACTA CRYSTALLOGR D, V65, P1098, DOI 10.1107/S0907444909029710
   Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508
   Lee BM, 2005, NUCLEIC ACIDS RES, V33, P577, DOI 10.1093/nar/gki206
   NEUHAUS FC, 1962, J BIOL CHEM, V237, P3128
   Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510
   LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5
   MULLINS LS, 1990, J BIOL CHEM, V265, P8993
   Doan TTN, 2008, ACTA CRYSTALLOGR F, V64, P1115, DOI 10.1107/S1744309108028820
   Gasteiger E, 2005, PROTEOMICS PROTOCOLS
   Krissinel E., 2012, J MOL BIOCH, V1, P76
   Laber B, 1996, FEBS LETT, V379, P94, DOI 10.1016/0014-5793(95)01499-3
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Otwinowski Z., 1997, METHOD ENZYMOL, V276, P19
   Soya M., 2009, BIOORG MED CHEM LETT, V19, P1376
   Stevenson R S, 1938, Proc R Soc Med, V31, P661
   Stevenson WO, 1938, CAN MED ASSOC J, V39, P522
   WALSH CT, 1989, J BIOL CHEM, V264, P2393
NR 22
TC 2
Z9 2
U1 5
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 92
EP 99
DI 10.1016/j.abb.2014.01.009
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700011
PM 24440607
ER

PT J
AU Jang, HH
   Dayydov, DR
   Lee, GY
   Yun, CH
   Halpert, JR
AF Jang, Hyun-Hee
   Dayydov, Dmitri R.
   Lee, Ga-Young
   Yun, Chul-Ho
   Halpert, James R.
TI The role of cytochrome P450 2B6 and 2B4 substrate access channel
   residues predicted based on crystal structures of the amlodipine
   complexes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Cytochrome P450 2B4 and 2B6; Substrate access channel 2f and 2a;
   Spectral titrations; Amlodipine
ID ACTIVE-SITE; FLUORESCENT SUBSTRATE; HEME MONOOXYGENASES;
   ESCHERICHIA-COLI; FUNCTIONAL-ROLE; BINDING; P450; 3A4; RESOLUTION;
   MECHANISM
AB Recent X-ray crystal structures of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 in complex with amlodipine showed two bound ligand molecules, one in the active site and one in the substrate access channel. Based on the X-ray crystal structures, we investigated the interactions of P450 2B4 and 2B6 with amlodipine using absorbance spectroscopy, and determined the steady-state kinetics of 7-ethoxy-4-(trifluoromethyl)coumarin and 7-benzyloxyresorufin oxidation by some access channel mutants to evaluate the functional role of these residues in substrate turnover. The results of absorbance titrations are consistent with a simple mechanism with two parallel binding events that result in the formation of the enzyme complex with two molecules of amlodipine. Using this model we were able to resolve two separate ligand-binding events, which are characterized by two distinct KID values in each enzyme. The access channel mutants R73K in P450 2B6 and R73K, V216W, L219W, and F220W in P450 284 showed a significant decrease in k(cat)/K-M with the both substrates. Overall, the results suggest that P450 2B4 and 2B6 form an enzyme complex with two molecules of amlodipine in solution, and R73, V216, L219 and F220 in P450 2B4 may play an important role in substrate metabolism. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Jang, Hyun-Hee; Dayydov, Dmitri R.; Halpert, James R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
   [Lee, Ga-Young; Yun, Chul-Ho] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea.
RP Jang, HH (reprint author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,MC 0703, La Jolla, CA 92093 USA.
EM hyj006@ucsd.edu
FU NIH [ES003619]
FX This research was supported by NIH grant ES003619 to J.R.H.
CR Al Omari A, 2007, J PHARM PRACT, V20, P206
   Fishelovitch D, 2009, J PHYS CHEM B, V113, P13018, DOI 10.1021/jp810386z
   Skopalik J, 2008, J PHYS CHEM B, V112, P8165, DOI 10.1021/jp800311c
   Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q
   Gay SC, 2011, BIOCHEMISTRY-US, V50, P4903, DOI 10.1021/bi200482g
   Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615
   Fernando H, 2011, XENOBIOTICA, V41, P281, DOI 10.3109/00498254.2010.538748
   Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057
   Anzenbacher P, 2008, ACTA CHIM SLOV, V55, P63
   Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140
   Kumar S, 2005, J BIOL CHEM, V280, P19569, DOI 10.1074/jbc.M500158200
   Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999
   HE YQ, 1995, CHEM RES TOXICOL, V8, P574, DOI 10.1021/tx00046a011
   Li WH, 2005, DRUG METAB DISPOS, V33, P910, DOI 10.1124/dmd.105.004200
   Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   Davydov DR, 2012, J BIOL CHEM, V287, P6797, DOI 10.1074/jbc.M111.325654
   Poulos TL, 2005, DRUG METAB DISPOS, V33, P10, DOI 10.1124/dmd.104.002071
   Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200
   POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2
   Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501
   Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075
   Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583
   Honma W, 2005, ARCH BIOCHEM BIOPHYS, V435, P157, DOI 10.1016/j.abb.2004.12.014
   Renaud JP, 1996, BIOCHEM J, V319, P675
   Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420
   Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805
   Poulos TL, 2005, BIOCHEM BIOPH RES CO, V338, P337, DOI 10.1016/j.bbrc.2005.07.204
   Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100
   Johnson EF, 2005, BIOCHEM BIOPH RES CO, V338, P331, DOI 10.1016/j.bbrc.2005.08.190
   Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200
   DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9
   Scott EE, 2002, CHEM RES TOXICOL, V15, P1407, DOI 10.1021/tx020057u
   Scott EE, 2001, ARCH BIOCHEM BIOPHYS, V395, P57, DOI 10.1006/abbi.2001.2574
   Zhang HM, 2013, BIOCHEMISTRY-US, V52, P355, DOI 10.1021/bi301567z
   Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200
   Shah MB, 2012, BIOCHEMISTRY-US, V51, P7225, DOI 10.1021/bi300894z
   Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005
   Davydov DR, 2002, BIOCHEM BIOPH RES CO, V294, P806, DOI 10.1016/S0006-291X(02)00565-X
   Davydov DR, 2008, BIOCHEMISTRY-US, V47, P11348, DOI 10.1021/bi8011803
   Davydov DR, 2006, BIOPHYS CHEM, V123, P95, DOI 10.1016/j.bpc.2006.04.007
   DeVore NM, 2012, J BIOL CHEM, V287, P26576, DOI 10.1074/jbc.M112.372813
   Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103
   Gay SC, 2010, BIOCHEMISTRY-US, V49, P8709, DOI 10.1021/bi100914z
   Harlow GR, 1997, BBA-PROTEIN STRUCT M, V1338, P259, DOI 10.1016/S0167-4838(96)00209-9
   Hodek P, 2007, ARCH BIOCHEM BIOPHYS, V468, P82, DOI 10.1016/j.abb.2007.09.017
   Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z
   Mitsuda M, 2006, PROTEIN EXPRES PURIF, V46, P401, DOI 10.1016/j.pep.2005.10.017
   POULOS TL, 1985, J BIOL CHEM, V260, P6122
   Scott EE, 2004, ARCH BIOCHEM BIOPHYS, V423, P266, DOI 10.1016/j.abb.2003.12.035
   Segel I. H., 1975, ENZYME KINETICS BEHA
   Wade RC, 2004, J INORG BIOCHEM, V98, P1175, DOI 10.1016/j.jinorgbio.2004.02.007
   Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200
NR 53
TC 5
Z9 5
U1 2
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 100
EP 107
DI 10.1016/j.abb.2014.01.008
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700012
PM 24445070
ER

PT J
AU Sun, SF
   Sono, M
   Wang, CX
   Du, J
   Lebioda, L
   Dawson, JH
AF Sun, Shengfang
   Sono, Masanori
   Wang, Chunxue
   Du, Jing
   Lebioda, Lukasz
   Dawson, John H.
TI Influence of heme environment structure on dioxygen affinity for the
   dual function Amphitrite ornata hemoglobin/dehaloperoxidase. Insights
   into the evolutional structure-function adaptations
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Amphitrite ornata dehaloperoxidase (DHP); Sperm whale myoglobin (Mb);
   O-2 affinity; Heme environment mutants; Evolutional structure-function
   adaptations
ID SPERM-WHALE MYOGLOBIN; HYDROGEN-PEROXIDE; HORSERADISH-PEROXIDASE;
   OXYGEN-AFFINITY; DEHALOPEROXIDASE-HEMOGLOBIN; DISTAL POCKET; COMPOUND I;
   LIGAND; BINDING; HALOPHENOL
AB Sea worm, Amphitrite ornata, has evolved its globin (an O-2 carrier) also to serves as a dehaloperoxidase (DHP) to detoxify haloaromatic pollutants generated by competing species. A previous mutagenesis study by our groups on both DHP and sperm whale myoglobin (SW Mb) revealed some structural factors that influence the dehaloperoxidase activities (significantly lower for Mb) of both proteins. Using an isocyanide/O-2 partition constant measurement method in this study, we have examined the effects of these structural factors on the O-2 equilibrium constants (1(O-2) of DHP, SW Mb, and their mutants. A clear trend of decreasing O-2 affinity and increasing catalytic activity along with the increase in the distal His N-epsilon-heme iron distance is observed. An H93K/T95H Mb double mutant mimicking the DHP proximal His positioning exhibited markedly enhanced O-2 affinity, confirming the essential effect of proximal His rotation on the globin function of DHP. For DHP, the L100F, T56G and M86E variants showed the effects of distal volume, distal His flexibility and proximal electronic push, respectively, on the O-2 affinity. This study provides insights into how DHP has evolved its heme environment to gain significantly enhanced peroxidase capability without compromising its primary function as an O-2 carrier. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Sun, Shengfang; Sono, Masanori; Wang, Chunxue; Du, Jing; Lebioda, Lukasz; Dawson, John H.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.
   [Dawson, John H.] Univ S Carolina, Sch Med, Columbia, SC 29208 USA.
RP Sono, M (reprint author), Univ S Carolina, Dept Chem & Biochem, 631 Sumter St, Columbia, SC 29208 USA.
EM msono@mailbox.sc.edu; lebioda@mailbox.sc.edu; jdawson@mailbox.sc.edu
RI Sun, Shengfang/J-2043-2015; 
OI Sun, Shengfang/0000-0002-9491-9338; Dawson, John/0000-0002-4902-4295
FU National Science Foundation [MCB 0820456]
FX This project was supported by the National Science Foundation (MCB
   0820456).
CR Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169
   WEBER RE, 1977, COMP BIOCHEM PHYS A, V56, P179, DOI 10.1016/0300-9629(77)90182-7
   Osborne RL, 2006, J AM CHEM SOC, V128, P1036, DOI 10.1021/ja056213b
   GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014
   HARUTYUNYAN EH, 1995, J MOL BIOL, V251, P104, DOI 10.1006/jmbi.1995.0419
   D'Antonio J, 2011, BIOCHEMISTRY-US, V50, P5999, DOI 10.1021/bi200311u
   CARTER MJ, 1974, J AM CHEM SOC, V96, P392, DOI 10.1021/ja00809a012
   CUTRUZZOLA F, 1991, FEBS LETT, V282, P281, DOI 10.1016/0014-5793(91)80495-O
   Alayash AI, 1999, J BIOL CHEM, V274, P2029, DOI 10.1074/jbc.274.4.2029
   Lebioda L, 2000, CELL MOL LIFE SCI, V57, P1817, DOI 10.1007/PL00000662
   Franzen S, 2001, J AM CHEM SOC, V123, P12578, DOI 10.1021/ja0108988
   Du J, 2010, BIOCHEMISTRY-US, V49, P6064, DOI 10.1021/bi100741z
   Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a
   Antonini E., 1971, HEMOGLOBIN MYOGLOBIN
   BARRICK D, 1994, BIOCHEMISTRY-US, V33, P6546, DOI 10.1021/bi00187a023
   Capece L, 2006, J AM CHEM SOC, V128, P12455, DOI 10.1021/ja0620033
   D'Antonio EL, 2011, BIOCHEMISTRY-US, V50, P9664, DOI 10.1021/bi201368u
   de Serrano V, 2010, ACTA CRYSTALLOGR D, V66, P529, DOI 10.1107/S0907444910004580
   Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200
   Du J, 2011, BIOCHEMISTRY-US, V50, P8172, DOI 10.1021/bi2009129
   Dunford H. B., 1999, HEME PEROXIDASES
   Franzen S., 2012, BIOCHIM BIOPHYS ACTA, V1842, P578
   GIULIVI C, 1993, FEBS LETT, V332, P287, DOI 10.1016/0014-5793(93)80651-A
   Han KP, 2001, MAR BIOTECHNOL, V3, P287, DOI 10.1007/s10126-001-0003-8
   HUFF AM, 1993, INORG CHEM, V32, P1460, DOI 10.1021/ic00060a023
   Ishikawa H, 2001, BIOPHYS J, V80, P1507
   Jiang S, 2013, BBA-PROTEINS PROTEOM, V1834, P2020, DOI 10.1016/j.bbapap.2013.06.005
   Kundu S, 2002, PROTEINS, V46, P268, DOI 10.1002/prot.10048
   LaCount MW, 2000, J BIOL CHEM, V275, P18712, DOI 10.1074/jbc.M001194200
   MAKINO R, 1974, ARCH BIOCHEM BIOPHYS, V165, P485, DOI 10.1016/0003-9861(74)90274-4
   Matsui T, 1999, J AM CHEM SOC, V121, P9952, DOI 10.1021/ja9914846
   Millero FJ, 2002, MAR CHEM, V78, P217, DOI 10.1016/S0304-4203(02)00034-8
   NARULA SS, 1988, EUR J BIOCHEM, V178, P419, DOI 10.1111/j.1432-1033.1988.tb14466.x
   NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4
   OBERG LG, 1985, BIOCHIM BIOPHYS ACTA, V842, P30, DOI 10.1016/0304-4165(85)90289-2
   PAUL KG, 1953, ACTA CHEM SCAND, V7, P1284, DOI 10.3891/acta.chem.scand.07-1284
   Plummer A, 2013, BIOCHEMISTRY-US, V52, P2218, DOI 10.1021/bi301509r
   Pond A.E., 1998, INORG CHIM ACTA, V275, P250, DOI 10.1016/S0020-1693(97)06106-9
   ROBINSON J, 1970, ANAL BIOCHEM, V33, P390, DOI 10.1016/0003-2697(70)90310-6
   RodriguezLopez JN, 1997, J BIOL CHEM, V272, P389
   SCHEIDT WR, 1986, J AM CHEM SOC, V108, P1163, DOI 10.1021/ja00266a008
   Shibata T, 2012, INORG CHEM, V51, P11955, DOI 10.1021/ic301848t
   SMERDON SJ, 1993, BIOCHEMISTRY-US, V32, P5132, DOI 10.1021/bi00070a023
   SONO M, 1975, J BIOL CHEM, V250, P5227
   Sumithran S, 2012, J INORG BIOCHEM, V117, P316, DOI 10.1016/j.jinorgbio.2012.09.017
   TIAN WD, 1993, J MOL BIOL, V233, P155, DOI 10.1006/jmbi.1993.1491
   Wang CX, 2013, BIOCHEMISTRY-US, V52, P6203, DOI 10.1021/bi400627w
   WHITBURN KD, 1987, ARCH BIOCHEM BIOPHYS, V253, P419, DOI 10.1016/0003-9861(87)90195-0
NR 48
TC 4
Z9 4
U1 3
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 108
EP 115
DI 10.1016/j.abb.2014.01.010
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700013
PM 24440609
ER

PT J
AU Jutila, AA
   Zignego, DL
   Hwang, BK
   Hilmer, JK
   Hamerly, T
   Minor, CA
   Walk, ST
   June, RK
AF Jutila, Aaron A.
   Zignego, Donald L.
   Hwang, Bradley K.
   Hilmer, Jonathan K.
   Hamerly, Timothy
   Minor, Cody A.
   Walk, Seth T.
   June, Ronald K.
TI Candidate mediators of chondrocyte mechanotransduction via targeted and
   untargeted metabolomic measurements
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Chondrocyte; Osteoarthritis; Mechanotransduction; Metabolomics; Joint
   biology; Cartilage
ID ATOMIC-FORCE MICROSCOPY; ARTICULAR-CARTILAGE; DYNAMIC COMPRESSION;
   MASS-SPECTROMETRY; CATABOLIC RESPONSES; STRESS-RELAXATION; PROFILE DATA;
   MATRIX; OSTEOARTHRITIS; PROTEIN
AB Chondrocyte mechanotransduction is the process by which cartilage cells transduce mechanical loads into biochemical and biological signals. Previous studies have identified several pathways by which chondrocytes transduce mechanical loads, yet a general understanding of which signals are activated and in what order remains elusive. This study was performed to identify candidate mediators of chondrocyte mechanotransduction using SW1353 chondrocytes embedded in physiologically stiff agarose. Dynamic compression was applied to cell-seeded constructs for 0-30 min, followed immediately by whole-cell metabolite extraction. Metabolites were detected via LC-MS, and compounds of interest were identified via database searches. We found several metabolites which were statistically different between the experimental groups, and we report the detection of 5 molecules which are not found in metabolite databases of known compounds indicating potential novel molecules. Targeted studies to quantify the response of central energy metabolites to compression found a transient increase in the ratio of NADP+ to NADPH and a continual decrease in the ratio of GDP to GTP, suggesting a flux of energy into the TCA cycle. These data are consistent with the remodeling of cytoskeletal components by mechanically induced signaling, and add substantial new data to a complex picture of how chondrocytes transduce mechanical loads. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Jutila, Aaron A.; Zignego, Donald L.; Hwang, Bradley K.; Minor, Cody A.] Montana State Univ, Dept Mech & Ind Engn, Bozeman, MT 59717 USA.
   [June, Ronald K.] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA.
   [Hilmer, Jonathan K.; Hamerly, Timothy] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.
   [Walk, Seth T.] Montana State Univ, Dept Immunol & Microbiol, Bozeman, MT 59717 USA.
RP June, RK (reprint author), Montana State Univ, Dept Cell Biol & Neurosci, POB 173800, Bozeman, MT 59717 USA.
EM rjune@me.montana.edu
FU NIH [P20GM10339405S1]; Montana State University; Murdock Charitable
   Trust
FX We thank Drs. Ross Carlson, Brian Bothner, and Edward Dratz, MSU, for
   critical insight provided during discussions. The SW1353 cell line was
   kindly donated by Martin Lotz. Funding was provided by NIH
   P20GM10339405S1, Montana State University, and the Murdock Charitable
   Trust.
CR Adatia A, 2012, J PHARM PHARMACOL, V64, P617, DOI 10.1111/j.2042-7158.2012.01458.x
   Alberts B, 2002, MOL BIOL CELL
   Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500
   O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862
   Grygorczyk R, 2013, J PHYSIOL-LONDON, V591, P1195, DOI 10.1113/jphysiol.2012.244145
   Haudenschild DR, 2011, J ORTHOP RES, V29, P20, DOI 10.1002/jor.21198
   Ko FC, 2013, ARTHRITIS RHEUM-US, V65, P1569, DOI 10.1002/art.37906
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   Rajpurohit R, 1996, J CELL PHYSIOL, V168, P424, DOI 10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1
   Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2
   Holledge MM, 2008, BIORHEOLOGY, V45, P275, DOI 10.3233/BIR-2008-0476
   Coleman JL, 2013, J BIOMECH, V46, P541, DOI 10.1016/j.jbiomech.2012.09.013
   Neu CP, 2007, ARTHRITIS RHEUM-US, V56, P3706, DOI 10.1002/art.23024
   Mansfield J, 2009, J ANAT, V215, P682, DOI 10.1111/j.1469-7580.2009.01149.x
   Darling EM, 2006, OSTEOARTHR CARTILAGE, V14, P571, DOI 10.1016/j.joca.2005.12.003
   Darling EM, 2010, BIOPHYS J, V98, P2848, DOI 10.1016/j.bpj.2010.03.037
   Haudenschild DR, 2008, BIORHEOLOGY, V45, P219, DOI 10.3233/BIR-2008-0499
   Campbell JJ, 2007, BIOCHEM BIOPH RES CO, V361, P329, DOI 10.1016/j.bbrc.2007.06.185
   Chen J, 2012, BIOPHYS J, V103, P1188, DOI 10.1016/j.bpj.2012.07.054
   Zhu ZJ, 2013, NAT PROTOC, V8, P451, DOI 10.1038/nprot.2013.004
   Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179
   Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200
   Umberger BR, 2007, J EXP BIOL, V210, P3255, DOI 10.1242/jeb.000950
   Ortmann AC, 2008, J VIROL, V82, P4874, DOI 10.1128/JVI.02583-07
   Haudenschild DR, 2010, ARTHRITIS RHEUM-US, V62, P191, DOI 10.1002/art.25051
   Farnsworth N.L., 2013, BIOTECHNOL BIOENG
   FOGH J, 1986, CANCER INVEST, V4, P157, DOI 10.3109/07357908609038260
   GRODZINSKY AJ, 1978, NATURE, V275, P448, DOI 10.1038/275448a0
   Hansen U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052793
   Haudenschild DR, 2008, ARTHRITIS RHEUM-US, V58, P2735, DOI 10.1002/art.23797
   Heinemann J, 2014, BBA-GEN SUBJECTS, V1840, P80, DOI 10.1016/j.bbagen.2013.08.009
   Jutila A.A., 2013, DEV VALIDATION SYSTE, P154
   Kanehisa Minoru, 2013, Methods Mol Biol, V939, P263, DOI 10.1007/978-1-62703-107-3_17
   Kawakita K, 2012, OSTEOARTHR CARTILAGE, V20, P1603, DOI 10.1016/j.joca.2012.08.022
   Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105
   Kisiday JD, 2009, ANN BIOMED ENG, V37, P1368, DOI 10.1007/s10439-009-9699-9
   Knight M.M., 2006, J BIOMECH, V39
   Macdonald DW, 2013, INT J MOL SCI, V14, P16515, DOI 10.3390/ijms140816515
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73
   Niehoff A, 2011, OSTEOARTHR CARTILAGE, V19, P1003, DOI 10.1016/j.joca.2011.04.012
   Nishida T, 2013, OSTEOARTHR CARTILAGE, V21, P700, DOI 10.1016/j.joca.2013.01.013
   Petursson F, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4254
   Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395
   RCTeam, 2013, R LANG ENV STAT COMP
   Schmitt C, 2005, HUM MOL GENET, V14, P3089, DOI 10.1093/hmg/ddi342
   Secor PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040973
   Vaughan NM, 2010, MED BIOL ENG COMPUT, V48, P1215, DOI 10.1007/s11517-010-0681-3
   Wang WJ, 2010, J BIOL CHEM, V285, P36608, DOI 10.1074/jbc.M110.159509
   Ward C. W., 2013, ANTIOXID REDOX SIGNA
   Wilusz R.E., 2013, OSTEOARTHRITIS CARTI
NR 50
TC 1
Z9 1
U1 1
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 116
EP 123
DI 10.1016/j.abb.2014.01.011
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700014
PM 24440608
ER

PT J
AU Wooten, CJ
   Adcock, AF
   Agina-Obu, DI
   Lopez, D
AF Wooten, Catherine J.
   Adcock, Audrey F.
   Agina-Obu, DaTonye I.
   Lopez, Dayami
TI Having excess levels of PCSK9 is not sufficient to induce complex
   formation between PCSK9 and the LDL receptor
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE LDL receptor; LDL; PCSK9; IDOL; Human hepatocyte-like C3A cells
ID DENSITY-LIPOPROTEIN RECEPTOR; CONVERTASE SUBTILISIN/KEXIN TYPE-9;
   HEPATOCELLULAR-CARCINOMA; CHOLESTEROL REDUCTION; MONOCLONAL-ANTIBODY;
   SQUALENE SYNTHASE; ANNEXIN A2; DEGRADATION; INHIBITION; STATINS
AB Proprotein convertase subtilisin/kexin-9 (PCSK9) acts mainly by forming complexes with the LDL receptor at the cell surface, which are then degraded in the lysosome. Studies were performed to determine whether excess levels of PCSK9 was sufficient to induce PCSK9/LDL receptor complex formation in human hepatocyte-like C3A cells. It was demonstrated using ELISA that instead of considering the overall levels of PCSK9 protein that is produced in response to certain treatment, what is critical is how much PCSK9 is actually capable of forming complexes. Despite the high levels, most of the PCSK9 produced as a result of incubating cells with a medium supplemented with BD (TM) MITO+ serum extender (MITO+ medium) appeared to be inhibited by a secreted factor. Having lower levels of PCSK9/LDL receptor complexes did not prevent an increase in the degradation rate of LDL receptors in MITO+ medium as compared to fetal bovine serum (FBS) containing medium (Regular medium), an effect that did not correlate with an increase in protein levels of the inducible degrader of LDL receptors (IDOL), as demonstrated using Western blotting analysis. Additional studies are required to determine the exact mechanism(s) for the degradation of the LDL receptor and/or to identify the secreted inhibitor of PCSK9. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wooten, Catherine J.; Adcock, Audrey F.; Agina-Obu, DaTonye I.; Lopez, Dayami] N Carolina Cent Univ, Coll Arts & Sci, BR1TE, Dept Pharmaceut Sci, Durham, NC 27707 USA.
RP Lopez, D (reprint author), N Carolina Cent Univ, Coll Arts & Sci, BR1TE, Dept Pharmaceut Sci, 1801 Fayetteville St, Durham, NC 27707 USA.
EM lopezd@nccu.edu
FU State of North Carolina; Golden LEAF Foundation
FX The project described was supported by funds from the State of North
   Carolina. The authors would like to acknowledge the support of the
   Golden LEAF Foundation and Dr. Li-An Yeh. We also want to thank Dr. Gene
   C. Ness (Department of Molecular Medicine, University of South Florida,
   Tampa, FL) for kindly providing the rabbit LDL receptor specific
   antibody.
CR Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Chasman DI, 2012, CIRC-CARDIOVASC GENE, V5, P257, DOI 10.1161/CIRCGENETICS.111.961144
   Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055
   Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370
   Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200
   Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104
   Kelly JH, 2000, J BIOMOL SCREEN, V5, P249, DOI 10.1089/108705700416119
   Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488
   Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423
   Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383
   Du JX, 2011, J BIOL CHEM, V286, P40354, DOI 10.1074/jbc.M111.258707
   Calkin AC, 2011, P NATL ACAD SCI USA, V108, P20107, DOI 10.1073/pnas.1111589108
   Davignon J, 2010, CURR ATHEROSCLER REP, V12, P308, DOI 10.1007/s11883-010-0123-6
   Suzuki N, 2004, J BIOL CHEM, V279, P17785, DOI 10.1074/jbc.M310772200
   Visser ME, 2012, EUR HEART J, V33, P1451, DOI 10.1093/eurheartj/ehs084
   Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200
   Sun YL, 2013, CARCINOGENESIS, V34, P595, DOI 10.1093/carcin/bgs372
   Lipari MT, 2012, J BIOL CHEM, V287, P43482, DOI 10.1074/jbc.M112.380618
   Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200
   Li N, 2004, AM J PHYSIOL-GASTR L, V287, pG726, DOI 10.1152/ajpgi.00012.2004
   Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200
   Ji NY, 2009, INT J MOL MED, V24, P765, DOI 10.3892/ijmm_00000290
   Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102
   Shen L, 2013, PHARMACOL RES, V73, P27, DOI 10.1016/j.phrs.2013.04.001
   BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8
   Bedi M, 2008, ARCH BIOCHEM BIOPHYS, V470, P116, DOI 10.1016/j.abb.2007.11.011
   Chong PH, 2000, DRUGS, V60, P55, DOI 10.2165/00003495-200060010-00005
   ESKO JD, 1983, J BIOL CHEM, V258, P3051
   Kohli P, 2012, CLIN CARDIOL, V35, P385, DOI 10.1002/clc.22014
   Lopez D, 1998, ARCH BIOCHEM BIOPHYS, V351, P159, DOI 10.1006/abbi.1997.0556
   McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200
   Ness GC, 1996, ARCH BIOCHEM BIOPHYS, V325, P242, DOI 10.1006/abbi.1996.0030
   Sawamura T, 2009, CLIN CHEM, V55, P2082, DOI 10.1373/clinchem.2009.134023
   Sorrentino V, 2011, J BIOL CHEM, V286, P30190, DOI 10.1074/jbc.M111.249557
   Tveten K, 2012, HUM MOL GENET, V21, P1402, DOI 10.1093/hmg/ddr578
   van Poelgeest EP, 2013, AM J KIDNEY DIS, V62, P796, DOI 10.1053/j.ajkd.2013.02.359
NR 37
TC 5
Z9 5
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 124
EP 132
DI 10.1016/j.abb.2014.01.018
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700015
PM 24486405
ER

PT J
AU Chang, JW
   Kang, SU
   Shin, YS
   Kim, KI
   Seo, SJ
   Yang, SS
   Lee, JS
   Moon, E
   Baek, SJ
   Lee, K
   Kim, CH
AF Chang, Jae Won
   Kang, Sung Un
   Shin, Yoo Seob
   Kim, Kang Il
   Seo, Seong Jin
   Yang, Sang Sik
   Lee, Jong-Soo
   Moon, Eunpyo
   Baek, Seung Jae
   Lee, Keunho
   Kim, Chul-Ho
TI Non-thermal atmospheric pressure plasma induces apoptosis in oral cavity
   squamous cell carcinoma: Involvement of DNA-damage-triggering sub-G(1)
   arrest via the ATM/p53 pathway
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Non-thermal atmospheric pressure plasma (NTP); Oral cavity squamous cell
   carcinoma (OSCC); DNA damage; Sub-G(1) arrest; Ataxia telangiectasia
   mutated (ATM); p53
ID P53; CANCER; ATM; MECHANISM; GROWTH; HEAD
AB Recent advances in physics have made possible the use of non-thermal atmospheric pressure plasma (NTP) in cancer research. Although increasing evidence suggests that NTP induces death of various cancer cell types, thus offering a promising alternative treatment, the mechanism of its therapeutic effect is little understood. In this study, we report for the first time that NTP led to apoptotic cell death in oral cavity squamous cell carcinoma (OSCC). Interestingly, NTP induced a sub-G(1) arrest in p53 wild-type OSCCs, but not in p53-mutated OSCCs. In addition, NTP increased the expression levels of ATM, p53 (Ser 15, 20 and 46), p21, and cyclin D1. A comet assay, Western blotting and immunocytochemistry of gamma H2AX suggested that NTP-induced apoptosis and sub-G(1) arrest were associated with DNA damage and the ATM/p53 signaling pathway in SCC25 cells. Moreover, ATM knockdown using siRNA attenuated the effect of NTP on cell death, sub-G(1) arrest and related signals. Taken together, these results indicate that NTP induced apoptotic cell death in p53 wild-type OSCCs through a novel mechanism involving DNA damage and triggering of sub-G(1) arrest via the ATM/p53 pathway. These findings show the therapeutic potential of NTP in OSCC. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Chang, Jae Won; Kang, Sung Un; Shin, Yoo Seob; Seo, Seong Jin; Kim, Chul-Ho] Ajou Univ, Dept Otolaryngol, Sch Med, Suwon 442749, Gyounggi Do, South Korea.
   [Kim, Kang Il; Yang, Sang Sik] Ajou Univ, Dept Elect & Comp Engn, Suwon 442749, Gyounggi Do, South Korea.
   [Lee, Jong-Soo; Moon, Eunpyo] Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, Gyounggi Do, South Korea.
   [Lee, Jong-Soo; Moon, Eunpyo] Ajou Univ, Dept Life Sci, Suwon 442749, Gyounggi Do, South Korea.
   [Baek, Seung Jae] Yonsei Univ, Wonju Coll Med, Dept Otolaryngol Head & Neck Surg, Wonju, Gangwon Do, South Korea.
   [Lee, Keunho] PSM Amer Inc, Colorado Springs, CO USA.
RP Kim, CH (reprint author), Ajou Univ, Dept Otolaryngol, Sch Med, 5 Wonchon Dong, Suwon 442749, Gyounggi Do, South Korea.
EM ostium@ajou.ac.kr
FU Bio & Medical Technology Development Program of the NRF; Korean
   government [2012M3A9B2052870]
FX This research was supported by the Bio & Medical Technology Development
   Program of the NRF funded by the Korean government (2012M3A9B2052870).
CR Bolt J, 2005, ORAL ONCOL, V41, P1013, DOI 10.1016/j.oraloncology.2005.06.003
   Lim D, 2009, CANCER LETT, V276, P109, DOI 10.1016/j.canlet.2008.10.038
   Cheng Q, 2010, CELL CYCLE, V9, P472
   Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325
   AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493
   Lam L, 2013, ORAL ONCOL, V49, P507, DOI 10.1016/j.oraloncology.2013.03.001
   Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x
   Zhang ZY, 2013, INT J ONCOL, V43, P289, DOI 10.3892/ijo.2013.1946
   Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X
   Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200
   Seward S, 2013, CANCER LETT, V336, P53, DOI 10.1016/j.canlet.2013.04.012
   Kim CH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3449575
   Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252
   Hurley PJ, 2007, CELL CYCLE, V6, P414
   Ouyang GL, 2009, CELL BIOL INT, V33, P1237, DOI 10.1016/j.cellbi.2009.08.011
   Berglind H, 2008, CANCER BIOL THER, V7, P699, DOI 10.4161/cbt.7.5.5712
   Cavicchi O, 2000, Acta Otorhinolaryngol Ital, V20, P413
   Ishaq M, 2014, INT J CANCER, V134, P1517, DOI 10.1002/ijc.28323
   Kalghatgi S., 2011, PLOS ONE, V6
   Kang J, 2005, MOL CELL BIOL, V25, P661, DOI 10.1128/MCB.25.2.661-670.2005
   Kang SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034988
   Mendoza-Rodriguez CA, 2001, REV INVEST CLIN, V53, P266
   Sachweh MCC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.61
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
NR 24
TC 8
Z9 8
U1 4
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 133
EP 140
DI 10.1016/j.abb.2014.01.022
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700016
PM 24486404
ER

PT J
AU Ledetzky, N
   Osawa, A
   Iki, K
   Pollmann, H
   Gassel, S
   Breitenbach, J
   Shindo, K
   Sandmann, G
AF Ledetzky, Nadine
   Osawa, Ayako
   Iki, Kanoko
   Pollmann, Hendrik
   Gassel, Soeren
   Breitenbach, Juergen
   Shindo, Kazutoshi
   Sandmann, Gerhard
TI Multiple transformation with the crtYB gene of the limiting enzyme
   increased carotenoid synthesis and generated novel derivatives in
   Xanthophyllomyces dendrorhous
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Astaxanthin biosynthesis; crtYB gene; 3-HO-4-keto-7 ',8
   '-dihydro-beta-carotene; Ketocarotenoids; Xanthophyllomces dendrorhous
   (=Phaffia rhodozyma)
ID PHAFFIA-RHODOZYMA; ESCHERICHIA-COLI; BIOSYNTHETIC-PATHWAY; PHYTOENE
   DESATURASE; BETA-CAROTENE; ASTAXANTHIN; CLONING; EXPRESSION; KETOLASE;
   CANTHAXANTHIN
AB Xanthophyllomces dendrorhous (in asexual state named as Phaffia rhodozyma) is a fungus which produces astaxanthin, a high value carotenoid used in aquafarming. Genetic pathway engineering is one of several steps to increase the astaxanthin yield. The limiting enzyme of the carotenoid pathway is phytoene synthase. Integration plasmids were constructed for transformation with up to three copies of the crtYB gene. Upon stepwise transformation, the copy numbers of crtYB was continuously increased leading to an almost saturated level of phytoene synthase as indicated by total carotenoid content. Several carotenoid intermediates accumulated which were absent in the wild type. Some of them are substrates and intermediates of astaxanthin synthase. They could be further converted into astaxanthin by additional transformation with the astaxanthin synthase gene. However, three intermediates exhibited an unusual optical absorbance spectrum not found before. These novel keto carotenoid were identified by HPLC co-chromatography with reference compounds generated in Escherichia coli and one of them 3-HO-4keto-7',8'-dihydro-beta-carotene additionally by NMR spectroscopy. The others were 4-keto-beta-zeacarotene and 4-keto-7',8'-dihydro-beta-carotene. A biosynthesis pathway with their origin from neurosporene and the reason for their synthesis especially in our transformants has been discussed. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Sandmann, Gerhard] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany.
   Japan Womens Univ, Dept Food & Nutr, Bunkyo Ku, Tokyo 1128681, Japan.
RP Sandmann, G (reprint author), Goethe Univ Frankfurt, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.
EM sandmann@bio.uni-frankfurt.de
FU LOEWE Project "Integrative Pilzforschung"
FX This work was supported by the LOEWE Project "Integrative
   Pilzforschung".
CR Albrecht M, 1997, J BIOTECHNOL, V58, P177, DOI 10.1016/S0168-1656(97)00151-X
   Alcaino J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-169
   ANDREWES AG, 1976, PHYTOCHEMISTRY, V15, P1009, DOI 10.1016/S0031-9422(00)84391-5
   Albrecht M, 2001, PHOTOCHEM PHOTOBIOL, V73, P551, DOI 10.1562/0031-8655(2001)073<0551:EOAKGM>2.0.CO;2
   PALOZZA P, 1992, ARCH BIOCHEM BIOPHYS, V297, P291, DOI 10.1016/0003-9861(92)90675-M
   DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0
   MISAWA N, 1995, J BACTERIOL, V177, P6575
   Gotz T, 2002, PLANT MOL BIOL, V50, P129, DOI 10.1023/A:1016072218801
   LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536
   Schmidt I, 2011, APPL MICROBIOL BIOT, V89, P555, DOI 10.1007/s00253-010-2976-6
   Verdoes JC, 1999, MOL GEN GENET, V262, P453, DOI 10.1007/s004380051105
   GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8
   Verdoes JC, 2003, APPL ENVIRON MICROB, V69, P3728, DOI 10.1128/AEM.69.7.3728-3738.2003
   KOVACH ME, 1994, BIOTECHNIQUES, V16, P800
   Rodriguez-Saiz M, 2010, APPL MICROBIOL BIOT, V88, P645, DOI 10.1007/s00253-010-2814-x
   Takaichi S, 1996, EUR J BIOCHEM, V241, P291, DOI 10.1111/j.1432-1033.1996.0291t.x
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Verdoes JC, 1999, BIOTECHNOL BIOENG, V63, P750, DOI 10.1002/(SICI)1097-0290(19990620)63:6<750::AID-BIT13>3.0.CO;2-7
   BEYER P, 1979, HELV CHIM ACTA, V62, P2551, DOI 10.1002/hlca.19790620807
   Breitenbach J, 1996, FEMS MICROBIOL LETT, V140, P241, DOI 10.1016/0378-1097(96)00187-5
   Breitenbach J, 2013, ARCH BIOCHEM BIOPHYS, V529, P86, DOI 10.1016/j.abb.2012.11.003
   Hausmann A, 2000, FUNGAL GENET BIOL, V30, P147, DOI 10.1006/fgbi.2000.1212
   KRUGEL H, 1988, GENE, V62, P209, DOI 10.1016/0378-1119(88)90559-8
   LINDEN H, 1993, FEMS MICROBIOL LETT, V106, P99, DOI 10.1111/j.1574-6968.1993.tb05941.x
   Mortensen A., 2006, CAROTENOIDS NUTR HLT, V5
   Ojima K, 2006, MOL GENET GENOMICS, V275, P148, DOI 10.1007/s00438-005-0072-x
   Ruther A, 1997, APPL MICROBIOL BIOT, V48, P162, DOI 10.1007/s002530051032
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCHROEDER WA, 1995, J IND MICROBIOL, V14, P502, DOI 10.1007/BF01573965
   Stickforth P, 2007, ARCH BIOCHEM BIOPHYS, V461, P235, DOI 10.1016/j.abb.2007.02.035
   Strobel I, 2009, CURR GENET, V55, P175, DOI 10.1007/s00294-009-0235-0
   Visser H, 2005, METHODS BIOTECHNOLOG, P257, DOI 10.1385/1-59259-847-1:257
NR 32
TC 0
Z9 0
U1 2
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 141
EP 147
DI 10.1016/j.abb.2014.01.014
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700017
PM 24486200
ER

PT J
AU de Vega, S
   Suzuki, N
   Nonaka, R
   Sasaki, T
   Forcinito, P
   Arikawa-Hirasawa, E
   Yamada, Y
AF de Vega, Susana
   Suzuki, Nobuharu
   Nonaka, Risa
   Sasaki, Takako
   Forcinito, Patricia
   Arikawa-Hirasawa, Eri
   Yamada, Yoshihiko
TI A C-terminal fragment of fibulin-7 interacts with endothelial cells and
   inhibits their tube formation in culture
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Fibulin-7 fragment; Endothelial cells; Angiogenesis
ID BASEMENT-MEMBRANE; TUMOR-GROWTH; CYTOSKELETAL DYNAMICS; ENDOGENOUS
   INHIBITOR; EXTRACELLULAR-MATRIX; FOCAL ADHESIONS; ANGIOGENESIS; BINDING;
   ANGIOSTATIN; ENDOSTATIN
AB We have previously demonstrated that fibulin-7 (Fbln7) is expressed in teeth by pre-odontoblast and odontoblast cells, localized in the basement membrane and dentin matrices, and is an adhesion molecule for dental mesenchyme cells and odontoblasts. Fbln7 is also expressed in blood vessels by endothelial cells. In this report, we show that a recombinant C-terminal Fbln7 fragment (Fbln7-C) bound to Human Umbilical Vein Endothelial Cells (HUVECs) but did not promote cell spreading and actin stress fiber formation. Fbln7-C binding to HUVECs induced integrin clustering at cell adhesion sites with other focal adhesion molecules, and sustained activation of PAK, p130Cas, and Ran. In addition, RhoA activation was inhibited, thereby preventing HUVEC spreading. As endothelial cell spreading is an important step for angiogenesis, we examined the effect of Fbln7-C on angiogenesis using in vitro assays for endothelial cell tube formation and vessel sprouting from aortic rings. We found that Fbln7-C inhibited the HUVEC tube formation and the vessel sprouting in aortic ring assays. Our findings suggest potential anti-angiogenic activity of the Fbln7 C-terminal region. Published by Elsevier Inc.
C1 [de Vega, Susana; Suzuki, Nobuharu; Forcinito, Patricia; Yamada, Yoshihiko] NIDCR, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA.
   [de Vega, Susana; Nonaka, Risa; Arikawa-Hirasawa, Eri] Juntendo Univ, Sch Med, Res Inst Dis Old Age, Tokyo 1138421, Japan.
   [Suzuki, Nobuharu] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Biochem & Biophys, Tokyo 1138510, Japan.
   [Sasaki, Takako] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Expt Med, D-91054 Erlangen, Germany.
RP Yamada, Y (reprint author), NIDCR, NIH, Bldg 30,Rm 407,30 Convent Dr MSC 4370, Bethesda, MD 20892 USA.
EM yoshi.yamada@nih.gov
FU NIDCR, NIH, USA; Ministry of Education, Culture, Sports, Science and
   Technology (MEXT)
FX We thank Deborah Philp and Vira Artym for their valuable suggestions,
   and Kenneth Yamada for the beta<INF>1</INF> integrin antibody. This work
   was supported by the Intramural Research Program of the NIDCR, NIH, USA
   (Y.Y.) and by the Ministry of Education, Culture, Sports, Science and
   Technology (MEXT) supported program for the Strategic Research
   Foundation at private universities 2011-2015 in Japan (E.A.-H. and
   S.V.).
CR KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1
   Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857
   Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096
   de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6
   Law EWL, 2012, ONCOGENE, V31, P728, DOI 10.1038/onc.2011.272
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   O'Reilly M S, 1997, EXS, V79, P273
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Couchman JR, 1999, J CELL SCI, V112, P3415
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Tran H, 1997, J BIOL CHEM, V272, P22600, DOI 10.1074/jbc.272.36.22600
   Ricard-Blum S, 2011, FRONT BIOSCI-LANDMRK, V16, P674, DOI 10.2741/3712
   Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957
   Gallagher WM, 2005, TRENDS MOL MED, V11, P336, DOI 10.1016/j.molmed.2005.06.001
   Schmidt G, 1997, NATURE, V387, P725
   Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI [10.1016/S0076-6879(08)02007-7, 10.1016/SO076-6879(08)02007-7]
   de Vega S, 2007, J BIOL CHEM, V282, P30878, DOI 10.1074/jbc.M705847200
   Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033
   Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4
   Albig AR, 2004, DNA CELL BIOL, V23, P367, DOI 10.1089/104454904323145254
   Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6
   Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216
   Sullivan KM, 2007, LAB INVEST, V87, P818, DOI 10.1038/labinvest.3700594
   Chu Mon-Li, 2004, Birth Defects Res C Embryo Today, V72, P25, DOI 10.1002/bdrc.20003
   Chung AS, 2010, ANNU REV CELL DEV BI, V27, P563
   Feldman AL, 2001, CANCER, V91, P1525, DOI 10.1002/1097-0142(20010415)91:8<1525::AID-CNCR1161>3.0.CO;2-P
   Fleming YM, 2004, J CELL SCI, V117, P2377, DOI 10.1242/jcs.01096
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   Sharma A, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-50
   Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167
NR 33
TC 0
Z9 0
U1 4
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 148
EP 153
DI 10.1016/j.abb.2014.01.013
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700018
PM 24480309
ER

PT J
AU Hu, MY
   Qin, YX
AF Hu, Minyi
   Qin, Yi-Xian
TI Dynamic fluid flow stimulation on cortical bone and alterations of the
   gene expressions of osteogenic growth factors and transcription factors
   in a rat functional disuse model
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Bone microarchitecture; Cell signaling; Bone mechanotransduction;
   Transcription factors; Osteoporosis; Osteogenic growth factors
ID RANDOM POSITIONING MACHINE; MESENCHYMAL STEM-CELLS; LOADING IN-VIVO;
   CLINICAL-APPLICATIONS; TRABECULAR BONE; OSTEOBLAST PROLIFERATION;
   BIOLOGY; DIFFERENTIATION; ADAPTATION; OSTEOPONTIN
AB Recently we have developed a dynamic hydraulic stimulation (DHS) as a loading modality to induce anabolic responses in bone. To further study the functional process of DHS regulated bone metabolism, the objective of this study was to evaluate the effects of DHS on cortical bone and its alterations on gene expressions of osteogenic growth factors and transcription factors as a function of time. Using a model system of 5-month-old hindlimb suspended (HLS) female Sprague-Dawley rats, DHS was applied to the right tibiae of the stimulated rats with a loading frequency of 2 Hz with 30 mmHg (p-p) dynamic pressure, 5 days/week, for a total of 28 days. Midshafts of the tibiae were analyzed using mu CT and histology. Total RNA was analyzed using RT-PCR on selected osteogenic genes (RUNX2, beta-catenin, osteopontin, VEGF, BMP2, IGF-1, and TGF-beta) on 3-, 7-, 14-, and 21-day. Results showed increased Cort.Th and Ct.BV/TV as well as a time-dependent fashion of gradual changes in mRNA levels upon DHS. While DHS-driven fold changes of the mRNA levels remained low before Day-7, its fold changes started to elevate by Day-14 and then dropped by Day-21. This study further delineates the underlying molecular mechanism of DHS-derived mechanical signals, and its time-dependent optimization. (C) 2014 Published by Elsevier Inc.
C1 [Hu, Minyi; Qin, Yi-Xian] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
RP Qin, YX (reprint author), SUNY Stony Brook, Dept Biomed Engn, Bioengn Bldg,Rm 215, Stony Brook, NY 11794 USA.
EM Yi-Xian.Qin@stonybrook.edu
FU National Institute of Health [R01 AR52379, AR61821]; US Army Medical
   Research and Materiel Command; National Space Biomedical Research
   Institute through NASA [NCC 9-58]
FX This research is kindly supported by the National Institute of Health
   (R01 AR52379 and AR61821), the US Army Medical Research and Materiel
   Command, and the National Space Biomedical Research Institute through
   NASA Cooperative Agreement NCC 9-58. The authors are grateful to
   Michelle Lien and Alyssa Tuthill for their excellent technical supports.
CR Ahdjoudj S, 2002, J BONE MINER RES, V17, P668, DOI 10.1359/jbmr.2002.17.4.668
   Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8
   Forwood MR, 1996, AM J PHYSIOL-ENDOC M, V270, pE419
   Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032
   Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660
   Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067
   Patel MJ, 2007, J CELL BIOCHEM, V101, P587, DOI 10.1002/jcb.21218
   Lin Z, 2014, J DENT RES, V93, P109, DOI 10.1177/0022034513506445
   Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116
   Ziros PG, 2008, INT J BIOCHEM CELL B, V40, P1659, DOI 10.1016/j.biocel.2007.05.024
   Schriefer JL, 2005, J BIOMECH, V38, P1838, DOI 10.1016/j.jbiomech.2004.08.017
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Allen MR, 2004, BONE, V35, P1003, DOI 10.1016/j.bone.2004.07.014
   Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030
   Zelzer E, 2005, CURR TOP DEV BIOL, V65, P169
   Ishijima M, 2007, J ENDOCRINOL, V193, P235, DOI 10.1677/joe.1.06704
   Hu MY, 2013, BONE, V57, P137, DOI 10.1016/j.bone.2013.07.030
   Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674
   Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119
   Papachroni KK, 2009, TRENDS MOL MED, V15, P208, DOI 10.1016/j.molmed.2009.03.001
   Tang LL, 2006, ARCH ORAL BIOL, V51, P1080, DOI 10.1016/j.archoralbio.2006.06.009
   Ishijima M, 2002, J BONE MINER RES, V17, P661, DOI 10.1359/jbmr.2002.17.4.661
   Zhang P, 2009, BONE, V44, P989, DOI 10.1016/j.bone.2009.01.367
   Hu MY, 2012, BONE, V51, P819, DOI 10.1016/j.bone.2012.06.030
   Bikle DD, 2008, OSTEOPOROSIS INT, V19, P1237, DOI 10.1007/s00198-008-0597-z
   Cillo JE, 2000, ORAL SURG ORAL MED O, V90, P147, DOI 10.1067/moe.2000.107531
   Duncan R L, 1995, ASGSB Bull, V8, P49
   Heino TJ, 2008, CURR STEM CELL RES T, V3, P131, DOI 10.2174/157488808784223032
   Hu MY, 2013, BONE RES, V1, DOI 10.4248/BR201301007
   Kreja L, 2008, BIOCHEM BIOPH RES CO, V368, P582, DOI 10.1016/j.bbrc.2008.01.106
   Laughlin MH, 2005, J APPL PHYSIOL, V99, P774, DOI 10.1152/japplphysiol.00578.2005
   Mantila Roosa SM, 2012, GENE REGULATION SYST, V6, P43
   Ng AFS, 2006, FRONT BIOSCI, V11, P949, DOI 10.2741/1851
   Otter MW, 1999, MED HYPOTHESES, V53, P363, DOI 10.1054/mehy.1998.0782
   Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223
   Papadopoulou AK, 2007, FEBS LETT, V581, P2041, DOI 10.1016/j.febslet.2007.04.037
   Pardo SJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1211, DOI 10.1152/ajpcell.00222.2004
   Qin YX, 2010, J MUSCULOSKEL NEURON, V10, P12
   Turner CH, 1998, BONE, V22, P463, DOI 10.1016/S8756-3282(98)00041-6
   Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064
   Winet H., 2003, EUR CELLS MATER, V6, P10
   Winet H., 2003, European Cells & Materials, V6, P1
   Zhang Ping, 2008, Genomics Proteomics & Bioinformatics, V6, P4, DOI 10.1016/S1672-0229(08)60016-9
   ZHANG RW, 1991, BONE MINER, V13, P201, DOI 10.1016/0169-6009(91)90069-C
NR 45
TC 5
Z9 5
U1 2
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 154
EP 161
DI 10.1016/j.abb.2014.01.021
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700019
PM 24486201
ER

PT J
AU Li, JL
   Cai, WS
   Shen, F
   Feng, Z
   Zhu, GH
   Cao, J
   Xu, B
AF Li, Jiang-lin
   Cai, Wen-song
   Shen, Fei
   Feng, Zhe
   Zhu, Guang-hui
   Cao, Jie
   Xu, Bo
TI Protease-activated receptor-2 modulates hepatic stellate cell collagen
   release and apoptotic status
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Hepatic fibrosis; Hepatic stellate cells; Protease-activated receptor 2;
   Collagen; Apoptosis
ID MAST-CELL; FIBROSIS; BETA; TRYPTASE; THERAPY; DEATH
AB The pathogenesis of hepatic fibrosis is to be further investigated. Protease-activated receptor-2 (PAR2) plays a role in hepatic fibrosis. This study aims to elucidate the role of activation of PAR2 in the regulation of hepatic stellate cell activities. In this study, the expression of PAR2, Fas and caveolin-1 in human hepatic stellate cell line, HHStec cell (HHStecs) was assessed by real time RT-PCR and Western blot. The levels of collagen were determined by enzyme-linked immunosorbent assay. The PAR2 gene was silenced in HHStecs using RNA interference. Apoptosis of HHStecs was assessed by flow cytometry. The results showed that HHStecs expressed PAR2, which was up regulated by activation with phorbol myristate acetate (PMA). Activation of PAR2 increased the release of collagen from HHStecs. Exposure to PMA induced HHStec apoptosis, which was significantly inhibited by activation of PAR2. The PAR2 activation also suppressed the expression of caveolin-1 and Fas in HHStecs. Over expression of caveolin-1 in HHStecs blocked PAR2-reduced apoptosis. We conclude that HHStecs express PAR2. Activation of PAR2 increases HHStecs to release collagen and reduces the activation-induced HHStec apoptosis, which can be inhibited by the over expression of caveolin-1. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Li, Jiang-lin; Cai, Wen-song; Shen, Fei; Feng, Zhe; Zhu, Guang-hui; Cao, Jie; Xu, Bo] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China.
RP Xu, B (reprint author), Guangzhou First Peoples Hosp, Dept Gen Surg, 1 Panfu Rd, Guangzhou 510180, Guangdong, Peoples R China.
EM BoXu44@163.com
FU Guangdong Province Science and technology plan project [2009B060700019];
   Guangzhou City Medical Science and Technology key project
   [201102A212018]; Research Fund of Bao-en Wang liver fibrosisi [20100020]
FX This work was supported by Guangdong Province Science and technology
   plan project (2009B060700019) and Guangzhou City Medical Science and
   Technology key project (201102A212018) and Research Fund of Bao-en Wang
   liver fibrosisi (20100020).
CR Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x
   Lohman RJ, 2012, FASEB J, V26, P2877, DOI 10.1096/fj.11-201004
   Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487
   Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Gressner AM, 2002, FRONT BIOSCI, V7, pD793, DOI 10.2741/gressner
   Su X, 2009, ANAT REC, V292, P580, DOI 10.1002/ar.20846
   CLAMAN HN, 1990, RHEUM DIS CLIN N AM, V16, P141
   Figgett WA, 2013, IMMUNITY, V39, P573, DOI 10.1016/j.immuni.2013.05.019
   Fukuoka Y, 2007, INT IMMUNOPHARMACOL, V7, P1900, DOI 10.1016/j.intimp.2007.07.007
   Huang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073492
   Knight V, 2012, HEPATOLOGY, V55, P879, DOI 10.1002/hep.24784
   Koruk ST, 2011, INDIAN J PATHOL MICR, V54, P736, DOI 10.4103/0377-4929.91510
   Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006
   MUNN DH, 1995, J EXP MED, V181, P127, DOI 10.1084/jem.181.1.127
   Schachtrup C, 2011, CELL CYCLE, V10, P1764, DOI 10.4161/cc.10.11.15828
   Shen DZ, 2008, MED HYPOTHESES, V70, P760, DOI 10.1016/j.mehy.2007.07.042
   Yolcu ES, 2008, IMMUNOL CELL BIOL, V86, P650, DOI 10.1038/icb.2008.62
   Zhang M, 2011, FREE RADICAL BIO MED, V50, P1252, DOI 10.1016/j.freeradbiomed.2011.02.031
   Zhao XY, 2013, TRANSPL P, V45, P824, DOI 10.1016/j.transproceed.2012.02.049
   Zois CD, 2008, ALIMENT PHARM THER, V28, P1175, DOI 10.1111/j.1365-2036.2008.03840.x
NR 21
TC 0
Z9 0
U1 2
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 162
EP 166
DI 10.1016/j.abb.2014.01.027
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700020
PM 24495782
ER

PT J
AU Lemeshko, VV
AF Lemeshko, Victor V.
TI Competitive interactions of amphipathic polycationic peptides and
   cationic fluorescent probes with lipid membrane: Experimental approaches
   and computational model
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Polycationic peptides; Fluorescent probes; Mitochondria; Liposomes;
   Peptide-membrane interaction; Computational model
ID HOST-DEFENSE PEPTIDES; HELICAL ANTIMICROBIAL PEPTIDES; CELL-SURFACE;
   DIS-C3-(5); MECHANISM; PERMEABILIZATION; BINDING; PORE; CYTOTOXICITY;
   PERSPECTIVES
AB The electrostatic interaction of polycationic peptides with negatively charged biomembranes has been recognized as the first and very important step of their selective binding to many bacteria and transformed cells. In this work we demonstrated the phenomenon of competition of some earlier designed polycationic peptides and fluorescent probes for their binding to the negatively charged inner membrane of mitochondria and to the PC/PG (9:1) liposomes. Rat liver mitochondria swelling induced by the antimicrobial polycationic peptide BTM-P1 (VAPIAKYLATALAKWALKQGFAKLKS) and by the retro-BTM-P1 was significantly diminished in the presence of 10 mu M fluorescent probe safranin O. In experiments with liposomes, the polycationic peptides BTM-P1 and P7-5 (IYLATALAKWALKQGF-GG-RRRRRRR) at the concentrations of 2-3 mu M completely displaced the membrane-bound fluorescent probe DiSC3(5) in a low ionic strength medium. The developed computational model allowed a mathematical description of such interactions, predicting membrane surface concentrations of bound peptides as the function of the membrane surface charge and lipid quantity in the sample, the peptide charge, hydrophobicity and concentration, the ionic strength of incubation medium and of the presence of a charged fluorescent probe used for monitoring the membrane surface potential under real-time peptide-membrane interactions. (C) 2014 Elsevier Inc. All rights reserved.
C1 Univ Nacl Colombia, Fac Ciencias, Escuela Fis, Medellin, Colombia.
RP Lemeshko, VV (reprint author), Univ Nacl Colombia, Fac Ciencias, Escuela Fis, Calle 59A 63-20, Medellin, Colombia.
EM vvasilie@unal.edu.co
FU Colciencias (Colombia) [111852128625, 5201-545-3156 (362-2011)];
   National University of Colombia, Medellin Branch
FX Financial support for this work was provided by the Colciencias
   (Colombia) research grants #111852128625 and #5201-545-3156 (362-2011)
   and by the National University of Colombia, Medellin Branch.
CR Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617
   Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1111/j.1574-6968.2002.tb11000.x
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   Melo MN, 2007, BBA-BIOMEMBRANES, V1768, P1277, DOI 10.1016/j.bbamem.2007.02.005
   Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2
   Iwasaki T, 2009, PEPTIDES, V30, P660, DOI 10.1016/j.peptides.2008.12.019
   Lazaridis T, 2005, PROTEINS, V58, P518, DOI 10.1002/prot.20358
   Lemeshko VV, 2013, BBA-BIOMEMBRANES, V1828, P1047, DOI 10.1016/j.bbamem.2012.12.012
   Xu C, 2003, BIOPHYS J, V84, P2768, DOI 10.1016/S0006-3495(03)75081-4
   Jiang ZQ, 2008, BIOPOLYMERS, V90, P369, DOI 10.1002/bip.20911
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001
   Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008
   Han X, 2004, BIOINFORMATICS, V20, P970, DOI 10.1093/bioinformatics/bth027
   CABRINI G, 1986, J MEMBRANE BIOL, V92, P171, DOI 10.1007/BF01870706
   Falla TJ, 1996, J BIOL CHEM, V271, P19298
   Rekdal O, 2012, J BIOL CHEM, V287, P233, DOI 10.1074/jbc.M111.279281
   Powers JPS, 2005, BIOCHEMISTRY-US, V44, P15504, DOI 10.1021/bi051302m
   Ferre R, 2009, BIOPHYS J, V96, P1815, DOI [10.1016/j.bpj.2008.11.053, 10.1016/j.bpj.2008.11053]
   CABRINI G, 1986, J MEMBRANE BIOL, V90, P163, DOI 10.1007/BF01869934
   Halevy R, 2003, PEPTIDES, V24, P1753, DOI 10.1016/j.peptides.2003.08.019
   Lemeshko VV, 2006, ARCH BIOCHEM BIOPHYS, V454, P114, DOI 10.1016/j.abb.2006.08.008
   Lemeshko VV, 2010, ARCH BIOCHEM BIOPHYS, V493, P213, DOI 10.1016/j.abb.2009.11.004
   Oren Z, 1998, BIOPOLYMERS, V47, P451
   Sanderson JM, 2005, ORG BIOMOL CHEM, V3, P201, DOI 10.1039/b415499a
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955
   CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103
   Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200
   Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004
   Arias M, 2009, BBA-BIOMEMBRANES, V1788, P532, DOI 10.1016/j.bbamem.2008.12.009
   Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001
   Chen LC, 2013, INT J MOL SCI, V14, P7932, DOI 10.3390/ijms14047932
   HAYNES DH, 1974, J MEMBRANE BIOL, V17, P341, DOI 10.1007/BF01870191
   Helmerhorst EJ, 1999, FEBS LETT, V449, P105, DOI 10.1016/S0014-5793(99)00411-1
   HUANG CH, 1971, J BIOL CHEM, V246, P2555
   IVKOVA MN, 1984, GEN PHYSIOL BIOPHYS, V3, P97
   IVKOVA MN, 1987, GEN PHYSIOL BIOPHYS, V6, P45
   Kang SJ, 2012, ARCH PHARM RES, V35, P791, DOI 10.1007/s12272-012-0505-0
   KRASNE S, 1980, BIOPHYS J, V30, P441
   Lemeshko VV, 2013, BIOSCIENCE REP, V33, P125, DOI 10.1042/BSR20120101
   Lemeshko VV, 2011, PEPTIDES, V32, P2010, DOI 10.1016/j.peptides.2011.08.023
   Lemeshko VV, 2005, J BIOL CHEM, V280, P15579, DOI 10.1074/jbc.M414064200
   Melo MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028549
   Melo MN, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00236
   Paredes-Gamero E.J., 1820, BIOCHIM BIOPHYS ACTA, V2012, P1062
   Perron G.G., 2006, P BIOL SCI, V271, P251
   Rodrigues M., 1818, BIOCHIM BIOPHYS ACTA, V2012, P2707
   Shental-Bechor D, 2007, BIOPHYS J, V93, P1858, DOI 10.1529/biophysj.106.103812
   Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060462
   Wieckowski MR, 1998, FEBS LETT, V423, P339, DOI 10.1016/S0014-5793(98)00118-5
NR 53
TC 4
Z9 4
U1 5
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 167
EP 178
DI 10.1016/j.abb.2014.01.024
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700021
PM 24500436
ER

PT J
AU Ryge, MR
   Tanabe, M
   Provost, P
   Persson, B
   Chen, XS
   Funk, CD
   Rinaldo-Matthis, A
   Hofmann, B
   Steinhilber, D
   Watanabe, T
   Samuelsson, B
   Radmark, O
AF Ryge, Marija Rakonjac
   Tanabe, Michiharu
   Provost, Patrick
   Persson, Bengt
   Chen, Xinsheng
   Funk, Colin D.
   Rinaldo-Matthis, Agnes
   Hofmann, Bettina
   Steinhilber, Dieter
   Watanabe, Takashi
   Samuelsson, Bengt
   Radmark, Olof
TI A mutation interfering with 5-lipoxygenase domain interaction leads to
   increased enzyme activity
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Leukotriene; Eicosanoid; Arachidonic acid; Two-hybrid system; Domain
   interaction
ID BETA-BARREL DOMAIN; COACTOSIN-LIKE PROTEIN; N-TERMINAL DOMAIN;
   MEMBRANE-BINDING; LEUKOTRIENE BIOSYNTHESIS; CATALYTIC-ACTIVITY;
   CRYSTAL-STRUCTURE; MOLECULAR-BASIS; C2-LIKE DOMAIN; 12-LIPOXYGENASE
AB 5-Lipoxygenase (5-LOX) catalyzes two steps in conversion of arachidonic acid to proinflammatory leukotrienes. Lipoxygenases, including human 5-LOX, consist of an N-terminal C2-like beta-sandwich and a catalytic domain. We expressed the 5-LOX domains separately, these were found to interact in the yeast two-hybrid system. The 5-LOX structure suggested association between Arg(101) in the beta-sandwich and Asp(166) in the catalytic domain, due to electrostatic interaction as well as hydrogen bonds. Indeed, mutagenic replacements of these residues led to loss of two-hybrid interaction. Interestingly, when Arg(101) was mutated to Asp in intact 5-LOX, enzyme activity was increased. Thus, higher initial velocity of the reaction (v(init)) and increased final amount of products were monitored for 5-LOX-R101D, at several different assay conditions. In the 5-LOX crystal structure, helix alpha 2 and adjacent loops (including Asp(166)) of the 5-LOX catalytic domain has been proposed to form a flexible lid controlling access to the active site, and lid movement would be determined by bonding of lid residues to the C2-like beta-sandwich. The more efficient catalysis following disruption of the R101-D166 ionic association supports the concept of such a flexible lid in human 5-LOX. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Ryge, Marija Rakonjac; Tanabe, Michiharu; Rinaldo-Matthis, Agnes; Samuelsson, Bengt; Radmark, Olof] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
   [Tanabe, Michiharu; Watanabe, Takashi] Tottori Univ, Fac Med, Inst Neurol Sci, Dept Neurosurg, Yonago, Tottori 6838504, Japan.
   [Provost, Patrick] CHUQ Res Ctr CHUL, Quebec City, PQ G1V 4G2, Canada.
   [Provost, Patrick] Univ Laval, Fac Med, Quebec City, PQ G1V 0A6, Canada.
   [Persson, Bengt] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, S-75124 Uppsala, Sweden.
   [Chen, Xinsheng; Funk, Colin D.] Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.
   [Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.
   [Hofmann, Bettina; Steinhilber, Dieter] Goethe Univ Frankfurt, Inst Pharmaceut Chem ZAFES, D-60438 Frankfurt, Germany.
RP Radmark, O (reprint author), Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
EM olof.radmark@ki.se
RI Fachbereich14, Dekanat/C-8553-2015; 
OI Persson, Bengt/0000-0003-3165-5344
FU Swedish Research Council [03X-217]; European Commission
   [LSHM-CT-2004-005033]; DFG [SFB 1039]; Natural Sciences and Engineering
   Research Council of Canada (NSERC) [262938-2013]; CIHR [MOP-68930];
   Canada Research Chair Award; Heart and Stroke Career Investigator Award
FX Supported by the Swedish Research Council (03X-217), European Commission
   FP6 (LSHM-CT-2004-005033), and DFG (SFB 1039). P.P. is supported by
   Natural Sciences and Engineering Research Council of Canada (NSERC)
   Discovery Grant 262938-2013. C.D.F. is supported by CIHR Grant MOP-68930
   and holds Canada Research Chair and Heart and Stroke Career Investigator
   Awards.
CR Allard JB, 2005, CURR PROTEIN PEPT SC, V6, P125, DOI 10.2174/1389203053545417
   Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106
   Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285
   Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104
   Walther M, 2011, ARCH BIOCHEM BIOPHYS, V516, P1, DOI 10.1016/j.abb.2011.09.004
   Hammel M, 2004, J MOL BIOL, V343, P917, DOI 10.1016/j.jmb.2004.08.076
   Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d
   Bair AM, 2012, MOL BIOL CELL, V23, P4456, DOI 10.1091/mbc.E12-06-0489
   HAMMARBERG T, 1995, EUR J BIOCHEM, V230, P401
   Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200
   Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052
   Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590
   Hafner AK, 2011, BIOL CHEM, V392, P1097, DOI [10.1515/BC.2011.200, 10.1515/BC-2011-200]
   Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173
   Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200
   Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003
   Pergola C, 2008, P NATL ACAD SCI USA, V105, P19881, DOI 10.1073/pnas.0809120105
   Walther M, 2002, J BIOL CHEM, V277, P27360, DOI 10.1074/jbc.M203234200
   Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203
   WATANABE T, 1993, EUR J BIOCHEM, V212, P605, DOI 10.1111/j.1432-1033.1993.tb17699.x
   Rakonjac M, 2006, P NATL ACAD SCI USA, V103, P13150, DOI 10.1073/pnas.0605150103
   Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809
   Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u
   James P, 1996, GENETICS, V144, P1425
   Pietra F, 2012, CHEM BIODIVERS, V9, P1019, DOI 10.1002/cbdv.201100305
   Zhang YY, 2000, BIOCHEM J, V351, P697, DOI 10.1042/0264-6021:3510697
   Buerkert Eva, 2003, Journal of Biological Chemistry, V278, P42846
   Chen XS, 2001, J BIOL CHEM, V276, P811
   CHEN XS, 1993, EUR J BIOCHEM, V214, P845, DOI 10.1111/j.1432-1033.1993.tb17988.x
   Esser J., 2009, BIOCHEM J, V425, P265
   Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200
   Ivanov I, 2011, BBA-MOL CELL BIOL L, V1811, P1001, DOI 10.1016/j.bbalip.2011.08.008
   IZUMI T, 1990, P NATL ACAD SCI USA, V87, P7477, DOI 10.1073/pnas.87.19.7477
   Luo M, 2005, J BIOL CHEM, V280, P40609, DOI 10.1074/jbc.M507045200
   Palmieri-Thiers C, 2011, ARCH BIOCHEM BIOPHYS, V509, P82, DOI 10.1016/j.abb.2011.02.008
   Provost P, 2001, J BIOL CHEM, V276, P16520, DOI 10.1074/jbc.M011205200
   Provost P, 1999, P NATL ACAD SCI USA, V96, P1881, DOI 10.1073/pnas.96.5.1881
   Reddy KV, 2000, BIOCHEMISTRY-US, V39, P1840, DOI 10.1021/bi9919246
   SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011
   Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018
NR 40
TC 3
Z9 4
U1 3
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAR 1
PY 2014
VL 545
BP 179
EP 185
DI 10.1016/j.abb.2014.01.017
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AC7ZB
UT WOS:000332751700022
ER

PT J
AU Gadda, G
AF Gadda, Giovanni
TI Cofactor assisted enzymatic catalysis
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Editorial Material
C1 Georgia State Univ, Ctr Nat Sci, Dept Chem, Atlanta, GA 30302 USA.
RP Gadda, G (reprint author), Georgia State Univ, Ctr Nat Sci, Dept Chem, Room 549,POB 4098, Atlanta, GA 30302 USA.
EM ggadda@gsu.edu
NR 0
TC 0
Z9 0
U1 3
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 2014
VL 544
SI SI
BP 1
EP 1
DI 10.1016/j.abb.2014.01.012
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AB9UM
UT WOS:000332141200001
PM 24491815
ER

PT J
AU Huijbers, MME
   Montersino, S
   Westphal, AH
   Tischler, D
   van Berkel, WJH
AF Huijbers, Mieke M. E.
   Montersino, Stefania
   Westphal, Adrie H.
   Tischler, Dirk
   van Berkel, Willem J. H.
TI Flavin dependent monooxygenases
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Biocatalysis; Enzyme classification; Flavin; Monooxygenase; Natural
   products; Oxidoreductase
ID FLAVOPROTEIN TRYPTOPHAN 2-MONOOXYGENASE; BAEYER-VILLIGER MONOOXYGENASES;
   SITE-DIRECTED MUTAGENESIS; P-HYDROXYPHENYLACETATE 3-HYDROXYLASE;
   PARA-HYDROXYBENZOATE HYDROXYLASE; SPHINGOBIUM-XENOPHAGUM BAYRAM;
   L-PHENYLALANINE OXIDASE; L-LACTATE MONOOXYGENASE; RHODOCOCCUS-OPACUS
   1CP; RAT SQUALENE EPOXIDASE
AB Flavin-dependent monooxygenases catalyze a wide variety of chemo-, regio- and enantioselective oxygenation reactions. As such, they are involved in key biological processes ranging from catabolism, detoxification and biosynthesis, to light emission and axon guidance. Based on fold and function, flavin-dependent monooxygenases can be distributed into eight groups. Groups A and B comprise enzymes that rely on NAD(P)H as external electron donor. Groups C-F are two-protein systems, composed of a monooxygenase and a flavin reductase. Groups G and H comprise internal monooxygenases that reduce the flavin cofactor through substrate oxidation. Recently, many new flavin-dependent monooxygenases have been discovered. In addition to posing basic enzymological questions, these proteins attract attention of pharmaceutical and fine-chemical industries, given their importance as regio- and enantioselective biocatalysts. In this review we present an update of the classification of flavin-dependent monooxygenases and summarize the latest advances in our understanding of their catalytic and structural properties. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Huijbers, Mieke M. E.; Montersino, Stefania; Westphal, Adrie H.; Tischler, Dirk; van Berkel, Willem J. H.] Wageningen Univ, Lab Biochem, NL-6703 HA Wageningen, Netherlands.
   [Tischler, Dirk] TU Bergakad Freiberg, Interdisciplinary Ecol Ctr, D-09599 Freiberg, Germany.
RP van Berkel, WJH (reprint author), Wageningen Univ, Lab Biochem, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.
EM willem.vanberkel@wur.nl
RI van Berkel, Willem/O-2431-2014; Tischler, Dirk/H-9431-2013
OI van Berkel, Willem/0000-0002-6551-2782; Tischler,
   Dirk/0000-0002-6288-2403
FU Netherlands Organization for Scientific Research (NWO) through ERA-IB
   and IBOS programs; European Social Fund; Saxonian Government [GETGEOWEB:
   100101363]
FX M.H. and S.M. received financial support from the Netherlands
   Organization for Scientific Research (NWO) through the ERA-IB and IBOS
   programs. D.T. received Grants from the European Social Fund and the
   Saxonian Government (GETGEOWEB: 100101363).
CR Ames BD, 2011, BIOCHEMISTRY-US, V50, P8756, DOI 10.1021/bi201302w
   Mohanty SK, 2012, J BACTERIOL, V194, P3872, DOI 10.1128/JB.00597-12
   Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836
   Sobrado P, 2003, BIOCHEMISTRY-US, V42, P13826, DOI 10.1021/bi035299n
   Tongsook C, 2011, J BIOL CHEM, V286, P44491, DOI 10.1074/jbc.M111.284463
   Amaral M, 2013, NATURE, V496, P382, DOI 10.1038/nature12039
   Sun WM, 1996, J BIOL CHEM, V271, P17226
   Vanoni MA, 2013, INT J MOL SCI, V14, P6920, DOI 10.3390/ijms14046920
   Chen YH, 2005, J BIOL CHEM, V280, P22508, DOI 10.1074/jbc.M414229200
   Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101
   Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d
   McDonald AG, 2014, FEBS J, V281, P583, DOI 10.1111/febs.12530
   Kantz A, 2005, ARCH BIOCHEM BIOPHYS, V442, P102, DOI 10.1016/j.abb.2005.07.020
   Dai XH, 2013, J BIOL CHEM, V288, P1448, DOI 10.1074/jbc.M112.424077
   Haynes SW, 2012, J AM CHEM SOC, V134, P17444, DOI 10.1021/ja308371z
   Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028
   van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044
   Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005
   Patrikainen P, 2012, CHEM BIOL, V19, P647, DOI 10.1016/j.chembiol.2012.04.010
   Furuichi M, 2008, J MOL BIOL, V378, P436, DOI 10.1016/j.jmb.2008.02.062
   Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257
   Phongsak T, 2012, J BIOL CHEM, V287, P26213, DOI 10.1074/jbc.M112.354472
   Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104
   Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007
   Shirey C, 2013, J BIOL CHEM, V288, P32440, DOI 10.1074/jbc.M113.487181
   Sucharitakul J, 2012, BIOCHEMISTRY-US, V51, P4309, DOI 10.1021/bi201823c
   Montersino S, 2011, ADV SYNTH CATAL, V353, P2301, DOI 10.1002/adsc.201100384
   Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u
   Kolvenbach B, 2007, APPL ENVIRON MICROB, V73, P4776, DOI 10.1128/AEM.00329-07
   Tischler D, 2009, J BACTERIOL, V191, P4996, DOI 10.1128/JB.00307-09
   Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200
   Walsh CT, 2012, NAT PROD REP, V29, P37, DOI 10.1039/c1np00072a
   Leisch H, 2011, CHEM REV, V111, P4165, DOI 10.1021/cr1003437
   YAMAMOTO S, 1965, J BIOL CHEM, V240, P3408
   Ralph EC, 2006, BIOCHEMISTRY-US, V45, P15844, DOI 10.1021/bi061894o
   Ukaegbu UE, 2010, BIOCHEMISTRY-US, V49, P1678, DOI 10.1021/bi901693u
   Teufel R, 2013, NATURE, V503, P552, DOI 10.1038/nature12643
   Hiromoto T, 2006, J MOL BIOL, V364, P878, DOI 10.1016/j.jmb.2006.09.031
   Takeo M, 2012, MICROBIOL-SGM, V158, P1796, DOI 10.1099/mic.0.055335-0
   Balke K, 2012, ORG BIOMOL CHEM, V10, P6249, DOI 10.1039/c2ob25704a
   Olucha J, 2011, BIOORG CHEM, V39, P171, DOI 10.1016/j.bioorg.2011.07.006
   Sucharitakul J, 2013, J BIOL CHEM, V288, P35210, DOI 10.1074/jbc.M113.515205
   Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021
   Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021
   Zucchini D, 2011, ARCH BIOCHEM BIOPHYS, V515, P1, DOI 10.1016/j.abb.2011.08.004
   Blasiak LC, 2009, ACCOUNTS CHEM RES, V42, P147, DOI 10.1021/ar800088r
   Giessen TW, 2011, BIOCHEMISTRY-US, V50, P5680, DOI 10.1021/bi2006114
   Kallio P, 2011, BIOCHEMISTRY-US, V50, P5535, DOI 10.1021/bi200600k
   Eppink MHM, 1997, PROTEIN SCI, V6, P2454
   Greenhagen BT, 2008, BIOCHEMISTRY-US, V47, P5281, DOI 10.1021/bi702480t
   BUCH K, 1995, FEBS LETT, V376, P45, DOI 10.1016/0014-5793(95)01243-9
   Montersino S, 2012, BBA-PROTEINS PROTEOM, V1824, P433, DOI 10.1016/j.bbapap.2011.12.003
   Howard-Jones AR, 2006, J AM CHEM SOC, V128, P12289, DOI 10.1021/ja063898m
   Baunach M, 2013, ANGEW CHEM INT EDIT, V52, P9040, DOI 10.1002/anie.201303733
   Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510
   Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213
   MAEDAYORITA K, 1995, BIOCHIMIE, V77, P631, DOI 10.1016/0300-9084(96)88178-8
   Fitzpatrick PF, 2010, ARCH BIOCHEM BIOPHYS, V493, P13, DOI 10.1016/j.abb.2009.07.019
   Ryan KS, 2007, P NATL ACAD SCI USA, V104, P15311, DOI 10.1073/pnas.0707190104
   Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087
   Kharel MK, 2007, J AM CHEM SOC, V129, P3780, DOI 10.1021/ja0681515
   Li SJ, 2007, BIOCHEM BIOPH RES CO, V358, P1002, DOI 10.1016/j.bbrc.2007.05.021
   ENTSCH B, 1995, FASEB J, V9, P476
   Baron R, 2009, P NATL ACAD SCI USA, V106, P10603, DOI 10.1073/pnas.0903809106
   Jimenez JI, 2008, P NATL ACAD SCI USA, V105, P11329, DOI 10.1073/pnas.0802273105
   Lindqvist Y, 2009, J MOL BIOL, V393, P966, DOI 10.1016/j.jmb.2009.09.003
   Gaweska HM, 2013, BIOCHEMISTRY-US, V52, P2620, DOI 10.1021/bi4001563
   Tischler D, 2012, APPL BIOCHEM BIOTECH, V167, P931, DOI 10.1007/s12010-012-9659-y
   Siebold C, 2005, P NATL ACAD SCI USA, V102, P16836, DOI 10.1073/pnas.0504997102
   Kharel MK, 2012, CURR OPIN CHEM BIOL, V16, P150, DOI 10.1016/j.cbpa.2012.03.007
   Gabriel FLP, 2007, APPL ENVIRON MICROB, V73, P3320, DOI 10.1128/AEM.02994-06
   Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724
   Tang HZ, 2011, J BIOL CHEM, V286, P39179, DOI 10.1074/jbc.M111.283929
   Bouvier F, 1996, J BIOL CHEM, V271, P28861
   Montersino S, 2013, J BIOL CHEM, V288, P26235, DOI 10.1074/jbc.M113.479303
   Riebel A, 2012, APPL MICROBIOL BIOT, V95, P1479, DOI 10.1007/s00253-011-3823-0
   Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x
   Pazmino DET, 2010, CURR OPIN CHEM BIOL, V14, P138, DOI 10.1016/j.cbpa.2009.11.017
   Chehade MH, 2013, J BIOL CHEM, V288, P20085, DOI 10.1074/jbc.M113.480368
   Hung RJ, 2011, CYTOSKELETON, V68, P415, DOI 10.1002/cm.20527
   SAKAKIBARA J, 1995, J BIOL CHEM, V270, P17
   MASSEY V, 1994, J BIOL CHEM, V269, P22459
   Abe I, 2007, BIOCHEM BIOPH RES CO, V352, P259, DOI 10.1016/j.bbrc.2006.11.014
   Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956
   ENTSCH B, 1976, J BIOL CHEM, V251, P2550
   Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004
   Volkers G, 2011, FEBS LETT, V585, P1061, DOI 10.1016/j.febslet.2011.03.012
   Tischler D, 2010, J BACTERIOL, V192, P5220, DOI 10.1128/JB.00723-10
   Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007
   Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614
   Asamizu S, 2011, BIOSCI BIOTECH BIOCH, V75, P2184, DOI 10.1271/bbb.110474
   Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z
   Ballou D.P., 2013, HDB FLAVOPROTEINS, VII, P1
   Bosserman MA, 2013, ACS CHEM BIOL, V8, P2466, DOI 10.1021/cb400399b
   Chen YH, 2010, CHEMBIOCHEM, V11, P1055, DOI 10.1002/cbic.201000178
   Francis K, 2013, IUBMB LIFE, V65, P759, DOI 10.1002/iub.1195
   Gadda G, 2010, ARCH BIOCHEM BIOPHYS, V493, P53, DOI 10.1016/j.abb.2009.06.018
   Gao X, 2011, J AM CHEM SOC, V133, P2729, DOI 10.1021/ja1101085
   Goldman PJ, 2012, CHEM BIOL, V19, P855, DOI 10.1016/j.chembiol.2012.05.016
   Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200
   Hicks KA, 2013, BIOCHEMISTRY-US, V52, P477, DOI 10.1021/bi301262p
   Ida K, 2011, J BIOCHEM, V150, P659, DOI 10.1093/jb/mvr103
   Ida K, 2008, J BIOL CHEM, V283, P16584, DOI 10.1074/jbc.M800366200
   Kallio P, 2013, BIOCHEMISTRY-US, V52, P4507, DOI 10.1021/bi400381s
   Kantz A, 2011, BIOCHEMISTRY-US, V50, P523, DOI 10.1021/bi101328r
   Katsuyama Y, 2012, ANGEW CHEM INT EDIT, V51, P9437, DOI 10.1002/anie.201204138
   Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027
   Lin H, 2012, J BIOTECHNOL, V161, P235, DOI 10.1016/j.jbiotec.2012.06.028
   Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001
   McDonald CA, 2013, BIOCHEMISTRY-US, V52, P6076, DOI 10.1021/bi4008462
   Montersino S., 2013, HDB FLAVOPROTEINS, VII, P51
   Morrison E, 2013, BIOCHEMISTRY-US, V52, P6063, DOI 10.1021/bi400763h
   MUH U, 1994, J BIOL CHEM, V269, P7989
   Nadella M, 2005, P NATL ACAD SCI USA, V102, P16830, DOI 10.1073/pnas.0504838102
   Nakano H, 1999, EUR J BIOCHEM, V260, P120, DOI 10.1046/j.1432-1327.1999.00124.x
   Porter AW, 2012, APPL MICROBIOL BIOT, V94, P261, DOI 10.1007/s00253-011-3621-8
   Robbins J.M., 2013, HDB FLAVOPROTEINS, VII, P255
   Robinson R.M., 2013, HDB FLAVOPROTEINS, VII, P29
   Rui Z, 2013, CHEM BIOL, V20, P879, DOI 10.1016/j.chembiol.2013.05.006
   Smitherman C, 2013, BIOCHEMISTRY-US, V52, P2694, DOI 10.1021/bi400030d
   Sobrado P, 2003, BIOCHEMISTRY-US, V42, P13833, DOI 10.1021/bi035300i
   SUTTON WB, 1957, J BIOL CHEM, V226, P395
   Tinikul R, 2013, BIOCHEMISTRY-US, V52, P6834, DOI 10.1021/bi4006545
   Tischler D, 2013, FEBS LETT, V587, P3848, DOI 10.1016/j.febslet.2013.10.013
   Tu S.C., 2013, HDB FLAVOPROTEINS, VI, P101
   Vervoort J., 2013, BIOCHEMISTRY-US, V52, P6834
   Walkiewicz K, 2011, PROTEINS, V79, P2335, DOI 10.1002/prot.23052
   Xiao Y, 2012, J BACTERIOL, V194, P1342, DOI 10.1128/JB.06411-11
NR 128
TC 34
Z9 34
U1 12
U2 91
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 2014
VL 544
SI SI
BP 2
EP 17
DI 10.1016/j.abb.2013.12.005
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AB9UM
UT WOS:000332141200002
PM 24361254
ER

PT J
AU Geng, JF
   Liu, AM
AF Geng, Jiafeng
   Liu, Aimin
TI Heme-dependent dioxygenases in tryptophan oxidation
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Metalloprotein; Oxygen activation; Peroxide reaction; Reactive oxygen
   species; High-valence iron; Free radical
ID HUMAN INDOLEAMINE 2,3-DIOXYGENASE; CHLOROPEROXIDASE COMPOUND-II;
   DENSITY-FUNCTIONAL THEORY; SUPEROXIDE ANION; KYNURENINE PATHWAY;
   REACTION-MECHANISM; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; CATALYTIC
   MECHANISM; FERRYL PROTONATION
AB L-Tryptophan is an essential amino acid for mammals. It is utilized not only for protein synthesis but also for the biosynthesis of serotonin and melatonin by the serotonin pathway as well as nicotinamide adenine dinucleotide by the kynurenine pathway. Although the kynurenine pathway is responsible for the catabolism of over 90% of L-tryptophan in the mammalian intracellular and extracellular pools, the scientific field was dominated in the last century by studies of the serotonin pathway, due to the physiological significance of the latter's catabolic intermediates and products. However, in the past decade, the focus gradually reversed as the link between the kynurenine pathway and various neurodegenerative disorders and immune diseases is increasingly highlighted. Notably, the first step of this pathway, which is catalyzed by heme-dependent dioxygenases, has been proven to be a potential target for immune regulation and cancer treatment. A thorough understanding of the intriguing chemistry of the heme-dependent dioxygenases may yield insight for the drug discovery of these prevalent illnesses. In this review, we survey enzymatic and mechanistic studies, initially started by Kotake and Masayama over 70 years ago, at the molecular level on the heme-dependent tryptophan dioxygenation reactions. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Geng, Jiafeng; Liu, Aimin] Georgia State Univ, Dept Chem, Atlanta, GA 30302 USA.
RP Liu, AM (reprint author), Georgia State Univ, Dept Chem, POB 3965,50 Decatur St SE, Atlanta, GA 30302 USA.
EM Feradical@gsu.edu
RI Geng, Jiafeng/G-4948-2015
OI Geng, Jiafeng/0000-0001-9488-0974
FU NSF [MCB-0843537]; Molecular Basis of Disease program of Georgia State
   University
FX This work was supported by NSF Grant MCB-0843537 (A.L.). J.G.
   acknowledges fellowship support from the Molecular Basis of Disease
   program of Georgia State University.
CR Capece L, 2010, PROTEINS, V78, P2961, DOI 10.1002/prot.22819
   KNOX WE, 1950, J BIOL CHEM, V187, P419
   Guillemin GJ, 2002, REDOX REP, V7, P199, DOI 10.1179/135100002125000550
   Zhang Y, 2007, BIOCHEMISTRY-US, V46, P145, DOI 10.1021/bi0620095
   Capece L, 2010, J BIOL INORG CHEM, V15, P811, DOI 10.1007/s00775-010-0646-x
   Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500
   Paglino A, 2008, INSECT BIOCHEM MOLEC, V38, P871, DOI 10.1016/j.ibmb.2008.05.011
   King NJC, 2007, INT J BIOCHEM CELL B, V39, P2167, DOI 10.1016/j.biocel.2007.01.004
   Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143
   Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569
   Stone KL, 2006, J AM CHEM SOC, V128, P6147, DOI 10.1021/ja057876w
   SHIMIZU T, 1978, J BIOL CHEM, V253, P4700
   Dolusic E, 2011, J MED CHEM, V54, P5320, DOI 10.1021/jm2006782
   Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3
   Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x
   YAMAMOTO S, 1967, J BIOL CHEM, V242, P5260
   Lu CY, 2009, J AM CHEM SOC, V131, P12866, DOI 10.1021/ja9029768
   Muller AJ, 2007, CURR CANCER DRUG TAR, V7, P31, DOI 10.2174/156800907780006896
   Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178
   Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011
   Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639
   Basran J, 2011, J AM CHEM SOC, V133, P16251, DOI 10.1021/ja207066z
   Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104
   Denisov IG, 2007, J BIOL CHEM, V282, P26865, DOI 10.1074/jbc.M704747200
   Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870
   Gouet P, 1996, NAT STRUCT BIOL, V3, P951, DOI 10.1038/nsb1196-951
   Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897
   TAYLOR MW, 1991, FASEB J, V5, P2516
   Kuo HH, 2012, P NATL ACAD SCI USA, V109, P13966, DOI 10.1073/pnas.1207191109
   Ronsein GE, 2008, CHEM RES TOXICOL, V21, P1271, DOI 10.1021/tx800026g
   van der Donk WA, 2010, CURR OPIN STRUC BIOL, V20, P673, DOI 10.1016/j.sbi.2010.08.005
   Thackray SJ, 2008, BIOCHEM SOC T, V36, P1120, DOI 10.1042/BST0361120
   Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457
   Davydov RM, 2010, J AM CHEM SOC, V132, P5494, DOI 10.1021/ja100518z
   Zhu XF, 2010, J BIOL CHEM, V285, P21126, DOI 10.1074/jbc.M110.120485
   Abu-Omar MM, 2005, CHEM REV, V105, P2227, DOI 10.1021/cr040653o
   Chauhan N, 2012, FEBS J, V279, P4501, DOI 10.1111/febs.12036
   SONO M, 1980, J BIOL CHEM, V255, P1339
   Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019
   Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103
   Huang W, 2013, J STRUCT BIOL, V181, P291, DOI 10.1016/j.jsb.2013.01.002
   Lu CY, 2011, J BIOL CHEM, V286, P21220, DOI 10.1074/jbc.M111.221507
   KOBAYASHI K, 1989, J BIOL CHEM, V264, P15280
   Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923
   Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478
   Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524
   Fu R, 2011, J BIOL CHEM, V286, P26541, DOI 10.1074/jbc.M111.253237
   De Marinis E, 2009, IUBMB LIFE, V61, P62, DOI 10.1002/iub.149
   Batabyal D, 2009, J AM CHEM SOC, V131, P3260, DOI 10.1021/ja807969a
   Batabyal D, 2007, J AM CHEM SOC, V129, P15690, DOI 10.1021/ja076186k
   Behan RK, 2006, J AM CHEM SOC, V128, P11471, DOI 10.1021/ja062428p
   BRADY FO, 1971, J BIOL CHEM, V246, P7119
   Burner U, 2000, J BIOL CHEM, V275, P20597, DOI 10.1074/jbc.M000181200
   Capece L, 2011, BIOCHEMISTRY-US, V50, P10910, DOI 10.1021/bi201439m
   Capece L, 2012, J PHYS CHEM B, V116, P1401, DOI 10.1021/jp2082825
   Chauhan N, 2009, J AM CHEM SOC, V131, P4186, DOI 10.1021/ja808326g
   Chauhan N, 2008, BIOCHEMISTRY-US, V47, P4761, DOI 10.1021/bi702405a
   Chung LW, 2010, J AM CHEM SOC, V132, P11993, DOI 10.1021/ja103530v
   Chung LW, 2008, J AM CHEM SOC, V130, P12299, DOI 10.1021/ja803107w
   Colabroy KL, 2005, J BACTERIOL, V187, P7866, DOI 10.1128/JB.187.22.7866-7869.2005
   DALEYYATES PT, 1988, TOXICOL APPL PHARM, V96, P222, DOI 10.1016/0041-008X(88)90082-8
   DEISSERO.A, 1970, PHYSIOL REV, V50, P319
   Efimov I, 2012, J AM CHEM SOC, V134, P3034, DOI 10.1021/ja208694g
   Efimov I, 2011, BIOCHEMISTRY-US, V50, P2717, DOI 10.1021/bi101732n
   Ferry G, 2005, BIOCHEM J, V388, P205, DOI 10.1042/BJ20042075
   Freewan M, 2013, J BIOL CHEM, V288, P1548, DOI 10.1074/jbc.M112.410993
   Fukumura E, 2009, J BIOCHEM, V145, P505, DOI 10.1093/jb/mvp002
   Geng Jiafeng, 2012, J Am Chem Soc, V134, P12209, DOI 10.1021/ja304164b
   Guillemin GJ, 2005, NEURODEGENER DIS, V2, P166, DOI 10.1159/000089622
   HAMILTON GA, 1969, ADV ENZYMOL RAMB, V32, P55
   HAYAISHI O, 1993, PROTEIN SCI, V2, P472
   HAYAISHI O, 1957, J BIOL CHEM, V229, P889
   Hayaishi O, 1976, J BIOCHEM-TOKYO, V79, P13
   HIGUCHI K, 1967, ARCH BIOCHEM BIOPHYS, V120, P397, DOI 10.1016/0003-9861(67)90256-1
   HIRATA F, 1972, BIOCHEM BIOPH RES CO, V47, P1112, DOI 10.1016/0006-291X(72)90949-7
   HIRATA F, 1977, J BIOL CHEM, V252, P4637
   Horner O, 2007, J BIOL INORG CHEM, V12, P509, DOI 10.1007/s00775-006-0203-9
   ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593
   Knox W.E., 1970, METHODS ENZYMOL A, V17, P415
   Kotake Y, 1936, H-S Z PHYSIOL CHEM, V243, P237, DOI 10.1515/bchm2.1936.243.6.237
   Lai WZ, 2011, J AM CHEM SOC, V133, P5444, DOI 10.1021/ja111376n
   LEEDS JM, 1993, J BIOL CHEM, V268, P17781
   Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106
   Li JS, 2007, ARCH INSECT BIOCHEM, V64, P74, DOI 10.1002/arch.20159
   Lu CY, 2010, BIOCHEMISTRY-US, V49, P5028, DOI 10.1021/bi1005078
   Maghzal GJ, 2008, J BIOL CHEM, V283, P12014, DOI 10.1074/jbc.M710266200
   Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5
   Mellor AL, 2001, SEMIN IMMUNOL, V13, P213, DOI 10.1006/smim.2000.0317
   Millett ES, 2012, CURR OPIN CHEM BIOL, V16, P60, DOI 10.1016/j.cbpa.2012.01.014
   OZAKI Y, 1987, ARCH BIOCHEM BIOPHYS, V257, P207, DOI 10.1016/0003-9861(87)90560-1
   Poljak A, 2006, ARCH BIOCHEM BIOPHYS, V450, P9, DOI 10.1016/j.abb.2006.03.003
   Ronsein GE, 2009, J AM SOC MASS SPECTR, V20, P188, DOI 10.1016/j.jasms.2008.08.016
   Rosell FI, 2011, J BIOL CHEM, V286, P29273, DOI 10.1074/jbc.M111.262139
   Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006
   Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032
   TAKIKAWA O, 1983, J BIOL CHEM, V258, P6808
   TANAKA T, 1959, J BIOL CHEM, V234, P1162
   TANIGUCHI T, 1977, J BIOL CHEM, V252, P2774
   TANIGUCHI T, 1979, J BIOL CHEM, V254, P3288
   Terentis AC, 2002, J BIOL CHEM, V277, P15788, DOI 10.1074/jbc.M200457200
   Thackray SJ, 2008, BIOCHEMISTRY-US, V47, P10677, DOI 10.1021/bi801202a
   Vottero E, 2006, FEBS LETT, V580, P2265, DOI 10.1016/j.febslet.2006.03.034
   YAGIL G, 1967, TETRAHEDRON, V23, P2855, DOI 10.1016/0040-4020(67)85151-2
   Yanagisawa S, 2010, CHEM LETT, V39, P36, DOI 10.1246/cl.2010.36
   Yanagisawa S, 2011, FARADAY DISCUSS, V148, P239, DOI 10.1039/c004552g
NR 105
TC 2
Z9 2
U1 6
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 15
PY 2014
VL 544
SI SI
BP 18
EP 26
DI 10.1016/j.abb.2013.11.009
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AB9UM
UT WOS:000332141200003
PM 24295960
ER

EF